FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Bayat, A
   Krett, B
   Duno, M
   Torring, PM
   Vissing, J
AF Bayat, Allan
   Krett, Bjorg
   Duno, Morten
   Torring, Pernille Mathiesen
   Vissing, John
TI Novel truncating variants in <i>FGD1</i> detected in two Danish families
   with Aarskog-Scott syndrome and myopathic features
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE Aarskog-Scott syndrome; adulthood; developmental disorder; FGD1;
   mitochondrial myopathy
ID MISSENSE MUTATION; GENE
AB Aarskog-Scott syndrome (AAS) is a developmental disorder, caused by disease-causing hemizygous variants in the FGD1 gene. AAS is characterized by dysmorphic features, genital malformation, skeletal anomalies, and in some cases, intellectual disability and behavioral difficulties. Myopathy has only been reported once in two affected siblings diagnosed with AAS. Only few adult cases have been reported. This article reports four adults with AAS (three male cases and one female carrier) from two unrelated Danish families, all males presented with variable features suggestive of myopathy. All four carried novel hemizygous pathogenic variants in the FGD1 gene; one family presented with the c.2266dup, p.Cys756Leufs*19 variant while the c.527dup; p.Leu177Thrfs*40 variant was detected in the second family. All males had some mild myopathic symptoms or histological abnormalities. Case 1 had the most severe myopathic phenotype with prominent proximal muscular fatigue and exercise intolerance. In addition, he had multiple deletions of mtDNA and low respiratory chain activity. His younger nephew, case 3, had difficulties doing sports in his youth and had a mildly abnormal muscle biopsy and relatively decreased mitochondrial enzyme activity. The singular case from family 2 (case 4), had a mildly myopathic muscle biopsy, but no overt myopathic symptoms. Our findings suggest that myopathic involvement should be considered in AAS.
C1 [Bayat, Allan] Danish Epilepsy Ctr, Dept Epilepsy Genet & Personalized Med, Dianalund, Denmark.
   [Bayat, Allan] Univ Southern Denmark, Inst Reg Hlth Serv, Odense, Denmark.
   [Krett, Bjorg; Vissing, John] Univ Copenhagen, Rigshosp, Copenhagen Neuromuscular Ctr, Dept Neurol, Copenhagen, Denmark.
   [Duno, Morten] Univ Hosp Copenhagen, Dept Clin Genet, Mol Genet Lab, Copenhagen, Denmark.
   [Torring, Pernille Mathiesen] Odense Univ Hosp, Dept Clin Genet, Odense, Denmark.
C3 University of Southern Denmark; University of Copenhagen;
   Rigshospitalet; University of Copenhagen; University of Southern
   Denmark; Odense University Hospital
RP Bayat, A (corresponding author), Danish Epilepsy Ctr, Dept Epilepsy Genet & Personalized Med, Dianalund, Denmark.
EM abaya@filadelfia.dk
RI Bayat, Allan/JGM-4122-2023; Vissing, John/IUN-4271-2023
OI Bayat, Allan/0000-0003-4986-8006
CR Al-Semari A, 2013, CLIN DYSMORPHOL, V22, P13, DOI 10.1097/MCD.0b013e32835b6dc4
   Altincik A, 2013, J PEDIATR ENDOCR MET, V26, P385, DOI 10.1515/jpem-2012-0233
   Aten E, 2013, HUM MUTAT, V34, P430, DOI 10.1002/humu.22252
   Bae GY, 2020, ANN CLIN LAB SCI, V50, P691
   Bedoyan JK, 2009, EUR J MED GENET, V52, P262, DOI 10.1016/j.ejmg.2008.12.001
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bottani A, 2007, AM J MED GENET A, V143A, P2334, DOI 10.1002/ajmg.a.31733
   Ge YH, 2017, EXP THER MED, V13, P2623, DOI 10.3892/etm.2017.4301
   Janssen MCH, 2013, EUR J HUM GENET, V21, P807, DOI 10.1038/ejhg.2012.256
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7
   Landrum MJ, 2018, HUM MUTAT, V39, P1623, DOI 10.1002/humu.23641
   Lebel RR, 2002, CLIN GENET, V61, P139, DOI 10.1034/j.1399-0004.2002.610209.x
   Orrico A, 2007, AM J MED GENET A, V143A, P58, DOI 10.1002/ajmg.a.31562
   Orrico A, 2004, EUR J HUM GENET, V12, P16, DOI 10.1038/sj.ejhg.5201081
   Orrico A, 2010, AM J MED GENET A, V152A, P313, DOI 10.1002/ajmg.a.33199
   Orrico A, 2015, EUR J HUM GENET, V23, DOI 10.1038/ejhg.2014.178
   PASTERIS NG, 1994, CELL, V79, P669
   Pilozzi-Edmonds L, 2011, AM J MED GENET A, V155A, P1987, DOI 10.1002/ajmg.a.34094
   Ronce N, 2012, CLIN GENET, V82, P93, DOI 10.1111/j.1399-0004.2011.01782.x
   Schwartz CE, 2000, EUR J HUM GENET, V8, P869, DOI 10.1038/sj.ejhg.5200553
   TEEBI AS, 1993, AM J MED GENET, V46, P501, DOI 10.1002/ajmg.1320460508
   Verhoeven WMA, 2012, GENET COUNSEL, V23, P157
   Whitehead IP, 1998, MOL CELL BIOL, V18, P4689, DOI 10.1128/MCB.18.8.4689
   Drumond VZ, 2021, GENET RES, V2021, DOI 10.1155/2021/6652957
NR 24
TC 2
Z9 3
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD JUL
PY 2022
VL 188
IS 7
BP 2251
EP 2257
DI 10.1002/ajmg.a.62753
EA APR 2022
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 2B3NI
UT WOS:000779438700001
PM 35388608
OA Green Published
DA 2024-11-01
ER

PT J
AU Bakis, H
   Trimouille, A
   Vermorel, A
   Redonnet, I
   Goizet, C
   Boulestreau, R
   Laconnbe, D
   Connbe, C
   Martin-Négrier, ML
   Rigothier, C
AF Bakis, Hugo
   Trimouille, Aurelien
   Vermorel, Agathe
   Redonnet, Isabelle
   Goizet, Cyril
   Boulestreau, Romain
   Laconnbe, Didier
   Connbe, Christian
   Martin-Negrier, Marie-Laure
   Rigothier, Claire
TI Adult onset tubulo-interstitial nephropathy in MT-ND5-related phenotypes
SO CLINICAL GENETICS
LA English
DT Article
DE adult; complex I; mitochondrial disorder; MT-ND5; tubulo-interstitial
   nephropathy
ID MITOCHONDRIAL-DNA; LEIGH-SYNDROME; G13513A MUTATION; FREQUENT CAUSE;
   DYSFUNCTION; MELAS; GENE; ND5
AB Kidney is a highly adenosine triphosphate dependent organ in human body. Healthy and functional mitochondria are essential for normal kidney function. Clinical and genetic variability are the hallmarks of mitochondrial disorders. We report here the involvement of two MT-ND5 pathogenic variants encoding for ND5 subunit of respiratory chain complex I, the m.13513G>A and the m.13514A>G, in adult-onset kidney disease in three unrelated patients. The first patient had myopathy encephalopathy lactic acidosis and stroke syndrome, left ventricular hypertrophy with Wolff-Parkinson-White syndrome and tubulo-interstitial kidney disease. The second presented Leber hereditary optic neuropathy associated with tubulo-interstitial kidney disease. The third presented with an isolated chronic tubulo-interstitial kidney disease. These mutations have never been associated with adulthood mitochondrial nephropathy. These case reports highlight the importance to consider mitochondrial dysfunction in tubulo-interstitial kidney disease.
C1 [Bakis, Hugo; Connbe, Christian; Rigothier, Claire] CHU Bordeaux, Serv Nephrol Transplantat Dialyse & Aphereses, Bordeaux, France.
   [Trimouille, Aurelien; Goizet, Cyril; Laconnbe, Didier] CHU Bordeaux, Serv Genet Med, Bordeaux, France.
   [Redonnet, Isabelle; Goizet, Cyril] CHU Bordeaux, Lab Biochim, Bordeaux, France.
   [Vermorel, Agathe; Martin-Negrier, Marie-Laure] CHU Bordeaux, Serv Pathol, Bordeaux, France.
   [Boulestreau, Romain] CHU Bordeaux, Serv Cardiol & Hypertens Arterielle, Bordeaux, France.
   [Redonnet, Isabelle; Laconnbe, Didier; Martin-Negrier, Marie-Laure] CHU Bordeaux, Ctr Reference Malad Mitochondriales Enfant Adulte, Bordeaux, France.
   [Trimouille, Aurelien; Redonnet, Isabelle; Goizet, Cyril; Laconnbe, Didier] Univ Bordeaux, INSERM, U1211, Bordeaux, France.
   [Connbe, Christian; Rigothier, Claire] INSERM, U1026, Tissue Bioengn, Bordeaux, France.
   [Martin-Negrier, Marie-Laure] Univ Bordeaux, UMR5293, Bordeaux, France.
C3 CHU Bordeaux; Universite de Bordeaux; Universite de Bordeaux; CHU
   Bordeaux; CHU Bordeaux; Universite de Bordeaux; Universite de Bordeaux;
   CHU Bordeaux; Universite de Bordeaux; CHU Bordeaux; Universite de
   Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite de Bordeaux; Institut National de la Sante
   et de la Recherche Medicale (Inserm); Universite de Bordeaux; Centre
   National de la Recherche Scientifique (CNRS); CNRS - National Institute
   for Biology (INSB)
RP Rigothier, C (corresponding author), CHU Bordeaux, Serv Nephrol Transplantat Dialyse & Aphereses, Bordeaux, France.
EM claire.rigothier@chu-bordeaux.fr
RI GOIZET, Cyril/M-4576-2014; Trimouille, Aurelien/KSM-0596-2024;
   BOULESTREAU, ROMAIN/AFC-7570-2022
OI BOULESTREAU, Romain/0000-0003-4157-6535; Rigothier,
   Claire/0000-0002-5569-5562; Goizet, Cyril/0000-0002-1913-889X
CR Alston CL, 2010, NEUROMUSCULAR DISORD, V20, P131, DOI 10.1016/j.nmd.2009.10.010
   Blackwood JK, 2010, BIOCHEM BIOPH RES CO, V393, P740, DOI 10.1016/j.bbrc.2010.02.072
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Emma F, 2012, PEDIATR NEPHROL, V27, P539, DOI 10.1007/s00467-011-1926-6
   Finsterer J, 2017, BIOMED REP, V6, P487, DOI 10.3892/br.2017.892
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015
   Magistroni R, 2003, J AM SOC NEPHROL, V14, P1164, DOI 10.1097/01.ASN.0000061774.90975.25
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   Monlleo-Neila L, 2013, J CHILD NEUROL, V28, P1531, DOI 10.1177/0883073812460580
   Motoda Atsuko, 2013, Rinsho Shinkeigaku, V53, P446
   O'Connor PM, 2006, CLIN EXP PHARMACOL P, V33, P961, DOI 10.1111/j.1440-1681.2006.04475.x
   O'Toole JF, 2014, INT J NEPHROL RENOV, V7, P57, DOI 10.2147/IJNRD.S37887
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Wang Shi-Bing, 2008, Pediatrics and Neonatology, V49, P145, DOI 10.1016/S1875-9572(08)60030-3
   Wang ZM, 2010, AM J CLIN NUTR, V92, P1369, DOI 10.3945/ajcn.2010.29885
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
NR 21
TC 12
Z9 12
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9163
EI 1399-0004
J9 CLIN GENET
JI Clin. Genet.
PD APR
PY 2020
VL 97
IS 4
BP 628
EP 633
DI 10.1111/cge.13670
EA JAN 2020
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA KT8CI
UT WOS:000506303300001
PM 31713837
DA 2024-11-01
ER

PT J
AU Namaghi, IB
   Vaziri, H
AF Namaghi, I. Bahrehmand
   Vaziri, H.
TI Sperm mitochondrial DNA deletion in Iranian infertiles with
   asthenozoospermia
SO ANDROLOGIA
LA English
DT Article
DE asthenozoospermia; gap; PCR; motility; mtDNA; sperm
ID OXIDATIVE STRESS; MUTATIONS; MOTILITY; FERTILITY; DISEASES;
   POLYMORPHISMS; DECLINE; MUSCLE; COMMON; DAMAGE
AB Asthenozoospermia is an important cause of male infertility. The mutations in sperm mitochondrial DNA (mtDNA) result in either functionless or malfunctioning some proteins, subsequently affecting sperm motility leading to asthenozoospermia. The purpose of this study was to investigate sperm mtDNA 4,977-bp deletion in infertile men with low sperm motility/immotile spermatozoa compared to healthy subjects with high sperm motility. Semen samples of 256 asthenozoospermic infertiles and 200 controls from northern Iran were collected. After extraction of spermatozoa total DNA, Gap-polymerase chain reaction (Gap-PCR) was performed. The deletion was observed in 85.93% of patients with asthenozoospermia compared with 14% in controls [OR=37.5397, 95% confidence interval=12.937-108.9276, p<.0001]. It is concluded that there is a strong association between sperm mtDNA 4,977-bp deletion and asthenozoospermia-induced infertility in the population examined. Large-scale mtDNA deletions in spermatozoa may induce bioenergetic disorders. Nevertheless, to validate our results broader research may be needed.
C1 [Namaghi, I. Bahrehmand; Vaziri, H.] Univ Guilan, Dept Biol, Fac Sci, Rasht, Iran.
C3 University of Guilan
RP Vaziri, H (corresponding author), Univ Guilan, Dept Biol, Fac Sci, Rasht, Iran.
EM vaziri@guilan.ac.ir
RI Vaziri, Hamidreza/AAS-1523-2020
OI Vaziri, Hamidreza/0000-0001-6325-8349
FU University of Guilan
FX We would also like to thank all patients from Alzhara and Razi Hospitals
   and Jam's clinic for their kind assistance in the collection of semen
   samples. This study was partly supported by University of Guilan.
CR Agarwal A, 2005, BJU INT, V95, P503, DOI 10.1111/j.1464-410X.2005.05328.x
   Aitken R John, 2003, Reprod Biomed Online, V7, P65
   Apostolova N., 2011, MITOCHONDRIAL DNA RE, DOI [10.5772/19162, DOI 10.5772/19162]
   Baklouti-Gargouri S, 2013, MOL BIOL REP, V40, P4705, DOI 10.1007/s11033-013-2566-7
   Chen SS, 2002, HUM REPROD, V17, P718, DOI 10.1093/humrep/17.3.718
   Chen T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-8
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cummins J, 1998, REV REPROD, V3, P172, DOI 10.1530/revreprod/3.3.172
   Curi SM, 2003, ARCH ANDROLOGY, V49, P343, DOI 10.1080/01485010390219656
   Fraczek M, 2007, J ANDROL, V28, P325, DOI 10.2164/jandrol.106.001149
   Gashti NG, 2014, ANDROLOGIA, V46, P258, DOI 10.1111/and.12073
   Gendron SP, 2012, MECH AGEING DEV, V133, P68, DOI 10.1016/j.mad.2012.01.002
   Ieremiadou F, 2009, BMC RES NOTES, V2, P1
   Iwai K, 2006, MUTAT RES-FUND MOL M, V595, P191, DOI 10.1016/j.mrfmmm.2005.10.001
   Kamalidehghan B, 2006, ARCH MED RES, V37, P730, DOI 10.1016/j.arcmed.2006.02.005
   Kao SH, 1998, MOL HUM REPROD, V4, P657, DOI 10.1093/molehr/4.7.657
   KAO SH, 1995, BIOL REPROD, V52, P729, DOI 10.1095/biolreprod52.4.729
   Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616
   Kumar D Prabhu, 2009, Indian J Hum Genet, V15, P93, DOI 10.4103/0971-6866.60183
   Lestienne P, 1997, MOL HUM REPROD, V3, P811, DOI 10.1093/molehr/3.9.811
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Paoli D, 2011, FERTIL STERIL, V95, P2315, DOI 10.1016/j.fertnstert.2011.03.059
   Pavicic WH, 2009, MUTAT RES-FUND MOL M, V670, P99, DOI 10.1016/j.mrfmmm.2009.07.009
   Sharma RK, 1996, UROLOGY, V48, P835, DOI 10.1016/S0090-4295(96)00313-5
   Shen SL, 2013, WORLD J UROL, V31, P1395, DOI 10.1007/s00345-013-1023-5
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOFFNER JM, 1994, ANNU REV NUTR, V14, P535, DOI 10.1146/annurev.nu.14.070194.002535
   Spiropoulos J, 2002, MOL HUM REPROD, V8, P719, DOI 10.1093/molehr/8.8.719
   St John JC, 2000, J ANDROL, V21, P189
   St John JC, 2001, MOL HUM REPROD, V7, P103, DOI 10.1093/molehr/7.1.103
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wei YH, 2000, ZOOL STUD, V39, P1
   Weng SL, 2002, MOL HUM REPROD, V8, P984, DOI 10.1093/molehr/8.11.984
   Wong EWP, 2011, TRENDS PHARMACOL SCI, V32, P290, DOI 10.1016/j.tips.2011.01.001
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yu M, 2012, ADV CLIN CHEM, V57, P99, DOI 10.1016/B978-0-12-394384-2.00004-8
NR 40
TC 20
Z9 20
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-4569
EI 1439-0272
J9 ANDROLOGIA
JI Andrologia
PD APR
PY 2017
VL 49
IS 3
AR e12627
DI 10.1111/and.12627
PG 6
WC Andrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA EP6NE
UT WOS:000397495400010
PM 27362525
DA 2024-11-01
ER

PT J
AU Copeland, WC
   Longley, MJ
AF Copeland, William C.
   Longley, Matthew J.
TI Mitochondrial genome maintenance in health and disease
SO DNA REPAIR
LA English
DT Article
DE POLG; Mitochondrial DNA replication; mtDNA; Mitochondrial disease;
   Mutagenesis
ID DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; BASE
   EXCISION-REPAIR; P55 ACCESSORY SUBUNIT; MTDNA MUTATOR MICE;
   SACCHAROMYCES-CEREVISIAE; POINT MUTATIONS; POLG MUTATIONS; MAMMALIAN
   MITOCHONDRIA; OXIDATIVE STRESS
AB Human mitochondria harbor an essential, high copy number, 16,569 base pair, circular DNA genome that encodes 13 gene products required for electron transport and oxidative phosphorylation. Mutation of this genome can compromise cellular respiration, ultimately resulting in a variety of progressive metabolic diseases collectively known as 'mitochondrial diseases'. Mutagenesis of mtDNA and the persistence of mtDNA mutations in cells and tissues is a complex topic, involving the interplay of DNA replication, DNA damage and repair, purifying selection, organelle dynamics, mitophagy, and aging. We briefly review these general elements that affect maintenance of mtDNA, and we focus on nuclear genes encoding the mtDNA replication machinery that can perturb the genetic integrity of the mitochondrial genome. Published by Elsevier B.V.
C1 [Copeland, William C.; Longley, Matthew J.] NIEHS, Mol Genet Lab, NIH, Durham, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, Durham, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953
FU NIH, NIEHS [ES 065078, ES 065080]
FX This work was supported by the Intramural Research Program of the NIH,
   NIEHS (ES 065078 and ES 065080).
CR Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002
   Alexeyev M., 2013, Cold Spring Harb Perspect Biol, V5, DOI DOI 10.1101/CSHPERSPECT.A012641
   Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Boyer PL, 2000, P NATL ACAD SCI USA, V97, P3056, DOI 10.1073/pnas.97.7.3056
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   CHI NW, 1994, J BIOL CHEM, V269, P29984
   CHIT NW, 1994, J BIOL CHEM, V269, P29993
   Clayton D A, 1975, Basic Life Sci, V5B, P589
   Cohen BH, 2010, POLG RELATED DISORDE
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Croteau DL, 1999, MUTAT RES-DNA REPAIR, V434, P137, DOI 10.1016/S0921-8777(99)00025-7
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021
   Doublié S, 1998, NATURE, V391, P251, DOI 10.1038/34593
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Ericson NG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002689
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407
   García-Gómez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   GROSSMAN LI, 1973, P NATL ACAD SCI USA, V70, P3339, DOI 10.1073/pnas.70.12.3339
   Guo XH, 2010, BBA-BIOENERGETICS, V1797, P1159, DOI 10.1016/j.bbabio.2010.04.005
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   Hasson S.A., 2013, NATURE
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   Kang DC, 2005, CURR MED CHEM, V12, P429, DOI 10.2174/0929867053363081
   Kasiviswanathan R, 2011, J BIOL CHEM, V286, P31490, DOI 10.1074/jbc.M111.252460
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283
   Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167
   McElhinny SAN, 2006, CELL CYCLE, V5, P958, DOI 10.4161/cc.5.9.2736
   McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/nchembio.424, 10.1038/NCHEMBIO.424]
   McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107
   Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Pascucci B, 1997, J MOL BIOL, V273, P417, DOI 10.1006/jmbi.1997.1268
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Pont-Kingdon G, 1998, J MOL EVOL, V46, P419, DOI 10.1007/PL00006321
   PONTKINGDON GA, 1995, NATURE, V375, P109, DOI 10.1038/375109b0
   REENAN RAG, 1992, GENETICS, V132, P975
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Salazar JJ, 1997, MUTAT RES-DNA REPAIR, V385, P139, DOI 10.1016/S0921-8777(97)00047-5
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Santo-Domingo J, 2012, J GEN PHYSIOL, V139, P415, DOI 10.1085/jgp.201110767
   Santos Janine H, 2002, Methods Mol Biol, V197, P159, DOI 10.1385/1-59259-284-8:159
   Sia EA, 2000, P NATL ACAD SCI USA, V97, P250, DOI 10.1073/pnas.97.1.250
   Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2013, GENETICS, V194, P519, DOI 10.1534/genetics.113.150920
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vermulst M, 2009, CELL METAB, V10, P437, DOI 10.1016/j.cmet.2009.11.001
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wan L, 2013, EMBO REP, V14, P1104, DOI 10.1038/embor.2013.159
   Wheeler LJ, 2011, J BIOL CHEM, V286, P16992, DOI 10.1074/jbc.M111.236968
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 132
TC 104
Z9 114
U1 0
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1568-7864
EI 1568-7856
J9 DNA REPAIR
JI DNA Repair
PD JUL
PY 2014
VL 19
SI SI
BP 190
EP 198
DI 10.1016/j.dnarep.2014.03.010
PG 9
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA AK4QC
UT WOS:000338408200022
PM 24780559
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Matsushima, Y
   Farr, CL
   Fan, L
   Kaguni, LS
AF Matsushima, Yuichi
   Farr, Carol L.
   Fan, Li
   Kaguni, Laurie S.
TI Physiological and biochemical defects in carboxyl-terminal mutants of
   mitochondrial DNA helicase
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; REPLICATIVE HELICASE;
   CRYSTAL-STRUCTURE; MULTIPLE DELETIONS; BACTERIOPHAGE T7; GENE-4
   HELICASE; BINDING PROTEIN; COPY NUMBER; TWINKLE; DOMAIN
AB Mitochondrial DNA helicase, also called Twinkle, is essential for mtDNA maintenance. Its helicase domain shares high homology with helicases from superfamily 4. Structural analyses of helicases from this family indicate that carboxyl-terminal residues contribute to NTP hydrolysis required for translocation and DNA unwinding, yet genetic and biochemical information is very limited. Here, we evaluate the effects of overexpression in Drosophila cell culture of variants carrying a series of deletion and alanine substitution mutations in the carboxyl terminus and identify critical residues between amino acids 572 and 596 of the 613 amino acid polypeptide that are essential for mitochondrial DNA helicase function in vivo. Likewise, amino acid substitution mutants K574A, R576A, Y577A, F588A, and F595A show dose-dependent dominant-negative phenotypes. Arg-576 and Phe-588 are analogous to the arginine finger and base stack of other helicases, including the bacteriophage T7 gene 4 protein and bacterial DnaB helicase, respectively. We show here that representative human recombinant proteins that are analogous to the alanine substitution mutants exhibit defects in nucleotide hydrolysis. Our findings may be applicable to understand the role of the carboxyl-terminal region in superfamily 4 DNA helicases in general.
C1 [Matsushima, Yuichi; Farr, Carol L.; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
   [Fan, Li] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.
C3 Michigan State University; Scripps Research Institute
RP Kaguni, LS (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
EM lskaguni@msu.edu
FU National Institutes of Health [GM45295, RO1 CA112093, PO1 CA92584]
FX This work was supported, in whole or in part, by National Institutes of
   Health Grants GM45295 (to L.S.K.) and RO1 CA112093 and PO1 CA92584 (NCI;
   to John A. Tainer in support of L. F.). The costs of publication of this
   article were defrayed in part by the payment of page charges. This
   article must therefore be hereby marked "advertisement" in accordance
   with 18 U. S. C. Section 1734 solely to indicate this fact.
CR Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353
   Bailey S, 2007, NUCLEIC ACIDS RES, V35, P4728, DOI 10.1093/nar/gkm507
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027
   Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101
   Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020
   Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kong DC, 1998, J BIOL CHEM, V273, P6556, DOI 10.1074/jbc.273.11.6556
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Lee SJ, 2006, J BIOL CHEM, V281, P25841, DOI 10.1074/jbc.M604602200
   Leipe DD, 2000, GENOME RES, V10, P5
   Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200
   Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094
   Niedenzu T, 2001, J MOL BIOL, V306, P479, DOI 10.1006/jmbi.2000.4398
   Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425
   Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7
   Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300
   Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
   Ziegelin G, 2003, NUCLEIC ACIDS RES, V31, P5917, DOI 10.1093/nar/gkg790
NR 35
TC 19
Z9 21
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD AUG 29
PY 2008
VL 283
IS 35
BP 23964
EP 23971
DI 10.1074/jbc.M803674200
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 340II
UT WOS:000258638900052
PM 18593709
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Fujita, Y
   Ito, M
   Kojima, T
   Yatsuga, S
   Koga, Y
   Tanaka, M
AF Fujita, Yasunori
   Ito, Masafumi
   Kojima, Toshio
   Yatsuga, Shuichi
   Koga, Yasutoshi
   Tanaka, Masashi
TI GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for
   mitochondrial diseases
SO MITOCHONDRION
LA English
DT Article
DE GDF15; Pyruvate; Mitochondrial diseases; Cybrid; Microarray; Biomarker
ID MACROPHAGE INHIBITORY CYTOKINE-1; ENDOPLASMIC-RETICULUM STRESS; CELLS
   HARBORING MELAS; STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; GENE-EXPRESSION;
   DNA MUTATIONS; P53; MYOPATHY; PATHWAY
AB Pyruvate therapy is a promising approach for the treatment of mitochondrial diseases. To identify novel biomarkers for diagnosis and to evaluate therapeutic efficacy, we performed microarray analysis of 2SD cybrid cells harboring a MELAS-causing mutation and control cells treated with either lactate or pyruvate. We found that expression and secretion of growth differentiation factor 15 (GDF15) were increased in 2SD cells treated with lactate and that serum GDF15 levels were significantly higher in patients with mitochondrial diseases than in those with other diseases, suggesting that GDF15 could be a useful marker for diagnosis and evaluating the therapeutic efficacy of pyruvate. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Fujita, Yasunori; Ito, Masafumi] Tokyo Metropolitan Inst Gerontol, Res Team Mechanism Aging, Tokyo, Tokyo 1730015, Japan.
   [Kojima, Toshio] Toyohashi Univ Technol, Hlth Support Ctr, Toyohashi, Aichi 4418580, Japan.
   [Yatsuga, Shuichi; Koga, Yasutoshi] Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 8300011, Japan.
   [Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Tokyo, Tokyo 1730015, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Toyohashi University of
   Technology; Kurume University; Tokyo Metropolitan Institute of
   Gerontology
RP Tanaka, M (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, 35-2 Sakae Cho, Tokyo, Tokyo 1730015, Japan.
EM mtanaka@tmig.or.jp
OI Fujita, Yasunori/0009-0006-0334-7212; Koga,
   Yasutoshi/0000-0002-6664-1295
FU Ministry of Education, Culture, Sports, Science, and Technology of
   Japan; GMEXT/JSPS [A-25242062, A-22240072, B-21390459, C-26670481,
   C-21590411, CER-24650414, C-26350922, C-25461571, YSB-25860891];
   Ministry of Health, Labor, and Welfare of Japan; Takeda Science
   Foundation;  [23-Nanchi-Ippan-016];  [23-Nanchi-Ippan-116]; 
   [24-Nanchi-Ippan-005]; Grants-in-Aid for Scientific Research [25242062,
   26350922, 21590411, 26670342, 25860891, 26670481, 25461571] Funding
   Source: KAKEN
FX This study was supported in part by the Ministry of Education, Culture,
   Sports, Science, and Technology of Japan; GMEXT/JSPS KAKENHI Grant
   Number: A-25242062, A-22240072, B-21390459, C-26670481, C-21590411,
   CER-24650414 (to M.T.), C-26350922 (to Y.F.), C-25461571 (to Y.K.), and
   YSB-25860891 (to S.Y.); the Ministry of Health, Labor, and Welfare of
   Japan; Grants-in-Aid for Research on Intractable Diseases (Mitochondrial
   Disorders): 23-Nanchi-Ippan-016, 23-Nanchi-Ippan-116, and
   24-Nanchi-Ippan-005 (to M.T., and Y.K.); and the Takeda Science
   Foundation (to M.T.).
CR Baek SJ, 2002, CARCINOGENESIS, V23, P425, DOI 10.1093/carcin/23.3.425
   Behan A, 2005, MITOCHONDRION, V5, P173, DOI 10.1016/j.mito.2005.03.002
   Brüning A, 2012, TOXICOL APPL PHARM, V264, P300, DOI 10.1016/j.taap.2012.08.011
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Dombroski BA, 2010, AM J HUM GENET, V86, P719, DOI 10.1016/j.ajhg.2010.03.017
   Dostálová I, 2009, EUR J ENDOCRINOL, V161, P397, DOI 10.1530/EJE-09-0417
   Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170
   Fuchs T, 2013, AGING CELL, V12, P882, DOI 10.1111/acel.12116
   Fujita Y, 2007, MITOCHONDRION, V7, P80, DOI 10.1016/j.mito.2006.11.003
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91
   Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9
   Hashimoto O, 2009, LIFE SCI, V85, P534, DOI 10.1016/j.lfs.2009.08.007
   Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004
   Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200
   Kami K, 2012, MITOCHONDRION, V12, P644, DOI 10.1016/j.mito.2012.07.113
   Kempf T, 2007, CLIN CHEM, V53, P284, DOI 10.1373/clinchem.2006.076828
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Koga Y, 2012, BRAIN DEV-JPN, V34, P87, DOI 10.1016/j.braindev.2011.03.003
   Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007
   Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065549
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Martin SD, 2014, BBA-GEN SUBJECTS, V1840, P1303, DOI 10.1016/j.bbagen.2013.09.019
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027
   Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191
   Saito K, 2012, BBA-GEN SUBJECTS, V1820, P632, DOI 10.1016/j.bbagen.2011.08.006
   Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48
   Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tanaka M, 2007, MITOCHONDRION, V7, P399, DOI 10.1016/j.mito.2007.07.002
   Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Unsicker K, 2013, CYTOKINE GROWTH F R, V24, P373, DOI 10.1016/j.cytogfr.2013.05.003
   Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100
   Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x
   Yang H, 2003, MOL CANCER THER, V2, P1023
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Zhang XD, 2010, ACTA PHARMACOL SIN, V31, P1208, DOI 10.1038/aps.2010.151
NR 42
TC 106
Z9 114
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN
PY 2015
VL 20
BP 34
EP 42
DI 10.1016/j.mito.2014.10.006
PG 9
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA CA0UQ
UT WOS:000348632200005
PM 25446397
DA 2024-11-01
ER

PT J
AU Khan, NA
   Nikkanen, J
   Yatsuga, S
   Jackson, C
   Wang, LY
   Pradhan, S
   Kivelä, R
   Pessia, A
   Velagapudi, V
   Suomalainen, A
AF Khan, Nahid A.
   Nikkanen, Joni
   Yatsuga, Shuichi
   Jackson, Christopher
   Wang, Liya
   Pradhan, Swagat
   Kivela, Riikka
   Pessia, Alberto
   Velagapudi, Vidya
   Suomalainen, Anu
TI mTORC1 Regulates Mitochondrial Integrated Stress Response and
   Mitochondrial Myopathy Progression
SO CELL METABOLISM
LA English
DT Article
ID UNFOLDED-PROTEIN RESPONSE; ONE-CARBON METABOLISM; NICOTINAMIDE RIBOSIDE;
   DNA DELETIONS; MOUSE MODEL; DISEASE; ACTIVATION; DISORDERS; BIOMARKER;
   MICE
AB Mitochondrial dysfunction elicits various stress responses in different model systems, but how these responses relate to each other and contribute to mitochondrial disease has remained unclear. Mitochondrial myopathy (MM) is the most common manifestation of adult-onset mitochondrial disease and shows a multifaceted tissue-specific stress response: (1) transcriptional response, including metabolic cytokines FGF21 and GDF15; (2) remodeling of one-carbon metabolism; and (3) mitochondrial unfolded protein response. We show that these processes are part of one integrated mitochondrial stress response (ISRmt), which is controlled by mTORC1 in muscle. mTORC1 inhibition by rapamycin downregulated all components of ISRmt, improved all MM hallmarks, and reversed the progression of even late-stage MM, without inducing mitochondrial biogenesis. Our evidence suggests that (1) chronic upregulation of anabolic pathways contributes to MM progression, (2) long-term induction of ISRmt is not protective for muscle, and (3) rapamycin treatment trials should be considered for adult-type MM with raised FGF21.
C1 [Khan, Nahid A.; Nikkanen, Joni; Yatsuga, Shuichi; Jackson, Christopher; Pradhan, Swagat; Suomalainen, Anu] Univ Helsinki, Res Programs Unit, Mol Neurol, FIN-00290 Helsinki, Finland.
   [Yatsuga, Shuichi] Kurume Univ, Dept Pediat & Child Hlth, Sch Med, Fukuoka, Japan.
   [Wang, Liya] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, S-75007 Uppsala, Sweden.
   [Kivela, Riikka] Univ Helsinki, Res Programs Unit, Translat Canc Biol, FIN-00290 Helsinki, Finland.
   [Pessia, Alberto; Velagapudi, Vidya] Univ Helsinki, Inst Mol Med Finland, Metabol Unit, FIN-00290 Helsinki, Finland.
   [Suomalainen, Anu] Helsinki Univ Hosp, Dept Neurol, Helsinki 00290, Finland.
   [Suomalainen, Anu] Univ Helsinki, Neurosci Ctr, Helsinki 00790, Finland.
C3 University of Helsinki; Kurume University; Swedish University of
   Agricultural Sciences; University of Helsinki; University of Helsinki;
   University of Helsinki; Helsinki University Central Hospital; University
   of Helsinki
RP Suomalainen, A (corresponding author), Univ Helsinki, Res Programs Unit, Mol Neurol, FIN-00290 Helsinki, Finland.; Suomalainen, A (corresponding author), Helsinki Univ Hosp, Dept Neurol, Helsinki 00290, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, Neurosci Ctr, Helsinki 00790, Finland.
EM anu.wartiovaara@helsinki.fi
RI Pessia, Alberto/N-3072-2014; Pradhan, Swagat/ABC-1053-2021; Velagapudi,
   Vidya/L-7278-2015; Jackson, Christopher B./M-3222-2013; Kivela,
   Riikka/I-2859-2016
OI Jackson, Christopher B./0000-0003-1035-6417; Khan,
   Nahid/0000-0002-2835-3655; Nikkanen, Joni/0000-0001-7099-4061; Pessia,
   Alberto/0000-0001-8607-9191; Pradhan, Swagat/0000-0002-3173-6542;
   Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Kivela,
   Riikka/0000-0002-2686-8890
FU United Mitochondrial Disease Foundation; Jane and Aatos Erkko
   Foundation; Sigrid Juselius Foundation; Academy of Finland; University
   of Helsinki; European Research Council [ERC-AdG10-268955]; Helsinki
   Biomedical Graduate School; Swiss National Foundation; Novartis
   Foundation for medical biological research
FX The authors wish to thank Anu Harju, Markus Innila, Tuula Manninen, and
   Jatin Nandania for technical help; Henna Tyynismaa, Emil Ylikallio,
   Alexandra Gotz, and Sofia Ahola for useful scientific discussions and
   expertise; Electron Microscopy Core Facility of Helsinki University for
   expertise in ultrastructural experiments; and the Helsinki University
   Laboratory Animal Centre for excellent maintenance of the animals. We
   also acknowledge the following funding sources: United Mitochondrial
   Disease Foundation, Jane and Aatos Erkko Foundation, Sigrid Juselius
   Foundation, Academy of Finland, University of Helsinki, European
   Research Council (ERC-AdG10-268955) (for A.S.), Helsinki Biomedical
   Graduate School (for J.N.) and Swiss National Foundation, and the
   Novartis Foundation for medical biological research (for C.J.).
CR Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592
   Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575
   Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489
   Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405
   Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4
   Cantó C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Christensen KE, 2006, BIOESSAYS, V28, P595, DOI 10.1002/bies.20420
   Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016
   Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002
   Heliö TM, 2013, CARDIOGENETICS, V3, P31, DOI 10.4081/cardiogenetics.2013.e6
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Koopman WJH, 2016, EMBO MOL MED, V8, P311, DOI 10.15252/emmm.201506131
   Kundu M, 2011, ANTIOXID REDOX SIGN, V14, P1953, DOI 10.1089/ars.2010.3809
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890
   Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128
   OLSON W, 1972, ARCH NEUROL-CHICAGO, V26, P193, DOI 10.1001/archneur.1972.00490090019001
   Richter U, 2015, J CELL BIOL, V211, P373, DOI 10.1083/jcb.201504062
   Rygiel KA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09906
   SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3
   Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.02.004, 10.1016/j.cell.2017.03.035]
   Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757
   Shoubridge E A, 1996, Methods Enzymol, V264, P465, DOI 10.1016/S0076-6879(96)64042-7
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Taylor RC, 2014, NAT REV MOL CELL BIO, V15, P211, DOI 10.1038/nrm3752
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.13374, 10.7554/eLife.18638]
NR 45
TC 258
Z9 284
U1 3
U2 30
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD AUG 1
PY 2017
VL 26
IS 2
BP 419
EP +
DI 10.1016/j.cmet.2017.07.007
PG 15
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA FC2PR
UT WOS:000406681000017
PM 28768179
OA Bronze
DA 2024-11-01
ER

PT J
AU Vázquez-Justes, D
   Carreño-Gago, L
   García-Arum, E
   Traveset, A
   Montoya, J
   Ruiz-Pesini, E
   López, R
   Brieva, L
AF Vazquez-Justes, Daniel
   Carreno-Gago, Lidia
   Garcia-Arum, Elena
   Traveset, Alicia
   Montoya, Julio
   Ruiz-Pesini, Eduardo
   Lopez, Ricard
   Brieva, Luis
TI Mitochondrial m.13513G&gt;A Point Mutation in ND5 in a 16-Year-Old Man
   with Leber Hereditary Optic Neuropathy Detected by Next-Generation
   Sequencing
SO JOURNAL OF PEDIATRIC GENETICS
LA English
DT Article
DE Leber hereditary optic neuropathy; whole genome sequencing;
   next-generation sequencing
ID DNA G13513A MUTATION; LEIGH-SYNDROME
AB This article reports a Leber hereditary optic neuropathy (LHON) case associated for the first time with mitochondrial m.13513G>A mutation. We present a 16-year-old man who complained of subacute, painless, visual loss. Ocular examination showed optic nerve atrophy, papillary pseudoedema, and optic disc pallor. Extraocular manifestations included hypertrophic myocardiopathy and myopathy. Initial genetic analysis excluded the three most common LHON mutations. Sanger sequencing of the whole mitochondrial deoxyribonucleic acid showed no mutation. Next-generation sequencing (NGS) revealed m.13513G>A mutation in the NADH dehydrogenase (ND5) subunit gene ( MT-ND5 ). The m.13513G>A mutation has never been associated with LHON phenotype without Leigh/mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes features. NGS techniques should be considered when this diagnosis is strongly suspected.
C1 [Vazquez-Justes, Daniel; Brieva, Luis] Hosp Arnau Vilanova, Dept Neurol, Lleida, Spain.
   [Carreno-Gago, Lidia; Garcia-Arum, Elena] Univ Autonoma Barcelona, Inst Recerca VHIR, Hosp Univ Vall dHebron, Dept Patol Mitocondrial & Neuromuscular, Barcelona, Spain.
   [Carreno-Gago, Lidia; Garcia-Arum, Elena] ISCIII, CIBERER, Barcelona, Spain.
   [Garcia-Arum, Elena] Hosp Univ Vall dHebron, Area Genet Clin & Mol, Barcelona, Spain.
   [Traveset, Alicia] Hosp Arnau Vilanova, Dept Ophthalmol, Lleida, Spain.
   [Montoya, Julio; Ruiz-Pesini, Eduardo] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, CIBERER, IISAragon, Zaragoza, Spain.
   [Lopez, Ricard] Hosp Arnau Vilanova, Lab Clin ICS, Unitat Citogenet, Lleida, Spain.
C3 University Hospital Arnau de Vilanova; Autonomous University of
   Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut
   de Recerca (VHIR); Instituto de Salud Carlos III; CIBER - Centro de
   Investigacion Biomedica en Red; CIBERER; Hospital Universitari Vall
   d'Hebron; University Hospital Arnau de Vilanova; CIBER - Centro de
   Investigacion Biomedica en Red; CIBERER; University of Zaragoza;
   University Hospital Arnau de Vilanova
RP Vázquez-Justes, D (corresponding author), Arnau Vilanova Univ Hosp, Dept Neurol, Rovira Roure 80, Lleida, Spain.
EM danivazkez@gmail.com
RI Ruiz, Luis/C-3812-2011; Brieva Ruiz, Luis/E-8505-2019; Lopez Ortega,
   Ricard/ABF-8142-2021
OI Brieva Ruiz, Luis/0000-0002-5871-6189; Lopez Ortega,
   Ricard/0000-0002-4604-7862; Vazquez Justes, Daniel/0000-0002-7946-2982
FU Instituto de Salud Carlos III; Departamento de Ciencia, Tecnologia y
   Universidad del Gobierno de Aragon [B33]; European Union
FX Dr. Garcia Arumi reports grants from Instituto de Salud Carlos III,
   during the conduct of the study. Dr. Montoya reports grants from
   Instituto de Salud Carlos III, grants from Departamento de Ciencia,
   Tecnologia y Universidad del Gobierno de Aragon (Grupos Consolidados
   B33), and FEDER Funding Program from the European Union, during the
   conduct of the study.
CR Blok MJ, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045716
   Brecht M, 2015, JIMD REP, V19, P95, DOI 10.1007/8904_2014_375
   Duan MQ, 2018, MOLECULES, V23, DOI 10.3390/molecules23020323
   Chacón-Camacho OF, 2017, GAC MED MEX, V153, P276
   Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   Monlleo-Neila L, 2013, J CHILD NEUROL, V28, P1531, DOI 10.1177/0883073812460580
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   UEMURA A, 1987, BRIT J OPHTHALMOL, V71, P531, DOI 10.1136/bjo.71.7.531
   van Karnebeek CDM, 2011, DEV MED CHILD NEUROL, V53, P565, DOI 10.1111/j.1469-8749.2010.03907.x
   Vasta V, 2009, GENOME MED, V1, DOI 10.1186/gm100
   Wang ZX, 2010, NEUROPATHOLOGY, V30, P606, DOI 10.1111/j.1440-1789.2010.01115.x
NR 15
TC 7
Z9 7
U1 0
U2 5
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 2146-4596
EI 2146-460X
J9 J PEDIATR GENET
JI J. Pediatr. Genet.
PD DEC
PY 2019
VL 8
IS 4
BP 231
EP 234
DI 10.1055/s-0039-1691812
PG 4
WC Pediatrics
WE Emerging Sources Citation Index (ESCI)
SC Pediatrics
GA JJ8BP
UT WOS:000494377800010
PM 31687263
OA Green Published
DA 2024-11-01
ER

PT J
AU Paredes, JA
   Zhou, XS
   Höglund, S
   Karlsson, A
AF Paredes, Joao A.
   Zhou, Xiaoshan
   Hoglund, Stefan
   Karlsson, Anna
TI Gene Expression Deregulation in Postnatal Skeletal Muscle of TK2
   Deficient Mice Reveals a Lower Pool of Proliferating Myogenic Progenitor
   Cells
SO PLOS ONE
LA English
DT Article
ID MITOCHONDRIAL THYMIDINE KINASE; CARDIOMYOCYTE DNA-SYNTHESIS;
   RETINOBLASTOMA PROTEIN; DEOXYNUCLEOTIDE POOLS; DEPLETION MYOPATHY;
   MOUSE-TISSUES; STEM-CELLS; DIFFERENTIATION; INHIBITION; MTDNA
AB Loss of thymidine kinase 2 (TK2) causes a heterogeneous myopathic form of mitochondrial DNA (mtDNA) depletion syndrome (MDS) in humans that predominantly affects skeletal muscle tissue. In mice, TK2 deficiency also affects several tissues in addition to skeletal muscle, including brain, heart, adipose tissue, kidneys and causes death about 3 weeks after birth. We analysed skeletal muscle and heart muscle tissues of Tk2 knockout mice at postnatal development phase and observed that TK2 deficient pups grew slower and their skeletal muscles appeared significantly underdeveloped, whereas heart was close to normal in size. Both tissues showed mtDNA depletion and mitochondria with altered ultrastructure, as revealed by transmission electron microscopy. Gene expression microarray analysis showed a strong down-regulation of genes involved in cell cycle and cell proliferation in both tissues, suggesting a lower pool of undifferentiated proliferating cells. Analysis of isolated primary myoblasts from Tk2 knockout mice showed slow proliferation, less ability to differentiate and signs of premature senescence, even in absence of mtDNA depletion. Our data demonstrate that TK2 deficiency disturbs myogenic progenitor cells function in postnatal skeletal muscle and we propose this as one of the causes of underdeveloped phenotype and myopathic characteristic of the TK2 deficient mice, in addition to the progressive mtDNA depletion, mitochondrial damage and respiratory chain deficiency in post-mitotic differentiated tissue.
C1 [Paredes, Joao A.; Zhou, Xiaoshan; Karlsson, Anna] Karolinska Univ Hosp Huddinge, Div Clin Microbiol, Dept Lab Med, Karolinska Inst, Stockholm, Sweden.
   [Hoglund, Stefan] Uppsala Univ, Dept Chem, BMC, Uppsala, Sweden.
C3 Karolinska Institutet; Karolinska University Hospital; Uppsala
   University
RP Paredes, JA (corresponding author), Karolinska Univ Hosp Huddinge, Div Clin Microbiol, Dept Lab Med, Karolinska Inst, Stockholm, Sweden.
EM joao.paredes@ki.se
RI Karlsson, Anna/E-7945-2018
OI Paredes, Joao/0000-0002-7788-8939
FU Swedish Cancer Society; Swedish Research Council; Karolinska Institute;
   board of research at the Karolinska Institute; research committee at the
   Karolinska hospital
FX This work was supported by grants from the Swedish Cancer Society
   (http://www.cancerfonden.se), the Swedish Research Council
   (http://www.vr.se) and the Karolinska Institute (http://www.ki.se/). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. We would like to
   thank the Microarray core facility at Novum, BEA, Bioinformatics and
   Expression Analysis, which is supported by the board of research at the
   Karolinska Institute and the research committee at the Karolinska
   hospital. We would also like to thank Hernan Concha from the Advanced
   Flow Cytometry Laboratory at Centre for Infectious Diseases, Karolinska
   Institute, for his help during the flow cytometry analysis performed in
   this study.
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1
   ARNER ESJ, 1992, BIOCHEM BIOPH RES CO, V188, P712, DOI 10.1016/0006-291X(92)91114-6
   Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   BERK AJ, 1973, J BIOL CHEM, V248, P2722
   BOGENHAGEN D, 1976, J BIOL CHEM, V251, P2938
   Cam H, 2006, CANCER CELL, V10, P281, DOI 10.1016/j.ccr.2006.08.024
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Dimri GP, 1996, MOL CELL BIOL, V16, P2987
   Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453
   Dou QP, 1996, PROG NUCLEIC ACID RE, V53, P197, DOI 10.1016/S0079-6603(08)60145-2
   DOU QP, 1994, J BIOL CHEM, V269, P1306
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Gokhin DS, 2008, J EXP BIOL, V211, P837, DOI 10.1242/jeb.014340
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C
   Gurer C, 2005, J VIROL, V79, P5557, DOI 10.1128/JVI.79.9.5557-5567.2005
   Höglund S, 2002, ANTIMICROB AGENTS CH, V46, P3597, DOI 10.1128/AAC.46.11.3597-3605.2002
   Huang DY, 2001, BIOCHEM J, V356, P829, DOI 10.1042/0264-6021:3560829
   Leanza L, 2008, J BIOL CHEM, V283, P16437, DOI 10.1074/jbc.M801572200
   Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209
   Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163
   Machida N, 1997, J MOL CELL CARDIOL, V29, P1895, DOI 10.1006/jmcc.1997.0427
   MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   McGeachie JK, 1999, J ANAT, V194, P287, DOI 10.1046/j.1469-7580.1999.19420287.x
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   NAKANISHI M, 1995, P NATL ACAD SCI USA, V92, P4352, DOI 10.1073/pnas.92.10.4352
   Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877
   PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   POULTON J, 1995, J INHERIT METAB DIS, V18, P4, DOI 10.1007/BF00711367
   Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   Rumyantsev P P, 1977, Int Rev Cytol, V51, P186
   Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097
   Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232
   Shaw CS, 2008, HISTOCHEM CELL BIOL, V129, P65, DOI 10.1007/s00418-007-0349-8
   Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406
   Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425
   Solaroli N, 2007, GENE THER, V14, P86, DOI 10.1038/sj.gt.3302835
   Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220
   Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15
   Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006
   Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373
   Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230
   Villarroya J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029691
   Vitale I, 2011, CELL DEATH DIFFER, V18, P1403, DOI 10.1038/cdd.2010.145
   Wang J, 1996, SCIENCE, V273, P359, DOI 10.1126/science.273.5273.359
   White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21
   ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 62
TC 7
Z9 7
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 14
PY 2013
VL 8
IS 1
AR e53698
DI 10.1371/journal.pone.0053698
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 087KE
UT WOS:000314759400069
PM 23341978
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Davis, RL
   Sue, CM
AF Davis, Ryan L.
   Sue, Carolyn M.
TI The Genetics of Mitochondrial Disease
SO SEMINARS IN NEUROLOGY
LA English
DT Article
DE Mitochondrial disease; mitochondria; mitochondrial DNA; nuclear
   DNA-encoded mitochondrial disease
ID HEREDITARY OPTIC NEUROPATHY; RAGGED-RED FIBERS; PROGRESSIVE EXTERNAL
   OPHTHALMOPLEGIA; COENZYME Q(10) DEFICIENCY; A3243G POINT MUTATION; DNA
   DELETIONS; UBIQUINONE DEFICIENCY; ABNORMAL MITOCHONDRIA; MYOCLONIC
   EPILEPSY; CEREBELLAR-ATAXIA
AB The discovery that defects in mitochondria and mitochondrial DNA could cause human disease has led to the development of a rapidly expanding group of disorders known as mitochondrial disease. Mitochondrial disease is so named because of the common feature of impaired mitochondrial function. The main function of the mitochondrion is to produce energy for the cell in the form of ATP. ATP is generated by the respiratory chain, a series of complex proteins that are located in the mitochondrial membrane, and are encoded for by both the mitochondrial and nuclear genomes. Consequently, mitochondrial disease can be caused by mutations in either mitochondrial or nuclear DNA. Given the distribution of mitochondria throughout the body, the specific properties of mitochondrial DNA, and the mitochondrion's dependence on nuclear genes for its normal function, the clinical presentation of mitochondrial disease can be highly variable. Thus, familiarity with typical clinical presentations and knowledge of the genes that contribute to mitochondrial function will aid the clinician in the recognition, diagnosis, and management of patients with this group of diverse disorders.
C1 [Davis, Ryan L.; Sue, Carolyn M.] Royal N Shore Hosp, Kolling Inst Med Res, Neurogenet Res Grp, Sydney, NSW, Australia.
   [Davis, Ryan L.; Sue, Carolyn M.] Univ Sydney, Sydney, NSW 2006, Australia.
   [Sue, Carolyn M.] Royal N Shore Hosp, Dept Neurol, Sydney, NSW, Australia.
C3 University of Sydney; Kolling Institute of Medical Research; Royal North
   Shore Hospital; University of Sydney; University of Sydney; Royal North
   Shore Hospital
RP Sue, CM (corresponding author), Royal N Shore Hosp, Kolling Inst Med Res, Dept Neurogenet, Bldg 6,Reserve Rd, St Leonards, NSW 2065, Australia.
EM carolyn.sue@sydney.edu.au
RI Davis, Ryan/A-7430-2015
OI Davis, Ryan/0000-0003-0512-8989; Sue, Carolyn/0000-0003-1255-3617
FU Royal North Shore Hospital; NHMRC
FX We thank the patients and referring neurologists who support the
   mitochondrial clinic at Royal North Shore Hospital. CMS is supported by
   a NHMRC Clinical Practitioner Fellowship.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Barth PG, 1999, J INHERIT METAB DIS, V22, P555, DOI 10.1023/A:1005568609936
   Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015
   Chinnery PF, 2000, ANN NEUROL, V47, P381, DOI 10.1002/1531-8249(200003)47:3<381::AID-ANA17>3.0.CO;2-2
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   CRIMMINS D, 1993, J NEUROL NEUROSUR PS, V56, P900, DOI 10.1136/jnnp.56.8.900
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   DIMAURO S, 1976, J NEUROL SCI, V27, P217, DOI 10.1016/0022-510X(76)90063-0
   DiMauro S, 1993, MOL GENETIC BASIS NE, P665
   DiMauro S., 2006, Mitochondrial Medicine, P261
   ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919
   Fichera M, 2004, NEUROLOGY, V63, P1108, DOI 10.1212/01.WNL.0000138731.60693.D2
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE, pS107
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirano M, 2005, GENE, V354, P152, DOI 10.1016/j.gene.2005.04.041
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   JOHNS DR, 1993, NEUROLOGY, V43, P2471, DOI 10.1212/WNL.43.12.2471
   Jun AS, 1996, MOL CELL BIOL, V16, P771
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Koene S, 2009, J INTERN MED, V265, P193, DOI 10.1111/j.1365-2796.2008.02058.x
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Lawson VH, 2005, NEUROLOGY, V65, P197, DOI 10.1212/01.wnl.0000168898.76071.70
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   POULTON J, 1989, LANCET, V1, P236
   POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58
   Rocher C, 2002, MOL GENET METAB, V76, P123, DOI 10.1016/S1096-7192(02)00024-0
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SHY GM, 1966, BRAIN, V89, P133, DOI 10.1093/brain/89.1.133
   SHY GM, 1964, SCIENCE, V145, P493, DOI 10.1126/science.145.3631.493
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Sue CM, 2010, MED J AUSTRALIA, V193, P195, DOI 10.5694/j.1326-5377.2010.tb03864.x
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Sue CM, 1999, J PEDIATR-US, V134, P696, DOI 10.1016/S0022-3476(99)70283-0
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tengan CH, 1996, BIOCHEM MOL MED, V58, P130, DOI 10.1006/bmme.1996.0040
   Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wong LJC, 2010, DEV DISABIL RES REV, V16, P154, DOI 10.1002/ddrr.104
   ZEVIANI M, 1990, AM J HUM GENET, V47, P904
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 71
TC 24
Z9 29
U1 2
U2 43
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0271-8235
EI 1098-9021
J9 SEMIN NEUROL
JI Semin. Neurol.
PD DEC
PY 2011
VL 31
IS 5
BP 519
EP 530
DI 10.1055/s-0031-1299790
PG 12
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 883SK
UT WOS:000299655000011
PM 22266889
DA 2024-11-01
ER

PT J
AU Kowald, A
   Kirkwood, TBL
AF Kowald, Axel
   Kirkwood, Thomas B. L.
TI Resolving the Enigma of the Clonal Expansion of mtDNA Deletions
SO GENES
LA English
DT Article
DE aging; mitochondrial deletion mutants; model of clonal expansion
ID MITOCHONDRIAL-DNA MUTATIONS; AGED MUSCLE-FIBERS; CAUSAL ROLE; FUSION;
   ACCUMULATION; FISSION; REPLICATION; MUTANTS; ABNORMALITIES;
   TRANSCRIPTION
AB Mitochondria are cell organelles that are special since they contain their own genetic material in the form of mitochondrial DNA (mtDNA). Damage and mutations of mtDNA are not only involved in several inherited human diseases but are also widely thought to play an important role during aging. In both cases, point mutations or large deletions accumulate inside cells, leading to functional impairment once a certain threshold has been surpassed. In most cases, it is a single type of mutant that clonally expands and out-competes the wild type mtDNA, with different mutant molecules being amplified in different cells. The challenge is to explain where the selection advantage for the accumulation comes from, why such a large range of different deletions seem to possess this advantage, and how this process can scale to species with different lifespans such as those of rats and man. From this perspective, we provide an overview of current ideas, present an update of our own proposal, and discuss the wider relevance of the phenomenon for aging.
C1 [Kowald, Axel; Kirkwood, Thomas B. L.] Newcastle Univ, Inst Cell & Mol Biosci, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Kowald, Axel; Kirkwood, Thomas B. L.] Newcastle Univ, Inst Ageing, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Kirkwood, Thomas B. L.] Univ Copenhagen, Dept Cellular & Mol Med, Ctr Healthy Aging, DK-2200 Copenhagen, Denmark.
C3 Newcastle University - UK; Newcastle University - UK; University of
   Copenhagen
RP Kowald, A (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.; Kowald, A (corresponding author), Newcastle Univ, Inst Ageing, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
EM axel.kowald@ncl.ac.uk; tom.kirkwood@ncl.ac.uk
OI Kowald, Axel/0000-0001-6448-4364
CR [Anonymous], MATH VERS 10
   ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Collins ML, 2003, J APPL PHYSIOL, V94, P2203, DOI 10.1152/japplphysiol.00691.2002
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Dai Y., 2013, HUM MOL GENET, V6, P327
   Damas J, 2014, NUCLEIC ACIDS RES, V42, pD1261, DOI 10.1093/nar/gkt982
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Greaves LC, 2011, MECH AGEING DEV, V132, P588, DOI 10.1016/j.mad.2011.10.004
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Herbst A, 2016, AGING CELL, V15, P1132, DOI 10.1111/acel.12520
   Holt IJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0451
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HUEMER RP, 1971, EXP GERONTOL, V6, P327, DOI 10.1016/0531-5565(71)90001-5
   Kandul NP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13100
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Khrapko K, 2011, NAT GENET, V43, P726, DOI 10.1038/ng.895
   Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768
   Kontis V, 2017, LANCET, V389, P1323, DOI 10.1016/S0140-6736(16)32381-9
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Kowald A, 2014, J THEOR BIOL, V340, P111, DOI 10.1016/j.jtbi.2013.09.009
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108
   Lakshmanan LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035271
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   Lehtinen SK, 2000, GENETICS, V154, P363
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959
   Nicholas A, 2009, EXP NEUROL, V218, P316, DOI 10.1016/j.expneurol.2009.04.029
   Popadin K, 2014, AGING CELL, V13, P579, DOI 10.1111/acel.12231
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Tam ZY, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004183
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Yang JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073318
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
NR 58
TC 27
Z9 30
U1 1
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4425
J9 GENES-BASEL
JI Genes
PD MAR
PY 2018
VL 9
IS 3
AR 126
DI 10.3390/genes9030126
PG 12
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA GA7IE
UT WOS:000428508800009
PM 29495484
OA Green Submitted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Bai, RK
   Cui, H
   Devaney, JM
   Allis, KM
   Balog, AM
   Liu, XY
   Schnur, RE
   Shapiro, FL
   Brautbar, A
   Estrada-Veras, J
   Hochstetler, L
   McConkie-Rosell, A
   McDonald, MT
   Solomon, BD
   Hofherr, S
   Richard, G
   Suchy, SF
AF Bai, Renkui
   Cui, Hong
   Devaney, Joseph M.
   Allis, Katrina M.
   Balog, Amanda M.
   Liu, Xinyue
   Schnur, Rhonda E.
   Shapiro, Faye L.
   Brautbar, Ariel
   Estrada-Veras, Juvianee, I
   Hochstetler, Laurel
   McConkie-Rosell, Allyn
   McDonald, Marie T.
   Solomon, Benjamin D.
   Hofherr, Sean
   Richard, Gabriele
   Suchy, Sharon F.
TI Interference of nuclear mitochondrial DNA segments in mitochondrial DNA
   testing resembles biparental transmission of mitochondrial DNA in humans
SO GENETICS IN MEDICINE
LA English
DT Article
AB Purpose Reports have questioned the dogma of exclusive maternal transmission of human mitochondrial DNA (mtDNA), including the recent report of an admixture of two mtDNA haplogroups in individuals from three multigeneration families. This was interpreted as being consistent with biparental transmission of mtDNA in an autosomal dominant-like mode. The authenticity and frequency of these findings are debated. Methods We retrospectively analyzed individuals with two mtDNA haplogroups from 2017 to 2019 and selected four families for further study. Results We identified this phenomenon in 104/27,388 (approximately 1/263) unrelated individuals. Further study revealed (1) a male with two mitochondrial haplogroups transmits only one haplogroup to some of his offspring, consistent with nuclear transmission; (2) the heteroplasmy level of paternally transmitted variants is highest in blood, lower in buccal, and absent in muscle or urine of the same individual, indicating it is inversely correlated with mtDNA content; and (3) paternally transmitted apparent large-scale mtDNA deletions/duplications are not associated with a disease phenotype. Conclusion These findings strongly suggest that the observed mitochondrial haplogroup of paternal origin resulted from coamplification of rare, concatenated nuclear mtDNA segments with genuine mtDNA during testing. Evaluation of additional specimen types can help clarify the clinical significance of the observed results.
C1 [Bai, Renkui; Cui, Hong; Devaney, Joseph M.; Allis, Katrina M.; Balog, Amanda M.; Liu, Xinyue; Schnur, Rhonda E.; Solomon, Benjamin D.; Hofherr, Sean; Richard, Gabriele; Suchy, Sharon F.] GeneDx Inc, Gaithersburg, MD 20877 USA.
   [Schnur, Rhonda E.; Shapiro, Faye L.] Rowan Univ, Cooper Univ Hlth Care, Cooper Med Sch, Camden, NJ USA.
   [Brautbar, Ariel] Cook Childrens Hlth Care Syst, Dept Genet, Ft Worth, TX USA.
   [Estrada-Veras, Juvianee, I; Hochstetler, Laurel] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA.
   [Estrada-Veras, Juvianee, I] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.
   [Estrada-Veras, Juvianee, I; Hochstetler, Laurel] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA.
   [McConkie-Rosell, Allyn; McDonald, Marie T.] Duke Univ, Med Ctr, Div Med Genet, Durham, NC USA.
   [Hochstetler, Laurel] UCSF, ZSFG Canc Genet & Prevent Program, San Francisco, CA USA.
   [Hochstetler, Laurel] Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA.
   [Solomon, Benjamin D.] NHGRI, NIH, Bethesda, MD 20892 USA.
C3 Rowan University; Cooper Medical School of Rowan University; Cook
   Children's Medical Center; Walter Reed National Military Medical Center;
   Uniformed Services University of the Health Sciences - USA; Henry M.
   Jackson Foundation for the Advancement of Military Medicine, Inc; Duke
   University; University of California System; University of California
   San Francisco; University of California System; University of California
   San Francisco; UCSF Medical Center; UCSF Helen Diller Family
   Comprehensive Cancer Center; National Institutes of Health (NIH) - USA;
   NIH National Human Genome Research Institute (NHGRI)
RP Bai, RK (corresponding author), GeneDx Inc, Gaithersburg, MD 20877 USA.
EM rbai@genedx.com
OI Solomon, Benjamin/0000-0002-8826-1023
FU GeneDx Inc.
FX We are grateful to the patients and their families for their
   enthusiastic support during this research study. We thank the referring
   physicians, genetic counselors, clinical staff, data analysts, and
   laboratory workers who helped with this project in general. We thank
   GeneDx Inc. for supporting this investigative study to continually
   improve the quality of its genetic testing service.
CR Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029
   Balciuniene J, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00518
   Calabrese FM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S15
   Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144
   Djordjevic D, 2016, MITOCHONDRION, V31, P40, DOI 10.1016/j.mito.2016.09.002
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Goldstein A., 1993, GeneReviews((R))
   Gustafson AW, 2002, NEW ENGL J MED, V347, P2081
   Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834
   HUTCHISO.CA, 1974, NATURE, V251, P536, DOI 10.1038/251536a0
   Johns DR, 2003, ANN NEUROL, V54, P422, DOI 10.1002/ana.10771
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Lutz-Bonengel S, 2019, P NATL ACAD SCI USA, V116, P1821, DOI 10.1073/pnas.1820533116
   Manfredi G, 1997, ANN NEUROL, V42, P180, DOI 10.1002/ana.410420208
   Marchington DR, 2002, MOL HUM REPROD, V8, P1046, DOI 10.1093/molehr/8.11.1046
   McWilliams TG, 2019, NATURE, V565, P296, DOI 10.1038/d41586-019-00093-1
   Mishmar D, 2004, HUM MUTAT, V23, P125, DOI 10.1002/humu.10304
   Pyle A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005040
   Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148
   Rius R, 2019, GENET MED, V21, P2823, DOI 10.1038/s41436-019-0568-0
   Salas A, 2020, FORENSIC SCI INT-GEN, V47, DOI 10.1016/j.fsigen.2020.102274
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Simone D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-517
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Taylor RW, 2003, ANN NEUROL, V54, P521, DOI 10.1002/ana.10673
   Vissing J, 2019, P NATL ACAD SCI USA, V116, P1475, DOI 10.1073/pnas.1821192116
   Wei W, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15336-3
   2018, EMBO MOL MED, V10, pE8262, DOI DOI 10.15252/emmm.201708262
NR 30
TC 9
Z9 9
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1098-3600
EI 1530-0366
J9 GENET MED
JI Genet. Med.
PD AUG
PY 2021
VL 23
IS 8
BP 1514
EP 1521
DI 10.1038/s41436-021-01166-1
EA APR 2021
PG 8
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA TY4MA
UT WOS:000639628000001
PM 33846581
OA Bronze
DA 2024-11-01
ER

PT J
AU Llewellyn, KJ
   Nalbandian, A
   Weiss, LN
   Chang, I
   Yu, H
   Khatib, B
   Tan, BC
   Scarfone, V
   Kimonis, VE
AF Llewellyn, Katrina J.
   Nalbandian, Angele
   Weiss, Lan N.
   Chang, Isabela
   Yu, Howard
   Khatib, Bibo
   Tan, Baichang
   Scarfone, Vanessa
   Kimonis, Virginia E.
TI Myogenic differentiation of VCP disease induced pluripotent stem cells:
   A novel platform for drug discovery
SO PLOS ONE
LA English
DT Article
ID INCLUSION-BODY MYOPATHY; MITOCHONDRIAL QUALITY-CONTROL; CONTAINING
   PROTEIN VCP; SKELETAL-MUSCLE CELLS; PAGET-DISEASE; FRONTOTEMPORAL
   DEMENTIA; IN-VITRO; ALZHEIMERS-DISEASE; IPS CELLS; BONE
AB Valosin Containing Protein (VCP) disease is an autosomal dominant multisystem proteinopathy caused by mutations in the VCP gene, and is primarily associated with progressive muscle weakness, including atrophy of the pelvic and shoulder girdle muscles. Currently, no treatments are available and cardiac and respiratory failures can lead to mortality at an early age. VCP is an AAA ATPase multifunction complex protein and mutations in the VCP gene resulting in disrupted autophagic clearance. Due to the rarity of the disease, the myopathic nature of the disorder, ethical and practical considerations, VCP disease muscle biopsies are difficult to obtain. Thus, disease-specific human induced pluripotent stem cells (hiPSCs) now provide a valuable resource for the research owing to their renewable and pluripotent nature. In the present study, we report the differentiation and characterization of a VCP disease-specific hiPSCs into precursors expressing myogenic markers including desmin, myogenic factor 5 (MYF5), myosin and heavy chain 2 (MYH2). VCP disease phenotype is characterized by high expression of TAR DNA Binding Protein-43 (TDP-43), ubiquitin (Ub), Light Chain 3-1/II protein (LC3-1/II), and p62/SOSTM1 (p62) protein indicating disruption of the autophagy cascade. Treatment of hiPSC precursors with autophagy stimulators Rapamycin, Perifosine, or AT101 showed reduction in VCP pathology markers TDP-43, LC3-1/II and p62/SOSTM1. Conversely, autophagy inhibitors chloroquine had no beneficial effect, and Spautin-1 or MHY1485 had modest effects. Our results illustrate that hiPSC technology provide a useful platform for a rapid drug discovery and hence constitutes a bridge between clinical and bench research in VCP and related diseases.
C1 [Llewellyn, Katrina J.; Nalbandian, Angele; Weiss, Lan N.; Chang, Isabela; Yu, Howard; Khatib, Bibo; Tan, Baichang; Kimonis, Virginia E.] Univ Calif Irvine, Sch Med, Dept Pediat, Div Genet & Genom Med, Irvine, CA 92717 USA.
   [Llewellyn, Katrina J.; Nalbandian, Angele; Weiss, Lan N.; Khatib, Bibo; Scarfone, Vanessa; Kimonis, Virginia E.] Univ Calif Irvine, Sch Med, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92717 USA.
C3 University of California System; University of California Irvine;
   University of California System; University of California Irvine
RP Kimonis, VE (corresponding author), Univ Calif Irvine, Sch Med, Dept Pediat, Div Genet & Genom Med, Irvine, CA 92717 USA.; Kimonis, VE (corresponding author), Univ Calif Irvine, Sch Med, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92717 USA.
EM vkimonis@uci.edu
OI Scarfone, Vanessa/0000-0001-8786-4191
FU California Stem Cell Clinical Fellowship [TG2-01152]; NIAMS, National
   Institute of Health [R01, R56, AR050236]; UC Irvine Institute of
   Clinical Translational Science (ICTS)
FX Funding for this study was provided by California Stem Cell Clinical
   Fellowship to KJL Grant # TG2-01152, NIAMS, National Institute of
   Health, R01 and R56, AR050236 to VEK, and the UC Irvine Institute of
   Clinical Translational Science (ICTS). The funder had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ABRAMSON S, 1977, J EXP MED, V145, P1567, DOI 10.1084/jem.145.6.1567
   Abujarour R, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00029
   Amantini Consuelo, 2015, Oncoscience, V2, P395
   Angelos MG, 2015, CURR OPIN ORGAN TRAN, V20, P663, DOI 10.1097/MOT.0000000000000244
   [Anonymous], NEUROBIOL AGING
   Awaya T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051638
   Badadani M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013183
   Balakrishnan K, 2009, BLOOD, V113, P149, DOI 10.1182/blood-2008-02-138560
   Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028
   Bersano A, 2009, NEUROBIOL AGING, V30, P752, DOI 10.1016/j.neurobiolaging.2007.08.009
   BISCHOFF R, 1969, J CELL BIOL, V41, P188, DOI 10.1083/jcb.41.1.188
   Borchin B, 2013, STEM CELL REP, V1, P620, DOI 10.1016/j.stemcr.2013.10.007
   Bové J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068
   Braun RJ, 2008, BBA-MOL CELL RES, V1783, P1418, DOI 10.1016/j.bbamcr.2008.01.015
   Braun RJ, 2006, J BIOL CHEM, V281, P25757, DOI 10.1074/jbc.M513699200
   Cai Zhiyou, 2013, J Biochem Pharmacol Res, V1, P84
   Chal J, 2015, NAT BIOTECHNOL, V33, P962, DOI 10.1038/nbt.3297
   Choi YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043418
   Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015
   Day K, 2009, DEV DYNAM, V238, P1001, DOI 10.1002/dvdy.21903
   de Boer AS, 2015, CELL CYCLE
   Dec E FD, 2014, J STEM CELL RES THER, V4
   Djamshidian A, 2009, MUSCLE NERVE, V39, P389, DOI 10.1002/mus.21225
   Forman MS, 2006, J NEUROPATH EXP NEUR, V65, P571, DOI 10.1097/00005072-200606000-00005
   Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002
   Grimm FA, 2015, ASSAY DRUG DEV TECHN
   Haston KM, 2015, ANN REV PHARM TOXICO
   Haubenberger D, 2005, NEUROLOGY, V65, P1304, DOI 10.1212/01.wnl.0000180407.15369.92
   Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360
   Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115
   Ju JS, HUMAN MOL GENETICS, V19, pR38
   KAUFMAN SJ, 1991, DEV BIOL, V146, P228, DOI 10.1016/0012-1606(91)90462-C
   Kim EJ, 2011, ARCH NEUROL-CHICAGO, V68, P787, DOI 10.1001/archneurol.2010.376
   Kim MN, 2015, CANCER CHEMOTH PHARM, V76, P257, DOI 10.1007/s00280-015-2787-7
   Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029
   Kimonis V, 2007, GENEREVIEWS, P1993
   Kimonis VE, 2005, ALZ DIS ASSOC DIS, V19, pS44, DOI 10.1097/01.wad.0000183081.76820.5a
   Kimonis VE, 2000, GENET MED, V2, P232, DOI 10.1097/00125817-200007000-00006
   Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862
   Kimonis VE, 2008, BBA-MOL BASIS DIS, V1782, P744, DOI 10.1016/j.bbadis.2008.09.003
   Klein JB, 2005, J BIOL CHEM, V280, P31870, DOI 10.1074/jbc.M501802200
   Knappe S, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00161
   Kumar KR, 2010, NEUROMUSCULAR DISORD, V20, P330, DOI 10.1016/j.nmd.2010.03.002
   LAL H, 1983, NEUROPHARMACOLOGY, V22, P1423, DOI 10.1016/0028-3908(83)90111-9
   Liang X, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-10
   Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037
   Maehr R, 2011, CLIN PHARMACOL THER, V89, P750, DOI 10.1038/clpt.2011.1
   Majounie E, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.011
   Mehta SG, 2013, CLIN GENET, V83, P422, DOI 10.1111/cge.12000
   Mei H, 2014, NEOPLASMA, V61, P186, DOI 10.4149/neo_2014_024
   MEOLA G, 1991, EUR J BASIC APPL HIS, V35, P219
   Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407
   Miller TD, 2009, J NEUROL NEUROSUR PS, V80, P583, DOI 10.1136/jnnp.2008.148676
   MIRRA JM, 1995, SKELETAL RADIOL, V24, P163
   Mizuno Y, 2010, FASEB J, V24, P2245, DOI 10.1096/fj.09-137174
   Moharil J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141365
   Moore BR, 2011, ANTIMICROB AGENTS CH, V55, P3899, DOI 10.1128/AAC.00067-11
   Nacmias B, 2014, CURR MOL MED, V14, P993, DOI 10.2174/1566524014666141010152143
   Nalbandian A, 2013, MUSCLE NERVE, V47, P260, DOI 10.1002/mus.23522
   Nalbandian A, 2012, CTS-CLIN TRANSL SCI, V5, P226, DOI 10.1111/j.1752-8062.2012.00407.x
   Nalbandian A, 2011, J MOL NEUROSCI, V45, P522, DOI 10.1007/s12031-011-9627-y
   Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9
   Nieweg K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.72
   Okano H, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-22
   Proud CG, 2007, BIOCHEM SOC T, V35, P1187, DOI 10.1042/BST0351187
   QUINN LS, 1985, NATURE, V313, P692, DOI 10.1038/313692a0
   Raikwar SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116582
   Ralston SH, 2008, BONE, V43, P819, DOI 10.1016/j.bone.2008.06.015
   Ralston SH, 2008, LANCET, V372, P155, DOI 10.1016/S0140-6736(08)61035-1
   Richardson PG, 2012, EXPERT OPIN DRUG MET, V8, P623, DOI 10.1517/17425255.2012.681376
   Roca I, 2015, J CLIN MED, V4, P243, DOI 10.3390/jcm4020243
   Rosso SM, 2001, BRAIN, V124, P1948, DOI 10.1093/brain/124.10.1948
   Salani S, 2012, J CELL MOL MED, V16, P1353, DOI 10.1111/j.1582-4934.2011.01498.x
   Schröder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407
   SCHULTZ E, 1985, MECH AGEING DEV, V30, P63, DOI 10.1016/0047-6374(85)90059-4
   Shamirian S, 2015, ALZ DIS ASSOC DIS, V29, P90, DOI 10.1097/WAD.0b013e318298e54f
   Shelton M., 2015, METHODS
   Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993
   Siddiqui A, 2015, J NEUROSCI, V35, P12833, DOI 10.1523/JNEUROSCI.0109-15.2015
   Singh R, 2015, MOL THER
   Singh R, 2013, HUM MOL GENET, V22, P593, DOI 10.1093/hmg/dds469
   STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1
   Stoccoa G, 2015, CURR DRUG METAB
   Stojkovic T, 2009, NEUROMUSCULAR DISORD, V19, P316, DOI 10.1016/j.nmd.2009.02.012
   Takahashi Jun, 2013, Rinsho Shinkeigaku, V53, P1009
   Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014
   Tzatzalos E, 2015, ADV DRUG DELIV REV
   Van Langenhove T, 2012, ANN MED, V44, P817, DOI 10.3109/07853890.2012.665471
   Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200
   Vesa J, 2009, NEUROMUSCULAR DISORD, V19, P766, DOI 10.1016/j.nmd.2009.08.003
   Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x
   Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332
   Watts GDJ, 2003, NEUROMUSCULAR DISORD, V13, P559, DOI 10.1016/S0960-8966(03)00070-1
   Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009
   Young-Pearse TL, 2016, CURR OPIN NEUROBIOL, V36, P66, DOI 10.1016/j.conb.2015.10.006
   Zhang JL, 2015, TUMOR BIOL, V36, P5699, DOI 10.1007/s13277-015-3244-2
   Zhou Yi Ping, 2009, Fen Zi Xi Bao Sheng Wu Xue Bao, V42, P193
   Zirin J, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001708
NR 98
TC 10
Z9 12
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 2
PY 2017
VL 12
IS 6
AR e0176919
DI 10.1371/journal.pone.0176919
PG 19
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EW6MJ
UT WOS:000402624300009
PM 28575052
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Jesina, P
   Tesarová, M
   Fornusková, D
   Vojtísková, A
   Pecina, P
   Kaplanová, V
   Hansíková, H
   Zeman, J
   Houstek, J
AF Jesina, P
   Tesarová, M
   Fornusková, D
   Vojtísková, A
   Pecina, P
   Kaplanová, V
   Hansíková, H
   Zeman, J
   Houstek, J
TI Diminished synthesis of subunit a (ATP6) and altered function of ATP
   synthase and cytochrome <i>c</i> oxidase due to the mtDNA 2 bp
   microdeletion of TA at positions 9205 and 9206
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE ATP6; ATP synthase; COX3; cytochrome c oxidase; mitochondrial disease;
   mitochondrial DNA (mtDNA)
ID BLUE-NATIVE-ELECTROPHORESIS; MITOCHONDRIAL-DNA MUTATION;
   RESPIRATORY-CHAIN; CELLS; GENE; FIBROBLASTS; DISEASE; DEFICIENCY;
   COMPLEXES; PROTEIN
AB Dysfunction of mitochondrial ATPase (F1F0-ATP synthase) due to missense mutations in ATP6 [mtDNA (mitochondrial DNA)encoded subunit a] is a frequent cause of severe mitochondrial encephalomyopathies. We have investigated a rare mtDNA mutation, i.e. a 2 bp deletion of TA at positions 9205 and 9206 (9205DeltaTA), which affects the STOP codon of the ATP6 gene and the cleavage site between the RNAs for ATP6 and COX3 (cytochrome c oxidase 3). The mutation was present at increasing load in a three-generation family (in blood: 16%/82%/>98%). In the affected boy with severe encephalopathy, a homoplasmic mutation was present in blood, fibroblasts and muscle. The fibroblasts from the patient showed normal aurovertin-sensitive ATPase hydrolytic activity, a 70% decrease in ATP synthesis and an 85% decrease in COX activity. ADP-stimulated respiration and the ADP-induced decrease in the mitochondrial membrane potential at state 4 were decreased by 50%. The content of subunit a was decreased 10-fold compared with other ATPase subunits, and [15 S] methionine labelling showed a 9-fold decrease in subunit a biosynthesis. The content of COX subunits 1, 4 and 6c was decreased by 30-60%. Northern Blot and quantitative real-time reverse transcription-PCR analysis further demonstrated that the primary ATP6-COX3 transcript is cleaved to the ATP6 and COX3 mRNAs 2-3-fold less efficiently. Structural studies by Blue-Native and two-dimensional electrophoresis revealed an altered pattern of COX assembly and instability of the ATPase complex, which dissociated into subcomplexes. The results indicate that the 9205DeltaTA mutation prevents the synthesis of ATPase subunit a, and causes the formation of incomplete ATPase complexes that are capable of ATP hydrolysis but not ATP synthesis. The mutation also affects the biogenesis of COX, which is present in a decreased amount in cells from affected individuals.
C1 Acad Sci Czech Republ, Dept Bioenerget, Inst Physiol, Prague 14220, Czech Republic.
   Acad Sci Czech Republ, Ctr Integrated Genom, Prague 14220, Czech Republic.
   Charles Univ Prague, Fac Med 1, Dept Pediat, Prague 12000, Czech Republic.
   Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague 12000, Czech Republic.
C3 Czech Academy of Sciences; Institute of Physiology of the Czech Academy
   of Sciences; Czech Academy of Sciences; Charles University Prague;
   Charles University Prague
RP Acad Sci Czech Republ, Dept Bioenerget, Inst Physiol, Videnska 1083, Prague 14220, Czech Republic.
EM houstek@biomed.cas.cz
RI Houstek, Josef/C-5019-2012; Hansikova, Hana/E-9350-2017; Kaplanova,
   Vilma/C-7960-2012; Zeman, Jiri/K-2691-2017; Pecinova, Alena/A-8695-2010;
   Pecina, Petr/A-9396-2010; Burska, Daniela/I-8169-2017; Tesarova,
   Marketa/I-1531-2016; Jesina, Pavel/A-9913-2012
OI Kaplanova, Vilma/0000-0003-2945-0235; Zeman, Jiri/0000-0002-2678-7919;
   Pecinova, Alena/0000-0002-0204-7502; Pecina, Petr/0000-0003-0641-2834;
   Burska, Daniela/0000-0001-6247-3848; Tesarova,
   Marketa/0000-0002-5141-2289; Jesina, Pavel/0000-0002-8513-0976
FU NINR NIH HHS [P20 NR007790] Funding Source: Medline
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BARACCA A, 1989, BIOCHIM BIOPHYS ACTA, V976, P77, DOI 10.1016/S0005-2728(89)80191-4
   Bentlage HACM, 1996, NEUROLOGY, V47, P243, DOI 10.1212/WNL.47.1.243
   Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983
   Carrozzo R, 2000, FEBS LETT, V486, P297, DOI 10.1016/S0014-5793(00)02244-4
   Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   Chowdhury SKR, 2000, CLIN CHIM ACTA, V298, P157, DOI 10.1016/S0009-8981(00)00300-4
   Chrzanowska-Lightowlers ZMA, 2004, BIOCHEM J, V377, P725, DOI 10.1042/bj20031556
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Dubot A, 2004, BIOCHEM BIOPH RES CO, V313, P687, DOI 10.1016/j.bbrc.2003.12.013
   El Meziane A, 1998, NAT GENET, V18, P350
   Ellis TP, 2004, J BIOL CHEM, V279, P15728, DOI 10.1074/jbc.M314162200
   FISCHER JC, 1985, CLIN CHIM ACTA, V153, P23, DOI 10.1016/0009-8981(85)90135-4
   FISCHER JC, 1986, CLIN CHIM ACTA, V155, P263, DOI 10.1016/0009-8981(86)90246-9
   Floryk D, 1999, BIOSCIENCE REP, V19, P27, DOI 10.1023/A:1020193906974
   Fornuskova D., 2003, CAS LEK CESK, V142, P313
   García JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075
   Hao HL, 1999, HUM MOL GENET, V8, P1117, DOI 10.1093/hmg/8.6.1117
   Hoffbuhr KC, 2000, J BIOL CHEM, V275, P13994, DOI 10.1074/jbc.275.18.13994
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   HOUSTEK J, 1995, J BIOL CHEM, V270, P7689, DOI 10.1074/jbc.270.13.7689
   HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A
   Hutcheon ML, 2001, P NATL ACAD SCI USA, V98, P8519, DOI 10.1073/pnas.151236798
   KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523
   MAKINEN MW, 1968, ARCH BIOCHEM BIOPHYS, V126, P75, DOI 10.1016/0003-9861(68)90561-4
   Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   MORADIAMELI M, 1983, P NATL ACAD SCI-BIOL, V80, P6167, DOI 10.1073/pnas.80.20.6167
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Nijtmans LGJ, 1995, BBA-MOL BASIS DIS, V1272, P190, DOI 10.1016/0925-4439(95)00087-9
   Ouhabi R, 1998, ANAL BIOCHEM, V263, P169, DOI 10.1006/abio.1998.2776
   PANSINI A, 1978, EUR J BIOCHEM, V92, P545, DOI 10.1111/j.1432-1033.1978.tb12776.x
   Pecina P, 2003, BBA-MOL BASIS DIS, V1639, P53, DOI 10.1016/S0925-4439(03)00127-3
   Plasek J, 1996, J PHOTOCH PHOTOBIO B, V33, P101, DOI 10.1016/1011-1344(96)07283-1
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Sambrook J, 1990, Cold Spring Harbor Laboratories, V186, P182
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281
   Seneca S, 1996, J INHERIT METAB DIS, V19, P115, DOI 10.1007/BF01799407
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Temperley RJ, 2003, HUM MOL GENET, V12, P2341, DOI 10.1093/hmg/ddg238
   WALKER JE, 1994, FEBS LETT, V346, P39, DOI 10.1016/0014-5793(94)00368-8
   Wanders RJA, 1996, J INHERIT METAB DIS, V19, P133, DOI 10.1007/BF01799412
   Wharton D.C., 1967, Methods Enzymol, V10, P245, DOI [10.1016/0076-6879(67)10048-7, DOI 10.1016/0076-6879(67)10048-7]
NR 49
TC 56
Z9 59
U1 0
U2 16
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FLR, 90 HIGH HOLBORN, LONDON WC1V 6LJ, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD NOV 1
PY 2004
VL 383
BP 561
EP 571
DI 10.1042/BJ20040407
PN 3
PG 11
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 873KQ
UT WOS:000225279300019
PM 15265003
OA Green Published
DA 2024-11-01
ER

PT J
AU Read, JL
   Whittaker, RG
   Miller, N
   Clark, S
   Taylor, R
   McFarland, R
   Turnbull, D
AF Read, Jennifer L.
   Whittaker, Roger G.
   Miller, Nick
   Clark, Sue
   Taylor, Robert
   McFarland, Robert
   Turnbull, Douglass
TI Prevalence and severity of voice and swallowing difficulties in
   mitochondrial disease
SO INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS
LA English
DT Article
DE Mitochondrial disease; voice; swallowing
ID HANDICAP INDEX; DNA MUTATIONS; PATIENT; EPIDEMIOLOGY
AB Background| Mutations of mitochondrial DNA(mtDNA) cause a broad spectrum of clinical phenotypes. Anecdotal evidence suggests that voice and swallow problems are a common feature of these diseases.
   Aims: To characterize accurately the prevalence and severity of voice and swallow problems in a large cohort of patients with mitochondrial disease.
   Methods & Procedures: Patients with proven mitochondrial disease were sent validated questionnaires to assess both voice and swallow function. The presence of voice and swallow symptoms was correlated with other clinical features of mitochondrial disease in affected patients.
   Outcomes & Results: From the original 177 patients contacted, 98 swallowing status questionnaires and 96 Voice Handicap Index questionnaires were returned, response rates of 55% and 54%, respectively. Swallow: 48% of patients reported more difficulties with swallowing than control participants. Patients with single mtDNA deletions were most likely to report problems (65.2%), with patients with an m. 8344A>G point mutation least likely (33.3%). All genotypes had a mean severity score in excess of the normal range, the highest mean score being found in the single large-scale mtDNA deletion group (10.12), the lowest in the m. 3243A>G group (5.56) Voice; 48% of patients reported some difficulty with voice. Patients with single large-scale deletions showed the highest prevalence (65.2%), patients with the m. 3243A>G mutation the lowest (33%). The most severe voice difficulties were reported by patients with an m. 8344A>G point mutation. Patients with an m. 3243A>G point mutation had the mildest and lowest incidence of voice problems. All genotypes scored outside of the normal range expected on the VHI overall (>= 11.5 in control trials). Patients with an m. 8344A>G point mutation reported a significantly higher degree of physical voice handicap than m. 3243A>G patients (13.13 versus 4.40, p = 0.02). In patients with either single or multiple mtDNA deletions the likely pathophysiological mechanism is of proximal muscle weakness, whereas in patients with the m. 8344A>G mutation cerebellar ataxia is the likely cause.
   Conclusions & Implications: Dysphagia and dysarthria have been identified as symptoms in previous research, however the prevalence and pathophysiology of these symptoms have not been explored. This paper indicates that voice and swallow problems are a common, though predominantly mild feature of mitochondrial disease and that there is a core group of pathophysiological symptoms linked to the presence of voice and swallowing problems. This paper recommends early referral to speech and language therapists to identify emerging dysphonia and dysphagia and to provide appropriate intervention.
C1 [Read, Jennifer L.] Manchester Metropolitan Univ, Dept Hlth Profess, Manchester M13 OJA, Lancs, England.
   [Whittaker, Roger G.; Clark, Sue; Taylor, Robert; McFarland, Robert; Turnbull, Douglass] Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Miller, Nick] Newcastle Univ, Inst Hlth & Soc Speech & Language Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Manchester Metropolitan University; Newcastle University - UK; Newcastle
   University - UK
RP Read, JL (corresponding author), Manchester Metropolitan Univ, Dept Hlth Profess, Elizabeth Gaskell Site, Manchester M13 OJA, Lancs, England.
EM j.read@mmu.ac.uk
OI Turnbull, Doug/0000-0002-8878-9901; Whittle, Jen/0000-0001-6527-6946;
   Whittaker, Roger/0000-0002-3403-0182; McFarland,
   Robert/0000-0002-8833-2688
FU EUMITOCOMBAT; MRC [G0700718, G0800674] Funding Source: UKRI
FX These studies were supported by EUMITOCOMBAT. Declaration of interest:
   The authors report no conflicts of interest. The authors are responsible
   for the content and writing of the paper.
CR Amir O, 2006, J VOICE, V20, P318, DOI 10.1016/j.jvoice.2005.08.006
   Behrman A, 2008, J SPEECH LANG HEAR R, V51, P350, DOI 10.1044/1092-4388(2008/026)
   CHINNERY P. F., 1999, AM J MED GENET, V106, P94
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1999, LANCET, V354, pSI17
   Helidoni ME, 2010, J VOICE, V24, P221, DOI 10.1016/j.jvoice.2008.06.005
   Jacobson BH., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI [DOI 10.1044/1058-0360.0603.66, 10.1044/1058-0360.0603.66]
   Malki KH, 2010, EUR ARCH OTO-RHINO-L, V267, P1743, DOI 10.1007/s00405-010-1296-x
   Nagashima T, 2001, NEUROMUSCULAR DISORD, V11, P470, DOI 10.1016/S0960-8966(01)00190-0
   Okun MS, 2004, AM J OPHTHALMOL, V137, P951, DOI 10.1016/j.ajo.2003.10.046
   Peeters AJGE, 2004, EUR ARCH OTO-RHINO-L, V261, P534, DOI 10.1007/s00405-003-0697-5
   Peng Y, 2003, MOVEMENT DISORD, V18, P716, DOI 10.1002/mds.10428
   Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Wallace AL, 2000, GASTROENTEROLOGY, V118, P678, DOI 10.1016/S0016-5085(00)70137-5
NR 16
TC 9
Z9 10
U1 0
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1368-2822
EI 1460-6984
J9 INT J LANG COMM DIS
JI Int. J. Lang. Commun. Disord.
PD JAN-FEB
PY 2012
VL 47
IS 1
BP 106
EP 111
DI 10.1111/j.1460-6984.2011.00072.x
PG 6
WC Audiology & Speech-Language Pathology; Linguistics; Rehabilitation
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Audiology & Speech-Language Pathology; Linguistics; Rehabilitation
GA 892KI
UT WOS:000300284700010
PM 22268906
DA 2024-11-01
ER

PT J
AU Jacobs, LJAM
   de Wert, G
   Geraedts, JPM
   de Coo, IFM
   Smeets, HJM
AF Jacobs, LJAM
   de Wert, G
   Geraedts, JPM
   de Coo, IFM
   Smeets, HJM
TI The transmission of OXPHOS disease and methods to prevent this
SO HUMAN REPRODUCTION UPDATE
LA English
DT Review
DE mitochondria; OXPHOS disease; PGD; PND; transmission
ID MITOCHONDRIAL-DNA MUTATIONS; TRANSCRIPTION FACTOR-A; PROGRESSIVE
   EXTERNAL OPHTHALMOPLEGIA; RANDOM GENETIC DRIFT; MTDNA COPY NUMBER;
   PRENATAL-DIAGNOSIS; HUMAN OOCYTES; OXIDATIVE-PHOSPHORYLATION;
   SKELETAL-MUSCLE; DILATED CARDIOMYOPATHY
AB Diseases owing to defects of oxidative phosphorylation (OXPHOS) affect approximately 1 in 8000 individuals. Clinical manifestations can be extremely variable and range from single-affected tissues to multisystemic syndromes. In general, tissues with a high energy demand, like brain, heart and muscle, are affected. The OXPHOS system is under dual genetic control, and mutations in both nuclear and mitochondrial genes can cause OXPHOS diseases. The expression and segregation of mitochondrial DNA (mtDNA) mutations is different from nuclear gene defects. The mtDNA mutations can be either homoplasmic or heteroplasmic and in the latter case disease becomes manifest when the mutation exceeds a tissue-specific threshold. This mutation load can vary between tissues and often an exact correlation between mutation load and phenotypic expression is lacking. The transmission of mtDNA mutations is exclusively maternal, but the mutation load between embryos can vary tremendously because of a segregational bottleneck. Diseases by nuclear gene mutations show a normal Mendelian inheritance pattern and often have a more constant clinical manifestation. Given the prevalence and severity of OXPHOS disorders and the lack of adequate therapy, existing and new methods for the prevention of transmission of OXPHOS disorders, like prenatal diagnosis (PND), preimplantation genetic diagnosis (PGD), cytoplasmic transfer (CT) and nuclear transfer (NT), are technically and ethically evaluated.
C1 Univ Maastricht, Dept Genet & Cell Biol, NL-6200 MD Maastricht, Netherlands.
   Univ Maastricht, Res Inst GROW, NL-6200 MD Maastricht, Netherlands.
   Univ Maastricht, Dept Eth & Philosophy, NL-6200 MD Maastricht, Netherlands.
   Univ Med Ctr, Erasmus MC, Dept Child Neurol, Rotterdam, Netherlands.
C3 Maastricht University; Maastricht University; Maastricht University;
   Erasmus University Rotterdam; Erasmus MC
RP Univ Maastricht, Dept Genet & Cell Biol, POB 616, NL-6200 MD Maastricht, Netherlands.
EM bert.smeets@molcelb.unimaas.nl
OI de Coo, Irenaeus/0000-0003-0533-7422
CR Akbari M, 2004, SCAND J CLIN LAB INV, V64, P86, DOI 10.1080/00365510410004209
   Aknin-Seifer IE, 2005, HUM REPROD, V20, P736, DOI 10.1093/humrep/deh666
   Amiel J, 2001, PRENATAL DIAG, V21, P602, DOI 10.1002/pd.126
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Arnon S, 2002, PRENATAL DIAG, V22, P34, DOI 10.1002/pd.232
   ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325
   Asin-Cayuela J, 2005, J BIOL CHEM, V280, P25499, DOI 10.1074/jbc.M501145200
   BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Barritt J A, 2000, Reprod Biomed Online, V1, P96
   Barritt JA, 1999, MOL HUM REPROD, V5, P927, DOI 10.1093/molehr/5.10.927
   Barritt JA, 2001, HUM REPROD, V16, P513, DOI 10.1093/humrep/16.3.513
   BARRITT JA, 2001, REPROD BIOMED ONLINE, V3, P47
   Bartley J., 1996, American Journal of Human Genetics, V59, pA316
   Bendall KE, 1996, AM J HUM GENET, V59, P1276
   Berdanier CD, 2001, MUTAT RES-FUND MOL M, V475, P169, DOI 10.1016/S0027-5107(01)00068-9
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Biousse V, 2002, J NEURO-OPHTHALMOL, V22, P279, DOI 10.1097/00041327-200212000-00005
   Blake JC, 1999, AM J PATHOL, V155, P67, DOI 10.1016/S0002-9440(10)65100-0
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Brenner CA, 1998, MOL HUM REPROD, V4, P887, DOI 10.1093/molehr/4.9.887
   Brenner CA, 2000, FERTIL STERIL, V74, P573, DOI 10.1016/S0015-0282(00)00681-6
   Briggs DA, 2000, LANCET, V355, P1520, DOI 10.1016/S0140-6736(00)02171-1
   Broekmans FJ, 2004, GYNECOL OBSTET INVES, V58, P225, DOI 10.1159/000080794
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Brown GK, 1997, J INHERIT METAB DIS, V20, P2, DOI 10.1023/A:1005336903888
   Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8
   Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004
   Buchanan A., 2000, CHANCE CHOICE GENETI
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 2004, REPROD BIOMED ONLINE, V8, P16, DOI 10.1016/S1472-6483(10)60494-4
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 2003, TRENDS GENET, V19, P60, DOI 10.1016/S0168-9525(02)00030-6
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Chou YJ, 2004, PRENATAL DIAG, V24, P367, DOI 10.1002/pd.876
   Cibelli JB, 2002, NAT BIOTECHNOL, V20, P13, DOI 10.1038/nbt0102-13
   CLAYTON DA, 1991, TRENDS BIOCHEM SCI, V16, P107, DOI 10.1016/0968-0004(91)90043-U
   COHEN CB, 1996, MED ETHICS SERIES
   Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7
   Cohen J, 1998, MOL HUM REPROD, V4, P269, DOI 10.1093/molehr/4.3.269
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Cottrell D A, 2000, Curr Opin Clin Nutr Metab Care, V3, P473, DOI 10.1097/00075197-200011000-00009
   Cummins J, 1998, REV REPROD, V3, P172, DOI 10.1530/revreprod/3.3.172
   Cummins JM, 1998, INT J ANDROL, V21, P47
   Cummins JM, 2001, HUM REPROD UPDATE, V7, P217, DOI 10.1093/humupd/7.2.217
   Danan C, 1999, AM J HUM GENET, V65, P463, DOI 10.1086/302484
   de Bruin JP, 2004, BIOL REPROD, V70, P419, DOI 10.1095/biolreprod.103.015784
   Dean NL, 2003, MOL HUM REPROD, V9, P631, DOI 10.1093/molehr/gag077
   deCoo IFM, 1996, AM J HUM GENET, V58, P636
   Degoul F, 1997, J INHERIT METAB DIS, V20, P49, DOI 10.1023/A:1005357506614
   DEWERT G, 2002, REPROD MED MOL CELLU, V40, P645
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Díez-Sánchez C, 2003, BIOL REPROD, V68, P180, DOI 10.1095/biolreprod.102.005140
   DiMauro S, 2004, ANN NY ACAD SCI, V1011, P232, DOI 10.1196/annals.1293.023
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Enriquez JA, 1996, EUR J BIOCHEM, V237, P601, DOI 10.1111/j.1432-1033.1996.0601p.x
   Ethics Comm Amer Society Reprod Me, 2004, FERTIL STERIL, V81, P527, DOI 10.1016/j.fertnstert.2003.11.011
   Ferlin T, 1997, J PEDIATR-US, V131, P447, DOI 10.1016/S0022-3476(97)80074-1
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Fulka H, 2004, REPRODUCTION, V127, P195, DOI 10.1530/rep.1.00093
   Gao J, 2001, GENOMICS, V74, P109, DOI 10.1006/geno.2001.6536
   Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003
   Goto Y, 2001, J INHERIT METAB DIS, V24, P181, DOI 10.1023/A:1010366917652
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Graff C, 2000, PRENATAL DIAG, V20, P426, DOI 10.1002/(SICI)1097-0223(200005)20:5<426::AID-PD845>3.3.CO;2-B
   Graff C, 2002, BEST PRACT RES CL OB, V16, P715, DOI 10.1053/beog.2002.0315
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573
   Hammarsund M, 2001, HUM GENET, V109, P542, DOI 10.1007/s00439-001-0610-5
   HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0
   HARDING AE, 1992, AM J HUM GENET, V50, P629
   HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686
   Hayakawa M, 1996, BIOCHEM BIOPH RES CO, V226, P369, DOI 10.1006/bbrc.1996.1363
   Hayashida K, 2005, CELL BIOL INT, V29, P472, DOI 10.1016/j.cellbi.2004.09.016
   HECHT NB, 1984, DEV BIOL, V102, P452, DOI 10.1016/0012-1606(84)90210-0
   Hoekstra R F, 2000, Hum Reprod, V15 Suppl 2, P102
   HOLDING C, 1989, LANCET, V2, P532
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Holt IJ, 2003, TRENDS BIOCHEM SCI, V28, P355, DOI 10.1016/S0968-0004(03)00133-6
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Holyoake AJ, 2001, INT J ANDROL, V24, P175, DOI 10.1046/j.1365-2605.2001.00292.x
   Houstek J, 1999, PRENATAL DIAG, V19, P552, DOI 10.1002/(SICI)1097-0223(199906)19:6<552::AID-PD588>3.0.CO;2-C
   HOWELL N, 1992, HUM GENET, V90, P117
   Hsieh RH, 2002, FERTIL STERIL, V77, P1012, DOI 10.1016/S0015-0282(02)02994-1
   HUOPONEN K, 1991, AM J HUM GENET, V48, P1147
   Hurvitz H, 2002, AM J MED GENET, V111, P446, DOI 10.1002/ajmg.10613
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jacobs HT, 2000, BIOESSAYS, V22, P564, DOI 10.1002/(SICI)1521-1878(200006)22:6<564::AID-BIES9>3.0.CO;2-4
   Jacobs HT, 2000, HUM MOL GENET, V9, P463, DOI 10.1093/hmg/9.4.463
   Jacobs LJAM, 2005, MOL HUM REPROD, V11, P223, DOI 10.1093/molehr/gah152
   Jacobs LJAM, 2004, J INHERIT METAB DIS, V27, P47, DOI 10.1023/B:BOLI.0000016601.49372.18
   Jaenisch R, 2004, NEW ENGL J MED, V351, P2787, DOI 10.1056/NEJMp048304
   Jansen JJ, 1997, J AM SOC NEPHROL, V8, P1118
   Jansen R P, 2000, Hum Reprod, V15 Suppl 2, P112
   Jansen RPS, 1998, MOL CELL ENDOCRINOL, V145, P81, DOI 10.1016/S0303-7207(98)00173-7
   Jensen M, 2004, HUM REPROD, V19, P65, DOI 10.1093/humrep/deh038
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Johns DR, 2003, ANN NEUROL, V54, P422, DOI 10.1002/ana.10771
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831
   Kagawa Y, 1997, GENE THER, V4, P6, DOI 10.1038/sj.gt.3300347
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   Kalfoglou A L, 2001, Am J Bioeth, V1, pW1
   Kalfoglou AL, 2000, WOMEN HEALTH ISS, V10, P226, DOI 10.1016/S1049-3867(00)00057-8
   Kang D, 2005, ANN NY ACAD SCI, V1042, P101, DOI 10.1196/annals.1338.010
   Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004
   Kao SH, 1998, MOL HUM REPROD, V4, P657, DOI 10.1093/molehr/4.7.657
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KEEFE DL, 1995, FERTIL STERIL, V64, P577, DOI 10.1016/S0015-0282(16)57796-6
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200
   Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200
   Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200
   KOEHLER CM, 1991, GENETICS, V129, P247
   KOSOVSKY MJ, 1993, BIOCHIM BIOPHYS ACTA, V1164, P101, DOI 10.1016/0167-4838(93)90117-A
   Krausz C, 2004, J CLIN ENDOCR METAB, V89, P4292, DOI 10.1210/jc.2004-0008
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Larsson NG, 1997, HUM MOL GENET, V6, P185, DOI 10.1093/hmg/6.2.185
   Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782
   LEE CM, 1993, J GERONTOL, V48, pB201, DOI 10.1093/geronj/48.6.B201
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Leshinsky-Silver E, 2003, PRENATAL DIAG, V23, P31, DOI 10.1002/pd.516
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Ling MF, 1997, GENE, V197, P325, DOI 10.1016/S0378-1119(97)00279-5
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   Lochmüller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Lutz S, 2000, INT J LEGAL MED, V113, P155, DOI 10.1007/s004140050288
   Ma JH, 1996, J BIOL CHEM, V271, P5805, DOI 10.1074/jbc.271.10.5805
   Maassen J. A., 2002, Archives of Physiology and Biochemistry, V110, P186, DOI 10.1076/apab.110.3.186.8294
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Mancuso M, 2004, ACTA NEUROL SCAND, V110, P72, DOI 10.1111/j.1600-0404.2004.00254.x
   Marchington DR, 1998, AM J HUM GENET, V63, P769, DOI 10.1086/302009
   Marchington DR, 2002, MOL HUM REPROD, V8, P1046, DOI 10.1093/molehr/8.11.1046
   May-Panloup P, 2003, HUM REPROD, V18, P550, DOI 10.1093/humrep/deg096
   McConnell JML, 2004, REPROD BIOMED ONLINE, V9, P418, DOI 10.1016/S1472-6483(10)61277-1
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   Meirelles FV, 1997, GENETICS, V145, P445
   Meirelles FV, 2001, GENETICS, V158, P351
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P1419, DOI 10.1093/nar/23.8.1419
   MICHAELS GS, 1982, DEV BIOL, V94, P246, DOI 10.1016/0012-1606(82)90088-4
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Moilanen JS, 2001, EUR J HUM GENET, V9, P59, DOI 10.1038/sj.ejhg.5200550
   Molnar MJ, 1999, NEUROMUSCULAR DISORD, V9, P521
   MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Nakada K, 2001, SEMIN CELL DEV BIOL, V12, P459, DOI 10.1006/scdb.2001.0283
   NASS MMK, 1966, P NATL ACAD SCI USA, V56, P1215, DOI 10.1073/pnas.56.4.1215
   Niers LEM, 2001, PRENATAL DIAG, V21, P871, DOI 10.1002/pd.162
   OTA Y, 1994, RETINA-J RET VIT DIS, V14, P270, DOI 10.1097/00006982-199414030-00015
   Poulton J, 2000, NEUROMUSCULAR DISORD, V10, P484, DOI 10.1016/S0960-8966(00)00130-9
   Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811
   Poulton J, 2002, REPRODUCTION, V123, P751, DOI 10.1530/rep.0.1230751
   POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23
   POULTON J, 1994, NAT GENET, V8, P313, DOI 10.1038/ng1294-313
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rantanen A, 2000, Hum Reprod, V15 Suppl 2, P86
   Rechitsky S, 1999, J ASSIST REPROD GEN, V16, P192, DOI 10.1023/A:1020312823155
   Reyes A, 2005, J BIOL CHEM, V280, P3242, DOI 10.1074/jbc.M411916200
   Reynier P, 2001, MOL HUM REPROD, V7, P425, DOI 10.1093/molehr/7.5.425
   Reynier P, 1998, BIOCHEM BIOPH RES CO, V252, P373, DOI 10.1006/bbrc.1998.9651
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Roberts RM, 1999, AM J MED GENET, V87, P265, DOI 10.1002/(SICI)1096-8628(19991126)87:3<265::AID-AJMG14>3.0.CO;2-S
   Robertson JA, 2004, HUM REPROD, V19, P1693, DOI 10.1093/humrep/deh326
   Robertson JA, 1999, FERTIL STERIL, V71, P219
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Rötig A, 2003, J AM SOC NEPHROL, V14, P2995, DOI 10.1097/01.ASN.0000095481.24091.C9
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Ruiz-Pesini E, 2000, CLIN CHIM ACTA, V300, P97, DOI 10.1016/S0009-8981(00)00305-3
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Sasarman F, 2002, HUM MOL GENET, V11, P1669, DOI 10.1093/hmg/11.14.1669
   Schaefer Andrew M., 2001, Current Opinion in Pharmacology, V1, P288
   Schwartz M, 2004, J NEUROL SCI, V218, P99, DOI 10.1016/j.jns.2003.11.008
   Schwartz M, 2003, BIOCHEM BIOPH RES CO, V310, P247, DOI 10.1016/j.bbrc.2003.09.037
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   Shitara H, 2000, GENETICS, V156, P1277
   Shitara H, 1998, GENETICS, V148, P851
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   Smith PM, 2004, BBA-BIOENERGETICS, V1659, P232, DOI 10.1016/j.bbabio.2004.09.003
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spiropoulos J, 2002, MOL HUM REPROD, V8, P719, DOI 10.1093/molehr/8.8.719
   St John J, 2000, LANCET, V355, P200, DOI 10.1016/S0140-6736(99)03842-8
   St John JC, 2001, MOL HUM REPROD, V7, P103, DOI 10.1093/molehr/7.1.103
   St John JC, 2005, INT J ANDROL, V28, P65, DOI 10.1111/j.1365-2605.2005.00515.x
   Steinbock B, 2004, MT SINAI J MED, V71, P255
   Sutovsky P, 2003, MICROSC RES TECHNIQ, V61, P88, DOI 10.1002/jemt.10319
   Sutovsky P, 2004, REPROD BIOMED ONLINE, V8, P24, DOI 10.1016/S1472-6483(10)60495-6
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2004, BBA-BIOENERGETICS, V1659, P221, DOI 10.1016/j.bbabio.2004.09.007
   Tang YY, 2000, MOL BIOL CELL, V11, P1471, DOI 10.1091/mbc.11.4.1471
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2003, ANN NEUROL, V54, P521, DOI 10.1002/ana.10673
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 2001, ADV DRUG DELIVER REV, V49, P121, DOI 10.1016/S0169-409X(01)00130-2
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Thundathil J, 2005, MOL REPROD DEV, V71, P405, DOI 10.1002/mrd.20260
   Torroni A, 2003, AM J HUM GENET, V72, P1005, DOI 10.1086/373936
   Treem WR, 1998, SEMIN LIVER DIS, V18, P237, DOI 10.1055/s-2007-1007160
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tsao K, 1999, BRIT J OPHTHALMOL, V83, P577, DOI 10.1136/bjo.83.5.577
   Usami S, 2000, J MED GENET, V37, P38, DOI 10.1136/jmg.37.1.38
   Van Blerkom J, 2001, HUM REPROD, V16, P719, DOI 10.1093/humrep/16.4.719
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   Van Coster RN, 1998, PRENATAL DIAG, V18, P1041, DOI 10.1002/(SICI)1097-0223(1998100)18:10<1041::AID-PD407>3.0.CO;2-J
   van den Heuvel L, 2001, BIOESSAYS, V23, P518, DOI 10.1002/bies.1071
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954
   VANDENOUWELAND JMW, 1995, MUSCLE NERVE, pS124
   Vekemans BC, 2003, PRENATAL DIAG, V23, P884, DOI 10.1002/pd.713
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Weber K, 1997, AM J HUM GENET, V60, P373
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   Weitzel JM, 2003, EXP PHYSIOL, V88, P121, DOI 10.1113/eph8802506
   White SL, 1999, PRENATAL DIAG, V19, P1165, DOI 10.1002/(SICI)1097-0223(199912)19:12<1165::AID-PD719>3.3.CO;2-4
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   Wong LJC, 2002, GENET MED, V4, P78, DOI 10.1097/00125817-200203000-00005
   XIN H, 1995, J BIOL CHEM, V270, P17243, DOI 10.1074/jbc.270.29.17243
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zeviani M, 2001, SEMIN CELL DEV BIOL, V12, P407, DOI 10.1006/scdb.2001.0278
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
   Zhang YL, 1998, BBA-GENE STRUCT EXPR, V1443, P245, DOI 10.1016/S0167-4781(98)00223-1
NR 255
TC 32
Z9 38
U1 0
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1355-4786
EI 1460-2369
J9 HUM REPROD UPDATE
JI Hum. Reprod. Update
PD MAR-APR
PY 2006
VL 12
IS 2
BP 119
EP 136
DI 10.1093/humupd/dmi042
PG 18
WC Obstetrics & Gynecology; Reproductive Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Obstetrics & Gynecology; Reproductive Biology
GA 011PL
UT WOS:000235280500003
PM 16199488
OA Bronze
DA 2024-11-01
ER

PT B
AU Wong, A
   Cortopassi, G
AF Wong, Alice
   Cortopassi, Gino
BE Gilman, S
TI Mitochondrial Genetic Diseases
SO NEUROBIOLOGY OF DISEASE
LA English
DT Article; Book Chapter
DE Dominant Optic Atrophy; Friedreich's ataxia; Kearns-Sayre
   syndrome/chronic progressive external ophthalmoplegia, Leber's
   hereditary optic neuropathy; Mitochondrial Encephalomyopathy, Lactic
   Acidosis, and Strokelike episodes; Myoclonic Epilepsy and Ragged Red
   Fibers; mitochondria; Neuropathy, Ataxia, and Retinitis pigmentosa
ID HEREDITARY OPTIC NEUROPATHY; OXIDATIVE STRESS; TRANSFER-RNA; COMPLEX-I;
   MUTATIONS; CELLS; MTDNA; AMINOACYLATION; MERRF; DNA
C1 [Wong, Alice; Cortopassi, Gino] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.
C3 University of California System; University of California Davis
RP Wong, A (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.
CR Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730
   Börner GV, 2000, HUM MOL GENET, V9, P467, DOI 10.1093/hmg/9.4.467
   Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012
   Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009
   Chomyn A, 1998, AM J HUM GENET, V62, P745, DOI 10.1086/301813
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Danielson SR, 2002, J BIOL CHEM, V277, P5810, DOI 10.1074/jbc.M110119200
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Genova ML, 2001, FEBS LETT, V505, P364, DOI 10.1016/S0014-5793(01)02850-2
   Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Kamei S, 2005, INVEST OPHTH VIS SCI, V46, P4288, DOI 10.1167/iovs.03-1407
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   McKenzie M, 2004, NEUROCHEM RES, V29, P589, DOI 10.1023/B:NERE.0000014829.42364.dd
   MORAES CT, 1995, MUSCLE NERVE, pS150
   Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281
   SHOFFNER JM, 1992, AM J HUM GENET, V51, P1179
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wei YH, 2001, CHINESE J PHYSIOL, V44, P1
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Zeviani M, 2003, CURR OPIN NEUROL, V16, P585, DOI 10.1097/00019052-200310000-00004
NR 30
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
BN 978-0-08-046638-5; 978-0-12-088592-3
PY 2007
BP 157
EP 161
DI 10.1016/B978-012088592-3/50016-5
PG 5
WC Neurosciences
WE Book Citation Index – Science (BKCI-S)
SC Neurosciences & Neurology
GA BCO40
UT WOS:000310853000015
DA 2024-11-01
ER

PT J
AU Hadzsiev, K
   Maasz, A
   Kisfali, P
   Kalman, E
   Gomori, E
   Pal, E
   Berenyi, E
   Komlosi, K
   Melegh, B
AF Hadzsiev, Kinga
   Maasz, Anita
   Kisfali, Peter
   Kalman, Endre
   Gomori, Eva
   Pal, Endre
   Berenyi, Ervin
   Komlosi, Katalin
   Melegh, Bela
TI Mitochondrial DNA 11777C&gt;A Mutation Associated Leigh Syndrome: Case
   Report with a Review of the Previously Described Pedigrees
SO NEUROMOLECULAR MEDICINE
LA English
DT Article
DE Leigh syndrome; Mitochondrial DNA; mtDNA 11777C > A; Mitochondrial
   mutation
ID CYTOCHROME-C-OXIDASE; COMPLEX-I DEFICIENCY; C11777A MUTATION;
   COMMON-CAUSE; DISEASE; NADH; ENCEPHALOPATHY; IDENTIFICATION; SUBUNITS;
   CHILDREN
AB Here, we present a male infant with clinical signs of typical Leigh syndrome. The first symptom, myoclonus was presented already on the 5th day of life; at 7 months of age limb convulsions and cerebral paresis with hypotonia were developed. At the age of 11 months, MRI verified increased signal intensity in the entire mesencephalon and medulla oblongata; while gray matter proton spectroscopy revealed presence of lactate increase in the brain. At age of 17 months, the child died in cardiorespiratory arrest. After autopsy, the diagnosis of Leigh syndrome was established; using DNA isolated from skeletal muscle and liver, heteroplasmic (> 50%) mitochondrial 11777C > A was detected in the fourth subunit of NADH dehydrogenase enzyme (MTND4) encoding gene, which causes Arg -> Ser replacement. The mutation was also detected in low copy number in blood of mother. Albeit this mutation type is well recognized as a typical mtDNA mutation, according the reports available on the PubMed, this mutation was described only in four patients with wide phenotypic variations; here, we reviewed the characteristic clinical features of them. Taken together, the earliest onset of symptoms, the nature of the first presentation signs, the most rapid progression, the character of minor additional symptoms, and the early fatal outcome differentiate the phenotypic variant of the proband presented here from cases reported so far by others.
C1 [Hadzsiev, Kinga; Maasz, Anita; Kisfali, Peter; Komlosi, Katalin; Melegh, Bela] Univ Pecs, Dept Med Genet, Pecs, Hungary.
   [Kalman, Endre; Gomori, Eva] Univ Pecs, Dept Pathol, Pecs, Hungary.
   [Pal, Endre] Univ Pecs, Dept Neurol, Pecs, Hungary.
   [Berenyi, Ervin] Ctr Med & Hlth Sci, Debrecen, Hungary.
C3 University of Pecs; University of Pecs; University of Pecs
RP Melegh, B (corresponding author), Univ Pecs, Dept Med Genet, Pecs, Hungary.
EM bela.melegh@aok.pte.hu
RI Pal, Endre/I-8962-2019
OI Maasz, Anita/0000-0002-5051-7708; Pal, Endre/0000-0001-6525-0754
FU Hungarian Scientific Research Foundation [OTKA T 73430]; Hungarian
   Ministry of Health [ETT 243/2009]
FX This work was supported by the grant of Hungarian Scientific Research
   Foundation OTKA T 73430 and from the grant of the Hungarian Ministry of
   Health: ETT 243/2009.
CR Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   CIAFALONI E, 1993, J PEDIATR-US, V122, P419, DOI 10.1016/S0022-3476(05)83431-6
   Dahl HHM, 1998, AM J HUM GENET, V63, P1594, DOI 10.1086/302169
   Deschauer M, 2003, NEUROLOGY, V60, P1357, DOI 10.1212/01.WNL.0000055869.99975.4B
   DI DS, 2009, J NEUROL, V256, P693
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 1996, ANN NEUROL, V40, P5, DOI 10.1002/ana.410400104
   Edmond Jane C, 2009, Int Ophthalmol Clin, V49, P27, DOI 10.1097/IIO.0b013e3181a8de58
   FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2009, J NEUROL SCI, V283, P143, DOI 10.1016/j.jns.2009.02.347
   HOMMES FA, 1968, ARCH DIS CHILD, V43, P423, DOI 10.1136/adc.43.230.423
   Komaki H, 2003, MITOCHONDRION, V2, P293, DOI 10.1016/S1567-7249(03)00003-5
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Maász A, 2008, CURR MED CHEM, V15, P1257, DOI 10.2174/092986708784534910
   Makino M, 2000, J HUM GENET, V45, P69, DOI 10.1007/s100380050014
   Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Smeitink JAM, 2004, CURR NEUROVASC RES, V1, P29, DOI 10.2174/1567202043480224
   SUMEGI B, 1990, CLIN CHIM ACTA, V192, P9, DOI 10.1016/0009-8981(90)90266-U
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Ton C, 1997, BIOCHEM BIOPH RES CO, V241, P589, DOI 10.1006/bbrc.1997.7707
   Torroni A, 1996, GENETICS, V144, P1835
   WORSLEY HE, 1965, ARCH DIS CHILD, V40, P492, DOI 10.1136/adc.40.213.492
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 32
TC 10
Z9 11
U1 0
U2 7
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1535-1084
EI 1559-1174
J9 NEUROMOL MED
JI Neuromol. Med.
PD SEP
PY 2010
VL 12
IS 3
BP 277
EP 284
DI 10.1007/s12017-010-8115-9
PG 8
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 642YZ
UT WOS:000281259200010
PM 20502985
DA 2024-11-01
ER

PT J
AU Pinós, T
   Melià, MJ
   Ortiz, N
   Martinez-Vea, A
   Raventós-Estellé, A
   Gallardo, E
   Hernández-Losa, J
   Cámara, Y
   Andreu, AL
   García-Arumí, E
AF Pinos, Tomas
   Jesus Melia, Maria
   Ortiz, Nicolau
   Martinez-Vea, Albert
   Raventos-Estelle, Antoni
   Gallardo, Eduard
   Hernandez-Losa, Javier
   Camara, Yolanda
   Andreu, Antoni L.
   Garcia-Arumi, Elena
TI Identification of the novel mutation m.5658T&gt;C in the mitochondrial
   tRNA(Asn) gene in a patient with myopathy, bilateral ptosis and
   ophthalmoparesis
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondria; mt-tRNA (Asn); Myopathy; Laser capture microdissection
ID RAGGED-RED FIBERS; TRNA(LYS) GENE; MYOCLONUS EPILEPSY; DISEASE; DNA;
   G8363A; A8296G
AB We report a heteroplasmic novel mutation m.5658T>C in the mt-tRNA(Asn) gene in a patient who initially presented myopathy, bilateral ptosis and ophthalmoparesis and several years later developed a non-nephrotic proteinuria. The muscle biopsy showed cytochrome c oxidase (COX) negative and ragged red fibers and in the kidney biopsy that was taken in order to identify the causes of non-nephrotic proteinuria, a focal segmental glomerulosclerosis was observed. Using laser capture microdissection we isolated COX negative fibers and COX positive fibers from the muscle of the patient and determined that there was a clear increase in the mutation load in the COX negative muscle fibers. However, the low degree of mutation load found in the renal biopsy of the patient does not allow us to conclude that the m.5658T>C mutation is responsible for focal glomerulosclerosis. Additionally, we hypothesize that the mutated m.5658T nucleotide might be structurally relevant, as it is one of the fifteen nucleotides conserved in all the species analyzed and is situated contiguously to the discriminator base in the 3'end of the mt-tRNA, where the tRNase Z cleaves the 3'trailer sequence during mt-tRNA maturation. (c) 2013 Elsevier B.V. All rights reserved.
C1 [Pinos, Tomas; Jesus Melia, Maria; Camara, Yolanda; Andreu, Antoni L.; Garcia-Arumi, Elena] Univ Autonoma Barcelona, Hosp Univ Vall dHebron Inst Recerca VHIR, Dept Patol Mitocondrial & Neuromuscular, E-08193 Barcelona, Spain.
   [Hernandez-Losa, Javier] Univ Autonoma Barcelona, Hosp Univ Vall dHebron Inst Recerca VHIR, Serv Anat Patol, E-08193 Barcelona, Spain.
   [Gallardo, Eduard] Univ Autonoma Barcelona, Inst Recerca Hosp Santa Creu & St Pau, Lab Malalties Neuromusculars, E-08193 Barcelona, Spain.
   [Ortiz, Nicolau] Hosp Univ St Joan, Seccio Neurol, Reus, Spain.
   [Martinez-Vea, Albert] Univ Rovira & Virgili, Hosp Univ Tarragona Joan 23, Serv Nephrol, Tarragona, Spain.
   [Raventos-Estelle, Antoni] Univ Rovira & Virgili, Hosp Univ Tarragona Joan 23, Pathol Serv, Tarragona, Spain.
   [Pinos, Tomas; Jesus Melia, Maria; Camara, Yolanda; Andreu, Antoni L.; Garcia-Arumi, Elena] ISCIII, CIBERER, Barcelona, Spain.
C3 Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron;
   Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of
   Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut
   de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; Autonomous
   University of Barcelona; Universitat Rovira i Virgili; Universitat
   Rovira i Virgili; Instituto de Salud Carlos III; CIBER - Centro de
   Investigacion Biomedica en Red; CIBERER
RP García-Arumí, E (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall dHebron Inst Recerca VHIR, Dept Patol Mitocondrial & Neuromuscular, E-08193 Barcelona, Spain.
EM elena.garcia@vhir.org
RI Cámara, Yolanda/P-2540-2019; Garcia-Arumi, Elena/ABH-4229-2020;
   Hernandez-Losa, Javier/C-1173-2008; Camara, Yolanda/K-4597-2014; Melia,
   Maria Jesus/L-2864-2014
OI Garcia-Arumi, Elena/0000-0003-0096-3336; Gallardo,
   Eduard/0000-0002-3942-3436; Hernandez-Losa, Javier/0000-0003-1526-3201;
   ANDREU, antonio luis/0000-0002-3936-3234; Camara,
   Yolanda/0000-0003-2458-6942; Melia, Maria Jesus/0000-0002-6497-7289;
   Ortiz-Castellon, Nicolau/0000-0001-9544-2642
FU Spanish Instituto de Salud Carlos III [PI07/0347, PI08/90355,
   PS09/01602]
FX This work has been supported by the Spanish Instituto de Salud Carlos
   III (PI07/0347; PI08/90355; PS09/01602). We would like to thank Teresa
   Moline for her technical assistance and Michael Terry for his English
   Language assistance.
CR Arenas J, 1999, NEUROLOGY, V52, P377, DOI 10.1212/WNL.52.2.377
   Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28
   Bornstein B, 2005, BIOCHEM J, V387, P773, DOI 10.1042/BJ20040949
   Coulbault L, 2005, BIOCHEM BIOPH RES CO, V329, P1152, DOI 10.1016/j.bbrc.2005.02.083
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Dubowitz C., 2007, MUSCLE BIOPSY PRACTI, V3rd
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Hall AM, 2008, QJM-INT J MED, V101, P755, DOI 10.1093/qjmed/hcn060
   Hao HL, 1997, MOL CELL BIOL, V17, P6831, DOI 10.1128/MCB.17.12.6831
   King T.E., 1967, METHODS ENZYMOLOGY, V10, P322, DOI [10.1016/0076-6879(67)10061-X, DOI 10.1016/0076-6879(67)10061-X]
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   Levinger L, 2003, NUCLEIC ACIDS RES, V31, P1904, DOI 10.1093/nar/gkg282
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Marotta M, 2007, NEUROMUSCULAR DISORD, V17, P707, DOI 10.1016/j.nmd.2007.05.007
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   SEIBEL P, 1994, BIOCHEM BIOPH RES CO, V204, P482, DOI 10.1006/bbrc.1994.2485
   Sissler M, 2004, RNA, V10, P841, DOI 10.1261/rna.5267604
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x
   Ueki I, 2006, MITOCHONDRION, V6, P29, DOI 10.1016/j.mito.2005.10.003
   Xayaphoummine A, 2005, NUCLEIC ACIDS RES, V33, pW605, DOI 10.1093/nar/gki447
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008
NR 33
TC 4
Z9 5
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD APR
PY 2013
VL 23
IS 4
BP 330
EP 336
DI 10.1016/j.nmd.2013.01.001
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 127LY
UT WOS:000317701700008
PM 23375258
DA 2024-11-01
ER

PT J
AU Shanske, S
   Pancrudo, J
   Kaufmann, P
   Engelstad, K
   Jhung, S
   Lu, JS
   Naini, A
   DiMauro, S
   De Vivo, DC
AF Shanske, S
   Pancrudo, J
   Kaufmann, P
   Engelstad, K
   Jhung, S
   Lu, JS
   Naini, A
   DiMauro, S
   De Vivo, DC
TI Varying loads of the mitochondrial DNA A3243G mutation in different
   tissues: Implications for diagnosis
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
ID STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; POINT MUTATION; MELAS SYNDROME;
   BLOOD; ENCEPHALOMYOPATHY; ENCEPHALOPATHY; MYOPATHY; SUBTYPE; MUSCLE
AB Testing for common mutations in mitochondrial DNA (mtDNA), including the A3243G MELAS (mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes) mutation, is routinely done in DNA isolated from blood. Since the blood level of the A3243G mutation may be low in probands and even lower in asymptomatic or oligosymptomatic maternal relatives, we assessed the proportion of A3243G mutant genomes in other accessible tissues. We studied five tissues (leukocytes, skin fibroblasts, hair roots, urinary sediment, and cheek mucosa) in 61 individuals from 22 families harboring the A3243G mutation. Although mutational loads varied widely among these tissues, as a rule DNA from urinary sediment had the highest and blood the lowest proportion of mutant genomes; individual hair roots differed markedly from one another; fibroblasts and cheek mucosa tended to have higher mutation loads than blood but lower than urinary sediment. In all individuals in whom the mutation was detectable in blood, it was also detected in other tissues. Conversely, in some individuals the mutation was undetectable in blood but clearly present in other tissues. We conclude that urinary sediment and cheek mucosa are tissues of choice for the diagnosis of mtDNA mutations, as they are easy to obtain and the mutation load is almost always greater than in blood. (C) 2004 Wiley-Liss, Inc.
C1 Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
   Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA.
C3 Columbia University; Columbia University
RP Columbia Univ Coll Phys & Surg, Dept Neurol, 630 W 168th St, New York, NY 10032 USA.
EM sd12@columbia.edu
FU NICHD NIH HHS [P01HD32062] Funding Source: Medline; NINDS NIH HHS
   [NS11766] Funding Source: Medline
CR CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   POULTON J, 1993, ANN NEUROL, V34, P116, DOI 10.1002/ana.410340124
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
NR 14
TC 94
Z9 101
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD OCT 1
PY 2004
VL 130A
IS 2
BP 134
EP 137
DI 10.1002/ajmg.a.30220
PG 4
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 858HV
UT WOS:000224183800004
PM 15372523
DA 2024-11-01
ER

PT J
AU Ferreira, M
   Evangelista, T
   Almeida, LS
   Martins, J
   Macario, MC
   Martins, E
   Moleirinho, A
   Azevedo, L
   Vilarinho, L
   Santorelli, FM
AF Ferreira, Mariana
   Evangelista, Teresinha
   Almeida, Ligia S.
   Martins, Joao
   Macario, Maria Carmo
   Martins, Esmeralda
   Moleirinho, Ana
   Azevedo, Luisa
   Vilarinho, Laura
   Santorelli, Filippo M.
TI Relative frequency of known causes of multiple mtDNA deletions: Two
   novel <i>POLG</i> mutations
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Multiple deletions; POLG; Mitochondrial disorders; Cancer; mtDNA;
   Oxidative metabolism
ID MITOCHONDRIAL-DNA DELETIONS; DISORDERS; DISEASE; PHENOTYPES; SPECTRUM;
   CRITERIA; ADULTS; COMMON
AB Diseases affecting mtDNA stability, termed nuclear mitochondrial intergenomic communication disorders, are caused by a primary nuclear gene defect resulting in multiple mtDNA deletions.
   The aim of this study was to estimate the frequency of known etiologies and the spectrum of mutations in a cohort of 21 patients harboring multiple mtDNA deletions in skeletal muscle.
   We showed that 10 cases (48%) display mutations in POLG, including eight previously reported variants and two novel mutations (namely, p.Trp585X and p.Arg1081Gln). The novel mutations affect evolutionary conserved residues and were absent in a large set of control chromosomes. These findings expand the array of mutations associated with multiple rearranged mtDNA attributed to mutations in POLG. The relatively high diagnostic yield (about one in two cases) supports the notion that it is recommended to test POLG routinely in diagnostic laboratories whenever multiple mtDNA deletions are present, regardless of the age of onset of patients and their clinical phenotype. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Ferreira, Mariana; Almeida, Ligia S.; Vilarinho, Laura] INSA, Ctr Genet Med Jacinto de Magalhaes, P-4099028 Oporto, Portugal.
   [Evangelista, Teresinha] Hosp Santa Maria, Serv Neurol, Lisbon, Portugal.
   [Martins, Joao] Hosp Egas Moniz, Serv Neurol, Lisbon, Portugal.
   [Macario, Maria Carmo] Hosp Univ Coimbra, Serv Neurol, Coimbra, Portugal.
   [Martins, Esmeralda] Ctr Hosp Porto, Unidade Doencas Metab, Oporto, Portugal.
   [Moleirinho, Ana; Azevedo, Luisa] Univ Porto, Inst Patol & Imunol, Oporto, Portugal.
   [Santorelli, Filippo M.] IRCCS Fdn Stella Maris, Pisa, Italy.
C3 Universidade de Lisboa; Hospital Santa Maria; Egas Moniz Hospital;
   Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra
   (CHUC); Universidade do Porto; IRCCS Fondazione Stella Maris
RP Vilarinho, L (corresponding author), INSA, Ctr Genet Med Jacinto de Magalhaes, Praca Pedro Nunes 88, P-4099028 Oporto, Portugal.
EM laura.vilarinho@insa.min-saude.pt; filippo3364@gmail.com
RI Moleirinho, Ana/I-5455-2013; de Carvalho, Mamede/I-6295-2019; Azevedo,
   Luisa/J-4051-2013; Santorelli, Filippo M/ABE-5124-2020
OI Martins, Esmeralda/0000-0002-9247-9391; Martins,
   Joao/0000-0003-2123-8977; Ferreira, Mariana/0009-0005-3888-7000;
   Azevedo, Luisa/0000-0002-3157-7342; Almeida, Ligia/0000-0003-1370-961X;
   Santorelli, Filippo M/0000-0002-1359-9062; Vilarinho,
   Laura/0000-0001-6186-779X
FU Portuguese Ministry of Health [PTDC/CVT/64154/2006]; Portuguese
   Foundation for Science and Technology [FCT-SFRH/BD/28197/2006]; FCT
   [C2008/INSA/P4, C2007/IPATIMUP/AA1]; European Social Fund; Italian
   Ministry of Health; Fundação para a Ciência e a Tecnologia
   [PTDC/CVT/64154/2006] Funding Source: FCT
FX This work was partially supported by the Portuguese Ministry of Health
   and by research project PTDC/CVT/64154/2006. MF holds a fellowship from
   the Portuguese Foundation for Science and Technology
   (FCT-SFRH/BD/28197/2006). LSA is supported by FCT (C2008/INSA/P4). LA is
   supported by FTC (C2007/IPATIMUP/AA1) and by European Social Fund.
   IPATIMUP is an Associate Laboratory of the Portuguese Ministry of
   Science, Technology and Higher Education and it is partially supported
   by FCT. FMS is supported by a grant from the Italian Ministry of Health.
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Chinnery Patrick F, 2008, Neuromuscul Disord, V18, P259, DOI 10.1016/j.nmd.2007.11.005
   Copeland WC, 2002, CANCER INVEST, V20, P557, DOI 10.1081/CNV-120002155
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Lamperti C, 2009, Acta Myol, V28, P2
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601
   Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802
   Palin EJH, 2010, BBA-MOL BASIS DIS, V1802, P545, DOI 10.1016/j.bbadis.2010.02.003
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
NR 24
TC 15
Z9 17
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUL
PY 2011
VL 21
IS 7
BP 483
EP 488
DI 10.1016/j.nmd.2011.03.011
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 805IF
UT WOS:000293719400005
PM 21550804
DA 2024-11-01
ER

PT J
AU Ding, Y
   Leng, JH
AF Ding, Yu
   Leng, Jianhang
TI Is mitochondrial tRNA<SUP>Leu(UUR)</SUP> 3291T&gt;C mutation pathogenic?
SO MITOCHONDRIAL DNA
LA English
DT Article
DE Mitochondrial tRNA(Leu(UUR)); 3291T > C mutation; phylogenetic analysis;
   minimum free energy
ID DNA
AB According to a recent report by Sunami et al., a maternally inherited Japanese family with variable phenotypes including mitochondrial myopathy, recurrent headache, and myoclonus and epilepsy had been described to be associated with mitochondrial tRNA(Leu(UUR)) 3291T > C mutation. In order to verify this association, we reanalyzed the clinical and molecular datasets obtained from Sunami's work; in addition, a phylogenetic approach was employed to evaluate the conservation index of this mutation among different species. We further utilized RNA Fold Web Server to predict the minimum free energy (MFE) of tRNA(Leu(UUR)) gene with and without this mutation. Most strikingly, a low level of conservation was found regarding 3291T > C mutation and a slight change in MFE had been observed between the wild type and the mutant. Our negative results gave no support for an active role for this mutation on the clinical expression of mitochondrial disorders.
C1 [Ding, Yu; Leng, Jianhang] Nanjing Med Univ, Cent Lab, Hangzhou Peoples Hosp 1, Hangzhou, Zhejiang, Peoples R China.
   [Ding, Yu; Leng, Jianhang] Nanjing Med Univ, Affiliated Hangzhou Hosp, Hangzhou, Zhejiang, Peoples R China.
C3 Nanjing Medical University; Nanjing Medical University
RP Leng, JH (corresponding author), Nanjing Med Univ, Cent Lab, Hangzhou Peoples Hosp 1, Hangzhou, Zhejiang, Peoples R China.
EM lengjh5@gmail.com
FU Nanjing Medical University [2010NJMU011]; Ministry of Science and
   Technology of Zhejiang Province [2008R40G2090027]
FX We thank all the members in our laboratory for discussion. This work was
   supported by the grants from Nanjing Medical University (No.
   2010NJMU011) and Ministry of Science and Technology of Zhejiang Province
   (No. 2008R40G2090027).
CR Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   Freyhult E, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-241
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188
   Park CB, 2011, J CELL BIOL, V5, P809
   Salsano E, 2011, J NEUROL SCI, V300, P165, DOI 10.1016/j.jns.2010.09.022
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Sunami Y, 2011, NEUROL SCI, V32, P861, DOI 10.1007/s10072-011-0719-9
   Uziel G, 2000, NEUROMUSCULAR DISORD, V10, P415, DOI 10.1016/S0960-8966(99)00115-7
   Woischnik M, 2002, GENOME RES, V12, P885, DOI 10.1101/gr.227202
   Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133
NR 14
TC 12
Z9 12
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1940-1736
EI 1940-1744
J9 MITOCHONDR DNA
JI Mitochondrial DNA
PD AUG
PY 2012
VL 23
IS 4
BP 323
EP 326
DI 10.3109/19401736.2012.674119
PG 4
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 967JX
UT WOS:000305904700023
PM 22471645
DA 2024-11-01
ER

PT J
AU Jang, YO
   Quan, XL
   Das, R
   Xu, SH
   Chung, CH
   Ahn, CM
   Baik, SK
   Kong, ID
   Park, KS
   Kim, MY
AF Jang, Yoon-Ok
   Quan, Xianglan
   Das, Ranjan
   Xu, Shanhua
   Chung, Choon-Hee
   Ahn, Chan Mug
   Baik, Soon-Koo
   Kong, In Deok
   Park, Kyu-Sang
   Kim, Moon Young
TI High-dose clevudine impairs mitochondrial function and
   glucose-stimulated insulin secretion in INS-1E cells
SO BMC GASTROENTEROLOGY
LA English
DT Article
DE clevudine; mitochondrial DNA; mitochondrial dysfunction;
   glucose-stimulated insulin secretion
ID CHRONIC HEPATITIS-B; DNA-POLYMERASE-GAMMA; REVERSE-TRANSCRIPTASE
   INHIBITORS; IN-VIVO; NUCLEOSIDE; DEPLETION; MYOPATHY; THERAPY;
   HEPATOCYTES; OXIDATION
AB Background: Clevudine is a nucleoside analog reverse transcriptase inhibitor that exhibits potent antiviral activity against hepatitis B virus (HBV) without serious side effects. However, mitochondrial myopathy has been observed in patients with chronic HBV infection taking clevudine. Moreover, the development of diabetes was recently reported in patients receiving long-term treatment with clevudine. In this study, we investigated the effects of clevudine on mitochondrial function and insulin release in a rat clonal beta-cell line, INS-1E.
   Methods: The mitochondrial DNA (mtDNA) copy number and the mRNA levels were measured by using quantitative PCR. MTT analysis, ATP/lactate measurements, and insulin assay were performed.
   Results: Both INS-1E cells and HepG2 cells, which originated from human hepatoma, showed dose-dependent decreases in mtDNA copy number and cytochrome c oxidase-1 (Cox-1) mRNA level following culture with clevudine (10 mu M-1 mM) for 4 weeks. INS-1E cells treated with clevudine had reduced total mitochondrial activities, lower cytosolic ATP contents, enhanced lactate production, and more lipid accumulation. Insulin release in response to glucose application was markedly decreased in clevudine-treated INS-1E cells, which might be a consequence of mitochondrial dysfunction.
   Conclusions: Our data suggest that high-dose treatment with clevudine induces mitochondrial defects associated with mtDNA depletion and impairs glucose-stimulated insulin secretion in insulin-releasing cells. These findings partly explain the development of diabetes in patients receiving clevudine who might have a high susceptibility to mitochondrial toxicity.
C1 [Quan, Xianglan; Das, Ranjan; Xu, Shanhua; Kong, In Deok; Park, Kyu-Sang] Yonsei Univ, Wonju Coll Med, Dept Physiol, Wonju 220701, South Korea.
   [Jang, Yoon-Ok; Chung, Choon-Hee; Baik, Soon-Koo; Kim, Moon Young] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju 220701, South Korea.
   [Ahn, Chan Mug] Yonsei Univ, Wonju Coll Med, Dept Basic Sci, Wonju 220701, South Korea.
   [Chung, Choon-Hee; Ahn, Chan Mug; Baik, Soon-Koo; Kong, In Deok; Park, Kyu-Sang; Kim, Moon Young] Yonsei Univ, Wonju Coll Med, Inst Lifestyle Med, Wonju 220701, South Korea.
C3 Yonsei University; Yonsei University; Yonsei University; Yonsei
   University
RP Park, KS (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Physiol, Wonju 220701, South Korea.
EM qsang@yonsei.ac.kr; drkimmy@yonsei.ac.kr
RI ; DAS, RANJAN/AFQ-6329-2022
OI Chung, Choon/0000-0003-1144-7206; Park, Kyu-Sang/0000-0003-0322-9807;
   DAS, RANJAN/0000-0002-7951-4121
FU Korean National Research Foundation [2010-0014617]; Yonsei University,
   Wonju College of Medicine [YUWCM-2009-19]
FX This study was supported by a grant from Korean National Research
   Foundation (2010-0014617) and a research grant from Yonsei University,
   Wonju College of Medicine (YUWCM-2009-19).
CR Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062
   Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624
   Fleischer RD, 2009, J HEPATOL, V51, P787, DOI 10.1016/j.jhep.2009.06.011
   FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6
   Goto M, 2003, J MED VIROL, V70, P497, DOI 10.1002/jmv.10423
   Igoudjil A, 2008, TOXICOL IN VITRO, V22, P887, DOI 10.1016/j.tiv.2008.01.011
   Jang JH, 2011, J VIRAL HEPATITIS, V18, P84, DOI 10.1111/j.1365-2893.2010.01281.x
   Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374
   Kim HJ, 2010, LIVER INT, V30, P834, DOI 10.1111/j.1478-3231.2010.02245.x
   Kwon SY, 2010, J VIROL, V84, P4494, DOI 10.1128/JVI.02066-09
   Lebrecht D, 2008, ARTHRITIS RHEUM-US, V58, P318, DOI 10.1002/art.23235
   Lebrecht D, 2007, HEPATOLOGY, V45, P72, DOI 10.1002/hep.21490
   Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   Mallon PWG, 2005, J INFECT DIS, V191, P1686, DOI 10.1086/429697
   Miró O, 1998, J NEUROSCI METH, V80, P107, DOI 10.1016/S0165-0270(97)00204-5
   Niu C, 2008, ANTIVIR THER, V13, P263
   Nolan D, 2003, AIDS, V17, P1329, DOI 10.1097/00002030-200306130-00007
   Pai SB, 1996, ANTIMICROB AGENTS CH, V40, P380, DOI 10.1128/AAC.40.2.380
   Pan-Zhou XR, 2000, ANTIMICROB AGENTS CH, V44, P496, DOI 10.1128/AAC.44.3.496-503.2000
   Park KS, 2008, J BIOL CHEM, V283, P33347, DOI 10.1074/jbc.M806251200
   Pinti M, 2006, BBA-BIOENERGETICS, V1757, P700, DOI 10.1016/j.bbabio.2006.05.001
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Seok JI, 2009, HEPATOLOGY, V49, P2080, DOI 10.1002/hep.22959
   Sorrell MF, 2009, ANN INTERN MED, V150, P104, DOI 10.7326/0003-4819-150-2-200901200-00100
   Stankov MV, 2007, ANTIVIR THER, V12, P205
   Tak WY, 2010, J HEPATOL, V53, P261, DOI 10.1016/j.jhep.2010.03.006
   Tak WY, 2009, HEPATOL RES, V39, P944, DOI 10.1111/j.1872-034X.2009.00515.x
   Wang CH, 2010, ANN NY ACAD SCI, V1201, P157, DOI 10.1111/j.1749-6632.2010.05625.x
   Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
   Yao GQ, 1996, BIOCHEM PHARMACOL, V51, P941, DOI 10.1016/0006-2952(96)00049-4
   김건우, 2010, [The Korean Journal of Medicine, 대한내과학회지], V79, P569
NR 36
TC 6
Z9 6
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-230X
J9 BMC GASTROENTEROL
JI BMC Gastroenterol.
PD JAN 10
PY 2012
VL 12
AR 4
DI 10.1186/1471-230X-12-4
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 902MC
UT WOS:000301041400001
PM 22230186
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Zarrouk-Mahjoub, S
   Daruich, A
AF Finsterer, Josef
   Zarrouk-Mahjoub, Sinda
   Daruich, Alejandra
TI The Eye on Mitochondrial Disorders
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Review
DE optic; nerve; ophthalmologic; eye; retina; vision; cataract; ptosis;
   mitochondrial disease
ID HEREDITARY OPTIC NEUROPATHY; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   COMPLEX I DEFICIENCY; OF-THE-LITERATURE; POINT MUTATION; DNA DELETION;
   PONTOCEREBELLAR HYPOPLASIA; WOLFRAM-SYNDROME; MISSENSE MUTATION; MACULAR
   DYSTROPHY
AB Ophthalmologic manifestations of mitochondrial disorders are frequently neglected or overlooked because they are often not regarded as part of the phenotype. This review aims at summarizing and discussing the etiology, pathogenesis, diagnosis, and treatment of ophthalmologic manifestations of mitochondrial disorders. Review of publications about ophthalmologic involvement in mitochondrial disorders by search of Medline applying appropriate search terms. The eye is frequently affected by syndromic as well as nonsyndromic mitochondrial disorders. Primary and secondary ophthalmologic manifestations can be differentiated. The most frequent ophthalmologic manifestations of mitochondrial disorders include ptosis, progressive external ophthalmoplegia, optic atrophy, retinopathy, and cataract. More rarely occurring are nystagmus and abnormalities of the cornea, ciliary body, intraocular pressure, the choroidea, or the brain secondarily affecting the eyes. It is important to recognize and diagnose ophthalmologic manifestations of mitochondrial disorders as early as possible because most are accessible to symptomatic treatment with partial or complete short-term or long-term beneficial effect. Ophthalmologic manifestations of mitochondrial disorders need to be appropriately diagnosed to initiate the most effective management and guarantee optimal outcome.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
   [Zarrouk-Mahjoub, Sinda] Pasteur Inst Tunis, Genom Platform, Tunis, Tunisia.
   [Daruich, Alejandra] Univ Lausanne, Jules Gonin Eye Hosp, Dept Ophthalmol, CH-1015 Lausanne, Switzerland.
C3 Rudolfstiftung Hospital; Pasteur Network; Universite de Tunis-El-Manar;
   Institut Pasteur Tunis; University of Lausanne
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
OI ZARROUK-MAHJOUB, SINDA/0000-0002-6763-4644
CR Al-Enezi M, 2008, MIDDLE EAST AFR J OP, V15, P81, DOI 10.4103/0974-9233.51998
   ALDENHOVEL HBG, 1991, NEUROPEDIATRICS, V22, P103, DOI 10.1055/s-2008-1071426
   Ali N, 2010, J NEURO-OPHTHALMOL, V30, P153, DOI 10.1097/WNO.0b013e3181dbfdcd
   Anesi L, 2011, J MOL NEUROSCI, V43, P346, DOI 10.1007/s12031-010-9448-4
   Banerjee D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070760
   Barboni P, 2004, GRAEF ARCH CLIN EXP, V242, P878, DOI 10.1007/s00417-004-0914-y
   Barrientos A, 1997, HUM MUTAT, V10, P212
   Bekir NA, 2000, ACTA OPHTHALMOL SCAN, V78, P480, DOI 10.1034/j.1600-0420.2000.078004480.x
   Bekri S, 1993, GENEREVIEWS
   Bene J, 2003, EUR J HUM GENET, V11, P375, DOI 10.1038/sj.ejhg.5200975
   Bostan A, 2012, AUTON NEUROSCI-BASIC, V170, P70, DOI 10.1016/j.autneu.2012.06.002
   Bremner FD, 1999, INVEST OPHTH VIS SCI, V40, P2528
   Burglen L, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-18
   Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024
   Carta A, 2005, BRIT J OPHTHALMOL, V89, P825, DOI 10.1136/bjo.2004.060590
   Chinnery PF, 1997, NEUROLOGY, V49, P1166, DOI 10.1212/WNL.49.4.1166
   Choi SY, 2012, J NEURO-OPHTHALMOL, V32, P135, DOI 10.1097/WNO.0b013e31824d2a15
   Da Pozzo P, 2009, EUR J HUM GENET, V17, P1092, DOI 10.1038/ejhg.2009.12
   Daruich A, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-77
   Delgado-Alvarado M, 2015, J NEUROL SCI, V350, P93, DOI 10.1016/j.jns.2015.02.011
   Dhalla MS, 2006, CAN J OPHTHALMOL, V41, P38, DOI 10.1016/S0008-4182(06)80064-5
   Dilber E, 2002, J CHILD NEUROL, V17, P64, DOI 10.1177/088307380201700119
   Filiano JJ, 2002, PEDIATR NEUROL, V26, P239, DOI 10.1016/S0887-8994(01)00377-0
   Finsterer J, 2005, ACTA OPHTHALMOL SCAN, V83, P628, DOI 10.1111/j.1600-0420.2005.00518.x
   Finsterer J, 2013, CAN J NEUROL SCI, V40, P635, DOI 10.1017/S0317167100014852
   Finsterer J, 2013, NEUROL INT, V5, P28, DOI 10.4081/ni.2013.e9
   Finsterer J, 2010, ACTA NEUROL BELG, V110, P110
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gendron SP, 2013, MUTAGENESIS, V28, P197, DOI 10.1093/mutage/ges071
   Gorman GS, 2011, SAUDI J OPHTHALMOL, V25, P395, DOI 10.1016/j.sjopt.2011.02.002
   Grau T, 2013, J MED GENET, V50, P848, DOI 10.1136/jmedgenet-2013-101774
   Grönlund MA, 2010, BRIT J OPHTHALMOL, V94, P121, DOI 10.1136/bjo.2008.154187
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Han J, 2015, BRIT J OPHTHALMOL, V99, P528, DOI 10.1136/bjophthalmol-2014-305704
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   Hayashi N, 2000, OPHTHALMOLOGY, V107, P1397, DOI 10.1016/S0161-6420(00)00110-X
   Heidary G, 2014, J NEURO-OPHTHALMOL, V34, P39, DOI 10.1097/WNO.0000000000000076
   Heiduschka P, 2010, INVEST OPHTH VIS SCI, V51, P1424, DOI 10.1167/iovs.09-3606
   Inagaki Y, 2006, JPN J OPHTHALMOL, V50, P128, DOI 10.1007/s10384-005-0290-0
   Isashiki Y, 1998, ACTA OPHTHALMOL SCAN, V76, P6, DOI 10.1034/j.1600-0420.1998.760103.x
   Ji JQ, 2010, MITOCHONDRION, V10, P188, DOI 10.1016/j.mito.2009.11.002
   Kasbekar SA, 2013, OPHTHALMIC GENET, V34, P55, DOI 10.3109/13816810.2011.610862
   Kiliç M, 2011, TURKISH J PEDIATR, V53, P79
   Kuncl R. W., 1999, WALSH HOYTS CLIN NEU, P1351
   La Morgia C, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-116
   Lachmund U, 2006, KLIN MONATSBL AUGENH, V223, P393, DOI 10.1055/s-2006-926559
   Lee JJ, 2012, PEDIATR NEPHROL, V27, P869, DOI 10.1007/s00467-011-2096-2
   Liskova P, 2013, ACTA OPHTHALMOL, V91, pE225, DOI 10.1111/aos.12038
   Lonnqvist Tuula, 2011, Duodecim, V127, P1460
   Maguluri Sri, 2007, Retin Cases Brief Rep, V1, P239, DOI 10.1097/01.iae.0000225281.84558.84
   MAKELABENGS P, 1995, PEDIATR RES, V37, P634
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   Metodiev MD, 2014, J MED GENET, V51, P834, DOI 10.1136/jmedgenet-2014-102532
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   Mori M, 2014, JIMD REP, V17, P47, DOI 10.1007/8904_2014_332
   Müller-Vahl KR, 2000, MUSCLE NERVE, V23, P647
   Nakaso K, 2012, J CLIN NEUROL, V8, P230, DOI 10.3988/jcn.2012.8.3.230
   Nikali K, 2009, GENEREVIEWS
   O'Neill EC, 2011, OPHTHALMOLOGY, V118, P964, DOI 10.1016/j.ophtha.2010.09.002
   Pablo LE, 2011, MOL VIS, V17
   Pathak D, 2011, MOL VIS, V17, P1514
   Payne M, 2004, AM J OPHTHALMOL, V138, P749, DOI 10.1016/j.ajo.2004.06.011
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Ponjavic V, 1996, ACTA OPHTHALMOL SCAN, V74, P632
   Rath PP, 2008, BRIT J OPHTHALMOL, V92, P623, DOI 10.1136/bjo.2007.131177
   Robberecht K, 2010, OPHTHALMIC GENET, V31, P240, DOI 10.3109/13816810.2010.520297
   Rose LVT, 2008, PEDIATR NEUROL, V38, P395, DOI 10.1016/j.pediatrneurol.2008.02.003
   RUMMELT V, 1993, OPHTHALMOLOGY, V100, P1757
   Schmitz K, 2003, CORNEA, V22, P267, DOI 10.1097/00003226-200304000-00019
   Shinmei Y, 2007, J NEURO-OPHTHALMOL, V27, P22, DOI 10.1097/WNO.0b013e3180334cb0
   SIEVERDING L, 1988, KLIN PADIATR, V200, P381, DOI 10.1055/s-2008-1033738
   Sonmez FM, 2012, GENET COUNSEL, V23, P347
   Taban M, 2006, J CHILD NEUROL, V21, P956, DOI 10.1177/08830738060210111601
   Tanaka Koji, 2013, Rinsho Shinkeigaku, V53, P205
   Titah SMC, 2012, EUR J OPHTHALMOL, V22, P254, DOI 10.5301/EJO.2011.8370
   Tyni T, 2004, PEDIATR RES, V56, P744, DOI 10.1203/01.PDR.0000141967.52759.83
   Valentino ML, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037507
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Wang K, 2009, NEUROGENETICS, V10, P337, DOI 10.1007/s10048-009-0194-0
   Weitgasser L, 2015, ARCH PLAST SURG-APS, V42, P214, DOI 10.5999/aps.2015.42.2.214
   Wojcik Katarzyna A, 2013, Klin Oczna, V115, P311
   Yu-Wai-Man P, 2010, J MED GENET, V47, P120, DOI 10.1136/jmg.2009.067512
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Yu-Wai-Man P., 1993, GENEREVIEWS
   Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
NR 86
TC 23
Z9 24
U1 0
U2 8
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD APR
PY 2016
VL 31
IS 5
BP 652
EP 662
DI 10.1177/0883073815599263
PG 11
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA DH5HY
UT WOS:000372818400017
PM 26275973
OA Bronze, Green Accepted
DA 2024-11-01
ER

PT J
AU Gago, MF
   Rosas, MJ
   Guirnaraes, J
   Ferreira, M
   Vilarinho, L
   Castro, L
   Carpenter, S
AF Gago, Miguel Fernandes
   Rosas, M. J.
   Guirnaraes, Joana
   Ferreira, Mariana
   Vilarinho, Laura
   Castro, Ligia
   Carpenter, Stirling
TI SANDO: Two novel mutations in POLG1 gene
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE SANDO; sensory ataxic neuropathy; dysarthria; ophthalmoparesis; POLG1
   gene
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; POLYMERASE-GAMMA MUTATIONS;
   SENSORY ATAXIC NEUROPATHY; MITOCHONDRIAL
AB Sensory ataxia with neuropathy, dysarthria and ophthalmoparesis represent the clinical triad of SANDO, a specific mitochondrial phenotype first reported in 1997 in association with multiple mitochondrial DNA deletions and mutations in POLGI or more rarely in the C10orf2 (twinkle-helicase) gene. We report a 44-year-old man with SANDO who harboured two novel mutations (P648R/R807C) in the POLGI gene. (C) 2006 Elsevier B.V. All rights reserved.
C1 Hosp Sao Joao, Dept Neurol, Oporto, Portugal.
C3 Sao Joao Hospital
RP Gago, MF (corresponding author), Hosp Sao Joao, Dept Neurol, Oporto, Portugal.
EM miguelfgago@yahoo.com
RI Guimarães, Joana/IXD-8762-2023; Gago, Miguel Fernandes/F-2355-2015
OI Guimaraes, Joana/0000-0003-1540-1395; Ferreira,
   Mariana/0009-0005-3888-7000; Gago, Miguel Fernandes/0000-0003-0894-6207
CR Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 10
TC 35
Z9 40
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD AUG
PY 2006
VL 16
IS 8
BP 507
EP 509
DI 10.1016/j.nmd.2006.05.016
PG 3
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 101RV
UT WOS:000241759100007
PM 16919951
DA 2024-11-01
ER

PT J
AU Ohsawa, Y
   Hagiwara, H
   Nishimatsu, SI
   Hirakawa, A
   Kamimura, N
   Ohtsubo, H
   Fukai, Y
   Murakami, T
   Koga, Y
   Goto, YI
   Ohta, S
   Sunada, Y
   Onoue, H
   Kaida, K
   Sato, K
   Uchiyama, T
   Ueda, A
   Mutoh, T
   Nakamura, M
   Nishida, K
   Funakawa, I
   Ogawa, A
   Nakata, R
   Shiraishi, H
   Tsujino, A
   Takahashi, T
   Matsumoto, M
AF Ohsawa, Yutaka
   Hagiwara, Hiroki
   Nishimatsu, Shin-ichiro
   Hirakawa, Akihiro
   Kamimura, Naomi
   Ohtsubo, Hideaki
   Fukai, Yuta
   Murakami, Tatsufumi
   Koga, Yasutoshi
   Goto, Yu-ichi
   Ohta, Shigeo
   Sunada, Yoshihide
   Onoue, H.
   Kaida, K.
   Sato, K.
   Uchiyama, T.
   Ueda, A.
   Mutoh, T.
   Nakamura, M.
   Nishida, K.
   Funakawa, I.
   Ogawa, A.
   Nakata, R.
   Shiraishi, H.
   Tsujino, A.
   Takahashi, T.
   Matsumoto, M.
CA KN01 Study Grp
TI Taurine supplementation for prevention of stroke-like episodes in MELAS:
   a multicentre, open-label, 52-week phase III trial
SO JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
LA English
DT Article
ID WOBBLE MODIFICATION DEFICIENCY; TRANSFER RNALEU(UUR) GENE; MITOCHONDRIAL
   MYOPATHY; LACTIC-ACIDOSIS; TRANSFER-RNA; MODIFICATION DEFECT;
   ENCEPHALOPATHY; MUTATION
AB Objective The aim of this study was to evaluate the efficacy and safety of high-dose taurine supplementation for prevention of stroke-like episodes of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes), a rare genetic disorder caused by point mutations in the mitochondrial DNA that lead to a taurine modification defect at the first anticodon nucleotide of mitochondrial tRNA(Leu(UUR)), resulting in failure to decode codons accurately.
   Methods After the nationwide survey of MELAS, we conducted a multicentre, open-label, phase III trial in which 10 patients with recurrent stroke-like episodes received high-dose taurine (9 g or 12 g per day) for 52 weeks. The primary endpoint was the complete prevention of stroke-like episodes during the evaluation period. The taurine modification rate of mitochondrial tRNA(Leu(UUR)) was measured before and after the trial.
   Results The proportion of patients who reached the primary endpoint (100% responder rate) was 60% (95% CI 26.2% to 87.8%). The 50% responder rate, that is, the number of patients achieving a 50% or greater reduction in frequency of stroke-like episodes, was 80% (95% CI 44.4% to 97.5%). Taurine reduced the annual relapse rate of stroke-like episodes from 2.22 to 0.72 (P=0.001). Five patients showed a significant increase in the taurine modification of mitochondrial tRNA(Leu(UUR)) from peripheral blood leukocytes (P<0.05). No severe adverse events were associated with taurine.
   Conclusions The current study demonstrates that oral taurine supplementation can effectively reduce the recurrence of stroke-like episodes and increase taurine modification in mitochondrial tRNA(Leu(UUR)) in MELAS.
C1 [Ohsawa, Yutaka; Ohtsubo, Hideaki; Fukai, Yuta; Murakami, Tatsufumi; Sunada, Yoshihide] Kawasaki Med Sch, Dept Neurol, Kurashiki, Okayama 7010192, Japan.
   [Hagiwara, Hiroki] Teikyo Univ Sci, Dept Med Sci, Adachi Ku, Tokyo, Japan.
   [Nishimatsu, Shin-ichiro] Kawasaki Med Sch, Dept Nat Sci, Kurashiki, Okayama, Japan.
   [Hirakawa, Akihiro] Nagoya Univ Hosp, Stat Anal Sect, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan.
   [Hirakawa, Akihiro] Univ Tokyo, Dept Biostat & Bioinformat, Grad Sch Med, Tokyo, Japan.
   [Kamimura, Naomi; Ohta, Shigeo] Nippon Med Sch, Grad Sch Med, Dept Biochem & Cell Biol, Tokyo, Japan.
   [Koga, Yasutoshi] Kurume Univ, Grad Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan.
   [Ohta, Shigeo] Juntendo Univ, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo, Japan.
   [Onoue, H.; Kaida, K.] Natl Def Med Coll Hosp, Tokyo, Japan.
   [Sato, K.; Uchiyama, T.] Seirei Hamamatsu Gen Hosp, Shizuoka, Japan.
   [Ueda, A.; Mutoh, T.] Fujita Hlth Univ Sch Hosp, Toyoake, Aichi, Japan.
   [Nakamura, M.] Natl Hosp Org Kyoto Med Ctr, Kyoto, Japan.
   [Nishida, K.; Funakawa, I.] Natl Hosp Org Hyogo Chuo Natl Hosp, Kobe, Hyogo, Japan.
   [Ogawa, A.] Fukuoka Univ, Chikushi Hosp, Fukuoka, Fukuoka, Japan.
   [Nakata, R.; Shiraishi, H.; Tsujino, A.] Nagasaki Univ Hosp, Nagasaki, Japan.
   [Takahashi, T.; Matsumoto, M.] Hiroshima Univ Hosp, Hiroshima, Japan.
C3 Kawasaki Medical School; Kawasaki Medical School; Nagoya University;
   University of Tokyo; Nippon Medical School; Kurume University; National
   Center for Neurology & Psychiatry - Japan; Juntendo University; Fukuoka
   University; Nagasaki University; Hiroshima University
RP Sunada, Y (corresponding author), Kawasaki Med Sch, Dept Neurol, Kurashiki, Okayama 7010192, Japan.
EM ysunada@med.kawasaki-m.ac.jp
RI Ohta, Shigeo/HKO-9826-2023; Hirakawa, Akihiro/HSE-0043-2023; Mutoh,
   Tatsuro/H-4317-2019
OI Murakami, Tatsufumi/0000-0001-7851-6822; Ohta,
   Shigeo/0000-0002-2539-470X; Koga, Yasutoshi/0000-0002-6664-1295
FU Research on Rare and Intractable Diseases, Health and Labour Sciences
   Research Grants from the Ministry of Health, Labour and Welfare of Japan
   [H24-Nanchitou(Nan)-Ippan-068]; Japan Agency for Medical Research and
   Development (AMED) [JP15ek0109093h0001, JP16ek0109093h0002,
   JP17ek0109093h0003]
FX This study was funded by Research on Rare and Intractable Diseases,
   Health and Labour Sciences Research Grants from the Ministry of Health,
   Labour and Welfare of Japan (H24-Nanchitou(Nan)-Ippan-068) and by Japan
   Agency for Medical Research and Development (AMED) under grant numbers
   JP15ek0109093h0001, JP16ek0109093h0002 and JP17ek0109093h0003.
CR Chinnery P F, 2003, Neuromuscul Disord, V13, P757, DOI 10.1016/S0960-8966(03)00097-X
   CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0
   DiMauro S., 1993, GENEREVIEWS R
   Fakruddin M, 2018, CELL REP, V22, P482, DOI 10.1016/j.celrep.2017.12.051
   Foswiki, MITOMAP REP MIT DNA
   Torres AG, 2014, TRENDS MOL MED, V20, P306, DOI 10.1016/j.molmed.2014.01.008
   Glover EI, 2010, MUSCLE NERVE, V42, P739, DOI 10.1002/mus.21758
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rikimaru M, 2012, INTERNAL MED, V51, P3351, DOI 10.2169/internalmedicine.51.7529
   Schaffer S, 2016, AMINO ACIDS, V48, P549, DOI 10.1007/s00726-015-2110-2
   Stacpoole PW, 2011, MITOCHONDRION, V11, P679, DOI 10.1016/j.mito.2011.05.002
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 27
TC 69
Z9 74
U1 1
U2 14
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-3050
EI 1468-330X
J9 J NEUROL NEUROSUR PS
JI J. Neurol. Neurosurg. Psychiatry
PD MAY
PY 2019
VL 90
IS 5
BP 529
EP 536
DI 10.1136/jnnp-2018-317964
PG 8
WC Clinical Neurology; Psychiatry; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Psychiatry; Surgery
GA IC6XR
UT WOS:000471116400008
PM 29666206
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Zeviani, M
   Carelli, V
AF Zeviani, M
   Carelli, V
TI Dominance in mitochondrial disorders
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article; Proceedings Paper
CT 41st Annual Symposium of the SSIEM
CY AUG 31-SEP 03, 2004
CL Amsterdam, NETHERLANDS
SP SSIEM
ID HEREDITARY OPTIC NEUROPATHY; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   DYNAMIN-RELATED PROTEIN; SENSORINEURAL HEARING-LOSS; AUTOSOMAL-DOMINANT;
   MULTIPLE DELETIONS; DNA POLYMERASE; OPA1 MUTATIONS; GENE; ATROPHY
AB Dominant traits are rare in mitochondrial disorders but include important nosological entities such as alterations of organellar biogenesis and abnormalities in the structural integrity of the mitochondrial genome, determined by mutations in genes involved in its maintenance and propagation. Both haplo-insufficiency and 'gain-of-function' mechanisms underlie the pathogenesis of these disorders. Impairment in energy supply, abnormal mitochondrial trafficking, increased toxic damage by oxygen radicals, and mitochondrially driven apoptosis have been documented in different dominant syndromes. In addition, maternally inherited mutations of mitochondrial DNA can sometimes simulate dominant traits, mainly because of reduced penetrance and complex interaction with genetic and environmental factors.
C1 Ist Nazl Neurol Carlo Besta, Div Neurogenet Mol, Unit Mol Neurogenet, I-20126 Milan, Italy.
   Univ Bologna, Dept Neurol Sci, Neurogenet Lab, I-40126 Bologna, Italy.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Bologna
RP Ist Nazl Neurol Carlo Besta, Div Neurogenet Mol, Unit Mol Neurogenet, Via Temolo 4, I-20126 Milan, Italy.
EM zeviani@tin.it
RI Zeviani, Massimo/K-2891-2014
OI Zeviani, Massimo/0000-0002-9067-5508; CARELLI,
   VALERIO/0000-0003-4923-6404
FU Telethon [GGP02323, GGP030039] Funding Source: Medline
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2003, AM J OPHTHALMOL, V136, P1170, DOI 10.1016/S0002-9394(03)00665-2
   Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200
   BENOTHMANE K, 1993, GENOMICS, V17, P370
   Borrás C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4
   BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198
   Bykhovskaya Y, 2000, AM J HUM GENET, V66, P1905, DOI 10.1086/302914
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Chalmers RM, 1996, AM J HUM GENET, V59, P103
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   CHEN JD, 1989, HUM GENET, V82, P203, DOI 10.1007/BF00291154
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278
   Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573
   Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963
   Howell N, 2003, AM J HUM GENET, V72, P1460, DOI 10.1086/375537
   Howell N, 1998, AM J HUM GENET, V63, P1220, DOI 10.1086/302049
   Hutchin T, 1999, ACTA OTO-LARYNGOL, V119, P48, DOI 10.1080/00016489950181927
   Hutchin TP, 2000, CELL MOL LIFE SCI, V57, P1927, DOI 10.1007/PL00000673
   Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565
   Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kaukonen J, 1999, AM J HUM GENET, V65, P256, DOI 10.1086/302445
   Kijima K, 2005, HUM GENET, V116, P23, DOI 10.1007/s00439-004-1199-2
   KJER P, 1959, ACTA OPHTHALMOL S54, V37, P1
   Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Leber T., 1871, ARCH OPHTHALMOL-CHIC, V17, P249
   Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.e02-06-0330
   Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Macmillan C, 2000, AM J HUM GENET, V66, P332, DOI 10.1086/302716
   Man PYW, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011247
   Melberg A, 1996, MUSCLE NERVE, V19, P751
   Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200
   NEWMAN NJ, 1998, WALSH HOYTS CLIN NEU, P753
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X
   Payne M, 2004, AM J OPHTHALMOL, V138, P749, DOI 10.1016/j.ajo.2004.06.011
   Pegoraro E, 2003, AM J MED GENET A, V119A, P37, DOI 10.1002/ajmg.a.10211
   Pegoraro E, 1996, AM J MED GENET, V61, P356
   Pesch UEA, 2001, HUM MOL GENET, V10, P1359, DOI 10.1093/hmg/10.13.1359
   Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Rojo M, 2002, J CELL SCI, V115, P1663
   Santel A, 2001, J CELL SCI, V114, P867
   Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   Thiselton DL, 2002, INVEST OPHTH VIS SCI, V43, P1715
   Toomes C, 2001, HUM MOL GENET, V10, P1369, DOI 10.1093/hmg/10.13.1369
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   ZEVIANI M, 1990, AM J HUM GENET, V47, P904
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 67
TC 3
Z9 3
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD JAN
PY 2005
VL 28
IS 3
BP 287
EP 299
DI 10.1007/s10545-005-0307-3
PG 13
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 923CD
UT WOS:000228885500005
PM 15868464
DA 2024-11-01
ER

PT J
AU Song, Z
   Cao, Y
   Samuels, DC
AF Song, Zhuo
   Cao, Yang
   Samuels, David C.
TI Replication Pauses of the Wild-Type and Mutant Mitochondrial DNA
   Polymerase Gamma: A Simulation Study
SO PLOS COMPUTATIONAL BIOLOGY
LA English
DT Article
ID POLG MUTATIONS; NUCLEOTIDE INCORPORATION; ACCESSORY SUBUNIT;
   ALPERS-SYNDROME; RECONSTITUTION; EFFICIENCY; DELETIONS; FIDELITY;
   SPECTRUM; MUSCLE
AB The activity of polymerase gamma is complicated, involving both correct and incorrect DNA polymerization events, exonuclease activity, and the disassociation of the polymerase: DNA complex. Pausing of pol-gamma might increase the chance of deletion and depletion of mitochondrial DNA. We have developed a stochastic simulation of pol-gamma that models its activities on the level of individual nucleotides for the replication of mtDNA. This method gives us insights into the pausing of two pol-gamma variants: the A467T substitution that causes PEO and Alpers syndrome, and the exonuclease deficient pol-gamma (exo(-)) in premature aging mouse models. To measure the pausing, we analyzed simulation results for the longest time for the polymerase to move forward one nucleotide along the DNA strand. Our model of the exo(-) polymerase had extremely long pauses, with a 30 to 300-fold increase in the time required for the longest single forward step compared to the wild-type, while the naturally occurring A467T variant showed at most a doubling in the length of the pauses compared to the wild-type. We identified the cause of these differences in the polymerase pausing time to be the number of disassociations occurring in each forward step of the polymerase.
C1 [Song, Zhuo; Samuels, David C.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37235 USA.
   [Cao, Yang] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA.
C3 Vanderbilt University; Virginia Polytechnic Institute & State University
RP Song, Z (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37235 USA.
EM david.samuels@chgr.mc.vanderbilt.edu
RI Samuels, David/A-5393-2008
OI Samuels, David/0000-0003-3529-7791
FU NIH/NIGMS [GM073744]
FX This work was funded by the NIH/NIGMS through grant GM073744. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028
   Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Bertram JG, 2010, BIOCHEMISTRY-US, V49, P20, DOI 10.1021/bi901653g
   Boes M, 2009, SEIZURE-EUR J EPILEP, V18, P232, DOI 10.1016/j.seizure.2008.08.003
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Estep PA, 2011, BIOCHEMISTRY-US, V50, P6376, DOI 10.1021/bi200280r
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3
   GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2004, STRUCTURE FUNCTION D, P64
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   Johnson AA, 2001, J BIOL CHEM, V276, P38097
   Johnson AA, 2001, J BIOL CHEM, V276, P38090
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   McHugh JC, 2010, MUSCLE NERVE, V41, P265, DOI 10.1002/mus.21494
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   POLLAK JK, 1970, BIOCHEM J, V117, P913, DOI 10.1042/bj1170913
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Song Z, 2010, METHODS, V51, P385, DOI 10.1016/j.ymeth.2010.02.019
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Utzig N, 2007, ACTA NEUROPATHOL, V114, P329
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2009, CELL METAB, V10, P437, DOI 10.1016/j.cmet.2009.11.001
   Wendelsdorf KV, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000261
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Young M.J., 2009, Mitochondrion, V10, P96
NR 49
TC 4
Z9 4
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-734X
EI 1553-7358
J9 PLOS COMPUT BIOL
JI PLoS Comput. Biol.
PD NOV
PY 2011
VL 7
IS 11
AR e1002287
DI 10.1371/journal.pcbi.1002287
PG 9
WC Biochemical Research Methods; Mathematical & Computational Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA 851JG
UT WOS:000297263700030
PM 22125488
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Wang, L
   Eriksson, S
AF Wang, L.
   Eriksson, S.
TI Tissue Specific Distribution of Pyrimidine Deoxynucleoside Salvage
   Enzymes Shed Light on the Mechanism of Mitochondrial DNA Depletion
SO NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
LA English
DT Article; Proceedings Paper
CT 13th International Symposium on Purine and Pyrimidine Metabolism in Man
CY JUN 21-24, 2009
CL Lidingo, SWEDEN
DE Thymidine kinase 2; rat tissue; mitochondrial; cytosolic; mitochondrial
   DNA depletion
ID THYMIDINE KINASE; MYOPATHY
AB Deficiency in thymidine kinase 2 (TK2) activity due to genetic alterations caused tissue specific mitochondrial DNA (mtDNA) depletion syndrome with symptoms resembling these of AIDS patients treated with nucleoside analogues. Mechanisms behind this mitochondrial effects is still not well understood. With rat as a model we isolated mitochondrial and cytosolic fractions from major organs and studied enzymes involved in thymidine (dT) and deoxycytidine (dC) phosphorylation by using ionic exchange column chromatography. A cytosolic form of TK2 was identified in all tested tissues in addition to mitochondrial TK2. TK1 was detected in liver and spleen cytosolic extracts while dCK was found in liver, spleen and lung cytosolic extracts. Thus, the nature of dT and dC salvage enzymes in each tissue type was determined. In most tissues TK2 is the only salvage enzyme present except liver and spleen. These results may help to explain the mechanisms of mitochondrial toxicity of antiviral nucleoside analogues and mtDNA depletion caused by TK2 deficiency.
C1 [Wang, L.] BMC, SLU, Sect Vet Med Biochem, Dept Anat Physiol & Biochem, SE-75123 Uppsala, Sweden.
C3 Swedish University of Agricultural Sciences
RP Wang, L (corresponding author), BMC, SLU, Sect Vet Med Biochem, Dept Anat Physiol & Biochem, Box 575, SE-75123 Uppsala, Sweden.
EM Liya.Wang@afb.slu.se
CR GRAHAM JM, 1999, CURRENT PROTOCOLS CE
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6
   Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200
   WANG LY, 1993, J BIOL CHEM, V268, P22847
NR 6
TC 18
Z9 19
U1 0
U2 4
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1525-7770
J9 NUCLEOS NUCLEOT NUCL
JI Nucleosides Nucleotides Nucleic Acids
PY 2010
VL 29
IS 4-6
BP 400
EP 403
AR PII 922991997
DI 10.1080/15257771003741042
PG 4
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology
GA 610EE
UT WOS:000278713200023
PM 20544526
DA 2024-11-01
ER

PT J
AU Nazli, A
   Safdar, A
   Saleem, A
   Akhtar, M
   Brady, LI
   Schwartzentruber, J
   Tarnopolsky, MA
AF Nazli, Aisha
   Safdar, Adeel
   Saleem, Ayesha
   Akhtar, Mahmood
   Brady, Lauren I.
   Schwartzentruber, Jeremy
   Tarnopolsky, Mark A.
TI A mutation in the <i>TMEM65</i> gene results in mitochondrial myopathy
   with severe neurological manifestations
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID COMPLEX-I DEFICIENCY; DNA DISEASE; ADULTS; PROTEIN
AB Recent research has suggested that transmembrane protein 65 (TMEM65) is localized within the inner mitochondrial membrane. Little else is known about its function. In this study we investigated the location and function of TMEM65. Further, we report the functional consequences of a novel homozygous splice variant (c.472+1G>A) in the TMEM65 gene in a patient with mitochondrial encephalomyopathy. Here we investigated the location of TMEM65 by immunofluorescence staining of the protein and by immunoblotting of the isolated mitochondrial fractions in healthy fibroblasts and those from the patient. To study the function of TMEM65 we knocked down mRNA using TMEM65-specific siRNA, and measured mitochondrial function by enzymology, protein abundance and oxygen consumption rate in fibroblasts. Subcellular fractionation confirmed that the TMEM65 protein was present in the inner mitochondrial membrane. Knocking down TMEM65 expression in dermal fibroblasts severely affected mitochondrial content and respiration rate. Further evidence for the essential role of TMEM65 in mitochondrial function came from the demonstration of severe cellular and clinical consequences resulting from the novel TMEM65 gene mutation. In conclusion, these findings suggest that TMEM65, an inner mitochondrial membrane protein, plays a significant role in mitochondrial respiratory chain function. We also provide the first evidence that a mutation in the TMEM65 gene results in mitochondrial dysfunction and a severe mitochondrial encephalomyopathy phenotype.
C1 [Nazli, Aisha; Safdar, Adeel; Saleem, Ayesha; Brady, Lauren I.; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada.
   [Nazli, Aisha; Akhtar, Mahmood; Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON, Canada.
   [Schwartzentruber, Jeremy] McGill Univ, Montreal, PQ, Canada.
   [Schwartzentruber, Jeremy] Genome Quebec Innovat Ctr, Montreal, PQ, Canada.
C3 McMaster University; McMaster University; McGill University
RP Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Pediat & Med, HSC 2H26,1200 Main St West, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
RI Nazli, Aisha/HTR-8854-2023; Saleem, Ayesha/J-6685-2019;
   Schwartzentruber, Jeremy/B-6727-2008
OI Schwartzentruber, Jeremy/0000-0002-6183-2092; Saleem,
   Ayesha/0000-0003-2146-5379; Nazli, Aisha/0000-0001-7410-9963
FU CIHR grant; Genome Canada; Canadian Institutes of Health Research;
   Ontario Genomics Institute; Ontario Research Fund; Genome Quebec;
   Children's Hospital of Eastern Ontario Foundation
FX This study was supported by a CIHR grant and a donation from Dan Wright
   and family and Terry's and Mario's Annual Charity Golf Tournament to
   MAT. A Safdar held a CIHR Banting Postdoctoral Fellowship at the time of
   the data collection. A Saleem held a NSERC Postdoctoral Fellowship at
   the time of data collection. We would also like to thank the family for
   permitting the investigations. Genetic testing was performed under the
   Care4Rare Canada Consortium funded by Genome Canada, the Canadian
   Institutes of Health Research, the Ontario Genomics Institute, Ontario
   Research Fund, Genome Quebec and Children's Hospital of Eastern Ontario
   Foundation. We wish to acknowledge the contribution of the high
   throughput sequencing platform of the McGill University and Genome
   Quebec Innovation Centre, Montreal, Canada. Acknowledgments also go to
   the Care4Rare Consortium: 'Enhanced Care for Rare Genetic Diseases in
   Canada'; Gene Discovery Steering Committee - Kym Boycott (lead;
   University of Ottawa), Alex MacKenzie (co-lead; University of Ottawa),
   Jacek Majewski (McGill University), Michael Brudno (University of
   Toronto), Dennis Bulman (University of Ottawa), David Dyment (University
   of Ottawa) as well as Clinical Coordinator Taila Hartley and Project
   Manager Chandree Beaulieu at the Children's Hospital of Eastern Ontario
   Research Institute.
CR Beaulieu CL, 2014, AM J HUM GENET, V94, P809, DOI 10.1016/j.ajhg.2014.05.003
   Carroll CJ, 2014, BRIT J PHARMACOL, V171, P1837, DOI 10.1111/bph.12469
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Falk MJ, 2015, MOL GENET METAB, V114, P388, DOI 10.1016/j.ymgme.2014.11.016
   Foulds Charles E, 2010, Mol Endocrinol, V24, P1090, DOI 10.1210/me.2009-0427
   Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562
   Gohil VM, 2010, J BIOL CHEM, V285, P13742, DOI 10.1074/jbc.M109.098400
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   Lines MA, 2014, NEUROLOGY, V82, P963, DOI 10.1212/WNL.0000000000000219
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   McKenzie S, 2000, AM J PHYSIOL-ENDOC M, V278, pE580, DOI 10.1152/ajpendo.2000.278.4.E580
   Nishimura N, 2014, PEERJ, V2, DOI 10.7717/peerj.349
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466
   Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778
   Sambuughin N, 2013, J HUM GENET, V58, P226, DOI 10.1038/jhg.2012.156
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Spiegel R, 2011, J MED GENET, V48, P177, DOI 10.1136/jmg.2010.084608
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
NR 22
TC 15
Z9 16
U1 0
U2 11
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD JUN
PY 2017
VL 25
IS 6
BP 744
EP 751
DI 10.1038/ejhg.2017.20
PG 8
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA EW8DO
UT WOS:000402748700012
PM 28295037
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Chou, YF
   Huang, RFS
AF Chou, Yi-Fang
   Huang, Rwei-Fen S.
TI Mitochondrial DNA deletions of blood lymphocytes as genetic markers of
   low folate-related mitochondrial genotoxicity in peripheral tissues
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Folate deficiency; mtDNA deletions; Lymphocytes; Genetic marker;
   Peripheral tissues
ID KEARNS-SAYRE SYNDROME; OXIDATIVE STRESS; COPY NUMBER;
   HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR; BP DELETION; MUTATIONS;
   RATS; AGE; DISEASE
AB A low folate status and mitochondrial DNA (mtDNA) mutations are risk factors for various cancers and degenerative diseases. It is not known if lymphocytic mtDNA deletions can be used as genetic "markers" to reflect global mtDNA damage during folate deficiency.
   The aim of this study was to characterize folate-related mtDNA deletions in lymphocytes and their associations with mt genotoxicity in peripheral tissues.
   Weaning Wistar rats were fed folate-deficient and folate-replete (control) diets for 2 and 4 weeks. Folate levels of blood lymphocytes and various tissues were assayed by the Lactobacillus casei method. mtDNA deletions were measured by a real-time polymerase chain reaction analysis of whole DNA extracts.
   Compared to the control counterparts, mtDNA deletions of lymphocytes increased by 3.5-fold (P < 0.05) after 4 weeks of folate deficiency. Lymphocytic mtDNA deletions were inversely associated with plasma (r = -0.619, P = 0.018), red blood cell (r = -0.668, P = 0.009), and lymphocytic folate levels (r = -0.536, P = 0.048). Frequencies of lymphatic mtDNA deletions were positively correlated with mtDNA deletions in tissues including the lungs (r = 0.803, P = 0.0005), muscles (r = 0.755, P = 0.001), heart (r = 0.633, P = 0.015), liver (r = 0.722, P = 0.003), kidneys (r = 0.737, P = 0.006), pancreas (r = 0.666, P = 0.009), and brain (r = 0.917, P < 0.0001). Conclusions: Our data demonstrate that accumulated mtDNA deletions of lymphocytes depended upon dietary folate deprivation. The accumulated mt deletions in lymphocytes closely reflected the mt genotoxicity in the peripheral tissues during folate deficiency.
C1 [Chou, Yi-Fang; Huang, Rwei-Fen S.] Fu Jen Catholic Univ, Dept Nutr Sci, Hsinchuang 242, Taipei County, Taiwan.
C3 Fu Jen Catholic University
RP Huang, RFS (corresponding author), Fu Jen Catholic Univ, Dept Nutr Sci, Hsinchuang 242, Taipei County, Taiwan.
EM 034825@mail.fju.edu.tw
FU National Science Council, Taiwan [NSC96-2320-B-002]
FX The authors are deeply grateful to Prof. Y.-H. Wei of the Department of
   Biochemistry at National Yang-Ming University, Taipei, Taiwan for his
   kind support and invaluable advice on mtDNA mutations. This study was
   supported by a grant (NSC96-2320-B-002) from the National Science
   Council, Taiwan to R. F. S. Huang.
CR Biagini G, 1998, MECH AGEING DEV, V101, P269, DOI 10.1016/S0047-6374(97)00181-4
   Branda RF, 2002, MUTAT RES-FUND MOL M, V501, P29, DOI 10.1016/S0027-5107(02)00014-3
   Chang CM, 2007, BRIT J NUTR, V97, P855, DOI 10.1017/S0007114507666410
   Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129
   CHOU YF, 2007, J NUTR, V100, P596
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Crott JW, 2005, MUTAT RES-FUND MOL M, V570, P63, DOI 10.1016/j.mrfmmm.2004.09.009
   Doria G, 2001, MECH AGEING DEV, V122, P985, DOI 10.1016/S0047-6374(01)00251-2
   Duthie SJ, 2000, BRIT J CANCER, V83, P1532, DOI 10.1054/bjoc.2000.1481
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Fenech M, 2001, MUTAT RES-FUND MOL M, V480, P51, DOI 10.1016/S0027-5107(01)00168-3
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HORNE DW, 1988, CLIN CHEM, V34, P2357
   Huang RFS, 2001, J NUTR, V131, P33, DOI 10.1093/jn/131.1.33
   Jerónimo C, 2001, ONCOGENE, V20, P5195, DOI 10.1038/sj.onc.1204646
   Kim UK, 2000, BASIC RES CARDIOL, V95, P163, DOI 10.1007/s003950050178
   KOPXIDAS G, 2000, ANN NY ACAD SCI, V908, P226
   Kuo CS, 2008, BRIT J NUTR, V100, P596, DOI 10.1017/S0007114508911557
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   LESTIENNE P, 1988, LANCET, V1, P885
   Loscalzo J, 1996, J CLIN INVEST, V98, P5, DOI 10.1172/JCI118776
   Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P86, DOI 10.1001/archneur.64.1.86
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Meissner C, 2000, FORENSIC SCI INT, V113, P109, DOI 10.1016/S0379-0738(00)00249-8
   Melberg A, 2005, ACTA NEUROPATHOL, V110, P315, DOI 10.1007/s00401-005-1047-z
   Mohamed SA, 2004, EXP GERONTOL, V39, P181, DOI 10.1016/j.exger.2003.10.011
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Rampersaud GC, 2000, AM J CLIN NUTR, V72, P998
   Ravagnan L, 2002, J CELL PHYSIOL, V192, P131, DOI 10.1002/jcp.10111
   Ross OA, 2002, EXP GERONTOL, V37, P329, DOI 10.1016/S0531-5565(01)00200-5
   VARELAMOREIRAS G, 1992, J NUTR, V122, P986, DOI 10.1093/jn/122.4.986
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   von Wurmb N, 1998, MUTAT RES-FUND MOL M, V422, P247, DOI 10.1016/S0027-5107(98)00205-X
   WALZEM RL, 1988, J NUTR, V118, P1089, DOI 10.1093/jn/118.9.1089
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
   Wei YH, 1998, CURR SCI INDIA, V74, P887
   Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838
NR 43
TC 28
Z9 28
U1 0
U2 6
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD OCT
PY 2009
VL 48
IS 7
BP 429
EP 436
DI 10.1007/s00394-009-0031-0
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 495TH
UT WOS:000269917400006
PM 19437061
DA 2024-11-01
ER

PT J
AU Ben Ayed, I
   Chamkha, I
   Mkaouar-Rebai, E
   Kammoun, T
   Mezghani, N
   Chabchoub, I
   Aloulou, H
   Hachicha, M
   Fakhfakh, F
AF Ben Ayed, Imen
   Chamkha, Imen
   Mkaouar-Rebai, Emna
   Kammoun, Thouraya
   Mezghani, Najla
   Chabchoub, Imen
   Aloulou, Hajer
   Hachicha, Mongia
   Fakhfakh, Faiza
TI A Tunisian patient with Pearson syndrome harboring the 4.977 kb common
   deletion associated to two novel large-scale mitochondrial deletions
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Pearson syndrome; mtDNA deletions; Mitochondrial DNA; Heteroplasmy; Long
   range-PCR; Common deletion
ID MARROW-PANCREAS-SYNDROME; KEARNS-SAYRE SYNDROME; DNA DELETION; MTDNA
   DELETION; PCR; REARRANGEMENTS; DUPLICATION; MYOPATHIES; DISEASES; INFANT
AB Pearson syndrome (PS) is a multisystem disease including refractory anemia, vacuolization of marrow precursors and pancreatic fibrosis. The disease starts during infancy and affects various tissues and organs, and most affected children die before the age of 3 years. Pearson syndrome is caused by de novo large-scale deletions or, more rarely, duplications in the mitochondrial genome. In the present report, we described a Pearson syndrome patient harboring multiple mitochondrial deletions which is, in our knowledge, the first case described and studied in Tunisia. In fact, we reported the common 4.977 kb deletion and two novel heteroplasmic deletions (5.030 and 5.234 kb) of the mtDNA. These deletions affect several protein-coding and tRNAs genes and could strongly lead to defects in mitochondrial polypeptides synthesis, and impair oxidative phosphorylation and energy metabolism in the respiratory chain in the studied patient. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Ben Ayed, Imen; Chamkha, Imen; Mkaouar-Rebai, Emna; Mezghani, Najla; Fakhfakh, Faiza] Univ Sfax, Fac Med Sfax, Lab Genet Mol Humaine, Sfax 3029, Tunisia.
   [Kammoun, Thouraya; Chabchoub, Imen; Aloulou, Hajer; Hachicha, Mongia] CHU Habib Bourguiba Sfax, Serv Pediat, Sfax, Tunisia.
C3 Universite de Sfax; Universite de Sfax; Hopital Hedi Chaker; Hopital
   Habib Bourguiba
RP Ben Ayed, I (corresponding author), Univ Sfax, Fac Med Sfax, Lab Genet Mol Humaine, Ave Magida Boulila, Sfax 3029, Tunisia.
EM imenbenayed60@yahoo.fr; emna_m@yahoo.fr
RI MKAOUAR-REBAI, Emna/AAE-6650-2019
OI Chamkha, Imen/0000-0002-6919-585X; Mkaouar-Rebai,
   Emna/0000-0003-3095-510X
FU Tunisian Ministry of Higher Education and Scientific Research
FX We thank the patient and her family for their cooperation in the present
   study. This work was supported by The Tunisian Ministry of Higher
   Education and Scientific Research.
CR BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   BLAW ME, 1990, J CHILD NEUROL, V5, P186, DOI 10.1177/088307389000500305
   BLOK RB, 1995, HUM GENET, V95, P75
   Coulter-Mackie MB, 1998, CLIN BIOCHEM, V31, P627, DOI 10.1016/S0009-9120(98)00074-5
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619
   HARDING AE, 1992, J INHERIT METAB DIS, V15, P480, DOI 10.1007/BF01799606
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   KAPSA R, 1994, J INHERIT METAB DIS, V17, P521, DOI 10.1007/BF00711584
   KIYOMOTO BH, 1997, J NEUROL SCI, V25, P160
   Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567
   Knerr I, 2003, J PEDIAT HEMATOL ONC, V25, P948, DOI 10.1097/00043426-200312000-00008
   Lacbawan F, 2000, AM J MED GENET, V95, P266, DOI 10.1002/1096-8628(20001127)95:3<266::AID-AJMG13>3.3.CO;2-S
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   Mkaouar-Rebai E, 2007, BIOCHEM BIOPH RES CO, V355, P1031, DOI 10.1016/j.bbrc.2007.02.083
   Mohri I, 1998, J NEUROL SCI, V158, P106, DOI 10.1016/S0022-510X(98)00082-3
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   NIAUDET P, 1994, PEDIATR NEPHROL, V8, P164, DOI 10.1007/BF00865468
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Ro LS, 2003, MUSCLE NERVE, V28, P737, DOI 10.1002/mus.10504
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   ROTIG A, 1989, LANCET, V1, P902
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   SANO T, 1993, PEDIATR RES, V34, P105, DOI 10.1203/00006450-199307000-00024
   Santorelli FM, 1996, NEUROLOGY, V47, P1320, DOI 10.1212/WNL.47.5.1320
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Seneca S, 1997, CLIN GENET, V51, P338
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   SUPERTIFURGA A, 1993, EUR J PEDIATR, V152, P44, DOI 10.1007/BF02072515
   Toth T, 1998, CLIN GENET, V53, P210
   van den Ouweland JMW, 2000, EUR J HUM GENET, V8, P195, DOI 10.1038/sj.ejhg.5200444
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 37
TC 5
Z9 6
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUL 29
PY 2011
VL 411
IS 2
BP 381
EP 386
DI 10.1016/j.bbrc.2011.06.154
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 806LS
UT WOS:000293809900027
PM 21741369
DA 2024-11-01
ER

PT J
AU Di Leo, V
   Gomes, TMB
   Vincent, AE
AF Di Leo, Valeria
   Gomes, Tiago M. Bernardino
   Vincent, Amy E.
TI Interactions of mitochondrial and skeletal muscle biology in
   mitochondrial myopathy
SO BIOCHEMICAL JOURNAL
LA English
DT Review
ID AMINO-ACID-METABOLISM; C-OXIDASE DEFICIENCY; CYTOCHROME-C;
   RESPIRATORY-CHAIN; DNA DELETIONS; REACTIVE OXYGEN; FIBER TYPES; EXTERNAL
   OPHTHALMOPLEGIA; THERAPEUTIC TARGETS; LACTIC-ACIDOSIS
AB Mitochondrial dysfunction in skeletal muscle fibres occurs with both healthy aging and a range of neuromuscular diseases. The impact of mitochondrial dysfunction in skeletal muscle and the way muscle fibres adapt to this dysfunction is important to understand disease mechanisms and to develop therapeutic interventions. Furthermore, interactions between mitochondrial dysfunction and skeletal muscle biology, in mitochondrial myopathy, likely have important implications for normal muscle function and physiology. In this review, we will try to give an overview of what is known to date about these interactions including metabolic remod-elling, mitochondrial morphology, mitochondrial turnover, cellular processes and muscle cell structure and function. Each of these topics is at a different stage of understanding, with some being well researched and understood, and others in their infancy. Furthermore, some of what we know comes from disease models. Whilst some findings are confirmed in humans, where this is not yet the case, we must be cautious in interpreting findings in the context of human muscle and disease. Here, our goal is to discuss what is known, highlight what is unknown and give a perspective on the future direction of research in this area.
C1 [Di Leo, Valeria; Gomes, Tiago M. Bernardino; Vincent, Amy E.] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, England.
   [Di Leo, Valeria; Gomes, Tiago M. Bernardino; Vincent, Amy E.] NIHR Newcastle Biomed Res Ctr, Biomed Res Bldg, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, England.
   [Gomes, Tiago M. Bernardino] Newcastle Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitochondrial Dis, Newcastle Upon Tyne NE2 4HH, England.
   [Vincent, Amy E.] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne NE2 4HH, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle Upon
   Tyne Hospitals NHS Foundation Trust; Newcastle University - UK
RP Vincent, AE (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, England.; Vincent, AE (corresponding author), NIHR Newcastle Biomed Res Ctr, Biomed Res Bldg, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, England.; Vincent, AE (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne NE2 4HH, England.
EM amy.vincent@ncl.ac.uk
RI Vincent, Amy/J-7284-2019; Gomes, Tiago/J-4598-2019
OI Di Leo, Valeria/0000-0002-0166-3426; Bernardino Gomes,
   Tiago/0000-0001-6520-5363; Vincent, Amy/0000-0002-0360-6644
FU Wellcome Centre for Mitochondrial Research; NIHR Newcastle Biomedical
   Research Centre, a Sir Henry Wellcome Postdoctoral Fellowship
   [215888/Z/19/Z]; Newcastle University
FX This work was supported by the Wellcome Centre for Mitochondrial
   Research and by the NIHR Newcastle Biomedical Research Centre, a Sir
   Henry Wellcome Postdoctoral Fellowship awarded to Dr A.E. Vincent
   (215888/Z/19/Z) and NUAcT Fellowship from Newcastle University awarded
   to Dr A. E. Vincent.
CR Ahmed ST, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14623-2
   Ajayi PT, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-30401-9
   Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   ARPE J, 1994, ACTA NEUROL SCAND, V90, P281
   Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Avellaneda J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22058-7
   Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Baldelli S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.458
   Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575
   Barriocanal-Casado E, 2019, EBIOMEDICINE, V42, P511, DOI 10.1016/j.ebiom.2019.03.025
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234
   Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015
   Bhosale G, 2017, BBA-MOL CELL RES, V1864, P1009, DOI 10.1016/j.bbamcr.2017.01.015
   Boczonadi V, 2015, J INHERIT METAB DIS, V38, P427, DOI 10.1007/s10545-014-9784-6
   Boczonadi V, 2013, HUM MOL GENET, V22, P4602, DOI 10.1093/hmg/ddt309
   Bottoni P, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24010124
   Bouchez C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040287
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396
   Britti Elena, 2018, Neuronal Signal, V2, pNS20180061, DOI 10.1042/NS20180061
   Bruno C, 2002, J CHILD NEUROL, V17, P233, DOI 10.1177/088307380201700318
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Chabi B, 2005, MED SCI SPORT EXER, V37, P2102, DOI 10.1249/01.mss.0000177426.68149.83
   Chakrabarty S, 2021, J NEUROL, V268, P2192, DOI 10.1007/s00415-020-10390-9
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen ZK, 2023, SCI ADV, V9, DOI 10.1126/sciadv.add3216
   Civiletto G, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708799
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Collier JJ, 2021, NEW ENGL J MED, V384, P2406, DOI 10.1056/NEJMoa1915722
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Cordero MD, 2016, J MED GENET, V53, P113, DOI 10.1136/jmedgenet-2015-103392
   Cornelissen T, 2018, ELIFE, V7, DOI 10.7554/eLife.35878
   CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x
   Dai ZW, 2020, NAT REV GENET, V21, P737, DOI 10.1038/s41576-020-0270-8
   Deng JW, 2020, BIOCHEM BIOPH RES CO, V523, P91, DOI 10.1016/j.bbrc.2019.12.005
   Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005
   Di Giovanni S, 2001, MOL CELL NEUROSCI, V17, P696, DOI 10.1006/mcne.2001.0970
   Di Leo V., 2022, Understanding the Effects of Resistance Exercise Training on Mitochondrial Myopathy in Mitochondrial Myopathy and Myotonic Dystrophy Type 1 Patients
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   Diaz F, 2008, CELL CALCIUM, V44, P24, DOI 10.1016/j.ceca.2007.12.004
   DiMauro S, 2010, Acta Myol, V29, P333
   Djouadi F, 2008, J INHERIT METAB DIS, V31, P217, DOI 10.1007/s10545-008-0844-7
   Dogan SA, 2022, ANTIOXID REDOX SIGN, V37, P301, DOI 10.1089/ars.2021.0266
   Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Enns GM, 2005, CLIN GENET, V68, P337, DOI 10.1111/j.1399-0004.2005.00499.x
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Faitg J, 2020, J MICROSC-OXFORD, V278, P89, DOI 10.1111/jmi.12891
   Farge G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112770
   FASSATI A, 1994, J NEUROL SCI, V123, P140, DOI 10.1016/0022-510X(94)90216-X
   Favaro G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10226-9
   Ferrari M, 2017, P NATL ACAD SCI USA, V114, pE4241, DOI 10.1073/pnas.1621511114
   Ferreira R, 2010, PROTEOMICS, V10, P3142, DOI 10.1002/pmic.201000173
   Formichi P., 2003, Journal of Submicroscopic Cytology and Pathology, V35, P29
   Forsström S, 2019, CELL METAB, V30, P1040, DOI [10.1016/j.cmet.2019.013.019, 10.1016/j.cmet.2019.08.019]
   Frontera WR, 2015, CALCIFIED TISSUE INT, V96, P183, DOI 10.1007/s00223-014-9915-y
   Fulle S, 2005, ARCH ITAL BIOL, V143, P229
   García-Pérez C, 2011, AM J PHYSIOL-HEART C, V301, pH1907, DOI 10.1152/ajpheart.00397.2011
   Gehrig SM, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0488-x
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Glancy B, 2021, J PHYSIOL-LONDON, V599, P863, DOI 10.1113/JP278930
   Glancy B, 2017, CELL REP, V19, P487, DOI 10.1016/j.celrep.2017.03.063
   Glancy B, 2015, NATURE, V523, P617, DOI 10.1038/nature14614
   Gobin-Limballe S, 2007, AM J HUM GENET, V81, P1133, DOI 10.1086/522375
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gottschalk B, 2022, CELL CALCIUM, V101, DOI 10.1016/j.ceca.2021.102517
   Gumeni S, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03952-w
   HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   HARATI Y, 1979, ARCH NEUROL-CHICAGO, V36, P454, DOI 10.1001/archneur.1979.00500430084024
   Hathazi D, 2020, EMBO J, V39, DOI 10.15252/embj.2020105364
   Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002
   Hepple RT, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081821
   Herbst A, 2016, AGING CELL, V15, P1132, DOI 10.1111/acel.12520
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057
   Hunt M, 2022, AIDS, V36, P1927, DOI 10.1097/QAD.0000000000003334
   Ibebunjo C, 2013, MOL CELL BIOL, V33, P194, DOI 10.1128/MCB.01036-12
   Ikezoe K, 2002, ACTA NEUROPATHOL, V103, P531, DOI 10.1007/s00401-001-0502-8
   Irazoki A, 2023, NAT COMMUN, V14, DOI 10.1038/s41467-022-35732-1
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Jeppesen TD, 2013, NEUROMUSCULAR DISORD, V23, P629, DOI 10.1016/j.nmd.2013.05.007
   Jiang SN, 1999, J BIOL CHEM, V274, P29905, DOI 10.1074/jbc.274.42.29905
   Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807
   Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005
   Katti P, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-34445-9
   Katti P, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-33678-y
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kim J, 2019, SCIENCE, V366, P1531, DOI 10.1126/science.aav4011
   Kim TY, 2012, MOL CELL PROTEOMICS, V11, P1586, DOI 10.1074/mcp.M112.021162
   KOO B, 1993, ANN NEUROL, V34, P25, DOI 10.1002/ana.410340107
   Kowald A, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030126
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11
   Lawless C, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200061
   Leduc-Gaudet JP, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22158179
   Lee-Young RS, 2009, J APPL PHYSIOL, V107, P283, DOI 10.1152/japplphysiol.91208.2008
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Leo D., 2023, The Effects of Resistance Exercise Training on Mitochondrial Dysfunction in Mitochondrial Myopathy and Myotonic Dystrophy Type 1 Patients
   LERTRIT P, 1992, AM J HUM GENET, V51, P457
   LEXELL J, 1991, J ANAT, V174, P239
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   Lin DS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010065
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Liu C C, 2001, Curr Rheumatol Rep, V3, P325, DOI 10.1007/s11926-001-0037-y
   Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014
   Liu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044375
   Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851
   Long Q, 2015, BIOPHYS J, V109, P892, DOI 10.1016/j.bpj.2015.07.039
   Mannella CA, 1998, BIOFACTORS, V8, P225, DOI 10.1002/biof.5520080309
   Mbaya E, 2010, CELL DEATH DIFFER, V17, P1855, DOI 10.1038/cdd.2010.51
   McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047
   MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   MERIKANGAS JR, 1995, AM J PSYCHIAT, V152, P142, DOI 10.1176/ajp.152.1.142
   Meunier B, 2013, BBA-BIOENERGETICS, V1827, P1346, DOI 10.1016/j.bbabio.2012.11.015
   Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93
   Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027
   Mito T, 2022, CELL METAB, V34, P197, DOI 10.1016/j.cmet.2021.12.017
   Moreno-Justicia R., 2023, MYOSIN HEAVY CHAINS, DOI [10.1101/2023.09.07.556665, DOI 10.1101/2023.09.07.556665]
   Moss T, 2021, CSH MOL CASE STUD, V7, DOI 10.1101/mcs.a006081
   Mposhi A, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23042197
   Murgia M, 2019, CELL REP, V29, P3825, DOI 10.1016/j.celrep.2019.11.055
   Murgia M, 2017, CELL REP, V19, P2396, DOI 10.1016/j.celrep.2017.05.054
   Murgia M, 2015, EMBO REP, V16, P387, DOI 10.15252/embr.201439757
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Nielsen J, 2017, J PHYSIOL-LONDON, V595, P2839, DOI 10.1113/JP273040
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   OHKOSHI N, 1995, MUSCLE NERVE, V18, P1265, DOI 10.1002/mus.880181108
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901
   Pascale RM, 2020, CANCERS, V12, DOI 10.3390/cancers12102819
   Payne BAI, 2015, JAMA NEUROL, V72, P603, DOI 10.1001/jamaneurol.2015.0150
   Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046
   Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7
   PETTE D, 1986, FED PROC, V45, P2910
   Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Picard M, 2013, AM J PHYSIOL-REG I, V304, pR393, DOI 10.1152/ajpregu.00584.2012
   Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012
   Picard M, 2012, AM J PHYSIOL-CELL PH, V302, pC629, DOI 10.1152/ajpcell.00368.2011
   Picca A, 2023, SEMIN CELL DEV BIOL, V143, P37, DOI 10.1016/j.semcdb.2022.03.023
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798
   Protasoni M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020586
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046
   RICHTER C, 1992, MUTAT RES, V275, P249, DOI 10.1016/0921-8734(92)90029-O
   Rimessi A, 2008, BBA-BIOENERGETICS, V1777, P808, DOI 10.1016/j.bbabio.2008.05.449
   Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014
   Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763
   Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Romanello V, 2021, CELL MOL LIFE SCI, V78, P1305, DOI 10.1007/s00018-020-03662-0
   Ross JM, 2011, JOVE-J VIS EXP, DOI 10.3791/3266
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Sánchez-González C, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-05016-z
   Santos JH, 2021, FREE RADICAL BIO MED, V170, P59, DOI 10.1016/j.freeradbiomed.2020.11.016
   Satrústegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schiaffino S, 2020, HISTOL HISTOPATHOL, V35, P239, DOI 10.14670/HH-18-170
   Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2
   Sekler I, 2015, BIOCHEM BIOPH RES CO, V460, P50, DOI 10.1016/j.bbrc.2015.02.170
   Sharma R, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136055
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Shuler KT, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122544
   Si HB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225214
   Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057
   Southwell N, 2023, EMBO MOL MED, V15, DOI 10.15252/emmm.202216951
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   Steele H, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911589
   Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Taivassalo T, 2012, BRAIN, V135, P53, DOI 10.1093/brain/awr293
   Takao M, 1996, J NEUROL SCI, V139, P111
   Takeuchi A, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23147948
   Tews DS, 2005, MUSCLE NERVE, V32, P443, DOI 10.1002/mus.20348
   Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021
   Tomar D, 2016, CELL REP, V15, P1673, DOI 10.1016/j.celrep.2016.04.050
   Trumpff C, 2021, MITOCHONDRION, V59, P225, DOI 10.1016/j.mito.2021.04.002
   Tu MK, 2016, CELL CALCIUM, V59, P91, DOI 10.1016/j.ceca.2016.02.005
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Umaki Y, 2002, ACTA NEUROPATHOL, V103, P163
   Varughese JT, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071737
   Vincent AE, 2019, CELL REP, V27, P321, DOI 10.1016/j.celrep.2019.03.051
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   Vincent AE, 2017, TRENDS CELL BIOL, V27, P797, DOI 10.1016/j.tcb.2017.08.009
   Vincent AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30610
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Wagenmakers AJM, 1998, EXERCISE SPORT SCI R, V26, P287
   Wagenmakers AJM, 1998, ADV EXP MED BIOL, V441, P307
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wang CX, 2009, ANNU REV GENET, V43, P95, DOI 10.1146/annurev-genet-102108-134850
   Wang T, 2019, EMBO REP, V20, DOI 10.15252/embr.201947892
   Warren C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70885-3
   Wenz T, 2009, IUBMB LIFE, V61, P1051, DOI 10.1002/iub.261
   Willingham TB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17579-6
   Wilson RJ, 2019, MITOCHONDRION, V44, P20, DOI 10.1016/j.mito.2017.12.008
   Wonnapinij P, 2008, AM J HUM GENET, V83, P582, DOI 10.1016/j.ajhg.2008.10.007
   Wu Z, 2019, NAT METAB, V1, P1209, DOI 10.1038/s42255-019-0150-8
   Xian HX, 2022, IMMUNITY, V55, P1370, DOI 10.1016/j.immuni.2022.06.007
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Yuan JH, 2013, J CLIN PATHOL, V66, P659, DOI 10.1136/jclinpath-2012-201431
   Yuan YX, 2017, MOL MED REP, V16, P7361, DOI 10.3892/mmr.2017.7554
   Zerbes RM, 2012, BIOL CHEM, V393, P1247, DOI 10.1515/hsz-2012-0239
   Zhang D, 2019, NATURE, V574, P575, DOI 10.1038/s41586-019-1678-1
   Zhang XN, 2020, ADV EXP MED BIOL, V1207, P103, DOI 10.1007/978-981-15-4272-5_6
   Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z
   Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013
   Zulian A, 2016, PHARMACOL RES, V113, P563, DOI 10.1016/j.phrs.2016.09.043
NR 225
TC 2
Z9 2
U1 3
U2 5
PU PORTLAND PRESS LTD
PI LONDON
PA 1ST FLR, 10 QUEEN STREET PLACE, LONDON, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD NOV
PY 2023
VL 480
IS 21
BP 1767
EP 1789
DI 10.1042/BCJ20220233
PG 23
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA Y2TE5
UT WOS:001103833500001
PM 37965929
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Stumpf, JD
   Copeland, WC
AF Stumpf, Jeffrey D.
   Copeland, William C.
TI Mitochondrial DNA replication and disease: insights from DNA polymerase
   γ mutations
SO CELLULAR AND MOLECULAR LIFE SCIENCES
LA English
DT Review
DE Mitochondria; mtDNA replication; DNA polymerase gamma; POLG; DNA repair
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; BASE EXCISION-REPAIR; P55
   ACCESSORY SUBUNIT; ENCODING MIP1 GENE; SACCHAROMYCES-CEREVISIAE; MTDNA
   MUTATIONS; POLG MUTATIONS; MUTATOR MICE; HEARING-LOSS;
   AUTOSOMAL-DOMINANT
AB DNA polymerase gamma (pol gamma), encoded by POLG, is responsible for replicating human mitochondrial DNA. About 150 mutations in the human POLG have been identified in patients with mitochondrial diseases such as Alpers syndrome, progressive external ophthalmoplegia, and ataxia-neuropathy syndromes. Because many of the mutations are described in single citations with no genotypic family history, it is important to ascertain which mutations cause or contribute to mitochondrial disease. The vast majority of data about POLG mutations has been generated from biochemical characterizations of recombinant pol gamma. However, recently, the study of mitochondrial dysfunction in Saccharomyces cerevisiae and mouse models provides important in vivo evidence for the role of POLG mutations in disease. Also, the published 3D-structure of the human pol gamma assists in explaining some of the biochemical and genetic properties of the mutants. This review summarizes the current evidence that identifies and explains disease-causing POLG mutations.
C1 [Stumpf, Jeffrey D.; Copeland, William C.] NIEHS, NIH, Mol Genet Lab, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, NIH, Mol Genet Lab, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953
FU NIH, National Institute of Environmental Health Sciences [ES 065078]
FX We thank Margaret Humble for maintaining and updating the Pol Gamma
   mutation database (http://tools.niehs.nih.gov/polg) and for her help in
   generating Fig. 3 of this review. We thank Dr. Rachelle Bienstock for
   help with the structural images in this review. We also thank Drs.
   Matthew Young and Rajesh Kasiviswanathan for the comments and
   suggestions from their critical reading of this manuscript. This work
   was supported by the Intramural Research Program of the NIH, National
   Institute of Environmental Health Sciences (ES 065078).
CR Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023
   Baruffini E, 2010, MITOCHONDRION, V10, P183, DOI 10.1016/j.mito.2009.10.002
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Bensch KG, 2007, DIABETES OBES METAB, V9, P74, DOI 10.1111/j.1463-1326.2007.00776.x
   Bensch KG, 2009, AM J PHYSIOL-ENDOC M, V296, pE672, DOI 10.1152/ajpendo.90839.2008
   Bienstock RJ, 2004, MITOCHONDRION, V4, P203, DOI 10.1016/j.mito.2004.05.018
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P404, DOI 10.1016/S0968-0004(03)00165-8
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Brown TA, 2008, J BIOL CHEM, V283, P36743, DOI 10.1074/jbc.M806174200
   Chabes A, 2007, P NATL ACAD SCI USA, V104, P1183, DOI 10.1073/pnas.0610585104
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   de Moura MB, 2010, ENVIRON MOL MUTAGEN, V51, P391, DOI 10.1002/em.20575
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Dubec SJ, 2008, REJUV RES, V11, P611, DOI 10.1089/rej.2007.0617
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x
   FOURY F, 1989, J BIOL CHEM, V264, P20552
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   GENGA A, 1986, J BIOL CHEM, V261, P9328
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x
   Guo XH, 2010, BBA-BIOENERGETICS, V1797, P1159, DOI 10.1016/j.bbabio.2010.04.005
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Holt IJ, 2003, TRENDS BIOCHEM SCI, V28, P355, DOI 10.1016/S0968-0004(03)00133-6
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   HU JP, 1995, GENE, V160, P105, DOI 10.1016/0378-1119(95)00215-R
   Kalifa L, 2007, DNA REPAIR, V6, P1732, DOI 10.1016/j.dnarep.2007.06.005
   Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   LECRENIER N, 1995, MOL GEN GENET, V249, P1, DOI 10.1007/BF00290229
   Lee DY, 1996, J BIOL CHEM, V271, P24262, DOI 10.1074/jbc.271.39.24262
   Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283
   Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Martínez-Azorín F, 2008, J NEUROCHEM, V105, P165, DOI 10.1111/j.1471-4159.2007.05122.x
   Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Mookerjee SA, 2006, MUTAT RES-FUND MOL M, V595, P91, DOI 10.1016/j.mrfmmm.2005.10.006
   Mott JL, 2004, BIOCHEM BIOPH RES CO, V319, P1210, DOI 10.1016/j.bbrc.2004.05.104
   Mott JL, 2006, BBA-BIOENERGETICS, V1757, P596, DOI 10.1016/j.bbabio.2006.04.014
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Niu X, 2007, EXP CELL RES, V313, P3924, DOI 10.1016/j.yexcr.2007.05.029
   Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092
   Pogorzala L, 2009, GENETICS, V182, P699, DOI 10.1534/genetics.109.103796
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Strand Micheline K, 2002, Methods Mol Biol, V197, P151, DOI 10.1385/1-59259-284-8:151
   Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Tarnopolsky MA, 2009, APPL PHYSIOL NUTR ME, V34, P348, DOI 10.1139/H09-022
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vermulst M, 2009, CELL METAB, V10, P437, DOI 10.1016/j.cmet.2009.11.001
   Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   WONG TW, 1985, CELL, V42, P951, DOI 10.1016/0092-8674(85)90291-0
   Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yamasoba T, 2007, HEARING RES, V226, P185, DOI 10.1016/j.heares.2006.06.004
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Zhang D, 2003, CARDIOVASC RES, V57, P147, DOI 10.1016/S0008-6363(02)00695-8
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
   Zhang DX, 2005, AM J PHYSIOL-HEART C, V288, pH302, DOI 10.1152/ajpheart.00661.2004
   Zhang HS, 2006, GENETICS, V172, P2683, DOI 10.1534/genetics.105.051029
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 122
TC 81
Z9 100
U1 0
U2 26
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 1420-682X
EI 1420-9071
J9 CELL MOL LIFE SCI
JI Cell. Mol. Life Sci.
PD JAN
PY 2011
VL 68
IS 2
BP 219
EP 233
DI 10.1007/s00018-010-0530-4
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 703IA
UT WOS:000285970400005
PM 20927567
OA Green Published
DA 2024-11-01
ER

PT J
AU Gang, Q
   Bettencourt, C
   Houlden, H
   Hanna, MG
   Machado, PM
AF Gang, Qiang
   Bettencourt, Conceicao
   Houlden, Henry
   Hanna, Michael G.
   Machado, Pedro M.
TI Genetic advances in sporadic inclusion body myositis
SO CURRENT OPINION IN RHEUMATOLOGY
LA English
DT Review
DE genetics; inclusion body myopathies; inclusion body myositis
ID MITOCHONDRIAL-DNA DELETIONS; VALOSIN-CONTAINING PROTEIN; ONSET
   ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; PAGET-DISEASE;
   POLYMORPHISM; VARIANTS; MYOPATHY; JAPANESE; TOMM40
AB Purpose of review
   To describe recent developments in the genetics of sporadic inclusion body myositis (sIBM).
   Recent findings
   Genes located within major histocompatibility complex regions remain the strongest genetic association with sIBM. The rs10527454 polymorphism in the TOMM40 gene seems to have a disease modifying effect on sIBM by delaying the onset of symptoms, and this effect may be enhanced by the APOE epsilon 3/epsilon 3 genotype. Rare variants in the VCP and SQSTM1 genes have been identified in sIBM patients in two studies using targeted next-generation sequencing and whole-exome sequencing. Two studies have confirmed the correlation between the amount of cytochrome c oxidase - deficient fibres and the proportion of mitochondrial DNA (mtDNA) deletions in sIBM. Some rare variants in mtDNA-related nuclear genes have also been reported.
   Summary
   There have been advances in the genetics of sIBM over the past 2 years facilitated by the use of next-generation sequencing. Genes that cause hereditary IBM, which has clinical or pathological features resembling sIBM, have provided clues to the genetic basis of sIBM. To date, genes located in major histocompatibility complex regions and genes involved in protein homeostasis or mtDNA maintenance have been implicated in sIBM. Whole-exome sequencing-association studies, RNA sequencing, and whole-genome sequencing in large sIBM cohorts will be key tools to unravel the genetics of sIBM and its contribution to disease aetiopathogenesis.
C1 [Gang, Qiang; Bettencourt, Conceicao; Houlden, Henry; Hanna, Michael G.; Machado, Pedro M.] UCL, MRC Ctr Neuromuscular Dis, Inst Neurol, Dept Mol Neurosci, London, England.
C3 University of London; University College London
RP Machado, PM (corresponding author), MRC Ctr Neuromuscular Dis, Box 102,8-11 Queen Sq, London WC1N 3BG, England.
EM p.machado@ucl.ac.uk
RI Bettencourt, Conceição/A-8791-2008; Houlden, Henry/C-1532-2008; Machado,
   Pedro/C-8621-2013
OI Hanna, Michael/0000-0003-0825-4075; Bettencourt,
   Conceicao/0000-0001-9090-7690; Machado, Pedro/0000-0002-8411-7972;
   Houlden, Henry/0000-0002-2866-7777
FU University College London (UCL) Impact Studentship; Chinese Scholarship
   Council; National Institute for Health Research (NIHR); MRC Centre grant
   [MR/K000608/01]; MRC [MR/J004758/1]; National Institute for Health
   Research Rare Diseases Translational Research Collaboration (NIHR
   RD-TRC); UCLH Biomedical Research Centre (BRC); MRC [G0802760,
   MR/K000608/1, G1001253, G108/638, MR/J004758/1] Funding Source: UKRI
FX Q.G. is supported by a University College London (UCL) Impact
   Studentship and a scholarship from the Chinese Scholarship Council.
   P.M.M. is funded by a Post-Doctoral Research Fellowship award from the
   National Institute for Health Research (NIHR). M.G.H. is supported by an
   MRC Centre grant 2013-2018 (MR/K000608/01). The International IBM
   Consortium Genetic Study is also supported by an MRC grant
   (MR/J004758/1). This publication has been supported by the National
   Institute for Health Research Rare Diseases Translational Research
   Collaboration (NIHR RD-TRC). Part of the research work undertaken by the
   authors is supported by the UCLH Biomedical Research Centre (BRC).
CR Amato AA, 1998, NEUROLOGY, V51, P598, DOI 10.1212/WNL.51.2.598
   [Anonymous], 2008, Proceedings of the National Academy of Sciences of the United States of America, DOI DOI 10.1073/PNAS.0806192105
   Badrising UA, 2004, NEUROLOGY, V63, P2396, DOI 10.1212/01.WNL.0000148588.15052.4C
   Brady S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004552
   Broccolini A, 2015, BBA-MOL BASIS DIS, V1852, P644, DOI 10.1016/j.bbadis.2014.08.007
   Cai HY, 2012, J NEUROL, V259, P1913, DOI 10.1007/s00415-012-6439-0
   Cortese A, 2014, NEUROBIOL AGING, V35, P1491, DOI 10.1016/j.neurobiolaging.2013.12.029
   Di Blasi C, 2000, ANN NEUROL, V47, P811, DOI 10.1002/1531-8249(200006)47:6<811::AID-ANA16>3.3.CO;2-0
   Gang Q, 2015, NEUROMUSCULAR DISORD, V25, P1
   Gang Q, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.12.039
   Gang Q, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-88
   GARLEPP MJ, 1994, CLIN EXP IMMUNOL, V98, P40
   Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851
   Kaleem M, 2007, NEURODEGENER DIS, V4, P376, DOI 10.1159/000105158
   Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922
   Kimonis VE, 2008, BBA-MOL BASIS DIS, V1782, P744, DOI 10.1016/j.bbadis.2008.09.003
   Koffman BM, 1998, J NEUROIMMUNOL, V84, P139, DOI 10.1016/S0165-5728(97)00245-2
   Kok CC, 2000, NEUROMUSCULAR DISORD, V10, P604, DOI 10.1016/S0960-8966(00)00144-9
   Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004
   Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Machado PM, 2014, CURR OPIN NEUROL, V27, P591, DOI 10.1097/WCO.0000000000000129
   Mastaglia FL, 2013, NEUROMUSCULAR DISORD, V23, P969, DOI 10.1016/j.nmd.2013.09.008
   Mastaglia FL, 2009, NEUROMUSCULAR DISORD, V19, P763, DOI 10.1016/j.nmd.2009.07.015
   Median AG, 2012, TRENDS GENET, V28, P487, DOI 10.1016/j.tig.2012.06.008
   Needham M, 2008, J NEUROL NEUROSUR PS, V79, P1056, DOI 10.1136/jnnp.2007.138891
   Needham M, 2007, MUSCLE NERVE, V35, P549, DOI 10.1002/mus.20766
   Newman WG, 2014, GENES-BASEL, V5, P1001, DOI 10.3390/genes5041001
   O'Hanlon TP, 2005, MEDICINE, V84, P338, DOI 10.1097/01.md.0000189818.63141.8c
   Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Pinkus JL, 2014, NEUROMUSCULAR DISORD, V24, P611, DOI 10.1016/j.nmd.2014.04.012
   Price P, 2004, TISSUE ANTIGENS, V64, P575, DOI 10.1111/j.1399-0039.2004.00310.x
   Ranque-Francois B, 2005, ANN RHEUM DIS, V64, P634, DOI 10.1136/ard.2004.025494
   Rohrer JD, 2011, J NEUROL, V258, P1494, DOI 10.1007/s00415-011-5966-4
   Rojana-udomsart A, 2013, J NEUROIMMUNOL, V254, P174, DOI 10.1016/j.jneuroim.2012.09.003
   Rojana-Udomsart A, 2012, J NEUROIMMUNOL, V250, P77, DOI 10.1016/j.jneuroim.2012.05.003
   Roses AD, 2010, PHARMACOGENOMICS J, V10, P375, DOI 10.1038/tpj.2009.69
   Roses AD, 2010, ARCH NEUROL-CHICAGO, V67, P536, DOI 10.1001/archneurol.2010.88
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   Scott AP, 2012, J NEUROIMMUNOL, V250, P66, DOI 10.1016/j.jneuroim.2012.04.021
   Scott AP, 2006, NEUROMUSCULAR DISORD, V16, P311, DOI 10.1016/j.nmd.2006.02.002
   Seelen M, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.152
   Sivakumar K, 1997, BRAIN, V120, P653, DOI 10.1093/brain/120.4.653
   Tateyama M, 2003, INTERNAL MED, V42, P1035, DOI 10.2169/internalmedicine.42.1035
   Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332
   Weihl CC, 2015, NEUROMUSCULAR DISORD, V25, P289, DOI 10.1016/j.nmd.2014.12.009
NR 48
TC 8
Z9 9
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8711
EI 1531-6963
J9 CURR OPIN RHEUMATOL
JI Curr. Opin. Rheumatol.
PD NOV
PY 2015
VL 27
IS 6
BP 586
EP 594
DI 10.1097/BOR.0000000000000213
PG 9
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA DD0PX
UT WOS:000369623000011
PM 26335925
DA 2024-11-01
ER

PT J
AU Janssen, AJM
   Schuelke, M
   Smeitink, JAM
   Trijbels, FJM
   Sengers, RCA
   Lucke, B
   Wintjes, LTM
   Morava, E
   van Engelen, BGM
   Struts, BW
   Hol, FA
   Siers, MH
   ter Laak, H
   van der Knaap, MS
   van Spronsen, FJ
   Rodenburg, RJT
   van den Heuvel, LP
AF Janssen, Antoon J. M.
   Schuelke, Markus
   Smeitink, Jan A. M.
   Trijbels, Frans J. M.
   Sengers, Rob C. A.
   Lucke, Barbara
   Wintjes, Liesbeth T. M.
   Morava, Eva
   van Engelen, Baziel G. M.
   Struts, Bart W.
   Hol, Frans A.
   Siers, Marloes H.
   ter Laak, Henk
   van der Knaap, Marjo S.
   van Spronsen, Francjan J.
   Rodenburg, Richard J. T.
   van den Heuvel, Lambert P.
TI Muscle 3243A→G mutation load and capacity of the mitochondrial
   energy-generating system
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID TRANSFER RNALEU(UUR) GENE; A3243G POINT MUTATION; STROKE-LIKE EPISODES;
   LACTIC-ACIDOSIS; CLINICAL-FEATURES; COMPLEX-I;
   OXIDATIVE-PHOSPHORYLATION; TRNA(LEU(UUR)) MUTATION; DELAYED DIAGNOSIS;
   SKELETAL-MUSCLE
AB Objective: The mitochondrial energy-generating system (MEGS) encompasses the mitochondrial enzymatic reactions from oxidation of pyruvate to the export of adenosine triphosphate. It is investigated in intact muscle mitochondria by measuring the pyruvate oxidation and adenosine triphosphate production rates, which we refer to as the "MEGS capacity." Currently, little is known about MEGS pathology in patients with mutations in the mitochondrial DNA. Because MEGS capacity is an indicator for the overall mitochondrial function related to energy production, we searched for a correlation between MEGS capacity and 3243A -> G mutation load in muscle of patients with the MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes) syndrome.
   Methods: In muscle tissue of 24 patients with the 3243A -> G mutation, we investigated the MEGS capacity, the respiratory chain enzymatic activities, and the 3243A -> G mutation load. To exclude coinciding mutations, we sequenced all 22 mitochondrial transfer RNA genes in the patients, if possible.
   Results: We found highly significant differences between patients and control subjects with respect to the MEGS capacity and complex I, III, and IV activities. MEGS-related measurements correlated considerably better with the mutation load than respiratory chain enzyme activities. We found no additional mutations in the mitochondrial transfer RNA genes of the patients.
   Interpretation: The results show that MEGS capacity has a greater sensitivity than respiratory chain enzymatic activities for detection of subtle mitochondrial dysfunction. This is important in the workup of patients with rare or new mitochondrial DNA mutations, and with low mutation loads. In these cases we suggest to determine the MEGS capacity.
C1 Radboud Univ Nijmegen, Med Ctr, Lab Pediat & Neurol, Nijmegen Ctr Mitochondrial Disorders, NL-6525 GA Nijmegen, Netherlands.
   Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6525 GA Nijmegen, Netherlands.
   [Schuelke, Markus; Lucke, Barbara] Charite, Med Ctr, Dept Neuropediat, Berlin, Germany.
   [van Engelen, Baziel G. M.; Struts, Bart W.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Nijmegen, Netherlands.
   [Hol, Frans A.; Siers, Marloes H.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands.
   [ter Laak, Henk] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, Nijmegen, Netherlands.
   [van der Knaap, Marjo S.] Vrije Univ Amsterdam, Med Ctr, Dept Child Neurol, Amsterdam, Netherlands.
   [van Spronsen, Francjan J.] Univ Groningen, Beatrix Children Hosp, Univ Med Ctr, Groningen, Netherlands.
C3 Radboud University Nijmegen; Radboud University Nijmegen; Berlin
   Institute of Health; Berlin Institute of Health; Free University of
   Berlin; Humboldt University of Berlin; Charite Universitatsmedizin
   Berlin; Radboud University Nijmegen; Radboud University Nijmegen;
   Radboud University Nijmegen; Vrije Universiteit Amsterdam; University of
   Groningen
RP van den Heuvel, LP (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Pediat & Neurol, Nijmegen Ctr Mitochondrial Disorders, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands.
EM b.vandenheuvel@cukz.umcn.nl; b.vandenheuvel@cukz.umcn.nl
RI Smeitink, Jan/C-1351-2013; van den Heuvel, Lambertus/AAM-1772-2021;
   Morava, E./L-4529-2015; Rodenburg, Richard/N-3579-2014; van Engelen,
   Baziel/H-8027-2014
OI Rodenburg, Richard/0000-0001-5227-3527; Schuelke,
   Markus/0000-0003-2824-3891; van Engelen, Baziel/0000-0001-9867-9047
CR [Anonymous], A Human Mitochondrial Genome Database
   ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2
   BENTLAGE H, 1995, EUR J BIOCHEM, V227, P909, DOI 10.1111/j.1432-1033.1995.tb20218.x
   Bentlage HACM, 1996, NEUROLOGY, V47, P243, DOI 10.1212/WNL.47.1.243
   Chang TM, 2004, PEDIATR NEUROL, V31, P374, DOI 10.1016/j.pediatrneurol.2004.05.009
   Chinnery PF, 2001, NEUROLOGY, V56, P1101, DOI 10.1212/WNL.56.8.1101
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Chomyn A, 2001, J BIOENERG BIOMEMBR, V33, P251, DOI 10.1023/A:1010791204961
   COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665
   Crimi M, 2003, EUR J HUM GENET, V11, P896, DOI 10.1038/sj.ejhg.5201056
   Deschauer M, 2004, J NEUROL NEUROSUR PS, V75, P1204, DOI 10.1136/jnnp.2003.026278
   Detjen AK, 2007, TWIN RES HUM GENET, V10, P486, DOI 10.1375/twin.10.3.486
   Durand-Dubief F, 2004, REV NEUROL-FRANCE, V160, P824, DOI 10.1016/S0035-3787(04)71038-3
   Finsterer J, 2001, EUR NEUROL, V46, P92, DOI 10.1159/000050770
   FISCHER JC, 1986, CLIN CHIM ACTA, V155, P263, DOI 10.1016/0009-8981(86)90246-9
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Janssen AJM, 2006, CLIN CHEM, V52, P860, DOI 10.1373/clinchem.2005.062414
   Jones M, 2004, AM J OPHTHALMOL, V138, P1051, DOI 10.1016/j.ajo.2004.06.026
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   KOBAYASHI M, 1987, J PEDIATR-US, V110, P223, DOI 10.1016/S0022-3476(87)80158-0
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   KOGA Y, 1995, MUSCLE NERVE, pS119
   Kornblum C, 2005, J NEUROL, V252, P1101, DOI 10.1007/s00415-005-0827-7
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   Munakata K, 2005, BIOL PSYCHIAT, V57, P525, DOI 10.1016/j.biopsych.2004.11.041
   Okhuijsen-Kroes EJ, 2001, NEUROPEDIATRICS, V32, P183, DOI 10.1055/s-2001-17372
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pons R, 2004, J PEDIATR-US, V144, P81, DOI 10.1016/j.jpeds.2003.10.023
   Sangkhathat S, 2005, PEDIATR SURG INT, V21, P745, DOI 10.1007/s00383-005-1471-0
   Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708
   Srere P.A., 1969, Methods in Enzymology, V13, P3
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Vielhaber S, 2002, J NEUROPATH EXP NEUR, V61, P885, DOI 10.1093/jnen/61.10.885
   Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006
   Wong LJC, 2002, AM J MED GENET, V113, P59, DOI 10.1002/ajmg.10767
NR 45
TC 23
Z9 25
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD APR
PY 2008
VL 63
IS 4
BP 473
EP 481
DI 10.1002/ana.21328
PG 9
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 295DE
UT WOS:000255454400010
PM 18306232
DA 2024-11-01
ER

PT J
AU Wu, YT
   Tay, HY
   Yang, JT
   Liao, HH
   Ma, YS
   Wei, YH
AF Wu, Yu-Ting
   Tay, Hui-Yi
   Yang, Jung-Tse
   Liao, Hsiao-Hui
   Ma, Yi-Shing
   Wei, Yau-Huei
TI Mitochondrial impairment and synaptic dysfunction are associated with
   neurological defects in iPSCs-derived cortical neurons of MERRF patients
SO JOURNAL OF BIOMEDICAL SCIENCE
LA English
DT Article
DE AMPARs; Disease modeling; Electrophysiological activity; Excitatory
   neurons; iPSCs; MERRF syndrome; mtDNA mutation; Neurological defect;
   Synaptic plasticity; Synaptophysin
ID A8344G MUTATION; FEMALE-PATIENT; DNA MUTATIONS; PLASTICITY; DISEASES;
   GENERATION; LINE
AB BackgroundMyoclonic epilepsy with ragged-red fibers (MERRF) syndrome is a rare inherited mitochondrial disease mainly caused by the m.8344A > G mutation in mitochondrial tRNA(Lys) gene, and usually manifested as complex neurological disorders and muscle weakness. Currently, the pathogenic mechanism of this disease has not yet been resolved, and there is no effective therapy for MERRF syndrome. In this study, MERRF patients-derived iPSCs were used to model patient-specific neurons for investigation of the pathogenic mechanism of neurological disorders in mitochondrial disease.MethodsMERRF patient-derived iPSCs were differentiated into excitatory glutamatergic neurons to unravel the effects of the m.8344A > G mutation on mitochondrial bioenergetic function, neural-lineage differentiation and neuronal function. By the well-established differentiation protocol and electrophysiological activity assay platform, we examined the pathophysiological behaviors in cortical neurons of MERRF patients.ResultsWe have successfully established the iPSCs-derived neural progenitor cells and cortical-like neurons of patients with MERRF syndrome that retained the heteroplasmy of the m.8344A > G mutation from the patients' skin fibroblasts and exhibited the phenotype of the mitochondrial disease. MERRF neural cells harboring the m.8344A > G mutation exhibited impaired mitochondrial bioenergetic function, elevated ROS levels and imbalanced expression of antioxidant enzymes. Our findings indicate that neural immaturity and synaptic protein loss led to the impairment of neuronal activity and plasticity in MERRF neurons harboring the m.8344A > G mutation. By electrophysiological recordings, we monitored the in vivo neuronal behaviors of MERRF neurons and found that neurons harboring a high level of the m.8344A > G mutation exhibited impairment of the spontaneous and evoked potential-stimulated neuronal activities.ConclusionsWe demonstrated for the first time the link of mitochondrial impairment and synaptic dysfunction to neurological defects through impeding synaptic plasticity in excitatory neurons derived from iPSCs of MERRF patients harboring the m.8344A > G mutation. This study has provided new insight into the pathogenic mechanism of the tRNA(Lys) gene mutation of mtDNA, which is useful for the development of a patient-specific iPSCs platform for disease modeling and screening of new drugs to treat patients with MERRF syndrome.
C1 [Wu, Yu-Ting; Tay, Hui-Yi; Yang, Jung-Tse; Liao, Hsiao-Hui; Ma, Yi-Shing; Wei, Yau-Huei] Changhua Christian Hosp, Ctr Mitochondrial Med & Free Rad Res, Changhua 50046, Taiwan.
   [Wei, Yau-Huei] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei 112, Taiwan.
C3 Changhua Christian Hospital; National Yang Ming Chiao Tung University
RP Wei, YH (corresponding author), Changhua Christian Hosp, Ctr Mitochondrial Med & Free Rad Res, Changhua 50046, Taiwan.; Wei, YH (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei 112, Taiwan.
EM yhweibabi@gmail.com
OI Wei, Yau-Huei/0000-0002-6429-2546
FU National Science and Technology Council of Taiwan Government (MOST)
   [MOST 110-2311-B-371-001, MOST 110-2320-B-371-001, MOST
   111-2320-B-371-001, 110-CCH-MST-179]; Changhua Christian Hospital,
   Taiwan [110-CCH-MST-127, 111-CCH-HCR-147, 110-CCH-MST-138];  [MOST
   110-2314-B-715-005]
FX The work described in this paper has been supported by Grants from the
   National Science and Technology Council of Taiwan Government (MOST
   110-2314-B-715-005, MOST 110-2311-B-371-001, MOST 110-2320-B-371-001,
   and MOST 111-2320-B-371-001) We would like to express our appreciation
   of the financial support of intramural Grants
   (110-CCH-MST-179,110-CCH-MST-127 and 111-CCH-HCR-147,110-CCH-MST-138)
   from Changhua Christian Hospital, Taiwan.
CR Abuhassan K, 2011, IEEE ENG MED BIO, P2065, DOI 10.1109/IEMBS.2011.6090382
   Bai Xiang, 2014, J Biochem Pharmacol Res, V2, P185
   Bhattacharya S, 2022, STEM CELL RES THER, V13, DOI 10.1186/s13287-022-02937-6
   Buck SA, 2021, J NEUROSCI, V41, P4937, DOI 10.1523/JNEUROSCI.2770-20.2021
   Chen YC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0488-y
   Chou SJ, 2018, STEM CELL RES, V30, P201, DOI 10.1016/j.scr.2018.05.011
   Chou SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23661
   Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867
   Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X
   Falcicchia C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165624
   Grant SGN, 2012, CURR OPIN NEUROBIOL, V22, P522, DOI 10.1016/j.conb.2012.02.002
   Gunnewiek TMK, 2021, STEM CELL REP, V16, P2197, DOI 10.1016/j.stemcr.2021.07.002
   Hatakeyama H, 2016, STEM CELLS, V34, P801, DOI 10.1002/stem.2292
   Hegde AN, 2010, LEARN MEMORY, V17, P314, DOI 10.1101/lm.1504010
   Holley SM, 2018, CNS NEUROSCI THER, V24, P329, DOI 10.1111/cns.12839
   Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699
   Hsu YH, 2017, STEM CELL RES, V25, P245, DOI 10.1016/j.scr.2017.10.024
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   Jurcau A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222111847
   Kang J, 2020, CELL MOL NEUROBIOL, V40, P861, DOI 10.1007/s10571-020-00785-7
   Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x
   Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]
   Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003
   Limanaqi F, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00299
   Liu YY, 2023, MICROSYST NANOENG, V9, DOI 10.1038/s41378-022-00479-8
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Lu CY, 2002, CLIN CHIM ACTA, V318, P97, DOI 10.1016/S0009-8981(01)00809-9
   Ma YS, 2005, ANN NY ACAD SCI, V1042, P55, DOI 10.1196/annals.1338.006
   Mavraki E, 2023, EUR J HUM GENET, V31, P148, DOI 10.1038/s41431-022-01249-w
   Nair RR, 2019, MAMM GENOME, V30, P173, DOI 10.1007/s00335-019-09807-2
   Ninan I, 2004, NEURON, V42, P129, DOI 10.1016/S0896-6273(04)00143-6
   Onder TT, 2012, CURR OPIN GENET DEV, V22, P500, DOI 10.1016/j.gde.2012.05.005
   Osimo EF, 2019, MOL PSYCHIATR, V24, P549, DOI 10.1038/s41380-018-0041-5
   Park SY, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00520
   Pelkonen A, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11010106
   Penn AC, 2017, NATURE, V549, P384, DOI 10.1038/nature23658
   Peron C, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.648916
   Purkey AM, 2020, FRONT SYNAPTIC NEURO, V12, DOI 10.3389/fnsyn.2020.00008
   Radwitz J, 2022, CELL MOL LIFE SCI, V79, DOI 10.1007/s00018-022-04607-5
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Shen FM, 2021, J ETHNOPHARMACOL, V275, DOI 10.1016/j.jep.2021.114164
   Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516
   Singh Pragya, 2022, Methods Mol Biol, V2549, P219, DOI 10.1007/7651_2021_384
   Son G, 2018, BMB REP, V51, P549, DOI 10.5483/BMBRep.2018.51.11.226
   Südhof TC, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202103052
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tampellini D, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00423
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
   Wu YT, 2018, STEM CELL RES, V27, P10, DOI 10.1016/j.scr.2017.12.013
   Yu Q, 2017, J ALZHEIMERS DIS, V59, P223, DOI 10.3233/JAD-170283
   Zalcman G, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00445
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   Zhang XY, 2021, NEURAL REGEN RES, V16, P2446, DOI 10.4103/1673-5374.313056
   Zhao YX, 2015, AM J TRANSL RES, V7, P15
NR 54
TC 5
Z9 5
U1 2
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1021-7770
EI 1423-0127
J9 J BIOMED SCI
JI J. Biomed. Sci.
PD AUG 21
PY 2023
VL 30
IS 1
AR 70
DI 10.1186/s12929-023-00966-8
PG 21
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA P7YP8
UT WOS:001052794600001
PM 37605213
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Galera-Monge, T
   Zurita-Díaz, F
   Garesse, R
   Gallardo, ME
AF Galera-Monge, Teresa
   Zurita-Diaz, Francisco
   Garesse, Rafael
   Esther Gallardo, Maria
TI The mutation m.13513G&gt;A impairs cardiac function, favoring a
   neuroectoderm commitment, in a mutant-load dependent way
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
DE cardiomyocytes; heteroplasmy; iPSc; Leigh syndrome; neuroectoderm
ID PLURIPOTENT STEM-CELLS; HUMAN IPSC LINE; LEIGH-SYNDROME; MITOCHONDRIAL;
   GENERATION; PATIENT
AB Mitochondrial disorders (MDs) arise as a result of a respiratory chain dysfunction. While some MDs can affect a single organ, many involve several organs, the brain being the most affected, followed by heart and/or muscle. Many of these diseases are associated with heteroplasmic mutations in the mitochondrial DNA (mtDNA). The proportion of mutated mtDNA must exceed a critical threshold to produce disease. Therefore, understanding how embryonic development determines the heteroplasmy level in each tissue could explain the organ susceptibility and the clinical heterogeneity observed in these patients. In this report, the dynamics of heteroplasmy and the influence in cardiac commitment of the mutational load of the m.13513G>A mutation has been analyzed. This mutation has been reported as a frequent cause of Leigh syndrome (LS) and is commonly associated with cardiac problems. In this report, induced pluripotent stem cell (iPSc) technology has been used to delve into the molecular mechanisms underlying cardiac disease in LS. When mutation m.13513G>A is above a threshold, iPSc-derived cardiomyocytes (iPSc-CMs) could not be obtained due to an inefficient epithelial-mesenchymal transition. Surprisingly, these cells are redirected toward neuroectodermal lineages that would give rise to the brain. However, when mutation is below that threshold, dysfunctional CM are generated in a mutant-load dependent way. We suggest that distribution of the m.13513G>A mutation during cardiac differentiation is not at random. We propose a possible explanation of why neuropathology is a frequent feature of MD, but cardiac involvement is not always present.
C1 [Galera-Monge, Teresa; Zurita-Diaz, Francisco; Garesse, Rafael; Esther Gallardo, Maria] Univ Autonoma Madrid, Fac Med, Dept Bioquim, Madrid, Spain.
   [Galera-Monge, Teresa; Zurita-Diaz, Francisco] UAM, CSIC, Inst Invest Biomed Alberto Sols, Dept Bioquim, Madrid, Spain.
   [Galera-Monge, Teresa; Zurita-Diaz, Francisco] Ctr Invest Biomed Red, Madrid, Spain.
   [Galera-Monge, Teresa; Zurita-Diaz, Francisco; Esther Gallardo, Maria] Inst Invest Sanitaria Hosp 12 Octubre, I 12 Ctr Actividades Ambulatorias, Ave Cordoba S-N, Madrid, Spain.
C3 Autonomous University of Madrid; Autonomous University of Madrid;
   Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de
   Investigacion Biomedica en Red; Hospital Universitario 12 de Octubre
RP Garesse, R; Gallardo, ME (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Bioquim, Madrid, Spain.
EM rafael.garesse@uam.es; egallardo.imas12@h12o.es
RI Gallardo, M./AFK-7298-2022
OI ZURITA DIAZ, FRANCSICO/0000-0003-0541-1637; GALLARDO PEREZ, M.
   ESTHER/0000-0002-8699-8734
FU Instituto de Salud Carlos III (Fondo de Investigacion Sanitaria and
   Regional Development Fund [ERDF/FEDER]) [PI16/00489, PI18/00151,
   PI10/00703, PI13/00556, PI15/00484]; Centro de Investigacion Biomedica
   en Red en Enfermedades Raras (CIBERER) [ER16P3AC717, 13-717/132.05];
   Miguel Servet Program [CP16/00046]
FX Instituto de Salud Carlos III (Fondo de Investigacion Sanitaria and
   Regional Development Fund [ERDF/FEDER]), Grant/Award Numbers:
   PI16/00489, PI18/00151, PI10/00703, PI13/00556, PI15/00484; Centro de
   Investigacion Biomedica en Red en Enfermedades Raras (CIBERER),
   Grant/Award Numbers: ER16P3AC717, 13-717/132.05; Miguel Servet Program,
   Grant/Award Number: CP16/00046
CR Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503
   Burridge PW., 2015, CURR PROTOC HUM GENE, V87, P21
   Chou SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23661
   DiMauro S, 2011, J INHERIT METAB DIS, V34, P261, DOI 10.1007/s10545-010-9082-x
   Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389
   Fujikura J, 2012, DIABETOLOGIA, V55, P1689, DOI 10.1007/s00125-012-2508-2
   Galera T, 2016, STEM CELL RES, V16, P88, DOI 10.1016/j.scr.2015.12.010
   Galera T, 2016, STEM CELL RES, V16, P63, DOI 10.1016/j.scr.2015.12.005
   Galera-Monge T, 2016, STEM CELL RES, V16, P766, DOI 10.1016/j.scr.2016.04.012
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104
   Kodaira M, 2015, FEBS OPEN BIO, V5, P219, DOI 10.1016/j.fob.2015.03.008
   Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150
   Lorenz C, 2017, CELL STEM CELL, V20, P659, DOI 10.1016/j.stem.2016.12.013
   Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546
   Monlleo-Neila L, 2013, J CHILD NEUROL, V28, P1531, DOI 10.1177/0883073812460580
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   Viscomi C, 2015, BBA-BIOENERGETICS, V1847, P544, DOI 10.1016/j.bbabio.2015.03.001
   Zheng XD, 2016, ELIFE, V5, DOI 10.7554/eLife.13378
NR 21
TC 15
Z9 17
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD NOV
PY 2019
VL 234
IS 11
BP 19511
EP 19522
DI 10.1002/jcp.28549
PG 12
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA IM5EX
UT WOS:000478018200035
PM 30950033
DA 2024-11-01
ER

PT J
AU Haast, RAM
   Ivanov, D
   IJsselstein, RJT
   Sallevelt, SCEH
   Jansen, JFA
   Smeets, HJM
   de Coo, IFM
   Formisano, E
   Uludag, K
AF Haast, Roy A. M.
   Ivanov, Dimo
   IJsselstein, Rutger J. T.
   Sallevelt, Suzanne C. E. H.
   Jansen, Jacobus F. A.
   Smeets, Hubert J. M.
   de Coo, Irenaeus F. M.
   Formisano, Elia
   Uludag, Kamil
TI Anatomic & metabolic brain markers of the m.3243A &GT; G mutation: A
   multi-parametric 7T MRI study
SO NEUROIMAGE-CLINICAL
LA English
DT Article
DE 7T MRI; Brain; Quantitative; m.3243A > G; Mitochondrial
ID STROKE-LIKE EPISODES; CONCURRENT FUNCTIONAL PERFUSION; MITOCHONDRIAL-DNA
   MUTATIONS; PARTICIPANTS AGED 24-81; NORMATIVE DATA; HEARING-LOSS;
   MEGALENCEPHALIC LEUKOENCEPHALOPATHY; M.3243A-GREATER-THAN-G MUTATION;
   LACTIC-ACIDOSIS; A3243G MUTATION
AB One of the most common mitochondrial DNA (mtDNA) mutations, the A to G transition at base pair 3243, has been linked to changes in the brain, in addition to commonly observed hearing problems, diabetes and myopathy. However, a detailed quantitative description of m.3243A> G patients' brains has not been provided so far. In this study, ultra-high field MRI at 7T and volume-and surface-based data analyses approaches were used to highlight morphology (i.e. atrophy)-, microstructure (i.e. myelin and iron concentration)-and metabolism (i.e. cerebral blood flow)-related differences between patients (N = 22) and healthy controls (N = 15). The use of quantitative MRI at 7T allowed us to detect subtle changes of biophysical processes in the brain with high accuracy and sensitivity, in addition to typically assessed lesions and atrophy. Furthermore, the effect of m. 3243A> G mutation load in blood and urine epithelial cells on these MRI measures was assessed within the patient population and revealed that blood levels were most indicative of the brain's state and disease severity, based on MRI as well as on neuropsychological data. Morphometry MRI data showed a wide-spread reduction of cortical, subcortical and cerebellar gray matter volume, in addition to significantly enlarged ventricles. Moreover, surface-based analyses revealed brain area-specific changes in cortical thickness (e.g. of the auditory cortex), and in T-1, T-2* and cerebral blood flow as a function of mutation load, which can be linked to typically m. 3243A> G-related clinical symptoms (e.g. hearing impairment). In addition, several regions linked to attentional control (e.g. middle frontal gyrus), the sensorimotor network (e.g. banks of central sulcus) and the default mode network (e.g. precuneus) were characterized by alterations in cortical thickness, T-1, T-2* and/or cerebral blood flow, which has not been described in previous MRI studies. Finally, several hypotheses, based either on vascular, metabolic or astroglial implications of the m. 3243A> G mutation, are discussed that potentially explain the underlying pathobiology. To conclude, this is the first 7T and also the largest MRI study on this patient population that provides macroscopic brain correlates of the m. 3243A> G mutation indicating potential MRI biomarkers of mitochondrial diseases and might guide future (longitudinal) studies to extensively track neuropathological and clinical changes.
C1 [Haast, Roy A. M.; Ivanov, Dimo; Formisano, Elia; Uludag, Kamil] Maastricht Univ, Dept Cognit Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.
   [Haast, Roy A. M.; Formisano, Elia] Maastricht Univ, Maastricht Ctr Syst Biol, POB 616, NL-6200 MD Maastricht, Netherlands.
   [IJsselstein, Rutger J. T.; de Coo, Irenaeus F. M.] Erasmus MC, Dept Neurol, Postbus 2040, NL-3000 CA Rotterdam, Netherlands.
   [Sallevelt, Suzanne C. E. H.] Maastricht Univ, Med Ctr, Dept Clin Genet, POB 5800, NL-6202 AZ Maastricht, Netherlands.
   [Jansen, Jacobus F. A.] Maastricht Univ, Med Ctr, Dept Radiol, POB 5800, NL-6202 AZ Maastricht, Netherlands.
   [Jansen, Jacobus F. A.] Maastricht Univ, Sch Mental Hlth & Neurosci, POB 5800, NL-6202 AZ Maastricht, Netherlands.
   [Smeets, Hubert J. M.] Maastricht Univ, Dept Genet & Cell Biol, POB 616, NL-6200 MD Maastricht, Netherlands.
   [Smeets, Hubert J. M.; de Coo, Irenaeus F. M.] NeMo Expertise Ctr, Postbus 2060, NL-3000 CB Rotterdam, Netherlands.
   [Smeets, Hubert J. M.] Maastricht Univ, Res Sch GROW, POB 616, NL-6200 MD Maastricht, Netherlands.
C3 Maastricht University; Maastricht University; Erasmus University
   Rotterdam; Erasmus MC; Maastricht University; Maastricht University;
   Maastricht University; Maastricht University; Maastricht University
RP Haast, RAM; Uludag, K (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.
EM roy.haast@maastrichtuniversity.nl; kamil.uludag@maastrichtuniversity.nl
RI Haast, Roy/ABB-1311-2020; Uludag, Kamil/KYQ-0844-2024; Jansen,
   Jacobus/C-4098-2009
OI Formisano, Elia/0000-0001-5008-2460; Haast, Roy/0000-0001-8543-2467;
   Uludag, Kamil/0000-0002-2813-5930; de Coo, Irenaeus/0000-0003-0533-7422;
   Sallevelt, Suzanne/0000-0002-9778-9823; Ivanov, Dimo/0000-0001-9387-5823
FU Maastricht University; Netherlands Organization for Scientific Research
   (NWO) [452-11-002]; Technology Foundation STW [12724]; Ride4Kids;
   Join4Energy; NeMo
FX The authors are indebted to Prof. Dr. Andrew Webb (Leiden University
   Medical Centre, Leiden, Netherlands), Dr. Jose Marques (Donders
   Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands) and
   Dr. Florence van Tienen for providing the dielectric pads, the MATLAB
   code to perform the T<INF>1</INF> correction and help with the genetic
   analyses used in this study, respectively. This work was supported by
   Maastricht University, the Netherlands Organization for Scientific
   Research (NWO; VIDI grant 452-11-002 to K.U.), Technology Foundation STW
   (12724 to E.F.) and Ride4Kids, Join4Energy and NeMo (to I.F.M.d.C.).
CR Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Barragán-Campos HM, 2005, ARCH NEUROL-CHICAGO, V62, P737, DOI 10.1001/archneur.62.5.737
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Bindu PS, 2015, MITOCHONDRION, V25, P6, DOI 10.1016/j.mito.2015.08.002
   Bock NA, 2013, NEUROIMAGE, V65, P1, DOI 10.1016/j.neuroimage.2012.09.051
   Bugiani M, 2017, ANN CLIN TRANSL NEUR, V4, P450, DOI 10.1002/acn3.405
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Dinopoulos A, 2005, NEUROPEDIATRICS, V36, P290, DOI 10.1055/s-2005-872807
   Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104
   Eckert MA, 2012, JARO-J ASSOC RES OTO, V13, P703, DOI 10.1007/s10162-012-0332-5
   Eggenschwiler F, 2012, MAGN RESON MED, V67, P1609, DOI 10.1002/mrm.23145
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   Finsterer J, 2012, ACTA NEUROL SCAND, V126, P1, DOI 10.1111/j.1600-0404.2012.01649.x
   Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4
   Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X
   Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318
   Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339
   Gardener AG, 2009, MAGN RESON MED, V61, P874, DOI 10.1002/mrm.21796
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Haast RAM, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00112
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Ikawa M, 2013, MITOCHONDRION, V13, P676, DOI 10.1016/j.mito.2013.09.007
   Ivanov D, 2017, MAGN RESON MED, V78, P121, DOI 10.1002/mrm.26351
   Ivanov D, 2017, NEUROIMAGE, V156, P363, DOI 10.1016/j.neuroimage.2017.05.038
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Keuken MC, 2017, BRAIN STRUCT FUNCT, V222, P2487, DOI 10.1007/s00429-016-1352-4
   Kollia K, 2009, AM J NEURORADIOL, V30, P699, DOI 10.3174/ajnr.A1434
   Kullar PJ, 2016, BRAIN, V139, pE33, DOI 10.1093/brain/aww051
   Lax NZ, 2016, NEUROPATH APPL NEURO, V42, P180, DOI 10.1111/nan.12238
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Li R, 2017, J MAGN RESON IMAGING, V45, P199, DOI 10.1002/jmri.25354
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Lorio S, 2016, HUM BRAIN MAPP, V37, P1801, DOI 10.1002/hbm.23137
   Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035
   Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002
   Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5
   Milham MP, 2002, BRAIN COGNITION, V49, P277, DOI 10.1006/brcg.2001.1501
   Nakada T, 2008, J NEUROIMAGING, V18, P125, DOI 10.1111/j.1552-6569.2007.00179.x
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Norris DG, 2003, J MAGN RESON IMAGING, V18, P519, DOI 10.1002/jmri.10390
   Pfeuffer J, 2002, NEUROIMAGE, V17, P272, DOI 10.1006/nimg.2002.1103
   Pohmann R, 2016, MAGN RESON MED, V75, P801, DOI 10.1002/mrm.25677
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   Rodan LH, 2015, MITOCHONDRION, V22, P66, DOI 10.1016/j.mito.2015.03.002
   Romero JE, 2017, NEUROIMAGE, V147, P916, DOI 10.1016/j.neuroimage.2016.11.003
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sallevelt SCEH, 2013, J MED GENET, V50, P125, DOI 10.1136/jmedgenet-2012-101172
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Scaglia F, 2005, AM J NEURORADIOL, V26, P1675
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Seidler R, 2015, NEUROIMAGE, V108, P47, DOI 10.1016/j.neuroimage.2014.12.023
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Sofou K, 2013, MITOCHONDRION, V13, P364, DOI 10.1016/j.mito.2013.04.008
   SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   Stüber C, 2014, NEUROIMAGE, V93, P95, DOI 10.1016/j.neuroimage.2014.02.026
   Syka J, 2002, PHYSIOL REV, V82, P601, DOI 10.1152/physrev.00002.2002
   Teeuwisse WM, 2012, MAGN RESON MED, V67, P1285, DOI 10.1002/mrm.23108
   Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110
   Trattnig S., 2016, NEUROIMAGE, P30651
   Tschampa HJ, 2013, J NEUROL, V260, P1071, DOI 10.1007/s00415-012-6763-4
   Tsujikawa K, 2016, MITOCHONDRION, V30, P229, DOI 10.1016/j.mito.2016.08.011
   Tsujikawa T, 2010, BRAIN DEV-JPN, V32, P143, DOI 10.1016/j.braindev.2008.12.003
   Ugurbil K., 2017, NEUROIMAGE, P30575
   Uludag K., 2017, NEUROIMAGE
   Van der Elst W, 2006, ASSESSMENT, V13, P62, DOI 10.1177/1073191105283427
   Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344
   van der Elst W, 2006, J CLIN EXP NEUROPSYC, V28, P998, DOI 10.1080/13803390591004428
   van der Knaap MS, 2012, LANCET NEUROL, V11, P973, DOI 10.1016/S1474-4422(12)70192-8
   van der Zwaag W, 2016, NMR BIOMED, V29, P1274, DOI 10.1002/nbm.3275
   Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156
   Virtanen SM, 2011, AM J NEURORADIOL, V32, P522, DOI 10.3174/ajnr.A2309
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105
   Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015
   Zhu XH, 2012, NEUROIMAGE, V60, P2107, DOI 10.1016/j.neuroimage.2012.02.013
NR 83
TC 14
Z9 14
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2213-1582
J9 NEUROIMAGE-CLIN
JI NeuroImage-Clin.
PY 2018
VL 18
BP 231
EP 244
DI 10.1016/j.nicl.2018.01.017
PG 14
WC Neuroimaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA GH1NG
UT WOS:000433169000023
PM 29868447
OA Green Accepted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Choi, JH
   Yoon, HR
   Kim, GH
   Park, SJ
   Shin, YL
   Yoo, HW
AF Choi, Jin-Ho
   Yoon, Hye-Ran
   Kim, Gu-Hwan
   Park, Seong-Jong
   Shin, Young-Lim
   Yoo, Han-Wook
TI Identification of novel mutations of the <i>HADHA</i> and <i>HADHB</i>
   genes in patients with mitochondrial trifunctional protein deficiency
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article
DE HADHA; HADHB; mitochondrial trifunctional deficiency; long-chain
   3-hydroxyacyl coenzyme A dehydrogenase; deficiency; long-chain
   2,3-enoyl-CoA hydratase; long chain 3-ketoacyl CoA thiolase
ID 3-HYDROXYACYL-COA DEHYDROGENASE-DEFICIENCY; TANDEM MASS-SPECTROMETRY;
   ACID OXIDATION DISORDER; INBORN-ERRORS; LIVER; METABOLISM; DIAGNOSIS
AB Patients with long-chain 3-hydroxyacyl coenzyme A dehydrogenase (LCHAD) deficiency manifest hypoketotic hypoglycemia, hepatomegaly, hypotonia, lactic acidemia, acute renal failure, cardiomyopathy, and sudden death. We describe four novel mutations of the alpha- and beta-subunits of the mitochondrial trifunctional protein in four patients from three unrelated families. Their plasma acylcarnitine profiles suggested the presence of LCHAD deficiency by demonstrating highly elevated 3-hydroxyacyl carnitines by tandem mass spectrometry (MS/MS). Patients 1 and 2 had siblings who had died of lactic acidemia during the neonatal period. These patients also manifested lactic acidemia and died in the neonatal period. Patient 3 had a family history of Reye-like syndrome. She exhibited acute renal failure, rhabdomyolysis, pericardial effusion, and myopathy at the age of 12 years. DNA analysis of patients 1 and 2 revealed homozygosity for a c.1689+2T > G mutation of the HADHA gene, resulting in the skipping of exon 16 with an in-frame 69-bp deletion. Patient 3 was a compound heterozygosity of the HADHB gene, N307D/N389D. Patient 4, a 25-month-old baby, manifested recurrent episodes of lethargy, metabolic acidosis, elevated liver enzymes, and dark urine from the age of 10 months. Mutation analysis of the HADHB gene of patient 4 identified compound heterozygosity of N114D/N307D.
C1 Univ Ulsan, Coll Med, Dept Pediat, Asan Med Ctr, Seoul 138736, South Korea.
   Chungnam Natl Univ Hosp, Coll Med, Dept Pediat, Taejon 301721, South Korea.
   Duksung Womens Univ, Biomed & Pharmaceut Anal Lab, Coll Pharm, Seoul 132714, South Korea.
   Univ Ulsan, Coll Med, Med Genet Clin & Lab, Seoul 138736, South Korea.
C3 University of Ulsan; Chungnam National University; Chungnam National
   University Hospital; Duksung Women's University; University of Ulsan
RP Yoo, HW (corresponding author), Univ Ulsan, Coll Med, Dept Pediat, Asan Med Ctr, 388-1 Pungnap Dong, Seoul 138736, South Korea.
EM hwyoo@amc.seoul.kr
RI Kim, Hyeon/F-8796-2019; Shin, Young-Lim/AAV-3928-2020; choi,
   jo/O-5940-2014
OI Park, Seong Jong/0000-0003-0250-2381
CR Das AM, 2000, EUR J PEDIATR, V159, P243, DOI 10.1007/s004310050063
   den Boer MEJ, 2003, J PEDIATR-US, V142, P684, DOI 10.1067/mpd.2003.231
   den Boer MEJ, 2002, PEDIATRICS, V109, P99, DOI 10.1542/peds.109.1.99
   Hintz SR, 2002, MOL GENET METAB, V75, P120, DOI 10.1006/mgme.2001.3282
   Ibdah JA, 1999, NEW ENGL J MED, V340, P1723, DOI 10.1056/NEJM199906033402204
   IJIST L, 1996, J CLIN INVEST, V98, P1028
   Ijist Lodewijk, 1994, Biochimica et Biophysica Acta, V1215, P347
   Matern D, 1999, PEDIATR RES, V46, P45, DOI 10.1203/00006450-199907000-00008
   MILLINGTON DS, 1990, J INHERIT METAB DIS, V13, P321, DOI 10.1007/BF01799385
   Rakheja D, 2002, LAB INVEST, V82, P815, DOI 10.1097/01.LAB.0000021175.50201.46
   Rashed MS, 1997, CLIN CHEM, V43, P1129
   Rinaldo P, 2001, SEMIN LIVER DIS, V21, P489, DOI 10.1055/s-2001-19037
   Sander J, 2005, MOL GENET METAB, V85, P108, DOI 10.1016/j.ymgme.2005.02.002
   SIMS HF, 1995, P NATL ACAD SCI USA, V92, P841, DOI 10.1073/pnas.92.3.841
   Spiekerkoetter U, 2003, HUM MUTAT, V21, P598, DOI 10.1002/humu.10211
   Tyni T, 1999, ACTA PAEDIATR, V88, P237, DOI 10.1080/08035259950169954
   Tyni T, 1996, NEUROMUSCULAR DISORD, V6, P327, DOI 10.1016/0960-8966(96)00352-5
   UCHIDA Y, 1992, J BIOL CHEM, V267, P1034
NR 18
TC 34
Z9 35
U1 0
U2 12
PU PROFESSOR D A SPANDIDOS
PI ATHENS
PA 1, S MERKOURI ST, EDITORIAL OFFICE,, ATHENS 116 35, GREECE
SN 1107-3756
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD JAN
PY 2007
VL 19
IS 1
BP 81
EP 87
PG 7
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 121GZ
UT WOS:000243147400011
PM 17143551
DA 2024-11-01
ER

PT J
AU Hedberg-Oldfors, C
   Macao, B
   Basu, S
   Lindberg, C
   Peter, B
   Erdinc, D
   Uhler, JP
   Larsson, E
   Falkenberg, M
   Oldfors, A
AF Hedberg-Oldfors, Carola
   Macao, Bertil
   Basu, Swaraj
   Lindberg, Christopher
   Peter, Bradley
   Erdinc, Direnis
   Uhler, Jay P.
   Larsson, Erik
   Falkenberg, Maria
   Oldfors, Anders
TI Deep sequencing of mitochondrial DNA and characterization of a novel
   <i>POLG</i> mutation in a patient with arPEO
SO NEUROLOGY-GENETICS
LA English
DT Article
ID POLYMERASE GAMMA; MAINTENANCE; DELETIONS; TWINKLE; GENE
AB Objective
   To determine the pathogenicity of a novel POLG mutation in a man with late-onset autosomal recessive progressive external ophthalmoplegia using clinical, molecular, and biochemical analyses.
   Methods
   A multipronged approach with detailed neurologic examinations, muscle biopsy analyses, molecular genetic studies, and in vitro biochemical characterization.
   Results
   The patient had slowly progressive bilateral ptosis and severely reduced horizontal and vertical gaze. Muscle biopsy showed slight variability in muscle fiber size, scattered ragged red fibers, and partial cytochrome c oxidase deficiency. Biallelic mutations were identified in the POLG gene encoding the catalytic A subunit of POL gamma. One allele carried a novel mutation in the exonuclease domain (c.590T>C; p.F197S), and the other had a previously characterized null mutation in the polymerase domain (c.2740A>C; p.T914P). Biochemical characterization revealed that the novel F197S mutant protein had reduced exonuclease and DNA polymerase activities and confirmed that T914P was inactive. By deep sequencing of mitochondrial DNA (mtDNA) extracted from muscle, multiple large-scale rearrangements were mapped and quantified.
   Conclusions
   The patient's phenotype was caused by biallelic POLG mutations, resulting in one inactive POL gamma A protein (T914P) and one with decreased polymerase and exonuclease activity (F197S). The reduction in polymerase activity explains the presence of multiple pathogenic large-scale deletions in the patient's mtDNA.
C1 [Hedberg-Oldfors, Carola; Oldfors, Anders] Univ Gothenburg, Dept Pathol & Genet, Gothenburg, Sweden.
   [Macao, Bertil; Basu, Swaraj; Peter, Bradley; Erdinc, Direnis; Uhler, Jay P.; Larsson, Erik; Falkenberg, Maria] Univ Gothenburg, Med Biochem & Cell Biol, Gothenburg, Sweden.
   [Lindberg, Christopher] Sahlgrens Univ Hosp, Dept Neurol, Neuromuscular Ctr, Gothenburg, Sweden.
C3 University of Gothenburg; University of Gothenburg; Sahlgrenska
   University Hospital
RP Oldfors, A (corresponding author), Univ Gothenburg, Dept Pathol & Genet, Gothenburg, Sweden.; Falkenberg, M (corresponding author), Univ Gothenburg, Med Biochem & Cell Biol, Gothenburg, Sweden.
EM maria.falkenberg@medkem.gu.se; anders.oldfors@pathology.gu.se
RI Basu, Swaraj/AAN-8338-2020; Larsson Lekholm, Erik/AHE-0932-2022
OI Erdinc, Direnis/0000-0002-5830-9911; Basu, Swaraj/0000-0001-6107-2487
FU Swedish Cancer Foundation; European Research Council; IngaBritt and Arne
   Lundberg Foundation; Knut and Alice Wallenberg Foundation; Vastra
   Gotalands Regionen [ALFGBG-727491, ALFGBG716821]
FX O.); the Swedish Cancer Foundation (M.F. and E.L.); the European
   Research Council (M.F.); the IngaBritt and Arne Lundberg Foundation
   (M.F.); the Knut and Alice Wallenberg Foundation (M.F. and E.L.); and
   Vastra Gotalands Regionen to M.F. (ALFGBG-727491) and A.O.
   (ALFGBG716821).
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Anagnostou ME, 2016, EPILEPSIA, V57, P1531, DOI 10.1111/epi.13508
   [Anonymous], 2013, MUSCLE BIOPSY PRACTI
   Bratic A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9808
   DeBalsi KL, 2017, J BIOL CHEM, V292, P4198, DOI 10.1074/jbc.M116.773341
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Macao B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8303
   Persson Ö, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08673-5
   Pitceathly RDS, 2016, EUR RADIOL, V26, P130, DOI 10.1007/s00330-015-3801-5
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Yu CY, 2005, NEUROMUSCULAR DISORD, V15, P17, DOI 10.1016/j.nmd.2004.10.002
   Yu-Wai-Man C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075048
NR 21
TC 7
Z9 7
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2376-7839
J9 NEUROL-GENET
JI Neurol.-Genet.
PD FEB
PY 2020
VL 6
IS 1
AR e391
DI 10.1212/NXG.0000000000000391
PG 10
WC Genetics & Heredity; Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Neurosciences & Neurology
GA LJ6PF
UT WOS:000530284200011
PM 32042919
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Samuels, DC
   Schon, EA
   Chinnery, PF
AF Samuels, DC
   Schon, EA
   Chinnery, PF
TI Two direct repeats cause most human mtDNA deletions
SO TRENDS IN GENETICS
LA English
DT Article
ID HUMAN MITOCHONDRIAL-DNA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   KEARNS-SAYRE SYNDROME; RECOMBINATION; REPLICATION; SEQUENCES; REGION;
   MODEL; DUPLICATION; MYOPATHIES
AB Mitochondrial DNA (mtDNA) deletions are a common cause of human mitochondrial disease and also occur as part of normal aging. However, it is unknown how the deletions actually occur. To gain further insight, we studied the sequences that flank 263 different human mtDNA deletions. The distribution of deletion breakpoints did not correspond to the basic parameters of wild-type mtDNA that are thought to predispose to deletion formation. But there was a striking correspondence to the position of two 13-bp direct repeats beginning at nucleotides 8470 and 13447. The vast majority of different mtDNA deletions appear to be related to these two repeats, suggesting a common mechanism related to mtDNA replication.
C1 Newcastle Univ, Sch Med, Dept Neurol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.
   Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10031 USA.
   Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10031 USA.
C3 Newcastle University - UK; Virginia Polytechnic Institute & State
   University; Columbia University; Columbia University
RP Newcastle Univ, Sch Med, Dept Neurol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM P.F.Chinnery@ncl.ac.uk
RI ; Samuels, David/A-5393-2008
OI Chinnery, Patrick/0000-0002-7065-6617; Samuels,
   David/0000-0003-3529-7791
FU NICHD NIH HHS [HD 32062] Funding Source: Medline; NINDS NIH HHS [NS
   39854, NS 28828] Funding Source: Medline
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Barrientos A, 1996, AM J HUM GENET, V58, P963
   BAUMER A, 1994, AM J HUM GENET, V54, P618
   BLOK RB, 1995, HUM GENET, V95, P75
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   BUROKER NE, 1990, GENETICS, V124, P157
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   de Massy B, 2003, TRENDS GENET, V19, P514, DOI 10.1016/S0168-9525(03)00201-4
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619
   Eisenbarth I, 2000, AM J HUM GENET, V67, P873, DOI 10.1086/303085
   Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   Lakshmipathy U, 1999, NUCLEIC ACIDS RES, V27, P1198, DOI 10.1093/nar/27.4.1198
   LARSEN A, 1982, CELL, V29, P609, DOI 10.1016/0092-8674(82)90177-5
   LARSSON NG, 1992, BIOCHIM BIOPHYS ACTA, V1139, P311, DOI 10.1016/0925-4439(92)90106-W
   LYAMICHEV VI, 1986, J BIOMOL STRUCT DYN, V3, P667, DOI 10.1080/07391102.1986.10508454
   Manfredi G, 1997, ANN NEUROL, V42, P180, DOI 10.1002/ana.410420208
   Marzuki S, 1997, J NEUROL SCI, V145, P155, DOI 10.1016/S0022-510X(96)00241-9
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MIYABAYASHI S, 1991, J INHERIT METAB DIS, V14, P805, DOI 10.1007/BF01799954
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1991, MOL CELL BIOL, V11, P1631, DOI 10.1128/MCB.11.3.1631
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Negrier MLM, 1998, AM J HUM GENET, V63, P1227, DOI 10.1086/302045
   NELSON I, 1989, CR HEBD ACAD SCI, V1, P403
   Rocher C, 2002, MOL GENET METAB, V76, P123, DOI 10.1016/S1096-7192(02)00024-0
   Saiwaki T, 2000, J CLIN PATHOL-MOL PA, V53, P333, DOI 10.1136/mp.53.6.333
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Servidei Serenella, 2003, Neuromuscul Disord, V13, P848
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Solano A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e86
   TRINH TQ, 1993, GENETICS, V134, P409
   WELLS RD, 1988, FASEB J, V2, P2939, DOI 10.1096/fasebj.2.14.3053307
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 40
TC 142
Z9 165
U1 0
U2 5
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0168-9525
EI 1362-4555
J9 TRENDS GENET
JI Trends Genet.
PD SEP
PY 2004
VL 20
IS 9
BP 393
EP 398
DI 10.1016/j.tig.2004.07.003
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 852AC
UT WOS:000223726600001
PM 15313545
DA 2024-11-01
ER

PT J
AU Birch-Machin, MA
   Swalwell, H
AF Birch-Machin, Mark A.
   Swalwell, Helen
TI How mitochondria record the effects of UV exposure and oxidative stress
   using human skin as a model tissue
SO MUTAGENESIS
LA English
DT Review
ID MTDNA CONTROL-REGION; ULTRAVIOLET-RADIATION EXPOSURE; SUBSTANTIA-NIGRA
   NEURONS; DNA DELETIONS; COMMON DELETION; DEGENERATIVE DISEASES; HACAT
   KERATINOCYTES; CELLULAR SENESCENCE; HYDROGEN-PEROXIDE; SKELETAL-MUSCLE
AB The accumulation of mitochondrial DNA (mtDNA) mutations has been proposed as an underlying cause of the ageing process and mutations have been associated with cancer in many tissues, including human skin. This involvement is linked to the key roles of mitochondrial function and mtDNA in oxidative stress production and as a mediator of apoptosis. We and others have pioneered the use of mtDNA damage as a highly sensitive biomarker of ultraviolet exposure in human skin and have also shown that the accumulation of an ageing-dependent mtDNA mutation is accelerated by exposure to sunlight, which is known to induce oxidative stress in skin. This is important as ultraviolet radiation (UVR)-induced gene mutations play a key role in the development of skin cancer and ageing in human skin. Novel applications of mtDNA as a biomarker of UVR-induced oxidative stress will also be highlighted in this review.
C1 [Birch-Machin, Mark A.; Swalwell, Helen] Newcastle Univ, Sch Med, Inst Cellular Med, Dept Dermatol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Birch-Machin, MA (corresponding author), Newcastle Univ, Sch Med, Inst Cellular Med, Dept Dermatol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM m.a.birch-machin@ncl.ac.uk
FU Cancer Research UK [C1474/A10235]
FX Cancer Research UK (C1474/A10235).
CR Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101
   Aitken GR, 2007, CLIN EXP DERMATOL, V32, P722, DOI 10.1111/j.1365-2230.2007.02474.x
   ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303
   Berneburg M, 2004, J INVEST DERMATOL, V122, P1277, DOI 10.1111/j.0022-202X.2004.22502.x
   Birch-Machin MA, 2006, CLIN EXP DERMATOL, V31, P548, DOI 10.1111/j.1365-2230.2006.02161.x
   Birch-Machin MA, 2000, CLIN EXP DERMATOL, V25, P141, DOI 10.1046/j.1365-2230.2000.00605.x
   Birch-Machin MA, 2005, BRIT J CANCER, V93, P271, DOI 10.1038/sj.bjc.6602711
   Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4
   Birch-Machin MA, 1998, J INVEST DERMATOL, V110, P149, DOI 10.1046/j.1523-1747.1998.00099.x
   Birket MJ, 2007, AGING CELL, V6, P557, DOI 10.1111/j.1474-9726.2007.00310.x
   Birket MJ, 2009, J INVEST DERMATOL, V129, P1361, DOI 10.1038/jid.2008.373
   Boukamp Petra, 2005, J Dtsch Dermatol Ges, V3, P493, DOI 10.1111/j.1610-0387.2005.05037.x
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Bowden GT, 2004, NAT REV CANCER, V4, P23, DOI 10.1038/nrc1253
   Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506
   CARON F, 1979, P NATL ACAD SCI USA, V76, P4265, DOI 10.1073/pnas.76.9.4265
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Deichmann M, 2004, INT J ONCOL, V24, P137
   Del Bo R, 2003, NEUROBIOL AGING, V24, P829, DOI 10.1016/S0197-4580(02)00233-6
   Diffey B, 2004, PHYS MED BIOL, V49, pR1, DOI 10.1088/0031-9155/49/1/R01
   Diffey BL, 2005, BRIT J DERMATOL, V153, P378, DOI 10.1111/j.1365-2133.2005.06729.x
   DiMauro S, 1998, BBA-BIOENERGETICS, V1366, P199, DOI 10.1016/S0005-2728(98)00113-3
   Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195
   Durham SE, 2003, BRIT J CANCER, V88, P90, DOI 10.1038/sj.bjc.6600773
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Gniadecki R, 2000, J CELL BIOCHEM, V80, P216
   Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Haldar S, 2007, EUR J CLIN NUTR, V61, P1011, DOI 10.1038/sj.ejcn.1602615
   Harbottle A, 2004, J INVEST DERMATOL, V122, P1518, DOI 10.1111/j.0022-202X.2004.22608.x
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HENDERSON JR, 2009, FREE RADICAL RES, P1
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1
   Ikehata H, 2004, MUTAT RES-FUND MOL M, V556, P11, DOI 10.1016/j.mrfmmm.2004.06.038
   Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6
   Jang JH, 2001, MUTAT RES-GEN TOX EN, V496, P181, DOI 10.1016/S1383-5718(01)00233-9
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635
   Krishnan KJ, 2006, J INVEST DERMATOL, V126, P408, DOI 10.1038/sj.jid.5700099
   Krishnan KJ, 2004, J INVEST DERMATOL, V123, P1020, DOI 10.1111/j.0022-202X.2004.23457.x
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0
   Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14
   LU J, 2005, J MOL DIAGN, V7, P258
   Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69
   Mason PA, 2003, FEBS LETT, V554, P6, DOI 10.1016/S0014-5793(03)01169-4
   Meeran SM, 2009, J INVEST DERMATOL, V129, P1258, DOI 10.1038/jid.2008.354
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   NASS MMK, 1969, J MOL BIOL, V42, P529, DOI 10.1016/0022-2836(69)90241-1
   NECKELMANN N, 1987, P NATL ACAD SCI USA, V84, P7580, DOI 10.1073/pnas.84.21.7580
   Parr Ryan L., 2006, Human Genomics, V2, P252
   Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004
   Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487
   Petersen AB, 2000, J PHOTOCH PHOTOBIO B, V59, P123, DOI 10.1016/S1011-1344(00)00149-4
   Poetsch M, 2004, DIAGN MOL PATHOL, V13, P26, DOI 10.1097/00019606-200403000-00005
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Ray AJ, 2000, J INVEST DERMATOL, V115, P674, DOI 10.1046/j.1523-1747.2000.00092.x
   RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S
   RIZWAN M, 2008, BRIT J DERMATOL, V158, P900
   Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Shin SM, 2009, MOL PHARMACOL, V76, P884, DOI 10.1124/mol.109.058479
   SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101
   Takeuchi H, 2004, ANN NY ACAD SCI, V1022, P50, DOI 10.1196/annals.1318.009
   Talalay P, 2007, P NATL ACAD SCI USA, V104, P17500, DOI 10.1073/pnas.0708710104
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thayer RE, 2003, EXP GERONTOL, V38, P567, DOI 10.1016/S0531-5565(03)00033-0
   Tobi SE, 2002, INT J CANCER, V102, P439, DOI 10.1002/ijc.10730
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   VANTUYLE GC, 1979, J BIOL CHEM, V254, P6044
   Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661
   Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
NR 94
TC 109
Z9 122
U1 2
U2 24
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0267-8357
EI 1464-3804
J9 MUTAGENESIS
JI Mutagenesis
PD MAR
PY 2010
VL 25
IS 2
BP 101
EP 107
DI 10.1093/mutage/gep061
PG 7
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA 561OA
UT WOS:000274986100001
PM 19955330
OA hybrid
DA 2024-11-01
ER

PT J
AU Prasun, P
   Kohli, U
AF Prasun, Pankaj
   Kohli, Utkarsh
TI Making a case for mitochondria in hypertrophic cardiomyopathy
SO FUTURE CARDIOLOGY
LA English
DT Article
DE cardiomyopathy; gene panel; hypertrophic cardiomyopathy; mitochondria;
   mitochondrial DNA
AB Hypertrophic cardiomyopathy (HCM) is a well-known manifestation of inherited mitochondrial disease. Still, currently available gene panels do not include mitochondrial genome sequencing. Mitochondrial dysfunction plays a very important role in the pathogenesis of HCM, whether tested positive or negative by the currently available gene panels for HCM. Mitochondrial DNA variations may act as modifiers of disease manifestation in genotype-positive individuals. In genotype-negative individuals, it may be the primary driver of pathogenesis. A recent study has demonstrated that mitochondrial dysfunction is correlated with septal hypertrophy in genotype-negative HCM, which can be amenable to mitochondria-targeted therapy. It is important to consider mitochondrial genome sequencing as part of the genetic evaluation of HCM.
   Plain language summary: Hypertrophic cardiomyopathy or 'thick heart' is a common heart problem that can lead to abnormal heart rhythm and even heart failure. In older adults, it is often due to high blood pressure that causes the heart to pump against high resistance and hence becoming thick. However, it can occur without high blood pressure, often in young individuals with underlying heart muscle disease. Sometimes, there are many individuals in a family with thick hearts. In these instances, it is likely genetic. The individual may have a faulty gene related to heart muscle function causing the heart to become thick as an adaptation to inefficient heart muscle function. Mitochondria are tiny organelles inside our cells that make energy. When there is mitochondrial damage, heart muscles cannot generate energy efficiently. This can lead to a thick heart as well. Hence, it is important to test mitochondrial genes along with the heart muscle genes to find the cause of thick heart when it is unexplained, or a genetic cause is suspected.
C1 [Prasun, Pankaj; Kohli, Utkarsh] West Virginia Univ Med, Dept Pediat, Morgantown, WV 26506 USA.
RP Prasun, P (corresponding author), West Virginia Univ Med, Dept Pediat, Morgantown, WV 26506 USA.
EM Pankaj.prasun@hsc.wvu.edu
RI Kohli, Utkarsh/ABD-9463-2021
OI Kohli, Utkarsh/0000-0003-3410-840X
CR Chiang S, 2018, NEUROCHEM INT, V117, P35, DOI 10.1016/j.neuint.2017.08.002
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Gruner C, 2013, CIRC-CARDIOVASC GENE, V6, P19, DOI 10.1161/CIRCGENETICS.112.963363
   Kargaran PK, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082349
   Kuno T, 2017, CASE REP CARDIOL, V2017, DOI 10.1155/2017/9473917
   Lioncino M, 2022, HEART FAIL CLIN, V18, P51, DOI 10.1016/j.hfc.2021.07.003
   Nollet EE, 2023, EUR HEART J, V44, P1170, DOI 10.1093/eurheartj/ehad028
   Ommen SR, 2021, J THORAC CARDIOV SUR, V162, pE23, DOI 10.1016/j.jtcvs.2021.04.001
   Ranjbarvaziri S, 2021, CIRCULATION, V144, P1714, DOI 10.1161/CIRCULATIONAHA.121.053575
   Sabater-Molina M, 2018, CLIN GENET, V93, P3, DOI 10.1111/cge.13027
   Seneca S, 2005, AM J MED GENET A, V137A, P170, DOI 10.1002/ajmg.a.30854
   Sequeira V, 2019, FEBS LETT, V593, P1616, DOI 10.1002/1873-3468.13496
   Takeda A, 2021, J CLIN PATHOL, V74, P365, DOI 10.1136/jclinpath-2020-206801
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Veitia RA, 2019, CLIN GENET, V95, P542, DOI 10.1111/cge.13496
NR 15
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1479-6678
EI 1744-8298
J9 FUTUR CARDIOL
JI Futur. Cardiol.
PD MAR 11
PY 2024
VL 20
IS 4
BP 179
EP 182
AR 2360355
DI 10.1080/14796678.2024.2360355
EA JUN 2024
PG 4
WC Cardiac & Cardiovascular Systems
WE Emerging Sources Citation Index (ESCI)
SC Cardiovascular System & Cardiology
GA ZN9U5
UT WOS:001242837600001
PM 39049772
DA 2024-11-01
ER

PT J
AU Grigalioniene, K
   Burnyte, B
   Balkeliene, D
   Ambrozaityte, L
   Utkus, A
AF Grigalioniene, Kristina
   Burnyte, Birute
   Balkeliene, Danute
   Ambrozaityte, Laima
   Utkus, Algirdas
TI Kearns-Sayre syndrome case. Novel 5,9 kb mtDNA deletion
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Article
DE Kearns-Sayre syndrome; KSS; mitochondrial disorder; single large-scale
   mitochondrial DNA deletion syndromes
ID MITOCHONDRIAL-DNA; SINGLE; PHENOTYPES; MECHANISMS
AB Background: Kearns-Sayre syndrome (KSS) is a rare multisystem mitochondrial disorder characterized by onset before 20 years of age and a typical clinical triad: progressive external ophthalmoplegia, pigmentary retinopathy and cardiac conduction anomalies. In most cases KSS is caused by spontaneous heteroplasmic single large-scale mitochondrial DNA (mtDNA) deletions. Long-range polymerase chain reaction (LR-PCR), next generation sequencing (NGS) and multiplex ligation-dependent probe amplification (MLPA) are the most widely applied methods for the identification of mtDNA deletions. Here, we report the case of 20-year-old male who presented with classic Kearns-Sayre syndrome, confirmed by novel 5,9 kb mtDNA deletion.
   Methods and results: LR-PCR and MLPA methods were applied to identify the mitochondrial DNA deletion for the patient, but the results were conflicting. Molecular analysis using primer walking and Sanger sequencing identified a novel 5888 base pairs mtDNA deletion (NC_012920.1:m.6069_11956del) with CAAC nucleotides repeat sequence at the breakpoints.
   Conclusion: Our study enriched the mtDNA variation spectrum associated with KSS and demonstrated the importance of choosing relevant molecular genetic methods.
C1 [Grigalioniene, Kristina; Burnyte, Birute; Balkeliene, Danute; Ambrozaityte, Laima; Utkus, Algirdas] Vilnius Univ, Fac Med, Inst Biomed Sci, Dept Human & Med Genet, Santariskiu Str 2, LT-08661 Vilnius, Lithuania.
C3 Vilnius University
RP Grigalioniene, K (corresponding author), Vilnius Univ, Fac Med, Inst Biomed Sci, Dept Human & Med Genet, Santariskiu Str 2, LT-08661 Vilnius, Lithuania.
EM kristina.grigalioniene@santa.lt
RI Burnyte, Birute/JTS-6369-2023; Ambrozaityte, Laima/JXN-6973-2024
OI Grigalioniene, Kristina/0000-0002-1245-4849; Ambrozaityte,
   Laima/0000-0001-5631-7005
FU Lietuvos Mokslo Taryba [TAP LLT-02/2015]
FX Lietuvos Mokslo Taryba, Grant/Award Number: TAP LLT-02/2015
CR [Anonymous], STATPEARLS
   Anteneová N, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10110766
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Goldstein A., 2019, GENEREVIEWS
   Gross-Jendroska M, 1992, Eur J Ophthalmol, V2, P15
   Guo L, 2020, DNA CELL BIOL, V39, P1449, DOI 10.1089/dna.2019.5010
   Kisilevsley E, 2020, SURV OPHTHALMOL, V65, P294, DOI 10.1016/j.survophthal.2019.11.001
   Leal M, 2016, OXF MED CASE REP, P34, DOI 10.1093/omcr/omw007
   Liu R, 2021, TRANSL PEDIATR, V10, P204, DOI 10.21037/tp-20-138
   Luca P, 2020, NEURORADIOLOGY, V62, P1315, DOI 10.1007/s00234-020-02501-0
   Maceluch Jaros Aw, 2006, Pediatr Endocrinol Rev, V4, P117
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mavraki E., 2020, BEST PRACTICE GUIDEL
   Mayorga L, 2016, MITOCHONDRIAL DNA A, V27, P2864, DOI 10.3109/19401736.2015.1053132
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Ruiz-Pesini E, 2010, MITOMAP HUMAN MITOCH
   Sabella-Jiménez V, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1509
   Tonska K, 2012, GENE, V506, P161, DOI 10.1016/j.gene.2012.06.081
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 20
TC 4
Z9 4
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD JAN
PY 2023
VL 11
IS 1
DI 10.1002/mgg3.2059
EA OCT 2022
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 7V9JQ
UT WOS:000862241400001
PM 36181358
OA Green Published
DA 2024-11-01
ER

PT J
AU Varhaug, KN
   Nido, GS
   de Coo, I
   Isohanni, P
   Suomalainen, A
   Tzoulis, C
   Knappskog, P
   Bindoff, LA
AF Varhaug, Kristin N.
   Nido, Gonzalo S.
   de Coo, Irenaeus
   Isohanni, Pirjo
   Suomalainen, Anu
   Tzoulis, Charalampos
   Knappskog, Per
   Bindoff, Laurence A.
TI Using urine to diagnose large-scale mtDNA deletions in adult patients
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
ID MITOCHONDRIAL-DNA; READ ALIGNMENT; SINGLE; PHENOTYPES; DISORDERS; DETECT
AB Objective: The aim of this study was to evaluate if urinary sediment cells offered a robust alternative to muscle biopsy for the diagnosis of single mtDNA deletions. Methods: Eleven adult patients with progressive external ophthalmoplegia and a known single mtDNA deletion were investigated. Urinary sediment cells were used to isolate DNA, which was then subjected to long-range polymerase chain reaction. Where available, the patient's muscle DNA was studied in parallel. Breakpoint and thus deletion size were identified using both Sanger sequencing and next generation sequencing. The level of heteroplasmy was determined using quantitative polymerase chain reaction. Results: We identified the deletion in urine in 9 of 11 cases giving a sensitivity of 80%. Breakpoints and deletion size were readily detectable in DNA extracted from urine. Mean heteroplasmy level in urine was 38% +/- 26 (range 8 - 84%), and 57% +/- 28 (range 12 - 94%) in muscle. While the heteroplasmy level in urinary sediment cells differed from that in muscle, we did find a statistically significant correlation between these two levels (R = 0.714, P = 0.031(Pearson correlation)). Interpretation: Our findings suggest that urine can be used to screen patients suspected clinically of having a single mtDNA deletion. Based on our data, the use of urine could considerably reduce the need for muscle biopsy in this patient group.
C1 [Varhaug, Kristin N.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Varhaug, Kristin N.; Nido, Gonzalo S.; Tzoulis, Charalampos; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med K1, Bergen, Norway.
   [Nido, Gonzalo S.; Tzoulis, Charalampos; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, NeurosysMed, Bergen, Norway.
   [de Coo, Irenaeus] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands.
   [de Coo, Irenaeus] Univ Maastricht, Dept Genet & Cell Biol, Maastricht, Netherlands.
   [Isohanni, Pirjo; Suomalainen, Anu] Univ Helsinki, Fac Med, Stem Cells & Metab, Res Programs Unit, Helsinki, Finland.
   [Isohanni, Pirjo] Univ Helsinki, Childrens Hosp, Helsinki, Finland.
   [Isohanni, Pirjo] Helsinki Univ Hosp, Helsinki, Finland.
   [Suomalainen, Anu] Helsinki Univ Hosp, HUSlab, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Neurosci Ctr, Helsinki, Finland.
   [Knappskog, Per] Haukeland Hosp, Ctr Med Genet & Mol Med, Bergen, Norway.
   [Knappskog, Per] Univ Bergen, Dept Clin Sci, Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of
   Bergen; University of Bergen; Haukeland University Hospital; Medical
   Spectrum Twente; Maastricht University; University of Helsinki;
   University of Helsinki; University of Helsinki; Helsinki University
   Central Hospital; University of Helsinki; Helsinki University Central
   Hospital; University of Helsinki; University of Bergen; Haukeland
   University Hospital; University of Bergen
RP Varhaug, KN (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
EM Kristin.nielsen.varhaug@helse-bergen.no
RI Tzoulis, Charalampos/AGD-5114-2022; Bindoff, Nathaniel/C-8050-2011
OI de Coo, Irenaeus/0000-0003-0533-7422; Suomalainen-Wartiovaara,
   Anu/0000-0003-4833-5195; Isohanni, Pirjo/0000-0002-0156-1614
CR [Anonymous], 2007, MITOMAP HUMAN MITOCH
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Blackwood JK, 2010, BIOCHEM BIOPH RES CO, V393, P740, DOI 10.1016/j.bbrc.2010.02.072
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Nido GS, 2018, NEUROBIOL AGING, V63, P120, DOI 10.1016/j.neurobiolaging.2017.10.024
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   POULTON J, 1994, HUM MOL GENET, V3, P947, DOI 10.1093/hmg/3.6.947
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 25
TC 11
Z9 11
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD AUG
PY 2020
VL 7
IS 8
BP 1318
EP 1326
DI 10.1002/acn3.51119
EA JUL 2020
PG 9
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA NE2SX
UT WOS:000545793900001
PM 32634300
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Yu-Wai-Man, P
   Votruba, M
   Burté, F
   La Morgia, C
   Barboni, P
   Carelli, V
AF Yu-Wai-Man, Patrick
   Votruba, Marcela
   Burte, Florence
   La Morgia, Chiara
   Barboni, Piero
   Carelli, Valerio
TI A neurodegenerative perspective on mitochondrial optic neuropathies
SO ACTA NEUROPATHOLOGICA
LA English
DT Review
DE Dominant optic atrophy; Leber hereditary optic neuropathy; Mitochondrial
   diseases; Neurodegenerative diseases; OPA1; Retinal ganglion cell
ID FIBER LAYER EVALUATION; GANGLION-CELL LOSS; NEUROMYELITIS-OPTICA; OPA1
   MUTATIONS; MULTIPLE-SCLEROSIS; COHERENCE-TOMOGRAPHY; DNA DELETIONS;
   EXTERNAL OPHTHALMOPLEGIA; PRONUCLEAR TRANSFER; NERVE STRUCTURE
AB Mitochondrial optic neuropathies constitute an important cause of chronic visual morbidity and registrable blindness in both the paediatric and adult population. It is a genetically heterogeneous group of disorders caused by both mitochondrial DNA (mtDNA) mutations and a growing list of nuclear genetic defects that invariably affect a critical component of the mitochondrial machinery. The two classical paradigms are Leber hereditary optic neuropathy (LHON), which is a primary mtDNA disorder, and autosomal dominant optic atrophy (DOA) secondary to pathogenic mutations within the nuclear gene OPA1 that encodes for a mitochondrial inner membrane protein. The defining neuropathological feature is the preferential loss of retinal ganglion cells (RGCs) within the inner retina but, rather strikingly, the smaller calibre RGCs that constitute the papillomacular bundle are particularly vulnerable, whereas melanopsin-containing RGCs are relatively spared. Although the majority of patients with LHON and DOA will present with isolated optic nerve involvement, some individuals will also develop additional neurological complications pointing towards a greater vulnerability of the central nervous system (CNS) in susceptible mutation carriers. These so-called "plus" phenotypes are mechanistically important as they put the loss of RGCs within the broader perspective of neuronal loss and mitochondrial dysfunction, highlighting common pathways that could be modulated to halt progressive neurodegeneration in other related CNS disorders. The management of patients with mitochondrial optic neuropathies still remains largely supportive, but the development of effective disease-modifying treatments is now within tantalising reach helped by major advances in drug discovery and delivery, and targeted genetic manipulation.
C1 [Yu-Wai-Man, Patrick; Burte, Florence] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Yu-Wai-Man, Patrick] Royal Victoria Infirm, Newcastle Eye Ctr, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Yu-Wai-Man, Patrick] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London EC1V 2PD, England.
   [Yu-Wai-Man, Patrick] UCL Inst Ophthalmol, London EC1V 2PD, England.
   [Votruba, Marcela] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales.
   [Votruba, Marcela] Univ Wales Hosp, Cardiff Eye Unit, Cardiff, S Glam, Wales.
   [La Morgia, Chiara; Carelli, Valerio] Bellaria Hosp, IRCCS Inst Neurol Sci Bologna, Bologna, Italy.
   [La Morgia, Chiara; Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Neurol Unit, Bologna, Italy.
   [Barboni, Piero] Studio Oculist Azeglio, Bologna, Italy.
   [Barboni, Piero] Ist Sci San Raffaele, Milan, Italy.
C3 Newcastle University - UK; Newcastle University - UK; University of
   London; University College London; Moorfields Eye Hospital NHS
   Foundation Trust; University of London; University College London;
   Cardiff University; Cardiff University; IRCCS Istituto delle Scienze
   Neurologiche di Bologna (ISNB); AUSL di Bologna; University of Bologna;
   Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele
RP Yu-Wai-Man, P (corresponding author), Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.; Yu-Wai-Man, P (corresponding author), Royal Victoria Infirm, Newcastle Eye Ctr, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.; Yu-Wai-Man, P (corresponding author), Moorfields Eye Hosp, NIHR Biomed Res Ctr, London EC1V 2PD, England.; Yu-Wai-Man, P (corresponding author), UCL Inst Ophthalmol, London EC1V 2PD, England.
EM Patrick.Yu-Wai-Man@ncl.ac.uk
RI La Morgia, Chiara/H-6765-2012; Votruba, Marcela/B-7306-2015; Burte,
   Florence/U-8257-2017; Votruba, Marcela/A-6182-2011; Barboni,
   Piero/AAA-9936-2020
OI Burte, Florence/0000-0001-9020-7838; Votruba,
   Marcela/0000-0002-7680-9135; Barboni, Piero/0000-0002-0118-4177
FU Medical Research Council (UK) [G1002570]; Fight for Sight (UK); UK
   National Institute of Health Research (NIHR) as part of the Rare
   Diseases Translational Research Collaboration; NIHR Biomedical Research
   Centre based at Moorfields Eye Hospital NHS Foundation Trust; UCL
   Institute of Ophthalmology; Italian Ministry of Research; Italian
   Ministry of Health; Telethon-Italy; e-RARE; IFOND; UMDF; MITOCON;
   Poincenot Family; Gino Galletti Foundation; MRC [G1002570, G0701386,
   G0700949] Funding Source: UKRI
FX PYWM is supported by a Clinician Scientist Fellowship Award (G1002570)
   from the Medical Research Council (UK), and also receives funding from
   Fight for Sight (UK), the UK National Institute of Health Research
   (NIHR) as part of the Rare Diseases Translational Research
   Collaboration, and the NIHR Biomedical Research Centre based at
   Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of
   Ophthalmology. MV is funded by Fight for Sight (UK) and the UK National
   Institute of Health Research (NIHR) as part of the Rare Diseases
   Translational Research Collaboration. The views expressed are those of
   the author(s) and not necessarily those of the NHS, the NIHR or the
   Department of Health. VC is funded by the Italian Ministries of Health
   and of Research, Telethon-Italy, e-RARE and patient-led organisations
   (IFOND, UMDF, MITOCON, The Poincenot Family, and the Gino Galletti
   Foundation). CLM receives financial support from the Italian Ministry of
   Health. We are grateful to Prof. Alfredo Sadun and Dr. Fred
   Ross-Cisneros (Doheny Eye Institute, UCLA) for the histological slides
   used in Fig 4, and to Dr. Terence Smith (Cardiff University) for the RGC
   images used in Fig 5.
CR Abrams AJ, 2015, NAT GENET, V47, P926, DOI 10.1038/ng.3354
   ADAMS JH, 1966, BRAIN, V89, P15, DOI 10.1093/brain/89.1.15
   Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005
   Alavi MV, 2009, EXP NEUROL, V220, P404, DOI 10.1016/j.expneurol.2009.09.026
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Andrews RM, 1999, BRIT J OPHTHALMOL, V83, P231, DOI 10.1136/bjo.83.2.231
   Angebault C, 2015, AM J HUM GENET, V97, P754, DOI 10.1016/j.ajhg.2015.09.012
   Anikster Y, 2001, AM J HUM GENET, V69, P1218, DOI 10.1086/324651
   Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004
   Bailie M, 2013, ACTA OPHTHALMOL, V91, pE413, DOI 10.1111/aos.12077
   Baker MR, 2011, NEUROLOGY, V77, P1309, DOI 10.1212/WNL.0b013e318230a15a
   Balducci N, 2016, BRIT J OPHTHALMOL, V100, P1232, DOI 10.1136/bjophthalmol-2015-307326
   Barboni P, 2005, OPHTHALMOLOGY, V112, P120, DOI 10.1016/j.ophtha.2004.06.034
   Barboni P, 2014, AM J OPHTHALMOL, V158, P628, DOI 10.1016/j.ajo.2014.05.034
   Barboni P, 2013, BRAIN, V136, DOI 10.1093/brain/awt014
   Barboni P, 2012, EUR J OPHTHALMOL, V22, P985, DOI 10.5301/ejo.5000154
   Barboni P, 2011, OPHTHALMOLOGY, V118, P2076, DOI 10.1016/j.ophtha.2011.02.027
   Barboni P, 2010, OPHTHALMOLOGY, V117, P1547, DOI 10.1016/j.ophtha.2009.12.042
   Barboni P, 2010, OPHTHALMOLOGY, V117, P623, DOI 10.1016/j.ophtha.2009.07.026
   Barcella V, 2010, HUM BRAIN MAPP, V31, P1900, DOI 10.1002/hbm.20985
   Bennett JL, 2015, MULT SCLER J, V21, P678, DOI 10.1177/1352458514567216
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Bonifert T, 2014, BRAIN, V137, P2164, DOI 10.1093/brain/awu165
   Bonneau D, 2014, BRAIN, V137, DOI 10.1093/brain/awu184
   Bristow EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P791
   Burté F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228
   Carbonelli M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127906
   Carelli V, 2004, BBA-BIOENERGETICS, V1657, P70
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2002, NEUROCHEM INT, V40, P573, DOI 10.1016/S0197-0186(01)00129-2
   Carelli V, 2001, J NEUROL NEUROSUR PS, V71, P813, DOI 10.1136/jnnp.71.6.813
   Carelli V, 2008, NEUROLOGY, V70, P1075, DOI 10.1212/01.wnl.0000307668.75233.35
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carelli V, 2015, BRAIN, V138, DOI 10.1093/brain/awu234
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   Carelli V, 2011, BRAIN, V134, DOI 10.1093/brain/awr180
   Charif M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00311
   Chen L, 2012, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2012-230
   Cohn AC, 2008, BRIT J OPHTHALMOL, V92, P1333, DOI 10.1136/bjo.2007.134726
   Cohn AC, 2007, AM J OPHTHALMOL, V143, P656, DOI 10.1016/j.ajo.2006.12.038
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   D'Aguanno S, 2008, J NEUROIMMUNOL, V193, P156, DOI 10.1016/j.jneuroim.2007.10.004
   Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Pereira WLDJ, 2015, J NEUROL SCI, V355, P7, DOI 10.1016/j.jns.2015.05.034
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Ferré M, 2009, HUM MUTAT, V30, pE692, DOI 10.1002/humu.21025
   Fortuna F, 2009, BRAIN, V132, P116, DOI 10.1093/brain/awn269
   Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002
   Fuhrmann N, 2009, J MED GENET, V46, P136, DOI 10.1136/jmg.2008.062570
   Gelfand JM, 2013, JAMA NEUROL, V70, P629, DOI 10.1001/jamaneurol.2013.1832
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gorman GS, 2015, NEW ENGL J MED, V372, P885, DOI 10.1056/NEJMc1500960
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Gueven N., 2013, EXP OPIN ORPH DRUG, V1, P1
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   Hanein S, 2009, AM J HUM GENET, V84, P493, DOI 10.1016/j.ajhg.2009.03.003
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   Heidary G, 2014, J NEURO-OPHTHALMOL, V34, P39, DOI 10.1097/WNO.0000000000000076
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature183030, 10.1038/nature18303]
   Jacob A, 2013, J NEUROL, V260, P2134, DOI 10.1007/s00415-013-6926-y
   Janer A, 2016, EMBO MOL MED
   Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177
   JOHNSON BM, 1987, AGE, V10, P5, DOI 10.1007/BF02431765
   JOHNSTON PB, 1979, AM J OPHTHALMOL, V88, P868, DOI 10.1016/0002-9394(79)90565-8
   KERRISON JB, 1995, OPHTHALMOLOGY, V102, P1509
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Kirkman MA, 2009, INVEST OPHTH VIS SCI, V50, P3112, DOI 10.1167/iovs.08-3166
   KJER P, 1959, Acta Ophthalmol Suppl, V164, P1
   KJER P, 1983, ACTA OPHTHALMOL, V61, P300
   Klebe S, 2012, BRAIN, V135, P2980, DOI 10.1093/brain/aws240
   Klopstock T, 2013, BRAIN, V136, DOI 10.1093/brain/aws279
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Kovács GG, 2005, BRAIN, V128, P35, DOI 10.1093/brain/awh310
   La Morgia C, 2010, BRAIN, V133, P2426, DOI 10.1093/brain/awq155
   Levin LA, 2015, J NEURO-OPHTHALMOL, V35, P152, DOI 10.1097/WNO.0000000000000250
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Mahad D, 2008, BRAIN, V131, P1722, DOI 10.1093/brain/awn105
   Majander A, 2016, OPHTHALMOLOGY, V123, P1624, DOI 10.1016/j.ophtha.2016.01.007
   Man PYW, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011247
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Manners DN, 2015, AM J NEURORADIOL, V36, P1259, DOI 10.3174/ajnr.A4272
   Marelli C, 2011, BRAIN, V134, DOI 10.1093/brain/awq306
   McClelland CM, 2011, J NEURO-OPHTHALMOL, V31, P265, DOI 10.1097/WNO.0b013e318225247b
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   Metodiev MD, 2014, J MED GENET, V51, P834, DOI 10.1136/jmedgenet-2014-102532
   Milesi J, 2012, J NEUROL, V259, P1801, DOI 10.1007/s00415-011-6406-1
   Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047
   Moura ALA, 2013, INVEST OPHTH VIS SCI, V54, P4471, DOI 10.1167/iovs.12-11137
   NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   Ostojic J, 2009, ACTA NEUROL BELG, V109, P305
   Palace J, 2009, J NEUROL SCI, V286, P24, DOI 10.1016/j.jns.2009.09.009
   Pan BX, 2012, INVEST OPHTH VIS SCI, V53, P7608, DOI 10.1167/iovs.12-10452
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pfeffer G, 2013, NEUROLOGY, V81, P2073, DOI 10.1212/01.wnl.0000437308.22603.43
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   Pyle Angela, 2014, J Neuromuscul Dis, V1, P55, DOI 10.3233/JND-140003
   Qi XP, 2007, ARCH OPHTHALMOL-CHIC, V125, P268, DOI 10.1001/archopht.125.2.268
   Renaldo F, 2012, BRAIN, V135, DOI 10.1093/brain/aws111
   Rendtorff ND, 2011, AM J MED GENET A, V155A, P1298, DOI 10.1002/ajmg.a.33970
   Reynier P, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016576
   Rocca MA, 2015, J NEUROL, V262, P1216, DOI 10.1007/s00415-015-7696-5
   Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371
   Roubertie A, 2015, J NEUROL SCI, V349, P154, DOI 10.1016/j.jns.2015.01.008
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Saadati HG, 1998, ARCH OPHTHALMOL-CHIC, V116, P911, DOI 10.1001/archopht.116.7.911
   Sadun A A, 2000, Trans Am Ophthalmol Soc, V98, P223
   SADUN AA, 1994, CLIN NEUROSCI, V2, P165
   Sadun AA, 2012, ARCH NEUROL-CHICAGO, V69, P331, DOI 10.1001/archneurol.2011.2972
   Sarzi E, 2012, BRAIN, V135, P3599, DOI 10.1093/brain/aws303
   Savini G, 2005, OPHTHALMOLOGY, V112, P127, DOI 10.1016/j.ophtha.2004.09.033
   Shiraishi W, 2014, MULT SCLER J, V20, P258, DOI 10.1177/1352458513513057
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   Spruijt L, 2007, ARCH NEUROL-CHICAGO, V64, P890, DOI 10.1001/archneur.64.6.890
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972
   Tranebjaerg L, 2001, Ophthalmic Genet, V22, P207
   Tun AW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106779
   Turnbull HE, 2010, BBA-MOL BASIS DIS, V1802, P111, DOI 10.1016/j.bbadis.2009.07.010
   Verny C, 2008, NEUROLOGY, V70, P1152, DOI 10.1212/01.wnl.0000289194.89359.a1
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wiley SE, 2013, EMBO MOL MED, V5, P904, DOI 10.1002/emmm.201201429
   Williams PA, 2012, BRAIN, V135, P493, DOI 10.1093/brain/awr330
   Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8
   Yu-Wai-Man P, 2014, EYE, V28, P521, DOI 10.1038/eye.2014.37
   Yu-Wai-Man P, 2011, EYE, V25, P597, DOI 10.1038/eye.2011.2
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2016, BRIT J OPHTHALMOL, V100, P1322, DOI 10.1136/bjophthalmol-2015-308329
   Yu-Wai-Man P, 2016, ANN CLIN TRANSL NEUR, V3, P723, DOI 10.1002/acn3.323
   Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038
   Yu-Wai-Man P, 2012, BRAIN, V135, P9, DOI 10.1093/brain/awr352
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 149
TC 124
Z9 127
U1 1
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0001-6322
EI 1432-0533
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD DEC
PY 2016
VL 132
IS 6
BP 789
EP 806
DI 10.1007/s00401-016-1625-2
PG 18
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA EC1DX
UT WOS:000387844900003
PM 27696015
OA Green Published, hybrid, Green Accepted
DA 2024-11-01
ER

PT J
AU Altmann, J
   Buchner, B
   Nadaj-Pakleza, A
   Schäfer, J
   Jackson, S
   Lehmann, D
   Deschauer, M
   Kopajtich, R
   Lautenschläger, R
   Kuhn, KA
   Karle, K
   Schöls, L
   Schulz, J
   Weis, J
   Prokisch, H
   Kornblum, C
   Claeys, KG
   Klopstock, T
AF Altmann, Judith
   Buchner, Boriana
   Nadaj-Pakleza, Aleksandra
   Schaefer, Jochen
   Jackson, Sandra
   Lehmann, Diana
   Deschauer, Marcus
   Kopajtich, Robert
   Lautenschlaeger, Ronald
   Kuhn, Klaus A.
   Karle, Kathrin
   Schoels, Ludger
   Schulz, Joerg B.
   Weis, Joachim
   Prokisch, Holger
   Kornblum, Cornelia
   Claeys, Kristl G.
   Klopstock, Thomas
TI Expanded phenotypic spectrum of the m.8344A&gt;G "MERRF" mutation: data
   from the German mitoNET registry
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Myoclonus; Ataxia; Epilepsy; Ragged-red fibres; Psychiatric; Hearing
   impairment
ID STROKE-LIKE EPISODES; A8344G MUTATION; MYOCLONIC EPILEPSY;
   CLINICAL-FEATURES; LEIGH-SYNDROME; MITOCHONDRIAL; HETEROGENEITY;
   LIPOMATOSIS; MYOPATHY; MELAS
AB The m.8344A > G mutation in the MTTK gene, which encodes the mitochondrial transfer RNA for lysine, is traditionally associated with myoclonic epilepsy and ragged-red fibres (MERRF), a multisystemic mitochondrial disease that is characterised by myoclonus, seizures, cerebellar ataxia, and mitochondrial myopathy with ragged-red fibres. We studied the clinical and paraclinical phenotype of 34 patients with the m.8344A > G mutation, mainly derived from the nationwide mitoREGISTER, the multicentric registry of the German network for mitochondrial disorders (mitoNET). Mean age at symptom onset was 24.5 years +/- 10.9 (6-48 years) with adult onset in 75 % of the patients. In our cohort, the canonical features seizures, myoclonus, cerebellar ataxia and ragged-red fibres that are traditionally associated with MERRF, occurred in only 61, 59, 70, and 63 % of the patients, respectively. In contrast, other features such as hearing impairment were even more frequently present (72 %). Other common features in our cohort were migraine (52 %), psychiatric disorders (54 %), respiratory dysfunction (45 %), gastrointestinal symptoms (38 %), dysarthria (36 %), and dysphagia (35 %). Brain MRI revealed cerebral and/or cerebellar atrophy in 43 % of our patients. There was no correlation between the heteroplasmy level in blood and age at onset or clinical phenotype. Our findings further broaden the clinical spectrum of the m.8344A > G mutation, document the large clinical variability between carriers of the same mutation, even within families and indicate an overlap of the phenotype with other mitochondrial DNA-associated syndromes.
C1 [Altmann, Judith; Schulz, Joerg B.; Claeys, Kristl G.] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.
   [Altmann, Judith; Weis, Joachim; Claeys, Kristl G.] Rhein Westfal TH Aachen, Inst Neuropathol, Aachen, Germany.
   [Buchner, Boriana; Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany.
   [Nadaj-Pakleza, Aleksandra] Univ Hosp Angers, Dept Neurol, Angers, France.
   [Schaefer, Jochen; Jackson, Sandra] Univ Hosp Carl Gustav Carus, Dept Neurol, Dresden, Germany.
   [Lehmann, Diana; Deschauer, Marcus] Univ Halle Wittenberg, Dept Neurol, D-06108 Halle, Germany.
   [Deschauer, Marcus] Univ Technol Munchen, Dept Neurol, Munich, Germany.
   [Kopajtich, Robert; Prokisch, Holger] Helmholtz Ctr Munchen, Inst Human Genet, Munich, Germany.
   [Kopajtich, Robert; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany.
   [Lautenschlaeger, Ronald; Kuhn, Klaus A.] Univ Technol Munchen, Inst Med Stat & Epidemiol, Munich, Germany.
   [Karle, Kathrin; Schoels, Ludger] Inst Clin Neurogenet, Dept Neurol, Tubingen, Germany.
   [Karle, Kathrin; Schoels, Ludger] Hertie Inst Clin Brain Res, Tubingen, Germany.
   [Schulz, Joerg B.] JARA Translat Brain Med, Aachen, Germany.
   [Kornblum, Cornelia] Univ Hosp Bonn, Dept Neurol, Bonn, Germany.
   [Kornblum, Cornelia] Univ Hosp Bonn, Ctr Rare Dis Bonn ZSEB, Bonn, Germany.
   [Claeys, Kristl G.] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium.
   [Claeys, Kristl G.] Univ Leuven KU Leuven, Leuven, Belgium.
   [Klopstock, Thomas] German Ctr Neurodegenerat Dis DZNE, Munich, Germany.
   [Klopstock, Thomas] Munich Cluster Syst Neurol SyNergy, Munich, Germany.
C3 RWTH Aachen University; RWTH Aachen University; University of Munich;
   Universite d'Angers; Centre Hospitalier Universitaire d'Angers;
   Technische Universitat Dresden; Carl Gustav Carus University Hospital;
   Martin Luther University Halle Wittenberg; Technical University of
   Munich; Technical University of Munich; Technical University of Munich;
   Eberhard Karls University of Tubingen; Eberhard Karls University
   Hospital; University of Bonn; University of Bonn; KU Leuven; University
   Hospital Leuven; KU Leuven; Helmholtz Association; German Center for
   Neurodegenerative Diseases (DZNE); University of Munich
RP Claeys, KG (corresponding author), Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.; Claeys, KG (corresponding author), Rhein Westfal TH Aachen, Inst Neuropathol, Aachen, Germany.; Claeys, KG (corresponding author), Univ Hosp Leuven, Dept Neurol, Leuven, Belgium.; Claeys, KG (corresponding author), Univ Leuven KU Leuven, Leuven, Belgium.
EM Kristl.Claeys@uzleuven.be
RI Schöls, Ludger/ABB-2482-2021; Prokisch, Holger/N-8964-2013; Kornblum,
   Cornelia/IUM-4180-2023; Schulz, Jorg B./D-9786-2012; Weis,
   Joachim/G-1984-2014
OI Claeys, Kristl/0000-0001-9937-443X; Schols, Ludger/0000-0001-7774-5025;
   Schulz, Jorg B./0000-0002-8903-0593; Prokisch,
   Holger/0000-0003-2379-6286; Weis, Joachim/0000-0003-3280-6773
FU German Bundesministerium fur Bildung und Forschung (BMBF) through German
   Network for mitochondrial disorders (mitoNET) [01GM1113A, 01GM1113C];
   Deutsche Gesellschaft fur Muskelkranke e.V. (DGM)
FX We are grateful to the participating patients and collaborating
   colleagues for collecting patients' data and providing these within the
   German network for mitochondrial disorders (mitoNET). The study was
   funded by the German Bundesministerium fur Bildung und Forschung (BMBF)
   through the German Network for mitochondrial disorders (mitoNET;
   01GM1113A to B. B. and T. K. for the registry, 01GM1113C to H. P. for
   biobanking and molecular diagnostics). K. G. Claeys received research
   Grants unrelated to the current study from the Deutsche Gesellschaft fur
   Muskelkranke e.V. (DGM).
CR Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   DiMauro S, 2002, J CHILD NEUROL, V17, pS35
   DiMauro S, 2003, GENE REV
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gámez J, 1998, NEUROLOGY, V51, P258, DOI 10.1212/WNL.51.1.258
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GRAF WD, 1993, ANN NEUROL, V33, P640, DOI 10.1002/ana.410330613
   Han JY, 2014, J CLIN NEUROSCI, V21, P2009, DOI 10.1016/j.jocn.2014.03.020
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2
   Muñoz-Málaga A, 2000, MUSCLE NERVE, V23, P538, DOI 10.1002/(SICI)1097-4598(200004)23:4<538::AID-MUS12>3.3.CO;2-K
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Schmitz-Hübsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92
   SHOFFNER JM, 1992, AM J HUM GENET, V51, P1179
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Weyer A, 2007, MOVEMENT DISORD, V22, P1633, DOI 10.1002/mds.21544
NR 25
TC 64
Z9 69
U1 0
U2 13
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD MAY
PY 2016
VL 263
IS 5
BP 961
EP 972
DI 10.1007/s00415-016-8086-3
PG 12
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DM1XU
UT WOS:000376141000014
PM 26995359
DA 2024-11-01
ER

PT J
AU Kaliszewska, M
   Kruszewski, J
   Kierdaszuk, B
   Kostera-Pruszczyk, A
   Nojszewska, M
   Lusakowska, A
   Vizueta, J
   Sabat, D
   Lutyk, D
   Lower, M
   Piekutowska-Abramczuk, D
   Kaniak-Golik, A
   Pronicka, E
   Kaminska, A
   Bartnik, E
   Golik, P
   Tonska, K
AF Kaliszewska, Magdalena
   Kruszewski, Jakub
   Kierdaszuk, Biruta
   Kostera-Pruszczyk, Anna
   Nojszewska, Monika
   Lusakowska, Anna
   Vizueta, Joel
   Sabat, Dorota
   Lutyk, Dorota
   Lower, Michal
   Piekutowska-Abramczuk, Dorota
   Kaniak-Golik, Aneta
   Pronicka, Ewa
   Kaminska, Anna
   Bartnik, Ewa
   Golik, Pawe
   Tonska, Katarzyna
TI Yeast model analysis of novel polymerase gamma variants found in
   patients with autosomal recessive mitochondrial disease
SO HUMAN GENETICS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DNA-POLYMERASE;
   SACCHAROMYCES-CEREVISIAE; POLG MUTATIONS; PATHOGENIC MUTATIONS; DEFECTS;
   MAINTENANCE; PHENOTYPE; SPECTRUM; SUBUNIT
AB Replication of the mitochondrial genome depends on the single DNA polymerase (pol gamma). Mutations in the POLG gene, encoding the catalytic subunit of the human polymerase gamma, have been linked to a wide variety of mitochondrial disorders that show remarkable heterogeneity, with more than 200 sequence variants, often very rare, found in patients. The pathogenicity and dominance status of many such mutations remain, however, unclear. Remarkable structural and functional conservation of human POLG and its S. cerevisiae ortholog (Mip1p) led to the development of many successful yeast models, enabling to study the phenotype of putative pathogenic mutations. In a group of patients with suspicion of mitochondrial pathology, we identified five novel POLG sequence variants, four of which (p.Arg869Ter, p.Gln968Glu, p.Thr1053Argfs*6, and p.Val1106Ala), together with one previously known but uncharacterised variant (p.Arg309Cys), were amenable to modelling in yeast. Familial analysis indicated causal relationship of these variants with disease, consistent with autosomal recessive inheritance. To investigate the effect of these sequence changes on mtDNA replication, we obtained the corresponding yeast mip1 alleles (Arg265Cys, Arg672Ter, Arg770Glu, Thr809Ter, and Val863Ala, respectively) and tested their effect on mitochondrial genome stability and replication fidelity. For three of them (Arg265Cys, Arg672Ter, and Thr809Ter), we observed a strong, partially dominant phenotype of a complete loss of functional mtDNA, whereas the remaining two led to partial mtDNA depletion and significant increase in point mutation frequencies. These results show good correlation with the severity of symptoms observed in patients and allow to establish these variants as pathogenic mutations.
C1 [Kaliszewska, Magdalena; Kruszewski, Jakub; Vizueta, Joel; Sabat, Dorota; Lutyk, Dorota; Bartnik, Ewa; Golik, Pawe; Tonska, Katarzyna] Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, PL-02106 Warsaw, Poland.
   [Kierdaszuk, Biruta; Kostera-Pruszczyk, Anna; Nojszewska, Monika; Lusakowska, Anna; Kaminska, Anna] Med Univ Warsaw, Dept Neurol, PL-02097 Warsaw, Poland.
   [Lower, Michal] Univ Warsaw, Dept Virol, Fac Biol, PL-02096 Warsaw, Poland.
   [Piekutowska-Abramczuk, Dorota; Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Med Genet, PL-04730 Warsaw, Poland.
   [Kaniak-Golik, Aneta; Bartnik, Ewa; Golik, Pawe] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland.
   [Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Pediat Nutr & Metab Dis, PL-04730 Warsaw, Poland.
C3 University of Warsaw; Medical University of Warsaw; University of
   Warsaw; Children's Memorial Health Institute; Polish Academy of
   Sciences; Institute of Biochemistry & Biophysics - Polish Academy of
   Sciences; Children's Memorial Health Institute
RP Golik, P (corresponding author), Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, Pawinskiego 5a, PL-02106 Warsaw, Poland.
EM pgolik@igib.uw.edu.pl; kaska@igib.uw.edu.pl
RI Kaniak-Golik, Aneta/CAF-8607-2022; Kruszewski, Mirosław/ABA-2851-2021;
   Nojszewska, Monika/M-3439-2018; Vizueta, Joel/A-8412-2018; Golik,
   Pawel/D-7788-2011
OI Piekutowska-Abramczuk, Dorota/0000-0002-9786-3704; Pronicka,
   Ewa/0000-0002-5705-4814; Lusakowska, Anna/0000-0003-1909-9963;
   Nojszewska, Monika/0000-0003-4231-5636; Kaniak-Golik,
   Aneta/0000-0003-4027-6282; Kaliszewska, Magdalena/0000-0003-3649-4375;
   Vizueta, Joel/0000-0003-0139-3013; Tonska,
   Katarzyna/0000-0002-1793-6089; Golik, Pawel/0000-0001-7814-482X;
   Kostera-Pruszczyk, Anna/0000-0002-7309-1914
FU EU Operational Programme Innovative Economy via the Foundation for
   Polish Science [TEAM/2010-6/6, VENTURES/2011-8/3]; National Science
   Center of Poland [NCN 2012/05/B/NZ2/01627]
FX We would like to state the authors' contributions as follows: study
   design and supervision, data analysis: PG (yeast modelling), KT (human
   variants); genetic study coordination: MK, KT; clinical evaluation: AK,
   BK (family A), EP (families B, D), AL (family C), AKP, MN (family E);
   preliminary genetic analysis: MK, KT, DP-A, EB; POLG sequencing: MK (85
   %), DL (15 %); population study: MK (variants: p.Arg869Ter,
   p.Thr1053Argfs* 6, p.Val1106Ala), JV (variant p.Arg309Cys), DS, ML
   (variant: p.Gln968Glu); family distribution studies: MK; yeast
   experiments: JK, AK-G (design and supervision of the point mutation rate
   test), preparation of the manuscript: MK, JK, PG, KT, EB. We wish to
   thank Aleksander Chlebowski for his assistance with fluorescent
   microscopy. This work was supported by the EU Operational Programme
   Innovative Economy via the Foundation for Polish Science [TEAM/2010-6/6
   to JK, PG and KT, VENTURES/2011-8/3 to MK], and by the National Science
   Center of Poland [NCN 2012/05/B/NZ2/01627 to DP-A].
CR Aanen DK, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0438
   Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Barrientos A, 2003, IUBMB LIFE, V55, P83, DOI 10.1080/1521654031000098122
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2015, MITOCHONDRION, V20, P52, DOI 10.1016/j.mito.2014.11.003
   Baruffini E, 2011, MITOCHONDRION, V11, P182, DOI 10.1016/j.mito.2010.09.007
   Baruffini E, 2010, MITOCHONDRION, V10, P183, DOI 10.1016/j.mito.2009.10.002
   Chan SSL, 2009, MITOCHONDRION, V9, P340, DOI 10.1016/j.mito.2009.05.002
   Chiron S, 2005, GENETICS, V169, P1891, DOI 10.1534/genetics.104.037473
   CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884
   EPHRUSSI B, 1955, NATURE, V176, P1207, DOI 10.1038/1761207b0
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Foury F, 2002, CURR OPIN CHEM BIOL, V6, P106, DOI 10.1016/S1367-5931(01)00276-9
   FOURY F, 1989, J BIOL CHEM, V264, P20552
   GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0
   Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   GROUDINSKY O, 1981, MOL GEN GENET, V184, P493, DOI 10.1007/BF00352529
   Holt IJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0451
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005
   Kierdaszuk B, 2009, NEUROL NEUROCHIR POL, V43, P216
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010
   Lipinski KA, 2010, BBA-BIOENERGETICS, V1797, P1086, DOI 10.1016/j.bbabio.2009.12.019
   Lodi T, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00106
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Lucas P, 2004, MITOCHONDRION, V4, P13, DOI 10.1016/j.mito.2004.04.001
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Montgomery JL, 2010, EXPERT REV MOL DIAGN, V10, P219, DOI 10.1586/ERM.09.84
   Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601
   OGUR M, 1957, SCIENCE, V125, P928, DOI 10.1126/science.125.3254.928
   Palin EJH, 2010, BBA-MOL BASIS DIS, V1802, P545, DOI 10.1016/j.bbadis.2010.02.003
   Puchta O, 2010, GENETICS, V184, P959, DOI 10.1534/genetics.110.113969
   Qian YF, 2014, J BIOL CHEM, V289, P5970, DOI 10.1074/jbc.M113.526418
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Stehling O, 2014, BIOCHIMIE, V100, P61, DOI 10.1016/j.biochi.2014.01.010
   Stricker S, 2009, J NEUROL NEUROSUR PS, V80, P1181, DOI 10.1136/jnnp.2008.166066
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004748
   Stumpf JD, 2013, GENETICS, V194, P519, DOI 10.1534/genetics.113.150920
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Viikov K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033482
   Viikov K, 2011, MITOCHONDRION, V11, P119, DOI 10.1016/j.mito.2010.08.007
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110
NR 67
TC 13
Z9 14
U1 0
U2 11
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0340-6717
EI 1432-1203
J9 HUM GENET
JI Hum. Genet.
PD SEP
PY 2015
VL 134
IS 9
BP 951
EP 966
DI 10.1007/s00439-015-1578-x
PG 16
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA CO8EY
UT WOS:000359399900003
PM 26077851
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Krishnan, KJ
   Reeve, AK
   Turnbull, DM
AF Krishnan, K. J.
   Reeve, A. K.
   Turnbull, D. M.
TI Do mitochondrial DNA mutations have a role in neurodegenerative disease?
SO BIOCHEMICAL SOCIETY TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT Focus Topic at Life Sciences 2007 Conference
CY JUL 09-12, 2007
CL Glasgow, SCOTLAND
DE mitochondrial DNA (mtDNA); mitochondrial DNA mutation; mitochondrial
   dysfunction; neurodegenerative disease; oxidative stress; Parkinson's
   disease
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MTDNA CONTROL-REGION;
   SUBSTANTIA-NIGRA NEURONS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE;
   ALPHA-SYNUCLEIN; ELDERLY-PATIENTS; POINT MUTATIONS; TRANSGENIC MICE;
   PARS-COMPACTA
AB A decline in mitochondrial function has long been shown to exist in neurodegenerative disease. Whether this decline is a secondary consequence of other factors or whether it causes the eventual death of a cell is unknown. In this review, we will discuss some of the major evidence surrounding mitochondrial DNA mutations leading to mitochondrial dysfunction in neurodegenerative disease and discuss their possible role in neurodegeneration.
C1 Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Krishnan, KJ (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM k.j.krishnan@ncl.ac.uk
RI Clugston, Kim/KBA-3107-2024
OI Reeve, Amy/0000-0002-4474-2204
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Aliev G, 2002, ANN NY ACAD SCI, V977, P45, DOI 10.1111/j.1749-6632.2002.tb04798.x
   Aomi Y, 2001, BIOCHEM BIOPH RES CO, V280, P265, DOI 10.1006/bbrc.2000.4113
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BINDOFF LA, 1989, LANCET, V2, P49, DOI 10.1016/S0140-6736(89)90291-2
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546
   Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K
   Chinnery PF, 2001, AM J HUM GENET, V68, P529, DOI 10.1086/318204
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Cottrell DA, 2001, NEUROLOGY, V57, P260, DOI 10.1212/WNL.57.2.260
   Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Elson JL, 2006, HUM GENET, V119, P241, DOI 10.1007/s00439-005-0123-8
   Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527
   Gu M, 1998, J NEUROL SCI, V158, P24, DOI 10.1016/S0022-510X(98)00095-1
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Ito S, 1999, P NATL ACAD SCI USA, V96, P2099, DOI 10.1073/pnas.96.5.2099
   JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7
   KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Melberg A, 2005, ACTA NEUROPATHOL, V110, P315, DOI 10.1007/s00401-005-1047-z
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   ROY S, 1969, J PATHOL, V99, P39, DOI 10.1002/path.1710990106
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X
   Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083
   Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trimmer PA, 2004, J NEUROCHEM, V88, P800, DOI 10.1046/j.1471-4159.2003.02168.x
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
NR 48
TC 8
Z9 8
U1 1
U2 6
PU PORTLAND PRESS LTD
PI LONDON
PA THIRD FLOOR, EAGLE HOUSE, 16 PROCTER STREET, LONDON WC1V 6 NX, ENGLAND
SN 0300-5127
J9 BIOCHEM SOC T
JI Biochem. Soc. Trans.
PD NOV
PY 2007
VL 35
BP 1232
EP 1235
DI 10.1042/BST0351232
PN 5
PG 4
WC Biochemistry & Molecular Biology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 236CE
UT WOS:000251279800092
PM 17956320
DA 2024-11-01
ER

PT J
AU Tiliscan, C
   Arama, V
   Mihailescu, R
   Streinu-Cercel, A
   Coman, OA
   Ion, D
   Ghita, I
   Arama, SS
AF Tiliscan, Catalin
   Arama, Victoria
   Mihailescu, Raluca
   Streinu-Cercel, Adrian
   Coman, Oana Andreia
   Ion, Daniela
   Ghita, Isabel
   Arama, Stefan Sorin
TI DIAGNOSIS AND MONITORING OF MITOCHONDRIAL TOXICITY INDUCED BY
   NUCLEOSIDE-ANALOGUE REVERSE-TRANSCRIPTASE INHIBITORS IN HIV-INFECTED
   PATIENTS UNDERGOING ANTIRETROVIRAL THERAPY
SO FARMACIA
LA English
DT Article
DE Mitochondrial DNA; HIV; Nucleoside reverse transcriptase inhibitors;
   Nucleoside reverse transcriptase inhibitors (NRTIs); Highly Active
   Antiretroviral Therapy (HAART)
ID MECHANISMS; DIDANOSINE
AB Highly Active Antiretroviral Therapy (HAART) containing nucleoside reverse transcriptase inhibitors (NRTIs) has been associated with various side effects following mitochondrial toxicity. The most important clincal consequences of mitochondrial DNA (mtDNA) depletion are: lipodystrophy, hepatic toxicity, lactic acidosis, myopathy and polyneuropathy.
   In order to prevent the onset of clinical and biological side effects during NRTIs treatment, different methods have been proposed to assess metabolic toxicity non-invasively and to adequately predict the metabolic risk. These methods have to be harmonized and validated, and there is a need for available commercial tests. Further studies are needed, in order to clarify whether clinicians can prevent mitochondrial toxicity based on the results of mtDNA measurements.
C1 [Tiliscan, Catalin; Arama, Victoria; Streinu-Cercel, Adrian; Coman, Oana Andreia; Ion, Daniela; Ghita, Isabel; Arama, Stefan Sorin] Univ Med & Pharm Carol Davila, Bucharest 020021, Romania.
   [Arama, Victoria; Mihailescu, Raluca; Streinu-Cercel, Adrian] Prof Dr Matei Bals Natl Inst Infect Dis, Bucharest 21106, Romania.
C3 Carol Davila University of Medicine & Pharmacy; National Institute for
   Infectious Diseases "Matei Bals"
RP Arama, SS (corresponding author), Univ Med & Pharm Carol Davila, 37 Dionisie Lupu Str, Bucharest 020021, Romania.
EM sorinarama@gmail.com
RI Tiliscan, Catalin/AAF-4402-2021; Coman, Oana/ABC-2942-2020; Ghita,
   Isabel Cristina Viorica/GSM-9553-2022; Ion, Daniela
   Adriana/GWR-3558-2022; Arama, Sorin/AAF-4442-2021; Streinu-Cercel,
   Adrian/M-5835-2017
OI Streinu-Cercel, Adrian/0000-0001-6382-5067
FU SLD-ART [62077/2008]; National Authority for Scientific Research (ANCS)
   [PNCDI-II]
FX This paper aims to disseminate results of the research grant "Evaluation
   by modern diagnostic techniques of abnormal patterns of lipid and
   carbohydrate metabolism in children and adults with HIV infection,
   undergoing antiretroviral therapy", acronym SLD-ART (contract
   62077/2008), grant PNCDI-II, funded by National Authority for Scientific
   Research (ANCS).
CR Bauer AM, 2004, HIV MED, V5, P371, DOI 10.1111/j.1468-1293.2004.00237.x
   BISSUEL F, 1994, J INTERN MED, V235, P367, DOI 10.1111/j.1365-2796.1994.tb01088.x
   Casademont J, 2004, MED SCI MONITOR, V10, pCS49
   de Mendoza C, 2004, AIDS REV, V6, P169
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201
   Loffler M, 1997, MOL CELL BIOCHEM, V174, P125, DOI 10.1023/A:1006859115450
   LOGAN J, 2009, FOX REAL TIME NASBA
   Mallon PWG, 2003, AIDS, V17, P971, DOI 10.1097/00002030-200305020-00005
   McComsey GA, 2004, ANTIVIR THER, V9, P205
   Negredo E, 2004, AIDS, V18, P459, DOI 10.1097/00002030-200402200-00012
   Pessayre D, 2001, SEMIN LIVER DIS, V21, P57, DOI 10.1055/s-2001-12929
   SCHEFFER IE, 2008, BASIC MOL BIOL MITOC, P37
   Scruggs ER, 2008, PHARMACOLOGY, V82, P83, DOI 10.1159/000134943
   Setzer B, 2005, ANTIVIR THER, V10, P327
   Timmermans EC, 2006, CLIN CHEM, V52, P979, DOI 10.1373/clinchem.2005.062901
   WALKER UA, 2008, LIPOATROPHY OTHER MA, P273
   Woodward CLN, 2009, HIV MED, V10, P482, DOI 10.1111/j.1468-1293.2009.00716.x
NR 18
TC 2
Z9 2
U1 0
U2 4
PU SOC STIINTE FARMACEUTICE ROMANIA
PI BUCURESTI
PA BUCURESTI, STR TRAIAN VUIA 6, SECT 1, BUCURESTI, 020956, ROMANIA
SN 0014-8237
EI 2065-0019
J9 FARMACIA
JI Farmacia
PD JUL-AUG
PY 2011
VL 59
IS 4
BP 453
EP 461
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 799UP
UT WOS:000293311900001
DA 2024-11-01
ER

PT J
AU Wu, SB
   Ma, YS
   Wu, YT
   Chen, YC
   Wei, YH
AF Wu, Shi-Bei
   Ma, Yi-Shing
   Wu, Yu-Ting
   Chen, Yin-Chiu
   Wei, Yau-Huei
TI Mitochondrial DNA Mutation-Elicited Oxidative Stress, Oxidative Damage,
   and Altered Gene Expression in Cultured Cells of Patients with MERRF
   Syndrome
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Mitochondrial disease; MERRF; Oxidative stress; Antioxidant enzyme;
   Mitochondrial aconitase; Prohibitin; Lon protease; MMP-1
ID AMYOTROPHIC-LATERAL-SCLEROSIS; ELECTRON-TRANSPORT-CHAIN; RAGGED-RED
   FIBERS; ALZHEIMERS-DISEASE BRAIN; LON PROTEASE; COMPLEX-I; MATRIX
   METALLOPROTEINASES; PROTEOMIC IDENTIFICATION; GLUTAMATE-DEHYDROGENASE;
   PYRUVATE-DEHYDROGENASE
AB Myoclonic epilepsy and ragged-red fibers (MERRF) syndrome is a rare disorder characterized by myoclonus, muscle weakness, cerebellar ataxia, heart conduction block, and dementia. It has been documented that 80-90% of the patients with MERRF syndrome are caused by the A8344G mutation in the tRNA(Lys) gene of mitochondrial DNA (mtDNA). We and other investigators have reported that the mtDNA mutation results in not only inefficient generation of adenosine triphosphate but also increased production of reactive oxygen species (ROS) in cultured cells harboring A8344G mutation of mtDNA. In addition, we found an imbalance in the gene expression of antioxidant enzymes in the skin fibroblasts of MERRF patients. The mRNA, protein, and enzyme activity levels of manganese-superoxide dismutase were increased, but those of Cu,Zn-SOD, catalase, and glutathione peroxidase did not show significant changes. Recently, we showed that the excess ROS could damage voltage-dependent anion channel, prohibitin, Lon protease, and aconitase in the MERRF cells. Moreover, there was a dramatic increase in the gene expression and activity of matrix metalloproteinase 1, which may contribute to the cytoskeleton remodeling involved in the weakness and atrophy of muscle commonly seen in MERRF patients. Taken together, we suggest that mtDNA mutation-elicited oxidative stress, oxidative damage, and altered gene expression are involved in the pathogenesis and progression of MERRF syndrome.
C1 [Wu, Shi-Bei; Ma, Yi-Shing; Wu, Yu-Ting; Chen, Yin-Chiu; Wei, Yau-Huei] Natl Yang Ming Univ, Dept Biochem & Mol Biol, Sch Life Sci, Taipei 112, Taiwan.
   [Wei, Yau-Huei] Mackay Med Coll, Dept Med, Taipei 252, Taiwan.
C3 National Yang Ming Chiao Tung University; Mackay Medical College
RP Wei, YH (corresponding author), Natl Yang Ming Univ, Dept Biochem & Mol Biol, Sch Life Sci, Taipei 112, Taiwan.
EM joeman@ym.edu.tw
RI Wei, Yau-Huei/ABA-6841-2021; TMU, barry0110/AAV-4030-2021
OI Wei, Yau-Huei/0000-0002-6429-2546
FU National Science Council, Executive Yuan, Taiwan [NSC96-2320-B-010-006,
   NSC97-2320 -B-010-013-MY3]; Nation Science Council of Taiwan
FX The data reported in this article are the results of studies supported
   by research grants from the National Science Council
   (NSC96-2320-B-010-006 and NSC97-2320 -B-010-013-MY3), Executive Yuan,
   Taiwan. We wish to thank the Nation Science Council of Taiwan for
   long-term support of the studies on mitochondrial dysfunction and mtDNA
   mutations in the pathophysiology of mitochondrial diseases.
CR Antonická H, 1999, BIOCHEM J, V342, P537, DOI 10.1042/0264-6021:3420537
   Babu GN, 2008, NEUROCHEM INT, V52, P1284, DOI 10.1016/j.neuint.2008.01.009
   BACMAN SR, 2003, BIOCHEM J, V15, P131
   Barghuti F, 2008, MOL GENET METAB, V94, P78, DOI 10.1016/j.ymgme.2007.11.013
   Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   Brenneisen P, 1997, FREE RADICAL BIO MED, V22, P515, DOI 10.1016/S0891-5849(96)00404-2
   Bulteau AL, 2005, P NATL ACAD SCI USA, V102, P5987, DOI 10.1073/pnas.0501519102
   Calabrese V, 2007, NEUROCHEM RES, V32, P757, DOI 10.1007/s11064-006-9203-y
   Cantu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007095
   Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x
   Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163
   Chevallet M, 2006, ELECTROPHORESIS, V27, P1574, DOI 10.1002/elps.200500704
   Conrad CC, 2001, PROTEOMICS, V1, P829, DOI 10.1002/1615-9861(200107)1:7<829::AID-PROT829>3.3.CO;2-I
   Danielson SR, 2002, J BIOL CHEM, V277, P5810, DOI 10.1074/jbc.M110119200
   Díez-Vives C, 2009, J NEUROCHEM, V111, P945, DOI 10.1111/j.1471-4159.2009.06374.x
   Dukes AA, 2008, J NEUROCHEM, V106, P333, DOI 10.1111/j.1471-4159.2008.05392.x
   Erol I, 2009, NEUROMUSCULAR DISORD, V19, P275, DOI 10.1016/j.nmd.2009.01.012
   FAFFMICHALAK L, 1993, BRAIN RES, V618, P299, DOI 10.1016/0006-8993(93)91279-2
   Ferrari DM, 1998, EUR J BIOCHEM, V255, P570, DOI 10.1046/j.1432-1327.1998.2550570.x
   Ferrer I, 2009, J BIOENERG BIOMEMBR, V41, P425, DOI 10.1007/s10863-009-9243-5
   Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515
   Gardner PR, 1997, BIOSCIENCE REP, V17, P33, DOI 10.1023/A:1027383100936
   Groenendyk J, 2005, ACTA BIOCHIM POL, V52, P381
   Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x
   Ikeda J, 1997, BIOCHEM BIOPH RES CO, V230, P94, DOI 10.1006/bbrc.1996.5890
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Katayama Y, 2009, MITOCHONDRION, V9, P306, DOI 10.1016/j.mito.2009.04.002
   Korolainen MA, 2006, NEUROBIOL AGING, V27, P42, DOI 10.1016/j.neurobiolaging.2004.11.010
   Kunishige M, 2003, MUSCLE NERVE, V28, P484, DOI 10.1002/mus.10466
   Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127
   Lijnen P, 2008, AM J HYPERTENS, V21, P1129, DOI 10.1038/ajh.2008.242
   Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301
   Liu CY, 2007, MITOCHONDRION, V7, P89, DOI 10.1016/j.mito.2006.11.020
   Liu CY, 2009, J FORMOS MED ASSOC, V108, P599, DOI 10.1016/S0929-6646(09)60380-6
   LIU CY, 2009, BIOCHIM BIOPHYS ACTA, V783, P1792
   LIU J, 1991, J ORTHOPAED RES, V9, P568, DOI 10.1002/jor.1100090413
   Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200
   Lu CY, 2003, MOL GENET METAB, V80, P321, DOI 10.1016/j.ymgme.2003.08.005
   Luce K, 2009, NAT CELL BIOL, V11, P852, DOI 10.1038/ncb1893
   Ma YS, 2009, BBA-GEN SUBJECTS, V1790, P1021, DOI 10.1016/j.bbagen.2009.04.012
   Ma YS, 2005, ANN NY ACAD SCI, V1042, P55, DOI 10.1196/annals.1338.006
   Mahata B, 2006, SCIENCE, V314, P471, DOI 10.1126/science.1129754
   Masucci JP, 1997, MOL CELL BIOCHEM, V174, P215, DOI 10.1023/A:1006808524536
   MATTHEWS PM, 1994, BRAIN, V117, P435, DOI 10.1093/brain/117.3.435
   McKenna MC, 2000, NEUROCHEM INT, V37, P229, DOI 10.1016/S0197-0186(00)00042-5
   Morgan-Hughes JA, 1999, BBA-BIOENERGETICS, V1410, P125, DOI 10.1016/S0005-2728(98)00162-5
   Muratai T, 2008, FREE RADICAL RES, V42, P221, DOI 10.1080/10715760701877262
   Nelson KK, 2004, FREE RADICAL BIO MED, V37, P768, DOI 10.1016/j.freeradbiomed.2004.06.008
   Nelson KK, 2006, J BIOL CHEM, V281, P14100, DOI 10.1074/jbc.M601820200
   Ngo JK, 2009, FREE RADICAL BIO MED, V46, P1042, DOI 10.1016/j.freeradbiomed.2008.12.024
   Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0
   Nikolic-Kokic A, 2006, CLIN CHEM LAB MED, V44, P589, DOI 10.1515/CCLM.2006.111
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229
   Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655
   OZAWA M, 1995, NEUROMUSCULAR DISORD, V5, P483, DOI 10.1016/0960-8966(95)00009-C
   OZAWA T, 1995, EXP GERONTOL, V30, P269, DOI 10.1016/0531-5565(94)00057-A
   PICCOLO G, 1991, J NEUROL SCI, V105, P57, DOI 10.1016/0022-510X(91)90118-Q
   Plecitá-Hlavatá L, 2009, INT J BIOCHEM CELL B, V41, P1697, DOI 10.1016/j.biocel.2009.02.015
   QUINTANA E, 2010, J INHERIT M IN PRESS
   RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S
   Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X
   Rusanen H, 2000, BBA-MOL BASIS DIS, V1500, P10, DOI 10.1016/S0925-4439(99)00081-2
   RUSTIN P, 1997, BIOCHIM BIOPHYS ACTA, V136, P185
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Schleicher M, 2008, J CELL BIOL, V180, P101, DOI 10.1083/jcb.200706072
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169
   Sorolla MA, 2008, FREE RADICAL BIO MED, V45, P667, DOI 10.1016/j.freeradbiomed.2008.05.014
   Stanyer L, 2008, NEUROCHEM INT, V53, P95, DOI 10.1016/j.neuint.2008.06.004
   Svineng G, 2008, CONNECT TISSUE RES, V49, P197, DOI 10.1080/03008200802143166
   Tabatabaie T, 1996, ARCH BIOCHEM BIOPHYS, V336, P290, DOI 10.1006/abbi.1996.0560
   Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003
   Tretter L, 2000, J NEUROSCI, V20, P8972
   Virgilio R, 2009, J NEUROL SCI, V281, P85, DOI 10.1016/j.jns.2009.01.025
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wani AA, 2008, FREE RADICAL RES, V42, P415, DOI 10.1080/10715760802068571
   Wei YH, 2001, CHINESE J PHYSIOL, V44, P1
   Wei YH, 2003, ADV CLIN CHEM, V37, P83, DOI 10.1016/S0065-2423(03)37007-6
   Zeviani Massimo, 2003, Curr Neurol Neurosci Rep, V3, P423, DOI 10.1007/s11910-003-0026-9
NR 85
TC 64
Z9 72
U1 0
U2 11
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD JUN
PY 2010
VL 41
IS 2-3
SI SI
BP 256
EP 266
DI 10.1007/s12035-010-8123-7
PG 11
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 601WI
UT WOS:000278095800021
PM 20411357
DA 2024-11-01
ER

PT J
AU Kashio, A
   Yamada, C
   Yasuhara, K
   Kamogashira, T
   Someya, S
   Yamasoba, T
AF Kashio, Akinori
   Yamada, Chikako
   Yasuhara, Kazuo
   Kamogashira, Teru
   Someya, Shinichi
   Yamasoba, Tatsuya
TI Taurine, Coenzyme Q 10, and Hydrogen Water Prevents Germanium
   Dioxide-Induced Mitochondrial Dysfunction and Associated Sensorineural
   Hearing Loss in mouse
SO HEARING RESEARCH
LA English
DT Article
DE Germanium dioxide; Hearing loss; Mitochondrial dysfunction; Taurine;
   Coenzyme Q10; Hydrogen water
ID OXIDATIVE STRESS; DNA MUTATIONS; INDUCED APOPTOSIS; CELL-LINE; GENE;
   MYOPATHY; MODEL; MICE; ISCHEMIA/REPERFUSION; NEPHROTOXICITY
AB Mitochondrial dysfunction has been implicated in numerous common diseases as well as aging and plays an important role in the pathogenesis of sensorineural hearing loss (SNHL). In the current study, we showed that supplementation with germanium dioxide (GeO 2 ) in CBA/J mice resulted in SNHL due to the degeneration of the stria vascularis and spiral ganglion, which were associated with down-regulation of mitochondrial respiratory chain associated genes and up-regulation in apoptosis associated genes in the cochlea. Supplementation with taurine, coenzyme Q10, or hydrogen-rich water, attenuated the cochlear degeneration and associated SNHL induced by GeO 2 . These results suggest that daily supplements or consumption of antioxidants, such as taurine, coenzyme Q10, and hydrogen-rich water, may be a promising intervention to slow SNHL associated with mitochondrial dysfunction.(c) 2022 Elsevier B.V. All rights reserved.
C1 [Kashio, Akinori; Yamada, Chikako; Yasuhara, Kazuo; Kamogashira, Teru; Yamasoba, Tatsuya] Univ Tokyo, Fac Med, Dept Otolaryngol & Head & Neck Surg, Tokyo, Japan.
   [Someya, Shinichi] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA.
C3 University of Tokyo; State University System of Florida; University of
   Florida
RP Yamasoba, T (corresponding author), Univ Tokyo, Fac Med, Dept Otolaryngol & Head & Neck Surg, Tokyo, Japan.
EM tyamasoba-tky@umin.ac.jp
OI Someya, Shinichi/0000-0001-9895-6227; Kamogashira,
   Teru/0000-0001-8410-930X
FU Government of Japan Ministry of Education, Culture, Sports, Science and
   Technology of Japan (MEXT) [JP20H00546, JP20K21646JP]; Government of
   Japan Ministry of Labour and Welfare [20FC1019]; Grants-in-Aid for
   Scientific Research [20K21646, 21K16853, 20H00546] Funding Source: KAKEN
FX Funding This study was supported by Grant Number JP20H00546,
   JP20K21646JP from Government of Japan Ministry of Education, Culture,
   Sports, Science and Technology of Japan (MEXT) , and Grant Number
   20FC1019 from Government of Japan Ministry of Labour and Welfare.
CR Affymetrix, 2004, EXPR AN TECHN MAN
   Alam SS, 2011, ENVIRON TOXICOL PHAR, V31, P143, DOI 10.1016/j.etap.2010.10.001
   ASAKA T, 1995, J NEUROL SCI, V130, P220, DOI 10.1016/0022-510X(95)00032-W
   Böttger EC, 2013, HEARING RES, V303, P12, DOI 10.1016/j.heares.2013.01.006
   Bustamante J, 1997, TOXICOLOGY, V118, P129, DOI 10.1016/S0300-483X(96)03607-4
   Chang KL, 2003, TOXICOL APPL PHARM, V193, P209, DOI 10.1016/j.taap.2003.07.004
   Chou CT, 2015, AMINO ACIDS, V47, P735, DOI 10.1007/s00726-014-1901-1
   Cortes NG, 2012, HUM MUTAT, V33, P681, DOI 10.1002/humu.22023
   Das J, 2009, DRUG CHEM TOXICOL, V32, P93, DOI 10.1080/01480540802564171
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Dereköy FS, 2004, LARYNGOSCOPE, V114, P1775, DOI 10.1097/00005537-200410000-00019
   Erdem A, 2000, NEPHROL DIAL TRANSPL, V15, P1175, DOI 10.1093/ndt/15.8.1175
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fransson AE, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.658662
   Fujimoto C, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8040109
   Fukuda KI, 2007, BIOCHEM BIOPH RES CO, V361, P670, DOI 10.1016/j.bbrc.2007.07.088
   Gopinath B, 2009, STROKE, V40, P1496, DOI 10.1161/STROKEAHA.108.535682
   Hargreaves I P, 2014, Int J Biochem Cell Biol, V49, P105, DOI 10.1016/j.biocel.2014.01.020
   Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165
   HIGUCHI I, 1989, ACTA NEUROPATHOL, V79, P300, DOI 10.1007/BF00294665
   HIGUCHI I, 1991, ACTA NEUROPATHOL, V82, P55, DOI 10.1007/BF00310923
   Horváth R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70
   Hoya N, 2004, NEUROREPORT, V15, P1597, DOI 10.1097/01.wnr.0000133226.94662.80
   Hu XM, 2003, CANCER CHEMOTH PHARM, V52, P47, DOI 10.1007/s00280-003-0629-5
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101
   Kantrow SP, 1997, ARCH BIOCHEM BIOPHYS, V345, P278, DOI 10.1006/abbi.1997.0264
   Kim KM, 1998, NEPHROL DIAL TRANSPL, V13, P3218, DOI 10.1093/ndt/13.12.3218
   Kinoshita M, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/325702
   Koh JH, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/397307
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lamperti C, 2012, NEUROMUSCULAR DISORD, V22, P990, DOI 10.1016/j.nmd.2012.06.003
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Li Xiaodong, 2001, Chinese Medical Sciences Journal, V16, P157
   Lin CH, 2006, NEUROTOXICOLOGY, V27, P1052, DOI 10.1016/j.neuro.2006.05.018
   Lin Y, 2011, NEUROSCI LETT, V487, P12, DOI 10.1016/j.neulet.2010.09.064
   Manna P, 2009, AMINO ACIDS, V36, P417, DOI 10.1007/s00726-008-0094-x
   Milton AG, 2004, BIOMETALS, V17, P707, DOI 10.1007/s10534-004-1210-3
   Nakashima-Kamimura N, 2009, CANCER CHEMOTH PHARM, V64, P753, DOI 10.1007/s00280-008-0924-2
   Ohlemiller KK, 2000, JARO-J ASSOC RES OTO, V1, P243, DOI 10.1007/s101620010043
   Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577
   Ohsawa I, 2008, BIOCHEM BIOPH RES CO, V377, P1195, DOI 10.1016/j.bbrc.2008.10.156
   Okamoto Y, 2005, AUDIOL NEURO-OTOL, V10, P220, DOI 10.1159/000084843
   Pelicano H, 2003, J BIOL CHEM, V278, P37832, DOI 10.1074/jbc.M301546200
   Qiao M, 2015, BIOTECHNOL LETT, V37, P1579, DOI 10.1007/s10529-015-1846-9
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Roy Anandita, 2012, Pathophysiology, V19, P137, DOI 10.1016/j.pathophys.2012.05.001
   SANAI T, 1990, TOXICOL APPL PHARM, V103, P345, DOI 10.1016/0041-008X(90)90234-L
   Sato Y, 2008, BIOCHEM BIOPH RES CO, V375, P346, DOI 10.1016/j.bbrc.2008.08.020
   Shen ZY, 2003, INT J MOL MED, V11, P479
   Shoubridge EA, 2001, SEMIN NEUROL, V21, P261, DOI 10.1055/s-2001-17943
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Sikorska M, 2014, NEUROBIOL AGING, V35, P2329, DOI 10.1016/j.neurobiolaging.2014.03.032
   Sohet FM, 2009, BIOCHEM PHARMACOL, V78, P1391, DOI 10.1016/j.bcp.2009.07.008
   Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014
   Someya S, 2007, BRAIN RES, V1182, P26, DOI 10.1016/j.brainres.2007.08.090
   Someya S, 2007, NEUROBIOL AGING, V28, P1613, DOI 10.1016/j.neurobiolaging.2006.06.024
   Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106
   TAKEUCHI A, 1992, NEPHRON, V60, P436, DOI 10.1159/000186805
   Wang W, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac7410
   WU CM, 1992, MUSCLE NERVE, V15, P1258, DOI 10.1002/mus.880151107
   Yamada Y, 2015, J CONTROL RELEASE, V213, P86, DOI 10.1016/j.jconrel.2015.06.037
   Yamasoba T, 2006, NEUROSCI LETT, V395, P18, DOI 10.1016/j.neulet.2005.10.045
   Yamasoba T, 2007, HEARING RES, V226, P185, DOI 10.1016/j.heares.2006.06.004
   Yoshida A, 2012, CARDIOVASC DRUG THER, V26, P217, DOI 10.1007/s10557-012-6381-5
NR 66
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-5955
EI 1878-5891
J9 HEARING RES
JI Hear. Res.
PD FEB
PY 2023
VL 428
AR 108678
DI 10.1016/j.heares.2022.108678
EA DEC 2022
PG 11
WC Audiology & Speech-Language Pathology; Neurosciences;
   Otorhinolaryngology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Audiology & Speech-Language Pathology; Neurosciences & Neurology;
   Otorhinolaryngology
GA 7W6BP
UT WOS:000913597300001
PM 36577362
OA Bronze
DA 2024-11-01
ER

PT J
AU Kanaumi, T
   Hirose, S
   Goto, Y
   Naitou, E
   Mitsudome, A
AF Kanaumi, T
   Hirose, S
   Goto, Y
   Naitou, E
   Mitsudome, A
TI An infant with a mitochondrial A3243G mutation demonstrating the MELAS
   phenotype
SO PEDIATRIC NEUROLOGY
LA English
DT Article
ID LATERALIZED EPILEPTIFORM DISCHARGES; EVOLUTION
AB Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a syndrome associated with mitochondrial DNA mutations such as A3243G, the most common mutation. Ragged-red fibers and strongly succinate dehydrogenase-reactive blood vessels in the muscle are diagnostic pathologic features of MELAS. In general, the first typical attack of MELAS occurs in children at school age; it is rare for stroke-like episodes to occur in early infancy. This report describes a 4-month-old male harboring A3243G, whose phenotype at onset was consistent with that of MELAS in infancy. The patient was admitted because of disturbances of consciousness and ventilatory insufficiency. Remarkable lactic acidosis was observed. MRI revealed several bilateral lesions. Periodic lateralized epileptic discharges on the EEG suggested regional lesions. Biopsied muscle displayed scattered ragged-red fibers and succinate dehydrogenase-reactive blood vessels; over 90% of muscle mitochondrial DNA had A3243G. This case suggests that MELAS can develop in early infancy with its typical clinical presentation. The high percentage of A3243G may contribute to the early onset of the MELAS phenotype in this patient. (c) 2006 by Elsevier Inc. All rights reserved.
C1 Fukuoka Univ, Sch Med, Dept Pediat, Jonan Ku, Fukuoka 8140180, Japan.
   Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Natl Ctr Neurol & Psychiat, Tokyo, Japan.
   Univ Tokushima, Sch Med, Fac Pediat, Tokushima 770, Japan.
C3 Fukuoka University; National Center for Neurology & Psychiatry - Japan;
   Tokushima University
RP Fukuoka Univ, Sch Med, Dept Pediat, Jonan Ku, 45-1,7 Chome, Fukuoka 8140180, Japan.
EM hirose@fukuoka-u.ac.jp
OI HIROSE, Shinichi/0000-0001-6796-3790
CR Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Chabolla DR, 1996, ELECTROEN CLIN NEURO, V98, P5, DOI 10.1016/0013-4694(95)00211-1
   de Lonlay-Debeney P, 2000, J PEDIATR-US, V136, P209, DOI 10.1016/S0022-3476(00)70103-X
   Deschauer M, 2001, ARCH NEUROL-CHICAGO, V58, P1885, DOI 10.1001/archneur.58.11.1885
   Funakawa I, 1997, ELECTROEN CLIN NEURO, V103, P370, DOI 10.1016/S0013-4694(97)00020-9
   García-Morales I, 2002, J CLIN NEUROPHYSIOL, V19, P172, DOI 10.1097/00004691-200203000-00009
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   KOO B, 1993, ANN NEUROL, V34, P25, DOI 10.1002/ana.410340107
   Okhuijsen-Kroes EJ, 2001, NEUROPEDIATRICS, V32, P183, DOI 10.1055/s-2001-17372
   SCHWARTZ MS, 1973, BRAIN, V96, P613, DOI 10.1093/brain/96.3.613
   SHOTTNER JM, 1995, METABOLIC MOL BASIS, P1535
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   WESTMORELAND BF, 1986, ARCH NEUROL-CHICAGO, V43, P494, DOI 10.1001/archneur.1986.00520050066024
NR 13
TC 13
Z9 14
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD MAR
PY 2006
VL 34
IS 3
BP 235
EP 238
DI 10.1016/j.pediatrneurol.2005.08.024
PG 4
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 022EO
UT WOS:000236037800012
PM 16504796
DA 2024-11-01
ER

PT J
AU Ambrogetti, R
   Kavanagh, E
   Eltayeb, K
AF Ambrogetti, Robert
   Kavanagh, Ethan
   Eltayeb, Khalid
TI Late-onset mitochondrial encephalopathy with lactic acidosis and
   stroke-like episodes and the role of serial imaging
SO BMJ CASE REPORTS
LA English
DT Article
DE Neurology; Epilepsy and seizures; Neuro genetics; Genetics
ID TRANSFER RNALEU(UUR) GENE; ANTIEPILEPTIC DRUGS; MELAS SYNDROME;
   MUTATION; DNA; A3243G; PREVALENCE; ENCEPHALOMYOPATHY; DIAGNOSIS;
   MYOPATHY
AB Mitochondria are essential for human metabolic function. Over 350 genetic mutations are associated with mitochondrial diseases, which are inherited in a matrilineal fashion. In mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), defective mitochondrial function and resultant impaired cellular energy production compromise vascular perfusion in affected tissues. Early diagnostic criteria suggested the diagnosis should be considered in those under 40. However, a broader range of phenotypes are now recognised, including those that present for the first time later in life. The primary presenting feature in MELAS is a stroke-like episode invariably resulting in patients undergoing neuroradiological imaging. We present a case of a woman with a first presentation of a stroke-like episode and seizures in her 40s who was eventually diagnosed with MELAS. We detail her clinical presentation, treatment and diagnosis, emphasising the role of serial imaging in her diagnosis.
C1 [Ambrogetti, Robert] Univ Hosp Leicester NHS Trust, Internal Med, Leicester, England.
   [Kavanagh, Ethan] Univ Hosp Leicester NHS Trust, Leicester, England.
   [Eltayeb, Khalid] Univ Hosp Leicester NHS Trust, Neurol, Leicester, England.
C3 University of Leicester; University Hospitals of Leicester NHS Trust;
   University Hospitals of Leicester NHS Trust; University of Leicester;
   University of Leicester; University Hospitals of Leicester NHS Trust
RP Ambrogetti, R (corresponding author), Univ Hosp Leicester NHS Trust, Internal Med, Leicester, England.
EM robert.ambrogetti1@nhs.net
CR Coussa RG, 2021, SURV OPHTHALMOL, V66, P838, DOI 10.1016/j.survophthal.2021.02.008
   Deschauer M, 1999, NEUROMUSCULAR DISORD, V9, P305, DOI 10.1016/S0960-8966(99)00019-X
   Dickerson BC, 2005, NEW ENGL J MED, V353, P2271, DOI 10.1056/NEJMcpc059032
   Dimauro S, 2004, ANN NY ACAD SCI, V1011, P217, DOI 10.1196/annals.1293.022
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Esterhuizen K, 2019, MITOCHONDRION, V45, P38, DOI 10.1016/j.mito.2018.02.003
   Fan HC, 2021, LIFE-BASEL, V11, DOI 10.3390/life11111111
   Finsterer J, 2020, AM J CASE REP, V21, DOI 10.12659/AJCR.927938
   Finsterer J, 2012, EXPERT OPIN DRUG MET, V8, P71, DOI 10.1517/17425255.2012.644535
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature183030, 10.1038/nature18303]
   Imasawa T, 2023, HELIYON, V9, DOI 10.1016/j.heliyon.2023.e14923
   Kanner AM, 2018, NEUROLOGY, V91, P82, DOI 10.1212/WNL.0000000000005756
   Khasminsky V, 2023, NEUROL-GENET, V9, DOI 10.1212/NXG.0000000000200082
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   Li DY, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.951185
   Liu GL, 2020, J NEUROL SCI, V408, DOI 10.1016/j.jns.2019.116562
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mavraki E, 2023, EUR J HUM GENET, V31, P148, DOI 10.1038/s41431-022-01249-w
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ng Yi Shiau, 2019, Wellcome Open Res, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Parikh S, 2017, GENET MED, V19, DOI 10.1038/gim.2017.107
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   Pizzamiglio C, 2021, GENES-BASEL, V12, DOI 10.3390/genes12101643
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Shen XY, 2021, NEUROSCIENCES, V26, P128, DOI 10.17712/nsj.2021.2.20200145
   Smeets Hubert J M, 2023, Handb Clin Neurol, V194, P207, DOI 10.1016/B978-0-12-821751-1.00004-X
   Strandberg MC, 2020, ACTA NEUROL SCAND, V142, P323, DOI 10.1111/ane.13312
   Vossler DG, 2019, EPILEPSY CURR, V19, P83, DOI 10.1177/1535759719835353
   Wei W, 2019, SCIENCE, V364, P749, DOI 10.1126/science.aau6520
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
NR 41
TC 0
Z9 0
U1 1
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
EI 1757-790X
J9 BMJ CASE REP
JI BMJ Case Rep.
PD FEB
PY 2024
VL 17
IS 2
AR e259102
DI 10.1136/bcr-2023-259102
PG 5
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA JN3M7
UT WOS:001173809000015
PM 38417938
DA 2024-11-01
ER

PT J
AU Suzuki, T
   Yamaguchi, H
   Kikusato, M
   Matsuhashi, T
   Matsuo, A
   Sato, T
   Oba, Y
   Watanabe, S
   Minaki, D
   Saigusa, D
   Shimbo, H
   Mori, N
   Mishima, E
   Shima, H
   Akiyama, Y
   Takeuchi, Y
   Yuri, A
   Kikuchi, K
   Toyohara, T
   Suzuki, C
   Kohzuki, M
   Anzai, J
   Mano, N
   Kure, S
   Yanagisawa, T
   Tomioka, Y
   Toyomizu, M
   Ito, S
   Osaka, H
   Hayashi, K
   Abe, T
AF Suzuki, Takehiro
   Yamaguchi, Hiroaki
   Kikusato, Motoi
   Matsuhashi, Tetsuro
   Matsuo, Akihiro
   Sato, Takeya
   Oba, Yuki
   Watanabe, Shun
   Minaki, Daichi
   Saigusa, Daisuke
   Shimbo, Hiroko
   Mori, Nobuyoshi
   Mishima, Eikan
   Shima, Hisato
   Akiyama, Yasutoshi
   Takeuchi, Yoichi
   Yuri, Akinori
   Kikuchi, Koichi
   Toyohara, Takafumi
   Suzuki, Chitose
   Kohzuki, Masahiro
   Anzai, Jun-ichi
   Mano, Nariyasu
   Kure, Shigeo
   Yanagisawa, Teruyuki
   Tomioka, Yoshihisa
   Toyomizu, Masaaki
   Ito, Sadayoshi
   Osaka, Hitoshi
   Hayashi, Ken-ichiro
   Abe, Takaaki
TI Mitochonic Acid 5 (MA-5), a Derivative of the Plant Hormone
   Indole-3-Acetic Acid, Improves Survival of Fibroblasts from Patients
   with Mitochondrial Diseases
SO TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE indole-3-acetic acid; Leigh syndrome; MELAS; mitochonic acid 5 (MA-5);
   mitochondrial disease
ID DYSFUNCTION; DISORDERS; MODELS; AUXIN
AB Mitochondria are key organelles implicated in a variety of processes related to energy and free radical generation, the regulation of apoptosis, and various signaling pathways. Mitochondrial dysfunction increases cellular oxidative stress and depletes ATP in a variety of inherited mitochondrial diseases and also in many other metabolic and neurodegenerative diseases. Mitochondrial diseases are characterized by the dysfunction of the mitochondrial respiratory chain, caused by mutations in the genes encoded by either nuclear DNA or mitochondrial DNA. We have hypothesized that chemicals that increase the cellular ATP levels may ameliorate the mitochondrial dysfunction seen in mitochondrial diseases. To search for the potential drugs for mitochondrial diseases, we screened an in-house chemical library of indole-3-acetic-acid analogs by measuring the cellular ATP levels in Hep3B human hepatocellular carcinoma cells. We have thus identified mitochonic acid 5 (MA-5), 4-(2,4-difluorophenyl)-2-(1H-indol-3-yl)-4-oxobutanoic acid, as a potential drug for enhancing ATP production. MA-5 is a newly synthesized derivative of the plant hormone, indole-3-acetic acid. Importantly, MA-5 improved the survival of fibroblasts established from patients with mitochondrial diseases under the stress-induced condition, including Leigh syndrome, MELAS (myopathy encephalopathy lactic acidosis and stroke-like episodes), Leber's hereditary optic neuropathy, and Kearns-Sayre syndrome. The improved survival was associated with the increased cellular ATP levels. Moreover, MA-5 increased the survival of mitochondrial disease fibroblasts even under the inhibition of the oxidative phosphorylation or the electron transport chain. These data suggest that MA-5 could be a therapeutic drug for mitochondrial diseases that exerts its effect in a manner different from anti-oxidant therapy.
C1 [Suzuki, Takehiro; Matsuo, Akihiro; Oba, Yuki; Watanabe, Shun; Mishima, Eikan; Shima, Hisato; Akiyama, Yasutoshi; Takeuchi, Yoichi; Kikuchi, Koichi; Toyohara, Takafumi; Suzuki, Chitose; Ito, Sadayoshi; Abe, Takaaki] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 9808574, Japan.
   [Suzuki, Takehiro] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA.
   [Suzuki, Takehiro] Harvard Univ, Sch Med, Boston, MA 02115 USA.
   [Yamaguchi, Hiroaki; Mano, Nariyasu] Tohoku Univ Hosp, Dept Pharmaceut Sci, Sendai, Miyagi, Japan.
   [Kikusato, Motoi; Toyomizu, Masaaki] Tohoku Univ, Grad Sch Agr Sci, Animal Nutr, Life Sci, Sendai, Miyagi 9808574, Japan.
   [Matsuhashi, Tetsuro; Kure, Shigeo] Tohoku Univ, Grad Sch Med, Div Pediat, Sendai, Miyagi 9808574, Japan.
   [Sato, Takeya; Yanagisawa, Teruyuki] Tohoku Univ, Grad Sch Med, Dept Mol Pharmacol, Sendai, Miyagi 9808574, Japan.
   [Minaki, Daichi; Anzai, Jun-ichi] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808574, Japan.
   [Saigusa, Daisuke] Tohoku Univ, Dept Integrat Genom, Tohoku Med Megabank Org, Sendai, Miyagi 9808574, Japan.
   [Shimbo, Hiroko] Kanagawa Childrens Med Ctr, Clin Res Inst, Yokohama, Kanagawa, Japan.
   [Mori, Nobuyoshi; Kohzuki, Masahiro] Tohoku Univ, Grad Sch Med, Dept Internal Med & Rehabil Sci, Sendai, Miyagi 9808574, Japan.
   [Yuri, Akinori; Tomioka, Yoshihisa] Tohoku Univ, Grad Sch Med, Lab Oncol Pharm Practice & Sci, Sendai, Miyagi 9808574, Japan.
   [Kikuchi, Koichi; Abe, Takaaki] Tohoku Univ, Grad Sch Med, Dept Clin Biol & Hormonal Regulat, Sendai, Miyagi 9808574, Japan.
   [Osaka, Hitoshi] Jichi Med Univ, Div Pediat, Shimotsuke, Tochigi, Japan.
   [Hayashi, Ken-ichiro] Okayama Univ Sci, Dept Biochem, Okayama, Okayama, Japan.
   [Abe, Takaaki] Tohoku Univ, Grad Sch Biomed Engn, Div Med Sci, Sendai, Miyagi 9808574, Japan.
C3 Tohoku University; Harvard University; Brigham & Women's Hospital;
   Harvard University; Harvard Medical School; Tohoku University; Tohoku
   University; Tohoku University; Tohoku University; Tohoku University;
   Tohoku University; Tohoku University; Tohoku University; Tohoku
   University; Jichi Medical University; Okayama University of Science;
   Tohoku University
RP Abe, T (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Div Med Sci, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.
EM takaabe@med.tohohu.ac.jp
RI Toyomizu, Masaaki/AAE-3439-2019; Mano, Nariyasu/AAS-9994-2020; Suzuki,
   Takehiro/AAE-2210-2019; Hayashi, Ken-ichiro/AAP-3513-2021; Ito,
   Sadayoshi/A-3933-2015; Shima, Hisato/KRO-8888-2024; Yamaguchi,
   Hiroaki/G-9969-2012
OI Akiyama, Yasutoshi/0000-0002-0211-7793; Saigusa,
   Daisuke/0000-0001-9484-9870; Sato, Takeya/0000-0003-2409-1819; Hayashi,
   Ken-ichiro/0000-0002-9812-2801; Mishima, Eikan/0000-0002-3706-2745; Ito,
   Sadayoshi/0000-0002-5092-3626; Mano, Nariyasu/0000-0003-1679-9024;
   Toyomizu, Masaaki/0000-0003-4157-2817; KIKUSATO,
   MOTOI/0000-0001-8145-5071; Yamaguchi, Hiroaki/0000-0003-3021-6120
FU National grant-in-aid for scientific research from the Ministry of
   Education, Culture, Sports, Science and Technology of Japan [26670070];
   Translational Research Network Program [B20]; Grants-in-Aid for
   Scientific Research [26860624, 26670070, 26293031] Funding Source: KAKEN
FX This work was supported in part by National grant-in-aid for scientific
   research from the Ministry of Education, Culture, Sports, Science and
   Technology of Japan (26670070) and Translational Research Network
   Program (B20).
CR Avula S, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0292-7
   Carelli V, 2013, CURR OPIN NEUROL, V26, P52, DOI 10.1097/WCO.0b013e32835c5f0b
   Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013
   CHUNG KT, 1975, J BACTERIOL, V124, P573, DOI 10.1128/JB.124.1.573-575.1975
   Coskuner O, 2014, J ALZHEIMERS DIS, V41, P561, DOI 10.3233/JAD-132300
   El-Hattab AW, 2014, INT J BIOCHEM CELL B, V48, P85, DOI 10.1016/j.biocel.2013.12.009
   Enns GM, 2014, J CHILD NEUROL, V29, P1235, DOI 10.1177/0883073814538509
   Enns GM, 2012, MOL GENET METAB, V105, P91, DOI 10.1016/j.ymgme.2011.10.009
   GORDON SA, 1972, AM J PHYSIOL, V222, P399, DOI 10.1152/ajplegacy.1972.222.2.399
   Habersetzer J, 2013, INT J BIOCHEM CELL B, V45, P99, DOI 10.1016/j.biocel.2012.05.017
   Hayashi K, 2012, ACS CHEM BIOL, V7, P590, DOI 10.1021/cb200404c
   Imagawa S, 2003, FASEB J, V17, P1742, DOI 10.1096/fj.02-1134fje
   Jiang Y, 2011, MUTAT RES-GEN TOX EN, V726, P75, DOI 10.1016/j.mrgentox.2011.08.006
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   Lim CK, 2008, MOL PHARMACOL, V74, P225, DOI 10.1124/mol.108.046847
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   Pagnussat GC, 2003, PLANT PHYSIOL, V132, P1241, DOI 10.1104/pp.103.022228
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Shrader WD, 2011, BIOORG MED CHEM LETT, V21, P3693, DOI 10.1016/j.bmcl.2011.04.085
   SINNA GA, 1983, COMP BIOCHEM PHYS C, V74, P433, DOI 10.1016/0742-8413(83)90127-5
   Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35
   Tanigawa J, 2012, BRAIN DEV-JPN, V34, P861, DOI 10.1016/j.braindev.2012.02.007
   Toyohara T, 2010, HYPERTENS RES, V33, P944, DOI 10.1038/hr.2010.113
   Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
NR 27
TC 35
Z9 42
U1 0
U2 17
PU TOHOKU UNIV MEDICAL PRESS
PI SENDAI
PA 2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN
SN 0040-8727
EI 1349-3329
J9 TOHOKU J EXP MED
JI Tohoku J. Exp. Med.
PD JUL
PY 2015
VL 236
IS 3
BP 225
EP 232
DI 10.1620/tjem.236.225
PG 8
WC Medicine, General & Internal; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Research & Experimental Medicine
GA CO0ER
UT WOS:000358823400009
PM 26118651
OA gold
DA 2024-11-01
ER

PT J
AU Tranchant, C
   Anheim, M
AF Tranchant, C.
   Anheim, M.
TI Movement disorders in mitochondrial diseases
SO REVUE NEUROLOGIQUE
LA English
DT Article
DE Movement disorders; Mitochondrial diseases; Ataxia; Dystonia;
   Parkinsonism; Myoclonus
ID ONSET SPINOCEREBELLAR ATAXIA; OPTIC NEUROPATHY; EXTERNAL
   OPHTHALMOPLEGIA; FAMILIAL PARKINSONISM; POLYMERASE-GAMMA; SPASTIC
   ATAXIA; LEIGH-SYNDROME; LEBERS PLUS; MUTATIONS; NEURODEGENERATION
AB Mitochondrial diseases (MIDs) are a large group of heterogeneous disorders due to mutations in either mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) genes, the latter encoding proteins involved in mitochondrial function. A multisystem clinical picture that involves several organs, including both the peripheral and central nervous systems, is a common presentation of MID. Movement disorders, even isolated ones, are not rare. Cerebellar ataxia is common in myoclonic epilepsy with ragged red fibers (MERFF) due to mutations in the mitochondrial transfer RNA (tRNA) lysine gene, in Kearns-Sayre syndrome due to mtDNA deletions, in sensory ataxic neuropathy with dysarthria and ophthalmoplegia (SANDO) due to nuclear POLG1 gene mutations, and also in ARCA2, Friedreich's ataxia, SPG7, SCA28 and autosomal-recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) due to mutations in nuclear genes involved in mitochondrial morphology or function. Myoclonus is a key feature of MERFF, but may also be encountered in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), ARCA2, POLG1 mutations and Leigh syndrome. Dystonia is common in Leigh syndrome (which may be caused by 75 different genes) and in Leber hereditary ocular neuropathy (LHON) plus disease, due to mutations in mtDNA genes that encode subunits of NADH dehydrogenase, as well as in ARCA2, pantothenate kinase-associated neurodegeneration (PECAN), mitochondrial membrane protein associated neurodegeneration (MPAN) and POLG1 mutations. Other movement disorders are rarer (such as parkinsonism, tremor, chorea). Although parkinsonism is more frequent in POLG1 mutations, and myoclonus in MERFF, most movement disorders are found either isolated or combined in numerous MIDs. The presence of associated neurological signs, whether central or peripheral, or of evocative magnetic resonance imaging (MRI) abnormalities (striatal necrosis) should prompt a search for MID. In cases of a particular clinical spectrum (LHON, MERFF, Kearns-Sayre, SANDO, SPG7, ARCA2, ARSACS), a search for the most frequently implicated mutation(s) is recommended. In other cases, muscle biopsies followed by metabolic and genetic studies may be useful for arriving at a diagnosis. (C) 2016 Elsevier Masson SAS. All rights reserved.
C1 [Tranchant, C.; Anheim, M.] Hop Hautepierre, Serv Neurol, 1 Ave Moliere, F-67000 Strasbourg, France.
   [Tranchant, C.; Anheim, M.] Federat Med Translat, F-67000 Strasbourg, France.
C3 Universites de Strasbourg Etablissements Associes; Universite de
   Strasbourg; CHU Strasbourg
RP Tranchant, C (corresponding author), Hop Hautepierre, Serv Neurol, 1 Ave Moliere, F-67000 Strasbourg, France.
EM christine.tranchant@chru-strasbourg.fr
RI Christine, Tranchant-Dubreuil/JAC-6513-2023
OI tranchant, christine/0000-0002-2895-1292; Anheim,
   Mathieu/0000-0001-8121-0605
CR Anheim M, 2012, NEW ENGL J MED, V366, P636, DOI 10.1056/NEJMra1006610
   Auré K, 2007, REV NEUROL-FRANCE, V163, P254, DOI 10.1016/S0035-3787(07)90400-2
   Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Caer M, 2005, MOVEMENT DISORD, V20, P490, DOI 10.1002/mds.20363
   Chandra SR, 2015, J PEDIATR NEUROSCI, V10, P254, DOI 10.4103/1817-1745.165683
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Dermaut B, 2010, J NEUROL NEUROSUR PS, V81, P90, DOI 10.1136/jnnp.2008.157354
   Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544
   Dündar H, 2012, PEDIATR NEUROL, V46, P172, DOI 10.1016/j.pediatrneurol.2011.12.006
   Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206
   Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769
   Engl G, 2012, HUM MOL GENET, V21, P287, DOI 10.1093/hmg/ddr458
   Finsterer J, 2002, ACTA NEUROL SCAND, V105, P384, DOI 10.1034/j.1600-0404.2002.01221.x
   Finsterer J, 2011, MOVEMENT DISORD, V26, P784, DOI 10.1002/mds.23651
   Finsterer J, 2009, CAN J NEUROL SCI, V36, P543, DOI 10.1017/S0317167100008027
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Garcia-Martin E, 2013, BRIT J OPHTHALMOL, V97, P238, DOI 10.1136/bjophthalmol-2012-302309
   Gautier CA, 2014, REV NEUROL-FRANCE, V170, P339, DOI 10.1016/j.neurol.2013.06.003
   Hartig MB, 2011, AM J HUM GENET, V89, P543, DOI 10.1016/j.ajhg.2011.09.007
   Hayflick SJ, 2003, NEW ENGL J MED, V348, P33, DOI 10.1056/NEJMoa020817
   Hayflick SJ, 2013, BRAIN, V136, P1708, DOI 10.1093/brain/awt095
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Hörtnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Klebe S, 2012, BRAIN, V135, P2980, DOI 10.1093/brain/aws240
   Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06
   KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507
   La Morgia C, 2008, NEUROLOGY, V70, P762, DOI 10.1212/01.wnl.0000295505.74234.d0
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lecocq C, 2016, MOVEMENT DISORD, V31, P62, DOI 10.1002/mds.26382
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Martin MH, 2007, AM J NEURORADIOL, V28, P1606, DOI 10.3174/ajnr.A0603
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Mignot C, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-173
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   Pfeffer G, 2015, NEUROLOGY, V84, P1174, DOI 10.1212/WNL.0000000000001369
   Pierian TM, 2011, PLOS GENET
   Pilliod J, 2015, ANN NEUROL, V78, P871, DOI 10.1002/ana.24509
   Puccio H, 2014, REV NEUROL-FRANCE, V170, P355, DOI 10.1016/j.neurol.2014.03.008
   Saracchi E, 2013, NEUROL SCI, V34, P407, DOI 10.1007/s10072-012-1013-1
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Sidiropoulos C, 2013, NEUROLOGY, V81, P197, DOI 10.1212/WNL.0b013e31829a3438
   Synofzik M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-41
   Thobois S, 1997, REV NEUROL, V153, P595
   Thomas M, 2004, MOVEMENT DISORD, V19, P36, DOI 10.1002/mds.10650
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Yang SY, 2007, MOL GENET METAB, V92, P36, DOI 10.1016/j.ymgme.2007.06.001
NR 59
TC 40
Z9 42
U1 1
U2 16
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0035-3787
EI 2213-0004
J9 REV NEUROL-FRANCE
JI Rev. Neurol.
PD AUG-SEP
PY 2016
VL 172
IS 8-9
BP 524
EP 529
DI 10.1016/j.neurol.2016.07.003
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA EA5FY
UT WOS:000386646000014
PM 27476418
DA 2024-11-01
ER

PT J
AU Castellani, CA
   Longchamps, RJ
   Sun, J
   Guallar, E
   Arking, DE
AF Castellani, Christina A.
   Longchamps, Ryan J.
   Sun, Jing
   Guallar, Eliseo
   Arking, Dan E.
TI Thinking outside the nucleus: Mitochondrial DNA copy number in health
   and disease
SO MITOCHONDRION
LA English
DT Review
DE mitochondrial DNA; Clinical biomarker; mtDNA; Complex disease
ID PERIPHERAL-BLOOD; EPIGENETIC REGULATION; ASSOCIATION; CANCER;
   INFLAMMATION; MTDNA; DEPLETION; MUSCLE; CELLS; QUANTIFICATION
AB Mitochondrial DNA copy number (mtDNA-CN) is a biomarker of mitochondrial function and levels of mtDNA-CN have been reproducibly associated with overall mortality and a number of age-related diseases, including cardiovascular disease, chronic kidney disease, and cancer. Recent advancements in techniques for estimating mtDNA-CN, in particular the use of DNA microarrays and next-generation sequencing data, have led to the comprehensive assessment of mtDNA-CN across these and other diseases and traits. The importance of mtDNA-CN measures to disease and these advancing technologies suggest the potential for mtDNA-CN to be a useful biomarker in the clinic. While the exact mechanism(s) underlying the association of mtDNA-CN with disease remain to be elucidated, we review the existing literature which supports roles for inflammatory dynamics, immune function and alterations to cell signaling as consequences of variation in mtDNA-CN. We propose that future studies should focus on characterizing longitudinal, cell-type and cross-tissue profiles of mtDNA-CN as well as improving methods for measuring mtDNA-CN which will expand the potential for its use as a clinical biomarker.
C1 [Castellani, Christina A.; Longchamps, Ryan J.; Arking, Dan E.] Johns Hopkins Univ, Sch Med, McKusick Nathans Dept Genet Med, Baltimore, MD USA.
   [Sun, Jing; Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA.
C3 Johns Hopkins University; Johns Hopkins University; Johns Hopkins
   Bloomberg School of Public Health; Johns Hopkins University; Johns
   Hopkins Bloomberg School of Public Health
RP Arking, DE (corresponding author), Johns Hopkins Univ, Sch Med, 733 North Broadway,MRB Room 459, Baltimore, MD 21205 USA.
EM arking@jhmi.edu
FU US National Institutes of Health [R01HL131573, R01HL14469]
FX We wish to thank Stephanie Y Yang, ThuyVy Duong, and Adrienne Tin for
   their thorough contributions and editing of this review. This work was
   supported by the US National Institutes of Health [grant numbers:
   R01HL131573, R01HL14469].
CR Aggarwal NT, 2013, ANTIOXID REDOX SIGN, V18, P432, DOI 10.1089/ars.2011.4234
   Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6
   Bianco Angelica, 2018, BMC Res Notes, V11, P911, DOI 10.1186/s13104-018-4025-y
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1821-7
   Cai N, 2015, CURR BIOL, V25, P3170, DOI 10.1016/j.cub.2015.10.065
   Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen SY, 2014, ATHEROSCLEROSIS, V237, P220, DOI 10.1016/j.atherosclerosis.2014.08.051
   Chen T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-8
   Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723
   Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082
   CLAYTON DA, 1992, INT REV CYTOL, V141, P217, DOI 10.1016/S0074-7696(08)62067-7
   Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450
   Czaja AJ, 2014, WORLD J GASTROENTERO, V20, P2515, DOI 10.3748/wjg.v20.i10.2515
   Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Ding J, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005306, 10.1371/journal.pgen.1005549]
   Eirin A, 2016, HYPERTENSION, V68, P401, DOI 10.1161/HYPERTENSIONAHA.116.07849
   Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008
   Fazzini F, 2019, KIDNEY INT, V96, P480, DOI 10.1016/j.kint.2019.04.021
   Friis RMN, 2014, CELL REP, V7, P565, DOI 10.1016/j.celrep.2014.03.029
   Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010
   Gasparre G, 2011, BBA-BIOENERGETICS, V1807, P633, DOI 10.1016/j.bbabio.2010.08.006
   Ghosh S, 2014, MITOCHONDRION, V18, P58, DOI 10.1016/j.mito.2014.07.007
   Goudenège D, 2019, GENET MED, V21, P1407, DOI 10.1038/s41436-018-0350-8
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Gu F, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.68
   Guha M, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.45
   Guha M, 2013, MITOCHONDRION, V13, P577, DOI 10.1016/j.mito.2013.08.007
   Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003
   Guyatt AL, 2018, MITOCHONDRION, V39, P9, DOI 10.1016/j.mito.2017.08.007
   Hertweck KL, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00262
   Hurtado-Roca Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163770
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973
   Jedrak P, 2017, METAB BRAIN DIS, V32, P1237, DOI 10.1007/s11011-017-0026-0
   Jeng JY, 2008, J CELL BIOCHEM, V103, P347, DOI 10.1002/jcb.21625
   Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935
   Kamfar S, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.40774
   Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770
   Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   Li B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29621-1
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Liu LP, 2017, ATHEROSCLEROSIS, V261, P105, DOI 10.1016/j.atherosclerosis.2017.02.013
   Liu M, 2010, CIRC RES, V107, P967, DOI 10.1161/CIRCRESAHA.110.220673
   Lo IC, 2005, J BIOMED SCI, V12, P377, DOI 10.1007/s11373-005-1703-2
   Longchamps RJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228166
   Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Mei H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.78
   Memon Ashfaque A, 2017, Biomol Detect Quantif, V13, P32, DOI 10.1016/j.bdq.2017.08.001
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Mizumachi T, 2008, PROSTATE, V68, P408, DOI 10.1002/pros.20697
   Morgan JT, 2012, BRAIN RES, V1456, P72, DOI 10.1016/j.brainres.2012.03.036
   Muir R, 2016, BIOESSAYS, V38, P150, DOI 10.1002/bies.201500105
   Nacheva E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180467
   Neeland IJ, 2012, AM HEART J, V164, P547, DOI 10.1016/j.ahj.2012.07.007
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nicolson GL, 2014, INTEGR MED CLIN J, V13, P35
   O'Hara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119
   Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303
   Phillips NR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03887
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Pirola CJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001480
   Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033
   Qian Y, 2017, BIOINFORMATICS, V33, P1399, DOI 10.1093/bioinformatics/btw835
   Raffoul Julian J, 2012, J Oncol, V2012, P370481
   Ramos ES, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008085
   Ravi S, 2014, INT J BIOCHEM CELL B, V53, P202, DOI 10.1016/j.biocel.2014.05.019
   Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769
   Rodriguez Juan I, 2011, Neuron Glia Biol, V7, P205, DOI 10.1017/S1740925X12000142
   Rodríguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698
   Rygiel KA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09906
   Sánchez-Santos A, 2018, MOL REPROD DEV, V85, P303, DOI 10.1002/mrd.22965
   Savagner F, 2001, J CLIN ENDOCR METAB, V86, P4920, DOI 10.1210/jc.86.10.4920
   Silverstein DM, 2009, PEDIATR NEPHROL, V24, P1445, DOI 10.1007/s00467-008-1046-0
   Sookoian S, 2010, HEPATOLOGY, V52, P1992, DOI 10.1002/hep.23927
   Srinivasan S, 2016, ONCOGENE, V35, P1585, DOI 10.1038/onc.2015.227
   Sun J, 2019, J INFECT DIS, V219, P1285, DOI 10.1093/infdis/jiy658
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thyagarajan B, 2012, CANCER EPIDEM BIOMAR, V21, P1574, DOI 10.1158/1055-9965.EPI-12-0138-T
   Tidwell TR, 2017, AGING DIS, V8, P662, DOI 10.14336/AD.2017.0713
   Tin A, 2016, J AM SOC NEPHROL, V27, P2467, DOI 10.1681/ASN.2015060661
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Vakifahmetoglu-Norberg H, 2017, BIOCHEM BIOPH RES CO, V482, P426, DOI 10.1016/j.bbrc.2016.11.088
   Vats D, 2006, CELL METAB, V4, P255, DOI 10.1016/j.cmet.2006.08.006
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wei PZ, 2018, NEPHROL DIAL TRANSPL, V33, P784, DOI 10.1093/ndt/gfx339
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-016-0404-6
   Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW64, DOI 10.1093/nar/gkw247
   Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213
   Yamada T, 2016, TRENDS BIOCHEM SCI, V41, P209, DOI 10.1016/j.tibs.2016.02.001
   Ye W, 2017, ANAL BIOANAL CHEM, V409, P2727, DOI 10.1007/s00216-017-0217-x
   Young MJ, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00074
   Yu EPK, 2014, TRENDS ENDOCRIN MET, V25, P481, DOI 10.1016/j.tem.2014.06.008
   Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Zhang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105242
   Zhang YY, 2017, EUR HEART J, V38, P3443, DOI 10.1093/eurheartj/ehx354
   Zhang YH, 2017, MITOCHONDRIAL DNA A, V28, P725, DOI 10.1080/24701394.2016.1177038
NR 109
TC 180
Z9 189
U1 4
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL
PY 2020
VL 53
BP 214
EP 223
DI 10.1016/j.mito.2020.06.004
PG 10
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA MO6RS
UT WOS:000551651100023
PM 32544465
OA hybrid, Green Accepted
DA 2024-11-01
ER

PT J
AU Pinós, T
   Marotta, M
   Gallardo, E
   Illa, I
   Díaz-Manera, J
   Gonzalez-Vioque, E
   García-Arumí, E
   Andreu, AL
   Martí, R
AF Pinos, Tomas
   Marotta, Mario
   Gallardo, Eduard
   Illa, Isabel
   Diaz-Manera, Jorge
   Gonzalez-Vioque, Emiliano
   Garcia-Arumi, Elena
   Andreu, Antoni L.
   Marti, Ramon
TI A novel mutation in the mitochondrial tRNA<SUP>Ala</SUP> gene
   (m.5636T&gt;C) in a patient with progressive external ophthalmoplegia
SO MITOCHONDRION
LA English
DT Article
DE Mitochondria; PEO; mt-tRNA(Ala); Laser capture microdissection
ID DNA DELETIONS
AB We report a heteroplasmic novel mutation m.5636T>C in the mt-tRNA(Ala) in a patient with bilateral ptosis and ophthalmoparesis in whom a muscle biopsy showed cytochrome c oxdidase (COX) negative and ragged red fibers. Using laser capture microdissection we have isolated COX negative fibers and COX positive fibers from the muscle of the patient and determined that the mutation load was clearly increased in COX negative muscle fibers. Additionally, the mutated m.5636T nucleotide is conserved in all the mammal and non-mammal species analyzed and might be structurally relevant as it is located in a position involved in the formation of tertiary structure of canonical mitochondrial tRNAs. (C) 2010 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Pinos, Tomas; Gonzalez-Vioque, Emiliano; Garcia-Arumi, Elena; Andreu, Antoni L.; Marti, Ramon] Univ Autonoma Barcelona, Unitat Patol Mitocondrial & Neuromuscular, Inst Recerca Hosp Univ Vall dHebron, E-08193 Barcelona, Spain.
   [Marotta, Mario] Univ Autonoma Barcelona, Lab Neurol Infantil, Inst Recerca Hosp Univ Vall dHebron, E-08193 Barcelona, Spain.
   [Gallardo, Eduard; Illa, Isabel; Diaz-Manera, Jorge] Hosp Santa Creu & Sant Pau, Serv Neurol, Barcelona, Spain.
   [Gallardo, Eduard; Illa, Isabel; Diaz-Manera, Jorge] CIBERNED, Barcelona, Spain.
C3 Autonomous University of Barcelona; Autonomous University of Barcelona;
   Hospital of Santa Creu i Sant Pau; CIBERNED
RP Martí, R (corresponding author), Inst Recerca Hosp Univ dHebron, Unitat Patol Mitocondrial & Neuromuscular, Pg Vall dHebron 119-129, Barcelona 08035, Spain.
EM tpinos@ir.vhebron.net; mmarotta@ir.vhebron.net; EGallardo@santpau.cat;
   iilla@santpau.cat; JdiazM@santpau.cat; emigonza@ir.vhebron.net;
   aandreu@ir.vhebron.net; rmarti@ir.vhebron.net
RI ILLA, Isabel/AAD-1816-2019; Martí, Ramon/Q-3442-2016; Garcia-Arumi,
   Elena/ABH-4229-2020; Marotta, Mario/R-9030-2019
OI Gallardo, Eduard/0000-0002-3942-3436; Gonzalez Vioque,
   Emiliano/0000-0001-7279-4311; Garcia-Arumi, Elena/0000-0003-0096-3336;
   Marotta, Mario/0000-0003-4933-0572; Marti, Ramon/0000-0002-8273-9540;
   ANDREU, antonio luis/0000-0002-3936-3234; Diaz-Manera,
   Jordi/0000-0003-2941-7988
FU Spanish Institut de Salud Carlos III [PI07/0347, PI08/90355, PS09/01602]
FX This work has been supported by the Spanish Institut de Salud Carlos III
   (PI07/0347; PI08/90355; PS09/01602). We would like to thank Michael
   Terry for his English Language assistance.
CR Borthwick Gillian M, 2006, Ann Neurol, V59, P570, DOI 10.1002/ana.20758
   Chinnery PF, 1997, NEUROLOGY, V49, P1166, DOI 10.1212/WNL.49.4.1166
   Di Mauro S., 2004, MYOLOGY PHILADELPHIA, P1623
   Dubowitz C., 2007, MUSCLE BIOPSY PRACTI, V3rd
   Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Marotta M, 2007, NEUROMUSCULAR DISORD, V17, P707, DOI 10.1016/j.nmd.2007.05.007
   Messmer M, 2009, NUCLEIC ACIDS RES, V37, P6881, DOI 10.1093/nar/gkp697
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   Pulkes T, 2003, NEUROLOGY, V61, P1144, DOI 10.1212/01.WNL.0000090465.27024.3D
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   SEIBEL P, 1994, BIOCHEM BIOPH RES CO, V204, P482, DOI 10.1006/bbrc.1994.2485
   Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
NR 22
TC 9
Z9 10
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN
PY 2011
VL 11
IS 1
BP 228
EP 233
DI 10.1016/j.mito.2010.08.008
PG 6
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 709OP
UT WOS:000286450300031
PM 20813205
DA 2024-11-01
ER

PT J
AU Parsons, T
   Weimer, L
   Engelstad, K
   Linker, A
   Battista, V
   Wei, Y
   Hirano, M
   DiMauro, S
   De Vivo, DC
   Kaufmann, P
AF Parsons, Timothy
   Weimer, Louis
   Engelstad, Kristin
   Linker, Alex
   Battista, Vanessa
   Wei, Ying
   Hirano, Michio
   DiMauro, Salvatore
   De Vivo, Darryl C.
   Kaufmann, Petra
TI Autonomic Symptoms in Carriers of the m.3243A&gt;G Mitochondrial DNA
   Mutation
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID QUALITY-OF-LIFE; A3243G MUTATION; MELAS; FEATURES; 3243A-GREATER-THAN-G;
   ENCEPHALOMYOPATHIES; IMPAIRMENT
AB Background: The m.3243A>G mutation can cause multisystem medical problems and can affect the autonomic nervous system.
   Objective: To study the frequency and spectrum of autonomic symptoms associated with the m.3243A>G mitochondrial DNA point mutation.
   Design, Setting, and Patients: We studied a cohort of 88 matrilineal relatives from 40 families, including 35 fully symptomatic patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS), 53 carrier relatives, and 16 controls using a questionnaire based on existing standard instruments for the evaluation of autonomic dysfunction. We compared the questionnaire with an expert evaluation. We compared data among the 3 groups using the Mantel-Haenszel chi(2) test to determine the statistical significance of differences between groups.
   Results: Mutation carriers frequently had symptoms of autonomic dysfunction, specifically gastrointestinal and orthostatic intolerance.
   Conclusions: Carriers of the m.3243A>G mutation have frequent autonomic symptoms. The m.3243A>G mutation should be considered as an etiological factor in patients with autonomic dysfunction and a medical or family history suggestive of mitochondrial disease. Because some autonomic symptoms are treatable, early detection and proactive management may mitigate the burden of morbidity.
C1 [Parsons, Timothy; Weimer, Louis; Engelstad, Kristin; Battista, Vanessa; Hirano, Michio; DiMauro, Salvatore; De Vivo, Darryl C.; Kaufmann, Petra] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
   [Wei, Ying] Columbia Univ, Med Ctr, Dept Biostat, New York, NY 10032 USA.
   [De Vivo, Darryl C.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA.
   [Linker, Alex] Columbia Univ, Med Ctr, Coll Phys & Surg, New York, NY 10032 USA.
C3 Columbia University; Columbia University; Columbia University; Columbia
   University
RP Kaufmann, P (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, 710 168th St, New York, NY 10032 USA.
EM pk88@columbia.edu
OI Parsons, Timothy/0000-0001-9088-1929
FU National Institute of Child Health and Human Development [PO1-HD32062];
   National Center for Research Resources [1 UL1 RR024156]; Irving Research
   Scholar Award; Marriott Mitochondrial Disorder Clinical Research Fund;
   Colleen Giblin Foundation
FX This work was supported by grant PO1-HD32062 from the National Institute
   of Child Health and Human Development (Drs DiMauro, De Vivo, and
   Kaufmann), Clinical and Translational Science Award 1 UL1 RR024156 from
   the National Center for Research Resources, the Irving Research Scholar
   Award (Dr Kaufmann), the Marriott Mitochondrial Disorder Clinical
   Research Fund (Drs Hirano and DiMauro), and the Colleen Giblin
   Foundation (Dr De Vivo).
CR Benrud-Larson LM, 2002, MAYO CLIN PROC, V77, P531, DOI 10.4065/77.6.531
   BIGGER JT, 1992, CIRCULATION, V85, P164, DOI 10.1161/01.CIR.85.1.164
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Di Leo R, 2007, J NEUROL, V254, P1498, DOI 10.1007/s00415-007-0536-5
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   MANTEL N, 1959, JNCI-J NATL CANCER I, V22, P719
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Suarez GA, 1999, NEUROLOGY, V52, P523, DOI 10.1212/WNL.52.3.523
   van den Berg MP, 2001, EUR HEART J, V22, P247, DOI 10.1053/euhj.2001.2180
   Zelnik N, 1996, PEDIATR NEUROL, V14, P251, DOI 10.1016/0887-8994(96)00046-X
NR 16
TC 20
Z9 26
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60654-0946 USA
SN 0003-9942
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD AUG
PY 2010
VL 67
IS 8
BP 976
EP 979
PG 4
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 637HU
UT WOS:000280809000010
PM 20697048
OA Bronze, Green Accepted
DA 2024-11-01
ER

PT J
AU Limongelli, A
   Schaefer, J
   Jackson, S
   Invernizzi, F
   Kirino, Y
   Suzuki, T
   Reichmann, H
   Zeviani, M
AF Limongelli, A
   Schaefer, J
   Jackson, S
   Invernizzi, F
   Kirino, Y
   Suzuki, T
   Reichmann, H
   Zeviani, M
TI Variable penetrance of a familial progressive necrotising encephalopathy
   due to a novel tRNA<SUP>ile</SUP> homoplasmic mutation in the
   mitochondrial genome
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID CYTOCHROME-C-OXIDASE; DNA; MTDNA; TRANSLATION; DELETIONS; CELLS
AB Introduction: We present a family comprising a clinically normal mother and two daughters, each with severe encephalopathy with onset in late childhood. A third daughter had died previously of an earlier onset but neuropathologically similar disease.
   Methods: Sequence analysis of the entire mtDNA was carried out in muscle, fibroblasts, and lymphocytes of the affected daughters and unaffected mother. Biochemical analysis of individual respiratory chain enzymes was performed on the same tissues, and on several transmitochondrial cybrid clones containing the nucleus of a 143B.206 osteosarcoma cell line and the mutant mtDNA.
   Results: Genetic analyses revealed in both daughters and mother the presence of a novel mutation in the tRNAIle gene of mtDNA, which was homoplasmic in fibroblasts, lymphocytes, and skeletal muscle of the two patients. It was also homoplasmic in fibroblast and skeletal muscle samples of the mother, and approximately 97% heteroplasmic in her lymphocytes. Combined defects of complexes I and IV of the mitochondrial respiratory chain were found not only in fibroblasts of the two probands, but surprisingly also in those of their clinically unaffected mother. The respiratory chain defect segregated in transmitochondrial cybrids containing the nucleus of a 143B.206 osteosarcoma cell line and the mutant mtDNA, indicating that the latter was responsible for the biochemical phenotype.
   Discussion: Our results support the concept that homoplasmic mutations in tRNA genes can be responsible for mitochondrial disorders characterised by extremely variable penetrance. Albeit still unexplained, this phenomenon has important consequences in the nosological characterisation, clinical management, and genetic counselling of mitochondrial disorders.
C1 Natl Neurol Inst Carlo Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, I-20133 Milan, Italy.
   Tech Univ Dresden, Sch Med, Neurol Clin, D-8027 Dresden, Germany.
   Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Tokyo, Japan.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; Technische
   Universitat Dresden; University of Tokyo
RP Natl Neurol Inst Carlo Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, Via Temolo 4, I-20133 Milan, Italy.
EM zeviani@tin.it
RI Zeviani, Massimo/K-2891-2014; Invernizzi, Federica/J-9849-2016; Suzuki,
   Tsutomu/J-1776-2015
OI Kirino, Yohei/0000-0001-5232-4742; Zeviani, Massimo/0000-0002-9067-5508;
   Invernizzi, Federica/0000-0001-8072-0152; Suzuki,
   Tsutomu/0000-0002-9731-1731
FU Telethon [GGP030039] Funding Source: Medline
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1997, QJM-INT J MED, V90, P657, DOI 10.1093/qjmed/90.11.657
   Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   Darley-Usmar V.M., 1987, MITOCHONDRIA PRACTIC
   DiMauro S, 1996, ANN NEUROL, V40, P5, DOI 10.1002/ana.410400104
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Hutchin TP, 2000, CELL MOL LIFE SCI, V57, P1927, DOI 10.1007/PL00000673
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Maassen JA, 2002, AM J MED GENET, V115, P66, DOI 10.1002/ajmg.10346
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Munaro M, 1997, HUM MOL GENET, V6, P221, DOI 10.1093/hmg/6.2.221
   Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Sasarman F, 2002, HUM MOL GENET, V11, P1669, DOI 10.1093/hmg/11.14.1669
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Taanman JW, 1996, BBA-MOL BASIS DIS, V1315, P199, DOI 10.1016/0925-4439(95)00127-1
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511
   Vu TH, 2002, NEUROL CLIN, V20, P809, DOI 10.1016/S0733-8619(01)00017-2
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 31
TC 42
Z9 44
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD MAY
PY 2004
VL 41
IS 5
BP 342
EP 349
DI 10.1136/jmg.2003.016048
PG 8
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 817GI
UT WOS:000221165600005
PM 15121771
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU La Morgia, C
   Achilli, A
   Iommarini, L
   Barboni, P
   Pala, M
   Olivieri, A
   Zanna, C
   Vidoni, S
   Tonon, C
   Lodi, R
   Vetrugno, R
   Mostacci, B
   Liguori, R
   Carroccia, R
   Montagna, P
   Rugolo, M
   Torroni, A
   Carelli, V
AF La Morgia, C.
   Achilli, A.
   Iommarini, L.
   Barboni, P.
   Pala, M.
   Olivieri, A.
   Zanna, C.
   Vidoni, S.
   Tonon, C.
   Lodi, R.
   Vetrugno, R.
   Mostacci, B.
   Liguori, R.
   Carroccia, R.
   Montagna, P.
   Rugolo, M.
   Torroni, A.
   Carelli, V.
TI Rare mtDNA variants in Leber hereditary optic neuropathy families with
   recurrence of myoclonus
SO NEUROLOGY
LA English
DT Article
ID MITOCHONDRIAL-DNA MUTATION; COMPLEX-I DEFICIENCY; MISSENSE MUTATION;
   GENE; DYSTONIA; DISEASE; MUSCLE; MELAS; MANIFESTATION; INVOLVEMENT
AB Objective: To investigate the mechanisms underlying myoclonus in Leber hereditary optic neuropathy (LHON).
   Methods: Five patients and one unaffected carrier from two Italian families bearing the homoplasmic 11778/ND4 and 3460/ND1 mutations underwent a uniform investigation including neurophysiologic studies, muscle biopsy, serum lactic acid after exercise, and muscle (P-31) and cerebral (H-1) magnetic resonance spectroscopy (MRS). Biochemical investigations on fibroblasts and complete mitochondrial DNA (mtDNA) sequences of both families were also performed.
   Results: All six individuals had myoclonus. In spite of a normal EEG background and the absence of giant SEPs and C reflex, EEG-EMG back-averaging showed a preceding jerk-locked EEG potential, consistent with a cortical generator of the myoclonus. Specific comorbidities in the 11778/ND4 family included muscular cramps and psychiatric disorders, whereas features common to both families were migraine and cardiologic abnormalities. Signs of mitochondrial proliferation were seen in muscle biopsies and lactic acid elevation was observed in four of six patients. P-31-MRS was abnormal in five of six patients and H-1-MRS showed ventricular accumulation of lactic acid in three of six patients. Fibroblast ATP depletion was evident at 48 hours incubation with galactose in LHON/myoclonus patients. Sequence analysis revealed haplogroup T2 (11778/ND4 family) and U4a (3460/ND1 family) mtDNAs. A functional role for the non-synonymous 4136A>G/ND1, 9139G>A/ATPase6, and 15773G>A/cyt b variants was supported by amino acid conservation analysis.
   Conclusions: Myoclonus and other comorbidities characterized our Leber hereditary optic neuropathy (LHON) families. Functional investigations disclosed a bioenergetic impairment in all individuals. Our sequence analysis suggests that the LHON plus phenotype in our cases may relate to the synergic role of mtDNA variants.
C1 [La Morgia, C.; Iommarini, L.; Vetrugno, R.; Mostacci, B.; Liguori, R.; Montagna, P.; Carelli, V.] Univ Bologna, Dipartimento Sci Neurol, I-40123 Bologna, Italy.
   [Zanna, C.; Vidoni, S.; Rugolo, M.] Univ Bologna, Dipartimento Biol Evoluz Sperimentale, I-40123 Bologna, Italy.
   [Tonon, C.; Lodi, R.] Univ Bologna, Dipartimento Med Clin & Biotecnol Appl, I-40123 Bologna, Italy.
   [Zanna, C.; Vidoni, S.; Rugolo, M.] Univ Pavia, Dipartimento Genet & Microbiol, Bologna, Italy.
   [Achilli, A.; Pala, M.; Olivieri, A.; Torroni, A.] Ctr Oftalmol Salus, Bologna, Italy.
C3 University of Bologna; University of Bologna; University of Bologna;
   University of Pavia
RP La Morgia, C (corresponding author), Univ Bologna, Dipartimento Sci Neurol, Via Ugo Foscolo 7, I-40123 Bologna, Italy.
EM valerio.carelli@unibo.it
RI Rugolo, Michela/AAY-8640-2020; Lodi, Raffaele/K-4984-2016; Torroni,
   Antonio/E-1557-2011; Mostacci, Barbara/AAB-7585-2022; La Morgia,
   Chiara/H-6765-2012; Liguori, Rocco/AAB-7860-2020; Zanna,
   Claudia/GVT-1932-2022; Tonon, Caterina/K-6680-2016; Achilli,
   Alessandro/I-9236-2012; Barboni, Piero/AAA-9936-2020; Iommarini,
   Luisa/J-2328-2018; OLIVIERI, ANNA/I-9235-2012
OI Torroni, Antonio/0000-0002-4163-4478; Mostacci,
   Barbara/0000-0002-6994-0821; Lodi, Raffaele/0000-0003-3878-304X;
   Liguori, Rocco/0000-0002-1815-1013; TONON, CATERINA/0000-0002-0506-499X;
   CARELLI, VALERIO/0000-0003-4923-6404; Achilli,
   Alessandro/0000-0001-6871-3451; Rugolo, Michela/0000-0002-4597-0452;
   Barboni, Piero/0000-0002-0118-4177; Iommarini,
   Luisa/0000-0002-6804-7302; LA MORGIA, Chiara/0000-0002-4639-8929; Pala,
   Maria/0000-0001-9202-8331; OLIVIERI, ANNA/0000-0002-3941-8098
FU Telethon [GGP06233] Funding Source: Medline
CR Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590
   Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Brown P, 2000, PROG NEUROBIOL, V60, P97, DOI 10.1016/S0301-0082(99)00029-5
   Brown P, 1999, BRAIN, V122, P461, DOI 10.1093/brain/122.3.461
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2001, J NEUROL NEUROSUR PS, V71, P813, DOI 10.1136/jnnp.71.6.813
   Crimi M, 2003, NEUROLOGY, V60, P1857, DOI 10.1212/01.WNL.0000066048.72780.69
   Cupini LM, 2003, NEUROLOGY, V60, P717, DOI 10.1212/01.WNL.0000048662.77572.FB
   DeVries DD, 1996, AM J HUM GENET, V58, P703
   DIEHL GE, 1990, LARYNGO RHINO OTOL, V69, P369, DOI 10.1055/s-2007-998210
   DiMauro S, 1998, BBA-BIOENERGETICS, V1366, P199, DOI 10.1016/S0005-2728(98)00113-3
   Esteitie N, 2005, ANN NEUROL, V58, P544, DOI 10.1002/ana.20570
   FUNAKAWA I, 1995, J NEUROL, V242, P75, DOI 10.1007/BF00887819
   Funalot B, 2002, ANN NEUROL, V52, P374, DOI 10.1002/ana.10299
   GHELLI A, 1994, THESIS U BOLOGNA
   Giordano C, 2006, GASTROENTEROLOGY, V130, P893, DOI 10.1053/j.gastro.2006.01.004
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   Howell N, 2002, J NEURO-OPHTHALMOL, V22, P262, DOI 10.1097/00041327-200212000-00002
   HOWELL N, 1991, AM J HUM GENET, V48, P935
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901
   LARSSON NG, 1991, ANN NEUROL, V30, P701, DOI 10.1002/ana.410300511
   Lodi R, 2002, J NEUROL NEUROSUR PS, V72, P805, DOI 10.1136/jnnp.72.6.805
   NEWMAN NJ, 2005, HOYTS CLIN NEURO OPH, P466
   NIKOSKELAINEN E, 1985, LANCET, V1, P696
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   NOVOTNY EJ, 1986, NEUROLOGY, V36, P1053, DOI 10.1212/WNL.36.8.1053
   PAULUS W, 1993, J NEUROL, V240, P251, DOI 10.1007/BF00818714
   Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493
   Shibasaki H, 2000, MUSCLE NERVE, V23, P321, DOI 10.1002/(SICI)1097-4598(200003)23:3<321::AID-MUS3>3.3.CO;2-V
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121
   Zanna C, 2005, APOPTOSIS, V10, P997, DOI 10.1007/s10495-005-0742-5
NR 44
TC 56
Z9 60
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD MAR 4
PY 2008
VL 70
IS 10
BP 762
EP 770
PG 9
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 271GE
UT WOS:000253776100005
PM 18216301
DA 2024-11-01
ER

PT J
AU Piekutowska-Abramczuk, D
   Pronicki, M
   Strawa, K
   Karkucinska-Wieckowska, A
   Szymanska-Debinska, T
   Fidzianska, A
   Wieckowski, MR
   Jurkiewicz, D
   Ciara, E
   Jankowska, I
   Sykut-Cegielska, J
   Krajewska-Walasek, M
   Ploski, R
   Pronicka, E
AF Piekutowska-Abramczuk, D.
   Pronicki, M.
   Strawa, K.
   Karkucinska-Wieckowska, A.
   Szymanska-Debinska, T.
   Fidzianska, A.
   Wieckowski, M. R.
   Jurkiewicz, D.
   Ciara, E.
   Jankowska, I.
   Sykut-Cegielska, J.
   Krajewska-Walasek, M.
   Ploski, R.
   Pronicka, E.
TI Novel c.191C&gt;G (p.Pro64Arg) <i>MPV17</i> mutation identified in two
   pairs of unrelated Polish siblings with mitochondrial
   hepatoencephalopathy
SO CLINICAL GENETICS
LA English
DT Article
DE hepatocerebral depletion syndrome; novel mutation; MPV17 gene;
   MDS-related pathology
ID DNA DEPLETION SYNDROME; PROTEIN
AB This study reports clinical, biochemical and histopathological findings associated with a novel homozygous MPV17 mutation in four patients with mitochondrial depletion syndrome. The severe course of the disease, which started in the first weeks of life, was dominated by a failure to thrive, hypotonia and liver dysfunction, with relatively mild neurological involvement. All affected infants died by 1 year of age. Laboratory findings included progressive liver failure (hypertransaminasaemia, icterus, and coagulopathy), recurrent hypoglycaemia, lactic acidaemia, hyperferritinaemia, and increased transferrin saturation. Histological and ultrastructural analyses uncovered significant lipid accumulation in hepatocytes and myocytes. A severe decrease in the mitochondrial/nuclear DNA (mtDNA/nDNA) ratio was found post-mortem in the livers (and in one muscle specimen) of both examined patients. Oxidative phosphorylation system (OXPHOS) Western blotting revealed low levels of complexes I, III and IV subunits. The highlights of our findings are as follows: (i) The novel p.Pro64Arg mutation is the second recurrent MPV17 mutation reported. The phenotype associated with the p.Pro64Arg mutation differs from the phenotype of the relatively common p.Arg50Gln mutation, suggesting the existence of a genotype-phenotype correlation. (ii) Tissues collected from patients during autopsy may be useful for both mtDNA/nDNA ratio assessment and OXPHOS Western blotting.
C1 [Piekutowska-Abramczuk, D.; Jurkiewicz, D.; Ciara, E.; Krajewska-Walasek, M.; Pronicka, E.] Childrens Mem Hlth Inst, Dept Med Genet, PL-04730 Warsaw, Poland.
   [Pronicki, M.; Karkucinska-Wieckowska, A.; Szymanska-Debinska, T.] Childrens Mem Hlth Inst, Dept Pathol, PL-04730 Warsaw, Poland.
   [Strawa, K.; Ploski, R.] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland.
   [Fidzianska, A.] Polish Acad Sci, Neuromuscular Unit, Mossakowski Res Med Ctr, Warsaw, Poland.
   [Wieckowski, M. R.] Nencki Inst Expt Biol, Dept Biochememistry, Lab Bioenerget Biomembranes & Metab Regulat, Warsaw, Poland.
   [Jankowska, I.] Childrens Mem Hlth Inst, Dept Liver Dis & Transplantat, PL-04730 Warsaw, Poland.
   [Sykut-Cegielska, J.; Pronicka, E.] Childrens Mem Hlth Inst, Dept Metab Dis, PL-04730 Warsaw, Poland.
C3 Children's Memorial Health Institute; Children's Memorial Health
   Institute; Medical University of Warsaw; Polish Academy of Sciences;
   Polish Academy of Sciences; Nencki Institute of Experimental Biology of
   the Polish Academy of Sciences; Children's Memorial Health Institute;
   Children's Memorial Health Institute
RP Piekutowska-Abramczuk, D (corresponding author), Childrens Mem Hlth Inst, Dept Med Genet, Al Dzieci Polskich 20, PL-04730 Warsaw, Poland.
EM d.abramczuk@czd.pl
RI Sykut-Cegielska, Jolanta/V-4253-2019
OI Pronicka, Ewa/0000-0002-5705-4814; Jurkiewicz,
   Dorota/0000-0003-3710-632X; Pronicki, Maciej/0000-0002-5589-0456; Ciara,
   Elzbieta/0000-0002-1065-7968; Krajewska-Walasek,
   Malgorzata/0000-0001-8721-210X; Ploski, Rafal/0000-0001-6286-5526;
   Karkucinska-Wieckowska, Agnieszka/0000-0003-4936-1571; Jankowska,
   Irena/0000-0001-6847-9570; Wieckowski, Mariusz/0000-0003-0789-4521;
   Sykut-Cegielska, Jolanta/0000-0003-0762-3721; Piekutowska-Abramczuk,
   Dorota/0000-0002-9786-3704
FU National Science Centre [2857/B/P01/2010/39]; Ministry of Science and
   Higher Education [0751/B/P01/2009/37]; EU Structural Funds
   [POIG.02.01.00-14-059/09]
FX The work was supported by the grants of the National Science Centre No
   2857/B/P01/2010/39, the Ministry of Science and Higher Education No
   0751/B/P01/2009/37, and EU Structural Funds, project
   POIG.02.01.00-14-059/09.
CR Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581
   El-Hattab A.W., 1993, GENEREVIEWS
   El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Kaji S, 2009, MOL GENET METAB, V97, P292, DOI 10.1016/j.ymgme.2009.04.014
   Mudd SH, 2012, MOL GENET METAB, V105, P228, DOI 10.1016/j.ymgme.2011.11.006
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921
   Walker JA, 2005, ANAL BIOCHEM, V337, P89, DOI 10.1016/j.ab.2004.09.036
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
NR 11
TC 6
Z9 6
U1 0
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9163
EI 1399-0004
J9 CLIN GENET
JI Clin. Genet.
PD JUN
PY 2014
VL 85
IS 6
BP 573
EP 577
DI 10.1111/cge.12228
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA AF7PW
UT WOS:000334908000013
PM 23829229
DA 2024-11-01
ER

PT J
AU Sun, R
   Eriksson, S
   Wang, LY
AF Sun, Ren
   Eriksson, Staffan
   Wang, Liya
TI Oxidative Stress Induced <i>S</i>-glutathionylation and Proteolytic
   Degradation of Mitochondrial Thymidine Kinase 2
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID DNA DEPLETION MYOPATHY; PROTEIN GLUTATHIONYLATION; MUTATIONS; MECHANISM;
   DYSFUNCTION; CANCER; DAMAGE
AB Protein glutathionylation in response to oxidative stress can affect both the stability and activity of target proteins. Mitochondrial thymidine kinase 2 (TK2) is a key enzyme in mitochondrial DNA precursor synthesis. Using an antibody specific for glutathione (GSH), S-glutathionylated TK2 was detected after the addition of glutathione disulfide (GSSG) but not GSH. This was reversed by the addition of dithiothreitol, suggesting that S-glutathionylation of TK2 is reversible. Site-directed mutagenesis of the cysteine residues and subsequent analysis of mutant enzymes demonstrated that Cys-189 and Cys-264 were specifically glutathionylated by GSSG. These cysteine residues do not appear to be part of the active site, as demonstrated by kinetic studies of the mutant enzymes. Treatment of isolated rat mitochondria with hydrogen peroxide resulted in S-glutathionylation of added recombinant TK2. Treatment of intact cells with hydrogen peroxide led to reduction of mitochondrial TK2 activity and protein levels, as well as S-glutathionylation of TK2. Furthermore, the addition of S-glutathionylated recombinant TK2 to mitochondria isolated from hydrogen peroxide-treated cells led to degradation of the S-glutathionylated TK2, which was not observed with unmodified TK2. S-Glutathionylation on Cys-189 was responsible for the observed selective degradation of TK2 in mitochondria. These results strongly suggest that oxidative damage-induced S-glutathionylation and degradation of TK2 have significant impact on mitochondrial DNA precursor synthesis.
C1 [Sun, Ren; Eriksson, Staffan; Wang, Liya] Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, SE-75123 Uppsala, Sweden.
C3 Swedish University of Agricultural Sciences
RP Wang, LY (corresponding author), Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, Box 575, SE-75123 Uppsala, Sweden.
EM liya.wang@slu.se
FU Swedish Research Council; Swedish Research Council for Environment,
   Agricultural Sciences, and Spatial Planning
FX This work was supported by a grant from the Swedish Research Council and
   in part by a grant from the Swedish Research Council for Environment,
   Agricultural Sciences, and Spatial Planning.
CR Anathy V, 2012, ANTIOXID REDOX SIGN, V16, P496, DOI 10.1089/ars.2011.4281
   Ayer A, 2010, FREE RADICAL BIO MED, V49, P1956, DOI 10.1016/j.freeradbiomed.2010.09.023
   Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004
   Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   Bulteau AL, 2012, BBA-MOL BASIS DIS, V1822, P212, DOI 10.1016/j.bbadis.2011.11.003
   Bulteau AL, 2006, EXP GERONTOL, V41, P653, DOI 10.1016/j.exger.2006.03.013
   Cooper AJL, 2011, EXPERT OPIN DRUG MET, V7, P891, DOI 10.1517/17425255.2011.577738
   Fariss MW, 2005, MOL INTERV, V5, P94, DOI 10.1124/mi.5.2.7
   Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Graham J. C., 1999, CURRENT PROTOCOLS CE, P331
   Hurd TR, 2005, BIOCHEM SOC T, V33, P1390, DOI 10.1042/BST0331390
   Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999
   JAIN A, 1991, P NATL ACAD SCI USA, V88, P1913, DOI 10.1073/pnas.88.5.1913
   Johansson K, 2001, NAT STRUCT BIOL, V8, P616, DOI 10.1038/89661
   Kil IS, 2005, J BIOL CHEM, V280, P10846, DOI 10.1074/jbc.M411306200
   Kline ER, 2009, CARDIOVASC TOXICOL, V9, P1, DOI 10.1007/s12012-008-9029-8
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Liedhegner EAS, 2012, ANTIOXID REDOX SIGN, V16, P543, DOI 10.1089/ars.2011.4119
   MARTENSSON J, 1990, P NATL ACAD SCI USA, V87, P7185, DOI 10.1073/pnas.87.18.7185
   MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431
   MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sun R, 2010, NUCLEOS NUCLEOT NUCL, V29, P382, DOI 10.1080/15257771003741018
   Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Ugarte N, 2010, ANTIOXID REDOX SIGN, V13, P539, DOI 10.1089/ars.2009.2998
   Verschoor ML, 2010, CAN J PHYSIOL PHARM, V88, P204, DOI 10.1139/Y09-135
   Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6
   Wang L, 2011, ANTIMICROB AGENTS CH, V55, P2552, DOI 10.1128/AAC.00109-11
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200
   Yusuf MA, 2010, FREE RADICAL BIO MED, V49, P908, DOI 10.1016/j.freeradbiomed.2010.06.020
NR 35
TC 36
Z9 41
U1 1
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 13
PY 2012
VL 287
IS 29
BP 24304
EP 24312
DI 10.1074/jbc.M112.381996
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 977IQ
UT WOS:000306651100024
PM 22661713
OA Green Published
DA 2024-11-01
ER

PT J
AU Apostolova, LG
   White, M
   Moore, SA
   Davis, PH
AF Apostolova, LG
   White, M
   Moore, SA
   Davis, PH
TI Deep white matter pathologic features in watershed regions - A novel
   pattern of central nervous system involvement in MELAS
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
AB Background: Myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome typically manifests in adults younger than 40 years with encephalopathy, stroke-like episodes, and lactic acidosis. Magnetic resonance imaging (MRI) abnormalities typically involve the cortical gray and the adjacent subcortical white matter.
   Objective: To describe a 58-year-old woman diagnosed with MELAS who was initially seen with acute myopathy, cardiac ischemia, psychosis, and MRI changes in a watershed distribution.
   Results: Initial MRI of the brain showed the characteristic parieto-occipital gray matter lesions involving the adjacent white matter. Follow-up MRI revealed striking deep white matter involvement in a watershed distribution. A cerebral angiogram and thorough hypercoagulable workup results were normal. Electromyography showed acute denervation and myopathy. A muscle biopsy specimen revealed ragged red and cytochrome-c oxidase-negative fibers. Mitochondrial DNA analysis revealed an A3243G mutation.
   Conclusions: Myopathy, encephalopathy, lactic acidosis, and stroke-like episodes should be considered in older patients with myopathy, cardiomyopathy, encephalopathy, and unaccountable MRI findings. Watershed pathologic features are a rare pattern of cerebral involvement in MELAS.
C1 Univ Calif Los Angeles, Alzheimers Dis Res Ctr, Dept Neurol, Los Angeles, CA 90095 USA.
   Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA.
C3 University of California System; University of California Los Angeles;
   University of Iowa; University of Iowa; University of Iowa
RP Apostolova, LG (corresponding author), Univ Calif Los Angeles, Alzheimers Dis Res Ctr, Dept Neurol, RNRC 2-238,710 Westwood Blvd, Los Angeles, CA 90095 USA.
EM lapostolova@mednet.ucla.edu
OI Moore, Steven/0000-0002-6353-7900
CR BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   CASTILLO M, 1995, AM J NEURORADIOL, V16, P233
   FUJII T, 1990, PEDIATR NEUROL, V6, P253, DOI 10.1016/0887-8994(90)90116-I
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Kimata KG, 1998, ARCH NEUROL-CHICAGO, V55, P722, DOI 10.1001/archneur.55.5.722
   MATTHEWS PM, 1991, NEUROLOGY, V41, P1043, DOI 10.1212/WNL.41.7.1043
   MCKELVIE PA, 1991, J NEUROL SCI, V102, P51, DOI 10.1016/0022-510X(91)90093-M
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
NR 9
TC 28
Z9 30
U1 0
U2 5
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610 USA
SN 0003-9942
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD JUL
PY 2005
VL 62
IS 7
BP 1154
EP 1156
DI 10.1001/archneur.62.7.1154
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 945NG
UT WOS:000230508600023
PM 16009776
DA 2024-11-01
ER

PT J
AU Sanchez-Contreras, M
   Kennedy, SR
AF Sanchez-Contreras, Monica
   Kennedy, Scott R.
TI The Complicated Nature of Somatic mtDNA Mutations in Aging
SO FRONTIERS IN AGING
LA English
DT Review
DE mtDNA; somatic mutations; aging; mitochondria; mutagenesis; sequencing
ID MITOCHONDRIAL-DNA MUTATIONS; GENOME-WIDE EXPRESSION; BASE
   EXCISION-REPAIR; AGED MUSCLE-FIBERS; POLYMERASE-GAMMA; POINT MUTATIONS;
   SKELETAL-MUSCLE; DELETION MUTATIONS; OXIDATIVE DAMAGE; COPY-NUMBER
AB Mitochondria are the main source of energy used to maintain cellular homeostasis. This aspect of mitochondrial biology underlies their putative role in age-associated tissue dysfunction. Proper functioning of the electron transport chain (ETC), which is partially encoded by the extra-nuclear mitochondrial genome (mtDNA), is key to maintaining this energy production. The acquisition of de novo somatic mutations that interrupt the function of the ETC have long been associated with aging and common diseases of the elderly. Yet, despite over 30 years of study, the exact role(s) mtDNA mutations play in driving aging and its associated pathologies remains under considerable debate. Furthermore, even fundamental aspects of age-related mtDNA mutagenesis, such as when mutations arise during aging, where and how often they occur across tissues, and the specific mechanisms that give rise to them, remain poorly understood. In this review, we address the current understanding of the somatic mtDNA mutations, with an emphasis of when, where, and how these mutations arise during aging. Additionally, we highlight current limitations in our knowledge and critically evaluate the controversies stemming from these limitations. Lastly, we highlight new and emerging technologies that offer potential ways forward in increasing our understanding of somatic mtDNA mutagenesis in the aging process.
C1 [Sanchez-Contreras, Monica; Kennedy, Scott R.] Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA.
C3 University of Washington; University of Washington Seattle
RP Kennedy, SR (corresponding author), Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA.
EM scottrk@uw.edu
FU We would like to acknowledge the following agencies/awards for
   supporting this manuscript R21DK128540 to MS-C; R21HG011229,
   1R21CA259780, and W81XWH-16-1-0579 to SK. [R21DK128540, R21HG011229,
   1R21CA259780, W81XWH-16-1-0579]; National Cancer Institute [R21CA259780]
   Funding Source: NIH RePORTER
FX We would like to acknowledge the following agencies/awards for
   supporting this manuscript R21DK128540 to MS-C; R21HG011229,
   1R21CA259780, and W81XWH-16-1-0579 to SK.
CR Abascal F, 2021, NATURE, V593, P405, DOI 10.1038/s41586-021-03477-4
   Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028
   Anderson AP, 2020, NUCLEIC ACIDS RES, V48, P817, DOI 10.1093/nar/gkz1018
   Andreazza S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10857-y
   Arbeithuber B, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000745
   Atilano SR, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246114
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Baker KT, 2019, MOL CANCER RES, V17, P488, DOI 10.1158/1541-7786.MCR-18-0520
   Bebenek A, 2018, CURR GENET, V64, P985, DOI 10.1007/s00294-018-0820-1
   Belle EMS, 2005, GENE, V355, P58, DOI 10.1016/j.gene.2005.05.019
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bielas JH, 2005, NAT METHODS, V2, P285, DOI 10.1038/NMETH751
   Bratic A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9808
   BROSSAS JY, 1994, BIOCHEM BIOPH RES CO, V202, P654, DOI 10.1006/bbrc.1994.1980
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Broz AK, 2021, GENETICS, V218, DOI 10.1093/genetics/iyab039
   Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Castellani CA, 2020, MITOCHONDRION, V53, P214, DOI 10.1016/j.mito.2020.06.004
   CHENG KC, 1992, J BIOL CHEM, V267, P166
   Chocron ES, 2019, BBA-MOL BASIS DIS, V1865, P285, DOI 10.1016/j.bbadis.2018.09.035
   Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002
   Cocco T, 2005, FREE RADICAL BIO MED, V38, P796, DOI 10.1016/j.freeradbiomed.2004.11.034
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Cottrell D A, 2000, Curr Opin Clin Nutr Metab Care, V3, P473, DOI 10.1097/00075197-200011000-00009
   Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   Degtyareva NP, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000263
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Fazal FM, 2019, CELL, V178, P473, DOI 10.1016/j.cell.2019.05.027
   FEIG DI, 1994, P NATL ACAD SCI USA, V91, P6609, DOI 10.1073/pnas.91.14.6609
   Fellous TG, 2009, STEM CELLS, V27, P1410, DOI 10.1002/stem.67
   Fernández-Vizarra E, 2011, MITOCHONDRION, V11, P207, DOI 10.1016/j.mito.2010.09.011
   Filograna R, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav9824
   Foury F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027847
   Fuke S, 2014, ANN CLIN TRANSL NEUR, V1, P909, DOI 10.1002/acn3.133
   Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k
   Gierahn TM, 2017, NAT METHODS, V14, P395, DOI 10.1038/nmeth.4179
   Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x
   Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Grimm A, 2017, J NEUROCHEM, V143, P418, DOI 10.1111/jnc.14037
   Gyllborg D, 2020, NUCLEIC ACIDS RES, V48, DOI 10.1093/nar/gkaa792
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Haroon S, 2018, CELL REP, V22, P3115, DOI 10.1016/j.celrep.2018.02.099
   Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6
   Hebert SL, 2010, MECH AGEING DEV, V131, P451, DOI 10.1016/j.mad.2010.03.007
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Hoekstra JG, 2016, ANN NEUROL, V80, P301, DOI 10.1002/ana.24709
   Itsara LS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003974
   KADENBACH B, 1995, MUTAT RES-DNAGING G, V338, P161, DOI 10.1016/0921-8734(95)00021-W
   Kauppila JHK, 2018, NUCLEIC ACIDS RES, V46, P6642, DOI 10.1093/nar/gky456
   Kauppila TES, 2018, P NATL ACAD SCI USA, V115, pE9620, DOI 10.1073/pnas.1721683115
   Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Kenney MC, 2010, INVEST OPHTH VIS SCI, V51, P4289, DOI 10.1167/iovs.09-4778
   Kent JA, 2016, J APPL PHYSIOL, V121, P996, DOI 10.1152/japplphysiol.00583.2016
   Khrapko K, 2004, ANN NY ACAD SCI, V1019, P240, DOI 10.1196/annals.1297.040
   Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044
   Komakula SSB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33151-1
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Kowaltowski AJ, 2000, BRAZ J MED BIOL RES, V33, P241, DOI 10.1590/S0100-879X2000000200014
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kraytsberg Y, 2009, METHODS MOL BIOL, V554, P329, DOI 10.1007/978-1-59745-521-3_21
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukreja L, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-16
   KUNKEL TA, 1986, J BIOL CHEM, V261, P160
   Lareau CA, 2021, NAT BIOTECHNOL, V39, P451, DOI 10.1038/s41587-020-0645-6
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200
   Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Liu Danhui, 2013, Front Biosci (Elite Ed), V5, P734
   Loh E, 2007, J BIOL CHEM, V282, P12201, DOI 10.1074/jbc.M611294200
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ludwig LS, 2019, CELL, V176, P1325, DOI 10.1016/j.cell.2019.01.022
   Lujan SA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02138-5
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Ma B, 2016, SCI REP-UK, V6, DOI 10.1038/srep22375
   Ma H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201304
   Macao B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8303
   Macken WL, 2021, NAT REV NEUROL, V17, P215, DOI 10.1038/s41582-021-00455-2
   Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002
   Maeda R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67686-z
   Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8
   Martínez-Azorín F, 2008, J NEUROCHEM, V105, P165, DOI 10.1111/j.1471-4159.2007.05122.x
   Matam K, 2014, MOL GENET GENOMICS, V289, P533, DOI 10.1007/s00438-014-0828-2
   Matic S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03552-x
   Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067
   MIQUEL J, 1992, MUTAT RES, V275, P209, DOI 10.1016/0921-8734(92)90024-J
   Moore L, 2021, NATURE, V597, P381, DOI 10.1038/s41586-021-03822-7
   Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807
   Navin NE, 2015, GENOME RES, V25, P1499, DOI 10.1101/gr.191098.115
   Nissanka N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04895-1
   Nomiyama T, 2002, DIABETOLOGIA, V45, P1577, DOI 10.1007/s00125-002-0893-7
   Park JS, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0829-3
   Payne Brendan A I, 2015, Methods Mol Biol, V1264, P67, DOI 10.1007/978-1-4939-2257-4_7
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Popadin K, 2014, AGING CELL, V13, P579, DOI 10.1111/acel.12231
   Pouget JP, 2002, RADIAT RES, V157, P589, DOI 10.1667/0033-7587(2002)157[0589:FOMDBI]2.0.CO;2
   Prakash A, 2015, J CELL BIOCHEM, V116, P1490, DOI 10.1002/jcb.25103
   Preissl S, 2018, NAT NEUROSCI, V21, P432, DOI 10.1038/s41593-018-0079-3
   PURMAL AA, 1994, NUCLEIC ACIDS RES, V22, P72, DOI 10.1093/nar/22.1.72
   Rinke C, 2014, NAT PROTOC, V9, P1038, DOI 10.1038/nprot.2014.067
   Rodriques SG, 2019, SCIENCE, V363, P1463, DOI 10.1126/science.aaw1219
   Rosenberg AB, 2018, SCIENCE, V360, P176, DOI 10.1126/science.aam8999
   Ross JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rotem A, 2015, NAT BIOTECHNOL, V33, P1165, DOI 10.1038/nbt.3383
   Salk JJ, 2018, NAT REV GENET, V19, P269, DOI 10.1038/nrg.2017.117
   Sampath H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051697
   Samstag CL, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007805
   Sanchez-Contreras M, 2021, NUCLEIC ACIDS RES, V49, P11103, DOI 10.1093/nar/gkab901
   Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Sevini F, 2014, EXP GERONTOL, V56, P234, DOI 10.1016/j.exger.2014.03.022
   Shah VO, 2009, GENET MED, V11, P147, DOI 10.1097/GIM.0b013e31819307a2
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Smith ALM, 2020, NAT CANCER, V1, P976, DOI 10.1038/s43018-020-00112-5
   Soltys DT, 2019, NEUROBIOL AGING, V73, P161, DOI 10.1016/j.neurobiolaging.2018.09.015
   Srivatsan SR, 2021, SCIENCE, V373, P111, DOI 10.1126/science.abb9536
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stickels RR, 2021, NAT BIOTECHNOL, V39, P313, DOI 10.1038/s41587-020-0739-1
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Szczepanowska K, 2017, ESSAYS BIOCHEM, V61, P325, DOI 10.1042/EBC20160090
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103
   Vecoli C, 2020, MUTAT RES-REV MUTAT, V784, DOI 10.1016/j.mrrev.2020.108309
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vermulst M, 2009, CELL METAB, V10, P437, DOI 10.1016/j.cmet.2009.11.001
   Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008
   Vitak SA, 2017, NAT METHODS, V14, P302, DOI [10.1038/NMETH.4154, 10.1038/nmeth.4154]
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang YQ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014610118
   Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-016-0404-6
   Williams SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003990
   Wu ZQ, 2020, P NATL ACAD SCI USA, V117, P16448, DOI 10.1073/pnas.2001998117
   Xu J, 2019, ELIFE, V8, DOI 10.7554/eLife.45105
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
   Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164
NR 171
TC 22
Z9 23
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2673-6217
J9 FRONT AGING-LAUSANNE
JI Front. Aging
PD JAN 10
PY 2022
VL 2
AR 805126
DI 10.3389/fragi.2021.805126
PG 16
WC Geriatrics & Gerontology
WE Emerging Sources Citation Index (ESCI)
SC Geriatrics & Gerontology
GA U8YD7
UT WOS:001087592200001
PM 35252966
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Carreño-Gago, L
   Juárez-Flores, DL
   Grau, JM
   Ramón, J
   Lozano, E
   Vila-Julià, F
   Martí, R
   Garrabou, G
   Garcia-Arumí, E
AF Carreno-Gago, Lidia
   Luz Juarez-Flores, Diana
   Maria Grau, Josep
   Ramon, Javier
   Lozano, Ester
   Vila-Julia, Ferran
   Marti, Ramon
   Garrabou, Gloria
   Garcia-Arumi, Elena
TI Two Novel Variants in <i>YARS2</i> Gene Are Responsible for an Extended
   MLASA Phenotype with Pancreatic Insufficiency
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE mitochondrial aminocyl-tRNA synthetase; novel pathogenic variant;
   Pearson's syndrome
ID SIDEROBLASTIC ANEMIA; LACTIC-ACIDOSIS; MITOCHONDRIAL MYOPATHY; MUTATION;
   SEQUENCE
AB Pathogenic variants in the mitochondrial tyrosyl-tRNA synthetase gene (YARS2) were associated with myopathy, lactic acidosis, and sideroblastic anemia (MLASA). However, patients can present mitochondrial myopathy, with exercise intolerance and muscle weakness, leading from mild to lethal phenotypes. Genes implicated in mtDNA replication were studied by Next Generation Sequencing (NGS) and whole exome sequence with the TruSeq Rapid Exome kit (Illumina, San Diego, CA, USA). Mitochondrial protein translation was studied following the Sasarman and Shoubridge protocol and oxygen consumption rates with Agilent Seahorse XF24 Analyzer Mitostress Test, (Agilent, Santa Clara, CA, USA). We report two siblings with two novel compound heterozygous pathogenic variants in YARS2 gene: a single nucleotide deletion in exon 1, c.314delG (p.(Gly105Alafs*4)), which creates a premature stop codon in the amino acid 109, and a single nucleotide change in exon 5 c.1391T>C (p.(Ile464Thr)), that cause a missense variant in amino acid 464. We demonstrate the pathogenicity of these new variants associated with reduced YARS2 mRNA transcript, reduced mitochondrial protein translation and dysfunctional organelle function. These pathogenic variants are responsible for late onset MLASA, herein accompanied by pancreatic insufficiency, observed in both brothers, clinically considered as Pearson's syndrome. Molecular study of YARS2 gene should be considered in patients presenting Pearson's syndrome characteristics and MLASA related phenotypes.
C1 [Carreno-Gago, Lidia; Ramon, Javier; Vila-Julia, Ferran; Marti, Ramon; Garcia-Arumi, Elena] Univ Autonoma Barcelona, Vall dHebron Hosp Univ, Vall dHebron Inst Recerca VHIR, Res Grp Neuromuscular & Mitochondrial Disorders, Barcelona 08035, Spain.
   [Carreno-Gago, Lidia; Luz Juarez-Flores, Diana; Maria Grau, Josep; Ramon, Javier; Vila-Julia, Ferran; Marti, Ramon; Garrabou, Gloria; Garcia-Arumi, Elena] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona 08036, Spain.
   [Luz Juarez-Flores, Diana; Maria Grau, Josep; Garrabou, Gloria] Univ Barcelona, Internal Med Serv, Hosp Clin Barcelona, Fac Med & Hlth Sci,Cellex IDIBAPS,Muscle Res & Mi, Barcelona 08036, Spain.
   [Lozano, Ester] Univ Barcelona, Dept Cell Biol Physiol & Immunol, Barcelona 08028, Spain.
   [Garcia-Arumi, Elena] Vall dHebron Hosp Univ, Dept Clin & Mol Genet, Barcelona 08035, Spain.
C3 Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron;
   Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de
   Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III;
   University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS;
   University of Barcelona
RP García-Arumí, E (corresponding author), Univ Autonoma Barcelona, Vall dHebron Hosp Univ, Vall dHebron Inst Recerca VHIR, Res Grp Neuromuscular & Mitochondrial Disorders, Barcelona 08035, Spain.; Grau, JM; García-Arumí, E (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona 08036, Spain.; Grau, JM (corresponding author), Univ Barcelona, Internal Med Serv, Hosp Clin Barcelona, Fac Med & Hlth Sci,Cellex IDIBAPS,Muscle Res & Mi, Barcelona 08036, Spain.; García-Arumí, E (corresponding author), Vall dHebron Hosp Univ, Dept Clin & Mol Genet, Barcelona 08035, Spain.
EM lidiacarre27@gmail.com; dian.juarez@icloud.com; jmgrau@clinic.cat;
   javier.ramon@vhir.org; elozano@ub.edu; ferran.vila@vhir.org;
   ramon.marti@vhir.org; garrabou@dinic.cat; e.garcia@vhebron.net
RI Martí, Ramon/Q-3442-2016; Lozano, Ester/H-2215-2014
OI Lozano, Ester/0000-0002-6307-9807; Garrabou, Gloria/0000-0001-8973-9933;
   Marti, Ramon/0000-0002-8273-9540; Ramon, Javier/0000-0002-0673-9338
FU Spanish Instituto de Salud Carlos III, Fondo de Investigaciones
   Sanitarias; ERDF funds [FIS PI15/01428, FIS PMP15/00025 PI18/00498,
   PI19/01772]; Centro de Investigacion Biomedica en Red de Enfermedades
   Raras (CIBERER)
FX This work was supported by the Spanish Instituto de Salud Carlos III,
   Fondo de Investigaciones Sanitarias and cofounded with ERDF funds (Grant
   No. FIS PI15/01428, FIS PMP15/00025 PI18/00498, PI19/01772, and the
   Centro de Investigacion Biomedica en Red de Enfermedades Raras
   (CIBERER).
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Ardissone A, 2015, JIMD REP, V20, P95, DOI 10.1007/8904_2014_397
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   CASADEMONT J, 1994, HUM MOL GENET, V3, P1945, DOI 10.1093/hmg/3.11.1945
   Chacko BK, 2014, CLIN SCI, V127, P367, DOI 10.1042/CS20140101
   Diodato Daria, 2014, Int J Cell Biol, V2014, P787956, DOI 10.1155/2014/787956
   Fleming MD, 2011, HEMATOL-AM SOC HEMAT, P525, DOI 10.1182/asheducation-2011.1.525
   González-Casacuberta I, 2018, NEUROBIOL AGING, V65, P206, DOI 10.1016/j.neurobiolaging.2018.01.021
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gustafson MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221829
   Lazaridis KN, 2016, MAYO CLIN PROC, V91, P297, DOI 10.1016/j.mayocp.2015.12.018
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   Long ZB, 2018, GENE, V668, P182, DOI 10.1016/j.gene.2018.05.074
   Meyer-Schuman R, 2017, HUM MOL GENET, V26, pR114, DOI 10.1093/hmg/ddx231
   Nakajima J, 2014, J HUM GENET, V59, P229, DOI 10.1038/jhg.2013.143
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Riley LG, 2018, HAEMATOLOGICA, V103, P2008, DOI 10.3324/haematol.2017.182659
   Riley LG, 2016, JIMD REP, V28, P49, DOI 10.1007/8904_2015_515
   Riley LG, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-193
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   ROTIG A, 1989, LANCET, V1, P902
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   Sasarman F, 2012, METHODS MOL BIOL, V837, P207, DOI 10.1007/978-1-61779-504-6_14
   Sommerville EW, 2017, JAMA NEUROL, V74, P686, DOI 10.1001/jamaneurol.2016.4357
   Wild KT, 2020, AM J MED GENET A, V182, P365, DOI 10.1002/ajmg.a.61433
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 29
TC 5
Z9 6
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD AUG
PY 2021
VL 10
IS 16
AR 3471
DI 10.3390/jcm10163471
PG 12
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA UI2LJ
UT WOS:000690445200001
PM 34441767
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Ramón, J
   Vila-Julia, F
   Molina-Granada, D
   Molina-Berenguer, M
   Melià, MJ
   Garcia-Arumí, E
   Torres-Torronteras, J
   Cámara, Y
   Martí, R
AF Ramon, Javier
   Vila-Julia, Ferran
   Molina-Granada, David
   Molina-Berenguer, Miguel
   Jesus Melia, Maria
   Garcia-Arumi, Elena
   Torres-Torronteras, Javier
   Camara, Yolanda
   Marti, Ramon
TI Therapy Prospects for Mitochondrial DNA Maintenance Disorders
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE mitochondria; mtDNA; replication; depletion; multiple deletions;
   therapy; nucleoside; gene therapy
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; STEM-CELL TRANSPLANTATION;
   PYRIMIDINE NUCLEOTIDE CARRIER; HEMATOPOIETIC GENE-THERAPY;
   ENZYME-REPLACEMENT THERAPY; IMPAIR MTDNA REPLICATION; THYMIDINE
   PHOSPHORYLASE; NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY; MURINE MODEL;
   MOUSE MODEL
AB Mitochondrial DNA depletion and multiple deletions syndromes (MDDS) constitute a group of mitochondrial diseases defined by dysfunctional mitochondrial DNA (mtDNA) replication and maintenance. As is the case for many other mitochondrial diseases, the options for the treatment of these disorders are rather limited today. Some aggressive treatments such as liver transplantation or allogeneic stem cell transplantation are among the few available options for patients with some forms of MDDS. However, in recent years, significant advances in our knowledge of the biochemical pathomechanisms accounting for dysfunctional mtDNA replication have been achieved, which has opened new prospects for the treatment of these often fatal diseases. Current strategies under investigation to treat MDDS range from small molecule substrate enhancement approaches to more complex treatments, such as lentiviral or adenoassociated vector-mediated gene therapy. Some of these experimental therapies have already reached the clinical phase with very promising results, however, they are hampered by the fact that these are all rare disorders and so the patient recruitment potential for clinical trials is very limited.
C1 [Ramon, Javier; Vila-Julia, Ferran; Molina-Granada, David; Molina-Berenguer, Miguel; Jesus Melia, Maria; Garcia-Arumi, Elena; Torres-Torronteras, Javier; Camara, Yolanda; Marti, Ramon] Univ Autonoma Barcelona, Vall dHebron Res Inst, Res Grp Neuromuscular & Mitochondrial Dis, Barcelona 08035, Spain.
   [Ramon, Javier; Vila-Julia, Ferran; Molina-Granada, David; Molina-Berenguer, Miguel; Jesus Melia, Maria; Garcia-Arumi, Elena; Torres-Torronteras, Javier; Camara, Yolanda; Marti, Ramon] Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid 28029, Spain.
C3 Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron;
   Vall d'Hebron Institut de Recerca (VHIR); Instituto de Salud Carlos III;
   University of Barcelona; CIBER - Centro de Investigacion Biomedica en
   Red; CIBERER
RP Martí, R (corresponding author), Univ Autonoma Barcelona, Vall dHebron Res Inst, Res Grp Neuromuscular & Mitochondrial Dis, Barcelona 08035, Spain.; Martí, R (corresponding author), Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid 28029, Spain.
EM javier.ramon@vhir.org; ferran.vila@vhir.org; david.molina@vhir.org;
   miguel.molina@vhir.org; maria.jesus.melia@vhir.org;
   elena.garcia@vhir.org; javier.torres@vhir.org; yolanda.camara@vhir.org;
   ramon.marti@vhir.org
RI Cámara, Yolanda/P-2540-2019; Martí, Ramon/Q-3442-2016; Berenguer,
   Miguel/ABH-3504-2020; Melia, Maria Jesus/L-2864-2014;
   Torres-Torronteras, Javier/K-4974-2014; Camara, Yolanda/K-4597-2014
OI Melia, Maria Jesus/0000-0002-6497-7289; Molina Berenguer,
   Miguel/0000-0001-8087-4709; Marti, Ramon/0000-0002-8273-9540;
   Torres-Torronteras, Javier/0000-0002-6092-9458; Camara,
   Yolanda/0000-0003-2458-6942; Ramon, Javier/0000-0002-0673-9338
FU Spanish Instituto de Salud Carlos III (E.R.D.F.) [PMP15/00025,
   PI18/01574]; Catalan Generalitat de Catalunya (PERIS program)
   [SLT002/16/00370]; Catalan Generalitat de Catalunya (FI-AGAUR program)
   [2018FI_B_01115]
FX This work has been supported by the Spanish Instituto de Salud Carlos
   III (Grants PMP15/00025 and PI18/01574 to R.M., co-funded with E.R.D.F.)
   and by the Catalan Generalitat de Catalunya (PERIS program,
   SLT002/16/00370 to J.T. and FI-AGAUR program 2018FI_B_01115 to F.V.).
CR Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alsina D, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911659
   Baderna V, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00975-w
   Bax BE, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081096
   Bax BE, 2013, NEUROLOGY, V81, P1269, DOI 10.1212/WNL.0b013e3182a6cb4b
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Blázquez-Bermejo C, 2019, EBIOMEDICINE, V46, P342, DOI 10.1016/j.ebiom.2019.07.042
   Blázquez-Bermejo C, 2019, FASEB J, V33, P7168, DOI 10.1096/fj.201801591R
   Boczonadi V, 2018, GENET MED, V20, P1224, DOI 10.1038/gim.2017.251
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Bonora E, 2021, BRAIN, V144, P1451, DOI 10.1093/brain/awab056
   Boschetti E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096692
   Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022
   Cabrera-Pérez R, 2019, HUM GENE THER, V30, P985, DOI 10.1089/hum.2018.217
   Cabrera-Pérez R, 2015, EXPERT OPIN ORPHAN D, V3, P1167, DOI 10.1517/21678707.2015.1090307
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Camp KM, 2016, MOL GENET METAB, V119, P187, DOI 10.1016/j.ymgme.2016.09.002
   Caporali L, 2018, BRAIN, V141, DOI 10.1093/brain/awx301
   Cass C E, 1999, Pharm Biotechnol, V12, P313
   Civiletto G, 2015, CELL METAB, V21, P845, DOI 10.1016/j.cmet.2015.04.016
   D'Angelo R, 2020, J NEUROL, V267, P3702, DOI 10.1007/s00415-020-10051-x
   D'Angelo R, 2017, MITOCHONDRION, V34, P101, DOI 10.1016/j.mito.2017.02.006
   D'Angelo R, 2016, NEUROL SCI, V37, P1149, DOI 10.1007/s10072-016-2552-7
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   De Giorgio R, 2016, ANN NEUROL, V80, P448, DOI 10.1002/ana.24724
   Breda CND, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101255
   De Vocht C, 2010, J CONTROL RELEASE, V148, pE19, DOI 10.1016/j.jconrel.2010.07.011
   De Vocht C, 2009, J CONTROL RELEASE, V137, P246, DOI 10.1016/j.jconrel.2009.03.020
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Del Dotto V, 2020, J CLIN INVEST, V130, P108, DOI 10.1172/JCI128514
   DESGRANGES C, 1981, BIOCHIM BIOPHYS ACTA, V654, P211, DOI 10.1016/0005-2787(81)90174-X
   Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004
   Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808
   DiMauro S, 2007, BIOSCIENCE REP, V27, P5, DOI 10.1007/s10540-007-9032-5
   Dominguez-Gonzalez C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66940-8
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1071-z
   El-Hattab A.W., 1993, GENEREVIEWS
   El-Hattab A. W., 2018, GENE REV
   El-Hattab AW, 2018, MOL GENET METAB, V125, P315, DOI 10.1016/j.ymgme.2018.10.003
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Epand RM, 2009, BIOCHEMISTRY-US, V48, P12358, DOI 10.1021/bi901769r
   Facchinello N, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03359-z
   Feichtinger RG, 2017, AM J HUM GENET, V101, P525, DOI 10.1016/j.ajhg.2017.08.015
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103
   Filosto M, 2012, J NEUROL, V259, P2699, DOI 10.1007/s00415-012-6572-9
   Flierl A, 2005, GENE THER, V12, P570, DOI 10.1038/sj.gt.3302443
   Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.E06-12-1109
   Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110
   Franzolin E, 2012, EXP CELL RES, V318, P2226, DOI 10.1016/j.yexcr.2012.05.028
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Garcia-Diaz B, 2014, BRAIN, V137, P1337, DOI 10.1093/brain/awu068
   Garc┬u┬ia-Rodr┬u┬iguez L.J, 2007, ECHINODERMS B, V80, P809, DOI [10.1016/s0091-679x(06)80040-3, DOI 10.1016/S0091-679X(06)80040-3]
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2017, HUM MOL GENET, V26, P4257, DOI 10.1093/hmg/ddx314
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   Gray MW, 2017, MOL BIOL CELL, V28, P1285, DOI 10.1091/mbc.E16-07-0509
   György H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016
   Haghighi A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0119-3
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Hasselmann O, 2010, MOL GENET METAB, V99, P58, DOI 10.1016/j.ymgme.2009.08.005
   Hernandez-Voth A, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000774
   Hikmat O, 2020, J INHERIT METAB DIS, V43, P726, DOI 10.1002/jimd.12211
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirano M, 2021, J INHERIT METAB DIS, V44, P376, DOI 10.1002/jimd.12300
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Hoff KE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203198
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hussein E, 2013, TRANSFUS APHER SCI, V49, P208, DOI 10.1016/j.transci.2013.01.014
   Jackson CB, 2020, TRENDS MOL MED, V26, P698, DOI 10.1016/j.molmed.2020.02.006
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Jiang HY, 2006, BLOOD, V108, P3321, DOI 10.1182/blood-2006-04-017913
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Jurkute N, 2019, ANN NEUROL, V86, P368, DOI 10.1002/ana.25550
   Kaji S, 2009, MOL GENET METAB, V97, P292, DOI 10.1016/j.ymgme.2009.04.014
   Karaa A, 2018, NEUROLOGY, V90, pE1212, DOI 10.1212/WNL.0000000000005255
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kelly D A, 2000, Pediatr Transplant, V4, P170, DOI 10.1034/j.1399-3046.2000.00125.x
   Kimura M, 2007, EXP CELL RES, V313, P1393, DOI 10.1016/j.yexcr.2007.02.004
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Kishita Y, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1427
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Korwitz A, 2016, J CELL BIOL, V212, P157, DOI 10.1083/jcb.201507022
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Krähenbühl S, 2000, LIVER, V20, P346, DOI 10.1034/j.1600-0676.2000.020004346.x
   Kripps KA, 2020, MOL GENET METAB, V130, P58, DOI 10.1016/j.ymgme.2020.03.001
   Kuszak AJ, 2018, ANNU REV PATHOL-MECH, V13, P163, DOI 10.1146/annurev-pathol-020117-043644
   Lai YR, 2004, J BIOL CHEM, V279, P4490, DOI 10.1074/jbc.M307938200
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Levene M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040457
   Levene M, 2013, TOXICOL SCI, V131, P311, DOI 10.1093/toxsci/kfs278
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Lopez-Gomez C, 2019, EBIOMEDICINE, V46, P356, DOI 10.1016/j.ebiom.2019.07.037
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Marchet S, 2020, HUM MUTAT, V41, P1745, DOI 10.1002/humu.24081
   Martin CA, 2018, AM J HUM GENET, V103, P221, DOI 10.1016/j.ajhg.2018.07.001
   Martinelli P, 2009, HUM MOL GENET, V18, P2001, DOI 10.1093/hmg/ddp124
   Martinez-Arribas B, 2020, CELL MOL LIFE SCI, V77, P1645, DOI 10.1007/s00018-019-03250-x
   McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054
   Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Moran NF, 2008, NEUROLOGY, V71, P686, DOI 10.1212/01.wnl.0000324602.97205.ab
   Morgan NV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000833
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   Munro B, 2019, HUM MOL GENET, V28, P796, DOI 10.1093/hmg/ddy389
   Nambot S, 2017, CLIN GENET, V92, P188, DOI 10.1111/cge.12985
   Nasca A, 2017, HUM MUTAT, V38, P970, DOI 10.1002/humu.23262
   Nathwani AC, 2006, BLOOD, V107, P2653, DOI 10.1182/blood-2005-10-4035
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oliveira MT, 2020, GENET MOL BIOL, V43, DOI [10.1590/1678-4685-GMB-2019-0069, 10.1590/1678-4685-gmb-2019-0069]
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Parikh S, 2016, MOL GENET METAB, V118, P178, DOI 10.1016/j.ymgme.2016.04.009
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pastor-Anglada M, 2018, COMPR PHYSIOL, V8, P1003, DOI 10.1002/cphy.c170039
   Pastor-Anglada M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00013
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pitayu L, 2016, HUM MOL GENET, V25, P715, DOI 10.1093/hmg/ddv509
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109
   Punzi G, 2018, HUM MOL GENET, V27, P499, DOI 10.1093/hmg/ddx419
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rahman S, 2015, EPILEPSY BEHAV, V49, P71, DOI 10.1016/j.yebeh.2015.05.003
   Rahn JJ, 2015, NUCLEIC ACIDS RES, V43, P10338, DOI 10.1093/nar/gkv1139
   Rajendran J, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809456
   Rampazzo C, 2000, P NATL ACAD SCI USA, V97, P8239, DOI 10.1073/pnas.97.15.8239
   Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011
   Requena CE, 2014, BIOCHEM J, V459, P171, DOI 10.1042/BJ20130894
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Rocha AG, 2018, SCIENCE, V360, P336, DOI 10.1126/science.aao1785
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Röeben B, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0687-0
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rosa ID, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005779
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   RUIZ MD, 2019, J TRANSL MED, V17, P290, DOI DOI 10.1186/S12967-019-2041-X
   Russell BE, 2019, HEPATOLOGY, V70, P1066, DOI 10.1002/hep.30627
   Ruzzenente B, 2016, HUM MOL GENET, V25, pR115, DOI 10.1093/hmg/ddw176
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Sharma H, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04643
   Shimura M, 2020, ORPHANET J RARE DIS, V15, DOI 10.1186/s13023-020-01441-5
   Siegmund SE, 2017, HUM MOL GENET, V26, P4588, DOI 10.1093/hmg/ddx341
   Silva-Pinheiro P, 2021, NUCLEIC ACIDS RES, V49, P5230, DOI 10.1093/nar/gkab282
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Stussi G, 2010, BONE MARROW TRANSPL, V45, P103, DOI 10.1038/bmt.2009.123
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Szeto HH, 2014, CLIN PHARMACOL THER, V96, P672, DOI 10.1038/clpt.2014.174
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Tarnopolsky MA, 2014, J CHILD NEUROL, V29, P1225, DOI 10.1177/0883073814538512
   Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907
   Torres-Torronteras J, 2011, GENE THER, V18, P795, DOI 10.1038/gt.2011.24
   Torres-Torronteras J, 2018, HUM GENE THER, V29, P708, DOI 10.1089/hum.2017.133
   Torres-Torronteras J, 2016, HUM GENE THER, V27, P656, DOI 10.1089/hum.2015.160
   Torres-Torronteras J, 2014, MOL THER, V22, P901, DOI 10.1038/mt.2014.6
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2010, METHODS, V51, P405, DOI 10.1016/j.ymeth.2010.03.009
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Varma H, 2016, EUR J MED GENET, V59, P540, DOI 10.1016/j.ejmg.2016.08.012
   Vercauteren K, 2016, MOL THER, V24, P1042, DOI 10.1038/mt.2016.61
   Vila-Julià F, 2020, EBIOMEDICINE, V62, DOI 10.1016/j.ebiom.2020.103133
   VIOQUE EG, 2011, PLOS GENET, V7
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Wang LY, 2016, NUCLEOS NUCLEOT NUCL, V35, P578, DOI 10.1080/15257770.2015.1125001
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wedding IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086340
   Wevers RA, 2019, J INHERIT METAB DIS, V42, P494, DOI 10.1002/jimd.12081
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Yadak R, 2018, MOL THER-METH CLIN D, V8, P152, DOI 10.1016/j.omtm.2018.01.001
   Yapa NMB, 2021, FEBS LETT, V595, P1184, DOI 10.1002/1873-3468.14077
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   YOSHIMURA A, 1990, BIOCHIM BIOPHYS ACTA, V1034, P107, DOI 10.1016/0304-4165(90)90160-X
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
   Zhou XS, 2019, HUM MOL GENET, V28, P2874, DOI 10.1093/hmg/ddz103
NR 215
TC 12
Z9 12
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUN
PY 2021
VL 22
IS 12
AR 6447
DI 10.3390/ijms22126447
PG 35
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA SY6UK
UT WOS:000666020300001
PM 34208592
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Sato, A
   Nakada, K
   Shitara, H
   Kasahara, A
   Yonekawa, H
   Hayashi, JI
AF Sato, Akitsugu
   Nakada, Kazuto
   Shitara, Hiroshi
   Kasahara, Atsuko
   Yonekawa, Hiromichi
   Hayashi, Jun-Ichi
TI Deletion-mutant mtDNA increases in somatic tissues but decreases in
   female germ cells with age
SO GENETICS
LA English
DT Article
ID MITOCHONDRIAL-DNA DELETION; KEARNS-SAYRE-SYNDROME; MOUSE MTDNA;
   MITO-MICE; MUTATION; SEGREGATION; GENOMES; HYBRIDS; DYSFUNCTION;
   EXPRESSION
AB The proportions Of mutant. and wild-type mtDNA are crucial in determining the severity of mitochondrial diseases. It has been generally considered that deletion-mutant mtDNA has replication advantages and accumulates with time. Here, we examine the tissue-by-tissue Proportions Of mutant mtDNA with a 4696-bp deletion (Delta mtDNA) and wild-type mtDNA in mitochondrial disease model mice (mito-mice). Comparison Of the proportions of Delta mtDNA in each tissue at various ages showed that the rate of accumulation of Delta mtDNA differed among tissues. The heart, skeletal muscles, kidney, liver, testis, and ovary, showed increases in the proportion of Delta mtDNA with age, but the pancreas, spleen, brain, and blood showed only a slight or no increase in proportion. In contrast to the somatic tissues, however, the germ cells of female mito-mice and resultant offspring showed a strong decrease in Delta mtDNA with maternal age. The decrease was so acute that some offspring showed complete disappearance of Delta mtDNA, even though their elder brothers and sisters had high proportions of Delta mtDNA. Female germ cells have a machinery that prevents the inheritence of defective mtDNA to the following generation since germ cells are kept for a long time until they are ovulated.
C1 [Sato, Akitsugu; Nakada, Kazuto; Kasahara, Atsuko; Hayashi, Jun-Ichi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.
   [Nakada, Kazuto; Kasahara, Atsuko] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058572, Japan.
   [Sato, Akitsugu; Shitara, Hiroshi; Yonekawa, Hiromichi] Tokyo Metropolitan Inst Med Sci, Dept Lab Anim Sci, Tokyo 1138613, Japan.
C3 University of Tsukuba; University of Tsukuba; Tokyo Metropolitan
   Institute of Medical Science
RP Sato, A (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058572, Japan.
EM asato@biol.tsukuba.ac.jp
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X
   BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480
   Brenner CA, 1998, MOL HUM REPROD, V4, P887, DOI 10.1093/molehr/4.9.887
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   DEVRIES D, 1994, J NEUROL SCI, V124, P77, DOI 10.1016/0022-510X(94)90014-0
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Elmore SP, 2004, ARCH BIOCHEM BIOPHYS, V422, P145, DOI 10.1016/j.abb.2003.12.031
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HAYASHI JI, 1987, EXP CELL RES, V172, P218, DOI 10.1016/0014-4827(87)90108-X
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Inoue SI, 2007, FEBS LETT, V581, P1910, DOI 10.1016/j.febslet.2007.03.092
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316
   Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031
   KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542
   Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   LESTIENNE P, 1988, LANCET, V1, P885
   Nakada K, 2004, BIOCHEM BIOPH RES CO, V323, P175, DOI 10.1016/j.bbrc.2004.08.073
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nakada K, 2006, P NATL ACAD SCI USA, V103, P15148, DOI 10.1073/pnas.0604641103
   Puoti G, 2003, J MED GENET, V40, P858, DOI 10.1136/jmg.40.11.858
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   Shitara H, 1998, GENETICS, V148, P851
   Tang YY, 2000, MOL BIOL CELL, V11, P2349, DOI 10.1091/mbc.11.7.2349
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   WALLACE DC, 1981, SOMAT CELL MOLEC GEN, V12, P41
NR 35
TC 40
Z9 42
U1 0
U2 9
PU GENETICS SOCIETY AMERICA
PI BETHESDA
PA 9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA
SN 0016-6731
EI 1943-2631
J9 GENETICS
JI Genetics
PD DEC
PY 2007
VL 177
IS 4
BP 2031
EP 2037
DI 10.1534/genetics.107.081026
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 245QF
UT WOS:000251949800007
PM 18073422
OA Green Published
DA 2024-11-01
ER

PT J
AU Chang, ES
   Song, K
   Song, JY
   Sung, M
   Lee, MS
   Oh, JH
   Kim, JY
   Park, YH
   Jung, K
   Choi, YL
AF Chang, Eun Sol
   Song, Kyoung
   Song, Ji-Young
   Sung, Minjung
   Lee, Mi-Sook
   Oh, Jung Han
   Kim, Ji-Yeon
   Park, Yeon Hee
   Jung, Kyungsoo
   Choi, Yoon-La
TI Real-time assessment of relative mitochondrial ATP synthesis response
   against inhibiting and stimulating substrates (MitoRAISE)
SO CANCER & METABOLISM
LA English
DT Article
DE Relative mitochondrial ATP synthesis rate; Mitochondrial function; ATP;
   mtDNA copy number; MitoRAISE
ID SKELETAL-MUSCLE; MUTATIONS; RATIOS; CELLS
AB BackgroundMitochondria are known to synthesize adenosine triphosphate (ATP) through oxidative phosphorylation. Understanding and accurately measuring mitochondrial ATP synthesis rate can provide insights into the functional status of mitochondria and how it contributes to overall cellular energy homeostasis. Traditional methods only estimate mitochondrial function by measuring ATP levels at a single point in time or through oxygen consumption rates. This study introduced the relative mitochondrial ATP synthesis response against inhibiting and stimulating substrates (MitoRAISE), designed to detect real-time changes in ATP levels as the cells respond to substrates.MethodsThe sensitivity and specificity of the MitoRAISE assay were verified under various conditions, including the isolation of mitochondria, variations in cell numbers, cells exhibiting mitochondrial damage, and heterogeneous mixtures. Using peripheral blood mononuclear cells (PBMCs), we analyzed MitoRAISE data from 19 patients with breast cancer and 23 healthy women.ResultsThe parameters observed in the MitoRAISE data increased depending on the quantity of isolated mitochondria and cell count, whereas it remained unmeasured in mitochondrial-damaged cell lines. Basal ATP, rotenone response, malonate response, and mitochondrial DNA copy numbers were lower in PBMCs from patients with breast cancer than in those from healthy women.ConclusionsThe MitoRAISE assay has demonstrated its sensitivity and specificity by measuring relative ATP synthesis rates under various conditions. We propose MitoRAISE assay as a potential tool for monitoring changes in the mitochondrial metabolic status associated with various diseases.
C1 [Chang, Eun Sol; Oh, Jung Han; Choi, Yoon-La] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea.
   [Chang, Eun Sol; Song, Ji-Young; Sung, Minjung; Lee, Mi-Sook; Oh, Jung Han; Jung, Kyungsoo; Choi, Yoon-La] Sungkyunkwan Univ, Samsung Med Ctr, Lab Mol Pathol & Theranost, Sch Med, Irwon Ro 81, Seoul 06351, South Korea.
   [Song, Kyoung] Duksung Womens Univ, Coll Pharm, Seoul, South Korea.
   [Kim, Ji-Yeon; Park, Yeon Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea.
   [Choi, Yoon-La] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Irwon Ro 81, Seoul 06351, South Korea.
C3 Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung
   Medical Center; Duksung Women's University; Sungkyunkwan University
   (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung
   Medical Center
RP Choi, YL (corresponding author), Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea.; Jung, K; Choi, YL (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Lab Mol Pathol & Theranost, Sch Med, Irwon Ro 81, Seoul 06351, South Korea.; Choi, YL (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Irwon Ro 81, Seoul 06351, South Korea.
EM ksjung0820@skku.edu; ylachoi@skku.edu
RI Lee, MiSook/KGL-0088-2024
FU National Research Foundation of Korea (NRF) grant funded by the Korean
   government
FX Figures were created using BioRender.com.
CR Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282
   Bandara AB, 2021, BMC MOL CELL BIOL, V22, DOI 10.1186/s12860-021-00370-w
   Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178
   Boyman L, 2020, TRENDS MOL MED, V26, P21, DOI 10.1016/j.molmed.2019.10.007
   Cheng H, 2021, METHODSX, V8, DOI 10.1016/j.mex.2021.101520
   Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007
   Deshpande OA, 2024, Biochemistry, Oxidative Phosphorylation
   Divakaruni Ajit S, 2014, Curr Protoc Toxicol, V60, DOI 10.1002/0471140856.tx2502s60
   Divakaruni AS, 2013, P NATL ACAD SCI USA, V110, P5422, DOI 10.1073/pnas.1303360110
   Farhadi P, 2022, BIOMED PHARMACOTHER, V146, DOI 10.1016/j.biopha.2021.112526
   Gatt AP, 2016, MOVEMENT DISORD, V31, P352, DOI 10.1002/mds.26513
   Gaude E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13041
   Hartman ML, 2014, VASC MED, V19, P67, DOI 10.1177/1358863X14521315
   Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034
   Hinkle PC, 2005, BBA-BIOENERGETICS, V1706, P1, DOI 10.1016/j.bbabio.2004.09.004
   Kurelac I, 2013, HUM MOL GENET, V22, P226, DOI 10.1093/hmg/dds422
   Langen P, 2008, ANGEW CHEM INT EDIT, V47, P1824, DOI 10.1002/anie.200702929
   Lark DS, 2016, AM J PHYSIOL-CELL PH, V311, pC239, DOI 10.1152/ajpcell.00124.2016
   Marcussen M, 1996, CELL MOTIL CYTOSKEL, V35, P94, DOI 10.1002/(SICI)1097-0169(1996)35:2<94::AID-CM2>3.0.CO;2-I
   Muller B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53066-9
   Nath S, 2019, BIOPHYS CHEM, V252, DOI 10.1016/j.bpc.2019.106208
   Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006
   Plitzko B, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2850
   Preble JM, 2014, JOVE-J VIS EXP, DOI 10.3791/51682
   Seyfried TN, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101761
   Shin JS, 2023, J PATHOL TRANSL MED, V57, P305, DOI 10.4132/jptm.2023.10.09
   Siegel MP, 2012, MECH AGEING DEV, V133, P620, DOI 10.1016/j.mad.2012.08.002
   Stehling O, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011312
   Sun L, 2020, CANCER RES TREAT, V52, P604, DOI 10.4143/crt.2019.444
   Szostaczuk N, 2020, FASEB J, V34, P9003, DOI 10.1096/fj.202000071RR
   Tomas C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186802
   Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611
   WARBURG O, 1956, SCIENCE, V124, P269
   Zhao RZ, 2019, INT J MOL MED, V44, P3, DOI 10.3892/ijmm.2019.4188
NR 34
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2049-3002
J9 CANCER METAB
JI Cancer Metab.
PD AUG 29
PY 2024
VL 12
IS 1
AR 25
DI 10.1186/s40170-024-00353-3
PG 12
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA E4D2H
UT WOS:001302516600001
PM 39210390
OA gold
DA 2024-11-01
ER

PT J
AU Galmiche, L
   Jaubert, F
   Sauvat, F
   Sarnacki, S
   Goulet, O
   Assouline, Z
   Vedrenne, V
   Lebre, AS
   Boddaert, N
   Brousse, N
   Chrétien, D
   Munnich, A
   Rötig, A
AF Galmiche, L.
   Jaubert, F.
   Sauvat, F.
   Sarnacki, S.
   Goulet, O.
   Assouline, Z.
   Vedrenne, V.
   Lebre, A-S.
   Boddaert, N.
   Brousse, N.
   Chretien, D.
   Munnich, A.
   Roetig, A.
TI Normal oxidative phosphorylation in intestinal smooth muscle of
   childhood chronic intestinal pseudo-obstruction
SO NEUROGASTROENTEROLOGY AND MOTILITY
LA English
DT Article
DE childhood; chronic intestinal pseudo-obstruction; mitochondria; smooth
   muscle
ID OF-THE-LITERATURE; HYPOPERISTALSIS SYNDROME; CHILDREN; MANIFESTATIONS;
   DIAGNOSIS; MYOPATHY; INFANTS; DISEASE; MNGIE
AB Background Chronic intestinal pseudo-obstruction (CIPO) is a severe disease of the digestive tract motility. In pediatric population, CIPO remains of unknown origin for most patients. Chronic intestinal pseudo-obstruction is also a common feature in the course of mitochondrial oxidative phosphorylation disorders related for some patients to mutations in TYMP, POLG1, mtDNA tRNAleu(UUR) or tRNAlys genes. We hypothesized that CIPOs could be the presenting symptom of respiratory chain enzyme deficiency and thus we investigated oxidative phosphorylation in small bowel and/or colon smooth muscle of primary CIPO children. Methods We studied eight children with CIPO and 12 pediatric controls. We collected clinical, radiological and pathological data and measured respiratory chain enzymatic activity in isolated smooth muscle of the small bowel and/or the colon. We also sequenced TYMP, POLG, mtDNA tRNAleu(UUR) and tRNAlys genes. Key Results Neither pathological nor radiological data were in favor of a mitochondrial dysfunction. No respiratory chain enzyme deficiency was detected in CIPO children. In myogenic CIPO, respiratory enzymes and citrate synthase activities were increased in small bowel and/or colon whereas no abnormality was noted in neurogenic and unclassified CIPO. Levels of enzyme activities were higher in control small bowel than in control colon muscle. Sequencing of TYMP, POLG, mtDNA tRNAleu(UUR) and tRNAlys genes and POLG gene did not reveal mutation for any of the patients. Conclusions & Inferences The normal enzymatic activities as the lack of radiological and genetic abnormalities indicate that, at variance with adult patients, oxidative phosphorylation deficiency is not a common cause of childhood CIPO.
C1 [Galmiche, L.] Univ Paris 05, Hop Necker Enfants Malad, Fac Med, INSERM,U781,Dept Pathol & Tumorotheque, F-75015 Paris, France.
   [Galmiche, L.; Jaubert, F.; Sauvat, F.; Sarnacki, S.; Goulet, O.; Assouline, Z.; Vedrenne, V.; Lebre, A-S.; Boddaert, N.; Brousse, N.; Chretien, D.; Munnich, A.; Roetig, A.] Univ Paris 05, AP HP, F-75015 Paris, France.
   [Galmiche, L.; Assouline, Z.; Vedrenne, V.; Lebre, A-S.; Chretien, D.; Munnich, A.; Roetig, A.] Univ Paris 05, Hop Necker Enfants Malad, Fac Med, Dept Genet, F-75015 Paris, France.
   [Sauvat, F.; Sarnacki, S.] Univ Paris 05, Hop Necker Enfants Malad, Fac Med, Dept Paediat Surg, F-75015 Paris, France.
   [Goulet, O.] Univ Paris 05, Hop Necker Enfants Malad, Fac Med, Dept Paediat Gastroenterol, F-75015 Paris, France.
   [Boddaert, N.] Univ Paris 05, Hop Necker Enfants Malad, Fac Med, Dept Paediat Radiol, F-75015 Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Necker-Enfants Malades - APHP; Institut National
   de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite;
   Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux
   Paris (APHP); Universite Paris Cite; Hopital Universitaire
   Necker-Enfants Malades - APHP; Universite Paris Cite; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants
   Malades - APHP; Universite Paris Cite; Assistance Publique Hopitaux
   Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP;
   Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Necker-Enfants Malades - APHP
RP Galmiche, L (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, Fac Med, INSERM,U781,Dept Pathol & Tumorotheque, 149 Rue Sevres, F-75015 Paris, France.
EM louise.galmiche@inserm.fr
RI boddaert, nathalie/GWV-2865-2022; Lebre, Anne-Sophie/AAO-1413-2020;
   ROTIG, AGNES/G-9592-2017; Sarnacki, Sabine/I-2692-2017
OI ROTIG, AGNES/0000-0003-0589-0703; boddaert,
   nathalie/0000-0003-0991-7774; Sarnacki, Sabine/0000-0003-4304-5578
CR Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Blondon H, 2005, GASTROEN CLIN BIOL, V29, P773, DOI 10.1016/S0399-8320(05)86346-8
   Ciftci AO, 1996, J PEDIATR SURG, V31, P1706, DOI 10.1016/S0022-3468(96)90058-5
   De Giorgio R, 2004, GUT, V53, P1549, DOI 10.1136/gut.2004.043968
   Di Lorenzo C, 1999, GASTROENTEROLOGY, V116, P980
   Faure C, 1999, DIGEST DIS SCI, V44, P953, DOI 10.1023/A:1026656513463
   Feldstein AE, 2003, J PEDIATR GASTR NUTR, V36, P492, DOI 10.1097/00005176-200304000-00016
   García-Velasco A, 2003, J INTERN MED, V253, P381, DOI 10.1046/j.1365-2796.2003.01095.x
   Gillis LA, 2003, GASTROENTEROL CLIN N, V32, P789, DOI 10.1016/S0889-8553(03)00052-9
   Goulet O, 1999, EUR J PEDIATR SURG, V9, P83, DOI 10.1055/s-2008-1072218
   HYMAN PE, 1995, SCAND J GASTROENTERO, V30, P39
   KERN IB, 1990, J PEDIATR GASTR NUTR, V11, P411, DOI 10.1097/00005176-199010000-00023
   Köhler M, 2004, EUR J PEDIATR SURG, V14, P362, DOI 10.1055/s-2004-821208
   KRISHNAMURTHY S, 1993, GASTROENTEROLOGY, V104, P1398, DOI 10.1016/0016-5085(93)90348-G
   Lapointe SP, 2002, J UROLOGY, V168, P1768, DOI 10.1016/S0022-5347(05)64410-2
   Martí R, 2005, ANN NEUROL, V58, P649, DOI 10.1002/ana.20615
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   NONAKA M, 1989, Pediatric Pathology, V9, P409
   Rudolph CD, 1997, J PEDIATR GASTR NUTR, V24, P102, DOI 10.1097/00005176-199701000-00021
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SCHUFFLER MD, 1988, GASTROENTEROLOGY, V94, P892, DOI 10.1016/0016-5085(88)90544-6
NR 21
TC 2
Z9 4
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1350-1925
EI 1365-2982
J9 NEUROGASTROENT MOTIL
JI Neurogastroenterol. Motil.
PD JAN
PY 2011
VL 23
IS 1
BP 24
EP E1
DI 10.1111/j.1365-2982.2010.01595.x
PG 7
WC Gastroenterology & Hepatology; Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Neurosciences & Neurology
GA 691WH
UT WOS:000285111000005
PM 20879992
OA Bronze
DA 2024-11-01
ER

PT J
AU Trevisson, E
   DiMauro, S
   Navas, P
   Salviati, L
AF Trevisson, Eva
   DiMauro, Salvatore
   Navas, Placido
   Salviati, Leonardo
TI Coenzyme Q deficiency in muscle
SO CURRENT OPINION IN NEUROLOGY
LA English
DT Article
DE CoQ10; CoQ10 deficiency; myopathy; oral supplementation
ID DIPHOSPHATE SYNTHASE SUBUNIT-2; RESPIRATORY-CHAIN DYSFUNCTION; COQ(10)
   DEFICIENCY; Q(10) DEFICIENCY; MITOCHONDRIAL ENCEPHALOMYOPATHY;
   DEHYDROGENASE-DEFICIENCY; UBIQUINONE DEFICIENCY; CEREBELLAR-ATAXIA;
   OXIDATIVE STRESS; MUTATIONS
AB Purpose of review
   Coenzyme Q (CoQ) is a vital component of the mitochondrial respiratory chain. A number of patients with CoQ deficiency presented with different clinical phenotypes, often affecting skeletal muscle, and responded well to CoQ supplementation. We discuss recent advances in this field with special attention to muscle involvement.
   Recent findings
   The identification of genetic defects causing CoQ deficiency has allowed to distinguish primary forms, due to mutations in biosynthetic genes, from secondary defects caused either by mutations in genes unrelated to CoQ biosynthesis or by nongenetic factors. To date, none of the patients with genetically proven primary deficiency presented with an exclusively (or prominently) myopathic phenotype. Most patients with myopathy were found to harbor other genetic defects (mutations in electron-transferring-flavoprotein dehydrogenase or mitochondrial DNA). The majority of patients with CoQ deficiency still lack a genetic diagnosis. The pathogenesis of CoQ deficiency cannot be attributed solely to the bioenergetic defect, suggesting that other roles of CoQ, including its antioxidant properties or its role in pyrimidine metabolism, may also play crucial roles.
   Summary
   Early recognition of CoQ deficiency is essential to institute appropriate and timely treatment, thus avoiding irreversible tissue damage.
C1 [Salviati, Leonardo] Univ Padua, Dipartimento Pediat, Serv Genet Clin, Clin Genet Unit, I-35128 Padua, Italy.
   [DiMauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA.
   [Navas, Placido] Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain.
   [Navas, Placido] Inst Salud Carlos III, CIBERER, Seville, Spain.
C3 University of Padua; Columbia University; Consejo Superior de
   Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC -
   Andalusian Center for Developmental Biology (CABD); CIBER - Centro de
   Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III
RP Salviati, L (corresponding author), Univ Padua, Dipartimento Pediat, Serv Genet Clin, Clin Genet Unit, Via Giustiniani 3, I-35128 Padua, Italy.
EM leonardo.salviati@unipd.it
RI NAVAS, PLACIDO/R-5943-2019; Salviati, Leonardo/L-1007-2016; Trevisson,
   Eva/K-8462-2016
OI Trevisson, Eva/0000-0002-5380-6265
FU CARIPARO Foundation; Telethon Italy [GGP09207]; Spanish FIS [PI080500];
   Junta de Andalucia [P08-CTS-03988]
FX L.S. is supported by a grant from CARIPARO Foundation, and from Telethon
   Italy (Grant GGP09207). P.N. is supported by Spanish FIS PI080500 and
   Junta de Andalucia P08-CTS-03988 grants.
CR Aeby A, 2007, J INHERIT METAB DIS, V30, P827, DOI 10.1007/s10545-007-0612-0
   Artuch R, 2009, ADV EXP MED BIOL, V652, P117, DOI 10.1007/978-90-481-2813-6_8
   Avis HJ, 2011, J PEDIATR-US, V158, P458, DOI 10.1016/j.jpeds.2010.08.015
   Barshop BA, 2007, MITOCHONDRION, V7, pS89, DOI 10.1016/j.mito.2007.04.002
   Bentinger M, 2003, FREE RADICAL BIO MED, V34, P563, DOI 10.1016/S0891-5849(02)01357-6
   Casarin A, 2008, BIOCHEM BIOPH RES CO, V372, P35, DOI 10.1016/j.bbrc.2008.04.172
   Caso G, 2007, AM J CARDIOL, V99, P1409, DOI 10.1016/j.amjcard.2006.12.063
   Castellotti B, 2011, NEUROGENETICS
   Cordero MD, 2009, CLIN BIOCHEM, V42, P732, DOI 10.1016/j.clinbiochem.2008.12.010
   Cordero MD, 2010, CLIN BIOCHEM, V43, P1174, DOI 10.1016/j.clinbiochem.2010.06.013
   COTAN D, 2011, FASEB J
   Di Giovanni S, 2001, NEUROLOGY, V57, P515, DOI 10.1212/WNL.57.3.515
   Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Emma F, 2012, PEDIATR NEPHROL, V27, P539, DOI 10.1007/s00467-011-1926-6
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Haas D, 2009, J INHERIT METAB DIS, V32, P570, DOI 10.1007/s10545-009-1150-8
   Harper CR, 2010, CURR ATHEROSCLER REP, V12, P322, DOI 10.1007/s11883-010-0120-9
   Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693
   Kaminsky P, 2011, MUSCLE NERVE, V43, P444, DOI 10.1002/mus.21881
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Liang WC, 2009, NEUROMUSCULAR DISORD, V19, P212, DOI 10.1016/j.nmd.2009.01.008
   López LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011897
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   López-Martín JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058
   Marbois B, 2009, BBA-MOL CELL BIOL L, V1791, P69, DOI 10.1016/j.bbalip.2008.10.006
   Mas E, 2010, CURR ATHEROSCLER REP, V12, P407, DOI 10.1007/s11883-010-0134-3
   Miles MV, 2008, MITOCHONDRION, V8, P170, DOI 10.1016/j.mito.2008.01.003
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089
   Montero R, 2005, BIOFACTORS, V25, P109, DOI 10.1002/biof.5520250112
   Montero R, 2008, CLIN BIOCHEM, V41, P697, DOI 10.1016/j.clinbiochem.2008.03.007
   Montero R, 2009, CLIN BIOCHEM, V42, P742, DOI 10.1016/j.clinbiochem.2008.10.027
   Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Peng M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000061
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113
   Quinzii CM, 2008, FASEB J, V22, P1874, DOI 10.1096/fj.07-100149
   Quinzii CM, 2007, MITOCHONDRION, V7, pS122, DOI 10.1016/j.mito.2007.03.004
   Quinzii CM, 2010, FASEB J, V24, P3733, DOI 10.1096/fj.09-152728
   Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58
   Rodríguez-Hernández A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014
   Saiki R, 2008, AM J PHYSIOL-RENAL, V295, pF1535, DOI 10.1152/ajprenal.90445.2008
   Salviati L, 2005, NEUROLOGY, V65, P606, DOI 10.1212/01.wnl.0000172859.55579.a7
   Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238
   Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007
   Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009
   Young JA, 2007, AM J CARDIOL, V100, P1400, DOI 10.1016/j.amjcard.2007.06.030
NR 51
TC 60
Z9 65
U1 0
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1350-7540
J9 CURR OPIN NEUROL
JI Curr. Opin. Neurol.
PD OCT
PY 2011
VL 24
IS 5
BP 449
EP 456
DI 10.1097/WCO.0b013e32834ab528
PG 8
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 817NB
UT WOS:000294679400006
PM 21844807
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Çekmen, N
   Bedel, P
   Erdemli, O
AF Cekmen, Nedim
   Bedel, Pasa
   Erdemli, Oezcan
TI "MELAS" Syndrome with Confusion and Lactic Acidosis (Case Report)
SO NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH
LA English
DT Article
DE Confusion; myopathy; lactic acidosis; MELAS syndrome
ID STROKE-LIKE EPISODES; MITOCHONDRIAL ENCEPHALOMYOPATHY; MANAGEMENT;
   DISORDERS; DIAGNOSIS; FEATURES
AB Introduction: MELAS characterized as mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes syndrome is a hereditary, progressive and a neurodegenerative disorder with mutations in mitochondrial DNA. Herewith, we aimed to present rarely seen a possible adult onset of MELAS syndrome with clinical demonstration of unconsciousness, myopathy and lactic acidosis.
   Case: A 45-year-old white man who is an army officer, with no significant past medical history represented to the emergency service with unconsciousness. First CT and MRI findings were unremarkable other than diffuse brain edema. He was accepted to intensive care unit. Response to painful stimulus were present with eye movement and extension of extremities. He did not respond to any verbal stimulus. No verbal communication was present. There was no significant finding in his history obtained from family members. Noninvasive monitoring measurements were blood pressure = 180/90 mmHg, heart rate = 100 beats/min, respiratory rate = 30/min, body temperature = 36.5 degrees C. Glascow score was 7 and immediate arterial blood gase findings were pH = 7.24, pO2 = 117 mmHg, pCO2 = 28,9 mmHg, lactate = 163 mg/dL. COHb and MetHb levels were normal. When he became unconcious, he was intubated and put on mechanical ventilation. Nasogastric decompression was applied. Drug profiles, heavy metal toxicity evaluations were performed regarding to drug toxicity. These test results related to intoxication were found negative. Chest X-ray. EKG and examination of other organ systems were unremarkable.
   Lactic acid level in cerebrospinal fluid was found higher (30 mg/dL), than normal values (10-22 mg/dL), as well as in serum. Along with, abnormal enzyme levels Such as aldolase and pyruvate kinase, Glukoz 6-P dehidrogenase 4.7 U/g (4.6-13.5) which can indicate the disorders in aerobic metabolism and oxidative phosphorylation did not co-exist. Besides, possible mitochondrial myopathy was considered and muscle biopsy was performed.
   On the second day of the admittance to intensive care unit, urine output and creatinine clearance decreased, emergent dialysis protocol was initiated. Everyday double dialyse protocol was performed. Lactate levels started to return normal ranges on the third day. On the tenth day, he was awake, responding to verbal stimulus, ventilated in CPAP mode, obeying the verbal commands and the Glascow score was 10. He was discharged from intensive care unit to another hospital in order to continue the dialysis program. Histopathological finding of previously performed muscle biopsy revealed accumulation of red painted fibres of abnormal mitochondria under sarcolemna when painted with Gomori trichrome and succinate dehidrogenase in concordance with mitochondrial myopathy. One month later, we were informed that the patient was walking with the support of a walker, his conscious level was normal and became a chronic dialiser patient.
   Conclusion: With these clinical findings and in concordance with mitochondrial myopathy, we diagnosed this patient as a late onset of MELAS syndrome. When unconsciousness, myopathy and lactic acidosis were present in combination, MELAS syndrome besides toxic metabolic encephalopathies should be considered as a possible diagnose even in late ages.
C1 [Cekmen, Nedim; Bedel, Pasa; Erdemli, Oezcan] Guven Hosp, Dept Anesthesiol & Intens Care, Kavaklidere, Turkey.
C3 Guven Hastanesi
RP Çekmen, N (corresponding author), Cayyolu Mah Guvengir 42 Sitesi Firuze Sok 52 Yeni, Ankara, Turkey.
EM nedimcekmen@yahoo.com
RI CEKMEN, NEDIM/AAJ-5235-2021
OI CEKMEN, NEDIM/0000-0002-6916-1772
CR Chinnery PF, 1997, J NEUROL NEUROSUR PS, V63, P559, DOI 10.1136/jnnp.63.5.559
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   FERNANDEZSOLA J, 1992, POSTGRAD MED J, V68, P212, DOI 10.1136/pgmj.68.797.212
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Finsterer J, 1999, CLIN NEUROPHYSIOL, V110, P1466, DOI 10.1016/S1388-2457(99)00090-5
   Gillis L, 2002, PEDIATR CLIN N AM, V49, P203, DOI 10.1016/S0031-3955(03)00115-9
   Honjo Kie, 2002, Nihon Ronen Igakkai Zasshi, V39, P318
   Kayacan D, 2005, J ISTANB FAC MED, V68, P119
   Kubota H, 2005, J CHILD NEUROL, V20, P116, DOI 10.1177/08830738050200020601
   Leonard JV, 2000, LANCET, V355, P389, DOI 10.1016/S0140-6736(99)05226-5
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Sano M, 1998, ANN NEUROL, V44, P576
   SCHAPIRO AHV, 1994, MITOCHONDRIAL DISORD, P1
   Shoffner JM, 2000, NEUROL CLIN, V18, P105, DOI 10.1016/S0733-8619(05)70180-8
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Walker HK., 1990, Clinical Methods: The History, Physical, and Laboratory Examinations, P296
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
NR 18
TC 0
Z9 0
U1 0
U2 4
PU UNIVERSITATSVERLAG ULM GMBH
PI ULM
PA BAHNHOFSTRASSE 20, D-89073 ULM, GERMANY
SN 0941-9500
J9 NEUROL PSYCHIAT BR
JI Neurol. Psychiatr. Brain Res.
PY 2008
VL 15
IS 4
BP 197
EP 202
PG 6
WC Neurosciences; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Psychiatry
GA 468XU
UT WOS:000267858700008
DA 2024-11-01
ER

PT J
AU Bradshaw, PC
   Samuels, DC
AF Bradshaw, PC
   Samuels, DC
TI A computational model of mitochondrial deoxynucleotide metabolism and
   DNA replication
SO AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
LA English
DT Article
DE simulation; nucleotide phosphorylation; nucleoside transport;
   mitochondrial DNA
ID NUCLEOSIDE-DIPHOSPHATE KINASE; RAT-LIVER MITOCHONDRIA; PERFORMANCE
   LIQUID-CHROMATOGRAPHY; GTP-AMP PHOSPHOTRANSFERASE; THYMIDINE KINASE;
   DEOXYRIBONUCLEOSIDE KINASES; DEOXYGUANOSINE KINASE; TRIPHOSPHATE POOLS;
   DEPLETION MYOPATHY; THYMIDYLATE KINASE
AB We present a computational model of mitochondrial deoxynucleotide metabolism and mitochondrial DNA (mtDNA) synthesis. The model includes the transport of deoxynucleosides and deoxynucleotides into the mitochondrial matrix space, as well as their phosphorylation and polymerization into mtDNA. Different simulated cell types (cancer, rapidly dividing, slowly dividing, and postmitotic cells) are represented in this model by different cytoplasmic deoxynucleotide concentrations. We calculated the changes in deoxynucleotide concentrations within the mitochondrion during the course of a mtDNA replication event and the time required for mtDNA replication in the different cell types. On the basis of the model, we define three steady states of mitochondrial deoxynucleotide metabolism: the phosphorylating state (the net import of deoxynucleosides and export of phosphorylated deoxynucleotides), the desphosphorylating state (the reverse of the phosphorylating state), and the efficient state (the net import of both deoxynucleosides and deoxynucleotides). We present five testable hypotheses based on this simulation. First, the deoxynucleotide pools within a mitochondrion are sufficient to support only a small fraction of even a single mtDNA replication event. Second, the mtDNA replication time in postmitotic cells is much longer than that in rapidly dividing cells. Third, mitochondria in dividing cells are net sinks of cytoplasmic deoxynucleotides, while mitochondria in postmitotic cells are net sources. Fourth, the deoxynucleotide carrier exerts the most control over the mtDNA replication rate in rapidly dividing cells, but in postmitotic cells, the NDPK and TK2 enzymes have the most control. Fifth, following from the previous hypothesis, rapidly dividing cells derive almost all of their mtDNA precursors from the cytoplasmic deoxynucleotides, not from phosphorylation within the mitochondrion.
C1 Virginia Polytech & State Univ, Virginia Bioinformat Inst, Bioinformat Facil I 0477, Blacksburg, VA 24061 USA.
C3 Virginia Polytechnic Institute & State University
RP Virginia Polytech & State Univ, Virginia Bioinformat Inst, Bioinformat Facil I 0477, Blacksburg, VA 24061 USA.
EM dsamuels@vbi.vt.edu
RI Bradshaw, Patrick/AAR-9189-2020; Samuels, David/A-5393-2008
OI Samuels, David/0000-0003-3529-7791
CR ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9
   ATTARDI G, 1975, J CELL SCI, V19, P55
   BERK AJ, 1973, J BIOL CHEM, V248, P2722
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Camins A, 1996, LIFE SCI, V58, P753, DOI 10.1016/0024-3205(95)02353-4
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   COHEN A, 1983, J BIOL CHEM, V258, P2334
   COLLINS A, 1987, EUR J BIOCHEM, V169, P299, DOI 10.1111/j.1432-1033.1987.tb13612.x
   Copeland William C, 2003, ScientificWorldJournal, V3, P34
   Curbo S, 2003, BIOCHEM BIOPH RES CO, V311, P440, DOI 10.1016/j.bbrc.2003.10.018
   Das M, 2003, J PHYSIOL-LONDON, V547, P893, DOI 10.1113/jphysiol.2002.035006
   DIPIERRO D, 1995, ANAL BIOCHEM, V231, P407, DOI 10.1006/abio.1995.0071
   Dolce V, 2001, P NATL ACAD SCI USA, V98, P2284, DOI 10.1073/pnas.031430998
   Elpeleg O, 2002, J MOL MED-JMM, V80, P389, DOI 10.1007/s00109-002-0343-5
   ENRIQUEZ JA, 1994, NUCLEIC ACIDS RES, V22, P1861, DOI 10.1093/nar/22.10.1861
   Erent M, 2001, EUR J BIOCHEM, V268, P1972, DOI 10.1046/j.1432-1327.2001.2076.doc.x
   ERIKSSON S, 1994, ADV ENZYME REGUL, V34, P13, DOI 10.1016/0065-2571(94)90006-X
   Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x
   FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333
   Gaillard RK, 2002, ANTIMICROB AGENTS CH, V46, P1005, DOI 10.1128/AAC.46.4.1005-1013.2002
   GAO WY, 1993, P NATL ACAD SCI USA, V90, P8925, DOI 10.1073/pnas.90.19.8925
   GEAR ARL, 1972, J CELL BIOL, V54, P325, DOI 10.1083/jcb.54.2.325
   GLAS U, 1966, J CELL BIOL, V29, P507, DOI 10.1083/jcb.29.3.507
   GREGER J, 1980, ENZYME, V25, P26, DOI 10.1159/000459211
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   HALL SW, 1986, EUR J BIOCHEM, V161, P551, DOI 10.1111/j.1432-1033.1986.tb10477.x
   HARMENBERG J, 1983, INTERVIROLOGY, V20, P48, DOI 10.1159/000149373
   Henneré G, 2003, J CHROMATOGR B, V789, P273, DOI 10.1016/S1570-0232(03)00099-0
   Huang D, 2003, J CHROMATOGR B, V784, P101, DOI 10.1016/S1570-0232(02)00780-8
   Iacobazzi V, 2001, CYTOGENET CELL GENET, V93, P40, DOI 10.1159/000056945
   JACKSON RC, 1980, CANCER RES, V40, P1286
   Jiménez A, 2000, EUR J PHARMACOL, V398, P31, DOI 10.1016/S0014-2999(00)00297-1
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   Johnson AA, 2001, J BIOL CHEM, V276, P38090
   Kacser H, 1973, Symp Soc Exp Biol, V27, P65
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050
   Lai YR, 2004, J BIOL CHEM, V279, P4490, DOI 10.1074/jbc.M307938200
   Lambeth DO, 1997, J BIOL CHEM, V272, P24604, DOI 10.1074/jbc.272.39.24604
   LEE LS, 1977, J BIOL CHEM, V252, P5686
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0
   Maher AD, 2003, EUR J BIOCHEM, V270, P3953, DOI 10.1046/j.1432-1033.2003.03783.x
   MARONGIU ME, 1990, BIOCHEM PHARMACOL, V39, P1523, DOI 10.1016/0006-2952(90)90516-N
   Martí R, 2003, CLIN CHEM LAB MED, V41, P845, DOI 10.1515/CCLM.2003.128
   Martomo SA, 2002, MUTAT RES-FUND MOL M, V499, P197, DOI 10.1016/S0027-5107(01)00283-4
   MAYBAUM J, 1980, J CHROMATOGR, V188, P149, DOI 10.1016/S0021-9673(00)88425-3
   Mazzon C, 2003, BIOCHEM PHARMACOL, V66, P471, DOI 10.1016/S0006-2952(03)00290-9
   Mehus JG, 1999, HUM GENET, V104, P454, DOI 10.1007/s004390050987
   Milon L, 1997, HUM GENET, V99, P550, DOI 10.1007/s004390050405
   MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032
   Noma T, 2001, BIOCHEM J, V358, P225, DOI 10.1042/0264-6021:3580225
   PAK YK, 1990, J BIOL CHEM, V265, P14298
   Pastor-Anglada M, 2001, MOL MEMBR BIOL, V18, P81, DOI 10.1080/096876800110033783
   Pennycooke M, 2001, BIOCHEM BIOPH RES CO, V280, P951, DOI 10.1006/bbrc.2000.4205
   PILLWEIN K, 1987, CANCER RES, V47, P3092
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   RAATIKAINEN MJP, 1992, BIOCHIM BIOPHYS ACTA, V1099, P238
   Rampazzo C, 2004, J BIOL CHEM, V279, P17019, DOI 10.1074/jbc.M313957200
   Rampazzo C, 2000, P NATL ACAD SCI USA, V97, P8239, DOI 10.1073/pnas.97.15.8239
   REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Rosenberg MJ, 2002, NAT GENET, V32, P175, DOI 10.1038/ng948
   Roy B, 1999, ANAL BIOCHEM, V269, P403, DOI 10.1006/abio.1999.4051
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Sampol J, 2001, J AM SOC NEPHROL, V12, P1721, DOI 10.1681/ASN.V1281721
   Sjöberg AH, 2001, ANTIMICROB AGENTS CH, V45, P739, DOI 10.1128/AAC.45.3.739-742.2001
   SNYDER RD, 1988, MUTAT RES, V209, P51, DOI 10.1016/0165-7992(88)90110-8
   SNYDER RD, 1984, MUTAT RES, V131, P163, DOI 10.1016/0167-8817(84)90057-9
   Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200
   TAMIYA N, 1989, BIOCHIM BIOPHYS ACTA, V995, P28, DOI 10.1016/0167-4838(89)90229-X
   TOMASSELLI AG, 1979, EUR J BIOCHEM, V93, P257, DOI 10.1111/j.1432-1033.1979.tb12818.x
   TOMASSELLI AG, 1979, EUR J BIOCHEM, V93, P263, DOI 10.1111/j.1432-1033.1979.tb12819.x
   TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361
   Tsuiki H, 2000, J CELL BIOCHEM, V76, P254, DOI 10.1002/(SICI)1097-4644(20000201)76:2<254::AID-JCB9>3.0.CO;2-G
   Turner TE, 2004, COMPUT BIOL CHEM, V28, P165, DOI 10.1016/j.compbiolchem.2004.05.001
   Valdés R, 2002, BIOCHEM BIOPH RES CO, V296, P575, DOI 10.1016/S0006-291X(02)00919-1
   WALTERS RA, 1973, BIOCHIM BIOPHYS ACTA, V319, P336, DOI 10.1016/0005-2787(73)90173-1
   Wang LY, 2003, FEBS LETT, V554, P319, DOI 10.1016/S0014-5793(03)01181-5
   Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200
   WATKINS LF, 1987, MOL CELL BIOCHEM, V77, P153
   WATKINS LF, 1987, MOL CELL BIOCHEM, V77, P71
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
NR 85
TC 24
Z9 27
U1 0
U2 3
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6143
EI 1522-1563
J9 AM J PHYSIOL-CELL PH
JI Am. J. Physiol.-Cell Physiol.
PD MAY
PY 2005
VL 288
IS 5
BP C989
EP C1002
DI 10.1152/ajpcell.00530.2004
PG 14
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA 917KY
UT WOS:000228461700005
PM 15634740
DA 2024-11-01
ER

PT J
AU Hynynen, J
   Pokka, T
   Komulainen-Ebrahim, J
   Myllynen, P
   Kärppä, M
   Pylvänen, L
   Kälviäinen, R
   Sokka, A
   Jyrkilä, A
   Lähdetie, J
   Haataja, L
   Mäkitalo, A
   Ylikotila, P
   Eriksson, K
   Haapala, P
   Ansakorpi, H
   Hinttala, R
   Vieira, P
   Majamaa, K
   Rantala, H
   Uusimaa, J
AF Hynynen, Johanna
   Pokka, Tytti
   Komulainen-Ebrahim, Jonna
   Myllynen, Paivi
   Karppa, Mikko
   Pylvanen, Laura
   Kalviainen, Reetta
   Sokka, Arja
   Jyrkila, Aino
   Lahdetie, Jaana
   Haataja, Leena
   Makitalo, Anna
   Ylikotila, Pauli
   Eriksson, Kai
   Haapala, Piia
   Ansakorpi, Hanna
   Hinttala, Reetta
   Vieira, Paivi
   Majamaa, Kari
   Rantala, Heikki
   Uusimaa, Johanna
TI Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma
   <i>POLG1</i> are not associated with increased risk for
   valproate-induced hepatotoxicity or pancreatic toxicity: A retrospective
   cohort study of patients with epilepsy
SO EPILEPSIA
LA English
DT Article
DE drug-induced liver injury; mtDNA; mutation; pancreatitis
ID W748S MUTATION; ALPERS-SYNDROME; LIVER-FAILURE; SPECTRUM; ATAXIA;
   ENCEPHALOPATHY; MYOPATHY; GENE
AB Objective Previous studies have suggested that heterozygous variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma (POLG1) increase the risk for liver injury for patients on valproate (VPA) therapy. We assessed the prevalence of these common variants and seven other pathogenic mutations in POLG1 and determined the occurrence of VPA-induced hepatotoxicity (VHT) or pancreatic toxicity in a cohort of patients with epilepsy. Methods Results Patients with epilepsy (N = 367) were retrospectively identified from medical record files and screened for mutations in POLG1. Patients who had received VPA monotherapy and carried either of the two variants, p.Q1236H or p.E1143G, without other pathogenic mutations in POLG1 (n = 33, variant group) and patients without these variants (n = 28, nonvariant group) were included in the study. Clinical data on epilepsy, characteristics of VPA treatment, risk factors for VHT, laboratory data on liver and pancreas functions, and adverse effects were collected. A total of 122 patients had either the POLG1 p.Q1236H (n = 99) or p.E1143G (n = 24) variant in the heterozygous or homozygous state. Transient liver dysfunction was identified in three (n = 33, 9.1%) variant group patients and in one (n = 28, 3.6%) nonvariant group patient (P = 0.62). Mild to moderate elevations in liver enzymes were encountered in both groups. Furthermore, two patients on VPA polytherapy developed acute pancreatitis, and two pediatric patients with heterozygous p.Q1236H variants and mutations in IQSEC2 and GLDC, respectively, had elevated levels of VPA metabolites in urine, elevated plasma glycine, and/or increased acylglycine excretion. Significance POLG1 p.Q1236H and p.E1143G variants could not be identified as statistically significant risk factors for VHT or pancreatic toxicity. We suggest that VPA treatment could be suitable for patients who harbor these common variants in the absence of other pathogenic mutations in POLG1.
C1 [Hynynen, Johanna; Pokka, Tytti; Komulainen-Ebrahim, Jonna; Hinttala, Reetta; Vieira, Paivi; Rantala, Heikki; Uusimaa, Johanna] Univ Oulu, Res Unit Pediat Pediat Neurol Pediat Surg Child P, Otorhinolaryngol & Ophthalmol, Oulu, Finland.
   [Hynynen, Johanna; Komulainen-Ebrahim, Jonna; Karppa, Mikko; Ansakorpi, Hanna; Hinttala, Reetta; Vieira, Paivi; Majamaa, Kari; Rantala, Heikki; Uusimaa, Johanna] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland.
   [Hynynen, Johanna; Komulainen-Ebrahim, Jonna; Hinttala, Reetta; Uusimaa, Johanna] Univ Oulu, Bioctr Oulu, Oulu, Finland.
   [Hynynen, Johanna; Pokka, Tytti; Komulainen-Ebrahim, Jonna; Vieira, Paivi; Rantala, Heikki; Uusimaa, Johanna] Oulu Univ Hosp, Div Pediat Neurol, Dept Children & Adolescents, Oulu, Finland.
   [Myllynen, Paivi] Oulu Univ Hosp, Nordlab Oulu, Oulu, Finland.
   [Karppa, Mikko; Kalviainen, Reetta; Ansakorpi, Hanna; Majamaa, Kari] Oulu Univ Hosp, Dept Neurol, Oulu, Finland.
   [Karppa, Mikko; Ansakorpi, Hanna; Majamaa, Kari] Univ Oulu, Res Unit Clin Neurosci, Neurol, Oulu, Finland.
   [Kalviainen, Reetta] Kuopio Univ Hosp, Dept Neurol, Kuopio, Finland.
   [Kalviainen, Reetta; Sokka, Arja; Jyrkila, Aino] Univ Eastern Finland, Inst Clin Med, Sch Med, Fac Hlth Sci, Kuopio, Finland.
   [Sokka, Arja; Jyrkila, Aino] Kuopio Univ Hosp, Dept Pediat Neurol, Kuopio, Finland.
   [Lahdetie, Jaana; Makitalo, Anna] Univ Turku, Dept Child Neurol, Turku, Finland.
   [Lahdetie, Jaana; Makitalo, Anna] Turku Univ Cent Hosp, Turku, Finland.
   [Haataja, Leena] Univ Helsinki, Childrens Hosp, Dept Pediat Neurol, Helsinki, Finland.
   [Haataja, Leena] Helsinki Univ Hosp, Helsinki, Finland.
   [Makitalo, Anna] Univ Turku, Dept Geriatr Med, Turku, Finland.
   [Ylikotila, Pauli] Univ Turku, Inst Clin Med, Dept Neurol, Turku, Finland.
   [Ylikotila, Pauli] Turku Univ Hosp, Div Clin Neurosci, Turku, Finland.
   [Eriksson, Kai] Tampere Univ Hosp, Tampere Ctr Child Hlth Res & Pediat Neurol, Tampere, Finland.
C3 University of Oulu; University of Oulu; University of Oulu; University
   of Oulu; University of Oulu; University of Oulu; University of Oulu;
   Kuopio University Hospital; University of Eastern Finland; University of
   Eastern Finland; University of Eastern Finland; Kuopio University
   Hospital; University of Turku; University of Turku; University of
   Helsinki; University of Helsinki; Helsinki University Central Hospital;
   University of Turku; University of Turku; University of Turku; Tampere
   University; Tampere University Hospital
RP Uusimaa, J (corresponding author), Univ Oulu, PEDEGO Res Unit, Oulu, Finland.; Uusimaa, J (corresponding author), Univ Oulu, Med Res Ctr Oulu, Oulu, Finland.
EM johanna.uusimaa@oulu.fi
RI Majamaa, Kari/A-1344-2012; Lahdetie, Jaana/AAR-3258-2020; Haataja,
   Leena/G-1160-2016; Kalviainen, Reetta/LDG-6033-2024
OI Lahdetie, Jaana/0000-0002-4962-248X; Hinttala,
   Reetta/0000-0002-7642-4008; Majamaa, Kari/0000-0002-9070-3791; Haataja,
   Leena/0000-0002-8057-6194
FU Special State Grants for Health Research in the Department of Pediatrics
   and Adolescence, Oulu University Hospital, Oulu, Finland; Arvo and Lea
   Ylppo Foundation; Orion Research Foundation; Foundation for Pediatric
   Research, Finland; Academy of Finland [138566]; Epilepsy Research
   Foundation, Finland; Academy of Finland (AKA) [138566] Funding Source:
   Academy of Finland (AKA)
FX Special State Grants for Health Research in the Department of Pediatrics
   and Adolescence, Oulu University Hospital, Oulu, Finland; Arvo and Lea
   Ylppo Foundation; Orion Research Foundation; Foundation for Pediatric
   Research, Finland; Academy of Finland, Grant/Award Number: Decision
   number 138566; Epilepsy Research Foundation, Finland
CR ASCONAPE JJ, 1993, EPILEPSIA, V34, P177, DOI 10.1111/j.1528-1157.1993.tb02395.x
   Baruffini E, 2015, MITOCHONDRION, V20, P52, DOI 10.1016/j.mito.2014.11.003
   Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006
   Béreau M, 2016, J NEUROL SCI, V368, P70, DOI 10.1016/j.jns.2016.06.062
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Fromenty B, 1997, J HEPATOL, V26, P43, DOI 10.1016/S0168-8278(97)80496-5
   Glauser T, 2013, EPILEPSIA, V54, P551, DOI 10.1111/epi.12074
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hynynen J, 2014, LIVER TRANSPLANT, V20, P1402, DOI 10.1002/lt.23965
   Janssen W, 2016, ACTA NEUROL BELG, V116, P17, DOI 10.1007/s13760-015-0499-8
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kayihan N, 2000, Pediatr Transplant, V4, P211, DOI 10.1034/j.1399-3046.2000.00115.x
   Koenig SA, 2006, EPILEPSIA, V47, P2027, DOI 10.1111/j.1528-1167.2006.00846.x
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Li SB, 2015, HEPATOLOGY, V61, P1730, DOI 10.1002/hep.27712
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Schmid MM, 2013, PHARMACOPSYCHIATRY, V46, P63, DOI 10.1055/s-0032-1323671
   Silva MFB, 2008, J INHERIT METAB DIS, V31, P205, DOI 10.1007/s10545-008-0841-x
   Sinclair DB, 2004, J CHILD NEUROL, V19, P498, DOI 10.1177/08830738040190070401
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Zabalza Ramon, 2014, BMC Res Notes, V7, P883, DOI 10.1186/1756-0500-7-883
   Zerem A, 2016, EPILEPSIA, V57, P1858, DOI 10.1111/epi.13560
NR 38
TC 9
Z9 10
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0013-9580
EI 1528-1167
J9 EPILEPSIA
JI Epilepsia
PD NOV
PY 2018
VL 59
IS 11
BP 2125
EP 2136
DI 10.1111/epi.14568
PG 12
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA HC4PA
UT WOS:000451784500014
PM 30255931
OA Bronze
DA 2024-11-01
ER

PT J
AU Panosyan, FB
   Tawil, R
   Herrmann, DN
AF Panosyan, Francis B.
   Tawil, Rabi
   Herrmann, David N.
TI EPISODIC WEAKNESS AND CHARCOT-MARIE-TOOTH DISEASE DUE TO A MITOCHONDRIAL
   <i>MT</i>-<i>ATP6</i> MUTATION
SO MUSCLE & NERVE
LA English
DT Article
DE Charcot-Marie-Tooth disease; episodic weakness; inherited neuropathy;
   mitochondrial ATPase; periodic paralysis
ID LEIGH-SYNDROME; T9176C MUTATION; ATAXIA; ATPASE; MTDNA; GENE; DISORDERS;
   PHENOTYPE; SUBTYPES; FAMILY
AB Introduction: Episodic muscle weakness is the hallmark of a heterogeneous group of disorders known as periodic paralysis. A majority are due to single nucleotide mutations causing membrane depolarization. Methods: We report 2 family members with chronic, slowly progressive, distal axonal neuropathy, or Charcot-Marie-Tooth disease type 2 (CMT2) and episodic weakness resembling periodic paralysis. Results: Next generation sequencing (NGS) identified a mitochondrial MT-ATP6 mutation m.9185T>C (p.Leu220Pro) in both patients, consistent with a previous report of an association with this phenotype. The episodic weakness has been responsive to acetazolamide therapy for a few decades. By contrast, the underlying axonal neuropathy is quite progressive despite treatment with acetazolamide. Conclusions: Mitochondrial DNA mutations should be considered in patients with a history of episodic weakness and axonal inherited neuropathy (CMT2). The episodic weakness is responsive to acetazolamide therapy, and electrophysiological testing for periodic paralysis with a long exercise protocol is negative in these cases.
C1 [Panosyan, Francis B.; Tawil, Rabi; Herrmann, David N.] Univ Rochester, Med Ctr, Dept Neurol, Box 673,601 Elmwood Ave, Rochester, NY 14642 USA.
C3 University of Rochester
RP Panosyan, FB (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Box 673,601 Elmwood Ave, Rochester, NY 14642 USA.
EM 4fbp@queensu.ca
CR Auré K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Braathen GJ, 2012, ACTA NEUROL SCAND, V126, DOI 10.1111/ane.12013
   Brum M, 2014, CASE REP NEUROL MED, V2014, DOI 10.1155/2014/701761
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   CAIN BD, 1986, J BIOL CHEM, V261, P43
   Campos Y, 1997, NEUROLOGY, V49, P595, DOI 10.1212/WNL.49.2.595
   Cannon SC, 2006, ANNU REV NEUROSCI, V29, P387, DOI 10.1146/annurev.neuro.29.051605.112815
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   Cleland JC, 2014, CLIN NEUROPHYSIOL, V125, P2134, DOI 10.1016/j.clinph.2014.02.005
   Craig K, 2007, J MED GENET, V44, P797, DOI 10.1136/jmg.2007.052902
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Dionisi-Vici C, 1998, J INHERIT METAB DIS, V21, P2, DOI 10.1023/A:1005397227996
   Duno M, 2013, GENE, V515, P372, DOI 10.1016/j.gene.2012.12.066
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012
   LAMMINEN T, 1995, AM J HUM GENET, V56, P1238
   López-Gallardo E, 2009, J MED GENET, V46, P64, DOI 10.1136/jmg.2008.060616
   Miller TM, 2004, NEUROLOGY, V63, P1647, DOI 10.1212/01.WNL.0000143383.91137.00
   Murphy SM, 2012, J NEUROL NEUROSUR PS, V83, P706, DOI 10.1136/jnnp-2012-302451
   Pfeffer G, 2012, J NEUROL NEUROSUR PS, V83, P883, DOI 10.1136/jnnp-2012-302568
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Rudnik-Schöneborn S, 2016, CLIN GENET, V89, P34, DOI 10.1111/cge.12594
   Sansone V, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005045.pub2
   Sansone VA, 2016, NEUROLOGY, V86, P1408, DOI 10.1212/WNL.0000000000002416
   Saporta ASD, 2011, ANN NEUROL, V69, P22, DOI 10.1002/ana.22166
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35
   Takahashi S, 1998, AM J HUM GENET, V62, P717, DOI 10.1086/301751
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tengan CH, 2004, J NEUROL NEUROSUR PS, V75, P497, DOI 10.1136/jnnp.2003.013870
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Venance SL, 2006, BRAIN, V129, P8, DOI 10.1093/brain/awh639
   Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027
   Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021
NR 39
TC 7
Z9 7
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD JUN
PY 2017
VL 55
IS 6
BP 922
EP +
DI 10.1002/mus.25453
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA EY5TA
UT WOS:000404041600028
PM 27783406
DA 2024-11-01
ER

PT J
AU Sinnecker, T
   Andelova, M
   Mayr, M
   Rüegg, S
   Sinnreich, M
   Hench, J
   Frank, S
   Schaller, A
   Stippich, C
   Wuerfel, J
   Bonati, LH
AF Sinnecker, Tim
   Andelova, Michaela
   Mayr, Michael
   Ruegg, Stephan
   Sinnreich, Michael
   Hench, Juergen
   Frank, Stephan
   Schaller, Andre
   Stippich, Christoph
   Wuerfel, Jens
   Bonati, Leo H.
TI Diagnosis of adult-onset MELAS syndrome in a 63-year-old patient with
   suspected recurrent strokes - a case report
SO BMC NEUROLOGY
LA English
DT Article
DE MELAS; Stroke-like episodes; Recurrent ischemic strokes; MRI
ID LACTIC-ACIDOSIS; MITOCHONDRIAL-MYOPATHY; EPISODES MELAS; ENCEPHALOPATHY;
   ENCEPHALOMYOPATHY; DIFFUSION; DISORDERS; SERIAL
AB BackgroundMitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) is a mitochondrial cytopathy caused by mutations in mitochondrial DNA. Clinical manifestation is typically before the age of 40.Case presentationWe present the case of a 63-year-old female in whom the symptoms of MELAS were initially misdiagnosed as episodes of recurrent ischemic strokes. Brain imaging including MRI, clinical and laboratory findings that lent cues to the diagnosis of MELAS are discussed. In addition, MRI findings in MELAS in comparison to imaging mimics of MELAS are presented.ConclusionsThis case underscores the importance of considering MELAS as a potential cause of recurrent stroke-like events if imaging findings are untypical for cerebral infarction, even among middle-aged patients with vascular risk factors.
C1 [Sinnecker, Tim; Andelova, Michaela; Ruegg, Stephan; Sinnreich, Michael; Bonati, Leo H.] Univ Hosp, Dept Med, Neurol Clin & Policlin, Petersgraben 4, CH-4031 Basel, Switzerland.
   [Sinnecker, Tim; Andelova, Michaela; Ruegg, Stephan; Sinnreich, Michael; Bonati, Leo H.] Univ Hosp, Dept Clin Res, Neurol Clin & Policlin, Petersgraben 4, CH-4031 Basel, Switzerland.
   [Sinnecker, Tim; Andelova, Michaela; Ruegg, Stephan; Sinnreich, Michael; Bonati, Leo H.] Univ Hosp, Dept Biomed Engn, Neurol Clin & Policlin, Petersgraben 4, CH-4031 Basel, Switzerland.
   [Sinnecker, Tim; Andelova, Michaela; Mayr, Michael; Ruegg, Stephan; Sinnreich, Michael; Hench, Juergen; Frank, Stephan; Stippich, Christoph; Bonati, Leo H.] Univ Basel, Petersgraben 4, CH-4031 Basel, Switzerland.
   [Sinnecker, Tim; Wuerfel, Jens] Med Imaging Anal Ctr AG, Basel, Switzerland.
   [Mayr, Michael] Univ Hosp, Dept Internal Med, Basel, Switzerland.
   [Hench, Juergen; Frank, Stephan] Univ Hosp, Inst Pathol, Div Neuropathol, Basel, Switzerland.
   [Schaller, Andre] Univ Bern, Bern Univ Hosp, Inselspital, Div Human Genet,Dept Pediat, Bern, Switzerland.
   [Stippich, Christoph] Univ Hosp, Dept Radiol, Basel, Switzerland.
C3 University of Basel; University of Bern; University Hospital of Bern
RP Bonati, LH (corresponding author), Univ Hosp, Dept Med, Neurol Clin & Policlin, Petersgraben 4, CH-4031 Basel, Switzerland.; Bonati, LH (corresponding author), Univ Hosp, Dept Clin Res, Neurol Clin & Policlin, Petersgraben 4, CH-4031 Basel, Switzerland.; Bonati, LH (corresponding author), Univ Hosp, Dept Biomed Engn, Neurol Clin & Policlin, Petersgraben 4, CH-4031 Basel, Switzerland.; Bonati, LH (corresponding author), Univ Basel, Petersgraben 4, CH-4031 Basel, Switzerland.
EM Tim.Sinnecker@usb.ch; Leo.Bonati@usb.ch
RI Rueegg, Stephan/ADO-2686-2022; Bonati, Leo/G-4058-2012; Schaller,
   Andre/L-4174-2018
OI Sinnreich, Michael/0000-0002-9835-1276; Andelova,
   Michaela/0000-0002-3812-7483; Wuerfel, Jens/0000-0002-0034-8053; Bonati,
   Leo/0000-0003-1163-8133; Schaller, Andre/0000-0001-5174-5764
CR Adam G, 2018, INSIGHTS IMAGING
   Aurangzeb Sidra, 2014, Pract Neurol, V14, P432, DOI 10.1136/practneurol-2014-000853
   Brady E, 2018, CLIN IMAG, V47, P80, DOI 10.1016/j.clinimag.2017.08.008
   CRIMMINS D, 1993, J NEUROL NEUROSUR PS, V56, P900, DOI 10.1136/jnnp.56.8.900
   Devine MJ, 2018, NAT REV NEUROSCI, V19, P63, DOI 10.1038/nrn.2017.170
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Fang GL, 2018, CLIN INTERV AGING, V13, P2421, DOI 10.2147/CIA.S186636
   Farrar MA, 2010, PEDIATRICS, V126, pE734, DOI 10.1542/peds.2009-2930
   Geberhiwot T, 2006, NEW ENGL J MED, V354, P1096
   Gieraerts C, 2013, J COMPUT ASSIST TOMO, V37, P279, DOI 10.1097/RCT.0b013e3182811170
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Ito H, 2011, BRAIN DEV-JPN, V33, P283, DOI 10.1016/j.braindev.2010.06.010
   Kim JH, 2011, KOREAN J RADIOL, V12, P15, DOI 10.3348/kjr.2011.12.1.15
   Kimata KG, 1998, ARCH NEUROL-CHICAGO, V55, P722, DOI 10.1001/archneur.55.5.722
   Kisanuki YY, 2006, ARCH NEUROL-CHICAGO, V63, P1200, DOI 10.1001/archneur.63.8.1200
   Koenig MK, 2016, JAMA NEUROL, V73, P591, DOI 10.1001/jamaneurol.2015.5072
   Kubota H, 2005, J CHILD NEUROL, V20, P116, DOI 10.1177/08830738050200020601
   Kung NH, 2016, JAMA NEUROL, V73, P880, DOI 10.1001/jamaneurol.2016.1336
   Li JY, 2007, J FORMOS MED ASSOC, V106, P528, DOI 10.1016/S0929-6646(07)60003-5
   Lyoubi-Idrissi A, 2017, STROKE, V48, P1408, DOI 10.1161/STROKEAHA.116.015724
   Malhotra K, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0583-7
   Marques-Matos C, 2016, JAMA NEUROL, V73, P604, DOI 10.1001/jamaneurol.2015.5061
   MARTINUZZI A, 1992, J NEUROL SCI, V113, P222, DOI 10.1016/0022-510X(92)90250-O
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Narita Hiroyuki, 2004, No To Shinkei, V56, P345
   Nightingale H, 2016, BRAIN, V139, P1633, DOI 10.1093/brain/aww081
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   Sharfstein SR, 1999, ARCH NEUROL-CHICAGO, V56, P241, DOI 10.1001/archneur.56.2.241
   Sheerin F, 2008, CLIN RADIOL, V63, P1245, DOI 10.1016/j.crad.2007.12.018
   Testai FD, 2010, ARCH NEUROL-CHICAGO, V67, P19, DOI 10.1001/archneurol.2009.309
   Tzoulis C, 2009, STROKE, V40, pE15, DOI 10.1161/STROKEAHA.108.523118
   Wang XY, 2003, NEURORADIOLOGY, V45, P640, DOI 10.1007/s00234-003-1029-6
   Wattjes MP, 2013, MULT SCLER J, V19, P1826, DOI 10.1177/1352458513510224
   Xu WXZ, 2018, J COMPUT ASSIST TOMO, V42, P510, DOI 10.1097/RCT.0000000000000712
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yoneda M, 1999, NEUROLOGY, V53, P2182, DOI 10.1212/WNL.53.9.2182
NR 37
TC 17
Z9 17
U1 1
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2377
J9 BMC NEUROL
JI BMC Neurol.
PD MAY 8
PY 2019
VL 19
AR 91
DI 10.1186/s12883-019-1306-6
PG 8
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA HX7ML
UT WOS:000467589100003
PM 31068171
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Chang, JC
   Hoel, F
   Liu, KH
   Wei, YH
   Cheng, FC
   Kuo, SJ
   Tronstad, KJ
   Liu, CS
AF Chang, Jui-Chih
   Hoel, Fredrik
   Liu, Ko-Hung
   Wei, Yau-Huei
   Cheng, Fu-Chou
   Kuo, Shou-Jen
   Tronstad, Karl Johan
   Liu, Chin-San
TI Peptide-mediated delivery of donor mitochondria improves mitochondrial
   function and cell viability in human cybrid cells with the MELAS A3243G
   mutation
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PENETRATING PEPTIDES; MEMBRANE INTERACTIONS; COMPLEX I; FISSION; RESCUE;
   PEP-1; OPA1; TRANSPLANTATION; TRANSLOCATION; DYNAMICS
AB The cell penetrating peptide, Pep-1, has been shown to facilitate cellular uptake of foreign mitochondria but further research is required to evaluate the use of Pep-1-mediated mitochondrial delivery (PMD) in treating mitochondrial defects. Presently, we sought to determine whether mitochondrial transplantation rescue mitochondrial function in a cybrid cell model of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) disease. Following PMD, recipient cells had internalized donor mitochondria after 1 h, and expressed higher levels of normal mitochondrial DNA, particularly at the end of the treatment and 11 days later. After 4 days, mitochondrial respiratory function had recovered and biogenesis was evident in the Pep-1 and PMD groups, compared to the untreated MELAS group. However, only PMD was able to reverse the fusion-to-fission ratio of mitochondrial morphology, and mitochondria shaping proteins resembled the normal pattern seen in the control group. Cell survival following hydrogen peroxide-induced oxidative stress was also improved in the PMD group. Finally, we observed that PMD partially normalized cytokine expression, including that of interleukin (IL)-7, granulocyte macrophage-colony-stimulating factor (GM-CSF), and vascular endothelial growth factor (VEGF), in the MELAS cells. Presently, our data further confirm the protective effects of PMD as well in MELAS disease.
C1 [Chang, Jui-Chih; Liu, Ko-Hung; Liu, Chin-San] Changhua Christian Hosp, Vasc & Genom Ctr, Changhua, Taiwan.
   [Hoel, Fredrik; Tronstad, Karl Johan] Univ Bergen, Dept Biomed, Bergen, Norway.
   [Wei, Yau-Huei] Natl Yang Ming Univ, Sch Life Sci, Dept Biochem & Mol Biol, Taipei, Taiwan.
   [Wei, Yau-Huei] Mackay Med Coll, Dept Med, Taipei, Taiwan.
   [Cheng, Fu-Chou] Taichung Vet Gen Hosp, Dept Med Res, Stem Cell Ctr, Changhua, Taiwan.
   [Kuo, Shou-Jen] Changhua Christian Hosp, Dept Surg, Changhua, Taiwan.
   [Liu, Chin-San] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan.
C3 Changhua Christian Hospital; University of Bergen; National Yang Ming
   Chiao Tung University; Mackay Medical College; Taichung Veterans General
   Hospital; Changhua Christian Hospital; Changhua Christian Hospital
RP Liu, CS (corresponding author), Changhua Christian Hosp, Vasc & Genom Ctr, Changhua, Taiwan.; Liu, CS (corresponding author), Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan.
EM 26602@cch.org.tw
RI Wei, Yau-Huei/ABA-6841-2021; Cheng, Chien-shan/I-4065-2019; Hoel,
   Fredrik/K-9041-2013
OI Chang, Jui Chih/0000-0002-8349-862X; Hoel, Fredrik/0000-0002-4820-3101;
   Wei, Yau-Huei/0000-0002-6429-2546; Tronstad, Karl
   Johan/0000-0003-3496-3123
FU Changhua Christian Hospital [104-CCH-IST-005]; National Science Council
   [MOST 103-2320-B-371 -001-, MOST 104-2314-B-371 -001 -MY2]
FX This research was supported by the Changhua Christian Hospital
   (104-CCH-IST-005) and National Science Council (MOST 103-2320-B-371
   -001-, MOST 104-2314-B-371 -001 -MY2). We thank Prof. Hong-Lin Su of
   National Chung Hsing University, Taiwan, for their effort in providing
   us with a TEM data for mitochondrial morphology.
CR Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   Buhlman L, 2014, BBA-MOL CELL RES, V1843, P2012, DOI 10.1016/j.bbamcr.2014.05.012
   Cavalli G, 2015, RHEUMATOLOGY, V54, P2134, DOI 10.1093/rheumatology/kev269
   Cerrato CP, 2015, FASEB J, V29, P4589, DOI 10.1096/fj.14-269225
   Chang JC, 2016, TRANSL RES, V170, P40, DOI 10.1016/j.trsl.2015.12.003
   Chang JC, 2013, CYTOTHERAPY, V15, P1580, DOI 10.1016/j.jcyt.2013.06.008
   Chang JC, 2013, NEUROSIGNALS, V21, P160, DOI 10.1159/000341981
   Cho YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032778
   Cselenyák A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-29
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946
   Garrido-Maraver J, 2015, BBA-MOL BASIS DIS, V1852, P2535, DOI 10.1016/j.bbadis.2015.08.027
   Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419
   Henriques ST, 2008, J PEPT SCI, V14, P482, DOI 10.1002/psc.1003
   Henriques ST, 2004, BIOCHEMISTRY-US, V43, P9716, DOI 10.1021/bi036325k
   Hsieh RH, 2001, J BIOMED SCI, V8, P328, DOI 10.1159/000054051
   HUANG CC, 1994, J NEUROL NEUROSUR PS, V57, P586, DOI 10.1136/jnnp.57.5.586
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Joseph AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069327
   Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004
   Lin BY, 2015, ANN NY ACAD SCI, V1350, P17, DOI 10.1111/nyas.12858
   Liu KM, 2014, MICROVASC RES, V92, P10, DOI 10.1016/j.mvr.2014.01.008
   Losón OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721
   MacVicar TDB, 2014, J CELL SCI, V127, P2313, DOI 10.1242/jcs.144337
   Margus H, 2012, MOL THER, V20, P525, DOI 10.1038/mt.2011.284
   Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, pH966, DOI 10.1152/ajpheart.00883.2012
   Meloni BP, 2014, CELL MOL NEUROBIOL, V34, P173, DOI 10.1007/s10571-013-9999-3
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011
   Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173
   Munyendo WL, 2012, BIOMOLECULES, V2, P187, DOI 10.3390/biom2020187
   Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006
   Nikolaisen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101365
   Pacak CA, 2015, BIOL OPEN, V4, P622, DOI 10.1242/bio.201511478
   Pasquier J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-94
   Peng JY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002212
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Picard M, 2013, J APPL PHYSIOL, V115, P1562, DOI 10.1152/japplphysiol.00819.2013
   Reddy PH, 2011, BRAIN RES REV, V67, P103, DOI 10.1016/j.brainresrev.2010.11.004
   RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X
   Ross MF, 2004, BIOCHEM J, V383, P457, DOI 10.1042/BJ20041095
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Suarez-Rivero Juan M, 2016, Diseases, V5, DOI 10.3390/diseases5010001
   Suliman HB, 2016, PHARMACOL REV, V68, P20, DOI 10.1124/pr.115.011502
   Tronstad KJ, 2014, CURR PHARM DESIGN, V20, P5634, DOI 10.2174/1381612820666140305230546
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Walker MA, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/164309
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211
   Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x
   Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599
NR 53
TC 47
Z9 48
U1 2
U2 14
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 6
PY 2017
VL 7
AR 10710
DI 10.1038/s41598-017-10870-5
PG 15
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FG0MI
UT WOS:000409439900128
PM 28878349
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Pallotti, F
   Binelli, G
   Fabbri, R
   Valentino, ML
   Vicenti, R
   Macciocca, M
   Cevoli, S
   Baruzzi, A
   DiMauro, S
   Carelli, V
AF Pallotti, Francesco
   Binelli, Giorgio
   Fabbri, Raffaella
   Valentino, Maria L.
   Vicenti, Rossella
   Macciocca, Maria
   Cevoli, Sabina
   Baruzzi, Agostino
   DiMauro, Salvatore
   Carelli, Valerio
TI A Wide Range of 3243A&gt;G/tRNALeu(UUR) (MELAS) Mutation Loads May
   Segregate in Offspring through the Female Germline Bottleneck
SO PLOS ONE
LA English
DT Article
ID MAMMALIAN MITOCHONDRIAL-DNA; RANDOM GENETIC DRIFT; MUTANT MTDNA; A3243G
   MUTATION; RAPID SEGREGATION; HUMAN OOCYTES; HUMAN-CELLS; HETEROPLASMY;
   DISEASE; COMPLEMENTATION
AB Segregation of mutant mtDNA in human tissues and through the germline is debated, with no consensus about the nature and size of the bottleneck hypothesized to explain rapid generational shifts in mutant loads. We investigated two maternal lineages with an apparently different inheritance pattern of the same pathogenic mtDNA 3243A > G/tRNA(Leu(UUR)) (MELAS) mutation. We collected blood cells, muscle biopsies, urinary epithelium and hair follicles from 20 individuals, as well as oocytes and an ovarian biopsy from one female mutation carrier, all belonging to the two maternal lineages to assess mutant mtDNA load, and calculated the theoretical germline bottleneck size (number of segregating units). We also evaluated "mother-to-offspring'' segregations from the literature, for which heteroplasmy assessment was available in at least three siblings besides the proband. Our results showed that mutation load was prevalent in skeletal muscle and urinary epithelium, whereas in blood cells there was an inverse correlation with age, as previously reported. The histoenzymatic staining of the ovarian biopsy failed to show any cytochrome-c-oxidase defective oocyte. Analysis of four oocytes and one offspring from the same unaffected mother of the first family showed intermediate heteroplasmic mutant loads (10% to 75%), whereas very skewed loads of mutant mtDNA (0% or 81%) were detected in five offspring of another unaffected mother from the second family. Bottleneck size was 89 segregating units for the first mother and 84 for the second. This was remarkably close to 88, the number of "segregating units'' in the "mother-to-offspring'' segregations retrieved from literature. In conclusion, a wide range of mutant loads may be found in offspring tissues and oocytes, resulting from a similar theoretical bottleneck size.
C1 [Pallotti, Francesco; DiMauro, Salvatore] Columbia Univ, Dept Neurol, New York, NY USA.
   [Pallotti, Francesco] Univ Insubria, Dipartimento Sci Chirurg & Morfol, Varese, Italy.
   [Binelli, Giorgio] Univ Insubria, Dipartimento Sci Teor & Appl, Varese, Italy.
   [Fabbri, Raffaella; Vicenti, Rossella; Macciocca, Maria] Univ Bologna, Osped S Orsola Malpighi, Unita Operat Ginecol & Fisiopatol Riprod Umana, Bologna, Italy.
   [Fabbri, Raffaella; Vicenti, Rossella; Macciocca, Maria] Univ Bologna, Dipartimento Sci Med & Chirurg DIMEC, Bologna, Italy.
   [Valentino, Maria L.; Cevoli, Sabina; Baruzzi, Agostino; Carelli, Valerio] Osped Bellaria, IRCCS, Ist Sci Neurol Bologna, Bologna, Italy.
   [Valentino, Maria L.; Cevoli, Sabina; Baruzzi, Agostino; Carelli, Valerio] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie DIBINEM, Bologna, Italy.
C3 Columbia University; University of Insubria; University of Insubria;
   University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di
   Bologna; University of Bologna; IRCCS Istituto delle Scienze
   Neurologiche di Bologna (ISNB); University of Bologna
RP Carelli, V (corresponding author), Osped Bellaria, IRCCS, Ist Sci Neurol Bologna, Bologna, Italy.
EM valerio.carelli@unibo.it
RI Binelli, Giorgio/JOH-3162-2023
OI CARELLI, VALERIO/0000-0003-4923-6404; Pallotti,
   Francesco/0000-0001-9946-8516; VALENTINO, MARIA
   LUCIA/0000-0001-5323-0115
FU FAR (Fondo di Ateneo per la Ricerca) from University of Bologna; FAR
   (Fondo di Ateneo per la Ricerca) from University of Insubria
FX This study was supported by FAR (Fondo di Ateneo per la Ricerca) from
   University of Bologna and from University of Insubria. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Cao LQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000756
   Carling PJ, 2011, MITOCHONDRION, V11, P686, DOI 10.1016/j.mito.2011.05.004
   Cevoli S, 2010, CEPHALALGIA, V30, P919, DOI 10.1177/0333102409354654
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326
   DEVRIES D, 1994, J NEUROL SCI, V124, P77, DOI 10.1016/0022-510X(94)90014-0
   Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z
   Dubowitz V., 2007, Muscle Biopsy: A Practical Approach
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Enríquez JA, 2000, J BIOL CHEM, V275, P11207, DOI 10.1074/jbc.275.15.11207
   Fabbri R, 2003, GYNECOL ONCOL, V89, P259, DOI 10.1016/S0090-8258(02)00098-7
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HOWELL N, 1992, HUM GENET, V90, P117
   Huang CC, 1996, ACTA NEUROL SCAND, V93, P198
   Jacobs HT, 2000, BIOESSAYS, V22, P564, DOI 10.1002/(SICI)1521-1878(200006)22:6<564::AID-BIES9>3.0.CO;2-4
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   KOEHLER CM, 1991, GENETICS, V129, P247
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Lehtinen SK, 2000, GENETICS, V154, P363
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   LIOU CW, 1994, ACTA NEUROL SCAND, V90, P354
   Marchington DR, 1998, AM J HUM GENET, V63, P769, DOI 10.1086/302009
   Marchington DR, 1997, AM J HUM GENET, V60, P408
   MARTINUZZI A, 1992, J NEUROL SCI, V113, P222, DOI 10.1016/0022-510X(92)90250-O
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0
   Poe BG, 2010, ANAL BIOANAL CHEM, V397, P3397, DOI 10.1007/s00216-010-3751-3
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Takai D, 1997, J BIOL CHEM, V272, P6028, DOI 10.1074/jbc.272.9.6028
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wonnapinij P, 2010, AM J HUM GENET, V86, P540, DOI 10.1016/j.ajhg.2010.02.023
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
   Zsurka G, 2007, AM J HUM GENET, V80, P298, DOI 10.1086/511282
NR 57
TC 12
Z9 13
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 7
PY 2014
VL 9
IS 5
AR e96663
DI 10.1371/journal.pone.0096663
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AG9HB
UT WOS:000335728900079
PM 24805791
OA Green Submitted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Gambelli, S
   Malandrini, A
   Ginanneschi, F
   Berti, G
   Cardaioli, E
   De Stefano, R
   Franci, M
   Salvadori, C
   Mari, F
   Bruttini, M
   Rossi, A
   Federico, A
   Renieri, A
AF Gambelli, S
   Malandrini, A
   Ginanneschi, F
   Berti, G
   Cardaioli, E
   De Stefano, R
   Franci, M
   Salvadori, C
   Mari, F
   Bruttini, M
   Rossi, A
   Federico, A
   Renieri, A
TI Mitochondrial abnormalities in genetically assessed oculopharyngeal
   muscular dystrophy
SO EUROPEAN NEUROLOGY
LA English
DT Article
DE muscle biopsy; mitochondrial abnormality; intranuclear inclusions;
   oculopharyngeal muscular dystrophy
ID INCLUSION-BODY MYOSITIS; DNA DELETIONS; MUSCLE-FIBERS; MYOPATHY; GENE
AB We report a family with a clinical diagnosis of oculopharyngeal muscular dystrophy in which muscle biopsy showed mitochondrial changes such as cytochrome-c-oxidasenegative fibers and aggregates of mitochondria containing paracrystalline inclusions. Molecular analysis demonstrated a GCG expansion in the poly( A)-binding protein 2 (PABP2) gene and failed to demonstrate multiple deletions of mtDNA. We hypothesize that mitochondrial abnormalities may be a secondary phenomenon. This observation may suggest that the PABP2 gene could interfere in the posttranscriptional regulation of genes involved in mitochondrial function. Copyright (C) 2004 S. Karger AG, Basel.
C1 Univ Siena, Dept Neurol & Behav Sci, IT-53100 Siena, Italy.
   Univ Siena, Inst Rheumatol, IT-53100 Siena, Italy.
   Univ Siena, Orthoped & Traumatol Clin, IT-53100 Siena, Italy.
C3 University of Siena; University of Siena; University of Siena
RP Univ Siena, Dept Neurol & Behav Sci, Viale Bracci 2, IT-53100 Siena, Italy.
EM malandrini@unisi.it
RI Federico, Antonio/H-8871-2017; Renieri, Alessandra/K-5950-2016; Mari,
   Francesca/E-7737-2012
OI Renieri, Alessandra/0000-0002-0846-9220; federico,
   antonio/0000-0002-5246-1621; Mari, Francesca/0000-0003-1992-1654;
   Cardaioli, Elena/0000-0003-2850-6698
FU Telethon [E.1145] Funding Source: Medline
CR Andersson U, 2000, BIOCHEM J, V346, P33, DOI 10.1042/0264-6021:3460033
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164
   Horvath R, 1998, J NEUROPATH EXP NEUR, V57, P396, DOI 10.1097/00005072-199805000-00003
   Jansson M, 2000, ACTA NEUROPATHOL, V100, P23, DOI 10.1007/s004010051188
   Kim YJ, 2001, HUM MOL GENET, V10, P1129, DOI 10.1093/hmg/10.11.1129
   Levine TD, 1998, MUSCLE NERVE, V21, P1724, DOI 10.1002/(SICI)1097-4598(199812)21:12<1724::AID-MUS15>3.0.CO;2-2
   Müller T, 2001, MUSCLE NERVE, V24, P120
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   PAUZNER R, 1991, MUSCLE NERVE, V14, P947, DOI 10.1002/mus.880141004
   Sambrook J., 1989, Molecular Cloning
   SCHRODER JM, 1995, NEUROPATH APPL NEURO, V21, P68, DOI 10.1111/j.1365-2990.1995.tb01030.x
   Wong KT, 1996, NEUROMUSCULAR DISORD, V6, P163, DOI 10.1016/0960-8966(95)00039-9
NR 13
TC 11
Z9 14
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0014-3022
EI 1421-9913
J9 EUR NEUROL
JI Eur. Neurol.
PY 2004
VL 51
IS 3
BP 144
EP 147
DI 10.1159/000077070
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 818KT
UT WOS:000221244700004
PM 14988608
DA 2024-11-01
ER

PT J
AU Stoll, EA
   Karapavlovic, N
   Rosa, H
   Woodmass, M
   Rygiel, K
   White, K
   Turnbull, DM
   Faulkes, CG
AF Stoll, Elizabeth A.
   Karapavlovic, Nevena
   Rosa, Hannah
   Woodmass, Michael
   Rygiel, Karolina
   White, Kathryn
   Turnbull, Douglass M.
   Faulkes, Chris G.
TI Naked mole-rats maintain healthy skeletal muscle and Complex IV
   mitochondrial enzyme function into old age
SO AGING-US
LA English
DT Article
DE naked mole-rat; mitochondria; oxidative stress; animal models of aging;
   sarcopenia
ID LONGEST-LIVING RODENT; DNA DELETIONS; OXIDATIVE DAMAGE; SINGLE CELLS;
   MICE; GENOME; MECHANISMS; MUTATIONS; DISEASE; ACCUMULATION
AB The naked mole-rat (NMR) Heterocephalus glaber is an exceptionally long-lived rodent, living up to 32 years in captivity. This extended lifespan is accompanied by a phenotype of negligible senescence, a phenomenon of very slow changes in the expected physiological characteristics with age. One of the many consequences of normal aging in mammals is the devastating and progressive loss of skeletal muscle, termed sarcopenia, caused in part by respiratory enzyme dysfunction within the mitochondria of skeletal muscle fibers. Here we report that NMRs avoid sarcopenia for decades. Muscle fiber integrity and mitochondrial ultrastructure are largely maintained in aged animals. While mitochondrial Complex IV expression and activity remains stable, Complex I expression is significantly decreased. We show that aged naked mole-rat skeletal muscle tissue contains some mitochondrial DNA rearrangements, although the common mitochondrial DNA deletions associated with aging in human and other rodent skeletal muscles are not present. Interestingly, NMR skeletal muscle fibers demonstrate a significant increase in mitochondrial DNA copy number. These results have intriguing implications for the role of mitochondria in aging, suggesting Complex IV, but not Complex I, function is maintained in the long-lived naked mole rat, where sarcopenia is avoided and healthy muscle function is maintained for decades.
C1 [Stoll, Elizabeth A.; Rosa, Hannah; Rygiel, Karolina; Turnbull, Douglass M.] Newcastle Univ, LLHW Ctr Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Stoll, Elizabeth A.; Rosa, Hannah; Rygiel, Karolina; Turnbull, Douglass M.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Stoll, Elizabeth A.; Rygiel, Karolina; Turnbull, Douglass M.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Karapavlovic, Nevena; Woodmass, Michael] Newcastle Univ, Undergrad Programme Biomed Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [White, Kathryn] Newcastle Univ, Sch Med, Electron Microscopy Res Serv, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Faulkes, Chris G.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle
   University - UK; Newcastle University - UK; Newcastle University - UK;
   University of London; Queen Mary University London
RP Stoll, EA (corresponding author), Newcastle Univ, LLHW Ctr Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Stoll, EA (corresponding author), Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Stoll, EA (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM elizabeth.stoll@ncl.ac.uk
RI Faulkes, Chris/O-8101-2019
OI Stoll, Elizabeth/0000-0003-1997-7949; Rosa, Hannah/0000-0003-4624-752X;
   Faulkes, Christopher/0000-0002-5228-9075; Turnbull,
   Doug/0000-0002-8878-9901
FU Newcastle University Centre for Brain Ageing and Vitality (Biotechnology
   and Biological Sciences Research Council); Newcastle University Centre
   for Brain Ageing and Vitality (Engineering and Physical Sciences
   Research Council); Newcastle University Centre for Brain Ageing and
   Vitality (Economic and Social Research Council); Newcastle University
   Centre for Brain Ageing and Vitality (Medical Research Council)
   [G0700718]; UK NIHR Biomedical Research Centre in Age; MRC Centre for
   Neuromuscular Disease [G000608-1]; Wellcome Trust Centre for
   Mitochondrial Research [096919/Z/11/Z]; MRC [G0700718, MR/L016354/1,
   MR/K000608/1, G0800674, MC_G0802536] Funding Source: UKRI
FX This project was funded by Newcastle University Centre for Brain Ageing
   and Vitality (supported by the Biotechnology and Biological Sciences
   Research Council, Engineering and Physical Sciences Research Council,
   Economic and Social Research Council and Medical Research Council
   [G0700718]), the UK NIHR Biomedical Research Centre in Age and Age
   Related Diseases award to the Newcastle upon Tyne Hospitals NHS
   Foundation Trust, MRC Centre for Neuromuscular Disease [G000608-1], The
   Wellcome Trust Centre for Mitochondrial Research [096919/Z/11/Z].
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andziak B, 2005, MECH AGEING DEV, V126, P1206, DOI 10.1016/j.mad.2005.06.009
   Andziak B, 2006, AGING CELL, V5, P525, DOI 10.1111/j.1474-9726.2006.00246.x
   Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x
   Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Buffenstein R, 2007, FASEB J, P21
   Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Csiszar A, 2007, AM J PHYSIOL-HEART C, V293, pH919, DOI 10.1152/ajpheart.01287.2006
   de Souza-Pinto NC, 2008, DNA REPAIR, V7, P1098, DOI 10.1016/j.dnarep.2008.03.011
   Edrey YH, 2011, ILAR J, V52, P41, DOI 10.1093/ilar.52.1.41
   Eimon PM, 1996, DEV GENET, V18, P107, DOI 10.1002/(SICI)1520-6408(1996)18:2<107::AID-DVG3>3.0.CO;2-D
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Greaves LC, 2011, MECH AGEING DEV, V132, P588, DOI 10.1016/j.mad.2011.10.004
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Kruse SE, 2016, AGING CELL, V15, P89, DOI 10.1111/acel.12412
   Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   Murase T, 2000, MODERN PATHOL, V13, P147, DOI 10.1038/modpathol.3880028
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Proctor DN, 1998, J NUTR, V128, p351S, DOI 10.1093/jn/128.2.351S
   Rahman S, 2000, BRAIN, V123, P591, DOI 10.1093/brain/123.3.591
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Tarry-Adkins JL, 2016, DIS MODEL MECH, V9, P1221, DOI 10.1242/dmm.026591
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Yu CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026729
NR 42
TC 24
Z9 24
U1 0
U2 20
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD DEC
PY 2016
VL 8
IS 12
BP 3468
EP +
DI 10.18632/aging.101140
PG 18
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EI5IP
UT WOS:000392527800025
PM 27997359
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Campbell, GR
   Ziabreva, I
   Reeve, AK
   Krishnan, KJ
   Reynolds, R
   Howell, O
   Lassmann, H
   Turnbull, DM
   Mahad, DJ
AF Campbell, Graham R.
   Ziabreva, Iryna
   Reeve, Amy K.
   Krishnan, Kim J.
   Reynolds, Richard
   Howell, Owen
   Lassmann, Hans
   Turnbull, Doug M.
   Mahad, Don J.
TI Mitochondrial DNA Deletions and Neurodegeneration in Multiple Sclerosis
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID SUBSTANTIA-NIGRA NEURONS; INCLUSION-BODY MYOSITIS; GRAY-MATTER ATROPHY;
   REAL-TIME PCR; NITRIC-OXIDE; CLONAL EXPANSION; INDIVIDUAL CELLS;
   MUSCLE-FIBERS; DISEASE; MUTATIONS
AB Objective: Cerebral atrophy is a correlate of clinical progression in multiple sclerosis (MS). Mitochondria are now established to play a part in the pathogenesis of MS. Uniquely, mitochondria harbor their own mitochondrial DNA (mtDNA), essential for maintaining a healthy central nervous system. We explored mitochondrial respiratory chain activity and mtDNA deletions in single neurons from secondary progressive MS (SPMS) cases.
   Methods: Ninety-eight snap-frozen brain blocks from 13 SPMS cases together with complex IV/complex II histochemistry, immunohistochemistry, laser dissection microscopy, long-range and real-time PCR and sequencing were used to identify and analyze respiratory-deficient neurons devoid of complex IV and with complex II activity.
   Results: The density of respiratory-deficient neurons in SPMS was strikingly in excess of aged controls. The majority of respiratory-deficient neurons were located in layer VI and immediate subcortical white matter (WM) irrespective of lesions. Multiple deletions of mtDNA were apparent throughout the gray matter (GM) in MS. The respiratory-deficient neurons harbored high levels of clonally expanded mtDNA deletions at a single-cell level. Furthermore, there were neurons lacking mtDNA-encoded catalytic subunits of complex IV. mtDNA deletions sufficiently explained the biochemical defect in the majority of respiratory-deficient neurons.
   Interpretation: These findings provide evidence that neurons in MS are respiratory-deficient due to mtDNA deletions, which are extensive in GM and may be induced by inflammation. We propose induced multiple deletions of mtDNA as an important contributor to neurodegeneration in MS. ANN NEUROL 2011;69:481-492
C1 [Campbell, Graham R.; Ziabreva, Iryna; Reeve, Amy K.; Krishnan, Kim J.; Turnbull, Doug M.; Mahad, Don J.] Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Reynolds, Richard; Howell, Owen] Univ London Imperial Coll Sci Technol & Med, Fac Med, Wolfson Neurosci Labs, London, England.
   [Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Dept Neuroimmunol, Vienna, Austria.
C3 Newcastle University - UK; Imperial College London; Medical University
   of Vienna
RP Mahad, DJ (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM d.j.mahad@ncl.ac.uk
RI Lassmann, Hans/Z-2269-2019; Clugston, Kim/KBA-3107-2024; Howell,
   Owain/A-2510-2012
OI Turnbull, Doug/0000-0002-8878-9901; Lassmann, Hans/0000-0001-8617-5052;
   Reeve, Amy/0000-0002-4474-2204; Howell, Owain/0000-0003-2157-9157;
   Reynolds, Richard/0000-0003-4622-4694; Campbell,
   Graham/0000-0003-4828-421X
FU Wellcome Trust; MS Society; Wissenschaftsfonds Austria [P 19854]
FX This research was supported by the Wellcome Trust (D.J.M.), MS Society
   (D.J.M.), and Wissenschaftsfonds Austria (H. L.; FWF Project P 19854).
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d
   Blokhin A, 2008, NEUROMOL MED, V10, P187, DOI 10.1007/s12017-008-8025-2
   Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chang A, 2008, BRAIN, V131, P2366, DOI 10.1093/brain/awn157
   Coller HA, 2002, ANN NY ACAD SCI, V959, P434, DOI 10.1111/j.1749-6632.2002.tb02113.x
   Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev
   Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736
   Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32
   Elfering SL, 2004, AM J PHYSIOL-HEART C, V286, pH22, DOI 10.1152/ajpheart.00766.2003
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fisher E, 2008, ANN NEUROL, V64, P255, DOI 10.1002/ana.21436
   Fisniku LK, 2008, ANN NEUROL, V64, P247, DOI 10.1002/ana.21423
   Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Kalman B, 2007, J NEUROIMMUNOL, V188, P1, DOI 10.1016/j.jneuroim.2007.03.020
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krieger C, 2002, EUR J PHARMACOL, V447, P177, DOI 10.1016/S0014-2999(02)01842-3
   Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Lu FM, 2000, J NEUROL SCI, V177, P95, DOI 10.1016/S0022-510X(00)00343-9
   Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046
   Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474
   Nicholas A, 2009, EXP NEUROL, V218, P316, DOI 10.1016/j.expneurol.2009.04.029
   Nicholls DG, 1999, BIOCHEM SOC SYMP, V66, P55, DOI 10.1042/bss0660055
   Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Pandit A, 2009, J NEUROL SCI, V279, P14, DOI 10.1016/j.jns.2009.01.009
   Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   Tanji K, 2007, METHOD CELL BIOL, V80, P135, DOI 10.1016/S0091-679X(06)80006-3
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trevelyan AJ, 2010, BRAIN, V133, P787, DOI 10.1093/brain/awq023
   Wei JP, 2002, J IMMUNOL, V168, P4721, DOI 10.4049/jimmunol.168.9.4721
   WEINSHENKER BG, 1989, BRAIN, V112, P1419, DOI 10.1093/brain/112.6.1419
   Witte ME, 2009, J PATHOL, V219, P193, DOI 10.1002/path.2582
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 46
TC 272
Z9 295
U1 0
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
J9 ANN NEUROL
JI Ann. Neurol.
PD MAR
PY 2011
VL 69
IS 3
BP 481
EP 492
DI 10.1002/ana.22109
PG 12
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 744FW
UT WOS:000289081300011
PM 21446022
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Genin, EC
   Hounoum, BM
   Bannwarth, S
   Fragaki, K
   Lacas-Gervais, S
   Mauri-Crouzet, A
   Lespinasse, F
   Neveu, J
   Ropert, B
   Augé, G
   Cochaud, C
   Lefebvre-Omar, C
   Bigou, S
   Chiot, A
   Mochel, F
   Boillée, S
   Lobsiger, CS
   Bohl, D
   Ricci, JE
   Paquis-Flucklinger, V
AF Genin, Emmanuelle C.
   Hounoum, Blandine Madji
   Bannwarth, Sylvie
   Fragaki, Konstantina
   Lacas-Gervais, Sandra
   Mauri-Crouzet, Alessandra
   Lespinasse, Francoise
   Neveu, Julien
   Ropert, Baptiste
   Auge, Gaelle
   Cochaud, Charlotte
   Lefebvre-Omar, Cynthia
   Bigou, Stephanie
   Chiot, Aude
   Mochel, Fanny
   Boillee, Severine
   Lobsiger, Christian S.
   Bohl, Delphine
   Ricci, Jean-Ehrland
   Paquis-Flucklinger, Veronique
TI Mitochondrial defect in muscle precedes neuromuscular junction
   degeneration and motor neuron death in CHCHD10<SUP>S59L/+</SUP> mouse
SO ACTA NEUROPATHOLOGICA
LA English
DT Article
DE CHCHD10; Mitochondrial disorder; ALS; Mouse model; iPSC
ID AMYOTROPHIC-LATERAL-SCLEROSIS; CHCHD10 MUTATIONS;
   ACETYLCHOLINE-RECEPTORS; PHOSPHORYLATION; PATHOGENESIS; SYSTEM; GENE
AB Recently, we provided genetic basis showing that mitochondrial dysfunction can trigger motor neuron degeneration, through identification of CHCHD10 encoding a mitochondrial protein. We reported patients, carrying the p.Ser59Leu heterozygous mutation in CHCHD10, from a large family with a mitochondrial myopathy associated with motor neuron disease (MND). Rapidly, our group and others reported CHCHD10 mutations in amyotrophic lateral sclerosis (ALS), frontotemporal dementia-ALS and other neurodegenerative diseases. Here, we generated knock-in (KI) mice, carrying the p.Ser59Leu mutation, that mimic the mitochondrial myopathy with mtDNA instability displayed by the patients from our original family. Before 14months of age, all KI mice developed a fatal mitochondrial cardiomyopathy associated with enhanced mitophagy. CHCHD10(S59L/+) mice also displayed neuromuscular junction (NMJ) and motor neuron degeneration with hyper-fragmentation of the motor end plate and moderate but significant motor neuron loss in lumbar spinal cord at the end stage of the disease. At this stage, we observed TDP-43 cytoplasmic aggregates in spinal neurons. We also showed that motor neurons differentiated from human iPSC carrying the p.Ser59Leu mutation were much more sensitive to Staurosporine or glutamate-induced caspase activation than control cells. These data confirm that mitochondrial deficiency associated with CHCHD10 mutations can be at the origin of MND. CHCHD10 is highly expressed in the NMJ post-synaptic part. Importantly, the fragmentation of the motor end plate was associated with abnormal CHCHD10 expression that was also observed closed to NMJs which were morphologically normal. Furthermore, we found OXPHOS deficiency in muscle of CHCHD10(S59L/+) mice at 3months of age in the absence of neuron loss in spinal cord. Our data show that the pathological effects of the p.Ser59Leu mutation target muscle prior to NMJ and motor neurons. They likely lead to OXPHOS deficiency, loss of cristae junctions and destabilization of internal membrane structure within mitochondria at motor end plate of NMJ, impairing neurotransmission. These data are in favor with a key role for muscle in MND associated with CHCHD10 mutations.
C1 [Genin, Emmanuelle C.; Bannwarth, Sylvie; Fragaki, Konstantina; Mauri-Crouzet, Alessandra; Lespinasse, Francoise; Neveu, Julien; Ropert, Baptiste; Auge, Gaelle; Cochaud, Charlotte; Paquis-Flucklinger, Veronique] Univ Cote Azur, CHU Nice, Sch Med, Inserm,U1081,CNRS,UMR7284,IRCAN, 28 Av Valombrose, F-06107 Nice 2, France.
   [Hounoum, Blandine Madji; Ricci, Jean-Ehrland] Univ Cote Azur, C3M, INSERM, U1065, Nice, France.
   [Lacas-Gervais, Sandra] Univ Cote Azur, Ctr Commun Microscopie Appl, Nice, France.
   [Lefebvre-Omar, Cynthia; Bigou, Stephanie; Chiot, Aude; Mochel, Fanny; Boillee, Severine; Lobsiger, Christian S.; Bohl, Delphine] Sorbonne Univ, Inst Cerveau & Moelle Epiniere, ICM, Inserm,U1127,CNRS,UMR7225, F-75013 Paris, France.
   [Mochel, Fanny] La Pitie Salpetriere Univ Hosp, AP HP, Dept Genet, Paris, France.
   [Mochel, Fanny] La Pitie Salpetriere Univ Hosp, AP HP, Reference Ctr Adult Neurometab Dis, Paris, France.
C3 Universite Cote d'Azur; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS);
   CNRS - National Institute for Biology (INSB); CHU Nice; Universite Cote
   d'Azur; Institut National de la Sante et de la Recherche Medicale
   (Inserm); Universite Cote d'Azur; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Centre National de la Recherche
   Scientifique (CNRS); CNRS - National Institute for Biology (INSB);
   Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Sorbonne
   Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP
RP Paquis-Flucklinger, V (corresponding author), Univ Cote Azur, CHU Nice, Sch Med, Inserm,U1081,CNRS,UMR7284,IRCAN, 28 Av Valombrose, F-06107 Nice 2, France.
EM paquis@unice.fr
RI Bohl, Delphine/L-8709-2016; Boillee, Severine/J-4027-2017; Lobsiger,
   Christian/AAA-5311-2019; GENIN, Emmanuelle/HSG-8378-2023; RICCI,
   Jean-Ehrland/I-7117-2016
OI RICCI, Jean-Ehrland/0000-0003-1585-8117; BOILLEE,
   Severine/0000-0001-5518-9005; Chiot, Aude/0000-0002-3451-2210; Mochel,
   Fanny/0000-0003-3970-3486; Bohl, Delphine/0000-0001-8262-5642; Genin,
   Emmanuelle C./0000-0003-3039-7101; Lobsiger,
   Christian/0000-0002-4313-010X; Bigou, Stephanie/0000-0002-6328-0703;
   Neveu, Julien/0000-0003-0799-037X
FU ANR (Agence Nationale de la Recherche) [ANR-16-CE16-0024-01];
   AFM-Telethon (Association Francaise contre les Myopathies) [20947];
   Fondation Maladies Rares; program "Investissements d'avenir"
   [ANR-11-INBS-0011-NeurATRIS];  [ANR-10-LABX-73]; Agence Nationale de la
   Recherche (ANR) [ANR-16-CE16-0024] Funding Source: Agence Nationale de
   la Recherche (ANR)
FX This work was made possible by Grants to VP-F from the ANR (Agence
   Nationale de la Recherche) ANR-16-CE16-0024-01, from the AFM-Telethon
   (Association Francaise contre les Myopathies) #20947 and from the
   Fondation Maladies Rares. The research leading to the iPSC results has
   received funding from the program "Investissements d'avenir"
   ANR-11-INBS-0011-NeurATRIS: Translational Research Infrastructure for
   Biotherapies in Neurosciences". ECG and BMH are postdoctoral fellows
   supported by ANR-16-CE16-0024-01. CL-O is a Ph.D. fellow supported by
   ANR-10-LABX-73.
CR Andrews PW, 2009, STEM CELL REV REP, V5, P301, DOI 10.1007/s12015-009-9085-x
   Auranen M, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000003
   Bannwarth S, 2016, MITOCHONDRION, V30, P126, DOI 10.1016/j.mito.2016.02.005
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Blasco H, 2014, CURR MED CHEM, V21, P3551, DOI 10.2174/0929867321666140916120118
   Bloch-Gallego E, 2015, CELL MOL LIFE SCI, V72, P1029, DOI 10.1007/s00018-014-1768-z
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cozzolino M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00031
   Dadon-Nachum M, 2011, J MOL NEUROSCI, V43, P470, DOI 10.1007/s12031-010-9467-1
   Desport JC, 2001, AM J CLIN NUTR, V74, P328
   Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002
   Dupuis L, 2004, NEURODEGENER DIS, V1, P245, DOI 10.1159/000085063
   Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6
   Dupuis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005390
   Genin EC, 2018, NEUROBIOL DIS, V119, P159, DOI 10.1016/j.nbd.2018.07.027
   Genin EC, 2016, EMBO MOL MED, V8, P58, DOI 10.15252/emmm.201505496
   Gorman GS, 2018, LANCET, V392, P1191, DOI 10.1016/S0140-6736(18)31868-3
   Guo W, 2017, NAT COMMUN
   Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005
   Huang MLH, 2013, AM J PATHOL, V183, P745, DOI 10.1016/j.ajpath.2013.05.032
   Johnson JO, 2014, BRAIN, V137, DOI 10.1093/brain/awu265
   Jones RA, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160240
   Lehmer C, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708558
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Maury Y, 2015, NAT BIOTECHNOL, V33, P89, DOI 10.1038/nbt.3049
   Mesci P, 2015, BRAIN, V138, P53, DOI 10.1093/brain/awu312
   Müller K, 2014, BRAIN, V137, DOI 10.1093/brain/awu227
   Musarò A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839
   Palma E, 2016, P NATL ACAD SCI USA, V113, P3060, DOI 10.1073/pnas.1600251113
   Palma E, 2011, P NATL ACAD SCI USA, V108, P20184, DOI 10.1073/pnas.1117975108
   Penttilä S, 2015, ANN NEUROL, V77, P163, DOI 10.1002/ana.24319
   Philips Thomas, 2015, Curr Protoc Pharmacol, V69, DOI 10.1002/0471141755.ph0567s69
   Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613
   Rocha MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073846
   Ronchi D, 2015, BRAIN, V138, pE372, DOI 10.1093/brain/awu384
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SALMON MA, 1971, LANCET, V2, P290
   Smith EF, 2017, NEUROSCI LETT
   Tong MM, 2016, CURR OPIN GENET DEV, V38, P8, DOI 10.1016/j.gde.2016.02.006
   Van den Bosch L, 2006, BBA-MOL BASIS DIS, V1762, P1068, DOI 10.1016/j.bbadis.2006.05.002
   Villa E, 2017, CELL REP, V20, P2846, DOI 10.1016/j.celrep.2017.08.087
   Willadt S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24849
   Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4
   Woo JAA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15558
   Yaplito-Lee J, 2007, J PEDIATR-US, V150, P407, DOI 10.1016/j.jpeds.2006.12.047
   Yuan X, 2016, DRUG DES DEV THER, V10, P2729, DOI 10.2147/DDDT.S111253
NR 46
TC 57
Z9 62
U1 0
U2 19
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0001-6322
EI 1432-0533
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD JUL
PY 2019
VL 138
IS 1
BP 123
EP 145
DI 10.1007/s00401-019-01988-z
PG 23
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA ID5IA
UT WOS:000471708700007
PM 30874923
DA 2024-11-01
ER

PT J
AU Pacheu-Grau, D
   Callegari, S
   Emperador, S
   Thompson, K
   Aich, A
   Topol, SE
   Spencer, EG
   McFarland, R
   Ruiz-Pesini, E
   Torkamani, A
   Taylor, RW
   Montoya, J
   Rehling, P
AF Pacheu-Grau, David
   Callegari, Sylvie
   Emperador, Sonia
   Thompson, Kyle
   Aich, Abhishek
   Topol, Sarah E.
   Spencer, Emily G.
   McFarland, Robert
   Ruiz-Pesini, Eduardo
   Torkamani, Ali
   Taylor, Robert W.
   Montoya, Julio
   Rehling, Peter
TI Mutations of the mitochondrial carrier translocase channel subunit TIM22
   cause early-onset mitochondrial myopathy
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID DEAFNESS DYSTONIA SYNDROME; ACYLGLYCEROL KINASE; INNER MEMBRANE; IMPORT
   PATHWAY; PROTEIN TRANSLOCASE; SENGERS SYNDROME; COMPLEX; MACHINERIES;
   BIOGENESIS; TRANSPORT
AB Protein import into mitochondria is facilitated by translocases within the outer and the inner mitochondrial membranes that are dedicated to a highly specific subset of client proteins. The mitochondrial carrier translocase (TIM22 complex) inserts multispanning proteins, such as mitochondrial metabolite carriers and translocase subunits (TIM23, TIM17A/B and TIM22), into the inner mitochondrial membrane. Both types of substrates are essential for mitochondrial metabolic function and biogenesis. Here, we report on a subject, diagnosed at 1.5 years, with a neuromuscular presentation, comprising hypotonia, gastroesophageal reflux disease and persistently elevated serum and Cerebrospinal fluid lactate (CSF). Patient fibroblasts displayed reduced oxidative capacity and altered mitochondrial morphology. Using trans-mitochondrial cybrid cell lines, we excluded a candidate variant in mitochondrial DNA as causative of these effects. Whole-exome sequencing identified compound heterozygous variants in the TIM22 gene (NM_013337), resulting in premature truncation in one allele (p.Tyr25Ter) and a point mutation in a conserved residue (p.Val33Leu), within the intermembrane space region, of the TIM22 protein in the second allele. Although mRNA transcripts of TIM22 were elevated, biochemical analyses revealed lower levels of TIM22 protein and an even greater deficiency of TIM22 complex formation. In agreement with a defect in carrier translocase function, carrier protein amounts in the inner membrane were found to be reduced. This is the first report of pathogenic variants in the TIM22 pore-forming subunit of the carrier translocase affecting the biogenesis of inner mitochondrial membrane proteins critical for metabolite exchange.
C1 [Pacheu-Grau, David; Callegari, Sylvie; Aich, Abhishek; Rehling, Peter] Univ Med Ctr Gottingen, Dept Cellular Biochem, D-37073 Gottingen, Germany.
   [Emperador, Sonia; Ruiz-Pesini, Eduardo; Montoya, Julio] Univ Zaragoza, CIBER Enfermedades Raras CIBERER, IIS Aragon, Dept Bioquim & Biol Mol & Celular, E-50013 Zaragoza, Spain.
   [Rehling, Peter] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.
   [Thompson, Kyle; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Topol, Sarah E.; Spencer, Emily G.; Torkamani, Ali] Scripps Res Inst, Scripps Translat Sci Inst, La Jolla, CA 92037 USA.
   [Torkamani, Ali] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.
C3 University of Gottingen; UNIVERSITY GOTTINGEN HOSPITAL; University of
   Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Max
   Planck Society; Newcastle University - UK; Scripps Research Institute;
   Scripps Research Institute
RP Rehling, P (corresponding author), Univ Med Ctr Gottingen, Dept Cellular Biochem, D-37073 Gottingen, Germany.; Rehling, P (corresponding author), Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.
EM Peter.Rehling@medizin.uni-goettingen.de
RI Callegari, Sylvie/T-1728-2019; Aich, Abhishek/AFS-0587-2022;
   Pacheu-Grau, David/A-9074-2017
OI McFarland, Robert/0000-0002-8833-2688; Pacheu-Grau,
   David/0000-0003-2645-3983; Callegari, Sylvie/0000-0002-4402-945X;
   Spencer, Emily/0000-0003-2650-4357
FU Deutsche Forschungsgemeinschaft [SFB1190]; European Research Council
   [ERC335080]; Max Planck Society; Copernicus Award of the Foundation for
   Polish Science and Deutsche Forschungsgemeinschaft; Instituto de Salud
   Carlos III-FIS [PI17/00021, PI/00166]; Departamento de Ciencia,
   Tecnologia y Universidad del Gobierno de Aragon; Asociacion de Enfermos
   con Patologia Mitocondrial; Wellcome Centre for Mitochondrial Research
   [203105/Z/16/Z]; Medical Research Council Centre for Translational
   Research in Neuromuscular Disease, Mitochondrial Disease Patient Cohort
   (UK) [G0800674]; Lily Foundation; UK NIHR Biomedical Research Centre for
   ageing and age-related disease award; Newcastle upon Tyne Foundation
   Hospitals NHS Trust; MRC/EPSRC Molecular Pathology Node; Scripps
   Translational Science Institute; NIH-NCATS Clinical and Translational
   Science Award [5 UL1 TR001114]; Shaffer Family Foundation; Anne and
   Henry Zarrow Foundation; Lavin Family Foundation [NIH-U01 HG006476,
   U54GM114833]; MRC [G0800674] Funding Source: UKRI
FX Deutsche Forschungsgemeinschaft; SFB1190 (to P.R.); the European
   Research Council ERC335080 (to P.R.); the Max Planck Society (P.R.); the
   Copernicus Award of the Foundation for Polish Science and Deutsche
   Forschungsgemeinschaft (P.R.); Instituto de Salud Carlos III-FIS
   (PI17/00021 to J.M.) and PI/00166 to E.R.P.); Departamento de Ciencia,
   Tecnologia y Universidad del Gobierno de Aragon (Grupos de Referencia
   B33_17R to J.M. and E.R.P.); Asociacion de Enfermos con Patologia
   Mitocondrial (to J.M.); the Wellcome Centre for Mitochondrial Research
   (203105/Z/16/Z to R.W.T. and R.M.), the Medical Research Council Centre
   for Translational Research in Neuromuscular Disease, Mitochondrial
   Disease Patient Cohort (UK; G0800674 to R.W.T. and R.M.); the Lily
   Foundation; the UK NIHR Biomedical Research Centre for ageing and
   age-related disease award to the Newcastle upon Tyne Foundation
   Hospitals NHS Trust; the MRC/EPSRC Molecular Pathology Node and the UK
   NHS Highly Specialised Service for Rare Mitochondrial Disorders of
   Adults and Children; the Scripps Translational Science Institute, an
   NIH-NCATS Clinical and Translational Science Award (5 UL1 TR001114 to
   A.T.); the Shaffer Family Foundation and the Anne and Henry Zarrow
   Foundation (to A.T.); the Lavin Family Foundation (NIH-U01 HG006476 and
   U54GM114833 to A.T.).
CR Baker MJ, 2009, MOL BIOL CELL, V20, P769, DOI 10.1091/mbc.E08-09-0903
   Bauer MF, 1999, FEBS LETT, V464, P41, DOI 10.1016/S0014-5793(99)01665-8
   Beverly KN, 2008, J MOL BIOL, V382, P1144, DOI 10.1016/j.jmb.2008.07.069
   Bloss CS, 2015, GENET MED, V17, P995, DOI 10.1038/gim.2015.21
   Callegari S, 2016, FEBS LETT, V590, P4147, DOI 10.1002/1873-3468.12450
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   CHOMYN A, 1994, AM J HUM GENET, V54, P966
   Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   Curran SP, 2002, J CELL BIOL, V158, P1017, DOI 10.1083/jcb.200205124
   O'Callaghan MD, 2012, NEUROGENETICS, V13, P245, DOI 10.1007/s10048-012-0322-0
   Dudek J, 2013, BBA-MOL CELL RES, V1833, P274, DOI 10.1016/j.bbamcr.2012.05.028
   Ehmke N, 2017, AM J HUM GENET, V101, P833, DOI 10.1016/j.ajhg.2017.09.016
   Emperador S, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00469
   Endo T, 2011, BBA-BIOMEMBRANES, V1808, P955, DOI 10.1016/j.bbamem.2010.07.018
   Gebert N, 2008, EMBO REP, V9, P548, DOI 10.1038/embor.2008.49
   Gómez-Durán A, 2012, BBA-MOL BASIS DIS, V1822, P1216, DOI 10.1016/j.bbadis.2012.04.014
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Hasson SA, 2010, P NATL ACAD SCI USA, V107, P9578, DOI 10.1073/pnas.0914387107
   Jia ZD, 2013, HUM MOL GENET, V22, P4064, DOI 10.1093/hmg/ddt256
   Kang YL, 2018, SEMIN CELL DEV BIOL, V76, P142, DOI 10.1016/j.semcdb.2017.07.028
   Kang YL, 2017, MOL CELL, V67, P457, DOI 10.1016/j.molcel.2017.06.014
   Kang YL, 2016, ELIFE, V5, DOI [10.7554/elife.17463, 10.7554/eLife.17463]
   Koehler CM, 1999, P NATL ACAD SCI USA, V96, P2141, DOI 10.1073/pnas.96.5.2141
   Kovermann P, 2002, MOL CELL, V9, P363, DOI 10.1016/S1097-2765(02)00446-X
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Morgenstern M, 2017, CELL REP, V19, P2836, DOI 10.1016/j.celrep.2017.06.014
   Mühlenbein N, 2004, J BIOL CHEM, V279, P13540, DOI 10.1074/jbc.M312485200
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   Pacheu-Grau D, 2015, CELL METAB, V21, P823, DOI 10.1016/j.cmet.2015.04.012
   Pacheu-Grau D, 2011, HUM MOL GENET, V20, P4224, DOI 10.1093/hmg/ddr350
   Paschen SA, 2000, EMBO J, V19, P6392, DOI 10.1093/emboj/19.23.6392
   PFANNER N, 1987, J BIOL CHEM, V262, P7528
   PFANNER N, 1985, EMBO J, V4, P2819, DOI 10.1002/j.1460-2075.1985.tb04009.x
   Pham PH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116815
   Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426
   Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945
   Roesch K, 2002, HUM MOL GENET, V11, P477, DOI 10.1093/hmg/11.5.477
   Rorbach J, 2012, NUCLEIC ACIDS RES, V40, P4097, DOI 10.1093/nar/gkr1282
   Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141
   Sirrenberg C, 1996, NATURE, V384, P582, DOI 10.1038/384582a0
   Stroud DA, 2015, HUM MOL GENET, V24, P5404, DOI 10.1093/hmg/ddv265
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Vögtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045
   Vukotic M, 2017, MOL CELL, V67, P471, DOI 10.1016/j.molcel.2017.06.013
   Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Wrobel L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27484
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
NR 49
TC 27
Z9 27
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD DEC 1
PY 2018
VL 27
IS 23
BP 4135
EP 4144
DI 10.1093/hmg/ddy305
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA HD4ZC
UT WOS:000452536200011
PM 30452684
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Moteki, H
   Azaiez, H
   Booth, KT
   Hattori, M
   Sato, A
   Sato, Y
   Motobayashi, M
   Sloan, CM
   Kolbe, DL
   Shearer, AE
   Smith, RJH
   Usami, S
AF Moteki, Hideaki
   Azaiez, Hela
   Booth, Kevin T.
   Hattori, Mitsuru
   Sato, Ai
   Sato, Yoshihiko
   Motobayashi, Mitsuo
   Sloan, Christina M.
   Kolbe, Diana L.
   Shearer, A. Eliot
   Smith, Richard J. H.
   Usami, Shin-ichi
TI Hearing Loss Caused by a <i>P2RX2</i> Mutation Identified in a MELAS
   Family With a Coexisting Mitochondrial 3243AG Mutation
SO ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
LA English
DT Article
DE hearing loss; genetics; P2X2; MELAS; massively parallel sequencing
ID DNA MUTATIONS; DEAFNESS; ENRICHMENT; COCHLEA; LOCUS
AB Objectives: We present a family with a mitochondrial DNA 3243A>G mutation resulting in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), of which some members have hearing loss in which a novel mutation in the P2RX2 gene was identified.
   Methods: One hundred ninety-four (194) Japanese subjects from unrelated families were enrolled in the study. Targeted genomic enrichment and massively parallel sequencing of all known nonsyndromic hearing loss genes were performed to identify the genetic causes of hearing loss.
   Results: A novel mutation in the P2RX2 gene that corresponded to c.601G>A (p.Asp201Tyr) was identified. Two patients carried the mutation and had severe sensorineural hearing loss, while other members with MELAS (who did not carry the P2RX2 mutation) had normal hearing.
   Conclusion: This is the first case report of a diagnosis of hearing loss caused by P2RX2 mutation in patients with MELAS. A potential explanation is that a decrease in adenosine triphosphate (ATP) production due to MELAS with a mitochondrial 3243A>G mutation might suppress activation of P2X2 receptors. We also suggest that hearing loss caused by the P2RX2 mutation might be influenced by the decrease in ATP production due to MELAS.
C1 [Moteki, Hideaki; Hattori, Mitsuru; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 3908621, Japan.
   [Moteki, Hideaki; Azaiez, Hela; Booth, Kevin T.; Sloan, Christina M.; Kolbe, Diana L.; Shearer, A. Eliot; Smith, Richard J. H.] Univ Iowa Hosp & Clin, Dept Otolaryngol Head & Neck Surg, Mol Otolaryngol & Renal Res Labs, Iowa City, IA 52242 USA.
   [Moteki, Hideaki; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Hearing Implant Sci, Matsumoto, Nagano 3908621, Japan.
   [Sato, Ai; Sato, Yoshihiko] Shinshu Univ, Sch Med, Dept Internal Med, Div Diabet Endocrinol & Metab, Matsumoto, Nagano 3908621, Japan.
   [Motobayashi, Mitsuo] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 3908621, Japan.
C3 Shinshu University; University of Iowa; Shinshu University; Shinshu
   University; Shinshu University
RP Usami, S (corresponding author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.
EM usami@shinshu-u.ac.jp
RI Booth, Kevin/P-9435-2019; Azaiez, Hela/AAQ-7011-2020; Smith,
   Richard/HMD-4857-2023
OI Shearer, Aiden/0000-0002-5324-4805; Booth, Kevin T./0000-0003-3061-3652;
   Smith, Richard/0000-0003-1201-6731
FU NIDCD [RO1s DC003544, DC002842, DC012049]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by NIDCD RO1s DC003544, DC002842, and DC012049 to R.J.H.S.
CR Blanton SH, 2002, J MED GENET, V39, P567, DOI 10.1136/jmg.39.8.567
   Faletra F, 2014, GENE, V534, P236, DOI 10.1016/j.gene.2013.10.052
   Frommolt P, 2012, HUM MUTAT, V33, P635, DOI 10.1002/humu.22036
   Housley GD, 2013, P NATL ACAD SCI USA, V110, P7494, DOI 10.1073/pnas.1222295110
   Housley GD, 2009, TRENDS NEUROSCI, V32, P128, DOI 10.1016/j.tins.2009.01.001
   Housley GD, 1999, J NEUROSCI, V19, P8377
   Jacobs HT, 2005, EUR J HUM GENET, V13, P26, DOI 10.1038/sj.ejhg.5201250
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Petersen MB, 2002, CLIN GENET, V62, P1, DOI 10.1034/j.1399-0004.2002.620101.x
   Scuderi C, 2010, MITOCHONDRION, V10, P548, DOI 10.1016/j.mito.2010.04.004
   Shearer AE, 2013, J MED GENET, V50, P627, DOI 10.1136/jmedgenet-2013-101749
   Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107
   Shearer AE, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-20
   Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3
   Telang RS, 2010, PURINERG SIGNAL, V6, P263, DOI 10.1007/s11302-010-9195-6
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   World Health Organization, PREV BLINDN DEAFN ES
   Yan D, 2005, J HUM GENET, V50, P516, DOI 10.1007/s10038-005-0286-0
   Yan D, 2013, P NATL ACAD SCI USA, V110, P2228, DOI 10.1073/pnas.1222285110
   Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102
   Zhu Y, 2010, PURINERG SIGNAL, V6, P221, DOI 10.1007/s11302-010-9184-9
NR 22
TC 14
Z9 17
U1 0
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0003-4894
EI 1943-572X
J9 ANN OTO RHINOL LARYN
JI Ann. Otol. Rhinol. Laryngol.
PD MAY
PY 2015
VL 124
SU 1
BP 177S
EP 183S
DI 10.1177/0003489415575045
PG 7
WC Otorhinolaryngology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Otorhinolaryngology
GA CG6PA
UT WOS:000353422900018
PM 25788561
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Kaufman, KR
   Zuber, N
   Rueda-Lara, MA
   Tobia, A
AF Kaufman, Kenneth R.
   Zuber, Nicole
   Rueda-Lara, Maria A.
   Tobia, Anthony
TI MELAS with recurrent complex partial seizures, nonconvulsive status
   epilepticus, psychosis, and behavioral disturbances: Case analysis with
   literature review
SO EPILEPSY & BEHAVIOR
LA English
DT Article
DE Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes
   (MELAS); Mitochondrial encephalopathy; Complex partial seizures;
   Nonconvulsive status epilepticus; Aggression; Psychosis, hallucinations;
   Paranoid delusions; Video/EEG monitoring; Oxidative stress; Valproate;
   Levocarnitine; Vitamin E; Coenzyme Q10; Treatment; Education
ID STROKE-LIKE EPISODES; CONVULSIVE STATUS EPILEPTICUS; LACTIC-ACIDOSIS;
   MITOCHONDRIAL MYOPATHY; A3243G MUTATION; 3243A-GREATER-THAN-G MUTATION;
   L-CARNITINE; ENCEPHALOPATHY; OLANZAPINE; DISORDERS
AB Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes (MELAS) is a progressive neurodegenerative disorder associated with polygenetic, maternally inherited, mitochondrial DNA mutations. MELAS has multisystem presentation including neurological, muscular, endocrine, auditory, visual, cardiac, psychiatric, renal, gastrointestinal and dermatological symptoms. Clinical course and prognosis are variable, often leading to cognitive decline, disability, and premature death. Both convulsive status epilepticus (CSE) and nonconvulsive status epilepticus (NCSE) are reported with MELAS. This report illustrates a case of MELAS with recurrent complex partial seizures, NCSE, confusion, aggressive behaviors, hallucinations, and paranoid delusions. Rapid video/EEG confirmation of diagnosis and aggressive antiepileptic drug intervention are required. Further education of medical professionals regarding this disorder, its appropriate management, and the significance of NCSE is indicated to avoid delay of treatment. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Kaufman, Kenneth R.; Zuber, Nicole; Rueda-Lara, Maria A.; Tobia, Anthony] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Psychiat, New Brunswick, NJ 08901 USA.
   [Kaufman, Kenneth R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ 08901 USA.
   [Kaufman, Kenneth R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Anesthesiol, New Brunswick, NJ 08901 USA.
   [Tobia, Anthony] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA.
C3 Rutgers University System; Rutgers University New Brunswick; Rutgers
   University Biomedical & Health Sciences; Rutgers University System;
   Rutgers University New Brunswick; Rutgers University Biomedical & Health
   Sciences; Rutgers University System; Rutgers University New Brunswick;
   Rutgers University Biomedical & Health Sciences; Rutgers University
   System; Rutgers University New Brunswick; Rutgers University Biomedical
   & Health Sciences
RP Kaufman, KR (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Psychiat, 125 Paterson St,Suite 2200, New Brunswick, NJ 08901 USA.
EM kaufmakr@umdnj.edu
CR Alemdar M, 2007, J NEUROPSYCH CLIN N, V19, P482, DOI 10.1176/appi.neuropsych.19.4.482
   Alper K, 2007, BIOL PSYCHIAT, V62, P345, DOI 10.1016/j.biopsych.2006.09.023
   [Anonymous], 2000, DIAGN STAT MAN MENT, DOI [DOI 10.1176/APPI.BOOKS.9780890425787, 10.1176/appi.books.9780890425787]
   BARAK Y, 1995, ISRAEL J MED SCI, V31, P224
   Berbel-Garcia A, 2004, CLIN NEUROPHARMACOL, V27, P187, DOI 10.1097/01.wnf.0000137862.67131.bf
   Bhuvaneswar Chaya G, 2008, Prim Care Companion J Clin Psychiatry, V10, P237
   Binienda Z, 2005, ANN NY ACAD SCI, V1053, P174, DOI 10.1196/annals.1344.015
   Camacho A, 2005, CLIN NEUROPHARMACOL, V28, P145, DOI 10.1097/01.wnf.0000165351.10841.fa
   Cock H, 2007, EPILEPSIA, V48, P24, DOI 10.1111/j.1528-1167.2007.01341.x
   Corda D, 2006, EPILEPSY BEHAV, V8, P655, DOI 10.1016/j.yebeh.2005.12.011
   DELGADOESCUETA AV, 1981, NEW ENGL J MED, V305, P711, DOI 10.1056/NEJM198109173051231
   Eriksson K, 2005, NEUROLOGY, V65, P1316, DOI 10.1212/01.wnl.0000180959.31355.92
   Fattal O, 2006, PSYCHOSOMATICS, V47, P1, DOI 10.1176/appi.psy.47.1.1
   Feddersen B, 2003, NEUROLOGY, V61, P1149, DOI 10.1212/01.WNL.0000092497.53706.1B
   Finsterer J, 2008, J NEUROL SCI, V272, P20, DOI 10.1016/j.jns.2008.05.011
   Higashikata T, 2001, INTERNAL MED, V40, P405, DOI 10.2169/internalmedicine.40.405
   Kanaumi T, 2006, PEDIATR NEUROL, V34, P235, DOI 10.1016/j.pediatrneurol.2005.08.024
   Kanner AM, 2004, EPILEPSIA, V45, P22, DOI 10.1111/j.0013-9580.2004.452004.x
   Kaplan PW, 2005, NEUROLOGIST, V11, P348, DOI 10.1097/01.nrl.0000162954.76053.d2
   Kaplan PW, 2003, NEUROLOGY, V61, P1035, DOI 10.1212/WNL.61.8.1035
   Klopstock T, 1999, NEUROLOGY, V53, P855, DOI 10.1212/WNL.53.4.855
   Korff CM, 2007, NAT CLIN PRACT NEURO, V3, P505, DOI 10.1038/ncpneuro0605
   Kovács R, 2002, J NEUROPHYSIOL, V88, P2909, DOI 10.1152/jn.00149.2002
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   Leff AP, 1998, EPILEPSIA, V39, P438, DOI 10.1111/j.1528-1157.1998.tb01397.x
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   Maganti R, 2008, EPILEPSY BEHAV, V12, P572, DOI 10.1016/j.yebeh.2007.12.002
   Majamaa-Voltti K, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.122648
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Misra UK, 2006, NEUROLOGY, V67, P340, DOI 10.1212/01.wnl.0000224880.35053.26
   Neargarder SA, 2007, COGN BEHAV NEUROL, V20, P83, DOI 10.1097/WNN.0b013e3180335faf
   Ribacoba R, 2006, NEUROLOGIA, V21, P1
   Riggio S, 2006, MT SINAI J MED, V73, P960
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Russell S, 2007, CURR OPIN PEDIATR, V19, P206, DOI 10.1097/MOP.0b013e32805e879a
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Sezen O, 2008, NEUROSURG REV, V31, P205, DOI 10.1007/s10143-007-0118-0
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Tan TMM, 2009, CLIN ENDOCRINOL, V70, P340, DOI 10.1111/j.1365-2265.2008.03341.x
   Treiman DM, 2008, LANCET NEUROL, V7, P667, DOI 10.1016/S1474-4422(08)70142-X
   Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Wheless JW, 2008, EPILEPSIA, V49, P74, DOI 10.1111/j.1528-1167.2008.01929.x
   Woolley J, 2001, BRIT J PSYCHIAT, V178, P85, DOI 10.1192/bjp.178.1.85-a
   Wyderski RJ, 1999, ANN PHARMACOTHER, V33, P787, DOI 10.1345/aph.18399
   Zaja-Milatovic S, 2008, NEUROTOXICOLOGY, V29, P621, DOI 10.1016/j.neuro.2008.04.009
NR 46
TC 37
Z9 42
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1525-5050
EI 1525-5069
J9 EPILEPSY BEHAV
JI Epilepsy Behav.
PD AUG
PY 2010
VL 18
IS 4
BP 494
EP 497
DI 10.1016/j.yebeh.2010.05.020
PG 4
WC Behavioral Sciences; Clinical Neurology; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Behavioral Sciences; Neurosciences & Neurology; Psychiatry
GA 643ON
UT WOS:000281306600026
PM 20580320
DA 2024-11-01
ER

PT J
AU Zelissen, R
   Ahmadian, S
   Montilla-Rojo, J
   Timmer, E
   Ummelen, M
   Hopman, A
   Smeets, H
   van Tienen, F
AF Zelissen, Ruby
   Ahmadian, Somaieh
   Montilla-Rojo, Joaquin
   Timmer, Erika
   Ummelen, Monique
   Hopman, Anton
   Smeets, Hubert
   van Tienen, Florence
TI Fusion of Wild-Type Mesoangioblasts with Myotubes of mtDNA Mutation
   Carriers Leads to a Proportional Reduction in mtDNA Mutation Load
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE mtDNA disease; mtDNA mutation; myogenic stem cell therapy; myotube
   fusion; mesoangioblast
ID LASER CAPTURE MICRODISSECTION; SKELETAL-MUSCLE; POINT MUTATION; CELLS;
   EXPRESSION; PATIENT; FIBERS
AB In 25% of patients with mitochondrial myopathies, pathogenic mitochondrial DNA (mtDNA) mutation are the cause. For heteroplasmic mtDNA mutations, symptoms manifest when the mutation load exceeds a tissue-specific threshold. Therefore, lowering the mutation load is expected to ameliorate disease manifestations. This can be achieved by fusing wild-type mesoangioblasts with mtDNA mutant myotubes. We have tested this in vitro for female carriers of the m.3271T>C or m.3291T>C mutation (mutation load >90%) using wild-type male mesoangioblasts. Individual fused myotubes were collected by a newly-developed laser capture microdissection (LCM) protocol, visualized by immunostaining using an anti-myosin antibody. Fusion rates were determined based on male-female nuclei ratios by fluorescently labelling the Y-chromosome. Using combined 'wet' and 'air dried' LCM imaging improved fluorescence imaging quality and cell yield. Wild-type mesoangioblasts fused in different ratios with myotubes containing either the m.3271T>C or the m.3291T>C mutation. This resulted in the reduction of the mtDNA mutation load proportional to the number of fused wild-type mesoangioblasts for both mtDNA mutations. The proportional reduction in mtDNA mutation load in vitro after fusion is promising in the context of muscle stem cell therapy for mtDNA mutation carriers in vivo, in which we propose the same strategy using autologous wild-type mesoangioblasts.
C1 [Zelissen, Ruby; Ahmadian, Somaieh; Timmer, Erika; Smeets, Hubert; van Tienen, Florence] Maastricht Univ, Dept Toxicogen, Med Ctr, NL-6229 HX Maastricht, Netherlands.
   [Zelissen, Ruby; Ahmadian, Somaieh; Timmer, Erika; Ummelen, Monique; Hopman, Anton; Smeets, Hubert] Maastricht Univ, Sch Dev Biol & Oncol GROW, Med Ctr, NL-6229 HX Maastricht, Netherlands.
   [Ahmadian, Somaieh; Ummelen, Monique; Hopman, Anton] Maastricht Univ, Dept Mol Cell Biol, Med Ctr, NL-6229 HX Maastricht, Netherlands.
   [Montilla-Rojo, Joaquin] Univ Utrecht, Fac Vet Med, Dept Clin Sci, Anat & Physiol, NL-3584 CS Utrecht, Netherlands.
   [Smeets, Hubert; van Tienen, Florence] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Med Ctr, NL-6229 HX Maastricht, Netherlands.
C3 Maastricht University; Maastricht University; Maastricht University;
   Utrecht University; Maastricht University
RP van Tienen, F (corresponding author), Maastricht Univ, Dept Toxicogen, Med Ctr, NL-6229 HX Maastricht, Netherlands.; van Tienen, F (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Med Ctr, NL-6229 HX Maastricht, Netherlands.
EM florence.vantienen@maastrichtuniversity.nl
OI Montilla-Rojo, Joaquin/0000-0002-3168-0796
FU Dutch "Prinses Beatrix Spierfonds" [PBS W.0R15-09]
FX This research was funded by The Dutch "Prinses Beatrix Spierfonds" (PBS
   W.0R15-09).
CR Amini P, 2017, BMC MOL BIOL, V18, DOI 10.1186/s12867-017-0099-7
   Berry SE, 2007, REGEN MED, V2, P275, DOI 10.2217/17460751.2.3.275
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Chen WJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48316-9
   Cossu G, 2015, EMBO MOL MED, V7, P1513, DOI 10.15252/emmm.201505636
   Dellavalle A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1508
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Gautam V, 2016, SCI REP-UK, V6, DOI 10.1038/srep21577
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Khodosevich K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001151
   Murakami H, 2000, KIDNEY INT, V58, P1346, DOI 10.1046/j.1523-1755.2000.00295.x
   Rai PK, 2018, ESSAYS BIOCHEM, V62, P455, DOI 10.1042/EBC20170113
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282
   SCHOUTEN HC, 1995, BRIT J HAEMATOL, V91, P162, DOI 10.1111/j.1365-2141.1995.tb05262.x
   Shi X, 2003, WORLD J GASTROENTERO, V9, P1337, DOI 10.3748/wjg.v9.i6.1337
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   So KH, 2011, INT J CARDIOL, V153, P277, DOI 10.1016/j.ijcard.2010.08.052
   Sohn RL, 2009, P NATL ACAD SCI USA, V106, P9274, DOI 10.1073/pnas.0904398106
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   Tayade C., 2014, The guide to investigation of mouse pregnancy, P567
   van Tienen F, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1510-8
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Williams DL, 2008, J HISTOCHEM CYTOCHEM, V56, P285, DOI 10.1369/jhc.7A7331.2007
NR 24
TC 3
Z9 3
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD FEB
PY 2023
VL 24
IS 3
AR 2679
DI 10.3390/ijms24032679
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 8U1KT
UT WOS:000929711000001
PM 36769001
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Yatsuga, S
   Povalko, N
   Nishioka, J
   Katayama, K
   Kakimoto, N
   Matsuishi, T
   Kakuma, T
   Koga, Y
AF Yatsuga, Shuichi
   Povalko, Nataliya
   Nishioka, Junko
   Katayama, Koju
   Kakimoto, Noriko
   Matsuishi, Toyojiro
   Kakuma, Tatsuyuki
   Koga, Yasutoshi
CA Taro Matsuoka MELAS Study Grp
TI MELAS: A nationwide prospective cohort study of 96 patients in Japan
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE Prevalence; MELAS; Cohort study; Natural course; Survival curve;
   Severity of disease
ID STROKE-LIKE EPISODES; MITOCHONDRIAL-DNA MUTATIONS; LACTIC-ACIDOSIS;
   CLINICAL-FEATURES; A3243G MUTATION; PREVALENCE; EPIDEMIOLOGY; DISORDERS;
   DISEASE; ENCEPHALOPATHY
AB Background: MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes) (OMIM 540000) is the most dominant subtype of mitochondrial myopathy. The aim of this study was to determine the prevalence, natural course, and severity of MELAS.
   Methods: A prospective cohort study of 96 Japanese patients with MELAS was followed between June 2003 and April 2008. Patients with MELAS were identified and enrolled based on questionnaires administered to neurologists in Japan. MELAS was defined using the Japanese diagnostic criteria for MELAS. Two follow-up questionnaires were administered to neurologists managing MELAS patients at an interval of 5 years.
   Results: A prevalence of at least 0.58 (95% confidential interval (CI), 0.54-0.62)/100,000 was calculated for mitochondrial myopathy, whereas the prevalence of MELAS was 0.18 (95%CI, 0.02-0.34)/100,000 in the total population. MELAS patients were divided into two sub-groups: juvenile form and adult form. Stroke-like episodes, seizure and headache were the most frequent symptoms seen in both forms of MELAS. Short stature was significantly more frequent in the juvenile form, whereas hearing loss, cortical blindness and diabetes mellitus were significantly more frequent in the adult form. According to the Japanese mitochondrial disease rating scale, MELAS patients showed rapidly increasing scores (mean +/- standard deviation, 12.8 +/- 8.7) within 5 years from onset of the disease. According to a Kaplan-Meier analysis, the juvenile form was associated with a higher risk of death than the adult form (hazard ratio, 3.29; 95%CI, 1.32-8.20; p = 0.0105).
   Conclusions and General Significance: We confirmed that MELAS shows a rapid degenerative progression within a 5-year interval and that this occurs in both the juvenile and the adult forms of MELAS and follows different natural courses. This article is part of a Special Issue entitled: Biochemistry of Mitochondria. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Yatsuga, Shuichi; Povalko, Nataliya; Nishioka, Junko; Katayama, Koju; Kakimoto, Noriko; Matsuishi, Toyojiro; Koga, Yasutoshi] Kurume Univ, Grad Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 300011, Japan.
   [Kakuma, Tatsuyuki] Kurume Univ, Grad Sch Med, Dept Biostat, Kurume, Fukuoka 300011, Japan.
   [Yatsuga, Shuichi] Univ Helsinki, Res Program Mol Neurol, Biomedicum Helsinki, Helsinki, Finland.
C3 Kurume University; Kurume University; University of Helsinki
RP Koga, Y (corresponding author), Kurume Univ, Sch Med, Dept Pediat & Child Hlth, 67 Asahi Machi, Kurume, Fukuoka 300011, Japan.
EM yasukoga@med.kurume-u.ac.jp
FU Ministry of Culture and Education in Japan [13670853, 16390308];
   Evidence-based Medicine, Ministry of Health, Labor and Welfare in Japan
   [CCT-B-1803]; Academy of Finland, the Center for International Mobility
   in Finland; Heiwa Research Foundation in Japan; Grants-in-Aid for
   Scientific Research [13670853, 16390308] Funding Source: KAKEN
FX All coauthors have seen the manuscript and have reported no conflicts of
   interest (financial or nonfinancial) and any other pertinent financial
   information. This work was supported in part by grants #13670853 (Y.K.)
   and #16390308 (Y.K.) from the Ministry of Culture and Education in
   Japan, as well as #CCT-B-1803 (Y.K.) from Evidence-based Medicine,
   Ministry of Health, Labor and Welfare in Japan. S.Y. is a recipient of a
   post-doctoral fellowship from the Academy of Finland, the Center for
   International Mobility in Finland. N.P. is a recipient of a grant-in-aid
   for young investigators from the Heiwa Research Foundation in Japan.
CR Chinnery P F, 2003, Neuromuscul Disord, V13, P757, DOI 10.1016/S0960-8966(03)00097-X
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Di Mauro S, 1993, GENE REV
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Koga Y, 2010, ANN NY ACAD SCI, V1201, P104, DOI 10.1111/j.1749-6632.2010.05624.x
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Phoenix C, 2006, NEUROMUSCULAR DISORD, V16, P814, DOI 10.1016/j.nmd.2006.08.006
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Skladal D, 2003, CLIN PEDIATR, V42, P703, DOI 10.1177/000992280304200806
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   VANDENOUWELAND JMW, 1995, MUSCLE NERVE, pS124
NR 28
TC 188
Z9 217
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD MAY
PY 2012
VL 1820
IS 5
SI SI
BP 619
EP 624
DI 10.1016/j.bbagen.2011.03.015
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 930JO
UT WOS:000303135900011
PM 21443929
DA 2024-11-01
ER

PT J
AU Atilano, SR
   Coskun, P
   Chwa, M
   Jordan, N
   Reddy, V
   Le, K
   Wallace, DC
   Kenney, MC
AF Atilano, SR
   Coskun, P
   Chwa, M
   Jordan, N
   Reddy, V
   Le, K
   Wallace, DC
   Kenney, MC
TI Accumulation of mitochondrial DNA damage in keratoconus corneas
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID HEREDITARY OPTIC NEUROPATHY; HUMAN SKELETAL-MUSCLE; MTDNA
   CONTROL-REGION; HYDROGEN-PEROXIDE; DOWNS-SYNDROME; OXIDATIVE DAMAGE;
   PENETRATING KERATOPLASTY; ALDEHYDE DEHYDROGENASE; PATHOLOGICAL CORNEAS;
   ALZHEIMERS-DISEASE
AB PURPOSE. To determine whether keratoconus ( KC) corneas have more mitochondrial (mt) DNA damage than do normal corneas.
   METHODS. Thirty-three normal corneas and 34 KC corneas were studied. Immunohistochemistry for mitochondria-encoded cytochrome c oxidase ( complex IV) subunit 1 (CO-I) and porins was performed. Total DNA was isolated and mtDNA genome amplified by either long-extension -polymerase chain reaction (LX-PCR) or short-extension-PCR (SX-PCR). LX-PCR mtDNA was digested with restriction enzymes to confirm full-length mtDNA amplicon. SX-PCR mtDNA was probed by Southern blot analysis. The T414G mutation was analyzed by peptide nucleic acid directed clamping PCR. Real-time PCR measured the ratio of mtDNA to nuclear (n) DNA.
   RESULTS. KC corneas had decreased CO-I in areas of corneal thinning. LX-PCR mtDNA digested with restriction enzymes showed expected size bands except for PstI, which showed two additional bands in some KC corneas (2/18). By both LX-PCR ( 7.4 +/- 3.8 vs. 4.3 +/- 2.7, P < 0.04) and SX-PCR (5.5 +/- 0.55 vs. 2.4 +/- 2.0, P < 0.006), KC corneas had an increased number of smaller-sized bands ( representing mtDNA deletions/ mutations) compared with normal corneas. Southern blot analysis of SX-PCR products confirmed their mtDNA origin. The T414G mutation was not detected in either KC or normal corneas. KC corneas showed a trend of lower mtDNA-to-nDNA ratio (26%, P < 0.7) than did normal corneas.
   CONCLUSIONS. KC corneas exhibit more mtDNA damage than do normal corneas. The previously reported increased oxidative stress and altered integrity of mtDNA may be related to each other and may be important in KC pathogenesis.
C1 Univ Calif Irvine, Med Ctr, Dept Ophthalmol, Orange, CA 92868 USA.
   Univ Calif Irvine, Dept Biol Chem, Orange, CA 92868 USA.
   Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Orange, CA 92868 USA.
   Univ Calif Irvine, Dept Pediat, Orange, CA 92668 USA.
   Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Orange, CA 92668 USA.
   Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA.
C3 University of California System; University of California Irvine;
   University of California System; University of California Irvine;
   University of California System; University of California Irvine;
   University of California System; University of California Irvine;
   University of California System; University of California Irvine; Cedars
   Sinai Medical Center
RP Univ Calif Irvine, Med Ctr, Dept Ophthalmol, 101 City Dr,Bldg 55,Room 220, Orange, CA 92868 USA.
EM mkenney@uci.edu
OI Atilano, Shari/0000-0002-7729-7864; Coskun, E.
   Pinar/0000-0002-8010-8403; Kenney, M. Cristina/0000-0003-1765-1750
FU NEI NIH HHS [EY06807] Funding Source: Medline
CR AMBROSIO G, 1993, J BIOL CHEM, V268, P18532
   *APPL BIOS, 2001, US B APPL BIOS, V2
   Arbuzova S, 2002, BIOESSAYS, V24, P681, DOI 10.1002/bies.10138
   Ballinger SW, 1999, EXP EYE RES, V68, P765, DOI 10.1006/exer.1998.0661
   Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960
   Behndig A, 2001, INVEST OPHTH VIS SCI, V42, P2293
   Brown DJ, 2004, MOL VIS, V10, P281
   BROWN MD, 1992, FASEB J, V6, P2791, DOI 10.1096/fasebj.6.10.1634041
   BROWN MD, 1994, J BIOENERG BIOMEMBR, V26, P273, DOI 10.1007/BF00763099
   Buddi R, 2002, J HISTOCHEM CYTOCHEM, V50, P341, DOI 10.1177/002215540205000306
   Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9
   BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Christoph R, 1998, RESTOR NEUROL NEUROS, V12, P59
   CIBIS GW, 2001, FUNDAMENTALS PRINCIP, V2, pCH11
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Cristina Kenney M, 2003, Cont Lens Anterior Eye, V26, P139
   Datta K, 2000, NATL MED J INDIA, V13, P304
   Druzhyna N, 1998, MUTAT RES-DNA REPAIR, V409, P81, DOI 10.1016/S0921-8777(98)00042-1
   GONDHOWIARDJO TD, 1993, CORNEA, V12, P146, DOI 10.1097/00003226-199303000-00010
   GONDHOWIARDJO TD, 1993, CORNEA, V12, P310, DOI 10.1097/00003226-199307000-00006
   Good PF, 1996, AM J PATHOL, V149, P21
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Haugen OH, 2001, ACTA OPHTHALMOL SCAN, V79, P616, DOI 10.1034/j.1600-0420.2001.790613.x
   Jessie BC, 2001, EXP GERONTOL, V37, P169, DOI 10.1016/S0531-5565(01)00153-X
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Kenney MC, 1997, CORNEA, V16, P345
   Kenney MC, 2005, INVEST OPHTH VIS SCI, V46, P823, DOI 10.1167/iovs.04-0549
   Kim JH, 2002, EYE, V16, P710, DOI 10.1038/sj.eye.6700208
   Kim WJ, 1999, EXP EYE RES, V69, P475, DOI 10.1006/exer.1999.0719
   LIN FB, 1995, ARCH BIOCHEM BIOPHYS, V317, P7, DOI 10.1006/abbi.1995.1129
   Liu E, 1997, CORNEA, V16, P414
   LUM JK, 1994, HUM BIOL, V66, P567
   MAMALIS N, 1992, ARCH OPHTHALMOL-CHIC, V110, P1409, DOI 10.1001/archopht.1992.01080220071023
   McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   MELTON T, 1995, AM J HUM GENET, V57, P403
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Murdock DG, 2000, NUCLEIC ACIDS RES, V28, P4350, DOI 10.1093/nar/28.21.4350
   Ogawa O, 2002, DEV CELL, V2, P255, DOI 10.1016/S1534-5807(02)00139-9
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Petit PX, 1996, FEBS LETT, V396, P7, DOI 10.1016/0014-5793(96)00988-X
   PHILLIPS CI, 1991, SURV OPHTHALMOL, V35, P463, DOI 10.1016/0039-6257(91)90110-2
   *QIAG INC, 2004, CRIT FACT SUCC REAL
   Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   Rodríguez-Santiago B, 2001, EUR J HUM GENET, V9, P279, DOI 10.1038/sj.ejhg.5200629
   Salazar JJ, 1997, MUTAT RES-DNA REPAIR, V385, P139, DOI 10.1016/S0921-8777(97)00047-5
   Shen J, 2004, NEURON, V43, P301, DOI 10.1016/j.neuron.2004.07.012
   Spector A, 2002, INVEST OPHTH VIS SCI, V43, P3251
   TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421
   van Splunder J, 2004, OPHTHALMOLOGY, V111, P1457, DOI 10.1016/j.ophtha.2003.12.051
   WALLACE DC, 1994, J BIOENERG BIOMEMBR, V26, P241, DOI 10.1007/BF00763096
   Wallace DC, 2001, MENT RETARD DEV D R, V7, P158, DOI 10.1002/mrdd.1023
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wallace Douglas C., 1998, Biofactors, V7, P187
   Winkler-Stuck K, 2004, J NEUROL SCI, V220, P41, DOI 10.1016/j.jns.2004.02.003
   Wong V, 1997, PEDIATR NEUROL, V16, P311, DOI 10.1016/S0887-8994(97)00029-5
   YAMADA M, 1991, DNA CELL BIOL, V10, P735, DOI 10.1089/dna.1991.10.735
   Yoo BC, 2001, ELECTROPHORESIS, V22, P172, DOI 10.1002/1522-2683(200101)22:1<172::AID-ELPS172>3.0.CO;2-P
NR 62
TC 91
Z9 100
U1 0
U2 6
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2005
VL 46
IS 4
BP 1256
EP 1263
DI 10.1167/iovs.04-1395
PG 8
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 910DB
UT WOS:000227908900021
PM 15790887
DA 2024-11-01
ER

PT J
AU Minczuk, M
   Papworth, MA
   Kolasinska, P
   Murphy, MP
   Klug, A
AF Minczuk, Michal
   Papworth, Monika A.
   Kolasinska, Paulina
   Murphy, Michael P.
   Klug, Aaron
TI Sequence-specific modification of mitochondrial DNA using a chimeric
   zinc finger methylase
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE gene therapy; mitochondria; mitochondrial diseases; synthetic zinc
   finger peptides; nuclear export signal
ID TRANSCRIPTION FACTORS; GENE-REGULATION; DRUG DISCOVERY; PROTEINS;
   METHYLTRANSFERASES; BINDING; MOUSE; INHIBITION; THERAPY; DISEASE
AB We used engineered zinc finger pepticles (ZFPs) to bind selectively to predetermined sequences in human mtDNA. Surprisingly, we found that engineered ZFPs cannot be reliably routed to mitochondria by using only conventional mitochondrial targeting sequences. We here show that addition of a nuclear export signal allows zinc finger chimeric enzymes to be imported into human mitochondria. The selective binding of mitochondria-specific ZFPs to mtDNA was exemplified by targeting the T8993G mutation, which causes two mitochondrial diseases, neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP) and also maternally inherited Leigh's syndrome. To develop a system that allows the monitoring of site-specific alteration of mtDNA we combined a UP with the easily assayed DNA-modifying activity of hDNMT3a methylase. Expression of the mutation-specific chimeric methylase resulted in the selective methylation of cytosines adjacent to the mutation site. This is a proof of principle that it is possible to target and alter mtDNA in a sequence-specific manner by using zinc finger technology.
C1 MRC, Mol Biol Lab, Cambridge CB2 2QH, England.
   MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England.
C3 MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI);
   Medical Research Council UK (MRC); MRC Human Nutrition Research
RP Minczuk, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.
EM mminczuk@mrc-lmb.cam.ac.uk; akl@mrc-lmb.cam.ac.uk
RI Minczuk, Michal/G-1638-2014; Murphy, Michael/C-2120-2009
OI Minczuk, Michal/0000-0001-8242-1420; Murphy, Michael/0000-0003-1115-9618
FU Medical Research Council [MC_U105184324, MC_U105663142] Funding Source:
   Medline; MRC [MC_U105184324, MC_U105663142] Funding Source: UKRI
CR Blancafort P, 2004, MOL PHARMACOL, V66, P1361, DOI 10.1124/mol.104.002758
   Carvin CD, 2003, NUCLEIC ACIDS RES, V31, P6493, DOI 10.1093/nar/gkg853
   CHOO Y, 1994, NATURE, V372, P642, DOI 10.1038/372642a0
   DiMauro S, 2004, ANN NY ACAD SCI, V1011, P232, DOI 10.1196/annals.1293.023
   Eichwald V, 2002, J VIROL, V76, P10307, DOI 10.1128/JVI.76.20.10307-10319.2002
   Falke D, 2003, CURR OPIN MOL THER, V5, P161
   FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710
   Handa V, 2005, J MOL BIOL, V348, P1103, DOI 10.1016/j.jmb.2005.02.044
   HARTMANN CM, 1993, EUR J BIOCHEM, V218, P905, DOI 10.1111/j.1432-1033.1993.tb18446.x
   Isalan M, 1998, BIOCHEMISTRY-US, V37, P12026, DOI 10.1021/bi981358z
   Izquierdo JM, 2000, BIOCHEM J, V346, P849, DOI 10.1042/0264-6021:3460849
   Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087
   Kang D, 2005, ANN NY ACAD SCI, V1042, P101, DOI 10.1196/annals.1338.010
   Klug A, 2005, P JPN ACAD B-PHYS, V81, P87, DOI 10.2183/pjab.81.87
   Maekawa M, 2004, CLIN CHEM, V50, P1480, DOI 10.1373/clinchem.2004.035139
   Margeot A, 2005, GENE, V354, P64, DOI 10.1016/j.gene.2005.04.022
   McNamara AR, 2002, NUCLEIC ACIDS RES, V30, P3818, DOI 10.1093/nar/gkf501
   Minczuk M, 2002, NUCLEIC ACIDS RES, V30, P5074, DOI 10.1093/nar/gkf647
   Moore M, 2001, P NATL ACAD SCI USA, V98, P1437, DOI 10.1073/pnas.98.4.1437
   Mund C, 2004, BIOCHEM J, V378, P763, DOI 10.1042/BJ20031567
   Murphy MP, 2000, ADV DRUG DELIVER REV, V41, P235, DOI 10.1016/S0169-409X(99)00069-1
   Papworth M, 2006, GENE, V366, P27, DOI 10.1016/j.gene.2005.09.011
   Papworth M, 2003, P NATL ACAD SCI USA, V100, P1621, DOI 10.1073/pnas.252773399
   Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006
   Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793
   Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556
   Xu GL, 1997, NAT GENET, V17, P376, DOI 10.1038/ng1297-376
NR 33
TC 126
Z9 154
U1 1
U2 21
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 26
PY 2006
VL 103
IS 52
BP 19689
EP 19694
DI 10.1073/pnas.0609502103
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 123GX
UT WOS:000243285500017
PM 17170133
OA Green Published
DA 2024-11-01
ER

PT J
AU Shinmei, Y
   Kase, M
   Suzuki, Y
   Nitta, T
   Chin, S
   Yoshida, K
   Goto, Y
   Nagashima, T
   Ohno, S
AF Shinmei, Yasuhiro
   Kase, Manahu
   Suzuki, Yasuo
   Nitta, Takuya
   Chin, Shinki
   Yoshida, Kazuhiko
   Goto, Yu-ichi
   Nagashima, Toshiko
   Ohno, Shigeaki
TI Ocular motor disorders in mitochondrial encephalopathy with lactic acid
   and stroke-like episodes with the 3271 (T-C) point mutation in
   mitochondrial DNA
SO JOURNAL OF NEURO-OPHTHALMOLOGY
LA English
DT Article
ID 3-DIMENSIONAL EYE POSITION; DOWNBEAT NYSTAGMUS; DISEASE;
   ENCEPHALOMYOPATHIES; MYOPATHY; MELAS
AB Background: Ocular motor function can provide insights into areas of dysfunction within the nervous system. There are no published eye movement recordings in patients with mitochondrial encephalopathy with lactic acid and stroke-like episodes (MELAS). Our purpose in this study was to analyze the ocular motor features of a family with MELAS with a (T-C) mutation at nucleotide position 3271 in the mitochondrial tRNA-Leu gene.
   Methods: The search coil method was used to record visually-guided saccades, antisaccades, and triangular pursuit tasks in the horizontal and vertical planes in three patients in a Japanese family with MELAS.
   Results: The patients showed saccadic dysmetria and prolonged saccadic reaction times, deficits in the ability to suppress reflex eye movements, and increased reaction time during antisaccades, downbeat nystagmus, square wave jerks, and impairment in pursuit.
   Conclusions: On the basis of eye movement recordings, patients with MELAS have frontal cortex as well as cerebellar dysfunction.
C1 Hokkaido Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sapporo, Hokkaido 0608638, Japan.
   Teine Keijinkai Hosp, Dept Ophthalmol, Sapporo, Hokkaido, Japan.
   Teine Keijinkai Hosp, Dept Neurol, Sapporo, Hokkaido, Japan.
   Sapporo Med Univ, Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan.
   Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan.
C3 Hokkaido University; Teine Keijinkai Hospital; Teine Keijinkai Hospital;
   Sapporo Medical University; National Center for Neurology & Psychiatry -
   Japan
RP Shinmei, Y (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, West 7,North 15, Sapporo, Hokkaido 0608638, Japan.
EM yshinmei@med.hokudai.ac.jp
CR Amador N, 2004, J NEUROPHYSIOL, V91, P1672, DOI 10.1152/jn.00138.2003
   Barash S, 1999, J NEUROSCI, V19, P10931, DOI 10.1523/JNEUROSCI.19-24-10931.1999
   BLASS JP, 1988, REV NEUROL, V144, P543
   FLETCHER WA, 1986, ANN NEUROL, V20, P464, DOI 10.1002/ana.410200405
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   FUKUSHIMA J, 1988, BIOL PSYCHIAT, V23, P670, DOI 10.1016/0006-3223(88)90050-9
   Glasauer S, 2003, J NEUROPHYSIOL, V89, P338, DOI 10.1152/jn.00297.2002
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE, pS107
   HALMAGYI GM, 1983, ARCH NEUROL-CHICAGO, V40, P777
   HESS BJM, 1992, VISION RES, V32, P1647, DOI 10.1016/0042-6989(92)90157-E
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KITAGAWA M, 1994, NEUROLOGY, V44, P2285, DOI 10.1212/WNL.44.12.2285
   LASKER AG, 1987, NEUROLOGY, V37, P364, DOI 10.1212/WNL.37.3.364
   MARIE SKN, 1994, BIOCHEM MED METAB B, V52, P136, DOI 10.1006/bmmb.1994.1045
   Marti S, 2005, INVEST OPHTH VIS SCI, V46, P143, DOI 10.1167/iovs.04-0235
   Mojon D, 2001, Ther Umsch, V58, P49, DOI 10.1024/0040-5930.58.1.49
   Nagashima T, 2001, NEUROMUSCULAR DISORD, V11, P470, DOI 10.1016/S0960-8966(01)00190-0
   Ohno, 2000, Jpn J Ophthalmol, V44, P695, DOI 10.1016/S0021-5155(00)00263-X
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rivaud-Péchoux S, 2000, NEUROLOGY, V54, P1029, DOI 10.1212/WNL.54.5.1029
   Sue CM, 1997, NEUROLOGY, V49, P1013, DOI 10.1212/WNL.49.4.1013
   Suzuki Y, 2000, INVEST OPHTH VIS SCI, V41, P2954
   ZEE DS, 1974, ARCH NEUROL-CHICAGO, V30, P227, DOI 10.1001/archneur.1974.00490330035006
NR 26
TC 11
Z9 11
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1070-8022
EI 1536-5166
J9 J NEURO-OPHTHALMOL
JI J. Neuro-Ophthal.
PD MAR
PY 2007
VL 27
IS 1
BP 22
EP 28
DI 10.1097/WNO.0b013e3180334cb0
PG 7
WC Clinical Neurology; Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Ophthalmology
GA 148JN
UT WOS:000245070800005
PM 17414868
OA Bronze
DA 2024-11-01
ER

PT J
AU Sakai, Y
   Kaga, K
   Kodama, K
   Higuchi, A
   Miyamoto, J
AF Sakai, Y
   Kaga, K
   Kodama, K
   Higuchi, A
   Miyamoto, J
TI Hearing evaluation in two sisters with a T8993G point mutation of
   mitochondrial DNA
SO INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY
LA English
DT Article
DE A T8993G point mutation of mitochondrial DNA; Leigh's syndrome;
   neurogenic muscle, weakness, ataxia and retinitis pigmentosa (NARP);
   sensorineural hearing loss; auditory brainstem responses
ID TRNA(SER(UCN)) GENE; SENSORINEURAL DEAFNESS; LEIGHS SYNDROME; PATIENT;
   DISEASE; FAMILY; MTDNA
AB We report on two sisters with a T8993G point mutation of mitochondrial DNA, and their hearing evaluation. Considering auditory function, hearing in the elder sister remains almost normal. However, in the younger sister, the auditory brainstem response (ABR) threshold has fluctuated remarkably during a 3-year follow-up. The threshold changes of ABR in the younger sister suggest that her hearing problems may well be caused by both cochlear nerves and retrocochlear lesions. Our experience is clinically important because there have been only a few reports on hearing evaluation in patients with a T8993G point mutation of mitochondrial DNA. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Tokyo, Sch Med, Dept Otolaryngol, Bunkyo Ku, Tokyo 1138655, Japan.
   Natl Ctr Childrens Rehabilitat, Itabashi Ku, Tokyo 1730037, Japan.
   Kiyose Childrens Hosp, Dept Pediat, Tokyo 2048567, Japan.
C3 University of Tokyo
RP Sakai, Y (corresponding author), 1-35-27 Hongo,Bunkyo Ku,ATORU MASAGO 701, Tokyo 1130033, Japan.
EM xxxsakai@tivedoor.com
CR COR WRJ, 2002, GENETIC HEARING IMPA, V61, P172
   ENSINK RJH, 1996, P 2 WORKSH EUR WORK
   Fischel-Ghodsian N, 1998, AM J HUM GENET, V62, P15, DOI 10.1086/301695
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hutchin TP, 2000, J MED GENET, V37, P692, DOI 10.1136/jmg.37.9.692
   KAGA M, 1987, Acta Paediatrica Japonica, V29, P254
   MANOUVRIER S, 1995, J MED GENET, V32, P654, DOI 10.1136/jmg.32.8.654
   NAKAMURA M, 1995, BIOCHEM BIOPH RES CO, V214, P86, DOI 10.1006/bbrc.1995.2260
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Reid FM, 1997, HUM MOL GENET, V6, P443, DOI 10.1093/hmg/6.3.443
   REID FM, 1994, HUM MOL GENET, V3, P1435
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   SOFFNER JM, 1992, NEUROLOGY, V42, P2168
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   YOSHINAGA H, 1993, J CHILD NEUROL, V8, P129, DOI 10.1177/088307389300800204
NR 16
TC 6
Z9 6
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0165-5876
J9 INT J PEDIATR OTORHI
JI Int. J. Pediatr. Otorhinolaryngol.
PD AUG
PY 2004
VL 68
IS 8
BP 1115
EP 1119
DI 10.1016/j.ijporl.2004.03.015
PG 5
WC Otorhinolaryngology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Otorhinolaryngology; Pediatrics
GA 845LM
UT WOS:000223244200020
PM 15236904
DA 2024-11-01
ER

PT J
AU Miró, O
   López, S
   Cardellach, F
   Casademont, J
AF Miró, O
   López, S
   Cardellach, F
   Casademont, J
TI Mitochondrial studies in HAART-related lipodystrophy:: from experimental
   hypothesis to clinical findings
SO ANTIVIRAL THERAPY
LA English
DT Article; Proceedings Paper
CT 1st Meeting on Mitochondrial Toxicity and HIV Infection
CY APR 19-MAY 21, 2005
CL Modena, ITALY
SP GILEAD, O sigma-tau
ID HIV-INFECTED PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; BLOOD
   MONONUCLEAR-CELLS; SUBCUTANEOUS ADIPOSE-TISSUE; DNA DEPLETION; PROTEASE
   INHIBITORS; NUCLEOSIDE ANALOGS; LACTIC-ACID; TOXICITY; LIPOATROPHY
AB Chronic use of antiretrovirals (ARVs) to treat HIV infection, along with more prolonged patient survival, has been associated with an increase in adverse drug effects in HIV-infected patients on treatment. It has been proposed that some of these adverse effects (including myopathy, cardiomyopathy, anaemia, hyperlactataemia/lactic acidosis, pancreatitis, polyneuritis and lipodystrophy) could be mediated by mitochondrial (mt) toxicity. From the experimental data, it has been proposed that nucleoside analogue reverse transcriptase inhibitors (NRTIs) also inhibit gamma-polymerase, the enzyme devoted to replicate (and, to a lesser extent, repair) mtDNA. It is now widely accepted that the use of most NRTIs in HIV-infected patients is associated with mtDNA depletion. Although cross-sectional studies suggest that certain ARVs, especially stavudine, are more toxic to mitochondria, the differences among different highly active ARV therapy (HAART) schedules detected in the analysis of longitudinal studies are not so clear. These types of study in previously untreated individuals suggest that the greatest mtDNA loss appears at the beginning of the treatment. Conversely, in ARV-experienced patients, the potential beneficial effects of HAART changes in terms of mtDNA content remain controversial and must be further investigated. Functional studies accompanying genetic investigations are needed for the correct pathogenic interpretation of the mtDNA abnormalities.
C1 Hosp Clin Barcelona, IDIBAPS, Dept Internal Med, Mitochondrial Res Lab, Barcelona, Catalonia, Spain.
C3 University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS
RP Hosp Clin Barcelona, IDIBAPS, Dept Internal Med, Mitochondrial Res Lab, Barcelona, Catalonia, Spain.
EM omiro@clinic.ub.es
RI Miro, Oscar/K-1798-2019; Casademont, Jordi/A-6828-2010; Lopez,
   Sonia/AAC-8830-2019
OI Lopez, Sonia/0000-0002-5023-5153
CR BADLEY AD, 2005, IN PRESS CELL DEAT D
   Barile M, 1997, BIOCHEM PHARMACOL, V53, P913, DOI 10.1016/S0006-2952(96)00831-3
   Caron M, 2004, AIDS, V18, P2127, DOI 10.1097/00002030-200411050-00004
   Casademont J, 2002, NEW ENGL J MED, V347, P217
   Chapplain JM, 2004, JAIDS-J ACQ IMM DEF, V37, P1477, DOI 10.1097/01.qai.0000138982.68106.6c
   Cherry CL, 2002, J ACQ IMMUN DEF SYND, V30, P271, DOI [10.1097/00126334-200207010-00002, 10.1097/01.QAI.0000017962.22053.0E]
   Chiappini F, 2004, LAB INVEST, V84, P908, DOI 10.1038/labinvest.3700113
   Christensen ER, 2004, CLIN INFECT DIS, V39, P1371, DOI 10.1086/424881
   Church JA, 2001, J PEDIATR-US, V138, P748, DOI 10.1067/mpd.2001.112653
   Cossarizza A, 2004, AIDS, V18, P137, DOI 10.1097/00002030-200401230-00002
   Cossarizza A, 2003, ANTIVIR THER, V8, P315
   Cossarizza A, 2002, J INFECT DIS, V185, P299, DOI 10.1086/338564
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   de Mendoza C, 2004, AIDS RES HUM RETROV, V20, P271, DOI 10.1089/088922204322996491
   Divi RL, 2004, AIDS, V18, P1013, DOI 10.1097/00002030-200404300-00009
   Goto M, 2003, J MED VIROL, V70, P497, DOI 10.1002/jmv.10423
   GRAU JM, 1993, ANN NEUROL, V34, P206, DOI 10.1002/ana.410340217
   HALL ET, 1994, J BIOL CHEM, V269, P14355
   Hammond E, 2004, AIDS, V18, P815, DOI 10.1097/00002030-200403260-00015
   HOBBS GA, 1995, BIOCHEM PHARMACOL, V50, P381, DOI 10.1016/0006-2952(95)00141-L
   Hoy JF, 2004, J INFECT DIS, V190, P688, DOI 10.1086/422602
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   López S, 2004, ANTIVIR THER, V9, P47
   Martin A, 2004, AIDS, V18, P1029, DOI 10.1097/00002030-200404300-00011
   Martin AM, 2003, AM J HUM GENET, V72, P549, DOI 10.1086/367849
   Masanés F, 1998, J NEUROL SCI, V159, P226, DOI 10.1016/S0022-510X(98)00151-8
   McComsey G, 2004, JAIDS-J ACQ IMM DEF, V37, pS30, DOI 10.1097/01.qai.0000137004.63376.27
   McComsey G, 2002, AIDS, V16, P513, DOI 10.1097/00002030-200203080-00001
   McComsey GA, 2005, AIDS, V19, P15, DOI 10.1097/00002030-200501030-00002
   Miró O, 2003, AIDS RES HUM RETROV, V19, P1027, DOI 10.1089/088922203322588387
   Miró O, 2000, AIDS, V14, P1855, DOI 10.1097/00002030-200008180-00024
   Miró O, 2004, CLIN INFECT DIS, V39, P710, DOI 10.1086/423176
   Miró O, 2003, ANTIVIR THER, V8, P333
   Miró O, 2004, JAIDS-J ACQ IMM DEF, V37, P1550, DOI 10.1097/00126334-200412150-00002
   Montaner JSG, 2004, CLIN INFECT DIS, V38, pS73, DOI 10.1086/381449
   Negredo E, 2005, JAIDS-J ACQ IMM DEF, V38, P47, DOI 10.1097/00126334-200501010-00009
   Nerurkar PV, 2003, CELL MOL BIOL, V49, P1205
   Nolan D, 2004, ANTIVIR THER, V9, P849
   Nolan D, 2003, ANTIVIR THER, V8, P617
   Pace CS, 2003, ANTIVIR THER, V8, P323
   Pan-Zhou XR, 2000, ANTIMICROB AGENTS CH, V44, P496, DOI 10.1128/AAC.44.3.496-503.2000
   Petit C, 2003, JAIDS-J ACQ IMM DEF, V33, P461, DOI 10.1097/00126334-200308010-00006
   Phenix BN, 2001, BLOOD, V98, P1078, DOI 10.1182/blood.V98.4.1078
   Pilon AA, 2002, ANTIMICROB AGENTS CH, V46, P2687, DOI 10.1128/AAC.46.8.2687-2691.2002
   Polo R, 2003, JAIDS-J ACQ IMM DEF, V34, P32, DOI 10.1097/00126334-200309010-00004
   Reiss P, 2004, HIV MED, V5, P11, DOI 10.1111/j.1468-1293.2004.00178.x
   Roge BT, 2002, AIDS, V16, P973, DOI 10.1097/00002030-200205030-00003
   Shikuma CM, 2001, AIDS, V15, P1801, DOI 10.1097/00002030-200109280-00009
   Valenti D, 2000, INT J MOL MED, V6, P93
   van der Valk M, 2004, ANTIVIR THER, V9, P385
   VANDERVALK M, 2004, HEPATOLOGY, V39, P311
   Villarroya F, 2005, TRENDS PHARMACOL SCI, V26, P88, DOI 10.1016/j.tips.2004.12.005
   Vittecoq D, 2002, JAIDS, V31, P299, DOI 10.1097/00126334-200211010-00005
   Walker UA, 2002, AIDS, V16, P2165, DOI 10.1097/00002030-200211080-00009
   Walker UA, 2002, J ACQ IMMUN DEF SYND, V29, P117, DOI 10.1097/00042560-200202010-00002
   White DJ, 2001, AIDS, V15, P1061, DOI 10.1097/00002030-200105250-00017
   Zaera MG, 2001, AIDS, V15, P1643, DOI 10.1097/00002030-200109070-00006
NR 60
TC 26
Z9 29
U1 0
U2 1
PU INT MEDICAL PRESS LTD
PI LONDON
PA 2-4 IDOL LANE, LONDON EC3R 5DD, ENGLAND
SN 1359-6535
J9 ANTIVIR THER
JI Antivir. Ther.
PY 2005
VL 10
SU 2
BP M73
EP M81
PG 9
WC Infectious Diseases; Pharmacology & Pharmacy; Virology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Infectious Diseases; Pharmacology & Pharmacy; Virology
GA 966QD
UT WOS:000232035000008
PM 16152708
DA 2024-11-01
ER

PT J
AU Yoshii, Y
   Yoneda, M
   Ikawa, M
   Furukawa, T
   Kiyono, Y
   Mori, T
   Yoshii, H
   Oyama, N
   Okazawa, H
   Saga, T
   Fujibayashi, Y
AF Yoshii, Yukie
   Yoneda, Makoto
   Ikawa, Masamichi
   Furukawa, Takako
   Kiyono, Yasushi
   Mori, Tetsuya
   Yoshii, Hiroshi
   Oyama, Nobuyuki
   Okazawa, Hidehiko
   Saga, Tsuneo
   Fujibayashi, Yasuhisa
TI Radio labeled Cu-ATSM as a novel indicator of overreduced intracellular
   state due to mitochondrial dysfunction: studies with mitochondrial
   DNA-less ρ<SUP>0</SUP> cells and cybnds carrying MELAS mitochondnal DNA
   mutation
SO NUCLEAR MEDICINE AND BIOLOGY
LA English
DT Article
DE Cu-ATSM; MELAS; Mitochondrial dysfunction; Overreduced state; PET;
   rho(0) cell
ID POSITRON-EMISSION-TOMOGRAPHY; TRANSFER RNALEU(UUR) GENE; ASSESSING TUMOR
   HYPOXIA; IN-VITRO; OXIDATIVE STRESS; LACTIC-ACIDOSIS; CERVICAL-CANCER;
   POINT MUTATION; PIMONIDAZOLE; CU-64-ATSM
AB Objectives: Radiolabeled Cu-diacetyl-bis (N-4-methylthiosemicarbazone) (*Cu-ATSM), including Cu-60/62/64-ATSM, is a potential imaging agent of hypoxic tumors for positron emission tomography (PET). We have reported that *Cu-ATSM is trapped in tumor cells under intracellular overreduced states, e.g., hypoxia. Here we evaluated *Cu-ATSM as an indicator of intracellular overreduced states in mitochondrial disorders using cell lines with mitochondrial dysfunction.
   Methods: Mitochondrial DNA-less rho(0)206 cells; the parental 143B human osteosarcoma cells; the cybrids carrying mutated mitochondria from a patient of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) (2SD); and that carrying wildtype one (2SA) were used. Cells were treated under normoxia or hypoxia, and Cu-64-ATSM uptake was examined to compare it with levels of biological reductant NADH and NADPH.
   Results: rho(0)206 cells showed higher Cu-64-ATSM uptake than control 143B cells under normoxia, whereas Cu-64-ATSM uptake was not significantly increased under hypoxia in rho(0)206 cells. Additionally, Cu-64-ATSM uptake showed correlate change to the NADH and NADPH levels, but not oxygenic conditions. 2SD cells showed increased Cu-64-ATSM uptake under normoxia as compared with the control 2SA, and Cu-64-ATSM uptake followed NADH and NADPH levels, but not oxygenic conditions.
   Conclusions: Cu-64-ATSM accumulated in cells with overreduced states due to mitochondrial dysfunction, even under normoxia. We recently reported that Cu-62-ATSM-PET can visualize stroke-like episodes maintaining oxygen supply in MELAS patients. Taken together, our data indicate that *Cu-ATSM uptake reflects overreduced intracellular states, despite oxygenic conditions; thus, *Cu-ATSM would be a promising marker of intracellular overreduced states for disorders with mitochondrial dysfunction, such as MELAS, Parkinson's disease and Alzheimer's disease. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Yoshii, Yukie; Furukawa, Takako; Saga, Tsuneo; Fujibayashi, Yasuhisa] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 2638555, Japan.
   [Yoshii, Yukie; Furukawa, Takako; Kiyono, Yasushi; Mori, Tetsuya; Okazawa, Hidehiko; Fujibayashi, Yasuhisa] Univ Fukui, Biomed Imaging Res Ctr, Fukui 9101193, Japan.
   [Yoneda, Makoto; Ikawa, Masamichi] Univ Fukui, Dept Neurol, Fac Med Sci, Fukui 9101193, Japan.
   [Yoshii, Hiroshi] Natl Inst Radiol Sci, Emergency Radiat Exposure Med Care Res Ctr, Chiba 2638555, Japan.
   [Oyama, Nobuyuki] Univ Fukui, Dept Urol, Fac Med Sci, Fukui 9101193, Japan.
C3 National Institutes for Quantum Science & Technology; University of
   Fukui; University of Fukui; National Institutes for Quantum Science &
   Technology; University of Fukui
RP Yoshii, Y (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 2638555, Japan.
EM yukiey@nirs.go.jp
RI Okazawa, Hidehiko/I-2488-2019; Ikawa, Masamichi/AGG-4951-2022; Yoshii,
   Hiroshi/AAB-1608-2021; Okazawa, Hidehiko/B-2795-2016
OI Ikawa, Masamichi/0000-0001-9785-0535; Okazawa,
   Hidehiko/0000-0001-7046-3383; Oyama, Nobuyuki/0000-0001-9349-8909
FU Japan Society for the Promotion of Science, Japan (JSPS); Ministry of
   Education, Culture, Sports, Science and Technology (MEXT), Japan
FX We would like to thank the staff of the Biomedical Imaging Research
   Centre of the University of Fukui, Japan, for their helpful discussion.
   This work was funded in part by Grants-in-Aid for Scientific Research
   (B) (H.O.); Scientific Research on Innovative Areas (M.Y.); Young
   Scientists (B) (to Y.Y., M.I.); the 21st Century CUE Program (Medical
   Science) from the Japan Society for the Promotion of Science, Japan
   (JSPS); and Japan Advanced Molecular Imaging Program from the Ministry
   of Education, Culture, Sports, Science and Technology (MEXT), Japan.
CR Arteel GE, 1998, EUR J BIOCHEM, V253, P743, DOI 10.1046/j.1432-1327.1998.2530743.x
   ARTEEL GE, 1995, BRIT J CANCER, V72, P889, DOI 10.1038/bjc.1995.429
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Dearling JLJ, 2010, NUCL MED BIOL, V37, P237, DOI 10.1016/j.nucmedbio.2009.11.004
   Dearling JLJ, 2002, J BIOL INORG CHEM, V7, P249, DOI 10.1007/s007750100291
   Dehdashti F, 2003, INT J RADIAT ONCOL, V55, P1233, DOI 10.1016/S0360-3016(02)04477-2
   Dehdashti F, 2008, J NUCL MED, V49, P201, DOI 10.2967/jnumed.107.048520
   Dence CS, 2008, NUCL MED BIOL, V35, P713, DOI 10.1016/j.nucmedbio.2008.06.001
   Dietz DW, 2008, DIS COLON RECTUM, V51, P1641, DOI 10.1007/s10350-008-9420-3
   Fujibayashi Y, 1997, J NUCL MED, V38, P1155
   Fukuyama R, 2002, J BIOL CHEM, V277, P41455, DOI 10.1074/jbc.M204176200
   Gao L, 2004, FEBS LETT, V569, P256, DOI 10.1016/j.febslet.2004.06.004
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Greco O, 2003, J CELL PHYSIOL, V197, P312, DOI 10.1002/jcp.10374
   Grigoryan R, 2005, METH MOLEC MED, V110, P87
   Grigsby PW, 2007, MOL IMAGING BIOL, V9, P278, DOI 10.1007/s11307-007-0095-2
   Guo SH, 2009, J NEUROCHEM, V108, P1309, DOI 10.1111/j.1471-4159.2009.05877.x
   Höckel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266
   Ikawa M, 2009, MITOCHONDRION, V9, P144, DOI 10.1016/j.mito.2009.01.011
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Lewis JS, 2001, J NUCL MED, V42, P655
   Lewis JS, 1999, J NUCL MED, V40, P177
   Lezza AMS, 1999, FASEB J, V13, P1083, DOI 10.1096/fasebj.13.9.1083
   Lohith TG, 2009, J NUCL MED, V50, P1948, DOI 10.2967/jnumed.109.069021
   Matsumoto KI, 2007, INT J ONCOL, V30, P873
   Mawrin C, 2004, NEUROSCI LETT, V357, P111, DOI 10.1016/j.neulet.2003.11.073
   McCarthy DW, 1997, NUCL MED BIOL, V24, P35, DOI 10.1016/S0969-8051(96)00157-6
   MORENO SNJ, 1983, J BIOL CHEM, V258, P4051
   O'Donoghue JA, 2005, INT J RADIAT ONCOL, V61, P1493, DOI 10.1016/j.ijrobp.2004.12.057
   Obata A, 2001, ANN NUCL MED, V15, P499, DOI 10.1007/BF02988502
   Obata A, 2003, NUCL MED BIOL, V30, P535, DOI 10.1016/S0969-8051(03)00024-6
   Obata A, 2003, NUCL MED BIOL, V30, P529, DOI 10.1016/S0969-8051(03)00047-7
   OBITABOT ET, 1993, J SURG RES, V55, P575, DOI 10.1006/jsre.1993.1187
   Oh M, 2009, NUCL MED BIOL, V36, P419, DOI 10.1016/j.nucmedbio.2009.01.016
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rosenberger Christian, 2009, V466, P161, DOI 10.1007/978-1-59745-352-3_12
   Takahashi N, 2000, ANN NUCL MED, V14, P323, DOI 10.1007/BF02988690
   Tanaka T, 2006, NUCL MED BIOL, V33, P743, DOI 10.1016/j.nucmedbio.2006.05.005
   Watabe M, 2008, MOL PHARMACOL, V74, P933, DOI 10.1124/mol.108.048546
   Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   Yoshii Y, 2011, NUCL MED BIOL, V38, P151, DOI 10.1016/j.nucmedbio.2010.08.009
   Yoshii Y, 2010, NUCL MED BIOL, V37, P395, DOI 10.1016/j.nucmedbio.2009.12.011
NR 48
TC 55
Z9 57
U1 1
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0969-8051
EI 1872-9614
J9 NUCL MED BIOL
JI Nucl. Med. Biol.
PD FEB
PY 2012
VL 39
IS 2
BP 177
EP 185
DI 10.1016/j.nucmedbio.2011.08.008
PG 9
WC Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Radiology, Nuclear Medicine & Medical Imaging
GA 890BY
UT WOS:000300121300002
PM 22033022
DA 2024-11-01
ER

PT J
AU Bahreini, F
   Houshmand, M
   Modaresi, MH
   Tonekaboni, H
   Nafissi, S
   Nazari, F
   Akrami, SM
AF Bahreini, Fatemeh
   Houshmand, Massoud
   Modaresi, Mohammad Hossein
   Tonekaboni, Hassan
   Nafissi, Shahriar
   Nazari, Ferdoss
   Akrami, Seyed Mohammad
TI Mitochondrial Copy Number and D-Loop Variants in Pompe Patients
SO CELL JOURNAL
LA English
DT Article
DE Pompe; Mitochondrial DNA; D-Loop; Copy Number
ID DNA MUTATIONS; DISPLACEMENT LOOP; LATE-ONSET; MONONUCLEOTIDE SEQUENCE;
   SKELETAL-MUSCLE; HUMAN-DISEASE; CANCER; GLYCOGENOSIS; PATHOGENESIS;
   DIAGNOSIS
AB Objective: Pompe disease is a rare neuromuscular genetic disorder and is classified into two forms of early and late-onset. Over the past two decades, mitochondrial abnormalities have been recognized as an important contributor to an array of neuromuscular diseases. We therefore aimed to compare mitochondrial copy number and mitochondrial displacement-loop sequence variation in infantile and adult Pompe patients.
   Materials and Methods: In this retrospective study, the mitochondrial D-loop sequence was analyzed by polymerase chain reaction (PCR) and direct sequencing to detect possible variation in 28 Pompe patients (17 infants and 11 adults). Results were compared with 100 healthy controls and sequences of all individuals were compared with the Cambridge reference sequence. Real-time PCR was used to quantify mitochondrial DNA copy number.
   Results: Among 59 variants identified, 37(62.71%) were present in the infant group, 14(23.333%) in the adult group and 8(13.333%) in both groups. Mitochondrial copy number in infant patients was lower than adults (P<0.05). A significant frequency difference was seen between the two groups for 12 single nucleotide polymorphism (SNP). A novel insertion (317-318 ins CCC) was observed in patients and six SNPs were identified as neutral variants in controls. There was an inverse association between mitochondrial copy number and D-loop variant number (r=0.54).
   Conclusion: The 317-318 ins CCC was detected as a new mitochondrial variant in Pompe patients.
C1 [Bahreini, Fatemeh; Modaresi, Mohammad Hossein; Akrami, Seyed Mohammad] Univ Tehran Med Sci, Sch Med, Dept Med Genet, POB 14176-13151,Keshavarz BLV,Poursina St, Tehran, Iran.
   [Houshmand, Massoud] Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran.
   [Tonekaboni, Hassan] Shahid Beheshti Univ Med Sci, Dept Pediat Neurol, Tehran, Iran.
   [Nafissi, Shahriar; Nazari, Ferdoss] Univ Tehran Med Sci, Iranian Ctr Neurol Res, Tehran, Iran.
C3 Tehran University of Medical Sciences; Shahid Beheshti University
   Medical Sciences; Tehran University of Medical Sciences
RP Akrami, SM (corresponding author), Univ Tehran Med Sci, Sch Med, Dept Med Genet, POB 14176-13151,Keshavarz BLV,Poursina St, Tehran, Iran.
EM akramism@tums.ac.ir
RI Houshmand, Massoud/AEG-9909-2022; Nafissi, Shahriar/AAS-1597-2020;
   bahreini, fatemeh/K-2437-2017
OI Nafissi, Shahriar/0000-0003-4763-4310; Houshmand,
   Massoud/0000-0002-2198-223X; bahreini, fatemeh/0000-0003-4444-1206; ,
   Masoud/0000-0001-7687-7464; Tonekaboni, Seyed Hassan/0000-0003-0853-8465
FU Tehran University of Medical Sciences, Tehran, Iran [23162]
FX We thank all the participants in this study. This study was funded by
   Tehran University of Medical Sciences, Tehran, Iran (Grant Number:
   23162). The authors declared no conflict of interest.
CR Akouchekian M, 2009, DIS COLON RECTUM, V52, P526, DOI 10.1007/DCR.0b013e31819acb99
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Chamkha I, 2012, BIOCHEM BIOPH RES CO, V429, P31, DOI 10.1016/j.bbrc.2012.10.105
   Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Dons Sink IJ, 2014, CASE REP ANESTHESIOL, V2014
   ENGEL AG, 1968, MAYO CLIN PROC, V43, P233
   Fernández R, 1999, NEUROMUSCULAR DISORD, V9, P136, DOI 10.1016/S0960-8966(98)00117-5
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   Ghaffarpour M, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-21
   HOUSHMAND M, 1994, BBA-MOL BASIS DIS, V1226, P49, DOI 10.1016/0925-4439(94)90058-2
   Huang HP, 2011, HUM MOL GENET, V20, P4851, DOI 10.1093/hmg/ddr424
   Hudgson P, 1975, Riv Istochim Norm Patol, V19, P101
   Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001
   Kishnani PS, 2006, GENET MED, V8, P267, DOI 10.1097/01.gim.0000218152.87434.f3
   Kroos M, 2012, HUM MUTAT, V33, P1161, DOI 10.1002/humu.22108
   Kurtz A, 2004, MOL CANCER RES, V2, P433
   Lachmann R, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-160
   Lewandowska E, 2008, FOLIA NEUROPATHOL, V46, P123
   Lim JA, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00177
   Mao L, 2002, CLIN CANCER RES, V8, P2021
   Marín-García J, 2002, J CARD FAIL, V8, P93, DOI 10.1054/jcaf.2002.32501
   Mezghani N, 2011, BIOCHEM BIOPH RES CO, V411, P247, DOI 10.1016/j.bbrc.2011.06.106
   Raben N, 2012, AM J MED GENET C, V160C, P13, DOI 10.1002/ajmg.c.31317
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Schmuczerova J, 2009, MUTAT RES-FUND MOL M, V666, P1, DOI 10.1016/j.mrfmmm.2009.03.002
   Seyedhassani SM, 2010, J ASSIST REPROD GEN, V27, P641, DOI 10.1007/s10815-010-9435-2
   Shakhssalim N, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-120
   Suzuki M, 2003, CLIN CANCER RES, V9, P5636
   Tang MY, 2004, CLIN CANCER RES, V10, P1041, DOI 10.1158/1078-0432.CCR-0701-3
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Thurberg BL, 2006, LAB INVEST, V86, P1208, DOI 10.1038/labinvest.3700484
   Thurberg Beth L, 2015, J Neuromuscul Dis, V2, pS72
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Udar N, 2009, INVEST OPHTH VIS SCI, V50, P2966, DOI 10.1167/iovs.08-2646
   Van der Beek NAME, 2009, NEUROMUSCULAR DISORD, V19, P113, DOI 10.1016/j.nmd.2008.11.007
   van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859
   Van Trappen PO, 2007, GYNECOL ONCOL, V104, P129, DOI 10.1016/j.ygyno.2006.07.010
   VERITY MA, 1991, MUSCLE NERVE, V14, P435, DOI 10.1002/mus.880140509
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Yanovitch TL, 2010, J PEDIAT OPHTH STRAB, V47, P34, DOI 10.3928/01913913-20100106-08
NR 41
TC 5
Z9 5
U1 0
U2 1
PU ROYAN INST
PI TEHRAN
PA PO BOX 19395-4644, TEHRAN, 00000, IRAN
SN 2228-5806
EI 2228-5814
J9 CELL J
JI Cell J.
PD FAL
PY 2016
VL 18
IS 3
BP 405
EP 415
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA DW7YN
UT WOS:000383869800014
PM 27602323
DA 2024-11-01
ER

PT J
AU Kornblum, C
   Schröder, R
   Müller, K
   Vorgerd, M
   Eggers, J
   Bogdanow, M
   Papassotiropoulos, A
   Fabian, K
   Klockgether, T
   Zange, J
AF Kornblum, C
   Schröder, R
   Müller, K
   Vorgerd, M
   Eggers, J
   Bogdanow, M
   Papassotiropoulos, A
   Fabian, K
   Klockgether, T
   Zange, J
TI Creatine has no beneficial effect on skeletal muscle energy metabolism
   in patients with single mitochondrial DNA deletions:: a
   placebo-controlled, double-blind <SUP>31</SUP>P-MRS crossover study
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article
DE chronic progressive external ophthalmoplegia; creatine monohydrate;
   Kearns-Sayre syndrome; mitochondrial disorders; mtDNA deletion; P-31-MRS
ID MAGNETIC-RESONANCE-SPECTROSCOPY; TRANSGENIC ANIMAL-MODEL;
   PHOSPHOCREATINE RESYNTHESIS; QUANTITATIVE-ANALYSIS; MYOTONIC-DYSTROPHY;
   MCARDLE-DISEASE; SUPPLEMENTATION; MONOHYDRATE; EXERCISE; ACCUMULATION
AB The purpose of our randomized, double-blind, placebo-controlled crossover study in 15 patients with chronic progressive external ophthalmoplegia (CPEO) or Kearns-Sayre syndrome (KSS) because of single large-scale mitochondrial (mt) DNA deletions was to determine whether oral creatine (Cr) monohydrate can improve skeletal muscle energy metabolism in vivo. Each treatment phase with Cr in a dosage of 150 mg/kg body weight/day or placebo lasted 6 weeks. The effect of Cr was estimated by phosphorus-31 magnetic resonance spectroscopy (P-31-MRS), clinical and laboratory tests. P-31-MRS analysis prior to treatment showed clear evidence of severe mitochondrial dysfunction. However, there were no relevant changes in P-31-MRS parameters under Cr. In particular, phosphocreatine (PCr)/ATP at rest did not increase, and there was no facilitation of post-exercise PCr recovery. Clinical scores and laboratory tests did not alter significantly under Cr, which was tolerated without major side-effects in all patients. Cr supplementation did not improve skeletal muscle oxidative phosphorylation in our series of patients. However, one explanation for our negative findings may be the short study duration or the limited number of patients included.
C1 Univ Bonn, Dept Neurol, D-5300 Bonn, Germany.
   DLR, Inst Aerosp Med, Cologne, Germany.
   Ruhr Univ Bochum, Dept Neurol, D-4630 Bochum, Germany.
   Univ Bonn, Dept Med Biometr Informat & Epidemiol, D-5300 Bonn, Germany.
   Univ Zurich, Dept Psychiat Res, Zurich, Switzerland.
   Univ Dresden, Inst Sports Med, Dresden, Germany.
C3 University of Bonn; Helmholtz Association; German Aerospace Centre
   (DLR); Ruhr University Bochum; University of Bonn; University of Zurich;
   Technische Universitat Dresden
RP Univ Hosp Bonn, Dept Neurol, Sigmund Freud Str 25, D-53105 Bonn, Germany.
EM cornelia.kornblum@ukb.uni-bonn.de
RI Schröder, Rolf/B-2774-2011; Kornblum, Cornelia/IUM-4180-2023; Vorgerd,
   Matthias/GRS-7540-2022
OI Zange, Jochen/0000-0003-1822-0952; Papassotiropoulos,
   Andreas/0000-0002-2210-9651; Schroder, Rolf/0000-0002-2772-2615
CR Andreassen OA, 2001, NEUROBIOL DIS, V8, P479, DOI 10.1006/nbdi.2001.0406
   ARGOV Z, 1987, NEUROLOGY, V37, P257, DOI 10.1212/WNL.37.2.257
   ARNOLD DL, 1984, MAGNET RESON MED, V1, P307, DOI 10.1002/mrm.1910010303
   ARNOLD DL, 1985, ANN NEUROL, V18, P189, DOI 10.1002/ana.410180205
   BALSOM PD, 1995, ACTA PHYSIOL SCAND, V154, P303, DOI 10.1111/j.1748-1716.1995.tb09914.x
   Brose A, 2003, J GERONTOL A-BIOL, V58, P11
   Casey A, 1996, AM J PHYSIOL-ENDOC M, V271, pE31, DOI 10.1152/ajpendo.1996.271.1.E31
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   COOKE WH, 1995, J APPL PHYSIOL, V78, P670, DOI 10.1152/jappl.1995.78.2.670
   DiMauro S, 2000, NEUROL SCI, V21, pS901
   FITCH CD, 1969, P SOC EXP BIOL MED, V132, P219
   Gold DR, 2001, SEMIN NEUROL, V21, P309, DOI 10.1055/s-2001-17948
   GREENHAFF PL, 1994, AM J PHYSIOL, V266, pE725, DOI 10.1152/ajpendo.1994.266.5.E725
   Grehl T, 1998, NEUROMUSCULAR DISORD, V8, P480, DOI 10.1016/S0960-8966(98)00066-2
   Guerrero-Ontiveros ML, 1998, MOL CELL BIOCHEM, V184, P427, DOI 10.1023/A:1006895414925
   HARRIS RC, 1992, CLIN SCI, V83, P367, DOI 10.1042/cs0830367
   Howell N, 1999, INT REV CYTOL, V186, P49
   Hultman E, 1996, J APPL PHYSIOL, V81, P232
   Jones B., 1989, Design and analysis of crossover trials
   KEMP GJ, 1993, NMR BIOMED, V6, P302, DOI 10.1002/nbm.1940060504
   Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568
   Klopstock T, 2000, NEUROLOGY, V55, P1748, DOI 10.1212/WNL.55.11.1748
   Komura K, 2003, PEDIATR NEUROL, V28, P53, DOI 10.1016/S0887-8994(02)00469-1
   KUSHMERICK MJ, 1992, AM J PHYSIOL, V263, pC598, DOI 10.1152/ajpcell.1992.263.3.C598
   LOIKE JD, 1988, P NATL ACAD SCI USA, V85, P807, DOI 10.1073/pnas.85.3.807
   Louis M, 2003, MUSCLE NERVE, V27, P604, DOI 10.1002/mus.10355
   MATTHEWS PM, 1991, NEUROLOGY, V41, P114, DOI 10.1212/WNL.41.1.114
   Matthews RT, 1998, J NEUROSCI, V18, P156
   MORGANHUGHES JA, 1995, MYOLOGY, P1610
   OVERSTEEGEN HJ, 1987, CLIN CHEM, V33, P720
   Passaquin AC, 2002, NEUROMUSCULAR DISORD, V12, P174, DOI 10.1016/S0960-8966(01)00273-5
   Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798
   RADDA GK, 1982, NATURE, V295, P608, DOI 10.1038/295608a0
   RADDA GK, 1995, BBA-MOL BASIS DIS, V1271, P15, DOI 10.1016/0925-4439(95)00004-N
   Rico-Sanz J, 2000, J APPL PHYSIOL, V88, P1181, DOI 10.1152/jappl.2000.88.4.1181
   Robinson TM, 1999, J APPL PHYSIOL, V87, P598, DOI 10.1152/jappl.1999.87.2.598
   Schröder R, 2000, J NEUROPATH EXP NEUR, V59, P353, DOI 10.1093/jnen/59.5.353
   Smith SA, 1999, J APPL PHYSIOL, V87, P116, DOI 10.1152/jappl.1999.87.1.116
   Tarnopolsky M, 2004, MUSCLE NERVE, V29, P51, DOI 10.1002/mus.10527
   Tarnopolsky M, 1999, NEUROLOGY, V52, P854, DOI 10.1212/WNL.52.4.854
   Tarnopolsky MA, 1999, MUSCLE NERVE, V22, P1228, DOI 10.1002/(SICI)1097-4598(199909)22:9<1228::AID-MUS9>3.3.CO;2-Y
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Tarnopolsky MA, 2001, ANN NEUROL, V49, P561, DOI 10.1002/ana.1028.abs
   Tarnopolsky MA, 2001, MUSCLE NERVE, V24, P682, DOI 10.1002/mus.1055
   Taylor D J, 1983, Mol Biol Med, V1, P77
   TAYLOR DJ, 1994, J NEUROL SCI, V127, P198, DOI 10.1016/0022-510X(94)90073-6
   Vandenberghe K, 1999, MED SCI SPORT EXER, V31, P236, DOI 10.1097/00005768-199902000-00006
   Vandenberghe K, 1997, J APPL PHYSIOL, V83, P2055, DOI 10.1152/jappl.1997.83.6.2055
   Vorgerd M, 2000, NEUROMUSCULAR DISORD, V10, P430, DOI 10.1016/S0960-8966(00)00108-5
   Vorgerd M, 2000, ARCH NEUROL-CHICAGO, V57, P956, DOI 10.1001/archneur.57.7.956
   Vorgerd M, 2002, ARCH NEUROL-CHICAGO, V59, P97, DOI 10.1001/archneur.59.1.97
   Walsh B, 2001, J PHYSIOL-LONDON, V537, P971
   Walter MC, 2002, J NEUROL, V249, P1717, DOI 10.1007/s00415-002-0923-x
   Walter MC, 2000, NEUROLOGY, V54, P1848, DOI 10.1212/WNL.54.9.1848
   WYSS M, 1994, MOL CELL BIOCHEM, V133, P51, DOI 10.1007/BF01267947
   Xu CJ, 1996, J BIOL CHEM, V271, P13435, DOI 10.1074/jbc.271.23.13435
   Yquel RJ, 2002, J SPORT SCI, V20, P427, DOI 10.1080/026404102317366681
   Zange J, 2002, ANN NEUROL, V52, P126, DOI 10.1002/ana.10197
NR 58
TC 52
Z9 57
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD APR
PY 2005
VL 12
IS 4
BP 300
EP 309
DI 10.1111/j.1468-1331.2004.00970.x
PG 10
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 908GN
UT WOS:000227775600010
PM 15804248
DA 2024-11-01
ER

PT J
AU Aoki, H
   Higashi, M
   Okita, M
   Ando, N
   Murayama, S
   Ishikawa, K
   Yokota, T
AF Aoki, Hanako
   Higashi, Miwa
   Okita, Michi
   Ando, Noboru
   Murayama, Shigeo
   Ishikawa, Kinya
   Yokota, Takanori
TI Thymidine Kinase 2 and Mitochondrial Protein COX I in the Cerebellum of
   Patients with Spinocerebellar Ataxia Type 31 Caused by Penta-nucleotide
   Repeats (TTCCA)<sub>n</sub>
SO CEREBELLUM
LA English
DT Article
DE Spinocerebellar ataxia type 31 (SCA31); Thymidine kinase 2 (TK2);
   Mitochondrial DNA depletion syndrome (MDS); Purkinje cell; Mitochondria;
   Cytochrome-c oxidase (COX)
ID DNA DEPLETION; NATURAL-HISTORY; MUTATIONS; CLONING; GENE; DEFICIENCY;
   EXPRESSION; MYOPATHY; DISEASES; ADCA
AB Spinocerebellar ataxia type 31 (SCA31), an autosomal-dominant neurodegenerative disorder characterized by progressive cerebellar ataxia with Purkinje cell degeneration, is caused by a heterozygous 2.5-3.8 kilobase penta-nucleotide repeat of (TTCCA)(n) in intron 11 of the thymidine kinase 2 (TK2) gene. TK2 is an essential mitochondrial pyrimidine-deoxyribonucleoside kinase. Bi-allelic loss-of-function mutations of TK2 lead to mitochondrial DNA depletion syndrome (MDS) in humans through severe (similar to 70%) reduction of mitochondrial electron-transport-chain activity, and tk2 knockout mice show Purkinje cell degeneration and ataxia through severe mitochondrial cytochrome-c oxidase subunit I (COX I) protein reduction. To clarify whether TK2 function is altered in SCA31, we investigated TK2 and COX I expression in human postmortem SCA31 cerebellum. We confirmed that canonical TK2 mRNA is transcribed from exons far upstream of the repeat site, and demonstrated that an extended version of TK2 mRNA ("TK2-EXT"), transcribed from exons spanning the repeat site, is expressed in human cerebellum. While canonical TK2 was conserved among vertebrates, TK2-EXT was specific to primates. Reverse transcription-PCR demonstrated that both TK2 mRNAs were preserved in SCA31 cerebella compared with control cerebella. The TK2 proteins, assessed with three different antibodies including our original polyclonal antibody against TK2-EXT, were detected as similar to 26 kilodalton proteins on western blot; their levels were similar in SCA31 and control cerebella. COX I protein level was preserved in SCA31 compared to nuclear DNA-encoded protein. We conclude that the expression and function of TK2 are preserved in SCA31, suggesting a mechanism distinct from that of MDS.
C1 [Aoki, Hanako; Higashi, Miwa; Okita, Michi; Yokota, Takanori] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.
   [Ando, Noboru] Tokyo Med & Dent Univ, Grad Sch, Dept Pathol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.
   [Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Dept Neuropathol, Brain Bank Aging Res, Itabashi Ku, 35-2 Sakae Chou, Tokyo 1730015, Japan.
   [Murayama, Shigeo] Inst Gerontol, Itabashi Ku, 35-2 Sakae Chou, Tokyo 1730015, Japan.
   [Ishikawa, Kinya] Tokyo Med & Dent Univ, Ctr Personalized Med Hlth Aging, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.
   [Murayama, Shigeo] Osaka Univ, Mol Res Ctr Childrens Mental Dev, United Grad Sch Child Dev, Brain Bank Neurodev Neurol & Psychiat Disorders, Suita, Osaka 5650871, Japan.
C3 Institute of Science Tokyo; Tokyo Medical & Dental University (TMDU);
   Institute of Science Tokyo; Tokyo Medical & Dental University (TMDU);
   Tokyo Metropolitan Institute of Gerontology; Institute of Science Tokyo;
   Tokyo Medical & Dental University (TMDU); Osaka University
RP Ishikawa, K (corresponding author), Tokyo Med & Dent Univ, Ctr Personalized Med Hlth Aging, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.
EM pico.nuro@tmd.ac.jp
OI Yokota, Takanori/0000-0002-6490-3263
FU Ministry of Education, Culture, Sports, Science and Technology (MEXT),
   Japan [15K09335, 18H02715, 21K07432]; Research Committee of Ataxia,
   Health Labour Sciences Research Grant, the Ministry of Health, Labour
   and Welfare, Japan [JPMH20FC1041]; Grants-in-Aid for Scientific Research
   [22H04923, 22K07538, 22K07550, 21K07432, 18H02715, 15K09335] Funding
   Source: KAKEN
FX This work was funded mostly by grants-in-aid for scientific research
   [15K09335, 18H02715, 21K07432], from the Ministry of Education, Culture,
   Sports, Science and Technology (MEXT), Japan, and from Grants-in-Aid
   from the Research Committee of Ataxia, Health Labour Sciences Research
   Grant, the Ministry of Health, Labour and Welfare, Japan (JPMH20FC1041).
CR Artuch R, 2006, J NEUROL SCI, V246, P153, DOI 10.1016/j.jns.2006.01.021
   Ayhan F, 2018, EMBO J, V37, DOI 10.15252/embj.201899023
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Cagnoli C, 2006, BRAIN, V129, P235, DOI 10.1093/brain/awh651
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Corral-Juan M, 2018, BRAIN, V141, P1981, DOI 10.1093/brain/awy137
   Fecher C, 2019, NAT NEUROSCI, V22, P1731, DOI 10.1038/s41593-019-0479-z
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Ishiguro T, 2017, NEURON, V94, P108, DOI 10.1016/j.neuron.2017.02.046
   Ishikawa K, 2011, NEUROLOGY, V77, P1853, DOI 10.1212/WNL.0b013e3182377e3a
   Ishikawa K, 2006, NEUROPATHOLOGY, V26, P352, DOI 10.1111/j.1440-1789.2006.00719.x
   Ishikawa K, 2010, NEUROPATHOLOGY, V30, P490, DOI 10.1111/j.1440-1789.2010.01142.x
   Ishiura H, 2018, NAT GENET, V50, P581, DOI 10.1038/s41588-018-0067-2
   Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454
   Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258
   Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244
   Kim S, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.33
   Mancini C, 2019, NEUROBIOL DIS, V124, P14, DOI 10.1016/j.nbd.2018.10.018
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   McFarland KN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135906
   Montero R, 2007, CEREBELLUM, V6, P118, DOI 10.1080/14734220601021700
   Nakamura K, 2017, CEREBELLUM, V16, P518, DOI 10.1007/s12311-016-0833-6
   Niimi Y, 2013, NEUROPATHOLOGY, V33, P600, DOI 10.1111/neup.12032
   Owada K, 2005, NEUROLOGY, V65, P629, DOI 10.1212/01.wnl.0000173065.75680.e2
   Quinzii CM, 2007, MITOCHONDRION, V7, pS122, DOI 10.1016/j.mito.2007.03.004
   Rodríguez-Labrada R, 2020, CEREBELLUM, V19, P446, DOI 10.1007/s12311-020-01109-7
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sakai H, 2010, NEUROGENETICS, V11, P409, DOI 10.1007/s10048-010-0245-6
   Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019
   Schmitz A, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.637548
   Shibata T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20487-4
   Tanahashi C, 2000, ACTA NEUROPATHOL, V99, P31, DOI 10.1007/PL00007403
   Tulinius M, 2005, NEUROMUSCULAR DISORD, V15, P412, DOI 10.1016/j.nmd.2005.03.010
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6
   Wang LY, 1996, FEBS LETT, V390, P39, DOI 10.1016/0014-5793(96)00623-0
   Yokoyama T, 2010, NEUROPATHOLOGY, V30, P56, DOI 10.1111/j.1440-1789.2009.01026.x
   Yoshida K, 2014, NEUROPATHOLOGY, V34, P261, DOI 10.1111/neup.12090
NR 42
TC 6
Z9 6
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1473-4222
EI 1473-4230
J9 CEREBELLUM
JI Cerebellum
PD FEB
PY 2023
VL 22
IS 1
BP 70
EP 84
DI 10.1007/s12311-021-01364-2
EA JAN 2022
PG 15
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 8K2CW
UT WOS:000749072900002
PM 35084690
OA Green Published, hybrid
DA 2024-11-01
ER

PT B
AU Yasukawa, T
   Poulton, J
AF Yasukawa, Takehiro
   Poulton, Joanna
BE Cox, LS
TI Mitochondrial DNA Replication
SO MOLECULAR THEMES IN DNA REPLICATION
LA English
DT Article; Book Chapter
ID TRANSCRIPTION-FACTOR-A; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MTDNA COPY
   NUMBER; POLYMERASE-GAMMA; HUMAN-CELLS; LAGGING-STRAND; THYMIDINE
   PHOSPHORYLASE; GEL-ELECTROPHORESIS; YEAST MITOCHONDRIA; DEPLETION
   SYNDROME
C1 [Yasukawa, Takehiro] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England.
   [Poulton, Joanna] Univ Oxford, John Radcliffe Hosp, Womens Ctr, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.
C3 University of London; University College London; University of Oxford
RP Yasukawa, T (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.
RI Poulton, Joanna/AAB-4828-2021; Yasukawa, Takehiro/AAP-1335-2020
OI Yasukawa, Takehiro/0000-0001-9531-8780
CR Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   ARNBERG A, 1971, BIOCHIM BIOPHYS ACTA, V246, P353, DOI 10.1016/0005-2787(71)90147-X
   Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Ashley N, 2009, BIOCHEM BIOPH RES CO, V378, P450, DOI 10.1016/j.bbrc.2008.11.059
   Bax BE, 2007, EUR J HAEMATOL, V79, P338, DOI 10.1111/j.1600-0609.2007.00927.x
   Blanche S, 1999, LANCET, V354, P1084, DOI 10.1016/S0140-6736(99)07219-0
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Bradshaw PC, 2005, AM J PHYSIOL-CELL PH, V288, pC989, DOI 10.1152/ajpcell.00530.2004
   BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8
   BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   CARRE D, 1978, BIOCHEMISTRY-US, V17, P3263, DOI 10.1021/bi00609a014
   Casteels K, 1999, LANCET, V353, P1499, DOI 10.1016/S0140-6736(98)05817-6
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Chinnery PF, 2005, LANCET, V366, P1650, DOI 10.1016/S0140-6736(05)67492-2
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   Ciliberti N, 2007, BIOORGAN MED CHEM, V15, P3065, DOI 10.1016/j.bmc.2007.01.049
   Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CLAYTON DA, 1987, PHILOS T ROY SOC B, V317, P473, DOI 10.1098/rstb.1987.0074
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424
   Díez-Sánchez C, 2003, BIOL REPROD, V68, P180, DOI 10.1095/biolreprod.102.005140
   DIFFLEY JFX, 1992, J BIOL CHEM, V267, P3368
   DIFFLEY JFX, 1991, P NATL ACAD SCI USA, V88, P7864, DOI 10.1073/pnas.88.17.7864
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   FISHER RP, 1991, J BIOL CHEM, V266, P9153
   Friedman KL, 1995, METHOD ENZYMOL, V262, P613
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HAN ZY, 1994, CHROMOSOMA, V103, P162, DOI 10.1007/BF00368008
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Holt IJ, 2003, TRENDS BIOCHEM SCI, V28, P355, DOI 10.1016/S0968-0004(03)00133-6
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   Iida R, 2006, BIOCHEM BIOPH RES CO, V344, P948, DOI 10.1016/j.bbrc.2006.04.008
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233
   Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004
   KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Khogali SS, 2001, LANCET, V357, P1265, DOI 10.1016/S0140-6736(00)04422-6
   KIRSCHNER RH, 1968, P NATL ACAD SCI USA, V60, P1466, DOI 10.1073/pnas.60.4.1466
   KOIKE K, 1974, J CELL BIOL, V61, P14, DOI 10.1083/jcb.61.1.14
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   KUNKEL TA, 1988, BIOCHIM BIOPHYS ACTA, V951, P1, DOI 10.1016/0167-4781(88)90020-6
   Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869
   Lakshmipathy U, 2001, NUCLEIC ACIDS RES, V29, P668, DOI 10.1093/nar/29.3.668
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LEDWITH BJ, 1986, J BIOL CHEM, V261, P6571
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Livesey KJ, 2004, J MED GENET, V41, P6, DOI 10.1136/jmg.2003.008805
   LOCKSHON D, 1995, CELL, V81, P947, DOI 10.1016/0092-8674(95)90014-4
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921
   May-Panloup P, 2005, HUM REPROD, V20, P593, DOI 10.1093/humrep/deh667
   MAYHOOK AG, 1992, P ROY SOC B-BIOL SCI, V248, P85, DOI 10.1098/rspb.1992.0046
   MEGRAW TL, 1993, J BIOL CHEM, V268, P12758
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Morten K, 2005, AM J PHYSIOL-ENDOC M, V289, pE1115, DOI 10.1152/ajpendo.00226.2005
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   NASS MMK, 1966, P NATL ACAD SCI USA, V56, P1215, DOI 10.1073/pnas.56.4.1215
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Ohgaki K, 2007, J BIOCHEM, V141, P201, DOI 10.1093/jb/mvm020
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   PARISI MA, 1993, MOL CELL BIOL, V13, P1951, DOI 10.1128/MCB.13.3.1951
   Park KS, 2008, DIABETOLOGIA, V51, P602, DOI 10.1007/s00125-008-0933-z
   PICAMATTOCCIA L, 1972, J MOL BIOL, V64, P465, DOI 10.1016/0022-2836(72)90511-6
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468
   POULTON J, 1995, DIABETOLOGIA, V38, P868, DOI 10.1007/s001250050366
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Reyes A, 2005, J BIOL CHEM, V280, P3242, DOI 10.1074/jbc.M411916200
   Reyes Aurelio, 2007, Methods Mol Biol, V372, P219, DOI 10.1007/978-1-59745-365-3_16
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   SIMPSON MV, 1989, BIOCHEM PHARMACOL, V38, P1033, DOI 10.1016/0006-2952(89)90245-1
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Spinazzola A, 2008, NEUROMUSCULAR DISORD, V18, P315, DOI 10.1016/j.nmd.2007.12.007
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Takamatsu C, 2002, EMBO REP, V3, P451, DOI 10.1093/embo-reports/kvf099
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trinei M, 2006, BBA-BIOENERGETICS, V1757, P624, DOI 10.1016/j.bbabio.2006.05.029
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VANTUYLE GC, 1985, J CELL BIOL, V100, P251, DOI 10.1083/jcb.100.1.251
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Viguera E, 2001, EMBO J, V20, P2587, DOI 10.1093/emboj/20.10.2587
   Walker Ulrich A, 2003, J HIV Ther, V8, P32
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Warburg O., 1930, METABOLISM TUMOURS
   WERNETTE CM, 1988, BIOCHEMISTRY-US, V27, P6046, DOI 10.1021/bi00416a033
   WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390
   WISEMAN A, 1978, MOL GEN GENET, V167, P51, DOI 10.1007/BF00270321
   WOLSTENHOLME DR, 1973, J CELL BIOL, V56, P230, DOI 10.1083/jcb.56.1.230
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   WONG TW, 1985, J BIOL CHEM, V260, P1530
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
   Zhang HL, 2007, BIOCHIMIE, V89, P474, DOI 10.1016/j.biochi.2006.11.002
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 147
TC 1
Z9 1
U1 0
U2 3
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, CAMBRIDGE CB4 4WF, CAMBS, ENGLAND
BN 978-0-85404-164-0
PY 2009
BP 316
EP 345
DI 10.1039/9781847559852-00316
D2 10.1039/9781847559852
PG 30
WC Biochemistry & Molecular Biology
WE Book Citation Index – Science (BKCI-S)
SC Biochemistry & Molecular Biology
GA BLV56
UT WOS:000271175600011
OA Green Published
DA 2024-11-01
ER

PT J
AU Liu, SF
   Kuo, HC
   Tseng, CW
   Huang, HT
   Chen, YC
   Tseng, CC
   Lin, MC
AF Liu, Shih-Feng
   Kuo, Ho-Chang
   Tseng, Ching-Wan
   Huang, Hung-Tu
   Chen, Yung-Che
   Tseng, Chia-Cheng
   Lin, Meng-Chih
TI Leukocyte Mitochondrial DNA Copy Number Is Associated with Chronic
   Obstructive Pulmonary Disease
SO PLOS ONE
LA English
DT Article
ID OXIDATIVE STRESS; SKELETAL-MUSCLE; QUADRICEPS; ENDURANCE
AB Background
   Oxidative stress is known to be involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). Evidence suggests that leukocytes mitochondria DNA (mtDNA) is susceptible to undergo mutations, insertions, or depletion in response to reactive oxidative stress (ROS). We hypothesize that mtDNA copy number is associated with the development of COPD.
   Methodology/Principal Findings
   Relative mtDNA copy number was measured by a quantitative realtime PCR assay using DNA extracted from peripheral leukocytes. MtDNA copy number of peripheral leukocytes in the COPD group (n = 86) is significantly decreased compared with nonsmoker group (n = 77) (250.3 +/- 21.5 VS. 464.2 +/- 49.9, P<0.001). MtDNA copy number in the COPD group was less than that in the healthy smoking group, but P value nearly achieved significance (250.3 +/- 21.5 VS. 404.0 +/- 76.7, P = 0.08) MtDNA copy number has no significance with age, gender, body mass index, current smoking, and pack-years in COPD group, healthy smoker group and no smoker group, respectively. Serum glutathione level in the COPD group is significantly decreased compared with healthy smoker and nonsmoker groups (4.5 +/- 1.3 VS. 6.2 +/- 1.9 and 4.5 +/- 1.3 VS. 7.1 +/- 1.1 mU/mL; P<0.001 respectively). Pearson correlation test shows a significant liner correlation between mtDNA copy number and serum glutathione level (R = 0.2, P = 0.009).
   Conclusions/Significance
   COPD is associated with decreased leukocyte mtDNA copy number and serum glutathione. COPD is a regulatory disorder of leukocytes mitochondria. However, further studies are needed to determine the real mechanisms about the gene and the function of mitochondria.
C1 [Liu, Shih-Feng; Chen, Yung-Che; Tseng, Chia-Cheng; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung, Taiwan.
   [Liu, Shih-Feng; Kuo, Ho-Chang; Tseng, Ching-Wan; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Dept Resp Therapy, Kaohsiung, Taiwan.
   [Liu, Shih-Feng; Kuo, Ho-Chang; Chen, Yung-Che; Tseng, Chia-Cheng; Lin, Meng-Chih] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.
   [Kuo, Ho-Chang] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan.
   [Huang, Hung-Tu] Kaohsiung Med Univ, Sch Med, Dept Anat, Coll Med, Kaohsiung, Taiwan.
C3 Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung
   University; Chang Gung Memorial Hospital; Kaohsiung Medical University
RP Liu, SF (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung, Taiwan.
EM liuphysico@yahoo.com.tw; mengchih@adm.cgmh.org.tw
RI Kuo, Ho-Chang/AAQ-6644-2020; Chen, Yung-Che/AAL-5167-2020; Lin,
   Xiaoqi/KFS-5750-2024
OI Liu, Shih-Feng/0000-0003-1394-5401; Kuo, Ho-Chang/0000-0002-3295-2984
FU Chang Gung Memorial Hospital [CMRPG891051]
FX This study was supported by a grant from the Chang Gung Memorial
   Hospital (CMRPG891051).
CR Afonso V, 2007, JOINT BONE SPINE, V74, P324, DOI 10.1016/j.jbspin.2007.02.002
   Allaire J, 2004, THORAX, V59, P673, DOI 10.1136/thx.2003.020636
   Barnes PJ, 1999, THORAX, V54, P245, DOI 10.1136/thx.54.3.245
   Berman SB, 2008, CELL DEATH DIFFER, V15, P1147, DOI 10.1038/cdd.2008.57
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080
   Engelen MPKJ, 2000, AM J RESP CRIT CARE, V161, P98, DOI 10.1164/ajrccm.161.1.9901031
   Falk Jeremy A, 2008, Proc Am Thorac Soc, V5, P543, DOI 10.1513/pats.200708-142ET
   Gosker HR, 2007, EUR RESPIR J, V30, P73, DOI 10.1183/09031936.00146906
   Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200
   Hoffmann RF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-97
   Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002
   Kim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067227
   Koechlin C, 2004, AM J RESP CRIT CARE, V169, P1022, DOI 10.1164/rccm.200310-1465OC
   Kroemer G, 2003, BIOCHEM BIOPH RES CO, V304, P433, DOI 10.1016/S0006-291X(03)00614-4
   Langen RCJ, 2003, FREE RADICAL BIO MED, V35, P226, DOI 10.1016/S0891-5849(03)00316-2
   Lee JW, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-7
   Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440
   Meissner C, 2007, Z GERONTOL GERIATR, V40, P325, DOI 10.1007/s00391-007-0481-z
   Meyer A, 2013, EXP PHYSIOL, V98, P1063, DOI 10.1113/expphysiol.2012.069468
   Peng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082739
   Puente-Maestu L, 2009, EUR RESPIR J, V33, P1045, DOI 10.1183/09031936.00112408
   Puente-Maestu L, 2011, THORAX, V66, P121, DOI 10.1136/thx.2010.153031
   Rahman I, 1996, FREE RADICAL BIO MED, V21, P669, DOI 10.1016/0891-5849(96)00155-4
   Rahman I, 1996, AM J RESP CRIT CARE, V154, P1055, DOI 10.1164/ajrccm.154.4.8887607
   Remels AH, 2007, EUR RESPIR J, V30, P245, DOI 10.1183/09031936.00144106
   Repine JE, 1997, AM J RESP CRIT CARE, V156, P341, DOI 10.1164/ajrccm.156.2.9611013
   Sandri M, 2002, CURR OPIN CLIN NUTR, V5, P249, DOI 10.1097/00075197-200205000-00003
   Sinden NJ, 2010, THORAX, V65, P930, DOI 10.1136/thx.2009.130260
   Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Wagner PD, 2008, EUR RESPIR J, V31, P492, DOI 10.1183/09031936.00074807
   WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739
   Yamagata T, 2007, CHEST, V132, P890, DOI 10.1378/chest.07-0569
NR 34
TC 38
Z9 43
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 22
PY 2015
VL 10
IS 9
AR e0138716
DI 10.1371/journal.pone.0138716
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CS0ZW
UT WOS:000361792100091
PM 26394041
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Sen, D
   Nandakumar, D
   Tang, GQ
   Patel, SS
AF Sen, Doyel
   Nandakumar, Divya
   Tang, Guo-Qing
   Patel, Smita S.
TI Human Mitochondrial DNA Helicase TWINKLE Is Both an Unwinding and
   Annealing Helicase
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SINGLE-STRANDED-DNA;
   STRUCTURE-FUNCTION DEFECTS; NUCLEOTIDE HYDROLYSIS; CENTRAL CHANNEL;
   GENE-4 PROTEIN; REPLICATION; BINDING; BACTERIOPHAGE-T7; PRIMASE
AB TWINKLE is a nucleus-encoded human mitochondrial (mt) DNA helicase. Point mutations in TWINKLE are associated with heritable neuromuscular diseases characterized by deletions in the mtDNA. To understand the biochemical basis of these diseases, it is important to define the roles of TWINKLE in mtDNA metabolism by studying its enzymatic activities. To this end, we purified native TWINKLE from Escherichia coli. The recombinant TWINKLE assembles into hexamers and higher oligomers, and addition of MgUTP stabilizes hexamers over higher oligomers. Probing into the DNA unwinding activity, we discovered that the efficiency of unwinding is greatly enhanced in the presence of a heterologous single strand-binding protein or a single-stranded (ss) DNA that is complementary to the unwound strand. We show that TWINKLE, although a helicase, has an antagonistic activity of annealing two complementary ssDNAs that interferes with unwinding in the absence of gp2.5 or ssDNA trap. Furthermore, only ssDNA and not double-stranded (ds)DNA competitively inhibits the annealing activity, although both DNAs bind with high affinities. This implies that dsDNA binds to a site that is distinct from the ssDNA-binding site that promotes annealing. Fluorescence anisotropy competition binding experiments suggest that TWINKLE has more than one ssDNA-binding sites, and we speculate that a surface-exposed ssDNA-specific site is involved in catalyzing DNA annealing. We propose that the strand annealing activity of TWINKLE may play a role in recombination-mediated replication initiation found in the mitochondria of mammalian brain and heart or in replication fork regression during repair of damaged DNA replication forks.
C1 [Sen, Doyel; Nandakumar, Divya; Tang, Guo-Qing; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.
C3 Rutgers University System; Rutgers University New Brunswick; Rutgers
   University Biomedical & Health Sciences
RP Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.
EM patelss@umdnj.edu
RI Tang, Guoqing/JVZ-2879-2024; Nandakumar, Divya/K-6250-2014
OI Nandakumar, Divya/0000-0001-7672-0213
FU National Institutes of Health [GM55310]
FX This work was supported, in whole or in part, by National Institutes of
   Health Grant GM55310.
CR Ahnert P, 2000, EMBO J, V19, P3418, DOI 10.1093/emboj/19.13.3418
   Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712
   Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001
   Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037
   Delagoutte E, 2011, BIOCHEMISTRY-US, V50, P932, DOI 10.1021/bi101583e
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   HALLER I, 1974, P NATL ACAD SCI USA, V71, P2018, DOI 10.1073/pnas.71.5.2018
   HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200
   Mao Chih-Chieh, 2009, Chang Gung Med J, V32, P354
   MATSON SW, 1985, J BIOL CHEM, V260, P2281
   MATSON SW, 1983, J BIOL CHEM, V258, P4017
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Oliveira MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015379
   PATEL SS, 1992, J BIOL CHEM, V267, P15013
   PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029
   Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651
   Picha KM, 2000, BIOCHEMISTRY-US, V39, P6401, DOI 10.1021/bi992857i
   Picha KM, 1998, J BIOL CHEM, V273, P27315, DOI 10.1074/jbc.273.42.27315
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Rasnik I, 2008, EMBO J, V27, P1727, DOI 10.1038/emboj.2008.106
   Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13
   Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
   Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663
NR 38
TC 49
Z9 59
U1 2
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD APR 27
PY 2012
VL 287
IS 18
BP 14545
EP 14556
DI 10.1074/jbc.M111.309468
PG 12
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 941XU
UT WOS:000304003200021
PM 22383523
OA Green Published
DA 2024-11-01
ER

PT J
AU He, ZW
   Zhang, CD
AF He, Zhenwei
   Zhang, Chaodong
TI Mitochondrial encephalomyopathy with lactic acidosis and stroke-like
   episodes correlates with heteroplasmic mutations of mitochondrial DNA
   3243 <i>A single-case genealogy analysis</i>
SO NEURAL REGENERATION RESEARCH
LA English
DT Article
DE MELAS syndrome; mitochondrial mutation; heteroplasmic level; clinical
   behavior
ID A3243G MUTATION; MELAS; ENCEPHALOPATHY; QUANTIFICATION; MANAGEMENT;
   DIAGNOSIS; PHENOTYPE; MYOPATHY; FEATURES
AB BACKGROUND: Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) is a common syndrome of mitochondrial diseases caused primarily by a mutation from adenine to guanine at mitochondrial DNA 3243. However, the correlation between heteroplasmic mutations and clinical characteristics of hereditary MELAS syndrome is unclear.
   OBJECTIVE: To survey the clinical behaviors, biochemical outcomes, and imaging data in a patient with suspected MELAS syndrome by maternal inheritance, and to investigate the correlation with heteroplasmic mutations of hemocyte mitochondrial DNA.
   DESIGN, TIME AND SETTING: A case analysis based on hereditary family surgery was performed in the Enliang Hospital of Anshan, Taian County, and biochemical tests and gene diagnosis were performed at the Department of Laboratory and Institute of Neurology, the First Affiliated Hospital of China Medical University, between March and September 2009.
   PARTICIPANTS: A 22-year-old female patient with MELAS syndrome was diagnosed in the First Affiliated Hospital of China Medical University in January, 2009. She had five males and seven females in her maternal family.
   METHODS: We obtained stroke and convulsion history in the patient and her family, as well as performing routine blood tests, plasma lactic acid levels before and after movement, and magnetic resonance of the head. A mutation at m.3243A > G was verified using polymerase chain reaction-restriction fragment length polymorphism and DNA sequencing, and quantitated using real-time polymerase chain reaction.
   MAIN OUTCOME MEASURES: Correlation of clinical behaviors and biochemical outcomes, as well as imaging data with heteroplasmic mutations in family members with typical and atypical MELAS syndrome.
   RESULTS: Some family members had typical symptoms of convulsion, stroke, and MELAS syndrome, as well as atypical symptoms of microsomia, movement intolerance, febrile, and migraine. Magnetic resonance of the head was consistent with typical imaging data of MELAS syndrome during attacks, and family members showed cerebellar atrophy. A heteroplasmic mutation of mitochondrial DNA 3243 occurred in all family members, although higher levels caused severe typical symptoms. The age of first-onset convulsion was negatively correlated with level of heteroplasmic mutation (r = -0.852, P < 0.05), but lactic acid was positively correlated with mutation levels (before movement, r = 0.945, P < 0.001; after movement, r = 0.945, P < 0.001).
   CONCLUSION: MELAS syndrome was diagnosed in this family by maternal inheritance, and the etiological factor was a mutation of mitochondrial A3243G. The level of heteroplasmic mutation correlated with anticipated convulsion and lactic acid levels.
C1 [He, Zhenwei; Zhang, Chaodong] China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang 110001, Liaoning Prov, Peoples R China.
C3 China Medical University
RP Zhang, CD (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang 110001, Liaoning Prov, Peoples R China.
EM xcdzhang@163.com
CR Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Chou HF, 2008, PEDIATR NEUROL, V38, P143, DOI 10.1016/j.pediatrneurol.2007.09.015
   da Rocha AJ, 2008, J NEUROIMAGING, V18, P1, DOI 10.1111/j.1552-6569.2007.00205.x
   Donovan LE, 2006, J CLIN ENDOCR METAB, V91, P4737, DOI 10.1210/jc.2006-1498
   Güçer S, 2005, PEDIATR DEVEL PATHOL, V8, P710, DOI 10.1007/s10024-005-0058-z
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Kang CS, 2008, NEURAL REGEN RES, V3, P652
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Lau KK, 2007, INT UROL NEPHROL, V39, P941, DOI 10.1007/s11255-006-9172-8
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   Mizrachi IB, 2006, J NEURO-OPHTHALMOL, V26, P38, DOI 10.1097/01.wno.0000204662.25935.8b
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Singh R, 2006, J MOL DIAGN, V8, P225, DOI 10.2353/jmoldx.2006.050067
   Sparaco M, 2006, CEPHALALGIA, V26, P361, DOI 10.1111/j.1468-2982.2005.01059.x
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Strand H, 2008, CLIN CHIM ACTA, V390, P126, DOI 10.1016/j.cca.2008.01.010
   Tierney MC, 1997, ARCH NEUROL-CHICAGO, V54, P713, DOI 10.1001/archneur.1997.00550180035009
   VANADEL BA, 2009, CLIN NEUROMUSCL DIS, V10, P97
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Zhang Shi, 2009, Chinese Medical Sciences Journal, V24, P20
NR 30
TC 0
Z9 0
U1 1
U2 4
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1673-5374
EI 1876-7958
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD FEB
PY 2010
VL 5
IS 4
BP 295
EP 300
DI 10.3969/j.issn.1673-5374.2010.04.010
PG 6
WC Cell Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Neurosciences & Neurology
GA 573PB
UT WOS:000275925500010
DA 2024-11-01
ER

PT S
AU Rosado-Ruiz, FA
   So, M
   Kaguni, LS
AF Rosado-Ruiz, Fernando A.
   So, Minyoung
   Kaguni, Laurie S.
BE McKenzie, M
TI Purification and Comparative Assay of the Human Mitochondrial
   Replicative DNA Helicase
SO MITOCHONDRIAL DNA: METHODS AND PROTOCOLS, 3RD EDITION
SE Methods in Molecular Biology
LA English
DT Article; Book Chapter
DE Mitochondrial DNA replication; mtDNA helicase; Helicases; Mitochondrial
   single-stranded DNA-binding protein; Human
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DEFECTS; TWINKLE; MUTATIONS;
   PRIMASE; CELLS
AB The replicative mitochondrial DNA (mtDNA) helicase is essential for mtDNA replication and maintenance of the mitochondrial genome. Despite substantial advances that have been made in its characterization, there is still much to be understood about the functional roles of its domains and its interactions with the other components of the minimal mitochondrial DNA replisome. Critical to achieving this is the ability to isolate the enzyme in a stable, active form. In this chapter we describe a modified, streamlined purification strategy for recombinant forms of the enzyme. We also present assays to assess its helix unwinding activity and the stimulatory effects of the mitochondrial single-stranded DNA-binding protein (mtSSB). Finally, we describe a concentration/buffer exchange method that we have employed to achieve greater enzyme stability and appropriate conditions for biochemical and biophysical studies.
C1 [Rosado-Ruiz, Fernando A.; So, Minyoung] Michigan State Univ, Dept Biochem & Mol Biol, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA.
   [Kaguni, Laurie S.] Univ Tampere, Inst Biosci & Med Technol, FIN-33101 Tampere, Finland.
   [Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
   [Kaguni, Laurie S.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA.
C3 Michigan State University; Tampere University; Michigan State
   University; Michigan State University
RP Rosado-Ruiz, FA (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA.
FU NIGMS NIH HHS [R01 GM045295, GM45295] Funding Source: Medline
CR Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243
   Korhonen J, 2003, J BIOL CHEM, V377, P691
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Matsushima Y, 2009, BBA-BIOENERGETICS, V1787, P290, DOI 10.1016/j.bbabio.2008.11.005
   Oliveira MT, 2011, J BIOL CHEM, V286, P40649, DOI 10.1074/jbc.M111.289983
   Oliveira MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015379
   Sanchez-Martinez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043954
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
   Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663
   Ziebarth TD, 2009, METHODS MOL BIOL, V554, P121, DOI 10.1007/978-1-59745-521-3_8
NR 14
TC 0
Z9 2
U1 0
U2 3
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
BN 978-1-4939-3040-1; 978-1-4939-3039-5
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PY 2016
VL 1351
BP 185
EP 198
DI 10.1007/978-1-4939-3040-1_14
D2 10.1007/978-1-4939-3040-1
PG 14
WC Biochemical Research Methods; Biochemistry & Molecular Biology
WE Book Citation Index – Science (BKCI-S)
SC Biochemistry & Molecular Biology
GA BE2DX
UT WOS:000369077400015
PM 26530683
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Sakata, A
   Kashio, A
   Koyama, H
   Uranaka, T
   Iwasaki, S
   Fujimoto, C
   Kinoshita, M
   Yamasoba, T
AF Sakata, Aki
   Kashio, Akinori
   Koyama, Hajime
   Uranaka, Tsukasa
   Iwasaki, Shinichi
   Fujimoto, Chisato
   Kinoshita, Makoto
   Yamasoba, Tatsuya
TI Long-Term Progression and Rapid Decline in Hearing Loss in Patients with
   a Point Mutation at Nucleotide 3243 of the Mitochondrial DNA
SO LIFE-BASEL
LA English
DT Article
DE hearing loss; dizziness; disequilibrium; diabetes; mitochondrial gene
   mutations
ID EVOKED MYOGENIC POTENTIALS; TRANSFER RNA(LEU(UUR)) GENE; A3243G
   MUTATION; DIABETES-MELLITUS; LACTIC-ACIDOSIS; MELAS; MYOPATHY;
   INHERITANCE; DYSFUNCTION; FEATURES
AB Patients with m.3243A>G mutation of mitochondrial DNA develop bilaterally symmetric sensorineural hearing loss. However, it is unclear how fast their hearing loss progresses over time, and whether they experience rapid progression of hearing loss. In the present study, we conducted a long-term hearing evaluation in patients with MELAS or MIDD who harbored the m.3243A>G mutation of mitochondrial DNA. A retrospective chart review was performed on 15 patients with this mutation who underwent pure-tone audiometry at least once a year for more than two years. The mean follow-up period was 12.8 years. The mean progression rate of hearing loss was 5.5 dB per year. Hearing loss progressed rapidly to be profoundly deaf in seven patients during the observation period. Heteroplasmy and age-corrected heteroplasmy levels correlated with the age of onset of hearing loss. These results indicate that patients with m.3243A>G mutation have a gradual progression of hearing loss in the early stages and rapid decline in hearing to be profoundly deaf in approximately half of the patients. Although it is possible to predict the age of onset of hearing loss from heteroplasmy and age-corrected heteroplasmy levels, it is difficult to predict whether and when the rapid hearing loss will occur.
C1 [Sakata, Aki; Kashio, Akinori; Koyama, Hajime; Uranaka, Tsukasa; Iwasaki, Shinichi; Fujimoto, Chisato; Kinoshita, Makoto; Yamasoba, Tatsuya] Univ Tokyo, Grad Sch Med, Dept Otolaryngol & Head & Neck Surg, Tokyo 1138654, Japan.
   [Iwasaki, Shinichi] Nagoya City Univ, Grad Sch Med, Dept Otolaryngol & Head & Neck Surg, Nagoya, Aichi 4678601, Japan.
C3 University of Tokyo; Nagoya City University
RP Yamasoba, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Otolaryngol & Head & Neck Surg, Tokyo 1138654, Japan.
EM harvest-tky@umin.ac.jp; kashioa-tky@umin.ac.jp; hakoyama-tky@umin.ac.jp;
   uranakat-oto@h.u-tokyo.ac.jp; iwashin@med.nagoya-cu.ac.jp;
   cfujimoto-tky@umin.ac.jp; kinoshitam-zao@umin.ac.jp;
   tyamasoba-tky@umin.ac.jp
RI Kinoshita, Makoto/ABH-2378-2020
OI Kashio, Akinori/0000-0001-9453-9813; Yamasoba,
   Tatsuya/0000-0003-3608-0973; Kinoshita, Makoto/0000-0001-5447-7232
FU Health and Labor Sciences Research Grant for Research on Rare and
   Intractable Diseases and Comprehensive Research on Disability Health and
   Welfare from Ministry of Health, Labor and Welfare of Japan
   [201324019B]; Ministry of Health, Labor, and Welfare Japan [20FC1019]
FX This research was funded by Grants-in-Aid of the Research on Intractable
   Diseases (Mitochondrial Disorder and Rett Syndrome) to T.Y. from the
   Ministry of Health, Labor, and Welfare Japan (funding number 20FC1019),
   and by the Health and Labor Sciences Research Grant for Research on Rare
   and Intractable Diseases Dand Comprehensive Research on Disability
   Health and Welfare to T.Y. from the Ministry of Health, Labor and
   Welfare of Japan (201324019B).
CR Asano T, 1999, DIABETOLOGIA, V42, P1439
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   Ciodaro F, 2020, INT ARCH OTORHINOLAR, V24, pE5, DOI 10.1055/s-0039-1697988
   Ciuman RR, 2009, J LARYNGOL OTOL, V123, P151, DOI 10.1017/S0022215108002624
   de Laat P, 2021, J MED GENET, V58, P48, DOI 10.1136/jmedgenet-2019-106800
   de Wit HM, 2012, NETH J MED, V70, P460
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Durand-Dubief F, 2004, REV NEUROL-FRANCE, V160, P824, DOI 10.1016/S0035-3787(04)71038-3
   Freni F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124187
   Fujimoto C, 2009, J NEUROL, V256, P1488, DOI 10.1007/s00415-009-5147-x
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   HIGUCHI I, 1989, ACTA NEUROPATHOL, V79, P300, DOI 10.1007/BF00294665
   HIGUCHI I, 1991, ACTA NEUROPATHOL, V82, P55, DOI 10.1007/BF00310923
   Inoue A, 2019, OTOL NEUROTOL, V40, P359, DOI 10.1097/MAO.0000000000002091
   Iwasaki S, 2005, OTOL NEUROTOL, V26, P1196, DOI 10.1097/01.mao.0000194890.44023.e6
   Iwasaki S, 2011, LARYNGOSCOPE, V121, P1821, DOI 10.1002/lary.21879
   Kanemoto K., 2022, LIFE, V12, DOI [10.3390/life12040482, DOI 10.3390/LIFE12040482]
   LINDSAY JR, 1976, ARCH OTOLARYNGOL, V102, P747
   Liu CH, 2012, J FORMOS MED ASSOC, V111, P489, DOI 10.1016/j.jfma.2011.06.014
   Murofushi T, 1999, ARCH OTOLARYNGOL, V125, P660, DOI 10.1001/archotol.125.6.660
   Oshima T, 1996, LARYNGOSCOPE, V106, P43, DOI 10.1097/00005537-199601000-00009
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   SANAI T, 1990, NEPHRON, V54, P53, DOI 10.1159/000185810
   Scarpelli M, 2012, GENET RES INT, V2012, DOI 10.1155/2012/287432
   Schmäl F, 2005, J VESTIBUL RES-EQUIL, V15, P215
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Takahashi K, 2003, LARYNGOSCOPE, V113, P1362, DOI 10.1097/00005537-200308000-00018
   Tamagawa Y, 1997, ANN OTO RHINOL LARYN, V106, P338
   Tsunenori Shimizu T., 2007, OTOL JPN, V17, P691
   Usami S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031276
   Vandana VP, 2016, CLIN NEUROL NEUROSUR, V148, P17, DOI 10.1016/j.clineuro.2016.04.024
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WU CM, 1992, MUSCLE NERVE, V15, P1258, DOI 10.1002/mus.880151107
   Yamasoba T, 2006, NEUROSCI LETT, V395, P18, DOI 10.1016/j.neulet.2005.10.045
   Yamasoba T, 1996, LARYNGOSCOPE, V106, P49, DOI 10.1097/00005537-199601000-00010
   Yamasoba T, 1999, NEUROLOGY, V52, P1705, DOI 10.1212/WNL.52.8.1705
   Yamasoba T, 2007, HEARING RES, V226, P185, DOI 10.1016/j.heares.2006.06.004
   Yano T, 2014, J HUM GENET, V59, P100, DOI 10.1038/jhg.2013.128
NR 41
TC 4
Z9 4
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-1729
J9 LIFE-BASEL
JI Life-Basel
PD APR
PY 2022
VL 12
IS 4
AR 543
DI 10.3390/life12040543
PG 13
WC Biology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Microbiology
GA 0T3BJ
UT WOS:000786845100001
PM 35455034
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Korzeniewski, B
AF Korzeniewski, Bernard
TI Effect of training on skeletal muscle bioenergetic system in patients
   with mitochondrial myopathies: A computational study
SO RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
LA English
DT Article
DE Mitochondrial myopathies; OXPHOS deficiencies; Muscle training; V-O2
   on-kinetics; Exercise duration; V(O2)max
ID EACH-STEP ACTIVATION; OXIDATIVE-PHOSPHORYLATION; EXERCISE; DISEASES;
   HUMANS; DNA; METABOLISM; DIAGNOSIS; RESPONSES; MUTATION
AB A computer model of the skeletal muscle bioenergetic system, involving the "Pi double-threshold" mechanism of muscle fatigue, was used to investigate the effect of muscle training on system kinetic properties in mitochondrial myopathies (MM) patients with inborn OXPHOS deficiencies. An increase in OXPHOS activity and decrease in peak Pi can account for the training-induced increase in VO2max, acceleration of the primary phase II of the VO2 on-kinetics, delay of muscle fatigue and prolongation of exercise at a given work intensity encountered in experimental studies. Depending on the mutation load and work intensity, training can bring the muscle from severe- to very-heavy- to moderate-exercise-like behavior, thus lessening the exertional fatigue and lengthening the physical activity of a given intensity. Training significantly increases critical power (CP) and slightly decreases the curvature constant (W') of the power-duration relationship. Generally, a mechanism underlying the training-induced changes in the skeletal muscle bioenergetic system in MM patients is proposed.
C1 [Korzeniewski, Bernard] BioSimulat Ctr, Ul Filarecka 6-7, PL-30110 Krakow, Poland.
RP Korzeniewski, B (corresponding author), BioSimulat Ctr, Ul Filarecka 6-7, PL-30110 Krakow, Poland.
EM bernard.korzeniewski@gmail.com
RI Korzeniewski, Bernard/KVB-8815-2024
OI Korzeniewski, Bernard/0000-0001-6654-5263
CR Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE672, DOI 10.1152/ajpendo.00043.2007
   Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007
   Burnley M, 2010, EXP PHYSIOL, V95, P798, DOI 10.1113/expphysiol.2010.052688
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Delaney NF, 2017, P NATL ACAD SCI USA, V114, P8402, DOI 10.1073/pnas.1703338114
   DiMauro S, 1998, BBA-BIOENERGETICS, V1366, P199, DOI 10.1016/S0005-2728(98)00113-3
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Grassi B, 2009, MED SCI SPORT EXER, V41, P2120, DOI 10.1249/MSS.0b013e3181aae96b
   Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Jeppesen TD, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00349
   Korzeniewski B, 2004, BIOCHEM J, V379, P703, DOI 10.1042/BJ20031740
   Korzeniewski B, 1998, BIOCHEM J, V330, P1189, DOI 10.1042/bj3301189
   Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3
   Korzeniewski B, 2021, J APPL PHYSIOL, V131, P768, DOI 10.1152/japplphysiol.00196.2021
   Korzeniewski B, 2021, J APPL PHYSIOL, V130, P498, DOI 10.1152/japplphysiol.00745.2020
   Korzeniewski B, 2020, EUR J APPL PHYSIOL, V120, P1609, DOI 10.1007/s00421-020-04388-4
   Korzeniewski B, 2019, EUR J APPL PHYSIOL, V119, P2201, DOI 10.1007/s00421-019-04204-8
   Korzeniewski B, 2017, PROG BIOPHYS MOL BIO, V125, P1, DOI 10.1016/j.pbiomolbio.2016.12.001
   Korzeniewski B, 2016, J APPL PHYSIOL, V121, P424, DOI 10.1152/japplphysiol.00358.2016
   Korzeniewski B, 2015, J PHYSIOL-LONDON, V593, P5255, DOI 10.1113/JP271299
   Korzeniewski B, 2015, BBA-BIOENERGETICS, V1847, P1310, DOI 10.1016/j.bbabio.2015.07.007
   Larsson NG, 2001, ACTA PHYSIOL SCAND, V171, P385, DOI 10.1046/j.1365-201x.2001.00842.x
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Porcelli S, 2016, J APPL PHYSIOL, V121, P699, DOI 10.1152/japplphysiol.00885.2015
   Taivassalo T, 2002, ANN NEUROL, V51, P38, DOI 10.1002/ana.10027
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Vanhatalo A, 2010, EXP PHYSIOL, V95, P528, DOI 10.1113/expphysiol.2009.050500
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WILSON JR, 1988, J APPL PHYSIOL, V64, P2333, DOI 10.1152/jappl.1988.64.6.2333
NR 35
TC 6
Z9 6
U1 1
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1569-9048
EI 1878-1519
J9 RESP PHYSIOL NEUROBI
JI Respir. Physiol. Neuro.
PD FEB
PY 2022
VL 296
AR 103799
DI 10.1016/j.resp.2021.103799
EA OCT 2021
PG 7
WC Physiology; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Respiratory System
GA WI0XB
UT WOS:000708089600001
PM 34624544
DA 2024-11-01
ER

PT J
AU Zhunina, OA
   Yabbarov, NG
   Grechko, AV
   Yet, SF
   Sobenin, IA
   Orekhov, AN
AF Zhunina, Olga A.
   Yabbarov, Nikita G.
   Grechko, Andrey, V
   Yet, Shaw-Fang
   Sobenin, Igor A.
   Orekhov, Alexander N.
TI Neurodegenerative Diseases Associated with Mitochondrial DNA Mutations
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Review
DE Parkinson disease; alzheimer disease; neuropathy; oxidative stress;
   mitochondria; DNA damage; reactive oxygen species
ID CYTOCHROME-C-OXIDASE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; OXIDATIVE
   STRESS; VASCULAR HYPOPERFUSION; MYOCLONIC EPILEPSY; SUBSTANTIA-NIGRA;
   POINT MUTATION; CELL-DEATH; DYSFUNCTION
AB Mitochondrial dysfunction underlies several human chronic pathologies, including cardiovascular disorders, cancers and neurodegenerative diseases. Impaired mitochondrial function associated with oxidative stress can be a result of both nuclear and mitochondrial DNA (mtDNA) mutations. Neurological disorders associated with mtDNA mutations include mitochondrial encephalomyopathy, chronic progressive external ophthalmoplegia, neurogenic weakness, and Leigh syndrome. Moreover, mtDNA mutations were shown to play a role in the development of Parkinson and Alzheimer's diseases. In this review, current knowledge on the distribution and possible roles of mtDNA mutations in the onset and development of various neurodegenerative diseases, with special focus on Parkinson's and Alzheimer's diseases has been discussed.
C1 [Zhunina, Olga A.; Yabbarov, Nikita G.] Russian Res Ctr Mol Diagnost & Therapy, Simferopolsky Blvd 8, Moscow 117149, Russia.
   [Grechko, Andrey, V] Fed Res & Clin Ctr Intens Care Med & Rehabilitol, 14-3 Solyanka St, Moscow 109240, Russia.
   [Yet, Shaw-Fang] Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town, Miaoli County, Taiwan.
   [Sobenin, Igor A.] Natl Med Res Ctr Cardiol, Lab Med Genet, 15A 3rd Cherepkovskaya St, Moscow 121552, Russia.
   [Orekhov, Alexander N.] Inst Human Morphol, 3 Tsyurupa St, Moscow 117418, Russia.
   [Orekhov, Alexander N.] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, 8 Baltiyskaya St, Moscow 125315, Russia.
C3 Federal Research & Clinical Center of Intensive Care Medicine &
   Rehabilitology; National Health Research Institutes - Taiwan; National
   Medical Research Center of Cardiology; Russian Academy of Medical
   Sciences; Research Institute of Human Morphology; Russian Academy of
   Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS
RP Orekhov, AN (corresponding author), Inst Gen Pathol & Pathophysiol, Lab Angiopathol, 8 Baltiyskaya St, Moscow 125315, Russia.
EM a.h.opexob@gmail.com
RI Yabbarov, Nikita/AFT-3574-2022; Yet, Shaw-Fang/B-1067-2010; Sobenin,
   Igor/J-4282-2013; Grechko, Andrey/C-8208-2018; Gruznova,
   Olga/AAE-1710-2022
OI Gruznova, Olga/0000-0002-0241-1482; Grechko, Andrey/0000-0003-3318-796X
FU Russian Science Foundation [19-15-00010]
FX This work was supported by the Russian Science Foundation (Grant
   #19-15-00010), Russia.
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Akbar M, 2016, BRAIN RES, V1637, P34, DOI 10.1016/j.brainres.2016.02.016
   Aliev G, 2004, MITOCHONDRION, V4, P649, DOI 10.1016/j.mito.2004.07.018
   Aliev G, 2003, NEUROL RES, V25, P665, DOI 10.1179/016164103101201977
   Aliev G, 2002, BRAIN PATHOL, V12, P21
   Aliev G, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/962984
   Aliev Gjumrakch, 2011, Recent Pat Cardiovasc Drug Discov, V6, P222
   Aliev G, 2010, PHARMACEUTICALS, V3, P158, DOI 10.3390/ph3010158
   Aliev G, 2008, VASC HEALTH RISK MAN, V4, P721, DOI 10.2147/VHRM.S2608
   Aliev G, 2009, INT J BIOCHEM CELL B, V41, P1989, DOI 10.1016/j.biocel.2009.03.015
   Andalib S, 2014, J NEUROL SCI, V346, P11, DOI 10.1016/j.jns.2014.07.067
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Cassereau J, 2014, REV NEUROL-FRANCE, V170, P366, DOI 10.1016/j.neurol.2013.11.005
   Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Clark J, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/659694
   Cookson MR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009415
   Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526
   de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9
   de Vries RLA, 2013, MOL CELL NEUROSCI, V55, P37, DOI 10.1016/j.mcn.2012.07.008
   DeBrosse S, 2012, SEMIN PEDIATR NEUROL, V19, P194, DOI 10.1016/j.spen.2012.09.006
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Duno M, 2013, GENE, V515, P372, DOI 10.1016/j.gene.2012.12.066
   Eckert GP, 2012, MOL NEUROBIOL, V46, P136, DOI 10.1007/s12035-012-8271-z
   Ehrenkrantz D, 1999, AM J MED GENET, V88, P378, DOI 10.1002/(SICI)1096-8628(19990820)88:4<378::AID-AJMG15>3.0.CO;2-8
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Finsterer J, 2009, J NEUROL SCI, V283, P143, DOI 10.1016/j.jns.2009.02.347
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013
   Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0
   Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420
   HARDING AE, 1995, MUSCLE NERVE, pS82
   Haskin J, 2013, HUM MOL GENET, V22, P2083, DOI 10.1093/hmg/ddt058
   Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   Hung KM, 2016, MITOCHONDRION, V31, P9, DOI 10.1016/j.mito.2016.08.015
   HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892
   Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288
   Keeney PM, 2009, EXP NEUROL, V220, P374, DOI 10.1016/j.expneurol.2009.09.025
   Keeney PM, 2009, HUM GENE THER, V20, P897, DOI 10.1089/hum.2009.023
   Khan SM, 2000, ANN NEUROL, V48, P148, DOI 10.1002/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kozin MS, 2018, BIOCHEMISTRY-MOSCOW+, V83, P813, DOI 10.1134/S0006297918070052
   Liang CL, 2007, EXP NEUROL, V203, P370, DOI 10.1016/j.expneurol.2006.08.015
   LIN FH, 1992, BIOCHEM BIOPH RES CO, V182, P238, DOI 10.1016/S0006-291X(05)80136-6
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Mancuso Michelangelo, 2008, Human Genomics, V3, P71
   Martikainen MH, 2013, MITOCHONDRION, V13, P83, DOI 10.1016/j.mito.2013.01.012
   Martinez M.S., 2017, Vessel Plus, V1, P130, DOI 10.20517/2574-1209.2017.34
   Maurer I, 2000, NEUROBIOL AGING, V21, P455, DOI 10.1016/S0197-4580(00)00112-3
   MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479
   Molnár MJ, 2000, NEUROLOGY, V55, P544, DOI 10.1212/WNL.55.4.544
   Moreira PI, 2007, AUTOPHAGY, V3, P614, DOI 10.4161/auto.4872
   Musicco C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072076
   Nagashima T, 2001, NEUROMUSCULAR DISORD, V11, P470, DOI 10.1016/S0960-8966(01)00190-0
   Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Otaegui D, 2004, NEUROSCI LETT, V370, P171, DOI 10.1016/j.neulet.2004.08.012
   Oyewole AO, 2015, FASEB J, V29, P4766, DOI 10.1096/fj.15-275404
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PETRUZZELLA V, 1992, BIOCHEM BIOPH RES CO, V186, P491, DOI 10.1016/S0006-291X(05)80834-4
   Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P639, DOI 10.1016/j.bbadis.2011.10.011
   Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8
   Sazonova M.A., 2017, Vessel Plus, V1, P182, DOI [DOI 10.20517/2574-1209.2017.16, 10.20517/2574-1209.2017.16]
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Siciliano G, 2001, J NEUROL NEUROSUR PS, V71, P685, DOI 10.1136/jnnp.71.5.685
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Sinyov V V., 2017, Vessel Plus, P145, DOI 10.20517/2574-1209.2016.04
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010
   Takahashi M, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8030061
   Turnbull HE, 2010, BBA-MOL BASIS DIS, V1802, P111, DOI 10.1016/j.bbadis.2009.07.010
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105
   Wu WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132499
   Young ML, 2019, MOL CELL NEUROSCI, V101, DOI 10.1016/j.mcn.2019.103409
NR 87
TC 7
Z9 7
U1 0
U2 16
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2020
VL 26
IS 1
BP 103
EP 109
DI 10.2174/1381612825666191122091320
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA KR6VV
UT WOS:000517755600008
PM 31755379
DA 2024-11-01
ER

PT J
AU Dhar, R
AF Dhar, Riddhiman
TI Role of Mitochondria in Generation of Phenotypic Heterogeneity in Yeast
SO JOURNAL OF THE INDIAN INSTITUTE OF SCIENCE
LA English
DT Review
ID DNA COPY NUMBER; INTRA-TUMOR HETEROGENEITY; TOXIN-ANTITOXIN SYSTEMS;
   HUMAN SKELETAL-MUSCLE; GENE-EXPRESSION; NONGENETIC HETEROGENEITY;
   DRUG-RESISTANCE; BACTERIAL PERSISTENCE; ANTIBIOTIC TOLERANCE;
   MULTIDRUG-RESISTANCE
AB A cell's phenotype is determined by its genome sequence and epigenetic state which translate into the biochemical reactions occurring inside the cells. As these biochemical processes are driven by small biological molecules, stochastic fluctuations may arise in the number of these biological molecules inside the cell and in the interactions between these molecules. These fluctuations can cause temporal variations in the cellular processes leading to variations in phenotype between two cells present in a population under identical environmental condition. Phenotypic variations in a population can enable a small fraction of cells to survive sudden changes in the environmental condition, as some of the cells are always prepared for such a change. Phenotypic variations can thus have very important implications for survival of a cell population and have been shown to affect our ability to treat human diseases-from eradication of a bacterial infection to treatment of cancer. In this review, I discuss the role of mitochondria, an important organelle in all eukaryotic cells, in generation of phenotypic heterogeneity. Mitochondria contains its own genome in multiple copies per cell and many proteins and RNA molecules required for proper functioning of mitochondria are present on the mitochondrial genome. Variations in number of copies of the mitochondrial genomes can thus lead to variations in mitochondrial functional state. As mitochondria have important roles in several cellular process, this can lead to variations in several cellular phenotypes including drug resistance. In this context, I also discuss the role of mitochondria in human diseases where mitochondrial heterogeneity could have important implications for disease progression and therapy. Thus, understanding the role of mitochondria in generation of phenotypic variation assumes significant importance in the context of human diseases as well as emergence of drug resistance.
C1 [Dhar, Riddhiman] IIT Kharagpur, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
C3 Indian Institute of Technology System (IIT System); Indian Institute of
   Technology (IIT) - Kharagpur
RP Dhar, R (corresponding author), IIT Kharagpur, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM riddhiman.dhar@iitkgp.ac.in
RI Dhar, Riddhiman/AAR-6678-2020
FU ISIRD Grant from IIT Kharagpur; ECR from Science and Engineering
   Research Board (SERB), India [ECR/2017/002328]
FX Work in the RD lab is supported by an ISIRD Grant from IIT Kharagpur and
   an ECR grant (ECR/2017/002328) from Science and Engineering Research
   Board (SERB), India.
CR Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110
   Ackermann M, 2015, NAT REV MICROBIOL, V13, P497, DOI 10.1038/nrmicro3491
   Alberts B., 2002, Molecular Biology of the Cell in Cell, V4th
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Arnoldini M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001928
   Assenov Y, 2018, SEMIN CANCER BIOL, V51, P12, DOI 10.1016/j.semcancer.2018.01.010
   Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460
   Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390
   Battich N, 2015, CELL, V163, P1596, DOI 10.1016/j.cell.2015.11.018
   Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575
   Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625
   Berg J. M., 2002, Biochemistry, V5
   BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0
   Bertram R, 2006, J THEOR BIOL, V243, P575, DOI 10.1016/j.jtbi.2006.07.019
   Bettenworth V, 2019, J MOL BIOL, V431, P4530, DOI 10.1016/j.jmb.2019.04.036
   Bishop AL, 2007, MOL MICROBIOL, V63, P507, DOI 10.1111/j.1365-2958.2006.05504.x
   Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546
   Böckler S, 2017, J CELL BIOL, V216, P2481, DOI 10.1083/jcb.201611197
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bohacek J, 2015, NAT REV GENET, V16, P641, DOI 10.1038/nrg3964
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brauner A, 2016, NAT REV MICROBIOL, V14, P320, DOI 10.1038/nrmicro.2016.34
   Brbic M, 2016, NUCLEIC ACIDS RES, V44, P10074, DOI 10.1093/nar/gkw964
   Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556
   Burga A, 2013, CURR OPIN BIOTECH, V24, P803, DOI 10.1016/j.copbio.2013.03.004
   Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625
   Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Cardamone MD, 2018, MOL CELL, V69, P757, DOI 10.1016/j.molcel.2018.01.037
   Carja O, 2019, GENETICS, V211, P977, DOI 10.1534/genetics.118.301758
   Carja O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05214-2
   Casacuberta JM, 2016, G3-GENES GENOM GENET, V6, P775, DOI 10.1534/g3.115.025502
   Casadesús J, 2016, ADV EXP MED BIOL, V945, P35, DOI 10.1007/978-3-319-43624-1_3
   Casadesús J, 2013, J BIOL CHEM, V288, P13929, DOI 10.1074/jbc.R113.472274
   Chen HC, 2017, CELL METAB, V26, P39, DOI 10.1016/j.cmet.2017.05.016
   Chen XS, 2016, CELL SYST, V2, P347, DOI 10.1016/j.cels.2016.03.009
   Cheung P, 2018, CELL, V173, P1385, DOI 10.1016/j.cell.2018.03.079
   Chevin LM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0089
   das Neves RP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000560
   Dewachter L, 2019, MOL CELL, V76, P255, DOI 10.1016/j.molcel.2019.09.028
   Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007
   Dhar R, 2019, ELIFE, V8, DOI 10.7554/eLife.38904
   Domingo J, 2019, ANNU REV GENOM HUM G, V20, P433, DOI 10.1146/annurev-genom-083118-014857
   Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115
   Drouin A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40561-2
   Truong DT, 2017, GENOME RES, V27, P626, DOI 10.1101/gr.216242.116
   Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015
   Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919
   ERNSTER L, 1959, NATURE, V184, P1851, DOI 10.1038/1841851a0
   Farquhar KS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10330-w
   Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581
   Freel KC, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov023
   Fridman O, 2014, NATURE, V513, P418, DOI 10.1038/nature13469
   Furlan-Magaril M, 2015, CURR OPIN GENET DEV, V31, P36, DOI 10.1016/j.gde.2015.04.004
   Gallion J, 2017, HUM MUTAT, V38, P569, DOI 10.1002/humu.23193
   Gawad C, 2016, NAT REV GENET, V17, P175, DOI 10.1038/nrg.2015.16
   Gilkerson R, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011080
   Gnoni GV, 2009, IUBMB LIFE, V61, P987, DOI 10.1002/iub.249
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Guantes R, 2015, GENOME RES, V25, P633, DOI 10.1101/gr.178426.114
   Guo RY, 2018, BIOMED J, V41, P9, DOI 10.1016/j.bj.2017.12.001
   Gupta PB, 2019, CELL STEM CELL, V24, P65, DOI 10.1016/j.stem.2018.11.011
   Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026
   Hallstrom TC, 2000, J BIOL CHEM, V275, P37347, DOI 10.1074/jbc.M007338200
   Hammerlindl H, 2018, J CELL COMMUN SIGNAL, V12, P133, DOI 10.1007/s12079-017-0435-1
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015
   Holland SL, 2014, ENVIRON MICROBIOL, V16, P1729, DOI 10.1111/1462-2920.12243
   Hornung G, 2012, GENOME RES, V22, P2409, DOI 10.1101/gr.139378.112
   Housman G, 2014, CANCERS, V6, P1769, DOI 10.3390/cancers6031769
   Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139
   Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729
   Ichikawa Y, 2012, P NATL ACAD SCI USA, V109, P4152, DOI 10.1073/pnas.1119338109
   Inde Z, 2018, CRIT REV BIOCHEM MOL, V53, P99, DOI 10.1080/10409238.2017.1412395
   Jamal-Hanjani M, 2015, CLIN CANCER RES, V21, P1258, DOI 10.1158/1078-0432.CCR-14-1429
   Jelier R, 2011, NAT GENET, V43, P1270, DOI 10.1038/ng.1007
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Kaspy I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4001
   Kelsey G, 2017, SCIENCE, V358, P69, DOI 10.1126/science.aan6826
   Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5
   Kiviet DJ, 2014, NATURE, V514, P376, DOI 10.1038/nature13582
   Koch L, 2019, NAT REV GENET, V20, P565, DOI 10.1038/s41576-019-0164-9
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kulkarni A, 2019, CURR OPIN BIOTECH, V58, P129, DOI 10.1016/j.copbio.2019.03.001
   Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352
   Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383
   Lehner B, 2007, J EXP BIOL, V210, P1559, DOI 10.1242/jeb.002311
   Lehner B, 2013, NAT REV GENET, V14, P168, DOI 10.1038/nrg3404
   Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445
   Levin-Reisman I, 2017, SCIENCE, V355, P826, DOI 10.1126/science.aaj2191
   Levy SF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001325
   Li S, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007744
   Li X, 2018, P NATL ACAD SCI USA, V115, P6679, DOI 10.1073/pnas.1718326115
   Libby E, 2019, AM NAT, V193, P409, DOI 10.1086/701786
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   LITI G, 2017, COLD SPRING HARB PRO, V2017, P606
   Lo Pang-Kuo, 2018, J Clin Genom, V1, DOI 10.4172/JCG.1000103
   Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818
   Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261
   Maughan H, 2004, J BACTERIOL, V186, P2212, DOI 10.1128/JB.186.7.2212-2214.2004
   McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814
   McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054
   Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624
   Mena NP, 2015, MITOCHONDRION, V21, P92, DOI 10.1016/j.mito.2015.02.001
   Meziti A, 2019, ISME J, V13, P767, DOI 10.1038/s41396-018-0307-6
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Mitchell S, 2018, P NATL ACAD SCI USA, V115, pE2888, DOI 10.1073/pnas.1715639115
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Moye-Rowley WS, 2005, GENE, V354, P15, DOI 10.1016/j.gene.2005.03.019
   Munro D, 2017, J EXP BIOL, V220, P1170, DOI 10.1242/jeb.132142
   NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064
   Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785
   Nguyen A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11246
   Nichol D, 2016, GENETICS, V204, P1523, DOI 10.1534/genetics.116.193474
   Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923
   Nuzhdin SV, 2012, TRENDS GENET, V28, P421, DOI 10.1016/j.tig.2012.06.003
   Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]
   Panel M, 2018, AGING CELL, V17, DOI 10.1111/acel.12793
   Patange O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07702-z
   Pavlicev M, 2011, J EXP ZOOL PART B, V316B, P371, DOI 10.1002/jez.b.21410
   PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9
   Pisco AO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3467
   Polster R, 2016, MOL BIOL EVOL, V33, P3213, DOI 10.1093/molbev/msw206
   Porto A, 2016, GENETICS, V204, P1601, DOI 10.1534/genetics.116.189431
   Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372
   Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032
   Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781
   Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769
   Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020
   Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3
   Rossolini GM, 2014, CURR OPIN PHARMACOL, V18, P56, DOI 10.1016/j.coph.2014.09.006
   Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107
   Rowley MJ, 2018, NAT REV GENET, V19, P789, DOI 10.1038/s41576-018-0060-8
   Ryzhkova AI, 2018, THER CLIN RISK MANAG, V14, P1933, DOI 10.2147/TCRM.S154863
   Sala A, 2014, TOXINS, V6, P1002, DOI 10.3390/toxins6031002
   Sánchez-Romero MA, 2015, CURR OPIN MICROBIOL, V25, P9, DOI 10.1016/j.mib.2015.03.004
   Sanglard D, 2016, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00011
   SCHANTZ PG, 1986, ACTA PHYSIOL SCAND, V128, P397, DOI 10.1111/j.1748-1716.1986.tb07993.x
   Schuster CF, 2016, TOXINS, V8, DOI 10.3390/toxins8050140
   Scott I, 2010, ESSAYS BIOCHEM, V47, P85, DOI [10.1042/BSE0470085, 10.1042/bse0470085]
   Sharma A, 2019, CELL REP, V29, P2164, DOI 10.1016/j.celrep.2019.10.045
   Sheng S, 2018, CANCER METAST REV, V37, P655, DOI 10.1007/s10555-018-9767-4
   Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100
   Silander OK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002443
   Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1
   SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0
   SPURLOCK B, 2019, J CELL SCI, V132
   Stanta G, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00085
   Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015
   Starrfelt J, 2012, BIOL REV, V87, P742, DOI 10.1111/j.1469-185X.2012.00225.x
   Stefano GB, 2017, ADV EXP MED BIOL, V982, P577, DOI 10.1007/978-3-319-55330-6_30
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stuart T, 2019, NAT REV GENET, V20, P257, DOI 10.1038/s41576-019-0093-7
   Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thomas P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06912-9
   Trujillano D, 2017, MOL GENET GENOM MED, V5, P66, DOI 10.1002/mgg3.262
   Turajlic S, 2019, NAT REV GENET, V20, P404, DOI 10.1038/s41576-019-0114-6
   Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7
   van Boxtel C, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0141
   van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072
   van Dijk D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8972
   Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014
   Verma A, 2019, AM J HUM GENET, V104, P55, DOI 10.1016/j.ajhg.2018.11.006
   Virdi JS, 2005, CURR SCI INDIA, V89, P113
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Wang YM, 2007, J BIOL CHEM, V282, P8228, DOI 10.1074/jbc.M609635200
   WHITTAKER PA, 1972, NATURE-NEW BIOL, V238, P266, DOI 10.1038/newbio238266a0
   Willbanks A, 2016, GENET EPIGENETICS, V8, P25, DOI 10.4137/GEG.S31863
   Williams JJ, 2011, FEMS MICROBIOL LETT, V322, P41, DOI 10.1111/j.1574-6968.2011.02330.x
   Williamson D H, 1979, Methods Enzymol, V56, P728
   Winkler LR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01077
   Woods DC, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/7068567
   Xue BK, 2018, P NATL ACAD SCI USA, V115, P12745, DOI 10.1073/pnas.1813447115
   Yaakov G, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0016
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838
   Zhang WL, 2019, BRIEF BIOINFORM, V20, P2098, DOI 10.1093/bib/bby071
   Ziv N, 2013, MOL BIOL EVOL, V30, P2568, DOI 10.1093/molbev/mst138
NR 181
TC 0
Z9 1
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0970-4140
EI 0019-4964
J9 J INDIAN I SCI
JI J. Indian Inst. Sci.
PD JUL
PY 2020
VL 100
IS 3
SI SI
BP 497
EP 514
DI 10.1007/s41745-020-00176-3
EA MAY 2020
PG 18
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA MF9KH
UT WOS:000536420800001
DA 2024-11-01
ER

PT J
AU Jou, C
   Nascimento, A
   Codina, A
   Montoya, J
   López-Gallardo, E
   Emperador, S
   Ruiz-Pesini, E
   Montero, R
   Natera-de Benito, D
   Ortez, CI
   Marquez, J
   Zelaya, MV
   Gutierrez-Mata, A
   Badosa, C
   Carrera-García, L
   Expósito-Escudero, J
   Roldán, M
   Camara, Y
   Marti, R
   Ferrer, I
   Jimenez-Mallebrera, C
   Artuch, R
AF Jou, Cristina
   Nascimento, Andres
   Codina, Anna
   Montoya, Julio
   Lopez-Gallardo, Ester
   Emperador, Sonia
   Ruiz-Pesini, Eduardo
   Montero, Raquel
   Natera-de Benito, Daniel
   Ortez, Carlos, I
   Marquez, Jesus
   Zelaya, Maria, V
   Gutierrez-Mata, Alfonso
   Badosa, Carmen
   Carrera-Garcia, Laura
   Exposito-Escudero, Jesica
   Roldan, Monica
   Camara, Yolanda
   Marti, Ramon
   Ferrer, Isidre
   Jimenez-Mallebrera, Cecilia
   Artuch, Rafael
TI Pathological Features in Paediatric Patients with TK2 Deficiency
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE TK2 deficiency; paediatric patients; ultrastructural studies; muscle
   biopsy; mitochondrial myopathies; ragged red fibres
ID MITOCHONDRIAL-DNA DEPLETION; THYMIDINE KINASE; SKELETAL-MUSCLE;
   MYOPATHIC FORM
AB Thymidine kinase (TK2) deficiency causes mitochondrial DNA depletion syndrome. We aimed to report the clinical, biochemical, genetic, histopathological, and ultrastructural features of a cohort of paediatric patients with TK2 deficiency. Mitochondrial DNA was isolated from muscle biopsies to assess depletions and deletions. The TK2 genes were sequenced using Sanger sequencing from genomic DNA. All muscle biopsies presented ragged red fibres (RRFs), and the prevalence was greater in younger ages, along with an increase in succinate dehydrogenase (SDH) activity and cytochrome c oxidase (COX)-negative fibres. An endomysial inflammatory infiltrate was observed in younger patients and was accompanied by an overexpression of major histocompatibility complex type I (MHC I). The immunofluorescence study for complex I and IV showed a greater number of fibres than those that were visualized by COX staining. In the ultrastructural analysis, we found three major types of mitochondrial alterations, consisting of concentrically arranged lamellar cristae, electrodense granules, and intramitochondrial vacuoles. The pathological features in the muscle showed substantial differences in the youngest patients when compared with those that had a later onset of the disease. Additional ultrastructural features are described in the muscle biopsy, such as sarcomeric de-structuration in the youngest patients with a more severe phenotype.
C1 [Jou, Cristina; Nascimento, Andres; Codina, Anna; Montero, Raquel; Natera-de Benito, Daniel; Ortez, Carlos, I; Marquez, Jesus; Badosa, Carmen; Carrera-Garcia, Laura; Exposito-Escudero, Jesica; Jimenez-Mallebrera, Cecilia; Artuch, Rafael] Hosp St Joan Deu, Pathol Biobank Pediat Neurol Neuromuscular Unit, Barcelona 08950, Spain.
   [Jou, Cristina; Nascimento, Andres; Codina, Anna; Montero, Raquel; Natera-de Benito, Daniel; Ortez, Carlos, I; Marquez, Jesus; Badosa, Carmen; Carrera-Garcia, Laura; Exposito-Escudero, Jesica; Jimenez-Mallebrera, Cecilia; Artuch, Rafael] Hosp St Joan Deu, Clin Biochem Dept, Barcelona 08950, Spain.
   [Jou, Cristina; Nascimento, Andres; Codina, Anna; Montero, Raquel; Natera-de Benito, Daniel; Ortez, Carlos, I; Marquez, Jesus; Badosa, Carmen; Carrera-Garcia, Laura; Exposito-Escudero, Jesica; Jimenez-Mallebrera, Cecilia; Artuch, Rafael] Inst Recerca St Joan Deu, Barcelona 08950, Spain.
   [Jou, Cristina; Nascimento, Andres; Montoya, Julio; Lopez-Gallardo, Ester; Emperador, Sonia; Ruiz-Pesini, Eduardo; Camara, Yolanda; Marti, Ramon; Jimenez-Mallebrera, Cecilia; Artuch, Rafael] Biomed Ctr Res Rare Dis CIBERER ISCIII, Madrid 28029, Spain.
   [Montoya, Julio; Lopez-Gallardo, Ester; Emperador, Sonia; Ruiz-Pesini, Eduardo] Univ Zaragoza, Inst Invest Sanitaria Aragon IISA, Zaragoza 50011, Spain.
   [Zelaya, Maria, V] Navarra Inst Hlth Res, Complejo Hosp Navarra IdiSNA, Dept Pathol, Pamplona 31008, Spain.
   [Gutierrez-Mata, Alfonso] Hosp Nacl Ninos Dr Carlos Saenz Herrera, Pediat Neurol Dept, San Jose 2671005, Costa Rica.
   [Roldan, Monica] Hosp St Joan Deu, Inst Pediat Malaties Rares IPER, Serv Med Genet & Mol, Unitat Microscopia Confocal & Imatge Cellular, Barcelona 08950, Spain.
   [Camara, Yolanda; Marti, Ramon] Univ Autonoma Barcelona, Vall dHebron Inst Recerca, Res Grp Neuromuscular & Mitochondrial Disorders, Barcelona 08193, Spain.
   [Ferrer, Isidre] Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona 08007, Spain.
   [Ferrer, Isidre] Bellvitge Inst Biomed Res IDI BELL, Biomed Ctr Res Neurodegenerat Dis CIBERNED, Barcelona 08007, Spain.
   [Ferrer, Isidre; Jimenez-Mallebrera, Cecilia] Univ Barcelona, Dept Genet Microbiol & Stat, Barcelona 08007, Spain.
C3 University of Barcelona; University of Barcelona; University of
   Zaragoza; Servicio Navarro de Salud - Osasunbidea; University of
   Barcelona; Autonomous University of Barcelona; Hospital Universitari
   Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of
   Barcelona; University of Barcelona
RP Jimenez-Mallebrera, C; Artuch, R (corresponding author), Hosp St Joan Deu, Pathol Biobank Pediat Neurol Neuromuscular Unit, Barcelona 08950, Spain.; Jimenez-Mallebrera, C; Artuch, R (corresponding author), Hosp St Joan Deu, Clin Biochem Dept, Barcelona 08950, Spain.; Jimenez-Mallebrera, C; Artuch, R (corresponding author), Inst Recerca St Joan Deu, Barcelona 08950, Spain.; Jimenez-Mallebrera, C; Artuch, R (corresponding author), Biomed Ctr Res Rare Dis CIBERER ISCIII, Madrid 28029, Spain.; Jimenez-Mallebrera, C (corresponding author), Univ Barcelona, Dept Genet Microbiol & Stat, Barcelona 08007, Spain.
EM cecilia.jimenez@sjd.es; rafael.artuch@sjd.es
RI Huerta, Maria/Y-5778-2019; Natera-de Benito, Daniel/AAC-9892-2021;
   Martí, Ramon/Q-3442-2016; Cámara, Yolanda/P-2540-2019;
   Jimenez-Mallebrera, Cecilia/F-5030-2016
OI Marti, Ramon/0000-0002-8273-9540; Lopez Gallardo,
   Ester/0000-0002-3217-1424; Artuch, Rafael/0000-0002-3422-9685;
   Roldan-Molina, Monica/0000-0002-9530-6234; Ferrer,
   Isidro/0000-0001-9888-8754; Natera-de Benito,
   Daniel/0000-0001-7764-2085; Ruiz Pesini, Eduardo/0000-0002-0269-7337;
   EXPOSITO ESCUDERO, JESICA MARIA/0000-0002-6233-823X; Ortez Gonzalez,
   Carlos Ignacio/0000-0001-8187-8103; Jimenez-Mallebrera,
   Cecilia/0000-0001-8203-7103; Zelaya, Maria Victoria/0000-0002-3692-3515;
   Montoya Villarroya, Julio/0000-0003-1770-6299
FU Instituto de Salud Carlos III [FIS-PI17-00021, PI17-00166, PI20-00340];
   European Regional Development Fund [PR194]; Gobierno de Aragon
   [B33_20R]; FEDER; Asociacion de Enfermos de Patologia Mitocondrial
   (AEPMI)
FX This research was funded by: Instituto de Salud Carlos III (Grant no.
   FIS-PI17-00021, PI17-00166, and PI20-00340) (co-funded by the European
   Regional Development Fund, "A way to make Europe"); crowdfunding Program
   Precipita-FECYT (PR194); Gobierno de Aragon (Grupos Consolidados
   B33_20R) and FEDER 2014-2020, "Construyendo Europa desde Aragon"; and
   Asociacion de Enfermos de Patologia Mitocondrial (AEPMI). CIBERER is an
   initiative from the Carlos III Health Institute.
CR Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Casado M, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1374-4
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Collins J, 2009, NEUROMUSCULAR DISORD, V19, P784, DOI 10.1016/j.nmd.2009.08.002
   De Paepe B, 2009, J CLIN PATHOL, V62, P172, DOI 10.1136/jcp.2008.061267
   Dominguez-Gonzalez C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66940-8
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1071-z
   Dubowitz V., 2020, Muscle biopsy: A practical approach
   Finsterer J, 2018, MOL GENET METAB REP, V16, P13, DOI 10.1016/j.ymgmr.2018.06.003
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91
   Marcuello A, 2005, J APPL PHYSIOL, V99, P1372, DOI 10.1152/japplphysiol.00289.2005
   Martí R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294
   Montero R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148709
   Navarro-Sastre A, 2012, MOL GENET METAB, V107, P409, DOI 10.1016/j.ymgme.2012.08.018
   Phadke R, 2017, J CLIN MED, V6, DOI 10.3390/jcm6070064
   Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Romero NB, 2013, HAND CLINIC, V113, P1321, DOI 10.1016/B978-0-444-59565-2.00004-6
   Roos S, 2014, NEUROMUSCULAR DISORD, V24, P713, DOI 10.1016/j.nmd.2014.05.009
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sabouny R, 2021, J CELL SCI, V134, DOI 10.1242/jcs.258944
   Sewry CA, 2010, ACTA NEUROPATHOL, V120, P343, DOI 10.1007/s00401-010-0727-5
   Stenton SL, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102784
   Vincent AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30610
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200
   Zeviani M, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11040637
NR 30
TC 1
Z9 1
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD OCT
PY 2022
VL 23
IS 19
AR 11002
DI 10.3390/ijms231911002
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 5H5TL
UT WOS:000867741500001
PM 36232299
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Tawk, A
   HusseinKamarreddine, M
   Dagher, M
   Abboud, G
   Chams, M
   Ghandour-Hajj, F
   Khoury, M
   Farhat, S
AF Tawk, Antonios
   HusseinKamarreddine, Mohammed
   Dagher, Mona
   Abboud, Ghadi
   Chams, Mohamad
   Ghandour-Hajj, Fatmeh
   Khoury, Mounir
   Farhat, Said
TI Clinicopathology and Diagnosis Delay in a 40-Year-Old with Mitochondrial
   Neurogastrointestinal Encephalomyopathy (MNGIE)
SO CASE REPORTS IN GASTROENTEROLOGY
LA English
DT Review
DE Mitochondrial neurogastrointestinal encephalomyopathy; Genetic mutation;
   Mitochondrial dysfunction; Gastroenterology; Neurogastroenterology
AB Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive and fatal multisystem metabolic disorder. It presents with wide-ranging gastrointestinal and neurologic symptoms. It is caused by a mutation in the TYMP gene which impairs thymidine phosphorylase (TP) activity, therefore leading to the accumulation of thymidine and deoxyuridine in plasma and tissues. Thus, MNGIE can be diagnosed by findings of high levels of thymidine and deoxyuridine. Herein, we present the case of a 40-year-old male who presented with diarrhea, vomiting, and abdominal pain, severe weight loss, neurologic deficits, and distal motor weakness progressing over a period of 13 years. The combination of this broad clinical picture along with results of magnetic resonance imaging, electromyography, colonic biopsies, genetic testing, and elevated plasma and tissue thymidine and deoxyuridine levels confirmed the diagnosis of MNGIE. TYMP gene mutation impairs TP function. TP mutations in the nuclear DNA lead to mitochondrial DNA deletions causing mitochondrial failure and ultimately cell death. Treatment modalities are targeting the restoration of TP activity or aiming to decrease the high levels of thymidine and pyrimide. However, diagnosing this disease is still a challenge and often overdue. This patient's 13-year delay in diagnosis shows the importance of a complete neurological exam and muscle strength testing in patients with gastrointestinal symptoms. The diagnosis of MNGIE requires interdepartmental collaborative work for diagnosis delay prevention and for optimal patient care. (C) 2020 The Author(s) Published by S. Karger AG, Basel
C1 [Tawk, Antonios; HusseinKamarreddine, Mohammed; Dagher, Mona; Chams, Mohamad] Univ Balamand, Fac Med & Med Sci, Beirut, Lebanon.
   [Abboud, Ghadi] Univ Balamand, St George Hosp Univ, Dept Diagnost Radiol, Med Ctr, Beirut, Lebanon.
   [Ghandour-Hajj, Fatmeh] St George Hosp Univ, Dept Pathol, Med Ctr, Beirut, Lebanon.
   [Khoury, Mounir] St George Hosp Univ, Dept Neurol, Med Ctr, Beirut, Lebanon.
   [Farhat, Said] St George Hosp Univ, Dept Gastroenterol, Med Ctr, Beirut 1100, Lebanon.
C3 University Balamand; University Balamand
RP Farhat, S (corresponding author), St George Hosp Univ, Dept Gastroenterol, Med Ctr, Beirut 1100, Lebanon.
EM saidfarhat@hotmail.com
OI Tawk, Antonios/0000-0002-5668-7310
CR Baris Z, 2010, EUR J PEDIATR, V169, P1375, DOI 10.1007/s00431-010-1237-0
   Etienne G, 2012, TRANSL NEUROSCI, V3, P413, DOI 10.2478/s13380-012-0042-9
   Filosto M, 2018, J CLIN MED, V7, DOI 10.3390/jcm7110389
   Filosto M, 2011, J INHERIT METAB DIS, V34, P1199, DOI 10.1007/s10545-011-9332-6
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   Laforce R, 2009, CLIN NEUROL NEUROSUR, V111, P691, DOI 10.1016/j.clineuro.2009.05.005
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Orphanet, 2019, ORPHANET REPORT SERI, V1
   Pacitti D, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00669
   Patel R, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-018-0925-5
   Scarpelli M, 2011, CASE REP NEUROL, V4, P248, DOI 10.1159/000346260
   Szigeti K, 2004, J MED GENET, V41, P125, DOI 10.1136/jmg.2003.013789
NR 15
TC 4
Z9 5
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
EI 1662-0631
J9 CASE REP GASTROENTER
JI Case Rep. Gastroenterol.
PD JAN-APR
PY 2020
VL 14
IS 1
BP 124
EP 130
DI 10.1159/000506187
PG 7
WC Gastroenterology & Hepatology
WE Emerging Sources Citation Index (ESCI)
SC Gastroenterology & Hepatology
GA VK7DU
UT WOS:000744668500018
PM 32355481
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Fraser, JA
   Biousse, V
   Newman, NJ
AF Fraser, J. Alexander
   Biousse, Valerie
   Newman, Nancy J.
TI The Neuro-ophthalmology of Mitochondrial Disease
SO SURVEY OF OPHTHALMOLOGY
LA English
DT Review
DE chronic progressive external ophthalmoplegia; dominant optic atrophy;
   Kearns-Sayre syndrome; Leber hereditary optic neuropathy; MELAS;
   mitochondria; NARP; neuro-ophthalmology; pigmentary retinopathy
ID HEREDITARY OPTIC NEUROPATHY; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   KEARNS-SAYRE-SYNDROME; STROKE-LIKE EPISODES; RESPIRATORY-CHAIN
   DYSFUNCTION; MACULAR PATTERN DYSTROPHY; FRENCH-CANADIAN FAMILIES; MARROW
   PANCREAS SYNDROME; PLACEBO-CONTROLLED TRIAL; WOLFRAM DIDMOAD SYNDROME
AB Mitochondrial diseases frequently manifest neuro-ophthalmologic symptoms and signs. Because of the predilection of mitochondrial disorders to involve the optic nerves, extraocular muscles, retina, and even the retrochiasmal visual pathways, the ophthalmologist is often the first physician to be consulted. Disorders caused by mitochondrial dysfunction can result from abnormalities in either the mitochondrial DNA or in nuclear genes which encode mitochondrial proteins. Inheritance of these mutations will follow patterns specific to their somatic or mitochondrial genetics. Genotype phenotype correlations are inconstant, and considerable overlap may occur among these syndromes. The diagnostic approach to the patient with suspected mitochondrial disease entails a detailed personal and family history, careful ophthalmic, neurologic, and systemic examination, directed investigations, and attention to potentially life-threatening sequelae. Although curative treatments for mitochondrial disorders are currently lacking, exciting research advances are being made, particularly in the area of gene therapy. Leber hereditary optic neuropathy, with its window of opportunity for timely intervention and its accessibility to directed therapy, offers a unique model to study future therapeutic interventions. Most patients and their relatives benefit from informed genetic counseling. (Surv Ophthalmol 55:299-334, 2010. (C) 2010 Elsevier Inc. All rights reserved.)
C1 [Fraser, J. Alexander; Biousse, Valerie; Newman, Nancy J.] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA.
   [Biousse, Valerie; Newman, Nancy J.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA.
   [Newman, Nancy J.] Emory Univ, Sch Med, Dept Neurol Surg, Atlanta, GA USA.
C3 Emory University; Emory University; Emory University
RP Newman, NJ (corresponding author), Emory Eye Ctr, Neuroophthalmol Unit, 1365-B Clifton Rd NE, Atlanta, GA 30322 USA.
EM ophtnjn@emory.edu
RI Newman, Nancy/AAB-2532-2021; Fraser, Alex/KBB-6191-2024
FU Research to Prevent Blindness, Inc., New York, NY; National Institutes
   of Health, Bethesda, MD [P30-EY06360]; Research to Prevent Blindness Lew
   R. Wasserman Merit Award
FX The authors reported no proprietary or commercial interest in any
   product mentioned or concept discussed in this article. This study was
   supported in part by a departmental grant (Department of Ophthalmology)
   from Research to Prevent Blindness, Inc., New York, NY, and by core
   grant P30-EY06360 (Department of Ophthalmology) from the National
   Institutes of Health, Bethesda, MD. Dr. Nancy J. Newman is a recipient
   of a Research to Prevent Blindness Lew R. Wasserman Merit Award. The
   authors would like to acknowledge Dr. Cedric Lamirel for his assistance
   in preparing figures.
CR Abe K, 2004, NEURORADIOLOGY, V46, P113, DOI 10.1007/s00234-003-1138-2
   Adjadj E, 2008, KLIN MONATSBL AUGENH, V225, P462, DOI 10.1055/s-2008-1027257
   Ahn J, 2008, BRIT J OPHTHALMOL, V92, P1685, DOI 10.1136/bjo.2008.144816
   Aijaz S, 2004, INVEST OPHTH VIS SCI, V45, P1667, DOI 10.1167/iovs.03-1093
   Amati-Bonneau P, 2003, AM J OPHTHALMOL, V136, P1170, DOI 10.1016/S0002-9394(03)00665-2
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amati-Bonneau P, 2009, INT J BIOCHEM CELL B, V41, P1855, DOI 10.1016/j.biocel.2009.04.012
   Andrews RM, 1999, BRIT J OPHTHALMOL, V83, P231, DOI 10.1136/bjo.83.2.231
   Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Barbet F, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.025502
   Barboni P, 2005, OPHTHALMOLOGY, V112, P120, DOI 10.1016/j.ophtha.2004.06.034
   Barboni P, 2006, INVEST OPHTH VIS SCI, V47, P5303, DOI 10.1167/iovs.06-0520
   Barrett TG, 1997, EYE, V11, P882, DOI 10.1038/eye.1997.226
   Barrientos A, 1996, J CLIN INVEST, V97, P1570, DOI 10.1172/JCI118581
   Bernardini Francesco P, 2002, Orbit, V21, P195, DOI 10.1076/orbi.21.3.195.7171
   Bette S, 2005, ACTA NEUROPATHOL, V109, P393, DOI 10.1007/s00401-004-0970-8
   Bette S, 2007, HISTOCHEM CELL BIOL, V128, P421, DOI 10.1007/s00418-007-0321-7
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Bhatti MT, 1999, J NEURO-OPHTHALMOL, V19, P28
   Biousse V, 1997, NEUROLOGY, V49, P1136, DOI 10.1212/WNL.49.4.1136
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Bremner FD, 2001, INVEST OPHTH VIS SCI, V42, P675
   Bristow EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P791
   Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1
   CAMPOS Y, 1995, PEDIATR NEUROL, V13, P69, DOI 10.1016/0887-8994(95)00082-Q
   Cardaioli E, 2008, J NEUROL SCI, V272, P106, DOI 10.1016/j.jns.2008.05.005
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2002, NEUROCHEM INT, V40, P573, DOI 10.1016/S0197-0186(01)00129-2
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Carlow TJ, 1998, AM J NEURORADIOL, V19, P95
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Chalmers RM, 1997, J NEUROL NEUROSUR PS, V62, P385, DOI 10.1136/jnnp.62.4.385
   Chalmers RM, 1996, J NEUROL NEUROSUR PS, V60, P195, DOI 10.1136/jnnp.60.2.195
   Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040
   CHANG TS, 1993, ARCH OPHTHALMOL-CHIC, V111, P1254, DOI 10.1001/archopht.1993.01090090106028
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2
   Chinnery PF, 1999, J MED GENET, V36, P505, DOI 10.1136/jmg.36.7.505
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   Chinnery PF, 2001, AM J MED GENET, V98, P235, DOI 10.1002/1096-8628(20010122)98:3<235::AID-AJMG1086>3.0.CO;2-O
   Chu BC, 1999, NEURORADIOLOGY, V41, P759, DOI 10.1007/s002340050838
   Cohn AC, 2008, BRIT J OPHTHALMOL, V92, P1333, DOI 10.1136/bjo.2007.134726
   Cohn AC, 2007, AM J OPHTHALMOL, V143, P656, DOI 10.1016/j.ajo.2006.12.038
   Cryns K, 2003, HUM MUTAT, V22, P275, DOI 10.1002/humu.10258
   Daut PM, 2000, AM J OPHTHALMOL, V130, P519, DOI 10.1016/S0002-9394(00)00558-4
   Davies VJ, 2008, BRAIN, V131, P368, DOI 10.1093/brain/awm333
   De Michele G, 1998, AM J HUM GENET, V63, P135, DOI 10.1086/301930
   Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278
   Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3
   Di Giovanni S, 2001, NEUROLOGY, V57, P515, DOI 10.1212/WNL.57.3.515
   Di Prospero NA, 2007, LANCET NEUROL, V6, P878, DOI 10.1016/S1474-4422(07)70220-X
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   DiMauro S, 2007, BIOSCIENCE REP, V27, P125, DOI 10.1007/s10540-007-9041-4
   Domenech Enric, 2006, Pediatr Endocrinol Rev, V3, P249
   ELIOTT D, 1993, AM J OPHTHALMOL, V115, P360, DOI 10.1016/S0002-9394(14)73589-5
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Enns GM, 2006, MOL GENET METAB, V88, P364, DOI 10.1016/j.ymgme.2006.02.001
   Ferrante KL, 2005, NEUROLOGY, V65, P1834, DOI 10.1212/01.wnl.0000187070.35365.d7
   Ferré M, 2005, HUM MUTAT, V25, P423, DOI 10.1002/humu.20161
   Ferré M, 2009, HUM MUTAT, V30, pE692, DOI 10.1002/humu.21025
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Finsterer J, 2006, NETH J MED, V64, P61
   Floreani M, 2005, FEBS J, V272, P1124, DOI 10.1111/j.1742-4658.2004.04542.x
   Fortuna F, 2009, BRAIN, V132, P116, DOI 10.1093/brain/awn269
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   GIRAUDET S, BR J OPHTHA IN PRESS
   Givre SJ, 2000, J NEURO-OPHTHALMOL, V20, P229, DOI 10.1097/00041327-200020040-00002
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE, pS107
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   Guy J, 2009, INVEST OPHTH VIS SCI, V50, P4205, DOI 10.1167/iovs.08-3214
   Han J, 2006, GENET MED, V8, P217, DOI 10.1097/01.gim.0000214299.61930.c0
   Hansrote S, 2002, J NEUROL SCI, V197, P63, DOI 10.1016/S0022-510X(02)00048-5
   HARDING AE, 1995, AM J HUM GENET, V57, P77
   Heidenreich JO, 2006, AM J ROENTGENOL, V187, P820, DOI 10.2214/AJR.05.0180
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   HOFFMAN PN, 2005, WALSH HOYTS CLIN NEU, P1085
   Hofmann S, 1997, GENOMICS, V39, P8, DOI 10.1006/geno.1996.4474
   Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Howell N, 1998, VISION RES, V38, P1495, DOI 10.1016/S0042-6989(97)00444-6
   HOWELL N, 1991, AM J HUM GENET, V48, P935
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Huoponen K, 2002, ACTA OPHTHALMOL SCAN, V80, P38, DOI 10.1034/j.1600-0420.2002.800108.x
   Iizuka T, 2007, J NEUROL SCI, V257, P126, DOI 10.1016/j.jns.2007.01.040
   Isashiki Y, 1998, ACTA OPHTHALMOL SCAN, V76, P6, DOI 10.1034/j.1600-0420.1998.760103.x
   Ito Y, 2007, INVEST OPHTH VIS SCI, V48, P4079, DOI 10.1167/iovs.07-0024
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Jacobson DM, 1998, AM J OPHTHALMOL, V126, P291, DOI 10.1016/S0002-9394(98)00152-4
   Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jin GF, 2001, CURR EYE RES, V23, P11, DOI 10.1076/ceyr.23.1.11.5423
   JOHNSTON PB, 1979, AM J OPHTHALMOL, V88, P868, DOI 10.1016/0002-9394(79)90565-8
   Ju WK, 2005, J COMP NEUROL, V488, P1, DOI 10.1002/cne.20586
   Kamei S, 2005, INVEST OPHTH VIS SCI, V46, P4288, DOI 10.1167/iovs.03-1407
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   Kerrison JB, 1999, ARCH OPHTHALMOL-CHIC, V117, P805
   Kerrison JB, 2000, ARCH OPHTHALMOL-CHIC, V118, P298
   KERRISON JB, 2001, AM J OPHTHALMOL, P803
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Kjer B, 1996, ACTA OPHTHALMOL SCAN, V74, P3
   KJER P, 1983, ACTA OPHTHALMOL, V61, P300
   KJER P, 1959, ACTA OPHTHALMOL    S, V54, P1
   KLINE LB, 1979, ARCH OPHTHALMOL-CHIC, V97, P1680, DOI 10.1001/archopht.1979.01020020248013
   Koene S, 2009, J INTERN MED, V265, P193, DOI 10.1111/j.1365-2796.2008.02058.x
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Kyriakouli DS, 2008, GENE THER, V15, P1017, DOI 10.1038/gt.2008.91
   Laird PW, 2006, AM J OPHTHALMOL, V142, P186, DOI 10.1016/j.ajo.2006.02.051
   Lamminen T, 1997, EUR J HUM GENET, V5, P271, DOI 10.1159/000484777
   LANG CJG, 1995, EUR J NEUROL, V2, P171, DOI 10.1111/j.1468-1331.1995.tb00112.x
   Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2
   LARSSON NG, 1991, ANN NEUROL, V30, P701, DOI 10.1002/ana.410300511
   Latkany P, 1999, AM J OPHTHALMOL, V128, P112, DOI 10.1016/S0002-9394(99)00057-4
   Latvala T, 2002, GRAEF ARCH CLIN EXP, V240, P795, DOI 10.1007/s00417-002-0555-y
   Leber T., 1871, ARCH OPHTHALMOL-CHIC, V17, P249
   Lee Andrew G, 2002, Curr Neurol Neurosci Rep, V2, P413, DOI 10.1007/s11910-002-0067-5
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   Lin DDM, 2003, AM J NEURORADIOL, V24, P33
   Lodi R, 1999, P NATL ACAD SCI USA, V96, P11492, DOI 10.1073/pnas.96.20.11492
   Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luzhansky JZ, 2001, AIDS, V15, P1588, DOI 10.1097/00002030-200108170-00022
   LYLE WM, 1990, REFERENCE EYE CARE P
   Macedo-Souza LI, 2005, ANN NEUROL, V57, P730, DOI 10.1002/ana.20478
   MACKEY DA, 1992, AUST NZ J OPHTHALMOL, V20, P177, DOI 10.1111/j.1442-9071.1992.tb00937.x
   Macmillan C, 1998, NEUROLOGY, V50, P417, DOI 10.1212/WNL.50.2.417
   Macmillan C, 2000, AM J HUM GENET, V66, P332, DOI 10.1086/302716
   MAKELABENGS P, 1995, PEDIATR RES, V37, P634
   Man CYYW, 2005, MED HYPOTHESES, V65, P1038, DOI 10.1016/j.mehy.2004.10.021
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Margineantu DH, 2002, MITOCHONDRION, V1, P425, DOI 10.1016/S1567-7249(02)00006-5
   MARGULIS L, 1976, EXP PARASITOL, V39, P277, DOI 10.1016/0014-4894(76)90127-2
   Mariotti C, 2003, NEUROLOGY, V60, P1676, DOI 10.1212/01.WNL.0000055872.50364.FC
   Mashima Y, 1998, CURR EYE RES, V17, P403, DOI 10.1080/02713689808951221
   Mashima Y, 2003, GRAEF ARCH CLIN EXP, V241, P75, DOI 10.1007/s00417-002-0598-0
   MASSIN P, 1995, AM J OPHTHALMOL, V120, P247, DOI 10.1016/S0002-9394(14)72615-7
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   McFarland R, 2009, J INTERN MED, V265, P210, DOI 10.1111/j.1365-2796.2008.02066.x
   MCKECHNIE NM, 1985, BRIT J OPHTHALMOL, V69, P63, DOI 10.1136/bjo.69.1.63
   MEIRE FM, 1995, OPHTHALMIC GENET, V16, P119, DOI 10.3109/13816819509059971
   Michaelides M, 2008, ARCH OPHTHALMOL-CHIC, V126, P320, DOI 10.1001/archopht.126.3.320
   MILEA D, 2009, ACTA OPHTHALMOL
   Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200
   Miyama S, 2000, NEUROPEDIATRICS, V31, P214, DOI 10.1055/s-2000-7462
   Mochizuki H, 1996, CLIN NEPHROL, V46, P347
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORIKAWA Y, 1993, VIRCHOWS ARCH A, V423, P227, DOI 10.1007/BF01614775
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Nakamura M, 2006, OPHTHALMOLOGY, V113, P483, DOI 10.1016/j.ophtha.2005.10.054
   Newman N. J., 2005, WALSH HOYTS CLIN NEU, P465
   Newman NJ, 2006, AM J OPHTHALMOL, V141, P1061, DOI 10.1016/j.ajo.2005.12.045
   Newman NJ, 2009, BRAIN, V132, P2306, DOI 10.1093/brain/awp195
   Newman NJ, 2005, AM J OPHTHALMOL, V140, P517, DOI 10.1016/j.ajo.2005.03.017
   Newman NJ, 2005, AM J OPHTHALMOL, V140, P407, DOI 10.1016/j.ajo.2005.03.058
   NEWMAN NJ, 1994, AM J OPHTHALMOL, V118, P158, DOI 10.1016/S0002-9394(14)72895-8
   Nikoskelainen EK, 1996, OPHTHALMOLOGY, V103, P504
   Nishino I, 2000, ANN NEUROL, V47, P792
   Ohkoshi N, 1998, J MED, V29, P13
   OLDFORS A, 1990, ACTA NEUROPATHOL, V80, P541, DOI 10.1007/BF00294616
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X
   Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950
   Olsen RKJ, 2007, BRAIN, V130, P2045, DOI 10.1093/brain/awm135
   Oppenheim C, 2000, J NEUROL NEUROSUR PS, V69, P248, DOI 10.1136/jnnp.69.2.248
   ORTIZ RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1525, DOI 10.1001/archopht.1993.01090110091031
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pesch UEA, 2004, INVEST OPHTH VIS SCI, V45, P4217, DOI 10.1167/iovs.03-1261
   Phillipson R, 1997, IMPACT, V1, P115
   Pott JWR, 2006, GRAEF ARCH CLIN EXP, V244, P1357, DOI 10.1007/s00417-006-0269-7
   Puomila A, 2005, ACTA OPHTHALMOL SCAN, V83, P337, DOI 10.1111/j.1600-0420.2005.00448.x
   Puomila A, 2007, EUR J HUM GENET, V15, P1079, DOI 10.1038/sj.ejhg.5201828
   Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P5360, DOI 10.1167/iovs.07-0254
   Qi XP, 2007, ARCH OPHTHALMOL-CHIC, V125, P268, DOI 10.1001/archopht.125.2.268
   Qi XP, 2004, ANN NEUROL, V56, P182, DOI 10.1002/ana.20175
   Ramos CDF, 2009, INVEST OPHTH VIS SCI, V50, P1666, DOI 10.1167/iovs.08-2695
   Rath PP, 2008, BRIT J OPHTHALMOL, V92, P623, DOI 10.1136/bjo.2007.131177
   Reynier P, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016576
   Riordan-Eva P, 2000, Curr Opin Ophthalmol, V11, P408, DOI 10.1097/00055735-200012000-00005
   RIORDANEVA P, 1995, J MED GENET, V32, P81, DOI 10.1136/jmg.32.2.81
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0
   Sadun Alfredo A, 2006, Trans Am Ophthalmol Soc, V104, P51
   Savini G, 2005, OPHTHALMOLOGY, V112, P127, DOI 10.1016/j.ophtha.2004.09.033
   Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Sgarbi G, 2009, ARCH NEUROL-CHICAGO, V66, P951, DOI 10.1001/archneurol.2009.134
   SHAEFER AM, 2004, BIOCHIM BIOPHYS ACTA, V1659, P115
   Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038
   Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Shimizu S, 2003, AM J OPHTHALMOL, V135, P256, DOI 10.1016/S0002-9394(02)01929-3
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Soejima K, 2006, ANN PLAS SURG, V56, P439, DOI 10.1097/01.sap.0000202885.98998.0a
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Spruijt L, 2006, AM J OPHTHALMOL, V141, P676, DOI 10.1016/j.ajo.2005.11.007
   Stachowiak O, 1998, J BIOL CHEM, V273, P16694, DOI 10.1074/jbc.273.27.16694
   Stelmack JA, 2008, ARCH OPHTHALMOL-CHIC, V126, P608, DOI 10.1001/archopht.126.5.608
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   STONE EM, 1992, J CLIN NEURO-OPHTHAL, V12, P10
   Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Takei D, 2006, FEBS LETT, V580, P5635, DOI 10.1016/j.febslet.2006.09.007
   Tan GL, 2003, HUM MOL GENET, V12, P1699, DOI 10.1093/hmg/ddg187
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tarnopolsky MA, 2008, ADV DRUG DELIVER REV, V60, P1561, DOI 10.1016/j.addr.2008.05.001
   TEIN I, 1990, PEDIATR RES, V28, P247, DOI 10.1203/00006450-199009000-00020
   Thambisetty M, 2004, EXPERT REV MOL DIAGN, V4, P631, DOI 10.1586/14737159.4.5.631
   Thambisetty M, 2002, NEUROLOGIST, V8, P302, DOI 10.1097/00127893-200209000-00003
   Thiselton DL, 2002, INVEST OPHTH VIS SCI, V43, P1715
   Thiselton DL, 2001, HUM GENET, V109, P498, DOI 10.1007/s004390100600
   Toomes C, 2001, HUM MOL GENET, V10, P1369, DOI 10.1093/hmg/10.13.1369
   Tsao CY, 2001, J CHILD NEUROL, V16, P533, DOI 10.1177/088307380101600716
   Tsao K, 1999, BRIT J OPHTHALMOL, V83, P577, DOI 10.1136/bjo.83.5.577
   Ueda K, 2005, EUR J ENDOCRINOL, V153, P167, DOI 10.1530/eje.1.01945
   Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Verny C, 2005, REV NEUROL-FRANCE, V161, P451, DOI 10.1016/S0035-3787(05)85075-1
   Votruba M, 2003, BRIT J OPHTHALMOL, V87, P48, DOI 10.1136/bjo.87.1.48
   Votruba M, 1998, ARCH OPHTHALMOL-CHIC, V116, P351, DOI 10.1001/archopht.116.3.351
   Wallace DC, 2000, AM HEART J, V139, pS70, DOI 10.1067/mhj.2000.103934
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DK, 1997, OPHTHALMOLOGY, V104, P695, DOI 10.1016/S0161-6420(97)30250-4
   Welzing L, 2009, EUR J PEDIATR, V168, P757, DOI 10.1007/s00431-008-0831-x
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Wolfram D. J., 1938, P MAYO CLIN, V13, P715
   Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yen MY, 2002, JPN J OPHTHALMOL, V46, P45, DOI 10.1016/S0021-5155(01)00460-9
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
   Zeviani Massimo, 1993, European Journal of Human Genetics, V1, P80
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
   ZUPANC ML, 1991, ANN NEUROL, V29, P680, DOI 10.1002/ana.410290619
NR 263
TC 177
Z9 193
U1 0
U2 26
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0039-6257
EI 1879-3304
J9 SURV OPHTHALMOL
JI Surv. Ophthalmol.
PD JUL-AUG
PY 2010
VL 55
IS 4
BP 299
EP 334
DI 10.1016/j.survophthal.2009.10.002
PG 36
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 623TU
UT WOS:000279768300001
PM 20471050
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Yarham, JW
   Al-Dosary, M
   Blakely, EL
   Alston, CL
   Taylor, RW
   Elson, JL
   McFarland, R
AF Yarham, John W.
   Al-Dosary, Mazhor
   Blakely, Emma L.
   Alston, Charlotte L.
   Taylor, Robert W.
   Elson, Joanna L.
   McFarland, Robert
TI A Comparative Analysis Approach to Determining the Pathogenicity of
   Mitochondrial tRNA Mutations
SO HUMAN MUTATION
LA English
DT Article
DE mitochondrial tRNA; pathogenicity; trans-mitochondrial cybrid study;
   MTTF; MTTL2
ID DNA MUTATIONS; HUMAN-DISEASE; DILATED CARDIOMYOPATHY; MYOPATHY;
   DATABASE; DEFECTS; GENOME
AB Distinguishing pathogenic from polymorphic changes poses significant problems for geneticists and despite 30 years of postgenomic experience this remains the case in mitochondrial genetics. Base substitutions in mitochondrial tRNA (mt-tRNA) genes are particularly difficult, but important, because they are common causes of pathology and associated with high rates of transmission. Providing accurate genetic advice to patients and their families is of paramount importance in disease prevention, and brings into sharp focus the factors used to distinguish pathogenic from polymorphic variants. We have reevaluated our pathogenicity scoring system for mt-tRNA mutations following a considerable increase in the number reported since the system was devised in 2004. This allowed us to address notable issues including the underestimation of "definitely pathogenic" mutations resulting from insufficient data collection. We illustrate the robustness of our revised scoring system using novel pathogenic and previously reported polymorphic changes and conclude that while clear evidence from single-fiber and/or trans-mitochondrial cybrid studies remains the gold standard for assigning pathogenicity, our scoring system is valuable for deciding which mt-tRNA mutations to investigate further using these labor-intensive techniques. Hum Mutat 32: 1319-1325, 2011. (C) 2011 Wiley Periodicals, Inc.
C1 [Yarham, John W.; Al-Dosary, Mazhor; Blakely, Emma L.; Alston, Charlotte L.; Taylor, Robert W.; Elson, Joanna L.; McFarland, Robert] Newcastle Univ, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP McFarland, R (corresponding author), Newcastle Univ, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.mcfarland@ncl.ac.uk
RI Alston, Charlotte/ABG-9602-2020
OI /0000-0002-3551-5624; McFarland, Robert/0000-0002-8833-2688; Yarham,
   John/0000-0003-4792-1790; Alston, Charlotte/0000-0003-2095-5464
FU Medical Research Council (UK); Research Council UK; Wellcome Trust
   [074454/Z/04/Z]; MRC Centre for Translational Research in Neuromuscular
   Disease, Mitochondrial Disease Patient Cohort (UK) [G0800674];
   HEFCE/DoH; NHS; MRC [G90/63, G0800674, G108/539] Funding Source: UKRI
FX Contract grant sponsor: Medical Research Council (UK) (to J.W.Y.).
   Contract grant sponsor: Research Council UK (to J.L.E.). Contract grant
   sponsor: Wellcome Trust Programme; Contract grant number: 074454/Z/04/Z
   (to R. W. T.). Contract grant sponsor: MRC Centre for Translational
   Research in Neuromuscular Disease, Mitochondrial Disease Patient Cohort
   (UK); Contract grant number: G0800674 (to R. M.). Contract grant
   sponsor: HEFCE/DoH Clinical Senior Lecturer Award (to R. M.). Contract
   grant sponsor: NHS Specialist Commissioners.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Bandelt HJ, 2009, HUM MUTAT, V30, P191, DOI 10.1002/humu.20846
   Bortot B, 2009, MITOCHONDRION, V9, P123, DOI 10.1016/j.mito.2009.01.006
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Davidson MM, 2009, J MOL CELL CARDIOL, V46, P936, DOI 10.1016/j.yjmcc.2009.02.011
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Gambello MJ, 2006, MUSCLE NERVE, V34, P437, DOI 10.1002/mus.20605
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Grasso M, 2001, EUR J HUM GENET, V9, P311, DOI 10.1038/sj.ejhg.5200622
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kleinle S, 1998, BIOCHEM BIOPH RES CO, V247, P112, DOI 10.1006/bbrc.1998.8729
   Kornblum C, 2008, BIOSCIENCE REP, V28, P89, DOI 10.1042/BSR20080004
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Meulemans A, 2007, ARCH NEUROL-CHICAGO, V64, P1339, DOI 10.1001/archneur.64.9.1339
   Mimaki M, 2009, MITOCHONDRION, V9, P115, DOI 10.1016/j.mito.2009.01.005
   Pereira C, 2007, BIOCHEM BIOPH RES CO, V354, P937, DOI 10.1016/j.bbrc.2007.01.068
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Sanaker PS, 2010, ACTA NEUROL SCAND, V121, P109, DOI 10.1111/j.1600-0404.2009.01243.x
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Servidei Serenella, 2003, Neuromuscul Disord, V13, P848
   Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Tessa A, 1999, EUR J HUM GENET, V7, P847, DOI 10.1038/sj.ejhg.5200380
   Tuppen HAL, 2010, BRAIN, V133, P2952, DOI 10.1093/brain/awq232
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
NR 36
TC 157
Z9 163
U1 0
U2 7
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1059-7794
J9 HUM MUTAT
JI Hum. Mutat.
PD NOV
PY 2011
VL 32
IS 11
BP 1319
EP 1325
DI 10.1002/humu.21575
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 840HJ
UT WOS:000296429800016
PM 21882289
OA gold
DA 2024-11-01
ER

PT J
AU Lakshmanan, LN
   Gruber, J
   Halliwell, B
   Gunawan, R
AF Lakshmanan, Lakshmi Narayanan
   Gruber, Jan
   Halliwell, Barry
   Gunawan, Rudiyanto
TI Are mutagenic non D-loop direct repeat motifs in mitochondrial DNA under
   a negative selection pressure?
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID MULTIPLE MTDNA DELETIONS; SYNONYMOUS CODON USAGE; SKELETAL-MUSCLE
   FIBERS; TANDEM REPEATS; CONTROL REGION; LIFE-SPAN; GENOME SEQUENCES;
   MUTATIONS; EVOLUTION; DISEASE
AB Non D-loop direct repeats (DRs) in mitochondrial DNA (mtDNA) have been commonly implicated in the mutagenesis of mtDNA deletions associated with neuromuscular disease and ageing. Further, these DRs have been hypothesized to put a constraint on the lifespan of mammals and are under a negative selection pressure. Using a compendium of 294 mammalian mtDNA, we re-examined the relationship between species lifespan and the mutagenicity of such DRs. Contradicting the prevailing hypotheses, we found no significant evidence that long-lived mammals possess fewer mutagenic DRs than short-lived mammals. By comparing DR counts in human mtDNA with those in selectively randomized sequences, we also showed that the number of DRs in human mtDNA is primarily determined by global mtDNA properties, such as the bias in synonymous codon usage (SCU) and nucleotide composition. We found that SCU bias in mtDNA positively correlates with DR counts, where repeated usage of a subset of codons leads to more frequent DR occurrences. While bias in SCU and nucleotide composition has been attributed to nucleotide mutational bias, mammalian mtDNA still exhibit higher SCU bias and DR counts than expected from such mutational bias, suggesting a lack of negative selection against non D-loop DRs.
C1 [Lakshmanan, Lakshmi Narayanan; Gunawan, Rudiyanto] ETH, Inst Chem & Bioengn, CH-8093 Zurich, Switzerland.
   [Lakshmanan, Lakshmi Narayanan] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117585, Singapore.
   [Gruber, Jan] Natl Univ Singapore, Neurobiol & Ageing Program, Dept Biochem, Yale NUS Coll, Singapore 117599, Singapore.
   [Halliwell, Barry] Natl Univ Singapore, Ctr Life Sci CeLS, Neurobiol & Ageing Program, Dept Biochem, Singapore 117599, Singapore.
   [Gunawan, Rudiyanto] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland.
C3 Swiss Federal Institutes of Technology Domain; ETH Zurich; National
   University of Singapore; National University of Singapore; Yale NUS
   College; National University of Singapore; Swiss Institute of
   Bioinformatics
RP Gunawan, R (corresponding author), ETH, Inst Chem & Bioengn, HCI F101,Vladimir Prelog Weg 1, CH-8093 Zurich, Switzerland.
EM rudi.gunawan@chem.ethz.ch
RI Gunawan, Rudiyanto/D-4650-2009; Halliwell, Barry/C-8318-2009
OI Lakshmanan, Lakshmi Narayanan/0000-0002-2892-1931; Halliwell,
   Barry/0000-0002-3560-7123; Gunawan, Rudiyanto/0000-0002-6480-7976
FU ETH Zurich; Swiss National Science Foundation [150522]; Ministry of
   Education Singapore [MOE2010-T2-2-048]
FX ETH Zurich; the Swiss National Science Foundation [150522]; Ministry of
   Education Singapore [MOE2010-T2-2-048]. Funding for open access charge:
   ETH Zurich.
CR Achaz G, 2002, NUCLEIC ACIDS RES, V30, P2987, DOI 10.1093/nar/gkf391
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Aledo JC, 2011, AGING CELL, V10, P198, DOI 10.1111/j.1474-9726.2010.00657.x
   Casane D, 1997, MOL BIOL EVOL, V14, P779, DOI 10.1093/oxfordjournals.molbev.a025818
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chung SS, 1996, AGE, V19, P117, DOI 10.1007/BF02434081
   Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x
   DOBSON GP, 1995, P NATL ACAD SCI USA, V92, P7317, DOI 10.1073/pnas.92.16.7317
   Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Fumagalli L, 1996, MOL BIOL EVOL, V13, P31, DOI 10.1093/oxfordjournals.molbev.a025568
   Gibson A, 2005, MOL BIOL EVOL, V22, P251, DOI 10.1093/molbev/msi012
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Gruber J, 2008, FRONT BIOSCI-LANDMRK, V13, P6554, DOI 10.2741/3174
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hughes KA, 2005, ANNU REV ENTOMOL, V50, P421, DOI 10.1146/annurev.ento.50.071803.130409
   James R. C., 2000, LONGEVITY RECORDS LI
   Jia WL, 2008, MOL BIOL EVOL, V25, P339, DOI 10.1093/molbev/msm259
   Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903
   Khaidakov M, 2006, MECH AGEING DEV, V127, P808, DOI 10.1016/j.mad.2006.07.008
   Kitazoe Y, 2011, GENOME BIOL EVOL, V3, P1233, DOI 10.1093/gbe/evr079
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Lakshmanan LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035271
   Larizza A, 2002, J MOL EVOL, V54, P145, DOI 10.1007/s00239-001-0063-4
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Levin L, 2013, GENOME BIOL EVOL, V5, P876, DOI 10.1093/gbe/evt058
   LEVINSON G, 1987, MOL BIOL EVOL, V4, P203
   Lunt DH, 1998, MOL ECOL, V7, P1441, DOI 10.1046/j.1365-294x.1998.00495.x
   Meganathan PR, 2012, GENE, V492, P121, DOI 10.1016/j.gene.2011.10.038
   Merker S, 2014, J MOL EVOL, V79, P40, DOI 10.1007/s00239-014-9631-2
   Mularoni L, 2010, GENOME RES, V20, P745, DOI 10.1101/gr.101261.109
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Pak JW, 2005, EXP GERONTOL, V40, P209, DOI 10.1016/j.exger.2004.12.005
   Pfeuty A, 2001, J MOL BIOL, V314, P709, DOI 10.1006/jmbi.2001.5160
   Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092
   PIERCE JC, 1991, NUCLEIC ACIDS RES, V19, P3901, DOI 10.1093/nar/19.14.3901
   Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899
   Poovathingal SK, 2012, BIOGERONTOLOGY, V13, P557, DOI 10.1007/s10522-012-9390-7
   Poovathingal SK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000572
   Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011
   SACCONE C, 1987, J MOL EVOL, V26, P205, DOI 10.1007/BF02099853
   Saccone C, 2002, GENE, V286, P3, DOI 10.1016/S0378-1119(01)00807-1
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Samuels DC, 2004, TRENDS GENET, V20, P226, DOI 10.1016/j.tig.2004.03.003
   Schmitz J, 2002, MOL BIOL EVOL, V19, P544, DOI 10.1093/oxfordjournals.molbev.a004110
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Speakman JR, 2005, AGING CELL, V4, P167, DOI 10.1111/j.1474-9726.2005.00162.x
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Tian XJ, 2011, MOL BIOL EVOL, V28, P899, DOI 10.1093/molbev/msq266
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Usdin K, 2008, GENOME RES, V18, P1011, DOI 10.1101/gr.070409.107
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   Wilkinson GS, 1997, GENETICS, V146, P1035
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Yang JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073318
   Zhao Liang, 2012, Zoological Research, V33, pE47, DOI 10.3724/SP.J.1141.2012.E03-04E47
NR 64
TC 4
Z9 5
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD APR 30
PY 2015
VL 43
IS 8
BP 4098
EP 4108
DI 10.1093/nar/gkv299
PG 11
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA CJ2LV
UT WOS:000355317200026
PM 25855815
OA Green Submitted, gold, Green Published
DA 2024-11-01
ER

PT J
AU Diebold, I
   Hennigs, JK
   Miyagawa, K
   Li, CYG
   Nickel, NP
   Kaschwich, M
   Cao, AQ
   Wang, LL
   Reddy, S
   Chen, PI
   Nakahira, K
   Alcazar, MAA
   Hopper, RK
   Ji, LJ
   Feldman, BJ
   Rabinovitch, M
AF Diebold, Isabel
   Hennigs, Jan K.
   Miyagawa, Kazuya
   Li, Caiyun G.
   Nickel, Nils P.
   Kaschwich, Mark
   Cao, Aiqin
   Wang, Lingli
   Reddy, Sushma
   Chen, Pin-I
   Nakahira, Kiichi
   Alcazar, Miguel A. Alejandre
   Hopper, Rachel K.
   Ji, Lijuan
   Feldman, Brian J.
   Rabinovitch, Marlene
TI BMPR2 Preserves Mitochondrial Function and DNA during Reoxygenation to
   Promote Endothelial Cell Survival and Reverse Pulmonary Hypertension
SO CELL METABOLISM
LA English
DT Article
ID MORPHOGENETIC PROTEIN-RECEPTOR; SMOOTH-MUSCLE-CELLS;
   ARTERIAL-HYPERTENSION; GERMLINE MUTATIONS; GENE-EXPRESSION;
   UP-REGULATION; TGF-BETA; MICE; DYSFUNCTION; APOPTOSIS
AB Mitochondrial dysfunction, inflammation, and mutant bone morphogenetic protein receptor 2 (BMPR2) are associated with pulmonary arterial hypertension (PAH), an incurable disease characterized by pulmonary arterial (PA) endothelial cell (EC) apoptosis, decreased microvessels, and occlusive vascular remodeling. We hypothesized that reduced BMPR2 induces PAEC mitochondrial dysfunction, promoting a pro-inflammatory or pro-apoptotic state. Mice with EC deletion of BMPR2 develop hypoxia-induced pulmonary hypertension that, incontrast tonon-transgenic littermates, does not reverse upon reoxygenation and is associated with reduced PA microvessels and lung EC p53, PGC1 alpha and TFAM, regulators of mitochondrial biogenesis, and mitochondrial DNA. Decreasing PAEC BMPR2 by siRNA during reoxygenation represses p53, PGC1 alpha, NRF2, TFAM, mitochondrial membrane potential, and ATP and induces mitochondrial DNA deletion and apoptosis. Reducing PAEC BMPR2 in normoxia increases p53, PGC1 alpha, TFAM, mitochondrial membrane potential, ATP production, and glycolysis, and induces mitochondrial fission and a pro-inflammatory state. These features are recapitulated in PAECs from PAH patients with mutant BMPR2.
C1 [Diebold, Isabel; Hennigs, Jan K.; Miyagawa, Kazuya; Li, Caiyun G.; Nickel, Nils P.; Kaschwich, Mark; Cao, Aiqin; Wang, Lingli; Reddy, Sushma; Chen, Pin-I; Alcazar, Miguel A. Alejandre; Hopper, Rachel K.; Ji, Lijuan; Feldman, Brian J.; Rabinovitch, Marlene] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.
   [Diebold, Isabel; Hennigs, Jan K.; Miyagawa, Kazuya; Li, Caiyun G.; Nickel, Nils P.; Kaschwich, Mark; Cao, Aiqin; Wang, Lingli; Reddy, Sushma; Chen, Pin-I; Alcazar, Miguel A. Alejandre; Hopper, Rachel K.; Ji, Lijuan; Feldman, Brian J.; Rabinovitch, Marlene] Stanford Univ, Sch Med, Cardiovasc Inst, Stanford, CA 94305 USA.
   [Diebold, Isabel; Hennigs, Jan K.; Miyagawa, Kazuya; Li, Caiyun G.; Nickel, Nils P.; Kaschwich, Mark; Cao, Aiqin; Wang, Lingli; Chen, Pin-I; Alcazar, Miguel A. Alejandre; Hopper, Rachel K.; Rabinovitch, Marlene] Stanford Univ, Sch Med, Vera Moulton Wall Ctr Pulm Vasc Dis, Stanford, CA 94305 USA.
   [Nakahira, Kiichi] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.
C3 Stanford University; Stanford University; Stanford University; Cornell
   University; Weill Cornell Medicine
RP Rabinovitch, M (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.
EM marlener@stanford.edu
RI Ji, Lijuan/C-4919-2012; Alejandre Alcazar, Miguel/JMC-0483-2023; li,
   caiyun/KOC-3929-2024
OI Hopper, Rachel/0000-0002-7483-2825; Alejandre Alcazar, Miguel
   Angel/0000-0002-3176-0411; Hennigs, Jan K./0000-0002-7784-8267
FU CMREF; NIH-NHLBI [R01 HL087118, R01 HL074186]; Deutsche Herzstiftung e.V
   [S/06/11]; German Research Foundation (DFG) [He 6855/1-1, Ni 1456/1-1,
   AL 1636/1-1]
FX We greatly appreciate the editorial and technical assistance of Dr.
   Michal Bental Roof and the administrative help of Ms. Michelle Fox.
   PAECs from PAH and control patients were provided by the PHBI, funded by
   the CMREF. Tissues were procured from the Transplant Procurement Centers
   at Allegheny General Hospital, Baylor College of Medicine, Cleveland
   Clinic, Stanford University, University of Alabama, and Vanderbilt
   University, and de-identified patient data were obtained from the Data
   Coordinating Center at the University of Michigan. The hypoxia
   workstation was kindly provided by Dr. A. Giaccia (Stanford). Studies
   were supported by NIH-NHLBI grants R01 HL087118 and R01 HL074186 and the
   Dunlevie Chair in Pediatric Cardiology (M.R.). I.D. was supported by
   Deutsche Herzstiftung e.V (S/06/11). J.K.H. (He 6855/1-1), N.P.N. (Ni
   1456/1-1), and M.A.A.A. (AL 1636/1-1) were supported by fellowships from
   the German Research Foundation (DFG).
CR Alastalo TP, 2011, J CLIN INVEST, V121, P3735, DOI 10.1172/JCI43382
   Aquilano K, 2013, ANTIOXID REDOX SIGN, V18, P386, DOI 10.1089/ars.2012.4615
   Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007
   Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098
   Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D
   Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008
   Burton VJ, 2011, BLOOD, V118, P4750, DOI 10.1182/blood-2011-05-347393
   Chen T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-8
   Cheng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.254
   Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871
   Culic O, 1997, AM J PHYSIOL-CELL PH, V273, pC205, DOI 10.1152/ajpcell.1997.273.1.C205
   Davies RJ, 2012, AM J PHYSIOL-LUNG C, V302, pL604, DOI 10.1152/ajplung.00309.2011
   Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059
   Diebold I, 2009, CIRC RES, V104, P1169, DOI 10.1161/CIRCRESAHA.109.196592
   Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200
   Fessel JP, 2013, AM J RESP CELL MOL, V49, P778, DOI 10.1165/rcmb.2012-0463OC
   Fijalkowska I, 2010, AM J PATHOL, V176, P1130, DOI 10.2353/ajpath.2010.090832
   Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7
   Gill SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088501
   Guignabert C, 2009, AM J PHYSIOL-LUNG C, V297, pL1082, DOI 10.1152/ajplung.00199.2009
   Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503
   Heo KS, 2011, J CELL BIOL, V193, P867, DOI 10.1083/jcb.201010051
   Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919
   Jilwan FN, 2013, CHEST, V143, P47, DOI 10.1378/chest.11-3124
   Julian MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072354
   Kim J, 2013, NAT MED, V19, P74, DOI 10.1038/nm.3040
   Kim YM, 2011, AM J PATHOL, V179, P1560, DOI 10.1016/j.ajpath.2011.05.051
   Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226
   Li M, 2011, J IMMUNOL, V187, P2711, DOI 10.4049/jimmunol.1100479
   Matuschak GM, 1998, AM J RESP CRIT CARE, V157, P629, DOI 10.1164/ajrccm.157.2.9707120
   McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f
   Michelakis ED, 2002, CIRC RES, V90, P1307, DOI 10.1161/01.RES.0000024689.07590.C2
   Michelakis ED, 2002, CIRCULATION, V105, P244, DOI 10.1161/hc0202.101974
   Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL753, DOI 10.1152/ajplung.00286.2010
   Mouraret N, 2013, CIRCULATION, V127, P1664, DOI 10.1161/CIRCULATIONAHA.113.002434
   O'Prey J, 2010, CELL CYCLE, V9, P947, DOI 10.4161/cc.9.5.10872
   Park KH, 2013, J IMMUNOL, V190, P6550, DOI 10.4049/jimmunol.1202284
   Potus F, 2014, AM J RESP CRIT CARE, V190, P318, DOI 10.1164/rccm.201402-0383OC
   RABINOVITCH M, 1981, AM J PHYSIOL, V240, pH62, DOI 10.1152/ajpheart.1981.240.1.H62
   Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818
   Ryan JJ, 2013, AM J RESP CRIT CARE, V187, P865, DOI 10.1164/rccm.201209-1687OC
   Sakao S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-95
   Sawada H, 2014, J EXP MED, V211, P263, DOI 10.1084/jem.20111741
   Sawada N, 2014, CELL METAB, V19, P246, DOI 10.1016/j.cmet.2013.12.014
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Shimasaki Y, 2013, CIRC RES, V113, P891, DOI 10.1161/CIRCRESAHA.113.301319
   Spiekerkoetter E, 2013, J CLIN INVEST, V123, P3600, DOI 10.1172/JCI65592
   Sutendra G, 2014, CELL METAB, V19, P558, DOI 10.1016/j.cmet.2014.01.004
   Sutendra G, 2011, J MOL MED, V89, P771, DOI 10.1007/s00109-011-0762-2
   Sutendra G, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001327
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Teichert-Kuliszewska K, 2006, CIRC RES, V98, P209, DOI 10.1161/01.RES.0000200180.01710.e6
   Urboniene D, 2010, AM J PHYSIOL-LUNG C, V299, pL401, DOI 10.1152/ajplung.00114.2010
   Villeneuve C, 2013, ANTIOXID REDOX SIGN, V18, P5, DOI 10.1089/ars.2011.4373
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975
   Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
NR 58
TC 170
Z9 179
U1 3
U2 35
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD APR 7
PY 2015
VL 21
IS 4
BP 596
EP 608
DI 10.1016/j.cmet.2015.03.010
PG 13
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA CF4EF
UT WOS:000352500800014
PM 25863249
OA Green Published, Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU Alston, CL
   Rocha, MC
   Lax, NZ
   Turnbull, DM
   Taylor, RW
AF Alston, Charlotte L.
   Rocha, Mariana C.
   Lax, Nichola Z.
   Turnbull, Doug M.
   Taylor, Robert W.
TI The genetics and pathology of mitochondrial disease
SO JOURNAL OF PATHOLOGY
LA English
DT Article
DE mitochondria; mitochondrial disease; mtDNA; respiratory chain
   deficiency; genetic diagnosis; muscle pathology; immunohistochemistry;
   neuropathology
ID CYTOCHROME-C-OXIDASE; COMPLEX-I DEFICIENCY; STROKE-LIKE EPISODES;
   HEREDITARY OPTIC NEUROPATHY; ATP SYNTHASE DEFICIENCY;
   KEARNS-SAYRE-SYNDROME; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; RAGGED-RED
   FIBERS; RESPIRATORY-CHAIN; LEIGH-SYNDROME
AB Mitochondria are double-membrane-bound organelles that are present in all nucleated eukaryotic cells and are responsible for the production of cellular energy in the form of ATP. Mitochondrial function is under dual genetic control-the 16.6-kb mitochondrial genome, with only 37 genes, and the nuclear genome, which encodes the remaining similar to 1300 proteins of the mitoproteome. Mitochondrial dysfunction can arise because of defects in either mitochondrial DNA or nuclear mitochondrial genes, and can present in childhood or adulthood in association with vast clinical heterogeneity, with symptoms affecting a single organ or tissue, or multisystem involvement. There is no cure for mitochondrial disease for the vast majority of mitochondrial disease patients, and a genetic diagnosis is therefore crucial for genetic counselling and recurrence risk calculation, and can impact on the clinical management of affected patients. Next-generation sequencing strategies are proving pivotal in the discovery of new disease genes and the diagnosis of clinically affected patients; mutations in > 250 genes have now been shown to cause mitochondrial disease, and the biochemical, histochemical, immunocytochemical and neuropathological characterization of these patients has led to improved diagnostic testing strategies and novel diagnostic techniques. This review focuses on the current genetic landscape associated with mitochondrial disease, before focusing on advances in studying associated mitochondrial pathology in two, clinically relevant organs-skeletal muscle and brain. (C) 2016 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
C1 [Alston, Charlotte L.; Rocha, Mariana C.; Lax, Nichola Z.; Turnbull, Doug M.; Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Newcastle University - UK
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
RI Alston, Charlotte/ABG-9602-2020; Rocha, Mariana/O-4313-2017
OI Alston, Charlotte/0000-0003-2095-5464; Turnbull,
   Doug/0000-0002-8878-9901; Rocha, Mariana/0000-0002-0056-9315
FU Wellcome Trust Strategic Award [096919/Z/11/Z]; MRC Centre for
   Neuromuscular Diseases [G0601943]; Newcastle University Centre for
   Ageing and Vitality [Biotechnology and Biological Sciences Research
   Council] [G016354/1]; Newcastle University Centre for Ageing and
   Vitality [Medical Research Council] [G016354/1]; UK NIHR Biomedical
   Research Centre in Age and Age Related Diseases award; MRC/ESPRC
   Newcastle Molecular Pathology Node; UK National Health Service Highly
   Specialised 'Rare Mitochondrial Disorders of Adults and Children'
   service; Lily Foundation; National Institute for Health Research (NIHR)
   doctoral fellowship [NIHR-HCS-D12-03-04]; MRC [MC_G0802536, G1100540,
   G0400074, G0502157, G0800674, G0900652, MR/K000608/1, MR/L016354/1,
   G0700718] Funding Source: UKRI
FX Work in our laboratories is supported by a Wellcome Trust Strategic
   Award (096919/Z/11/Z), the MRC Centre for Neuromuscular Diseases
   (G0601943), Newcastle University Centre for Ageing and Vitality
   [supported by the Biotechnology and Biological Sciences Research Council
   and Medical Research Council (G016354/1)], the UK NIHR Biomedical
   Research Centre in Age and Age Related Diseases award to the Newcastle
   upon Tyne Hospitals NHS Foundation, the MRC/ESPRC Newcastle Molecular
   Pathology Node, the UK National Health Service Highly Specialised 'Rare
   Mitochondrial Disorders of Adults and Children' service, and the Lily
   Foundation. CLA is in receipt of a National Institute for Health
   Research (NIHR) doctoral fellowship (NIHR-HCS-D12-03-04). The views
   expressed are those of the authors and not necessarily of the NHS, NIHR,
   or the Department of Health. The authors would like to thank Alexia
   Chrysostomou, Hannah Rosa and Amy Vincent for contributing images shown
   in the figures.
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Alston CL, 2016, J MED GENET, V53, P634, DOI 10.1136/jmedgenet-2015-103576
   Alston CL, 2016, AM J HUM GENET, V99, P217, DOI 10.1016/j.ajhg.2016.05.021
   Alston C, 2015, HUM GENET, V134, P869, DOI 10.1007/s00439-015-1568-z
   Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Angebault C, 2015, HUM MOL GENET, V24, P3948, DOI 10.1093/hmg/ddv133
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015
   Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871
   Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020
   Bénit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Berger I, 2008, ANN NEUROL, V63, P405, DOI 10.1002/ana.21332
   Bestwick ML, 2013, TRENDS BIOCHEM SCI, V38, P283, DOI 10.1016/j.tibs.2013.03.006
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chrysostomou A, 2016, NEUROPATH APPL NEURO, V42, P477, DOI 10.1111/nan.12282
   Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/NMETH.2481, 10.1038/nmeth.2481]
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Diodato Daria, 2014, Int J Cell Biol, V2014, P787956, DOI 10.1155/2014/787956
   Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x
   Dumoulin R, 1996, MOL CELL PROBE, V10, P389, DOI 10.1006/mcpr.1996.0053
   Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748
   EGGER J, 1981, ARCH DIS CHILD, V56, P741, DOI 10.1136/adc.56.10.741
   ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919
   Fernandez-Moreira D, 2007, ANN NEUROL, V61, P73, DOI 10.1002/ana.21036
   Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033
   Fukutani Y, 1996, J NEUROL SCI, V137, P103, DOI 10.1016/0022-510X(95)00303-J
   Gaignard P, 2013, AM J HUM GENET, V93, P384, DOI 10.1016/j.ajhg.2013.06.015
   Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562
   Gerards M, 2013, BRAIN, V136, P882, DOI 10.1093/brain/awt013
   Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   Ghosh A, 2014, HUM MOL GENET, V23, P3596, DOI 10.1093/hmg/ddu069
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   GOMORI G, 1950, AM J CLIN PATHOL, V20, P661, DOI 10.1093/ajcp/20.7_ts.661
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Hallmann K, 2016, BRAIN, V139, P338, DOI 10.1093/brain/awv357
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Hartmannová H, 2016, HUM MOL GENET, V25, P4062, DOI 10.1093/hmg/ddw245
   Hatakeyama H, 2016, STEM CELLS, V34, P801, DOI 10.1002/stem.2292
   Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0
   Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009
   Hensen EF, 2011, CLIN ENDOCRINOL, V75, P650, DOI 10.1111/j.1365-2265.2011.04097.x
   Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700
   Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007
   Hoefs SJG, 2011, EUR J HUM GENET, V19, P270, DOI 10.1038/ejhg.2010.204
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Huigsloot M, 2011, AM J HUM GENET, V88, P488, DOI 10.1016/j.ajhg.2011.03.002
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   Invernizzi F, 2013, HUM MUTAT, V34, P1619, DOI 10.1002/humu.22441
   Iommarini L, 2015, MITOCHONDRION, V22, P96, DOI 10.1016/j.mito.2015.01.008
   Jackson CB, 2014, J MED GENET, V51, P170, DOI 10.1136/jmedgenet-2013-101932
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Jain-Ghai S, 2013, AM J MED GENET A, V161A, P285, DOI 10.1002/ajmg.a.35714
   JOHNSON MA, 1983, J NEUROL SCI, V60, P31, DOI 10.1016/0022-510X(83)90125-9
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Lax NZ, 2016, NEUROPATH APPL NEURO, V42, P180, DOI 10.1111/nan.12238
   Lax NZ, 2012, ARCH NEUROL-CHICAGO, V69, P490, DOI 10.1001/archneurol.2011.2167
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Lim SC, 2014, AM J HUM GENET, V94, P209, DOI 10.1016/j.ajhg.2013.12.015
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   Lott MT, 2013, CURR PROTOC BIOINFOR, V44
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Marcu R, 2014, MOL CELL BIOL, V34, P2890, DOI 10.1128/MCB.00068-14
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Melchionda L, 2014, AM J HUM GENET, V95, P315, DOI 10.1016/j.ajhg.2014.08.003
   Metodiev MD, 2014, J MED GENET, V51, P834, DOI 10.1136/jmedgenet-2014-102532
   Miyake N, 2013, HUM MUTAT, V34, P446, DOI 10.1002/humu.22257
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Mordaunt DA, 2015, AM J MED GENET A, V167, P1330, DOI 10.1002/ajmg.a.36968
   Mori O, 2000, ACTA NEUROPATHOL, V100, P712, DOI 10.1007/s004010000209
   Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652
   Nesbitt V, 2014, EUR J HUM GENET, V22, P1255, DOI 10.1038/ejhg.2014.35
   Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002
   Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543
   Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   OLDFORS A, 1990, ACTA NEUROPATHOL, V80, P541, DOI 10.1007/BF00294616
   Ostergaard E, 2015, J MED GENET, V52, P203, DOI 10.1136/jmedgenet-2014-102914
   Ostergaard E, 2011, J MED GENET, V48, P737, DOI 10.1136/jmg.2011.088856
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pagniez-Mammeri H, 2012, MOL GENET METAB, V105, P163, DOI 10.1016/j.ymgme.2011.11.188
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033
   Peralta S, 2015, MITOCHONDRION, V23, P71, DOI 10.1016/j.mito.2015.01.007
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Phillips J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26013
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Pitceathly RDS, 2013, CELL REP, V3, P1795, DOI 10.1016/j.celrep.2013.05.005
   Prigione A, 2011, STEM CELLS, V29, P1338, DOI 10.1002/stem.683
   Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Sánchez-Caballero L, 2016, AM J HUM GENET, V99, P208, DOI 10.1016/j.ajhg.2016.05.022
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   SINGH G, 1989, NEW ENGL J MED, V320, P1300, DOI 10.1056/NEJM198905183202002
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sperl W, 2015, J INHERIT METAB DIS, V38, P391, DOI 10.1007/s10545-014-9787-3
   Spiegel R, 2011, J MED GENET, V48, P177, DOI 10.1136/jmg.2010.084608
   Spiegel R, 2009, EUR J HUM GENET, V17, P1200, DOI 10.1038/ejhg.2009.24
   Stehling O, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011312
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stroud DA, 2015, HUM MOL GENET, V24, P5404, DOI 10.1093/hmg/ddv265
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Szklarczyk R, 2013, HUM MOL GENET, V22, P656, DOI 10.1093/hmg/dds473
   Tamiya G, 2014, AM J HUM GENET, V95, P294, DOI 10.1016/j.ajhg.2014.07.013
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tanji K, 1999, J NEUROL SCI, V166, P64, DOI 10.1016/S0022-510X(99)00114-8
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Tetreault M, 2015, HUM GENET, V134, P981, DOI 10.1007/s00439-015-1577-y
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Timmers HJLM, 2009, ENDOCR-RELAT CANCER, V16, P391, DOI 10.1677/ERC-08-0284
   Torraco A, 2015, MITOCHONDRION, V21, P76, DOI 10.1016/j.mito.2015.01.009
   Triepels RH, 1999, ANN NEUROL, V45, P787, DOI 10.1002/1531-8249(199906)45:6<787::AID-ANA13>3.0.CO;2-6
   Tucker EJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004034
   Tzoulis C, 2014, ANN NEUROL, V76, P66, DOI 10.1002/ana.24185
   Ugalde C, 2007, MOL GENET METAB, V90, P10, DOI 10.1016/j.ymgme.2006.08.003
   Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   van Bon BWM, 2013, HUM MOL GENET, V22, P3138, DOI 10.1093/hmg/ddt170
   van den Bosch BJC, 2012, J MED GENET, V49, P10, DOI 10.1136/jmedgenet-2011-100466
   van Rahden VA, 2015, AM J HUM GENET, V96, P640, DOI 10.1016/j.ajhg.2015.02.002
   Vincent AE, 2016, NEUROMUSCULAR DISORD, V26, P691, DOI 10.1016/j.nmd.2016.08.004
   Wanschers BFJ, 2014, HUM MOL GENET, V23, P6356, DOI 10.1093/hmg/ddu357
   Wedatilake Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-96
   Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Wilson IJ, 2016, HUM MOL GENET, V25, P1031, DOI 10.1093/hmg/ddv626
   Wolf AR, 2014, CELL REP, V7, P918, DOI 10.1016/j.celrep.2014.03.035
   Wong LJC, 2001, AM J MED GENET, V102, P95, DOI 10.1002/1096-8628(20010722)102:1<95::AID-AJMG1412>3.0.CO;2-U
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 189
TC 284
Z9 323
U1 4
U2 121
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD JAN
PY 2017
VL 241
IS 2
BP 236
EP 250
DI 10.1002/path.4809
PG 15
WC Oncology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pathology
GA EI9RA
UT WOS:000392845200012
PM 27659608
OA Green Published, hybrid
HC Y
HP N
DA 2024-11-01
ER

PT J
AU Tzoulis, C
   Tran, GT
   Coxhead, J
   Bertelsen, B
   Lilleng, PK
   Balafkan, N
   Payne, B
   Miletic, H
   Chinnery, PF
   Bindoff, LA
AF Tzoulis, Charalampos
   Gia Tuong Tran
   Coxhead, Jonathan
   Bertelsen, Bjorn
   Lilleng, Peer K.
   Balafkan, Novin
   Payne, Brendan
   Miletic, Hrvoje
   Chinnery, Patrick F.
   Bindoff, Laurence A.
TI Molecular Pathogenesis of Polymerase Gamma-Related Neurodegeneration
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID MITOCHONDRIAL-DNA POLYMERASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   SUBSTANTIA-NIGRA NEURONS; PARKINSON-DISEASE; W748S MUTATION; RECESSIVE
   ATAXIA; DELETIONS; DISORDERS; EPILEPSY; A467T
AB Objective: Polymerase gamma (POLG) mutations are a common cause of mitochondrial disease and have also been linked to neurodegeneration and aging. We studied the molecular mechanisms underlying POLG-related neurodegeneration using postmortem tissue from a large number of patients.
   Methods: Clinical information was available from all subjects. Formalin-fixed and frozen brain tissue from 15 patients and 23 controls was studied employing a combination of histopathology, immunohistochemistry, and molecular studies of microdissected neurons.
   Results: The primary consequence of POLG mutation in neurons is mitochondrial DNA depletion. This was already present in infants with little evidence of neuronal loss or mitochondrial dysfunction. With longer disease duration, we found an additional, progressive accumulation of mitochondrial DNA deletions and point mutations accompanied by increasing numbers of complex I-deficient neurons. Progressive neurodegeneration primarily affected the cerebellar systems and dopaminergic cells of the substantia nigra. Superimposed on this chronic process were acute, focal cortical lesions that correlated with epileptogenic foci and that showed massive neuronal loss.
   Interpretation: POLG mutations appear to compromise neuronal respiration via a combination of early and stable depletion and a progressive somatic mutagenesis of the mitochondrial genome. This leads to 2 distinct but overlapping biological processes: a chronic neurodegeneration reflected clinically by progressive ataxia and cognitive impairment, and an acute focal neuronal necrosis that appears to be related to the presence of epileptic seizures. Our findings offer an explanation of the acute-on-chronic clinical course of this common mitochondrial encephalopathy.
C1 [Tzoulis, Charalampos; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Tzoulis, Charalampos; Gia Tuong Tran; Balafkan, Novin; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Coxhead, Jonathan; Payne, Brendan; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Coxhead, Jonathan] Newcastle Univ, Newcastle Biomed Res Ctr Ageing & Chron Dis, Natl Inst Hlth Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Bertelsen, Bjorn; Lilleng, Peer K.; Miletic, Hrvoje] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway.
   [Lilleng, Peer K.] Univ Bergen, Haukeland Univ Hosp, Dept Clin Med, Gade Lab Pathol, Bergen, Norway.
   [Miletic, Hrvoje] Univ Bergen, Dept Biomed, Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of
   Bergen; Newcastle University - UK; Newcastle University - UK; University
   of Bergen; Haukeland University Hospital; University of Bergen;
   Haukeland University Hospital; University of Bergen
RP Bindoff, LA (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
EM laurence.bindoff@nevro.uib.no
RI Bindoff, Nathaniel/C-8050-2011; Balafkan, Novin/AAE-9134-2019; Payne,
   Brendan/I-1233-2016; Tzoulis, Charalampos/AGD-5114-2022
OI Payne, Brendan/0000-0002-3101-3512; Chinnery,
   Patrick/0000-0002-7065-6617; Tzoulis, Charalampos/0000-0003-0341-5191;
   Balafkan, Novin/0000-0001-8868-3800; Bindoff,
   Laurence/0000-0003-0988-276X
FU Western Norway Health Trust; University of Bergen; Meltzer Foundation;
   MRC [MR/K000608/1, G0800470] Funding Source: UKRI
FX This work was supported by grants from the Western Norway Health Trust,
   University of Bergen, and Meltzer Foundation.
CR Balafkan N, 2012, MITOCHONDRION, V12, P640, DOI 10.1016/j.mito.2012.08.004
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Elstner M, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-43
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Kann O, 2011, BRAIN, V134, P345, DOI 10.1093/brain/awq333
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lascano AM, 2013, EPILEPSY RES, V105, P245, DOI 10.1016/j.eplepsyres.2012.12.010
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Palin EJH, 2013, BRAIN, V136, P2379, DOI 10.1093/brain/awt160
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Rodin E, 2005, CLIN EEG NEUROSCI, V36, P263, DOI 10.1177/155005940503600405
   Sequeira KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053204
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wiest R, 2013, J NEUROL, V260, P1601, DOI 10.1007/s00415-013-6841-2
   Zsurka G, 2008, J NEUROPATH EXP NEUR, V67, P857, DOI 10.1097/NEN.0b013e3181839b2d
NR 31
TC 62
Z9 65
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD JUL
PY 2014
VL 76
IS 1
BP 66
EP 81
DI 10.1002/ana.24185
PG 16
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AM7JQ
UT WOS:000340043200008
PM 24841123
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Borgione, E
   Lo Giudice, M
   Santa Paola, S
   Giuliano, M
   Lanza, GSP
   Cantone, M
   Ferri, R
   Scuderi, C
AF Borgione, Eugenia
   Lo Giudice, Mariangela
   Santa Paola, Sandro
   Giuliano, Marika
   Lanza, Giuseppe
   Cantone, Mariagiovanna
   Ferri, Raffaele
   Scuderi, Carmela
TI The Y831C Mutation of the <i>POLG</i> Gene in Dementia
SO BIOMEDICINES
LA English
DT Article
DE neurodegeneration; movement disorders; dementia; POLG; Y831C
ID DNA-POLYMERASE-GAMMA; MITOCHONDRIAL-DNA; NEURODEGENERATION; ALZHEIMERS;
   VARIANTS; DISEASES
AB Background: The POLG gene encodes the catalytic subunit of DNA polymerase gamma, which is crucial for mitochondrial DNA (mtDNA) repair and replication. Gene mutation alters the stability of mtDNA and is associated with several clinical presentations, such as dysarthria and ophthalmoplegia (SANDO), progressive external ophthalmoplegia (PEO), spinocerebellar ataxia and epilepsy (SCAE), Alpers syndrome, and sensory ataxic neuropathy. Recent evidence has also indicated that POLG mutations may be involved in some neurodegenerative disorders, although systematic screening is currently lacking. Methods: To investigate the frequency of POLG gene mutations in neurodegenerative disorders, we screened a group of 33 patients affected by neurodegenerative diseases, including Parkinson's disease, some atypical parkinsonisms, and dementia of different types. Results: Mutational analysis revealed the presence of the heterozygous Y831C mutation in two patients, one with frontotemporal dementia and one with Lewy body dementia. The allele frequency of this mutation reported by the 1000 Genomes Project in the healthy population is 0.22%, while in our group of patients, it was 3.03%, thus showing a statistically significant difference between the two groups. Conclusions: Our results may expand the genotype-phenotype spectrum associated with mutations in the POLG gene and strengthen the hypothesis of a pathogenic role of the Y831C mutation in neurodegeneration.
C1 [Borgione, Eugenia; Lo Giudice, Mariangela; Santa Paola, Sandro; Giuliano, Marika; Lanza, Giuseppe; Ferri, Raffaele; Scuderi, Carmela] IRCCS, Oasi Res Inst, I-94018 Troina, Italy.
   [Lanza, Giuseppe] Univ Catania, Dept Surg & Med Surg Specialties, I-95123 Catania, Italy.
   [Cantone, Mariagiovanna] Univ Hosp Policlin G Rodol San Marco, Neurol Unit, I-95123 Catania, Italy.
C3 University of Catania
RP Borgione, E (corresponding author), IRCCS, Oasi Res Inst, I-94018 Troina, Italy.
EM eborgione@oasi.en.it
RI Santa Paola, Sandro/D-4174-2017; Lo Giudice, Mariangela/D-4261-2017;
   Marika, Giuliano/JVZ-6377-2024; Cantone, Mariagiovanna/C-9392-2017;
   Ferri, Raffaele/B-5439-2013; Borgione, Eugenia/D-9168-2017; Lanza,
   Giuseppe/R-3065-2017
OI Santa Paola, Sandro/0000-0002-3310-782X; Lo Giudice,
   Mariangela/0000-0001-5961-0362; Marika, Giuliano/0000-0002-5083-1174;
   Cantone, Mariagiovanna/0000-0002-9072-4971; Ferri,
   Raffaele/0000-0001-6937-3065; Borgione, Eugenia/0000-0001-5458-7415;
   Lanza, Giuseppe/0000-0002-5659-662X
FU Italian Ministry of Health; Ricerca Corrente
FX This work was supported by a grant from the Italian Ministry of Health,
   Ricerca Corrente 2023.
CR Abeliovich A, 2016, NATURE, V539, P207, DOI 10.1038/nature20414
   Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   Barthélémy C, 2002, HUM GENET, V110, P479, DOI 10.1007/s00439-002-0708-4
   Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138
   Briston T, 2018, BIOCHEM SOC T, V46, P829, DOI 10.1042/BST20180025
   Canter RG, 2016, NATURE, V539, P187, DOI 10.1038/nature20412
   Cantone M, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.721906
   Caruso G, 2022, NUTRIENTS, V14, DOI 10.3390/nu14040819
   Da Pozzo P, 2017, NEUROL SCI, V38, P563, DOI 10.1007/s10072-016-2734-3
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Gui YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050086
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Hsieh PC, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1281
   Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164
   Kasahara T, 2017, PSYCHIAT CLIN NEUROS, V71, P518, DOI 10.1111/pcn.12496
   Kiaei M, 2013, BASIC CLIN NEUROSCI, V4, P3
   Lanza G, 2020, J INT MED RES, V48, DOI 10.1177/0300060519854626
   Lanza G, 2018, COMPLEMENT THER MED, V38, P74, DOI 10.1016/j.ctim.2018.04.013
   Lanza G, 2018, J NEUROL, V265, P968, DOI 10.1007/s00415-018-8795-x
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Ma L, 2020, INT J NEUROSCI, V130, P319, DOI 10.1080/00207454.2019.1681422
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20
   Min J., 2014, J STROKE CEREBROVASC, V1, P1021
   Muddapu VR, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00213
   Ortega-Moreno L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188978
   Russo SN, 2022, MOL GENET METAB REP, V32, DOI 10.1016/j.ymgmr.2022.100890
   Salemi M, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23031535
   Scuderi C, 2015, NEUROMUSCULAR DISORD, V25, P333, DOI 10.1016/j.nmd.2015.01.004
   Spracklen TF, 2021, CIRC-GENOM PRECIS ME, V14, DOI 10.1161/CIRCGEN.120.003138
   Stopinska K, 2006, ACTA BIOCHIM POL, V53, P591
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Woodbridge P, 2013, INTERN MED J, V43, P150, DOI 10.1111/j.1445-5994.2012.02847.x
   Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Ylönen S, 2013, J NEUROL, V260, P3144, DOI 10.1007/s00415-013-7132-7
   Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004
NR 41
TC 2
Z9 2
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9059
J9 BIOMEDICINES
JI Biomedicines
PD APR
PY 2023
VL 11
IS 4
AR 1172
DI 10.3390/biomedicines11041172
PG 11
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA E9YR2
UT WOS:000979014500001
PM 37189790
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Graziewicz, MA
   Bienstock, RJ
   Copeland, WC
AF Graziewicz, Maria A.
   Bienstock, Rachelle J.
   Copeland, William C.
TI The DNA polymerase γ Y955C disease variant associated with PEO and
   parkinsonism mediates the incorporation and translesion synthesis
   opposite 7,8-dihydro-8-oxo-2'-deoxyguanosine
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL-DNA; OXIDATIVE
   DAMAGE; SACCHAROMYCES-CEREVISIAE; REVERSE-TRANSCRIPTASE; NUCLEOTIDE
   INSERTION; AUTOSOMAL-DOMINANT; DOPAMINE NEURONS; NUCLEIC-ACIDS;
   STEADY-STATE
AB Mitochondrial DNA is replicated and repaired by DNA polymerase gamma (pol gamma), encoded by the POLG gene. The Y955C substitution in POLG leads to autosomal dominant progressive external ophthalmoplegia (PEO) with other severe phenotypes. PEO patients with this mutation can further develop parkinsonism or premature ovarian failure. Mouse and yeast models with this mutation show enhanced amounts of oxidative lesions and increased mtDNA damage. In DNA pol gamma, Tyr955 plays a critical role in catalysis and high fidelity DNA synthesis. 7,8-dihydro-8-oxo-2 '-deoxyguanosine (8-oxo-dG) is one of the most common oxidative lesions in DNA and can promote transversion mutations. Mitochondria are thought to be a major source of endogenous reactive oxygen species that can react with dG to form 8-oxo-dG as one of the more common products. DNA polymerases can mitigate mutagenesis by 8-oxo-dG through allosteric interactions from amino acid side chains, which limit the anti-conformation of the 8-oxo-dG template base during translesion DNA synthesis. Here, we show that the Y955C pol g displays relaxed discrimination when either incorporating 8-oxo-dGTP or translesion synthesis opposite 8-oxo-dG. Molecular modeling and biochemical analysis suggest that this residue, Tyr955, in conjunction with Phe961 helps attenuate the anti-conformation in human pol g for error free bypass of 8-oxo-dG and substitution to Cys allows the mutagenic syn conformation. Collectively, these results offer a biochemical link between the observed oxidative stress in model systems and parkinsonism in patients, suggesting that patients harboring the Y955C POLG mutation may undergo enhanced oxidative stress and DNA mutagenesis.
C1 Natl Inst Environm Hlth Sci, Mol Genet Lab, Natl Inst Hlth, Res Triangle Pk, NC 27709 USA.
   Natl Inst Environm Hlth Sci, Comp Sci Lab, Natl Inst Hlth, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS); National Institutes of Health
   (NIH) - USA; NIH National Institute of Environmental Health Sciences
   (NIEHS)
RP Copeland, WC (corresponding author), Natl Inst Environm Hlth Sci, Mol Genet Lab, Natl Inst Hlth, POB 12233, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI ; Copeland, William/C-4242-2019
OI Bienstock, Rachelle/0000-0001-5228-3610; Copeland,
   William/0000-0002-0359-0953
FU Intramural NIH HHS [Z01 ES065078-14] Funding Source: Medline
CR Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Beckman KB, 2000, FREE RADICAL BIO MED, V29, P357, DOI 10.1016/S0891-5849(00)00316-6
   Beckman KB, 1999, MUTAT RES-FUND MOL M, V424, P51, DOI 10.1016/S0027-5107(99)00007-X
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689
   Brieba LG, 2005, STRUCTURE, V13, P1653, DOI 10.1016/j.str.2005.07.020
   Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354
   Croteau DL, 1999, MUTAT RES-DNA REPAIR, V434, P137, DOI 10.1016/S0921-8777(99)00025-7
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   DIMAURO S, 1993, NEUROLOGY, V43, P2170, DOI 10.1212/WNL.43.11.2170
   DiMauro S, 2006, BRAIN, V129, P1637, DOI 10.1093/brain/awl169
   Doudican NA, 2005, MOL CELL BIOL, V25, P5196, DOI 10.1128/MCB.25.12.5196-5204.2005
   Fukae J, 2007, MITOCHONDRION, V7, P58, DOI 10.1016/j.mito.2006.12.002
   Furge LL, 1998, BIOCHEMISTRY-US, V37, P3567, DOI 10.1021/bi9722094
   Furge LL, 1997, BIOCHEMISTRY-US, V36, P6475, DOI 10.1021/bi9627267
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213
   Greene JG, 2005, NEUROBIOL DIS, V18, P19, DOI 10.1016/j.nbd.2004.10.003
   Hanes JW, 2006, J BIOL CHEM, V281, P36241, DOI 10.1074/jbc.M607965200
   HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659
   Karagiozova D, 2003, IMP DAM STRUCT, V1, P1
   Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Nakabeppu Y, 2006, BIOL CHEM, V387, P373, DOI 10.1515/BC.2006.050
   Nakabeppu Y, 2007, J NEUROSCI RES, V85, P919, DOI 10.1002/jnr.21191
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   O'Rourke TW, 2002, MOL CELL BIOL, V22, P4086, DOI 10.1128/MCB.22.12.4086-4093.2002
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   PAVLOV YI, 1994, BIOCHEMISTRY-US, V33, P4695, DOI 10.1021/bi00181a029
   PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   REARDON JE, 1990, J BIOL CHEM, V265, P20302
   Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606
   SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0
   Shimura-Miura H, 1999, ANN NEUROL, V46, P920, DOI 10.1002/1531-8249(199912)46:6<920::AID-ANA17>3.0.CO;2-R
   Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VYAS I, 1986, J NEUROCHEM, V46, P1501, DOI 10.1111/j.1471-4159.1986.tb01768.x
   Wang YL, 2007, BIOPHYS J, V92, P3063, DOI 10.1529/biophysj.106.092106
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Yamaguchi H, 2006, CELL DEATH DIFFER, V13, P551, DOI 10.1038/sj.cdd.4401788
   Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 68
TC 79
Z9 86
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD NOV 15
PY 2007
VL 16
IS 22
BP 2729
EP 2739
DI 10.1093/hmg/ddm227
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 227SZ
UT WOS:000250679400009
PM 17725985
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Yokoyama, T
   Hasegawa, K
   Obama, R
   Ishihara, T
   Yagishita, S
AF Yokoyama, Teruo
   Hasegawa, Kazuko
   Obama, Runko
   Ishihara, Tadayuki
   Yagishita, Saburou
TI MELAS with diffuse degeneration of the cerebral white matter: Report of
   an autopsy case
SO NEUROPATHOLOGY
LA English
DT Article
DE A3243G transition; cerebral white matter; MELAS; metabolic abnormality;
   mitochondrial angiopathy
ID STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; MITOCHONDRIAL ENCEPHALOMYOPATHY;
   POINT MUTATION; MYOPATHY; ENCEPHALOPATHY; BRAIN; DNA; FEATURES
AB Up to now diffuse white matter demyelination of the cerebrum has been reported in only a few cases of mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS). Here we document an autopsy case with this rare neuropathology. Most MELAS cases are diagnosed antemortem by A3243G transition of mitochondrial DNA. While cerebral damage including necrotic foci in the cerebral cortex are common findings in MELAS, prominent white matter involvement best characterizes this MELAS case. There were numerous necrotic foci, varying in size and chronological stage, in the cerebral white matter. In the areas of the white matter without necrotic foci, there was diffuse fibrillary gliosis with the loss of axons and oligodendrocytes. The gliosis was dominant in the deep white matter, sparing the U-fiber. The cerebral cortex showed diffuse cortical atrophy with few scattered necrotic foci. Distribution of the cerebral lesions does not coincide with the territory of blood supply. The vascular wall presented only slight to mild hyalinosis. We assumed a common pathogenesis to the cortical lesions and the white matter change. The pathogenesis of the present diffuse cerebral lesions may not be just secondary to circulatory disturbance but partly due to metabolic abnormality.
C1 [Hasegawa, Kazuko] Natl Sagamihara Hosp, Dept Neurol, Sagamihara, Kanagawa 2288522, Japan.
   [Yokoyama, Teruo; Obama, Runko; Ishihara, Tadayuki] Hakone Natl Hosp, Dept Neurol, Kanagawa, Japan.
   [Yagishita, Saburou] Kanagawa Rehabil Ctr, Div Pathol, Kanagawa, Japan.
RP Yokoyama, T (corresponding author), Natl Sagamihara Hosp, Dept Neurol, Sacradai 18-1, Sagamihara, Kanagawa 2288522, Japan.
EM teruoyokoyamamd@yahoo.co.jp
CR BOGOUSSLAVSKY J, 1982, J NEUROL SCI, V55, P351, DOI 10.1016/0022-510X(82)90132-0
   FUJII T, 1990, PEDIATR NEUROL, V6, P253, DOI 10.1016/0887-8994(90)90116-I
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Kawasaki Y, 1990, No To Shinkei, V42, P533
   KISHI M, 1988, J NEUROL SCI, V86, P31, DOI 10.1016/0022-510X(88)90005-6
   MIZUKAMI K, 1992, ACTA NEUROPATHOL, V83, P449, DOI 10.1007/BF00713541
   MUKOYAMA M, 1986, J NEUROL, V233, P228, DOI 10.1007/BF00314025
   NICOLL JAR, 1993, CLIN NEUROPATHOL, V12, P38
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Prayson RA, 1998, ARCH PATHOL LAB MED, V122, P978
   Sharfstein SR, 1999, ARCH NEUROL-CHICAGO, V56, P241, DOI 10.1001/archneur.56.2.241
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   Tanahashi C, 2000, ACTA NEUROPATHOL, V99, P31, DOI 10.1007/PL00007403
   Terauchi A, 1996, BRAIN DEV-JPN, V18, P224, DOI 10.1016/0387-7604(96)00015-0
   Tsuchiya K, 1999, ACTA NEUROPATHOL, V97, P520, DOI 10.1007/s004010051023
   Yanagihara C, 2001, INTERNAL MED, V40, P662, DOI 10.2169/internalmedicine.40.662
NR 18
TC 14
Z9 14
U1 0
U2 3
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0919-6544
J9 NEUROPATHOLOGY
JI Neuropathology
PD FEB
PY 2010
VL 30
IS 1
BP 56
EP 60
DI 10.1111/j.1440-1789.2009.01026.x
PG 5
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA 545XX
UT WOS:000273771400008
PM 19496942
DA 2024-11-01
ER

PT J
AU Tarnopolsky, MA
   Safdar, A
AF Tarnopolsky, Mark A.
   Safdar, Adeel
TI The potential benefits of creatine and conjugated linoleic acid as
   adjuncts to resistance training in older adults
SO APPLIED PHYSIOLOGY NUTRITION AND METABOLISM
LA English
DT Article; Proceedings Paper
CT Symposium on Exercise and the Endothelium
CY 2005
CL Gatineau, CANADA
SP Canadian Soc Exercise Physiol
DE sarcopenia; aging; mitochondrial dysfunction; mitochondrial DNA
   deletions; oxidative stress; dietary supplement; resistance exercise
   training
ID HUMAN SKELETAL-MUSCLE; MITOCHONDRIAL-DNA MUTATIONS; AGE-RELATED-CHANGES;
   MYOSIN HEAVY-CHAIN; BODY-COMPOSITION; OXIDATIVE STRESS; ORAL CREATINE;
   PROTEIN-SYNTHESIS; ANIMAL-MODELS; ELDERLY-MEN
AB Human aging is associated with a significant reduction in muscle mass (sarcopenia) resulting in muscle weakness and functional limitations in the elderly. Sarcopenia has been associated with mitochondrial dysfunction and the accumulation of mtDNA deletions. Resistance training increases muscle strength and size and can increase mitochondrial capacity and decrease oxidative stress in older adults. Creatine monohydrate (CrM) and conjugated linoleic acid (CLA) have biological effects that could enhance some of the beneficial effects of resistance training in older adults (i.e., up arrow fat-free mass, down arrow total body fat). We have completed two resistance-training studies with CrM alone and CrM + CLA supplementation in older adults to evaluate the independent effects of exercise and dietary supplements, as well as their interactive effects. Our studies, and several others, have found that CrM enhanced the resistance exercise mediated gains in fat-free mass and strength. More recently, we found that the addition of CLA also lead to a significant reduction of body fat after six months of resistance training in older adults. Older adults have fewer wild-type mtDNA copies and higher amounts of mtDNA deletions as compared with younger adults in mature skeletal muscle; however, these deletions are not seen in the satellite cell-derived myoblast cultures. These findings, and the fact that mtDNA deletions are lower and wildtype mtDNA copy number is higher after resistance training in older adults, suggests that activation of satellite cells secondary to resistance exercise-induced muscle damage can dilute or "shift'' the proportion of mtDNA genotype towards that of a younger adult. Recent evidence suggests that CrM supplementation in combination with strength training can enhance satellite cell activation and total myonuclei number per muscle fiber in young men. Future studies are required to determine whether the mitochondrial adaptations to resistance exercise in older adults are further enhanced with CrM supplementation and whether this is due to increased recruitment of satellite cells. It will also be important to determine whether these changes are maintained over a longer time period.
C1 [Tarnopolsky, Mark A.; Safdar, Adeel] McMaster Univ, Dept Pediat & Med, Hamilton, ON L8N 3Z5, Canada.
C3 McMaster University
RP Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Pediat & Med, HSC-2H26,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
OI Safdar, Adeel/0000-0002-7453-7770; Safdar, Adeel/0000-0003-2469-0467
CR Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x
   Antolic A, 2007, MED SCI SPORT EXER, V39, P816, DOI 10.1249/mss.0b013e318031fac4
   Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790
   BASSEY EJ, 1992, CLIN SCI, V82, P321, DOI 10.1042/cs0820321
   Becque MD, 2000, MED SCI SPORT EXER, V32, P654, DOI 10.1097/00005768-200003000-00016
   Bermon S, 1998, ACTA PHYSIOL SCAND, V164, P147, DOI 10.1046/j.1365-201X.1998.00427.x
   Berneis K, 1999, AM J PHYSIOL-ENDOC M, V276, pE188, DOI 10.1152/ajpendo.1999.276.1.E188
   Blankson H, 2000, J NUTR, V130, P2943, DOI 10.1093/jn/130.12.2943
   Brose A, 2003, J GERONTOL A-BIOL, V58, P11
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Butterfield GE, 1997, AM J PHYSIOL-ENDOC M, V272, pE94, DOI 10.1152/ajpendo.1997.272.1.E94
   Camougrand N, 2001, RESP PHYSIOL, V128, P393, DOI 10.1016/S0034-5687(01)00314-0
   Campbell WW, 1999, J APPL PHYSIOL, V86, P29, DOI 10.1152/jappl.1999.86.1.29
   Campos GER, 2002, EUR J APPL PHYSIOL, V88, P50, DOI 10.1007/s00421-002-0681-6
   Carter Jack M, 2005, J Geriatr Phys Ther, V28, P40
   Casey A, 1996, AM J PHYSIOL-ENDOC M, V271, pE31, DOI 10.1152/ajpendo.1996.271.1.E31
   Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1
   CHARETTE SL, 1991, J APPL PHYSIOL, V70, P1912, DOI 10.1152/jappl.1991.70.5.1912
   Chilibeck PD, 2005, J NUTR HEALTH AGING, V9, P352
   CHOI YC, 2000, ADV MATER, V10, P12
   Chrusch MJ, 2001, MED SCI SPORT EXER, V33, P2111, DOI 10.1097/00005768-200112000-00021
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Clevenger CM, 2002, J APPL PHYSIOL, V93, P2105, DOI 10.1152/japplphysiol.00315.2002
   Cree MG, 2004, J CLIN ENDOCR METAB, V89, P3864, DOI 10.1210/jc.2003-031986
   Dangott B, 2000, INT J SPORTS MED, V21, P13, DOI 10.1055/s-2000-8848
   Dhiman TR, 2000, J DAIRY SCI, V83, P1016, DOI 10.3168/jds.S0022-0302(00)74966-6
   Doherty TJ, 1997, J APPL PHYSIOL, V82, P93, DOI 10.1152/jappl.1997.82.1.93
   EARNEST CP, 1995, ACTA PHYSIOL SCAND, V153, P207, DOI 10.1111/j.1748-1716.1995.tb09854.x
   Eijnde BO, 2003, J APPL PHYSIOL, V95, P818, DOI 10.1152/japplphysiol.00891.2002
   Evans W J, 1998, Gerodontology, V15, P15, DOI 10.1111/j.1741-2358.1998.00015.x
   EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P147
   FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029
   FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501
   FORSBERG AM, 1991, CLIN SCI, V81, P249, DOI 10.1042/cs0810249
   Francaux M, 1999, EUR J APPL PHYSIOL O, V80, P165, DOI 10.1007/s004210050575
   Frontera WR, 2000, J APPL PHYSIOL, V88, P1321
   FRONTERA WR, 1988, J APPL PHYSIOL, V64, P1038, DOI 10.1152/jappl.1988.64.3.1038
   FUCHI T, 1989, EUR J APPL PHYSIOL, V58, P884, DOI 10.1007/BF02332223
   Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002
   Gillette-Goyonnet S, 2003, MECH AGEING DEV, V124, P311, DOI 10.1016/S0047-6374(02)00198-7
   Giresi PG, 2005, PHYSIOL GENOMICS, V21, P253, DOI 10.1152/physiolgenomics.00249.2004
   Golden TR, 2001, MECH AGEING DEV, V122, P1577, DOI 10.1016/S0047-6374(01)00288-3
   Greenlund LJS, 2003, MECH AGEING DEV, V124, P287, DOI 10.1016/S0047-6374(02)00196-3
   GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902
   GUTHMILLER P, 1994, J BIOL CHEM, V269, P17556
   HAGBERG JM, 1989, J APPL PHYSIOL, V66, P2589, DOI 10.1152/jappl.1989.66.6.2589
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARRIS RC, 1992, CLIN SCI, V83, P367, DOI 10.1042/cs0830367
   Hasten DL, 2000, AM J PHYSIOL-ENDOC M, V278, pE620, DOI 10.1152/ajpendo.2000.278.4.E620
   Hespel P, 2001, J PHYSIOL-LONDON, V536, P625, DOI 10.1111/j.1469-7793.2001.0625c.xd
   Hultman E, 1996, J APPL PHYSIOL, V81, P232
   Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x
   Jówko E, 2001, NUTRITION, V17, P558, DOI 10.1016/S0899-9007(01)00540-8
   Juhn MS, 1999, J AM DIET ASSOC, V99, P593, DOI 10.1016/S0002-8223(99)00145-5
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P41, DOI 10.1111/j.1748-1716.1990.tb08974.x
   Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568
   Kovalenko SA, 1997, BIOCHEM BIOPH RES CO, V232, P147, DOI 10.1006/bbrc.1997.6251
   Kreider RB, 1998, MED SCI SPORT EXER, V30, P73, DOI 10.1097/00005768-199801000-00011
   Kreider RB, 2002, J STRENGTH COND RES, V16, P325
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lau EMC, 2005, J GERONTOL A-BIOL, V60, P213, DOI 10.1093/gerona/60.2.213
   LAUKKANEN P, 1995, AGE AGEING, V24, P468, DOI 10.1093/ageing/24.6.468
   Lawler JM, 2002, BIOCHEM BIOPH RES CO, V290, P47, DOI 10.1006/bbrc.2001.6164
   Leveille SG, 2004, CURR OPIN RHEUMATOL, V16, P114, DOI 10.1097/00002281-200403000-00007
   Li Y, 1999, J BONE MINER RES, V14, P1153, DOI 10.1359/jbmr.1999.14.7.1153
   Louis M, 2003, MUSCLE NERVE, V27, P604, DOI 10.1002/mus.10355
   Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje
   Mahoney Douglas J, 2005, Phys Med Rehabil Clin N Am, V16, P859
   Matthews RT, 1998, J NEUROSCI, V18, P156
   Matthews RT, 1999, EXP NEUROL, V157, P142, DOI 10.1006/exnr.1999.7049
   McCartney N, 1996, J GERONTOL A-BIOL, V51, pB425, DOI 10.1093/gerona/51A.6.B425
   Mecocci P, 1999, FREE RADICAL BIO MED, V26, P303, DOI 10.1016/S0891-5849(98)00208-1
   Melov S, 2002, ANN NY ACAD SCI, V959, P330, DOI 10.1111/j.1749-6632.2002.tb02104.x
   Melov S, 2002, INT J BIOCHEM CELL B, V34, P1395, DOI 10.1016/S1357-2725(02)00086-9
   Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000465
   Melton LJ, 2000, J AM GERIATR SOC, V48, P625
   Musarò A, 1999, NATURE, V400, P581, DOI 10.1038/23060
   Olsen S, 2006, J PHYSIOL-LONDON, V573, P525, DOI 10.1113/jphysiol.2006.107359
   Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   Parise G, 2001, J APPL PHYSIOL, V91, P1041, DOI 10.1152/jappl.2001.91.3.1041
   Pariza MW, 2000, P SOC EXP BIOL MED, V223, P8, DOI 10.1046/j.1525-1373.2000.22302.x
   Park Y, 1999, LIPIDS, V34, P243, DOI 10.1007/s11745-999-0359-7
   Park Y, 1997, LIPIDS, V32, P853, DOI 10.1007/s11745-997-0109-x
   Passaquin AC, 2002, NEUROMUSCULAR DISORD, V12, P174, DOI 10.1016/S0960-8966(01)00273-5
   Payne ET, 2006, MUSCLE NERVE, V33, P66, DOI 10.1002/mus.20436
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Pinkoski C, 2006, MED SCI SPORT EXER, V38, P339, DOI 10.1249/01.mss.0000183860.42853.15
   PROVINCE MA, 1995, JAMA-J AM MED ASSOC, V273, P1341, DOI 10.1001/jama.1995.03520410035023
   Rawson ES, 1999, EUR J APPL PHYSIOL O, V80, P139, DOI 10.1007/s004210050570
   Rawson ES, 2000, INT J SPORTS MED, V21, P71
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8
   ROGERS MA, 1990, J APPL PHYSIOL, V68, P2195, DOI 10.1152/jappl.1990.68.5.2195
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Sandoval N, 1996, GENOMICS, V35, P383, DOI 10.1006/geno.1996.0373
   Sehat N, 1999, LIPIDS, V34, P407, DOI 10.1007/s11745-999-0379-3
   Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888
   Smith SA, 1998, J APPL PHYSIOL, V85, P1349, DOI 10.1152/jappl.1998.85.4.1349
   Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5<723::AID-ANA5>3.0.CO;2-W
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Tarnopolsky M, 1999, NEUROLOGY, V52, P854, DOI 10.1212/WNL.52.4.854
   Tarnopolsky MA, 2004, NEUROLOGY, V62, P1771, DOI 10.1212/01.WNL.0000125178.18862.9D
   Tarnopolsky MA, 2001, MED SCI SPORT EXER, V33, P2044, DOI 10.1097/00005768-200112000-00011
   Tarnopolsky M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000991
   Tracy BL, 1999, J APPL PHYSIOL, V86, P195, DOI 10.1152/jappl.1999.86.1.195
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   van Leemputte M, 1999, J APPL PHYSIOL, V86, P840, DOI 10.1152/jappl.1999.86.3.840
   Vandenberghe K, 1997, J APPL PHYSIOL, V83, P2055, DOI 10.1152/jappl.1997.83.6.2055
   Vincent KR, 2002, ARCH INTERN MED, V162, P673, DOI 10.1001/archinte.162.6.673
   Visonneau S, 1997, ANTICANCER RES, V17, P969
   Volek JS, 1999, MED SCI SPORT EXER, V31, P1147, DOI 10.1097/00005768-199908000-00011
   WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021
   Watkins BA, 2000, J AM COLL NUTR, V19, p478S, DOI 10.1080/07315724.2000.10718951
   Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011
   WHIPPLE RH, 1987, J AM GERIATR SOC, V35, P13, DOI 10.1111/j.1532-5415.1987.tb01313.x
   Willoughby DS, 2001, MED SCI SPORT EXER, V33, P1674, DOI 10.1097/00005768-200110000-00010
   WYSS M, 1994, MOL CELL BIOCHEM, V133, P51, DOI 10.1007/BF01267947
   Yarasheski KE, 1999, AM J PHYSIOL-ENDOC M, V277, pE118, DOI 10.1152/ajpendo.1999.277.1.E118
   Yasuda N, 2005, J APPL PHYSIOL, V99, P1085, DOI 10.1152/japplphysiol.00247.2005
   Yu LK, 2002, J AGR FOOD CHEM, V50, P4135, DOI 10.1021/jf020086a
   Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115
NR 124
TC 32
Z9 37
U1 1
U2 22
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 1715-5312
EI 1715-5320
J9 APPL PHYSIOL NUTR ME
JI Appl. Physiol. Nutr. Metab.
PD FEB
PY 2008
VL 33
IS 1
BP 213
EP 227
DI 10.1139/H07-142
PG 15
WC Nutrition & Dietetics; Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Nutrition & Dietetics; Physiology; Sport Sciences
GA 318OE
UT WOS:000257100600025
PM 18347674
DA 2024-11-01
ER

PT J
AU Huang, XP
   Bedoyan, JK
   Demirbas, D
   Harris, DJ
   Miron, A
   Edelheit, S
   Grahame, G
   DeBrosse, SD
   Wong, LJ
   Hoppel, CL
   Kerr, DS
   Anselm, I
   Berry, GT
AF Huang, Xiaoping
   Bedoyan, Jirair K.
   Demirbas, Didem
   Harris, David J.
   Miron, Alexander
   Edelheit, Simone
   Grahame, George
   DeBrosse, Suzanne D.
   Wong, Lee Jun
   Hoppel, Charles L.
   Kerr, Douglas S.
   Anselm, Irina
   Berry, Gerard T.
TI Succinyl-CoA synthetase (<i>SUCLA2</i>) deficiency in two siblings with
   impaired activity of other mitochondrial oxidative enzymes in skeletal
   muscle without mitochondrial DNA depletion
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Succinyl-CoA synthetase deficiency; Pyruvate dehydrogenase complex
   deficiency; Electron transport chain complexes; Propionyl-CoA; Liquid
   chromatography tandem mass spectrometry; SUCLA2
ID MILD METHYLMALONIC ACIDURIA; LIGASE DEFICIENCY; DEHYDROGENASE COMPLEX;
   PYRUVATE-CARBOXYLASE; BETA-SUBUNIT; ENCEPHALOMYOPATHY; MUTATION;
   FIBROBLASTS; CARNITINE; SYNTHASE
AB Mutations in SUCLA2 result in succinyl-CoA ligase (ATP-forming) or succinyl-CoA synthetase (ADP-forming) (A-SCS) deficiency, a mitochondrial tricarboxylic acid cycle disorder. The phenotype associated with this gene defect is largely encephalomyopathy. We describe two siblings compound heterozygous for SUCLA2 mutations, c.985A>G (p.M329V) and c.920C>T (p.A307V), with parents confirmed as carriers of each mutation. We developed a new LC-MS/MS based enzyme assay to demonstrate the decreased SCS activity in the siblings with this unique genotype. Both siblings shared bilateral progressive hearing loss, encephalopathy, global developmental delay, generalized myopathy, and dystonia with choreoathetosis. Prior to diagnosis and because of lactic acidosis and low activity of muscle pyruvate dehydrogenase complex (PDC), sibling 1 (S1) was placed on dichloroacetate, while sibling 2 (S2) was on a ketogenic diet. S1 developed severe cyclic vomiting refractory to therapy, while S2 developed Leigh syndrome, severe GI dysmotility, intermittent anemia, hypogammaglobulinemia and eventually succumbed to his disorder. The mitochondrial DNA contents in skeletal muscle (SM) were normal in both siblings. Pyruvate dehydrogenase complex, ketoglutarate dehydrogenase complex, and several mitochondrial electron transport chain (ETC) activities were low or at the low end of the reference range in frozen SM from S1 and/or S2. In contrast, activities of PDC, other mitochondrial enzymes of pyruvate metabolism, ETC and, integrated oxidative phosphorylation, in skin fibroblasts were not significantly impaired. Although we show that propionyl-CoA inhibits PDC, it does not appear to account for decreased PDC activity in SM. A better understanding of the mechanisms of phenotypic variability and the etiology for tissue-specific secondary deficiencies of mitochondrial enzymes of oxidative metabolism, and independently mitochondrial DNA depletion (common in other cases of A-SCS deficiency), is needed given the implications for control of lactic acidosis and possible clinical management. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Huang, Xiaoping; Demirbas, Didem; Harris, David J.; Berry, Gerard T.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA USA.
   [Bedoyan, Jirair K.; DeBrosse, Suzanne D.] Univ Hosp Cleveland, Med Ctr, Ctr Human Genet, Cleveland, OH 44106 USA.
   [Bedoyan, Jirair K.; Miron, Alexander; Edelheit, Simone; DeBrosse, Suzanne D.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.
   [Bedoyan, Jirair K.; Grahame, George; Hoppel, Charles L.; Kerr, Douglas S.] Univ Hosp Cleveland, Med Ctr, CIDEM, Cleveland, OH 44106 USA.
   [Harris, David J.; Berry, Gerard T.] Harvard Med Sch, Dept Pediat, Boston, MA USA.
   [Wong, Lee Jun] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Hoppel, Charles L.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.
   [Hoppel, Charles L.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA.
   [Anselm, Irina] Boston Childrens Hosp, Dept Neurol, Boston, MA USA.
   [Bedoyan, Jirair K.; DeBrosse, Suzanne D.; Kerr, Douglas S.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA.
C3 Harvard University; Boston Children's Hospital; University System of
   Ohio; Case Western Reserve University; Case Western Reserve University
   Hospital; University Hospitals of Cleveland; University System of Ohio;
   Case Western Reserve University; University Hospitals of Cleveland;
   University System of Ohio; Case Western Reserve University; Case Western
   Reserve University Hospital; Harvard University; Harvard Medical School;
   Baylor College of Medicine; University System of Ohio; Case Western
   Reserve University; University System of Ohio; Case Western Reserve
   University; Harvard University; Boston Children's Hospital; University
   System of Ohio; Case Western Reserve University
RP Berry, GT (corresponding author), Boston Childrens Hosp, Ctr Life Sci, Suite 14070,3 Blackfan Circle, Boston, MA 02115 USA.
EM Gerard.Berry@childrens.harvard.edu
RI Harris, David/E-1946-2011
OI Demirbas, Didem/0000-0003-2865-2708
FU Manton Center for Orphan Disease Research Gene Discovery Core, Boston
   Children's Hospital; Genomics Core Facility of the Case Western Reserve
   University (CWRU) School of Medicine's Genetics and Genome Sciences
   Department; Clinical and Translational Science Collaborative (CTSC) CWRU
   Core Utilization Pilot Grant [05496]; NIH [RDCRN 5U54NS078059-05];
   project NAMDC [7413]
FX This research was supported in part by the Manton Center for Orphan
   Disease Research Gene Discovery Core, Boston Children's Hospital and the
   Genomics Core Facility of the Case Western Reserve University (CWRU)
   School of Medicine's Genetics and Genome Sciences Department, and by
   funds from the Clinical and Translational Science Collaborative (CTSC)
   CWRU Core Utilization Pilot Grant 2014 (05496) (to JKB) and NIH RDCRN
   5U54NS078059-05 project NAMDC 7413 grant (to JKB and SDD).
CR ATKIN BM, 1979, PEDIATR RES, V13, P38, DOI 10.1203/00006450-197901000-00009
   BEHAL RH, 1993, ANNU REV NUTR, V13, P497, DOI 10.1146/annurev.nu.13.070193.002433
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Carrozzo R, 2016, J INHERIT METAB DIS, V39, P243, DOI 10.1007/s10545-015-9894-9
   CHUANG DT, 1983, BIOCHEM J, V214, P177, DOI 10.1042/bj2140177
   Coonrod EM, 2013, EXPERT REV MOL DIAGN, V13, P529, DOI 10.1586/14737159.2013.811907
   Donti TR, 2014, DIS MODEL MECH, V7, P271, DOI 10.1242/dmm.013466
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   FRIOLET R, 1994, J CLIN INVEST, V94, P1490, DOI 10.1172/JCI117488
   HOPPEL CL, 1987, J CLIN INVEST, V80, P71, DOI 10.1172/JCI113066
   Jaberi E, 2013, J HUM GENET, V58, P526, DOI 10.1038/jhg.2013.45
   Kacso G, 2016, BIOCHEM J, V473, P3463, DOI 10.1042/BCJ20160594
   Kerr D, 2012, METHODS MOL BIOL, V837, P93, DOI 10.1007/978-1-61779-504-6_7
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998
   KRAHENBUHL S, 1994, CLIN CHIM ACTA, V230, P177, DOI 10.1016/0009-8981(94)90270-4
   Lamperti C, 2012, MOL GENET METAB, V107, P403, DOI 10.1016/j.ymgme.2012.08.020
   Matilainen S, 2015, EUR J HUM GENET, V23, P325, DOI 10.1038/ejhg.2014.128
   Miller C, 2011, BBA-MOL BASIS DIS, V1812, P625, DOI 10.1016/j.bbadis.2011.01.013
   Minkler PE, 2015, MOL GENET METAB, V116, P231, DOI 10.1016/j.ymgme.2015.10.002
   Minkler PE, 2015, ANAL CHEM, V87, P8994, DOI 10.1021/acs.analchem.5b02198
   Morava E, 2009, MITOCHONDRION, V9, P438, DOI 10.1016/j.mito.2009.08.003
   Navarro-Sastre A, 2012, MOL GENET METAB, V107, P409, DOI 10.1016/j.ymgme.2012.08.018
   Nogueira C, 2015, J CHILD NEUROL, V30, P228, DOI 10.1177/0883073814527158
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Stacpoole PW, 2012, MITOCHONDRION, V12, P623, DOI 10.1016/j.mito.2012.09.005
   Van Hove JLK, 2010, PEDIATR RES, V68, P159, DOI 10.1203/00006450-201011001-00310
   Venegas Victor, 2011, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1907s68
   Ye F, 2013, ANAL BIOCHEM, V437, P52, DOI 10.1016/j.ab.2013.02.010
NR 29
TC 14
Z9 15
U1 1
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD MAR
PY 2017
VL 120
IS 3
BP 213
EP 222
DI 10.1016/j.ymgme.2016.11.005
PG 10
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA EP0ME
UT WOS:000397080600007
PM 27913098
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Palin, EJH
   Lesonen, A
   Farr, CL
   Euro, L
   Suomalainen, A
   Kaguni, LS
AF Palin, Eino J. H.
   Lesonen, Annamari
   Farr, Carol L.
   Euro, Liliya
   Suomalainen, Anu
   Kaguni, Laurie S.
TI Functional analysis of <i>H-sapiens</i> DNA polymerase γ spacer mutation
   W748S with and without common variant E1143G
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE DNA polymerase gamma; POLG; POLG1; Ataxia; MIRAS; Alpers
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; ONSET SPINOCEREBELLAR ATAXIA;
   AUTOSOMAL RECESSIVE ATAXIA; POLG MUTATIONS; ACCESSORY SUBUNIT; MTDNA
   DEPLETION; ALPERS-SYNDROME; DISEASE; TWINKLE; MITOCHONDRIA
AB Mitochondrial DNA polymerase, POLG, is the sole DNA polymerase found in animal mitochondria. In humans, POLG alpha W748S in cis with an E1143G mutation has been linked to a new type of recessive ataxia. MIRAS, which is the most common inherited ataxia in Finland. We investigated the biochemical phenotypes of the W748S amino acid change, using recombinant human POLG. We measured processive and non-processive DNA polymerase activity, DNA binding affinity, enzyme processivity, and subunit interaction with recombinant POLG beta. In addition, we studied the effects of the W748S and E1143G mutations in primary human cell cultures using retroviral transduction. Here, we examined cell viability, mitochondrial DNA copy number, and products of mitochondrial translation. Our results indicate that the W748S mutant POLGa does not exhibit a clear biochemical phenotype, making it indistinguishable from wild type POLG alpha and as such, fail to replicate previously published results. Furthermore, results from the cell models were concurrent with the findings from patients, and support our biochemical findings. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Farr, Carol L.; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
   [Farr, Carol L.; Kaguni, Laurie S.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA.
   [Palin, Eino J. H.; Lesonen, Annamari; Euro, Liliya; Suomalainen, Anu] Univ Helsinki, Biomedicum Helsinki, Res Program Mol Neurol, FIN-00290 Helsinki, Finland.
   [Suomalainen, Anu] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland.
C3 Michigan State University; Michigan State University; University of
   Helsinki; University of Helsinki; Helsinki University Central Hospital
RP Kaguni, LS (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
EM lskaguni@msu.edu
RI ; Liliya, Euro/F-3808-2015
OI Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Liliya,
   Euro/0000-0001-9705-3886
FU National Institutes of Health [GM45295]; Helsinki Biomedical Graduate
   School; Academy of Finland; Sigrid Juselius Foundation; Jane and Aatos
   Erkko Foundation; University of Helsinki
FX The authors wish to thank the Helsingin Sanomain 100 year foundation for
   E.P. to visit the LS.K. laboratory; Helsinki Biomedical Graduate School
   for A.L; the Academy of Finland, the Sigrid Juselius Foundation, and the
   Jane and Aatos Erkko Foundation, University of Helsinki (A.S.); and
   grant GM45295 from the National Institutes of Health (LS.K.).
CR Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Fan L, 1999, P NATL ACAD SCI USA, V96, P9527, DOI 10.1073/pnas.96.17.9527
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Rantamäki M, 2001, NEUROLOGY, V57, P1043, DOI 10.1212/WNL.57.6.1043
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   TIRANTI V, 1993, GENE, V126, P219, DOI 10.1016/0378-1119(93)90370-I
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wang YX, 1999, J BIOL CHEM, V274, P28972, DOI 10.1074/jbc.274.41.28972
   WERNETTE CM, 1986, J BIOL CHEM, V261, P4764
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
NR 34
TC 8
Z9 9
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 0006-3002
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD JUN
PY 2010
VL 1802
IS 6
BP 545
EP 551
DI 10.1016/j.bbadis.2010.02.003
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 605AZ
UT WOS:000278321000006
PM 20153822
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Yarham, JW
   Lamichhane, TN
   Pyle, A
   Mattijssen, S
   Baruffini, E
   Bruni, F
   Donnini, C
   Vassilev, A
   He, LP
   Blakely, EL
   Griffin, H
   Santibanez-Koref, M
   Bindoff, LA
   Ferrero, I
   Chinnery, PF
   McFarland, R
   Maraia, RJ
   Taylor, RW
AF Yarham, John W.
   Lamichhane, Tek N.
   Pyle, Angela
   Mattijssen, Sandy
   Baruffini, Enrico
   Bruni, Francesco
   Donnini, Claudia
   Vassilev, Alex
   He, Langping
   Blakely, Emma L.
   Griffin, Helen
   Santibanez-Koref, Mauro
   Bindoff, Laurence A.
   Ferrero, Ileana
   Chinnery, Patrick F.
   McFarland, Robert
   Maraia, Richard J.
   Taylor, Robert W.
TI Defective i<SUP>6</SUP>A37 Modification of Mitochondrial and Cytosolic
   tRNAs Results from Pathogenic Mutations in TRIT1 and Its Substrate tRNA
SO PLOS GENETICS
LA English
DT Article
ID STRUCTURAL ASPECTS; NUCLEAR; RECOGNITION; BIOGENESIS; MYOPATHY; ENZYME;
   GENES
AB Identifying the genetic basis for mitochondrial diseases is technically challenging given the size of the mitochondrial proteome and the heterogeneity of disease presentations. Using next-generation exome sequencing, we identified in a patient with severe combined mitochondrial respiratory chain defects and corresponding perturbation in mitochondrial protein synthesis, a homozygous p.Arg323Gln mutation in TRIT1. This gene encodes human tRNA isopentenyltransferase, which is responsible for i(6)A37 modification of the anticodon loops of a small subset of cytosolic and mitochondrial tRNAs. Deficiency of i(6)A37 was previously shown in yeast to decrease translational efficiency and fidelity in a codon-specific manner. Modelling of the p.Arg323Gln mutation on the co-crystal structure of the homologous yeast isopentenyltransferase bound to a substrate tRNA, indicates that it is one of a series of adjacent basic side chains that interact with the tRNA backbone of the anticodon stem, somewhat removed from the catalytic center. We show that patient cells bearing the p.Arg323Gln TRIT1 mutation are severely deficient in i(6)A37 in both cytosolic and mitochondrial tRNAs. Complete complementation of the i(6)A37 deficiency of both cytosolic and mitochondrial tRNAs was achieved by transduction of patient fibroblasts with wild-type TRIT1. Moreover, we show that a previously-reported pathogenic m.7480A>G mt-tRNA(Ser(UCN)) mutation in the anticodon loop sequence A36A37A38 recognised by TRIT1 causes a loss of i(6)A37 modification. These data demonstrate that deficiencies of i(6)A37 tRNA modification should be considered a potential mechanism of human disease caused by both nuclear gene and mitochondrial DNA mutations while providing insight into the structure and function of TRIT1 in the modification of cytosolic and mitochondrial tRNAs.
C1 [Yarham, John W.; Bruni, Francesco; He, Langping; Blakely, Emma L.; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Lamichhane, Tek N.; Mattijssen, Sandy; Vassilev, Alex; Maraia, Richard J.] NICHD, Intramural Res Program, NIH, Bethesda, MD USA.
   [Pyle, Angela; Griffin, Helen; Santibanez-Koref, Mauro; Chinnery, Patrick F.] Newcastle Univ, Sch Med, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Baruffini, Enrico; Donnini, Claudia; Ferrero, Ileana] Univ Parma, Dept Life Sci, I-43100 Parma, Italy.
   [Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, Bergen, Norway.
C3 Newcastle University - UK; National Institutes of Health (NIH) - USA;
   NIH Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD); Newcastle University - UK; University of Parma;
   University of Bergen; Haukeland University Hospital; University of
   Bergen
RP Yarham, JW (corresponding author), Newcastle Univ, Sch Med, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM maraiar@mail.nih.gov; robert.taylor@ncl.ac.uk
RI Mattijssen, Sandy/A-9060-2015; Bruni, Francesco/I-4074-2018; Bindoff,
   Nathaniel/C-8050-2011; Maraia, Richard/ABC-1442-2020; Baruffini,
   Enrico/C-1057-2015; Donnini, Claudia/B-5548-2015
OI Griffin, Helen R/0000-0002-5288-3322; Chinnery,
   Patrick/0000-0002-7065-6617; Vassilev, Alex/0000-0002-5483-3791;
   Baruffini, Enrico/0000-0002-8280-7849; McFarland,
   Robert/0000-0002-8833-2688; Maraia, Richard/0000-0002-5209-0066;
   Bindoff, Laurence/0000-0003-0988-276X; BRUNI,
   Francesco/0000-0001-5120-5936; Donnini, Claudia/0000-0002-4901-2358
FU Medical Research Council (UK) Centenary Early Career Award; HEFCE/DoH
   Clinical Senior Lecturer Award; Wellcome Trust Strategic Award
   [096919/Z/11/Z]; MRC Centre for Neuromuscular Diseases [G0601943]; Lily
   Foundation; UK NHS Highly Specialised "Rare Mitochondrial Disorders of
   Adults and Children" Service in Newcastle upon Tyne; Eunice Kennedy
   Shriver National Institute of Child Health and Human Development of the
   National Institutes of Health; Fondazione CARIPLO [2011/0526]; Wellcome
   Trust [096919/Z/11/Z] Funding Source: Wellcome Trust; MRC [G0601943,
   MR/K000608/1, G0800674] Funding Source: UKRI
FX This work was supported by a Medical Research Council (UK) Centenary
   Early Career Award (JWY), an HEFCE/DoH Clinical Senior Lecturer Award
   (RM), a Wellcome Trust Strategic Award (096919/Z/11/Z) (RWT and PFC),
   the MRC Centre for Neuromuscular Diseases (G0601943) (PFC, RM and RWT),
   the Lily Foundation (RM and RWT) and the UK NHS Highly Specialised "Rare
   Mitochondrial Disorders of Adults and Children" Service in Newcastle
   upon Tyne. PFC is a Wellcome Trust Senior Fellow in Clinical Science
   (101876/Z/13/Z) and a UK NIHR Senior Investigator. Work in the Maraia
   laboratory was supported by the Intramural Research Program of the
   Eunice Kennedy Shriver National Institute of Child Health and Human
   Development of the National Institutes of Health. The work performed by
   IF, EB and CD were supported by Fondazione CARIPLO grant 2011/0526. The
   funders had no role in study design, data collection and analysis,
   decision to publish or preparation of the manuscript.
CR Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110
   Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004
   Benko AL, 2000, P NATL ACAD SCI USA, V97, P61, DOI 10.1073/pnas.97.1.61
   Bidooki S, 2004, NEUROMUSCULAR DISORD, V14, P417, DOI 10.1016/j.nmd.2004.03.004
   BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609
   Bruni F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064670
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   CAPONE JP, 1985, EMBO J, V4, P213, DOI 10.1002/j.1460-2075.1985.tb02338.x
   Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918
   Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14
   GILLMAN EC, 1991, MOL CELL BIOL, V11, P2382, DOI 10.1128/MCB.11.5.2382
   Golovko A, 2000, GENE, V258, P85, DOI 10.1016/S0378-1119(00)00421-2
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790
   Kalakonda S, 2013, P NATL ACAD SCI USA, V110, pE4213, DOI 10.1073/pnas.1303760110
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Lamichhane TN, 2013, MOL CELL BIOL, V33, P4900, DOI 10.1128/MCB.01041-13
   Lamichhane TN, 2013, MOL CELL BIOL, V33, P2918, DOI 10.1128/MCB.00278-13
   Lamichhane TN, 2011, RNA, V17, P1846, DOI 10.1261/rna.2628611
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lemieux J, 2001, GENETICS, V159, P147
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301
   Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996
   McKenzie M, 2009, METHOD ENZYMOL, V456, P321, DOI 10.1016/S0076-6879(08)04418-2
   Nicholls TJ, 2013, INT J BIOCHEM CELL B, V45, P845, DOI 10.1016/j.biocel.2013.01.005
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pratt-Hyatt M, 2013, P NATL ACAD SCI USA, V110, pE3081, DOI 10.1073/pnas.1219946110
   Radichev I, 2006, J BIOL CHEM, V281, P23264, DOI 10.1074/jbc.M603873200
   Spinola M, 2005, ONCOGENE, V24, P5502, DOI 10.1038/sj.onc.1208687
   Spinola M, 2007, LUNG CANCER, V55, P271, DOI 10.1016/j.lungcan.2006.10.023
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Tolerico LH, 1999, GENETICS, V151, P57
   Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Yokogawa T, 1991, NUCLEIC ACIDS RES, V19, P6101, DOI 10.1093/nar/19.22.6101
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
   Zhou C, 2008, P NATL ACAD SCI USA, V105, P16142, DOI 10.1073/pnas.0805680105
NR 45
TC 106
Z9 112
U1 0
U2 28
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD JUN
PY 2014
VL 10
IS 6
AR e1004424
DI 10.1371/journal.pgen.1004424
PG 14
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA AL0WL
UT WOS:000338847700040
PM 24901367
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Grönlund, MA
   Honarvar, AKS
   Andersson, S
   Moslemi, AR
   Oldfors, A
   Holme, E
   Tulinius, M
   Darin, N
AF Gronlund, M. A.
   Honarvar, A. K. Seyedi
   Andersson, S.
   Moslemi, A. R.
   Oldfors, A.
   Holme, E.
   Tulinius, M.
   Darin, N.
TI Ophthalmological findings in children and young adults with genetically
   verified mitochondrial disease
SO BRITISH JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID CLINICAL SPECTRUM; LIGHT; ENCEPHALOMYOPATHIES; DEATH
AB Aim: To describe ophthalmological phenotypes in patients with mitochondrial disease and known genotypes.
   Methods: A retrospective study was performed on 59 patients (29 male, 30 female) with a mean age of 11.8 years who had mitochondrial disease with known DNA mutations. Fifty-seven of the 59 subjects underwent a detailed ophthalmological examination including visual acuity (VA), eye motility, refraction, slit-lamp examination, ophthalmoscopy and, in almost one-half of the cases, a full-field electroretinogram (ERG).
   Results: Forty-six (81%) of the patients had one or more ophthalmological findings such as ptosis (n = 16), reduced eye motility (n = 22) including severe external ophthalmoplegia (n = 9), strabismus (n = 4), nystagmus (n = 9), low VA (n = 21), refractive errors (n = 26), photophobia (n = 4), and partial or total optic atrophy (n = 25). Pigmentation in the macula and/or periphery was noted in 16 patients. In 10/27 investigated individuals with full field ERG, retinal dystrophy was recorded in six different genotypes representing Kearns-Sayre syndrome (n = 5), Leigh syndrome (n = 1), Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) (n = 1), Myoclonus epilepsy with red ragged fibres (MERRF) (n = 1), Leber hereditary optic neuropathy (n = 1) and mitochondrial myopathy (n = 1).
   Conclusion: The results show that a majority of patients with mitochondrial disorders have ophthalmological abnormalities. We recommend that an ophthalmological examination, including ERG, be performed on all children and adolescents who are suspected of having a mitochondrial disease.
C1 [Gronlund, M. A.; Honarvar, A. K. Seyedi; Andersson, S.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol Ophthalmol, Gothenburg, Sweden.
   [Moslemi, A. R.; Oldfors, A.] Sahlgrens Univ Hosp, Dept Pathol, Gothenburg, Sweden.
   [Holme, E.] Sahlgrens Univ Hosp, Dept Clin Chem, Gothenburg, Sweden.
   [Tulinius, M.; Darin, N.] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden.
C3 University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska
   University Hospital; University of Gothenburg
RP Grönlund, MA (corresponding author), Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Dept Paediat Ophthalmol, SE-41685 Gothenburg, Sweden.
EM marita.gronlund@neuro.gu.se
RI Darin, Niklas/AAL-6345-2020
FU Goteborg Medical Society; W & M Lundgrens Vetenskapsfond II; Petter
   Silfverskolds Minnesfond; Vastra Gotaland ALF
FX This study was supported by the Goteborg Medical Society, the W & M
   Lundgrens Vetenskapsfond II, the Petter Silfverskolds Minnesfond, and a
   government grant through the Vastra Gotaland ALF-agreement.
CR AMBROSIO G, 1995, DOC OPHTHALMOL, V89, P211, DOI 10.1007/BF01203374
   Andreasson S, 1997, AM J OPHTHALMOL, V124, P95
   Barron MJ, 2004, BRIT J OPHTHALMOL, V88, P286, DOI 10.1136/bjo.2003.027664
   Bristow EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P791
   Chevrollier A, 2008, ANN NEUROL, V63, P794, DOI 10.1002/ana.21385
   Cooper LL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1055
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Grönlund MA, 2006, ACTA OPHTHALMOL SCAN, V84, P169, DOI 10.1111/j.1600-0420.2005.00615.x
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lascaratos G, 2007, VISION RES, V47, P1191, DOI 10.1016/j.visres.2006.12.014
   Man CYYW, 2005, MED HYPOTHESES, V65, P1038, DOI 10.1016/j.mehy.2004.10.021
   Marmor MF, 1999, DOC OPHTHALMOL, V97, P143
   Moslemi AR, 2007, MITOCHONDRION, V7, P241, DOI 10.1016/j.mito.2007.02.002
   MULLIE MA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1825, DOI 10.1001/archopht.1985.01050120059020
   Osborne NN, 2008, J NEUROCHEM, V105, P2013, DOI 10.1111/j.1471-4159.2008.05320.x
   Osborne NN, 2006, BRIT J OPHTHALMOL, V90, P237, DOI 10.1136/bjo.2005.082230
   Phillips P, 1997, J AAPOS, V2, P115
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Skladal D, 2003, CLIN PEDIATR, V42, P703, DOI 10.1177/000992280304200806
   Spinazzi M, 2008, HUM MOL GENET, V17, P3291, DOI 10.1093/hmg/ddn225
   Staudt S, 2003, OPHTHALMOLOGE, V100, P234, DOI 10.1007/s00347-002-0662-5
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Wallace Douglas C., 1998, Biofactors, V7, P187
NR 24
TC 55
Z9 61
U1 0
U2 7
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0007-1161
EI 1468-2079
J9 BRIT J OPHTHALMOL
JI Br. J. Ophthalmol.
PD JAN
PY 2010
VL 94
IS 1
BP 121
EP 127
DI 10.1136/bjo.2008.154187
PG 7
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 544IW
UT WOS:000273650300024
PM 20385529
DA 2024-11-01
ER

PT J
AU Tomita, K
   Kuwahara, Y
   Igarashi, K
   Roudkenar, MH
   Roushandeh, AM
   Kurimasa, A
   Sato, T
AF Tomita, Kazuo
   Kuwahara, Yoshikazu
   Igarashi, Kento
   Roudkenar, Mehryar Habibi
   Roushandeh, Amaneh Mohammadi
   Kurimasa, Akihiro
   Sato, Tomoaki
TI Mitochondrial Dysfunction in Diseases, Longevity, and Treatment
   Resistance: Tuning Mitochondria Function as a Therapeutic Strategy
SO GENES
LA English
DT Review
DE mitochondria; mitochondrial DNA; clinically relevant radioresistant
   (CRR) cells; cancer radioresistance
ID CLINICALLY RELEVANT RADIORESISTANT; DNA COPY NUMBER; PROGRESSIVE
   EXTERNAL OPHTHALMOPLEGIA; PERIPHERAL-BLOOD CELLS; STROKE-LIKE-EPISODES;
   HYDROGEN-PEROXIDE; OXIDATIVE STRESS; CANCER RISK; PRONUCLEAR TRANSFER;
   RESPIRATORY-CHAIN
AB Mitochondria are very important intracellular organelles because they have various functions. They produce ATP, are involved in cell signaling and cell death, and are a major source of reactive oxygen species (ROS). Mitochondria have their own DNA (mtDNA) and mutation of mtDNA or change the mtDNA copy numbers leads to disease, cancer chemo/radioresistance and aging including longevity. In this review, we discuss the mtDNA mutation, mitochondrial disease, longevity, and importance of mitochondrial dysfunction in cancer first. In the later part, we particularly focus on the role in cancer resistance and the mitochondrial condition such as mtDNA copy number, mitochondrial membrane potential, ROS levels, and ATP production. We suggest a therapeutic strategy employing mitochondrial transplantation (mtTP) for treatment-resistant cancer.
C1 [Tomita, Kazuo; Kuwahara, Yoshikazu; Igarashi, Kento; Roudkenar, Mehryar Habibi; Roushandeh, Amaneh Mohammadi; Sato, Tomoaki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Appl Pharmacol, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima 8908544, Japan.
   [Kuwahara, Yoshikazu; Kurimasa, Akihiro] Tohoku Med & Pharmaceut Univ, Fac Med, Div Radiat Biol & Med, 1-15-1 Fukumuro, Sendai, Miyagi 9838536, Japan.
   [Roudkenar, Mehryar Habibi; Roushandeh, Amaneh Mohammadi] Guilan Univ Med Sci, Sch Med, Velayat Hosp, Burn & Regenerat Med Res Ctr, Parastar St, Rasht 4188794755, Iran.
C3 Kagoshima University; Tohoku Medical & Pharmaceutical University; Guilan
   University of Medical Sciences
RP Tomita, K (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Appl Pharmacol, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima 8908544, Japan.
EM ktomita@dent.kagoshima-u.ac.jp; y-kuwahara@tohoku-mpu.ac.jp;
   knt-igrs@dent.kagoshima-u.ac.jp; roudkenar@gums.ac.ir;
   mohammadi_roushandeh@gums.ac.ir; kurimasa@tohoku-mpu.ac.jp;
   tomsato@dent.kagoshima-u.ac.jp
RI Igarashi, Kento/JKJ-3896-2023; Roushandeh, Amaneh/AAA-2860-2021; Habibi
   Roudkenar, Mehryar/ABI-5197-2020
OI Habibi Roudkenar, Mehryar/0000-0001-8364-7245; Mohammadi Roushandeh,
   Amaneh/0000-0002-3639-2291; Tomita, Kazuo/0000-0003-1266-7948
FU JSPS KAKENHI [19K10138]; Grants-in-Aid for Scientific Research
   [19K10138] Funding Source: KAKEN
FX This research was funded by JSPS KAKENHI, grant number 19K10138.
CR Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   Callaway E, 2012, NATURE, V481, P419, DOI 10.1038/481419a
   Cardoso SA, 2004, NEUROCHEM INT, V45, P693, DOI 10.1016/j.neuint.2004.03.003
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Chang JC, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1028-z
   Chang JC, 2016, TRANSL RES, V170, P40, DOI 10.1016/j.trsl.2015.12.003
   Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Elliott RL, 2012, BREAST CANCER RES TR, V136, P347, DOI 10.1007/s10549-012-2283-2
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Emani SM, 2017, J THORAC CARDIOV SUR, V154, P286, DOI 10.1016/j.jtcvs.2017.02.018
   Forkink M, 2010, BBA-BIOENERGETICS, V1797, P1034, DOI 10.1016/j.bbabio.2010.01.022
   Fukumoto M, 2014, CANCER SCI, V105, P1351, DOI 10.1111/cas.12489
   Gao JJ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw7215
   Gao MH, 2019, MOL CELL, V73, P354, DOI 10.1016/j.molcel.2018.10.042
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Gong JS, 1998, J CLIN BIOCHEM NUTR, V24, P105
   Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9
   Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320
   Guariento A, 2020, J HEART LUNG TRANSPL, V39, P1279, DOI 10.1016/j.healun.2020.06.023
   Gupta S, 2003, INT J ONCOL, V22, P15
   Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928
   Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045
   Howell N, 2003, AM J MED GENET A, V119A, P147, DOI 10.1002/ajmg.a.20135
   Huang B, 2014, CANCER EPIDEM BIOMAR, V23, P2357, DOI 10.1158/1055-9965.EPI-14-0297
   Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature183030, 10.1038/nature18303]
   Idelchik MDS, 2017, SEMIN CANCER BIOL, V47, P57, DOI 10.1016/j.semcancer.2017.04.005
   Indo HP, 2018, FREE RADICAL BIO MED, V120, pS134, DOI 10.1016/j.freeradbiomed.2018.04.440
   Ishihara Y, 2016, J CLIN BIOCHEM NUTR, V59, P182, DOI 10.3164/jcbn.16-19
   Jabbari H, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165809
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   Kang D., 1998, MITOCHONDRIAL DNA MU, P1
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kheirandish-Rostami M, 2020, LIFE SCI, V244, DOI 10.1016/j.lfs.2020.117339
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kinnally KW, 2011, BBA-MOL CELL RES, V1813, P616, DOI 10.1016/j.bbamcr.2010.09.013
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590
   Kong Ling-hong, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P990
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kulkarni R, 2009, MUTAT RES-FUND MOL M, V663, P46, DOI 10.1016/j.mrfmmm.2009.01.004
   Kuo CC, 2017, NEUROSURGERY, V80, P475, DOI 10.1093/neuros/nyw090
   Kuwahara Y, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.56
   Kuwahara Y, 2020, TECHNOL CANCER RES T, V19, DOI 10.1177/1533033820980077
   Kuwahara Y, 2017, MED MOL MORPHOL, V50, P195, DOI 10.1007/s00795-017-0171-x
   Kuwahara Y, 2016, INT J RADIAT ONCOL, V96, P556, DOI 10.1016/j.ijrobp.2016.07.002
   Kuwahara Y, 2014, CANCER MED-US, V3, P310, DOI 10.1002/cam4.185
   Kuwahara Y, 2010, J RADIAT RES, V51, P297, DOI 10.1269/jrr.09094
   Kuwahara Y, 2009, CANCER SCI, V100, P747, DOI 10.1111/j.1349-7006.2009.01082.x
   LARSSON NG, 1995, MUSCLE NERVE, pS102
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lemnrau A, 2015, CANCER RES, V75, P2844, DOI 10.1158/0008-5472.CAN-14-1692
   Li MK, 2016, GENOME RES, V26, P417, DOI 10.1101/gr.203216.115
   Liu YQ, 2009, HYPERTENSION, V53, P1083, DOI 10.1161/HYPERTENSIONAHA.109.128702
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Lorenzoni PJ, 2014, ARQ NEURO-PSIQUIAT, V72, P803, DOI 10.1590/0004-282X20140124
   Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002
   Macmillan C, 1998, NEUROLOGY, V50, P417, DOI 10.1212/WNL.50.2.417
   McCully JD, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0095-4
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Mi J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10039
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Morita M, 2017, MOL CELL, V67, P922, DOI 10.1016/j.molcel.2017.08.013
   Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107
   Nitzan K, 2019, J ALZHEIMERS DIS, V72, P587, DOI 10.3233/JAD-190853
   Ogura A, 2009, CANCER LETT, V277, P64, DOI 10.1016/j.canlet.2008.11.021
   Otaegui D, 2004, NEUROSCI LETT, V370, P171, DOI 10.1016/j.neulet.2004.08.012
   Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2
   Pallast S, 2009, J NEUROCHEM, V111, P882, DOI 10.1111/j.1471-4159.2009.06379.x
   Park SY, 2004, J BIOL CHEM, V279, P7512, DOI 10.1074/jbc.M307677200
   Petragnano F, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00683-6
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Pourmohammadi-Bejarpasi Z, 2020, BRAIN RES BULL, V165, P70, DOI 10.1016/j.brainresbull.2020.09.018
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Qiu XX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19828-7
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769
   Rose MR, 1998, ARCH NEUROL-CHICAGO, V55, P17, DOI 10.1001/archneur.55.1.17
   Roushandeh AM, 2020, MOL BIOL REP, V47, P4401, DOI 10.1007/s11033-020-05493-5
   Roushandeh AM, 2019, CYTOTECHNOLOGY, V71, P647, DOI 10.1007/s10616-019-00302-9
   Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133
   Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Shen J, 2015, CARCINOGENESIS, V36, P1307, DOI 10.1093/carcin/bgv130
   Shen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131649
   Shin B, 2017, ADV EXP MED BIOL, V982, P595, DOI 10.1007/978-3-319-55330-6_31
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Singh KK, 2004, ANN NY ACAD SCI, V1019, P260, DOI 10.1196/annals.1297.043
   Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Sun XC, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0011-z
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Takagi K, 2004, ATHEROSCLEROSIS, V175, P281, DOI 10.1016/j.atherosclerosis.2004.03.008
   Takashi Y, 2020, FREE RADICAL BIO MED, V161, P60, DOI 10.1016/j.freeradbiomed.2020.09.027
   Takashi Y, 2018, DATA BRIEF, V20, P402, DOI 10.1016/j.dib.2018.08.025
   TAKAYANAGI R, 1980, BIOCHEM J, V192, P853, DOI 10.1042/bj1920853
   TAKESHIGE K, 1979, BIOCHEM J, V180, P129, DOI 10.1042/bj1800129
   Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8
   Tarnopolsky MA, 1998, MUSCLE NERVE, V21, P25, DOI 10.1002/(SICI)1097-4598(199801)21:1<25::AID-MUS4>3.0.CO;2-I
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tomita K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22158300
   Tomita K, 2019, BIOCHEM BIOPH RES CO, V518, P712, DOI 10.1016/j.bbrc.2019.08.117
   Tomita Kazuo, 2018, Tumour Biol, V40, p1010428318799250, DOI 10.1177/1010428318799250
   Tomita K, 2017, BIOCHEM BIOPH RES CO, V490, P330, DOI 10.1016/j.bbrc.2017.06.044
   Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   van Gisbergen MW, 2015, MUTAT RES-REV MUTAT, V764, P16, DOI 10.1016/j.mrrev.2015.01.001
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Woods DC, 2015, SEMIN REPROD MED, V33, P410, DOI 10.1055/s-0035-1567826
   Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213
   Yahata N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15871-y
   ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661
NR 125
TC 11
Z9 12
U1 2
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD SEP
PY 2021
VL 12
IS 9
AR 1348
DI 10.3390/genes12091348
PG 14
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA UV9KD
UT WOS:000699787400001
PM 34573330
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Katsuno, M
   Tanaka, F
   Adachi, H
   Banno, H
   Suzuki, K
   Watanabe, H
   Sobue, G
AF Katsuno, Masahisa
   Tanaka, Fumiaki
   Adachi, Hiroaki
   Banno, Haruhiko
   Suzuki, Keisuke
   Watanabe, Hirohisa
   Sobue, Gen
TI Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA)
SO PROGRESS IN NEUROBIOLOGY
LA English
DT Review
DE Spinal and bulbar muscular atrophy; Androgen receptor; Polyglutamine;
   Motor neuron; Neurodegeneration; Luteinizing hormone-releasing hormone
   analog; Ubiquitin-proteasome; Molecular chaperone; Autophagy; Animal
   model; Clinical trial
ID RECESSIVE BULBOSPINAL NEURONOPATHY; TRANSGENIC MOUSE MODEL; MUTANT
   ANDROGEN RECEPTOR; AMYOTROPHIC-LATERAL-SCLEROSIS; HISTONE DEACETYLASE
   INHIBITORS; ELONGATED POLYGLUTAMINE TRACT; SKELETAL-MUSCLE PATHOLOGY;
   FAST AXONAL-TRANSPORT; HEAT-SHOCK PROTEINS; CAG-REPEAT LENGTH
AB Spinal and bulbar muscular atrophy (SBMA) is a late-onset motor neuron disease characterized by slowly progressive muscle weakness and atrophy. During the last two decades, basic and clinical research has provided important insights into the disease phenotype and pathophysiology. The cause of SBMA is the expansion of a trinucleotide CAG repeat encoding a polyglutamine tract within the first exon of the androgen receptor (AR) gene. SBMA exclusively affects adult males, whereas females homozygous for the AR mutation do not manifest neurological symptoms. The ligand-dependent nuclear accumulation of the polyglutamine-expanded AR protein is central to the gender-specific pathogenesis of SBMA, although additional steps, e.g., DNA binding, inter-domain interactions, and post-translational modification of AR, modify toxicity. The interactions with co-regulators are another requisite for the toxic properties of the polyglutamine-expanded AR. It is also shown that the polyglutamine-expanded AR induces diverse molecular events, such as transcriptional dysregulation, axonal transport disruption, and mitochondrial dysfunction, which play causative roles in the neurodegeneration in SBMA. The pathogenic AR-induced myopathy also contributes to the non-cell autonomous degeneration of motor neurons. Pre-clinical studies using animal models show that the pathogenic AR-mediated neurodegeneration is suppressed by androgen inactivation, the efficacy of which has been tested in clinical trials. Pharmacological activation of cellular defense machineries, such as molecular chaperones, ubiquitin proteasome system, and autophagy, also exerts neuroprotective effects in experimental models of SBMA. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Katsuno, Masahisa; Tanaka, Fumiaki; Adachi, Hiroaki; Banno, Haruhiko; Suzuki, Keisuke; Watanabe, Hirohisa; Sobue, Gen] Nagoya Univ, Dept Neurol, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan.
   [Banno, Haruhiko] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan.
C3 Nagoya University; Nagoya University
RP Sobue, G (corresponding author), Nagoya Univ, Dept Neurol, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.
EM ka2no@med.nagoya-u.ac.jp; sobueg@med.nagoya-u.ac.jp
RI Adachi, Hiroaki/AAM-7812-2020; KATSUNO, MASAHISA/I-7502-2014; Adachi,
   Hiroaki/I-2669-2012; Banno, Haruhiko/Q-1029-2015
OI Adachi, Hiroaki/0000-0002-9302-4663; Banno,
   Haruhiko/0000-0002-0404-3839; Watanabe, Hirohisa/0000-0001-8553-8536
FU Kennedy Disease Association; Center-of-Excellence (COE) grant; Ministry
   of Education, Culture, Sports, Science, and Technology of Japan;
   Ministry of Health, Labor and Welfare of Japan; Core Research for
   Evolutional Science and Technology (CREST) from the Japan Science and
   Technology Agency (JST); Grants-in-Aid for Scientific Research
   [21229011, 24659428, 23390230, 23790986] Funding Source: KAKEN
FX This work was supported by a grant from Kennedy Disease Association, a
   Center-of-Excellence (COE) grant, a Grant-in-Aid for Scientific Research
   on Innovated Areas "Foundation of Synapse and Neurocircuit Pathology",
   and Grant-in-Aids from Ministry of Education, Culture, Sports, Science,
   and Technology of Japan; grants from the Ministry of Health, Labor and
   Welfare of Japan; and Core Research for Evolutional Science and
   Technology (CREST) from the Japan Science and Technology Agency (JST).
   There were no other funding sources, and the investigators had sole
   discretion over study design, collection, analysis, and interpretation
   of data, writing of the report, and decision to submit it for
   publication.
CR Adachi H, 2005, BRAIN, V128, P659, DOI 10.1093/brain/awh381
   Adachi H, 2003, J NEUROSCI, V23, P2203
   Adachi H, 2001, HUM MOL GENET, V10, P1039, DOI 10.1093/hmg/10.10.1039
   Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007
   Andrew SE, 1997, HUM MOL GENET, V6, P2005, DOI 10.1093/hmg/6.12.2005
   Atsuta N, 2006, BRAIN, V129, P1446, DOI 10.1093/brain/awl096
   Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515
   Banno H, 2006, ANN NEUROL, V59, P520, DOI 10.1002/ana.20735
   Banno H, 2009, ANN NEUROL, V65, P140, DOI 10.1002/ana.21540
   Battaglia F, 2003, J Clin Neuromuscul Dis, V4, P165, DOI 10.1097/00131402-200306000-00001
   Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x
   Brinkmann AO, 2001, EUR J DERMATOL, V11, P301
   Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989
   Chahin N, 2009, MUSCLE NERVE, V40, P126, DOI 10.1002/mus.21310
   CHANG CS, 1995, CRIT REV EUKAR GENE, V5, P97, DOI 10.1615/CritRevEukarGeneExpr.v5.i2.10
   Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004
   Clark Peter E, 2003, Methods Mol Med, V81, P255
   Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750
   Davis-Dao C, 2012, J CLIN ENDOCR METAB, V97, pE393, DOI 10.1210/jc.2011-2439
   Dejager S, 2002, J CLIN ENDOCR METAB, V87, P3893, DOI 10.1210/jc.87.8.3893
   DOYU M, 1992, ANN NEUROL, V32, P707, DOI 10.1002/ana.410320517
   Fernández-Rhodes LE, 2011, LANCET NEUROL, V10, P140, DOI 10.1016/S1474-4422(10)70321-5
   Finsterer J, 2010, J NEUROL SCI, V298, P1, DOI 10.1016/j.jns.2010.08.025
   Fischbeck KH, 1997, J INHERIT METAB DIS, V20, P152, DOI 10.1023/A:1005344403603
   FISCHBECK KH, 1986, NEUROLOGY, V36, P1595, DOI 10.1212/WNL.36.12.1595
   Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018
   Guidetti D, 1996, J NEUROL SCI, V135, P140, DOI 10.1016/0022-510X(95)00283-8
   Guidetti D, 2001, EUR J EPIDEMIOL, V17, P587, DOI 10.1023/A:1014580219761
   Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129
   Hama T, 2012, MUSCLE NERVE, V45, P169, DOI 10.1002/mus.22291
   Hanajima R, 2009, MOVEMENT DISORD, V24, P2063, DOI 10.1002/mds.22566
   HARDING AE, 1982, J NEUROL NEUROSUR PS, V45, P1012, DOI 10.1136/jnnp.45.11.1012
   Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144
   Heinlein CA, 2002, MOL ENDOCRINOL, V16, P2181, DOI 10.1210/me.2002-0070
   Higashihara M, 2011, MUSCLE NERVE, V44, P539, DOI 10.1002/mus.22119
   IGARASHI S, 1992, NEUROLOGY, V42, P2300, DOI 10.1212/WNL.42.12.2300
   Inoue K, 2009, EUR J NEUROL, V16, P76, DOI 10.1111/j.1468-1331.2008.02349.x
   Ishihara H, 2001, J NEUROL, V248, P856, DOI 10.1007/s004150170069
   JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341
   Jochum T, 2012, BBA-MOL BASIS DIS, V1822, P1070, DOI 10.1016/j.bbadis.2012.02.006
   Johansen JA, 2009, NEUROBIOL DIS, V34, P113, DOI 10.1016/j.nbd.2008.12.009
   KACHI T, 1992, J NEUROL NEUROSUR PS, V55, P394, DOI 10.1136/jnnp.55.5.394
   Karitzky J, 1999, ARCH NEUROL-CHICAGO, V56, P1465, DOI 10.1001/archneur.56.12.1465
   Kassubek J, 2007, J NEUROL NEUROSUR PS, V78, P1209, DOI 10.1136/jnnp.2006.112532
   Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102
   Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878
   Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6
   Katsuno M, 2006, J NEUROSCI, V26, P12106, DOI 10.1523/JNEUROSCI.3032-06.2006
   Katsuno M, 2006, EXP NEUROL, V200, P8, DOI 10.1016/j.expneurol.2006.01.021
   Katsuno M, 2010, LANCET NEUROL, V9, P875, DOI 10.1016/S1474-4422(10)70182-4
   Katsuno M, 2010, J NEUROSCI, V30, P5702, DOI 10.1523/JNEUROSCI.0388-10.2010
   Kawahara H., 1897, AICHIMEDJ, V16, P3
   Kemp MQ, 2011, HUM MOL GENET, V20, P4475, DOI 10.1093/hmg/ddr380
   KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671
   Kinirons P, 2008, J NEUROL NEUROSUR PS, V79, P106, DOI 10.1136/jnnp.2006.101899
   Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X
   Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772
   La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748
   Lafevre-Bernt MA, 2003, J BIOL CHEM, V278, P34918, DOI 10.1074/jbc.M302841200
   LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0
   Lehky TJ, 2009, MUSCLE NERVE, V40, P809, DOI 10.1002/mus.21399
   Li I, 1998, AM J PATHOL, V153, P695, DOI 10.1016/S0002-9440(10)65612-X
   Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216
   LI M, 1995, MUSCLE NERVE, V18, P301, DOI 10.1002/mus.880180306
   Li M, 2007, J BIOL CHEM, V282, P3157, DOI 10.1074/jbc.M609972200
   Lund A, 2001, EUR J HUM GENET, V9, P431, DOI 10.1038/sj.ejhg.5200656
   Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259
   Malik B, 2011, HUM MOL GENET, V20, P1776, DOI 10.1093/hmg/ddr061
   Meriggioli MN, 2003, MUSCLE NERVE, V27, P249, DOI 10.1002/mus.10295
   Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/NCHEMBIO.694, 10.1038/nchembio.694]
   Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131
   Mirowska-Guzel D, 2009, NEUROCASE, V15, P332, DOI 10.1080/13554790902842003
   Mo KG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012922
   Monks DA, 2007, P NATL ACAD SCI USA, V104, P18259, DOI 10.1073/pnas.0705501104
   Montie HL, 2011, J NEUROSCI, V31, P17425, DOI 10.1523/JNEUROSCI.3958-11.2011
   Montie HL, 2009, HUM MOL GENET, V18, P1937, DOI 10.1093/hmg/ddp115
   Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717
   Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587
   Mukherjee S, 2009, J BIOL CHEM, V284, P21296, DOI 10.1074/jbc.M109.011494
   Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215
   Nagai Y, 2010, CURR PHARM BIOTECHNO, V11, P188, DOI 10.2174/138920110790909650
   NAGASHIMA T, 1988, J NEUROL SCI, V87, P141, DOI 10.1016/0022-510X(88)90240-7
   Nedelsky NB, 2010, NEURON, V67, P936, DOI 10.1016/j.neuron.2010.08.034
   Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784
   Orr CR, 2010, J BIOL CHEM, V285, P35567, DOI 10.1074/jbc.M110.146845
   Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042
   Pachatz C, 2007, CLIN NEUROPHYSIOL, V118, P262, DOI 10.1016/j.clinph.2006.10.006
   Palazzolo I, 2008, J STEROID BIOCHEM, V108, P245, DOI 10.1016/j.jsbmb.2007.09.016
   Palazzolo I, 2007, HUM MOL GENET, V16, P1593, DOI 10.1093/hmg/ddm109
   Palazzolo I, 2009, NEURON, V63, P316, DOI 10.1016/j.neuron.2009.07.019
   Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853
   Parboosingh JS, 1997, NEUROLOGY, V49, P568, DOI 10.1212/WNL.49.2.568
   Parodi S, 2011, FRONT NEUROENDOCRIN, V32, P416, DOI 10.1016/j.yfrne.2011.06.003
   Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773
   Piccioni F, 2002, FASEB J, V16, P1418, DOI 10.1096/fj.01-1035fje
   Poletti A, 2004, FRONT NEUROENDOCRIN, V25, P1, DOI 10.1016/j.yfrne.2004.03.001
   Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123
   Ranganathan S, 2010, TRENDS PHARMACOL SCI, V31, P523, DOI 10.1016/j.tips.2010.08.005
   Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310
   Rhodes LE, 2009, BRAIN, V132, P3242, DOI 10.1093/brain/awp258
   Rocchi C, 2011, MUSCLE NERVE, V44, P737, DOI 10.1002/mus.22159
   Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3
   Rusmini P, 2011, NEUROBIOL DIS, V41, P83, DOI 10.1016/j.nbd.2010.08.023
   Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1
   Schmidt BJ, 2002, NEUROLOGY, V59, P770, DOI 10.1212/WNL.59.5.770
   Simeoni S, 2000, HUM MOL GENET, V9, P133, DOI 10.1093/hmg/9.1.133
   Sinclair R, 2007, BRIT J DERMATOL, V157, P290, DOI 10.1111/j.1365-2133.2007.08026.x
   SOBUE G, 1993, J NEUROL SCI, V117, P74, DOI 10.1016/0022-510X(93)90157-T
   SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209
   SOBUE G, 1990, ACTA NEUROPATHOL, V79, P402, DOI 10.1007/BF00308716
   Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0
   Sorarù G, 2008, J NEUROL SCI, V264, P100, DOI 10.1016/j.jns.2007.08.012
   Sperfeld AD, 2005, NEUROLOGY, V64, P753, DOI 10.1212/01.WNL.0000151978.74467.E7
   Sperfeld AD, 2002, ARCH NEUROL-CHICAGO, V59, P1921, DOI 10.1001/archneur.59.12.1921
   Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568
   Suzuki E, 2009, P NATL ACAD SCI USA, V106, P3818, DOI 10.1073/pnas.0809819106
   Suzuki K, 2008, BRAIN, V131, P229, DOI 10.1093/brain/awm289
   Suzuki K, 2010, J NEUROL NEUROSUR PS, V81, P567, DOI 10.1136/jnnp.2009.190462
   Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5
   Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9
   Tanaka F, 1996, HUM MOL GENET, V5, P1253, DOI 10.1093/hmg/5.9.1253
   Tanaka F, 1999, AM J HUM GENET, V65, P966, DOI 10.1086/302578
   Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074
   Thomas M, 2004, J BIOL CHEM, V279, P8389, DOI 10.1074/jbc.M311761200
   Tokui K, 2009, HUM MOL GENET, V18, P898, DOI 10.1093/hmg/ddn419
   Udd B, 1998, ACTA NEUROL SCAND, V98, P128
   Unrath A, 2010, HUM BRAIN MAPP, V31, P1727, DOI 10.1002/hbm.20971
   Verhovshek T, 2010, ENDOCRINOLOGY, V151, P253, DOI 10.1210/en.2009-1036
   Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298
   Wyttenbach A, 2004, J MOL NEUROSCI, V23, P69, DOI 10.1385/JMN:23:1-2:069
   Yamada M, 1997, J NEUROL SCI, V146, P183, DOI 10.1016/S0022-510X(96)00303-6
   Yang ZM, 2007, NAT MED, V13, P348, DOI 10.1038/nm1547
   Young JE, 2009, J NEUROSCI, V29, P1987, DOI 10.1523/JNEUROSCI.4072-08.2009
   Yu Z, 2006, J CLIN INVEST, V116, P2663, DOI 10.1172/JCI28773
   Yu ZG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002321
   Yu ZG, 2009, DIS MODEL MECH, V2, P500, DOI 10.1242/dmm.003301
NR 136
TC 84
Z9 92
U1 0
U2 26
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0301-0082
EI 1873-5118
J9 PROG NEUROBIOL
JI Prog. Neurobiol.
PD DEC
PY 2012
VL 99
IS 3
SI SI
BP 246
EP 256
DI 10.1016/j.pneurobio.2012.05.007
PG 11
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 052BJ
UT WOS:000312172400005
PM 22609045
DA 2024-11-01
ER

PT J
AU Viikov, K
   Jasnovidova, O
   Tamm, T
   Sedman, J
AF Viikov, Katrin
   Jasnovidova, Olga
   Tamm, Tiina
   Sedman, Juhan
TI C-Terminal Extension of the Yeast Mitochondrial DNA Polymerase
   Determines the Balance between Synthesis and Degradation
SO PLOS ONE
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; STRAND DISPLACEMENT SYNTHESIS;
   SACCHAROMYCES-CEREVISIAE; ACCESSORY SUBUNIT; GAMMA MUTATIONS;
   EXCISION-REPAIR; HUMAN-DISEASE; ACTIVE-SITE; REPLICATION; PROTEIN
AB Saccharomyces cerevisiae mitochondrial DNA polymerase (Mip1) contains a C-terminal extension (CTE) of 279 amino acid residues. The CTE is required for mitochondrial DNA maintenance in yeast but is absent in higher eukaryotes. Here we use recombinant Mip1 C-terminal deletion mutants to investigate functional importance of the CTE. We show that partial removal of the CTE in Mip1 Delta 216 results in strong preference for exonucleolytic degradation rather than DNA polymerization. This disbalance in exonuclease and polymerase activities is prominent at suboptimal dNTP concentrations and in the absence of correctly pairing nucleotide. Mip1 Delta 216 also displays reduced ability to synthesize DNA through double-stranded regions. Full removal of the CTE in Mip1 Delta 279 results in complete loss of Mip1 polymerase activity, however the mutant retains its exonuclease activity. These results allow us to propose that CTE functions as a part of Mip1 polymerase domain that stabilizes the substrate primer end at the polymerase active site, and is therefore required for efficient mitochondrial DNA replication in vivo.
C1 [Viikov, Katrin; Jasnovidova, Olga; Tamm, Tiina; Sedman, Juhan] Univ Tartu, Dept Biochem, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia.
C3 University of Tartu
RP Viikov, K (corresponding author), Univ Tartu, Dept Biochem, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.
EM jsedman@ebc.ee
RI Tamm, Tiina/D-4004-2014; Sedman, Juhan/H-1820-2011
OI Tamm, Tiina/0000-0001-9943-2097; Sedman, Juhan/0000-0003-2081-1452;
   Jasnovidova, Olga/0000-0002-8362-7647
FU Estonian Science Foundation [7013, 8845]
FX This work has been supported by grants 7013 and 8845 from Estonian
   Science Foundation http://www.etf.ee. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Andraos N, 2004, J BIOL CHEM, V279, P50609, DOI 10.1074/jbc.M408428200
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2011, MITOCHONDRION, V11, P182, DOI 10.1016/j.mito.2010.09.007
   BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0
   BLANCO L, 1989, J BIOL CHEM, V264, P8935
   Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039
   ERIKSSON S, 1995, J BIOL CHEM, V270, P18929, DOI 10.1074/jbc.270.32.18929
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103
   Foury F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027847
   GENGA A, 1986, J BIOL CHEM, V261, P9328
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Imoto S, 2008, BIOCHEMISTRY-US, V47, P4306, DOI 10.1021/bi7021427
   ITO J, 1990, NUCLEIC ACIDS RES, V18, P6716, DOI 10.1093/nar/18.22.6716
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Lucas P, 2004, MITOCHONDRION, V4, P13, DOI 10.1016/j.mito.2004.04.001
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198
   PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120
   Pérez-Arnaiz P, 2006, NUCLEIC ACIDS RES, V34, P3107, DOI 10.1093/nar/gkl402
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460
   Sedman T, 2000, MOL CELL BIOL, V20, P1816, DOI 10.1128/MCB.20.5.1816-1824.2000
   Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390
   Singh K, 2007, J BIOL CHEM, V282, P10594, DOI 10.1074/jbc.M611242200
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Viikov K, 2011, MITOCHONDRION, V11, P119, DOI 10.1016/j.mito.2010.08.007
   WERNETTE CM, 1986, J BIOL CHEM, V261, P4764
   Young MJ, 2006, YEAST, V23, P101, DOI 10.1002/yea.1344
   Zhu YL, 2003, J VIROL, V77, P10147, DOI 10.1128/JVI.77.18.10147-10153.2003
NR 42
TC 11
Z9 12
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 14
PY 2012
VL 7
IS 3
AR e33482
DI 10.1371/journal.pone.0033482
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 931EO
UT WOS:000303198600071
PM 22432028
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Katayama, Y
   Maeda, K
   Iizuka, T
   Hayashi, M
   Hashizume, Y
   Sanada, M
   Kawai, H
   Kashiwagi, A
AF Katayama, Yuri
   Maeda, Kengo
   Iizuka, Takahiro
   Hayashi, Masaharu
   Hashizume, Yoshio
   Sanada, Mitsuru
   Kawai, Hiromichi
   Kashiwagi, Atsunori
TI Accumulation of oxidative stress around the stroke-like lesions of MELAS
   patients
SO MITOCHONDRION
LA English
DT Article
DE MELAS; Stroke-like episode; Oxidative stress; Edaravone; 8-hydroxy-2
   '-deoxyguanosine; Manganese superoxide dismutase
ID FREE-RADICAL SCAVENGER; AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSIENT
   CEREBRAL-ISCHEMIA; MITOCHONDRIAL-DNA; LACTIC-ACIDOSIS; EPISODES MELAS;
   L-ARGININE; SUPEROXIDE DISMUTASES; REDUCTASE DEFICIENCY; ANTIOXIDANT
   ENZYMES
AB To investigate the relationship between oxidative stress and progressive spread of the stroke-like lesions in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) with 3243A>G mutation, we retrospectively analyzed the spread frequency in patients with and without treatment with the radical scavenger edaravone. Oxidative damage and defensive enzymes were histologically evaluated. Spread was significantly less frequent in the patients treated with edaravone. Although 8-hydroxy-2'-deoxyguanosine, a marker for oxidative damage of DNA, was obviously accumulated in peri-lesional surviving neurons, manganese superoxide dismutase and 8-oxoguanine glycosylase 1 were not up-regulated in those neurons. Increased oxidative stress and insufficient defense could be involved in the pathogenesis of the spreading lesions in MELAS. (C) 2009 Elsevier B. V. and Mitochondria Research Society. All rights reserved.
C1 [Katayama, Yuri; Maeda, Kengo; Sanada, Mitsuru; Kawai, Hiromichi] Shiga Univ Med Sci, Dept Internal Med, Div Neurol, Shiga 5202192, Japan.
   [Iizuka, Takahiro] Kitasato Univ, Sch Med, Dept Neurol, Kanagawa 2288555, Japan.
   [Hayashi, Masaharu] Tokyo Metropolitan Inst Neurosci, Dept Clin Neuropathol, Tokyo 1838526, Japan.
   [Hashizume, Yoshio] Aichi Med Univ, Inst Med Sci Aging, Aichi 4801195, Japan.
   [Kashiwagi, Atsunori] Shiga Univ Med Sci, Dept Internal Med, Div Endocrinol & Metab, Shiga 5202192, Japan.
C3 Shiga University of Medical Science; Kitasato University; Tokyo
   Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of
   Medical Science; Aichi Medical University; Shiga University of Medical
   Science
RP Maeda, K (corresponding author), Shiga Hosp, Dept Neurol, Natl Hosp Org, 255 Gochi, Shiga 5278505, Japan.
EM iky05@shiga-hp.jp
RI Kashiwagi, Atsunori/H-8712-2019
OI Iizuka, Takahiro/0000-0002-7234-0720
CR ABE K, 1988, STROKE, V19, P480, DOI 10.1161/01.STR.19.4.480
   Aguirre N, 2005, FREE RADICAL RES, V39, P383, DOI 10.1080/10715760400027979
   Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x
   Candelario-Jalil E, 2001, NEUROSCI RES, V41, P233, DOI 10.1016/S0168-0102(01)00282-6
   Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Clark JM, 1996, NEUROLOGY, V46, P223, DOI 10.1212/WNL.46.1.223
   COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908
   Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003
   DiMauro S, 2004, ANN NY ACAD SCI, V1011, P232, DOI 10.1196/annals.1293.023
   DiMauro S, 2000, NEUROL SCI, V21, pS901
   DiMauro S, 2007, BIOSCIENCE REP, V27, P125, DOI 10.1007/s10540-007-9041-4
   DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598
   Ferrante RJ, 1997, J NEUROCHEM, V69, P2064
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Folkerth RD, 2004, J NEUROPATH EXP NEUR, V63, P990, DOI 10.1093/jnen/63.9.990
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hersch SM, 2006, NEUROLOGY, V66, P250, DOI 10.1212/01.wnl.0000194318.74946.b6
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   ICHIKI T, 1988, ANN NEUROL, V23, P287, DOI 10.1002/ana.410230312
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Iizuka T, 2007, J NEUROL SCI, V257, P126, DOI 10.1016/j.jns.2007.01.040
   Jarrett SG, 2008, NEUROBIOL DIS, V30, P130, DOI 10.1016/j.nbd.2007.12.009
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kawai H, 1997, J PHARMACOL EXP THER, V281, P921
   Kim GW, 2002, STROKE, V33, P809, DOI 10.1161/hs0302.103745
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   KOBAYASHI M, 1987, J PEDIATR-US, V110, P223, DOI 10.1016/S0022-3476(87)80158-0
   KOBAYASHI M, 1986, J INHERIT METAB DIS, V9, P301, DOI 10.1007/BF01799670
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Kovács R, 2002, J NEUROPHYSIOL, V88, P2909, DOI 10.1152/jn.00149.2002
   Liang LP, 2004, FREE RADICAL BIO MED, V36, P542, DOI 10.1016/j.freeradbiomed.2003.11.029
   Liang LP, 2000, NEUROSCIENCE, V101, P563, DOI 10.1016/S0306-4522(00)00397-3
   MAEDA K, 2005, CLIN NEUROL, V45, P416
   Mecocci P, 1997, MOL CHEM NEUROPATHOL, V31, P53, DOI 10.1007/BF02815160
   Morgan-Hughes JA, 1999, BBA-BIOENERGETICS, V1410, P125, DOI 10.1016/S0005-2728(98)00162-5
   Nagayama T, 2000, J NEUROCHEM, V75, P1716, DOI 10.1046/j.1471-4159.2000.0751716.x
   NISHI H, 1989, STROKE, V20, P1236, DOI 10.1161/01.STR.20.9.1236
   Nunomura A, 1999, J NEUROSCI, V19, P1959
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Ohtaki H, 2007, NEUROSCI RES, V58, P349, DOI 10.1016/j.neures.2007.04.005
   Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318
   Pang CY, 2001, DIABETES RES CLIN PR, V54, pS45, DOI 10.1016/S0168-8227(01)00335-7
   Patel M, 2004, FREE RADICAL BIO MED, V37, P1951, DOI 10.1016/j.freeradbiomed.2004.08.021
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rusanen H, 2000, BBA-MOL BASIS DIS, V1500, P10, DOI 10.1016/S0925-4439(99)00081-2
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   Sandhu JK, 2005, BIOCHEM J, V391, P191, DOI 10.1042/BJ20050272
   Sato S, 2005, NEUROLOGY, V64, P1081, DOI 10.1212/01.WNL.0000154597.24838.6B
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Seki S, 2003, HISTOPATHOLOGY, V42, P365, DOI 10.1046/j.1365-2559.2003.01599.x
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Sugimoto K, 1997, DIABETOLOGIA, V40, P1380, DOI 10.1007/s001250050839
   Takamatsu Y., 1997, JPN PHARM THER S, V25, ps1793
   Tanahashi C, 2000, ACTA NEUROPATHOL, V99, P31, DOI 10.1007/PL00007403
   Terauchi A, 1996, BRAIN DEV-JPN, V18, P224, DOI 10.1016/0387-7604(96)00015-0
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   Vladimirova O, 1998, MULT SCLER, V4, P413, DOI 10.1177/135245859800400503
   Wang A.L., 2008, NEUROBIOL AGING
   WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597
   WATANABE T, 1994, J PHARMACOL EXP THER, V271, P1624
   Wei YH, 2001, CHINESE J PHYSIOL, V44, P1
   Yamamoto T, 1997, BRAIN RES, V762, P240, DOI 10.1016/S0006-8993(97)00490-3
   Yamamoto Y, 1996, REDOX REP, V2, P333, DOI 10.1080/13510002.1996.11747069
   Yoneda M, 1999, NEUROLOGY, V53, P2182, DOI 10.1212/WNL.53.9.2182
   Yoshida H, 2006, CNS DRUG REV, V12, P9, DOI 10.1111/j.1527-3458.2006.00009.x
   Zhang N, 2005, STROKE, V36, P2220, DOI 10.1161/01.STR.0000182241.07096.06
NR 75
TC 29
Z9 35
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP
PY 2009
VL 9
IS 5
BP 306
EP 313
DI 10.1016/j.mito.2009.04.002
PG 8
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 541LC
UT WOS:000273416200003
PM 19393775
DA 2024-11-01
ER

PT J
AU Christensen, ER
   Stegger, M
   Jensen-Fangel, S
   Laursen, AL
   Ostergaard, L
AF Christensen, ER
   Stegger, M
   Jensen-Fangel, S
   Laursen, AL
   Ostergaard, L
TI Mitochondrial DNA levels in fat and blood cells from patients with
   lipodystrophy or peripheral neuropathy and the effect of 90 days of
   high-dose coenzyme Q treatment: A randomized, double-blind,
   placebo-controlled pilot study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
ID REVERSE-TRANSCRIPTASE INHIBITORS; SUBCUTANEOUS FAT; NUCLEOSIDE;
   TOXICITY; THERAPY; INFECTION; MYOPATHY; DEPLETION; DISORDER; DAMAGE
AB Background. Mitochondrial toxicity can be induced by reverse-transcriptase inhibitors, and an association between levels of mitochondrial DNA (mtDNA) per cell and lipodystrophy, peripheral neuropathy, and HIV infection per se has been suggested. Studies aimed at increasing the oxidative capacity in HIV-infected patients have been sparse.
   Methods. Levels of mtDNA in fat and peripheral blood mononuclear cells (PBMCs) from 25 HIV infected patients and 10 healthy control subjects were studied with real-time PCR analysis. A placebo-controlled and doubleblind design was used to assign individuals to receive either 100 mg of coenzyme Q twice daily for 3 months or a matching placebo regimen. Levels of mtDNA and other parameters were assessed before and after the intervention period.
   Results. The mean number of mtDNA copies per cell was lower in fat tissue obtained from patients with peripheral neuropathy (1547 mtDNA copies/cell; P = .045), patients with lipodystrophy (1732 mtDNA copies/cell; P = .003) and in HIV patients with no complications associated with highly active antiretroviral therapy (2935 mtDNA copies/cell; P = .078), compared with healthy control subjects (6198 mtDNA copies/cell). No clear difference was seen in mtDNA content in PBMCs. Coenzyme Q therapy improved the general condition of patients (P = .005) and caused a reversible increase in peripheral neuropathy pain (P = .048). Compared with placebo, treatment with coenzyme Q did not result in changes in mtDNA levels in fat cells or in PBMCs after the treatment period.
   Conclusions. Levels of mtDNA in fat tissue, but not in PBMCs, were associated with peripheral neuropathy and lipodystrophy. High-dose coenzyme Q therapy increased well-being in asymptomatic HIV-infected patients and those with lipodystrophy, as well as in control subjects, but aggravated pain in patients with peripheral neuropathy.
C1 Aarhus Univ Hosp, Skejby Sygehus, Dept Infect Dis, Res Unit Q, DK-8200 Aarhus N, Denmark.
C3 Aarhus University
RP Aarhus Univ Hosp, Skejby Sygehus, Dept Infect Dis, Res Unit Q, DK-8200 Aarhus N, Denmark.
EM eva.rabing@studmed.au.dk
RI Ostergaard, Lars/AAA-3020-2020
OI Laursen, Alex Lund/0000-0002-1206-156X; Stegger,
   Marc/0000-0003-0321-1180; Ostergaard, Lars/0000-0003-2459-0511;
   Ostergaard, Lars/0000-0002-7619-605X
CR Belloso WH, 2003, JAIDS-J ACQ IMM DEF, V32, P104, DOI 10.1097/00126334-200301010-00015
   Benbrik E, 1997, J NEUROL SCI, V149, P19, DOI 10.1016/S0022-510X(97)05376-8
   Bril V, 2002, DIABETIC MED, V19, P661, DOI 10.1046/j.1464-5491.2002.00759.x
   Brinkman K, 1999, LANCET, V354, P1112, DOI 10.1016/S0140-6736(99)06102-4
   Carter V M, 2001, HIV Med, V2, P174, DOI 10.1046/j.1468-1293.2001.00073.x
   Chariot P, 1999, J HEPATOL, V30, P156, DOI 10.1016/S0168-8278(99)80020-8
   Cherry CL, 2002, J ACQ IMMUN DEF SYND, V30, P271, DOI [10.1097/00126334-200207010-00002, 10.1097/01.QAI.0000017962.22053.0E]
   Dalakas MC, 2001, J PERIPHER NERV SYST, V6, P14, DOI 10.1046/j.1529-8027.2001.006001014.x
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   GALLI M, 2003, PROGR ABSTR 40 INT C
   Goto M, 2003, J MED VIROL, V70, P497, DOI 10.1002/jmv.10423
   Kakuda TN, 1999, AIDS, V13, P2311, DOI 10.1097/00002030-199911120-00019
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   Mallal SA, 2000, AIDS, V14, P1309, DOI 10.1097/00002030-200007070-00002
   Masini A, 1999, J NEUROL SCI, V166, P131, DOI 10.1016/S0022-510X(99)00126-4
   Miller Alan L, 2003, Altern Med Rev, V8, P7
   Moyle G, 2000, CLIN THER, V22, P911, DOI 10.1016/S0149-2918(00)80064-8
   Nolan D, 2003, AIDS, V17, P1329, DOI 10.1097/00002030-200306130-00007
   Polo R, 2003, JAIDS-J ACQ IMM DEF, V34, P32, DOI 10.1097/00126334-200309010-00004
   Saint-Marc T, 1999, AIDS, V13, P1659, DOI 10.1097/00002030-199909100-00009
   Shikuma CM, 2001, AIDS, V15, P1801, DOI 10.1097/00002030-200109280-00009
   SIMPSON DM, 1995, J ACQ IMMUN DEF SYND, V9, P153
   van der Valk M, 2001, AIDS, V15, P847, DOI 10.1097/00002030-200105040-00005
   Vittecoq D, 2002, JAIDS, V31, P299, DOI 10.1097/00126334-200211010-00005
   Walker UA, 2002, AIDS, V16, P2165, DOI 10.1097/00002030-200211080-00009
   Walker Ulrich A, 2003, J HIV Ther, V8, P32
   White AJ, 2001, SEX TRANSM INFECT, V77, P158, DOI 10.1136/sti.77.3.158
NR 27
TC 23
Z9 25
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 1
PY 2004
VL 39
IS 9
BP 1371
EP 1379
DI 10.1086/424881
PG 9
WC Immunology; Infectious Diseases; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases; Microbiology
GA 904JG
UT WOS:000227491800014
PM 15494915
OA Bronze
DA 2024-11-01
ER

PT J
AU Lax, NZ
   Whittaker, RG
   Hepplewhite, PD
   Reeve, AK
   Blakely, EL
   Jaros, E
   Ince, PG
   Taylor, RW
   Fawcett, PRW
   Turnbull, DM
AF Lax, Nichola Z.
   Whittaker, Roger G.
   Hepplewhite, Philippa D.
   Reeve, Amy K.
   Blakely, Emma L.
   Jaros, Evelyn
   Ince, Paul G.
   Taylor, Robert W.
   Fawcett, Peter R. W.
   Turnbull, Doug M.
TI Sensory neuronopathy in patients harbouring recessive polymerase γ
   mutations
SO BRAIN
LA English
DT Article
DE polymerase gamma; mitochondrial DNA; sensory neuronopathy;
   neurodegeneration
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL-DNA DELETIONS;
   REAL-TIME PCR; POLG MUTATIONS; ATAXIC NEUROPATHY; OPHTHALMOPARESIS
   SANDO; INDIVIDUAL CELLS; DISEASE; GENE; INVOLVEMENT
AB Defects in the mitochondrial DNA replication enzyme, polymerase gamma, are an important cause of mitochondrial disease with similar to 25% of all adult diagnoses attributed to mutations in the POLG gene. Peripheral neuronopathy is often part of the clinical syndrome and can represent the most disabling feature. In spite of this, the molecular mechanisms underlying the neuronopathy remain to be elucidated and treatment strategies are limited. In the present study, we use a combined approach comprising clinical, electrophysiological, neuropathological and molecular genetic investigations to unravel the mechanisms underpinning peripheral neuronopathy in autosomal recessive polymerase gamma-related disease. Electrophysiological assessments documented a dorsal root ganglionopathy in all 11 cases. Of the 11 cases, eight also showed changes consistent with motor fibre loss. Detailed neuropathological investigation of two patients confirmed the electrophysiological findings, revealing atrophy of posterior columns and striking neuronal cell loss from the dorsal root ganglia, which was accompanied by severe mitochondrial biochemical abnormalities involving respiratory chain complexes I and IV due to clonally-expanded mitochondrial DNA deletions and a significant reduction in mitochondrial DNA copy number in affected neurons. We propose that the respiratory chain defects, secondary to mitochondrial DNA deletion and depletion, are likely to be responsible for pathology observed in the dorsal root ganglion and the sensory ganglionopathy documented electrophysiologically.
C1 [Turnbull, Doug M.] Newcastle Univ, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Lax, Nichola Z.; Reeve, Amy K.; Turnbull, Doug M.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Univ Ctr Brain Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Whittaker, Roger G.; Fawcett, Peter R. W.] Royal Victoria Infirm, Dept Clin Neurophysiol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Jaros, Evelyn] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Ince, Paul G.] Univ Sheffield, Sheffield Inst Translat Neurosci, Dept Neurosci, Sheffield S10 2HQ, S Yorkshire, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle
   University - UK; Newcastle University - UK; University of Sheffield
RP Turnbull, DM (corresponding author), Newcastle Univ, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@newcastle.ac.uk
RI Ince, Paul/A-5064-2009
OI Reeve, Amy/0000-0002-4474-2204; Turnbull, Doug/0000-0002-8878-9901;
   Whittaker, Roger/0000-0002-3403-0182
FU UK Medical Research Council [G0400074]; Wellcome Trust [074454/Z/04/Z];
   BBSRC; EPSRC; ESRC; MRC as part of the cross-council Lifelong Health and
   Wellbeing Initiative [G0700718]; UK NIHR Biomedical Research Centre for
   Ageing; UK NHS; MRC [G0502157, G0900652, G0700718, G0400074, G1100540]
   Funding Source: UKRI
FX Tissue for this study was provided by the Newcastle Brain Tissue
   Resource, which is funded in part by a grant from the UK Medical
   Research Council (G0400074). This work was supported by The Wellcome
   Trust (074454/Z/04/Z); the Newcastle University Centre for Brain Ageing
   and Vitality supported by BBSRC, EPSRC, ESRC and MRC as part of the
   cross-council Lifelong Health and Wellbeing Initiative (G0700718); UK
   NIHR Biomedical Research Centre for Ageing and Age-related disease award
   to the Newcastle upon Tyne Hospitals NHS Foundation Trust; the UK NHS
   Specialist Commissioners, which funds the 'Rare Mitochondrial Disorders
   of Adults and Children' Diagnostic Service in Newcastle upon Tyne
   (http://www.mitochondrialncg.nhs.uk).
CR Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Cottrell DA, 2000, J NEUROPATH EXP NEUR, V59, P621, DOI 10.1093/jnen/59.7.621
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Hopkins SE, 2010, J CHILD NEUROL, V25, P752, DOI 10.1177/0883073809343313
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   McHugh JC, 2010, MUSCLE NERVE, V41, P265, DOI 10.1002/mus.21494
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Rantamäki M, 2001, NEUROLOGY, V57, P1043, DOI 10.1212/WNL.57.6.1043
   Schicks J, 2010, MOVEMENT DISORD, V25, P2678, DOI 10.1002/mds.23286
   Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Stricker S, 2009, J NEUROL NEUROSUR PS, V80, P1181, DOI 10.1136/jnnp.2008.166066
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 26
TC 54
Z9 56
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
J9 BRAIN
JI Brain
PD JAN
PY 2012
VL 135
BP 62
EP 71
DI 10.1093/brain/awr326
PN 1
PG 10
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 888ZX
UT WOS:000300044400015
PM 22189570
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Amato, P
   Tachibana, M
   Sparman, M
   Mitalipov, S
AF Amato, Paula
   Tachibana, Masahito
   Sparman, Michelle
   Mitalipov, Shoukhrat
TI Three-parent in vitro fertilization: gene replacement for the prevention
   of inherited mitochondrial diseases
SO FERTILITY AND STERILITY
LA English
DT Article
DE Mitochondria; nuclear transfer; gene replacement
ID DIAGNOSIS; OOCYTES; MTDNA; SEGREGATION; DISORDERS; MUTATION; EMBRYOS
AB The exchange of nuclear genetic material between oocytes and embryos offers a novel reproductive option for the prevention of inherited mitochondrial diseases. Mitochondrial dysfunction has been recognized as a significant cause of a number of serious multiorgan diseases. Tissues with a high metabolic demand, such as brain, heart, muscle, and central nervous system, are often affected. Mitochondrial disease can be due to mutations in mitochondrial DNA or in nuclear genes involved in mitochondrial function. There is no curative treatment for patients with mitochondrial disease. Given the lack of treatments and the limitations of prenatal and preimplantation diagnosis, attention has focused on prevention of transmission of mitochondrial disease through germline gene replacement therapy. Because mitochondrial DNA is strictly maternally inherited, two approaches have been proposed. In the first, the nuclear genome from the pronuclear stage zygote of an affected woman is transferred to an enucleated donor zygote. A second technique involves transfer of the metaphase II spindle from the unfertilized oocyte of an affected woman to an enucleated donor oocyte. Our group recently reported successful spindle transfer between human oocytes, resulting in blastocyst development and embryonic stem cell derivation, with very low levels of heteroplasmy. In this review we summarize these novel assisted reproductive techniques and their use to prevent transmission of mitochondrial disorders. The promises and challenges are discussed, focusing on their potential clinical application. (Fertil Steril (R) 2014; 101:31-5. (C) 2014 by American Society for Reproductive Medicine.)
C1 [Amato, Paula] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA.
   [Tachibana, Masahito] South Miyagi Med Ctr, Dept Obstet & Gynecol, Ishinomaki, Miyagi, Japan.
   [Sparman, Michelle; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Portland, OR 97201 USA.
C3 Oregon Health & Science University; Oregon Health & Science University;
   Oregon National Primate Research Center
RP Amato, P (corresponding author), Oregon Hlth & Sci Univ, 3303 SW Bond Ave,CH10F, Portland, OR 97239 USA.
EM amatop@ohsu.edu
FU NICHD NIH HHS [R01 HD063276] Funding Source: Medline
CR Battaglia DE, 1996, HUM REPROD, V11, P2217
   Bredenoord AL, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6021
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011
   Manipalviratn S, 2009, FERTIL STERIL, V91, P305, DOI 10.1016/j.fertnstert.2009.01.002
   MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250
   Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800
   Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Steffann J, 2007, J MED GENET, V44, P664, DOI 10.1136/jmg.2006.048553
   Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thorburn DR, 2009, MOL GENET METAB, V98, P5
   Treff NR, 2012, FERTIL STERIL, V98, P1236, DOI 10.1016/j.fertnstert.2012.07.1119
NR 18
TC 81
Z9 99
U1 0
U2 147
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD JAN
PY 2014
VL 101
IS 1
BP 31
EP 35
DI 10.1016/j.fertnstert.2013.11.030
PG 5
WC Obstetrics & Gynecology; Reproductive Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Obstetrics & Gynecology; Reproductive Biology
GA 281VJ
UT WOS:000329128800011
PM 24382342
OA Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU Mavroudis, I
   Petridis, F
   Kazis, D
AF Mavroudis, Ioannis
   Petridis, Foivos
   Kazis, Dimitrios
TI Inclusion body myositis. Genetics, biomarkers and muscle biopsy
SO INTERNATIONAL JOURNAL OF NEUROSCIENCE
LA English
DT Review
DE inclusion body myositis; biomarkers; muscle biopsy
ID MITOCHONDRIAL-DNA DELETIONS; RIMMED VACUOLES; CLINICAL-COURSE;
   ASSOCIATION; EPIDEMIOLOGY; PROTEINS; FEATURES; CELLS; MHC
AB Sporadic inclusion body myositis is the most common idiopathic inflammatory myopathy over the age of 50, with a male-to-female ratio of 3:1. Symptoms onset before age of 60 occurs in 18-20% of patients, with a delay in diagnosis of 5 to 8 years.The classic clinical presentation of SIBM consists of proximal leg and distal arm weakness, and most commonly patients present early slowly progressive quadriceps weakness which leads to falls and to difficulties in climbing stairs, while less common the initial complaints refer to finger flexor weakness and atrophy, foot drop, or dysphagia, and rare presentations include prominent forearm weakness, sparing the quadriceps. The aetiopathogenesis of the disease remains unclear and despite some preliminary promising results, to the day there is no effective treatment.The diagnosis of SIBM is based on the clinical presentation and the histopathological findings in muscle biopsy, however increasing evidence on genetics and paraclinical biomarkers has recently come to light giving new insights on the pathogenesis, the diagnosis and the potential treatment of the disease. In the present study we aim to review the histopathological findings, genetics and blood biomarkers, and to review the role of muscle biopsy in the diagnosis of SIBM.
C1 [Mavroudis, Ioannis] Leeds Teaching Hosp, Dept Neurol, Leeds, England.
   [Petridis, Foivos; Kazis, Dimitrios] Aristotle Univ Thessaloniki, Dept Neurol 3, Thessaloniki, Greece.
C3 University of Leeds; Aristotle University of Thessaloniki
RP Mavroudis, I (corresponding author), Leeds Teaching Hosp, Dept Neurol, Leeds, England.
EM ioannis.mavroudis@nhs.net
RI Kazis, Dimitrios/IXM-9888-2023
CR Ahmed M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad4583
   Alhammad RM, 2019, NEUROMUSCULAR DISORD, V29, P39, DOI 10.1016/j.nmd.2018.10.007
   Amato AA, 1996, ANN NEUROL, V40, P581, DOI 10.1002/ana.410400407
   Amato AA, 2014, NEUROLOGY, V83, P2239, DOI 10.1212/WNL.0000000000001070
   Amlani A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00745
   Badrising UA, 2000, NEUROLOGY, V55, P1385, DOI 10.1212/WNL.55.9.1385
   Badrising UA, 2005, J NEUROL, V252, P1448, DOI 10.1007/s00415-005-0884-y
   Barohn, 2000, Curr Treat Options Neurol, V2, P7, DOI 10.1007/s11940-000-0019-9
   BEYENBURG S, 1993, CLIN INVESTIGATOR, V71, P351
   Brady S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004552
   Buzkova J, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809091
   Catalán-García M, 2016, CLIN SCI, V130, P1741, DOI 10.1042/CS20160080
   Chahin N, 2008, NEUROLOGY, V70, P418, DOI 10.1212/01.wnl.0000277527.69388.fe
   Cherin P, 2002, NEUROLOGY, V58, P326, DOI 10.1212/WNL.58.2.326
   Dahlbom K, 2019, ACTA NEUROL SCAND, V139, P177, DOI 10.1111/ane.13040
   Gang Q, 2016, NEUROBIOL AGING, V47, DOI 10.1016/j.neurobiolaging.2016.07.024
   Gang Q, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-88
   Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176
   Greenberg SA, 2007, MUSCLE NERVE, V35, P17, DOI 10.1002/mus.20649
   Greenberg Steven A, 2016, Continuum (Minneap Minn), V22, P1871
   Greenberg SA, 2016, BRAIN, V139, P1348, DOI 10.1093/brain/aww024
   Güttsches AK, 2017, ANN NEUROL, V81, P227, DOI 10.1002/ana.24847
   Guinto JB, 2007, ACTA NEUROPATHOL, V114, P55, DOI 10.1007/s00401-007-0224-7
   Ioannis M, 2019, INT J NEUROSCI, V129, P297, DOI 10.1080/00207454.2018.1527329
   Johari M, 2017, EUR J NEUROL, V24, P572, DOI 10.1111/ene.13244
   Larman HB, 2013, ANN NEUROL, V73, P408, DOI 10.1002/ana.23840
   Larue S, 2011, J NEUROL NEUROSUR PS, V82, P674, DOI 10.1136/jnnp.2009.190751
   Lilleker JB, 2019, ANN RHEUM DIS, V78, P657, DOI 10.1136/annrheumdis-2018-214644
   LINDBERG C, 1994, ACTA NEUROL SCAND, V89, P123
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Lloyd TE, 2014, NEUROLOGY, V83, P426, DOI 10.1212/WNL.0000000000000642
   LOTZ BP, 1989, BRAIN, V112, P727, DOI 10.1093/brain/112.3.727
   Maetzler W, 2011, J NEUROL NEUROSUR PS, V82, P1060, DOI 10.1136/jnnp.2009.197640
   MENDELL JR, 1991, ARCH NEUROL-CHICAGO, V48, P1229, DOI 10.1001/archneur.1991.00530240033013
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Needham M, 2008, J NEUROL NEUROSUR PS, V79, P1056, DOI 10.1136/jnnp.2007.138891
   Nishino I, 2015, J NEUROL NEUROSUR PS, V86, P385, DOI 10.1136/jnnp-2013-307051
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Phillips BA, 2000, MUSCLE NERVE, V23, P970, DOI 10.1002/(SICI)1097-4598(200006)23:6<970::AID-MUS20>3.0.CO;2-I
   Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076
   Roda RH, 2014, ANN CLIN TRANSL NEUR, V1, P1053, DOI 10.1002/acn3.140
   Rose MR, 2013, NEUROMUSCULAR DISORD, V23, P1044, DOI 10.1016/j.nmd.2013.08.007
   Rothwell S, 2016, ANN RHEUM DIS, V75, P1558, DOI 10.1136/annrheumdis-2015-208119
   Rutkove SB, 2002, NEUROLOGY, V58, P1081, DOI 10.1212/WNL.58.7.1081
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   SAYERS ME, 1992, J RHEUMATOL, V19, P1385
   Tasca G, 2015, MUSCLE NERVE, V52, P956, DOI 10.1002/mus.24661
   Udd B, 2012, NEUROMUSCULAR DISORD, V22, P5, DOI 10.1016/j.nmd.2011.10.003
   van der Meulen MFG, 2001, NEUROMUSCULAR DISORD, V11, P447, DOI 10.1016/S0960-8966(00)00219-4
   Weihl CC, 2015, NEUROMUSCULAR DISORD, V25, P289, DOI 10.1016/j.nmd.2014.12.009
   Wilson FC, 2008, J RHEUMATOL, V35, P445
NR 52
TC 2
Z9 2
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0020-7454
EI 1563-5279
J9 INT J NEUROSCI
JI Int. J. Neurosci.
PD NOV 2
PY 2023
VL 133
IS 11
BP 1211
EP 1217
DI 10.1080/00207454.2020.1763340
EA JUL 2023
PG 7
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA U8PA5
UT WOS:001031981700001
PM 32364415
DA 2024-11-01
ER

PT J
AU Park, JY
   Wang, PY
   Matsumoto, T
   Sung, HJ
   Ma, WZ
   Choi, JW
   Anderson, SA
   Leary, SC
   Balaban, RS
   Kang, JG
   Hwang, PM
AF Park, Joon-Young
   Wang, Ping-yuan
   Matsumoto, Takumi
   Sung, Ho Joong
   Ma, Wenzhe
   Choi, Jeong W.
   Anderson, Stasia A.
   Leary, Scot C.
   Balaban, Robert S.
   Kang, Ju-Gyeong
   Hwang, Paul M.
TI p53 Improves Aerobic Exercise Capacity and Augments Skeletal Muscle
   Mitochondrial DNA Content
SO CIRCULATION RESEARCH
LA English
DT Article
DE aerobic; exercise; mitochondrial DNA; p53; TFAM
ID TRANSCRIPTION FACTOR-A; RIBONUCLEOTIDE REDUCTASE; PHYSICAL-FITNESS;
   BIOGENESIS; MICE; ACTIVATION; EXPRESSION; MORTALITY; APOPTOSIS; DISEASE
AB Rationale: Exercise capacity is a physiological characteristic associated with protection from both cardiovascular and all-cause mortality. p53 regulates mitochondrial function and its deletion markedly diminishes exercise capacity, but the underlying genetic mechanism orchestrating this is unclear. Understanding the biology of how p53 improves exercise capacity may provide useful insights for improving both cardiovascular as well as general health.
   Objective: The purpose of this study was to understand the genetic mechanism by which p53 regulates aerobic exercise capacity.
   Methods and Results: Using a variety of physiological, metabolic, and molecular techniques, we further characterized maximum exercise capacity and the effects of training, measured various nonmitochondrial and mitochondrial determinants of exercise capacity, and examined putative regulators of mitochondrial biogenesis. As p53 did not affect baseline cardiac function or inotropic reserve, we focused on the involvement of skeletal muscle and now report a wider role for p53 in modulating skeletal muscle mitochondrial function. p53 interacts with Mitochondrial Transcription Factor A (TFAM), a nuclear-encoded gene important for mitochondrial DNA ( mtDNA) transcription and maintenance, and regulates mtDNA content. The increased mtDNA in p53(+/+) compared to p53(-/-) mice was more marked in aerobic versus glycolytic skeletal muscle groups with no significant changes in cardiac tissue. These in vivo observations were further supported by in vitro studies showing overexpression of p53 in mouse myoblasts increases both TFAM and mtDNA levels whereas depletion of TFAM by shRNA decreases mtDNA content.
   Conclusions: Our current findings indicate that p53 promotes aerobic metabolism and exercise capacity by using different mitochondrial genes and mechanisms in a tissue-specific manner. (Circ Res. 2009; 105: 705-712.)
C1 [Park, Joon-Young; Wang, Ping-yuan; Matsumoto, Takumi; Sung, Ho Joong; Ma, Wenzhe; Choi, Jeong W.; Anderson, Stasia A.; Balaban, Robert S.; Kang, Ju-Gyeong; Hwang, Paul M.] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA.
   [Park, Joon-Young] Temple Univ, Philadelphia, PA 19122 USA.
   [Leary, Scot C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.
   [Leary, Scot C.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada.
C3 National Institutes of Health (NIH) - USA; NIH National Heart Lung &
   Blood Institute (NHLBI); Pennsylvania Commonwealth System of Higher
   Education (PCSHE); Temple University; McGill University; McGill
   University
RP Hwang, PM (corresponding author), NHLBI, Translat Med Branch, NIH, 10CRC-5-5330,10 Ctr Dr, Bethesda, MD 20892 USA.
EM hwangp@mail.nih.gov
RI Leary, Scot/B-3036-2012; Ma, Wenzhe/N-3320-2017
OI Kang, Ju-Gyeong/0000-0002-3397-232X; Park,
   Joon-Young/0000-0002-7705-7086; Hwang, Paul/0000-0002-5976-7834;
   Anderson, Stasia/0000-0002-2566-6947
FU Division of Intramural Research; National Heart, Lung, and Blood
   Institute; National Institutes of Health; Japan Society for the
   Promotion of Science
FX This research was supported by the Division of Intramural Research,
   National Heart, Lung, and Blood Institute, National Institutes of
   Health, and a postdoctoral fellowship to T. M. from the Japan Society
   for the Promotion of Science.
CR Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200
   Bakhanashvili M, 2008, CELL DEATH DIFFER, V15, P1865, DOI 10.1038/cdd.2008.122
   Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036
   Bernal-Mizrachi C, 2005, NATURE, V435, P502, DOI 10.1038/nature03527
   Boopathi E, 2008, MOL CELL, V32, P32, DOI 10.1016/j.molcel.2008.09.008
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   Chen DX, 2006, CANCER RES, V66, P3485, DOI 10.1158/0008-5472.CAN-05-4103
   Chen YW, 2002, J PHYSIOL-LONDON, V545, P27, DOI 10.1113/jphysiol.2002.021220
   D'Souza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001
   Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Erikssen G, 1998, LANCET, V352, P759, DOI 10.1016/S0140-6736(98)02268-5
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Gates AC, 2007, CELL METAB, V6, P497, DOI 10.1016/j.cmet.2007.10.010
   Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105
   Héron-Milhavet L, 2004, ENDOCRINOLOGY, V145, P4667, DOI 10.1210/en.2003-1543
   HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831
   Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111
   Ibrahim MM, 1998, BBA-MOL CELL RES, V1403, P254, DOI 10.1016/S0167-4889(98)00066-4
   Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006
   Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604
   Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764
   Kulawiec Mariola, 2009, J Carcinog, V8, P8, DOI 10.4103/1477-3163.50893
   Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lebedeva MA, 2009, BBA-BIOENERGETICS, V1787, P328, DOI 10.1016/j.bbabio.2009.01.004
   Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560
   Mason SD, 2007, AM J PHYSIOL-REG I, V293, pR2059, DOI 10.1152/ajpregu.00335.2007
   Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863
   Matsumoto K, 1996, J APPL PHYSIOL, V81, P1843, DOI 10.1152/jappl.1996.81.4.1843
   MCLEOD CJ, 2005, J BIOL CHEM
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Patino WD, 2005, P NATL ACAD SCI USA, V102, P3423, DOI 10.1073/pnas.0408032102
   POOL CW, 1979, HISTOCHEMISTRY, V64, P251, DOI 10.1007/BF00495025
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395
   Saleem A, 2009, PHYSIOL GENOMICS, V37, P58, DOI 10.1152/physiolgenomics.90346.2008
   SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803
   Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208
   Shadel GS, 2008, AM J PATHOL, V172, P1445, DOI 10.2353/ajpath.2008.071163
   SULLIVAN SM, 1987, AM J PHYSIOL, V252, pH149, DOI 10.1152/ajpheart.1987.252.1.H149
   Wang H, 1999, EUR J APPL PHYSIOL O, V80, P22, DOI 10.1007/s004210050553
   Weibel ER, 1979, STEREOLOGICAL METHOD, V1
   Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200
   Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4
   Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177
   Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974
   Yoshida Y, 2003, CANCER RES, V63, P3729
NR 51
TC 160
Z9 173
U1 3
U2 16
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7330
EI 1524-4571
J9 CIRC RES
JI Circ.Res.
PD SEP 25
PY 2009
VL 105
IS 7
BP 705
EP U110
DI 10.1161/CIRCRESAHA.109.205310
PG 19
WC Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular
   Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Hematology
GA 498OJ
UT WOS:000270150800013
PM 19696408
OA Bronze, Green Accepted
DA 2024-11-01
ER

PT S
AU Copeland, WC
AF Copeland, William C.
BE Nasheuer, HP
TI The Mitochondrial DNA Polymerase in Health and Disease
SO GENOME STABILITY AND HUMAN DISEASES
SE Subcellular Biochemistry
LA English
DT Article; Book Chapter
DE DNA polymerase gamma; Mitochondrial disease; Mitochondrial DNA
   replication; Mitochondrial DNA repair; Nucleoside analogs
ID BASE EXCISION-REPAIR; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; VIRUS
   REVERSE-TRANSCRIPTASE; ANTIVIRAL NUCLEOSIDE ANALOGS; ANTI-HIV
   DEOXYNUCLEOTIDES; P55 ACCESSORY SUBUNIT; SELECTIVE ACTION; POLG
   MUTATIONS; W748S MUTATION; IN-VITRO
AB Since mutations in mitochondrial DNA (mtDNA) have been shown to be a cause of many mitochondrial diseases as well as aging, it is important to understand the origin of these mutations and how replication proteins modulate this process. DNA polymerase gamma (pol gamma) is the polymerase that is responsible for replication and repair of mtDNA. Pol gamma has three main roles in mtDNA maintenance and mutagenesis. As the only known DNA polymerase in mitochondria, pol gamma is required for all replication and repair functions and is the main source of errors produced in human mtDNA. Pol gamma is also sensitive to a host of antiviral nucleoside analogs used to treat HIV-1 infections, which can cause an induced mitochondrial toxicity. Finally, the gene for pol gamma, POLG, is a genetic locus for several mitochondrial disease with over 150 genetic mutations currently identified.
C1 Natl Inst Environm Hlth Sci, Mol Genet Lab, Durham, NC 27709 USA.
RP Copeland, WC (corresponding author), Natl Inst Environm Hlth Sci, Mol Genet Lab, Durham, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953
FU Intramural NIH HHS [ZIA ES065080-16, ZIA ES065078-17] Funding Source:
   Medline
CR Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   COPELAND WC, 1992, J BIOL CHEM, V267, P21459
   Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   ERIKSSON S, 1995, J BIOL CHEM, V270, P18929, DOI 10.1074/jbc.270.32.18929
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   FRICK LW, 1988, BIOCHEM BIOPH RES CO, V154, P124, DOI 10.1016/0006-291X(88)90659-6
   FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HART GJ, 1992, ANTIMICROB AGENTS CH, V36, P1688, DOI 10.1128/AAC.36.8.1688
   HUANG P, 1992, J BIOL CHEM, V267, P2817
   HUANG P, 1990, J BIOL CHEM, V265, P11914
   Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200
   KAGUNI LS, 1988, EUKARYOTIC DNA REPLI
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   LEWIS W, 1994, CIRC RES, V74, P344, DOI 10.1161/01.RES.74.2.344
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   LONGLEY MJ, 1991, J BIOL CHEM, V266, P24702
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   NICKEL W, 1992, J BIOL CHEM, V267, P848
   PARKER WB, 1991, J BIOL CHEM, V266, P1754
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 50
TC 55
Z9 58
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0306-0225
BN 978-90-481-3470-0
J9 SUBCELL BIOCHEM
JI Subcell. Biochem.
PY 2010
VL 50
BP 211
EP 222
DI 10.1007/978-90-481-3471-7_11
D2 10.1007/978-90-481-3471-7
PG 12
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
WE Book Citation Index – Science (BKCI-S)
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA BNH48
UT WOS:000274566100011
PM 20012584
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Gianotti, TF
   Castaño, G
   Gemma, C
   Burgueño, AL
   Rosselli, MS
   Pirola, CJ
   Sookoian, S
AF Fernandez Gianotti, Tomas
   Castano, Gustavo
   Gemma, Carolina
   Burgueno, Adriana L.
   Soledad Rosselli, Maria
   Pirola, Carlos J.
   Sookoian, Silvia
TI Mitochondrial DNA copy number is modulated by genetic variation in the
   signal transducer and activator of transcription 3 (<i>STAT3</i>)
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; INSULIN SENSITIVITY; SKELETAL-MUSCLE; DISEASE;
   VARIANTS; CANCER; CELLS; PCR; BIOGENESIS; EXPRESSION
AB The regulation of mitochondrial DNA (mtDNA) copy number not only is critical for the maintenance of the normal mitochondrial function but has a strong clinical significance. A recent report revealed that the signal transducer and activator of transcription 3 (STAT3) is involved in the regulation of the mitochondrial function and is required for the optimal function of the electron transport chain. In this study, we explored whether gene variants in the STAT3 influence the leukocyte mtDNA copy number. Clinical data and blood samples were collected from 179 subjects (aged 52.8 +/- 0.9 years). Mitochondrial DNA quantification using nuclear DNA (nDNA) as a reference was carried out by a real-time quantitative polymerase chain reaction method; results are presented as the mtDNA/nDNA ratio. We selected 3 tag single nucleotide polymorphisms showing a minor allele frequency greater than 10% (rs2293152 C/G, rs6503695 C/T, and rs9891119 A/C), representing 24 polymorphic sites of the STAT3 (r(2) > 0.8). We observed a significant association between mtDNA/nDNA ratio and both rs6503695 and rs9891119, adjusted by age and homeostasis model assessment index. The proportion of the total variance of the mtDNA/nDNA ratio accounted for by the rs6503695 and rs9891119 genotypes was 4.7% and 6.53%, respectively. Common variation in the STAT3 may influence mtDNA copy number. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Castano, Gustavo; Sookoian, Silvia] Govt City Buenos Aires, Res Council Hlth, Buenos Aires, DF, Argentina.
   [Castano, Gustavo; Sookoian, Silvia] Hosp Abel Zubizarreta, Dept Med & Surg, Buenos Aires, DF, Argentina.
   [Soledad Rosselli, Maria] Univ Buenos Aires, Dept Clin & Mol Hepatol, Inst Med Res A Lanari IDIM, CONICET, Buenos Aires, DF, Argentina.
   [Fernandez Gianotti, Tomas; Gemma, Carolina; Burgueno, Adriana L.; Pirola, Carlos J.] Univ Buenos Aires, Dept Mol Genet & Biol Complex Dis, Inst Med Res A Lanari IDIM, CONICET, Buenos Aires, DF, Argentina.
C3 Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET);
   University of Buenos Aires; Consejo Nacional de Investigaciones
   Cientificas y Tecnicas (CONICET); University of Buenos Aires
RP Sookoian, S (corresponding author), Inst Invest Med A Lanari, RA-1427 Buenos Aires, DF, Argentina.
EM ssookoian@lanari.fmed.uba.ar
RI Pirola, Carlos/H-2720-2019
OI Pirola, Carlos Jose/0000-0001-8234-4058; Fernandez Gianotti,
   Tomas/0000-0003-2569-9156; Gemma, Carolina/0000-0002-4890-9972;
   Burgueno, Adriana L./0000-0001-7584-7044
FU UBACyT, Universidad de Buenos Aires [M055]; Agencia Nacional de
   Promocion Cientifica y Tecnologica [PICT 2006-124, PICT 2008-1521];
   Consejo de Investigacion en Salud, Gobierno de la Ciudad de Buenos Aires
FX Source of funding: This study was partially supported by grants M055
   (UBACyT, Universidad de Buenos Aires), PICT 2006-124, and PICT 2008-1521
   (Agencia Nacional de Promocion Cientifica y Tecnologica), and Consejo de
   Investigacion en Salud, Gobierno de la Ciudad de Buenos Aires. TFG, ALB,
   MSR, SS, and CJP belong to Consejo Nacional de Investigaciones
   Cientificas. SS and GC belong to Consejo de Investigacion en Salud,
   Gobiemo de la Ciudad de Buenos Aires.
CR Alvarez V, 2008, J ALZHEIMERS DIS, V13, P275
   Alvarez V, 2008, NEUROSCI LETT, V432, P79, DOI 10.1016/j.neulet.2007.12.010
   Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   Curran JE, 2010, HUM GENET, V127, P183, DOI 10.1007/s00439-009-0756-0
   Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099
   Elam MB, 2010, METABOLISM, V59, P587, DOI 10.1016/j.metabol.2009.09.001
   Gemma C, 2006, OBESITY, V14, P2193, DOI 10.1038/oby.2006.257
   Gianotti TF, 2008, OBESITY, V16, P1591, DOI 10.1038/oby.2008.253
   Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721
   Günther C, 2004, NEUROSCI LETT, V369, P219, DOI 10.1016/j.neulet.2004.07.070
   Higuchi M, 2007, MITOCHONDRION, V7, P53, DOI 10.1016/j.mito.2006.12.001
   Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687
   Inghirami G, 2005, CELL CYCLE, V4, P1131, DOI 10.4161/cc.4.9.1985
   Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100
   Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017
   Kawasaki E-S., 1990, PCR PROTOCOLS GUIDE
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650
   Miglio G, 2009, NEUROCHEM INT, V55, P496, DOI 10.1016/j.neuint.2009.05.001
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Myakishev MV, 2001, GENOME RES, V11, P163, DOI 10.1101/gr.157901
   Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177
   Shen YH, 2004, MOL CELL BIOL, V24, P407, DOI 10.1128/MCB.24.1.407-419.2004
   Song J, 2001, DIABETES CARE, V24, P865, DOI 10.2337/diacare.24.5.865
   Sookoian S, 2008, CYTOKINE, V44, P201, DOI 10.1016/j.cyto.2008.08.001
   Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801
   Tang YY, 2000, MOL BIOL CELL, V11, P1471, DOI 10.1091/mbc.11.4.1471
   Vassilev AO, 2002, LEUKEMIA LYMPHOMA, V43, P1461, DOI 10.1080/1042819022386716
   VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122
   Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551
   Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003
   Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290
   Yang Y, 2005, CANCER SCI, V96, P425, DOI 10.1111/j.1349-7006.2005.00063.x
NR 41
TC 12
Z9 14
U1 0
U2 7
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0026-0495
J9 METABOLISM
JI Metab.-Clin. Exp.
PD AUG
PY 2011
VL 60
IS 8
BP 1142
EP 1149
DI 10.1016/j.metabol.2010.12.008
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 799AW
UT WOS:000293256900013
PM 21310444
DA 2024-11-01
ER

PT J
AU Bonomi, M
   Somigliana, E
   Cacciatore, C
   Busnelli, M
   Rossetti, R
   Bonetti, S
   Paffoni, A
   Mari, D
   Ragni, G
   Persani, L
AF Bonomi, Marco
   Somigliana, Edgardo
   Cacciatore, Chiara
   Busnelli, Marta
   Rossetti, Raffaella
   Bonetti, Silvia
   Paffoni, Alessio
   Mari, Daniela
   Ragni, Guido
   Persani, Luca
CA Italian Network Study Ovarian
TI Blood Cell Mitochondrial DNA Content and Premature Ovarian Aging
SO PLOS ONE
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; COPY NUMBER; POLYMERASE-GAMMA;
   SKELETAL-MUSCLE; POOR RESPONSE; X-CHROMOSOME; IN-VITRO; FAILURE; OOCYTE;
   INSUFFICIENCY
AB Primary ovarian insufficiency (POI) is a critical fertility defect characterized by an anticipated and silent impairment of the follicular reserve, but its pathogenesis is largely unexplained. The frequent maternal inheritance of POI together with a remarkable dependence of ovarian folliculogenesis upon mitochondrial biogenesis and bioenergetics suggested the possible involvement of a generalized mitochondrial defect. Here, we verified the existence of a significant correlation between blood and ovarian mitochondrial DNA (mtDNA) content in a group of women undergoing ovarian hyperstimulation (OH), and then aimed to verify whether mtDNA content was significantly altered in the blood cells of POI women. We recruited 101 women with an impaired ovarian reserve: 59 women with premature ovarian failure (POF) and 42 poor responders (PR) to OH. A Taqman copy number assay revealed a significant mtDNA depletion (P<0.001) in both POF and PR women in comparison with 43 women of similar age and intact ovarian reserve, or 53 very old women with a previous physiological menopause. No pathogenic variations in the mitochondrial DNA polymerase gamma (POLG) gene were detected in 57 POF or PR women with low blood mtDNA content. In conclusion, blood cell mtDNA depletion is a frequent finding among women with premature ovarian aging, suggesting that a still undetermined but generalized mitochondrial defect may frequently predispose to POI which could then be considered a form of anticipated aging in which the ovarian defect may represent the first manifestation. The determination of mtDNA content in blood may become an useful tool for the POI risk prediction.
C1 [Bonomi, Marco; Busnelli, Marta; Persani, Luca] Fdn Ist Ricovero & Cura Carattere Sci Ist Auxol I, Lab Ric Endocrinometab E, Milan, Italy.
   [Cacciatore, Chiara; Persani, Luca] Fdn Ist Ricovero & Cura Carattere Sci Ist Auxol I, UO Med Gen Indirizzo Endocrinometab, Milan, Italy.
   [Somigliana, Edgardo; Bonetti, Silvia; Paffoni, Alessio; Ragni, Guido] Fdn Ist Ricovero & Cura Carattere Sci Ca Granda O, Ctr Sterilita, Milan, Italy.
   [Cacciatore, Chiara; Rossetti, Raffaella; Mari, Daniela; Persani, Luca] Univ Milan, Dipartimento Sci Clin & Comunita, Milan, Italy.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan
RP Bonomi, M (corresponding author), Fdn Ist Ricovero & Cura Carattere Sci Ist Auxol I, Lab Ric Endocrinometab E, Milan, Italy.
EM luca.persani@unimi.it
RI Rossetti, Raffaella/B-4972-2013; Somigliana, Edgardo/Z-3749-2019;
   Busnelli, Marta/AGW-2144-2022; Mari, Daniela/K-5663-2016; PETRAGLIA,
   Felice/K-6535-2016; Bonomi, Marco/A-3285-2009; fusi, franco/K-4637-2013;
   Nappi, Rossella/AAC-1793-2022; Cannavo, Salvatore/D-7608-2013; Persani,
   Luca/B-6543-2008; paffoni, alessio/I-7404-2015; Ricca,
   Ivana/AAA-4125-2021; Renieri, Alessandra/K-5950-2016; MAROZZI,
   ANNA/Q-7282-2017
OI Mari, Daniela/0000-0002-6950-0789; PALLI, Domenico/0000-0002-5558-2437;
   PETRAGLIA, Felice/0000-0002-8851-625X; zuffardi,
   orsetta/0000-0002-1466-4559; Bonomi, Marco/0000-0001-5454-6074; tumino,
   rosario/0000-0003-2666-414X; fusi, franco/0000-0002-4349-0842; Villa,
   Nicoletta/0000-0002-4439-9880; Venkatasubramanian,
   Siddharth/0000-0002-5860-0768; Busnelli, Marta/0000-0003-3387-2190; s,
   hema/0000-0002-3440-9475; Nappi, Rossella/0000-0003-1713-6396; MAGHNIE,
   Mohamad/0000-0002-7183-5238; Tonacchera, Massimo/0000-0001-5431-5823;
   somigliana, edgardo/0000-0002-0223-0032; Cannavo,
   Salvatore/0000-0001-8779-7283; cavallo, luciano/0000-0003-4787-8681;
   Persani, Luca/0000-0003-2068-9581; Bione, Silvia/0000-0002-3924-4606;
   paffoni, alessio/0000-0003-3112-3161; Vegetti,
   Walter/0000-0003-0422-643X; Ricca, Ivana/0000-0001-8939-1447; Rossetti,
   Raffaella/0000-0001-9112-6175; Renieri, Alessandra/0000-0002-0846-9220;
   MAROZZI, ANNA/0000-0001-9007-2590
FU Telethon Foundation - Italy [GGP09126A]; Istituto Auxologico Italiano,
   Italy [05C501]
FX The financial support of Telethon Foundation - Italy (Grant no.
   GGP09126A) and Istituto Auxologico Italiano, Italy (Ricerca Corrente
   Funds: 05C501) are gratefully acknowledged. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR BOLAND NI, 1993, BIOL REPROD, V48, P798, DOI 10.1095/biolreprod48.4.798
   Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Davis CJ, 2000, HUM REPROD, V15, P2418, DOI 10.1093/humrep/15.11.2418
   de Boer EJ, 2003, HUM REPROD, V18, P1544, DOI 10.1093/humrep/deg278
   Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8
   Farhi J, 1997, HUM REPROD, V12, P241, DOI 10.1093/humrep/12.2.241
   Gagnon A, 2009, AM J HUM BIOL, V21, P533, DOI 10.1002/ajhb.20893
   Harris SE, 2009, MOL REPROD DEV, V76, P231, DOI 10.1002/mrd.20945
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   HUTCHINSON EW, 1991, GENETICS, V127, P729
   Jansen RPS, 1998, MOL CELL ENDOCRINOL, V145, P81, DOI 10.1016/S0303-7207(98)00173-7
   Johannsen DL, 2009, CURR OPIN PHARMACOL, V9, P780, DOI 10.1016/j.coph.2009.09.002
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lawson R, 2003, HUM REPROD, V18, P527, DOI 10.1093/humrep/deg101
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   May-Panloup P, 2005, HUM REPROD, V20, P593, DOI 10.1093/humrep/deh667
   May-Panloup P, 2007, CURR TOP DEV BIOL, V77, P51, DOI 10.1016/S0070-2153(06)77003-X
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Pang CY, 2008, FRONT BIOSCI-LANDMRK, V13, P3661, DOI 10.2741/2957
   Perls TT, 1997, NATURE, V389, P133, DOI 10.1038/38148
   Persani L, 2010, J MOL ENDOCRINOL, V45, P257, DOI 10.1677/JME-10-0070
   Persani L, 2009, J AUTOIMMUN, V33, P35, DOI 10.1016/j.jaut.2009.03.004
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Rizzolio F, 2009, J MED GENET, V46, P585, DOI 10.1136/jmg.2007.056093
   Rossetti R, 2009, HUM MUTAT, V30, P804, DOI 10.1002/humu.20961
   Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1
   Simpson JL, 2008, ANN NY ACAD SCI, V1135, P146, DOI 10.1196/annals.1429.019
   Smith KR, 2009, J GERONTOL A-BIOL, V64, P740, DOI 10.1093/gerona/glp055
   Spikings EC, 2007, BIOL REPROD, V76, P327, DOI 10.1095/biolreprod.106.054536
   Tatone C, 2006, MOL HUM REPROD, V12, P655, DOI 10.1093/molehr/gal080
   Tong ZB, 2010, FERTIL STERIL, V94, P2932, DOI 10.1016/j.fertnstert.2010.06.049
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trinei M, 2006, BBA-BIOENERGETICS, V1757, P624, DOI 10.1016/j.bbabio.2006.05.029
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954
   Vegetti W, 2000, MOL CELL ENDOCRINOL, V161, P53, DOI 10.1016/S0303-7207(99)00224-5
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Welt CK, 2008, CLIN ENDOCRINOL, V68, P499, DOI 10.1111/j.1365-2265.2007.03073.x
   Wycherley G, 2005, HUM REPROD, V20, P2757, DOI 10.1093/humrep/dei132
NR 45
TC 39
Z9 46
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 3
PY 2012
VL 7
IS 8
AR e42423
DI 10.1371/journal.pone.0042423
PG 5
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 985QT
UT WOS:000307284100086
PM 22879975
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Sato, A
   Nakada, K
   Hayashi, JI
AF Sato, Akitsugu
   Nakada, Kazuto
   Hayashi, Jun-Ichi
TI Mitochondrial dynamics and aging: Mitochondrial interaction preventing
   individuals from expression of respiratory deficiency caused by mutant
   mtDNA
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
LA English
DT Review
DE mitochondrial theory of aging; mitochondrial complementation; mito-mice;
   mtDNA recombination; gene therapy; nuclear transplantation
ID CYTOCHROME-C-OXIDASE; DNA RECOMBINATION; FUNCTIONAL INTEGRITY;
   PRENATAL-DIAGNOSIS; SKELETAL-MUSCLE; MOUSE MTDNA; HUMAN-HEART;
   MUTATIONS; COMPLEMENTATION; CELLS
AB In mammalian cells, there is an extensive and continuous exchange of mitochondrial DNA (mtDNA) and its products between mitochondria. This mitochondrial complementation prevents individuals from expression of respiration deficiency caused by mutant mtDNAs. Thus, the presence of mitochondrial complementation does not support the generally accepted mitochondrial theory of aging, which proposes that accumulation of somatic mutations in mtDNA is responsible for age-associated mitochondrial dysfunction. Moreover, the presence of mitochondrial complementation enables gene therapy for mitochondrial diseases using nuclear transplantation of zygotes. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan.
   Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Ibaraki 3058572, Japan.
   Tokyo Metropolitan Inst Med Sci, Dept Lab Anim Sci, Tokyo 1138613, Japan.
C3 University of Tsukuba; University of Tsukuba; Tokyo Metropolitan
   Institute of Medical Science
RP Hayashi, JI (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan.
EM jih45@sakura.cc.tsukuba.ac.jp
CR ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Attardi G, 2002, NAT GENET, V30, P360, DOI 10.1038/ng0402-360
   Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524
   BELLIARD G, 1979, NATURE, V281, P401, DOI 10.1038/281401a0
   BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303
   BOWLING AC, 1993, J NEUROCHEM, V60, P1964, DOI 10.1111/j.1471-4159.1993.tb13430.x
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7
   Cohen J, 1998, MOL HUM REPROD, V4, P269, DOI 10.1093/molehr/4.3.269
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326
   Dean NL, 2003, MOL HUM REPROD, V9, P631, DOI 10.1093/molehr/gag077
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   DUJON B, 1974, GENETICS, V78, P415
   Enríquez JA, 2000, J BIOL CHEM, V275, P11207, DOI 10.1074/jbc.275.15.11207
   Eyre-Walker A, 2000, PHILOS T R SOC B, V355, P1573, DOI 10.1098/rstb.2000.0718
   Eyre-Walker A, 2001, J MOL EVOL, V53, P430, DOI 10.1007/s002390010232
   Hagelberg E, 1999, P ROY SOC B-BIOL SCI, V266, P485, DOI 10.1098/rspb.1999.0663
   HARDING AE, 1992, AM J HUM GENET, V50, P629
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HAYASHI JI, 1994, J BIOL CHEM, V269, P6878
   HAYASHI JI, 1985, EXP CELL RES, V160, P387, DOI 10.1016/0014-4827(85)90185-5
   HAYASHI JI, 1994, J CELL BIOL, V125, P43, DOI 10.1083/jcb.125.1.43
   HOWELL N, 1992, HUM GENET, V90, P117
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Isobe K, 1998, J BIOL CHEM, V273, P4601, DOI 10.1074/jbc.273.8.4601
   Ito S, 1998, BIOCHEM BIOPH RES CO, V247, P432, DOI 10.1006/bbrc.1998.8800
   Ito S, 1999, P NATL ACAD SCI USA, V96, P2099, DOI 10.1073/pnas.96.5.2099
   Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   JORDE LB, 2000, SCIENCE, V288, pA1931
   Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233
   KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542
   Kivisild T, 2000, Science, V288, p1931a, DOI 10.1126/science.288.5473.1931a
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   KUMAR S, 2000, SCIENCE, V288, pA1931
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   Ladoukakis ED, 2001, MOL BIOL EVOL, V18, P1168, DOI 10.1093/oxfordjournals.molbev.a003904
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102
   Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488
   Marchington DR, 1998, AM J HUM GENET, V63, P769, DOI 10.1086/302009
   MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41
   Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Nagley P, 1998, TRENDS GENET, V14, P513, DOI 10.1016/S0168-9525(98)01580-7
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   NASS MMK, 1969, J MOL BIOL, V42, P521, DOI 10.1016/0022-2836(69)90240-X
   NASS MMK, 1970, P NATL ACAD SCI USA, V67, P1926, DOI 10.1073/pnas.67.4.1926
   Ono T, 2004, BIOCHEM BIOPH RES CO, V314, P1107, DOI 10.1016/j.bbrc.2003.12.201
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   PAABO S, 1990, J BIOL CHEM, V265, P4718
   Papa S, 1996, BBA-BIOENERGETICS, V1276, P87, DOI 10.1016/0005-2728(96)00077-1
   PARSONS TJ, 2004, SCIENCE, V288, pA1931
   Rokas A, 2003, TRENDS ECOL EVOL, V18, P411, DOI 10.1016/S0169-5347(03)00125-3
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   Sato A, 2005, P NATL ACAD SCI USA, V102, P6057, DOI 10.1073/pnas.0408666102
   Sato A, 2004, GENETICS, V167, P1855, DOI 10.1534/genetics.103.021287
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Shitara H, 2000, GENETICS, V156, P1277
   Shitara H, 1998, GENETICS, V148, P851
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SOONG NW, 1992, NAT GENET, V2, P318
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Takai D, 1997, J BIOL CHEM, V272, P6028, DOI 10.1074/jbc.272.9.6028
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
   Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606
NR 87
TC 37
Z9 49
U1 0
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0167-4889
EI 1879-2596
J9 BBA-MOL CELL RES
JI Biochim. Biophys. Acta-Mol. Cell Res.
PD MAY-JUN
PY 2006
VL 1763
IS 5-6
BP 473
EP 481
DI 10.1016/j.bbamcr.2006.03.001
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 069XB
UT WOS:000239481400009
PM 16624428
OA Bronze
DA 2024-11-01
ER

PT S
AU Zhang, XN
   Zheng, YR
   Chen, Z
AF Zhang, Xiangnan
   Zheng, Yanrong
   Chen, Zhong
BE Le, W
TI Autophagy and Mitochondrial Encephalomyopathies
SO AUTOPHAGY: BIOLOGY AND DISEASES: CLINICAL SCIENCE
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE Encephalomyopathy; Autophagy; Mitochondria; Mitophagy
ID COMPLEX I; MUTATION; DNA; MELAS; FIBROBLASTS; DELETIONS; MYOPATHY
AB Mitochondrial encephalomyopathies are a group of disorders affecting skeletal muscles and brain. Although the symptoms vary among these disorders, mitochondrial DNA mutation or loss is the common characteristic. The abnormality of mitochondrial genome usually causes the dysfunction of mitochondrial respiratory and even mitochondrial damage. As a critical way of degradation, attention has been paid to the involvement of autophagy in encephalomyopathies. Autophagy is found activated in these encephalomyopathies-relevant cells as a compensatory manner to eliminate these damaged and dysfunctional mitochondria. However, accumulating evidences indicate that autophagy is incompetent to clear them. The insufficient mitophagy may ultimately accelerate cell death. Here we discuss the involvement of autophagy in encephalomyopathies based on the current evidence. We further look into the future to rescue encephalomyopathies by regulating autophagy. Only five encephalomyopathies are included in this chapter due to the availability of evidence. Nevertheless, these encephalomyopathies share a variety of common features and autophagy may also be regulated in the other encephalomyopathies.
C1 [Zhang, Xiangnan; Zheng, Yanrong; Chen, Zhong] Zhejiang Univ, Coll Pharmaceut Sci, NHC & CAMS Key Lab Med Neurobiol, Inst Pharmacol & Toxicol, Hangzhou 310058, Peoples R China.
C3 Zhejiang University
RP Chen, Z (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, NHC & CAMS Key Lab Med Neurobiol, Inst Pharmacol & Toxicol, Hangzhou 310058, Peoples R China.
EM chenzhong@zju.edu.cn
RI Zhang, xiangnan/C-9649-2010; Wang, Tianqi/JJD-7473-2023
CR Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   Bacalhau M, 2018, NEUROMUSCULAR DISORD, V28, P350, DOI 10.1016/j.nmd.2017.11.006
   Bernardi P, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011387
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Chen CY, 2011, MITOCHONDRION, V11, P739, DOI 10.1016/j.mito.2011.05.014
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   De la Mata M, 2012, NEUROTHERAPEUTICS, V9, P446, DOI 10.1007/s13311-012-0103-3
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Garrido-Maraver J, 2012, BRIT J PHARMACOL, V167, P1311, DOI 10.1111/j.1476-5381.2012.02086.x
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110
   Houshmand M, 2006, NEUROL INDIA, V54, P182
   HUOPONEN K, 1991, AM J HUM GENET, V48, P1147
   Ikeda T, 2018, HUM GENOME VAR, V5, DOI 10.1038/s41439-018-0026-6
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Lin DS, 2017, ONCOTARGET, V8, P73627, DOI 10.18632/oncotarget.20617
   López LC, 2014, MOL SYNDROMOL, V5, P163, DOI 10.1159/000360494
   Ogle RF, 1997, J PEDIATR-US, V130, P138, DOI 10.1016/S0022-3476(97)70323-8
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Rodríguez-Hernández A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174
   Sharma LK, 2019, HUM MOL GENET, V28, P422, DOI 10.1093/hmg/ddy354
   Wang TK, 2014, BIOCHEM J, V459, P149, DOI 10.1042/BJ20131235
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
   Yuan JH, 2013, J CLIN PATHOL, V66, P659, DOI 10.1136/jclinpath-2012-201431
   Zeviani Massimo, 1993, European Journal of Human Genetics, V1, P80
   Zhang JJ, 2018, HUM MOL GENET, V27, P1999, DOI 10.1093/hmg/ddy107
NR 27
TC 8
Z9 8
U1 1
U2 6
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-15-4272-5; 978-981-15-4271-8
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2020
VL 1207
BP 103
EP 110
DI 10.1007/978-981-15-4272-5_6
D2 10.1007/978-981-15-4272-5
PG 8
WC Medicine, Research & Experimental; Clinical Neurology
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Neurosciences & Neurology
GA BP5KY
UT WOS:000556133800007
PM 32671741
DA 2024-11-01
ER

PT J
AU Mayer, J
   Reichart, G
   Tokay, T
   Lange, F
   Baltrusch, S
   Junghanss, C
   Wolkenhauer, O
   Jaster, R
   Kunz, M
   Tiedge, M
   Ibrahim, S
   Fuellen, G
   Köhling, R
AF Mayer, Johannes
   Reichart, Gesine
   Tokay, Tursonjan
   Lange, Falko
   Baltrusch, Simone
   Junghanss, Christian
   Wolkenhauer, Olaf
   Jaster, Robert
   Kunz, Manfred
   Tiedge, Markus
   Ibrahim, Saleh
   Fuellen, Georg
   Koehling, Ruediger
TI Reduced Adolescent-Age Spatial Learning Ability Associated with Elevated
   Juvenile-Age Superoxide Levels in Complex I Mouse Mutants
SO PLOS ONE
LA English
DT Article
ID LONG-TERM POTENTIATION; MITOCHONDRIAL-DNA MUTATIONS; OXIDATIVE STRESS;
   SYNAPTIC PLASTICITY; NADH-DEHYDROGENASE; FREE-RADICALS; MEMORY; DISEASE;
   MICE; HIPPOCAMPUS
AB Large-scale, heteroplasmic and generally pathogenic mtDNA defects (as induced by defective mitochondrial DNA polymerase, clonal mutations or DNA deletions) are known to negatively impact on life span and can result in apoptosis and tissue loss in, e.g., skeletal muscle or reduce learning abilities. The functional impact of homoplasmic specific mtDNA point mutations, e.g., in genes coding for the electron transport chain, however, remains a matter of debate. The present study contributes to this discussion and provides evidence that a single point mutation in complex I of the respiratory chain is associated with impairment of spatial navigation in adolescent (6-month-old) mice, i.e., reduced performance in the Morris Water Maze, which goes along with increased production of reactive oxygen species (ROS) in juvenile mice (3 months) but not at the age of phenotype expression. A point mutation in complex III goes along with only a mild and non-significant negative effect on cognitive performance and no significant changes in ROS production. These findings suggest to also consider the ontogenetic development of phenotypes when studying mtDNA mutations and highlights a possible impact of complex I dysfunction on the emergence of neurological deficits.
C1 [Mayer, Johannes; Reichart, Gesine; Tokay, Tursonjan; Lange, Falko; Koehling, Ruediger] Univ Rostock, Med Ctr, Oscar Langendorff Inst Physiol, D-18055 Rostock, Germany.
   [Baltrusch, Simone; Tiedge, Markus] Univ Rostock, Med Ctr, Inst Med Biochem & Mol Biol, D-18055 Rostock, Germany.
   [Junghanss, Christian] Univ Rostock, Med Ctr, Dept Hematol Oncol Palliat Med, D-18055 Rostock, Germany.
   [Wolkenhauer, Olaf] Univ Rostock, Dept Syst Biol & Bioinformat, D-18055 Rostock, Germany.
   [Jaster, Robert] Univ Rostock, Med Ctr, Dept Med 2, Div Gastroenterol, D-18055 Rostock, Germany.
   [Kunz, Manfred] Univ Leipzig, Dept Dermatol Venereol & Allergol, D-04109 Leipzig, Germany.
   [Ibrahim, Saleh] Lubeck Univ, Med Ctr, Dept Dermatol, Lubeck, Germany.
   [Fuellen, Georg] Inst Biostat & Informat Med & Ageing Res, Rostock, Germany.
   [Fuellen, Georg; Koehling, Ruediger] Univ Rostock, Interdisciplinary Fac, D-18055 Rostock, Germany.
   [Tokay, Tursonjan] Nazarbayev Univ, Ctr Life Sci, Astana, Kazakhstan.
C3 University of Rostock; University of Rostock; University of Rostock;
   University of Rostock; University of Rostock; Leipzig University;
   University of Lubeck; University of Rostock; Nazarbayev University
RP Mayer, J (corresponding author), Univ Rostock, Med Ctr, Oscar Langendorff Inst Physiol, D-18055 Rostock, Germany.
EM johannes.mayer@uni-rostock.de; ruediger.koehling@uni-rostock.de
RI Ibrahim, Saleh/AAO-9541-2020; Fuellen, Georg/KMX-0974-2024; tokay,
   tursonjan/D-2457-2016; Kohling, Rudiger/K-8647-2013
OI Lange, Falko/0000-0001-8782-5205; Tokay, Tursonjan/0000-0003-2219-3301;
   Kohling, Rudiger/0000-0003-3330-4898; Ibrahim,
   Saleh/0000-0001-7827-2290; Mayer, Johannes/0000-0003-4331-7465; Fuellen,
   Georg/0000-0002-4994-9829
FU Bundesministerium fur Bildung und Forschung (BMBF) [ROSAge 31P6662];
   Rostock University Medical Center FORUN programme [889062]
FX This work was supported by Bundesministerium fur Bildung und Forschung
   (BMBF) grant ROSAge 31P6662, http://www.bmbf.de/, and Rostock University
   Medical Center FORUN programme funding no. 889062,
   https://www.med.uni-rostock.de/. The funders had no role in study
   design,
CR ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   Bleier L, 2013, BBA-BIOENERGETICS, V1827, P1320, DOI 10.1016/j.bbabio.2012.12.002
   BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0
   Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Fukui K, 2001, ANN NY ACAD SCI, V928, P168
   Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   HRUSZKEWYCZ AM, 1992, MUTAT RES, V275, P243, DOI 10.1016/0921-8734(92)90028-N
   Hu DY, 2007, NEUROBIOL LEARN MEM, V87, P372, DOI 10.1016/j.nlm.2006.10.003
   Huang H, 2004, FRONT BIOSCI-LANDMRK, V9, P1100, DOI 10.2741/1298
   Huang Y, 2013, NEUROSCIENCE, V231, P432, DOI 10.1016/j.neuroscience.2012.11.010
   Ishihara K, 1997, BEHAV BRAIN RES, V83, P235, DOI 10.1016/S0166-4328(97)86077-9
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Kamsler A, 2003, J NEUROSCI, V23, P269
   Keefe J.O., 1978, HIPPOCAMPUS COGNITIV
   Khrapko K, 2007, NAT GENET, V39, P445, DOI 10.1038/ng0407-445
   Knapp LT, 2002, J NEUROSCI RES, V70, P1, DOI 10.1002/jnr.10371
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kumar A, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00007
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Lauritzen KH, 2010, MOL CELL BIOL, V30, P1357, DOI 10.1128/MCB.01149-09
   Levy M, 2003, J BIOL CHEM, V278, P17727, DOI 10.1074/jbc.M212878200
   Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   LOMO T, 1966, ACTA PHYSIOL SCAND, VS 68, P128
   Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003
   Maharjan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05896
   MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510
   MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4
   MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0
   MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0
   Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038
   Nicolle MM, 2001, NEUROSCIENCE, V107, P415, DOI 10.1016/S0306-4522(01)00374-8
   Olsen RHJ, 2013, J NEUROCHEM, V125, P303, DOI 10.1111/jnc.12187
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014
   Schauer M, 2014, EXP DERMATOL, V23, pE6
   Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   Tanaka D., 2008, MOL BRAIN, V16, P1, DOI DOI 10.1186/1756-6606-1-21
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wei Yau-Huei, 2009, Chang Gung Med J, V32, P113
   Weiss H, 2013, DIABETOLOGIA, V56, pS87
   Yu X, 2009, GENOME RES, V19, P159, DOI 10.1101/gr.078865.108
NR 55
TC 6
Z9 6
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 8
PY 2015
VL 10
IS 4
AR e0123863
DI 10.1371/journal.pone.0123863
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CF3WA
UT WOS:000352478400122
PM 25853418
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU DeBrosse, S
   Ubogu, EE
   Yaniglos, S
   Hassan, MO
   Leigh, RJ
AF DeBrosse, S.
   Ubogu, E. E.
   Yaniglos, S.
   Hassan, M. O.
   Leigh, R. J.
TI Dynamic properties of eye movements in mitochondrial chronic progressive
   external ophthalmoplegia
SO EYE
LA English
DT Article
DE extraocular muscle; saccades; diplopia; vestibulo-ocular reflex
ID BRAIN-STEM; SACCADES
AB Aims To relate dynamic properties of eye movements to visual disability in a patient with chronic progressive external ophthalmoplegia ( CPEO) due to mitochondrial DNA deletion.
   Methods Visual function was evaluated by neuro-ophthalmological examination and visual function index (VF-14). Eye movements were measured using the magnetic search coil technique.
   Results The patient denied diplopia or oscillopsia at rest or during locomotion. His range of eye movements was limited to <12 degrees horizontally, and <19 degrees vertically with smaller movements of the left eye. All classes of movements were impaired, but the eyes accelerated to over 1000 degrees/s/s at the onset of saccades and in response to brisk head rotations.
   Conclusions Diplopia and oscillopsia were suppressed, probably due to visual system adaptation during the slow disease progression. We postulate that relative sparing of pale global extraocular fibres accounted for preserved acceleration of saccades and vestibular eye movements.
C1 [DeBrosse, S.; Ubogu, E. E.; Leigh, R. J.] Case Western Reserve Univ, Dept Neurol, Vet Affairs Med Ctr, Cleveland, OH 44106 USA.
   [Yaniglos, S.; Leigh, R. J.] Case Western Reserve Univ, Dept Optometry, Vet Affairs Med Ctr, Cleveland, OH 44106 USA.
   [Hassan, M. O.] Case Western Reserve Univ, Dept Pathol, Vet Affairs Med Ctr, Cleveland, OH 44106 USA.
C3 University System of Ohio; Case Western Reserve University; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Louis Stokes Cleveland Veterans Affairs Medical Center; University
   System of Ohio; Case Western Reserve University; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Louis Stokes
   Cleveland Veterans Affairs Medical Center; University System of Ohio;
   Case Western Reserve University; US Department of Veterans Affairs;
   Veterans Health Administration (VHA); Louis Stokes Cleveland Veterans
   Affairs Medical Center
RP Leigh, RJ (corresponding author), Case Western Reserve Univ, Dept Neurol, Vet Affairs Med Ctr, 11100 Euclid Ave, Cleveland, OH 44106 USA.
EM rjl4@case.edu
RI Ubogu, Eroboghene/R-3894-2019
FU NEI NIH HHS [EY06717, R01 EY006717, R01 EY006717-24] Funding Source:
   Medline
CR Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Engle EC, 2007, ARCH NEUROL-CHICAGO, V64, P633, DOI 10.1001/archneur.64.5.633
   GROSSMAN GE, 1988, EXP BRAIN RES, V70, P470
   HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015
   KHANNA S, 2007, J NEUROL
   Kumar AN, 2005, ANN NY ACAD SCI, V1039, P404, DOI 10.1196/annals.1325.038
   Leigh RJ., 2006, NEUROLOGY EYE MOVEME, V4th
   Lossos A, 2005, BRAIN, V128, P42, DOI 10.1093/brain/awh338
   Man CYW, 2006, EYE, V20, P564, DOI 10.1038/sj.eye.6701924
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Porschke H, 1997, NEUROMUSCULAR DISORD, V7, pS57, DOI 10.1016/S0960-8966(97)00084-9
   Ramat S, 1999, EXP BRAIN RES, V129, P500, DOI 10.1007/s002210050920
   Ramat S, 1999, INVEST OPHTH VIS SCI, V40, P1681
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   SCOTT AB, 1973, ARCH OPHTHALMOL-CHIC, V90, P319
   Spencer RF, 2006, PROG BRAIN RES, V151, P43, DOI 10.1016/S0079-6123(05)51002-1
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Versino M, 2002, J NEUROL NEUROSUR PS, V72, P236, DOI 10.1136/jnnp.72.2.236
   YEE RD, 1987, OPHTHALMOLOGY, V94, P219
   Yu CY, 2005, NEUROMUSCULAR DISORD, V15, P17, DOI 10.1016/j.nmd.2004.10.002
   ZEE DS, 1992, J NEUROPHYSIOL, V68, P1624, DOI 10.1152/jn.1992.68.5.1624
NR 21
TC 2
Z9 2
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-222X
EI 1476-5454
J9 EYE
JI Eye
PD FEB
PY 2009
VL 23
IS 2
BP 382
EP 388
DI 10.1038/sj.eye.6703024
PG 7
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 406US
UT WOS:000263321000024
PM 17962819
OA Bronze
DA 2024-11-01
ER

PT J
AU Dillon, LM
   Rebelo, AP
   Moraes, CT
AF Dillon, Lloye M.
   Rebelo, Adriana P.
   Moraes, Carlos T.
TI The role of PGC-1 coactivators in aging skeletal muscle and heart
SO IUBMB LIFE
LA English
DT Review
DE aging; mitochondria; mitochondrial biogenesis; PGC-1; skeletal muscle;
   heart
ID DNA-DELETION MUTATIONS; MITOCHONDRIAL BIOGENESIS;
   OXIDATIVE-PHOSPHORYLATION; CALORIC RESTRICTION; ENDURANCE EXERCISE;
   RESPIRATORY-CHAIN; ENERGY-METABOLISM; RECEPTOR-ALPHA; PGC-1-ALPHA;
   CARDIOMYOPATHY
AB Aging is the progressive decline in cellular, tissue, and organ function. This complex process often manifests as loss of muscular strength, cardiovascular function, and cognitive ability. Mitochondrial dysfunction and decreased mitochondrial biogenesis are believed to participate in metabolic abnormalities and loss of organ function, which will eventually contribute to aging and decreased lifespan. In this review, we discuss what is currently known about mitochondrial dysfunction in the aging skeletal muscle and heart. We focused our discussion on the role of PGC-1 coactivators in the regulation of mitochondrial biogenesis and function and possible therapeutic benefits of increased mitochondrial biogenesis in compensating for mitochondrial dysfunction and circumventing aging and aging-related diseases. (c) 2012 IUBMB IUBMB Life, 2012
C1 [Dillon, Lloye M.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA.
   [Rebelo, Adriana P.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
C3 University of Miami; University of Miami
RP Moraes, CT (corresponding author), 1420 NW 9th Ave,Rm 229, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
RI Moraes, Carlos/AAT-3818-2021
OI Rebelo, Adriana/0000-0001-5669-7415; Dillon, Lloye/0000-0002-5118-1126
FU National Institutes of Health [1R01AG036871, 5R01CA085700, R56NS041777,
   5R01EY010804]; Muscular Dystrophy Association
FX This work was supported in part by the National Institutes of Health
   Grants 1R01AG036871, 5R01CA085700, R56NS041777, and 5R01EY010804, and
   the Muscular Dystrophy Association.
CR Adhihetty PJ, 2009, AM J PHYSIOL-CELL PH, V297, pC217, DOI 10.1152/ajpcell.00070.2009
   Anderson R, 2009, BBA-GEN SUBJECTS, V1790, P1059, DOI 10.1016/j.bbagen.2009.04.005
   Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169
   Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002
   Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018
   Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106
   Combaret L, 2009, CURR OPIN CLIN NUTR, V12, P37, DOI 10.1097/MCO.0b013e32831b9c31
   Conley KE, 2007, CURR OPIN CLIN NUTR, V10, P688, DOI 10.1097/MCO.0b013e3282f0dbfb
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002
   Eisele JC, 2008, BASIC RES CARDIOL, V103, P12, DOI 10.1007/s00395-007-0684-x
   Fagard RH, 2011, PROG CARDIOVASC DIS, V53, P404, DOI 10.1016/j.pcad.2011.03.006
   Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Hoeks J, 2012, J CELL PHYSIOL, V227, P1026, DOI 10.1002/jcp.22812
   Iversen N, 2011, EXP GERONTOL, V46, P670, DOI 10.1016/j.exger.2011.03.004
   Jackson J. R., J GERONTOL A, V66, P751
   Kelly DP, 2011, NATURE, V470, P342, DOI 10.1038/nature09896
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708
   Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Lehman JJ, 2008, AM J PHYSIOL-HEART C, V295, pH185, DOI 10.1152/ajpheart.00081.2008
   Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369
   Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li L, 2011, BASIC RES CARDIOL, V106, P1221, DOI 10.1007/s00395-011-0213-9
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200
   Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009
   Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000465
   Mirebeau-Prunier D, 2010, FEBS J, V277, P713, DOI 10.1111/j.1742-4658.2009.07516.x
   MONK JP, 1987, DRUGS, V33, P539, DOI 10.2165/00003495-198733060-00002
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Murase T, 2009, BIOGERONTOLOGY, V10, P423, DOI 10.1007/s10522-008-9177-z
   Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Philp A, 2011, AM J PHYSIOL-REG I, V301, pR864, DOI 10.1152/ajpregu.00232.2011
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905
   Rasbach KA, 2010, P NATL ACAD SCI USA, V107, P21866, DOI 10.1073/pnas.1016089107
   Rasmussen UF, 2003, EXP GERONTOL, V38, P877, DOI 10.1016/S0531-5565(03)00092-5
   Rebelo AP, 2011, J INHERIT METAB DIS, V34, P941, DOI 10.1007/s10545-011-9330-8
   Ren J., J MOL MED BERL, V88, P993
   Rowe GC, 2011, AM J PHYSIOL-ENDOC M, V301, pE155, DOI 10.1152/ajpendo.00681.2010
   Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818
   Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB
   Ryall JG, 2008, BIOGERONTOLOGY, V9, P213, DOI 10.1007/s10522-008-9131-0
   Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com
   Safdar A., PLOS ONE, V5
   Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Sihag S, 2009, J MOL CELL CARDIOL, V46, P201, DOI 10.1016/j.yjmcc.2008.10.025
   Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104
   Srivastava S, 2007, HUM MOL GENET, V16, P993, DOI 10.1093/hmg/ddm045
   Srivastava S, 2009, HUM MOL GENET, V18, P1805, DOI 10.1093/hmg/ddp093
   St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200
   Tatarková Z, 2011, PHYSIOL RES, V60, P281, DOI 10.33549/physiolres.932019
   Tenenbaum A, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-14
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003
   Viña J, 2009, ADV DRUG DELIVER REV, V61, P1369, DOI 10.1016/j.addr.2009.06.006
   VIRBASIUS CMA, 1993, GENE DEV, V7, P2431, DOI 10.1101/gad.7.12a.2431
   VIRBASIUS JV, 1993, GENE DEV, V7, P380, DOI 10.1101/gad.7.3.380
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Volkova M, 2005, CARDIOVASC RES, V66, P194, DOI 10.1016/j.cardiores.2004.11.016
   Wallace DC, 2000, AM HEART J, V139, pS70, DOI 10.1067/mhj.2000.103934
   Wang X, 2011, MOL ONCOL, V5, P399, DOI 10.1016/j.molonc.2011.07.008
   Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911
   Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115
   Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008
NR 100
TC 97
Z9 105
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1521-6543
EI 1521-6551
J9 IUBMB LIFE
JI IUBMB Life
PD MAR
PY 2012
VL 64
IS 3
BP 231
EP 241
DI 10.1002/iub.608
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 897QF
UT WOS:000300668200004
PM 22279035
OA Bronze, Green Accepted
DA 2024-11-01
ER

PT J
AU Tzoulis, C
   Tran, GT
   Schwarzlmüller, T
   Specht, K
   Haugarvoll, K
   Balafkan, N
   Lilleng, PK
   Miletic, H
   Biermann, M
   Bindoff, LA
AF Tzoulis, Charalampos
   Gia Tuong Tran
   Schwarzlmuller, Thomas
   Specht, Karsten
   Haugarvoll, Kristoffer
   Balafkan, Novin
   Lilleng, Peer K.
   Miletic, Hrvoje
   Biermann, Martin
   Bindoff, Laurence A.
TI Severe nigrostriatal degeneration without clinical parkinsonism in
   patients with polymerase gamma mutations
SO BRAIN
LA English
DT Article
DE substantia nigra; POLG; mitochondria; neurodegenerative disease;
   Parkinson's disease
ID MITOCHONDRIAL-DNA POLYMERASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   CHARLEVOIX-SAGUENAY ARSACS; SUBSTANTIA-NIGRA NEURONS; RECESSIVE SPASTIC
   ATAXIA; DISEASE; DELETIONS; DYSFUNCTION; POLG
AB The role of mitochondria in the pathogenesis of neurodegeneration is an area of intense study. It is known that defects in proteins involved in mitochondrial quality control can cause Parkinson's disease, and there is increasing evidence linking mitochondrial dysfunction, and particularly mitochondrial DNA abnormalities, to neuronal loss in the substantia nigra. Mutations in the catalytic subunit of polymerase gamma are among the most common causes of mitochondrial disease and owing to its role in mitochondrial DNA homeostasis, polymerase gamma defects are often considered a paradigm for mitochondrial diseases generally. Yet, despite this, parkinsonism is uncommon with polymerase gamma defects. In this study, we investigated structural and functional changes in the substantia nigra of 11 patients with polymerase gamma encephalopathy. We characterized the mitochondrial DNA abnormalities and examined the respiratory chain in neurons of the substantia nigra. We also investigated nigrostriatal integrity and function using a combination of post-mortem and in vivo functional studies with dopamine transporter imaging and positron emission tomography. At the cellular level, dopaminergic nigral neurons of patients with polymerase gamma encephalopathy contained a significantly lower copy number of mitochondrial DNA (depletion) and higher levels of deletions than normal control subjects. A selective and progressive complex I deficiency was seen and this was associated with a severe and progressive loss of the dopaminergic neurons of the pars compacta. Dopamine transporter imaging and positron emission tomography showed that the degree of nigral neuronal loss and nigrostriatal depletion were severe and appeared greater even than that seen in idiopathic Parkinson's disease. Despite this, however, none of our patients showed any signs of parkinsonism. The additional presence of both thalamic and cerebellar dysfunction in our patients suggested that these may play a role in counteracting the effects of basal ganglia dysfunction and prevent the development of clinical parkinsonism.
C1 [Tzoulis, Charalampos; Haugarvoll, Kristoffer; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Tzoulis, Charalampos; Gia Tuong Tran; Haugarvoll, Kristoffer; Balafkan, Novin; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Schwarzlmuller, Thomas; Biermann, Martin] Haukeland Hosp, Dept Radiol, Ctr Nucl Med PET, N-5021 Bergen, Norway.
   [Schwarzlmuller, Thomas; Biermann, Martin] Univ Bergen, Inst Surg Sci, Bergen, Norway.
   [Specht, Karsten] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.
   [Specht, Karsten] Haukeland Hosp, Dept Med Engn, N-5021 Bergen, Norway.
   [Lilleng, Peer K.; Miletic, Hrvoje] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway.
   [Lilleng, Peer K.] Univ Bergen, Gade Inst, Sect Pathol, Bergen, Norway.
   [Miletic, Hrvoje] Univ Bergen, Dept Biomed, Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of
   Bergen; University of Bergen; Haukeland University Hospital; University
   of Bergen; University of Bergen; University of Bergen; Haukeland
   University Hospital; University of Bergen; Haukeland University
   Hospital; University of Bergen; University of Bergen
RP Bindoff, LA (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
EM laurence.bindoff@nevro.uib.no
RI Biermann, Martin/AAM-8791-2020; Balafkan, Novin/AAE-9134-2019;
   Haugarvoll, Kristoffer/AAB-5860-2019; Haugarvoll,
   Kristoffer/L-1486-2015; Specht, Karsten/C-3762-2009; Tzoulis,
   Charalampos/AGD-5114-2022
OI Balafkan, Novin/0000-0001-8868-3800; Haugarvoll,
   Kristoffer/0000-0001-9381-1109; Bindoff, Laurence/0000-0003-0988-276X;
   Biermann, Martin/0000-0002-5550-1035; Schwarzlmuller,
   Thomas/0000-0002-8771-5548; Specht, Karsten/0000-0002-9946-3704;
   Tzoulis, Charalampos/0000-0003-0341-5191
FU Western Norway Health Trust; University of Bergen; Meltzer Foundation
FX This work was supported by grants from the Western Norway Health Trust,
   University of Bergen and the Meltzer Foundation.
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
   BOUCHARD RW, 1979, CAN J NEUROL SCI, V6, P191, DOI 10.1017/S0317167100119626
   Cottrell DA, 2000, J NEUROPATH EXP NEUR, V59, P621, DOI 10.1093/jnen/59.7.621
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Dickson DW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009258
   Dickson JC, 2012, EUR J NUCL MED MOL I, V39, P188, DOI 10.1007/s00259-011-1884-z
   Erichsen AK, 2009, BRAIN, V132, P1577, DOI 10.1093/brain/awp056
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Greenamyre JT, 1999, BIOCHEM SOC SYMP, V66, P85, DOI 10.1042/bss0660085
   Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Kann O, 2011, BRAIN, V134, P345, DOI 10.1093/brain/awq333
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Kozlov G, 2011, J BIOL CHEM, V286, P20407, DOI 10.1074/jbc.M111.232884
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lim SM, 2009, J NUCL MED, V50, P1638, DOI 10.2967/jnumed.109.065870
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Machado A, 2006, MOVEMENT DISORD, V21, pS247, DOI 10.1002/mds.20959
   Martinez TN, 2012, ANTIOXID REDOX SIGN, V16, P920, DOI 10.1089/ars.2011.4033
   Mills EM, 1999, TOXICOL APPL PHARM, V156, P6, DOI 10.1006/taap.1999.8630
   MINOSHIMA S, 1995, J NUCL MED, V36, P1238
   Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058
   Pifl C, 2012, MOVEMENT DISORD, V27, P1618, DOI 10.1002/mds.25109
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Reeve A.K., 2012, Mitochondrial Dysfunction in Neurodegenerative Disorders
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SINGER TP, 1990, FEBS LETT, V274, P1, DOI 10.1016/0014-5793(90)81315-F
   TOTH S, 1961, J NEUROL NEUROSUR PS, V24, P143, DOI 10.1136/jnnp.24.2.143
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Varrone A, 2004, ANN NEUROL, V55, P426, DOI 10.1002/ana.20054
NR 42
TC 71
Z9 72
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
J9 BRAIN
JI Brain
PD AUG
PY 2013
VL 136
BP 2393
EP 2404
DI 10.1093/brain/awt103
PN 8
PG 12
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 190KG
UT WOS:000322338000013
PM 23625061
OA Bronze
DA 2024-11-01
ER

PT J
AU Johnston, APW
   De Lisio, M
   Parise, G
AF Johnston, Adam P. W.
   De Lisio, Michael
   Parise, Gianni
TI Resistance training, sarcopenia, and the mitochondrial theory of aging
SO APPLIED PHYSIOLOGY NUTRITION AND METABOLISM
LA English
DT Article; Proceedings Paper
CT Symposium on Exercise and the Endothelium
CY 2005
CL Gatineau, CANADA
SP Canadian Soc Exercise Physiol
DE mitochondria; muscle atrophy; resistance exercise; electron transport
   chain; aging; reactive oxygen species
ID HUMAN SKELETAL-MUSCLE; DNA-DELETION MUTATIONS; FORCE PRODUCTION
   CHARACTERISTICS; FIBER CONTRACTILE FUNCTION; RESPIRATORY-CHAIN FUNCTION;
   ELECTRON-TRANSPORT CHAIN; PROTEIN-SYNTHESIS RATE; AGE-RELATED-CHANGES;
   OLDER MEN; OXIDATIVE DAMAGE
AB Skeletal muscle aging is associated with a significant loss of muscle mass, strength, function, and quality of life. In addition, the healthcare cost of aging and age-related disease is growing, and will continue to grow as a larger proportion of our population reaches retirement age and beyond. The mitochondrial theory of aging has been identified as a leading explanation of the aging process and describes a path leading to cellular senescence that includes electron transport chain deficiency, reactive oxygen species production, and the accumulation of mitochondrial DNA deletions and mutations. It is also quite clear that regular resistance exercise is a potent and effective countermeasure for skeletal muscle aging. In this review, we discuss age-related sarcopenia, the mitochondrial theory of aging, and how resistance exercise may directly affect key components of the mitochondrial theory. It is clear from the data discussed that regular resistance training can effectively disturb processes that contribute to the progression of aging as it pertains to the mitochondrial theory.
C1 [Johnston, Adam P. W.; De Lisio, Michael; Parise, Gianni] McMaster Univ, Dept Kinesiol, Hamilton, ON L8N 3Z5, Canada.
C3 McMaster University
RP Parise, G (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON L8N 3Z5, Canada.
EM pariseg@mcmaster.ca
CR Al Snih S, 2006, ETHNIC DIS, V16, P640
   [Anonymous], TELOMERES TELOMERASE
   BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205
   Balagopal P, 2001, AM J PHYSIOL-ENDOC M, V280, pE203, DOI 10.1152/ajpendo.2001.280.2.E203
   Barrientos A, 1996, BIOCHEM BIOPH RES CO, V229, P536, DOI 10.1006/bbrc.1996.1839
   Beaton LJ, 2002, CAN J APPL PHYSIOL, V27, P516, DOI 10.1139/h02-028
   Binder EF, 2005, J GERONTOL A-BIOL, V60, P1425, DOI 10.1093/gerona/60.11.1425
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Brill PA, 2000, MED SCI SPORT EXER, V32, P412, DOI 10.1097/00005768-200002000-00023
   BROWN AB, 1990, J APPL PHYSIOL, V69, P1725, DOI 10.1152/jappl.1990.69.5.1725
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   CAMPBELL WW, 1994, AM J CLIN NUTR, V60, P167, DOI 10.1093/ajcn/60.2.167
   Campisi J, 1996, EXP GERONTOL, V31, P7, DOI 10.1016/0531-5565(95)02024-1
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   CHARETTE SL, 1991, J APPL PHYSIOL, V70, P1912, DOI 10.1152/jappl.1991.70.5.1912
   Chretien D, 1998, BIOCHEM J, V329, P249, DOI 10.1042/bj3290249
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Fanò G, 2001, J MUSCLE RES CELL M, V22, P345, DOI 10.1023/A:1013122805060
   FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501
   Flynn MG, 1999, J APPL PHYSIOL, V86, P1905, DOI 10.1152/jappl.1999.86.6.1905
   Franceschi C, 1989, Aging (Milano), V1, P3
   Fries JF, 1996, J ROY SOC MED, V89, P64, DOI 10.1177/014107689608900202
   Frontera WR, 2000, J APPL PHYSIOL, V88, P1321
   FRONTERA WR, 1988, J APPL PHYSIOL, V64, P1038, DOI 10.1152/jappl.1988.64.3.1038
   Ganguli M, 2002, ARCH GEN PSYCHIAT, V59, P1046, DOI 10.1001/archpsyc.59.11.1046
   Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002
   Häkkinen K, 1998, J GERONTOL A-BIOL, V53, pB415, DOI 10.1093/gerona/53A.6.B415
   Häkkinen K, 2002, CAN J APPL PHYSIOL, V27, P213
   Häkkinen K, 2001, ACTA PHYSIOL SCAND, V171, P51, DOI 10.1046/j.1365-201x.2001.171001051.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harridge SDR, 1999, MUSCLE NERVE, V22, P831, DOI 10.1002/(SICI)1097-4598(199907)22:7<831::AID-MUS4>3.0.CO;2-3
   Herrero A, 1998, MECH AGEING DEV, V103, P133, DOI 10.1016/S0047-6374(98)00035-9
   Hikida RS, 2000, J GERONTOL A-BIOL, V55, pB347, DOI 10.1093/gerona/55.7.B347
   HSIEH RH, 1994, BIOCHEM MOL BIOL INT, V32, P1009
   HUNTER GR, 1995, J AM GERIATR SOC, V43, P756, DOI 10.1111/j.1532-5415.1995.tb07045.x
   Ivey FM, 2000, J GERONTOL A-BIOL, V55, pM641, DOI 10.1093/gerona/55.11.M641
   Janssen I, 2000, J APPL PHYSIOL, V89, P81
   KONDO H, 1993, AM J PHYSIOL, V265, pE839, DOI 10.1152/ajpendo.1993.265.6.E839
   Korhonen MT, 2006, J APPL PHYSIOL, V101, P906, DOI 10.1152/japplphysiol.00299.2006
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   LEEUWENBURGH C, 1994, AM J PHYSIOL, V267, pR439, DOI 10.1152/ajpregu.1994.267.2.R439
   Lemmer JT, 2000, MED SCI SPORT EXER, V32, P1505, DOI 10.1097/00005768-200008000-00021
   LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11
   Lindle RS, 1997, J APPL PHYSIOL, V83, P1581, DOI 10.1152/jappl.1997.83.5.1581
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LUHTALA TA, 1994, J GERONTOL, V49, pB231, DOI 10.1093/geronj/49.5.B231
   Lynch NA, 1999, J APPL PHYSIOL, V86, P188, DOI 10.1152/jappl.1999.86.1.188
   Martel GF, 2006, EXP PHYSIOL, V91, P457, DOI 10.1113/expphysiol.2005.032771
   Martinez M, 1996, BRAIN RES, V731, P246, DOI 10.1016/0006-8993(96)00708-1
   McCord J M, 1985, Adv Myocardiol, V5, P183
   Muller F, 2000, J AM AGING ASSOC, V23, P227, DOI 10.1007/s11357-000-0022-9
   Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200
   Ohishi S, 1997, CLIN EXP PHARMACOL P, V24, P326, DOI 10.1111/j.1440-1681.1997.tb01196.x
   ORGEL LE, 1963, P NATL ACAD SCI USA, V49, P517, DOI 10.1073/pnas.49.4.517
   PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804
   Pansarasa O, 2000, FREE RADICAL RES, V33, P287, DOI 10.1080/10715760000301451
   Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   Parise G, 2000, Curr Opin Clin Nutr Metab Care, V3, P489, DOI 10.1097/00075197-200011000-00012
   Phillips SM, 2005, J AM COLL NUTR, V24, p134S, DOI 10.1080/07315724.2005.10719454
   Rasmussen UF, 2003, EXP GERONTOL, V38, P877, DOI 10.1016/S0531-5565(03)00092-5
   Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130
   SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803
   Schlicht J, 2001, J GERONTOL A-BIOL, V56, pM281, DOI 10.1093/gerona/56.5.M281
   Singh MAF, 1999, AM J PHYSIOL-ENDOC M, V277, pE135
   *STAT CAN, 2007, AG SEX PERC DISTR BO
   *STAT CAN, 2007, AG SEX PERC CHANG 20
   Stupka N, 2000, J APPL PHYSIOL, V89, P2325, DOI 10.1152/jappl.2000.89.6.2325
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Trappe S, 2003, J PHYSIOL-LONDON, V552, P47, DOI 10.1113/jphysiol.2003.044966
   Trappe S, 2000, J APPL PHYSIOL, V89, P143, DOI 10.1152/jappl.2000.89.1.143
   Trappe S, 2001, AM J PHYSIOL-CELL PH, V281, pC398, DOI 10.1152/ajpcell.2001.281.2.C398
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vincent KR, 2002, EUR J APPL PHYSIOL, V87, P416, DOI 10.1007/s00421-002-0640-2
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Welle S, 1996, J GERONTOL A-BIOL, V51, pM270, DOI 10.1093/gerona/51A.6.M270
   Yarasheski KE, 1999, AM J PHYSIOL-ENDOC M, V277, pE118, DOI 10.1152/ajpendo.1999.277.1.E118
   YARASHESKI KE, 1995, AM J PHYSIOL-ENDOC M, V268, pE268, DOI 10.1152/ajpendo.1995.268.2.E268
   YARASHESKI KE, 1993, AM J PHYSIOL, V265, pE210, DOI 10.1152/ajpendo.1993.265.2.E210
NR 82
TC 114
Z9 151
U1 3
U2 20
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 1715-5312
EI 1715-5320
J9 APPL PHYSIOL NUTR ME
JI Appl. Physiol. Nutr. Metab.
PD FEB
PY 2008
VL 33
IS 1
BP 191
EP 199
DI 10.1139/H07-141
PG 9
WC Nutrition & Dietetics; Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Nutrition & Dietetics; Physiology; Sport Sciences
GA 318OE
UT WOS:000257100600023
PM 18347672
DA 2024-11-01
ER

PT J
AU Childs, AM
   Hutchin, T
   Pysden, K
   Highet, L
   Bamford, J
   Livingston, J
   Crow, YJ
AF Childs, A. -M.
   Hutchin, T.
   Pysden, K.
   Highet, L.
   Bamford, J.
   Livingston, J.
   Crow, Y. -J.
TI Variable phenotype including Leigh syndrome with a 9185T&gt;C mutation
   in the <i>MTATP6</i> gene
SO NEUROPEDIATRICS
LA English
DT Article
DE mitochondrial disease; Leigh syndrome; NARP; MTATP6; 9185T > C
ID MITOCHONDRIAL-DNA; DISEASE
AB We describe 15 members of a Caucasian family with an apparently homoplasmic T -> C mutation at nucleotide position 9185 (9185T>C) in the mtDNA encoded MTATP6 (ATPase 6) gene. The clinical phenotype is extremely variable and includes late-onset Leigh syndrome (LS), isolated demyelinating peripheral neuropathy and neurogenic muscle weakness, ataxia and retinitis pigmentosa (NARP). Following recent reports of this same mutation in a single case and in a family with late-onset LS and NARP-like features, our paper emphasises the role of MTATP6 in LS and expands the associated clinical phenotype further.
C1 [Childs, A. -M.; Pysden, K.; Highet, L.; Livingston, J.] Leeds Teaching Hosp Trust, Gen Infirm Leeds Belmont Grove, Dept Paediat Neurol, Leeds LS2 9NS, W Yorkshire, England.
   [Hutchin, T.; Crow, Y. -J.] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England.
   [Bamford, J.] Leeds Teaching Hosp Trust, Dept Neurol, Leeds Gen Infirm, Leeds, W Yorkshire, England.
C3 University of Leeds; Leeds General Infirmary; University of Leeds;
   University of Leeds; Leeds General Infirmary
RP Childs, AM (corresponding author), Leeds Teaching Hosp Trust, Gen Infirm Leeds Belmont Grove, Dept Paediat Neurol, B Floor,Clarendon Wing, Leeds LS2 9NS, W Yorkshire, England.
EM anne-marie.childs@leedsth.nhs.uk
RI Bamford, John/ABE-6218-2021; Crow, Yanick/N-6120-2014
OI Crow, Yanick/0000-0001-7211-7564; Bamford, John/0000-0002-7817-8832
CR Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   DAVIS PC, 1987, AM J NEURORADIOL, V8, P71
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   LYONS G, 1996, EARLY INFANTILE PROG
   Makino M, 2000, J HUM GENET, V45, P69, DOI 10.1007/s100380050014
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   Ogilvie I, 1999, FEBS LETT, V453, P179, DOI 10.1016/S0014-5793(99)00605-5
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Santorelli FM, 1996, PEDIATR RES, V39, P914, DOI 10.1203/00006450-199605000-00028
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
NR 10
TC 40
Z9 43
U1 1
U2 10
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0174-304X
J9 NEUROPEDIATRICS
JI Neuropediatrics
PD DEC
PY 2007
VL 38
IS 6
BP 313
EP 316
DI 10.1055/s-2008-1065355
PG 4
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 306HF
UT WOS:000256238200009
PM 18461509
DA 2024-11-01
ER

PT J
AU von Kleist-Retzow, JC
   Hornig-Do, HT
   Schauen, M
   Eckertz, S
   Dinh, TAD
   Stassen, F
   Lottmann, N
   Bust, M
   Galunska, B
   Wielckens, K
   Hein, W
   Beuth, J
   Braun, JM
   Fischer, JH
   Ganitkevich, VY
   Maniura-Weber, K
   Wiesner, RJ
AF von Kleist-Retzow, Juergen-Christoph
   Hornig-Do, Hue-Tran
   Schauen, Matthias
   Eckertz, Sabrina
   Dinh, Tuan Anh Duong
   Stassen, Frank
   Lottmann, Nadine
   Bust, Maria
   Galunska, Bistra
   Wielckens, Klaus
   Hein, Wolfgang
   Beuth, Joseph
   Braun, Jan-Matthias
   Fischer, Juergen H.
   Ganitkevich, Vladimir Y.
   Maniura-Weber, Katharina
   Wiesner, Rudolf J.
TI Impaired mitochondrial Ca<SUP>2+</SUP> homeostasis in respiratory
   chain-deficient cells but efficient compensation of energetic
   disadvantage by enhanced anaerobic glycolysis due to low ATP steady
   state levels
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
DE mitochondria; cell culture; tRNALeu(UUR)
ID MODIFICATION DEFECT; A3302G MUTATION; LACTIC-ACIDOSIS; DNA; MTDNA; RNA;
   MYOPATHY; ENCEPHALOPATHY; PATHOGENESIS; DYSFUNCTION
AB Energy-producing pathways, adenine nucleotide levels, oxidative stress response and Ca2+ homeostasis were investigated in cybrid cells incorporating two pathogenic mitochondrial DNA point mutations, 3243A>G and 3302A>G in tRNA(Leu(UUR)), as well as Rho(o) cells and compared to their parental 143B osteosarcoma cell line. All cells suffering from a severe respiratory chain deficiency were able to proliferate as fast as controls. The major defect in oxidative phosphorylation was efficiently compensated by a rise in anaerobic glycolysis, so that the total ATP production rate was preserved. This enhancement of glycolysis was enabled by a considerable decrease of cellular total adenine nucleotide pools and a concomitant shift in the AMP+ADP/ATP ratios, while the energy charge potential was still in the normal range. Further important consequences were an increased production of superoxide which, however, was neither escorted by major changes in the antioxidative defence systems nor was it leading to substantial oxidative damage. Most interestingly, the lowered mitochondrial membrane potential led to a disturbed intramitochondrial calcium homeostasis, which most likely is a major pathomechanism in mitochondrial diseases. (c) 2007 Elsevier Inc. All rights reserved.
C1 Univ Cologne, Inst Vegetat Physiol, D-50931 Cologne, Germany.
   Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany.
   Univ Cologne, Dept Pediat, D-50924 Cologne, Germany.
   Univ Med Varna, Dept Preclin, Clin Pharmacol & Biochem, Varna 9002, Bulgaria.
   Univ Cologne, Inst Clin Chem, D-50924 Cologne, Germany.
   Univ Cologne, Inst Naturopathy, D-50924 Cologne, Germany.
   Univ Cologne, Inst Expt Med, D-50931 Cologne, Germany.
   Univ Jena, Inst Physiol 2, D-07743 Jena, Germany.
C3 University of Cologne; University of Cologne; University of Cologne;
   Medical University Varna; University of Cologne; University of Cologne;
   University of Cologne; Friedrich Schiller University of Jena
RP von Kleist-Retzow, JC (corresponding author), Univ Cologne, Inst Vegetat Physiol, Robert Koch Str 39, D-50931 Cologne, Germany.
EM juergen-christoph.vonkleist@uk-koeln.de
RI Braun, Jan/B-1001-2009; Maniura, Katharina/N-2955-2016
OI Galunska, Bistra/0000-0002-2937-2874; Maniura,
   Katharina/0000-0001-7895-3563
CR Alberts B., 2007, MOL BIOL CELL
   Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x
   BINDOFF LA, 1993, J BIOL CHEM, V268, P19559
   Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396
   Campanella M, 2004, BIOL RES, V37, P653
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   El Meziane A, 1998, HUM MOL GENET, V7, P2141, DOI 10.1093/hmg/7.13.2141
   Fischer J., 1995, LC-GC Int., V8, P254
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   Hutchison WM, 2005, ARCH NEUROL-CHICAGO, V62, P1920, DOI 10.1001/archneur.62.12.1920
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   LEVINE RL, 1994, METHOD ENZYMOL, V233, P346
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921
   Maniura-Weber K, 2006, NUCLEIC ACIDS RES, V34, P6404, DOI 10.1093/nar/gkl727
   *MITOMAP, 2003, HUM MIT GEN DAT
   Möllers M, 2005, NUCLEIC ACIDS RES, V33, P5647, DOI 10.1093/nar/gki876
   MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Piva TJ, 1998, J CELL BIOCHEM, V68, P213, DOI 10.1002/(SICI)1097-4644(19980201)68:2<213::AID-JCB8>3.0.CO;2-Y
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034
   RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Schauen M, 2006, J CELL PHYSIOL, V209, P103, DOI 10.1002/jcp.20711
   SELLEVOLD OFM, 1986, J MOL CELL CARDIOL, V18, P517, DOI 10.1016/S0022-2828(86)80917-8
   Tavi P, 2005, HUM MOL GENET, V14, P1069, DOI 10.1093/hmg/ddi119
   Toompuu M, 2004, BIOCHEM BIOPH RES CO, V322, P803, DOI 10.1016/j.bbrc.2004.07.181
   van den Bosch BJC, 2004, NEUROMUSCULAR DISORD, V14, P683, DOI 10.1016/j.nmd.2004.06.004
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   von Kleist-Retzow JC, 2003, EXP PHYSIOL, V88, P155, DOI 10.1113/eph8802509
   WIESNER RJ, 2003, EUR J PHYSL, V445, pP4
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
NR 37
TC 51
Z9 53
U1 0
U2 4
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD AUG 15
PY 2007
VL 313
IS 14
BP 3076
EP 3089
DI 10.1016/j.yexcr.2007.04.015
PG 14
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA 199EU
UT WOS:000248679800011
PM 17509565
DA 2024-11-01
ER

PT J
AU Imasawa, T
   Tanaka, M
   Yamaguchi, Y
   Nakazato, T
   Kitamura, H
   Nishimura, M
AF Imasawa, Toshiyuki
   Tanaka, Masashi
   Yamaguchi, Yutaka
   Nakazato, Takashi
   Kitamura, Hiroshi
   Nishimura, Motonobu
TI 7501 T&gt;A mitochondrial DNA variant in a patient with
   glomerulosclerosis
SO RENAL FAILURE
LA English
DT Article
DE Glomerulosclerosis; granular swollen epithelial cell; mitochondria;
   mitochondrial DNA
ID FOCAL SEGMENTAL GLOMERULOSCLEROSIS; GENE MUTATION; NEPHROPATHY;
   INVOLVEMENT
AB The presence of granular swollen epithelial cells (GSECs) in tubular cells was recently reported to be a specific change associated with mitochondrial cytopathy. However, at present, GSEC is not routinely evaluated. We, in this study, present a case of glomerulosclerosis, in which the presence of GSECs should provide us one clue to understand the pathogenesis of its progressive decline of renal function. A 54-year-old Japanese female, who had been diagnosed with Graves' disease, was referred for the examination and treatment of her proteinuria (5.4 g/gCre at the first visit to our hospital). A kidney biopsy showed 28.6% of the glomeruli to be globally sclerosed and 10.7% of the glomeruli to have completely collapsed. However, according to a light microscopic analysis, all other glomeruli showed an almost normal appearance, except for some slight enlargement. Almost 30% of the interstitium was damaged by fibrosis. Characteristically, GSECs were observed in the medulla collecting ducts. Although she had no symptoms of either myopathy or encephalopathy, no history of stroke-like episodes or difficulty in hearing, her serum concentrations of lactate and pyruvate were both elevated. Therefore, mitochondrial DNA sequencing was performed to assess the etiopathogenesis of her nephropathy. Consequently, a homoplasmic 7501 T>A replacement, which has not been previously reported in patients with renal diseases, was detected. This case suggests that the routine evaluation of GSECs can provide important clues to assess the etiopathogenesis of cryptogenic glomerulosclerosis.
C1 [Imasawa, Toshiyuki; Kitamura, Hiroshi; Nishimura, Motonobu] Chiba East Hosp, Natl Hosp Org, Kidney & Diabet Ctr, Chiba 2608712, Japan.
   [Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Itabashi Ku, Tokyo, Japan.
   [Yamaguchi, Yutaka] Yamaguchi Pathol Lab, Matsudo, Chiba, Japan.
   [Nakazato, Takashi] Natl Hosp Org, Chiba Med Ctr, Dept Cardiol, Chiba, Japan.
C3 Tokyo Metropolitan Institute of Gerontology
RP Imasawa, T (corresponding author), Chiba East Hosp, Natl Hosp Org, Kidney & Diabet Ctr, Chuoh Ku, 673 Nitona Cho, Chiba 2608712, Japan.
EM imasawa@cehpnet.com
FU JSPS (Japan Society for the Promotion Science) KAKENHI [80348276];
   National Hospital Organization of Japan; Grants-in-Aid for Scientific
   Research [25242062] Funding Source: KAKEN
FX This work was supported by the JSPS (Japan Society for the Promotion
   Science) KAKENHI Grant Number 80348276 to T. Imasawa, and a grant from
   the National Hospital Organization of Japan to T. I.
CR Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833
   Doleris LM, 2000, KIDNEY INT, V58, P1851, DOI 10.1046/j.1523-1755.2000.00356.x
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Imasawa T, 2013, INT J BIOCHEM CELL B, V45, P2109, DOI 10.1016/j.biocel.2013.06.013
   Ishii R, 2010, ENDOCR J, V57, P73, DOI 10.1507/endocrj.K09E-230
   Kobayashi A, 2010, AM J SURG PATHOL, V34, P262, DOI 10.1097/PAS.0b013e3181cb4ed3
   Möllers M, 2005, NUCLEIC ACIDS RES, V33, P5647, DOI 10.1093/nar/gki876
   Mutai H, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-135
   O'Toole JF, 2014, INT J NEPHROL RENOV, V7, P57, DOI 10.2147/IJNRD.S37887
   Wrutniak-Cabello C, 2001, J MOL ENDOCRINOL, V26, P67, DOI 10.1677/jme.0.0260067
   Zaragoza MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012295
NR 13
TC 5
Z9 7
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0886-022X
EI 1525-6049
J9 RENAL FAILURE
JI Ren. Fail.
PD OCT
PY 2014
VL 36
IS 9
BP 1461
EP 1465
DI 10.3109/0886022X.2014.945181
PG 5
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA AS6RY
UT WOS:000344391200020
PM 25088491
DA 2024-11-01
ER

PT J
AU Rath, PP
   Jenkins, S
   Michaelides, M
   Smith, A
   Sweeney, MG
   Davis, MB
   Fitzke, FW
   Bird, AC
AF Rath, P. P.
   Jenkins, S.
   Michaelides, M.
   Smith, A.
   Sweeney, M. G.
   Davis, M. B.
   Fitzke, F. W.
   Bird, A. C.
TI Characterisation of the macular dystrophy in patients with the A3243G
   mitochondrial DNA point mutation with fundus autofluorescence
SO BRITISH JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID TRANSFER RNALEU(UUR) GENE; DIABETES-MELLITUS; GEOGRAPHIC ATROPHY;
   PATTERN DYSTROPHY; RETINAL MANIFESTATIONS; TRANSFER RNA(LEU(UUR));
   PREVALENCE; DEAFNESS; MELAS; MYOPATHY
AB Introduction: The mitochondrial DNA A3243G point mutation is associated with a wide variety of systemic manifestations including a macular dystrophy. The characteristics of fundus autofluorescence (AF) in these patients are distinctive and have not been previously described.
   Methods: A complete history and ophthalmic examination, including fundus photography and autofluorescence imaging, was performed on twelve probands harbouring the A3243G point mutation.
   Results: Four patients had diabetes, 10/12 hearing loss, and 7/12 were visually symptomatic. A positive family history was present in 5/12. Fundus findings consisted of two primary phenotypes: discontinuous circumferentially oriented perifoveal atrophy (9/12) or an appearance consistent with pattern dystrophy (3/12). In both phenotypes pale deposits and pigment clumping were seen at the level of the retinal pigment epithelium, with occasional changes also noted outside the arcades and nasal to the optic nerve. Fundus AF imaging revealed decreased autofluorescence in areas of atrophy and increased AF of the pale subretinal deposits. In areas of the retina that appeared normal clinically, variable sized flecks of increased and decreased AF were present.
   Conclusions: The mitochondrial DNA A3243G point mutation can result in disease with a variable presentation. Fundus autofluorescence reveals a recognisable phenotype in most cases that is different from other macular dystrophies.
C1 [Rath, P. P.] Retina Vitreous Consultants, Pittsburgh, PA 15213 USA.
   [Rath, P. P.; Jenkins, S.; Michaelides, M.; Smith, A.; Bird, A. C.] Moorfields Eye Hosp, London, England.
   [Jenkins, S.; Michaelides, M.; Fitzke, F. W.; Bird, A. C.] Inst Ophthalmol, London, England.
   [Smith, A.] Cty Hosp, Hereford HR1 2ER, England.
   [Sweeney, M. G.; Davis, M. B.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.
C3 University of London; University College London; Moorfields Eye Hospital
   NHS Foundation Trust; University of London; University College London;
   University of London; University College London
RP Rath, PP (corresponding author), Retina Vitreous Consultants, 3501 Forbes Ave,Suite 500, Pittsburgh, PA 15213 USA.
EM prprath@yahoo.com
RI Fitzke, Fred/C-3535-2008
CR Andrews RM, 1999, EYE, V13, P595, DOI 10.1038/eye.1999.151
   Bellmann C, 2002, ARCH OPHTHALMOL-CHIC, V120, P579, DOI 10.1001/archopht.120.5.579
   Bonte CA, 1997, RETINA-J RET VIT DIS, V17, P216, DOI 10.1097/00006982-199705000-00008
   Chinnery PF, 1999, J MED GENET, V36, P505, DOI 10.1136/jmg.36.7.505
   Chinnery PF, 1999, J MED GENET, V36, P425
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Deschauer M, 1999, NEUROMUSCULAR DISORD, V9, P305, DOI 10.1016/S0960-8966(99)00019-X
   Downes SM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1373, DOI 10.1001/archopht.117.10.1373
   Downes SM, 2001, ARCH OPHTHALMOL-CHIC, V119, P96
   Gavin JR, 1999, DIABETES CARE, V22, pS5
   Goodship JA, 2002, J MED GENET, V39, P221, DOI 10.1136/jmg.39.3.221
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   Harrison TJ, 1997, AM J OPHTHALMOL, V124, P217, DOI 10.1016/S0002-9394(14)70787-1
   Holmes-Walker DJ, 1999, DIABETOLOGIA, V42, P1028
   Holz FG, 1999, GRAEF ARCH CLIN EXP, V237, P145, DOI 10.1007/s004170050209
   Isashiki Y, 1998, ACTA OPHTHALMOL SCAN, V76, P6, DOI 10.1034/j.1600-0420.1998.760103.x
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   KISHIMOTO M, 1995, DIABETOLOGIA, V38, P193, DOI 10.1007/s001250050270
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Kurz-Levin MM, 2002, ARCH OPHTHALMOL-CHIC, V120, P567, DOI 10.1001/archopht.120.5.567
   Latkany P, 1999, AM J OPHTHALMOL, V128, P112, DOI 10.1016/S0002-9394(99)00057-4
   Lehto M, 1999, DIABETOLOGIA, V42, P1131, DOI 10.1007/s001250051281
   Lois N, 2001, ARCH OPHTHALMOL-CHIC, V119, P359, DOI 10.1001/archopht.119.3.359
   MANOUVRIER S, 1995, J MED GENET, V32, P654, DOI 10.1136/jmg.32.8.654
   MASSIN P, 1995, AM J OPHTHALMOL, V120, P247, DOI 10.1016/S0002-9394(14)72615-7
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   MORGANHUGHES JA, 1995, BBA-MOL BASIS DIS, V1271, P135, DOI 10.1016/0925-4439(95)00020-5
   MULLIE MA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1825, DOI 10.1001/archopht.1985.01050120059020
   Newkirk JE, 1997, DIABETIC MED, V14, P457, DOI 10.1002/(SICI)1096-9136(199706)14:6<457::AID-DIA372>3.3.CO;2-N
   OTABE S, 1994, J CLIN ENDOCR METAB, V79, P768, DOI 10.1210/jc.79.3.768
   REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3
   Saker PJ, 1997, DIABETIC MED, V14, P42, DOI 10.1002/(SICI)1096-9136(199701)14:1<42::AID-DIA295>3.0.CO;2-T
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   THART LM, 1994, DIABETOLOGIA, V37, P1169
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   VIONNET N, 1993, LANCET, V342, P1429, DOI 10.1016/0140-6736(93)92792-R
   VONRUCKMANN A, 1995, BRIT J OPHTHALMOL, V79, P407, DOI 10.1136/bjo.79.5.407
   vonRuckmann A, 1997, ARCH OPHTHALMOL-CHIC, V115, P609, DOI 10.1001/archopht.1997.01100150611006
NR 41
TC 39
Z9 42
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0007-1161
EI 1468-2079
J9 BRIT J OPHTHALMOL
JI Br. J. Ophthalmol.
PD MAY
PY 2008
VL 92
IS 5
BP 623
EP 629
DI 10.1136/bjo.2007.131177
PG 7
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 293MC
UT WOS:000255338400010
PM 18441172
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Swerdlow, RH
   Khan, SM
AF Swerdlow, RH
   Khan, SM
TI A "mitochondrial cascade hypthesis" for sporadic Alzheimer's disease
SO MEDICAL HYPOTHESES
LA English
DT Review
ID CYTOCHROME-C-OXIDASE; AMYLOID PRECURSOR PROTEIN;
   AMYOTROPHIC-LATERAL-SCLEROSIS; RESPIRATORY-CHAIN FUNCTION; MTDNA POINT
   MUTATIONS; HUMAN SKELETAL-MUSCLE; PARKINSONS-DISEASE; OXIDATIVE STRESS;
   HYDROGEN-PEROXIDE; DNA DELETION
AB Alzheimer's disease (AD) includes etiologically heterogenous disorders characterized by senile or presenile dementia, extracellular amyloid protein aggregations containing an insoluble amytoid precursor protein derivative, and intracytoptasmic tau protein aggregations. Recent studies also show excess neuronal aneuptoidy, programmed cell death (PCD), and mitochondrial dysfunction. The leading AD molecular paradigm, the "amyloid cascade hypothesis", is based on studies of rare autosomal dominant variants and does not specify what initiates the common late-onset, sporadic form. We propose for late-onset, sporadic AD a "mitochondrial cascade hypothesis" that comprehensively reconciles seemingly disparate histopathologic and pathophysiologic features. In our model, the inherited, gene-determined make-up of an individual's electron transport chain sets basal rates of reactive oxygen species (ROS) production, which determines the pace at which acquired mitochondrial damage accumulates. Oxidative mitochondrial DNA, RNA, lipid, and protein damage amplifies ROS production and triggers three events: (1) a reset response in which cells respond to elevated ROS by generating the beta-sheet protein, beta amyloid, which further perturbs mitochondrial function, (2) a removal response in which compromised cells are purged via PCD mechanisms, and (3) a replace response in which neuronal progenitors unsuccessfully attempt to re-enter the cell cycle, with resultant aneuploidy, tau phosphorylation, and neurofibrillary tangle formation. In addition to defining a rote for aging in AD pathogenesis, the mitochondrial cascade hypothesis also allows and accounts for histopathologic overlap between the sporadic, late-onset and autosomal dominant, early onset forms of the disease. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Virginia Hlth Syst, Dept Neurol, Charlottesville, VA 22908 USA.
   Univ Virginia Hlth Syst, Ctr Study Neurodegenerat Dis, Charlottesville, VA 22908 USA.
   Univ Virginia Hlth Syst, Dept Neurosci, Charlottesville, VA 22908 USA.
   Gencia Corp, Charlottesville, VA 22903 USA.
C3 University of Virginia; University of Virginia; University of Virginia
RP Univ Virginia Hlth Syst, Dept Neurol, POB 800394,1 Hosp Dr, Charlottesville, VA 22908 USA.
EM rhs7e@virginia.edu
CR Alzheimer A., 1907, Allgemeine Zeitschrift fur Psychiatrie und psychisch-gerichtliche Medizin, P146
   AMADUCCI LA, 1986, NEUROLOGY, V36, P1497, DOI 10.1212/WNL.36.11.1497
   Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030
   Anderton BH, 2002, MECH AGEING DEV, V123, P811, DOI 10.1016/S0047-6374(01)00426-2
   Arendt T, 2000, NEUROBIOL AGING, V21, P783, DOI 10.1016/S0197-4580(00)00216-5
   Arias C, 2002, EXP NEUROL, V176, P163, DOI 10.1006/exnr.2002.7912
   Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081
   Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817
   Barinaga M, 1998, SCIENCE, V281, P1303, DOI 10.1126/science.281.5381.1303
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Beckman KB, 1998, ANN NY ACAD SCI, V854, P118, DOI 10.1111/j.1749-6632.1998.tb09897.x
   Bijur GN, 1999, MOL BRAIN RES, V71, P69, DOI 10.1016/S0169-328X(99)00168-0
   Billingsley ML, 1997, BIOCHEM J, V323, P577, DOI 10.1042/bj3230577
   BLASS JP, 1990, ARCH NEUROL-CHICAGO, V47, P864, DOI 10.1001/archneur.1990.00530080046009
   Boller F, 1998, J NEUROL SCI, V158, P125, DOI 10.1016/S0022-510X(98)00128-2
   BOROWSKY IW, 1989, NEUROSCIENCE, V33, P253, DOI 10.1016/0306-4522(89)90204-2
   Bosetti F, 2002, NEUROBIOL AGING, V23, P371, DOI 10.1016/S0197-4580(01)00314-1
   BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617
   BOWLING AC, 1993, J NEUROCHEM, V60, P1964, DOI 10.1111/j.1471-4159.1993.tb13430.x
   BRAND FN, 1992, J CLIN EPIDEMIOL, V45, P169, DOI 10.1016/0895-4356(92)90009-C
   Brierley EJ, 1997, MOL CELL BIOCHEM, V174, P325, DOI 10.1023/A:1006847319162
   BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Canevari L, 1999, FEBS LETT, V457, P131, DOI 10.1016/S0014-5793(99)01028-5
   Capuano F, 1997, J BIOENERG BIOMEMBR, V29, P379, DOI 10.1023/A:1022402915431
   Capuano F, 1996, BIOCHEM MOL BIOL INT, V38, P1013
   Cardoso S. M., 1999, Society for Neuroscience Abstracts, V25, P337
   Cardoso SM, 2001, FASEB J, V15, P1439, DOI 10.1096/fj.00-0561fje
   Cardoso SM, 2002, BRAIN RES, V931, P117, DOI 10.1016/S0006-8993(02)02256-4
   CARDOSOS SM, IN PRESS J NEUROCHEM
   Cassarino DS, 1997, BBA-MOL BASIS DIS, V1362, P77, DOI 10.1016/S0925-4439(97)00070-7
   Cassarino DS, 2000, J NEUROCHEM, V74, P1384, DOI 10.1046/j.1471-4159.2000.0741384.x
   Cassarino DS, 1998, BIOCHEM BIOPH RES CO, V248, P168, DOI 10.1006/bbrc.1998.8866
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CHENG KC, 1992, J BIOL CHEM, V267, P166
   CHOMYN A, 1994, AM J HUM GENET, V54, P966
   Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9
   Chueh PJ, 2000, ANTIOXID REDOX SIGN, V2, P177, DOI 10.1089/ars.2000.2.2-177
   Coller HA, 2002, ANN NY ACAD SCI, V959, P434, DOI 10.1111/j.1749-6632.2002.tb02113.x
   CONNOLLY JA, 1977, P NATL ACAD SCI USA, V74, P2437, DOI 10.1073/pnas.74.6.2437
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cummings JL, 2002, JAMA-J AM MED ASSOC, V287, P2335, DOI 10.1001/jama.287.18.2335
   Curti D, 1997, NEUROSCI LETT, V236, P13, DOI 10.1016/S0304-3940(97)00741-6
   Davis DG, 1999, J NEUROPATH EXP NEUR, V58, P376, DOI 10.1097/00005072-199904000-00008
   Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   de Grey A.D.N.J., 1998, J. Anti-Aging Med, V1, P53, DOI [10.1089/rej.1.1998.1.53, DOI 10.1089/REJ.1.1998.1.53]
   De Sarno P, 2000, NEUROBIOL AGING, V21, P31, DOI 10.1016/S0197-4580(00)00095-6
   Delobel P, 2002, J NEUROCHEM, V83, P412, DOI 10.1046/j.1471-4159.2002.01143.x
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Dorward A, 1997, J BIOENERG BIOMEMBR, V29, P385, DOI 10.1023/A:1022454932269
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   DUARA R, 1993, NEUROLOGY, V43, P1377, DOI 10.1212/WNL.43.7.1377
   Dyall SD, 2003, J BIOL CHEM, V278, P30548, DOI 10.1074/jbc.M304032200
   Edland SD, 1996, NEUROLOGY, V47, P254, DOI 10.1212/WNL.47.1.254
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Esiri MM, 2001, LANCET, V357, P169
   EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.1989.03430180093036
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Fischer O, 1907, MON PSYCHIATR NEUROL, V22, P361
   Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0
   GABUZDA D, 1994, J BIOL CHEM, V269, P13623
   Gadaleta MN, 1998, BIOCHIMIE, V80, P863, DOI 10.1016/S0300-9084(00)88881-1
   Gershon D, 1999, EXP GERONTOL, V34, P613, DOI 10.1016/S0531-5565(99)00010-8
   Ghosh SS, 1999, ANN NY ACAD SCI, V893, P176, DOI 10.1111/j.1749-6632.1999.tb07825.x
   Ginsberg MD, 2003, J MOL BIOL, V327, P885, DOI 10.1016/S0022-2836(03)00173-6
   GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V
   HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARTIGAN JA, 1998, ALZHEIMERS DIS REV, V3, P125
   Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4
   Jauniaux E, 2003, PLACENTA, V24, pS86, DOI 10.1053/plac.2002.0932
   Johansson CB, 2003, J CELL PHYSIOL, V196, P409, DOI 10.1002/jcp.10293
   JOHNSON MH, 1994, BIOESSAYS, V16, P31, DOI 10.1002/bies.950160105
   KATZMAN R, 1986, NEW ENGL J MED, V314, P964, DOI 10.1056/NEJM198604103141506
   KATZMAN R, 1976, ARCH NEUROL-CHICAGO, V33, P217, DOI 10.1001/archneur.1976.00500040001001
   Katzman R., 1978, Alzheimers Disease: Senile Dementia and Related Disorders, P579
   Khan SM, 2000, ANN NEUROL, V48, P148, DOI 10.1002/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Klein JA, 2003, J CLIN INVEST, V111, P785, DOI 10.1172/JCI200318182
   Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132
   Kovalenko SA, 1997, BIOCHEM BIOPH RES CO, V232, P147, DOI 10.1006/bbrc.1997.6251
   Kowald A, 1999, EXP GERONTOL, V34, P605, DOI 10.1016/S0531-5565(99)00011-X
   Kraepelin E., 1910, Psychiatrie, Ein Lehrbuch fur Studierende und Arzte
   Kwon YW, 2003, BIOL CHEM, V384, P991, DOI 10.1515/BC.2003.111
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   LARM JA, 1994, J BIOL CHEM, V269, P30097
   LAWEN A, 1994, MOL ASPECTS MED, V15, P13
   LEDESMA A, 2003, GENOME BIOL, V3, P3015
   Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x
   LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622
   Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9
   Lovestone S, 1997, NEUROSCIENCE, V78, P309
   Mancuso M, 2003, EXP NEUROL, V182, P421, DOI 10.1016/S0014-4886(03)00092-X
   Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025
   Mark RJ, 1997, BRAIN RES, V756, P205, DOI 10.1016/S0006-8993(97)00196-0
   Mattson MP, 2002, NEUROMOL MED, V2, P215, DOI 10.1385/NMM:2:2:215
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   Melov S, 1999, NEUROBIOL AGING, V20, P565, DOI 10.1016/S0197-4580(99)00092-5
   Melov S, 2000, ANN NY ACAD SCI, V908, P219
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   *MITOMAP, 2001, HUM MIT GEN DAT
   Morré DM, 2000, J EXP BIOL, V203, P1513
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   NASRESFAHANI MH, 1990, DEVELOPMENT, V109, P501
   NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Nunomura A, 1999, J NEUROSCI, V19, P1959
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z
   Papa S, 1996, BBA-BIOENERGETICS, V1276, P87, DOI 10.1016/0005-2728(96)00077-1
   PARKER WD, 1994, NEUROLOGY, V44, P1086, DOI 10.1212/WNL.44.6.1086
   PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302
   Pereira C, 1998, NEUROREPORT, V9, P1749, DOI 10.1097/00001756-199806010-00015
   PERUSINI G, 1911, RIV ITALIANA NEUROPA, V4, P145
   Petit PX, 1997, MOL CELL BIOCHEM, V174, P185, DOI 10.1023/A:1006848205880
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Robinson SR, 2002, NEUROBIOL AGING, V23, P1051, DOI 10.1016/S0197-4580(01)00342-6
   ROTH GS, 1995, NAT MED, V1, P414, DOI 10.1038/nm0595-414
   Roubertoux PL, 2003, NAT GENET, V35, P65, DOI 10.1038/ng1230
   SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105
   Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17
   Shan X, 2003, J NEUROSCI, V23, P4913
   Sheehan JP, 1997, J NEUROSCI, V17, P4612
   Sheehan JP, 1997, J NEUROCHEM, V68, P1221
   SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Shults CW, 1998, MOV DISORD S2, V13, P217
   SMIGRODZKI R, IN PRESS NEUROBIOL A
   Smith MA, 2000, ANTIOXID REDOX SIGN, V2, P413, DOI 10.1089/15230860050192198
   Snowdon DA, 2003, ANN INTERN MED, V139, P450, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00014
   SOHAL RS, 1995, J BIOL CHEM, V270, P15671, DOI 10.1074/jbc.270.26.15671
   SOONG NW, 1992, NAT GENET, V2, P318
   SWEET S, 1995, CANCER RES, V55, P5164
   Swerdlow RH, 2000, AMYOTROPH LATERAL SC, V1, P185, DOI 10.1080/14660820050515179
   Swerdlow RH, 2000, J NEUROCHEM, V75, P1681, DOI 10.1046/j.1471-4159.2000.0751681.x
   Swerdlow RH, 1998, EXP NEUROL, V153, P135, DOI 10.1006/exnr.1998.6866
   Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918
   Swerdlow RH, 2002, INT REV NEUROBIOL, V53, P341
   Swerdlow RH, 2002, ARCH PATHOL LAB MED, V126, P271
   Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   SWERDLOW RH, 2000, MOL MECH NEURODEGENE, P233
   SWERDLOW RH, 2001, PARKINSONISM RELAT D, V7, P47
   Sylvestre J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r44
   Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8
   Taylor DR, 2002, P NATL ACAD SCI USA, V99, P3690, DOI 10.1073/pnas.072660299
   Trimarchi JR, 2000, BIOL REPROD, V62, P1866, DOI 10.1095/biolreprod62.6.1866
   Trimmer PA, 2000, EXP NEUROL, V162, P37, DOI 10.1006/exnr.2000.7333
   Trimmer PA, 2004, J NEUROCHEM, V88, P800, DOI 10.1046/j.1471-4159.2003.02168.x
   Trimmer PA, 2004, NEUROBIOL DIS, V15, P29, DOI 10.1016/j.nbd.2003.09.011
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Uriel J, 1979, Adv Cancer Res, V29, P127, DOI 10.1016/S0065-230X(08)60847-7
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Veech GA, 2000, J NEUROSCI RES, V61, P693
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Webster MT, 1998, J NEURAL TRANSM, V105, P839, DOI 10.1007/s007020050098
   Wolin Michael S., 1996, Microcirculation (Philadelphia), V3, P1, DOI 10.3109/10739689609146778
   WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3
   Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129
   Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   ZABAR Y, 2000, NEURODEGENERATIVE DE, P79
   Zamzami N, 1997, J BIOENERG BIOMEMBR, V29, P185, DOI 10.1023/A:1022694131572
   Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549
NR 180
TC 556
Z9 659
U1 1
U2 61
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PY 2004
VL 63
IS 1
BP 8
EP 20
DI 10.1016/j.mehy.2003.12.045
PG 13
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 832VA
UT WOS:000222294200002
PM 15193340
DA 2024-11-01
ER

PT J
AU Sadeesh, EM
   Singla, N
   Lahamge, MS
   Kumari, S
   Ampadi, AN
   Anuj, M
AF Sadeesh, E. M.
   Singla, Nancy
   Lahamge, Madhuri S.
   Kumari, Sweta
   Ampadi, A. N.
   Anuj, M.
TI Tissue heterogeneity of mitochondrial activity, biogenesis and
   mitochondrial protein gene expression in buffalo
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE Buffalo; Tissue-specific; Mitochondria; OXPHOS complexes; Mitochondria
   protein coding gene
ID DNA COPY NUMBER; LIVER MITOCHONDRIAL; DYSFUNCTION; MECHANISMS; DISEASE;
   CATFISH; MUSCLE
AB BackgroundCellular metabolism is most invariant process, occurring in all living organisms, which involves mitochondrial proteins from both nuclear and mitochondrial genomes. The mitochondrial DNA (mtDNA) copy number, protein-coding genes (mtPCGs) expression, and activity vary between various tissues to fulfill specific energy demands across the tissues.Methods and ResultsIn present study, we investigated the OXPHOS complexes and citrate synthase activity in isolated mitochondria from various tissues of freshly slaughtered buffaloes (n = 3). Further, the evaluation of tissue-specific diversity based on the quantification of mtDNA copy numbers was performed and also comprised an expression study of 13 mtPCGs. We found that the functional activity of individual OXPHOS complex I was significantly higher in the liver compared to muscle and brain. Additionally, OXPHOS complex III and V activities was observed significantly higher levels in liver compared to heart, ovary, and brain. Similarly, CS-specific activity differs between tissues, with the ovary, kidney, and liver having significantly greater. Furthermore, we revealed the mtDNA copy number was strictly tissue-specific, with muscle and brain tissues exhibiting the highest levels. Among 13 PCGs expression analyses, mRNA abundances in all genes were differentially expressed among the different tissue.ConclusionsOverall, our results indicate the existence of a tissue-specific variation in mitochondrial activity, bioenergetics, and mtPCGs expression among various types of buffalo tissues. This study serves as a critical first stage in gathering vital comparable data about the physiological function of mitochondria in energy metabolism in distinct tissues, laying the groundwork for future mitochondrial based diagnosis and research.
C1 [Sadeesh, E. M.; Singla, Nancy; Lahamge, Madhuri S.; Kumari, Sweta; Ampadi, A. N.; Anuj, M.] ICAR Natl Dairy Res Inst, Anim Biochem Div, Lab Mitochondrial Biol Farm Anim, Karnal, Haryana, India.
C3 Indian Council of Agricultural Research (ICAR); ICAR - National Dairy
   Research Institute
RP Sadeesh, EM (corresponding author), ICAR Natl Dairy Res Inst, Anim Biochem Div, Lab Mitochondrial Biol Farm Anim, Karnal, Haryana, India.
EM sadeeshcirb@gmail.com
RI E.M, Sadeesh/ABB-8558-2020
OI E.M, Sadeesh/0000-0001-9101-4288; Anuj, Anuj/0000-0001-9442-3319
CR 20th Livestock census, 2019, All India Report
   Al-Kafaji G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/754946
   Alex AP, 2015, J DAIRY SCI, V98, P4439, DOI 10.3168/jds.2014-8917
   Annesley SJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070680
   Basu U, 2020, J BIOL CHEM, V295, P18406, DOI 10.1074/jbc.REV120.011202
   Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006
   Bujan N, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11040741
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013
   Dorji J, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-07018-7
   Eigentler A., 2020, Mitochondrial Physiol Netw, V17, P1
   Fernández-Vizarra E, 2011, MITOCHONDRION, V11, P207, DOI 10.1016/j.mito.2010.09.011
   Fukunaga H, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126634
   Glaister M, 2005, SPORTS MED, V35, P757, DOI 10.2165/00007256-200535090-00003
   Gureev AP, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00435
   Hebert JF, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2020.165967
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   Hood WR, 2018, INTEGR COMP BIOL, V58, P480, DOI 10.1093/icb/icy089
   Jezek P, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10121921
   Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC698, DOI 10.1152/ajpcell.00109.2006
   Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770
   Kennedy KM, 2021, J DAIRY SCI, V104, P9287, DOI 10.3168/jds.2020-20031
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kunz WS, 2003, EXP PHYSIOL, V88, P149, DOI 10.1113/eph8802512
   Lane RK, 2015, BBA-BIOENERGETICS, V1847, P1387, DOI 10.1016/j.bbabio.2015.05.021
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Laubenthal L, 2016, J DAIRY SCI, V99, P1571, DOI 10.3168/jds.2015-9847
   Lee JY, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/586017
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Manczak M, 2005, J NEUROCHEM, V92, P494, DOI 10.1111/j.1471-4159.2004.02884.x
   Marí M, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10020314
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003
   Poulton J, 2017, MOL DIAGN THER, V21, P419, DOI 10.1007/s40291-017-0279-7
   Protasoni M, 2020, EMBO J, V39, DOI 10.15252/embj.2019102817
   Qu B, 2012, ACTA HISTOCHEM, V114, P448, DOI 10.1016/j.acthis.2011.08.007
   Ramanathan R., 2021, Meat and Muscle Biology, V5, DOI DOI 10.22175/MMB.11705
   Sanglard LP, 2022, J ANIM SCI, V100, DOI 10.1093/jas/skac059
   Spehar Marija, 2017, Agriculturae Conspectus Scientificus, V82, P263
   Uittenbogaard M, 2014, CURR PHARM DESIGN, V20, P5574, DOI 10.2174/1381612820666140305224906
   Vaughan OR, 2016, REPROD DOMEST ANIM, V51, P25, DOI 10.1111/rda.12797
   Vuda M, 2016, MITOCHONDRION, V31, P63, DOI 10.1016/j.mito.2016.10.005
   Weikard R, 2018, MOL BIOL REP, V45, P1209, DOI 10.1007/s11033-018-4273-x
   Yan YL, 2015, COMP BIOCHEM PHYS A, V183, P64, DOI 10.1016/j.cbpa.2014.12.011
   Yan YL, 2011, CURR ZOOL, V57, P109, DOI 10.1093/czoolo/57.1.109
NR 47
TC 5
Z9 5
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD JUN
PY 2023
VL 50
IS 6
BP 5255
EP 5266
DI 10.1007/s11033-023-08416-2
EA MAY 2023
PG 12
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA F8W6Y
UT WOS:000980316900001
PM 37140692
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Di Donato, S
AF Di Donato, Stefano
TI Multisystem manifestations of mitochondrial disorders
SO JOURNAL OF NEUROLOGY
LA English
DT Review
DE Mitochondrial disorders; Respiratory chain; Oxidative phosphorylation;
   Multisystem manifestations
ID CYTOCHROME-C-OXIDASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; KEARNS-SAYRE
   SYNDROME; INHERITED HYPERTROPHIC CARDIOMYOPATHY; COMPLEX-III DEFICIENCY;
   DIABETES-MELLITUS; POINT MUTATION; OXIDATIVE-PHOSPHORYLATION;
   RESPIRATORY-CHAIN; DNA MUTATION
AB Mitochondria are cytoplasmic organelles in eukaryotic cells that accomplish several distinct vital functions, including oxidative phosphorylation, metabolic anaplerotic and degradative pathways, and integration of signaling for apoptosis. Impaired oxidative phosphorylation, the common final pathway of mitochondrial metabolism, results in a variety of clinical manifestations, and the term mitochondrial disorders is currently ascribed to (mostly) genetic diseases of the respiratory chain associated with mitochondrial DNA mutation or nuclear DNA mutations. Genetic disorders with impaired oxidative phosphorylation are extremely heterogeneous, as their clinical presentation ranges from lesions of single tissues or specialized structures, such as the optic nerve in the mitochondrial DNA-associated Leber's hereditary optic neuropathy and in the nuclear DNA-associated dominant optic atrophy, to more widespread pathologies, including myopathies, peripheral neuropathies, encephalomyopathies, cardiopathies, or complex multisystem disorders. The age at onset ranges from neonatal to adult life. This review focuses on mitochondrial diseases that find significant expression outside the central nervous system and the peripheral neuromuscular system, and manifest with substantial clinical signs and symptoms in tissues and organs such as the heart, endocrine system, liver, kidney, blood, and gastrointestinal tract. The available information on putative genotype-phenotype correlations and the related pathogenic mechanisms are summarized when appropriate.
C1 [Di Donato, Stefano] Fdn IRCCS Ist Neurol Carlo Besta, Milano Via Celoria 11, I-20133 Milan, Italy.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta
RP Di Donato, S (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Milano Via Celoria 11, I-20133 Milan, Italy.
EM didonato@istituto-besta.it
RI Di Donato, Stefano/B-9717-2012
FU Ministero della Salute; Fondazione Cariplo [2005-1602]
FX I am indebted to Dr. Loredana Lamantea, Division of Molecular
   Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta,
   Milano, for the artwork shown in Fig. 1, and to Dr. Franco Taroni, Unit
   of Genetics of Neurodegenerative and Metabolic Disease, Fondazione IRCCS
   Istituto Neurologico `` Carlo Besta'', Milano, for his critical reading
   of the manuscript. The author was supported by grants from Ministero
   della Salute (Ex art. 56, 2007, Italy) and Fondazione Cariplo (Prot.
   2005-1602, Italy).
CR Alcolado JC, 2002, DIABETIC MED, V19, P89, DOI 10.1046/j.1464-5491.2002.00675.x
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   AnkelSimons F, 1996, P NATL ACAD SCI USA, V93, P13859, DOI 10.1073/pnas.93.24.13859
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Antozzi C, 1997, CARDIOVASC RES, V35, P184, DOI 10.1016/S0008-6363(97)00141-7
   Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282
   BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Baughman JM, 2006, NAT GENET, V38, P1232, DOI 10.1038/ng1106-1232
   Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848
   Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X
   Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   CASALI C, 1995, BIOCHEM BIOPH RES CO, V213, P588, DOI 10.1006/bbrc.1995.2172
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Di Donato S, 2000, J INHERIT METAB DIS, V23, P247, DOI 10.1023/A:1005684029429
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   DiMauro S, 2007, J CLIN INVEST, V117, P587, DOI 10.1172/JCI31423
   Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   EVIATAR L, 1990, NEUROLOGY, V40, P1761, DOI 10.1212/WNL.40.11.1761
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fernández-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028
   FINOCCHIARO G, 1988, NEUROLOGY, V38, P1292, DOI 10.1212/WNL.38.8.1292
   Gámez J, 1998, NEUROLOGY, V51, P258, DOI 10.1212/WNL.51.1.258
   Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grasso M, 2001, EUR J HUM GENET, V9, P311, DOI 10.1038/sj.ejhg.5200622
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0
   Hinson JT, 2007, NEW ENGL J MED, V356, P809, DOI 10.1056/NEJMoa055262
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hsieh RH, 2001, J BIOMED SCI, V8, P328, DOI 10.1159/000054051
   Hutchin TP, 2000, CELL MOL LIFE SCI, V57, P1927, DOI 10.1007/PL00000673
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Kameoka K, 1998, BIOCHEM BIOPH RES CO, V245, P523, DOI 10.1006/bbrc.1998.8437
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lee WS, 2007, HEPATOLOGY, V45, P1555, DOI 10.1002/hep.21710
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Lynn S, 1998, DIABETES, V47, P1800, DOI 10.2337/diabetes.47.11.1800
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   MANOUVRIER S, 1995, J MED GENET, V32, P654, DOI 10.1136/jmg.32.8.654
   Marti R, 2002, MITOCHONDRION, V2, P143, DOI 10.1016/S1567-7249(02)00036-3
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   MERANTE F, 1994, AM J HUM GENET, V55, P437
   Merante F, 1996, HUM MUTAT, V8, P216, DOI 10.1002/(SICI)1098-1004(1996)8:3<216::AID-HUMU4>3.0.CO;2-7
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   NIAUDET P, 1994, PEDIATR NEPHROL, V8, P164, DOI 10.1007/BF00865468
   Niaudet P, 1998, ARCH DIS CHILD, V78, P387, DOI 10.1136/adc.78.4.387
   Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OSTERGAARD E, 2008, J INHERIT M IN PRESS
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Piruat JI, 2005, J BIOL CHEM, V280, P42676, DOI 10.1074/jbc.M507044200
   POULTON J, 1995, DIABETOLOGIA, V38, P868, DOI 10.1007/s001250050366
   Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Quinzii CM, 2007, MITOCHONDRION, V7, pS122, DOI 10.1016/j.mito.2007.03.004
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   ROBERTS NK, 1979, AM J CARDIOL, V44, P1396, DOI 10.1016/0002-9149(79)90459-4
   Roesch K, 2002, HUM MOL GENET, V11, P477, DOI 10.1093/hmg/11.5.477
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   Rötig A, 2007, MITOCHONDRION, V7, pS112, DOI 10.1016/j.mito.2007.02.008
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Santorelli FM, 2001, AM HEART J, V141, P1
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Scaglia F, 2003, AM J MED GENET A, V123A, P172, DOI 10.1002/ajmg.a.20315
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107
   SIMONSZ HJ, 1992, DOC OPHTHALMOL, V82, P73, DOI 10.1007/BF00156996
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   SWEENEY MG, 1993, Q J MED, V86, P435
   Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x
   Valianpour F, 2002, J PEDIATR-US, V141, P729, DOI 10.1067/mpd.2002.129174
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Verma A, 1997, PEDIATR RES, V42, P448, DOI 10.1203/00006450-199710000-00005
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
   Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zeviani M, 1997, J BIOENERG BIOMEMBR, V29, P121, DOI 10.1023/A:1022633912917
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zeviani M, 2008, BRAIN, V131, P314, DOI 10.1093/brain/awm339
NR 136
TC 76
Z9 82
U1 0
U2 12
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD MAY
PY 2009
VL 256
IS 5
BP 693
EP 710
DI 10.1007/s00415-009-5028-3
PG 18
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 447AX
UT WOS:000266165100001
PM 19252802
DA 2024-11-01
ER

PT J
AU Ma, YN
   Fang, F
   Cao, YY
   Yang, YL
   Zou, LP
   Zhang, Y
   Wang, ST
   Zhu, SN
   Xu, YF
   Pei, P
   Qi, Y
AF Ma, Yinan
   Fang, Fang
   Cao, Yanyan
   Yang, Yanling
   Zou, Liping
   Zhang, Ying
   Wang, Songtao
   Zhu, Sainan
   Xu, Yufeng
   Pei, Pei
   Qi, Yu
TI Clinical features of mitochondrial DNA m.3243A&gt;G mutation in 47
   Chinese families
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Mitochondrion; m.3243A > G mutation; MELAS; Urine; Family; China
ID LACTIC-ACIDOSIS; MELAS MUTATION; EPISODES MELAS; DISEASE;
   ENCEPHALOPATHY; A3243G; PRESENTATIONS; PHENOTYPE; MYOPATHY; CELLS
AB m.3243A>G mutation in mitochondrial DNA is the most common pathogenic point mutation, causing a variety of phenotypes. To further elucidate its clinical characteristics, we recruited 47 Chinese families carrying m.3243A>G mutation and analyzed their symptoms, disease history, inheritance, and mitochondria-related complications. In the probands, lactic acidosis, myopathy, seizures, short stature, weight loss and hirsutism were the most common clinical features. In their mothers, lactic acidosis, exercise intolerance, short stature and weight loss were the frequent manifestations, and normal phenotype was found in 59.6% mothers. m.3243A>G mutation was detected in 47 probands and 42 mothers. In the probands, the mutation ratio in blood was threefold higher and the ratio in urine was twofold higher than those of their mothers. m.3243A>G mutation ratio in mothers' urine and in their probands' blood were weakly correlated. In conclusion, (a) stroke-like episode induced by m.3243A>G mutation may be the symptom predominantly found in older patients; (b) m.3243A>G mutation ratio correlates with the severity of the disease; (c) m.3243A>G mutation ratio in mothers' urine may correlate to the ratio in blood in their offspring. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Ma, Yinan; Cao, Yanyan; Zhang, Ying; Wang, Songtao; Xu, Yufeng; Pei, Pei; Qi, Yu] Peking Univ, Hosp 1, Dept Cent Lab, Beijing 100034, Peoples R China.
   [Fang, Fang] Beijing Childrens Hosp, Dept Neurol, Beijing 100045, Peoples R China.
   [Yang, Yanling] Peking Univ, Hosp 1, Dept Pediat, Beijing 100034, Peoples R China.
   [Zou, Liping] Gen Hosp Peoples Liberat Army, Dept Pediat, Beijing 100853, Peoples R China.
   [Zhu, Sainan] Peking Univ, Hosp 1, Dept Stat, Beijing 100034, Peoples R China.
C3 Peking University; Capital Medical University; Peking University; Peking
   University
RP Qi, Y (corresponding author), Peking Univ, Hosp 1, Dept Cent Lab, 8 Xishiku St, Beijing 100034, Peoples R China.
EM qiyu0724@yahoo.com
RI Yang, Yanling/F-5954-2014
FU National Natural Science Foundation of China [30700912]; Peking
   University First Hospital
FX We thank the families who took part in the study, and the clinicians who
   supported this project. This study was financially supported by grants
   from National Natural Science Foundation of China (No. 30700912) and
   Science Foundation for Young Researchers from Peking University First
   Hospital.
CR Asano T, 1999, DIABETOLOGIA, V42, P1439
   BOYLE JS, 1995, TRENDS GENET, V11, P8, DOI 10.1016/S0168-9525(00)88977-5
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 2000, MOL MED TODAY, V6, P425, DOI 10.1016/S1357-4310(00)01805-0
   Chiyonobu T, 2008, BRAIN DEV-JPN, V30, P430, DOI 10.1016/j.braindev.2007.12.006
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2006, NETH J MED, V64, P61
   Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339
   Gropman AL, 2004, MITOCHONDRION, V4, P503, DOI 10.1016/j.mito.2004.07.009
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Majamaa K, 1997, NEUROLOGY, V49, P1331, DOI 10.1212/WNL.49.5.1331
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
NR 20
TC 18
Z9 20
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD APR 15
PY 2010
VL 291
IS 1-2
BP 17
EP 21
DI 10.1016/j.jns.2010.01.012
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 582UG
UT WOS:000276624200004
PM 20149394
DA 2024-11-01
ER

PT J
AU Orekhov, AN
   Poznyak, AV
   Sobenin, IA
   Nikifirov, NN
   Ivanova, EA
AF Orekhov, Alexander N.
   Poznyak, Anastasia, V
   Sobenin, Igor A.
   Nikifirov, Nikita N.
   Ivanova, Ekaterina A.
TI Mitochondrion as a Selective Target for the Treatment of
   Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective
   Mitophagy in the Pathogenesis of Atherosclerosis and Chronic
   Inflammation
SO CURRENT NEUROPHARMACOLOGY
LA English
DT Review
DE Atherosclerosis; mitochondrion; inflammation; mtDNA; oxidative stress;
   LDL metabolism
ID INTRACELLULAR LIPID-ACCUMULATION; SMOOTH-MUSCLE-CELLS; INDUCED
   APOPTOSIS; OXIDATIVE STRESS; VITAMIN-C; MACROPHAGE; DISEASE; RISK;
   DYSFUNCTION; METABOLISM
AB Background: Atherosclerosis is a chronic inflammatory condition that affects different arteries in the human body and often leads to severe neurological complications, such as stroke and its sequelae. Affected blood vessels develop atherosclerotic lesions in the form of focal thickening of the intimal layer, so called atherosclerotic plaques.
   Objectives: Despite the high priority of atherosclerosis research for global health and the numerous preclinical and clinical studies conducted, currently, there is no effective pharmacological treatment that directly impacts atherosclerotic plaques. Many knowledge gaps exist in our understanding of the mechanisms of plaque formation. In this review, we discuss the role of mitochondria in different cell types involved in atherogenesis and provide information about mtDNA mutations associated with the disease.
   Results: Mitochondria of blood and arterial wall cells appear to be one of the important factors in disease initiation and development. Significant experimental evidence connects oxidative stress associated with mitochondrial dysfunction and vascular disease. Moreover, mitochondrial DNA (mtDNA) deletions and mutations are being considered as potential disease markers. Further study of mtDNA damage and associated dysfunction may open new perspectives for atherosclerosis treatment.
   Conclusion: Mitochondria can be considered as important disease-modifying factors in several chronic pathologies. Deletions and mutations of mtDNA may be used as potential disease markers. Mitochondria-targeting antioxidant therapies appear to be promising for the development of treatment of atherosclerosis and other diseases associated with oxidative stress and chronic inflammation.
C1 [Orekhov, Alexander N.; Poznyak, Anastasia, V; Sobenin, Igor A.] Skolkovo Innovat Ctr, Inst Atherosclerosis Res, Moscow 121609, Russia.
   [Orekhov, Alexander N.; Sobenin, Igor A.; Nikifirov, Nikita N.] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, Moscow 125315, Russia.
   [Orekhov, Alexander N.] Inst Human Morphol, Moscow 117418, Russia.
   [Sobenin, Igor A.; Nikifirov, Nikita N.] Natl Med Res Ctr Cardiol, Lab Med Genet, 15A 3 Rd Cherepkovskaya Str, Moscow 121552, Russia.
   [Nikifirov, Nikita N.] Russian Acad Sci, Ctr Collect Usage, Inst Gene Biol, 34-5 Vavilova St, Moscow 119334, Russia.
   [Ivanova, Ekaterina A.] Keyrus Biopharma, B-1410 Waterloo, Belgium.
C3 Russian Academy of Medical Sciences; Institute of General Pathology &
   Pathophysiology, RAMS; Russian Academy of Medical Sciences; Research
   Institute of Human Morphology; National Medical Research Center of
   Cardiology; Russian Academy of Sciences; Institute of Gene Biology (IGB)
   of Russian Academy of Sciences
RP Orekhov, AN (corresponding author), Inst Human Morphol, Lab Angiopathol, Tsyurupa St 3, Moscow 125315, Russia.
EM a.h.opexob@gmail.com
RI Poznyak, Anastasia/HLQ-3178-2023; Sobenin, Igor/J-4282-2013
OI Poznyak, Anastasia/0000-0002-1516-1320
FU Russian Science Foundation [19-15-00010]; Russian Science Foundation
   [19-15-00010] Funding Source: Russian Science Foundation
FX This work was supported by the Russian Science Foundation (Grant
   #19-15-00010).
CR Aliev G, 2004, MITOCHONDRION, V4, P649, DOI 10.1016/j.mito.2004.07.018
   Aliev G, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/962984
   Aliev G, 2008, VASC HEALTH RISK MAN, V4, P721, DOI 10.2147/VHRM.S2608
   Alipov VI., 2017, Vessel Plus, P107, DOI [10.20517/2574-1209.2017.20, DOI 10.20517/2574-1209.2017.20]
   Andreeva ER, 1998, TISSUE CELL, V30, P127, DOI 10.1016/S0040-8166(98)80014-1
   Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89
   Bories GFP, 2017, FEBS LETT, V591, P3042, DOI 10.1002/1873-3468.12786
   Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788
   Caja S, 2017, REDOX BIOL, V12, P821, DOI 10.1016/j.redox.2017.04.021
   Chalmers S, 2016, J PHYSIOL-LONDON, V594, P4283, DOI 10.1113/JP271942
   Chen F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00412
   Chen S, 2019, INT J BIOL SCI, V15, P1440, DOI 10.7150/ijbs.30193
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Chistiakov DA, 2017, J MOL MED, V95, P1153, DOI 10.1007/s00109-017-1575-8
   De Bock K, 2013, CELL METAB, V18, P634, DOI 10.1016/j.cmet.2013.08.001
   Dima-Cozma C, 2016, MED-SURG J, V120, P768
   Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657
   Finucane OM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40619-1
   Förstermann U, 2017, CIRC RES, V120, P713, DOI 10.1161/CIRCRESAHA.116.309326
   Fujimoto H, 2008, EUR HEART J, V29, P1267, DOI 10.1093/eurheartj/ehm500
   Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301
   Golub AS, 2011, AM J PHYSIOL-HEART C, V301, pH737, DOI 10.1152/ajpheart.00353.2011
   Gowdar S., 2017, Vessel Plus, V1, P129, DOI [DOI 10.20517/2574-1209.2017.12, 10.20517/2574-1209.2017.12]
   Graham D, 2009, HYPERTENSION, V54, P322, DOI 10.1161/HYPERTENSIONAHA.109.130351
   Grootaert MOJ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7687083
   Haslip M, 2015, ARTERIOSCL THROM VAS, V35, P1166, DOI 10.1161/ATVBAHA.114.304865
   Herrington W, 2016, CIRC RES, V118, P535, DOI 10.1161/CIRCRESAHA.115.307611
   Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016
   Isaev NK, 2016, REV NEUROSCIENCE, V27, P849, DOI 10.1515/revneuro-2016-0036
   Katsouras CS, 2013, BIOMARK MED, V7, P189, DOI [10.2217/bmm.13.4, 10.2217/BMM.13.4]
   Kattoor AJ, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0678-6
   Kieser KJ, 2017, NAT REV IMMUNOL, V17, P376, DOI 10.1038/nri.2017.25
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Liao XH, 2012, CELL METAB, V15, P545, DOI 10.1016/j.cmet.2012.01.022
   Liu PS, 2018, MITOCHONDRION, V41, P45, DOI 10.1016/j.mito.2017.11.002
   Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848
   Marulanda-Londoño E, 2016, NEUROL-CLIN PRACT, V6, P252, DOI 10.1212/CPJ.0000000000000247
   Maytin EV, 2018, CLIN CANCER RES, V24, P3026, DOI 10.1158/1078-0432.CCR-17-2020
   Meyer A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00536
   Michels AJ, 2013, NUTRIENTS, V5, P5161, DOI 10.3390/nu5125161
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Ng KK, 2015, CHEM REV, V115, P11012, DOI 10.1021/acs.chemrev.5b00140
   Nicolson GL, 2014, INTEGR MED CLIN J, V13, P35
   Nonnenmacher Y, 2018, CELL MOL LIFE SCI, V75, P2093, DOI 10.1007/s00018-018-2784-1
   O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570
   Orekhov AN, 2015, EXP MOL PATHOL, V99, P672, DOI 10.1016/j.yexmp.2015.11.006
   Orekhov A.N., 2017, Vessel Plus, V1, P163, DOI [10.20517/2574-1209.2017.33, 10.20517/25741209.2017.33, DOI 10.20517/2574-1209.2017.33]
   Orekhov AN, 2018, CURR PHARM DESIGN, V24, P2883, DOI 10.2174/1381612824666180911120726
   Orekhov AN, 2014, CARDIOVASC RES, V103, P438, DOI 10.1093/cvr/cvu168
   Peng WX, 2019, DNA CELL BIOL, V38, P597, DOI 10.1089/dna.2018.4552
   Pepe S, 2007, MITOCHONDRION, V7, pS154, DOI 10.1016/j.mito.2007.02.005
   Pisoschi AM, 2015, EUR J MED CHEM, V97, P55, DOI 10.1016/j.ejmech.2015.04.040
   Price TO, 2017, BBA-MOL BASIS DIS, V1863, P929, DOI 10.1016/j.bbadis.2017.01.025
   Ruparelia N, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2016.185
   Ryabova A.V., 2019, VESSEL PLUS, V3, P17
   Salabei JK, 2013, REDOX BIOL, V1, P542, DOI 10.1016/j.redox.2013.10.011
   Sazonova MA, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4647214
   Sazonova MA, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6934394
   Sazonova MA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/825468
   Siasos G, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.06.21
   Sinyov V V., 2017, Vessel Plus, P145, DOI 10.20517/2574-1209.2016.04
   Sobenin IA, 2015, CURR PHARM DESIGN, V21, P1158, DOI 10.2174/1381612820666141013133000
   Sobenin IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068070
   Stefano GB, 2017, ADV EXP MED BIOL, V982, P577, DOI 10.1007/978-3-319-55330-6_30
   Summerhill V, 2019, ADV EXP MED BIOL, V1147, P279, DOI 10.1007/978-3-030-16908-4_13
   Swiader A, 2016, ONCOTARGET, V7, P28821, DOI 10.18632/oncotarget.8936
   TERTOV VV, 1992, LAB INVEST, V67, P665
   TERTOV VV, 1989, BIOCHEM BIOPH RES CO, V163, P489, DOI 10.1016/0006-291X(89)92163-3
   Tousoulis D, 2007, HEART, V93, P244, DOI 10.1136/hrt.2006.093112
   Truban D, 2017, J PARKINSON DIS, V7, P13, DOI 10.3233/JPD-160989
   Tur J, 2017, ADV IMMUNOL, V133, P1, DOI 10.1016/bs.ai.2016.12.001
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   van der Bliek AM, 2018, GENETICS, V208, P1673, DOI 10.1534/genetics.118.300816
   van der Bliek AM, 2017, GENETICS, V207, P843, DOI 10.1534/genetics.117.300262
   Vásquez-Trincado C, 2016, J PHYSIOL-LONDON, V594, P509, DOI 10.1113/JP271301
   Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103
   Widlansky ME, 2011, ANTIOXID REDOX SIGN, V15, P1517, DOI 10.1089/ars.2010.3642
   Xu Q, 2014, PLOS ONE
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Zhang JX, 2014, J GERIATR CARDIOL, V11, P141, DOI 10.3969/j.issn.1671-5411.2014.02.003
   Zhang ZY, 2015, IMMUNITY, V43, P1137, DOI 10.1016/j.immuni.2015.10.018
   Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057
NR 82
TC 39
Z9 44
U1 1
U2 23
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-159X
EI 1875-6190
J9 CURR NEUROPHARMACOL
JI Curr. Neuropharmacol.
PY 2020
VL 18
IS 11
BP 1064
EP 1075
DI 10.2174/1570159X17666191118125018
PG 12
WC Neurosciences; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA OS1PE
UT WOS:000589936500002
PM 31744449
OA Green Published
DA 2024-11-01
ER

PT J
AU Tay, SKH
   Shanske, S
   Crowe, C
   Shanske, A
   Schafer, I
   Pancrudo, J
   Lu, JS
   Bonilla, E
   DiMauro, S
AF Tay, SKH
   Shanske, S
   Crowe, C
   Shanske, A
   Schafer, I
   Pancrudo, J
   Lu, JS
   Bonilla, E
   DiMauro, S
TI Clinical and genetic features in two families with MELAS and the T3271C
   mutation in mitochondrial DNA
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
ID STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; POINT MUTATION; ENCEPHALOPATHY;
   MYOPATHY; NEUROPATHY
AB The majority of patients with MELAS (mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes) have the A3243G point mutation. The much rarer T3271C mutation has been reported predominantly in Japanese subjects. Our objective was to better define the clinical phenotype and mutation load in patients with MELAS and the T3271C mutation in mitochondrial DNA. We present clinical and molecular genetic data in two pedigrees with the T3271C mutation. The age at onset was 8 years in one proband and 14 years in the other. Both patients had migrainelike headache, seizures, and strokelike episodes. Mutation loads were quantified in multiple tissues front the patients and from family members by polymerase chain reaction-restriction fragment length polymorphism analysis. The symptoms in both probands were typical of MELAS, and, contrary to previous reports, onset was early. Hearing loss was less common than in typical MELAS, and ragged red fibers were absent. The proportion of mutant genomes was consistently and markedly greater in DNA from urinary sediment than from blood. In the mother of one proband, mutant genomes were detected only in DNA from hair follicles and cheek mucosa. The phenotype of patients with the T3271C mutation might not be as distinct as that of the A3243G mutation, as previously described. Our data also suggest that urine is a better source of DNA than blood for diagnosis and that multiple tissues should be studied in maternal relatives, especially when the mutation cannot be detected in blood.
C1 Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
   Metrohlth Med Ctr, Cleveland, OH 44109 USA.
   Montefiore Med Ctr, Ctr Congenital Disorders, Bronx, NY 10467 USA.
C3 Columbia University; MetroHealth System; Montefiore Medical Center;
   Albert Einstein College of Medicine
RP Columbia Univ Coll Phys & Surg, Dept Neurol, 630 W 168th St,4-420, New York, NY 10032 USA.
EM sd12@columbia.edu
RI Lu, Joseph/KFA-6624-2024; tay, stacey/E-7029-2015
OI tay, stacey/0000-0002-3077-4184
FU NICHD NIH HHS [HD32062] Funding Source: Medline; NINDS NIH HHS [NS11766]
   Funding Source: Medline
CR Barisic N, 2002, CROAT MED J, V43, P37
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE, pS107
   MARIE SKN, 1994, BIOCHEM MED METAB B, V52, P136, DOI 10.1006/bmmb.1994.1045
   Nagashima T, 2001, NEUROMUSCULAR DISORD, V11, P470, DOI 10.1016/S0960-8966(01)00190-0
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   SAKUTA R, 1993, J NEUROL SCI, V115, P158, DOI 10.1016/0022-510X(93)90219-O
   Sambrook J, 1990, Cold Spring Harbor Laboratories, V186, P182
   Suzuki Y, 2002, DIABETES CARE, V25, P407, DOI 10.2337/diacare.25.2.407
   Tarnopolsky MA, 1998, MUSCLE NERVE, V21, P25, DOI 10.1002/(SICI)1097-4598(199801)21:1<25::AID-MUS4>3.0.CO;2-I
   Tsukuda K, 1997, DIABETIC MED, V14, P1032, DOI 10.1002/(SICI)1096-9136(199712)14:12<1032::AID-DIA504>3.0.CO;2-Y
NR 13
TC 9
Z9 12
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD FEB
PY 2005
VL 20
IS 2
BP 142
EP 146
DI 10.1177/08830738050200022301
PG 5
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 907UA
UT WOS:000227742300012
PM 15794182
DA 2024-11-01
ER

PT J
AU Van Maldergem, L
   Besse, A
   De Paepe, B
   Blakely, EL
   Appadurai, V
   Humble, MM
   Piard, J
   Craig, K
   He, LP
   Hella, P
   Debray, FG
   Martin, JJ
   Gaussen, M
   Laloux, P
   Stevanin, G
   Van Coster, R
   Taylor, RW
   Copeland, WC
   Mormont, E
   Bonnen, PE
AF Van Maldergem, Lionel
   Besse, Arnaud
   De Paepe, Boel
   Blakely, Emma L.
   Appadurai, Vivek
   Humble, Margaret M.
   Piard, Juliette
   Craig, Kate
   He, Langping
   Hella, Pierre
   Debray, Francois-Guillaume
   Martin, Jean-Jacques
   Gaussen, Marion
   Laloux, Patrice
   Stevanin, Giovanni
   Van Coster, Rudy
   Taylor, Robert W.
   Copeland, William C.
   Mormont, Eric
   Bonnen, Penelope E.
TI POLG2 deficiency causes adult-onset syndromic sensory neuropathy, ataxia
   and parkinsonism
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
ID MITOCHONDRIAL-DNA DELETIONS; POLYMERASE GAMMA-SUBUNITS; MUTATIONS;
   DISEASE; OPHTHALMOPLEGIA; MAINTENANCE; VARIANTS; DEMENTIA; PATIENT;
   TWINKLE
AB Objective: Mitochondrial dysfunction plays a key role in the pathophysiology of neurodegenerative disorders such as ataxia and Parkinson's disease. We describe an extended Belgian pedigree where seven individuals presented with adult-onset cerebellar ataxia, axonal peripheral ataxic neuropathy, and tremor, in variable combination with parkinsonism, seizures, cognitive decline, and ophthalmoplegia. We sought to identify the underlying molecular etiology and characterize the mitochondrial pathophysiology of this neurological syndrome. Methods: Clinical, neurophysiological, and neuroradiological evaluations were conducted. Patient muscle and cultured fibroblasts underwent extensive analyses to assess mitochondrial function. Genetic studies including genome-wide sequencing were conducted. Results: Hallmarks of mitochondrial dysfunction were present in patients' tissues including ultrastructural anomalies of mitochondria, mosaic cytochrome c oxidase deficiency, and multiple mtDNA deletions. We identified a splice acceptor variant in POLG2, c.970-1G>C, segregating with disease in this family and associated with a concomitant decrease in levels of POLG2 protein in patient cells. Interpretation: This work extends the clinical spectrum of POLG2 deficiency to include an overwhelming, adult-onset neurological syndrome that includes cerebellar syndrome, peripheral neuropathy, tremor, and parkinsonism. We therefore suggest to include POLG2 sequencing in the evaluation of ataxia and sensory neuropathy in adults, especially when it is accompanied by tremor or parkinsonism with white matter disease. The demonstration that deletions of mtDNA resulting from autosomal-dominant POLG2 variant lead to a monogenic neurodegenerative multicomponent syndrome provides further evidence for a major role of mitochondrial dysfunction in the pathomechanism of nonsyndromic forms of the component neurodegenerative disorders.
C1 [Van Maldergem, Lionel; Piard, Juliette] Univ Franche Comte, Ctr Genet Humaine, Besancon, France.
   [Van Maldergem, Lionel; Debray, Francois-Guillaume] Univ Hosp, Ctr Human Genet, Metab Unit, Liege, Belgium.
   [Besse, Arnaud; Appadurai, Vivek; Bonnen, Penelope E.] Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA.
   [De Paepe, Boel; Van Coster, Rudy] Ghent Univ Hosp, Div Child Neurol & Metab, Dept Pediat, Ghent, Belgium.
   [Blakely, Emma L.; Craig, Kate; He, Langping; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Humble, Margaret M.; Copeland, William C.] NIEHS, Mitochondrial DNA Replicat Grp, Durham, NC USA.
   [Hella, Pierre] Sambre & Meuse Reg Hosp, Dept Neurol, Namur, Belgium.
   [Martin, Jean-Jacques] Univ Antwerp, Born Bunge Fdn, Antwerp, Belgium.
   [Gaussen, Marion; Stevanin, Giovanni] Sorbonne Univ, UPMC, CNRS, INSERM,U1127,UMR7225, Paris, France.
   [Gaussen, Marion; Stevanin, Giovanni] Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, Paris, France.
   [Gaussen, Marion; Stevanin, Giovanni] PSL Univ, Lab Neurogenet, Ecole Prat Hautes Etud, F-75013 Paris, France.
   [Laloux, Patrice; Mormont, Eric] Catholic Univ Louvain, CHU UCL Namur, Dept Neurol, B-5530 Yvoir, Belgium.
   [Mormont, Eric; Bonnen, Penelope E.] UCL Inst Neurosci IoNS, B-1200 Brussels, Belgium.
C3 Universite de Franche-Comte; University of Liege; Baylor College of
   Medicine; Ghent University; Ghent University Hospital; Newcastle
   University - UK; National Institutes of Health (NIH) - USA; NIH National
   Institute of Environmental Health Sciences (NIEHS); University of
   Antwerp; Centre National de la Recherche Scientifique (CNRS); CNRS -
   National Institute for Biology (INSB); Sorbonne Universite; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere
   - APHP; Sorbonne Universite; Universite PSL; Ecole Pratique des Hautes
   Etudes (EPHE); Universite Catholique Louvain
RP Van Maldergem, L (corresponding author), Univ Franche Comte, Ctr Genet Humaine, Besancon, France.; Bonnen, PE (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA.
EM vmald@hotmail.com; pbonnen@bcm.edu
RI De Paepe, Boel/B-7548-2013; Van Maldergem, Lionel/O-3242-2019; Copeland,
   William/C-4242-2019; Stevanin, Giovanni/E-5038-2016
OI Copeland, William/0000-0002-0359-0953; Piard,
   Juliette/0000-0001-5244-5325; Stevanin, Giovanni/0000-0001-9368-8657
FU Intramural Research Program of the NIH, National Institute of
   Environmental Health Sciences [ES065078]; French National Agency for
   Research (SPATAX-QUEST project); Verum Foundation; European community
   [E12009DD]; Investissements d'Avenir program [ANR-10-IAIHU-06]; Wellcome
   Trust Strategic Award [096919Z/11/Z]; Medical Research Council (UK)
   Centre for Translational Muscle Disease Research [G0601943]; Lily
   Foundation; UK NHS Highly Specialised "Rare Mitochondrial Disorders of
   Adults and Children" Service; NIH National Human Genome Research
   Institute [U54HG006542]; National Institute of Neurological Disorders
   and Stroke of the National Institutes of Health [R01NS08372]; MRC
   [G0601943] Funding Source: UKRI
FX This work was financially supported by the Intramural Research Program
   of the NIH, National Institute of Environmental Health Sciences
   (ES065078 to M.M.H. and W.C.C.), the French National Agency for Research
   (SPATAX-QUEST project, to GS), the Verum Foundation (to GS), the
   European community (7th framework program, Neuromics, E12009DD, to GS),
   and the Investissements d'Avenir program ANR-10-IAIHU-06 (to ICM
   institute). RWT is supported by a Wellcome Trust Strategic Award
   (096919Z/11/Z), the Medical Research Council (UK) Centre for
   Translational Muscle Disease Research (G0601943), The Lily Foundation,
   and the UK NHS Highly Specialised "Rare Mitochondrial Disorders of
   Adults and Children" Service. Exome sequencing was performed at
   Baylor-Hopkins Center for Mendelian Genomics funded by the NIH National
   Human Genome Research Institute (U54HG006542). Research reported in this
   publication was supported by National Institute of Neurological
   Disorders and Stroke of the National Institutes of Health under award
   number R01NS08372 to PEB.
CR Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berry-Kravis E, 2007, MOVEMENT DISORD, V22, P2018, DOI 10.1002/mds.21493
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Craig K, 2012, MITOCHONDRION, V12, P313, DOI 10.1016/j.mito.2011.11.006
   Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025
   DesPaepe B, 2012, PEDIATR RES, V72, P232
   di Poggio MB, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-105
   DisRe M, 2009, NUCLEIC ACIDS RES, V37, P5701
   Echaniz-Laguna A, 2010, NEUROGENETICS, V11, P21, DOI 10.1007/s10048-009-0202-4
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Graham J.M., 1997, Subcellular Fractionation: A Practical Approach
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Sommerville Ewen W, 2014, J Neuromuscul Dis, V1, P119
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
NR 27
TC 15
Z9 15
U1 0
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD JAN
PY 2017
VL 4
IS 1
BP 4
EP 14
DI 10.1002/acn3.361
PG 11
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA EK1CY
UT WOS:000393664600001
PM 28078310
OA Green Submitted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Needham, M
   Mastaglia, FL
AF Needham, M.
   Mastaglia, F. L.
TI Sporadic inclusion body myositis: a continuing puzzle
SO NEUROMUSCULAR DISORDERS
LA English
DT Review
DE inclusion body myositis; pathogenesis; myodegeneration;
   immunopathogenesis
ID AMYLOID PRECURSOR PROTEIN; MHC CLASS-I; MITOCHONDRIAL-DNA DELETIONS;
   IDIOPATHIC INFLAMMATORY MYOPATHIES; ENDOPLASMIC-RETICULUM STRESS;
   UBIQUITIN-PROTEASOME SYSTEM; CELL-ADHESION MOLECULES; INFILTRATING
   T-CELLS; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY
AB There is now compelling evidence that sporadic inclusion body myositis (sIBM) is a muscle-specific autoimmune disease in which both T and B-cells play a part and in which both cytotoxic muscle fibre necrosis and degeneration occur. However the factors responsible for breakdown of immune tolerance and the nature of the target antigens expressed by muscle fibres remain unknown. Genetic factors are known to contribute to susceptibility, in particular MHC haplotyes which may influence antigenic presentation, and could also operate through genetic variations in muscle fibre constituents or immune effector mechanisms. Viral infection may act as a trigger mechanism, as in cases of HIV-associated sIBM. Our understanding of the mechanisms leading to the degenerative changes in muscle fibres is still incomplete. Protein misfolding and proteasomal dysfunction rather than defective transcriptional control is likely to underlie the abnormal accumulation of multiple proteins in the muscle fibre inclusions. However, aberrant transcription is thought to be the basis for the accumulation of potentially toxic mutant protein forms (e.g. UBB+1). The origin of the multiple clonally expanded somatic mtDNA mutations in COX-negative segments of muscle fibres remains uncertain but may be linked to the effects of oxidative stress. It is proposed that the disproportionate involvement of certain muscles in sIBM may be due to the existence of muscle group-specific transcriptomes which are differentially affected by the disease process and that the male predominance of the disease may indicate the influence of genes preferentially expressed in males. There is a need to develop better animal models of sIBM in which the relationship between the inflammatory and degenerative components of the disease as well as the gender difference in susceptibility and differential vulnerability of different muscle groups can be more critically investigated. Crown copyright (C) 2007 Published by Elsevier B.V. All rights reserved.
C1 [Needham, M.; Mastaglia, F. L.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Australian Neuromuscular Res Inst, Queen Elizabeth II Med Ctr, Perth, WA 6009, Australia.
C3 University of Western Australia
RP Mastaglia, FL (corresponding author), Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Australian Neuromuscular Res Inst, Queen Elizabeth II Med Ctr, Level 4,A Block, Perth, WA 6009, Australia.
EM flmast@cyllene.uwa.edu.au
RI Needham, Merrilee/HJA-4469-2022
OI Needham, Merrilee/0000-0001-6591-1444
CR Amemiya K, 2000, BRAIN, V123, P2030, DOI 10.1093/brain/123.10.2030
   APPLEYARD ST, 1985, LANCET, V1, P361
   ARAHATA K, 1984, ANN NEUROL, V16, P193, DOI 10.1002/ana.410160206
   Argov Z, 1998, MUSCLE NERVE, V21, P1523, DOI 10.1002/(SICI)1097-4598(199811)21:11<1523::AID-MUS22>3.0.CO;2-#
   Arnardottir S, 2004, J NEUROL NEUROSUR PS, V75, P917, DOI 10.1136/jnnp.2003.018994
   ASKANAS V, 1991, NEUROSCI LETT, V130, P73, DOI 10.1016/0304-3940(91)90230-Q
   Askanas V, 2006, NEUROLOGY, V66, pS39, DOI 10.1212/01.wnl.0000192128.13875.1e
   Askanas V, 2005, MICROSC RES TECHNIQ, V67, P114, DOI 10.1002/jemt.20186
   Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314
   Askanas V, 1997, NEUROREPORT, V8, P2155, DOI 10.1097/00001756-199707070-00012
   Askanas V, 1998, ARCH NEUROL-CHICAGO, V55, P915, DOI 10.1001/archneur.55.7.915
   ASKANAS V, 2002, ACTA MYOL, V21, P131
   ASKANAS V, 1996, NEUROLOGY, V46, P487
   ASKANAS V, 1998, INCLUSION BODY MYOSI, P3
   Badrising UA, 2004, NEUROLOGY, V63, P2396, DOI 10.1212/01.WNL.0000148588.15052.4C
   Banwell BL, 2000, NEUROLOGY, V54, P1033, DOI 10.1212/WNL.54.5.1033
   BAO S, 1990, IMMUNOL CELL BIOL, V68, P235, DOI 10.1038/icb.1990.33
   Behrens L, 1997, BRAIN, V120, P929, DOI 10.1093/brain/120.6.929
   Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552
   Bender A, 1998, J NEUROIMMUNOL, V84, P86, DOI 10.1016/S0165-5728(97)00246-4
   Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021
   Broccolini A, 2000, NEUROSCI LETT, V287, P1, DOI 10.1016/S0304-3940(00)01156-3
   Butterfield DA, 1997, CHEM RES TOXICOL, V10, P495, DOI 10.1021/tx960130e
   Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924
   CANTUTICASTELVE I, 2007, NEUROBIOL DIS
   CARPENTER S, 1978, NEUROLOGY, V28, P8, DOI 10.1212/WNL.28.1.8
   CHOU SM, 1986, HUM PATHOL, V17, P765, DOI 10.1016/S0046-8177(86)80197-6
   CHOU SM, 1967, SCIENCE, V158, P1453, DOI 10.1126/science.158.3807.1453
   Christen U, 2004, CURR OPIN IMMUNOL, V16, P759, DOI 10.1016/j.coi.2004.09.002
   Cupler EJ, 1996, BRAIN, V119, P1887, DOI 10.1093/brain/119.6.1887
   Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200
   Dalakas MC, 2007, ANN NEUROL, V61, P466, DOI 10.1002/ana.21103
   Dalakas MC, 2006, NAT CLIN PRACT NEURO, V2, P437, DOI 10.1038/ncpneuro0261
   Dalakas MC, 1998, ARCH NEUROL-CHICAGO, V55, P1509, DOI 10.1001/archneur.55.12.1509
   Dalakas MC, 2002, RHEUM DIS CLIN N AM, V28, P779, DOI 10.1016/S0889-857X(02)00030-3
   Dalakas MC, 1997, ANN NEUROL, V41, P100, DOI 10.1002/ana.410410116
   DALAKAS MC, 2007, ANN NEUROL
   Dewing P, 2006, CURR BIOL, V16, P415, DOI 10.1016/j.cub.2006.01.017
   Dimitri D, 2006, BRAIN, V129, P986, DOI 10.1093/brain/awl020
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Ferrer I, 2004, J NEUROPATH EXP NEUR, V63, P484, DOI 10.1093/jnen/63.5.484
   Fidzianska A, 2004, ACTA NEUROPATHOL, V107, P197, DOI 10.1007/s00401-003-0794-y
   Fidzianska A, 2003, J NEUROL SCI, V210, P47, DOI 10.1016/S0022-510X(03)00012-1
   Figarella-Branger D, 2003, MUSCLE NERVE, V28, P659, DOI 10.1002/mus.10462
   FIGARELLABRANGER D, 1990, ACTA NEUROPATHOL, V79, P528, DOI 10.1007/BF00296113
   Fox SA, 1996, MUSCLE NERVE, V19, P23, DOI 10.1002/(SICI)1097-4598(199601)19:1<23::AID-MUS4>3.3.CO;2-Y
   FOX SA, 1994, J NEUROL SCI, V125, P70, DOI 10.1016/0022-510X(94)90244-5
   Fratta P, 2005, AM J PATHOL, V167, P517, DOI 10.1016/S0002-9440(10)62994-X
   Fratta P, 2004, NEUROLOGY, V63, P1114, DOI 10.1212/01.WNL.0000138574.56908.5D
   Fukuchi K, 1998, AM J PATHOL, V153, P1687, DOI 10.1016/S0002-9440(10)65682-9
   Fyhr IM, 1998, ANN NEUROL, V43, P127, DOI 10.1002/ana.410430123
   Fyhr IM, 1997, J NEUROIMMUNOL, V79, P185, DOI 10.1016/S0165-5728(97)00122-7
   GARLEPP MJ, 1994, CLIN EXP IMMUNOL, V98, P40
   GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0
   GILLESPIE KM, 1920, CMAJ, V175, P165
   Giresi PG, 2005, PHYSIOL GENOMICS, V21, P253, DOI 10.1152/physiolgenomics.00249.2004
   GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606
   Goronzy JJ, 2003, ARTHRITIS RES THER, V5, P225, DOI 10.1186/ar974
   Greenberg SA, 2005, NEUROLOGY, V65, P1782, DOI 10.1212/01.wnl.0000187124.92826.20
   Greenberg SA, 2002, NEUROLOGY, V59, P1170, DOI 10.1212/WNL.59.8.1170
   Greenberg SA, 2007, MUSCLE NERVE, V35, P17, DOI 10.1002/mus.20649
   Greenberg SA, 2006, MUSCLE NERVE, V34, P406, DOI 10.1002/mus.20584
   GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504
   Horvath R, 1998, J NEUROPATH EXP NEUR, V57, P396, DOI 10.1097/00005072-199805000-00003
   HUTCHINSON DO, IN PRESS J CLIN NEUR
   Jaworska-Wilczynska M, 2002, NEUROLOGY, V58, P438, DOI 10.1212/WNL.58.3.438
   Jin LW, 1998, AM J PATHOL, V153, P1679, DOI 10.1016/S0002-9440(10)65681-7
   Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883
   JONGEN PJH, 1993, ANN RHEUM DIS, V52, P575, DOI 10.1136/ard.52.8.575
   KARPATI G, 1993, BAILLIERE CLIN NEUR, V2, P527
   KARPATI G, 1988, ANN NEUROL, V23, P64, DOI 10.1002/ana.410230111
   Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211
   Kefi M, 2002, NEUROLOGY, V58, pA391
   Kitazawa M, 2006, AM J PATHOL, V168, P1986, DOI 10.2353/ajpath.2006.051232
   Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998
   Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3
   Krause S, 2005, EXP CELL RES, V304, P365, DOI 10.1016/j.yexcr.2004.11.010
   Krüger R, 2002, TRENDS MOL MED, V8, P236, DOI 10.1016/S1471-4914(02)02333-X
   Kumamoto T, 2004, ACTA NEUROPATHOL, V107, P59, DOI 10.1007/s00401-003-0774-2
   LEFF RL, 1992, LANCET, V339, P1192, DOI 10.1016/0140-6736(92)91134-T
   LEONMONZON M, 1992, ANN NEUROL, V32, P219, DOI 10.1002/ana.410320215
   Lepidi H, 1998, NEUROPATH APPL NEURO, V24, P73, DOI 10.1046/j.1365-2990.1998.00092.x
   Li J, 2006, J NEUROPATH EXP NEUR, V65, P826, DOI 10.1097/01.jnen.0000228204.19915.69
   Li M, 2000, J NEUROIMMUNOL, V106, P1, DOI 10.1016/S0165-5728(99)00162-9
   Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034
   Lodi R, 1998, BRAIN, V121, P2119, DOI 10.1093/brain/121.11.2119
   Lundberg I, 1995, J NEUROIMMUNOL, V63, P9, DOI 10.1016/0165-5728(95)00122-0
   Lünemann JD, 2007, AUTOPHAGY, V3, P384
   Mayer R.J., 1998, UBIQUITIN MOL PATHOL
   McFerrin J, 1999, NEUROLOGY, V53, P2184, DOI 10.1212/WNL.53.9.2184
   McFerrin J, 2002, NEUROLOGY, V58, pA489
   MICHAELIS D, 1993, AM J PATHOL, V143, P1142
   Müntzing K, 2003, SCAND J IMMUNOL, V58, P195, DOI 10.1046/j.1365-3083.2003.01251.x
   Murata K, 1999, AM J PATHOL, V155, P453, DOI 10.1016/S0002-9440(10)65141-3
   Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103
   Nagaraju K, 2000, P NATL ACAD SCI USA, V97, P9209, DOI 10.1073/pnas.97.16.9209
   Nakano S, 2008, NEUROMUSCULAR DISORD, V18, P27, DOI 10.1016/j.nmd.2007.08.005
   NALBANTOGLU J, 1994, AM J PATHOL, V144, P874
   Needham M, 2007, MUSCLE NERVE, V35, P549, DOI 10.1002/mus.20766
   Needham M, 2007, LANCET NEUROL, V6, P620, DOI 10.1016/S1474-4422(07)70171-0
   NISHINO H, 1989, ANN NEUROL, V25, P260, DOI 10.1002/ana.410250309
   O'Hanlon TP, 2005, MEDICINE, V84, P338, DOI 10.1097/01.md.0000189818.63141.8c
   Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   OLDFORS A, 1998, INCLUSION BODY MYOSI, P306
   Ozden S, 2004, J VIROL, V78, P10320, DOI 10.1128/JVI.78.19.10320-10327.2004
   Ozden S, 2001, CLIN INFECT DIS, V32, P510, DOI 10.1086/318506
   PACIELLO W, 2006, ACTA MYOL, V25, P13
   Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239
   Pak JW, 2003, AGING CELL, V2, P1, DOI 10.1046/j.1474-9728.2003.00034.x
   Pavlath GK, 2002, J NEUROIMMUNOL, V125, P42, DOI 10.1016/S0165-5728(02)00026-7
   Price P, 2004, TISSUE ANTIGENS, V64, P575, DOI 10.1111/j.1399-0039.2004.00310.x
   Price P, 1999, IMMUNOL REV, V167, P257, DOI 10.1111/j.1600-065X.1999.tb01398.x
   Pruitt JN, 1996, ANN NEUROL, V39, P139, DOI 10.1002/ana.410390122
   Raju R, 2005, BRAIN, V128, P1887, DOI 10.1093/brain/awh518
   Raju R, 2003, J NEUROIMMUNOL, V141, P125, DOI 10.1016/S0165-5728(03)00218-2
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   Schmidt J, 2004, BRAIN, V127, P1182, DOI 10.1093/brain/awh148
   Schneider C, 1996, J NEUROPATH EXP NEUR, V55, P1205, DOI 10.1097/00005072-199612000-00003
   Scott A, 2007, NEUROMUSCULAR DISORD, V17, P853, DOI 10.1016/j.nmd.2007.06.309
   SCOTT AP, 1961, NEUROMUSCULAR DISORD, V16, P311
   Semino-Mora C, 1998, NEUROLOGY, V50, pA204
   Serdaroglu P, 2007, HDB CLIN NEUROLOGY M, P357
   SHERRIFF FE, 1995, NEUROSCI LETT, V194, P37, DOI 10.1016/0304-3940(95)11718-C
   Sivakumar K, 1997, BRAIN, V120, P653, DOI 10.1093/brain/120.4.653
   Sugarman MC, 2006, NEUROBIOL AGING, V27, P423, DOI 10.1016/j.neurobiolaging.2005.02.011
   Sugarman MC, 2002, P NATL ACAD SCI USA, V99, P6334, DOI 10.1073/pnas.082545599
   Tateyama M, 2003, ACTA NEUROPATHOL, V105, P581, DOI 10.1007/s00401-003-0685-2
   Tiidus PM, 2003, EXERC SPORT SCI REV, V31, P40, DOI 10.1097/00003677-200301000-00008
   Tiidus PM, 2000, CAN J APPL PHYSIOL, V25, P274, DOI 10.1139/h00-022
   Toepfer M, 1995, EUR J NEUROL, V2, P31
   Tsuruta Y, 2001, ACTA NEUROPATHOL, V101, P579
   van der Vlies D, 2003, AMINO ACIDS, V25, P397, DOI 10.1007/s00726-003-0025-9
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   van der Werf N, 2007, DIABETES-METAB RES, V23, P169, DOI 10.1002/dmrr.695
   van Leeuwen FW, 2000, NEUROBIOL AGING, V21, P879, DOI 10.1016/S0197-4580(00)00151-2
   Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5
   Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1
   Vattemi G, 2001, LANCET, V358, P1962, DOI 10.1016/S0140-6736(01)06969-0
   Vattemi Gaetano, 2003, Neurology, V60, pA333
   Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39
   VILLANOVA M, 1993, BRAIN RES, V603, P343, DOI 10.1016/0006-8993(93)91260-Y
   von der Hagen M, 2005, NEUROMUSCULAR DISORD, V15, P863, DOI 10.1016/j.nmd.2005.09.002
   Weyand CM, 2003, EXP GERONTOL, V38, P833, DOI 10.1016/S0531-5565(03)00090-1
   Wiendl H, 2003, BRAIN, V126, P1026, DOI 10.1093/brain/awg114
   Yang CC, 1996, NEUROREPORT, V8, P153, DOI 10.1097/00001756-199612200-00031
   Yang CC, 1998, NEUROSCI LETT, V254, P77, DOI 10.1016/S0304-3940(98)00657-0
   YUNIS EJ, 1971, LAB INVEST, V25, P240
NR 149
TC 34
Z9 38
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JAN
PY 2008
VL 18
IS 1
BP 6
EP 16
DI 10.1016/j.nmd.2007.11.001
PG 11
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 276OH
UT WOS:000254151400002
PM 18160291
DA 2024-11-01
ER

PT J
AU Kowald, A
   Dawson, M
   Kirkwood, TBL
AF Kowald, Axel
   Dawson, Marcus
   Kirkwood, Thomas B. L.
TI Mitochondrial mutations and ageing: Can mitochondrial deletion mutants
   accumulate via a size based replication advantage?
SO JOURNAL OF THEORETICAL BIOLOGY
LA English
DT Article
DE Mitochondrial mutation; Mathematical model; Ageing
ID FREE-RADICAL THEORY; AGED MUSCLE-FIBERS; DNA MUTATIONS; DEGENERATIVE
   DISEASES; IN-VIVO; TURNOVER; SEGREGATION; FISSION; TISSUES; CELLS
AB The mitochondrial theory of ageing is one of the main contenders to explain the biochemical basis of the ageing process. An important line of support comes from the observation that mtDNA deletions accumulate over the life course in post-mitotic cells of many species. A single mutant expands clonally and finally replaces the wild-type population of a whole cell. One proposal to explain the driving force behind this accumulation states that the reduced size leads to a shorter replication time, which provides a selection advantage. However, this idea has been questioned on the grounds that the mitochondrial half-life is much longer than the replication time, so that the latter cannot be a rate limiting step. To clarify this question, we modelled this process mathematically and performed extensive deterministic and stochastic computer simulations to study the effects of replication time, mitochondrial half-life and deletion size. Our study shows that the shorter size does in principle provide a selection advantage, which can lead to an accumulation of the deletion mutant. However, this selection advantage diminishes the shorter is the replication time of wt mtDNA in relation to its half-life. Using generally accepted literature values, the resulting time frame for the accumulation of mutant mtDNAs is only compatible with the ageing process in very long lived species like humans, but could not reasonably explain ageing in short lived species like mice and rats. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Kowald, Axel; Dawson, Marcus; Kirkwood, Thomas B. L.] Newcastle Univ, Ctr Integrated Syst Biol Ageing & Nutr, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Dawson, Marcus] Univ Manchester, Manchester M13 9PT, Lancs, England.
C3 Newcastle University - UK; University of Manchester
RP Kowald, A (corresponding author), Newcastle Univ, Ctr Integrated Syst Biol Ageing & Nutr, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
EM Axel.Kowald@ncl.ac.uk; Tom.Kirkwood@ncl.ac.uk;
   Marcus.Dawson@student.manchester.ac.uk
OI Kowald, Axel/0000-0001-6448-4364
FU Glenn Foundation; National Institute for Health Research (NIHR)
   Newcastle Biomedical Research Centre; MRC [MR/K006312/1] Funding Source:
   UKRI
FX This work was funded by a Glenn Foundation award to T.K. The research
   was also supported by the National Institute for Health Research (NIHR)
   Newcastle Biomedical Research Centre based at Newcastle upon Tyne
   Hospitals NHS Foundation Trust and Newcastle University. The views
   expressed are those of the authors and not necessarily those of the NHS,
   the NIHR or the Department of Health.
CR ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   BERK AJ, 1974, J MOL BIOL, V86, P801, DOI 10.1016/0022-2836(74)90355-6
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Collins ML, 2003, J APPL PHYSIOL, V94, P2203, DOI 10.1152/japplphysiol.00691.2002
   Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883
   de Grey ADJ., 1999, MITOCHONDRIAL FREE R
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   HARMAN D, 1983, AGE, V6, P86, DOI 10.1007/BF02432509
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   HUEMER RP, 1971, EXP GERONTOL, V6, P327, DOI 10.1016/0531-5565(71)90001-5
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768
   Kirkwood TBL, 1996, BIOESSAYS, V18, P1009, DOI 10.1002/bies.950181211
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Kowald A., 2013, AGING CELL
   Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   RICHTER C, 1988, FEBS LETT, V241, P1, DOI 10.1016/0014-5793(88)81018-4
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
NR 33
TC 24
Z9 29
U1 0
U2 20
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-5193
EI 1095-8541
J9 J THEOR BIOL
JI J. Theor. Biol.
PD JAN 7
PY 2014
VL 340
BP 111
EP 118
DI 10.1016/j.jtbi.2013.09.009
PG 8
WC Biology; Mathematical & Computational Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA 261TZ
UT WOS:000327688800013
PM 24055401
DA 2024-11-01
ER

PT S
AU Pak, JW
   Aiken, JM
AF Pak, JW
   Aiken, JM
BE DeGrey, ADN
TI Low levels of mtDNA deletion mutations in ETS normal fibers from aged
   rats
SO STRATEGIES FOR ENGINEERED NEGLIGIBLE SENESCENCE: WHY GENUINE CONTROL OF
   AGING MAY BE FORESEEABLE
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT 10th Congress of the International-Association-of-Biomedical-Gerontology
CY SEP 19-23, 2003
CL Cambridge, ENGLAND
SP Int Assoc Biomed Gerontol
DE mitochondrial DNA; deletion mutations; ETS abnormality; fiber type;
   quantitative PCR
ID MUSCLE-FIBERS; WILD-TYPE; ABNORMALITIES; SARCOPENIA; DISEASE
AB The objectives were (1) to determine whether deletion mutations occur in phenotypically normal type I and type 11 fibers, (2) to quantify the levels of both deletion mutant and wild-type (wt) mtDNA (nondeletion) within single normal fibers containing mutant mtDNA, and (3) to quantify the amount of wt mtDNA in genotypically and phenotypically normal type I and type 11 fibers. Deletion mutations in normal fibers are not restricted to specific fiber types, although clonal accumulation of mtDNA deletion mutations and subsequent ETS abnormalities occur exclusively in type 11 fibers.
C1 Univ Wisconsin, Dept Anim Hlth & Biomed Sci, Madison, WI 53706 USA.
C3 University of Wisconsin System; University of Wisconsin Madison
RP Aiken, JM (corresponding author), Univ Wisconsin, Dept Anim Hlth & Biomed Sci, 1656 Linden Dr, Madison, WI 53706 USA.
EM aiken@svm.vetmed.wisc.edu
OI Aiken, Judd/0000-0001-6119-4521
CR Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Moraes C T, 1996, Methods Enzymol, V264, P522, DOI 10.1016/S0076-6879(96)64046-4
   Mueller-Hoecker J., 1993, Virchows Archiv A Pathological Anatomy and Histopathology, V422, P7
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
NR 9
TC 8
Z9 8
U1 0
U2 2
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-496-X
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2004
VL 1019
BP 289
EP 293
DI 10.1196/annals.1297.049
PG 5
WC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Science & Technology - Other Topics
GA BAN77
UT WOS:000223002700049
PM 15247031
DA 2024-11-01
ER

PT J
AU Nicholas, A
   Kraytsberg, Y
   Guo, XH
   Khrapko, K
AF Nicholas, Alexander
   Kraytsberg, Yevgenya
   Guo, Xinhong
   Khrapko, Konstantin
TI On the timing and the extent of clonal expansion of mtDNA deletions:
   Evidence from single-molecule PCR
SO EXPERIMENTAL NEUROLOGY
LA English
DT Article
ID MITOCHONDRIAL-DNA DELETIONS; POINT MUTATIONS; MUSCLE-FIBERS; STEM-CELLS;
   SKELETAL-MUSCLE; IMPAIRMENT; ABUNDANT; TISSUES; BURDEN; MICE
AB mtDNA deletions are pathogenic mutations that remove Substantial portions of the mitochondrial genome. mtDNA deletions accumulate with age and have been implicated in various degenerative diseases There are. multiple mtDNA per cell and mtDNA mutations become toxic only if they accumulate to substantial intracellular levels, i.e. exceed so-called "phenotypic threshold". This is usually achieved via clonal expansion of a single initial mutated molecule. Intracellular mitochondrial genomes are analogous to a population of individuals in that mitochondria are born by division and die by degradation, Clonal expansion within cells is thus analogous to genetic drift within populations and is driven by a combination of random processes and selection. mtDNA mutations Occurring early in development are expected to end up spread across tissues, while mutations of late origin are expected to be localized, i.e. limited a single post-mitotic cell or progeny of a single stern cell. We have explored the extent and timing of clonality of mtDNA deletion in human muscle Using single-molecule PCR. We analyzed deletions from two nearby locations within the same tissue sample. Altogether we analyzed over 130 mutant molecules, but almost every deletion type detected was represented by several identical mutant molecules, so that altogether there were only 21 different kinds of deletions, implying that essentially all deletions were clonal. At the same time the sets of deletions in the two locations were completely different. This observation implies that all of the clonal expansions spanned very small areas and therefore that the corresponding mutations were likely events of older age. More Studies are necessary to further validate these findings in muscle and to explore the other tissues. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Nicholas, Alexander; Kraytsberg, Yevgenya; Guo, Xinhong; Khrapko, Konstantin] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA.
C3 Harvard University; Beth Israel Deaconess Medical Center; Harvard
   Medical School
RP Khrapko, K (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, 330 Brookline Ave, Boston, MA 02215 USA.
EM khrapko@hms.harvard.edu
RI guo, xin/KRP-4196-2024; Khrapko, Konstantin/A-3244-2009
OI khrapko, konstantin/0000-0002-9250-8033
FU NIH [NS058988, AG19787]
FX This work was supported in part by NIH grants NS058988 and AG19787 to
   KK.
CR Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Coller HA, 2005, MUTAT RES-FUND MOL M, V578, P256, DOI 10.1016/j.mrfmmm.2005.05.014
   Coller HA, 2002, ANN NY ACAD SCI, V959, P434, DOI 10.1111/j.1749-6632.2002.tb02113.x
   Del Bo R, 2003, NEUROBIOL AGING, V24, P829, DOI 10.1016/S0197-4580(02)00233-6
   Dubec SJ, 2008, REJUV RES, V11, P611, DOI 10.1089/rej.2007.0617
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Jockusch H, 2003, J CELL SCI, V116, P1611, DOI 10.1242/jcs.00364
   Khaidakov A, 2005, EXP GERONTOL, V40, P396, DOI 10.1016/j.exger.2005.02.007
   Khrapko K, 2004, ANN NY ACAD SCI, V1019, P240, DOI 10.1196/annals.1297.040
   Khrapko K, 2003, MUTAT RES-FUND MOL M, V522, P13, DOI 10.1016/S0027-5107(02)00306-8
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809
   Kraytsberg Y, 2008, METHODS, V46, P269, DOI 10.1016/j.ymeth.2008.10.005
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   *MITOMAP, MITOMAP HUM MIT GEN
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Sato A, 2007, GENETICS, V177, P2031, DOI 10.1534/genetics.107.081026
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
NR 27
TC 23
Z9 25
U1 0
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
EI 1090-2430
J9 EXP NEUROL
JI Exp. Neurol.
PD AUG
PY 2009
VL 218
IS 2
SI SI
BP 316
EP 319
DI 10.1016/j.expneurol.2009.04.029
PG 4
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 472GE
UT WOS:000268117400017
PM 19426731
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Yan, CJ
   Duanmu, XY
   Zeng, L
   Liu, B
   Song, ZY
AF Yan, Chaojun
   Duanmu, Xiaoying
   Zeng, Ling
   Liu, Bing
   Song, Zhiyin
TI Mitochondrial DNA: Distribution, Mutations, and Elimination
SO CELLS
LA English
DT Review
DE mitochondria; mtDNA; mitophagy; mtDNA distribution; mitochondrial
   dynamics
ID DYNAMIN-RELATED PROTEIN; CYTOCHROME-C RELEASE; PATERNAL MITOCHONDRIA;
   CONTACT SITE; SELECTIVE DEGRADATION; MATERNAL INHERITANCE; MYOCLONIC
   EPILEPSY; OXIDATIVE STRESS; SKELETAL-MUSCLE; MTDNA MUTATIONS
AB Mitochondrion harbors its own DNA (mtDNA), which encodes many critical proteins for the assembly and activity of mitochondrial respiratory complexes. mtDNA is packed by many proteins to form a nucleoid that uniformly distributes within the mitochondrial matrix, which is essential for mitochondrial functions. Defects or mutations of mtDNA result in a range of diseases. Damaged mtDNA could be eliminated by mitophagy, and all paternal mtDNA are degraded by endonuclease G or mitophagy during fertilization. In this review, we describe the role and mechanism of mtDNA distribution and elimination. In particular, we focus on the regulation of paternal mtDNA elimination in the process of fertilization.
C1 [Yan, Chaojun; Duanmu, Xiaoying; Zeng, Ling; Liu, Bing; Song, Zhiyin] Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Hubei, Peoples R China.
C3 Wuhan University
RP Song, ZY (corresponding author), Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Hubei, Peoples R China.
EM ycj114@whu.edu.cn; duanmu@whu.edu.cn; zengling368@whu.edu.cn;
   bingbingliu@whu.edu.cn; songzy@whu.edu.cn
OI Song, Zhiyin/0000-0002-5003-081X
FU National Natural Science Foundation of China [31671393, 91854107];
   Fundamental Research Funds for the Central Universities [2042017kf0197,
   2042017kf0242]
FX This work is supported by National Natural Science Foundation of China
   (31671393, and 91854107), and the Fundamental Research Funds for the
   Central Universities (2042017kf0197 and 2042017kf0242).
CR Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Arakaki N, 2006, BIOL PHARM BULL, V29, P1962, DOI 10.1248/bpb.29.1962
   Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Ban-Ishihara R, 2013, P NATL ACAD SCI USA, V110, P11863, DOI 10.1073/pnas.1301951110
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chan DC, 2012, DEV CELL, V22, P469, DOI 10.1016/j.devcel.2012.02.008
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021
   Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   DeLuca SZ, 2012, DEV CELL, V22, P660, DOI 10.1016/j.devcel.2011.12.021
   Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1
   Desai R, 2017, BRAIN, V140, P1595, DOI 10.1093/brain/awx094
   Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Ding CL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16064
   Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Finkel T, 2009, P NATL ACAD SCI USA, V106, P11825, DOI 10.1073/pnas.0906430106
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385
   Fujimoto M, 2012, BIOCHEM BIOPH RES CO, V417, P635, DOI 10.1016/j.bbrc.2011.12.022
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Gerhold JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15292
   Gilkerson R, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011080
   GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012
   HOWELL N, 1991, AM J HUM GENET, V49, P939
   Hubstenberger A, 2010, J BIOENERG BIOMEMBR, V42, P143, DOI 10.1007/s10863-010-9269-8
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Itoh K, 2013, MOL BIOL CELL, V24, P1842, DOI 10.1091/mbc.E13-03-0125
   Jayashankar V, 2014, CURR OPIN CELL BIOL, V26, P34, DOI 10.1016/j.ceb.2013.09.002
   Jian FL, 2018, CELL REP, V23, P2989, DOI 10.1016/j.celrep.2018.05.015
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kandul NP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13100
   Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111
   Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132
   Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360
   Kozjak-Pavlovic V, 2017, CELL TISSUE RES, V367, P83, DOI 10.1007/s00441-016-2433-7
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549
   Li H, 2016, CELL DEATH DIFFER, V23, P380, DOI 10.1038/cdd.2015.102
   Li Z., 2016, MITOCHONDRIAL MECH D, P49
   Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001
   Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921
   McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Murley A, 2013, ELIFE, V2, DOI 10.7554/eLife.00422
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Nicholls TJ, 2018, TRENDS BIOCHEM SCI, V43, P869, DOI 10.1016/j.tibs.2018.08.007
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Osman C, 2015, P NATL ACAD SCI USA, V112, pE947, DOI 10.1073/pnas.1501737112
   Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257
   Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608
   Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320
   Peeva V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04131-w
   Peralta S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.217075
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Renken C, 2002, J STRUCT BIOL, V138, P137, DOI 10.1016/S1047-8477(02)00012-6
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   Riley JS, 2018, EMBO J, V37, DOI 10.15252/embj.201899238
   Sastri M, 2017, J CELL SCI, V130, P3248, DOI 10.1242/jcs.201400
   Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010
   Sato M, 2012, AUTOPHAGY, V8, P424, DOI 10.4161/auto.19243
   Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333
   Sbisà E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6
   Schorr S, 2018, SEMIN CELL DEV BIOL, V76, P191, DOI 10.1016/j.semcdb.2017.09.021
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052
   Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Song WH, 2016, P NATL ACAD SCI USA, V113, pE5261, DOI 10.1073/pnas.1605844113
   Song WH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/981867
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Stefano GB, 2016, BIOMED REP, V4, P259, DOI 10.3892/br.2016.590
   Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508
   Sutovsky P, 2004, REPROD BIOMED ONLINE, V8, P24, DOI 10.1016/S1472-6483(10)60495-6
   Sutovsky P, 2003, BIOL REPROD, V68, P1793, DOI 10.1095/biolreprod.102.012799
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Thompson WE, 2003, BIOL REPROD, V69, P254, DOI 10.1095/biolreprod.102.010975
   van der Laan M, 2016, CURR OPIN CELL BIOL, V41, P33, DOI 10.1016/j.ceb.2016.03.013
   van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
   Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339
   Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wang XD, 1999, SCIENTIST, V13, P16
   Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108
   Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042
   Yamamoto H, 2002, MOL BIOL CELL, V13, p128A
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Yu ZS, 2017, CURR BIOL, V27, P1033, DOI 10.1016/j.cub.2017.02.014
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhou QH, 2016, SCIENCE, V353, P394, DOI 10.1126/science.aaf4777
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 121
TC 159
Z9 179
U1 8
U2 71
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD APR
PY 2019
VL 8
IS 4
AR 379
DI 10.3390/cells8040379
PG 15
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA HX3PN
UT WOS:000467304300093
PM 31027297
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Ng, YS
   Lax, NZ
   Maddison, P
   Alston, CL
   Blakely, EL
   Hepplewhite, PD
   Riordan, G
   Meldau, S
   Chinnery, PF
   Pierre, G
   Chronopoulou, E
   Du, AL
   Hughes, I
   Morris, AA
   Kamakari, S
   Chrousos, G
   Rodenburg, RJ
   Saris, CGJ
   Feeney, C
   Hardy, SA
   Sakakibara, T
   Sudo, A
   Okazaki, Y
   Murayama, K
   Mundy, H
   Hanna, MG
   Ohtake, A
   Schaefer, AM
   Champion, MP
   Turnbull, DM
   Taylor, RW
   Pitceathly, RDS
   McFarland, R
   Gorman, GS
AF Ng, Yi Shiau
   Lax, Nichola Z.
   Maddison, Paul
   Alston, Charlotte L.
   Blakely, Emma L.
   Hepplewhite, Philippa D.
   Riordan, Gillian
   Meldau, Surita
   Chinnery, Patrick F.
   Pierre, Germaine
   Chronopoulou, Efstathia
   Du, Ailian
   Hughes, Imelda
   Morris, Andrew A.
   Kamakari, Smaragda
   Chrousos, Georgia
   Rodenburg, Richard J.
   Saris, Christiaan G. J.
   Feeney, Catherine
   Hardy, Steven A.
   Sakakibara, Takafumi
   Sudo, Akira
   Okazaki, Yasushi
   Murayama, Kei
   Mundy, Helen
   Hanna, Michael G.
   Ohtake, Akira
   Schaefer, Andrew M.
   Champion, Mike P.
   Turnbull, Doug M.
   Taylor, Robert W.
   Pitceathly, Robert D. S.
   McFarland, Robert
   Gorman, Grainne S.
TI <i>MT</i>-<i>ND5</i> Mutation Exhibits Highly Variable Neurological
   Manifestations at Low Mutant Load
SO EBIOMEDICINE
LA English
DT Article
DE Mitochondrial encephalomyopathy Lactic acidosis and stroke-like episodes
   (MELAS); Leigh syndrome (LS); Mitochondrial DNA; Heteroplasmy;
   Neuropathology
ID MITOCHONDRIAL-DNA; LEIGH-SYNDROME; COMPLEX I; CLINICAL-FEATURES; G13513A
   MUTATION; OVERLAP-SYNDROME; ND5 GENE; MELAS; DISEASES; ABNORMALITIES
AB Mutations in the m.13094TNC MT-ND5 gene have been previously described in three cases of Leigh Syndrome (LS). In this retrospective, international cohort study we identified 20 clinically affected individuals (13 families) and four asymptomatic carriers. Ten patients were deceased at the time of analysis (median age of death was 10 years (range: 5.4months-37 years, IQR = 17.9 years). Nine patients manifested with LS, one with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), and one with Leber hereditary optic neuropathy. The remaining nine patients presented with either overlapping syndromes or isolated neurological symptoms. Mitochondrial respiratory chain activity analysis was normal in five out of ten muscle biopsies. We confirmed maternal inheritance in six families, and demonstrated marked variability in tissue segregation, and phenotypic expression at relatively low blood mutant loads. Neuropathological studies of two patients manifesting with LS/MELAS showed prominent capillary proliferation, microvacuolation and severe neuronal cell loss in the brainstem and cerebellum, with conspicuous absence of basal ganglia involvement. These findings suggest that whole mtDNA genome sequencing should be considered in patients with suspected mitochondrial disease presenting with complex neurological manifestations, which would identify over 300 known pathogenic variants including the m.13094TNC. (C) 2018 The Authors. Published by Elsevier B.V.
C1 [Ng, Yi Shiau; Lax, Nichola Z.; Alston, Charlotte L.; Blakely, Emma L.; Hepplewhite, Philippa D.; Chinnery, Patrick F.; Feeney, Catherine; Hardy, Steven A.; Schaefer, Andrew M.; Turnbull, Doug M.; Taylor, Robert W.; McFarland, Robert; Gorman, Grainne S.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Maddison, Paul] Queens Med Ctr, Dept Neurol, Nottingham, England.
   [Riordan, Gillian] Red Cross War Mem Childrens Hosp, Paediat Neurol Dept, Cape Town, South Africa.
   [Meldau, Surita] Univ Cape Town, Fac Hlth Sci, Div Chem Pathol, Cape Town, South Africa.
   [Chinnery, Patrick F.] Med Res Council Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge, England.
   [Pierre, Germaine; Chronopoulou, Efstathia] Univ Hosp Bristol NHS Fdn Trust, Dept Inherited Metab Dis, Div Womens & Childrens Serv, Bristol, Avon, England.
   [Du, Ailian] Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Shanghai, Peoples R China.
   [Hughes, Imelda] Cent Manchester Univ Hosp NHS Fdn Trust, Royal Manchester Childrens Hosp, Manchester, Lancs, England.
   [Morris, Andrew A.] Univ Manchester, Inst Human Dev, Manchester M13 9WL, Lancs, England.
   [Kamakari, Smaragda] OMMA, Inst Ophthalmol, Ophthalm Genet Unit, Athens, Greece.
   [Chrousos, Georgia] MITERA Childrens Hosp, Pediat Ophthalmol Dept, Athens, Greece.
   [Rodenburg, Richard J.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Radboud Ctr Mitochondrial Med, Nijmegen, Netherlands.
   [Saris, Christiaan G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Nijmegen, Netherlands.
   [Sakakibara, Takafumi] Nara Med Univ Hosp, Dept Pediat, Nara 6348522, Japan.
   [Sudo, Akira] Sapporo City Gen Hosp, Dept Pediat, Sapporo, Hokkaido 0608604, Japan.
   [Okazaki, Yasushi] Juntendo Univ, Grad Sch Med, Intractable Dis Res Ctr, Diagnost & Therapeut Intractable Dis, Tokyo 1138421, Japan.
   [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Chiba 2660007, Japan.
   [Mundy, Helen; Champion, Mike P.] Guys & St Thomas NHS Fdn Trust, Evelina London Childrens Hosp, London, England.
   [Hanna, Michael G.; Pitceathly, Robert D. S.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England.
   [Hanna, Michael G.; Pitceathly, Robert D. S.] Natl Hosp Neurol & Neurosurg, London, England.
   [Ohtake, Akira] Saitama Med Univ, Fac Med, Dept Pediat, Saitama 3500495, Japan.
   [Meldau, Surita] Natl Hlth Lab Serv, Cape Town, South Africa.
   [Morris, Andrew A.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England.
C3 Newcastle University - UK; University of Nottingham; University of Cape
   Town; UK Research & Innovation (UKRI); Medical Research Council UK
   (MRC); University of Bristol; Shanghai Jiao Tong University; Royal
   Manchester Children's Hospital; University of Manchester; University of
   Manchester; Radboud University Nijmegen; Radboud University Nijmegen;
   Nara Medical University; Sapporo City General Hospital; Juntendo
   University; Chiba Children's Hospital; Guy's & St Thomas' NHS Foundation
   Trust; University of London; University College London; University of
   London; University College London; UCL Medical School; University
   College London Hospitals NHS Foundation Trust; Saitama Medical
   University; University of Manchester
RP Gorman, GS (corresponding author), Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
EM grainne.gorman@ncl.ac.uk
RI Ng, Yi/AFF-1445-2022; Rodenburg, Richard/N-3579-2014; Saris,
   C.G.J./L-4623-2015; Maier, Andrea/Q-5548-2019; Alston,
   Charlotte/ABG-9602-2020; Murayama, Kei/JGM-3674-2023
OI Meldau, Surita/0000-0002-0612-2071; Alston,
   Charlotte/0000-0003-2095-5464; Ohtake, Akira/0000-0003-1147-3113;
   Feeney, Catherine/0000-0003-3189-3991; McFarland,
   Robert/0000-0002-8833-2688; Okazaki, Yasushi/0000-0003-3241-5502;
   Schaefer, Andrew/0000-0001-9891-7332; Ng, Yi Shiau/0000-0002-7591-2034;
   Pitceathly, Robert/0000-0002-6123-4551; Turnbull,
   Doug/0000-0002-8878-9901; Chinnery, Patrick/0000-0002-7065-6617; Gorman,
   Grainne/0000-0002-7585-3409; Hanna, Michael/0000-0003-0825-4075
FU Wellcome Trust [203105]; Newcastle University Centre for Ageing and
   Vitality (Biotechnology and Biological Sciences Research Council and
   Medical Research Council) [L016354]; UK NIHR Biomedical Research Centre
   for Ageing and Age-related disease award; National Institute for Health
   Research (NIHR); UK NHS; UK Medical Research Council (MRC) Centre
   Mitochondrial Disease Patient Cohort: A Natural History Study and
   Patient Registry [13/NE/0326]; NIHR Biomedical Research Centre,
   Newcastle and North Tyneside Comprehensive Local Research Network; MRC
   Centre of Neuromuscular diseases [MR/K000608/1]; National Institute for
   Health Research (NIHR) doctoral fellowship [NIHR-HCS-D12-03-04]; Medical
   Research Council Centre grant [G0601943]; Department of Health's
   National Institute for Health Research Biomedical Research Centres;
   Japanese Ministry of Education, Culture, Sports, Science and Technology;
   Agency for Medical Research and Development (AMED); AMED; MRC [G0601943,
   G1100540, G0400074, G0502157, MR/L016354/1, MR/K000608/1, G0900652,
   G0800674] Funding Source: UKRI
FX This work was supported by The Wellcome Trust (203105), Newcastle
   University Centre for Ageing and Vitality (supported by the
   Biotechnology and Biological Sciences Research Council and Medical
   Research Council L016354), UK NIHR Biomedical Research Centre for Ageing
   and Age-related disease award to the Newcastle upon Tyne Hospitals NHS
   Foundation Trust, National Institute for Health Research (NIHR) and the
   UK NHS Specialist Commissioners which funds the "Rare Mitochondrial
   Disorders of Adults and Children" Diagnostic Service in Newcastle upon
   Tyne (http://www.newcastle-mitochondria.com/). This work also received
   infrastructure support from the UK Medical Research Council (MRC) Centre
   Mitochondrial Disease Patient Cohort: A Natural History Study and
   Patient Registry (REC ref. 13/NE/0326), NIHR Biomedical Research Centre,
   Newcastle and North Tyneside Comprehensive Local Research Network. YSN
   currently holds an NIHR Clinical Lectureship in Neurology, and was
   previously funded by the MRC Centre of Neuromuscular diseases for his
   PhD study (MR/K000608/1). C.L.A is the recipient of a National Institute
   for Health Research (NIHR) doctoral fellowship (NIHR-HCS-D12-03-04).
   R.D.S.P. and M.G.H. are supported by a Medical Research Council Centre
   grant (G0601943). Part of this work was undertaken in the University
   College London Hospitals/University College London Institute of
   Neurology sequencing facility, which received a proportion of funding
   from the Department of Health's National Institute for Health Research
   Biomedical Research Centres funding scheme. Y.O. and A.O. are supported
   by both Strategic Research Center in Private Universities from the
   Japanese Ministry of Education, Culture, Sports, Science and Technology
   and Practical Research Project for Rare/Intractable Diseases from Agency
   for Medical Research and Development (AMED). K.M. is supported by AMED.
   Our funding sources do no play any role in the writing of the manuscript
   or the decision to submit it for publication. The views expressed are
   those of the author(s) and not necessarily those of the NHS, the NIHR or
   the Department of Health.
CR Ahmed ST, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14623-2
   Alston CL, 2010, NEUROMUSCULAR DISORD, V20, P131, DOI 10.1016/j.nmd.2009.10.010
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Blok MJ, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045716
   Ching CK, 2013, HONG KONG MED J, V19, P357, DOI 10.12809/hkmj133673
   Crimi M, 2003, NEUROLOGY, V60, P1857, DOI 10.1212/01.WNL.0000066048.72780.69
   Diodato Daria, 2014, Int J Cell Biol, V2014, P787956, DOI 10.1155/2014/787956
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   HOWELL N, 1993, AM J HUM GENET, V53, P959
   Katramados AM, 2009, EPILEPSIA, V50, P265, DOI 10.1111/j.1528-1167.2008.01736.x
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Matthews L, 2015, J NEUROL NEUROSUR PS, V86, P537, DOI 10.1136/jnnp-2014-308186
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450
   Palesi F, 2015, BRAIN STRUCT FUNCT, V220, P3369, DOI 10.1007/s00429-014-0861-2
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rodenburg RJ, 2016, BBA-BIOENERGETICS, V1857, P938, DOI 10.1016/j.bbabio.2016.02.012
   Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   TIEN RD, 1992, AM J ROENTGENOL, V158, P1155, DOI 10.2214/ajr.158.5.1566683
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Yu-Wai-Man P, 2016, ANN CLIN TRANSL NEUR, V3, P723, DOI 10.1002/acn3.323
   Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095
NR 30
TC 44
Z9 45
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD APR
PY 2018
VL 30
BP 86
EP 93
DI 10.1016/j.ebiom.2018.02.010
PG 8
WC Medicine, General & Internal; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Research & Experimental Medicine
GA GD2AR
UT WOS:000430303000014
PM 29506874
OA gold, Green Accepted, Green Published
DA 2024-11-01
ER

PT J
AU Olimpio, C
   Paramonov, I
   Matalonga, L
   Laurie, S
   Schon, K
   Polavarapu, K
   Kirschner, J
   Schara-Schmidt, U
   Lochmüller, H
   Chinnery, PF
   Horvath, R
AF Olimpio, Catarina
   Paramonov, Ida
   Matalonga, Leslie
   Laurie, Steven
   Schon, Katherine
   Polavarapu, Kiran
   Kirschner, Janbernd
   Schara-Schmidt, Ulrike
   Lochmueller, Hanns
   Chinnery, Patrick F.
   Horvath, Rita
TI Increased Diagnostic Yield by Reanalysis of Whole Exome Sequencing Data
   in Mitochondrial Disease
SO JOURNAL OF NEUROMUSCULAR DISEASES
LA English
DT Article
DE Mitochondrial diseases; respiratory chain deficiencies; next generation
   sequencing; mitochondrial genes
ID MEDICAL GENETICS; AMERICAN-COLLEGE; MUTATIONS; MYOPATHY; GENOMICS
AB Background: The genetic diagnosis of mitochondrial disorders is complicated by its genetic and phenotypic complexity. Next generation sequencing techniques have much improved the diagnostic yield for these conditions. A cohort of individuals with multiple respiratory chain deficiencies, reported in the literature 10 years ago, had a diagnostic rate of 60% by whole exome sequencing (WES) but 40% remained undiagnosed.
   Objective: We aimed to identify a genetic diagnosis by reanalysis of the WES data for the undiagnosed arm of this 10-year-old cohort of patients with suspected mitochondrial disorders.
   Methods: The WES data was transferred and processed by the RD-Connect Genome-Phenome Analysis Platform (GPAP) using their standardized pipeline. Variant prioritisation was carried out on the RD-Connect GPAP.
   Results: Singleton WES data from 14 individuals was reanalysed. We identified a possible or likely genetic diagnosis in 8 patients (8/14, 57%). The variants identified were in a combination of mitochondrial DNA (n= 1, MT-TN), nuclear encoded mitochondrial genes (n= 2, PDHA1, and SUCLA2) and nuclear genes associated with nonmitochondrial disorders (n= 5, PNPLA2, CDC40, NBAS and SLC7A7). Variants in both the NBAS and CDC40 genes were established as disease causing after the original cohort was published. We increased the diagnostic yield for the original cohort by 15% without generating any further genomic data.
   Conclusions: In the era of multiomics we highlight that reanalysis of existing WES data is a valid tool for generating additional diagnosis in patients with suspected mitochondrial disease, particularly when more time has passed to allow for new bioinformatic pipelines to emerge, for the development of new tools in variant interpretation aiding in reclassification of variants and the expansion of scientific knowledge on additional genes.
C1 [Olimpio, Catarina; Schon, Katherine; Horvath, Rita] Univ Cambridge, John Van Geest Ctr Brain Repair, Dept Clin Neurosci, Robinson Way, Cambridge CB2 0PY, England.
   [Olimpio, Catarina; Schon, Katherine] Cambridge Univ Hosp NHS Fdn Trust, East Anglian Med Genet Serv, Cambridge, England.
   [Paramonov, Ida; Matalonga, Leslie; Laurie, Steven; Lochmueller, Hanns] Ctr Nacl Anal Genom, Barcelona, Spain.
   [Kirschner, Janbernd; Lochmueller, Hanns] Univ Freiburg, Med Ctr, Fac Med, Dept Neuropediat & Muscle Disorders, Freiburg, Germany.
   [Schara-Schmidt, Ulrike] Univ Hosp Essen, C TNBS, Ctr Neuromuscular Disorders, Dept Pediat Neurol, Essen, Germany.
   [Polavarapu, Kiran; Lochmueller, Hanns] Childrens Hosp Eastern Ontario Res Inst, Ottawa, ON, Canada.
   [Lochmueller, Hanns] Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON, Canada.
   [Polavarapu, Kiran; Lochmueller, Hanns] Ottawa Hosp, Dept Med, Div Neurol, Ottawa, ON, Canada.
   [Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, MRC Mitochondrial Biol Unit, Cambridge, England.
C3 University of Cambridge; University of Cambridge; University of
   Freiburg; University of Duisburg Essen; University of Ottawa; Children's
   Hospital of Eastern Ontario; University of Ottawa; University of Ottawa;
   Ottawa Hospital Research Institute; University of Cambridge
RP Horvath, R (corresponding author), Univ Cambridge, John Van Geest Ctr Brain Repair, Dept Clin Neurosci, Robinson Way, Cambridge CB2 0PY, England.
EM rh732@medschl.cam.ac.uk
RI Matalonga, Leslie/AAH-9703-2019; Kirschner, Janbernd/H-7418-2016
OI Schon, Katherine/0000-0001-8054-8954
FU Evelyn Trust [G117372]; Wellcome Trust [G118015]; Muscular Dystrophy UK;
   Medical Research Council (UK) [MR/V009346/1]; Addenbrookes Charitable
   Trust [G100142]; Evelyn Trust; Stoneygate Trust; Lily Foundation; Action
   for AT; MRC [MR/S005021/1]; NIHR Cambridge Biomedical Research Centre
   [BRC-1215-20014]
FX C.O. is supported by the Evelyn Trust (G117372). R.H. is supported by
   theWellcome Trust (G118015), Muscular Dystrophy UK, the Medical Research
   Council (UK) (MR/V009346/1), the Addenbrookes Charitable Trust
   (G100142), the Evelyn Trust, the Stoneygate Trust, the Lily Foundation,
   Action for AT and an MRC strategic award to establish an International
   Centre for Genomic Medicine in Neuromuscular Diseases (ICGNMD)
   (MR/S005021/1). This researchwas supported by the NIHR Cambridge
   Biomedical Research Centre (BRC-1215-20014). The views expressed are
   those of the authors and not necessarily those of the NIHR or the
   Department of Health and Social Care.
CR Bartsakoulia M, 2018, HUM MOL GENET, V27, P1186, DOI 10.1093/hmg/ddy033
   Chai GL, 2021, NEURON, V109, P241, DOI 10.1016/j.neuron.2020.10.035
   de Boer E, 2021, EUR J HUM GENET, V29, P1359, DOI 10.1038/s41431-021-00900-2
   Deignan JL, 2019, GENET MED, V21, P1267, DOI 10.1038/s41436-019-0478-1
   Ellard S., 2020, ACGS BEST PRACTICE G, DOI [10.1101/531210, DOI 10.1101/531210]
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Garret P, 2019, HUM MUTAT, V40, P2430, DOI 10.1002/humu.23885
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Haack TB, 2015, AM J HUM GENET, V97, P163, DOI 10.1016/j.ajhg.2015.05.009
   Issa MY, 2020, BMC MED GENOMICS, V13, DOI 10.1186/s12920-020-0714-1
   Jousserand G, 2016, M S-MED SCI, V32, P10, DOI 10.1051/medsci/201632s203
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Laurie S, 2022, HUM MUTAT, V43, P717, DOI 10.1002/humu.24353
   Matalonga L, 2021, EUR J HUM GENET, V29, P1337, DOI 10.1038/s41431-021-00852-7
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   McCormick EM, 2020, HUM MUTAT, V41, P2028, DOI 10.1002/humu.24107
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Mingirulli N, 2020, J INHERIT METAB DIS, V43, P297, DOI 10.1002/jimd.12156
   O'Brien TD, 2022, GENET MED, V24, P192, DOI 10.1016/j.gim.2021.09.007
   Otero LJ, 1998, HUM MUTAT, V12, P114, DOI 10.1002/(SICI)1098-1004(1998)12:2<114::AID-HUMU6>3.0.CO;2-#
   Pennisi EM, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0646-9
   Poole OV, 2021, ANN NEUROL, V89, P1240, DOI 10.1002/ana.26063
   Puusepp S, 2018, MOL GENET METAB REP, V15, P80, DOI 10.1016/j.ymgmr.2018.03.004
   Pyle A, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000006
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Sanchis-Juan A, 2023, AM J HUM GENET, V110, P1343, DOI 10.1016/j.ajhg.2023.07.007
   Schon KR, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-066288
   Sperandeo MP, 2008, HUM MUTAT, V29, P14, DOI 10.1002/humu.20589
   Spinazzola A, 2004, NEUROMUSCULAR DISORD, V14, P815, DOI 10.1016/j.nmd.2004.09.002
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Theunissen TEJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00400
   Thompson JLP, 2023, ORPHANET J RARE DIS, V18, DOI 10.1186/s13023-023-02754-x
   Töpf A, 2021, EUR J HUM GENET, V29, P1348, DOI 10.1038/s41431-021-00851-8
   Wortmann SB, 2017, NEUROPEDIATRICS, V48, P309, DOI 10.1055/s-0037-1603776
   Wright CF, 2023, NEW ENGL J MED, V388, P1559, DOI 10.1056/NEJMoa2209046
   Zurek B, 2021, EUR J HUM GENET, V29, P1325, DOI 10.1038/s41431-021-00859-0
NR 36
TC 0
Z9 0
U1 0
U2 0
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 2214-3599
EI 2214-3602
J9 J NEUROMUSCULAR DIS
JI J. Neuromusc. Dis.
PY 2024
VL 11
IS 4
BP 767
EP 775
DI 10.3233/JND-240020
PG 9
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA ZC5C4
UT WOS:001273094500003
PM 38759022
OA hybrid
DA 2024-11-01
ER

PT J
AU Lodi, R
   Tonon, C
   Valentino, ML
   Manners, D
   Testa, C
   Malucelli, E
   La Morgia, C
   Barboni, P
   Carbonelli, M
   Schimpf, S
   Wissinger, B
   Zeviani, M
   Baruzzi, A
   Liguori, R
   Barbiroli, B
   Carelli, V
AF Lodi, Raffaele
   Tonon, Caterina
   Valentino, Maria Lucia
   Manners, David
   Testa, Claudia
   Malucelli, Emil
   La Morgia, Chiara
   Barboni, Piero
   Carbonelli, Michele
   Schimpf, Simone
   Wissinger, Bernd
   Zeviani, Massimo
   Baruzzi, Agostino
   Liguori, Rocco
   Barbiroli, Bruno
   Carelli, Valerio
TI Defective Mitochondrial Adenosine Triphosphate Production in Skeletal
   Muscle From Patients With Dominant Optic Atrophy Due to <i>OPA1</i>
   Mutations
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID MAGNETIC-RESONANCE-SPECTROSCOPY; EXTERNAL OPHTHALMOPLEGIA; COMPLEX-I;
   NEUROPATHY; DISEASE; GENE; DYSFUNCTION; METABOLISM; DELETION; CARRIERS
AB Objective: To assess whether impaired energy metabolism in skeletal muscle is a hallmark feature of patients with dominant optic atrophy due to several different mutations in the OPA1 gene.
   Design: We used phosphorus 31 magnetic resonance spectroscopy to assess calf muscle oxidative metabolism in subjects with molecularly defined dominant optic atrophy carrying different mutations in the OPA1 gene. In a subset of patients, we also evaluated serum lactate levels after exercise and muscle biopsy results for histology and mitochondrial DNA analysis.
   Setting: University neuromuscular and neurogenetics and magnetic resonance imaging units.
   Patients: Eighteen patients with dominant optic atrophy were enrolled from 8 unrelated families, 7 of which carried an OPA1 mutation predicted to induce haplo-insufficiency and 1 with a missense mutation in exon 27. Fifteen patients had documented optic atrophy.
   Main Outcome Measures: Presence of skeletal muscle mitochondrial oxidative phosphorylation dysfunction as assessed by phosphorus 31 magnetic resonance spectroscopy, serum lactate levels, and histological and mitochondrial DNA analysis.
   Results: Phosphorus 31 magnetic resonance spectroscopy showed reduced phosphorylation potential in the calf muscle at rest in patients with an OPA1 mutation (-24% from normal mean; P=.003) as well as a reduced maximum rate of mitochondrial adenosine triphosphate synthesis (-36%; P<.001; ranging from -28% to -49% in association with different mutations). In 4 of 10 patients (40%), the serum lactate level after exercise was elevated. Only 2 of 5 muscle biopsies, from the 2 patients with a missense mutation, showed slight myopathic changes. Low levels of mitochondrial DNA multiple deletions were found in all muscle biopsies.
   Conclusions: Defective oxidative phosphorylation in skeletal muscle is a subclinical feature of patients with OPA1-related dominant optic atrophy, indicating a systemic expression of the OPA1 defect, similar to that previously reported for Leber hereditary optic neuropathy due to complex I dysfunction. This defect of oxidative phosphorylation does not appear to depend on the low amounts of mitochondrial DNA multiple deletions detected in muscle biopsies.
C1 [Lodi, Raffaele; Tonon, Caterina; Manners, David; Testa, Claudia; Malucelli, Emil; Barbiroli, Bruno] Univ Bologna, MR Spect Unit, Dept Internal Med Aging & Nephrol, I-40138 Bologna, Italy.
   [Valentino, Maria Lucia; La Morgia, Chiara; Barboni, Piero; Carbonelli, Michele; Baruzzi, Agostino; Liguori, Rocco; Carelli, Valerio] Univ Bologna, Dept Neurol Sci, I-40138 Bologna, Italy.
   [Carbonelli, Michele] Studio Oculist dAzeglio, Bologna, Italy.
   [Zeviani, Massimo] Natl Neurol Inst, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, Unit Mol Neurogenet, Milan, Italy.
   [Schimpf, Simone; Wissinger, Bernd] Univ Augenklin, Mol Genet Lab, Tubingen, Germany.
C3 University of Bologna; University of Bologna; Fondazione IRCCS Istituto
   Neurologico Carlo Besta; Eberhard Karls University of Tubingen; Eberhard
   Karls University Hospital
RP Lodi, R (corresponding author), Univ Bologna, MR Spect Unit, Dept Internal Med Aging & Nephrol, Via Massarenti 9, I-40138 Bologna, Italy.
EM raffaele.lodi@unibo.it
RI Zeviani, Massimo/K-2891-2014; Liguori, Rocco/AAB-7860-2020; Lodi,
   Raffaele/K-4984-2016; Malucelli, Emil/IXD-9846-2023; Tonon,
   Caterina/K-6680-2016; La Morgia, Chiara/H-6765-2012; Barboni,
   Piero/AAA-9936-2020; Manners, David/J-2415-2012; MALUCELLI,
   EMIL/I-3991-2017
OI Zeviani, Massimo/0000-0002-9067-5508; Liguori,
   Rocco/0000-0002-1815-1013; VALENTINO, MARIA LUCIA/0000-0001-5323-0115;
   Barboni, Piero/0000-0002-0118-4177; TESTA, CLAUDIA/0000-0002-8591-9803;
   LA MORGIA, Chiara/0000-0002-4639-8929; Manners,
   David/0000-0002-2404-1101; CARELLI, VALERIO/0000-0003-4923-6404;
   MALUCELLI, EMIL/0000-0002-1077-0098; TONON,
   CATERINA/0000-0002-0506-499X; Lodi, Raffaele/0000-0003-3878-304X
FU Telethon-Italy [GGP06233]
FX This work was supported by grant GGP06233 from Telethon-Italy (Dr
   Carelli).
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   ARNOLD DL, 1985, ANN NEUROL, V18, P189, DOI 10.1002/ana.410180205
   BARBIROLI B, 1995, NEUROLOGY, V45, P1364, DOI 10.1212/WNL.45.7.1364
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 1998, J NEUROL SCI, V160, P183, DOI 10.1016/S0022-510X(98)00239-1
   Carelli V, 2007, BIOSCIENCE REP, V27, P173, DOI 10.1007/s10540-007-9045-0
   Chevrollier A, 2008, ANN NEUROL, V63, P794, DOI 10.1002/ana.21385
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Ferré M, 2005, HUM MUTAT, V25, P423, DOI 10.1002/humu.20161
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   KJER P, 1959, ACTA OPHTHALMOL    S, V54, P1
   Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417
   LARSSON NG, 1991, ANN NEUROL, V30, P701, DOI 10.1002/ana.410300511
   Lodi R, 2000, BRAIN, V123, P1896, DOI 10.1093/brain/123.9.1896
   Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278
   Lodi R, 1997, ANN NEUROL, V42, P573, DOI 10.1002/ana.410420407
   Martinuzzi A, 2008, MUSCLE NERVE, V37, P350, DOI 10.1002/mus.20937
   Mayorov Vladimir I., 2008, BMC Biochemistry, V9, P9, DOI 10.1186/1471-2091-9-22
   MONTAGNA P, 1995, J NEUROL NEUROSUR PS, V58, P640, DOI 10.1136/jnnp.58.5.640
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Olichon A, 2006, BBA-MOL CELL RES, V1763, P500, DOI 10.1016/j.bbamcr.2006.04.003
   Pesch UEA, 2001, HUM MOL GENET, V10, P1359, DOI 10.1093/hmg/10.13.1359
   Schimpf S, 2006, HUM GENET, V118, P767, DOI 10.1007/s00439-005-0096-7
   Spinazzi M, 2008, HUM MOL GENET, V17, P3291, DOI 10.1093/hmg/ddn225
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Yu-Wai-Man P, 2009, INVEST OPHTH VIS SCI, V50, P4561, DOI 10.1167/iovs.09-3634
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
NR 35
TC 33
Z9 37
U1 0
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610-0946 USA
SN 0003-9942
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD JAN
PY 2011
VL 68
IS 1
BP 67
EP 73
DI 10.1001/archneurol.2010.228
PG 7
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 704MO
UT WOS:000286057300009
PM 20837821
DA 2024-11-01
ER

PT J
AU Cao, YY
   Ma, YN
   Zhang, Y
   Li, YJE
   Fang, F
   Wang, ST
   Bu, DF
   Xu, YF
   Pei, P
   Li, L
   Xiao, Y
   Wu, HR
   Yang, YL
   Zou, LP
   Qi, Y
AF Cao, Yanyan
   Ma, Yinan
   Zhang, Ying
   Li, Yujie
   Fang, Fang
   Wang, Songtao
   Bu, Dingfang
   Xu, Yufeng
   Pei, Pei
   Li, Lin
   Xiao, Yang
   Wu, Hairong
   Yang, Yanling
   Zou, Liping
   Qi, Yu
TI Detection of eight frequently encountered point mutations in
   mitochondria in Chinese patients suggestive of mitochondrial
   encephalomyopathies
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial encephalomyopathy; Mitochondrial DNA; Mutation; MELAS
ID RESPIRATORY-CHAIN DISORDERS; DIAGNOSTIC-CRITERIA; A3243G MUTATION;
   PREVALENCE; CHILDREN; DNA; DISEASE; ADULTS; MELAS; EPIDEMIOLOGY
AB To evaluate eight frequently encountered mitochondrial DNA (mtDNA) point mutations (A3243G, T8993G/C, A8344G, A1555G, G11778A, G3460A and T14484C) in Chinese, we recruited 1559 sporadic patients suspected of mitochondrial diseases and 206 family members. In suspected patients, 158 cases were detected with one of these eight mtDNA mutations (10.1%). A3243G was the most common mtDNA mutation both in suspected patients (9.4%) and in the relatives (34.2%). In addition, the ratios of A3243G (mutant/wild-type) and A8344G were significantly correlated with the patients' age of examination. Moreover, in 76 unrelated probands, the ratio of A3243G was correlated well with their seizures and myopathies. (C) 2010 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Cao, Yanyan; Ma, Yinan; Zhang, Ying; Li, Yujie; Wang, Songtao; Bu, Dingfang; Xu, Yufeng; Pei, Pei; Li, Lin; Xiao, Yang; Wu, Hairong; Qi, Yu] Peking Univ, Hosp 1, Dept Cent Lab, Beijing 100034, Peoples R China.
   [Fang, Fang] Beijing Childrens Hosp, Dept Neurol, Beijing 100045, Peoples R China.
   [Yang, Yanling] Peking Univ, Hosp 1, Dept Pediat, Beijing 100034, Peoples R China.
   [Zou, Liping] Gen Hosp Chinese Peoples Liberat Army, Dept Pediat, Beijing 100853, Peoples R China.
C3 Peking University; Capital Medical University; Peking University
RP Qi, Y (corresponding author), Peking Univ, Hosp 1, Dept Cent Lab, 8 Xishiku St, Beijing 100034, Peoples R China.
EM qiyu0724@yahoo.com
RI Yang, Yanling/F-5954-2014; Li, Yifei/GYA-2567-2022
FU National Natural Science Foundation of China [30700912]
FX We greatly acknowledge the related physicians, patients and their family
   members for their collaboration in this investigation. This study was
   financially supported by grants from National Natural Science Foundation
   of China (No. 30700912).
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405
   Diogo L, 2009, PEDIATR NEUROL, V40, P351, DOI 10.1016/j.pediatrneurol.2008.11.012
   Kogelnik AM, 1998, NUCLEIC ACIDS RES, V26, P112, DOI 10.1093/nar/26.1.112
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Marotta R, 2004, INTERN MED J, V34, P10, DOI 10.1111/j.1444-0903.2004.t01-3-.x
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Niu Shu-lan, 2003, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V25, P153
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   [王朝霞 Wang Zhaoxia], 2003, [中华神经科杂志, Chinese Journal of Neurology], V36, P28
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wolny S, 2009, ACTA PAEDIATR, V98, P553, DOI 10.1111/j.1651-2227.2008.01148.x
   Yu Q, 2007, MITOCHONDRION, V7, P147, DOI 10.1016/j.mito.2006.11.019
   Zhang Ying, 2005, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V27, P77
NR 22
TC 6
Z9 11
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUN
PY 2010
VL 10
IS 4
BP 330
EP 334
DI 10.1016/j.mito.2010.01.008
PG 5
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 604FL
UT WOS:000278262600004
PM 20123042
DA 2024-11-01
ER

PT J
AU Nguyen, KV
   Sharlef, FS
   Chan, SSL
   Copeland, WC
   Naviaux, RK
AF Nguyen, Khue V.
   Sharlef, Farida S.
   Chan, Sherine S. L.
   Copeland, William C.
   Naviaux, Robert K.
TI Molecular diagnosis of Alpers syndrome
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE Alpers-Huttenlocher syndrome; POLG; mtDNA depletion; seizures; cirrhosis
ID DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   DEOXYGUANOSINE KINASE GENE; BASE EXCISION-REPAIR; MITOCHONDRIAL-DNA;
   POLG MUTATIONS; ACCESSORY SUBUNIT; NEURONAL DEGENERATION; DEPLETION;
   ATAXIA
AB Background/Aims: Alpers syndrome is a developmental mitochondrial DNA depletion syndrome leading to fatal brain and liver disease in children and young adults. Mutations in the gene for the mitochondrial DNA polymerase (POLG) have recently been shown to cause this disorder.
   Methods: The POLG locus was sequenced in 15 sequential probands diagnosed with Alpers syndrome. In addition, the POLG mutations found to cause Alpers syndrome in the 20 cases published to date were analyzed.
   Results: POLG DNA testing accurately diagnosed 87% (13/15 = 87%: 95% confidence interval = 60-98%) of cases. Five new POLG amino acid substitutions (F749S, R852C, T914P, L966R, and L1173fsX) were found that were associated with Alpers syndrome in five unrelated kindreds, and 14 different allelic combinations of POLG mutations were found to cause Alpers syndrome in the 20 probands published to date. The most common Alpers-causing mutation was the A467T substitution, located in the linker region of the pol gamma protein, which accounted for about 40% of the alleles and was present in 65% of the patients. All patients with POLG mutations had either the A467T or the W748S substitution in the linker region.
   Conclusions: Screening for A467T and W748S substitutions in POLG now constitutes the most rapid and sensitive test available for confirming the clinical diagnosis of Alpers syndrome. (c) 2006 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
C1 Univ Calif San Diego, San Diego Sch Med, Dept Med, San Diego, CA 92103 USA.
   Univ Calif San Diego, San Diego Sch Med, Dept Pediat, San Diego, CA 92103 USA.
   Univ Calif San Diego, San Diego Sch Med, Mitochondrial & Metab Dis Ctr, San Diego, CA 92103 USA.
   NIEHS, Genet Mol Lab, NIH, Res Triangle Pk, NC 27709 USA.
C3 University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Naviaux, RK (corresponding author), Univ Calif San Diego, San Diego Sch Med, Dept Med, Bldg CTF,Rm C-103,214 Dickinson St, San Diego, CA 92103 USA.
EM naviaux@ucsd.edu
RI Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   Broughton BC, 2002, P NATL ACAD SCI USA, V99, P815, DOI 10.1073/pnas.022473899
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Copeland William C, 2003, ScientificWorldJournal, V3, P34
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Heath EM, 2001, ARCH PATHOL LAB MED, V125, P127
   Hübscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Labarthe F, 2005, J HEPATOL, V43, P333, DOI 10.1016/j.jhep.2005.03.023
   Lamantea E, 2004, ANN NEUROL, V56, P454, DOI 10.1002/ana.20219
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   LONGLEY MJ, 2005, GENE
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Pinz KG, 2006, DNA REPAIR, V5, P121, DOI 10.1016/j.dnarep.2005.08.014
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Sambrook J, 1990, Cold Spring Harbor Laboratories, V186, P182
   Taanman JW, 2002, ANN NEUROL, V52, P237, DOI 10.1002/ana.10247
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
NR 41
TC 100
Z9 106
U1 0
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD JUL
PY 2006
VL 45
IS 1
BP 108
EP 116
DI 10.1016/j.jhep.2005.12.026
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 060DK
UT WOS:000238782200014
PM 16545482
DA 2024-11-01
ER

PT J
AU Mezghani, N
   Mkaouar-Rebai, E
   Mnif, M
   Charfi, N
   Rekik, N
   Youssef, S
   Abid, M
   Fakhfakh, F
AF Mezghani, Najla
   Mkaouar-Rebai, Emna
   Mnif, Mouna
   Charfi, Nadia
   Rekik, Nabila
   Youssef, Saoussan
   Abid, Mohamed
   Fakhfakh, Faiza
TI The heteroplasmic m.14709T&gt;C mutation in the tRNA<SUP>Glu</SUP> gene
   in two Tunisian families with mitochondrial diabetes
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Diabetes mellitus; Mitochondrial mutations; m.14709T > C; m.3243A > G;
   Heteroplasmy
ID CHINESE HAN POPULATION; A3243G MUTATION; TRNA(LEU(UUR)) MUTATION;
   T14709C MUTATION; DNA EXTRACTION; ONSET MYOPATHY; POINT MUTATION;
   HEARING-LOSS; MELLITUS; PREVALENCE
AB Diabetes mellitus (DM) is a heterogeneous disorder characterized by the presence of chronic hyperglycemia. Genetic factors play an important role in the development of this disorder, and several studies reported mutations in nuclear genes implicated in the insulin function. Besides, DM can be maternally transmitted in some families, possibly due to the maternal mitochondrial inheritance. In fact, mitochondrial genes may be plausible causative agents for diabetes, since mitochondrial oxidative phosphorylation plays an important role in glucose-stimulated insulin secretion from beta cells. Materials and Methods: In this report, we screened two Tunisian families with mitochondrial diabetes for the m.3243A>G and the m.14709T>C mutations, respectively, in the tRNA(Leu(UUR)) and the tRNA(Glu) genes. Results: The polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) and the sequence-specific primers by polymerase chain reaction (SSP-PCR) analysis in the leucocytes and the buccal mucosa in the members of the two families showed the absence of the m.3243A>G mutation and the presence of the heteroplasmic m.14709T>C mutation in the tRNA(Glu) gene in the two tested tissues. Conclusions: We conclude that the tn.14709T>C mutation in the tRNA(Glu) gene could be a cause of mitochondrial diabetes in Tunisian affected families. In addition, the heteroplasmic loads correlated with the severity and the onset of mitochondrial diabetes in one family but not in the other, suggesting the presence of environmental factors or nuclear modifier genes. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Mezghani, Najla; Mkaouar-Rebai, Emna; Youssef, Saoussan; Fakhfakh, Faiza] Fac Med Sfax, Human Mol Genet Lab, Sfax 3029, Tunisia.
   [Mnif, Mouna; Charfi, Nadia; Rekik, Nabila; Abid, Mohamed] CHU Habib Bourguiba Sfax, Serv Endocrinol, Sfax, Tunisia.
C3 Universite de Sfax; Universite de Sfax; Hopital Habib Bourguiba; Hopital
   Hedi Chaker
RP Fakhfakh, F (corresponding author), Fac Med Sfax, Human Mol Genet Lab, Ave Magida Boulila, Sfax 3029, Tunisia.
EM emna_mkaouar@mail2world.com; faiza.fakhfakh@gnet.tn
RI MKAOUAR-REBAI, Emna/AAE-6650-2019
OI Mkaouar-Rebai, Emna/0000-0003-3095-510X
FU Tunisian Ministry of Higher Education, Scientific Research and
   Technology
FX This work was supported by The Tunisian Ministry of Higher Education,
   Scientific Research and Technology.
CR Akbari M, 2004, SCAND J CLIN LAB INV, V64, P86, DOI 10.1080/00365510410004209
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Au WS, 2008, J MOL ENDOCRINOL, V41, P229, DOI 10.1677/JME-08-0080
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   Cao W, 2003, CANCER DETECT PREV, V27, P397, DOI 10.1016/S0361-090X(03)00103-X
   Chen Gang, 2008, Yichuan, V30, P1279, DOI 10.3724/SP.J.1005.2008.01279
   Crispim D, 2008, ARQ BRAS ENDOCRINOL, V52, P1228, DOI 10.1590/S0004-27302008000800005
   Crispim Daisy, 2006, Arq Bras Endocrinol Metab, V50, P862, DOI 10.1590/S0004-27302006000500006
   Damore ME, 1999, J PEDIATR ENDOCR MET, V12, P207
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590
   Kong Weijia, 2002, Zhonghua Er Bi Yan Hou Ke Za Zhi, V37, P338
   Kornblum C, 2005, J NEUROL, V252, P1101, DOI 10.1007/s00415-005-0827-7
   Lee HC, 1997, J CLIN ENDOCR METAB, V82, P372, DOI 10.1210/jc.82.2.372
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   Li MZ, 2008, CHINESE MED J-PEKING, V121, P682, DOI 10.1097/00029330-200804020-00004
   Liao WQ, 2008, TOHOKU J EXP MED, V215, P377, DOI 10.1620/tjem.215.377
   Liu LM, 2010, DIABETES CARE, V33, P144, DOI 10.2337/dc09-1258
   Liu SM, 2007, DIABETES RES CLIN PR, V76, P425, DOI 10.1016/j.diabres.2006.09.032
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Mancuso M, 2005, J NEUROL SCI, V228, P93, DOI 10.1016/j.jns.2004.10.018
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   Mkaouar-Rebai E, 2007, BIOCHEM BIOPH RES CO, V355, P1031, DOI 10.1016/j.bbrc.2007.02.083
   Ng MCY, 2000, CLIN ENDOCRINOL, V52, P557, DOI 10.1046/j.1365-2265.2000.00989.x
   Ohkubo K, 2001, CLIN CHEM, V47, P1641
   Pandey AK, 2009, FEBS J, V276, P4181, DOI 10.1111/j.1742-4658.2009.07091.x
   Pang CY, 1999, J FORMOS MED ASSOC, V98, P326
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   Ren Yan, 2003, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V20, P181
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Rigoli L, 2001, DIABETIC MED, V18, P334, DOI 10.1046/j.1464-5491.2001.00429-2.x
   Salles JE, 2007, PANCREAS, V34, P133, DOI 10.1097/01.mpa.0000246659.38375.4d
   Suzuki Y, 1997, DIABETES CARE, V20, P1138, DOI 10.2337/diacare.20.7.1138
   Suzuki Y, 2003, DIABETES CARE, V26, P1315, DOI 10.2337/diacare.26.4.1315
   Tang Dong-ling, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P636
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
NR 41
TC 26
Z9 26
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD JUL-AUG
PY 2010
VL 24
IS 4
BP 270
EP 277
DI 10.1016/j.jdiacomp.2009.11.002
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 613JB
UT WOS:000278974100009
PM 20045353
DA 2024-11-01
ER

PT J
AU Liao, NY
   Lai, KL
   Liao, YC
   Hsiao, CT
   Lee, YC
AF Liao, Nai-Yi
   Lai, Kuan-Lin
   Liao, Yi-Chu
   Hsiao, Cheng-Tsung
   Lee, Yi-Chung
TI Identification of m.3243A&gt;G mitochondrial DNA mutation in patients
   with cerebellar ataxia
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Article
DE Cerebellar ataxia; m.3243A > G; MELAS
ID HETEROPLASMY; DISEASE; CLASSIFICATION; FEATURES; URINE
AB Background: The mitochondrial DNA m.3243A>G mutation can affect mitochondrial function and lead to a wide phenotypic spectrum, including mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome, diabetes mellitus, hearing impairment, cardiac involvement, epilepsy, migraine, myopathy, and cerebellar ataxia. However, m.3243A>G has been rarely reported in patients with cerebellar ataxia as their predominant manifestation. The aim of this study is to investigate the prevalence and clinical features of m.3243A>G in a Taiwanese cohort of cerebellar ataxia with unknown genetic diagnosis.Methods: This retrospective cohort study conducted the mutation analysis of m.3243A>G by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) in 232 unrelated Han Chinese patients with genetically-undetermined cerebellar ataxia. The clinical presentation and neuroimaging features of patients with m.3243A>G mutation-related cere-bellar ataxia were characterized.Results: We identified two patients harboring m.3243A>G mutation. These patients have suf-fered from apparently sporadic and slowly progressive cerebellar ataxia since age 52 and 35 years, respectively. Both patients had diabetes mellitus and/or hearing impairment. The neu-roimaging studies revealed generalized brain atrophy with predominantly cerebellar involve-ment in both individuals and bilateral basal ganglia calcifications in one of the patients.Conclusion: Mitochondrial m.3243A>G mutation accounted for 0.9% (2/232) of genetically -undetermined cerebellar ataxia in the Han Chinese cohort in Taiwan. These findings highlight the importance of investigating m.3243A>G in patients with genetically-undetermined cere-bellar ataxia.Copyright 2023, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Liao, Nai-Yi] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan.
   [Lai, Kuan-Lin; Liao, Yi-Chu; Hsiao, Cheng-Tsung; Lee, Yi-Chung] Natl Yang Ming Chiao Tung Univ, Sch Med, Dept Neurol, Taipei, Taiwan.
   [Lai, Kuan-Lin; Liao, Yi-Chu; Hsiao, Cheng-Tsung; Lee, Yi-Chung] Natl Yang Ming Chiao Tung Univ, Brain Res Ctr, Sch Med, Taipei, Taiwan.
   [Hsiao, Cheng-Tsung; Lee, Yi-Chung] Taipei Vet Gen Hosp, Dept Neurol, 201,Sec 2,Shih Pai Rd, Taipei 11217, Taiwan.
C3 Taipei Veterans General Hospital; National Yang Ming Chiao Tung
   University; National Yang Ming Chiao Tung University; Taipei Veterans
   General Hospital
RP Hsiao, CT; Lee, YC (corresponding author), Taipei Vet Gen Hosp, Dept Neurol, 201,Sec 2,Shih Pai Rd, Taipei 11217, Taiwan.
EM cthsiao@vghtpe.gov.tw; ycli@vghtpe.gov.tw
RI Lee, Yi-Chung/GZK-7162-2022
OI Liao, Yi-Chu/0000-0002-9644-2086; Lee, Yi-Chung/0000-0003-0102-164X;
   Liao, Nai Yi/0000-0002-1036-1956
FU Ministry of Science and Technology, Taiwan [109-2314-B-075-044-MY3,
   110-2314-B-075-004- MY2]; Taipei Veterans General Hospital [V111C-033];
   Brain Research Center of National Yang Ming Chiao Tung University from
   The Featured Areas Research Center Program within the framework of the
   Higher Education Sprout Project by the Ministry of Education in Taiwan
FX We are grateful to the patients and their families who participated in
   the study. This study was supported by research grants from Ministry of
   Science and Technology, Taiwan (109-2314-B-075-044-MY3,
   110-2314-B-075-004- MY2) , and Taipei Veterans General Hospital
   (V111C-033) , and from The Brain Research Center of National Yang Ming
   Chiao Tung University from The Featured Areas Research Center Program
   within the framework of the Higher Education Sprout Project by the
   Ministry of Education in Taiwan.
CR Abele M, 2002, BRAIN, V125, P961, DOI 10.1093/brain/awf107
   Almannai M, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.682780
   Ashizawa T, 2018, NAT REV NEUROL, V14, P590, DOI 10.1038/s41582-018-0051-6
   Bargiela David, 2015, Cerebellum Ataxias, V2, P16, DOI 10.1186/s40673-015-0035-x
   Chae HW, 2020, EUR J ENDOCRINOL, V183, P505, DOI 10.1530/EJE-20-0189
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   De Vries MC, 2020, J INHERIT METAB DIS, V43, P800, DOI 10.1002/jimd.12196
   Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3
   Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Gruosso F, 2021, J CLIN MED, V10, DOI 10.3390/jcm10010094
   Hadjivassiliou M, 2017, J NEUROL NEUROSUR PS, V88, P301, DOI 10.1136/jnnp-2016-314863
   Ito H, 2011, BRAIN DEV-JPN, V33, P283, DOI 10.1016/j.braindev.2010.06.010
   Klockgether T, 2010, LANCET NEUROL, V9, P94, DOI 10.1016/S1474-4422(09)70305-9
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lee YC, 2007, J NEUROL SCI, V254, P65, DOI 10.1016/j.jns.2007.01.005
   Lopriore P, 2022, NEUROL INT, V14, P337, DOI 10.3390/neurolint14020028
   Malhotra K, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0583-7
   Scholle LM, 2020, GENES-BASEL, V11, DOI 10.3390/genes11020212
   Ng YS, 2022, BRAIN, V145, P542, DOI 10.1093/brain/awab353
   Parikh S, 2017, GENET MED, V19, DOI 10.1038/gim.2017.107
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Paulson HL, 2017, NAT REV NEUROSCI, V18, P613, DOI 10.1038/nrn.2017.92
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Schöls L, 2000, HUM GENET, V107, P132, DOI 10.1007/s004390000346
   Soong Bing-Wen, 2018, Handb Clin Neurol, V155, P143, DOI 10.1016/B978-0-444-64189-2.00010-X
   Stefanetti RJ, 2022, NEUROLOGY, V98, pE2318, DOI 10.1212/WNL.0000000000200299
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Xia CY, 2016, CHINESE MED J-PEKING, V129, P1945, DOI 10.4103/0366-6999.187845
NR 33
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD OCT
PY 2023
VL 122
IS 10
BP 1028
EP 1034
DI 10.1016/j.jfma.2023.05.031
EA SEP 2023
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA W6OV1
UT WOS:001092809400001
PM 37311680
OA gold
DA 2024-11-01
ER

PT J
AU Tay, SHK
   Nordli, DR
   Bonilla, E
   Null, E
   Monaco, S
   Hirano, M
   DiMauro, S
AF Tay, SHK
   Nordli, DR
   Bonilla, E
   Null, E
   Monaco, S
   Hirano, M
   DiMauro, S
TI Aortic rupture in mitochondrial encephalopathy lactic acidosis, and
   stroke-like episodes
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID VASCULAR INVOLVEMENT; MYOPATHY; ANGIOPATHY; MUTATION; MELAS
AB Background: Microangiopathy has been well described in the brain and muscle of patients with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).
   Objective: To describe a patient with the common A3243G/MELAS point mutation who had aortic rupture and whose mother also died of large vessel rupture.
   Design: Case report.
   Setting: Collaboration between a primary care hospital and 2 academic tertiary care hospitals.
   Results: Histologically, there was marked disarray of the smooth muscle architecture of the aorta, and immunohistochemical staining with antibodies against the mitochondrial DNA-encoded cytochrome-C oxidase I subunit showed uniformly decreased immunostaining of the endothelial and smooth muscle cells of the aorta and vasa vasorum. Polymerase chain reaction and restriction fragment length polymorphism analysis showed that the mutation load was 40.5% in blood but 85.3% in the blood vessels.
   Conclusions: The severe vasculopathy in this patient is probably directly related to the high mutation load in the blood vessels. Although aortic rupture is an unusual manifestation of MELAS, it is an important potential complication in patients undergoing minor surgical procedures.
C1 Natl Univ Singapore, Dept Pediat, Singapore 117548, Singapore.
   Childrens Mem Hosp, Dept Neurol, Chicago, IL 60614 USA.
   Childrens Mem Hosp, Dept Pediat, Chicago, IL 60614 USA.
   Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA.
   Columbia Univ, Med Ctr, Dept Pathol, New York, NY USA.
   OSF St Francis Med Ctr, Dept Pathol, Peoria, IL USA.
C3 National University of Singapore; Ann & Robert H. Lurie Children's
   Hospital of Chicago; Ann & Robert H. Lurie Children's Hospital of
   Chicago; Columbia University; Columbia University
RP Coll Phys & Surg 4 420, 630 W 168th St, New York, NY 10032 USA.
EM sd12@columbia.edu
RI Savcenko, Irina/N-1416-2018; tay, stacey/E-7029-2015
OI Savcenko, Irina/0000-0002-2721-7029; tay, stacey/0000-0002-3077-4184
FU NICHD NIH HHS [HD32062] Funding Source: Medline
CR FORSTER C, 1992, NEUROPEDIATRICS, V23, P165, DOI 10.1055/s-2008-1071335
   MOLNAR M, 1995, NEUROPATH APPL NEURO, V21, P432, DOI 10.1111/j.1365-2990.1995.tb01080.x
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   SATO W, 1994, AM HEART J, V128, P733, DOI 10.1016/0002-8703(94)90272-0
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Takahashi N, 2005, AM J MED SCI, V329, P265, DOI 10.1097/00000441-200505000-00008
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
NR 8
TC 34
Z9 39
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD FEB
PY 2006
VL 63
IS 2
BP 281
EP 283
DI 10.1001/archneur.63.2.281
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 010LH
UT WOS:000235195700016
PM 16476819
DA 2024-11-01
ER

PT J
AU Ikawa, M
   Okazawa, H
   Arakawa, K
   Kudo, T
   Kimura, H
   Fujibayashi, Y
   Kuriyama, M
   Yoneda, M
AF Ikawa, Masamichi
   Okazawa, Hidehiko
   Arakawa, Kenichiro
   Kudo, Takashi
   Kimura, Hirohiko
   Fujibayashi, Yasuhisa
   Kuriyama, Masaru
   Yoneda, Makoto
TI PET imaging of redox and energy states in stroke-like episodes of MELAS
SO MITOCHONDRION
LA English
DT Article
DE MELAS; Stroke-like episodes; Oxidative stress; Over-reduction state;
   PET; Functional imaging
ID MITOCHONDRIAL-DNA; OXIDATIVE STRESS; A3243G MUTATION; HYPOXIA; CELLS;
   DAMAGE; ENCEPHALOMYOPATHY; PREVALENCE; ANGIOPATHY; AGENT
AB In stroke-like episodes of patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS), changes in oxidative stress and glucose metabolism and their sequence remain obscure. We developed a novel double imaging method using positron emission tomography (PET) with [Cu-62]-diacetyl-bis(N4-methylthiosemicarbazone) ((CU)-C-62-ATSM) and [F-18]-fluorodeoxyglucose ((18)FDG) to visualize the regional oxidative stress, glucose metabolism and blood flow in brain lesions of stroke-like episodes non-invasively and rapidly. These PET imagings were performed on a MELAS patient with stroke-like lesions, and clearly demonstrated that oxidative stress following hyperemia along with increased glucose metabolism plays crucial roles in the pathogenesis of MELAS stroke-like episodes. (C) 2009 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Ikawa, Masamichi; Kuriyama, Masaru; Yoneda, Makoto] Univ Fukui, Fac Med Sci, Dept Internal Med Neurol 2, Fukui 9101193, Japan.
   [Okazawa, Hidehiko; Kudo, Takashi; Fujibayashi, Yasuhisa] Univ Fukui, Biomed Imaging Res Ctr, Fukui 9101193, Japan.
   [Arakawa, Kenichiro] Univ Fukui, Fac Med Sci, Dept Internal Med Cardiol 3, Fukui 9101193, Japan.
   [Kimura, Hirohiko] Univ Fukui, Fac Med Sci, Dept Radiol, Fukui 9101193, Japan.
C3 University of Fukui; University of Fukui; University of Fukui;
   University of Fukui
RP Yoneda, M (corresponding author), Univ Fukui, Fac Med Sci, Dept Internal Med Neurol 2, 23-3 Shimoaiduki,Eiheiji Cho, Fukui 9101193, Japan.
EM myoneda@u-fukui.ac.jp
RI Ikawa, Masamichi/AGG-4951-2022; Kudo, Takashi/L-4564-2018; Okazawa,
   Hidehiko/I-2488-2019; Okazawa, Hidehiko/B-2795-2016
OI Ikawa, Masamichi/0000-0001-9785-0535; Okazawa,
   Hidehiko/0000-0001-7046-3383
FU National Institute of Radiological Sciences, Chiba, Japan; Japan Society
   for the Promotion of Science [17209040]; 21st Century COE Program
   (Medical Science); Grants-in-Aid for Scientific Research [17209040]
   Funding Source: KAKEN
FX This study was supported by the National Institute of Radiological
   Sciences, Chiba, Japan. This study was partly funded by a Grant-in-Aid
   for Scientific Research from the Japan Society for the Promotion of
   Science (17209040), and the 21st Century COE Program (Medical Science).
CR BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3
   Dearling JLJ, 2002, J BIOL INORG CHEM, V7, P249, DOI 10.1007/s007750100291
   Fowler JS, 2002, SEMIN NUCL MED, V32, P6, DOI 10.1053/snuc.2002.29270
   Fujibayashi Y, 1999, NUCL MED BIOL, V26, P117, DOI 10.1016/S0969-8051(98)00049-3
   Fujibayashi Y, 1997, J NUCL MED, V38, P1155
   FUJII T, 1991, J NEUROL SCI, V103, P37, DOI 10.1016/0022-510X(91)90280-K
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   Ishikawa K, 2005, CIRC J, V 69, P617, DOI 10.1253/circj.69.617
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Lewis JS, 2001, J NUCL MED, V42, P655
   Lewis JS, 2002, J NUCL MED, V43, P1557
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   McKenzie M, 2004, NEUROCHEM RES, V29, P589, DOI 10.1023/B:NERE.0000014829.42364.dd
   Molnár MJ, 2000, NEUROLOGY, V55, P544, DOI 10.1212/WNL.55.4.544
   Nishioka J, 2008, BRAIN DEV-JPN, V30, P100, DOI 10.1016/j.braindev.2007.06.008
   Obata A, 2001, ANN NUCL MED, V15, P499, DOI 10.1007/BF02988502
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Pang CY, 2001, DIABETES RES CLIN PR, V54, pS45, DOI 10.1016/S0168-8227(01)00335-7
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rusanen H, 2000, BBA-MOL BASIS DIS, V1500, P10, DOI 10.1016/S0925-4439(99)00081-2
   Shelly MJ, 2007, CLIN NUCL MED, V32, P479, DOI 10.1097/RLU.0b013e3180537852
   SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Yoneda M, 1999, NEUROLOGY, V53, P2182, DOI 10.1212/WNL.53.9.2182
   Zhang J, 1998, BIOCHEM MOL BIOL INT, V46, P71
NR 28
TC 72
Z9 78
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD APR
PY 2009
VL 9
IS 2
BP 144
EP 148
DI 10.1016/j.mito.2009.01.011
PG 5
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 428PO
UT WOS:000264861400009
PM 19460295
DA 2024-11-01
ER

PT J
AU Huang, JH
   Hood, DA
AF Huang, Julianna H.
   Hood, David A.
TI Age-associated Mitochondrial Dysfunction in Skeletal Muscle:
   Contributing Factors and Suggestions for Long-term Interventions
SO IUBMB LIFE
LA English
DT Review
DE ageing; biogenesis; exercise; mitochondria; oxidative stress; reactive
   oxygen species
ID DNA-DELETION MUTATIONS; CYTOCHROME-C-OXIDASE; LIFELONG CALORIE
   RESTRICTION; ANTIOXIDANT ENZYME-ACTIVITY; OXIDATIVE STRESS; PROTEIN
   IMPORT; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CONTRACTILE ACTIVITY;
   H2O2 RELEASE
AB It has been established that the impairment of mitochondrial function is associated with various disorders, such as type 2 diabetes and Alzheimer's disease. In addition, mitochondria have been implicated in the progression of cellular aging through a multitude of studies that connect increased mitochondrial dysfunction, such as increased reactive oxygen species production and decreased ATP synthesis, with skeletal muscle undergoing sarcopenia. Studies reveal an inverse relationship between mitochondrial biogenesis and aging such that as an individual increases in age, mitochondrial function, and content decreases. This review aims to summarize the relationship of mitochondria with skeletal muscle function, the regulation of mitochondrial biogenesis, and the alterations in skeletal muscle and mitochondrial function that result due to the aging process. (C) 2009 IUBMB
C1 [Huang, Julianna H.; Hood, David A.] York Univ, Sch Kinesiol & Hlth Sci, N York, ON M3J 1P3, Canada.
   [Hood, David A.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada.
C3 York University - Canada; York University - Canada
RP Hood, DA (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Farqhuarson Life Sci Bldg,Rm 302,4700 Keele St, N York, ON M3J 1P3, Canada.
EM dhood@yorku.ca
CR Adamo ML, 2006, AGEING RES REV, V5, P310, DOI 10.1016/j.arr.2006.05.001
   Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE672, DOI 10.1152/ajpendo.00043.2007
   Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006
   Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE748, DOI 10.1152/ajpendo.00311.2006
   Adhihetty PJ, 2005, AM J PHYSIOL-CELL PH, V289, pC994, DOI 10.1152/ajpcell.00031.2005
   Adhihetty PJ, 2003, EXP PHYSIOL, V88, P99, DOI 10.1113/eph8802505
   Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x
   Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104
   Ames BN, 2004, ANN NY ACAD SCI, V1019, P406, DOI 10.1196/annals.1297.073
   Armeni T, 2003, J BIOENERG BIOMEMBR, V35, P181, DOI 10.1023/A:1023754305218
   Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081
   Baker DJ, 2006, EXP GERONTOL, V41, P1149, DOI 10.1016/j.exger.2006.08.007
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Baragona R., 2001, QUADERNI STAT, V3, P1
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barreiro E, 2006, FREE RADICAL BIO MED, V41, P797, DOI 10.1016/j.freeradbiomed.2006.05.027
   Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   BEREGI E, 1988, Z GERONTOL, V21, P83
   Bernardi P, 1999, ITAL J NEUROL SCI, V20, P395
   Berneburg M, 2006, PHOTOCH PHOTOBIO SCI, V5, P190, DOI 10.1039/b507380d
   Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, pE429, DOI 10.1152/ajpendo.00435.2004
   Bézaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev
   Bizeau ME, 1998, J APPL PHYSIOL, V85, P1279, DOI 10.1152/jappl.1998.85.4.1279
   Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759
   Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126
   Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4
   Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251
   Bua EA, 2004, FASEB J, V18, P582, DOI 10.1096/fj.03-0668fje
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016
   Capel F, 2005, MECH AGEING DEV, V126, P505, DOI 10.1016/j.mad.2004.11.001
   Capel F, 2004, MECH AGEING DEV, V125, P367, DOI 10.1016/j.mad.2004.02.005
   Chabi B, 2005, BIOCHEM BIOPH RES CO, V332, P542, DOI 10.1016/j.bbrc.2005.04.153
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Chapman IM, 2006, MED CLIN N AM, V90, P887, DOI 10.1016/j.mcna.2006.05.010
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006
   Chilibeck PD, 1998, EXP PHYSIOL, V83, P107, DOI 10.1113/expphysiol.1998.sp004087
   Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006
   CHRZANOWSKALIGHTOWLERS ZMA, 1993, ANAL BIOCHEM, V214, P45, DOI 10.1006/abio.1993.1454
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   COGGAN AR, 1993, J APPL PHYSIOL, V75, P2125, DOI 10.1152/jappl.1993.75.5.2125
   COGGAN AR, 1992, J APPL PHYSIOL, V72, P1780, DOI 10.1152/jappl.1992.72.5.1780
   COGGAN AR, 1992, J GERONTOL, V47, pB71, DOI 10.1093/geronj/47.3.B71
   COGSWELL AM, 1993, AM J PHYSIOL, V264, pC383, DOI 10.1152/ajpcell.1993.264.2.C383
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   Conley KE, 2007, CURR OPIN CLIN NUTR, V10, P688, DOI 10.1097/MCO.0b013e3282f0dbfb
   Conley KE, 2007, EXERC SPORT SCI REV, V35, P43
   Corsetti G, 2008, AM J CARDIOL, V101, p26E, DOI 10.1016/j.amjcard.2008.02.078
   Craig EE, 1997, AM J PHYSIOL-HEART C, V272, pH2983, DOI 10.1152/ajpheart.1997.272.6.H2983
   de Cavanagh EMV, 2003, FASEB J, V17, P1096, DOI 10.1096/fj.02-0063fje
   de Grey ADNJ, 2004, REJUV RES, V7, P171, DOI 10.1089/rej.2004.7.171
   Deveaud C, 2004, MOL CELL BIOCHEM, V267, P157, DOI 10.1023/B:MCBI.0000049374.52989.9b
   Dhar SS, 2008, J BIOL CHEM, V283, P3120, DOI 10.1074/jbc.M707587200
   DIRKS A, 2002, AM J PHYSIOL-REG I, V282, pR51
   Dirks AJ, 2004, FREE RADICAL BIO MED, V36, P27, DOI 10.1016/j.freeradbiomed.2003.10.003
   Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002
   Drew B, 2004, ACTA PHYSIOL SCAND, V182, P333, DOI 10.1111/j.1365-201X.2004.01371.x
   Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002
   DUGAN LL, 2005, SCI AGING KNOWLEDGE, pE20
   Feige JN, 2008, CURR OPIN CELL BIOL, V20, P303, DOI 10.1016/j.ceb.2008.03.012
   FISHER RP, 1985, J BIOL CHEM, V260, P1330
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0
   Fontenay M, 2006, ONCOGENE, V25, P4757, DOI 10.1038/sj.onc.1209606
   Freyssenet D, 2004, AM J PHYSIOL-CELL PH, V286, pC1053, DOI 10.1152/ajpcell.00418.2003
   Gabaldón T, 2004, BBA-BIOENERGETICS, V1659, P212, DOI 10.1016/j.bbabio.2004.07.011
   Gabaldón T, 2007, PLOS COMPUT BIOL, V3, P2209, DOI 10.1371/journal.pcbi.0030219
   Gordon JW, 2001, J APPL PHYSIOL, V90, P389, DOI 10.1152/jappl.2001.90.1.389
   Hagen JL, 2004, J GERONTOL A-BIOL, V59, P1099, DOI 10.1093/gerona/59.11.1099
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   Harper ME, 2004, ACTA PHYSIOL SCAND, V182, P321, DOI 10.1111/j.1365-201X.2004.01370.x
   Haus JM, 2007, J APPL PHYSIOL, V103, P2068, DOI 10.1152/japplphysiol.00670.2007
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hollander J, 2000, MECH AGEING DEV, V116, P33, DOI 10.1016/S0047-6374(00)00130-5
   HOLLOSZY JO, 1991, J APPL PHYSIOL, V70, P1529, DOI 10.1152/jappl.1991.70.4.1529
   HOLLOSZY JO, 1993, J GERONTOL, V48, pB97, DOI 10.1093/geronj/48.3.B97
   Hood DA, 2003, MED SCI SPORT EXER, V35, P86, DOI 10.1097/00005768-200301000-00015
   HOOD DA, 1994, CAN J APPL PHYSIOL, V19, P12, DOI 10.1139/h94-002
   Hood DA, 2006, J EXP BIOL, V209, P2265, DOI 10.1242/jeb.02182
   Hoogenraad NJ, 2002, BBA-MOL CELL RES, V1592, P97, DOI 10.1016/S0167-4889(02)00268-9
   Hoppel CL, 2002, BIOGERONTOLOGY, V3, P41, DOI 10.1023/A:1015251212039
   HOPPELER H, 1987, J PHYSIOL-LONDON, V385, P661, DOI 10.1113/jphysiol.1987.sp016513
   Huang H, 2004, FRONT BIOSCI-LANDMRK, V9, P1100, DOI 10.2741/1298
   Hütter E, 2007, AGING CELL, V6, P245, DOI 10.1111/j.1474-9726.2007.00282.x
   Jackson MJ, 2008, FREE RADICAL BIO MED, V44, P132, DOI 10.1016/j.freeradbiomed.2007.06.003
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   Jubrias SA, 2001, J APPL PHYSIOL, V90, P1663, DOI 10.1152/jappl.2001.90.5.1663
   Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Kent-Braun JA, 2000, J APPL PHYSIOL, V89, P1072, DOI 10.1152/jappl.2000.89.3.1072
   Kerner J, 2001, AM J PHYSIOL-ENDOC M, V281, pE1054
   Khodorov B, 1996, FEBS LETT, V397, P230, DOI 10.1016/S0014-5793(96)01139-8
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906
   Kontani Y, 2002, J BIOCHEM, V132, P309, DOI 10.1093/oxfordjournals.jbchem.a003225
   Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kumaran S, 2005, MOL CELL BIOCHEM, V280, P83, DOI 10.1007/s11010-005-8234-z
   Kumaran S, 2004, CHEM-BIOL INTERACT, V148, P11, DOI 10.1016/j.cbi.2003.10.010
   Kurz T, 2007, ARCH BIOCHEM BIOPHYS, V462, P220, DOI 10.1016/j.abb.2007.01.013
   Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121
   Lambert AJ, 2007, AGING CELL, V6, P417, DOI 10.1111/j.1474-9726.2007.00316.x
   Lanza IR, 2005, J APPL PHYSIOL, V99, P1736, DOI 10.1152/japplphysiol.00566.2005
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee CM, 1998, ANN NY ACAD SCI, V854, P182, DOI 10.1111/j.1749-6632.1998.tb09901.x
   Lee HJ, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-2
   Leeuwenburgh C, 2005, AM J PHYSIOL-REG I, V288, pR1288, DOI 10.1152/ajpregu.00576.2004
   Leeuwenburgh C, 2003, J GERONTOL A-BIOL, V58, P999
   LEEUWENBURGH C, 1994, AM J PHYSIOL, V267, pR439, DOI 10.1152/ajpregu.1994.267.2.R439
   Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Lister R, 2006, CURR BIOL, V16, pR197, DOI 10.1016/j.cub.2006.02.024
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102
   Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x
   Lopez ME, 2000, MUTAT RES-FUND MOL M, V452, P123, DOI 10.1016/S0027-5107(00)00059-2
   LUHTALA TA, 1994, J GERONTOL, V49, pB231, DOI 10.1093/geronj/49.5.B231
   MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   Marcinek DJ, 2005, J PHYSIOL-LONDON, V569, P467, DOI 10.1113/jphysiol.2005.097782
   Martin C, 2007, AGING CELL, V6, P165, DOI 10.1111/j.1474-9726.2007.00271.x
   Marzetti E, 2008, FREE RADICAL BIO MED, V44, P160, DOI 10.1016/j.freeradbiomed.2007.05.028
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   McArdle A, 2001, AM J PHYSIOL-CELL PH, V280, pC621, DOI 10.1152/ajpcell.2001.280.3.C621
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974
   Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000465
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x
   Mihara K, 1996, TRENDS CELL BIOL, V6, P104, DOI 10.1016/0962-8924(96)81000-2
   Mihara K, 1996, EXPERIENTIA, V52, P1063, DOI 10.1007/BF01952103
   Milenkovic D, 2007, BIOL CHEM, V388, P891, DOI 10.1515/BC.2007.097
   Moghaddas S, 2002, J GERONTOL A-BIOL, V57, pB22, DOI 10.1093/gerona/57.1.B22
   Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036
   Musatov A, 2006, FREE RADICAL BIO MED, V41, P238, DOI 10.1016/j.freeradbiomed.2006.03.018
   Nair KS, 2005, AM J CLIN NUTR, V81, P953
   Naito H, 2001, MED SCI SPORT EXER, V33, P729
   Nargang FE, 2002, J BIOL CHEM, V277, P12846, DOI 10.1074/jbc.M112099200
   Nauratil M, 2008, EXP CELL RES, V314, P164, DOI 10.1016/j.yexcr.2007.09.013
   OhIshi S, 1995, MECH AGEING DEV, V84, P65, DOI 10.1016/0047-6374(95)01637-F
   OLIVE M, 1995, J ANAT, V187, P127
   Pak JW, 2003, AGING CELL, V2, P1, DOI 10.1046/j.1474-9728.2003.00034.x
   PALMER JW, 1977, J BIOL CHEM, V252, P8731
   PALMER JW, 1985, ARCH BIOCHEM BIOPHYS, V236, P691, DOI 10.1016/0003-9861(85)90675-7
   Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9
   Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   PARISI MA, 1993, MOL CELL BIOL, V13, P1951, DOI 10.1128/MCB.13.3.1951
   Pastoris O, 2000, EXP GERONTOL, V35, P95, DOI 10.1016/S0531-5565(99)00077-7
   Payne AM, 2003, J APPL PHYSIOL, V95, P2554, DOI 10.1152/japplphysiol.00758.2003
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje
   Pistilli EE, 2006, APOPTOSIS, V11, P2115, DOI 10.1007/s10495-006-0194-6
   Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443
   POWERS SK, 1994, AM J PHYSIOL, V266, pR375, DOI 10.1152/ajpregu.1994.266.2.R375
   Primeau AJ, 2002, CAN J APPL PHYSIOL, V27, P349, DOI 10.1139/h02-020
   Proctor DN, 1997, J APPL PHYSIOL, V82, P1411, DOI 10.1152/jappl.1997.82.5.1411
   Prokisch H, 2006, NUCLEIC ACIDS RES, V34, pD705, DOI 10.1093/nar/gkj127
   Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160
   Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Radák Z, 2002, PFLUG ARCH EUR J PHY, V445, P273, DOI 10.1007/s00424-002-0918-6
   Radák Z, 1999, FREE RADICAL BIO MED, V27, P69, DOI 10.1016/S0891-5849(99)00038-6
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Rasmussen UF, 2003, EXP GERONTOL, V38, P877, DOI 10.1016/S0531-5565(03)00092-5
   Ren J, 2007, MECH AGEING DEV, V128, P276, DOI 10.1016/j.mad.2006.12.007
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   ROSENBERG IH, 1995, ANN INTERN MED, V123, P727, DOI 10.7326/0003-4819-123-9-199511010-00014
   Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S
   Sammut IA, 2003, CLIN EXP PHARMACOL P, V30, P110, DOI 10.1046/j.1440-1681.2003.03799.x
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011
   Servais S, 2003, FREE RADICAL BIO MED, V35, P24, DOI 10.1016/S0891-5849(03)00177-1
   Sharman MJ, 2001, EUR J APPL PHYSIOL, V84, P127, DOI 10.1007/s004210000334
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Sirk D, 2007, J NEUROCHEM, V103, P1989, DOI 10.1111/j.1471-4159.2007.04907.x
   Siu PM, 2005, J PHYSIOL-LONDON, V565, P309, DOI 10.1113/jphysiol.2004.081083
   Skorjanc D, 1998, J APPL PHYSIOL, V85, P437, DOI 10.1152/jappl.1998.85.2.437
   Song W, 2006, ANTIOXID REDOX SIGN, V8, P517, DOI 10.1089/ars.2006.8.517
   Stangel M, 1996, J NEUROPATH EXP NEUR, V55, P36, DOI 10.1097/00005072-199601000-00004
   Takahashi M, 1998, AM J PHYSIOL-CELL PH, V274, pC1380, DOI 10.1152/ajpcell.1998.274.5.C1380
   Takahashi M, 1996, J BIOL CHEM, V271, P27285, DOI 10.1074/jbc.271.44.27285
   Tamilselvan J, 2007, FREE RADICAL BIO MED, V43, P1656, DOI 10.1016/j.freeradbiomed.2007.08.028
   Terman A, 2007, J PATHOL, V211, P134, DOI 10.1002/path.2094
   Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197
   Terman A, 2006, CHEM-BIOL INTERACT, V163, P29, DOI 10.1016/j.cbi.2006.04.013
   Tonkonogi M, 2003, PFLUG ARCH EUR J PHY, V446, P261, DOI 10.1007/s00424-003-1044-9
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Tuominen EKJ, 2002, J BIOL CHEM, V277, P8822, DOI 10.1074/jbc.M200056200
   VANLOON APGM, 1987, EMBO J, V6, P2433, DOI 10.1002/j.1460-2075.1987.tb02522.x
   VANLOON APGM, 1986, CELL, V44, P801, DOI 10.1016/0092-8674(86)90846-9
   Venditti P, 1999, ARCH BIOCHEM BIOPHYS, V372, P315, DOI 10.1006/abbi.1999.1494
   Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Weber K, 2002, ENDOCRINOLOGY, V143, P177, DOI 10.1210/en.143.1.177
   Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011
   Welle S, 2000, J APPL PHYSIOL, V89, P297, DOI 10.1152/jappl.2000.89.1.297
   Welle S, 2003, J APPL PHYSIOL, V94, P1479, DOI 10.1152/japplphysiol.01061.2002
   Westphal CH, 2007, TRENDS BIOCHEM SCI, V32, P555, DOI 10.1016/j.tibs.2007.09.008
   Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200
   Williams AD, 2007, J CARD FAIL, V13, P79, DOI 10.1016/j.cardfail.2006.10.017
   XIA EN, 1995, J NUTR, V125, P195
   Yarian CS, 2005, BIOCHEM BIOPH RES CO, V330, P151, DOI 10.1016/j.bbrc.2005.02.135
   Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3
   Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115
   Zainal TA, 2000, FASEB J, V14, P1825, DOI 10.1096/fj.99-0881com
NR 221
TC 53
Z9 62
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1521-6543
EI 1521-6551
J9 IUBMB LIFE
JI IUBMB Life
PD MAR
PY 2009
VL 61
IS 3
BP 201
EP 214
DI 10.1002/iub.164
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 417PV
UT WOS:000264089500002
PM 19243006
OA Bronze
DA 2024-11-01
ER

PT J
AU Durham, SE
   Samuels, DC
   Chinnery, PF
AF Durham, S. E.
   Samuels, D. C.
   Chinnery, P. F.
TI Is selection required for the accumulation of somatic mitochondrial DNA
   mutations in post-mitotic cells?
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mitochondrial DNA; ageing; mutation
ID MTDNA POINT MUTATIONS; CONTROL REGION; HUMAN TISSUES; MUSCLE;
   REPLICATION; AGE; TRANSCRIPTION; POLYMERASE; FREQUENCY; SEQUENCE
AB Mitochondrial DNA (mtDNA) mutations accumulate in the skeletal muscle of patients with mtDNA disease, and also as part of healthy ageing. Simulations of human muscle fibres suggest that, over many decades, the continuous destruction and copying of mtDNA (relaxed replication) can lead to dramatic changes in the percentage level of mutant mtDNA in non-dividing cells through random genetic drift. This process should apply to both pathogenic and neutral mutations. To test this hypothesis we sequenced the entire mitochondrial genome for 20 muscle fibres from a healthy elderly 85-year-old individual, chosen because of the low frequency of cytochrome c oxidase negative fibres. Phenotypically neutral single base substitutions were detected in 15% of the healthy fibres, supporting the hypothesis that positive selection is not essential for the clonal expansion of mtDNA point mutations during human life. Treatments that enhance mtDNA replication, such as vigorous excercise, could amplify this process, with potentially detrimental long-term consequences. (C) 2006 Elsevier B.V. All fights reserved.
C1 Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.
   Univ Newcastle Upon Tyne, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Newcastle University - UK; Virginia Polytechnic Institute & State
   University; Newcastle University - UK
RP Chinnery, PF (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, M4014,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM p.f.chinnery@ncl.ac.uk
RI ; Samuels, David/A-5393-2008
OI Chinnery, Patrick/0000-0002-7065-6617; Samuels,
   David/0000-0003-3529-7791
FU Wellcome Trust Funding Source: Medline
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Barron MJ, 2005, NEUROMUSCULAR DISORD, V15, P768, DOI 10.1016/j.nmd.2005.06.018
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Calloway CD, 2000, AM J HUM GENET, V66, P1384, DOI 10.1086/302844
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   Cormio A, 2005, NEUROBIOL AGING, V26, P655, DOI 10.1016/j.neurobiolaging.2004.06.014
   CORTOPASSI G, 1990, NUCLEIC ACIDS RES, V275, P169
   Del Bo R, 2003, NEUROBIOL AGING, V24, P829, DOI 10.1016/S0197-4580(02)00233-6
   DELBO R, 2003, NEUROLOGY
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   GHIVIZZANI SC, 1994, MOL CELL BIOL, V14, P7717, DOI 10.1128/MCB.14.12.7717
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   KUNKEL TA, 1986, J BIOL CHEM, V261, P3581
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   Michikawa Y, 1999, Somat Cell Mol Genet, V25, P333, DOI 10.1023/A:1019972500785
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Samuels DC, 2003, NUCLEIC ACIDS RES, V31, P6043, DOI 10.1093/nar/gkg784
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Weber K, 1997, AM J HUM GENET, V60, P373
NR 27
TC 17
Z9 18
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUN
PY 2006
VL 16
IS 6
BP 381
EP 386
DI 10.1016/j.nmd.2006.03.012
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 064ZT
UT WOS:000239129900005
PM 16684599
DA 2024-11-01
ER

PT J
AU Salsano, E
   Giovagnoli, AR
   Morandi, L
   Maccagnano, C
   Lamantea, E
   Marchesi, C
   Zeviani, M
   Pareyson, D
AF Salsano, Ettore
   Giovagnoli, Anna Rita
   Morandi, Lucia
   Maccagnano, Carmelo
   Lamantea, Eleonora
   Marchesi, Chiara
   Zeviani, Massimo
   Pareyson, Davide
TI Mitochondrial dementia: A sporadic case of progressive cognitive and
   behavioral decline with hearing loss due to the rare m.3291T&gt;C MELAS
   mutation
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Mitochondrial disorders; Dementia; Hearing loss; MELAS syndrome;
   Olanzapine; Wolff-Parkinson-White syndrome
ID POINT MUTATION; DICHLOROACETATE; PATIENT; DISEASE; GENE; DNA
AB We report the case of a 23-year-old Italian female harboring the rare m.3291T>C mutation in the MT-TL1 gene, that encodes the mitochondria! transfer RNA for leucine 1 (UUA/G). MT-TL1 mutations usually cause the MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes) syndrome. Our patient, however, suffered from a non-syndromic mitochondrial disorder (MID), clinically characterized by progressive cognitive and behavioral decline, and hearing loss; brain MRI disclosed diffuse supratentorial and infratentorial atrophy; EKG revealed a Wolff-Parkinson-White syndrome; combined neuroleptic and antidepressant treatment markedly improved her behavioral symptoms. This case expands the clinical spectrum of non-syndromic MIDs, and further confirms that no obvious genotype-phenotype correlation exists for the m.3291T>C DNA mutation; indeed, this mutation has been previously reported in a Japanese child, who suffered from MELAS, and in an Italian child, who presented an apparently isolated mild myopathy. Moreover, it supports the hypothesis that at least in MT-TL1-related MIDs, dementia may be caused by a progressive neurodegenerative process, rather than by injury accumulation due to stroke-like episodes. Finally, our case suggests that common neuroleptic and antidepressant drugs may be clinically efficacious in the management of psychiatric symptoms associated with MIDs. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Salsano, Ettore] C Besta Neurol Inst, IRCCS Fdn, Dept Clin Neurosci, Clin Cent & Peripheral Degenerat Neuropathies, I-20133 Milan, Italy.
RP Salsano, E (corresponding author), C Besta Neurol Inst, IRCCS Fdn, Dept Clin Neurosci, Clin Cent & Peripheral Degenerat Neuropathies, Via Celoria 11, I-20133 Milan, Italy.
EM ettore.salsano@istituto-besta.it
RI Giovagnoli, Anna/AAP-2442-2021; Zeviani, Massimo/K-2891-2014; Pareyson,
   Davide/K-5890-2016; Salsano, Ettore/I-7996-2018; Lamantea,
   Eleonora/J-8339-2016
OI Pareyson, Davide/0000-0001-6854-765X; Salsano,
   Ettore/0000-0001-9167-1878; Giovagnoli, Anna Rita/0000-0002-5719-0998;
   Zeviani, Massimo/0000-0002-9067-5508; Lamantea,
   Eleonora/0000-0001-5090-6028
CR Finsterer J, 2009, J NEUROL SCI, V283, P143, DOI 10.1016/j.jns.2009.02.347
   Giovagnoli AR, 2008, NEUROPSYCHOLOGIA, V46, P1495, DOI 10.1016/j.neuropsychologia.2007.12.023
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Manes F, 2009, J NEUROL SCI, V283, P95, DOI 10.1016/j.jns.2009.02.316
   NEARY D, 1988, J NEUROL NEUROSUR PS, V51, P353, DOI 10.1136/jnnp.51.3.353
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Silvestri G, 2000, AM J MED GENET, V94, P201, DOI 10.1002/1096-8628(20000918)94:3<201::AID-AJMG5>3.0.CO;2-2
   Sudo A, 2004, NEUROLOGY, V62, P338, DOI 10.1212/01.WNL.0000103443.61141.76
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Uziel G, 2000, NEUROMUSCULAR DISORD, V10, P415, DOI 10.1016/S0960-8966(99)00115-7
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 15
TC 23
Z9 27
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD JAN 15
PY 2011
VL 300
IS 1-2
BP 165
EP 168
DI 10.1016/j.jns.2010.09.022
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 714ZT
UT WOS:000286850900033
PM 20943236
DA 2024-11-01
ER

PT J
AU Atanassova, N
   Fusté, JM
   Wanrooij, S
   Macao, B
   Goffart, S
   Bäckström, S
   Farge, G
   Khvorostov, I
   Larsson, NG
   Spelbrink, JN
   Falkenberg, M
AF Atanassova, Neli
   Fuste, Javier Miralles
   Wanrooij, Sjoerd
   Macao, Bertil
   Goffart, Steffi
   Backstrom, Stefan
   Farge, Geraldine
   Khvorostov, Ivan
   Larsson, Nils-Goran
   Spelbrink, Johannes N.
   Falkenberg, Maria
TI Sequence-specific stalling of DNA polymerase γ and the effects of
   mutations causing progressive ophthalmoplegia
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID HUMAN MITOCHONDRIAL-DNA; SYNTHESIS IN-VITRO; EXTERNAL OPHTHALMOPLEGIA;
   AUTOSOMAL-DOMINANT; ACCESSORY SUBUNIT; RIBONUCLEOTIDE REDUCTASE; MTDNA
   MAINTENANCE; RNA-POLYMERASE; REPLICATION; TWINKLE
AB A large number of mutations in the gene encoding the catalytic subunit of mitochondrial DNA polymerase gamma (POL gamma A) cause human disease. The Y955C mutation is common and leads to a dominant disease with progressive external ophthalmoplegia and other symptoms. The biochemical effect of the Y955C mutation has been extensively studied and it has been reported to lower enzyme processivity due to decreased capacity to utilize dNTPs. However, it is unclear why this biochemical defect leads to a dominant disease. Consistent with previous reports, we show here that the POL gamma A:Y955C enzyme only synthesizes short DNA products at dNTP concentrations that are sufficient for proper function of wild-type POL gamma A. In addition, we find that this phenotype is overcome by increasing the dNTP concentration, e.g. dATP. At low dATP concentrations, the POL gamma A:Y955C enzyme stalls at dATP insertion sites and instead enters a polymerase/exonuclease idling mode. The POL gamma A:Y955C enzyme will compete with wild-type POL gamma A for primer utilization, and this will result in a heterogeneous population of short and long DNA replication products. In addition, there is a possibility that POL gamma A:Y955C is recruited to nicks of mtDNA and there enters an idling mode preventing ligation. Our results provide a novel explanation for the dominant mtDNA replication phenotypes seen in patients harboring the Y955C mutation, including the existence of site-specific stalling. Our data may also explain why mutations that disturb dATP pools can be especially deleterious for mtDNA synthesis.
C1 [Fuste, Javier Miralles; Wanrooij, Sjoerd; Macao, Bertil; Backstrom, Stefan; Falkenberg, Maria] Univ Gothenburg, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden.
   [Atanassova, Neli; Fuste, Javier Miralles; Farge, Geraldine; Khvorostov, Ivan; Larsson, Nils-Goran] Karolinska Inst, Div Metab Dis, SE-17177 Stockholm, Sweden.
   [Farge, Geraldine] Vrije Univ Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands.
   [Farge, Geraldine] Vrije Univ Amsterdam, Ctr Laser, Amsterdam, Netherlands.
   [Goffart, Steffi; Spelbrink, Johannes N.] Univ Tampere, Pirkanmaa Hosp Dist, Tampere Univ Hosp, Inst Med Technol, FI-33014 Tampere, Finland.
   [Goffart, Steffi; Spelbrink, Johannes N.] Univ Tampere, Pirkanmaa Hosp Dist, Tampere Univ Hosp, Ctr Lab Med, FI-33014 Tampere, Finland.
   [Spelbrink, Johannes N.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Inst Genet & Metab Dis, Dept Pediat, NL-6500 HB Nijmegen, Netherlands.
   [Larsson, Nils-Goran; Falkenberg, Maria] Max Planck Inst Biol Alterns, D-50931 Cologne, Germany.
C3 University of Gothenburg; Karolinska Institutet; Vrije Universiteit
   Amsterdam; Vrije Universiteit Amsterdam; Tampere University; Tampere
   University Hospital; Pirkanmaa Hospital District; Tampere University;
   Tampere University Hospital; Pirkanmaa Hospital District; Radboud
   University Nijmegen; Max Planck Society
RP Falkenberg, M (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.
EM maria.falkenberg@medkem.gu.se
RI Larsson, Nils-Göran/GVS-5578-2022; Goffart, Steffi/N-3597-2015; farge,
   geraldine/M-2803-2018; Wanrooij, Sjoerd/J-1367-2019; Spelbrink,
   Johannes/L-4661-2015
OI Larsson, Nils-Goran/0000-0001-5100-996X; Falkenberg,
   Maria/0000-0001-8713-173X; Spelbrink, Johannes/0000-0002-9756-2602;
   farge, geraldine/0000-0003-1054-4274; Wanrooij,
   Sjoerd/0000-0001-6126-4382
FU Swedish Research Council; Swedish Cancer Society; Swedish Strategic
   Foundation; Academy of Finland (CoE); Sigrid Juselius Foundation;
   Tampere University Hospital [9J119, 9K126, 9L097]; Netherlands
   Organization for Scientific Research (NWO)
FX This work was supported by the Swedish Research Council (to M.F. and
   N.G.L.), the Swedish Cancer Society (to M.F. and to N.G.L) and the
   Swedish Strategic Foundation (FFL3 grant to M.F.). J.N.S. is supported
   by the Academy of Finland (CoE funding), the Sigrid Juselius Foundation,
   the Tampere University Hospital Medical Research Fund (9J119, 9K126 and
   9L097) and the Netherlands Organization for Scientific Research (NWO).
CR Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614
   Falkenberg M, 2000, P NATL ACAD SCI USA, V97, P3896, DOI 10.1073/pnas.97.8.3896
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   ITO J, 1990, NUCLEIC ACIDS RES, V18, P6716, DOI 10.1093/nar/18.22.6716
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li Y, 2004, NAT STRUCT MOL BIOL, V11, P784, DOI 10.1038/nsmb792
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   YOUNG P, 1994, BIOCHEM BIOPH RES CO, V203, P46, DOI 10.1006/bbrc.1994.2146
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 39
TC 23
Z9 26
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAR 15
PY 2011
VL 20
IS 6
BP 1212
EP 1223
DI 10.1093/hmg/ddq565
PG 12
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 726WW
UT WOS:000287758600015
PM 21228000
OA Bronze
DA 2024-11-01
ER

PT J
AU Ding, L
   Liu, YL
AF Ding, Lin
   Liu, Yilun
TI Borrowing Nuclear DNA Helicases to Protect Mitochondrial DNA
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE mitochondrial DNA; DNA replication; DNA repair; RECQ4; Twinkle; PIF1;
   DNA2; SUV3
ID HUMAN PIF1 HELICASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; G-QUADRUPLEX
   DNA; COPY NUMBER; SACCHAROMYCES-CEREVISIAE; POLYNUCLEOTIDE
   PHOSPHORYLASE; BIOCHEMICAL-ANALYSIS; TWINKLE-HELICASE; POLYMERASE-ALPHA;
   RNA/DNA HELICASE
AB In normal cells, mitochondria are the primary organelles that generate energy, which is critical for cellular metabolism. Mitochondrial dysfunction, caused by mitochondrial DNA (mtDNA) mutations or an abnormal mtDNA copy number, is linked to a range of human diseases, including Alzheimer's disease, premature aging and cancer. mtDNA resides in the mitochondrial lumen, and its duplication requires the mtDNA replicative helicase, Twinkle. In addition to Twinkle, many DNA helicases, which are encoded by the nuclear genome and are crucial for nuclear genome integrity, are transported into the mitochondrion to also function in mtDNA replication and repair. To date, these helicases include RecQ-like helicase 4 (RECQ4), petite integration frequency 1 (PIF1), DNA replication helicase/nuclease 2 (DNA2) and suppressor of var1 3-like protein 1 (SUV3). Although the nuclear functions of some of these DNA helicases have been extensively studied, the regulation of their mitochondrial transport and the mechanisms by which they contribute to mtDNA synthesis and maintenance remain largely unknown. In this review, we attempt to summarize recent research progress on the role of mammalian DNA helicases in mitochondrial genome maintenance and the effects on mitochondria-associated diseases.
C1 [Ding, Lin; Liu, Yilun] City Hope Natl Med Ctr, Beckman Res Inst, Dept Radiat Biol, Duarte, CA 91010 USA.
C3 City of Hope; Beckman Research Institute of City of Hope
RP Liu, YL (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Radiat Biol, Duarte, CA 91010 USA.
EM lding@coh.org; yiliu@coh.org
FU National Cancer Institute [R01 CA151245]
FX We thank Nancy Linford and Keely Walker for their comments and expert
   editing of this manuscript. Yilun Liu was supported by funding from the
   National Cancer Institute (R01 CA151245).
CR Akiyama T, 2008, MOL CANCER THER, V7, P3461, DOI 10.1158/1535-7163.MCT-08-0530
   ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348
   Almeida M., 2010, INT BONE MINERAL DEN, V7, P340, DOI [DOI 10.1138/20100467, 10.1138/20100467]
   Arenas J, 2003, ANN NEUROL, V53, P278, DOI 10.1002/ana.10430
   Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200
   Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004
   Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073
   Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006
   BUTOW RA, 1989, GENOME, V31, P757, DOI 10.1139/g89-134
   Byrd AK, 2015, J BIOL CHEM, V290, P6482, DOI 10.1074/jbc.M114.630749
   Carew JS, 2004, LEUKEMIA, V18, P1934, DOI 10.1038/sj.leu.2403545
   Chen PL, 2013, ONCOGENE, V32, P1193, DOI 10.1038/onc.2012.120
   Cheng X, 2007, MITOCHONDRION, V7, P211, DOI 10.1016/j.mito.2006.11.023
   Cheng X, 2010, EUR J CELL BIOL, V89, P742, DOI 10.1016/j.ejcb.2010.06.008
   Chi ZF, 2012, INT J BIOCHEM CELL B, V44, P1942, DOI 10.1016/j.biocel.2012.07.016
   Crawford DR, 1997, FREE RADICAL BIO MED, V22, P551, DOI 10.1016/S0891-5849(96)00380-2
   Croteau DL, 2012, AGING CELL, V11, P456, DOI 10.1111/j.1474-9726.2012.00803.x
   D'Souza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001
   Daley JM, 2014, NUCLEIC ACIDS RES, V42, P11083, DOI 10.1093/nar/gku803
   De S, 2012, J CELL SCI, V125, P2509, DOI 10.1242/jcs.101501
   Desler Claus, 2011, J Aging Res, V2011, P407536, DOI 10.4061/2011/407536
   Dhar SK, 2009, J BIOL CHEM, V284, P16409, DOI 10.1074/jbc.M109.005736
   Dmochowska A, 1999, ACTA BIOCHIM POL, V46, P155, DOI 10.18388/abp.1999_4193
   Duan XL, 2015, J BIOL CHEM, V290, P7722, DOI 10.1074/jbc.M114.628008
   DUMAS LB, 1982, MOL GEN GENET, V187, P42, DOI 10.1007/BF00384381
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Eki T, 1996, GENOMICS, V37, P408, DOI 10.1006/geno.1996.0581
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09
   Formosa T, 1999, GENETICS, V151, P1459
   FOURY F, 1983, P NATL ACAD SCI-BIOL, V80, P5345, DOI 10.1073/pnas.80.17.5345
   Futami K, 2007, BIOL PHARM BULL, V30, P1685, DOI 10.1248/bpb.30.1685
   Gagou ME, 2014, ONCOTARGET, V5, P11381, DOI 10.18632/oncotarget.2501
   Gagou ME, 2011, CANCER RES, V71, P4998, DOI 10.1158/0008-5472.CAN-10-4404
   Gebert N, 2011, BBA-BIOMEMBRANES, V1808, P1002, DOI 10.1016/j.bbamem.2010.08.003
   George T, 2009, NUCLEIC ACIDS RES, V37, P6491, DOI 10.1093/nar/gkp671
   Gilkerson R, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011080
   Gilkerson RW, 2000, FEBS LETT, V474, P1, DOI 10.1016/S0014-5793(00)01527-1
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Gu YQ, 2008, NUCLEIC ACIDS RES, V36, P6295, DOI 10.1093/nar/gkn609
   Gu YQ, 2013, PRION, V7, P341, DOI 10.4161/pri.26022
   Gupta S, 2014, CARCINOGENESIS, V35, P34, DOI 10.1093/carcin/bgt315
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012971
   Hou XM, 2015, BIOCHEM J, V466, P189, DOI 10.1042/BJ20140997
   Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   Ichikawa K., 2002, NIHON YAKURIGAKU ZAS, V119, P219, DOI [10.1254/fpj.119.21911979727, DOI 10.1254/FPJ.119.21911979727]
   Im JS, 2015, CELL CYCLE, V14, P1001, DOI 10.1080/15384101.2015.1007001
   Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106
   Imamura O, 2003, P NATL ACAD SCI USA, V100, P8193, DOI 10.1073/pnas.1431624100
   Itahana K, 2008, CANCER CELL, V13, P542, DOI 10.1016/j.ccr.2008.04.002
   Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653
   Jeng JY, 2008, J CELL BIOCHEM, V103, P347, DOI 10.1002/jcb.21625
   Jeon JP, 2007, CANCER GENET CYTOGEN, V173, P122, DOI 10.1016/j.cancergencyto.2006.10.010
   Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102
   Karanja KK, 2012, CELL CYCLE, V11, P3983, DOI 10.4161/cc.22215
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770
   Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200
   Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102
   Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595
   Kohzaki M, 2012, CARCINOGENESIS, V33, P1203, DOI 10.1093/carcin/bgs149
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000
   Lan Q, 2008, BLOOD, V112, P4247, DOI 10.1182/blood-2008-05-157974
   Lee CH, 2013, J BIOL CHEM, V288, P9468, DOI 10.1074/jbc.M112.418715
   Li FY, 1999, NEUROLOGY, V53, P1265, DOI 10.1212/WNL.53.6.1265
   Lin WQ, 2013, EMBO J, V32, P1425, DOI 10.1038/emboj.2013.88
   Liu YL, 2010, DNA REPAIR, V9, P325, DOI 10.1016/j.dnarep.2010.01.006
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Lucic B, 2011, NUCLEIC ACIDS RES, V39, P1703, DOI 10.1093/nar/gkq1031
   Mann MB, 2005, HUM MOL GENET, V14, P813, DOI 10.1093/hmg/ddi075
   Marino F, 2013, BIOPHYS CHEM, V177, P34, DOI 10.1016/j.bpc.2013.02.009
   Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070
   Mateyak MK, 2006, CELL CYCLE, V5, P2796, DOI 10.4161/cc.5.23.3524
   Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Minczuk M, 2002, NUCLEIC ACIDS RES, V30, P5074, DOI 10.1093/nar/gkf647
   Miyazaki T, 2012, ARTHRITIS RES THER, V14
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Muta T, 1997, J BIOL CHEM, V272, P24363, DOI 10.1074/jbc.272.39.24363
   Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Peng G, 2012, CANCER RES, V72, P2802, DOI 10.1158/0008-5472.CAN-11-3152
   Pereira M, 2007, MECH AGEING DEV, V128, P609, DOI 10.1016/j.mad.2007.09.001
   Pohjoismäki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612
   Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Shapovalov Y, 2011, J BIOL CHEM, V286, P22331, DOI 10.1074/jbc.M111.250092
   Siitonen HA, 2009, EUR J HUM GENET, V17, P151, DOI 10.1038/ejhg.2008.154
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Sturzenegger A, 2014, J BIOL CHEM, V289, P27314, DOI 10.1074/jbc.M114.578823
   Suzuki T, 2009, J BIOCHEM, V146, P327, DOI 10.1093/jb/mvp074
   Szczesny RJ, 2007, BIOL CELL, V99, P323, DOI 10.1042/BC20060108
   Szczesny RJ, 2010, NUCLEIC ACIDS RES, V38, P279, DOI 10.1093/nar/gkp903
   Thangavel S, 2010, MOL CELL BIOL, V30, P1382, DOI 10.1128/MCB.01290-09
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Veno ST, 2011, BIOCHEM J, V440, P293, DOI 10.1042/BJ20100991
   Wang DDH, 2014, J BIOL CHEM, V289, P16727, DOI 10.1074/jbc.M113.536540
   Wang DDH, 2009, J BIOL CHEM, V284, P20812, DOI 10.1074/jbc.M109.009605
   Wang JT, 2014, CELL REP, V7, P848, DOI 10.1016/j.celrep.2014.03.037
   West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975
   Westermann B, 2014, BBA-BIOENERGETICS, V1837, P1039, DOI 10.1016/j.bbabio.2013.10.005
   Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235
   Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Yu M, 2011, LIFE SCI, V89, P65, DOI 10.1016/j.lfs.2011.05.010
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang DH, 2006, NUCLEIC ACIDS RES, V34, P1393, DOI 10.1093/nar/gkl029
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Zhou RB, 2014, ELIFE, V3, DOI 10.7554/eLife.02190
NR 121
TC 30
Z9 33
U1 0
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY
PY 2015
VL 16
IS 5
BP 10870
EP 10887
DI 10.3390/ijms160510870
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA CK5DC
UT WOS:000356241400104
PM 25984607
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Mohamed, SA
   Wesch, D
   Blumenthal, A
   Bruse, P
   Windler, K
   Ernst, M
   Kabelitz, D
   Oehmichen, M
   Meissner, C
AF Mohamed, SA
   Wesch, D
   Blumenthal, A
   Bruse, P
   Windler, K
   Ernst, M
   Kabelitz, D
   Oehmichen, M
   Meissner, C
TI Detection of the 4977 bp deletion of mitochondrial DNA in different
   human blood cells
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE human peripheral blood cells; mitochondrial DNA; fluorescent-labelled
   primer; 4977 bp deletion; aging
ID OXIDATIVE STRESS; SKELETAL-MUSCLE; COMMON DELETION; HUMAN TISSUES; HUMAN
   BRAIN; DISEASE; MUTATION; AGE; DAMAGE; PCR
AB As recently reported, it is possible to detect and quantify the amount of the deleted human mitochondrial DNA (mtDNA) in whole blood, platelets and peripheral blood mononuclear cells using real-time PCR. The aim of this study was to identify the cell types in human blood carrying the 4977 bp deleted mtDNA and their accumulation with regard to donor age.
   Whole blood from 10 healthy donors (five individuals aged from 19 to 22 years, five aged from 57 to 61 years) was separated in various cell populations such as granulocytes, B cells/monocytes and T cells. Purity of the cell isolates was determined by flow cytometry. Total DNA was extracted and 250 ng DNA of each cell type was subjected to PCR using fluorescent-labelled primer pairs. The specific PCR product of the 4977 bp deletion was quantified using an automated detection system.
   The accumulation of the 4977 bp deletion was more pronounced in T lymphocytes and granulocytes in comparison to B lymphocytes/monocytes. The amount of the 4977 bp deletion in whole blood varied from 0 to 0.00018%, in T lymphocytes from 0.00009 to 0.00160%, in granulocytes from 0 to 0.00162% and in the B lymphocyte/monocyte fraction from 0 to 0.00025%. The higher amount of the deletion in T lymphocytes may be due to a subset of lymphocytes with a longer lifespan thus facilitating the accumulation of mitochondrial damage. The higher amount in granulocytes could have the explanation in the higher release of free radicals for prevention of infectious diseases, because free radicals are supposed to damage the macromolecules of this cell type. The 10 donors displayed differences in the pattern of the accumulation with regard to the different cell types, but no age-dependent accumulation was observed. Differences of the accumulation pattern may be due to actual individual living behaviour or environmental factors. (C) 2003 Elsevier Inc. All rights reserved.
C1 Med Univ Lubeck, Dept Legal Med, D-23562 Lubeck, Germany.
   Univ Kiel, Dept Immunol, D-2300 Kiel, Germany.
   Dept Immunol & Cell Biol, Borstel, Germany.
C3 University of Lubeck; University of Kiel
RP Med Univ Lubeck, Dept Legal Med, Kahlhorststr 31-35, D-23562 Lubeck, Germany.
EM meissner@rmed.mu-luebeck.de
RI Mohamed, Salah/O-2955-2018; Kabelitz, Dieter/A-2757-2010; Wesch,
   Daniela/C-1940-2019; Blumenthal, Antje/A-3608-2011
OI Wesch, Daniela/0000-0001-6509-208X; Blumenthal,
   Antje/0000-0003-3673-7015
CR BABIOR BM, 1990, SEMIN HEMATOL, V27, P247
   Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345
   Biagini G, 1998, MECH AGEING DEV, V101, P269, DOI 10.1016/S0047-6374(97)00181-4
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Cortopassi GA, 1999, BBA-BIOENERGETICS, V1410, P183, DOI 10.1016/S0005-2728(98)00166-2
   GATTERMANN N, 1995, LEUKEMIA, V9, P1704
   Gershon D, 1999, EXP GERONTOL, V34, P613, DOI 10.1016/S0531-5565(99)00010-8
   HAMBLET NS, 1995, BIOCHEM BIOPH RES CO, V207, P839, DOI 10.1006/bbrc.1995.1262
   Hetts SW, 1998, JAMA-J AM MED ASSOC, V279, P300, DOI 10.1001/jama.279.4.300
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hou JH, 1996, BIOCHEM J, V318, P1065, DOI 10.1042/bj3181065
   ISHIHARA T, 1983, PROGR TOPICS CYTOGEN, V4, P475
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   Kanungo M.S., 1994, GENES AGING
   Kim UK, 2000, BASIC RES CARDIOL, V95, P163, DOI 10.1007/s003950050178
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Lee HC, 2000, J BIOMED SCI, V7, P2, DOI 10.1159/000025424
   LEE HC, 1994, FEBS LETT, V354, P79, DOI 10.1016/0014-5793(94)01063-3
   Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   MARTINEZCAYUELA M, 1995, BIOCHIMIE, V77, P147, DOI 10.1016/0300-9084(96)88119-3
   Meissner C, 1997, INT J LEGAL MED, V110, P288, DOI 10.1007/s004140050089
   Meissner C, 1999, FORENSIC SCI INT, V105, P115, DOI 10.1016/S0379-0738(99)00126-7
   Meissner C, 2000, FORENSIC SCI INT, V113, P109, DOI 10.1016/S0379-0738(00)00249-8
   Merril CR, 1996, ARCH BIOCHEM BIOPHYS, V326, P172, DOI 10.1006/abbi.1996.0062
   MOHAMED SA, 1999, J CLIN FORENSIC MED, V6, P210
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   Pawelec G, 2002, FRONT BIOSCI-LANDMRK, V7, pD1056
   POULTON J, 1991, AM J HUM GENET, V48, P649
   Ray AJ, 2000, J INVEST DERMATOL, V115, P674, DOI 10.1046/j.1523-1747.2000.00092.x
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SMITH OP, 1995, BRIT J HAEMATOL, V90, P469, DOI 10.1111/j.1365-2141.1995.tb05178.x
   SOONG NW, 1992, NAT GENET, V2, P318
   TOUGH DF, 1995, IMMUNOL RES, V14, P1, DOI 10.1007/BF02918494
   von Wurmb N, 1998, MUTAT RES-FUND MOL M, V422, P247, DOI 10.1016/S0027-5107(98)00205-X
   von Wurmb-Schwark N, 2002, FORENSIC SCI INT, V126, P34, DOI 10.1016/S0379-0738(02)00026-9
   WALLACE DC, 1990, PEDIATR RES, V28, P525, DOI 10.1203/00006450-199011000-00023
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   Wei YH, 1998, CURR SCI INDIA, V74, P887
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhang CF, 1996, BIOCHEM BIOPH RES CO, V223, P450, DOI 10.1006/bbrc.1996.0914
NR 50
TC 31
Z9 37
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD FEB
PY 2004
VL 39
IS 2
BP 181
EP 188
DI 10.1016/j.exger.2003.10.011
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 776PC
UT WOS:000189124100005
PM 15036410
DA 2024-11-01
ER

PT J
AU Alexanderson, H
   Lundberg, IE
AF Alexanderson, H
   Lundberg, IE
TI The role of exercise in the rehabilitation of idiopathic inflammatory
   myopathies
SO CURRENT OPINION IN RHEUMATOLOGY
LA English
DT Review
DE dermatomyositis; exercise; idiopathic inflammatory myopathies; inclusion
   body myositis; outcome measures; polymyositis; rehabilitation
ID INCLUSION-BODY MYOSITIS; MITOCHONDRIAL-DNA DELETIONS; RESONANCE
   SPECTROSCOPY; SKELETAL-MUSCLE; CLASS-I; POLYMYOSITIS; DERMATOMYOSITIS;
   STRENGTH; PROGRAM; SAFETY
AB Purpose of review The objective of this review is to provide an update on exercise and clinical assessment in the idiopathic inflammatory myopathies.
   Recent findings Polymyositis, dermatomyositis and inclusion body myositis are rare conditions with muscle weakness as a common prominent feature. Earlier, these patients were discouraged from active exercise due to a fear of increased muscle inflammation with recommendations to rest, perform range of motion exercises and in some cases, isometric exercises. However, beginning in the 1990s, studies reported reduced disability in patients with chronic polymyositis/dermatomyositis following resistive mild/moderate to intensive muscular training and aerobic endurance training, without signs of increased muscle inflammation. Patients with active, recent onset disease seem to benefit from mild/moderate muscular exercise without signs of increased muscle inflammation. There is no evidence of increased muscle inflammation following exercise in inclusion body myositis. However, the beneficial effects are unclear as one study report increased muscle strength, while the other could not achieve impairment reduction.
   Summary Studies evaluating active exercise in IIM support the notion of safety and benefits. However, large multi-center studies are needed to fully establish the safety and benefits of different types of exercise. Data indicate that active exercise, adapted to disease activity and disability should be included in the rehabilitation of patients in all stages of IIM. The newly developed and validated outcome measures for patients with polymyositis and dermatomyositis help assess the effects of interventions on disease activity and disability in clinical trials and in clinical practice. However, there are no sensitive and valid outcome measure for patients with inclusion body myositis.
C1 Karolinska Univ Hosp, Dept Phys Therapy, Rheumatol Unit, SE-17176 Stockholm, Sweden.
   Karolinska Univ Hosp, Dept Med, Rheumatol Unit, Karolinska Inst, SE-17176 Stockholm, Sweden.
C3 Karolinska Institutet; Karolinska University Hospital; Karolinska
   Institutet; Karolinska University Hospital
RP Karolinska Univ Hosp, Dept Phys Therapy, Rheumatol Unit D2 07, SE-17176 Stockholm, Sweden.
EM helene.alexandersson@karolinska.se
RI Alexanderson, Helene/KPY-5559-2024
OI Lundberg, Ingrid/0000-0002-6068-9212
CR Alexanderson H, 2000, SCAND J RHEUMATOL, V29, P295
   Alexanderson H, 1999, RHEUMATOLOGY, V38, P608, DOI 10.1093/rheumatology/38.7.608
   Alexanderson H, 2002, J RHEUMATOL, V29, P2386
   [Anonymous], 2001, Physiotherapy, DOI DOI 10.1016/S0031-9406(05)60764-X
   Argov Z, 1998, MUSCLE NERVE, V21, P1523, DOI 10.1002/(SICI)1097-4598(199811)21:11<1523::AID-MUS22>3.0.CO;2-#
   Arnardottir S, 2003, J REHABIL MED, V35, P31, DOI 10.1080/16501970306110
   Askanas V, 2003, J CHILD NEUROL, V18, P185, DOI 10.1177/08830738030180030401
   Brandt E.N., 1997, Enabling America: Assessing the role of rehabilitation science and engineering
   Cea G, 2002, BRAIN, V125, P1635, DOI 10.1093/brain/awf163
   Christopher-Stine L, 2004, BEST PRACT RES CL RH, V18, P331, DOI 10.1016/j.berh.2004.02.009
   Chung YL, 2001, CLIN EXP RHEUMATOL, V19, P447
   CLARKE AE, 1995, ARTHRITIS RHEUM, V38, P1218, DOI 10.1002/art.1780380907
   CROSBY CA, 1995, AM J HAND SURG, V19, P665
   Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1
   Dorph C, 2001, J RHEUMATOL, V28, P1591
   EMSLIESMITH AM, 1990, ANN NEUROL, V27, P343, DOI 10.1002/ana.410270402
   Englund P, 2002, ARTHRITIS RHEUM, V46, P1044, DOI 10.1002/art.10140
   ESCALANTE A, 1993, J RHEUMATOL, V20, P1340
   Felice KJ, 1998, MUSCLE NERVE, V21, P659, DOI 10.1002/(SICI)1097-4598(199805)21:5<659::AID-MUS17>3.0.CO;2-Q
   FRESE E, 1987, PHYS THER, V67, P1072, DOI 10.1093/ptj/67.7.1072
   HENRIKSSON KG, 1990, PROG NEUROBIOL, V35, P181, DOI 10.1016/0301-0082(90)90026-D
   HENRIKSSON KG, 1982, ACTA NEUROL SCAND, V65, P280, DOI 10.1111/j.1600-0404.1982.tb03087.x
   HICKS JE, 1993, J RHEUMATOL, V20, P1399
   Josefson A, 1996, J RHEUMATOL, V23, P1380
   Lodi R, 1998, BRAIN, V121, P2119, DOI 10.1093/brain/121.11.2119
   Macey AC, 1995, J HAND SURG-BRIT EUR, V20B, P841, DOI 10.1016/S0266-7681(95)80059-X
   Marie I, 2001, J RHEUMATOL, V28, P2230
   Mastaglia FL, 2003, MUSCLE NERVE, V27, P407, DOI 10.1002/mus.10313
   Mastaglia FL, 2002, RHEUM DIS CLIN N AM, V28, P723, DOI 10.1016/S0889-857X(02)00021-2
   Miller FW, 2001, RHEUMATOLOGY, V40, P1262, DOI 10.1093/rheumatology/40.11.1262
   Minor MA, 1999, RHEUM DIS CLIN N AM, V25, P233, DOI 10.1016/S0889-857X(05)70062-4
   Nagi S.Z., 1965, SOCIOLOGY REHABILITA
   Nyberg P, 2000, J RHEUMATOL, V27, P940
   ODDIS CV, 1988, J RHEUMATOL, V15, P807
   ODDIS CV, 1990, J RHEUMATOL, V17, P1329
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   PARK JH, 1995, ARTHRITIS RHEUM, V38, P68, DOI 10.1002/art.1780380111
   PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402
   PETERSEN P, 1989, AM J OCCUP THER, V43, P444, DOI 10.5014/ajot.43.7.444
   Pfleiderer B, 2004, RHEUMATOLOGY, V43, P696, DOI 10.1093/rheumatology/keh182
   PLOTZ PH, 1995, ANN INTERN MED, V122, P715, DOI 10.7326/0003-4819-122-9-199505010-00010
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   Schroder JM, 1997, MOL CELL BIOCHEM, V174, P277, DOI 10.1023/A:1006829129079
   SEKUL EA, 1993, SEMIN NEUROL, V13, P256, DOI 10.1055/s-2008-1041132
   Spector SA, 1997, MUSCLE NERVE, V20, P1242, DOI 10.1002/(SICI)1097-4598(199710)20:10<1242::AID-MUS6>3.3.CO;2-X
   Stenström CH, 2003, ARTHRIT RHEUM-ARTHR, V49, P428, DOI 10.1002/art.11051
   Sultan SM, 2002, RHEUMATOLOGY, V41, P22, DOI 10.1093/rheumatology/41.1.22
   *US DEP HHS, 1993, PLAN NAT CTR MED REH
   Varjú C, 2003, CLIN REHABIL, V17, P83, DOI 10.1191/0269215503cr572oa
   Vencovsky J, 2000, SCAND J RHEUMATOL, V29, P95, DOI 10.1080/030097400750001897
   Wiesinger GF, 1998, BRIT J RHEUMATOL, V37, P196
   Wiesinger GF, 1998, BRIT J RHEUMATOL, V37, P1338
   Wiesinger GF, 2000, ARCH PHYS MED REHAB, V81, P1, DOI 10.1016/S0003-9993(00)90212-0
   World Health Organization, 2001, ICF: International Classification of Functioning, Disability and Health
NR 54
TC 32
Z9 40
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8711
EI 1531-6963
J9 CURR OPIN RHEUMATOL
JI Curr. Opin. Rheumatol.
PD MAR
PY 2005
VL 17
IS 2
BP 164
EP 171
DI 10.1097/01.bor.0000152665.41493.49
PG 8
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA 912LH
UT WOS:000228079200010
PM 15711230
DA 2024-11-01
ER

PT J
AU Leshinsky-Silver, E
   Lev, D
   Tzofi-Berman, Z
   Cohen, S
   Saada, A
   Yanoov-Sharav, M
   Gilad, E
   Lerman-Sagle, T
AF Leshinsky-Silver, E
   Lev, D
   Tzofi-Berman, Z
   Cohen, S
   Saada, A
   Yanoov-Sharav, M
   Gilad, E
   Lerman-Sagle, T
TI Fulminant neurological deterioration in a neonate with Leigh syndrome
   due to a maternally transmitted missense mutation in the mitochondrial
   ND3 gene
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Leigh; mtDNA; complex I; ND3
ID COMPLEX-I DEFICIENCY; DNA G13513A MUTATION; TRNA(TRP) GENE; DISEASE;
   ENCEPHALOPATHY; INSERTION
AB Leigh syndrome can result from both nuclear and mitochondrial DNA defects. Mutations in complex V genes of the respiratory chain were considered until recently as the most frequent cause for mitochondrial inherited Leigh syndrome, while gene defects in complex I were related to recessive Leigh syndrome. Recently few reports of mutations in the mitochondrial-encoded complex I subunit genes causing Leigh syndrome have been reported. We describe a I-month-old baby who acutely deteriorated, with abrupt onset of brainstem dysfunction, due to basal ganglia lesions extending to the brainstem. A muscle biopsy demonstrated complex I deficiency. Subsequent analysis of the mitochondrial genome revealed a homoplastic T10191C mutation in the ND3 gene (in blood and muscle), resulting in a substitution of serine to proline. Hair root analysis revealed a 50% mutant load, reflecting heteroplasmy in early embryonic stages. The mutation was also detected in his mother (5%). Western blot analysis revealed a decrease of the 20 kDa subunit (likely ND6) and of the 30 kDa subunit (NDUFA9), which is probably due to instability attributed to the inability to form subcomplexes with ND3. This is the first description of infantile Leigh syndrome due to a maternally transmitted T 10 19 1 C substitution in ND3 and not due to a de novo mutation. This mutation is age and tissue dependent and therefore may not be amenable to prenatal testing. (c) 2005 Elsevier Inc. All rights reserved.
C1 Wolfson Med Ctr, Mol Genet Lab, Holon, Israel.
   Wolfson Med Ctr, Mitochondrial Dis Ctr, Holon, Israel.
   Wolfson Med Ctr, Inst Med Genet, Holon, Israel.
   Wolfson Med Ctr, Pediat Intens Care Unit, Holon, Israel.
   Wolfson Med Ctr, Pediat Neurol Unit, Holon, Israel.
   Shaare Zedek Med Ctr, Metab Unit, Jerusalem, Israel.
C3 Hebrew University of Jerusalem; Shaare Zedek Medical Center
RP Leshinsky-Silver, E (corresponding author), Wolfson Med Ctr, Mol Genet Lab, Holon, Israel.
EM leshinsky@wolfson.health.gov.il
RI Lerman-Sagie, Tally/AAY-7598-2021; Saada, Ann/J-6864-2017
OI Saada, Ann/0000-0003-2951-0656; Lerman-Sagie, Tally/0000-0001-6641-6875
CR Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Campos Y, 1997, NEUROLOGY, V49, P595, DOI 10.1212/WNL.49.2.595
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Komaki H, 2003, MITOCHONDRION, V2, P293, DOI 10.1016/S1567-7249(03)00003-5
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   PASTORES GM, 1994, AM J MED GENET, V50, P265, DOI 10.1002/ajmg.1320500310
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2004, ANAL BIOCHEM, V335, P66, DOI 10.1016/j.ab.2004.08.015
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Srere P.A., 1969, Methods in Enzymology, V13, P3
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   Taylor RW, 2002, EUR J HUM GENET, V10, P141, DOI 10.1038/sj.ejhg.5200773
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Tsao CY, 2003, J CHILD NEUROL, V18, P62, DOI 10.1177/08830738030180011401
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
   Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262
   Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
NR 33
TC 31
Z9 40
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD AUG 26
PY 2005
VL 334
IS 2
BP 582
EP 587
DI 10.1016/j.bbrc.2005.06.134
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 950TI
UT WOS:000230880200040
PM 16023078
DA 2024-11-01
ER

PT J
AU Kang, I
   Chu, CT
   Kaufman, BA
AF Kang, Inhae
   Chu, Charleen T.
   Kaufman, Brett A.
TI The mitochondrial transcription factor TFAM in neurodegeneration:
   emerging evidence and mechanisms
SO FEBS LETTERS
LA English
DT Review
DE mitochondrial DNA; neurodegeneration; TFAM
ID FACTOR-A TFAM; APPSWE/PS1DE9 MOUSE MODEL; MTDNA COPY NUMBER;
   ALZHEIMERS-DISEASE; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; DNA
   MUTATIONS; ENERGY-METABOLISM; SKELETAL-MUSCLE; DYSFUNCTION
AB The mitochondrial transcription factor A, or TFAM, is a mitochondrial DNA (mtDNA)-binding protein essential for genome maintenance. TFAM functions in determining the abundance of the mitochondrial genome by regulating packaging, stability, and replication. More recently, TFAM has been shown to play a central role in the mtDNA stress-mediated inflammatory response. Emerging evidence indicates that decreased mtDNA copy number is associated with several aging-related pathologies; however, little is known about the association of TFAM abundance and disease. In this Review, we evaluate the potential associations of altered TFAM levels or mtDNA copy number with neurodegeneration. We also describe potential mechanisms by which mtDNA replication, transcription initiation, and TFAM-mediated endogenous danger signals may impact mitochondrial homeostasis in Alzheimer, Huntington, Parkinson, and other neurodegenerative diseases.
C1 [Kang, Inhae] Jeju Natl Univ, Dept Food Sci & Nutr, Jeju City, South Korea.
   [Kang, Inhae; Kaufman, Brett A.] Univ Pittsburgh, Sch Med, Ctr Metab & Mitochondrial Med C3M, Dept Med,Div Cardiol,Vasc Med Inst, Pittsburgh, PA USA.
   [Chu, Charleen T.] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, McGowan Inst Regenerat Med, Conformat Prot Dis Ctr,Dept Pathol,Ctr Neurosci, Pittsburgh, PA USA.
C3 Jeju National University; Pennsylvania Commonwealth System of Higher
   Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth
   System of Higher Education (PCSHE); University of Pittsburgh
RP Kaufman, BA (corresponding author), Univ Pittsburgh, Sch Med, Vasc Med Inst, Dept Med,Ctr Metab & Mitochondrial Med C3M, 200 Lothrop St,BST E1241, Pittsburgh, PA 15261 USA.
EM bkauf@pitt.edu
RI Chu, Charleen/B-1601-2008; Kaufman, Brett/IUP-1225-2023
FU National Institutes of Health [TR000503, GM110424, NS065789, NS101628,
   AG026389]
FX Research in the authors' laboratories has been supported in part by the
   National Institutes of Health (Grants GM110424, AG026389, NS065789,
   TR000503, NS101628).
CR Acevedo-Torres K, 2009, DNA REPAIR, V8, P126, DOI 10.1016/j.dnarep.2008.09.004
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890
   Andreu AL, 1998, BIOCHEM BIOPH RES CO, V252, P577, DOI 10.1006/bbrc.1998.9703
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Belin AC, 2007, NEUROSCI LETT, V420, P257, DOI 10.1016/j.neulet.2007.05.010
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bogaerts V, 2008, HUM MUTAT, V29, P832, DOI 10.1002/humu.20713
   Bose A, 2016, J NEUROCHEM, V139, P216, DOI 10.1111/jnc.13731
   Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293
   Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002
   Cannon JR, 2011, TOXICOL SCI, V124, P225, DOI 10.1093/toxsci/kfr239
   Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008
   Coskun Pinar E, 2012, Curr Gerontol Geriatr Res, V2012, P383170, DOI 10.1155/2012/383170
   Coskun PE, 2010, J ALZHEIMERS DIS, V20, pS293, DOI 10.3233/JAD-2010-100351
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458
   Dagda RK, 2014, J NEUROCHEM, V128, P864, DOI 10.1111/jnc.12494
   Dinardo MM, 2003, BIOCHEM BIOPH RES CO, V301, P187, DOI 10.1016/S0006-291X(02)03008-5
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Farge G, 2014, CELL REP, V8, P66, DOI 10.1016/j.celrep.2014.05.046
   Farshbaf MJ, 2017, NEUROTOX RES, V32, P518, DOI 10.1007/s12640-017-9766-1
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   FISHER RP, 1985, J BIOL CHEM, V260, P1330
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Fuke S, 2011, BBA-BIOENERGETICS, V1807, P270, DOI 10.1016/j.bbabio.2010.11.016
   Galter D, 2010, GENES BRAIN BEHAV, V9, P173, DOI 10.1111/j.1601-183X.2009.00542.x
   Garstka HL, 2003, NUCLEIC ACIDS RES, V31, P5039, DOI 10.1093/nar/gkg717
   Gatt AP, 2013, NEUROSCI LETT, V557, P177, DOI 10.1016/j.neulet.2013.10.045
   Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002
   Gaweda-Walerych K, 2010, NEUROSCI LETT, V469, P24, DOI 10.1016/j.neulet.2009.11.037
   Giannoccaro MP, 2017, MOVEMENT DISORD, V32, P346, DOI 10.1002/mds.26966
   Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625
   Grimm A, 2016, BIOGERONTOLOGY, V17, P281, DOI 10.1007/s10522-015-9618-4
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Günther C, 2004, NEUROSCI LETT, V369, P219, DOI 10.1016/j.neulet.2004.07.070
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011
   Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008
   Hillen HS, 2017, CELL, V171, P1072, DOI 10.1016/j.cell.2017.10.036
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   Ikeda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119687
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Jiang M, 2017, CELL METAB, V26, P429, DOI 10.1016/j.cmet.2017.07.003
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]
   Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831
   Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004
   Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Keeney PM, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-21
   Keeney PM, 2009, HUM GENE THER, V20, P897, DOI 10.1089/hum.2009.023
   Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306
   Kirches E, 2009, CURR GENOMICS, V10, P585, DOI 10.2174/138920209789503879
   Kühl I, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600963
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lee JY, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/586017
   Lillenes MS, 2017, NEUROSCI LETT, V645, P46, DOI 10.1016/j.neulet.2017.02.062
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Malarkey CS, 2012, NUCLEIC ACIDS RES, V40, P614, DOI 10.1093/nar/gkr787
   Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   Memon Ashfaque A, 2017, Biomol Detect Quantif, V13, P32, DOI 10.1016/j.bdq.2017.08.001
   Morimoto N, 2012, J NEUROSCI RES, V90, P1200, DOI 10.1002/jnr.23000
   Morozov YI, 2015, NUCLEIC ACIDS RES, V43, P3726, DOI 10.1093/nar/gkv235
   Morozov YI, 2014, NUCLEIC ACIDS RES, V42, P3884, DOI 10.1093/nar/gkt1356
   Ngo Huu B, 2014, Nat Commun, V5, P3077, DOI 10.1038/ncomms4077
   Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159
   Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nishiyama S, 2010, BIOCHEM BIOPH RES CO, V401, P26, DOI 10.1016/j.bbrc.2010.08.143
   Oka S, 2016, SCI REP-UK, V6, DOI 10.1038/srep37889
   Pedrós I, 2014, BBA-MOL BASIS DIS, V1842, P1556, DOI 10.1016/j.bbadis.2014.05.025
   Petrov D, 2016, MOL NEUROBIOL, V53, P6183, DOI 10.1007/s12035-015-9522-6
   Phillips NR, 2014, ALZHEIMERS DEMENT, V10, P393, DOI 10.1016/j.jalz.2013.04.508
   Piao Y, 2012, BBA-GEN SUBJECTS, V1820, P577, DOI 10.1016/j.bbagen.2011.08.007
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Pohjoismäki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703
   Posse V, 2017, J BIOL CHEM, V292, P2637, DOI 10.1074/jbc.M116.751008
   Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784
   Ramachandran A, 2017, NUCLEIC ACIDS RES, V45, P861, DOI 10.1093/nar/gkw1157
   Reeve A, 2013, J NEUROSCI, V33, P10790, DOI 10.1523/JNEUROSCI.3525-12.2013
   Rice AC, 2014, J ALZHEIMERS DIS, V40, P319, DOI 10.3233/JAD-131715
   Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5
   Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291
   Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160
   Santos JM, 2014, EXP EYE RES, V121, P168, DOI 10.1016/j.exer.2014.02.010
   Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397
   Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x
   Shlevkov E, 2016, P NATL ACAD SCI USA, V113, pE6097, DOI 10.1073/pnas.1612283113
   Smith EF, 2017, NEUROSCI LETT
   Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Steer EK, 2015, ANTIOXID REDOX SIGN, V22, P1047, DOI 10.1089/ars.2014.6206
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Stevens DA, 2015, P NATL ACAD SCI USA, V112, P11696, DOI 10.1073/pnas.1500624112
   Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013
   Suarez J, 2008, AM J PHYSIOL-CELL PH, V295, pC1561, DOI 10.1152/ajpcell.00076.2008
   Taherzadeh-Fard E, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-32
   Takamatsu C, 2002, EMBO REP, V3, P451, DOI 10.1093/embo-reports/kvf099
   Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430
   Thomas RR, 2012, AGING-US, V4, P620, DOI 10.18632/aging.100488
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Turnbull HE, 2010, BBA-MOL BASIS DIS, V1802, P111, DOI 10.1016/j.bbadis.2009.07.010
   Van Laar VS, 2011, HUM MOL GENET, V20, P927, DOI 10.1093/hmg/ddq531
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x
   Wang KZQ, 2014, MITOCHONDRION, V17, P132, DOI 10.1016/j.mito.2014.04.008
   Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059449
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-016-0404-6
   West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   Woo DK, 2012, AM J PATHOL, V180, P24, DOI 10.1016/j.ajpath.2011.10.003
   Wright AF, 2004, NAT GENET, V36, P1153, DOI 10.1038/ng1448
   Xu SC, 2009, FEBS J, V276, P4224, DOI 10.1111/j.1742-4658.2009.07094.x
   Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955
   Zhang Q, 2011, BRAIN RES, V1368, P355, DOI 10.1016/j.brainres.2010.10.074
   Zhong Y, 2011, FEBS J, V278, P2500, DOI 10.1111/j.1742-4658.2011.08176.x
   Zhu JH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.46
   Zhu JH, 2003, BRAIN PATHOL, V13, P473
   Zhu JH, 2002, AM J PATHOL, V161, P2087, DOI 10.1016/S0002-9440(10)64487-2
   Zsurka G, 2013, IUBMB LIFE, V65, P263, DOI 10.1002/iub.1126
NR 138
TC 188
Z9 204
U1 1
U2 29
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD MAR
PY 2018
VL 592
IS 5
SI SI
BP 793
EP 811
DI 10.1002/1873-3468.12989
PG 19
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA FZ3FW
UT WOS:000427473100011
PM 29364506
OA Bronze, Green Accepted
DA 2024-11-01
ER

PT J
AU Grünewald, A
   Lax, NZ
   Rocha, MC
   Reeve, AK
   Hepplewhite, PD
   Rygiel, KA
   Taylor, RW
   Turnbull, DM
AF Gruenewald, Anne
   Lax, Nichola Z.
   Rocha, Mariana C.
   Reeve, Amy K.
   Hepplewhite, Philippa D.
   Rygiel, Karolina A.
   Taylor, Robert W.
   Turnbull, Doug M.
TI Quantitative quadruple-label immunofluorescence of mitochondrial and
   cytoplasmic proteins in single neurons from human midbrain tissue
SO JOURNAL OF NEUROSCIENCE METHODS
LA English
DT Article
DE Mitochondria; Complex I; Complex IV; Single cell analysis; Midbrain
   neurons; Immunofluorescent labelling
ID SUBSTANTIA-NIGRA NEURONS; COMPLEX I DEFICIENCY; DNA MUTATIONS;
   RESPIRATORY-CHAIN; OXIDATIVE-PHOSPHORYLATION; PARKINSONS-DISEASE;
   SKELETAL-MUSCLE; CHANNEL VDAC; DELETIONS; MEMBRANE
AB Background: Respiratory chain (RC) deficiencies are found in primary mtDNA diseases. Focal RC defects are also associated with ageing and neurodegenerative disorders, e.g. in substantia nigra (SN) neurons from Parkinson's disease patients. In mitochondrial disease and ageing, mtDNA mutational loads vary considerably between neurons necessitating single cell-based assessment of RC deficiencies. Evaluating the full extent of RC deficiency within SN neurons is challenging because their size precludes investigations in serial sections. We developed an assay to measure RC abnormalities in individual SN neurons using quadruple immunofluorescence.
   New method: Using antibodies against subunits of complex I (Cl) and IV, porin and tyrosine hydroxylase together with IgG subtype-specific fluorescent labelled secondary antibodies, we quantified the expression of CI and CIV compared to mitochondrial mass in dopaminergic neurons. CI:porin and CIV:porin ratios were determined relative to a standard control.
   Results: Quantification of expression of complex subunits in midbrain sections from patients with mtDNA disease and known RC deficiencies consistently showed reduced CI: porin and/or CIV:porin ratios.
   Comparison with existing method(s): The standard histochemical method to investigate mitochondrial dysfunction, the cytochrome c oxidase/succinate dehydrogenase assay, measures CIV and CH activities. To also study CI in a patient, immunohistology in additional sections, i.e. in different neurons, is required. Our method allows correlation of the expression of CI, CIV and mitochondrial mass at a single cell level.
   Conclusion: Quantitative quadruple-label immunofluorescence is a reliable tool to measure RC deficiencies in individual neurons that will enable new insights in the molecular mechanisms underlying inherited and acquired mitochondrial dysfunction. 0 2014 The Authors. Published by Elsevier B.V.
C1 [Gruenewald, Anne; Lax, Nichola Z.; Rocha, Mariana C.; Reeve, Amy K.; Hepplewhite, Philippa D.; Rygiel, Karolina A.; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Gruenewald, Anne] Med Univ Lubeck, Inst Neurogenet, D-23538 Lubeck, Germany.
C3 Newcastle University - UK; University of Lubeck
RP Turnbull, DM (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM anne.gruenewald@newcastle.ac.uk; nichola.lax@newcastle.ac.uk;
   m.rocha@newcastle.ac.uk; amy.reeve@newcastle.ac.uk;
   philippa.hepplewhite@newcastle.ac.uk; karolina.rygiel@newcastle.ac.uk;
   Robert.taylor@newcastle.ac.uk; doug.turnbull@newcastle.ac.uk
RI Grünewald, Anne/ABD-1255-2021; Rocha, Mariana/O-4313-2017
OI Turnbull, Doug/0000-0002-8878-9901; Grunewald, Anne/0000-0002-4179-2994;
   Rocha, Mariana/0000-0002-0056-9315; Reeve, Amy/0000-0002-4474-2204
FU German Research Foundation; Newcastle University Centre for Brain Ageing
   and Vitality; Biotechnology and Biological Sciences Research Council;
   Engineering and Physical Sciences Research Council; Economic and Social
   Research Council; Medical Research Council [G0700718]; Wellcome Trust
   Centre for Mitochondrial Research [G906919]; MRC Centre for
   Translational Research in Neuromuscular Disease Mitochondrial Disease
   Patient Cohort (UK) [G0800674]; UK NIHR Biomedical Research Centre in
   Age and Age Related Diseases; UK Medical Research Council [G0400074];
   MRC [G0400074, G1100540, G0800674, G0900652, MR/K000608/1, G0700718,
   G0502157] Funding Source: UKRI
FX This work was supported by the German Research Foundation [to A.G.].
   This work was funded by Newcastle University Centre for Brain Ageing and
   Vitality (supported by the Biotechnology and Biological Sciences
   Research Council, Engineering and Physical Sciences Research Council
   Economic and Social Research Council and Medical Research Council
   [G0700718]), The Wellcome Trust Centre for Mitochondrial Research
   [G906919], The MRC Centre for Translational Research in Neuromuscular
   Disease Mitochondrial Disease Patient Cohort (UK) [G0800674], the UK
   NIHR Biomedical Research Centre in Age and Age Related Diseases award to
   the Newcastle upon Tyne Hospitals NHS Foundation Trust and UK NHS
   Specialist Commissioners "Rare Mitochondrial Disorders of Adults and
   Children" Service. Tissue for this study was provided by the Newcastle
   Brain Tissue Resource, which is funded in part by a grant from the UK
   Medical Research Council (G0400074).
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006
   BLACHLYDYSON E, 1994, GENOMICS, V20, P62, DOI 10.1006/geno.1994.1127
   Campbell GR, 2013, MULT SCLER J, V19, P1858, DOI 10.1177/1352458513490547
   Colombini M, 1980, Ann N Y Acad Sci, V341, P552, DOI 10.1111/j.1749-6632.1980.tb47198.x
   de Vries RLA, 2013, MOL CELL NEUROSCI, V55, P37, DOI 10.1016/j.mcn.2012.07.008
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Flatmark T, 1999, CHEM REV, V99, P2137, DOI 10.1021/cr980450y
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015
   JOHNSON MA, 1988, J NEUROL SCI, V87, P75, DOI 10.1016/0022-510X(88)90056-1
   Koob AO, 2012, ANAL BIOCHEM, V425, P120, DOI 10.1016/j.ab.2012.02.034
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Mahad DJ, 2009, J NEUROSCI METH, V184, P310, DOI 10.1016/j.jneumeth.2009.08.020
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Reeve A, 2013, J NEUROSCI, V33, P10790, DOI 10.1523/JNEUROSCI.3525-12.2013
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   Romijn HJ, 1999, J HISTOCHEM CYTOCHEM, V47, P229, DOI 10.1177/002215549904700211
   Rowan SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029082
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Sisková Z, 2010, AM J PATHOL, V177, P1411, DOI 10.2353/ajpath.2010.091037
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Tanji K, 2008, METHODS, V46, P274, DOI 10.1016/j.ymeth.2008.09.027
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
NR 27
TC 25
Z9 25
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0270
EI 1872-678X
J9 J NEUROSCI METH
JI J. Neurosci. Methods
PD JUL 30
PY 2014
VL 232
BP 143
EP 149
DI 10.1016/j.jneumeth.2014.05.026
PG 7
WC Biochemical Research Methods; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA AL4ZW
UT WOS:000339144300018
PM 24880043
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Yamada, Y
   Fujishita, N
   Harashima, H
AF Yamada, Yuma
   Fujishita, Naoki
   Harashima, Hideyoshi
TI A nanocarrier for the mitochondrial delivery of nucleic acids to
   cardiomyocytes
SO NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
LA English
DT Article
DE Cardiac myoblasts; mitochondria; nucleic acids delivery; liposomes;
   mitochondrial delivery; multifunctional envelope-type nano device (MEND)
ID MITO-PORTER; DNA VECTOR; SYSTEM; CELLS; RNA; MACROMOLECULE; VALIDATION;
   PEPTIDES
AB Cardiomyopathy caused by mitochondrial dysfunction associated with the mutation/deletion of mitochondrial DNA has been reported, and nucleic acid therapy targeting cardiac mitochondria represents a possible therapy for treating these diseases. Such a treatment, however, has not yet been achieved because delivering nucleic acids to mitochondria of cardiac muscle is difficult. In this study, H9c2 cells a type of rat cardiac myoblasts, were used as model cardiac muscle cells. The use of a lipid composition used to prepare the ?-MEND (where MEND denotes multifunctional envelope-type nano device) permitted the particles to be efficiently internalized by H9c2 cells, as evidenced by flow cytometry analyses. Intracellular observations by confocal laser scanning microscopy showed that the ?-MEND efficiently accumulated in mitochondria of H9c2 cells. We also constructed an RP/?-MEND that contained a mitochondrial RNA aptamer to achieve mitochondrial delivery in H9c2 cells. The successful direct mitochondrial transfection of exogenous RNA was confirmed using these carrier systems, based on PCR experiments after reverse transcription. Thus, the ?-MEND holds promise as a direct mitochondrial transfection system for delivering nucleic acids targeted to H9c2 cells.
C1 [Yamada, Yuma; Fujishita, Naoki; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan.
C3 Hokkaido University
RP Yamada, Y; Harashima, H (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.
EM u-ma@pharm.hokudai.ac.jp; harasima@pharm.hokudai.ac.jp
RI Harashima, Hideyoshi/D-8390-2012; Yamada, Yuma/D-5505-2012
OI Yamada, Yuma/0000-0002-4637-5102
FU Japan Agency for Medical Research and Development; Ministry of
   Education, Culture, Sports, Science and Technology; Takeda Science
   Foundation
FX This work was supported by Japan Agency for Medical Research and
   Development; Ministry of Education, Culture, Sports, Science and
   Technology; Takeda Science Foundation.
CR Abe J, 2018, J CONTROL RELEASE, V269, P177, DOI 10.1016/j.jconrel.2017.11.024
   Bertero E, 2018, J CLIN INVEST, V128, P5191, DOI 10.1172/JCI124944
   Biswas S, 2014, ADV DRUG DELIVER REV, V66, P26, DOI 10.1016/j.addr.2013.11.004
   Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657
   Furukawa R, 2015, BIOMATERIALS, V57, P107, DOI 10.1016/j.biomaterials.2015.04.022
   Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l
   Ishikawa T, 2018, J CONTROL RELEASE, V274, P109, DOI 10.1016/j.jconrel.2018.02.005
   Katayama T, 2019, MITOCHONDRION, V49, P66, DOI 10.1016/j.mito.2019.07.005
   Kawamura E, 2013, MITOCHONDRION, V13, P610, DOI 10.1016/j.mito.2013.08.010
   Kusumoto K, 2013, ACS NANO, V7, P7534, DOI 10.1021/nn401317t
   Lee SR, 2017, ADV EXP MED BIOL, V982, P81, DOI 10.1007/978-3-319-55330-6_5
   McCully JD, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0095-4
   Milane L, 2015, J CONTROL RELEASE, V207, P40, DOI 10.1016/j.jconrel.2015.03.036
   Nakamura T, 2019, BIOMATERIALS, V218, DOI 10.1016/j.biomaterials.2019.119329
   Sato Y, 2017, MACROMOL BIOSCI, V17, DOI 10.1002/mabi.201600179
   Takano Y, 2017, NANOSCALE, V9, P18690, DOI 10.1039/c7nr06310e
   Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035
   Wen R, 2016, ADV DRUG DELIVER REV, V99, P52, DOI 10.1016/j.addr.2015.12.024
   Yamada Y, 2008, ADV DRUG DELIVER REV, V60, P1439, DOI 10.1016/j.addr.2008.04.016
   Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002
   Yamada Y, 2019, CHEM COMMUN, V55, P7203, DOI 10.1039/c9cc03272j
   Yamada Y, 2017, BIOMATERIALS, V136, P56, DOI 10.1016/j.biomaterials.2017.05.016
   Yamada Y, 2016, J PHARM SCI-US, V105, P1705, DOI 10.1016/j.xphs.2016.03.002
   Yamada Y, 2015, J CONTROL RELEASE, V213, P86, DOI 10.1016/j.jconrel.2015.06.037
   Yamada Y, 2014, BIOMATERIALS, V35, P6430, DOI 10.1016/j.biomaterials.2014.04.017
   Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99
   Yasuzaki Y, 2015, MOL PHARMACEUT, V12, P4311, DOI 10.1021/acs.molpharmaceut.5b00511
NR 27
TC 13
Z9 14
U1 1
U2 17
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1525-7770
EI 1532-2335
J9 NUCLEOS NUCLEOT NUCL
JI Nucleosides Nucleotides Nucleic Acids
PD FEB 20
PY 2020
VL 39
IS 1-3
BP 141
EP 155
DI 10.1080/15257770.2019.1675167
EA OCT 2019
PG 15
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA LF1XH
UT WOS:000492243500001
PM 31595823
DA 2024-11-01
ER

PT J
AU McKinney, EA
   Oliveira, MT
AF McKinney, Emily A.
   Oliveira, Marcos T.
TI Replicating animal mitochondrial DNA
SO GENETICS AND MOLECULAR BIOLOGY
LA English
DT Review
DE DNA replication; mitochondria; mtSSB; pol gamma; Twinkle
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; LIGHT-STRAND ORIGINS; N-TERMINAL
   DOMAIN; FUNCTIONAL INTERACTIONS; BIOCHEMICAL DEFECTS; ACCESSORY SUBUNIT;
   POLYMERASE GAMMA; HELICASE TWINKLE; BINDING PROTEIN; MTDNA HELICASE
AB The field of mitochondrial DNA (mtDNA) replication has been experiencing incredible progress in recent years, and yet little is certain about the mechanism(s) used by animal cells to replicate this plasmid-like genome. The long-standing strand-displacement model of mammalian mtDNA replication (for which single-stranded DNA intermediates are a hallmark) has been intensively challenged by a new set of data, which suggests that replication proceeds via coupled leading-and lagging-strand synthesis (resembling bacterial genome replication) and/or via long stretches of RNA intermediates laid on the mtDNA lagging-strand (the so called RITOLS). The set of proteins required for mtDNA replication is small and includes the catalytic and accessory subunits of DNA polymerase gamma, the mtDNA helicase Twinkle, the mitochondrial single-stranded DNA-binding protein, and the mitochondrial RNA polymerase (which most likely functions as the mtDNA primase). Mutations in the genes coding for the first three proteins are associated with human diseases and premature aging, justifying the research interest in the genetic, biochemical and structural properties of the mtDNA replication machinery. Here we summarize these properties and discuss the current models of mtDNA replication in animal cells.
C1 [McKinney, Emily A.; Oliveira, Marcos T.] Univ Tampere, Inst Biomed Technol, Tampere 33014, Finland.
C3 Tampere University
RP Oliveira, MT (corresponding author), Univ Tampere, Inst Biomed Technol, Biokatu 6, Tampere 33014, Finland.
EM marcos.oliveira@uta.fi
RI Oliveira, Marcos/AAN-2804-2020; Oliveira, Marcos Tulio/B-3249-2014
OI Oliveira, Marcos Tulio/0000-0003-4779-5755
CR BOGENHAGEN D, 1979, COLD SPRING HARB SYM, V43, P253, DOI 10.1101/SQB.1979.043.01.031
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P404, DOI 10.1016/S0968-0004(03)00165-8
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Cámara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002
   Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Fan L, 1999, P NATL ACAD SCI USA, V96, P9527, DOI 10.1073/pnas.96.17.9527
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779
   Farr CL, 2004, J BIOL CHEM, V279, P17047, DOI 10.1074/jbc.M400283200
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653
   Joers P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053249
   Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275
   Kasiviswanathan R, 2012, BBA-GENE REGUL MECH, V1819, P970, DOI 10.1016/j.bbagrm.2011.12.005
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Matsushima Y, 2009, BBA-BIOENERGETICS, V1787, P290, DOI 10.1016/j.bbabio.2008.11.005
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   NASS MMK, 1980, J MOL BIOL, V140, P257, DOI 10.1016/0022-2836(80)90105-9
   NASS MMK, 1980, J MOL BIOL, V140, P231, DOI 10.1016/0022-2836(80)90104-7
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Oliveira MT, 2011, J BIOL CHEM, V286, P40649, DOI 10.1074/jbc.M111.289983
   Oliveira MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015379
   Oliveira MT, 2010, EXP GERONTOL, V45, P489, DOI 10.1016/j.exger.2010.01.019
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Reyes A, 2005, J BIOL CHEM, V280, P3242, DOI 10.1074/jbc.M411916200
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663
NR 58
TC 52
Z9 70
U1 0
U2 23
PU SOC BRASIL GENETICA
PI RIBEIRAO PRET
PA RUA CAP ADELMIO NORBET DA SILVA, 736, ALTO DA BOA VISTA, 14025-670
   RIBEIRAO PRET, BRAZIL
SN 1415-4757
EI 1678-4685
J9 GENET MOL BIOL
JI Genet. Mol. Biol.
PY 2013
VL 36
IS 3
BP 308
EP 315
DI 10.1590/S1415-47572013000300002
PG 8
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 209AO
UT WOS:000323725500002
PM 24130435
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU de Laat, P
   Koene, S
   van den Heuvel, LPWJ
   Rodenburg, RJT
   Janssen, MCH
   Smeitink, JAM
AF de Laat, Paul
   Koene, Saskia
   van den Heuvel, Lambert P. W. J.
   Rodenburg, Richard J. T.
   Janssen, Mirian C. H.
   Smeitink, Jan A. M.
TI Clinical features and heteroplasmy in blood, urine and saliva in 34
   Dutch families carrying the m.3243A &gt; G mutation
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
ID TRANSFER RNALEU(UUR) GENE; STROKE-LIKE EPISODES; MTDNA MUTATION;
   LACTIC-ACIDOSIS; A3243G MUTATION; MITOCHONDRIAL MYOPATHY; MONITOR
   PROGRESSION; MELAS; DISEASE; EPIDEMIOLOGY
AB The m.3243A > G mutation has become known as the MELAS mutation. However, many other clinical phenotypes associated with this mutation have been described, most frequently being maternally inherited diabetes and deafness (MIDD). The m.3243A > G mutation, can be detected in virtually all tissues, however heteroplasmy differs between samples. Recent reports indicate, a preference to perform mutation analysis in urinary epithelial cells (UEC). To test this, and to study a correlation between the mutational load in different tissues with two mitochondrial scoring systems (NMDAS and NPMDS) we investigated 34 families carrying the m.3243A > G mutation. Heteroplasmy was determined in three non-invasively collected samples, namely leucocytes, UEC and buccal mucosa. We included 127 patients, of which 82 carried the m.3243A > G mutation. None of the children (n = 11) had specific complaints. In adults (n = 71), a median NMDAS score of 15 (IQR 10-24) was found. The most prevalent symptoms were hearing loss(48%), gastro-intestinal problems(42%), exercise intolerance(38%) and glucose intolerance(37%). Ten patients had neurologic involvement. Buccal mucosa had the best correlation with the NMDAS in all adults (r = 0.437,p < 0.001), whereas UEC had the strongest correlation with the NMDAS in severely affected patients (r = 0.593,p = 0.002). Heteroplasmy declined significantly with increasing age in all three samples (leucocytes r = -0.705 (p < 0.001), UEC r = -0.374(p = 0.001), buccal mucosa r = -0.460(p < 0.001). In our cohort of 82 patients, the m.3243A > G mutation causes a wide variety of signs and symptoms, MIDD being far more prevalent than MELAS. Looking at the characteristics of the three non-invasively available tissues for testing heteroplasmy we confirm that UEC are the preferred sample to test.
C1 [de Laat, Paul; Koene, Saskia; van den Heuvel, Lambert P. W. J.; Rodenburg, Richard J. T.; Smeitink, Jan A. M.] Radboud Univ Nijmegen, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, Med Ctr, NL-6500 HB Nijmegen, Netherlands.
   [Janssen, Mirian C. H.] Radboud Univ Nijmegen, Dept Internal Med, Nijmegen Ctr Mitochondrial Disorders, Med Ctr, NL-6500 HB Nijmegen, Netherlands.
C3 Radboud University Nijmegen; Radboud University Nijmegen
RP de Laat, P (corresponding author), Radboud Univ Nijmegen, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, Med Ctr, Huispost 804,Geert Grootepl 10,POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM p.laat@cukz.umcn.nl
RI de Laat, Paul/O-9851-2019; van den Heuvel, Lambertus/AAM-1772-2021;
   Smeitink, Jan/C-1351-2013; Janssen, Mirian/D-9777-2016; Rodenburg,
   Richard/N-3579-2014; Koene, Saskia/G-9321-2015; de Laat,
   Paul/B-5855-2011
OI Rodenburg, Richard/0000-0001-5227-3527; Koene,
   Saskia/0000-0002-9876-744X; de Laat, Paul/0000-0003-2541-3090
FU Energy4All foundation; ZonMW
FX Part of this work was supported by the Energy4All foundation and ZonMW.
CR Bergamin CS, 2008, ARQ BRAS ENDOCRINOL, V52, P1345, DOI 10.1590/S0004-27302008000800023
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002
   Durand-Dubief F, 2004, REV NEUROL-FRANCE, V160, P824, DOI 10.1016/S0035-3787(04)71038-3
   Fayssoil Abdallah, 2009, Congest Heart Fail, V15, P284, DOI 10.1111/j.1751-7133.2009.00108.x
   Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Ma YN, 2010, J NEUROL SCI, V291, P17, DOI 10.1016/j.jns.2010.01.012
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Marotta R, 2009, J CLIN NEUROSCI, V16, P1223, DOI 10.1016/j.jocn.2008.11.012
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   Michaelides M, 2008, ARCH OPHTHALMOL-CHIC, V126, P320, DOI 10.1001/archopht.126.3.320
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Phoenix C, 2006, NEUROMUSCULAR DISORD, V16, P814, DOI 10.1016/j.nmd.2006.08.006
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Verny C, 2008, DIABETES METAB, V34, P620, DOI 10.1016/j.diabet.2008.06.001
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
   Wortmann SB, 2007, ACTA PAEDIATR, V96, P450, DOI 10.1111/j.1651-2227.2006.00158.x
NR 28
TC 96
Z9 99
U1 0
U2 17
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-8955
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD NOV
PY 2012
VL 35
IS 6
BP 1059
EP 1069
DI 10.1007/s10545-012-9465-2
PG 11
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 021GT
UT WOS:000309874000015
PM 22403016
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Khan, SM
   Bennett, JP
AF Khan, SM
   Bennett, JP
TI Development of mitochondrial gene replacement therapy
SO JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
LA English
DT Article; Proceedings Paper
CT Mitochondria and Neuroprotection Symposium
CY APR 16-19, 2004
CL Ft Lauderdale, FL
DE mitochondria; mitochondrial DNA; protein transduction; mitochondrial
   genome
ID PROTEIN TRANSDUCTION DOMAIN; ISCHEMIC BRAIN INJURY; TRANSCRIPTION
   FACTOR; FUSION PROTEIN; BASIC DOMAIN; CELL-DEATH; IN-VITRO; CALCIUM;
   VIVO; DNA
AB Many "classic" mitochondrial diseases have been described that arise from single homoplasmic mutations in mitochondrial DNA(mtDNA). These diseases typically affect nonmitotic tissues (brain, retina, muscle), present with variable phenotypes, can appear sporadically, and are untreatable. Evolving evidence implicates mtDNA abnormalities in diseases such as Alzheimer's, Parkinson's, and type II diabetes, but specific causal mutations for these conditions remain to be defined. Understanding the mtDNA genotype-phenotype relationships and developing specific treatment for mtDNA-based diseases is hampered by inability to manipulate the mitochondrial genome. We present a novel protein transduction technology ("protofection") that allows insertion and expression of the human mitochondrial genome into mitochondria of living cells. With protofection, the mitochondrial genotype can be altered, or exogenous genes can be introduced to be expressed and either retained in mitochondria or be directed to other organelles. Protofection also delivers mtDNA in vivo, opening the way to rational development of mitochondrial gene replacement therapy of mtDNA-based diseases.
C1 Univ Virginia, Ctr Study Neurodegenerat Dis, Dept Neurol, Charlottesville, VA 22908 USA.
   GENCIA Corp, Charlottesville, VA USA.
C3 University of Virginia
RP Univ Virginia, Ctr Study Neurodegenerat Dis, Dept Neurol, POB 800394, Charlottesville, VA 22908 USA.
EM bennett@virginia.edu
FU NINDS NIH HHS [NS 39788, NS39005] Funding Source: Medline
CR Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Asoh S, 2002, P NATL ACAD SCI USA, V99, P17107, DOI 10.1073/pnas.262460299
   Cao GD, 2002, J NEUROSCI, V22, P5423
   Choi YS, 2004, BIOCHEM BIOPH RES CO, V314, P118, DOI 10.1016/j.bbrc.2003.12.065
   Del Gaizo V, 2003, MOL GENET METAB, V80, P170, DOI 10.1016/j.ymgme.2003.08.017
   Del Gaizo V, 2003, MOL THER, V7, P720, DOI 10.1016/S1525-0016(03)00130-8
   DEROSSI D, 1994, J BIOL CHEM, V269, P10444
   Dolgilevich S, 2002, BIOCHEM BIOPH RES CO, V299, P505, DOI 10.1016/S0006-291X(02)02664-5
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   Ganitkevich VY, 2003, EXP PHYSIOL, V88, P91, DOI 10.1113/eph8802504
   Graff C, 2002, BEST PRACT RES CL OB, V16, P715, DOI 10.1053/beog.2002.0315
   Gray MW, 2001, GENOME BIOL, V2
   Hajnóczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8
   Hajnóczky G, 2002, CELL CALCIUM, V32, P363, DOI 10.1016/S0143416002001872
   Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023
   Ho A, 2001, CANCER RES, V61, P474
   Jin LH, 2001, FREE RADICAL BIO MED, V31, P1509, DOI 10.1016/S0891-5849(01)00734-1
   Kilic Ü, 2003, STROKE, V34, P1304, DOI 10.1161/01.STR.0000066869.45310.50
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Leifert JA, 2002, GENE THER, V9, P1422, DOI 10.1038/sj.gt.3301819
   Lescuyer P, 2003, PROTEOMICS, V3, P157, DOI 10.1002/pmic.200390024
   Margulis L, 2001, ANN NY ACAD SCI, V929, P55
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150
   PARISI MA, 1993, MOL CELL BIOL, V13, P1951, DOI 10.1128/MCB.13.3.1951
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Schapira AHV, 2000, CURR OPIN NEUROL, V13, P527, DOI 10.1097/00019052-200010000-00004
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100
   Smaili SS, 2003, BRAZ J MED BIOL RES, V36, P183, DOI 10.1590/S0100-879X2003000200004
   Smaili SS, 2000, J BIOENERG BIOMEMBR, V32, P35, DOI 10.1023/A:1005508311495
   Toborek M, 2003, J NEUROCHEM, V84, P169, DOI 10.1046/j.1471-4159.2003.01543.x
   Vandecasteele G, 2001, IUBMB LIFE, V52, P213, DOI 10.1080/15216540152846028
   Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010
   Wallace D C, 2001, Novartis Found Symp, V235, P247
   Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003
   Zeviani M, 2003, CURR OPIN NEUROL, V16, P585, DOI 10.1097/00019052-200310000-00004
NR 37
TC 40
Z9 62
U1 0
U2 23
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0145-479X
EI 1573-6881
J9 J BIOENERG BIOMEMBR
JI J. Bioenerg. Biomembr.
PD AUG
PY 2004
VL 36
IS 4
BP 387
EP 393
DI 10.1023/B:JOBB.0000041773.20072.9e
PG 7
WC Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biophysics; Cell Biology
GA 854PR
UT WOS:000223916300022
PM 15377877
DA 2024-11-01
ER

PT J
AU Sproule, DM
   Kaufmann, P
   Engelstad, K
   Starc, TJ
   Hordof, AJ
   De Vivo, DC
AF Sproule, Douglas M.
   Kaufmann, Petra
   Engelstad, Kristen
   Starc, Thomas J.
   Hordof, Allan J.
   De Vivo, Darryl C.
TI Wolff-Parkinson-White syndrome in patients with MELAS
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; MITOCHONDRIAL MYOPATHY;
   ENCEPHALOPATHY; ENCEPHALOMYOPATHY; GENE
AB Background: Tissues with high energy demands, such as the heart, are susceptible to the effects of mitochondrial DNA point mutations.
   Objective: To investigate the frequency of Wolff-Parkinson-White (WPW) syndrome among a phenotypically and genotypically homogeneous cohort of patients with MELAS (mitochondrial encephalopathy, lactic acidosis, and strokelike episodes) and the A3243G mutation most commonly associated with MELAS syndrome.
   Design: Survey.
   Setting: The Pediatric Neuromuscular Disease Center at Columbia University.
   Patients: Thirty patients with the A3243G mutation and MELAS syndrome enrolled in a clinical trial to assess the effect of dichloroacetate on neurologic symptoms.
   Interventions: Medical histories and electrocardiograms were reviewed and DNA samples from fibroblasts, urine and cheek epithelial cells, leukocytes, and hair were analyzed to determine mitochondrial mutation abundance and estimate total mutation burden.
   Results: Four of 30 patients (13%) had a clinical history of, or electrocardiographic findings consistent with, WPW syndrome. In 2 patients, WPW syndrome preceded MELAS syndrome by 15 and 21 years. The tissue burden of mutant mitochondria was similar in patients with (49.4%) and without (39.1%) WPW syndrome.
   Conclusions: The prevalence of WPW syndrome among patients with MELAS syndrome and the A3243G mutation appears much higher than in the normal population and may become manifest earlier than neurologic symptoms. Patients with WPW syndrome and neurologic abnormalities consistent with MELAS syndrome, such as seizures, deafness, short stature, and stroke, should be screened for the A3243G mutation. Moreover, patients with MELAS syndrome should be monitored for cardiac anomalies including cardiomyopathy and WPW syndrome.
C1 Columbia Univ, Dept Neurol, Div Pediat Neurol, New York, NY USA.
   Columbia Univ, Dept Pediat, New York, NY 10027 USA.
   Childrens Hosp New York, Dept Pediat, Div Pediat Cardiol, New York, NY USA.
C3 Columbia University; Columbia University
RP De Vivo, DC (corresponding author), Neurol Inst, 710 W 168th St,Room 2-201, New York, NY 10032 USA.
FU NCRR NIH HHS [K12 RR017648] Funding Source: Medline; NICHD NIH HHS
   [P01-HD32062] Funding Source: Medline
CR Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403
   Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208
   KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   SATO W, 1994, AM HEART J, V128, P733, DOI 10.1016/0002-8703(94)90272-0
   YONEDA M, 1989, J NEUROL SCI, V92, P143, DOI 10.1016/0022-510X(89)90132-9
NR 10
TC 49
Z9 61
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610-0946 USA
SN 0003-9942
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD NOV
PY 2007
VL 64
IS 11
BP 1625
EP 1627
DI 10.1001/archneur.64.11.1625
PG 3
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 229YZ
UT WOS:000250843800009
PM 17998445
DA 2024-11-01
ER

PT J
AU Malena, A
   Pantic, B
   Borgia, D
   Sgarbi, G
   Solaini, G
   Holt, IJ
   Spinazzola, A
   Perissinotto, E
   Sandri, M
   Baracca, A
   Vergani, L
AF Malena, Adriana
   Pantic, Boris
   Borgia, Doriana
   Sgarbi, Gianluca
   Solaini, Giancarlo
   Holt, Ian J.
   Spinazzola, Antonella
   Perissinotto, Egle
   Sandri, Marco
   Baracca, Alessandra
   Vergani, Lodovica
TI Mitochondrial quality control: Cell-type-dependent responses to
   pathological mutant mitochondrial DNA
SO AUTOPHAGY
LA English
DT Article
DE A549; B2 adenocarcinoma cells; autophagy; mitochondria; mitochondrial
   dynamics; mitochondrial quality control; mitophagy; mutation-m3243G;
   pathological mtDNA; RD; Myo rhabdomyosarcoma cells
ID PARKIN-MEDIATED MITOPHAGY; SKELETAL-MUSCLE; MTDNA MUTATIONS; PATHOGENIC
   MECHANISM; MEMBRANE FUSION; ATP SYNTHESIS; CYBRID CELLS; AUTOPHAGY;
   DYNAMICS; TISSUE
AB Pathological mutations in the mitochondrial DNA (mtDNA) produce a diverse range of tissue-specific diseases and the proportion of mutant mitochondrial DNA can increase or decrease with time via segregation, dependent on the cell or tissue type. Previously we found that adenocarcinoma (A549.B2) cells favored wild-type (WT) mtDNA, whereas rhabdomyosarcoma (RD.Myo) cells favored mutant (m3243G) mtDNA. Mitochondrial quality control (mtQC) can purge the cells of dysfunctional mitochondria via mitochondrial dynamics and mitophagy and appears to offer the perfect solution to the human diseases caused by mutant mtDNA. In A549.B2 and RD.Myo cybrids, with various mutant mtDNA levels, mtQC was explored together with macroautophagy/autophagy and bioenergetic profile. The 2 types of tumor-derived cell lines differed in bioenergetic profile and mitophagy, but not in autophagy. A549.B2 cybrids displayed upregulation of mitophagy, increased mtDNA removal, mitochondrial fragmentation and mitochondrial depolarization on incubation with oligomycin, parameters that correlated with mutant load. Conversely, heteroplasmic RD.Myo lines had lower mitophagic markers that negatively correlated with mutant load, combined with a fully polarized and highly fused mitochondrial network. These findings indicate that pathological mutant mitochondrial DNA can modulate mitochondrial dynamics and mitophagy in a cell-type dependent manner and thereby offer an explanation for the persistence and accumulation of deleterious variants.
C1 [Malena, Adriana; Pantic, Boris; Borgia, Doriana; Vergani, Lodovica] Univ Padua, Dept Neurosci, I-35100 Padua, Italy.
   [Sgarbi, Gianluca; Solaini, Giancarlo; Baracca, Alessandra] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40126 Bologna, Italy.
   [Holt, Ian J.; Spinazzola, Antonella] Mill Hill Lab, MRC, London, England.
   [Perissinotto, Egle] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Biostat Epidemiol & Publ Hlth Unit, Padua, Italy.
   [Sandri, Marco] Univ Padua, Dept Biomed Sci, I-35100 Padua, Italy.
   [Sandri, Marco] Venetian Inst Mol Med, Via Orus 2, I-35129 Padua, Italy.
C3 University of Padua; University of Bologna; University of Padua;
   University of Padua; Veneto Institute Molecular Medicine
RP Sandri, M (corresponding author), Venetian Inst Mol Med, Via Orus 2, I-35129 Padua, Italy.; Baracca, A (corresponding author), Dipartimento Sci Biomed & Neuromotorie, Via Irnerio 48, I-40126 Bologna, Italy.; Vergani, L (corresponding author), Ctr Biomed Pietro DAbano, Dipartimento Neurosci, Via Orus 2B, I-35129 Padua, Italy.
EM marco.sandri@unipd.it; alessandra.baracca@unibo.it;
   lodovica.vergani@unipd.it
RI Sgarbi, Gianluca/AAD-8061-2021; Spinazzola, Antonella/P-5298-2017; holt,
   ian/AFT-2565-2022
OI Spinazzola, Antonella/0000-0003-4242-8091; BARACCA,
   ALESSANDRA/0000-0002-0490-1776; holt, ian/0000-0001-5468-0193
FU Associazione Neuromuscolare Angela Maria Nieddu (ARNAN); AFM [14631];
   Telethon Grant [GGP10145]; Medical Research Council Senior Non-Clinical
   Fellowship [MC_PC_13029]; MRC [MC_PC_13029/2, MC_U105663140,
   MC_PC_13029/1] Funding Source: UKRI
FX We thank the Associazione Neuromuscolare Angela Maria Nieddu (ARNAN) for
   the financial support. This work was supported by the following grants:
   AFM grant No 14631 to LVergani; Telethon Grant No GGP10145 to LVergani.
   A. Spinazzola is supported by Medical Research Council Senior
   Non-Clinical Fellowship (MC_PC_13029).
CR ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2
   Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004
   Baracca A, 2003, BBA-BIOENERGETICS, V1606, P137, DOI 10.1016/S0005-2728(03)00110-5
   Baracca A, 2013, INT J BIOCHEM CELL B, V45, P1356, DOI 10.1016/j.biocel.2013.03.013
   Becker D, 2012, J BIOL CHEM, V287, P22969, DOI 10.1074/jbc.M112.365700
   Benard G, 2009, SEMIN CELL DEV BIOL, V20, P365, DOI 10.1016/j.semcdb.2008.12.012
   Campesi I, 2013, LIFE SCI, V93, P145, DOI 10.1016/j.lfs.2013.06.001
   Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105
   Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048
   Charan RA, 2015, MOL CELL NEUROSCI, V66, P62, DOI 10.1016/j.mcn.2015.02.008
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   Chinnery PF, 2002, TRENDS GENET, V18, P173, DOI 10.1016/S0168-9525(01)02636-1
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   DESJARDINS P, 1985, MOL CELL BIOL, V5, P1163, DOI 10.1128/MCB.5.5.1163
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fan TWM, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-79
   Fernández-Vizarra E, 2010, MITOCHONDRION, V10, P253, DOI 10.1016/j.mito.2009.12.148
   Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339
   Galloway CA, 2012, FREE RADICAL BIO MED, V53, P2218, DOI 10.1016/j.freeradbiomed.2012.09.035
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guha M, 2007, J BIOL CHEM, V282, P14536, DOI 10.1074/jbc.M611693200
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110
   Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198
   Holt IJ, 1997, HUM MOL GENET, V6, P1251, DOI 10.1093/hmg/6.8.1251
   Hyvärinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676
   Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487
   Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356
   Komatsu M, 2010, GENES CELLS, V15, P923, DOI 10.1111/j.1365-2443.2010.01433.x
   Kuznetsov AV, 2009, INT J BIOCHEM CELL B, V41, P1928, DOI 10.1016/j.biocel.2009.03.007
   LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110
   Losón OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721
   Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246
   Mailloux RJ, 2014, REDOX BIOL, V2, P123, DOI 10.1016/j.redox.2013.12.011
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001
   Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008
   Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006
   Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021
   Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026
   Morán M, 2014, BBA-MOL BASIS DIS, V1842, P1059, DOI 10.1016/j.bbadis.2014.03.013
   Moreno-Sánchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x
   Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959
   Murakawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8527
   Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Naue J, 2015, MITOCHONDRION, V20, P82, DOI 10.1016/j.mito.2014.12.002
   Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006
   Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9
   Norton M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004374
   Novak I, 2012, ANTIOXID REDOX SIGN, V17, P794, DOI 10.1089/ars.2011.4407
   O'Riordan TC, 2007, ANAL CHEM, V79, P9414, DOI 10.1021/ac701770b
   Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x
   Oliván S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/652817
   Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021
   Pantic B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.385
   Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109
   Samuels DC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003929
   Sauvanet C, 2010, SEMIN CELL DEV BIOL, V21, P558, DOI 10.1016/j.semcdb.2009.12.006
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Sgarbi G, 2014, AGING-US, V6, P296, DOI 10.18632/aging.100654
   Shutt T, 2012, EMBO REP, V13, P909, DOI 10.1038/embor.2012.128
   Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7
   Solaini G, 2008, BBA-BIOENERGETICS, V1777, P941, DOI 10.1016/j.bbabio.2008.04.034
   Solaini G, 2007, BIOSCIENCE REP, V27, P11, DOI 10.1007/s10540-007-9033-4
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Sunada Y, 1998, NEUROSCI LETT, V254, P180, DOI 10.1016/S0304-3940(98)00697-1
   TONIN PN, 1991, CANCER RES, V51, P5100
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Valenci I, 2015, MITOCHONDRION, V20, P64, DOI 10.1016/j.mito.2014.11.001
   Vergani L, 2004, EUR J BIOCHEM, V271, P3646, DOI 10.1111/j.1432-1033.2004.04298.x
   VERGANI L, 1995, BIOCHEM BIOPH RES CO, V210, P880, DOI 10.1006/bbrc.1995.1740
   Vergani L, 2000, NEUROMUSCULAR DISORD, V10, P454, DOI 10.1016/S0960-8966(00)00096-1
   Vergani L, 2007, BRAIN, V130, P2715, DOI 10.1093/brain/awm151
   Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502
   Wani WY, 2015, LAB INVEST, V95, P14, DOI 10.1038/labinvest.2014.131
   Wei HF, 2015, BBA-MOL CELL RES, V1853, P2784, DOI 10.1016/j.bbamcr.2015.03.013
   Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033
   Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006
   Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136
NR 96
TC 21
Z9 23
U1 0
U2 4
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1554-8627
EI 1554-8635
J9 AUTOPHAGY
JI Autophagy
PY 2016
VL 12
IS 11
BP 2098
EP 2112
DI 10.1080/15548627.2016.1226734
PG 15
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA EB8TW
UT WOS:000387665000011
PM 27627835
OA Green Submitted, Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Samanta, A
   Srivastava, A
   Mandal, K
   Sarma, MS
   Poddar, U
AF Samanta, Arghya
   Srivastava, Anshu
   Mandal, Kausik
   Sarma, Moinak Sen
   Poddar, Ujjal
TI MPV17 mutation-related mitochondrial DNA depletion syndrome: A case
   series in infants
SO INDIAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Children; Cholestasis; Fatty liver; Hepato-cerebral form; Hypoketotic
   hypoglycemia; Infantile liver failure; Liver transplantation; Metabolic
   liver disease; Mitochondrial hepatopathy; Myopathy; Next-generation
   sequencing
ID DISEASE
AB MPV17 is a mitochondrial inner membrane protein, involved in transporting deoxynucleotides into the mitochondria. Pathogenic MPV17 mutations can cause mitochondrial deoxyribonucleic acid (DNA) depletion syndrome, which has a varied presentation with neurological, muscular and hepatic involvement. Presentation as liver failure is relatively uncommon. Here, we report four infants from four separate families with pathogenic, homozygous MPV17 mutations. All had predominant hepatic involvement with cholestasis, lactic acidosis and hypoketotic hypoglycemia. Three of them had presented with liver failure. Interestingly, one of them showed fluctuating liver functions, which worsened with infection and improved after aggressive treatment with antibiotics and supplements. Two of the four cases died in infancy, while the other two improved on conservative management with medium-chain triglyceride-based diet, vitamin supplements, co-enzyme Q and carnitine. The two surviving children are alive at 12 and 25 months of age with native liver with normal to mildly deranged liver function and no neurological dysfunction. Next-generation sequencing confirmed the diagnosis in all of our cases. One of the detected mutations, c.55delC (p.Gln19ArgfsTer3) is a novel pathogenic frameshift mutation, while another mutation c.388G>C (p.Ala130Pro), which was previously reported in Single Nucleotide Polymorphism Database in heterozygous form, is being predicted as likely pathogenic in our case series. We, therefore, propose mutation testing for MPV17 gene during evaluation of indeterminate infantile liver failure, especially those with hypoglycemia and raised plasma lactate.
C1 [Samanta, Arghya; Srivastava, Anshu; Sarma, Moinak Sen; Poddar, Ujjal] Sanjay Gandhi Postgrad Inst Med Sci, Dept Pediat Gastroenterol, Lucknow 226014, India.
   [Mandal, Kausik] Sanjay Gandhi Postgrad Inst Med Sci, Dept Med Genet, Lucknow 226014, India.
C3 Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi
   Postgraduate Institute of Medical Sciences
RP Srivastava, A (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Pediat Gastroenterol, Lucknow 226014, India.
EM avanianshu@yahoo.com
RI Mandal, Kausik/HPG-2176-2023; Sarma, Moinak/T-4846-2019
OI Samanta, arghya/0000-0002-1768-0263; sen sarma,
   moinak/0000-0003-2015-4069
CR Al-Hussaini A, 2014, J PEDIATR-US, V164, P553, DOI 10.1016/j.jpeds.2013.10.082
   Bijarnia-Mahay S, 2014, INDIAN PEDIATR, V51, P666, DOI 10.1007/s13312-014-0475-z
   El-Hattab AW, 2018, HUM MUTAT, V39, P461, DOI 10.1002/humu.23387
   Feldman AG, 2017, J PEDIATR-US, V182, P217, DOI 10.1016/j.jpeds.2016.12.031
   Kaji S, 2009, MOL GENET METAB, V97, P292, DOI 10.1016/j.ymgme.2009.04.014
   Kamate M, 2021, INDIAN J PEDIATR, V88, P377, DOI 10.1007/s12098-020-03583-7
   McKiernan P, 2016, J PEDIATR GASTR NUTR, V63, P592, DOI 10.1097/MPG.0000000000001345
   Murali CN, 2021, MOL GENET METAB, V132, P146, DOI 10.1016/j.ymgme.2021.01.005
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Shimura M, 2020, ORPHANET J RARE DIS, V15, DOI 10.1186/s13023-020-01441-5
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Zweers H, 2021, ORPHANET J RARE DIS, V16, DOI 10.1186/s13023-021-01927-w
NR 12
TC 2
Z9 2
U1 0
U2 3
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0254-8860
EI 0975-0711
J9 INDIAN J GASTROENTER
JI Indian J. Gastroenterol.
PD AUG
PY 2023
VL 42
IS 4
BP 569
EP 574
DI 10.1007/s12664-022-01281-0
EA FEB 2023
PG 6
WC Gastroenterology & Hepatology
WE Emerging Sources Citation Index (ESCI)
SC Gastroenterology & Hepatology
GA N5YQ7
UT WOS:000929364000002
PM 36753038
DA 2024-11-01
ER

PT J
AU Reeve, A
   Meagher, M
   Lax, N
   Simcox, E
   Hepplewhite, P
   Jaros, E
   Turnbull, D
AF Reeve, Amy
   Meagher, Martin
   Lax, Nichola
   Simcox, Eve
   Hepplewhite, Philippa
   Jaros, Evelyn
   Turnbull, Doug
TI The Impact of Pathogenic Mitochondrial DNA Mutations on Substantia Nigra
   Neurons
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID KEARNS-SAYRE-SYNDROME; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   POLYMERASE-GAMMA MUTATIONS; COMPLEX I DEFICIENCY; PARKINSONS-DISEASE;
   PARS COMPACTA; DOPAMINERGIC-NEURONS; CLINICAL-DISEASE; DISECTOR COUNTS;
   POLG1 MUTATIONS
AB Mitochondrial defects within substantia nigra (SN) neurons are implicated in the pathogenesis of Parkinson's disease. SN neurons show increased mitochondrial defects, mitochondrial DNA deletion levels, and susceptibility to such dysfunction, although the role of mitochondria in neuronal degeneration remains uncertain. In this study, we addressed this important question by exploring changes within the mitochondria of SN neurons from patients with primary mitochondrial diseases to determine whether mitochondrial dysfunction leads directly to neuronal cell loss. We counted the pigmented neurons and quantified mitochondrial respiratory activity, deficiencies in mitochondrial proteins, and the percentage of pathogenic mutations in single neurons. We found evidence of defects of both complex I and complex IV of the respiratory chain in all patients. We found that marked neuronal cell loss was only observed in a few patients with mitochondrial disease and that all these patients had mutations in polymerase gamma (POLG), which leads to the formation of multiple mitochondrial DNA deletions over time, similar to aging and Parkinson's disease. Interestingly, we detected alpha-synuclein pathology in two mitochondrial patients with POLG mutations. Our observations highlight the complex relationship between mitochondrial dysfunction and the susceptibility of SN neurons to degeneration and alpha-synuclein pathology. Our finding that the loss of SN neurons was only severe in patients with POLG mutations suggests that acquired mitochondrial defects may be less well tolerated by SN neurons than by inherited ones.
C1 [Reeve, Amy; Simcox, Eve; Hepplewhite, Philippa; Turnbull, Doug] Newcastle Univ, Ctr Brain Ageing & Vital, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Reeve, Amy; Meagher, Martin; Lax, Nichola; Simcox, Eve; Hepplewhite, Philippa; Turnbull, Doug] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Jaros, Evelyn] Newcastle Upon Tyne Hosp Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res Newcastle Biomed Res Ctr Agein, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Jaros, Evelyn] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle Upon
   Tyne Hospitals NHS Foundation Trust; Newcastle University - UK
RP Turnbull, D (corresponding author), Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@newcastle.ac.uk
OI Reeve, Amy/0000-0002-4474-2204; Turnbull, Doug/0000-0002-8878-9901
FU Newcastle University Centre for Brain Ageing and Vitality; Biotechnology
   and Biological Sciences Research Council; Engineering and Physical
   Sciences Research Council; Economic and Social Research Council; Medical
   Research Council [G0700718, G0400074]; The Wellcome Trust Centre for
   Mitochondrial Research [G906919]; National Institute for Health Research
   Newcastle Biomedical Research Centre in Ageing and Chronic Diseases;
   Alzheimer's Society; Alzheimer's Research Trust; Brains for Dementia
   Research Project; MRC [G0900652, G0400074, G0502157, G0700718] Funding
   Source: UKRI
FX This work was supported by the Newcastle University Centre for Brain
   Ageing and Vitality (supported by the Biotechnology and Biological
   Sciences Research Council, Engineering and Physical Sciences Research
   Council, Economic and Social Research Council and Medical Research
   Council Grant #G0700718), The Wellcome Trust Centre for Mitochondrial
   Research (Grant #G906919), and the National Institute for Health
   Research Newcastle Biomedical Research Centre in Ageing and Chronic
   Diseases (award to the Newcastle upon Tyne Hospitals National Health
   Service Foundation Trust). Tissue for this study was provided by the
   Newcastle Brain Tissue Resource, which is funded by the Medical Research
   Council (Grant #G0400074), and the Alzheimer's Society and Alzheimer's
   Research Trust as part of the Brains for Dementia Research Project.
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   Abramov AY, 2010, BRAIN, V133, P797, DOI 10.1093/brain/awq015
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546
   Celotto AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025823
   Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865
   Chan CS, 2009, TRENDS NEUROSCI, V32, P249, DOI 10.1016/j.tins.2009.01.006
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Elstner M, 2011, ACTA NEUROPATHOL, V122, P75, DOI 10.1007/s00401-011-0828-9
   FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   MA SY, 1995, NEUROPATH APPL NEURO, V21, P341, DOI 10.1111/j.1365-2990.1995.tb01068.x
   MA SY, 1995, NEUROPATH APPL NEURO, V21, P10, DOI 10.1111/j.1365-2990.1995.tb01023.x
   Mahad DJ, 2009, J NEUROSCI METH, V184, P310, DOI 10.1016/j.jneumeth.2009.08.020
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mandel S, 2005, ANN NY ACAD SCI, V1053, P356, DOI 10.1196/annals.1344.031
   Mitsumoto A, 2001, FREE RADICAL RES, V35, P885, DOI 10.1080/10715760100301381
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561
   Parihar MS, 2008, CELL MOL LIFE SCI, V65, P1272, DOI 10.1007/s00018-008-7589-1
   Reeve AK, 2012, ARCH NEUROL-CHICAGO, V69, P385, DOI 10.1001/archneurol.2011.2675
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Sato K, 2011, J NEUROL, V258, P1327, DOI 10.1007/s00415-011-5936-x
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schapira AHV, 2007, CELL DEATH DIFFER, V14, P1261, DOI 10.1038/sj.cdd.4402160
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Surmeier DJ, 2011, NEUROSCIENCE, V198, P221, DOI 10.1016/j.neuroscience.2011.08.045
   Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Tanji K, 1999, ANN NEUROL, V45, P377, DOI 10.1002/1531-8249(199903)45:3<377::AID-ANA14>3.0.CO;2-M
   Tanji K, 1999, J NEUROL SCI, V166, P64, DOI 10.1016/S0022-510X(99)00114-8
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Vives-Bauza C, 2011, TRENDS MOL MED, V17, P158, DOI 10.1016/j.molmed.2010.11.002
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
   Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195
NR 56
TC 74
Z9 79
U1 0
U2 14
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD JUN 26
PY 2013
VL 33
IS 26
BP 10790
EP 10801
DI 10.1523/JNEUROSCI.3525-12.2013
PG 12
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 171LE
UT WOS:000320928900022
PM 23804100
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Handzel, O
   Ungar, OJ
   Lee, DJ
   Nadol, JB
AF Handzel, Ophir
   Ungar, Omer J.
   Lee, Dan J.
   Nadol, Joseph B., Jr.
TI Temporal bone histopathology in MELAS syndrome
SO LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY
LA English
DT Article
DE genetics; MELAS syndrome; otology; otopathology; sensorineural hearing
   loss
ID PROFOUNDLY DEAF PATIENT; COCHLEAR IMPLANTATION; MITOCHONDRIAL-DNA
AB Objectives Describe the histopathology of the temporal bones in MELAS (myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) syndrome. The syndrome results from a known point mutation in mitochondrial DNA. Methods Histopathology analysis of a pair of temporal bones from the oldest surviving MELAS syndrome temporal bone donor. Histopathologic findings were correlated with known premortem clinical data. Results The inner ears showed severe but incomplete atrophy of the stria vascularis for the length of the cochleae. In contrast, the organ of Corti and inner hair cells appeared intact with some loss of outer hair cells. Other than moderate loss at the basal turn, spiral ganglion cells numbers were normal. The vestibular neuroepithelium was mostly normal with the exception of moderate degeneration of the macula sacculi and partial collapse of the saccular wall on the right. The cerebral cortex had infarct-like lesions with adjacent gliosis. Conclusion This is an analysis of the oldest patient with MELAS syndrome to date, an addition to only two previously published patients. It supports the notion that hearing loss is a result of dysfunction of the stria vascularis and not loss of hair cells or neurons. Patterns of vestibular pathology are in agreement to in-vivo measurements. These findings support auditory rehabilitation with cochlear implants and may be relevant to hearing loss due to other mitochondrial mutations. Level of evidence 4
C1 [Handzel, Ophir] Tel Aviv Univ, Dept Otolaryngol Head Neck & Maxillofacial Surg, Cochlear Implant Ctr, Tel Aviv Sourasky Med Ctr,Sackler Fac Med, Tel Aviv, Israel.
   [Ungar, Omer J.] Tel Aviv Univ, Dept Otolaryngol Head Neck & Maxillofacial Surg, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Tel Aviv, Israel.
   [Lee, Dan J.; Nadol, Joseph B., Jr.] Harvard Med Sch, Dept Otolaryngol Head & Neck Surg, Otopathol Lab, Massachusetts Eye & Ear, Boston, MA 02115 USA.
C3 Tel Aviv University; Tel Aviv Sourasky Medical Center; Tel Aviv
   University; Tel Aviv Sourasky Medical Center; Harvard University;
   Harvard Medical School; Massachusetts Eye & Ear Infirmary
RP Handzel, O (corresponding author), Tel Aviv Univ, Dept Otolaryngol Head & Neck & Maxillofacial Surg, Tel Aviv Sourasky Med Ctr, Cochlear Implant Program,Sackler Fac Med, 6 Weizmann St, IL-6423906 Tel Aviv, Israel.
EM ophir.handzel@ozen.co.il
RI Handzel, Ophir/D-8236-2017; Ungar, Omer Jacob/V-1157-2019
OI Handzel, Ophir/0000-0002-6905-3034; Ungar, Omer
   Jacob/0000-0002-5904-1291
FU Margaret and Leo Meyer and Hans M. Hirsch Foundation
FX Margaret and Leo Meyer and Hans M. Hirsch Foundation
CR Corrado A, 2014, GENETIC NEUROMUSCULA, P233
   Di Stadio A, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0770-1
   Hill D, 2001, J NEUROL NEUROSUR PS, V71, P281, DOI 10.1136/jnnp.71.2.281
   Karkos PD, 2005, EUR ARCH OTO-RHINO-L, V262, P322, DOI 10.1007/s00405-004-0817-x
   Koda H, 2010, ACTA OTO-LARYNGOL, V130, P344, DOI [10.1080/00016480903148282, 10.3109/00016480903148282]
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   Merchant SN, 2010, SCHUKNECHTS PATHOLOG, V3e, P29
   Nadol JB, 2001, INT J PEDIATR OTORHI, V61, P1, DOI 10.1016/S0165-5876(01)00546-8
   Rosenthal EL, 1999, AM J OTOL, V20, P187
   Scaglia F., 2017, J. Inborn. Errors. Metab. Screen, V5, DOI 10.1177/
   Scarpelli M, 2012, GENET RES INT, V2012, DOI 10.1155/2012/287432
   Sinnathuray AR, 2002, J NEUROL NEUROSUR PS, V73, P97, DOI 10.1136/jnnp.73.1.97
   Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010
   Takahashi K, 2003, LARYNGOSCOPE, V113, P1362, DOI 10.1097/00005537-200308000-00018
   van der Wijst MGP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00263-z
   Vandana VP, 2016, CLIN NEUROL NEUROSUR, V148, P17, DOI 10.1016/j.clineuro.2016.04.024
NR 16
TC 6
Z9 6
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2378-8038
J9 LARYNGOSCOPE INVEST
JI Laryngoscope Investig. Otol.
PD FEB
PY 2020
VL 5
IS 1
BP 152
EP 156
DI 10.1002/lio2.344
EA JAN 2020
PG 5
WC Otorhinolaryngology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Otorhinolaryngology
GA KO9AG
UT WOS:000505883100001
PM 32128442
OA gold, Green Published
DA 2024-11-01
ER

PT S
AU Saneto, RP
AF Saneto, Russell P.
BE Friedmann, T
   Dunlap, JC
   Goodwin, SF
TI Genetics of Mitochondrial Disease
SO ADVANCES IN GENETICS, VOL 98
SE Advances in Genetics
LA English
DT Review; Book Chapter
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HEREDITARY OPTIC NEUROPATHY;
   IMPAIR MTDNA REPLICATION; KEARNS-SAYRE SYNDROME; LOSS-OF-FUNCTION;
   CLINICAL-FEATURES; MUTATIONS CAUSE; INTRAMITOCHONDRIAL FIBERS; SEVERE
   HYPERMETABOLISM; DNA CHARACTERISTICS
AB Mitochondria are intracellular organelles responsible for adenosine triphosphate production. The strict control of intracellular energy needs require proper mitochondrial functioning. The mitochondria are under dual controls of mitochondrial DNA (mtDNA) and nuclear DNA (nDNA). Mitochondrial dysfunction can arise from changes in either mtDNA or nDNA genes regulating function. There are an estimated similar to 1500 proteins in the mitoproteome, whereas the mtDNA genome has 37 proteins. There are, to date, similar to 275 genes shown to give rise to disease. The unique physiology of mitochondrial functioning contributes to diverse gene expression. The onset and range of phenotypic expression of disease is diverse, with onset from neonatal to seventh decade of life. The range of dysfunction is heterogeneous, ranging from single organ to multisystem involvement. The complexity of disease expression has severely limited gene discovery. Combining phenotypes with improvements in gene sequencing strategies are improving the diagnosis process. This chapter focuses on the interplay of the unique physiology and gene discovery in the current knowledge of genetically derived mitochondrial disease.
C1 [Saneto, Russell P.] Univ Washington, Seattle Childrens Hosp, Seattle, WA 98195 USA.
C3 University of Washington; University of Washington Seattle; Seattle
   Children's Hospital
RP Saneto, RP (corresponding author), Univ Washington, Seattle Childrens Hosp, Seattle, WA 98195 USA.
EM russ.saneto@seattlechildrens.org
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Boczonadi V, 2015, J INHERIT METAB DIS, V38, P427, DOI 10.1007/s10545-014-9784-6
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Bratic A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006028
   Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026
   Cai W, 2008, J GENET GENOMICS, V35, P649, DOI 10.1016/S1673-8527(08)60086-7
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Cao LQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000756
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375
   Carrozzo R, 2016, J INHERIT METAB DIS, V39, P243, DOI 10.1007/s10545-015-9894-9
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430
   Christian B, 2009, MOL CELL, V35, P400, DOI 10.1016/j.molcel.2009.08.003
   CLARK DS, 1975, CHEST, V68, P727, DOI 10.1378/chest.68.5.727
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Crosby AH, 2010, AM J HUM GENET, V87, P655, DOI 10.1016/j.ajhg.2010.09.013
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Desbats MA, 2015, J INHERIT METAB DIS, V38, P145, DOI 10.1007/s10545-014-9749-9
   Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004
   DIMAURO S, 1976, J NEUROL SCI, V27, P217, DOI 10.1016/0022-510X(76)90063-0
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   DiMauro S. H. M., 2015, GENEREVIEWS
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Ding Y, 2013, BIOCHEM GENET, V51, P588, DOI 10.1007/s10528-013-9589-6
   Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x
   DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Falk MJ, 2015, MOL GENET METAB, V114, P388, DOI 10.1016/j.ymgme.2014.11.016
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Farge G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2001
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Fernández-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   GALLASTEGUI J, 1987, AM J CARDIOL, V60, P385, DOI 10.1016/0002-9149(87)90255-4
   Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Giordano L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.364
   Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   Groto Y., 1990, NATURE, V348, P651
   Guda Purnima, 2007, Genomics Proteomics & Bioinformatics, V5, P166, DOI 10.1016/S1672-0229(08)60004-2
   Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   HAYDAR NA, 1971, ANN INTERN MED, V74, P548, DOI 10.7326/0003-4819-74-4-548
   Hirano M, 2005, GENE, V354, P152, DOI 10.1016/j.gene.2005.04.041
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hirano M., 1996, Handbook of Muscle Disease, P479
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horvath R, 2012, J INHERIT METAB DIS, V35, P679, DOI 10.1007/s10545-011-9434-1
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Janer A, 2012, AM J HUM GENET, V91, P737, DOI 10.1016/j.ajhg.2012.08.020
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   KASAMATSU H, 1974, ANNU REV BIOCHEM, V43, P695, DOI 10.1146/annurev.bi.43.070174.003403
   KAWAI H, 1995, MUSCLE NERVE, V18, P753, DOI 10.1002/mus.880180712
   Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   KOEHLER CM, 1991, GENETICS, V129, P247
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743
   Koopman WJH, 2016, EMBO MOL MED, V8, P311, DOI 10.15252/emmm.201506131
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X
   Lehmann D, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000113
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   MACREADIE IG, 1983, NUCLEIC ACIDS RES, V11, P4435, DOI 10.1093/nar/11.13.4435
   Mai N, 2017, CELL TISSUE RES, V367, P5, DOI 10.1007/s00441-016-2456-0
   Majamaa P. G., 2012, COCHRANE LIB
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Mayr JA, 2014, J INHERIT METAB DIS, V37, P553, DOI 10.1007/s10545-014-9705-8
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   McKelvie P, 2012, J CLIN NEUROSCI, V19, P195, DOI 10.1016/j.jocn.2011.09.009
   Menezes MJ, 2015, HUM MOL GENET, V24, P2297, DOI 10.1093/hmg/ddu747
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Milone M, 2012, NEUROLOGY, V78, P1612, DOI 10.1212/WNL.0b013e3182563c46
   Minczuk M, 2011, NUCLEIC ACIDS RES, V39, P4284, DOI 10.1093/nar/gkq1224
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Mordaunt DA, 2015, AM J MED GENET A, V167, P1330, DOI 10.1002/ajmg.a.36968
   Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   NASS S, 1963, J CELL BIOL, V19, P613, DOI 10.1083/jcb.19.3.613
   Ng YS, 2016, J MED GENET, V53, P768, DOI 10.1136/jmedgenet-2016-103910
   Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003
   OBRIEN TW, 1971, J BIOL CHEM, V246, P3409
   Ojala D., 1981, NATURE, V290, P246
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334
   Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pierson TM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002325
   Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105
   Posse V, 2014, NUCLEIC ACIDS RES, V42, P3638, DOI 10.1093/nar/gkt1397
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Renaldo F, 2012, BRAIN, V135, DOI 10.1093/brain/aws111
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Richter-Dennerlein R, 2014, CELL METAB, V20, P158, DOI 10.1016/j.cmet.2014.04.016
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P5787, DOI 10.1093/nar/gkn576
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176
   Sadikovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015687
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014
   Shahni R, 2015, BRAIN, V138, P2834, DOI 10.1093/brain/awv182
   Shamseldin HE, 2012, J MED GENET, V49, P234, DOI 10.1136/jmedgenet-2012-100836
   SHAPIRA Y, 1977, ISRAEL J MED SCI, V13, P161
   SHOFFNER JM, 1995, ANN NEUROL, V38, P163, DOI 10.1002/ana.410380207
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SHY GM, 1966, BRAIN, V89, P133, DOI 10.1093/brain/89.1.133
   SHY GM, 1964, SCIENCE, V145, P493, DOI 10.1126/science.145.3631.493
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Smits P, 2011, EUR J HUM GENET, V19, P394, DOI 10.1038/ejhg.2010.214
   Sofou K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-52
   Soleimanpour-Lichaei HR, 2007, MOL CELL, V27, P745, DOI 10.1016/j.molcel.2007.06.031
   Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spiegel R, 2011, J MED GENET, V48, P177, DOI 10.1136/jmg.2010.084608
   Spiegel R, 2009, ANN NEUROL, V66, P419, DOI 10.1002/ana.21752
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   SPIRO AJ, 1970, ARCH NEUROL-CHICAGO, V23, P103, DOI 10.1001/archneur.1970.00480260009002
   Stehling O, 2014, BIOCHIMIE, V100, P61, DOI 10.1016/j.biochi.2014.01.010
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Swalwell H., 2011, EUROPEAN J HUMAN GEN, V19, P169
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   Tamiya G, 2014, AM J HUM GENET, V95, P294, DOI 10.1016/j.ajhg.2014.07.013
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Tchikviladze M, 2015, J NEUROL NEUROSUR PS, V86, P646, DOI 10.1136/jnnp-2013-306799
   Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Timmers HJLM, 2009, ENDOCR-RELAT CANCER, V16, P391, DOI 10.1677/ERC-08-0284
   Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923
   Trevisson E, 2011, CURR OPIN NEUROL, V24, P449, DOI 10.1097/WCO.0b013e32834ab528
   Tsuboi M, 2009, MOL CELL, V35, P502, DOI 10.1016/j.molcel.2009.06.028
   Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wallace D.C., 2001, The Metabolic and Molecular Basis of Inherited Disease, P2425
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Watanabe K, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/623095
   Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436
   Wedatilake Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-96
   WILLEMS JL, 1977, PEDIATRICS, V60, P850
   Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2016, MITOCHONDRIAL CASE S, P55
   Zhang YL, 1998, BBA-GENE STRUCT EXPR, V1443, P245, DOI 10.1016/S0167-4781(98)00223-1
   Zhou QH, 2016, SCIENCE, V353, P394, DOI 10.1126/science.aaf4777
NR 218
TC 14
Z9 16
U1 0
U2 5
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0065-2660
BN 978-0-12-812280-8
J9 ADV GENET
JI Adv. Genet.
PY 2017
VL 98
BP 63
EP 116
DI 10.1016/bs.adgen.2017.06.002
PG 54
WC Genetics & Heredity
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA BI7LS
UT WOS:000414415300003
PM 28942795
DA 2024-11-01
ER

PT J
AU Cadalbert, LC
   Ghaffar, FN
   Stevenson, D
   Bryson, S
   Vaz, FM
   Gottlieb, E
   Strathdee, D
AF Cadalbert, Laurence C.
   Ghaffar, Farah Naz
   Stevenson, David
   Bryson, Sheila
   Vaz, Frederic M.
   Gottlieb, Eyal
   Strathdee, Douglas
TI Mouse Tafazzin Is Required for Male Germ Cell Meiosis and
   Spermatogenesis
SO PLOS ONE
LA English
DT Article
ID BARTH-SYNDROME; PIRNA BIOGENESIS; MITOCHONDRIAL DYNAMICS; NUAGE
   FORMATION; EXPRESSION; MICE; GENE; CARDIOLIPIN; MODEL; MITOPLD
AB Barth syndrome is an X-linked mitochondrial disease, symptoms of which include neutropenia and cardiac myopathy. These symptoms are the most significant clinical consequences of a disease, which is increasingly recognised to have a variable presentation. Mutation in the Taz gene in Xq28 is thought to be responsible for the condition, by altering mitochondrial lipid content and mitochondrial function. Male chimeras carrying a targeted mutation of Taz on their X-chromosome were infertile. Testes from the Taz knockout chimeras were smaller than their control counterparts and this was associated with a disruption of the progression of spermatocytes through meiosis to spermiogenesis. Taz knockout ES cells also showed a defect when differentiated to germ cells in vitro. Mutant spermatocytes failed to progress past the pachytene stage of meiosis and had higher levels of DNA double strand damage and increased levels of endogenous retrotransposon activity. Altogether these data revealed a novel role for Taz in helping to maintain genome integrity in meiosis and facilitating germ cell differentiation. We have unravelled a novel function for the Taz protein, which should contribute to an understanding of how a disruption of the Taz gene results in the complex symptoms underlying Barth Syndrome.
C1 [Cadalbert, Laurence C.; Ghaffar, Farah Naz; Stevenson, David; Bryson, Sheila; Strathdee, Douglas] Canc Res UK Beatson Inst, Transgen Technol Lab, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.
   [Gottlieb, Eyal] Canc Res UK Beatson Inst, Cell Death & Metab Lab, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.
   [Vaz, Frederic M.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands.
C3 Beatson Institute; Beatson Institute; University of Amsterdam; Academic
   Medical Center Amsterdam
RP Strathdee, D (corresponding author), Canc Res UK Beatson Inst, Transgen Technol Lab, Garscube Estate, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.
EM d.strathdee@beatson.gla.ac.uk
RI Vaz, Frederic/JJE-4884-2023; Gottlieb, Eyal/G-6450-2010
OI Vaz, Frederic/0000-0002-9048-1041; Stevenson, David/0000-0001-9117-138X;
   Gilbey, Thomas/0000-0001-5677-3318; Gottlieb, Eyal/0000-0002-9770-0956;
   Cadalbert, Laurence/0000-0003-1333-2146; Ghaffar,
   Farah/0000-0001-6131-2604
FU Cancer Research UK; Barth Syndrome Foundation; Barth Syndrome Trust
FX This work was supported by funding from Cancer Research UK
   (www.cancerresearchuk.org) and a grant from the Barth Syndrome
   Foundation (www.barthsyndrome.org) and the Barth Syndrome Trust
   (www.barthsyndrome.org.uk). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439
   Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764
   Baba T, 2014, J BIOL CHEM, V289, P11497, DOI 10.1074/jbc.M113.531921
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200
   Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385
   Cadalbert L, 2005, CELL SIGNAL, V17, P1254, DOI 10.1016/j.cellsig.2005.01.003
   Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001
   Castañeda J, 2014, EMBO J, V33, P1999, DOI 10.15252/embj.201386855
   Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23
   Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X
   Dudek J, 2013, STEM CELL RES, V11, P806, DOI 10.1016/j.scr.2013.05.005
   Gao Q, 2012, BMB REP, V45, P7, DOI 10.5483/BMBRep.2012.45.1.7
   Gonzalez IL, 2005, AM J MED GENET A, V134A, P409, DOI 10.1002/ajmg.a.30661
   Ha H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-545
   Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009
   Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032
   Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004
   Huhta J, 2013, SEMIN FETAL NEONAT M, V18, P245, DOI 10.1016/j.siny.2013.05.003
   Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502
   Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831
   Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562
   Khuchua Z, 2006, CIRC RES, V99, P201, DOI 10.1161/01.RES.0000233378.95325.ce
   Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728
   Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973
   Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011
   Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203
   Lucchinetti E, 2006, PHYSIOL GENOMICS, V25, P314, DOI 10.1152/physiolgenomics.00251.2005
   Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106
   McEwan C, 2003, TRANSGENIC RES, V12, P519, DOI 10.1023/A:1024273324890
   Neuwald AF, 1997, CURR BIOL, V7, pR465
   Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509
   Phoon CKL, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000455
   Powers C, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00074
   Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057
   Rao DD, 2009, CANCER GENE THER, V16, P807, DOI 10.1038/cgt.2009.53
   Reynolds N, 2005, REPROD BIOMED ONLINE, V10, P72, DOI 10.1016/S1472-6483(10)60806-1
   Saxena A, 2012, DIS MARKERS, V33, P261, DOI [10.1155/2012/396737, 10.3233/DMA-2012-0932]
   Schachtner H, 2012, EUR J CELL BIOL, V91, P923, DOI 10.1016/j.ejcb.2012.04.002
   Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007
   Schlame M, 2012, NAT CHEM BIOL, V8, P862, DOI 10.1038/NCHEMBIO.1064
   Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004
   SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756
   Shidoji Y, 1999, BIOCHEM BIOPH RES CO, V264, P343, DOI 10.1006/bbrc.1999.1410
   Shiromoto Y, 2013, RNA, V19, P803, DOI 10.1261/rna.038521.113
   Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012
   Singh DK, 2012, RNA BIOL, V9, P1380, DOI 10.4161/rna.22402
   Singh S, 2011, PHARM RES-DORDR, V28, P2996, DOI 10.1007/s11095-011-0608-1
   Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015
   Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007
   Soustek MS, 2011, HUM GENE THER, V22, P865, DOI 10.1089/hum.2010.199
   St Laurent G, 2010, MECH AGEING DEV, V131, P299, DOI 10.1016/j.mad.2010.03.008
   van der Weyden L, 2005, GENESIS, V41, P171, DOI 10.1002/gene.20111
   Vangompel Michael J W, 2011, Spermatogenesis, V1, P36
   Vinet L, 2008, AM J PHYSIOL-HEART C, V295, pH352, DOI 10.1152/ajpheart.01101.2007
   Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005
   Whited K, 2013, HUM MOL GENET, V22, P483, DOI 10.1093/hmg/dds447
   Xu MG, 2008, BIOL REPROD, V79, P51, DOI 10.1095/biolreprod.108.068072
   Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103
   Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200
   Yang XSW-X, 2010, ADV BIOSCIENCE BIOTE, V1, P97
   Yin DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027154
NR 62
TC 14
Z9 18
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 26
PY 2015
VL 10
IS 6
AR e0131066
DI 10.1371/journal.pone.0131066
PG 22
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CN1AM
UT WOS:000358147500124
PM 26114544
OA Green Published, gold, Green Accepted, Green Submitted
DA 2024-11-01
ER

PT J
AU Martin, FM
   Xu, XL
   von Löhneysen, K
   Gilmartin, TJ
   Friedman, JS
AF Martin, Florent M.
   Xu, Xiuling
   von Loehneysen, Katharina
   Gilmartin, Timothy J.
   Friedman, Jeffrey S.
TI SOD2 Deficient Erythroid Cells Up-Regulate Transferrin Receptor and
   Down-Regulate Mitochondrial Biogenesis and Metabolism
SO PLOS ONE
LA English
DT Article
ID LINKED SIDEROBLASTIC ANEMIA; MISSENSE MUTATION; DNA MUTATIONS;
   GENE-ONTOLOGY; PROTEIN CIA1; EXPRESSION; MYOPATHY; PATIENT; RNA;
   ERYTHROPOIESIS
AB Background: Mice irradiated and reconstituted with hematopoietic cells lacking manganese superoxide dismutase (SOD2) show a persistent hemolytic anemia similar to human sideroblastic anemia (SA), including characteristic intra-mitochondrial iron deposition. SA is primarily an acquired, clonal marrow disorder occurring in individuals over 60 years of age with uncertain etiology.
   Methodology/Principal Findings: To define early events in the pathogenesis of this murine model of SA, we compared erythroid differentiation of Sod2(-/-) and normal bone marrow cells using flow cytometry and gene expression profiling of erythroblasts. The predominant transcriptional differences observed include widespread down-regulation of mitochondrial metabolic pathways and mitochondrial biogenesis. Multiple nuclear encoded subunits of complexes I-IV of the electron transport chain, ATP synthase (complex V), TCA cycle and mitochondrial ribosomal proteins were coordinately downregulated in Sod2(-/-) erythroblasts. Despite iron accumulation within mitochondria, we found increased expression of transferrin receptor, Tfrc, at both the transcript and protein level in SOD2 deficient cells, suggesting deregulation of iron delivery. Interestingly, there was decreased expression of ABCb7, the gene responsible for X-linked hereditary SA with ataxia, a component required for iron-sulfur cluster biogenesis.
   Conclusions/Significance: These results indicate that in erythroblasts, mitochondrial oxidative stress reduces expression of multiple nuclear genes encoding components of the respiratory chain, TCA cycle and mitochondrial protein synthesis. An additional target of particular relevance for SA is iron: sulfur cluster biosynthesis. By decreasing transcription of components of cluster synthesis machinery, both iron utilization and regulation of iron uptake are impacted, contributing to the sideroblastic phenotype.
C1 [Martin, Florent M.; Xu, Xiuling; von Loehneysen, Katharina; Friedman, Jeffrey S.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.
   [Gilmartin, Timothy J.] Scripps Res Inst, DNA Array Core Facil, La Jolla, CA 92037 USA.
C3 Scripps Research Institute; Scripps Research Institute
RP Martin, FM (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.
EM friedman@scripps.edu
FU NIH, NIDDK [R21DK075063, R01DK062473]
FX Sources of support for this work were NIH grants R21DK075063 and
   R01DK062473 from the NIDDK. The website for the NIDDK is
   http://www2.niddk.nih.gov/. The funders had no role in study design,
   data collection and analysis, decision to publish or preparation of the
   this manuscript.
CR Alcindor T, 2002, BRIT J HAEMATOL, V116, P733, DOI 10.1046/j.0007-1048.2002.03378.x
   Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743
   Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005
   BECK EA, 1967, ACTA HAEMATOL-BASEL, V38, P1
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   BERGMANN AK, 2009, PEDIAT BLOOD CANC
   Bottomley Sylvia S, 2006, Curr Hematol Rep, V5, P41
   Boultwood J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001970
   Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Bykhovskaya Y, 2007, MOL GENET METAB, V91, P148, DOI 10.1016/j.ymgme.2007.02.006
   Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520
   COTTER PD, 1994, BLOOD, V84, P3915, DOI 10.1182/blood.V84.11.3915.bloodjournal84113915
   Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7
   Fleming MD, 2002, SEMIN HEMATOL, V39, P270, DOI 10.1053/shem.2002.35637
   Friedman JS, 2004, BLOOD, V104, P2565, DOI 10.1182/blood-2003-11-3858
   Friedman JS, 2001, J EXP MED, V193, P925, DOI 10.1084/jem.193.8.925
   Gattermann N, 2000, LEUKEMIA RES, V24, P141, DOI 10.1016/S0145-2126(99)00160-5
   Gattermann N, 2004, BLOOD, V103, P1499, DOI 10.1182/blood-2003-07-2446
   Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972
   Gattermann N, 1996, BRIT J HAEMATOL, V93, P845, DOI 10.1046/j.1365-2141.1996.d01-1724.x
   Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359
   HENTZE MW, 1987, P NATL ACAD SCI USA, V84, P6730, DOI 10.1073/pnas.84.19.6730
   HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710
   KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675
   Martin FM, 2006, ANTIOXID REDOX SIGN, V8, P1217, DOI 10.1089/ars.2006.8.1217
   Martin FM, 2005, EXP HEMATOL, V33, P1493, DOI 10.1016/j.exphem.2005.08.009
   MARTIN FM, 2008, BRIT J HAEM IN PRESS
   MAY A, 1994, BAILLIERE CLIN HAEM, V7, P851, DOI 10.1016/S0950-3536(05)80128-3
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807
   Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   SHARP RA, 1990, BRIT J CLIN PRACT, V44, P706
   Shin MG, 2003, BLOOD, V101, P3118, DOI 10.1182/blood-2002-06-1825
   Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261
   Spiegelman B.M., 2007, Novartis Found Symp, V287, P60, DOI [10.1002/9780470725207.ch5, DOI 10.1002/9780470725207.CH5]
   Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60
   Srinivasan V, 2007, STRUCTURE, V15, P1246, DOI 10.1016/j.str.2007.08.009
   Wallace D C, 2001, Novartis Found Symp, V235, P247
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang YL, 1999, AM J HEMATOL, V60, P83, DOI 10.1002/(SICI)1096-8652(199901)60:1<83::AID-AJH19>3.0.CO;2-N
   YUNIS AA, 1980, CLIN HAEMATOL, V9, P607
   Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479
NR 52
TC 15
Z9 15
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 4
PY 2011
VL 6
IS 2
AR e16894
DI 10.1371/journal.pone.0016894
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 717IN
UT WOS:000287037000030
PM 21326867
OA Green Submitted, gold, Green Published
DA 2024-11-01
ER

PT J
AU Gill, EL
   Wang, J
   Viaene, AN
   Master, SR
   Ganetzky, RD
AF Gill, Emily L.
   Wang, Jing
   Viaene, Angela N.
   Master, Stephen R.
   Ganetzky, Rebecca D.
TI Methodologies in Mitochondrial Testing: Diagnosing a Primary
   Mitochondrial Respiratory Chain Disorder
SO CLINICAL CHEMISTRY
LA English
DT Review
ID SKELETAL-MUSCLE; 3-METHYLGLUTACONIC ACIDURIA; COENZYME Q(10); DISEASE;
   MUTATIONS; DEHYDROGENASE; MAINTENANCE; DYSFUNCTION; DEFICIENCY;
   BIOMARKER
AB Background Mitochondria are cytosolic organelles within most eukaryotic cells. Mitochondria generate the majority of cellular energy in the form of adenosine triphosphate (ATP) through oxidative phosphorylation (OxPhos). Pathogenic variants in mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) lead to defects in OxPhos and physiological malfunctions (Nat Rev Dis Primer 2016;2:16080.). Patients with primary mitochondrial disorders (PMD) experience heterogeneous symptoms, typically in multiple organ systems, depending on the tissues affected by mitochondrial dysfunction. Because of this heterogeneity, clinical diagnosis is challenging (Annu Rev Genomics Hum Genet 2017;18:257-75.). Laboratory diagnosis of mitochondrial disease depends on a multipronged analysis that can include biochemical, histopathologic, and genetic testing. Each of these modalities has complementary strengths and limitations in diagnostic utility. Content The primary focus of this review is on diagnosis and testing strategies for primary mitochondrial diseases. We review tissue samples utilized for testing, metabolic signatures, histologic findings, and molecular testing approaches. We conclude with future perspectives on mitochondrial testing. This review offers an overview of the current biochemical, histologic, and genetic approaches available for mitochondrial testing. For each we review their diagnostic utility including complementary strengths and weaknesses. We identify gaps in current testing and possible future avenues for test development.
C1 [Gill, Emily L.; Wang, Jing; Viaene, Angela N.; Master, Stephen R.; Ganetzky, Rebecca D.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA USA.
   [Gill, Emily L.; Viaene, Angela N.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA.
   [Ganetzky, Rebecca D.] Childrens Hosp Philadelphia, Mitochondrial Med Frontier Program, Div Human Genet, Philadelphia, PA USA.
   [Ganetzky, Rebecca D.] Univ Penn, Dept Pediat, Philadelphia, PA USA.
   [Ganetzky, Rebecca D.] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of
   Philadelphia; University of Pennsylvania; University of Pennsylvania;
   Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of
   Pennsylvania; University of Pennsylvania; Pennsylvania Medicine;
   Childrens Hospital of Philadelphia
RP Ganetzky, RD (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.
EM ganetzkyr@chop.edu
OI Gill, Emily/0000-0002-6562-3001; Master, Stephen/0000-0002-6808-631X
FU NIDDK; NIH
FX R.D. Ganetzky, salary support from NIDDK; S.R. Master, NIH.
CR Abela L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176363
   Alston CL, 2021, J PATHOL, V254, P430, DOI 10.1002/path.5641
   Andersen LW, 2013, MAYO CLIN PROC, V88, P1127, DOI 10.1016/j.mayocp.2013.06.012
   Arias A, 2012, J CHROMATOGR B, V908, P23, DOI 10.1016/j.jchromb.2012.09.027
   Baker PR, 2014, BRAIN, V137, P366, DOI 10.1093/brain/awt328
   Barshop BA, 2004, MITOCHONDRION, V4, P521, DOI 10.1016/j.mito.2004.07.010
   Bedoyan Jirair K, 2020, JIMD Rep, V56, P70, DOI 10.1002/jmd2.12153
   Bedoyan JK, 2017, MOL GENET METAB, V120, P342, DOI 10.1016/j.ymgme.2017.02.002
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Broberg K, 2021, BIOESSAYS, V43, DOI 10.1002/bies.202000299
   Buján N, 2014, J INHERIT METAB DIS, V37, P53, DOI 10.1007/s10545-013-9620-4
   Charles-Schoeman C, 2012, J RHEUMATOL, V39, P94, DOI 10.3899/jrheum.110739
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Davis RL, 2022, NEUROLOGY, V99, pE730, DOI 10.1212/WNL.0000000000200745
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Djafarzadeh S, 2017, JOVE-J VIS EXP, DOI 10.3791/54985
   El-Hattab AW, 2017, GENEREVIEWS
   Enns GM, 2017, J CLIN MED, V6, DOI 10.3390/jcm6050050
   Esterhuizen K, 2017, MITOCHONDRION, V35, P97, DOI 10.1016/j.mito.2017.05.012
   Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x
   Forny P, 2021, NEUROL-GENET, V7, DOI 10.1212/NXG.0000000000000597
   Frazier AE, 2020, METHOD CELL BIOL, V155, P121, DOI 10.1016/bs.mcb.2019.11.007
   Ganetzky R, 2019, GENEREVIEWS, P1993
   GOMORI G, 1950, AM J CLIN PATHOL, V20, P661, DOI 10.1093/ajcp/20.7_ts.661
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grier J, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000230
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   He M, 2007, AM J HUM GENET, V81, P87, DOI 10.1086/519219
   HORAK V, 1983, HISTOCHEMISTRY, V78, P545, DOI 10.1007/BF00496207
   Hu QX, 2021, CELL REP METHODS, V1, DOI 10.1016/j.crmeth.2021.100116
   Imasawa T, 2022, KIDNEY INT REP, V7, P580, DOI 10.1016/j.ekir.2021.12.028
   Jarreta D, 2000, CARDIOVASC RES, V45, P860, DOI 10.1016/S0008-6363(99)00388-0
   KOWALOFF EM, 1977, P NATL ACAD SCI USA, V74, P5368, DOI 10.1073/pnas.74.12.5368
   Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lu WY, 2018, ANTIOXID REDOX SIGN, V28, P167, DOI 10.1089/ars.2017.7014
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   Marin-Garcia J, 1999, PEDIATRICS, V103, P456, DOI 10.1542/peds.103.2.456
   Montero R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148709
   Moore T, 2013, J CHROMATOGR B, V929, P51, DOI 10.1016/j.jchromb.2013.04.004
   Morovat A, 2017, J CLIN MED, V6, DOI 10.3390/jcm6080080
   Mudhar HS, 2001, J CLIN PATHOL, V54, P321, DOI 10.1136/jcp.54.4.321
   MUNNICH A, 1992, J INHERIT METAB DIS, V15, P448, DOI 10.1007/BF01799603
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Neergheen Viruna, 2017, J. inborn errors metab. screen., V5, pe160063
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Oglesbee D, 2006, PEDIATR NEUROL, V35, P289, DOI 10.1016/j.pediatrneurol.2006.05.007
   Pajares S, 2013, MOL GENET METAB, V108, P119, DOI 10.1016/j.ymgme.2012.11.283
   Panetta J, 2005, NEUROPEDIATRICS, V36, P256, DOI 10.1055/s-2005-865866
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Peretz RH, 2021, MOL GENET METAB, V134, P37, DOI 10.1016/j.ymgme.2021.06.007
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   PRICE HM, 1967, J NEUROPATH EXP NEUR, V26, P475, DOI 10.1097/00005072-196707000-00009
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Rahman S, 2012, NEUROMUSCULAR DISORD, V22, P76, DOI 10.1016/j.nmd.2011.05.001
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   Seymour Christopher W, 2011, BMC Res Notes, V4, P169, DOI 10.1186/1756-0500-4-169
   Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107
   Sharma R, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136055
   Sleigh K, 2011, MUSCLE NERVE, V43, P795, DOI 10.1002/mus.21962
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Takemura G, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.116.003283
   Theunissen TEJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00400
   Trammell SAJ, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301012
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001
   Wang J, 2022, MOL GENET METAB, V135, P93, DOI 10.1016/j.ymgme.2021.12.006
   Wang YD, 2019, J BIOL CHEM, V294, P12380, DOI 10.1074/jbc.RA119.008680
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P923, DOI 10.1007/s10545-012-9580-0
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P913, DOI 10.1007/s10545-012-9579-6
   Yamada K, 2012, BRAIN DEV-JPN, V34, P92, DOI 10.1016/j.braindev.2011.08.004
   Yamada K, 2014, MOLEC GENET METAB RE, V1, P455, DOI 10.1016/j.ymgmr.2014.10.003
   Zhang FF, 2015, MOL ENDOCRINOL, V29, P1400, DOI 10.1210/me.2015-1155
NR 77
TC 3
Z9 3
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0009-9147
EI 1530-8561
J9 CLIN CHEM
JI Clin. Chem.
PD JUN 1
PY 2023
VL 69
IS 6
BP 564
EP 582
DI 10.1093/clinchem/hvad037
EA APR 2023
PG 19
WC Medical Laboratory Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology
GA I1MG2
UT WOS:000976642100001
PM 37099687
DA 2024-11-01
ER

PT J
AU Luo, NG
   Kaguni, LS
AF Luo, NG
   Kaguni, LS
TI Mutations in the Spacer region of <i>Drosophila</i> mitochondrial DNA
   polymerase affect DNA binding, processivity, and the balance between Pol
   and Exo function
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID I KLENOW FRAGMENT; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   CRYSTAL-STRUCTURE; BIOCHEMICAL-CHARACTERIZATION; FRAMESHIFT FIDELITY;
   ACCESSORY SUBUNIT; CATALYTIC SUBUNIT; 3'-5' EXONUCLEASE; THUMB
   SUBDOMAIN; ACTIVE-SITE
AB The catalytic subunit (alpha) of mitochondrial DNA polymerase (poly) shares conserved DNA polymerase and 3'-5' exonuclease active site motifs with Escherichia coli DNA polymerase I and bacteriophage T7 DNA polymerase. A major difference between the prokaryotic and mitochondrial proteins is the size and sequence of the region between the exonuclease and DNA polymerase domains, referred to as the spacer in pol gamma-alpha. Four gamma-specific conserved sequence elements are located within the spacer region of the catalytic subunit in eukaryotic species from yeast to humans. To elucidate the functional roles of the spacer region, we pursued deletion and site-directed mutagenesis of Drosophila poly. Mutant proteins were expressed from baculovirus constructs in insect cells, purified to near homogeneity, and analyzed biochemically. We find that mutations in three of the four conserved sequence elements within the spacer alter enzyme activity, processivity, and/or DNA binding affinity. In addition, several mutations affect differentially DNA polymerase and exonuclease activity and/or functional interactions with mitochondrial single-stranded DNA-binding protein. Based on these results and crystallographic evidence showing that the template-primer binds in a cleft between the exonuclease and DNA polymerase domains in family A DNA polymerases, we propose that conserved sequences within the spacer of pol gamma may position the substrate with respect to the enzyme catalytic domains.
C1 Michigan State Univ, Grad Program Genet, E Lansing, MI 48823 USA.
   Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48823 USA.
C3 Michigan State University; Michigan State University
RP Michigan State Univ, Grad Program Genet, E Lansing, MI 48823 USA.
EM lskaguni@msu.edu
FU NIGMS NIH HHS [GM45295] Funding Source: Medline
CR Bailey MF, 2004, J MOL BIOL, V336, P673, DOI 10.1016/j.jmb.2003.11.023
   BEBENEK K, 1995, J BIOL CHEM, V270, P19516, DOI 10.1074/jbc.270.33.19516
   BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chowdhury K, 2000, P NATL ACAD SCI USA, V97, P12469, DOI 10.1073/pnas.230448397
   COWART M, 1989, BIOCHEMISTRY-US, V28, P1975, DOI 10.1021/bi00431a004
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Doublié S, 1998, NATURE, V391, P251, DOI 10.1038/34593
   Doublié S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4
   Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0
   Fan L, 2001, BIOCHEMISTRY-US, V40, P4780, DOI 10.1021/bi010102h
   Fansler B S, 1974, Methods Enzymol, V29, P53
   Farr Carol L, 2002, Methods Mol Biol, V197, P273, DOI 10.1385/1-59259-284-8:273
   Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779
   Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392
   ITO J, 1990, NUCLEIC ACIDS RES, V18, P6716, DOI 10.1093/nar/18.22.6716
   ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045
   Iyengar B, 1999, GENETICS, V153, P1809
   JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.biochem.63.1.777
   JOYCE CM, 1982, J BIOL CHEM, V257, P1958
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693
   KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0
   KOROLEV S, 1995, P NATL ACAD SCI USA, V92, P9264, DOI 10.1073/pnas.92.20.9264
   Lam WC, 1998, BIOCHEMISTRY-US, V37, P1513, DOI 10.1021/bi9720181
   Lam WC, 2002, BIOCHEMISTRY-US, V41, P3943, DOI 10.1021/bi0120603
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lewis DL, 1996, J BIOL CHEM, V271, P23389, DOI 10.1074/jbc.271.38.23389
   Minnick DT, 1996, J BIOL CHEM, V271, P24954, DOI 10.1074/jbc.271.40.24954
   Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0
   OLSON MW, 1995, J BIOL CHEM, V270, P28932, DOI 10.1074/jbc.270.48.28932
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   THOMMES P, 1995, J BIOL CHEM, V270, P21137, DOI 10.1074/jbc.270.36.21137
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tuske S, 2000, J BIOL CHEM, V275, P23759, DOI 10.1074/jbc.M001804200
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang YX, 1999, J BIOL CHEM, V274, P28972, DOI 10.1074/jbc.274.41.28972
   Wang YX, 1997, J BIOL CHEM, V272, P13640, DOI 10.1074/jbc.272.21.13640
   WERNETTE CM, 1986, J BIOL CHEM, V261, P4764
   WILLIAMS AJ, 1995, J BIOL CHEM, V270, P860, DOI 10.1074/jbc.270.2.860
   WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2
NR 45
TC 33
Z9 39
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JAN 28
PY 2005
VL 280
IS 4
BP 2491
EP 2497
DI 10.1074/jbc.M411447200
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 889NG
UT WOS:000226449100015
PM 15537632
OA hybrid
DA 2024-11-01
ER

PT J
AU Chan, SSL
   Longley, MJ
   Naviaux, RK
   Copeland, WC
AF Chan, SSL
   Longley, MJ
   Naviaux, RK
   Copeland, WC
TI Mono-allelic <i>POLG</i> expression resulting from nonsense-mediated
   decay and alternative splicing in a patient with Alpers syndrome
SO DNA REPAIR
LA English
DT Article; Proceedings Paper
CT Dale W Mosbaugh Memorial Symposium on Genetic Toxicology and DNA Repair
CY OCT 11-12, 2004
CL Oregon State Univ, Corvallis, OR
HO Oregon State Univ
DE nonsense-mediated mRNA decay; exon skipping; Alpers syndrome; DNA
   polymerase gamma; premature termination codon; nonsense-associated
   alternative splicing
ID MITOCHONDRIAL-DNA POLYMERASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   MESSENGER-RNA DECAY; GAMMA MUTATIONS; TRANSLATION; DEPLETION;
   DEGENERATION; SUBUNIT; DISEASE; CELLS
AB Alpers syndrome is an autosomal recessive mitochondrial DNA depletion disorder that affects children and young adults. It is characterized by a progressive, fatal brain and liver disease. This syndrome has been associated with mutations in POLG, the gene encoding the mitochondrial DNA polymerase (pol gamma). Most patients with Alpers syndrome have been found to be compound heterozygotes, carrying two pathogenic mutations in trans at the POLG locus. POLG is a nuclear-encoded gene whose protein product is imported into mitochondria, where it is essential for mtDNA replication and repair. We studied the skin fibroblasts of a patient with Alpers syndrome having the genotype E873stop/A467T. The E873stop mutation produces a premature termination codon (TAG) in exon 17. The A467T mutation produces a threonine to alanine substitution at a highly conserved site in exon 7. The allele bearing the stop codon (E873-TAG) is predicted to produce a truncated, catalytically inactive polymerase. However, only full-length pol gamma protein was detected by Western blot analysis. Here, we show that transcripts containing this stop codon undergo nonsense-associated alternative splicing and nonsense-mediated decay. More than 95% of the functional POLG mRNA was derived from the allele bearing the A467T mutation and less than 5% contained the E873stop mutation. These events ensured that virtually all POLG protein in the cell was expressed from the A467T allele. Therefore, the Alpers phenotype in this patient was a consequence of a single-copy gene dose of the A467T allele, and selective elimination of transcripts bearing the E873stop mutation. Published by Elsevier B.V.
C1 NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.
   Univ Calif San Diego, Dept Med, Mitochondrial & Metab Dis Ctr, San Diego, CA 92103 USA.
   Univ Calif San Diego, Dept Pediat, Mitochondrial & Metab Dis Ctr, San Diego, CA 92103 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS); University of California System;
   University of California San Diego; University of California System;
   University of California San Diego
RP NIEHS, Mol Genet Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953
FU Intramural NIH HHS Funding Source: Medline
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320
   Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5
   Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403
   Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5
   Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Maquat LE, 2002, GENE DEV, V16, P1743, DOI 10.1101/gad.1014502
   Naviaux RK, 2005, ANN NEUROL, V58, P491, DOI 10.1002/ana.20544
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   NGUYEN KV, UNPUB MOL DIAGNOSIS
   NGUYEN KV, 2005, IN PRESS NEUROLOGY, V65
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Usuki F, 2004, ANN NEUROL, V55, P740, DOI 10.1002/ana.20107
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 30
TC 37
Z9 41
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1568-7864
EI 1568-7856
J9 DNA REPAIR
JI DNA Repair
PD DEC 8
PY 2005
VL 4
IS 12
BP 1381
EP 1389
DI 10.1016/j.dnarep.2005.08.010
PG 9
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Genetics & Heredity; Toxicology
GA 994NP
UT WOS:000234038800007
PM 16181814
DA 2024-11-01
ER

PT J
AU Li, Y
   Zhang, HH
   Yu, CJ
   Dong, XL
   Yang, FH
   Wang, MJ
   Wen, ZY
   Su, MH
   Li, B
   Yang, LN
AF Li, Ya
   Zhang, Huhu
   Yu, Chunjuan
   Dong, Xiaolei
   Yang, Fanghao
   Wang, Mengjun
   Wen, Ziyuan
   Su, Mohan
   Li, Bing
   Yang, Lina
TI New Insights into Mitochondria in Health and Diseases
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE mitochondrial; bioenergetics; ROS; aging; mtDNA; mutations;
   mitochondrial dysfunction; mitochondrial targeted therapy
ID COMPLEX I DEFICIENCY; PARKINSONS-DISEASE; OXIDATIVE STRESS; PERMEABILITY
   TRANSITION; MEMBRANE TRANSITION; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN;
   MITOFUSIN 2; DYSFUNCTION; DNA
AB Mitochondria are a unique type of semi-autonomous organelle within the cell that carry out essential functions crucial for the cell's survival and well-being. They are the location where eukaryotic cells carry out energy metabolism. Aside from producing the majority of ATP through oxidative phosphorylation, which provides essential energy for cellular functions, mitochondria also participate in other metabolic processes within the cell, such as the electron transport chain, citric acid cycle, and beta-oxidation of fatty acids. Furthermore, mitochondria regulate the production and elimination of ROS, the synthesis of nucleotides and amino acids, the balance of calcium ions, and the process of cell death. Therefore, it is widely accepted that mitochondrial dysfunction is a factor that causes or contributes to the development and advancement of various diseases. These include common systemic diseases, such as aging, diabetes, Parkinson's disease, and cancer, as well as rare metabolic disorders, like Kearns-Sayre syndrome, Leigh disease, and mitochondrial myopathy. This overview outlines the various mechanisms by which mitochondria are involved in numerous illnesses and cellular physiological activities. Additionally, it provides new discoveries regarding the involvement of mitochondria in both disorders and the maintenance of good health.
C1 [Li, Ya; Zhang, Huhu; Yu, Chunjuan; Dong, Xiaolei; Yang, Fanghao; Wang, Mengjun; Wen, Ziyuan; Su, Mohan; Li, Bing; Yang, Lina] Qingdao Univ, Basic Med Coll, Dept Genet & Cell Biol, Qingdao 266071, Peoples R China.
C3 Qingdao University
RP Yang, LN (corresponding author), Qingdao Univ, Basic Med Coll, Dept Genet & Cell Biol, Qingdao 266071, Peoples R China.
EM liyaemail2022@163.com; ts_zhh2580@163.com; 17861281992@163.com;
   dongxiaoleiqd@163.com; yfhao1996@163.com; wangmj90405@163.com;
   13287377676@163.com; smh13731390822@163.com; libing_516@qdu.edu.cn;
   yanglina@qdu.edu.cn
RI dong, xiaolei/HPH-5298-2023
FU National Natural Science Foundation of China [81803895]; Shandong
   Province Natural Science Foundation [ZR2021YQ57]; China Postdoctoral
   Science Foundation [2020M682131, 2021T140357]
FX This work was supported by National Natural Science Foundation of China
   (No. 81803895), Shandong Province Natural Science Foundation
   (ZR2021YQ57), and the China Postdoctoral Science Foundation (No.
   2020M682131, No. 2021T140357).
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Angelova PR, 2018, FEBS LETT, V592, P692, DOI 10.1002/1873-3468.12964
   Argueti-Ostrovsky S, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10092438
   Aubert G, 2013, BBA-MOL CELL RES, V1833, P840, DOI 10.1016/j.bbamcr.2012.08.015
   Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Baglivo M, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms241612580
   Balsa E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16423-1
   Barrea L, 2022, CRIT REV FOOD SCI, V62, P1800, DOI 10.1080/10408398.2020.1847030
   BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216
   Blaszczyk JW, 2020, METABOLITES, V10, DOI 10.3390/metabo10110450
   Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203
   Browne SE, 1999, BRAIN PATHOL, V9, P147
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162
   Christoffersen BO, 2022, OBESITY, V30, P841, DOI 10.1002/oby.23374
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Compagnoni GM, 2020, MOL NEUROBIOL, V57, P2959, DOI 10.1007/s12035-020-01926-1
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   de Laat P, 2015, NETH J MED, V73, P30
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166
   Diaz F, 2011, SEMIN FETAL NEONAT M, V16, P197, DOI 10.1016/j.siny.2011.05.004
   Eckert GP, 2013, NEUROCHEM INT, V62, P595, DOI 10.1016/j.neuint.2013.02.014
   Efremov RG, 2011, CURR OPIN STRUC BIOL, V21, P532, DOI 10.1016/j.sbi.2011.07.002
   Finsterer J, 2001, ACTA MED AUST, V28, P152, DOI 10.1046/j.1563-2571.2001.01036.x
   Flores K, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23116205
   Fromenty B, 2023, J HEPATOL, V78, P415, DOI 10.1016/j.jhep.2022.09.020
   Fu WY, 2019, ACS CHEM NEUROSCI, V10, P872, DOI 10.1021/acschemneuro.8b00402
   Garcia I, 2017, FRONT BIOSCI-LANDMRK, V22, P710, DOI 10.2741/4511
   Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419
   GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Giovannini L, 2017, NUTRITION, V34, P82, DOI 10.1016/j.nut.2016.09.008
   Haas RH, 2007, MITOCHONDRION, V7, pS136, DOI 10.1016/j.mito.2007.03.008
   Hage R, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.651639
   Harrington JS, 2023, PHYSIOL REV, V103, P2349, DOI 10.1152/physrev.00058.2021
   Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005
   HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hong YM, 2020, AGING CELL, V19, DOI 10.1111/acel.13128
   Hoppins S, 2011, MOL CELL, V41, P150, DOI 10.1016/j.molcel.2010.11.030
   Horvath R, 2008, NEUROTHERAPEUTICS, V5, P558, DOI 10.1016/j.nurt.2008.07.002
   Hu TT, 2023, METABOLISM, V146, DOI 10.1016/j.metabol.2023.155658
   Huang DH, 2020, J CELL MOL MED, V24, P5850, DOI 10.1111/jcmm.15256
   HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0
   Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078
   Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989
   Javadov S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051177
   Jin P, 2022, EMBO MOL MED, V14, DOI 10.15252/emmm.202216082
   Jin P, 2022, J HEMATOL ONCOL, V15, DOI 10.1186/s13045-022-01313-4
   Karanjia R, 2024, OPHTHALMOLOGY, V131, P422, DOI 10.1016/j.ophtha.2023.10.033
   Kawakita E, 2021, MOL CANCER RES, V19, P61, DOI 10.1158/1541-7786.MCR-20-0115
   Khoo TK, 2013, NEUROLOGY, V80, P276, DOI 10.1212/WNL.0b013e31827deb74
   Klemmensen MM, 2024, NEUROTHERAPEUTICS, V21, DOI 10.1016/j.neurot.2023.10.002
   Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001
   Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3
   Leavitt BR, 2020, JAMA NEUROL, V77, P764, DOI 10.1001/jamaneurol.2020.0299
   Lee IC, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10121950
   Liu CY, 2022, EMBO MOL MED, V14, DOI 10.15252/emmm.202215851
   Liu Y, 2023, INT J BIOL SCI, V19, P897, DOI 10.7150/ijbs.81609
   Lopriore P, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms232113216
   Malpartida AB, 2021, TRENDS BIOCHEM SCI, V46, P329, DOI 10.1016/j.tibs.2020.11.007
   Marchi S, 2023, NAT REV IMMUNOL, V23, P159, DOI 10.1038/s41577-022-00760-x
   Marin SE, 2013, GENE, V516, P162, DOI 10.1016/j.gene.2012.12.024
   Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006
   McCormick EM, 2023, ANN NEUROL, V94, P696, DOI 10.1002/ana.26716
   Morton H, 2021, FREE RADICAL BIO MED, V172, P652, DOI 10.1016/j.freeradbiomed.2021.07.013
   Moslehi J, 2012, CIRC RES, V110, P1226, DOI 10.1161/CIRCRESAHA.111.246868
   Nakamura K, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23073587
   Narasimhaiah R, 2005, CEREB CORTEX, V15, P696, DOI 10.1093/cercor/bhh171
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Ojuka EO, 2003, FASEB J, V17, P675, DOI 10.1096/fj.02-0951com
   OKANE MJ, 1992, BRIT J CLIN PHARMACO, V33, P451, DOI 10.1111/j.1365-2125.1992.tb04067.x
   Okuno D, 2011, J BIOCHEM, V149, P655, DOI 10.1093/jb/mvr049
   Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884
   Parikh S, 2013, MITOCHONDRION, V13, P681, DOI 10.1016/j.mito.2013.09.003
   Perry JB, 2019, J MOL CELL CARDIOL, V135, P160, DOI 10.1016/j.yjmcc.2019.08.010
   Picca A, 2018, NAT REV CARDIOL, V15, P543, DOI 10.1038/s41569-018-0059-z
   Pinti MV, 2019, AM J PHYSIOL-ENDOC M, V316, pE268, DOI 10.1152/ajpendo.00314.2018
   Postuma RB, 2012, MOVEMENT DISORD, V27, P617, DOI 10.1002/mds.24996
   Prakoso D, 2022, TRENDS PHARMACOL SCI, V43, P940, DOI 10.1016/j.tips.2022.04.005
   Read AD, 2021, REDOX BIOL, V47, DOI 10.1016/j.redox.2021.102164
   Ribeiro RF, 2018, FREE RADICAL BIO MED, V117, P18, DOI 10.1016/j.freeradbiomed.2018.01.012
   Rusek M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20163892
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schubert MB, 2020, ORPHANET J RARE DIS, V15, DOI 10.1186/s13023-020-1297-9
   Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741
   Shi YF, 2019, NATURE, V567, P341, DOI 10.1038/s41586-019-0993-x
   Sirk D, 2007, J NEUROCHEM, V103, P1989, DOI 10.1111/j.1471-4159.2007.04907.x
   Slone J, 2020, NPJ GENOM MED, V5, DOI 10.1038/s41525-020-0116-5
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004
   Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004
   Sun LF, 2017, P NATL ACAD SCI USA, V114, pE476, DOI 10.1073/pnas.1618657114
   Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461
   Tabrizi SJ, 2022, LANCET NEUROL, V21, P645, DOI 10.1016/S1474-4422(22)00121-1
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Takeda K, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01720-2
   Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457
   Twarowski B, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24076518
   Upadhayay S, 2024, PHARMACOL REP, V76, P693, DOI 10.1007/s43440-024-00619-z
   Vasan K, 2020, CELL METAB, V32, P341, DOI 10.1016/j.cmet.2020.06.019
   Wang XJ, 2018, ANN INTERN MED, V169, pITC65, DOI 10.7326/AITC201811060
   Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009
   Wesol-Kucharska D, 2021, CHILDREN-BASEL, V8, DOI 10.3390/children8070532
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Wu YT, 2023, HEARING RES, V438, DOI 10.1016/j.heares.2023.108876
   Xia WM, 2024, NAT METAB, V6, P273, DOI 10.1038/s42255-024-00978-0
   Xiao HP, 2020, CELL, V180, P968, DOI 10.1016/j.cell.2020.02.012
   Xourafa G, 2024, NAT REV ENDOCRINOL, V20, P27, DOI 10.1038/s41574-023-00898-1
   Xu DC, 2023, SIGNAL TRANSDUCT TAR, V8, DOI 10.1038/s41392-023-01353-3
   Xu XX, 2022, CELL STEM CELL, V29, P840, DOI 10.1016/j.stem.2022.03.003
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Yu-Wai-Man P, 2016, AM J HUM GENET, V98, P1271, DOI 10.1016/j.ajhg.2016.05.015
   Yu-Wai-Man P, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz7423
   Zhang TQ, 2023, BIOMED PHARMACOTHER, V165, DOI 10.1016/j.biopha.2023.114706
   Zhang ZR, 2017, J EXP MED, V214, P2671, DOI 10.1084/jem.20162040
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
   Zweers H, 2018, JPEN-PARENTER ENTER, V42, P581, DOI 10.1177/0148607117699792
NR 127
TC 0
Z9 0
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD SEP
PY 2024
VL 25
IS 18
AR 9975
DI 10.3390/ijms25189975
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA H5Q6P
UT WOS:001323989800001
PM 39337461
OA gold
DA 2024-11-01
ER

PT J
AU Goios, A
   Nogueira, C
   Pereira, C
   Vilarinho, L
   Amorim, A
   Pereira, L
AF Goios, A
   Nogueira, C
   Pereira, C
   Vilarinho, L
   Amorim, A
   Pereira, L
TI mtDNA single macrodeletions associated with myopathies: Absence of
   haplogroup-related increased risk
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
ID MITOCHONDRIAL-DNA; REGION SEQUENCES; MUTATIONS; DELETIONS; NETWORK;
   DISEASE
AB As for any non-recombining genome, any mutation at mtDNA, if not recurrent, appears on a particular haplotype background, allowing its detection by haplogroup association studies. It has been shown that the propensity for occurrence of single macrodeletions at a level beyond the pathological threshold is associated with super-haplogroup U/K. However, in this report, we present evidence for the absence of preferential haplogroup backgrounds for single macrodeletions. We have analysed how haplogroup diagnostic polymorphisms could disrupt direct repeats usually flanking the deleted segment, and we have concluded that for the Common Deletion, no such polymorphisms are observed in humans, but they do occur in other primates. Furthermore, we also report five new single macrodeletions.
C1 Univ Porto, Inst Patol & Imunol Mol, P-4200465 Oporto, Portugal.
   IGM, Oporto, Portugal.
   Univ Porto, Fac Ciencias, P-4100 Oporto, Portugal.
C3 Universidade do Porto; Universidade do Porto
RP Univ Porto, Inst Patol & Imunol Mol, R Dr Roberto Frias S-N, P-4200465 Oporto, Portugal.
EM aalmeida@ipatimup.pt
RI Goios, Ana/J-6012-2013; Amorim, Antonio/A-7938-2008; Pereira,
   Luisa/H-3050-2011
OI Goios, Ana/0000-0002-3297-8420; Nogueira, Celia/0000-0003-3640-8537;
   Amorim, Antonio/0000-0002-7518-6247; Pereira,
   Cristina/0000-0002-5794-127X; Pereira, Luisa/0000-0002-4271-1527
CR Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Crimi M, 2003, EUR J HUM GENET, V11, P896, DOI 10.1038/sj.ejhg.5201056
   Finnilä S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   Hou JH, 1996, BIOCHEM J, V318, P1065, DOI 10.1042/bj3181065
   Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204
   Mohri I, 1998, J NEUROL SCI, V158, P106, DOI 10.1016/S0022-510X(98)00082-3
   Pereira L, 2004, INT J LEGAL MED, V118, P132, DOI 10.1007/s00414-003-0424-1
   PEREIRA L, 2005, IN PRESS INT J ANDRO
   Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1
   Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   Torroni A, 2003, AM J HUM GENET, V72, P1005, DOI 10.1086/373936
   Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
NR 19
TC 3
Z9 3
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PY 2005
VL 28
IS 5
BP 769
EP 778
DI 10.1007/s10545-005-0023-z
PG 10
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 962VA
UT WOS:000231759900017
PM 16151908
DA 2024-11-01
ER

PT J
AU Masuyama, M
   Iida, R
   Takatsuka, H
   Yasuda, T
   Matsuki, T
AF Masuyama, M
   Iida, R
   Takatsuka, H
   Yasuda, T
   Matsuki, T
TI Quantitative change in mitochondrial DNA content in various mouse
   tissues during aging
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE mitochondrial DNA; aging; real-time PCR; gene expression; mouse tissue
ID FLUORESCENCE DIFFERENTIAL DISPLAY; HUMAN SKELETAL-MUSCLE; COPY NUMBER;
   M-LP; EXPRESSION; AGE; ABNORMALITIES; DELETION; DISEASE; PROTEIN
AB In order to systematically characterize age-related changes in the mtDNA content of various tissues during aging, we analyzed the mtDNA content of eight tissues from mice at five different ages from young to senescent by quantitative real-time PCR analysis. Obvious variations of mtDNA content among the tissues were detected: There was a 20-fold range in 2-week-old mice and a 50-fold range in 15-month-old mice. The mtDNA contents of the heart, lung, kidney, spleen and skeletal muscle increased gradually with age, whereas those of bone marrow and brain showed no age-related pattern. The expression patterns of mitochondrial transcription factor A (mtTFA) and mitochondrial single-strand DNA binding protein (mtSSB), possible regulatory factors of the mtDNA copy number, were not necessarily linked with the age-related pattern of the mtDNA content, suggesting the existence of other factors that affect the mtDNA content. The Western blot analysis of mtDNA-encoded cytochrome c oxidase subunit III (MTCO3) demonstrated that the expression levels of this protein in the heart and skeletal muscle increase with age in parallel with the mtDNA content. These findings confirm that the mtDNA content of tissues changes during aging. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Fukui, Fac Med Sci, Dept Forens Med, Matsuoka, Fukui 9101193, Japan.
   Univ Fukui, Fac Med Sci, Dept Med Genet & Biochem, Matsuoka, Fukui 9101193, Japan.
C3 University of Fukui; University of Fukui
RP Univ Fukui, Fac Med Sci, Dept Forens Med, Matsuoka, Fukui 9101193, Japan.
EM ireiko@fmsra.fukui-med.ac.jp
CR Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Barrientos A, 1997, BIOCHEM MOL MED, V62, P165, DOI 10.1006/bmme.1997.2647
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   DiMauro S, 2002, MUSCLE NERVE, V26, P597, DOI 10.1002/mus.10194
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001
   Iida R, 2003, J BIOL CHEM, V278, P6301, DOI 10.1074/jbc.M210886200
   Iida R, 2000, MECH AGEING DEV, V113, P135, DOI 10.1016/S0047-6374(99)00104-9
   Iida R, 2002, EXP GERONTOL, V37, P1121, DOI 10.1016/S0531-5565(02)00066-9
   Iida R, 2001, BIOCHEM BIOPH RES CO, V283, P292, DOI 10.1006/bbrc.2001.4769
   Kornberg A., 1992, DNA REPLICATION
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6
   Papa S, 1996, BBA-BIOENERGETICS, V1276, P87, DOI 10.1016/0005-2728(96)00077-1
   Parfait B, 1998, BIOCHEM BIOPH RES CO, V247, P57, DOI 10.1006/bbrc.1998.8666
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Schultz RA, 1998, J BIOL CHEM, V273, P3447, DOI 10.1074/jbc.273.6.3447
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
NR 25
TC 71
Z9 86
U1 1
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD MAY 25
PY 2005
VL 1723
IS 1-3
BP 302
EP 308
DI 10.1016/j.bbagen.2005.03.001
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 934FI
UT WOS:000229691900035
PM 15820144
DA 2024-11-01
ER

PT J
AU Shaibani, A
   Shchelochkov, OA
   Zhang, SL
   Katsonis, P
   Lichtarge, O
   Wong, LJ
   Shinawi, M
AF Shaibani, Aziz
   Shchelochkov, Oleg A.
   Zhang, Shulin
   Katsonis, Panagiotis
   Lichtarge, Olivier
   Wong, Lee-Jun
   Shinawi, Marwan
TI Mitochondrial Neurogastrointestinal Encephalopathy Due to Mutations in
   <i>RRM2B</i>
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID DNA DEPLETION; GENE; ENCEPHALOMYOPATHY; FEATURES; REPLICATION; DISORDER;
   FAILURE; P53R2; MNGIE
AB Background: Mitochondrial neurogastrointestinal encephalopathy (MNGIE) is a progressive neurodegenerative disorder associated with thymidine phosphorylase deficiency resulting in high levels of plasma thymidine and a characteristic clinical phenotype.
   Objective: To investigate the molecular basis of MNGIE in a patient with a normal plasma thymidine level.
   Design: Clinical, neurophysiological, and histopathological examinations as well as molecular and genetic analyses.
   Setting: Nerve and muscle center and genetic clinic. Patient: A 42-year-old woman with clinical findings strongly suggestive for MNGIE.
   Main Outcome Measures: Clinical description of the disease and its novel genetic cause.
   Results: Identification of mitochondrial DNA depletion in muscle samples (approximately 12% of the control mean content) prompted us to look for other causes of our patient's condition. Sequencing of genes associated with mitochondrial DNA depletion-POLG, PEO1, ANT1, SUCLG1, and SUCLA2-did not reveal deleterious mutations. Results of sequencing and array comparative genomic hybridization of the mitochondrial DNA for point mutations and deletions in blood and muscle were negative. Sequencing of RRM2B, a gene encoding cytosolic p53-inducible ribonucleoside reductase small subunit (RIR2B), revealed 2 pathogenic mutations, c.329G>A (p. R110H) and c.362G >A (p.R121H). These mutations are predicted to affect the docking interface of the RIR2B homodimer and likely result in impaired enzyme activity.
   Conclusions: This study expands the clinical spectrum of impaired RIR2B function, challenges the notion of locus homogeneity of MNGIE, and sheds light on the pathogenesis of conditions involved in the homeostasis of the mitochondrial nucleotide pool. Our findings suggest that patients with MNGIE who have normal thymidine levels should be tested for RRM2B mutations.
C1 [Shchelochkov, Oleg A.; Zhang, Shulin; Katsonis, Panagiotis; Lichtarge, Olivier; Wong, Lee-Jun; Shinawi, Marwan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Shaibani, Aziz] Nerve & Muscle Ctr Texas, Houston, TX USA.
   [Shaibani, Aziz] Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
   [Lichtarge, Olivier] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.
   [Lichtarge, Olivier] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA.
   [Zhang, Shulin; Wong, Lee-Jun] Baylor Coll Med, Med Genet Labs, Houston, TX 77030 USA.
   [Shchelochkov, Oleg A.; Shinawi, Marwan] Texas Childrens Hosp, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine; Baylor College of Medicine; Baylor College of Medicine;
   Baylor College of Medicine
RP Shinawi, M (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room T619, Houston, TX 77030 USA.
EM mshinawi@bcm.tmc.edu
RI Katsonis, Panagiotis/L-6391-2019; Shaibani, Aziz/AAE-1755-2022
OI shinawi, Marwan/0000-0003-1329-4100
FU NIDDK NIH HHS [5 R90 DK071505-03, 5 R90 DK071505-04, R90 DK071505]
   Funding Source: Medline; NIGMS NIH HHS [R01-GM066099, R01-GM079656, R01
   GM066099, R01 GM079656-02, R01 GM079656, R01 GM079656-03] Funding
   Source: Medline
CR Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Lehnhardt FG, 2008, ARCH NEUROL-CHICAGO, V65, P407, DOI 10.1001/archneur.65.3.407
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Ward RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002136
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
NR 15
TC 85
Z9 90
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD AUG
PY 2009
VL 66
IS 8
BP 1028
EP 1032
DI 10.1001/archneurol.2009.139
PG 5
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 481YA
UT WOS:000268848100017
PM 19667227
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Jones, CN
   Jones, CI
   Graham, WD
   Agris, PF
   Spremulli, LL
AF Jones, Christie N.
   Jones, Christopher I.
   Graham, William D.
   Agris, Paul F.
   Spremulli, Linda L.
TI A Disease-causing Point Mutation in Human Mitochondrial
   tRNA<SUP>Met</SUP> Results in tRNA Misfolding Leading to Defects in
   Translational Initiation and Elongation
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SELECTIVE 2'-HYDROXYL ACYLATION; AMINOACYL-TRANSFER-RNAS; HIGHER-ORDER
   STRUCTURE; STEADY-STATE LEVELS; FACTOR TU; PROTEIN-SYNTHESIS;
   ESCHERICHIA-COLI; DNA; TRNA(PHE); SHAPE
AB The mitochondrial tRNA genes are hot spots for mutations that lead to human disease. A single point mutation (T4409C) in the gene for human mitochondrial tRNAMet (hmtRNA(Met)) has been found to cause mitochondrial myopathy. This mutation results in the replacement of U8 in hmtRNA(Met) with a C8. The hmtRNAMet serves both in translational initiation and elongation in human mitochondria making this tRNA of particular interest in mitochondrial protein synthesis. Here we show that the single 8U -> C mutation leads to a failure of the tRNA to respond conformationally to Mg2+. This mutation results in a drastic disruption of the structure of the hmtRNAMet, which significantly reduces its aminoacylation. The small fraction of hmtRNAMet that can be aminoacylated is not formylated by the mitochondrial Met-tRNA transformylase preventing its function in initiation, and it is unable to form a stable ternary complex with elongation factor EF-Tu preventing any participation in chain elongation. We have used structural probing and molecular reconstitution experiments to examine the structures formed by the normal and mutated tRNAs. In the presence of Mg2+, the normal tRNA displays the structural features expected of a tRNA. However, even in the presence of Mg2+, the mutated tRNA does not form the cloverleaf structure typical of tRNAs. Thus, we believe that this mutation has disrupted a critical Mg2+-binding site on the tRNA required for formation of the biologically active structure. This work establishes a foundation for understanding the physiological consequences of the numerous mitochondrial tRNA mutations that result in disease in humans.
C1 [Jones, Christopher I.; Graham, William D.; Agris, Paul F.] N Carolina State Univ, Dept Struct & Mol Biol, Raleigh, NC 27695 USA.
   [Jones, Christie N.; Spremulli, Linda L.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.
C3 North Carolina State University; University of North Carolina;
   University of North Carolina Chapel Hill
RP Agris, PF (corresponding author), N Carolina State Univ, Dept Struct & Mol Biol, Campus Box 7622, Raleigh, NC 27695 USA.
EM Paul_Agris@ncsu.edu; Linda_Spremulli@unc.edu
RI Jones, Christopher/D-6210-2013; Jones, Cameron/W-8992-2019
FU National Institutes of Health [GM32734, GM23037]; United Mitochondrial
   Disease Foundation; National Science Foundation [MCB 548602]
FX This work was supported, in whole or in part, by National Institutes of
   Health Grants GM32734 (to L. L. S.) and GM23037. This work was also
   supported by a United Mitochondrial Disease Foundation grant (to L. L.
   S. and P. F. A.) and National Science Foundation Grant MCB 548602 (to P.
   F. A.). The costs of publication of this article were defrayed in part
   by the payment of page charges. This article must therefore be hereby
   marked "advertisement" in accordance with 18 U. S. C. Section 1734
   solely to indicate this fact.
CR ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1
   [Anonymous], [No title captured]
   Ashraf SS, 2000, CELL BIOCHEM BIOPHYS, V33, P241, DOI 10.1385/CBB:33:3:241
   ATTARDI G, 1985, INT REV CYTOL, V93, P93, DOI 10.1016/S0074-7696(08)61373-X
   Bacman SR, 2003, BIOCHEM J, V374, P131, DOI 10.1042/BJ20030222
   Badorrek CS, 2006, BIOCHEMISTRY-US, V45, P12664, DOI 10.1021/bi060521k
   BAEYENS KJ, 1995, NAT STRUCT BIOL, V2, P56, DOI 10.1038/nsb0195-56
   Bonnefond L, 2008, RNA, V14, P641, DOI 10.1261/rna.938108
   Bullard JM, 1999, BBA-GENE STRUCT EXPR, V1446, P102, DOI 10.1016/S0167-4781(99)00077-9
   Cai YC, 2000, J BIOL CHEM, V275, P20308, DOI 10.1074/jbc.M001899200
   CENATIEMPO Y, 1987, BIOCHEMISTRY-US, V26, P5070, DOI 10.1021/bi00390a028
   Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405
   Dirheimer G., 1995, P93
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   Hao HL, 1997, MOL CELL BIOL, V17, P6831, DOI 10.1128/MCB.17.12.6831
   Helm M, 1999, BIOCHEMISTRY-US, V38, P13338, DOI 10.1021/bi991061g
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Hunter SE, 2004, MITOCHONDRION, V4, P21, DOI 10.1016/j.mito.2004.04.003
   Jones CI, 2006, J MOL BIOL, V362, P771, DOI 10.1016/j.jmb.2006.07.036
   Jovine L, 2000, J MOL BIOL, V301, P401, DOI 10.1006/jmbi.2000.3950
   Kelley SO, 2000, NAT STRUCT BIOL, V7, P862, DOI 10.1038/79612
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242
   Levinger L, 2001, NUCLEIC ACIDS RES, V29, P4334, DOI 10.1093/nar/29.21.4334
   Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104
   Lombes A, 1998, HUM MUTAT, pS175
   LOUIE A, 1984, J BIOL CHEM, V259, P5010
   Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v
   Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028
   Pavlov MY, 2008, EMBO J, V27, P1706, DOI 10.1038/emboj.2008.99
   Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665
   SCHULMAN LH, 1988, SCIENCE, V242, P765, DOI 10.1126/science.3055296
   Schwartzbach C J, 1996, Methods Enzymol, V264, P248, DOI 10.1016/S0076-6879(96)64025-7
   Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1
   Spencer AC, 2004, NUCLEIC ACIDS RES, V32, P5464, DOI 10.1093/nar/gkh886
   Spencer AC, 2004, BIOCHEMISTRY-US, V43, P9743, DOI 10.1021/bi049639w
   SPRINZL M, 1980, NUCLEIC ACIDS RES, V8, P4737, DOI 10.1093/nar/8.20.4737
   Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148
   STEIN A, 1976, BIOCHEMISTRY-US, V15, P160, DOI 10.1021/bi00646a025
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Takeuchi N, 1998, J BIOL CHEM, V273, P15085, DOI 10.1074/jbc.273.24.15085
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
   WAKITA K, 1994, NUCLEIC ACIDS RES, V22, P347, DOI 10.1093/nar/22.3.347
   WATANABE Y, 1994, NUCLEIC ACIDS RES, V22, P5378, DOI 10.1093/nar/22.24.5378
   Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749
   Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
   Wittenhagen LM, 2003, NUCLEIC ACIDS RES, V31, P596, DOI 10.1093/nar/gkg131
   Yarian CS, 1999, NUCLEIC ACIDS RES, V27, P3543, DOI 10.1093/nar/27.17.3543
   Yokogawa T, 1991, NUCLEIC ACIDS RES, V19, P6101, DOI 10.1093/nar/19.22.6101
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
NR 53
TC 25
Z9 33
U1 1
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 5
PY 2008
VL 283
IS 49
BP 34445
EP 34456
DI 10.1074/jbc.M806992200
PG 12
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 377UY
UT WOS:000261277700072
PM 18835817
OA Green Published
DA 2024-11-01
ER

PT J
AU Zsurka, G
   Becker, F
   Heinen, M
   Gdynia, HJ
   Lerche, H
   Kunz, WS
   Weber, YG
AF Zsurka, Gabor
   Becker, Felicitas
   Heinen, Markus
   Gdynia, Hans-Juergen
   Lerche, Holger
   Kunz, Wolfram S.
   Weber, Yvonne G.
TI Mutation in the mitochondrial tRNA<SUP>Ile</SUP> gene causes progressive
   myoclonus epilepsy
SO SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
LA English
DT Article
DE Myoclonic; Metabolism; Photosensitivity; Progressive; MERRF; Myoclonic
   epilepsy with ragged red fibres
ID FEATURES; BRAIN
AB Purpose: The group of the rare progressive myoclonic epilepsies (PME) include a wide spectrum of mitochondrial and metabolic diseases. In juvenile and adult ages, MERRF (myoclonic epilepsy with ragged red fibres) is the most common form. The underlying genetic defect in most patients with the syndrome of MERRF is a mutation in the tRNALys gene, but mutations were also detected in the tRNAPhe gene.
   Method: Here, we describe a 40 year old patient with prominent myoclonic seizures since 39 years of age without a mutation in the known genes who underwent intensive clinical, genetic and functional workup.
   Results: The patient had a slight mental retardation and a severe progressive hearing loss based on a defect of the inner ear on both sides. Ictal electroencephalography (EEG) showed bilateral occipital and generalized spikes and polyspikes induced and aggravated by photostimulation. A cranial magnetic resonance imaging (cMRI) detected a global cortical atrophy of the brain and mild periventricular white matter lesions. The electromyography (EMG) was normal but the muscle biopsy showed abundant ragged red fibres. Sequencing of the mitochondrial DNA from the skeletal muscle biopsy revealed a novel heteroplasmic mutation (m.4279A>G) in the tRNAIle gene which was functionally relevant as tested in single skeletal muscle fibre investigations.
   Conclusion: Mutations in tRNAIle were described in patients with chronic progressive external ophthalmoplegia (CPEO), prominent deafness or cardiomyopathy but, up to now, not in patients with myoclonic epilepsy. The degree of heteroplasmy of this novel mitochondrial DNA mutation was 70% in skeletal muscle but only 15% in blood, pointing to the diagnostic importance of a skeletal muscle biopsy also in patients with myoclonic epilepsy. (C) 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
C1 [Zsurka, Gabor; Heinen, Markus; Kunz, Wolfram S.] Univ Bonn, Dept Epileptol, Bonn, Germany.
   [Zsurka, Gabor; Heinen, Markus; Kunz, Wolfram S.] Univ Bonn, Life & Brain Ctr, Bonn, Germany.
   [Becker, Felicitas; Lerche, Holger; Weber, Yvonne G.] Univ Tubingen, Dept Neurol & Epileptol, Hertie Inst Clin Brain Res, Tubingen, Germany.
   [Gdynia, Hans-Juergen] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany.
C3 University of Bonn; University of Bonn; Eberhard Karls University of
   Tubingen; Eberhard Karls University Hospital; Ulm University
RP Kunz, WS (corresponding author), Univ Bonn, Dept Epileptol, Bonn, Germany.
EM gabor.zsurka@ukb.uni-bonn.de; felicitas.becker@uni-tuebingen.de;
   markus.heinen@ukb.uni-bonn.de;
   hansjuergen.gdynia@neurologie-kipfenberg.de;
   holger.lerche@uni-tuebingen.de; wolfram.kunz@ukb.uni-bonn.de;
   Yvonne.weber@uni-tuebingen.de
RI Marson, Anthony/AAW-9776-2020; Kunz, Wolfram/K-1232-2019
OI Kunz, Wolfram/0000-0003-1113-3493; Zsurka, Gabor/0000-0002-6379-849X
CR de Siqueira LF, 2012, J NEUROL, V257, P1612
   DiMauro S, 2002, ADV NEUROL, V89, P217
   Ito S, 2008, AM J NEURORADIOL, V29, P392, DOI 10.3174/ajnr.A0865
   KAIDO M, 1995, J NEUROL SCI, V131, P170, DOI 10.1016/0022-510X(95)00111-E
   Kudin AP, 2009, EXP NEUROL, V218, P326, DOI 10.1016/j.expneurol.2009.02.014
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Taniike M, 1986, BIOCH BIOPHYSICAL RE, V186, P47
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
   Yarham JW, 2012, MITOCHONDRION, V12, P533, DOI 10.1016/j.mito.2012.06.009
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Zsurka G, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.022566
   Zsurka G, 2010, NEUROLOGY, V74, P507, DOI 10.1212/WNL.0b013e3181cef7ab
NR 12
TC 13
Z9 13
U1 0
U2 8
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1059-1311
EI 1532-2688
J9 SEIZURE-EUR J EPILEP
JI Seizure
PD JUL
PY 2013
VL 22
IS 6
BP 483
EP 486
DI 10.1016/j.seizure.2013.03.003
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 173PU
UT WOS:000321092200015
PM 23601850
OA Bronze
DA 2024-11-01
ER

PT J
AU de Laat, P
   Rodenburg, RJ
   Smeitink, JAM
   Janssen, MCH
AF de Laat, Paul
   Rodenburg, Richard J.
   Smeitink, Jan A. M.
   Janssen, Mirian C. H.
TI Intra-patient variability of heteroplasmy levels in urinary epithelial
   cells in carriers of the m.3243A>G mutation
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Article
DE heteroplasmy; m.3243A>G; maternally inherited diabetes deafness;
   mitochondrial medicine; mitochondrial myopathy; encephalopathy; lactic
   acidosis and stroke-like episodes; NMDAS; outcome measures
ID TRANSFER RNALEU(UUR) GENE; LACTIC-ACIDOSIS; MITOCHONDRIAL MYOPATHY;
   MELAS; A3243G; ENCEPHALOPATHY; EPIDEMIOLOGY; PREVALENCE; EPISODES
AB Background The mitochondrial DNA m.3243A>G mutation is one the most prevalent mutation causing mitochondrial disease in adult patients. Several cohort studies have used heteroplasmy levels in urinary epithelial cells (UEC) to correlate the genotype of the patients to the clinical severity. However, the interpretation of these data is hampered by a lack of knowledge on the intra-patient variability of the heteroplasmy levels. The goal of this study was to determine the day-to-day variation of the heteroplasmy levels in UEC. Methods Fifteen carriers of the m.3243A>G mutation collected five urine samples in a 14-day window. Heteroplasmy levels of the m.3243A>G mutation were determined in these samples. Data from the national cohort study, including Newcastle Mitochondrial Disease Adult Scale scores and clinical diagnosis, were used. Results In the samples of six patients, heteroplasmy levels were within a 5% margin. In the samples collected from five patients, the margin was >20%. Conclusion Heteroplasmy levels of UEC in carriers of the m.3243A>G mutation have a significant day-to-day variation. The interpretation of a correlation between heteroplasmy levels in urine and disease severity is therefore not reliable. Therefore, heteroplasmy levels in UEC should not be used as a prognostic biomarker in these patients.
C1 [de Laat, Paul; Rodenburg, Richard J.; Smeitink, Jan A. M.; Janssen, Mirian C. H.] Radboudumc Amalia Childrens Hosp, Radboud Ctr Mitochondrial Med, Dept Pediat, Nijmegen, Netherlands.
   [Janssen, Mirian C. H.] Radboudumc, Radboud Ctr Mitochondrial Med, Dept Internal Med, Nijmegen, Netherlands.
C3 Radboud University Nijmegen
RP Janssen, MCH (corresponding author), Radboudumc Amalia Childrenshosp, Radboud Ctr Mitochondrial Med, Nijmegen, Netherlands.
EM paul.delaat@radboudumc.nl
RI Rodenburg, Richard/N-3579-2014; Smeitink, Jan/D-6064-2011; de Laat,
   Paul/O-9851-2019; de Laat, Paul/B-5855-2011; Janssen, Mirian/D-9777-2016
OI de Laat, Paul/0000-0003-2541-3090; Janssen, Mirian/0000-0003-4668-9977
FU ZonMW Priority Medicines [113302003]; Stichting Energy4All
FX ZonMW Priority Medicines, Grant/Award Number: 113302003; Stichting
   Energy4All
CR [Anonymous], J INHERIT METAB DIS
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002
   desLaat P., 2013, OPHTHALMOLOGY, V120, P2684, DOI [10.1016/j.ophtha.2013.05.013, DOI 10.1016/J.OPHTHA.2013.05.013]
   desLaat P, 2015, NETH J MED, V73, P30
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Liu CH, 2012, J FORMOS MED ASSOC, V111, P489, DOI 10.1016/j.jfma.2011.06.014
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Marotta R, 2009, J CLIN NEUROSCI, V16, P1223, DOI 10.1016/j.jocn.2008.11.012
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   SCHUMANN GB, 1981, ACTA CYTOL, V25, P147
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
NR 24
TC 9
Z9 9
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD FEB
PY 2019
VL 7
IS 2
AR e523
DI 10.1002/mgg3.523
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA HN0ZM
UT WOS:000459916900014
PM 30516030
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Hahn, A
   Zuryn, S
AF Hahn, Anne
   Zuryn, Steven
TI The Cellular Mitochondrial Genome Landscape in Diesease
SO TRENDS IN CELL BIOLOGY
LA English
DT Review
ID OXYGEN SPECIES PRODUCTION; DNA MUTATIONS; SKELETAL-MUSCLE; MTDNA
   MUTATIONS; IN-VIVO; OXIDATIVE-PHOSPHORYLATION; GENETIC BOTTLENECK;
   CLONAL EXPANSION; ROS PRODUCTION; NARP MUTATION
AB Mitochondrial genome (mitochondrial DNA, mtDNA) lesions that unbalance bioenergetic and oxidative outputs are an important cause of human disease. A major impediment in our understanding of the pathophysiology of mitochondrial disorders is the complexity with which mtDNA mutations are spatiotemporally distributed and managed within individual cells, tissues, and organs. Unlike the comparatively static nuclear genome, accumulating evidence highlights the variability, dynamism, and modifiability of the mtDNA nucleotide sequence between individual cells overtime. In this review, we summarize and discuss the impact of mtDNA defects on disease within the context of a mosaic and shifting mutational landscape.
C1 [Hahn, Anne; Zuryn, Steven] Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld, Australia.
C3 University of Queensland
RP Zuryn, S (corresponding author), Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld, Australia.
EM s.zuryn@uq.edu.au
RI Zuryn, Steven/C-7967-2018
OI Zuryn, Steven/0000-0002-3551-6790
FU University of Queensland International Scholarship; Stafford Fox Senior
   Research Fellowship; NHMRC [1128381]; National Health and Medical
   Research Council of Australia [1128381] Funding Source: NHMRC
FX We thank colleagues of the Zuryn laboratory for discussions and comments
   on this review article as well as Rowan Tweedale for helpful input. We
   apologize to the many authors with articles on the subject of this
   review that we were not able to discuss or cite because of space
   restrictions. A.H. is supported by a University of Queensland
   International Scholarship. S.Z. is supported by a Stafford Fox Senior
   Research Fellowship and funding by an NHMRC Project Grant 1128381.
CR Ahier A, 2018, NAT CELL BIOL, V20, P352, DOI 10.1038/s41556-017-0023-x
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Arnold RS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/239257
   Auré K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Bagwan N, 2018, CELL REP, V23, P3685, DOI 10.1016/j.celrep.2018.05.080
   Ballana E, 2006, BIOCHEM BIOPH RES CO, V341, P950, DOI 10.1016/j.bbrc.2006.01.049
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   BARRELL BG, 1979, NATURE, V282, P189, DOI 10.1038/282189a0
   Barshad G, 2018, TRENDS GENET, V34, P682, DOI 10.1016/j.tig.2018.05.009
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, P NATL ACAD SCI USA, V105, P16496, DOI 10.1073/pnas.0802779105
   Berendzen KM, 2016, CELL, V166, P1553, DOI 10.1016/j.cell.2016.08.042
   Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258
   Berridge MV, 2016, CURR OPIN GENET DEV, V38, P75, DOI 10.1016/j.gde.2016.04.003
   Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Burgstaller JP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04797-2
   Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020
   Burr SP, 2018, DEV GROWTH DIFFER, V60, P21, DOI 10.1111/dgd.12420
   Cadet J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012559
   Carelli V, 2015, INT J BIOCHEM CELL B, V63, P21, DOI 10.1016/j.biocel.2015.01.023
   Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Cornelissen T, 2018, ELIFE, V7, DOI 10.7554/eLife.35878
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cruz-Bermúdez A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146816
   Cruz-Bermúdez A, 2015, ONCOTARGET, V6, P13628, DOI 10.18632/oncotarget.3698
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Dasgupta S, 2008, CANCER RES, V68, P700, DOI 10.1158/0008-5472.CAN-07-5532
   Degoul F, 1995, J INHERIT METAB DIS, V18, P682, DOI 10.1007/BF02436757
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002
   Floros VI, 2018, NAT CELL BIOL, V20, P144, DOI 10.1038/s41556-017-0017-8
   Formosa LE, 2018, NAT CELL BIOL, V20, P511, DOI 10.1038/s41556-018-0098-z
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   García JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   GAREY JR, 1989, J MOL EVOL, V28, P374, DOI 10.1007/BF02603072
   Georgakopoulos ND, 2017, NAT CHEM BIOL, V13, P136, DOI [10.1038/nchembio.2287, 10.1038/NCHEMBIO.2287]
   Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   GIULIVI C, 1995, ARCH BIOCHEM BIOPHYS, V316, P909, DOI 10.1006/abbi.1995.1122
   Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466
   Gonzalo R, 2005, FEBS LETT, V579, P6909, DOI 10.1016/j.febslet.2005.11.034
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620
   Greaves LC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003082
   Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006
   Haag S, 2016, EMBO J, V35, P2104, DOI 10.15252/embj.201694885
   HAGINOYA K, 1990, ACTA NEUROPATHOL, V80, P642, DOI 10.1007/BF00307633
   Hämäläinen RH, 2015, CELL REP, V11, P1614, DOI 10.1016/j.celrep.2015.05.009
   Harper JW, 2018, NAT REV MOL CELL BIO, V19, P93, DOI 10.1038/nrm.2017.129
   Hatakeyama H, 2017, AM J PATHOL, V187, P110, DOI 10.1016/j.ajpath.2016.09.003
   Hatakeyama H, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0227-x
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Higuchi R, 2013, CURR BIOL, V23, P2417, DOI 10.1016/j.cub.2013.10.022
   Hopkins JF, 2018, GASTROENTEROLOGY, V154, P1620, DOI 10.1053/j.gastro.2018.01.029
   Horvath R, 2009, J NEUROL, V256, P810, DOI 10.1007/s00415-009-5023-8
   Huang CC, 1999, ACTA NEUROL SCAND, V99, P125, DOI 10.1111/j.1600-0404.1999.tb00670.x
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Jena NR, 2012, J BIOSCIENCES, V37, P503, DOI 10.1007/s12038-012-9218-2
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jiang CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109984
   Johnston IG, 2016, AM J HUM GENET, V99, P1150, DOI 10.1016/j.ajhg.2016.09.016
   Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935
   Kandul NP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13100
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Kolesar JE, 2014, FREE RADICAL BIO MED, V75, P241, DOI 10.1016/j.freeradbiomed.2014.07.038
   Kolesnikov AA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1424, DOI 10.1134/S0006297912130020
   Koshikawa N, 2009, J BIOL CHEM, V284, P33185, DOI 10.1074/jbc.M109.054221
   Kretzschmar C, 2016, ONCOTARGET, V7, P74460, DOI 10.18632/oncotarget.11952
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kulawiec M, 2009, CANCER BIOL THER, V8, P1378, DOI 10.4161/cbt.8.14.8751
   Lehtinen SK, 2000, GENETICS, V154, P363
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li HY, 2018, BIOCHEM BIOPH RES CO, V495, P574, DOI 10.1016/j.bbrc.2017.11.061
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Li W, 2015, MOL CELL BIOCHEM, V408, P171, DOI 10.1007/s11010-015-2493-0
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Liu YQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03303-w
   Liu Z, 2014, J MED GENET, V51, P176, DOI 10.1136/jmedgenet-2013-101818
   Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212
   MACINO G, 1979, P NATL ACAD SCI USA, V76, P3784, DOI 10.1073/pnas.76.8.3784
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Marchington DR, 2006, EUR J HUM GENET, V14, P816, DOI 10.1038/sj.ejhg.5201618
   Marchington DR, 1998, AM J HUM GENET, V63, P769, DOI 10.1086/302009
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Morris J, 2017, CELL REP, V21, P2706, DOI 10.1016/j.celrep.2017.11.031
   Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Neupane J, 2015, CELL REP, V13, P1304, DOI 10.1016/j.celrep.2015.10.019
   Niemann J, 2017, FREE RADICAL BIO MED, V102, P174, DOI 10.1016/j.freeradbiomed.2016.11.035
   Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956
   NONAKA I, 1992, CURR OPIN NEUROL NEU, V5, P622
   OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Park JS, 2009, HUM MOL GENET, V18, P1578, DOI 10.1093/hmg/ddp069
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Pearce SF, 2017, TRENDS BIOCHEM SCI, V42, P625, DOI 10.1016/j.tibs.2017.02.003
   Pellegrino MW, 2014, NATURE, V516, P414, DOI 10.1038/nature13818
   Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Pryde KR, 2016, J CELL BIOL, V213, P163, DOI 10.1083/jcb.201509003
   Radzvilavicius AL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000410
   Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027
   Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.3.CO;2-9
   Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Samuels DC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003929
   Sazonova MA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/825468
   Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151
   Schull S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.62
   SHADEL GS, 1993, J BIOL CHEM, V268, P16083
   Shao LW, 2016, CELL RES, V26, P1182, DOI 10.1038/cr.2016.118
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Shen J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0145-x
   Shokolenko Inna N, 2014, World J Exp Med, V4, P46
   Shpilka T, 2018, NAT REV MOL CELL BIO, V19, P109, DOI 10.1038/nrm.2017.110
   Singh RK, 2014, SCI REP-UK, V4, DOI 10.1038/srep06571
   Skoczén N, 2018, BBA-BIOENERGETICS, V1859, P602, DOI 10.1016/j.bbabio.2018.05.009
   SOONG NW, 1992, NAT GENET, V2, P318
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Sun WY, 2009, CLIN CANCER RES, V15, P476, DOI 10.1158/1078-0432.CCR-08-0930
   Szczepanowska K, 2017, ESSAYS BIOCHEM, V61, P325, DOI 10.1042/EBC20160090
   Tam ZY, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004183
   Torralba D, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00107
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Valenci I, 2015, MITOCHONDRION, V20, P64, DOI 10.1016/j.mito.2014.11.001
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van Gisbergen MW, 2015, MUTAT RES-REV MUTAT, V764, P16, DOI 10.1016/j.mrrev.2015.01.001
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   Wang SW, 2011, CIRC RES, V108, P862, DOI 10.1161/CIRCRESAHA.110.231811
   WEISIGER RA, 1973, J BIOL CHEM, V248, P4793
   Weiss H, 2012, ENDOCRINOLOGY, V153, P4666, DOI 10.1210/en.2012-1296
   Williams SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003990
   Wilton PR, 2018, GENETICS, V208, P1261, DOI 10.1534/genetics.118.300711
   Wolf DP, 2015, TRENDS MOL MED, V21, P68, DOI 10.1016/j.molmed.2014.12.001
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
   Xue L, 2016, MITOCHONDRION, V30, P208, DOI 10.1016/j.mito.2016.08.008
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yu JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114650
   Yuan Y, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1349-z
   Zhang Q, 2018, CELL, V174, P870, DOI 10.1016/j.cell.2018.06.029
   Zhou M, 2018, J BIOL CHEM, V293, P1425, DOI 10.1074/jbc.RA117.000317
NR 171
TC 55
Z9 61
U1 0
U2 38
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0962-8924
EI 1879-3088
J9 TRENDS CELL BIOL
JI Trends Cell Biol.
PD MAR
PY 2019
VL 29
IS 3
BP 227
EP 240
DI 10.1016/j.tcb.2018.11.004
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA HL4NM
UT WOS:000458698800004
PM 30509558
DA 2024-11-01
ER

PT J
AU Saravanabavan, S
   Rangan, GK
AF Saravanabavan, Sayanthooran
   Rangan, Gopala K.
TI Possible role of the mitochondrial genome in the pathogenesis of
   autosomal dominant polycystic kidney disease
SO NEPHROLOGY
LA English
DT Review
DE autosomal dominant polycystic kidney disease; metabolic reprogramming;
   mitochondrial genome
ID STAGE RENAL-DISEASE; TRANSCRIPTION FACTOR; SKELETAL-MUSCLE; CYST
   FORMATION; DNA DELETIONS; COPY NUMBER; NUCLEAR-DNA; MUTATION;
   HAPLOGROUPS; VARIABILITY
AB Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic renal disease in adults and is due to heterozygous germ line variants in either PKD1, PKD2 or rarely other genes. It is characterized by marked intra-familial disease variability suggesting that other genetic and/or environmental factors are involved in determining the lifetime course ADPKD. Recently, research indicates that polycystin-mediated mitochondrial dysfunction and metabolic re-programming contributes to the progression of ADPKD. Although biochemical abnormalities have gained the most interest, variants in the mitochondrial genome could be one of the mechanisms underlying the phenotypic variability in ADPKD. This narrative review aims to evaluate the role of the mitochondrial genome in the pathogenesis of APDKD.
C1 [Saravanabavan, Sayanthooran; Rangan, Gopala K.] Univ Sydney, Westmead Inst Med Res, Michael Stern Lab Polycyst Kidney Dis, Westmead, NSW, Australia.
   [Saravanabavan, Sayanthooran; Rangan, Gopala K.] Westmead Hosp, Dept Renal Med, Westmead, NSW, Australia.
C3 University of Sydney; Westmead Institute for Medical Research; NSW
   Health; Westmead Hospital; University of Sydney
RP Saravanabavan, S (corresponding author), Westmead Inst Med Res, Ctr Transplant & Renal Res, 176 Hawkesbury Rd POB 412, Westmead, NSW 2145, Australia.
EM sayan.saravanabavan@sydney.edu.au
OI Sayanthooran, Saravanabavan/0000-0002-1334-6364
FU National Health and Medical Research Council [1164128]; PKD Australia
   [2019]; National Health and Medical Research Council of Australia
   [1164128] Funding Source: NHMRC
FX National Health and Medical Research Council, Grant/Award Number:
   1164128; PKD Australia, Grant/Award Number: 2019
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Alexeyev M, 2020, MITOCHONDRIAL DNA A, V31, P45, DOI 10.1080/24701394.2020.1734586
   Allio R, 2017, MOL BIOL EVOL, V34, P2762, DOI 10.1093/molbev/msx197
   Alston CL, 2010, NEUROMUSCULAR DISORD, V20, P131, DOI 10.1016/j.nmd.2009.10.010
   [Anonymous], 2017, CURRENT PROTOCOLS HU
   Beadnell TC, 2018, CANCER METAST REV, V37, P615, DOI 10.1007/s10555-018-9772-7
   Booker LM, 2006, J UROLOGY, V175, P468, DOI 10.1016/S0022-5347(05)00163-1
   Carney EF, 2017, NAT REV NEPHROL, V13, P260, DOI 10.1038/nrneph.2017.33
   Cassina L, 2020, FASEB J, V34, P6493, DOI 10.1096/fj.201901739RR
   Chebib FT, 2016, AM J KIDNEY DIS, V67, P792, DOI 10.1053/j.ajkd.2015.07.037
   Chiaravalli M, 2016, J AM SOC NEPHROL, V27, P1958, DOI 10.1681/ASN.2015030231
   Chinnery PF, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00682
   CHOMYN A, 1994, AM J HUM GENET, V54, P966
   Cohen T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006407
   Connor TM, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006620
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002
   de Laat P, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.523
   Del Bo R, 2002, J NEUROL SCI, V202, P85, DOI 10.1016/S0022-510X(02)00247-2
   Diaz-Morales N, 2018, J CLIN MED, V7, DOI 10.3390/jcm7080220
   Dipple KM, 2000, MOL GENET METAB, V71, P43, DOI 10.1006/mgme.2000.3052
   Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109
   Eirin A, 2017, HANDB EXP PHARMACOL, V240, P229, DOI 10.1007/164_2016_6
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Emperador S, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1128-z
   Estopinal CB, 2014, INVEST OPHTH VIS SCI, V55, P5589, DOI 10.1167/iovs.14-15149
   Fain PR, 2005, KIDNEY INT, V67, P1256, DOI 10.1111/j.1523-1755.2005.00203.x
   Fazzini F, 2019, KIDNEY INT, V96, P480, DOI 10.1016/j.kint.2019.04.021
   Fazzini F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33684-5
   Feeley KP, 2015, CANCER RES, V75, P4429, DOI 10.1158/0008-5472.CAN-15-0074
   Fervenza FC, 2019, AM J KIDNEY DIS, V73, P273, DOI 10.1053/j.ajkd.2018.06.032
   Fetterman JL, 2013, BIOCHEM J, V455, P157, DOI 10.1042/BJ20130029
   Freedman BI, 2000, AM J KIDNEY DIS, V35, P35, DOI 10.1016/S0272-6386(00)70298-8
   Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202
   Gabow PA., 1990, INHERITANCE KIDNEY U, P247
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Govers LP, 2021, PEDIATR NEPHROL, V36, P9, DOI 10.1007/s00467-019-04404-6
   Granata C, 2018, SPORTS MED, V48, P1541, DOI 10.1007/s40279-018-0894-4
   GRETZ N, 1995, KIDNEY INT, V48, P496, DOI 10.1038/ki.1995.319
   Grober OMV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-36
   Groennebaek T, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00713
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Guha M, 2013, MITOCHONDRION, V13, P577, DOI 10.1016/j.mito.2013.08.007
   Gurgey A, 1996, PEDIATR NEPHROL, V10, P637
   Hajarnis S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14395
   Hall AM, 2008, QJM-INT J MED, V101, P755, DOI 10.1093/qjmed/hcn060
   Hall AM, 2009, J AM SOC NEPHROL, V20, P1293, DOI 10.1681/ASN.2008070759
   Halvorson CR, 2010, INT J NEPHROL RENOV, V3, P69
   Hansell P, 2013, CLIN EXP PHARMACOL P, V40, P123, DOI 10.1111/1440-1681.12034
   Hasan-Olive MM, 2019, NEUROCHEM RES, V44, P22, DOI 10.1007/s11064-018-2588-6
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Heyer CM, 2016, J AM SOC NEPHROL, V27, P2872, DOI 10.1681/ASN.2015050583
   Hood DA, 2016, BIOCHEM J, V473, P2295, DOI 10.1042/BCJ20160009
   Hopp K, 2020, KIDNEY INT, V97, P370, DOI 10.1016/j.kint.2019.08.038
   IAKOUBOVA OA, 1995, GENOMICS, V26, P107, DOI 10.1016/0888-7543(95)80088-4
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Ishii K, 2021, KIDNEY INT, V99, P657, DOI 10.1016/j.kint.2020.10.013
   Ishikawa I, 2000, AM J KIDNEY DIS, V35, P1072, DOI 10.1016/S0272-6386(00)70042-4
   Ishimoto Y, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00337-17
   Jansen JJ, 1997, J AM SOC NEPHROL, V8, P1118
   Jiang M, 2017, CELL METAB, V26, P429, DOI 10.1016/j.cmet.2017.07.003
   Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935
   Rangan GK, 2020, EXPERT OPIN ORPHAN D, V8, P285, DOI 10.1080/21678707.2020.1804859
   Kanagasundaram NS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37944-2
   Karise I, 2019, BIOMED PHARMACOTHER, V111, P1156, DOI 10.1016/j.biopha.2019.01.021
   Kenney MC, 2014, BBA-MOL BASIS DIS, V1842, P208, DOI 10.1016/j.bbadis.2013.10.016
   Kesterson Robert A, 2016, Bio Protoc, V6
   Lanktree MB, 2019, KIDNEY INT REP, V4, P995, DOI 10.1016/j.ekir.2019.04.018
   Lanktree MB, 2018, J AM SOC NEPHROL, V29, P2593, DOI 10.1681/ASN.2018050493
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lee JE, 2009, EXP MOL MED, V41, P253, DOI 10.3858/emm.2009.41.4.028
   Lee W, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.34
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Lim PS, 2000, FREE RADICAL BIO MED, V29, P454, DOI 10.1016/S0891-5849(00)00334-8
   Lin CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20856-6
   Liu CS, 2001, NEPHROL DIAL TRANSPL, V16, P561, DOI 10.1093/ndt/16.3.561
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   Lu Y, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aba3613
   Luciano RL, 2014, NEPHROL DIAL TRANSPL, V29, P247, DOI 10.1093/ndt/gft437
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011
   MANOUVRIER S, 1995, J MED GENET, V32, P654, DOI 10.1136/jmg.32.8.654
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   McMartin KE., 2018, MITOCHONDRIAL BIOL E, P193
   Menezes LF, 2016, EBIOMEDICINE, V5, P183, DOI 10.1016/j.ebiom.2016.01.027
   Menezes LF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003053
   Menezes LF, 2019, NAT REV NEPHROL, V15, P736, DOI 10.1038/s41581-019-0183-y
   Murphy EL, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1241-1
   NAKAO E, 1993, INTERNAL MED, V32, P742, DOI 10.2169/internalmedicine.32.742
   Naviaux RK, 2000, EUR J PEDIATR, V159, pS219, DOI 10.1007/PL00014407
   Nowak KL, 2020, CLIN J AM SOC NEPHRO, V15, P577, DOI 10.2215/CJN.13291019
   O'Hara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119
   Padovano V, 2018, NAT REV NEPHROL, V14, P678, DOI 10.1038/s41581-018-0051-1
   Padovano V, 2017, MOL BIOL CELL, V28, P261, DOI 10.1091/mbc.E16-08-0597
   Pandey P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-56
   Parr RL, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-3
   Peral B, 1996, HUM MOL GENET, V5, P539, DOI 10.1093/hmg/5.4.539
   Podrini C, 2020, CELL SIGNAL, V68, DOI 10.1016/j.cellsig.2019.109495
   Podrini C, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0200-x
   Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6
   Qian F, 1999, MOL GENET METAB, V68, P237, DOI 10.1006/mgme.1999.2896
   Rangan GK, 2016, NEPHROLOGY, V21, P705, DOI 10.1111/nep.12658
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Riley V, 2018, GENES-BASEL, V9, DOI 10.3390/genes9080395
   Rossato LB, 2008, RENAL FAILURE, V30, P9, DOI 10.1080/08860220701741650
   Rossetti S, 2009, KIDNEY INT, V75, P848, DOI 10.1038/ki.2008.686
   Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092
   Samuels DC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003929
   Song J, 2001, DIABETES CARE, V24, P865, DOI 10.2337/diacare.24.5.865
   Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165
   SOONG NW, 1992, NAT GENET, V2, P318
   Srivastava SP, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.543973
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Tan J, 2020, EBIOMEDICINE, V54, DOI 10.1016/j.ebiom.2020.102730
   Torres JA, 2019, CELL METAB, V30, P1007, DOI 10.1016/j.cmet.2019.09.012
   TSUZUKI T, 1983, GENE, V25, P223, DOI 10.1016/0378-1119(83)90226-3
   van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
   Vivian CJ, 2017, CANCER RES, V77, P6202, DOI 10.1158/0008-5472.CAN-17-1473
   von Wurmb-Schwark N, 2010, MECH AGEING DEV, V131, P179, DOI 10.1016/j.mad.2010.01.005
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   Warner G, 2016, J AM SOC NEPHROL, V27, P1437, DOI 10.1681/ASN.2015020132
   Yamakawa T, 2001, AM J KIDNEY DIS, V37, DOI 10.1053/ajkd.2001.21358
   Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101
   YIUM J, 1994, J AM SOC NEPHROL, V4, P1670
   Zascavage Roxanne R, 2019, Curr Protoc Hum Genet, V104, pe94, DOI 10.1002/cphg.94
   Zhang YH, 2017, MITOCHONDRIAL DNA A, V28, P725, DOI 10.1080/24701394.2016.1177038
   Zhou HB, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1062314
NR 128
TC 1
Z9 1
U1 2
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1320-5358
EI 1440-1797
J9 NEPHROLOGY
JI Nephrology
PD NOV
PY 2021
VL 26
IS 11
BP 920
EP 930
DI 10.1111/nep.13957
EA AUG 2021
PG 11
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA WL1VX
UT WOS:000682896900001
PM 34331378
OA Bronze
DA 2024-11-01
ER

PT J
AU Malfatti, E
   Laforêt, P
   Jardel, C
   Stojkovic, T
   Behin, A
   Eymard, B
   Lombès, A
   Benmalek, A
   Bécane, HM
   Berber, N
   Meune, C
   Duboc, D
   Wahbi, K
AF Malfatti, Edoardo
   Laforet, Pascal
   Jardel, Claude
   Stojkovic, Tanya
   Behin, Anthony
   Eymard, Bruno
   Lombes, Anne
   Benmalek, Amria
   Becane, Henri-Marc
   Berber, Nawal
   Meune, Christophe
   Duboc, Denis
   Wahbi, Karim
TI High risk of severe cardiac adverse events in patients with
   mitochondrial m.3243A&gt;G mutation
SO NEUROLOGY
LA English
DT Article
ID LEFT-VENTRICULAR HYPERTROPHY; LACTIC-ACIDOSIS; CLINICAL-FEATURES;
   EPISODES MELAS; FOLLOW-UP; ENCEPHALOPATHY; INVOLVEMENT; MYOPATHY; DNA;
   DYSFUNCTION
AB Objectives: To determine the long-term incidence of cardiac life-threatening complications and death in patients with the m.3243A>G mutation, and to identify cardiac prognostic factors.
   Methods: We retrospectively included patients carrying the m.3243A>G mutation who were admitted to the Neuromuscular Disease Clinic of Pitie Salpetriere Hospital between January 1992 and December 2010. We collected information relative to their yearly neurologic and cardiac investigations, their mutation load in blood, urine, and muscle at initial admission, and the occurrence of cardiac life-threatening adverse events and death during follow-up.
   Results: Forty-one patients (median age 5 47 years [36-55 years], men 5 13) were included, of whom 38 had clinical manifestations of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) and 3 were asymptomatic. One patient had a personal history of cardiac transplantation. Cardiac investigations displayed left ventricular hypertrophy, left ventricular dysfunction, or both abnormalities in 18 patients, along with Wolff-Parkinson-White syndrome in 7, conduction system disease in 4, and atrial fibrillation in 1. Over a median 5-year (3-9 years) follow-up period, 11 patients died, including 3 due to heart failure; 7 had life-threatening adverse events, including 6 hospitalizations for severe heart failure and 1 resuscitated cardiac arrest. By multivariate analysis, left ventricular hypertrophy was the only parameter independently associated with occurrence of cardiac adverse events.
   Conclusion: Patients with the m.3243A>G mutation have a high incidence of cardiac death and life-threatening adverse events. Left ventricular hypertrophy was the only parameter independently associated with occurrence of these events. Neurology (R) 2013;80:100-105
C1 [Malfatti, Edoardo; Laforet, Pascal; Stojkovic, Tanya; Behin, Anthony; Eymard, Bruno; Benmalek, Amria; Becane, Henri-Marc; Berber, Nawal; Wahbi, Karim] Hop La Pitie Salpetriere, AP HP, Reference Ctr Muscle Dis Paris Est, Myol Inst, Paris, France.
   [Malfatti, Edoardo] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy.
   [Jardel, Claude] Hop La Pitie Salpetriere, AP HP, Dept Biochem, Paris, France.
   [Meune, Christophe; Duboc, Denis] Paris Descartes Univ, Dept Cardiol, Cochin Hosp, AP HP, Paris, France.
   [Lombes, Anne] UMRS 975 Cochin Hosp, APHP, INSERM, Paris, France.
   [Meune, Christophe; Duboc, Denis] Sorbonne Paris Cite Univ, Paris, France.
   [Wahbi, Karim] Univ Paris 06, Myol Inst, Hop La Pitie Salpetriere, Paris, France.
C3 Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; University of Siena; Sorbonne
   Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; Assistance Publique Hopitaux
   Paris (APHP); Universite Paris Cite; Hopital Universitaire Cochin -
   APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante
   et de la Recherche Medicale (Inserm); Hopital Universitaire
   Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite
RP Wahbi, K (corresponding author), Hop La Pitie Salpetriere, AP HP, Reference Ctr Muscle Dis Paris Est, Myol Inst, Paris, France.
EM karim.wahbi@psl.aphp.fr
RI Lombes, Anne/G-4684-2014; STOJKOVIC, Tanya/AAA-3967-2021; Malfatti,
   Edoardo/KEI-9379-2024
OI wahbi, karim/0000-0001-7682-7387; Behin, Anthony/0000-0001-7179-5152
FU AFM (Association Francaise contre les Myopathies)
FX This study was funded by grants from the AFM (Association Francaise
   contre les Myopathies).
CR Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Cheitlin MD, 2003, J AM SOC ECHOCARDIOG, V16, P1091, DOI 10.1016/S0894-7317(03)00685-0
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   DEVIVO DC, 1990, BIOL NEONATE, V58, P54
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Hirano M, 2001, CURR OPIN CARDIOL, V16, P201, DOI 10.1097/00001573-200105000-00008
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Majamaa-Voltti Kirsi, 2002, BMC Cardiovasc Disord, V2, P12
   Momiyama Y, 2001, DIABETES CARE, V24, P604, DOI 10.2337/diacare.24.3.604
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366
   SATO W, 1994, AM HEART J, V128, P733, DOI 10.1016/0002-8703(94)90272-0
   SCHUMANN GB, 1981, ACTA CYTOL, V25, P147
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Verdecchia P, 2001, CIRCULATION, V104, P2039, DOI 10.1161/hc4201.097944
   Vilarinho L, 1997, J MED GENET, V34, P607, DOI 10.1136/jmg.34.7.607
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wortmann SB, 2007, ACTA PAEDIATR, V96, P450, DOI 10.1111/j.1651-2227.2006.00158.x
NR 28
TC 51
Z9 54
U1 0
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD JAN
PY 2013
VL 80
IS 1
BP 100
EP 105
DI 10.1212/WNL.0b013e31827b1a2f
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 061ZT
UT WOS:000312889600020
PM 23243073
DA 2024-11-01
ER

PT J
AU Rose, S
   Niyazov, DM
   Rossignol, DA
   Goldenthal, M
   Kahler, SG
   Frye, RE
AF Rose, Shannon
   Niyazov, Dmitriy M.
   Rossignol, Daniel A.
   Goldenthal, Michael
   Kahler, Stephen G.
   Frye, Richard E.
TI Clinical and Molecular Characteristics of Mitochondrial Dysfunction in
   Autism Spectrum Disorder
SO MOLECULAR DIAGNOSIS & THERAPY
LA English
DT Review
ID ASPARTATE/GLUTAMATE CARRIER SLC25A12; MAGNETIC-RESONANCE-SPECTROSCOPY;
   GLUTATHIONE REDOX IMBALANCE; SPARE RESPIRATORY CAPACITY; COMORBID
   ANXIETY DISORDER; PERIPHERAL-BLOOD CELLS; AMINO-ACID-TRANSPORT; DNA COPY
   NUMBER; OXIDATIVE STRESS; PROPIONIC-ACID
AB Autism spectrum disorder (ASD) affects similar to 2% of children in the United States. The etiology of ASD likely involves environmental factors triggering physiological abnormalities in genetically sensitive individuals. One of these major physiological abnormalities is mitochondrial dysfunction, which may affect a significant subset of children with ASD. Here we systematically review the literature on human studies of mitochondrial dysfunction related to ASD. Clinical aspects of mitochondrial dysfunction in ASD include unusual neurodevelopmental regression, especially if triggered by an inflammatory event, gastrointestinal symptoms, seizures, motor delays, fatigue and lethargy. Traditional biomarkers of mitochondrial disease are widely reported to be abnormal in ASD, but appear non-specific. Newer biomarkers include buccal cell enzymology, biomarkers of fatty acid metabolism, non-mitochondrial enzyme function, apoptosis markers and mitochondrial antibodies. Many genetic abnormalities are associated with mitochondrial dysfunction in ASD, including chromosomal abnormalities, mitochondrial DNA mutations and large-scale deletions, and mutations in both mitochondrial and non-mitochondrial nuclear genes. Mitochondrial dysfunction has been described in immune and buccal cells, fibroblasts, muscle and gastrointestinal tissue and thebrains of individuals with ASD. Several environmental factors, including toxicants, microbiome metabolites and an oxidized microenvironment are shown to modulate mitochondrial function in ASD tissues. Investigations of treatments for mitochondrial dysfunction in ASD are promising but preliminary. The etiology of mitochondrial dysfunction and how to define it in ASD is currently unclear. However, preliminary evidence suggests that the mitochondria may be a fruitful target for treatment and prevention of ASD. Further research is needed to better understand the role of mitochondrial dysfunction in the pathophysiology of ASD.
C1 [Rose, Shannon; Kahler, Stephen G.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA.
   [Rose, Shannon; Kahler, Stephen G.] Arkansas Childrens Res Inst, Little Rock, AR USA.
   [Niyazov, Dmitriy M.] Ochsner Hlth Syst, Sect Med Genet, New Orleans, LA USA.
   [Rossignol, Daniel A.] Rossignol Med Ctr, Aliso Viejo, CA USA.
   [Goldenthal, Michael] Drexel Univ, St Christophers Hosp Children, Coll Med, Dept Pediat,Neurol Sect, Philadelphia, PA 19104 USA.
   [Frye, Richard E.] Phoenix Childrens Hosp, Barrow Neurol Inst, Div Neurodev Disorders, Dept Neurol, 1919 E Thomas St, Phoenix, AZ 85016 USA.
   [Frye, Richard E.] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA.
C3 University of Arkansas System; University of Arkansas Medical Sciences;
   Ochsner Health System; Drexel University; Barrow Neurological Institute;
   Phoenix Children's Hospital; University of Arizona
RP Frye, RE (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Div Neurodev Disorders, Dept Neurol, 1919 E Thomas St, Phoenix, AZ 85016 USA.; Frye, RE (corresponding author), Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA.
EM rfrye@phoenixchildrens.com
RI Frye, Richard/AAB-5543-2020; Rose, Shannon/JZE-1449-2024; Rossignol,
   Daniel/I-5947-2019
OI Rossignol, Daniel/0000-0002-4405-8664; Rose, Shannon/0000-0003-0595-4367
FU Arkansas Biosciences Institute (Little Rock, AR, USA); Jonty Foundation
   (St. Paul, MN); Autism Research Institute (San Diego, CA); Gupta Family
   Foundation (Atherton, CA); Jane Bostford Johnson Foundation (New York,
   NY); Jager Family Foundation (Chicago, IL); Phoenix Children's Hospital
   Foundation (Phoenix, AZ)
FX We thank the families and individuals with ASD that participated in the
   Autism Genetic Research Exchange and the studies at the National
   Institutes of Mental Health for providing cell lines to us for research.
   We would like to thank the supporters of our research studies, including
   the Arkansas Biosciences Institute (Little Rock, AR, USA), the Jonty
   Foundation (St. Paul, MN), the Autism Research Institute (San Diego,
   CA), the Gupta Family Foundation (Atherton, CA), the Jane Bostford
   Johnson Foundation (New York, NY), the Jager Family Foundation (Chicago,
   IL) and the Phoenix Children's Hospital Foundation (Phoenix, AZ).
CR Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346
   Abu Shmais GA, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-4
   Adams J.B., 2011, Autism Insights, V3, P3
   Adi A, 2015, MOL MED REP, V12, P2307, DOI 10.3892/mmr.2015.3663
   Al-Mosalem OA, 2009, CLIN BIOCHEM, V42, P949, DOI 10.1016/j.clinbiochem.2009.04.006
   Alvarez-Iglesias V, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-50
   Anitha A, 2013, BRAIN PATHOL, V23, P294, DOI 10.1111/bpa.12002
   Anitha A, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-12
   Aoki Y, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.65
   Aoki Y, 2016, MOL NEUROBIOL, V53, P1579, DOI 10.1007/s12035-015-9116-3
   Avdjieva-Tzavella D, 2012, BALK J MED GENET, V15, P47, DOI 10.2478/bjmg-2013-0006
   Aydin HI, 2018, INDIAN PEDIATR, V55, P67, DOI 10.1007/s13312-018-1232-5
   Blasi F, 2006, EUR J HUM GENET, V14, P123, DOI 10.1038/sj.ejhg.5201444
   Blossom SJ, 2006, TOXICOL SCI, V92, P103, DOI 10.1093/toxsci/kfj212
   Blossom SJ, 2013, TOXICOL APPL PHARM, V269, P263, DOI 10.1016/j.taap.2013.03.025
   Boccuto L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-16
   Brown Bradley D, 2015, Innov Clin Neurosci, V12, P29
   Bu XS, 2017, NEUROPSYCH DIS TREAT, V13, P1633, DOI 10.2147/NDT.S129081
   Budd MA, 2018, VIRUSES
   Burger BJ, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00219
   Castro-Gago N, 2008, REV NEUROLOGIA, V47, P52, DOI 10.33588/rn.4701.2007542
   Celestino-Soper PBS, 2012, P NATL ACAD SCI USA, V109, P7974, DOI 10.1073/pnas.1120210109
   Ch'ng C, 2015, AUTISM RES, V8, P593, DOI 10.1002/aur.1475
   Chalkia D, 2017, JAMA PSYCHIAT, V74, P1161, DOI 10.1001/jamapsychiatry.2017.2604
   Chauhan A, 2009, J NEUROCHEM, V109, P273
   Chauhan A, 2012, NEUROCHEM RES, V37, P1681, DOI 10.1007/s11064-012-0775-4
   Chauhan A, 2011, J NEUROCHEM, V117, P209, DOI 10.1111/j.1471-4159.2011.07189.x
   Chen C, 2015, PROTEIN CELL, V6, P862, DOI 10.1007/s13238-015-0175-z
   Chen S, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0432-y
   Chien WH, 2010, PROG NEURO-PSYCHOPH, V34, P189, DOI 10.1016/j.pnpbp.2009.11.004
   Chiocchetti AG, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-10
   Chugani DC, 1999, PROG NEURO-PSYCHOPH, V23, P635, DOI 10.1016/S0278-5846(99)00022-6
   Clark-Taylor T, 2004, MED HYPOTHESES, V62, P970, DOI 10.1016/j.mehy.2004.01.011
   COLEMAN M, 1985, J AUTISM DEV DISORD, V15, P1, DOI 10.1007/BF01837894
   Comi AM, 1999, J CHILD NEUROL, V14, P388, DOI 10.1177/088307389901400608
   Connolly BS, 2010, BIOCHEM BIOPH RES CO, V402, P443, DOI 10.1016/j.bbrc.2010.10.060
   Correia C, 2006, J AUTISM DEV DISORD, V36, P1137, DOI 10.1007/s10803-006-0138-6
   Corrigan NM, 2012, J AUTISM DEV DISORD, V42, P105, DOI 10.1007/s10803-011-1216-y
   Craig AK, 2012, SEIZURE-EUR J EPILEP, V21, P17, DOI 10.1016/j.seizure.2011.08.010
   Dager SR, 2015, JAMA PSYCHIAT, V72, P190, DOI 10.1001/jamapsychiatry.2014.2419
   Dager SR, 2012, J AUTISM DEV DISORD, V42, P643, DOI 10.1007/s10803-011-1352-4
   De Rubeis S., 2014, NATURE, V515, P209, DOI DOI 10.1038/NATURE13772
   Delhey L, 2017, METAB BRAIN DIS, V32, P2021, DOI 10.1007/s11011-017-0087-0
   Delhey LM, 2017, J CLIN MED, V6, DOI 10.3390/jcm6020018
   Desler Claus, 2012, J Aging Res, V2012, P192503, DOI 10.1155/2012/192503
   Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005
   Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015
   Durdiaková J, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-25
   El-Ansary A, 2010, OPEN ACCESS J CLIN T, V2, P49
   El-Ansary A, 2017, METAB BRAIN DIS, V32, P1209, DOI 10.1007/s11011-017-0029-x
   El-Ansary AK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-142
   El-Ansary AK, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-62
   Enns GM, 2008, AAP NEWS, V29, P20
   Esparham Anna E, 2015, Integr Med (Encinitas), V14, P40
   Essa MM, 2012, BIOL TRACE ELEM RES, V147, P25, DOI 10.1007/s12011-011-9280-x
   Ezugha H, 2010, J CHILD NEUROL, V25, P1232, DOI 10.1177/0883073809361165
   Fahmy SF, 2013, RES AUTISM SPECT DIS, V7, P159, DOI 10.1016/j.rasd.2012.07.006
   Fayed N, 2005, ACAD RADIOL, V12, P566, DOI 10.1016/j.acra.2005.01.016
   Fernell E, 2007, NEUROSCI LETT, V418, P82, DOI 10.1016/j.neulet.2007.03.004
   Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008
   Filiano JJ, 2002, J CHILD NEUROL, V17, P435, DOI 10.1177/088307380201700607
   Filipek PA, 2004, J AUTISM DEV DISORD, V34, P615, DOI 10.1007/s10803-004-5283-1
   Filipek PA, 2003, ANN NEUROL, V53, P801, DOI 10.1002/ana.10596
   Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914
   Finsterer J, 2018, J CLIN MED, V7, DOI 10.3390/jcm7020016
   Fluegge Keith, 2016, Innov Clin Neurosci, V13, P13
   Frackowiak J, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-61
   Frye RE, 2018, MOL PSYCHIATR, V23, P247, DOI 10.1038/mp.2016.168
   Frye R, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.189
   Frye RE, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.89
   Frye RE, 2013, MOL PSYCHIATR, V18, P369, DOI 10.1038/mp.2011.175
   Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.51
   Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143
   Frye R.E., 2012, NAJ Med Sci, V5, P141
   Frye RE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01670
   Frye RE, 2016, CLIN MED INSIGHTS-PE, V10, P43, DOI 10.4137/CMPed.S38337
   Frye RE, 2016, SCI REP-UK, V6, DOI 10.1038/srep19544
   Frye Richard E., 2015, Microbial Ecology in Health and Disease, V26, P27458, DOI 10.3402/mehd.v26.27458
   Frye RE, 2012, J CHILD NEUROL, V27, P942, DOI 10.1177/0883073811429858
   Frye RE, 2012, J PEDIATR NEUROL, V10, P35, DOI 10.3233/JPN-2012-0530
   Frye RE, 2011, J PEDIATR NEUROL, V9, P427, DOI 10.3233/JPN-2011-0507
   Frye RE, 2011, PEDIATR RES, V69, p41R, DOI 10.1203/PDR.0b013e318212f16b
   Frye RE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04821-3
   Frye RE, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00066
   Geier DA, 2011, MED SCI MONITOR, V17, pPI15
   Gimelli S, 2014, MOL CYTOGENET, V7, DOI 10.1186/s13039-014-0054-y
   Ginsberg MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044736
   Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706
   Goh S, 2014, JAMA PSYCHIAT, V71, P665, DOI 10.1001/jamapsychiatry.2014.179
   Goldenthal MJ, 2015, BIOMARK MED, V9, P957, DOI 10.2217/bmm.15.72
   Goldenthal MJ, 2012, MOL GENET METAB, V105, P457, DOI 10.1016/j.ymgme.2011.11.193
   Golomb BA, 2014, J CHILD NEUROL, V29, P187, DOI 10.1177/0883073813498466
   Golzio C, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0049
   Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601
   Gu F, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.68
   Guevara-Campos J, 2015, INT J MOL SCI, V16, P3870, DOI 10.3390/ijms16023870
   Guevara-Campos J, 2013, METAB BRAIN DIS, V28, P605, DOI 10.1007/s11011-013-9419-x
   Guevara-Campos J, 2010, INVEST CLIN, V51, P423
   Gupta S, 1996, J AUTISM DEV DISORD, V26, P439, DOI 10.1007/BF02172828
   Gvozdjáková A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/798957
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Haas RH, 2010, DEV DISABIL RES REV, V16, P144, DOI 10.1002/ddrr.112
   Hadjixenofontos A, 2013, ANN HUM GENET, V77, P9, DOI 10.1111/j.1469-1809.2012.00736.x
   Hall L, 2014, AUTISM, V18, P872, DOI 10.1177/1362361313503501
   Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76
   Hill BG, 2010, BBA-BIOENERGETICS, V1797, P285, DOI 10.1016/j.bbabio.2009.11.005
   Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934
   Holtzman D, 2008, ACTA PAEDIATR, V97, P859, DOI 10.1111/j.1651-2227.2008.00883.x
   Howsmon DP, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005385
   Ipser JC, 2012, METAB BRAIN DIS, V27, P275, DOI 10.1007/s11011-012-9293-y
   Iqbal M, 2015, FUTUR NEUROL, V10, P203, DOI 10.2217/FNL.15.11
   James SJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.8
   James SJ, 2006, AM J MED GENET B, V141B, P947, DOI 10.1002/ajmg.b.30366
   James SJ, 2009, FASEB J, V23, P2374, DOI 10.1096/fj.08-128926
   James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611
   Karim M., 2016, J BANGLADESH SOC PHY, V10, P56, DOI DOI 10.3329/JBSP.V10I2.27165
   Kaur K, 2014, FREE RADICAL BIO MED, V76, P25, DOI 10.1016/j.freeradbiomed.2014.07.030
   Kelley RI, 2009, EVALUATION TREATMENT
   Kent L, 2008, AM J MED GENET B, V147B, P987, DOI 10.1002/ajmg.b.30687
   Kent L, 2006, J PEDIATR-US, V149, P280, DOI 10.1016/j.jpeds.2005.08.060
   Khemakhem AM, 2017, METAB BRAIN DIS, V32, P1983, DOI 10.1007/s11011-017-0085-2
   Kong SW, 2013, NEUROGENETICS, V14, P143, DOI 10.1007/s10048-013-0363-z
   Kuwabara H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073814
   LASZLO A, 1994, CLIN CHIM ACTA, V229, P205, DOI 10.1016/0009-8981(94)90243-7
   Legido A., 2018, Neurology, V90, pP3.313
   Legido A, 2013, SEMIN PEDIATR NEUROL, V20, P163, DOI 10.1016/j.spen.2013.10.008
   Lepagnol-Bestel AM, 2008, MOL PSYCHIATR, V13, P385, DOI 10.1038/sj.mp.4002120
   Lintas C, 2012, NEUROBIOL DIS, V45, P57, DOI 10.1016/j.nbd.2010.11.010
   Liu J, 2015, AM J MED GENET B, V168, P236, DOI 10.1002/ajmg.b.32304
   Lv MN, 2016, TRANSL NEUROSCI, V7, P6, DOI 10.1515/tnsci-2016-0002
   Macfabe Derrick, 2013, Glob Adv Health Med, V2, P52, DOI 10.7453/gahmj.2013.089
   MacFabe DF, 2007, BEHAV BRAIN RES, V176, P149, DOI 10.1016/j.bbr.2006.07.025
   MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005
   Maestrini E, 2010, MOL PSYCHIATR, V15, P954, DOI 10.1038/mp.2009.34
   Mahfouz A, 2015, J MOL NEUROSCI, V57, P580, DOI 10.1007/s12031-015-0641-3
   Martinez TN, 2012, ANTIOXID REDOX SIGN, V16, P920, DOI 10.1089/ars.2011.4033
   Marui T, 2011, ACTA PSYCHIAT SCAND, V123, P118, DOI 10.1111/j.1600-0447.2010.01600.x
   Melnyk S, 2012, J AUTISM DEV DISORD, V42, P367, DOI 10.1007/s10803-011-1260-7
   Ming X, 2016, BRAIN DEV-JPN, V38, P225, DOI 10.1016/j.braindev.2015.07.003
   MINSHEW NJ, 1993, BIOL PSYCHIAT, V33, P762, DOI 10.1016/0006-3223(93)90017-8
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   MORENO H, 1992, INVEST CLIN, V33, P13
   Morris G, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0310-y
   Morscher RJ, 2018, NATURE, V554, P128, DOI 10.1038/nature25460
   Mostafa G. A., 2005, INT J CHILD NEUROPSY, V2, P179
   Mousavinejad E, 2017, J NEUROL NEUROREHABI, V2, P25, DOI [10.35841/neurology-neurorehabilitation.2.2.64-68, DOI 10.35841/neurology-neurorehabilitation.2.2.64-68]
   Mousavinejad E, 2018, PSYCHIAT RES, V265, P62, DOI 10.1016/j.psychres.2018.03.061
   Mousavizadeh K, 2013, J RES MED SCI, V18, P926
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Murphy DGM, 2002, ARCH GEN PSYCHIAT, V59, P885, DOI 10.1001/archpsyc.59.10.885
   Mussap M, 2016, EXPERT REV MOL DIAGN, V16, P869, DOI 10.1080/14737159.2016.1202765
   Nankova BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103740
   Napoli E, 2014, PEDIATRICS, V133, pE1405, DOI 10.1542/peds.2013-1545
   Napoli E, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-2
   Napoli E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042504
   Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631
   Oikonomakis V, 2016, CLIN GENET, V89, P708, DOI 10.1111/cge.12740
   Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332
   Oliveira G, 2007, DEV MED CHILD NEUROL, V49, P726, DOI 10.1111/j.1469-8749.2007.00726.x
   Palmieri L, 2010, MOL PSYCHIATR, V15, P38, DOI 10.1038/mp.2008.63
   Parikh S, 2017, GENET MED, V19, DOI 10.1038/gim.2017.164
   Park E, 2017, ADV EXP MED BIOL, V975, P3, DOI 10.1007/978-94-024-1079-2_1
   Parvaneh N, 2014, J CLIN IMMUNOL, V34, P753, DOI 10.1007/s10875-014-0076-6
   Pastural E, 2009, PROSTAG LEUKOTR ESS, V81, P253, DOI 10.1016/j.plefa.2009.06.003
   Patowary A, 2017, AUTISM RES, V10, P1338, DOI 10.1002/aur.1792
   Pecorelli A, 2016, CYTOKINE, V77, P180, DOI 10.1016/j.cyto.2015.10.002
   Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090
   Petek E, 2007, MOL GENET GENOMICS, V277, P71, DOI 10.1007/s00438-006-0173-1
   Peterson BS, 2015, JAMA PSYCHIAT, V72, P190, DOI 10.1001/jamapsychiatry.2014.2425
   Piryaei F, 2012, CELL J, V14, P98
   Poling JS, 2006, J CHILD NEUROL, V21, P170, DOI 10.1177/08830738060210021401
   Pons R, 2004, J PEDIATR-US, V144, P81, DOI 10.1016/j.jpeds.2003.10.023
   Priya L, 2011, REDOX REP, V16, P216, DOI 10.1179/1351000211Y.0000000012
   Rabionet R, 2006, AM J PSYCHIAT, V163, p929A
   Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P276, DOI 10.1055/s-2008-1065354
   Ramaekers VT, 2003, NEUROLOGY, V61, P506, DOI 10.1212/01.WNL.0000078939.64774.1B
   Ramaekers VT, 2004, DEV MED CHILD NEUROL, V46, P843, DOI 10.1017/S0012162204001471
   Ramoz N, 2004, AM J PSYCHIAT, V161, P662, DOI 10.1176/appi.ajp.161.4.662
   Ramoz N, 2008, AM J MED GENET B, V147B, P1152, DOI 10.1002/ajmg.b.30739
   Rogers George W, 2014, Curr Protoc Toxicol, V60, DOI 10.1002/0471140856.tx2503s60
   Rose S, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.29
   Rose S, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.15
   Rose S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.61
   Rose S, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-017-0089-z
   Rose S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186377
   Rose S, 2017, FASEB J, V31, P904, DOI 10.1096/fj.201601004R
   Rose S, 2015, J TOXICOL-US, V2015, DOI 10.1155/2015/573701
   Rose S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085436
   Rose Shannon, 2012, Autism Res Treat, V2012, P986519, DOI 10.1155/2012/986519
   Rosenfeld CS, 2015, DRUG METAB DISPOS, V43, P1557, DOI 10.1124/dmd.115.063826
   Rossi M, 2017, PEDIATR NEUROL, V70, P34, DOI 10.1016/j.pediatrneurol.2017.01.033
   Rossignol DA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.4
   Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165
   Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136
   Rossignol DA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00150
   Rossignol DA, 2012, J AUTISM DEV DISORD, V42, P640, DOI 10.1007/s10803-011-1276-z
   Sandin S, 2014, JAMA-J AM MED ASSOC, V311, P1770, DOI 10.1001/jama.2014.4144
   Sansbury BE, 2011, CHEM-BIOL INTERACT, V191, P288, DOI 10.1016/j.cbi.2010.12.002
   Scaglia F., 2009, AM SOC HUM GEN 59 AN
   Schaefer GB, 2008, GENET MED, V10, P4, DOI 10.1097/GIM.0b013e31815efdd7
   Schaefer GB, 2013, GENET MED, V15, P669, DOI 10.1038/gim.2013.32
   Schaefer KA, 2016, INVEST OPHTH VIS SCI, V57, P2509, DOI 10.1167/iovs.15-18680
   Sdek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058319
   Segurado R, 2005, AM J PSYCHIAT, V162, P2182, DOI 10.1176/appi.ajp.162.11.2182
   Serajee FJ, 2006, NEUROPEDIATRICS S1, V37, pS127
   Shahjadi S., 2017, J DHAKA MED COLL, V26, P43, DOI DOI 10.3329/JDMC.V26I1.34000
   Sharpe MA, 2013, J TOXICOL-US, V2013, DOI 10.1155/2013/801517
   SHAW W, 1995, CLIN CHEM, V41, P1094
   Shaw William, 2017, Integr Med (Encinitas), V16, P50
   Shoffner J, 2016, NEUROLOGY, V86, P2258, DOI 10.1212/WNL.0000000000002766
   Shoffner J, 2010, J CHILD NEUROL, V25, P429, DOI 10.1177/0883073809342128
   Sie L, 2009, J NEUROSCI RES, V87, P1953, DOI 10.1002/jnr.22000
   Silverman JM, 2008, AM J MED GENET B, V147B, P408, DOI 10.1002/ajmg.b.30614
   Slattery J, 2016, CLIN MED INSIGHTS-PE, V10, P91, DOI [10.4137/CMPed.S38338, 10.4137/cmped.s38338]
   Smith M, 2012, BBA-BIOENERGETICS, V1817, P1796, DOI 10.1016/j.bbabio.2012.04.004
   Smith M, 2009, ANN NY ACAD SCI, V1151, P102, DOI 10.1111/j.1749-6632.2008.03571.x
   Tammimies K, 2015, JAMA-J AM MED ASSOC, V314, P895, DOI 10.1001/jama.2015.10078
   Tang GM, 2013, NEUROBIOL DIS, V54, P349, DOI 10.1016/j.nbd.2013.01.006
   Tarlungeanu DC, 2016, CELL, V167, P1481, DOI 10.1016/j.cell.2016.11.013
   Taurines R, 2010, EUR CHILD ADOLES PSY, V19, P441, DOI 10.1007/s00787-009-0074-z
   Thomas RH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-153
   Thomas RH, 2010, J NEUROCHEM, V113, P515, DOI 10.1111/j.1471-4159.2010.06614.x
   Tsao CY, 2007, J CHILD NEUROL, V22, P1121, DOI 10.1177/0883073807306266
   Turunen JA, 2008, AUTISM RES, V1, P189, DOI 10.1002/aur.25
   Varga NA, 2018, BEHAV BRAIN FUNCT, V14, DOI 10.1186/s12993-018-0135-x
   Villafuerte S, 2011, ACTA PSYCHIAT SCAND, V123, P95, DOI 10.1111/j.1600-0447.2010.01654.x
   Waly Mostafa I, 2012, Autism Res Treat, V2012, P190930, DOI 10.1155/2012/190930
   Wang L, 2012, DIGEST DIS SCI, V57, P2096, DOI 10.1007/s10620-012-2167-7
   Wang YQ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006391
   Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002
   Weissman JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003815
   Williams BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024585
   Witters P, 2016, MOL GENET METAB, V119, P317, DOI 10.1016/j.ymgme.2016.10.009
   Wong S, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1888
   Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007
   Yoo HJ, 2017, WORLD J BIOL PSYCHIA, V18, P151, DOI 10.1080/15622975.2016.1234069
   Yorns WR, 2012, J CHILD NEUROL, V27, P398, DOI 10.1177/0883073811420870
   Zaki MM, 2017, TURK J MED SCI, V47, P260, DOI 10.3906/sag-1506-105
   Zelnik N, 1996, PEDIATR NEUROL, V14, P251, DOI 10.1016/0887-8994(96)00046-X
   Zerbo O, 2015, BRAIN BEHAV IMMUN, V46, P232, DOI 10.1016/j.bbi.2015.02.001
   Zhang BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-80
   Zhang LS, 2015, EUR ARCH PSY CLIN N, V265, P511, DOI 10.1007/s00406-014-0524-6
   Zhang YQ, 2018, AM J MED GENET B, V177, P93, DOI 10.1002/ajmg.b.32608
   Ziats MN, 2015, AM J MED GENET A, V167, P2162, DOI 10.1002/ajmg.a.37144
NR 246
TC 143
Z9 153
U1 2
U2 43
PU ADIS INT LTD
PI NORTHCOTE
PA 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND
SN 1177-1062
EI 1179-2000
J9 MOL DIAGN THER
JI Mol. Diagn. Ther.
PD OCT
PY 2018
VL 22
IS 5
BP 571
EP 593
DI 10.1007/s40291-018-0352-x
PG 23
WC Genetics & Heredity; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Genetics & Heredity; Pharmacology & Pharmacy
GA GS8ZO
UT WOS:000444004500006
PM 30039193
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Jokinen, R
   Marttinen, P
   Sandell, HK
   Manninen, T
   Teerenhovi, H
   Wai, T
   Teoli, D
   Loredo-Osti, JC
   Shoubridge, EA
   Battersby, BJ
AF Jokinen, Riikka
   Marttinen, Paula
   Sandell, Helen Katarin
   Manninen, Tuula
   Teerenhovi, Heli
   Wai, Timothy
   Teoli, Daniella
   Loredo-Osti, J. C.
   Shoubridge, Eric A.
   Battersby, Brendan J.
TI <i>Gimap3</i> Regulates Tissue-Specific Mitochondrial DNA Segregation
SO PLOS GENETICS
LA English
DT Article
ID SKELETAL-MUSCLE; MTDNA MUTATION; HETEROPLASMIC MICE; RAPID SEGREGATION;
   PEPTIDE EXPORT; SELECTION; REPLICATION; SURVIVAL; DISEASE; GENOMES
AB Mitochondrial DNA (mtDNA) sequence variants segregate in mutation and tissue-specific manners, but the mechanisms remain unknown. The segregation pattern of pathogenic mtDNA mutations is a major determinant of the onset and severity of disease. Using a heteroplasmic mouse model, we demonstrate that Gimap3, an outer mitochondrial membrane GTPase, is a critical regulator of this process in leukocytes. Gimap3 is important for T cell development and survival, suggesting that leukocyte survival may be a key factor in the genetic regulation of mtDNA sequence variants and in modulating human mitochondrial diseases.
C1 [Jokinen, Riikka; Marttinen, Paula; Sandell, Helen Katarin; Manninen, Tuula; Teerenhovi, Heli; Battersby, Brendan J.] Univ Helsinki, Res Program Mol Neurol, Biomedicum Helsinki, Helsinki, Finland.
   [Jokinen, Riikka; Marttinen, Paula; Sandell, Helen Katarin; Manninen, Tuula; Teerenhovi, Heli; Battersby, Brendan J.] Univ Helsinki, Inst Biomed, Biomedicum Helsinki, Helsinki, Finland.
   [Wai, Timothy; Teoli, Daniella; Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.
   [Wai, Timothy; Teoli, Daniella; Shoubridge, Eric A.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada.
   [Loredo-Osti, J. C.] Mem Univ Newfoundland, Dept Math & Stat, St John, NF A1C 5S7, Canada.
C3 University of Helsinki; University of Helsinki; McGill University;
   McGill University; Memorial University Newfoundland
RP Jokinen, R (corresponding author), Univ Helsinki, Res Program Mol Neurol, Biomedicum Helsinki, Helsinki, Finland.
EM brendan.battersby@helsinki.fi
RI Wai, Timothy/AAA-7226-2019; Gorski, Katarin/U-7619-2017
OI Gorski, Katarin/0000-0002-1359-0957; Wai, Timothy/0000-0002-6770-6222
FU Canadian Institutes of Health Research; NSERC; Academy of Finland;
   University of Helsinki; Biocentrum Helsinki; UMDF-USA; Helsinki
   Biomedical Graduate School
FX This work was supported by grants to EAS from the Canadian Institutes of
   Health Research; to JCLO from NSERC; and to BJB from the Academy of
   Finland, University of Helsinki, Biocentrum Helsinki, and UMDF-USA. RJ
   is supported by the Helsinki Biomedical Graduate School. EAS is a HHMI
   International Scholar. BJB is an Academy of Finland Research Fellow. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206
   Battersby BJ, 2005, HUM MOL GENET, V14, P2587, DOI 10.1093/hmg/ddi293
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Dahéron L, 2001, NUCLEIC ACIDS RES, V29, P1308, DOI 10.1093/nar/29.6.1308
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   KAWAKAMI Y, 1994, ANN NEUROL, V35, P370, DOI 10.1002/ana.410350322
   Krücken J, 2004, GENE, V341, P291, DOI 10.1016/j.gene.2004.07.005
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F
   MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Nitta T, 2006, PLOS BIOL, V4, P593, DOI 10.1371/journal.pbio.0040103
   Nitta T, 2007, TRENDS IMMUNOL, V28, P58, DOI 10.1016/j.it.2006.12.002
   Perego M, 1997, P NATL ACAD SCI USA, V94, P8612, DOI 10.1073/pnas.94.16.8612
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Schulteis RD, 2008, BLOOD, V112, P4905, DOI 10.1182/blood-2008-03-146555
   SHAWAR SM, 1991, J EXP MED, V174, P941, DOI 10.1084/jem.174.4.941
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Weber K, 1997, AM J HUM GENET, V60, P373
   Young L, 2001, SCIENCE, V291, P2135, DOI 10.1126/science.1056957
NR 35
TC 50
Z9 53
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1553-7390
J9 PLOS GENET
JI PLoS Genet.
PD OCT
PY 2010
VL 6
IS 10
AR e1001161
DI 10.1371/journal.pgen.1001161
PG 9
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 673GP
UT WOS:000283647800032
PM 20976251
OA Green Accepted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Cagin, U
   Enriquez, JA
AF Cagin, Umut
   Antonio Enriquez, Jose
TI Mitochondrial DNA-related disorders: emphasis on mechanisms and
   heterogeneity
SO TURKISH JOURNAL OF BIOLOGY
LA English
DT Review
DE Mitochondria; oxidative phosphorylation; mitochondrial DNA;
   mitochondrial DNA disorders; mitochondrial DNA mutations
ID HEREDITARY OPTIC NEUROPATHY; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   RESPIRATORY-CHAIN DISORDERS; SUBSTANTIA-NIGRA NEURONS; KEARNS-SAYRE
   SYNDROME; COMPLEX-I DEFICIENCY; CYTOCHROME-C-OXIDASE; PATERNAL
   INHERITANCE; REPLICATION BUBBLE; OXIDATIVE STRESS
AB Mitochondrial diseases are a heterogeneous group of disorders that are currently the focus of intense research. The many cell functions performed by mitochondria include ATP production, calcium homeostasis, and apoptosis. One of the unique properties of mitochondria is the existence of a separate mitochondrial genome (mitochondrial DNA, mtDNA) found in varying copy numbers and containing 37 genes, 13 of them encoding proteins. All 13 mitochondrially encoded proteins form part of oxidative phosphorylation complexes through combination with approximately 100 nuclear DNA-encoded proteins. Coregulation of nDNA and mtDNA is therefore essential for mitochondrial function, and this coregulation contributes to the heterogeneity and complexity observed in mitochondrial disorders. In recent times, significant advances have been made in our understanding of mtDNA-related disorders. A comprehensive review of these studies will benefit both current and new researchers and clinicians involved in the field. This review examines the major types of mtDNA-related defects and their pathogenic mechanisms, with a special emphasis on the heterogeneity of mitochondrial disorders. Potential treatment strategies specialized for each of the disorders, including the hormone melatonin and the recent advances in gene therapy, related to their potential applications for the management of the primary mtDNA disorders are also discussed.
C1 [Cagin, Umut; Antonio Enriquez, Jose] Natl Ctr Cardiovasc Res CNIC, Cardiovasc Dev & Repair Dept, Madrid, Spain.
   [Antonio Enriquez, Jose] Univ Zaragoza, Fac Sci, Dept Biochem & Mol & Cellular Biol, Zaragoza, Spain.
C3 Centro Nacional de Investigaciones Cardiovasculares (CNIC); University
   of Zaragoza
RP Cagin, U (corresponding author), Natl Ctr Cardiovasc Res CNIC, Cardiovasc Dev & Repair Dept, Madrid, Spain.
EM ucagin@cnic.es
RI CAGIN, UMUT/T-4618-2019; Enriquez, Jose Antonio/M-8468-2016
OI Enriquez, Jose Antonio/0000-0002-3671-2961
FU Ministerio de Economia y Competitividad [SAF2012-1207, CSD2007-00020];
   Comunidad de Madrid [CAM/API1009]; EU (Mitochondrial European
   Educational Training, MEET: European Commission Seventh Framework
   Programme, FP7-PEOPLE-ITN MARIE CURIE) [317433]; Instituto de Salud
   Carlos III (FIS) [PI11-00078]; Ministerio de Economia y Competitividad;
   Pro-CNIC Foundation
FX We would like to thank Dr Manuel Jose Gomez Rodriguez for the useful
   suggestions on the manuscript. This study was supported by grants from
   the Ministerio de Economia y Competitividad (SAF2012-1207 &
   CSD2007-00020), the Comunidad de Madrid (CAM/API1009), the EU
   (Mitochondrial European Educational Training, MEET: European Commission
   Seventh Framework Programme, FP7-PEOPLE-2012-ITN MARIE CURIE, grant
   agreement No. 317433), and the Instituto de Salud Carlos III (FIS grant
   PI11-00078). The CNIC is supported by the Ministerio de Economia y
   Competitividad and the Pro-CNIC Foundation.
CR Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Alavi MV, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-32
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Bacman SR, 2012, GENE THER, V19, P1101, DOI 10.1038/gt.2011.196
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BERNSEN PLJA, 1993, J NEUROL SCI, V118, P181, DOI 10.1016/0022-510X(93)90108-B
   Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P404, DOI 10.1016/S0968-0004(03)00165-8
   Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009
   Bonnefont JP, 2010, CLIN PHARMACOL THER, V88, P101, DOI 10.1038/clpt.2010.55
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bouchet C, 2006, J MED GENET, V43, P788, DOI 10.1136/jmg.2005.034140
   BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Bugiani M, 2006, BRAIN DEV-JPN, V28, P576, DOI 10.1016/j.braindev.2006.04.001
   Cagin U, 2015, INT J BIOCHEM CELL B, V63, P10, DOI 10.1016/j.biocel.2015.01.026
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Carelli V, 2011, BRAIN, V134, DOI 10.1093/brain/awr180
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Carroll CJ, 2014, BRIT J PHARMACOL, V171, P1837, DOI 10.1111/bph.12469
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Danan C, 1999, AM J HUM GENET, V65, P463, DOI 10.1086/302484
   Danhauser K, 2011, MOL GENET METAB, V103, P161, DOI 10.1016/j.ymgme.2011.03.004
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   DiMauro S, 2009, BBA-MOL BASIS DIS, V1792, P1159, DOI 10.1016/j.bbadis.2008.10.015
   Dogan SA, 2011, PHYSIOL RES, V60, pS61, DOI 10.33549/physiolres.932179
   Dragicevic N, 2011, J PINEAL RES, V51, P75, DOI 10.1111/j.1600-079X.2011.00864.x
   Dunn DA, 2012, BBA-GEN SUBJECTS, V1820, P601, DOI 10.1016/j.bbagen.2011.08.005
   ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Furda AM, 2012, DNA REPAIR, V11, P684, DOI 10.1016/j.dnarep.2012.06.002
   Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Golubitzky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026883
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Greaves LC, 2011, MECH AGEING DEV, V132, P588, DOI 10.1016/j.mad.2011.10.004
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Hashimoto M, 2015, MOL THER IN PRESS
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Hellebrekers DMEI, 2012, HUM REPROD UPDATE, V18, P341, DOI 10.1093/humupd/dms008
   Hensen F, 2014, BIOCHIMIE, V100, P219, DOI 10.1016/j.biochi.2013.09.017
   Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Holt IJ, 2003, TRENDS BIOCHEM SCI, V28, P355, DOI 10.1016/S0968-0004(03)00133-6
   HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739
   Huang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081546
   Iommarini L, 2012, NEUROLOGY, V79, P1517, DOI 10.1212/WNL.0b013e31826d5f72
   Janssen AJM, 2003, ANN CLIN BIOCHEM, V40, P3, DOI 10.1258/000456303321016114
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   JOHNSON MA, 1983, J NEUROL SCI, V60, P31, DOI 10.1016/0022-510X(83)90125-9
   Jou MJ, 2007, J PINEAL RES, V43, P389, DOI 10.1111/j.1600-079X.2007.00490.x
   Kanabus M, 2014, BRIT J PHARMACOL, V171, P1798, DOI 10.1111/bph.12456
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kaufmann KB, 2013, EMBO MOL MED, V5, P1642, DOI 10.1002/emmm.201202287
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kerr DS, 2013, NEUROTHERAPEUTICS, V10, P307, DOI 10.1007/s13311-013-0176-7
   Khan NA, 2015, INDIAN J MED RES, V141, P13
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   LARSSON NG, 1992, BIOCHIM BIOPHYS ACTA, V1139, P311, DOI 10.1016/0925-4439(92)90106-W
   Li J, 2008, GENET MOL RES, V7, P1054, DOI 10.4238/vol7-4gmr480
   Libri V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051395
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x
   Lombès A, 2014, BIOCHIMIE, V100, P171, DOI 10.1016/j.biochi.2013.08.012
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Marchington DR, 2002, MOL HUM REPROD, V8, P1046, DOI 10.1093/molehr/8.11.1046
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   Marriage BJ, 2004, MOL GENET METAB, V81, P263, DOI 10.1016/j.ymgme.2003.12.008
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   McInerny SC, 2009, MECH AGEING DEV, V130, P343, DOI 10.1016/j.mad.2009.01.008
   Menezes MJ, 2014, BBA-GEN SUBJECTS, V1840, P1368, DOI 10.1016/j.bbagen.2013.12.025
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Moraes CT, 2014, TRENDS CELL BIOL, V24, P209, DOI 10.1016/j.tcb.2014.02.002
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Naviaux RK, 2004, MITOCHONDRION, V4, P351, DOI 10.1016/j.mito.2004.07.002
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Ohtake A, 2014, BBA-GEN SUBJECTS, V1840, P1355, DOI 10.1016/j.bbagen.2014.01.025
   Oliveira MT, 2010, EXP GERONTOL, V45, P489, DOI 10.1016/j.exger.2010.01.019
   OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0
   Palladino MJ, 2010, NEUROBIOL DIS, V40, P40, DOI 10.1016/j.nbd.2010.05.009
   Pan Y, 2012, GERONTOLOGY, V58, P524, DOI 10.1159/000342204
   Pandi-Perumal SR, 2013, NEUROTOX RES, V23, P267, DOI 10.1007/s12640-012-9337-4
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Peng TI, 2012, J PINEAL RES, V52, P93, DOI 10.1111/j.1600-079X.2011.00923.x
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Poulton J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b94
   Pozzan T, 2000, CELL CALCIUM, V28, P279, DOI 10.1054/ceca.2000.0166
   Quinzii CM, 2010, DEV DISABIL RES REV, V16, P183, DOI 10.1002/ddrr.108
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Santorelli FM, 1996, PEDIATR RES, V39, P914, DOI 10.1203/00006450-199605000-00028
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schwartz M, 2004, J NEUROL SCI, V218, P99, DOI 10.1016/j.jns.2003.11.008
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Sgarbi G, 2009, ARCH NEUROL-CHICAGO, V66, P951, DOI 10.1001/archneurol.2009.134
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Sitarz KS, 2012, NEUROLOGY, V79, P1515, DOI 10.1212/WNL.0b013e31826d5f60
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Szklarczyk R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0439
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, ANN NEUROL, V54, P521, DOI 10.1002/ana.10673
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Temperley RJ, 2003, HUM MOL GENET, V12, P2341, DOI 10.1093/hmg/ddg238
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Vasta V, 2012, PEDIATR INT, V54, P585, DOI 10.1111/j.1442-200X.2012.03644.x
   VILKKI J, 1990, AM J HUM GENET, V47, P95
   Villa-Cuesta E, 2014, J CELL SCI, V127, P2282, DOI 10.1242/jcs.142026
   Viscomi C, 2010, NAT MED, V16, P869, DOI 10.1038/nm.2188
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
   Yang JH, 2009, BIOCHEM BIOPH RES CO, V386, P50, DOI 10.1016/j.bbrc.2009.05.127
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 166
TC 1
Z9 1
U1 0
U2 14
PU Tubitak Scientific & Technological Research Council Turkey
PI ANKARA
PA ATATURK BULVARI NO 221, KAVAKLIDERE, TR-06100 ANKARA, TURKIYE
SN 1300-0152
EI 1303-6092
J9 TURK J BIOL
JI Turk. J. Biol.
PY 2015
VL 39
IS 6
BP 840
EP 855
DI 10.3906/biy-1505-20
PG 16
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA CX2DM
UT WOS:000365505600006
OA Green Published, Bronze, Green Submitted
DA 2024-11-01
ER

PT J
AU Abrigo, J
   Simon, F
   Cabrera, D
   Vilos, C
   Cabello-Verrugio, C
AF Abrigo, Johanna
   Simon, Felipe
   Cabrera, Daniel
   Vilos, Cristian
   Cabello-Verrugio, Claudio
TI Mitochondrial Dysfunction in Skeletal Muscle Pathologies
SO CURRENT PROTEIN & PEPTIDE SCIENCE
LA English
DT Review
DE Mitochondria; ROS; skeletal muscle; atrophy; dystrophy; ATP production
ID UBIQUITIN-PROTEASOME SYSTEM; DNA-DELETION MUTATIONS; DUCHENNE
   MUSCULAR-DYSTROPHY; PROTEIN-DEGRADATION; OXIDATIVE STRESS;
   HUNTINGTONS-DISEASE; INSULIN-RESISTANCE; PERMEABILITY TRANSITION;
   LACTATE PRODUCTION; MOLECULAR-BASIS
AB Several molecular mechanisms are involved in the regulation of skeletal Muscle function. Among them, mitochondrial activity can be identified. The mitochondria is an important and essential organelle in the skeletal muscle that is involved in metabolic regulation and ATP production, which are two key elements of muscle contractibility and plasticity. Thus, in this review, we present the critical and recent antecedents regarding the mechanisms through which mitochondrial dysfunction can be involved in the generation and development of skeletal muscle pathologies, its contribution to detrimental functioning in skeletal muscle and its crosstalk with other typical signaling pathways related to muscle diseases. In addition, an update on the development of new strategies with therapeutic potential to inhibit the deleterious impact of mitochondrial dysfunction in skeletal muscle is discussed.
C1 [Abrigo, Johanna; Cabello-Verrugio, Claudio] Univ Andres Bello, Fac Ciencias Vida, Dept Ciencias Biol, Lab Muscle Pathol Fragil & Aging, Santiago 8370186, Chile.
   [Abrigo, Johanna; Simon, Felipe; Cabello-Verrugio, Claudio] Millennium Inst Immunol & Immunotherapy, Santiago, Chile.
   [Abrigo, Johanna; Vilos, Cristian; Cabello-Verrugio, Claudio] Univ Santiago Chile, Ctr Dev Nanosci & Nanotechnol CEDENNA, Santiago, Chile.
   [Simon, Felipe] Univ Andres Bello, Fac Ciencias Vida, Dept Ciencias Biol, Lab Integrat Physiopathol, Santiago, Chile.
   [Cabrera, Daniel] Pontificia Univ Catolica Chile, Fac Med, Dept Gastroenterol, Santiago, Chile.
   [Cabrera, Daniel] Univ Bernardo O Higgins, Fac Salud, Dept Ciencias Quim & Biol, Santiago, Chile.
   [Vilos, Cristian] Univ Talca, Sch Med, Ctr Med Res, Lab Nanomed & Targeted Delivery, Talca, Chile.
C3 Universidad Andres Bello; Universidad de Santiago de Chile; Universidad
   Andres Bello; Pontificia Universidad Catolica de Chile; Universidad 
   Bernardo O'Higgins; Universidad de Talca
RP Cabello-Verrugio, C (corresponding author), Univ Andres Bello, Fac Ciencias Vida, Dept Ciencias Biol, Lab Muscle Pathol Fragil & Aging, Santiago 8370186, Chile.
EM claudio.cabello@unab.cl
RI Cabello-Verrugio, Claudio/AAD-1454-2020; CABRERA, DANIEL/AAR-5027-2020;
   Vilos, Cristian/KPA-9958-2024
OI Cabello-Verrugio, Claudio/0000-0001-7273-2102; Abrigo,
   Johanna/0000-0002-5598-513X; Simon, Felipe/0000-0002-2653-9798
FU National Fund for Science & Technology Development [FONDECYT 1161646,
   1161288, 1161438, 11171001]; Millennium Institute on Immunology and
   Immunotherapy [P09-016-F]; Programa de Cooperacion Cientifica
   ECOS-CONICYT [C16S02]; Center for Aging and Regeneration [CARE
   PFB12/2007]; BASAL Grant CEDENNA [FB0807]; H2020-MSCA-RISE-2016 [734801
   MAG-NAMED]; Nucleus-UNAB [DI 36-18/N]; Conicyt [21161353]
FX This study was supported by research grants from the National Fund for
   Science & Technology Development, [FONDECYT 1161646 (CCV), 1161288 (FS),
   1161438 (CV), 11171001 (DC)], Millennium Institute on Immunology and
   Immunotherapy [P09-016-F (CCV, FS)]; Programa de Cooperacion Cientifica
   ECOS-CONICYT [C16S02 (CCV)]; Center for Aging and Regeneration [CARE
   PFB12/2007 (DC)]; BASAL Grant CEDENNA [FB0807 (CCV-CV)];
   H2020-MSCA-RISE-2016 [734801 MAG-NAMED (CV)]; Nucleus-UNAB [DI 36-18/N
   (CV)]. J. Abrigo thanks to Conicyt for providing a PhD Scholarship
   [21161353].
CR Agustí AGN, 2002, AM J RESP CRIT CARE, V166, P485, DOI 10.1164/rccm.2108013
   Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001
   Asami Y, 2018, INT J MED SCI, V15, P628, DOI 10.7150/ijms.22723
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barreiro E, 2018, J THORAC DIS, V10, pS1415, DOI 10.21037/jtd.2018.04.168
   Bialek P, 2011, PHYSIOL GENOMICS, V43, P1075, DOI 10.1152/physiolgenomics.00247.2010
   Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011
   Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389
   Bongers KS, 2013, AM J PHYSIOL-ENDOC M, V305, pE907, DOI 10.1152/ajpendo.00380.2013
   Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601
   Bragoszewski P, 2013, MOL CELL BIOL, V33, P2136, DOI 10.1128/MCB.01579-12
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092
   Bronstad E, 2012, EUR RESPIR J, V40, P1130, DOI 10.1183/09031936.00193411
   Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004
   Brown JL, 2017, J CACHEXIA SARCOPENI, V8, P926, DOI 10.1002/jcsm.12232
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Busse ME, 2008, J NEUROL, V255, P1534, DOI 10.1007/s00415-008-0964-x
   Campos F, 2018, PFLUG ARCH EUR J PHY, V470, P1503, DOI 10.1007/s00424-018-2167-3
   Cantó C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Chakrabarty S, 2018, MITOCHONDRION, V43, P25, DOI 10.1016/j.mito.2018.06.006
   Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243
   Cheema N, 2015, AGING CELL, V14, P1085, DOI 10.1111/acel.12399
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Ciammola A, 2006, CELL DEATH DIFFER, V13, P2068, DOI 10.1038/sj.cdd.4401967
   Ciammola A, 2011, MOVEMENT DISORD, V26, P130, DOI 10.1002/mds.23258
   Cole MA, 2002, NEUROMUSCULAR DISORD, V12, P247, DOI 10.1016/S0960-8966(01)00278-4
   Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Damas F, 2018, EUR J APPL PHYSIOL, V118, P485, DOI 10.1007/s00421-017-3792-9
   Dasarathy S, 2016, CURR OPIN GASTROEN, V32, P159, DOI 10.1097/MOG.0000000000000261
   De Palma C, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00188
   Debashree B, 2018, J NEUROCHEM, V145, P323, DOI 10.1111/jnc.14318
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Dhanapal Raghu, 2011, J Oral Maxillofac Pathol, V15, P257, DOI 10.4103/0973-029X.86670
   Di Meo S, 2017, J ENDOCRINOL, V233, pR15, DOI 10.1530/JOE-16-0598
   Dirks A, 2002, AM J PHYSIOL-REG I, V282, pR519, DOI 10.1152/ajpregu.00458.2001
   Dirks AJ, 2005, SPORTS MED, V35, P473, DOI 10.2165/00007256-200535060-00002
   Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002
   Doehner W, 2015, ESC HEART FAIL, V2, P85, DOI 10.1002/ehf2.12035
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Dumas JF, 2009, DIABETES METAB, V35, P159, DOI 10.1016/j.diabet.2009.02.002
   DUNN JF, 1991, J NEUROL SCI, V103, P226, DOI 10.1016/0022-510X(91)90168-7
   Dupont-Versteegden EE, 2005, EXP GERONTOL, V40, P473, DOI 10.1016/j.exger.2005.04.003
   Ebner N, 2015, ESC HEART FAIL, V2, P58, DOI 10.1002/ehf2.12033
   Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81
   Fanzani A, 2012, J CACHEXIA SARCOPENI, V3, P163, DOI 10.1007/s13539-012-0074-6
   Favero G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030765
   Fealy CE, 2018, TRANSL RES, V202, P69, DOI 10.1016/j.trsl.2018.07.011
   Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030
   Frontera WR, 2012, PHYS MED REH CLIN N, V23, P201, DOI 10.1016/j.pmr.2011.11.012
   Gallegly JC, 2004, J APPL PHYSIOL, V97, P1082, DOI 10.1152/japplphysiol.00006.2004
   Gammage PA, 2018, METHODS MOL BIOL, V1867, P43, DOI 10.1007/978-1-4939-8799-3_4
   Gammage PA, 2016, METHODS MOL BIOL, V1351, P145, DOI 10.1007/978-1-4939-3040-1_11
   Geng TY, 2011, AM J PATHOL, V178, P1738, DOI 10.1016/j.ajpath.2011.01.005
   Gosker HR, 2007, EUR RESPIR J, V30, P73, DOI 10.1183/09031936.00146906
   Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247
   Guido C, 2012, ONCOTARGET, V3, P798, DOI 10.18632/oncotarget.574
   Guillot M, 2014, J VASC SURG, V60, P1043, DOI 10.1016/j.jvs.2013.07.100
   Guo YT, 2013, AM J RESP CRIT CARE, V188, P1313, DOI 10.1164/rccm.201304-0732OC
   GUSELLA JF, 1993, ARCH NEUROL-CHICAGO, V50, P1157, DOI 10.1001/archneur.1993.00540110037003
   Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4
   Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137
   Hornikx M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-84
   Hou YJ, 2016, AM J PHYSIOL-RENAL, V310, pF547, DOI 10.1152/ajprenal.00574.2014
   Iqbal S, 2013, MUSCLE NERVE, V48, P963, DOI 10.1002/mus.23838
   Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003
   Jangamreddy JR, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.6159
   Kanabus M, 2014, BRIT J PHARMACOL, V171, P1798, DOI 10.1111/bph.12456
   Karam C, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0123-0
   Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001
   Laporte C, 2007, CELL DEATH DIFFER, V14, P266, DOI 10.1038/sj.cdd.4401994
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083
   LEE CM, 1994, MECH AGEING DEV, V75, P69, DOI 10.1016/0047-6374(94)90029-9
   Lee IH, 2013, CURR OPIN CELL BIOL, V25, P724, DOI 10.1016/j.ceb.2013.07.002
   Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1
   Lehmann G, 2016, BIOCHEM BIOPH RES CO, V473, P80, DOI 10.1016/j.bbrc.2016.03.055
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Liu J, 2016, MOL PHARMACEUT, V13, P73, DOI 10.1021/acs.molpharmaceut.5b00516
   Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13
   Lodi R, 2000, ANN NEUROL, V48, P72
   Lokireddy S, 2012, AM J PHYSIOL-CELL PH, V303, pC512, DOI 10.1152/ajpcell.00402.2011
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186
   Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001
   Marzetti E, 2017, EXP GERONTOL, V87, P92, DOI 10.1016/j.exger.2016.10.003
   Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008
   McLean JB, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00503
   Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200
   Miljkovic N, 2015, ANN REHABIL MED-ARM, V39, P155, DOI 10.5535/arm.2015.39.2.155
   Mishra N, 2010, BIOCHEM BIOPH RES CO, V395, P17, DOI 10.1016/j.bbrc.2010.03.093
   Mofarrahi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047265
   Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006
   Murton AJ, 2008, BBA-MOL BASIS DIS, V1782, P730, DOI 10.1016/j.bbadis.2008.10.011
   Naimi AI, 2011, CLIN PHYSIOL FUNCT I, V31, P124, DOI 10.1111/j.1475-097X.2010.00988.x
   Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799
   Nathan J, 2010, THORAX, V65, P97, DOI 10.1136/thx.2009.120824
   Neutzner Albert, 2007, Novartis Found Symp, V287, P4
   O'Leary MF, 2013, AM J PHYSIOL-CELL PH, V304, pC422, DOI 10.1152/ajpcell.00240.2012
   O'Leary MFN, 2012, AM J PHYSIOL-CELL PH, V303, pC447, DOI 10.1152/ajpcell.00451.2011
   O'Leary MFN, 2009, AUTOPHAGY, V5, P230, DOI 10.4161/auto.5.2.7391
   Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54
   Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884
   Pejznochova M, 2010, MITOCHONDRION, V10, P321, DOI 10.1016/j.mito.2010.01.006
   Percival JM, 2013, HUM MOL GENET, V22, P153, DOI 10.1093/hmg/dds415
   Perry BD, 2016, EXERC IMMUNOL REV, V22, P94
   Picard M, 2008, AM J RESP CRIT CARE, V178, P1040, DOI 10.1164/rccm.200807-1005OC
   Pistilli EE, 2006, J GERONTOL A-BIOL, V61, P245, DOI 10.1093/gerona/61.3.245
   Powers SK, 2012, AM J PHYSIOL-ENDOC M, V303, pE31, DOI 10.1152/ajpendo.00609.2011
   Puente-Maestu L, 2009, EUR RESPIR J, V33, P1045, DOI 10.1183/09031936.00112408
   Qi YB, 2016, J CELL BIOL, V215, P621, DOI 10.1083/jcb.201609019
   Rabinovich RA, 2007, EUR RESPIR J, V29, P643, DOI 10.1183/09031936.00086306
   Rahman M, 2014, ANTIOXID REDOX SIGN, V20, P443, DOI 10.1089/ars.2013.5410
   Reddy PH, 2014, DRUG DISCOV TODAY, V19, P951, DOI 10.1016/j.drudis.2014.03.020
   Reiter RJ, 2002, ANN NY ACAD SCI, V959, P238, DOI 10.1111/j.1749-6632.2002.tb02096.x
   Remels AH, 2008, EUR RESPIR J, V31, P502, DOI 10.1183/09031936.00068207
   Remels AHV, 2010, FASEB J, V24, P5052, DOI 10.1096/fj.09-150714
   ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6
   Romanello V, 2013, J MOL CELL CARDIOL, V55, P64, DOI 10.1016/j.yjmcc.2012.08.001
   Romanello V, 2010, CURR HYPERTENS REP, V12, P433, DOI 10.1007/s11906-010-0157-8
   Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60
   Roos MR, 1997, MUSCLE NERVE, V20, P679
   Rybalka E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115763
   Saft C, 2005, MOVEMENT DISORD, V20, P674, DOI 10.1002/mds.20373
   Sakellariou GK, 2016, SCI REP-UK, V6, DOI 10.1038/srep33944
   Salazar-Roa M, 2017, TRENDS CELL BIOL, V27, P69, DOI 10.1016/j.tcb.2016.08.009
   Sandri M, 2001, J NEUROPATH EXP NEUR, V60, P302, DOI 10.1093/jnen/60.3.302
   Sandri M, 1997, J NEUROPATH EXP NEUR, V56, P45, DOI 10.1097/00005072-199701000-00005
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023
   Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043
   Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006
   Schrauwen P, 2006, J CLIN ENDOCR METAB, V91, P1520, DOI 10.1210/jc.2005-1572
   Sishi B, 2011, EXP PHYSIOL, V96, P179, DOI 10.1113/expphysiol.2010.054189
   Spendiff S, 2016, J PHYSIOL-LONDON, V594, P7361, DOI 10.1113/JP272487
   Sreekumar R, 2007, INDIAN J MED RES, V125, P399
   Stowe DF, 2006, AM J PHYSIOL-HEART C, V290, pH434, DOI 10.1152/ajpheart.00763.2005
   Taivassalo T, 2016, CHEST, V149, P1302, DOI 10.1016/j.chest.2015.11.021
   Takagi D, 2017, GERIATR GERONTOL INT, V17, P402, DOI 10.1111/ggi.12728
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509
   Tews DS, 2005, MUSCLE NERVE, V32, P443, DOI 10.1002/mus.20348
   Tews DS, 1996, NEUROMUSCULAR DISORD, V6, P265, DOI 10.1016/0960-8966(96)00018-1
   Thomas DA, 2007, J AM SOC NEPHROL, V18, P213, DOI 10.1681/ASN.2006080825
   Tryon LD, 2014, INTEGR MED RES, V3, P161, DOI 10.1016/j.imr.2014.09.001
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   Vainshtein A, 2015, AM J PHYSIOL-CELL PH, V308, pC710, DOI 10.1152/ajpcell.00380.2014
   Vainshtein A, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0033-y
   VanderVeen BN, 2017, OXID MED CELL LONGEV, V2017, P1, DOI 10.1155/2017/3292087
   Vinciguerra M, 2010, ADV EXP MED BIOL, V694, P211
   Visser M, 2003, J CLIN ENDOCR METAB, V88, P5766, DOI 10.1210/jc.2003-030604
   von Haehling S, 2017, NAT REV CARDIOL, V14, P323, DOI 10.1038/nrcardio.2017.51
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang X, 2008, J NEUROSCI, V28, P9473, DOI 10.1523/JNEUROSCI.1867-08.2008
   Wang X, 2011, J NEUROSCI, V31, P14496, DOI 10.1523/JNEUROSCI.3059-11.2011
   Wasilewski M, 2009, TRENDS ENDOCRIN MET, V20, P287, DOI 10.1016/j.tem.2009.03.007
   Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548
   Wenz T, 2009, IUBMB LIFE, V61, P1051, DOI 10.1002/iub.261
   White JP, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-14
   Wu J, 2015, MOL NEUROBIOL, V52, P783, DOI 10.1007/s12035-014-8918-z
   Xiao YJ, 2018, PHARMACOL RES, V138, P25, DOI 10.1016/j.phrs.2018.09.008
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zhang YL, 2013, ORG GEOCHEM, V55, P26, DOI 10.1016/j.orggeochem.2012.11.007
   Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004
   Zielonka D, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00380
   Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107
   ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857
NR 176
TC 57
Z9 64
U1 3
U2 32
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2037
EI 1875-5550
J9 CURR PROTEIN PEPT SC
JI Curr. Protein Pept. Sci.
PY 2019
VL 20
IS 6
BP 536
EP 546
DI 10.2174/1389203720666190402100902
PG 11
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA HY7RH
UT WOS:000468333200005
PM 30947668
DA 2024-11-01
ER

PT J
AU Yin, HZ
   Nalbandian, A
   Hsu, CI
   Li, S
   Llewellyn, KJ
   Mozaffar, T
   Kimonis, VE
   Weiss, JH
AF Yin, H. Z.
   Nalbandian, A.
   Hsu, C-I
   Li, S.
   Llewellyn, K. J.
   Mozaffar, T.
   Kimonis, V. E.
   Weiss, J. H.
TI Slow development of ALS-like spinal cord pathology in mutant
   valosin-containing protein gene knock-in mice
SO CELL DEATH & DISEASE
LA English
DT Article
DE motor neuron; SOD1; TDP-43; amyotrophic lateral sclerosis; animal models
ID AMYOTROPHIC-LATERAL-SCLEROSIS; DNA-BINDING PROTEIN; MOTOR-NEURONS;
   PAGET-DISEASE; TDP-43; MUTATIONS; AGGREGATION; DEGENERATION; SOD1; VCP
AB Pathological features of amyotrophic lateral sclerosis (ALS) include, in addition to selective motor neuron (MN) degeneration, the occurrence of protein aggregates, mitochondrial dysfunction and astrogliosis. SOD1 mutations cause rare familial forms of ALS and have provided the most widely studied animal models. Relatively recent studies implicating another protein, TDP-43, in familial and sporadic forms of ALS have led to the development of new animal models. More recently, mutations in the valosin-containing protein (VCP) gene linked to the human genetic disease, Inclusion Body Myopathy associated with Paget's disease of bone and frontotemporal dementia (IBMPFD), were found also to be associated with ALS in some patients. A heterozygous knock-in VCP mouse model of IBMPFD (VCPR155H/+) exhibited muscle, bone and brain pathology characteristic of the human disease. We have undertaken studies of spinal cord pathology in VCPR155H/+ mice and find age-dependent degeneration of ventral horn MNs, TDP-43-positive cytosolic inclusions, mitochondrial aggregation and progressive astrogliosis. Aged animals (similar to 24-27 months) show electromyography evidence of denervation consistent with the observed MN loss. Although these animals do not develop rapidly progressive fatal ALS-like disease during their lifespans, they recapitulate key pathological features of both human disease and other animal models of ALS, and may provide a valuable new model for studying events preceding onset of catastrophic disease. Cell Death and Disease (2012) 3, e374; doi:10.1038/cddis.2012.115; published online 16 August 2012
C1 [Yin, H. Z.; Hsu, C-I; Li, S.; Mozaffar, T.; Weiss, J. H.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92697 USA.
   [Nalbandian, A.; Llewellyn, K. J.; Kimonis, V. E.] Univ Calif Irvine, Dept Pediat, Div Genet & Metab, Irvine, CA 92697 USA.
   [Weiss, J. H.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.
   [Mozaffar, T.] Univ Calif Irvine, Dept Orthopaed Surg, Irvine, CA 92697 USA.
C3 University of California System; University of California Irvine;
   University of California System; University of California Irvine;
   University of California System; University of California Irvine;
   University of California System; University of California Irvine
RP Weiss, JH (corresponding author), Univ Calif Irvine, Dept Neurol, 2101 Gillespie Bldg, Irvine, CA 92697 USA.
EM vkimonis@uci.edu; jweiss@uci.edu
RI Mozaffar, Tahseen/AAE-6971-2020; Chen, Huanhuan/HTO-5007-2023; weiss,
   john/B-4283-2008
OI weiss, john/0000-0001-9323-7813
FU National Institutes of Health [NS36548, AR050236]; Muscular Dystrophy
   Association
FX This work was supported by National Institutes of Health grants NS36548
   (JHW) and AR050236 (VEK), and a grant from the Muscular Dystrophy
   Association (VEK). We appreciate the work of Drs. Watts, Vesa and
   Badadani who performed the preliminary characterization studies of the
   R155H knock-in mice.
CR ALEXIANU ME, 1994, ANN NEUROL, V36, P846, DOI 10.1002/ana.410360608
   Ayala V, 2011, ACTA NEUROPATHOL, V122, P259, DOI 10.1007/s00401-011-0850-y
   Badadani M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013183
   Baloh RH, 2011, FEBS J, V278, P3539, DOI 10.1111/j.1742-4658.2011.08256.x
   Braun RJ, 2011, J BIOL CHEM, V286, P19958, DOI 10.1074/jbc.M110.194852
   Carriedo SG, 1996, J NEUROSCI, V16, P4069
   Carriedo SG, 2000, J NEUROSCI, V20, P240, DOI 10.1523/JNEUROSCI.20-01-00240.2000
   Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18
   Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x
   Custer SK, 2010, HUM MOL GENET, V19, P1741, DOI 10.1093/hmg/ddq050
   Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353
   Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103
   Duan W, 2010, NEUROSCIENCE, V169, P1621, DOI 10.1016/j.neuroscience.2010.06.018
   Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250
   Fecto F, 2011, J MOL NEUROSCI, V45, P663, DOI 10.1007/s12031-011-9637-9
   Ferri A, 2010, HUM MOL GENET, V19, P4529, DOI 10.1093/hmg/ddq383
   Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103
   Geser F, 2010, ARCH NEUROL-CHICAGO, V67, P1238, DOI 10.1001/archneurol.2010.254
   Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003
   Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036
   Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115
   Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862
   Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137
   Manfredi G, 2005, MITOCHONDRION, V5, P77, DOI 10.1016/j.mito.2005.01.002
   Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971
   Nalbandian A, 2013, MUSCLE NERVE, V47, P260, DOI 10.1002/mus.23522
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
   Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200
   Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1
   Rao SD, 2004, TRENDS NEUROSCI, V27, P17, DOI 10.1016/j.tins.2003.11.001
   Rao SD, 2003, J NEUROSCI, V23, P2627
   Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543
   Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107
   Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584
   Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155
   Van Den Bosch L, 2000, J NEUROL SCI, V180, P29, DOI 10.1016/S0022-510X(00)00414-7
   Vanselow BK, 2000, J PHYSIOL-LONDON, V525, P433, DOI 10.1111/j.1469-7793.2000.t01-1-00433.x
   Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332
   Wegorzewska I, 2011, NEURODEGENER DIS, V8, P262, DOI 10.1159/000321547
   Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010
   Yin HZ, 2007, EXP NEUROL, V207, P177, DOI 10.1016/j.expneurol.2007.07.011
NR 41
TC 58
Z9 61
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD AUG
PY 2012
VL 3
AR e374
DI 10.1038/cddis.2012.115
PG 12
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 002SC
UT WOS:000308553800015
PM 22898872
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Kinghorn, KJ
   Kaliakatsos, M
   Blakely, EL
   Taylor, RW
   Rich, P
   Clarke, A
   Omer, S
AF Kinghorn, K. J.
   Kaliakatsos, M.
   Blakely, E. L.
   Taylor, R. W.
   Rich, P.
   Clarke, A.
   Omer, S.
TI Hypertrophic olivary degeneration on magnetic resonance imaging in
   mitochondrial syndromes associated with <i>POLG</i> and <i>SURF1</i>
   mutations
SO JOURNAL OF NEUROLOGY
LA English
DT Review
DE POLG; SURF1; Hypertrophic olivary degeneration; MR imaging;
   Guillain-Mollaret triangle; Dento-rubro-olivary pathway
ID LEIGH-SYNDROME; ATAXIC NEUROPATHY; PALATAL TREMOR; GENE-MUTATIONS; COX
   DEFICIENCY
AB Hypertrophic olivary degeneration (HOD) is associated with lesions within the dento-rubro-olivary pathway or Guillain-Mollaret triangle and may be associated clinically with palatal tremor. Here we report HOD on brain magnetic resonance (MR) imaging in three patients with progressive mitochondrial syndromes in the absence of palatal tremor. Two of the patients were found to have identical compound heterozygous mutations in the POLG gene, encoding the catalytic subunit of the mitochondrial DNA polymerase-gamma, but presented with different clinical phenotypes. The first patient displayed the clinical syndrome of sensory ataxia, neuropathy, dysarthria, and ophthalmoparesis (SANDO), while the second patient was affected by a neurological disorder consisting of an ophthalmoplegia, myopathy, and neuropathy. The third case was a child with Leigh syndrome due to SURF1 gene mutations, who presented with a generalized tremor. We discuss the brain MR imaging findings in these three cases along with a literature review on the MR features of previously reported cases of patients with POLG gene mutations and Leigh disease due to SURF1 gene mutations. Our findings suggest that the presence of HOD, in the appropriate clinical setting, should alert the clinician to the possibility of a mitochondrial disorder and the need to screen for mutations in POLG and SURF1 genes.
C1 [Kinghorn, K. J.; Omer, S.] St George Hosp, Dept Neurol, London, England.
   [Kaliakatsos, M.; Clarke, A.] St George Hosp, Dept Paediat Neurol, London, England.
   [Blakely, E. L.; Taylor, R. W.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Rich, P.] St George Hosp, Dept Neuroradiol, London, England.
C3 City St Georges, University of London; City St Georges, University of
   London; Newcastle University - UK; City St Georges, University of London
RP Omer, S (corresponding author), St George Hosp, Dept Neurol, London, England.
EM salah.omer@stgeorges.nhs.uk
OI Kaliakatsos, Marios/0000-0001-6299-9866; Kinghorn, Kerri
   J/0000-0003-2048-4332
FU Wellcome Trust Centre for Mitochondrial Research [906919]; UK NHS; MRC
   [MR/K000608/1] Funding Source: UKRI
FX RWT is supported by The Wellcome Trust Centre for Mitochondrial Research
   (906919) and the UK NHS Specialist Commissioners which fund the "Rare
   Mitochondrial Disorders of Adults and Children" Diagnostic Service in
   Newcastle upon Tyne (http://www.mitochondrialncg.nhs.uk).
CR BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   Barkovich AJ, 2005, PEDIAT NEUROIMAGING, P76
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   GAUTIER JC, 1961, BRAIN, V84, P341, DOI 10.1093/brain/84.3.341
   Goyal M, 2000, AM J NEURORADIOL, V21, P1073
   Guillain G, 1931, REV NEUROL PARIS, V2545, P566
   Haas R, 2004, MITOCHONDRION, V4, P471, DOI 10.1016/j.mito.2004.07.008
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Jensen M, 2004, HUM REPROD, V19, P65, DOI 10.1093/humrep/deh038
   Johansen KK, 2008, MOVEMENT DISORD, V23, P1624, DOI 10.1002/mds.22178
   Komulainen T, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-29
   Lax N., 2012, Mitochondrial Dysfunction in Neurodegenerative Disorders, P21
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Melick NR, 2007, PEDIATR NEUROL, V37, P280, DOI 10.1016/j.pediatrneurol.2007.06.015
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Moslemi AR, 2003, NEUROLOGY, V61, P991, DOI 10.1212/01.WNL.0000082391.98672.0A
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishie M, 2002, BRAIN, V125, P1348, DOI 10.1093/brain/awf126
   Rossi A, 2003, AM J NEURORADIOL, V24, P1188
   Tiranti V, 1999, ANN NEUROL, V46, P161, DOI 10.1002/1531-8249(199908)46:2<161::AID-ANA4>3.0.CO;2-O
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Trelles J-O, 1935, THESIS PARIS
   Trelles JO, 1943, REV NEUROPSIQUAT, V6, P433
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Xie S, 2009, CLIN IMAG, V33, P1, DOI 10.1016/j.clinimag.2008.08.001
NR 31
TC 34
Z9 35
U1 0
U2 6
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD JAN
PY 2013
VL 260
IS 1
BP 3
EP 9
DI 10.1007/s00415-012-6564-9
PG 7
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 063NV
UT WOS:000313007600002
PM 22729384
DA 2024-11-01
ER

PT J
AU Young, MJ
   Court, DA
AF Young, M. J.
   Court, D. A.
TI Effects of the S288c genetic background and common auxotrophic markers
   on mitochondrial DNA function in <i>Saccharomyces cerevisiae</i>
SO YEAST
LA English
DT Article
DE mitochondrial DNA; Saccharomyces cerevisiae; ADE2; HAP1; MIP1; MRM1
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; ENCODING MIP1 GENE; TRANSLATION
   INITIATION; YEAST MITOCHONDRIA; GLOBAL ANALYSIS; BUDDING YEAST; STRAINS;
   PROTEIN; CARDIOLIPIN; MUTATIONS
AB Saccharomyces cerevisiae is a valuable model organism for the study of eukaryotic processes. Throughout its development as a research tool, several strain backgrounds have been utilized and different combinations of auxotrophic marker genes have been introduced into them, creating a useful but non-homogeneous set of strains. The ade2 allele was used as an auxotrophic marker, and for 'red-white' screening for respiratory competence. his3 alleles that influence the expression of MRM1 have been used as selectable markers, and the MIP1[S] allele, found in the commonly used S228c strain, is associated with mitochondrial DNA defects. The focus of the current work was to examine the effects of these alleles, singly and in combination, on the maintenance of mitochondrial function. The combination of the ade2 and MIP1[S] alleles is associated with a slight increase in point mutations in mitochondrial DNA. The deletion in the his3 Delta 200 allele, which removes the promoter for MRM1, is associated with loss of respiratory competence at 37 degrees C in the presence of either MIP1 allele. Thus, multiple factors can contribute to the maintenance of mitochondrial function, reinforcing the concept that strain background is an important consideration in both designing experiments and comparing results obtained by different research groups. Copyright (C) 2009 John Wiley & Sons, Ltd.
C1 [Young, M. J.; Court, D. A.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.
C3 University of Manitoba
RP Court, DA (corresponding author), Univ Manitoba, Dept Microbiol, 301 Buller Bldg, Winnipeg, MB R3T 2N2, Canada.
EM Deboroh_Court@UManitoba.ca
OI Young, Matthew/0000-0002-5109-4719; Court, Deborah
   A./0000-0003-1919-8339
FU Natural Sciences and Engineering Research Council (NSERC); University of
   Manitoba
FX This work was supported by a Discovery Grant from the Natural Sciences
   and Engineering Research Council (NSERC) to D.A.C., and a Graduate
   Fellowship from the University of Manitoba to M.J.Y. We thank Suman
   Lakhi, Enisa Zildzic, Stephen Szczerba, Kristen Creek and Heather
   McIntosh for excellent technical assistance. We greatly appreciate
   information about strain backgrounds provided by Dr C. Giroux (Wayne
   State University), Dr J. Woolford (Carnegie Mellon University) and Dr T.
   Mason (University of Massachusetts at Amherst).
CR [Anonymous], SCIENCE
   [Anonymous], METHOD ENZYMOL
   Barrientos A, 2003, IUBMB LIFE, V55, P83, DOI 10.1080/1521654031000098122
   Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43
   Baruffini E, 2007, GENETICS, V177, P1227, DOI 10.1534/genetics.107.079293
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Becerra M, 2002, MOL MICROBIOL, V43, P545, DOI 10.1046/j.1365-2958.2002.02724.x
   Boubekeur S, 2001, EUR J BIOCHEM, V268, P5057, DOI 10.1046/j.1432-1033.2001.02418.x
   Brachmann CB, 1998, YEAST, V14, P115
   Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626
   Cohen R, 2007, FEMS MICROBIOL LETT, V273, P239, DOI 10.1111/j.1574-6968.2007.00798.x
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   Dunstan HM, 1997, GENETICS, V147, P87
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   FOLLEY LS, 1991, GENETICS, V129, P659
   Foury F, 2002, CURR OPIN CHEM BIOL, V6, P106, DOI 10.1016/S1367-5931(01)00276-9
   Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07
   Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046
   Gietz RD, 2002, METHOD ENZYMOL, V350, P87
   GLERUM DM, 1994, P NATL ACAD SCI USA, V91, P8452, DOI 10.1073/pnas.91.18.8452
   HALDI M, 1989, J BIOL CHEM, V264, P17107
   HU JP, 1995, GENE, V160, P105, DOI 10.1016/0378-1119(95)00215-R
   Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026
   Iida M, 1998, FEBS LETT, V428, P281, DOI 10.1016/S0014-5793(98)00546-8
   Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x
   Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172
   Kumar C, 2003, YEAST, V20, P857, DOI 10.1002/yea.1012
   Lecrenier N, 2000, GENE, V246, P37, DOI 10.1016/S0378-1119(00)00107-4
   LECRENIER N, 1995, MOL GEN GENET, V249, P1, DOI 10.1007/BF00290229
   Luk E, 2005, J BIOL CHEM, V280, P22715, DOI 10.1074/jbc.M504257200
   Ma LN, 2004, J BIOL CHEM, V279, P44394, DOI 10.1074/jbc.M405479200
   MAARSE AC, 1992, EMBO J, V11, P3619, DOI 10.1002/j.1460-2075.1992.tb05446.x
   MATTOON JR, 1990, CURR GENET, V17, P179, DOI 10.1007/BF00312865
   MORTIMER RK, 1986, GENETICS, V113, P35
   OGUR M, 1957, SCIENCE, V125, P928, DOI 10.1126/science.125.3254.928
   Paschen SA, 2000, EMBO J, V19, P6392, DOI 10.1093/emboj/19.23.6392
   Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200
   Rieger KJ, 1997, YEAST, V13, P1547, DOI 10.1002/(SICI)1097-0061(199712)13:16<1547::AID-YEA230>3.3.CO;2-P
   Sato H, 2004, PROTOPLASMA, V223, P175, DOI 10.1007/s00709-004-0040-z
   SCHERER S, 1979, P NATL ACAD SCI USA, V76, P4951, DOI 10.1073/pnas.76.10.4951
   Schlossmann J, 1996, J BIOL CHEM, V271, P17890, DOI 10.1074/jbc.271.30.17890
   Schwimmer Christine, 2006, Biotechnology Journal, V1, P270, DOI 10.1002/biot.200500053
   Shadel GS, 1999, AM J HUM GENET, V65, P1230, DOI 10.1086/302630
   SHERMAN F, 1964, GENETICS, V49, P39
   Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X
   Sherman F., 1986, LAB COURSE MANUAL ME
   SIKORSKI RS, 1989, GENETICS, V122, P19
   SIRUMCONNOLLY K, 1993, SCIENCE, V262, P1886, DOI 10.1126/science.8266080
   STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353
   Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929
   STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Ter Linde JJM, 2002, YEAST, V19, P825, DOI 10.1002/yea.879
   Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200
   WernerWashburne M, 1996, MOL MICROBIOL, V19, P1159, DOI 10.1111/j.1365-2958.1996.tb02461.x
   Winzeler EA, 2003, GENETICS, V163, P79
   Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901
   Young M., 2004, B GENET SOC CAN, V35, P109
   Young MJ, 2006, YEAST, V23, P101, DOI 10.1002/yea.1344
   Zhang M, 2003, J BIOL CHEM, V278, P35204, DOI 10.1074/jbc.M306729200
   Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200
NR 61
TC 29
Z9 31
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0749-503X
EI 1097-0061
J9 YEAST
JI Yeast
PD DEC
PY 2008
VL 25
IS 12
BP 903
EP 912
DI 10.1002/yea.1644
PG 10
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Microbiology; Mycology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Microbiology; Mycology
GA 405JA
UT WOS:000263217900004
PM 19160453
DA 2024-11-01
ER

PT S
AU Chan, SSL
   Copeland, WC
AF Chan, Sherine S. L.
   Copeland, William C.
BE Stuart, JA
TI Functional Analysis of Mutant Mitochondrial DNA Polymerase Proteins
   Involved in Human Disease
SO MITOCHONDRIAL DNA: METHODS AND PROTOCOLS
SE Methods in Molecular Biology
LA English
DT Article; Book Chapter
DE DNA polymerase gamma; mitochondrial DNA polymerase; DNA replication; DNA
   repair; mitochondrial disease; enzyme assays; POLG; POLG2
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; ACCESSORY SUBUNIT; GAMMA;
   MUTATION; IDENTIFICATION; TOXICITY; DEFECTS
AB DNA polymerase gamma (pol gamma) is the only DNA polymerase within the mitochondrion and is thus essential for replication and repair of mtDNA. POLG, the gene encoding the catalytic subunit of pol gamma, is a major locus for a wide spectrum of mitochondrial diseases with more than 100 known disease mutations. Thus, we need to understand how and why pol gamma defects lead to disease. By using an extensive array of methods, we are developing a clearer understanding of how defects in pol gamma contribute to disease. Furthermore, crucial knowledge concerning the role of pol gamma in mtDNA replication and repair can be acquired. Here we present the protocols to characterize mutant DNA pol gamma proteins, namely, assays for processivc DNA synthesis, exonuclease activity, DNA binding, subunit interaction, and protein stability.
C1 [Chan, Sherine S. L.; Copeland, William C.] Natl Inst Environm Hlth Sci, Mol Genet Lab, Mitochondrial DNA Replicat Grp, NIH, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Chan, SSL (corresponding author), Natl Inst Environm Hlth Sci, Mol Genet Lab, Mitochondrial DNA Replicat Grp, NIH, Res Triangle Pk, NC 27709 USA.
RI Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953
FU Intramural NIH HHS [Z01 ES065078-14] Funding Source: Medline; NIEHS NIH
   HHS [1K99-ES015555-01, K99 ES015555, R00 ES015555, K99 ES015555-01]
   Funding Source: Medline
CR Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   DeRose EF, 2003, BIOCHEMISTRY-US, V42, P9564, DOI 10.1021/bi034298s
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley Matthew J, 2002, Methods Mol Biol, V197, P245, DOI 10.1385/1-59259-284-8:245
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Naviaux RK, 2004, MITOCHONDRION, V4, P351, DOI 10.1016/j.mito.2004.07.002
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
NR 18
TC 4
Z9 4
U1 1
U2 1
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
BN 978-1-934115-60-2
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PY 2009
VL 554
BP 59
EP 72
DI 10.1007/978-1-59745-521-3_4
D2 10.1007/978-1-59745-521-3
PG 14
WC Biochemical Research Methods
WE Book Citation Index – Science (BKCI-S)
SC Biochemistry & Molecular Biology
GA BKY51
UT WOS:000269615700004
PM 19513667
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Jang, YC
   Van Remmen, H
AF Jang, Youngmok C.
   Van Remmen, Holly
TI The mitochondrial theory of aging: Insight from transgenic and knockout
   mouse models
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Review
DE Mitochondria; Mitochondrial theory of aging; Oxidative stress; Aging;
   Transgenic and knockout mouse models
ID MANGANESE SUPEROXIDE-DISMUTASE; LIFE-SPAN; OXIDATIVE STRESS; DNA-DAMAGE;
   SKELETAL-MUSCLE; MICE; OVEREXPRESSION; MUTATIONS; BRAIN; RESTRICTION
AB A substantial body of evidence has accumulated over the past 35 years in support of a role for oxidative damage to the mitochondrial respiratory chain and mitochondrial DNA in the determination of mammalian lifespan. The goal of this review is to provide a concise summary of recent studies using transgenic and knockout mouse models with altered expression of mitochondrial antioxidant enzymes (MnSOD (Sod2Tg and Sod2(+/-)), thioredoxin 2 (Trx2(+/-)), mitochondrial targeted catalase (mCAT) and mutant mice models that have been genetically manipulated to increase mitochondrial deletions or mutations (Poly(D257A/D257A) mutant mice) to examine the role of mitochondrial oxidative stress in aging. The majority of studies using these strategies do not support a clear role for mitochondrial oxidative stress or a vicious cycle of oxidative damage in the determination of lifespan in mice and furthermore do not support the free radical theory of aging. However, several key questions remain to be addressed and clearly more studies are required to fully understand the role of mitochondria in age-related disease and aging. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Jang, Youngmok C.; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
   [Jang, Youngmok C.; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
   [Van Remmen, Holly] S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; University of Texas System; University of Texas Health
   Science Center at San Antonio; US Department of Veterans Affairs;
   Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans
   Hospital
RP Van Remmen, H (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr,MSC 7762, San Antonio, TX 78229 USA.
EM vanremmen@uthscsa.edu
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46
   Croteau DL, 1999, MUTAT RES-DNA REPAIR, V434, P137, DOI 10.1016/S0921-8777(99)00025-7
   Figueiredo PA, 2008, BIOGERONTOLOGY, V9, P67, DOI 10.1007/s10522-007-9121-7
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hu DY, 2007, NEUROBIOL LEARN MEM, V87, P372, DOI 10.1016/j.nlm.2006.10.003
   JANG YC, J GERONTOL UNPUB
   Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   Miller RA, 2005, SCIENCE, V310, P441, DOI 10.1126/science.310.5747.441
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Mitsui A, 2002, ANTIOXID REDOX SIGN, V4, P693, DOI 10.1089/15230860260220201
   Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   Perez VI, 2008, FREE RADICAL BIO MED, V44, P882, DOI 10.1016/j.freeradbiomed.2007.11.018
   Pérez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x
   Rikke BA, 2006, PHYSIOL GENOMICS, V27, P122, DOI 10.1152/physiolgenomics.00068.2006
   Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Sun JT, 2002, GENETICS, V161, P661
   Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179
   Treuting PM, 2008, J GERONTOL A-BIOL, V63, P813, DOI 10.1093/gerona/63.8.813
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003
   Van Remmen H, 2001, EXP GERONTOL, V36, P957
   Van Remmen H, 1999, ARCH BIOCHEM BIOPHYS, V363, P91, DOI 10.1006/abbi.1998.1060
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200
   Yoshida T, 2003, ANTIOXID REDOX SIGN, V5, P563, DOI 10.1089/152308603770310211
NR 42
TC 131
Z9 149
U1 0
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD APR
PY 2009
VL 44
IS 4
BP 256
EP 260
DI 10.1016/j.exger.2008.12.006
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 435JQ
UT WOS:000265340600004
PM 19171187
DA 2024-11-01
ER

PT J
AU Ridge, PG
   Maxwell, TJ
   Foutz, SJ
   Bailey, MH
   Corcoran, CD
   Tschanz, JT
   Norton, MC
   Munger, RG
   O'Brien, E
   Kerber, RA
   Cawthon, RM
   Kauwe, JSK
AF Ridge, Perry G.
   Maxwell, Taylor J.
   Foutz, Spencer J.
   Bailey, Matthew H.
   Corcoran, Christopher D.
   Tschanz, JoAnn T.
   Norton, Maria C.
   Munger, Ronald G.
   O'Brien, Elizabeth
   Kerber, Richard A.
   Cawthon, Richard M.
   Kauwe, John S. K.
TI Mitochondrial genomic variation associated with higher mitochondrial
   copy number: the Cache County Study on Memory Health and Aging
SO BMC BIOINFORMATICS
LA English
DT Article
ID TRANSCRIPTION FACTOR; GENETIC-STRUCTURE; UTAH MORMONS; MUTATION; AGE;
   ACTIVATION; MUSCLE; DAMAGE; PROLIFERATION; PREVALENCE
AB Background: The mitochondria are essential organelles and are the location of cellular respiration, which is responsible for the majority of ATP production. Each cell contains multiple mitochondria, and each mitochondrion contains multiple copies of its own circular genome. The ratio of mitochondrial genomes to nuclear genomes is referred to as mitochondrial copy number. Decreases in mitochondrial copy number are known to occur in many tissues as people age, and in certain diseases. The regulation of mitochondrial copy number by nuclear genes has been studied extensively. While mitochondrial variation has been associated with longevity and some of the diseases known to have reduced mitochondrial copy number, the role that the mitochondrial genome itself has in regulating mitochondrial copy number remains poorly understood.
   Results: We analyzed the complete mitochondrial genomes from 1007 individuals randomly selected from the Cache County Study on Memory Health and Aging utilizing the inferred evolutionary history of the mitochondrial haplotypes present in our dataset to identify sequence variation and mitochondrial haplotypes associated with changes in mitochondrial copy number. Three variants belonging to mitochondrial haplogroups U5A1 and T2 were significantly associated with higher mitochondrial copy number in our dataset.
   Conclusions: We identified three variants associated with higher mitochondrial copy number and suggest several hypotheses for how these variants influence mitochondrial copy number by interacting with known regulators of mitochondrial copy number. Our results are the first to report sequence variation in the mitochondrial genome that causes changes in mitochondrial copy number. The identification of these variants that increase mtDNA copy number has important implications in understanding the pathological processes that underlie these phenotypes.
C1 [Ridge, Perry G.; Foutz, Spencer J.; Bailey, Matthew H.; Kauwe, John S. K.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.
   [Ridge, Perry G.] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA.
   [Maxwell, Taylor J.] Univ Texas Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX USA.
   [Corcoran, Christopher D.] Utah State Univ, Dept Math & Stat, Logan, UT 84322 USA.
   [Corcoran, Christopher D.; Tschanz, JoAnn T.; Norton, Maria C.; Munger, Ronald G.] Utah State Univ, Ctr Epidemiol Studies, Logan, UT 84322 USA.
   [Tschanz, JoAnn T.; Norton, Maria C.] Utah State Univ, Dept Psychol, Logan, UT 84322 USA.
   [Norton, Maria C.] Utah State Univ, Dept Family Consumer & Human Dev, Logan, UT 84322 USA.
   [Munger, Ronald G.] Utah State Univ, Dept Nutr Dietet & Food Sci, Logan, UT 84322 USA.
   [O'Brien, Elizabeth; Kerber, Richard A.] Univ Louisville, Dept Epidemiol & Populat Hlth, Louisville, KY 40292 USA.
   [Cawthon, Richard M.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA.
C3 Brigham Young University; Utah System of Higher Education; University of
   Utah; ARUP Laboratories; University of Texas System; University of Texas
   Health Science Center Houston; University of Texas School Public Health;
   Utah System of Higher Education; Utah State University; Utah System of
   Higher Education; Utah State University; Utah System of Higher
   Education; Utah State University; Utah System of Higher Education; Utah
   State University; Utah System of Higher Education; Utah State
   University; University of Louisville; Utah System of Higher Education;
   University of Utah
RP Ridge, PG (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.
RI Bailey, Matthew/AAE-1118-2021; Kauwe, John/AAC-6646-2021; Kerber,
   Richard/B-8038-2009
OI Bailey, Matthew H./0000-0003-4526-9727
FU NIH [R01AG11380, R01AG21136, R01AG31272, R01AG042611]; Alzheimer's
   Association [MNIRG-11-205368]; Utah Science, Technology, and Research
   initiative (USTAR); Brigham Young University Gerontology Program (JSKK)
FX This work was supported by grants from NIH (R01AG11380, R01AG21136,
   R01AG31272, R01AG042611), the Alzheimer's Association (MNIRG-11-205368)
   and the Utah Science, Technology, and Research initiative (USTAR), and
   the Brigham Young University Gerontology Program (JSKK). This article
   has been published as part of BMC Bioinformatics Volume 15 Supplement 7,
   2014: Selected articles from the 10th Annual Biotechnology and
   Bioinformatics Symposium (BIOT 2013). The full contents of the
   supplement are available online at http://www. biomedcentral. com/
   bmcbioinformatics/supplements/15/S7
CR Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140
   Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Bianchi M, 2011, BIOCHEM BIOPH RES CO, V415, P300, DOI 10.1016/j.bbrc.2011.10.049
   Blokhin A, 2008, J MOL NEUROSCI, V35, P283, DOI 10.1007/s12031-008-9115-1
   Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321
   Carling PJ, 2011, MITOCHONDRION, V11, P686, DOI 10.1016/j.mito.2011.05.004
   Carnesecchi S, 2006, EXP CELL RES, V312, P3413, DOI 10.1016/j.yexcr.2006.07.003
   Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027
   Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x
   Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev
   Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Gianotti TF, 2011, METABOLISM, V60, P1142, DOI 10.1016/j.metabol.2010.12.008
   Finnilä S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591
   Finsterer J, 2007, ACTA HAEMATOL-BASEL, V118, P88, DOI 10.1159/000105676
   Gao N, 2002, J BIOL CHEM, V277, P45041, DOI 10.1074/jbc.M202775200
   Gu M, 2000, LANCET, V356, P469, DOI 10.1016/S0140-6736(00)02556-3
   Guo JH, 2011, CANCER RES, V71, P2978, DOI 10.1158/0008-5472.CAN-10-3482
   Hartmann N, 2011, AGING CELL, V10, P824, DOI 10.1111/j.1474-9726.2011.00723.x
   Hassanin A, 2009, J MOL EVOL, V68, P293, DOI 10.1007/s00239-009-9208-7
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   JORDE LB, 1987, AM J PHYS ANTHROPOL, V72, P403, DOI 10.1002/ajpa.1330720313
   JORDE LB, 1982, HUM BIOL, V54, P583
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   KERBER RA, 1995, GENET EPIDEMIOL, V12, P291, DOI 10.1002/gepi.1370120306
   Kleefstra T, 2011, EUR J HUM GENET, V19, P138, DOI 10.1038/ejhg.2010.171
   Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300
   Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345
   Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111
   Kulawiec Mariola, 2009, J Carcinog, V8, P8, DOI 10.4103/1477-3163.50893
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Lamson Davis W, 2002, Altern Med Rev, V7, P94
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lassus P, 2000, ONCOGENE, V19, P2377, DOI 10.1038/sj.onc.1203553
   Lebedeva MA, 2007, CELL CYCLE, V6, P2048, DOI 10.4161/cc.6.16.4572
   Lee JJ, 2010, ONCOGENE, V29, P561, DOI 10.1038/onc.2009.355
   Lee JW, 2010, CLIN CHIM ACTA, V411, P592, DOI 10.1016/j.cca.2010.01.024
   Lee JE, 2009, EXP MOL MED, V41, P253, DOI 10.3858/emm.2009.41.4.028
   Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107
   Li ZW, 2006, IUBMB LIFE, V58, P581, DOI 10.1080/15216540600946456
   Liu HY, 2009, J BIOL CHEM, V284, P14087, DOI 10.1074/jbc.M807992200
   Lu YJ, 2010, AM J RESP CELL MOL, V42, P432, DOI 10.1165/rcmb.2009-0002OC
   Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002
   Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189
   Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107
   McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029
   OBRIEN E, 1994, HUM BIOL, V66, P743
   Parfait B, 1998, BIOCHEM BIOPH RES CO, V247, P57, DOI 10.1006/bbrc.1998.8666
   Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310
   Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303
   Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200
   Posada D, 2005, BIOINFORMATICS, V21, P2130, DOI 10.1093/bioinformatics/bti293
   Ridge PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045134
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Santos RX, 2010, INT J CLIN EXP PATHO, V3, P570
   Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926
   Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176
   Sequeira Adolfo, 2012, Frontiers in Genetics, V3, P103, DOI 10.3389/fgene.2012.00103
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731
   Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045
   Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, pS265, DOI 10.3233/JAD-2010-100339
   Swerdlow RH, 2009, EXP NEUROL, V218, P308, DOI 10.1016/j.expneurol.2009.01.011
   Taylor RW, 2002, EUR J HUM GENET, V10, P141, DOI 10.1038/sj.ejhg.5200773
   Taylor SD, 2005, MOL BIOL CELL, V16, P3010, DOI 10.1091/mbc.E05-01-0053
   Templeton AR, 2005, GENETICS, V169, P441, DOI 10.1534/genetics.104.030080
   Tewari S, 2012, ANTIOXID REDOX SIGN, V17, P492, DOI 10.1089/ars.2011.4333
   Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00
   Thyagarajan B, 2012, CANC EPIDEMIOLOGY BI
   Trinei M, 2006, BBA-BIOENERGETICS, V1757, P624, DOI 10.1016/j.bbabio.2006.05.029
   van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Vendelbo MH, 2011, BBA-MOL CELL RES, V1813, P634, DOI 10.1016/j.bbamcr.2011.01.029
   VILMING ST, 1986, ACTA NEUROL SCAND, V73, P502, DOI 10.1111/j.1600-0404.1986.tb04594.x
   Westfall P.H., 1993, RESAMPLING BASED MUL
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955
   Yu M, 2010, CLIN CHIM ACTA, V411, P679, DOI 10.1016/j.cca.2010.01.035
   Zaid A, 1999, J BIOENERG BIOMEMBR, V31, P129, DOI 10.1023/A:1005499727732
   Zou T, 2010, ACTA BIOCH BIOPH SIN, V42, P908, DOI 10.1093/abbs/gmq102
NR 93
TC 17
Z9 18
U1 0
U2 17
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD MAY 28
PY 2014
VL 15
SU 7
AR S6
DI 10.1186/1471-2105-15-S7-S6
PG 14
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA AJ2DP
UT WOS:000337465800006
PM 25077862
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Ikonen, L
   Pirnes-Karhu, S
   Pradhan, S
   Jacobs, HT
   Szibor, M
   Suomalainen, A
AF Ikonen, Lilli
   Pirnes-Karhu, Sini
   Pradhan, Swagat
   Jacobs, Howard T.
   Szibor, Marten
   Suomalainen, Anu
TI Alternative oxidase causes cell type- and tissue-specific responses in
   mutator mice
SO LIFE SCIENCE ALLIANCE
LA English
DT Article
ID SKELETAL-MUSCLE; STRESS RESPONSES; MITOCHONDRIA; EXPRESSION; DEFECTS;
   UNDERSTAND; ACTIVATION; MUTATIONS; DELETIONS; PATHWAY
AB Energetic insufficiency, excess production of reactive oxygen species (ROS), and aberrant signaling partially account for the diverse pathology of mitochondrial diseases. Whether interventions affecting ROS, a regulator of stem cell pools, could modify somatic stem cell homeostasis remains unknown. Previous data from mitochondrial DNA mutator mice showed that increased ROS leads to oxidative damage in erythroid progenitors, causing lifespan-limiting anemia. Also unclear is how ROStargeted interventions affect terminally differentiated tissues. Here, we set out to test in mitochondrial DNA mutator mice how ubiquitous expression of the Ciona intestinalis alternative oxidase (AOX), which attenuates ROS production, affects murine stem cell pools. We found that AOX does not affect neural stem cells but delays the progression of mutator-driven anemia. Furthermore, when combined with the mutator, AOX potentiates mitochondrial stress and inflammatory responses in skeletal muscle. These differential cell type-specific findings demonstrate that AOX expression is not a global panacea for curing mitochondrial dysfunction. ROS attenuation must be carefully studied regarding specific underlying defects before AOX can be safely used in therapy.
C1 [Ikonen, Lilli; Pradhan, Swagat; Suomalainen, Anu] Univ Helsinki, Fac Med, Stem Cells & Metab Res Program, Helsinki, Finland.
   [Pirnes-Karhu, Sini] Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Helsinki, Finland.
   [Jacobs, Howard T.; Szibor, Marten] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland.
   [Szibor, Marten] Friedrich Schiller Univ Jena, Jena Univ Hosp, Ctr Sepsis Control & Care, Dept Cardiothorac Surg, Jena, Germany.
   [Suomalainen, Anu] Helsinki Univ Hosp, HUSLAB, Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; Tampere University;
   Friedrich Schiller University of Jena; University of Helsinki; Helsinki
   University Central Hospital
RP Ikonen, L; Suomalainen, A (corresponding author), Univ Helsinki, Fac Med, Stem Cells & Metab Res Program, Helsinki, Finland.; Suomalainen, A (corresponding author), Helsinki Univ Hosp, HUSLAB, Helsinki, Finland.
EM lilli.ikonen@helsinki.fi; anu.wartiovaara@helsinki.fi
RI Pradhan, Swagat/ABC-1053-2021; Jacobs, Howard/G-2434-2011
OI Szibor, Marten/0000-0003-4029-160X; Jacobs, Howard/0000-0003-1895-6003;
   Ikonen, Lilli/0000-0002-4347-1748; Pradhan, Swagat/0000-0002-3173-6542
FU Biomedicum Helsinki Foundation; Finnish Medical Foundation; Academy of
   Finland; Sigrid Juselius Foundation; University of Helsinki; European
   Research Council; Bio-center Finland
FX We are grateful to Markus Innila, Babette Hollman, Sonja Jansson, Maarit
   Partanen, and Tea Tuomela for technical assistance; Mito Takayuki,
   Chris-topher Jackson, and Nahid Khan for assistance with imaging;
   Gulayse Ince-Dunn for RNAseq insight; Yilin Kang for helpful
   discussions; and Biomedicum Imaging Unit and Biomedicum Functional
   Genomics Unit for services and infrastructure. The authors acknowledge
   funding from the Biomedicum Helsinki Foundation (L Ikonen) , The Finnish
   Medical Foundation (L Ikonen) , the Academy of Finland (A Suomalainen,
   HT Jacobs, and M Szibor) , the Sigrid Juselius Foundation (L Ikonen and
   A Suomalainen) , the University of Helsinki (A Suomalainen) , and the
   European Research Council (HT Jacobs and M Szibor) . The work used core
   facilities part-supported by funding from Bio-center Finland.
CR Aarreberg LD, 2019, MOL CELL, V74, P801, DOI 10.1016/j.molcel.2019.02.038
   Abdel-Nour M, 2019, SCIENCE, V365, P47, DOI 10.1126/science.aaw4144
   Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657
   Ahlqvist KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7494
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028
   AZZARELLO G, 1987, J CANCER RES CLIN, V113, P417, DOI 10.1007/BF00390035
   Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273
   Cannino G, 2012, J BIOL CHEM, V287, P38729, DOI 10.1074/jbc.M112.386060
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   Chin AC, 2019, J NEUROPHYSIOL, V121, P1087, DOI 10.1152/jn.00848.2018
   Cláudio N, 2013, EMBO J, V32, P1214, DOI 10.1038/emboj.2013.80
   Coleman V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20901-4
   Dassa EP, 2009, PHYSIOL PLANTARUM, V137, P427, DOI 10.1111/j.1399-3054.2009.01248.x
   Dhandapani PK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49231-9
   Dhandapani PK, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14159
   DINARELLO CA, 1984, NEW ENGL J MED, V311, P1413
   Dogan SA, 2018, CELL METAB, V28, P764, DOI 10.1016/j.cmet.2018.07.012
   El-Khoury R, 2014, BRIT J PHARMACOL, V171, P2243, DOI 10.1111/bph.12570
   El-Khoury R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003182
   Fang R, 2017, J IMMUNOL, V199, P3222, DOI 10.4049/jimmunol.1700699
   Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004
   Fessler E, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-29479-y
   Giordano L, 2019, AM J RESP CELL MOL, V60, P515, DOI 10.1165/rcmb.2018-0261OC
   Hämäläinen RH, 2019, NAT METAB, V1, P958, DOI 10.1038/s42255-019-0120-1
   Hämäläinen RH, 2015, CELL REP, V11, P1614, DOI 10.1016/j.celrep.2015.05.009
   Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482
   Kammoun M, 2014, EUR J HISTOCHEM, V58, P163, DOI 10.4081/ejh.2014.2254
   Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x
   Krämer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lei YJ, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe7548
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lucas CA, 2000, BIOCHEM BIOPH RES CO, V272, P303, DOI 10.1006/bbrc.2000.2768
   Mayer-Barber KD, 2017, CELL MOL IMMUNOL, V14, P22, DOI 10.1038/cmi.2016.25
   McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970
   Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064
   Mito T, 2022, CELL METAB, V34, P197, DOI 10.1016/j.cmet.2021.12.017
   Motwani M, 2019, NAT REV GENET, V20, P657, DOI 10.1038/s41576-019-0151-1
   Newman LE, 2018, J CELL BIOL, V217, P3327, DOI 10.1083/jcb.201808118
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Persson Ö, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08673-5
   Pierre P, 2019, SCIENCE, V365, P28, DOI 10.1126/science.aay0987
   Piltti K, 2006, ONCOGENE, V25, P4880, DOI 10.1038/sj.onc.1209492
   Rajendran J, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809456
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107
   Rustin P, 2009, PHYSIOL PLANTARUM, V137, P362, DOI 10.1111/j.1399-3054.2009.01249.x
   SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810
   Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9
   Spangenburg EE, 2003, ACTA PHYSIOL SCAND, V178, P413, DOI 10.1046/j.1365-201X.2003.01158.x
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Szibor M, 2020, BBA-BIOENERGETICS, V1861, DOI 10.1016/j.bbabio.2019.148137
   Szibor M, 2017, DIS MODEL MECH, V10, P163, DOI 10.1242/dmm.027839
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Vanlerberghe GC, 2013, INT J MOL SCI, V14, P6805, DOI 10.3390/ijms14046805
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Yi YS, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147580
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
NR 66
TC 1
Z9 1
U1 0
U2 0
PU LIFE SCIENCE ALLIANCE LLC
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
EI 2575-1077
J9 LIFE SCI ALLIANCE
JI Life Sci. Alliance
PD NOV
PY 2023
VL 6
IS 11
AR e202302036
DI 10.26508/lsa.202302036
PG 12
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA Y9VL9
UT WOS:001108664200009
PM 37657934
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Ross, JM
   Coppotelli, G
   Branca, RM
   Kim, KM
   Lehtiö, J
   Sinclair, DA
   Olson, L
AF Ross, Jaime M.
   Coppotelli, Giuseppe
   Branca, Rui M.
   Kim, Kyung M.
   Lehtio, Janne
   Sinclair, David A.
   Olson, Lars
TI Voluntary exercise normalizes the proteomic landscape in muscle and
   brain and improves the phenotype of progeroid mice
SO AGING CELL
LA English
DT Article
DE aging; exercise; mitochondria; mtDNA; PolG; proteomics
ID MITOCHONDRIAL-DNA MUTATIONS; NEURONS
AB The accumulation of mitochondrial DNA (mtDNA) mutations is a suspected driver of aging and age-related diseases, but forestalling these changes has been a major challenge. One of the best-studied models is the prematurely aging mtDNA mutator mouse, which carries a homozygous knock-in of a proofreading deficient version of the catalytic subunit of mtDNA polymerase-gamma (PolgA). We investigated how voluntary exercise affects the progression of aging phenotypes in this mouse, focusing on mitochondrial and protein homeostasis in both brain and peripheral tissues. Voluntary exercise significantly ameliorated several aspects of the premature aging phenotype, including decreased locomotor activity, alopecia, and kyphosis, but did not have major effects on the decreased lifespan of mtDNA mutator mice. Exercise also decreased the mtDNA mutation load. In-depth tissue proteomics revealed that exercise normalized the levels of about half the proteins, with the majority involved in mitochondrial function and nuclear-mitochondrial crosstalk. There was also a specific increase in the nuclear-encoded proteins needed for the tricarboxylic acid cycle and complex II, but not in mitochondrial-encoded oxidative phosphorylation proteins, as well as normalization of enzymes involved in coenzyme Q biosynthesis. Furthermore, we found tissue-specific alterations, with brain coping better as compared to muscle and with motor cortex being better protected than striatum, in response to mitochondrial dysfunction. We conclude that voluntary exercise counteracts aging in mtDNA mutator mice by counteracting protein dysregulation in muscle and brain, decreasing the mtDNA mutation burden in muscle, and delaying overt aging phenotypes.
C1 [Ross, Jaime M.; Coppotelli, Giuseppe; Olson, Lars] Karolinska Inst, Dept Neurosci, Biomed, Stockholm, Sweden.
   [Ross, Jaime M.; Coppotelli, Giuseppe; Kim, Kyung M.; Sinclair, David A.] Harvard Med Sch, Blavatn Inst, Dept Genet, Paul F Glenn Ctr Biol Aging Res, Boston, MA 02115 USA.
   [Branca, Rui M.; Lehtio, Janne] Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, Stockholm, Sweden.
C3 Karolinska Institutet; Harvard University; Harvard Medical School;
   Karolinska Institutet
RP Ross, JM; Coppotelli, G (corresponding author), Karolinska Inst, Dept Neurosci, Biomed, Stockholm, Sweden.
EM Jaime.Ross@ki.se; Giuseppe_Coppotelli@hms.harvard.edu
RI Ross, Jaime/A-6893-2012
OI Ross, Jaime/0000-0002-3879-4817
FU National Institute on Aging [K99AG055683]; Radiumhemmets
   Forskningsfonder; Stiftelsen for Strategisk Forskning; Barncancerfonden;
   Swedish Brain Power; Hjarnfonden; Konung Gustaf V:s och Drottning
   Victorias Frimurarestiftelse; Loo och Hans Ostermans Stiftelse for
   Medicinsk Forskning; FP7 Ideas: European Research Council [322744];
   Svenska Sallskapet for Medicinsk Forskning; Karolinska Institutet;
   Swedish Research Council [537-2014-6856, 2015-04622,
   K2012-62X-03185-42-4]; Swedish Cancer Society; Swedish Lundbeck
   Foundation; Glenn Foundation for Medical Research; National Institutes
   of Health [R37AG028730, R01DK100263]; Harvard Brain Science Initiative
   Bipolar Disorder Seed Grant; Swedish Research Council [2015-04622]
   Funding Source: Swedish Research Council
FX National Institute on Aging, Grant/Award Number: K99AG055683;
   Radiumhemmets Forskningsfonder; Stiftelsen for Strategisk Forskning;
   Barncancerfonden; Swedish Brain Power; Hjarnfonden; Konung Gustaf V:s
   och Drottning Victorias Frimurarestiftelse; Loo och Hans Ostermans
   Stiftelse for Medicinsk Forskning; FP7 Ideas: European Research Council,
   Grant/Award Number: 322744; Svenska Sallskapet for Medicinsk Forskning;
   Karolinska Institutet; Swedish Research Council, Grant/Award Number:
   537-2014-6856, 2015-04622 and K2012-62X-03185-42-4; Swedish Cancer
   Society; Swedish Lundbeck Foundation; Per Nydahl donation; Glenn
   Foundation for Medical Research; National Institutes of Health,
   Grant/Award Number: R37AG028730 and R01DK100263; Harvard Brain Science
   Initiative Bipolar Disorder Seed Grant
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bereczki E, 2018, BRAIN, V141, P582, DOI 10.1093/brain/awx352
   Brustovetsky N, 2003, J NEUROSCI, V23, P4858
   Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055
   Chen YH, 2019, J NEUROCHEM, V150, P56, DOI 10.1111/jnc.14702
   Clark-Matott J, 2015, NEUROBIOL AGING, V36, P2972, DOI 10.1016/j.neurobiolaging.2015.07.020
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, pG914, DOI 10.1152/ajpgi.00402.2011
   Huang J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003323
   Jensen J, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00112
   Jiang M, 2017, CELL METAB, V26, P429, DOI 10.1016/j.cmet.2017.07.003
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kelly SA, 2016, PHYSL REP, V4, P21
   Kühl I, 2017, ELIFE, V6, DOI 10.7554/eLife.30952
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Memon Ashfaque A, 2017, Biomol Detect Quantif, V13, P32, DOI 10.1016/j.bdq.2017.08.001
   Oliveira JMA, 2009, J BIOL CHEM, V284, P5010, DOI 10.1074/jbc.M807459200
   Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011
   Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033
   Reiner M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-813
   Ross JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Ross JM, 2011, JOVE-J VIS EXP, DOI 10.3791/3266
   Roxas BAP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-187
   Safdar A, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0075-9
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Sandberg A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M112.016998
   Sasaki H, 2016, SCI REP-UK, V6, DOI 10.1038/srep27607
   Savitski MM, 2015, MOL CELL PROTEOMICS, V14, P2394, DOI 10.1074/mcp.M114.046995
   Shabalina IG, 2017, AGING-US, V9, P315, DOI 10.18632/aging.101174
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Someya S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171159
   Suwa M, 2016, INT J SPORTS MED, V37, P483, DOI 10.1055/s-0042-101412
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Wall CE, 2015, P NATL ACAD SCI USA, V112, P8714, DOI 10.1073/pnas.1509930112
   Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439
   Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]
NR 39
TC 21
Z9 23
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD DEC
PY 2019
VL 18
IS 6
AR e13029
DI 10.1111/acel.13029
EA SEP 2019
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA JJ8VY
UT WOS:000485670500001
PM 31489782
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Saneto, RP
AF Saneto, Russell P.
TI An update on Alpers-Huttenlocher syndrome: pathophysiology of disease
   and rational treatment designs
SO EXPERT OPINION ON ORPHAN DRUGS
LA English
DT Review
DE Mitochondrial disease; polymerase gamma 1 (POLG1); Alpers-Huttenlocher
   syndrome; nuclear-encoded; epilepsy; mitochondrial DNA replication
ID MITOCHONDRIAL-DNA POLYMERASE; PROGRESSIVE NEURONAL DEGENERATION; DIFFUSE
   CEREBRAL DEGENERATION; TRANSFER-RNA SYNTHETASE; POLG MUTATIONS; W748S
   MUTATION; CAENORHABDITIS-ELEGANS; STATUS EPILEPTICUS; MTDNA DEPLETION;
   GRAY-MATTER
AB Introduction: Alpers-Huttenlocher syndrome (AHS) is a unique nuclear DNA-encoded mitochondrial disease. Clinically, after normal development the syndrome is manifested by psychomotor decline, medically refractory seizures, and hepatopathy. The disease is caused by biallelic recessive mutations in the mitochondrial DNA polymerase catalytic subunit, polymerase gamma 1 (POLG1), which is relentlessly progressive with death occurring several years after diagnosis. Areas covered: The consistency of neuropathology, biochemical, genetic, and clinical findings are discussed. However, the lack of phenotype and genotype correlations, presence of ecovariants, and multiple environmental influences create variable onset of symptoms and degrees of clinical expression. Coupled with the low prevalence of AHS, standard clinical trials are not possible and treatment modalities must be extrapolated from other mitochondrial and clinical diseases or animal models. Expert opinion: Currently, treatment is mostly supportive. Animal models of AHS are sorely needed. However, there are hints to possible disease-altering treatments based on animal and in vitro and other disease treatment studies. In a worm model of POLG1 dysfunction, the cardiac medication clofilium tosylate can correct the deficit. Exosomes made from stem cells can deliver genes and protein products to muscle cells and presumably neurons. These studies begin the journey toward possible treatments.
C1 [Saneto, Russell P.] Univ Washington, Dept Neurol, Div Pediat Neurol, Seattle, WA 98195 USA.
   [Saneto, Russell P.] Seattle Childrens Hosp, Seattle, WA USA.
   [Saneto, Russell P.] Seattle Childrens Hosp, Neurosci Inst, Ctr Integrat Brain Res, Seattle, WA USA.
C3 University of Washington; University of Washington Seattle; Seattle
   Children's Hospital; Seattle Children's Hospital
RP Saneto, RP (corresponding author), Univ Washington, Seattle Childrens Hosp, Dept Neurol, Div Pediat Neurol, 4800 Sand Point Way NE, Seattle, WA 98105 USA.
EM russ.saneto@seattlechildrens.org
CR Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807
   Aminzadeh MA, 2018, STEM CELL REP, V10, P942, DOI 10.1016/j.stemcr.2018.01.023
   Anagnostou ME, 2016, EPILEPSIA, V57, P1531, DOI 10.1111/epi.13508
   [Anonymous], 2017, J INBORN ERRORS META
   Avula B, 2012, J PHARMACEUT BIOMED, V70, P53, DOI 10.1016/j.jpba.2012.05.021
   BICKNESE AR, 1992, ANN NEUROL, V32, P767, DOI 10.1002/ana.410320610
   BLACKWOOD W, 1963, ARCH DIS CHILD, V38, P193, DOI 10.1136/adc.38.199.193
   Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Clark-Matott J, 2015, NEUROBIOL AGING, V36, P2972, DOI 10.1016/j.neurobiolaging.2015.07.020
   Cohen B. H., 1993, GeneReviews((R))
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Diener HC, 2004, EUR NEUROL, V51, P89, DOI 10.1159/000076535
   El-Hattab Ayman W., 2017, J. inborn errors metab. screen., V5, pe160051, DOI 10.1177/2326409817697399
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   FORD FR, 1951, J PEDIATR-US, V39, P33, DOI 10.1016/S0022-3476(51)80278-6
   Ganetzky RD, 2018, MOL GENET METAB, V123, P301, DOI 10.1016/j.ymgme.2018.01.010
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   HUTTENLOCHER PR, 1976, ARCH NEUROL-CHICAGO, V33, P186, DOI 10.1001/archneur.1976.00500030042009
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Krasich R, 2017, FRONT BIOSCI-LANDMRK, V22, P692, DOI 10.2741/4510
   Lagrue E, 2007, PEDIATR RES, V62, P14, DOI 10.1203/PDR.0b013e31806790d7
   Lax NZ, 2016, NEUROPATH APPL NEURO, V42, P180, DOI 10.1111/nan.12238
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Lee CF, 2016, CIRCULATION, V134, P883, DOI 10.1161/CIRCULATIONAHA.116.022495
   Lee Y, 2012, HUM MOL GENET, V21, pR125, DOI 10.1093/hmg/dds317
   Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   MORSE WI, 1949, B JOHNS HOPKINS HOSP, V84, P116
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Naviaux RK, 2006, ALPERS SYNDROME
   Naviaux RK, 2016, Mitochondrial case studies: underlying mechanisms and diagnosis, P135
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nikkanen J, 2018, EMBO MOL MED, V10, P13, DOI 10.15252/emmm.201707993
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Parikh S, 2017, GENET MED, V19, DOI 10.1038/gim.2017.107
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   Pitayu L, 2016, HUM MOL GENET, V25, P715, DOI 10.1093/hmg/ddv509
   Polyak E, 2018, MOL GENET METAB, V123, P449, DOI 10.1016/j.ymgme.2018.02.013
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   SANDBANK U, 1972, J NEUROL NEUROSUR PS, V35, P749, DOI 10.1136/jnnp.35.6.749
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Saneto RP, 2017, ADV GENET, V98, P63, DOI 10.1016/bs.adgen.2017.06.002
   Saneto RP, 2016, J MULTIDISCIP HEALTH, V9, P323, DOI 10.2147/JMDH.S84900
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Siegmund SE, 2017, HUM MOL GENET, V26, P4588, DOI 10.1093/hmg/ddx341
   Singh B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140409
   Sofou K, 2015, MOL GENET GENOM MED, V3, P59, DOI 10.1002/mgg3.115
   Sofou K, 2012, EUR J PAEDIATR NEURO, V16, P379, DOI 10.1016/j.ejpn.2011.12.006
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2014, ANN NEUROL, V76, P66, DOI 10.1002/ana.24185
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Uusimaa J, 2013, EPILEPSIA, V54, P1002, DOI 10.1111/epi.12115
   West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Young MJ, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00074
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
NR 83
TC 0
Z9 0
U1 0
U2 13
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2167-8707
J9 EXPERT OPIN ORPHAN D
JI Exp. Opin. Orphan Drugs
PD DEC 2
PY 2018
VL 6
IS 12
BP 741
EP 751
DI 10.1080/21678707.2018.1540979
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA HD8FF
UT WOS:000452789500005
DA 2024-11-01
ER

PT J
AU Wojewoda, M
   Duszynski, J
   Szczepanowska, J
AF Wojewoda, Marta
   Duszynski, Jerzy
   Szczepanowska, Joanna
TI Antioxidant defence systems and generation of reactive oxygen species in
   osteosarcoma cells with defective mitochondria: Effect of selenium
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
CT 16th European Bioenergetics Conference
CY JUL 17-22, 2010
CL Univ Warsaw, Old Lib, Warsaw, POLAND
SP Nencki Inst Expt Biol, Polish Biochem Soc, Sect Bioenerget
HO Univ Warsaw, Old Lib
DE Mitochondria; NARP; Selenium; ROS; Antioxidant enzyme
ID OXIDATIVE STRESS; NARP MUTATION; HUMAN-DISEASE; ATP SYNTHASE; MTDNA;
   REDUCTASE; GENE; DNA; HYDROETHIDINE; THIOREDOXIN
AB Mitochondrial diseases originate from mutations in mitochondrial or nuclear genes encoding for mitochondrial proteome. Neurogenic muscle weakness, ataxia and retinitis pigmentosa (NARP) syndrome is associated with the T8993G transversion in ATP6 gene which results in substitution at the very conservative site in the subunit 6 of mitochondrial ATP synthase. Defects in the mitochondrial respiratory chain and the ATPase are considered to be accompanied by changes in the generation of reactive oxygen species (ROS). This study aimed to elucidate effects of selenium on ROS and antioxidant system of NARP cybrid cells with 98% of T8993G mutation load. We found that selenium decreased ROS generation and increased the level and activity of antioxidant enzymes such as glutathione peroxidase (GPx) and thioredoxin reductase (TrxR). Therefore, we propose selenium to be a promising therapeutic agent not only in the case of NARP syndrome but also other diseases associated with mitochondrial dysfunctions and oxidative stress. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Wojewoda, Marta; Duszynski, Jerzy; Szczepanowska, Joanna] M Nencki Inst Expt Biol, Dept Biochem, PL-02093 Warsaw, Poland.
C3 Polish Academy of Sciences; Nencki Institute of Experimental Biology of
   the Polish Academy of Sciences
RP Duszynski, J (corresponding author), M Nencki Inst Expt Biol, Dept Biochem, Pasteura 3, PL-02093 Warsaw, Poland.
EM j.duszynski@nencki.gov.pl; j.szczepanowska@nencki.gov.pl
OI Szczepanowska, Joanna/0000-0002-0434-1262; Smeda,
   Marta/0000-0002-0219-2574
CR Arnér ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009
   Arrigo AP, 2005, METHODS, V35, P126, DOI 10.1016/j.ymeth.2004.08.003
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029
   Dassa EP, 2008, BIOCHEM BIOPH RES CO, V368, P620, DOI 10.1016/j.bbrc.2008.01.125
   Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DiMauro S, 2009, BBA-MOL BASIS DIS, V1792, P1159, DOI 10.1016/j.bbadis.2008.10.015
   García JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075
   Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221
   HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199
   Jang YC, 2009, EXP GERONTOL, V44, P256, DOI 10.1016/j.exger.2008.12.006
   Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010
   Kim HY, 2007, BIOCHEM J, V407, P321, DOI 10.1042/BJ20070929
   King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4
   Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007
   Lee JW, 2006, EXP EYE RES, V82, P816, DOI 10.1016/j.exer.2005.10.003
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Marchetti MA, 2006, EXP EYE RES, V83, P1281, DOI 10.1016/j.exer.2006.07.005
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Máximo V, 2009, VIRCHOWS ARCH, V454, P481, DOI 10.1007/s00428-009-0766-2
   McKenzie M, 2004, NEUROCHEM RES, V29, P589, DOI 10.1023/B:NERE.0000014829.42364.dd
   Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Perez VI, 2008, FREE RADICAL BIO MED, V44, P882, DOI 10.1016/j.freeradbiomed.2007.11.018
   ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Szczepanowska J, 2004, FEBS LETT, V578, P316, DOI 10.1016/j.febslet.2004.11.022
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026
   Yang JL, 2008, DNA REPAIR, V7, P1110, DOI 10.1016/j.dnarep.2008.03.012
   Zielonka J, 2006, ARCH BIOCHEM BIOPHYS, V456, P39, DOI 10.1016/j.abb.2006.09.031
NR 34
TC 23
Z9 26
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD JUN-JUL
PY 2010
VL 1797
IS 6-7
BP 890
EP 896
DI 10.1016/j.bbabio.2010.01.035
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Biophysics
GA 622KV
UT WOS:000279663200034
PM 20138159
OA Bronze
DA 2024-11-01
ER

PT J
AU Walter, JH
AF Walter, J. H.
TI Genes, patients, families, doctors-Mutation analysis in clinical
   practice
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article; Proceedings Paper
CT 40th Meeting of the European-Metabolic-Group
CY JUN 01, 2008
CL Milupa Metabol, Heidelberg, GERMANY
SP European Metabol Grp
HO Milupa Metabol
ID MITOCHONDRIAL-DNA DEPLETION; TK2 GENE; ALPERS-SYNDROME; POLG MUTATIONS;
   MYOPATHY; SYNTHASE; DISEASE
AB Developments in mutation analysis have led to significant benefits for patients with inherited metabolic disorders and their families. This is particularly the case where new methodologies have prevented the need for invasive tissue biopsies or have allowed carrier detection or first trimester prenatal testing to be undertaken. Whereas in the past it may have only been possible to identify specific 'common' mutations, the availability of techniques, such as automated sequencing, and novel technologies including mutation scanning techniques, multiplex ligation dependent probe amplification, and array technologies, have vastly improved the diagnostic efficiency of molecular testing.
C1 Royal Manchester Childrens Hosp, Willink Biochem Genet Unit, Manchester M27 4HA, Lancs, England.
C3 Royal Manchester Children's Hospital
RP Walter, JH (corresponding author), Royal Manchester Childrens Hosp, Willink Biochem Genet Unit, Manchester M27 4HA, Lancs, England.
EM john.walter@cmft.nhs.uk
CR Bandmann O, 1998, ANN NEUROL, V44, P649, DOI 10.1002/ana.410440411
   Besley GTN, 1999, J INHERIT METAB DIS, V22, P263, DOI 10.1023/A:1005534105933
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Carrozzo R, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9135
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Elsas LJ, 1998, GENET MED, V1, P40
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Mancuso M, 2005, ARCH NEUROL-CHICAGO, V62, P745, DOI 10.1001/archneur.62.5.745
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Orho M, 1998, J CLIN INVEST, V102, P507, DOI 10.1172/JCI2890
   Rabinowitz SS, 2004, J PEDIATR GASTR NUTR, V38, P216, DOI 10.1097/00005176-200402000-00022
   Ridout CK, 2008, HUM GENET, V124, P187, DOI 10.1007/s00439-008-0538-0
   Thöny B, 2006, HUM MUTAT, V27, P870, DOI 10.1002/humu.20366
   Tulinius M, 2005, NEUROMUSCULAR DISORD, V15, P412, DOI 10.1016/j.nmd.2005.03.010
   Yamaguchi S, 2006, HUM MUTAT, V27, P626, DOI 10.1002/humu.20339
   Zschocke J, 2008, J INHERIT METAB DIS, V31, P697, DOI 10.1007/s10545-008-1052-1
NR 20
TC 1
Z9 1
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-8955
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD JUN
PY 2009
VL 32
IS 3
BP 441
EP 446
DI 10.1007/s10545-009-1085-0
PG 6
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 451EF
UT WOS:000266452800016
PM 19306072
DA 2024-11-01
ER

PT J
AU Gellerich, FN
   Mayr, JA
   Reuter, S
   Sperl, W
   Zierz, S
AF Gellerich, FN
   Mayr, JA
   Reuter, S
   Sperl, W
   Zierz, S
TI The problem of interlab variation in methods for mitochondrial disease
   diagnosis: enzymatic measurement of respiratory chain complexes
SO MITOCHONDRION
LA English
DT Article; Proceedings Paper
CT 1st Mitochondrial Standards Workshop
CY 2002
CL Dallas, TX
SP United Mitochondrial Dis Fdn, Mitochondrial Res Soc, Natl Inst Stand & Technol
DE interlab variation; mitochondrial disease; respiratory chain complexes
ID OXIDATIVE-PHOSPHORYLATION; ENERGY-METABOLISM; ASSAY; NADH; DNA;
   DYSFUNCTION; MYOPATHY; DEFECTS; BABOONS; RATS
AB Due to the large importance of mitochondrial function for numerous diseases the detection of respiratory chain defects for diagnostic purposes is an important task of mitochondrial medicine. For comparing the methods, standard mitochondrial homogenate prepared from bovine skeletal muscle was sent on dry ice to 14 labs of 8 countries. Activities of complexes I, I+III, II, II+III, IV (cytochrome c oxidase) and V (F(0)F(1)ATPase) as well as of citrate synthase were measured. For all enzymes the results differed at more than one order of magnitude. From eight labs we were able to compare the results with their control values for human skeletal muscle. Four labs found normal activity of cytochrome-c-oxidase whereas three labs found higher and one lab found lower activities compared to the own controls. Since all labs used different temperatures (25, 30 and 37 degreesC) in one lab the temperature dependencies were measured experimentally. The temperature correction did not much reduce the divergence of the results. It is concluded that differences in the lab protocols are the reason for the large variation of results. Since the experimental results strongly depend on the used method a strict standardization is necessary. (C) 2004 Published by Elsevier B.V. on behalf of Mitochondria Research Society.
C1 Univ Halle Wittenberg, Muskellabor Neurol Klin & Poliklin, D-06097 Halle An Der Saale, Germany.
   Labor Univ Klin Kinder & Jugendheilkunde Salzburg, Osterreich, Germany.
C3 Martin Luther University Halle Wittenberg
RP Univ Halle Wittenberg, Muskellabor Neurol Klin & Poliklin, Julius Kuhn Str 7, D-06097 Halle An Der Saale, Germany.
EM frank.gellerich@medizin.uni-halle.de
OI Mayr, Johannes/0000-0001-6970-336X
CR Berger A, 2003, ACTA NEUROPATHOL, V105, P245, DOI 10.1007/s00401-002-0638-1
   Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4
   BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X
   COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665
   ESTORNELL E, 1993, FEBS LETT, V332, P127, DOI 10.1016/0014-5793(93)80498-J
   FISCHER JC, 1986, CLIN CHIM ACTA, V155, P263, DOI 10.1016/0009-8981(86)90246-9
   GELLERICH F, 1998, J NEUROL, V245, P425
   Gellerich FN, 2002, BIOSCIENCE REP, V22, P99, DOI 10.1023/A:1016017224003
   Gellerich FN, 1999, SHOCK, V11, P336, DOI 10.1097/00024382-199905000-00006
   GELLERICH FN, 2003, BIOCHIM BIOPHYS ACTA, V1556, P41
   GENOVA ML, 1995, BIOCHEM J, V311, P105, DOI 10.1042/bj3110105
   Hatefi Y, 1978, Methods Enzymol, V53, P21
   KRAHENBUHL S, 1994, CLIN CHIM ACTA, V230, P177, DOI 10.1016/0009-8981(94)90270-4
   KUNZ WS, 1993, BIOCHIM BIOPHYS ACTA, V1144, P46, DOI 10.1016/0005-2728(93)90029-F
   LETELLIER T, 1992, PEDIATR RES, V32, P17, DOI 10.1203/00006450-199207000-00004
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LUFT R, 1995, BBA-MOL BASIS DIS, V1271, P1, DOI 10.1016/0925-4439(95)00002-L
   MAYR H, 2004, ERGEBNISSE RINDERMUS, P132
   Mayr J., 2000, EUR J MED, V5, P47
   Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b
   Morgan-Hughes JA, 1999, BBA-BIOENERGETICS, V1410, P125, DOI 10.1016/S0005-2728(98)00162-5
   Rubio-Gozalbo ME, 2000, NEUROPEDIATRICS, V31, P114, DOI 10.1055/s-2000-7491
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SCHAGGER H, 1996, METHOD ENZYMOL, P555
   Scheubel RJ, 2002, J AM COLL CARDIOL, V40, P2174, DOI 10.1016/S0735-1097(02)02600-1
   Shepherd D., 1969, Methods in Enzymology, V13, P11, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]
   SHERRATT HSA, 1988, METHOD BIOCHEM ANAL, V33, P243
   Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100
   Silva JP, 2002, BBA-BIOENERGETICS, V1555, P106, DOI 10.1016/S0005-2728(02)00263-3
   SINGER TP, 1976, METHOD BIOCHEM ANAL, V22, P123
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   Srere P.A., 1969, Methods in Enzymology, V13, P3
   SZCZESNAKACZMAREK A, 1984, INT J BIOCHEM, V16, P1231, DOI 10.1016/0020-711X(84)90221-0
   Taylor R.W., 1997, Organelle Diseases : Clinical Features, Diagnosis, Pathogenesis, and Management, P341
   TAYLOR RW, 1993, BIOCHIM BIOPHYS ACTA, V1181, P261, DOI 10.1016/0925-4439(93)90030-5
   Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793
   TERVOORT MJ, 1981, BIOCHIM BIOPHYS ACTA, V637, P245, DOI 10.1016/0005-2728(81)90163-8
   Tisdale HD., 1967, Methods in Enzymology, V10, P213
   Trijbels FJM, 1997, MOL CELL BIOCHEM, V174, P243, DOI 10.1023/A:1006868810424
   TRIJBELS JMF, 1993, EUR J PEDIATR, V152, P178, DOI 10.1007/BF01956139
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Trumbeckaite S, 2001, EUR J BIOCHEM, V268, P1422, DOI 10.1046/j.1432-1327.2001.02012.x
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1
   Wiedemann FR, 2000, ANAL BIOCHEM, V279, P55, DOI 10.1006/abio.1999.4434
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZHENG XX, 1990, BIOCHIM BIOPHYS ACTA, V1019, P1, DOI 10.1016/0005-2728(90)90118-N
NR 49
TC 44
Z9 49
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP
PY 2004
VL 4
IS 5-6
BP 427
EP 439
DI 10.1016/j.mito.2004.07.007
PG 13
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Cell Biology; Genetics & Heredity
GA 885QS
UT WOS:000226172600009
PM 16120404
DA 2024-11-01
ER

PT J
AU Ng, YS
   Turnbull, DM
AF Ng, Yi Shiau
   Turnbull, Doug M.
TI Mitochondrial disease: genetics and management
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Mitochondrial disease; Mitochondrial DNA (mtDNA); Nuclear genes; Acute
   and chronic neurological presentations; Treatment
ID STROKE-LIKE EPISODES; HEREDITARY OPTIC NEUROPATHY; ENCEPHALOMYOPATHY
   (MNGIE)-LIKE PHENOTYPE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; INTESTINAL
   PSEUDOOBSTRUCTION; CLINICAL SPECTRUM; LACTIC-ACIDOSIS; DNA MUTATIONS;
   MONITOR PROGRESSION; POLG1 MUTATIONS
AB Mitochondrial disease is one of the most common groups of genetic diseases with a minimum prevalence of greater than 1 in 5000 in adults. Whilst multi-system involvement is often evident, neurological manifestation is the principal presentation in most cases. The multiple clinical phenotypes and the involvement of both the mitochondrial and nuclear genome make mitochondrial disease particularly challenging for the clinician. In this review article we cover mitochondrial genetics and common neurological presentations associated with adult mitochondrial disease. In addition, specific and supportive treatments are discussed.
C1 [Ng, Yi Shiau; Turnbull, Doug M.] Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Turnbull, DM (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@ncl.ac.uk
RI Ng, Yi/AFF-1445-2022
OI Turnbull, Doug/0000-0002-8878-9901; Ng, Yi Shiau/0000-0002-7591-2034
FU Wellcome Trust [074454/Z/04/Z]; Newcastle University Centre for Ageing
   and Vitality - Biotechnology and Biological Sciences Research Council;
   Newcastle University Centre for Ageing and Vitality - Medical Research
   Council [M501700]; MRC Centre for Neuromuscular Disease; UK NIHR
   Biomedical Research Centre for Ageing and Age-related disease award;
   Lily Foundation; UK NHS Specialist Commissioners; MRC [MR/L016354/1]
   Funding Source: UKRI
FX Work in the authors laboratory is supported by The Wellcome Trust
   (074454/Z/04/Z), Newcastle University Centre for Ageing and Vitality
   [supported by the Biotechnology and Biological Sciences Research Council
   and Medical Research Council (M501700)], MRC Centre for Neuromuscular
   Disease, UK NIHR Biomedical Research Centre for Ageing and Age-related
   disease award to the Newcastle upon Tyne Hospitals NHS Foundation Trust,
   Lily Foundation and the UK NHS Specialist Commissioners which funds the
   "Rare Mitochondrial Disorders of Adults and Children" Clinical Service
   in Newcastle upon Tyne. This work also received infrastructure support
   from the Newcastle NIHR Biomedical Research Centre, Newcastle and North
   Tyneside Comprehensive Local Research Network.
CR Ahmad KE, 2015, J NEUROL, P1
   Ahn J, 2008, BRIT J OPHTHALMOL, V92, P1685, DOI 10.1136/bjo.2008.144816
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Angelini C, 2009, Acta Myol, V28, P16
   Aurangzeb Sidra, 2014, Pract Neurol, V14, P432, DOI 10.1136/practneurol-2014-000853
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Cheldi A, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-8
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chiyonobu T, 2008, BRAIN DEV-JPN, V30, P430, DOI 10.1016/j.braindev.2007.12.006
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284
   Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Giordano C, 2013, HUM PATHOL, V44, P1262, DOI 10.1016/j.humpath.2012.10.011
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gorman GS, 2015, NEW ENGL J MED, V372, P885, DOI 10.1056/NEJMc1500960
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Hasselmann O, 2010, MOL GENET METAB, V99, P58, DOI 10.1016/j.ymgme.2009.08.005
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Jung I, 2015, J CLIN NEUROL, V11, P104, DOI 10.3988/jcn.2015.11.1.104
   Karkos PD, 2005, EUR ARCH OTO-RHINO-L, V262, P322, DOI 10.1007/s00405-004-0817-x
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   La Morgia C, 2008, NEUROLOGY, V70, P762, DOI 10.1212/01.wnl.0000295505.74234.d0
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Martikainen MH, 2012, EPILEPTIC DISORD, V14, P438, DOI 10.1684/epd.2012.0543
   Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Meisinger C, 2008, CELL, V134, P22, DOI 10.1016/j.cell.2008.06.043
   Mokranjac D, 2005, BIOCHEM SOC T, V33, P1019, DOI 10.1042/BST0331019
   Nesbitt V, 2014, EUR J HUM GENET, V22, P1255, DOI 10.1038/ejhg.2014.35
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Nesbitt V, 2012, DEV MED CHILD NEUROL, V54, P500, DOI 10.1111/j.1469-8749.2012.04224.x
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   Noack R, 2012, HUM MOL GENET, V21, P150, DOI 10.1093/hmg/ddr450
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   Pfeffer G, 2015, NEUROLOGY, V84, P1174, DOI 10.1212/WNL.0000000000001369
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pfeffer G, 2013, NEUROLOGY, V81, P2073, DOI 10.1212/01.wnl.0000437308.22603.43
   Pfeffer G, 2012, MUSCLE NERVE, V46, P593, DOI 10.1002/mus.23538
   Phoenix C, 2006, NEUROMUSCULAR DISORD, V16, P814, DOI 10.1016/j.nmd.2006.08.006
   Prasun P, 2014, J NEUROL, V261, P1818, DOI 10.1007/s00415-014-7428-2
   Prüss H, 2008, EPILEPSY RES, V82, P219, DOI 10.1016/j.eplepsyres.2008.08.005
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rance G, 2012, J NEUROL, V259, P542, DOI 10.1007/s00415-011-6230-7
   Sadun AA, 2012, ARCH NEUROL-CHICAGO, V69, P331, DOI 10.1001/archneurol.2011.2972
   Sallevelt SCEH, 2013, J MED GENET, V50, P125, DOI 10.1136/jmedgenet-2012-101172
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schwabe MJ, 1997, PEDIATR NEUROL, V16, P337, DOI 10.1016/S0887-8994(97)00030-1
   Sekino Y, 2012, WORLD J GASTROENTERO, V18, P4557, DOI 10.3748/wjg.v18.i33.4557
   Sicurelli F, 2012, J NEUROL, V259, P1985, DOI 10.1007/s00415-012-6500-z
   Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385
   Sommerville Ewen W, 2014, J Neuromuscul Dis, V1, P119
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Steriade C, 2014, PEDIATR NEUROL, V50, P498, DOI 10.1016/j.pediatrneurol.2014.01.009
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Treff NR, 2012, FERTIL STERIL, V98, P1236, DOI 10.1016/j.fertnstert.2012.07.1119
   Tucker EJ, 2010, CURR NEUROL NEUROSCI, V10, P277, DOI 10.1007/s11910-010-0112-8
   van Berge L, 2014, BRAIN, V137, P1019, DOI 10.1093/brain/awu026
   Verny C, 2008, DIABETES METAB, V34, P620, DOI 10.1016/j.diabet.2008.06.001
   Visser NA, 2011, J NEUROL, V258, P218, DOI 10.1007/s00415-010-5721-2
   Vrettou CS, 2013, INTENS CARE MED, V39, P1148, DOI 10.1007/s00134-013-2884-1
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Zimón M, 2011, NEUROLOGY, V77, P540, DOI 10.1212/WNL.0b013e318228fc70
   Zoccolella S, 2010, J NEUROL, V257, P1999, DOI 10.1007/s00415-010-5649-6
NR 96
TC 82
Z9 95
U1 2
U2 29
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD JAN
PY 2016
VL 263
IS 1
BP 179
EP 191
DI 10.1007/s00415-015-7884-3
PG 13
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DB9HV
UT WOS:000368827900026
PM 26315846
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Zsurka, G
   Kunz, WS
AF Zsurka, Gabor
   Kunz, Wolfram S.
TI Mitochondrial involvement in neurodegenerative diseases
SO IUBMB LIFE
LA English
DT Review
DE mitochondria; neurodegenerative diseases; reactive oxygen species
ID DOMINANT OPTIC ATROPHY; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   ALPHA-KETOGLUTARATE DEHYDROGENASE; ELECTRON-TRANSPORT CHAIN;
   SUBSTANTIA-NIGRA NEURONS; DNA-POLYMERASE-GAMMA; KINESIN HEAVY-CHAIN;
   SUPEROXIDE-PRODUCTION; COMPLEX-I; BRAIN MITOCHONDRIA
AB The classical bioenergetical view of the involvement of mitochondria in neurogeneration is based on the fact that mitochondria are the central players of ATP synthesis in neurons and their failure leads to neuronal dysfunction and eventually to cell death. Mutations in at least 39 genes in inherited neurodegenerative disorders seem to alter directly or indirectly mitochondrial function. Most of these mutations do not directly affect oxidative phosphorylation, but act through disturbed mitochondrial dynamics and quality control. This, however, does not invalidate the bioenergetic hypothesis. Neurodegeneration is not necessarily associated with a gross failure of ATP production, but might rather be a consequence of local insufficiencies of ATP supply in critical compartments of neurons, like the presynaptic terminal. We hypothesize that slow disease progression, at least in a subgroup of neurodegenerative diseases, can be explained by the parallel action of subcellular ATP insufficiency and clonal expansion of somatic mitochondrial DNA mutations, and particularly deletions. (c) 2013 IUBMB Life, 65(3):263272, 2013
C1 Univ Bonn, Dept Epileptol, D-53105 Bonn, Germany.
   Univ Bonn, Life & Brain Ctr, D-53105 Bonn, Germany.
C3 University of Bonn; University of Bonn
RP Kunz, WS (corresponding author), Univ Bonn, Med Ctr, Dept Epileptol, Div Neurochem, Sigmund Freud Str 25, D-53105 Bonn, Germany.
EM wolfram.kunz@ukb.uni-bonn.de
RI Kunz, Wolfram/K-1232-2019
OI Kunz, Wolfram/0000-0003-1113-3493; Zsurka, Gabor/0000-0002-6379-849X
FU Bundesministerium fur Bildung und Forschung [mitoNET 01GM0868]; Deutsche
   Forschungsgemeinschaft [SFB TR3 A11, D12]; Stiftung fur Medizinische
   Wissenschaft, Frankfurt am Main
FX This work was supported by the Bundesministerium fur Bildung und
   Forschung (mitoNET 01GM0868), the Deutsche Forschungsgemeinschaft (SFB
   TR3 A11 and D12), and the Stiftung fur Medizinische Wissenschaft,
   Frankfurt am Main.
CR Abramov AY, 2005, J NEUROSCI, V25, P9176, DOI 10.1523/JNEUROSCI.1632-05.2005
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   ASTRUP J, 1981, STROKE, V12, P726, DOI 10.1161/01.STR.12.6.726
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bindokas VP, 1998, J NEUROSCI, V18, P4570
   BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435
   Brickley K, 2005, J BIOL CHEM, V280, P14723, DOI 10.1074/jbc.M409095200
   Campbell GR, 2012, ACTA NEUROPATHOL, V124, P209, DOI 10.1007/s00401-012-1001-9
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Cooper A.J. L., 1997, The Molecular and Genetic Basis of Neurological Disease, P1195
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116
   Dringen R, 1999, J NEUROSCI, V19, P562, DOI 10.1523/jneurosci.19-02-00562.1999
   Folbergrová J, 2012, MITOCHONDRION, V12, P35, DOI 10.1016/j.mito.2011.04.004
   Fransson Å, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gal S, 2005, J NEUROCHEM, V95, P79, DOI 10.1111/j.1471-4159.2005.03341.x
   Genova ML, 2001, FEBS LETT, V505, P364, DOI 10.1016/S0014-5793(01)02850-2
   Gerards M, 2010, MITOCHONDRION, V10, P510, DOI 10.1016/j.mito.2010.05.008
   Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101
   Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777
   Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067
   Gonzalez FJ, 2005, MUTAT RES-FUND MOL M, V569, P101, DOI 10.1016/j.mrfmmm.2004.04.021
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Gulyás AI, 2006, EUR J NEUROSCI, V23, P2581, DOI 10.1111/j.1460-9568.2006.04814.x
   Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x
   Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Khrapko K, 2003, MUTAT RES-FUND MOL M, V522, P13, DOI 10.1016/S0027-5107(02)00306-8
   Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300
   Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793
   Krause KH, 2004, JPN J INFECT DIS, V57, pS28
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kudin AP, 2009, EXP NEUROL, V218, P326, DOI 10.1016/j.expneurol.2009.02.014
   Kudin AP, 2005, BIOMED PHARMACOTHER, V59, P163, DOI 10.1016/j.biopha.2005.03.012
   Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200
   Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200
   Langeveld CH, 1996, NEUROREPORT, V7, P1833, DOI 10.1097/00001756-199607290-00029
   LIOCHEV SI, 1994, FREE RADICAL BIO MED, V16, P29, DOI 10.1016/0891-5849(94)90239-9
   Liu XG, 2009, INT J BIOCHEM CELL B, V41, P1972, DOI 10.1016/j.biocel.2009.05.013
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Malinska D, 2010, BBA-BIOENERGETICS, V1797, P1163, DOI 10.1016/j.bbabio.2010.03.001
   Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612
   Näpänkangas JP, 2012, J MOL CELL CARDIOL, V53, P906, DOI 10.1016/j.yjmcc.2012.09.011
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655
   Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526
   Rice SE, 2006, J CELL BIOL, V173, P459, DOI 10.1083/jcb.200604071
   Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165
   Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spencer JPE, 1998, J NEUROCHEM, V71, P2112
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004
   Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605
   Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9
   THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094
   Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018
   Vielhaber S., ACTA NEUROP IN PRESS
   Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wiesner RJ, 2006, FREE RADICAL RES, V40, P1284, DOI 10.1080/10715760600913168
   Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748
   Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038
   Zsurka G, 2010, NEUROLOGY, V74, P507, DOI 10.1212/WNL.0b013e3181cef7ab
   Zsurka G, 2008, J NEUROPATH EXP NEUR, V67, P857, DOI 10.1097/NEN.0b013e3181839b2d
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 86
TC 34
Z9 35
U1 0
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1521-6543
EI 1521-6551
J9 IUBMB LIFE
JI IUBMB Life
PD MAR
PY 2013
VL 65
IS 3
BP 263
EP 272
DI 10.1002/iub.1126
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 096OW
UT WOS:000315415100011
PM 23341346
DA 2024-11-01
ER

PT J
AU Lenaz, G
   Baracca, A
   Carelli, V
   D'Aurelio, M
   Sgarbi, G
   Solaini, G
AF Lenaz, G
   Baracca, A
   Carelli, V
   D'Aurelio, M
   Sgarbi, G
   Solaini, G
TI Bioenergetics of mitochondrial diseases associated with mtDNA mutations
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
CT 13th European Bioenergetics Conference (EBEC 2004)
CY AUG 21-26, 2004
CL Pisa, ITALY
DE mitochondrial cytopathy; LHON; NARP; complex I; ATP synthase; cytochrome
   oxidase subunit III
ID CYTOCHROME-C-OXIDASE; HEREDITARY OPTIC NEUROPATHY; DNA T8993G MUTATION;
   SUBUNIT-III; COMPLEX-I; RHODOBACTER-SPHAEROIDES; PROTON UPTAKE;
   D-PATHWAY; OXYGEN; SITE
AB This mini-review summarizes our present view of the biochemical alterations associated with mitochondrial DNA (mtDNA) point mutations. Mitochondrial cytopathies caused by mutations of mtDNA are well-known genetic and clinical entities, but the biochemical pathogenic mechanisms are often obscure.
   Leber's hereditary optic neuropathy (LHON) is due to three main mutations in genes for complex I subunits. Even if the catalytic activity of complex I is maintained except in cells carrying the 3460/ND1 mutation, in all cases there is a change in sensitivity to complex I inhibitors and an impairment of mitochondrial respiration, eliciting the possibility of generation of reactive oxygen species (ROS) by the complex.
   eurogenic muscle weakness, Ataxia and Retinitis Pigmentosa (HARP), is due to a mutation in the ATPase-6 gene. In NARP patients ATP synthesis is strongly depressed to an extent proportional to the mutation load; nevertheless, ATP hydrolysis and ATP-driven proton translocation are not affected. It is suggested that the NARP mutation affects the ability of the enzyme to couple proton transport to ATP synthesis.
   A point mutation in subunit III of cytochrome c oxidase is accompanied by a syndrome resembling MELAS: however, no major biochemical defect is found, if we except an enhanced production of ROS. The mechanism of such enhancement is at present unknown.
   In this review, we draw attention to a few examples in which the overproduction of ROS might represent a common step in the induction of clinical phenotypes and/or in the progression of several human pathologies associated with mtDNA point mutations. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Bologna, Dipartimento Biochim, I-40126 Bologna, Italy.
   Univ Bologna, Dipartimento Sci Neurol, I-40126 Bologna, Italy.
   Univ Pisa, Scuola Super & Perfezionamento S Anna, I-56127 Pisa, Italy.
C3 University of Bologna; University of Bologna; University of Pisa; Scuola
   Superiore Sant'Anna
RP Univ Bologna, Dipartimento Biochim, Via Irnerio 48, I-40126 Bologna, Italy.
EM lenaz@biocfarm.unibo.it
RI Sgarbi, Gianluca/AAD-8061-2021; Lenaz, Giorgio/B-5751-2013
OI CARELLI, VALERIO/0000-0003-4923-6404; SOLAINI,
   GIANCARLO/0000-0001-7825-0446; BARACCA, ALESSANDRA/0000-0002-0490-1776
FU Telethon [GGP02323] Funding Source: Medline
CR Baracca A, 2003, BBA-BIOENERGETICS, V1606, P137, DOI 10.1016/S0005-2728(03)00110-5
   Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177
   Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188
   Brown MD, 1999, J NEUROL SCI, V165, P1, DOI 10.1016/S0022-510X(99)00087-8
   Carelli V, 1999, ANN NEUROL, V45, P320, DOI 10.1002/1531-8249(199903)45:3<320::AID-ANA7>3.3.CO;2-C
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Carelli V, 1997, NEUROLOGY, V48, P1623, DOI 10.1212/WNL.48.6.1623
   Carelli V, 2002, NEUROCHEM INT, V40, P573, DOI 10.1016/S0197-0186(01)00129-2
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Carelli V., 2002, Mitochondrial Disorders in Neurology, V2nd, P115
   COCK HR, 1995, AM J HUM GENET, V57, P1501
   ESPOSTI MD, 1994, FEBS LETT, V352, P375, DOI 10.1016/0014-5793(94)00971-6
   Genova ML, 2001, FEBS LETT, V505, P364, DOI 10.1016/S0014-5793(01)02850-2
   Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200
   Ghelli A, 1997, MOL ASPECTS MED, V18, pS263
   Gilderson G, 2003, BIOCHEMISTRY-US, V42, P7400, DOI 10.1021/bi0341298
   HALTIA T, 1991, EMBO J, V10, P2015, DOI 10.1002/j.1460-2075.1991.tb07731.x
   Hanson BJ, 2001, J BIOL CHEM, V276, P16296, DOI 10.1074/jbc.M011162200
   Hoffbuhr KC, 2000, J BIOL CHEM, V275, P13994, DOI 10.1074/jbc.275.18.13994
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   HOWELL N, 1991, AM J HUM GENET, V49, P939
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KLEISTRETZOW JC, 2003, EXP PHYSIOL, V88, P155
   Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121
   Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957
   Lenaz G, 2001, FEBS LETT, V509, P151, DOI 10.1016/S0014-5793(01)03172-6
   Lincoln AJ, 2003, ARCH BIOCHEM BIOPHYS, V416, P81, DOI 10.1016/S0003-9861(03)00202-9
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   Majander A, 1996, EUR J BIOCHEM, V239, P201, DOI 10.1111/j.1432-1033.1996.0201u.x
   MAJANDER A, 1991, FEBS LETT, V292, P289, DOI 10.1016/0014-5793(91)80886-8
   MAKELABENGS P, 1995, PEDIATR RES, V37, P634
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   Mather MW, 1998, FEBS LETT, V433, P93, DOI 10.1016/S0014-5793(98)00891-6
   McLennan HR, 2000, J BIOENERG BIOMEMBR, V32, P153, DOI 10.1023/A:1005507913372
   Meunier B, 2001, BIOCHEM J, V354, P407, DOI 10.1042/0264-6021:3540407
   Mills DA, 2003, BIOCHEMISTRY-US, V42, P7410, DOI 10.1021/bi0341307
   Morgan-Hughes JA, 1999, BBA-BIOENERGETICS, V1410, P125, DOI 10.1016/S0005-2728(98)00162-5
   Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
NR 44
TC 84
Z9 92
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD JUL 23
PY 2004
VL 1658
IS 1-2
SI SI
BP 89
EP 94
DI 10.1016/j.bbabio.2004.03.013
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Biophysics
GA 845KA
UT WOS:000223240100013
PM 15282179
DA 2024-11-01
ER

PT J
AU Yang, MG
   Xu, LS
   Xu, CM
   Cui, YY
   Jiang, S
   Dong, JJ
   Liao, L
AF Yang, Mengge
   Xu, Lusi
   Xu, Chunmei
   Cui, Yuying
   Jiang, Shan
   Dong, Jianjun
   Liao, Lin
TI The Mutations and Clinical Variability in Maternally Inherited Diabetes
   and Deafness: An Analysis of 161 Patients
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Review
DE treatment; diagnosis; mitochondrial gene mutations; heteroplasmy;
   maternally inherited diabetes and deafness
ID TRANSFER RNA(LEU(UUR)) GENE; MITOCHONDRIAL-DNA MUTATION; A3243G
   MUTATION; INSULIN-RESISTANCE; MELLITUS; MIDD; MELAS; HETEROPLASMY;
   POLYMORPHISM; DYSFUNCTION
AB Aims: To investigate the clinical features and mitochondrial mutations for maternally inherited diabetes and deafness.
   Methods: PubMed, Embase, Medline, Web of Science, the China National Knowledge Infrastructure, and Wanfang were searched with the following search terms: "Maternally inherited diabetes and deafness" OR "MIDD" OR "Mitochondrial diabetes". The mutations and clinical features were analyzed. Correlation between the heteroplasmy levels of the m.3243A>G mutation in the peripheral blood and age at the onset of diabetes was conducted by Spearman test. The significance level was set as p < 0.05. Statistical analysis was performed using the Statistical Package for the Social Sciences version 26 for Windows.
   Results: Totally 161 patients with 21 different mitochondrial mutations were enrolled. The most common mutation was the m.3243A>G mutation in 136 cases. Of 142 patients, 120 (84.51%) had family histories of diabetes or hearing loss. Hearing loss presented in 85.71% of the patients with mitochondrial mutations. Central nervous system diseases were found in 29.19%, myopathy in 22.98%, oculopathy in 23.60%, cardiac disease in 23.60%, and nephropathy in 13.66% of the patients. Forty-two of 101 (41.58%) patients were underweight. A significant negative correlation was found between the heteroplasmy levels of the m.3243A>G mutation in the peripheral blood and age at the onset of diabetes.
   Conclusions: The young onset of diabetes with low or normal BMI, maternal inheritance, and presence of impairments of multiple systems should prompt a genetic testing in order to differentiate MIDD from other types of diabetes earlier.
C1 [Yang, Mengge; Xu, Lusi; Xu, Chunmei; Liao, Lin] Shandong Univ, Dept Endocrinol & Metabol, Cheeloo Coll Med, Shandong Prov Qianfoshan Hosp,Shandong Key Lab Rh, Jinan, Peoples R China.
   [Yang, Mengge; Xu, Lusi; Xu, Chunmei; Liao, Lin] Shandong First Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metabol, Jinan, Peoples R China.
   [Yang, Mengge; Xu, Lusi; Xu, Chunmei; Liao, Lin] Shandong Prov Qianfoshan Hosp, Jinan, Peoples R China.
   [Cui, Yuying] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Jinan, Peoples R China.
   [Jiang, Shan; Dong, Jianjun] Shandong Univ, Qilu Hosp, Dept Internal Med, Div Endocrinol, Jinan, Peoples R China.
C3 Shandong First Medical University & Shandong Academy of Medical
   Sciences; Shandong University; Shandong First Medical University &
   Shandong Academy of Medical Sciences; Shandong First Medical University
   & Shandong Academy of Medical Sciences; Shandong University of
   Traditional Chinese Medicine; Shandong University
RP Liao, L (corresponding author), Shandong Univ, Dept Endocrinol & Metabol, Cheeloo Coll Med, Shandong Prov Qianfoshan Hosp,Shandong Key Lab Rh, Jinan, Peoples R China.; Liao, L (corresponding author), Shandong First Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metabol, Jinan, Peoples R China.; Liao, L (corresponding author), Shandong Prov Qianfoshan Hosp, Jinan, Peoples R China.; Dong, JJ (corresponding author), Shandong Univ, Qilu Hosp, Dept Internal Med, Div Endocrinol, Jinan, Peoples R China.
EM dongjianjun@sdu.edu.cn; liaolin@sdu.edu.cn
FU National Natural Science Foundation of China [81770822]
FX This work was funded by the National Natural Science Foundation of China
   (81770822).
CR Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Cao XY, 2013, INDIAN J PATHOL MICR, V56, P272, DOI 10.4103/0377-4929.120392
   Chatzispyrou IA, 2015, CANCER RES, V75, P4446, DOI 10.1158/0008-5472.CAN-15-1626
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   DIMARIO U, 1990, ACTA ENDOCRINOL-COP, V122, P303, DOI 10.1530/acta.0.1220303
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Finsterer Josef, 2018, Oman Med J, V33, P437, DOI 10.5001/omj.2018.80
   Fragaki K, 2016, BIOL RES, V49, DOI 10.1186/s40659-015-0065-0
   Fukao T, 2009, MOL MED REP, V2, P69, DOI 10.3892/mmr_00000063
   Gebhart SSP, 1996, METABOLISM, V45, P526, DOI 10.1016/S0026-0495(96)90231-0
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Greenfield A, 2018, NAT BIOTECHNOL, V36, P196, DOI 10.1038/nbt0218-196b
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Henzen C, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13690
   Hoptasz M, 2014, NEUROL NEUROCHIR POL, V48, P150, DOI 10.1016/j.pjnns.2013.12.007
   Hu L, 2006, J MODERN LAB MED, V02, P15, DOI [10.3969/j.issn.1671-7414.2006.02.005, DOI 10.3969/J.ISSN.1671-7414.2006.02.005]
   Kim NH, 2021, ANN INTERN MED, V174, P124, DOI 10.7326/L20-0292
   Kytövuori L, 2016, J NEUROL, V263, P2188, DOI 10.1007/s00415-016-8249-2
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   Leiter LM, 1999, J CELL PHYSIOL, V180, P334, DOI 10.1002/(SICI)1097-4652(199909)180:3<334::AID-JCP4>3.0.CO;2-Q
   Li HZ, 2014, FRONT BIOSCI-LANDMRK, V19, P777, DOI 10.2741/4244
   Lien LM, 2001, ACTA NEUROL SCAND, V103, P159, DOI 10.1034/j.1600-0404.2001.103003159.x
   Liou CW, 2001, DIABETES RES CLIN PR, V54, pS39, DOI 10.1016/S0168-8227(01)00334-5
   Maassen J. A., 2002, Archives of Physiology and Biochemistry, V110, P186, DOI 10.1076/apab.110.3.186.8294
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   Moyle Graeme, 2004, J HIV Ther, V9, P45
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Narbonne H, 2004, DIABETES METAB, V30, P61, DOI 10.1016/S1262-3636(07)70090-3
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Oexle K, 1996, EXP CLIN ENDOCR DIAB, V104, P212, DOI 10.1055/s-0029-1211445
   Okuyama H, 2015, EXPERT REV CLIN PHAR, V8, P189, DOI 10.1586/17512433.2015.1011125
   Poulton J, 1998, DIABETOLOGIA, V41, P54, DOI 10.1007/s001250050866
   Robinson KN, 2020, ENDOCR PRACT, V26, P241, DOI 10.4158/EP-2019-0270
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Rong Y., 2011, THESIS HEBEI MED U
   Salles JE, 2006, DIABETES RES CLIN PR, V72, P100, DOI 10.1016/j.diabres.2005.09.005
   Schleiffer T, 2000, EXP CLIN ENDOCR DIAB, V108, P81, DOI 10.1055/s-2000-5800
   Shin CS, 1998, ENDOCR J, V45, P105, DOI 10.1507/endocrj.45.105
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Suzuki S, 1998, DIABETOLOGIA, V41, P584, DOI 10.1007/s001250050950
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Tanaka K, 2000, INTERNAL MED, V39, P249, DOI 10.2169/internalmedicine.39.249
   van den Ameele J, 2020, SEMIN CELL DEV BIOL, V97, P156, DOI 10.1016/j.semcdb.2019.10.001
   van Essen EHR, 2000, DIABETIC MED, V17, P841, DOI 10.1046/j.1464-5491.2000.00379.x
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Verny C, 2008, DIABETES METAB, V34, P620, DOI 10.1016/j.diabet.2008.06.001
   Xiu L, 1997, NATL MED J CHINA, V06, P111, DOI [10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2002.0036, DOI 10.13471/J.CNKI.J.SUN.YAT-SEN.UNIV(MED.SCI).2002.0036]
   Yu P, 2003, CHINESE J MED GENET, V03, P63
   Yu Z, 2020, INT J ENDOCRINOL MET, V40, P279
NR 52
TC 23
Z9 26
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2392
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD NOV 25
PY 2021
VL 12
AR 728043
DI 10.3389/fendo.2021.728043
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 6A3ZU
UT WOS:000880597300001
PM 34899594
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Sturm, G
   Karan, KR
   Monzel, AS
   Santhanam, B
   Taivassalo, T
   Bris, C
   Ware, SA
   Cross, M
   Towheed, A
   Higgins-Chen, A
   McManus, MJ
   Cardenas, A
   Lin, J
   Epel, ES
   Rahman, S
   Vissing, J
   Grassi, B
   Levine, M
   Horvath, S
   Haller, RG
   Lenaers, G
   Wallace, DC
   St-Onge, MP
   Tavazoie, S
   Procaccio, V
   Kaufman, BA
   Seifert, EL
   Hirano, M
   Picard, M
AF Sturm, Gabriel
   Karan, Kalpita R.
   Monzel, Anna S.
   Santhanam, Balaji
   Taivassalo, Tanja
   Bris, Celine
   Ware, Sarah A.
   Cross, Marissa
   Towheed, Atif
   Higgins-Chen, Albert
   McManus, Meagan J.
   Cardenas, Andres
   Lin, Jue
   Epel, Elissa S.
   Rahman, Shamima
   Vissing, John
   Grassi, Bruno
   Levine, Morgan
   Horvath, Steve
   Haller, Ronald G.
   Lenaers, Guy
   Wallace, Douglas C.
   St-Onge, Marie-Pierre
   Tavazoie, Saeed
   Procaccio, Vincent
   Kaufman, Brett A.
   Seifert, Erin L.
   Hirano, Michio
   Picard, Martin
TI OxPhos defects cause hypermetabolism and reduce lifespan in cells and in
   patients with mitochondrial diseases
SO COMMUNICATIONS BIOLOGY
LA English
DT Article
ID C-OXIDASE DEFICIENCY; ENERGY-EXPENDITURE; METABOLIC-RATE;
   STRESS-RESPONSE; DNA DELETIONS; EXERCISE; DYSFUNCTION; MUTATIONS;
   MYOPATHIES; MECHANISM
AB A meta-analysis of 17 cohorts of mitochondrial disease patients reveals that OxPhos defects are associated with signs of hypermetabolism. Experiments in patient-derived fibroblast show that mitochondrial OxPhos defects trigger hypermetabolism in a cell-autonomous manner and this is linked to accelerated telomere shortening and epigenetic aging.
   Patients with primary mitochondrial oxidative phosphorylation (OxPhos) defects present with fatigue and multi-system disorders, are often lean, and die prematurely, but the mechanistic basis for this clinical picture remains unclear. By integrating data from 17 cohorts of patients with mitochondrial diseases (n = 690) we find evidence that these disorders increase resting energy expenditure, a state termed hypermetabolism. We examine this phenomenon longitudinally in patient-derived fibroblasts from multiple donors. Genetically or pharmacologically disrupting OxPhos approximately doubles cellular energy expenditure. This cell-autonomous state of hypermetabolism occurs despite near-normal OxPhos coupling efficiency, excluding uncoupling as a general mechanism. Instead, hypermetabolism is associated with mitochondrial DNA instability, activation of the integrated stress response (ISR), and increased extracellular secretion of age-related cytokines and metabokines including GDF15. In parallel, OxPhos defects accelerate telomere erosion and epigenetic aging per cell division, consistent with evidence that excess energy expenditure accelerates biological aging. To explore potential mechanisms for these effects, we generate a longitudinal RNASeq and DNA methylation resource dataset, which reveals conserved, energetically demanding, genome-wide recalibrations. Taken together, these findings highlight the need to understand how OxPhos defects influence the energetic cost of living, and the link between hypermetabolism and aging in cells and patients with mitochondrial diseases.
C1 [Sturm, Gabriel; Karan, Kalpita R.; Monzel, Anna S.; Cross, Marissa; Towheed, Atif; Picard, Martin] Columbia Univ Irving Med Ctr, Dept Psychiat, Div Behav Med, New York, NY 10032 USA.
   [Sturm, Gabriel; Lin, Jue] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA.
   [Santhanam, Balaji; Tavazoie, Saeed] Columbia Univ, New York, NY USA.
   [Taivassalo, Tanja] Univ Florida, Dept Physiol & Funct Genom, Clin & Translat Res Bldg, Gainesville, FL USA.
   [Bris, Celine; Lenaers, Guy; Procaccio, Vincent] Angers Hosp, Dept Genet & Neurol, Angers, France.
   [Bris, Celine; Lenaers, Guy; Procaccio, Vincent] Univ Angers, Angers, France.
   [Ware, Sarah A.; Kaufman, Brett A.] Univ Pittsburgh, Vasc Med Inst, Ctr Metab & Mitochondrial Med, Dept Med, Pittsburgh, PA USA.
   [Towheed, Atif] Univ Pittsburgh Med Ctr, Internal Med Pediat Residency Program, Pittsburgh, PA USA.
   [Higgins-Chen, Albert] Yale Univ Sch Med, Dept Psychiat, New Haven, CT USA.
   [McManus, Meagan J.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA USA.
   [McManus, Meagan J.; Wallace, Douglas C.] Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA USA.
   [Cardenas, Andres] Stanford Univ, Dept Epidemiol & Populat Hlth, Stanford, CA USA.
   [Epel, Elissa S.] Univ Calif San Francisco, Dept Psychiat & Behav Sci, San Francisco, CA USA.
   [Rahman, Shamima] Great Ormond St Hosp Children NHS Fdn Trust, UCL Great Ormond St Inst Child Hlth, Metab Unit, Mitochondrial Res Grp, London, England.
   [Vissing, John] Univ Copenhagen, Copenhagen Neuromuscular Ctr, Dept Neurol, Rigshospitalet, Copenhagen, Denmark.
   [Grassi, Bruno] Univ Udine, Dept Med, Udine, Italy.
   [Levine, Morgan; Horvath, Steve] Altos Labs, San Diego, CA USA.
   [Haller, Ronald G.] Univ Texas Southwestern Med Ctr, Inst Exercise & Environm Med Texas Hlth Resources, Neuromuscular Ctr, Dept Neurol, Dallas, TX USA.
   [St-Onge, Marie-Pierre] Columbia Univ Irving Med Ctr, Ctr Excellence Sleep & Circadian Res, Dept Med, Div Gen Med, New York, NY USA.
   [Seifert, Erin L.] Thomas Jefferson Univ, MitoCare Ctr, Dept Pathol & Genom Med, Philadelphia, PA USA.
   [Hirano, Michio; Picard, Martin] Columbia Univ Irving Med Ctr, H Houston Merritt Ctr, Dept Neurol, Columbia Translat Neurosci Initiat, New York, NY 10032 USA.
   [Picard, Martin] New York State Psychiat Inst & Hosp, New York, NY 10032 USA.
C3 NewYork-Presbyterian Hospital; University of California System;
   University of California San Francisco; Columbia University; State
   University System of Florida; University of Florida; Universite
   d'Angers; Centre Hospitalier Universitaire d'Angers; Universite
   d'Angers; Pennsylvania Commonwealth System of Higher Education (PCSHE);
   University of Pittsburgh; Pennsylvania Commonwealth System of Higher
   Education (PCSHE); University of Pittsburgh; Yale University; University
   of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of
   Philadelphia; University of Pennsylvania; Pennsylvania Medicine;
   Childrens Hospital of Philadelphia; Stanford University; University of
   California System; University of California San Francisco; University of
   London; University College London; Great Ormond Street Hospital for
   Children NHS Foundation Trust; University of Copenhagen; University of
   Udine; University of Texas System; University of Texas Southwestern
   Medical Center Dallas; NewYork-Presbyterian Hospital; Jefferson
   University; NewYork-Presbyterian Hospital; New York State Psychiatry
   Institute
RP Picard, M (corresponding author), Columbia Univ Irving Med Ctr, Dept Psychiat, Div Behav Med, New York, NY 10032 USA.; Picard, M (corresponding author), Columbia Univ Irving Med Ctr, H Houston Merritt Ctr, Dept Neurol, Columbia Translat Neurosci Initiat, New York, NY 10032 USA.; Picard, M (corresponding author), New York State Psychiat Inst & Hosp, New York, NY 10032 USA.
EM martin.picard@columbia.edu
RI Grassi, Bruno/AAC-7262-2022; McManus, Meagan/F-7932-2018; Rahman,
   Shamima/C-5232-2008; Kaufman, Brett/IUP-1225-2023; St-Onge,
   Marie-Pierre/AAB-3523-2020; Procaccio, Vincent/M-2596-2015; Epel,
   Elissa/ABI-6703-2022; karan, kalpita/ABC-4486-2020; Vissing,
   John/IUN-4271-2023; Higgins-Chen, Albert/ITU-0273-2023
OI Cardenas, Andres/0000-0003-2284-3298; Horvath,
   Steve/0000-0002-4110-3589; Higgins-Chen, Tzongyang/0000-0003-2904-2741;
   Sturm, Gabriel/0000-0002-7280-4310
FU NIH [R01AG066828, R01GM123771]; Baszucki Brain Research Fund; J. Willard
   and Alice S. Marriott Foundation; Muscular Dystrophy Association;
   Nicholas Nunno Foundation; JDF Fund for Mitochondrial Research; Shuman
   Mitochondrial Disease Fund
FX We are grateful to Jane Newman, Renae Stefanetti, Robert W Taylor, and
   Grainne S Gorman (Wellcome Center for Mitochondrial Research) for
   contributing data for Cohort 2, Rohit Sharma and Vamsi Mootha
   (Massachusetts General Hospital) for contributing data for Cohort 4,
   Robert McFarland (Wellcome Center for Mitochondrial Research) for
   contributing data for Cohort 17, and other investigators whose work
   contributed to the meta-analysis in Fig. 1. We thank Marlon McGill for
   technical assistance with parts of this project and Herman Pontzer for
   analytical advice. The cellular studies and analyses were supported by
   NIH grant R01AG066828 and the Baszucki Brain Research Fund to M.P., the
   J. Willard and Alice S. Marriott Foundation, Muscular Dystrophy
   Association, Nicholas Nunno Foundation, JDF Fund for Mitochondrial
   Research, and Shuman Mitochondrial Disease Fund to M.H. Further support
   was provided by NIH grants R01GM123771 and R01GM123771 awarded to E.L.S.
   and M-P.S-O., respectively. All research at Great Ormond Street Hospital
   NHS Foundation Trust and UCL Great Ormond Street Institute of Child
   Health is made possible by the NIHR Great Ormond Street Hospital
   Biomedical Research Centre. The views expressed are those of the
   author(s) and not necessarily those of the NIH, NHS, the NIHR, or the
   Department of Health.
CR Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038
   Apabhai S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022294
   Barends M, 2016, JIMD REP, V26, P103, DOI 10.1007/8904_2015_449
   Basan M, 2015, NATURE, V528, P99, DOI 10.1038/nature15765
   Basisty N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000599
   Bates MGD, 2013, INT J CARDIOL, V168, P3599, DOI 10.1016/j.ijcard.2013.05.062
   Becker C, 2018, EMBO REP, V19, DOI 10.15252/embr.201745126
   Belmonte FR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25186
   Bobba-Alves N., 2022, METABOLOMICS, V146, P105951, DOI 10.1016/j.psyneuen.2022.105951
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519
   Bris C, 2021, GENET MED, V23, P1769, DOI 10.1038/s41436-021-01206-w
   Brydges CR, 2019, INNOV AGING, V3, DOI 10.1093/geroni/igz036
   BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163
   Cao YS, 2015, NAT PHYS, V11, P772, DOI 10.1038/NPHYS3412
   Caporali L, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007210
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Celotto AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025823
   Chen DP, 2016, BRIEF FUNCT GENOMICS, V15, P485, DOI 10.1093/bfgp/elw018
   Chung HK, 2017, J CELL BIOL, V216, P149, DOI 10.1083/jcb.201607110
   Delaney NF, 2017, P NATL ACAD SCI USA, V114, P8402, DOI 10.1073/pnas.1703338114
   Eom S, 2017, PEDIATR NEUROL, V66, P82, DOI 10.1016/j.pediatrneurol.2016.10.006
   Forsström S, 2019, CELL METAB, V30, P1040, DOI [10.1016/j.cmet.2019.013.019, 10.1016/j.cmet.2019.08.019]
   Galna B, 2014, J NEUROL, V261, P73, DOI 10.1007/s00415-013-7129-2
   Ganeshan K, 2019, CELL, V177, P399, DOI 10.1016/j.cell.2019.01.050
   Ganetzky RD, 2022, NEW ENGL J MED, V387, P1395, DOI 10.1056/NEJMoa2202949
   Ge SX, 2020, BIOINFORMATICS, V36, P2628, DOI 10.1093/bioinformatics/btz931
   Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, NEUROMUSCULAR DISORD, V25, P563, DOI 10.1016/j.nmd.2015.03.001
   Goudenège D, 2019, GENET MED, V21, P1407, DOI 10.1038/s41436-018-0350-8
   Grassi B, 2007, MUSCLE NERVE, V35, P510, DOI 10.1002/mus.20708
   Grassi B, 2009, MED SCI SPORT EXER, V41, P2120, DOI 10.1249/MSS.0b013e3181aae96b
   Green JA, 2011, COMP BIOCHEM PHYS A, V158, P287, DOI 10.1016/j.cbpa.2010.09.011
   Guimier A, 2021, GENET MED, V23, P2415, DOI 10.1038/s41436-021-01296-6
   Guo XY, 2020, NATURE, V579, P427, DOI 10.1038/s41586-020-2078-2
   Gutierrez JM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13867-y
   Hämäläinen RH, 2019, NAT METAB, V1, P958, DOI 10.1038/s42255-019-0120-1
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Heinicke K, 2011, AM J PHYSIOL-REG I, V301, pR873, DOI 10.1152/ajpregu.00001.2011
   Higgins-Chen AT, 2022, NATURE AGING, V2, P644, DOI 10.1038/s43587-022-00248-2
   Hoitzing H, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007023
   Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3
   Hou Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219628
   Inak G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22117-z
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Jeppesen TD, 2013, NEUROMUSCULAR DISORD, V23, P629, DOI 10.1016/j.nmd.2013.05.007
   Jeppesen TD, 2009, ARCH NEUROL-CHICAGO, V66, P365, DOI 10.1001/archneurol.2009.24
   Jumpertz R, 2011, J CLIN ENDOCR METAB, V96, pE972, DOI 10.1210/jc.2010-2944
   Kafri M, 2016, CELL REP, V14, P22, DOI 10.1016/j.celrep.2015.12.015
   Karan KR, 2020, BRAIN BEHAV IMMUN-HL, V5, DOI 10.1016/j.bbih.2020.100080
   Kaspar S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf0971
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Keshavan N, 2018, ESSAYS BIOCHEM, V62, P423, DOI 10.1042/EBC20170108
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Klein HU, 2021, MOL NEURODEGENER, V16, DOI 10.1186/s13024-021-00495-8
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Kühl I, 2017, ELIFE, V6, DOI 10.7554/eLife.30952
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lan G, 2012, NAT PHYS, V8, P422, DOI 10.1038/NPHYS2276
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Lehallier B, 2019, NAT MED, V25, P1843, DOI 10.1038/s41591-019-0673-2
   Lehmann D, 2019, NUCLEIC ACIDS RES, V47, P7430, DOI 10.1093/nar/gkz472
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Lozoya OA, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108131
   Lozoya OA, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005707
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Makarieva AM, 2008, P NATL ACAD SCI USA, V105, P16994, DOI 10.1073/pnas.0802148105
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   McManus MJ, 2019, CELL METAB, V29, P78, DOI 10.1016/j.cmet.2018.08.002
   Mehta NM, 2015, CLIN NUTR, V34, P151, DOI 10.1016/j.clnu.2014.02.008
   Mick E, 2020, ELIFE, V9, DOI 10.7554/eLife.49178
   Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82
   Mookerjee SA, 2017, J BIOL CHEM, V292, P7189, DOI 10.1074/jbc.M116.774471
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Morrow RM, 2017, P NATL ACAD SCI USA, V114, P2705, DOI 10.1073/pnas.1700997114
   Newman Jane, 2015, J Neuromuscul Dis, V2, P151
   Oexle K, 1997, HUM MOL GENET, V6, P905, DOI 10.1093/hmg/6.6.905
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Picard M, 2015, P NATL ACAD SCI USA, V112, pE6614, DOI 10.1073/pnas.1515733112
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Picard M, 2012, AM J RESP CRIT CARE, V186, P1140, DOI 10.1164/rccm.201206-0982OC
   Pinti M, 2014, EUR J IMMUNOL, V44, P1552, DOI 10.1002/eji.201343921
   Pontzer H, 2021, SCIENCE, V373, P808, DOI 10.1126/science.abe5017
   Pontzer H, 2018, PHYSIOLOGY, V33, P384, DOI 10.1152/physiol.00027.2018
   Porcelli S, 2016, J APPL PHYSIOL, V121, P699, DOI 10.1152/japplphysiol.00885.2015
   Qian W, 2019, P NATL ACAD SCI USA, V116, P18435, DOI 10.1073/pnas.1910574116
   Quadalti C, 2018, BBA-MOL BASIS DIS, V1864, P2131, DOI 10.1016/j.bbadis.2018.03.021
   Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107
   Quirós PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Rabenstein A, 2021, ORPHANET J RARE DIS, V16, DOI 10.1186/s13023-021-01724-5
   Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011
   Ratheiser KM, 1998, AM J CLIN NUTR, V68, P1046, DOI 10.1093/ajcn/68.5.1046
   Raule N, 2014, AGING CELL, V13, P401, DOI 10.1111/acel.12186
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Ruggiero C, 2008, J GERONTOL A-BIOL, V63, P698, DOI 10.1093/gerona/63.7.698
   Saleem A, 2015, MITOCHONDRION, V21, P19, DOI 10.1016/j.mito.2014.12.001
   Schmidt CA, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101140
   Schrack JA, 2014, J AM GERIATR SOC, V62, P667, DOI 10.1111/jgs.12740
   Sharma R, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136055
   SHELMET JJ, 1988, J CLIN INVEST, V81, P1137, DOI 10.1172/JCI113428
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Sturm G, 2022, SCI DATA, V9, DOI 10.1038/s41597-022-01852-y
   Sturm G, 2019, EPIGENETICS-US, V14, P961, DOI 10.1080/15592294.2019.1626651
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   SUTER PM, 1992, NEW ENGL J MED, V326, P983, DOI 10.1056/NEJM199204093261503
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Takauji Y, 2016, EXP CELL RES, V345, P239, DOI 10.1016/j.yexcr.2016.06.011
   Takauji Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep18722
   Tanaka T, 2018, AGING CELL, V17, DOI 10.1111/acel.12799
   Tencerova M, 2019, CELL REP, V27, P2050, DOI 10.1016/j.celrep.2019.04.066
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vincent AE, 2018, J PATHOL, V246, P261, DOI 10.1002/path.5146
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   Vissing J, 1996, ANN NEUROL, V40, P655, DOI 10.1002/ana.410400416
   Ware SA, 2020, J BIOL CHEM, V295, P15677, DOI 10.1074/jbc.RA120.015237
   Wedatilake Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-96
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Yang XB, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026786118
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
NR 127
TC 34
Z9 37
U1 5
U2 20
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2399-3642
J9 COMMUN BIOL
JI Commun. Biol.
PD JAN 12
PY 2023
VL 6
IS 1
AR 22
DI 10.1038/s42003-022-04303-x
PG 22
WC Biology; Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Science & Technology - Other
   Topics
GA 9E1GU
UT WOS:000936542400004
PM 36635485
OA Green Submitted, gold, Green Published
HC Y
HP N
DA 2024-11-01
ER

PT J
AU Waldrop, MA
   Gumienny, F
   Boue, D
   de los Reyes, E
   Shell, R
   Weiss, RB
   Flanigan, KM
AF Waldrop, Megan A.
   Gumienny, Felecia
   Boue, Daniel
   de los Reyes, Emily
   Shell, Richard
   Weiss, Robert B.
   Flanigan, Kevin M.
TI Low-level expression of <i>EPG5</i> leads to an attenuated Vici syndrome
   phenotype
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE agenesis of the corpus callosum; EPG5; myopathy; Vici syndrome
ID SENSORINEURAL HEARING-LOSS; CORPUS-CALLOSUM; MUSCLE BIOPSY; MUTATION;
   AGENESIS; IMMUNODEFICIENCY; ALBINISM
AB Vici syndrome is a multisystem disorder characterized by agenesis of the corpus callosum, oculocutaneous hypopigmentation, cataracts, cardiomyopathy, combined immunodeficiency, failure to thrive, profound developmental delay, and acquired microcephaly. Most individuals are severely affected and have a markedly reduced life span. Here we describe an 8-year-old boy with a history of developmental delay, agenesis of the corpus callosum, failure to thrive, myopathy, and well-controlled epilepsy. He was initially diagnosed with a mitochondrial disorder, based in part upon nonspecific muscle biopsy findings, but mitochondrial DNA mutation analysis revealed no mutations. Whole exome sequencing revealed compound heterozygosity for two EPG5 variants, inherited in trans. One was a known pathogenic mutation in exon 13 (c.2461C>T, p.Arg821X). The second was reported as a variant of unknown significance found within intron 16, six nucleotides before the exon 17 splice acceptor site (c.3099-6C>G). Reverse transcription-polymerase chain reaction of the EPG5 mRNA showed skipping of exon 17-which maintains an open reading frame-in 77% of the transcript, along with 23% expression of wild-type mRNA suggesting that intronic mutations may affect splicing of the EPG5 gene and result in symptoms. However, the expression of 23% wild-type mRNA may result in a significantly attenuated Vici syndrome phenotype.
C1 [Waldrop, Megan A.; Gumienny, Felecia; Flanigan, Kevin M.] Nationwide Childrens Hosp, Ctr Gene Therapy, Columbus, OH USA.
   [Waldrop, Megan A.; Flanigan, Kevin M.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA.
   [Waldrop, Megan A.; Flanigan, Kevin M.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA.
   [Boue, Daniel] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.
   [de los Reyes, Emily] Nationwide Childrens Hosp, Dept Pediat Neurol, Columbus, OH USA.
   [Shell, Richard] Nationwide Childrens Hosp, Dept Pulmonol, Columbus, OH USA.
   [Weiss, Robert B.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA.
C3 University System of Ohio; Ohio State University; Nationwide Childrens
   Hospital; Research Institute at Nationwide Children's Hospital;
   University System of Ohio; Ohio State University; University System of
   Ohio; Ohio State University; University System of Ohio; Ohio State
   University; University System of Ohio; Ohio State University; Nationwide
   Childrens Hospital; University System of Ohio; Ohio State University;
   Nationwide Childrens Hospital; Utah System of Higher Education;
   University of Utah
RP Flanigan, KM (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, 700 Childrens Dr,Rm WA3011, Columbus, OH 43205 USA.
EM kevin.flanigan@nationwidechildrens.org
RI de los Reyes, Emily/AAP-3836-2020
OI Flanigan, Kevin/0000-0001-6440-3376; Waldrop, Megan/0000-0001-9621-8319
FU National Institute for Health [4T32NS077984-05]
FX National Institute for Health, Grant/Award Number: 4T32NS077984-05
CR Al-Owain M, 2010, AM J MED GENET A, V152A, P1849, DOI 10.1002/ajmg.a.33421
   Byrne S, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0399-x
   Byrne S, 2016, BRAIN, V139, P765, DOI 10.1093/brain/awv393
   Chiyonobu T, 2002, AM J MED GENET, V109, P61, DOI 10.1002/ajmg.10298
   Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497
   del Campo M, 1999, AM J MED GENET, V85, P479, DOI 10.1002/(SICI)1096-8628(19990827)85:5<479::AID-AJMG9>3.0.CO;2-D
   Ehmke N, 2014, AM J MED GENET A, V164, P3170, DOI 10.1002/ajmg.a.36772
   Finocchi A, 2012, AM J MED GENET A, V158A, P434, DOI 10.1002/ajmg.a.34244
   Hedberg-Oldfors C, 2017, NEUROMUSCULAR DISORD, V27, P771, DOI 10.1016/j.nmd.2017.05.005
   Maillard C, 2017, AM J MED GENET A, V173, P706, DOI 10.1002/ajmg.a.38061
   McClelland V, 2010, AM J MED GENET A, V152A, P741, DOI 10.1002/ajmg.a.33296
   Miyata R, 2007, AM J MED GENET A, V143A, P189, DOI 10.1002/ajmg.a.31584
   Miyata R, 2014, AM J MED GENET A, V164, P3203, DOI 10.1002/ajmg.a.36753
   Nickless A, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0153-7
   Özkale M, 2012, PEDIATR NEUROL, V47, P375, DOI 10.1016/j.pediatrneurol.2012.07.007
   Rogers R. C., 2011, CASE REP GENET, V2011
   Said E, 2012, AM J MED GENET A, V158A, P440, DOI 10.1002/ajmg.a.34273
   Tasdemir S, 2016, AM J MED GENET A, V170, P220, DOI 10.1002/ajmg.a.37398
   Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418
NR 19
TC 8
Z9 8
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD MAY
PY 2018
VL 176
IS 5
BP 1207
EP 1211
DI 10.1002/ajmg.a.38676
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA GH5FA
UT WOS:000433440600021
PM 29681093
DA 2024-11-01
ER

PT J
AU Jokinen, R
   Battersby, BJ
AF Jokinen, Riikka
   Battersby, Brendan J.
TI Insight into mammalian mitochondrial DNA segregation
SO ANNALS OF MEDICINE
LA English
DT Article
DE Autophagy; disease; genetics; metabolism; mitochondria; mitochondrial
   DNA
ID MTDNA COPY NUMBER; TRANSCRIPTION FACTOR; SKELETAL-MUSCLE; RETICULOCYTE
   MATURATION; HETEROPLASMIC MICE; HISTOCOMPATIBILITY ANTIGEN;
   EMBRYONIC-DEVELOPMENT; RAPID SEGREGATION; AXONAL-TRANSPORT; POINT
   MUTATION
AB Mitochondrial DNA (mtDNA) is essential for aerobic energy production in eukaryotic cells, and mutations in this genome can lead to mitochondrial dysfunction. Human mtDNA mutations are typically heteroplasmic, a mix of mutant and wild-type genomes, which can present as a heterogeneous group of disorders ranging in severity from mild to fatal, and commonly affecting highly aerobic tissues such as heart, skeletal muscle, and neurons. During the 1990s, many research groups started to notice that mtDNA mutations could segregate depending upon the mutation and tissue. This segregation pattern can have a direct effect on the onset and severity of these mutations. However, these segregation patterns could not be easily explained by respiratory chain function, implying that there is regulation of mtDNA independent of its bioenergetic role. A lot of research on this topic has been largely descriptive, but over the last several years advances in mitochondrial biology have provided some mechanistic insight into the regulation of the organelle and its genome. This review addresses these advances with respect to somatic segregation of mtDNA in mammals.
C1 [Battersby, Brendan J.] Univ Helsinki, Biomedicum Helsinki, Res Programs Unit Mol Neurol, FIN-00290 Helsinki, Finland.
   Univ Helsinki, Biomedicum Helsinki, Inst Biomed, FIN-00290 Helsinki, Finland.
C3 University of Helsinki; University of Helsinki
RP Battersby, BJ (corresponding author), Univ Helsinki, Biomedicum Helsinki, Res Programs Unit Mol Neurol, R C524B,Haartmaninkatu 8, FIN-00290 Helsinki, Finland.
EM brendan.battersby@helsinki.fi
FU Academy of Finland; Jane and Aatos Erkko Foundation; University of
   Helsinki; Biocentrum Helsinki; UMDF-USA; Helsinki Biomedical Graduate
   School
FX Research in the lab of B.J.B. was supported by the Academy of Finland,
   Jane and Aatos Erkko Foundation, University of Helsinki, Biocentrum
   Helsinki, and UMDF-USA. R.J. is supported by the Helsinki Biomedical
   Graduate School. B.J.B. is an Academy of Finland Research Fellow. The
   authors report no conflicts of interest.
CR Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrade-Navarro MA, 2009, CURR OPIN CELL BIOL, V21, P560, DOI 10.1016/j.ceb.2009.04.005
   Battersby BJ, 2005, HUM MOL GENET, V14, P2587, DOI 10.1093/hmg/ddi293
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469
   BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7
   Bogenhagen D.F., 2011, BIOCH BIOPHYS ACTA
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101
   Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027
   HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   Ishikawa K, 2010, J EXP MED, V207, P2297, DOI 10.1084/jem.20092296
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Jokinen R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001161
   KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542
   Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Lindahl KF, 1997, ANNU REV IMMUNOL, V15, P851
   Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255
   LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038
   Ney PA, 2011, CURR OPIN HEMATOL, V18, P152, DOI 10.1097/MOH.0b013e328345213e
   Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233
   Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Reis K, 2009, FEBS LETT, V583, P1391, DOI 10.1016/j.febslet.2009.04.015
   Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006
   Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104
   Schwefel D, 2010, P NATL ACAD SCI USA, V107, P20299, DOI 10.1073/pnas.1010322107
   SHOUBRIDGE EA, 1995, BIOCHEM BIOPH RES CO, V213, P189, DOI 10.1006/bbrc.1995.2115
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2
   Takeda K, 2000, GENETICS, V155, P777
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   tHart LM, 1996, HUM MUTAT, V7, P193
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046
   Weber K, 1997, AM J HUM GENET, V60, P373
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Young L, 2001, SCIENCE, V291, P2135, DOI 10.1126/science.1056957
   Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
NR 98
TC 18
Z9 19
U1 0
U2 31
PU INFORMA HEALTHCARE
PI NEW YORK
PA 52 VANDERBILT AVE, NEW YORK, NY 10017 USA
SN 0785-3890
J9 ANN MED
JI Ann. Med.
PD MAR
PY 2013
VL 45
IS 2
BP 149
EP 155
DI 10.3109/07853890.2012.693190
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 084GX
UT WOS:000314527800007
PM 22775146
DA 2024-11-01
ER

PT J
AU Bisceglia, L
   Zoccolella, S
   Torraco, A
   Piemontese, MR
   Dell'Aglio, R
   Amati, A
   De Bonis, P
   Artuso, L
   Copetti, M
   Santorelli, FM
   Serlenga, L
   Zelante, L
   Bertini, E
   Petruzzella, V
AF Bisceglia, Luigi
   Zoccolella, Stefano
   Torraco, Alessandra
   Piemontese, Maria Rosaria
   Dell'Aglio, Rosa
   Amati, Angela
   De Bonis, Patrizia
   Artuso, Lucia
   Copetti, Massimiliano
   Santorelli, Filippo Maria
   Serlenga, Luigi
   Zelante, Leopoldo
   Bertini, Enrico
   Petruzzella, Vittoria
TI A new locus on 3p23-p25 for an autosomal-dominant limb-girdle muscular
   dystrophy, LGMD1H
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE autosomal-dominant limb-girdle muscular dystrophy; multiple mtDNA
   deletions; linkage analysis; chromosome 3
ID IDENTIFICATION; MUTATIONS; LINKAGE; DELETIONS; DESCENT; MAPS
AB Limb-girdle muscular dystrophies (LGMDs) are a genetically heterogeneous group of neuromuscular disorders with a selective or predominant involvement of shoulder and pelvic girdles. We clinically examined 19 members in a four-generation Italian family with autosomal-dominant LGMD. A total of 11 subjects were affected. Clinical findings showed variable expressivity in terms of age at onset and disease severity. Five subjects presented with a slowly progressive proximal muscle weakness, in both upper and lower limbs, with onset during the fourth-fifth decade of life, which fulfilled the consensus diagnostic criteria for LGMD. Earlier onset of the disease was observed in a group of patients presenting with muscle weakness and/or calf hypertrophy, and/or occasionally high CK and lactate serum levels. Two muscle biopsies showed morphological findings compatible with MD associated with subsarcolemmal accumulation of mitochondria and the presence of multiple mitochondrial DNA deletions. A genome-wide scan performed using microsatellite markers mapped the disease on chromosome 3p23-p25.1 locus in a 25-cM region between markers D3S1263 and D3S3685. The highest two-point LOD score was 3.26 (theta=0) at marker D3S1286 and D3S3613, whereas non-parametric analysis reached a P-value=0.0004. Four candidate genes within the refined region were analysed but did not reveal any mutations. Our findings further expand the clinical and genetic heterogeneity of LGMDs. European Journal of Human Genetics (2010) 18, 636-641; doi: 10.1038/ejhg.2009.235; published online 13 January 2010
C1 [Torraco, Alessandra; Dell'Aglio, Rosa; Artuso, Lucia; Petruzzella, Vittoria] Univ Bari, Dept Med Biochem Biol & Phys, I-00165 Bari, Italy.
   [Bisceglia, Luigi; Piemontese, Maria Rosaria; De Bonis, Patrizia; Zelante, Leopoldo] IRCCS Osped Casa Sollievo Sofferenza, Med Genet Unit, Dept Evolut Age, Foggia, Italy.
   [Zoccolella, Stefano] Osped Riuniti Foggia, Clin Nervous Syst Dis, Foggia, Italy.
   [Torraco, Alessandra; Santorelli, Filippo Maria; Bertini, Enrico] IRCCS Osped Bambino Gesu, Rome, Italy.
   [Amati, Angela] Univ Bari, Dept Neurol & Psychiat Sci, Bari, Italy.
   [Copetti, Massimiliano] IRCCS Osped Casa Sollievo Sofferenza, Biostat Unit, Foggia, Italy.
   [Serlenga, Luigi] L Bonomo Hosp, Operat Unit Neurol, Andria, Italy.
   [Petruzzella, Vittoria] CNR, Inst Biomembranes & Bioenerget, Bari, Italy.
C3 Universita degli Studi di Bari Aldo Moro; IRCCS Casa Sollievo Della
   Sofferenza; IRCCS Bambino Gesu; Universita degli Studi di Bari Aldo
   Moro; IRCCS Casa Sollievo Della Sofferenza; Consiglio Nazionale delle
   Ricerche (CNR)
RP Petruzzella, V (corresponding author), Univ Bari, Dept Med Biochem Biol & Phys, Piazza Giulio Cesare 11, I-00165 Bari, Italy.
EM v.petruzzella@biochem.uniba.it
RI zoccolella, stefano/AAA-2515-2020; d’Amati, Antonio/AAT-7253-2021;
   Torraco, Alessandra/AAA-6212-2020; COPETTI, MASSIMILIANO/K-3186-2016;
   Petruzzella, Vittoria/K-8863-2016; Bertini, Enrico/A-2284-2014;
   Santorelli, Filippo M/ABE-5124-2020; Bisceglia, Luigi/B-8720-2017
OI Artuso, Lucia/0000-0002-3058-9739; COPETTI,
   MASSIMILIANO/0000-0002-7960-5947; Torraco,
   Alessandra/0000-0002-8148-9295; Petruzzella,
   Vittoria/0000-0001-8771-6033; Bertini, Enrico/0000-0001-9276-4590;
   Santorelli, Filippo M/0000-0002-1359-9062; Bisceglia,
   Luigi/0000-0001-5367-8518
FU Italian Ministry of Health; MIUR-PRIN [2005052128_001]; Research
   Foundation Cassa di Risparmio di Puglia
FX This study was supported in part by grants from the Italian Ministry of
   Health 'Ricerca Corrente 2009-2011'; MIUR-PRIN 'Molecular mechanisms,
   physiology and pathology of membrane bioenergetics system', Project No.
   2005052128_001; and Research Foundation Cassa di Risparmio di Puglia.
CR Beckmann J S, 1999, Neuromuscul Disord, V9, P436, DOI 10.1016/S0960-8966(99)00064-4
   Bisceglia L, 2009, INVEST OPHTH VIS SCI, V50, P1081, DOI 10.1167/iovs.08-2382
   BUSHBY KMD, 1997, DIAGNOSTIC CRITERIA, P17
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Futai E, 2001, BBA-GENE STRUCT EXPR, V1517, P316, DOI 10.1016/S0167-4781(00)00256-6
   Gamez J, 2001, NEUROLOGY, V56, P450, DOI 10.1212/WNL.56.4.450
   Guglieri M, 2008, CURR OPIN NEUROL, V21, P576, DOI 10.1097/WCO.0b013e32830efdc2
   Hauser MA, 2000, HUM MOL GENET, V9, P2141, DOI 10.1093/hmg/9.14.2141
   Jansson M, 2000, ACTA NEUROPATHOL, V100, P23, DOI 10.1007/s004010051188
   Jung-Ching Lin Jim, 2005, J Med Sci, V25, P215
   Messina DN, 1997, AM J HUM GENET, V61, P909, DOI 10.1086/514896
   Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365
   Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453
   OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175
   Palenzuela L, 2003, NEUROLOGY, V61, P404, DOI 10.1212/01.WNL.0000073984.46546.4F
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Sobel E, 1996, AM J HUM GENET, V58, P1323
   Speer MC, 1999, AM J HUM GENET, V64, P556, DOI 10.1086/302252
   Starling A, 2004, EUR J HUM GENET, V12, P1033, DOI 10.1038/sj.ejhg.5201289
   vanderKooi AJ, 1997, AM J HUM GENET, V60, P891
   Weeks DE., 1990, AM J HUM GENET, V47, pA204
   WHITTEMORE AS, 1994, BIOMETRICS, V50, P109, DOI 10.2307/2533201
   Zeviani M, 2003, CURR OPIN GENET DEV, V13, P262, DOI 10.1016/S0959-437X(03)00052-2
NR 24
TC 17
Z9 19
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD JUN
PY 2010
VL 18
IS 6
BP 636
EP 641
DI 10.1038/ejhg.2009.235
PG 6
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 599DR
UT WOS:000277890900003
PM 20068593
OA Green Published, Green Submitted, Bronze
DA 2024-11-01
ER

PT J
AU López-Gallardo, E
   Solano, A
   Herrero-Martín, MD
   Martínez-Romero, I
   Castaño-Pérez, MD
   Andreu, AL
   Herrera, A
   López-Pérez, MJ
   Ruiz-Pesini, E
   Montoya, J
AF Lopez-Gallardo, E.
   Solano, A.
   Herrero-Martin, M. D.
   Martinez-Romero, I.
   Castano-Perez, M. D.
   Andreu, A. L.
   Herrera, A.
   Lopez-Perez, M. J.
   Ruiz-Pesini, E.
   Montoya, J.
TI NARP syndrome in a patient harbouring an insertion in the <i>MT-ATP6</i>
   gene that results in a truncated protein
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID POLYACRYLAMIDE-GEL ELECTROPHORESIS; ATP SYNTHASE; MUTATION;
   MITOCHONDRIA; SEPARATION; PHENOTYPE; DISEASES; MTDNA
AB Background: Neurogenic muscle weakness, ataxia and retinitis pigmentosa (NARP) syndrome have been associated to m.8993T>G/C mutations in the subunit 6 of the ATP synthase (p.MT-ATP6).
   Methods: We have performed a mutational screening of the mitochondrial DNA gene encoding for this protein in 62 patients with the disease, that do not carry any of the common mutations described to date.
   Results: We report clinical and molecular data in one patient who harbours a de novo insertion in the MT-ATP6 gene that results in a truncated subunit. The mutation was heteroplasmic (85%) in muscle DNA and the BN-PAGE analysis showed a clear decrease in the amount of ATP synthase.
   Conclusion: Molecular analysis of NARP patients cannot be limited to the search of the m.8993T>G/C and either the ATP6 or the whole mtDNA should be sequenced.
C1 [Lopez-Gallardo, E.; Solano, A.; Herrero-Martin, M. D.; Martinez-Romero, I.; Lopez-Perez, M. J.; Ruiz-Pesini, E.; Montoya, J.] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, E-50013 Zaragoza, Spain.
   [Castano-Perez, M. D.] Hosp Virgen Lirios, Serv Neurol, Alicante, Spain.
   [Andreu, A. L.] Hosp Valle De Hebron, Barcelona, Spain.
   [Herrera, A.] Hosp Miguel Servet, Serv Cirugia Ortoped & Traumatol, Zaragoza, Spain.
C3 University of Zaragoza; Hospital Universitari Vall d'Hebron; Miguel
   Servet University Hospital
RP Montoya, J (corresponding author), Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Miguel Servet 177, E-50013 Zaragoza, Spain.
EM jmontoya@unizar.es
RI Herrera, Antonio/E-5532-2011; Herrera, Antonio/H-9775-2013
OI Herrera, Antonio/0000-0001-7877-4733; ANDREU, antonio
   luis/0000-0002-3936-3234; Lopez Gallardo, Ester/0000-0002-3217-1424
FU Instituto de Salud Carlos III-FIS [PI07-0045, PI07/90512]; Diputacion
   General de Aragon; FIS [FI05/00501, FI0700184]; The CIBER de
   Enfermedades Raras; ISCIII
FX This project was supported by grants from Instituto de Salud Carlos
   III-FIS (PI07-0045, PI07/90512), Diputacion General de Aragon (Grupos
   Consolidados B33). MDH-M and IM-R are supported by a predoctoral
   fellowships FIS (FI05/00501 and FI0700184). The CIBER de Enfermedades
   Raras is an initiative of the ISCIII.
CR Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325
   GrandierVazeille X, 1996, ANAL BIOCHEM, V242, P248, DOI 10.1006/abio.1996.0460
   Herrero-Martin Maria D, 2008, Hum Mutat, V29, pE112, DOI 10.1002/humu.20800
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   JOHN UP, 1986, NUCLEIC ACIDS RES, V14, P7437, DOI 10.1093/nar/14.18.7437
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Marotta R, 2004, INTERN MED J, V34, P10, DOI 10.1111/j.1444-0903.2004.t01-3-.x
   Mishmar D, 2004, HUM MUTAT, V23, P125, DOI 10.1002/humu.10304
   MORADIAMELI M, 1983, P NATL ACAD SCI-BIOL, V80, P6167, DOI 10.1073/pnas.80.20.6167
   Ono S, 2004, J BIOL CHEM, V279, P33409, DOI 10.1074/jbc.M404993200
   Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200
   Ruiz-Pesini E, 2006, REV NEUROLOGIA, V43, P416, DOI 10.33588/rn.4307.2005508
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   Sciacco M, 2003, J NEUROL, V250, P1498, DOI 10.1007/s00415-003-0246-6
   SHOFFNER JM, 1992, NEUROLOGY, V42, P2168, DOI 10.1212/WNL.42.11.2168
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
NR 20
TC 36
Z9 39
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD JAN
PY 2009
VL 46
IS 1
BP 64
EP 67
DI 10.1136/jmg.2008.060616
PG 4
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 390XW
UT WOS:000262198000009
PM 19124644
DA 2024-11-01
ER

PT J
AU Brautbar, A
   Wang, J
   Abdenur, JE
   Chang, RC
   Thomas, JA
   Grebe, TA
   Lim, C
   Weng, SW
   Graham, BH
   Wong, LJ
AF Brautbar, Ariel
   Wang, Jing
   Abdenur, Jose E.
   Chang, Richard C.
   Thomas, Janet A.
   Grebe, Theresa A.
   Lim, Cynthia
   Weng, Shao-Wen
   Graham, Brett H.
   Wong, Lee-Jun
TI The mitochondrial 13513G&gt;A mutation is associated with Leigh disease
   phenotypes independent of complex I deficiency in muscle
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE mitochondrial disease; Leigh syndrome; MELAS; mtDNA; 13513G > A; 13514A
   > G
ID DNA G13513A MUTATION; CLINICAL-FEATURES; GENE; ABNORMALITIES;
   DYSFUNCTION; DISORDERS; CHILDREN; FREQUENT; SUBUNIT; MELAS
AB The mitochondrial 13513G>A (D393N) mutation in the ND5 subunit of the respiratory chain complex I was initially described in association with MELAS syndrome. Recent observations have linked this mutation to Leigh disease. We screened for the 13513G>A mutation in a cohort of 265 patients with Leigh and Leigh-like disease. The mutation was found in a total of 5 patients. An additional patient who had clinical presentation consistent with a Leigh-like phenotype but with a normal brain MRI was added to the cohort. None of an additional 88 patients meeting MELAS disease criteria, nor 56 patients with respiratory chain deficiency screened for the 13513G>A were found positive for the mutation. The most frequent clinical manifestations in our patients were hypotonia, ocular and cerebellar involvement. Low mutation heteroplasmy in the range of 20-40% was observed in all 6 patients. This observation is consistent with the previously reported low heteroplasmy of this mutation in some patients with the 13513G>A mutation and complex I deficiency. However, normal complex I activity was observed in two patients in our cohort. As most patients with Leigh-like disease and the 13513G>A mutation have been described with complex I deficiency, this report adds to the previously reported subset of patients with normal respiratory complex function. We conclude that in any patient with Leigh or Leigh-like disease, testing for the 13513G>A mutation is clinically relevant and low mutant loads in blood or muscle may be considered pathogenic, in the presence of normal respiratory chain enzyme activities. (C) 2008 Published by Elsevier Inc.
C1 [Brautbar, Ariel; Wang, Jing; Wong, Lee-Jun] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Abdenur, Jose E.; Chang, Richard C.] Childrens Hosp Orange Cty, Div Metab Disorders, Orange, CA 92668 USA.
   [Thomas, Janet A.] Univ Colorado, Sch Med, Dept Pediat, Sect Clin Genet & Metab, Denver, CO USA.
   [Grebe, Theresa A.; Lim, Cynthia] St Josephs Hosp, Phoenix Genet Program, Phoenix, AZ USA.
   [Weng, Shao-Wen] Chang Gung Univ, Coll Med, Kaohsiung Med Ctr, Chang Gung Mem Hosp,Dept Internal Med, Kaohsiung, Taiwan.
C3 Baylor College of Medicine; Childrens Hospital of Orange County;
   University of Colorado System; University of Colorado Anschutz Medical
   Campus; University of Colorado Denver; St. Joseph's Hospital and Medical
   Center; Chang Gung Memorial Hospital; Chang Gung University
RP Wong, LJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,NAB 2015, Houston, TX 77030 USA.
EM ljwong@bcm.edu
RI Graham, Brett/R-8685-2018; Weng, Shape wen/GYU-9746-2022
OI Graham, Brett/0000-0001-8451-8154; Chang, Richard/0000-0002-6920-8059
CR Abu-Amero KK, 2005, ARCH PATHOL LAB MED, V129, P1295
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Enns GM, 2005, CLIN GENET, V68, P337, DOI 10.1111/j.1399-0004.2005.00499.x
   Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Petruzzella V, 2003, NEUROLOGY, V61, P1017, DOI 10.1212/01.WNL.0000080363.10902.E9
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Shanske S, 2004, MITOCHONDRION, V4, P403, DOI 10.1016/j.mito.2004.07.026
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   Tang HY, 2002, GENET MED, V4, P336, DOI 10.1097/00125817-200209000-00004
   Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
   Wong LJC, 2002, CLIN CHEM, V48, P1901
   Wong LJC, 2001, AM J MED GENET, V102, P95, DOI 10.1002/1096-8628(20010722)102:1<95::AID-AJMG1412>3.0.CO;2-U
NR 22
TC 35
Z9 38
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD AUG
PY 2008
VL 94
IS 4
BP 485
EP 490
DI 10.1016/j.ymgme.2008.04.004
PG 6
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 330IT
UT WOS:000257935000017
PM 18495510
DA 2024-11-01
ER

PT J
AU Rodriguez, MC
   MacDonald, JR
   Mahoney, DJ
   Parise, G
   Beal, MF
   Tarnopolsky, MA
AF Rodriguez, M. Christine
   MacDonald, Jay R.
   Mahoney, Douglas J.
   Parise, Gianni
   Beal, M. Flint
   Tarnopolsky, Mark A.
TI Beneficial effects of creatine, CoQ<sub>10</sub>, and lipoic acid in
   mitochondrial disorders
SO MUSCLE & NERVE
LA English
DT Article
DE coenzyme Q(10); creatine; lipoic acid; mitochondrial cytopathy;
   randomized trial
ID DOUBLE-BLIND; COFACTOR TREATMENT; PEDIATRIC-PATIENTS; MULTIPLE VITAMINS;
   BODY-COMPOSITION; COENZYME Q(10); MONOHYDRATE; DNA; MYOPATHIES; STRENGTH
AB Mitochondrial disorders share common cellular consequences: (1) decreased ATP production; (2) increased reliance on alternative anaerobic energy sources; and (3) increased production of reactive oxygen species. The purpose of the present study was to determine the effect of a combination therapy (creatine monohydrate, coenzyme Q(10), and lipoic acid to target the above-mentioned cellular consequences) on several outcome variables using a randomized, double-blind, placebo-controlled, crossover study design in patients with mitochondrial cytopathies. Three patients had mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), four had mitochondrial DNA deletions (three patients with chronic progressive external ophthalmoplegia and one with Kearns-Sayre syndrome), and nine had a variety of other mitochondrial diseases not falling into the two former groups. The combination therapy resulted in lower resting plasma lactate and urinary 8-isoprostanes, as well as attenuation of the decline in peak ankle dorsiflexion strength in all patient groups, whereas higher fat-free mass was observed only in the MELAS group. Together, these results suggest that combination therapies targeting multiple final common pathways of mitochondrial dysfunction favorably influence surrogate markers of cellular energy dysfunction. Future studies with larger sample sizes in relatively homogeneous groups will be required to determine whether such combination therapies influence function and quality of life.
C1 McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.
   McMaster Univ, Dept Kinesiol, Hamilton, ON L8N 3Z5, Canada.
   McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada.
   Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA.
C3 McMaster University; McMaster University; McMaster University; Cornell
   University; Weill Cornell Medicine
RP Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Pediat, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
CR Artuch R, 1998, J INHERIT METAB DIS, V21, P837, DOI 10.1023/A:1005470702369
   Berbel-Garcia A, 2004, CLIN NEUROPHARMACOL, V27, P187, DOI 10.1097/01.wnf.0000137862.67131.bf
   Bogdanov MB, 1999, FREE RADICAL BIO MED, V27, P647, DOI 10.1016/S0891-5849(99)00113-6
   BRESOLIN N, 1990, J NEUROL SCI, V100, P70, DOI 10.1016/0022-510X(90)90015-F
   Brose A, 2003, J GERONTOL A-BIOL, V58, P11
   Burke DG, 2003, INT J SPORT NUTR EXE, V13, P294, DOI 10.1123/ijsnem.13.3.294
   Canter JA, 2005, FREE RADICAL BIO MED, V38, P678, DOI 10.1016/j.freeradbiomed.2004.11.031
   Chariot P, 1999, MOVEMENT DISORD, V14, P855, DOI 10.1002/1531-8257(199909)14:5<855::AID-MDS1023>3.0.CO;2-9
   Chen RS, 1997, EUR NEUROL, V37, P212, DOI 10.1159/000117445
   Geromel V, 2002, MOL GENET METAB, V77, P21, DOI 10.1016/S1096-7192(02)00145-2
   HARRIS RC, 1992, CLIN SCI, V83, P367, DOI 10.1042/cs0830367
   Klopstock T, 2000, NEUROLOGY, V55, P1748, DOI 10.1212/WNL.55.11.1748
   Komura K, 2003, PEDIATR NEUROL, V28, P53, DOI 10.1016/S0887-8994(02)00469-1
   Kornblum C, 2005, EUR J NEUROL, V12, P300, DOI 10.1111/j.1468-1331.2004.00970.x
   Lawler JM, 2002, BIOCHEM BIOPH RES CO, V290, P47, DOI 10.1006/bbrc.2001.6164
   Mahoney DJ, 2002, CURR OPIN CLIN NUTR, V5, P619, DOI 10.1097/00075197-200211000-00004
   Marangon K, 1999, FREE RADICAL BIO MED, V27, P1114, DOI 10.1016/S0891-5849(99)00155-0
   Marriage B, 2003, J AM DIET ASSOC, V103, P1029, DOI 10.1016/S0002-8223(03)00476-0
   Marriage BJ, 2004, MOL GENET METAB, V81, P263, DOI 10.1016/j.ymgme.2003.12.008
   MATTHEWS PM, 1993, NEUROLOGY, V43, P884, DOI 10.1212/WNL.43.5.884
   Migliore L, 2004, MUTAGENESIS, V19, P43, DOI 10.1093/mutage/geg036
   Milne GL, 2005, BIOMARKERS, V10, pS10, DOI 10.1080/13547500500216546
   Montine KS, 2004, CHEM PHYS LIPIDS, V128, P117, DOI 10.1016/j.chemphyslip.2003.10.010
   Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev
   Napolitano A, 2000, NEUROL SCI, V21, pS981, DOI 10.1007/s100720070015
   Panetta J, 2004, J INHERIT METAB DIS, V27, P487, DOI 10.1023/B:BOLI.0000037354.66587.38
   PETERSON PL, 1995, BBA-MOL BASIS DIS, V1271, P275, DOI 10.1016/0925-4439(95)00039-7
   Rodriguez MC, 2003, FREE RADICAL BIO MED, V34, P1217, DOI 10.1016/S0891-5849(03)00141-2
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   Sestili P, 2006, FREE RADICAL BIO MED, V40, P837, DOI 10.1016/j.freeradbiomed.2005.10.035
   Smith AR, 2004, CURR MED CHEM, V11, P1135, DOI 10.2174/0929867043365387
   Tanaka J, 1997, BRAIN DEV-JPN, V19, P262, DOI 10.1016/S0387-7604(97)00573-1
   Tarnopolsky M, 1999, NEUROLOGY, V52, P854, DOI 10.1212/WNL.52.4.854
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Tarnopolsky MA, 2004, NEUROLOGY, V62, P1771, DOI 10.1212/01.WNL.0000125178.18862.9D
   Tarnopolsky MA, 1999, MUSCLE NERVE, V22, P1228, DOI 10.1002/(SICI)1097-4598(199909)22:9<1228::AID-MUS9>3.3.CO;2-Y
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Tarnopolsky MA, 2001, ANN NEUROL, V49, P561, DOI 10.1002/ana.1028.abs
   Yen MY, 2004, INVEST OPHTH VIS SCI, V45, P1688, DOI 10.1167/iovs.03-0568
NR 39
TC 195
Z9 214
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD FEB
PY 2007
VL 35
IS 2
BP 235
EP 242
DI 10.1002/mus.20688
PG 8
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 132LM
UT WOS:000243944300014
PM 17080429
DA 2024-11-01
ER

PT J
AU Spiekerkoetter, U
   Bennett, MJ
   Ben-Zeev, B
   Strauss, AW
   Tein, I
AF Spiekerkoetter, U
   Bennett, MJ
   Ben-Zeev, B
   Strauss, AW
   Tein, I
TI Peripheral neuropathy, episodic myoglobinuria, and respiratory failure
   in deficiency of the mitochondrial trifunctional protein
SO MUSCLE & NERVE
LA English
DT Article
DE myoglobinuria; myopathy; peripheral neuropathy; rhabdomyolysis; TFP
   deficiency
ID 3-HYDROXYACYL-COA DEHYDROGENASE-DEFICIENCY; COENZYME-A DEHYDROGENASE;
   ACID OXIDATION DEFECTS; BETA-OXIDATION; MOLECULAR CHARACTERIZATION;
   ALPHA-SUBUNIT; DNA ANALYSIS; DIAGNOSIS; PHENOTYPE; MUTATIONS
AB Mitochondrial trifunctional protein (TFP) deficiency is a rare disorder of the fatty acid beta-oxidation cycle with heterogeneous phenotypes and occurs secondary to either alpha- or beta-subunit mutations. We characterized the neuromyopathic phenotype of TFP deficiency through adolescence or adulthood in 11 patients, 8 with beta-subunit mutations and 3 with alpha-subunit mutations. Two independent clinical features occurred: infantile-onset progressive peripheral neuropathy and episodic exercise-, illness- or fasting-induced rhabdomyolysis accompanied by respiratory failure (in five patients). The combination of episodic rhabdomyolysis and peripheral neuropathy occurred in 10 of the 11 patients. The neuromyopathic phenotype is common in TFP deficiency (11 of 27 families from our cohort). Therefore, this disorder must be considered in the differential diagnosis of progressive peripheral neuropathy with or without episodic myoglobinuria.
C1 Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA.
   Univ Dusseldorf, Childrens Hosp, Clin Gen Pediat, D-40225 Dusseldorf, Germany.
   Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75230 USA.
   Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75230 USA.
   Chaim Sheba Med Ctr, Dept Pediat Neurol, IL-52621 Tel Hashomer, Israel.
   Univ Toronto, Hosp Sick Children, Dept Lab Med & Pathobiol, Dept Pediat, Toronto, ON M5G 1X8, Canada.
C3 Vanderbilt University; Heinrich Heine University Dusseldorf; University
   of Texas System; University of Texas Southwestern Medical Center Dallas;
   University of Texas Dallas; University of Texas System; University of
   Texas Southwestern Medical Center Dallas; University of Texas Dallas;
   Chaim Sheba Medical Center; University of Toronto; Hospital for Sick
   Children (SickKids)
RP Spiekerkoetter, U (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, 221 Kirkland Hall, Nashville, TN 37212 USA.
RI Scarpa, Maurizio/AAC-1467-2019
OI Spiekerkoetter, Ute/0000-0002-5385-6705
CR BRACKETT JC, 1995, J CLIN INVEST, V95, P2076, DOI 10.1172/JCI117894
   Darras BT, 2000, PEDIATR NEUROL, V23, P289, DOI 10.1016/S0887-8994(00)00202-2
   den Boer MEJ, 2002, PEDIATRICS, V109, P99, DOI 10.1542/peds.109.1.99
   Ferdinandusse S, 2001, J LIPID RES, V42, P1987
   Gillingham M, 1999, J INHERIT METAB DIS, V22, P123, DOI 10.1023/A:1005437616934
   Gregersen N, 2001, HUM MUTAT, V18, P169, DOI 10.1002/humu.1174
   Hintz SR, 2002, MOL GENET METAB, V75, P120, DOI 10.1006/mgme.2001.3282
   Hurvitz H, 2000, PEDIATR NEUROL, V22, P148, DOI 10.1016/S0887-8994(99)00125-3
   Ibdah JA, 2001, J CLIN INVEST, V107, P1403, DOI 10.1172/JCI12590
   Ibdah JA, 1999, NEW ENGL J MED, V340, P1723, DOI 10.1056/NEJM199906033402204
   Ibdah JA, 1998, J CLIN INVEST, V102, P1193, DOI 10.1172/JCI2091
   Ibdah JA, 2001, J PEDIATR-US, V138, P396, DOI 10.1067/mpd.2001.111503
   Isaacs JD, 1996, PEDIATR RES, V40, P393, DOI 10.1203/00006450-199609000-00005
   JOUTEL A, 1993, REV NEUROL, V149, P797
   KAMIJO T, 1994, BIOCHEM BIOPH RES CO, V199, P818, DOI 10.1006/bbrc.1994.1302
   MAK IT, 1986, J BIOL CHEM, V261, P1153
   Matern D, 1999, PEDIATR RES, V46, P45, DOI 10.1203/00006450-199907000-00008
   OGILVIE I, 1994, NEUROLOGY, V44, P467, DOI 10.1212/WNL.44.3_Part_1.467
   Orii KE, 1997, HUM MOL GENET, V6, P1215, DOI 10.1093/hmg/6.8.1215
   SADEH M, 1990, ISRAEL J MED SCI, V26, P510
   Saudubray JM, 1999, J INHERIT METAB DIS, V22, P488
   Schaefer J, 1996, ANN NEUROL, V40, P597, DOI 10.1002/ana.410400409
   Scholte HR, 1999, NEUROMUSCULAR DISORD, V9, P313, DOI 10.1016/S0960-8966(99)00032-2
   Spiekerkoetter U., 2002, Journal of Inherited Metabolic Disease, V25, P72
   Spiekerkoetter U, 2003, HUM MUTAT, V21, P598, DOI 10.1002/humu.10211
   Tein I, 1999, NEUROLOGY, V52, P640, DOI 10.1212/WNL.52.3.640
   TEIN I, 1995, PEDIATR NEUROL, V12, P68, DOI 10.1016/0887-8994(94)00109-F
   Ushikubo S, 1996, AM J HUM GENET, V58, P979
   WANDERS RJA, 1992, BIOCHEM BIOPH RES CO, V188, P1139, DOI 10.1016/0006-291X(92)91350-Y
NR 29
TC 56
Z9 60
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0148-639X
J9 MUSCLE NERVE
JI Muscle Nerve
PD JAN
PY 2004
VL 29
IS 1
BP 66
EP 72
DI 10.1002/mus.10500
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 759PY
UT WOS:000187747100007
PM 14694500
DA 2024-11-01
ER

PT J
AU Ryzhkova, AI
   Sazonova, MA
   Sinyov, VV
   Galitsyna, EV
   Chicheva, MM
   Melnichenko, AA
   Grechko, AV
   Postnov, AY
   Orekhov, AN
   Shkurat, TP
AF Ryzhkova, Anastasia I.
   Sazonova, Margarita A.
   Sinyov, Vasily V.
   Galitsyna, Elena V.
   Chicheva, Mariya M.
   Melnichenko, Alexandra A.
   Grechko, Andrey V.
   Postnov, Anton Yu
   Orekhov, Alexander N.
   Shkurat, Tatiana P.
TI Mitochondrial diseases caused by mtDNA mutations: a mini-review
SO THERAPEUTICS AND CLINICAL RISK MANAGEMENT
LA English
DT Review
DE mitochondrial cytopathy; mitochondrial dysfunction; mtDNA mutation;
   mitochondrial gene mutation
ID HEREDITARY OPTIC NEUROPATHY; STROKE-LIKE-EPISODES; PROGRESSIVE EXTERNAL
   OPHTHALMOPLEGIA; TRNA(VAL) T1658C MUTATION; TYPE-2 DIABETES-MELLITUS;
   KEARNS-SAYRE-SYNDROME; RAGGED-RED FIBERS; LACTIC-ACIDOSIS;
   LEIGH-SYNDROME; GENE MUTATION
AB There are several types of mitochondrial cytopathies, which cause a set of disorders, arise as a result of mitochondria's failure. Mitochondria's functional disruption leads to development of physical, growing and cognitive disabilities and includes multiple organ pathologies, essentially disturbing the nervous and muscular systems. The origins of mitochondrial cytopathies are mutations in genes of nuclear DNA encoding mitochondrial proteins or in mitochondrial DNA. Nowadays, numerous mtDNA mutations significant to the appearance and progress of pathologies in humans are detected. In this mini-review, we accent on the mitochondrial cytopathies related to mutations of mtDNA. As well known, there are definite set of symptoms of mitochondrial cytopathies distinguishing or similar for different syndromes. The present article contains data about mutations linked with cytopathies that facilitate diagnosis of different syndromes by using genetic analysis methods. In addition, for every individual, more effective therapeutic approach could be developed after wide-range mutant background analysis of mitochondrial genome.
C1 [Ryzhkova, Anastasia I.; Sazonova, Margarita A.; Sinyov, Vasily V.; Postnov, Anton Yu] Natl Med Res Ctr Cardiol, Lab Med Genet, Moscow, Russia.
   [Ryzhkova, Anastasia I.] KI Skryabin Moscow State Acad Vet Med & Biotechno, Dept Virol, 23 Skryabina St, Moscow 109472, Russia.
   [Sazonova, Margarita A.; Orekhov, Alexander N.] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, Moscow, Russia.
   [Galitsyna, Elena V.; Chicheva, Mariya M.; Melnichenko, Alexandra A.; Shkurat, Tatiana P.] Southern Fed Univ, Dept Genet, Rostov Na Donu, Russia.
   [Grechko, Andrey V.] Fed Res & Clin Ctr Reanimatol & Rehabilitol, Moscow, Russia.
   [Orekhov, Alexander N.] Skolkovo Innovat Ctr, Inst Atherosclerosis Res, Moscow, Moscow Region, Russia.
C3 National Medical Research Center of Cardiology; Moscow State Academy of
   Veterinary Medicine & Biotechnology named after K.I. Skryabin; Russian
   Academy of Medical Sciences; Institute of General Pathology &
   Pathophysiology, RAMS; Southern Federal University; Federal Research &
   Clinical Center of Intensive Care Medicine & Rehabilitology
RP Ryzhkova, AI (corresponding author), KI Skryabin Moscow State Acad Vet Med & Biotechno, Dept Virol, 23 Skryabina St, Moscow 109472, Russia.
EM ryzhkovaai@gmail.com
RI Grechko, Andrey/C-8208-2018; Shkurat, Tatiana/A-1612-2014; Melnichenko,
   Alexandra/V-5783-2018; GALITSYNA, ELENA/K-1158-2018; Sazonova,
   Margarita/O-9685-2017; Chicheva, Mariia/I-4196-2017; Ryzhkova,
   Anastasiya/F-1677-2014; Sinyov, Vasiliy/K-9084-2014
OI Melnichenko, Alexandra/0000-0002-4989-7600; Postnov,
   Anton/0000-0002-2501-7269; Sazonova, Margarita/0000-0002-8610-4593;
   Galitsyna, Elena/0000-0003-2305-4936; Chicheva,
   Mariia/0000-0002-8014-8798; Grechko, Andrey/0000-0003-3318-796X;
   Ryzhkova, Anastasiya/0000-0002-8838-7750; Sinyov,
   Vasiliy/0000-0001-5105-5763
FU Russian Science Foundation [14-14-01038]; Russian Science Foundation
   [17-14-00092] Funding Source: Russian Science Foundation
FX This study was supported by the Russian Science Foundation, Grant No
   14-14-01038. The authors record their sincere thanks to Zukhra B
   Khasanova (National Medical Research Center of Cardiology, Moscow,
   Russian Federation) and Dr Igor A Sobenin (National Medical Research
   Center of Cardiology, Moscow, Russian Federation) for their facilitation
   and constructive comments in the manuscript.
CR Al-Enezi M, 2008, MIDDLE EAST AFR J OP, V15, P81, DOI 10.4103/0974-9233.51998
   ALCOLADO JC, 1995, DIABETIC MED, V12, P102, DOI 10.1111/j.1464-5491.1995.tb00438.x
   Arbustini E, 1998, CARDIOMYOPATHIES ADV, P117
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Berardo A, 2011, Acta Myol, V30, P9
   Bonekamp NA, 2017, CELL, V172
   Buhmann C, 2002, ACTA NEUROL SCAND, V106, P236, DOI 10.1034/j.1600-0404.2002.01323.x
   Cao YY, 2010, MITOCHONDRION, V10, P330, DOI 10.1016/j.mito.2010.01.008
   Cardaioli E, 2008, J NEUROL SCI, V272, P106, DOI 10.1016/j.jns.2008.05.005
   Chan SSL, 2017, TOXICOLOGY, V391, P75, DOI 10.1016/j.tox.2017.07.014
   Chen FL, 2006, MUTAT RES-FUND MOL M, V602, P26, DOI 10.1016/j.mrfmmm.2006.07.006
   Dahiya Neha, 2018, Indian J Med Ethics, V3, P169, DOI 10.20529/IJME.2017.097
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657
   Donthamsetty S, 2014, CELL CYCLE, V13, P2056, DOI 10.4161/cc.29061
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   El-Hattab AW, 2016, CELL CALCIUM, V60, P199, DOI 10.1016/j.ceca.2016.03.003
   Elson JL, 2009, HUM MUTAT, V30, pE984, DOI 10.1002/humu.21113
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Fetterman JL, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0372-y
   Finsterer J, 2011, EUR J NEUROL, V18, P28, DOI 10.1111/j.1468-1331.2010.03086.x
   Finsterer Josef, 2012, Open Neurol J, V6, P26, DOI 10.2174/1874205X01206010026
   Finsterer J, 2013, SEIZURE-EUR J EPILEP, V22, P119, DOI 10.1016/j.seizure.2012.11.005
   Florian A, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0145-x
   Fosslien E, 2003, ANN CLIN LAB SCI, V33, P371
   Gelfand JM, 2011, J NEUROL, V258, P440, DOI 10.1007/s00415-010-5775-1
   Borlado MCG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012801
   Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Griffin HR, 2014, GENET MED, V16, P962, DOI 10.1038/gim.2014.66
   Herst PM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00296
   Hirai M, 1996, BIOCHEM BIOPH RES CO, V219, P951, DOI 10.1006/bbrc.1996.0324
   Huang SS, 2015, INT J PEDIATR OTORHI, V79, P1067, DOI 10.1016/j.ijporl.2015.04.028
   Iida Y, 2016, J NEUROL SCI, V363, P77, DOI 10.1016/j.jns.2016.02.036
   Ivanova M M, 2012, Patol Fiziol Eksp Ter, P115
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Jaksch M, 2001, NEUROLOGY, V57, P1440, DOI 10.1212/WNL.57.8.1440
   Jun AS, 1996, MOL CELL BIOL, V16, P771
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   Karadimas CL, 2002, NEUROMUSCULAR DISORD, V12, P865, DOI 10.1016/S0960-8966(02)00072-X
   Kauppila JHK, 2015, BBA-BIOENERGETICS, V1847, P1354, DOI 10.1016/j.bbabio.2015.06.001
   Kaushal PS, 2015, BIOCHIMIE, V114, P119, DOI 10.1016/j.biochi.2015.03.013
   Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737
   Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000
   Lee SR, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8060949
   Lee SR, 2017, FRONT BIOSCI-LANDMRK, V22, P1177, DOI 10.2741/4541
   Lee WTY, 2015, ANN NY ACAD SCI, V1350, P95, DOI 10.1111/nyas.12873
   Leis JA, 2015, CAN MED ASSOC J, V187, pE52, DOI 10.1503/cmaj.140339
   Leng YL, 2015, MITOCHONDR DNA, V26, P208, DOI 10.3109/19401736.2014.905860
   Liu YQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03303-w
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Lorenzoni PJ, 2014, ARQ NEURO-PSIQUIAT, V72, P803, DOI 10.1590/0004-282X20140124
   Ma LJ, 2000, CHINESE MED J-PEKING, V113, P111
   Maassen JA, 1997, HORM METAB RES, V29, P50, DOI 10.1055/s-2007-978984
   Mancuso M, 2007, BIOCHEM BIOPH RES CO, V354, P1058, DOI 10.1016/j.bbrc.2007.01.099
   Marie Suely Kazue Nagahashi, 2014, MedicalExpress (São Paulo, online), V1, P239, DOI 10.5935/MedicalExpress.2014.05.05
   Martín MA, 2005, ARCH NEUROL-CHICAGO, V62, P659, DOI 10.1001/archneur.62.4.659
   Meng FL, 2017, J BIOL CHEM, V292, P2881, DOI 10.1074/jbc.M116.749374
   Mimaki M, 2003, J HUM GENET, V48, P47, DOI 10.1007/s100380300005
   Mkaouar-Rebai E, 2014, MITOCHONDR DNA, V25, P394, DOI 10.3109/19401736.2013.803086
   Mohammed Shamayel, 2012, Front Biosci (Elite Ed), V4, P1706
   Naing A, 2014, J DIABETES COMPLICAT, V28, P542, DOI 10.1016/j.jdiacomp.2014.03.006
   Nikitin AG, 2012, DIAB MET SYND CLIN R, V6, P150, DOI 10.1016/j.dsx.2012.09.005
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   O'Brien T, 2003, IUBMB LIFE, V55, P505, DOI 10.1080/15216540310001626610
   O'Brien TW, 2002, GENE, V286, P73, DOI 10.1016/S0378-1119(01)00808-3
   Ohkubo E, 2000, BIOCHEM BIOPH RES CO, V278, P808, DOI 10.1006/bbrc.2000.3867
   Orogo AM, 2015, J BIOL CHEM, V290, P22061, DOI 10.1074/jbc.M115.649657
   Parikh S, 2010, DEV DISABIL RES REV, V16, P120, DOI 10.1002/ddrr.110
   Pätsi J, 2008, BIOCHEM J, V409, P129, DOI 10.1042/BJ20070866
   Pereira L, 2011, AM J HUM GENET, V88, P433, DOI 10.1016/j.ajhg.2011.03.006
   Persad PJ, 2017, INVEST OPHTH VIS SCI, V58, P4027, DOI 10.1167/iovs.17-21734
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   Rawle MJ, 2013, CASE REP NEUROL, V5, P204, DOI 10.1159/000357518
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   Schinwelski M, 2015, METAB BRAIN DIS, V30, P1083, DOI 10.1007/s11011-014-9645-x
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Sobenin IA, 2013, WORLD J CARDIOL, V5, P132, DOI 10.4330/wjc.v5.i5.132
   St John J, 2014, BBA-GEN SUBJECTS, V1840, P1345, DOI 10.1016/j.bbagen.2013.10.036
   St John JC, 2016, SEMIN CELL DEV BIOL, V52, P93, DOI 10.1016/j.semcdb.2016.01.028
   Steriade C, 2014, PEDIATR NEUROL, V50, P498, DOI 10.1016/j.pediatrneurol.2014.01.009
   Szczepanowska K, 2015, BBA-BIOENERGETICS, V1847, P1362, DOI 10.1016/j.bbabio.2015.05.016
   Tang Jing, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P198
   Tansel T, 2014, CARDIOL YOUNG, V24, P531, DOI 10.1017/S1047951113000668
   Tawata M, 2000, DIABETES, V49, P1269, DOI 10.2337/diabetes.49.7.1269
   Thomas T, 2015, MOLEC GENET METAB RE, V4, P9, DOI 10.1016/j.ymgmr.2015.05.002
   TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334
   Turnbull DM, 2016, NEUROBIOL DIS, V92, P55, DOI 10.1016/j.nbd.2015.02.003
   Ueki I, 2006, MITOCHONDRION, V6, P29, DOI 10.1016/j.mito.2005.10.003
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Wallace DC, 2001, MENT RETARD DEV D R, V7, P158, DOI 10.1002/mrdd.1023
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wang K, 2009, NEUROGENETICS, V10, P337, DOI 10.1007/s10048-009-0194-0
   Wang YX, 2015, CHINESE MED J-PEKING, V128, P1820, DOI 10.4103/0366-6999.159360
   Wang ZX, 2010, NEUROPATHOLOGY, V30, P606, DOI 10.1111/j.1440-1789.2010.01115.x
   Williams AJ, 1999, HUM MOL GENET, V8, P1691, DOI 10.1093/hmg/8.9.1691
   Wortmann SB, 2012, EUR J MED GENET, V55, P552, DOI 10.1016/j.ejmg.2012.06.002
   Wu J, 2015, J MED GENET, V52, P95, DOI 10.1136/jmedgenet-2014-102753
   Yan NH, 2010, MOL VIS, V16, P1736
   Yoshii Y, 2012, NUCL MED BIOL, V39, P177, DOI 10.1016/j.nucmedbio.2011.08.008
   Young TJ, 2005, PACE, V28, P454, DOI 10.1111/j.1540-8159.2005.40049.x
   Yu JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114650
   Zapico SC, 2013, AGING DIS, V4, P364, DOI 10.14336/AD.2013.0400364
   Zhelankin A V, 2012, Patol Fiziol Eksp Ter, P123
   Zhou LJ, 2014, MITOCHONDR DNA, V25, P385, DOI 10.3109/19401736.2013.803097
   Zhu CC, 2017, OPHTHALMIC GENET, V38, P67, DOI 10.3109/13816810.2015.1130153
NR 113
TC 49
Z9 55
U1 1
U2 24
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-203X
J9 THER CLIN RISK MANAG
JI Therap. Clin. Risk Manag.
PY 2018
VL 14
BP 1933
EP 1942
DI 10.2147/TCRM.S154863
PG 10
WC Health Care Sciences & Services
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services
GA GW3EP
UT WOS:000446775200001
PM 30349272
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Finsterer, J
AF Finsterer, Josef
TI Cognitive decline as a manifestation of mitochondrial disorders
   (mitochondrial dementia)
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Review
DE mitochondrial disorder; encephalomyopathy; metabolic disease;
   respiratory chain disorder; myopathy; intellectual decline; cognitive
   deficits
ID STROKE-LIKE EPISODES; KEARNS-SAYRE-SYNDROME; COMPLEX-I-DEFICIENCY;
   C-OXIDASE DEFICIENCY; HETEROPLASMIC MTDNA MUTATION; ADULT-ONSET MELAS;
   ATPASE 6 GENE; LEIGH-SYNDROME; LACTIC-ACIDOSIS; POINT MUTATION
AB Mitochondrial disorders, in particular respiratory chain diseases (RCDs), present either as single organ problem or as multi-system disease. One of the most frequently affected organs in RCDs, in addition to the skeletal muscle, is the central nervous system (CNS). CNS manifestations of RCDs include epilepsy, stroke-like episodes, migraine-like headache, ataxia, spasticity, movement disorders, psychosis, demyelination, calcification, but also dementia. Cognitive impairment may be a feature of syndromic as well as non-syndromic RCDs. Syndromic RCDs associated with cognitive impairment include MELAS, KSS, Leigh syndrome, and many others. RCDs with cognitive decline not only result from nuDNA mutations but also from mutations in nuclear genes. At onset there is often no general intellectual deterioration in these patients but specific cognitive deficits, particularly in the Visual construction, attention, abstraction, or flexibility. Diagnosis of cognitive impairment from RCDs is based on neuropsychological testing, imaging studies, including MRI, PET, SPECT, or MR-spectroscopy, CSF investigations, or electroencephalography. Therapeutic strategies for dementia in RCDs rely on symptomatic measures. Only single patients may profit from cholinesterase inhibitors or memantine, antioxidants, vitamins, or other substitutes. Overall, cognitive decline in RCDs (mitochondrial dementia) needs to be included in the differentials of dementia. (C) 2008 Elsevier B.V All rights reserved.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
C3 Rudolfstiftung Hospital
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fipaps@yahoo.de
CR Abe K, 2004, NEURORADIOLOGY, V46, P113, DOI 10.1007/s00234-003-1138-2
   Amemiya S, 2000, NEUROLOGY, V55, P600, DOI 10.1212/WNL.55.4.600
   Ames BN, 2004, ANN NY ACAD SCI, V1033, P108, DOI 10.1196/annals.1320.010
   [Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
   Apostolova LG, 2005, ARCH NEUROL-CHICAGO, V62, P1154, DOI 10.1001/archneur.62.7.1154
   Atwood CS, 2005, J NEUROPATH EXP NEUR, V64, P93, DOI 10.1093/jnen/64.2.93
   Bartels C, 2007, NERVENARZT, V78, P597, DOI 10.1007/s00115-006-2248-y
   Bénit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Berio A, 2002, PANMINERVA MED, V44, P265
   Bidooki S, 2004, NEUROMUSCULAR DISORD, V14, P417, DOI 10.1016/j.nmd.2004.03.004
   Binder J, 2003, BRAIN, V126, P1814, DOI 10.1093/brain/awg174
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Bruno C, 2002, J CHILD NEUROL, V17, P233, DOI 10.1177/088307380201700318
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Campos Y, 1997, NEUROLOGY, V49, P595, DOI 10.1212/WNL.49.2.595
   Campos Y, 2001, J INHERIT METAB DIS, V24, P685, DOI 10.1023/A:1012719211505
   Cantuti-Castelvetria I, 2005, NEUROBIOL AGING, V26, P1343, DOI 10.1016/j.neurobiolaging.2004.11.008
   Carod-Artal FJ, 2007, EUR J NEUROL, V14, P581, DOI 10.1111/j.1468-1331.2007.01720.x
   Chalmers RM, 1997, NEUROLOGY, V49, P589, DOI 10.1212/WNL.49.2.589
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2
   Chinnery PF, 1997, J NEUROL NEUROSUR PS, V63, P559, DOI 10.1136/jnnp.63.5.559
   COREYBLOOM J, 1995, NEUROLOGY, V45, P211, DOI 10.1212/WNL.45.2.211
   Corona P, 2002, ANN NEUROL, V51, P118, DOI 10.1002/ana.10059
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Degoul F, 1995, J INHERIT METAB DIS, V18, P682, DOI 10.1007/BF02436757
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   DESNUELLE C, 1989, REV NEUROL-FRANCE, V145, P842
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Dickerson BC, 2005, NEW ENGL J MED, V353, P2271, DOI 10.1056/NEJMcpc059032
   DiMauro S, 1996, J INHERIT METAB DIS, V19, P489, DOI 10.1007/BF01799110
   Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z
   Durga J, 2006, NEUROBIOL AGING, V27, P334, DOI 10.1016/j.neurobiolaging.2005.01.003
   Fattal O, 2006, PSYCHOSOMATICS, V47, P1, DOI 10.1176/appi.psy.47.1.1
   Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Finsterer J, 2006, NETH J MED, V64, P61
   Finsterer J, 2005, CLIN NEUROPHARMACOL, V28, P148, DOI 10.1097/01.wnf.0000165352.10841.21
   Finsterer J, 2001, NEURORADIOLOGY, V43, P997, DOI 10.1007/s002340100618
   Gardner A, 2003, ACTA PSYCHIAT SCAND, V107, P233, DOI 10.1034/j.1600-0447.2003.02188.x
   Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420
   Goto Yu-ichi, 2004, Nihon Rinsho, V62 Suppl 4, P220
   Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601
   GRUNWALD F, 1990, J NUCL MED, V31, P1740
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Hattori Y, 2001, Rinsho Shinkeigaku, V41, P668
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Houshmand M, 1999, HUM MUTAT, V13, P203, DOI 10.1002/(SICI)1098-1004(1999)13:3<203::AID-HUMU4>3.0.CO;2-3
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Hudson S A., 2003, Cochrane Database of Systematic Reviews, DOI DOI 10.1002/14651858.CD003158
   Ishrat T, 2006, BEHAV BRAIN RES, V171, P9, DOI 10.1016/j.bbr.2006.03.009
   ISOZUMI K, 1994, INTERNAL MED, V33, P543, DOI 10.2169/internalmedicine.33.543
   Jaksch M, 2001, NEUROLOGY, V57, P1930, DOI 10.1212/WNL.57.10.1930
   Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   KALIMO H, 1979, ANN NEUROL, V6, P200, DOI 10.1002/ana.410060304
   KARTSOUNIS LD, 1992, ARCH NEUROL-CHICAGO, V49, P158, DOI 10.1001/archneur.1992.00530260058020
   Kato Tadafumi, 2005, Nihon Shinkei Seishin Yakurigaku Zasshi, V25, P61
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Köller H, 2003, J NEUROL, V250, P1501, DOI 10.1007/s00415-003-0260-8
   LANG CJG, 1995, EUR J NEUROL, V2, P171, DOI 10.1111/j.1468-1331.1995.tb00112.x
   Lemon JA, 2003, EXP BIOL MED, V228, P800, DOI 10.1177/15353702-0322807-05
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   López-Fraile MIP, 2006, NEUROLOGIA, V21, P327
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa K, 1997, NEUROLOGY, V49, P1331, DOI 10.1212/WNL.49.5.1331
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Mancuso M, 2008, J AFFECT DISORDERS, V106, P173, DOI 10.1016/j.jad.2007.05.016
   Martín MA, 2005, ARCH NEUROL-CHICAGO, V62, P659, DOI 10.1001/archneur.62.4.659
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Melone MAB, 2004, ARCH NEUROL-CHICAGO, V61, P269, DOI 10.1001/archneur.61.2.269
   Möller HE, 2005, J NEUROL SCI, V229, P131, DOI 10.1016/j.jns.2004.11.014
   Montirosso R, 2002, J NEUROL SCI, V194, P3, DOI 10.1016/S0022-510X(01)00664-5
   Morimoto N, 2004, NEUROLOGY, V63, P2451, DOI 10.1212/01.WNL.0000147321.38129.ED
   Naidu S, 2005, ANN NEUROL, V58, P929, DOI 10.1002/ana.20671
   NAKAI A, 1994, LANCET, V343, P1397, DOI 10.1016/S0140-6736(94)92527-5
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Nishino I, 1996, BIOCHEM BIOPH RES CO, V225, P180, DOI 10.1006/bbrc.1996.1150
   Nishioka J, 2008, BRAIN DEV-JPN, V30, P100, DOI 10.1016/j.braindev.2007.06.008
   Nomura T, 1993, Rinsho Shinkeigaku, V33, P1198
   Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332
   Pachalska M, 2001, Neurol Neurochir Pol, V35, P681
   Park SB, 2004, YONSEI MED J, V45, P727, DOI 10.3349/ymj.2004.45.4.727
   Patel IB, 2007, SOUTH MED J, V100, P70, DOI 10.1097/01.smj.0000223691.66759.8f
   Playán A, 2002, REV NEUROLOGIA, V34, P1124, DOI 10.33588/rn.3412.2002252
   RIGGS JE, 1984, NEUROLOGY, V34, P48, DOI 10.1212/WNL.34.1.48
   Vasconcellos LFR, 2007, ARQ NEURO-PSIQUIAT, V65, P114, DOI 10.1590/S0004-282X2007000100023
   Rojo A, 2006, ACTA NEUROPATHOL, V111, P610, DOI 10.1007/s00401-006-0040-5
   Rossi A, 2003, AM J NEURORADIOL, V24, P1188
   Salviati L, 2005, NEUROLOGY, V65, P606, DOI 10.1212/01.wnl.0000172859.55579.a7
   Sano M, 1995, ACTA NEUROL SCAND, V92, P497
   Sartor H, 2002, ACTA NEUROL SCAND, V106, P309, DOI 10.1034/j.1600-0404.2002.01089.x
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Schapira AHV, 2002, J NEUROL NEUROSUR PS, V72, P144, DOI 10.1136/jnnp.72.2.144
   SCHAUB RT, 2005, DEMENZEN, P59
   Schmitt-Schillig S, 2005, J Physiol Pharmacol, V56 Suppl 1, P23
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772
   Scuderi C, 2007, NEUROMUSCULAR DISORD, V17, P258, DOI 10.1016/j.nmd.2006.11.006
   Shaag A, 1997, BIOCHEM BIOPH RES CO, V233, P637, DOI 10.1006/bbrc.1997.6496
   Sharfstein SR, 1999, ARCH NEUROL-CHICAGO, V56, P241, DOI 10.1001/archneur.56.2.241
   Shoffner JM, 1996, LANCET, V348, P1283, DOI 10.1016/S0140-6736(96)09138-6
   SHOFFNER JM, 1992, NEUROLOGY, V42, P2168, DOI 10.1212/WNL.42.11.2168
   SHOFFNER JM, 1995, NEUROLOGY, V45, P286, DOI 10.1212/WNL.45.2.286
   Shtilbans A, 1999, J CHILD NEUROL, V14, P610, DOI 10.1177/088307389901400910
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Siwak CT, 2005, PROG NEURO-PSYCHOPH, V29, P461, DOI 10.1016/j.pnpbp.2004.12.011
   Sperl W, 1997, WIEN KLIN WOCHENSCHR, V109, P93
   Stryer L., 1996, BIOCHEMIE
   Sue CM, 1999, J PEDIATR-US, V134, P696, DOI 10.1016/S0022-3476(99)70283-0
   SUZUKI T, 1989, J NEUROL NEUROSUR PS, V52, P920, DOI 10.1136/jnnp.52.7.920-a
   Suzuki Y, 1997, MOL ASPECTS MED, V18, pS181
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   TRANEBJAERG L, 1995, J MED GENET, V32, P257, DOI 10.1136/jmg.32.4.257
   Triepels RH, 1999, ANN NEUROL, V45, P787, DOI 10.1002/1531-8249(199906)45:6<787::AID-ANA13>3.0.CO;2-6
   Tsao CY, 2007, J CHILD NEUROL, V22, P1121, DOI 10.1177/0883073807306266
   Tsao CY, 2001, J CHILD NEUROL, V16, P533, DOI 10.1177/088307380101600716
   Tsuchiya K, 1999, ACTA NEUROPATHOL, V97, P520, DOI 10.1007/s004010051023
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
   Turconi AC, 1999, J NEUROL SCI, V170, P57, DOI 10.1016/S0022-510X(99)00199-9
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Ujike H, 2001, ARCH NEUROL-CHICAGO, V58, P1004, DOI 10.1001/archneur.58.6.1004
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Maldergem L, 2002, ANN NEUROL, V52, P750, DOI 10.1002/ana.10371
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Verma A, 1997, PEDIATR RES, V42, P448, DOI 10.1203/00006450-199710000-00005
   Wang JQ, 2006, J NEUROCHEM, V96, P825, DOI 10.1111/j.1471-4159.2005.03615.x
   Wolf NI, 2003, NEUROPEDIATRICS, V34, P156
   Zeviani M, 2003, CURR OPIN NEUROL, V16, P585, DOI 10.1097/00019052-200310000-00004
   Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd
NR 144
TC 43
Z9 47
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD SEP 15
PY 2008
VL 272
IS 1-2
BP 20
EP 33
DI 10.1016/j.jns.2008.05.011
PG 14
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 347HM
UT WOS:000259131200003
PM 18572195
DA 2024-11-01
ER

PT J
AU Winkler-Stuck, K
   Kirches, E
   Mawrin, C
   Dietzmann, K
   Lins, H
   Wallesch, CW
   Kunz, WS
   Wiedemann, FR
AF Winkler-Stuck, K
   Kirches, E
   Mawrin, C
   Dietzmann, K
   Lins, H
   Wallesch, CW
   Kunz, WS
   Wiedemann, FR
TI Re-evaluation of the dysfunction of mitochondrial respiratory chain in
   skeletal muscle of patients with Parkinsons disease
SO JOURNAL OF NEURAL TRANSMISSION
LA English
DT Article
DE mitochondria; mitochondrial DNA; oxidative phosphorylation; Parkinsons
   disease; skeletal muscle
ID OXIDATIVE-PHOSPHORYLATION DEFECTS; AMYOTROPHIC-LATERAL-SCLEROSIS;
   CYTOCHROME-C-OXIDASE; COMPLEX-I; REPAIR ACTIVITY; DNA-REPAIR; FIBERS;
   DISORDERS; BRAIN; MTDNA
AB The origin and tissue distribution of the mitochondrial dysfunction in Parkinson's disease (PD) remains still a matter of controversy. To re-evaluate a probably free radical-born, generalized mitochondrial impairment in PD, we applied optimized enzymatic assays, high resolution oxygraphic measurements of permeabilized muscle fibers, and application of metabolic control analysis to skeletal muscle samples of 19 PD patients and 36 age-matched controls. We detected decreased activities of respiratory chain complexes I and IV being accompanied by increased flux control coefficients of complexes I and IV on oxygen consumption of muscle fibers. We further investigated if randomly distributed point mutations in two discrete regions of the mitochondrial DNA are increased in PD muscle, and if they could contribute to the mitochondrial impairment. Our data confirm the previously debated presence of a mild mitochondrial defect in skeletal muscle of patients with PD which is accompanied with an about 1.5 to 2-fold increase of point mutated mtDNA.
C1 Univ Klinikum Magdeburg, Neurol Klin, Leipziger Str 44, D-39120 Magdeburg, Germany.
   Otto Von Guericke Univ, Neurol Klin, Magdeburg, Germany.
   Otto Von Guericke Univ, Inst Neuropathol, Magdeburg, Germany.
   Univ Bonn, Klin Epileptol, D-5300 Bonn, Germany.
C3 University Hospital Magdeburg; Otto von Guericke University; Otto von
   Guericke University; University of Bonn
RP Otto Von Guericke Univ, Neurol Klin, Magdeburg, Germany.
EM falk.wiedemann@medizin.uni-magdeburg.de
RI Kunz, Wolfram/K-1232-2019
OI Kunz, Wolfram/0000-0003-1113-3493
CR ANDERSON JJ, 1993, J NEUROL NEUROSUR PS, V56, P477, DOI 10.1136/jnnp.56.5.477
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bergmeyer H.U., 1974, In methods of enzymatic Analysis, P727
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   BINDOFF LA, 1989, LANCET, V2, P49, DOI 10.1016/S0140-6736(89)90291-2
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Bohr VA, 2002, GENE, V286, P127, DOI 10.1016/S0378-1119(01)00813-7
   Byrne E, 2002, J CLIN NEUROSCI, V9, P497, DOI 10.1054/jocn.2001.0991
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Chen DX, 2002, J NEUROCHEM, V81, P1273, DOI 10.1046/j.1471-4159.2002.00916.x
   DIDONATO S, 1993, NEUROLOGY, V43, P2262, DOI 10.1212/WNL.43.11.2262
   DIMONTE DA, 1993, NEURODEGENERATION, V2, P275
   Dubowitz V., 1973, MUSCLE BIOPSY MODERN
   Gasser T, 2001, J NEUROL, V248, P833, DOI 10.1007/s004150170066
   Grishko VI, 1999, NUCLEIC ACIDS RES, V27, P4510, DOI 10.1093/nar/27.22.4510
   HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409
   HEINRICH R, 1974, EUR J BIOCHEM, V42, P97, DOI 10.1111/j.1432-1033.1974.tb03319.x
   Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483
   KACSER H, 1973, RATE CONTROL BIOL PR
   Karahalil B, 2002, FASEB J, V16, P1895, DOI 10.1096/fj.02-0463com
   Kirches EJF, 1998, J INHERIT METAB DIS, V21, P400, DOI 10.1023/A:1005306725644
   Koutsilieri E., 2002, J NEUROL, V249, P111, DOI DOI 10.1007/S00415-002-1201-7
   KUNZ WS, 1993, BIOCHIM BIOPHYS ACTA, V1144, P46, DOI 10.1016/0005-2728(93)90029-F
   Kuznetsov AV, 1997, BBA-MOL BASIS DIS, V1360, P142, DOI 10.1016/S0925-4439(96)00072-5
   Kuznetsov AV, 1998, J CELL BIOL, V140, P1091, DOI 10.1083/jcb.140.5.1091
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167
   Miró O, 1998, J NEUROSCI METH, V80, P107, DOI 10.1016/S0165-0270(97)00204-5
   *MITOMAP, 2004, HUM MIT GEN DAT
   MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8
   NAKAGAWAHATTORI Y, 1992, J NEUROL SCI, V107, P29, DOI 10.1016/0022-510X(92)90205-Y
   Orth M, 2002, NEUROCHEM INT, V40, P533, DOI 10.1016/S0197-0186(01)00124-3
   Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425
   Pallotti F, 1996, AM J HUM GENET, V59, P591
   REICHMANN H, 1994, EUR NEUROL, V34, P263, DOI 10.1159/000117053
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Richter G, 2002, J NEURAL TRANSM, V109, P721, DOI 10.1007/s007020200060
   Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257
   Saxowsky TT, 2002, J BIOL CHEM, V277, P37201, DOI 10.1074/jbc.M206654200
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   SINGER TP, 1995, BBA-MOL BASIS DIS, V1271, P211, DOI 10.1016/0925-4439(95)00030-8
   Sperl W, 1997, MOL CELL BIOCHEM, V174, P71, DOI 10.1023/A:1006880529195
   TAYLOR I, 1994, ENGL LANG NOTES, V31, P77
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   VANKUILENBURG ABP, 1991, EUR J BIOCHEM, V199, P615
   Vielhaber S, 2003, ANN NEUROL, V53, P686, DOI 10.1002/ana.10564
   Wharton D.C., 1967, Methods Enzymol, V10, P245, DOI [10.1016/0076-6879(67)10048-7, DOI 10.1016/0076-6879(67)10048-7]
   Wiedemann FR, 1998, J NEUROL SCI, V156, P65, DOI 10.1016/S0022-510X(98)00008-2
   Wiedemann FR, 2000, ANAL BIOCHEM, V279, P55, DOI 10.1006/abio.1999.4434
   Wiedemann FR, 1999, ANN NY ACAD SCI, V893, P426, DOI 10.1111/j.1749-6632.1999.tb07870.x
   ZHANG CF, 1993, BIOCHEM BIOPH RES CO, V195, P1104, DOI 10.1006/bbrc.1993.2158
NR 57
TC 51
Z9 62
U1 0
U2 6
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0300-9564
EI 1435-1463
J9 J NEURAL TRANSM
JI J. Neural Transm.
PD APR
PY 2005
VL 112
IS 4
BP 499
EP 518
DI 10.1007/s00702-004-0195-y
PG 20
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 910BW
UT WOS:000227905400004
PM 15340872
DA 2024-11-01
ER

PT J
AU Wolf, J
   Obermaier-Kusser, B
   Jacobs, M
   Milles, C
   Mörl, M
   von Pein, HD
   Grau, AJ
   Bauer, MF
AF Wolf, Joachim
   Obermaier-Kusser, Bert
   Jacobs, Martina
   Milles, Cornelia
   Moerl, Mario
   von Pein, Harald D.
   Grau, Armin J.
   Bauer, Matthias F.
TI A new mitochondrial point mutation in the transfer RNA<SUP>LYs</SUP>
   gene associated with progressive external ophthalmoplegia with impaired
   respiratory regulation
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Progressive external ophthalmoplegia; Mitochondrial disorders;
   Mitochondrial tRNA; Mitochondrial DNA mutation; Respiratory
   insufficiency
ID CCA-ADDING ENZYME; TRANSFER-RNA; TRNA(LYS); CARDIOMYOPATHY
AB We report a novel heteroplasmic point mutation G8299A in the gene for mitochondrial tRNA(LYs) in a patient with progressive external ophthalmoplegia complicated by recurrent respiratory insufficiency. Biochemical analysis of respiratory chain complexes in muscle homogenate showed a combined complex I and IV deficiency. The transition does not represent a known neutral polymorphism and affects a position in the tRNA acceptor stem which is conserved in primates, leading to a destabilization of this functionally important domain. In vitro analysis of an essential maturation step of the tRNA transcript indicates the probable pathogenicity of this mutation. We hypothesize that there is a causal relationship between the novel G8299A transition and progressive external ophthalmoplegia with recurrent respiratory failure due to a depressed respiratory drive. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Wolf, Joachim; Grau, Armin J.] Klinikum Ludwigshafen, Dept Neurol, Ludwigshafen, Germany.
   [Obermaier-Kusser, Bert; Jacobs, Martina; Bauer, Matthias F.] Klinikum Ludwigshafen, Inst Clin Chem & Mol Diagnost, Ludwigshafen, Germany.
   [Milles, Cornelia; Moerl, Mario] Univ Leipzig, Inst Biochem, Leipzig, Germany.
   [von Pein, Harald D.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neuropathol, D-6500 Mainz, Germany.
C3 Ludwigshafen Hospital; Ludwigshafen Hospital; Leipzig University;
   Johannes Gutenberg University of Mainz
RP Wolf, J (corresponding author), Klinikum Stadt Ludwigshafen, Dept Neurol, Bremserstr 79, D-67063 Ludwigshafen, Germany.
EM wolfj@klilu.de
OI Morl, Mario/0000-0003-0972-9386
FU Fritz Thyssen-Stiftung [Az 10.08.1.175]
FX The biochemical in vitro-analysis was supported by a grant of the "Fritz
   Thyssen-Stiftung" (Az 10.08.1.175).
CR Akita Y, 2000, HUM MUTAT, V15, P382, DOI 10.1002/(SICI)1098-1004(200004)15:4<382::AID-HUMU15>3.0.CO;2-B
   Augustin MA, 2003, J MOL BIOL, V328, P985, DOI 10.1016/S0022-2836(03)00381-4
   BAROHN RJ, 1990, NEUROLOGY, V40, P103, DOI 10.1212/WNL.40.1.103
   Bornstein B, 2002, HUM MUTAT, V19, P234, DOI 10.1002/humu.10050
   Cho HDD, 2002, J BIOL CHEM, V277, P3447, DOI 10.1074/jbc.M109559200
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   Gambello MJ, 2006, MUSCLE NERVE, V34, P437, DOI 10.1002/mus.20605
   Helm M, 1999, BIOCHEMISTRY-US, V38, P13338, DOI 10.1021/bi991061g
   Kameoka K, 1998, BIOCHEM BIOPH RES CO, V245, P523, DOI 10.1006/bbrc.1998.8437
   Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7
   Lizano E, 2008, BIOCHIMIE, V90, P762, DOI 10.1016/j.biochi.2007.12.007
   MANNI R, 1991, EUR NEUROL, V31, P12, DOI 10.1159/000116627
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Rossmanith W, 2003, ANN NEUROL, V54, P820, DOI 10.1002/ana.10753
   Sakuta R, 2002, PEDIATR NEUROL, V27, P397, DOI 10.1016/S0887-8994(02)00456-3
   Sanaker PS, 2007, ACTA NEUROL SCAND, V115, P64, DOI 10.1111/j.1600-0404.2007.00850.x
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Scheibe M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-92
   Shtilbans A, 2000, J CHILD NEUROL, V15, P759, DOI 10.1177/088307380001501109
   Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Toh Y, 2009, EMBO J, V28, P3353, DOI 10.1038/emboj.2009.260
   Tomari Y, 2003, J BIOL CHEM, V278, P16828, DOI 10.1074/jbc.M213216200
   Tomita K, 2004, NATURE, V430, P700, DOI 10.1038/nature02712
   Wilusz JE, 2011, SCIENCE, V334, P817, DOI 10.1126/science.1213671
NR 30
TC 6
Z9 6
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD MAY 15
PY 2012
VL 316
IS 1-2
BP 108
EP 111
DI 10.1016/j.jns.2012.01.013
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 930XK
UT WOS:000303177900020
PM 22326363
DA 2024-11-01
ER

PT J
AU Horvath, R
   Bender, A
   Abicht, A
   Holinski-Feder, E
   Czermin, B
   Trips, T
   Schneiderat, P
   Lochmüller, H
   Klopstock, T
AF Horvath, Rita
   Bender, Andreas
   Abicht, Angela
   Holinski-Feder, Elke
   Czermin, Birgit
   Trips, Tobias
   Schneiderat, Peter
   Lochmueller, Hanns
   Klopstock, Thomas
TI Heteroplasmic mutation in the anticodon-stem of mitochondrial
   tRNA<SUP>Val</SUP> causing MNGIE-like gastrointestinal dysmotility and
   cachexia
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Mitochondrial encephalomyopathy; MNGIE-like gastrointestinal dysmotility
   and cachexia; tRNA(Val)
ID STROKE-LIKE EPISODES; TRANSFER-RNA GENES; NEUROGASTROINTESTINAL
   ENCEPHALOMYOPATHY; LACTIC-ACIDOSIS; NEUROLOGICAL PRESENTATION; POINT
   MUTATION; DNA DELETIONS; MELAS; FEATURES; DISEASE
AB While mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is typically associated with mutations in the nuclear gene encoding for thymidine phosphorylase (ECGF1, TYMP), a similar clinical phenotype was described in patients carrying mutations in the nuclear-encoded polymerase gamma (POLG1) as well as a few mitochondrial tRNA genes. Here we report a novel mutation in the mitochondrial tRNA(Val) (MTTV) gene in a girl presenting with clinical symptoms of MNGIE-like gastrointestinal dysmotility and cachexia. Clinical, histological, biochemical and single cell investigations were performed. The heteroplasmic m.1630A > G mutation was detected in the mitochondrial tRNA(Val) (MTTV) gene in the patient's muscle, blood leukocytes and myoblasts, as well as in blood DNA of the unaffected mother. We provide clinical, biochemical, histological, and molecular genetic evidence on the single cell level for the pathogenicity of this mutation. Our finding adds to the genetic heterogeneity of MNGIE-like gastrointestinal symptoms and highlights the importance of a thorough genetic workup in case of suspected mitochondrial disease.
C1 [Horvath, Rita] Newcastle Univ, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Horvath, Rita; Schneiderat, Peter; Lochmueller, Hanns; Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80336 Munich, Germany.
   [Bender, Andreas] Univ Munich, Dept Neurol, D-81377 Munich, Germany.
   [Horvath, Rita; Abicht, Angela; Holinski-Feder, Elke; Czermin, Birgit] Ctr Med Genet, D-80335 Munich, Germany.
   [Trips, Tobias] Hosp Traunstein, Dept Pediat, D-83278 Traunstein, Germany.
   [Lochmueller, Hanns] Newcastle Univ, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
C3 Newcastle University - UK; University of Munich; University of Munich;
   Newcastle University - UK
RP Horvath, R (corresponding author), Newcastle Univ, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM Rita.Horvath@ncl.ac.uk
RI Horvath, Rita/AAY-7042-2020; Bender, Andreas/A-7401-2012
OI Bender, Andreas/0000-0002-6328-7104; Lochmuller,
   Hanns/0000-0003-2324-8001; Horvath, Rita/0000-0002-9841-170X
FU Deutsche Forschungsgemeinschaft [HO 2505/2-1]
FX The excellent technical assistance of Solvig Muller-Ziermann, Ira Kaus
   and Eva Neugebauer is gratefully acknowledged. This work is supported by
   grants from the Deutsche Forschungsgemeinschaft HO 2505/2-1 ( RH).
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Blakely EL, 2004, J NEUROL SCI, V225, P99, DOI 10.1016/j.jns.2004.07.007
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Chalmers RM, 1997, NEUROLOGY, V49, P589, DOI 10.1212/WNL.49.2.589
   Chang TM, 2004, PEDIATR NEUROL, V31, P374, DOI 10.1016/j.pediatrneurol.2004.05.009
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   de Coo IFM, 1998, NEUROLOGY, V50, P293, DOI 10.1212/WNL.50.1.293
   DOUGHERTY FE, 1994, J PEDIATR-US, V125, P758, DOI 10.1016/S0022-3476(94)70073-7
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   García-Velasco A, 2003, J INTERN MED, V253, P381, DOI 10.1046/j.1365-2796.2003.01095.x
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Inoue K, 2003, DIABETES CARE, V26, P2219, DOI 10.2337/diacare.26.7.2219
   LAUBER J, 1991, NUCLEIC ACIDS RES, V19, P1393, DOI 10.1093/nar/19.7.1393
   Lehnhardt FG, 2008, ARCH NEUROL-CHICAGO, V65, P407, DOI 10.1001/archneur.65.3.407
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Marti R, 2002, MITOCHONDRION, V2, P143, DOI 10.1016/S1567-7249(02)00036-3
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Reichenbach J, 2006, PEDIATR RES, V60, P321, DOI 10.1203/01.pdr.0000233252.60457.cf
   Sacconi S, 2002, ARCH NEUROL-CHICAGO, V59, P1013, DOI 10.1001/archneur.59.6.1013
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Shimotake T, 1998, J PEDIATR SURG, V33, P1837, DOI 10.1016/S0022-3468(98)90301-3
   Taylor RW, 1996, ANN NEUROL, V40, P459, DOI 10.1002/ana.410400318
   Tiranti V, 1998, ANN NEUROL, V43, P98, DOI 10.1002/ana.410430116
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Verma A, 1997, PEDIATR RES, V42, P448, DOI 10.1203/00006450-199710000-00005
   Vissing J, 2002, NEUROLOGY, V59, P926, DOI 10.1212/WNL.59.6.926
NR 29
TC 27
Z9 27
U1 0
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
J9 J NEUROL
JI J. Neurol.
PD MAY
PY 2009
VL 256
IS 5
BP 810
EP 815
DI 10.1007/s00415-009-5023-8
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 447AX
UT WOS:000266165100016
PM 19252805
DA 2024-11-01
ER

PT J
AU Chen, J
   Xiao, JF
   Chen, G
   Xu, Q
   Wu, XW
   Tian, LF
   Huang, ZH
   Xin, CL
   Zhao, Y
   Guo, Z
   Zou, Y
   Wu, QF
AF Chen, Jia
   Xiao, Junfang
   Chen, Ge
   Xu, Qiang
   Wu, Xingwu
   Tian, Lifeng
   Huang, Zhihui
   Xin, Cailin
   Zhao, Yan
   Guo, Zhen
   Zou, Yang
   Wu, Qiongfang
TI Indentification of novel <i>MSTO1</i> compound heterozygous mutations in
   a Chinese family with recessive cerebellar atrophy and ataxia
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE MSTO1; myopathy and ataxia; mitochondrial disorders; whole exome
   sequencing; missense variant
ID MITOCHONDRIAL; SACCHAROMYCES; DROSOPHILA; MYOPATHY; PROTEIN; MISATO;
   GENE
AB Misato mitochondrial distribution and morphology regulator 1 (MSTO1) is a nuclear-encoded cytoplasmic protein involved in mitochondrial fusion and distribution. Its disruption causes an extremely rare mitochondrial disorder characterized by early-onset myopathy and cerebellar ataxia. The genotype-phenotype correlation in the MSTO1 gene is rarely studied before 2017, and only 25 mutations have been described in the patients. Here, we reported two siblings with progressive cerebellar atrophy and ataxia in a Chinese family. Two compound heterozygous mutations in the MSTO1 gene, a novel missense mutation c.571C>T (p.Arg191Trp), and a reported frameshift mutation c.1259delG (p.Gly420ValfsTer2) were identified in the patients by whole exome sequencing. in vitro experiments found both of the mutations lead to reduced protein abundance and link to decreased mtDNA content. Except for ataxia and delayed motor, both of the siblings also have low birth weights, learning difficulties, and dysarthria. Our report enriched the genotype and phenotype spectrums of the MSTO1-related disorder and supported the recessive inheritance of the disease.
C1 [Chen, Jia; Xu, Qiang; Wu, Xingwu; Tian, Lifeng; Huang, Zhihui; Xin, Cailin; Zhao, Yan; Wu, Qiongfang] Jiangxi Prov Maternal & Child Hlth Hosp, Reprod Med Ctr, Nanchang, Peoples R China.
   [Xiao, Junfang] Jiangxi Prov Maternal & Child Hlth Hosp, Med Genet Ctr, Nanchang, Peoples R China.
   [Xiao, Junfang] Jiangxi Prov Key Lab Birth Defect Prevent & Contro, Nanchang, Peoples R China.
   [Chen, Ge; Zou, Yang] Jiangxi Prov Maxternal & Child Hlth Hosp, Cent Lab, Nanchang, Peoples R China.
   [Guo, Zhen] Jiangxi Prov Maternal & Child Hlth Hosp, Med Imaging Ctr, Nanchang, Peoples R China.
RP Wu, QF (corresponding author), Jiangxi Prov Maternal & Child Hlth Hosp, Reprod Med Ctr, Nanchang, Peoples R China.; Zou, Y (corresponding author), Jiangxi Prov Maxternal & Child Hlth Hosp, Cent Lab, Nanchang, Peoples R China.
EM zouyang81@163.com; wuqiongfang898@sina.com
RI Wu, Xingwu/JSK-9683-2023; Zou, Yang/JJC-7125-2023
OI Tian, Lifeng/0009-0003-3797-3674; Zhao, Yan/0009-0005-4105-2696
CR Ardicli D, 2019, NEUROMUSCULAR DISORD, V29, P448, DOI 10.1016/j.nmd.2019.03.011
   Chen J, 2020, BMC CARDIOVASC DISOR, V20, DOI 10.1186/s12872-019-01322-1
   Donkervoort S, 2019, ACTA NEUROPATHOL, V138, P1013, DOI 10.1007/s00401-019-02059-z
   Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604
   Gal A, 2017, EMBO MOL MED, V9, P967, DOI 10.15252/emmm.201607058
   Gurvitz A, 2002, FEMS YEAST RES, V2, P123, DOI 10.1111/j.1567-1364.2002.tb00077.x
   Iwama K, 2018, J HUM GENET, V63, P263, DOI 10.1038/s10038-017-0405-8
   Jiao YQ, 2021, ACTA NEUROL BELG, V121, P795, DOI 10.1007/s13760-020-01544-7
   Kimura M, 2007, EXP CELL RES, V313, P1393, DOI 10.1016/j.yexcr.2007.02.004
   Li K, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2019.01.013
   Liu LQ, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.947886
   Miklos GLG, 1997, P NATL ACAD SCI USA, V94, P5189, DOI 10.1073/pnas.94.10.5189
   Mottier-Pavie V, 2011, J CELL SCI, V124, P706, DOI 10.1242/jcs.072348
   Nasca A, 2021, J HUM GENET, V66, P835, DOI 10.1038/s10038-020-00897-4
   Nasca A, 2017, HUM MUTAT, V38, P970, DOI 10.1002/humu.23262
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Schultz-Rogers L, 2019, CSH MOL CASE STUD, V5, DOI 10.1101/mcs.a004309
   Tian Yang, 2022, Zhonghua Yixue Yichuanxue Zazhi, V39, P417, DOI 10.3760/cma.j.cn511374-20210319-00249
NR 19
TC 0
Z9 0
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD NOV 17
PY 2022
VL 13
AR 988519
DI 10.3389/fneur.2022.988519
PG 12
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 7S0RR
UT WOS:000910470800001
PM 36468072
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU DeBalsi, KL
   Longley, MJ
   Hoff, KE
   Copeland, WC
AF DeBalsi, Karen L.
   Longley, Matthew J.
   Hoff, Kirsten E.
   Copeland, William C.
TI Synergistic Effects of the <i>in cis</i> T251I and P587L Mitochondrial
   DNA Polymerase γ Disease Mutations
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; POLG MUTATIONS; PATHOGENIC
   MUTATIONS; EXONUCLEASE ACTIVITY; BIOCHEMICAL-ANALYSIS;
   AUTOSOMAL-DOMINANT; ACCESSORY SUBUNIT; REPLICATION; DISORDERS; TOXICITY
AB Human mitochondrial DNA (mtDNA) polymerase gamma (Pol gamma) is the only polymerase known to replicate the mitochondrial genome. The Pol gamma holoenzyme consists of the p140 catalytic subunit (POLG) and the p55 homodimeric accessory subunit (POLG2), which enhances binding of Pol gamma to DNA and promotes processivity of the holoenzyme. Mutations within POLG impede maintenance of mtDNA and cause mitochondrial diseases. Two common POLG mutations usually found in cis in patients primarily with progressive external ophthalmoplegia generate T251I and P587L amino acid substitutions. To determine whether T251I or P587L is the primary pathogenic allele or whether both substitutions are required to cause disease, we overproduced and purified WT, T251I, P587L, and T251I + P587L double variant forms of recombinant Pol gamma. Biochemical characterization of these variants revealed impaired DNA binding affinity, reduced thermostability, diminished exonuclease activity, defective catalytic activity, and compromisedDNAprocessivity, even in the presence of the p55 accessory subunit. However, physical association with p55 was unperturbed, suggesting intersubunit affinities similar to WT. Notably, although the single mutants were similarly impaired, a dramatic synergistic effect was found for the double mutant across all parameters. In conclusion, our analyses suggest that individually both T251I and P587L substitutions functionally impair Pol gamma, with greater pathogenicity predicted for the single P587L variant. Combining T251I and P587L induces extreme thermal lability and leads to synergistic nucleotide and DNA binding defects, which severely impair catalytic activity and correlate with presentation of disease in patients.
C1 [DeBalsi, Karen L.; Longley, Matthew J.; Hoff, Kirsten E.; Copeland, William C.] NIH, NIEHS, Genome Integr & Struct Biol Lab, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIH, NIEHS, Genome Integr & Struct Biol Lab, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953
FU Intramural Research Program of the NIEHS, National Institutes of Health
   [ES 065078]
FX This study was supported by the Intramural Research Program of the
   NIEHS, National Institutes of Health, Grant ES 065078. The authors
   declare that they have no conflicts of interest with the contents of
   this article. The content is solely the responsibility of the authors
   and does not necessarily represent the official views of the National
   Institutes of Health.
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Al-Zubeidi D, 2014, PEDIATR NEUROL, V51, P448, DOI 10.1016/j.pediatrneurol.2014.04.006
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Caito SW, 2015, ANTIOXID REDOX SIGN, V23, P578, DOI 10.1089/ars.2015.6289
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chiappini F, 2009, CURR HIV RES, V7, P244, DOI 10.2174/157016209787581409
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Copeland WC, 2014, J CHILD NEUROL, V29, P1216, DOI 10.1177/0883073814537380
   Copeland WC, 2010, SUBCELL BIOCHEM, V50, P211, DOI 10.1007/978-90-481-3471-7_11
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Harris MO, 2010, ARCH NEUROL-CHICAGO, V67, P493, DOI 10.1001/archneurol.2010.36
   HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kasiviswanathan R, 2013, J BIOL CHEM, V288, P14247, DOI 10.1074/jbc.M113.458802
   Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003
   Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   Lamantea E, 2004, ANN NEUROL, V56, P454, DOI 10.1002/ana.20219
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   LONGLEY MJ, 1991, J BIOL CHEM, V266, P24702
   Lucas P, 1997, CR ACAD SCI III-VIE, V320, P299, DOI 10.1016/S0764-4469(97)82771-0
   Macao B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8303
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rouzier C, 2014, EUR J HUM GENET, V22, P542, DOI 10.1038/ejhg.2013.171
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Scuderi C, 2015, NEUROMUSCULAR DISORD, V25, P333, DOI 10.1016/j.nmd.2015.01.004
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Stumpf JD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004748
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tzoulis C, 2009, ACTA NEUROL SCAND, V120, P38, DOI 10.1111/j.1600-0404.2009.01212.x
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
NR 67
TC 14
Z9 14
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR
PY 2017
VL 292
IS 10
BP 4198
EP 4209
DI 10.1074/jbc.M116.773341
PG 12
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA EN2JZ
UT WOS:000395837100018
PM 28154168
OA Green Published
DA 2024-11-01
ER

PT J
AU Sanaker, PS
   Nakkestad, HL
   Downham, E
   Bindoff, LA
AF Sanaker, P. S.
   Nakkestad, H. L.
   Downham, E.
   Bindoff, L. A.
TI A novel mutation in the mitochondrial tRNA for tryptophan causing a
   late-onset mitochondrial encephalomyopathy
SO ACTA NEUROLOGICA SCANDINAVICA
LA English
DT Article
DE mitochondrial diseases; mitochondrial genome; metabolic brain diseases
ID C-OXIDASE DEFICIENCY; TRNA(TRP) GENE; POINT MUTATION; LEIGH-SYNDROME;
   DNA MUTATION; DISEASE; ENCEPHALOPATHY; INSERTION; DATABASE
AB Background -
   Mitochondrial DNA (mtDNA) mutations are increasingly being recognized as causes of late-onset disease. We report a patient with a late-onset mitochondrial encephalomyopathy caused by a novel G > C transition in mtDNA at position 5556 in the gene encoding the tRNA for tryptophan (MTTW).
   Aims -
   To investigate the cause of disease and assess the pathogenicity of this new mutation.
   Methods -
   Clinical, histopathological and gene sequencing studies. Quantification of the mutation was performed in different tissues from the patient and two relatives and in single muscle fibres.
   Results -
   The mutation was heteroplasmic, segregated in biochemically affected muscle fibres and was absent in blood. The level of mutation in skeletal muscle was higher than in brain, although the brain was clinically the most affected tissue.
   Discussion -
   The 5556G > C mutation appears sporadic. It was not found in any of the family members tested, although some of them manifested disorders that can be associated with mtDNA disease. In addition to reporting the eighth mutation in MTTW, our case illustrates the challenges posed when assigning pathogenicity to mtDNA mutations.
C1 [Sanaker, P. S.; Bindoff, L. A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Sanaker, P. S.; Nakkestad, H. L.; Downham, E.; Bindoff, L. A.] Univ Bergen, Dept Clin Med, Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of
   Bergen
RP Bindoff, LA (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
EM laurence.bindoff@nevro.uib.no
OI Bindoff, Laurence/0000-0003-0988-276X
FU Norwegian Research Council (PSS); Helse Vest RHF and University of
   Bergen
FX We are grateful to Synnove Wintherthun for valuable technical assistance
   and to the Department of Pathology, Haukeland University Hospital for
   the original investigation of the diagnostic muscle biopsy. This work
   was funded by The Norwegian Research Council (PSS), Helse Vest RHF and
   University of Bergen.
CR Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Chalmers RM, 1997, NEUROLOGY, V49, P589, DOI 10.1212/WNL.49.2.589
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   Martínez-Fernández E, 2001, STROKE, V32, P2507, DOI 10.1161/hs1101.098328
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
NR 20
TC 7
Z9 7
U1 2
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6314
EI 1600-0404
J9 ACTA NEUROL SCAND
JI Acta Neurol. Scand.
PD FEB
PY 2010
VL 121
IS 2
BP 109
EP 113
DI 10.1111/j.1600-0404.2009.01243.x
PG 5
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 541EC
UT WOS:000273395700006
PM 19744136
OA gold
DA 2024-11-01
ER

PT J
AU Liu, ZR
   Ding, Y
   Du, AL
   Zhang, BR
   Zhao, GH
   Ding, MP
AF Liu, Zhirong
   Ding, Yao
   Du, Ailian
   Zhang, Baorong
   Zhao, Guohua
   Ding, Meiping
TI A novel Twinkle (<i>PEO1</i>) gene mutation in a Chinese family with
   adPEO
SO MOLECULAR VISION
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; AUTOSOMAL-DOMINANT;
   POLYMERASE-GAMMA; MTDNA DELETIONS; DNA HELICASE; REGION; DEPLETION;
   DISORDER; POLG
AB Purpose: Autosomal dominant progressive external ophthalmoplegia (adPEO) is a genetically heterogeneous, adult-onset disease. Thus far, disease loci have been identified on four different nuclear genes. The purpose of this study is to identify the gene responsible for causing adPEO in a Chinese family.
   Methods: Clinical data and genomic DNA of a Chinese adPEO family were collected following informed consent. Gene scan by two-point linkage analysis was performed for four genes, and mutation screening was conducted in the Twinkle (PEO1) gene by direct sequencing.
   Results: A maximum two-point LOD score of 2.8 at theta=0.00 was obtained with marker D10S192 in close proximity to PEO1. A novel missense mutation (c. 1423G>A, p.475A>T) was identified.
   Conclusions: This study widens the mutation spectrum of PEO1 and is the first to report the PEO1 mutation in the Chinese population.
C1 [Liu, Zhirong; Ding, Yao; Du, Ailian; Zhang, Baorong; Zhao, Guohua; Ding, Meiping] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Neurol, Hangzhou 310009, Zhejiang, Peoples R China.
C3 Zhejiang University
RP Ding, MP (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Neurol, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.
EM dingmeiping@tom.com
RI Zhao, Guohua/GOV-4955-2022
FU National Natural Science Foundation of China [305070643]; Youth
   Foundation of the College of Medicine, Zhejiang University
   [491020-542966]
FX The authors would like to thank the families for their enthusiasm and
   participation in this study. This study was partly supported by grants
   from the National Natural Science Foundation of China (No. 305070643)
   and the Youth Foundation of the College of Medicine, Zhejiang University
   (No. 491020-542966).
CR Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   Houshmand M, 2006, NEUROL INDIA, V54, P182
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Li FY, 1999, NEUROLOGY, V53, P1265, DOI 10.1212/WNL.53.6.1265
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VIRGILIO R, 2008, J NEUROL
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 22
TC 9
Z9 9
U1 0
U2 3
PU MOLECULAR VISION
PI ATLANTA
PA C/O JEFF BOATRIGHT, LAB B, 5500 EMORY EYE CENTER, 1327 CLIFTON RD, N E,
   ATLANTA, GA 30322 USA
SN 1090-0535
J9 MOL VIS
JI Mol. Vis.
PD NOV 3
PY 2008
VL 14
IS 235-36
BP 1995
EP 2000
PG 6
WC Biochemistry & Molecular Biology; Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Ophthalmology
GA 406WB
UT WOS:000263324500001
PM 18989381
DA 2024-11-01
ER

PT J
AU Verity, MA
AF Verity, M. Anthony
TI Diagnostic uncertainty in the inflammatory myopathies
SO BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
LA English
DT Article
DE dermatomyositis; eosinophilic myositis; inflammatory dysferlinopathy;
   inflammatory myopathy with abundant macrophages; membrane attack
   complex; MHC-I complex; myopathic polyarteritis nodosa; necrotizing
   myopathy; pipe stem capillaries; polymyositis
ID INCLUSION-BODY MYOSITIS; MINIMAL CELLULAR INFILTRATION;
   MITOCHONDRIAL-DNA DELETIONS; MACROPHAGIC MYOFASCIITIS; HEMOPHAGOCYTIC
   SYNDROME; EOSINOPHILIC POLYMYOSITIS; ANGIOLYMPHOID HYPERPLASIA;
   DYSFERLIN DEFICIENCY; PIPESTEM CAPILLARIES; POLYARTERITIS-NODOSA
AB A group of case histories with appropriate muscle biopsy findings is presented to demonstrate some atypical presentations of the inflammatory myopathies. Differential diagnostic possibilities are considered in presentations of idiopathic polymyositis, statin myotoxicity, the inflammatory component with the dysferlinopathies, treated dermatomyositis, a necrotizing myopathy with pipe-stem microvascular change, an inflammatory myopathy with abundant macrophages, inclusion-body myositis, and the differential diagnosis of problems with eosinophilic infiltration in the muscle biopsy. Attention is given to the role of membrane attack complex deposition in the microvasculature and the role of major histiocompatibility complex-I-expressing muscle fibers indicating activation of the endoplasmic reticulum stress response.
C1 Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA
RP Verity, MA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
EM mverity@mednet.ucla.edu
CR Argov Z, 2000, BRAIN, V123, P1229, DOI 10.1093/brain/123.6.1229
   Authier FJ, 1996, NEUROLOGY, V46, P1448, DOI 10.1212/WNL.46.5.1448
   Bassez G, 2003, J NEUROPATH EXP NEUR, V62, P464, DOI 10.1093/jnen/62.5.464
   BJELLE A, 1980, EUR NEUROL, V19, P128, DOI 10.1159/000115137
   BUCHANAN R, 1980, HISTOPATHOLOGY, V4, P197, DOI 10.1111/j.1365-2559.1980.tb02912.x
   CARPENTER S, 1978, NEUROLOGY, V28, P8, DOI 10.1212/WNL.28.1.8
   DEVERE R, 1975, BRAIN, V98, P637, DOI 10.1093/brain/98.4.637
   EISEN A, 1983, NEUROLOGY, V33, P1109, DOI 10.1212/WNL.33.9.1109
   EMSLIESMITH AM, 1991, NEUROLOGY, V41, P936
   FANG MA, 1988, J RHEUMATOL, V15, P1291
   Fanin M, 2002, NEUROPATH APPL NEURO, V28, P461, DOI 10.1046/j.1365-2990.2002.00417.x
   FAUCI AS, 1982, ANN INTERN MED, V97, P78, DOI 10.7326/0003-4819-97-1-78
   Gallardo E, 2001, NEUROLOGY, V57, P2136, DOI 10.1212/WNL.57.11.2136
   Gherardi RK, 1998, LANCET, V352, P347, DOI 10.1016/S0140-6736(98)02326-5
   Gherardi RK, 2001, BRAIN, V124, P1821, DOI 10.1093/brain/124.9.1821
   Giordano N, 1997, LANCET, V349, P1600, DOI 10.1016/S0140-6736(05)61628-5
   Hall C, 2001, J RHEUMATOL, V28, P871
   HALL FC, 1995, QJM-MON J ASSOC PHYS, V88, P581
   Han R, 2007, J CLIN INVEST, V117, P1805, DOI 10.1172/JCI30848
   HOHLFELD R, 1991, NEW ENGL J MED, V324, P877, DOI 10.1056/NEJM199103283241303
   KAMM MA, 1987, J RHEUMATOL, V14, P831
   LAKHANPAL S, 1988, SEMIN ARTHRITIS RHEU, V17, P221, DOI 10.1016/0049-0172(88)90008-X
   LAYZER RB, 1977, ANN NEUROL, V1, P65, DOI 10.1002/ana.410010106
   Madaule S, 2000, RHEUMATOLOGY, V39, P1157, DOI 10.1093/rheumatology/39.10.1157
   Mastaglia FL, 2003, MUSCLE NERVE, V27, P407, DOI 10.1002/mus.10313
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103
   Nakamura T, 2003, CLIN RHEUMATOL, V22, P149, DOI 10.1007/s10067-002-0688-8
   Needham M, 2007, NEUROMUSCULAR DISORD, V17, P194, DOI 10.1016/j.nmd.2006.10.007
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Papo T, 1999, J RHEUMATOL, V26, P927
   Piccolo F, 2000, ANN NEUROL, V48, P902, DOI 10.1002/1531-8249(200012)48:6<902::AID-ANA11>3.0.CO;2-Z
   Rowin J, 1999, NEUROMUSCULAR DISORD, V9, P417, DOI 10.1016/S0960-8966(99)00041-3
   SERRATRICE G, 1980, J RHEUMATOL, V7, P199
   STARK RJ, 1979, ARCH NEUROL-CHICAGO, V36, P721, DOI 10.1001/archneur.1979.00500470091022
   Tager RE, 1999, RHEUMATOLOGY, V38, P397, DOI 10.1093/rheumatology/38.5.397
   van der Pas J, 2004, J NEUROL NEUROSUR PS, V75, P136
   VERITY MA, 1992, J NEUROPATH EXP NEUR, V51, P356
   WINCHESTER RJ, 1971, ARTHRITIS RHEUM-US, V14, P650, DOI 10.1002/art.1780140513
   Yasuda S, 1998, BRIT J RHEUMATOL, V37, P1357
NR 40
TC 6
Z9 6
U1 0
U2 2
PU BAILLIERE TINDALL
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1521-6942
J9 BEST PRACT RES CL RH
JI Best Pract. Res. Clin. Rheumatol.
PD DEC
PY 2007
VL 21
IS 6
BP 1051
EP 1070
DI 10.1016/j.berh.2007.10.004
PG 20
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA 247QH
UT WOS:000252093900007
PM 18068861
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Kothari, S
AF Finsterer, Josef
   Kothari, Sonam
TI Cardiac manifestations of primary mitochondrial disorders
SO INTERNATIONAL JOURNAL OF CARDIOLOGY
LA English
DT Review
DE Mitochondrial disorder; Myopathy; Neuropathy; Cardiac involvement;
   Arrhythmias; Heart failure; Systolic dysfunction; Sudden cardiac death;
   Takotsubo; Cardiomyopathy
ID KEARNS-SAYRE-SYNDROME; HYPERTROPHIC CARDIOMYOPATHY; LACTIC-ACIDOSIS;
   HISTIOCYTOID CARDIOMYOPATHY; A3243G MUTATION; POINT MUTATION; AUTONOMIC
   DYSFUNCTION; CLINICAL-FEATURES; DNA MUTATIONS; HEART-DISEASE
AB Objectives: One of the most frequently affected organs in mitochondrial disorders (MIDs), defined as hereditary diseases due to affection of the mitochondrial energy metabolism, is the heart. Cardiac involvement (CI) in MIDs has therapeutic and prognostic implications. This review aims at summarizing and discussing the various cardiac manifestations in MIDs.
   Methods: Data for this review were identified by searches of MEDLINE, Current Contents, and PubMed using appropriate search terms.
   Results: CI in MIDs may be classified according to various different criteria. In the present review cardiac abnormalities in MIDs are discussed according to their frequency with which they occur. CI in MIDs includes cardiomyopathy, arrhythmias, heart failure, pulmonary hypertension, dilation of the aortic root, pericardial effusion, coronary heart disease, autonomous nervous system dysfunction, congenital heart defects, or sudden cardiac death. The most frequent among the cardiomyopathies is hypertrophic cardiomyopathy, followed by dilated cardiomyopathy, and noncompaction.
   Conclusions: CI in MID is more variable and prevalent than previously thought. All tissues of the heart may be variably affected. The most frequently affected tissue is the myocardium. MIDs should be included in the differential diagnoses of cardiac disease. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
   [Kothari, Sonam] NIMHANS, Bangalore, Karnataka, India.
C3 Rudolfstiftung Hospital; National Institute of Mental Health &
   Neurosciences - India
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Abaci N., 2014, CARDIOL YOU IN PRESS, V1-2
   Akavia UD, 2008, J CELL PHYSIOL, V216, P663, DOI 10.1002/jcp.21442
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008
   Atay Z, 2013, GENE, V515, P197, DOI 10.1016/j.gene.2012.11.044
   Ayalon N, 2013, INT J CARDIOL, V167, pE143, DOI 10.1016/j.ijcard.2013.04.018
   Barisic N, 2002, CROAT MED J, V43, P37
   Barragan-Campos Hector Manuel, 1999, Archivos del Instituto de Cardiologia de Mexico, V69, P559
   Baruffini E, 2013, HUM MUTAT, V34, P1501, DOI 10.1002/humu.22393
   Bates MGD, 2012, INT J CARDIOL, V155, P305, DOI 10.1016/j.ijcard.2011.11.063
   Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010
   Bregel LV, 2012, KARDIOLOGIYA, V52, P93
   BRESOLIN N, 1987, ANN NEUROL, V21, P564, DOI 10.1002/ana.410210607
   Brunetti-Pierri N, 2011, MOL GENET METAB, V103, P167, DOI 10.1016/j.ymgme.2011.02.007
   Campos Y, 2000, NEUROMUSCULAR DISORD, V10, P56, DOI 10.1016/S0960-8966(99)00072-3
   Cardaioli E, 2012, J NEUROL SCI, V321, P92, DOI 10.1016/j.jns.2012.07.027
   Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375
   Casali C, 1999, J AM COLL CARDIOL, V33, P1584, DOI 10.1016/S0735-1097(99)00079-0
   Cave D, 2013, CONGENIT HEART DIS, V8, pE20, DOI 10.1111/j.1747-0803.2011.00569.x
   Chamkha I, 2012, BIOCHEM BIOPH RES CO, V429, P31, DOI 10.1016/j.bbrc.2012.10.105
   Choi JH, 2007, INT J MOL MED, V19, P81
   Dhandapany PS, 2007, INT J CARDIOL, V120, P284, DOI 10.1016/j.ijcard.2006.07.229
   Di Leo R, 2007, J NEUROL, V254, P1498, DOI 10.1007/s00415-007-0536-5
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Ergul Y, 2011, CARDIOL J, V18, P176
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Fassone E, 2011, J MED GENET, V48, P691, DOI 10.1136/jmedgenet-2011-100340
   Fijolek Justyna, 2003, Pneumonol Alergol Pol, V71, P449
   Finsterer J, 2007, Minerva Gastroenterol Dietol, V53, P285
   Finsterer J, 2000, EUR NEUROL, V44, P37, DOI 10.1159/000008190
   Finsterer J, 2004, ACTA CARDIOL, V59, P187, DOI 10.2143/AC.59.2.2005175
   Finsterer J, 2012, NUTR METAB CARDIOVAS, V22, P393, DOI 10.1016/j.numecd.2012.01.002
   Finsterer J, 2003, CARDIOLOGY, V100, P48, DOI 10.1159/000072393
   Finsterer J, 2001, J INHERIT METAB DIS, V24, P560, DOI 10.1023/A:1012415810881
   Finsterer J, 2008, CLIN CARDIOL, V31, P225, DOI 10.1002/clc.20224
   Finsterer J, 2007, J CARDIOVASC MED, V8, P859, DOI 10.2459/JCM.0b013e3280103d1b
   Finsterer J, 2013, WIEN MED WOCHENSCHR, V163, P505, DOI 10.1007/s10354-013-0243-z
   Finsterer J, 2013, INT J CARDIOL, V167, pE101, DOI 10.1016/j.ijcard.2013.03.194
   Finsterer Josef, 2011, Kobe J Med Sci, V56, pE239
   Finsterer J, 2010, EUR J HEART FAIL, V12, P637, DOI 10.1093/eurjhf/hfq046
   Finsterer J, 2009, INT J LEGAL MED, V123, P507, DOI 10.1007/s00414-008-0290-y
   Finsterer J, 2009, PEDIATR CARDIOL, V30, P659, DOI 10.1007/s00246-008-9359-0
   Franklin JA, 2005, CLEFT PALATE-CRAN J, V42, P327, DOI 10.1597/03-040.1
   Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562
   Gerber B., 2010, BMJ CASE REP
   Giordano C, 2013, HUM PATHOL, V44, P1262, DOI 10.1016/j.humpath.2012.10.011
   GONSKA BD, 1985, Z KARDIOL, V74, P281
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Govindaraj P, 2014, MITOCHONDRION, V16, P65, DOI 10.1016/j.mito.2013.10.006
   Guo H, 2012, BBA-MOL BASIS DIS, V1822, P1535, DOI 10.1016/j.bbadis.2012.06.010
   Hernández-Luis C, 2007, REV ESP CARDIOL, V60, P89, DOI 10.1016/S0300-8932(07)74995-3
   Hollingsworth KG, 2012, NEUROMUSCULAR DISORD, V22, P592, DOI 10.1016/j.nmd.2012.03.001
   Hung PC, 2012, BRAIN DEV-JPN, V34, P866, DOI 10.1016/j.braindev.2012.02.011
   Inamori M, 1997, J Cardiol, V30, P341
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   ISHIKAWA Y, 1995, PATHOL RES PRACT, V191, P64, DOI 10.1016/S0344-0338(11)80927-1
   Jain-Ghai S, 2013, AM J MED GENET A, V161A, P285, DOI 10.1002/ajmg.a.35714
   Jia ZD, 2013, HUM MOL GENET, V22, P4064, DOI 10.1093/hmg/ddt256
   Johnson ECB, 2011, NEUROHOSPITALIST, V1, P48, DOI 10.1177/1941875210385948
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Jose T, 2011, INT J CARDIOL, V149, pE24, DOI 10.1016/j.ijcard.2009.03.057
   Josef F, 2006, INT J CARDIOVAS IMAG, V22, P393, DOI 10.1007/s10554-005-9073-4
   Kanjwal K, 2010, CLIN CARDIOL, V33, P626, DOI 10.1002/clc.20805
   Karanikis P, 2005, INT J CARDIOL, V101, P147, DOI 10.1016/j.ijcard.2004.01.027
   Kawagoe Izumi, 2013, Masui, V62, P431
   Leary SC, 2013, HUM MUTAT, V34, P1366, DOI 10.1002/humu.22385
   Lee K T, 2001, Kaohsiung J Med Sci, V17, P336
   Letsas Konstantinos P, 2006, Am Heart Hosp J, V4, P301, DOI 10.1111/j.1541-9215.2006.06040.x
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Limongelli G, 2012, FUTUR CARDIOL, V8, P71, DOI [10.2217/fca.11.79, 10.2217/FCA.11.79]
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Liu CH, 2012, J FORMOS MED ASSOC, V111, P489, DOI 10.1016/j.jfma.2011.06.014
   Liu HY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-29
   Liu Z, 2014, J MED GENET, V51, P176, DOI 10.1136/jmedgenet-2013-101818
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Majamaa-Voltti K, 2004, ANN MED, V36, P225, DOI 10.1080/07853890410028456
   Majamaa-Voltti Kirsi, 2002, BMC Cardiovasc Disord, V2, P12
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   MATSUSHITA T, 1993, PEDIATR NEUROL, V9, P391, DOI 10.1016/0887-8994(93)90109-P
   Meyers Deborah E, 2013, Tex Heart Inst J, V40, P635
   Mezghani N, 2011, BIOCHEM BIOPH RES CO, V411, P247, DOI 10.1016/j.bbrc.2011.06.106
   Mima A, 2011, RENAL FAILURE, V33, P622, DOI 10.3109/0886022X.2011.585730
   Mkaouar-Rebai E, 2013, MITOCHONDR DNA, V24, P163, DOI 10.3109/19401736.2012.748045
   Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005
   Ngu L.H., 2012, BIOCHIM BIOPHYS ACTA, P168
   Obara-Moszynska M, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-27
   Oginosawa Y, 2003, PACE, V26, P1911, DOI 10.1046/j.1460-9592.2003.00292.x
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   ORTIZ RG, 1992, AM J OPHTHALMOL, V113, P561, DOI 10.1016/S0002-9394(14)74730-0
   Palecek T, 2012, INT HEART J, V53, P383, DOI 10.1536/ihj.53.383
   Parikh S, 2013, SEMIN PEDIATR NEUROL, V20, P31, DOI 10.1016/j.spen.2013.01.003
   Park SY, 2014, AM J PHYSIOL-HEART C, V307, pH346, DOI 10.1152/ajpheart.00227.2014
   Parsons T, 2010, ARCH NEUROL-CHICAGO, V67, P976, DOI 10.1001/archneurol.2010.174
   Riera ARP, 2008, J ELECTROCARDIOL, V41, P675, DOI 10.1016/j.jelectrocard.2008.04.001
   Polisecki EY, 2004, J FORENSIC SCI, V49, P1335
   Prasad GN, 2006, INT J CARDIOL, V109, P432, DOI 10.1016/j.ijcard.2005.07.065
   Rahman OU, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-78
   Rashid A, 2002, J CARDIOVASC ELECTR, V13, P184, DOI 10.1046/j.1540-8167.2002.00184.x
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ryan JJ, 2013, AM J RESP CRIT CARE, V187, P865, DOI 10.1164/rccm.201209-1687OC
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Santorelli FM, 2002, NEUROMUSCULAR DISORD, V12, P56, DOI 10.1016/S0960-8966(01)00248-6
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schwarz K, 2014, INT J CARDIOL, V171, P134, DOI 10.1016/j.ijcard.2013.12.014
   Shahni R, 2013, AM J MED GENET A, V161, P2334, DOI 10.1002/ajmg.a.36065
   SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107
   Smits P, 2011, EUR J HUM GENET, V19, P394, DOI 10.1038/ejhg.2010.214
   Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008
   Sproule D.M., 2008, J INHERIT M IN PRESS
   Stalder N, 2012, CIRC-HEART FAIL, V5, pE1, DOI 10.1161/CIRCHEARTFAILURE.111.963900
   Stollberger Claudia, 2009, Clin Cardiol, V32, pE46, DOI 10.1002/clc.20366
   Subbiah RN, 2007, PACE, V30, P137
   Taniguchi Akira, 2002, Nihon Rinsho, V60 Suppl 4, P606
   Torraco Alessandra, 2012, Neurogenetics, V13, P375, DOI 10.1007/s10048-012-0343-8
   Tsujita Y, 2008, INT J CARDIOL, V128, pE43, DOI 10.1016/j.ijcard.2007.05.072
   Vallance HD, 2004, PEDIATR CARDIOL, V25, P538, DOI 10.1007/s00246-003-0446-y
   Van Hove JLK, 2008, EUR J PEDIATR, V167, P771, DOI 10.1007/s00431-007-0587-8
   Verdijk RM, 2008, AM J MED GENET A, V146A, P2822, DOI 10.1002/ajmg.a.32523
   Verhoeven WMA, 2011, NEUROPSYCH DIS TREAT, V7, P293, DOI 10.2147/NDT.S20153
   Vilarinho L, 1997, J MED GENET, V34, P607, DOI 10.1136/jmg.34.7.607
   Villar P, 2013, CIRC J, V77, P2799, DOI 10.1253/circj.CJ-13-0557
   von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6
   Vondrácková A, 2014, EUR J HUM GENET, V22, P431, DOI 10.1038/ejhg.2013.148
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wang Shi-Bing, 2008, Pediatrics and Neonatology, V49, P145, DOI 10.1016/S1875-9572(08)60030-3
   Wang Shu-Mei, 2006, Acta Paediatrica Taiwanica, V47, P83
   Wang W, 2008, AM J EMERG MED, V26, DOI 10.1016/j.ajem.2007.05.027
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Wei Xiao-Qiong, 2009, Zhongguo Dang Dai Er Ke Za Zhi, V11, P333
   Wilichowski E, 1998, J NEUROL SCI, V157, P206, DOI 10.1016/S0022-510X(98)00068-9
   Wilmin Stephan, 2012, Pract Neurol, V12, P199, DOI 10.1136/practneurol-2012-000256
   Wortmann SB, 2012, EUR J MED GENET, V55, P552, DOI 10.1016/j.ejmg.2012.06.002
   Yajima N, 2009, J NUCL CARDIOL, V16, P989, DOI 10.1007/s12350-009-9149-y
   Yaplito-Lee J, 2007, J PEDIATR-US, V150, P407, DOI 10.1016/j.jpeds.2006.12.047
   Yilmaz A, 2012, CLIN RES CARDIOL, V101, P255, DOI 10.1007/s00392-011-0387-z
   Zaragoza MV, 2011, EUR J HUM GENET, V19, P200, DOI 10.1038/ejhg.2010.169
   Zarrouk-Mahjoub S., 2013, HERZ IN PRESS
   Zhang Li-hua, 2009, Zhonghua Xin Xue Guan Bing Za Zhi, V37, P892
NR 140
TC 82
Z9 87
U1 0
U2 15
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-5273
EI 1874-1754
J9 INT J CARDIOL
JI Int. J. Cardiol.
PD DEC 20
PY 2014
VL 177
IS 3
BP 754
EP 763
DI 10.1016/j.ijcard.2014.11.014
PG 10
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA AU6EX
UT WOS:000345697200044
PM 25465824
DA 2024-11-01
ER

PT J
AU Lax, NZ
   Gnanapavan, S
   Dowson, SJ
   Alston, CL
   He, LP
   Polvikoski, TM
   Jaros, E
   O'Donovan, DG
   Yarham, JW
   Turnbull, DM
   Dean, AF
   Taylor, RW
AF Lax, Nichola Z.
   Gnanapavan, Sharmilee
   Dowson, Sarah J.
   Alston, Charlotte L.
   He, Langping
   Polvikoski, Tuomo M.
   Jaros, Evelyn
   O'Donovan, Dominic G.
   Yarham, John W.
   Turnbull, Douglass M.
   Dean, Andrew F.
   Taylor, Robert W.
TI Early-Onset Cataracts, Spastic Paraparesis, and Ataxia Caused by a Novel
   Mitochondrial tRNA<SUP>Glu</SUP> (<i>MT-TE</i>) Gene Mutation Causing
   Severe Complex I Deficiency: A Clinical, Molecular, and Neuropathologic
   Study
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Mitochondrial disease; Neurodegeneration; Neurologic impairments;
   Neuronal complex I deficiency; tRNA mutations
ID TRANSFER-RNA MUTATIONS; STROKE-LIKE EPISODES; CEREBELLAR-ATAXIA;
   EXTERNAL OPHTHALMOPLEGIA; LACTIC-ACIDOSIS; POINT MUTATION; DNA DISEASE;
   MELAS; A3243G; MUSCLE
AB Mitochondrial respiratory chain disease is associated with a spectrum of clinical presentations and considerable genetic heterogeneity. Here we report molecular genetic and neuropathologic findings from an adult with an unusual manifestation of mitochondrial DNA disease. Clinical features included early-onset cataracts, ataxia, and progressive paraparesis, with sequencing revealing the presence of a novel de novo m. 14685G>A mitochondrial tRNAGlu (MT-TE) gene mutation. Muscle biopsy showed that 13% and 34% of muscle fibers lacked cytochrome c oxidase activity and complex I subunit expression, respectively. Biochemical studies confirmed a marked decrease in complex I activity. Neuropathologic investigation revealed a large cystic lesion affecting the left putamen, caudate nucleus, and internal capsule, with evidence of marked microvacuolation, neuron loss, perivascular lacunae, and blood vessel mineralization. The internal capsule showed focal axonal loss, whereas brainstem and spinal cord showed descending anterograde degeneration in medullary pyramids and corticospinal tracts. In agreement with muscle biopsy findings, reduced complex I immunoreactivity was detected in the remaining neuronal populations, particularly in the basal ganglia and cerebellum, correlating with the neurologic dysfunction exhibited by the patient. This study emphasizes the importance of molecular genetic and postmortem neuropathologic analyses for furthering our understanding of underlying mechanisms of mitochondrial disorders.
C1 [Lax, Nichola Z.; Dowson, Sarah J.; Alston, Charlotte L.; He, Langping; Yarham, John W.; Turnbull, Douglass M.; Taylor, Robert W.] Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Lax, Nichola Z.; Turnbull, Douglass M.] Newcastle Univ, Sch Med, Ctr Brain Ageing & Vital, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Gnanapavan, Sharmilee] Inst Neurol, Dept Neuroimmunol, London WC1N 3BG, England.
   [Polvikoski, Tuomo M.; Jaros, Evelyn] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Jaros, Evelyn] Newcastle Upon Tyne Hosp NHS Fdn Trust, UK NIHR Biomed Res Ctr Ageing & Age Related Dis, Newcastle Upon Tyne, Tyne & Wear, England.
   [O'Donovan, Dominic G.; Dean, Andrew F.] Addenbrookes Hosp, Dept Histopathol, Cambridge CB2 2QQ, England.
   [O'Donovan, Dominic G.] Queens Hosp, Dept Cellular Pathol, Romford, Essex, England.
C3 Newcastle University - UK; Newcastle University - UK; University of
   London; University College London; Newcastle University - UK; Newcastle
   Upon Tyne Hospitals NHS Foundation Trust; Cambridge University Hospitals
   NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
RI Alston, Charlotte/ABG-9602-2020
OI Turnbull, Doug/0000-0002-8878-9901; Alston,
   Charlotte/0000-0003-2095-5464
FU Wellcome Trust Centre for Mitochondrial Research [906919]; BBSRC; EPSRC;
   ESRC; MRC as part of the cross-council Lifelong Health and Wellbeing
   Initiative [G0700718]; UK NIHR Biomedical Research Centre for Ageing and
   Age-related Disease; UK NHS Specialist Commissioners; MRC [G0700718,
   G1100540, G0400074, G0502157, MR/K000608/1, G0900652] Funding Source:
   UKRI
FX This work was supported by The Wellcome Trust Centre for Mitochondrial
   Research (Grant No. 906919), the Newcastle University Centre for Brain
   Ageing and Vitality supported by BBSRC, EPSRC, ESRC, and MRC as part of
   the cross-council Lifelong Health and Wellbeing Initiative (Grant No.
   G0700718), UK NIHR Biomedical Research Centre for Ageing and Age-related
   Disease Award to the Newcastle upon Tyne Hospitals NHS Foundation Trust,
   and the UK NHS Specialist Commissioners that funds the "Rare
   Mitochondrial Disorders of Adults and Children'' Diagnostic Service in
   Newcastle upon Tyne (http://www.mitochondrialncg.nhs.uk).
CR Bene J, 2003, EUR J HUM GENET, V11, P375, DOI 10.1038/sj.ejhg.5200975
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Casali C, 1999, NEUROLOGY, V52, P1103, DOI 10.1212/WNL.52.5.1103
   Corona P, 2002, ANN NEUROL, V51, P118, DOI 10.1002/ana.10059
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Elson JL, 2009, HUM MUTAT, V30, pE984, DOI 10.1002/humu.21113
   Feekes JA, 2006, BRAIN, V129, P2189, DOI 10.1093/brain/awl158
   Ferrer I., 2008, GREENFIELDS NEUROPAT, P121, DOI [10.1201/b13319-4, DOI 10.1201/B13319-4]
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2007, J NEUROL SCI, V257, P126, DOI 10.1016/j.jns.2007.01.040
   Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Schicks J, 2010, MOVEMENT DISORD, V25, P2678, DOI 10.1002/mds.23286
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   VANDENOUWELAND JMW, 1992, NUCLEIC ACIDS RES, V20, P679, DOI 10.1093/nar/20.4.679
   Verny C, 2011, MITOCHONDRION, V11, P70, DOI 10.1016/j.mito.2010.07.006
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Zhou L, 1997, J NEUROSCI, V17, P7746
NR 38
TC 13
Z9 15
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-3069
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD FEB
PY 2013
VL 72
IS 2
BP 164
EP 175
DI 10.1097/NEN.0b013e31828129c5
PG 12
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA 079HE
UT WOS:000314160400008
PM 23334599
OA Bronze
DA 2024-11-01
ER

PT J
AU Zanini, G
   Selleri, V
   Nasi, M
   De Gaetano, A
   Martinelli, I
   Gianferrari, G
   Lofaro, FD
   Boraldi, F
   Mandrioli, J
   Pinti, M
AF Zanini, Giada
   Selleri, Valentina
   Nasi, Milena
   De Gaetano, Anna
   Martinelli, Ilaria
   Gianferrari, Giulia
   Lofaro, Francesco Demetrio
   Boraldi, Federica
   Mandrioli, Jessica
   Pinti, Marcello
TI Mitochondrial and Endoplasmic Reticulum Alterations in a Case of
   Amyotrophic Lateral Sclerosis Caused by TDP-43 A382T Mutation
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE TDP-43; amyotrophic lateral sclerosis; mitochondria; mtDNA
ID LON PROTEASE; MULTIPLE-SCLEROSIS; GENE-MUTATIONS; DISEASE; DNA
AB Amyotrophic lateral sclerosis is the most common form of motor neuron disease. Mutations in TARDBP, the gene encoding the RNA-binding protein TDP-43, are responsible for about 5% of familial ALS. Here we report the clinical and biological features of an ALS patients with pA382T mutation in TPD-43 protein. Disease began with right hand muscles weakness, and equally involved upper and lower motor neuron with a classic phenotype, without cognitive impairment. While a family history of neurological diseases was reported, there was no evidence of familial frontotemporal dementia. Cultured fibroblasts from the patient were characterized by profound alterations of cell proteome, which impacts particularly the mitochondrial metabolic pathways and the endoplasmic reticulum. TDP-43 levels were similar to control, healthy fibroblasts, but a higher fraction localized in mitochondria. Mitochondrial network appeared fragmented, and the organelles smaller and more spheric. In agreement with impaired proteome and morphology of mitochondria, basal cell respiration was reduced. Mitochondrial DNA levels appeared normal. However, a higher amount of mitochondrial DNA was present in the cytosol, suggesting a pronounced mitochondrial DNA misplacement which can promote a pro-inflammatory response mediating by cGAS/STING. Thus, this case report further expands the clinical and pathological phenotype of A382T mutation.
C1 [Zanini, Giada; Selleri, Valentina; De Gaetano, Anna; Lofaro, Francesco Demetrio; Boraldi, Federica; Pinti, Marcello] Univ Modena & Reggio Emilia, Dept Life Sci, Via G Campi 287, I-41125 Modena, Italy.
   [Selleri, Valentina; De Gaetano, Anna] Natl Inst Cardiovasc Res, Via Irnerio 28, I-40126 Bologna, Italy.
   [Nasi, Milena] Univ Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, I-41125 Modena, Italy.
   [Martinelli, Ilaria; Gianferrari, Giulia; Mandrioli, Jessica] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neurosci, Via G Campi 287, I-41125 Modena, Italy.
C3 Universita di Modena e Reggio Emilia; Universita di Modena e Reggio
   Emilia; Universita di Modena e Reggio Emilia
RP Pinti, M (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Via G Campi 287, I-41125 Modena, Italy.; Mandrioli, J (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neurosci, Via G Campi 287, I-41125 Modena, Italy.
EM jessica.mandrioli@unimore.it; marcello.pinti@unimore.it
RI GIANFERRARI, GIULIA/IQR-7406-2023; Boraldi, Federica/D-1263-2015;
   MARTINELLI, ILARIA/AAB-2799-2019; Nasi, Milena/J-4425-2016; Pinti,
   Marcello/C-9351-2015; MANDRIOLI, JESSICA/K-7235-2016
OI GIANFERRARI, GIULIA/0000-0002-4260-0915; Boraldi,
   Federica/0000-0002-0277-9017; MARTINELLI, ILARIA/0000-0003-2566-3671;
   Nasi, Milena/0000-0003-3079-8001; Pinti, Marcello/0000-0001-9118-1262;
   MANDRIOLI, JESSICA/0000-0002-9244-9782
FU Agenzia Italiana del Farmaco [2016-02364678]
FX This study was supported by Agenzia Italiana del Farmaco, grant number
   2016-02364678 to J.M.
CR Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028
   Benajiba L, 2009, ANN NEUROL, V65, P470, DOI 10.1002/ana.21612
   Borghero G, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.07.012
   Borghero G, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.009
   Bozzo F, 2017, NEUROSCI LETT, V636, P3, DOI 10.1016/j.neulet.2016.04.065
   Cannas A, 2013, NEUROGENETICS, V14, P161, DOI 10.1007/s10048-013-0360-2
   Chaudhry A, 2020, AM J PHYSIOL-ENDOC M, V318, pE87, DOI 10.1152/ajpendo.00457.2019
   Cheng WW, 2019, NEURON, V104, P885, DOI 10.1016/j.neuron.2019.09.003
   Chiò A, 2011, ARCH NEUROL-CHICAGO, V68, P594, DOI 10.1001/archneurol.2010.352
   Corcia P, 2012, NEUROLOGY, V78, P1519, DOI 10.1212/WNL.0b013e3182553c88
   Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950
   Cui C, 2021, AMYOTROPH LAT SCL FR, V22, P211, DOI 10.1080/21678421.2020.1861022
   D'Amico E, 2013, FREE RADICAL BIO MED, V65, P509, DOI 10.1016/j.freeradbiomed.2013.06.029
   De Marco G, 2017, NEUROPATH APPL NEURO, V43, P133, DOI 10.1111/nan.12328
   Etemadifar M, 2012, MULT SCLER J, V18, P902, DOI 10.1177/1352458511427719
   François-Moutal L, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00301
   Gianferrari G, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10040819
   Gianini M, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009260
   Gibellini L, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00254
   Gibellini L, 2014, MITOCHONDRION, V18, P76, DOI 10.1016/j.mito.2014.08.001
   Gibellini L, 2014, FASEB J, V28, P5122, DOI 10.1096/fj.14-255869
   Goris A, 2014, HUM MOL GENET, V23, P1916, DOI 10.1093/hmg/ddt574
   Hemminki K, 2009, NEUROGENETICS, V10, P111, DOI 10.1007/s10048-008-0164-y
   Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534
   Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200
   Lofaro FD, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms221910564
   Lofaro FD, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.610266
   Longinetti E, 2022, AMYOTROPH LAT SCL FR, V23, P209, DOI 10.1080/21678421.2021.1946084
   Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200
   Mandrioli J, 2020, SEMIN CELL DEV BIOL, V99, P183, DOI 10.1016/j.semcdb.2019.06.003
   Mutihac R, 2015, NEUROBIOL DIS, V75, P64, DOI 10.1016/j.nbd.2014.12.010
   Nasi M, 2020, J NEUROIMMUNOL, V338, DOI 10.1016/j.jneuroim.2019.577107
   Onesto E, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0316-5
   Orrù S, 2016, HUM MOL GENET, V25, P4473, DOI 10.1093/hmg/ddw276
   Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303
   Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011
   Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584
   Suk TR, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00397-1
   Theunissen F, 2021, TRANSL NEURODEGENER, V10, DOI 10.1186/s40035-021-00272-z
   Tsai TH, 2020, MOL CELL PROTEOMICS, V19, P944, DOI 10.1074/mcp.RA119.001792
   Turner MR, 2013, NEUROLOGY, V81, P1222, DOI 10.1212/WNL.0b013e3182a6cc13
   Wang WZ, 2016, NAT MED, V22, P869, DOI 10.1038/nm.4130
   Watanabe S, 2013, J BIOL CHEM, V288, P3641, DOI 10.1074/jbc.M112.433615
   Wood A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094705
   Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020
   Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6
NR 46
TC 7
Z9 8
U1 1
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD OCT
PY 2022
VL 23
IS 19
AR 11881
DI 10.3390/ijms231911881
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 5H5UG
UT WOS:000867743600001
PM 36233180
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Durham, SE
   Samuels, DC
   Cree, LM
   Chinnery, PF
AF Durham, Steve E.
   Samuels, David C.
   Cree, Lynsey M.
   Chinnery, Patrick F.
TI Normal levels of wild-type mitochondrial DNA maintain cytochrome
   <i>c</i> oxidase activity for two pathogenic mitochondrial DNA mutations
   but not for m.3243A→G
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID DEFICIENT MUSCLE-FIBERS; STROKE-LIKE EPISODES; WOBBLE MODIFICATION;
   PROTEIN-SYNTHESIS; SKELETAL-MUSCLE; LACTIC-ACIDOSIS; MTDNA MUTATION;
   POINT MUTATION; TRANSFER-RNAS; MELAS
AB Mitochondrial DNA (mtDNA) mutations are a common cause of human disease and accumulate as part of normal ageing and in common neurodegenerative disorders. Cells express a biochemical defect only when the proportion of mutated mtDNA exceeds a critical threshold, but it is not clear whether the actual cause of this defect is a loss of wild-type mtDNA, an excess of mutated mtDNA, or a combination of the two. Here, we show that segments of human skeletal muscle fibers harboring two pathogenic mtDNA mutations retain normal cytochrome c oxidase (COX) activity by maintaining a minimum amount of wild- type mtDNA. For these mutations, direct measurements of mutated and wild- type mtDNA molecules within the same skeletal muscle fiber are consistent with the "maintenance of wild type" hypothesis, which predicts that there is nonselective proliferation of mutated and wild- type mtDNA in response to the molecular defect. However, for the m. 3243A -> G mutation, a superabundance of wild-type mtDNA was found in many muscle-fiber sections with negligible COX activity, indicating that the pathogenic mechanism for this particular mutation involves interference with the function of the wild- type mtDNA or wild-type gene products.
C1 Newcastle Univ, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.
   Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England.
   Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.
C3 Newcastle University - UK; Newcastle University - UK; Virginia
   Polytechnic Institute & State University
RP Chinnery, PF (corresponding author), Med Sch Newcastle Upon Tyne, M4014, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM P.F.Chinnery@ncl.ac.uk
RI ; Samuels, David/A-5393-2008
OI Chinnery, Patrick/0000-0002-7065-6617; Cree, Lynsey/0000-0003-2090-1589;
   Samuels, David/0000-0003-3529-7791
FU Wellcome Trust Funding Source: Medline
CR ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2
   Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Capps GJ, 2003, J THEOR BIOL, V221, P565, DOI 10.1006/jtbi.2003.3207
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88
   Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   HAMMANS SR, 1992, J NEUROL SCI, V107, P87, DOI 10.1016/0022-510X(92)90213-5
   Hao R, 2004, FEBS LETT, V578, P135, DOI 10.1016/j.febslet.2004.11.004
   HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Kim JY, 2005, NEUROLOGY, V64, P966, DOI 10.1212/01.WNL.0000157282.76715.B1
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirino Y, 2006, HUM MOL GENET, V15, P897, DOI 10.1093/hmg/ddl007
   KOGA Y, 1995, MUSCLE NERVE, pS119
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   SUOMALAINEN A, 1993, HUM MOL GENET, V2, P525, DOI 10.1093/hmg/2.5.525
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   TOKUNAGA M, 1994, ANN NEUROL, V35, P413, DOI 10.1002/ana.410350407
   Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166
   Yasukawa T, 2005, FEBS LETT, V579, P2948, DOI 10.1016/j.febslet.2005.04.038
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
NR 34
TC 64
Z9 72
U1 0
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD JUL
PY 2007
VL 81
IS 1
BP 189
EP 195
DI 10.1086/518901
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 175UO
UT WOS:000247039700018
PM 17564976
OA Green Accepted, Green Published, Bronze
DA 2024-11-01
ER

PT J
AU White, MA
   Sreedharan, J
AF White, Matthew A.
   Sreedharan, Jemeen
TI Amyotrophic lateral sclerosis: recent genetic highlights
SO CURRENT OPINION IN NEUROLOGY
LA English
DT Review
DE amyotrophic lateral sclerosis; C9orf72; genetics; RNA processing; TDP-43
ID MESSENGER-RNA EXPORT; DOMINANT DISTAL MYOPATHY; FRONTOTEMPORAL DEMENTIA;
   CHCHD10 MUTATIONS; REPEAT EXPANSIONS; CYCLIN-F; C9ORF72; TBK1; GLE1; ALS
AB Purpose of reviewAmyotrophic lateral sclerosis (ALS), like other neurodegenerative diseases, remains incurable, but gene mutations linked to ALS are providing clues as to how to target therapies. It is important for researchers to keep abreast of the rapid influx of new data in ALS, and we aim to summarize the major genetic advances made in the field over the past 2 years.Recent findingsSignificant variation in seven genes has recently been found in ALS: TBK1, CCNF, GLE1, MATR3, TUBA4A, CHCHD10 and NEK1. These have mostly been identified through large exome screening studies, though traditional linkage approaches and candidate gene screening remain important. We briefly update C9orf72 research, noting in particular the development of reagents to better understand the normal role of C9orf72 protein.SummaryStriking advances in our understanding of the genetic heterogeneity of ALS continue to be made, year on year. These implicate proteostasis, RNA export, nuclear transport, the cytoskeleton, mitochondrial function, the cell cycle and DNA repair. Functional studies to integrate these hits are needed. By building a web of knowledge with interlinked genes and mechanisms, it is hoped we can better understand ALS and work toward effective therapies.
C1 [White, Matthew A.; Sreedharan, Jemeen] Babraham Inst, Cambridge CB22 3AT, England.
C3 UK Research & Innovation (UKRI); Biotechnology and Biological Sciences
   Research Council (BBSRC); Babraham Institute
RP Sreedharan, J (corresponding author), Babraham Inst, Cambridge CB22 3AT, England.
EM jemeen.sreedharan@babraham.ac.uk
RI ; sreedharan, jemeen/E-7327-2016
OI White, Matthew Anthony/0000-0002-4147-4267; sreedharan,
   jemeen/0000-0002-8682-6844
FU Medical Research Council; Motor Neuron Disease Association; MRC
   [MR/K010611/1] Funding Source: UKRI
FX The current work was supported by the Medical Research Council and the
   Motor Neuron Disease Association (Lady Edith Wolfson Fellowship awarded
   to J.S.).
CR Alcázar-Román AR, 2010, J BIOL CHEM, V285, P16683, DOI 10.1074/jbc.M109.082370
   [Anonymous], ADV BIOL REGUL
   [Anonymous], J NEUROCHEM
   [Anonymous], NEUROBIOLOGY AGING
   [Anonymous], J NEUROCHEM
   [Anonymous], MOL NEUROBIOL
   [Anonymous], NEUROBIOL AGING
   [Anonymous], NEUROBIOL AGING
   Appert-Collin A, 2006, LIFE SCI, V79, P484, DOI 10.1016/j.lfs.2006.01.032
   Atanasio A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23204
   BAI C, 1994, EMBO J, V13, P6087, DOI 10.1002/j.1460-2075.1994.tb06955.x
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Bolger TA, 2011, J BIOL CHEM, V286, P39750, DOI 10.1074/jbc.M111.299321
   Bolger Timothy A, 2008, Cell, V134, P624, DOI 10.1016/j.cell.2008.06.027
   Borghero G, 2016, NEUROBIOL AGING, V43, DOI 10.1016/j.neurobiolaging.2016.03.028
   Brenner D, 2016, BRAIN, V139, pCP14, DOI 10.1093/brain/aww033
   Chaussenot A, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.07.022
   Chen YM, 2011, CELL CYCLE, V10, P655, DOI 10.4161/cc.10.4.14814
   Chen Y, 2009, CELL CYCLE, V8, P257, DOI 10.4161/cc.8.2.7551
   Chew J, 2015, SCIENCE, V348, P1151, DOI 10.1126/science.aaa9344
   Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650
   Cooper-Knock J, 2015, NEUROTHERAPEUTICS, V12, P326, DOI 10.1007/s13311-015-0342-1
   Dekker AM, 2016, NEUROBIOL AGING, V39, DOI 10.1016/j.neurobiolaging.2015.12.012
   Dols-Icardo O, 2015, BRAIN, V138, pE400, DOI 10.1093/brain/awv175
   Fang X, 2015, ACTA BIOCH BIOPH SIN, V47, P834, DOI 10.1093/abbs/gmv076
   Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250
   Feige E, 2006, BBA-MOL CELL RES, V1763, P272, DOI 10.1016/j.bbamcr.2006.01.009
   Feit H, 1998, AM J HUM GENET, V63, P1732, DOI 10.1086/302166
   Folkmann Andrew W., 2014, Advances in Biological Regulation, V54, P74, DOI 10.1016/j.jbior.2013.10.002
   Folkmann AW, 2013, CELL, V155, P582, DOI 10.1016/j.cell.2013.09.023
   Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000
   Fung TK, 2002, J BIOL CHEM, V277, P35140, DOI 10.1074/jbc.M205503200
   Gallego-Iradi MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142144
   Genin EC, 2016, EMBO MOL MED, V8, P58, DOI 10.15252/emmm.201505496
   Gijselinck I, 2015, NEUROLOGY, V85, P2116, DOI 10.1212/WNL.0000000000002220
   Haeusler AR, 2016, NAT REV NEUROSCI, V17, P383, DOI 10.1038/nrn.2016.38
   Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016
   Jiang J, 2016, NEURON, V90, P535, DOI 10.1016/j.neuron.2016.04.006
   Jiao B, 2016, BRAIN, V139, DOI 10.1093/brain/awv367
   Johnson JO, 2014, BRAIN, V137, DOI 10.1093/brain/awu265
   Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688
   Joyce PI, 2015, HUM MOL GENET, V24, P1883, DOI 10.1093/hmg/ddu605
   Kaneb HM, 2015, HUM MOL GENET, V24, P1363, DOI 10.1093/hmg/ddu545
   Kendirgi F, 2005, MOL BIOL CELL, V16, P4304, DOI 10.1091/mbc.E04-11-0998
   Kurzwelly D, 2015, BRAIN, V138, DOI 10.1093/brain/awv014
   Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917
   Lattante S, 2014, NEUROLOGY, V83, P990, DOI 10.1212/WNL.0000000000000778
   Le Ber I, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.08.009
   Leblond CS, 2016, NEUROBIOL AGING, V37, DOI 10.1016/j.neurobiolaging.2015.09.013
   Li XL, 2016, AMYOTROPH LAT SCL FR, V17, P458, DOI 10.3109/21678421.2016.1170151
   Lin KP, 2015, NEUROBIOL AGING, V36, P2005, DOI 10.1016/j.neurobiolaging.2015.02.008
   Ling JP, 2015, SCIENCE, V349, P650, DOI 10.1126/science.aab0983
   Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107
   Liu YJ, 2016, NEURON, V90, P521, DOI 10.1016/j.neuron.2016.04.005
   Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971
   Matsumoto G, 2015, HUM MOL GENET, V24, P4429, DOI 10.1093/hmg/ddv179
   Millecamps S, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.07.016
   Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015
   Movsesyan V, 1996, EXP CELL RES, V227, P203, DOI 10.1006/excr.1996.0268
   Müller K, 2014, BRAIN, V137, DOI 10.1093/brain/awu227
   Müller TJ, 2014, ANN NEUROL, V76, P669, DOI 10.1002/ana.24255
   Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030
   Nousiainen HO, 2008, NAT GENET, V40, P155, DOI 10.1038/ng.2007.65
   O'Rourke JG, 2016, SCIENCE, V351, P1324, DOI 10.1126/science.aaf1064
   O'Rourke JG, 2015, NEURON, V88, P892, DOI 10.1016/j.neuron.2015.10.027
   Özoguz A, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.12.032
   Pasanen P, 2016, ACTA NEUROL SCAND, V133, P361, DOI 10.1111/ane.12470
   Pelegrini AL, 2010, MUTAGENESIS, V25, P447, DOI 10.1093/mutage/geq026
   Peters OM, 2015, NEURON, V88, P902, DOI 10.1016/j.neuron.2015.11.018
   Pottier C, 2015, ACTA NEUROPATHOL, V130, P77, DOI 10.1007/s00401-015-1436-x
   Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200
   Richter B, 2016, P NATL ACAD SCI USA, V113, P4039, DOI 10.1073/pnas.1523926113
   Ronchi D, 2015, BRAIN, V138, pE372, DOI 10.1093/brain/awu384
   Senderek J, 2009, AM J HUM GENET, V84, P511, DOI 10.1016/j.ajhg.2009.03.006
   Smith BN, 2014, NEURON, V84, P324, DOI 10.1016/j.neuron.2014.09.027
   Sreedharan J, 2015, CURR BIOL, V25, P2130, DOI 10.1016/j.cub.2015.06.045
   Sudria-Lopez E, 2016, ACTA NEUROPATHOL, V132, P145, DOI 10.1007/s00401-016-1581-x
   Sullivan PM, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0324-5
   Teyssou E, 2016, NEUROBIOL AGING, V42, DOI 10.1016/j.neurobiolaging.2016.03.022
   Tsai PC, 2016, NEUROBIOL AGING, V40, DOI 10.1016/j.neurobiolaging.2015.12.022
   Van Blitterswijk M, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.04.016
   Williams KL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11253
   Williams KL, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.08.013
   Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040
   Xiao SX, 2015, ANN NEUROL, V78, P568, DOI 10.1002/ana.24469
NR 85
TC 29
Z9 34
U1 0
U2 47
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1350-7540
EI 1473-6551
J9 CURR OPIN NEUROL
JI Curr. Opin. Neurol.
PD OCT
PY 2016
VL 29
IS 5
BP 557
EP 564
DI 10.1097/WCO.0000000000000367
PG 8
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DW9SR
UT WOS:000384003500004
PM 27538057
OA Green Published
DA 2024-11-01
ER

PT J
AU Langdahl, JH
   Frederiksen, AL
   Hansen, SJ
   Andersen, PH
   Yderstræde, KB
   Duno, M
   Vissing, J
   Frost, M
AF Langdahl, Jakob Hogild
   Frederiksen, Anja Lisbeth
   Hansen, Stinus Jorn
   Andersen, Per Heden
   Yderstraede, Knud Bonnet
   Duno, Morten
   Vissing, John
   Frost, Morten
TI Mitochondrial Point Mutation m.3243A&gt;G Associates With Lower Bone
   Mineral Density, Thinner Cortices, and Reduced Bone Strength: A
   Case-Control Study
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Article
DE M.3243A > G; MITOCHONDRIAL; BONE TURNOVER MARKERS; DIABETES; HRPQCT
ID OXIDATIVE STRESS; DIABETES-MELLITUS; A3243G MUTATION; BODY-WEIGHT; DNA;
   WOMEN; MICROARCHITECTURE; MEN; DYSFUNCTION; PREVALENCE
AB Mitochondrial dysfunction is associated with several clinical manifestations including diabetes mellitus (DM), neurological disorders, renal and hepatic diseases, and myopathy. Although mitochondrial dysfunction is associated with increased bone resorption and decreased bone formation in mouse models, effects of alterations in mitochondrial function on bone remodeling and mass have not been investigated in humans. We recruited 45 carriers (29 females, 16 males) with the m.3243A>G mutation and healthy controls matched for gender, age, height, and menopausal status. DXA and HRpQCT scans were performed, and bone turnover markers (BTMs) P1NP and CTX were measured. Cases and controls were well matched except for body weight, which was lower in cases (63.6 +/- 18.1kg versus 74.6 +/- 14.8kg, p<0.01), and manifest DM was present in 25 of 45 cases (none in controls). Bone scans showed lower BMD at the lumbar spine, total hip, and femoral neck in cases. Mean lumbar spine, total hip, and femoral neck T-scores were -1.5, -1.3, and -1.6 in cases, respectively, and -0.8, -0.3, and -0.7 in controls (all p<0.05). The m.3243A>G mutation was associated with lower BMD, cortical but not trabecular density, cortical thickness, and estimated bone strength. Furthermore, BTMs were lower in the m.3243A>G group before but not after adjustment for DM. The mitochondrial point mutation m.3243A>G was associated with decreased bone mass and strength. Although the coexistence of DM may have influenced bone turnover, the bone phenotype observed in m.3243A>G cases appeared to mirror age-related deterioration in bone, suggesting that mitochondrial dysfunction may cause a premature aging of bone. (C) 2017 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.
C1 [Langdahl, Jakob Hogild; Frederiksen, Anja Lisbeth] Odense Univ Hosp, Dept Clin Genet, Odense, Denmark.
   [Langdahl, Jakob Hogild; Frederiksen, Anja Lisbeth; Hansen, Stinus Jorn] Univ Southern Denmark, Inst Clin Res, Odense, Denmark.
   [Langdahl, Jakob Hogild; Andersen, Per Heden] Hosp Southwest Jutland, Dept Endocrinol, Esbjerg, Denmark.
   [Hansen, Stinus Jorn; Yderstraede, Knud Bonnet; Frost, Morten] Odense Univ Hosp, Dept Endocrinol, Sdr Blvd 29, DK-5000 Odense C, Denmark.
   [Duno, Morten] Rigshosp, Dept Clin Genet, Copenhagen, Denmark.
   [Vissing, John] Rigshosp, Dept Neurol, Copenhagen Neuromuscular Ctr, Copenhagen, Denmark.
C3 University of Southern Denmark; Odense University Hospital; University
   of Southern Denmark; University of Southern Denmark; Odense University
   Hospital; University of Copenhagen; Rigshospitalet; Rigshospitalet;
   University of Copenhagen
RP Frost, M (corresponding author), Odense Univ Hosp, Dept Endocrinol, Sdr Blvd 29, DK-5000 Odense C, Denmark.
EM frostnielsen@yahoo.com
RI Vissing, John/IUN-4271-2023; Frederiksen, Anja/AAF-1983-2019;
   /G-9410-2011; Hansen, Stinus/F-8240-2016
OI /0000-0002-5608-1589; Frederiksen, Anja Lisbeth/0000-0002-7944-8910;
   Hansen, Stinus/0000-0001-9486-0316; Yderstraede,
   Knud/0000-0002-4411-3598; Langdahl, Jakob Hogild/0000-0003-1601-3132
FU Region of Southern Denmark; A.P. Moeller and Chastine Mc-Kinney Moeller
   Foundation; Karola Joergensen Research Foundation; Danish Council for
   Independent Research
FX This research project was supported by grants from Region of Southern
   Denmark, The A.P. Moeller and Chastine Mc-Kinney Moeller Foundation for
   General Purposes, and The Karola Joergensen Research Foundation. MF was
   supported by grants from the Danish Council for Independent Research and
   The Region of Southern Denmark. The authors thank Lotte Hoerlyck for
   excellent technical assistance.
CR Abate EG, 2017, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00172
   Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Altindag O, 2008, RHEUMATOL INT, V28, P317, DOI 10.1007/s00296-007-0452-0
   Apabhai S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022294
   Bartell SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4773
   Bhattacharyya A, 1998, QJM-MON J ASSOC PHYS, V91, P375
   Burnstock G, 2013, PURINERG SIGNAL, V9, P541, DOI 10.1007/s11302-013-9381-4
   Cervellati C, 2013, CLIN CHEM LAB MED, V51, P333, DOI 10.1515/cclm-2012-0095
   DAWSONHUGHES B, 1987, CALCIFIED TISSUE INT, V40, P310, DOI 10.1007/BF02556691
   Evans AL, 2015, J BONE MINER RES, V30, P920, DOI 10.1002/jbmr.2407
   FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507
   Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339
   Frederiksen AL, 2009, J CLIN ENDOCR METAB, V94, P2872, DOI 10.1210/jc.2009-0235
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Hansen S, 2014, CALCIFIED TISSUE INT, V94, P269, DOI 10.1007/s00223-013-9808-5
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   Hoxha Rexhep, 2014, Mater Sociomed, V26, P306, DOI 10.5455/msm.2014.26.306-308
   Kobayashi K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09148
   Larson CM, 2000, J PEDIATR ORTHOPED, V20, P71, DOI 10.1097/00004694-200001000-00016
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024
   McKay H, 2011, ACTA PAEDIATR, V100, P97, DOI 10.1111/j.1651-2227.2010.01995.x
   Miyazaki T, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.385369
   Napoli N, 2017, NAT REV ENDOCRINOL, V13, P208, DOI 10.1038/nrendo.2016.153
   Pang CY, 2001, DIABETES RES CLIN PR, V54, pS45, DOI 10.1016/S0168-8227(01)00335-7
   Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022
   Rumney RMH, 2012, J BIOMECH, V45, P549, DOI 10.1016/j.jbiomech.2011.11.036
   Rumney Robin M H, 2012, Front Endocrinol (Lausanne), V3, P116, DOI 10.3389/fendo.2012.00116
   Saraví FD, 2013, J OSTEOPOROS, V2013, DOI 10.1155/2013/953271
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   Shanbhogue VV, 2016, J BONE MINER RES, V31, P1541, DOI 10.1002/jbmr.2817
   Shanbhogue VV, 2016, LANCET DIABETES ENDO, V4, P159, DOI 10.1016/S2213-8587(15)00283-1
   Shanbhogue VV, 2015, J BONE MINER RES, V30, P2188, DOI 10.1002/jbmr.2573
   Shigemoto M, 1998, INTERNAL MED, V37, P265, DOI 10.2169/internalmedicine.37.265
   Sornay-Rendu E, 2013, J BONE MINER RES, V28, P1679, DOI 10.1002/jbmr.1880
   Tanaka K, 2000, INTERNAL MED, V39, P249, DOI 10.2169/internalmedicine.39.249
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   van den Berg LEM, 2010, BONE, V47, P643, DOI 10.1016/j.bone.2010.06.021
   Varanasi SS, 1999, OSTEOPOROSIS INT, V10, P143, DOI 10.1007/s001980050209
   Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4
NR 41
TC 12
Z9 14
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-0431
EI 1523-4681
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD OCT
PY 2017
VL 32
IS 10
BP 2041
EP 2048
DI 10.1002/jbmr.3193
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA FJ7HH
UT WOS:000412927400009
PM 28603900
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Compagnoni, GM
   Di Fonzo, A
   Corti, S
   Comi, GP
   Bresolin, N
   Masliah, E
AF Compagnoni, Giacomo Monzio
   Di Fonzo, Alessio
   Corti, Stefania
   Comi, Giacomo P.
   Bresolin, Nereo
   Masliah, Eliezer
TI The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from
   Alzheimer's Disease and Parkinson's Disease
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Neurodegeneration; Mitochondria; Alzheimer's disease; Parkinson's
   disease; Pathogenesis
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MULTIPLE SYSTEM ATROPHY;
   DNA-POLYMERASE-GAMMA; AMYLOID PRECURSOR PROTEIN; CYTOCHROME-C-OXIDASE;
   POSITRON EMISSION TOMOGRAPHY; RESPIRATORY-CHAIN ACTIVITY;
   ELECTRON-TRANSPORT CHAIN; MATERNAL FAMILY-HISTORY; COMPLEX-I DEFICIENCY
AB Although the pathogenesis of neurodegenerative diseases is still widely unclear, various mechanisms have been proposed and several pieces of evidence are supportive for an important role of mitochondrial dysfunction. The present review provides a comprehensive and up-to-date overview about the role of mitochondria in the two most common neurodegenerative disorders: Alzheimer's disease (AD) and Parkinson's disease (PD). Mitochondrial involvement in AD is supported by clinical features like reduced glucose and oxygen brain metabolism and by numerous microscopic and molecular findings, including altered mitochondrial morphology, impaired respiratory chain function, and altered mitochondrial DNA. Furthermore, amyloid pathology and mitochondrial dysfunction seem to be bi-directionally correlated. Mitochondria have an even more remarkable role in PD. Several hints show that respiratory chain activity, in particular complex I, is impaired in the disease. Mitochondrial DNA alterations, involving deletions, point mutations, depletion, and altered maintenance, have been described. Mutations in genes directly implicated in mitochondrial functioning (like Parkin and PINK1) are responsible for rare genetic forms of the disease. A close connection between alpha-synuclein accumulation and mitochondrial dysfunction has been observed. Finally, mitochondria are involved also in atypical parkinsonisms, in particular multiple system atrophy. The available knowledge is still not sufficient to clearly state whether mitochondrial dysfunction plays a primary role in the very initial stages of these diseases or is secondary to other phenomena. However, the presented data strongly support the hypothesis that whatever the initial cause of neurodegeneration is, mitochondrial impairment has a critical role in maintaining and fostering the neurodegenerative process.
C1 [Compagnoni, Giacomo Monzio; Di Fonzo, Alessio; Corti, Stefania; Comi, Giacomo P.; Bresolin, Nereo] IRCCS Fdn Ca Granda Osped Maggiore Policlin, Milan, Italy.
   [Compagnoni, Giacomo Monzio] Univ Milano Bicocca, Sch Med & Surg, Dept Neurol, Monza, Italy.
   [Compagnoni, Giacomo Monzio] Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Khurana Lab, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.
   [Compagnoni, Giacomo Monzio] Harvard Med Sch, Boston, MA 02115 USA.
   [Corti, Stefania; Comi, Giacomo P.; Bresolin, Nereo] Univ Milan, Dino Ferrari Ctr, Neurosci Sect, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Masliah, Eliezer] NIA, Div Neurosci, NIH, Bethesda, MD 20892 USA.
   [Masliah, Eliezer] NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; University of
   Milano-Bicocca; Harvard University; Brigham & Women's Hospital; Harvard
   University; Harvard Medical School; University of Milan; National
   Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA);
   National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA)
RP Compagnoni, GM (corresponding author), IRCCS Fdn Ca Granda Osped Maggiore Policlin, Milan, Italy.; Compagnoni, GM (corresponding author), Univ Milano Bicocca, Sch Med & Surg, Dept Neurol, Monza, Italy.; Compagnoni, GM (corresponding author), Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Khurana Lab, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.; Compagnoni, GM (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.
EM gmonziocompagnoni@bwh.harvard.edu
RI Corti, Stefania/K-6034-2016; Di Fonzo, Alessio/A-5702-2013; Comi,
   Giacomo/K-5702-2016
OI Di Fonzo, Alessio/0000-0001-6478-026X
FU Fresco Institute for Parkinson's and Movement Disorders; National
   Institute on Aging [ZIAAG000936] Funding Source: NIH RePORTER
FX The financial support was received from the Fresco Institute for
   Parkinson's and Movement Disorders.
CR Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030
   Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   Balafkan N, 2012, MITOCHONDRION, V12, P640, DOI 10.1016/j.mito.2012.08.004
   Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Baloyannis SJ, 2006, J ALZHEIMERS DIS, V9, P119
   Banerjee K, 2010, FEBS LETT, V584, P1571, DOI 10.1016/j.febslet.2010.03.012
   Barca E, 2016, J NEUROPATH EXP NEUR, V75, P663, DOI 10.1093/jnen/nlw037
   Beal MF, 2014, JAMA NEUROL, V71, P543, DOI 10.1001/jamaneurol.2014.131
   Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550
   Beck JS, 2016, CURR ALZHEIMER RES, V13, P610, DOI 10.2174/1567205013666151221145445
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062277
   Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004
   Bentley SR, 2014, MITOCHONDRION, V15, P65, DOI 10.1016/j.mito.2014.01.004
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546
   Canevari L, 1999, FEBS LETT, V457, P131, DOI 10.1016/S0014-5793(99)01028-5
   Cannon JR, 2013, EXP NEUROL, V240, P44, DOI 10.1016/j.expneurol.2012.11.007
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Cardoso SM, 2004, NEUROBIOL AGING, V25, P105, DOI 10.1016/S0197-4580(03)00033-2
   Cardoso SM, 2001, FASEB J, V15, P1439, DOI 10.1096/fj.00-0561fje
   Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje
   Cenini G, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00902
   Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K
   Champy P, 2004, J NEUROCHEM, V88, P63, DOI 10.1046/j.1471-4159.2003.02138.x
   Chang SW, 2000, BIOCHEM BIOPH RES CO, V273, P203, DOI 10.1006/bbrc.2000.2885
   Charan RA, 2015, MOL CELL NEUROSCI, V66, P62, DOI 10.1016/j.mcn.2015.02.008
   Chen JX, 2010, J ALZHEIMERS DIS, V20, pS569, DOI 10.3233/JAD-2010-100357
   Cheng Y, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00163
   Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061
   Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Collier TJ, 2011, NAT REV NEUROSCI, V12, P359, DOI 10.1038/nrn3039
   Compagnoni GM, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0730-6
   Compagnoni GM, 2018, STEM CELL REP, V11, P1185, DOI 10.1016/j.stemcr.2018.09.007
   Compagnoni GM, 2018, BBA-MOL BASIS DIS, V1864, P3588, DOI 10.1016/j.bbadis.2018.09.018
   Compta Y, 2018, PARKINSONISM RELAT D, V46, P16, DOI 10.1016/j.parkreldis.2017.10.010
   Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Coskun PE, 2010, J ALZHEIMERS DIS, V20, pS293, DOI 10.3233/JAD-2010-100351
   Coxhead J, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.036
   Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005
   Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599
   David DC, 2005, J BIOL CHEM, V280, P23802, DOI 10.1074/jbc.M500356200
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   DAVIS GC, 1979, PSYCHIAT RES, V1, P249, DOI 10.1016/0165-1781(79)90006-4
   DELEON MJ, 1983, AM J NEURORADIOL, V4, P568
   Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006
   Di Maio R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3634
   DIDONATO S, 1993, NEUROLOGY, V43, P2262, DOI 10.1212/WNL.43.11.2262
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Dolhun R, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-92
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868
   Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777
   Eckert A, 2014, BBA-MOL BASIS DIS, V1842, P1258, DOI 10.1016/j.bbadis.2013.08.013
   Edland SD, 1996, NEUROLOGY, V47, P254, DOI 10.1212/WNL.47.1.254
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Egensperger R, 1997, NEUROPATH APPL NEURO, V23, P315, DOI 10.1046/j.1365-2990.1997.4098040.x
   Elfawy HA, 2019, LIFE SCI, V218, P165, DOI 10.1016/j.lfs.2018.12.029
   Elson JL, 2006, HUM GENET, V119, P241, DOI 10.1007/s00439-005-0123-8
   Erkkinen MG, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a033118
   Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007
   Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2
   Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007
   Fang EF, 2019, NAT NEUROSCI, V22, P401, DOI 10.1038/s41593-018-0332-9
   FERRIS SH, 1980, NEUROBIOL AGING, V1, P127, DOI 10.1016/0197-4580(80)90005-6
   Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102
   FOSTER NL, 1983, NEUROLOGY, V33, P961, DOI 10.1212/WNL.33.8.961
   Fountaine TM, 2007, J NEUROSCI RES, V85, P351, DOI 10.1002/jnr.21125
   FRACKOWIAK RSJ, 1981, BRAIN, V104, P753, DOI 10.1093/brain/104.4.753
   FRIEDLAND RP, 1983, J COMPUT ASSIST TOMO, V7, P590, DOI 10.1097/00004728-198308000-00003
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104
   FUKUYAMA H, 1994, J NUCL MED, V35, P1
   GABUZDA D, 1994, J BIOL CHEM, V269, P13623
   García-Lozano JR, 2002, EUR NEUROL, V48, P34, DOI 10.1159/000064955
   Gasparini L, 1997, NEUROSCI LETT, V231, P113, DOI 10.1016/S0304-3940(97)00536-3
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Giannoccaro MP, 2017, MOVEMENT DISORD, V32, P346, DOI 10.1002/mds.26966
   GIBSON GE, 1988, ARCH NEUROL-CHICAGO, V45, P836, DOI 10.1001/archneur.1988.00520320022009
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   Gu M, 1997, MOVEMENT DISORD, V12, P418, DOI 10.1002/mds.870120323
   Guardia-Laguarta C, 2014, J NEUROSCI, V34, P249, DOI 10.1523/JNEUROSCI.2507-13.2014
   Guardia-Laguarta C, 2015, MOVEMENT DISORD, V30, P1026, DOI 10.1002/mds.26239
   Gui YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050086
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Hamblet NS, 1997, MUTAT RES-FUND MOL M, V379, P253, DOI 10.1016/S0027-5107(97)00158-9
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409
   HEIKKILA RE, 1984, SCIENCE, V224, P1451, DOI 10.1126/science.6610213
   Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001
   Höglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x
   Höglinger GU, 2003, J NEUROCHEM, V84, P491, DOI 10.1046/j.1471-4159.2003.01533.x
   Honea RA, 2010, NEUROLOGY, V74, P113, DOI 10.1212/WNL.0b013e3181c918cb
   Hudson G, 2012, NEUROLOGY, V78, P1038, DOI 10.1212/WNL.0b013e31824e8f1d
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Imaizumi Y, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-35
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Ishii K, 1996, J NUCL MED, V37, P1159
   JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7
   Jang JY, 2018, J CLIN INVEST, V128, P3662, DOI 10.1172/JCI120842
   JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173
   Jenner P, 2001, TRENDS NEUROSCI, V24, P245, DOI 10.1016/S0166-2236(00)01789-6
   Jeon BS, 2014, NEW ENGL J MED, V371, P80, DOI 10.1056/NEJMc1311763
   Jiang HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1669
   Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223
   Kapsa RMI, 1996, J NEUROL SCI, V144, P204, DOI 10.1016/S0022-510X(96)00247-X
   Kasai T, 2016, PLOS ONE, V11, P1
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Kerr JS, 2017, TRENDS NEUROSCI, V40, P151, DOI 10.1016/j.tins.2017.01.002
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Khan SM, 2000, ANN NEUROL, V48, P148, DOI 10.1002/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7
   Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018
   Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004
   Kosel S, 1998, NEUROGENETICS, V1, P197, DOI 10.1007/s100480050029
   Kösel S, 2000, NEUROGENETICS, V2, P227
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612
   Krüger J, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-8
   Krüger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukreja L, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-16
   Lakatos A, 2010, NEUROBIOL AGING, V31, P1355, DOI 10.1016/j.neurobiolaging.2010.04.031
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406
   LESTIENNE P, 1990, J NEUROCHEM, V55, P1810, DOI 10.1111/j.1471-4159.1990.tb04973.x
   Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085815
   Li XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep24756
   Lin CH, 2015, MOVEMENT DISORD, V30, P436, DOI 10.1002/mds.26138
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Liu GW, 2009, NEUROSCI LETT, V454, P187, DOI 10.1016/j.neulet.2009.02.056
   Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051
   Ludtmann MHR, 2016, J NEUROSCI, V36, P10510, DOI 10.1523/JNEUROSCI.1659-16.2016
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230
   Luth ES, 2014, J BIOL CHEM, V289, P21490, DOI 10.1074/jbc.M113.545749
   Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774
   Mancuso M, 2007, NEUROL SCI, V28, P142, DOI 10.1007/s10072-007-0807-z
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Manczak M, 2012, HUM MOL GENET, V21, P2538, DOI 10.1093/hmg/dds072
   Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   MANN VM, 1994, ANN NEUROL, V36, P876, DOI 10.1002/ana.410360612
   MANN VM, 1992, FEBS LETT, V299, P218, DOI 10.1016/0014-5793(92)80118-Z
   Martin MA, 1996, NEUROLOGY, V46, P1343, DOI 10.1212/WNL.46.5.1343
   Martín-Maestro P, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00291
   Maruszak A, 2009, NEUROBIOL AGING, V30, P1749, DOI 10.1016/j.neurobiolaging.2008.01.004
   Masters CL, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.56
   Mawrin C, 2004, NEUROSCI LETT, V357, P111, DOI 10.1016/j.neulet.2003.11.073
   Melberg A, 2005, ACTA NEUROPATHOL, V110, P315, DOI 10.1007/s00401-005-1047-z
   Meredith GE, 2011, J PARKINSON DIS, V1, P19, DOI 10.3233/JPD-2011-11023
   Miguel R, 2014, CLIN NEUROL NEUROSUR, V126, P47, DOI 10.1016/j.clineuro.2014.08.020
   Mitsui J, 2016, JAMA NEUROL, V73, P977, DOI 10.1001/jamaneurol.2016.1325
   Mitsui J, 2013, NEW ENGL J MED, V369, P233, DOI 10.1056/NEJMoa1212115
   MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8
   Mosconi L, 2007, P NATL ACAD SCI USA, V104, P19067, DOI 10.1073/pnas.0705036104
   Mosconi L, 2010, P NATL ACAD SCI USA, V107, P5949, DOI 10.1073/pnas.0914141107
   Müftüoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695
   Nakamoto FK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32573-1
   Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538
   Nguyen TN, 2016, TRENDS CELL BIOL, V26, P733, DOI 10.1016/j.tcb.2016.05.008
   NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8
   Nieto M, 2006, NEUROBIOL AGING, V27, P848, DOI 10.1016/j.neurobiolaging.2005.04.010
   Ogaki K, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-44
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Ordonez DG, 2018, NEURON, V97, P108, DOI 10.1016/j.neuron.2017.11.036
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P483, DOI 10.1016/0006-291X(90)90698-M
   Pacelli C, 2015, CURR BIOL, V25, P2349, DOI 10.1016/j.cub.2015.07.050
   Pagani MR, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/497080
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Parihar MS, 2008, CELL MOL LIFE SCI, V65, P1272, DOI 10.1007/s00018-008-7589-1
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302
   Pereira C, 1998, NEUROREPORT, V9, P1749, DOI 10.1097/00001756-199806010-00015
   PERRY EK, 1980, NEUROSCI LETT, V18, P105, DOI 10.1016/0304-3940(80)90220-7
   Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955
   Poewe W, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.13
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Porras G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009308
   Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010
   Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033
   Pyle A, 2015, ANN NEUROL, V78, P1000, DOI 10.1002/ana.24515
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Quinzii CM, 2011, BIOFACTORS, V37, P361, DOI 10.1002/biof.155
   Rango M, 2018, GENES-BASEL, V9, DOI 10.3390/genes9050250
   Rappold PM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6244
   Reeve AK, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.166
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106
   Rice AC, 2014, J ALZHEIMERS DIS, V40, P319, DOI 10.3233/JAD-131715
   Richter G, 2002, J NEURAL TRANSM, V109, P721, DOI 10.1007/s007020200060
   Ridge PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045134
   Ronchi D, 2016, NEUROBIOL AGING, V45, DOI 10.1016/j.neurobiolaging.2016.05.022
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Santoro A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012037
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x
   SCHAPIRA AHV, 1990, MOVEMENT DISORD, V5, P294, DOI 10.1002/mds.870050406
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1
   Schon EA, 1998, NEUROLOGY, V51, P326, DOI 10.1212/WNL.51.1.326
   Schottlaender LV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149557
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011
   Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741
   Shaltouki A, 2015, STEM CELL REP, V4, P847, DOI 10.1016/j.stemcr.2015.02.019
   Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005
   Sheehan JP, 1997, J NEUROSCI, V17, P4612
   Sherer TB, 2002, J NEUROSCI, V22, P7006
   SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Shokouhi S, 2014, J ALZHEIMERS DIS PAR, V4, P2, DOI [10.4172/2161-0460.1000143, DOI 10.4172/2161-0460.1000143]
   Silva DF, 2013, HUM MOL GENET, V22, P3931, DOI 10.1093/hmg/ddt247
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278
   Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X
   Song LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131281
   SORBI S, 1983, ANN NEUROL, V13, P72, DOI 10.1002/ana.410130116
   Sorrentino V, 2017, NATURE, V552, P187, DOI 10.1038/nature25143
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Stefanova N, 2005, AM J PATHOL, V166, P869, DOI 10.1016/S0002-9440(10)62307-3
   Subramaniam SR, 2014, NEUROBIOL DIS, V70, P204, DOI 10.1016/j.nbd.2014.06.017
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Supnet C, 2010, J ALZHEIMERS DIS, V20, pS487, DOI 10.3233/JAD-2010-100306
   Suzuki S, 2017, BIOCHEM BIOPH RES CO, V483, P88, DOI 10.1016/j.bbrc.2016.12.188
   Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Swerdlow RH, 2018, J ALZHEIMERS DIS, V62, P1403, DOI 10.3233/JAD-170585
   Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, pS265, DOI 10.3233/JAD-2010-100339
   Synofzik M, 2010, MOVEMENT DISORD, V25, P243, DOI 10.1002/mds.22865
   Szabados T, 2004, BEHAV BRAIN RES, V154, P31, DOI 10.1016/j.bbr.2004.01.016
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   Tabata Y, 2018, STEM CELL REP, V11, P1171, DOI 10.1016/j.stemcr.2018.09.006
   Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515
   Tapias V, 2017, CELL MOL LIFE SCI, V74, P2851, DOI 10.1007/s00018-017-2541-x
   Theurey P, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010022
   Thomas B, 2010, MOVEMENT DISORD, V25, pS155, DOI 10.1002/mds.22781
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Tohgi H, 1998, NEURORADIOLOGY, V40, P131, DOI 10.1007/s002340050553
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Ubhi K, 2011, TRENDS NEUROSCI, V34, P581, DOI 10.1016/j.tins.2011.08.003
   Ubhi K, 2009, J NEUROSCI RES, V87, P2728, DOI 10.1002/jnr.22089
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang J, 2016, GENES DIS, V3, P3, DOI 10.1016/j.gendis.2016.01.002
   Wang XL, 2008, AM J PATHOL, V173, P470, DOI 10.2353/ajpath.2008.071208
   Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009
   Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-016-0404-6
   Winkler-Stuck K, 2005, J NEURAL TRANSM, V112, P499, DOI 10.1007/s00702-004-0195-y
   Wragg MA, 1995, NEUROSCI LETT, V201, P107, DOI 10.1016/0304-3940(95)12146-3
   Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105
   Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106
   Ye X, 2015, HUM MOL GENET, V24, P2938, DOI 10.1093/hmg/ddv056
   Ylönen S, 2013, J NEUROL, V260, P3144, DOI 10.1007/s00415-013-7132-7
   YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619
   Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795
   Zhang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep18725
   Zhao QZ, 2016, NEUROL SCI, V37, P423, DOI 10.1007/s10072-015-2414-8
   Zharikov AD, 2015, J CLIN INVEST, V125, P2721, DOI 10.1172/JCI64502
NR 302
TC 194
Z9 206
U1 13
U2 73
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD JUL
PY 2020
VL 57
IS 7
BP 2959
EP 2980
DI 10.1007/s12035-020-01926-1
EA MAY 2020
PG 22
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA MC7MN
UT WOS:000534844900001
PM 32445085
OA Green Accepted
HC Y
HP N
DA 2024-11-01
ER

PT J
AU Pickles, S
   Vigié, P
   Youle, RJ
AF Pickles, Sarah
   Vigie, Pierre
   Youle, Richard J.
TI Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance
SO CURRENT BIOLOGY
LA English
DT Review
ID UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR; DNA DELETIONS;
   AUTOPHAGIC DEGRADATION; PATERNAL MITOCHONDRIA; UBIQUITIN CHAIN;
   SKELETAL-MUSCLE; STRESS-RESPONSE; PARKIN; PINK1
AB The maintenance of a healthy and functional mitochondrial network is critical during development as well as throughout life in the response to physiological adaptations and stress conditions. Owing to their role in energy production, mitochondria are exposed to high levels of reactive oxygen species, making them particularly vulnerable to mitochondrial DNA mutations and protein misfolding. Given that mitochondria are formed from proteins encoded by both nuclear and mitochondrial genomes, an additional layer of complexity is inherent in the coordination of protein synthesis and the mitochondrial import of nuclear-encoded proteins. For these reasons, mitochondria have evolved multiple systems of quality control to ensure that the requisite number of functional mitochondria are present to meet the demands of the cell. These pathways work to eliminate damaged mitochondrial proteins or parts of the mitochondrial network by mitophagy and renew components by adding protein and lipids through biogenesis, collectively resulting in mitochondrial turnover. Mitochondrial quality control mechanisms are multi-tiered, operating at the protein, organelle and cell levels. Herein, we discuss mitophagy in different physiological contexts and then relate it to other quality control pathways, including the unfolded protein response, shedding of vesicles, proteolysis, and degradation by the ubiquitin-proteasome system. Understanding how these pathways contribute to the maintenance of mitochondrial homeostasis could provide insights into the development of targeted treatments when these systems fail in disease.
C1 [Pickles, Sarah; Youle, Richard J.] NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.
   [Vigie, Pierre] CNRS, IBGC, UMR5095, 1 Rue Camille St Saens, F-33000 Bordeaux, France.
   [Vigie, Pierre] Univ Bordeaux, IBGC, UMR5095, 1 Rue Camille St Saens, F-33000 Bordeaux, France.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Neurological Disorders & Stroke (NINDS); Universite de Bordeaux; Centre
   National de la Recherche Scientifique (CNRS); CNRS - National Institute
   for Biology (INSB); Centre National de la Recherche Scientifique (CNRS);
   CNRS - National Institute for Biology (INSB); Universite de Bordeaux
RP Youle, RJ (corresponding author), NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.
EM youle@helix.nih.gov
FU NIH National Institute of Neurological Disorders and Stroke Intramural
   Research Program; Canadian Institutes of Health Research; University of
   Bordeaux; International Doctoral Program of the Idex of Bordeaux; Agence
   Nationale de la Recherche [ANR-10-IDEX-03-02]
FX We apologize to the authors of any key studies that were omitted due to
   space limitations. We would like to thank all members of the Youle
   laboratory for insightful comments and critiques. The Youle laboratory
   is supported by the NIH National Institute of Neurological Disorders and
   Stroke Intramural Research Program. S.P. is supported by the Canadian
   Institutes of Health Research. P.V. is supported by the University of
   Bordeaux, the International Doctoral Program of the Idex of Bordeaux and
   the Agence Nationale de la Recherche (ANR-10-IDEX-03-02).
CR Abeliovich H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3789
   Aerbajinai W, 2003, BLOOD, V102, P712, DOI 10.1182/blood-2002-11-3324
   Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878
   Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874
   Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145
   Aouacheria A, 2005, MOL BIOL EVOL, V22, P2395, DOI 10.1093/molbev/msi234
   Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002
   Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580
   Breton S, 2015, GENOME, V58, P423, DOI 10.1139/gen-2015-0090
   Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082
   Burbulla LF, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.103
   Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106
   Cai X, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023580
   Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Costello MJ, 2013, EXP EYE RES, V116, P141, DOI 10.1016/j.exer.2013.08.017
   Dave KD, 2014, NEUROBIOL DIS, V70, P190, DOI 10.1016/j.nbd.2014.06.009
   Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526
   DeLuca SZ, 2012, DEV CELL, V22, P660, DOI 10.1016/j.devcel.2011.12.021
   Dhar SS, 2008, J BIOL CHEM, V283, P3120, DOI 10.1074/jbc.M707587200
   Dikic I, 2017, ANNU REV BIOCHEM, V86, P193, DOI 10.1146/annurev-biochem-061516-044908
   Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104
   Dzierzak E, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011601
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Eiyama A, 2013, FEBS LETT, V587, P1787, DOI 10.1016/j.febslet.2013.04.030
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002
   Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Hadjivasiliou Z, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1920
   Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110
   Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933
   Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748
   Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016
   Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016
   Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501
   Honda S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5004
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Hughes AL, 2016, ELIFE, V5, DOI 10.7554/eLife.13943
   Ito K, 2016, SCIENCE, V354, P1156, DOI 10.1126/science.aaf5530
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850
   Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3
   Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104
   Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200
   Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014
   Karbowski M, 2011, CURR OPIN CELL BIOL, V23, P476, DOI 10.1016/j.ceb.2011.05.007
   Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384
   Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013
   Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029
   Kim TY, 2012, MOL CELL PROTEOMICS, V11, P1586, DOI 10.1074/mcp.M112.021162
   Kissová I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200
   Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080
   Kondo-Okamoto N, 2012, J BIOL CHEM, V287, P10631, DOI 10.1074/jbc.M111.299917
   Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kumar A, 2017, NAT STRUCT MOL BIOL, V24, P475, DOI 10.1038/nsmb.3400
   Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Luo SM, 2013, P NATL ACAD SCI USA, V110, P13038, DOI 10.1073/pnas.1303231110
   Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024
   Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x
   Matsumoto G, 2015, HUM MOL GENET, V24, P4429, DOI 10.1093/hmg/ddv179
   Matsushima M, 1998, GENE CHROMOSOME CANC, V21, P230, DOI 10.1002/(SICI)1098-2264(199803)21:3<230::AID-GCC7>3.0.CO;2-0
   McLelland GL, 2016, J CELL BIOL, V214, P275, DOI 10.1083/jcb.201603105
   McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902
   McWilliams TG, 2016, J CELL BIOL, V214, P333, DOI 10.1083/jcb.201603039
   Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x
   Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004
   Moore AS, 2016, P NATL ACAD SCI USA, V113, pE3349, DOI 10.1073/pnas.1523810113
   Münch C, 2016, NATURE, V534, P710, DOI 10.1038/nature18302
   Napolitano G, 2016, J CELL SCI, V129, P2475, DOI 10.1242/jcs.146365
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426
   Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Nezich CL, 2015, J CELL BIOL, V210, P435, DOI 10.1083/jcb.201501002
   Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256
   Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013
   Okatsu K, 2015, J CELL BIOL, V209, P111, DOI 10.1083/jcb.201410050
   Okatsu K, 2013, J BIOL CHEM, V288, P36372, DOI 10.1074/jbc.M113.509653
   Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x
   Ongwijitwat S, 2006, GENE, V374, P39, DOI 10.1016/j.gene.2006.01.009
   Onoue K, 2013, J CELL SCI, V126, P176, DOI 10.1242/jcs.111211
   Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850
   Politi Y, 2014, DEV CELL, V29, P305, DOI 10.1016/j.devcel.2014.04.005
   Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697
   Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107
   Pyle A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005040
   Quirós PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Quirós PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984
   Rainbolt TK, 2013, CELL METAB, V18, P908, DOI 10.1016/j.cmet.2013.11.006
   REME CE, 1977, INVEST OPHTH VIS SCI, V16, P815
   Richter B, 2016, P NATL ACAD SCI USA, V113, P4039, DOI 10.1073/pnas.1523926113
   Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982
   Rojansky R, 2016, ELIFE, V5, DOI 10.7554/eLife.17896
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006
   Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043
   Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494
   Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104
   Scott I, 2014, J BIOL CHEM, V289, P2864, DOI 10.1074/jbc.M113.521641
   Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718
   Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Shiba-Fukushima K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004861
   Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8
   Song LY, 2017, NEUROBIOL DIS, V100, P30, DOI 10.1016/j.nbd.2016.12.024
   Song WH, 2016, P NATL ACAD SCI USA, V113, pE5261, DOI 10.1073/pnas.1605844113
   Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057
   Sowter HM, 2001, CANCER RES, V61, P6669
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979
   Stotland A, 2016, J MOL CELL CARDIOL, V90, P53, DOI 10.1016/j.yjmcc.2015.11.032
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Nguyen TN, 2016, J CELL BIOL, V215, P857, DOI 10.1083/jcb.201607039
   Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138
   Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06
   Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tsunemi T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003799
   Valenci I, 2015, MITOCHONDRION, V20, P64, DOI 10.1016/j.mito.2014.11.001
   Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110
   Wang XW, 2015, NATURE, V524, P481, DOI 10.1038/nature14859
   Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879
   Wauer T, 2015, EMBO J, V34, P307, DOI 10.15252/embj.201489847
   Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125
   Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042
   Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405
   Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111
   Wrobel L, 2015, NATURE, V524, P485, DOI 10.1038/nature14951
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748
   Yamano K, 2014, ELIFE, V3, DOI 10.7554/eLife.01612
   Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633
   Yamashita S, 2016, J CELL BIOL, V215, P649, DOI 10.1083/jcb.201605093
   Yang JY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3428
   Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249
   Yun JN, 2014, ELIFE, V3, DOI 10.7554/eLife.01958
   Zhang J, 2012, AUTOPHAGY, V8, P1325, DOI 10.4161/auto.20764
   Zhang J, 2009, AUTOPHAGY, V5, P1064, DOI 10.4161/auto.5.7.9749
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
   Zhou QH, 2016, SCIENCE, V353, P394, DOI 10.1126/science.aaf4777
   Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345
NR 170
TC 1276
Z9 1384
U1 14
U2 289
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD FEB 19
PY 2018
VL 28
IS 4
BP R170
EP R185
DI 10.1016/j.cub.2018.01.004
PG 16
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA FW5SI
UT WOS:000425377900014
PM 29462587
OA Bronze, Green Accepted
HC Y
HP N
DA 2024-11-01
ER

PT J
AU Iommarini, L
   Peralta, S
   Torraco, A
   Diaz, F
AF Iommarini, Luisa
   Peralta, Susana
   Torraco, Alessandra
   Diaz, Francisca
TI Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies
   caused by defects in regulatory factors and other components required
   for mitochondrial function
SO MITOCHONDRION
LA English
DT Review
DE Mitochondrial DNA; Mitochondrial transcription; Mouse models;
   Mitochondrial dynamics; Quality control; Mitochondrial diseases
ID ADENINE-NUCLEOTIDE TRANSLOCATOR; THYMIDINE KINASE 2; DOMINANT OPTIC
   ATROPHY; M-AAA PROTEASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   RESPIRATORY-CHAIN DEFICIENCY; IMPAIRED INSULIN-SECRETION;
   APOPTOSIS-INDUCING FACTOR; MULTIPLE MTDNA DELETIONS; DNA DEPLETION
   SYNDROME
AB Mitochondrial disorders are defined as defects that affect the oxidative phosphotylation system (OXPHOS). They are characterized by a heterogeneous array of clinical presentations due in part to a wide variety of factors required for proper function of the components of the OXPHOS system. There is no cure for these disorders owing to our poor knowledge of the pathogenic mechanisms of disease. To understand the mechanisms of human disease numerous mouse models have been developed in recent years. Here we summarize the features of several mouse models of mitochondrial diseases directly related to those factors affecting mtDNA maintenance, replication, transcription, translation as well as other proteins that are involved in mitochondrial dynamics and quality control which affect mitochondrial OXPHOS function without being intrinsic components of the system. We discuss how these models have contributed to our understanding of mitochondrial diseases and their pathogenic mechanisms. (C) 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Iommarini, Luisa] Univ Bologna, Dept Pharm & Biotechnol FABIT, I-40128 Bologna, Italy.
   [Peralta, Susana; Diaz, Francisca] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Torraco, Alessandra] IRCCS, Bambino Gesu Childrens Hosp, Mol Med Lab, Unit Neuromuscular & Neurodegenerat Disorders, I-00146 Rome, Italy.
C3 University of Bologna; University of Miami; IRCCS Bambino Gesu
RP Diaz, F (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
EM luisa.iommarini2@unibo.it; SPeralta@med.miami.edu;
   alessandra.torraco@opbg.net; fdiaz1@med.miami.edu
RI Torraco, Alessandra/AAA-6212-2020; Iommarini, Luisa/J-2328-2018
OI Iommarini, Luisa/0000-0002-6804-7302; Torraco,
   Alessandra/0000-0002-8148-9295
FU James and Esther King Research Program, Florida Department of Health
   [08KN-01]; National Institute of Health [GM101225]; United Mitochondrial
   Disease Foundation [14050R]
FX We are thankful to Nadee Nissanka for revision of this manuscript. FD
   work has been funded by the James and Esther King Research Program,
   Florida Department of Health (grant 08KN-01), the National Institute of
   Health (grant GM101225) and the United Mitochondrial Disease Foundation
   (grant 14050R).
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003
   Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015
   Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005
   Alavi MV, 2009, EXP NEUROL, V220, P404, DOI 10.1016/j.expneurol.2009.09.026
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Almajan ER, 2012, J CLIN INVEST, V122, P4048, DOI 10.1172/JCI64604
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andersson DC, 2011, ANTIOXID REDOX SIGN, V15, P2455, DOI 10.1089/ars.2011.3915
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   Baughman JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000590
   Bayot A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-112
   Bensch KG, 2009, AM J PHYSIOL-ENDOC M, V296, pE672, DOI 10.1152/ajpendo.90839.2008
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bruni F, 2012, MITOCHONDRION, V12, P492, DOI 10.1016/j.mito.2012.06.010
   Cámara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Cartoni R, 2010, BRAIN, V133, P1460, DOI 10.1093/brain/awq082
   Casalena G, 2014, AM J PHYSIOL-RENAL, V306, pF1372, DOI 10.1152/ajprenal.00608.2013
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003012
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585
   Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276
   Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021
   Clozel M, 1999, EXP GERONTOL, V34, P1007, DOI 10.1016/S0531-5565(99)00074-1
   Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   COPPOCK DL, 1987, MOL CELL BIOL, V7, P2925, DOI 10.1128/MCB.7.8.2925
   Coppola G, 2006, NEUROBIOL DIS, V22, P302, DOI 10.1016/j.nbd.2005.11.014
   Cossée M, 2000, HUM MOL GENET, V9, P1219, DOI 10.1093/hmg/9.8.1219
   Cotney J, 2006, J MOL EVOL, V63, P707, DOI 10.1007/s00239-006-0075-1
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Debray FG, 2011, J MED GENET, V48, P183, DOI 10.1136/jmg.2010.081976
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Detmer SA, 2008, HUM MOL GENET, V17, P367, DOI 10.1093/hmg/ddm314
   Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544
   Di Meo I, 2011, ANTIOXID REDOX SIGN, V15, P353, DOI 10.1089/ars.2010.3520
   Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004
   Dorman DC, 2002, TOXICOL SCI, V65, P18, DOI 10.1093/toxsci/65.1.18
   DUCHEN LW, 1983, J PHYSIOL-LONDON, V345, pP166
   Dufour E, 2008, HUM MOL GENET, V17, P1418, DOI 10.1093/hmg/ddn030
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   ELKOUNI MH, 1993, CANCER RES, V53, P3687
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138
   Fischer F, 2012, TRENDS BIOCHEM SCI, V37, P284, DOI 10.1016/j.tibs.2012.02.004
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, pG914, DOI 10.1152/ajpgi.00402.2011
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Freyer C, 2010, NUCLEIC ACIDS RES, V38, P6577, DOI 10.1093/nar/gkq527
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gall JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031074
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Gispert S, 2013, HUM MOL GENET, V22, P4871, DOI 10.1093/hmg/ddt338
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112
   Guillet V, 2011, FASEB J, V25, P1618, DOI 10.1096/fj.10-173609
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Haraguchi M, 2002, MOL CELL BIOL, V22, P5212, DOI 10.1128/MCB.22.14.5212-5221.2002
   HARDING AE, 1993, SEMIN NEUROL, V13, P333, DOI 10.1055/s-2008-1041143
   Harmel J, 2013, J BIOL CHEM, V288, P15510, DOI 10.1074/jbc.M113.471649
   He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400
   Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Hoppins S, 2014, CURR OPIN CELL BIOL, V29, P46, DOI 10.1016/j.ceb.2014.03.005
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   Jenkinson EM, 2013, AM J HUM GENET, V92, P605, DOI 10.1016/j.ajhg.2013.02.013
   Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052
   Joseph AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069327
   Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Kang S, 2013, CELL DEATH DIFFER, V20, P259, DOI 10.1038/cdd.2012.117
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   Kasashima K, 2008, EXP CELL RES, V314, P988, DOI 10.1016/j.yexcr.2008.01.005
   Käser M, 2003, J BIOL CHEM, V278, P46414, DOI 10.1074/jbc.M305584200
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034
   Ko KS, 2010, HEPATOLOGY, V52, P2096, DOI 10.1002/hep.23919
   Koeck T, 2011, CELL METAB, V13, P80, DOI 10.1016/j.cmet.2010.12.007
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Kondadi AK, 2014, EMBO J, V33, P1011, DOI 10.1002/embj.201387009
   Kong YXG, 2011, AGING CELL, V10, P572, DOI 10.1111/j.1474-9726.2011.00690.x
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kühl I, 2014, NATURE, V514, pE7, DOI 10.1038/nature13690
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lamperti C, 2009, Acta Myol, V28, P2
   Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lee J, 2009, BBA-BIOENERGETICS, V1787, P364, DOI 10.1016/j.bbabio.2009.01.014
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   LI K, 1989, J BIOL CHEM, V264, P13998
   Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Maltecca F, 2008, J NEUROSCI, V28, P2827, DOI 10.1523/JNEUROSCI.4677-07.2008
   Maltecca F, 2009, J NEUROSCI, V29, P9244, DOI 10.1523/JNEUROSCI.1532-09.2009
   Mancuso G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036337
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Manczak M, 2012, BBA-MOL BASIS DIS, V1822, P862, DOI 10.1016/j.bbadis.2012.02.017
   Martelli A, 2007, HUM MOL GENET, V16, P2651, DOI 10.1093/hmg/ddm163
   Martelli A, 2012, DIS MODEL MECH, V5, P860, DOI 10.1242/dmm.009829
   Martinelli P, 2010, BBA-BIOENERGETICS, V1797, P1, DOI 10.1016/j.bbabio.2009.07.013
   Martinelli P, 2009, HUM MOL GENET, V18, P2001, DOI 10.1093/hmg/ddp124
   Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004
   MCCLUNG JK, 1989, BIOCHEM BIOPH RES CO, V164, P1316, DOI 10.1016/0006-291X(89)91813-5
   MERANTE F, 1993, AM J HUM GENET, V53, P481
   Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708
   Merkwirth C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003021
   Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Miranda CJ, 2002, FEBS LETT, V512, P291, DOI 10.1016/S0014-5793(02)02251-2
   Moore BA, 2010, MAMM GENOME, V21, P350, DOI 10.1007/s00335-010-9272-8
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117
   Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Papadimitriou A, 1998, NEUROLOGY, V51, P1086, DOI 10.1212/WNL.51.4.1086
   Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10
   Paredes JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053698
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   PARKER NJ, 1994, GENOMICS, V19, P91, DOI 10.1006/geno.1994.1017
   Peralta S, 2012, BBA-GENE REGUL MECH, V1819, P961, DOI 10.1016/j.bbagrm.2011.11.001
   Perdomini M, 2013, J NEUROCHEM, V126, P65, DOI 10.1111/jnc.12219
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   Phillips MJ, 2010, INVEST OPHTH VIS SCI, V51, P6744, DOI 10.1167/iovs.10-5421
   Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011
   Pickrell AM, 2011, J NEUROSCI, V31, P9895, DOI 10.1523/JNEUROSCI.6223-10.2011
   Pierson TM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002325
   Piquereau J, 2012, CARDIOVASC RES, V94, P408, DOI 10.1093/cvr/cvs117
   Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047
   Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818
   Quirós PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70
   Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI [10.1139/H06-071, 10.1139/h06-071]
   REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025
   Richter-Dennerlein R, 2014, CELL METAB, V20, P158, DOI 10.1016/j.cmet.2014.04.016
   Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107
   Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013
   Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38
   Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Sanz MA, 2003, J BIOL CHEM, V278, P32091, DOI 10.1074/jbc.M304877200
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sarzi E, 2012, BRAIN, V135, P3599, DOI 10.1093/brain/aws303
   Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Sebastián D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109
   Sesaki H, 2014, BBA-MOL BASIS DIS, V1842, P1179, DOI 10.1016/j.bbadis.2013.11.024
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Sharoyko VV, 2014, HUM MOL GENET, V23, P5733, DOI 10.1093/hmg/ddu288
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Simon D, 2004, J NEUROSCI, V24, P1987, DOI 10.1523/JNEUROSCI.4549-03.2004
   Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0
   Song LY, 2012, HUM MOL GENET, V21, P5147, DOI 10.1093/hmg/dds365
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Spinazzola A, 2011, SEMIN FETAL NEONAT M, V16, P190, DOI 10.1016/j.siny.2011.04.011
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Steglich G, 1999, MOL CELL BIOL, V19, P3435
   STEPIEN G, 1992, J BIOL CHEM, V267, P14592
   Sterky FH, 2010, BIOCHEM BIOPH RES CO, V398, P759, DOI 10.1016/j.bbrc.2010.07.019
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Supale S, 2013, DIABETES, V62, P3488, DOI 10.2337/db13-0152
   Takata A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r92
   Terzioglu M, 2013, CELL METAB, V17, P618, DOI 10.1016/j.cmet.2013.03.006
   Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trott A, 2004, EUKARYOT CELL, V3, P620, DOI 10.1128/EC.3.3.620-631.2004
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461
   Valentino ML, 2007, FEBS LETT, V581, P3410, DOI 10.1016/j.febslet.2007.06.042
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016
   Villarroya J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029691
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6
   Wang LY, 2000, BIOCHEM J, V351, P469, DOI 10.1042/0264-6021:3510469
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Wang X, 2013, HUM MOL GENET, V22, P3976, DOI 10.1093/hmg/ddt251
   Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436
   WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3
   Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010
   Williams PA, 2011, VISION RES, V51, P229, DOI 10.1016/j.visres.2010.08.031
   Williams PA, 2012, BRAIN, V135, P493, DOI 10.1093/brain/awr330
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Wortmann SB, 2012, EUR J MED GENET, V55, P552, DOI 10.1016/j.ejmg.2012.06.002
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Xiao X, 2014, AM J PHYSIOL-RENAL, V306, pF1318, DOI 10.1152/ajprenal.00036.2014
   Xu FH, 2012, BIOCHEM J, V441, P275, DOI 10.1042/BJ20110985
   Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469
   Yin H, 2005, INVEST OPHTH VIS SCI, V46, P4555, DOI 10.1167/iovs.05-0695
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Yu-Wai-Man P, 2009, INVEST OPHTH VIS SCI, V50, P4561, DOI 10.1167/iovs.09-3634
   Zhang D, 2005, AM J PHYSIOL-HEART C, V288, pH2476, DOI 10.1152/ajpheart.00670.2004
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
   Zhou XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058843
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   zum Gottesberge AMM, 2005, HISTOCHEM CELL BIOL, V124, P507, DOI 10.1007/s00418-005-0027-7
   zum Gottesberge AMM, 2012, CELL TISSUE RES, V347, P343, DOI 10.1007/s00441-012-1326-7
   zumGottesberge AMM, 1996, EUR ARCH OTO-RHINO-L, V253, P470, DOI 10.1007/BF00179952
NR 255
TC 17
Z9 19
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAY
PY 2015
VL 22
BP 96
EP 118
DI 10.1016/j.mito.2015.01.008
PG 23
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA CJ7YD
UT WOS:000355715400012
PM 25640959
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Tuppen, HAL
   Blakely, EL
   Turnbull, DM
   Taylor, RW
AF Tuppen, Helen A. L.
   Blakely, Emma L.
   Turnbull, Douglass M.
   Taylor, Robert W.
TI Mitochondrial DNA mutations and human disease
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Review
DE mtDNA; Mitochondrial disease; Molecular mechanism; Diagnosis; Treatment
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; RAGGED-RED FIBERS; ANTICODON
   WOBBLE NUCLEOTIDE; TRANSFER-RNA SYNTHETASE; RANDOM GENETIC DRIFT;
   COMPLEX-I; MTDNA MUTATION; PROTEIN-SYNTHESIS; LACTIC-ACIDOSIS;
   OXIDATIVE-PHOSPHORYLATION
AB Mitochondrial disorders are a group of clinically heterogeneous diseases, commonly defined by a lack of cellular energy due to oxidative phosphorylation (OXPHOS) defects. Since the identification of the first human pathological mitochondrial DNA (mtDNA) mutations in 1988, significant efforts have been spent in cataloguing the vast array of causative genetic defects of these disorders. Currently, more than 250 pathogenic mtDNA mutations have been identified. An ever-increasing number of nuclear DNA mutations are also being reported as the majority of proteins involved in mitochondrial metabolism and maintenance are nuclear-encoded. Understanding the phenotypic diversity and elucidating the molecular mechanisms at the basis of these diseases has however proved challenging. Progress has been hampered by the peculiar features of mitochondrial genetics, an inability to manipulate the mitochondrial genome, and difficulties in obtaining suitable models of disease. In this review, we will first outline the unique features of mitochondrial genetics before detailing the diseases and their genetic causes, focusing specifically on primary mtDNA genetic defects. The functional consequences of mtDNA mutations that have been characterised to date will also be discussed, along with current and potential future diagnostic and therapeutic advances. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Tuppen, Helen A. L.; Blakely, Emma L.; Turnbull, Douglass M.; Taylor, Robert W.] Newcastle Univ, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Taylor, RW (corresponding author), Newcastle Univ, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
OI Turnbull, Doug/0000-0002-8878-9901; Tuppen, Helen/0000-0001-8762-0824
FU Wellcome Trust; Muscular Dystrophy Campaign and SPARKS charity; UK
   National Commissioning Group
FX We are grateful to Prof. R.N. Lightowlers for his comments on the
   manuscript, and to the Wellcome Trust, the Muscular Dystrophy Campaign
   and SPARKS charity for their continuing financial support of our work.
   The Mitochondrial Diagnostic Laboratory in Newcastle is funded by the UK
   National Commissioning Group to provide a "Rare Mitochondrial Disease of
   Adults and Children" Service (http://www. mitochondrialncg.nhs.uk/).
CR Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Annunen-Rasila J, 2007, PROTEOMICS, V7, P2189, DOI 10.1002/pmic.200601031
   Arakaki N, 2006, BIOL PHARM BULL, V29, P1962, DOI 10.1248/bpb.29.1962
   Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Baranowska I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000499
   Battersby BJ, 2005, HUM MOL GENET, V14, P2587, DOI 10.1093/hmg/ddi293
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Behan A, 2005, MITOCHONDRION, V5, P173, DOI 10.1016/j.mito.2005.03.002
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bonnefond L, 2008, RNA, V14, P641, DOI 10.1261/rna.938108
   Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2
   Bonnet C, 2008, BBA-MOL CELL RES, V1783, P1707, DOI 10.1016/j.bbamcr.2008.04.018
   Bonnet C, 2007, REJUV RES, V10, P127, DOI 10.1089/rej.2006.0526
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cai W, 2008, J GENET GENOMICS, V35, P649, DOI 10.1016/S1673-8527(08)60086-7
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Cardaioli E, 2008, J NEUROL SCI, V272, P106, DOI 10.1016/j.jns.2008.05.005
   Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Cízková A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-38
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Cortopassi G, 2006, MITOCHONDRION, V6, P161, DOI 10.1016/j.mito.2006.05.002
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   Danielson SR, 2005, BRAIN, V128, P1026, DOI 10.1093/brain/awh447
   Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048
   De Luca C, 2006, GENE, V377, P169, DOI 10.1016/j.gene.2006.04.003
   de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021
   Dean NL, 2003, MOL HUM REPROD, V9, P631, DOI 10.1093/molehr/gag077
   DESJARDINS P, 1985, MOL CELL BIOL, V5, P1163, DOI 10.1128/MCB.5.5.1163
   Dianov GL, 2001, PROG NUCLEIC ACID RE, V68, P285
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   El Meziane A, 1998, NAT GENET, V18, P350
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   FISCHER SG, 1979, CELL, V16, P191, DOI 10.1016/0092-8674(79)90200-9
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200
   Fujita Y, 2007, MITOCHONDRION, V7, P80, DOI 10.1016/j.mito.2006.11.003
   Gardner JL, 2007, BIOSCIENCE REP, V27, P139, DOI 10.1007/s10540-007-9042-3
   Gaucher SP, 2004, J PROTEOME RES, V3, P495, DOI 10.1021/pr034102a
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GREAVES LC, 2009, BIOCH BIOPHYS ACTA
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hakkaart GAJ, 2006, EMBO REP, V7, P341, DOI 10.1038/sj.embor.7400601
   Hammarsund M, 2001, HUM GENET, V109, P542, DOI 10.1007/s00439-001-0610-5
   Hartmann A, 2009, HUM MUTAT, V30, P115, DOI 10.1002/humu.20816
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015
   Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968
   Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   Hino N, 2004, GENES CELLS, V9, P243, DOI 10.1111/j.1356-9597.2004.00718.x
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Jacobs LJAM, 2006, HUM REPROD UPDATE, V12, P119, DOI 10.1093/humupd/dmi042
   Janssen AJM, 2008, ANN NEUROL, V63, P473, DOI 10.1002/ana.21328
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kerscher S, 2004, BBA-BIOENERGETICS, V1659, P197, DOI 10.1016/j.bbabio.2004.07.006
   Khan SM, 2007, AM J PHYSIOL-CELL PH, V292, pC658, DOI 10.1152/ajpcell.00224.2006
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200
   Koene S, 2009, J INTERN MED, V265, P193, DOI 10.1111/j.1365-2796.2008.02058.x
   Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P817, DOI 10.1016/j.bbamcr.2009.02.011
   Kyriakouli DS, 2008, GENE THER, V15, P1017, DOI 10.1038/gt.2008.91
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Levinger L, 2001, NUCLEIC ACIDS RES, V29, P4334, DOI 10.1093/nar/29.21.4334
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   Li J, 2008, GENET MOL RES, V7, P1054, DOI 10.4238/vol7-4gmr480
   LIAO HX, 1991, J BIOL CHEM, V266, P20714
   Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Maceluch Jaros Aw, 2006, Pediatr Endocrinol Rev, V4, P117
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Marella M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001433
   MARGULIS L, 1971, SCI AM, V225, P49
   McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Michikawa Y, 1997, NUCLEIC ACIDS RES, V25, P2455, DOI 10.1093/nar/25.12.2455
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   *MITOMAP, 2009, HUM MIT GEN DAT
   Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106
   Mokranjac D, 2005, BIOCHEM SOC T, V33, P1019, DOI 10.1042/BST0331019
   Möllers M, 2005, NUCLEIC ACIDS RES, V33, P5647, DOI 10.1093/nar/gki876
   Montanari A, 2008, RNA, V14, P275, DOI 10.1261/rna.740108
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   MORAES CT, 1995, MUSCLE NERVE, pS150
   MORAIS R, 1988, IN VITRO CELL DEV B, V24, P649, DOI 10.1007/BF02623602
   Munakata K, 2005, BIOL PSYCHIAT, V57, P525, DOI 10.1016/j.biopsych.2004.11.041
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Nagaike T, 2008, BBA-GENE REGUL MECH, V1779, P266, DOI 10.1016/j.bbagrm.2008.02.001
   Naini A, 2007, METHOD CELL BIOL, V80, P437, DOI 10.1016/S0091-679X(06)80022-1
   Nakada K, 2004, BIOCHEM BIOPH RES CO, V323, P175, DOI 10.1016/j.bbrc.2004.08.073
   Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8
   OBRIEN TW, 1977, INT CELL BIOL
   Oefner P. J., 1995, American Journal of Human Genetics, V57, pA266
   Ojaimi J, 2002, MOL BIOL CELL, V13, P3836, DOI 10.1091/mbc.E02-05-0306
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0
   Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Park H, 2008, RNA, V14, P2407, DOI 10.1261/rna.1208808
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Pozzan T, 2000, CELL CALCIUM, V28, P279, DOI 10.1054/ceca.2000.0166
   Rabilloud T, 2002, BIOCHEMISTRY-US, V41, P144, DOI 10.1021/bi0114776
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013
   Rohou H, 2001, YEAST, V18, P219, DOI 10.1002/1097-0061(200102)18:3<219::AID-YEA651>3.0.CO;2-C
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P5787, DOI 10.1093/nar/gkn576
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147
   Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Roy MD, 2005, RNA, V11, P254, DOI 10.1261/rna.7143305
   Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Santos C, 2008, CURR TOP MED CHEM, V8, P1351, DOI 10.2174/156802608786141151
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SEIBEL P, 1991, J NEUROL SCI, V105, P217, DOI 10.1016/0022-510X(91)90148-Z
   Serero A, 2003, J BIOL CHEM, V278, P52953, DOI 10.1074/jbc.M309770200
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Soleimanpour-Lichaei HR, 2007, MOL CELL, V27, P745, DOI 10.1016/j.molcel.2007.06.031
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015
   Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   Swerdlow RH, 2007, J NEUROSCI RES, V85, P3416, DOI 10.1002/jnr.21167
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Tafrechi RSJ, 2005, MUTAT RES-FUND MOL M, V578, P43, DOI 10.1016/j.mrfmmm.2005.02.002
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Taylor RW, 1996, ANN NEUROL, V40, P459, DOI 10.1002/ana.410400318
   Temperley RJ, 2003, HUM MOL GENET, V12, P2341, DOI 10.1093/hmg/ddg238
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tryoen-Tóth P, 2003, J BIOL CHEM, V278, P24314, DOI 10.1074/jbc.M301530200
   Tuppen HAL, 2008, J MED GENET, V45, P55, DOI 10.1136/jmg.2007.051185
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7
   van den Bosch BJC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e89
   van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397
   Vempati UD, 2008, METHODS, V46, P241, DOI 10.1016/j.ymeth.2008.09.008
   Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339
   VILKKI J, 1990, AM J HUM GENET, V47, P95
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Weber K, 1997, AM J HUM GENET, V60, P373
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   White SL, 1999, PRENATAL DIAG, V19, P1165, DOI 10.1002/(SICI)1097-0223(199912)19:12<1165::AID-PD719>3.3.CO;2-4
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
   Woriax VL, 1995, BBA-GENE STRUCT EXPR, V1264, P347, DOI 10.1016/0167-4781(95)00176-X
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   XIN H, 1995, J BIOL CHEM, V270, P17243, DOI 10.1074/jbc.270.29.17243
   Yagi T, 2001, J BIOENERG BIOMEMBR, V33, P233, DOI 10.1023/A:1010787004053
   Yang JH, 2009, BIOCHEM BIOPH RES CO, V386, P50, DOI 10.1016/j.bbrc.2009.05.127
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   YONEDA M, 1990, BIOCHEM INT, V21, P789
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhang YL, 1998, BBA-GENE STRUCT EXPR, V1443, P245, DOI 10.1016/S0167-4781(98)00223-1
   Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008
   Zhu XY, 2009, ACTA BIOCH BIOPH SIN, V41, P179, DOI 10.1093/abbs/gmn021
NR 256
TC 453
Z9 518
U1 0
U2 75
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 1879-2650
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD FEB
PY 2010
VL 1797
IS 2
BP 113
EP 128
DI 10.1016/j.bbabio.2009.09.005
PG 16
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 556FD
UT WOS:000274574200001
PM 19761752
OA Bronze
DA 2024-11-01
ER

PT J
AU Wong, J
   McLennan, SV
   Molyneaux, L
   Min, D
   Twigg, SM
   Yue, DK
AF Wong, J.
   McLennan, S. V.
   Molyneaux, L.
   Min, D.
   Twigg, S. M.
   Yue, D. K.
TI Mitochondrial DNA content in peripheral blood monocytes: relationship
   with age of diabetes onsetand diabetic complications
SO DIABETOLOGIA
LA English
DT Article
DE Age of onset; Diabetic complications; DNA; Macrophage; Mitochondria;
   Monocyte; Type 2 diabetes
ID OF-ONSET; INSULIN-SECRETION; SKELETAL-MUSCLE; INCREASED RISK; GENE
   VARIATION; NITRIC-OXIDE; MELLITUS; INFLAMMATION; NEPHROPATHY;
   SENSITIVITY
AB We examined whether age of type 2 diabetes onset is related to mitochondrial DNA content in peripheral blood monocytes (PBMCs).
   PBMCs were isolated from 65 patients with type 2 diabetes. To minimise age as a confounder, only patients aged a parts per thousand yen50 years were studied. Sample mitochondrial DNA (mtDNA) content was determined by amplification of the mitochondrial gene CYT-B (also known as MT-CYB) and adjusted for single-copy nuclear control genes (36B4 [also known as RPLPO] and GAPDH).
   Age of diabetes onset ranged from 25 to 69 years. There was a significant positive relationship between age of diabetes onset in quartiles and mtDNA content for the whole group (p = 0.02 for trend). When stratified by the presence of diabetes complications, a strong positive relationship was observed between age of diagnosis and mtDNA content for participants without diabetic complications (r = 0.7; p = 0.0002), but not for those with complications (r = -0.04; p = 0.8). Multivariate analysis confirmed age of onset and complication status as independent determinants. There was co-linearity between age of onset and disease duration, with similar relationships also seen between duration and mtDNA content.
   An earlier age of type 2 diabetes onset is associated with a lower PBMC mtDNA content, but only in patients without diabetes complications. This may reflect a differing biology of PBMC mtDNA in those with early-onset diabetes and those who are prone to complications. PBMC mtDNA depletion may accelerate diabetes onset; however the independent effect of diabetes duration remains to be evaluated.
C1 [Wong, J.; Molyneaux, L.; Twigg, S. M.; Yue, D. K.] Royal Prince Alfred Hosp, Ctr Diabet, Sydney, NSW 2050, Australia.
   [Wong, J.; McLennan, S. V.; Molyneaux, L.; Twigg, S. M.; Yue, D. K.] Univ Sydney, Discipline Med, Sydney, NSW 2006, Australia.
   [Wong, J.; McLennan, S. V.; Min, D.; Twigg, S. M.; Yue, D. K.] Royal Prince Alfred Hosp, Dept Endocrinol, Sydney, NSW 2050, Australia.
C3 NSW Health; Royal Prince Alfred Hospital; University of Sydney;
   University of Sydney; University of Sydney; NSW Health; Royal Prince
   Alfred Hospital
RP Wong, J (corresponding author), Royal Prince Alfred Hosp, Ctr Diabet, Level 6,Missenden Rd, Sydney, NSW 2050, Australia.
EM jencia.wong@email.cs.nsw.gov.au
RI wong, jencia/ABE-4724-2020; Twigg, Stephen/I-7664-2013
OI Min, Danqing/0000-0002-2576-4344
CR Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   [Anonymous], 1991, OPHTHALMOLOGY, V98, P786
   ANTONETTI DA, 1995, J CLIN INVEST, V95, P1383, DOI 10.1172/JCI117790
   Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185
   Baughman JM, 2006, NAT GENET, V38, P1232, DOI 10.1038/ng1106-1232
   Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392
   Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615
   Curran JE, 2007, HUM MOL GENET, V16, P1504, DOI 10.1093/hmg/ddm101
   Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650
   Flavell DM, 2005, DIABETES, V54, P582, DOI 10.2337/diabetes.54.2.582
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gourlain K, 2003, HIV Med, V4, P287, DOI 10.1046/j.1468-1293.2003.00158.x
   Guo Y, 2006, DIABETES, V55, P3625, DOI 10.2337/db06-0379
   Hanson RL, 2007, DIABETES, V56, P3045, DOI 10.2337/db07-0462
   Heine GH, 2008, KIDNEY INT, V73, P622, DOI 10.1038/sj.ki.5002744
   Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561
   Hillier TA, 2003, DIABETES CARE, V26, P2999, DOI 10.2337/diacare.26.11.2999
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Jaakkola U, 2006, EXP CLIN ENDOCR DIAB, V114, P147, DOI 10.1055/s-2006-924079
   Ji LN, 2001, CHINESE MED J-PEKING, V114, P1205
   Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7
   Lehman DM, 2007, DIABETES, V56, P389, DOI 10.2337/db06-0860
   MCGILL M, 1993, DIABETIC MED, V10, P366, DOI 10.1111/j.1464-5491.1993.tb00082.x
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Nisoli E, 2006, J CELL SCI, V119, P2855, DOI 10.1242/jcs.03062
   Ochi M, 2007, DIABETES, V56, P2834, DOI 10.2337/db06-1157
   Oliva R, 2004, ENDOCRINE, V24, P111, DOI 10.1385/ENDO:24:2:111
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Schick BA, 2007, CLIN PHARMACOL THER, V81, P650, DOI 10.1038/sj.clpt.6100124
   SERRADAS P, 1995, ENDOCRINOLOGY, V136, P5623, DOI 10.1210/en.136.12.5623
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Singh R, 2007, DIABETIC MED, V24, P784, DOI 10.1111/j.1464-5491.2007.02164.x
   Song J, 2001, DIABETES CARE, V24, P865, DOI 10.2337/diacare.24.5.865
   Sukhorukov V. S., 2000, Arkhiv Patologii, V62, P19
   Tedesco L, 2008, DIABETES, V57, P2028, DOI 10.2337/db07-1623
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang H, 1999, EUR J APPL PHYSIOL O, V80, P22, DOI 10.1007/s004210050553
   Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057
   Wiltshire S, 2004, DIABETES, V53, P855, DOI 10.2337/diabetes.53.3.855
   Wong J, 2008, DIABETES CARE, V31, P1985, DOI 10.2337/dc08-0580
   YOSHIHARU T, 2008, METAB CLIN EXP, V57, P453
   Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103
   Zeggini E, 2004, DIABETES, V53, P3319, DOI 10.2337/diabetes.53.12.3319
NR 44
TC 46
Z9 48
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD SEP
PY 2009
VL 52
IS 9
BP 1953
EP 1961
DI 10.1007/s00125-009-1424-6
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 480ZN
UT WOS:000268776100030
PM 19629432
OA Bronze
DA 2024-11-01
ER

PT J
AU Bardanzellu, F
   Pintus, MC
   Fanos, V
   Marcialis, MA
AF Bardanzellu, Flaminia
   Pintus, Maria Cristina
   Fanos, Vassilios
   Marcialis, Maria Antonietta
TI Once we were bacteria ... mitochondria to infinity and beyond
SO JOURNAL OF PEDIATRIC AND NEONATAL INDIVIDUALIZED MEDICINE
LA English
DT Review
DE Mitochondria; microbiota; mitobiota; stem cells; tunneling nanotubes
ID DNA MOLECULES; COPY NUMBER; CELL; METHYLATION; HEALTH; LIFE;
   RESTRICTION; REPLICATION; DYSFUNCTION; OBESITY
AB Mitochondria, cytoplasmic organelles originated from endosymbiotic bacteria, can be metaphorically described using "Janus bifrons" image, due to their involvement in life, providing cellular energy and resulting essential even for stem cells, but playing a key role also in cell death. Mitochondria own a maternally inherited genome and are the site of aerobic respiration; they can produce proteins, nucleotides, lipids, steroids and heme and result involved in iron homeostasis. Moreover, mitochondria can generate free radicals, break down waste products and represent the primary source of cellular heat. The size and shape of mitochondria depend on the intracellular metabolic status, from tubular presentation to a blob form in case of irreversible damage. Each mitochondrion carries different sets of DNA; when one set accumulates mutations, it can be replaced by another. It has been widely demonstrated that mitochondrial disorders are involved in many pathologies, including autism, multiple endocrinopathies, diabetes, Alzheimer's disease, ataxia, Barth's syndrome, myopathy, and even aging and cancer. Human population is characterized by different mitochondrial DNA haplogroups reflecting the mutations accumulated and useful to characterize genetic diversity. The mitochondrial role also results relevant in pregnancy, providing information about maternal-fetal dyad in physiological and in pathological conditions. Recent evidence suggests that an intriguing bidirectional inter-talk exists between microbiota and mitochondria, influencing cellular homeostasis and metabolism. A recently demonstrated mitochondrial property is the possibility to be transferred from a donor cell to a recipient cell, through a system of tunneling nanotubes. Recently, a promising integrated approach involving omics sophisticate technologies has been applied in mitochondrial pathophysiology. This is still at an early stage, and further studies will clarify such complex genotype-phenotype relationships. In conclusion, mitochondria are not simple energetic organelles but represent dynamic structures communicating with the cell nucleus and even with other cells, influencing metabolism and their targets' functions. More detailed knowledge of their involvement in disease, even though a combined omics approach, could represent a chance for new therapies.
C1 [Bardanzellu, Flaminia] AOU, Neonatal Pathol & Neonatal Sect, Neonatal Intens Care Unit, Cagliari, Italy.
   [Bardanzellu, Flaminia] Univ Cagliari, Cagliari, Italy.
C3 University of Cagliari
RP Bardanzellu, F (corresponding author), AOU, Neonatal Pathol & Neonatal Sect, Neonatal Intens Care Unit, Cagliari, Italy.; Bardanzellu, F (corresponding author), Univ Cagliari, Cagliari, Italy.
EM bardanzellu.flaminia@virgilio.it
RI Fanos, Vassilios/AHI-0685-2022
CR Ahmad T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.213
   Alexeyev M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012641
   Altmann R., 1890, Die elementarorganismen und ihre beziehungen zu den zellen, P145
   Anelli GM, 2017, J MATERN FETAL NEON, P2388
   [Anonymous], 2018, HUM EVOL
   Austefjord Magnus Wiger, 2014, Commun Integr Biol, V7, pe27934, DOI 10.4161/cib.27934
   Bajpai P, 2018, MITOCHONDRION, V39, P20, DOI 10.1016/j.mito.2017.08.008
   Benda C., 1898, Arch Anat Physiol, V73, P393
   Berridge MV, 2017, CLIN EXP PHARMACOL P, V44, P15, DOI 10.1111/1440-1681.12764
   Blanch M, 2016, AM J PATHOL, V186, P385, DOI 10.1016/j.ajpath.2015.10.004
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Cao X, 2012, MOL MED REP, V6, P426, DOI 10.3892/mmr.2012.913
   Cavelier L, 2000, EXP CELL RES, V259, P79, DOI 10.1006/excr.2000.4949
   Chiaratti MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130631
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   Chrétien D, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003992
   Clark A, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00319
   Colleoni F, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.027
   Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101
   Fattuoni C, 2018, PLACENTA, V61, P89, DOI 10.1016/j.placenta.2017.11.014
   Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947
   Franco-Obregon A, 2017, MSYSTEMS, V9, P2
   Gruber J, 2017, CELL, V169, P1168, DOI 10.1016/j.cell.2017.05.048
   Hastie R, 2014, PLACENTA, V35, P673, DOI 10.1016/j.placenta.2014.06.368
   Hirose M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15377-7
   Hsu YC, 2016, SEMIN CELL DEV BIOL, V52, P119, DOI 10.1016/j.semcdb.2016.02.011
   Ito K, 2016, ANNU REV CELL DEV BI, V32, P399, DOI 10.1146/annurev-cellbio-111315-125134
   Janssen BG, 2015, EPIGENETICS-US, V10, P536, DOI 10.1080/15592294.2015.1048412
   Lamb R, 2015, ONCOTARGET, V6, P4569, DOI 10.18632/oncotarget.3174
   Lane N., 2015, VITAL QUESTION WHY I
   Lee JW, 2010, CLIN CHIM ACTA, V411, P592, DOI 10.1016/j.cca.2010.01.024
   Lee WTY, 2015, ANN NY ACAD SCI, V1350, P95, DOI 10.1111/nyas.12873
   Lees JG, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/2874283
   Lezi E, 2012, ADV EXP MED BIOL, V942, P269, DOI 10.1007/978-94-007-2869-1_12
   Lim YA, 2010, PROTEOMICS, V10, P1621, DOI 10.1002/pmic.200900651
   Ma J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-257
   Mandò C, 2014, AM J PHYSIOL-ENDOC M, V306, pE404, DOI 10.1152/ajpendo.00426.2013
   Mandò C, 2016, STEM CELL TRANSL MED, V5, P451, DOI 10.5966/sctm.2015-0155
   Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270
   Marcialis MA, 2016, J PEDIATR NEONATAL I, V5, DOI 10.7363/050215
   Martijn J, 2018, NATURE, V557, P101, DOI 10.1038/s41586-018-0059-5
   Mayeur S, 2013, AM J PHYSIOL-ENDOC M, V304, pE14, DOI 10.1152/ajpendo.00332.2012
   Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704
   Myatt L, 2016, SEMIN REPROD MED, V34, P42, DOI 10.1055/s-0035-1570027
   NASS S, 1963, J CELL BIOL, V19, P613, DOI 10.1083/jcb.19.3.613
   Novielli C, 2017, PLACENTA, V55, P63, DOI 10.1016/j.placenta.2017.05.008
   O'Rourke B, 2005, PHYSIOLOGY, V20, P303, DOI 10.1152/physiol.00020.2005
   Palmfeldt J, 2017, MITOCHONDRION, V33, P2, DOI 10.1016/j.mito.2016.07.006
   Palmieri L, 2010, BBA-BIOENERGETICS, V1797, P1130, DOI 10.1016/j.bbabio.2010.04.018
   Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Rambold AS, 2018, TRENDS IMMUNOL, V39, P6, DOI 10.1016/j.it.2017.08.006
   Rando OJ, 2015, CELL, V161, P93, DOI 10.1016/j.cell.2015.02.021
   Retzius G., 1890, BIOL UNTERSUCH, V1, P51
   Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Saint-Georges-Chaumet Y, 2015, CELL MOL BIOL, V61, P121
   Saint-Georges-Chaumet Y, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv096
   Sathananthan A H, 2000, Hum Reprod, V15 Suppl 2, P148
   Shahan ST, 2017, ENG APPL SCI THESES, V2017, P228
   SIEKEVITZ P, 1957, SCI AM, V197, P131, DOI 10.1038/scientificamerican0757-131
   Srinivasan S, 2017, BBA-BIOENERGETICS, V1858, P602, DOI 10.1016/j.bbabio.2017.01.004
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914
   Viale A, 2015, CANCER RES, V75, P3687, DOI 10.1158/0008-5472.CAN-15-0491
   Vignais ML, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/6917941
   Vincent AE, 2017, TRENDS CELL BIOL, V27, P797, DOI 10.1016/j.tcb.2017.08.009
   Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002
   Wang Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep07949
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhang HB, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.143420
   Zorov DB, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1017, DOI 10.1134/S0006297914100046
   Zorov DB, 2012, BIOCHEMISTRY-MOSCOW+, V77, P742, DOI 10.1134/S0006297912070073
NR 76
TC 0
Z9 0
U1 0
U2 8
PU HYGEIA PRESS CORRIDORI MARINELLA
PI QUARTU SANT ELENA
PA VIA MONTECATINI 53, QUARTU SANT ELENA, CA09045, ITALY
SN 2281-0692
J9 J PEDIATR NEONATAL I
JI J. Pediatr. Neonatal Individ. Med.
PD APR
PY 2019
VL 8
IS 1
AR e080106
DI 10.7363/080106
PG 13
WC Pediatrics
WE Emerging Sources Citation Index (ESCI)
SC Pediatrics
GA HZ4AT
UT WOS:000468790200021
DA 2024-11-01
ER

PT J
AU Lenaers, G
   Hamel, C
   Delettre, C
   Amati-Bonneau, P
   Procaccio, V
   Bonneau, D
   Reynier, P
   Milea, D
AF Lenaers, Guy
   Hamel, Christian
   Delettre, Cecile
   Amati-Bonneau, Patrizia
   Procaccio, Vincent
   Bonneau, Dominique
   Reynier, Pascal
   Milea, Dan
TI Dominant optic atrophy
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Review
ID MITOCHONDRIAL-DNA INSTABILITY; SENSORINEURAL HEARING-LOSS;
   DYNAMIN-RELATED PROTEIN; RETINAL GANGLION-CELLS; CHROMOSOME 3Q REGION;
   MOUSE MODEL; OPA1 MUTATIONS; MISSENSE MUTATION; GENETIC-HETEROGENEITY;
   CLINICAL-FEATURES
AB Definition of the disease: Dominant Optic Atrophy (DOA) is a neuro-ophthalmic condition characterized by a bilateral degeneration of the optic nerves, causing insidious visual loss, typically starting during the first decade of life. The disease affects primary the retinal ganglion cells (RGC) and their axons forming the optic nerve, which transfer the visual information from the photoreceptors to the lateral geniculus in the brain.
   Epidemiology: The prevalence of the disease varies from 1/10000 in Denmark due to a founder effect, to 1/30000 in the rest of the world.
   Clinical description: DOA patients usually suffer of moderate visual loss, associated with central or paracentral visual field deficits and color vision defects. The severity of the disease is highly variable, the visual acuity ranging from normal to legal blindness. The ophthalmic examination discloses on fundoscopy isolated optic disc pallor or atrophy, related to the RGC death. About 20% of DOA patients harbour extraocular multi-systemic features, including neurosensory hearing loss, or less commonly chronic progressive external ophthalmoplegia, myopathy, peripheral neuropathy, multiple sclerosis-like illness, spastic paraplegia or cataracts.
   Aetiology: Two genes (OPA1, OPA3) encoding inner mitochondrial membrane proteins and three loci (OPA4, OPA5, OPA8) are currently known for DOA. Additional loci and genes (OPA2, OPA6 and OPA7) are responsible for X-linked or recessive optic atrophy. All OPA genes yet identified encode mitochondrial proteins embedded in the inner membrane and ubiquitously expressed, as are the proteins mutated in the Leber Hereditary Optic Neuropathy. OPA1 mutations affect mitochondrial fusion, energy metabolism, control of apoptosis, calcium clearance and maintenance of mitochondrial genome integrity. OPA3 mutations only affect the energy metabolism and the control of apoptosis.
   Diagnosis: Patients are usually diagnosed during their early childhood, because of bilateral, mild, otherwise unexplained visual loss related to optic discs pallor or atrophy, and typically occurring in the context of a family history of DOA. Optical Coherence Tomography further discloses non-specific thinning of retinal nerve fiber layer, but a normal morphology of the photoreceptors layers. Abnormal visual evoked potentials and pattern ERG may also reflect the dysfunction of the RGCs and their axons. Molecular diagnosis is provided by the identification of a mutation in the OPA1 gene (75% of DOA patients) or in the OPA3 gene (1% of patients).
   Prognosis: Visual loss in DOA may progress during puberty until adulthood, with very slow subsequent chronic progression in most of the cases. On the opposite, in DOA patients with associated extra-ocular features, the visual loss may be more severe over time.
   Management: To date, there is no preventative or curative treatment in DOA; severely visually impaired patients may benefit from low vision aids. Genetic counseling is commonly offered and patients are advised to avoid alcohol and tobacco consumption, as well as the use of medications that may interfere with mitochondrial metabolism. Gene and pharmacological therapies for DOA are currently under investigation.
C1 [Lenaers, Guy; Hamel, Christian; Delettre, Cecile] Univ Montpellier I & II, Inst Neurosci Montpellier, U1051, INSERM, F-34091 Montpellier 05, France.
   [Hamel, Christian] Hop Gui De Chauliac, CHRU Montpellier, Ctr Reference Malad Sensorielles Genet, F-34295 Montpellier, France.
   [Amati-Bonneau, Patrizia; Procaccio, Vincent; Bonneau, Dominique; Reynier, Pascal; Milea, Dan] INSERM, U1083, F-49000 Angers, France.
   [Amati-Bonneau, Patrizia; Procaccio, Vincent; Bonneau, Dominique; Reynier, Pascal; Milea, Dan] CNRS 6214, F-49000 Angers, France.
   [Amati-Bonneau, Patrizia; Procaccio, Vincent; Bonneau, Dominique; Reynier, Pascal; Milea, Dan] CHU Angers, F-49000 Angers, France.
   [Milea, Dan] Glostrup Univ Hosp, Copenhagen, Denmark.
C3 Universite de Montpellier; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universite de Montpellier; CHU de
   Montpellier; Institut National de la Sante et de la Recherche Medicale
   (Inserm); Universite d'Angers; Centre National de la Recherche
   Scientifique (CNRS); Universite d'Angers; Centre Hospitalier
   Universitaire d'Angers; University of Copenhagen
RP Lenaers, G (corresponding author), Univ Montpellier I & II, Inst Neurosci Montpellier, U1051, INSERM, BP 74103, F-34091 Montpellier 05, France.
EM guy.lenaers@inserm.fr
RI amati-bonneau, patrizia/K-6198-2015; Procaccio, Vincent/M-2596-2015;
   Milea, Dan/AAT-8661-2021; Reynier, Pascal/K-3677-2015; Lenaers,
   guy/X-4727-2019; Bonneau, Dominique/K-6110-2015; Delettre,
   Cécile/HPH-2003-2023; lenaers, guy/K-2421-2015
OI Bonneau, Dominique/0000-0002-6886-0969; Reynier,
   Pascal/0000-0003-0802-4608; procaccio, Vincent/0000-0002-1537-4684;
   lenaers, guy/0000-0003-2736-3349; Delettre, Cecile/0000-0003-3269-2155
FU INSERM; CNRS, Universite Montpellier I et II, France; University of
   Angers, France; European E-Rare program
FX This work was supported by the INSERM, the CNRS, Universite Montpellier
   I et II, France and the University of Angers, France, and by an European
   E-Rare program.
CR Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005
   Alavi MV, 2009, EXP NEUROL, V220, P404, DOI 10.1016/j.expneurol.2009.09.026
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Almind GJ, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-49
   Alward WLM, 2003, BRIT J OPHTHALMOL, V87, P2, DOI 10.1136/bjo.87.1.2
   Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Amati-Bonneau P, 2003, AM J OPHTHALMOL, V136, P1170, DOI 10.1016/S0002-9394(03)00665-2
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amati-Bonneau P, 2009, INT J BIOCHEM CELL B, V41, P1855, DOI 10.1016/j.biocel.2009.04.012
   Andrews RM, 1999, BRIT J OPHTHALMOL, V83, P231, DOI 10.1136/bjo.83.2.231
   Anikster Y, 2001, AM J HUM GENET, V69, P1218, DOI 10.1086/324651
   Assink JJM, 1997, AM J HUM GENET, V61, P934, DOI 10.1086/514884
   Barbet F, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.025502
   Barbet F, 2003, EUR J HUM GENET, V11, P966, DOI 10.1038/sj.ejhg.5201070
   Barboni P, 2010, OPHTHALMOLOGY, V117, P1547, DOI 10.1016/j.ophtha.2009.12.042
   Barnard AR, 2011, EXP EYE RES, V93, P771, DOI 10.1016/j.exer.2011.07.004
   Barrett TG, 1997, J MED GENET, V34, P838, DOI 10.1136/jmg.34.10.838
   Barrett TG, 1997, EYE, V11, P882, DOI 10.1038/eye.1997.226
   Batten B., 1896, Trans Ophthalmol Soc UK, V16, P125
   BONNEAU D, 1995, J MED GENET, V32, P951, DOI 10.1136/jmg.32.12.951
   Bremner FD, 2001, INVEST OPHTH VIS SCI, V42, P675
   Bristow EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P791
   Carelli V, 2007, BIOSCIENCE REP, V27, P173, DOI 10.1007/s10540-007-9045-0
   Carelli V, 2011, HUM MOL GENET, V20, P1893, DOI 10.1093/hmg/ddr071
   Chevrollier A, 2008, ANN NEUROL, V63, P794, DOI 10.1002/ana.21385
   Cohn AC, 2008, BRIT J OPHTHALMOL, V92, P1333, DOI 10.1136/bjo.2007.134726
   Cornille K, 2008, ANN NEUROL, V63, P667, DOI 10.1002/ana.21376
   Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Dayanithi G, 2010, OPHTHALMIC GENET, V31, P53, DOI 10.3109/13816811003698117
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278
   Eiberg H, 2006, J MED GENET, V43, P435, DOI 10.1136/jmg.2005.034892
   EIBERG H, 1994, HUM MOL GENET, V3, P977, DOI 10.1093/hmg/3.6.977
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Ferré M, 2009, HUM MUTAT, V30, pE692, DOI 10.1002/humu.21025
   Fuhrmann N, 2009, J MED GENET, V46, P136, DOI 10.1136/jmg.2008.062570
   Fuhrmann N, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-25
   Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200
   Griscom J, 1921, AM J OPHTHALMOL, V5, P347
   Hanein S, 2009, AM J HUM GENET, V84, P493, DOI 10.1016/j.ajhg.2009.03.003
   Heiduschka P, 2010, INVEST OPHTH VIS SCI, V51, P1424, DOI 10.1167/iovs.09-3606
   Holder GE, 1998, DOC OPHTHALMOL, V95, P217, DOI 10.1023/A:1001844021014
   Huang TS, 2009, BRAIN RES, V1300, P97, DOI 10.1016/j.brainres.2009.08.083
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177
   Katz BJ, 2006, AM J MED GENET A, V140A, P2207, DOI 10.1002/ajmg.a.31455
   Kerrison JB, 1999, ARCH OPHTHALMOL-CHIC, V117, P805
   Kjer B, 1996, ACTA OPHTHALMOL SCAN, V74, P3
   KJER P, 1959, Acta Ophthalmol Suppl, V164, P1
   Kleta R, 2002, MOL GENET METAB, V76, P201, DOI 10.1016/S1096-7192(02)00047-1
   La Morgia C, 2010, BRAIN, V133, P2426, DOI 10.1093/brain/awq155
   Lenaers G, 2009, INT J BIOCHEM CELL B, V41, P1866, DOI 10.1016/j.biocel.2009.04.013
   Li CM, 2005, AM J MED GENET A, V138A, P208, DOI 10.1002/ajmg.a.30794
   Man CYYW, 2005, MED HYPOTHESES, V65, P1038, DOI 10.1016/j.mehy.2004.10.021
   Marelli C, 2011, BRAIN, V134, DOI 10.1093/brain/awq306
   Milea D, 2010, ACTA OPHTHALMOL, V88, P342, DOI 10.1111/j.1755-3768.2008.01469.x
   Milea D, 2010, CURR OPIN NEUROL, V23, P24, DOI 10.1097/WCO.0b013e3283347b27
   Milone M, 2009, MITOCHONDRION, V9, P279, DOI 10.1016/j.mito.2009.03.001
   Nettleship E, 1909, T OPHTHAL SOC UK, V29, P116
   Nochez Y, 2009, MOL VIS, V15, P598
   Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X
   Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950
   Osborne NN, 2008, J NEUROCHEM, V105, P2013, DOI 10.1111/j.1471-4159.2008.05320.x
   Payne M, 2004, AM J OPHTHALMOL, V138, P749, DOI 10.1016/j.ajo.2004.06.011
   Pierron D, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-70
   Pretegiani E, 2011, BRAIN, V134, DOI 10.1093/brain/awr101
   Puomila A, 2005, ACTA OPHTHALMOL SCAN, V83, P337, DOI 10.1111/j.1600-0420.2005.00448.x
   Rendtorff ND, 2011, AM J MED GENET A, V155A, P1298, DOI 10.1002/ajmg.a.33970
   Reynier P, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016576
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Schaaf CP, 2011, MOL GENET METAB, V103, P383, DOI 10.1016/j.ymgme.2011.04.018
   SMITH DP, 1972, AMER J OPT ARCH AM A, V49, P183
   Snell S., 1897, Trans Ophthalmol Soc UK, V17, P66
   Spinazzi M, 2008, HUM MOL GENET, V17, P3291, DOI 10.1093/hmg/ddn225
   Taban M, 2006, J CHILD NEUROL, V21, P956, DOI 10.1177/08830738060210111601
   Thiselton DL, 2002, INVEST OPHTH VIS SCI, V43, P1715
   Toomes C, 2001, HUM MOL GENET, V10, P1369, DOI 10.1093/hmg/10.13.1369
   TRANEBJAERG L, 1995, J MED GENET, V32, P257, DOI 10.1136/jmg.32.4.257
   Verny C, 2008, NEUROLOGY, V70, P1152, DOI 10.1212/01.wnl.0000289194.89359.a1
   Voisin J, 1949, B SOC OPHT FRANCE, V2
   Volker-Dieben H J, 1974, Mod Probl Ophthalmol, V13, P277
   Voo I, 2003, AM J OPHTHALMOL, V136, P670, DOI 10.1016/S0002-9394(03)00390-8
   Votruba M, 1998, J MED GENET, V35, P793, DOI 10.1136/jmg.35.10.793
   Votruba M, 2003, BRIT J OPHTHALMOL, V87, P48, DOI 10.1136/bjo.87.1.48
   Votruba M, 1998, ARCH OPHTHALMOL-CHIC, V116, P351, DOI 10.1001/archopht.116.3.351
   Wang L, 2003, INVEST OPHTH VIS SCI, V44, P2, DOI 10.1167/iovs.02-0333
   WENT LN, 1975, J MED GENET, V12, P94, DOI 10.1136/jmg.12.1.94
   White KE, 2009, INVEST OPHTH VIS SCI, V50, P2567, DOI 10.1167/iovs.08-2913
   Williams PA, 2010, BRAIN, V133, P2942, DOI 10.1093/brain/awq218
   Yu-Wai-Man P, 2011, EYE, V25, P597, DOI 10.1038/eye.2011.2
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2010, J MED GENET, V47, P120, DOI 10.1136/jmg.2009.067512
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Yu-Wai-Man P, 2010, BRAIN
   Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 101
TC 189
Z9 203
U1 0
U2 41
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1750-1172
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD JUL 9
PY 2012
VL 7
AR 46
DI 10.1186/1750-1172-7-46
PG 12
WC Genetics & Heredity; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Research & Experimental Medicine
GA 066RG
UT WOS:000313237300001
PM 22776096
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Poole, OV
   Hanna, MG
   Pitceathly, RDS
AF Poole, Olivia V.
   Hanna, Michael G.
   Pitceathly, Robert D. S.
TI Mitochondrial Disorders: Disease Mechanisms and Therapeutic Approaches
SO DISCOVERY MEDICINE
LA English
DT Article
ID GENE-THERAPY; DNA; TRANSMISSION; PROGRESSION; ACTIVATION; DELETIONS;
   MYOPATHY; GENOMES; PREVENT; SINGLE
AB Mitochondrial disorders are now well recognized as an important cause of genetic disease. They exhibit remarkable phenotypic, biochemical, and molecular heterogeneity, and frequently involve multiple organ systems. Their complexity partly relates to the dual expression of mitochondrial proteins by both mitochondrial and nuclear genomic DNA. Multiple copies of mitochondrial DNA ( mtDNA) are present in a single human mitochondrion. Each molecule exists as a double-stranded, circular, helical structure containing 37 genes: 13 encode polypeptide subunits, whilst the remaining 24 encode 22 transfer and 2 ribosomal RNAs necessary for their synthesis. These protein subunits contribute towards four of five multimeric enzymes (so-called complex I/III/IV/V, with complex II entirely nuclear-encoded) embedded in the inner mitochondrial membrane. The enzymes catalyze a sequence of redox reactions which ultimately generates adenine triphosphate, the cellular unit of energy, during oxidative phosphorylation (OXPHOS). The remaining OXPHOS subunits (more than 70 in total), in addition to the apparatus required for their transcription, translation, post-translational modification and assembly, are nuclear-encoded. The mitochondrion's dependence on nuclear DNA extends further to include the machinery required for the maintenance, replication, and repair of mtDNA molecules, the proteins for which are synthesized in the cell cytoplasm prior to transport across mitochondrial membrane for replication. Recent advancements in DNA analysis using next generation sequencing technology have provided an unprecedented expansion in the depth of knowledge concerning both molecular mechanisms and biological pathways which underpin many mitochondrial diseases. This understanding has led to the emergence of many potential targets and treatment strategies for these disorders for which there is currently no cure. This review highlights the challenges to therapy development and clinical trial design and outlines the approaches currently being investigated to treat this diverse group of disorders.
C1 [Poole, Olivia V.; Hanna, Michael G.; Pitceathly, Robert D. S.] UCL, Inst Neurol, MRC, Ctr Neuromuscular Dis, London WC1N 3BG, England.
   [Poole, Olivia V.; Hanna, Michael G.; Pitceathly, Robert D. S.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Pitceathly, Robert D. S.] Kings Coll London, Dept Basic & Clin Neurosci, Inst Psychiat Psychol & Neurosci, London SE5 8AF, England.
C3 University of London; University College London; University of London;
   University College London; UCL Medical School; University College London
   Hospitals NHS Foundation Trust; University of London; King's College
   London
RP Pitceathly, RDS (corresponding author), UCL, Inst Neurol, MRC, Ctr Neuromuscular Dis, Queen Sq, London WC1N 3BG, England.
EM r.pitceathly@ucl.ac.uk
OI Hanna, Michael/0000-0003-0825-4075; Pitceathly,
   Robert/0000-0002-6123-4551
FU MRC Centre for Neuromuscular Diseases grant [G0601943]; UK NHS
   Specialised Service for Rare Mitochondrial Diseases of Adults and
   Children; NIHR UCLH/UCL Biomedical Research Centre; Lily Foundation
   (Clinical Research Fellowship); MRC [G0601943, MR/K000608/1] Funding
   Source: UKRI
FX Our research is supported by an MRC Centre for Neuromuscular Diseases
   grant (G0601943), the UK NHS Specialised Service for Rare Mitochondrial
   Diseases of Adults and Children, the NIHR UCLH/UCL Biomedical Research
   Centre, and The Lily Foundation (Clinical Research Fellowship to O.P.).
CR Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Cámara Y, 2013, DRUG DISCOV TODAY, V18, P950, DOI 10.1016/j.drudis.2013.06.009
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Di Meo I, 2012, EMBO MOL MED, V4, P1008, DOI 10.1002/emmm.201201433
   El-Khoury R, 2014, BRIT J PHARMACOL, V171, P2243, DOI 10.1111/bph.12570
   Falk MJ, 2015, MOL GENET METAB, V114, P388, DOI 10.1016/j.ymgme.2014.11.016
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Golubitzky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026883
   Goodyear LJ, 2008, NEW ENGL J MED, V359, P1842, DOI 10.1056/NEJMcibr0806723
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Herbert M, 2015, EMBO REP, V16, P539, DOI 10.15252/embr.201540354
   Kanabus M, 2014, BRIT J PHARMACOL, V171, P1798, DOI 10.1111/bph.12456
   Kerr DS, 2013, NEUROTHERAPEUTICS, V10, P307, DOI 10.1007/s13311-013-0176-7
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Libri V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051395
   López-Lluch G, 2015, BIOGERONTOLOGY, V16, P599, DOI 10.1007/s10522-015-9585-9
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, DOI 10.1136/jnnp-2013-306573.69
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Peralta S, 2015, MITOCHONDRION, V23, P71, DOI 10.1016/j.mito.2015.01.007
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Pitceathly RDS, 2014, CURR OPIN NEUROL, V27, P576, DOI 10.1097/WCO.0000000000000126
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Torres-Torronteras J, 2014, MOL THER, V22, P901, DOI 10.1038/mt.2014.6
   Tyynismaa H, 2014, EMBO MOL MED, V6, P155, DOI 10.1002/emmm.201303586
   Viscomi C, 2015, BBA-BIOENERGETICS, V1847, P544, DOI 10.1016/j.bbabio.2015.03.001
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Viscomi C, 2010, NAT MED, V16, P869, DOI 10.1038/nm.2188
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
NR 40
TC 12
Z9 15
U1 0
U2 5
PU DISCOVERY MEDICINE
PI TIMONIUM
PA 10 GERARD AVE, STE 201, TIMONIUM, MD 21093 USA
SN 1539-6509
EI 1944-7930
J9 DISCOV MED
JI Discov. Med.
PD NOV
PY 2015
VL 20
IS 111
BP 325
EP 331
PG 7
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA CY3MH
UT WOS:000366313400007
PM 26645904
DA 2024-11-01
ER

PT J
AU Sequiera, GL
   Srivastava, A
   Alagarsamy, KN
   Rockman-Greenberg, C
   Dhingra, S
AF Sequiera, Glen Lester
   Srivastava, Abhay
   Alagarsamy, Keshav Narayan
   Rockman-Greenberg, Cheryl
   Dhingra, Sanjiv
TI Generation and Evaluation of Isogenic iPSC as a Source of Cell
   Replacement Therapies in Patients with Kearns Sayre Syndrome
SO CELLS
LA English
DT Article
DE Kearns Sayre syndrome; mitochondria; iPSC; stem cells
AB Kearns Sayre syndrome (KSS) is mitochondrial multisystem disorder with no proven effective treatment. The underlying cause for multisystem involvement is the energy deficit resulting from the load of mutant mitochondrial DNA (mtDNA), which manifests as loss of cells and tissue dysfunction. Therefore, functional organ or cellular replacement provides a promising avenue as a therapeutic option. Patient-specific induced pluripotent stem cells (iPSC) have become a handy tool to create personalized cell -based therapies. iPSC are capable of self-renewal, differentiation into all types of body cells including cardiomyocytes (CM) and neural progenitor cells (NPC). In KSS patients, mutations in mtDNA are largely found in the muscle tissue and are predominantly absent in the blood cells. Therefore, we conceptualized that peripheral blood mononuclear cells (PBMNC) from KSS patients can be reprogrammed to generate mutation free, patient specific iPSC lines that can be used as isogenic source of cell replacement therapies to treat affected organs. In the current study we generated iPSC lines from two female patients with clinical diagnosis of classic KSS. Our data demonstrate that iPSC from these KSS patients showed normal differentiation potential toward CM, NPC and fibroblasts without any mtDNA deletions over passages. Next, we also found that functional studies including ATP production, reactive oxygen species generation, lactate accumulation and mitochondrial membrane potential in iPSC, CM, NPC and fibroblasts of these KSS patients were not different from respective cells from healthy controls. PBMNCs from these KSS patients in the current study did not reproduce mtDNA mutations which were present in muscle biopsies. Furthermore, we demonstrate for the first time that this phenomenon provides opportunities to create isogenic mutation free iPSC with absent or very low level of expression of mtDNA deletion which can be banked for future cell replacement therapies in these patients as the disease progresses.
C1 [Sequiera, Glen Lester; Srivastava, Abhay; Alagarsamy, Keshav Narayan; Dhingra, Sanjiv] Univ Manitoba, Max Rady Coll Med,Rady Fac Hlth Sci, St Boniface Hosp,Dept Physiol & Pathophysiol, Albrechtsen Res Ctr,Regenerat Med Program,Inst Ca, Winnipeg, MB R2H 2A6, Canada.
   [Rockman-Greenberg, Cheryl] Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Dept Pediat & Child Hlth, Winnipeg, MB R3E 3P4, Canada.
C3 University of Manitoba; Children's Hospital Research Institute of
   Manitoba; University of Manitoba
RP Dhingra, S (corresponding author), Univ Manitoba, Max Rady Coll Med,Rady Fac Hlth Sci, St Boniface Hosp,Dept Physiol & Pathophysiol, Albrechtsen Res Ctr,Regenerat Med Program,Inst Ca, Winnipeg, MB R2H 2A6, Canada.
EM gsequiera@sbrc.ca; asrivastava@sbrc.ca; kalagarsamy@sbrc.ca;
   cgreenberg@hsc.mb.ca; sdhingra@sbrc.ca
RI Alagarsamy, Keshav Narayan/AFM-9551-2022; Dhingra, Sanjiv/D-8766-2014
OI Dhingra, Sanjiv/0000-0002-2664-7633; SRIVASTAVA,
   ABHAY/0000-0002-6637-4297; Alagarsamy, Keshav
   Narayan/0000-0002-7363-9345
FU Canadian Institutes of Health Research [MOP142265]
FX This research was funded by a grant from the Canadian Institutes of
   Health Research (MOP142265 to S.D.).
CR Björklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705
   CHANNER KS, 1988, BRIT HEART J, V59, P486
   Cherry ABC, 2013, STEM CELLS, V31, P1287, DOI 10.1002/stem.1354
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Cohen B.H., 2016, MITOCHONDRIAL CASE S, P43
   Coulter-Mackie MB, 1998, CLIN BIOCHEM, V31, P627, DOI 10.1016/S0009-9120(98)00074-5
   Deinsberger J, 2020, NPJ REGEN MED, V5, DOI 10.1038/s41536-020-00100-4
   Elitt MS, 2018, HUM MOL GENET, V27, pR89, DOI 10.1093/hmg/ddy186
   Forbes TA, 2018, AM J HUM GENET, V102, P816, DOI 10.1016/j.ajhg.2018.03.014
   Gao L, 2018, CIRC RES, V123, P1313, DOI 10.1161/CIRCRESAHA.118.313094
   Gibson K, 2008, PEDIATRICS, V122, P1003, DOI 10.1542/peds.2007-3502
   Holloman Conisha Mone, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2012-007272
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Lax NZ, 2012, ARCH NEUROL-CHICAGO, V69, P490, DOI 10.1001/archneurol.2011.2167
   Li JP, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0643-y
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li SS, 2018, STEM CELL REP, V10, P808, DOI 10.1016/j.stemcr.2018.01.013
   Li Y, 2017, CHEMSUSCHEM, V10, P68, DOI 10.1002/cssc.201601188
   Mahato B, 2011, MITOCHONDRION, V11, P564, DOI 10.1016/j.mito.2011.03.006
   Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368
   Margolin E., 2020, STATPEARLS
   Nagoshi N, 2018, CELL MOL LIFE SCI, V75, P989, DOI 10.1007/s00018-017-2676-9
   Ohashi Toya, 2012, Pediatr Endocrinol Rev, V10 Suppl 1, P26
   Parikh S, 2017, GENET MED, V19, DOI 10.1038/gim.2017.107
   Parikh S, 2016, MOL GENET METAB, V118, P178, DOI 10.1016/j.ymgme.2016.04.009
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Sequiera GL, 2020, STEM CELL RES, V48, DOI 10.1016/j.scr.2020.101964
   Viscomi C, 2015, BBA-BIOENERGETICS, V1847, P544, DOI 10.1016/j.bbabio.2015.03.001
NR 30
TC 11
Z9 11
U1 2
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD MAR
PY 2021
VL 10
IS 3
AR 568
DI 10.3390/cells10030568
PG 15
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA RD4PL
UT WOS:000633462000001
PM 33807701
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Bonnet, C
   Kaltimbacher, V
   Ellouze, S
   Augustin, S
   Bénit, P
   Forster, V
   Rustin, P
   Sahel, JA
   Corral-Debrinski, M
AF Bonnet, Crystel
   Kaltimbacher, Valerie
   Ellouze, Sami
   Augustin, Sebastien
   Benit, Paule
   Forster, Valerie
   Rustin, Pierre
   Sahel, Jose-Alain
   Corral-Debrinski, Marisol
TI Allotopic mRNA localization to the mitochondrial surface rescues
   respiratory chain defects in fibroblasts harboring mitochondrial DNA
   mutations affecting complex I or V subunits
SO REJUVENATION RESEARCH
LA English
DT Article
ID HEREDITARY OPTIC NEUROPATHY; CULTURED SKIN FIBROBLASTS; HYDROPHOBIC
   PROTEINS; YEAST MITOCHONDRIA; ATP SYNTHESIS; HUMAN-CELLS; GENE;
   DEFICIENCY; DISORDERS; IMPORT
AB The possibility of synthesizing mitochondrial DNA (mtDNA)-coded proteins in the cytosolic compartment, called allotopic expression, provides an attractive option for genetic treatment of human diseases caused by mutations of the corresponding genes. However, it is now appreciated that the high hydrophobicity of proteins encoded by the mitochondrial genome represents a strong limitation on their mitochondrial import when translated in the cytosol. Recently, we optimized the allotopic expression of a recoded ATP6 gene in human cells, by forcing its mRNA to localize to the mitochondrial surface. In this study, we show that this approach leads to a long-lasting and complete rescue of mitochondrial dysfunction of fibroblasts harboring the neurogenic muscle weakness, ataxia and retinitis Pigmentosa T8993G ATP6 mutation or the Leber hereditary optic neuropathy G11778A ND4 mutation. The recoded ATP6 gene was associated with the cis-acting elements of SOD2, while the ND4 gene was associated with the cis-acting elements of COX10. Both ATP6 and ND4 gene products were efficiently translocated into the mitochondria and functional within their respective respiratory chain complexes. Indeed, the abilities to grow in galactose and to produce adenosine triphosphate (ATP) in vitro were both completely restored in fibroblasts allotopically expressing either ATP6 or ND4. Notably, in fibroblasts harboring the ATP6 mutation, allotopic expression of ATP6 led to the recovery of complex V enzymatic activity. Therefore, mRNA sorting to the mitochondrial surface represents a powerful strategy that could ultimately be applied in human therapy and become available for an array of devastating disorders caused by mtDNA mutations.
C1 Univ Paris 06, Hop St Antoine, INSERM, U592,Lab Physiopathol Cellulaire & Mol Retine, F-75571 Paris 12, France.
   Hop Robert Debre 48, INSERM, U676, F-75019 Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Sorbonne Universite; Hopital
   Universitaire Saint-Antoine - APHP; Institut National de la Sante et de
   la Recherche Medicale (Inserm); Institut National de la Sante et de la
   Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP);
   Universite Paris Cite; Hopital Universitaire Robert-Debre - APHP
RP Corral-Debrinski, M (corresponding author), Univ Paris 06, Hop St Antoine, INSERM, U592,Lab Physiopathol Cellulaire & Mol Retine, Bat Kourilsky 184,Rue Fbg St Antoine, F-75571 Paris 12, France.
EM corral@st-antoine.inserm.fr
RI Bonnet, Crystel/AAN-5950-2021; Sahel, Jose-Alain/F-3172-2017
OI paule, BENIT/0000-0002-2321-8972; Sahel, Jose-Alain/0000-0002-4831-1153;
   Rustin, Pierre/0000-0002-5500-7280; Corral-Debrinski,
   Marisol/0000-0003-2854-9997; Bonnet, Crystel/0000-0002-1916-9119
CR Benit P, 2006, CLIN CHIM ACTA, V374, P81, DOI 10.1016/j.cca.2006.05.034
   Bokori-Brown M, 2006, REJUV RES, V9, P455, DOI 10.1089/rej.2006.9.455
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Chretien D, 2003, BIOCHEM BIOPH RES CO, V301, P222, DOI 10.1016/S0006-291X(02)03016-4
   Claros M G, 1996, Methods Enzymol, V264, P389, DOI 10.1016/S0076-6879(96)64036-1
   CLAROS MG, 1995, EUR J BIOCHEM, V228, P762, DOI 10.1111/j.1432-1033.1995.0762m.x
   Cock HR, 1999, J NEUROL SCI, V165, P10, DOI 10.1016/S0022-510X(99)00088-X
   Corral-Debrinski M, 1999, MOL MICROBIOL, V31, P1499, DOI 10.1046/j.1365-2958.1999.01295.x
   Corral-Debrinski M, 2000, MOL CELL BIOL, V20, P7881, DOI 10.1128/MCB.20.21.7881-7892.2000
   D'Aurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102
   Fünfschilling U, 1999, MOL BIOL CELL, V10, P3289, DOI 10.1091/mbc.10.10.3289
   George R, 2002, FEBS LETT, V516, P213, DOI 10.1016/S0014-5793(02)02528-0
   Geromel V, 1997, BIOCHEM BIOPH RES CO, V236, P643, DOI 10.1006/bbrc.1997.7024
   Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221
   Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200
   Ginsberg MD, 2003, J MOL BIOL, V327, P885, DOI 10.1016/S0022-2836(03)00173-6
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   Hakkaart GAJ, 2006, EMBO REP, V7, P341, DOI 10.1038/sj.embor.7400601
   Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155
   Kaltimbacher V, 2006, RNA, V12, P1408, DOI 10.1261/rna.18206
   Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Margeot A, 2002, EMBO J, V21, P6893, DOI 10.1093/emboj/cdf690
   Oca-Cossio J, 2003, GENETICS, V165, P707
   Ojaimi J, 2002, MOL BIOL CELL, V13, P3836, DOI 10.1091/mbc.E02-05-0306
   Ouhabi R, 1998, ANAL BIOCHEM, V263, P169, DOI 10.1006/abio.1998.2776
   Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561
   Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006
   Rötig A, 2003, J AM SOC NEPHROL, V14, P2995, DOI 10.1097/01.ASN.0000095481.24091.C9
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Smith PM, 2004, BBA-BIOENERGETICS, V1659, P232, DOI 10.1016/j.bbabio.2004.09.003
   Surace EM, 2003, PROG RETIN EYE RES, V22, P705, DOI 10.1016/S1350-9462(03)00052-1
   Sylvestre J, 2003, MOL BIOL CELL, V14, P3848, DOI 10.1091/mbc.E03-02-0074
   Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071
   Yen MY, 2006, PROG RETIN EYE RES, V25, P381, DOI 10.1016/j.preteyeres.2006.05.002
   Zeviani M, 2003, CURR OPIN NEUROL, V16, P585, DOI 10.1097/00019052-200310000-00004
   Zullo SJ, 2005, REJUV RES, V8, P18, DOI 10.1089/rej.2005.8.18
NR 41
TC 75
Z9 84
U1 0
U2 9
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-1684
EI 1557-8577
J9 REJUV RES
JI Rejuv. Res.
PD JUN
PY 2007
VL 10
IS 2
BP 127
EP 143
DI 10.1089/rej.2006.0526
PG 17
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 180IS
UT WOS:000247357000002
PM 17518546
DA 2024-11-01
ER

PT J
AU Malik, AN
   Czajka, A
   Cunningham, P
AF Malik, Afshan N.
   Czajka, Anna
   Cunningham, Phil
TI Accurate quantification of mouse mitochondrial DNA without
   co-amplification of nuclear mitochondrial insertion sequences
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial DNA; Mitochondrial pseudogenes; NumtS; Real time PCR;
   Mouse mitochondrial genome
ID OXIDATIVE STRESS; DISEASE; GENOME; BIOGENESIS; PSEUDOGENES; DYSFUNCTION;
   APOPTOSIS; BIOMARKER; TISSUES; MUSCLE
AB Background: Mitochondria contain an extra-nuclear genome in the form of mitochondrial DNA (MtDNA), damage to which can lead to inflammation and bioenergetic deficit. Changes in MtDNA levels are increasingly used as a biomarker of mitochondrial dysfunction. We previously reported that in humans, fragments in the nuclear genome known as nuclear mitochondrial insertion sequences (NumtS) affect accurate quantification of MtDNA. In the current paper our aim was to determine whether mouse NumtS affect the quantification of MtDNA and to establish a method designed to avoid this.
   Methods: The existence of NumtS in the mouse genome was confirmed using blast N, unique MtDNA regions were identified using FASTA, and MtDNA primers which do not co-amplify NumtS were designed and tested. MtDNA copy numbers were determined in a range of mouse tissues as the ratio of the mitochondrial and nuclear genome using real time qPCR and absolute quantification.
   Results: Approximately 95% of mouse MtDNA was duplicated in the nuclear genome as NumtS which were located in 15 out of 21 chromosomes. A unique region was identified and primers flanking this region were used. MtDNA levels differed significantly in mouse tissues being the highest in the heart, with levels in descending order (highest to lowest) in kidney, liver, blood, brain, islets and lung.
   Conclusion: The presence of NumtS in the nuclear genome of mouse could lead to erroneous data when studying MtDNA content or mutation. The unique primers described here will allow accurate quantification of MtDNA content in mouse models without co-amplification of NumtS. (C) 2016 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Malik, Afshan N.; Czajka, Anna; Cunningham, Phil] Kings Coll London, Diabet Res Grp, Div Diabet & Nutr Sci, Sch Life Sci & Med, London SE1 1UL, England.
C3 University of London; King's College London
RP Malik, AN (corresponding author), Kings Coll London, Diabet Res Grp, Div Diabet & Nutr Sci, Sch Life Sci & Med, London SE1 1UL, England.
EM afshan.malik@kcl.ac.uk
RI Malik, Afshan/F-5652-2011
OI Malik, Afshan/0000-0001-7207-1666
CR Ajaz Saima, 2015, Methods Mol Biol, V1264, P117, DOI 10.1007/978-1-4939-2257-4_12
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601
   Calabrese FM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S15
   Caro P, 2010, MITOCHONDRION, V10, P479, DOI 10.1016/j.mito.2010.05.004
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fernández-Vizarra E, 2011, MITOCHONDRION, V11, P207, DOI 10.1016/j.mito.2010.09.011
   Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972
   Goios A, 2007, GENOME RES, V17, P293, DOI 10.1101/gr.5941007
   Goo HG, 2013, BBA-MOL CELL RES, V1833, P1866, DOI 10.1016/j.bbamcr.2013.03.016
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Guo JB, 2014, EUR J PHARMACOL, V737, P117, DOI 10.1016/j.ejphar.2014.05.017
   Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   Liu B, 2015, BBA-MOL BASIS DIS, V1852, P2086, DOI 10.1016/j.bbadis.2015.07.002
   Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011
   Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067
   Malik Afshan N, 2009, Diabetes Res Clin Pract, V86, pe22, DOI 10.1016/j.diabres.2009.07.002
   Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051
   Morscher RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129802
   PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110
   Schatz G, 1996, J BIOL CHEM, V271, P31763, DOI 10.1074/jbc.271.50.31763
   Stangenberg S, 2015, INT J BIOCHEM CELL B, V64, P81, DOI 10.1016/j.biocel.2015.03.017
   Supale S, 2013, DIABETES, V62, P3488, DOI 10.2337/db13-0152
   Wallace DC, 1997, P NATL ACAD SCI USA, V94, P14900, DOI 10.1073/pnas.94.26.14900
   Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909
   WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390
   Woischnik M, 2002, GENOME RES, V12, P885, DOI 10.1101/gr.227202
   Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhao M, 2014, BIOCHEM BIOPH RES CO, V450, P1446, DOI 10.1016/j.bbrc.2014.07.010
NR 37
TC 83
Z9 87
U1 3
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL
PY 2016
VL 29
BP 59
EP 64
DI 10.1016/j.mito.2016.05.003
PG 6
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA DQ8IF
UT WOS:000379452700008
PM 27181048
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Pye, D
   Watt, DJ
   Walker, C
   Lightowlers, RN
   Turnbull, DM
AF Pye, D
   Watt, DJ
   Walker, C
   Lightowlers, RN
   Turnbull, DM
TI Identification of the RAG-1 as a suitable mouse model for mitochondrial
   DNA disease
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE recombinase activating gene-1; severe combined immunodeficient mouse;
   muscle fibres
ID MYOBLAST TRANSPLANTATION; SCID MICE; MUSCLE-FIBERS; EXPRESSION
AB Previous studies have shown that transfer of human myoblasts carrying a mitochondrial DNA mutation into muscles of the severe combined immunodeficient mouse may provide an important animal model for mitochondrial myopathy. However, a major drawback of this mouse is its extreme sensitivity to ionising radiation, a pre-treatment which enhances the efficiency of myoblast transfer success. We implanted human myoblasts into the tibialis anterior muscles of another immunodeficient mouse, mutated in the recombinase activating gene-1 (RAG-1), to determine if this mouse could be an alternative to the severe combined immunodeficient for our mitochondrial myoblast transfer model. We also examined several different methods of muscle degeneration prior to myoblast transfer to determine which method resulted in the greatest amount of human tissue in implanted muscles. Our results show that the RAG-1 mouse displayed no sensitivity to the irradiation process compared to the high sensitivity in the severe combined immunodeficient mouse which resulted in early termination of the study. We also show that degeneration of host muscles by the myotoxin barium chloride (BaCl2) resulted in the greatest amount of regenerating human muscle fibres in both the severe combined immunodeficient and RAG-1 mice. In addition, the maximum amount of human fibres observed in transplanted muscles was similar in each mouse strain. The average number of fibres throughout muscles was significantly greater in severe combined immunodeficient mice injured by BaCl2, but was similar between all other muscle groups. This study suggests that the RAG-1 mouse is a suitable host for the mitochondrial myoblast transfer model and may also prove valuable for other myoblast transfer models such as muscular dystrophy. (C) 2004 Elsevier B.V. All rights reserved.
C1 Newcastle Univ, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   Brighton & Sussex Med Sch, Brighton BN1 9PX, E Sussex, England.
   Newcastle Gen Hosp, Dept Reg Med Phys, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.
C3 Newcastle University - UK; University of Brighton; University of Sussex;
   Newcastle General Hospital
RP Newcastle Univ, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM d.m.turnbull@ncl.ac.uk
CR Clark KM, 1998, J CLIN INVEST, V102, P2090, DOI 10.1172/JCI944
   Cooper RN, 2001, HUM GENE THER, V12, P823, DOI 10.1089/104303401750148784
   Figarella-Branger D, 1999, J NEUROL SCI, V170, P149, DOI 10.1016/S0022-510X(99)00284-1
   Guigal N, 2002, J BIOL CHEM, V277, P47407, DOI 10.1074/jbc.M208048200
   HUARD J, 1994, J CLIN INVEST, V93, P586, DOI 10.1172/JCI117011
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Leriche-Guérin K, 2002, NEUROMUSCULAR DISORD, V12, P167, DOI 10.1016/S0960-8966(01)00254-1
   MCARDLE A, 1994, J APPL PHYSIOL, V76, P1274, DOI 10.1152/jappl.1994.76.3.1274
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Skuk D, 1999, J NEUROPATH EXP NEUR, V58, P921, DOI 10.1097/00005072-199909000-00003
   Taanman JW, 1996, BBA-MOL BASIS DIS, V1315, P199, DOI 10.1016/0925-4439(95)00127-1
   Wells DJ, 1998, J PHARM SCI, V87, P763, DOI 10.1021/js970391o
   Wernig A, 2000, J PHYSIOL-LONDON, V522, P333, DOI 10.1111/j.1469-7793.2000.t01-2-00333.x
NR 15
TC 8
Z9 11
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD MAY
PY 2004
VL 14
IS 5
BP 329
EP 336
DI 10.1016/j.nmd.2004.02.010
PG 8
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 818YP
UT WOS:000221280700008
PM 15099593
DA 2024-11-01
ER

PT J
AU Mito, T
   Ishizaki, H
   Suzuki, M
   Morishima, H
   Ota, A
   Ishikawa, K
   Nakada, K
   Maeno, A
   Shiroishi, T
   Hayashi, JI
AF Mito, Takayuki
   Ishizaki, Hikari
   Suzuki, Michiko
   Morishima, Hitomi
   Ota, Azusa
   Ishikawa, Kaori
   Nakada, Kazuto
   Maeno, Akiteru
   Shiroishi, Toshihiko
   Hayashi, Jun-Ichi
TI Transmitochondrial mito-miceΔ and mtDNA mutator mice, but not aged mice,
   share the same spectrum of musculoskeletal disorders
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE mtDNA mutator mice; Mito-mice Delta; Mitochondrial diseases; Aging;
   Osteoporosis; Sarcopenia
ID MITOCHONDRIAL-DNA MUTATIONS; DYSFUNCTION; PHENOTYPES; NUCLEAR
AB The spectra of phenotypes associated with aging and mitochondrial diseases sometimes appear to overlap with each other. We used aged mice and a mouse model of mitochondrial diseases (transmitochondrial mito-mice Delta with deleted mtDNA) to study whether premature aging phenotypes observed in mtDNA mutator mice are associated with aging or mitochondrial diseases. Here, we provide convincing evidence that all the mice examined had musculoskeletal disorders of osteoporosis and muscle atrophy, which correspond to phenotypes prevalently observed in the elderly. However, precise investigation of musculoskeletal disorders revealed that the spectra of osteoporosis and muscle atrophy phenotypes in mtDNA mutator mice were very close to those in mito-mice Delta, but different from those of aged mice. Therefore, mtDNA mutator mice and mito-mice Delta, but not aged mice, share the spectra of musculoskeletal disorders. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Mito, Takayuki; Ishizaki, Hikari; Suzuki, Michiko; Morishima, Hitomi; Ota, Azusa; Ishikawa, Kaori; Nakada, Kazuto; Hayashi, Jun-Ichi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.
   [Nakada, Kazuto; Hayashi, Jun-Ichi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058572, Japan.
   [Maeno, Akiteru; Shiroishi, Toshihiko] Natl Inst Genet, Mammalian Genet Lab, Mishima, Shizuoka 411, Japan.
   [Hayashi, Jun-Ichi] Univ Tsukuba, TARA Ctr, Tsukuba, Ibaraki 3058572, Japan.
C3 University of Tsukuba; University of Tsukuba; Research Organization of
   Information & Systems (ROIS); National Institute of Genetics (NIG) -
   Japan; University of Tsukuba
RP Hayashi, JI (corresponding author), Univ Tsukuba, TARA Ctr, Tsukuba, Ibaraki 3058572, Japan.
EM jih45@biol.tsukuba.ac.jp
OI Mito, Takayuki/0000-0002-6796-5478
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   (MEXT) [23240058, 25250011];  [26-467]; Grants-in-Aid for Scientific
   Research [25250011, 23240058] Funding Source: KAKEN
FX This work was supported by Grants-in-Aid for Scientific Research (A)
   (No. 23240058 and No. 25250011) from the Ministry of Education, Culture,
   Sports, Science and Technology of Japan (MEXT) to K.N. and J.I.H.,
   respectively. This work was also supported by a Grant-in-Aid for Japan
   Society for the Promotion of Science (JSPS) Fellows (No. 26-467) to T.M.
CR Cohen BH, 2013, NEUROTHERAPEUTICS, V10, P227, DOI 10.1007/s13311-013-0188-3
   Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9
   HAYASHI JI, 1994, J BIOL CHEM, V269, P6878
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Isobe K, 1998, J BIOL CHEM, V273, P4601, DOI 10.1074/jbc.273.8.4601
   Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102
   Mito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055789
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nedergaard A, 2013, BEST PRACT RES CL OB, V27, P673, DOI 10.1016/j.bpobgyn.2013.06.001
   ROSENBERG AE, 1991, RADIOL CLIN N AM, V29, P19
   Sakuma K, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00230
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
NR 18
TC 7
Z9 7
U1 1
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JAN 24
PY 2015
VL 456
IS 4
BP 933
EP 937
DI 10.1016/j.bbrc.2014.12.009
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA CA1UF
UT WOS:000348696100017
PM 25511702
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Chennupati, SK
   Levi, J
   Loftus, P
   Jornlin, C
   Morlet, T
   O'Reilly, RC
AF Chennupati, Sri Kiran
   Levi, Jessica
   Loftus, Patricia
   Jornlin, Carly
   Morlet, Thierry
   O'Reilly, Robert C.
TI Hearing loss in children with mitochondrial disorders
SO INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY
LA English
DT Article
DE Hearing loss; Mitochondrial disorder
ID KEARNS-SAYRE-SYNDROME; RAGGED-RED FIBERS; AUDITORY NEUROPATHY; MELAS
   SYNDROME; DEAFNESS; IMPAIRMENT; MUTATIONS; DIAGNOSIS; EPILEPSY; GENE
AB Objective: At least 1-5 children per 1000 suffer from congenital hearing loss, and 50% of these cases can be attributed to genetic causes. It has been estimated that 1% of pre-lingual hearing loss is due to mutations in mitochondrial DNA. Previous literature reports audiometric data for few patients, usually less than 20 per study. The goal of this study was to characterize the hearing loss associated with mitochondrial mutations and determine whether previously characterized patterns of hearing loss in these patients (progressive, sensorineural, high frequency losses) are found in our population as well.
   Methods: An IRB-approved retrospective chart review of the electronic medical records in the Nemours/Alfred I. dupont Hospital for Children system from January 2004 to October 2009 (a five-year period) was undertaken using ICD-9 codes 277.87 (mitochondrial disorder) and 359.89BA (mitochondrial myopathy). These 149 records were then evaluated for audiologic data, resulting in 26 charts with both a mitochondrial disorder and hearing evaluation.
   Results: Of 26 patients with known mitochondrial disorders and audiometric documentation, 15 (58%) had hearing loss, and 11 patients had normal hearing (42%). Ten patients had sensorineural hearing loss (38%), two patients had conductive hearing loss (7.7%), one patient had a mixed hearing loss (3.8%), and two patients had an as yet undefined hearing loss (ABR had not yet been performed at the time of this study) (7.7%).
   Conclusion: In comparison with previous studies, generally including less than 20 patients, this is one of the largest collections of audiometric data on children with mitochondrial disorders. Unlike prior studies describing a progressive, sensorineural loss across all frequencies or mainly affecting high frequencies, the hearing loss in our patients was more variable including low frequency losses, mid-frequency losses, and conductive losses and was often not progressive or even improved. Our overall 38% rate of sensorineural hearing loss correlates well with previous case series: this study clearly justifies the use of routine audiometric screening in children with mitochondrial disorders, including use of A,BR and OAEs as ASND can be seen in this population, as well as repeat testing over time to evaluate for progression. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Levi, Jessica; Jornlin, Carly; Morlet, Thierry; O'Reilly, Robert C.] Alfred I duPont Hosp Children, Div Pediat Otolaryngol, Wilmington, DE 19899 USA.
   [Chennupati, Sri Kiran] St Christophers Hosp Children, Div Otolaryngol, Philadelphia, PA 19134 USA.
   [Loftus, Patricia] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA.
C3 Nemours Alfred I. duPont Hospital for Children; Jefferson University
RP O'Reilly, RC (corresponding author), Alfred I duPont Hosp Children, Div Pediat Otolaryngol, POB 269, Wilmington, DE 19899 USA.
EM roreilly@nemours.org
RI Morlet, Thierry/AAL-8442-2021
OI Levi, Jessica/0000-0002-5594-9374; Morlet, Thierry/0000-0002-4846-5232
CR Ballana E, 2006, BIOCHEM BIOPH RES CO, V341, P950, DOI 10.1016/j.bbrc.2006.01.049
   Berlin CI, 2010, INT J AUDIOL, V49, P30, DOI 10.3109/14992020903160892
   Ceranic B, 2004, J NEUROL NEUROSUR PS, V75, P626, DOI 10.1136/jnnp.2003.017673
   Clark J G, 1981, ASHA, V23, P493
   Corley V M, 1999, J Am Acad Audiol, V10, P484
   Forli F, 2006, J LARYNGOL OTOL, V120, P888, DOI 10.1017/S0022215106001472
   Jacobs HT, 2005, EUR J HUM GENET, V13, P26, DOI 10.1038/sj.ejhg.5201250
   Karkos PD, 2004, CLIN OTOLARYNGOL, V29, P1, DOI 10.1111/j.1365-2273.2004.00769.x
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   Kornblum C, 2005, J NEUROL, V252, P1101, DOI 10.1007/s00415-005-0827-7
   MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504
   OLDFORS A, 1995, ACTA NEUROPATHOL, V90, P328
   Scaglia F, 2006, GENET MED, V8, P641, DOI 10.1097/01.gim.0000237781.10594.d1
   SEIBEL P, 1991, J NEUROL SCI, V105, P217, DOI 10.1016/0022-510X(91)90148-Z
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   Tsutsumi T, 2001, J LARYNGOL OTOL, V115, P777
   Warrick PD, 1997, J LARYNGOL OTOL, V111, P279, DOI 10.1017/S0022215100137089
   Wong LJC, 2004, ANN NY ACAD SCI, V1011, P246, DOI 10.1196/annals.1293.024
   Yamasoba T, 1996, LARYNGOSCOPE, V106, P49, DOI 10.1097/00005537-199601000-00010
   Young TJ, 2005, PACE, V28, P454, DOI 10.1111/j.1540-8159.2005.40049.x
   Zwirner P, 2001, LARYNGOSCOPE, V111, P515, DOI 10.1097/00005537-200103000-00024
NR 21
TC 13
Z9 14
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-5876
J9 INT J PEDIATR OTORHI
JI Int. J. Pediatr. Otorhinolaryngol.
PD DEC
PY 2011
VL 75
IS 12
BP 1519
EP 1524
DI 10.1016/j.ijporl.2011.08.019
PG 6
WC Otorhinolaryngology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Otorhinolaryngology; Pediatrics
GA 854JQ
UT WOS:000297491200008
PM 21982076
DA 2024-11-01
ER

PT J
AU Dündar, H
   Özgül, RK
   Yalnizoglu, D
   Erdem, S
   Oguz, KK
   Tuncel, D
   Temuçin, ÇM
   Dursun, A
AF Dundar, Hall
   Ozgul, Riza Koksal
   Yalnizoglu, Dilek
   Erdem, Sevim
   Oguz, Kader Karli
   Tuncel, Deniz
   Temucin, Cagri Mesut
   Dursun, Ali
TI Identification of a Novel Twinkle Mutation in a Family With Infantile
   Onset Spinocerebellar Ataxia by Whole Exome Sequencing
SO PEDIATRIC NEUROLOGY
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL-DNA; GENE MUTATION;
   SENSORY NEUROPATHY; MULTIPLE DELETIONS; MTDNA DELETIONS; POLG; FEATURES;
   DEFECTS; DISEASE
AB Whole exome sequencing combined with homozygosity mapping comprises a genetic diagnostic tool to identify genetic defects in families with multiple affected members, compatible with presumed autosomal recessively inherited neurometabolic/neurogenetic disease. These tools were applied to a family with two individuals manifesting ataxia, associated with peripheral sensory neuropathy, athetosis, seizures, deafness, and ophthalmoplegia. A novel homozygous missense mutation c.1366C>G (L456V) in C10orf2 (the Twinkle gene) was identified, confirming infantile onset spinocerebellar ataxia in the probands. Signs in infantile onset spinocerebellar ataxia follow a fairly distinct pattern, affecting early development, followed by ataxia and loss of skills. However, this very rare disease was previously reported only in Finland. We suggest that infantile onset spinocerebellar ataxia should be more frequently considered in the differential diagnosis of neurometabolic diseases in childhood. Next-generation sequencing and its use along with homozygosity mapping offer highly promising techniques for molecular diagnosis, especially in small families affected with very rare neurometabolic disorders such as infantile onset spinocerebellar ataxia. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Dundar, Hall; Ozgul, Riza Koksal; Dursun, Ali] Hacettepe Univ, Fac Med, Metab Unit, Dept Pediat, TR-06100 Ankara, Turkey.
   [Ozgul, Riza Koksal] Hacettepe Univ, Inst Child Hlth, TR-06100 Ankara, Turkey.
   [Yalnizoglu, Dilek] Hacettepe Univ, Fac Med, Dept Child Neurol, TR-06100 Ankara, Turkey.
   [Erdem, Sevim; Temucin, Cagri Mesut] Hacettepe Univ, Fac Med, Dept Neurol, TR-06100 Ankara, Turkey.
   [Oguz, Kader Karli] Hacettepe Univ, Fac Med, Dept Radiol, TR-06100 Ankara, Turkey.
   [Tuncel, Deniz] Sutcu Imam Univ, Fac Med, Dept Neurol, Kahramanmaras, Turkey.
C3 Hacettepe University; Hacettepe University; Hacettepe University;
   Hacettepe University; Hacettepe University; Kahramanmaras Sutcu Imam
   University
RP Dursun, A (corresponding author), Hacettepe Univ, Fac Med, Metab Unit, Dept Pediat, TR-06100 Ankara, Turkey.
EM adursun@hacettepe.edu.tr
RI OZGUL, RIZA/J-1569-2013; Dundar, Halil/J-9245-2018; Dursun,
   Ali/AAA-1586-2020; Oguz, Kader/AAF-1791-2020; Temucin, Cagri/I-9435-2013
OI Ozgul, Riza Koksal/0000-0002-0283-635X; Dundar,
   Halil/0000-0001-9021-0105; Erdem Ozdamar, Sevim/0000-0001-9348-6457;
   KARLI OGUZ, H.KADER/0000-0002-3385-4665
FU Scientific and Technology Research Council of Turkey
   [TUBITAK-SBAG-108S259]
FX The authors thank the members of the family for their participation.
   This study was supported by the Scientific and Technology Research
   Council of Turkey (grant TUBITAK-SBAG-108S259).
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Echaniz-Laguna A, 2010, NEUROGENETICS, V11, P21, DOI 10.1007/s10048-009-0202-4
   Gob V, J PEDIAT GASTRO 0614
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Houshmand M, 2006, NEUROL INDIA, V54, P182
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Jeppesen TD, 2008, NEUROMUSCULAR DISORD, V18, P306, DOI 10.1016/j.nmd.2007.10.007
   Kallio A K., 1985, Adv Audiol, V3, P84
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507
   KOSKINEN T, 1995, AM J NEURORADIOL, V16, P1427
   Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   NIKALI K, 1995, AM J HUM GENET, V56, P1088
   NIKALI K, 1994, PEDIATR RES, V36, P607, DOI 10.1203/00006450-199411000-00012
   Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030
   Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
NR 34
TC 16
Z9 19
U1 1
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD MAR
PY 2012
VL 46
IS 3
BP 172
EP 177
DI 10.1016/j.pediatrneurol.2011.12.006
PG 6
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 902JU
UT WOS:000301035200007
PM 22353293
DA 2024-11-01
ER

PT J
AU Zhou, NW
   Tang, L
   Jiang, YY
   Qin, SM
   Cui, J
   Wang, YN
   Zhu, WQ
   Zhao, WP
   Pan, CZ
   Shu, XH
AF Zhou, Nianwei
   Tang, Lu
   Jiang, Yingying
   Qin, Shengmei
   Cui, Jie
   Wang, Yanan
   Zhu, Wenqing
   Zhao, Weipeng
   Pan, Cuizhen
   Shu, Xianhong
TI Whole-exome sequencing reveals a novel mutation of <i>MT</i>-<i>ND5</i>
   gene in a mitochondrial cardiomyopathy pedigree: Patients who show
   biventricular hypertrophy, hyperlactacidemia, pulmonary hypertension,
   and decreased exercise tolerance
SO ANATOLIAN JOURNAL OF CARDIOLOGY
LA English
DT Article
DE MT-ND5; whole-exome sequencing; cardiomyopathy; pulmonary hypertension
ID STROKE-LIKE EPISODES; LEIGH-SYNDROME; COMPLEX-I; MISSENSE MUTATION;
   LACTIC-ACIDOSIS; ND5 GENE; MELAS; DNA
AB Objective: The aim of the present study was to determine whether pathogenic mutations were present in families with mitochondrial cardiomyopathy that presented during adolescence.
   Methods: The proband was a 21-year-old man who presented clinically with palpitations, chest tightness, pulmonary hypertension, and limited exercise tolerance. Cardiac magnetic resonance imaging studies showed biventricular cardiac hypertrophy. We determine whether pathogenic mutations were present by whole-exome sequencing (WES) in families.
   Results: Screening of the family using tandem mass spectrometry showed elevated lactic acid levels, glutaric aciduria, a mildly increased glutarylca rnitine-to-octanoylcarnitine ratio, and normal blood alpha-glucosidase, which was consistent with a respiratory chain complex 1 metabolic disorder. We identified a novel mutation of MT-ND5, c.1315A>G (p.Thr439Ala). Skeletal muscle biopsy histology showed predominantly ragged red fibers and few ragged blue fibers, which was consistent with mitochondrial myopathy.
   Conclusion: In the present study, we identified a novel mutation of MT-ND5, c.1315A>G (p.Thr439Ala), in a family pedigree using WES.
C1 [Zhou, Nianwei; Tang, Lu; Jiang, Yingying; Wang, Yanan; Zhao, Weipeng; Pan, Cuizhen; Shu, Xianhong] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai Inst Med Imaging,Dept Echocardiog, Shanghai, Peoples R China.
   [Qin, Shengmei; Cui, Jie; Zhu, Wenqing] Fudan Univ, Zhongshan Hosp, Shanghai Inst Med Imaging, Shanghai Inst Cardiovasc Dis,Dept Cardiol, Shanghai, Peoples R China.
C3 Fudan University; Fudan University
RP Shu, XH (corresponding author), Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai Inst Med Imaging,Dept Echocardiog, Shanghai, Peoples R China.
EM shu.xianhong@zs-hospital.sh.cn
RI jiang, yingying/HPO-9902-2023
FU National Science Foundation of China [81200170]; Science and Technology
   Committee Foundation of Shanghai [17411954400]
FX This study was supported by grant no. 81200170 from the National Science
   Foundation of China and grant no. 17411954400 from the Science and
   Technology Committee Foundation of Shanghai.
CR [Anonymous], EUR J MED GENET
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Brecht M, 2015, JIMD REP, V19, P95, DOI 10.1007/8904_2014_375
   Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Crimi M, 2003, NEUROLOGY, V60, P1857, DOI 10.1212/01.WNL.0000066048.72780.69
   Curry JL, 2012, SEMIN CUTAN MED SURG, V31, P267, DOI 10.1016/j.sder.2012.07.007
   Kingsmore SF, 2012, GENOME MED, V4, DOI 10.1186/gm324
   LERTRIT P, 1992, AM J HUM GENET, V51, P457
   Li WW, 2015, INT J CLIN EXP PATHO, V8, P7022
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Monlleo-Neila L, 2013, J CHILD NEUROL, V28, P1531, DOI 10.1177/0883073812460580
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Petersen BS, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0479-5
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Roncarati R, 2013, EUR J HUM GENET, V21, P1105, DOI 10.1038/ejhg.2013.16
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   Sazonova MA, 2016, CURR PHARM DESIGN, V22, P390, DOI 10.2174/1381612822666151112152335
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
NR 21
TC 5
Z9 5
U1 0
U2 3
PU TURKISH SOC CARDIOLOGY
PI BAHCELIEVLER
PA COBANCESME SANAYI CAD NO 11, NISH ISTANBUL A BLOK KAT 8 NO 47-48,
   YENIBOSNA, BAHCELIEVLER, ISTANBUL 34196, TURKEY
SN 2149-2263
EI 2149-2271
J9 ANATOL J CARDIOL
JI Anat. J. Cardiol.
PD JAN
PY 2019
VL 21
IS 1
BP 18
EP 24
DI 10.14744/AnatolJCardiol.2018.53258
PG 7
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA HQ3XW
UT WOS:000462344800005
PM 30587702
OA Green Submitted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Khan, NA
   Govindaraj, P
   Meena, AK
   Thangaraj, K
AF Khan, Nahid Akhtar
   Govindaraj, Periyasamy
   Meena, Angamuthu Kannan
   Thangaraj, Kumarasamy
TI Mitochondrial disorders: Challenges in diagnosis & treatment
SO INDIAN JOURNAL OF MEDICAL RESEARCH
LA English
DT Review
DE Diagnosis; diseases; mitochondrial DNA; mutation; treatment
ID HEREDITARY OPTIC NEUROPATHY; CYTOCHROME-C-OXIDASE; COMPLEX-I DEFICIENCY;
   PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HUMAN EMBRYOFETAL DEVELOPMENT; DNA
   MUTATIONS; LEIGH-SYNDROME; PRENATAL-DIAGNOSIS; LACTIC-ACIDOSIS;
   KETOGENIC DIET
AB Mitochondrial dysfunctions are known to be responsible for a number of heterogenous clinical presentations with multi-systemic involvement. Impaired oxidative phosphorylation leading to a decrease in cellular energy (ATP) production is the most important cause underlying these disorders. Despite significant progress made in the field of mitochondrial medicine during the last two decades, the molecular mechanisms underlying these disorders are not fully understood. Since the identification of first mitochondrial DNA (mtDNA) mutation in 1988, there has been an exponential rise in the identification of mtDNA and nuclear DNA mutations that are responsible for mitochondrial dysfunction and disease. Genetic complexity together with ever widening clinical spectrum associated with mitochondrial dysfunction poses a major challenge in diagnosis and treatment. Effective therapy has remained elusive till date and is mostly efficient in relieving symptoms. In this review, we discuss the important clinical and genetic features of mitochondrials disorders with special emphasis on diagnosis and treatment.
C1 [Khan, Nahid Akhtar; Govindaraj, Periyasamy; Thangaraj, Kumarasamy] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Telangana, India.
   [Meena, Angamuthu Kannan] Nizams Inst Med Sci, Dept Neurol, Hyderabad, Andhra Pradesh, India.
C3 Council of Scientific & Industrial Research (CSIR) - India; CSIR -
   Centre for Cellular & Molecular Biology (CCMB); Nizam's Institute of
   Medical Sciences
RP Thangaraj, K (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Telangana, India.
EM thangs@ccmb.res.in
RI Thangaraj, Kumarasamy/G-5596-2010
OI Thangaraj, Kumarasamy/0000-0002-0075-0106; Khan,
   Nahid/0000-0002-2835-3655
FU Department of Biotechnology (DBT), Government of India, New Delhi;
   Department of Biotechnology (DBT); Council of Scientific and Industrial
   Research (CSIR), Government of India, New Delhi [BioAge-BSC0208]
FX The first author (NAK) acknowledges the Department of Biotechnology
   (DBT), Government of India, New Delhi for providing Senior Research
   Fellowship (SRF). The last author (KT) acknowledges the Department of
   Biotechnology (DBT), and the Council of Scientific and Industrial
   Research (CSIR), (BioAge-BSC0208), Government of India, New Delhi, for
   financial support in various studies. Authors thank Dr Gayathri N.
   (NIMHANS, Bengaluru, India) for providing histopathological and electron
   microscopic pictures.
CR Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Angebault Claire, 2011, BMC Res Notes, V4, P557, DOI 10.1186/1756-0500-4-557
   Barshop BA, 2004, MOL GENET METAB, V83, P138, DOI 10.1016/j.ymgme.2004.06.009
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z
   Bouchet C, 2006, J MED GENET, V43, P788, DOI 10.1136/jmg.2005.034140
   Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Bugiani M, 2006, BRAIN DEV-JPN, V28, P576, DOI 10.1016/j.braindev.2006.04.001
   Carelli V, 2011, BRAIN, V134, DOI 10.1093/brain/awr180
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1999, J MED GENET, V36, P425
   Chinnery PF, 1997, J NEUROL NEUROSUR PS, V63, P559, DOI 10.1136/jnnp.63.5.559
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598
   DiMauro S, 2009, BBA-MOL BASIS DIS, V1792, P1159, DOI 10.1016/j.bbadis.2008.10.015
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elson JL, 2009, HUM MUTAT, V30, pE984, DOI 10.1002/humu.21113
   ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Govindaraj P, 2011, MITOCHONDRION, V11, P504, DOI 10.1016/j.mito.2011.01.009
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002
   Hellebrekers DMEI, 2012, HUM REPROD UPDATE, V18, P341, DOI 10.1093/humupd/dms008
   HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739
   Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kisler JE, 2010, DEV MED CHILD NEUROL, V52, P422, DOI 10.1111/j.1469-8749.2009.03605.x
   Klopstock T, 2000, NEUROLOGY, V55, P1748, DOI 10.1212/WNL.55.11.1748
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065
   Marchington D, 2010, J MED GENET, V47, P257, DOI 10.1136/jmg.2009.072900
   Marriage BJ, 2004, MOL GENET METAB, V81, P263, DOI 10.1016/j.ymgme.2003.12.008
   Masino SA, 2008, TRENDS NEUROSCI, V31, P273, DOI 10.1016/j.tins.2008.02.009
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   McFarland R, 2009, J INTERN MED, V265, P210, DOI 10.1111/j.1365-2796.2008.02066.x
   MORAES CT, 1995, MUSCLE NERVE, pS150
   Morava E, 2006, J INHERIT METAB DIS, V29, P589, DOI 10.1007/s10545-006-0227-x
   Naviaux RK, 2004, MITOCHONDRION, V4, P351, DOI 10.1016/j.mito.2004.07.002
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Okuno D, 2011, J BIOCHEM, V149, P655, DOI 10.1093/jb/mvr049
   Olsen RKJ, 2007, BRAIN, V130, P2045, DOI 10.1093/brain/awm135
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811
   Poulton J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001066
   Poulton J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b94
   Prietsch V, 2002, J INHERIT METAB DIS, V25, P531, DOI 10.1023/A:1022040422590
   Quinzii CM, 2010, DEV DISABIL RES REV, V16, P183, DOI 10.1002/ddrr.108
   RICHTER C, 1992, MUTAT RES, V275, P249, DOI 10.1016/0921-8734(92)90029-O
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6
   Steenweg ME, 2011, BRAIN, V134, P3333, DOI 10.1093/brain/awr254
   Steffann J, 2007, J MED GENET, V44, P664, DOI 10.1136/jmg.2006.048553
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Suomalainen A, 2011, SEMIN FETAL NEONAT M, V16, P236, DOI 10.1016/j.siny.2011.05.003
   Swalwell H, 2006, NEUROLOGY, V66, P447, DOI 10.1212/01.wnl.0000196490.36349.83
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   TEIN I, 1990, PEDIATR RES, V28, P247, DOI 10.1203/00006450-199009000-00020
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vanniarajan A, 2006, ACTA NEUROL SCAND, V114, P350, DOI 10.1111/j.1600-0404.2006.00673.x
   Voelker DR, 2009, ANNU REV BIOCHEM, V78, P827, DOI 10.1146/annurev.biochem.78.081307.112144
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 121
TC 58
Z9 67
U1 0
U2 14
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0971-5916
J9 INDIAN J MED RES
JI Indian J. Med. Res.
PD JAN
PY 2015
VL 141
BP 13
EP 26
PG 14
WC Immunology; Medicine, General & Internal; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; General & Internal Medicine; Research & Experimental
   Medicine
GA CF9RU
UT WOS:000352904600005
PM 25857492
DA 2024-11-01
ER

PT J
AU Houshmand, M
   Gardner, A
   Hällström, T
   Müntzing, K
   Oldfors, A
   Holme, E
AF Houshmand, M
   Gardner, A
   Hällström, T
   Müntzing, K
   Oldfors, A
   Holme, E
TI Different tissue distribution of a mitochondrial DNA duplication and the
   corresponding deletion in a patient with a mild mitochondrial
   encephalomyopathy:: deletion in muscle, duplication in blood
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mitochondria; mtDNA; duplication; deletion; long PCR
ID KEARNS-SAYRE SYNDROME; MARROW-PANCREAS SYNDROME; C-OXIDASE DEFICIENCY;
   TANDEM DUPLICATION; DIABETES-MELLITUS; REARRANGEMENTS; MYOPATHY;
   MAINTENANCE; MTDNA; SCALE
AB Large-scale heteroplasmic mtDNA rearrangements were identified in a 57-year-old woman with chronic depressive disorder, hearing-loss, diabetes mellitus and a slowly progressive encephalomyopathy. A high percentage of a 24.2 kb duplicated molecule was found in lymphocytes whereas the corresponding deletion dimer dominated in muscle. PCR and Southern blot analyses were used to identify a 7658 bp duplication/deletion fragment. The duplicated mtDNA disrupted the cytochrome oxidase subunit I and cytochrome b genes at a position where there were no direct repeats. Duplicated mtDNA was not observed in the mother and brother of the patient. Histochemical analysis of skeletal muscle demonstrated pathological accumulation of mitochondria in cytochrome c oxidase negative fibers. In situ hybridization demonstrated only deleted mtDNA in cytochrome c oxidase negative fibres. We conclude that occurrence of deleted mtDNA correlates with phenotypic expression and that the duplicated mtDNA might serve as a generator of deletions, but is not directly pathogenic. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Gothenburg, Sahlgrens Univ Hosp, Dept Clin Chem, S-41345 Gothenburg, Sweden.
   Huddinge Univ Hosp, Karolinska Inst, Div Psychiat, NEUROTEC, Stockholm, Sweden.
   Univ Gothenburg, Sahlgrens Univ Hosp, Dept Pathol, S-41345 Gothenburg, Sweden.
C3 Sahlgrenska University Hospital; University of Gothenburg; Karolinska
   Institutet; University of Gothenburg; Sahlgrenska University Hospital
RP Univ Gothenburg, Sahlgrens Univ Hosp, Dept Clin Chem, S-41345 Gothenburg, Sweden.
EM elisabeth.holme@clinchem.gu.se
RI Hällström, Tore/AAE-9255-2021; Houshmand, Massoud/AEG-9909-2022
OI , Masoud/0000-0001-7687-7464
CR BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67
   DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 1997, HUM MOL GENET, V6, P1251, DOI 10.1093/hmg/6.8.1251
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   LESTIENNE P, 1988, LANCET, V1, P885
   Manfredi G, 1997, ANN NEUROL, V42, P180, DOI 10.1002/ana.410420208
   McCann BS, 2000, J NEUROPSYCH CLIN N, V12, P240, DOI 10.1176/appi.neuropsych.12.2.240
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   NEGRIER MLM, 1988, AM J HUM GENET, V63, P1227
   OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G
   OLDFORS A, 1989, ACTA NEUROPATHOL, V77, P267, DOI 10.1007/BF00687578
   POULTON J, 1995, DIABETOLOGIA, V38, P868, DOI 10.1007/s001250050366
   POULTON J, 1994, HUM MOL GENET, V3, P947, DOI 10.1093/hmg/3.6.947
   POULTON J, 1989, LANCET, V1, P236
   POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23
   POULTON J, 1989, NUCLEIC ACIDS RES, V17, P10223, DOI 10.1093/nar/17.24.10223
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   ROTIG A, 1989, LANCET, V1, P902
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Tang YY, 2000, MOL BIOL CELL, V11, P2349, DOI 10.1091/mbc.11.7.2349
   Tang YY, 2000, MOL BIOL CELL, V11, P1471, DOI 10.1091/mbc.11.4.1471
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 26
TC 10
Z9 10
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD MAR
PY 2004
VL 14
IS 3
BP 195
EP 201
DI 10.1016/j.nmd.2003.12.002
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 802FR
UT WOS:000220149900003
PM 15036329
DA 2024-11-01
ER

PT J
AU Cheema, NJ
   Cameron, JM
   Hood, DA
AF Cheema, Nashwa J.
   Cameron, Jessie M.
   Hood, David A.
TI Effect of rapamycin on mitochondria and lysosomes in fibroblasts from
   patients with mtDNA mutations
SO AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
LA English
DT Article
DE human fibroblasts; lysosomes; mitochondrial health; mitochondrial
   myopathies; therapeutic agent
ID STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; OXIDATIVE STRESS; MELAS SYNDROME;
   ENCEPHALOPATHY; METABOLISM; MITOPHAGY; CELLS
AB Maintaining mitochondrial function and dynamics is crucial for cellular health. In muscle, defects in mitochondria result in severe myopathies where accumulation of damaged mitochondria causes deterioration and dysfunction. Importantly, understanding the role of mitochondria in disease is a necessity to determine future therapeutics. One of the most common myopathies is mitochondrial encephalopathy lactic acidosis stroke-like episodes (MELAS), which has no current treatment. Recently, patients with MELAS treated with rapamycin exhibited improved clinical outcomes. However, the cellular mechanisms of rapamycin effects in patients with MELAS are currently unknown. In this study, we used cultured skin fibroblasts as a window into the mitochondrial dysfunction evident in MELAS cells, as well as to study the mechanisms of rapamycin action, compared with control, healthy individuals. We observed that mitochondria from patients were fragmented, had a threefold decline in the average speed of motility, a twofold reduced mitochondrial membrane potential, and a 1.5- to 2-fold decline in basal respiration. Despite the reduction in mitochondrial function, mitochondrial import protein Tim23 was elevated in patient cell lines. MELAS fibroblasts exhibited increased MnSOD levels and lysosomal function when compared with healthy controls. Treatment of MELAS fibroblasts with rapamycin for 24 h resulted in increased mitochondrial respiration compared with control cells, a higher lysosome content, and a greater localization of mitochondria to lysosomes. Our studies suggest that rapamycin has the potential to improve cellular health even in the presence of mtDNA defects, primarily via an increase in lysosomal content.
C1 [Cheema, Nashwa J.; Hood, David A.] York Univ, Muscle Hlth Res Ctr, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada.
   [Cameron, Jessie M.] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON, Canada.
   [Cameron, Jessie M.] Univ Toronto, Hosp Sick Children, Dept Pathol & Lab Med, Toronto, ON, Canada.
C3 York University - Canada; University of Toronto; Hospital for Sick
   Children (SickKids); University of Toronto; Hospital for Sick Children
   (SickKids)
RP Hood, DA (corresponding author), York Univ, Muscle Hlth Res Ctr, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada.
EM dhood@yorku.ca
OI Hood, David/0000-0002-9553-152X
FU Natural Sciences and Engineering Research Council of Canada
FX This research was supported by funding from the Natural Sciences and
   Engineering Research Council of Canada.
CR Barca E, 2018, NEUROLOGY, V90
   Bartolomé A, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00441-17
   Berbel-Garcia A, 2004, CLIN NEUROPHARMACOL, V27, P187, DOI 10.1097/01.wnf.0000137862.67131.bf
   Civiletto G, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708799
   Connolly BS, 2010, BIOCHEM BIOPH RES CO, V402, P443, DOI 10.1016/j.bbrc.2010.10.060
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   Demers-Lamarche J, 2016, J BIOL CHEM, V291, P10263, DOI 10.1074/jbc.M115.695825
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189
   Garrido-Maraver J, 2015, BBA-MOL BASIS DIS, V1852, P2535, DOI 10.1016/j.bbadis.2015.08.027
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Iqbal S, 2014, AM J PHYSIOL-CELL PH, V306, pC1176, DOI 10.1152/ajpcell.00017.2014
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Johnson SC, 2019, KIDNEY INT, V95, P455, DOI 10.1016/j.kint.2018.08.038
   Joseph AM, 2004, AM J PHYSIOL-CELL PH, V286, pC867, DOI 10.1152/ajpcell.00191.2003
   Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208
   Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009
   McAlary L, 2019, CNS DRUGS, V33, P883, DOI 10.1007/s40263-019-00657-9
   Menzies KJ, 2009, AM J PHYSIOL-CELL PH, V296, pC355, DOI 10.1152/ajpcell.00415.2007
   Moran M, 1842, BIOCH BIOPHYS ACTA, P1059
   Paik K, 2019, CAN J NEUROL SCI, V46, P717, DOI 10.1017/cjn.2019.240
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Sato M, 2019, J PHARMACOL SCI, V140, P201, DOI 10.1016/j.jphs.2019.05.007
   Shin YJ, 2011, CURR EYE RES, V36, P1116, DOI 10.3109/02713683.2011.614372
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Steriade C, 2014, PEDIATR NEUROL, V50, P498, DOI 10.1016/j.pediatrneurol.2014.01.009
   Suarez-Rivero Juan M, 2016, Diseases, V5, DOI 10.3390/diseases5010001
   Tokuyama T, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030450
   Villa-Cuesta E, 2014, J CELL SCI, V127, P2282, DOI 10.1242/jcs.142026
   Zhang XL, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000252
NR 31
TC 12
Z9 12
U1 1
U2 5
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 0363-6143
EI 1522-1563
J9 AM J PHYSIOL-CELL PH
JI Am. J. Physiol.-Cell Physiol.
PD JUL
PY 2021
VL 321
IS 1
BP C176
EP C186
DI 10.1152/ajpcell.00471.2020
PG 11
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA WC6WT
UT WOS:000704397000016
PM 34106788
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Pronicka, E
   Weglewska-Jurkiewicz, A
   Taybert, J
   Pronicki, M
   Szymanska-Debinska, T
   Karkucinska-Wieckowska, A
   Jakobkiewicz-Banecka, J
   Kowalski, P
   Piekutowska-Abramczuk, D
   Pajdowska, M
   Socha, P
   Sykut-Cegielska, J
   Wegrzyn, G
AF Pronicka, Ewa
   Weglewska-Jurkiewicz, Anna
   Taybert, Joanna
   Pronicki, Maciej
   Szymanska-Debinska, Tamara
   Karkucinska-Wieckowska, Agnieszka
   Jakobkiewicz-Banecka, Joanna
   Kowalski, Pawel
   Piekutowska-Abramczuk, Dorota
   Pajdowska, Magdalena
   Socha, Piotr
   Sykut-Cegielska, Jolanta
   Wegrzyn, Grzegorz
TI Post mortem identification of deoxyguanosine kinase (<i>DGUOK</i>) gene
   mutations combined with impaired glucose homeostasis and iron overload
   features in four infants with severe progressive liver failure
SO JOURNAL OF APPLIED GENETICS
LA English
DT Article
DE DGUOK gene mutation; mtDNA depletion; Neonatal liver failure;
   Hypoglycemia; Iron overload; Natural history of the disease
ID MITOCHONDRIAL-DNA DEPLETION; RESPIRATORY-CHAIN; DEFICIENCY; METABOLISM
AB Deoxyguanosine kinase deficiency (dGK) is a frequent cause of the hepatocerebral form of mitochondrial depletion syndrome (MDS). A group of 28 infants with severe progressive liver failure of unknown cause was recruited for post mortem search for deoxyguanosine kinase (DGUOK) gene mutations. Four affected patients (14% of the studied group), two homozygotes, one compound heterozygote, and one heterozygote, with DGUOK mutation found on only one allele, were identified. Three known pathogenic mutations in the DGUOK gene were detected, c.3G > A (p.Met1Ile), c. 494A > T (p.Glu165Val), and c.766_767insGATT (p.Phe256X), and one novel molecular variant of unknown pathogeneity, c.813_814insTTT (p.Asn271_Thr272insPhe). Profound mitochondrial DNA depletion was confirmed in available specimens of the liver (4%, 15%, and 10% of the normal value) and in the muscle (4%, 23%, 45%, and 6%, respectively). The patients were born with low weights for gestational age and they presented adaptation trouble during the first days of life. Subsequently, liver failure developed, leading to death at the ages of 18, 6, 5.5, and 2.25 months, respectively. Mild neurological involvement was observed in all children (hypotonia, psychomotor retardation, and ptosis). Hypoglycemia (hypoketotic) and lactic acidosis were the constant laboratory findings. Elevated transferrin saturation, high ferritin, and alpha-fetoprotein levels resembled, in two cases, a neonatal hemochromatosis. Liver histopathology showed severe hepatic damage ranging from micronodular formation and cirrhosis to the total loss of liver architecture with diffuse fibrosis and neocholangiolar proliferation. Pancreatic islet cell hyperplasia with numerous confluent giant islets was found in both autopsied infants. Analysis of the natural history of the disease in our patients and the literature data led us to the following observations: (i) islet cell hyperplasia (and hyperinsulinism) may contribute to MDS-associated hypoglycemia; (ii) iron overload may additionally damage mtDNA-depleted tissues; (iii) low birth weight, adaptation trouble, and abnormal amino acids in newborn screening are frequent in dGK-deficient neonates.
C1 [Pronicka, Ewa; Weglewska-Jurkiewicz, Anna; Taybert, Joanna; Sykut-Cegielska, Jolanta] CMHI, Dept Metab Dis Endocrinol & Diabetol, PL-04730 Warsaw, Poland.
   [Weglewska-Jurkiewicz, Anna; Jakobkiewicz-Banecka, Joanna; Wegrzyn, Grzegorz] Univ Gdansk, Dept Mol Biol, PL-80952 Gdansk, Poland.
   [Pronicki, Maciej; Szymanska-Debinska, Tamara; Karkucinska-Wieckowska, Agnieszka] CMHI, Dept Pathol, PL-04730 Warsaw, Poland.
   [Kowalski, Pawel; Piekutowska-Abramczuk, Dorota] CMHI, Dept Med Genet, PL-04730 Warsaw, Poland.
   [Pajdowska, Magdalena] CMHI, Dept Biochem & Expt Med, PL-04730 Warsaw, Poland.
   [Socha, Piotr] CMHI, Dept Gastroenterol Hepatol & Immunol, PL-04730 Warsaw, Poland.
C3 Children's Memorial Health Institute; Fahrenheit Universities;
   University of Gdansk; Children's Memorial Health Institute; Children's
   Memorial Health Institute; Children's Memorial Health Institute;
   Children's Memorial Health Institute
RP Pronicka, E (corresponding author), CMHI, Dept Metab Dis Endocrinol & Diabetol, Aleja Dzieci Polskich 20, PL-04730 Warsaw, Poland.
EM e.pronicka@czd.pl
RI Sykut-Cegielska, Jolanta/V-4253-2019; Wegrzyn, Grzegorz/AAL-1179-2020;
   Jakóbkiewicz-Banecka, Joanna/C-2365-2014; Pajdowska,
   Magdalena/V-9639-2018
OI Karkucinska-Wieckowska, Agnieszka/0000-0003-4936-1571; Kowalski,
   Pawel/0000-0002-0240-6974; Sykut-Cegielska, Jolanta/0000-0003-0762-3721;
   Pajdowska, Magdalena/0000-0002-1334-3534; Pronicki,
   Maciej/0000-0002-5589-0456; Socha, Piotr/0000-0002-1621-464X;
   Piekutowska-Abramczuk, Dorota/0000-0002-9786-3704; Wegrzyn,
   Grzegorz/0000-0003-4042-7466; Pronicka, Ewa/0000-0002-5705-4814;
   Taybert, Joanna/0000-0002-3352-2126; Jakobkiewicz-Banecka,
   Joanna/0000-0002-8846-5448
FU Polish Mitochondrial Network;  [PB 0890/P05/2005/29]
FX The study was supported by grant no. PB 0890/P05/2005/29 and the Polish
   Mitochondrial Network.
CR BACON BR, 1993, GASTROENTEROLOGY, V105, P1134, DOI 10.1016/0016-5085(93)90959-G
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Brahimi N, 2009, MOL GENET METAB, V97, P221, DOI 10.1016/j.ymgme.2009.03.007
   Dimmock DP, 2008, LIVER TRANSPLANT, V14, P1480, DOI 10.1002/lt.21556
   Filosto M, 2004, ACTA NEUROPATHOL, V108, P168, DOI 10.1007/s00401-004-0872-9
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Hargreaves IP, 2002, J INHERIT METAB DIS, V25, P7, DOI 10.1023/A:1015104910239
   Labarthe F, 2005, J HEPATOL, V43, P333, DOI 10.1016/j.jhep.2005.03.023
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1445, DOI 10.1001/archneur.60.10.1445
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Müller-Höcker J, 2002, HUM PATHOL, V33, P247, DOI 10.1053/hupa.2002.31477
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   Ponka P, 2002, SEMIN HEMATOL, V39, P249, DOI 10.1053/shem.2002.35638
   Poulton J, 2009, BBA-MOL BASIS DIS, V1792, P1109, DOI 10.1016/j.bbadis.2009.08.016
   Rabinowitz SS, 2004, J PEDIATR GASTR NUTR, V38, P216, DOI 10.1097/00005176-200402000-00022
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Scheers I, 2005, J PEDIATR-US, V146, P414, DOI 10.1016/j.jpeds.2004.10.023
   Siafakas CG, 1997, J PEDIATR GASTR NUTR, V25, P321, DOI 10.1097/00005176-199709000-00015
   Slama A, 2005, MOL GENET METAB, V86, P462, DOI 10.1016/j.ymgme.2005.09.006
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Weglewska Anna, 2005, Journal of Applied Genetics, V46, P423
   Weglewska-Jurkiewicz A, 2009, THESIS GDANSK
NR 26
TC 40
Z9 44
U1 0
U2 5
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1234-1983
EI 2190-3883
J9 J APPL GENET
JI J. Appl. Genetics
PD FEB
PY 2011
VL 52
IS 1
BP 61
EP 66
DI 10.1007/s13353-010-0008-y
PG 6
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 760SY
UT WOS:000290345300008
PM 21107780
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Urban, DL
   Scholle, LM
   Wagner, M
   Ludolph, AC
   Rosenbohm, A
AF Urban, Diana Lehmann
   Scholle, Leila Motlagh
   Wagner, Matias
   Ludolph, Albert C.
   Rosenbohm, Angela
TI The m.9143T&gt;C Variant: Recurrent Infections and Immunodeficiency as
   an Extension of the Phenotypic Spectrum in <i>MT-ATP6</i> Mutations?
SO DISEASES
LA English
DT Article
DE MT-ATP6; mitochondrial disease; immune deficiency; phenotypic spectrum
ID MITOCHONDRIAL; MTDNA; DYSFUNCTION; DISEASE
AB Pathogenic variants in the MT-ATP6 are a well-known cause for maternally inherited mitochondrial disorders associated with a wide range of clinical phenotypes. Here, we present a 31- year old female with insulin-dependent diabetes mellitus, recurrent lactic acidosis and ketoacidosis recurrent infections with suspected immunodeficiency with T cell lymphopenia and hypogammaglobulinemia as well as proximal tetraparesis with severe muscle and limb pain and rapid physical exhaustion. Muscle biopsy and respiratory chain activities were normal. Single-exome sequencing revealed a variant in the MT-ATP6 gene: m.9143T>C. Analysis of further specimen of the index and mother (segregation studies) revealed the highest mutation load in muscle (99% level of mtDNA heteroplasmy) of the index patient. Interestingly, acute metabolic and physical decompensation during recurrent illness was documented to be a common clinical feature in patients with MT-ATP6 variants. However, it was not mentioned as a key symptom. Thus, we suggest that the clinical spectrum might be expanded in ATP6-associated diseases.
C1 [Urban, Diana Lehmann; Ludolph, Albert C.; Rosenbohm, Angela] Ulm Univ, Dept Neurol, D-89081 Ulm, Germany.
   [Scholle, Leila Motlagh] Univ Halle S, Dept Neurol, D-06120 Halle, Germany.
   [Wagner, Matias] Tech Univ Munich, Sch Med, Inst Human Genet, D-81675 Munich, Germany.
   [Wagner, Matias] Helmholtz Zentrum Munchen, Inst Neurogen, D-85764 Munich, Germany.
C3 Ulm University; Martin Luther University Halle Wittenberg; Technical
   University of Munich; Helmholtz Association; Helmholtz-Center Munich -
   German Research Center for Environmental Health
RP Urban, DL (corresponding author), Ulm Univ, Dept Neurol, D-89081 Ulm, Germany.
EM diana.lehmann@rku.de; leila.scholle@medizin.uni-halle.de;
   Matias.Wagner@mri.tum.de; albert.ludolph@rku.de;
   angela.rosenbohm@uni-ulm.de
RI Rosenbohm, Angela/GOJ-9292-2022; Wagner, Matias/AEB-0432-2022
FU German Research Foundation (DFG)
FX We acknowledge the excellent technical assistance of Martina Leis
   (Muscle Laboratory of the Department of Neurology, University Hospital
   Ulm, Germany). We acknowledge the financial support within the funding
   programme Open Access Publishing by the German Research Foundation
   (DFG).
CR Angajala A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01605
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   CIAFALONI E, 1993, J PEDIATR-US, V122, P419, DOI 10.1016/S0022-3476(05)83431-6
   Eom S, 2017, PEDIATR NEUROL, V66, P82, DOI 10.1016/j.pediatrneurol.2016.10.006
   Ganetzky RD, 2019, HUM MUTAT, V40, P499, DOI 10.1002/humu.23723
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Kapniciz SM, 2018, METABOLISM, V81, P97, DOI 10.1016/j.metabol.2017.11.010
   Mohanty A, 2019, J CELL COMMUN SIGNAL, V13, P303, DOI 10.1007/s12079-019-00507-9
   Scholle LM, 2020, GENES-BASEL, V11, DOI 10.3390/genes11020212
   Ng YS, 2019, ANN NEUROL, V86, P310, DOI 10.1002/ana.25525
   Pfeffer G, 2012, J NEUROL NEUROSUR PS, V83, P883, DOI 10.1136/jnnp-2012-302568
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Posey JE, 2016, GENET MED, V18, P678, DOI 10.1038/gim.2015.142
   Quadalti C, 2018, BBA-MOL BASIS DIS, V1864, P2131, DOI 10.1016/j.bbadis.2018.03.021
   Ruppert V, 2004, BIOCHEM BIOPH RES CO, V318, P535, DOI 10.1016/j.bbrc.2004.04.061
   Sikorska M, 2009, MUSCLE NERVE, V40, P381, DOI 10.1002/mus.21355
   Stendel C, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000393
   Tabbada KA, 2010, MOL BIOL EVOL, V27, P21, DOI 10.1093/molbev/msp215
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Thorburn D.R., 1993, GENEREVIEWS R
   Tiku V, 2020, TRENDS CELL BIOL, V30, P263, DOI [10.1016/j.tcb.2020.01.006, 10.1016/j.tcb.2020.07.001]
   Wagner M, 2019, J INHERIT METAB DIS, V42, P909, DOI 10.1002/jimd.12109
NR 23
TC 1
Z9 1
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-9721
J9 DISEASES-BASEL
JI Diseases
PD JUN
PY 2020
VL 8
IS 2
AR 19
DI 10.3390/diseases8020019
PG 7
WC Medicine, Research & Experimental
WE Emerging Sources Citation Index (ESCI)
SC Research & Experimental Medicine
GA TY8EW
UT WOS:000684013600012
PM 32527054
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Casademont, J
   Perea, M
   López, S
   Beato, A
   Miró, O
   Cardellach, F
AF Casademont, J
   Perea, M
   López, S
   Beato, A
   Miró, O
   Cardellach, F
TI Enzymatic diagnosis of oxidative phosphorylation defects on muscle
   biopsy:: Better on tissue homogenate or on a mitochondria-enriched
   suspension?
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE mitochondria; respiratory chain; heteroplasmy; MELAS; enzymatic
   diagnosis
ID HUMAN SKELETAL-MUSCLE; RESPIRATORY-CHAIN; IN-VIVO; MAINTENANCE;
   DISORDERS; DISEASES; MTDNA
AB Background: The enzymatic analysis of mitochondrial respiratory chain (MRC) complexes of skeletal muscle is an important step in the diagnosis of mitochondrial disorders. Because of its lesser turbidity and increased sensitivity, mitochondrial fractionation has been increasingly considered the diagnostic method of choice compared with the more classical analysis of muscle homogenate. In circumstances in which mitochondria become abnormal in number, size or shape, the process of mitochondrial enrichment made by sequential centrifugation and washing may favor the selection of the most normal mitochondria, eliminating the most abnormal ones. In this situation, the study of muscle homogenate, paradoxically, may better reflect what happens in vivo.
   Case Report: To exemplify this situation we present a 60-year-old woman with a complete mitochondrial phenotype and a 70% heteroplasmic presence of the mtDNA A3243G mutation in muscle tissue. The respiratory and enzymatic activities from mitochondria-enriched muscle suspension were within normal control limits. In contrast, when muscle homogenate was studied, enzyme activities of complexes I, III, and V were found to be decreased.
   Conclusions: Although mitochondria-enriched muscle suspensions are usually more informative than muscle homogenates for studies of MRC, in some situations it may be necessary to study both to uncover the biochemical defect.
C1 Univ Barcelona, Hosp Clin Barcelona, Fac Med, Sch Med,Dept Med Grp Invest Muscular,IDIBAPS,Dept, E-08036 Barcelona, Catalonia, Spain.
C3 University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS
RP Univ Barcelona, Hosp Clin Barcelona, Fac Med, Sch Med,Dept Med Grp Invest Muscular,IDIBAPS,Dept, UB,Villarroel 170, E-08036 Barcelona, Catalonia, Spain.
EM jordi@medicina.ub.es
RI Miro, Oscar/K-1798-2019; Lopez, Sonia/AAC-8830-2019; Casademont,
   Jordi/A-6828-2010
OI Miro Andreu, Oscar/0000-0001-8127-166X; Lopez, Sonia/0000-0002-5023-5153
CR Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210
   Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CARDELLACH F, 1992, ANN NEUROL, V31, P515, DOI 10.1002/ana.410310509
   CARDELLACH F, 1991, BIOCHEM J, V274, P565, DOI 10.1042/bj2740565
   DiMauro S, 2000, BRAIN PATHOL, V10, P431
   Fischel-Ghodsian N, 2000, MOL GENET METAB, V71, P93, DOI 10.1006/mgme.2000.3014
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HOWELL N, 2000, HUM REPROD         S, V2, P235
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Miró O, 1999, EUR J CLIN PHARMACOL, V55, P35, DOI 10.1007/s002280050589
   Miró O, 1998, J NEUROSCI METH, V80, P107, DOI 10.1016/S0165-0270(97)00204-5
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   RUSTIN P, 1991, LANCET, V338, P60, DOI 10.1016/0140-6736(91)90057-V
   Schaefer Andrew M., 2001, Current Opinion in Pharmacology, V1, P288
   SHAPIRA AHV, 1994, MITOCHONDRIAL DISORD, P75
   SLINDE E, 1975, ANAL BIOCHEM, V66, P151, DOI 10.1016/0003-2697(75)90733-2
   Turnbull DM, 1998, NAT GENET, V18, P199, DOI 10.1038/ng0398-199
   Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Zeviani M, 1998, MEDICINE, V77, P59, DOI 10.1097/00005792-199801000-00006
NR 22
TC 12
Z9 12
U1 0
U2 0
PU INT SCIENTIFIC INFORMATION, INC
PI MELVILLE
PA 150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD SEP
PY 2004
VL 10
IS 9
BP CS49
EP CS53
PG 5
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 867HR
UT WOS:000224833800016
PM 15328490
DA 2024-11-01
ER

PT J
AU Martín-Jiménez, R
   Martín-Hernández, E
   Cabello, A
   García-Silva, MT
   Arenas, J
   Campos, Y
AF Martin-Jimenez, Rebeca
   Martin-Hernandez, Elena
   Cabello, Ana
   Teresa Garcia-Silva, Maria
   Arenas, Joaquin
   Campos, Yolanda
TI Clinical and cellular consequences of the mutation m.12300G&gt;A in the
   mitochondrial tRNA<SUP>Leu(CUN)</SUP> gene
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial disease; Mitochondrial DNA tRNA(Leu(CUN)) gene; Cybrid;
   ATP; Mitochondrial membrane potential; Reactive oxygen species
ID MTDNA; MELAS; ENCEPHALOMYOPATHY; FIBROBLASTS; DISEASE; CELLS; PATIENT;
   MUSCLE; MERRF; LINES
AB We report, for the first time, a patient with an overlap MERRF-NARP syndrome who carries the mutation m.12300G>A in the mitochondrial tRNA(Leu(CUN)) gene. The mutation was heteroplamic and more abundant in her muscle and fibroblast than in blood from her oligosymptomatic mother. Single muscle fiber analysis revealed that the proportion of mutant mtDNA in ragged red fibers was higher than that in normal fibers. Combined defects of mitochondrial respiratory chain complexes were detected in muscle, fibroblasts and transmitochondrial hybrid cells. Significant reduction of total ATP and mitochondrial membrane potential and an increased production of reactive oxygen species were observed. (C) 2011 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Martin-Jimenez, Rebeca; Campos, Yolanda] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Patol Mitocondrial, Madrid 28220, Spain.
   [Martin-Hernandez, Elena; Teresa Garcia-Silva, Maria] Hosp Univ 12 Octubre, Dept Pediat, Unidad Enfermedades Metabol Hereditarias & Mitoco, Madrid, Spain.
   [Cabello, Ana] Hosp Univ 12 Octubre, Dept Neuropatol, Madrid, Spain.
   [Arenas, Joaquin] Inst Salud Carlos III, Subdirecc Gen Evaluac & Promoc Invest, Madrid 28220, Spain.
C3 Instituto de Salud Carlos III; Centro Nacional de Microbiologia (CNM);
   Hospital Universitario 12 de Octubre; Hospital Universitario 12 de
   Octubre; Instituto de Salud Carlos III
RP Campos, Y (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Patol Mitocondrial, Ctra Majadahonda Pozuelo Km 2, Madrid 28220, Spain.
EM rmartin@isciii.es; emartinh.hdoc@salud.madrid.org;
   acabello.hdoc@salud.madrid.org; mgarcias.hdoc@salud.madrid.org;
   jarenas@isciii.es; ycampos@isciii.es
RI Yolanda, Campos/A-8711-2017
OI Martin-Hernandez, Elena/0000-0002-0656-7660; /0000-0003-2897-4918;
   Arenas, Joaquin/0000-0002-2877-5049; CAMPOS, YOLANDA/0000-0003-4785-9659
FU Fondo de Investigacion Sanitaria (FIS) [PI 06/1030, PS09/2341];
   Instituto de Salud Carlos III, Spanish Ministry of Science and
   Innovation [UIPY 07/1464]
FX This work was supported by grants from Fondo de Investigacion Sanitaria
   (FIS) (PI 06/1030; PS09/2341) and Instituto de Salud Carlos III (UIPY
   07/1464), Spanish Ministry of Science and Innovation. R. Martin was
   supported by grants from FIS (PI 06/1030, PS09/2341). We want to
   acknowledge the excellent technical assistance of Eva Maria Fernandez,
   Veronica Merino, Ainhoa Martinez and Jose Luis Alvarez. We would like to
   thank Rafael Garesse and Emiliano Gonzalez-Vioque for their assistance
   in the generation of cybrid cells.
CR Antonická H, 1999, BIOCHEM J, V342, P537, DOI 10.1042/0264-6021:3420537
   Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Campos Y, 1996, NEUROLOGY, V47, P1012, DOI 10.1212/WNL.47.4.1012
   Chalmers-Redman RME, 1999, BIOCHEM BIOPH RES CO, V257, P440, DOI 10.1006/bbrc.1999.0487
   del Hoyo P, 2006, NEUROCHEM RES, V31, P1103, DOI 10.1007/s11064-006-9110-2
   DiMauro S, 2006, CURR OPIN RHEUMATOL, V18, P636, DOI 10.1097/01.bor.0000245729.17759.f2
   El Meziane A, 1998, NAT GENET, V18, P350
   El Meziane A, 1998, HUM MOL GENET, V7, P2141, DOI 10.1093/hmg/7.13.2141
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kirino Y, 2006, HUM MOL GENET, V15, P897, DOI 10.1093/hmg/ddl007
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Maneiro E, 2005, ANN RHEUM DIS, V64, P388, DOI 10.1136/ard.2004.022152
   McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Navarro-Sastre A, 2008, MOL GENET METAB, V94, P234, DOI 10.1016/j.ymgme.2008.01.012
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   SCHON EA, 1992, BIOCHIM BIOPHYS ACTA, V1101, P206, DOI 10.1016/0005-2728(92)90226-R
   Schon EA, 2010, TRENDS MOL MED, V16, P268, DOI 10.1016/j.molmed.2010.04.007
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Seibel P, 2008, NUCLEIC ACIDS RES, V36, P5872, DOI 10.1093/nar/gkn592
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Vergani L, 1999, HUM MOL GENET, V8, P1751, DOI 10.1093/hmg/8.9.1751
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
NR 27
TC 3
Z9 3
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR
PY 2012
VL 12
IS 2
BP 288
EP 293
DI 10.1016/j.mito.2011.10.004
PG 6
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 913VX
UT WOS:000301906600015
PM 22094595
DA 2024-11-01
ER

PT J
AU Morava, E
   Rodenburg, RJ
   Hol, F
   de Vries, M
   Janssen, A
   van den Heuvel, L
   Nijtmans, L
   Smeitink, J
AF Morava, E
   Rodenburg, RJ
   Hol, F
   de Vries, M
   Janssen, A
   van den Heuvel, L
   Nijtmans, L
   Smeitink, J
TI Clinical and biochemical characteristics in patients with a high mutant
   load of the mitochondrial T8993G/C mutations
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE T8993C/G; mitochondrial mutation; Leigh syndrome; complex V; assembly
   defect
ID ATP-SYNTHASE; LEIGH-SYNDROME; OXIDATIVE-PHOSPHORYLATION;
   ELECTRON-MICROSCOPY; NARP SYNDROME; DNA MUTATION; MTDNA; GENE;
   DEFICIENCY; SUBUNIT-6
AB We retrospectively analyzed the clinical, histological, and biochemical data of 11 children, five of which carried the maternally-inherited mitochondrial T8993C and six carrying the T8993G point mutations in the ATP synthase 6 gene. The percentage of heteroplasmy was 95% or higher in muscle and in blood. All patients had an early clinical presentation with muscle hypotonia, severe extrapyramidal dysfunction and Leigh disease demonstrated by the cranial MRI. A slower clinical progression and more frequent sensory-neuronal involvement were noted in the patients carrying the T8993C mutation in a high Mutation load in muscle and blood. No histological abnormality was found, In 9 out of 11 patients a decreased ATP production was detected, and complex V activity was deficient in all children. The activities of the respiratory enzyme complexes II and IV were normal, whereas an associated combined complex I and III deficiency were present in two patients. No obvious difference was found between the biochemical parameters of the two patient groups harboring different mutations in the same gene. No correlation was found between the degree of complex V enzyme deficiency and the severity of the phenotype. We confirmed an impaired assembly/stability of complex V in our patients. This is the first report of decreased activity and impaired assembly/stability of complex V in patients with T8993C mutations measured in muscle tissue. (c) 2006 Wiley-Liss, Inc.
C1 Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, NL-6500 HB Nijmegen, Netherlands.
   Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.
C3 Radboud University Nijmegen; Radboud University Nijmegen
RP Morava, E (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM E.Morava@cukz.umcn.nl
RI Morava, E./L-4529-2015; Nijtmans, L.G.J./L-4549-2015; Smeitink,
   Jan/C-1351-2013; van den Heuvel, Lambertus/AAM-1772-2021; Rodenburg,
   Richard/N-3579-2014
OI Rodenburg, Richard/0000-0001-5227-3527
CR Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200
   Coskun U, 2004, J BIOL CHEM, V279, P38644, DOI 10.1074/jbc.M406196200
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Fujii T, 1998, PEDIATR NEUROL, V18, P275, DOI 10.1016/S0887-8994(97)00187-2
   García JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A
   Janssen AJM, 2003, ANN CLIN BIOCHEM, V40, P3, DOI 10.1258/000456303321016114
   Majander A, 1997, FEBS LETT, V412, P351, DOI 10.1016/S0014-5793(97)00757-6
   MAKELABENGS P, 1995, PEDIATR RES, V37, P634
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Parfait B, 1999, EUR J PEDIATR, V158, P55, DOI 10.1007/s004310051009
   PASTORES GM, 1994, AM J MED GENET, V50, P265, DOI 10.1002/ajmg.1320500310
   ROBINSON BH, 1994, J BIOENERG BIOMEMBR, V26, P311, DOI 10.1007/BF00763102
   Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3
   Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608
   Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281
   SGARBI G, 2006, BIOCH J
   Smeitink J, 2001, J BIOENERG BIOMEMBR, V33, P259, DOI 10.1023/A:1010743321800
   TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390
   TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
NR 27
TC 62
Z9 64
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4825
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD APR 15
PY 2006
VL 140A
IS 8
BP 863
EP 868
DI 10.1002/ajmg.a.31194
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 029OC
UT WOS:000236571700008
PM 16532470
DA 2024-11-01
ER

PT J
AU Divi, RL
   Walker, VE
   Wade, NA
   Nagashima, K
   Seilkopf, SK
   Adams, ME
   Nesel, CJ
   O'Neill, JP
   Abrams, EJ
   Poirier, MC
AF Divi, RL
   Walker, VE
   Wade, NA
   Nagashima, K
   Seilkopf, SK
   Adams, ME
   Nesel, CJ
   O'Neill, JP
   Abrams, EJ
   Poirier, MC
TI Mitochondrial damage and DNA depletion in cord blood and umbilical cord
   from infants exposed in utero to Combivir
SO AIDS
LA English
DT Article
DE leukocytes; zidovudine; lamivudine; electron microscopy;
   PCR-chemiluminescence immunoasssay detection
ID IMMUNODEFICIENCY-VIRUS TYPE-1; UNINFECTED INFANTS; PREGNANT-WOMEN;
   ZIDOVUDINE; TOXICITY; FETAL; TRANSMISSION; DYSFUNCTION; MYOPATHY;
   HYPERLACTATEMIA
AB Objective: Although most uninfected infants born to women infected with HIV-1 show no clinical evidence of mitochondrial compromise, mitochondrial dysfunction has been reported in children born to women receiving zidovudine and/or lamivudine during pregnancy. In this pilot study we examined mitochondrial integrity in HIV-1-uninfected infants born to HIV-1-infected women receiving Combivir during pregnancy.
   Design: Samples of umbilical cord and cord blood were obtained from HIV-1-uninfected infants born to either HIV-1-infected women receiving Combivir therapy during pregnancy (n = 10) or HIV-1-uninfected women (n = 9).
   Methods: Mitochondrial morphological integrity was examined in umbilical cords (n = 16) by electron microscopy and mtDNA quantity was determined in DNA from cord blood (n = 18) and umbilical cord (n = 18) by PCR-chemiluminescence immunoassay detection.
   Results: In umbilical cords from six of nine infants born to HIV-1-infected mothers taking Combivir moderate to severe mitochondrial morphological damage was observed (P = 0.011), while none of seven unexposed infants showed similar damage. Compared to unexposed infants, statistically significant mtDNA depletion was observed in umbilical cord (P = 0.006) and cord blood (P = 0.003) from drug-exposed infants.
   Conclusions: A cohort of HIV-1-uninfected Combivir-exposed infants with no clinical symptoms showed morphological and molecular evidence of mitochondrial damage. (C) 2004 Lippincott Williams Wilkins.
C1 NCI, CDI Sect, NIH, Bethesda, MD 20892 USA.
   Lovelace Resp Res Inst, Albuquerque, NM USA.
   Albany Med Ctr, Childrens Hosp, Dept Pediat, Albany, NY USA.
   New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.
   NCI, SAIC, Frederick, MD 21701 USA.
   SKS Consulting Serv, Siler City, NC USA.
   Westat Corp, Rockville, MD USA.
   Univ Vermont, Genet Lab, Burlington, VT USA.
   Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY USA.
   Columbia Univ Coll Phys & Surg, Harlem Hosp Ctr, New York, NY 10032 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI); Lovelace Respiratory Research Institute; Albany Medical College;
   State University of New York (SUNY) System; Wadsworth Center; Science
   Applications International Corporation (SAIC); SAIC-Frederick; National
   Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI);
   Westat; University of Vermont; Columbia University; Columbia University
RP NCI, CDI Sect, NIH, Bldg 37,Rm 4032,37 Convent Dr,MSC-4255, Bethesda, MD 20892 USA.
RI WALKER, VERNON/AAC-8500-2020
FU NHLBI NIH HHS [R01-HL72727] Funding Source: Medline; NICHD NIH HHS
   [R01-HD33648] Funding Source: Medline
CR AGRESTI A, 1996, STAT SCI, V7, P131
   Alimenti A, 2003, PEDIATR INFECT DIS J, V22, P782, DOI 10.1097/01.inf.0000086400.93257.74
   Anderson J, 2002, OBSTET GYNECOL, V99, P1117
   Barret B, 2003, AIDS, V17, P1769, DOI 10.1097/00002030-200308150-00006
   Beach JW, 1998, CLIN THER, V20, P2
   Blanche S, 1999, LANCET, V354, P1084, DOI 10.1016/S0140-6736(99)07219-0
   Brinkman K, 2001, AIDS, V15, P795, DOI 10.1097/00002030-200104130-00016
   Bulterys M, 2000, J ACQ IMMUN DEF SYND, V25, P261, DOI 10.1097/00126334-200011010-00009
   Caselli D, 2000, J CLIN ONCOL, V18, P3854, DOI 10.1200/JCO.2000.18.22.3854
   CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   Culnane M, 1999, JAMA-J AM MED ASSOC, V281, P151, DOI 10.1001/jama.281.2.151
   CUPLER EJ, 1995, ACTA NEUROPATHOL, V90, P1
   Dagan T, 2002, MITOCHONDRION, V1, P397, DOI 10.1016/S1567-7249(02)00003-X
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   Ewings EL, 2000, J ACQ IMMUN DEF SYND, V24, P100
   Feng JY, 2001, J BIOL CHEM, V276, P23832, DOI 10.1074/jbc.M101156200
   Gérard Y, 2000, AIDS, V14, P2723
   Gerschenson M, 2000, AIDS RES HUM RETROV, V16, P635, DOI 10.1089/088922200308864
   Gerschenson M, 2004, AIDS RES HUM RETROV, V20, P91, DOI 10.1089/088922204322749530
   Glantz S., 1997, PRIMER BIOSTATISTICS
   Hanson IC, 1999, J ACQ IMMUN DEF SYND, V20, P463, DOI 10.1097/00042560-199904150-00008
   Hollander M., 1973, Nonparametric statistical methods
   LEWIS W, 1994, CIRC RES, V74, P344, DOI 10.1161/01.RES.74.2.344
   LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417
   Lipshultz SE, 2000, NEW ENGL J MED, V343, P759, DOI 10.1056/NEJM200009143431102
   Meng QX, 2000, P NATL ACAD SCI USA, V97, P12667, DOI 10.1073/pnas.220203197
   MHIRI C, 1991, ANN NEUROL, V29, P606, DOI 10.1002/ana.410290607
   Mofenson LM, 2002, J ACQ IMMUN DEF SYND, V30, P200, DOI [10.1097/00042560-200206010-00010, 10.1097/01.QAI.0000018366.28828.86]
   Mofenson LM, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.6.e88
   Newschaffer CJ, 2000, J ACQ IMMUN DEF SYND, V24, P249
   Olivero OA, 2002, J ACQ IMMUN DEF SYND, V29, P323
   Olivero OA, 1999, AIDS, V13, P919, DOI 10.1097/00002030-199905280-00007
   Pennell CE, 1999, AUST NZ J OBSTET GYN, V39, P227, DOI 10.1111/j.1479-828X.1999.tb03379.x
   Poirier MC, 2003, JAIDS-J ACQ IMM DEF, V33, P175, DOI 10.1097/00126334-200306010-00010
   Shiramizu B, 2003, JAIDS-J ACQ IMM DEF, V32, P370, DOI 10.1097/00126334-200304010-00004
   Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201
   TOMELLERI G, 1992, ITAL J NEUROL SCI, V13, P723, DOI 10.1007/BF02229156
   Tuomala RE, 2002, NEW ENGL J MED, V346, P1863, DOI 10.1056/NEJMoa991159
   Veal GJ, 1996, AIDS, V10, P546, DOI 10.1097/00002030-199605000-00016
   Walker UA, 2002, AIDS, V16, P2165, DOI 10.1097/00002030-200211080-00009
   Walker UA, 2002, J ACQ IMMUN DEF SYND, V29, P117, DOI 10.1097/00042560-200202010-00002
   Walker V. E., 2001, Environmental and Molecular Mutagenesis, V37, P77
   *WHO, IARC MON EV CARC RIS, V76, P1
NR 44
TC 69
Z9 78
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0269-9370
EI 1473-5571
J9 AIDS
JI Aids
PD APR 30
PY 2004
VL 18
IS 7
BP 1013
EP 1021
DI 10.1097/00002030-200404300-00009
PG 9
WC Immunology; Infectious Diseases; Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases; Virology
GA 821OG
UT WOS:000221470100010
PM 15096804
OA Bronze
DA 2024-11-01
ER

PT J
AU Da Pozzo, P
   Cardaioli, E
   Radi, E
   Federico, A
AF Da Pozzo, P
   Cardaioli, E
   Radi, E
   Federico, A
TI Sequence analysis of the complete mitochondrial genome in patients with
   mitochondrial encephaloneuromyopathies lacking the common pathogenic DNA
   mutations
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE mitochondrial encephaloneuromyopathies; mtDNA; mutation; polymorphism;
   heteroplasmic; homoplasmic
ID MTDNA; ENCEPHALOMYOPATHY; CARDIOMYOPATHY; DISORDERS
AB The purpose of this study was to identify novel mitochondrial deoxyribonucleic acid (mtDNA) mutations in a series of patients with clinical and/or morphological features of mitochondrial dysfunction, but still no genetic diagnosis. A heterogeneous group of clinical disorders is caused by mutations in mtDNA that damage respiratory chain function of cell energy production. We developed a method to systematically screen the entire mitochondrial genome. The sequence-data were obtained with a rapid automated system. In the six mitochondrial genomes analysed we found 20 variants of the revised Cambridge reference sequence [Nat. Genet. 23 (1999) 147]. In skeletal muscle nineteen novel mtDNA variants were homoplasmic, suggesting secondary pathogenicity or co-responsibility in determination of the disease. In one patient we identified a novel heteroplasmic mtDNA mutation which presumably has a pathogenic role. This screening is therefore useful to extend the mtDNA polymorphism database and should facilitate definition of disease-related mutations in human mtDNA. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Siena, Dept Neurol & Behav Sci, Unit Neurol & Neurmetab Dis, I-53100 Siena, Italy.
   Univ Siena, Ctr Res Therapy & Prevent Neurhandicap, I-53100 Siena, Italy.
   Associaz Anni Verdi, Rome, Italy.
C3 University of Siena; University of Siena
RP Univ Siena, Dept Neurol & Behav Sci, Unit Neurol & Neurmetab Dis, Via Laterina 8, I-53100 Siena, Italy.
EM federico@unisi.it
RI Federico, Antonio/H-8871-2017
OI Cardaioli, Elena/0000-0003-2850-6698; federico,
   antonio/0000-0002-5246-1621
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   DiMauro S, 2000, BRAIN PATHOL, V10, P431
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Fauser S, 2002, BIOCHEM BIOPH RES CO, V295, P342, DOI 10.1016/S0006-291X(02)00672-1
   Hutchin TP, 2000, CELL MOL LIFE SCI, V57, P1927, DOI 10.1007/PL00000673
   Kovalenko SA, 1996, BIOCHEM BIOPH RES CO, V222, P201, DOI 10.1006/bbrc.1996.0722
   Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M
   Marchington DR, 1996, HUM MOL GENET, V5, P473, DOI 10.1093/hmg/5.4.473
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   SHOFFNER JM, 1995, NEUROLOGY, V45, P286, DOI 10.1212/WNL.45.2.286
   Simon DK, 1999, ANNU REV MED, V50, P111
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   TORRONI K, 1996, GENETICS, V144, P1835
   WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661
   Zeviani M, 1997, MOL HUM REPROD, V3, P133, DOI 10.1093/molehr/3.2.133
NR 17
TC 13
Z9 13
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD NOV 5
PY 2004
VL 324
IS 1
BP 360
EP 364
DI 10.1016/j.bbrc.2004.09.058
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 863WX
UT WOS:000224595300055
PM 15465027
DA 2024-11-01
ER

PT J
AU Fang, P
   Wu, CS
   Zhou, MH
   Xu, RS
   Liu, XH
   Wei, CX
AF Fang, Pu
   Wu, Chengsi
   Zhou, Meihong
   Xu, Renshi
   Liu, Xianhua
   Wei, Caixia
TI Myopathological features in MELAS syndrome without significant changes
   in muscle biopsy pathology
SO NEURAL REGENERATION RESEARCH
LA English
DT Article
DE mitochondrial encephalomyopathy, lactic acidosis, and stroke-like
   episodes syndrome; muscle biopsy; neuroimaging; pathology
ID STROKE-LIKE-EPISODES; A3243G MUTATION; MITOCHONDRIAL; DISEASES; LOAD;
   MRI
AB Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) are common types of mitochondrial encephalomyopathy. The involved muscular pathology is characterized by typical changes of mitochondrial abnormalities. Gene screening has been the gold diagnostic standard for MELAS diagnosis. This study presents three primary MELAS patients, with an age of onset from 13 to 18 years, including one patient with seizure, and two with headache and vomiting. All patients had a family history of disease, with maternal inheritance. Cerebral magnetic resonance imaging revealed abnormally high signals in T2-weighted images: temporal lobe in three cases, occipital lobe in two cases, and parietal lobe in one case. Migrating stroke-like lesions were confirmed in one patient. Muscle biopsy revealed several strongly succinate dehydrogenase-reactive vessels scattered in muscle sections of three patients, but ragged-red fibers and cytochrome c oxidase-negative/dense (COX-/+) fibers were not observed. Mitochondrial DNA A3243G mutation was identified in all three cases. MELAS syndrome has obvious clinical heterogeneity, and muscle weakness was not prominent in some of the cases. Muscle pathological changes did not accompany ragged-red fibers or COX-/+ fibers, but succinate dehydrogenase-reactive vessels are important for MELAS diagnosis.
C1 [Fang, Pu; Wu, Chengsi; Zhou, Meihong; Xu, Renshi; Liu, Xianhua; Wei, Caixia] Nanchang Univ, Dept Neurol, Hosp 1, Nanchang 330006, Jiangxi, Peoples R China.
C3 Nanchang University
RP Fang, P (corresponding author), Nanchang Univ, Dept Neurol, Hosp 1, Nanchang 330006, Jiangxi, Peoples R China.
EM fangpu1972@163.com
OI Xu, Renshi/0000-0003-0313-3434
CR Abu-Amero Khaled K, 2009, J Med Case Rep, V3, P77, DOI 10.1186/1752-1947-3-77
   Choi BO, 2010, EXP MOL MED, V42, P446, DOI 10.3858/emm.2010.42.6.046
   Edmond Jane C, 2009, Int Ophthalmol Clin, V49, P27, DOI 10.1097/IIO.0b013e3181a8de58
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Finsterer J, 2009, EUR J NEUROL, V16, P1178, DOI 10.1111/j.1468-1331.2009.02789.x
   Finsterer J, 2009, INT J CARDIOL, V137, P60, DOI 10.1016/j.ijcard.2008.04.089
   Geldof K, 2007, JBR-BTR, V90, P288
   Hong DJ, 2010, MUSCLE NERVE, V41, P92, DOI 10.1002/mus.21439
   Ito H, 2008, BRAIN DEV-JPN, V30, P483, DOI 10.1016/j.braindev.2008.01.003
   Janssen AJM, 2008, ANN NEUROL, V63, P473, DOI 10.1002/ana.21328
   Kerr DS, 2010, MOL GENET METAB, V99, P246, DOI 10.1016/j.ymgme.2009.11.005
   Koga Y, 2010, ANN NY ACAD SCI, V1201, P104, DOI 10.1111/j.1749-6632.2010.05624.x
   Lorenzoni PJ, 2009, ARQ NEURO-PSIQUIAT, V67, P668, DOI 10.1590/S0004-282X2009000400018
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Marotta R, 2009, J CLIN NEUROSCI, V16, P1223, DOI 10.1016/j.jocn.2008.11.012
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   Montoya J, 2009, BBA-BIOENERGETICS, V1787, P476, DOI 10.1016/j.bbabio.2008.09.003
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Stoquart-ElSankari S, 2008, J NEUROL, V255, P1593, DOI 10.1007/s00415-008-0968-6
   Tzoulis C, 2009, STROKE, V40, pE15, DOI 10.1161/STROKEAHA.108.523118
   Zhang ZQ, 2010, NEUROL RES, V32, P403, DOI 10.1179/016164110X12670144526345
NR 21
TC 0
Z9 0
U1 0
U2 4
PU SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES
PI SHENYANG
PA PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA
SN 1673-5374
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD NOV 15
PY 2010
VL 5
IS 21
BP 1673
EP 1677
DI 10.3969/j.issn.1673-5374.2010.21.013
PG 5
WC Cell Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Neurosciences & Neurology
GA 701EC
UT WOS:000285796100013
DA 2024-11-01
ER

PT J
AU Ylönen, S
   Ylikotila, P
   Siitonen, A
   Finnilä, S
   Autere, J
   Majamaa, K
AF Ylonen, S.
   Ylikotila, P.
   Siitonen, A.
   Finnila, S.
   Autere, J.
   Majamaa, K.
TI Variations of mitochondrial DNA polymerase γ in patients with
   Parkinson's disease
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Molecular epidemiology; Basal ganglia diseases; Neurodegenerative
   diseases; POLG; Mitochondrion
ID W748S MUTATION; POLG1; POLYMORPHISMS; VARIANTS; ATAXIA
AB Parkinson's disease is associated with mitochondrial dysfunction. The POLG1 gene encodes DNA-polymerase gamma, which is responsible for the replication of mitochondrial DNA. Mutations in POLG1 cause neurodegenerative diseases such as progressive external ophthalmoplegia and Alpers syndrome. In this study, we investigated if mutations in POLG1 had any correlation with Parkinson's disease. Subjects consisted of Finnish patients with early-onset Parkinson's disease (EOPD, N = 441) or late-onset Parkinson's disease (LOPD, N = 263). The POLG1 gene was screened for nine previously known mutations. Two patients were compound heterozygotes with respect to putatively pathogenic alleles. Twenty-eight patients harbored a heterozygous missense mutation, but the allele frequencies did not differ from those of the controls. Interestingly, the frequency of affected siblings was 4.6-fold higher (95 % confidence interval; 1.09, 19.5) among the patients with EOPD and with heterozygous POLG1 mutations than among patients without mutations. Clinically the patients with or without POLG1 mutations did not differ from each other. Our findings provide two lines of evidence suggesting a role for POLG1 mutations in Parkinson's disease: (1) identification of patients with compound heterozygous mutations in POLG1, and (2) higher frequency of affected siblings among the EOPD patients with heterozygous POLG1 mutations than among EOPD patients without mutations.
C1 [Ylonen, S.; Siitonen, A.; Finnila, S.; Majamaa, K.] Univ Oulu, Inst Clin Med, Dept Neurol, Oulu 90014, Finland.
   [Ylonen, S.; Siitonen, A.; Majamaa, K.] Med Res Ctr Oulu, Oulu, Finland.
   [Ylikotila, P.] Univ Turku, Dept Neurol, FIN-20520 Turku, Finland.
   [Ylikotila, P.] Turku Univ Hosp, Dept Neurol, FIN-20520 Turku, Finland.
   [Autere, J.] Univ Eastern Finland, Dept Neurosci & Neurol, Kuopio, Finland.
   [Autere, J.] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland.
C3 University of Oulu; University of Turku; University of Turku; University
   of Eastern Finland; University of Eastern Finland; Kuopio University
   Hospital
RP Majamaa, K (corresponding author), Univ Oulu, Inst Clin Med, Dept Neurol, POB 5000, Oulu 90014, Finland.
EM kari.majamaa@oulu.fi
RI Majamaa, Kari/A-1344-2012
OI Siitonen, Ari/0000-0002-4695-9861; Majamaa, Kari/0000-0002-9070-3791
FU Council for Health Research of the Academy of Finland [127764]; Sigrid
   Juselius Foundation; Finnish Brain Foundation; Finnish Parkinson
   Foundation
FX This study was supported in part by grants from the Council for Health
   Research of the Academy of Finland (project number 127764), Sigrid
   Juselius Foundation, Finnish Brain Foundation and Finnish Parkinson
   Foundation. The expert technical assistance of Ms. Anja Heikkinen and
   Ms. Pirjo Keranen is acknowledged.
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Ali SF, 2011, INT J ENV RES PUB HE, V8, P4702, DOI 10.3390/ijerph8124702
   Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9
   Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Fall PA, 1996, J CLIN EPIDEMIOL, V49, P637, DOI 10.1016/0895-4356(96)00003-0
   Ferrer-Costa C, 2004, PROTEINS, V57, P811, DOI 10.1002/prot.20252
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Gui YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050086
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   Komulainen T, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-29
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Meinilä M, 2001, HUM HERED, V52, P160, DOI 10.1159/000053372
   Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
NR 24
TC 13
Z9 15
U1 0
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD DEC
PY 2013
VL 260
IS 12
BP 3144
EP 3149
DI 10.1007/s00415-013-7132-7
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 264AN
UT WOS:000327849400026
PM 24122062
DA 2024-11-01
ER

PT J
AU Alston, CL
   Bender, A
   Hargreaves, IP
   Mundy, H
   Deshpande, C
   Klopstock, T
   McFarland, R
   Horvath, R
   Taylor, RW
AF Alston, Charlotte L.
   Bender, Andreas
   Hargreaves, Iain P.
   Mundy, Helen
   Deshpande, Charulata
   Klopstock, Thomas
   McFarland, Robert
   Horvath, Rita
   Taylor, Robert W.
TI The pathogenic m.3243A&gt;T mitochondrial DNA mutation is associated
   with a variable neurological phenotype
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial DNA; m.3243; CPEO; Pathogenicity; Single fibres
ID HUMAN-DISEASE; MTDNA; DIAGNOSIS; CELLS
AB The m.3243A>G point mutation in the mitochondrial tRNA(Leu(UUR)) (MTTL1) gene is a common cause of mitochondrial DNA disease and is associated with a variety of clinical presentations. A different mutation occurring at the same site - an m.3243A>T transversion - is less prevalent, but has previously been observed in two patients with encephalopathy and lactic acidosis. We report the investigations of a further two patients with the m.3243A>T mutation who presented with either a chronic progressive external ophthalmoplegia (CPEO) phenotype or sensorineural hearing loss, with single fibre mutation studies confirming segregation of the m.3243A>T mutation with COX deficiency. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Alston, Charlotte L.; McFarland, Robert; Horvath, Rita; Taylor, Robert W.] Newcastle Univ, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Bender, Andreas; Klopstock, Thomas] Univ Munich, Dept Neurol, Klinikum Grosshadern, D-81377 Munich, Germany.
   [Hargreaves, Iain P.] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England.
   [Mundy, Helen] Guys & St Thomas NHS Fdn Trust, Ctr Inherited Metab Dis, London, England.
   [Deshpande, Charulata] Guys & St Thomas NHS Fdn Trust, Dept Clin Genet, London, England.
   [Klopstock, Thomas] Univ Munich, Friedrich Baur Inst, Dept Neurol, Klinikum Innenstadt, D-80336 Munich, Germany.
C3 Newcastle University - UK; University of Munich; University of London;
   University College London; UCL Medical School; University College London
   Hospitals NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust;
   Guy's & St Thomas' NHS Foundation Trust; University of Munich
RP Taylor, RW (corresponding author), Newcastle Univ, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
RI Horvath, Rita/AAY-7042-2020; Hargreaves, Iain/AAJ-6757-2020; Alston,
   Charlotte/ABG-9602-2020; Bender, Andreas/A-7401-2012
OI Horvath, Rita/0000-0002-9841-170X; McFarland,
   Robert/0000-0002-8833-2688; Alston, Charlotte/0000-0003-2095-5464;
   Bender, Andreas/0000-0002-6328-7104
FU Wellcome Trust; UK National Commissioning Group for Rare Mitochondrial
   Disorders of Adults and Children Service; German ministry of education
   and research (BMBF), Bonn, Germany [01GM0862]; MRC [G0800674] Funding
   Source: UKRI
FX R.W.T acknowledges the continuing financial support of a Wellcome Trust
   Programme Grant. The Mitochondrial Diagnostic Laboratories in Newcastle
   upon Tyne and at the Neurometabolic Unit at the National Hospital for
   Neurology and Neurosurgery are funded by the UK National Commissioning
   Group for Rare Mitochondrial Disorders of Adults and Children Service
   (www.mitochondrialncg.nhs.uk). T.K. is coordinator of the German network
   for mitochondrial disorders (mitoNET, 01GM0862), funded by the German
   ministry of education and research (BMBF, Bonn, Germany).
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Elson JL, 2009, HUM MUTAT, V30, pE984, DOI 10.1002/humu.21113
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Longo N, 2008, AM J MED GENET A, V146A, P361, DOI 10.1002/ajmg.a.31841
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Oppenheim MLS, 2009, J INHERIT METAB DIS, V32, P269, DOI 10.1007/s10545-009-1061-8
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Shaag A, 1997, BIOCHEM BIOPH RES CO, V233, P637, DOI 10.1006/bbrc.1997.6496
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
NR 22
TC 5
Z9 9
U1 1
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUN
PY 2010
VL 20
IS 6
BP 403
EP 406
DI 10.1016/j.nmd.2010.04.003
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 614ZS
UT WOS:000279099100006
PM 20471262
DA 2024-11-01
ER

PT J
AU Yu, EPK
   Bennett, MR
AF Yu, Emma P. K.
   Bennett, Martin R.
TI The role of mitochondrial DNA damage in the development of
   atherosclerosis
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Mitochondria; Atherosclerosis; Inflammation
ID PERMEABILITY TRANSITION PORE; SMOOTH-MUSCLE-CELLS; NLRP3 INFLAMMASOME;
   OXIDATIVE STRESS; ACCELERATES ATHEROSCLEROSIS; PROMOTES ATHEROSCLEROSIS;
   ENERGY HOMEOSTASIS; METABOLIC SYNDROME; MTDNA MUTATIONS; ATP SYNTHASE
AB Mitochondria are the cellular powerhouses, fuelling metabolic processes through their generation of ATP. However we now recognise that these organelles also have pivotal roles in producing reactive oxygen species (ROS) and in regulating cell death, inflammation and metabolism. Mitochondrial dysfunction therefore leads to oxidative stress, cell death, metabolic dysfunction and inflammation, which can all promote atherosclerosis. Recent evidence indicates that mitochondrial DNA (mtDNA) damage is present and promotes atherosclerosis through mitochondrial dysfunction. We will review the mechanisms that link mtDNA damage with atherosclerotic disease, and identify mitochondrial processes that may have therapeutic benefit. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Yu, Emma P. K.; Bennett, Martin R.] Univ Cambridge, Addenbrookes Hosp, Addenbrookes Ctr Clin Invest, Div Cardiovasc Med, Box 110, Cambridge CB2 2QQ, England.
C3 University of Cambridge; Cambridge University Hospitals NHS Foundation
   Trust; Addenbrooke's Hospital
RP Yu, EPK (corresponding author), Univ Cambridge, Addenbrookes Hosp, Addenbrookes Ctr Clin Invest, Div Cardiovasc Med, Box 110, Cambridge CB2 2QQ, England.
EM epky2@cam.ac.uk
OI Bennett, Martin/0000-0002-2565-1825
FU British Heart Foundation [PG/14/69/31032, RG/13/14/30314]; National
   Institute for Health Research Cambridge Biomedical Research Centre;
   Academy of Medical Sciences
FX This work was supported by British Heart Foundation grants
   PG/14/69/31032 and RG/13/14/30314, the National Institute for Health
   Research Cambridge Biomedical Research Centre, and the Academy of
   Medical Sciences.
CR Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89
   BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837
   Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u
   Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976
   Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459
   Cochemé HM, 2012, NAT PROTOC, V7, P946, DOI 10.1038/nprot.2012.035
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938
   Freigang S, 2013, NAT IMMUNOL, V14, P1045, DOI 10.1038/ni.2704
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110
   Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008
   Gorenne I, 2013, CIRCULATION, V127, P386, DOI 10.1161/CIRCULATIONAHA.112.124404
   Gray K, 2015, CIRC RES, V116, P816, DOI 10.1161/CIRCRESAHA.116.304921
   Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001
   Jiang X, 2014, P NATL ACAD SCI USA, V111, P14782, DOI 10.1073/pnas.1417253111
   Karunakaran D, 2015, CIRC RES, V117, P266, DOI 10.1161/CIRCRESAHA.117.305624
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014
   Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250
   Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1
   Liao XH, 2012, CELL METAB, V15, P545, DOI 10.1016/j.cmet.2012.01.022
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Logan A., 2014, AGING CELL
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Mercer JR, 2012, FREE RADICAL BIO MED, V52, P841, DOI 10.1016/j.freeradbiomed.2011.11.026
   Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966
   Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550
   Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017
   Myung SK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f10
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200
   Niessner A, 2006, CIRCULATION, V114, P2482, DOI 10.1161/CIRCULATIONAHA.106.642801
   Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Pohjoismäki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Qiu X., 2010, CELL METAB, V12
   Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Sack M.N., 2012, Cold Spring Harb Perspect Biol, V4
   Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048
   Schrijvers DM, 2005, ARTERIOSCL THROM VAS, V25, P1256, DOI 10.1161/01.ATV.0000166517.18801.a7
   Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Stoneman V, 2007, CIRC RES, V100, P884, DOI 10.1161/01.RES.0000260802.75766.00
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052
   Thorp E, 2009, ARTERIOSCL THROM VAS, V29, P169, DOI 10.1161/ATVBAHA.108.176495
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Wang Y, 2014, CIRC RES, V114, P421, DOI 10.1161/CIRCRESAHA.114.302153
   Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036
   Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu EPK, 2014, TRENDS ENDOCRIN MET, V25, P481, DOI 10.1016/j.tem.2014.06.008
   Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
NR 86
TC 69
Z9 73
U1 3
U2 33
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD NOV
PY 2016
VL 100
BP 223
EP 230
DI 10.1016/j.freeradbiomed.2016.06.011
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA EC3AH
UT WOS:000387995900023
PM 27320189
DA 2024-11-01
ER

PT J
AU Chan, SSL
   Longley, MJ
   Copeland, WC
AF Chan, SSL
   Longley, MJ
   Copeland, WC
TI The common A467T mutation in the human mitochondrial DNA polymerase
   (<i>POLG</i>) compromises catalytic efficiency and interaction with the
   accessory subunit
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID MULTIPLE DELETIONS; SPACER-REGION; GAMMA; IDENTIFICATION; DISORDERS;
   DEFECTS; PROCESSIVITY; DEPLETION; BINDING; ATAXIA
AB dAmong the nearly 50 disease mutations in the gene for the catalytic subunit of human DNA polymerase gamma, POLG, the A467T substitution is the most common and has been found in 0.6% of the Belgian population. The A467T mutation is associated with a wide range of mitochondrial disorders, including Alpers syndrome, juvenile spinocerebellar ataxia-epilepsy syndrome, and progressive external ophthalmoplegia, each with vastly different clinical presentations, tissue specificities, and ages of onset. The A467T mutant enzyme possesses only 4% of wild-type DNA polymerase activity, and the catalytic defect is manifest primarily through a 6-fold reduction in k(cat) with minimal effect on exonuclease function. Human DNA polymerase gamma (pol gamma) requires association of a 55-kDa accessory subunit for enhanced DNA binding and highly processive DNA synthesis. However, the A467T mutant enzyme failed to interact with and was not stimulated by the accessory subunit, as judged by processivity, heat inactivation, and N-ethylmaleimide protection assays in vitro. Thermolysin digestion and immunoprecipitation experiments further indicate weak association of the subunits for A467T pol gamma. This is the first example of a mutation in POLG that disrupts physical association of the pol gamma subunits. We propose that reduced polymerase activity and loss of accessory subunit interaction are responsible for the depletion and deletion of mitochondrial DNA observed in patients with this POLG mutation.
C1 NIEHS, NIH, Lab Mol Genet, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP NIEHS, NIH, Lab Mol Genet, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Bienstock RJ, 2004, MITOCHONDRION, V4, P203, DOI 10.1016/j.mito.2004.05.018
   CHAN SSL, 2005, IN PRESS DNA REPAIR
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Doublié S, 1998, NATURE, V391, P251, DOI 10.1038/34593
   Fan L, 2001, BIOCHEMISTRY-US, V40, P4780, DOI 10.1021/bi010102h
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   HUBER HE, 1987, J BIOL CHEM, V262, P16224
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley Matthew J, 2002, Methods Mol Biol, V197, P245, DOI 10.1385/1-59259-284-8:245
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   LONGLEY MJ, 1991, J BIOL CHEM, V266, P24702
   LONGLEY MJ, 2005, IN PRESS GENE
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   NGUYEN KV, 2005, IN PRESS NEUROLOGY
   POLESKY AH, 1990, J BIOL CHEM, V265, P14579
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   SPINAZZOLA A, 2005, IN PRESS GENE
   TABOR S, 1987, J BIOL CHEM, V262, P16212
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 35
TC 111
Z9 116
U1 0
U2 9
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 9
PY 2005
VL 280
IS 36
BP 31341
EP 31346
DI 10.1074/jbc.M506762200
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 961LZ
UT WOS:000231665200002
PM 16024923
OA hybrid
DA 2024-11-01
ER

PT J
AU Rodríguez-Aguilera, JC
   Cortés, AB
   Fernández-Ayala, DJM
   Navas, P
AF Carlos Rodriguez-Aguilera, Juan
   Cortes, Ana Belen
   Fernandez-Ayala, Daniel J. M.
   Navas, Placido
TI Biochemical Assessment of Coenzyme Q<sub>10</sub> Deficiency
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Review
DE coenzyme Q(10); CoQ(10) deficiency syndrome; CoQ(10) biosynthesis;
   mitochondria diseases
ID DIPHOSPHATE SYNTHASE SUBUNIT-2; Q BIOSYNTHESIS; CEREBELLAR-ATAXIA;
   COQ(10) DEFICIENCY; UBIQUINONE DEFICIENCY; MITOCHONDRIAL
   ENCEPHALOMYOPATHY; PHENOTYPIC VARIABILITY; RESPIRATORY-CHAIN; MUTATIONS
   CAUSE; ADCK3
AB Coenzyme Q(10) (CoQ(10)) deficiency syndrome includes clinically heterogeneous mitochondrial diseases that show a variety of severe and debilitating symptoms. A multiprotein complex encoded by nuclear genes carries out CoQ(10) biosynthesis. Mutations in any of these genes are responsible for the primary CoQ(10) deficiency, but there are also different conditions that induce secondary CoQ(10) deficiency including mitochondrial DNA (mtDNA) depletion and mutations in genes involved in the fatty acid beta-oxidation pathway. The diagnosis of CoQ(10) deficiencies is determined by the decrease of its content in skeletal muscle and/or dermal skin fibroblasts. Dietary CoQ(10) supplementation is the only available treatment for these deficiencies that require a rapid and distinct diagnosis. Here we review methods for determining CoQ(10) content by HPLC separation and identification using alternative approaches including electrochemical detection and mass spectrometry. Also, we review procedures to determine the CoQ(10) biosynthesis rate using labeled precursors.
C1 [Carlos Rodriguez-Aguilera, Juan; Cortes, Ana Belen] Lab Fisiopatol Celular & Bioenerget, Seville 41013, Spain.
   [Carlos Rodriguez-Aguilera, Juan; Cortes, Ana Belen; Fernandez-Ayala, Daniel J. M.; Navas, Placido] Univ Pablo de Olavide CISC, Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Seville 41013, Spain.
   [Fernandez-Ayala, Daniel J. M.; Navas, Placido] Ctr Andaluz Biol Desarrollo, Seville 41013, Spain.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de
   Salud Carlos III; Consejo Superior de Investigaciones Cientificas
   (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for
   Developmental Biology (CABD)
RP Navas, P (corresponding author), Univ Pablo de Olavide CISC, Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Seville 41013, Spain.; Navas, P (corresponding author), Ctr Andaluz Biol Desarrollo, Seville 41013, Spain.
EM jcrodagu@upo.es; abcorrod@upo.es; dmorfer@upo.es; pnavas@upo.es
RI NAVAS, PLACIDO/R-5943-2019; Fernández-Ayala, Daniel José/ACW-6800-2022
OI Fernandez-Ayala, Daniel Jose Moreno/0000-0001-8176-1431
FU Instituto de Salud Carlos III [FIS PI14-01962]; Junta de Andalucia
   [BIO177]
FX This work has been funded by the Instituto de Salud Carlos III FIS
   PI14-01962 grant. Authors were also funded by the Junta de Andalucia
   BIO177 research group.
CR Alcázar-Fabra M, 2016, BBA-BIOENERGETICS, V1857, P1073, DOI 10.1016/j.bbabio.2016.03.010
   Arias A, 2012, J CHROMATOGR B, V908, P23, DOI 10.1016/j.jchromb.2012.09.027
   Ashraf S, 2013, J CLIN INVEST, V123, P5179, DOI 10.1172/JCI69000
   Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147
   Bentinger M, 2008, BIOFACTORS, V32, P99, DOI 10.1002/biof.5520320112
   Blumkin L, 2014, JIMD REP, V12, P103, DOI 10.1007/8904_2013_251
   Brea-Calvo G, 2015, AM J HUM GENET, V96, P309, DOI 10.1016/j.ajhg.2014.12.023
   Brea-Calvo G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005301
   Buján N, 2014, J INHERIT METAB DIS, V37, P53, DOI 10.1007/s10545-013-9620-4
   Cascajo MV, 2016, RNA BIOL, V13, P622, DOI 10.1080/15476286.2015.1119366
   Chung WK, 2015, J MED GENET, V52, P627, DOI 10.1136/jmedgenet-2015-103140
   Desbats MA, 2015, J INHERIT METAB DIS, V38, P145, DOI 10.1007/s10545-014-9749-9
   Doimo M, 2014, MOL SYNDROMOL, V5, P156, DOI 10.1159/000362826
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Fernández-Ayala DJM, 2005, BBA-BIOENERGETICS, V1706, P174, DOI 10.1016/j.bbabio.2004.10.009
   Fragaki K, 2011, MITOCHONDRION, V11, P533, DOI 10.1016/j.mito.2011.02.002
   Freyer C, 2015, J MED GENET, V52, P779, DOI 10.1136/jmedgenet-2015-102986
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   González-Mariscal I, 2014, MOL SYNDROMOL, V5, P107, DOI 10.1159/000362897
   González-Mariscal I, 2014, IUBMB LIFE, V66, P63, DOI 10.1002/iub.1243
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Haas D, 2009, J INHERIT METAB DIS, V32, P570, DOI 10.1007/s10545-009-1150-8
   Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693
   Hikmat O, 2016, EUR J NEUROL, V23, P1188, DOI 10.1111/ene.13003
   Horvath R, 2012, J NEUROL NEUROSUR PS, V83, P174, DOI 10.1136/jnnp-2011-301258
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Lanning NJ, 2014, CELL REP, V7, P907, DOI 10.1016/j.celrep.2014.03.065
   Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381
   Liu YT, 2014, J NEUROL NEUROSUR PS, V85, P493, DOI 10.1136/jnnp-2013-306483
   Lohman DC, 2014, P NATL ACAD SCI USA, V111, pE4697, DOI 10.1073/pnas.1413128111
   López LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011897
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   López-Lluch G, 2015, BIOGERONTOLOGY, V16, P599, DOI 10.1007/s10522-015-9585-9
   López-Lluch G, 2010, MECH AGEING DEV, V131, P225, DOI 10.1016/j.mad.2010.02.003
   Maes M, 2009, NEUROENDOCRINOL LETT, V30, P470
   Martín-Montalvo A, 2013, J BIOL CHEM, V288, P28126, DOI 10.1074/jbc.M113.474494
   Martín-Montalvo A, 2011, BIOCHEM J, V440, P107, DOI 10.1042/BJ20101422
   Mignot C, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-173
   Miles MV, 2011, MITOCHONDRION, V11, P127, DOI 10.1016/j.mito.2010.08.010
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089
   Montero R, 2009, CLIN BIOCHEM, V42, P742, DOI 10.1016/j.clinbiochem.2008.10.027
   Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Padilla S, 2009, CELL MOL LIFE SCI, V66, P173, DOI 10.1007/s00018-008-8547-7
   Parrado-Fernández C, 2011, FREE RADICAL BIO MED, V50, P1728, DOI 10.1016/j.freeradbiomed.2011.03.024
   Pineda M, 2010, MOVEMENT DISORD, V25, P1262, DOI 10.1002/mds.23129
   Public Health, COMM REG ORPH MED PR
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Quinzii CM, 2014, MOL SYNDROMOL, V5, P141, DOI 10.1159/000360490
   Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58
   Saiki R, 2008, AM J PHYSIOL-RENAL, V295, pF1535, DOI 10.1152/ajprenal.90445.2008
   Salviati L, 2012, J MED GENET, V49, P187, DOI 10.1136/jmedgenet-2011-100394
   Schon EA, 2010, TRENDS MOL MED, V16, P268, DOI 10.1016/j.molmed.2010.04.007
   Stefely JA, 2016, MOL CELL, V63, P608, DOI 10.1016/j.molcel.2016.06.030
   Stefely JA, 2015, MOL CELL, V57, P83, DOI 10.1016/j.molcel.2014.11.002
   Trevisson E, 2011, CURR OPIN NEUROL, V24, P449, DOI 10.1097/WCO.0b013e32834ab528
   Turunen M, 2000, J MOL BIOL, V297, P607, DOI 10.1006/jmbi.2000.3596
   Yubero D, 2016, MITOCHONDRION, V30, P51, DOI 10.1016/j.mito.2016.06.007
   Yubero D, 2015, BIOFACTORS, V41, P424, DOI 10.1002/biof.1242
   Yubero D, 2015, EXPERT REV MOL DIAGN, V15, P1049, DOI 10.1586/14737159.2015.1062727
   Yubero D, 2014, MOL SYNDROMOL, V5, P147, DOI 10.1159/000362390
NR 62
TC 38
Z9 38
U1 1
U2 13
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD MAR
PY 2017
VL 6
IS 3
AR 27
DI 10.3390/jcm6030027
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA EP3NI
UT WOS:000397288600005
PM 28273876
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU McComsey, GA
   Paulsen, DM
   Lonergan, JT
   Hessenthaler, SM
   Hoppel, CL
   Williams, VC
   Fisher, RL
   Cherry, CL
   White-Owen, C
   Thompson, KA
   Ross, ST
   Hernandez, JE
   Ross, LL
AF McComsey, GA
   Paulsen, DM
   Lonergan, JT
   Hessenthaler, SM
   Hoppel, CL
   Williams, VC
   Fisher, RL
   Cherry, CL
   White-Owen, C
   Thompson, KA
   Ross, ST
   Hernandez, JE
   Ross, LL
TI Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis
   after replacing stavudine with abacavir or zidovudine
SO AIDS
LA English
DT Article
DE stavudine; abacavir; mitochondrial DNA; mitochondrial toxicity; electron
   transport chain; apoptosis; lipoatrophy
ID REVERSE-TRANSCRIPTASE INHIBITORS; HIV-INFECTED PATIENTS; SUBCUTANEOUS
   ADIPOCYTE APOPTOSIS; ACTIVE ANTIRETROVIRAL THERAPY; ANTIVIRAL NUCLEOSIDE
   ANALOGS; ADIPOSE-TISSUE; TOXICITY; LIPODYSTROPHY; MYOPATHY; SUBSTITUTION
AB Objective: To determine if stavudine (alpha4T)-associated mitochondrial toxicity could be reversed by substitution with another nucleoside reverse transcriptase inhibitor. As apoptosis and dysfunction of electron transport chain (ETC) activities may underlie mitochondrial toxicity, these parameters were also evaluated.
   Design: The 16 participants (on d4T for >3 years; with lipoatrophy and/or hyperlactatemia) substituted abacavir or zidovudine for stavudine in their antiretroviral regimen. Key parameters including dual-energy X-ray absorptiometry (DEXA) scans, fat apoptosis, mitochondrial DNA (mtDNA) content in peripheral blood mononuclear cells (PBMC), skeletal muscle and fat, as well as skeletal muscle mitochondrial ETC activities were evaluated at study entry and at 48 weeks after the substitution.
   Methods: Quantitative PCR was used to evaluate mtDNA levels and the presence of deletions/rearrangements; CLIA-validated methods for ETC activities; terminal deoxynucleotidyl transferase dUTP-digoxigenin nick-end labeling assays to evaluate adipocyte apoptosis; and DEXA scans to measure changes in body fat.
   Results: MtDNA was depleted at study entry in muscle, adipose tissue and PBMC but levels rebounded with respective mean increases of 141%, 146%, and 369% at week 48. Corresponding fat improvements were noted with DEXA increases of 21%, 11%, and 16% in arm, leg, and trunk, respectively. Quantitative adipocyte apoptosis were significantly increased at baseline (P < 0.01 versus HIV-negative controls), with a significant reduction at week 48 (P < 0.05 versus baseline). Mean values for seven mitochondrial enzyme activities assays at entry indicated substantial loss of function (48% to 85% of controls) with significant improvement of complex I activity by week 48.
   Conclusions: Substitution of stavudine with abacavir or zidovudine improves mitochondrial indices and fat apoptosis in the setting of lipoatrophy. (C) 2005 Lippincott Williams Wilkins.
C1 Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA.
   Case Sch Med Ctr AIDS Res, Cleveland, OH 44106 USA.
   GlaxoSmithKline, San Diego, CA USA.
   Univ Calif San Diego, San Diego, CA 92103 USA.
   Monash Univ, Melbourne, Vic 3004, Australia.
   Burnet Inst, Melbourne, Vic, Australia.
C3 University System of Ohio; Case Western Reserve University; Case Western
   Reserve University Hospital; University Hospitals of Cleveland; Rainbow
   Babies & Children's Hospital; University System of Ohio; Case Western
   Reserve University; GlaxoSmithKline; University of California System;
   University of California San Diego; Monash University; Burnet Institute
RP McComsey, GA (corresponding author), 11100 Euclid Ave,Mailstop 8A, Cleveland, OH 44106 USA.
EM mccomsey.grace@clevelandactu.org
OI Cherry, Catherine Louise/0000-0001-9816-5193
CR Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   Bhat HK, 1999, CIRCULATION, V99, P807, DOI 10.1161/01.CIR.99.6.807
   Brinkman K, 1999, LANCET, V354, P1112, DOI 10.1016/S0140-6736(99)06102-4
   Brinkman K, 1998, AIDS, V12, P1735, DOI 10.1097/00002030-199814000-00004
   Canevari L, 1999, FEBS LETT, V457, P131, DOI 10.1016/S0014-5793(99)01028-5
   Carr A, 2002, JAMA-J AM MED ASSOC, V288, P207, DOI 10.1001/jama.288.2.207
   CHEN CH, 1991, MOL PHARMACOL, V39, P625
   Cherry CL, 2002, J ACQ IMMUN DEF SYND, V30, P271, DOI [10.1097/00126334-200207010-00002, 10.1097/01.QAI.0000017962.22053.0E]
   Cossarizza A, 2003, ANTIVIR THER, V8, P315
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   Domingo P, 1999, AIDS, V13, P2261, DOI 10.1097/00002030-199911120-00008
   Domingo P, 2001, J INFECT DIS, V184, P1197, DOI 10.1086/323805
   Gahan ME, 2001, J CLIN VIROL, V22, P241, DOI 10.1016/S1386-6532(01)00195-0
   HOPPEL CL, 1987, J CLIN INVEST, V80, P71, DOI 10.1172/JCI113066
   Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200
   JOHNSON JA, 2002, 14 INT AIDS C BARC S
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   KRAHENBUHL S, 1994, CLIN CHIM ACTA, V230, P177, DOI 10.1016/0009-8981(94)90270-4
   LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417
   Mallal SA, 2000, AIDS, V14, P1309, DOI 10.1097/00002030-200007070-00002
   MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743
   Masini A, 1999, J NEUROL SCI, V166, P131, DOI 10.1016/S0022-510X(99)00126-4
   McComsey G, 2002, AIDS, V16, P513, DOI 10.1097/00002030-200203080-00001
   McComsey GA, 2004, CLIN INFECT DIS, V38, P263, DOI 10.1086/380790
   Moyle GJ, 2003, JAIDS-J ACQ IMM DEF, V33, P22, DOI 10.1097/00126334-200305010-00004
   Nolan D, 2003, AIDS, V17, P1329, DOI 10.1097/00002030-200306130-00007
   PAULSEN DM, 2002, 14 INT C AIDS BARC J
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Saint-Marc T, 1999, AIDS, V13, P1659, DOI 10.1097/00002030-199909100-00009
   Shikuma CM, 2001, AIDS, V15, P1801, DOI 10.1097/00002030-200109280-00009
   Walker UA, 2002, J ACQ IMMUN DEF SYND, V29, P117, DOI 10.1097/00042560-200202010-00002
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Zaera MG, 2001, AIDS, V15, P1643, DOI 10.1097/00002030-200109070-00006
   ZINN AB, 1986, NEW ENGL J MED, V315, P469, DOI 10.1056/NEJM198608213150801
NR 34
TC 125
Z9 132
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0269-9370
J9 AIDS
JI Aids
PD JAN 3
PY 2005
VL 19
IS 1
BP 15
EP 23
DI 10.1097/00002030-200501030-00002
PG 9
WC Immunology; Infectious Diseases; Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases; Virology
GA 887MR
UT WOS:000226310700002
PM 15627029
OA Bronze
DA 2024-11-01
ER

PT J
AU Wang, ZX
   Xiao, JX
   Xie, S
   Zhao, DH
   Liu, XW
   Zhang, J
   Yuan, Y
   Huang, YN
AF Wang, Zhaoxia
   Xiao, Jiangxi
   Xie, Sheng
   Zhao, Danhua
   Liu, Xiwei
   Zhang, Jue
   Yuan, Yun
   Huang, Yining
TI MR evaluation of cerebral oxygen metabolism and blood flow in
   stroke-like episodes of MELAS
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like
   pisodes; Magnetic resonance imaging; Oxygen extraction fraction;
   Cerebral blood flow
ID MITOCHONDRIAL MYOPATHY; LACTIC-ACIDOSIS; GLUCOSE-METABOLISM;
   ENCEPHALOPATHY; PERFUSION; MUTATION
AB Metabolic information is essential in the investigation of the pathophysiology of stroke-like episodes in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). Here, we used magnetic resonance imaging to evaluate the dynamic metabolic changes before and after a stroke-like episode in two patients with MELAS caused by the mitochondrial DNA mutation A3243G. We performed functional magnetic resonance imaging, including arterial spin labeling and oxygen extraction fraction imaging, and generated cerebral blood flow and oxygen extraction fraction maps. We recruited eight healthy volunteers to define the normal range of the oxygen extraction fraction. We detected a heterogeneous reduction in the oxygen extraction fraction in the brain in the interictal period as well as at the onset of a stroke-like attack. However, the oxygen extraction fraction in the stroke-like lesions normalized in the acute stage. The stroke-like lesions showed consistent hyperperfusion in the acute phase but hypoperfusion in the chronic phase. We have demonstrated the utility of using new magnetic resonance imaging techniques in the evaluation of the pathophysiology of stroke-like lesions. The increased utilization of oxygen in an acute lesion is a novel finding in our study, which might play a role in the oxidative stress. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Xie, Sheng; Liu, Xiwei] China Japan Friendship Hosp, Dept Radiol, Beijing 100029, Peoples R China.
   [Wang, Zhaoxia; Zhao, Danhua; Yuan, Yun; Huang, Yining] Peking Univ First Hosp, Dept Neurol, Beijing 100034, Peoples R China.
   [Xiao, Jiangxi] Peking Univ First Hosp, Dept Radiol, Beijing 100034, Peoples R China.
   [Zhang, Jue] Peking Univ, Adv Acad Interdisciplinary Sci, Beijing 100083, Peoples R China.
C3 China-Japan Friendship Hospital; Peking University; Peking University;
   Peking University
RP Xie, S (corresponding author), China Japan Friendship Hosp, Dept Radiol, YingHuaDongJie 2, Beijing 100029, Peoples R China.
EM xs_mri@126.com
RI Liu, Xiwei/K-5366-2013; Zhang, Jue/N-7594-2013
FU National Natural Science Foundation of China [30870864, 81201154]
FX This work was supported in part by the National Natural Science
   Foundation of China [No. 30870864 to Z Wang and No. 81201154 to Xie
   Sheng].
CR An H, 2003, MAGN RESON MED, V50, P708, DOI 10.1002/mrm.10576
   An HY, 2000, J CEREBR BLOOD F MET, V20, P1225, DOI 10.1097/00004647-200008000-00008
   Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420
   GROPEN TI, 1994, STROKE, V25, P1873, DOI 10.1161/01.STR.25.9.1873
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Iizuka T, 2007, J NEUROL SCI, V257, P126, DOI 10.1016/j.jns.2007.01.040
   Ikawa M, 2009, MITOCHONDRION, V9, P144, DOI 10.1016/j.mito.2009.01.011
   Kim JH, 2011, KOREAN J RADIOL, V12, P15, DOI 10.3348/kjr.2011.12.1.15
   Lindroos MM, 2009, BRAIN, V132, P3274, DOI 10.1093/brain/awp259
   Miyamoto A, 1997, NEURORADIOLOGY, V39, P427, DOI 10.1007/s002340050438
   Molnár MJ, 2000, NEUROLOGY, V55, P544, DOI 10.1212/WNL.55.4.544
   Nariai R, 2001, J NEUROIMAGING, V11, P325, DOI 10.1111/j.1552-6569.2001.tb00057.x
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   OOIWA Y, 1993, STROKE, V24, P304, DOI 10.1161/01.STR.24.2.304
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Sano M, 1995, ACTA NEUROL SCAND, V92, P497
   Takahashi S, 1998, J NEUROL SCI, V158, P58, DOI 10.1016/S0022-510X(98)00105-1
   Thajeb P, 2005, ANN NY ACAD SCI, V1042, P48, DOI 10.1196/annals.1338.005
   Tsujikawa T, 2010, BRAIN DEV-JPN, V32, P143, DOI 10.1016/j.braindev.2008.12.003
   Xie S, 2011, AM J NEURORADIOL, V32, P1504, DOI 10.3174/ajnr.A2523
NR 21
TC 20
Z9 24
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD DEC 15
PY 2012
VL 323
IS 1-2
BP 173
EP 177
DI 10.1016/j.jns.2012.09.011
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 037UT
UT WOS:000311132700030
PM 23062409
DA 2024-11-01
ER

PT J
AU Abrishamdar, M
   Jalali, MS
   Farbood, Y
AF Abrishamdar, Maryam
   Jalali, Maryam Sadat
   Farbood, Yaghoob
TI Targeting Mitochondria as a Therapeutic Approach for Parkinson's Disease
SO CELLULAR AND MOLECULAR NEUROBIOLOGY
LA English
DT Review
DE Parkinson's disease; Mitochondrial dysfunction; Neurodegeneration
ID DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; COMPLEX-I
   ACTIVITY; ALPHA-SYNUCLEIN; TAUROURSODEOXYCHOLIC ACID; JUVENILE
   PARKINSONISM; FAMILIAL PARKINSONISM; DOPAMINERGIC-NEURONS;
   RESPIRATORY-CHAIN; OXIDATIVE DAMAGE
AB Neurodegeneration is among the most critical challenges that involve modern societies and annually influences millions of patients worldwide. While the pathophysiology of Parkinson's disease (PD) is complicated, the role of mitochondrial is demonstrated. The in vitro and in vivo models and genome-wide association studies in human cases proved that specific genes, including PINK1, Parkin, DJ-1, SNCA, and LRRK2, linked mitochondrial dysfunction with PD. Also, mitochondrial DNA (mtDNA) plays an essential role in the pathophysiology of PD. Targeting mitochondria as a therapeutic approach to inhibit or slow down PD formation and progression seems to be an exciting issue. The current review summarized known mutations associated with both mitochondrial dysfunction and PD. The significance of mtDNA in Parkinson's disease pathogenesis and potential PD therapeutic approaches targeting mitochondrial dysfunction was then discussed.
C1 [Abrishamdar, Maryam; Jalali, Maryam Sadat] Ahvaz Jundishapur Univ Med Sci, Med Basic Sci Res Inst, Dept Physiol, Persian Gulf Physiol Res Ctr, Ahvaz, Iran.
   [Farbood, Yaghoob] Ahvaz Jundishapur Univ Med Sci, Med Basic Sci Res Inst, Fac Med, Dept Physiol,Persian Gulf Physiol Res Ctr, Ahvaz, Iran.
C3 Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz
   Jundishapur University of Medical Sciences (AJUMS)
RP Jalali, MS (corresponding author), Ahvaz Jundishapur Univ Med Sci, Med Basic Sci Res Inst, Dept Physiol, Persian Gulf Physiol Res Ctr, Ahvaz, Iran.
EM MaryamJalali3231@gmail.com
RI Farbood, Yaghoob/M-3076-2017
OI Farbood, Yaghoob/0000-0002-6390-0079; Jalali,
   Maryam/0000-0001-6492-1114; Abrishamdar, Maryam/0000-0002-5986-9726
CR Abdelkader NF, 2016, MOL NEUROBIOL, V53, P810, DOI 10.1007/s12035-014-9043-8
   Abrahams S, 2021, BIOCHEM BIOPHYS REP, V27, DOI 10.1016/j.bbrep.2021.101035
   Aerts L, 2015, J BIOL CHEM, V290, P2798, DOI 10.1074/jbc.M114.620906
   Aman Y, 2020, INT REV NEUROBIOL, V155, P169, DOI 10.1016/bs.irn.2020.02.008
   Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andres RH, 2005, NEUROSCIENCE, V133, P701, DOI 10.1016/j.neuroscience.2005.03.004
   Anis E, 2020, PHYTOTHER RES, V34, P214, DOI 10.1002/ptr.6523
   Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   Arias-Fuenzalida J, 2017, STEM CELL REP, V9, P1423, DOI 10.1016/j.stemcr.2017.08.026
   Athauda D, 2017, LANCET, V390, P1664, DOI 10.1016/S0140-6736(17)31585-4
   Balafkan N, 2012, MITOCHONDRION, V12, P640, DOI 10.1016/j.mito.2012.08.004
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Barceló-Coblijn G, 2007, J NEUROCHEM, V101, P132, DOI 10.1111/j.1471-4159.2006.04348.x
   Beal MF, 1998, BRAIN RES, V783, P109, DOI 10.1016/S0006-8993(97)01192-X
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2006, NEUROLOGY, V67, P1262, DOI 10.1212/01.wnl.0000238518.34389.12
   Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004
   Bennett JP, 2020, MITOCHONDRION, V53, P154, DOI 10.1016/j.mito.2020.05.012
   Bentley SR, 2014, MITOCHONDRION, V15, P65, DOI 10.1016/j.mito.2014.01.004
   Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060
   Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483
   Biju KC, 2018, NEUROSCIENCE, V380, P111, DOI 10.1016/j.neuroscience.2018.04.008
   Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200
   Bonkowski MS, 2016, NAT REV MOL CELL BIO, V17, P679, DOI 10.1038/nrm.2016.93
   Boon JY, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00064
   Borsche M, 2021, J PARKINSON DIS, V11, P45, DOI 10.3233/JPD-201981
   Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066
   Cannon JR, 2013, EXP NEUROL, V240, P44, DOI 10.1016/j.expneurol.2012.11.007
   Carbone C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00187
   Castro-Caldas M, 2012, MOL NEUROBIOL, V46, P475, DOI 10.1007/s12035-012-8295-4
   Chakraborty J, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809014
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chandra G, 2019, J CHEM NEUROANAT, V95, P29, DOI 10.1016/j.jchemneu.2017.12.004
   Chandra G, 2018, J NEUROIMMUNE PHARM, V13, P143, DOI 10.1007/s11481-017-9771-4
   Chang CY, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0158-8
   Chang JL, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83080-9
   Chang JC, 2016, TRANSL RES, V170, P40, DOI 10.1016/j.trsl.2015.12.003
   Chen C, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104631
   Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061
   Chun HS, 2012, TOXICOLOGY, V292, P105, DOI 10.1016/j.tox.2011.11.020
   Cichewicz RH, 2004, MED RES REV, V24, P90, DOI 10.1002/med.10053
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Compagnoni GM, 2020, MOL NEUROBIOL, V57, P2959, DOI 10.1007/s12035-020-01926-1
   Copeland William C, 2003, ScientificWorldJournal, V3, P34
   Cornelissen T, 2020, HUM MOL GENET, V29, P1096, DOI 10.1093/hmg/ddaa028
   Costa LG, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2986796
   Coxhead J, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.036
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Deng H, 2018, AGEING RES REV, V42, P72, DOI 10.1016/j.arr.2017.12.007
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Dolhun R, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-92
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Dorsey ER, 2018, LANCET NEUROL, V17, P939, DOI 10.1016/S1474-4422(18)30295-3
   East DA, 2016, INT J BIOCHEM CELL B, V79, P382, DOI 10.1016/j.biocel.2016.08.019
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Fares MB, 2021, NAT REV NEUROSCI, V22, P111, DOI 10.1038/s41583-020-00416-6
   Ferreira AFF, 2020, BEHAV BRAIN RES, V387, DOI 10.1016/j.bbr.2020.112607
   Fountaine TM, 2007, J NEUROSCI RES, V85, P351, DOI 10.1002/jnr.21125
   Funayama M, 2015, LANCET NEUROL, V14, P274, DOI 10.1016/S1474-4422(14)70266-2
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Gerhardt E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028855
   Giannoccaro MP, 2017, MOVEMENT DISORD, V32, P346, DOI 10.1002/mds.26966
   Giorgio V, 2018, BBA-BIOENERGETICS, V1859, P901, DOI 10.1016/j.bbabio.2018.04.006
   Grassi D, 2018, P NATL ACAD SCI USA, V115, pE2634, DOI 10.1073/pnas.1713849115
   Gray MW, 1998, NUCLEIC ACIDS RES, V26, P865, DOI 10.1093/nar/26.4.865
   Grünewald A, 2019, PROG NEUROBIOL, V177, P73, DOI 10.1016/j.pneurobio.2018.09.003
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Grünewald A, 2013, JAMA NEUROL, V70, P1186, DOI 10.1001/jamaneurol.2013.488
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Gui YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050086
   Gureev AP, 2019, NEUROCHEM RES, V44, P2273, DOI 10.1007/s11064-018-02711-2
   Haleagrahara N, 2011, NEUROSCI LETT, V500, P139, DOI 10.1016/j.neulet.2011.06.021
   Hallberg BM, 2011, NAT STRUCT MOL BIOL, V18, P1179, DOI 10.1038/nsmb.2167
   Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303
   Heo JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032629
   Ho DH, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0145-7
   Hu QS, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0060-6
   Huang XP, 2019, HUM MOL GENET, V28, P349, DOI 10.1093/hmg/ddy340
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Ikeda A, 2019, HUM MOL GENET, V28, P3895, DOI 10.1093/hmg/ddz241
   Inose Y, 2020, NEUROSCI LETT, V736, DOI 10.1016/j.neulet.2020.135268
   Inoue N, 2018, EMBO REP, V19, DOI 10.15252/embr.201744860
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288
   Ishikawa S, 2010, J BIOL CHEM, V285, P39718, DOI 10.1074/jbc.M110.137034
   Jamebozorgi K, 2019, MOL NEUROBIOL, V56, P4799, DOI 10.1007/s12035-018-1419-8
   JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7
   Jiang X, 2016, MOL CELL, V63, P229, DOI 10.1016/j.molcel.2016.06.016
   Jin F, 2008, EUR J PHARMACOL, V600, P78, DOI 10.1016/j.ejphar.2008.10.005
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Kaidery NA, 2018, NEUROCHEM INT, V117, P91, DOI 10.1016/j.neuint.2018.03.001
   Kakhlon O, 2010, CAN J PHYSIOL PHARM, V88, P187, DOI 10.1139/Y09-128
   Karimi-Moghadam A, 2018, CELL MOL NEUROBIOL, V38, P1153, DOI 10.1007/s10571-018-0587-4
   Kasten M, 2018, MOVEMENT DISORD, V33, P730, DOI 10.1002/mds.27352
   Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334
   Khan MM, 2010, BRAIN RES, V1328, P139, DOI 10.1016/j.brainres.2010.02.031
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kim YY, 2019, FASEB J, V33, P9742, DOI 10.1096/fj.201900073R
   Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018
   Klivenyi P, 2004, NEUROBIOL DIS, V15, P610, DOI 10.1016/j.nbd.2003.12.014
   Kogelnik AM, 1996, NUCLEIC ACIDS RES, V24, P177, DOI 10.1093/nar/24.1.177
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krebiehl G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009367
   Kumar N, 2018, J CELL BIOL, V217, P3625, DOI 10.1083/jcb.201807019
   Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006
   Kwon SH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235832
   Lai JH, 2019, BRAIN RES, V1720, DOI 10.1016/j.brainres.2019.146301
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406
   Lee JJ, 2018, J CELL BIOL, V217, P1613, DOI 10.1083/jcb.201801044
   Lees AJ, 2015, MOVEMENT DISORD, V30, P19, DOI 10.1002/mds.26120
   Lesage S, 2016, AM J HUM GENET, V98, P500, DOI 10.1016/j.ajhg.2016.01.014
   Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085815
   Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x
   Li YI, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08912-9
   Li ZG, 2015, EUR NEUROL, V73, P205, DOI 10.1159/000377676
   Lin KJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215312
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Liu GW, 2009, NEUROSCI LETT, V454, P187, DOI 10.1016/j.neulet.2009.02.056
   Liu QQ, 2019, BEHAV BRAIN RES, V367, P10, DOI 10.1016/j.bbr.2019.03.043
   Liu YT, 2020, HUM MOL GENET, V29, P1547, DOI 10.1093/hmg/ddaa077
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Lu KT, 2008, J AGR FOOD CHEM, V56, P6910, DOI 10.1021/jf8007212
   Ludtmann MHR, 2018, NEUROSCI LETT, V663, P86, DOI 10.1016/j.neulet.2017.08.044
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Luth ES, 2014, J BIOL CHEM, V289, P21490, DOI 10.1074/jbc.M113.545749
   MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033
   Maita C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054087
   Malek N, 2014, ACTA NEUROL SCAND, V130, P59, DOI 10.1111/ane.12247
   Malpartida AB, 2021, TRENDS BIOCHEM SCI, V46, P329, DOI 10.1016/j.tibs.2020.11.007
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   Marder KS, 2010, ARCH NEUROL-CHICAGO, V67, P731, DOI 10.1001/archneurol.2010.95
   Martins RD, 2018, CELL BIOL INT, V42, P725, DOI 10.1002/cbin.10969
   Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200
   Matsumine H, 1997, AM J HUM GENET, V60, P588
   Mautone N, 2020, EXPERT OPIN THER PAT, V30, P389, DOI 10.1080/13543776.2020.1749264
   Melrose H, 2006, NEUROSCIENCE, V139, P791, DOI 10.1016/j.neuroscience.2006.01.017
   Meng H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15500
   Mezzaroba L, 2019, NEUROTOXICOLOGY, V74, P230, DOI 10.1016/j.neuro.2019.07.007
   Miguel R, 2014, CLIN NEUROL NEUROSUR, V126, P47, DOI 10.1016/j.clineuro.2014.08.020
   Minakawa EN, 2013, NEUROSCI RES, V77, P228, DOI 10.1016/j.neures.2013.09.006
   Moors TE, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0154-3
   Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161
   Mortiboys H, 2013, BRAIN, V136, P3038, DOI 10.1093/brain/awt224
   Müller-Rischart AK, 2013, MOL CELL, V49, P908, DOI 10.1016/j.molcel.2013.01.036
   Mukai R, 2012, FREE RADICAL RES, V46, P1019, DOI 10.3109/10715762.2012.673720
   Muñoz Y, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/7049108
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   NASS S, 1963, J CELL BIOL, V19, P613, DOI 10.1083/jcb.19.3.613
   Negida A, 2016, CNS NEUROL DISORD-DR, V15, P45, DOI 10.2174/1871527314666150821103306
   Nieto M, 2006, NEUROBIOL AGING, V27, P848, DOI 10.1016/j.neurobiolaging.2005.04.010
   Nuamnaichati N, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00805
   Obeso JA, 2017, MOVEMENT DISORD, V32, P1, DOI 10.1002/mds.26904
   Okatsu K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28656-8
   Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016
   Orr AL, 2017, NEUROCHEM INT, V109, P106, DOI 10.1016/j.neuint.2017.04.006
   Ouzren N, 2019, ANN NEUROL, V86, P324, DOI 10.1002/ana.25510
   Paisán-Ruíz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023
   Palle S, 2018, N-S ARCH PHARMACOL, V391, P445, DOI 10.1007/s00210-018-1474-8
   Parihar MS, 2008, CELL MOL LIFE SCI, V65, P1272, DOI 10.1007/s00018-008-7589-1
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Park JS, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0829-3
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   Patel RV, 2018, EUR J MED CHEM, V155, P889, DOI 10.1016/j.ejmech.2018.06.053
   Pereira SS, 2019, J CELL BIOCHEM, V120, P894, DOI 10.1002/jcb.27451
   Pickett SJ, 2022, MITOCHONDRION, V63, P85, DOI 10.1016/j.mito.2022.02.002
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644
   Podlesniy P, 2019, EBIOMEDICINE, V48, P554, DOI 10.1016/j.ebiom.2019.09.015
   Poenisch M, 2009, J VIROL, V83, P4297, DOI 10.1128/JVI.02321-08
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Prasuhn J, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.615461
   Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172
   Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033
   Pyle A, 2015, ANN NEUROL, V78, P1000, DOI 10.1002/ana.24515
   Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568
   Rappold PM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6244
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Ren Q, 2018, P NATL ACAD SCI USA, V115, pE5815, DOI 10.1073/pnas.1802179115
   Richter G, 2002, J NEURAL TRANSM, V109, P721, DOI 10.1007/s007020200060
   Rizek P, 2016, CAN MED ASSOC J, V188, P1157, DOI 10.1503/cmaj.151179
   Rojas JC, 2009, NEUROSCIENCE, V163, P877, DOI 10.1016/j.neuroscience.2009.07.012
   Rosa AI, 2017, BBA-MOL BASIS DIS, V1863, P2171, DOI 10.1016/j.bbadis.2017.06.004
   Rothfuss O, 2009, HUM MOL GENET, V18, P3832, DOI 10.1093/hmg/ddp327
   Saarni SI, 2006, QUAL LIFE RES, V15, P1403, DOI 10.1007/s11136-006-0020-1
   Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Scorziello A, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00100
   Shahmoradian SH, 2019, NAT NEUROSCI, V22, P1099, DOI 10.1038/s41593-019-0423-2
   Shanmughapriya S, 2020, AGEING RES REV, V62, DOI 10.1016/j.arr.2020.101128
   Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005
   Shi XX, 2017, MITOCHONDRION, V34, P91, DOI 10.1016/j.mito.2017.02.005
   Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z
   Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541
   Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   Smith ES, 2017, NEUROSCIENCE, V359, P8, DOI 10.1016/j.neuroscience.2017.07.001
   Snow BJ, 2010, MOVEMENT DISORD, V25, P1670, DOI 10.1002/mds.23148
   Song LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131281
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Steger M, 2016, ELIFE, V5, DOI 10.7554/eLife.12813
   Subramaniam SR, 2014, NEUROBIOL DIS, V70, P204, DOI 10.1016/j.nbd.2014.06.017
   Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39
   Synofzik M, 2010, MOVEMENT DISORD, V25, P243, DOI 10.1002/mds.22865
   Szelechowski M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6181
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   Tang BL, 2017, J NEUROSCI RES, V95, P930, DOI 10.1002/jnr.23806
   Tang FL, 2015, CELL REP, V12, P1631, DOI 10.1016/j.celrep.2015.08.001
   Tapias V, 2017, CELL MOL LIFE SCI, V74, P2851, DOI 10.1007/s00018-017-2541-x
   Tarohda T, 2005, ANAL BIOANAL CHEM, V383, P224, DOI 10.1007/s00216-005-3423-x
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Tomiyama H, 2008, J HUM GENET, V53, P1012, DOI 10.1007/s10038-008-0336-5
   Trinh D, 2021, J NEUROCHEM, V156, P715, DOI 10.1111/jnc.15154
   Trinh J, 2018, MOVEMENT DISORD, V33, P1857, DOI 10.1002/mds.27527
   Tzeng IS, 2022, J CLIN LAB ANAL, V36, DOI 10.1002/jcla.24274
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Uhrbrand A, 2015, J NEUROL SCI, V353, P9, DOI 10.1016/j.jns.2015.04.004
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522
   van der Merwe C, 2017, MOL NEUROBIOL, V54, P2752, DOI 10.1007/s12035-016-9843-0
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Wang H, 2018, ANAT REC, V301, P1115, DOI 10.1002/ar.23781
   Wang WW, 2021, AGING-US, V13, P11738, DOI 10.18632/aging.202868
   Wang WZ, 2016, NAT MED, V22, P54, DOI 10.1038/nm.3983
   Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003
   Wang YJ, 2019, EUR J MED CHEM, V161, P48, DOI 10.1016/j.ejmech.2018.10.028
   Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966
   Winkler-Stuck K, 2005, J NEURAL TRANSM, V112, P499, DOI 10.1007/s00702-004-0195-y
   Winklhofer KF, 2014, TRENDS CELL BIOL, V24, P332, DOI 10.1016/j.tcb.2014.01.001
   Wu YC, 2011, NEUROSIGNALS, V19, P163, DOI 10.1159/000328516
   Xi Y, 2018, BBA-MOL BASIS DIS, V1864, P2859, DOI 10.1016/j.bbadis.2018.05.018
   Xia XY, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00182
   Xu DC, 2016, GENE DEV, V30, P1718, DOI 10.1101/gad.285122.116
   Yan AJ, 2019, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00529
   Yang XF, 2016, CURR TOP MED CHEM, V16, P858, DOI 10.2174/1568026615666150827095252
   Ylönen S, 2013, J NEUROL, V260, P3144, DOI 10.1007/s00415-013-7132-7
   Yoon JH, 2017, BBA-MOL CELL RES, V1864, P2356, DOI 10.1016/j.bbamcr.2017.09.001
   YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619
   Zhou K, 2018, NEURAL REGEN RES, V13, P1552, DOI 10.4103/1673-5374.235299
   Zhu ZG, 2017, NEUROL SCI, V38, P215, DOI 10.1007/s10072-016-2757-9
   Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005
   Zsurka G, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040175
NR 254
TC 10
Z9 10
U1 2
U2 20
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0272-4340
EI 1573-6830
J9 CELL MOL NEUROBIOL
JI Cell. Mol. Neurobiol.
PD MAY
PY 2023
VL 43
IS 4
BP 1499
EP 1518
DI 10.1007/s10571-022-01265-w
EA AUG 2022
PG 20
WC Cell Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Neurosciences & Neurology
GA F6YP2
UT WOS:000839320400001
PM 35951210
DA 2024-11-01
ER

PT J
AU Zeviani, M
   Di Donato, S
AF Zeviani, M
   Di Donato, S
TI Mitochondrial disorders
SO BRAIN
LA English
DT Review
DE respiratory chain; oxidative phosphorylation; mitochondrial DNA
   mutations; nuclear DNA mutations
ID HEREDITARY OPTIC NEUROPATHY; CYTOCHROME-C-OXIDASE; RAGGED-RED FIBERS;
   PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; RESPIRATORY-CHAIN DEFICIENCY;
   DEAFNESS DYSTONIA SYNDROME; COENZYME Q(10) DEFICIENCY; COMPLEX-III
   DEFICIENCY; KEARNS-SAYRE SYNDROME; POINT MUTATION
C1 Ist Nazl Neurol C Besta, Div Mol Neurogenet, I-20133 Milan, Italy.
   Ist Nazl Neurol C Besta, Div Biochem & Genet, I-20133 Milan, Italy.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; Fondazione IRCCS
   Istituto Neurologico Carlo Besta
RP Zeviani, M (corresponding author), Ist Nazl Neurol C Besta, Div Mol Neurogenet, Via Celoria 11, I-20133 Milan, Italy.
EM zeviani@istituto-besta.it; didonato@istituto-besta.it
RI Zeviani, Massimo/AAU-2632-2021
OI Zeviani, Massimo/0000-0002-9067-5508
FU Telethon [GGP030039, GGP02323] Funding Source: Medline
CR Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038
   Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   AnkelSimons F, 1996, P NATL ACAD SCI USA, V93, P13859, DOI 10.1073/pnas.93.24.13859
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Aung T, 2002, HUM GENET, V110, P52, DOI 10.1007/s00439-001-0645-7
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178
   Baysal BE, 2002, J MED GENET, V39, P617, DOI 10.1136/jmg.39.9.617
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   BERKOVIC SF, 1993, EPILEPSIA, V34, pS19
   Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   BRESOLIN N, 1990, J NEUROL SCI, V100, P70, DOI 10.1016/0022-510X(90)90015-F
   Bristow EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P791
   Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8
   Buono Lawrence M, 2002, Curr Opin Ophthalmol, V13, P362, DOI 10.1097/00055735-200212000-00004
   Bykhovskaya Y, 2000, AM J HUM GENET, V66, P1905, DOI 10.1086/302914
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   Carelli V, 2002, NEUROCHEM INT, V40, P573, DOI 10.1016/S0197-0186(01)00129-2
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200
   CASALI C, 1995, BIOCHEM BIOPH RES CO, V213, P588, DOI 10.1006/bbrc.1995.2172
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Chalmers RM, 1996, AM J HUM GENET, V59, P103
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   CHINNERY PF, 1999, LANCET S1, V354, P17
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   de Lonlay P, 2002, HUM MOL GENET, V11, P3273, DOI 10.1093/hmg/11.26.3273
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Di Donato S, 2000, J INHERIT METAB DIS, V23, P247, DOI 10.1023/A:1005684029429
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 1996, ANN NEUROL, V40, P5, DOI 10.1002/ana.410400104
   Dionisi-Vici C, 1998, J INHERIT METAB DIS, V21, P2, DOI 10.1023/A:1005397227996
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Finnilä S, 2003, EUR J HUM GENET, V11, P652, DOI 10.1038/sj.ejhg.5201017
   Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Gimenez-Roqueplo AP, 2001, AM J HUM GENET, V69, P1186, DOI 10.1086/324413
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   Haraguchi M, 2002, MOL CELL BIOL, V22, P5212, DOI 10.1128/MCB.22.14.5212-5221.2002
   Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Howell N, 1998, AM J HUM GENET, V63, P1220, DOI 10.1086/302049
   HOWELL N, 1991, AM J HUM GENET, V49, P939
   HU DN, 1991, J MED GENET, V28, P79, DOI 10.1136/jmg.28.2.79
   Hutchin TP, 2000, CELL MOL LIFE SCI, V57, P1927, DOI 10.1007/PL00000673
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Inoue K, 1996, BIOCHEM BIOPH RES CO, V223, P496, DOI 10.1006/bbrc.1996.0923
   Irwin W, 2002, J BIOL CHEM, V277, P12221, DOI 10.1074/jbc.M108938200
   JABER L, 1992, J MED GENET, V29, P86, DOI 10.1136/jmg.29.2.86
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Jaksch M, 2001, HUM MOL GENET, V10, P3025, DOI 10.1093/hmg/10.26.3025
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kim JY, 2002, ANN NEUROL, V51, P630, DOI 10.1002/ana.10177
   Koehler CM, 1999, P NATL ACAD SCI USA, V96, P2141, DOI 10.1073/pnas.96.5.2141
   KWITTKEN J, 1958, AM J PATHOL, V34, P185
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Leonard JV, 2000, LANCET, V355, P389, DOI 10.1016/S0140-6736(99)05226-5
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Levy SE, 1999, TRANSGENIC RES, V8, P137, DOI 10.1023/A:1008967412955
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   LOMBES A, 1989, ANN NEUROL, V26, P20, DOI 10.1002/ana.410260104
   LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731
   MACKEY D, 1992, AM J HUM GENET, V51, P1218
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Mariotti C, 2003, NEUROLOGY, V60, P1676, DOI 10.1212/01.WNL.0000055872.50364.FC
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Melov S, 1999, MUTAT RES-DNA REPAIR, V434, P233, DOI 10.1016/S0921-8777(99)00031-2
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   MIZUKAMI K, 1992, ACTA NEUROPATHOL, V83, P449, DOI 10.1007/BF00713541
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   Nijtmans LGJ, 2001, FEBS LETT, V498, P46, DOI 10.1016/S0014-5793(01)02447-4
   NIKOSKELAINEN E, 1983, ARCH OPHTHALMOL-CHIC, V101, P1059, DOI 10.1001/archopht.1983.01040020061011
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   OLDFORS A, 1995, ACTA NEUROPATHOL, V90, P328
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   POULTON J, 1989, LANCET, V1, P236
   Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818
   Roesch K, 2002, HUM MOL GENET, V11, P477, DOI 10.1093/hmg/11.5.477
   Rosenberg MJ, 2002, NAT GENET, V32, P175, DOI 10.1038/ng948
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   Rustin P, 1999, LANCET, V354, P477, DOI 10.1016/S0140-6736(99)01341-0
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sadun A A, 2000, Trans Am Ophthalmol Soc, V98, P223
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Salviati L, 2002, BIOCHEM J, V363, P321, DOI 10.1042/0264-6021:3630321
   Salviati L, 2002, ARCH NEUROL-CHICAGO, V59, P862, DOI 10.1001/archneur.59.5.862
   Santorelli F M, 2001, Am Heart J, V141, pE1, DOI 10.1067/mhj.2001.112088
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOFFNER JM, 1995, ANN NEUROL, V38, P163, DOI 10.1002/ana.410380207
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   SMITH JL, 1973, ARCH OPHTHALMOL-CHIC, V90, P349
   Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533
   Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397
   Tsao K, 1999, BRIT J OPHTHALMOL, V83, P577, DOI 10.1136/bjo.83.5.577
   Tsuchiya K, 1999, ACTA NEUROPATHOL, V97, P520, DOI 10.1007/s004010051023
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Valianpour F, 2002, J PEDIATR-US, V141, P729, DOI 10.1067/mpd.2002.129174
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Maldergem L, 2002, ANN NEUROL, V52, P750, DOI 10.1002/ana.10371
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zeviani M, 2003, CURR OPIN NEUROL, V16, P585, DOI 10.1097/00019052-200310000-00004
   Zeviani M, 2003, CURR OPIN GENET DEV, V13, P262, DOI 10.1016/S0959-437X(03)00052-2
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zeviani Massimo, 1993, European Journal of Human Genetics, V1, P80
   Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 175
TC 330
Z9 381
U1 0
U2 34
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
J9 BRAIN
JI Brain
PD OCT
PY 2004
VL 127
BP 2153
EP 2172
DI 10.1093/brain/awh259
PN 10
PG 20
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 856YQ
UT WOS:000224082400002
PM 15358637
OA Bronze
DA 2024-11-01
ER

PT J
AU DeBrosse, S
   Parikh, S
AF DeBrosse, Suzanne
   Parikh, Sumit
TI Neurologic Disorders Due to Mitochondria! DNA Mutations
SO SEMINARS IN PEDIATRIC NEUROLOGY
LA English
DT Review
ID HEREDITARY OPTIC NEUROPATHY; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   KEARNS-SAYRE SYNDROME; STROKE-LIKE EPISODES; RIBOSOMAL-RNA MUTATION;
   RAGGED-RED FIBERS; LEIGH-SYNDROME; HEARING-LOSS; DIABETES-MELLITUS;
   PEARSON-SYNDROME
AB The mitochondrial DNA (mtDNA) is a compact genome inherited through the maternal lineage. Mutations in mtDNA lead to many of the earliest identified syndromic mitochondrial diseases and display a diverse range of age of onset, symptoms, and outcomes-from isolated childhood onset vision or hearing loss to a multisystemic neurodegenerative disorder with strokes, neuropathy, ophthalmoparesis, and epilepsy beginning at any age. As a heterogeneous group, mitochondrial diseases represent one of the most common metabolic disorders in children and adults, frequently seen by both pediatric and adult specialists. Although the myriad of diseases can make diagnosis seems daunting, the need for extensive supportive care and treatment (the latter for at least a select few mitochondrial disorders) and a rapid and accurate recognition of these disorders is necessary. Here, we provide a review of the most common mitochondrial disease syndromes due to mtDNA mutations. Semin Pediatr Neurol 19:194-202 (C) 2012 Elsevier Inc. All rights reserved.
C1 [Parikh, Sumit] Cleveland Clin, Neurogenet Inst, Cleveland, OH 44195 USA.
   [DeBrosse, Suzanne] Univ Hosp Cleveland, Case Med Ctr, Ctr Human Genet, Cleveland, OH 44106 USA.
C3 Cleveland Clinic Foundation; University Hospitals of Cleveland;
   University System of Ohio; Case Western Reserve University
RP Parikh, S (corresponding author), Cleveland Clin, Neurogenet Inst, 9500 Euclid Ave,S60, Cleveland, OH 44195 USA.
EM parikhs@ccf.org
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Alexeyev MF, 2008, GENE THER, V15, P516, DOI 10.1038/sj.gt.2008.11
   Anderson CM, 2002, J NEUROSCI, V22, P9203
   [Anonymous], 2012, ARCH NEUROL
   [Anonymous], 2002, PEDIAT NEUROL
   [Anonymous], 1997, GEN DIAGN PATHOL
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104
   Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Brackmann F, 2012, EUR J PEDIATR, V171, P859, DOI 10.1007/s00431-011-1662-8
   BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198
   Buchan JC, 2007, EYE, V21, P859, DOI 10.1038/sj.eye.6702729
   Carelli V, 2001, J NEUROL NEUROSUR PS, V71, P813, DOI 10.1136/jnnp.71.6.813
   Carelli V, 2007, ENVIRON HEALTH PERSP, V115, P113, DOI 10.1289/ehp.9245
   Chalmers RM, 1996, AM J HUM GENET, V59, P103
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   Chong P Siao Tick, 2003, J Clin Neuromuscul Dis, V5, P1, DOI 10.1097/00131402-200309000-00001
   Chowers I, 1999, BRIT J OPHTHALMOL, V83, P190, DOI 10.1136/bjo.83.2.190
   Danielson SR, 2002, J BIOL CHEM, V277, P5810, DOI 10.1074/jbc.M110119200
   de Laat P, 2012, J INHERIT METAB DIS
   DeVries DD, 1996, AM J HUM GENET, V58, P703
   DiMauro S, 1993, MITOCHONDRIAL DNA DE
   Donovan LE, 2006, J CLIN ENDOCR METAB, V91, P4737, DOI 10.1210/jc.2006-1498
   El-Hattab AW, 2012, MOL GENET METAB, V105, P607, DOI 10.1016/j.ymgme.2012.01.016
   Emma F, 2012, PEDIATR NEPHROL, V27, P539, DOI 10.1007/s00467-011-1926-6
   Emmanuele V, 2011, MUSCLE NERVE, V44, P448, DOI 10.1002/mus.22149
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Goldenberg PC, 2003, NEUROLOGY, V60, P865, DOI 10.1212/01.WNL.0000049460.72439.7F
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horváth R, 2000, J NEUROL, V247, P65, DOI 10.1007/s004150050015
   Howell N, 2003, AM J MED GENET A, V119A, P147, DOI 10.1002/ajmg.a.20135
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Ito S, 2008, AM J NEURORADIOL, V29, P392, DOI 10.3174/ajnr.A0865
   Ji YL, 2010, MOL VIS, V16, P416
   JOHNS DR, 1992, ARCH OPHTHALMOL-CHIC, V110, P1577, DOI 10.1001/archopht.1992.01080230077025
   JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   KELLARWOOD H, 1994, ANN NEUROL, V36, P109, DOI 10.1002/ana.410360121
   Kerrison JB, 2000, AM J OPHTHALMOL, V130, P803, DOI 10.1016/S0002-9394(00)00603-6
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2010, ANN NY ACAD SCI, V1201, P104, DOI 10.1111/j.1749-6632.2010.05624.x
   Kornblum C, 2001, NEUROLOGY, V56, P1409, DOI 10.1212/WNL.56.10.1409
   KOTAGAL S, 1988, PEDIATR NEUROL, V4, P241, DOI 10.1016/0887-8994(88)90038-0
   Kubota M, 2004, BRAIN DEV-JPN, V26, P481, DOI 10.1016/j.braindev.2004.01.006
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Lau KK, 2007, INT UROL NEPHROL, V39, P941, DOI 10.1007/s11255-006-9172-8
   Lax NZ, 2012, ARCH NEUROL-CHICAGO, V69, P490, DOI 10.1001/archneurol.2011.2167
   Leber hereditary optic neuropathy, 1993, GENEREVIEWS
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Leshinsky-Silver E, 2003, MOL GENET METAB, V79, P288, DOI 10.1016/S1096-7192(03)00097-0
   Maassen JA, 2002, AM J MED GENET, V115, P66, DOI 10.1002/ajmg.10346
   Mancuso M, 2007, BIOCHEM BIOPH RES CO, V354, P1058, DOI 10.1016/j.bbrc.2007.01.099
   Mashima Y, 2000, J NEURO-OPHTHALMOL, V20, P166, DOI 10.1097/00041327-200020030-00006
   MASSIN P, 1995, AM J OPHTHALMOL, V120, P247, DOI 10.1016/S0002-9394(14)72615-7
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Melegh B, 1997, NEUROPEDIATRICS, V28, P257, DOI 10.1055/s-2007-973710
   Mnatsakanyan L, 2011, J NEURO-OPHTHALMOL, V31, P6, DOI 10.1097/WNO.0b013e3181fab1b4
   Morimoto N, 2004, NEUROLOGY, V63, P2451, DOI 10.1212/01.WNL.0000147321.38129.ED
   Nance WE, 2002, GENET MED, V4, P162
   Negrier MLM, 1998, AM J HUM GENET, V63, P1227, DOI 10.1086/302045
   NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   NIKOSKELAINEN EK, 1994, LANCET, V344, P857, DOI 10.1016/S0140-6736(94)92830-4
   Nye JS, 2000, TERATOLOGY, V61, P165, DOI 10.1002/(SICI)1096-9926(200003)61:3<165::AID-TERA3>3.3.CO;2-5
   OGASAHARA S, 1986, NEUROLOGY, V36, P45, DOI 10.1212/WNL.36.1.45
   Olmos PR, 2011, J OTOLARYNGOL-HEAD N, V40, P93, DOI 10.2310/7070.2010.100078
   Palace J, 2009, J NEUROL SCI, V286, P24, DOI 10.1016/j.jns.2009.09.009
   Pandya A., 1993, GENEREVIEWS
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   POULTON J, 1989, LANCET, V1, P236
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Qi XP, 2007, ARCH OPHTHALMOL-CHIC, V125, P268, DOI 10.1001/archopht.125.2.268
   Qi XP, 2004, ANN NEUROL, V56, P182, DOI 10.1002/ana.20175
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROWLAND LP, 1975, HDB CLINICAL NEUROLO, V22, P177
   Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0
   Sadun F, 2004, AM J OPHTHALMOL, V137, P271, DOI 10.1016/j.ajo.2003.08.010
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Santorelli FM, 1996, PEDIATR RES, V39, P914, DOI 10.1203/00006450-199605000-00028
   Scalais E, 2007, Eur J Neurol, V14, pe3, DOI 10.1111/j.1468-1331.2007.01926.x
   Schon EA, 2003, GENETICS MITOCHONDRI, P111
   SCHULZ JB, 1993, LANCET, V341, P438
   Sevior KB, 1998, AM J MED GENET, V75, P179, DOI 10.1002/(SICI)1096-8628(19980113)75:2<179::AID-AJMG11>3.0.CO;2-M
   Sgarbi G, 2009, ARCH NEUROL-CHICAGO, V66, P951, DOI 10.1001/archneurol.2009.134
   Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607
   Shear T, 2004, PEDIATR ANESTH, V14, P792, DOI 10.1111/j.1460-9592.2004.01289.x
   SHOFFNER JM, 1992, NEUROLOGY, V42, P2168, DOI 10.1212/WNL.42.11.2168
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Smits BW, 2011, J NEUROL, V258, P2020, DOI 10.1007/s00415-011-6060-7
   Spector Reynold, 2010, Cerebrospinal Fluid Res, V7, P14, DOI 10.1186/1743-8454-7-14
   Spruijt L, 2006, AM J OPHTHALMOL, V141, P676, DOI 10.1016/j.ajo.2005.11.007
   Spruijt L, 2007, ARCH NEUROL-CHICAGO, V64, P890, DOI 10.1001/archneur.64.6.890
   Stacpoole PW, 2008, PEDIATRICS, V121, pE1223, DOI 10.1542/peds.2007-2062
   Suzuki S, 1998, DIABETOLOGIA, V41, P584, DOI 10.1007/s001250050950
   Takanashi J, 1997, J NEUROL SCI, V145, P83, DOI 10.1016/S0022-510X(96)00248-1
   Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449
   Thorburn DR, 1993, GENEREVIEWS
   Uimonen S, 2001, HUM GENET, V108, P284, DOI 10.1007/s004390100475
   Velho G, 1996, DIABETES, V45, P478, DOI 10.2337/diabetes.45.4.478
   Verma A, 1997, PEDIATR RES, V42, P448, DOI 10.1203/00006450-199710000-00005
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Williams TB, 2012, MOL GENET METAB, V106, P104, DOI 10.1016/j.ymgme.2012.01.018
NR 124
TC 10
Z9 10
U1 0
U2 34
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1071-9091
J9 SEMIN PEDIATR NEUROL
JI Semin. Pediatr. Neurol.
PD DEC
PY 2012
VL 19
IS 4
BP 194
EP 202
DI 10.1016/j.spen.2012.09.006
PG 9
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 063UB
UT WOS:000313026400006
PM 23245552
DA 2024-11-01
ER

PT J
AU Lam, J
   McKeague, M
AF Lam, Juwela
   McKeague, Maureen
TI Dietary modulation of mitochondrial DNA damage: implications in aging
   and associated diseases
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Review
DE Mitochondria; Dietary restriction; DNA damage; Aging; Lifespan
ID CALORIC RESTRICTION MIMETICS; FOXO TRANSCRIPTION FACTORS; HEAVY-STRAND
   PROMOTER; FATTY-ACID OXIDATION; BASE-EXCISION-REPAIR; LIFE-SPAN
   EXTENSION; COPY NUMBER; SKELETAL-MUSCLE; STRESS; MUTATIONS
AB Mammalian mitochondria contain small genomes [mitochondrial DNA (mtDNA)], which encode several of the proteins that are crucial for respiration. As such, maintaining the integrity of mtDNA is essential for healthy life. Nutritional strategies such as "Calorie Restriction" may play an important role in regulating mtDNA integrity and prolonging lifespan. In this review, we compare mtDNA with nuclear DNA damage and discuss how the resulting cell fates relate to human health. We provide a description of the mechanisms behind Calorie Restriction as an approach to induce mitochondrial processes contributing to a longer lifespan. We make connections between the current repertoire of studies to propose that how nutrition may mitigate mitochondrial dysfunction and potentially reduce DNA damage. Finally, we describe nutritional based approaches to prevent mitochondrial dysfunction with a focus on mimetics of dietary and calorie restriction. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Lam, Juwela; McKeague, Maureen] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Inst Food Nutr & Hlth, Schmelzbergstr 9, CH-8092 Zurich, Switzerland.
C3 Swiss Federal Institutes of Technology Domain; ETH Zurich
RP McKeague, M (corresponding author), Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Inst Food Nutr & Hlth, Schmelzbergstr 9, CH-8092 Zurich, Switzerland.
EM maureen.mckeague@mcgill.ca
RI McKeague, Maureen/AAP-4667-2020
OI McKeague, Maureen/0000-0002-3750-6027
FU Swiss National Foundation
FX The authors thank Dr. Tim Julian and Dr. Jeannette Nuessli Guth for
   feedback and the Swiss National Foundation for support.
CR Adarme-Vega TC, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-96
   Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002
   [Anonymous], EUKARYOTIC DNA POLYM
   Bankoglu EE, 2016, FREE RADICAL BIO MED, V94, P208, DOI 10.1016/j.freeradbiomed.2016.02.033
   Bess AS, 2012, NUCLEIC ACIDS RES, V40, P7916, DOI 10.1093/nar/gks532
   Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616
   Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012
   Busch C, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0095-z
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Cedikova M, 2016, PHYSIOL RES, V65, pS519, DOI 10.33549/physiolres.933538
   Cook CC, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.141
   Dhahbi JM, 2005, PHYSIOL GENOMICS, V23, P343, DOI 10.1152/physiolgenomics.00069.2005
   Diot A, 2016, MAMM GENOME, V27, P381, DOI 10.1007/s00335-016-9651-x
   Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884
   Eisenberg T, 2017, AUTOPHAGY, V13, P767, DOI 10.1080/15548627.2017.1280225
   Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222
   Fogg Vanessa C, 2011, Chin J Cancer, V30, P526, DOI 10.5732/cjc.011.10018
   Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986
   Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633
   GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F
   Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086
   Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002
   Hayashi JI, 2016, CURR OPIN GENET DEV, V38, P63, DOI 10.1016/j.gde.2016.03.004
   He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004
   Horio Y, 2011, CLIN SCI, V121, P191, DOI 10.1042/CS20100587
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108
   Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535
   Kaeberlein M, 2009, SCIENCE, V326, P55, DOI 10.1126/science.1181034
   Kakimoto M, 2002, DIABETES, V51, P1588, DOI 10.2337/diabetes.51.5.1588
   Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014
   Kauppila JHK, 2015, BBA-BIOENERGETICS, V1847, P1354, DOI 10.1016/j.bbabio.2015.06.001
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Kim DH, 2014, AGE, V36, DOI 10.1007/s11357-014-9679-3
   Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501
   Kisby GE, 2010, EXP GERONTOL, V45, P208, DOI 10.1016/j.exger.2009.12.003
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091
   Lee HC, 2014, WORLD J GASTROENTERO, V20, P3950, DOI 10.3748/wjg.v20.i14.3950
   Lee SH, 2013, BMB REP, V46, P181, DOI 10.5483/BMBRep.2013.46.4.033
   Li WT, 2017, P NATL ACAD SCI USA, V114, P6752, DOI 10.1073/pnas.1706021114
   Li Y, 2009, HUM MOL GENET, V18, P4897, DOI 10.1093/hmg/ddp459
   Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023
   Lodeiro MF, 2012, P NATL ACAD SCI USA, V109, P6513, DOI 10.1073/pnas.1118710109
   Lujan SA, 2016, TRENDS CELL BIOL, V26, P640, DOI 10.1016/j.tcb.2016.04.012
   Madeo F, 2018, SCIENCE, V359, P410, DOI 10.1126/science.aan2788
   Madeo F, 2014, NAT REV DRUG DISCOV, V13, P727, DOI 10.1038/nrd4391
   Madreiter-Sokolowski CT, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030165
   Mao PZ, 2012, BBA-MOL BASIS DIS, V1822, P111, DOI 10.1016/j.bbadis.2011.10.014
   Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250
   MCCAY CM, 1989, NUTRITION, V5, P155
   Meeran SM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0011-5
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Mikhed Y, 2015, INT J MOL SCI, V16, P15918, DOI 10.3390/ijms160715918
   Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x
   Molz P, 2016, AN ACAD BRAS CIENC, V88, P1863, DOI 10.1590/0001-3765201620150608
   Moro L, 2009, CELL DEATH DIFFER, V16, P571, DOI 10.1038/cdd.2008.178
   Mukherjee S, 2010, DOSE-RESPONSE, V8, P478, DOI 10.2203/dose-response.09-015.Mukherjee
   Niu YC, 2013, AGING CELL, V12, P1041, DOI 10.1111/acel.12133
   O'Flanagan CH, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0873-x
   Pamplona R, 2006, BBA-BIOENERGETICS, V1757, P496, DOI 10.1016/j.bbabio.2006.01.009
   Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100
   Picca A, 2017, CLIN INTERV AGING, V12, P1887, DOI 10.2147/CIA.S126458
   Picca A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074644
   Piper MDW, 2005, J GERONTOL A-BIOL, V60, P549, DOI 10.1093/gerona/60.5.549
   Qi WB, 2017, AGING CELL, V16, P1125, DOI 10.1111/acel.12651
   Qiu GH, 2015, MUTAT RES-REV MUTAT, V764, P108, DOI 10.1016/j.mrrev.2015.04.001
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Quarrie Jason K, 2004, Sci Aging Knowledge Environ, V2004, pre5, DOI 10.1126/sageke.2004.31.re5
   Reuter S, 2011, GENES NUTR, V6, P93, DOI 10.1007/s12263-011-0222-1
   Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow
   Rodriguez-Rocha H, 2011, MUTAT RES-FUND MOL M, V711, P158, DOI 10.1016/j.mrfmmm.2011.03.007
   Rubio-Cosials A, 2013, CURR OPIN STRUC BIOL, V23, P116, DOI 10.1016/j.sbi.2012.12.004
   Ruetenik A, 2015, BBA-BIOENERGETICS, V1847, P1434, DOI 10.1016/j.bbabio.2015.05.005
   Sanz A, 2004, J BIOENERG BIOMEMBR, V36, P545, DOI 10.1007/s10863-004-9001-7
   Satoh A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5211
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schiavi A, 2014, EXP GERONTOL, V56, P147, DOI 10.1016/j.exger.2014.02.015
   Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com
   Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221
   Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009
   Shintani T, 2017, BIOCHEM BIOPH RES CO, V493, P1528, DOI 10.1016/j.bbrc.2017.09.147
   Shokolenko IN, 2013, DNA REPAIR, V12, P488, DOI 10.1016/j.dnarep.2013.04.023
   Singh KP, 2011, CHEM RES TOXICOL, V24, P340, DOI 10.1021/tx1003112
   Smieszek A., 2017, International Journal of Molecular Sciences, V18
   Soda Kuniyasu, 2012, Glob J Health Sci, V4, P170, DOI 10.5539/gjhs.v4n6p170
   Sohal RS, 2014, FREE RADICAL BIO MED, V73, P366, DOI 10.1016/j.freeradbiomed.2014.05.015
   Sohl CD, 2013, HUM MOL GENET, V22, P1074, DOI 10.1093/hmg/dds509
   Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002
   Trantakis IA, 2016, J AM CHEM SOC, V138, P8497, DOI 10.1021/jacs.6b03599
   Tu HK, 2015, ONCOTARGET, V6, P41988, DOI 10.18632/oncotarget.5889
   Van Houten B, 2016, FRONT BIOSCI-LANDMRK, V21, P42, DOI 10.2741/4375
   Vermeij WP, 2016, NATURE, V537, P427, DOI 10.1038/nature19329
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069
   Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377
   Webb AE, 2016, AGING CELL, V15, P673, DOI 10.1111/acel.12479
   Wegman MP, 2015, REJUV RES, V18, P162, DOI 10.1089/rej.2014.1624
   Wei M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8700
   Woo DK, 2012, AM J PATHOL, V180, P24, DOI 10.1016/j.ajpath.2011.10.003
   Wullschleger S, 2006, CELL, V127, P5
   Yu EPK, 2014, TRENDS ENDOCRIN MET, V25, P481, DOI 10.1016/j.tem.2014.06.008
   Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955
   Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011
   Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013
   Zhu ZH, 2017, ADV EXP MED BIOL, V1038, P219, DOI 10.1007/978-981-10-6674-0_15
   Zollo O, 2012, P NATL ACAD SCI USA, V109, P6508, DOI 10.1073/pnas.1118594109
NR 110
TC 15
Z9 17
U1 0
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD JAN
PY 2019
VL 63
BP 1
EP 10
DI 10.1016/j.jnutbio.2018.07.003
PG 10
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA HF9NZ
UT WOS:000454570000001
PM 30071405
DA 2024-11-01
ER

PT J
AU Cerbelli, B
   Pisano, A
   Colafrancesco, S
   Pignataro, MG
   Biffoni, M
   Berni, S
   De Luca, A
   Riccieri, V
   Priori, R
   Valesini, G
   d'Amati, G
   Giordano, C
AF Cerbelli, Bruna
   Pisano, Annalinda
   Colafrancesco, Serena
   Pignataro, Maria Gemma
   Biffoni, Marco
   Berni, Silvia
   De Luca, Antonia
   Riccieri, Valeria
   Priori, Roberta
   Valesini, Guido
   d'Amati, Giulia
   Giordano, Carla
TI Anti-aminoacyl-tRNA synthetase-related myositis and dermatomyositis:
   clues for differential diagnosis on muscle biopsy
SO VIRCHOWS ARCHIV
LA English
DT Article
DE Myositis; Anti-synthetase syndrome; Dermatomyositis; Muscle biopsy;
   mtDNA damage
ID MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY; IDIOPATHIC
   INFLAMMATORY MYOPATHIES; CLASSIFICATION; AUTOANTIBODIES; IMMUNE;
   ABNORMALITIES; PATHOLOGY; DEPLETION; FEATURES; CRITERIA
AB Anti-synthetase syndrome is an autoimmune disease characterized by autoantibodies toward amino acyl-tRNA synthetases (ARS), anti-Jo 1 being the most commonly detected. Muscle damage develops in up to 90% of ARS-positive patients, characterized by a necrotizing myositis restricted to the perifascicular region. This topographic distribution of muscle damage may lead to a misdiagnosis of dermatomyositis (DM) at muscle biopsy. We compared morphological, immunohistochemical, and histoenzymatic features of muscle from ARS-positive patients (n = 11) with those of DM (n = 7) providing clues for their differential diagnosis. In addition, we evaluated markers of mitochondrial damage to provide a further distinction between these two entities. Necrosis occurred in the majority of ARS patients, mainly located in the perifascicular region. It was often limited to small foci of fibers, always associated with myocyte regeneration. This last often overwhelmed necrosis, representing occasionally the main finding. In DM, necrosis/regeneration was scarce while the peculiar feature was a diffuse atrophy of perifascicular fibers. These last showed decreased cytochrome c oxidase (COX) stain and mitochondrial DNA depletion, consistent with mitochondrial dysfunction. In contrast to DM, ARS displayed scattered COX-deficient fibers, not restricted to the perifascicular region. This feature occurred in up to 91% of patients, being prominent only in two.
C1 [Cerbelli, Bruna; Pisano, Annalinda; Pignataro, Maria Gemma; Berni, Silvia; De Luca, Antonia; d'Amati, Giulia; Giordano, Carla] Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, Policlin Umberto 1, Viale Regina Elena 324, I-00161 Rome, Italy.
   [Colafrancesco, Serena; Riccieri, Valeria; Priori, Roberta; Valesini, Guido] Sapienza Univ Rome, Dept Internal Med & Med Specialties, Rheumatol Unit, I-00161 Rome, Italy.
   [Biffoni, Marco] Sapienza Univ Rome, Dept Surg Sci, I-00161 Rome, Italy.
C3 Sapienza University Rome; University Hospital Sapienza Rome; Sapienza
   University Rome; Sapienza University Rome
RP Giordano, C (corresponding author), Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, Policlin Umberto 1, Viale Regina Elena 324, I-00161 Rome, Italy.
EM carla.giordano@uniroma1.it
RI priori, roberta/Z-6259-2019; d'Amati, Giulia/F-1251-2011; Luca,
   Alessandro/AAE-5524-2020; Colafrancesco, Serena/AAB-4997-2019; GIORDANO,
   Carla/L-5657-2015; RICCIERI, Valeria/AAC-6079-2022
OI Colafrancesco, Serena/0000-0001-7802-1192; GIORDANO,
   Carla/0000-0002-3716-4303; priori, roberta/0000-0002-6695-1445;
   RICCIERI, Valeria/0000-0002-7507-5483; Valesini,
   Guido/0000-0002-7757-8092
CR Alhatou MI, 2004, J MOL HISTOL, V35, P615
   Allenbach Y, 2016, BRAIN, V139, DOI 10.1093/brain/aww126
   BANKER BQ, 1966, MEDICINE, V45, P261, DOI 10.1097/00005792-196607000-00001
   Batten F E, 1912, Proc R Soc Med, V5, P103
   BROOKE MH, 1969, NEUROLOGY, V19, P378, DOI 10.1212/WNL.19.4.378
   Brouwer R, 2001, ANN RHEUM DIS, V60, P116, DOI 10.1136/ard.60.2.116
   CARPENTER S, 1976, NEUROLOGY, V26, P952, DOI 10.1212/WNL.26.10.952
   Cavagna L, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001144
   Cavazzana I, 2016, J IMMUNOL METHODS, V433, P1, DOI 10.1016/j.jim.2016.02.017
   Colafrancesco S, 2015, BEST PRACT RES CL RH, V29, P810, DOI 10.1016/j.berh.2016.02.005
   Dalakas MC, 2015, NEW ENGL J MED, V372, P1734, DOI 10.1056/NEJMra1402225
   EMSLIESMITH AM, 1990, ANN NEUROL, V27, P343, DOI 10.1002/ana.410270402
   Giordano C, 2006, GASTROENTEROLOGY, V130, P893, DOI 10.1053/j.gastro.2006.01.004
   Giordano C, 2011, METHODS MOL BIOL, V755, P223, DOI 10.1007/978-1-61779-163-5_18
   Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464
   Hoogendijk Jessica E, 2004, Neuromuscul Disord, V14, P337, DOI 10.1016/j.nmd.2004.02.006
   Iaccarino L, 2013, AUTOIMMUN REV, V12, P363, DOI 10.1016/j.autrev.2012.06.004
   Koenig M, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2276
   Lahoria R, 2016, BRAIN, V139, P1891, DOI 10.1093/brain/aww122
   LOVE LA, 1991, MEDICINE, V70, P360, DOI 10.1097/00005792-199111000-00002
   Mahler M, 2014, AUTOIMMUN REV, V13, P367, DOI 10.1016/j.autrev.2014.01.022
   Mescam-Mancini L, 2015, BRAIN, V138, P2485, DOI 10.1093/brain/awv192
   Miró O, 1998, BRIT J RHEUMATOL, V37, P1047
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   Pestronk A, 2011, CURR OPIN RHEUMATOL, V23, P595, DOI 10.1097/BOR.0b013e32834bab42
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Senécal JL, 2017, ARTHRITIS RHEUMATOL, V69, P878, DOI 10.1002/art.40063
   Temiz P, 2009, J NEUROL SCI, V278, P25, DOI 10.1016/j.jns.2008.11.010
   Troyanov Y, 2005, MEDICINE, V84, P231, DOI 10.1097/01.md.0000173991.74008.b0
   Troyanov Y, 2014, MEDICINE, V93, P318, DOI 10.1097/MD.0000000000000222
   Uruha A, 2016, BRAIN, V139, DOI 10.1093/brain/aww125
   Varadhachary AS, 2010, CURR OPIN RHEUMATOL, V22, P651, DOI 10.1097/BOR.0b013e32833f108a
   Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554
   WOO M, 1988, J NEUROL SCI, V88, P133, DOI 10.1016/0022-510X(88)90211-0
NR 35
TC 10
Z9 10
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0945-6317
EI 1432-2307
J9 VIRCHOWS ARCH
JI Virchows Arch.
PD MAR
PY 2018
VL 472
IS 3
BP 477
EP 487
DI 10.1007/s00428-017-2269-x
PG 11
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA GB8UF
UT WOS:000429350100018
PM 29147923
DA 2024-11-01
ER

PT J
AU Wibrand, F
   Jeppesen, TD
   Frederiksen, AL
   Olsen, DB
   Duno, M
   Schwartz, M
   Vissing, J
AF Wibrand, Flemming
   Jeppesen, Tina D.
   Frederiksen, Anja L.
   Olsen, David B.
   Duno, Morten
   Schwartz, Marianne
   Vissing, John
TI LIMITED DIAGNOSTIC VALUE OF ENZYME ANALYSIS IN PATIENTS WITH
   MITOCHONDRIAL tRNA MUTATIONS
SO MUSCLE & NERVE
LA English
DT Article
DE mitochondrial myopathy; respiratory chain enzyme analysis; single,
   large-scale deletions; tRNA gene mutations; 3243A > G
ID RESPIRATORY-CHAIN COMPLEXES; SKELETAL-MUSCLE; POINT MUTATION;
   ENCEPHALOMYOPATHIES; DEFICIENCY; DISORDERS; DELETIONS; CAPACITY; MTDNA;
   LOAD
AB We evaluated the diagnostic value of respiratory chain (RC) enzyme analysis of muscle in adult patients with mitochondria! myopathy (MM). RC enzyme activity was measured in muscle biopsies from 39 patients who carry either the 3243A>G mutation, other tRNA point mutations, or single, large-scale deletions of mtDNA. Findings were compared with those obtained from asymptomatic relatives with the 3243A>G mutation, myotonic dystrophy patients, and healthy subjects. Plasma lactate concentration, maximal oxygen uptake, and ragged-red fibers/cytochrome c-negative fibers in muscle were also determined. Only 10% of patients with the 3243A>G point mutation had decreased enzyme activity of one or more RC complexes, whereas this was the case for 83% of patients with other point mutations and 62% of patients with deletions. Abnormal muscle histochemistry was found in 65%, 100%, and 85% of patients, respectively, in these three groups. The results indicate that RC enzyme analysis in muscle is not a sensitive test for MM in adults. In these patients, abnormal muscle histochemistry appears to be a better predictor of MM. Muscle Nerve 41: 607-613, 2010
C1 [Wibrand, Flemming; Duno, Morten; Schwartz, Marianne] Rigshosp, Dept Clin Genet 4061, DK-2100 Copenhagen, Denmark.
   [Jeppesen, Tina D.; Olsen, David B.; Vissing, John] Univ Copenhagen, Dept Neurol, Neuromuscular Res Unit, Copenhagen, Denmark.
   [Jeppesen, Tina D.; Olsen, David B.; Vissing, John] Univ Copenhagen, Rigshosp, Copenhagen Muscle Res Ctr, DK-2100 Copenhagen, Denmark.
   [Frederiksen, Anja L.] Ribe Cty Hosp, Dept Endocrinol, Esbjerg, Denmark.
C3 University of Copenhagen; Rigshospitalet; University of Copenhagen;
   University of Copenhagen; Rigshospitalet
RP Wibrand, F (corresponding author), Rigshosp, Dept Clin Genet 4061, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM flemming.wibrand@rh.regionh.dk
RI Vissing, John/IUN-4271-2023; Frederiksen, Anja/AAF-1983-2019; Jeppesen,
   Tina/AAV-7195-2020
OI Frederiksen, Anja Lisbeth/0000-0002-7944-8910
FU Novo Nordisk Foundation; P.C. Petersen's Foundation; Copenhagen Muscle
   Research Center; Sara and Ludvig Elsass Foundation; Danish National
   Research Council [22-03-0474]; Fabrikant Vilhelm Pedersen og Hustrus
   Legat
FX The study was supported by grants from the Novo Nordisk Foundation, P.C.
   Petersen's Foundation, the Copenhagen Muscle Research Center (supported
   by grants from the University of Copenhagen and the Copenhagen Hospital
   Corporation, H:S), the Sara and Ludvig Elsass Foundation, the Danish
   National Research Council (22-03-0474), and the Fabrikant Vilhelm
   Pedersen og Hustrus Legat, on recommendation from the Novo Nordisk
   Foundation.
CR ARGOV Z, 1991, ANN NEUROL, V30, P90, DOI 10.1002/ana.410300116
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   Hui J, 2006, DEV MED CHILD NEUROL, V48, P132, DOI 10.1017/S0012162206000284
   ISASHIKI Y, 1989, NEURO-OPHTHALMOLOGY, V9, P115, DOI 10.3109/01658108909007466
   Janssen AJM, 2008, ANN NEUROL, V63, P473, DOI 10.1002/ana.21328
   Jensen TD, 2002, NEUROLOGY, V58, P1533, DOI 10.1212/WNL.58.10.1533
   Jeppesen TD, 2003, J NEUROL SCI, V214, P17, DOI 10.1016/S0022-510X(03)00168-0
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Kirino Yohei, 2005, RNA Biol, V2, P41, DOI 10.4161/rna.2.2.1610
   KRAHENBUHL S, 1994, CLIN CHIM ACTA, V230, P177, DOI 10.1016/0009-8981(94)90270-4
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   McDermott CJ, 2003, NEUROREPORT, V14, P485, DOI 10.1097/01.wnr.0000058774.36017.cf
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Olsen DB, 2003, J NEUROL, V250, P1328, DOI 10.1007/s00415-003-0206-1
   ONO S, 1986, J NEUROL SCI, V74, P247, DOI 10.1016/0022-510X(86)90110-3
   Piemonte F, 2001, NEUROMUSCULAR DISORD, V11, P565, DOI 10.1016/S0960-8966(01)00214-0
   Schröder R, 2000, J NEUROPATH EXP NEUR, V59, P353, DOI 10.1093/jnen/59.5.353
   Sciacco M, 2001, J NEUROL, V248, P778, DOI 10.1007/s004150170094
   Seijo-Martínez M, 2003, J NEUROL SCI, V208, P87, DOI 10.1016/S0022-510X(02)00442-2
   Srere P.A., 1969, Methods in Enzymology, V13, P3
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003
   Vielhaber S, 2002, J NEUROPATH EXP NEUR, V61, P885, DOI 10.1093/jnen/61.10.885
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Wiedemann FR, 1998, J NEUROL SCI, V156, P65, DOI 10.1016/S0022-510X(98)00008-2
NR 30
TC 20
Z9 20
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD MAY
PY 2010
VL 41
IS 5
BP 607
EP 613
DI 10.1002/mus.21541
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 589ZE
UT WOS:000277191900004
PM 19941338
DA 2024-11-01
ER

PT J
AU Young, TJ
   Shah, AK
   Lee, MH
   Hayes, DL
AF Young, TJ
   Shah, AK
   Lee, MH
   Hayes, DL
TI Kearns-Sayre syndrome: A case report and review of cardiovascular
   complications
SO PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
LA English
DT Review
DE Kearns-Sayre syndrome; conduction defects; cardiac pacing
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL-DNA DELETIONS;
   COMPLETE HEART-BLOCK; PACEMAKER IMPLANTATION; PYRUVATE METABOLISM;
   CARDIAC INVOLVEMENT; COENZYME-Q10; IMPROVEMENT; GUIDELINES; CONDUCTION
AB Kearns-Sayre syndrome (KSS) is a rare genetic abnormality. Classified as a mitochondrial cytopothy, the primary pathology of this syndrome is a disturbance of mitochondrial DNA, which codes for the proteins required for the respiratory chain reaction. Onset occurs before age 20, and is manifest as chronic progressive external ophthalmoplegia and retinal degeneration. Management issues of KSS include prophylactic cardiac pacing for conduction defects, which has been shown to improve survival. Other clinical considerations relate to dietary supplements to attempt to control the progressive effects of the disease.
C1 Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA.
   Univ Cambridge, Addenbrookes Hosp, Dept Surg, Cambridge CB2 1TN, England.
   Raffles Med Grp, Singapore, Singapore.
   Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.
C3 Mayo Clinic; Cambridge University Hospitals NHS Foundation Trust;
   Addenbrooke's Hospital; University of Cambridge; Mayo Clinic
RP Mayo Clin, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.
EM dhayes@mayo.edu
RI Shah, Ankit/AAJ-9554-2021
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   ANAN R, 1992, EUR HEART J, V13, P1718, DOI 10.1093/oxfordjournals.eurheartj.a060129
   BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104
   BRESOLIN N, 1988, NEUROLOGY, V38, P892, DOI 10.1212/WNL.38.6.892
   CHARLES R, 1981, CIRCULATION, V63, P214, DOI 10.1161/01.CIR.63.1.214
   Choi C, 2000, YONSEI MED J, V41, P676, DOI 10.3349/ymj.2000.41.5.676
   CLARK DS, 1975, CHEST, V68, P727, DOI 10.1378/chest.68.5.727
   DeCoo IFM, 1997, J NEUROL SCI, V149, P37, DOI 10.1016/S0022-510X(97)05366-5
   Fromenty B, 1997, AM J MED GENET, V71, P443, DOI 10.1002/(SICI)1096-8628(19970905)71:4<443::AID-AJMG14>3.0.CO;2-G
   GALLASTEGUI J, 1987, AM J CARDIOL, V60, P385, DOI 10.1016/0002-9149(87)90255-4
   Gregoratos G, 1998, CIRCULATION, V97, P1325, DOI 10.1161/01.CIR.97.13.1325
   Gregoratos Gabriel, 2002, Circulation, V106, P2145, DOI 10.1161/01.CIR.0000035996.46455.09
   Hayes DL, 1998, AM J CARDIOL, V82, P1082
   Hayes DL., 2001, PACE 2, V24, P576
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   OGASAHARA S, 1986, NEUROLOGY, V36, P45, DOI 10.1212/WNL.36.1.45
   OGASAHARA S, 1985, NEUROLOGY, V35, P372, DOI 10.1212/WNL.35.3.372
   POLAK PE, 1989, EUR HEART J, V10, P281, DOI 10.1093/oxfordjournals.eurheartj.a059477
   REMES AM, 1992, BRIT HEART J, V68, P408
   ROBERTS NK, 1979, AM J CARDIOL, V44, P1396, DOI 10.1016/0002-9149(79)90459-4
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 23
TC 18
Z9 24
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0147-8389
EI 1540-8159
J9 PACE
JI PACE-Pacing Clin. Electrophysiol.
PD MAY
PY 2005
VL 28
IS 5
BP 454
EP 457
DI 10.1111/j.1540-8159.2005.40049.x
PG 4
WC Cardiac & Cardiovascular Systems; Engineering, Biomedical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Engineering
GA 927LM
UT WOS:000229195400017
PM 15869681
OA Bronze
DA 2024-11-01
ER

PT J
AU Löwik, M
   Levtchenko, E
   Westra, D
   Groenen, P
   Steenbergen, E
   Weening, J
   Lilien, M
   Monnens, L
   van den Heuvel, L
AF Lowik, Marije
   Levtchenko, Elena
   Westra, Dineke
   Groenen, Patricia
   Steenbergen, Eric
   Weening, Jan
   Lilien, Marc
   Monnens, Leo
   van den Heuvel, Lambert
TI Bigenic heterozygosity and the development of steroid-resistant focal
   segmental glomerulosclerosis
SO NEPHROLOGY DIALYSIS TRANSPLANTATION
LA English
DT Article
DE bigenic; CD2AP; focal segmental glomerulosclerosis en podocin
ID CONGENITAL NEPHROTIC SYNDROME; NPHS2 MUTATION ANALYSIS; CLINICAL
   SPECTRUM; FINNISH TYPE; RECURRENCE; PODOCIN; TRANSPLANTATION;
   PROTEINURIA; DISEASE; CD2AP
AB Background. Focal segmental glomerulosclerosis (FSGS) is a major cause of steroid-resistant nephrotic syndrome in childhood with a central role for the podocytes in the pathogenesis. Mutated proteins expressed in podocytes cause proteinuria. The role of combined gene defects in the development of FSGS is less clear.
   Methods. We analysed seven podocyte genes known to cause proteinuria and FSGS in a group of 19 non-familial childhood-onset steroid-resistant FSGS patients. These genes include NPHS1, NPHS2, ACTN4, CD2AP, WT-1, TRPC6 and PLCE1. We also screened for the mitochondrial A3243G DNA transition associated with the MELAS syndrome (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes), and occasionally FSGS.
   Results. No mutations were found in the ACTN4 and TRPC6 genes, and no mitochondrial A3243G DNA transition was found in our group of patients. Two patients showed mutations in the CD2AP gene, one combined with an NPHS2 mutation. A tri-allelic hit was found in a patient carrying compound heterozygous NPHS2 mutations and a heterozygous NPHS1 mutation. In another patient a de novo WT-1 mutation was found combined with a heterozygous NPHS1 mutation, and finally two patients showed three heterozygous PLCE1 mutations.
   Conclusions. In our rather small group of 19 steroid-resistant FSGS patients, we found 11 mutations in podocyte genes in 6 patients. In four of them the found mutations could explain the pathology. Our data suggest that combined gene defects in podocyte genes may play a role in the development of FSGS.
C1 [Lowik, Marije; Levtchenko, Elena; Westra, Dineke; Monnens, Leo; van den Heuvel, Lambert] Radboud Univ Nijmegen, Med Ctr, Dept Paediat Nephrol, NL-6500 HB Nijmegen, Netherlands.
   [Groenen, Patricia; Steenbergen, Eric; Weening, Jan] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands.
   [Lilien, Marc] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Nephrol, Utrecht, Netherlands.
C3 Radboud University Nijmegen; Radboud University Nijmegen; Utrecht
   University; Utrecht University Medical Center; Wilhelmina
   Kinderziekenhuis
RP van den Heuvel, L (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Paediat Nephrol, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM B.vandenheuvel@cukz.umcn.nl
RI Lilien, Marc/AAE-1452-2020; Levtchenko, Elena/AAO-7125-2020; van den
   Heuvel, Lambertus/AAM-1772-2021; Groenen, Patricia/L-4336-2015; Monnens,
   L.A.H./L-4526-2015; Westra, Dineke/P-6911-2015
OI Levtchenko, Elena/0000-0002-8352-7312; Westra,
   Dineke/0000-0002-5567-1704
FU Dutch Kidney Foundation [C.98-1764]
FX We would like to thank the families and their physicians for their
   participation in this study. This work was supported by a grant of the
   Dutch Kidney Foundation (project number C.98-1764).
CR Billing H, 2004, PEDIATR NEPHROL, V19, P561, DOI 10.1007/s00467-003-1408-6
   Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166
   Caridi G, 2005, PEDIATR RES, V57, p54R, DOI 10.1203/01.PDR.0000160446.01907.B1
   Hasselbacher K, 2006, KIDNEY INT, V70, P1008, DOI 10.1038/sj.ki.5001679
   Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918
   Huber TB, 2006, J CLIN INVEST, V116, P1337, DOI 10.1172/JCI27400
   Jansen JJ, 1997, J AM SOC NEPHROL, V8, P1118
   Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456
   Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068
   Klamt B, 1998, HUM MOL GENET, V7, P709, DOI 10.1093/hmg/7.4.709
   Koziell A, 2002, HUM MOL GENET, V11, P379, DOI 10.1093/hmg/11.4.379
   Kurogouchi F, 1998, AM J NEPHROL, V18, P551, DOI 10.1159/000013406
   Lenkkeri U, 1999, AM J HUM GENET, V64, P51, DOI 10.1086/302182
   Liu XL, 2005, FEBS J, V272, P228, DOI 10.1111/j.1432-1033.2004.04408.x
   Löwik MM, 2007, KIDNEY INT, V72, P1198, DOI 10.1038/sj.ki.5002469
   Löwik MM, 2003, CLIN NEPHROL, V59, P143
   Piechota Janusz, 2001, Journal of Applied Genetics, V42, P351
   Ruf RG, 2004, KIDNEY INT, V66, P564, DOI 10.1111/j.1523-1755.2004.00775.x
   Savin VJ, 1996, NEW ENGL J MED, V334, P878, DOI 10.1056/NEJM199604043341402
   Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI200112849
   Srivastava T, 2006, PEDIATR NEPHROL, V21, P711, DOI 10.1007/s00467-006-0047-0
   Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb
   Weber S, 2004, KIDNEY INT, V66, P571, DOI 10.1111/j.1523-1755.2004.00776.x
   Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215
   Woroniecki RP, 2007, PEDIATR NEPHROL, V22, P638, DOI 10.1007/s00467-007-0445-y
NR 25
TC 57
Z9 65
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0931-0509
J9 NEPHROL DIAL TRANSPL
JI Nephrol. Dial. Transplant.
PD OCT
PY 2008
VL 23
IS 10
BP 3146
EP 3151
DI 10.1093/ndt/gfn208
PG 6
WC Transplantation; Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Transplantation; Urology & Nephrology
GA 350CQ
UT WOS:000259330500020
PM 18443213
OA Bronze
DA 2024-11-01
ER

PT J
AU Fervenza, FC
   Gavrilova, RH
   Nasr, SH
   Irazabal, MV
   Nath, KA
AF Fervenza, Fernando C.
   Gavrilova, Ralitza H.
   Nasr, Samih H.
   Irazabal, Maria, V
   Nath, Karl A.
TI CKD Due to a Novel Mitochondrial DNA Mutation: A Case Report
SO AMERICAN JOURNAL OF KIDNEY DISEASES
LA English
DT Article
ID COX-I GENE; KIDNEY; DISEASE; PROTEINURIA; NUCLEAR
AB In human kidney disease, mitochondrial ultrastructural damage has long been recognized. Although the extent to which such mitochondrial changes contribute to human kidney disease is uncertain, experimental studies clearly demonstrate that mitochondrial damage can instigate pathogenetic processes that drive ongoing kidney disease. Clinical credence for this experimentally based hypothesis is provided by the development of kidney disease in patients with primary mitochondrial disorders. In this regard, substantial interest surrounds the occurrence of kidney disease in primary mitochondrial cytopathies, a heterogeneous group of conditions in which mutations in mitochondrial DNA (mtDNA) or nuclear DNA impair the functionality of components of the mitochondrial respiratory chain. We describe a novel mtDNA mutation in a patient who developed chronic kidney disease. The patient exhibited mitochondrial abnormalities in both muscle and kidney, chronic tubulointerstitial changes, and recurrent episodes of rhabdomyolysis. We outline mechanisms that may underlie the occurrence of chronic kidney disease in the setting of this novel mtDNA mutation. We also underscore the need to consider in relevant kidney diseases the presence of an underlying mitochondrial cytopathy because the latter more commonly exists than is generally recognized.
C1 [Fervenza, Fernando C.; Irazabal, Maria, V; Nath, Karl A.] Mayo Clin, Div Nephrol & Hypertens, Coll Med, Rochester, MN 55905 USA.
   [Gavrilova, Ralitza H.] Mayo Clin, Dept Clin Genom, Coll Med, Rochester, MN 55905 USA.
   [Gavrilova, Ralitza H.] Mayo Clin, Dept Neurol, Coll Med, Rochester, MN 55905 USA.
   [Nasr, Samih H.] Mayo Clin, Dept Lab Med & Pathol, Coll Med, Rochester, MN 55905 USA.
C3 Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic
RP Nath, KA (corresponding author), Mayo Clin, Guggenheim 542,200 First St SW, Rochester, MN 55905 USA.
EM nath.karl@mayo.edu
RI Fervenza, Fernando/AAK-2400-2020
OI Irazabal, Maria V./0000-0002-9904-7778
FU National Institutes of Health National Institute of Diabetes and
   Digestive and Kidney Diseases [R01-47060]
FX Dr Nath is supported by National Institutes of Health National Institute
   of Diabetes and Digestive and Kidney Diseases R01-47060.
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Hansell P, 2013, CLIN EXP PHARMACOL P, V40, P123, DOI 10.1111/1440-1681.12034
   Jaksch M, 1998, J MED GENET, V35, P895, DOI 10.1136/jmg.35.11.895
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   Kobayashi A, 2010, AM J SURG PATHOL, V34, P262, DOI 10.1097/PAS.0b013e3181cb4ed3
   Lucioli S, 2006, NEUROGENETICS, V7, P51, DOI 10.1007/s10048-005-0015-z
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   Nasr SH, 2003, AM J KIDNEY DIS, V41, P259, DOI 10.1053/ajkd.2003.50068
   Nath KA, 2000, KIDNEY INT, V57, P2423, DOI 10.1046/j.1523-1755.2000.00101.x
   Nath KA, 1998, KIDNEY INT, V53, P100, DOI 10.1046/j.1523-1755.1998.00731.x
   NATH KA, 1992, AM J KIDNEY DIS, V20, P1
   Nath KA, 2000, AM J MED, V109, P665, DOI 10.1016/S0002-9343(00)00612-4
   Niaudet P, 1997, KIDNEY INT, V51, P1000, DOI 10.1038/ki.1997.140
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Rudnicki M, 2016, AM J KIDNEY DIS, V68, P949, DOI 10.1053/j.ajkd.2016.06.027
   SZABOLCS MJ, 1994, KIDNEY INT, V45, P1388, DOI 10.1038/ki.1994.181
   Szeto HH, 2017, J AM SOC NEPHROL, V28, P2856, DOI 10.1681/ASN.2017030247
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Wallace DC, 1997, P NATL ACAD SCI USA, V94, P14900, DOI 10.1073/pnas.94.26.14900
NR 21
TC 6
Z9 7
U1 0
U2 4
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0272-6386
EI 1523-6838
J9 AM J KIDNEY DIS
JI Am. J. Kidney Dis.
PD FEB
PY 2019
VL 73
IS 2
BP 273
EP 277
DI 10.1053/j.ajkd.2018.06.032
PG 5
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA HI2YV
UT WOS:000456314000016
PM 30309714
DA 2024-11-01
ER

PT J
AU Belostotsky, R
   Ben-Shalom, E
   Rinat, C
   Becker-Cohen, R
   Feinstein, S
   Zeligson, S
   Segel, R
   Elpeleg, O
   Nassar, S
   Frishberg, Y
AF Belostotsky, Ruth
   Ben-Shalom, Efrat
   Rinat, Choni
   Becker-Cohen, Rachel
   Feinstein, Sofia
   Zeligson, Sharon
   Segel, Reeval
   Elpeleg, Orly
   Nassar, Suheir
   Frishberg, Yaacov
TI Mutations in the Mitochondrial Seryl-tRNA Synthetase Cause
   Hyperuricemia, Pulmonary Hypertension, Renal Failure in Infancy and
   Alkalosis, HUPRA Syndrome
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID DUAL-MODE RECOGNITION; AMINOACYLATION; DEFICIENCY; TRNAS(SER);
   DISORDERS; MYOPATHY; GENE
AB An uncharacterized multisystemic mitochondrial cytopathy was diagnosed in two infants from consanguineous Palestinian kindred living in a single village. The most significant clinical findings were tubulopathy (hyperuricemia, metabolic alkalosis), pulmonary hypertension, and progressive renal failure in infancy (HUPRA syndrome). Analysis of the consanguineous pedigree suggested that the. causative mutation is in the nuclear DNA. By using genome-wide SNP homozygosity analysis, we identified a homozygous identity-by-descent region on chromosome 19 and detected the pathogenic mutation c.1169A>G (p.Asp390Gly) in SARS2, encoding the mitochondrial seryl-tRNA synthetase. The same homozygous mutation was later identified in a third infant with HUPRA syndrome. The carrier rate of this mutation among inhabitants of this Palestinian isolate was found to be 1:15. The mature enzyme catalyzes the ligation of serine to two mitochondrial tRNA isoacceptors: tRNA(AGY)(Ser) and tRNA(UCN)(Ser). Analysis of amino acylation of the two target tRNAs, extracted from immortalized peripheral lymphocytes derived from two patients, revealed that the p.Asp390Gly mutation significantly impacts on the acylation of tRNA(AGY)(Ser) but probably not that of tRNA(UCN)(Ser). Marked decrease in the expression of the nonacylated transcript and the complete absence of the acylated tRNA(AGY)(Ser) suggest that this mutation leads to significant loss of function and that the uncharged transcripts undergo degradation.
C1 [Belostotsky, Ruth; Ben-Shalom, Efrat; Rinat, Choni; Becker-Cohen, Rachel; Feinstein, Sofia; Frishberg, Yaacov] Shaare Zedek Med Ctr, Div Pediat Nephrol, IL-91031 Jerusalem, Israel.
   [Zeligson, Sharon; Segel, Reeval; Frishberg, Yaacov] Shaare Zedek Med Ctr, Inst Med Genet, IL-91031 Jerusalem, Israel.
   [Ben-Shalom, Efrat; Rinat, Choni; Becker-Cohen, Rachel; Feinstein, Sofia] Hadassah Hebrew Univ, Sch Med, IL-91120 Jerusalem, Israel.
   [Elpeleg, Orly] Hadassah Hebrew Univ, Monique & Jacques Roboh Dept Genet Res, Dept Genet & Metab Dis, Med Ctr, IL-91120 Jerusalem, Israel.
   [Nassar, Suheir] Makassed Hosp, Mol Genet Lab, IL-91194 Jerusalem, Israel.
C3 Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew
   University of Jerusalem; Shaare Zedek Medical Center; Hebrew University
   of Jerusalem; Hadassah University Medical Center; Hebrew University of
   Jerusalem; Hadassah University Medical Center
RP Frishberg, Y (corresponding author), Shaare Zedek Med Ctr, Div Pediat Nephrol, IL-91031 Jerusalem, Israel.
EM yaacovf@ekmd.huji.ac.il
RI Segel, Reeval/AAT-1498-2020
CR Bacman SR, 2003, BIOCHEM J, V374, P131, DOI 10.1042/BJ20030222
   Bendayan D, 2003, RESP MED, V97, P130, DOI 10.1053/rmed.2003.1440
   Chernyakov I, 2008, METHOD ENZYMOL, V449, P221, DOI 10.1016/S0076-6879(08)02411-7
   Chimnaronk S, 2005, EMBO J, V24, P3369, DOI 10.1038/sj.emboj.7600811
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x
   Gibbons WJ, 2004, BIOCHEM BIOPH RES CO, V317, P774, DOI 10.1016/j.bbrc.2004.03.113
   Hall AM, 2008, QJM-INT J MED, V101, P755, DOI 10.1093/qjmed/hcn060
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Hutchin TP, 2001, EUR J HUM GENET, V9, P385, DOI 10.1038/sj.ejhg.5200640
   Papp LV, 2008, NUCLEIC ACIDS RES, V36, P7192, DOI 10.1093/nar/gkn829
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Robinson BH, 2006, MOL GENET METAB, V89, P3, DOI 10.1016/j.ymgme.2006.05.015
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Shimada N, 2001, J BIOL CHEM, V276, P46770, DOI 10.1074/jbc.M105150200
   STEINBERG S, 1994, J MOL BIOL, V236, P982, DOI 10.1016/0022-2836(94)90004-3
   Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x
   VARSHNEY U, 1991, J BIOL CHEM, V266, P24712
   Wong LJC, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.040626
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
   Yokogawa T, 2000, J BIOL CHEM, V275, P19913, DOI 10.1074/jbc.M908473199
   Zhu XY, 2009, ACTA BIOCH BIOPH SIN, V41, P179, DOI 10.1093/abbs/gmn021
NR 23
TC 137
Z9 162
U1 0
U2 21
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD FEB 11
PY 2011
VL 88
IS 2
BP 193
EP 200
DI 10.1016/j.ajhg.2010.12.010
PG 8
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 725YZ
UT WOS:000287684100007
PM 21255763
OA Green Published, Bronze, Green Accepted
DA 2024-11-01
ER

PT J
AU Tauchmannová, K
   Pecinová, A
   Houstek, J
   Mracek, T
AF Tauchmannova, Katerina
   Pecinova, Alena
   Houstek, Josef
   Mracek, Tomas
TI Variability of Clinical Phenotypes Caused by Isolated Defects of
   Mitochondrial ATP Synthase
SO PHYSIOLOGICAL RESEARCH
LA English
DT Review
DE Mitochondrial diseases; ATP synthase; Nuclear DNA; Mitochondrial DNA;
   TMEM70
ID COMPLEX-V DEFICIENCY; HEREDITARY SPASTIC PARAPLEGIA; NEUROGENIC MUSCLE
   WEAKNESS; CYTOCHROME-C-OXIDASE; ONSET LEIGH-SYNDROME; DNA T8993G
   MUTATION; ACIDURIA TYPE-IV; RETINITIS-PIGMENTOSA; 3-METHYLGLUTACONIC
   ACIDURIA; 6 GENE
AB Disorders of ATP synthase, the key enzyme in mitochondrial energy supply, belong to the most severe metabolic diseases, manifesting as early-onset mitochondrial encephalocardiomyopathies. Since ATP synthase subunits are encoded by both mitochondrial and nuclear DNA, pathogenic variants can be found in either genome. In addition, the biogenesis of ATP synthase requires several assembly factors, some of which are also hotspots for pathogenic variants. While variants of MT-ATP6 and TMEM70 represent the most common cases of mitochondrial and nuclear DNA mutations respectively, the advent of nextgeneration sequencing has revealed new pathogenic variants in a number of structural genes and TMEM70, sometimes with truly reported cases and discuss biochemical mechanisms, through enzyme biogenesis and function.
C1 [Tauchmannova, Katerina; Pecinova, Alena; Houstek, Josef; Mracek, Tomas] Czech Acad Sci, Inst Physiol, Lab Bioenerget, Prague, Czech Republic.
C3 Czech Academy of Sciences; Institute of Physiology of the Czech Academy
   of Sciences
RP Mracek, T (corresponding author), Czech Acad Sci, Inst Physiol, Lab Bioenerget, Prague, Czech Republic.
EM tomas.mracek@fgu.cas.cz
FU National Institute for Research of Metabolic and Cardiovascular Diseases
   [LX22NPO5104]; European Union - Next Generation EU; Czech Science
   Foundation [GACR 21-18993S]; Czech Health Research Council
   [NU21-07-00550]; Institute of Physiology of the Czech Academy of
   Sciences [RVO:67985823]
FX This research was supported by the project National Institute for
   Research of Metabolic and Cardiovascular Diseases (Programme EXCELES, ID
   Project No. LX22NPO5104) - Funded by the European Union - Next
   Generation EU, by the Czech Science Foundation GACR 21-18993S and by the
   Czech Health Research Council NU21-07-00550. Institutional funding to
   the Institute of Physiology of the Czech Academy of Sciences is provided
   through the RVO:67985823.
CR Abicht A, 2018, MOL GENET GENOM MED, V6, P1188, DOI 10.1002/mgg3.500
   Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295
   Adema AY, 2016, NETH J MED, V74, P455
   Akagi M, 2002, NEUROMUSCULAR DISORD, V12, P53, DOI 10.1016/S0960-8966(01)00242-5
   Al-Kafaji G, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0263606
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Ardissone A, 2023, EUR J NEUROL, V30, P2079, DOI 10.1111/ene.15814
   Atay Z, 2013, GENE, V515, P197, DOI 10.1016/j.gene.2012.11.044
   Auré K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Baban A, 2020, AM J MED GENET A, V182, P64, DOI 10.1002/ajmg.a.61383
   Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Barca E, 2018, HUM MOL GENET, V27, P3305, DOI 10.1093/hmg/ddy231
   Bardakjian T, 2019, J NEUROMUSCULAR DIS, V6, P385, DOI 10.3233/JND-190400
   Bergs PMJ, 2022, MOL GENET METAB, V135, P102, DOI 10.1016/j.ymgme.2021.12.010
   Berhe S, 2018, HAEMATOLOGICA, V103, pE561, DOI 10.3324/haematol.2018.199109
   Blanco-Grau A, 2013, GENES BRAIN BEHAV, V12, P812, DOI 10.1111/gbb.12089
   Braczynski AK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/462592
   Brambilla A, 2020, ORPHANET J RARE DIS, V15, DOI 10.1186/s13023-020-01466-w
   Brum M, 2014, CASE REP NEUROL MED, V2014, DOI 10.1155/2014/701761
   Bugiardini E, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000381
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Cameron JM, 2011, MITOCHONDRION, V11, P191, DOI 10.1016/j.mito.2010.09.008
   Campos Y, 1997, NEUROLOGY, V49, P595, DOI 10.1212/WNL.49.2.595
   Capiau S, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11030489
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Carroll CJ, 2014, BRIT J PHARMACOL, V171, P1837, DOI 10.1111/bph.12469
   Carroll J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2100558118
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Catteruccia M, 2014, MOL GENET METAB, V111, P353, DOI 10.1016/j.ymgme.2014.01.001
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Claeys KG, 2016, MUSCLE NERVE, V54, P328, DOI 10.1002/mus.25125
   Cortés-Hernández P, 2007, J BIOL CHEM, V282, P1051, DOI 10.1074/jbc.M606828200
   Craig K, 2007, J MED GENET, V44, P797, DOI 10.1136/jmg.2007.052902
   D'Aurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Dautant A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00329
   Dawod PGA, 2020, GENES-BASEL, V11, DOI 10.3390/genes11091037
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   de Mello AH, 2018, LIFE SCI, V192, P26, DOI 10.1016/j.lfs.2017.11.019
   Del Dotto V, 2024, INT J MOL SCI, V25, DOI 10.3390/ijms25042239
   DEMEIRLEIR L, 1995, PEDIATR NEUROL, V13, P242, DOI 10.1016/0887-8994(95)00184-H
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   DIMAURO S, 1976, J NEUROL SCI, V27, P217, DOI 10.1016/0022-510X(76)90063-0
   DiMauro S, 2007, BIOSCIENCE REP, V27, P125, DOI 10.1007/s10540-007-9041-4
   DiMauro S, 2011, J INHERIT METAB DIS, V34, P261, DOI 10.1007/s10545-010-9082-x
   Diodato D, 2015, JIMD REP, V15, P71, DOI 10.1007/8904_2014_300
   Duno M, 2013, GENE, V515, P372, DOI 10.1016/j.gene.2012.12.066
   Vazquez-Memije ME, 2009, J CELL BIOCHEM, V106, P878, DOI 10.1002/jcb.22055
   Fragaki K, 2019, MOL GENET METAB REP, V21, DOI 10.1016/j.ymgmr.2019.100543
   FRYER A, 1994, ARCH DIS CHILD, V71, P419, DOI 10.1136/adc.71.5.419
   Galber C, 2021, LIFE-BASEL, V11, DOI 10.3390/life11040325
   Ganapathi M, 2022, J INHERIT METAB DIS, V45, P996, DOI 10.1002/jimd.12526
   Ganetzky RD, 2019, HUM MUTAT, V40, P499, DOI 10.1002/humu.23723
   Ganetzky RD, 2022, NEW ENGL J MED, V387, P1395, DOI 10.1056/NEJMoa2202949
   Gilbert DL, 2009, MOVEMENT DISORD, V24, P364, DOI 10.1002/mds.22363
   Giorgio V, 2019, BRIT J PHARMACOL, V176, P4247, DOI 10.1111/bph.14513
   Green DW, 2000, BBA-BIOENERGETICS, V1458, P343, DOI 10.1016/S0005-2728(00)00085-2
   Harrington JS, 2023, PHYSIOL REV, V103, P2349, DOI 10.1152/physrev.00058.2021
   He JY, 2018, P NATL ACAD SCI USA, V115, P2988, DOI 10.1073/pnas.1722086115
   He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114
   Hejzlarová K, 2015, BIOCHEM J, V466, P601, DOI 10.1042/BJ20141462
   Hirono K, 2019, CLIN CASE REP, V7, P553, DOI 10.1002/ccr3.2050
   HOLME E, 1992, PEDIATR RES, V32, P731, DOI 10.1203/00006450-199212000-00022
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Honzik T, 2013, MOL GENET METAB, V108, P102, DOI 10.1016/j.ymgme.2012.11.002
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Honzík T, 2010, ARCH DIS CHILD, V95, P296, DOI 10.1136/adc.2009.168096
   Houstek J, 1999, HUM MOL GENET, V8, P1967
   HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A
   Hu CP, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2020.103898
   Imai A, 2016, INT J CARDIOL, V207, P203, DOI 10.1016/j.ijcard.2016.01.026
   Imai-Okazaki A, 2019, INT J CARDIOL, V279, P115, DOI 10.1016/j.ijcard.2019.01.017
   Isohanni P, 2018, NEUROGENETICS, V19, P49, DOI 10.1007/s10048-018-0537-9
   Jackson CB, 2017, EUR J MED GENET, V60, P345, DOI 10.1016/j.ejmg.2017.04.006
   Jesina P, 2004, BIOCHEM J, V383, P561, DOI 10.1042/BJ20040407
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086
   Jonckheere AI, 2011, MITOCHONDRION, V11, P954, DOI 10.1016/j.mito.2011.08.012
   Jones DE, 2021, CLIN CHIM ACTA, V522, P96, DOI 10.1016/j.cca.2021.08.016
   Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2
   Knight KM, 2020, MITOCHONDRION, V55, P8, DOI 10.1016/j.mito.2020.08.009
   Kobayashi R, 2020, P NATL ACAD SCI USA, V117, P1447, DOI 10.1073/pnas.1909407117
   Kovalcíková J, 2019, FASEB J, V33, P14103, DOI 10.1096/fj.201900685RR
   Kühlbrandt W, 2019, ANNU REV BIOCHEM, V88, P515, DOI 10.1146/annurev-biochem-013118-110903
   Kumar M, 2010, MOL VIS, V16, P782
   Kytövuori L, 2016, J NEUROL, V263, P2188, DOI 10.1007/s00415-016-8249-2
   Lai YZ, 2023, MOL CELL, V83, P2137, DOI 10.1016/j.molcel.2023.04.029
   LAMMINEN T, 1995, AM J HUM GENET, V56, P1238
   Larson AA, 2019, MITOCHONDRION, V44, P58, DOI 10.1016/j.mito.2018.01.001
   Lemoine S, 2018, AM J KIDNEY DIS, V71, P754, DOI 10.1053/j.ajkd.2017.09.020
   Li Y, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005653
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Lines MA, 2021, EUR J HUM GENET, V29, P1719, DOI 10.1038/s41431-021-00956-0
   López-Gallardo E, 2009, J MED GENET, V46, P64, DOI 10.1136/jmg.2008.060616
   López-Gallardo E, 2014, HUM MOL GENET, V23, P6191, DOI 10.1093/hmg/ddu339
   Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Mackay L, 2023, AM J MED GENET A, V191, P1366, DOI 10.1002/ajmg.a.63131
   Magner M, 2015, J INHERIT METAB DIS, V38, P417, DOI 10.1007/s10545-014-9774-8
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   Mkaouar-Rebai E, 2009, PEDIATR NEUROL, V40, P437, DOI 10.1016/j.pediatrneurol.2009.01.004
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   Mordel P, 2017, BIOCHEM BIOPH RES CO, V494, P133, DOI 10.1016/j.bbrc.2017.10.066
   Mori M, 2014, JIMD REP, V17, P47, DOI 10.1007/8904_2014_332
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   Nasca A, 2023, BRAIN, V146, P2730, DOI 10.1093/brain/awad068
   Neilson DE, 2022, MOVEMENT DISORD, V37, P375, DOI 10.1002/mds.28821
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Ng YS, 2019, ANN NEUROL, V86, P310, DOI 10.1002/ana.25525
   Nolte D, 2021, J NEUROL, V268, P4866, DOI 10.1007/s00415-021-10607-5
   Ogawa E, 2017, J INHERIT METAB DIS, V40, P685, DOI 10.1007/s10545-017-0042-6
   Oláhová M, 2018, AM J HUM GENET, V102, P494, DOI 10.1016/j.ajhg.2018.01.020
   Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561
   Panosyan FB, 2017, MUSCLE NERVE, V55, P922, DOI 10.1002/mus.25453
   Panwala TF, 2022, PEDIATR NEUROL, V130, P7, DOI 10.1016/j.pediatrneurol.2022.02.007
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   PASTORES GM, 1994, AM J MED GENET, V50, P265, DOI 10.1002/ajmg.1320500310
   Pfeffer G, 2012, J NEUROL NEUROSUR PS, V83, P883, DOI 10.1136/jnnp-2012-302568
   Piekutowska-Abramczuk D, 2018, METAB BRAIN DIS, V33, P191, DOI 10.1007/s11011-017-0122-1
   Pinke G, 2020, NAT STRUCT MOL BIOL, V27, P1077, DOI 10.1038/s41594-020-0503-8
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Porto FBO, 2001, AM J OPHTHALMOL, V132, P935, DOI 10.1016/S0002-9394(01)01187-4
   Prasun P, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165838
   PUDDU P, 1993, BRIT J OPHTHALMOL, V77, P84, DOI 10.1136/bjo.77.2.84
   Rabier D, 1998, J INHERIT METAB DIS, V21, P216, DOI 10.1023/A:1005391300203
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Ribas GS, 2022, CELL MOL NEUROBIOL, V42, P2593, DOI 10.1007/s10571-021-01156-6
   Ronchi D, 2011, BIOCHEM BIOPH RES CO, V412, P245, DOI 10.1016/j.bbrc.2011.07.076
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rucheton B, 2020, MITOCHONDRION, V55, P64, DOI 10.1016/j.mito.2020.08.004
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Saneto RP, 2010, MITOCHONDRION, V10, P567, DOI 10.1016/j.mito.2010.05.006
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   Sarajlija A, 2017, CONGENIT ANOM, V57, P64, DOI 10.1111/cga.12194
   Scaglia Fernando, 2002, BMC Pediatr, V2, P12, DOI 10.1186/1471-2431-2-12
   Seneca S, 1996, J INHERIT METAB DIS, V19, P115, DOI 10.1007/BF01799407
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Shchelochkov OA, 2010, MOL GENET METAB, V101, P282, DOI 10.1016/j.ymgme.2010.07.012
   Sikorska M, 2009, MUSCLE NERVE, V40, P381, DOI 10.1002/mus.21355
   Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008
   Spiegel R, 2011, J MED GENET, V48, P177, DOI 10.1136/jmg.2010.084608
   Spikes TE, 2020, P NATL ACAD SCI USA, V117, P23519, DOI 10.1073/pnas.2013998117
   Staretz-Chacham O, 2019, AM J MED GENET A, V179, P1293, DOI 10.1002/ajmg.a.61138
   Stendel C, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000393
   Stenton SL, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102784
   Stojanovic V, 2013, J PEDIATR ENDOCR MET, V26, P151, DOI 10.1515/jpem-2012-0291
   Synofzik M, 2012, EUR J NEUROL, V19, pe114, DOI 10.1111/j.1468-1331.2012.03812.x
   Takada R, 2020, BRAIN DEV-JPN, V42, P69, DOI 10.1016/j.braindev.2019.08.006
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tatuch Yuriy, 1994, European Journal of Human Genetics, V2, P35
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Theunissen TEJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00400
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Torraco A, 2012, NEUROGENETICS, V13, P375, DOI 10.1007/s10048-012-0343-8
   Tort F, 2011, CLIN GENET, V80, P297, DOI 10.1111/j.1399-0004.2011.01650.x
   Tsao CY, 2001, J CHILD NEUROL, V16, P533, DOI 10.1177/088307380101600716
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Varadi M, 2022, NUCLEIC ACIDS RES, V50, pD439, DOI 10.1093/nar/gkab1061
   Vázquez-Memije ME, 1998, J INHERIT METAB DIS, V21, P829, DOI 10.1023/A:1005418718299
   Verny C, 2011, MITOCHONDRION, V11, P70, DOI 10.1016/j.mito.2010.07.006
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Walsh N, 2024, J MED GENET, V61, P207, DOI 10.1136/jmg-2023-109488
   Wang YM, 2007, J BIOL CHEM, V282, P8228, DOI 10.1074/jbc.M609635200
   Wang ZG, 2001, J BIOL CHEM, V276, P30773, DOI 10.1074/jbc.M104133200
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Waterham HR, 2023, GENET MED, V25, DOI 10.1016/j.gim.2023.100944
   Wei YP, 2018, J NEUROL, V265, P2388, DOI 10.1007/s00415-018-9014-5
   Wen SZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36313
   Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021
   Wong LJC, 2020, HUM MUTAT, V41, P1783, DOI 10.1002/humu.24082
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P923, DOI 10.1007/s10545-012-9580-0
   Wortmann SB, 2009, BRAIN, V132, P136, DOI 10.1093/brain/awn296
   Yaribeygi H, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/8609213
   Yu JL, 2020, J CLIN INVEST, V130, P4935, DOI 10.1172/JCI134965
   Yu XL, 2018, CHINESE MED J-PEKING, V131, P2705, DOI 10.4103/0366-6999.245265
   Zech M, 2022, ANN NEUROL, V91, P225, DOI 10.1002/ana.26293
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
   Zigman T, 2021, J PEDIATR ENDOCR MET, V34, P389, DOI 10.1515/jpem-2020-0396
NR 186
TC 0
Z9 0
U1 2
U2 2
PU ACAD SCIENCES CZECH REPUBLIC, INST PHYSIOLOGY
PI PRAGUE 4
PA VIDENSKA 1083, PRAGUE 4 142 20, CZECH REPUBLIC
SN 0862-8408
EI 1802-9973
J9 PHYSIOL RES
JI Physiol. Res.
PD AUG
PY 2024
VL 73
SU 1
BP S243
EP S278
DI 10.33549/physiolres.935407
PG 36
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA D3O3L
UT WOS:001295308400014
PM 39016153
DA 2024-11-01
ER

PT J
AU Pelnena, D
   Burnyte, B
   Jankevics, E
   Lace, B
   Dagyte, E
   Grigalioniene, K
   Utkus, A
   Krumina, Z
   Rozentale, J
   Adomaitiene, I
   Stavusis, J
   Pliss, L
   Inashkina, I
AF Pelnena, Dita
   Burnyte, Birute
   Jankevics, Eriks
   Lace, Baiba
   Dagyte, Evelina
   Grigalioniene, Kristina
   Utkus, Algirdas
   Krumina, Zita
   Rozentale, Jolanta
   Adomaitiene, Irina
   Stavusis, Janis
   Pliss, Liana
   Inashkina, Inna
TI Complete mtDNA sequencing reveals mutations m.9185T&gt;C and
   m.13513G&gt;A in three patients with Leigh syndrome
SO MITOCHONDRIAL DNA PART A
LA English
DT Article
DE Leigh syndrome; mitochondria DNA; brain MRI
ID MITOCHONDRIAL-DNA MUTATIONS; DISEASE PHENOTYPES; I-DEFICIENCY;
   COMMON-CAUSE; MTATP6 GENE; CHILDREN; MELAS; MUSCLE
AB The most common mitochondrial disorder in children is Leigh syndrome, which is a progressive and genetically heterogeneous neurodegenerative disorder caused by mutations in nuclear genes or mito-chondrial DNA (mtDNA). In the present study, a novel and robust method of complete mtDNA sequenc-ing, which allows amplification of the whole mitochondrial genome, was tested. Complete mtDNA sequencing was performed in a cohort of patients with suspected mitochondrial mutations. Patients from Latvia and Lithuania (n = 92 and n = 57, respectively) referred by clinical geneticists were included. The de novo point mutations m.9185T>C and m.13513G>A, respectively, were detected in two patients with lactic acidosis and neurodegenerative lesions. In one patient with neurodegenerative lesions, the mutation m.9185T>C was identified. These mutations are associated with Leigh syndrome. The present data suggest that full-length mtDNA sequencing is recommended as a supplement to nuclear gene testing and enzymatic assays to enhance mitochondrial disease diagnostics.
C1 [Pelnena, Dita; Jankevics, Eriks; Lace, Baiba; Stavusis, Janis; Pliss, Liana; Inashkina, Inna] Latvian Biomed Res & Study Ctr, Ratsupites 1, LV-1067 Riga, Latvia.
   [Burnyte, Birute; Dagyte, Evelina; Grigalioniene, Kristina; Utkus, Algirdas] Vilnius Univ, Fac Med, Dept Human & Med Genet, Vilnius, Lithuania.
   [Lace, Baiba] Ctr Hosp Univ Quebec, Ville De Quebec, PQ, Canada.
   [Krumina, Zita] Childrens Clin Univ Hosp, Riga, Latvia.
   [Rozentale, Jolanta] Pauls Stradins Clin Univ Hosp, Riga, Latvia.
   [Adomaitiene, Irina] Vilnius Univ Hosp Santaros Klin, Childrens Hosp, Dept Radiol, Vilnius, Lithuania.
C3 Latvian Biomedical Research & Study Centre; Vilnius University; Laval
   University; Pauls Stradins Clinical University Hospital
RP Pelnena, D (corresponding author), Latvian Biomed Res & Study Ctr, Ratsupites 1, LV-1067 Riga, Latvia.
EM dita@biomed.lu.lv
RI Inashkina, Inna/AAH-9955-2021; Lace, Baiba/AAY-9362-2020; Kasiulevicius,
   Vytautas/P-6819-2014
OI Utkus, Algirdas/0000-0001-5766-6653; Inashkina,
   Inna/0000-0002-7560-797X; Stavusis, Janis/0000-0002-0109-3312; Pliss,
   Liana/0009-0007-9352-5197; Lace, Baiba/0000-0001-5371-6756;
   Kasiulevicius, Vytautas/0000-0001-9967-8257
FU European Regional Development Fund (ERDF)
   [2010/0223/2DP/2.1.1.1.0/10/APIA/VIAA/025]; ERDF
   [2014/0021/2DP/2.1.1.1.0/14/APIA/VIAA/058]; Taiwan-Latvian-Lithuanian
   Collaboration Project 'Functional model for the mitochondrial disease
   evaluation'
FX The study was supported by European Regional Development Fund (ERDF)
   grant 2010/0223/2DP/2.1.1.1.0/10/APIA/VIAA/025 'New tests for the
   diagnosis of inherited neuromuscular diseases', and ERDF Grant
   2014/0021/2DP/2.1.1.1.0/14/APIA/VIAA/058 'Development of novel in vitro
   tests for diagnostics and prognostics of individualized therapies of
   tumors and mitochondrial disease treatment'. The study was also
   supported by the Taiwan-Latvian-Lithuanian Collaboration Project
   'Functional model for the mitochondrial disease evaluation and
   bio-marker development'.
CR Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Brautbar A, 2008, MOL GENET METAB, V94, P485, DOI 10.1016/j.ymgme.2008.04.004
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Hsieh YT, 2011, OPHTHALMIC GENET, V32, P31, DOI 10.3109/13816810.2010.531880
   Jankevics E, 2016, European patent, Patent No. [EP3091083 (A1)-2016-11-09, 3091083]
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Kolarova H, 2016, OPHTHALMIC GENET, V37, P419, DOI 10.3109/13816810.2015.1092045
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Makino M, 2000, J HUM GENET, V45, P69, DOI 10.1007/s100380050014
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   Naess K, 2009, BBA-BIOENERGETICS, V1787, P484, DOI 10.1016/j.bbabio.2008.11.014
   Pliss L, 2011, EXP GERONTOL, V46, P560, DOI 10.1016/j.exger.2011.02.016
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Ramos A, 2009, ELECTROPHORESIS, V30, P1587, DOI 10.1002/elps.200800601
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Thorburn D.R., 1993, GeneReviews
   Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   Wang ZX, 2010, NEUROPATHOLOGY, V30, P606, DOI 10.1111/j.1440-1789.2010.01115.x
   Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065
   Wortmann SB, 2017, NEUROPEDIATRICS, V48, P309, DOI 10.1055/s-0037-1603776
NR 30
TC 3
Z9 4
U1 0
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2470-1394
EI 2470-1408
J9 MITOCHONDRIAL DNA A
JI Mitochondrial DNA Part A
PY 2018
VL 29
IS 7
BP 1115
EP 1120
DI 10.1080/24701394.2017.1413365
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA HA4YU
UT WOS:000450274300013
PM 29228836
DA 2024-11-01
ER

PT J
AU McKiernan, SH
   Colman, RJ
   Lopez, M
   Beasley, TM
   Aiken, JM
   Anderson, RM
   Weindruch, R
AF McKiernan, Susan H.
   Colman, Ricki J.
   Lopez, Marisol
   Beasley, T. Mark
   Aiken, Judd M.
   Anderson, Rozalyn M.
   Weindruch, Richard
TI Caloric restriction delays aging-induced cellular phenotypes in rhesus
   monkey skeletal muscle
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Sarcopenia; Calorie restriction; Rhesus monkey
ID DNA DELETION MUTATIONS; DIETARY RESTRICTION; CAUSAL ROLE; SARCOPENIA;
   MASS; ABNORMALITIES; APOPTOSIS; DISEASE; ATROPHY; FIBERS
AB Sarcopenia is the age-related loss of skeletal muscle mass and function and is characterized by a reduction in muscle mass and fiber cross-sectional area, alterations in muscle fiber type and mitochondrial functional changes. In rhesus monkeys, calorie restriction (CR) without malnutrition improves survival and delays the onset of age-associated diseases and disorders including sarcopenia. We present a longitudinal study on the impact of CR on early stage sarcopenia in the upper leg of monkeys from similar to 16 years to similar to 22 years of age. Using dual-energy X-ray absorptiometry we show that CR delayed the development of maximum muscle mass and, unlike Control animals, muscle mass of the upper leg was preserved in CR animals during early phase sarcopenia. Histochemical analyses of vastus lateralis muscle biopsies revealed that CR opposed age-related changes in the proportion of Type II muscle fibers and fiber cross-sectional area. In contrast the number of muscle fibers with mitochondrial electron transport system enzyme abnormalities (ETSab) was not significantly affected by CR. Laser capture microdissection of ETSab fibers and subsequent PCR analysis of the mitochondria! DNA revealed large deletion mutations in fibers with abnormal mitochondrial enzyme activities. CR did not prevent stochastic mitochondrial deletion mutations in muscle fibers but CR may have contributed to the maintenance of affected fibers. (c) 2010 Elsevier Inc. All rights reserved.
C1 [McKiernan, Susan H.] Univ Wisconsin, Dept Kinesiol, Madison, WI 53706 USA.
   [McKiernan, Susan H.; Colman, Ricki J.; Lopez, Marisol] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA.
   [Lopez, Marisol; Aiken, Judd M.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA.
   [Beasley, T. Mark] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA.
   [Aiken, Judd M.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2M8, Canada.
   [Anderson, Rozalyn M.; Weindruch, Richard] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53706 USA.
   [Anderson, Rozalyn M.; Weindruch, Richard] Univ Wisconsin, William S Middleton Mem Vet Hosp, Geriatr Res Educ & Clin Ctr, Madison, WI 53705 USA.
C3 University of Wisconsin System; University of Wisconsin Madison;
   University of Wisconsin System; University of Wisconsin Madison;
   University of Wisconsin System; University of Wisconsin Madison;
   University of Alabama System; University of Alabama Birmingham;
   University of Alberta; University of Wisconsin System; University of
   Wisconsin Madison; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); William S Middleton Memorial Veterans Hospital;
   University of Wisconsin System; University of Wisconsin Madison;
   Geriatric Research Education & Clinical Center
RP McKiernan, SH (corresponding author), Univ Wisconsin, Dept Kinesiol, 2000 Observ Dr, Madison, WI 53706 USA.
EM shmckier@wisc.edu
OI LOPEZ, MARISOL/0000-0001-9412-524X; Aiken, Judd/0000-0001-6119-4521;
   Colman, Ricki/0000-0001-9706-0525
FU NIH [P01 AG-11915, P51 RR000167]; Ellison Medical Foundation; Research
   Facilities Improvement Program [RR15459-01, RR020141-01]
FX We acknowledge the efforts of the veterinary staff of the Wisconsin
   National Primate Research Center. This work was supported by NIH grants
   P01 AG-11915; P51 RR000167 and the Ellison Medical Foundation Senior
   Scholar Award (Judd Aiken). This research was conducted in part at a
   facility constructed with support from the Research Facilities
   Improvement Program grant numbers RR15459-01 and RR020141-01.
CR Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005
   Bua EA, 2004, FASEB J, V18, P582, DOI 10.1096/fj.03-0668fje
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Colman RJ, 2008, J GERONTOL A-BIOL, V63, P556, DOI 10.1093/gerona/63.6.556
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Colman RJ, 2005, EXP GERONTOL, V40, P573, DOI 10.1016/j.exger.2005.05.001
   Degens H., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P246
   Degens H, 2006, INT J SPORTS MED, V27, P94, DOI 10.1055/s-2005-837571
   Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002
   Dubowitz V., 1985, MUSCLE BIOPSY PRACTI, V2nd
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Gresl TA, 2001, AM J PHYSIOL-ENDOC M, V281, pE757, DOI 10.1152/ajpendo.2001.281.4.E757
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hollmann W, 2007, EUR J CARDIOV PREV R, V14, P730, DOI 10.1097/HJR.0b013e32828622f9
   Holloszy JO, 2007, EXP GERONTOL, V42, P709, DOI 10.1016/j.exger.2007.03.009
   Hughes VA, 2001, J GERONTOL A-BIOL, V56, pB209, DOI 10.1093/gerona/56.5.B209
   Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x
   KEMNITZ JW, 1993, J GERONTOL, V48, pB17, DOI 10.1093/geronj/48.1.B17
   LARSSON L, 1995, J GERONTOL A-BIOL, V50, P91
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   Lushaj EB, 2008, J GERONTOL A-BIOL, V63, P921, DOI 10.1093/gerona/63.9.921
   Marzetti E, 2010, BBA-GEN SUBJECTS, V1800, P235, DOI 10.1016/j.bbagen.2009.05.007
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   McKiernan SH, 2009, EXP GERONTOL, V44, P170, DOI 10.1016/j.exger.2008.09.014
   Nair K S, 2000, Mayo Clin Proc, V75 Suppl, pS14
   Pette D, 2002, CAN J APPL PHYSIOL, V27, P423, DOI 10.1139/h02-023
   Ramsey JJ, 2000, EXP GERONTOL, V35, P1131, DOI 10.1016/S0531-5565(00)00166-2
   Redman LM, 2008, PHYSIOL BEHAV, V94, P643, DOI 10.1016/j.physbeh.2008.04.017
   Rossi Paola, 2008, Curr Aging Sci, V1, P182
   Roth SM, 2006, CURR OPIN RHEUMATOL, V18, P625, DOI 10.1097/01.bor.0000245722.10136.6d
   Roy A, 2006, BIOMETRICAL J, V48, P286, DOI 10.1002/bimj.200510192
   SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1
   Sheehan D.C., 1980, Theory and Practice of Histotechnology, Vsecond
   Tews DS, 2005, MUSCLE NERVE, V32, P443, DOI 10.1002/mus.20348
   Thomas DR, 2007, CLIN NUTR, V26, P389, DOI 10.1016/j.clnu.2007.03.008
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348
NR 37
TC 74
Z9 79
U1 0
U2 33
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JAN
PY 2011
VL 46
IS 1
BP 23
EP 29
DI 10.1016/j.exger.2010.09.011
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 710UP
UT WOS:000286542800004
PM 20883771
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Mancuso, M
   Orsucci, D
   Angelini, C
   Bertini, E
   Carelli, V
   Comi, GP
   Minetti, C
   Moggio, M
   Mongini, T
   Servidei, S
   Tonin, P
   Toscano, A
   Uziel, G
   Bruno, C
   Ienco, EC
   Filosto, M
   Lamperti, C
   Martinelli, D
   Moroni, I
   Musumeci, O
   Pegoraro, E
   Ronchi, D
   Santorelli, FM
   Sauchelli, D
   Scarpelli, M
   Sciacco, M
   Spinazzi, M
   Valentino, ML
   Vercelli, L
   Zeviani, M
   Siciliano, G
AF Mancuso, Michelangelo
   Orsucci, Daniele
   Angelini, Corrado
   Bertini, Enrico
   Carelli, Valerio
   Comi, Giacomo Pietro
   Minetti, Carlo
   Moggio, Maurizio
   Mongini, Tiziana
   Servidei, Serenella
   Tonin, Paola
   Toscano, Antonio
   Uziel, Graziella
   Bruno, Claudio
   Ienco, Elena Caldarazzo
   Filosto, Massimiliano
   Lamperti, Costanza
   Martinelli, Diego
   Moroni, Isabella
   Musumeci, Olimpia
   Pegoraro, Elena
   Ronchi, Dario
   Santorelli, Filippo Maria
   Sauchelli, Donato
   Scarpelli, Mauro
   Sciacco, Monica
   Spinazzi, Marco
   Valentino, Maria Lucia
   Vercelli, Liliana
   Zeviani, Massimo
   Siciliano, Gabriele
TI Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutation
SO NEUROLOGY
LA English
DT Article
ID RAGGED-RED FIBERS; MITOCHONDRIAL-DNA DISEASE; TRANSFER RNALYS MUTATION;
   MYOCLONIC EPILEPSY; CLINICAL-FEATURES; INVOLVEMENT; DISORDERS
AB Objectives: Myoclonic epilepsy with ragged-red fibers (MERRF) is a rare mitochondrial syndrome, mostly caused by the 8344A>G mitochondrial DNA mutation. Most of the previous studies have been based on single case/family reports or series with few patients. The primary aim of this study was the characterization of a large cohort of patients with the 8344A>G mutation. The secondary aim was revision of the previously published data.
   Methods: Retrospective, database-based study (Nation-wide Italian Collaborative Network of Mitochondrial Diseases) and systematic revision.
   Results: Forty-two patients carrying the mutation were identified. The great majority did not have full-blown MERRF syndrome. Myoclonus was present in 1 of 5 patients, whereas myopathic signs and symptoms, generalized seizures, hearing loss, eyelid ptosis, and multiple lipomatosis represented the most common clinical features. Some asymptomatic mutation carriers have also been observed. Myoclonus was more strictly associated with ataxia than generalized seizures in adult 8344A>G subjects. Considering all of the 321 patients so far available, including our dataset and previously published cases, at the mean age of approximately 35 years, the clinical picture was characterized by the following signs/symptoms, in descending order: myoclonus, muscle weakness, ataxia (35%-45% of patients); generalized seizures, hearing loss (25%-34.9%); cognitive impairment, multiple lipomatosis, neuropathy, exercise intolerance (15%-24.9%); and increased creatine kinase levels, ptosis/ophthalmoparesis, optic atrophy, cardiomyopathy, muscle wasting, respiratory impairment, diabetes, muscle pain, tremor, migraine (5%-14.9%).
   Conclusions: Our results showed higher clinical heterogeneity than commonly thought. Moreover, MERRF could be better defined as a myoclonic ataxia rather than a myoclonic epilepsy.
C1 [Mancuso, Michelangelo; Orsucci, Daniele; Ienco, Elena Caldarazzo; Siciliano, Gabriele] Univ Pisa, Neurol Clin, I-56100 Pisa, Italy.
   [Angelini, Corrado; Pegoraro, Elena; Spinazzi, Marco] Univ Padua, Neurol Clin, Venice, Italy.
   [Angelini, Corrado; Pegoraro, Elena; Spinazzi, Marco] IRCCS S Camillo, Venice, Italy.
   [Bertini, Enrico; Martinelli, Diego] Bambino Gesu Pediat Hosp, Rome, Italy.
   [Carelli, Valerio; Valentino, Maria Lucia] Univ Bologna, IRCCS Ist Sci Neurol, I-40126 Bologna, Italy.
   [Carelli, Valerio; Valentino, Maria Lucia] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40126 Bologna, Italy.
   [Comi, Giacomo Pietro; Ronchi, Dario] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat DEPT, Neurol Unit,Neurosci Sect,Dino Ferrari Ctr, Milan, Italy.
   [Minetti, Carlo; Bruno, Claudio] Univ Genoa, Neuropediat & Muscle Disorders Unit, Genoa, Italy.
   [Minetti, Carlo; Bruno, Claudio] G Gaslini Inst Children, Genoa, Italy.
   [Moggio, Maurizio; Sciacco, Monica] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuromuscular Unit, Milan, Italy.
   [Moggio, Maurizio; Sciacco, Monica] Univ Milan, Dino Ferrari Ctr, I-20122 Milan, Italy.
   [Mongini, Tiziana; Vercelli, Liliana] Univ Turin, Dept Neurosci, I-10124 Turin, Italy.
   [Servidei, Serenella; Sauchelli, Donato] Catholic Univ, Inst Neurol, Rome, Italy.
   [Tonin, Paola; Scarpelli, Mauro] Univ Verona, Neurol Clin, I-37100 Verona, Italy.
   [Toscano, Antonio; Musumeci, Olimpia] Univ Messina, Dept Neurosci, I-98100 Messina, Italy.
   [Uziel, Graziella; Moroni, Isabella] Fdn Carlo Besta Inst Neurology IRCCS, Child Neurol Unit, Milan, Italy.
   [Lamperti, Costanza; Zeviani, Massimo] Fdn Carlo Besta Inst Neurology IRCCS, Unit Mol Neurogenet, Milan, Italy.
   [Filosto, Massimiliano] Univ Hosp Spedali Civili, Neurol Clin, Brescia, Italy.
   [Santorelli, Filippo Maria] IRCCS Stella Maris, Pisa, Italy.
C3 University of Pisa; University of Padua; IRCCS Ospedale San Camillo;
   IRCCS Bambino Gesu; IRCCS Istituto delle Scienze Neurologiche di Bologna
   (ISNB); University of Bologna; University of Bologna; University of
   Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of
   Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Ca
   Granda Ospedale Maggiore Policlinico; University of Milan; University of
   Turin; Catholic University of the Sacred Heart; IRCCS Policlinico
   Gemelli; University of Verona; University of Messina; Fondazione IRCCS
   Istituto Neurologico Carlo Besta; Fondazione IRCCS Istituto Neurologico
   Carlo Besta; Hospital Spedali Civili Brescia; IRCCS Fondazione Stella
   Maris
RP Mancuso, M (corresponding author), Univ Pisa, Neurol Clin, I-56100 Pisa, Italy.
EM mancusomichelangelo@gmail.com
RI Spinazzi, Marco/AFO-9978-2022; Sciacco, Monica/AAC-6500-2022; Mancuso,
   Michelangelo/K-4170-2016; Ronchi, Dario/K-8011-2016; Ienco,
   Elena/K-9142-2016; Bruno, Claudio/A-3148-2015; Toscano,
   Antonio/AHE-4657-2022; Tonin, Paola/AAC-5052-2022; Filosto,
   Massimiliano/S-9446-2019; Servidei, Serenella/ABC-4262-2021; Zeviani,
   Massimo/K-2891-2014; Comi, Giacomo/K-5702-2016; Angelini,
   Corrado/J-3655-2019; Orsucci, Daniele/AAA-7576-2019; lamperti,
   costanza/J-8801-2016; Musumeci, Olimpia/AHE-3041-2022; Santorelli,
   Filippo M/ABE-5124-2020; moroni, isabella/AAL-1336-2021; MINETTI,
   Carlo/K-4666-2018; Bertini, Enrico/A-2284-2014; Siciliano,
   Gabriele/K-7259-2016
OI Comi, Giacomo/0000-0002-1383-5248; VALENTINO, MARIA
   LUCIA/0000-0001-5323-0115; SERVIDEI, Serenella/0000-0001-8478-2799;
   Angelini, Corrado/0000-0002-9554-8794; Orsucci,
   Daniele/0000-0003-4847-7812; Caldarazzo Ienco,
   Elena/0000-0003-0134-5062; Santorelli, Filippo M/0000-0002-1359-9062;
   SPINAZZI, Marco/0000-0003-0048-9558; moroni,
   isabella/0000-0002-3322-1681; MINETTI, Carlo/0000-0002-0640-1804;
   Sauchelli, Donato/0000-0003-0254-0767; Bertini,
   Enrico/0000-0001-9276-4590; Filosto, Massimiliano/0000-0002-2852-7512;
   Siciliano, Gabriele/0000-0002-6142-2384; Ronchi,
   Dario/0000-0002-6093-9816; Zeviani, Massimo/0000-0002-9067-5508;
   Sciacco, Monica/0000-0003-4593-4977; CARELLI,
   VALERIO/0000-0003-4923-6404
FU Telethon [GUP09004]; MRC [MC_UP_1002/1] Funding Source: UKRI
FX This work was supported by Telethon (grant GUP09004).
CR Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   DiMauro S, 2002, ADV NEUROL, V89, P217
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Girlanda P, 1999, CLIN NEUROPHYSIOL, V110, P1284, DOI 10.1016/S1388-2457(98)00041-8
   GRAF WD, 1993, ANN NEUROL, V33, P640, DOI 10.1002/ana.410330613
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Mancuso M, 2009, CURR MOL MED, V9, P1095, DOI 10.2174/156652409789839099
   Mancuso M, 2012, NEUROL SCI, V33, P449, DOI 10.1007/s10072-011-0703-4
   Muñoz-Málaga A, 2000, MUSCLE NERVE, V23, P538, DOI 10.1002/(SICI)1097-4598(200004)23:4<538::AID-MUS12>3.3.CO;2-K
   NOER AS, 1991, AM J HUM GENET, V49, P715
   Remes AM, 2003, J NEUROL NEUROSUR PS, V74, P1158, DOI 10.1136/jnnp.74.8.1158
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Shibasaki H, 2011, MOVEMENT DISORD, V26, P1142, DOI 10.1002/mds.23673
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Wiedemann FR, 2008, CLIN NEUROL NEUROSUR, V110, P859, DOI 10.1016/j.clineuro.2008.06.010
NR 19
TC 128
Z9 134
U1 0
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD MAY
PY 2013
VL 80
IS 22
BP 2049
EP 2054
DI 10.1212/WNL.0b013e318294b44c
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 300LX
UT WOS:000330466500017
PM 23635963
DA 2024-11-01
ER

PT S
AU Finsterer, J
AF Finsterer, Josef
BE Scatena, R
   Bottoni, P
   Giardina, B
TI Inherited Mitochondrial Disorders
SO ADVANCES IN MITOCHONDRIAL MEDICINE
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE Neuromuscular; Encephalomyopathy; Metabolic disease; Multisystem
   disease; Genetics; Mitochondrial DNA
ID HEREDITARY OPTIC NEUROPATHY; C-OXIDASE DEFICIENCY; ONSET SPINOCEREBELLAR
   ATAXIA; LINKED SIDEROBLASTIC ANEMIA; KEARNS-SAYRE-SYNDROME; PROGRESSIVE
   EXTERNAL OPHTHALMOPLEGIA; POLYMERASE-GAMMA MUTATIONS; SURF1
   GENE-MUTATIONS; RNA-SYNTHETASE GENE; DNA DEPLETION
AB Though inherited mitochondrial disorders (MIDs) are most well known for their syndromic forms, for which widely known acronyms (MELAS, MERRF, NARP, LHON etc.) have been coined, the vast majority of inherited MIDs presents in a non-syndromic form. Since MIDs are most frequently multisystem disorders already at onset or during the disease course, a MID should be suspected if there is a combination of neurological and non-neurological abnormalities. Neurological abnormalities occurring as a part of a MID include stroke-like episodes, epilepsy, migraine-like headache, movement disorders, cerebellar ataxia, visual impairment, encephalopathy, cognitive impairment, dementia, psychosis, hypopituitarism, aneurysms, or peripheral nervous system disease, such as myopathy, neuropathy, or neuronopathy. Non-neurological manifestations concern the ears, the endocrine organs, the heart, the gastrointestinal tract, the kidneys, the bone marrow, and the skin. Whenever there is an unexplained combination of neurological and non-neurological disease in a patient or kindred, a MID should be suspected and appropriate diagnostic measures initiated. Genetic testing should be guided by the phenotype, the biopsy findings, and the biochemical results.
C1 Danube Univ Krems, A-1180 Vienna, Austria.
C3 Danube University Krems
RP Finsterer, J (corresponding author), Danube Univ Krems, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Aguirre LA, 2008, NEUROMUSCULAR DISORD, V18, P979, DOI 10.1016/j.nmd.2008.09.009
   Ajlouni K, 2002, AM J MED GENET, V115, P61, DOI 10.1002/ajmg.10345
   Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Ances BM, 2006, J CHILD NEUROL, V21, P805, DOI 10.1177/08830738060210090901
   Barrientos A, 1996, AM J HUM GENET, V58, P963
   Barth M, 2010, J INHERIT M IN PRESS
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   Bhatti MT, 1999, J NEURO-OPHTHALMOL, V19, P28
   Binder J, 2003, BRAIN, V126, P1814, DOI 10.1093/brain/awg174
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Bleyl SB, 1997, AM J MED GENET, V72, P257, DOI 10.1002/(SICI)1096-8628(19971031)72:3<257::AID-AJMG2>3.0.CO;2-O
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Casarin A, 2008, BIOCHEM BIOPH RES CO, V372, P35, DOI 10.1016/j.bbrc.2008.04.172
   Chen YF, 2010, ANN NY ACAD SCI, V1201, P58, DOI 10.1111/j.1749-6632.2010.05619.x
   Chen Yung-Nien, 2004, Chang Gung Med J, V27, P66
   Chinnery PF, 1999, LANCET, V354, pSI17
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   Chinnery PF, 2010, GENEREVIEWS
   Chowers I, 1999, BRIT J OPHTHALMOL, V83, P190, DOI 10.1136/bjo.83.2.190
   Condie J, 2010, J CHILD NEUROL, V25, P633, DOI 10.1177/0883073809342004
   Cryns K, 2003, HUM MUTAT, V22, P275, DOI 10.1002/humu.10258
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Debouverie M, 1997, REV NEUROL, V153, P547
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Fassone E, 2010, HUM MOL GENET, V19, P4837, DOI 10.1093/hmg/ddq414
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Finsterer J, 2007, VASA-J VASCULAR DIS, V36, P229, DOI 10.1024/0301-1526.36.4.229
   Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2009, CAN J NEUROL SCI, V36, P143, DOI 10.1017/S0317167100006508
   Fuhrmann N, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-25
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Giordano C, 2010, ARCH NEUROL-CHICAGO, V67, P1144, DOI 10.1001/archneurol.2010.200
   Gordon N, 2006, DEV MED CHILD NEUROL, V48, P1001, DOI 10.1017/S0012162206002209
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hellier KD, 2001, J NEUROL NEUROSUR PS, V70, P65, DOI 10.1136/jnnp.70.1.65
   Hinson JT, 2007, NEW ENGL J MED, V356, P809, DOI 10.1056/NEJMoa055262
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hirano M., 1996, Handbook of Muscle Disease, P479
   Hofmann S, 2002, J BIOL CHEM, V277, P23287, DOI 10.1074/jbc.M201154200
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horváth R, 2000, J NEUROL, V247, P65, DOI 10.1007/s004150050015
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hourani RG, 2006, NEUROPEDIATRICS, V37, P110, DOI 10.1055/s-2006-924226
   HOWELL N, 1995, GENETICS, V140, P285
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   INBAL A, 1995, AM J MED GENET, V55, P372, DOI 10.1002/ajmg.1320550325
   Isohanni P, 2010, J MED GENET, V47, P66, DOI 10.1136/jmg.2009.068221
   Jansen PHP, 1996, J NEUROL SCI, V135, P176, DOI 10.1016/0022-510X(95)00287-C
   Jones CN, 2008, J BIOL CHEM, V283, P34445, DOI 10.1074/jbc.M806992200
   Kang N, 2010, J BIOL CHEM, V285, P28343, DOI 10.1074/jbc.M110.109199
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KELLARWOOD H, 1994, ANN NEUROL, V36, P109, DOI 10.1002/ana.410360121
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   Leonard JV, 2000, LANCET, V355, P389, DOI 10.1016/S0140-6736(99)05226-5
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Leshinsky-Silver E, 2003, MOL GENET METAB, V79, P288, DOI 10.1016/S1096-7192(03)00097-0
   Liguori M, 2008, J NEUROL, V255, P127, DOI 10.1007/s00415-008-0571-x
   Lissens W, 2000, HUM MUTAT, V15, P209, DOI 10.1002/(SICI)1098-1004(200003)15:3<209::AID-HUMU1>3.3.CO;2-B
   Lodi R, 2011, ARCH NEUROL-CHICAGO, V68, P67, DOI 10.1001/archneurol.2010.228
   Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Maguire A, 2001, BRIT J HAEMATOL, V115, P910, DOI 10.1046/j.1365-2141.2001.03015.x
   Makino M, 1998, NEUROMUSCULAR DISORD, V8, P149, DOI 10.1016/S0960-8966(98)00017-0
   Malfatti E, 2010, J NEUROL SCI, V297, P105, DOI 10.1016/j.jns.2010.06.009
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Mancuso M, 2005, ARCH NEUROL-CHICAGO, V62, P745, DOI 10.1001/archneur.62.5.745
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Marti R, 2002, MITOCHONDRION, V2, P143, DOI 10.1016/S1567-7249(02)00036-3
   Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Medlej R, 2004, J CLIN ENDOCR METAB, V89, P1656, DOI 10.1210/jc.2002-030015
   Millar David S, 2010, Hum Genomics, V4, P384
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Montero R, 2007, CEREBELLUM, V6, P118, DOI 10.1080/14734220601021700
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   Morán M, 2010, HUM MUTAT, V31, P930, DOI 10.1002/humu.21294
   Morgan NV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000833
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Namavar Y, 2011, BRAIN, V134, P143, DOI 10.1093/brain/awq287
   Naumann M, 1997, MUSCLE NERVE, V20, P833, DOI 10.1002/(SICI)1097-4598(199707)20:7<833::AID-MUS7>3.0.CO;2-8
   Naviaux RK, 2005, ANN NEUROL, V58, P491, DOI 10.1002/ana.20544
   Nicolino M, 1997, J CLIN ENDOCR METAB, V82, P3063, DOI 10.1210/jc.82.9.3063
   Nijveldt R, 2004, LANCET, V364, P636, DOI 10.1016/S0140-6736(04)16858-X
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   NIKOSKELAINEN EK, 1994, CLIN NEUROSCI, V2, P115
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nishioka K, 2010, PARKINSONISM RELAT D, V16, P686, DOI 10.1016/j.parkreldis.2010.09.007
   ORTIZ RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1525, DOI 10.1001/archopht.1993.01090110091031
   Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   Peng Y, 2003, MOVEMENT DISORD, V18, P716, DOI 10.1002/mds.10428
   Riera ARP, 2008, J ELECTROCARDIOL, V41, P675, DOI 10.1016/j.jelectrocard.2008.04.001
   Pondarre C, 2007, BLOOD, V109, P3567, DOI 10.1182/blood-2006-04-015768
   Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811
   Pupo Altair Cadrobbi, 2008, Braz J Otorhinolaryngol, V74, P786, DOI 10.1016/S1808-8694(15)31392-6
   Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rankin J, 2010, AM J MED GENET A, V152A, P2079, DOI 10.1002/ajmg.a.33531
   Rantamäki M, 2007, CLIN GENET, V72, P532, DOI 10.1111/j.1399-0004.2007.00908.x
   RICCI E, 1992, BRAIN PATHOL, V2, P141, DOI 10.1111/j.1750-3639.1992.tb00682.x
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Roesch K, 2002, HUM MOL GENET, V11, P477, DOI 10.1093/hmg/11.5.477
   Rossi A, 2003, AM J NEURORADIOL, V24, P1188
   Rydzanicz M, 2010, BIOCHEM BIOPH RES CO, V395, P116, DOI 10.1016/j.bbrc.2010.03.149
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003
   Sadun Alfredo A, 2006, Trans Am Ophthalmol Soc, V104, P51
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Scharfe C, 2000, J MED GENET, V37, P669, DOI 10.1136/jmg.37.9.669
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Smits P, 2011, EUR J HUM GENET, V19, P275, DOI 10.1038/ejhg.2010.208
   Spector Reynold, 2010, Cerebrospinal Fluid Res, V7, P14, DOI 10.1186/1743-8454-7-14
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spencer CT, 2006, PEDIATRICS, V118, pE337, DOI 10.1542/peds.2005-2667
   Spiegel R, 2009, ANN NEUROL, V66, P419, DOI 10.1002/ana.21752
   Spiegel R, 2009, EUR J HUM GENET, V17, P1200, DOI 10.1038/ejhg.2009.24
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Spruijt L, 2007, ARCH NEUROL-CHICAGO, V64, P890, DOI 10.1001/archneur.64.6.890
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Tay SHK, 2006, ARCH NEUROL-CHICAGO, V63, P281, DOI 10.1001/archneur.63.2.281
   Tay SKH, 2005, J CHILD NEUROL, V20, P670, DOI 10.1177/08830738050200080701
   Teitelbaum JE, 2002, J PEDIATR GASTR NUTR, V35, P377, DOI 10.1097/00005176-200209000-00029
   Thorburn DR, 2006, GENEREVIEWS, P1993
   Tranebjoerg L, 2000, ADV OTO-RHINO-LARYNG, V56, P97
   Tsao CY, 2003, J CHILD NEUROL, V18, P62, DOI 10.1177/08830738030180011401
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   van de Glind G, 2007, EUR J PAEDIATR NEURO, V11, P243, DOI 10.1016/j.ejpn.2007.01.004
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VANDENOUWELAND JMW, 1995, MUSCLE NERVE, pS124
   Verny C, 2011, MITOCHONDRION, V11, P70, DOI 10.1016/j.mito.2010.07.006
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Wiedemann FR, 2008, CLIN NEUROL NEUROSUR, V110, P859, DOI 10.1016/j.clineuro.2008.06.010
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Worle H, 1998, CLIN NEUROPATHOL, V17, P63
   Young TM, 2010, ARCH NEUROL-CHICAGO, V67, P1399, DOI 10.1001/archneurol.2010.283
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
   Zoccolella S, 2006, FUNCT NEUROL, V21, P39
NR 177
TC 24
Z9 26
U1 0
U2 11
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
EI 2214-8019
BN 978-94-007-2868-4; 978-94-007-2869-1
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2012
VL 942
BP 187
EP 213
DI 10.1007/978-94-007-2869-1_8
D2 10.1007/978-94-007-2869-1
PG 27
WC Oncology; Medicine, Research & Experimental
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA BA2RR
UT WOS:000333840200009
PM 22399423
DA 2024-11-01
ER

PT J
AU Oller, J
   Gabandé-Rodríguez, E
   Ruiz-Rodríguez, MJ
   Desdín-Micó, G
   Aranda, JF
   Rodrigues-Diez, R
   Ballesteros-Martínez, C
   Blanco, EM
   Roldan-Montero, R
   Acuña, P
   Gil, AF
   Martín-López, CE
   Nistal, JF
   Cardenas, CLL
   Lindsay, ME
   Martín-Ventura, JL
   Briones, AM
   Redondo, JM
   Mittelbrunn, M
AF Oller, Jorge
   Gabande-Rodriguez, Enrique
   Ruiz-Rodriguez, Maria Jesus
   Desdin-Mico, Gabriela
   Aranda, Juan Francisco
   Rodrigues-Diez, Raquel
   Ballesteros-Martinez, Constanza
   Blanco, Eva Maria
   Roldan-Montero, Raquel
   Acuna, Pedro
   Forteza Gil, Alberto
   Martin-Lopez, Carlos E.
   Nistal, J. Francisco
   Lino Cardenas, Christian L.
   Lindsay, Mark Evan
   Martin-Ventura, Jose Luis
   Briones, Ana M.
   Miguel Redondo, Juan
   Mittelbrunn, Maria
TI Extracellular Tuning of Mitochondrial Respiration Leads to Aortic
   Aneurysm
SO CIRCULATION
LA English
DT Article
DE aortic aneurysm; DNA; mitochondrial; extracellular matrix; genetic
   diseases; inborn; glycolysis; Marfan syndrome; muscle; smooth; vascular
ID VASCULAR SMOOTH-MUSCLE; MARFAN-SYNDROME; MOUSE MODEL; NAD(+) DEFICIENCY;
   METABOLISM; CELLS; LOSARTAN; GENETICS; MECHANOTRANSDUCTION; DEGENERATION
AB Background:
   Marfan syndrome (MFS) is an autosomal dominant disorder of the connective tissue caused by mutations in the FBN1 (fibrillin-1) gene encoding a large glycoprotein in the extracellular matrix called fibrillin-1. The major complication of this connective disorder is the risk to develop thoracic aortic aneurysm. To date, no effective pharmacologic therapies have been identified for the management of thoracic aortic disease and the only options capable of preventing aneurysm rupture are endovascular repair or open surgery. Here, we have studied the role of mitochondrial dysfunction in the progression of thoracic aortic aneurysm and mitochondrial boosting strategies as a potential treatment to managing aortic aneurysms.
   Methods:
   Combining transcriptomics and metabolic analysis of aortas from an MFS mouse model (Fbn1(c1039g/+)) and MFS patients, we have identified mitochondrial dysfunction alongside with mtDNA depletion as a new hallmark of aortic aneurysm disease in MFS. To demonstrate the importance of mitochondrial decline in the development of aneurysms, we generated a conditional mouse model with mitochondrial dysfunction specifically in vascular smooth muscle cells (VSMC) by conditional depleting Tfam (mitochondrial transcription factor A; Myh11-Cre(ERT2)Tfam(flox/flox) mice). We used a mouse model of MFS to test for drugs that can revert aortic disease by enhancing Tfam levels and mitochondrial respiration.
   Results:
   The main canonical pathways highlighted in the transcriptomic analysis in aortas from Fbn1(c1039g/+) mice were those related to metabolic function, such as mitochondrial dysfunction. Mitochondrial complexes, whose transcription depends on Tfam and mitochondrial DNA content, were reduced in aortas from young Fbn1(c1039g/+) mice. In vitro experiments in Fbn1-silenced VSMCs presented increased lactate production and decreased oxygen consumption. Similar results were found in MFS patients. VSMCs seeded in matrices produced by Fbn1-deficient VSMCs undergo mitochondrial dysfunction. Conditional Tfam-deficient VSMC mice lose their contractile capacity, showed aortic aneurysms, and died prematurely. Restoring mitochondrial metabolism with the NAD precursor nicotinamide riboside rapidly reverses aortic aneurysm in Fbn1(c1039g/+) mice.
   Conclusions:
   Mitochondrial function of VSMCs is controlled by the extracellular matrix and drives the development of aortic aneurysm in Marfan syndrome. Targeting vascular metabolism is a new available therapeutic strategy for managing aortic aneurysms associated with genetic disorders.
C1 [Oller, Jorge; Gabande-Rodriguez, Enrique; Desdin-Mico, Gabriela; Aranda, Juan Francisco; Blanco, Eva Maria; Acuna, Pedro; Mittelbrunn, Maria] Consejo Super Invest Cient Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, Madrid, Spain.
   [Oller, Jorge; Gabande-Rodriguez, Enrique; Desdin-Mico, Gabriela; Aranda, Juan Francisco; Blanco, Eva Maria; Mittelbrunn, Maria] Inst Invest Sanitaria Hosp 12 Octubre i 12, Madrid, Spain.
   [Oller, Jorge; Rodrigues-Diez, Raquel; Roldan-Montero, Raquel; Briones, Ana M.; Miguel Redondo, Juan] Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid, Spain.
   [Ruiz-Rodriguez, Maria Jesus; Miguel Redondo, Juan] Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain.
   [Rodrigues-Diez, Raquel; Ballesteros-Martinez, Constanza; Briones, Ana M.] Univ Autonoma Madrid, Inst Invest Hosp La Paz, Dept Farmacol, Madrid, Spain.
   [Roldan-Montero, Raquel; Martin-Ventura, Jose Luis] Fdn Jimenez Diaz, Inst Invest Sanitaria, Madrid, Spain.
   [Roldan-Montero, Raquel; Martin-Ventura, Jose Luis] Hosp Univ Puerta Hierro, Madrid, Spain.
   [Nistal, J. Francisco] Univ Cantabria, Hosp Univ Marques Valdecilla, Cardiovasc Surg, IDIVAL, Santander, Spain.
   [Lino Cardenas, Christian L.; Lindsay, Mark Evan] Massachusetts Gen Hosp, Thorac Aort Ctr, Boston, MA 02114 USA.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de
   Biologia Molecular Severo Ochoa (CBM); Hospital Universitario 12 de
   Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV;
   Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous
   University of Madrid; Fundacion Jimenez Diaz; Hospital Puerta de
   Hierro-Majadahonda; Hospital Universitario Marques de Valdecilla (HUMV);
   Universidad de Cantabria; Harvard University; Massachusetts General
   Hospital
RP Mittelbrunn, M (corresponding author), Ctr Biol Mol Severo Ochoa, Immunometab & Inflammat Lab, C Nicolas Cabrera 1, Madrid 28049, Spain.
EM jorge.oller@cbm.csic.es; egabande@cbm.csic.es; gdesdin@cbm.csic.es;
   jmredondo@cnic.es; Raquel.roldanm@quironsalud.es;
   constanza.ballesteros.martinez@gmail.com; eblanco@cbm.csic.es;
   Raquel.roldanm@quironsalud.es; pedro.acunna@estudiante.uam.es;
   apforteza@yahoo.es; carlosestebanmartin@hotmail.com; jfnistal@gmail.com;
   CLINOCARDENAS@mgh.harvard.edu; Lindsay.Mark@mgh.harvard.edu;
   jmredondo@cnic.es; mmittelbrunn@cbm.csic.es
RI Gabandé-Rodríguez, Enrique/AAC-2428-2020; Díez, Raquel/ABE-9703-2020;
   MARTIN-VENTURA, JOSE/Z-2386-2019; BLANCO RUIZ, EVA MARIA/JHT-8040-2023;
   Mittelbrunn, Maria/J-9146-2019; Desdin Mico, Gabriela/ABE-5242-2021;
   Aranda Gomez, Juan Francisco/S-6388-2018; Redondo, Juan
   Miguel/H-6351-2015; Mittelbrunn, Maria/I-5882-2015
OI Gabande-Rodriguez, Enrique/0000-0002-9715-8714; Rodrigues Diez,
   Raquel/0000-0002-6348-1505; Desdin Mico, Gabriela/0000-0001-8136-4145;
   Blanco-Ruiz, Eva/0000-0001-5940-1827; Aranda Gomez, Juan
   Francisco/0000-0002-5598-2465; Ballesteros Martinez,
   Constanza/0000-0003-4085-0459; Oller Pedrosa, Jorge/0000-0002-2224-2954;
   Redondo, Juan Miguel/0000-0001-5779-9122; Mittelbrunn,
   Maria/0000-0003-3487-8762; Ruiz-Rodriguez, Maria
   Jesus/0000-0002-9317-8646
FU Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III
   [PI16/188, PI19/855]; European Regional Development Fund; European
   Commission through H2020-EU.1.1; European Research Council grant
   ERC-2016-StG [715322]; Gobierno de Espana [SAF2016-80305P]; Comunidad de
   Madrid [S2017/BMD 3867 RENIM-CM]; European Structural and Investment
   Fund; Miguel Servet Program (Fundacion de Investigacion del Hospital 12
   de Octubre) [CP 19/014]; Juan de la Cierva [FJCI2017-33855,
   IJC2018-036850-I, IJCI-2017-31399]; Ministerio de Ciencia e Innovacion
   [RTI2018-099246-B-I00, PI18/00543]; Comunidad de Madrid; Fondo Social
   Europeo funds (AORTASANA-CM) [B2017/BMD-3676]; Fundacion La Caixa
   [HR18-00068]; Marfan Foundation (USA); Centro de Investigacion Biomedica
   en Red Enfermedades Cardiovasculares of Ministerio de Ciencia e
   Innovacion [CB16/11/00264]; Ministerio de Economia y Competitividad
   [PI18/00543]; Centro de Investigacion Biomedica en Red Enfermedades
   Cardiovasculares [CB16/11/00264]; Fondo Europeo de Desarrollo Regional;
   European Research Council (ERC) [715322] Funding Source: European
   Research Council (ERC)
FX This study was supported by the Fondo de Investigacion Sanitaria del
   Instituto de Salud Carlos III (PI16/188, PI19/855), the European
   Regional Development Fund, and the European Commission through
   H2020-EU.1.1, European Research Council grant ERC-2016-StG
   715322-EndoMitTalk, and Gobierno de Espana SAF2016-80305P. This work was
   partially supported by Comunidad de Madrid (S2017/BMD 3867 RENIM-CM) and
   cofinanced by the European Structural and Investment Fund. M.M. is
   supported by the Miguel Servet Program (CP 19/014, Fundacion de
   Investigacion del Hospital 12 de Octubre). J.O., E.G., and R.R-D. are
   supported by Juan de la Cierva (FJCI2017-33855, IJC2018-036850-I, and
   IJCI-2017-31399, respectively). Support was also provided by Ministerio
   de Ciencia e Innovacion grants (RTI2018-099246-B-I00 to J.M.R. and
   PI18/00543 to J.F.N.) and Comunidad de Madrid and Fondo Social Europeo
   funds (AORTASANA-CM; B2017/BMD-3676 to A.M.B., A.F., and J.M.R.). J.M.R.
   was also funded by Fundacion La Caixa (HR18-00068) and the Marfan
   Foundation (USA). J.M.R. and J.L.M.V. were also funded by Centro de
   Investigacion Biomedica en Red Enfermedades Cardiovasculares of
   Ministerio de Ciencia e Innovacion (CB16/11/00264). J.F.N. was funded by
   Ministerio de Economia y Competitividad (PI18/00543) and Centro de
   Investigacion Biomedica en Red Enfermedades Cardiovasculares
   (CB16/11/00264), and was cofunded by Fondo Europeo de Desarrollo
   Regional.
CR Ailawadi G, 2009, J THORAC CARDIOV SUR, V138, P1392, DOI 10.1016/j.jtcvs.2009.07.075
   Bartolák-Suki E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081812
   Bays JL, 2017, NAT CELL BIOL, V19, P724, DOI 10.1038/ncb3537
   Bernard K, 2015, J BIOL CHEM, V290, P25427, DOI 10.1074/jbc.M115.646984
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Castello-Cros Remedios, 2009, V522, P275, DOI 10.1007/978-1-59745-413-1_19
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chou EL, 2020, AM J MED GENET C, V184, P136, DOI 10.1002/ajmg.c.31771
   Chung KW, 2019, CELL METAB, V30, P784, DOI 10.1016/j.cmet.2019.08.003
   Crosas-Molist E, 2015, ARTERIOSCL THROM VAS, V35, P960, DOI 10.1161/ATVBAHA.114.304412
   Dai JB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06376-x
   De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037
   DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R
   Desdín-Micó G, 2020, SCIENCE, V368, P1371, DOI 10.1126/science.aax0860
   DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0
   Esteban V, 2011, J EXP MED, V208, P2125, DOI 10.1084/jem.20110503
   Forteza A, 2016, EUR HEART J, V37, P978, DOI 10.1093/eurheartj/ehv575
   Gillis E, 2013, CIRC RES, V113, P327, DOI 10.1161/CIRCRESAHA.113.300675
   Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Hu H, 2016, CELL, V164, P433, DOI 10.1016/j.cell.2015.12.042
   Humphrey JD, 2015, CIRC RES, V116, P1448, DOI 10.1161/CIRCRESAHA.114.304936
   Jana S, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0286-3
   Keane MG, 2008, CIRCULATION, V117, P2802, DOI 10.1161/CIRCULATIONAHA.107.693523
   Kiotsekoglou A, 2011, ECHOCARDIOGR-J CARD, V28, P29, DOI 10.1111/j.1540-8175.2010.01241.x
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695
   Luo W, 2020, CIRCULATION, V141, P42, DOI 10.1161/CIRCULATIONAHA.119.041460
   Michel JB, 2018, CARDIOVASC RES, V114, P578, DOI 10.1093/cvr/cvy006
   Nolasco P, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2019.165587
   Okamura H, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13257
   Oller J, 2017, NAT MED, V23, P200, DOI 10.1038/nm.4266
   Oller J, 2015, MOL CELL BIOL, V35, P3409, DOI 10.1128/MCB.00494-15
   Park JS, 2020, NATURE, V578, P621, DOI 10.1038/s41586-020-1998-1
   Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001
   Petsophonsakul P, 2019, ARTERIOSCL THROM VAS, V39, P1351, DOI 10.1161/ATVBAHA.119.312787
   Pinard A, 2019, CIRC RES, V124, P588, DOI 10.1161/CIRCRESAHA.118.312436
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Prolla TA, 2014, CELL METAB, V19, P178, DOI 10.1016/j.cmet.2014.01.005
   Quintana RA, 2019, CIRC RES, V124, P607, DOI 10.1161/CIRCRESAHA.118.313187
   Rocha RV, 2020, J VASC SURG, V71, P1396, DOI 10.1016/j.jvs.2019.06.216
   Roussin I, 2011, CIRCULATION, V124, P100, DOI 10.1161/CIRCULATIONAHA.111.025056
   SCHLATMANN TJM, 1977, AM J CARDIOL, V39, P21, DOI 10.1016/S0002-9149(77)80005-2
   Soto-Heredero G, 2020, FEBS J, V287, P3350, DOI 10.1111/febs.15327
   Sullivan WJ, 2018, CELL, V175, P117, DOI 10.1016/j.cell.2018.08.017
   Teixido-Tura G, 2018, J AM COLL CARDIOL, V72, P1613, DOI 10.1016/j.jacc.2018.07.052
   Uriarte JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152124
   van der Pluijm I, 2018, CARDIOVASC RES, V114, P1776, DOI 10.1093/cvr/cvy150
   Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854
   Watson A, 2017, CIRC RES, V120, P1889, DOI 10.1161/CIRCRESAHA.116.310022
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
   Zhao X, 2019, NAT METAB, V1, P147, DOI 10.1038/s42255-018-0008-5
NR 57
TC 60
Z9 63
U1 2
U2 27
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD MAY 25
PY 2021
VL 143
IS 21
BP 2091
EP 2109
DI 10.1161/CIRCULATIONAHA.120.051171
PG 19
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA SH2JJ
UT WOS:000653959500010
PM 33709773
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Xu, MT
   Kopajtich, R
   Elstner, M
   Wang, ZX
   Liu, ZM
   Wang, JL
   Prokisch, H
   Fang, F
AF Xu, Manting
   Kopajtich, Robert
   Elstner, Matthias
   Wang, Zhaoxia
   Liu, Zhimei
   Wang, Junling
   Prokisch, Holger
   Fang, Fang
TI Identification of a Novel Variant in <i>MT-CO3</i> Causing MELAS
SO FRONTIERS IN GENETICS
LA English
DT Article
DE MELAS; novel mitochondrial DNA variant; MT-CO3 gene; complex IV of
   respiratory chain; mitochondrial diseases
ID STROKE-LIKE-EPISODES; MITOCHONDRIAL; ENCEPHALOPATHY; MUTATIONS; DISEASE;
   FAMILY; GENE
AB Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) is a maternally inherited mitochondrial disease. Most cases of MELAS are caused by the m.3243A > G variant in the MT-TL1 gene encoding tRNALeu((UUR)). However, the genetic cause in 10% of patients with MELAS is unknown. We investigated the pathogenicity of the novel mtDNA variant m.9396G > A/MT-CO3 (p.E64K), which affects an extremely conserved amino acid in the CO3 subunit of mitochondrial respiratory chain (MRC) complex IV (CIV) in a patient with MELAS. Biochemical assays of a muscle biopsy confirmed remarkable CIV deficiency, and pathological examination showed ragged red fibers and generalized COX non-reactive muscle fibers. Transfer of the mutant mtDNA into cybrids impaired CIV assembly, followed by remarkable mitochondrial dysfunction and ROS production. Our findings highlight the pathogenicity of a novel m.9396G > A variant and extend the spectrum of pathogenic mtDNA variants.
C1 [Xu, Manting; Liu, Zhimei; Wang, Junling; Fang, Fang] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Neurol, Beijing, Peoples R China.
   [Xu, Manting; Kopajtich, Robert; Prokisch, Holger] Tech Univ Munich, Sch Med, Inst Human Genet, Munich, Germany.
   [Xu, Manting; Kopajtich, Robert; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Neurogen, Munich, Germany.
   [Elstner, Matthias] Tech Univ Munich, Sch Med, Dept Neurol, Munich, Germany.
   [Wang, Zhaoxia] Peking Univ First Hosp, Dept Neurol, Beijing, Peoples R China.
C3 Capital Medical University; Technical University of Munich; Helmholtz
   Association; Helmholtz-Center Munich - German Research Center for
   Environmental Health; Technical University of Munich; Peking University
RP Fang, F (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Neurol, Beijing, Peoples R China.
EM fangfang@bch.com.cn
RI Wang, Zilong/IQV-2260-2023; Prokisch, Holger/N-8964-2013
FU Capital Health Research and Development Fund [2018-2-2096]; National
   Natural Science Foundation of China [81541115]; German BMBF through the
   ERA PerMed project PerMiM [01KU2016A]; Horizon 2020 through the ERA
   PerMed project PerMiM [01KU2016A]; European Joint Programme on Rare
   Diseases project GENOMIT [01GM1920A]
FX This work was supported by the Capital Health Research and Development
   Fund (2018-2-2096), the National Natural Science Foundation of China
   (81541115), the German BMBF and Horizon 2020 through the ERA PerMed
   project PerMiM (01KU2016A) and the European Joint Programme on Rare
   Diseases project GENOMIT (01GM1920A).
CR Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76
   Cheldi A, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-8
   Choi BO, 2008, EXP MOL MED, V40, P354, DOI 10.3858/emm.2008.40.3.354
   Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195
   Chomyn A, 1996, Methods Enzymol, V264, P334, DOI 10.1016/S0076-6879(96)64031-2
   Delmiro A, 2013, HUM MUTAT, V34, P1623, DOI 10.1002/humu.22445
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182
   Ji KQ, 2020, ANN CLIN TRANSL NEUR, V7, P980, DOI 10.1002/acn3.51069
   Ji KQ, 2014, NEUROMOL MED, V16, P119, DOI 10.1007/s12017-013-8264-8
   Kremer LS, 2017, METHODS MOL BIOL, V1567, P391, DOI 10.1007/978-1-4939-6824-4_24
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   Ogawa E, 2017, J INHERIT METAB DIS, V40, P685, DOI 10.1007/s10545-017-0042-6
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076
   Wang SW, 2011, CIRC RES, V108, P862, DOI 10.1161/CIRCRESAHA.110.231811
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 20
TC 5
Z9 6
U1 1
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD MAY 12
PY 2021
VL 12
AR 638749
DI 10.3389/fgene.2021.638749
PG 9
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA SI0HE
UT WOS:000654508500001
PM 34054915
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Haimi, M
   Elhasid, R
   Gershoni-Baruch, R
   Izraeli, S
   Randers, RJA
   Mandel, H
AF Haimi, M
   Elhasid, R
   Gershoni-Baruch, R
   Izraeli, S
   Randers, RJA
   Mandel, H
TI Myeloid dysplasia in familial 3-methylglutaconic aciduria
SO JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
LA English
DT Article
DE 3-methylglutaconic aciduria; myelodysplastic syndrome; acute myeloid
   leukemia; monosomy 7
ID MITOCHONDRIAL-DNA MUTATIONS; MYELODYSPLASTIC SYNDROMES; SIDEROBLASTIC
   ANEMIA; PARTIAL MONOSOMY-7; PEARSON SYNDROME; GENE; MECHANISMS;
   CHILDHOOD; LEUKEMIA; MYOPATHY
AB A kindred is reported with four members affected with neurodegenerative disorder and 3-methylglutaconic aciduria. Two siblings developed thrombocytopenia heralding a myelodysplastic syndrome; in one patient it evolved into acute myeloid leukemia with monosomy 7 in the marrow. The hematologic complications have hitherto not been previously reported in other cases of 3-methylglutaconic aciduria and are thus thought to represent a new disease entity. This family adds additional evidence to the genetic heterogeneity of Mendelian disorders in which the primary Mutation may have a mutator effect that could give origin to myelodysplastic syndrome and acute myeloid leukemia through acquired chromosomal changes.
C1 Technion Israel Inst Technol, Meyer Childrens Hosp, Fac Med, Rambam Med Ctr,Metab Unit, Haifa, Israel.
   Meyer Childrens Hosp, Rambam Med Ctr, Dept Pediat Hemato Oncol, Haifa, Israel.
   Technion Israel Inst Technol, Meyer Childrens Hosp, Fac Med, Rambam Med Ctr,Dept Human Genet, Haifa, Israel.
   Chaim Sheba Med Ctr, Dept Pediat Hematol, IL-52621 Tel Hashomer, Israel.
   Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Inst Haematol, Tel Hashomer, Israel.
   Tel Aviv Med Sch, Tel Aviv, Israel.
   Univ Amsterdam, Acad Med Ctr, Dept Pediat, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands.
C3 Rambam Health Care Campus; Technion Israel Institute of Technology;
   Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion
   Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam
   Health Care Campus; Chaim Sheba Medical Center; Chaim Sheba Medical
   Center; Tel Aviv University; University of Amsterdam; Academic Medical
   Center Amsterdam
RP Technion Israel Inst Technol, Meyer Childrens Hosp, Fac Med, Rambam Med Ctr,Metab Unit, Haifa, Israel.
EM h_mandel@rainbam.health.gov.il
RI Haimi, Motti/R-6443-2019
OI Haimi, Motti/0000-0001-8751-9793
CR Anikster Y, 2001, AM J HUM GENET, V69, P1218, DOI 10.1086/324651
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Chen WN, 2004, AM J CLIN PATHOL, V122, P588, DOI 10.1309/6UGDU03VVD0L98LO
   Crisan D, 2000, CLIN LAB MED, V20, P49
   Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013
   Gattermann N, 2000, LEUKEMIA RES, V24, P141, DOI 10.1016/S0145-2126(99)00160-5
   GIBSON KM, 1993, PEDIATR NEUROL, V9, P120, DOI 10.1016/0887-8994(93)90046-F
   GIBSON KM, 1992, J PEDIATR-US, V121, P940, DOI 10.1016/S0022-3476(05)80348-8
   Gunay-Aygun M, 2005, MOL GENET METAB, V84, P1, DOI 10.1016/j.ymgme.2004.12.003
   Hasle H, 1999, LEUKEMIA, V13, P376, DOI 10.1038/sj.leu.2401342
   Leonard C, 1997, LEUKEMIA, V11, P1478
   LICHTERKONECKI U, 1993, EUR J PEDIATR, V152, P378, DOI 10.1007/BF01956761
   Linnartz B, 2004, CANCER RES, V64, P1966, DOI 10.1158/0008-5472.CAN-03-2956
   Luna-Fineman S, 1999, BLOOD, V93, P459, DOI 10.1182/blood.V93.2.459.402k19_459_466
   Ly TBN, 2003, HUM MUTAT, V21, P401, DOI 10.1002/humu.10202
   Maserati E, 2004, CANCER GENET CYTOGEN, V148, P155, DOI 10.1016/S0165-4608(03)00271-1
   Minelli A, 2001, CANCER GENET CYTOGEN, V124, P147, DOI 10.1016/S0165-4608(00)00344-7
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Reddy PL, 2002, BRIT J HAEMATOL, V116, P564, DOI 10.1046/j.0007-1048.2001.03323.x
   Roumier C, 2003, LEUKEMIA, V17, P9, DOI 10.1038/sj.leu.2402766
   Shin MG, 2003, BLOOD, V101, P3118, DOI 10.1182/blood-2002-06-1825
NR 22
TC 2
Z9 2
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1077-4114
EI 1536-3678
J9 J PEDIAT HEMATOL ONC
JI J. Pediatr. Hematol. Oncol.
PD FEB
PY 2006
VL 28
IS 2
BP 69
EP 72
DI 10.1097/01.mph.0000199585.98926.55
PG 4
WC Oncology; Hematology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Hematology; Pediatrics
GA 014EB
UT WOS:000235460700004
PM 16462576
DA 2024-11-01
ER

PT J
AU Koga, Y
   Povalko, N
   Nishioka, J
   Katayama, K
   Yatsuga, S
   Matsuishi, T
AF Koga, Yasutoshi
   Povalko, Nataliya
   Nishioka, Junko
   Katayama, Koujyu
   Yatsuga, Shuichi
   Matsuishi, Toyojiro
TI Molecular pathology of MELAS and L-arginine effects
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Review
DE Mitochondrial cytopathy; Translation; RNA 19; Angiopathy; Endothelial
   dysfunction; L-arginine
ID STROKE-LIKE EPISODES; ANTICODON WOBBLE NUCLEOTIDE; MITOCHONDRIAL-DNA
   MUTATION; CEREBRAL-BLOOD-FLOW; LACTIC-ACIDOSIS; TRANSFER-RNA; POINT
   MUTATION; TRANSCRIPTION TERMINATION; MODIFICATION DEFECT;
   RESPIRATORY-CHAIN
AB Background: The pathogenic mechanism of stroke-like episodes seen in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) has not been clarified yet. About 80% of MELAS patients have an A3243G mutation in the mitochondrial tRNA(LeU(UUR)) gene, which is the base change at position 14 in the consensus structure of tRNA(LeU(UUR)) gene.
   Scope of review: This review aims to give an overview on the actual knowledge about the pathogenic mechanism of mitochondrial cytopathy at the molecular levels, the possible pathogenic mechanism of mitochondrial angiopathy to cause stroke-like episodes at the clinical and pathophysiological levels, and the proposed site of action of L-arginine therapy on MELAS.
   Major conclusions: Molecular pathogenesis is mainly demonstrated using rho degrees cybrid system. The mutation creates the protein synthesis defects caused by 1) decreased life span of steady state amount of tRNA(Leu(UUR)) molecules; 2) decreased ratio of aminoacyl-tRNA(Leu(UUR))) versus uncharged tRNA(Leu(UUR))) molecules; 3) the accumulation of aminoacylation with leucine without any misacylation; 4) accumulation of processing intermediates such as RNA 19.5) wobble modification defects. All of these loss of function abnormalities are created by the threshold effects of cell or organ to the mitochondrial energy requirement when they establish the phenotype. Mitochondrial angiopathy demonstrated by muscle or brain pathology, as SW (SDH strongly stained vessels), and by vascular physiology using FMD (flow mediated dilation). MELAS patients show decreased capacity of NO dependent vasodilation because of the low plasma levels of L-arginine and/or of respiratory chain dysfunction. Although the underlying mechanisms are not completely understood in stroke-like episodes in MELAS, L-arginine therapy improved endothelial dysfunction.
   General significance: Though the molecular pathogenesis of an A3243G or T3271C mutation of mitochondrial tRNA(Leu(UUR)) gene has been clarified as a mitochondrial cytopathy, the underlying mechanisms of stroke-like episodes in MELAS are not completely understood. At this point, L-arginine therapy showed promise in treating of the stroke-like episodes in MELAS. This article is part of a Special Issue entitled Biochemistry of Mitochondria. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Koga, Yasutoshi; Povalko, Nataliya; Nishioka, Junko; Katayama, Koujyu; Yatsuga, Shuichi; Matsuishi, Toyojiro] Kurume Univ, Grad Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 300011, Japan.
   [Yatsuga, Shuichi] Univ Helsinki, Res Program Mol Neurol, Biomedicum Helsinki, Helsinki, Finland.
C3 Kurume University; University of Helsinki
RP Koga, Y (corresponding author), Kurume Univ, Sch Med, Dept Pediat & Child Hlth, 67 Asahi Machi, Kurume, Fukuoka 300011, Japan.
EM yasukoga@med.kurume-u.ac.jp
OI Koga, Yasutoshi/0000-0002-6664-1295
FU Ministry of Culture and Education in Japan [13670853, 16390308];
   Evidence-based Medicine, Ministry of Health, Labor and Welfare in Japan
   [CCT-B-1803]; Academy of Finland, the Center for International Mobility
   in Finland; Grants-in-Aid for Scientific Research [13670853, 16390308]
   Funding Source: KAKEN
FX All coauthors have seen the manuscript and have reported no conflicts of
   interest (financial or nonfinancial) and declared all other pertinent
   financial information. This work was supported in part by grants
   #13670853 (Y.K.) and #16390308 (Y.K) from the Ministry of Culture and
   Education in Japan, as well as #CCT-B-1803 (Y.K.) from Evidence-based
   Medicine, Ministry of Health, Labor and Welfare in Japan. S.Y. is a
   recipient of a post-doctoral fellowship from the Academy of Finland, the
   Center for International Mobility in Finland.
CR BINDOFF LA, 1993, J BIOL CHEM, V268, P19559
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Di Mauro S, 1993, GENE REV
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Flierl H., 1997, BIOL CHEM, V272, P27189
   GELFAND R, 1981, MOL CELL BIOL, V1, P497, DOI 10.1128/MCB.1.6.497
   Gerriets T, 2004, BRAIN RES PROTOC, V12, P137, DOI 10.1016/j.brainresprot.2003.08.006
   GODDARD JP, 1977, PROG BIOPHYS MOL BIO, V32, P233
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hao R, 2004, FEBS LETT, V578, P135, DOI 10.1016/j.febslet.2004.11.004
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   Iizuka T, 2007, J NEUROL SCI, V257, P126, DOI 10.1016/j.jns.2007.01.040
   Iizuka T, 2010, FUTUR NEUROL, V5, P61, DOI 10.2217/FNL.09.71
   Iizuka T, 2009, J NEUROL SCI, V278, P35, DOI 10.1016/j.jns.2008.11.016
   Ikawa M, 2009, MITOCHONDRION, V9, P144, DOI 10.1016/j.mito.2009.01.011
   Ito H, 2008, BRAIN DEV-JPN, V30, P483, DOI 10.1016/j.braindev.2008.01.003
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208
   KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirino Y, 2006, HUM MOL GENET, V15, P897, DOI 10.1093/hmg/ddl007
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   KISHI M, 1988, J NEUROL SCI, V86, P31, DOI 10.1016/0022-510X(88)90005-6
   Koga A, 2003, NEUROMUSCULAR DISORD, V13, P259, DOI 10.1016/S0960-8966(02)00267-5
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   KOGA Y, 1993, NUCLEIC ACIDS RES, V21, P657, DOI 10.1093/nar/21.3.657
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   KOGA Y, 1995, MUSCLE NERVE, pS119
   KOGA Y, 1988, ANN NEUROL, V24, P749, DOI 10.1002/ana.410240609
   Koge Y, 1998, ANN NEUROL, V43, P835, DOI 10.1002/ana.410430620
   KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2
   Kubota M, 2004, BRAIN DEV-JPN, V26, P481, DOI 10.1016/j.braindev.2004.01.006
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   Molnár MJ, 2000, NEUROLOGY, V55, P544, DOI 10.1212/WNL.55.4.544
   MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9
   Moro MA, 2005, FREE RADICAL BIO MED, V39, P1291, DOI 10.1016/j.freeradbiomed.2005.07.010
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Nariai R, 2001, J NEUROIMAGING, V11, P325, DOI 10.1111/j.1552-6569.2001.tb00057.x
   Nishioka J, 2008, BRAIN DEV-JPN, V30, P100, DOI 10.1016/j.braindev.2007.06.008
   Noguchi A, 2005, PEDIATR NEUROL, V33, P70, DOI 10.1016/j.pediatrneurol.2005.01.013
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Ohshita T, 2000, NEURORADIOLOGY, V42, P651, DOI 10.1007/s002340000335
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Roy MD, 2005, RNA, V11, P254, DOI 10.1261/rna.7143305
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   SCHON EA, 1992, BIOCHIM BIOPHYS ACTA, V1101, P206, DOI 10.1016/0005-2728(92)90226-R
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Stoquart-ElSankari S, 2008, J NEUROL, V255, P1593, DOI 10.1007/s00415-008-0968-6
   Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656
   Tanahashi C, 2000, ACTA NEUROPATHOL, V99, P31, DOI 10.1007/PL00007403
   WAKITA K, 1994, NUCLEIC ACIDS RES, V22, P347, DOI 10.1093/nar/22.3.347
   Wang XL, 1996, NAT MED, V2, P41, DOI 10.1038/nm0196-41
   Wang XY, 2003, NEURORADIOLOGY, V45, P640, DOI 10.1007/s00234-003-1029-6
   Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
NR 67
TC 50
Z9 54
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD MAY
PY 2012
VL 1820
IS 5
SI SI
BP 608
EP 614
DI 10.1016/j.bbagen.2011.09.005
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 930JO
UT WOS:000303135900009
PM 21944974
DA 2024-11-01
ER

PT J
AU Baruffini, E
   Horvath, R
   Dallabona, C
   Czermin, B
   Lamantea, E
   Bindoff, L
   Invernizzi, F
   Ferrero, I
   Zeviani, M
   Lodi, T
AF Baruffini, Enrico
   Horvath, Rita
   Dallabona, Cristina
   Czermin, Birgit
   Lamantea, Eleonora
   Bindoff, Laurence
   Invernizzi, Federica
   Ferrero, Iliana
   Zeviani, Massimo
   Lodi, Tiziana
TI Predicting the contribution of novel POLG mutations to human disease
   through analysis in yeast model
SO MITOCHONDRION
LA English
DT Article
DE Yeast model; POLG; Mitochondrial diseases; MIPI; mtDNA mutability; ROS
   scavengers
ID DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   MITOCHONDRIAL-DNA; SACCHAROMYCES-CEREVISIAE; RIB2 LOCUS; DEFECTS; GENE;
   REPLICATION; MTDNA; ERYTHROMYCIN
AB The yeast Saccharomyces cerevisiae was used to validate the pathogenic significance of eight human mutations in the gene encoding for the mitochondrial DNA polymerase gamma, namely C303R, S305R, R386H, R574W, P625R, D930N, K947R and P1073L, among which three are novel and four are of unclear pathological significance. Mitochondrial DNA extended and point mutability as well as dominance/recessivity of each mutation has been evaluated. The analysis in yeast revealed that two mutations. S305R and R386H, cannot be the sole cause of pathology observed in patients. These data led us to search for a second mutation in compound with S305R and we found a mutation. P1073L, missed in the first genetic analysis. Finally, a significant rescue of extended mutability has been observed for several dominant mutations by treatment with mitochondrial antioxidants. (C) 2010 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Baruffini, Enrico; Dallabona, Cristina; Ferrero, Iliana; Lodi, Tiziana] Univ Parma, Dept Genet, I-43124 Parma, Italy.
   [Horvath, Rita] Newcastle Univ, Mitochondrial Res Grp, Inst Hlth & Aging, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Horvath, Rita; Czermin, Birgit] Ctr Med Genet, Munich, Germany.
   [Lamantea, Eleonora; Invernizzi, Federica; Zeviani, Massimo] Pierfranco & Luisa Mariani Ctr Study Childrens Mi, Unit Mol Neurogenet, Milan, Italy.
   [Bindoff, Laurence] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
C3 University of Parma; Newcastle University - UK; University of Bergen;
   Haukeland University Hospital
RP Lodi, T (corresponding author), Univ Parma, Dept Genet, I-43124 Parma, Italy.
EM tiziana.lodi@unipr.it
RI Zeviani, Massimo/K-2891-2014; Horvath, Rita/AAY-7042-2020; Baruffini,
   Enrico/C-1057-2015; Invernizzi, Federica/J-9849-2016; Lodi,
   Tiziana/A-5993-2012; Lamantea, Eleonora/J-8339-2016
OI Zeviani, Massimo/0000-0002-9067-5508; Baruffini,
   Enrico/0000-0002-8280-7849; Invernizzi, Federica/0000-0001-8072-0152;
   Bindoff, Laurence/0000-0003-0988-276X; Lodi,
   Tiziana/0000-0002-7294-8971; Horvath, Rita/0000-0002-9841-170X;
   Lamantea, Eleonora/0000-0001-5090-6028; DALLABONA,
   Cristina/0000-0003-4397-9143
FU Fondazione Pierfranco and Luisa Mariani; Fondazione Telethon-Italy
   [GGP07019]; Ricerca Finalizzata of the Italian Ministry of Health
   [RF-IN-2007-634163]; Academy of Medical Sciences UK [BH090164]
FX We thank Antonietta Cirasolo and Roberto Silva for their skilful
   technical assistance. This work was funded by grants from Fondazione
   Pierfranco and Luisa Mariani, Fondazione Telethon-Italy no. GGP07019,
   Ricerca Finalizzata of the Italian Ministry of Health RF-IN-2007-634163.
   RH is supported by the Academy of Medical Sciences UK (BH090164).
CR Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023
   BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609
   Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   CUI Z, 1989, CURR GENET, V16, P273, DOI 10.1007/BF00422114
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Fontanesi F, 2009, CURR PROTOC HUM GENE
   Foury Francoise, 2007, Methods Mol Biol, V372, P167, DOI 10.1007/978-1-59745-365-3_12
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Hisama FM, 2005, AM J MED GENET A, V135A, P217, DOI 10.1002/ajmg.a.30672
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   HU JP, 1995, GENE, V160, P105, DOI 10.1016/0378-1119(95)00215-R
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200
   Kurt B, 2010, ARCH NEUROL-CHICAGO, V67, P239, DOI 10.1001/archneurol.2009.332
   Lecrenier N, 2000, GENE, V246, P37, DOI 10.1016/S0378-1119(00)00107-4
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   SLONIMSKI PP, 1976, EUR J BIOCHEM, V61, P27, DOI 10.1111/j.1432-1033.1976.tb09994.x
   SOR F, 1984, NUCLEIC ACIDS RES, V12, P8313, DOI 10.1093/nar/12.22.8313
   SOR F, 1982, NUCLEIC ACIDS RES, V11, P1625
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   STEWART JD, HEPATOLOGY IN PRESS, DOI DOI 10.1002/HEP.23891
   Stricker S, 2009, J NEUROL NEUROSUR PS, V80, P1181, DOI 10.1136/jnnp.2008.166066
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
NR 36
TC 21
Z9 23
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN
PY 2011
VL 11
IS 1
BP 182
EP 190
DI 10.1016/j.mito.2010.09.007
PG 9
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 709OP
UT WOS:000286450300025
PM 20883824
DA 2024-11-01
ER

PT J
AU Genin, EC
   Plutino, M
   Bannwarth, S
   Villa, E
   Cisneros-Barroso, E
   Roy, M
   Ortega-Vila, B
   Fragaki, K
   Lespinasse, F
   Pinero-Martos, E
   Augé, G
   Moore, D
   Burté, F
   Lacas-Gervais, S
   Kageyama, Y
   Itoh, K
   Yu-Wai-Man, P
   Sesaki, H
   Ricci, JE
   Vives-Bauza, C
   Paquis-Flucklinger, V
AF Genin, Emmanuelle C.
   Plutino, Morgane
   Bannwarth, Sylvie
   Villa, Elodie
   Cisneros-Barroso, Eugenia
   Roy, Madhuparna
   Ortega-Vila, Bernardo
   Fragaki, Konstantina
   Lespinasse, Francoise
   Pinero-Martos, Estefania
   Auge, Gaelle
   Moore, David
   Burte, Florence
   Lacas-Gervais, Sandra
   Kageyama, Yusuke
   Itoh, Kie
   Yu-Wai-Man, Patrick
   Sesaki, Hiromi
   Ricci, Jean-Ehrland
   Vives-Bauza, Cristofol
   Paquis-Flucklinger, Veronique
TI <i>CHCHD10</i> mutations promote loss of mitochondrial cristae junctions
   with impaired mitochondrial genome maintenance and inhibition of
   apoptosis
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE CHCHD10; mitochondria; mitochondrial disease; motor neuron disease;
   mtDNA instability
ID AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEATH; CELL-DEATH; MEMBRANE
   ORGANIZATION; MITOFILIN COMPLEXES; DNA NUCLEOIDS; CONTACT SITE; GENE;
   AUTOPHAGY; REVEALS
AB CHCHD10-related diseases include mitochondrial DNA instability disorder, frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) clinical spectrum, late-onset spinal motor neuropathy (SMAJ), and Charcot-Marie-Tooth disease type 2 (CMT2). Here, we show that CHCHD10 resides with mitofilin, CHCHD3 and CHCHD6 within the "mitochondrial contact site and cristae organizing system" (MICOS) complex. CHCHD10 mutations lead to MICOS complex disassembly and loss of mitochondrial cristae with a decrease in nucleoid number and nucleoid disorganization. Repair of the mitochondrial genome after oxidative stress is impaired in CHCHD10 mutant fibroblasts and this likely explains the accumulation of deleted mtDNA molecules in patient muscle. CHCHD10 mutant fibroblasts are not defective in the delivery of mitochondria to lysosomes suggesting that impaired mitophagy does not contribute to mtDNA instability. Interestingly, the expression of CHCHD10 mutant alleles inhibits apoptosis by preventing cytochrome c release.
C1 [Genin, Emmanuelle C.; Plutino, Morgane; Bannwarth, Sylvie; Fragaki, Konstantina; Lespinasse, Francoise; Auge, Gaelle; Paquis-Flucklinger, Veronique] Univ Nice Sophia Antipolis, Sch Med, IRCAN, UMR CNRS 7284,INSERM U1081,UNS, F-06189 Nice 2, France.
   [Bannwarth, Sylvie; Fragaki, Konstantina; Auge, Gaelle; Paquis-Flucklinger, Veronique] Nice Teaching Hosp, Dept Med Genet, Natl Ctr Mitochondrial Dis, Nice 2, France.
   [Villa, Elodie; Ricci, Jean-Ehrland] Univ Nice Sophia Antipolis, INSERM, Ctr Mediterraneen Med Mol, Equipe Controle Metab Morts Cellulaires,U1065, F-06189 Nice 2, France.
   [Cisneros-Barroso, Eugenia; Ortega-Vila, Bernardo; Pinero-Martos, Estefania; Vives-Bauza, Cristofol] Son Espases Univ Hosp, Res Unit, Res Hlth Inst Palma IdISPa, Palma De Mallorca, Spain.
   [Roy, Madhuparna; Kageyama, Yusuke; Itoh, Kie; Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA.
   [Moore, David; Burte, Florence; Yu-Wai-Man, Patrick] Newcastle Univ, Inst Med Genet, Int Ctr Life, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Moore, David; Burte, Florence; Yu-Wai-Man, Patrick] Royal Victoria Infirm, Newcastle Eye Ctr, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Lacas-Gervais, Sandra] Univ Nice Sophia Antipolis, Joint Ctr Appl Electron Microscopy, F-06189 Nice 2, France.
C3 Universite Cote d'Azur; Institut National de la Sante et de la Recherche
   Medicale (Inserm); CHU Nice; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universite Cote d'Azur; Institut
   Investigacio Sanitaria Illes Balears (IdISBa); Hospital Universitari Son
   Espases; Johns Hopkins University; Newcastle University - UK; Newcastle
   University - UK; Universite Cote d'Azur
RP Paquis-Flucklinger, V (corresponding author), Univ Nice Sophia Antipolis, Sch Med, IRCAN, UMR CNRS 7284,INSERM U1081,UNS, F-06189 Nice 2, France.
EM paquis@hermes.unice.fr
RI Vives-Bauza, Cristofol/N-7044-2015; Roy, Madhuparna/AAQ-8180-2020;
   Plutino, Morgane/JGD-4310-2023; GENIN, Emmanuelle/HSG-8378-2023; RICCI,
   Jean-Ehrland/I-7117-2016; Eugenia, Cisneros-Barroso/H-1519-2017; Burte,
   Florence/U-8257-2017
OI RICCI, Jean-Ehrland/0000-0003-1585-8117; Vives-Bauza,
   Cristofol/0000-0001-5735-8335; Eugenia,
   Cisneros-Barroso/0000-0002-4109-4635; Kageyama,
   Yusuke/0000-0002-3382-9881; LESPINASSE, francoise/0000-0001-7710-0649;
   Moore, David/0000-0002-0161-7390; Genin, Emmanuelle
   C./0000-0003-3039-7101; Burte, Florence/0000-0001-9020-7838
FU Fondation pour la Recherche Medicale (FRM); Association Francaise contre
   les Myopathies (AFM); National Institutes of Health [GM089853];
   Fondation ARC pour la Recherche sur le Cancer; Clinician Scientist
   Fellowship Award from Medical Research Council (UK) [G1002570]; Fight
   for Sight (UK); UK National Institute of Health Research (NIHR) as part
   of the Rare Diseases Translational Research Collaboration; Spanish
   Instituto de Salud Carlos III [CP11/00046]; FRM fellowship
   [DEA20130727390]; MRC [G1002570, G0701386] Funding Source: UKRI
FX We acknowledge Pasteur-IRCAN Cellular and Molecular Imaging platform
   (PICMI). This work was made possible by grants to VP-F from the
   Fondation pour la Recherche Medicale (FRM) and the Association Francaise
   contre les Myopathies (AFM), to HS from National Institutes of Health
   (GM089853) and to J-ER from la Fondation ARC pour la Recherche sur le
   Cancer. PYWM is supported by a Clinician Scientist Fellowship Award
   (G1002570) from the Medical Research Council (UK) and also receives
   funding from Fight for Sight (UK) and the UK National Institute of
   Health Research (NIHR) as part of the Rare Diseases Translational
   Research Collaboration. CV-B is supported by the Spanish Instituto de
   Salud Carlos III (CP11/00046). MP is granted by an FRM fellowship
   (DEA20130727390).
CR Agostini M, 2011, BIOCHEM BIOPH RES CO, V414, P451, DOI 10.1016/j.bbrc.2011.09.081
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Alkhaja AK, 2012, MOL BIOL CELL, V23, P247, DOI 10.1091/mbc.E11-09-0774
   Auranen M, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000003
   Ballinger SW, 1999, EXP EYE RES, V68, P765, DOI 10.1006/exer.1998.0661
   Ban-Ishihara R, 2013, P NATL ACAD SCI USA, V110, P11863, DOI 10.1073/pnas.1301951110
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Burté F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228
   Chaussenot A, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.07.022
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chiò A, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.01.017
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Dadon-Nachum M, 2011, J MOL NEUROSCI, V43, P470, DOI 10.1007/s12031-010-9467-1
   Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460
   Friedman JR, 2015, ELIFE, V4, DOI 10.7554/eLife.07739
   Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379
   Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053
   Hori A, 2009, NUCLEIC ACIDS RES, V37, P749, DOI 10.1093/nar/gkn993
   Itoh K, 2013, MOL BIOL CELL, V24, P1842, DOI 10.1091/mbc.E13-03-0125
   Jans DC, 2013, P NATL ACAD SCI USA, V110, P8936, DOI 10.1073/pnas.1301820110
   John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.E04-08-0697
   Johnson JO, 2014, BRAIN, V137, DOI 10.1093/brain/awu265
   Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658
   Kanki T, 2004, ANN NY ACAD SCI, V1011, P61, DOI 10.1196/annals.1293.007
   Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013
   Kurzwelly D, 2015, BRAIN, V138, DOI 10.1093/brain/awv014
   Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029
   Meyer JN, 2012, AUTOPHAGY, V8, P1822, DOI 10.4161/auto.21741
   Moser JM, 2013, MOL GENET GENOMICS, V288, P207, DOI 10.1007/s00438-013-0741-0
   Müller K, 2014, BRAIN, V137, DOI 10.1093/brain/awu227
   Nassif M, 2010, ANTIOXID REDOX SIGN, V13, P1955, DOI 10.1089/ars.2009.2991
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Penttilä S, 2015, ANN NEUROL, V77, P163, DOI 10.1002/ana.24319
   Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006
   Pirooznia SK, 2014, NEURON, V81, P961, DOI 10.1016/j.neuron.2014.02.024
   Popper P, 1997, EXP NEUROL, V143, P246, DOI 10.1006/exnr.1996.6364
   Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099
   Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011
   Ronchi D, 2015, BRAIN, V138, pE372, DOI 10.1093/brain/awu384
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Santos Janine H, 2006, Methods Mol Biol, V314, P183
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351
   Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devcel.2010.03.014, 10.1016/j.devce1.2010.03.014]
   Tashiro Y, 2012, J BIOL CHEM, V287, P42984, DOI 10.1074/jbc.M112.417600
   von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Yeo W, 2004, DEV BIOL, V274, P233, DOI 10.1016/j.ydbio.2004.07.026
   Zerbes RM, 2012, BIOL CHEM, V393, P1247, DOI 10.1515/hsz-2012-0239
   Zhang M, 2015, BRAIN, V138, DOI 10.1093/brain/awv082
NR 50
TC 133
Z9 149
U1 1
U2 27
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD JAN
PY 2016
VL 8
IS 1
BP 58
EP 72
DI 10.15252/emmm.201505496
PG 15
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA DA9NI
UT WOS:000368135800006
PM 26666268
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Lau, KK
   Yang, SP
   Haddad, MN
   Butani, L
   Makker, SP
AF Lau, Keith K.
   Yang, Samuel P.
   Haddad, Maha N.
   Butani, Lavjay
   Makker, Sudesh P.
TI Mitochondrial encephalopathy with lactic acidosis and stroke-like
   episodes syndrome with hypothyroidism and focal segmental
   glomerulosclerosis in a paediatric patient
SO INTERNATIONAL UROLOGY AND NEPHROLOGY
LA English
DT Article
DE FSGS; Hypothyroidism; MELAS; Nephrotic syndrome; Paediatrics
ID ENCEPHALOMYOPATHY MELAS; DIABETES-MELLITUS; GENE MUTATION; DNA;
   DISORDERS; COMPLEXES; MYOPATHY; FEATURES; DEFECTS
AB Herein, we report on a paediatric patient with mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) who was hospitalized for acute on chronic renal insufficiency, seizures and deterioration of the level of consciousness. She also had hypertension, hypothyroidism and nephrotic range proteinuria. Kidney biopsy revealed many sclerotic glomeruli and focal segmental glomerulosclerosis (FSGS). Glomerulopathy is rare in patients with MELAS, and FSGS has been reported only in a few patients. The histopathological features of the renal biopsy suggested that the aetiology of the FSGS may have been secondary to chronic renal injury rather than from a primary immunologic cause. Moreover, our case is unique in that, the coexistence of MELAS, hypothalamic hypothyroidism and FSGS has not been reported in the past. The purpose of this report is to increase the awareness of health-care professionals, especially in the fields of paediatrics, neurology, endocrinology and nephrology, regarding the manifestations and complications of MELAS.
C1 Univ Calif Davis, Dept Paediat, Sacramento, CA 95817 USA.
C3 University of California System; University of California Davis
RP Lau, KK (corresponding author), Univ Calif Davis, Dept Paediat, 2516 Stockton Blvd, Sacramento, CA 95817 USA.
EM keith.lau@ucdmc.ucdavis.edu
CR Balestri P, 2000, J CHILD NEUROL, V15, P755, DOI 10.1177/088307380001501108
   BAN S, 1992, ACTA PATHOL JAPON, V42, P818
   CAMPOS Y, 1995, PEDIATR NEUROL, V13, P69, DOI 10.1016/0887-8994(95)00082-Q
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Leonard JV, 2000, LANCET, V355, P389, DOI 10.1016/S0140-6736(99)05226-5
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Mochizuki H, 1996, CLIN NEPHROL, V46, P347
   Nakamura S, 1999, DIABETES RES CLIN PR, V44, P183, DOI 10.1016/S0168-8227(99)00051-0
   Naviaux R K, 2000, Hum Reprod, V15 Suppl 2, P44
   Oshima T, 1999, LARYNGOSCOPE, V109, P334, DOI 10.1097/00005537-199902000-00029
   Petermann AT, 2005, KIDNEY INT, V67, P157, DOI 10.1111/j.1523-1755.2005.00066.x
   Rosenthal EL, 1999, AM J OTOL, V20, P187
   Schapira AHV, 1999, EUR J CLIN INVEST, V29, P886
   SCHATZ G, 1995, BBA-MOL BASIS DIS, V1271, P123, DOI 10.1016/0925-4439(95)00018-Y
   SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513
   TANAKA M, 1991, BIOCHEM BIOPH RES CO, V174, P861, DOI 10.1016/0006-291X(91)91497-Z
   Tay SKH, 2005, J CHILD NEUROL, V20, P142, DOI 10.1177/08830738050200022301
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Yanagihara C, 2001, INTERNAL MED, V40, P662, DOI 10.2169/internalmedicine.40.662
   YANG CY, 1995, CLIN ENDOCRINOL, V43, P235, DOI 10.1111/j.1365-2265.1995.tb01922.x
   YONEDA M, 1989, J NEUROL SCI, V92, P143, DOI 10.1016/0022-510X(89)90132-9
NR 23
TC 17
Z9 17
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-1623
J9 INT UROL NEPHROL
JI Int. Urol. Nephrol.
PD SEP
PY 2007
VL 39
IS 3
BP 941
EP 946
DI 10.1007/s11255-006-9172-8
PG 6
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA 206WQ
UT WOS:000249214000047
PM 17294289
DA 2024-11-01
ER

PT J
AU Markaryan, A
   Nelson, EG
   Hinojosa, R
AF Markaryan, Adam
   Nelson, Erik G.
   Hinojosa, Raul
TI Detection of mitochondrial DNA deletions in the cochlea and its
   structural elements from archival human temporal bone tissue
SO MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
LA English
DT Article
DE MtDNA deletions; nested PCR; cochlea
ID POLYMERASE-CHAIN-REACTION; COMMON DELETION; HUMAN BRAIN; MUTATIONS;
   REARRANGEMENTS; PRESBYCUSIS; PATHOLOGY; PATTERNS; INCREASE; PCR
AB Large-scale deletions of mitochondrial DNA (mtDNA) have been associated with aging and disease in post-mitotic tissues. These post-mitotic tissues, including skeletal muscle, heart and brain, are heavily dependent on intact functional mitochondria. The cochlear tissues are known to contain an abundance of mitochondria. This observation stimulated a search for mtDNA deletions in the cochlea and its elements using a sensitive nested PCR methodology and long range PCR to explain the functional deficits observed in age-related hearing loss. The presence of the so-called "common" deletion (CD) was detected in cochlear tissue from two individuals with age-related hearing loss, 73 and 78 years of age. Three additional deletions, that to our knowledge have not been previously reported, were also identified in these two individuals, including a 5354 bp deletion flanked with a 3 bp repeat, a 9682 bp deletion flanked by a 10 bp repeat and a 5142 bp deletion without a flanking repeat. The 9682 and 5142 bp deletions were also detected in an individual 39 years of age with normal hearing, however, these two deletions were not detected in a normal hearing individual 9 years of age. In contrast, the 5354 bp deletion was detected in all four of the individuals studied. To localize the deletions within the cochlea, the cochlear elements were removed by laser capture microdissection (LCM) and the mtDNA from these tissues was studied. The 5142 and 5354 bp deletions were detected in the organ of corti, spiral ligament, and ganglion cells, but not in the stria vascularis. These findings correlate with the reduction in the number of spiral ganglion cells and outer hair cells, and the normal stria vascularis volume observed in this individual. All four of these deletions involve the cytochrome c oxidase (COX) subunit III gene, encoded by mtDNA. These observations suggest that multiple mtDNA deletions may contribute to a deficit in mitochondrial function in the cochlea and result in hearing loss if a level of physiological significance is reached. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Markaryan, Adam; Nelson, Erik G.; Hinojosa, Raul] Univ Chicago, Dept Surg, Sect Otolaryngol Head & Neck Surg, Chicago, IL 60637 USA.
C3 University of Chicago
RP Markaryan, A (corresponding author), Univ Chicago, Dept Surg, Sect Otolaryngol Head & Neck Surg, 5841 S Maryland Ave,MC 1035, Chicago, IL 60637 USA.
EM amarkary@surgery.bsd.uchicago.edu
CR Bai U, 1997, AM J OTOL, V18, P449
   Bai UM, 2001, HEARING RES, V154, P73, DOI 10.1016/S0378-5955(01)00221-0
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Dai P, 2004, ACTA OTO-LARYNGOL, V124, P130, DOI 10.1080/00016480410016586
   FRIEDMANN I, 1984, ULTRASTRUCTURAL ATAL, P99
   Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   IURATO S, 1967, SUBMICROSCOPIC STRUC, P59
   Kimura Y, 2005, ACTA OTO-LARYNGOL, V125, P697, DOI 10.1080/00016480510027510
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   MARTON A, 1991, NUCLEIC ACIDS RES, V19, P2423, DOI 10.1093/nar/19.9.2423
   Meissner C, 2006, EXP GERONTOL, V41, P518, DOI 10.1016/j.exger.2006.03.010
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   Melov S, 1999, NEUROBIOL AGING, V20, P565, DOI 10.1016/S0197-4580(99)00092-5
   Nelson EG, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236089.44566.62
   PAABO S, 1990, J BIOL CHEM, V265, P4718
   Pogozelski WK, 2003, MITOCHONDRION, V2, P415, DOI 10.1016/S1567-7249(03)00033-3
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Seidman MD, 2004, ACTA OTO-LARYNGOL, V124, P16, DOI 10.1080/03655230410017823
   Seidman MD, 1996, LARYNGOSCOPE, V106, P777, DOI 10.1097/00005537-199606000-00021
   SIMPSON TA, 1995, LARYNGOSCOPE, V105, P28, DOI 10.1288/00005537-199501000-00009
   SOONG NW, 1992, NAT GENET, V2, P318
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Thayer RE, 2003, EXP GERONTOL, V38, P567, DOI 10.1016/S0531-5565(03)00033-0
   Wackym PA, 1998, LARYNGOSCOPE, V108, P4, DOI 10.1097/00005537-199808001-00002
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
NR 33
TC 32
Z9 39
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-1964
EI 1873-135X
J9 MUTAT RES-FUND MOL M
JI Mutat. Res.-Fundam. Mol. Mech. Mutagen.
PD APR 2
PY 2008
VL 640
IS 1-2
BP 38
EP 45
DI 10.1016/j.mrfmmm.2007.12.007
PG 8
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA 289UZ
UT WOS:000255080700005
PM 18242646
DA 2024-11-01
ER

PT J
AU Rinaldi, T
   Dallabona, C
   Ferrero, I
   Frontali, L
   Bolotin-Fukuhara, M
AF Rinaldi, Teresa
   Dallabona, Cristina
   Ferrero, Ileana
   Frontali, Laura
   Bolotin-Fukuhara, Monique
TI Mitochondrial diseases and the role of the yeast models
SO FEMS YEAST RESEARCH
LA English
DT Review
DE mitochondrial diseases; fusion; fission; mitochondrial transformation;
   mitochondrial tRNAs; mtDNA stability and maintenance
ID DYNAMIN-RELATED GTPASE; DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL
   OPHTHALMOPLEGIA; DIFFERENTIATION-ASSOCIATED PROTEIN-1;
   ADENINE-NUCLEOTIDE TRANSLOCATOR; CYTOCHROME-B MUTATIONS; DOMINANT OPTIC
   ATROPHY; SACCHAROMYCES-CEREVISIAE; SUCCINATE-DEHYDROGENASE; MEMBRANE
   PROTEIN
AB Nowadays, mitochondrial diseases are recognized and studied with much attention and they cannot be considered anymore as 'rare diseases'. Yeast has been an instrumental organism to understand the genetic and molecular aspects of the many roles of mitochondria within the cells. Thanks to the general conservation of mitochondrial genes and pathways between human and yeast, it can also be used to model some diseases. In this review, we focus on the most recent topics, exemplifying those for which yeast models have been especially valuable.
C1 [Bolotin-Fukuhara, Monique] Univ Paris 11, Inst Genet & Microbiol, CNRS, F-91405 Orsay, France.
   [Rinaldi, Teresa; Frontali, Laura] Univ Roma La Sapienza, Dept Cell & Dev Biol, Inst Pasteur, Cenci Bolognetti Fdn, Rome, Italy.
   [Dallabona, Cristina; Ferrero, Ileana] Univ Parma, Dept Genet, I-43100 Parma, Italy.
C3 Universite Paris Saclay; Centre National de la Recherche Scientifique
   (CNRS); Fondazione Cenci Bolognetti; Sapienza University Rome;
   University of Parma
RP Bolotin-Fukuhara, M (corresponding author), Univ Paris 11, Inst Genet & Microbiol, CNRS, Batiment 400, F-91405 Orsay, France.
EM bolotin@igmors.u-psud.fr
RI Rinaldi, Teresa/AAC-9710-2020
OI Rinaldi, Teresa/0000-0001-6291-245X; Bolotin-Fukuhara,
   Monique/0000-0002-5285-5006; DALLABONA, Cristina/0000-0003-4397-9143
FU Telethon [GGP07164]
FX M.B-F has been continuously supported by the 'Association Francaise
   Contre les Myopathies (AFM) for the work on yeast mitochondrial tRNA
   models. L. F. has been supported by Telethon project GGP07164.
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   [Anonymous], A Human Mitochondrial Genome Database
   Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282
   Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855
   Baines CP, 2010, ANNU REV PHYSIOL, V72, P61, DOI 10.1146/annurev-physiol-021909-135929
   Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023
   Bassett DE, 1996, NATURE, V379, P589, DOI 10.1038/379589a0
   Baxter RV, 2002, NAT GENET, V30, P21, DOI 10.1038/ng796
   Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848
   Baysal BE, 2000, FEBS J, V272, P3583
   Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x
   Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014
   BOLOTIN M, 1971, B I PASTEUR, V69, P215
   Bonnefoy Nathalie, 2007, Methods Mol Biol, V372, P153, DOI 10.1007/978-1-59745-365-3_11
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Bratton M, 2003, EUR J BIOCHEM, V270, P1222, DOI 10.1046/j.1432-1033.2003.03482.x
   Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206
   Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009
   Cerveny KL, 2001, MOL BIOL CELL, V12, P309, DOI 10.1091/mbc.12.2.309
   Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Chen XJ, 2002, HUM MOL GENET, V11, P1835, DOI 10.1093/hmg/11.16.1835
   Chen Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005386
   Cheng WC, 2006, ONCOGENE, V25, P4697, DOI 10.1038/sj.onc.1209596
   Cheng WC, 2008, BBA-MOL CELL RES, V1783, P1272, DOI 10.1016/j.bbamcr.2008.04.012
   CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651
   Cuesta A, 2002, NAT GENET, V30, P22, DOI 10.1038/ng798
   Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581
   Davidson MM, 2009, J MOL CELL CARDIOL, V46, P936, DOI 10.1016/j.yjmcc.2009.02.011
   De Luca C, 2006, GENE, V377, P169, DOI 10.1016/j.gene.2006.04.003
   De Luca C, 2009, MITOCHONDRION, V9, P408, DOI 10.1016/j.mito.2009.07.004
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Diaz-Ruiz R, 2009, BBA-REV CANCER, V1796, P252, DOI 10.1016/j.bbcan.2009.07.003
   DiMauro S, 2010, J INHERIT METAB DIS
   Ding MG, 2008, BBA-BIOENERGETICS, V1777, P1147, DOI 10.1016/j.bbabio.2008.04.029
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fekkes P, 2000, J CELL BIOL, V151, P333, DOI 10.1083/jcb.151.2.333
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   Fisher N, 2005, PEST MANAG SCI, V61, P973, DOI 10.1002/ps.1066
   Fisher N, 2004, J BIOL CHEM, V279, P12951, DOI 10.1074/jbc.M313866200
   Fisher N, 2004, EUR J BIOCHEM, V271, P1292, DOI 10.1111/j.1432-1033.2004.04036.x
   Fisher N, 2001, EUR J BIOCHEM, V268, P1155, DOI 10.1046/j.1432-1327.2001.02010.x
   Fisher N, 2008, FEMS YEAST RES, V8, P183, DOI 10.1111/j.1567-1364.2007.00328.x
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Foury F, 2004, CELL MOL LIFE SCI, V61, P2799, DOI 10.1007/s00018-004-4220-y
   Foury F, 2002, CURR OPIN CHEM BIOL, V6, P106, DOI 10.1016/S1367-5931(01)00276-9
   FOX TD, 1988, P NATL ACAD SCI USA, V85, P7288, DOI 10.1073/pnas.85.19.7288
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   García-Rodríguez LJ, 2009, CURR BIOL, V19, P1730, DOI 10.1016/j.cub.2009.08.041
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010
   Goffrini P, 2009, HUM MOL GENET, V18, P1860, DOI 10.1093/hmg/ddp102
   Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213
   Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148
   Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689
   Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359
   Hisama FM, 2005, AM J MED GENET A, V135A, P217, DOI 10.1002/ajmg.a.30672
   Horváth R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200
   Johannsen DL, 2009, CURR OPIN PHARMACOL, V9, P780, DOI 10.1016/j.coph.2009.09.002
   JOHNSTON SA, 1988, SCIENCE, V240, P1538, DOI 10.1126/science.2836954
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kessl JJ, 2005, J BIOL CHEM, V280, P17142, DOI 10.1074/jbc.M500388200
   Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809
   Kijima K, 2005, HUM GENET, V116, P23, DOI 10.1007/s00439-004-1199-2
   Klanner C, 2000, FEBS LETT, V470, P365, DOI 10.1016/S0014-5793(00)01322-3
   Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417
   Kolesnikova O, 2010, RNA, V16, P926, DOI 10.1261/rna.1914110
   Kucharczyk R, 2010, BBA-BIOENERGETICS, V1797, P1105, DOI 10.1016/j.bbabio.2009.12.022
   Kucharczyk R, 2009, HUM MOL GENET, V18, P2889, DOI 10.1093/hmg/ddp226
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P817, DOI 10.1016/j.bbamcr.2009.02.011
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lecrenier N, 2000, GENE, V246, P37, DOI 10.1016/S0378-1119(00)00107-4
   LECRENIER N, 1995, MOL GEN GENET, V249, P1, DOI 10.1007/BF00290229
   Levitas A, 2010, EUR J HUM GENET, V18, P1160, DOI 10.1038/ejhg.2010.83
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9
   Lin Tsu-Kung, 2009, Chang Gung Med J, V32, P589
   Lodi T, 2006, BIOCHEM BIOPH RES CO, V341, P810, DOI 10.1016/j.bbrc.2006.01.034
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mayevsky A, 2009, MITOCHONDRION, V9, P165, DOI 10.1016/j.mito.2009.01.009
   MCCONNELL SJ, 1990, J CELL BIOL, V111, P967, DOI 10.1083/jcb.111.3.967
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   McGregor A, 2001, MOL GENET GENOMICS, V265, P721, DOI 10.1007/s004380100469
   Meunier B, 2001, BIOCHEM J, V354, P407, DOI 10.1042/0264-6021:3540407
   Mithani SK, 2007, CLIN CANCER RES, V13, P4331, DOI 10.1158/1078-0432.CCR-06-2613
   Montanari A, 2008, RNA, V14, P275, DOI 10.1261/rna.740108
   Moraes CT, 2001, NAT GENET, V28, P200, DOI 10.1038/90020
   Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367
   Nachman MW, 1996, GENETICS, V142, P953
   Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087
   Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382
   Poulton J, 2009, BBA-MOL BASIS DIS, V1792, P1109, DOI 10.1016/j.bbadis.2009.08.016
   Poyton RO, 2009, TRENDS ENDOCRIN MET, V20, P332, DOI 10.1016/j.tem.2009.04.001
   Pradelli LA, 2010, CELL MOL LIFE SCI, V67, P1589, DOI 10.1007/s00018-010-0285-y
   Quintanilla RA, 2009, BRAIN RES BULL, V80, P242, DOI 10.1016/j.brainresbull.2009.07.010
   Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200
   Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150
   Reddy PH, 2009, BRAIN RES REV, V61, P33, DOI 10.1016/j.brainresrev.2009.04.001
   Remacle C, 2006, P NATL ACAD SCI USA, V103, P4771, DOI 10.1073/pnas.0509501103
   Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Santel A, 2001, J CELL SCI, V114, P867
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schriner SE, 2000, FREE RADICAL BIO MED, V29, P664, DOI 10.1016/S0891-5849(00)00352-X
   Schwimmer C, 2005, J BIOL CHEM, V280, P30751, DOI 10.1074/jbc.M501831200
   Schwimmer Christine, 2006, Biotechnology Journal, V1, P270, DOI 10.1002/biot.200500053
   Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022
   Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123
   Shepard KA, 1999, J CELL BIOL, V144, P711, DOI 10.1083/jcb.144.4.711
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253
   Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Stricker S, 2009, J NEUROL NEUROSUR PS, V80, P1181, DOI 10.1136/jnnp.2008.166066
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   TARASSOV I, 1995, EMBO J, V14, P3461, DOI 10.1002/j.1460-2075.1995.tb07352.x
   Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353
   Tribouillard Deborah, 2006, Biotechnology Journal, V1, P58, DOI 10.1002/biot.200500001
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trott A, 2004, EUKARYOT CELL, V3, P620, DOI 10.1128/EC.3.3.620-631.2004
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Van Coster R, 2003, AM J MED GENET A, V120A, P13, DOI 10.1002/ajmg.a.10202
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909
   Wang XW, 2008, HUM MOL GENET, V17, P4036, DOI 10.1093/hmg/ddn306
   WARBURG O, 1956, SCIENCE, V124, P269
   Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436
   WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3
   Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x
   Wenz T, 2006, BIOCHEMISTRY-US, V45, P9042, DOI 10.1021/bi060280g
   Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341
   Xu H, 2008, SCIENCE, V321, P575, DOI 10.1126/science.1160226
   Yan SD, 2006, J ALZHEIMERS DIS, V9, P127
   Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4
   Zhou JW, 2010, EUKARYOT CELL, V9, P806, DOI 10.1128/EC.00349-09
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   ZWACKA RM, 1994, EMBO J, V13, P5129, DOI 10.1002/j.1460-2075.1994.tb06842.x
NR 171
TC 34
Z9 37
U1 0
U2 30
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1567-1356
EI 1567-1364
J9 FEMS YEAST RES
JI FEMS Yeast Res.
PD DEC
PY 2010
VL 10
IS 8
BP 1006
EP 1022
DI 10.1111/j.1567-1364.2010.00685.x
PG 17
WC Biotechnology & Applied Microbiology; Microbiology; Mycology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Microbiology; Mycology
GA 674GR
UT WOS:000283725500006
PM 20946356
OA Bronze
DA 2024-11-01
ER

PT S
AU Larsson, NG
AF Larsson, Nils-Goeran
BE Kornberg, RD
   Raetz, CRH
   Rothman, JE
   Thorner, JW
TI Somatic Mitochondrial DNA Mutations in Mammalian Aging
SO ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79
SE Annual Review of Biochemistry
LA English
DT Review; Book Chapter
DE mitochondria; oxidative phosphorylation; respiratory chain
ID CULTURED SKIN FIBROBLASTS; OXYGEN SPECIES PRODUCTION; SUBSTANTIA-NIGRA
   NEURONS; MTDNA MUTATOR MICE; POINT MUTATIONS; POLYMERASE-GAMMA;
   SKELETAL-MUSCLE; IN-VIVO; OXIDATIVE-PHOSPHORYLATION; TRANSCRIPTION
   FACTOR
AB Mitochondrial dysfunction is heavily implicated in the multifactorial aging process. Aging humans have increased levels of somatic mtDNA mutations that tend to undergo clonal expansion to cause mosaic respiratory chain deficiency in various tissues, such as heart, brain, skeletal muscle, and gut. Genetic mouse models have shown that somatic mtDNA mutations and cell type-specific respiratory chain dysfunction can cause a variety of phenotypes associated with aging and age-related disease. There is thus strong observational and experimental evidence to implicate somatic mtDNA mutations and mosaic respiratory chain dysfunction in the mammalian aging process. The hypothesis that somatic mtDNA mutations are generated by oxidative damage has not been conclusively proven. Emerging data instead suggest that the inherent error rate of mitochondrial DNA (mtDNA) polymerase gamma (Pol gamma) may be responsible for the majority of somatic mtDNA mutations. The roles for mtDNA damage and replication errors in aging need to be further experimentally addressed.
C1 Max Planck Inst Biol Ageing, D-50931 Cologne, Germany.
C3 Max Planck Society
RP Larsson, NG (corresponding author), Max Planck Inst Biol Ageing, D-50931 Cologne, Germany.
EM larsson@age.mpg.de
RI Larsson, Nils-Göran/GVS-5578-2022
OI Larsson, Nils-Goran/0000-0001-5100-996X
CR Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038
   [Anonymous], WHY WE AGE WHAT SCI
   Antoshechkin I, 1997, EMBO J, V16, P3198, DOI 10.1093/emboj/16.11.3198
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   BENZER S, 1958, P NATL ACAD SCI USA, V44, P112, DOI 10.1073/pnas.44.2.112
   Berneburg M, 2004, J INVEST DERMATOL, V122, P1277, DOI 10.1111/j.0022-202X.2004.22502.x
   Birket MJ, 2007, AGING CELL, V6, P557, DOI 10.1111/j.1474-9726.2007.00310.x
   Birket MJ, 2009, J INVEST DERMATOL, V129, P1361, DOI 10.1038/jid.2008.373
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bogenhagen DF, 1999, AM J HUM GENET, V64, P1276, DOI 10.1086/302392
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P404, DOI 10.1016/S0968-0004(03)00165-8
   Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126
   Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890
   Brockmann GA, 2002, TRENDS GENET, V18, P367, DOI 10.1016/S0168-9525(02)02703-8
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Cermakian N, 1996, NUCLEIC ACIDS RES, V24, P648, DOI 10.1093/nar/24.4.648
   Chan SW, 2009, METHODS MOL BIOL, V554, P183, DOI 10.1007/978-1-59745-521-3_12
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Clayton D A, 1975, Int Rev Exp Pathol, V14, P1
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cottrell DA, 2001, NEUROLOGY, V57, P260, DOI 10.1212/WNL.57.2.260
   de Souza-Pinto NC, 2008, DNA REPAIR, V7, P1098, DOI 10.1016/j.dnarep.2008.03.011
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780
   Dufour E, 2008, HUM MOL GENET, V17, P1418, DOI 10.1093/hmg/ddn030
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Ekstrand Mats, 2002, Methods Mol Biol, V197, P391, DOI 10.1385/1-59259-284-8:391
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066
   FISHER RP, 1992, J BIOL CHEM, V267, P3358
   Freyer C, 2007, CELL, V131, P448, DOI 10.1016/j.cell.2007.10.027
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gowrishankar J, 2004, MOL MICROBIOL, V54, P598, DOI 10.1111/j.1365-2958.2004.04289.x
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x
   Hamilton ML, 2001, NUCLEIC ACIDS RES, V29, P2117, DOI 10.1093/nar/29.10.2117
   Hancock DK, 2005, GENOMICS, V86, P446, DOI 10.1016/j.ygeno.2005.06.006
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hirano M, 1997, P NATL ACAD SCI USA, V94, P14894, DOI 10.1073/pnas.94.26.14894
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2003, TRENDS BIOCHEM SCI, V28, P355, DOI 10.1016/S0968-0004(03)00133-6
   Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048
   Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kajander OA, 1999, NAT MED, V5, P965, DOI 10.1038/12379
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kraytsberg Y, 2009, METHODS MOL BIOL, V554, P329, DOI 10.1007/978-1-59745-521-3_21
   Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x
   Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krishnan KJ, 2006, J INVEST DERMATOL, V126, P408, DOI 10.1038/sj.jid.5700099
   Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LARSSON NG, 1992, AM J HUM GENET, V50, P360
   Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451
   Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653
   Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5
   MacAlpine DM, 2001, EMBO J, V20, P1807, DOI 10.1093/emboj/20.7.1807
   MADSEN CS, 1993, P NATL ACAD SCI USA, V90, P7671, DOI 10.1073/pnas.90.16.7671
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1991, MOL CELL BIOL, V11, P1631, DOI 10.1128/MCB.11.3.1631
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Murdock DG, 2000, NUCLEIC ACIDS RES, V28, P4350, DOI 10.1093/nar/28.21.4350
   Niu X, 2007, EXP CELL RES, V313, P3924, DOI 10.1016/j.yexcr.2007.05.029
   Pak JW, 2003, AGING CELL, V2, P1, DOI 10.1046/j.1474-9728.2003.00034.x
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Pellegrini M, 2009, BBA-BIOENERGETICS, V1787, P294, DOI 10.1016/j.bbabio.2009.01.018
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202
   Piper MDW, 2008, J INTERN MED, V263, P179, DOI 10.1111/j.1365-2796.2007.01906.x
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rivera J, 2008, IMMUNITY, V28, P1, DOI 10.1016/j.immuni.2007.12.008
   Rorbach J, 2007, BIOCHEM SOC T, V35, P1290, DOI 10.1042/BST0351290
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1
   Shen EL, 2001, NUCLEIC ACIDS RES, V29, P2822, DOI 10.1093/nar/29.13.2822
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Silva JP, 2005, EMBO J, V24, P4061, DOI 10.1038/sj.emboj.7600866
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   SOONG NW, 1992, NAT GENET, V2, P318
   Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Stuart JA, 2005, FREE RADICAL BIO MED, V38, P737, DOI 10.1016/j.freeradbiomed.2004.12.003
   Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Terzioglu Mugen, 2007, Novartis Found Symp, V287, P197
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Keuren ML, 2009, TRANSGENIC RES, V18, P769, DOI 10.1007/s11248-009-9271-2
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010
   Wilding CS, 2006, RADIAT RES, V165, P202, DOI 10.1667/RR3494.1
   Wong GT, 2002, NEUROPEPTIDES, V36, P230, DOI 10.1054/npep.2002.0905
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Zelenaya-Troitskaya O, 1998, GENETICS, V148, P1763
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 152
TC 392
Z9 442
U1 0
U2 72
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0066-4154
BN 978-0-8243-0879-7
J9 ANNU REV BIOCHEM
JI Annu. Rev. Biochem..
PY 2010
VL 79
BP 683
EP 706
DI 10.1146/annurev-biochem-060408-093701
PG 24
WC Biochemistry & Molecular Biology
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA BPX29
UT WOS:000280225300024
PM 20350166
DA 2024-11-01
ER

PT B
AU Magner, M
AF Magner, Martin
BE Ahmad, SI
TI Clinical Manifestation of Mitochondrial Disorders in Childhood
SO HANDBOOK OF MITOCHONDRIAL DYSFUNCTION
LA English
DT Article; Book Chapter
ID CYTOCHROME-C-OXIDASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   LEIGH-SYNDROME; NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY; CARDIAC
   MANIFESTATIONS; MYOCLONIC EPILEPSY; PRESENTING FEATURE; DEAFNESS
   SYNDROME; NATURAL-HISTORY; DNA MUTATIONS
C1 [Magner, Martin] Charles Univ Prague, Gen Univ Hosp, Dept Paediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Magner, Martin] Charles Univ Prague, Fac Med 1, Ke Karlovu 2, Prague 12808 2, Czech Republic.
C3 General University Hospital Prague; Charles University Prague; Charles
   University Prague
RP Magner, M (corresponding author), Charles Univ Prague, Gen Univ Hosp, Dept Paediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.; Magner, M (corresponding author), Charles Univ Prague, Fac Med 1, Ke Karlovu 2, Prague 12808 2, Czech Republic.
RI Magner, Martin/J-3553-2017
FU Charles University in Prague [UNCE 204064, AZV 17-30965A, RVO-VFN
   64165/2012]
FX The work was supported by project of Charles University in Prague UNCE
   204064, AZV 17-30965A and RVO-VFN 64165/2012.
CR Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Astuti D, 2004, BRIT J CANCER, V91, P1835, DOI 10.1038/sj.bjc.6602202
   Bachmann-Gagescu R., 2009, J INHERIT METAB D S1, P1101
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bargiela David, 2015, Cerebellum Ataxias, V2, P16, DOI 10.1186/s40673-015-0035-x
   Barragán-Campos HM, 2005, ARCH NEUROL-CHICAGO, V62, P737, DOI 10.1001/archneur.62.5.737
   Barrett TG, 1997, J MED GENET, V34, P838, DOI 10.1136/jmg.34.10.838
   BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Bates MGD, 2012, INT J CARDIOL, V155, P305, DOI 10.1016/j.ijcard.2011.11.063
   Berio A, 2013, Pediatr Med Chir, V35, P137
   Blondon H, 2005, GASTROEN CLIN BIOL, V29, P773, DOI 10.1016/S0399-8320(05)86346-8
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Braczynski AK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/462592
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Burki F, 2016, CURR BIOL, V26, pR410, DOI 10.1016/j.cub.2016.04.032
   Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012
   Cameron JM, 2004, AM J MED GENET A, V131A, P59, DOI 10.1002/ajmg.a.30287
   Carrozzo R., 2007, BRAIN 3, V130, P862
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   CHARLES R, 1981, CIRCULATION, V63, P214, DOI 10.1161/01.CIR.63.1.214
   Chi CS, 2015, PEDIATR NEONATOL, V56, P7, DOI 10.1016/j.pedneo.2014.03.009
   Chiang S, 2016, CLIN SCI, V130, P853, DOI 10.1042/CS20160072
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Debray FG, 2006, EUR J PEDIATR, V165, P462, DOI 10.1007/s00431-006-0104-5
   Desguerre I, 2014, REV NEUROL-FRANCE, V170, P375, DOI 10.1016/j.neurol.2014.03.010
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2002, ADV NEUROL, V89, P217
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   DiMauro S., 2015, GENEREVIEWS R
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Emma F, 2017, NEPHROL THER, V13, pS23, DOI 10.1016/j.nephro.2017.01.014
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Filosto M., 2008, NEUROMUSCULAR DISORD, V18, P204
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Finsterer J, 2006, NETH J MED, V64, P61
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2007, ACTA HAEMATOL-BASEL, V118, P88, DOI 10.1159/000105676
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Finsterer J, 2017, BIOMED REP, V6, P487, DOI 10.3892/br.2017.892
   Finsterer J, 2015, SINGAP MED J, V56, P412, DOI 10.11622/smedj.2015112
   Finsterer J, 2014, INT J CARDIOL, V177, P754, DOI 10.1016/j.ijcard.2014.11.014
   Finsterer J, 2012, SEIZURE-EUR J EPILEP, V21, P316, DOI 10.1016/j.seizure.2012.03.003
   Fontenay M, 2006, ONCOGENE, V25, P4757, DOI 10.1038/sj.onc.1209606
   Gano LB, 2014, J LIPID RES, V55, P2211, DOI 10.1194/jlr.R048975
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gebhart SSP, 1996, METABOLISM, V45, P526, DOI 10.1016/S0026-0495(96)90231-0
   Giordano C, 2009, NEUROLOGY, V72, P1103, DOI 10.1212/01.wnl.0000345002.47396.e1
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Graham BR, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-10
   Gueyen N, 2015, REDOX BIOL, V4, P289, DOI 10.1016/j.redox.2015.01.009
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hirano M., 2016, GENEREVIEWS R
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Honzik T, 2006, Cas Lek Cesk, V145, P665
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   Ichida F, 2001, CIRCULATION, V103, P1256
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Kaufman KR, 2010, EPILEPSY BEHAV, V18, P494, DOI 10.1016/j.yebeh.2010.05.020
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kozak Igor, 2018, Retin Cases Brief Rep, V12, P349, DOI 10.1097/ICB.0000000000000503
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lamont PJ, 1998, ARCH DIS CHILD, V79, P22, DOI 10.1136/adc.79.1.22
   Lax NZ, 2017, NEUROPATH APPL NEURO, V43, P102, DOI 10.1111/nan.12333
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197
   Lee K T, 2001, Kaohsiung J Med Sci, V17, P336
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Li YY, 2018, GENE, V674, P15, DOI 10.1016/j.gene.2018.06.058
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   Listernick R, 2007, PEDIATR ANN, V36, P254, DOI 10.3928/0090-4481-20070501-04
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Magner M, 2011, Prague Med Rep, V112, P18
   Magner M., 2010, CESK SLOV NEUROL N, V106, P73
   Magner M, 2015, J INHERIT METAB DIS, V38, P417, DOI 10.1007/s10545-014-9774-8
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Marin SE, 2013, GENE, V516, P162, DOI 10.1016/j.gene.2012.12.024
   Martí R, 2005, ANN NEUROL, V58, P649, DOI 10.1002/ana.20615
   Mignarri A, 2015, J NEUROL SCI, V349, P254, DOI 10.1016/j.jns.2014.12.040
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   MOHR JAN, 1960, ACTA GENET ET STATIST MED, V10, P54
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Mozzillo E, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-88
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Niaudet P, 1997, KIDNEY INT, V51, P1000, DOI 10.1038/ki.1997.140
   Nye JS, 2000, TERATOLOGY, V61, P165, DOI 10.1002/(SICI)1096-9926(200003)61:3<165::AID-TERA3>3.3.CO;2-5
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Piekutowska-Abramczuk D, 2009, CLIN GENET, V76, P195, DOI 10.1111/j.1399-0004.2009.01195.x
   POULTON J, 1989, LANCET, V1, P236
   Pronicka E, 2013, MITOCHONDRION, V13, P810, DOI 10.1016/j.mito.2013.05.007
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Rötig A, 2003, J NEPHROL, V16, P286
   Saneto RP, 2013, NEUROTHERAPEUTICS, V10, P199, DOI 10.1007/s13311-012-0167-0
   Scaglia F, 2005, AM J NEURORADIOL, V26, P1675
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCHON EA, 1994, J BIOENERG BIOMEMBR, V26, P291, DOI 10.1007/BF00763100
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Shigemoto M, 1998, INTERNAL MED, V37, P265, DOI 10.2169/internalmedicine.37.265
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sperl W, 2015, J INHERIT METAB DIS, V38, P391, DOI 10.1007/s10545-014-9787-3
   Subramanian V. S., 2006, AM J PHYSIOL-CELL PH, V291, pC851
   Taanman JW, 2009, NEUROMUSCULAR DISORD, V19, P151, DOI 10.1016/j.nmd.2008.11.002
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tay SKH, 2004, ARCH NEUROL-CHICAGO, V61, P950, DOI 10.1001/archneur.61.6.950
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Tesarova M, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.28007
   Thorburn D. R., 2017, GENEREVIEWS R
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Tranebjaerg L, 2001, Ophthalmic Genet, V22, P207
   TRANEBJAERG L, 1995, J MED GENET, V32, P257, DOI 10.1136/jmg.32.4.257
   Turconi AC, 1999, J NEUROL SCI, V170, P57, DOI 10.1016/S0022-510X(99)00199-9
   Ujike H, 2001, ARCH NEUROL-CHICAGO, V58, P1004, DOI 10.1001/archneur.58.6.1004
   Urano F, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0702-6
   Uziel G., 1997, J NEUROL NEUROSUR PS, V63, P16
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   van Adel Brian A, 2009, J Clin Neuromuscul Dis, V10, P97, DOI 10.1097/CND.0b013e3181903126
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Vissing J, 2002, NEUROLOGY, V59, P926, DOI 10.1212/WNL.59.6.926
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Wallace DC, 1999, P NATL ACAD SCI USA, V96, P1817, DOI 10.1073/pnas.96.5.1817
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wedatilake Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-96
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Yaplito-Lee J, 2007, J PEDIATR-US, V150, P407, DOI 10.1016/j.jpeds.2006.12.047
   Yu-Wai-Man P., 2016, GENEREVIEWS R
   Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 155
TC 0
Z9 0
U1 0
U2 0
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-138-33608-7
PY 2019
BP 243
EP 263
PG 21
WC Cell Biology; Genetics & Heredity; Pathology
WE Book Citation Index – Science (BKCI-S)
SC Cell Biology; Genetics & Heredity; Pathology
GA BQ1CL
UT WOS:000575159400022
DA 2024-11-01
ER

PT J
AU Shen, CZ
   Xian, WB
   Zhou, HY
   Li, XH
   Liang, XL
   Chen, L
AF Shen, Cunzhou
   Xian, Wenbiao
   Zhou, Hongyan
   Li, Xunhua
   Liang, Xiuling
   Chen, Ling
TI Overlapping Leigh Syndrome/Myoclonic Epilepsy With Ragged Red Fibres in
   an Adolescent Patient With a Mitochondrial DNA A8344G Mutation
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE Leigh syndrome; MERRF; mitochondrial DNA; A8344G mutation; mitochondrial
   disease
ID MTDNA MERRF MUTATION; MYOCLONIC EPILEPSY; CLINICAL-FEATURES; DISEASE;
   ABNORMALITIES; DIAGNOSIS; FAMILIES
AB We present the case of a 16-year-old boy with a family history of epilepsy who presented with acute respiratory failure, limb weakness, diabetes mellitus, sinus tachycardia, lactic acidosis, and pneumonia. He went on to develop cranial nerve palsy, myoclonus, generalized seizures, ataxia, recurrent pneumonia, and hypotension. Biochemical investigation revealed elevated lactate, pyruvate, and glucose levels. Cerebral magnetic resonance imaging (MRI) revealed bilateral, symmetric, high-intensity T2-weighted signals in the thalamus, brainstem, and gray matter of the spinal cord. Histochemical analyses revealed ragged red fibers (RRF) and decreased cytochrome oxidase activity. Blood and muscle-derived DNA demonstrated a high level (95% and 96%, respectively) of the m.8344A>G mutation, while almost all of his maternal relatives (n = 17, including his mother) carried the same point mutation. The point mutation level of his mother (who had short stature, high blood lactate levels, and epilepsy) was 77% (blood-derived DNA). Although this mutation has been identified in approximately 30 individuals with these disorders, to our knowledge, this is the first reported case of overlapping Leigh syndrome/myoclonic epilepsy with RRF in an adolescent patient, and the largest reported pedigree of mitochondrial DNA A8344G mutation.
C1 [Chen, Ling] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Natl Key Clin Dept, Guangzhou, Guangdong, Peoples R China.
   Sun Yat Sen Univ, Affiliated Hosp 1, Key Discipline Neurol, Guangzhou, Guangdong, Peoples R China.
C3 Sun Yat Sen University; Sun Yat Sen University
RP Chen, L (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Natl Key Clin Dept, Guangzhou, Guangdong, Peoples R China.
EM chenl2@mail.sysu.edu.cn
FU Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major
   Neurological Diseases [2014B030301035]; Southern China International
   Cooperation Base for Early Intervention and Functional Rehabilitation of
   Neurological Diseases [2015B050501003]; Guangzhou Clinical Research and
   Translational Center for Major Neurological Diseases [201604020010];
   Guangdong Provincial Engineering Center for Major Neurological Disease
   Treatment
FX The study was supported by the grants from Guangdong Provincial Key
   Laboratory for Diagnosis and Treatment of Major Neurological Diseases
   (2014B030301035); The Southern China International Cooperation Base for
   Early Intervention and Functional Rehabilitation of Neurological
   Diseases (2015B050501003); Guangzhou Clinical Research and Translational
   Center for Major Neurological Diseases (201604020010); Guangdong
   Provincial Engineering Center for Major Neurological Disease Treatment.
CR Alston CL, 2011, EUR J HUM GENET, V19, P1226, DOI 10.1038/ejhg.2011.124
   Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   BERKOVIC SF, 1991, LANCET, V338, P457, DOI 10.1016/0140-6736(91)91090-H
   Emmanuele V, 2011, MUSCLE NERVE, V44, P448, DOI 10.1002/mus.22149
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Liu KM, 2014, METAB BRAIN DIS, V29, P139, DOI 10.1007/s11011-013-9464-5
   Lorenzoni PJ, 2014, ARQ NEURO-PSIQUIAT, V72, P803, DOI 10.1590/0004-282X20140124
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Marie TL, 2014, CURR PROTOC BIOINFOR, V1, DOI 10.1002/0471250953.bi0123s44
   Monden Y, 2013, BRAIN DEV-JPN, V35, P582, DOI 10.1016/j.braindev.2012.08.006
   Nakamura M, 2010, J MED GENET, V47, P659, DOI 10.1136/jmg.2009.072058
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   SWEENEY MG, 1994, J NEUROL SCI, V121, P57, DOI 10.1016/0022-510X(94)90157-0
   Tavares WC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177403
   Tuppen HAL, 2010, BRAIN, V133, P2952, DOI 10.1093/brain/awq232
NR 20
TC 4
Z9 5
U1 0
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD SEP 13
PY 2018
VL 9
AR 724
DI 10.3389/fneur.2018.00724
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA GT4GV
UT WOS:000444463100001
PM 30271374
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Potluri, P
   Davila, A
   Ruiz-Pesini, E
   Mishmar, D
   O'Hearn, S
   Hancock, S
   Simon, M
   Scheffler, IE
   Wallace, DC
   Procaccio, V
AF Potluri, Prasanth
   Davila, Antonio
   Ruiz-Pesini, Eduardo
   Mishmar, Dan
   O'Hearn, Sean
   Hancock, Saege
   Simon, Mariella
   Scheffler, Immo E.
   Wallace, Douglas C.
   Procaccio, Vincent
TI A novel NDUFA1 mutation leads to a progressive mitochondrial complex
   I-specific neurodegenerative disease
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Mitochondria; Mitochondrial disorders; Complex I; mtDNA; NDUFA1
ID HEREDITARY OPTIC NEUROPATHY; BOVINE HEART-MITOCHONDRIA; TISSUE-CULTURE
   CELLS; CHLORAMPHENICOL RESISTANCE; ADAPTIVE SELECTION;
   MOLECULAR-GENETICS; MAMMALIAN-CELLS; MEMBRANE DOMAIN; DNA; SUBUNITS
AB Mitochondrial diseases have been shown to result from mutations in mitochondrial genes located in either the nuclear DNA (nDNA) or mitochondrial DNA (mtDNA). Mitochondrial OXPHOS complex I has 45 subunits encoded by 38 nuclear and 7 mitochondrial genes. Two male patients in a putative X-linked pedigree exhibiting a progressive neurodegenerative disorder and a severe muscle complex I enzyme defect were analyzed for mutations in the 38 nDNA and seven mtDNA encoded complex I subunits. The nDNA X-linked NDUFA1 gene (MWFE polypeptide) was discovered to harbor a novel missense mutation which changed a highly conserved glycine at position 32 to an arginine, shown to segregate with the disease. When this mutation was introduced into a NDUFA1 null hamster cell line, a substantial decrease in the complex I assembly and activity was observed. When the mtDNA of the patient was analyzed, potentially relevant missense mutations were observed in the complex I genes. Transmitochondrial cybrids containing the patient's mtDNA resulted in a mild complex I deficiency. Interestingly enough, the nDNA encoded MWFE polypeptide has been shown to interact with various mtDNA encoded complex I subunits. Therefore, we hypothesize that the novel G32R mutation in NDUFA1 is causing complex I deficiency either by itself or in synergy with additional mtDNA variants. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Potluri, Prasanth; Davila, Antonio; Hancock, Saege; Simon, Mariella; Wallace, Douglas C.; Procaccio, Vincent] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA.
   [Ruiz-Pesini, Eduardo] Univ Zaragoza, ISCII, CIBERER, Dept Bioquim Biol Mol & Celular, E-50013 Zaragoza, Spain.
   [Ruiz-Pesini, Eduardo] Univ Zaragoza, Fundac ARAID, E-50013 Zaragoza, Spain.
   [Mishmar, Dan] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.
   [Mishmar, Dan] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel.
   [Hancock, Saege; Wallace, Douglas C.; Procaccio, Vincent] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA.
   [Scheffler, Immo E.] Univ Calif San Diego, San Diego, CA 92103 USA.
C3 University of California System; University of California Irvine;
   University of Zaragoza; CIBER - Centro de Investigacion Biomedica en
   Red; CIBERER; University of Zaragoza; Ben Gurion University; Ben Gurion
   University; University of California System; University of California
   Irvine; University of California System; University of California San
   Diego
RP Procaccio, V (corresponding author), Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, 2034 Hewitt Hall, Irvine, CA 92697 USA.
EM vproca@uci.edu
RI Mishmar, Dan/AAJ-6109-2020; Procaccio, Vincent/M-2596-2015
OI Mishmar, Dan/0000-0003-3488-8792; procaccio,
   Vincent/0000-0002-1537-4684; Simon, Mariella/0000-0002-8200-3277;
   DAVILA, ANTONIO/0000-0003-1672-2713
FU NIH [RO1 NS21328, NS41850, AG24373, FIS-PI08/0264]
FX This research was supported in part by NIH Grants RO1 NS21328, NS41850,
   AG24373 and FIS-PI08/0264.
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Au HC, 1999, P NATL ACAD SCI USA, V96, P4354, DOI 10.1073/pnas.96.8.4354
   Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026
   Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210
   Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng100
   Blok MJ, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045716
   Brown MD, 1997, AM J HUM GENET, V60, P381
   BUNN CL, 1974, P NATL ACAD SCI USA, V71, P1681, DOI 10.1073/pnas.71.5.1681
   Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200
   Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200
   Chomyn A, 2001, J BIOENERG BIOMEMBR, V33, P251, DOI 10.1023/A:1010791204961
   Fernandez-Moreira D, 2007, ANN NEUROL, V61, P73, DOI 10.1002/ana.21036
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015
   McKenzie M, 2000, J BIOL CHEM, V275, P31514, DOI 10.1074/jbc.M004070200
   McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200
   Mishmar D, 2006, GENE, V378, P11, DOI 10.1016/j.gene.2006.03.015
   Munakata K, 2004, GENOMICS, V84, P1041, DOI 10.1016/j.ygeno.2004.08.015
   Procaccio V, 2004, NEUROLOGY, V62, P1899, DOI 10.1212/01.WNL.0000125251.56131.65
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t
   Scheffler IE, 2004, BBA-BIOENERGETICS, V1659, P160, DOI 10.1016/j.bbabio.2004.08.002
   Scheffler IE, 2001, J BIOENERG BIOMEMBR, V33, P243, DOI 10.1023/A:1010739120891
   Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Wallace D.C., 2007, Emery and Rimoin's Principles and Practice of Medical Genetics, V5th, P194
   WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661
   WALLACE DC, 1975, J CELL BIOL, V67, P174, DOI 10.1083/jcb.67.1.174
   WALLACE DC, 1979, SOM CELL GENET, V5, P396
   Wissinger B, 1997, BIOCHEM BIOPH RES CO, V234, P511, DOI 10.1006/bbrc.1997.6660
   Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200
   Yadava N, 2008, INT J BIOCHEM CELL B, V40, P447, DOI 10.1016/j.biocel.2007.08.015
   Yadava N, 2002, J BIOL CHEM, V277, P21221, DOI 10.1074/jbc.M202016200
   Zhuchenko O, 1996, GENOMICS, V37, P281, DOI 10.1006/geno.1996.0561
NR 39
TC 73
Z9 78
U1 0
U2 16
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD APR
PY 2009
VL 96
IS 4
BP 189
EP 195
DI 10.1016/j.ymgme.2008.12.004
PG 7
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 426VZ
UT WOS:000264737700007
PM 19185523
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Tabebi, M
   Khabou, B
   Boukadi, H
   Ben Hamad, M
   Ben Rhouma, B
   Tounsi, S
   Maalej, A
   Kamoun, H
   Keskes-Ammar, L
   Abid, M
   Mnif, M
   Fakhfakh, F
AF Tabebi, Mouna
   Khabou, Bodour
   Boukadi, Hanen
   Ben Hamad, Mariam
   Ben Rhouma, Bochra
   Tounsi, Slim
   Maalej, Abdellatif
   Kamoun, Hassen
   Keskes-Ammar, Leila
   Abid, Mohamed
   Mnif, Mouna
   Fakhfakh, Faiza
TI Association study of apoptosis gene polymorphisms in mitochondrial
   diabetes: A potential role in the pathogenicity of MD
SO GENE
LA English
DT Article
DE Mitochondrial diabetes; Apoptosis; Polymorphisms; TUNEL; Cytochrome c;
   Protein expression
ID SINGLE-NUCLEOTIDE POLYMORPHISMS; PROGRAMMED CELL-DEATH; LINKAGE
   DISEQUILIBRIUM; MOLECULAR-MECHANISMS; TUNISIAN FAMILY; HUMAN GENOME;
   P53; MUTATION; MIDD; ACTIVATION
AB Mitochondrial diabetes (MD) is a heterogeneous disorder characterized by a chronic hyperglycemia and is maternally transmitted. Syndromic MD is a subgroup of MD including diabetic microangiopathy and macroangiopathy, in addition to extrapancreatic disorder. MD is caused by genetic mutations and deletions affecting mitochondrial DNA. This mitochondrial damage initiates apoptosis. In this study, we hypothesized that functional polymorphisms in genes involved in apoptotic pathway could be associated with the development of apoptosis in MD disease and increased its risk. Detection of apoptosis was confirmed on muscle biopsies taken from MD patients using the TUNEL method and the Cytochrome c protein expression level. We genotyped then 11 published SNPs from intrinsic and extrinsic apoptotic pathway and assessed the signification of these polymorphisms in 43 MD patients and 100 healthy controls. We found 10 selected polymorphisms (p53 (rs1042522 and rs17878362), BCL2 (rs2279115), BAX (rs1805419), BAK1 (rs210132 and rs2227925), CASP3 (rs1405937), CASP7 (rs2227310), CASP8 (rs1045485) and CASPIO (rs13006529)) with a potential apoptosis effect in MD patients compared to control population. Specifically, SNPs involved in the intrinsic pathway (p53, BCL2, BAK1 and CASP3) presented the highest risk of apoptosis. Our result proved that apoptosis initiated by mtDNA mutations, can be emphasized by a functional apoptotic polymorphisms associated with high expression of cytochrome c protein and more myofibers with apoptosis in syndromic MD subgroup compared with non-syndromic MD subgroup.
C1 [Tabebi, Mouna; Khabou, Bodour; Ben Hamad, Mariam; Ben Rhouma, Bochra; Maalej, Abdellatif; Kamoun, Hassen; Keskes-Ammar, Leila] Univ Sfax, Fac Med Sfax, Human Mol Genet Lab, Sfax, Tunisia.
   [Boukadi, Hanen; Tounsi, Slim] Univ Sfax, Ctr Biotechnol Sfax, Lab Biopesticides, Sfax, Tunisia.
   [Abid, Mohamed; Mnif, Mouna] Univ Hosp Hedi Chaker, Dept Endocrinol, Sfax, Tunisia.
   [Fakhfakh, Faiza] Univ Sfax, Fac Sci Sfax, Dept Life Sci, Sfax, Tunisia.
C3 Universite de Sfax; Centre de Biotechnologie de Sfax; Universite de
   Sfax; Universite de Sfax; Hopital Hedi Chaker; Universite de Sfax;
   Faculty of Sciences Sfax
RP Tabebi, M (corresponding author), Fac Med, Lab Human Mol Genet, Ave Magida Boulila, Sfax 3029, Tunisia.
EM mounamouna62@yahoo.fr
RI Boukedi, Hanen/AAB-2877-2021; tabebi, mouna/AAL-2270-2020
OI BEN HAMAD, Mariem/0000-0001-5473-7209; tabebi,
   mouna/0000-0002-2873-161X; Keskes, Leila/0000-0002-8420-139X; hanen,
   boukedi/0000-0003-0620-5843; kamoun, hassen/0000-0002-1798-3862
FU Ministry of Higher Education and Scientific Research in Tunisia
FX We thank the patients and their families for their cooperation in the
   present study. This work was supported by The Ministry of Higher
   Education and Scientific Research in Tunisia. The authors are also
   thankful to Mrs. Rim TRABELSI for having proofread the manuscript.
CR Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200
   Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777
   Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305
   Bendesky A, 2007, MUTAT RES-FUND MOL M, V619, P38, DOI 10.1016/j.mrfmmm.2007.01.001
   Biros E, 2002, PHYSIOL RES, V51, P59, DOI 10.33549/physiolres.930134
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Fan BJ, 2010, INVEST OPHTH VIS SCI, V51, P4110, DOI 10.1167/iovs.09-4974
   Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424
   Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320
   Hu ZB, 2008, J CANCER EPIDEMIOL, V2008, DOI 10.1155/2008/147905
   Javid J., 2016, CELL DEATH DIS, V4, pe492
   Ke XY, 2001, BIOINFORMATICS, V17, P838, DOI 10.1093/bioinformatics/17.9.838
   Ko CB, 2004, TOXICOLOGY, V199, P35, DOI 10.1016/j.tox.2004.01.039
   KORSMEYER SJ, 1995, TRENDS GENET, V11, P101, DOI 10.1016/S0168-9525(00)89010-1
   Lei W, 1998, CANCER RES, V58, P2102
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004
   Mezghani N, 2010, J DIABETES COMPLICAT, V24, P270, DOI 10.1016/j.jdiacomp.2009.11.002
   Miller JB, 2006, TRENDS MOL MED, V12, P279, DOI 10.1016/j.molmed.2006.04.003
   MIYASHITA T, 1995, CELL, V80, P293
   Mkaouar-Rebai E, 2009, PEDIATR NEUROL, V40, P437, DOI 10.1016/j.pediatrneurol.2009.01.004
   Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236
   Salem IH, 2012, MOL BIOL REP, V39, P7479, DOI 10.1007/s11033-012-1581-4
   Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579
   Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272
   Tabebi M, 2017, J DIABETES COMPLICAT, V31, P253, DOI 10.1016/j.jdiacomp.2016.06.028
   Tabebi M, 2015, BIOCHEM BIOPH RES CO, V459, P353, DOI 10.1016/j.bbrc.2015.01.151
   THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464
   WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x
   ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367
NR 35
TC 4
Z9 6
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD JAN 10
PY 2018
VL 639
BP 18
EP 26
DI 10.1016/j.gene.2017.09.063
PG 9
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA FN9XL
UT WOS:000416396100003
PM 28987347
DA 2024-11-01
ER

PT J
AU Sacconi, S
   Salviati, L
   Trevisson, E
AF Sacconi, Sabrina
   Salviati, Leonardo
   Trevisson, Eva
TI Mutation analysis of <i>COX18</i> in 29 patients with isolated
   cytochrome <i>c</i> oxidase deficiency
SO JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE Cytochrome c oxidase; cytochrome c oxidase deficiency; COX18;
   mitochondrial encephalomyopathy
ID LEIGH-SYNDROME; SACCHAROMYCES-CEREVISIAE; GENE-MUTATIONS; SURF1;
   BIOGENESIS; DEFECTS; YEAST
AB Isolated cytochrome c oxidase (COX) deficiency (MIM#220110) is a relatively common biochemical finding in pediatric patients with mitochondrial disorder. It has been associated with different clinical phenotypes ranging from isolated myopathy to severe multisystem disorder. It is a genetically heterogeneous trait, and the most frequent genetic defects affect SURF1 and SCO2, two genes required for COX assembly. However, a significant proportion of patients lacks mutation in these genes and in other known genes that require COX biogenesis. COX18 is a novel COX assembly gene required for membrane insertion of the C-terminal portion of COX subunit II. We have studied 29 pediatric patients with isolated COX deficiency in the skeletal muscle associated with different clinical phenotypes. Mutations in SURF1, SC02, SC01, COX10, COX15 and in mitochondrial DNA, had been ruled out earlier. The COX18 gene was analyzed using a PCR-single-stranded conformation polymorphism (PCR-SSCP) protocol, and in 15 patients, the analysis was repeated by direct sequencing. No pathogenic mutations were detected in our cohort of patients indicating that COX18 mutations may be very rare or associated with other phenotypes than isolated COX deficiency in infancy. Journal of Human Genetics (2009) 54, 419-421; doi: 10.1038/jhg.2009.36; published online 17 April 2009
C1 [Salviati, Leonardo] Univ Padua, Pediat Clin Genet Unit, Dept Pediat, Hematol Oncol Lab, I-35128 Padua, Italy.
   [Salviati, Leonardo; Trevisson, Eva] Univ Padua, Clin Genet Unit, I-35128 Padua, Italy.
   [Sacconi, Sabrina] Univ Nice, Fac Med, Ctr Reference Malad Neuromusculaires, Nice, France.
   [Sacconi, Sabrina] Univ Nice, Fac Med, CNRS, UMR 6543, Nice, France.
C3 University of Padua; University of Padua; Universite Cote d'Azur; Centre
   National de la Recherche Scientifique (CNRS); Universite Cote d'Azur
RP Salviati, L (corresponding author), Univ Padua, Pediat Clin Genet Unit, Dept Pediat, Hematol Oncol Lab, Via Giustiniani 3, I-35128 Padua, Italy.
EM leonardo.salviati@unipd.it
RI SACCONI, Sabrina/AFT-1096-2022; Salviati, Leonardo/L-1007-2016;
   Trevisson, Eva/K-8462-2016
OI Trevisson, Eva/0000-0002-5380-6265; SACCONI, Sabrina/0000-0002-0246-1455
FU Telethon Italy Grant [GGP06256]; Association Francaise Contre les
   Myopathies
FX This work has been supported by Telethon Italy Grant GGP06256 and by a
   grant from Association Francaise Contre les Myopathies. We are grateful
   to Dr Salvatore DiMauro, Columbia University, Department of Neurology,
   New York, for providing the patients samples for this study.
CR Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Bugiani M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029926
   Coenen MJH, 2006, J CHILD NEUROL, V21, P508, DOI 10.1177/08830738060210062501
   Gaisne M, 2006, FEMS YEAST RES, V6, P869, DOI 10.1111/j.1567-1364.2006.00083.x
   Kuhn A, 2003, TRENDS CELL BIOL, V13, P510, DOI 10.1016/j.tcb.2003.08.005
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Michel H, 1998, P NATL ACAD SCI USA, V95, P12819, DOI 10.1073/pnas.95.22.12819
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   Sacconi S, 2005, BIOCHEM BIOPH RES CO, V337, P832, DOI 10.1016/j.bbrc.2005.09.127
   Sacconi S, 2003, PEDIATR RES, V53, P224, DOI 10.1203/01.PDR.0000048100.91730.6A
   Salviati L, 2004, AM J MED GENET A, V128A, P195, DOI 10.1002/ajmg.a.30073
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Souza RL, 2000, J BIOL CHEM, V275, P14898, DOI 10.1074/jbc.275.20.14898
   Tay SKH, 2005, J CHILD NEUROL, V20, P670, DOI 10.1177/08830738050200080701
   TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990
   Vempati UD, 2007, MOL CELL BIOL, V27, P1771, DOI 10.1128/MCB.00287-06
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 20
TC 7
Z9 9
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1434-5161
EI 1435-232X
J9 J HUM GENET
JI J. Hum. Genet.
PD JUL
PY 2009
VL 54
IS 7
BP 419
EP 421
DI 10.1038/jhg.2009.36
PG 3
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 474WD
UT WOS:000268314100009
PM 19373256
OA Bronze
DA 2024-11-01
ER

PT J
AU Edvardson, S
   Shaag, A
   Kolesnikova, O
   Gomori, JM
   Tarassov, I
   Einbinder, T
   Saada, A
   Elpeleg, O
AF Edvardson, Simon
   Shaag, Avraham
   Kolesnikova, Olga
   Gomori, John Moshe
   Tarassov, Ivan
   Einbinder, Tom
   Saada, Ann
   Elpeleg, Orly
TI Deleterious mutation in the mitochondrial arginyl-transfer RNA
   synthetase gene is associated with pontocerebellar hypoplasia
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID TRANSLATION; DEFICIENCY; MYOPATHY; IMPORT; MTDNA; YEAST
AB Homozygosity mapping was performed in a consanguineous Sephardic Jewish family with three patients who presented with severe infantile encephalopathy associated with pontocerebellar hypoplasia and multiple mitochondrial respiratory-chain defects. This resulted in the identification of an intronic mutation in RARS2, the gene encoding mitochondrial arginine-transfer RNA (tRNA) synthetase. The mutation was associated with the production of an abnormally short RARS2 transcript and a marked reduction of the mitochondrial tRNA(Arg) transcript in the patients' fibroblasts. We speculate that missplicing mutations in mitochondrial aminoacy1-tRNA synthethase genes preferentially affect the brain because of a tissue-specific vulnerability of the splicing machinery.
C1 Hebrew Univ Jerusalem, Hadassah Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel.
   Hebrew Univ Jerusalem, Hadassah Med Ctr, Pediat Neurol Unit, IL-91120 Jerusalem, Israel.
   Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Radiol, IL-91120 Jerusalem, Israel.
   Univ Strasbourg 1, CNRS, UMR 7156, Dept Genet Mol & Cellulaire, Strasbourg, France.
C3 Hebrew University of Jerusalem; Hadassah University Medical Center;
   Hebrew University of Jerusalem; Hadassah University Medical Center;
   Hebrew University of Jerusalem; Hadassah University Medical Center;
   Universites de Strasbourg Etablissements Associes; Universite de
   Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS -
   National Institute for Biology (INSB)
RP Elpeleg, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel.
EM Elpeleg@hadassah.org.il
RI Kolesnikova, Olga/ABD-2423-2021; Saada, Ann/J-6864-2017
OI Saada, Ann/0000-0003-2951-0656; Edvardson, Simon/0000-0003-2878-1278;
   Tarassov, Ivan/0000-0001-8763-6703
CR Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   de Koning TJ, 1999, NEUROPEDIATRICS, V30, P93, DOI 10.1055/s-2007-973467
   Entelis N, 2002, GENET ENG P, V24, P191
   Entelis NS, 2001, ADV DRUG DELIVER REV, V49, P199, DOI 10.1016/S0169-409X(01)00135-1
   Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Patel MS, 2006, AM J MED GENET A, V140A, P594, DOI 10.1002/ajmg.a.31095
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Schneider A, 2000, TRENDS CELL BIOL, V10, P509, DOI 10.1016/S0962-8924(00)01854-7
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   TZAGOLOFF A, 1995, EUR J BIOCHEM, V230, P582
   Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   VARSHNEY U, 1991, J BIOL CHEM, V266, P24712
   Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875
NR 20
TC 273
Z9 299
U1 0
U2 9
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
SN 0002-9297
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD OCT
PY 2007
VL 81
IS 4
BP 857
EP 862
DI 10.1086/521227
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 208GK
UT WOS:000249307600028
PM 17847012
OA Green Published, Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU O'Hara, R
   Tedone, E
   Ludlow, A
   Huang, E
   Arosio, B
   Mari, D
   Shay, JW
AF O'Hara, Ryan
   Tedone, Enzo
   Ludlow, Andrew
   Huang, Ejun
   Arosio, Beatrice
   Mari, Daniela
   Shay, Jerry W.
TI Quantitative mitochondrial DNA copy number determination using droplet
   digital PCR with single-cell resolution
SO GENOME RESEARCH
LA English
DT Article
ID LEUKOCYTE TELOMERE LENGTH; REAL-TIME PCR; GENE-EXPRESSION;
   QUANTIFICATION; BIOGENESIS; DELETION; ASSOCIATION; ACTIVATION;
   DEPLETION; MUSCLE
AB Mitochondria are involved in a number of diverse cellular functions, including energy production, metabolic regulation, apoptosis, calcium homeostasis, cell proliferation, and motility, as well as free radical generation. Mitochondrial DNA (mtDNA) is present at hundreds to thousands of copies per cell in a tissue-specific manner. mtDNA copy number also varies during aging and disease progression and therefore might be considered as a biomarker that mirrors alterations within the human body. Here, we present a new quantitative, highly sensitive droplet digital PCR (ddPCR) method, droplet digital mitochondrial DNA measurement (ddMDM), to measure mtDNA copy number not only from cell populations but also from single cells. Our developed assay can generate data in as little as 3 h, is optimized for 96-well plates, and also allows the direct use of cell lysates without the need for DNA purification or nuclear reference genes. We show that ddMDM is able to detect differences between samples whose mtDNA copy number was close enough as to be indistinguishable by other commonly used mtDNA quantitation methods. By utilizing ddMDM, we show quantitative changes in mtDNA content per cell across a wide variety of physiological contexts including cancer progression, cell cycle progression, human T cell activation, and human aging.
C1 [O'Hara, Ryan; Tedone, Enzo; Ludlow, Andrew; Huang, Ejun; Shay, Jerry W.] UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.
   [Arosio, Beatrice; Mari, Daniela] Univ Milan, Dept Med Sci & Community Hlth, Geriatr Unit, I-20122 Milan, Italy.
   [Arosio, Beatrice; Mari, Daniela] IRCCS Osped Maggiore Policlin, Fdn Ca Granda, I-20122 Milan, Italy.
C3 University of Texas System; University of Texas Southwestern Medical
   Center Dallas; University of Milan; IRCCS Ca Granda Ospedale Maggiore
   Policlinico
RP Shay, JW (corresponding author), UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.
EM Jerry.Shay@UTSouthwestern.edu
OI O'Hara, Ryan/0000-0002-0188-0316; Ludlow, Andrew/0000-0003-0423-4800
FU National Institutes of Health [AG01228, C06RR30414]; Harold Simmons
   National Cancer Institute Designated Comprehensive Cancer Center Support
   Grant [CA142543]; Southland Financial Corporation Distinguished Chair in
   Geriatric Research
FX This work was supported by the National Institutes of Health (AG01228),
   the Harold Simmons National Cancer Institute Designated Comprehensive
   Cancer Center Support Grant (CA142543), and the Southland Financial
   Corporation Distinguished Chair in Geriatric Research (J.W.S.). This
   work was performed in laboratories constructed with support from the
   National Institutes of Health (grant C06RR30414).
CR Afrifa J, 2019, MITOCHONDRION, V47, P238, DOI 10.1016/j.mito.2018.12.003
   Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0
   Chen J, 2007, NUCLEIC ACIDS RES, V35, P1377, DOI 10.1093/nar/gkm010
   Chen N, 2016, SCI REP-UK, V6, DOI 10.1038/srep37404
   Chen T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-8
   Cohen T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006407
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   D'Souza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001
   Dimeloe S, 2017, IMMUNOLOGY, V150, P35, DOI 10.1111/imm.12655
   Ding J, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005306, 10.1371/journal.pgen.1005549]
   Eskiocak U, 2011, CANCER RES, V71, P4359, DOI 10.1158/0008-5472.CAN-11-0794
   Gammage PA, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0668-y
   Guantes R, 2015, GENOME RES, V25, P633, DOI 10.1101/gr.178426.114
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Hu LW, 2016, SCI REP-UK, V6, DOI 10.1038/srep35859
   Huang E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05174-7
   Hurtado-Roca Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163770
   Ibrahim-Hashim A, 2017, CANCER RES, V77, P2242, DOI 10.1158/0008-5472.CAN-16-2844
   Januszyk Michael, 2015, Microarrays (Basel), V4, P540, DOI 10.3390/microarrays4040540
   KABELITZ D, 1993, IMMUNOL TODAY, V14, P338, DOI 10.1016/0167-5699(93)90231-9
   Kawada K, 2017, INT J CLIN ONCOL, V22, P651, DOI 10.1007/s10147-017-1156-4
   Kim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067227
   Kiselinova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085999
   Klingbeil MM, 2009, MOL CELL, V35, P398, DOI 10.1016/j.molcel.2009.08.007
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Lakshmanan LN, 2018, AGING CELL, V17, DOI 10.1111/acel.12814
   Lee W, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.34
   Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005
   Ludlow AT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku439
   Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067
   Malik Afshan N, 2009, Diabetes Res Clin Pract, V86, pe22, DOI 10.1016/j.diabres.2009.07.002
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Mendenhall A, 2016, AGING CELL, V15, P4, DOI 10.1111/acel.12424
   Menendez JA, 2015, CELL CYCLE, V14, P3801, DOI 10.1080/15384101.2015.1022697
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Monickaraj F, 2012, MOL CELL BIOCHEM, V365, P343, DOI 10.1007/s11010-012-1276-0
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Morandi A, 2017, BBA-REV CANCER, V1868, P1, DOI 10.1016/j.bbcan.2016.12.004
   PIERCE DJ, 1990, BIOTECHNIQUES, V9, P724
   Pieters N, 2015, MECH AGEING DEV, V145, P51, DOI 10.1016/j.mad.2015.02.003
   Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x
   Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955
   Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033
   Qian Y, 2017, BIOINFORMATICS, V33, P1399, DOI 10.1093/bioinformatics/btw835
   Qiu CF, 2015, CLIN LAB, V61, P363, DOI 10.7754/Clin.Lab.2014.140313
   Ramirez RD, 2003, ONCOGENE, V22, P433, DOI 10.1038/sj.onc.1206046
   Regier N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-57
   Rice AC, 2014, J ALZHEIMERS DIS, V40, P319, DOI 10.3233/JAD-131715
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Robin JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep24067
   Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743
   SHAY JW, 1990, J BIOL CHEM, V265, P14802
   Tedone E, 2019, AGING CELL, V18, DOI 10.1111/acel.12859
   Tedone E, 2015, J ALZHEIMERS DIS, V46, P761, DOI 10.3233/JAD-142808
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyrka AR, 2015, EXP GERONTOL, V66, P17, DOI 10.1016/j.exger.2015.04.002
   Van Peer G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00222
   VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122
   Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939
   Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014
   Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103
   Yue P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206003
   Zhang L, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S1-S8
   Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644
   Zhao Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159004
NR 69
TC 74
Z9 80
U1 6
U2 27
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1088-9051
EI 1549-5469
J9 GENOME RES
JI Genome Res.
PD NOV
PY 2019
VL 29
IS 11
BP 1878
EP 1888
DI 10.1101/gr.250480.119
PG 11
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA JJ1WN
UT WOS:000493952800011
PM 31548359
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Durrleman, C
   Grevent, D
   Aubart, M
   Kossorotoff, M
   Roux, CJ
   Kaminska, A
   Rio, M
   Barcia, G
   Boddaert, N
   Munnich, A
   Nabbout, R
   Desguerre, I
AF Durrleman, Chloe
   Grevent, David
   Aubart, Melodie
   Kossorotoff, Manoelle
   Roux, Charles-Joris
   Kaminska, Anna
   Rio, Marlene
   Barcia, Giulia
   Boddaert, Nathalie
   Munnich, Arnold
   Nabbout, Rima
   Desguerre, Isabelle
TI Clinical and radiological description of 120 pediatric stroke-like
   episodes
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article
DE children; energy deficit; mitochondrial disorder; neuronal
   hyperexcitability; stroke-like episodes
ID REVERSIBLE ENCEPHALOPATHY SYNDROME; FAMILIAL HEMIPLEGIC MIGRAINE;
   LACTIC-ACIDOSIS; MITOCHONDRIAL MYOPATHY; CONGENITAL DISORDER; STATUS
   EPILEPTICUS; BLOOD-VESSELS; MELAS; DIFFUSION; EPILEPSY
AB Background and purpose Stroke-like episodes (SLEs) are defined as acute onset of neurological symptoms mimicking a stroke and radiological lesions non-congruent to vascular territory. We aimed to analyze the acute clinical and radiological features of SLEs to determine their pathophysiology.Methods We performed a monocenter retrospective analysis of 120 SLEs in 60 children over a 20-year period. Inclusion criteria were compatible clinical symptoms and stroke-like lesions on brain magnetic resonance imaging (MRI; performed for all 120 events) with focal hyperintensity on diffusion-weighted imaging in a non-vascular territory.Results Three groups were identified: children with mitochondrial diseases (n = 22) involving mitochondrial DNA mutations (55%) or nuclear DNA mutations (45%); those with other metabolic diseases or epilepsy disorders (n = 22); and those in whom no etiology was found despite extensive investigations (n = 16). Age at first SLE was younger in the group with metabolic or epilepsy disorders (18 months vs. 128 months; p < 0.0001) and an infectious trigger was more frequent (69% vs. 20%; p = 0.0001). Seizures occurred in 75% of episodes, revealing 50% episodes of SLEs and mainly leading to status epilepticus (90%). Of the 120 MRI scans confirming the diagnosis, 28 were performed within a short and strict 48-h period and were further analyzed to better understand the underlying mechanisms. The scans showed primary cortical hyperintensity (n = 28/28) with decreased apparent diffusion coefficient in 52% of cases. Systematic hyperperfusion was found on spin labeling sequences when available (n = 18/18).Conclusion Clinical and radiological results support the existence of a vicious circle based on two main mechanisms: energy deficit and neuronal hyperexcitability at the origin of SLE.
C1 [Durrleman, Chloe; Aubart, Melodie; Kossorotoff, Manoelle; Nabbout, Rima; Desguerre, Isabelle] Univ Paris Cite, APHP, Necker Enfants Malad Hosp, Pediat Neurol Dept, Paris, France.
   [Grevent, David; Roux, Charles-Joris; Boddaert, Nathalie] Univ Paris Cite, APHP, Necker Enfants Malad Hosp, Pediat Imaging Dept, Paris, France.
   [Grevent, David; Boddaert, Nathalie] Univ Paris Cite, Lumiere Platform, Paris, France.
   [Kaminska, Anna] Univ Paris Cite, APHP, Necker Enfants Malad Hosp, Neurophysiol Dept, Paris, France.
   [Rio, Marlene; Barcia, Giulia; Munnich, Arnold] Univ Paris Cite, APHP, Necker Enfants Malad Hosp, Genet Dept, Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Necker-Enfants Malades - APHP; Hopital
   Universitaire Hotel-Dieu - APHP; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP;
   Hopital Universitaire Necker-Enfants Malades - APHP; Universite Paris
   Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire
   Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants
   Malades - APHP; Hopital Universitaire Hotel-Dieu - APHP
RP Durrleman, C (corresponding author), Univ Paris Cite, APHP, Necker Enfants Malad Hosp, Pediat Neurol Dept, Paris, France.
EM chloe.durrleman@aphp.fr
RI Barcia, Giulia/H-7907-2017; boddaert, nathalie/GWV-2865-2022; Aubart,
   Mélodie/AHA-5006-2022
OI Durrleman, Chloe/0000-0002-1988-5967
CR Al-Hassnan ZN, 2008, J NEUROL SCI, V264, P187, DOI 10.1016/j.jns.2007.08.003
   Auvin S, 2012, EUR J PAEDIATR NEURO, V16, P413, DOI 10.1016/j.ejpn.2012.01.007
   Barcia G, 2013, DEV MED CHILD NEUROL, V55, P1150, DOI 10.1111/dmcn.12233
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Corda D, 2006, EPILEPSY BEHAV, V8, P655, DOI 10.1016/j.yebeh.2005.12.011
   Demarest ST, 2014, J CHILD NEUROL, V29, P1249, DOI 10.1177/0883073814538511
   Dinopoulos A, 2007, PEDIATRICS, V119, pE768, DOI 10.1542/peds.2006-0763
   Forkert ND, 2016, AM J NEURORADIOL, V37, P1738, DOI 10.3174/ajnr.A4772
   Fugate JE, 2015, LANCET NEUROL, V14, P914, DOI [10.1016/S1474-4422(15)00111-8, 10.1016/S1474-4422(15)00195-7]
   Funakawa I, 1997, ELECTROEN CLIN NEURO, V103, P370, DOI 10.1016/S0013-4694(97)00020-9
   Garcelon N, 2018, J BIOMED INFORM, V80, P52, DOI 10.1016/j.jbi.2018.02.019
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Gropman AL, 2007, J INHERIT METAB DIS, V30, P865, DOI 10.1007/s10545-007-0709-5
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Howarth C, 2012, J CEREBR BLOOD F MET, V32, P1222, DOI 10.1038/jcbfm.2012.35
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Iizuka T, 2015, J NEUROL NEUROSUR PS, V86, P344, DOI 10.1136/jnnp-2014-307731
   Ito H, 2008, BRAIN DEV-JPN, V30, P483, DOI 10.1016/j.braindev.2008.01.003
   Jurkat-Rott K, 2004, NEUROLOGY, V62, P1857, DOI 10.1212/01.WNL.0000127310.11526.FD
   Kastrup O, 2015, CLIN NEURORADIOL, V25, P161, DOI 10.1007/s00062-014-0293-7
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kim JH, 2011, KOREAN J RADIOL, V12, P15, DOI 10.3348/kjr.2011.12.1.15
   Koepp MJ, 2010, EPILEPSY BEHAV, V19, P127, DOI 10.1016/j.yebeh.2010.06.036
   Kunz WS, 2000, ANN NEUROL, V48, P766, DOI 10.1002/1531-8249(200011)48:5<766::AID-ANA10>3.0.CO;2-M
   Lax NZ, 2017, NEUROPATH APPL NEURO, V43, P102, DOI 10.1111/nan.12333
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   Li R, 2017, J MAGN RESON IMAGING, V45, P199, DOI 10.1002/jmri.25354
   Li YX, 2019, CLIN NEURORADIOL, V29, P321, DOI 10.1007/s00062-018-0662-8
   Liman TG, 2012, J NEUROL, V259, P155, DOI 10.1007/s00415-011-6152-4
   Ng YS, 2022, BRAIN, V145, P542, DOI 10.1093/brain/awab353
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Ohshita T, 2000, NEURORADIOLOGY, V42, P651, DOI 10.1007/s002340000335
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Prasun P, 2015, J CHILD NEUROL, V30, P782, DOI 10.1177/0883073814535490
   Rahman S, 2015, EPILEPSY BEHAV, V49, P71, DOI 10.1016/j.yebeh.2015.05.003
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   Ribacoba R, 2006, NEUROLOGIA, V21, P1
   Russell MB, 2011, LANCET NEUROL, V10, P457, DOI 10.1016/S1474-4422(11)70048-5
   Thomsen LL, 2003, NEUROLOGY, V60, P595, DOI 10.1212/01.WNL.0000046524.25369.7D
   Todd RB, 2005, EPILEPSIA, V46, P995
   Tschampa HJ, 2013, J NEUROL, V260, P1071, DOI 10.1007/s00415-012-6763-4
   Tzoulis C, 2017, MITOCHONDRION, V32, P10, DOI 10.1016/j.mito.2016.11.004
   Tzoulis C, 2012, BRAIN, V135, P3627, DOI 10.1093/brain/aws223
   van Baalen A, 2009, BRAIN DEV-JPN, V31, P183, DOI 10.1016/j.braindev.2008.08.014
   Whitehead MT, 2017, NEURORADIOLOGY, V59, P813, DOI 10.1007/s00234-017-1866-3
   Xu WXZ, 2018, J COMPUT ASSIST TOMO, V42, P510, DOI 10.1097/RCT.0000000000000712
   Yoneda M, 1999, NEUROLOGY, V53, P2182, DOI 10.1212/WNL.53.9.2182
NR 49
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD JUL
PY 2023
VL 30
IS 7
BP 2051
EP 2061
DI 10.1111/ene.15821
EA MAY 2023
PG 11
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA I1CO0
UT WOS:000985802900001
PM 37046408
OA hybrid
DA 2024-11-01
ER

PT J
AU Alonso, M
   Zabala, C
   Mansilla, S
   De Brun, L
   Martínez, J
   Garau, M
   Rivas, G
   Acosta, C
   Lens, D
   Cerisola, A
   Graña, M
   Naya, H
   Puentes, R
   Spangenberg, L
   Raggio, V
   Lemes, A
   Castro, L
   Quijano, C
AF Alonso, Martina
   Zabala, Cristina
   Mansilla, Santiago
   De Brun, Laureana
   Martinez, Jennyfer
   Garau, Mariela
   Rivas, Gabriela
   Acosta, Cecilia
   Lens, Daniela
   Cerisola, Alfredo
   Grana, Martin
   Naya, Hugo
   Puentes, Rodrigo
   Spangenberg, Lucia
   Raggio, Victor
   Lemes, Aida
   Castro, Laura
   Quijano, Celia
TI Blood cell respiration rates and mtDNA copy number: A promising tool for
   the diagnosis of mitochondrial disease
SO MITOCHONDRION
LA English
DT Article
DE Bioenergetics; Mitochondrial disease; Aging; PBMC; Platelets; mtDNA
ID SKELETAL-MUSCLE; OXIDATIVE-PHOSPHORYLATION; DNA CONTENT; MUTATION; AGE;
   PLATELETS; DYSFUNCTION; CAPACITY; DECLINE; QUANTIFICATION
AB Human mitochondrial diseases are a group of heterogeneous diseases caused by defects in oxidative phosphorylation, due to mutations in mitochondrial (mtDNA) or nuclear DNA. The diagnosis of mitochondrial disease is challenging since mutations in multiple genes can affect mitochondrial function, there is considerable clinical variability and a poor correlation between genotype and phenotype. Herein we assessed mitochondrial function in peripheral blood mononuclear cells (PBMCs) and platelets from volunteers without known metabolic pathology and patients with mitochondrial disease. Oxygen consumption rates were evaluated and respiratory parameters indicative of mitochondrial function were obtained. A negative correlation between age and respiratory parameters of PBMCs from control individuals was observed. Surprisingly, respiratory parameters of PBMCs normalized by cell number were similar in patients and young controls. Considering possible compensatory mechanisms, mtDNA copy number in PBMCs was quantified and an increase was found in patients with respect to controls. Hence, respiratory parameters normalized by mtDNA copy number were determined, and in these conditions a decrease in maximum respiration rate and spare respiratory capacity was observed in patients relative to control individuals. In platelets no decay was seen in mitochondrial function with age, while a reduction in basal, ATP independent and ATP-dependent respiration normalized by cell number was detected in patients compared to control subjects.
C1 [Alonso, Martina; Martinez, Jennyfer; Castro, Laura; Quijano, Celia] Univ Republica, Dept Bioquim, Fac Med, Ave Gen Flores 2125, Montevideo 11800, Uruguay.
   [Alonso, Martina; Mansilla, Santiago; Martinez, Jennyfer; Castro, Laura; Quijano, Celia] Univ Republica, Ctr Invest Biomed CEINBIO, Montevideo, Uruguay.
   [Zabala, Cristina] Univ Republica, Clin Pediat A, Ctr Hosp Pereira Rossell, Fac Med, Montevideo, Uruguay.
   [Zabala, Cristina; Cerisola, Alfredo; Lemes, Aida] Banco Previs Social BPS, Ctr Referencia Nacl Defectos Congenitos & Enferme, Montevideo, Uruguay.
   [Mansilla, Santiago; Garau, Mariela] Univ Republica, Dept Metodos Cuantitat, Fac Med, Montevideo, Uruguay.
   [De Brun, Laureana; Puentes, Rodrigo] Univ Republica, Dept Patobiol, Unidad Microbiol, Fac Vet, Montevideo, Uruguay.
   [Rivas, Gabriela; Acosta, Cecilia] Univ Republica, Catedra & Dept Hemoterapia & Med Transfus, Hosp Clin, Fac Med, Montevideo, Uruguay.
   [Lens, Daniela] Univ Republica, Dept B asico Med, Hosp Clin, Fac Med, Montevideo, Uruguay.
   [Cerisola, Alfredo] Univ Republica, Catedra Neuropediat, Fac Med, Montevideo, Uruguay.
   [Grana, Martin; Naya, Hugo; Spangenberg, Lucia] Inst Pasteur Montevideo, Unidad Bioinformat, Montevideo, Uruguay.
   [Naya, Hugo] Univ Republica, Dept Prod Anim & Pasturas, Fac Agron, Montevideo, Uruguay.
   [Raggio, Victor] Univ Republica, Dept Genet, Fac Med, Montevideo, Uruguay.
C3 Universidad de la Republica, Uruguay; Universidad de la Republica,
   Uruguay; Universidad de la Republica, Uruguay; Universidad de la
   Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de
   la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad
   de la Republica, Uruguay; Pasteur Network; Institut Pasteur de
   Montevideo; Universidad de la Republica, Uruguay; Universidad de la
   Republica, Uruguay
RP Castro, L; Quijano, C (corresponding author), Univ Republica, Dept Bioquim, Fac Med, Ave Gen Flores 2125, Montevideo 11800, Uruguay.; Castro, L; Quijano, C (corresponding author), Univ Republica, Ctr Invest Biomed CEINBIO, Fac Med, Ave Gen Flores 2125, Montevideo 11800, Uruguay.
EM lcastro@fmed.edu.uy; celiq@fmed.edu.uy
RI Grana, Martin/R-7245-2019
OI Martinez, Jennyfer/0000-0001-8116-5920; Zabala,
   Cristina/0000-0003-3413-7083; Spangenberg, Lucia/0000-0001-5124-9250;
   Garau, Mariela/0000-0002-9632-7539; Grana, Martin/0000-0003-1182-8236
CR Ajaz S, 2021, AM J PHYSIOL-CELL PH, V320, pC57, DOI 10.1152/ajpcell.00426.2020
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Banas B, 2004, EUR J MED RES, V9, P371
   Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049
   Bianco Angelica, 2018, BMC Res Notes, V11, P911, DOI 10.1186/s13104-018-4025-y
   Blanco-Grau A, 2013, GENES BRAIN BEHAV, V12, P812, DOI 10.1111/gbb.12089
   Braganza A, 2020, MOL ASPECTS MED, V71, DOI 10.1016/j.mam.2019.100835
   Braganza A, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128248
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006
   Cardenes N, 2014, BLOOD, V123, P2864, DOI 10.1182/blood-2013-09-529420
   Chabi B, 2005, MED SCI SPORT EXER, V37, P2102, DOI 10.1249/01.mss.0000177426.68149.83
   Chacko BK, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101165
   Chacko BK, 2013, LAB INVEST, V93, P690, DOI 10.1038/labinvest.2013.53
   Czajka A, 2015, EBIOMEDICINE, V2, P499, DOI 10.1016/j.ebiom.2015.04.002
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Davizon-Castillo P, 2019, BLOOD, V134, P727, DOI 10.1182/blood.2019000200
   Breda CND, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101255
   Dogan SA, 2018, CELL METAB, V28, P764, DOI 10.1016/j.cmet.2018.07.012
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Garrabou G, 2012, J INFECT DIS, V205, P392, DOI 10.1093/infdis/jir764
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Gómez LA, 2012, SEMIN CELL DEV BIOL, V23, P758, DOI 10.1016/j.semcdb.2012.04.002
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Gutmann C, 2020, ATHEROSCLEROSIS, V307, P87, DOI 10.1016/j.atherosclerosis.2020.05.022
   Hakim FT, 2007, TISSUE ANTIGENS, V70, P179, DOI 10.1111/j.1399-0039.2007.00891.x
   Howell N, 2000, J NEUROL SCI, V172, P1, DOI 10.1016/S0022-510X(99)00207-5
   Jang JY, 2018, J CLIN INVEST, V128, P3662, DOI 10.1172/JCI120842
   Japiassú AM, 2011, CRIT CARE MED, V39, P1056, DOI 10.1097/CCM.0b013e31820eda5c
   Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x
   Kapniciz SM, 2018, METABOLISM, V81, P97, DOI 10.1016/j.metabol.2017.11.010
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kleiveland C. R., 2015, IMPACT FOOD BIOACTIV, P161
   LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Lee SH, 2016, EMBO MOL MED, V8, P779, DOI 10.15252/emmm.201506046
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lesnefsky EJ, 2006, AGEING RES REV, V5, P402, DOI 10.1016/j.arr.2006.04.001
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Lluberas N, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1532-3
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   Melchinger H, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00153
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Montero R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148709
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Napoli E, 2014, PEDIATRICS, V133, pE1405, DOI 10.1542/peds.2013-1545
   Naresh NU, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033944
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   O'Hara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119
   O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005
   Pence BD, 2018, EXP GERONTOL, V108, P112, DOI 10.1016/j.exger.2018.04.008
   Phillips NR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03887
   Picard M, 2021, MITOCHONDRION, V60, P1, DOI 10.1016/j.mito.2021.06.010
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Rausser S., 2020, BIORXIV2020101634292, V2020
   Reynolds LM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1522-4
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sack MN, 2018, J CLIN INVEST, V128, P3651, DOI 10.1172/JCI120845
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Shim HB, 2020, MITOCHONDRION, V52, P108, DOI 10.1016/j.mito.2020.03.001
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   SHUSTER RC, 1988, BIOCHEM BIOPH RES CO, V155, P1360, DOI 10.1016/S0006-291X(88)81291-9
   Sjövall F, 2013, MITOCHONDRION, V13, P7, DOI 10.1016/j.mito.2012.11.001
   Sjövall F, 2010, CRIT CARE, V14, DOI 10.1186/cc9337
   Spangenberg L, 2019, MITOCHONDRION, V46, P337, DOI 10.1016/j.mito.2018.09.004
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Thavorntanaburt S, 2018, J PEDIATR SURG, V53, P489, DOI 10.1016/j.jpedsurg.2017.06.006
   Tonkonogi M, 2003, PFLUG ARCH EUR J PHY, V446, P261, DOI 10.1007/s00424-003-1044-9
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Urata M, 2008, ANN CLIN BIOCHEM, V45, P513, DOI 10.1258/acb.2008.008008
   van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731
   Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939
   Walker MA, 2020, NEW ENGL J MED, V383, P1556, DOI 10.1056/NEJMoa2001265
   Wen SZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36313
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yen MY, 2002, BRIT J OPHTHALMOL, V86, P1027, DOI 10.1136/bjo.86.9.1027
   Zhang RY, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4287-0
   Zheng YF, 2020, PROTEIN CELL, V11, P740, DOI 10.1007/s13238-020-00762-2
NR 95
TC 6
Z9 6
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV
PY 2021
VL 61
BP 31
EP 43
DI 10.1016/j.mito.2021.09.004
EA SEP 2021
PG 13
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA WC9QP
UT WOS:000704585100004
PM 34536563
DA 2024-11-01
ER

PT J
AU Kazachkova, N
   Ramos, A
   Santos, C
   Lima, M
AF Kazachkova, Nadiya
   Ramos, Amanda
   Santos, Cristina
   Lima, Manuela
TI Mitochondrial DNA Damage Patterns and Aging: Revising the Evidences for
   Humans and Mice
SO AGING AND DISEASE
LA English
DT Review
DE aging; mtDNA; damage patterns; deletion; copy number; point mutation
ID MTDNA POINT MUTATIONS; HUMAN SKELETAL-MUSCLE; 4977 BP DELETION;
   SUBSTANTIA-NIGRA; COPY NUMBER; MOUSE-TISSUES; HUMAN BRAIN; HUMAN HEART;
   AGE; ACCUMULATION
AB A significant body of work, accumulated over the years, strongly suggests that damage in mitochondrial DNA (mtDNA) contributes to aging in humans. Contradictory results, however, are reported in the literature, with some studies failing to provide support to this hypothesis. With the purpose of further understanding the aging process, several models, among which mouse models, have been frequently used. Although important affinities are recognized between humans and mice, differences on what concerns physiological properties, disease pathogenesis as well as life-history exist between the two; the extent to which such differences limit the translation, from mice to humans, of insights on the association between mtDNA damage and aging remains to be established. In this paper we revise the studies that analyze the association between patterns of mtDNA damage and aging, investigating putative alterations in mtDNA copy number as well as accumulation of deletions and of point mutations. Reports from the literature do not allow the establishment of a clear association between mtDNA copy number and age, either in humans or in mice. Further analysis, using a wide spectrum of tissues and a high number of individuals would be necessary to elucidate this pattern. Likewise humans, mice demonstrated a clear pattern of age-dependent and tissue-specific accumulation of mtDNA deletions. Deletions increase with age, and the highest amount of deletions has been observed in brain tissues both in humans and mice. On the other hand, mtDNA point mutations accumulation has been clearly associated with age in humans, but not in mice. Although further studies, using the same methodologies and targeting a larger number of samples would be mandatory to draw definitive conclusions, the revision of the available data raises concerns on the ability of mouse models to mimic the mtDNA damage patterns of humans, a fact with implications not only for the study of the aging process, but also for investigations of other processes in which mtDNA dysfunction is a hallmark, such as neurodegeneration.
C1 [Kazachkova, Nadiya; Ramos, Amanda; Lima, Manuela] Univ Azores, Dept Biol, CIRN, P-9501801 Ponta Delgada, Azores, Portugal.
   [Kazachkova, Nadiya; Ramos, Amanda; Lima, Manuela] Univ Porto, IBMC, P-4100 Oporto, Portugal.
   [Santos, Cristina] Univ Autonoma Barcelona, Unitat Antropol Biol, E-08193 Barcelona, Spain.
C3 Universidade dos Acores; Universidade do Porto; Autonomous University of
   Barcelona
RP Kazachkova, N (corresponding author), Univ Azores, Dept Biol, CIRN, Rua Mae Deus,Apartado 1422, P-9501801 Ponta Delgada, Azores, Portugal.
EM nadya@uac.pt
RI Santos, Cristina/AAE-7665-2020; Kazachkova, Nadiya/W-9516-2018; Ramos,
   Amanda/K-3739-2014; Santos, Cristina/K-2348-2014
OI Lima, Manuela/0000-0002-3357-3273; Kazachkova,
   Nadiya/0000-0002-0687-648X; Ramos, Amanda/0000-0002-9806-6651; Santos,
   Cristina/0000-0002-7014-8014
CR Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Barrientos A, 1997, BIOCHEM MOL MED, V62, P165, DOI 10.1006/bmme.1997.2647
   Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Gomez-Cabrera MC, 2012, CLIN CHEM LAB MED, V50, P1287, DOI 10.1515/cclm-2011-0795
   Chen T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-8
   CHUNG SS, 1994, AGING-CLIN EXP RES, V6, P193, DOI 10.1007/BF03324239
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Dai JG, 2005, J EXP BIOL, V208, P4445, DOI 10.1242/jeb.01920
   Del Bo R, 2002, J NEUROL SCI, V202, P85, DOI 10.1016/S0022-510X(02)00247-2
   Demetrius L, 2006, ANN NY ACAD SCI, V1067, P66, DOI 10.1196/annals.1354.010
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   FERRIS SD, 1983, GENETICS, V105, P681
   FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Gerhard GS, 2002, MECH AGEING DEV, V123, P155, DOI 10.1016/S0047-6374(01)00328-1
   Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002
   Goios A, 2007, GENOME RES, V17, P293, DOI 10.1101/gr.5941007
   Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403
   Guo XH, 2010, BBA-BIOENERGETICS, V1797, P1159, DOI 10.1016/j.bbabio.2010.04.005
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   Kazachkova N, 2013, NEURODEGENER DIS, V11, P206, DOI 10.1159/000339207
   Kennedy SR, 2012, MECH AGEING DEV, V133, P118, DOI 10.1016/j.mad.2011.10.009
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083
   KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0
   Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682
   Kopsidas G, 1998, MUTAT RES-FUND MOL M, V421, P27, DOI 10.1016/S0027-5107(98)00150-X
   Kovalenko SA, 1998, ANN NY ACAD SCI, V854, P171, DOI 10.1111/j.1749-6632.1998.tb09900.x
   Kovalenko SA, 1998, BIOCHEM MOL BIOL INT, V46, P1233
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   LINNANE AW, 1992, MUTAT RES, V275, P195, DOI 10.1016/0921-8734(92)90023-I
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   Medawar P. B., 1952, UNSOLVED PROBLEM BIO
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Mohamed SA, 2006, EXP GERONTOL, V41, P508, DOI 10.1016/j.exger.2006.03.014
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047
   Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425
   Pallotti F, 1996, AM J HUM GENET, V59, P591
   Pavicic WH, 2009, MUTAT RES-FUND MOL M, V670, P99, DOI 10.1016/j.mrfmmm.2009.07.009
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   Ross OA, 2002, EXP GERONTOL, V37, P329, DOI 10.1016/S0531-5565(01)00200-5
   Santos C, 2005, MOL BIOL EVOL, V22, P1490, DOI 10.1093/molbev/msi141
   Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Song XF, 2005, GENE, V350, P193, DOI 10.1016/j.gene.2005.02.008
   SUGIYAMA S, 1991, BIOCHEM BIOPH RES CO, V180, P894, DOI 10.1016/S0006-291X(05)81149-0
   Takai D, 1995, BIOCHEM BIOPH RES CO, V217, P668, DOI 10.1006/bbrc.1995.2826
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Thèves C, 2006, J FORENSIC SCI, V51, P865, DOI 10.1111/j.1556-4029.2006.00163.x
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262
   Welle S, 2003, J APPL PHYSIOL, V94, P1479, DOI 10.1152/japplphysiol.01061.2002
   WILLIAMS GC, 1957, EVOLUTION, V11, P32, DOI 10.2307/2405809
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   YEN TC, 1992, BIOCHEM INT, V26, P457
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Zeng ZH, 1999, J CELL BIOCHEM, V73, P545, DOI 10.1002/(SICI)1097-4644(19990615)73:4<545::AID-JCB12>3.0.CO;2-Q
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
   Zhang Y, 2007, BIOSENS BIOELECTRON, V23, P438, DOI 10.1016/j.bios.2007.06.010
   Zheng YJ, 2012, BOSNIAN J BASIC MED, V12, P187, DOI 10.17305/bjbms.2012.2480
NR 94
TC 46
Z9 59
U1 0
U2 17
PU INT SOC AGING & DISEASE
PI FORT WORTH
PA EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA
SN 2152-5250
J9 AGING DIS
JI Aging Dis.
PD DEC
PY 2013
VL 4
IS 6
BP 337
EP 350
DI 10.14336/AD.2013.0400337
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AI5KB
UT WOS:000336903900004
PM 24307967
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Uusimaa, J
   Finnilä, S
   Remes, AM
   Rantala, H
   Vainionpää, L
   Hassinen, IE
   Majamaa, K
AF Uusimaa, J
   Finnilä, S
   Remes, AM
   Rantala, H
   Vainionpää, L
   Hassinen, IE
   Majamaa, K
TI Molecular epidemiology of childhood mitochondrial encephalomyopathies in
   a Finnish population:: Sequence analysis of entire mtDNA of 17 children
   reveals heteroplasmic mutations in tRNA<SUP>Arg</SUP>,
   tRNA<SUP>Glu</SUP>, and tRNA<SUP>Leu(UUR)</SUP> genes
SO PEDIATRICS
LA English
DT Article
DE encephalomyopathy; mitochondrial DNA; tRNA mutation; conformation
   sensitive gel electrophoresis
ID SENSITIVE GEL-ELECTROPHORESIS; STROKE-LIKE EPISODES; TRANSFER-RNA; POINT
   MUTATION; PHYLOGENETIC NETWORK; DIABETES-MELLITUS; LACTIC-ACIDOSIS;
   CODING-REGION; PCR PRODUCTS; DNA
AB Objectives. Many heteroplasmic point mutations in tRNA genes of mitochondrial DNA ( mtDNA) have been associated with human diseases. We recently reported on a prospective 7-year study in which we enrolled 116 consecutive children with undefined encephalomyopathy. Seventeen of them were found to have both a defect in the mitochondrial respiratory chain and abnormal ultrastructure of muscle mitochondria, suggesting a clinically probable mitochondrial encephalopathy.
   Methods. We determined the frequency of mtDNA mutations in these 17 children by analyzing the entire sequence of mtDNA by conformation-sensitive gel electrophoresis and sequencing.
   Results. Three heteroplasmic tRNA mutations that were considered to be pathogenic were detected. Two of the mutations were novel transitions, 10438A>G in the tRNAArg gene and 14696A>G in the tRNAGlu gene, whereas the third one was 3243A>G, the common MELAS mutation. The mutant load was very high in the blood and skeletal muscle of the patients and markedly lower in the blood of asymptomatic maternal relatives. The 10438A>G mutation changes the nucleotide flanking the anticodon, whereas 14696A>G changes a nucleotide in the stem of the pseudouridine loop, creating a novel base pair and reducing the wobble.
   Conclusions. Our results emphasize that the analysis of the entire sequence of mtDNA is worthwhile in the diagnostic evaluation of patients with clinically probable mitochondrial encephalomyopathy. The frequency of pathogenic mtDNA mutations was found to be 18% among children with biochemically and histologically defined mitochondrial disease, suggesting that the likelihood of nuclear DNA mutations in such a group is several times higher than that of mtDNA mutations.
C1 Univ Oulu, Dept Neurol, FIN-90014 Oulu, Finland.
   Univ Oulu, Dept Pediat, FIN-90014 Oulu, Finland.
   Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland.
   Univ Oulu, Bioctr, FIN-90014 Oulu, Finland.
C3 University of Oulu; University of Oulu; University of Oulu; University
   of Oulu
RP Univ Oulu, Dept Neurol, POB 5000, FIN-90014 Oulu, Finland.
EM kari.majamaa@oulu.fi
RI Majamaa, Kari/A-1344-2012
OI Majamaa, Kari/0000-0002-9070-3791
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   BROWN MD, 1994, J BIOENERG BIOMEMBR, V26, P273, DOI 10.1007/BF00763099
   Brulé H, 1998, NUCLEIC ACIDS RES, V26, P537, DOI 10.1093/nar/26.2.537
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Finnilä S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591
   Finnilä S, 1999, MUTAT RES-GENOMICS, V406, P109, DOI 10.1016/S1383-5726(99)00007-2
   Finnilä S, 2000, AM J HUM GENET, V66, P1017, DOI 10.1086/302802
   GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325
   Gattermann N, 1996, BRIT J HAEMATOL, V93, P845, DOI 10.1046/j.1365-2141.1996.d01-1724.x
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Helm M, 1999, BIOCHEMISTRY-US, V38, P13338, DOI 10.1021/bi991061g
   Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Kogelnik AM, 1998, NUCLEIC ACIDS RES, V26, P112, DOI 10.1093/nar/26.1.112
   Körkkö J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   MCCLAIN WH, 1990, P NATL ACAD SCI USA, V87, P9260, DOI 10.1073/pnas.87.23.9260
   Meinilä M, 2001, HUM HERED, V52, P160, DOI 10.1159/000053372
   Merante F, 1996, HUM MUTAT, V8, P216, DOI 10.1002/(SICI)1098-1004(1996)8:3<216::AID-HUMU4>3.0.CO;2-7
   Servidei S, 2000, Neuromuscul Disord, V10, pX
   SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101
   Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148
   Torroni A, 1996, GENETICS, V144, P1835
   Uusimaa J, 2000, PEDIATRICS, V105, P598, DOI 10.1542/peds.105.3.598
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354
   YOON KL, 1991, BIOCHEM BIOPH RES CO, V176, P1112, DOI 10.1016/0006-291X(91)90399-R
NR 30
TC 45
Z9 48
U1 1
U2 5
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD AUG
PY 2004
VL 114
IS 2
BP 443
EP 450
DI 10.1542/peds.114.2.443
PG 8
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 842YG
UT WOS:000223040000016
PM 15286228
DA 2024-11-01
ER

PT J
AU Mendell, JR
   Sahenk, Z
   Al-Zaidy, S
   Rodino-Klapac, LR
   Lowes, LP
   Alfano, LN
   Berry, K
   Miller, N
   Yalvac, M
   Dvorchik, I
   Moore-Clingenpeel, M
   Flanigan, KM
   Church, K
   Shontz, K
   Curry, C
   Lewis, S
   McColly, M
   Hogan, MJ
   Kaspar, BK
AF Mendell, Jerry R.
   Sahenk, Zarife
   Al-Zaidy, Samiah
   Rodino-Klapac, Louise R.
   Lowes, Linda P.
   Alfano, Lindsay N.
   Berry, Katherine
   Miller, Natalie
   Yalvac, Mehmet
   Dvorchik, Igor
   Moore-Clingenpeel, Melissa
   Flanigan, Kevin M.
   Church, Kathleen
   Shontz, Kim
   Curry, Choumpree
   Lewis, Sarah
   McColly, Markus
   Hogan, Mark J.
   Kaspar, Brian K.
TI Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves
   Functional Outcomes
SO MOLECULAR THERAPY
LA English
DT Article
ID MITOCHONDRIAL-DNA DELETIONS; TGF-BETA SUPERFAMILY; MUSCULAR-DYSTROPHY;
   PILOT TRIAL; MUSCLE MASS; EXPRESSION; IMMUNOLOCALIZATION; POLYMYOSITIS;
   PROTEIN; MICE
AB Sporadic inclusion body myositis, a variant of inflammatory myopathy, has features distinct from polymyositis/dermato-myositis. The disease affects men more than women, most commonly after age 50. Clinical features include weakness of the quadriceps, finger flexors, ankle dorsiflexors, and dysphagia. The distribution of weakness is similar to Becker muscular dystrophy, where we previously reported improvement following intramuscular injection of an isoform of follistatin (FS344) by AAV1. For this clinical trial, rAAV1.CMV. huFS344, 6 x 10(11) vg/kg, was delivered to the quadriceps muscles of both legs of six sporadic inclusion body myositis subjects. The primary outcome for this trial was distance traveled for the 6-min walk test. The protocol included an exercise regimen for each participant. Performance, annualized to a median 1-year change, improved +56.0 m/year for treated subjects compared to a decline of -25.8 m/year (p = 0.01) in untreated subjects (n = 8), matched for age, gender, and baseline measures. Four of the six treated subjects showed increases ranging from 58-153 m, whereas two were minimally improved (5-23 m). Treatment effects included decreased fibrosis and improved regeneration. These findings show promise for follistatin gene therapy for mild to moderately affected, ambulatory sporadic inclusion body myositis patients. More advanced disease with discernible muscle loss poses challenges.
C1 [Mendell, Jerry R.; Sahenk, Zarife; Al-Zaidy, Samiah; Rodino-Klapac, Louise R.; Lowes, Linda P.; Alfano, Lindsay N.; Berry, Katherine; Miller, Natalie; Yalvac, Mehmet; Flanigan, Kevin M.; Church, Kathleen; Shontz, Kim; Curry, Choumpree; Lewis, Sarah; McColly, Markus; Kaspar, Brian K.] Nationwide Childrens Hosp, Ctr Gene Therapy, Columbus, OH 43205 USA.
   [Mendell, Jerry R.; Sahenk, Zarife; Al-Zaidy, Samiah; Rodino-Klapac, Louise R.; Flanigan, Kevin M.; Kaspar, Brian K.] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA.
   [Mendell, Jerry R.; Sahenk, Zarife; Lowes, Linda P.; Alfano, Lindsay N.; Berry, Katherine; Miller, Natalie; Flanigan, Kevin M.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA.
   [Lowes, Linda P.; Alfano, Lindsay N.; Berry, Katherine; Miller, Natalie] Nationwide Childrens Hosp, Clin Therapies, Columbus, OH 43205 USA.
   [Dvorchik, Igor; Moore-Clingenpeel, Melissa] Nationwide Childrens Hosp, Biostat Res Core, Columbus, OH 43205 USA.
   [Hogan, Mark J.] Nationwide Childrens Hosp, Dept Radiol, Vasc & Intervent Radiol, Columbus, OH 43205 USA.
C3 University System of Ohio; Ohio State University; Nationwide Childrens
   Hospital; Research Institute at Nationwide Children's Hospital;
   University System of Ohio; Ohio State University; University System of
   Ohio; Ohio State University; University System of Ohio; Ohio State
   University; Nationwide Childrens Hospital; University System of Ohio;
   Ohio State University; Nationwide Childrens Hospital; University System
   of Ohio; Ohio State University; Nationwide Childrens Hospital
RP Mendell, JR (corresponding author), Nationwide Childrens Hosp, Gene Therapy Ctr, 700 Childrens Dr, Columbus, OH 43205 USA.
EM jerry.mendell@nationwidechildrens.org
RI Lowes, Linda/C-9471-2009; Kaspar, Brian/E-6490-2010; Rodino-Klapac,
   Louise/E-3968-2011; Moore-Clingenpeel, Melissa/K-7232-2019
OI Reash, Natalie/0000-0002-0573-9504; Alfano, Lindsay/0000-0002-2263-7569;
   Flanigan, Kevin/0000-0001-6440-3376; Rodino-Klapac,
   Louise/0000-0002-8966-5177; Lowes, Linda/0000-0003-4206-0557
FU Parent Project Muscular Dystrophy
FX The Parent Project Muscular Dystrophy supported the clinical trial.
   Staff for this trial and some of the materials and supplies were
   provided by the Senator Paul D. Wellstone Muscular Dystrophy Research
   Center, NICHD, NIH (5U54HD066409-05). Jesse's Journey supported some of
   the participating staff. The Myositis Association helped bring this
   trial to the clinic by supporting the preclinical studies.
CR Amato AA, 1996, ANN NEUROL, V40, P581, DOI 10.1002/ana.410400407
   Amato AA, 2014, NEUROLOGY, V83, P2239, DOI 10.1212/WNL.0000000000001070
   Badrising UA, 2002, ANN NEUROL, V51, P369, DOI 10.1002/ana.10121
   Banwell BL, 2000, NEUROLOGY, V54, P1033, DOI 10.1212/WNL.54.5.1033
   Barohn RJ, 2006, NEUROLOGY, V66, pS123, DOI 10.1212/01.wnl.0000192258.32408.54
   Benveniste O, 2011, BRAIN, V134, P3176, DOI 10.1093/brain/awr213
   Chahin N, 2008, NEUROLOGY, V70, P418, DOI 10.1212/01.wnl.0000277527.69388.fe
   Cox FM, 2011, BRAIN, V134, P3167, DOI 10.1093/brain/awr217
   Dalakas MC, 2010, CURR OPIN PHARMACOL, V10, P346, DOI 10.1016/j.coph.2010.03.001
   Dalakas MC, 2009, BRAIN, V132, P1536, DOI 10.1093/brain/awp104
   Dalakas MC, 2004, CURR OPIN NEUROL, V17, P561, DOI 10.1097/00019052-200410000-00006
   Dalakas MC, 2001, NEUROLOGY, V56, P323, DOI 10.1212/WNL.56.3.323
   Dalakas MC, 1997, NEUROLOGY, V48, P712, DOI 10.1212/WNL.48.3.712
   Dimachkie MM, 2012, SEMIN NEUROL, V32, P237, DOI 10.1055/s-0032-1329197
   Dong YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058554
   EMSLIESMITH AM, 1989, HUM PATHOL, V20, P224, DOI 10.1016/0046-8177(89)90128-7
   Greenberg SA, 2007, MUSCLE NERVE, V35, P17, DOI 10.1002/mus.20649
   GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504
   Hansen J, 2011, ENDOCRINOLOGY, V152, P164, DOI 10.1210/en.2010-0868
   HAWLEY RJ, 1984, ARCH NEUROL-CHICAGO, V41, P383, DOI 10.1001/archneur.1984.04050160045014
   Hilton-Jones D, 2010, NEUROMUSCULAR DISORD, V20, P622, DOI [10.1016/j.nmd.2010.07.087, 10.1016/j.nmd.2009.11.003]
   Johnson Liam G, 2009, J Clin Neuromuscul Dis, V10, P178, DOI 10.1097/CND.0b013e3181a23c86
   Jorgensen AN, 2016, CLIN PHYSIOL FUNCT I, V36, P504, DOI 10.1111/cpf.12259
   KARPATI G, 1988, ANN NEUROL, V23, P64, DOI 10.1002/ana.410230111
   Kinali M, 2011, NEUROLOGY, V76, P346, DOI 10.1212/WNL.0b013e318208811f
   Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789
   Li ZB, 2008, J BIOL CHEM, V283, P19371, DOI 10.1074/jbc.M802585200
   Lin SY, 2003, REPRODUCTION, V126, P133, DOI 10.1530/rep.0.1260133
   Lindberg C, 2003, NEUROLOGY, V61, P260, DOI 10.1212/01.WNL.0000071852.27182.C7
   LOTZ BP, 1989, BRAIN, V112, P727, DOI 10.1093/brain/112.3.727
   McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0
   Mendell JR, 2015, MOL THER, V23, P192, DOI 10.1038/mt.2014.200
   Mendell JR, 2010, ANN NEUROL, V68, P629, DOI 10.1002/ana.22251
   Mendell JR, 2009, ANN NEUROL, V66, P290, DOI 10.1002/ana.21732
   MENDELL JR, 1991, ARCH NEUROL-CHICAGO, V48, P1229, DOI 10.1001/archneur.1991.00530240033013
   Mercuri E, 2002, NEUROMUSCULAR DISORD, V12, P631, DOI 10.1016/S0960-8966(02)00023-8
   Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329
   Morita M, 2015, CELL CYCLE, V14, P473, DOI 10.4161/15384101.2014.991572
   Mounier R, 2015, TRENDS ENDOCRIN MET, V26, P275, DOI 10.1016/j.tem.2015.02.009
   Muth IE, 2009, J NEUROL NEUROSUR PS, V80, P1344, DOI 10.1136/jnnp.2009.174276
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Phillips DJ, 2009, CYTOKINE GROWTH F R, V20, P153, DOI 10.1016/j.cytogfr.2009.02.007
   Sancricca C, 2011, NEUROL SCI, V32, P841, DOI 10.1007/s10072-011-0657-6
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   SUGINO K, 1993, J BIOL CHEM, V268, P15579
   Tawil R, 2004, NEUROLOGY, V63, P718
   Tawil R, 2001, NEUROLOGY, V57, P1566
   TAWIL R, 1994, NEUROLOGY, V44, P442, DOI 10.1212/WNL.44.3_Part_1.442
   Viollet L, 2009, MUSCLE NERVE, V40, P438, DOI 10.1002/mus.21420
   Wilson FC, 2008, J RHEUMATOL, V35, P445
   Winbanks CE, 2012, J CELL BIOL, V197, P997, DOI 10.1083/jcb.201109091
   YUNIS EJ, 1971, LAB INVEST, V25, P240
   Zhu JH, 2011, AM J PATHOL, V179, P915, DOI 10.1016/j.ajpath.2011.04.008
NR 54
TC 79
Z9 101
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD APR 5
PY 2017
VL 25
IS 4
BP 870
EP 879
DI 10.1016/j.ymthe.2017.02.015
PG 10
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA ER5YC
UT WOS:000398879500007
PM 28279643
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU de la Hoz, CPDF
   Morís, G
   Jiménez-Mallebrera, C
   Badosa, C
   Hernández-Laín, A
   Encinar, AB
   Martín, MA
   Domínguez-González, C
AF de Fuenmayor-Fernandez de la Hoz, Carlos Pablo
   Moris, German
   Jimenez-Mallebrera, Cecilia
   Badosa, Carmen
   Hernandez-Lain, Aurelio
   Blazquez Encinar, Alberto
   Angel Martin, Miguel
   Dominguez-Gonzalez, Cristina
TI Recurrent rhabdomyolysis and exercise intolerance: A new phenotype of
   late-onset thymidine kinase 2 deficiency
SO MOLECULAR GENETICS AND METABOLISM REPORTS
LA English
DT Article
AB A 29-year-old man developed, since the age of 18, exercise intolerance and exercise-induced rhabdomyolysis, with myoglobinuria. Muscle biopsy showed ragged-red fibers. Multiple mitochondrial DNA deletions were detected. The previously reported pathogenic homozygous mutation c.323C>T (p.Thr108Met) in TK2 was identified.
   This case expands the phenotypic spectrum of TK2 deficiency and indicates that it should be considered in the differential diagnosis of episodic rhabdomyolysis and exercise intolerance, along with other metabolic and mitochondrial myopathies. Since a new treatment is under development, it is essential improving knowledge of the natural history of TK2 deficiency.
C1 [de Fuenmayor-Fernandez de la Hoz, Carlos Pablo; Dominguez-Gonzalez, Cristina] Hosp 12 Octubre, Dept Neurol, Neuromuscular Unit, Madrid, Spain.
   [Moris, German] Hosp Cent Asturias, Dept Neurol, Neuromuscular Unit, Oviedo, Spain.
   [Jimenez-Mallebrera, Cecilia; Badosa, Carmen] Hosp St Joan de Deu, Inst Recerca St Joan de Deu, Neuropediat Dept, Neuromuscular Unit, Barcelona, Spain.
   [Jimenez-Mallebrera, Cecilia; Blazquez Encinar, Alberto; Angel Martin, Miguel; Dominguez-Gonzalez, Cristina] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain.
   [Hernandez-Lain, Aurelio] Hosp 12 Octubre, Dept Pathol Neuropathol, Neuromuscular Unit, Madrid, Spain.
   [Blazquez Encinar, Alberto; Angel Martin, Miguel; Dominguez-Gonzalez, Cristina] Hosp 12 Octubre Res Inst Imas12, Madrid, Spain.
   [Blazquez Encinar, Alberto; Angel Martin, Miguel] Hosp 12 Octubre, Dept Clin Biochem, Mitochondrial Dis Lab, Madrid, Spain.
C3 Hospital Universitario 12 de Octubre; Central University Hospital
   Asturias; University of Barcelona; Instituto de Salud Carlos III; CIBER
   - Centro de Investigacion Biomedica en Red; CIBERER; Hospital
   Universitario 12 de Octubre; Hospital Universitario 12 de Octubre
RP Domínguez-González, C (corresponding author), Hosp Univ 12 Octubre, Serv Neurol, Unidad Enfermedades Neuromusculares, Ave Cordoba Sin Numero, Madrid 28041, Spain.
EM edgonzalez@salud.madrid.org
RI Jiménez-Mallebrera, Cecilia/F-5030-2016; Encinar, Alberto/S-4425-2018;
   Moris, German/AAT-8916-2021; Martin, Miguel/S-2758-2018; Martin, Miguel
   Angel/B-6261-2017; Moris, German/M-2920-2018
OI Martin, Miguel Angel/0000-0003-4741-772X; de Fuenmayor Fernandez de la
   Hoz, Carlos Pablo/0000-0003-4766-4974; Moris, German/0000-0001-7608-2194
FU Spanish Instituto de Salud Carlos III (ISCIII) [PMP15-00025]
FX This work was supported by research grant of Spanish Instituto de Salud
   Carlos III (ISCIII), PMP15-00025 to MAM.
CR Dominguez-Gonzalez C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66940-8
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1071-z
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Wang LY, 2016, NUCLEOS NUCLEOT NUCL, V35, P578, DOI 10.1080/15257770.2015.1125001
NR 7
TC 4
Z9 4
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2214-4269
J9 MOL GENET METAB REP
JI Molec. Genet. Metab. Rep.
PD MAR
PY 2021
VL 26
AR 100701
DI 10.1016/j.ymgmr.2020.100701
EA JAN 2021
PG 3
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA QI2PD
UT WOS:000618816000007
PM 33457207
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Karkare, K
   Sinha, S
   Ravishankar, S
   Gayathri, N
   Yasha, TC
   Goyal, MK
   Vijayan, J
   Vanniarajan, A
   Thangaraj, K
   Taly, AB
AF Karkare, Kalyani
   Sinha, Sanjib
   Ravishankar, Shivashankar
   Gayathri, Narayanappa
   Yasha, T. Chikkabasavaiah
   Goyal, Manoj K.
   Vijayan, Joy
   Vanniarajan, Ayyasamy
   Thangaraj, Kumarswamy
   Taly, Arun B.
TI Epilepsia partialis continua in mitochondrial dysfunction: Interesting
   phenotypic and MRI observations
SO ANNALS OF INDIAN ACADEMY OF NEUROLOGY
LA English
DT Article
DE chronic progressive external ophtalmoplegia; epilepsia partialis
   continua; mitochondrial dysfunction; Mitochondrial Encephalopathy with
   Ragged Red Fiber; MRI; periodic lateralized epileptiform discharges
ID PARTIAL STATUS EPILEPTICUS; MELAS; COMPLEX
AB An 11-year-old girl manifested with photophobia, ptosis, external ophthalmoplegia, hypotonia, weakness of proximal limb muscles, hyporeflexia, and generalized seizures (six months). Her elder sister had had uncontrolled seizures and photophobia and died at seven years of age. In the patient, serum lactate was high (55 mg/dl). Muscle biopsy revealed characteristic ragged red and ragged blue fibers, diagnostic of mitochondrial cytopathy. Sequencing of the complete mitochondrial genome of the DNA obtained from the muscle biopsy of the patient did not show any characteristic mutation. Four months later, the girl was admitted with a one-week history of epilepsia partialis continua (EPC). EEG revealed Periodic Lateralized Epileptiform Discharges (PLEDs), once in 2-4 seconds, over the right temporo-occipital leads. MRI revealed signal change of right motor cortex, which had restricted diffusion. MR spectroscopy (MRS) from this region revealed lactate peak. EPC remained refractory to multiple anti-epileptic drugs, immuno-modulators, coenzyme-Q, and carnitine. This thought provoking report expands the spectrum of mitochondrial cytopathies.
C1 [Karkare, Kalyani; Sinha, Sanjib; Goyal, Manoj K.; Vijayan, Joy; Taly, Arun B.] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India.
   [Ravishankar, Shivashankar] Natl Inst Mental Hlth & Neurosci, Dept Neuroimaging & Intervent Radiol, Bangalore 560029, Karnataka, India.
   [Vanniarajan, Ayyasamy; Thangaraj, Kumarswamy] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.
   [Gayathri, Narayanappa; Yasha, T. Chikkabasavaiah] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India.
C3 National Institute of Mental Health & Neurosciences - India; National
   Institute of Mental Health & Neurosciences - India; Council of
   Scientific & Industrial Research (CSIR) - India; CSIR - Centre for
   Cellular & Molecular Biology (CCMB); National Institute of Mental Health
   & Neurosciences - India
RP Sinha, S (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurol, Hosur Rd, Bangalore 560029, Karnataka, India.
EM sanjib_sinha2004@yahoo.co.in
RI Vanniarajan, A./AAB-4896-2022; Taly, Arun/AAV-3517-2021; Thangaraj,
   Kumarasamy/G-5596-2010
OI Sinha, Sanjib/0000-0002-9736-2985
CR Cockerell OC, 1996, BRAIN, V119, P393, DOI 10.1093/brain/119.2.393
   Corda D, 2006, EPILEPSY BEHAV, V8, P655, DOI 10.1016/j.yebeh.2005.12.011
   Feddersen B, 2003, NEUROLOGY, V61, P1149, DOI 10.1212/01.WNL.0000092497.53706.1B
   Gropman AL, 2004, MITOCHONDRION, V4, P503, DOI 10.1016/j.mito.2004.07.009
   HORI A, 1989, JPN J PSYCHIAT NEUR, V43, P536
   Kim BS, 2001, YONSEI MED J, V42, P128
   Leff AP, 1998, EPILEPSIA, V39, P438, DOI 10.1111/j.1528-1157.1998.tb01397.x
   Miyamoto A, 1997, NEURORADIOLOGY, V39, P427, DOI 10.1007/s002340050438
   PohlmannEden B, 1996, J CLIN NEUROPHYSIOL, V13, P519, DOI 10.1097/00004691-199611000-00007
   Ribacoba R, 2006, NEUROLOGIA, V21, P1
   Schapira AHV, 1999, EUR J CLIN INVEST, V29, P886
   Schomer DL, 1993, EPILEPSIA S1, V34, P29
   Sinha S, 2007, EPILEPSY RES, V74, P55, DOI 10.1016/j.eplepsyres.2006.12.003
   Stenqvist L, 2005, PEDIATR RES, V58, P258, DOI 10.1203/01.PDR.0000169966.82325.1A
   VEGGIOTTI P, 1995, NEUROPHYSIOL CLIN, V25, P158, DOI 10.1016/0987-7053(96)80168-7
   Yapici Z, 2005, J CHILD NEUROL, V20, P517, DOI 10.1177/08830738050200060901
NR 16
TC 3
Z9 3
U1 0
U2 2
PU MEDKNOW PUBLICATIONS
PI MUMBAI
PA A-108-109 KANARA BUSINESS CENTRE, GHAKTOPAR, MUMBAI, 400075, INDIA
SN 0972-2327
J9 ANN INDIAN ACAD NEUR
JI Ann. Indian Acad. Neurol.
PD JUL-SEP
PY 2008
VL 11
IS 3
BP 193
EP 196
PG 4
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 349QT
UT WOS:000259296800012
PM 19893669
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Wakil, S
AF Finsterer, Josef
   Wakil, Salma
TI Abnormalities of Skin and Cutaneous Appendages in Neuromuscular
   Disorders
SO PEDIATRIC NEUROLOGY
LA English
DT Review
DE cutaneous; dermis; sweat glands; hairs; dermatological; myopathy;
   neuropathy; neuromuscular transmission
ID EPIDERMOLYSIS-BULLOSA SIMPLEX; MUSCULAR-DYSTROPHY; MITOCHONDRIAL-DNA;
   CONGENITAL INSENSITIVITY; LACTIC-ACIDOSIS; PLEC MUTATIONS;
   FABRY-DISEASE; PATIENT; NEUROPATHY; HAIR
AB OBJECTIVES: A thorough evaluation of the skin and its appendages is frequently outside the area of expertise of the neurologist who deals with neuromuscular disorders. However, the skin is more frequently affected in neuromuscular disorders and deserves more attention than so far acknowledged. METHODS: Review of publications by searching Medline dealing with skin disorders in neuromuscular disorders. RESULTS: Skin abnormalities are most frequently found in patients with dermatomyositis, myotonic dystrophies, mitochondrial disorders, muscular dystrophies, and neuropathies. The hairs and the sweat glands are the appendages most frequently affected in neuromuscular disorders. In myotonic dystrophies and mitochondrial disorders there are indications that the rate of skin neoplasms is increased compared with the general population. CONCLUSIONS: Skin lesions in neuromuscular disorders are not unusual. Neurologists should be aware of the cutaneous implications of neuromuscular disorders and should take a thorough history relative to cutaneous manifestations and complete a comprehensive investigation of the skin and its appendages. If there is evidence of a dermatological problem in a neuromuscular disorder, a dermatologist should be consulted. Dermatological involvement in neuromuscular disorders may contribute to the diagnosis of neuromuscular disorders and may help to differentiate between various entities. The skin should become a focus of the neurologist as well.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
   [Wakil, Salma] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.
C3 Rudolfstiftung Hospital; King Faisal Specialist Hospital & Research
   Center
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
RI Majid, Salma/AAT-2616-2020
OI WAKIL, SALMA/0000-0002-7883-2515
CR Aghaei Shahin, 2006, Dermatol Online J, V12, P5
   [Anonymous], GENEREVIEWS
   Artuch R, 1998, HORM RES, V50, P99, DOI 10.1159/000023243
   Baertling F, 2013, J INHERIT METAB DIS, V36, P1081, DOI 10.1007/s10545-013-9593-3
   Bodemer C, 1999, PEDIATRICS, V103, P428, DOI 10.1542/peds.103.2.428
   Born AP, 2010, NEUROMUSCULAR DISORD, V20, P136, DOI 10.1016/j.nmd.2009.11.009
   CABLE WJL, 1982, NEUROLOGY, V32, P347, DOI 10.1212/WNL.32.4.347
   Carmi E, 2001, ANN DERMATOL VENER, V128, P1031
   Cassano N, 2014, GIORN ITAL DERMAT V, V149, P555
   Chakrabarty B, 2014, J CHILD NEUROL, V29, pNP5, DOI 10.1177/0883073813488662
   Chakrabarty B, 2014, J CHILD NEUROL, V29, P469, DOI 10.1177/0883073813482769
   Charlesworth A, 2013, BRIT J DERMATOL, V168, P808, DOI 10.1111/bjd.12202
   CHARROW J, 1986, J PEDIATR-US, V108, P729, DOI 10.1016/S0022-3476(86)81054-X
   Chong P Siao Tick, 2003, J Clin Neuromuscul Dis, V5, P1, DOI 10.1097/00131402-200309000-00001
   CLANCY RR, 1980, J NEUROL SCI, V46, P257, DOI 10.1016/0022-510X(80)90050-7
   Dimachkie MM, 2012, SEMIN NEUROL, V32, P227, DOI 10.1055/s-0032-1329201
   Du-Thanh A, 2006, ANN DERMATOL VENER, V133, P991, DOI 10.1016/S0151-9638(06)71085-7
   Esteban-García A, 2004, REV NEUROLOGIA, V39, P525, DOI 10.33588/rn.3906.2004237
   Finsterer J, 2005, ACTA OPHTHALMOL SCAN, V83, P628, DOI 10.1111/j.1600-0420.2005.00518.x
   Finsterer J, 2013, J Med Life, V6, P477
   Finsterer J, 2011, REV INVEST CLIN, V63, P322
   Fiorentino D, 2011, J AM ACAD DERMATOL, V65, P25, DOI 10.1016/j.jaad.2010.09.016
   Fujita T, 1974, Nihon Rinsho, V32, P554
   Graells J, 1996, INT J DERMATOL, V35, P732, DOI 10.1111/j.1365-4362.1996.tb00651.x
   HAYASAKA S, 1989, GRAEF ARCH CLIN EXP, V227, P209, DOI 10.1007/BF02172750
   Hermanns-Lê T, 2014, ULTRASTRUCT PATHOL, V38, P164, DOI 10.3109/01913123.2013.829151
   Iaccarino L, 2014, J AUTOIMMUN, V48-49, P122, DOI 10.1016/j.jaut.2013.11.005
   Itin PH, 2001, HAUTARZT, V52, P244, DOI 10.1007/s001050051298
   Karvonen SL, 1999, BRIT J DERMATOL, V140, P634
   Katirji B, 2014, NEUROMUSCULAR DISORD, VXXV, P476
   Katona I, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-17
   Kefala-Agoropoulou K, 2008, PEDIATR BLOOD CANCER, V50, P939, DOI 10.1002/pbc.21379
   Kim JE, 2011, J CLIN NEUROL, V7, P233, DOI 10.3988/jcn.2011.7.4.233
   Kim W, 2013, ORTHOP TRAUMATOL-SUR, V99, P881, DOI 10.1016/j.otsr.2013.05.006
   King ICC, 2015, PEDIATR DERMATOL, V32, P97, DOI 10.1111/pde.12353
   KUNTZER T, 1991, REV NEUROL, V147, P819
   Kwok T, 2013, J CUTAN MED SURG, V17, pS1, DOI 10.2310/7750.2013.WOUND3
   Latronico N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075696
   Marque M, 2010, BRIT J DERMATOL, V163, P1337, DOI 10.1111/j.1365-2133.2010.09912.x
   Mehta SG, 2006, AM J MED GENET A, V140A, P322, DOI 10.1002/ajmg.a.31008
   Moghadam-Kia S, 2013, DERMATOL CLIN, V31, P75, DOI 10.1016/j.det.2012.08.008
   MORI K, 1991, AM J MED GENET, V38, P583, DOI 10.1002/ajmg.1320380417
   Nakai K, 2009, EUR J DERMATOL, V19, P507, DOI 10.1684/ejd.2009.0713
   Nance CS, 2006, ARCH NEUROL-CHICAGO, V63, P453, DOI 10.1001/archneur.63.3.453
   Oaklander AL, 2013, PEDIATRICS, V131, pE1091, DOI 10.1542/peds.2012-2597
   Ortonne N, 2002, ANN PATHOL, V22, P39
   Park Y, 2014, ANN REHABIL MED-ARM, V38, P292, DOI 10.5535/arm.2014.38.2.292
   Parodi A, 2014, GIORN ITAL DERMAT V, V149, P79
   Pellegrini C, 2013, J CELL PHYSIOL, V228, P1323, DOI 10.1002/jcp.24290
   Reichart B, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-12
   Requena L, 1997, BRIT J DERMATOL, V136, P768, DOI 10.1111/j.1365-2133.1997.tb03668.x
   Rocha N, 2005, J EUR ACAD DERMATOL, V19, P605, DOI 10.1111/j.1468-3083.2005.01222.x
   Sagnelli A, 2014, NEUROMUSCULAR DISORD, V24, P272, DOI 10.1016/j.nmd.2013.11.006
   Santos G, 2013, AN BRAS DERMATOL, V88, P1009, DOI 10.1590/abd1806-4841.20132266
   Sayyahfar S, 2013, PEDIATR DERMATOL, V30, P754, DOI 10.1111/j.1525-1470.2012.01833.x
   Sharma RC, 2002, DERMATOLOGY, V205, P305, DOI 10.1159/000065852
   Sherrod Quyn J, 2008, Dermatol Online J, V14, P22
   Sidhu A, 2014, J PEDIATR-US, V165, P1060, DOI 10.1016/j.jpeds.2014.06.016
   Sprecher E, 2005, AM J HUM GENET, V77, P242, DOI 10.1086/432556
   Stagi S, 2010, HORM RES PAEDIAT, V73, P409, DOI 10.1159/000308176
   Steggink Lars C, 2013, Ned Tijdschr Geneeskd, V157, pA6306
   Teive HAG, 2008, MOVEMENT DISORD, V23, P1191, DOI 10.1002/mds.21990
   TULINIUS MH, 1995, EUR J PEDIATR, V154, P35, DOI 10.1007/BF01972970
   Verma A, 1996, NEUROLOGY, V46, P1334, DOI 10.1212/WNL.46.5.1334
   WEISS BJ, 1991, ANN NEUROL, V30, P419, DOI 10.1002/ana.410300316
   Winter L, 2013, ACTA NEUROPATHOL, V125, P77, DOI 10.1007/s00401-012-1026-0
   Yin JH, 2015, INT J DERMATOL, V54, P185, DOI 10.1111/ijd.12655
   Zemtsov A, 2010, ARCH DERMATOL RES, V302, P169, DOI 10.1007/s00403-009-0997-8
NR 68
TC 8
Z9 9
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD OCT
PY 2015
VL 53
IS 4
BP 301
EP 308
DI 10.1016/j.pediatrneurol.2015.03.005
PG 8
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA CS4OX
UT WOS:000362056500004
PM 26385056
DA 2024-11-01
ER

PT J
AU de Laat, P
   Fleuren, LHJ
   Bekker, MN
   Smeitink, JAM
   Janssen, MCH
AF de Laat, Paul
   Fleuren, Leanne H. J.
   Bekker, Mireille N.
   Smeitink, Jan A. M.
   Janssen, Mirian C. H.
TI Obstetric complications in carriers of the m.3243A&gt;G mutation, a
   retrospective cohort study on maternal and fetal outcome
SO MITOCHONDRION
LA English
DT Article
DE m.3243A>G mutation; Mitochondrial myopathy; Encephalomyopathy; Lactic
   acidosis and stroke-like episodes (MELAS syndrome); Maternally inherited
   diabetes deafness (MIDD); Mitochondrial medicine; Preeclampsia; Diabetes
   gravidarum; Prematurity; Dysmaturity; Obstetric complications
ID STROKE-LIKE EPISODES; PREIMPLANTATION GENETIC DIAGNOSIS;
   LACTIC-ACIDOSIS; MITOCHONDRIAL ENCEPHALOPATHY; CLINICAL PRESENTATIONS;
   DIABETES-MELLITUS; PREGNANCY; MELAS; EPIDEMIOLOGY; A3243G
AB Introduction: The mitochondrial DNA m.3243A>G mutation is the most prevalent mutation causing mitochondrial disease in adult patients. Aside from some case reports, there are no studies on obstetric complications in a cohort of m.3243A>G carriers. We aimed to identify the prevalence of obstetric complications in a cohort of women carrying the m.3243A>G mutation.
   Methods: All female carriers of the m.3243A>G mutation known from our previous national inventory were sent a questionnaire regarding their obstetric history. Data were compared to national references. Data from the national inventory, including NMDAS (disease severity) scores and heteroplasmy levels in urinary epithelial cells (UEC) were used to stratify women.
   Results: Sixty women participated, the mean age was 47 years (range 20-70), mean NMDAS was 14.6 (range 0-46), and mean heteroplasmy percentage in UEC was 19.9% (range 5-85%). Ninety-eight pregnancies in 46 women were reported. Twenty-three (25.3%) had a premature delivery and five of them (5.5%) had a gestation of <= 32 weeks and eleven of the women (12%) suffered from preeclampsia. No different heteroplasmy level was found in the women with preeclampsia. Nine pregnancies (11%) were complicated by gestational diabetes.
   Discussion: Obstetric complications occur frequently in carriers of the m.3243A>G mutation. Proper guidance during pregnancies and early detection of possible obstetric complications are needed. As techniques to prevent transmission of mitochondrial mutations are studied it is important to know the possible complications patients may experience from the ensuing pregnancy. (C) 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [de Laat, Paul; Fleuren, Leanne H. J.; Smeitink, Jan A. M.; Janssen, Mirian C. H.] Radboudumc Amalia Childrens Hosp, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, NL-6500 HB Nijmegen, Netherlands.
   [Bekker, Mireille N.] Radboudumc, Dept Obstet & Gynecol, Nijmegen, Netherlands.
   [Janssen, Mirian C. H.] Radboudumc, Dept Internal Med, Nijmegen, Netherlands.
C3 Radboud University Nijmegen; Radboud University Nijmegen; Radboud
   University Nijmegen
RP de Laat, P (corresponding author), Radboudumc Amalia Childrens Hosp, Nijmegen Ctr Mitochondrial Disorders, Huispost 804,Geert Grootepl 10,POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM paul.delaat@radboudumc.nl
RI Smeitink, Jan/C-1351-2013; Janssen, Mirian/D-9777-2016; Bekker,
   M.N./L-4191-2015; de Laat, Paul/O-9851-2019; de Laat, Paul/B-5855-2011
OI de Laat, Paul/0000-0003-2541-3090
FU Energy4All Foundation
FX Part of this work was supported by the Energy4All Foundation. Jan
   Smeitink is the CEO of Khondrion BV.
CR Annaiah TK, 2007, J OBSTET GYNAECOL, V27, P618, DOI 10.1080/01443610701546318
   [Anonymous], 2002, OBSTET GYNECOL, V99, P159
   Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003
   Butte NF, 1999, AM J CLIN NUTR, V69, P299
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002
   CUNNINGHAM FG, 1975, OBSTET GYNECOL, V46, P581
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   de Laat P, 2013, JIMD REP, V8, P47, DOI 10.1007/8904_2012_159
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Durand-Dubief F, 2004, REV NEUROL-FRANCE, V160, P824, DOI 10.1016/S0035-3787(04)71038-3
   GANT NF, 1974, OBSTET GYNECOL, V43, P854
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Gorman GS, 2015, NEW ENGL J MED, V372, P885, DOI 10.1056/NEJMc1500960
   Hung TH, 2002, CIRC RES, V90, P1274, DOI 10.1161/01.RES.0000024411.22110.AA
   JovanovicPeterson L, 1996, DIABETES METAB REV, V12, P287, DOI 10.1002/(SICI)1099-0895(199612)12:4<287::AID-DMR170>3.0.CO;2-E
   Kovilam OP, 1999, OBSTET GYNECOL, V93, P853, DOI 10.1016/S0029-7844(98)00457-8
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Ma YN, 2010, J NEUROL SCI, V291, P17, DOI 10.1016/j.jns.2010.01.012
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Moriarty KT, 2008, J OBSTET GYNAECOL, V28, P349, DOI 10.1080/01443610802048545
   Nesbitt V., 2013, J NEUROL NEUROSURG P
   Padmini E, 2009, CLIN CHEM LAB MED, V47, P1073, DOI 10.1515/CCLM.2009.247
   Penney GC, 2003, BJOG-INT J OBSTET GY, V110, P315, DOI 10.1016/S1470-0328(03)02967-7
   Perinatale Zorg in Nederland, 2011, PER ZORG NED 2011
   Poulton J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b94
   Sallevelt SCEH, 2013, J MED GENET, V50, P125, DOI 10.1136/jmedgenet-2012-101172
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Shi ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064351
   Shibata E, 2003, PLACENTA, V24, P698, DOI 10.1016/S0143-4004(03)00083-3
   Stark R, 2007, EUR J CLIN INVEST, V37, P236, DOI 10.1111/j.1365-2362.2007.01773.x
   Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6
   Szendroedi J, 2009, DIABETES CARE, V32, P677, DOI 10.2337/dc08-2078
   Temple R, 2002, BRIT MED J, V325, P1275, DOI 10.1136/bmj.325.7375.1275
   TORBERGSEN T, 1989, ACTA OBSTET GYN SCAN, V68, P145, DOI 10.3109/00016348909009902
   Treff NR, 2012, FERTIL STERIL, V98, P1236, DOI 10.1016/j.fertnstert.2012.07.1119
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Vollebregt KC, 2010, ACTA OBSTET GYN SCAN, V89, P261, DOI 10.3109/00016340903433982
NR 43
TC 28
Z9 31
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV
PY 2015
VL 25
BP 98
EP 103
DI 10.1016/j.mito.2015.10.005
PG 6
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA CX8DW
UT WOS:000365933800012
PM 26455484
DA 2024-11-01
ER

PT J
AU Kume, K
   Morino, H
   Miyamoto, R
   Matsuda, Y
   Ohsawa, R
   Kanaya, Y
   Tada, Y
   Kurashige, T
   Kawakami, H
AF Kume, Kodai
   Morino, Hiroyuki
   Miyamoto, Ryosuke
   Matsuda, Yukiko
   Ohsawa, Ryosuke
   Kanaya, Yuhei
   Tada, Yui
   Kurashige, Takashi
   Kawakami, Hideshi
TI Middle-age-onset cerebellar ataxia caused by a homozygous <i>TWNK</i>
   variant: a case report
SO BMC MEDICAL GENETICS
LA English
DT Article
DE TWNK; Cerebellar ataxia; Perrault syndrome
ID PERRAULT SYNDROME; MUTATION
AB Background The TWNK gene encodes the twinkle protein, which is a mitochondrial helicase for DNA replication. The dominant TWNK variants cause progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, while the recessive variants cause mitochondrial DNA depletion syndrome 7 and Perrault syndrome 5. Perrault syndrome is characterized by sensorineural hearing loss in both males and females and gonadal dysfunction in females. Patients with Perrault syndrome may present early-onset cerebellar ataxia, whereas middle-age-onset cerebellar ataxia caused by TWNK variants is rare. Case presentation A Japanese female born to consanguineous parents presented hearing loss at age 48, a staggering gait at age 53, and numbness in her distal extremities at age 57. Neurological examination revealed sensorineural hearing loss, cerebellar ataxia, decreased deep tendon reflexes, and sensory disturbance in the distal extremities. Laboratory tests showed no abnormal findings other than a moderate elevation of pyruvate concentration levels. Brain magnetic resonance imaging revealed mild cerebellar atrophy. Using exome sequencing, we identified a homozygous TWNK variant (NM_021830: c.1358G>A, p.R453Q). Conclusions TWNK variants could cause middle-age-onset cerebellar ataxia. Screening for TWNK variants should be considered in cases of cerebellar ataxia associated with deafness and/or peripheral neuropathy, even if the onset is not early.
C1 [Kume, Kodai; Morino, Hiroyuki; Matsuda, Yukiko; Ohsawa, Ryosuke; Kanaya, Yuhei; Tada, Yui; Kawakami, Hideshi] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Epidemiol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.
   [Miyamoto, Ryosuke] Tokushima Univ, Inst Biomed Sci, Dept Clin Neurosci, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7700042, Japan.
   [Kurashige, Takashi] Natl Hosp Org Kure Med Ctr, Dept Neurol, 3-1 Aoyama Cho, Kure 7370023, Japan.
   [Kurashige, Takashi] Chugoku Canc Ctr, 3-1 Aoyama Cho, Kure 7370023, Japan.
C3 Hiroshima University; Tokushima University
RP Morino, H (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Epidemiol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.
EM morino@hiroshima-u.ac.jp
RI Matsuda, Yukiko/HTS-9583-2023; Kawakami, Hideshi/A-2086-2009; Kurashige,
   Takashi/N-1767-2014; Morino, Hiroyuki/H-9583-2013; Kume,
   Kodai/N-9493-2019
OI Morino, Hiroyuki/0000-0002-5190-3547; Matsuda,
   Yukiko/0000-0002-6213-7745; Kume, Kodai/0000-0001-9266-2543
CR Chatzispyrou IA, 2017, HUM MOL GENET, V26, P2541, DOI 10.1093/hmg/ddx152
   Demain LAM, 2017, CLIN GENET, V91, P302, DOI 10.1111/cge.12776
   Domínguez-Ruiz M, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2041-x
   Fekete B, 2019, BMC MED GENET, V20, DOI 10.1186/s12881-019-0934-4
   Jamali F, 2019, ARCH IRAN MED, V22, P728
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Lerat J, 2016, HUM MUTAT, V37, P1354, DOI 10.1002/humu.23120
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   Oldak M, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1129-4
   Pierce SB, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a001107
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Schicks J, 2010, MOVEMENT DISORD, V25, P2678, DOI 10.1002/mds.23286
   van der Knaap MS, 2019, NEUROLOGY, V92, pE1225, DOI 10.1212/WNL.0000000000007098
NR 13
TC 10
Z9 10
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2350
J9 BMC MED GENET
JI BMC Med. Genet.
PD MAR 31
PY 2020
VL 21
IS 1
AR 68
DI 10.1186/s12881-020-01002-4
PG 4
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA LA1KN
UT WOS:000523713900001
PM 32234020
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Dorison, N
   Gaignard, P
   Bayot, A
   Gelot, A
   Becker, PH
   Fourati, S
   Lebigot, E
   Charles, P
   Wai, T
   Therond, P
   Slama, A
AF Dorison, Nathalie
   Gaignard, Pauline
   Bayot, Aurelien
   Gelot, Antoinette
   Becker, Pierre Hadrien
   Fourati, Salma
   Lebigot, Elise
   Charles, Perrine
   Wai, Timothy
   Therond, Patrice
   Slama, Abdelhamid
TI Mitochondrial dysfunction caused by novel <i>ATAD3A</i> mutations
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Mitochondrial disease; ATAD3A; Sensitive motor neuropathy; Congenital
   cataract
ID RECURRENT DE-NOVO; MEMBRANE-PROTEIN; CHOLESTEROL; DYNAMICS; ATROPHY;
   INNER; DNA
AB Mitochondrial respiratory chain integrity depends on a number of proteins encoded by nuclear and mitochondrial genomes. Mutations of such factors can result in isolated or combined respiratory chain deficits, some of which can induce abnormal morphology of the mitochondrial network or accumulation of intermediary metabolites. Consequently, affected patients are clinically heterogeneous, presenting with central nervous system, muscular, or neurodegenerative disorders. ATAD3A is a nuclear-encoded ATPase protein of the AAA+ family and has been localized to the inner mitochondrial membrane. Recently reported mutations or large deletions in the ATDA3A gene in patients have been shown to induce altered mitochondrial structure and function and abnormal cholesterol metabolism in a recessive or dominant manner. Here, we report two siblings presenting axonal sensory-motor neuropathy associated with neonatal cataract. Genetic analyses identified two novel mutations in ATAD3A; a point mutation and an intronic 15 bp deletion affecting splicing and leading to exon skipping. Biochemical analysis in patient cells and tissues showed abnormal function of the mitochondrial respiratory chain in muscle and abnormal mitochondrial cristae structure. These new cases underline the large spectrum of biochemical and clinical presentations of ATAD3A deficiency and the different modes of inheritance, making it an atypical mitochondrial disorder.
C1 [Dorison, Nathalie] Fdn Rothschild Hosp, Pediat Neurosurg Unit, Paris, France.
   [Dorison, Nathalie] Univ Paris, Hosp Trousseau, AP HP, Neuropediat Unit, Paris, France.
   [Gaignard, Pauline; Becker, Pierre Hadrien; Fourati, Salma; Lebigot, Elise; Therond, Patrice; Slama, Abdelhamid] Univ Paris Saclay, Hop Bicetre, AP HP, Biochem Dept, F-94275 Le Kremlin Bicetre, France.
   [Bayot, Aurelien; Wai, Timothy] Inst Pasteur, Mitochondrial Biol Grp, CNRS, UMR 3691, Paris, France.
   [Gelot, Antoinette] Hop Trousseau, AP HP, Serv Anat Pathol, 26 Ave Dr Arnold Netter, F-75571 Paris 12, France.
   [Charles, Perrine] Salphriere Hosp, Neurogenet Reference Ctr, Genet Dept, 47 Blvd Hop, F-75013 Paris, France.
   [Gelot, Antoinette] Aix Marseille Univ, INMED, INSERM, Campus Luminy, Marseille, France.
   [Bayot, Aurelien] Nord Univ Paris, Hop Bichat, AP HP, Dept Genet, 46 Rue Henri Huchard, F-75018 Paris, France.
C3 Fondation Adolphe de Rothschild; Assistance Publique Hopitaux Paris
   (APHP); Sorbonne Universite; Hopital Universitaire Armand-Trousseau -
   APHP; Universite Paris Cite; Universite Paris Saclay; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere -
   APHP; Institut National de la Sante et de la Recherche Medicale
   (Inserm); Universite Paris Cite; Hopital Universitaire Bicetre - APHP;
   Centre National de la Recherche Scientifique (CNRS); CNRS - National
   Institute for Biology (INSB); Pasteur Network; Universite Paris Cite;
   Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP);
   Aix-Marseille Universite; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP);
   Universite Paris Cite; Hopital Universitaire Bichat-Claude Bernard -
   APHP
RP Slama, A (corresponding author), Univ Paris Saclay, Hop Bicetre, AP HP, Biochem Dept, F-94275 Le Kremlin Bicetre, France.
EM abdel.slama@aphp.fr
RI Wai, Timothy/AAA-7226-2019
OI Fourati, Salma/0000-0002-8025-8575; Gelot,
   Antoinette/0000-0002-3032-014X
FU Association des Maladies Mitochondriales (AMMi), France; European
   Research Council (ERC) [714472]; European Research Council (ERC)
   [714472] Funding Source: European Research Council (ERC)
FX The authors would like to acknowledge Association des Maladies
   Mitochondriales (AMMi), France, for the financial support. T.W. was
   supported by the European Research Council (ERC) Starting Grant No.
   714472 (Acronym "Mitomorphosis").
CR Al Madhoun A, 2019, APPL CLIN GENET, V12, P163, DOI 10.2147/TACG.S224520
   Bouali N, 2017, FERTIL STERIL, V108, P694, DOI 10.1016/j.fertnstert.2017.07.015
   Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309
   CHRETIEN D, 1994, CLIN CHIM ACTA, V228, P53, DOI 10.1016/0009-8981(94)90056-6
   Cooper HM, 2017, HUM MOL GENET, V26, P1432, DOI 10.1093/hmg/ddx042
   Desai R, 2017, BRAIN, V140, P1595, DOI 10.1093/brain/awx094
   Fang HY, 2010, J CELL SCI, V123, P1171, DOI 10.1242/jcs.062034
   Frazier A.E., 2020, CLIN TRANSLATIONAL A, P1, DOI [10.1016/j.medj.2020.06.004, DOI 10.1016/J.MEDJ.2020.06.004]
   Gilquin B, 2010, MOL CELL BIOL, V30, P1984, DOI 10.1128/MCB.00007-10
   Gunning AC, 2020, AM J HUM GENET, V106, P272, DOI 10.1016/j.ajhg.2020.01.007
   Harel T, 2016, AM J HUM GENET, V99, P831, DOI 10.1016/j.ajhg.2016.08.007
   Hubstenberger A, 2010, J BIOENERG BIOMEMBR, V42, P143, DOI 10.1007/s10863-010-9269-8
   Lee J, 2016, MOL MED REP, V14, P33, DOI 10.3892/mmr.2016.5209
   Li SJ, 2012, J BIOENERG BIOMEMBR, V44, P189, DOI 10.1007/s10863-012-9424-5
   Peeters-Scholte CMPCD, 2017, BRAIN, V140, DOI 10.1093/brain/awx239
   Peralta S, 2019, MOL GENET METAB, V128, P452, DOI 10.1016/j.ymgme.2019.10.012
   Peralta S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.217075
   Rone MB, 2012, MOL ENDOCRINOL, V26, P1868, DOI 10.1210/me.2012-1159
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Zhao JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19849-2
NR 20
TC 19
Z9 21
U1 1
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD SEP-OCT
PY 2020
VL 131
IS 1-2
BP 107
EP 113
DI 10.1016/j.ymgme.2020.09.002
PG 7
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA PH7ZV
UT WOS:000600626600010
PM 32933822
OA Green Submitted, Bronze
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Winklehner, M
AF Finsterer, Josef
   Winklehner, Michael
TI ADULT-ONSET, ISOLATED RESPIRATORY CHAIN COMPLEX-IV DEFICIENCY WITH MILD
   MANIFESTATIONS
SO POLISH JOURNAL OF PATHOLOGY
LA English
DT Article
DE mtDNA; mitochondrial; respiratory chain; multisystem; myopathy
ID PEDIATRIC-PATIENTS; CLINICAL SPECTRUM; MITOCHONDRIAL; MUTATION
AB Isolated respiratory chain complex-IV deficiency (ICIVD) usually manifests clin-ically as an early-onset, severe, multisystem mitochondrial disorder (MID) and only rarely with mild manifestations. Here we present an adult patient with late onset ICIVD with slowly progressive, mild clinical manifestations. In a 57-years old Caucasian male with exercise-induced myalgia, muscle cramps, ptosis, and recurrent creatine-kinase (CK) elevation, muscle biopsy and biochemi-cal investigations of the left lateral vastus muscle revealed ICIVD. He additionally had developed diabetes, arterial hypertension, hyperlipidemia, retinal detachment, transient hypothyroidism, and a hearing fall. The family history was positive for diabetes, Parkinsonism, and dementia in the mother and myopathy in the brother, suggesting maternal transmission of the MID. Conclusions: ICIVD may manifest in adulthood with only mild manifestations and may take a slowly progressive course. Patients with mild hyper-CKemia and mild multisystem manifestations, including the muscle, profit from muscle biopsy and biochemical investigations.
C1 [Finsterer, Josef] Messerli Inst, Klinikum Landstr, Vienna, Austria.
   [Winklehner, Michael] Med Univ Vienna, Dept Neurol, Div Neuropathol & Neurochem, Vienna, Austria.
C3 Medical University of Vienna
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
RI Finsterer, J/AAE-5733-2020
OI Winklehner, Michael/0000-0003-4938-7827
CR Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Lamperti C, 2012, NEUROMUSCULAR DISORD, V22, P990, DOI 10.1016/j.nmd.2012.06.003
   Pillai NR, 2019, AM J MED GENET A, V179, P2138, DOI 10.1002/ajmg.a.61288
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Renkema GH, 2017, HUM GENET, V136, P759, DOI 10.1007/s00439-017-1794-7
   Roos S, 2019, EUR J HUM GENET, V27, P331, DOI 10.1038/s41431-018-0286-0
   Rossmanith Walter, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.08.2008.0666
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Zhou M, 2018, J BIOL CHEM, V293, P1425, DOI 10.1074/jbc.RA117.000317
   Zierz CM, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060789
NR 10
TC 1
Z9 1
U1 0
U2 1
PU VESALIUS UNIV MEDICAL PUBL
PI CRACOW
PA WISLISKO 1, CRACOW, 00000, POLAND
SN 1233-9687
J9 POL J PATHOL
JI Pol. J. Pathol.
PY 2021
VL 72
IS 2
BP 185
EP 189
DI 10.5114/PJP.2021.109523
PG 5
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA XM2YA
UT WOS:000728698100016
PM 34706528
DA 2024-11-01
ER

PT J
AU Finsterer, J
AF Finsterer, Josef
TI Leigh and Leigh-Like Syndrome in Children and Adults
SO PEDIATRIC NEUROLOGY
LA English
DT Review
ID CYTOCHROME-C-OXIDASE; COMPLEX-I-DEFICIENCY; SUBACUTE NECROTIZING
   ENCEPHALOMYELOPATHY; MITOCHONDRIAL-DNA MUTATION; RESPIRATORY-CHAIN
   DEFICIENCY; SURF1 GENE-MUTATIONS; ATPASE 6 GENE; COX DEFICIENCY;
   3-METHYLGLUTACONIC ACIDURIA; OXIDATIVE-PHOSPHORYLATION
AB Leigh syndrome (also termed subacute, necrotizing encephalopathy) is a devastating neurodegenerative disorder, characterized by almost identical brain changes, e.g., focal, bilaterally symmetric lesions, particularly in the basal ganglia, thalamus, and brainstem, but with considerable clinical and genetic heterogeneity. Clinically, Leigh syndrome is characterized by a wide variety of abnormalities, from severe neurologic problems to a near absence of abnormalities. Most frequently the central nervous system is affected, with psychomotor retardation, seizures, nystagmus, ophthalmoparesis, optic atrophy, ataxia, dystonia, or respiratory failure. Some patients also present with peripheral nervous system involvement, including polyneuropathy or myopathy, or non-neurologic abnormalities, e.g., diabetes, short stature, hypertrichosis, cardiomyopathy, anemia, renal failure, vomiting, or diarrhea (Leigh-like syndrome). In the majority of cases, onset is in early childhood, but in a small number of cases, adults are affected. In the majority of cases, dysfunction of the respiratory chain (particularly complexes I, II, IV, or V), of coenzyme Q, or of the pyruvate dehydrogenase complex are responsible for the disease. Associated mutations affect genes of the mitochondrial or nuclear genome. Leigh syndrome and Leigh-like syndrome are the mitochondrial disorders with the largest genetic heterogeneity. (C) 2008 by Elsevier Inc. All rights reserved.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
C3 Rudolfstiftung Hospital
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Araki S, 1997, PEDIATR NEUROL, V16, P329, DOI 10.1016/S0887-8994(97)00020-9
   Arii J, 2000, AM J NEURORADIOL, V21, P1502
   BAUMGARTNER ER, 1989, PEDIATR RES, V26, P260, DOI 10.1203/00006450-198909000-00021
   Bénit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   BERKOVIC SF, 1991, LANCET, V338, P457, DOI 10.1016/0140-6736(91)91090-H
   Blok MJ, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045716
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Bugiani M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029926
   Campos Y, 1997, NEUROLOGY, V49, P595, DOI 10.1212/WNL.49.2.595
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   CAVANAGH JB, 1994, BRAIN, V117, P1357, DOI 10.1093/brain/117.6.1357
   CHAE JH, 2000, BRAIN DEV, V30, P387
   Chalmers RM, 1997, NEUROLOGY, V49, P589, DOI 10.1212/WNL.49.2.589
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Coenen MJH, 2006, J INHERIT METAB DIS, V29, P212, DOI 10.1007/s10545-006-0185-3
   Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906
   Debray FG, 2007, AM J MED GENET A, V143A, P2046, DOI 10.1002/ajmg.a.31880
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Degoul F, 1997, J INHERIT METAB DIS, V20, P49, DOI 10.1023/A:1005357506614
   DEMEIRLEIR L, 1994, PEDIATR RES, V36, P707, DOI 10.1203/00006450-199412000-00004
   Desguerre I, 2003, NEUROPEDIATRICS, V34, P265
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Di Rocco M, 1999, J INHERIT METAB DIS, V22, P593, DOI 10.1023/A:1005565610613
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Formichi P, 2004, J NEUROL NEUROSUR PS, V75, P930, DOI 10.1136/jnnp.2003.016410
   Funalot B, 2002, ANN NEUROL, V52, P374, DOI 10.1002/ana.10299
   Goldenberg PC, 2003, NEUROLOGY, V60, P865, DOI 10.1212/01.WNL.0000049460.72439.7F
   GREENBERG SB, 1990, PEDIATR RADIOL, V21, P5, DOI 10.1007/BF02010803
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   Horváth R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   KOCH TK, 1986, ANN NEUROL, V19, P605, DOI 10.1002/ana.410190617
   Laugel V, 2007, PEDIATR NEUROL, V36, P54, DOI 10.1016/j.pediatrneurol.2006.08.007
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Lebon S, 2007, MOL GENET METAB, V90, P379, DOI 10.1016/j.ymgme.2006.12.007
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Leshinsky-Silver E, 2005, BIOCHEM BIOPH RES CO, V334, P582, DOI 10.1016/j.bbrc.2005.06.134
   Leshinsky-Silver E, 2003, PRENATAL DIAG, V23, P31, DOI 10.1002/pd.516
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   Mak SC, 1998, J CHILD NEUROL, V13, P349, DOI 10.1177/088307389801300709
   Makino M, 1998, NEUROMUSCULAR DISORD, V8, P149, DOI 10.1016/S0960-8966(98)00017-0
   Malandrini A, 1998, J NEUROL SCI, V155, P218, DOI 10.1016/S0022-510X(98)00014-8
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   MARTIN E, 1990, PEDIATR RADIOL, V20, P349, DOI 10.1007/BF02013174
   Martín MA, 2005, ARCH NEUROL-CHICAGO, V62, P659, DOI 10.1001/archneur.62.4.659
   MATTHEWS PM, 1993, ANN NEUROL, V33, P652, DOI 10.1002/ana.410330616
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   MEDINA L, 1990, AM J ROENTGENOL, V154, P1269, DOI 10.2214/ajr.154.6.2159689
   MERANTE F, 1993, AM J HUM GENET, V53, P481
   MIRANDA AF, 1989, NEUROLOGY, V39, P697, DOI 10.1212/WNL.39.5.697
   MONTPETIT VJ, 1971, BRAIN, V94, P1, DOI 10.1093/brain/94.1.1
   MORIN C, 1993, AM J HUM GENET, V53, P488
   Munaro M, 1997, HUM MOL GENET, V6, P221, DOI 10.1093/hmg/6.2.221
   Jareño NM, 2007, J CHILD NEUROL, V22, P218, DOI 10.1177/0883073807300300
   Nagashima T, 1999, ACTA NEUROPATHOL, V97, P416, DOI 10.1007/s004010051007
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033
   Pecina P, 2004, AM J PHYSIOL-CELL PH, V287, pC1384, DOI 10.1152/ajpcell.00286.2004
   Péquignot MO, 2001, J BIOL CHEM, V276, P15326, DOI 10.1074/jbc.M100388200
   Petruzzella V, 2001, HUM MOL GENET, V10, P529, DOI 10.1093/hmg/10.5.529
   Piao YS, 2006, NEUROPATHOLOGY, V26, P218, DOI 10.1111/j.1440-1789.2006.00686.x
   Poyau A, 2000, HUM GENET, V106, P194, DOI 10.1007/s004390051028
   Pronicki M, 2008, J CLIN PATHOL, V61, P460, DOI 10.1136/jcp.2007.051060
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rojo A, 2006, ACTA NEUROPATHOL, V111, P610, DOI 10.1007/s00401-006-0040-5
   Rossi A, 2003, AM J NEURORADIOL, V24, P1188
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   Salviati L, 2004, AM J MED GENET A, V128A, P195, DOI 10.1002/ajmg.a.30073
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Scacco S, 2003, J BIOL CHEM, V278, P44161, DOI 10.1074/jbc.M307615200
   Scaglia F, 2005, AM J NEURORADIOL, V26, P1675
   Schiff M, 2006, ANN NEUROL, V59, P709, DOI 10.1002/ana.20818
   Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772
   SHOFFNER JM, 1992, NEUROLOGY, V42, P2168, DOI 10.1212/WNL.42.11.2168
   Shtilbans A, 2000, J CHILD NEUROL, V15, P759, DOI 10.1177/088307380001501109
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2002, EUR J HUM GENET, V10, P141, DOI 10.1038/sj.ejhg.5200773
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Tiranti V, 1999, J MED GENET, V36, P927
   Triepels RH, 1999, ANN NEUROL, V45, P787, DOI 10.1002/1531-8249(199906)45:6<787::AID-ANA13>3.0.CO;2-6
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   Ugalde C, 2007, MOL GENET METAB, V90, P10, DOI 10.1016/j.ymgme.2006.08.003
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716
   Van Maldergem L, 2002, ANN NEUROL, V52, P750, DOI 10.1002/ana.10371
   van Riesen AKJ, 2006, NEUROPEDIATRICS, V37, P88, DOI 10.1055/s-2006-924227
   Vanniarajan A, 2006, ACTA NEUROL SCAND, V114, P350, DOI 10.1111/j.1600-0404.2006.00673.x
   Von Kleist-Retzow JC, 2001, J MED GENET, V38, P109, DOI 10.1136/jmg.38.2.109
   Wick Regula, 2007, J Forensic Leg Med, V14, P42, DOI 10.1016/j.jcfm.2006.01.002
   WILLEMS JL, 1977, PEDIATRICS, V60, P850
   Wilson CJ, 2000, J CHILD NEUROL, V15, P830, DOI 10.1177/088307380001501218
   Wortmann S, 2006, MOL GENET METAB, V88, P47, DOI 10.1016/j.ymgme.2006.01.013
   Yang YL, 2006, CHINESE MED J-PEKING, V119, P373, DOI 10.1097/00029330-200603010-00004
   Yoshinaga H, 2003, NEUROPEDIATRICS, V34, P81
   Yüksel A, 2006, PEDIATR NEUROL, V34, P486, DOI 10.1016/j.pediatrneurol.2005.10.020
   ZAFEIRIOU DI, 1995, BRAIN DEV-JPN, V17, P117, DOI 10.1016/0387-7604(94)00098-I
   Zhadanov SI, 2007, MITOCHONDRION, V7, P260, DOI 10.1016/j.mito.2007.01.003
   Zhang Y, 2007, J INHERIT METAB DIS, V30, P265, DOI 10.1007/s10545-006-0481-y
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 111
TC 250
Z9 290
U1 0
U2 57
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD OCT
PY 2008
VL 39
IS 4
BP 223
EP 235
DI 10.1016/j.pediatrneurol.2008.07.013
PG 13
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 363RU
UT WOS:000260285200001
PM 18805359
DA 2024-11-01
ER

PT S
AU Barends, M
   Verschuren, L
   Morava, E
   Nesbitt, V
   Turnbull, D
   McFarland, R
AF Barends, Marlieke
   Verschuren, Lotte
   Morava, Eva
   Nesbitt, Victoria
   Turnbull, Doug
   McFarland, Robert
BE Baumgartner, M
   Patterson, M
   Rahman, S
   Zschocke, J
   Morava, E
TI Causes of Death in Adults with Mitochondrial Disease
SO JIMD REPORTS, VOL 26
SE JIMD Reports
LA English
DT Article; Book Chapter
ID KEARNS-SAYRE-SYNDROME; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   ATRIOVENTRICULAR-BLOCK; CARDIAC INVOLVEMENT; LACTIC-ACIDOSIS; MUTATION;
   DNA; PREVALENCE; DISORDERS; CHILDREN
AB Introduction: Mitochondrial diseases are a clinically, biochemically and genetically heterogeneous group of disorders with a variable age of onset and rate of disease progression. It might therefore be expected that this variation be reflected in the age and cause of death. However, to date, little has been reported regarding the 'end-of-life' period and causes of death in mitochondrial disease patients. For some specific syndromes, the associated clinical problems might predict the cause of death, but for many patients, it remains difficult to provide an accurate prognosis.
   Aims: To describe a retrospective cohort of adult mitochondrial disease patients who had attended the NHS Highly Specialised Services for Rare Mitochondrial Diseases in Newcastle upon Tyne (UK), evaluate life expectancy and causes of death and assess the consequences for daily patient care.
   Methods: All deceased adult patients cared for at this centre over a period of 10 years were included in the study. Patient history, data on laboratory findings, biochemical investigations and genetic studies were analysed retrospectively.
   Results: A total of 30 adult mitochondrial patients died within the time period of the study. The main mitochondrial disease-related causes of death in this patient cohort were respiratory failure, cardiac failure and acute cerebral incidents such as seizures and strokes. In almost half of the patients, the cause of death remained unknown. Based on our study, we present recommendations regarding the care of patients with mitochondrial disease.
C1 [Barends, Marlieke; Verschuren, Lotte] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Nijmegen, Netherlands.
   [Barends, Marlieke; Verschuren, Lotte] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen, Netherlands.
   [Barends, Marlieke; Verschuren, Lotte; Nesbitt, Victoria; Turnbull, Doug; McFarland, Robert] Newcastle Univ, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Morava, Eva] Tulane Univ, Sch Med, Hayward Genet Ctr SL 31, 1430 Tulane Ave, New Orleans, LA 70112 USA.
C3 Radboud University Nijmegen; Radboud University Nijmegen; Newcastle
   University - UK; Tulane University
RP McFarland, R (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
EM Robert.mcfarland@ncl.ac.uk
OI Turnbull, Doug/0000-0002-8878-9901; McFarland,
   Robert/0000-0002-8833-2688
FU MRC [G1100540, G0800674, G0900652, G0502157, MR/L016451/1, G0400074]
   Funding Source: UKRI; Medical Research Council [G0400074, G0502157,
   G0900652, G0800674, G1100540, MR/L016451/1] Funding Source: Medline
CR Arpa J, 2003, MUSCLE NERVE, V28, P690, DOI 10.1002/mus.10507
   Ashizawa T, 2001, ARCH NEUROL-CHICAGO, V58, P1053, DOI 10.1001/archneur.58.7.1053
   Bates MGD, 2013, EUR HEART J-CARD IMG, V14, P650, DOI 10.1093/ehjci/jes226
   Benditt JO, 2013, AM J RESP CRIT CARE, V187, P1046, DOI 10.1164/rccm.201210-1804CI
   BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104
   Chawla S, 2008, PEDIATR CARDIOL, V29, P659, DOI 10.1007/s00246-007-9040-z
   Coenen MJH, 1999, BIOCHEM BIOPH RES CO, V265, P339, DOI 10.1006/bbrc.1999.1662
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Herrero-Martín MD, 2010, J NEUROL NEUROSUR PS, V81, P471, DOI 10.1136/jnnp.2009.173831
   Finsterer J, 2014, INT J CARDIOL, V177, P754, DOI 10.1016/j.ijcard.2014.11.014
   Greden JF, 2001, J CLIN PSYCHIAT, V62, pS26
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Caballero PEJ, 2007, NEUROLOGIST, V13, P33, DOI 10.1097/01.nrl.0000252953.49721.f5
   Kato H, 2006, J NEUROL, V253, P529, DOI 10.1007/s00415-005-0010-1
   Katsanos KH, 2002, INT J CARDIOL, V83, P179, DOI 10.1016/S0167-5273(02)00040-2
   Klopstock T, 1999, NEUROLOGY, V53, P855, DOI 10.1212/WNL.53.4.855
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa-Voltti K, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.122648
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Mancuso M, 2013, NEUROL SCI, V34, P71, DOI 10.1007/s10072-011-0901-0
   Marcus KA, 2011, MITOCHONDRION, V11, P405, DOI 10.1016/j.mito.2010.12.005
   McFarland R, 2009, J INTERN MED, V265, P210, DOI 10.1111/j.1365-2796.2008.02066.x
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   Morava E, 2010, MITOCHONDRION, V10, P528, DOI 10.1016/j.mito.2010.05.011
   Palmio J, 2014, J NEUROL NEUROSUR PS, V85, P345, DOI 10.1136/jnnp-2013-304965
   Pfeiffer RF, 2011, PARKINSONISM RELAT D, V17, P10, DOI 10.1016/j.parkreldis.2010.08.003
   Sanger TD, 1996, PEDIATR NEUROL, V14, P57, DOI 10.1016/0887-8994(95)00226-X
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Smits BW, 2011, J NEUROL, V258, P2020, DOI 10.1007/s00415-011-6060-7
   Sweet D, 2011, SOCIAL TRENDS 41 HLT
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Welzing L, 2009, EUR J PEDIATR, V168, P757, DOI 10.1007/s00431-008-0831-x
   Wortmann SB, 2007, ACTA PAEDIATR, V96, P450, DOI 10.1111/j.1651-2227.2006.00158.x
   Yilmaz A, 2012, CLIN RES CARDIOL, V101, P255, DOI 10.1007/s00392-011-0387-z
NR 42
TC 29
Z9 29
U1 0
U2 1
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2192-8304
BN 978-3-662-49833-0; 978-3-662-49832-3
J9 JIMD REP
PY 2016
VL 26
BP 103
EP 113
DI 10.1007/8904_2015_449
D2 10.1007/978-3-662-49833-0
PG 11
WC Endocrinology & Metabolism; Genetics & Heredity
WE Book Citation Index – Science (BKCI-S)
SC Endocrinology & Metabolism; Genetics & Heredity
GA BI0RB
UT WOS:000405113200015
PM 26354038
OA Green Published
DA 2024-11-01
ER

PT J
AU Li, HZ
   Sharma, LK
   Li, YF
   Hu, PQ
   Idowu, A
   Liu, DH
   Lu, JX
   Bai, YD
AF Li, Hongzhi
   Sharma, Lokendra Kumar
   Li, Youfen
   Hu, Peiqing
   Idowu, Abimbola
   Liu, Danhui
   Lu, Jianxin
   Bai, Yidong
TI Comparative bioenergetic study of neuronal and muscle mitochondria
   during aging
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Mitochondria; Aging; Skeletal muscle; Synaptosome; Cybrid; Free radicals
ID OXIDATIVE-PHOSPHORYLATION; DNA MUTATIONS; HUMAN FIBROBLASTS;
   SKELETAL-MUSCLE; MTDNA MUTATIONS; CELLS; DECLINE; BRAIN; RESPIRATION;
   SUPEROXIDE
AB Mitochondrial respiratory chain defects have been associated with various diseases and with normal aging, particularly in tissues with high energy demands, including brain and skeletal muscle. Tissue-specific manifestation of mitochondria DNA (mtDNA) mutations and mitochondrial dysfunction are hallmarks of mitochondrial diseases although the underlying mechanisms are largely unclear. Previously, we and others have established approaches for transferring mtDNA from muscle and synaptosomes of mice at various ages to cell cultures. In this study, we carried out a comprehensive bioenergetic analysis of cells bearing mitochondria derived from young, middle-aged, and old mouse skeletal muscles and synaptosomes. Significant age-associated alterations in oxidative phosphorylation and regulation during aging were observed in cybrids carrying mitochondria from both skeletal muscle and synaptosomes. Our results also revealed that loss of oxidative phosphorylation capacity may occur at various ages in muscle and brain. These findings indicate the existence of a tissue-specific regulatory mechanism for oxidative phosphorylation. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Li, Hongzhi; Liu, Danhui; Lu, Jianxin] Wenzhou Med Coll, Sch Life Sci, Wenzhou 325035, Zhejiang, Peoples R China.
   [Li, Hongzhi; Sharma, Lokendra Kumar; Li, Youfen; Hu, Peiqing; Idowu, Abimbola; Bai, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
   [Li, Youfen] Xi An Jiao Tong Univ, Sch Life Sci, Xian 710049, Shanxi, Peoples R China.
C3 Wenzhou Medical University; University of Texas System; University of
   Texas Health Science Center at San Antonio; Xi'an Jiaotong University
RP Bai, YD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
EM baiy@uthscsa.edu
RI Li, You-Fen/W-9042-2019; Bai, Yidong/A-4959-2012
OI Idowu, Abimbola/0000-0002-3627-0235
FU National Institutes of Health [R01 AG025223]; Morrison Trust
FX This work was supported by grants from the National Institutes of Health
   (R01 AG025223) and the Morrison Trust to Y.B. We thank Drs. Anne Chomyn,
   Mai Zhou, and James Lechleiter for helpful discussion.
CR Alexeyev MF, 2009, FEBS J, V276, P5768, DOI 10.1111/j.1742-4658.2009.07269.x
   Anderton BH, 2002, MECH AGEING DEV, V123, P811, DOI 10.1016/S0047-6374(01)00426-2
   Bai YD, 2004, ANN NY ACAD SCI, V1011, P272, DOI 10.1196/annals.1293.026
   Bai YD, 2005, ANN NY ACAD SCI, V1042, P25, DOI 10.1196/annals.1338.003
   Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000
   Bishop N. A., NATURE, V464, P529
   BOSS GR, 1981, WESTERN J MED, V135, P434
   Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   Chabi B, 2005, BIOCHEM BIOPH RES CO, V332, P542, DOI 10.1016/j.bbrc.2005.04.153
   Cocco T, 2005, FREE RADICAL BIO MED, V38, P796, DOI 10.1016/j.freeradbiomed.2004.11.034
   Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a
   Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109
   Enríquez JA, 2000, J BIOL CHEM, V275, P11207, DOI 10.1074/jbc.275.15.11207
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197
   Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   Lesnefsky EJ, 2006, AGEING RES REV, V5, P402, DOI 10.1016/j.arr.2006.04.001
   Li Y., NUCL ACIDS RES, V38, P1913
   Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69
   Lushaj EB, 2008, J GERONTOL A-BIOL, V63, P921, DOI 10.1093/gerona/63.9.921
   Montoya J, 2009, ADV EXP MED BIOL, V652, P47, DOI 10.1007/978-90-481-2813-6_5
   Montoya J, 2009, BBA-BIOENERGETICS, V1787, P476, DOI 10.1016/j.bbabio.2008.09.003
   Nair KS, 2005, AM J CLIN NUTR, V81, P953
   Navarro A, 2009, J BIOENERG BIOMEMBR, V41, P517, DOI 10.1007/s10863-009-9250-6
   Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425
   Parihar MS, 2004, J CLIN NEUROSCI, V11, P456, DOI 10.1016/j.jocn.2003.12.007
   POLOSA PL, 1991, J BIOL CHEM, V266, P10011
   Rossi Paola, 2008, Curr Aging Sci, V1, P182
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Remmen H, 2001, EXP GERONTOL, V36, P957
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   Witelson SF, 2006, BRAIN, V129, P386, DOI 10.1093/brain/awh696
   Yao YG, 2007, HUM MOL GENET, V16, P286, DOI 10.1093/hmg/ddl457
NR 43
TC 17
Z9 22
U1 0
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD OCT
PY 2013
VL 63
SI SI
BP 30
EP 40
DI 10.1016/j.freeradbiomed.2013.04.030
PG 11
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 200TV
UT WOS:000323094700002
PM 23643721
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Brinckmann, A
   Weiss, C
   Wilbert, F
   von Moers, A
   Zwirner, A
   Stoltenburg-Didinger, G
   Wilichowski, E
   Schuelke, M
AF Brinckmann, Anja
   Weiss, Claudia
   Wilbert, Friederike
   von Moers, Arpad
   Zwirner, Angelika
   Stoltenburg-Didinger, Gisela
   Wilichowski, Ekkehard
   Schuelke, Markus
TI Regionalized Pathology Correlates with Augmentation of mtDNA Copy
   Numbers in a Patient with Myoclonic Epilepsy with Ragged-Red Fibers
   (MERRF-Syndrome)
SO PLOS ONE
LA English
DT Article
ID MITOCHONDRIAL-DNA MUTATION; ANTERIOR CINGULATE CORTEX; TISSUE
   DISTRIBUTION; CLINICAL PHENOTYPE; TRANSFER RNA(LYS); OXIDATIVE STRESS;
   RNALYS MUTATION; HUMAN-CELLS; DISEASE; SEGREGATION
AB Human patients with myoclonic epilepsy with ragged-red fibers (MERRF) suffer from regionalized pathology caused by a mutation in the mitochondrial DNA (m.8344A -> G). In MERRF-syndrome brain and skeletal muscles are predominantly affected, despite mtDNA being present in any tissue. In the past such tissue-specificity could not be explained by varying mtDNA mutation loads. In search for a region-specific pathology in human individuals we determined the mtDNA/nDNA ratios along with the mutation loads in 43 different post mortem tissue samples of a 16-year-old female MERRF patient and in four previously healthy victims of motor vehicle accidents. In brain and muscle we further determined the quantity of mitochondrial proteins (COX subunits II and IV), transcription factors (NRF1 and TFAM), and VDAC1 (Porin) as a marker for the mitochondrial mass. In the patient the mutation loads varied merely between 89-100%. However, mtDNA copy numbers were increased 3-7 fold in predominantly affected brain areas (e.g. hippocampus, cortex and putamen) and in skeletal muscle. Similar increases were absent in unaffected tissues (e.g. heart, lung, kidney, liver, and gastrointestinal organs). Such mtDNA copy number increase was not paralleled by an augmentation of mitochondrial mass in some investigated tissues, predominantly in the most affected tissue regions of the brain. We thus conclude that "futile'' stimulation of mtDNA replication per se or a secondary failure to increase the mitochondrial mass may contribute to the regionalized pathology seen in MERRF-syndrome.
C1 [Brinckmann, Anja; Weiss, Claudia; Wilbert, Friederike; Zwirner, Angelika; Schuelke, Markus] Charite, Dept Neuropediat, Berlin, Germany.
   [von Moers, Arpad] DRK Kliniken Westend, Berlin, Germany.
   [Stoltenburg-Didinger, Gisela] Charite, Dept Neuropathol, Berlin, Germany.
   [Wilichowski, Ekkehard] Univ Gottingen, Dept Pediat & Pediat Neurol, Gottingen, Germany.
   [Wilbert, Friederike; Schuelke, Markus] Charite, NeuroCure Clin Res Ctr, Berlin, Germany.
C3 Berlin Institute of Health; Berlin Institute of Health; Free University
   of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin
   Berlin; Berlin Institute of Health; Berlin Institute of Health; Free
   University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; University of Gottingen; Berlin Institute of
   Health; Berlin Institute of Health; Free University of Berlin; Humboldt
   University of Berlin; Charite Universitatsmedizin Berlin
RP Brinckmann, A (corresponding author), Charite, Dept Neuropediat, Berlin, Germany.
EM markus.schuelke@charite.de
OI Weiss, Claudia/0000-0001-6167-5878; Schuelke, Markus/0000-0003-2824-3891
FU Deutsche Forschungsgemeinschaft [SFB 665 TP C4]; NeuroCure Cluster of
   Excellence at the Charite, Berlin [Exc 257]; German ministry of
   education and research (BMBF, Bonn, Germany)
FX The project was funded by the Deutsche Forschungsgemeinschaft within the
   SFB 665 TP C4 "Developmental Disorders of the Nervous System'' and the
   NeuroCure Cluster of Excellence (Exc 257) at the Charite, Berlin. M. S.
   is a member of the German network for mitochondrial disorders (mitoNET,
   01GM0866), funded by the German ministry of education and research
   (BMBF, Bonn, Germany). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ABERCROMBIE M, 1946, ANAT RECORD, V94, P239, DOI 10.1002/ar.1090940210
   Acquaviva F, 2005, J CELL SCI, V118, P3917, DOI 10.1242/jcs.02516
   Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104
   Battersby BJ, 2007, NAT GENET, V39, P571, DOI 10.1038/ng0507-571
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brinckmann A, 2007, J MOL MED-JMM, V85, P163, DOI 10.1007/s00109-006-0112-y
   Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Foran DR, 2006, J FORENSIC SCI, V51, P766, DOI 10.1111/j.1556-4029.2006.00176.x
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gittins R, 2004, BRAIN RES, V1013, P212, DOI 10.1016/j.brainres.2004.03.064
   Gittins R, 2004, BRAIN RES BULL, V63, P155, DOI 10.1016/j.brainresbull.2004.02.005
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   Hori A, 2009, NUCLEIC ACIDS RES, V37, P749, DOI 10.1093/nar/gkn993
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425
   LERTRIT P, 1992, HUM GENET, V90, P251
   LOMBES A, 1992, NEUROMUSCULAR DISORD, V2, P323, DOI 10.1016/S0960-8966(06)80003-9
   MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   OLDFORS A, 1995, ACTA NEUROPATHOL, V90, P328
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   TANNO Y, 1993, NEUROLOGY, V43, P1198, DOI 10.1212/WNL.43.6.1198
   Wei YH, 2001, ANN NY ACAD SCI, V928, P97
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
NR 30
TC 22
Z9 24
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 20
PY 2010
VL 5
IS 10
AR e13513
DI 10.1371/journal.pone.0013513
PG 8
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 667TI
UT WOS:000283216400018
PM 20976001
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Eluamai, A
   Brooks, K
AF Eluamai, Anusha
   Brooks, Kelly
TI Effect of aerobic exercise on mitochondrial DNA and aging
SO JOURNAL OF EXERCISE SCIENCE & FITNESS
LA English
DT Review
DE Aerobic exercise; Aging; DNA
ID MTDNA; MUTATIONS; MUSCLE; DELETIONS; DAMAGE
AB The aging process occurs at different rates among different tissues. The complication of the definition of aging is due to the occurrence of various diseases that modify body functions and tissue structure. Advances in medicine and public health have considerably increased life expectancy over the past 200 years. An enormous effort has recently been expended to understand how the aging process is regulated at the molecular and cellular levels with hopes to find a way to extend maximal life span. There are several determinants of life span, but one common thread that has emerged in a variety of species from yeast to rodents is regulation of life span by mitochondria. Mitochondria decay that occurs with age cannot be counteracted unless physical activity is enhanced. As the frontiers of understanding the senescence and life span increases, the countermeasures for reducing aging senescence has brought to light the effectiveness of enhanced physical activities in aging individuals. Regular aerobic exercise may increase healthy life expectance and prolong life through beneficial effects at the mitochondrial level. Copyright (C) 2013, The Society of Chinese Scholars on Exercise Physiology and Fitness. Published by Elsevier (Singapore) Pte Ltd. All rights reserved.
C1 [Eluamai, Anusha; Brooks, Kelly] Texas A&M Univ Corpus Christi, Corpus Christi, TX 78412 USA.
C3 Texas A&M University System; Texas A&M University Corpus Christi
RP Brooks, K (corresponding author), Texas A&M Univ Corpus Christi, 6300 Ocean Dr, Corpus Christi, TX 78412 USA.
EM kelly.brooks@tamucc.edu
RI Brooks, Kelly/I-6871-2012
CR Aminuddin A., 2011, NEW IRAQI J MED, V7, P52
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Bloomer RJ, 2005, J STRENGTH COND RES, V19, P276
   Jafari A, 2005, BRIT J SPORT MED, V39, P517, DOI 10.1136/bjsm.2004.014068
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   LeBlanc PJ, 2004, J PHYSIOL-LONDON, V557, P559, DOI 10.1113/jphysiol.2003.058263
   Lindstedt SL, 2001, J EXP BIOL, V204, P3195
   Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102
   Marcuello A, 2012, J APPL PHYSIOL, V99, P1372
   Mirzaei B, 2010, S AFR J RES SPORT PH, V32, P99
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   Rhoads DM, 2006, PLANT PHYSIOL, V141, P357, DOI 10.1104/pp.106.079129
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Timmons JA, 2012, J APPL PHYSIOL, V108, P1487
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
NR 20
TC 10
Z9 14
U1 1
U2 18
PU ELSEVIER SINGAPORE PTE LTD
PI SINGAPORE
PA 3 KILLINEY ROAD 08-01, WINSLAND HOUSE 1, SINGAPORE, 239519, SINGAPORE
SN 1728-869X
J9 J EXERC SCI FIT
JI J. Exerc. Sci. Fit.
PY 2013
VL 11
IS 1
BP 1
EP 5
DI 10.1016/j.jesf.2013.03.003
PG 5
WC Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Sport Sciences
GA 181RJ
UT WOS:000321685900001
OA gold
DA 2024-11-01
ER

PT J
AU Weakley, SM
   Jiang, J
   Kougias, P
   Lin, PH
   Yao, QZ
   Brunicardi, FC
   Gibbs, RA
   Chen, CY
AF Weakley, Sarah M.
   Jiang, Jun
   Kougias, Panagiotis
   Lin, Peter H.
   Yao, Qizhi
   Brunicardi, F. Charles
   Gibbs, Richard A.
   Chen, Changyi
TI Role of somatic mutations in vascular disease formation
SO EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
LA English
DT Review
DE atherosclerosis; human genome project; mitochondrial DNA; pulmonary
   artery hypertension; somatic mutation
ID SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; MITOCHONDRIA DNA DELETIONS;
   ATHEROSCLEROTIC LESIONS; BRAIN MICROVESSELS; MICROSATELLITE INSTABILITY;
   PULMONARY-HYPERTENSION; CELLULAR SENESCENCE; ENDOTHELIAL-CELLS;
   OXIDATIVE STRESS
AB Coronary artery disease, cerebrovascular disease, pulmonary artery hypertension and Alzheimer's disease all lead to substantial morbidity and mortality, and we currently lack effective treatments for these vascular diseases. Since the discovery, decades ago, that atherosclerotic lesions display clonal growth, atherosclerosis and other vascular diseases have been postulated to be neoplastic processes, arising through a series of critical somatic mutations. There is conflicting evidence supporting this but studies of DNA damage and mutagenesis, both genomic and mitochondrial, in atherosclerotic and vascular lesions, have yielded evidence that somatic mutations are involved in atherogenesis and vascular disease development. The roles of mitochondrial DNA damage, oxidative stress and signaling by members of the TGF-beta receptor family are implicated. With the increasing convenience and cost-effectiveness of genome sequencing, it is feasible to continue to seek specific genetic targets in the pathogenesis of these devastating diseases, with the hope of developing personalized genomic medicine in the future.
C1 [Chen, Changyi] Baylor Coll Med, Michael E DeBakey Dept Surg R413, Houston, TX 77030 USA.
   [Jiang, Jun; Kougias, Panagiotis; Lin, Peter H.; Yao, Qizhi; Chen, Changyi] Michael E DeBakey VA Med Ctr, Houston, TX USA.
   [Weakley, Sarah M.; Jiang, Jun; Kougias, Panagiotis; Lin, Peter H.; Yao, Qizhi; Brunicardi, F. Charles] Baylor Coll Med, Michael E DeBakey Dept Surg, Mol Surg Res Ctr, Houston, TX 77030 USA.
   [Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine; Baylor College of Medicine
RP Chen, CY (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg R413, 1 Baylor Plaza,Mail Stop BCM391, Houston, TX 77030 USA.
EM jchen@bcm.tmc.edu
FU NIH [R01HL083471, T32HL083774, K08HL076345]; Michael E DeBakey
   Department of Surgery, Baylor College of Medicine, Houston, TX, USA
FX This work was partially supported by grants (R01HL083471, T32HL083774,
   and K08HL076345)from the NIH and by the Michael E DeBakey Department of
   Surgery, Baylor College of Medicine, Houston, TX, USA. The authors have
   no other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript a part from those disclosed.
CR Aliev G, 2002, ANN NY ACAD SCI, V977, P45, DOI 10.1111/j.1749-6632.2002.tb04798.x
   Aliev G, 2003, NEUROL RES, V25, P665, DOI 10.1179/016164103101201977
   Aliev G, 2008, VASC HEALTH RISK MAN, V4, P721, DOI 10.2147/VHRM.S2608
   Aliyev A, 2005, J NEUROL SCI, V229, P285, DOI 10.1016/j.jns.2004.11.040
   Anderson Jeffrey L, 2007, Curr Atheroscler Rep, V9, P179, DOI 10.1007/s11883-007-0017-4
   Andreassi MG, 2008, J MOL MED, V86, P1033, DOI 10.1007/s00109-008-0358-7
   Andreassi MG, 2009, MUTAT RES-FUND MOL M, V667, P35, DOI 10.1016/j.mrfmmm.2008.10.018
   [Anonymous], HEART DIS STROK STAT
   [Anonymous], 317 WHO
   Arvanitis DA, 2005, J CELL MOL MED, V9, P153, DOI 10.1111/j.1582-4934.2005.tb00345.x
   Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D
   Bartsch H, 2004, CANCER DETECT PREV, V28, P385, DOI 10.1016/j.cdp.2004.07.004
   BENDITT EP, 1973, P NATL ACAD SCI USA, V70, P1753, DOI 10.1073/pnas.70.6.1753
   Binková B, 2002, MUTAT RES-FUND MOL M, V501, P115, DOI 10.1016/S0027-5107(02)00019-2
   Binková B, 2001, INT J HYG ENVIR HEAL, V204, P49, DOI 10.1078/1438-4639-00072
   Bogliolo M, 1999, MUTAGENESIS, V14, P77, DOI 10.1093/mutage/14.1.77
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Botto N, 2002, CORONARY ARTERY DIS, V13, P269, DOI 10.1097/00019501-200208000-00004
   Botto N, 2001, MUTAT RES-GEN TOX EN, V493, P23, DOI 10.1016/S1383-5718(01)00162-0
   Brunicardi FC, 2009, WORLD J SURG, V33, P612, DOI 10.1007/s00268-008-9861-9
   Cakir Y, 2007, FREE RADICAL BIO MED, V43, P1279, DOI 10.1016/j.freeradbiomed.2007.07.015
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chung IM, 1998, AM J PATHOL, V152, P913
   Clark KJ, 2001, ARTERIOSCL THROM VAS, V21, P555, DOI 10.1161/01.ATV.21.4.555
   Costopouzos C, 2008, BIOCHEM PHARMACOL, V75, P1251, DOI 10.1016/j.bcp.2007.10.006
   Curfs DMJ, 2005, FASEB J, V19, P1290, DOI 10.1096/fj.04-2269fje
   Curfs DMJ, 2004, AM J PATHOL, V164, P101, DOI 10.1016/S0002-9440(10)63101-X
   Dandona Sonny, 2009, Curr Cardiol Rep, V11, P282
   Dandona S, 2009, CURR ATHEROSCLER REP, V11, P175, DOI 10.1007/s11883-009-0028-4
   David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978
   Daw EW, 2007, HUM MOL GENET, V16, P2463, DOI 10.1093/hmg/ddm202
   de la Chapelle A, 2003, NEW ENGL J MED, V349, P209, DOI 10.1056/NEJMp038099
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Federici C, 2008, AM J CARDIOL, V102, P1296, DOI 10.1016/j.amjcard.2008.07.024
   Feng ZH, 2004, P NATL ACAD SCI USA, V101, P8598, DOI 10.1073/pnas.0402794101
   Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074
   Godschalk R, 2003, FREE RADICAL RES, V37, P1299, DOI 10.1080/10715760310001621333
   Godschalk RWL, 2007, MUTAT RES-FUND MOL M, V621, P87, DOI 10.1016/j.mrfmmm.2007.02.012
   Gojova A, 2003, BLOOD, V102, P4052, DOI 10.1182/blood-2003-05-1729
   Gorgoulis VG, 2005, LAB INVEST, V85, P502, DOI 10.1038/labinvest.3700241
   Hamsten A, 2008, J INTERN MED, V263, P538, DOI 10.1111/j.1365-2796.2008.01958.x
   Hatzistamou J, 1996, BIOCHEM BIOPH RES CO, V225, P186, DOI 10.1006/bbrc.1996.1151
   Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379
   Hezel AF, 2005, CURR MOL MED, V5, P145, DOI 10.2174/1566524053586563
   Hong KH, 2008, CIRCULATION, V118, P722, DOI 10.1161/CIRCULATIONAHA.107.736801
   Iarmarcovai G, 2008, MUTAT RES-REV MUTAT, V658, P215, DOI 10.1016/j.mrrev.2007.10.001
   Izzotti A, 2007, MUTAT RES-FUND MOL M, V621, P119, DOI 10.1016/j.mrfmmm.2006.12.012
   Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Laghi L, 2008, ONCOGENE, V27, P6313, DOI 10.1038/onc.2008.217
   Lavezzi AM, 2005, APMIS, V113, P112, DOI 10.1111/j.1600-0463.2005.apm1130204.x
   Lee SD, 1998, J CLIN INVEST, V101, P927, DOI 10.1172/JCI1910
   Limaye N, 2009, NAT GENET, V41, P118, DOI 10.1038/ng.272
   Little MP, 2008, RADIAT RES, V169, P99, DOI 10.1667/RR1070.1
   Little MP, 2010, RADIAT ENVIRON BIOPH, V49, P139, DOI 10.1007/s00411-009-0250-z
   Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69
   Lutgens E, 2002, ARTERIOSCL THROM VAS, V22, P975, DOI 10.1161/01.ATV.0000019729.39500.2F
   Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285
   Machado RD, 2005, CIRCULATION, V111, P607, DOI 10.1161/01.CIR.0000154543.07679.08
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21
   Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006
   Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc
   Matturri L, 2003, J THROMB HAEMOST, V1, P2234, DOI 10.1046/j.1538-7836.2003.00409.x
   Matturri L, 2001, ATHEROSCLEROSIS, V154, P755, DOI 10.1016/S0021-9150(00)00488-3
   McCaffrey TA, 1997, J CLIN INVEST, V100, P2182, DOI 10.1172/JCI119754
   McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203
   Milei J, 2008, CAN J CARDIOL, V24, P137, DOI 10.1016/S0828-282X(08)70570-1
   Minamino T, 2008, NAT CLIN PRACT CARD, V5, P637, DOI 10.1038/ncpcardio1324
   Mishima T, 2008, INT J MOL MED, V21, P181
   Mulvihill ER, 2004, ARTERIOSCL THROM VAS, V24, P1283, DOI 10.1161/01.ATV.0000132401.12275.0c
   Naira J, 2007, MUTAT RES-FUND MOL M, V621, P95, DOI 10.1016/j.mrfmmm.2007.02.013
   Napoli C, 2002, NEOPLASIA, V4, P185, DOI 10.1038/sj.neo.7900232
   Nomiyama T, 2004, ANN NY ACAD SCI, V1011, P193, DOI 10.1196/annals.1293.020
   Nomiyama T, 2002, DIABETOLOGIA, V45, P1577, DOI 10.1007/s00125-002-0893-7
   PARKES JL, 1991, AM J PATHOL, V138, P765
   PENN A, 1986, P NATL ACAD SCI USA, V83, P7951, DOI 10.1073/pnas.83.20.7951
   Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796
   Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP
   Richter A, 2004, AM J RESP CRIT CARE, V170, P1340, DOI 10.1164/rccm.200311-1602OC
   Roberts R, 2008, CURR OPIN CARDIOL, V23, P629, DOI 10.1097/HCO.0b013e32830e6b4e
   Roy H, 2009, HUM GENET, V125, P467, DOI 10.1007/s00439-009-0654-5
   Sazonova M, 2009, ATHEROSCLEROSIS, V204, P184, DOI 10.1016/j.atherosclerosis.2008.09.001
   Schwartz SM, 1998, ANNU REV MED, V49, P437
   Simonneau G, 2013, J AM COLL CARDIOL, V62, pD34, DOI [10.1016/j.jacc.2013.10.029, 10.1016/j.jacc.2009.04.012]
   Singh NN, 2006, CYTOKINE GROWTH F R, V17, P487, DOI 10.1016/j.cytogfr.2006.09.002
   Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467
   Spandidos DA, 1996, BIOCHEM BIOPH RES CO, V220, P137, DOI 10.1006/bbrc.1996.0370
   Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177
   Takeshita J, 2006, J BIOL CHEM, V281, P3096, DOI 10.1074/jbc.M509236200
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tuder RM, 1998, AM J RESP CRIT CARE, V158, P1999, DOI 10.1164/ajrccm.158.6.9805002
   Tuder RM, 2001, CLIN CHEST MED, V22, P405, DOI 10.1016/S0272-5231(05)70280-X
   Wamhoff BR, 2004, CIRC RES, V95, P981, DOI 10.1161/01.RES.0000147961.09840.fb
   Yeager ME, 2001, CIRC RES, V88, pE2
   Yuan JXJ, 2005, CIRCULATION, V111, P534, DOI 10.1161/01.CIR.0000156326.48823.55
   Zaiman A, 2005, AM J RESP CELL MOL, V33, P425, DOI 10.1165/rcmb.F307
NR 99
TC 26
Z9 33
U1 0
U2 12
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 1473-7159
EI 1744-8352
J9 EXPERT REV MOL DIAGN
JI Expert Rev. Mol. Diagn.
PD MAR
PY 2010
VL 10
IS 2
BP 173
EP 185
DI 10.1586/ERM.10.1
PG 13
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 571VQ
UT WOS:000275784400005
PM 20214536
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Greaves, LC
   Taylor, RW
AF Greaves, Laura C.
   Taylor, Robert W.
TI Mitochondrial DNA mutations in human disease
SO IUBMB LIFE
LA English
DT Review
DE mtDNA disorders; mitochondrial genetics; neurodegenerative disease;
   ageing; cancer
ID MTDNA MUTATIONS; TRANSFER-RNA; GENE-THERAPY; STEM-CELLS; DISORDERS;
   SEGREGATION; POLYMERASE; EXPRESSION; HAPLOTYPE; APOPTOSIS
AB Since their first association with human disease in 1988, more than 250 pathogenic point mutations and rearrangements of the 16.6 kb mitochondrial genome (mtDNA) have been reported in a spectrum of clinical disorders which exhibit prominent muscle and central nervous system involvement. With novel mutations and disease phenotypes still being described, mtDNA disorders are recognized collectively as common, inherited genetic diseases although relatively little is still known concerning the precise pathophysiological mechanisms that lead to cell dysfunction and pathology. This review considers the basic principles of mitochondrial genetics which govern both the behaviour and investigation of pathogenic mtDNA mutations summarizing recent advances in this area, and an assessment of the ongoing debate into the role of somatic mtDNA mutations in neurodegenerative disease, ageing and cancer.
C1 Univ Newcastle Upon Tyne, Mitochondrial Res Grp, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Taylor, RW (corresponding author), Univ Newcastle Upon Tyne, Mitochondrial Res Grp, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.w.taylor@ncl.ac.uk
OI Greaves, Laura/0000-0002-8071-5916
CR Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Borthwick Gillian M, 2006, Ann Neurol, V59, P570, DOI 10.1002/ana.20758
   BROWN DT, 2006, IN PRESS LANCET
   Chinnery PF, 2005, LANCET, V366, P1650, DOI 10.1016/S0140-6736(05)67492-2
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Kirino Y, 2006, HUM MOL GENET, V15, P897, DOI 10.1093/hmg/ddl007
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Nishimura Y, 2006, P NATL ACAD SCI USA, V103, P1382, DOI 10.1073/pnas.0506911103
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Preston SL, 2003, CANCER RES, V63, P3819
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665
   Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012
   Shin MG, 2004, BLOOD, V103, P4466, DOI 10.1182/blood-2003-11-3949
   Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326
   Swalwell H, 2006, NEUROLOGY, V66, P447, DOI 10.1212/01.wnl.0000196490.36349.83
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, EXPERT OPIN BIOL TH, V5, P183, DOI 10.1517/14712598.5.2.183
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, ANN NEUROL, V54, P521, DOI 10.1002/ana.10673
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
NR 45
TC 35
Z9 42
U1 0
U2 39
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1521-6543
J9 IUBMB LIFE
JI IUBMB Life
PD MAR
PY 2006
VL 58
IS 3
BP 143
EP 151
DI 10.1080/15216540600686888
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 042SR
UT WOS:000237550300004
PM 16766381
OA Bronze
DA 2024-11-01
ER

PT J
AU Dimmock, DP
   Lawlor, MW
AF Dimmock, David P.
   Lawlor, Michael W.
TI Presentation and Diagnostic Evaluation of Mitochondrial Disease
SO PEDIATRIC CLINICS OF NORTH AMERICA
LA English
DT Article
DE Mitochondrial; Myopathy; Metabolic; Electron transport chain; mtDNA;
   Diagnosis
ID DISORDERS; DYSFUNCTION; NUCLEAR; GENES
AB Mitochondrial disease (MD) occurs when alteration of mitochondria] respiratory chain complex function caused by genetic mutation produces a detectable disease state. These mutations may be found in either the nuclear or mitochondrial genomes, and may only be present in a subset of cells or body tissues. Thus, the phenotype of MD is extremely variable and the definitive diagnosis of MD is complex. This article provides a brief description of a strategy used in the diagnosis of MD, by integrating data. from clinical, imaging, pathologic, molecular, and enzymatic assessments. Additional information on characteristic findings seen in classic MD syndromes is also provided.
C1 [Dimmock, David P.] Rady Childrens Inst Genom Med, 3020 Childrens Way,MC 5129, San Diego, CA 92123 USA.
   [Dimmock, David P.] Med Coll Wisconsin, Dept Pediat, Div Genet, Human Mol Genet Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
   [Lawlor, Michael W.] Med Coll Wisconsin, Dept Pathol & Lab Med, Div Pediat Pathol, Neurosci Res Ctr, 8701 Watertown Plank Rd,TBRC Bldg,Room C4490, Milwaukee, WI 53226 USA.
C3 Medical College of Wisconsin; Medical College of Wisconsin
RP Lawlor, MW (corresponding author), 8701 Watertown Plank Rd,TBRC Bldg,Room C4490, Milwaukee, WI 53226 USA.
EM mlawlor@mcw.edu
RI Dimmock, David/I-7913-2015
OI Dimmock, David/0000-0001-6690-2523
FU Children's Hospital of Wisconsin Research Institute; Clinical and
   Translational Science Institute of Southeastern Wisconsin (NCATS) [8UL1
   TR000055]
FX The authors thank Ms Maggie Beatka and Dr Hui Meng for their artwork in
   the design of Fig. 1. Electron microscopy images were obtained at the
   Medical College of Wisconsin's Electron Microscopy Core Facility. This
   work was supported by grants from the Children's Hospital of Wisconsin
   Research Institute and the Clinical and Translational Science Institute
   of Southeastern Wisconsin (through funding provided by NCATS 8UL1
   TR000055).
CR Bennett B, 2016, FREE RADICAL BIO MED, V92, P141, DOI 10.1016/j.freeradbiomed.2016.01.001
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Chinnery PF, 1993, GENEREVIEWS
   Gellerich FN, 2004, MITOCHONDRION, V4, P427, DOI 10.1016/j.mito.2004.07.007
   Gloerich J, 2007, J PROTEOME RES, V6, P506, DOI 10.1021/pr060487w
   Goh V, 2012, J PEDIATR GASTR NUTR, V54, P291, DOI 10.1097/MPG.0b013e318227e53c
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320
   Legati A, 2016, BBA-BIOENERGETICS, V1857, P1326, DOI 10.1016/j.bbabio.2016.02.022
   Meyers DE, 2013, TEX HEART I J, V40, P385
   Parikh S, 2014, MITOCHONDRION, V14, P26, DOI 10.1016/j.mito.2013.07.116
   Spinazzi M, 2011, MITOCHONDRION, V11, P893, DOI 10.1016/j.mito.2011.07.006
   Thorburn DR, 1993, GENEREVIEWS
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P913, DOI 10.1007/s10545-012-9579-6
NR 14
TC 14
Z9 18
U1 0
U2 21
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0031-3955
EI 1557-8240
J9 PEDIATR CLIN N AM
JI Pediatr. Clin. N. Am.
PD FEB
PY 2017
VL 64
IS 1
BP 161
EP +
DI 10.1016/j.pcl.2016.08.011
PG 12
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA EG3YR
UT WOS:000390981100012
PM 27894442
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Menezes, MP
   Ouvrier, RA
AF Menezes, Manoj P.
   Ouvrier, Robert A.
TI Peripheral neuropathy associated with mitochondrial disease in children
SO DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
LA English
DT Review
ID MARIE-TOOTH-DISEASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   PYRUVATE-DEHYDROGENASE DEFICIENCY; ONSET SPINOCEREBELLAR ATAXIA;
   RECESSIVE TWINKLE MUTATIONS; HEREDITARY OPTIC NEUROPATHY; SPINAL-CORD
   INVOLVEMENT; KEARNS-SAYRE SYNDROME; C-OXIDASE DEFICIENCY;
   DNA-POLYMERASE-GAMMA
AB Mitochondrial diseases in children are often associated with a peripheral neuropathy but the presence of the neuropathy is under-recognized because of the overwhelming involvement of the central nervous system (CNS). These mitochondrial neuropathies are heterogeneous in their clinical, neurophysiological, and histopathological characteristics. In this article, we provide a comprehensive review of childhood mitochondrial neuropathy. Early recognition of neuropathy may help with the identification of the mitochondrial syndrome. While it is not definite that the characteristics of the neuropathy would help in directing genetic testing without the requirement for invasive skin, muscle or liver biopsies, there appears to be some evidence for this hypothesis in Leigh syndrome, in which nuclear SURF1 mutations cause a demyelinating neuropathy and mitochondrial DNA MTATP6 mutations cause an axonal neuropathy. POLG1 mutations, especially when associated with late-onset phenotypes, appear to cause a predominantly sensory neuropathy with prominent ataxia. The identification of the peripheral neuropathy also helps to target genetic testing in the mitochondrial optic neuropathies. Although often subclinical, the peripheral neuropathy may occasionally be symptomatic and cause significant disability. Where it is symptomatic, recognition of the neuropathy will help the early institution of rehabilitative therapy. We therefore suggest that nerve conduction studies should be a part of the early evaluation of children with suspected mitochondrial disease.
C1 [Menezes, Manoj P.; Ouvrier, Robert A.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW 2145, Australia.
C3 University of Sydney; NSW Health; The Children's Hospital at Westmead
RP Menezes, MP (corresponding author), Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW 2145, Australia.
EM drmanojpm@yahoo.co.in
RI Menezes, Manoj/K-6372-2012
OI Menezes, Manoj/0000-0003-3160-6112
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   APPENZELLER O, 1976, ARCH NEUROL-CHICAGO, V33, P733, DOI 10.1001/archneur.1976.00500110001001
   Barkovich AJ, 2007, J NEURORADIOLOGY, V34, P75, DOI 10.1016/j.neurad.2007.01.125
   Bedlack RS, 2004, MUSCLE NERVE, V29, P364, DOI 10.1002/mus.10546
   BONNE G, 1993, PEDIATR RES, V33, P284, DOI 10.1203/00006450-199303000-00016
   Bouillot S, 2002, J PERIPHER NERV SYST, V7, P213, DOI 10.1046/j.1529-8027.2002.02027.x
   Bruno C, 2002, J CHILD NEUROL, V17, P233, DOI 10.1177/088307380201700318
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Cassereau J, 2009, NEUROGENETICS, V10, P145, DOI 10.1007/s10048-008-0166-9
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   CHABROL B, 1994, J CHILD NEUROL, V9, P52, DOI 10.1177/088307389400900113
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   Claramunt R, 2005, J MED GENET, V42, P358, DOI 10.1136/jmg.2004.022178
   Colomer J, 2000, REV NEUROLOGIA, V30, P1117, DOI 10.33588/rn.3012.2000079
   Craig K, 2007, J MED GENET, V44, P797, DOI 10.1136/jmg.2007.052902
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   den Boer MEJ, 2003, J PEDIATR-US, V142, P684, DOI 10.1067/mpd.2003.231
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Di Rocco M, 2000, Eur J Paediatr Neurol, V4, P115, DOI 10.1053/ejpn.2000.0278
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Erol I, 2009, NEUROMUSCULAR DISORD, V19, P275, DOI 10.1016/j.nmd.2009.01.012
   EYMARD B, 1991, REV NEUROL, V147, P508
   FEDERICO A, 1990, EUR NEUROL, V30, P123
   Távora DGF, 2007, ARQ NEURO-PSIQUIAT, V65, P506, DOI 10.1590/S0004-282X2007000300028
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012
   Fujii T, 1998, PEDIATR NEUROL, V18, P275, DOI 10.1016/S0887-8994(97)00187-2
   Funalot B, 2009, REV NEUROL-FRANCE, V165, P1118, DOI 10.1016/j.neurol.2009.10.001
   Gilhuis HJ, 2006, NEUROMUSCULAR DISORD, V16, P394, DOI 10.1016/j.nmd.2006.03.006
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Halter J, 2011, BONE MARROW TRANSPL, V46, P330, DOI 10.1038/bmt.2010.100
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   Hirano M, 1998, AM J HUM GENET, V63, P526, DOI 10.1086/301979
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Isohanni P, 2011, NEUROLOGY, V76, P811, DOI 10.1212/WNL.0b013e31820e7b25
   Isohanni P, 2010, J MED GENET, V47, P66, DOI 10.1136/jmg.2009.068221
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Marsac C, 1997, HUM GENET, V99, P785, DOI 10.1007/s004390050449
   McDonald DGM, 2002, AM J MED GENET, V111, P191, DOI 10.1002/ajmg.10522
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008
   Miyake N, 2011, CLIN GENET, V80, P293, DOI 10.1111/j.1399-0004.2011.01644.x
   MOLNAR M, 1995, NEUROPATH APPL NEURO, V21, P432, DOI 10.1111/j.1365-2990.1995.tb01080.x
   Morava E, 2009, MITOCHONDRION, V9, P438, DOI 10.1016/j.mito.2009.08.003
   Nelis E, 2002, NEUROLOGY, V59, P1865, DOI 10.1212/01.WNL.0000036272.36047.54
   Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Ostergaard E, 2008, J INHERIT METAB DIS, V31, P226, DOI 10.1007/s10545-008-0828-7
   OUVRIER RA, 1982, J NEUROL SCI, V55, P137, DOI 10.1016/0022-510X(82)90095-8
   Pandolfo M, 2009, J NEUROL, V256, P9, DOI 10.1007/s00415-009-1003-2
   Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3
   Papadimitriou A, 1998, NEUROLOGY, V51, P1086, DOI 10.1212/WNL.51.4.1086
   Patel KP, 2012, MOL GENET METAB, V105, P34, DOI 10.1016/j.ymgme.2011.09.032
   Perez-Atayde AR, 1998, AM J SURG PATHOL, V22, P1141, DOI 10.1097/00000478-199809000-00014
   Rojo A, 2006, ACTA NEUROPATHOL, V111, P610, DOI 10.1007/s00401-006-0040-5
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Santoro L, 2000, NEUROMUSCULAR DISORD, V10, P450, DOI 10.1016/S0960-8966(99)00122-4
   Santoro L, 1999, J NEUROL NEUROSUR PS, V66, P93, DOI 10.1136/jnnp.66.1.93
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   SCHRODER JM, 1993, BRAIN PATHOL, V3, P177, DOI 10.1111/j.1750-3639.1993.tb00742.x
   Sedel F, 2008, J NEUROL NEUROSUR PS, V79, P846, DOI 10.1136/jnnp.2007.136630
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   SIMON LT, 1990, ANN NEUROL, V28, P349, DOI 10.1002/ana.410280308
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Spiekerkoetter U, 2004, MUSCLE NERVE, V29, P66, DOI 10.1002/mus.10500
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Stickler DE, 2006, PEDIATR NEUROL, V34, P127, DOI 10.1016/j.pediatrneurol.2005.08.006
   Stickler DE, 2003, J CHILD NEUROL, V18, P574, DOI 10.1177/08830738030180081101
   Thorburn DR, 2003, GENE REV
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Vallat JM, 2008, J NEUROPATH EXP NEUR, V67, P1097, DOI 10.1097/NEN.0b013e31818b6cbc
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   VANERVEN PMM, 1987, J NEUROL, V234, P215
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Zanssen S, 1998, CLIN NEUROPATHOL, V17, P291
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 95
TC 25
Z9 27
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0012-1622
J9 DEV MED CHILD NEUROL
JI Dev. Med. Child Neurol.
PD MAY
PY 2012
VL 54
IS 5
BP 407
EP 414
DI 10.1111/j.1469-8749.2012.04271.x
PG 8
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 922KP
UT WOS:000302546100011
PM 22435634
DA 2024-11-01
ER

PT J
AU Latchman, K
   Saporta, M
   Moraes, CT
AF Latchman, Kumarie
   Saporta, Mario
   Moraes, Carlos T.
TI Mitochondrial dysfunction characterized in human induced pluripotent
   stem cell disease models in MELAS syndrome: A brief summary
SO MITOCHONDRION
LA English
DT Article
ID MUTATION
AB Human induced pluripotent stem cells (hiPSCs) for MELAS syndrome (mitochondrial myopathy, encephalopathy, lactic acidosis, stroke-like episodes) may allow deeper understanding of how tissue-specific mitochondrial dysfunction result in multi-systemic disease. Here, we summarize how the m.3243G mtDNA mutation affects mitochondrial function in different tissues using iPSC and iPSC-differentiated cell type disease models and what significant findings have been replicated in the independent studies. Through this brief review and with a focus on mitochondrial dysfunction in iPSC-differentiated cell types, namely fibroblast, neuron, and retinal pigment epithelium cells, we aim to bring awareness of hiPSC as a robust mitochondrial disease model even if many unanswered questions remain.
C1 [Latchman, Kumarie] Univ Miami, Dept Clin & Translat Genet, Miller Sch Med, Miami, FL 33136 USA.
   [Saporta, Mario; Moraes, Carlos T.] Univ Miami, Dept Neurol, Miller Sch Med, Miami, FL USA.
C3 University of Miami; University of Miami
RP Latchman, K (corresponding author), Univ Miami, Dept Clin & Translat Genet, Miller Sch Med, Miami, FL 33136 USA.
EM o604@med.miami.edu
RI ; Saporta, Mario/B-5992-2013
OI Latchman, Kumarie/0000-0002-0828-4795; Saporta,
   Mario/0000-0002-7142-9993
CR Bhattacharya S, 2022, STEM CELL RES THER, V13, DOI 10.1186/s13287-022-02937-6
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gunnewiek TMK, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107538
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110
   Homma K, 2021, REDOX BIOL, V41, DOI 10.1016/j.redox.2021.101921
   Kodaira M, 2015, FEBS OPEN BIO, V5, P219, DOI 10.1016/j.fob.2015.03.008
   Lin DS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010065
   Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
NR 12
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP
PY 2023
VL 72
BP 102
EP 105
DI 10.1016/j.mito.2023.08.003
EA AUG 2023
PG 4
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA T1JR2
UT WOS:001075623200001
PM 37633406
DA 2024-11-01
ER

PT J
AU Riccio, AA
   Bouvette, J
   Perera, L
   Longley, MJ
   Krahn, JM
   Williams, JG
   Dutcher, R
   Borgnia, MJ
   Copeland, WC
AF Riccio, Amanda A.
   Bouvette, Jonathan
   Perera, Lalith
   Longley, Matthew J.
   Krahn, Juno M.
   Williams, Jason G.
   Dutcher, Robert
   Borgnia, Mario J.
   Copeland, William C.
TI Structural insight and characterization of human Twinkle helicase in
   mitochondrial disease
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE mitochondrial DNA; Twinkle helicase; mitochondrial DNA replication;
   cryo-electron microscopy; progressive external ophthalmoplegia
ID STRANDED-DNA-BINDING; CRYSTAL-STRUCTURE; BACTERIOPHAGE T7; MODULAR
   ARCHITECTURE; PRIMASE; PROTEIN; MUTATIONS; DYNAMICS; VISUALIZATION;
   SIMULATION
AB Twinkle is the mammalian helicase vital for replication and integrity of mitochondrial DNA. Over 90 Twinkle helicase disease variants have been linked to progressive external ophthalmoplegia and ataxia neuropathies among other mitochondrial diseases. Despite the biological and clinical importance, Twinkle represents the only remaining component of the human minimal mitochondrial replisome that has yet to be structurally characterized. Here, we present 3-dimensional structures of human Twinkle W315L. Employing cryo-electron microscopy (cryo-EM), we characterize the oligomeric assemblies of human full-length Twinkle W315L, define its multimeric interface, and map clinical variants associated with Twinkle in inherited mitochondrial disease. Cryo-EM, crosslinking-mass spectrometry, and molecular dynamics simulations provide insight into the dynamic movement and molecular consequences of the W315L clinical variant. Collectively, this ensemble of structures outlines a framework for studying Twinkle function in mitochondrial DNA replication and associated disease states.
C1 [Riccio, Amanda A.; Longley, Matthew J.; Copeland, William C.] NIEHS, Mitochondrial DNA Replicat Grp, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA.
   [Bouvette, Jonathan; Borgnia, Mario J.] NIEHS, Mol Microscopy Consortium, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA.
   [Perera, Lalith] NIEHS, Computat Chem & Mol Modeling Support Grp, NIH, Res Triangle Pk, NC 27709 USA.
   [Krahn, Juno M.] NIEHS, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA.
   [Williams, Jason G.] NIEHS, Mass Spectrometry Res & Support Grp, Epigenet & Stem Cell Biol Lab, Genome Integr & Struct Biol Lab,NIH, Res Triangle Pk, NC 27709 USA.
   [Dutcher, Robert] NIEHS, Macromol Struct Grp, Epigenet & Stem Cell Biol Lab, NIH, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS); National Institutes of Health
   (NIH) - USA; NIH National Institute of Environmental Health Sciences
   (NIEHS); National Institutes of Health (NIH) - USA; NIH National
   Institute of Environmental Health Sciences (NIEHS); National Institutes
   of Health (NIH) - USA; NIH National Institute of Environmental Health
   Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH
   National Institute of Environmental Health Sciences (NIEHS); National
   Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Mitochondrial DNA Replicat Grp, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Perera, Lalith/ABB-9995-2021; Copeland, William/C-4242-2019
OI Riccio, Amanda A./0000-0001-7782-0363; Bouvette,
   Jonathan/0000-0003-3550-5319; Borgnia, Mario/0000-0001-9159-1413;
   Williams, Jason/0000-0002-7500-7077; Dutcher,
   Robert/0000-0002-5144-2111; Krahn, Juno Michelle/0000-0002-4640-0267;
   Copeland, William/0000-0002-0359-0953
FU Division of Intramural Research of the NIH, National Institute of
   Environmental Health Sciences (NIEHS) [Z01 ES065078, Z01 ES065080, Z01
   ES043010, ZIC ES 103326]; NIH [P41-GM103311]; National Institute of
   Environmental Health Sciences [ZIAES065078] Funding Source: NIH RePORTER
FX We thank Drs. Margaret Gustafson and Venkata Dandey for their critical
   reading of this manuscript and insightful discussions. This work was
   supported by the Division of Intramural Research of the NIH, National
   Institute of Environmental Health Sciences (NIEHS) (Z01 ES065078 and Z01
   ES065080 to W.C.C., Z01 ES043010 to L.P., and ZIC ES 103326 to M.J.B.).
   Molecular graphics and analyses performed with UCSF Chimera, developed
   by the Resource for Biocomputing, Visualization, and Informatics at the
   University of California, San Francisco, with support from NIH
   P41-GM103311.
CR [Anonymous], 2015, The PyMOL Molecular Graphics System
   Case DA., 2018, AMBER2018
   Combe CW, 2015, MOL CELL PROTEOMICS, V14, P1137, DOI 10.1074/mcp.O114.042259
   CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002
   Drulyte I, 2018, ACTA CRYSTALLOGR D, V74, P560, DOI 10.1107/S2059798318006496
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Fernández-Millán P, 2015, NUCLEIC ACIDS RES, V43, P4284, DOI 10.1093/nar/gkv189
   Gao Y, 2019, SCIENCE, V363, P835, DOI 10.1126/science.aav7003
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Jones M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14856-2
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kaguni LS, 2016, CRIT REV BIOCHEM MOL, V51, P53, DOI 10.3109/10409238.2015.1117056
   Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3
   Kaur P, 2020, J BIOL CHEM, V295, P5564, DOI 10.1074/jbc.RA120.012795
   Khan I, 2016, J BIOL CHEM, V291, P14324, DOI 10.1074/jbc.M115.712026
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Merkley ED, 2014, PROTEIN SCI, V23, P747, DOI 10.1002/pro.2458
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Patel G, 2011, J BIOL CHEM, V286, P20490, DOI 10.1074/jbc.M110.201657
   Peter B, 2020, GENES-BASEL, V11, DOI 10.3390/genes11040408
   Peter B, 2019, HUM MOL GENET, V28, P1090, DOI 10.1093/hmg/ddy415
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pilion MC, 2019, NAT STRUCT MOL BIOL, V26, P830, DOI 10.1038/s41594-019-0289-8
   Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/NMETH.4169, 10.1038/nmeth.4169]
   Riccio A. A., OCTAMERIC TWINKLE HE
   Riccio A. A., HEPTAMERIC HUMAN TWI
   Riccio A. A., OCTAMERIC HUMAN TWIN
   Riccio AA, 2021, WWPDB, DOI 10.2210/pdb7T8C/pdb
   Riccio AA, 2021, WWPDB, DOI 10.2210/pdb7T8B/pdb
   Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p
   Sanchez-Garcia R, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02399-1
   Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Senior AW, 2020, NATURE, V577, P706, DOI 10.1038/s41586-019-1923-7
   Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Vos SM, 2018, NATURE, V560, P607, DOI 10.1038/s41586-018-0440-4
   Wallen JR, 2017, STRUCTURE, V25, P157, DOI 10.1016/j.str.2016.11.019
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002
   Zhang HD, 2012, J BIOL CHEM, V287, P34273, DOI 10.1074/jbc.M112.401158
   Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
   Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663
NR 54
TC 7
Z9 9
U1 1
U2 11
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 1091-6490
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 9
PY 2022
VL 119
IS 32
AR e2207459119
DI 10.1073/pnas.2207459119
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 8X4GV
UT WOS:000931973700072
PM 35914129
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Björkman, K
   Vissing, J
   Ostergaard, E
   Bindoff, LA
   de Coo, IFM
   Engvall, M
   Hikmat, O
   Isohanni, P
   Kollberg, G
   Lindberg, C
   Majamaa, K
   Naess, K
   Uusimaa, J
   Tulinius, M
   Darin, N
AF Bjorkman, Kristoffer
   Vissing, John
   ostergaard, Elsebet
   Bindoff, Laurence A.
   de Coo, Irenaeus F. M.
   Engvall, Martin
   Hikmat, Omar
   Isohanni, Pirjo
   Kollberg, Gittan
   Lindberg, Christopher
   Majamaa, Kari
   Naess, Karin
   Uusimaa, Johanna
   Tulinius, Mar
   Darin, Niklas
TI Phenotypic spectrum and clinical course of single large-scale
   mitochondrial DNA deletion disease in the paediatric population: a
   multicentre study
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE congenital; hereditary; and neonatal diseases and abnormalities;
   sequence deletion; paediatrics; phenotype; prognosis
ID KEARNS-SAYRE SYNDROME; PEARSON-SYNDROME; PREVALENCE; PROGRESSION;
   MANAGEMENT; DISORDERS; CHILDHOOD; DIAGNOSIS; FEATURES; COHORT
AB Background Large-scale mitochondrial DNA deletions (LMD) are a common genetic cause of mitochondrial disease and give rise to a wide range of clinical features. Lack of longitudinal data means the natural history remains unclear. This study was undertaken to describe the clinical spectrum in a large cohort of patients with paediatric disease onset. Methods A retrospective multicentre study was performed in patients with clinical onset <16 years of age, diagnosed and followed in seven European mitochondrial disease centres. Results A total of 80 patients were included. The average age at disease onset and at last examination was 10 and 31 years, respectively. The median time from disease onset to death was 11.5 years. Pearson syndrome was present in 21%, Kearns-Sayre syndrome spectrum disorder in 50% and progressive external ophthalmoplegia in 29% of patients. Haematological abnormalities were the hallmark of the disease in preschool children, while the most common presentations in older patients were ptosis and external ophthalmoplegia. Skeletal muscle involvement was found in 65% and exercise intolerance in 25% of the patients. Central nervous system involvement was frequent, with variable presence of ataxia (40%), cognitive involvement (36%) and stroke-like episodes (9%). Other common features were pigmentary retinopathy (46%), short stature (42%), hearing impairment (39%), cardiac disease (39%), diabetes mellitus (25%) and renal disease (19%). Conclusion Our study provides new insights into the phenotypic spectrum of childhood-onset, LMD-associated syndromes. We found a wider spectrum of more prevalent multisystem involvement compared with previous studies, most likely related to a longer time of follow-up.
C1 [Bjorkman, Kristoffer; Tulinius, Mar; Darin, Niklas] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden.
   [Bjorkman, Kristoffer; Tulinius, Mar; Darin, Niklas] Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Gothenburg, Sweden.
   [Vissing, John] Rigshosp, Copenhagen Neuromuscular Ctr, Copenhagen, Denmark.
   [ostergaard, Elsebet] Rigshosp, Dept Clin Genet, Copenhagen, Denmark.
   [ostergaard, Elsebet] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark.
   [Bindoff, Laurence A.; Hikmat, Omar] Univ Bergen, Dept Clin Med K1, Bergen, Norway.
   [Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, NeurosysMed, Bergen, Norway.
   [de Coo, Irenaeus F. M.] Maastricht Univ, Dept Toxicogen, Unit Clin Genom, Maastricht, Netherlands.
   [de Coo, Irenaeus F. M.] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.
   [Engvall, Martin; Naess, Karin] Karolinska Univ Hosp, Ctr Inherited Metab Dis, Stockholm, Sweden.
   [Engvall, Martin] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
   [Hikmat, Omar] Haukeland Hosp, Dept Pediat, Bergen, Norway.
   [Isohanni, Pirjo] Univ Helsinki, Fac Med, Res Programs Unit, Stem Cells & Metab, Helsinki, Finland.
   [Isohanni, Pirjo] Univ Helsinki, Childrens Hosp, Helsinki, Finland.
   [Kollberg, Gittan] Univ Gothenburg, Dept Clin Chem, Gothenburg, Sweden.
   [Lindberg, Christopher] Sahlgrens Univ Hosp, Neuromuscular Ctr, Dept Neurol, Gothenburg, Sweden.
   [Majamaa, Kari] Oulu Univ, Fac Med, Med Res Ctr, Oulu, Finland.
   [Majamaa, Kari] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland.
   [Naess, Karin] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.
   [Uusimaa, Johanna] Oulu Univ, Fac Med, PEDEGO Res Unit, Oulu, Finland.
   [Uusimaa, Johanna] Oulu Univ Hosp, Clin Children & Adolescents, Oulu, Finland.
   [Darin, Niklas] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland.
C3 University of Gothenburg; Sahlgrenska University Hospital; Queen Silvia
   Children's Hospital; Rigshospitalet; University of Copenhagen;
   University of Copenhagen; Rigshospitalet; University of Copenhagen;
   University of Bergen; University of Bergen; Haukeland University
   Hospital; Maastricht University; Maastricht University; Karolinska
   Institutet; Karolinska University Hospital; Karolinska Institutet;
   University of Bergen; Haukeland University Hospital; University of
   Helsinki; University of Helsinki; University of Gothenburg; Sahlgrenska
   University Hospital; University of Oulu; University of Oulu; Karolinska
   Institutet; University of Oulu; University of Oulu; University of Oulu
RP Björkman, K (corresponding author), Univ Gothenburg, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden.
EM kristoffer.bjorkman@gu.se
RI Bindoff, Nathaniel/C-8050-2011; Björkman, Kristoffer/B-6805-2016;
   Østergaard, Elsebet/IZE-6519-2023; Vissing, John/IUN-4271-2023
OI Bjorkman, Kristoffer/0000-0001-6035-1388; Ostergaard,
   Elsebet/0000-0002-8047-063X
FU Queen Silvia Children's Hospital Research Foundation; Swedish government
   [ALFGBG-718681, ALFGBG-427421]; Swedish country councils [ALFGBG-718681,
   ALFGBG-427421]; Gothenburg Society of Medicine; NeMO [20_P10]
FX The study was supported by the Queen Silvia Children's Hospital Research
   Foundation (KB, ND, MT), the Swedish state under an agreement between
   the Swedish government and the country councils (ND: ALFGBG-718681; MT:
   ALFGBG-427421), and the Gothenburg Society of Medicine (KB). IFMdC is
   funded by NeMO (nr. 20_P10).
CR Anteneová N, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10110766
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   CAMPOS Y, 1995, PEDIATR NEUROL, V13, P69, DOI 10.1016/0887-8994(95)00082-Q
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Cerri C, 1983, MITOCHONDRIAL PATHOL, P141
   Chen J, 2018, ANTIOXID REDOX SIGN, V29, P1361, DOI 10.1089/ars.2017.7346
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Emma F, 2012, PEDIATR NEPHROL, V27, P539, DOI 10.1007/s00467-011-1926-6
   Farruggia P, 2016, JIMD REP, V26, P37, DOI 10.1007/8904_2015_470
   Ferrington DA, 2020, TRENDS MOL MED, V26, P105, DOI 10.1016/j.molmed.2019.10.008
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holzer T, 2019, J CELL BIOL, V218, P1853, DOI 10.1083/jcb.201809056
   Karaa A, 2015, PEDIATR DIABETES, V16, P1, DOI 10.1111/pedi.12223
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   McDonald DGM, 2002, AM J MED GENET, V111, P191, DOI 10.1002/ajmg.10522
   OLDFORS A, 1990, ACTA NEUROPATHOL, V80, P541, DOI 10.1007/BF00294616
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   Pijl S, 2008, EAR HEARING, V29, P472, DOI 10.1097/01.aud.0000310791.83193.62
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Quintos JB, 2016, J PEDIATR ENDOCR MET, V29, P1319, DOI 10.1515/jpem-2016-0172
   Rai PK, 2018, ESSAYS BIOCHEM, V62, P455, DOI 10.1042/EBC20170113
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1995, MUSCLE NERVE, pS159
   Sacher M, 2005, NEURORADIOLOGY, V47, P241, DOI 10.1007/s00234-004-1314-z
   Sadikovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015687
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Sofou K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-52
   TULINIUS MH, 1995, EUR J PEDIATR, V154, P35, DOI 10.1007/BF01972970
   Varhaug KN, 2020, ANN CLIN TRANSL NEUR, V7, P1318, DOI 10.1002/acn3.51119
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
   Wild KT, 2020, AM J MED GENET A, V182, P365, DOI 10.1002/ajmg.a.61433
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yu M, 2016, CHINESE MED J-PEKING, V129, P1419, DOI 10.4103/0366-6999.183417
NR 47
TC 4
Z9 4
U1 1
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD JAN
PY 2023
VL 60
IS 1
BP 65
EP 73
DI 10.1136/jmedgenet-2021-108006
EA DEC 2021
PG 9
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 7O9TO
UT WOS:000728713700001
PM 34872991
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Mömke, S
   Distl, O
AF Moemke, Stefanie
   Distl, Ottmar
TI Bilateral convergent strabismus with exophthalmus (BCSE) in cattle:: An
   overview of clinical signs and genetic traits
SO VETERINARY JOURNAL
LA English
DT Review
DE cattle; strabismus; inheritance; candidate gene; comparative genomics
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; NUCLEOTIDE TRANSLOCATOR-1 GENE;
   DAIRY-CATTLE; MITOCHONDRIAL-DNA; MTDNA DELETIONS; MUTATION; MNGIE
AB Bilateral convergent strabismus with exophthalmus (BCSE) is a heritable eye defect prevalent in many cattle breeds and known worldwide. BCSE shows a progressive course often terminating in complete blindness. The onset of the defect can sometimes be slowly progressing (late in life) and, as the first signs of the defect are frequently not noticed prior to first breeding, prevention cannot be achieved only by exclusion of affected animals from the breeding program.
   This paper provides an overview of the clinical signs, histopathology and genetics of BCSE, its distribution in different cattle breeds and analyses the association between milk production traits and US Brown Swiss. There were different modes of inheritance proposed for BCSE, but although an autosomal dominant major gene is considered most likely in German Brown cattle, an association with milk production traits could not be found. Comparative molecular genetic approaches could help to characterize the responsible genes for this ocular disease in cattle. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Vet Med Hannover, Inst Genet & Anim Breeding, D-30559 Hannover, Germany.
C3 University of Veterinary Medicine Hannover
RP Distl, O (corresponding author), Univ Vet Med Hannover, Inst Genet & Anim Breeding, Bunteweg 17P, D-30559 Hannover, Germany.
EM ottmar.distl@tiho-hannover.de
CR BARRIER M, 1885, B SOC CENTRALE MED V, V29, P303
   Deschauer M, 2001, NERVENARZT, V72, P122, DOI 10.1007/s001150050724
   DISTL O, 1994, DEUT TIERARZTL WOCH, V101, P202
   DISTL O, 1993, J ANIM BREED GENET, V110, P393, DOI 10.1111/j.1439-0388.1993.tb00752.x
   Distl O, 2000, J VET MED A, V47, P31, DOI 10.1046/j.1439-0442.2000.00259.x
   DISTL O, 1991, DEUT TIERARZTL WOCH, V98, P354
   Gerst M, 1997, ARCH TIERZUCHT, V40, P401
   Gerst M, 1998, TIERARZTL UMSCHAU, V53, P6
   GERST M, 1996, THESIS L MAXIMILIANS
   HAUKE G, 2003, THESIS TIERARZTLICHE
   Holmes J. R., 1957, Veterinary Record, V69, P148
   JAKOB H, 1920, TIERARZTLICHE AUGENH, P71
   JUBB TF, 1988, AUST VET J, V65, P353, DOI 10.1111/j.1751-0813.1988.tb14263.x
   JULIAN RJ, 1975, VET MED SMALL ANIMAL, P1151
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KOCH, 1875, LEHRBUCH AUGENHEILKU, P400
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Magnusson R. A., 1983, Bovine Practitioner, V18, P195
   MILES KA, 1932, VET REC, V12, P759
   MINTSCHEV P, 1965, RIND MONATSHEFTE VET, V20, P41
   Mojon D, 2001, Ther Umsch, V58, P49, DOI 10.1024/0040-5930.58.1.49
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   POWER EP, 1987, IRISH VET J, V41, P357
   Regan WM, 1944, J HERED, V35, P233, DOI 10.1093/oxfordjournals.jhered.a105391
   SCHUTZHANKE W, 1979, DEUT TIERARZTL WOCH, V86, P185
   SISSON S, 1953, ANATOMY DOMESTIC ANI, P860
   Sorkin JA, 1997, AM J OPHTHALMOL, V123, P235, DOI 10.1016/S0002-9394(14)71041-4
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VEENENDAL H, 1958, TIJDSCHRIFT DIERGEEN, V83, P337
   Vissing J, 2002, NEUROLOGY, V59, P926, DOI 10.1212/WNL.59.6.926
   Vogt C., 2002, Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere, V30, P148
   VOGT C, 2000, THESIS TIERARZLTLICH
NR 35
TC 7
Z9 7
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-0233
J9 VET J
JI Vet. J.
PD MAR
PY 2007
VL 173
IS 2
BP 272
EP 277
DI 10.1016/j.tvjl.2005.11.020
PG 6
WC Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences
GA 145IQ
UT WOS:000244858900012
PM 16434218
DA 2024-11-01
ER

PT J
AU Domínguez-González, C
   Hernández-Voth, A
   De la Hoz, CPDF
   Guerrero, LB
   Morís, G
   García-García, J
   Muelas, N
   Hernández, JCL
   Rabasa, M
   Lora, D
   Blázquez, A
   Arenas, J
   Martin, MA
AF Dominguez-Gonzalez, Cristina
   Hernandez-Voth, Ana
   De Fuenmayor-Fernandez De la Hoz, Carlos Pablo
   Guerrero, Laura Bermejo
   Moris, German
   Garcia-Garcia, Jorge
   Muelas, Nuria
   Leon Hernandez, Juan Carlos
   Rabasa, Maria
   Lora, David
   Blazquez, Alberto
   Arenas, Joaquin
   Martin, Miguel Angel
TI Metrics of progression and prognosis in untreated adults with thymidine
   kinase 2 deficiency: An observational study
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Thymidine kinase 2 deficiency; Creatinine; Mitochondrial disease;
   Clinical trials (observational study)
ID MITOCHONDRIAL-DNA DEPLETION; DIFFERENTIATION FACTOR 15; NATURAL-HISTORY;
   MUTATIONS; BIOMARKER; GROWTH; MECHANISMS; DEFECT
AB This historical cohort study evaluated clinical characteristics of progression and prognosis in adults with thymidine kinase 2 deficiency (TK2d). Records were available for 17 untreated adults with TK2d (mean age of onset, 32 years), including longitudinal data from 6 patients (mean follow-up duration, 26.5 months). Pearson's correlation assessed associations between standard motor and respiratory assessments, clinical characteristics, and laboratory values. Longitudinal data were assessed by linear regression mixed models. Respiratory involvement progressed at an annual rate of 8.16% decrement in forced vital capacity (FVC). Most patients under noninvasive ventilation (NIV) remained ambulant (12/14, 86%), reduced FVC was not associated with concomitant decline in 6-minute walk test (6MWT), and 6MWT results were not correlated with FVC. Disease severity, assessed by age at NIV onset, correlated most strongly at diagnosis with: creatinine levels ( r = 0.8036; P = 0.0 0 09), followed by FVC ( r = 0.7265; P = 0.0033), mtDNA levels in muscle ( r = 0.7933; P = 0.0188), and age at disease onset ( r = 0.7128; P = 0.0042). This population of adults with TK2d demonstrates rapid deterioration of respiratory muscles, which progresses independently of motor impairment. The results support FVC at diagnosis, mtDNA levels in muscle, and age at disease onset as prognostic indicators. Creatinine levels may also be potentially prognostic, as previously reported in other neuromuscular disorders.(c) 2022 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
C1 [Dominguez-Gonzalez, Cristina; De Fuenmayor-Fernandez De la Hoz, Carlos Pablo; Guerrero, Laura Bermejo] Hosp 12 Octubre, Neuromuscular Disorders Unit, Neurol Dept, Madrid 28041, Spain.
   [Dominguez-Gonzalez, Cristina; Muelas, Nuria; Blazquez, Alberto; Martin, Miguel Angel] Inst Salud Carlos III, Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain.
   [Hernandez-Voth, Ana] Hosp 12 Octubre, Mech Ventilat Unit, Pneumol Dept, Madrid, Spain.
   [Moris, German] Hosp Univ Cent Asturias, Neurol Dept, Neuromuscular Disorders Unit, Asturias, Spain.
   [Garcia-Garcia, Jorge] Hosp Univ Albacete, Dept Neurol, Albacete, Spain.
   [Muelas, Nuria] Hosp Univ & Politecn La Fe, Inst Invest Sanitaria La Fe, Neurol Dept, Neuromuscular Dis Unit,Neuromuscular & Ataxias Re, Valencia, Spain.
   [Leon Hernandez, Juan Carlos] Hosp Univ Nuestra Senora Candelaria, Neurol Dept, Tenerife, Spain.
   [Rabasa, Maria] Hosp Fuenlabrada, Neurol Dept, Madrid, Spain.
   [Lora, David] Hosp 12 Octubre Res Inst Imas12, Clin Res Unit, Madrid 28041, Spain.
   [Blazquez, Alberto; Arenas, Joaquin; Martin, Miguel Angel] Hosp Univ 12 Octubre, Res Inst Imas12, Clin Biochem Dept, Mitochondrial Disorders Lab, Madrid, Spain.
   [Dominguez-Gonzalez, Cristina] Hosp 12 Octubre, Inst Invest Imas12, Madrid, Spain.
   [Lora, David] Univ Complutense Madrid, Fac Estudios Estadist, Dept Estadist & Ciencia Datos, Madrid 28040, Spain.
   [Lora, David] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid, Spain.
C3 Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion
   Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Hospital
   Universitario 12 de Octubre; Central University Hospital Asturias;
   Hospital Universitari i Politecnic La Fe; Hospital Universitario
   Fuenlabrada; Hospital Universitario 12 de Octubre; Hospital
   Universitario 12 de Octubre; Complutense University of Madrid; CIBER -
   Centro de Investigacion Biomedica en Red; CIBERESP
RP Domínguez-González, C (corresponding author), Hosp 12 Octubre, Neuromuscular Disorders Unit, Neurol Dept, Madrid 28041, Spain.
EM cdgonzalez@salud.madrid.org
RI Lora, David/R-9816-2016; GARCIA-GARCIA, JORGE/GRY-0234-2022; Martin,
   Miguel/S-2758-2018; Encinar, Alberto/S-4425-2018; Martin, Miguel
   Angel/B-6261-2017; Moris, German/M-2920-2018
OI Garcia-Garcia, Jorge/0000-0001-9867-9709; Martin, Miguel
   Angel/0000-0003-4741-772X; Bermejo-Guerrero, Laura/0000-0002-8349-715X;
   de Fuenmayor Fernandez de la Hoz, Carlos Pablo/0000-0003-4766-4974;
   Dominguez, Cristina/0000-0001-5151-988X; Moris,
   German/0000-0001-7608-2194
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alves CRR, 2020, NEUROLOGY, V94, pE921, DOI 10.1212/WNL.0000000000008762
   Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006
   Annane D, 1999, EUR RESPIR J, V13, P157, DOI 10.1183/09031936.99.13115799
   Annane D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001941.pub3
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Blázquez-Bermejo C, 2019, EBIOMEDICINE, V46, P342, DOI 10.1016/j.ebiom.2019.07.042
   Boenzi S, 2018, ESSAYS BIOCHEM, V62, P443, DOI 10.1042/EBC20170111
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Buzkova J, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809091
   Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   de la Hoz CPDF, 2021, MOL GENET METAB REP, V26, DOI 10.1016/j.ymgmr.2020.100701
   Desler C, 2006, NUCLEOS NUCLEOT NUCL, V25, P1171, DOI 10.1080/15257770600894501
   Dominguez-Gonzalez C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66940-8
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1071-z
   Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453
   Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88
   Eriksson S, 2008, NUCLEOS NUCLEOT NUCL, V27, P800, DOI 10.1080/15257770802146197
   Esterhuizen K, 2019, MITOCHONDRION, V45, P38, DOI 10.1016/j.mito.2018.02.003
   Garone C, 2014, J NEUROMUSCUL DIS, V1, pS240
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Guo QF, 2021, ANN CLIN TRANSL NEUR, V8, P448, DOI 10.1002/acn3.51299
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   Hamon SM, 2019, CLIN CHEM LAB MED, V57, P510, DOI 10.1515/cclm-2018-0534
   Hijikata Y, 2018, NEUROLOGY, V90, pE1501, DOI 10.1212/WNL.0000000000005360
   Hijikata Y, 2016, ANN CLIN TRANSL NEUR, V3, P537, DOI 10.1002/acn3.324
   Holdom CJ, 2021, EUR J NEUROL, V28, P3615, DOI 10.1111/ene.15003
   Ji XB, 2017, MOL NEUROBIOL, V54, P8110, DOI 10.1007/s12035-016-0283-7
   Knierim E, 2015, MITOCHONDRION, V20, P1, DOI 10.1016/j.mito.2014.10.007
   Laine-Menéndez S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115598
   Leshinsky-Silver E, 2008, EUR J PAEDIATR NEURO, V12, P309, DOI 10.1016/j.ejpn.2007.09.005
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Lopez-Gomez C, 2021, ANN NEUROL, V90, P640, DOI 10.1002/ana.26185
   Lopez-Gomez C, 2019, EBIOMEDICINE, V46, P356, DOI 10.1016/j.ebiom.2019.07.037
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Martín-Hernández E, 2017, PEDIATR DEVEL PATHOL, V20, P416, DOI 10.1177/1093526616686439
   Mayhew AG, 2013, DEV MED CHILD NEUROL, V55, P1046, DOI 10.1111/dmcn.12220
   Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902
   Montero R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148709
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Poulsen NS, 2020, MITOCHONDRION, V50, P35, DOI 10.1016/j.mito.2019.10.005
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Wang J, 2019, TK2 RELATED MITOCHON
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   Wang L, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00196
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Zhang HL, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/141856
NR 50
TC 3
Z9 3
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD SEP
PY 2022
VL 32
IS 9
BP 728
EP 735
DI 10.1016/j.nmd.2022.07.399
EA SEP 2022
PG 8
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 5H1WB
UT WOS:000867474800003
PM 35907766
OA hybrid
DA 2024-11-01
ER

PT J
AU Tschampa, HJ
   Urbach, H
   Greschus, S
   Kunz, WS
   Kornblum, C
AF Tschampa, Henriette J.
   Urbach, Horst
   Greschus, Susanne
   Kunz, Wolfram S.
   Kornblum, Cornelia
TI Neuroimaging characteristics in mitochondrial encephalopathies
   associated with the m.3243A&gt;G <i>MTTL1</i> mutation
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE MELAS; Mitochondrial myopathy; MRI; Basal ganglia; Stroke-like episodes
ID STROKE-LIKE EPISODES; DELAYED ISCHEMIC HYPERINTENSITY; MELAS SYNDROME;
   BLOOD; MRI; DNA; CT; CAUDOPUTAMEN; FEATURES
AB Stroke-like lesions (SLL) are common radiological findings in patients with mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (SLE; MELAS) harboring the m.3243A > G MTTL1 mutation. Imaging patterns in the m.3243A > G mutation carriers with encephalopathies lacking SLE have not been systematically examined to date. The aim of this study was to analyze brain imaging findings in encephalopathies associated with the m.3243A > G mutation irrespective of the presence or absence of SLE. Brain MRI and cranial CT scans from 11 m.3243A > G mutation carriers with encephalopathies were analyzed by two neuroradiologists in consensus. We evaluated stroke-like lesions (SLL), deep grey matter (DGM) changes on T1- and T2-weighted MR images, calcification on CT, brain atrophy, and white matter (WM) changes. SLL were present in all patients showing the full MELAS phenotype with SLE (4/11). Seven patients did not show SLE. DGM changes with T1 hyperintensity and T2 hypointensity were a distinctive finding in most patients (7/11) and present in the majority of m.3243A > G mutation carriers lacking SLE (5/7). DGM changes were also seen in half of our MELAS patients with SLL (2/4), though less pronounced. Brain atrophy was a prominent finding in general and accentuated in the cerebellum. In contrast, WM changes were rather mild and more prevalent and pronounced in MELAS. Our data stress that the distinction between MELAS with SLE and m.3243A > G mutation carriers lacking SLE is rather artificial. In clinical practice, mitochondrial disorders associated with the m.3243A > G mutation should be taken into consideration in encephalopathies with DGM changes, even when SLE and SLL are lacking.
C1 [Tschampa, Henriette J.; Urbach, Horst; Greschus, Susanne] Univ Bonn, Dept Radiol Neuroradiol, Bonn, Germany.
   [Kunz, Wolfram S.] Univ Bonn, Dept Epileptol, Bonn, Germany.
   [Kornblum, Cornelia] Univ Bonn, Dept Neurol, Bonn, Germany.
C3 University of Bonn; University of Bonn; University of Bonn
RP Tschampa, HJ (corresponding author), Univ Bonn, Dept Radiol Neuroradiol, Bonn, Germany.
EM henriette.tschampa@ukb.uni-bonn.de
RI Kornblum, Cornelia/IUM-4180-2023; Kunz, Wolfram/K-1232-2019
OI Kunz, Wolfram/0000-0003-1113-3493
CR BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   BOYKO OB, 1992, AM J NEURORADIOL, V13, P1439
   Chung SH, 2005, NEUROLOGY, V65, pE19, DOI 10.1212/01.wnl.0000184112.34211.d1
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Fujioka M, 2003, ANN NEUROL, V54, P732, DOI 10.1002/ana.10751
   Fujioka M, 1999, STROKE, V30, P1043, DOI 10.1161/01.STR.30.5.1043
   Fujioka M, 1999, STROKE, V30, P1038, DOI 10.1161/01.STR.30.5.1038
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gutierrez LG, 2010, NEURORADIOLOGY, V52, P949, DOI 10.1007/s00234-010-0728-z
   Haas R, 2004, MITOCHONDRION, V4, P471, DOI 10.1016/j.mito.2004.07.008
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Iizuka T, 2007, J NEUROL SCI, V257, P126, DOI 10.1016/j.jns.2007.01.040
   Ito H, 2008, BRAIN DEV-JPN, V30, P483, DOI 10.1016/j.braindev.2008.01.003
   Ito H, 2011, BRAIN DEV-JPN, V33, P283, DOI 10.1016/j.braindev.2010.06.010
   Kim IO, 1996, AM J ROENTGENOL, V166, P641, DOI 10.2214/ajr.166.3.8623642
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Ohshita T, 2000, NEURORADIOLOGY, V42, P651, DOI 10.1007/s002340000335
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Tzoulis C, 2009, STROKE, V40, pE15, DOI 10.1161/STROKEAHA.108.523118
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   VANDERKNAAP MS, 1993, NEUROPEDIATRICS, V24, P143, DOI 10.1055/s-2008-1071532
   Virtanen SM, 2011, AM J NEURORADIOL, V32, P522, DOI 10.3174/ajnr.A2309
   Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318
   Wang XY, 2003, NEURORADIOLOGY, V45, P640, DOI 10.1007/s00234-003-1029-6
NR 32
TC 27
Z9 29
U1 0
U2 6
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD APR
PY 2013
VL 260
IS 4
BP 1071
EP 1080
DI 10.1007/s00415-012-6763-4
PG 10
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 122XM
UT WOS:000317351900016
PM 23196335
DA 2024-11-01
ER

PT J
AU Crugnola, V
   Lamperti, C
   Lucchini, V
   Ronchi, D
   Peverelli, L
   Prelle, A
   Sciacco, M
   Bordoni, A
   Fassone, E
   Fortunato, F
   Corti, S
   Silani, V
   Bresolin, N
   Di Mauro, S
   Comi, GP
   Moggio, M
AF Crugnola, Veronica
   Lamperti, Costanza
   Lucchini, Valeria
   Ronchi, Dario
   Peverelli, Lorenzo
   Prelle, Alessandro
   Sciacco, Monica
   Bordoni, Andreina
   Fassone, Elisa
   Fortunato, Francesco
   Corti, Stefania
   Silani, Vincenzo
   Bresolin, Nereo
   Di Mauro, Salvatore
   Comi, Giacomo Pietro
   Moggio, Maurizio
TI Mitochondrial Respiratory Chain Dysfunction in Muscle From Patients With
   Amyotrophic Lateral Sclerosis
SO ARCHIVES OF NEUROLOGY
LA English
DT Article
ID MOTOR-NEURON DISEASE; SUPEROXIDE-DISMUTASE GENE; SPINAL
   MUSCULAR-ATROPHY; SKELETAL-MUSCLE; OXIDATIVE STRESS; ALS PATIENTS;
   MUTATIONS; PROTEIN; DNA; ULTRASTRUCTURE
AB Background: Amyotrophic lateral sclerosis (ALS) is a major cause of neurological disability and its pathogenesis remains elusive despite a multitude of studies. Although defects of the mitochondrial respiratory chain have been described in several ALS patients, their pathogenic significance is unclear.
   Objective: To review systematically the muscle biopsy specimens from patients with typical sporadic ALS to search for possible mitochondrial oxidative impairment.
   Design: Retrospective histochemical, biochemical, and molecular studies of muscle specimens.
   Setting: Tertiary care university.
   Subjects: Fifty patients with typical sporadic ALS (mean age, 55 years).
   Main Outcome Measure: Number of patients showing a clear muscle mitochondrial dysfunction assessed through histochemical and biochemical muscle analysis.
   Results: Histochemical data showed cytochrome c oxidase (COX)-negative fibers in 46% patients. Based on COX histochemical activity, patients fell into 4 groups: 27 had normal COX activity; and 8 had mild (2-4 COX-negative fibers of 100 fibers), 8 had moderate (5-10 COX-negative fibers of 100), and 7 had severe (>10 COX-negative fibers of 100) COX deficiency. Spectrophotometric measurement of respiratory chain activities showed that 3 patients with severe histochemical COX deficiency also showed combined enzyme defects. In 1 patient, COX deficiency worsened in a second biopsy taken 9 months after the first. Among the patients with severe COX deficiency, one had a new mutation in the SOD1 gene, another a mutation in the TARDBP gene, and a third patient with biochemically confirmed COX deficiency had multiple mitochondrial DNA deletions detectable by Southern blot analysis.
   Conclusions: Our data confirm that the histochemical finding of COX-negative fibers is common in skeletal muscle from patients with sporadic ALS. We did not find a correlation between severity of the oxidative defect and age of the patients or duration of the disease. However, the only patient who underwent a second muscle biopsy did show a correlation between severity of symptoms and worsening of the respiratory chain defect. In 7 patients, the oxidative defect was severe enough to support the hypothesis that mitochondrial dysfunction must play a role in the pathogenesis of the disease.
C1 [Crugnola, Veronica; Lamperti, Costanza; Lucchini, Valeria; Ronchi, Dario; Peverelli, Lorenzo; Prelle, Alessandro; Sciacco, Monica; Fassone, Elisa; Corti, Stefania; Bresolin, Nereo; Comi, Giacomo Pietro; Moggio, Maurizio] Univ Milan, Dept Neurol Sci, IRCCS Fdn Osped Maggiore Policlin Mangiagalli & R, Dino Ferrari Ctr,Sci Inst Res & Treatment, I-20122 Milan, Italy.
   [Silani, Vincenzo] Univ Milan, Dept Neurol & Lab Neurosci, Dino Ferrari Ctr, IRCCS Ist Auxologico Italiano, I-20122 Milan, Italy.
   [Di Mauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan;
   IRCCS Istituto Auxologico Italiano; University of Milan; Columbia
   University
RP Moggio, M (corresponding author), Univ Milan, Dept Neurol Sci, IRCCS Fdn Osped Maggiore Policlin Mangiagalli & R, Dino Ferrari Ctr,Sci Inst Res & Treatment, Via Francesco Sforza 35, I-20122 Milan, Italy.
EM maurizio.moggio@unimi.it
RI Sciacco, Monica/AAC-6500-2022; lamperti, costanza/J-8801-2016; Ronchi,
   Dario/K-8011-2016; Padovani, Alessandro/ABI-7312-2020; Comi,
   Giacomo/K-5702-2016; corti, stefania/K-6034-2016; Silani,
   Vincenzo/P-4421-2017
OI Sciacco, Monica/0000-0003-4593-4977; Comi, Giacomo/0000-0002-1383-5248;
   Bresolin, Nereo/0000-0001-6694-3595; corti,
   stefania/0000-0001-5425-969X; Silani, Vincenzo/0000-0002-7698-3854;
   Peverelli, Lorenzo/0000-0001-6175-025X; prelle,
   alessandro/0000-0002-7019-5291; Ronchi, Dario/0000-0002-6093-9816
FU Associazione Amici del Centro Dino Ferrari; Italian Ministry of
   University and Research [2006069034]; EuroBioBank [QLTR-2001-02769];
   Fondazione Telethon Funding Source: Custom
FX This research received support from Associazione Amici del Centro Dino
   Ferrari. Dr Comi received funding from research grant Progetti Ricerca
   Interesse Nazionale (PRIN) 2006 2006069034 from the Italian Ministry of
   University and Research for the project entitled "An Integrated Approach
   to the Study of the Etiopathogenesis of Mitochondrial Disorders." Dr
   Comi was also funded by the Italian Ministry of Health for the 2009
   project entitled "Mitochondrial Disorders: From Medical Genetics to
   Molecular Mechanisms, Toward the Development of Therapeutic Strategies."
   The Telethon Network of Genetics Biobanks (Genetic Telethon Biobank No.
   07001E) was the source of muscle, DNA, and cells used in this study.
   EuroBioBank project QLTR-2001-02769 is also gratefully acknowledged.
CR AFIFI AK, 1966, NEUROLOGY, V16, P475, DOI 10.1212/WNL.16.5.475
   Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700
   Andersen PM, 2001, AMYOTROPH LATERAL SC, V2, pS37
   Appel SH, 2006, EXP NEUROL, V198, P1, DOI 10.1016/j.expneurol.2005.12.025
   ATSUMI T, 1981, ACTA NEUROPATHOL, V55, P193, DOI 10.1007/BF00691318
   Bendotti C, 2001, J NEUROL SCI, V191, P25, DOI 10.1016/S0022-510X(01)00627-X
   Borthwick Gillian M, 2006, Ann Neurol, V59, P570, DOI 10.1002/ana.20758
   Brierley EJ, 1997, MOL CELL BIOCHEM, V174, P325, DOI 10.1023/A:1006847319162
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0
   Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Corcia P, 2002, ANN NEUROL, V51, P243, DOI 10.1002/ana.10104
   Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950
   Corti S, 2009, J NEUROL SCI, V276, P170, DOI 10.1016/j.jns.2008.09.030
   Dubowitz V., 1985, MUSCLE BIOPSY PRACTI, V2nd
   Dupuis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005390
   Echaniz-Laguna A, 2006, EXP NEUROL, V198, P25, DOI 10.1016/j.expneurol.2005.07.020
   Echaniz-Laguna A, 2002, ANN NEUROL, V52, P623, DOI 10.1002/ana.10357
   Fetoni V, 2004, NEUROMUSCULAR DISORD, V14, P723, DOI 10.1016/j.nmd.2004.07.002
   Finsterer J, 2003, NEUROLOGIST, V9, P45, DOI 10.1097/01.nrl.0000038589.58012.a8
   Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344
   Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742
   Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166
   Hirano M, 2008, ARCH NEUROL-CHICAGO, V65, P403, DOI 10.1001/archneurol.2007.65
   JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106
   Krasnianski A, 2005, BRAIN, V128, P1870, DOI 10.1093/brain/awh540
   Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066
   Lacomblez L, 2002, NEUROLOGY, V58, P1112, DOI 10.1212/WNL.58.7.1112
   Magnus T, 2002, MUSCLE NERVE, V25, P709, DOI 10.1002/mus.10090
   Mahoney DJ, 2006, MUSCLE NERVE, V33, P809, DOI 10.1002/mus.20542
   Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287
   Przedborski S, 2004, NEUROLOGIST, V10, P1, DOI 10.1097/01.nrl.0000106920.84668.37
   Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123
   Rizzardini M, 2005, J NEUROL SCI, V232, P95, DOI 10.1016/j.jns.2005.02.004
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Rubio-Gozalbo ME, 1999, NEUROLOGY, V52, P383, DOI 10.1212/WNL.52.2.383
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Sasaki S, 1996, NEUROSCI LETT, V204, P53, DOI 10.1016/0304-3940(96)12314-4
   Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P10, DOI 10.1097/nen.0b013e31802c396b
   Sciacco M, 2001, J NEUROL, V248, P778, DOI 10.1007/s004150170094
   Siklos L, 1996, ANN NEUROL, V39, P203, DOI 10.1002/ana.410390210
   Simpson EP, 2003, CURR OPIN RHEUMATOL, V15, P730, DOI 10.1097/00002281-200311000-00008
   Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584
   Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007
   Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942
   Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x
   Xu ZS, 2004, J BIOENERG BIOMEMBR, V36, P395, DOI 10.1023/B:JOBB.0000041774.12654.e1
   Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160
NR 51
TC 114
Z9 131
U1 0
U2 22
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0003-9942
EI 1538-3687
J9 ARCH NEUROL-CHICAGO
JI Arch. Neurol.
PD JUL
PY 2010
VL 67
IS 7
BP 849
EP 854
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 624EC
UT WOS:000279798100011
PM 20625092
DA 2024-11-01
ER

PT J
AU Zhang, YL
   Song, FL
   Gao, ZY
   Ding, W
   Qiao, LX
   Yang, SF
   Chen, X
   Jin, RH
   Chen, DX
AF Zhang, Yulin
   Song, Fengli
   Gao, Ziyun
   Ding, Wei
   Qiao, Luxin
   Yang, Sufang
   Chen, Xi
   Jin, Ronghua
   Chen, Dexi
TI Long-Term Exposure of Mice to Nucleoside Analogues Disrupts
   Mitochondrial DNA Maintenance in Cortical Neurons
SO PLOS ONE
LA English
DT Article
ID REVERSE-TRANSCRIPTASE INHIBITORS; ACTIVE ANTIRETROVIRAL THERAPY;
   LACTIC-ACIDOSIS; TOXICITY; DYSFUNCTION; BRAIN; HYPERLACTATEMIA;
   HIV/AIDS; CAPTURE; GENOME
AB Nucleoside analogue reverse transcriptase inhibitor (NRTI), an integral component of highly active antiretroviral therapy (HAART), was widely used to inhibit HIV replication. Long-term exposure to NRTIs can result in mitochondrial toxicity which manifests as lipoatrophy, lactic acidosis, cardiomyopathy and myopathy, as well as polyneuropathy. But the cerebral neurotoxicity of NRTIs is still not well known partly due to the restriction of blood-brain barrier (BBB) and the complex microenvironment of the central nervous system (CNS). In this study, the Balb/c mice were administered 50 mg/kg stavudine (D4T), 100 mg/kg zidovudine (AZT), 50 mg/kg lamivudine (3TC) or 50 mg/kg didanosine (DDI) per day by intraperitoneal injection, five days per week for one or four months, and primary cortical neurons were cultured and exposed to 25 mu M D4T, 50 mu M AZT, 25 mu M 3TC or 25 mu M DDI for seven days. Then, single neuron was captured from mouse cerebral cortical tissues by laser capture microdissection. Mitochondrial DNA (mtDNA) levels of the primary cultured cortical neurons, and captured neurons or glial cells, and the tissues of brains and livers and muscles were analyzed by relative quantitative real-time PCR. The data showed that mtDNA did not lose in both NRTIs exposed cultured neurons and one month NRTIs treated mouse brains. In four months NRTIs treated mice, brain mtDNA levels remained unchanged even if the mtDNA levels of liver (except for 3TC) and muscle significantly decreased. However, mtDNA deletion was significantly higher in the captured neurons from mtDNA unchanged brains. These results suggest that long-term exposure to NRTIs can result in mtDNA deletion in mouse cortical neurons.
C1 [Zhang, Yulin; Song, Fengli; Ding, Wei; Qiao, Luxin; Yang, Sufang; Jin, Ronghua; Chen, Dexi] Capital Med Univ, Beijing You An Hosp, Dept Infect Dis, Beijing, Peoples R China.
   [Gao, Ziyun] Nanchang Univ, Affiliated Hosp 2, Dept Neurosurg, Nanchang, Jiangxi, Peoples R China.
   [Chen, Xi] Nanjing Med Univ, Affiliated Hosp 1, Dept Otolaryngol, Nanjing, Jiangsu, Peoples R China.
C3 Capital Medical University; Nanchang University; Nanjing Medical
   University
RP Chen, X (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Otolaryngol, Nanjing, Jiangsu, Peoples R China.
EM jsxycx@sina.com; jin_eagle@sina.com; dexi0963@yahoo.com
RI Zhang, Yulin/ABP-2104-2022
FU National Natural Science Foundation of China [81371399, 81272266,
   30910103915]; Twelfth Key Science and Technology Five Year Plan of China
   [2012ZX10001-002, 2012ZX10001-003, 2012ZX10001-004]; Beijing Natural
   Science Foundation [7092045, 7101005]
FX This work was supported by The National Natural Science Foundation of
   China (81371399, 81272266, 30910103915) and The Twelfth Key Science and
   Technology Five Year Plan of China (2012ZX10001-002, 2012ZX10001-003,
   2012ZX10001-004). and Beijing Natural Science Foundation (7092045,
   7101005). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Brogly SB, 2011, AIDS RES HUM RETROV, V27, P777, DOI [10.1089/aid.2010.0204, 10.1089/AID.2010.0204]
   Dagan T, 2002, MITOCHONDRION, V1, P397, DOI 10.1016/S1567-7249(02)00003-X
   Dalakas MC, 2001, J PERIPHER NERV SYST, V6, P14, DOI 10.1046/j.1529-8027.2001.006001014.x
   Davison FD, 1996, J NEUROL, V243, P648, DOI 10.1007/BF00878661
   Dragovic G, 2012, BIOMED PHARMACOTHER, V66, P308, DOI 10.1016/j.biopha.2011.09.016
   Eimon PM, 1996, DEV GENET, V18, P107, DOI 10.1002/(SICI)1520-6408(1996)18:2<107::AID-DVG3>3.0.CO;2-D
   Einsiedel L, 2010, MITOCHONDRION, V10, P534, DOI 10.1016/j.mito.2010.05.010
   Ewings EL, 2000, J ACQ IMMUN DEF SYND, V24, P100
   FELDMAN D, 1994, ACTA NEUROPATHOL, V87, P71
   FLINT OP, 1994, TOXICOL IN VITRO, V8, P677, DOI 10.1016/0887-2333(94)90042-6
   Fosslien E, 2001, ANN CLIN LAB SCI, V31, P25
   Gallagher RI, 2012, METHODS MOL BIOL, V823, P157, DOI 10.1007/978-1-60327-216-2_11
   Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1
   Kandanearatchi A, 2003, BRAIN PATHOL, V13, P104, DOI 10.1111/j.1750-3639.2003.tb00011.x
   Koczor C, 2010, METHODS, V51, P399, DOI 10.1016/j.ymeth.2009.12.013
   Kohler JJ, 2008, CARDIOVASC TOXICOL, V8, P57, DOI 10.1007/s12012-008-9015-1
   Kohler JJ, 2011, METHODS MOL BIOL, V755, P267, DOI 10.1007/978-1-61779-163-5_22
   Lanoy E, 2011, NEUROLOGY, V76, P644, DOI 10.1212/WNL.0b013e31820c3089
   Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31
   Mothobi NZ, 2012, CURR OPIN INFECT DIS, V25, P4, DOI 10.1097/QCO.0b013e32834ef586
   Moyle G, 2000, DRUG SAFETY, V23, P467, DOI 10.2165/00002018-200023060-00001
   Nolan D, 2004, ANTIVIR THER, V9, P849
   Obiako O R, 2011, West Afr J Med, V30, P354
   Papp E, 2008, J ANTIMICROB CHEMOTH, V61, P1048, DOI 10.1093/jac/dkn067
   Pavili L, 2010, FERTIL STERIL, V94, P2151, DOI 10.1016/j.fertnstert.2009.12.080
   Rook MS, 2004, AM J PATHOL, V164, P23, DOI 10.1016/S0002-9440(10)63092-1
   Seok JI, 2009, HEPATOLOGY, V49, P2080, DOI 10.1002/hep.22959
   Smurzynski M, 2011, AIDS, V25, P357, DOI 10.1097/QAD.0b013e32834171f8
   Tozzi V, 2001, J ACQ IMMUN DEF SYND, V28, P19, DOI 10.1097/00042560-200109010-00004
   Walker UA, 2002, AIDS, V16, P2165, DOI 10.1097/00002030-200211080-00009
   Wester CW, 2012, AIDS RES HUM RETROV, V28, P759, DOI [10.1089/aid.2011.0303, 10.1089/AID.2011.0303]
   Zhang YL, 2012, BRAIN RES, V1458, P1, DOI 10.1016/j.brainres.2012.04.001
NR 32
TC 35
Z9 38
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 20
PY 2014
VL 9
IS 1
AR e85637
DI 10.1371/journal.pone.0085637
PG 7
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 297FH
UT WOS:000330240500063
PM 24465628
OA gold, Green Submitted, Green Published
DA 2024-11-01
ER

PT J
AU Lechuga-Vieco, AV
   Latorre-Pellicer, A
   Calvo, E
   Torroja, C
   Pellico, J
   Acín-Pérez, R
   García-Gil, ML
   Santos, A
   Bagwan, N
   Bonzon-Kulichenko, E
   Magni, R
   Benito, M
   Justo-Méndez, R
   Simon, AK
   Sánchez-Cabo, F
   Vázquez, J
   Ruíz-Cabello, J
   Enríquez, JA
AF Victoria Lechuga-Vieco, Ana
   Latorre-Pellicer, Ana
   Calvo, Enrique
   Torroja, Carlos
   Pellico, Juan
   Acin-Perez, Rebeca
   Luisa Garcia-Gil, Maria
   Santos, Arnoldo
   Bagwan, Navratan
   Bonzon-Kulichenko, Elena
   Magni, Ricardo
   Benito, Marina
   Justo-Mendez, Raquel
   Katharina Simon, Anna
   Sanchez-Cabo, Fatima
   Vazquez, Jesus
   Ruiz-Cabello, Jesus
   Antonio Enriquez, Jose
TI Heteroplasmy of Wild-Type Mitochondrial DNA Variants in Mice Causes
   Metabolic Heart Disease With Pulmonary Hypertension and Frailty
SO CIRCULATION
LA English
DT Article
DE DNA; mitochondrial; haplotypes; heart diseases; heteroplasmy;
   hypertension; pulmonary; mice; oxidative phosphorylation
ID ARTERIAL-HYPERTENSION; PRONUCLEAR TRANSFER; STROMAL CELLS; MTDNA;
   SEGREGATION; REPLACEMENT; EVOLUTION; AUTOPHAGY; RESPONSES; SELECTION
AB Background: In most eukaryotic cells, the mitochondrial DNA (mtDNA) is transmitted uniparentally and present in multiple copies derived from the clonal expansion of maternally inherited mtDNA. All copies are therefore near-identical, or homoplasmic. The presence of >1 mtDNA variant in the same cytoplasm can arise naturally or result from new medical technologies aimed at preventing mitochondrial genetic diseases and improving fertility. The latter is called divergent nonpathologic mtDNA heteroplasmy (DNPH). We hypothesized that DNPH is maladaptive and usually prevented by the cell. Methods: We engineered and characterized DNPH mice throughout their lifespan using transcriptomic, metabolomic, biochemical, physiologic, and phenotyping techniques. We focused on in vivo imaging techniques for noninvasive assessment of cardiac and pulmonary energy metabolism. Results: We show that DNPH impairs mitochondrial function, with profound consequences in critical tissues that cannot resolve heteroplasmy, particularly cardiac and skeletal muscle. Progressive metabolic stress in these tissues leads to severe pathology in adulthood, including pulmonary hypertension and heart failure, skeletal muscle wasting, frailty, and premature death. Symptom severity is strongly modulated by the nuclear context. Conclusions: Medical interventions that may generate DNPH should address potential incompatibilities between donor and recipient mtDNA.
C1 [Victoria Lechuga-Vieco, Ana; Magni, Ricardo; Benito, Marina; Justo-Mendez, Raquel; Ruiz-Cabello, Jesus] Ctr Nacl Invest Cardiovasc carlos III, Melchor Fernandez Almagro 3, Madrid 28029, Spain.
   [Victoria Lechuga-Vieco, Ana; Katharina Simon, Anna] Univ Oxford, Kennedy Inst Rheumatol, NDORMS, Oxford, England.
   [Victoria Lechuga-Vieco, Ana; Pellico, Juan; Santos, Arnoldo; Ruiz-Cabello, Jesus] Ciber Enfermedades Respiratorias CIBERES, Madrid, Spain.
   [Latorre-Pellicer, Ana] Univ Zaragoza, Dept Pharmacol Physiol, Sch Med, Unit Clin Genet & Funct Genom,IIS Aragon, Zaragoza, Spain.
   [Luisa Garcia-Gil, Maria] Univ Complutense Madrid, Ctr Nacl Microscopia Elect ICTS CNME, Madrid, Spain.
   [Santos, Arnoldo] ITC Ingenioria & Tecn Clin, Madrid, Spain.
   [Bonzon-Kulichenko, Elena; Vazquez, Jesus] Ciber Enfermedades Cardiova Dates CIBERCV, Madrid, Spain.
   [Ruiz-Cabello, Jesus] CIC biomaGUNE, Doniostia San Sebastian, Spain.
   [Ruiz-Cabello, Jesus] Basque Fdn Sci, IKE RBASOUE, Bilbao, Spain.
   [Ruiz-Cabello, Jesus] Univ Complutense Madrid, Madrid, Spain.
   [Antonio Enriquez, Jose] Ciber Fragilidad & Envejecimiento Saludable CIBER, Madrid, Spain.
   [Pellico, Juan] Kings Coll London, Sch Biomed Engn & Imaging Sci, London, England.
C3 Centro Nacional de Investigaciones Cardiovasculares (CNIC); University
   of Oxford; CIBER - Centro de Investigacion Biomedica en Red; CIBERES;
   University of Zaragoza; Complutense University of Madrid; CIC biomaGUNE;
   Basque Foundation for Science; Complutense University of Madrid; CIBER -
   Centro de Investigacion Biomedica en Red; CIBERFES; University of
   London; King's College London
RP Enríquez, JA (corresponding author), Ctr Nacl Invest Cardiovasc carlos III, Melchor Fernandez Almagro 3, Madrid 28029, Spain.
EM jaenriquez@cnic.es
RI Vazquez, Jesus/D-3067-2019; Sanchez-Cabo, Fatima/IZD-8966-2023;
   Acin-Perez, Rebeca/AAU-4913-2020; Pellicer, Ana/A-8601-2019;
   Bonzon-Kulichenko, Elena/R-4208-2018; Simon, Anna/IAM-0780-2023; Benito
   Vicente, Marina/N-5884-2014; Sanchez-Cabo, Fatima/N-5030-2014;
   Acin-Perez, Rebeca/H-6160-2015; Torroja, Carlos/N-6022-2014; Enriquez,
   Jose Antonio/M-8468-2016; Ruiz-Cabello, Jesus/A-9570-2012; Pellico,
   Juan/H-1596-2015
OI Benito Vicente, Marina/0000-0002-0661-755X; Latorre-Pellicer,
   Ana/0000-0002-4703-6620; Sanchez-Cabo, Fatima/0000-0003-1881-1664;
   Acin-Perez, Rebeca/0000-0001-9553-8337; Justo-Mendez,
   Raquel/0000-0002-7648-3550; Torroja, Carlos/0000-0001-8914-3400;
   Enriquez, Jose Antonio/0000-0002-3671-2961; Ruiz-Cabello,
   Jesus/0000-0001-8681-5056; Lechuga-Vieco, Ana
   Victoria/0000-0001-5546-9752; Pellico, Juan/0000-0003-2787-8641
FU European Molecular Biology Organization [ALTF115-2019]; Ministerio de
   Ciencia e Innovacion [SAF2015-65633-R, RTI2018-099357-B-I00,
   PGC2018-097019-B-I00, PRB3-IPT17/0019/0003-ISCIII-SGEFI/ERDF,
   SVP-2013-068089]; Humand Frontier Science Program [RGP0016/2018];
   Ministerio de Economia, Industria y Competitivida [SAF2017-84494-C2-R];
   Programa Red Guipuzcoana de Ciencia, Tecnologia e Informacion
   [2018-CIEN-000058-01]; Gobierno Vasco, Dpto Industria, Innovacion,
   Comercio y Turismo under the ELKARTEK Program [KK-2019/bmG19]; BBVA
   Foundation (Ayudas a Equipos de Investigacion Cientifica Biomedicina
   2018); Maria de Maeztu Units of Excellence Program from the Spanish
   State Research Agency [MDM-2017-0720]; European Union's Horizon 2020
   research and innovation program under the Marie Sklodowska-Curie grant
   [796721]; Fundacio MaratoTV3 [122/C/2015]; "la Caixa" Banking Foundation
   [HR17-00247]; Instituto de Salud Carlos III; Ministerio de Ciencia e
   Innovacion; Pro Centro Nacional de Investigaciones Cardiovasculares
   Foundation; Marie Curie Actions (MSCA) [796721] Funding Source: Marie
   Curie Actions (MSCA)
FX Dr Lechuga-Vieco was supported by a Predoctoral Fellowship from
   Ministerio de Ciencia e Innovacion (SVP-2013-068089) and by a
   Postdoctoral Fellowship from the European Molecular Biology Organization
   (ALTF115-2019). This study was supported by grants to Dr Enriquez from
   Ministerio de Ciencia e Innovacion (grants SAF2015-65633-R and
   RTI2018-099357-B-I00) and Humand Frontier Science Program (grant
   RGP0016/2018). Dr Ruiz-Cabello is supported by grants from the
   Ministerio de Economia, Industria y Competitivida (grant
   SAF2017-84494-C2-R), Programa Red Guipuzcoana de Ciencia, Tecnologia e
   Informacion (grant 2018-CIEN-000058-01), and the Gobierno Vasco, Dpto
   Industria, Innovacion, Comercio y Turismo under the ELKARTEK Program
   (grant KK-2019/bmG19). Dr Ruiz-Cabello received funding from the BBVA
   Foundation (Ayudas a Equipos de Investigacion Cientifica Biomedicina
   2018). CIC biomaGUNE is supported by the Maria de Maeztu Units of
   Excellence Program from the Spanish State Research Agency (grant
   MDM-2017-0720). Dr Santos has received funding from the European Union's
   Horizon 2020 research and innovation program under the Marie
   Sklodowska-Curie grant agreement 796721. Dr Vazquez received funding
   from Ministerio de Ciencia e Innovacion (grants PGC2018-097019-B-I00 and
   PRB3-IPT17/0019/0003-ISCIII-SGEFI/ERDF, ProteoRed), the Fundacio
   MaratoTV3 (grant 122/C/2015), and "la Caixa" Banking Foundation (project
   code HR17-00247). The Centro Nacional de Investigaciones
   Cardiovasculares is supported by the Instituto de Salud Carlos III, the
   Ministerio de Ciencia e Innovacion, and the Pro Centro Nacional de
   Investigaciones Cardiovasculares Foundation and is a Severo Ochoa Center
   of Excellence.
CR Acton BM, 2007, BIOL REPROD, V77, P569, DOI 10.1095/biolreprod.107.060806
   Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878
   Enríquez JA, 2019, NAT METAB, V1, P5, DOI 10.1038/s42255-018-0018-3
   Baertling F, 2017, HUM MUTAT, V38, P692, DOI 10.1002/humu.23210
   Bagwan N, 2018, CELL REP, V23, P3685, DOI 10.1016/j.celrep.2018.05.080
   Barritt JA, 2001, HUM REPROD UPDATE, V7, P428, DOI 10.1093/humupd/7.4.428
   Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469
   Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, P5349, DOI 10.1093/nar/gkg739
   Ben Chorin A, 2020, PROTEIN SCI, V29, P258, DOI 10.1002/pro.3779
   Bray AW, 2017, CURR OPIN CARDIOL, V32, P267, DOI 10.1097/HCO.0000000000000383
   Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Fernández-Vizarra E, 2010, MITOCHONDRION, V10, P253, DOI 10.1016/j.mito.2009.12.148
   Fragoso CAV, 2019, EXP GERONTOL, V115, P96, DOI 10.1016/j.exger.2018.11.023
   Gameiro PA, 2013, J BIOL CHEM, V288, P12967, DOI 10.1074/jbc.M112.396796
   Garcia-Alvarez A, 2013, J AM COLL CARDIOL, V62, P1621, DOI 10.1016/j.jacc.2013.07.037
   García-Marqués F, 2016, MOL CELL PROTEOMICS, V15, P1740, DOI 10.1074/mcp.M115.055905
   Goios A, 2007, GENOME RES, V17, P293, DOI 10.1101/gr.5941007
   Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928
   Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature183030, 10.1038/nature18303]
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Johnston IG, 2016, AM J HUM GENET, V99, P1150, DOI 10.1016/j.ajhg.2016.09.016
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   Kim SJ, 2015, INT J MOL SCI, V16, P21486, DOI 10.3390/ijms160921486
   Kraja AT, 2019, AM J HUM GENET, V104, P112, DOI 10.1016/j.ajhg.2018.12.001
   Lane N, 2012, CELL, V151, P246, DOI 10.1016/j.cell.2012.09.028
   Latorre-Pellicer A, 2019, CELL METAB, V30, P1120, DOI 10.1016/j.cmet.2019.09.007
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Martínez-Bartolomé S, 2008, MOL CELL PROTEOMICS, V7, P1135, DOI 10.1074/mcp.M700239-MCP200
   McCully JD, 2009, AM J PHYSIOL-HEART C, V296, pH94, DOI 10.1152/ajpheart.00567.2008
   Meirelles FV, 1997, GENETICS, V145, P445
   Navarro P, 2014, J PROTEOME RES, V13, P1234, DOI 10.1021/pr4006958
   Navarro P, 2009, J PROTEOME RES, V8, P1792, DOI 10.1021/pr800362h
   Plotnikov EY, 2010, EXP CELL RES, V316, P2447, DOI 10.1016/j.yexcr.2010.06.009
   Roushandeh AM, 2019, CYTOTECHNOLOGY, V71, P647, DOI 10.1007/s10616-019-00302-9
   Royrvik EC, 2016, MOL HUM REPROD, V22, P809, DOI 10.1093/molehr/gaw062
   Ryan JJ, 2015, CIRCULATION, V131, P1691, DOI 10.1161/CIRCULATIONAHA.114.006979
   Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333
   Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Spindler M, 2002, AM J PHYSIOL-HEART C, V283, pH680, DOI 10.1152/ajpheart.00800.2001
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Takeda K, 2000, GENETICS, V155, P777
   Talati M, 2015, PULM CIRC, V5, P269, DOI 10.1086/681227
   Theophilus BDM., 2002, METHODS MOL BIOL, V187, P57, DOI [10.1007/978-1-60761-947-5, DOI 10.1007/978-1-60761-947-5]
   Trevisan-Herraz M, 2019, BIOINFORMATICS, V35, P1594, DOI 10.1093/bioinformatics/bty815
   TUFT SJ, 1986, INVEST OPHTH VIS SCI, V27, P1199
   van den Ameele J, 2020, SEMIN CELL DEV BIOL, V97, P156, DOI 10.1016/j.semcdb.2019.10.001
   Lechuga-Vieco AV, 2021, IUBMB LIFE, V73, P511, DOI 10.1002/iub.2434
   Lechuga-Vieco AV, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba5345
   Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5
   Woods DC, 2015, SEMIN REPROD MED, V33, P410, DOI 10.1055/s-0035-1567826
   Yonova-Doing E, 2021, NAT GENET, V53, P982, DOI 10.1038/s41588-021-00868-1
NR 59
TC 12
Z9 12
U1 4
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD APR 5
PY 2022
VL 145
IS 14
BP 1084
EP 1101
DI 10.1161/CIRCULATIONAHA.121.056286
PG 18
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA 0C2ZS
UT WOS:000775188200009
PM 35236094
OA Green Published, Green Accepted, hybrid
DA 2024-11-01
ER

PT J
AU Tran, NQ
   Phan, CC
   Vuong, TB
   Tran, TV
   Ma, PT
AF Tran, Nam Quang
   Phan, Chien Cong
   Vuong, Tran Bao
   Tran, Thang Viet
   Ma, Phat Tung
TI Acute onset of diabetes and rapid cognitive decline in a patient with
   mitochondrial encephalomyopathy, lactic acidosis, and stroke-like
   episodes syndrome
SO ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS
LA English
DT Article
DE Adult; Female; White; United States; Pancreas; Diabetes; Unique;
   unexpected symptoms or presentations of a disease; April; 2023
ID DNA MUTATION; ENCEPHALOPATHY; MYOPATHY; MELAS; MELLITUS
AB Mitochondrial diseases are a group of rare diseases presenting with heterogeneous clinical, biochemical, and genetic disorders caused by mutations in the mitochondrial or nuclear genome. Multiple organs can be affected, particularly those with high energy demand. Diabetes is a common endocrine manifestation of mitochondrial diseases. The onset of mitochondrial diabetes can be latent or acute, and the presenting phenotype can be type 1- or type 2-like. Studies show that diabetes ais associated with latent progression of cognitive decline in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. Herein, we report a case of rapid cognitive decline after the acute onset of diabetes in a patient with MELAS syndrome. The patient was a 36-year-old woman who was hospitalized due to hyperglycemic crisis and seizures. She was diagnosed with MELAS syndrome two years previously, and had gradually progressing dementia and hearing loss. However, following the acute onset of diabetes, she developed rapid cognitive decline and loss of ability to perform daily activities. In conclusion, the acute onset of diabetes could be an associated risk factor for rapid cognitive decline in patients with MELAS syndrome. Thus, these patients as well as healthy carriers with related genetic mutations should undergo diabetes education and screening tests. Moreover, clinicians should be aware of the possibility for acute onset of hyperglycemic crisis, particularly in the presence of triggering factors. Learning points Diabetes is a common endocrine manifestation of mitochondrial diseases, presenting with a type 1- or type 2-like phenotype depending on the level of insulinopenia. Metformin should be avoided in patients with mitochondrial diseases to prevent metformin-induced lactic acidosis. Mitochondrial diabetes can manifest before or after the onset of MELAS syndrome. In patients with MELAS syndrome, diabetes can initially manifest with a life-threatening severe hyperglycemic crisis and can cause rapid cognitive decline. Diabetes screening tests (e.g. hemoglobin A1c, oral glucose tolerance test, or random blood glucose level measurement) should be performed either systematically or in the presence of symptoms, particularly after triggering events. Genetic testing and counseling should be provided to patients and their families for the purpose of better understanding the inheritance, progression, and possible outcomes of the disease.
C1 [Tran, Nam Quang; Vuong, Tran Bao; Tran, Thang Viet; Ma, Phat Tung] Univ Med & Pharm Ho Chi Minh City, Dept Endocrinol, Ho Chi Minh City, Vietnam.
   [Tran, Nam Quang; Tran, Thang Viet; Ma, Phat Tung] Univ Med Ctr Ho Chi Minh City, Dept Endocrinol, Ho Chi Minh City, Vietnam.
   [Phan, Chien Cong] Univ Med Ctr Ho Chi Minh City, Dept Imaging, Ho Chi Minh City, Vietnam.
C3 Hochiminh City University of Medicine & Pharmacy
RP Ma, PT (corresponding author), Univ Med & Pharm Ho Chi Minh City, Dept Endocrinol, Ho Chi Minh City, Vietnam.; Ma, PT (corresponding author), Univ Med Ctr Ho Chi Minh City, Dept Endocrinol, Ho Chi Minh City, Vietnam.
EM matungphat@ump.edu.vn
OI Vuong, Bao Tran/0000-0003-4036-9876; Ma, Phat Tung/0000-0003-1715-0323
CR Frederiksen AL, 2009, J CLIN ENDOCR METAB, V94, P2872, DOI 10.1210/jc.2009-0235
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Murakami T, 2016, TOHOKU J EXP MED, V238, P311, DOI 10.1620/tjem.238.311
   Nakamura S, 2000, DIABETES METAB, V26, P407
   Newcastle mitochondrial disease guidelines, DIABETES MELLITUS A
   Reed EM, 2020, AM J FOREN MED PATH, V41, P331, DOI 10.1097/PAF.0000000000000563
   Simoncini C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/803942
   Stefano GB, 2016, EUR J NUTR, V55, P2339, DOI 10.1007/s00394-016-1212-2
   Toki T, 2021, PEDIATR NEUROL, V114, P1, DOI 10.1016/j.pediatrneurol.2020.09.013
   Vento JM, 2013, NEUROTHERAPEUTICS, V10, P243, DOI 10.1007/s13311-012-0173-2
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 13
TC 1
Z9 1
U1 1
U2 1
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND
EI 2052-0573
J9 ENDOCR DIAB MET C R
JI Endocrinol. Diabetes Metab. Case Rep.
PD APR 1
PY 2023
VL 2023
IS 2
AR 220416
DI 10.1530/EDM-22-0416
PG 5
WC Endocrinology & Metabolism
WE Emerging Sources Citation Index (ESCI)
SC Endocrinology & Metabolism
GA N9ZA5
UT WOS:001040495300001
PM 37073829
OA gold, Green Accepted
DA 2024-11-01
ER

PT B
AU Brodsky, MC
AF Brodsky, Michael C.
BA Brodsky, MC
BF Brodsky, MC
TI Optic Atrophy in Children
SO PEDIATRIC NEURO-OPHTHALMOLOGY, SECOND EDITION
LA English
DT Article; Book Chapter
ID DOMINANT CEREBELLAR-ATAXIA; MITOCHONDRIAL-DNA MUTATIONS; INFANTILE
   NEUROAXONAL DYSTROPHY; LEBERS CONGENITAL AMAUROSIS;
   HALLERVORDEN-SPATZ-SYNDROME; SENSORINEURAL HEARING-LOSS; WOLFRAM DIDMOAD
   SYNDROME; CENTRAL-NERVOUS-SYSTEM; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   PELIZAEUS-MERZBACHER DISEASE
C1 Mayo Clin, Rochester, MN 55905 USA.
C3 Mayo Clinic
RP Brodsky, MC (corresponding author), Mayo Clin, Rochester, MN 55905 USA.
CR Abdel-Salam GMH, 2006, BRAIN DEV-JPN, V28, P529, DOI 10.1016/j.braindev.2006.01.009
   Abe T, 1997, ARCH OPHTHALMOL-CHIC, V115, P231, DOI 10.1001/archopht.1997.01100150233013
   Abrams LS, 1997, J PEDIAT OPHTH STRAB, V34, P223
   Abramson DH, 1999, OPHTHALMOLOGY, V106, P1947, DOI 10.1016/S0161-6420(99)90406-2
   Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295
   Abu-Serieh B, 2007, NEUROSURGERY, V60, P1039, DOI 10.1227/01.NEU.0000255456.12978.31
   Acaroglu Golge, 2001, International Ophthalmology, V24, P349, DOI 10.1023/B:INTE.0000006855.48323.f1
   ADAMS RD, 1989, PRINCIPLES NEUROLOGY, P804
   Adegbehingbe BO, 2007, AUST J RURAL HEALTH, V15, P269, DOI 10.1111/j.1440-1584.2007.00906.x
   Adeoti Caroline O, 2004, West Afr J Med, V23, P249
   AICARDI J, 1979, BRAIN, V102, P727, DOI 10.1093/brain/102.4.727
   Ajlouni K, 2002, AM J MED GENET, V115, P61, DOI 10.1002/ajmg.10345
   Al-Dirbashi OY, 2007, J INHERIT METAB DIS, V30, P612, DOI 10.1007/s10545-007-0635-6
   Al-Essa M, 1999, BRAIN DEV-JPN, V21, P24, DOI 10.1016/S0387-7604(98)00064-3
   Al-Essa M, 1999, CLIN PEDIATR, V38, P77, DOI 10.1177/000992289903800203
   Al-Merjan JI, 2005, OPHTHAL EPIDEMIOL, V12, P251, DOI 10.1080/09286580591005813
   Al-Sheyyab M, 2001, EUR J PEDIATR, V160, P243, DOI 10.1007/s004310000704
   Al-Till M, 2002, EUR J OPHTHALMOL, V12, P84, DOI 10.1177/112067210201200202
   ALDENHOVEL HBG, 1991, NEUROPEDIATRICS, V22, P103, DOI 10.1055/s-2008-1071426
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Allali F, 2004, SCAND J RHEUMATOL, V33, P362, DOI 10.1080/03009740410005980
   Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306
   ALVORD EC, 1988, J NEUROSURG, V68, P85, DOI 10.3171/jns.1988.68.1.0085
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   AMEMIYA T, 1994, OPHTHALMIC GENET, V15, P87, DOI 10.3109/13816819409098868
   Amitava AK, 2001, J PEDIAT OPHTH STRAB, V38, P229
   Anderson NE, 1999, NEUROLOGY, V52, P163, DOI 10.1212/WNL.52.1.163
   Andersson S, 2009, BRIT J OPHTHALMOL, V93, P526, DOI 10.1136/bjo.2008.142315
   ANGELINI L, 1992, J NEUROL, V239, P417, DOI 10.1007/BF00856805
   Anteby I, 2001, ARCH OPHTHALMOL-CHIC, V119, P1525
   ARAS C, 2000, INT OPHTHALMOL, V24, P147
   ARTS WFM, 1993, ANN NEUROL, V33, P535, DOI 10.1002/ana.410330519
   Ashworth JL, 2006, EYE, V20, P553, DOI 10.1038/sj.eye.6701921
   Assink JJM, 1997, AM J HUM GENET, V61, P934, DOI 10.1086/514884
   Astle WE, 2006, J CATARACT REFR SURG, V32, P103, DOI 10.1016/j.jcrs.2005.11.028
   Atchaneeyasakul LO, 1998, AM J MED GENET, V80, P501, DOI 10.1002/(SICI)1096-8628(19981228)80:5<501::AID-AJMG12>3.0.CO;2-J
   Atmaca LS, 2004, JPN J OPHTHALMOL, V48, P386, DOI 10.1007/s10384-003-0069-0
   Aung T, 2003, BRIT J OPHTHALMOL, V87, P149, DOI 10.1136/bjo.87.2.149
   Awad AH, 1999, J AAPOS, V3, P40, DOI 10.1016/S1091-8531(99)70093-5
   AYSUN S, 1994, PEDIATR NEUROL, V10, P40, DOI 10.1016/0887-8994(94)90065-5
   Babalola E, 2003, BRIT J OPHTHALMOL, V87, P282, DOI 10.1136/bjo.87.3.282
   Babovic-Vuksanovic D, 1998, AM J MED GENET, V79, P383
   Badea N, 1991, Oftalmologia, V35, P63
   BAKER RH, 1990, OPHTHALMOLOGY, V97, P1176
   Bamashmus MA, 2004, EYE, V18, P257, DOI 10.1038/sj.eye.6700606
   Bandello F, 2002, EUR J OPHTHALMOL, V12, P556, DOI 10.1177/112067210201200620
   BANNA M, 1973, J PEDIATR-US, V83, P781, DOI 10.1016/S0022-3476(73)80369-5
   Barbet F, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.025502
   Barbet F, 2003, EUR J HUM GENET, V11, P966, DOI 10.1038/sj.ejhg.5201070
   Barboni P, 2005, OPHTHALMOLOGY, V112, P120, DOI 10.1016/j.ophtha.2004.06.034
   BARKOVICH AJ, 2005, PEDIAT NEUROIMAGING, P231
   BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6
   Barrientos A, 1996, J CLIN INVEST, V97, P1570, DOI 10.1172/JCI118581
   Bartels MC, 2004, J CRANIOFAC SURG, V15, P1019, DOI 10.1097/00001665-200411000-00026
   BARTLETT JR, 1971, J NEUROL NEUROSUR PS, V34, P37, DOI 10.1136/jnnp.34.1.37
   Basel-Vanagaite L, 2004, NEUROLOGY, V62, P87, DOI 10.1212/01.WNL.0000101680.49036.69
   Baskan EB, 2006, J EUR ACAD DERMATOL, V20, P829, DOI 10.1111/j.1468-3083.2006.01655.x
   BASKIN DS, 1986, J NEUROSURG, V65, P22, DOI 10.3171/jns.1986.65.1.0022
   BEATTY RM, 1982, J NEUROL NEUROSUR PS, V45, P143, DOI 10.1136/jnnp.45.2.143
   BEHR C, 1909, KLIN MB AUGENHEILK, V47, P318
   Bekibele CO, 2003, INT J CLIN PRACT, V57, P14
   BELL RA, 1978, AM J OPHTHALMOL, V85, P538, DOI 10.1016/S0002-9394(14)75251-1
   Ben-Dov IZ, 2001, TRANSPLANTATION, V72, P958, DOI 10.1097/00007890-200109150-00037
   BENECKE R, 1983, J NEUROL, V230, P143, DOI 10.1007/BF00313625
   Bénichou OD, 2000, BONE, V26, P87, DOI 10.1016/S8756-3282(99)00244-6
   Bénit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316
   Bennett JL, 2002, J NEURO-OPHTHALMOL, V22, P286, DOI 10.1097/00041327-200212000-00006
   BENNETT MJ, 1993, J INHERIT METAB DIS, V16, P831, DOI 10.1007/BF00714274
   BENOMAR A, 1995, NAT GENET, V10, P84, DOI 10.1038/ng0595-84
   Berk AT, 2003, J PEDIAT OPHTH STRAB, V40, P272, DOI 10.3928/0191-3913-20030901-07
   Berker N, 2007, EUR J OPHTHALMOL, V17, P797, DOI 10.1177/112067210701700518
   Berker N, 2004, AM J OPHTHALMOL, V138, P879, DOI 10.1016/j.ajo.2004.05.068
   BERMAN JL, 1990, OPHTHALMOLOGY, V97, P1606
   BERNINGER TA, 1991, BRIT J OPHTHALMOL, V75, P49, DOI 10.1136/bjo.75.1.49
   Bhattacharyya P C, 1985, J Assoc Physicians India, V33, P674
   Bhatti MT, 1999, J NEURO-OPHTHALMOL, V19, P28
   Bindu PS, 2006, BRAIN DEV-JPN, V28, P343, DOI 10.1016/j.braindev.2005.11.007
   Bindu PS, 2005, J NEUROL NEUROSUR PS, V76, P1698, DOI 10.1136/jnnp.2005.063776
   Biousse V, 1999, NEUROLOGY, V53, P1537, DOI 10.1212/WNL.53.7.1537
   BITOUN P, 1994, ANN GENET-PARIS, V37, P75
   Blazo MA, 2004, AM J MED GENET A, V127A, P224, DOI 10.1002/ajmg.a.20650
   Blohmé J, 2000, ACTA OPHTHALMOL SCAN, V78, P560, DOI 10.1034/j.1600-0420.2000.078005560.x
   Bodunde O T, 2006, Niger J Med, V15, P291
   Boiko AN, 2000, J NEUROVIROL, V6, pS152
   BORGNAPIGNATTI C, 1989, J PEDIATR-US, V114, P405, DOI 10.1016/S0022-3476(89)80558-X
   BORRETT D, 1985, BRAIN, V108, P367, DOI 10.1093/brain/108.2.367
   Borruat FX, 2005, AM J OPHTHALMOL, V139, P715, DOI 10.1016/j.ajo.2004.09.061
   BORRUAT FX, 1992, BRIT J OPHTHALMOL, V76, P571, DOI 10.1136/bjo.76.9.571
   BORRUAT FX, 1993, J CLIN NEURO-OPHTHAL, V13, P98
   Bosley TM, 2008, INVEST OPHTH VIS SCI, V49, P5250, DOI 10.1167/iovs.08-2193
   BOTHE N, 1991, KLIN MONATSBL AUGENH, V198, P509, DOI 10.1055/s-2008-1046023
   Bouhlal Y, 2005, Acta Myol, V24, P155
   BOWER SPC, 1992, LANCET, V339, P1427, DOI 10.1016/0140-6736(92)91257-9
   Bowman RJC, 2010, BRIT J OPHTHALMOL, V94, P146, DOI 10.1136/bjo.2009.160713
   Bozkurt B, 2002, CLIN EXP OPHTHALMOL, V30, P411, DOI 10.1046/j.1442-9071.2002.00570.x
   BRACKEN MB, 1993, J NEUROSURG, V79, P500, DOI 10.3171/jns.1993.79.4.0500
   Bremner FD, 1999, INVEST OPHTH VIS SCI, V40, P2528
   BRODSKY MC, 1988, J NEUROSURG, V68, P300, DOI 10.3171/jns.1988.68.2.0300
   BRODSKY MC, 1990, ARCH OPHTHALMOL-CHIC, V108, P1562, DOI 10.1001/archopht.1990.01070130064032
   Brodsky MC, 2002, OPHTHALMOLOGY, V109, P85, DOI 10.1016/S0161-6420(01)00849-1
   BRODSKY MC, 1993, SURV OPHTHALMOL, V38, P213, DOI 10.1016/0039-6257(93)90104-F
   BRODSKY MC, 1988, J CLIN NEURO-OPHTHAL, V8, P67
   Brodsky MC, 2001, ARCH OPHTHALMOL-CHIC, V119, P626
   Brookes JT, 2008, INT J PEDIATR OTORHI, V72, P121, DOI 10.1016/j.ijporl.2007.08.019
   Brown MD, 2004, MOVEMENT DISORD, V19, P235, DOI 10.1002/mds.10646
   Brown MD, 2001, AM J MED GENET, V104, P331, DOI 10.1002/1096-8628(2001)104:4<331::AID-AJMG10054>3.0.CO;2-8
   Brown MD, 2001, HUM GENET, V109, P33, DOI 10.1007/s004390100538
   BROWN WF, 1990, STROKE, V21, P1700, DOI 10.1161/01.STR.21.12.1700
   BRUETON LA, 1990, J MED GENET, V27, P701, DOI 10.1136/jmg.27.11.701
   Brunette J. R., 1969, PROGR NEUROOPHTHALMO, P91
   BU XD, 1993, LANCET, V342, P598, DOI 10.1016/0140-6736(93)91416-J
   Buchfelder M, 1986, Zentralbl Neurochir, V47, P89
   BUNCIC JR, 1991, CLIN PLAST SURG, V18, P315
   Buncic JR, 2004, OPHTHALMOLOGY, V111, P1935, DOI 10.1016/j.ophtha.2004.03.036
   Buono LM, 2005, SURV OPHTHALMOL, V50, P15, DOI 10.1016/j.survophthal.2004.10.005
   Burk K, 1996, BRAIN, V119, P1497, DOI 10.1093/brain/119.5.1497
   Burke J P, 1991, Metab Pediatr Syst Ophthalmol (1985), V14, P12
   BURKE JP, 1989, BRIT J OPHTHALMOL, V73, P427, DOI 10.1136/bjo.73.6.427
   Buttner N, 1998, ARCH NEUROL-CHICAGO, V55, P1353, DOI 10.1001/archneur.55.10.1353
   BYRD DJ, 1989, EUR J PEDIATR, V148, P543, DOI 10.1007/BF00441554
   CABEZUDO JM, 1981, J NEUROSURG, V55, P127, DOI 10.3171/jns.1981.55.1.0127
   CABEZUDO JM, 1981, SURG NEUROL, V15, P422, DOI 10.1016/S0090-3019(81)80027-4
   Caines E, 2007, ACTA OPHTHALMOL SCAN, V85, P662, DOI 10.1111/j.1600-0420.2007.00905.x
   Çaksen H, 2003, GENET COUNSEL, V14, P343
   CALOGERO JA, 1971, J NEUROSURG, V34, P236, DOI 10.3171/jns.1971.34.2part1.0236
   CAMPANA G, 1987, OPHTHALMIC PAED GEN, V8, P125, DOI 10.3109/13816818709028528
   Campbell Carrie Lahnstein, 2003, Optometry, V74, P417
   Cano A, 2007, DIABETES CARE, V30, P2327, DOI 10.2337/dc07-0380
   CARANGO P, 1995, ANN NEUROL, V38, P610, DOI 10.1002/ana.410380409
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2007, ENVIRON HEALTH PERSP, V115, P113, DOI 10.1289/ehp.9245
   Carroll AL, 2001, CLIN EXP OPHTHALMOL, V29, P38, DOI 10.1046/j.1442-9071.2001.00363.x
   CARROLL WM, 1980, BRAIN, V103, P413, DOI 10.1093/brain/103.2.413
   Carta A, 2005, BRIT J OPHTHALMOL, V89, P825, DOI 10.1136/bjo.2004.060590
   Cassidy L, 2000, MED PEDIATR ONCOL, V34, P43, DOI 10.1002/(SICI)1096-911X(200001)34:1<43::AID-MPO8>3.3.CO;2-8
   CASTEELS I, 1994, NEUROPEDIATRICS, V25, P265, DOI 10.1055/s-2008-1073034
   Castelnau P, 2001, PEDIATR NEUROL, V25, P170, DOI 10.1016/S0887-8994(01)00295-8
   Castro FJ, 2000, ACTA OPHTHALMOL SCAN, V78, P118, DOI 10.1034/j.1600-0420.2000.078001118.x
   CASTROGAGO M, 1993, ARCH FR PEDIATR, V50, P327
   Cerovski B, 2004, COLLEGIUM ANTROPOL, V28, P927
   Chan JW, 2003, SURV OPHTHALMOL, V48, P12, DOI 10.1016/S0039-6257(02)00416-2
   CHAN T, 1991, BRIT J OPHTHALMOL, V75, P524, DOI 10.1136/bjo.75.9.524
   Chang Chi-Wu, 2003, Kaohsiung Journal of Medical Sciences, V19, P516
   Chansoria Maya, 2005, Indian Journal of Pediatrics, V72, P1047, DOI 10.1007/BF02724409
   CHELLURI L, 1988, RESUSCITATION, V16, P45, DOI 10.1016/0300-9572(88)90017-2
   Chen AS, 2000, GENET MED, V2, P283, DOI 10.1097/00125817-200009000-00003
   Chen Hsin-Yi, 1998, Kaohsiung Journal of Medical Sciences, V14, P710
   Chen SQ, 2007, AM J OPHTHALMOL, V143, P186, DOI 10.1016/j.ajo.2006.06.049
   CHERNINKOVA S, 1990, OPHTHALMOLOGICA, V201, P201, DOI 10.1159/000310152
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   CHITAYAT D, 1992, AM J MED GENET, V43, P517, DOI 10.1002/ajmg.1320430304
   Christiansen SP, 2002, J PEDIAT OPHTH STRAB, V39, P157, DOI 10.3928/0191-3913-20020501-07
   Chronister Connie L, 2005, Optometry, V76, P302, DOI 10.1016/S1529-1839(05)70313-4
   Chuenkongkaew WL, 2005, J NEURO-OPHTHALMOL, V25, P173, DOI 10.1097/01.wno.0000176631.87234.49
   Chuenkongkaew WL, 2001, JPN J OPHTHALMOL, V45, P665, DOI 10.1016/S0021-5155(01)00423-3
   Chuenkongkaew WL, 2005, EUR J NEUROL, V12, P388, DOI 10.1111/j.1468-1331.2004.01060.x
   Chung KW, 2006, BRAIN, V129, P2103, DOI 10.1093/brain/awl174
   Chutorian AM, 2003, REV NEUROLOGIA, V36, P264, DOI 10.33588/rn.3603.2002178
   Chutorian AM, 2002, PEDIATR NEUROL, V26, P358, DOI 10.1016/S0887-8994(02)00398-3
   CILLINO S, 1989, GRAEF ARCH CLIN EXP, V227, P131, DOI 10.1007/BF02169784
   Coats DK, 2000, J AAPOS, V4, P110, DOI 10.1067/mpa.2000.103870
   COCKAYNE EA, 1946, ARCH DIS CHILD, V21, P52, DOI 10.1136/adc.21.105.52
   COGAN DG, 1980, AM J OPHTHALMOL, V90, P251, DOI 10.1016/S0002-9394(14)74863-9
   COHEN SM, 1992, AM J OPHTHALMOL, V95, P82
   Cohn AC, 2007, AM J OPHTHALMOL, V143, P656, DOI 10.1016/j.ajo.2006.12.038
   Coleman P, 2007, OPHTHAL PHYSL OPT, V27, P547, DOI 10.1111/j.1475-1313.2007.00513.x
   COLLINS MLZ, 1990, OPHTHALMOLOGY, V97, P1445
   Colosimo A, 2003, HUM MUTAT, V21, P622, DOI 10.1002/humu.10215
   Comaish I. F., 2002, Documenta Ophthalmologica, V104, P195, DOI 10.1023/A:1014603229383
   Copeliovitch L, 2001, J PEDIATR ORTHOPED, V21, P512, DOI 10.1097/00004694-200107000-00018
   CORBETT JJ, 1986, SEMIN NEUROL, V6, P111, DOI 10.1055/s-2008-1041454
   CORDES FC, 1952, AM J OPHTHALMOL, V35, P1272, DOI 10.1016/0002-9394(52)91144-6
   Corona-Rivera JR, 2005, AM J MED GENET A, V135A, P69, DOI 10.1002/ajmg.a.30669
   COSTEFF H, 1989, NEUROLOGY, V39, P595, DOI 10.1212/WNL.39.4.595
   COSTEFF H, 1993, ANN NEUROL, V33, P103, DOI 10.1002/ana.410330117
   Costenbader FD., 1968, Journal of Pediatric Ophthalmology, V5, P77, DOI 10.3928/0191-3913-19680501-03
   Craig JE, 2006, BRIT J OPHTHALMOL, V90, P1420, DOI 10.1136/bjo.2006.099333
   CULLOM ME, 1993, ARCH OPHTHALMOL-CHIC, V111, P1482, DOI 10.1001/archopht.1993.01090110048021
   Curé JK, 2000, AM J NEURORADIOL, V21, P1110
   D'Arrigo S, 2005, J CHILD NEUROL, V20, P454, DOI 10.1177/08830738050200051801
   Dailey R., 1991, OPHTHALMOL CLIN N AM, V4, P519
   Damji KF, 2001, CAN J OPHTHALMOL, V36, P252, DOI 10.1016/S0008-4182(01)80018-1
   Dandona L, 2000, Indian J Ophthalmol, V48, P59
   Dandona R, 2002, OPHTHALMOLOGY, V109, P1871, DOI 10.1016/S0161-6420(02)01183-1
   Daneshvar H, 1999, OPHTHALMOLOGY, V106, P1792, DOI 10.1016/S0161-6420(99)90345-7
   David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65
   David LR, 2002, J CRANIOFAC SURG, V13, P676, DOI 10.1097/00001665-200209000-00015
   DAVIS PC, 1986, AM J NEURORADIOL, V7, P639
   de Vries L, 2003, J PEDIATR ENDOCR MET, V16, P703
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   DeCarlo D K, 1999, J Am Optom Assoc, V70, P647
   Deda G, 2003, GENET COUNSEL, V14, P253
   Defoort-Dhellemmes S, 2006, J PEDIATR ENDOCR MET, V19, P321
   Delague V, 2002, NEUROGENETICS, V4, P23, DOI 10.1007/s10048-001-0127-z
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Demer JL, 2005, INVEST OPHTH VIS SCI, V46, P530, DOI 10.1167/iovs.04-1125
   den Hollander AI, 2001, AM J HUM GENET, V69, P198
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   Dhalla MS, 2006, CAN J OPHTHALMOL, V41, P38, DOI 10.1016/S0008-4182(06)80064-5
   Dharmaraj S R, 2000, Ophthalmic Genet, V21, P135
   Di Gennaro G, 1999, PEDIATR NEUROL, V21, P566, DOI 10.1016/S0887-8994(99)00030-2
   DIAMOND GA, 1987, AM J OPHTHALMOL, V104, P645, DOI 10.1016/0002-9394(87)90179-6
   Dillmann U, 1997, J NEUROL, V244, P562, DOI 10.1007/s004150050144
   DiMauro S, 1996, ANN NEUROL, V40, P5, DOI 10.1002/ana.410400104
   Dimitratos SD, 1998, GENOMICS, V51, P308, DOI 10.1006/geno.1998.5404
   DINEEN J, 1982, EXP BRAIN RES, V47, P446
   Dogulu CF, 2001, EYE, V15, P183, DOI 10.1038/eye.2001.57
   DOHI MT, 1993, OPHTHAL PAEDIAT GENE, V14, P5
   DOLL R, 1992, AM J HUM GENET, V51, P161
   Dollfus H, 2000, ARCH OPHTHALMOL-CHIC, V118, P1386
   Domènech E, 2004, PRENATAL DIAG, V24, P787, DOI 10.1002/pd.982
   Domenech Enric, 2006, Pediatr Endocrinol Rev, V3, P249
   Dörfler A, 2000, NEUROPEDIATRICS, V31, P151, DOI 10.1055/s-2000-7490
   DRACK AV, 1992, ARCH OPHTHALMOL-CHIC, V110, P712, DOI 10.1001/archopht.1992.01080170134041
   DREYER M, 1982, KLIN WOCHENSCHR, V60, P471, DOI 10.1007/BF01720362
   Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113
   DU JW, 2005, OPTOMETRY VISION SCI, V82, P1000
   DUBOIS LG, 1992, J CLIN NEURO-OPHTHAL, V12, P15
   Duman O, 2004, J CHILD NEUROL, V19, P552
   DURR A, 1995, CLIN NEUROSCI, V3, P12
   DUTTON JJ, 1994, SURV OPHTHALMOL, V38, P427, DOI 10.1016/0039-6257(94)90173-2
   DUTTON JJ, 1983, J CLIN NEURO-OPHTHAL, V3, P137
   Eckhardt SME, 1998, PEDIATR NEUROL, V19, P234, DOI 10.1016/S0887-8994(98)00042-3
   Edwards AO, 1999, AM J OPHTHALMOL, V127, P426, DOI 10.1016/S0002-9394(98)00331-6
   Edwards TL, 2007, NEURO-OPHTHALMOLOGY, V31, P87, DOI 10.1080/01658100701501125
   Egan RA, 2005, AM J OPHTHALMOL, V140, P267, DOI 10.1016/j.ajo.2005.03.024
   Eiberg H, 2006, J MED GENET, V43, P435, DOI 10.1136/jmg.2005.034892
   Eke T, 1997, BRIT MED J, V314, P180, DOI 10.1136/bmj.314.7075.180
   El-Shanti H, 2000, AM J HUM GENET, V66, P1229, DOI 10.1086/302858
   ELAZAZI M, 1990, AM J OPHTHALMOL, V109, P1
   ELBERG H, 1994, HUM MOL GENET, V3, P977
   Eldevik OP, 1996, AM J NEURORADIOL, V17, P1427
   ELIOTT D, 1993, AM J OPHTHALMOL, V115, P360, DOI 10.1016/S0002-9394(14)73589-5
   Ells AL, 2003, J AAPOS, V7, P223, DOI 10.1016/S1091-8531(03)00005-3
   ELPELEG ON, 1994, DEV MED CHILD NEUROL, V36, P167
   ENEVOLDSON TP, 1994, BRAIN, V117, P445, DOI 10.1093/brain/117.3.445
   Ergür Ö, 2000, TURKISH J PEDIATR, V42, P48
   ERSAHIN Y, 1993, NEUROSURGERY, V33, P219, DOI 10.1097/00006123-199308000-00006
   Ersanli D, 2006, RETINA-J RET VIT DIS, V26, P32, DOI 10.1097/00006982-200601000-00006
   Esmaili N, 2007, OPHTHALMOLOGY, V114, P1773, DOI 10.1016/j.ophtha.2006.12.015
   Esteitie N, 2005, ANN NEUROL, V58, P544, DOI 10.1002/ana.20570
   Eustis H S, 1990, J Pediatr Ophthalmol Strabismus, V27, P237
   Farber MD, 2003, OPHTHAL EPIDEMIOL, V10, P267, DOI 10.1076/opep.10.4.267.15910
   Fardet L, 2003, ACTA NEUROL SCAND, V108, P193, DOI 10.1034/j.1600-0404.2003.02178.x
   Farina L, 1999, NEURORADIOLOGY, V41, P376, DOI 10.1007/s002340050768
   Farukhi F, 2006, OPHTHALMIC GENET, V27, P89, DOI 10.1080/13816810600862626
   Fauser S, 2002, BIOCHEM BIOPH RES CO, V295, P342, DOI 10.1016/S0006-291X(02)00672-1
   Fawzi AA, 2005, ARCH OPHTHALMOL-CHIC, V123, P486, DOI 10.1001/archopht.123.4.486
   Fazzi E, 2007, DEV MED CHILD NEUROL, V49, P503, DOI 10.1111/j.1469-8749.2007.00503.x
   Fein-Levy C, 1998, J PEDIAT HEMATOL ONC, V20, P577, DOI 10.1097/00043426-199811000-00015
   Felicio AC, 2008, PARKINSONISM RELAT D, V14, P370, DOI 10.1016/j.parkreldis.2007.08.008
   Feng XM, 2000, CHINESE MED J-PEKING, V113, P743
   Ferguson FR, 1928, J NEUROL PSYCHOPATHO, V9, P120
   FERNANDEZ GR, 1992, ACTA OPHTHALMOL, V70, P135
   Ferreira RC, 1997, AM J OPHTHALMOL, V123, P264, DOI 10.1016/S0002-9394(14)71051-7
   FERRER I, 1987, J NEUROL, V234, P416, DOI 10.1007/BF00314088
   Field MJ, 2003, AM J MED GENET A, V122A, P6, DOI 10.1002/ajmg.a.20216
   Filiano JJ, 2002, PEDIATR NEUROL, V26, P239, DOI 10.1016/S0887-8994(01)00377-0
   Finger PT, 2007, AM J OPHTHALMOL, V143, P335, DOI 10.1016/j.ajo.2006.09.014
   Fink JK, 2003, ARCH NEUROL-CHICAGO, V60, P1045, DOI 10.1001/archneur.60.8.1045
   Finsterer J, 2001, CAN J CARDIOL, V17, P464
   FLETCHER WA, 1986, J NEUROSURG, V65, P154, DOI 10.3171/jns.1986.65.2.0154
   FOLZ SJ, 1991, SURV OPHTHALMOL, V35, P353, DOI 10.1016/0039-6257(91)90185-I
   Fournier AV, 2001, OPHTHALMOLOGY, V108, P1595, DOI 10.1016/S0161-6420(01)00696-0
   FRAIOLI B, 1983, J NEUROSURG, V59, P590, DOI 10.3171/jns.1983.59.4.0590
   FRANCOIS J, 1966, J GENET HUM, V15, P147
   Francois J, 1979, Adv Ophthalmol, V39, P1
   FRANCOIS J, 1961, HEREDITARY OPHATHALM, P508
   FREEMAN JW, 1980, ARCH NEUROL-CHICAGO, V37, P176, DOI 10.1001/archneur.1980.00500520074015
   FRIEDBERG EC, 1992, CELL, V128, P1233
   FRISEN L, 1984, OPHTHALMOLOGY, V91, P1342
   Fukuoka H, 2007, J HUM GENET, V52, P510, DOI 10.1007/s10038-007-0144-3
   Funalot B, 2002, ANN NEUROL, V52, P374, DOI 10.1002/ana.10299
   Galluzzi P, 1999, NEURORADIOLOGY, V41, P729, DOI 10.1007/s002340050832
   Gamez J, 2001, AM J OPHTHALMOL, V131, P398, DOI 10.1016/S0002-9394(00)00799-6
   Ganesh A, 2005, J AAPOS, V9, P604, DOI 10.1016/j.jaapos.2005.05.001
   Ganesh SK, 2004, J CATARACT REFR SURG, V30, P2371, DOI 10.1016/j.jcrs.2004.02.091
   García-Silva MT, 2004, J INHERIT METAB DIS, V27, P591, DOI 10.1023/B:BOLI.0000042984.42433.d8
   Garcia-Valenzuela E, 1999, RETINA-J RET VIT DIS, V19, P424, DOI 10.1097/00006982-199909000-00010
   Gasch AT, 2002, OPHTHALMOLOGY, V109, P1477, DOI 10.1016/S0161-6420(02)01095-3
   GASCON GG, 1990, NEUROLOGY, V40, P1876, DOI 10.1212/WNL.40.12.1876
   GASCON GG, 1994, BRAIN DEV-JPN, V16, P94, DOI 10.1016/0387-7604(94)90102-3
   GASTON H, 1991, Eye (London), V5, P279
   GAY C, 1991, ARCH FR PEDIATR, V48, P409
   GELBER SJ, 1992, J PEDIATR-US, V120, P931, DOI 10.1016/S0022-3476(05)81966-3
   Geneviève D, 2004, AM J MED GENET A, V129A, P64, DOI 10.1002/ajmg.a.30144
   Georgy BA, 1998, AM J NEURORADIOL, V19, P281
   Gerber S, 2001, EUR J HUM GENET, V9, P561, DOI 10.1038/sj.ejhg.5200689
   GHOSE S, 1983, T OPHTHAL SOC UK, V103, P217
   Gilles EE, 2003, J PEDIATR-US, V143, P494, DOI 10.1067/S0022-3476(03)00416-5
   Gillis L, 2002, PEDIATR CLIN N AM, V49, P203, DOI 10.1016/S0031-3955(03)00115-9
   Giuliano Fabienne, 2005, Hum Mutat, V25, P99, DOI 10.1002/humu.9300
   Gnanaraj L, 2005, OPHTHAL PLAST RECONS, V21, P445, DOI 10.1097/01.iop.0000189222.20693.ff
   Goddey Nmorsi Onyebiguwa Patrick, 2001, Journal of Communicable Diseases, V33, P185
   Goebel HH, 2004, BRAIN PATHOL, V14, P61, DOI 10.1111/j.1750-3639.2004.tb00499.x
   Goebel HH, 2004, BRAIN PATHOL, V14, P59, DOI 10.1111/j.1750-3639.2004.tb00498.x
   Goizet C, 2003, ANN GENET-PARIS, V46, P25, DOI 10.1016/S0003-3995(03)00003-0
   GOLDBERG MF, 1993, OPHTHALMOLOGY, V100, P1645
   GOLDBERG MF, 1970, AM J OPHTHALMOL, V69, P969, DOI 10.1016/0002-9394(70)91040-8
   Goldenberg-Cohen N, 2004, J AAPOS, V8, P20, DOI 10.1016/j.jaapos.2003.08.009
   GOOD W V, 1987, Investigative Ophthalmology and Visual Science, V28, P309
   GOODMAN SJ, 1975, ARCH OPHTHALMOL-CHIC, V93, P991
   Gordon N, 2001, Eur J Paediatr Neurol, V5, P65, DOI 10.1053/ejpn.2001.0467
   Gordon Neil, 2002, Eur J Paediatr Neurol, V6, P243, DOI 10.1053/ejpn.2002.0606
   Gotoh Y, 2004, ARCH OPHTHALMOL-CHIC, V122, P341, DOI 10.1001/archopht.122.3.341
   Gourie-Devi M, 2003, J NEUROL SCI, V209, P13, DOI 10.1016/S0022-510X(02)00458-6
   GOUW LG, 1994, NEUROLOGY, V44, P1441, DOI 10.1212/WNL.44.8.1441
   GOUW LG, 1997, NAT GENET, V17, P65
   Graham JM, 2004, AM J MED GENET A, V128A, P235, DOI 10.1002/ajmg.a.30060
   Graham JM, 2001, AM J HUM GENET, V69, P291, DOI 10.1086/321295
   Granse Lotta, 2003, Ophthalmic Genet, V24, P233, DOI 10.1076/opge.24.4.233.17230
   GRANT WM, 1986, TOXICOLOGY EYE, P1048
   Grattan-Smith PJ, 2001, J PAEDIATR CHILD H, V37, P81, DOI 10.1046/j.1440-1754.2001.00560.x
   Gray TL, 2005, OPHTHALMOLOGY, V112, P1129, DOI 10.1016/j.ophtha.2004.12.037
   Grazina MM, 2007, EUR J PAEDIATR NEURO, V11, P115, DOI 10.1016/j.ejpn.2006.11.015
   Greven CM, 2002, RETINA-J RET VIT DIS, V22, P575, DOI 10.1097/00006982-200210000-00007
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   Gropman A L, 2001, Curr Neurol Neurosci Rep, V1, P185
   Gropman AL, 2004, MITOCHONDRION, V4, P503, DOI 10.1016/j.mito.2004.07.009
   Gücüyener K, 2001, NEUROPEDIATRICS, V32, P142, DOI 10.1055/s-2001-16616
   Gupta DK, 2006, CHILD NERV SYST, V22, P1194, DOI 10.1007/s00381-006-0055-1
   GUPTA S, 1993, DOC OPHTHALMOL, V83, P271, DOI 10.1007/BF01204328
   GUSTAVSON KH, 1993, AM J MED GENET, V45, P654, DOI 10.1002/ajmg.1320450527
   GUY J, 1991, J NEUROSURG, V74, P426, DOI 10.3171/jns.1991.74.3.0426
   HABERLAND C, 1972, ARCH NEUROL-CHICAGO, V26, P391, DOI 10.1001/archneur.1972.00490110025002
   Haddad MAO, 2007, J PEDIAT OPHTH STRAB, V44, P232, DOI 10.3928/01913913-20070701-04
   Haddad Maria Aparecida Onuki, 2006, Clinics, V61, P239, DOI 10.1590/S1807-59322006000300009
   HADDAD R, 1976, ARCH OPHTHALMOL-CHIC, V94, P1927, DOI 10.1001/archopht.1976.03910040633011
   Hadidy AM, 2004, SAUDI MED J, V25, P638
   Haftel LT, 2000, J CHILD NEUROL, V15, P386, DOI 10.1177/088307380001500606
   HAGEMOSER K, 1989, AM J MED GENET, V33, P61, DOI 10.1002/ajmg.1320330108
   HAINES SJ, 1988, NEUROSURGERY, V23, P470, DOI 10.1227/00006123-198810000-00011
   HALTIA M, 1993, ACTA NEUROPATHOL, V85, P241
   HAMED LM, 1988, J CLIN NEURO-OPHTHAL, V8, P239
   HAMED LM, 1992, J CLIN NEURO-OPHTHAL, V12, P192
   HAMED LM, 1994, OPHTHALMOLOGY S, V101, P134
   Hamid R, 2007, Mymensingh Med J, V16, P123
   HAMILTON SR, 1990, ARCH OPHTHALMOL-CHIC, V108, P551, DOI 10.1001/archopht.1990.01070060099057
   HAMILTON SR, 1999, P N AM NEUR SOC SNOW, P195
   Hammerstein W, 1991, Fortschr Ophthalmol, V88, P463
   HAMMOND EJ, 1983, ARCH NEUROL-CHICAGO, V40, P366, DOI 10.1001/archneur.1983.04050060066012
   Han J, 2006, GENET MED, V8, P217, DOI 10.1097/01.gim.0000214299.61930.c0
   Hanemann CO, 1996, J NEUROL, V243, P297, DOI 10.1007/BF00868531
   HANSEN E, 1992, ACTA OPHTHALMOL, V70, P597
   Hansen L, 2005, EUR J HUM GENET, V13, P1275, DOI 10.1038/sj.ejhg.5201491
   Hansen RM, 2008, VISION RES, V48, P325, DOI 10.1016/j.visres.2007.07.009
   Harding A.R., 1984, The hereditary ataxias and related disorders
   HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1
   Harding GFA, 2000, NEUROLOGY, V55, P347, DOI 10.1212/WNL.55.3.347
   Hardy C, 1999, AM J HUM GENET, V65, P1279, DOI 10.1086/302609
   HARLEY R D, 1970, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V74, P1011
   Harrison DA, 1998, OPHTHALMOLOGY, V105, P1886, DOI 10.1016/S0161-6420(98)91035-1
   HAYASAKA S, 1986, ARCH OPHTHALMOL-CHIC, V104, P1656
   Hayashi N, 2000, OPHTHALMOLOGY, V107, P1397, DOI 10.1016/S0161-6420(00)00110-X
   HEHER KL, 1993, ARCH OPHTHALMOL-CHIC, V111, P1495, DOI 10.1001/archopht.1993.01090110061024
   Herman GE, 2003, HUM MOL GENET, V12, pR75, DOI 10.1093/hmg/ddg072
   Higgins JJ, 1996, NEUROLOGY, V46, P208, DOI 10.1212/WNL.46.1.208
   Hirai T, 2002, OPHTHALMOLOGY, V109, P1692, DOI 10.1016/S0161-6420(02)01171-5
   HO G, 2008, J INHERIT MED DIS
   Hofmann S, 1997, GENOMICS, V39, P8, DOI 10.1006/geno.1996.4474
   HOLMBERG M, 1995, HUM MOL GENET, V10, P89
   Houlden H, 2002, BRAIN, V125, P2681, DOI 10.1093/brain/awf270
   HOWELL N, 1994, AM J HUM GENET, V55, P219
   HOWELL N, 1993, AM J HUM GENET, V53, P959
   HOYT CS, 1979, AM J DIS CHILD, V133, P955, DOI 10.1001/archpedi.1979.02130090083017
   HOYT CS, 1980, OPHTHALMOLOGY, V87, P245
   HOYT CS, 1979, BRIT J OPHTHALMOL, V63, P191, DOI 10.1136/bjo.63.3.191
   HOYT CS, 1992, EYE, V6, P201, DOI 10.1038/eye.1992.39
   HOYT WF, 1990, INT CONGR SER, V882, P239
   HOYT WF, 1987, PROG EXP TUMOR RES, V30, P113
   HOYT WF, 1972, BRIT J OPHTHALMOL, V56, P537, DOI 10.1136/bjo.56.7.537
   Hoyt WF., 1976, AUST J OPHTHALMOL, V4, P14, DOI [10.1111/j.1442-9071.1976.tb00846.x, DOI 10.1111/J.1442-9071.1976.TB00846.X]
   HUBER A, 1994, CURR OPIN NEUROL, V7, P65, DOI 10.1097/00019052-199402000-00012
   HUDSON G, 2006, AM J HUM GENET, V78, P564
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Huisman TAGM, 2006, AM J NEURORADIOL, V27, P1555
   HULL BM, 1989, OPHTHAL PHYSL OPT, V9, P143, DOI 10.1111/j.1475-1313.1989.tb00834.x
   Huna-Baron R, 1999, PEDIATR NEUROSURG, V31, P322, DOI 10.1159/000028883
   Hung Hsiang-Ling, 2003, Chang Gung Med J, V26, P41
   Huo R, 1999, BRIT J OPHTHALMOL, V83, P670, DOI 10.1136/bjo.83.6.670
   HUOPONEN K, 1993, HUM GENET, V92, P379, DOI 10.1007/BF01247339
   HUR DJ, 2006, AM J MED GENET, V140, P1487
   Hussain IHMI, 1999, BRAIN DEV-JPN, V21, P229
   Hwang JM, 2000, PEDIATR NEUROSURG, V33, P328, DOI 10.1159/000055980
   HWANG TN, 2007, P FB WALSH SESS FEB
   Ianchulev T, 2003, OPHTHALMOLOGY, V110, P1850, DOI 10.1016/S0161-6420(03)00573-6
   ICHIYAMA T, 1993, BRAIN DEV-JPN, V15, P153, DOI 10.1016/0387-7604(93)90054-C
   Ilker SS, 1999, JPN J OPHTHALMOL, V43, P48, DOI 10.1016/S0021-5155(98)00058-6
   IMES RK, 1991, AM J OPHTHALMOL, V111, P729, DOI 10.1016/S0002-9394(14)76780-7
   IMES RK, 1986, BRIT J OPHTHALMOL, V70, P179, DOI 10.1136/bjo.70.3.179
   Ingelse J, 2001, Optometry, V72, P761
   Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441
   Ishikawa K, 2005, JPN J OPHTHALMOL, V49, P121, DOI 10.1007/s10384-004-0166-8
   Ishikawa T, 2000, PEDIATR NEUROL, V22, P322, DOI 10.1016/S0887-8994(99)00147-2
   Ito S, 2007, AM J NEURORADIOL, V28, P305
   IWASHITA H, 1970, ARCH NEUROL-CHICAGO, V22, P357, DOI 10.1001/archneur.1970.00480220071010
   JACOBSON DM, 1990, NEUROLOGY, V40, P804, DOI 10.1212/WNL.40.5.804
   JACOBSON DM, 1991, J CLIN NEURO-OPHTHAL, V11, P152
   Jacobson L, 1997, ARCH OPHTHALMOL-CHIC, V115, P1263, DOI 10.1001/archopht.1997.01100160433007
   Jacobson SG, 2007, P NATL ACAD SCI USA, V104, P15123, DOI 10.1073/pnas.0706367104
   JAKOBIEC FA, 1984, OPHTHALMOLOGY, V91, P137
   JAMPEL RS, 1962, ARCH OPHTHALMOL-CHIC, V67, P123, DOI 10.1001/archopht.1962.00960020125004
   JAN JE, 1977, DEV MED CHILD NEUROL, V19, P353
   JENSEN ME, 1990, RADIOGRAPHICS, V10, P53, DOI 10.1148/radiographics.10.1.2296697
   JENSEN PKA, 1987, AM J MED GENET, V28, P517, DOI 10.1002/ajmg.1320280234
   Ji Y H, 1999, Korean J Ophthalmol, V13, P52
   Jia XY, 2006, J HUM GENET, V51, P851, DOI 10.1007/s10038-006-0032-2
   JOHNS DR, 1993, AM J HUM GENET, V53, P916
   JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P1491, DOI 10.1001/archopht.1993.01090110057023
   JOHNS DR, 1992, ARCH OPHTHALMOL-CHIC, V110, P1577, DOI 10.1001/archopht.1992.01080230077025
   JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038
   JOHNS DR, 1993, OPHTHALMOLOGY, V100, P981
   Johnson AB, 2002, INT J DEV NEUROSCI, V20, P391, DOI 10.1016/S0736-5748(02)00045-X
   JOHNSTON PB, 1979, AM J OPHTHALMOL, V88, P868, DOI 10.1016/0002-9394(79)90565-8
   Johnston RL, 1999, OPHTHALMOLOGY, V106, P123, DOI 10.1016/S0161-6420(99)90013-1
   Jonas JB, 2000, INVEST OPHTH VIS SCI, V41, P1764
   Jonas JB, 2006, CLIN EXP OPHTHALMOL, V34, P654, DOI 10.1111/j.1442-9071.2006.01310.x
   Jonas JB, 2006, J GLAUCOMA, V15, P206, DOI 10.1097/01.ijg.0000212209.25642.01
   Jones M, 2005, FETAL PEDIATR PATHOL, V24, P191, DOI 10.1080/15227950500305843
   Junck L, 1996, NEUROLOGY, V46, P4, DOI 10.1212/WNL.46.1.4
   Jurkiewicz E, 2005, PEDIATR RADIOL, V35, P1027, DOI 10.1007/s00247-005-1498-3
   Kalman B, 1998, ACTA NEUROL SCAND, V98, P232, DOI 10.1111/j.1600-0404.1998.tb07301.x
   Kalviainen R, 2001, CNS DRUGS, V15, P217
   KAPLAN PW, 1995, ANN NEUROL, V37, P550, DOI 10.1002/ana.410370419
   Kardon R, 2006, OPHTHALMOLOGY, V113, P1345, DOI 10.1016/j.ophtha.2006.02.055
   Kasmann-Kellner B, 1999, OPHTHALMOLOGICA, V213, P200, DOI 10.1159/000027420
   Käsmann-Kellner B, 1999, OPHTHALMOLOGICA, V213, P63, DOI 10.1159/000027396
   Katz BJ, 2006, AM J MED GENET A, V140A, P2207, DOI 10.1002/ajmg.a.31455
   KAUL R, 1994, AM J HUM GENET, V55, P34
   Kaye LC, 2000, DEV MED CHILD NEUROL, V42, P704, DOI 10.1017/S0012162200001304
   Kazek B, 2007, J CHILD NEUROL, V22, P1256, DOI 10.1177/0883073807307092
   Keltner JL, 1999, J NEURO-OPHTHALMOL, V19, P71
   KENDALL BE, 1992, AM J NEURORADIOL, V13, P621
   Kenyon K R, 1976, Birth Defects Orig Artic Ser, V12, P133
   Kerrison JB, 1999, ARCH OPHTHALMOL-CHIC, V117, P805
   Kerrison JB, 2000, AM J OPHTHALMOL, V130, P803, DOI 10.1016/S0002-9394(00)00603-6
   Khaliq S, 2003, EXP EYE RES, V76, P343, DOI 10.1016/S0014-4835(02)00304-4
   Khan R I, 2007, Ir Med J, V100, P458
   KHODADOUST AA, 1968, AM J OPHTHALMOL, V66, P502, DOI 10.1016/0002-9394(68)91536-5
   Khong JJ, 2006, OPHTHALMOLOGY, V113, P347, DOI 10.1016/j.ophtha.2005.10.011
   Khong JJ, 2006, AM J OPHTHALMOL, V142, P328, DOI 10.1016/j.ajo.2006.02.046
   Kim CH, 2006, AM J OPHTHALMOL, V141, P398, DOI 10.1016/j.ajo.2005.08.071
   KIM I, 1980, CLIN NEUROL, V20, P264
   Kim JW, 2006, J NEURO-OPHTHALMOL, V26, P30, DOI 10.1097/01.wno.0000205980.32023.2d
   Kim JY, 2005, NEUROLOGY, V64, P966, DOI 10.1212/01.WNL.0000157282.76715.B1
   Kim JY, 2002, ANN NEUROL, V51, P630, DOI 10.1002/ana.10177
   Kim TW, 2007, J GLAUCOMA, V16, P655, DOI 10.1097/IJG.0b013e31804d23aa
   Kimber J, 2003, J NEUROL NEUROSUR PS, V74, P654, DOI 10.1136/jnnp.74.5.654
   KINDER RSL, 1963, AM J DIS CHILD, V106, P331, DOI 10.1001/archpedi.1963.02080050333014
   KING KM, 1993, J PEDIATR OPHTHALMOL, V30, P84
   Kinjo S, 2004, ENDOCR J, V51, P473, DOI 10.1507/endocrj.51.473
   KINSLEY BT, 1992, IRISH MED J, V85, P34
   Kiratli H, 2002, AM J OPHTHALMOL, V133, P715, DOI 10.1016/S0002-9394(01)01429-5
   Kjer B, 1996, ACTA OPHTHALMOL SCAN, V74, P3
   KJER P, 1956, Dan Med Bull, V3, P135
   KJER P, 1959, Acta Ophthalmol Suppl, V164, P1
   KJER P, 1983, ACTA OPHTHALMOL, V61, P300
   KJER P, 1966, 18 ANN FC CORD EY SO
   Klein A, 2004, EUR J PAEDIATR NEURO, V8, P317, DOI 10.1016/j.ejpn.2004.08.006
   Kleta R, 2002, MOL GENET METAB, V76, P201, DOI 10.1016/S1096-7192(02)00047-1
   KLINE LB, 1979, ARCH OPHTHALMOL-CHIC, V97, P1680, DOI 10.1001/archopht.1979.01020020248013
   Kobayashi K, 2005, JPN J OPHTHALMOL, V49, P306, DOI 10.1007/S10384-004-0204-6
   Kocur I, 2002, BRIT J OPHTHALMOL, V86, P716, DOI 10.1136/bjo.86.7.716
   Koeppen AH, 2002, J NEUROPATH EXP NEUR, V61, P747, DOI 10.1093/jnen/61.9.747
   Kotb AA, 2006, OPHTHAL EPIDEMIOL, V13, P1, DOI 10.1080/09286580500477317
   Koul R, 2001, ARCH DIS CHILD, V85, P469, DOI 10.1136/adc.85.6.469
   Krägeloh-Mann I, 1999, ACTA PAEDIATR, V88, P897
   KRAGELOHMANN I, 1992, PEDIATR NEUROL, V8, P60, DOI 10.1016/0887-8994(92)90055-4
   Krauss GL, 1998, NEUROLOGY, V50, P614, DOI 10.1212/WNL.50.3.614
   KRETZER FL, 1981, ARCH OPHTHALMOL-CHIC, V99, P2000
   Kronenberg A, 2005, J AAPOS, V9, P169, DOI 10.1016/j.jaapos.2004.08.012
   Krumpaszky HG, 1999, OPHTHALMOLOGICA, V213, P176, DOI 10.1159/000027415
   Krumpaszky HG, 1999, OPHTHALMOLOGICA, V213, P48, DOI 10.1159/000027393
   Kumar R, 1999, ARCH DIS CHILD, V81, P221, DOI 10.1136/adc.81.3.221
   Kurian MA, 2008, NEUROLOGY, V70, P1623, DOI 10.1212/01.wnl.0000310986.48286.8e
   Kurschel S, 2007, CHILD NERV SYST, V23, P901, DOI 10.1007/s00381-007-0355-0
   Kusuhara S, 2006, EYE, V20, P882, DOI 10.1038/sj.eye.6702013
   Lagunju I A, 2007, Afr J Med Med Sci, V36, P71
   LAMBERT SL, 1990, PEDIAT OPHTHALMOLOGY, P507
   LAMBERT SR, 1987, ARCH OPHTHALMOL-CHIC, V105, P1371
   Lana-Peixoto MA, 2001, ARQ NEURO-PSIQUIAT, V59, P311, DOI 10.1590/S0004-282X2001000300001
   Lapresle J, 1986, Adv Neurol, V43, P265
   Larnaout A, 1998, ACTA NEUROL SCAND, V98, P452, DOI 10.1111/j.1600-0404.1998.tb07329.x
   Lavrov Arseni Y, 2002, Eur J Paediatr Neurol, V6, P161, DOI 10.1053/ejpn.2002.0584
   LAWDEN MC, 1999, J NEUROL NEUROSUR PS, V67, P1784
   Lawthom C, 2009, OPHTHALMOLOGY, V116, P565, DOI 10.1016/j.ophtha.2008.09.047
   Leber T., 1871, ARCH OPHTHALMOL-CHIC, V17, P249
   Lee AG, 1998, J NEURO-OPHTHALMOL, V18, P102
   Lee CW, 2003, YONSEI MED J, V44, P331, DOI 10.3349/ymj.2003.44.2.331
   Lee HBH, 2008, SURV OPHTHALMOL, V53, P543, DOI 10.1016/j.survophthal.2008.08.022
   LEES F, 1964, J NEUROL NEUROSUR PS, V27, P415, DOI 10.1136/jnnp.27.5.415
   LEEUWEN MA, 1949, BRAIN, V72, P340
   LEI SB, 2009, F WALSH SOC M FEBR 2
   LEINONEN MT, 1992, OPHTHALMOLOGICA, V204, P204, DOI 10.1159/000310295
   Lempert P, 2000, J AAPOS, V4, P258, DOI 10.1067/mpa.2000.106963
   Lesperance MM, 2003, ARCH OTOLARYNGOL, V129, P411, DOI 10.1001/archotol.129.4.411
   LESSELL S, 1977, ARCH NEUROL-CHICAGO, V34, P759, DOI 10.1001/archneur.1977.00500240047008
   WEERDT CJD, 1971, ACTA NEUROL SCAND, V47, P541, DOI 10.1111/j.1600-0404.1971.tb07507.x
   [Anonymous], 2007, OPHTHALMIC GENET, V28, P224, DOI 10.1080/13816810701663550
   Cano A, 2007, AM J MED GENET A, V143A, P1605, DOI 10.1002/ajmg.a.31809
   DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369
   LEUZZI V, 1992, J NEUROL NEUROSUR PS, V55, P16, DOI 10.1136/jnnp.55.1.16
   Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1
   LEVIN ML, 1986, J CLIN NEURO-OPHTHAL, V6, P1
   LEVIN PS, 1983, ARCH OPHTHALMOL-CHIC, V101, P1093
   Levy RL, 2006, ANN ACAD MED SINGAP, V35, P151
   LEWIS RA, 1984, OPHTHALMOLOGY, V91, P929
   Li CM, 2005, AM J MED GENET A, V138A, P208, DOI 10.1002/ajmg.a.30794
   Lieberman AP, 2000, MUSCLE NERVE, V23, P843, DOI 10.1002/(SICI)1097-4598(200006)23:6<843::AID-MUS2>3.0.CO;2-8
   Lin CH, 2004, J PEDIATR ENDOCR MET, V17, P1461
   Lin Ling, 2002, Yan Ke Xue Bao, V18, P147
   Lindenbaum Y, 2001, Eur J Paediatr Neurol, V5, P225, DOI 10.1053/ejpn.2001.0523
   Linhares SDC, 2006, ARQ NEURO-PSIQUIAT, V64, P222, DOI 10.1590/S0004-282X2006000200010
   LISTERNICK R, 1989, J PEDIATR-US, V114, P778, DOI 10.1016/s0022-3476(89)80137-4
   LIU GT, 1992, AM J OPHTHALMOL, V114, P193, DOI 10.1016/S0002-9394(14)73984-4
   Liu GT, 2001, SURV OPHTHALMOL, V46, P35, DOI 10.1016/S0039-6257(01)00225-9
   LIVINGSTONE IR, 1981, ARCH NEUROL-CHICAGO, V38, P75, DOI 10.1001/archneur.1981.00510020033003
   Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278
   Loeffler J, 2002, PRENATAL DIAG, V22, P827, DOI 10.1002/pd.419
   Longman C, 2003, CLIN DYSMORPHOL, V12, P133, DOI 10.1097/00019605-200304000-00012
   Looi A, 2006, OPHTHAL PLAST RECONS, V22, P1, DOI 10.1097/01.iop.0000189820.02983.3a
   Losowska-Kaniewska D, 2007, Adv Med Sci, V52 Suppl 1, P176
   Lotery AJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P538
   Lotery AJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P415, DOI 10.1001/archopht.119.3.415
   Luberichs J, 2002, GRAEF ARCH CLIN EXP, V240, P96, DOI 10.1007/s00417-001-0423-1
   Lynch DR, 2002, J NEURO-OPHTHALMOL, V22, P297, DOI 10.1097/00041327-200212000-00007
   Mabuchi F, 2007, AM J OPHTHALMOL, V143, P125, DOI 10.1016/j.ajo.2006.09.028
   MACDERMOT KD, 1987, J NEUROL NEUROSUR PS, V50, P1342, DOI 10.1136/jnnp.50.10.1342
   Macedo-Souza LI, 2005, ANN NEUROL, V57, P730, DOI 10.1002/ana.20478
   MACKEY D, 1992, AM J HUM GENET, V51, P1218
   Mackey DA, 2003, EYE, V17, P312, DOI 10.1038/sj.eye.6700362
   Mackey DA, 1996, AM J HUM GENET, V59, P481
   MACKEY DA, 1992, AUST NZ J OPHTHALMOL, V20, P177, DOI 10.1111/j.1442-9071.1992.tb00937.x
   MacLaren RE, 2006, CLIN EXP OPHTHALMOL, V34, P233, DOI 10.1111/j.1442-9071.2006.01191.x
   MADREPERLA SA, 1993, OPHTHALMIC PAED GEN, V14, P61, DOI 10.3109/13816819309042904
   MAFFEI L, 1981, SCIENCE, V211, P953, DOI 10.1126/science.7466368
   MAFFEI L, 1985, EXP BRAIN RES, V59, P423
   Mahapatra A, 1992, J Neurosurg Sci, V36, P79
   MAKHOUL J, 2002, B SOC BELG OPHTHALM, V286, P9
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   MANCHESTER PT, 1958, ARCH OPHTHALMOL-CHIC, V60, P479
   MANTYJARVI MI, 1992, J CLIN NEURO-OPHTHAL, V12, P98
   MARGO CE, 1991, ARCH OPHTHALMOL-CHIC, V109, P1120, DOI 10.1001/archopht.1991.01080080080033
   MARSZAL E, 2004, NEUROL NEUROCHIR POL, V14, P388
   Martin-Kleiner I, 2006, COLLEGIUM ANTROPOL, V30, P171
   MARUYAMA K, 1989, EUR J PEDIATR, V148, P682, DOI 10.1007/BF00441534
   MARZAN KAB, 1994, PEDIATR NEUROL, V10, P247, DOI 10.1016/0887-8994(94)90033-7
   Mashima Y, 2002, JPN J OPHTHALMOL, V46, P660, DOI 10.1016/S0021-5155(02)00562-2
   Mashima Y, 1996, CLIN GENET, V50, P535
   MATSON DD, 1969, J NEUROSURG, V30, P377, DOI 10.3171/jns.1969.30.4.0377
   Matsuba CA, 2006, DEV MED CHILD NEUROL, V48, P508, DOI 10.1017/S0012162206001071
   MCADAMS HP, 1990, AM J NEURORADIOL, V11, P397
   MCCLUSKEY DJ, 1986, J CLIN NEURO-OPHTHAL, V6, P76
   MCCOMAS AJ, 1991, MUSCLE NERVE, V14, P585, DOI 10.1002/mus.880140702
   MCDONNELL JM, 1990, OPTHALMOLOGY, V97, P1445
   MCGINNITY FG, 1992, BRIT J OPHTHALMOL, V76, P520, DOI 10.1136/bjo.76.9.520
   McKusick V. A, 1998, Mendelian Inheritance in Man: A Catalog of Human Genes and Genetic Disorders
   MCKUSICK VA, 1965, MEDICINE, V44, P445, DOI 10.1097/00005792-196511000-00001
   Medlej R, 2004, J CLIN ENDOCR METAB, V89, P1656, DOI 10.1210/jc.2002-030015
   MEFTY O, 1988, J NEUROSURG, V68, P80
   Mégarbané A, 2001, AM J MED GENET, V101, P135, DOI 10.1002/1096-8628(20010615)101:2<135::AID-AJMG1134>3.0.CO;2-J
   Mégarbané A, 1999, J MED GENET, V36, P637
   Mégarbané A, 2003, AM J MED GENET A, V116A, P381, DOI 10.1002/ajmg.a.10023
   Meira LB, 2000, AM J HUM GENET, V66, P1221, DOI 10.1086/302867
   MEIRE F, 1985, OPHTHALMIC PAED GEN, V5, P91, DOI 10.3109/13816818509007861
   Mellersh CS, 2006, GENOMICS, V88, P293, DOI 10.1016/j.ygeno.2006.05.004
   MENKES JH, 1962, PEDIATRICS, V29, P764
   MENON V, 1992, ACTA OPHTHALMOL, V70, P725
   Meola G, 2000, MUSCLE NERVE, V23, P1789, DOI 10.1002/1097-4598(200012)23:12<1789::AID-MUS2>3.0.CO;2-4
   Merchany SN, 2001, OTOL NEUROTOL, V22, P506, DOI 10.1097/00129492-200107000-00017
   Merrick Joav, 2004, Int J Adolesc Med Health, V16, P79
   Mets M B, 1999, Trans Am Ophthalmol Soc, V97, P653
   METS MB, 1985, OPHTHALMIC PAED GEN, V5, P85, DOI 10.3109/13816818509007860
   Michelakakis HM, 2004, PEDIATR NEUROL, V31, P146, DOI 10.1016/j.pediatrneurol.2004.01.013
   MIKELBERG FS, 1993, CAN J OPHTHALMOL, V28, P69
   Milam AH, 2003, OPHTHALMOLOGY, V110, P549, DOI 10.1016/S0161-6420(02)01757-8
   MILLER NR, 1981, ARCH OPHTHALMOL-CHIC, V99, P1654
   Miller NR, 2004, CLIN EXP OPHTHALMOL, V32, P233, DOI 10.1111/j.1442-9071.2004.00809.x
   MILLER NR, 1991, AUST NZ J OPHTHALMOL, V19, P105, DOI 10.1111/j.1442-9071.1991.tb00636.x
   MILLER NR, 1982, CLIN NEUROOPHTHALMOL, P329
   Mirdehghan SA, 2005, BRIT J OPHTHALMOL, V89, P612, DOI 10.1136/bjo.2004.050799
   MIYAKE Y, 1985, ARCH OPHTHALMOL-CHIC, V103, P1496
   Miyama S, 2000, NEUROPEDIATRICS, V31, P214, DOI 10.1055/s-2000-7462
   Mohamed MD, 2003, BRIT J OPHTHALMOL, V87, P473, DOI 10.1136/bjo.87.4.473
   Mohn A, 2004, Minerva Pediatr, V56, P115
   Moll Agnieszka, 2005, Klin Oczna, V107, P93
   MOLLER HU, 1992, OPHTHALMIC PAED GEN, V13, P31, DOI 10.3109/13816819209070051
   MOORE AT, 1985, OPHTHALMOLOGY, V92, P12
   Moorman CM, 1999, EYE, V13, P76, DOI 10.1038/eye.1999.15
   Morava E, 2006, AM J MED GENET A, V140A, P752, DOI 10.1002/ajmg.a.31117
   MORIYA N, 1995, AM J MED GENET, V58, P257, DOI 10.1002/ajmg.1320580312
   Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107
   Morse LE, 2006, PEDIATR NEUROL, V35, P154, DOI 10.1016/j.pediatrneurol.2006.02.004
   MOSCHNER C, 1994, BRAIN, V117, P15, DOI 10.1093/brain/117.1.15
   Moser CL, 2002, BRIT J OPHTHALMOL, V86, P257, DOI 10.1136/bjo.86.3.257
   Moser HW, 2007, NAT CLIN PRACT NEURO, V3, P140, DOI 10.1038/ncpneuro0421
   Moura FC, 2007, OPHTHALMOLOGY, V114, P175, DOI 10.1016/j.ophtha.2006.06.045
   Mudgil AV, 2000, CLIN EXP OPHTHALMOL, V28, P34, DOI 10.1046/j.1442-9071.2000.00254.x
   MUKAI K, 1986, J NEURO-ONCOL, V4, P79, DOI 10.1007/BF02158007
   Mullaney PB, 1997, ARCH OPHTHALMOL-CHIC, V115, P940, DOI 10.1001/archopht.1997.01100160110028
   Muller U, 1997, GRAEF ARCH CLIN EXP, V235, P545, DOI 10.1007/BF00947081
   MUNNICH A, 1992, J INHERIT METAB DIS, V15, P448, DOI 10.1007/BF01799603
   Muthukumar N, 1998, BRIT J NEUROSURG, V12, P458
   Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2
   MWANZA JC, 2000, B SOC BELG OPHTHALM, V277, P75
   Nabi NU, 2003, J AAPOS, V7, P178, DOI 10.1016/S1091-8531(02)42005-8
   Nakamura M, 2006, OPHTHALMOLOGY, V113, P483, DOI 10.1016/j.ophtha.2005.10.054
   Nakamura M, 2003, ARCH OPHTHALMOL-CHIC, V121, P1028, DOI 10.1001/archopht.121.7.1028
   NAKAMURA M, 1994, JPN J OPHTHALMOL, V38, P267
   Nakhla M, 2005, PEDIATR CLIN N AM, V52, P1637, DOI 10.1016/j.pcl.2005.07.005
   NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115
   Narula P, 2006, J PEDIATR GASTR NUTR, V43, P348, DOI 10.1097/01.mpg.0000221895.51748.44
   Neas K, 2005, J INHERIT METAB DIS, V28, P525, DOI 10.1007/s10545-005-0525-8
   Neetens A, 1982, Bull Soc Belge Ophtalmol, V203, P75
   NEETENS A, 1985, OPHTHALMIC PAED GEN, V5, P79, DOI 10.3109/13816818509007859
   NEETENS A, 1986, NEURO-OPHTHALMOLOGY, V6, P277, DOI 10.3109/01658108609053872
   NEUFELD EF, 1989, METABOLIC BASIS INHE, V2, P1565
   Newman N. J., 2005, WALSH HOYTS CLIN NEU, P465
   Newman N.J., 1993, OPHTHALMOL CLIN N AM, V4, P431
   Newman NJ, 2005, AM J OPHTHALMOL, V140, P517, DOI 10.1016/j.ajo.2005.03.017
   Newman NJ, 2004, EYE, V18, P1144, DOI 10.1038/sj.eye.6701591
   NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021
   NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4
   NEWMAN NJ, 1993, SURV OPHTHALMOL, V37, P273, DOI 10.1016/0039-6257(93)90010-5
   Newman S A, 1991, Neurosurg Clin N Am, V2, P587
   NEWMAN SA, 1983, ARCH OPHTHALMOL-CHIC, V101, P1241, DOI 10.1001/archopht.1983.01040020243018
   Nguyen C, 2005, KLIN MONATSBL AUGENH, V222, P275, DOI 10.1055/s-2005-857981
   Nguyen TN, 2002, OPHTHALMOLOGY, V109, P520, DOI 10.1016/S0161-6420(01)00985-X
   Nicolaides P, 1996, J MED GENET, V33, P419, DOI 10.1136/jmg.33.5.419
   NIKOSKELAINEN E, 1985, LANCET, V1, P696
   NIKOSKELAINEN E, 1983, ARCH OPHTHALMOL-CHIC, V101, P1059, DOI 10.1001/archopht.1983.01040020061011
   Nikoskelainen EK, 1996, OPHTHALMOLOGY, V103, P504
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   NIKOSKELAINEN EK, 1987, ARCH OPHTHALMOL-CHIC, V105, P665, DOI 10.1001/archopht.1987.01060050083043
   NIKOSKELAINEN EK, 1994, LANCET, V344, P857, DOI 10.1016/S0140-6736(94)92830-4
   Nmorsi OPG, 2007, PARASITOL RES, V100, P1261, DOI 10.1007/s00436-006-0421-7
   Nmorsi O. P. G., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P28
   Noguchi Y, 2005, ACTA OTO-LARYNGOL, V125, P1189, DOI 10.1080/00016480510044232
   Nomura S, 1999, PEDIATR NEUROSURG, V31, P213, DOI 10.1159/000028864
   NORTH KN, 1995, J PEDIATR-US, V126, P916, DOI 10.1016/S0022-3476(95)70208-3
   NOVOTNY EJ, 1986, NEUROLOGY, V36, P1053, DOI 10.1212/WNL.36.8.1053
   Numabe H, 2001, Ryoikibetsu Shokogun Shirizu, P382
   O'Hara CM, 2006, PEDIATR NEUROSURG, V42, P100, DOI 10.1159/000090463
   O'Keefe M, 2001, BRIT J OPHTHALMOL, V85, P357, DOI 10.1136/bjo.85.3.357
   Ohata T, 1998, HUM GENET, V103, P470, DOI 10.1007/s004390050852
   Ohba N, 1976, Mod Probl Ophthalmol, V17, P315
   Ohlenbusch A, 1998, NEUROPEDIATRICS, V29, P313, DOI 10.1055/s-2007-973584
   OHTSUKA Y, 1993, J CHILD NEUROL, V8, P366, DOI 10.1177/088307389300800414
   Okamoto K, 2003, AM J NEURORADIOL, V24, P1946
   Okuno T, 1985, Pediatr Neurol, V1, P311, DOI 10.1016/0887-8994(85)90036-0
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Oluleye TS, 2006, EUR J OPHTHALMOL, V16, P604, DOI 10.1177/112067210601600416
   Oluwole OSA, 2000, J NEUROL NEUROSUR PS, V69, P96, DOI 10.1136/jnnp.69.1.96
   Omran H, 2002, J AM SOC NEPHROL, V13, P75, DOI 10.1681/ASN.V13175
   OPAL P, 2007, EMERY RIMOINS PRINCI, V3, P2755
   Orbak Z, 2002, J PEDIATR ENDOCR MET, V15, P865
   ORTIZ RG, 1992, AM J OPHTHALMOL, V113, P561, DOI 10.1016/S0002-9394(14)74730-0
   OUVRIER RA, 1990, AUST NZ J OPHTHALMOL, V18, P375, DOI 10.1111/j.1442-9071.1990.tb01820.x
   Ozden Serap, 2002, Ophthalmic Genet, V23, P29, DOI 10.1076/opge.23.1.29.2208
   Ozer PA, 2007, J GLAUCOMA, V16, P685, DOI 10.1097/IJG.0b013e318073bd4d
   OZKAN H, 1991, TURKISH J PEDIATR, V33, P247
   Packwood EA, 2000, J AAPOS, V4, P321, DOI 10.1067/mpa.2000.106958
   Pakdemirli E, 2005, Australas Radiol, V49, P189, DOI 10.1111/j.1440-1673.2005.01420.x
   PALAN A, 1989, DOC OPHTHALMOL, V71, P77, DOI 10.1007/BF00155135
   Pan WJ, 2007, NEUROIMAGE, V37, P212, DOI 10.1016/j.neuroimage.2007.05.014
   Pang CY, 1999, J FORMOS MED ASSOC, V98, P326
   PARRAVANO JG, 1993, J COMPUT ASSIST TOMO, V17, P688, DOI 10.1097/00004728-199309000-00003
   Parsa CF, 2001, ARCH OPHTHALMOL-CHIC, V119, P516
   Patil CG, 2008, SPINE, V33, P1491, DOI 10.1097/BRS.0b013e318175d1bf
   Patton N, 2000, Ophthalmic Genet, V21, P151, DOI 10.1076/1381-6810(200009)21:3;1-Z;FT151
   PAULI RM, 1984, CLIN GENET, V26, P383
   PAULUS W, 1993, J NEUROL, V240, P251, DOI 10.1007/BF00818714
   Payne M, 2004, AM J OPHTHALMOL, V138, P749, DOI 10.1016/j.ajo.2004.06.011
   PEARCE WG, 1985, OPHTHALMIC PAED GEN, V5, P99, DOI 10.3109/13816818509007862
   PENA SDJ, 1974, CLIN GENET, V5, P285
   Perrault I, 1999, MOL GENET METAB, V68, P200, DOI 10.1006/mgme.1999.2906
   Perrault Isabelle, 2007, Hum Mutat, V28, P416, DOI 10.1002/humu.9485
   Peters U, 2003, ANTICANCER RES, V23, P1249
   PETERSEN J R, 1990, Ugeskrift for Laeger, V152, P3865
   Pezzi PP, 1998, PEDIATR NEUROL, V19, P308, DOI 10.1016/S0887-8994(98)00060-5
   Phasukkijwatana N, 2006, J HUM GENET, V51, P1110, DOI 10.1007/s10038-006-0073-6
   PHILLIPS CI, 1993, OPHTHALMOLOGICA, V206, P89, DOI 10.1159/000310369
   Phillipson R, 1997, IMPACT, V1, P115
   PILLEY SFJ, 1976, BRIT J OPHTHALMOL, V60, P294, DOI 10.1136/bjo.60.4.294
   Pitz S, 2007, ARCH OPHTHALMOL-CHIC, V125, P1353, DOI 10.1001/archopht.125.10.1353
   Pollack IF, 1996, PEDIATR NEUROSURG, V24, P202, DOI 10.1159/000121038
   POLLOCK SC, 1986, INT OPHTHALMOL CLIN, V26, P201, DOI 10.1097/00004397-198602640-00019
   POLYMEROPOULOS MH, 1994, NAT GENET, V8, P95, DOI 10.1038/ng0994-95
   Pomeranz HD, 1999, ARCH OPHTHALMOL-CHIC, V117, P128
   POSNICK JC, 1993, PEDIATR NEUROSURG, V19, P260, DOI 10.1159/000120742
   Pott J W, 1999, Strabismus, V7, P97, DOI 10.1076/stra.7.2.97.648
   Poussaint TY, 1996, AM J NEURORADIOL, V17, P1907
   Prietsch V, 2002, J INHERIT METAB DIS, V25, P126, DOI 10.1023/A:1015628810892
   PROUD VK, 1992, AM J MED GENET, V43, P458, DOI 10.1002/ajmg.1320430169
   PRUZON J, 2005, N AM NEUR SOC FEB 12
   PTACEK LJ, 1995, CLIN NEUROSCI, V3, P28
   Pulzer F, 2007, ACTA PAEDIATR, V96, P353, DOI 10.1111/j.1651-2227.2007.00087.x
   Puomila A, 2005, ACTA OPHTHALMOL SCAN, V83, P337, DOI 10.1111/j.1600-0420.2005.00448.x
   Puomila A, 2007, EUR J HUM GENET, V15, P1079, DOI 10.1038/sj.ejhg.5201828
   PUSEY E, 1987, AM J ROENTGENOL, V149, P383, DOI 10.2214/ajr.149.2.383
   Qi XP, 2007, ARCH OPHTHALMOL-CHIC, V125, P268, DOI 10.1001/archopht.125.2.268
   Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665
   Qu J, 2007, MITOCHONDRION, V7, P140, DOI 10.1016/j.mito.2006.11.015
   QUIGLEY HA, 1977, INVEST OPHTH VIS SCI, V16, P841
   QUIGLEY HA, 1982, AM J OPHTHALMOL, V93, P689, DOI 10.1016/0002-9394(82)90461-5
   QUIGLEY HA, 1977, AM J OPHTHALMOL, V83, P709, DOI 10.1016/0002-9394(77)90138-6
   RAHMAN AM, 2009, EYE
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   RAHN EK, 1968, AM J OPHTHALMOL, V66, P1143, DOI 10.1016/0002-9394(68)90825-8
   RAMAEKERS VT, 1993, NEUROPEDIATRICS, V24, P98, DOI 10.1055/s-2008-1071522
   Ramprasad VL, 2008, MOL VIS, V14, P481
   RANDO TA, 1992, NEUROLOGY, V42, P1220, DOI 10.1212/WNL.42.6.1220
   Raney RB, 1999, MED PEDIATR ONCOL, V33, P362, DOI 10.1002/(SICI)1096-911X(199910)33:4<362::AID-MPO4>3.0.CO;2-I
   Ranjan P, 2003, NEURORADIOLOGY, V45, P277, DOI 10.1007/s00234-003-0958-4
   RAPID I, 1995, MERRITTS TXB NEUROLO, P547
   RAPIN I, 1995, MERRITTS TXB NEUROLO, P597
   Rathinam SR, 1998, OCUL IMMUNOL INFLAMM, V6, P155, DOI 10.1076/ocii.6.3.155.4041
   Reed UC, 1999, BRAIN DEV-JPN, V21, P274, DOI 10.1016/S0387-7604(98)00100-4
   Repka MX, 2002, MENT RETARD DEV D R, V8, P249, DOI 10.1002/mrdd.10045
   REPKA MX, 1989, OPHTHALMOLOGY, V96, P195
   REPKA MX, 1988, AM J OPHTHALMOL, V106, P191, DOI 10.1016/0002-9394(88)90833-1
   Reynier P, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016576
   Ricci D, 2006, EARLY HUM DEV, V82, P591, DOI 10.1016/j.earlhumdev.2005.12.007
   RICHMOND IL, 1978, J NEUROSURG, V49, P163, DOI 10.3171/jns.1978.49.2.0163
   Riggs JE, 2001, NEUROLOGY, V56, P570, DOI 10.1212/WNL.56.4.570
   Riikonen R, 1999, EPILEPSIA, V40, P1642, DOI 10.1111/j.1528-1157.1999.tb02051.x
   Riikonen R, 2001, BRAIN DEV-JPN, V23, P765, DOI 10.1016/S0387-7604(01)00283-2
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Rizvi Raza, 2005, JPMA Journal of the Pakistan Medical Association, V55, P502
   RIZZO JF, 1986, AM J OPHTHALMOL, V102, P463, DOI 10.1016/0002-9394(86)90074-7
   ROBB RM, 1984, AM J OPHTHALMOL, V97, P691, DOI 10.1016/0002-9394(84)90499-9
   ROGGEVEEN HCJ, 1985, OPHTHALMIC PAED GEN, V5, P103, DOI 10.3109/13816818509007863
   RON E, 1988, NEW ENGL J MED, V319, P1033, DOI 10.1056/NEJM198810203191601
   Roodhooft J M J, 2003, Bull Soc Belge Ophtalmol, P45
   Rose AL, 1999, J CHILD NEUROL, V14, P123, DOI 10.1177/088307389901400211
   ROSENBER.RN, 1967, NEUROLOGY, V17, P827, DOI 10.1212/WNL.17.9.827
   ROSENBERG RN, 1989, NEUROL CLIN, V7, P25, DOI 10.1016/S0733-8619(18)30826-0
   Rosenblatt DS, 1997, J INHERIT METAB DIS, V20, P528, DOI 10.1023/A:1005353530303
   Rothermel H, 2001, PEDIATRICS, V108, P477, DOI 10.1542/peds.108.2.477
   ROTIG A, 1993, J CLIN INVEST, V91, P1095, DOI 10.1172/JCI116267
   Ruberto G, 2006, INVEST OPHTH VIS SCI, V47, P484, DOI 10.1167/iovs.05-0529
   Rudanko SL, 2004, OPHTHALMOLOGY, V111, P2307, DOI 10.1016/j.ophtha.2004.05.033
   Rudanko SL, 2003, OPHTHALMOLOGY, V110, P1639, DOI 10.1016/S0161-6420(03)00498-6
   Rutner D, 2006, BRAIN INJURY, V20, P1079, DOI 10.1080/02699050600909904
   Rutzen AR, 2007, OPHTHAL EPIDEMIOL, V14, P360, DOI 10.1080/01658100701436033
   RYAN SJ, 1971, AM J OPHTHALMOL, V71, P838, DOI 10.1016/0002-9394(71)90251-0
   SAATCI U, 1990, Turkish Journal of Pediatrics, V32, P211
   SACHDEV M S, 1990, Indian Journal of Ophthalmology, V38, P151
   Sadun A, 1998, Trans Am Ophthalmol Soc, V96, P881
   SADUN AA, 1994, ARCH OPHTHALMOL-CHIC, V112, P691, DOI 10.1001/archopht.1994.01090170139037
   Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0
   SADUN AA, 1994, CLIN NEUROSCI, V2, P165
   Sadun F, 2004, AM J OPHTHALMOL, V137, P271, DOI 10.1016/j.ajo.2003.08.010
   Saeed P, 2003, OPHTHALMOLOGY, V110, P2019, DOI 10.1016/S0161-6420(03)00787-5
   SAFRAN AB, 1984, AM J OPHTHALMOL, V98, P494, DOI 10.1016/0002-9394(84)90138-7
   SALBERT BA, 1993, OPHTHALMOLOGICA, V206, P177, DOI 10.1159/000310387
   SALIH MAM, 1991, ACTA PAEDIATR SCAND, V80, P567, DOI 10.1111/j.1651-2227.1991.tb11908.x
   SALONEN R, 1991, CLIN GENET, V39, P287
   Sanchez RN, 2006, J NEURO-OPHTHALMOL, V26, P268, DOI 10.1097/01.wno.0000249320.27110.ab
   Nielsen LS, 2007, ACTA OPHTHALMOL SCAN, V85, P149, DOI 10.1111/j.1600-0420.2006.00867.x
   Santorelli FM, 1996, NEUROLOGY, V47, P1320, DOI 10.1212/WNL.47.5.1320
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Santucci M, 2001, EPILEPSIA, V42, P1074, DOI 10.1046/j.1528-1157.2001.0420081074.x
   SARKAR HR, 2007, MYMENSIGH M J L, V16, P123
   Sass JO, 2004, CLIN PEDIATR, V43, P837, DOI 10.1177/000992280404300908
   Sathasivam S, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-9
   SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257
   Savini G, 2005, OPHTHALMOLOGY, V112, P127, DOI 10.1016/j.ophtha.2004.09.033
   Savino PJ, 2009, J NEURO-OPHTHALMOL, V29, P245, DOI 10.1097/WNO.0b013e3181b1b3d7
   SAVOIARDO M, 1990, RADIOLOGY, V174, P693, DOI 10.1148/radiology.174.3.2305051
   Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x
   SAYLI BS, 1993, AM J MED GENET, V47, P342, DOI 10.1002/ajmg.1320470309
   Schimel AM, 2006, OPHTHALMIC GENET, V27, P9, DOI 10.1080/13816810500481758
   Schmack I, 2006, AM J OPHTHALMOL, V142, P310, DOI 10.1016/j.ajo.2006.02.044
   Schollen E, 2005, EUR J MED GENET, V48, P153, DOI 10.1016/j.ejmg.2005.01.002
   SCHOR NF, 1992, J CHILD NEUROL, V7, P253, DOI 10.1177/088307389200700303
   Schramm P, 2005, ACTA NEUROCHIR, V147, P679, DOI 10.1007/s00701-005-0508-4
   Schröder JM, 2004, ACTA NEUROPATHOL, V108, P154, DOI 10.1007/s00401-004-0877-4
   Schuil J, 1998, NEUROPEDIATRICS, V29, P294, DOI 10.1055/s-2007-973580
   Schwankhaus JD, 1995, NEUROLOGY, V45, P2266, DOI 10.1212/WNL.45.12.2266
   Scolding NJ, 1996, ANN NEUROL, V39, P352, DOI 10.1002/ana.410390312
   Scott IU, 2005, OPHTHAL SURG LAS IM, V36, P374, DOI 10.3928/1542-8877-20050901-05
   Seiff S R., 1992, Ophthalmol Clin North Am, V5, P389
   SEIFF SR, 1987, ARCH OPHTHALMOL-CHIC, V105, P1689, DOI 10.1001/archopht.1987.01060120087032
   SELLENFR.MH, 1968, ARCH OPHTHALMOL-CHIC, V80, P718
   Semple P, 2007, CHILD NERV SYST, V23, P213, DOI 10.1007/s00381-006-0177-5
   SENANAYAKE N, 1992, J NEUROL, V239, P293
   SENER RN, 1993, PEDIATR RADIOL, V23, P321, DOI 10.1007/BF02010928
   Serdaroglu G, 2004, DEV MED CHILD NEUROL, V46, P733, DOI 10.1017/S0012162204001264
   Shah SA, 1995, PEDIATR RADIOL, V25, pS26
   Shah VA, 2008, SURV OPHTHALMOL, V53, P403, DOI 10.1016/j.survophthal.2008.04.003
   Shaikh S, 2001, AM J OPHTHALMOL, V131, P143, DOI 10.1016/S0002-9394(00)00716-9
   Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607
   SHAPIRO BL, 1989, LIFE SCI, V44, P1327, DOI 10.1016/0024-3205(89)90389-5
   Shawky R M, 2001, East Mediterr Health J, V7, P981
   SHEDDEN AH, 1985, J CLIN NEURO-OPHTHAL, V5, P209
   SHEFFER RN, 1992, AM J OPHTHALMOL, V114, P494, DOI 10.1016/S0002-9394(14)71864-1
   Shimizu S, 2003, AM J OPHTHALMOL, V135, P256, DOI 10.1016/S0002-9394(02)01929-3
   Shimizu S, 2002, JPN J OPHTHALMOL, V46, P336, DOI 10.1016/S0021-5155(02)00484-7
   Shokunbi MT, 2002, EYE, V16, P739, DOI 10.1038/sj.eye.6700085
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   SHURIN SB, 1982, PEDIATRICS, V70, P288
   Simsek E, 2003, ACTA PAEDIATR, V92, P55
   Sinha S, 2004, SEIZURE-EUR J EPILEP, V13, P235, DOI 10.1016/S1059-1311(03)00163-8
   Sitorus RS, 2003, VISION RES, V43, P3087, DOI 10.1016/j.visres.2003.08.008
   SLY WS, 1985, NEW ENGL J MED, V313, P139, DOI 10.1056/NEJM198507183130302
   SMALL KW, 1988, AM J OPHTHALMOL, V106, P96, DOI 10.1016/S0002-9394(14)76398-6
   Smith CJA, 2004, DIABETES CARE, V27, P2003, DOI 10.2337/diacare.27.8.2003
   SMITH DP, 1972, AMER J OPT ARCH AM A, V49, P183
   SMITH DP, 1973, INVEST OPHTH VISUAL, V12, P608
   SMITH DP, 1972, AMER J OPT ARCH AM A, V49, P574
   SMITH DW, 1964, J PEDIATR-US, V64, P210, DOI 10.1016/S0022-3476(64)80264-X
   SMITH JL, 1973, ARCH OPHTHALMOL-CHIC, V90, P349
   SMITH KH, 1993, ARCH OPHTHALMOL-CHIC, V111, P1486, DOI 10.1001/archopht.1993.01090110052022
   SOMER M, 1993, EPILEPSIA, V34, P727, DOI 10.1111/j.1528-1157.1993.tb00453.x
   SOMER M, 1993, AM J NEURORADIOL, V14, P861
   Sorajja P, 2003, HEART, V89, P791, DOI 10.1136/heart.89.7.791
   SPALTON DJ, 1980, BRIT J OPHTHALMOL, V64, P726, DOI 10.1136/bjo.64.10.726
   SPERLI D, 1993, J MED GENET, V30, P877, DOI 10.1136/jmg.30.10.877
   Spruijt L, 2006, AM J OPHTHALMOL, V141, P676, DOI 10.1016/j.ajo.2005.11.007
   Stannard C, 2002, INT J RADIAT ONCOL, V54, P1446, DOI 10.1016/S0360-3016(02)03756-2
   Stark KL, 1999, J AAPOS, V3, P366, DOI 10.1016/S1091-8531(99)70047-9
   Stavrou P, 2001, OCUL IMMUNOL INFLAMM, V9, P141, DOI 10.1076/ocii.9.3.141.3965
   Steinsapir KD, 2006, J NEURO-OPHTHALMOL, V26, P65, DOI 10.1097/01.wno.0000204646.94991.68
   STERN J, 1980, ARCH OPHTHALMOL-CHIC, V98, P505
   Steward CG, 2003, NEUROPATH APPL NEURO, V29, P87, DOI 10.1046/j.1365-2990.2003.00474.x
   Stöhr H, 1999, HUM GENET, V104, P99, DOI 10.1007/s004390050917
   Stojanov S, 2004, PEDIATRICS, V114, pE124, DOI 10.1542/peds.114.1.e124
   Stokkermans TJW, 1999, OPTOMETRY VISION SCI, V76, P444, DOI 10.1097/00006324-199907000-00019
   STONE EM, 1992, J CLIN NEURO-OPHTHAL, V12, P10
   Straussberg R, 1998, NEUROPEDIATRICS, V29, P54, DOI 10.1055/s-2007-973537
   Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021
   STROMLAND K, 1982, BIRTH DEFECTS-ORIG, V18, P651
   Subramony SH, 2001, NEUROLOGY, V56, P287, DOI 10.1212/WNL.56.3.287
   SUGITA S, 1995, SURG NEUROL, V43, P154, DOI 10.1016/0090-3019(95)80127-3
   SULLIVAN TJ, 1994, AUST NZ J OPHTHALMOL, V22, P25, DOI 10.1111/j.1442-9071.1994.tb01691.x
   SULLIVAN TJ, 1992, J PEDIATR OPHTHALMOL, V29, P246
   Sullu Y, 2003, AM J OPHTHALMOL, V136, P367, DOI 10.1016/S0002-9394(03)00187-9
   SWAIMAN KF, 1991, ARCH NEUROL-CHICAGO, V48, P1285, DOI 10.1001/archneur.1991.00530240091029
   Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299
   SWEETMAN L, 1979, JAMA-J AM MED ASSOC, V242, P1048, DOI 10.1001/jama.242.10.1048
   SYLVESTER PE, 1958, ARCH DIS CHILD, V33, P217, DOI 10.1136/adc.33.169.217
   Szedelyova L, 1989, Cesk Oftalmol, V45, P440
   Taban M, 2006, J CHILD NEUROL, V21, P956, DOI 10.1177/08830738060210111601
   Tambe KA, 2003, EUR J PAEDIATR NEURO, V7, P77, DOI 10.1016/S1090-3798(03)00017-5
   Tarnaris A, 2005, J NEUROSURG, V102, P224, DOI 10.3171/jns.2005.102.2.0224
   Tay T, 2006, CLIN EXP OPHTHALMOL, V34, P434, DOI 10.1111/j.1442-9071.2006.01242.x
   TAYLOR D, 1982, BRIT J OPHTHALMOL, V66, P455, DOI 10.1136/bjo.66.7.455
   Taylor D, 1983, Bull Soc Belge Ophtalmol, V208 Pt 1, P405
   TEEBI AS, 1998, J MED GENET, V20, P143
   Tekgül H, 2000, TURKISH J PEDIATR, V42, P246
   Tekgül S, 1999, J UROLOGY, V161, P616, DOI 10.1016/S0022-5347(01)61982-7
   Terraciano Anthony J, 2002, Curr Opin Ophthalmol, V13, P97, DOI 10.1097/00055735-200204000-00008
   Tessa A, 2001, Hum Mutat, V17, P348, DOI 10.1002/humu.32
   Thieme H, 1999, GRAEF ARCH CLIN EXP, V237, P714, DOI 10.1007/s004170050301
   Thiselton DL, 2002, INVEST OPHTH VIS SCI, V43, P1715
   Thomas M, 2004, MOVEMENT DISORD, V19, P36, DOI 10.1002/mds.10650
   THOMAS PK, 1984, J NEUROL SCI, V64, P137, DOI 10.1016/0022-510X(84)90032-7
   Thomson APJ, 1999, J MED GENET, V36, P251
   Thuente DD, 2005, OPHTHALMOLOGY, V112, P724, DOI 10.1016/j.ophtha.2004.11.049
   TILL JS, 1987, J CLIN NEURO-OPHTHAL, V7, P40
   Timoney P, 2007, J AAPOS, V11, P291, DOI 10.1016/j.jaapos.2006.09.020
   Toker E, 2003, CORNEA, V22, P198, DOI 10.1097/00003226-200304000-00003
   Tong L, 2004, AM J OPHTHALMOL, V138, P160, DOI 10.1016/j.ajo.2004.02.026
   Towbin R, 1998, PEDIATR RADIOL, V28, P995, DOI 10.1007/s002470050518
   TRABOULSI EI, 1992, AM J OPHTHALMOL, V114, P579, DOI 10.1016/S0002-9394(14)74486-1
   TRABOULSI EI, 1988, ARCH OPHTHALMOL-CHIC, V106, P801, DOI 10.1001/archopht.1988.01060130871043
   TRABOULSI EI, 1992, AM J OPHTHALMOL, V113, P269, DOI 10.1016/S0002-9394(14)71578-8
   TRABOULSI EI, 1987, OPHTHALMOLOGY, V94, P47, DOI 10.1016/S0161-6420(87)33504-3
   Tranebjærg L, 2000, EUR J HUM GENET, V8, P464, DOI 10.1038/sj.ejhg.5200483
   Trautner C, 2003, INVEST OPHTH VIS SCI, V44, P1031, DOI 10.1167/iovs.02-0304
   TREFT RL, 1984, OPHTHALMOLOGY, V91, P908
   Trisciuzzi MTS, 2004, CLIN NEUROPHYSIOL, V115, P217, DOI 10.1016/S1388-2457(03)00282-7
   TROBE JD, 1980, ARCH OPHTHALMOL-CHIC, V98, P1040, DOI 10.1001/archopht.1980.01020031030003
   TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X
   Tsina EK, 2005, ARCH OPHTHALMOL-CHIC, V123, P1143, DOI 10.1001/archopht.123.8.1143
   Tugal-Tutkun I, 2003, AM J OPHTHALMOL, V136, P1114, DOI 10.1016/S0002-9394(03)00791-8
   Tugal-Tutkun Ilknur, 2007, International Ophthalmology, V27, P117, DOI 10.1007/s10792-006-9001-1
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
   Tullu M S, 2000, Indian Pediatr, V37, P939
   TUPPURAINEN K, 1993, GRAEF ARCH CLIN EXP, V231, P261, DOI 10.1007/BF00919102
   Turbin RE, 1998, J NEURO-OPHTHALMOL, V18, P242
   Tusa RJ, 1999, J CHILD NEUROL, V14, P621, DOI 10.1177/088307389901401001
   Twigg SRF, 2004, P NATL ACAD SCI USA, V101, P8652, DOI 10.1073/pnas.0402819101
   TZEKOV C, 1992, PEDIATR NEUROSURG, V17, P317, DOI 10.1159/000120617
   Udar N, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9109
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   UNSOLD R, 1980, ARCH OPHTHALMOL-CHIC, V98, P1637, DOI 10.1001/archopht.1980.01020040489020
   Vaegan, 2006, OPTOMETRY VISION SCI, V83, P486, DOI 10.1097/01.opx.0000225920.97380.62
   Vaher U, 2001, BRAIN DEV-JPN, V23, P236, DOI 10.1016/S0387-7604(01)00184-X
   Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193
   Van den Ouweland JMW, 2003, J MOL DIAGN, V5, P88, DOI 10.1016/S1525-1578(10)60457-6
   VANCOSTER R, 1991, J NEUROL SCI, V104, P97, DOI 10.1016/0022-510X(91)90222-S
   VANDENBERGE JH, 1992, J NEUROSURG, V77, P545, DOI 10.3171/jns.1992.77.4.0545
   VANDENBERGH L, 1993, DOC OPHTHALMOL, V84, P119, DOI 10.1007/BF01206246
   Vanhatalo S, 2000, EPILEPSIA, V41, P705, DOI 10.1111/j.1528-1157.2000.tb00231.x
   Vanhatalo S, 2002, NEUROPEDIATRICS, V33, P100, DOI 10.1055/s-2002-32371
   Vedantham Vasumathy, 2007, Indian Journal of Ophthalmology, V55, P113
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   Verloes A, 2006, AM J MED GENET A, V140A, P1285, DOI 10.1002/ajmg.a.31270
   Verny C, 2005, REV NEUROL-FRANCE, V161, P451, DOI 10.1016/S0035-3787(05)85075-1
   Vijayalakshmi P, 2003, J AAPOS, V7, P91, DOI 10.1016/S1091-8531(02)42002-2
   VIKKI J, 1991, AM J HUM GENET, V48, P486
   Villanueva-Mendoza C, 2009, OPHTHALMIC GENET, V30, P45, DOI 10.1080/13816810802502962
   Vinkler C, 2003, AM J MED GENET A, V121A, P263, DOI 10.1002/ajmg.a.20238
   VOLKERDIEBEN HJM, 1974, DOC OPHTHALMOL, V37, P307, DOI 10.1007/BF00147264
   VOLPE IJ, 1987, NEUROLOGY NEWBORN
   VOLPE NJ, 1993, INT OPHTHALMOL CLIN, V33, P153, DOI 10.1097/00004397-199303320-00015
   Voo I, 2003, AM J OPHTHALMOL, V136, P670, DOI 10.1016/S0002-9394(03)00390-8
   Votruba M, 2003, BRIT J OPHTHALMOL, V87, P48, DOI 10.1136/bjo.87.1.48
   Votruba M, 1998, ARCH OPHTHALMOL-CHIC, V116, P351, DOI 10.1001/archopht.116.3.351
   Vougioukas VI, 2001, PEDIATR NEUROSURG, V35, P35, DOI 10.1159/000050383
   WAARDENBURG P J, 1957, Acta Genet Stat Med, V7, P287
   WAJNTAL A, 1990, AM J MED GENET, V37, P213, DOI 10.1002/ajmg.1320370210
   WAKAI S, 1993, PEDIATR NEUROL, V9, P309, DOI 10.1016/0887-8994(93)90070-S
   WAKAKURA M, 1995, BRIT J OPHTHALMOL, V79, P442, DOI 10.1136/bjo.79.5.442
   WALSH FB, 1969, CLIN NEUROOPHTHALMOL, V1, P494
   Wang JY, 2008, J INT MED RES, V36, P544, DOI 10.1177/147323000803600320
   WANG PJ, 1995, PEDIATR NEUROL, V12, P47, DOI 10.1016/0887-8994(94)00124-K
   Warner RB, 2002, AM J OPHTHALMOL, V134, P918, DOI 10.1016/S0002-9394(02)01706-3
   WARNER TT, 2009, PRACTICAL NEUROGENET, P92
   Webb C, 2008, ARCH PATHOL LAB MED, V132, P77, DOI 10.1043/1543-2165(2008)132[77:PPA]2.0.CO;2
   Weber P, 2004, DEV MED CHILD NEUROL, V46, P481, DOI 10.1017/S0012162204000799
   WEINER HL, 1994, NEUROSURGERY, V35, P1001, DOI 10.1227/00006123-199412000-00001
   WEISMAN JS, 1990, AM J OPHTHALMOL, V110, P244, DOI 10.1016/S0002-9394(14)76338-X
   WELEBER RG, 1992, ARCH OPHTHALMOL-CHIC, V110, P640, DOI 10.1001/archopht.1992.01080170062025
   Weleber RG., 1988, RETINAL DYSTROPHIES, P233
   Weleber Richard G, 2002, Ophthalmic Genet, V23, P71, DOI 10.1076/opge.23.2.71.2214
   WERTENBAKER C, 1985, SURV OPHTHALMOL, V29, P297, DOI 10.1016/0039-6257(85)90153-5
   Westall CA, 2000, J AAPOS, V4, P295, DOI 10.1067/mpa.2000.107898
   WEYAND RD, 1952, P STAFF M MAYO CLIN, V27, P505
   Wild JM, 1999, EPILEPSIA, V40, P1784, DOI 10.1111/j.1528-1157.1999.tb01599.x
   Wilichowski E, 1998, NEUROPEDIATRICS, V29, P307, DOI 10.1055/s-2007-973583
   Wilkinson M E, 2001, Optometry, V72, P724
   Williams ZR, 2009, AM J OPHTHALMOL, V147, P929, DOI 10.1016/j.ajo.2008.12.024
   Wilne S, 2007, LANCET ONCOL, V8, P685, DOI 10.1016/S1470-2045(07)70207-3
   WILSON J, 1963, BRAIN, V86, P347, DOI 10.1093/brain/86.2.347
   WILSON WB, 1981, NEUROOPHTHALMOLOGY, V1, P175
   WOLF B, 1981, J PEDIATR-US, V99, P835, DOI 10.1016/S0022-3476(81)80004-2
   Wolfram DJ, 1938, Mayo Clin Proc, V1, P715, DOI DOI 10.1186/1757-1626-2-9355
   Wong VCN, 2006, J CHILD NEUROL, V21, P462, DOI 10.1177/08830738060210061201
   WRAY SH, 1976, INVEST OPHTH VISUAL, V15, P128
   WRAY SH, 1976, AM J OPHTHALMOL, V82, P480, DOI 10.1016/0002-9394(76)90498-0
   WRIGHT JE, 1989, BRIT J OPHTHALMOL, V73, P967, DOI 10.1136/bjo.73.12.967
   WRIGHT JE, 1989, BRIT J OPHTHALMOL, V73, P960, DOI 10.1136/bjo.73.12.960
   Wu Horng-Jiun, 2000, Kaohsiung Journal of Medical Sciences, V16, P422
   Yamada T, 2003, JPN J OPHTHALMOL, V47, P409, DOI 10.1016/S0021-5155(03)00056-X
   Yan Jianhua, 2004, Orbit, V23, P245
   Yang MS, 2005, J FORMOS MED ASSOC, V104, P129
   Yang YL, 2007, J CHILD NEUROL, V22, P156, DOI 10.1177/0883073807300307
   Yen M Y, 2000, Zhonghua Yi Xue Za Zhi (Taipei), V63, P864
   Yen MY, 2004, INVEST OPHTH VIS SCI, V45, P1688, DOI 10.1167/iovs.03-0568
   Yen MY, 2002, JPN J OPHTHALMOL, V46, P45, DOI 10.1016/S0021-5155(01)00460-9
   Yen MY, 1999, JPN J OPHTHALMOL, V43, P196, DOI 10.1016/S0021-5155(99)00008-8
   Yen MY, 2002, BRIT J OPHTHALMOL, V86, P1027, DOI 10.1136/bjo.86.9.1027
   YOSHIOKA M, 1990, BRAIN DEV-JPN, V12, P423, DOI 10.1016/S0387-7604(12)80076-3
   Yuksel D, 2007, J CHILD NEUROL, V22, P1143, DOI 10.1177/0883073807306270
   Yun Yie-Min, 2005, Korean J Ophthalmol, V19, P68
   ZACHMANN M, 1979, J PEDIATR-US, V95, P86, DOI 10.1016/S0022-3476(79)80095-5
   Zafeiriou DI, 1999, PEDIATR NEUROL, V21, P843, DOI 10.1016/S0887-8994(99)00093-4
   Zervos A, 2002, EUR J OPHTHALMOL, V12, P253, DOI 10.1177/112067210201200401
   Zhou XT, 2006, BIOCHEM BIOPH RES CO, V340, P69, DOI 10.1016/j.bbrc.2005.11.150
   ZIMMERMAN CF, 1990, OPHTHALMOLOGY, V97, P585
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
   Zumrová A, 2005, NEUROENDOCRINOL LETT, V26, P213
NR 967
TC 0
Z9 1
U1 10
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
BN 978-0-387-69066-7
PY 2010
BP 155
EP 211
DI 10.1007/978-0-387-69069-8_4
PG 57
WC Clinical Neurology; Ophthalmology; Pediatrics
WE Book Citation Index – Science (BKCI-S)
SC Neurosciences & Neurology; Ophthalmology; Pediatrics
GA BOO64
UT WOS:000277155200004
DA 2024-11-01
ER

PT J
AU Dong, HL
   Ma, Y
   Li, QF
   Du, YC
   Yang, L
   Chen, S
   Wu, ZY
AF Dong, Hai-Lin
   Ma, Yin
   Li, Quan-Fu
   Du, Yi-Chu
   Yang, Lu
   Chen, Sheng
   Wu, Zhi-Ying
TI Genetic and clinical features of Chinese patients with mitochondrial
   ataxia identified by targeted next-generation sequencing
SO CNS NEUROSCIENCE & THERAPEUTICS
LA English
DT Article
DE ataxia; Chinese; mitochondria; targeted next-generation sequencing
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; ONSET SPINOCEREBELLAR ATAXIA;
   TRANSFER-RNA; LEIGH-SYNDROME; DNA; MUTATIONS; VARIANTS; DISEASE; COMMON;
   CLASSIFICATION
AB Aim To characterize the mutations in mitochondrial DNA (mtDNA) and mitochondrion-related nuclear genes (nDNA), and clinical features in Chinese patients with mitochondrial ataxia. Methods Targeted next-generation sequencing (NGS) technology was performed to screen the whole mtDNA sequence and nDNA genes in a cohort of 33 unrelated ataxia patients. Results A total of 5 pedigrees were finally genetically diagnosed as mitochondrial ataxia, with 3 pathogenic mutations (m.8344A>G, m.9176T>C, and m.9185T>C), one likely pathogenic mutation (m.3995A>G) in mtDNA, and one pathogenic mutation (c.1159_1162dupAAGT, p.Ser388Terfs) in PDHA1. The prevalence of mitochondrial ataxia in our patient cohort is 15.2%. In addition, all 4 patients with mtDNA mutations experienced symptoms of ataxia with age at onset ranging from 12 to 39 years (21 +/- 12.2) and developed extrapyramidal symptoms during the disease course. One male patient with pyruvate dehydrogenase deficiency showed an acute intermittent ataxia phenotype. Conclusions Our results implicate that mitochondrial ataxia might not be as rare in Chinese as previously assumed. This study firstly defines the mutations of mitochondrial ataxia in a Chinese population by targeted NGS, which broadens the clinical spectrum of mtDNA mutations and highlights the importance of screening mtDNA and nDNA mutations among undefined ataxia patients.
C1 [Dong, Hai-Lin; Ma, Yin; Li, Quan-Fu; Du, Yi-Chu; Yang, Lu; Wu, Zhi-Ying] Zhejiang Univ, Sch Med, Dept Neurol, Hangzhou, Zhejiang, Peoples R China.
   [Dong, Hai-Lin; Ma, Yin; Li, Quan-Fu; Du, Yi-Chu; Yang, Lu; Wu, Zhi-Ying] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Res Ctr Neurol, Hangzhou, Zhejiang, Peoples R China.
   [Dong, Hai-Lin; Ma, Yin; Li, Quan-Fu; Du, Yi-Chu; Yang, Lu; Wu, Zhi-Ying] Zhejiang Univ, Sch Med, Key Lab Med Neurobiol Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China.
   [Chen, Sheng] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Neurol, Shanghai, Peoples R China.
C3 Zhejiang University; Zhejiang University; Zhejiang University; Fudan
   University
RP Wu, ZY (corresponding author), Zhejiang Univ, Sch Med, Dept Neurol, Hangzhou, Zhejiang, Peoples R China.; Wu, ZY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Res Ctr Neurol, Hangzhou, Zhejiang, Peoples R China.
EM zhiyingwu@zju.edu.cn
OI Chen, Sheng/0000-0002-7934-015X
FU National Natural Science Foundation [81125009]; research foundation for
   distinguished scholar of Zhejiang University [188020-193810101/089]
FX This work was supported by National Natural Science Foundation,
   Grant/Award number: 81125009; The research foundation for distinguished
   scholar of Zhejiang University, Grant/Award number:
   188020-193810101/089.
CR Alsemari A, 2016, CLIN CASE REP, V4, P111, DOI 10.1002/ccr3.435
   Bargiela David, 2015, Cerebellum Ataxias, V2, P16, DOI 10.1186/s40673-015-0035-x
   Castellana S, 2015, HUM MUTAT, V36, pE2413, DOI 10.1002/humu.22720
   Chen B, 2008, AM J MED GENET A, V146A, P1248, DOI 10.1002/ajmg.a.32285
   Chen S, 2016, CNS NEUROSCI THER, V22, P38, DOI 10.1111/cns.12443
   DeBrosse SD, 2012, MOL GENET METAB, V107, P394, DOI 10.1016/j.ymgme.2012.09.001
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Dong Y, 2015, PARKINSONISM RELAT D, V21, P398, DOI 10.1016/j.parkreldis.2015.01.006
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2009, CAN J NEUROL SCI, V36, P543, DOI 10.1017/S0317167100008027
   Gamba J, 2012, J NEUROL SCI, V320, P131, DOI 10.1016/j.jns.2012.05.037
   Gan SR, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-47
   Gerards M, 2016, MOL GENET METAB, V117, P300, DOI 10.1016/j.ymgme.2015.12.004
   Goodship JA, 2002, J MED GENET, V39, P221, DOI 10.1136/jmg.39.3.221
   Hadjivassiliou M, 2017, J NEUROL NEUROSUR PS, V88, P301, DOI 10.1136/jnnp-2016-314863
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HATTORI Y, 1994, J NEUROL SCI, V125, P50, DOI 10.1016/0022-510X(94)90241-0
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   Klockgether T, 2010, LANCET NEUROL, V9, P94, DOI 10.1016/S1474-4422(09)70305-9
   Lee YC, 2007, J NEUROL SCI, V254, P65, DOI 10.1016/j.jns.2007.01.005
   Li HF, 2017, NEUROBIOL AGING, V49, DOI 10.1016/j.neurobiolaging.2016.09.018
   Li LX, 2017, HUM MUTAT, V38, P1569, DOI 10.1002/humu.23309
   Lin J, 2014, MITOCHONDR DNA, V25, P56, DOI 10.3109/19401736.2013.779259
   Liu ZJ, 2017, CLIN GENET, V92, P267, DOI 10.1111/cge.13015
   Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44
   Makino M, 1998, NEUROMUSCULAR DISORD, V8, P149, DOI 10.1016/S0960-8966(98)00017-0
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   NAITO E, 1994, HUM MOL GENET, V3, P1193, DOI 10.1093/hmg/3.7.1193
   Niroula A, 2016, NUCLEIC ACIDS RES, V44, P2020, DOI 10.1093/nar/gkw046
   Okura T, 2003, HUM GENET, V113, P432, DOI 10.1007/s00439-003-0983-8
   Pfeffer G, 2012, J NEUROL NEUROSUR PS, V83, P883, DOI 10.1136/jnnp-2012-302568
   Piccoli C, 2008, J MED GENET, V45, P596, DOI 10.1136/jmg.2008.058628
   Pulkes T, 2012, J NEUROL NEUROSUR PS, V83, P857, DOI 10.1136/jnnp-2012-302959
   Qin YW, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000437
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Saitoh S, 1998, J CHILD NEUROL, V13, P573, DOI 10.1177/088307389801301109
   Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X
   Sun YM, 2016, CLIN GENET, V90, P305, DOI 10.1111/cge.12808
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Synofzik M, 2012, EUR J NEUROL, V19, pe114, DOI 10.1111/j.1468-1331.2012.03812.x
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Ueki I, 2006, MITOCHONDRION, V6, P29, DOI 10.1016/j.mito.2005.10.003
   Verny C, 2011, MITOCHONDRION, V11, P70, DOI 10.1016/j.mito.2010.07.006
   Wang J, 2012, GENET MED, V14, P620, DOI 10.1038/gim.2012.4
   Wei YL, 2009, CLIN EXP PHARMACOL P, V36, P933, DOI 10.1111/j.1440-1681.2009.05183.x
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 49
TC 6
Z9 6
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1755-5930
EI 1755-5949
J9 CNS NEUROSCI THER
JI CNS Neurosci. Ther.
PD JAN
PY 2019
VL 25
IS 1
BP 21
EP 29
DI 10.1111/cns.12972
PG 9
WC Neurosciences; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA HE8GS
UT WOS:000453684300003
PM 29756269
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Lamperti, C
   Zeviani, M
AF Lamperti, Costanza
   Zeviani, Massimo
TI Myoclonus epilepsy in mitochondrial disorders
SO EPILEPTIC DISORDERS
LA English
DT Review
DE MERRF; MELAS; Alpers-Huttenlocher syndrome; hepatopathic poliodystrophy;
   mitochondrial DNA; oxidative phosphorylation; mitochondrial respiratory
   chain; progressive myoclonus epilepsies
ID RAGGED-RED FIBERS; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   DNA-POLYMERASE-GAMMA; MERRF/MELAS OVERLAP SYNDROME; RESPIRATORY-CHAIN
   DEFECTS; MTDNA MERRF MUTATION; POLG MUTATIONS; EKBOMS SYNDROME; RNALYS
   GENE; DISEASE
AB Mitochondrial disorders is a group of clinical entities associated with abnormalities of the mitochondrial respiratory chain (MRC), which carries out the oxidative phosphorylation (OXPHOS) of ADP into ATP. As the MRC is the result of genetic complementation between two separate genomes, nuclear and mitochondrial, OXPHOS failure can derive from mutations in either nuclear-encoded, or mitochondrial-encoded, genes. Epilepsy is a relatively common feature of mitochondrial disease, especially in early-onset encephalopathies of infants and children. However, the two most common entities associated with epilepsy include MERRF, for Myoclonic Epilepsy with Ragged Red Fibers, and AHS, or Alpers-Huttenlocher syndrome, also known as hepatopathic poliodystrophy. Whilst MERRF is a maternally inherited condition caused by mtDNA mutations, particularly the 8344A>G substitution in the gene encoding mt-tRNA(Iys), AHS is typically caused by recessive mutations in POLG, encoding the catalytic subunit of polymerase gamma, the only mtDNA polymerase in humans. AHS is the most severe, early-onset, invariably fatal syndrome within a disease spectrum, which also include other epileptogenic entities, all due to POLG mutations and including Spino-cerebellar Ataxia and Epilepsy (SCAE). This review reports the main clinical, neuroimaging, biochemical, and molecular features of epilepsy-related mitochondrial syndrome, particularly MERRF and AHS.
C1 [Lamperti, Costanza] Carlo Besta Inst Neurol, Unit Mol Neurogenet, Milan, Italy.
   [Zeviani, Massimo] MRC Mitochondrial Biol Unit, Cambridge, England.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta
RP Zeviani, M (corresponding author), MRC Mitochondrial Biol Unit, Cambridge, England.
EM mdz21@mrc-mbu.cam.ac.uk
RI Zeviani, Massimo/AAU-2632-2021; lamperti, costanza/J-8801-2016
OI Zeviani, Massimo/0000-0002-9067-5508
FU Medical Research Council [MC_UP_1002/1] Funding Source: Medline
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   BERKOVIC SF, 1991, LANCET, V338, P457, DOI 10.1016/0140-6736(91)91090-H
   CALABRESI PA, 1994, MUSCLE NERVE, V17, P943, DOI 10.1002/mus.880170815
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   DiMauro S, 2000, NEUROL SCI, V21, pS901
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   EKBOM K, 1975, ACTA NEUROL SCAND, V51, P393
   El Sabbagh S, 2010, EPILEPSIA, V51, P1225, DOI 10.1111/j.1528-1167.2009.02504.x
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HOLME E, 1993, AM J HUM GENET, V52, P551
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Hunt JR, 1921, BRAIN, V44, P490
   Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737
   Lagrue E, 2007, PEDIATR RES, V62, P14, DOI 10.1203/PDR.0b013e31806790d7
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Lee YM, 2008, EPILEPSIA, V49, P685, DOI 10.1111/j.1528-1167.2007.01522.x
   Liu KM, 2014, METAB BRAIN DIS, V29, P139, DOI 10.1007/s11011-013-9464-5
   LOMBES A, 1989, ANN NEUROL, V26, P20, DOI 10.1002/ana.410260104
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Minassian Berge A, 2016, Epileptic Disord, V18, P1
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Mokranjac D, 2005, BIOCHEM SOC T, V33, P1019, DOI 10.1042/BST0331019
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   NASS MMK, 1966, P NATL ACAD SCI USA, V56, P1215, DOI 10.1073/pnas.56.4.1215
   NAUMANN M, 1995, ACTA NEUROPATHOL, V89, P152
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Parikh S, 2008, PEDIATR NEUROL, V38, P191, DOI 10.1016/j.pediatrneurol.2007.10.011
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   ROSING HS, 1985, ANN NEUROL, V17, P228, DOI 10.1002/ana.410170303
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Sano M, 1996, J NEUROL, V243, P441, DOI 10.1007/BF00900496
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   TEIN I, 1993, PEDIATR RES, V34, P281, DOI 10.1203/00006450-199309000-00008
   TRAFF J, 1995, ACTA NEUROL SCAND, V92, P394
   TSAIRIS P, 1973, NEUROLOGY, V23, P408
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   Zeviani Massimo, 1993, European Journal of Human Genetics, V1, P80
NR 56
TC 19
Z9 22
U1 0
U2 3
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 1294-9361
EI 1950-6945
J9 EPILEPTIC DISORD
JI Epileptic Disord.
PD SEP
PY 2016
VL 18
SU S
BP S94
EP S102
PG 9
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA FA7NB
UT WOS:000405632300009
PM 27618766
DA 2024-11-01
ER

PT J
AU Bailey, CM
   Anderson, KS
AF Bailey, Christopher M.
   Anderson, Karen S.
TI A mechanistic view of human mitochondrial DNA polymerase γ: Providing
   insight into drug toxicity and mitochondrial disease
SO BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
LA English
DT Review
DE DNA polymerase gamma; Mitochondrial genome; Nucleoside analog toxicity;
   Progressive external ophthalmoplegia; Pre-steady-state kinetics
ID DEOXYRIBONUCLEIC-ACID POLYMERASE; TRANSFER-RNA SYNTHETASES; CHRONIC
   HEPATITIS-B; ACCESSORY SUBUNIT; REVERSE-TRANSCRIPTASE; MULTIPLE
   DELETIONS; NUCLEOSIDE ANALOG; ANTIRETROVIRAL THERAPY; CATALYTIC SUBUNIT;
   CRYSTAL-STRUCTURE
AB Mitochondrial DNA polymerase gamma (Pol gamma) is the sole polymerase responsible for replication of the mitochondrial genome. The study of human Pol gamma is of key importance to clinically relevant issues such as nucleoside analog toxicity and mitochondrial disorders such as progressive external ophthalmoplegia. The development of a recombinant form of the human Pol gamma holoenzyme provided an essential tool in understanding the mechanism of these clinically relevant phenomena using kinetic methodologies. This review will provide a brief history on the discovery and characterization of human mitochondrial DNA polymerase gamma, focusing on kinetic analyses of the polymerase and mechanistic data illustrating structure-function relationships to explain drug toxicity and mitochondrial disease. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Bailey, Christopher M.; Anderson, Karen S.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA.
C3 Yale University
RP Anderson, KS (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.
EM karen.anderson@yale.edu
OI Bailey, Chris/0000-0002-5962-9511
FU NIH [GM49551]
FX This work was supported by NIH GM49551 to KSA.
CR ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Astatke M, 1998, J MOL BIOL, V278, P147, DOI 10.1006/jmbi.1998.1672
   Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   BOLDEN A, 1977, J BIOL CHEM, V252, P3351
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   BRAHAMS D, 1994, LANCET, V343, P1494, DOI 10.1016/S0140-6736(94)92599-2
   BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787
   Carrodeguas JA, 2000, NUCLEIC ACIDS RES, V28, P1237, DOI 10.1093/nar/28.5.1237
   Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200
   Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   CHAN SS, 2008, BIOCHIM BIOPHYS ACTA, V1787, P312
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   CHEN CH, 1989, J BIOL CHEM, V264, P11934
   CHEN CH, 1991, MOL PHARMACOL, V39, P625
   CHERRINGTON JM, 1994, BIOCHEM PHARMACOL, V48, P1986, DOI 10.1016/0006-2952(94)90600-9
   Chiappini F, 2009, CURR HIV RES, V7, P244, DOI 10.2174/157016209787581409
   CHU CK, 1995, ANTIMICROB AGENTS CH, V39, P979, DOI 10.1128/AAC.39.4.979
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   COLACINO JM, 1994, ANTIMICROB AGENTS CH, V38, P1997, DOI 10.1128/AAC.38.9.1997
   CUI LX, 1995, J CLIN INVEST, V95, P555, DOI 10.1172/JCI117698
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703
   DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461
   Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614
   DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031
   Doublié S, 1998, NATURE, V391, P251, DOI 10.1038/34593
   EDENBERG HJ, 1978, J BIOL CHEM, V253, P3273
   Fan L, 1999, P NATL ACAD SCI USA, V96, P9527, DOI 10.1073/pnas.96.17.9527
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Feng JY, 2001, J BIOL CHEM, V276, P23832, DOI 10.1074/jbc.M101156200
   Feng JY, 2004, ANTIMICROB AGENTS CH, V48, P1300, DOI 10.1128/AAC.48.4.1300-1306.2004
   Feng JY, 1999, FASEB J, V13, P1511, DOI 10.1096/fasebj.13.12.1511
   Feng JY, 1999, BIOCHEMISTRY-US, V38, P55, DOI 10.1021/bi982340r
   Fowler JD, 2008, J BIOL CHEM, V283, P15339, DOI 10.1074/jbc.M800310200
   FRIDLENDER B, 1972, P NATL ACAD SCI USA, V69, P452, DOI 10.1073/pnas.69.2.452
   FRY M, 1973, J BIOL CHEM, V248, P2678
   GEUSKENS M, 1981, NUCLEIC ACIDS RES, V9, P1599, DOI 10.1093/nar/9.7.1599
   GOODY RS, 1991, FEBS LETT, V291, P1, DOI 10.1016/0014-5793(91)81089-Q
   Graves SW, 1998, BIOCHEMISTRY-US, V37, P6050, DOI 10.1021/bi972685u
   GRAY H, 1992, J BIOL CHEM, V267, P5835
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   GROVE KL, 1995, CANCER RES, V55, P3008
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hanes JW, 2007, J BIOL CHEM, V282, P25159, DOI 10.1074/jbc.M703972200
   HERSKOWITZ A, 1992, ANN INTERN MED, V116, P311, DOI 10.7326/0003-4819-116-4-311
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   Johnson AA, 2001, J BIOL CHEM, V276, P38097
   Johnson AA, 2001, J BIOL CHEM, V276, P38090
   Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   KALF GF, 1968, J BIOL CHEM, V243, P4904
   KEILBAUGH SA, 1991, BIOCHEM PHARMACOL, V42, pR5, DOI 10.1016/0006-2952(91)90672-R
   Kim BK, 2009, J HEPATOL, V51, P829, DOI 10.1016/j.jhep.2009.04.019
   KIM HO, 1992, TETRAHEDRON LETT, V33, P6899, DOI 10.1016/S0040-4039(00)60890-0
   KLECKER RW, 1994, MOL PHARMACOL, V46, P1204
   KNOPF KW, 1976, BIOCHEMISTRY-US, V15, P4540, DOI 10.1021/bi00665a032
   KUNKEL TA, 1988, J BIOL CHEM, V263, P4450
   Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351
   Lee H, 2003, BIOCHEMISTRY-US, V42, P14711, DOI 10.1021/bi035596s
   Lee HR, 2007, J BIOL CHEM, V282, P31982, DOI 10.1074/jbc.M705392200
   Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200
   Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   LEWIS W, 1994, BIOCHEMISTRY-US, V33, P14620, DOI 10.1021/bi00252a030
   Lewis W, 1996, P NATL ACAD SCI USA, V93, P3592, DOI 10.1073/pnas.93.8.3592
   LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417
   Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702
   MEYER RR, 1968, P NATL ACAD SCI USA, V61, P130, DOI 10.1073/pnas.61.1.130
   Murakami E, 2003, J BIOL CHEM, V278, P36403, DOI 10.1074/jbc.M306236200
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   OLSON MW, 1995, J BIOL CHEM, V270, P28932, DOI 10.1074/jbc.270.48.28932
   OLSON MW, 1992, J BIOL CHEM, V267, P23136
   Pai SB, 1996, ANTIMICROB AGENTS CH, V40, P380, DOI 10.1128/AAC.40.2.380
   Parker W.B., 1994, J. Natl. Inst. Health Res, V6, P57
   Pfeffer G, 2009, NEUROLOGY, V73, P71, DOI 10.1212/WNL.0b013e3181aae814
   Pinz KG, 2000, J BIOL CHEM, V275, P12509, DOI 10.1074/jbc.275.17.12509
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402
   Seok JI, 2009, HEPATOLOGY, V49, P2080, DOI 10.1002/hep.22959
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Shadel GS, 1999, AM J HUM GENET, V65, P1230, DOI 10.1086/302630
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   STARNES MC, 1987, J BIOL CHEM, V262, P988
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   TABOR S, 1987, J BIOL CHEM, V262, P16212
   TABOR S, 1995, P NATL ACAD SCI USA, V92, P6339, DOI 10.1073/pnas.92.14.6339
   Tak WY, 2009, HEPATOL RES, V39, P944, DOI 10.1111/j.1872-034X.2009.00515.x
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   VANDERVLIET PC, 1981, BIOCHEMISTRY-US, V20, P2628, DOI 10.1021/bi00512a041
   WERNETTE CM, 1986, J BIOL CHEM, V261, P4764
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yakubovskaya E, 2007, EMBO J, V26, P4283, DOI 10.1038/sj.emboj.7601843
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yao GQ, 1996, BIOCHEM PHARMACOL, V51, P941, DOI 10.1016/0006-2952(96)00049-4
   YARCHOAN R, 1989, NEW ENGL J MED, V321, P726, DOI 10.1056/NEJM198909143211106
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   ZEVIANI M, 1990, AM J HUM GENET, V47, P904
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   ZIMMERMANN W, 1980, J BIOL CHEM, V255, P1847
NR 120
TC 20
Z9 29
U1 0
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1570-9639
EI 1878-1454
J9 BBA-PROTEINS PROTEOM
JI BBA-Proteins Proteomics
PD MAY
PY 2010
VL 1804
IS 5
SI SI
BP 1213
EP 1222
DI 10.1016/j.bbapap.2010.01.007
PG 10
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 584YB
UT WOS:000276789300016
PM 20083238
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Winanto
   Khong, ZJ
   Soh, BS
   Fan, Y
   Ng, SY
AF Winanto
   Khong, Zi Jian
   Soh, Boon-Seng
   Fan, Yong
   Ng, Shi-Yan
TI Organoid cultures of MELAS neural cells reveal hyperactive Notch
   signaling that impacts neurodevelopment
SO CELL DEATH & DISEASE
LA English
DT Article
ID MITOCHONDRIAL-DNA; NEURITE OUTGROWTH; MAINTENANCE
AB Mutations in mitochondrial DNA (mtDNA), typically maternally inherited, can result in severe neurological conditions. There is currently no cure for mitochondrial DNA diseases and treatments focus on management of the symptoms rather than correcting the defects downstream of the mtDNA mutation. Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) is one such mitochondrial disease that affects many bodily systems, particularly the central nervous system and skeletal muscles. Given the motor deficits seen in MELAS patients, we investigate the contribution of motor neuron pathology to MELAS. Using a spinal cord organoid system derived from induced pluripotent stem cells of a MELAS patient, as well as its isogenically corrected control, we found that high levels of Notch signaling underlie neurogenesis delays and neurite outgrowth defects that are associated with MELAS neural cultures. Furthermore, we demonstrate that the gamma-secretase inhibitor DAPT can reverse these neurodevelopmental defects.
C1 [Winanto; Khong, Zi Jian; Soh, Boon-Seng; Ng, Shi-Yan] A STAR Res Ent, Inst Mol & Cell Biol, Singapore 138673, Singapore.
   [Khong, Zi Jian] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.
   [Soh, Boon-Seng] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.
   [Soh, Boon-Seng; Fan, Yong; Ng, Shi-Yan] Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou 510150, Peoples R China.
   [Ng, Shi-Yan] Natl Univ Singapore, Yong Loo Lin Sch Med Physiol, Singapore 117456, Singapore.
   [Ng, Shi-Yan] Natl Neurosci Inst, Singapore 308433, Singapore.
C3 Agency for Science Technology & Research (A*STAR); A*STAR - Institute of
   Molecular & Cell Biology (IMCB); Nanyang Technological University;
   National University of Singapore; Guangzhou Medical University; National
   University of Singapore; National Neuroscience Institute (NNI)
RP Soh, BS; Ng, SY (corresponding author), A STAR Res Ent, Inst Mol & Cell Biol, Singapore 138673, Singapore.; Soh, BS (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.; Soh, BS; Fan, Y; Ng, SY (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou 510150, Peoples R China.; Ng, SY (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med Physiol, Singapore 117456, Singapore.; Ng, SY (corresponding author), Natl Neurosci Inst, Singapore 308433, Singapore.
EM bssoh@imcb.a-star.edu.sg; yongfan011@gzmh.edu.cn;
   syng@imcb.a-star.edu.sg
OI Ng, Winanto/0000-0003-3873-0511; Ng, Shi-Yan/0000-0003-3418-2757; Soh,
   Boon Seng/0000-0001-9134-3081
FU Institute of Molecular and Cell Biology; National Medical Research
   Council, Singapore [NMRC/OFYIRG/0011/2016]; National Natural Science
   Foundation of China [81871162]; National Research Foundation Singapore
   [NRF-NRFF2018-03]
FX This work is supported by the Institute of Molecular and Cell Biology,
   as well as the following grants to S.-Y.N.: NRF-NRFF2018-03 (National
   Research Foundation Singapore), NMRC/OFYIRG/0011/2016 (National Medical
   Research Council, Singapore), and partially supported by the National
   Natural Science Foundation of China (grant number 81871162) to Y.F. We
   thank the Advanced Molecular Pathology Lab of the Institute of Molecular
   and Cell Biology for their assistance with cryosectioning of the
   organoids. We also thank the Nikon Imaging Centre, Singapore for their
   assistance with microscopy.
CR Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8
   Chang JC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10870-5
   Chen L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1083-y
   Du ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7626
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110
   Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202
   Hor JH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1081-0
   Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Levy OA, 2002, DEV NEUROSCI-BASEL, V24, P79, DOI 10.1159/000064948
   Perumalsamy LR, 2010, P NATL ACAD SCI USA, V107, P6882, DOI 10.1073/pnas.0910060107
   Shi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014570
   Tan GC, 2016, CELL REP, V16, P907, DOI 10.1016/j.celrep.2016.06.067
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
NR 16
TC 28
Z9 28
U1 3
U2 18
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD MAR 13
PY 2020
VL 11
IS 3
AR 182
DI 10.1038/s41419-020-2383-6
PG 8
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA KW2AA
UT WOS:000520970900005
PM 32170107
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Nakashima-Kamimura, N
   Asoh, S
   Ishibashi, Y
   Mukai, Y
   Shidara, Y
   Oda, H
   Munakata, K
   Goto, Y
   Ohta, S
AF Nakashima-Kamimura, N
   Asoh, S
   Ishibashi, Y
   Mukai, Y
   Shidara, Y
   Oda, H
   Munakata, K
   Goto, Y
   Ohta, S
TI MIDAS/GPP34, a nuclear gene product, regulates total mitochondrial mass
   in response to mitochondrial dysfunction
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE mitochondria; mitochondrial mass; cardiolipin; mitochondrial DNA;
   mitochondrial disease; Golgi apparatus
ID STROKE-LIKE EPISODES; TRANSFER RNALEU(UUR) GENE; LACTIC-ACIDOSIS;
   SKELETAL-MUSCLE; CELL-DEATH; SACCHAROMYCES-CEREVISIAE;
   RESPIRATORY-CHAIN; OXIDATIVE STRESS; POINT MUTATION; DNA-REPAIR
AB To investigate the regulatory system in mitochondrial biogenesis involving crosstalk between the mitochondria and nucleus, we found a factor named MIDAS (mitochondrial DNA absence sensitive factor) whose expression was enhanced by the absence of mitochondrial DNA (mtDNA). In patients with mitochondrial diseases, MIDAS expression was increased only in dysfunctional muscle fibers. A majority of MIDAS localized to mitochondria with a small fraction in the Golgi apparatus in HeLa cells. To investigate the function of MIDAS, we stably transfected HeLa cells with an expression vector carrying MIDAS cDNA or siRNA. Cells expressing the MIDAS protein and the siRNA constitutively showed an increase and decrease in the total mass of mitochondria, respectively, accompanying the regulation of a mitochondria-specific phospholipid, cardiolipin. In contrast, amounts of the mitochondrial DNA, RNA and proteins did not depend upon MMAS. Thus, MIDAS is involved in the regulation of mitochondrial lipids, leading to increases of total mitochondrial mass in response to mitochondrial dysfunction.
C1 Nippon Med Coll, Dept Biochem & Cell Biol, Inst Dev & Aging Sci, Grad Sch Med, Kawasaki, Kanagawa 2118533, Japan.
   Tokyo Womens Med Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 1628666, Japan.
   Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, NCNP, Kodaira, Tokyo 1878502, Japan.
C3 Nippon Medical School; Tokyo Women's Medical University; National Center
   for Neurology & Psychiatry - Japan
RP Nippon Med Coll, Dept Biochem & Cell Biol, Inst Dev & Aging Sci, Grad Sch Med, 1-396 Kosugi Cho, Kawasaki, Kanagawa 2118533, Japan.
EM ohta@nms.ac.jp
RI Ohta, Shigeo/HKO-9826-2023
OI Ohta, Shigeo/0000-0002-2539-470X
CR Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910
   Asoh S, 1996, J BIOCHEM-TOKYO, V120, P600
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200
   BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303
   Bidlingmaier Scott, 2002, Functional and Integrative Genomics, V1, P345, DOI 10.1007/s10142-001-0043-1
   Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522
   Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005
   BRUNK CF, 1981, EXP CELL RES, V136, P305, DOI 10.1016/0014-4827(81)90008-2
   Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616
   Cortopassi GA, 1999, BBA-BIOENERGETICS, V1410, P183, DOI 10.1016/S0005-2728(98)00166-2
   DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450
   Dubowitz V., 1985, Muscle Biopsy-A Practical Approach, VSecond, P19
   ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919
   Erlich R, 1996, J BIOL CHEM, V271, P8328, DOI 10.1074/jbc.271.14.8328
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5
   Goglia F, 1999, FEBS LETT, V452, P115, DOI 10.1016/S0014-5793(99)00642-0
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320
   Griparic L, 2001, TRAFFIC, V2, P235, DOI 10.1034/j.1600-0854.2001.1r008.x
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HAYASHI JI, 1994, J BIOL CHEM, V269, P6878
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Jishage M, 2003, ONCOGENE, V22, P41, DOI 10.1038/sj.onc.1206074
   Kanamori T, 2003, EMBO J, V22, P2913, DOI 10.1093/emboj/cdg299
   Kang D, 2002, CURR GENET, V41, P311, DOI 10.1007/s00294-002-0312-0
   KAWAHARA H, 1991, J SUBMICR CYTOL PATH, V23, P397
   KLAUS S, 1991, INT J BIOCHEM, V23, P791, DOI 10.1016/0020-711X(91)90062-R
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590
   Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0
   Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Melov S, 2000, ANN NY ACAD SCI, V908, P219
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345
   MULLERHOCKER J, 1986, J NEUROL SCI, V74, P199, DOI 10.1016/0022-510X(86)90105-X
   MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9
   Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368
   Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101
   Ohta S, 2003, CURR MED CHEM, V10, P2485, DOI 10.2174/0929867033456440
   Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006
   Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   VOROBJEV IA, 1983, FEBS LETT, V163, P311, DOI 10.1016/0014-5793(83)80842-4
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Weber K, 2002, BIOL CHEM, V383, P283, DOI 10.1515/BC.2002.030
   WEI YF, 1995, MOL CELL BIOL, V15, P3206
   Westermann B, 2002, EMBO REP, V3, P527, DOI 10.1093/embo-reports/kvf113
   Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901
   Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x
   Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493
   ZELLER R, 1998, CELLS LAB MANUAL, V3
NR 60
TC 57
Z9 64
U1 1
U2 5
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD NOV 15
PY 2005
VL 118
IS 22
BP 5357
EP 5367
DI 10.1242/jcs.02645
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 992KT
UT WOS:000233883500019
PM 16263763
DA 2024-11-01
ER

PT J
AU Haque, S
   Crawley, K
   Shrestha, R
   Schofield, D
   Sue, CM
AF Haque, Sameen
   Crawley, Karen
   Shrestha, Rupendra
   Schofield, Deborah
   Sue, Carolyn M.
TI Healthcare resource utilization of patients with mitochondrial disease
   in an outpatient hospital setting
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Article
DE Mitochondrial diseases; Mitochondrial disorders; Health care costs;
   Health services; Health resources; Outpatients
ID DIAGNOSIS; SPECTRUM; DEFECTS
AB Background and objectivesMitochondrial diseases present as multi-system disorders requiring a comprehensive multidisciplinary approach. The data on healthcare resource utilization associated with mitochondrial diseases and the clinical drivers of these costs are limited including for the out-patient setting where the majority of the clinical care for mitochondrial disease patients occurs. We performed a cross-sectional retrospective study of out-patient healthcare resource utilization and costs for patients with a confirmed diagnosis of mitochondrial disease.MethodsWe recruited participants from the Mitochondrial Disease Clinic in Sydney and stratified them into three groups: those with mitochondrial DNA (mtDNA) mutations (Group 1), those with nuclear DNA (nDNA) mutations and the predominant phenotype of chronic progressive external ophthalmoplegia (CPEO) or optic atrophy (Group 2) and those without a confirmed genetic diagnosis but clinical criteria and muscle biopsy findings supportive of a diagnosis of mitochondrial disease (Group 3). Data was collected through retrospective chart review and out-patient costs were calculated using the Medicare Benefits Schedule.ResultsWe analyzed the data from 91 participants and found that Group 1 had the greatest average out-patient costs per person per annum ($838.02; SD 809.72). Neurological investigations were the largest driver of outpatient healthcare costs in all groups (average costs per person per annum:-Group 1: $364.11; SD 340.93, Group 2: $247.83; SD 113.86 and Group 3: $239.57; SD 145.69) consistent with the high frequency (94.5%) of neurological symptoms. Gastroenterological and cardiac-related out-patient costs were also major contributors to out-patient healthcare resource utilization in Groups 1 and 3. In Group 2, ophthalmology was the second-most resource intensive specialty ($136.85; SD 173.35). The Group 3 had the greatest average healthcare resource utilization per person over the entire duration of out-patient clinic care ($5815.86; SD 3520.40) most likely due to the lack of a molecular diagnosis and a less customized management approach.ConclusionThe drivers of healthcare resource utilization are dependent on the phenotype-genotype characteristics. Neurological, cardiac, and gastroenterological costs were the top three drivers in the out-patient clinics unless the patient had nDNA mutations with predominant phenotype of CPEO and/or optic atrophy wherein ophthalmological-related costs were the second most resource intensive driver.
C1 [Haque, Sameen] Nepean Hosp, Derby St, Kingswood, NSW 2747, Australia.
   [Haque, Sameen; Crawley, Karen; Sue, Carolyn M.] Royal North Shore Hosp, Kolling Inst, Reserve Rd, St Leonards, NSW 2065, Australia.
   [Shrestha, Rupendra; Schofield, Deborah] Macquarie Univ, Ctr Econ Impacts Genom Med GenIMPACT, Macquarie Business Sch, Eastern Rd, Macquarie Pk, NSW 2109, Australia.
   [Sue, Carolyn M.] Univ New South Wales, Neurosci Res Australia, Sydney, Australia.
C3 Nepean Hospital; University of Sydney; Kolling Institute of Medical
   Research; Royal North Shore Hospital; Macquarie University; Neuroscience
   Research Australia; University of New South Wales Sydney
RP Haque, S (corresponding author), Nepean Hosp, Derby St, Kingswood, NSW 2747, Australia.; Haque, S (corresponding author), Royal North Shore Hosp, Kolling Inst, Reserve Rd, St Leonards, NSW 2065, Australia.
EM sameenhaque@hotmail.com
OI Schofield, Deborah/0000-0002-1658-494X; Haque,
   Sameen/0000-0002-6204-6640; Sue, Carolyn/0000-0003-1255-3617; Shrestha,
   Rupendra/0000-0001-5455-0735
CR Ahn J, 2008, BRIT J OPHTHALMOL, V92, P1685, DOI 10.1136/bjo.2008.144816
   aihw, About us
   Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Boggan RM, 2019, MOL GENET METAB, V128, P19, DOI 10.1016/j.ymgme.2019.09.003
   Buajitti E, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0265744
   Chinnery PF, 1997, QJM-INT J MED, V90, P657, DOI 10.1093/qjmed/90.11.657
   Cohen B, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0949-5
   Davis RL, 2022, NEUROLOGY, V99, pE730, DOI 10.1212/WNL.0000000000200745
   Davis Ryan L, 2018, Handb Clin Neurol, V147, P125, DOI 10.1016/B978-0-444-63233-3.00010-5
   Doherty M, 2013, ORBIT, V32, P12, DOI 10.3109/01676830.2012.736599
   Eshaghi M, 2021, EUR J OPHTHALMOL, V31, P2064, DOI 10.1177/1120672120952344
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grier J, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000230
   Guo Yi, 2018, Zhongguo Dang Dai Er Ke Za Zhi, V20, P887
   health, About us
   Hom XB, 2004, MITOCHONDRION, V4, P601, DOI 10.1016/j.mito.2004.07.014
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   Klopstock T, 2021, DTSCH ARZTEBL INT, V118, P741, DOI 10.3238/arztebl.m2021.0251
   La Morgia C, 2020, J INTERN MED, V287, P592, DOI 10.1111/joim.13064
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Meyers DE, 2013, TEX HEART I J, V40, P385
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   National Health and Medical Research Council (NHMRC), US
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Nolte E., 2008, Caring for people with chronic conditions: a health system perspective
   Parikh S, 2017, GENET MED, V19, DOI 10.1038/gim.2017.107
   Parsons T, 2010, ARCH NEUROL-CHICAGO, V67, P976, DOI 10.1001/archneurol.2010.174
   Sue CM, 2022, INTERN MED J, V52, P110, DOI 10.1111/imj.15505
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   who, US
NR 33
TC 2
Z9 2
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1750-1172
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD MAY 29
PY 2023
VL 18
IS 1
AR 129
DI 10.1186/s13023-023-02746-x
PG 9
WC Genetics & Heredity; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Research & Experimental Medicine
GA H3HL7
UT WOS:000994909200001
PM 37246228
OA gold, Green Submitted, Green Published
DA 2024-11-01
ER

PT J
AU Saha, D
   Kothari, S
   Kulkarni, SD
   Thambiraja, M
   Yennamalli, RM
   Das, DK
AF Saha, Debolina
   Kothari, Sonam
   Kulkarni, Shilpa Duttaprasanna
   Thambiraja, Menaka
   Yennamalli, Ragothaman M.
   Das, Dhanjit K.
TI Genetic heterogeneity and respiratory chain enzyme analysis in pediatric
   Indian patients with mitochondrial disorder: Report of novel variants in
   POLG1 gene and their functional implication using molecular dynamic
   simulation
SO MITOCHONDRION
LA English
DT Article
DE POLG1; Mitochondrial disorders; Respiratory chain enzyme analysis;
   Sanger sequencing; Molecular docking
ID DNA-POLYMERASE GAMMA; DISEASES; RESIDUE; GROMACS; MUTANT
AB Mitochondrial disorders are a heterogeneous group of disorders caused by mutations in the mitochondrial DNA or in nuclear genes encoding the mitochondrial proteins and subunits. Polymerase Gamma (POLG) is a nuclear gene and mutation in the POLG gene are one of the major causes of inherited mitochondrial disorders. In this study, 15 pediatric patients, with a wide spectrum of clinical phenotypes were screened using blood samples (n = 15) and muscle samples (n = 4). Respiratory chain enzyme analysis in the muscle samples revealed multicomplex deficiencies with Complex I deficiency present in (1/4) patients, Complex II (2/4), Complex III (3/4) and Complex IV (2/4) patients. Multiple large deletions were observed in 4/15 patients using LR-PCR. Whole exome sequencing (WES) revealed a compound heterozygous mutation consisting of a POLG1 novel variant (NP_002684.1:p.Trp261X) and a missense variant (NP_002684.1:p. Leu304Arg) in one patient and another patient harboring a novel homozygous POLG1 variant (NP_002684.1:p. Phe750Val). These variants (NP_002684.1: p. Leu304Arg) and (NP_002684.1:p. Phe750Val) and their interactions with DNA were modelled using molecular docking and molecular dynamics (MD) simulation studies. The protein conformation was analyzed as root mean square deviation (RMSD), root mean square fluctuation (RMSF) which showed local fluctuations in the mutants compared to the wildtype. However, Solvent Accessible Surface Area (SASA) significantly increased for NP_002684.1:p.Leu304Arg and decreased in NP_002684.1:p.Phe750Val mutants. Further, Contact Order analysis indicated that the Aromatic-sulfur interactions were destabilizing in the mutants. Overall, these in-silico analysis has revealed a destabilizing mutations suggesting pathogenic variants in POLG1 gene.
C1 [Saha, Debolina; Das, Dhanjit K.] ICMR Natl Inst Res Reprod & Child Hlth, Stem Cell Biol Dept, JM St, Mumbai 400012, India.
   [Kothari, Sonam; Kulkarni, Shilpa Duttaprasanna] Bai Jerbai Wadia Hosp Children, Dept Pediat Neurol, Acharya Donde Marg, Mumbai 400012, Maharashtra, India.
   [Thambiraja, Menaka; Yennamalli, Ragothaman M.] SASTRA Deemed Univ, Sch Chem & Biotechnol, Dept Bioinformat, Thanjavur 613401, Tamil Nadu, India.
C3 Indian Council of Medical Research (ICMR); ICMR - National Institute for
   Research in Reproductive & Child Health (NIRRCH); Shanmugha Arts,
   Science, Technology & Research Academy (SASTRA)
RP Das, DK (corresponding author), ICMR Natl Inst Res Reprod & Child Hlth, Stem Cell Biol Dept, JM St, Mumbai 400012, India.; Yennamalli, RM (corresponding author), SASTRA Deemed Univ, Sch Chem & Biotechnol, Dept Bioinformat, Thanjavur 613401, Tamil Nadu, India.
EM ragothaman@scbt.sastra.edu; dasd@nirrch.res.in
RI Yennamalli, Ragothaman/M-7870-2017
OI Yennamalli, Ragothaman/0000-0002-3327-1582
FU Writing Accountability Group of India
FX We are thankful to all the participants and their families who have
   taken part in the study. We are also thankful to all the staff of
   Pediatric Neurology department for providing the patient samples and
   also to all the doctors and staff of pediatric orthopedics department
   for providing control samples. We are also grateful to (Indian Council
   of Medical research) ICMR, India for providing Senior Research
   Fellowship to DS (F. No.45/05/2022/HUM/BMS) and Department of
   Biotechnology, India (DBT-BioCARE: BT/PR30443/BIC/101/1119/2018) for
   providing funding to SK. We are also thankful to Director, ICMR-NIRRCH
   for providing the necessary facilities to undertake the study. MT is
   supported by Senior Research Fellowship from Indian Council of
   Agricultural Research, India-National Agricultural Science Fund. RMY lab
   is supported by UGC-BSR, India (F.30-561/2021 (BSR) ) , ICAR-NASF, India
   (F. No. NASF/SUTRA-02/2022-23/50) , and IKS Division of MoE@AICTE, India
   (F. No. 2-23/AICTE/IKS/Research project/18) . MT and RMY thank SASTRA
   Deemed to be University for the infrastructuralsupport and research
   facilities. The computational infrastructure and support provided by the
   "Bioinformatics Research and Applications Facility (BRAF) " funded by
   the National Supercomputing Mission, Government of India at the Centre
   For Development of Advanced Computing, Pune, India are gratefully
   acknowledged. RMY acknowledges the support and encouragement from the
   Writing Accountability Group of India.r support and research facilities.
   The computational infrastructure and support provided by the
   "Bioinformatics Research and Applications Facility (BRAF) " funded by
   the National Supercomputing Mission, Government of India at the Centre
   For Development of Advanced Computing, Pune, India are gratefully
   acknowledged. RMY acknowl-edges the support and encouragement from the
   Writing Accountability Group of India.
CR Behera SK, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86712-2
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Brodkin HR, 2015, PROTEIN SCI, V24, P762, DOI 10.1002/pro.2648
   Chakrabarty S, 2021, J NEUROL, V268, P2192, DOI 10.1007/s00415-020-10390-9
   Chatterjee J, 2021, J EXP BOT, V72, P3122, DOI 10.1093/jxb/erab039
   Chinnery P.F., 2021, GeneReviews, P1
   Deepha S, 2021, J MOL NEUROSCI, V71, P2219, DOI 10.1007/s12031-020-01765-8
   Drawz SM, 2009, BIOCHEMISTRY-US, V48, P4557, DOI 10.1021/bi9003292
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Kisler JE, 2010, DEV MED CHILD NEUROL, V52, P422, DOI 10.1111/j.1469-8749.2009.03605.x
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Monteith WB, 2014, P NATL ACAD SCI USA, V111, P11335, DOI 10.1073/pnas.1406845111
   Nakadai M, 2016, SCI REP-UK, V6, DOI 10.1038/srep18543
   Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645
   Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27
   Rader AJ, 2012, J BIOMOL STRUCT DYN, V30, P628, DOI 10.1080/07391102.2012.689696
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Sonam K, 2017, MITOCHONDRION, V32, P42, DOI 10.1016/j.mito.2016.11.002
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tchikviladze M, 2015, J NEUROL NEUROSUR PS, V86, P646, DOI 10.1136/jnnp-2013-306799
   Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014
NR 29
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAY
PY 2024
VL 76
AR 101870
DI 10.1016/j.mito.2024.101870
EA MAR 2024
PG 10
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA PT2C3
UT WOS:001216259000001
PM 38471579
DA 2024-11-01
ER

PT J
AU Greaves, LC
   Barron, MJ
   Campbell-Shiel, G
   Kirkwood, TBL
   Turnbull, DM
AF Greaves, Laura C.
   Barron, Martin J.
   Campbell-Shiel, George
   Kirkwood, Thomas B. L.
   Turnbull, Douglass M.
TI Differences in the accumulation of mitochondrial defects with age in
   mice and humans
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Mitochondria; Colonic epithelium; Ciliary epithelium; Ageing
ID DNA MUTATIONS; STEM-CELLS; INTESTINAL CRYPTS; DELETIONS; DISEASE;
   CANCER; FIBERS; MUSCLE; MOUSE
AB Mitochondrial DNA mutations and associated defects in cytochrome c oxidase (COX) are proposed to play an important role in human ageing; however there have been limited studies on the frequency of these defects in normal mouse ageing. Here we compare COX-deficiency in two epithelial tissues; the colon and the ciliary epithelium, from human and mouse. The pattern of accumulation of COX-deficiency is similar in both tissues in the two species; however the frequency of colonic crypts with COX-deficiency in aged humans is significantly higher than in aged mice, whereas the levels of COX-deficiency in the ciliary epithelium are higher in the mouse than in humans. This suggests the impact of mitochondrial defects on normal ageing may differ significantly between species. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Greaves, Laura C.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Kirkwood, Thomas B. L.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP Greaves, LC (corresponding author), Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM laura.greaves@ncl.ac.uk; Martin.Barron@manchester.ac.uk;
   g.r.campbell-shiel@ncl.ac.uk; tom.kirkwood@ncl.ac.uk;
   doug.turnbull@newcastle.ac.uk
RI ; Barron, Martin/E-9649-2015
OI Turnbull, Doug/0000-0002-8878-9901; Greaves, Laura/0000-0002-8071-5916;
   Barron, Martin/0000-0002-2047-3513
FU Wellcome Trust; Medical Research Council; Newcastle University Centre
   for Brain Ageing Vitality; BBSRC; EPSRC; ESRC; MRC as part of the
   crosscouncil Lifelong Health and Wellbeing Initiative; BBSRC Centre for
   Integrated Systems Biology of Ageing and Nutrition; MRC [G0601943,
   G0700718] Funding Source: UKRI
FX This work has been supported by Wellcome Trust, and the Medical Research
   Council. Part of this work was supported by the Newcastle University
   Centre for Brain Ageing & Vitality supported by the BBSRC, EPSRC, ESRC
   and MRC as part of the crosscouncil Lifelong Health and Wellbeing
   Initiative. TBLK was also supported by the BBSRC Centre for Integrated
   Systems Biology of Ageing and Nutrition.
CR Blasco MA, 2005, EMBO J, V24, P1095, DOI 10.1038/sj.emboj.7600598
   Cottrell DA, 2001, NEUROPATH APPL NEURO, V27, P206, DOI 10.1046/j.1365-2990.2001.00315.x
   Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791
   Guo XH, 2010, BBA-BIOENERGETICS, V1797, P1159, DOI 10.1016/j.bbabio.2010.04.005
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Martin K, 1998, EXP CELL RES, V241, P316, DOI 10.1006/excr.1998.4001
   Martin K, 1998, J CELL SCI, V111, P2297
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   O'Sullivan J, 2006, CANCER EPIDEM BIOMAR, V15, P573, DOI 10.1158/1055-9965.EPI-05-0542
   ROWLATT C, 1976, Laboratory Animals (London), V10, P419, DOI 10.1258/002367776780956917
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
NR 16
TC 24
Z9 24
U1 0
U2 7
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD NOV-DEC
PY 2011
VL 132
IS 11-12
BP 588
EP 591
DI 10.1016/j.mad.2011.10.004
PG 4
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 888CG
UT WOS:000299980800008
PM 22015485
DA 2024-11-01
ER

PT J
AU Bekheirnia, MR
   Zhang, W
   Eble, T
   Willis, A
   Shaibani, A
   Wong, LJC
   Scaglia, F
   Dhar, SU
AF Bekheirnia, Mir Reza
   Zhang, Wei
   Eble, Tanya
   Willis, Alecia
   Shaibani, Aziz
   Wong, Lee-Jun C.
   Scaglia, Fernando
   Dhar, Shweta U.
TI <i>POLG</i> mutation in a patient with cataracts, early-onset distal
   muscle weakness and atrophy, ovarian dysgenesis and 3-methylglutaconic
   aciduria
SO GENE
LA English
DT Article
DE POLG; 3-Methylglutaconic aciduria; Muscle weakness; Cataracts; Ovarian
   dysgenesis
ID MITOCHONDRIAL-DNA POLYMERASE; DEPLETION; SPECTRUM
AB Mutations in POLG account for one of the most frequent nuclear encoded causes of mitochondrial disorders to date. Individuals harboring POLG mutations exhibit fairly heterogeneous clinical presentations leading to increasing difficulties in classifying these patients into defined clinical phenotypes. This study aims to investigate the molecular basis of a mitochondrial cytopathy in a patient with 3-methylglutaconic aciduria and to expand the clinical phenotype associated with POLG mutations.
   Clinical, molecular and genetic analyses as well as neurophysiological examinations were carried out for a 23-year-old woman of mixed Caucasian and Latin American ancestry with a history of cataracts diagnosed at age 1year, she had onset of distal muscle weakness at age 2years progressing to atrophy and ovarian dysgenesis at puberty. The patient was found to have 3-methylglutaconic acid with normal 3 hydroxyisovaleric acid on urine organic acid analysis. POLG sequencing was done and a heterozygous variant, c.2851T>A (p.Y951N) was found which is predicted to be deleterious. There are limited reports of POLG mutations in individuals with 3-methylglutaconic aciduria. This case report of a young woman with a heterozygous mutation in POLG, presenting with muscle weakness and atrophy at a young age aims to aid clinicians in similar challenging diagnostic situations as well as enhances our understanding of POLG-related disease phenotypes. Published by Elsevier B.V.
C1 [Bekheirnia, Mir Reza; Zhang, Wei; Eble, Tanya; Willis, Alecia; Wong, Lee-Jun C.; Scaglia, Fernando; Dhar, Shweta U.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Shaibani, Aziz; Dhar, Shweta U.] Nerve & Muscle Ctr Texas, Houston, TX USA.
   [Shaibani, Aziz] Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine
RP Dhar, SU (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1709 Dryden Rd,Rm 17-20, Houston, TX 77030 USA.
EM dhar@bcm.edu
RI Shaibani, Aziz/AAE-1755-2022
CR Atiq M., 2004, Indian Journal of Pediatrics, V71, P437, DOI 10.1007/BF02725636
   Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   DiMauro S, 2006, BRAIN, V129, P1637, DOI 10.1093/brain/awl169
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Giordano C, 2010, ARCH NEUROL-CHICAGO, V67, P1144, DOI 10.1001/archneurol.2010.200
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Gunay-Aygun M, 2005, MOL GENET METAB, V84, P1, DOI 10.1016/j.ymgme.2004.12.003
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Ledig S, 2010, SEX DEV, V4, P225, DOI 10.1159/000314958
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   REDDY VN, 1988, OPHTHALMIC RES, V20, P191, DOI 10.1159/000266585
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tong ZB, 2010, FERTIL STERIL, V94, P2932, DOI 10.1016/j.fertnstert.2010.06.049
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Wortmann SB, 2009, BRAIN, V132, P136, DOI 10.1093/brain/awn296
NR 24
TC 15
Z9 16
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD MAY 10
PY 2012
VL 499
IS 1
BP 209
EP 212
DI 10.1016/j.gene.2012.02.034
PG 4
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 936WT
UT WOS:000303621400032
PM 22405928
DA 2024-11-01
ER

PT J
AU Gasser, RB
   Campbell, BE
   Jex, AR
AF Gasser, Robin B.
   Campbell, Bronwyn E.
   Jex, Aaron R.
TI Mutation scanning-coupled tools for the analysis of genetic variation in
   <i>Taenia</i> and diagnosis - Status and prospects
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Review
DE Taenia; Mutation scanning; Specific identification; Systematics;
   Epidemiology; Population genetics
ID STRAND CONFORMATION POLYMORPHISM; POLYMERASE-CHAIN-REACTION; DNA
   DIFFERENTIAL-DIAGNOSIS; REAL-TIME PCR; RIBOSOMAL DNA; MITOCHONDRIAL
   GENOMES; CAPILLARY-ELECTROPHORESIS; SAGINATA CYSTICERCOSIS; PARASITIC
   NEMATODES; ECHINOCOCCUS-MULTILOCULARIS
AB Cestodes of the genus Taenia occur as adult tapeworms in the small intestine of carnivorous definitive hosts and are transmitted to particular mammalian intermediate hosts, in which they develop as fluid-filled larvae in tissues, causing the disease cysticercosis or coenuriasis. A number of species are of medical importance and/or cause losses to the meat and livestock industry mainly due to the condemnation of infected muscle and offal. The control of taeniid cestodes relies upon epidemiological data, including the precise identification and characterization of the causative agents. Traditional, phenetic techniques have limitations for specific diagnosis. Although there has been progress in the establishment of molecular tools, there has been relatively limited application of mutation scanning approaches to species of Taenia. In the present article, we briefly review key genetic markers used for the specific identification of taeniids and tools for the analysis of genetic variation within and among populations and the diagnosis of taeniasis and cysticercosis/coenuriasis. We also discuss the advantages and disadvantages of selected techniques and emphasize the benefits of utilizing mutation scanning-based approaches in achieving detailed insights into the population genetics and epidemiology of Taenia species. (C) 2009 Published by Elsevier B.V.
C1 [Gasser, Robin B.; Campbell, Bronwyn E.; Jex, Aaron R.] Univ Melbourne, Dept Vet Sci, Werribee, Vic 3030, Australia.
C3 University of Melbourne
RP Gasser, RB (corresponding author), Univ Melbourne, Dept Vet Sci, 250 Princes Highway, Werribee, Vic 3030, Australia.
EM robinbg@unimelb.edu.au
RI Jex, Aaron/AGZ-7897-2022; Gasser, Robin/ABH-6185-2020; Jex,
   Aaron/A-7421-2019
OI Campbell, Bronwyn/0000-0001-9090-764X; Jex, Aaron/0000-0002-1285-7947;
   Gasser, Robin B./0000-0002-4423-1690
FU Australian Research Council (ARC); Melbourne Water Corporation, and Meat
   and Livestock Australia (MLA); American-Australian Fulbright Commission
FX Thanks to colleagues, including Ian Beveridge, Neil Chilton, Dennis
   Jacobs and Lynda Gibbons, for cooperation and collaborations. Our
   genetic studies of taeniids were supported by a small grant from the
   Australian Research Council (ARC) in 1994. RBG's laboratory is currently
   in receipt of grants from the Australian Research Council (ARC),
   Melbourne Water Corporation, and Meat and Livestock Australia (MLA):
   support from the American-Australian Fulbright Commission is gratefully
   acknowledged.
CR Abuladze K., 1970, Essentials of Cestodology, VIV
   Abuseir S, 2006, PARASITOL RES, V99, P405, DOI 10.1007/s00436-006-0158-3
   Aguilar-Díaz H, 2006, PARASITOL INT, V55, pS127, DOI 10.1016/j.parint.2005.11.020
   ALLSOPP BA, 1987, PARASITOLOGY, V95, P593, DOI 10.1017/S0031182000058017
   [Anonymous], 2008, Georgis' Parasitology for Veterinarians-E-Book
   Arnheim N., 1983, P38
   Avise J.C., 2000, PHYLOGEOGRAPHY HIST, DOI DOI 10.2307/J.CTV1NZFGJ7
   Avise John C., 1994, pi
   Badaraco JL, 2008, EXP PARASITOL, V119, P453, DOI 10.1016/j.exppara.2008.02.004
   Bart JM, 2006, INFECT GENET EVOL, V6, P390, DOI 10.1016/j.meegid.2006.01.006
   Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517
   BEVERIDGE I, 1976, AUST VET J, V52, P369, DOI 10.1111/j.1751-0813.1976.tb09491.x
   BOWLES J, 1993, MOL BIOCHEM PARASIT, V57, P231, DOI 10.1016/0166-6851(93)90199-8
   BOWLES J, 1994, AM J TROP MED HYG, V50, P33, DOI 10.4269/ajtmh.1994.50.1.TM0500010033
   BOWLES J, 1993, INT J PARASITOL, V23, P969, DOI 10.1016/0020-7519(93)90065-7
   BOWLES J, 1992, MOL BIOCHEM PARASIT, V54, P165, DOI 10.1016/0166-6851(92)90109-W
   Campbell G, 2006, PARASITOL INT, V55, pS121, DOI 10.1016/j.parint.2005.11.019
   Carabin H, 2005, TRENDS PARASITOL, V21, P327, DOI 10.1016/j.pt.2005.05.009
   Casulli A, 2009, INT J PARASITOL, V39, P837, DOI 10.1016/j.ijpara.2008.12.001
   Chervy L, 2002, SYST PARASITOL, V52, P1, DOI 10.1023/A:1015086301717
   Chilton NB, 1999, INT J PARASITOL, V29, P1971, DOI 10.1016/S0020-7519(99)00148-4
   CHILTON NB, 1995, INT J PARASITOL, V25, P647, DOI 10.1016/0020-7519(94)00171-J
   Chung JH, 2007, ELECTROPHORESIS, V28, P2416, DOI 10.1002/elps.200600570
   Constantine CC, 2003, TRENDS PARASITOL, V19, P346, DOI 10.1016/S1471-4922(03)00167-3
   DINNIK JA, 1972, Z TROPENMED PARASIT, V23, P197
   Doi K, 2004, ELECTROPHORESIS, V25, P833, DOI 10.1002/elps.200305721
   DOVER GA, 1989, GENETICS, V122, P249
   EDWARDS GT, 1981, J HELMINTHOL, V55, P1, DOI 10.1017/S0022149X00025384
   ELDER JF, 1995, Q REV BIOL, V70, P297, DOI 10.1086/419073
   ELLSWORTH DL, 1993, BIOTECHNIQUES, V14, P214
   EORN KS, 2006, PARASITOL INT, V55, pS137
   Flisser A, 2006, VET PARASITOL, V139, P283, DOI 10.1016/j.vetpar.2006.04.019
   Foronda P, 2005, J HELMINTHOL, V79, P139, DOI 10.1079/JOH2005280
   Gasser RB, 1999, VET PARASITOL, V84, P229, DOI 10.1016/S0304-4017(99)00036-9
   Gasser RB, 1998, INT J PARASITOL, V28, P1775, DOI 10.1016/S0020-7519(98)00126-X
   Gasser RB, 1998, ELECTROPHORESIS, V19, P2391, DOI 10.1002/elps.1150191405
   GASSER RB, 1995, ACTA TROP, V59, P31, DOI 10.1016/0001-706X(94)00085-F
   Gasser RB, 1997, INT J PARASITOL, V27, P1449, DOI 10.1016/S0020-7519(97)00131-8
   Gasser RB, 2006, VET PARASITOL, V136, P69, DOI 10.1016/j.vetpar.2005.12.002
   Gasser RB, 1999, ELECTROPHORESIS, V20, P2834, DOI 10.1002/(SICI)1522-2683(19991001)20:14<2834::AID-ELPS2834>3.0.CO;2-F
   Gasser RB, 2006, NAT PROTOC, V1, P3121, DOI 10.1038/nprot.2006.485
   Geysen D, 2007, J FOOD PROTECT, V70, P236, DOI 10.4315/0362-028X-70.1.236
   González LM, 2006, VET PARASITOL, V142, P95, DOI 10.1016/j.vetpar.2006.06.009
   González LM, 2004, DIAGN MICR INFEC DIS, V49, P183, DOI 10.1016/j.diagmicrobio.2004.03.013
   González LM, 2002, DIAGN MICR INFEC DIS, V42, P243
   González LM, 2000, J CLIN MICROBIOL, V38, P737
   Gonzalez Luis Miguel, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS243, DOI 10.1016/S0035-9203(02)90083-0
   Gudewar J, 2009, MOL BIOL REP, V36, P1381, DOI 10.1007/s11033-008-9324-2
   Gupta PK, 2008, TRENDS BIOTECHNOL, V26, P602, DOI 10.1016/j.tibtech.2008.07.003
   Haag KL, 1999, PARASITOLOGY, V118, P63, DOI 10.1017/S0031182098003485
   Haag KL, 1998, MEM I OSWALDO CRUZ, V93, P695, DOI 10.1590/S0074-02761998000500024
   Haag KL, 1997, PARASITOLOGY, V115, P521, DOI 10.1017/S0031182097001649
   HALL BG, 2007, PHYLOGENETIC TREES M, P302
   HANCOCK JM, 1988, MOL BIOL EVOL, V5, P393
   HANCOCK JM, 1990, NUCLEIC ACIDS RES, V18, P5949, DOI 10.1093/nar/18.20.5949
   Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427
   Harrison LJS, 2005, TROP ANIM HEALTH PRO, V37, P103, DOI 10.1023/B:TROP.0000048459.98067.99
   Hawkins GA, 1997, NAT BIOTECHNOL, V15, P803, DOI 10.1038/nbt0897-803
   Hernández M, 2008, ANN TROP MED PARASIT, V102, P317, DOI 10.1179/136485908X278856
   Hoberg EP, 2006, PARASITOL INT, V55, pS23, DOI 10.1016/j.parint.2005.11.049
   Hoberg EP, 2001, P ROY SOC B-BIOL SCI, V268, P781, DOI 10.1098/rspb.2000.1579
   Hoberg EP, 2000, J PARASITOL, V86, P89, DOI 10.1645/0022-3395(2000)086[0089:APHFSO]2.0.CO;2
   Hu M, 2006, TRENDS PARASITOL, V22, P78, DOI 10.1016/j.pt.2005.12.003
   Hu M, 2004, ADV PARASIT, V56, P133, DOI 10.1016/S0065-308X(03)56003-1
   Ito A, 2003, LANCET, V362, P1918, DOI 10.1016/S0140-6736(03)14965-3
   Ito A, 2003, ACTA TROP, V87, P95, DOI 10.1016/S0001-706X(03)00024-X
   Jeon HK, 2005, PARASITOLOGY, V130, P717, DOI 10.1017/S0031182004007164
   Jeon HK, 2009, EXP PARASITOL, V121, P151, DOI 10.1016/j.exppara.2008.10.014
   Jespersgaard C, 2006, ELECTROPHORESIS, V27, P3816, DOI 10.1002/elps.200600095
   Jex AR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-79
   Jex AR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-11
   JONES A, 1988, SYST PARASITOL, V11, P31, DOI 10.1007/BF00006974
   Jones Arlene, 2001, P150, DOI 10.1002/9780470377000.ch7
   Kedra AH, 2001, PARASITOL INT, V50, P145, DOI 10.1016/S1383-5769(01)00064-2
   Dias AKK, 2007, EXP PARASITOL, V117, P9, DOI 10.1016/j.exppara.2007.03.005
   King S, 2005, J MICROBIOL METH, V60, P83, DOI 10.1016/j.mimet.2004.08.014
   Kirkpatrick NC, 2009, AVIAN PATHOL, V38, P13, DOI 10.1080/03079450802596053
   Knapp J, 2008, INFECT GENET EVOL, V8, P367, DOI 10.1016/j.meegid.2008.02.010
   Lavikainen A, 2008, PARASITOLOGY, V135, P1457, DOI 10.1017/S003118200800499X
   Lavikainen A, 2006, PARASITOLOGY, V133, P565, DOI 10.1017/S0031182006000667
   Le TH, 2000, ACTA TROP, V77, P243, DOI 10.1016/S0001-706X(00)00157-1
   Le TH, 2002, TRENDS PARASITOL, V18, P206, DOI 10.1016/S1471-4922(02)02252-3
   Loos-Frank B, 2000, SYST PARASITOL, V45, P155, DOI 10.1023/A:1006219625792
   MACPHERSON JM, 1993, MOL CELL PROBE, V7, P293, DOI 10.1006/mcpr.1993.1043
   Maravilla P, 2003, J PARASITOL, V89, P1250, DOI 10.1645/GE-2786RN
   Maravilla P, 2008, INFECT GENET EVOL, V8, P213, DOI 10.1016/j.meegid.2007.11.006
   Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359
   Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959
   Mathis A, 2006, PARASITOL INT, V55, pS87, DOI 10.1016/j.parint.2005.11.012
   Mayta H, 2000, J CLIN MICROBIOL, V38, P133
   Mayta H, 2008, J CLIN MICROBIOL, V46, P286, DOI 10.1128/JCM.01172-07
   McManus D.P., 1990, Revue Scientifique et Technique Office International des Epizooties, V9, P489
   MCMANUS D P, 1990, Southeast Asian Journal of Tropical Medicine and Public Health, V21, P161
   McManus DP, 2006, PARASITOL INT, V55, pS31, DOI 10.1016/j.parint.2005.11.004
   McManus DP, 1996, INT J PARASITOL, V26, P687, DOI 10.1016/0020-7519(96)82612-9
   Mitchelson KR, 2003, MOL BIOTECHNOL, V24, P41, DOI 10.1385/MB:24:1:41
   Mitreva M, 2007, VET PARASITOL, V148, P31, DOI 10.1016/j.vetpar.2007.05.008
   Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001
   Nakao M, 2007, PARASITOLOGY, V134, P713, DOI 10.1017/S0031182006001934
   Nakao M, 2002, PARASITOLOGY, V124, P657, DOI 10.1017/S0031182002001725
   Nkouawa A, 2009, J CLIN MICROBIOL, V47, P168, DOI 10.1128/JCM.01573-08
   Nunes CM, 2005, EXP PARASITOL, V110, P412, DOI 10.1016/j.exppara.2005.03.008
   Nunes CRM, 2003, EXP PARASITOL, V104, P67, DOI 10.1016/S0014-4894(03)00111-5
   OKAMOTO M, 1995, PARASITOL RES, V81, P451, DOI 10.1007/BF00931785
   ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8
   Oudni-M'Rad M, 2006, PARASITE, V13, P131, DOI 10.1051/parasite/2006132131
   Pandey V., 2008, Applied Biosystems SOLiD System: Ligation-based sequencing. Next generation genome sequencing: Towards personalized medicine, P29
   Pangasa A, 2009, MOL CELL PROBE, V23, P10, DOI 10.1016/j.mcp.2008.10.003
   Rasmussen JP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-107
   Rausch R.L., 1994, P665
   Rausch RL, 2003, COMP PARASITOL, V70, P1, DOI 10.1654/1525-2647(2003)070[0001:TPNSFT]2.0.CO;2
   Righetti PG, 2002, ELECTROPHORESIS, V23, P1361, DOI 10.1002/1522-2683(200205)23:10<1361::AID-ELPS1361>3.0.CO;2-J
   Robinson BS, 2006, APPL ENVIRON MICROB, V72, P5857, DOI 10.1128/AEM.00113-06
   SACHS R, 1968, Bulletin of Epizootic Diseases of Africa, V16, P455
   SACHS R, 1970, Journal of the South African Veterinary Medical Association, V41, P79
   SACHS R, 1969, Bulletin of Epizootic Diseases of Africa, V17, P337
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
   Sato MO, 2006, AM J TROP MED HYG, V75, P933, DOI 10.4269/ajtmh.2006.75.933
   Schantz PM, 2006, PARASITOL INT, V55, pS7, DOI 10.1016/j.parint.2005.11.050
   SCHLOTTERER C, 1994, CURR BIOL, V4, P777, DOI 10.1016/S0960-9822(00)00175-5
   Shin GW, 2008, ANAL BIOCHEM, V383, P31, DOI 10.1016/j.ab.2008.08.021
   Somers R, 2006, TROP MED INT HEALTH, V11, P65, DOI 10.1111/j.1365-3156.2005.01537.x
   Somers R, 2007, T ROY SOC TROP MED H, V101, P275, DOI 10.1016/j.trstmh.2006.04.007
   Stefanic S, 2004, PARASITOL RES, V92, P347, DOI 10.1007/s00436-003-1043-y
   TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463
   TAUTZ D, 1993, EXS, V67, P21
   ten Bosch JR, 2008, J MOL DIAGN, V10, P484, DOI 10.2353/jmoldx.2008.080027
   Theis JH, 1996, AM J TROP MED HYG, V55, P456, DOI 10.4269/ajtmh.1996.55.456
   Trachsel D, 2007, PARASITOLOGY, V134, P911, DOI 10.1017/S0031182007002235
   van Herwerden L, 2000, INT J PARASITOL, V30, P157, DOI 10.1016/S0020-7519(00)00002-3
   Varcasia A, 2006, PARASITOL RES, V99, P622, DOI 10.1007/s00436-006-0179-y
   Vega R, 2003, INT J PARASITOL, V33, P1479, DOI 10.1016/S0020-7519(03)00206-6
   Verster A., 1969, J VET RES, V36, P3
   WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213
   WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531
   Yamasaki H, 2006, PARASITOL INT, V55, pS81, DOI 10.1016/j.parint.2005.11.013
   Yamasaki H, 2004, J CLIN MICROBIOL, V42, P548, DOI 10.1128/JCM.42.2.548-553.2004
   Yamasaki H, 2002, J CLIN MICROBIOL, V40, P3818, DOI 10.1128/JCM.40.10.3818-3821.2002
   YAMASAKI H, 2005, SE ASIAN J TROP MED, V36, pS131
   Yamasaki H, 2006, PARASITOL INT, V55, P127, DOI 10.1016/j.parint.2005.11.057
   ZARLENGA DS, 1991, EXP PARASITOL, V72, P174, DOI 10.1016/0014-4894(91)90135-J
   ZARLENGA DS, 1991, SE ASIAN J TROP MED, V22, pS251
   Zhang L, 2007, MOL CELL PROBE, V21, P379, DOI 10.1016/j.mcp.2007.05.003
   Zhu XQ, 1998, ELECTROPHORESIS, V19, P1366, DOI 10.1002/elps.1150190828
   Zinger L, 2008, J MICROBIOL METH, V73, P209, DOI 10.1016/j.mimet.2008.03.001
   Zinger L, 2008, J MICROBIOL METH, V72, P42, DOI 10.1016/j.mimet.2007.10.005
   Zinger L, 2007, MICROB ECOL, V54, P203, DOI 10.1007/s00248-006-9151-8
NR 147
TC 7
Z9 7
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD SEP
PY 2009
VL 9
IS 5
BP 740
EP 747
DI 10.1016/j.meegid.2009.05.005
PG 8
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA 487KD
UT WOS:000269271400002
PM 19454324
DA 2024-11-01
ER

PT J
AU Kierdaszuk, B
   Jamrozik, Z
   Tonska, K
   Bartnik, E
   Kaliszewska, M
   Kaminska, A
   Kwiecinski, H
AF Kierdaszuk, Biruta
   Jamrozik, Zygmunt
   Tonska, Katarzyna
   Bartnik, Ewa
   Kaliszewska, Magdalena
   Kaminska, Anna
   Kwiecinski, Hubert
TI Mitochondrial cytopathies: clinical, morphological and genetic
   characteristics
SO NEUROLOGIA I NEUROCHIRURGIA POLSKA
LA English
DT Article
DE mitochondrial cytopathies; skeletal muscle biopsy; ragged-red fibres;
   mitochondrial DNA
ID DISORDERS; MUTATIONS; DISEASES
AB Background and purpose: Mitochondrial cytopathies are heterogeneous disorders affecting multiple systems but most commonly involving the skeletal muscle and central nervous system. The variety of symptoms and signs requires biochemical, morphological and genetic evaluation. The results of genetic studies indicate that there is no direct correlation between genotype and phenotype in mitochondrial cytopathies. This study is the first such analysis of a group of Polish patients with mitochondrial cytopathies. Its aim is to define the clinical features of mitochondrial cytopathies in relation to their genetic defects.
   Material and methods: In a retrospective study, 46 patients with final diagnosis of mitochondrial cytopathy were evaluated clinically and electrophysiologically. Each patient underwent electromyography, electroneurography, and some patients were also assessed using electroencephalography. Clinical diagnoses were confirmed through the histopathological evaluation of muscle biopsies. In 36 cases mitochondrial DNA (mtDNA) testing was performed.
   Results: Eight different clinical syndromes were diagnosed among the evaluated patients. In the skeletal muscle biopsy, ragged-red fibres, which are a significant symptom for these disorders, were present in the majority of cases (93%). The presence of specific gene mutations was confirmed in 9 out of the 36 cases in which mtDNA was examined.
   Conclusions: The results of our study confirm the remarkable clinical heterogeneity of mitochondrial cytopathies. Final diagnosis in many cases Could only be confirmed by detection of the genetic defects. Molecular diagnosis may in the future have a significant impact on new therapeutic approaches.
C1 [Kierdaszuk, Biruta; Jamrozik, Zygmunt; Kaminska, Anna; Kwiecinski, Hubert] Warszawski Uniwersytet Med, Neurol Klin, PL-02097 Warsaw, Poland.
   [Tonska, Katarzyna; Bartnik, Ewa; Kaliszewska, Magdalena] Uniwersytet Warszawski, Inst Genet & Biotechnol, PL-02097 Warsaw, Poland.
C3 University of Warsaw
RP Kierdaszuk, B (corresponding author), Warszawski Uniwersytet Med, Neurol Klin, Ul Banacha 1A, PL-02097 Warsaw, Poland.
EM bi_ruta@vp.pl
OI Kaliszewska, Magdalena/0000-0003-3649-4375; Tonska,
   Katarzyna/0000-0002-1793-6089
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Chinnery PF, 1999, J MED GENET, V36, P425
   Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DUBOWITZ V, 2007, MUSCLE BIOPSY PRACTI, P481
   Lacomis D, 2002, NEUROL CLIN, V20, P587, DOI 10.1016/S0733-8619(01)00013-5
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Maceluch Jaros Aw, 2006, Pediatr Endocrinol Rev, V4, P117
   Mancuso M, 2007, BIOSCIENCE REP, V27, P31, DOI 10.1007/s10540-007-9035-2
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   *MITOMAP, MITOMAP HUM MIT GEN
   Naviaux RK, 2004, MITOCHONDRION, V4, P351, DOI 10.1016/j.mito.2004.07.002
   *NEUR DIS CTR, MIT DIS
   ROWLAND LP, 2005, MERRITTS NEUROLOGY, P695
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   Sciacco M, 2001, J NEUROL, V248, P778, DOI 10.1007/s004150170094
   Soong N W, 1996, Methods Enzymol, V264, P421, DOI 10.1016/S0076-6879(96)64038-5
   WALLACE DC, 1994, J BIOENERG BIOMEMBR, V26, P241, DOI 10.1007/BF00763096
NR 19
TC 7
Z9 7
U1 0
U2 3
PU TERMEDIA PUBLISHING HOUSE LTD
PI POZNAN
PA WENEDOW ST 9-1, POZNAN, 61-614, POLAND
SN 0028-3843
J9 NEUROL NEUROCHIR POL
JI Neurol. Neurochir. Pol.
PD MAY-JUN
PY 2009
VL 43
IS 3
BP 216
EP 227
PG 12
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 549FG
UT WOS:000274031300002
PM 19618304
DA 2024-11-01
ER

PT J
AU Jarrett, SG
   Lewin, AS
   Boulton, ME
AF Jarrett, Stuart G.
   Lewin, Alfred S.
   Boulton, Michael E.
TI The Importance of Mitochondria in Age-Related and Inherited Eye
   Disorders
SO OPHTHALMIC RESEARCH
LA English
DT Article
DE Mitochondria; Ocular function; Reactive oxygen species
ID RETINAL-PIGMENT EPITHELIUM; DNA-POLYMERASE-GAMMA; HEREDITARY OPTIC
   NEUROPATHY; BASE EXCISION-REPAIR; OXIDATIVE STRESS;
   SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; NUCLEAR-DNA; MACULAR
   DEGENERATION; PROGRESSIVE STAGES
AB Mitochondria are critical for ocular function as they represent the major source of a cell's supply of energy and play an important role in cell differentiation and survival. Mitochondrial dysfunction can occur as a result of inherited mitochondrial mutations (e.g. Leber's hereditary optic neuropathy and chronic progressive external ophthalmoplegia) or stochastic oxidative damage which leads to cumulative mitochondrial damage and is an important factor in age-related disorders (e.g. age-related macular degeneration, cataract and diabetic retinopathy). Mitochondrial DNA (mtDNA) instability is an important factor in mitochondrial impairment culminating in age-related changes and pathology, and in all regions of the eye mtDNA damage is increased as a consequence of aging and age-related disease. It is now apparent that the mitochondrial genome is a weak link in the defenses of ocular cells since it is susceptible to oxidative damage and it lacks some of the systems that protect the nuclear genome, such as nucleotide excision repair. Accumulation of mitochondrial mutations leads to cellular dysfunction and increased susceptibility to adverse events which contribute to the pathogenesis of numerous sporadic and chronic disorders in the eye. Copyright (C) 2010 S. Karger AG, Basel
C1 [Boulton, Michael E.] Univ Florida, Dept Anat & Cell Biol, Coll Med, Gainesville, FL 32610 USA.
   [Jarrett, Stuart G.] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY USA.
   [Lewin, Alfred S.] Univ Florida, Dept Mol Genet, Gainesville, FL 32610 USA.
C3 State University System of Florida; University of Florida; University of
   Kentucky; State University System of Florida; University of Florida
RP Boulton, ME (corresponding author), Univ Florida, Dept Anat & Cell Biol, Coll Med, POB 100235, Gainesville, FL 32610 USA.
EM meboulton@ufl.edu
OI Lewin, Alfred/0000-0002-4192-9727; Jarrett, Stuart/0000-0001-8029-1554
FU NIH [EY019688]
FX This work was supported by NIH grant EY019688.
CR Abner CW, 2004, DNA REPAIR, V3, P1141, DOI 10.1016/j.dnarep.2004.03.009
   Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P2533, DOI 10.1167/iovs.05-1639
   Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Ballinger SW, 1999, EXP EYE RES, V68, P765, DOI 10.1006/exer.1998.0661
   Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960
   Barreau E, 1996, INVEST OPHTH VIS SCI, V37, P384
   Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Beckman KB, 1998, ANN NY ACAD SCI, V854, P118, DOI 10.1111/j.1749-6632.1998.tb09897.x
   Bedlack RS, 2004, MUSCLE NERVE, V29, P364, DOI 10.1002/mus.10546
   Besch D, 2000, OPHTHALMOLOGE, V97, P27, DOI 10.1007/PL00007105
   Bohr VA, 2007, NEUROSCIENCE, V145, P1183, DOI 10.1016/j.neuroscience.2007.03.015
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Bosch-Morell F, 2002, FREE RADICAL BIO MED, V33, P669, DOI 10.1016/S0891-5849(02)00954-1
   Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034
   BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3
   Brennan LA, 2009, EXP EYE RES, V88, P195, DOI 10.1016/j.exer.2008.05.018
   Burkhalter MD, 2009, DNA REPAIR, V8, P1258, DOI 10.1016/j.dnarep.2009.07.009
   Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2001, J NEUROL NEUROSUR PS, V71, P813, DOI 10.1136/jnnp.71.6.813
   Carelli V, 2001, OPHTHALMOLOGY, V108, P1172, DOI 10.1016/S0161-6420(01)00618-2
   Carelli V, 2007, BIOSCIENCE REP, V27, P173, DOI 10.1007/s10540-007-9045-0
   Cavelier L, 2000, EXP CELL RES, V259, P79, DOI 10.1006/excr.2000.4949
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   CHEN EP, 1992, CURR EYE RES, V11, P825, DOI 10.3109/02713689209033480
   Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Decanini A, 2007, AM J OPHTHALMOL, V143, P607, DOI 10.1016/j.ajo.2006.12.006
   Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Ellis EA, 2000, FREE RADICAL BIO MED, V28, P91, DOI 10.1016/S0891-5849(99)00216-6
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   ESTABROOK RW, 1962, BIOCHIM BIOPHYS ACTA, V60, P249, DOI 10.1016/0006-3002(62)90400-6
   Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012
   Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515
   Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   GERSCHMAN R, 1954, P SOC EXP BIOL MED, V86, P27
   GERSCHMAN R, 1954, SCIENCE, V119, P623, DOI 10.1126/science.119.3097.623
   Godley BF, 2005, J BIOL CHEM, V280, P21061, DOI 10.1074/jbc.M502194200
   Godley BF, 2008, INVEST OPHTHALMOL VI, V49
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   GREEN K, 1995, OPHTHALMIC RES, V27, P143, DOI 10.1159/000267860
   Grishko VI, 2005, J BIOL CHEM, V280, P8901, DOI 10.1074/jbc.M413022200
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Gusdon AM, 2008, J BIOL CHEM, V283, P10690, DOI 10.1074/jbc.M708801200
   Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harrison JF, 2005, NUCLEIC ACIDS RES, V33, P4660, DOI 10.1093/nar/gki759
   Hightower KR, 1999, PHOTOCHEM PHOTOBIOL, V69, P595, DOI 10.1111/j.1751-1097.1999.tb03333.x
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   HOWELL N, 1991, AM J HUM GENET, V49, P939
   HOWELL N, 1993, AM J HUM GENET, V53, P959
   Huang L, 2006, FREE RADICAL BIO MED, V41, P926, DOI 10.1016/j.freeradbiomed.2006.05.023
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Jarrett SG, 2005, FREE RADICAL BIO MED, V38, P1382, DOI 10.1016/j.freeradbiomed.2005.02.003
   Jarrett SG, 2007, OPHTHALMIC RES, V39, P213, DOI 10.1159/000104683
   Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001
   Johns D R, 1995, Semin Ophthalmol, V10, P295, DOI 10.3109/08820539509063800
   Jones M, 2004, AM J OPHTHALMOL, V138, P1051, DOI 10.1016/j.ajo.2004.06.026
   Jones MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1235, DOI 10.1001/archopht.125.9.1235
   Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432
   Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104
   Kanwar M, 2007, INVEST OPHTH VIS SCI, V48, P3805, DOI 10.1167/iovs.06-1280
   KERRISON JB, 1995, OPHTHALMOLOGY, V102, P1509
   Khurana RN, 2008, INVEST OPHTH VIS SCI, V49, P3299, DOI 10.1167/iovs.07-1607
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   Kong GYX, 2009, J GLAUCOMA, V18, P93, DOI 10.1097/IJG.0b013e318181284f
   Kortvely E, 2010, INVEST OPHTH VIS SCI, V51, P79, DOI 10.1167/iovs.09-3850
   Kowluru RA, 2006, INVEST OPHTH VIS SCI, V47, P1594, DOI 10.1167/iovs.05-1276
   Kowluru RA, 2005, ANTIOXID REDOX SIGN, V7, P1581, DOI 10.1089/ars.2005.7.1581
   Kowluru RA, 2003, INVEST OPHTH VIS SCI, V44, P5327, DOI 10.1167/iovs.03-0353
   Kowluru RA, 2003, DIABETES, V52, P818, DOI 10.2337/diabetes.52.3.818
   Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603
   Kowluru RA, 2006, FREE RADICAL BIO MED, V41, P1191, DOI 10.1016/j.freeradbiomed.2006.01.012
   Kowluru RA, 2010, BRAIN RES BULL, V81, P297, DOI 10.1016/j.brainresbull.2009.05.006
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Lascaratos G, 2007, VISION RES, V47, P1191, DOI 10.1016/j.visres.2006.12.014
   LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967
   Lee HC, 2007, EXP BIOL MED, V232, P592
   Liang FQ, 2005, EXP EYE RES, V80, P113, DOI 10.1016/j.exer.2004.08.017
   Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X
   Liang LP, 2004, J NEUROCHEM, V90, P1076, DOI 10.1111/j.1471-4159.2004.02567.x
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200
   Liu ZR, 2008, MOL VIS, V14, P1995
   Lou MF, 2003, PROG RETIN EYE RES, V22, P657, DOI 10.1016/S1350-9462(03)00050-8
   Mackey DA, 1996, AM J HUM GENET, V59, P481
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001
   Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167
   Mathews CE, 2005, DIABETOLOGIA, V48, P261, DOI 10.1007/s00125-004-1644-8
   MCCORD JM, 1969, J BIOL CHEM, V244, P6056
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   Min D B, 2002, Compr Rev Food Sci Food Saf, V1, P58, DOI 10.1111/j.1541-4337.2002.tb00007.x
   Mittag TW, 2000, INVEST OPHTH VIS SCI, V41, P3451
   Monsalve M, 2007, FRONT BIOSCI-LANDMRK, V12, P1131, DOI 10.2741/2132
   Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871
   Nishikawa T, 2007, DIABETES RES CLIN PR, V77, pS41, DOI 10.1016/j.diabres.2007.01.031
   Nordgaard CL, 2006, INVEST OPHTH VIS SCI, V47, P815, DOI 10.1167/iovs.05-0976
   Nordgaard CL, 2008, INVEST OPHTH VIS SCI, V49, P2848, DOI 10.1167/iovs.07-1352
   OCONNOR GR, 1983, AM J OPHTHALMOL, V96, P577, DOI 10.1016/S0002-9394(14)73415-4
   Ohia SE, 2005, MUTAT RES-FUND MOL M, V579, P22, DOI 10.1016/j.mrfmmm.2005.03.025
   Osborne NN, 2006, BRIT J OPHTHALMOL, V90, P237, DOI 10.1136/bjo.2005.082230
   Panahi MSS, 2006, ARCH MED RES, V37, P1028, DOI 10.1016/j.arcmed.2006.04.009
   Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5
   Puomila A, 2002, J NEUROL SCI, V205, P41, DOI 10.1016/S0022-510X(02)00276-9
   Rajendram R, 2007, BRIT J OPHTHALMOL, V91, P531, DOI 10.1136/bjo.2006.101576
   Reddan JR, 1999, EXP EYE RES, V68, P117, DOI 10.1006/exer.1998.0606
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SanGiovanni JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005508
   Santos DL, 2003, MOL CELL BIOCHEM, V246, P163, DOI 10.1023/A:1023475022025
   Santosa S, 2005, CAN MED ASSOC J, V173, P861, DOI 10.1503/cmaj.1031425
   Saraswathy S, 2009, INVEST OPHTH VIS SCI, V50, P5559, DOI 10.1167/iovs.08-2842
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Simpkins JW, 2005, CNS NEUROL DISORD-DR, V4, P69, DOI 10.2174/1568007053005073
   SPECTOR A, 1995, FASEB J, V9, P1173, DOI 10.1096/fasebj.9.12.7672510
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stitt AW, 2005, PHARMACOL REP, V57, P156
   Stuart JA, 2005, NUCLEIC ACIDS RES, V33, P3722, DOI 10.1093/nar/gki683
   Tatton W, 2001, SURV OPHTHALMOL, V45, pS295
   Tatton WG, 2001, SURV OPHTHALMOL, V45, pS277, DOI 10.1016/S0039-6257(01)00207-7
   Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197
   Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010
   TOMKINSON AE, 1990, NUCLEIC ACIDS RES, V18, P929, DOI 10.1093/nar/18.4.929
   TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0
   Uchigata Y, 2002, DIABETES CARE, V25, P2106, DOI 10.2337/diacare.25.11.2106
   Udar N, 2009, INVEST OPHTH VIS SCI, V50, P2966, DOI 10.1167/iovs.08-2646
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Wang AL, 2008, MOL VIS, V14, P644
   Whiteside CL, 2005, CURR HYPERTENS REP, V7, P148, DOI 10.1007/s11906-005-0090-4
   Williams DL, 2008, VET CLIN N AM-SMALL, V38, P179, DOI 10.1016/j.cvsm.2007.10.006
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yao K, 2009, AM J CHINESE MED, V37, P785, DOI 10.1142/S0192415X09007247
   Yorek MA, 2003, FREE RADICAL RES, V37, P471, DOI 10.1080/1071576031000083161
NR 147
TC 83
Z9 94
U1 0
U2 20
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0030-3747
EI 1423-0259
J9 OPHTHALMIC RES
JI Ophthalmic Res.
PY 2010
VL 44
IS 3
BP 179
EP 190
DI 10.1159/000316480
PG 12
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 652AN
UT WOS:000281972300006
PM 20829642
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Wang, PL
   Castellani, CA
   Yao, J
   Huan, TX
   Bielak, LF
   Zhao, W
   Haessler, J
   Joehanes, R
   Sun, XB
   Guo, XQ
   Longchamps, RJ
   Manson, JE
   Grove, ML
   Bressler, J
   Taylor, KD
   Lappalainen, T
   Kasela, S
   Van den Berg, DJ
   Hou, LF
   Reiner, A
   Liu, YM
   Boerwinkle, E
   Smith, JA
   Peyser, PA
   Fornage, M
   Rich, SS
   Rotter, JI
   Kooperberg, C
   Arking, DE
   Levy, D
   Liu, CY
AF Wang, Penglong
   Castellani, Christina A.
   Yao, Jie
   Huan, Tianxiao
   Bielak, Lawrence F.
   Zhao, Wei
   Haessler, Jeffrey
   Joehanes, Roby
   Sun, Xianbang
   Guo, Xiuqing
   Longchamps, Ryan J.
   Manson, JoAnn E.
   Grove, Megan L.
   Bressler, Jan
   Taylor, Kent D.
   Lappalainen, Tuuli
   Kasela, Silva
   Van den Berg, David J.
   Hou, Lifang
   Reiner, Alexander
   Liu, Yongmei
   Boerwinkle, Eric
   Smith, Jennifer A.
   Peyser, Patricia A.
   Fornage, Myriam
   Rich, Stephen S.
   Rotter, Jerome, I
   Kooperberg, Charles
   Arking, Dan E.
   Levy, Daniel
   Liu, Chunyu
CA NHLBI Trans-Omics Precision Med TO
TI Epigenome-wide association study of mitochondrial genome copy number
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID DNA METHYLATION; GENE-EXPRESSION; ATHEROSCLEROSIS RISK;
   PERIPHERAL-BLOOD; SKELETAL-MUSCLE; DESIGN; HEALTH; TRANSCRIPTION;
   INTERFACE; DISCOVERY
AB We conducted cohort- and race-specific epigenome-wide association analyses of mitochondrial deoxyribonucleic acid (mtDNA) copy number (mtDNA CN) measured in whole blood from participants of African and European origins in five cohorts (n = 6182, mean age = 57-67 years, 65% women). In the meta-analysis of all the participants, we discovered 21 mtDNA CN-associated DNA methylation sites (CpG) (P < 1 x 10(-7)), with a 0.7-3.0 standard deviation increase (3 CpGs) or decrease (18 CpGs) in mtDNA CN corresponding to a 1% increase in DNA methylation. Several significant CpGs have been reported to be associated with at least two risk factors (e.g. chronological age or smoking) for cardiovascular disease (CVD). Five genes [PR/SET domain 16, nuclear receptor subfamily 1 group H member 3 (NR1H3), DNA repair protein, DNA polymerase kappa and decaprenyl-diphosphate synthase subunit 2], which harbor nine significant CpGs, are known to be involved in mitochondrial biosynthesis and functions. For example, NR1H3 encodes a transcription factor that is differentially expressed during an adipose tissue transition. The methylation level of cg09548275 in NR1H3 was negatively associated with mtDNA CN (effect size = -1.71, P = 4 x 10(-8)) and was positively associated with the NR1H3 expression level (effect size = 0.43, P = 0.0003), which indicates that the methylation level in NR1H3 may underlie the relationship between mtDNA CN, the NR1H3 transcription factor and energy expenditure. In summary, the study results suggest that mtDNA CN variation in whole blood is associated with DNA methylation levels in genes that are involved in a wide range of mitochondrial activities. These findings will help reveal molecular mechanisms between mtDNA CN and CVD.
C1 [Wang, Penglong; Huan, Tianxiao; Joehanes, Roby; Levy, Daniel] NHLBI, Populat Sci Branch, NIH, Bethesda, MD 20892 USA.
   [Castellani, Christina A.; Longchamps, Ryan J.; Arking, Dan E.] Johns Hopkins Univ, McKusick Nathans Dept Genet Med, Sch Med, Baltimore, MD 21287 USA.
   [Castellani, Christina A.; Taylor, Kent D.] Western Univ, Dept Pathol & Lab Med, London, ON N6A 5C1, Canada.
   [Yao, Jie; Guo, Xiuqing; Rotter, Jerome, I] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Dept Pediat, Lundquist Inst Biomed Innovat, Torrance, CA 90502 USA.
   [Bielak, Lawrence F.; Zhao, Wei; Smith, Jennifer A.; Peyser, Patricia A.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Haessler, Jeffrey; Reiner, Alexander; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA.
   [Sun, Xianbang; Liu, Chunyu] Boston Univ, Dept Biostat, Boston, MA 02118 USA.
   [Manson, JoAnn E.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Grove, Megan L.; Bressler, Jan; Boerwinkle, Eric; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA.
   [Lappalainen, Tuuli; Kasela, Silva] New York Genome Ctr, New York, NY 10013 USA.
   [Lappalainen, Tuuli; Kasela, Silva] Columbia Univ, Dept Syst Biol, New York, NY 10034 USA.
   [Van den Berg, David J.] Univ Southern Calif, Ctr Genet Epidemiol, Keck Sch Med USC, Dept Populat & Publ Hlth Sci, Los Angeles, CA 90033 USA.
   [Hou, Lifang] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Liu, Yongmei] Duke Univ, Dept Med, Div Cardiol, Med Ctr, Durham, NC 27704 USA.
   [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.
   [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, McGovern Med Sch, Houston, TX 77030 USA.
   [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA.
   [Levy, Daniel; Liu, Chunyu] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Heart Lung &
   Blood Institute (NHLBI); Johns Hopkins University; Western University
   (University of Western Ontario); University of California System;
   University of California Los Angeles; University of California Los
   Angeles Medical Center; University of Michigan System; University of
   Michigan; Fred Hutchinson Cancer Center; Boston University; Harvard
   University; Harvard T.H. Chan School of Public Health; University of
   Texas System; University of Texas Health Science Center Houston;
   University of Texas School Public Health; Columbia University;
   University of Southern California; Northwestern University; Feinberg
   School of Medicine; Duke University; Baylor College of Medicine;
   University of Texas System; University of Texas Health Science Center
   Houston; University of Virginia; National Institutes of Health (NIH) -
   USA; NIH National Heart Lung & Blood Institute (NHLBI); Framingham Heart
   Study
RP Liu, CY (corresponding author), Boston Univ, Dept Biostat, Sch Publ Hlth, 801 Massachusetts Ave,3rd Floor, Boston, MA 02118 USA.
EM liuc@bu.edu
RI Reiner-Benaim, Anat/HGQ-1183-2022; Van Den Berg, David/G-8598-2017;
   Boerwinkle, Eric/B-9599-2015; Levy, Daniel/ABF-6873-2021; Huan,
   Tianxiao/AAF-3577-2021; Ripke, Stephan/AAK-5486-2021; Rotter,
   Jerome/AAY-6598-2021
OI Rich, Stephen/0000-0003-3872-7793; Levy, Daniel/0000-0003-1843-8724;
   Smith, Jennifer Ann/0000-0002-3575-5468; Lappalainen,
   Tuuli/0000-0002-7746-8109
FU National Heart, Lung, and Blood Institute [R01HL105756, R01HL155569]
FX Core support, including centralized genomic read mapping and genotype
   calling, along with variant quality metrics and filtering were provided
   by the IRC (3R01HL-11762602S1; contract HHSN268201800002I). Core
   support, including phenotype harmonization, data management,
   sample-identity QC and general program coordination, were provided by
   the TOPMed Data Coordinating Center (R01HL-120393; U01HL120393; contract
   HHSN268201800001I). Infrastructure for the CHARGE Consortium is
   supported in part by the National Heart, Lung, and Blood Institute grant
   R01HL105756. Statistical analyses in this study are partly supported by
   supported by R01HL155569.
CR Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61
   [Anonymous], 2007, LINEAR NONLINEAR MIX
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Bartolomé MA, 2002, OBES SURG, V12, P324, DOI 10.1381/096089202321088084
   Basse AL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1405-8
   Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008
   Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887
   Battram T, 2021, OSF PREPR, DOI 10.31219/osf.io/837wn
   Bellizzi D, 2012, EPIGENOMICS-UK, V4, P17, DOI [10.2217/EPI.11.109, 10.2217/epi.11.109]
   Benton MC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0569-x
   Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518
   Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045
   Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007
   Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14
   Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113
   Blokhin A, 2008, J MOL NEUROSCI, V35, P283, DOI 10.1007/s12031-008-9115-1
   Breeze CE, 2019, BIOINFORMATICS, V35, P4767, DOI 10.1093/bioinformatics/btz456
   Castellani CA, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00778-7
   Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470
   D'Agostino Sabrina, 2018, Oncotarget, V9, P23334, DOI 10.18632/oncotarget.25101
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Daniels PR, 2004, AM J MED, V116, P676, DOI 10.1016/j.amjmed.2003.12.032
   Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x
   Ding J, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005306, 10.1371/journal.pgen.1005549]
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7
   Hemani G., 2020, MENDELIAN RANDOMIZAT
   HONDA H, 1994, BLOOD, V84, P4186, DOI 10.1182/blood.V84.12.4186.bloodjournal84124186
   Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86
   Huan TX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12228-z
   Joehanes R, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1142-6
   Joehanes R, 2013, ARTERIOSCL THROM VAS, V33, P1418, DOI 10.1161/ATVBAHA.112.301169
   Kasiviswanathan R, 2012, BBA-GENE REGUL MECH, V1819, P970, DOI 10.1016/j.bbagrm.2011.12.005
   Kuan PF, 2010, BIOINFORMATICS, V26, P2849, DOI 10.1093/bioinformatics/btq553
   Lee W, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.34
   Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161
   Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li Y, 2018, CANCER RES, V78, P4471, DOI 10.1158/0008-5472.CAN-17-2172
   Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533
   Longchamps R.J., 2021, GENOME WIDE ANAL MIT, DOI [10.1101/2021.01.25.428086, DOI 10.1101/2021.01.25.428086]
   Longchamps RJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228166
   Martens JHA, 2013, HAEMATOLOGICA, V98, P1487, DOI 10.3324/haematol.2013.094243
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038
   Mishra A, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00489-17
   Monickaraj F, 2012, MOL CELL BIOCHEM, V365, P343, DOI 10.1007/s11010-012-1276-0
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112
   Morrison AC, 2013, NAT GENET, V45, P899, DOI 10.1038/ng.2671
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pagliarini DJ, 2013, GENE DEV, V27, P2615, DOI 10.1101/gad.229724.113
   Peng M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000061
   Permuth-Wey J, 2011, CANCER EPIDEM BIOMAR, V20, P1131, DOI 10.1158/1055-9965.EPI-10-1224
   Petersen MH, 2014, MITOCHONDRION, V17, P14, DOI 10.1016/j.mito.2014.05.001
   Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685
   Price EM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-4
   Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033
   Rajao MA, 2009, MOL MICROBIOL, V71, P185, DOI 10.1111/j.1365-2958.2008.06521.x
   Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769
   Rodríguez-Hernández A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174
   Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846
   Schwarze G, 2015, GEN PACKAGE METAANAL
   Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001
   SHERRATT HSA, 1991, REV NEUROL, V147, P417
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021
   Sun X, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0223-z
   Taguchi Y, 2005, BIOINFORMATICS, V21, P730, DOI 10.1093/bioinformatics/bti067
   Taliun D, 2021, NATURE, V590, DOI 10.1038/s41586-021-03205-y
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tin A, 2016, J AM SOC NEPHROL, V27, P2467, DOI 10.1681/ASN.2015060661
   Vivian CJ, 2017, CANCER RES, V77, P6202, DOI 10.1158/0008-5472.CAN-17-1473
   WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184
   Yang SY, 2021, GENOME RES, V31, P349, DOI 10.1101/gr.269381.120
   Yao J., 2020, ASS MITOCHONDRIAL DN, DOI [10.1101/2020.04.20.20016337, DOI 10.1101/2020.04.20.20016337]
   Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613
NR 79
TC 5
Z9 5
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JAN 15
PY 2022
VL 31
IS 2
BP 309
EP 319
DI 10.1093/hmg/ddab240
EA AUG 2021
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA YI5XZ
UT WOS:000743922000013
PM 34415308
OA Green Published
DA 2024-11-01
ER

PT J
AU Chang, XL
   Wu, YX
   Zhou, J
   Meng, HX
   Zhang, W
   Guo, JH
AF Chang, Xueli
   Wu, Yaxin
   Zhou, Jie
   Meng, Huaxing
   Zhang, Wei
   Guo, Junhong
TI A meta-analysis and systematic review of Leigh syndrome: clinical
   manifestations, respiratory chain enzyme complex deficiency, and gene
   mutations
SO MEDICINE
LA English
DT Article
DE clinical features; gene mutations; Leigh syndrome; mitochondrial
   respiratory chain enzyme complex
ID MITOCHONDRIAL DISORDERS; DIAGNOSIS; CHILDREN
AB Leigh syndrome (also called Leigh disease or subacute necrotizing encephalomyelopathy) is a rare inherited neurometabolic disorder, which affects the central nervous system. This meta-study systematically analyzed clinical manifestations, respiratory chain enzyme complex deficiency, and gene mutations.Literature was searched for publications in MEDLINE, EMBASE, and the China National Knowledge Infrastructure database for meta-analyses of the incidence of clinical symptoms, laboratory assessments, imaging data, muscle biopsy histochemical staining, activity of the mitochondrial respiratory chain enzyme complex, gene mutations, and the association between age at disease onset and type of gene mutations.This study included 5 studies with 385 Leigh syndrome patients. The most common clinical features of Leigh syndrome included elevated blood and/or cerebrospinal fluid (CSF) levels of lactate (72%), developmental retardation (57%), hypotonia (42%), followed by respiratory dysfunction (34%), epileptic seizures (33%), poor feeding (29%), and weakness (27%). Approximately 80% of the patients had deficiencies of the respiratory chain enzyme complex or isolated complex I deficiency (35%), 32% had mitochondrial DNA (mtDNA) mutations, and 38% had nuclear DNA (nDNA) mutations. Patients with nDNA mutations were younger than those with mtDNA mutations (8.82 13.88 vs 26.20 +/- 41.11 years, P=.007).The data from the current meta-analysis demonstrated a variety of clinical and molecular manifestations of Leigh syndrome, with upregulated lactate levels in the blood or CSF being the most common feature. Diagnosis of Leigh syndrome could be confirmed using combined enzymatic and genetic analyses.
C1 [Chang, Xueli; Zhou, Jie; Meng, Huaxing; Zhang, Wei; Guo, Junhong] Shanxi Med Univ, Hosp 1, Dept Neurol, 85 Jiefang South Rd, Taiyuan 030001, Shanxi, Peoples R China.
   [Wu, Yaxin] First Peoples Hosp Xianyang, Xianyang, Shaanxi, Peoples R China.
C3 Shanxi Medical University
RP Guo, JH (corresponding author), Shanxi Med Univ, Hosp 1, Dept Neurol, 85 Jiefang South Rd, Taiyuan 030001, Shanxi, Peoples R China.
EM neuroguo@163.com
RI Guo, Junhong/O-6316-2017
CR Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Dahl HHM, 1998, AM J HUM GENET, V63, P1594, DOI 10.1086/302169
   Fang F, 2017, Zhonghua Er Ke Za Zhi, V55, P205, DOI 10.3760/cma.j.issn.0578-1310.2017.03.008
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Gerards M, 2016, MOL GENET METAB, V117, P300, DOI 10.1016/j.ymgme.2015.12.004
   Goldenberg PC, 2003, NEUROLOGY, V60, P865, DOI 10.1212/01.WNL.0000049460.72439.7F
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   Jin TR, 2014, J CHILD NEUROL, V29, pNP143, DOI 10.1177/0883073813512524
   Jüni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lee HF, 2009, PEDIATR NEUROL, V40, P88, DOI 10.1016/j.pediatrneurol.2008.09.020
   Lee JS, 2016, J CLIN NEUROL, V12, P181, DOI 10.3988/jcn.2016.12.2.181
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Loney P L, 1998, Chronic Dis Can, V19, P170
   Ma YY, 2013, J CLIN NEUROSCI, V20, P1591, DOI 10.1016/j.jocn.2013.03.034
   Mak SC, 1998, J CHILD NEUROL, V13, P349, DOI 10.1177/088307389801300709
   MONTPETIT VJ, 1971, BRAIN, V94, P1, DOI 10.1093/brain/94.1.1
   Ogawa E, 2017, J INHERIT METAB DIS, V40, P685, DOI 10.1007/s10545-017-0042-6
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Richardson WS, 2003, J GEN INTERN MED, V18, P203, DOI 10.1046/j.1525-1497.2003.20215.x
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Sobreira C, 2009, J NEUROL SCI, V278, P132, DOI 10.1016/j.jns.2008.11.023
   Sofou K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-52
   Sofou K, 2013, MITOCHONDRION, V13, P364, DOI 10.1016/j.mito.2013.04.008
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Yang YL, 2006, CHINESE MED J-PEKING, V119, P373, DOI 10.1097/00029330-200603010-00004
NR 27
TC 37
Z9 41
U1 0
U2 24
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD JAN
PY 2020
VL 99
IS 5
AR e18634
DI 10.1097/MD.0000000000018634
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA LD1BP
UT WOS:000525767500014
PM 32000367
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Durhuus, JA
   Desler, C
   Rasmussen, LJ
AF Durhuus, Jon Ambaek
   Desler, Claus
   Rasmussen, Lene Juel
TI Mitochondria in Health and Disease-3rd Annual Conference of Society for
   Mitochondrial Research and Medicine-19-20 December 2013-Bengaluru, India
SO MITOCHONDRION
LA English
DT Article
DE Mitochondria; Tumorigenesis; Premature aging; Metabolic regulation;
   Neurological degeneration; Current and future strategies for diagnosis
   and treatment
ID DNA; CELLS; DELETIONS; MYOPATHY; MUSCLE
AB The primary role of mitochondria was long considered to be production of cellular energy. However, as the understanding of mitochondria in disease is ever expanding, so is their additional function for a healthy organism. Mitochondrial dysfunction is linked to a range of pathologies, including cancer, neurodegenerative disorders, premature aging, diabetes and muscular diseases. Mitochondrial diseases can be hard to diagnose and treat and, therefore, interdisciplinary research and communication are important. The Third Annual Conference of Society for Mitochondrial Research and Medicine India (SMRM) was titled "Mitochondria in Health and Disease". The conference was organized by Gayathri N, K Thangaraj, and la Singh and was held at the National Institute of Mental Health 82 Neuro Sciences (NIMHANS) in Bangalore, India, from the 19th to 20th of December 2013. The meeting featured internationally renowned speakers within the field of mitochondrial research and medicine with the goal of bridging the gap between basic and clinical researchers. This review summarizes key outcomes of the conference. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Durhuus, Jon Ambaek; Desler, Claus; Rasmussen, Lene Juel] Univ Copenhagen, Ctr Hlth Aging, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark.
C3 University of Copenhagen
RP Rasmussen, LJ (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Dept Cellular & Mol Med, Bldg 18-1,Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.
EM lenera@sund.ku.dk
RI Durhuus, Jon/AAZ-8283-2021
OI Rasmussen, Lene Juel/0000-0001-6864-963X; desler,
   claus/0000-0002-0125-004X
CR Agrawal RK, 2012, CURR OPIN STRUC BIOL, V22, P797, DOI 10.1016/j.sbi.2012.08.003
   Ande S, 2014, FASEB J, V28
   Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792
   Bhalla S, 2009, BIOCHEM BIOPH RES CO, V385, P445, DOI 10.1016/j.bbrc.2009.05.083
   Chakrabarty S., 2014, MITOCHONDRION
   Chakrabarty S, 2012, GENE, V500, P186, DOI 10.1016/j.gene.2012.03.054
   Davidson MM, 2009, MITOCHONDRION, V9, P463, DOI 10.1016/j.mito.2009.08.006
   Desler Claus, 2011, J Aging Res, V2011, P407536, DOI 10.4061/2011/407536
   Finsterer J, 2010, EUR J PAEDIATR NEURO, V14, P29, DOI 10.1016/j.ejpn.2009.07.005
   Gogada R, 2011, J BIOL CHEM, V286, P28749, DOI 10.1074/jbc.M110.202440
   Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jash S, 2012, FASEB J, V26, P4187, DOI 10.1096/fj.11-203232
   Jash S, 2011, MITOCHONDRION, V11, P607, DOI 10.1016/j.mito.2011.03.124
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kulawiec M, 2008, CANCER BIOL THER, V7, P1732, DOI 10.4161/cbt.7.11.6729
   Ho L, 2013, AGING-US, V5, P835, DOI 10.18632/aging.100616
   Loyo-Berrios Nilsa I, 2007, WMJ, V106, P85
   Mahato B, 2011, MITOCHONDRION, V11, P564, DOI 10.1016/j.mito.2011.03.006
   Marrache S, 2013, P NATL ACAD SCI USA, V110, P9445, DOI 10.1073/pnas.1301929110
   Pesta D, 2011, AM J PHYSIOL-REG I, V301, pR1078, DOI 10.1152/ajpregu.00285.2011
   Piyathilake C, 2013, NUTR RES PRACT, V7, P315, DOI 10.4162/nrp.2013.7.4.315
   Piyathilake CJ, 2012, CANCER PREV RES, V5, P385, DOI 10.1158/1940-6207.CAPR-11-0387
   Prabhu V, 2013, MITOCHONDRION, V13, P493, DOI 10.1016/j.mito.2012.10.010
   Rai N, 2014, MITOCHONDRION, V14, P1, DOI 10.1016/j.mito.2013.12.002
   Singh PK, 2013, MOL BIOL CELL, V24, P3776, DOI 10.1091/mbc.E13-05-0261
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Uppin MS, 2008, NEUROL INDIA, V56, P391
   Wu YT, 2013, BBA-MOL BASIS DIS, V1832, P216, DOI 10.1016/j.bbadis.2012.10.002
NR 30
TC 7
Z9 8
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN
PY 2015
VL 20
BP 7
EP 12
DI 10.1016/j.mito.2014.10.004
PG 6
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA CA0UQ
UT WOS:000348632200002
PM 25446394
DA 2024-11-01
ER

PT J
AU Vantroys, E
   Smet, J
   Vanlander, AV
   Vergult, S
   De Bruyne, R
   Roels, F
   Stepman, H
   Roeyers, H
   Menten, B
   Van Coster, R
AF Vantroys, Elise
   Smet, Joel
   Vanlander, Arnaud V.
   Vergult, Sarah
   De Bruyne, Ruth
   Roels, Frank
   Stepman, Hedwig
   Roeyers, Herbert
   Menten, Bjorn
   Van Coster, Rudy
TI Severe hepatopathy and neurological deterioration after start of
   valproate treatment in a 6-year-old child with mitochondrial
   tryptophanyl-tRNA synthetase deficiency
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Article
DE Mitochondrial tryptophanyl-tRNA synthetase; WARS2; Mitochondria;
   Mitochondrial aminoacyl-tRNA synthetase; Valproate; Hepatotoxicity;
   Cytochrome c oxidase; Mosaic
ID ALPERS-SYNDROME; STATUS EPILEPTICUS; DNA DEPLETION; MUTATIONS; GENE;
   ENCEPHALOPATHY; DISEASE; LIVER; LEUKOENCEPHALOPATHY; MYOPATHY
AB Background: The first subjects with deficiency of mitochondrial tryptophanyl-tRNA synthetase (WARS2) were reported in 2017. Their clinical characteristics can be subdivided into three phenotypes (neonatal phenotype, severe infantile onset phenotype, Parkinson-like phenotype).
   Results: Here, we report on a subject who presented with early developmental delay, motor weakness and intellectual disability and who was considered during several years as having a non-progressive encephalopathy. At the age of six years, she had an epileptic seizure which was treated with sodium valproate. In the months after treatment was started, she developed acute liver failure and severe progressive encephalopathy. Although valproate was discontinued, she died six months later. Spectrophotometric analysis of the oxidative phosphorylation complexes in liver revealed a deficient activity of complex III and low normal activities of the complexes I and IV. Activity staining in the BN-PAGE gel confirmed the low activities of complex I, III and IV and, in addition, showed the presence of a subcomplex of complex V. Histochemically, a mosaic pattern was seen in hepatocytes after cytochrome c oxidase staining. Using Whole Exome Sequencing two known pathogenic variants were detected in WARS2 (c. 797delC, p. Pro266ArgfsTer10/c. 938 A > T, p. Lys313Met).
   Conclusion: This is the first report of severe hepatopathy in a subject with WARS2 deficiency. The hepatopathy occurred soon after start of sodium valproate treatment. In the literature, valproate-induced hepatotoxicity was reported in the subjects with pathogenic mutations in POLG and TWNK. This case report illustrates that the course of the disease in the subjects with a mitochondrial defect can be non-progressive during several years. The subject reported here was first diagnosed as having cerebral palsy. Only after a mitochondriotoxic medication was started, the disease became progressive, and the diagnosis of a mitochondrial defect was made.
C1 [Vantroys, Elise; Smet, Joel; Vanlander, Arnaud V.; Van Coster, Rudy] Ghent Univ Hosp, Dept Pediat Neurol & Metab, Ghent, Belgium.
   [Vergult, Sarah; Menten, Bjorn] Univ Ghent, Ctr Med Genet Ghent, Ghent, Belgium.
   [De Bruyne, Ruth] Ghent Univ Hosp, Dept Pediat Gastroenterol Hepatol & Nutr, Ghent, Belgium.
   [Roels, Frank] Ghent Univ Hosp, Dept Pathol, Ghent, Belgium.
   [Stepman, Hedwig] Ghent Univ Hosp, Dept Lab Med, Ghent, Belgium.
   [Roeyers, Herbert] Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium.
C3 Ghent University; Ghent University Hospital; Ghent University; Ghent
   University; Ghent University Hospital; Ghent University; Ghent
   University Hospital; Ghent University; Ghent University Hospital; Ghent
   University
RP Van Coster, R (corresponding author), Ghent Univ Hosp, Dept Pediat Neurol & Metab, Ghent, Belgium.
EM rudy.vancoster@ugent.be
RI Arnaud, Vanlander/ABB-5978-2021; Roeyers, Herbert/A-5557-2018; Menten,
   Björn/B-3072-2013; Smet, Joél/B-7428-2013; De Bruyne, Ruth/S-9144-2019
OI Vergult, Sarah/0000-0002-0816-6262; Vanlander,
   Arnaud/0000-0002-9520-5564; De Bruyne, Ruth/0000-0002-5623-3300
FU Marguerite-Marie Delacroix; Special Research Fund (BOF) from the Ghent
   University [BOF.24 J.2014.0005.02]; Fund for Scientific Research
   Flanders (FWO)
FX This work was supported by the support fund Marguerite-Marie Delacroix
   and the Special Research Fund (BOF) from the Ghent University (grant
   number BOF.24 J.2014.0005.02) (EV). SV was supported by a postdoctoral
   fellowship of the Fund for Scientific Research Flanders (FWO).
CR Bao XH, 2008, BRAIN DEV-JPN, V30, P295, DOI 10.1016/j.braindev.2007.08.009
   Bolar NA, 2013, HUM MOL GENET, V22, P2590, DOI 10.1093/hmg/ddt107
   Burke EA, 2017, CLIN GENET
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497
   DiMauro S., 1993, GENEREVIEWS
   Diodato Daria, 2014, Int J Cell Biol, V2014, P787956, DOI 10.1155/2014/787956
   Finsterer J, 2012, EXPERT OPIN DRUG MET, V8, P71, DOI 10.1517/17425255.2012.644535
   Gauthier-Villars M, 2001, NEUROPEDIATRICS, V32, P150, DOI 10.1055/s-2001-16614
   Krähenbühl S, 2000, LIVER, V20, P346, DOI 10.1034/j.1600-0676.2000.020004346.x
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   Martinez-Dominguez MT, 1998, CYTOGENET CELL GENET, V83, P249, DOI 10.1159/000015196
   Müller-Höcker J, 2011, J CELL MOL MED, V15, P445, DOI 10.1111/j.1582-4934.2009.00819.x
   Müller-Höcker J, 2002, HUM PATHOL, V33, P247, DOI 10.1053/hupa.2002.31477
   Musante L, 2017, HUM MUTAT
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nikali K., 1993, GeneReviews
   PONCHAUT S, 1992, BIOCHEM PHARMACOL, V43, P644, DOI 10.1016/0006-2952(92)90590-F
   Rasmussen M, 2000, J CHILD NEUROL, V15, P473, DOI 10.1177/088307380001500709
   Roels F, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-4
   Schaller A, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-4
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Theisen BE, 2017, AM J MED GENET A, V173, P2505, DOI 10.1002/ajmg.a.38339
   Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   van der Westhuizen FH, 2010, J INHERIT METAB DIS, V33, pS55, DOI 10.1007/s10545-009-9020-y
   Vanlander AV, 2015, HUM MUTAT, V36, P222, DOI 10.1002/humu.22728
   Vantroys E, 2017, MOL GENET METAB, V122, P172, DOI 10.1016/j.ymgme.2017.10.004
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   Wortmann SB, 2017, HUM MUTAT, V38, P1786, DOI 10.1002/humu.23340
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P99, DOI 10.1007/s10545-014-9759-7
NR 36
TC 14
Z9 16
U1 0
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1750-1172
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD MAY 21
PY 2018
VL 13
AR 80
DI 10.1186/s13023-018-0822-6
PG 9
WC Genetics & Heredity; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Research & Experimental Medicine
GA GH0ME
UT WOS:000433095900001
PM 29783990
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Kaufmann, P
   Shungu, DC
   Sano, MC
   Jhung, S
   Engelstad, K
   Mitsis, E
   Mao, X
   Shanske, S
   Hirano, M
   DiMauro, S
   De Vivo, DC
AF Kaufmann, P
   Shungu, DC
   Sano, MC
   Jhung, S
   Engelstad, K
   Mitsis, E
   Mao, X
   Shanske, S
   Hirano, M
   DiMauro, S
   De Vivo, DC
TI Cerebral lactic acidosis correlates with neurological impairment in
   MELAS
SO NEUROLOGY
LA English
DT Article
ID ISCHEMIC CELL-DAMAGE; STROKE-LIKE EPISODES; RAGGED-RED FIBERS;
   MITOCHONDRIAL MYOPATHY; HIPPOCAMPAL-NEURONS; BRAIN; MUTATION; GLIA;
   ENCEPHALOMYOPATHY; ENCEPHALOPATHY
AB Objective: To evaluate the role of chronic cerebral lactic acidosis in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes ( MELAS). Methods: The authors studied 91 individuals from 34 families with MELAS and the A3243G point mutation and 15 individuals from two families with myoclonus epilepsy and ragged red fibers ( MERRF) and the A8344G mutation. Subjects were divided into four groups. Paternal relatives were studied as controls ( Group 1). The maternally related subjects were divided clinically into three groups: asymptomatic ( no clinical evidence of neurologic disease) ( Group 2), oligosymptomatic ( neurologic symptoms but without the full clinical picture of MELAS or MERRF) ( Group 3), and symptomatic ( fulfilling MELAS or MERRF criteria) ( Group 4). The authors performed a standardized neurologic examination, neuropsychological testing, MRS, and leukocyte DNA analysis in all subjects. Results: The symptomatic and oligosymptomatic MELAS subjects had significantly higher ventricular lactate than the other groups. There was a significant correlation between degree of neuropsychological and neurologic impairment and cerebral lactic acidosis as estimated by ventricular MRS lactate levels. Conclusions: High levels of ventricular lactate, the brain spectroscopic signature of MELAS, are associated with more severe neurologic impairment.
C1 Columbia Univ, Neurol Inst, New York, NY 10032 USA.
   Columbia Univ, Dept Pediat, New York, NY 10027 USA.
   Columbia Univ, Dept Radiol, New York, NY USA.
   Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA.
C3 Columbia University; Columbia University; Columbia University; Columbia
   University
RP Columbia Univ, Neurol Inst, 710 W 168th St, New York, NY 10032 USA.
EM dcd1@columbia.edu
RI Shungu, Dikoma/H-7110-2019
OI Shungu, Dikoma C/0000-0001-9452-2245
CR Anderson RE, 1999, STROKE, V30, P160, DOI 10.1161/01.STR.30.1.160
   BALENTINE JD, 1987, ACTA NEUROPATHOL, V73, P233, DOI 10.1007/BF00686616
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   De Vivo D C, 2001, Curr Neurol Neurosci Rep, V1, P203
   Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z
   DUYN JH, 1993, RADIOLOGY, V188, P277, DOI 10.1148/radiology.188.1.8511313
   GOLDMAN SA, 1989, J CEREBR BLOOD F MET, V9, P471, DOI 10.1038/jcbfm.1989.70
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Himmelseher S, 1998, CRIT CARE MED, V26, P2029, DOI 10.1097/00003246-199812000-00035
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208
   KRAIG RP, 1987, J CEREBR BLOOD F MET, V7, P379, DOI 10.1038/jcbfm.1987.80
   Magistretti PJ, 2000, BRAIN RES, V886, P108, DOI 10.1016/S0006-8993(00)02945-0
   MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872
   NEDERGAARD M, 1991, J NEUROSCI, V11, P2489
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   PALJARVI L, 1984, ACTA NEUROPATHOL, V64, P89, DOI 10.1007/BF00695571
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PETITO CK, 1987, J CEREBR BLOOD F MET, V7, P625, DOI 10.1038/jcbfm.1987.115
   Phillis JW, 1999, NEUROSCI LETT, V272, P195, DOI 10.1016/S0304-3940(99)00584-4
   REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   Sano M, 1998, ANN NEUROL, V44, P576
   Shanske Sara, 2003, Neurology, V60, pA462
   SHOFFNER JM, 1990, CELL, V43, P1200
   SHUNGU DC, 2002, P INT SOC MAGN RESON, V10, P695
   STAUB F, 1993, J NEUROL SCI, V119, P79, DOI 10.1016/0022-510X(93)90194-4
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   TOMBAUGH GC, 1990, BRAIN RES, V506, P343, DOI 10.1016/0006-8993(90)91277-N
NR 29
TC 139
Z9 183
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD APR 27
PY 2004
VL 62
IS 8
BP 1297
EP 1302
DI 10.1212/01.WNL.0000120557.83907.A8
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 815UM
UT WOS:000221067200010
PM 15111665
DA 2024-11-01
ER

PT J
AU Bellanti, F
   Buglio, AL
   Vendemiale, G
AF Bellanti, Francesco
   Buglio, Aurelio Lo
   Vendemiale, Gianluigi
TI Muscle Delivery of Mitochondria-Targeted Drugs for the Treatment of
   Sarcopenia: Rationale and Perspectives
SO PHARMACEUTICS
LA English
DT Review
DE sarcopenia; mitochondrial dysfunction; oxidative stress
ID AGE-RELATED-CHANGES; VASTUS LATERALIS MUSCLE; DNA DELETION MUTATIONS;
   SKELETAL-MUSCLE; FIBER TYPES; OXIDATIVE CAPACITY; PROTEIN-METABOLISM;
   ACUTE EXERCISE; OLDER WOMEN; YOUNG
AB An impairment in mitochondrial homeostasis plays a crucial role in the process of aging and contributes to the incidence of age-related diseases, including sarcopenia, which is defined as an age-dependent loss of muscle mass and strength. Mitochondrial dysfunction exerts a negative impact on several cellular activities, including bioenergetics, metabolism, and apoptosis. In sarcopenia, mitochondria homeostasis is disrupted because of reduced oxidative phosphorylation and ATP generation, the enhanced production of reactive species, and impaired antioxidant defense. This review re-establishes the most recent evidence on mitochondrial defects that are thought to be relevant in the pathogenesis of sarcopenia and that may represent promising therapeutic targets for its prevention/treatment. Furthermore, we describe mechanisms of action and translational potential of promising mitochondria-targeted drug delivery systems, including molecules able to boost the metabolism and bioenergetics, counteract apoptosis, antioxidants to scavenge reactive species and decrease oxidative stress, and target mitophagy. Even though these mitochondria-delivered strategies demonstrate to be promising in preclinical models, their use needs to be promoted for clinical studies. Therefore, there is a compelling demand to further understand the mechanisms modulating mitochondrial homeostasis, to characterize powerful compounds that target muscle mitochondria to prevent sarcopenia in aged people.
C1 [Bellanti, Francesco; Buglio, Aurelio Lo; Vendemiale, Gianluigi] Univ Foggia, Dept Med & Surg Sci, Viale Pinto 1, I-71122 Foggia, Italy.
C3 University of Foggia
RP Vendemiale, G (corresponding author), Univ Foggia, Dept Med & Surg Sci, Viale Pinto 1, I-71122 Foggia, Italy.
EM gianluigi.vendemiale@unifg.it
RI Lo Buglio, Aurelio/ABC-5292-2020; Bellanti, Francesco/K-4059-2016
OI BELLANTI, Francesco/0000-0002-8196-7373; Lo Buglio,
   Aurelio/0000-0003-1569-3658
CR Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE672, DOI 10.1152/ajpendo.00043.2007
   Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x
   Akbarzadeh A, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-102
   Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200
   Armstrong JS, 2007, BRIT J PHARMACOL, V151, P1154, DOI 10.1038/sj.bjp.0707288
   Beavers KM, 2013, AM J CLIN NUTR, V97, P552, DOI 10.3945/ajcn.112.047860
   Bellanti F, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10010031
   BEREGI E, 1988, Z GERONTOL, V21, P83
   Biolo G, 2014, CLIN NUTR, V33, P737, DOI 10.1016/j.clnu.2014.03.007
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Callahan DM, 2013, CURR OPIN CLIN NUTR, V16, P66, DOI 10.1097/MCO.0b013e32835a8842
   Campbell MD, 2019, FREE RADICAL BIO MED, V134, P268, DOI 10.1016/j.freeradbiomed.2018.12.031
   Carter HN, 2018, J PHYSIOL-LONDON, V596, P3567, DOI 10.1113/JP275998
   Carter HN, 2015, PHYSIOLOGY, V30, P208, DOI 10.1152/physiol.00039.2014
   Cento AS, 2022, CURR OSTEOPOROS REP, V20, P249, DOI 10.1007/s11914-022-00739-6
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Chamberlain GR, 2013, ACS CHEM BIOL, V8, P1389, DOI 10.1021/cb400095v
   Chen CCW, 2018, AM J PHYSIOL-ENDOC M, V315, pE404, DOI 10.1152/ajpendo.00391.2017
   Cholok D, 2017, J TRAUMA ACUTE CARE, V82, P174, DOI 10.1097/TA.0000000000001290
   Cobley JN, 2014, FREE RADICAL BIO MED, V70, P23, DOI 10.1016/j.freeradbiomed.2014.02.004
   Cobley James N, 2013, Longev Healthspan, V2, P11, DOI 10.1186/2046-2395-2-11
   COGGAN AR, 1992, J GERONTOL, V47, pB71, DOI 10.1093/geronj/47.3.B71
   COGSWELL AM, 1993, AM J PHYSIOL, V264, pC383, DOI 10.1152/ajpcell.1993.264.2.C383
   Consitt LA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112636
   Correia-Melo C, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.159
   Croley AN, 2005, J APPL PHYSIOL, V99, P1872, DOI 10.1152/japplphysiol.00498.2005
   Cruz-Jentoft AJ, 2019, AGE AGEING, V48, DOI 10.1093/ageing/afz046
   D'Angelo E, 2019, J GERONTOL GERIATR, V67, P46
   D'Antona G, 2003, J PHYSIOL-LONDON, V552, P499, DOI 10.1113/jphysiol.2003.046276
   Derbré F, 2012, AGE, V34, P669, DOI 10.1007/s11357-011-9264-y
   Dhillon RJS, 2017, CLIN GERIATR MED, V33, P17, DOI 10.1016/j.cger.2016.08.002
   Dodds RM, 2018, EXP GERONTOL, V113, P80, DOI 10.1016/j.exger.2018.09.020
   Drummond MJ, 2014, J GERONTOL A-BIOL, V69, P1040, DOI 10.1093/gerona/glu004
   Ebner DC, 2015, CURR PHARM DESIGN, V21, P1327, DOI 10.2174/1381612820666140929095755
   Englund DA, 2021, MECH AGEING DEV, V200, DOI 10.1016/j.mad.2021.111595
   Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A
   Favaro G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10226-9
   Fernando R, 2019, FREE RADICAL BIO MED, V132, P58, DOI 10.1016/j.freeradbiomed.2018.08.037
   Fry Christopher S, 2011, Curr Aging Sci, V4, P260
   Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137
   Gao XJ, 2014, MOL THER, V22, P1333, DOI 10.1038/mt.2014.63
   Gaster M, 2000, AM J PHYSIOL-ENDOC M, V278, pE910, DOI 10.1152/ajpendo.2000.278.5.E910
   Gheller BJF, 2016, ANNU REV NUTR, V36, P129, DOI 10.1146/annurev-nutr-071715-050901
   Gouspillou G, 2014, FASEB J, V28, P1621, DOI 10.1096/fj.13-242750
   Guglielmi V, 2019, INT J PHARMACEUT, V560, P347, DOI 10.1016/j.ijpharm.2019.02.017
   Herbst A, 2021, AGING CLIN EXP RES, V33, P1811, DOI 10.1007/s40520-020-01698-7
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137
   Horton KL, 2008, CHEM BIOL, V15, P375, DOI 10.1016/j.chembiol.2008.03.015
   Iqbal S, 2013, MUSCLE NERVE, V48, P963, DOI 10.1002/mus.23838
   Jang EH, 2021, LIFE-BASEL, V11, DOI 10.3390/life11080811
   Jativa SD, 2019, MOL PHARMACEUT, V16, P2376, DOI 10.1021/acs.molpharmaceut.8b01313
   Johnson ML, 2013, TRENDS ENDOCRIN MET, V24, P247, DOI 10.1016/j.tem.2012.12.003
   Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189
   Joseph AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069327
   Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x
   Kent-Braun JA, 2000, J APPL PHYSIOL, V89, P1072, DOI 10.1152/jappl.2000.89.3.1072
   Kim C, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041079
   Köller M, 2023, WIEN MED WOCHENSCHR, V173, P97, DOI 10.1007/s10354-022-00927-0
   Kragstrup TW, 2011, SCAND J MED SCI SPOR, V21, P749, DOI 10.1111/j.1600-0838.2011.01377.x
   Landers-Ramos RQ, 2018, EXERC SPORT SCI REV, V46, P172, DOI 10.1249/JES.0000000000000151
   Landi F, 2019, CLIN NUTR, V38, P2113, DOI 10.1016/j.clnu.2018.11.021
   Landi F, 2014, CURR OPIN CLIN NUTR, V17, P25, DOI 10.1097/MCO.0000000000000018
   Leduc-Gaudet JP, 2019, J PHYSIOL-LONDON, V597, P1975, DOI 10.1113/JP277157
   Leduc-Gaudet JP, 2015, J PHYSIOL-LONDON, V593, P2993, DOI 10.1113/JP270736
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   Lezza AMS, 2001, FEBS LETT, V501, P74, DOI 10.1016/S0014-5793(01)02628-X
   Liu DM, 2013, J GERONTOL A-BIOL, V68, P1035, DOI 10.1093/gerona/glt015
   Liu YQ, 2020, INT UROL NEPHROL, V52, P1551, DOI 10.1007/s11255-020-02508-9
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu P, 2016, J CONTROL RELEASE, V240, P38, DOI 10.1016/j.jconrel.2015.10.023
   Marcinek DJ, 2005, J PHYSIOL-LONDON, V569, P467, DOI 10.1113/jphysiol.2005.097782
   Marcus RL, 2010, J NUTR HEALTH AGING, V14, P362, DOI 10.1007/s12603-010-0081-2
   Maretti E, 2022, PHARMACEUTICS, V14, DOI 10.3390/pharmaceutics14030648
   Martone AM, 2019, J GERONTOL GERIATR, V67, P39
   Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011
   Marzetti E, 2013, INT J BIOCHEM CELL B, V45, P2288, DOI 10.1016/j.biocel.2013.06.024
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   McGregor Robin A, 2014, Longev Healthspan, V3, P9, DOI 10.1186/2046-2395-3-9
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   McKiernan SH, 2009, EXP GERONTOL, V44, P170, DOI 10.1016/j.exger.2008.09.014
   Mitchell WK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00260
   Murgia M, 2017, CELL REP, V19, P2396, DOI 10.1016/j.celrep.2017.05.054
   Narici MV, 2010, BRIT MED BULL, V95, P139, DOI 10.1093/bmb/ldq008
   Narici MV, 2003, J APPL PHYSIOL, V95, P2229, DOI 10.1152/japplphysiol.00433.2003
   Nawawi A, 2021, J GERONTOL GERIATR, V69, P45, DOI 10.36150/2499-6564-340
   O'Leary MF, 2013, AM J PHYSIOL-CELL PH, V304, pC422, DOI 10.1152/ajpcell.00240.2012
   Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002
   Papadopoulou SK, 2020, J NUTR HEALTH AGING, V24, P83, DOI 10.1007/s12603-019-1267-x
   Pesce V, 2005, J GERONTOL A-BIOL, V60, P715, DOI 10.1093/gerona/60.6.715
   Phu S, 2015, J CLIN DENSITOM, V18, P488, DOI 10.1016/j.jocd.2015.04.011
   Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012
   Picard M, 2011, AGING CELL, V10, P1047, DOI 10.1111/j.1474-9726.2011.00745.x
   Picca A, 2017, EXP GERONTOL, V96, P63, DOI 10.1016/j.exger.2017.06.005
   Pin F, 2022, FRONT CELL DEV BIOL, V10, DOI 10.3389/fcell.2022.861622
   Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002
   Pollock N, 2017, FREE RADICAL BIO MED, V112, P84, DOI 10.1016/j.freeradbiomed.2017.07.017
   PROCTOR DN, 1995, J APPL PHYSIOL, V78, P2033, DOI 10.1152/jappl.1995.78.6.2033
   Raimondo TM, 2018, P NATL ACAD SCI USA, V115, P10648, DOI 10.1073/pnas.1806908115
   Rennie MJ, 2009, APPL PHYSIOL NUTR ME, V34, P377, DOI 10.1139/H09-012
   Romanello V, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00422
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S
   Rygiel KA, 2014, NEUROBIOL AGING, V35, P2230, DOI 10.1016/j.neurobiolaging.2014.02.027
   Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778
   Salucci S, 2017, MICROSC RES TECHNIQ, V80, P1174, DOI 10.1002/jemt.22914
   Samoylova TI, 1999, MUSCLE NERVE, V22, P460, DOI 10.1002/(SICI)1097-4598(199904)22:4<460::AID-MUS6>3.0.CO;2-L
   Sayed RKA, 2018, J GERONTOL A-BIOL, V73, P1330, DOI 10.1093/gerona/gly059
   Scott W, 2001, PHYS THER, V81, P1810, DOI 10.1093/ptj/81.11.1810
   Sebastián D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084
   Serviddio G, 2010, CURR MED CHEM, V17, P2325, DOI 10.2174/092986710791698530
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Song W, 2006, ANTIOXID REDOX SIGN, V8, P517, DOI 10.1089/ars.2006.8.517
   Supinski GS, 2020, AM J PHYSIOL-LUNG C, V319, pL228, DOI 10.1152/ajplung.00473.2019
   Szeto HH, 2006, AAPS J, V8, pE277, DOI 10.1007/BF02854898
   Thom JM, 2007, EUR J APPL PHYSIOL, V100, P613, DOI 10.1007/s00421-007-0481-0
   Tieland M, 2018, J CACHEXIA SARCOPENI, V9, P3, DOI 10.1002/jcsm.12238
   Torchilin VP, 2001, P NATL ACAD SCI USA, V98, P8786, DOI 10.1073/pnas.151247498
   Tucker MZ, 2003, AM J PHYSIOL-ENDOC M, V285, pE827, DOI 10.1152/ajpendo.00222.2002
   Tucker MZ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1102, DOI 10.1152/ajpendo.00175.2001
   van de Weijer T, 2015, DIABETES, V64, P1193, DOI 10.2337/db14-0667
   Volpi E, 2001, JAMA-J AM MED ASSOC, V286, P1206, DOI 10.1001/jama.286.10.1206
   Volpi E, 2000, DIABETES NUTR METAB, V13, P99
   Westerblad H, 2010, EXP CELL RES, V316, P3093, DOI 10.1016/j.yexcr.2010.05.019
   Wilkinson DJ, 2018, AGEING RES REV, V47, P123, DOI 10.1016/j.arr.2018.07.005
   Wongrakpanich A, 2014, NANOMEDICINE-UK, V9, P2531, DOI [10.2217/NNM.14.161, 10.2217/nnm.14.161]
   Yamada Y, 2008, ADV DRUG DELIVER REV, V60, P1439, DOI 10.1016/j.addr.2008.04.016
   Yamada Y, 2012, BIOMATERIALS, V33, P1589, DOI 10.1016/j.biomaterials.2011.10.082
   Yeo D, 2019, FREE RADICAL BIO MED, V130, P361, DOI 10.1016/j.freeradbiomed.2018.10.456
   Yoo SZ, 2018, J EXERC REHABIL, V14, P551, DOI 10.12965/jer.1836268.134
NR 131
TC 15
Z9 15
U1 2
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4923
J9 PHARMACEUTICS
JI Pharmaceutics
PD DEC
PY 2022
VL 14
IS 12
AR 2588
DI 10.3390/pharmaceutics14122588
PG 13
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 7G8VQ
UT WOS:000902794800001
PM 36559079
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Ghatak, A
   Faheem, O
   Thompson, PD
AF Ghatak, Abhijit
   Faheem, Osman
   Thompson, Paul D.
TI The genetics of statin-induced myopathy
SO ATHEROSCLEROSIS
LA English
DT Review
DE Genetics; Organic anion transporter; Inherited
ID COA REDUCTASE INHIBITORS; RIPPLING MUSCLE DISEASE;
   MALIGNANT-HYPERTHERMIA SUSCEPTIBILITY; MYOADENYLATE DEAMINASE
   DEFICIENCY; SKELETAL-MUSCLE; SLCO1B1 POLYMORPHISM; MITOCHONDRIAL-DNA;
   SARCOPLASMIC-RETICULUM; LACTIC-ACIDOSIS; EPISODES MELAS
AB Objective: Our goal was to use genetic variants to identify factors contributing to the muscular side effects of statins.
   Background: Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are usually well tolerated medications, but muscle symptoms, ranging from mild myalgia to clinically important rhabdomyolysis are an important side effect of these drugs and a leading cause of noncompliance. Recent results suggest that genetic factors increase the risk of statin-related muscle complaints. We performed a systematic review of the medical literature to determine genetic factors associated with statin myopathy.
   Methods: We identified English language articles relating statin myopathy and genetic diseases and gene variants via a PubMed search. Articles pertinent to the topic were reviewed in detail.
   Results/Conclusions: Our review suggests that some patients are susceptible to statin myopathy because of pre-existing subclinical inherited muscular disorders, or genetic variation in statin uptake proteins encoded by SLCO1B1 or the cytochrome P enzyme system. Variations in genes affecting pain perception and polymorphism in vascular receptors may also contribute to statin myopathy. None of the variants identified in this review suggested novel metabolic mechanisms leading to statin myopathy. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
C1 [Faheem, Osman; Thompson, Paul D.] Hartford Hosp, Div Cardiol, Henry Low Heart Ctr, Hartford, CT 06102 USA.
   [Ghatak, Abhijit] Univ Connecticut, Dept Internal Med, Farmington, CT 06032 USA.
C3 Hartford Hospital; University of Connecticut
RP Thompson, PD (corresponding author), Hartford Hosp, Div Cardiol, Henry Low Heart Ctr, 80 Seymour St,POB 5037, Hartford, CT 06102 USA.
EM pthomps@harthosp.org
FU GlaxoSmithKline; Merck; Roche; Pfizer; Astra Zeneca B. Braun; Genomas
FX Grant/Research Support: GlaxoSmithKline/Merck/Roche/Pfizer/Astra Zeneca
   B. Braun/Genomas.
CR Ansevin CF, 1996, ARCH NEUROL-CHICAGO, V53, P197, DOI 10.1001/archneur.1996.00550020113023
   Baker SK, 2001, CLIN INVEST MED, V24, P258
   Baker SK, 2006, MUSCLE NERVE, V34, P478, DOI 10.1002/mus.20575
   Barth JH, 2003, ANN CLIN BIOCHEM, V40, P576, DOI 10.1258/000456303322326542
   Bhuiyan J, 1996, LIPIDS, V31, P867, DOI 10.1007/BF02522982
   Blake JC, 1999, AM J PATHOL, V155, P67, DOI 10.1016/S0002-9440(10)65100-0
   Bolego C, 2002, CARDIOVASC DRUG THER, V16, P251, DOI 10.1023/A:1020656607497
   Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004
   Bonnefont JP, 1999, MOL GENET METAB, V68, P424, DOI 10.1006/mgme.1999.2938
   Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z
   Bullen WW, 1999, J AM SOC MASS SPECTR, V10, P55, DOI 10.1016/S1044-0305(98)00118-4
   BURNS RJ, 1994, J NEUROL NEUROSUR PS, V57, P344, DOI 10.1136/jnnp.57.3.344
   BUTLER MA, 1992, PHARMACOGENETICS, V2, P116, DOI 10.1097/00008571-199206000-00003
   Carswell CI, 2002, DRUGS, V62, P2075, DOI 10.2165/00003495-200262140-00008
   CHARIOT P, 1993, AM J MED, V94, P109, DOI 10.1016/0002-9343(93)90129-D
   Chen CP, 2008, DRUG METAB DISPOS, V36, P1840, DOI 10.1124/dmd.108.020594
   Corti S, 2008, J NEUROL SCI, V266, P97, DOI 10.1016/j.jns.2007.09.015
   DAHL ML, 1995, J PHARMACOL EXP THER, V274, P516
   Draeger A, 2006, J PATHOL, V210, P94, DOI 10.1002/path.2018
   GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grable-Esposito P, 2010, MUSCLE NERVE, V41, P185, DOI 10.1002/mus.21486
   Gray DF, 2000, CARDIOVASC RES, V47, P329, DOI 10.1016/S0008-6363(00)00106-1
   Guijarro C, 1998, CIRC RES, V83, P490, DOI 10.1161/01.RES.83.5.490
   Guis S, 2006, ARTHRIT RHEUM-ARTHR, V55, P551, DOI 10.1002/art.22100
   Heydemann A, 2009, J CLIN INVEST, V119, P448, DOI 10.1172/JCI38618
   Ikemoto T, 2001, BRIT J PHARMACOL, V134, P719, DOI 10.1038/sj.bjp.0704306
   Inoue R, 2003, J PHARMACOL SCI, V93, P279, DOI 10.1254/jphs.93.279
   Ishikawa C, 2004, J HUM GENET, V49, P582, DOI 10.1007/s10038-004-0188-6
   Jacobson TA, 2006, AM J CARDIOL, V97, p44C, DOI 10.1016/j.amjcard.2005.12.009
   JOHANSSON I, 1993, P NATL ACAD SCI USA, V90, P11825, DOI 10.1073/pnas.90.24.11825
   KALOW W, 1979, International Anesthesiology Clinics, V17, P119, DOI 10.1097/00004311-197917040-00008
   Kameyama Y, 2005, PHARMACOGENET GENOM, V15, P513, DOI 10.1097/01.fpc.0000170913.73780.5f
   Kim K, 2004, J CLIN PHARMACOL, V44, P1083, DOI 10.1177/0091270004268128
   Koeppe C, 2004, SCAND J RHEUMATOL, V33, P24, DOI 10.1080/03009740410006989
   König J, 2006, N-S ARCH PHARMACOL, V372, P432, DOI 10.1007/s00210-006-0040-y
   Krivosic-Horber R, 2004, EUR J ANAESTH, V21, P572, DOI 10.1017/S0265021504227120
   Kubisch C, 2005, ANN NEUROL, V57, P303, DOI 10.1002/ana.20350
   Lennernas H, 1997, CLIN PHARMACOKINET, V32, P403, DOI 10.2165/00003088-199732050-00005
   Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936
   Livingstone C, 2004, ANN CLIN BIOCHEM, V41, P338, DOI 10.1258/0004563041201554
   Lorenzoni PJ, 2007, ARQ NEURO-PSIQUIAT, V65, P834, DOI 10.1590/S0004-282X2007000500020
   Marcoff L, 2007, J AM COLL CARDIOL, V49, P2231, DOI 10.1016/j.jacc.2007.02.049
   Marez D, 1997, PHARMACOGENETICS, V7, P193, DOI 10.1097/00008571-199706000-00004
   McClure DL, 2007, J CLIN EPIDEMIOL, V60, P812, DOI 10.1016/j.jclinepi.2006.11.006
   Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365
   Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454
   Moosmann B, 2004, LANCET, V363, P892, DOI 10.1016/S0140-6736(04)15739-5
   Morimoto Kaori, 2004, Drug Metab Pharmacokinet, V19, P453, DOI 10.2133/dmpk.19.453
   MORISAKI T, 1992, P NATL ACAD SCI USA, V89, P6457, DOI 10.1073/pnas.89.14.6457
   Mosieniak G, 1997, J NEUROCHEM, V68, P1142
   Mulder AB, 2001, CLIN PHARMACOL THER, V70, P546, DOI 10.1067/mcp.2001.120251
   NAKAHARA K, 1994, BIOCHEM BIOPH RES CO, V202, P1579, DOI 10.1006/bbrc.1994.2112
   Niemi M, 2004, PHARMACOGENETICS, V14, P429, DOI 10.1097/01.fpc.0000114750.08559.32
   Niemi M, 2006, CLIN PHARMACOL THER, V80, P356, DOI 10.1016/j.clpt.2006.06.010
   Nishino I, 1996, MUSCLE NERVE, V19, P1603, DOI 10.1002/(SICI)1097-4598(199612)19:12<1603::AID-MUS10>3.0.CO;2-S
   Nordin C, 1997, LANCET, V350, P29, DOI 10.1016/S0140-6736(05)66238-1
   Oh J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-7
   Päivä H, 2005, CLIN PHARMACOL THER, V78, P60, DOI 10.1016/j.clpt.2005.03.006
   Pasanen MK, 2007, CLIN PHARMACOL THER, V82, P726, DOI 10.1038/sj.clpt.6100220
   Pasanen MK, 2006, PHARMACOGENET GENOM, V16, P873, DOI 10.1097/01.fpc.0000230416.82349.90
   Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2
   Phillips Paul S, 2008, Expert Rev Cardiovasc Ther, V6, P971, DOI 10.1586/14779072.6.7.971
   Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Rosenson RS, 2004, AM J MED, V116, P408, DOI 10.1016/j.amjmed.2003.10.033
   Ruaño G, 2005, PHARMACOGENOMICS, V6, P865, DOI 10.2217/14622416.6.8.865
   Ruaño G, 2007, MUSCLE NERVE, V36, P329, DOI 10.1002/mus.20871
   Sailler L, 2008, ANN RHEUM DIS, V67, P614, DOI 10.1136/ard.2007.075523
   Schick BA, 2007, CLIN PHARMACOL THER, V81, P650, DOI 10.1038/sj.clpt.6100124
   Shepherd J, 2006, J INTERN MED, V260, P305, DOI 10.1111/j.1365-2796.2006.01700.x
   Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721
   Stephan DA, 1999, GENOMICS, V55, P268, DOI 10.1006/geno.1998.5689
   Tarnopolsky MA, 2001, J PHYSIOL-LONDON, V533, P881, DOI 10.1111/j.1469-7793.2001.t01-1-00881.x
   Tay SKH, 2008, PEDIATR NEUROL, V39, P426, DOI 10.1016/j.pediatrneurol.2008.09.002
   Thomas JE, 2007, EUR NEUROL, V57, P232, DOI 10.1159/000101287
   Thompson PD, 2006, AM J CARDIOL, V97, p69C, DOI 10.1016/j.amjcard.2005.12.013
   Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681
   Torbergsen T, 2002, MUSCLE NERVE, pS103, DOI 10.1002/mus.10156
   TORBERGSEN T, 1975, ACTA NEUROL SCAND, V51, P225, DOI 10.1111/j.1600-0404.1975.tb07603.x
   Transon C, 1996, EUR J CLIN PHARMACOL, V50, P209, DOI 10.1007/s002280050094
   Urso ML, 2005, ARTERIOSCL THROM VAS, V25, P2560, DOI 10.1161/01.ATV.0000190608.28704.71
   Urwyler A, 2001, BRIT J ANAESTH, V86, P283, DOI 10.1093/bja/86.2.283
   Venero CV, 2009, ENDOCRIN METAB CLIN, V38, P121, DOI 10.1016/j.ecl.2008.11.002
   Verzijl HTFM, 1998, ANN NEUROL, V44, P140, DOI 10.1002/ana.410440124
   VLADITU G, 2004, AM COLL RHEUM 2004 M
   Vladutiu GD, 2006, MUSCLE NERVE, V34, P153, DOI 10.1002/mus.20567
   Voermans NC, 2005, J INTERN MED, V258, P196, DOI 10.1111/j.1365-2796.2005.01515.x
   Voora D, 2009, J AM COLL CARDIOL, V54, P1609, DOI 10.1016/j.jacc.2009.04.053
   Wilke RA, 2005, PHARMACOGENET GENOM, V15, P415, DOI 10.1097/01213011-200506000-00007
   Williams D, 2002, CLIN PHARMACOKINET, V41, P343, DOI 10.2165/00003088-200241050-00003
   Wolfe GI, 2000, MUSCLE NERVE, V23, P641, DOI 10.1002/(SICI)1097-4598(200004)23:4<641::AID-MUS25>3.0.CO;2-M
   Yokoyama M, 2007, J LIPID RES, V48, P646, DOI 10.1194/jlr.M600301-JLR200
   Zuccaro P, 2007, PHARMACOL RES, V55, P310, DOI 10.1016/j.phrs.2006.12.009
   2009, HARRISONS PRINCIPLES
NR 96
TC 93
Z9 101
U1 0
U2 10
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD JUN
PY 2010
VL 210
IS 2
BP 337
EP 343
DI 10.1016/j.atherosclerosis.2009.11.033
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA 601CY
UT WOS:000278036800002
PM 20042189
DA 2024-11-01
ER

PT J
AU Nikkanen, J
   Landoni, JC
   Balboa, D
   Haugas, M
   Partanen, J
   Paetau, A
   Isohanni, P
   Brilhante, V
   Suomalainen, A
AF Nikkanen, Joni
   Landoni, Juan Cruz
   Balboa, Diego
   Haugas, Maarja
   Partanen, Juha
   Paetau, Anders
   Isohanni, Pirjo
   Brilhante, Virginia
   Suomalainen, Anu
TI A complex genomic locus drives mtDNA replicase POLG expression to its
   disease-related nervous system regions
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE enhancer; gene regulation; mtDNA maintenance; POLG; tissue specificity
ID MITOCHONDRIAL-DNA POLYMERASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   GAMMA MUTATIONS; RECESSIVE ATAXIA; LANDSCAPE; CHROMATIN; BRAIN; CELLS;
   MICE
AB DNA polymerase gamma (POLG), the mtDNA replicase, is a common cause of mitochondrial neurodegeneration. Why POLG defects especially cause central nervous system (CNS) diseases is unknown. We discovered a complex genomic regulatory locus for POLG, containing three functional CNS-specific enhancers that drive expression specifically in oculomotor complex and sensory interneurons of the spinal cord, completely overlapping with the regions showing neuronal death in POLG patients. The regulatory locus also expresses two functional RNAs, LINC00925-RNA and MIR9-3, which are coexpressed with POLG. The MIR9-3 targets include NR2E1, a transcription factor maintaining neural stem cells in undifferentiated state, and MTHFD2, the regulatory enzyme of mitochondrial folate cycle, linking POLG expression to stem cell differentiation and folate metabolism. Our evidence suggests that distant genomic non-coding regions contribute to regulation of genes encoding mitochondrial proteins. Such genomic arrangement of POLG locus, driving expression to CNS regions affected in POLG patients, presents a potential mechanism for CNS-specific manifestations in POLG disease.
C1 [Nikkanen, Joni; Landoni, Juan Cruz; Balboa, Diego; Isohanni, Pirjo; Brilhante, Virginia; Suomalainen, Anu] Univ Helsinki, Mol Neurol, Res Programs Unit, Helsinki, Finland.
   [Balboa, Diego] Univ Helsinki, Biomed Stem Cell Ctr, Helsinki, Finland.
   [Haugas, Maarja; Partanen, Juha] Univ Helsinki, Dept Biosci, Helsinki, Finland.
   [Paetau, Anders] Univ Helsinki, HUSLAB, Helsinki, Finland.
   [Paetau, Anders] Univ Helsinki, Dept Pathol, Helsinki, Finland.
   [Paetau, Anders; Isohanni, Pirjo; Suomalainen, Anu] Helsinki Univ Hosp, Helsinki, Finland.
   [Isohanni, Pirjo] Univ Helsinki, Childrens Hosp, Dept Pediat Neurol, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Dept Neurol, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Neurosci Ctr, Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; University of Helsinki;
   University of Helsinki; University of Helsinki; University of Helsinki;
   Helsinki University Central Hospital; University of Helsinki; University
   of Helsinki; University of Helsinki
RP Suomalainen, A (corresponding author), Univ Helsinki, Mol Neurol, Res Programs Unit, Helsinki, Finland.; Suomalainen, A (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, Dept Neurol, Helsinki, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, Neurosci Ctr, Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
RI Partanen, Juha/JQI-1097-2023; Landoni, Juan/AAE-3716-2019
OI Balboa, Diego/0000-0002-4784-5452; Nikkanen, Joni/0000-0001-7099-4061;
   Haugas, Maarja/0000-0002-7577-8779; Landoni, Juan
   Cruz/0000-0002-0318-6707; Suomalainen-Wartiovaara,
   Anu/0000-0003-4833-5195; Partanen, Juha/0000-0001-8850-4825
FU European Research Council; Academy of Finland; Sigrid Juselius
   Foundation; Jane and Aatos Erkko Foundation; University of Finland;
   Helsinki Biomedical Graduate School
FX The authors wish to thank Anu Harju for experimental expertise, Timo
   Otonkoski for technical consultations, and the following funding
   sources: European Research Council, Academy of Finland, Sigrid Juselius
   Foundation, Jane and Aatos Erkko Foundation, University of Finland (for
   A.S.), Helsinki Biomedical Graduate School (for J.N.).
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   [Anonymous], DATABASE
   Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575
   Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014
   Copp A.J., 1990, POSTIMPLANTATION MAM
   GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042
   Hikmat O, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091845
   Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Madelaine R, 2017, CELL REP, V20, P1533, DOI 10.1016/j.celrep.2017.07.051
   Mameza MG, 2007, J NEUROCHEM, V103, P927, DOI 10.1111/j.1471-4159.2007.04854.x
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020
   Palin EJH, 2012, J NEUROL SCI, V315, P160, DOI 10.1016/j.jns.2011.11.028
   Plank JL, 2014, MOL CELL, V55, P5, DOI 10.1016/j.molcel.2014.06.015
   Rowland LP, 1997, NEUROMUSCULAR DISORD, V7, pS15, DOI 10.1016/S0960-8966(97)00076-X
   Selcuklu SD, 2012, J BIOL CHEM, V287, P29516, DOI 10.1074/jbc.M111.335943
   Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211
   Steinfeld R, 2009, AM J HUM GENET, V85, P354, DOI 10.1016/j.ajhg.2009.08.005
   Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232
   Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 31
TC 6
Z9 7
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD JAN
PY 2018
VL 10
IS 1
BP 13
EP 21
DI 10.15252/emmm.201707993
PG 9
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA FS3RD
UT WOS:000419699000005
PM 29109127
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Spikings, EC
   Alderson, J
   St John, JC
AF Spikings, E. C.
   Alderson, J.
   St John, J. C.
TI Transmission of mitochondrial DNA following assisted reproduction and
   nuclear transfer
SO HUMAN REPRODUCTION UPDATE
LA English
DT Review
DE assisted reproduction technology; mitochondrial DNA; nuclear transfer
ID EMBRYONIC STEM-CELLS; KEARNS-SAYRE-SYNDROME; IN-VITRO FERTILIZATION;
   PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; INTRACYTOPLASMIC SPERM INJECTION;
   HEREDITARY OPTIC NEUROPATHY; GERMINAL VESICLE TRANSFER; TRANSCRIPTION
   FACTOR-A; RABBIT CLONED EMBRYOS; HUMAN OOCYTES
AB Mitochondria are the organelles responsible for producing the majority of a cell's ATP and also play an essential role in gamete maturation and embryo development. ATP production within the mitochondria is dependent on proteins encoded by both the nuclear and the mitochondrial genomes, therefore co-ordination between the two genomes is vital for cell survival. To assist with this co-ordination, cells normally contain only one type of mitochondrial DNA (mtDNA) termed homoplasmy. Occasionally, however, two or more types of mtDNA are present termed heteroplasmy. This can result from a combination of mutant and wild-type mtDNA molecules or from a combination of wild-type mtDNA variants. As heteroplasmy can result in mitochondrial disease, various mechanisms exist in the natural fertilization process to ensure the maternal-only transmission of mtDNA and the maintenance of homoplasmy in future generations. However, there is now an increasing use of invasive oocyte reconstruction protocols, which tend to bypass mechanisms for the maintenance of homoplasmy, potentially resulting in the transmission of either form of mtDNA heteroplasmy. Indeed, heteroplasmy caused by combinations of wild-type variants has been reported following cytoplasmic transfer (CT) in the human and following nuclear transfer (NT) in various animal species. Other techniques, such as germinal vesicle transfer and pronuclei transfer, have been proposed as methods of preventing transmission of mitochondrial diseases to future generations. However, resulting embryos and offspring may contain mtDNA heteroplasmy, which itself could result in mitochondrial disease. It is therefore essential that uniparental transmission of mtDNA is ensured before these techniques are used therapeutically.
C1 Univ Birmingham, Sch Med, Mitochondrial & Reprod Genet Grp, Birmingham B15 2TT, W Midlands, England.
C3 University of Birmingham
RP St John, JC (corresponding author), Univ Birmingham, Sch Med, Mitochondrial & Reprod Genet Grp, Birmingham B15 2TT, W Midlands, England.
EM j.stjohn.1@bham.ac.uk
RI St. John, Justin/A-2942-2010
OI St. John, Jus/0000-0002-3993-1449
CR Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   AnkelSimons F, 1996, P NATL ACAD SCI USA, V93, P13859, DOI 10.1073/pnas.93.24.13859
   BARRITT JA, 2001, REPROD BIOMED ONLINE, V3, P47
   Bavister B D, 2000, Hum Reprod, V15 Suppl 2, P189
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brenner CA, 2000, FERTIL STERIL, V74, P573, DOI 10.1016/S0015-0282(00)00681-6
   BRISON DR, 1991, J REPROD FERTIL, V93, P245, DOI 10.1530/jrf.0.0930245
   BROWN DR, 1989, J ANIM SCI, V67, P1926
   BROWN MD, 1992, GENETICS, V130, P163
   Campbell KHS, 2005, REPROD DOMEST ANIM, V40, P256, DOI 10.1111/j.1439-0531.2005.00591.x
   Chang KH, 2003, FERTIL STERIL, V80, P1380, DOI 10.1016/j.fertnstert.2003.07.006
   Chen DY, 2002, BIOL REPROD, V67, P637, DOI 10.1095/biolreprod67.2.637
   Chen Y, 2003, CELL RES, V13, P251, DOI 10.1038/sj.cr.7290170
   Chinnery PF, 2001, AM J MED GENET, V98, P235, DOI 10.1002/1096-8628(20010122)98:3<235::AID-AJMG1086>3.0.CO;2-O
   Chung YG, 2002, BIOL REPROD, V66, P1178, DOI 10.1095/biolreprod66.4.1178
   Cibelli JB, 2002, NAT BIOTECHNOL, V20, P13, DOI 10.1038/nbt0102-13
   Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7
   Cortesini R, 2005, TRANSPL IMMUNOL, V15, P81, DOI 10.1016/j.trim.2005.09.013
   Cui LB, 2005, HUM REPROD, V20, P1624, DOI 10.1093/humrep/deh826
   Cummins J, 1998, REV REPROD, V3, P172, DOI 10.1530/revreprod/3.3.172
   Cummins JM, 1997, ZYGOTE, V5, P301, DOI 10.1017/S0967199400003889
   D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326
   Dailey T, 1996, AM J HUM GENET, V59, P176
   Danan C, 1999, AM J HUM GENET, V65, P463, DOI 10.1086/302484
   Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883
   De Block CEM, 2004, EXP CLIN ENDOCR DIAB, V112, P80, DOI 10.1055/s-2004-815754
   Dean NL, 2003, MOL HUM REPROD, V9, P631, DOI 10.1093/molehr/gag077
   Dumollard R, 2003, DEVELOPMENT, V130, P683, DOI 10.1242/dev.00296
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Eichenlaub-Ritter U, 2004, REPROD BIOMED ONLINE, V8, P45, DOI 10.1016/S1472-6483(10)60497-X
   EISEN A, 1985, J CELL BIOL, V100, P1522, DOI 10.1083/jcb.100.5.1522
   El Shourbagy SH, 2006, REPRODUCTION, V131, P233, DOI 10.1530/rep.1.00551
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   FISHER RP, 1985, J BIOL CHEM, V260, P1330
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   Fulka H, 2004, REPRODUCTION, V127, P195, DOI 10.1530/rep.1.00093
   Gahan ME, 2001, J CLIN VIROL, V22, P241, DOI 10.1016/S1386-6532(01)00195-0
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0
   Hammer CJ, 2001, THERIOGENOLOGY, V55, P1447, DOI 10.1016/S0093-691X(01)00493-9
   Han ZM, 2004, MOL REPROD DEV, V67, P207, DOI 10.1002/mrd.10398
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   HANNA MG, 1995, J NEUROL SCI, V130, P154, DOI 10.1016/0022-510X(95)00022-T
   HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686
   He ZY, 2003, FERTIL STERIL, V79, P347, DOI 10.1016/S0015-0282(02)04674-5
   HECHT NB, 1984, EXP CELL RES, V154, P293, DOI 10.1016/0014-4827(84)90688-8
   Hiendleder S, 1999, MOL REPROD DEV, V54, P24, DOI 10.1002/(SICI)1098-2795(199909)54:1<24::AID-MRD4>3.0.CO;2-S
   Hiendleder S, 2004, CLONING STEM CELLS, V6, P150, DOI 10.1089/1536230041372391
   Hiendleder S, 2003, BIOL REPROD, V68, P159, DOI 10.1095/biolreprod.102.008201
   Holden C, 2005, SCIENCE, V310, P1402, DOI 10.1126/science.310.5753.1402
   Houghton FD, 1996, MOL REPROD DEV, V44, P476, DOI 10.1002/(SICI)1098-2795(199608)44:4<476::AID-MRD7>3.0.CO;2-I
   Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399
   Inoue K, 2004, GENESIS, V39, P79, DOI 10.1002/gene.20029
   Irwin MH, 1999, TRANSGENIC RES, V8, P119, DOI 10.1023/A:1008925419758
   Jansen RPS, 1998, MOL CELL ENDOCRINOL, V145, P81, DOI 10.1016/S0303-7207(98)00173-7
   KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542
   KEEFE DL, 1995, FERTIL STERIL, V64, P577, DOI 10.1016/S0015-0282(16)57796-6
   Kenyon L, 1997, P NATL ACAD SCI USA, V94, P9131, DOI 10.1073/pnas.94.17.9131
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kirches E, 2001, J MED GENET, V38, P312, DOI 10.1136/jmg.38.5.312
   KLOPSTOCK T, 1995, ACTA NEUROPATHOL, V90, P126
   KOEHLER CM, 1991, GENETICS, V129, P247
   KONDO R, 1992, GENET RES, V59, P81, DOI 10.1017/S0016672300030287
   KONDO R, 1990, GENETICS, V126, P657
   Kong Ling-hong, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P747
   Kong Ling-hong, 2004, Zhonghua Fu Chan Ke Za Zhi, V39, P105
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 1996, NAT GENET, V13, P296, DOI 10.1038/ng0796-296
   LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603
   Larsson NG, 1997, HUM MOL GENET, V6, P185, DOI 10.1093/hmg/6.2.185
   LEESE HJ, 1993, BIOESSAYS, V15, P259, DOI 10.1002/bies.950150406
   Lertrit P, 1999, HUM GENET, V105, P127, DOI 10.1007/s004390051074
   Lestienne P, 1997, MOL HUM REPROD, V3, P811, DOI 10.1093/molehr/3.9.811
   Levy SE, 1999, TRANSGENIC RES, V8, P137, DOI 10.1023/A:1008967412955
   Lin DPC, 2004, FERTIL STERIL, V81, P73, DOI 10.1016/j.fertnstert.2003.05.005
   Liu H, 1999, HUM REPROD, V14, P2357, DOI 10.1093/humrep/14.9.2357
   Liu L, 2001, CELL CALCIUM, V30, P423, DOI 10.1054/ceca.2001.0251
   Liu SZ, 2004, MOL REPROD DEV, V69, P296, DOI 10.1002/mrd.20091
   LLOYD RE, 2006, GENETICS
   Ludwig Michael, 2001, Reprod Biomed Online, V3, P230
   Luetjens CM, 1999, LANCET, V353, P1240, DOI 10.1016/S0140-6736(99)80059-2
   Macháty Z, 2001, MOL REPROD DEV, V58, P39, DOI 10.1002/1098-2795(200101)58:1<39::AID-MRD6>3.0.CO;2-B
   Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Marchington DR, 2002, MOL HUM REPROD, V8, P1046, DOI 10.1093/molehr/8.11.1046
   Margineantu DH, 2002, MITOCHONDRION, V1, P425, DOI 10.1016/S1567-7249(02)00006-5
   May-Panloup P, 2005, HUM REPROD, V20, P593, DOI 10.1093/humrep/deh667
   McConnell JML, 2004, REPROD BIOMED ONLINE, V9, P418, DOI 10.1016/S1472-6483(10)61277-1
   McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604
   McKenzie M, 2000, J BIOL CHEM, V275, P31514, DOI 10.1074/jbc.M004070200
   McKenzie M, 2004, P NATL ACAD SCI USA, V101, P1685, DOI 10.1073/pnas.0303184101
   McKenzie M, 2003, MOL BIOL EVOL, V20, P1117, DOI 10.1093/molbev/msg132
   Meirelles FV, 1998, GENETICS, V148, P877
   Meirelles FV, 1997, GENETICS, V145, P445
   Meirelles FV, 2001, GENETICS, V158, P351
   MEUSEL MS, 1993, CURR GENET, V24, P539, DOI 10.1007/BF00351719
   MICHAELS GS, 1982, DEV BIOL, V94, P246, DOI 10.1016/0012-1606(82)90088-4
   MONNAT RJ, 1985, CANCER RES, V45, P1809
   Moyes CD, 1998, J EXP BIOL, V201, P299
   MUNNE S, 1995, FERTIL STERIL, V64, P382, DOI 10.1016/S0015-0282(16)57739-5
   Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5
   Nagao Y, 1998, GENES GENET SYST, V73, P21, DOI 10.1266/ggs.73.21
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   NAKAMURA M, 1995, BIOCHEM BIOPH RES CO, V214, P86, DOI 10.1006/bbrc.1995.2260
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nishi Yayoi, 2003, Journal of Nippon Medical School, V70, P408, DOI 10.1272/jnms.70.408
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nishimura Y, 2006, P NATL ACAD SCI USA, V103, P1382, DOI 10.1073/pnas.0506911103
   Normile D, 2005, SCIENCE, V307, P664, DOI 10.1126/science.307.5710.664
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Palermo GD, 2002, HUM REPROD, V17, P2165, DOI 10.1093/humrep/17.8.2165
   Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079
   PIKO L, 1976, DEV BIOL, V49, P1, DOI 10.1016/0012-1606(76)90253-0
   PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2
   PONZETTO C, 1990, J NEUROL SCI, V96, P207, DOI 10.1016/0022-510X(90)90133-8
   POULTON J, 1994, HUM MOL GENET, V3, P1763, DOI 10.1093/hmg/3.10.1763
   Reynier P, 2001, MOL HUM REPROD, V7, P425, DOI 10.1093/molehr/7.5.425
   Reynier P, 1997, CR ACAD SCI III-VIE, V320, P629, DOI 10.1016/S0764-4469(97)85696-X
   Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5
   Rubart M, 2006, HANDB EXP PHARM, V174, P73
   Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040
   Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017
   Sathananthan A H, 2000, Hum Reprod, V15 Suppl 2, P148
   Sathananthan Henry, 2002, Reprod Biomed Online, V4, P56
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   SAZER S, 1990, J CELL SCI, V97, P509
   Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3
   Schon E A, 2000, Hum Reprod, V15 Suppl 2, P160
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Seifer DB, 2002, FERTIL STERIL, V78, P1046, DOI 10.1016/S0015-0282(02)04214-0
   SHERRATT HSA, 1991, REV NEUROL, V147, P417
   Shitara H, 2000, GENETICS, V156, P1277
   Shoubridge E A, 2000, Hum Reprod, V15 Suppl 2, P229
   Siciliano G, 2000, NEUROL SCI, V21, pS985, DOI 10.1007/s100720070017
   SMITH LC, 1993, J REPROD FERTIL, P31
   Sokolova VA, 2004, MOL REPROD DEV, V68, P299, DOI 10.1002/mrd.20075
   Spelbrink JN, 1998, HUM GENET, V102, P327, DOI 10.1007/s004390050700
   Spiropoulos J, 2002, MOL HUM REPROD, V8, P719, DOI 10.1093/molehr/8.8.719
   St John J, 2000, LANCET, V355, P200, DOI 10.1016/S0140-6736(99)03842-8
   St John JC, 2005, MOL REPROD DEV, V72, P450, DOI 10.1002/mrd.20370
   St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141
   St John JC, 2004, REPRODUCTION, V127, P631, DOI 10.1530/rep.1.00138
   St John JC, 2004, REPROD BIOMED ONLINE, V8, P34, DOI 10.1016/S1472-6483(10)60496-8
   St John JC, 2004, GENETICS, V167, P897, DOI 10.1534/genetics.103.025049
   St John JC, 2002, HUM REPROD, V17, P1954, DOI 10.1093/humrep/17.8.1954
   St John JC, 2001, MOL HUM REPROD, V7, P103, DOI 10.1093/molehr/7.1.103
   Steinborn R, 1998, FEBS LETT, V426, P352, DOI 10.1016/S0014-5793(98)00350-0
   Steinborn R, 2002, GENETICS, V162, P823
   Steuerwald N, 2000, ZYGOTE, V8, P209, DOI 10.1017/S0967199400001003
   Stojanovski D, 2003, EXP PHYSIOL, V88, P57, DOI 10.1113/eph8802501
   Stojkovic M, 2001, BIOL REPROD, V64, P904, DOI 10.1095/biolreprod64.3.904
   Sturmey RG, 2003, REPRODUCTION, V126, P197, DOI 10.1530/rep.0.1260197
   Sun QY, 2001, REPRODUCTION, V122, P155, DOI 10.1530/rep.0.1220155
   Sun YH, 2005, BIOL REPROD, V72, P510, DOI 10.1095/biolreprod.104.031302
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Sutarno, 2002, THERIOGENOLOGY, V57, P1603, DOI 10.1016/S0093-691X(02)00664-7
   Sutovsky P, 2003, MICROSC RES TECHNIQ, V61, P88, DOI 10.1002/jemt.10319
   Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466
   Takeda K, 2006, MOL REPROD DEV, V73, P306, DOI 10.1002/mrd.20403
   Takeda K, 2005, BIOL REPROD, V72, P1397, DOI 10.1095/biolreprod.104.036129
   Takeda K, 2003, MOL REPROD DEV, V64, P429, DOI 10.1002/mrd.10279
   Takeuchi T, 2005, BIOL REPROD, V72, P584, DOI 10.1095/biolreprod.104.032391
   Takeuchi T, 2001, HUM REPROD, V16, P730, DOI 10.1093/humrep/16.4.730
   Taylor H, 2005, CURR OPIN BIOTECH, V16, P487, DOI 10.1016/j.copbio.2005.08.005
   Tessa A, 2000, FUNCT NEUROL, V15, P211
   Thompson JG, 1996, J REPROD FERTIL, V106, P299, DOI 10.1530/jrf.0.1060299
   Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615
   Trounce IA, 2004, J BIOENERG BIOMEMBR, V36, P421, DOI 10.1023/B:JOBB.0000041778.84464.16
   Trounson A, 2001, REPROD FERT DEVELOP, V13, P31, DOI 10.1071/RD01007
   Tsaousis AD, 2005, MOL BIOL EVOL, V22, P925, DOI 10.1093/molbev/msi084
   Vajta G, 2001, Cloning, V3, P89, DOI 10.1089/15204550152475590
   Van Blerkom J, 2000, HUM REPROD, V15, P2621, DOI 10.1093/humrep/15.12.2621
   Van Blerkom J, 2002, HUM REPROD, V17, P393, DOI 10.1093/humrep/17.2.393
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954
   Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399
   WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200
   White DJ, 2001, AIDS, V15, P1061, DOI 10.1097/00002030-200105250-00017
   White K L, 1999, Cloning, V1, P47, DOI 10.1089/15204559950020085
   WIESNER RJ, 1992, BIOCHEM BIOPH RES CO, V183, P553, DOI 10.1016/0006-291X(92)90517-O
   Wilding M, 2001, HUM REPROD, V16, P909, DOI 10.1093/humrep/16.5.909
   Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0
   XU BJ, 1995, MOL CELL BIOL, V15, P580, DOI 10.1128/MCB.15.1.580
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yang CX, 2003, MOL REPROD DEV, V65, P396, DOI 10.1002/mrd.10320
   Yang L, 2005, MOL REPROD DEV, V71, P431, DOI 10.1002/mrd.20311
   Zhang J, 1999, FERTIL STERIL, V71, P726, DOI 10.1016/S0015-0282(98)00549-4
   Zhao X, 2004, HEREDITY, V93, P399, DOI 10.1038/sj.hdy.6800516
   ZOUROS E, 1992, NATURE, V359, P412, DOI 10.1038/359412a0
NR 198
TC 60
Z9 76
U1 0
U2 20
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1355-4786
EI 1460-2369
J9 HUM REPROD UPDATE
JI Hum. Reprod. Update
PD JUL-AUG
PY 2006
VL 12
IS 4
BP 401
EP 415
DI 10.1093/humupd/dml011
PG 15
WC Obstetrics & Gynecology; Reproductive Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Obstetrics & Gynecology; Reproductive Biology
GA 056PO
UT WOS:000238537800007
PM 16581809
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Fattal, O
   Budur, K
   Vaughan, AJ
   Franco, K
AF Fattal, O
   Budur, K
   Vaughan, AJ
   Franco, K
TI Review of the literature on major mental disorders in adult patients
   with mitochondrial diseases
SO PSYCHOSOMATICS
LA English
DT Review
ID PSYCHIATRIC-SYMPTOMS; DEPRESSIVE DISORDER; BIPOLAR DISORDER;
   DIABETES-MELLITUS; SCHIZOPHRENIA; DYSFUNCTION; MUTATION; MELAS; DNA;
   ENCEPHALOMYOPATHIES
AB Mitochondria are intracellular organelles crucial to the production cellular energy. Mitochondrial disease results from a malfunction in this biochemical cascade. These disorders can affect any organ system, producing diverse signs and symptoms, including psychiatric ones. Several authors argue that mitochondrial dysfunction is related to the pathophysiology of bipolar disorder and schizophrenia. Also, the authors retrieved 19 case reports that describe patients with mitochondrial diseases and psychiatric disorders. Most of these patients have psychiatric presentations that preceded the diagnosis of mitochondrial disease. The most common physical findings are fatigue, muscle weakness with or without atrophy, and hearing loss.
C1 Cleveland Clin Fdn, Cleveland, OH 44195 USA.
C3 Cleveland Clinic Foundation
RP P57,9500 Euclid Ave, Cleveland, OH 44195 USA.
EM FrancoK@ccf.org
CR Amemiya S, 2000, NEUROLOGY, V55, P600, DOI 10.1212/WNL.55.4.600
   Ben-Shachar D, 2002, J NEUROCHEM, V83, P1241, DOI 10.1046/j.1471-4159.2002.01263.x
   Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273
   CAVELIER L, 1995, GENOMICS, V29, P217, DOI 10.1006/geno.1995.1234
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   Dimauro S, 2004, ANN NY ACAD SCI, V1011, P217, DOI 10.1196/annals.1293.022
   DiMauro S, 2000, NEUROL SCI, V21, pS901
   Gardner A, 2003, J AFFECT DISORDERS, V76, P55, DOI 10.1016/S0165-0327(02)00067-8
   Gardner A, 2003, ACTA PSYCHIAT SCAND, V107, P233, DOI 10.1034/j.1600-0447.2003.02188.x
   Gold DR, 2001, SEMIN NEUROL, V21, P309, DOI 10.1055/s-2001-17948
   Inagaki T, 1997, BIOL PSYCHIAT, V42, P1067, DOI 10.1016/S0006-3223(97)00351-X
   Jaksch M, 2001, NEUROLOGY, V57, P1930, DOI 10.1212/WNL.57.10.1930
   Johns DR, 1996, NAT MED, V2, P1065, DOI 10.1038/nm1096-1065
   Kato T, 1996, J AFFECT DISORDERS, V37, P67, DOI 10.1016/0165-0327(95)00050-X
   Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x
   Kiejna Andrzej, 2002, Med Sci Monit, V8, pCS66
   King L, 1999, SYNAPSE, V31, P67, DOI 10.1002/(SICI)1098-2396(199901)31:1<67::AID-SYN9>3.0.CO;2-#
   Köller H, 2003, J NEUROL, V250, P1501, DOI 10.1007/s00415-003-0260-8
   Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300
   Lindholm E, 1997, EUR J HUM GENET, V5, P406, DOI 10.1159/000484799
   Mahoney DJ, 2002, CURR OPIN CLIN NUTR, V5, P619, DOI 10.1097/00075197-200211000-00004
   Maurer I, 2001, SCHIZOPHR RES, V48, P125, DOI 10.1016/S0920-9964(00)00075-X
   Miyaoka H, 1997, BIOL PSYCHIAT, V42, P524, DOI 10.1016/S0006-3223(97)00280-1
   MULCRONE J, 1995, SCHIZOPHR RES, V14, P203, DOI 10.1016/0920-9964(94)00040-F
   Odawara M, 1997, DIABETIC MED, V14, P503, DOI 10.1002/(SICI)1096-9136(199706)14:6<503::AID-DIA394>3.0.CO;2-1
   ODAWARA M, 2002, NUCL ACIDS RES S, V2, P253
   Onishi H, 1997, BIOL PSYCHIAT, V41, P1137, DOI 10.1016/S0006-3223(97)00005-X
   Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425
   Prince JA, 2000, NEUROPSYCHOPHARMACOL, V22, P284, DOI 10.1016/S0893-133X(99)00111-6
   SAIJO T, 1991, NEUROPEDIATRICS, V22, P166, DOI 10.1055/s-2008-1071436
   Shanske AL, 2001, ARCH PEDIAT ADOL MED, V155, P1210
   Shinkai T, 2000, AUST NZ J PSYCHIAT, V34, P1034, DOI 10.1080/000486700286
   Spellberg B, 2001, ARCH INTERN MED, V161, P2497, DOI 10.1001/archinte.161.20.2497
   STEWART J B, 1990, Medical Science Research, V18, P265
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   SUZUKI T, 1990, NEURORADIOLOGY, V32, P74, DOI 10.1007/BF00593949
   Thomeer EC, 1998, J NEUROL NEUROSUR PS, V64, P692, DOI 10.1136/jnnp.64.5.692
   Whatley SA, 1996, NEUROCHEM RES, V21, P995, DOI 10.1007/BF02532409
NR 38
TC 159
Z9 181
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0033-3182
J9 PSYCHOSOMATICS
JI Psychosomatics
PD FEB
PY 2006
VL 47
IS 1
BP 1
EP 7
DI 10.1176/appi.psy.47.1.1
PG 7
WC Psychiatry; Psychology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Psychiatry; Psychology
GA 997TD
UT WOS:000234270000001
PM 16384802
OA Bronze
DA 2024-11-01
ER

PT J
AU Manczak, M
   Jung, YS
   Park, BS
   Partovi, D
   Reddy, PH
AF Manczak, M
   Jung, YS
   Park, BS
   Partovi, D
   Reddy, PH
TI Time-course of mitochondrial gene expressions in mice brains::
   implications for mitochondrial dysfunction, oxidative damage, and
   cytochrome <i>c</i> in aging
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Article
DE aging; ATPase 6; C57BL6 mice; cytochrome c; 8-hydroxyguanosine;
   mitochondrial dysfunction
ID ALZHEIMERS-DISEASE; SKELETAL-MUSCLE; DNA DELETIONS; PHOSPHORYLATION;
   METABOLISM; TISSUES; STRESS; RESTRICTION; MUTATIONS; NUCLEAR
AB The study of aging is critical for a better understanding of many age-related diseases. The free radical theory of aging, one of the prominent aging hypotheses, holds that during aging, increasing reactive oxygen species in mitochondria causes mutations in the mitochondrial DNA and damages mitochondrial components, resulting in senescence. Understanding a mitochondrial gene expression profile and its relationship to mitochondrial function becomes an important step in understanding aging. The objective of the present study was to determine mRNA expression of mitochondrial-encoded genes in brain slices from C57BL6 mice at four ages (2, 12, 18, and 24 months) and to determine how these altered mitochondrial genes influence age-related changes, including oxidative damage and cytochrome c in apoptosis. Using northern blot analysis, in situ hybridization, and immunofluorescence analyses, we analyzed changes in the expression of mitochondrial RNA encoding the mitochondrial genes, oxidative damage marker, 8-hydroxyguanosine (8-OHG), and cytochrome c in brain slices from the cortex of C57BL6 mice at each of the four ages. Our northern blot analysis revealed an increased expression of mitochondrial-encoded genes in complexes I, III, IV, and V of the respiratory chain in 12- and 18-month-old C57BL6 mice compared to 2-month-old mice, suggesting a compensatory mechanism that allows the production of proteins involved in the electron transport chain. In contrast to the up-regulation of mitochondrial genes in 12- and 18-month-old C57BL6 mice, mRNA expression in 24-month-old C57BL6 mice was decreased, suggesting that compensation maintained by the up-regulated genes cannot be sustained and that the down-regulation of expression results in the later stage of aging. Our in situ hybridization analyses of mitochondrial genes from the hippocampus and the cortex revealed that mitochondrial genes were over-expressed, suggesting that these brain areas are critical for mitochondrial functions. Our immunofluorescence analysis of 8-OHG and cytochrome c revealed increased 8-OHG and cytochrome c in 12-month-old C57BL6 mice, suggesting that age-related mitochondrial oxidative damage and apoptosis are associated with mitochondrial dysfunction. Our double-labeling analysis of in situ hybridization of ATPase 6 and our immunofluorescence analysis of 8-OHG suggest that specific neuronal populations undergo oxidative damage. Further, double-labeling analysis of in situ hybridization of ATPase 6 and immunofluorescence analysis of cytochrome c suggest cytochrome c release is related to mitochondrial dysfunction in the aging C57BL6 mouse brain. This study also suggests that these mitochondrial gene expression changes may relate to the role of mitochondrial dysfunction, oxidative damage, and cytochrome c in aging and in age-related diseases such as Alzheimer's disease and Parkinson's disease.
C1 Oregon Hlth & Sci Univ, Inst Neurol Sci, Neurogenet Lab, Beaverton, OR 97006 USA.
   Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
C3 Oregon Health & Science University; Oregon Health & Science University
RP Oregon Hlth & Sci Univ, Inst Neurol Sci, Neurogenet Lab, 505 NW 185th Ave, Beaverton, OR 97006 USA.
EM reddyh@ohsu.edu
OI /0000-0003-3516-7516
FU NIA NIH HHS [AG 22643] Funding Source: Medline
CR Aksenov MY, 1999, NEUROCHEM RES, V24, P767, DOI 10.1023/A:1020783614031
   [Anonymous], J ANTIAGING MED, DOI DOI 10.1089/rej.1.1999.2.15
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Beers M.H., 2004, The Merck Manual of Health Aging
   Biesalski HK, 2002, CURR OPIN CLIN NUTR, V5, P5, DOI 10.1097/00075197-200201000-00002
   Blass JP, 2001, J NEUROSCI RES, V66, P851, DOI 10.1002/jnr.10087
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Cadenas Enrique, 2004, Molecular Aspects of Medicine, V25, P17, DOI 10.1016/j.mam.2004.02.005
   Chandrasekaran K, 1997, MOL BRAIN RES, V44, P99, DOI 10.1016/S0169-328X(96)00191-X
   CHANDRASEKARAN K, 1994, NEUROBIOL AGING, V14, P343
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   de Carvalho CV, 2000, BIOGERONTOLOGY, V1, P357, DOI 10.1023/A:1026542618182
   DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208
   FERNANDEZSILVA P, 1991, BIOCHEM BIOPH RES CO, V176, P645, DOI 10.1016/S0006-291X(05)80233-5
   Kayo T, 2001, P NATL ACAD SCI USA, V98, P5093, DOI 10.1073/pnas.081061898
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   Manczak M, 2004, NEUROMOL MED, V5, P147, DOI 10.1385/NMM:5:2:147
   Mattson MP, 2000, EXP GERONTOL, V35, P489, DOI 10.1016/S0531-5565(00)00115-7
   Mattson MP, 1999, ANN NY ACAD SCI, V893, P154, DOI 10.1111/j.1749-6632.1999.tb07824.x
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003
   Navarro A, 2002, AM J PHYSIOL-REG I, V282, pR985, DOI 10.1152/ajpregu.00537.2001
   Perry G, 2002, FREE RADICAL BIO MED, V33, P1475, DOI 10.1016/S0891-5849(02)01113-9
   PIKO L, 1984, MECH AGEING DEV, V26, P113, DOI 10.1016/0047-6374(84)90170-2
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   Reddy PH, 2004, HUM MOL GENET, V13, P1225, DOI 10.1093/hmg/ddh140
   Schapira AHV, 1999, EUR J CLIN INVEST, V29, P886
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Shoffner JM, 1997, NEUROGENETICS, V1, P13, DOI 10.1007/s100480050002
   SOONG NW, 1992, NAT GENET, V2, P318
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vijg J, 2000, MUTAT RES-FUND MOL M, V447, P117, DOI 10.1016/S0027-5107(99)00202-X
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
NR 37
TC 165
Z9 188
U1 0
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD FEB
PY 2005
VL 92
IS 3
BP 494
EP 504
DI 10.1111/j.1471-4159.2004.02884.x
PG 11
WC Biochemistry & Molecular Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 888VI
UT WOS:000226401900007
PM 15659220
OA Bronze
DA 2024-11-01
ER

PT J
AU Pineda, M
   Solano, A
   Artuch, R
   Andreu, AL
   Playan, A
   Vilaseca, MA
   Colomer, J
   Briones, P
   Casademont, J
   Montoya, J
AF Pineda, M
   Solano, A
   Artuch, R
   Andreu, AL
   Playan, A
   Vilaseca, MA
   Colomer, J
   Briones, P
   Casademont, J
   Montoya, J
TI Peripheral neuropathy with ataxia in childhood as a result of the G8363A
   mutation in mitochondrial DNA
SO PEDIATRIC RESEARCH
LA English
DT Article
ID SENSORY NEUROPATHY; MYOCLONUS EPILEPSY; RESPIRATORY-CHAIN; TRNA(LYS);
   GENE
AB Peripheral neuropathy has been identified in children with mitochondrial encephalomyopathies but not as a main clinical landmark. Here we report the clinical, electrophysiologic, biochemical, and genetic findings in a family who harbors the G8363A mutation in the tRNALys gene of mitochondrial DNA. Affected individuals presented with peripheral neuropathy and ataxia as the main clinical sign. Additional involvement included muscle weakness and multiple lipomatosis. Other common clinical characteristics associated with the G8363A mutation, such as cardiomyopathy and myoclonus epilepsy, were not observed. These findings suggest that a mitochondrial disease should be considered in the differential diagnosis of children with heredoataxic syndrome and peripheral neuropathy of unknown origin.
C1 Clin Hosp Sant Joan Deu, Serv Neuropediat, Unitat Integrada, Barcelona 08950, Spain.
   Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, E-50013 Zaragoza, Spain.
   Univ Barcelona, Hosp Gen Valle Hebron, Ctr Invest Bioquim & Biol Mol, Barcelona 08035, Spain.
   CSIC, Inst Bioquim Clin, Barcelona 08280, Spain.
   Clin Hosp Sant Joan Deu, Serv Bioquim & Med Interna, Unitat Integrada, Barcelona 08950, Spain.
C3 University of Zaragoza; University of Barcelona; Hospital Universitari
   Vall d'Hebron; Consejo Superior de Investigaciones Cientificas (CSIC);
   University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y
   Fotosintesis (IBVF)
RP Clin Hosp Sant Joan Deu, Serv Neuropediat, Unitat Integrada, Passeig St,Joan Deu 2, Barcelona 08950, Spain.
EM pineda@hsjdben.org
RI Casademont, Jordi/A-6828-2010
OI ANDREU, antonio luis/0000-0002-3936-3234; Artuch,
   Rafael/0000-0002-3422-9685
CR Arenas J, 1999, NEUROLOGY, V52, P377, DOI 10.1212/WNL.52.2.377
   ARTUCH R, 1995, EUR J CLIN CHEM CLIN, V33, P529
   Artuch R, 2000, CLIN BIOCHEM, V33, P481, DOI 10.1016/S0009-9120(00)00137-5
   BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004
   Casali C, 1999, NEUROLOGY, V52, P1103, DOI 10.1212/WNL.52.5.1103
   FISCHER JC, 1985, CLIN CHIM ACTA, V153, P23, DOI 10.1016/0009-8981(85)90135-4
   Gámez J, 1998, NEUROLOGY, V51, P258, DOI 10.1212/WNL.51.1.258
   Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601
   HARDING AE, 1993, ADV NEUROL, V61, P1
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   MIZUSAWA H, 1991, REV NEUROL, V147, P501
   OUVRIER RA, 1999, PERIPHERAL NEUROPATH, P188
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Rubio-Gozalbo ME, 2000, NEUROPEDIATRICS, V31, P114, DOI 10.1055/s-2000-7491
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Shtilbans A, 2000, J CHILD NEUROL, V15, P759, DOI 10.1177/088307380001501109
   SUBRAMONY SH, 1995, J CHILD NEUROL, V10, P353, DOI 10.1177/088307389501000503
   Suzuki Y, 2002, DIABETES CARE, V25, P407, DOI 10.2337/diacare.25.2.407
   vanDomburg PHMF, 1996, BRAIN, V119, P997, DOI 10.1093/brain/119.3.997
   YIANNIKAS C, 1986, ANN NEUROL, V20, P249, DOI 10.1002/ana.410200211
NR 21
TC 9
Z9 10
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0031-3998
EI 1530-0447
J9 PEDIATR RES
JI Pediatr. Res.
PD JUL
PY 2004
VL 56
IS 1
BP 55
EP 59
DI 10.1203/01.PDR.0000130475.20571.98
PG 5
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 831WE
UT WOS:000222226400010
PM 15128915
OA Bronze
DA 2024-11-01
ER

PT J
AU Murray, J
   Schilling, B
   Row, RH
   Yoo, CB
   Gibson, BW
   Marusich, MF
   Capaldi, RA
AF Murray, James
   Schilling, Birgit
   Row, Richard H.
   Yoo, Chris B.
   Gibson, Bradford W.
   Marusich, Michael F.
   Capaldi, Roderick A.
TI Small-scale immunopurification of cytochrome c oxidase for a
   high-throughput multiplexing analysis of enzyme activity and amount
SO BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
LA English
DT Article
ID MITOCHONDRIAL RESPIRATORY-CHAIN; COMPLEX-I DEFICIENCY;
   ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; PYRUVATE-DEHYDROGENASE;
   ZIDOVUDINE MYOPATHY; ENCODED SUBUNITS; NECK-CANCER; DNA CONTENT;
   EXPRESSION
AB COX (cytochrome c oxidase) deficiency is one of the main causes of genetic mitochondrial disease and presents with multiple phenotypes, depending on whether the causative mutation exists in a mitochondrial or nuclear gene and on whether it involves an altered catalytic or structural component or an assembly factor for this membrane-em bedded 13-subunit enzyme complex. COX deficiency is routinely observed in AD (Alzheimer's disease), although there is continuing debate about whether this is a causative or a secondary consequence of the condition. Altered levels of COX and reduced oxidative phosphorylation capacity have been reported in other common diseases, including cancer, and are seen as unwanted side effects in a number of drug treatments, particularly with antiretroviral and antibiotic treatments. Here, we introduce a simple, rapid, high-throughput 96-well plate protocol that uses a multiplex approach to determine the amount and activity of COX, which should find widespread use in evaluating the above diseases and in drug safety studies. Importantly, the method uses very small amounts of cell material or tissue and does not require the isolation of mitochondria. We show the utility of this approach by example of the analysis of fibroblasts from patients with COX activity deficiency and the effect of the antiretroviral drug ddC (2',3'-dideoxycytidine) on the biogenesis of the enzyme.
C1 [Murray, James; Marusich, Michael F.; Capaldi, Roderick A.] Mitosci Inc, Eugene, OR 97403 USA.
   [Schilling, Birgit; Row, Richard H.; Yoo, Chris B.; Gibson, Bradford W.] Buck Inst Age Res, Novato, CA 94945 USA.
   [Gibson, Bradford W.] Univ Calif San Francisco, Dept Pharmaceut Sci, San Francisco, CA 94143 USA.
   [Marusich, Michael F.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.
   [Capaldi, Roderick A.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.
C3 Buck Institute for Research on Aging; University of California System;
   University of California San Francisco; University of Oregon; University
   of Oregon
RP Capaldi, RA (corresponding author), Mitosci Inc, Eugene, OR 97403 USA.
EM rcapaldi@mitosciences.com
RI Marusich, Michael/AAQ-3447-2020
FU NIGMS NIH HHS [2R42GM071052-02] Funding Source: Medline
CR Aggeler R, 2002, J BIOL CHEM, V277, P33906, DOI 10.1074/jbc.M204538200
   ANTHONY G, 1990, FEBS LETT, V277, P97, DOI 10.1016/0014-5793(90)80817-3
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Bosetti F, 2002, NEUROBIOL AGING, V23, P371, DOI 10.1016/S0197-4580(01)00314-1
   Bringsjord S, 2001, PSYCOLOQUY, V12, P1
   CAPALDI RA, 1988, J BIOENERG BIOMEMBR, V20, P291, DOI 10.1007/BF00769634
   Cardoso SM, 2004, NEUROBIOL AGING, V25, P105, DOI 10.1016/S0197-4580(03)00033-2
   Chandrasekaran K, 1996, EXP NEUROL, V142, P80, DOI 10.1006/exnr.1996.0180
   CHARIOT P, 1993, ANN NEUROL, V34, P561, DOI 10.1002/ana.410340409
   Coenen MJH, 2006, J CHILD NEUROL, V21, P508, DOI 10.1177/08830738060210062501
   Collins ML, 2004, JAIDS-J ACQ IMM DEF, V37, P1132, DOI 10.1097/01.qai.0000131585.77530.64
   Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Genova ML, 2004, ANN NY ACAD SCI, V1011, P86, DOI 10.1196/annals.1293.010
   Grandjean F, 2002, BIOCHEM PHARMACOL, V63, P823, DOI 10.1016/S0006-2952(01)00865-6
   Hanson BJ, 2001, J BIOL CHEM, V276, P16296, DOI 10.1074/jbc.M011162200
   Herrmann PC, 2003, PROTEOMICS, V3, P1801, DOI 10.1002/pmic.200300461
   Jiang WW, 2006, CLIN CANCER RES, V12, P1564, DOI 10.1158/1078-0432.CCR-05-1471
   Jiang WW, 2005, CLIN CANCER RES, V11, P2486, DOI 10.1158/1078-0432.CCR-04-2147
   Jové M, 2004, J LIPID RES, V45, P113, DOI 10.1194/jlr.M300208-JLR200
   Krieg RC, 2004, PROTEOMICS, V4, P2789, DOI 10.1002/pmic.200300796
   Lib M, 2003, ANAL BIOCHEM, V314, P121, DOI 10.1016/S0003-2697(02)00645-0
   Mancuso M, 2003, EXP NEUROL, V182, P421, DOI 10.1016/S0014-4886(03)00092-X
   Marusich MF, 1997, BBA-MOL BASIS DIS, V1362, P145, DOI 10.1016/S0925-4439(97)00061-6
   Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863
   Maurer I, 2000, NEUROBIOL AGING, V21, P455, DOI 10.1016/S0197-4580(00)00112-3
   McKee EE, 2006, ANTIMICROB AGENTS CH, V50, P2042, DOI 10.1128/AAC.01411-05
   MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8
   Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200
   Murray J, 2002, FEBS LETT, V529, P173, DOI 10.1016/S0014-5793(02)03278-7
   Musatov A, 2002, BIOCHEMISTRY-US, V41, P8212, DOI 10.1021/bi025896u
   Payne CM, 2005, CANCER EPIDEM BIOMAR, V14, P2066, DOI 10.1158/1055-9965.EPI-05-0180
   Perkins AC, 1999, NUCL MED COMMUN, V20, P1, DOI 10.1097/00006231-199901000-00001
   Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101
   Schägger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777
   Schapira AHV, 2002, J INHERIT METAB DIS, V25, P207, DOI 10.1023/A:1015629912477
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schilling B, 2006, BBA-MOL BASIS DIS, V1762, P213, DOI 10.1016/j.bbadis.2005.07.003
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   SIMONIAN NA, 1994, J NEUROPATH EXP NEUR, V53, P508, DOI 10.1097/00005072-199409000-00010
   Smith A.L., 1967, Methods in Enzymology, P81, DOI [10.1016/0076-6879(67)10016-5, DOI 10.1016/0076-6879(67)10016-5]
   TAANMAN JW, 1993, BIOCHIM BIOPHYS ACTA, V1225, P95, DOI 10.1016/0925-4439(93)90128-N
   Tschischka K, 2000, J EXP BIOL, V203, P3355
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   von Kleist-Retzow JC, 2003, EXP PHYSIOL, V88, P155, DOI 10.1113/eph8802509
   Yerroum M, 2000, ACTA NEUROPATHOL, V100, P82, DOI 10.1007/s004010051196
NR 47
TC 10
Z9 12
U1 0
U2 3
PU PORTLAND PRESS LTD
PI LONDON
PA THIRD FLOOR, EAGLE HOUSE, 16 PROCTER STREET, LONDON WC1V 6 NX, ENGLAND
SN 0885-4513
J9 BIOTECHNOL APPL BIOC
JI Biotechnol. Appl. Biochem.
PD DEC
PY 2007
VL 48
BP 167
EP 178
DI 10.1042/BA20060223
PN 3-4
PG 12
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 244RM
UT WOS:000251883000006
PM 17508937
DA 2024-11-01
ER

PT J
AU Pawlowski, W
   Reszec-Gielazyn, J
   Cechowska-Pasko, M
   Urban, B
   Bakunowicz-Lazarczyk, A
AF Pawlowski, Wojciech
   Reszec-Gielazyn, Joanna
   Cechowska-Pasko, Marzanna
   Urban, Beata
   Bakunowicz-Lazarczyk, Alina
TI A Preliminary Study of the Occurrence of Genetic Changes in mtDNA in the
   Muscles in Children Treated for Strabismus
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE mtDNA; extraocular muscles; strabismus; ANT1
ID TENDON AXONAL PROFILES; MEDIAL RECTUS MUSCLES; EXTRAOCULAR-MUSCLES;
   EXPRESSION; INFANTILE; ANT1
AB Background: The dysregulation of extraocular muscles (EOMs) in the strabismus may be partly due to modification in the mitochondrial DNA (mtDNA). Currently, little is known about changes occurring in mtDNA of EOMs in patients with strabismus, therefore the aim of our study was to analyze if there are any changes occurring in the mitochondrial DNA of extraocular muscles in children that underwent strabismus surgery in our clinic. Methods: MtDNA was isolated from the tissue material using the Qiagen kit. Assessment of mtDNA mutations was performed by next-generation sequencing (NGS) using the Illumina MiSeq protocol. Results: The examination revealed the presence of atrophic changes in muscle fibers. NGS evaluation revealed a dominant genetic mutation in the ANT1 gene in 12 of the 15 patients examined. Conclusions: The presented results constitute the beginning of research on changes in mtDNA occurring in the muscles of children with strabismus surgery. Further studies are necessary in the context of resolving the transcriptomic differences between strabismic and non-strabismic EOMs. Better understanding of the molecular genetics of strabismus will lead to improved knowledge of the disease mechanisms and ultimately to a more effective treatment.
C1 [Pawlowski, Wojciech; Urban, Beata; Bakunowicz-Lazarczyk, Alina] Med Univ Bialystok, Dept Pediat Ophthalmol & Strabismus, PL-15089 Bialystok, Poland.
   [Reszec-Gielazyn, Joanna] Med Univ Bialystok, Dept Med Pathomorphol, PL-15296 Bialystok, Poland.
   [Cechowska-Pasko, Marzanna] Med Univ Bialystok, Dept Pharmaceut Biochem, PL-15089 Bialystok, Poland.
C3 Medical University of Bialystok; Medical University of Bialystok;
   Medical University of Bialystok
RP Bakunowicz-Lazarczyk, A (corresponding author), Med Univ Bialystok, Dept Pediat Ophthalmol & Strabismus, PL-15089 Bialystok, Poland.; Cechowska-Pasko, M (corresponding author), Med Univ Bialystok, Dept Pharmaceut Biochem, PL-15089 Bialystok, Poland.
EM wojciech.pawlowski@umb.edu.pl; joanna.reszec-gielazyn@umb.edu.pl;
   marzanna.cechowska-pasko@umb.edu.pl; beata.urban@umb.edu.pl;
   alina.bakunowicz-lazarczyk@umb.edu.pl
RI Cechowska-Pasko, Marzanna/W-4203-2018
OI Urban, Beata/0000-0001-7100-3362
CR Altick AL, 2012, INVEST OPHTH VIS SCI, V53, P5168, DOI 10.1167/iovs.12-9785
   [Anonymous], Strabismus Surgery
   Antunes-Foschini RS, 2008, INVEST OPHTH VIS SCI, V49, P215, DOI 10.1167/iovs.07-0507
   Arbogast S, 2022, REDOX BIOL, V56, DOI 10.1016/j.redox.2022.102450
   Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7
   CORSI M, 1990, OPHTHALMOLOGICA, V200, P154, DOI 10.1159/000310097
   Coyne LP, 2019, MITOCHONDRION, V49, P46, DOI 10.1016/j.mito.2019.06.001
   DOMENICILOMBARDO L, 1992, OPHTHALMOLOGICA, V205, P29, DOI 10.1159/000310308
   Fischer MD, 2005, PHYSIOL GENOMICS, V22, P283, DOI 10.1152/physiolgenomics.00158.2004
   Janbaz AH, 2014, INVEST OPHTH VIS SCI, V55, P5151, DOI 10.1167/iovs.14-14316
   Jung SK, 2015, GRAEF ARCH CLIN EXP, V253, P551, DOI 10.1007/s00417-014-2794-0
   Khan AO, 2011, MOL VIS, V17, P1997
   Kim SH, 2008, EYE, V22, P1076, DOI 10.1038/eye.2008.133
   Kim SH, 2006, ACTA OPHTHALMOL SCAN, V84, P182, DOI 10.1111/j.1600-0420.2005.00556.x
   Kitada Mizue, 2003, Strabismus, V11, P145, DOI 10.1076/stra.11.3.145.16647
   Li J, 2001, Zhonghua Yan Ke Za Zhi, V37, P200
   Liu Gui-xiang, 2007, Zhonghua Yan Ke Za Zhi, V43, P618
   MARTINEZ AJ, 1980, ARCH OPHTHALMOL-CHIC, V98, P533
   Michaelides M, 2004, J MED GENET, V41, P641, DOI 10.1136/jmg.2004.021667
   Park Sung-Eun, 2009, Korean J Ophthalmol, V23, P93, DOI 10.3341/kjo.2009.23.2.93
   Sharer JD, 2005, IUBMB LIFE, V57, P607, DOI 10.1080/15216540500217735
   Simoncini Costanza, 2017, Acta Myol, V36, P25
   Wright K.W., 1995, Pediatric Ophthalmology and Strabismus, P96
   Yamane T, 2003, ACTA MED OKAYAMA, V57, P199
   Yu CY, 2005, NEUROMUSCULAR DISORD, V15, P17, DOI 10.1016/j.nmd.2004.10.002
   Zhu YJ, 2013, MOL MED REP, V7, P217, DOI 10.3892/mmr.2012.1149
   Zuo Xu-hong, 2012, Zhonghua Yan Ke Za Zhi, V48, P794
NR 27
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD JUL
PY 2024
VL 13
IS 14
AR 4041
DI 10.3390/jcm13144041
PG 10
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA ZS8I7
UT WOS:001277368700001
PM 39064081
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Scaglia, F
   Towbin, JA
   Craigen, WJ
   Belmont, JW
   Smith, EO
   Neish, SR
   Ware, SM
   Hunter, JV
   Fernbach, SD
   Vladutiu, GD
   Wong, LJC
   Vogel, H
AF Scaglia, F
   Towbin, JA
   Craigen, WJ
   Belmont, JW
   Smith, EO
   Neish, SR
   Ware, SM
   Hunter, JV
   Fernbach, SD
   Vladutiu, GD
   Wong, LJC
   Vogel, H
TI Clinical spectrum, morbidity, and mortality in 113 pediatric patients
   with mitochondrial disease
SO PEDIATRICS
LA English
DT Article
DE mitochondrial encephalomyopathies; mitochondrial cardiomyopathies;
   modified Walker criteria; morbidity; survival rate
ID RESPIRATORY-CHAIN DISORDERS; COMPLEX-I DEFICIENCY; BARTH SYNDROME;
   CARDIOMYOPATHY; DNA; ENCEPHALOMYOPATHIES; CHILDREN; MYOPATHIES;
   CHILDHOOD; MUTATIONS
AB Objectives. The aim of this study was to elucidate the frequency of major clinical manifestations in children with mitochondrial disease and establish their clinical course, prognosis, and rates of survival depending on their clinical features.
   Methods. We performed a retrospective review of the medical records of 400 patients who were referred for evaluation of mitochondrial disease. By use of the modified Walker criteria, only patients who were assigned a definite diagnosis were included in the study.
   Results. A total of 113 pediatric patients with mitochondrial disease were identified. A total of 102 (90%) patients underwent a muscle biopsy as part of the diagnostic workup. A significant respiratory chain ( RC) defect, according to the diagnostic criteria, was found in 71% of the patients who were evaluated. In this cohort, complex I deficiency (32%) and combined complex I, III, and IV deficiencies (26%) were the most common causes of RC defects, followed by complex IV (19%), complex III (16%), and complex II deficiencies (7%). Pathogenic mitochondrial DNA abnormalities were found in 11.5% of the patients. A substantial fraction (40%) of patients with mitochondrial disorders exhibited cardiac disease, diagnosed by Doppler echocardiography; however, the majority (60%) of patients had predominant neuromuscular manifestations. No correlation between the type of RC defect and the clinical presentation was observed. Overall, the mean age at presentation was 40 months. However, the mean age at presentation was 33 months in the cardiac group and 44 months in the noncardiac group. Twenty-six (58%) patients in the cardiac group exhibited hypertrophic cardiomyopathy, 29% had dilated cardiomyopathy, and the remainder (13%) had left ventricular noncompaction. Patients with cardiomyopathy had an 18% survival rate at 16 years of age. Patients with neuromuscular features but no cardiomyopathy had a 95% survival at the same age.
   Conclusions. This study gives strong support to the view that in patients with RC defects, cardiomyopathy is more common than previously thought and tends to follow a different and more severe clinical course. Although with a greater frequency than previously reported, mitochondrial DNA mutations were found in a minority of patients, emphasizing that most mitochondrial disorders of childhood follow a Mendelian pattern of inheritance.
C1 Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   Texas Childrens Hosp, Houston, TX 77030 USA.
   Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
   Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA.
   SUNY Buffalo, Sch Med & Biomed Sci, Dept Pediat, Buffalo, NY 14260 USA.
   Georgetown Univ, Med Ctr, Inst Mol & Human Genet, Washington, DC 20007 USA.
   Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine; Baylor College of Medicine; State University of New York
   (SUNY) System; University at Buffalo, SUNY; Georgetown University;
   Stanford University
RP Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.
EM fscaglia@bcm.tmc.edu
RI Neish, Steven/AAJ-7974-2021; Towbin, Jeffrey/J-5595-2019; Ware,
   Stephanie/AAF-5577-2020; Belmont, John/AAI-2494-2019
OI Vogel, Otto Hannes/0000-0002-0960-3508; Belmont,
   John/0000-0001-7409-3578
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Applegarth DA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e10
   BENECKE R, 1992, ANN NEUROL, V32, P683, DOI 10.1002/ana.410320512
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   BERNSEN PLJA, 1991, ARCH NEUROL-CHICAGO, V48, P334, DOI 10.1001/archneur.1991.00530150106028
   Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385
   Bleyl SB, 1997, AM J HUM GENET, V61, P868, DOI 10.1086/514879
   CASAZZA F, 1998, G ITAL CARDIOL, V18, P615
   Chinnery PF, 1997, QJM-INT J MED, V90, P657, DOI 10.1093/qjmed/90.11.657
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Dimauro S, 2004, ANN NY ACAD SCI, V1011, P217, DOI 10.1196/annals.1293.022
   Edmonds JL, 2002, ARCH OTOLARYNGOL, V128, P355, DOI 10.1001/archotol.128.4.355
   GOLD M, 1994, INT J PEDIATR OTORHI, V30, P91, DOI 10.1016/0165-5876(94)90191-0
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   KARTSOUNIS LD, 1992, ARCH NEUROL-CHICAGO, V49, P158, DOI 10.1001/archneur.1992.00530260058020
   KELLEY RI, 1991, J PEDIATR-US, V119, P738, DOI 10.1016/S0022-3476(05)80289-6
   King T E., 1967, Methods in enzymology Eds, V10, P275, DOI DOI 10.1016/0076-6879(67)10055-4
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M
   Lincke CR, 1996, NEUROPEDIATRICS, V27, P216, DOI 10.1055/s-2007-973792
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Momiyama Y, 1999, JPN CIRC J, V63, P130, DOI 10.1253/jcj.63.130
   Munnich A, 1996, EUR J PEDIATR, V155, P262
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   Nissenkorn A, 2000, J CHILD NEUROL, V15, P44, DOI 10.1177/088307380001500110
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Pignatelli RH, 2003, CIRCULATION, V108, P2672, DOI 10.1161/01.CIR.0000100664.10777.B8
   ROBINSON BH, 1993, BIOCHIM BIOPHYS ACTA, V1182, P231, DOI 10.1016/0925-4439(93)90064-8
   Rubio-Gozalbo ME, 2000, HUM MUTAT, V15, P522, DOI 10.1002/1098-1004(200006)15:6<522::AID-HUMU4>3.0.CO;2-Y
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Shoffner JM, 1996, LANCET, V348, P1283, DOI 10.1016/S0140-6736(96)09138-6
   Skladal D, 2003, CLIN PEDIATR, V42, P703, DOI 10.1177/000992280304200806
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smeitink J, 1999, AM J HUM GENET, V64, P1505, DOI 10.1086/302432
   Smeitink JAM, 1998, HUM MOL GENET, V7, P1573, DOI 10.1093/hmg/7.10.1573
   Srere PA., 1969, METHOD ENZYMOL, V13, P3, DOI [DOI 10.1016/0076-6879(69)13005-0, 10.1016/0076-6879(69)13005-0]
   Szigeti K, 2004, J MED GENET, V41, P125, DOI 10.1136/jmg.2003.013789
   Thorburn D R, 2000, Hum Reprod, V15 Suppl 2, P57
   Thorburn DR, 2001, J INHERIT METAB DIS, V24, P312, DOI 10.1023/A:1010347808082
   Towbin JA, 1999, CURR OPIN CARDIOL, V14, P250, DOI 10.1097/00001573-199905000-00010
   Turconi AC, 1999, J NEUROL SCI, V170, P57, DOI 10.1016/S0022-510X(99)00199-9
   Uusimaa J, 2000, PEDIATRICS, V105, P598, DOI 10.1542/peds.105.3.598
   Vogel H, 2001, J NEUROPATH EXP NEUR, V60, P217, DOI 10.1093/jnen/60.3.217
   von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957
   Wong LJC, 1997, CLIN CHEM, V43, P1857
   Wong LJC, 2002, CLIN CHEM, V48, P1901
   WONG LJC, 2003, J MED GENET, V40, pE15
   Yonetan T., 1967, METHODS ENZYMOL, P332
NR 49
TC 335
Z9 367
U1 0
U2 13
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD OCT
PY 2004
VL 114
IS 4
BP 925
EP 931
DI 10.1542/peds.2004-0718
PG 7
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 859DI
UT WOS:000224242200024
PM 15466086
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Binder, MS
   Roda, RH
   Corse, AM
   Sidhu, S
   Stewart, S
   Barth, AS
AF Scott Binder, M.
   Roda, Ricardo H.
   Corse, Andrea M.
   Sidhu, Sunjeet
   Stewart, Sarah
   Barth, Andreas S.
TI Prevalence of heart disease in patients with mitochondrial abnormalities
   on skeletal muscle biopsy
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
AB Objective: Mitochondrial DNA mutations are associated with an increased risk of heart disease. Whether an increased prevalence of cardiovascular disease is present in patients presenting with mitochondrial abnormalities on skeletal muscle biopsy remains unknown. This study was designed to determine the prevalence of cardiac conduction disease and structural heart disease in patients presenting with mitochondrial abnormalities on skeletal muscle biopsy. Methods: This is a retrospective cohort study of 103 patients with mitochondrial abnormalities on skeletal muscle biopsy who were referred for evaluation of muscle weakness at a single tertiary care referral center from 2012 to 2018. Of these patients, 59 (57.3%) had an electrocardiogram available and were evaluated for the presence of conduction disease. An echocardiogram was available in 43 patients (42%) who were evaluated for the presence of structural heart disease. The prevalence of cardiac disease was compared to control cohort populations (Framingham and the Atherosclerosis Risk in Communities, ARIC cohorts). Results: Mitochondrial abnormalities associated with cardiac conduction disease (defined as QRS duration >= 120 msec) were present in 8.9%, versus 2.0% (p < 0.001) in the Framingham population and 2.6% (p = 0.003) in the ARIC cohort. LV systolic dysfunction (LVEF <= 50%) was present in 11.6%, versus 3.6% (p < 0.01) in the Framingham and 3% (p < 0.01) in the ARIC populations. Left ventricular hypertrophy was present in 28.6%, versus 13.6% (p < 0.02) in the Framingham and 10.4% (p < 0.001) in the ARIC populations. Interpretation: Given the increased prevalence of cardiovascular disease, patients with mitochondrial abnormalities on skeletal muscle biopsy should undergo routine cardiac screening with physical exam, electrocardiography, and cardiac imaging.
C1 [Scott Binder, M.] Johns Hopkins Bayview Med Ctr, Dept Med, Baltimore, MD 21224 USA.
   [Roda, Ricardo H.; Corse, Andrea M.; Stewart, Sarah] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Sidhu, Sunjeet; Barth, Andreas S.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.
C3 Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins
   University; Johns Hopkins University
RP Barth, AS (corresponding author), Johns Hopkins Univ Hosp, Div Cardiol, 720 Rutland Ave,Ross 871, Baltimore, MD 21287 USA.
EM abarth3@jh.edu
CR Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Chamberlain AM, 2011, AM J CARDIOL, V107, P85, DOI 10.1016/j.amjcard.2010.08.049
   Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888
   Chong-Nguyen C, 2020, J INHERIT METAB DIS, V43, P478, DOI 10.1002/jimd.12195
   Fernandes-Silva MM, 2017, JACC-HEART FAIL, V5, P157, DOI 10.1016/j.jchf.2016.10.011
   Ho JE, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.003116
   Joyce NC, 2012, PHYS MED REH CLIN N, V23, P609, DOI 10.1016/j.pmr.2012.06.006
   Konety SH, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004431
   Kouyoumdjian João A., 2018, J. Bras. Patol. Med. Lab., V54, P325, DOI 10.5935/1676-2444.20180054
   KREGER BE, 1989, AM HEART J, V117, P903, DOI 10.1016/0002-8703(89)90630-3
   Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Quadir A, 2019, NEUROL-GENET, V5, DOI 10.1212/NXG.0000000000000339
   SAVAGE DD, 1987, CIRCULATION, V75, P26
   Schroeder EB, 2003, HYPERTENSION, V42, P1106, DOI 10.1161/01.HYP.0000100444.71069.73
   Sleigh K, 2011, MUSCLE NERVE, V43, P795, DOI 10.1002/mus.21962
   Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Zhang ZM, 2015, J CARD FAIL, V21, P307, DOI 10.1016/j.cardfail.2015.01.001
NR 21
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD APR
PY 2021
VL 8
IS 4
BP 825
EP 830
DI 10.1002/acn3.51327
EA FEB 2021
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA RW6JN
UT WOS:000622344900001
PM 33638621
OA Green Published
DA 2024-11-01
ER

PT J
AU Livingston, K
   Schlaak, RA
   Puckett, LL
   Bergom, C
AF Livingston, Katie
   Schlaak, Rachel A.
   Puckett, Lindsay L.
   Bergom, Carmen
TI The Role of Mitochondrial Dysfunction in Radiation-Induced Heart
   Disease: From Bench to Bedside
SO FRONTIERS IN CARDIOVASCULAR MEDICINE
LA English
DT Review
DE mitochondria; radiation-adverse effects; radiation-induced
   cardiovascular toxicity; oxidative stress; radiation; cardiomyocyte;
   endothelial cell; apoptosis
ID INFLAMMATORY PLAQUE PHENOTYPE; IONIZING-RADIATION; CONFORMAL
   RADIOTHERAPY; CARDIAC-MUSCLE; LUNG-CANCER; DNA; IRRADIATION; MECHANISMS;
   ACTIVATION; DELETION
AB Radiation is a key modality in the treatment of many cancers; however, it can also affect normal tissues adjacent to the tumor, leading to toxic effects. Radiation to the thoracic region, such as that received as part of treatment for breast and lung cancer, can result in incidental dose to the heart, leading to cardiac dysfunction, such as pericarditis, coronary artery disease, ischemic heart disease, conduction defects, and valvular dysfunction. The underlying mechanisms for these morbidities are currently being studied but are not entirely understood. There has been increasing focus on the role of radiation-induced mitochondrial dysfunction and the ensuing impact on various cardiac functions in both preclinical models and in humans. Cardiomyocyte mitochondria are critical to cardiac function, and mitochondria make up a substantial part of a cardiomyocyte's volume. Mitochondrial dysfunction can also alter other cell types in the heart. This review summarizes several factors related to radiation-induced mitochondrial dysfunction in cardiomyocytes and endothelial cells. These factors include mitochondrial DNA mutations, oxidative stress, alterations in various mitochondrial function-related transcription factors, and apoptosis. Through improved understanding of mitochondria-dependent mechanisms of radiation-induced heart dysfunction, potential therapeutic targets can be developed to assist in prevention and treatment of radiation-induced heart damage.
C1 [Livingston, Katie; Puckett, Lindsay L.; Bergom, Carmen] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA.
   [Livingston, Katie; Schlaak, Rachel A.; Puckett, Lindsay L.; Bergom, Carmen] Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA.
   [Schlaak, Rachel A.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA.
   [Bergom, Carmen] Med Coll Wisconsin, Cardiovasc Ctr, Milwaukee, WI 53226 USA.
C3 Medical College of Wisconsin; Medical College of Wisconsin; Medical
   College of Wisconsin; Medical College of Wisconsin
RP Bergom, C (corresponding author), Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA.; Bergom, C (corresponding author), Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA.; Bergom, C (corresponding author), Med Coll Wisconsin, Cardiovasc Ctr, Milwaukee, WI 53226 USA.
EM cbergom@mcw.edu
OI Bergom, Carmen/0000-0002-0886-5055
FU Medical College of Wisconsin (MCW) Cancer Center; Dr. Nancy Sobczak Fund
   for Breast Cancer; Mary Kay Foundation [01729]; Susan G. Komen Grant
   [CCR17483233]; Cardiovascular Center at the Medical College ofWisconsin;
   NIH/NHLBI [1R01HL147884]; Michael H. Keelan, Jr., MD, Research
   Foundation Grant
FX This work was supported by the Medical College of Wisconsin (MCW) Cancer
   Center and the Dr. Nancy Sobczak Fund for Breast Cancer (CB). Support
   was also received fromNIH/NHLBI 1R01HL147884 (CB), the Mary Kay
   Foundation Grant No. 01729 (CB), a Susan G. Komen Grant #CCR17483233
   (CB), and the Michael H. Keelan, Jr., MD, Research Foundation Grant and
   the Cardiovascular Center at the Medical College ofWisconsin (CB).
CR Azimzadeh O, 2017, ONCOTARGET, V8, P9067, DOI 10.18632/oncotarget.10424
   Azimzadeh O, 2015, J PROTEOME RES, V14, P1203, DOI 10.1021/pr501141b
   Azimzadeh O, 2013, J PROTEOME RES, V12, P2700, DOI 10.1021/pr400071g
   Azimzadeh O, 2011, PROTEOMICS, V11, P3299, DOI 10.1002/pmic.201100178
   Azizova TV, 2010, RADIAT RES, V174, P155, DOI 10.1667/RR1789.1
   Azizova TV, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150169
   Barjaktarovic Z, 2013, RADIOTHER ONCOL, V106, P404, DOI 10.1016/j.radonc.2013.01.017
   Barjaktarovic Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027811
   BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S
   Baselet B, 2019, CELL MOL LIFE SCI, V76, P699, DOI 10.1007/s00018-018-2956-z
   Baselet B, 2016, INT J MOL MED, V38, P1623, DOI 10.3892/ijmm.2016.2777
   Bergom C, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00087
   Bergom C, 2012, INT J RADIAT ONCOL, V83, P821, DOI 10.1016/j.ijrobp.2011.08.020
   Bernard ME, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00001
   Boerma M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/858262
   Boerma M, 2016, MUTAT RES-REV MUTAT, V770, P319, DOI 10.1016/j.mrrev.2016.07.003
   Boerma M, 2015, RADIAT RES, V183, P610, DOI 10.1667/RR13979.1
   Bradley JD, 2015, LANCET ONCOL, V16, P187, DOI 10.1016/S1470-2045(14)71207-0
   Bradley JA, 2018, ANNU REV MED, V69, P277, DOI 10.1146/annurev-med-042716-103422
   BURCH GE, 1968, ARCH INTERN MED, V121, P230, DOI 10.1001/archinte.121.3.230
   Ciccarelli M, 2013, ARTERIOSCL THROM VAS, V33, P2415, DOI 10.1161/ATVBAHA.113.302262
   Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825
   Dess RT, 2017, J CLIN ONCOL, V35, P1395, DOI 10.1200/JCO.2016.71.6142
   Ehrbar S, 2016, RADIOTHER ONCOL, V121, P328, DOI 10.1016/j.radonc.2016.10.011
   Ellulu MS, 2016, INFLAMMOPHARMACOLOGY, V24, P1, DOI 10.1007/s10787-015-0255-y
   Ferreira-Machado SC, 2013, AN ACAD BRAS CIENC, V85, P215, DOI 10.1590/S0001-37652013005000009
   Franco A, 2016, TRANSL MED UNISA, V14, P45
   Franco A, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0028-7
   Grygiel-Górniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17
   Haddy N, 2016, CIRCULATION, V133, P31, DOI 10.1161/CIRCULATIONAHA.115.016686
   Haque W, 2018, INT J RADIAT ONCOL, V100, P470, DOI 10.1016/j.ijrobp.2017.10.031
   Holmstrom Kira M., 2016, Current Opinion in Toxicology, V1, P80, DOI 10.1016/j.cotox.2016.10.002
   Hoving S, 2008, INT J RADIAT ONCOL, V71, P848, DOI 10.1016/j.ijrobp.2008.02.031
   Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974
   Kaczmarek A, 2004, STRUCT CHEM, V15, P517, DOI 10.1023/B:STUC.0000037910.26456.59
   Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001
   KHAN MY, 1973, AM J PATHOL, V73, P131
   Koleini N, 2017, ONCOTARGET, V8, P46663, DOI 10.18632/oncotarget.16944
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Lin PH, 2003, FREE RADICAL BIO MED, V35, P1310, DOI 10.1016/j.freeradbiomed.2003.07.002
   Little MP, 2009, J RADIOL PROT, V29, pA43, DOI 10.1088/0952-4746/29/2A/S04
   LJUNGMAN M, 1992, MOL CARCINOGEN, V5, P264, DOI 10.1002/mc.2940050406
   Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c
   Modiri A, 2017, INT J RADIAT ONCOL, V99, P317, DOI 10.1016/j.ijrobp.2017.05.039
   Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606
   Nojiri H, 2006, J BIOL CHEM, V281, P33789, DOI 10.1074/jbc.M602118200
   Piquereau J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00102
   Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078
   Richard SM, 2000, CANCER RES, V60, P4231
   Rivas V, 2013, J CLIN INVEST, V123, P4714, DOI 10.1172/JCI67333
   Salata C, 2014, INT J RADIAT BIOL, V90, P284, DOI 10.3109/09553002.2014.887869
   Schilling-Tóth B, 2011, MUTAT RES-FUND MOL M, V716, P33, DOI 10.1016/j.mrfmmm.2011.07.018
   Schlaak RA, 2019, AM J PHYSIOL-HEART C, V316, pH1267, DOI 10.1152/ajpheart.00482.2018
   Simonetto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096309
   Sorriento D, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00064
   Sorriento D, 2014, TRANSL MED UNISA, V10, P3
   Speirs CK, 2017, J THORAC ONCOL, V12, P293, DOI 10.1016/j.jtho.2016.09.134
   Sridharan V, 2014, RADIAT RES, V181, P324, DOI 10.1667/RR13452.1
   Stewart F. A., 2012, Annals of the ICRP, V41, P72, DOI 10.1016/j.icrp.2012.06.031
   Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409
   STEWART JR, 1984, PROG CARDIOVASC DIS, V27, P173
   Tanno M, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0273-5
   Tapio S, 2016, J RADIAT RES, V57, P439, DOI 10.1093/jrr/rrw064
   VOS J, 1983, VIRCHOWS ARCH B, V43, P1, DOI 10.1007/BF02932938
   Wang HR, 2019, INT J BIOL SCI, V15, P2128, DOI 10.7150/ijbs.35460
   Wang K, 2017, RADIOTHER ONCOL, V125, P293, DOI 10.1016/j.radonc.2017.10.001
   Wang L, 2007, INT J RADIAT BIOL, V83, P433, DOI 10.1080/09553000701370878
   Wang YY, 2016, RADIAT RES, V186, P153, DOI 10.1667/RR14445.1
   Yegya-Raman N, 2018, J THORAC ONCOL, V13, P1508, DOI 10.1016/j.jtho.2018.05.028
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
NR 70
TC 42
Z9 47
U1 0
U2 14
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2297-055X
J9 FRONT CARDIOVASC MED
JI Front. Cardiovasc. Med.
PD FEB 21
PY 2020
VL 7
AR 20
DI 10.3389/fcvm.2020.00020
PG 8
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA KZ8CT
UT WOS:000523487000001
PM 32154269
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Kasiviswanathan, R
   Longley, MJ
   Young, MJ
   Copeland, WC
AF Kasiviswanathan, Rajesh
   Longley, Matthew J.
   Young, Matthew J.
   Copeland, William C.
TI Purification and functional characterization of human mitochondrial DNA
   polymerase gamma harboring disease mutations
SO METHODS
LA English
DT Article
DE Mitochondrial DNA; DNA polymerase gamma; p55 accessory subunit; Alpers
   syndrome; Progressive external ophthalmoplegia
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; ACCESSORY SUBUNIT; W748S MUTATION;
   REPLICATION; DEFECTS
AB More than 150 different point mutations in POLG, the gene encoding the human mitochondrial DNA polymerase gamma (pol gamma), cause a broad spectrum of childhood and adult onset diseases like Alpers syndrome, ataxia-neuropathy syndrome and progressive external ophthalmoplegia. These disease mutations can affect the pot gamma enzyme's properties in numerous ways, thus potentially influencing the severity of the disease. Hence, a detailed characterization of disease mutants will greatly assist researchers and clinicians to develop a clear understanding of the functional defects caused by these mutant enzymes. Experimental approaches for characterizing the wild-type (WT) and mutant pot gamma enzymes are extensively described in this manuscript. The methods start with construction and purification of the recombinant wild-type and mutant forms of pot gamma protein, followed by assays to determine its structural integrity and thermal stability. Next, the biochemical characterization of these enzymes is described in detail, which includes measuring the purified enzyme's catalytic activity, its steady-state kinetic parameters and DNA binding activity, and determining the physical and functional interaction of these pot gamma proteins with the p55 accessory subunit. Published by Elsevier Inc.
C1 [Kasiviswanathan, Rajesh; Longley, Matthew J.; Young, Matthew J.; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Kasiviswanathan, Rajesh/D-2744-2012; Copeland, William/C-4242-2019
OI Young, Matthew/0000-0002-5109-4719; Copeland,
   William/0000-0002-0359-0953
FU NIEHS
FX The authors would like to thank Drs. Deepti Dwivedi and Rajendra Prasad
   for critical reading of this manuscript. This work was supported by the
   NIEHS Intramural Research Program.
CR Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, METHODS MOL BIOL, V554, P59, DOI 10.1007/978-1-59745-521-3_4
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 19
TC 19
Z9 21
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD AUG
PY 2010
VL 51
IS 4
BP 379
EP 384
DI 10.1016/j.ymeth.2010.02.015
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 640KK
UT WOS:000281049900004
PM 20176107
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Povea-Cabello, S
   Villanueva-Paz, M
   Suárez-Rivero, JM
   Alvarez-Córdoba, M
   Villalón-García, I
   Talaverón-Rey, M
   Suárez-Carrillo, A
   Munuera-Cabeza, M
   Sánchez-Alcázar, JA
AF Povea-Cabello, Suleva
   Villanueva-Paz, Marina
   Suarez-Rivero, Juan M.
   alvarez-Cordoba, Monica
   Villalon-Garcia, Irene
   Talaveron-Rey, Marta
   Suarez-Carrillo, Alejandra
   Munuera-Cabeza, Manuel
   Sanchez-Alcazar, Jose A.
TI Advances in mt-tRNA Mutation-Caused Mitochondrial Disease Modeling:
   Patients' Brain in a Dish
SO FRONTIERS IN GENETICS
LA English
DT Review
DE mitochondrial diseases; mtDNA; disease modeling; direct reprogramming;
   induced neurons
ID PLURIPOTENT STEM-CELLS; RESPIRATORY-CHAIN SUPERCOMPLEXES; HUMAN
   FIBROBLASTS; DIRECT CONVERSION; DRUG DISCOVERY; MOUSE MODELS; SELECTIVE
   DEGRADATION; MYOCLONIC EPILEPSY; OXIDATIVE STRESS; DNA MUTATION
AB Mitochondrial diseases are a heterogeneous group of rare genetic disorders that can be caused by mutations in nuclear (nDNA) or mitochondrial DNA (mtDNA). Mutations in mtDNA are associated with several maternally inherited genetic diseases, with mitochondrial dysfunction as a main pathological feature. These diseases, although frequently multisystemic, mainly affect organs that require large amounts of energy such as the brain and the skeletal muscle. In contrast to the difficulty of obtaining neuronal and muscle cell models, the development of induced pluripotent stem cells (iPSCs) has shed light on the study of mitochondrial diseases. However, it is still a challenge to obtain an appropriate cellular model in order to find new therapeutic options for people suffering from these diseases. In this review, we deepen the knowledge in the current models for the most studied mt-tRNA mutation-caused mitochondrial diseases, MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) and MERRF (myoclonic epilepsy with ragged red fibers) syndromes, and their therapeutic management. In particular, we will discuss the development of a novel model for mitochondrial disease research that consists of induced neurons (iNs) generated by direct reprogramming of fibroblasts derived from patients suffering from MERRF syndrome. We hypothesize that iNs will be helpful for mitochondrial disease modeling, since they could mimic patient's neuron pathophysiology and give us the opportunity to correct the alterations in one of the most affected cellular types in these disorders.
C1 [Povea-Cabello, Suleva; Suarez-Rivero, Juan M.; alvarez-Cordoba, Monica; Villalon-Garcia, Irene; Talaveron-Rey, Marta; Suarez-Carrillo, Alejandra; Munuera-Cabeza, Manuel; Sanchez-Alcazar, Jose A.] Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, Seville, Spain.
   [Povea-Cabello, Suleva; Suarez-Rivero, Juan M.; alvarez-Cordoba, Monica; Villalon-Garcia, Irene; Talaveron-Rey, Marta; Suarez-Carrillo, Alejandra; Munuera-Cabeza, Manuel; Sanchez-Alcazar, Jose A.] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Seville, Spain.
   [Villanueva-Paz, Marina] Univ Malaga, Inst Invest Biomed Malaga, Dept Farmacol & Pediat, Fac Med, Malaga, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); Universidad
   Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology
   (CABD); Instituto de Salud Carlos III; CIBER - Centro de Investigacion
   Biomedica en Red; CIBERER; Universidad de Malaga
RP Sánchez-Alcázar, JA (corresponding author), Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, Seville, Spain.; Sánchez-Alcázar, JA (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Seville, Spain.
EM jasanalc@upo.es
RI Sanchéz-Alcázar, José/L-4925-2014; Povea, Suleva/LCE-7098-2024;
   Villanueva, Marina/AAN-9818-2020; Suarez Carrillo,
   Alejandra/JSK-9506-2023
OI Talaveron, Marta/0000-0002-5006-3814; Suarez-Rivero, Juan
   Miguel/0000-0002-6260-7284; Alvarez-Cordoba, Monica/0000-0002-7596-8708;
   Villanueva Paz, Marina/0000-0003-4728-201X; Suarez Carrillo,
   Alejandra/0000-0001-5765-4134; munuera cabeza,
   Manuel/0000-0003-1901-0332
FU Instituto de Salud Carlos III, Spain [PI19/00377]; Fondo Europeo de
   Desarrollo Regional (FEDER-Union Europea); Spanish Ministry of
   Education, Culture and Sport, "Ayudas para la Formacion de Profesorado
   Universitario" (FPU); AEPMI (Asociacion de Enfermos de Patologia
   Mitocondrial)
FX This work was supported by PI19/00377 grant, Instituto de Salud Carlos
   III, Spain, and Fondo Europeo de Desarrollo Regional (FEDER-Union
   Europea), Spanish Ministry of Education, Culture and Sport, "Ayudas para
   la Formacion de Profesorado Universitario" (FPU), and AEPMI (Asociacion
   de Enfermos de Patologia Mitocondrial).
CR Alberts B., 2007, MOL BIOL CELL
   Amin ND, 2018, NEURON, V100, P389, DOI 10.1016/j.neuron.2018.10.007
   Angelini C., 2014, GENETIC NEUROMUSCULA, P39
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Baile MG, 2013, FRONT BIOSCI-LANDMRK, V18, P241, DOI 10.2741/4098
   Balsa E, 2019, MOL CELL, V74, P877, DOI 10.1016/j.molcel.2019.03.031
   Birtele M, 2019, FEBS LETT, V593, P3370, DOI 10.1002/1873-3468.13612
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   BOURGERON T, 1992, BIOCHEM BIOPH RES CO, V186, P16, DOI 10.1016/S0006-291X(05)80769-7
   Brisca G, 2015, BIOCHEM BIOPH RES CO, V458, P601, DOI 10.1016/j.bbrc.2015.01.157
   Brzezinski P, 2020, TRENDS BIOCHEM SCI, V45, P3, DOI 10.1016/j.tibs.2019.10.011
   Bulthuis EP, 2019, ANTIOXID REDOX SIGN, V30, P2066, DOI 10.1089/ars.2018.7534
   Busch KB, 2020, INT J BIOCHEM CELL B, V120, DOI 10.1016/j.biocel.2020.105694
   Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284
   Celotto AM, 2006, J NEUROSCI, V26, P810, DOI 10.1523/JNEUROSCI.4162-05.2006
   Chang JC, 2013, CYTOTHERAPY, V15, P1580, DOI 10.1016/j.jcyt.2013.06.008
   Chapman J, 2020, LIFE-BASEL, V10, DOI 10.3390/life10090164
   Cherry ABC, 2013, STEM CELLS, V31, P1287, DOI 10.1002/stem.1354
   Chin Randall Marcelo, 2018, BMC Res Notes, V11, P205, DOI 10.1186/s13104-018-3297-6
   Chou SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23661
   Cogliati S, 2016, NATURE, V539, P579, DOI 10.1038/nature20157
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   Crow D, 2019, CELL, V177, P1667, DOI 10.1016/j.cell.2019.05.043
   De la Mata M, 2012, NEUROTHERAPEUTICS, V9, P446, DOI 10.1007/s13311-012-0103-3
   DiMauro S., 1993, GENEREVIEWS
   DiMauro S. H. M., 2015, GENEREVIEWS
   DiMauro S, 2007, BIOSCIENCE REP, V27, P5, DOI 10.1007/s10540-007-9032-5
   Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034
   Drouin-Ouellet J, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00530
   Drouin-Ouellet J, 2017, EMBO MOL MED, V9, P1117, DOI 10.15252/emmm.201607471
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Falk MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006607
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2019, EXPERT OPIN PHARMACO, V20, P1289, DOI 10.1080/14656566.2019.1609941
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Garrido-Maraver J, 2015, BBA-MOL BASIS DIS, V1852, P2535, DOI 10.1016/j.bbadis.2015.08.027
   Garrido-Maraver J, 2012, BRIT J PHARMACOL, V167, P1311, DOI 10.1111/j.1476-5381.2012.02086.x
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gunnewiek TMK, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107538
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Hsu YC, 2016, BBA-GEN SUBJECTS, V1860, P686, DOI 10.1016/j.bbagen.2016.01.009
   Hu SY, 2019, J ZHEJIANG UNIV-SC B, V20, P449, DOI 10.1631/jzus.B1900196
   Huh CJ, 2016, ELIFE, V5, DOI [10.7554/elife.18648, 10.7554/eLife.18648]
   Ikejiri Y, 1996, NEUROLOGY, V47, P583, DOI 10.1212/WNL.47.2.583
   Inak G, 2017, STEM CELLS, V35, P1655, DOI 10.1002/stem.2637
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Iommarini L, 2015, MITOCHONDRION, V22, P96, DOI 10.1016/j.mito.2015.01.008
   Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331
   Jang S, 2020, MITOCHONDRION, V51, P30, DOI 10.1016/j.mito.2019.11.006
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200
   Kirino Yohei, 2005, RNA Biol, V2, P41, DOI 10.4161/rna.2.2.1610
   Kodaira M, 2015, FEBS OPEN BIO, V5, P219, DOI 10.1016/j.fob.2015.03.008
   Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009
   Ladewig J, 2013, NAT REV MOL CELL BIO, V14, P225, DOI 10.1038/nrm3543
   Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/nmeth.1972, 10.1038/NMETH.1972]
   Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Liu WS, 2007, GENETICS, V176, P937, DOI 10.1534/genetics.107.071688
   Lorenz C, 2017, CELL STEM CELL, V20, P659, DOI 10.1016/j.stem.2016.12.013
   Lott MT., 2013, Curr Protoc Bioinf, V44, P1231, DOI DOI 10.1002/0471250953.BI0123S44
   Martín-Jiménez R, 2020, DNA CELL BIOL, V39, P1421, DOI 10.1089/dna.2020.5398
   Mast JD, 2008, DEVELOPMENT, V135, P2669, DOI 10.1242/dev.020644
   McGregor A, 2001, MOL GENET GENOMICS, V265, P721, DOI 10.1007/s004380100469
   Mertens J, 2015, CELL STEM CELL, V17, P705, DOI 10.1016/j.stem.2015.09.001
   Meyerson C, 2015, CLIN OPHTHALMOL, V9, P1165, DOI 10.2147/OPTH.S62021
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Murphy E, 2016, CIRC RES, V118, P1960, DOI 10.1161/RES.0000000000000104
   Nakada K, 2001, SEMIN CELL DEV BIOL, V12, P459, DOI 10.1006/scdb.2001.0283
   Napolitano A, 2000, NEUROL SCI, V21, pS981, DOI 10.1007/s100720070015
   Nissanka N, 2020, EMBO REP, V21, DOI 10.15252/embr.201949612
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   Pacitti D, 2018, NUCLEOS NUCLEOT NUCL, V37, P603, DOI 10.1080/15257770.2018.1492139
   Palladino MJ, 2010, NEUROBIOL DIS, V40, P40, DOI 10.1016/j.nbd.2010.05.009
   Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293
   Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202
   Parmar M, 2011, CELL RES, V21, P1386, DOI 10.1038/cr.2011.130
   Perales-Clemente E, 2016, EMBO J, V35, P1979, DOI 10.15252/embj.201694892
   Pfisterer U, 2016, SCI REP-UK, V6, DOI 10.1038/srep38290
   Pickrell AM, 2013, CURR BIOL, V23, pR1052, DOI 10.1016/j.cub.2013.10.048
   Qin H, 2018, SCI CHINA LIFE SCI, V61, P1151, DOI 10.1007/s11427-018-9359-8
   Reddy P, 2020, GENES-BASEL, V11, DOI 10.3390/genes11090976
   Rinaldi T, 2010, FEMS YEAST RES, V10, P1006, DOI 10.1111/j.1567-1364.2010.00685.x
   Rusanen H, 2000, BBA-MOL BASIS DIS, V1500, P10, DOI 10.1016/S0925-4439(99)00081-2
   Russell O, 2014, EXP CELL RES, V325, P38, DOI 10.1016/j.yexcr.2014.03.012
   Sage-Schwaede A, 2019, ANN CLIN TRANSL NEUR, V6, P1877, DOI 10.1002/acn3.50846
   Santa KM, 2010, PHARMACOTHERAPY, V30, P1179, DOI 10.1592/phco.30.11.1179
   Saxena Nishtha, 2018, J Hum Reprod Sci, V11, P3, DOI [10.4103/jhrs.jhrs_54_17, 10.4103/jhrs.JHRS_54_17]
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shrigley S, 2018, JOVE-J VIS EXP, DOI 10.3791/56904
   Sie L, 2009, J NEUROSCI RES, V87, P1953, DOI 10.1002/jnr.22000
   Smith C, 2015, MOL THER, V23, P570, DOI 10.1038/mt.2014.226
   Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014
   Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Swerdlow RH, 2009, J ALZHEIMERS DIS, V17, P737, DOI 10.3233/JAD-2009-1095
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110
   Torraco A, 2015, MITOCHONDRION, V21, P76, DOI 10.1016/j.mito.2015.01.009
   Tsang WY, 2003, BBA-MOL BASIS DIS, V1638, P91, DOI 10.1016/S0925-4439(03)00079-6
   Tsang WY, 2001, J BIOL CHEM, V276, P32240, DOI 10.1074/jbc.M103999200
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200
   Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797
   Villanueva-Paz M, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165726
   Villanueva-Paz M, 2019, BBA-MOL CELL RES, V1866, P861, DOI 10.1016/j.bbamcr.2019.02.010
   Viscomi C, 2020, J INTERN MED, V287, P665, DOI 10.1111/joim.13046
   Vithayathil SA, 2012, METHODS MOL BIOL, V837, P219, DOI 10.1007/978-1-61779-504-6_15
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wilkins HM, 2014, REDOX BIOL, V2, P619, DOI 10.1016/j.redox.2014.03.006
   Wollweber F, 2017, BBA-MOL CELL RES, V1864, P1481, DOI 10.1016/j.bbamcr.2017.05.004
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
   Xu Z, 2016, MOL PSYCHIATR, V21, P62, DOI 10.1038/mp.2015.101
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
   YONEDA M, 1990, BIOCHEM INT, V21, P789
   Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zeviani M, 2003, CURR OPIN NEUROL, V16, P585, DOI 10.1097/00019052-200310000-00004
   Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd
   Zhang X, 2016, METHODS MOL BIOL, V1353, P323, DOI 10.1007/7651_2014_195
NR 131
TC 10
Z9 10
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD JAN 12
PY 2021
VL 11
AR 610764
DI 10.3389/fgene.2020.610764
PG 13
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA PX7YT
UT WOS:000611571100001
PM 33510772
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Raule, N
   Sevini, F
   Santoro, A
   Altilia, S
   Franceschi, C
AF Raule, Nicola
   Sevini, Federica
   Santoro, Aurelia
   Altilia, Serena
   Franceschi, Claudio
TI Association studies on human mitochondrial DNA: Methodological aspects
   and results in the most common age-related diseases
SO MITOCHONDRION
LA English
DT Review
DE mitochondrial DNA; longevity; mtDNA mutations; mtDNA haplogroups;
   centenarians; mtDNA resequencing
ID PARKINSONS-DISEASE; HUMAN MTDNA; ALZHEIMER-DISEASE; CONTROL-REGION;
   POPULATION-GENETICS; REPLICATION ORIGIN; OXIDATIVE STRESS; ISLAND
   MELANESIA; SKELETAL-MUSCLE; HUMAN-EVOLUTION
AB Mitochondrial DNA (mtDNA) follows direct maternal inheritance and, as such, can be used in phylogenetic studies to determine a human lineage tree. The presence of common polymorphisms allows a classification of mtDNA in haplogroups and sub-haplogroups, according to the branch they belong to. Thanks to the rapidly growing number of mtDNA sequences available, this classification is being corrected and redefined to be more accurate. In parallel with this process, several studies are trying to identify an association between common mtDNA polymorphisms and common complex traits, as hypothesized by the common disease-common variant theory. Here we review the associations already reported with the main age-related complex diseases and we identify the critical points (sample size, size of the recruiting area, careful matching between cases and controls regarding geographical origin and ethnicity, data quality checking) to be taken in account in planning such studies. On the whole, this research area is opening a new perspective as an important component of "mitochondrial medicine", capable of identifying new molecular targets for the diagnosis, prevention and treatment of common complex diseases. (c) 2007 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 Ctr Interdipartimentale L Galvani, I-40126 Bologna, Italy.
   Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.
   INRCA Ancona, Dept Gerontol Sci, I-60121 Ancona, Italy.
C3 University of Bologna; IRCCS INRCA
RP Raule, N (corresponding author), Ctr Interdipartimentale L Galvani, Via S Giacomo 12, I-40126 Bologna, Italy.
EM nicola.raule@unibo.it
RI Franceschi, Claudio/L-4484-2017
OI Santoro, Aurelia/0000-0002-7187-1116
CR Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590
   Alcolado JC, 2002, DIABETIC MED, V19, P89, DOI 10.1046/j.1464-5491.2002.00675.x
   Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9
   Bandelt HJ, 2005, J MED GENET, V42, P957, DOI 10.1136/jmg.2005.033589
   Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055
   Bandelt HJ, 2004, SCIENCE, V305, P1402
   Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397
   Booker LM, 2006, J UROLOGY, V175, P468, DOI 10.1016/S0022-5347(05)00163-1
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605
   CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0
   Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463
   Casali C, 1999, J AM COLL CARDIOL, V33, P1584, DOI 10.1016/S0735-1097(99)00079-0
   CASTRO MG, 2005, IN PRESS INT J CARDI
   Cavalli LR, 1998, MUTAT RES-FUND MOL M, V398, P19, DOI 10.1016/S0027-5107(97)00223-6
   Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K
   Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482
   Chinnery PF, 2000, NEUROLOGY, V55, P302, DOI 10.1212/WNL.55.2.302
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100
   Cournil A, 2001, TRENDS GENET, V17, P233, DOI 10.1016/S0168-9525(01)02306-X
   D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326
   Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768
   DiMauro S., 1993, Mitochondrial DNA in Human Pathology
   Elson JL, 2006, HUM GENET, V119, P241, DOI 10.1007/s00439-005-0123-8
   Eyre-Walker A, 1999, P ROY SOC B-BIOL SCI, V266, P477, DOI 10.1098/rspb.1999.0662
   Finch CE., 2000, CHANCE DEV AGING
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Forster R, 2003, ANN HUM GENET, V67, P2, DOI 10.1046/j.1469-1809.2003.00002.x
   Franceschi C, 2005, MECH AGEING DEV, V126, P351, DOI 10.1016/j.mad.2004.08.028
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Gibson BW, 2005, INT J BIOCHEM CELL B, V37, P927, DOI 10.1016/j.biocel.2004.11.013
   GRAY MW, 1989, ANNU REV CELL BIOL, V5, P25, DOI 10.1146/annurev.cb.05.110189.000325
   Hagelberg E, 2000, P ROY SOC B-BIOL SCI, V267, P1595, DOI 10.1098/rspb.2000.1183
   Hagelberg E, 1999, P ROY SOC B-BIOL SCI, V266, P485, DOI 10.1098/rspb.1999.0663
   Herrnstadt C, 2004, MITOCHONDRION, V4, P791, DOI 10.1016/j.mito.2004.07.041
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   ITO T, 1992, JPN CIRC J, V56, P1045, DOI 10.1253/jcj.56.1045
   Kang DC, 2005, CLIN BIOCHEM, V38, P685, DOI 10.1016/j.clinbiochem.2005.04.014
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901
   Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   Lander Harry M., 1996, Methods (Orlando), V10, P15, DOI 10.1006/meth.1996.0073
   Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792
   Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204
   Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a
   MERANTE F, 1994, AM J HUM GENET, V55, P437
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100
   MITCHELL P, 1976, BIOCHEM SOC T, V4, P399, DOI 10.1042/bst0040399
   MIYATA T, 1982, J MOL EVOL, V19, P28, DOI 10.1007/BF02100221
   Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4
   Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308
   Niemi AK, 2005, EUR J HUM GENET, V13, P965, DOI 10.1038/sj.ejhg.5201438
   Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y
   Oikawa H, 2002, BIOCHEM BIOPH RES CO, V297, P341, DOI 10.1016/S0006-291X(02)02198-8
   Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871
   Parr Ryan L., 2006, Human Genomics, V2, P252
   Pereira L, 2005, INT J ANDROL, V28, P241, DOI 10.1111/j.1365-2605.2005.00539.x
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   ROFF DA, 1989, MOL BIOL EVOL, V6, P539
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296
   Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161
   Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682
   Sato A, 2005, P NATL ACAD SCI USA, V102, P6057, DOI 10.1073/pnas.0408666102
   Schwartz M, 2003, BIOCHEM BIOPH RES CO, V310, P247, DOI 10.1016/j.bbrc.2003.09.037
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Scott RA, 2005, COMP BIOCHEM PHYS B, V140, P497, DOI 10.1016/j.cbpc.2004.11.014
   SHERROD LR, 1999, NATL HEAD START ASS, V2, P412
   Torroni A, 1996, GENETICS, V144, P1835
   TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098
   TORRONI A, 2006, IN PRESS TRENDS GENE
   van der Walt JM, 2005, HUM GENET, V118, P115, DOI 10.1007/s00439-005-0032-x
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661
   WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739
   Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
   Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
   Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606
NR 98
TC 41
Z9 49
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD FEB-APR
PY 2007
VL 7
IS 1-2
BP 29
EP 38
DI 10.1016/j.mito.2006.11.013
PG 10
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 157EM
UT WOS:000245701400006
PM 17306632
DA 2024-11-01
ER

PT J
AU Bass, MG
   Sokolova, VA
   Kustova, ME
   Grachyova, EV
   Kidgotko, OV
   Sorokin, AV
   Vasilyev, VB
AF Bass, Mikhail G.
   Sokolova, Vassilina A.
   Kustova, Maria E.
   Grachyova, Elena V.
   Kidgotko, Oksana V.
   Sorokin, Alexander V.
   Vasilyev, Vadim B.
TI Assaying the probabilities of obtaining maternally inherited
   heteroplasmy as the basis for modeling OXPHOS diseases in animals
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
CT 14th European Bioenergetic Conference
CY JUL 22-27, 2006
CL Moscow, RUSSIA
DE energy metabolism; OXPHOS diseases modeling; human mtDNA; mtDNA
   transfer; transgenic mice; maternal inheritance
ID HUMAN MITOCHONDRIAL-DNA; TRANSMITOCHONDRIAL MICE; MOUSE; ORGANIZATION;
   GENE; CHLORAMPHENICOL; MICROINJECTION; CYTOSKELETON; POPULATIONS;
   SEGREGATION
AB Gross alterations in cell energy metabolism underlie manifestations of hereditary OXPHOS (oxidative phosphorylation) diseases, many of which depend on proportion of mutant mitochondrial DNA (mtDNA) in tissues. An animal model of OXPHOS disease with maternal inheritance of mitochondrial heteroplasmy might help understanding the peculiarities of abnormal mtDNA distribution and its effect on pre- and postnatal development. Previously we obtained mice that carry human mtDNA in some tissues. It co-existed with murine mtDNA (heteroplasmy) and was transmitted maternally to the progeny of animals developed from zygotes injected with human mitochondria. To analyze the probability of obtaining heteroplasmic mice we increased the number of experiments with early embryos and obtained more specimens from F-1. About 33% of zygotes injected with human mtDNA developed into post-implantation embryos (7th-13th days). Lower amount of such developed into neonate mice (ca. 21%). Among post-implantation embryos and in generations F-0 and F-1 percentages of human mtDNA-carriers were ca. 14-16%. Such percentages are sufficient for modeling maternally inherited heteroplasmy in small animal groups. More data are needed to understand the regularities of anomalous mtDNA distribution among cells and tissues and whether heart and muscles frequently carrying human mtDNA in our experiments are particularly susceptible to heteroplasmy. (c) 2006 Elsevier B.V. All rights reserved.
C1 Inst Expt Med, Dept Mol Genet, St Petersburg 197376, Russia.
C3 Institute of Experimental Medicine
RP Vasilyev, VB (corresponding author), Inst Expt Med, Dept Mol Genet, 12 Pavlov St, St Petersburg 197376, Russia.
EM vadim@biomed.spb.su
RI Vasilyev, Vadim/G-4297-2015; Sorokin, Alexander/AAG-1703-2021
OI Kustova, Maria/0000-0002-4149-2895
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BASS MG, 2005, MED ACAD J, V5, P55
   BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759
   BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7
   DVOIRIN VV, 1985, METHODS CONTROLLED C
   Dykens James A., 1997, P29
   Glantz S., 1994, Primer of Biostatistics
   Hermann GJ, 1997, J CELL BIOL, V137, P141, DOI 10.1083/jcb.137.1.141
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Howell N, 1999, INT REV CYTOL, V186, P49
   Irwin MH, 1999, TRANSGENIC RES, V8, P119, DOI 10.1023/A:1008925419758
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Levy SE, 1999, TRANSGENIC RES, V8, P137, DOI 10.1023/A:1008967412955
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Maniatis T., 1982, Molecular Cloning: A Laboratory Manual. Vol, V2
   Marchington DR, 1999, NAT MED, V5, P957, DOI 10.1038/11403
   Nagao Yasumitsu, 1998, Journal of Reproduction and Development, V44, P129, DOI 10.1262/jrd.44.129
   PENMAN S, 1995, P NATL ACAD SCI USA, V92, P5251, DOI 10.1073/pnas.92.12.5251
   Poulton J, 1996, PRENATAL DIAG, V16, P1247, DOI 10.1002/(SICI)1097-0223(199612)16:13<1247::AID-PD99>3.0.CO;2-P
   Rinaudo P, 1999, FERTIL STERIL, V71, P912, DOI 10.1016/S0015-0282(99)00089-8
   Sokolova VA, 2004, MOL REPROD DEV, V68, P299, DOI 10.1002/mrd.20075
   TORRONI A, 1992, GENETICS, V130, P153
   TOURTE M, 1991, MOL REPROD DEV, V30, P353, DOI 10.1002/mrd.1080300410
   Vasilyev VB, 1999, ZYGOTE, V7, P279, DOI 10.1017/S0967199499000672
NR 26
TC 5
Z9 7
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD MAY-JUN
PY 2006
VL 1757
IS 5-6
BP 679
EP 685
DI 10.1016/j.bbabio.2006.05.021
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 069XF
UT WOS:000239481800049
PM 16829232
OA Bronze
DA 2024-11-01
ER

PT J
AU Gonzalez-Freire, M
   de Cabo, R
   Bernier, M
   Sollott, SJ
   Fabbri, E
   Navas, P
   Ferrucci, L
AF Gonzalez-Freire, Marta
   de Cabo, Rafael
   Bernier, Michel
   Sollott, Steven J.
   Fabbri, Elisa
   Navas, Placido
   Ferrucci, Luigi
TI Reconsidering the Role of Mitochondria in Aging
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Mitochondria; Aging; Lifespan
ID FATTY-ACID UNSATURATION; SKELETAL-MUSCLE MITOCHONDRIA; OXIDATIVE STRESS;
   ELECTRON-TRANSPORT; DELETION MUTATIONS; LON PROTEASE; PERMEABILITY
   TRANSITION; ENDOPLASMIC-RETICULUM; AEROBIC CAPACITY; COENZYME-Q
AB Background: Mitochondrial dysfunction has long been considered a major contributor to aging and age-related diseases. Harman's Mitochondrial Free Radical Theory of Aging postulated that somatic mitochondrial DNA mutations that accumulate over the life span cause excessive production of reactive oxygen species that damage macromolecules and impair cell and tissue function. Indeed, studies have shown that maximal oxidative capacity declines with age while reactive oxygen species production increases. Harman's hypothesis has been seriously challenged by recent studies showing that reactive oxygen species evoke metabolic health and longevity, perhaps through hormetic mechanisms that include autophagy. The purpose of this review is to scan the ever-growing literature on mitochondria from the perspective of aging research and try to identify priority questions that should be addressed in future research.Methods: A systematic search of peer-reviewed studies was performed using PubMed. Search terms included (i) mitochondria or mitochondrial; (ii) aging, ageing, older adults or elderly; and (iii) reactive oxygen species, mitochondria dynamics, mitochondrial proteostasis, cytosol, mitochondrial-associated membranes, redox homeostasis, electron transport chain, electron transport chain efficiency, epigenetic regulation, DNA heteroplasmy.Results: The importance of mitochondrial biology as a trait d'union between the basic biology of aging and the pathogenesis of age-related diseases is stronger than ever, although the emphasis has moved from reactive oxygen species production to other aspects of mitochondrial physiology, including mitochondrial biogenesis and turnover, energy sensing, apoptosis, senescence, and calcium dynamics. Conclusions: Mitochondria could play a key role in the pathophysiology of aging or in the earlier stages of some events that lead to the aging phenotype. Therefore, mitochondria will increasingly be targeted to prevent and treat chronic diseases and to promote healthy aging.
C1 [Gonzalez-Freire, Marta; de Cabo, Rafael; Bernier, Michel; Fabbri, Elisa; Ferrucci, Luigi] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.
   [Sollott, Steven J.] NIA, Lab Cardiovasc Sci, NIH, Baltimore, MD 21224 USA.
   [Fabbri, Elisa] Univ Bologna, Dept Med & Surg Sci, I-40126 Bologna, Italy.
   [Navas, Placido] Univ Pablo de Olavide, CSIC, Inst Salud Carlos 3, Ctr Andaluz Biol Desarrollo,CIBERER, Seville 41013, Spain.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); National Institutes of Health (NIH) - USA; NIH National
   Institute on Aging (NIA); University of Bologna; Consejo Superior de
   Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC -
   Andalusian Center for Developmental Biology (CABD); CIBER - Centro de
   Investigacion Biomedica en Red; CIBERER
RP Gonzalez-Freire, M (corresponding author), NIA, NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.
EM marta.gonzalezfreire@nih.gov
RI Bernier, Michel/Y-7139-2019; NAVAS, PLACIDO/R-5943-2019; Ferrucci,
   Luigi/AED-9724-2022; Gonzalez-Freire, Marta/ABG-1197-2020; Sollott,
   Steven/KIH-9232-2024; de Cabo, Rafael/J-5230-2016; de Cabo,
   Rafael/E-7996-2010
OI Bernier, Michel/0000-0002-5948-368X; Ferrucci,
   Luigi/0000-0002-6273-1613; Gonzalez-Freire, Marta/0000-0001-9741-2826;
   de Cabo, Rafael/0000-0002-3354-2442; de Cabo, Rafael/0000-0003-2830-5693
FU Intramural Research Program of NIH, National Institute on Aging
FX This research was supported by the Intramural Research Program of NIH,
   National Institute on Aging.
CR Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104
   [Anonymous], 2011, COLD SPRING HARB PER, DOI DOI 10.1101/CSHPER-SPECT.A007559
   Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3
   Azzu V, 2010, J CELL SCI, V123, P578, DOI 10.1242/jcs.060004
   Bernales S, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00005
   Bhattacharya A, 2011, FREE RADICAL BIO MED, V50, P592, DOI 10.1016/j.freeradbiomed.2010.12.014
   Birk AV, 2014, BRIT J PHARMACOL, V171, P2017, DOI 10.1111/bph.12468
   Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chen YN, 2012, J GERONTOL A-BIOL, V67, P1121, DOI 10.1093/gerona/gls113
   Coen PM, 2013, J GERONTOL A-BIOL, V68, P447, DOI 10.1093/gerona/gls196
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   Crescenzo R, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-79
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119
   Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010
   Fabbri E, 2015, J GERONTOL A-BIOL, V70, P1297, DOI 10.1093/gerona/glu209
   Fernandez-Sanz C, 2015, THROMB HAEMOSTASIS, V113, P441, DOI 10.1160/TH14-10-0901
   Frenzel M, 2010, EXP GERONTOL, V45, P563, DOI 10.1016/j.exger.2010.02.003
   Giuliani C, 2014, AGING-US, V6, P454, DOI 10.18632/aging.100661
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Gómez A, 2014, AGING CELL, V13, P551, DOI 10.1111/acel.12205
   Gouspillou G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103044
   Gouspillou G, 2014, FASEB J, V28, P1621, DOI 10.1096/fj.13-242750
   Guarente L, 2014, CELL, V159, P15, DOI 10.1016/j.cell.2014.08.041
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   HARMAN D, 1972, AM J CLIN NUTR, V25, P839
   Hepple RT, 2006, REJUV RES, V9, P219, DOI 10.1089/rej.2006.9.219
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Hirota Yuko, 2012, Int J Cell Biol, V2012, P354914, DOI 10.1155/2012/354914
   Houtkooper RH, 2010, CELL, V142, P9, DOI 10.1016/j.cell.2010.06.029
   Isaya G, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00029
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603
   Jensen MB, 2014, CELL METAB, V20, P214, DOI 10.1016/j.cmet.2014.05.006
   Joseph AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069327
   Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604
   Kitazoe Y, 2011, GENOME BIOL EVOL, V3, P1233, DOI 10.1093/gbe/evr079
   Kotzbauer PT, 2005, J NEUROSCI, V25, P689, DOI 10.1523/JNEUROSCI.4265-04.2005
   Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lawless C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032117
   Lenaz G, 2012, ADV EXP MED BIOL, V748, P107, DOI 10.1007/978-1-4614-3573-0_5
   Li L, 2011, BASIC RES CARDIOL, V106, P1221, DOI 10.1007/s00395-011-0213-9
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Liu SY, 2014, AM J PHYSIOL-RENAL, V306, pF970, DOI 10.1152/ajprenal.00697.2013
   López-Domínguez JA, 2015, J GERONTOL A-BIOL, V70, P1181, DOI 10.1093/gerona/glu177
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   López-Lluch G, 2010, MECH AGEING DEV, V131, P225, DOI 10.1016/j.mad.2010.02.003
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Maharjan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05896
   Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   McCarty MF, 2004, MED HYPOTHESES, V63, P334, DOI 10.1016/j.mehy.2004.01.043
   Mendelsohn AR, 2014, REJUV RES, V17, P62, DOI 10.1089/rej.2014.1546
   Mookerjee SA, 2010, MECH AGEING DEV, V131, P463, DOI 10.1016/j.mad.2010.03.010
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200
   Newgard CB, 2014, J GERONTOL A-BIOL, V69, pS21, DOI 10.1093/gerona/glu058
   Ngo JK, 2013, REDOX BIOL, V1, P258, DOI 10.1016/j.redox.2013.01.015
   Ngo JK, 2009, FREE RADICAL BIO MED, V46, P1042, DOI 10.1016/j.freeradbiomed.2008.12.024
   O'Leary MF, 2013, AM J PHYSIOL-CELL PH, V304, pC422, DOI 10.1152/ajpcell.00240.2012
   Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021
   Pak JW, 2004, ANN NY ACAD SCI, V1019, P289, DOI 10.1196/annals.1297.049
   Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x
   Pamplona R, 1996, MECH AGEING DEV, V86, P53, DOI 10.1016/0047-6374(95)01673-2
   Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Peterson Courtney M, 2012, J Aging Res, V2012, P194821, DOI 10.1155/2012/194821
   Petrosillo G, 2009, FREE RADICAL BIO MED, V46, P88, DOI 10.1016/j.freeradbiomed.2008.09.031
   Prolla TA, 2014, CELL METAB, V19, P178, DOI 10.1016/j.cmet.2014.01.005
   Rajawat YS, 2009, AGEING RES REV, V8, P199, DOI 10.1016/j.arr.2009.05.001
   Rambold Angelika S, 2011, Commun Integr Biol, V4, P752
   Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008
   Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763
   Rodríguez-Hernández A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174
   Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184
   Rose G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013395
   Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215
   Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050
   Sahin E, 2012, NAT REV MOL CELL BIO, V13, P397, DOI 10.1038/nrm3352
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Salminen A, 2014, CELL SIGNAL, V26, P1598, DOI 10.1016/j.cellsig.2014.03.030
   Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Sevini F, 2014, EXP GERONTOL, V56, P234, DOI 10.1016/j.exger.2014.03.022
   Sgarbi G, 2014, AGING-US, V6, P296, DOI 10.18632/aging.100654
   Shaughnessy DT, 2014, ENVIRON HEALTH PERSP, V122, P1271, DOI 10.1289/ehp.1408418
   Shi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100834
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Szeto HH, 2014, CLIN PHARMACOL THER, V96, P672, DOI 10.1038/clpt.2014.174
   Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461
   Takeuchi A, 2015, J PHYSIOL SCI, V65, P11, DOI 10.1007/s12576-014-0326-7
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Umanskaya A, 2014, P NATL ACAD SCI USA, V111, P15250, DOI 10.1073/pnas.1412754111
   van Vliet AR, 2014, BBA-MOL CELL RES, V1843, P2253, DOI 10.1016/j.bbamcr.2014.03.009
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Weiss N, 2010, PFLUG ARCH EUR J PHY, V459, P631, DOI 10.1007/s00424-009-0764-x
   Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055
   Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004
NR 101
TC 165
Z9 182
U1 3
U2 107
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD NOV
PY 2015
VL 70
IS 11
BP 1334
EP 1342
DI 10.1093/gerona/glv070
PG 9
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA CW1QF
UT WOS:000364765700006
PM 25995290
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Ishikawa, K
   Miyata, D
   Hattori, S
   Tani, H
   Kuriyama, T
   Wei, FY
   Miyakawa, T
   Nakada, K
AF Ishikawa, Kaori
   Miyata, Daiki
   Hattori, Satoko
   Tani, Haruna
   Kuriyama, Takayoshi
   Wei, Fan-Yan
   Miyakawa, Tsuyoshi
   Nakada, Kazuto
TI Accumulation of mitochondrial DNA with a point mutation in tRNALeu(UUR)
   gene induces brain dysfunction in mice
SO PHARMACOLOGICAL RESEARCH
LA English
DT Article
DE Mitochondrial DNA; Brain dysfunction; MtDNA tRNALeu(UUR); Prepulse
   inhibition; Environmental factors; Memory
ID A3302G MUTATION; GENERATION; SCHIZOPHRENIA; DISEASES; MODELS; MTDNA
AB Brain functions are mediated via the complex interplay between several complex factors, and hence, identifying the underlying cause of an abnormality within a certain brain region can be challenging. In mitochondrial disease, abnormalities in brain function are thought to be attributed to accumulation of mitochondrial DNA (mtDNA) with pathogenic mutations; however, only few previous studies have directly demonstrated that accumulation of mutant mtDNA induced abnormalities in brain function. Herein, we examined the effects of mtDNA mutations on brain function via behavioral analyses using a mouse model with an A2748G point mutation in mtDNA tRNALeu(UUR). Our results revealed that mice with a high percentage of mutant mtDNA showed a characteristic trend toward reduced prepulse inhibition and memory-dependent test performance, similar to that observed in psychiatric disorders, such as schizophrenia; however, muscle strength and motor coordination were not markedly affected. Upon examining the hippocampus and frontal lobes of the brain, mitochondrial morphology was abnormal, and the brain weight was slightly reduced. These results indicate that the predominant accumulation of a point mutation in the tRNALeu(UUR) gene may affect brain functions, particularly the coordination of sensory and motor functions and memory processes. These abnormalities probably caused by both direct effects of accumulation of the mutant mtDNA in neuronal cells and indirect effects via changes of systemic extracellular environments. Overall, these findings will lead to a better understanding of the pathogenic mechanism underlying this complex disease and facilitate the development of optimal treatment methods.
C1 [Ishikawa, Kaori; Nakada, Kazuto] Univ Tsukuba, Inst Life & Environm Sci, Tsukuba, Japan.
   [Miyata, Daiki; Kuriyama, Takayoshi; Miyakawa, Tsuyoshi] Univ Tsukuba, Grad Sch Sci & Technol, Degree Programs Life & Earth Sci, Tsukuba, Japan.
   [Hattori, Satoko] Fujita Hlth Univ, Ctr Med Sci, Div Syst Med Sci, Toyoake, Japan.
   [Hattori, Satoko] Aichi Med Univ, Res Creat Support Ctr, Nagakute, Japan.
   [Tani, Haruna; Wei, Fan-Yan] Tohoku Univ, Inst Dev Aging & Canc, Dept Mod Biol & Med, Sendai, Japan.
C3 University of Tsukuba; University of Tsukuba; Fujita Health University;
   Aichi Medical University; Tohoku University
RP Ishikawa, K; Nakada, K (corresponding author), Univ Tsukuba, Inst Life & Environm Sci, Tsukuba, Japan.
EM k_ishikawa@biol.tsukuba.ac.jp; knakada@biol.tsukuba.ac.jp
FU Japan Society for the Promotion of Science (JSPS) [23H04951, 22H02536,
   23K23801]; Japan Science and Technology Agency (JST) [JPMJFR204M];
   AMED-CREST Japan Agency for Medical Research and Development (AMED)
   [JP23gm1110006]; Grant-in-Aid for Scientific Research on Innovative
   Areas (Platform of Advanced Animal Model Support) [22H04922]; Promotion
   of Distinctive Joint Research Center Program Ministry of Education,
   Culture, Sports, Science and Technology (MEXT) in Japan
   [JPMXP0621467949]
FX This work was supported by the Grant-in-Aid for Transformative Research
   Areas (A) [23H04951 to K.I.] , Scientific Research B [22H02536 and
   23K23801 to K.N.] from the Japan Society for the Promotion of Science
   (JSPS), JST FOREST Program [JPMJFR204M to K. I.] from Japan Science and
   Technology Agency (JST) , the AMED-CREST [JP23gm1110006 to K.N.] from
   the Japan Agency for Medical Research and Development (AMED) , and the
   Grant-in-Aid for Scientific Research on Innovative Areas (Platform of
   Advanced Animal Model Support [22H04922 to T.M.] ) , Promotion of
   Distinctive Joint Research Center Program (JPMXP0621467949) from the
   Ministry of Education, Culture, Sports, Science and Technology (MEXT) in
   Japan.
CR Ball M., 1993, GeneReviews
   Ballhausen D, 2010, J INHERIT METAB DIS, V33, pS219, DOI 10.1007/s10545-010-9098-2
   Borsche M, 2024, CEREBELLUM, V23, P479, DOI 10.1007/s12311-023-01557-x
   Carlén M, 2017, SCIENCE, V358, P478, DOI 10.1126/science.aan8868
   Ding Y, 2016, REPROD SCI, V23, P228, DOI 10.1177/1933719115602777
   Goto M, 2014, BRAIN DEV-JPN, V36, P180, DOI 10.1016/j.braindev.2013.03.001
   Goto Y, 2001, J INHERIT METAB DIS, V24, P181, DOI 10.1023/A:1010366917652
   Hutchison WM, 2005, ARCH NEUROL-CHICAGO, V62, P1920, DOI 10.1001/archneur.62.12.1920
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Ishikawa K, 2021, PHARMACOL RES, V163, DOI 10.1016/j.phrs.2020.105246
   Ishikawa K, 2019, J NEUROSCI, V39, P1588, DOI 10.1523/JNEUROSCI.2139-18.2018
   Kang HC, 2013, BRAIN DEV-JPN, V35, P757, DOI 10.1016/j.braindev.2013.01.006
   Kanungo S, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.12.13
   Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005
   KOLB B, 1974, J COMP PHYSIOL PSYCH, V87, P772, DOI 10.1037/h0036970
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Lim K, 2024, BMB REP, V57, P19, DOI 10.5483/BMBRep.2023-0224
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0
   Nakajima Ryuichi, 2019, Neuropsychopharmacology Reports, V39, P223, DOI 10.1002/npr2.12073
   Ogasawara E, 2020, PHARMACOL RES, V160, DOI 10.1016/j.phrs.2020.105204
   Shimizu A, 2014, P NATL ACAD SCI USA, V111, P3104, DOI 10.1073/pnas.1318109111
   SHOFFNER JM, 1993, AM J HUM GENET, V53, P949
   Shoji H, 2012, JOVE-J VIS EXP, DOI 10.3791/3300
   Sugawara A, 2006, COMPARATIVE MED, V56, P31
   Swerdlow NR, 2008, PSYCHOPHARMACOLOGY, V199, P331, DOI 10.1007/s00213-008-1072-4
   Swerdlow NR, 2006, ARCH GEN PSYCHIAT, V63, P1325, DOI 10.1001/archpsyc.63.12.1325
   Takao K, 2013, NEUROPSYCHOPHARMACOL, V38, P1409, DOI 10.1038/npp.2013.38
   Takao Keizo, 2006, J Vis Exp, P104, DOI 10.3791/104
   Tanaka D, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-21
   Tani H, 2022, NUCLEIC ACIDS RES, V50, P9382, DOI 10.1093/nar/gkac699
   van den Bosch BJC, 2004, NEUROMUSCULAR DISORD, V14, P683, DOI 10.1016/j.nmd.2004.06.004
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WATMOUGH NJ, 1990, J CLIN INVEST, V85, P177, DOI 10.1172/JCI114409
   YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458
   Yokota M, 2010, FEBS LETT, V584, P3943, DOI 10.1016/j.febslet.2010.07.048
   Zehavi Y, 2021, METAB BRAIN DIS, V36, P581, DOI 10.1007/s11011-021-00671-1
   Zsurka G, 2015, LANCET NEUROL, V14, P956, DOI 10.1016/S1474-4422(15)00148-9
NR 38
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-6618
EI 1096-1186
J9 PHARMACOL RES
JI Pharmacol. Res.
PD OCT
PY 2024
VL 208
AR 107374
DI 10.1016/j.phrs.2024.107374
EA AUG 2024
PG 10
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA E9U8R
UT WOS:001306388900001
PM 39197713
OA hybrid
DA 2024-11-01
ER

PT J
AU Cardaioli, E
   Mignarri, A
   Cantisani, TA
   Malandrini, A
   Nesti, C
   Rubegni, A
   Funel, N
   Federico, A
   Santorelli, FM
   Dotti, MT
AF Cardaioli, Elena
   Mignarri, Andrea
   Cantisani, Teresa Anna
   Malandrini, Alessandro
   Nesti, Claudia
   Rubegni, Anna
   Funel, Niccola
   Federico, Antonio
   Santorelli, Filippo Maria
   Dotti, Maria Teresa
TI Myoclonus epilepsy, retinitis pigmentosa, leukoencephalopathy and
   cerebral calcifications associated with a novel m.5513G>A mutation in
   the <i>MT</i>-<i>TW</i> gene
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Mitochondrial disease; mtDNA; tRNA(Trp); MT-TW gene; New mutation
ID MITOCHONDRIAL TRANSFER-RNA; TRNA(TRP) GENE; DNA MUTATIONS; MTDNA
   MUTATION; POINT MUTATION; ONSET; ENCEPHALOMYOPATHY; ENCEPHALOPATHY;
   PATHOGENICITY; DEFICIENCY
AB We sequenced the mitochondrial genome from a 40-year-old woman with myoclonus epilepsy, retinitis pigmentosa, leukoencephalopathy and cerebral calcifications. Histological and biochemical features of mitochondrial respiratory chain dysfunction were present. Direct sequencing showed a novel hetero-plasmic mutation at nucleotide 5513 in the MT-TW gene that encodes tRNA(TrP). Restriction Fragment Length Polymorphism analysis confirmed that about 80% of muscle mtDNA harboured the mutation while it was present in minor percentages in mtDNA from other tissues. The mutation is predicted to disrupt a highly conserved base pair within the aminoacyl acceptor stem of the tRNA. This is the 17 mutation in MT-TW gene and expands the known causes of late-onset mitochondrial diseases. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Cardaioli, Elena; Mignarri, Andrea; Malandrini, Alessandro; Federico, Antonio; Dotti, Maria Teresa] Univ Siena, Dept Med Surg & Neurosci, Viale Bracci 2, I-53100 Siena, Italy.
   [Cantisani, Teresa Anna] Azienda Osped Perugia, Perugia Hosp, Neurophysiopathol Unit, I-06156 Perugia, Italy.
   [Nesti, Claudia; Rubegni, Anna; Santorelli, Filippo Maria] IRCCS Stella Maris, Mol Med, Via Giacinti 2, I-56128 Pisa, Italy.
   [Funel, Niccola] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Via Paradisa 2, I-56124 Pisa, Italy.
C3 University of Siena; University of Perugia; Azienda Ospedaliera di
   Perugia; IRCCS Fondazione Stella Maris; University of Pisa
RP Cardaioli, E (corresponding author), Univ Siena, Dept Med Surg & Neurosci, Viale Bracci 2, I-53100 Siena, Italy.
EM cardaioli@unisi.it
RI Federico, Antonio/H-8871-2017; Rubegni, Anna/I-3221-2018; Nesti,
   Claudia/K-5866-2016; Santorelli, Filippo M/ABE-5124-2020
OI Cardaioli, Elena/0000-0003-2850-6698; Rubegni, Anna/0000-0002-0484-3799;
   Malandrini, Alessandro/0000-0003-1034-0845; Nesti,
   Claudia/0000-0001-5769-8655; Funel, Niccola/0000-0002-5028-2363;
   Santorelli, Filippo M/0000-0002-1359-9062
CR Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Baric I, 2013, EUR J HUM GENET, V21, P871, DOI 10.1038/ejhg.2012.272
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Da Pozzo P, 2004, BIOCHEM BIOPH RES CO, V324, P360, DOI 10.1016/j.bbrc.2004.09.058
   O'Callaghan MD, 2012, NEUROGENETICS, V13, P245, DOI 10.1007/s10048-012-0322-0
   Jacobs HT, 2005, EUR J HUM GENET, V13, P26, DOI 10.1038/sj.ejhg.5201250
   Malfatti E, 2010, J NEUROL SCI, V297, P105, DOI 10.1016/j.jns.2010.06.009
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   Mkaouar-Rebai E, 2009, MOL GENET METAB, V97, P179, DOI 10.1016/j.ymgme.2009.03.003
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Niroula A, 2016, NUCLEIC ACIDS RES, V44, P2020, DOI 10.1093/nar/gkw046
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Sanaker PS, 2010, ACTA NEUROL SCAND, V121, P109, DOI 10.1111/j.1600-0404.2009.01243.x
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 23
TC 4
Z9 4
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUN 2
PY 2018
VL 500
IS 2
BP 158
EP 162
DI 10.1016/j.bbrc.2018.04.009
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA GF3HR
UT WOS:000431836700009
PM 29625105
DA 2024-11-01
ER

PT J
AU Faria, R
   Boisguérin, P
   Sousa, A
   Costa, D
AF Faria, Ruben
   Boisguerin, Prisca
   Sousa, Angela
   Costa, Diana
TI Delivery Systems for Mitochondrial Gene Therapy: A Review
SO PHARMACEUTICS
LA English
DT Review
DE gene therapy; mitochondria; mitochondria-targeted delivery systems;
   mitochondrial diseases; mitochondrial gene therapy
ID MITO-PORTER; COMPLEX-I; CERIA NANOPARTICLES; SKELETAL-MUSCLE; DNA
   MUTATIONS; CANCER; DRUG; MEMBRANE; TRIPHENYLPHOSPHONIUM; EFFICIENT
AB Mitochondria are membrane-bound cellular organelles of high relevance responsible for the chemical energy production used in most of the biochemical reactions of cells. Mitochondria have their own genome, the mitochondrial DNA (mtDNA). Inherited solely from the mother, this genome is quite susceptible to mutations, mainly due to the absence of an effective repair system. Mutations in mtDNA are associated with endocrine, metabolic, neurodegenerative diseases, and even cancer. Currently, therapeutic approaches are based on the administration of a set of drugs to alleviate the symptoms of patients suffering from mitochondrial pathologies. Mitochondrial gene therapy emerges as a promising strategy as it deeply focuses on the cause of mitochondrial disorder. The development of suitable mtDNA-based delivery systems to target and transfect mammalian mitochondria represents an exciting field of research, leading to progress in the challenging task of restoring mitochondria's normal function. This review gathers relevant knowledge on the composition, targeting performance, or release profile of such nanosystems, offering researchers valuable conceptual approaches to follow in their quest for the most suitable vectors to turn mitochondrial gene therapy clinically feasible. Future studies should consider the optimization of mitochondrial genes' encapsulation, targeting ability, and transfection to mitochondria. Expectedly, this effort will bring bright results, contributing to important hallmarks in mitochondrial gene therapy.
C1 [Faria, Ruben; Sousa, Angela; Costa, Diana] Univ Beira Interior, Hlth Sci Res Ctr, CICS UBI, P-6201506 Covilha, Portugal.
   [Boisguerin, Prisca] Univ Montpellier, INSERM, CNRS, PhyMedExp, F-34295 Montpellier, France.
C3 Universidade da Beira Interior; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Centre National de la Recherche
   Scientifique (CNRS); Universite de Montpellier
RP Costa, D (corresponding author), Univ Beira Interior, Hlth Sci Res Ctr, CICS UBI, P-6201506 Covilha, Portugal.
EM dcosta@fcsaude.ubi.pt
RI Boisguerin, Prisca/AAG-6565-2020; Costa, Diana/KHY-5522-2024
OI Costa, Diana/0000-0002-5049-4518; Boisguerin,
   Prisca/0000-0002-6955-1340; Sousa, Angela/0000-0001-9155-7581; Ribeiro
   Faria, Ruben Miguel/0000-0002-4500-0018
FU FEDER [POCI-01-0145-FEDER-007491]; National Funds by FCT-Foundation for
   Science and Technology [UID/Multi/00709/2019]; CICS-UBI projects
   [UIDB/00709/2020, UIDP/00709/2020]; national funds through Portuguese
   Foundation for Science and Technology/MCTES; "Agence National de la
   Recherche" (ANR NanoCard) [ANR-21-CE18-0022-01]; "Centre National de la
   Recherche Scientifique" (CNRS); Agence Nationale de la Recherche (ANR)
   [ANR-21-CE18-0022] Funding Source: Agence Nationale de la Recherche
   (ANR)
FX This work was supported by FEDER funds through the POCI-COMPETE
   2020-Operational Program Competitiveness and Internationalization in
   Axis I-strengthening research, technological development, and innovation
   (Project POCI-01-0145-FEDER-007491) and National Funds by FCT-Foundation
   for Science and Technology (Project UID/Multi/00709/2019). This work was
   also developed within the scope of the CICS-UBI projects UIDB/00709/2020
   and UIDP/00709/2020, financed by national funds through the Portuguese
   Foundation for Science and Technology/MCTES. P. Boisguerin was supported
   by the "Agence National de la Recherche" (ANR NanoCard,
   ANR-21-CE18-0022-01) and "Centre National de la Recherche Scientifique"
   (CNRS).
CR Abate M, 2020, SEMIN CELL DEV BIOL, V98, P139, DOI 10.1016/j.semcdb.2019.05.022
   Akita H, 2009, BIOMATERIALS, V30, P2940, DOI 10.1016/j.biomaterials.2009.02.009
   Allemailem KS, 2021, INT J NANOMED, V16, P3907, DOI 10.2147/IJN.S303832
   Alston CL, 2021, J PATHOL, V254, P430, DOI 10.1002/path.5641
   Ammar M, 2016, BIOCHEM BIOPH RES CO, V474, P702, DOI 10.1016/j.bbrc.2016.05.014
   Arafa KK, 2022, RSC ADV, V12, P21690, DOI 10.1039/d2ra03240f
   Athanasopoulos T, 2017, HEMATOL ONCOL CLIN N, V31, P753, DOI 10.1016/j.hoc.2017.06.007
   Aversa R., 2016, Am. J. Eng. Appl. Sci., V9, P991, DOI [10.3844/ajeassp.2016.991.1002, DOI 10.3844/AJEASSP.2016.991.1002]
   Avula S, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0292-7
   Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544
   Bae Y, 2019, MACROMOL RES, V27, P1071, DOI 10.1007/s13233-019-7153-x
   Bae Y, 2018, EUR J PHARM BIOPHARM, V124, P104, DOI 10.1016/j.ejpb.2017.12.013
   Bae Y, 2017, MITOCHONDRION, V37, P27, DOI 10.1016/j.mito.2017.06.005
   Baertling F, 2018, J PEDIATR-US, V196, P309, DOI 10.1016/j.jpeds.2017.12.043
   Ban R, 2018, CHINESE MED J-PEKING, V131, P1569, DOI 10.4103/0366-6999.235120
   Batabyal S, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.6.060504
   Battogtokh G, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00922
   Bayda S, 2020, MOLECULES, V25, DOI 10.3390/molecules25010112
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Bi R, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.10.009
   Birk AV, 2014, BRIT J PHARMACOL, V171, P2017, DOI 10.1111/bph.12468
   Biswas S, 2012, BIOMATERIALS, V33, P4773, DOI 10.1016/j.biomaterials.2012.03.032
   Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1
   Bonnefoy Nathalie, 2007, Methods Mol Biol, V372, P153, DOI 10.1007/978-1-59745-365-3_11
   Bordoni L, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080764
   Brischigliaro M, 2021, BBA-BIOENERGETICS, V1862, DOI 10.1016/j.bbabio.2020.148335
   Buneeva O, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8120591
   Bykov YS, 2020, TRENDS BIOCHEM SCI, V45, P650, DOI 10.1016/j.tibs.2020.04.001
   Carreño-Gago L, 2017, BBA-MOL BASIS DIS, V1863, P182, DOI 10.1016/j.bbadis.2016.09.002
   Chen HC, 2017, J MATER CHEM B, V5, P972, DOI 10.1039/c6tb02714h
   Chokchaiwong S, 2018, FREE RADICAL RES, V52, P1445, DOI 10.1080/10715762.2018.1500695
   Chu QH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17170
   Cordani M, 2019, CELL MOL LIFE SCI, V76, P1215, DOI 10.1007/s00018-018-2973-y
   Costa D, 2017, BIOMACROMOLECULES, V18, P2928, DOI 10.1021/acs.biomac.7b00877
   Coutinho E, 2017, MOL PHARMACEUT, V14, P626, DOI 10.1021/acs.molpharmaceut.6b00823
   D'Souza AR, 2018, ESSAYS BIOCHEM, V62, P309, DOI 10.1042/EBC20170102
   D'Souza GGM, 2005, MITOCHONDRION, V5, P352, DOI 10.1016/j.mito.2005.07.001
   Dafinca R, 2020, STEM CELL REP, V14, P892, DOI 10.1016/j.stemcr.2020.03.023
   de Mello AH, 2018, LIFE SCI, V192, P26, DOI 10.1016/j.lfs.2017.11.019
   Dolatabadi JEN, 2015, ADV PHARM BULL, V5, P151, DOI 10.15171/apb.2015.022
   Du XF, 2018, DRUG DELIV, V25, P1516, DOI 10.1080/10717544.2018.1480674
   Elorza AA, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.625020
   Lopes AFC, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-00976-5
   Fan XX, 2020, NANO-MICRO LETT, V12, DOI 10.1007/s40820-020-0410-x
   Faria R, 2022, PHARMACEUTICS, V14, DOI 10.3390/pharmaceutics14040757
   Faria R, 2021, POLYMERS-BASEL, V13, DOI 10.3390/polym13111836
   Faria R, 2020, J MOL LIQ, V316, DOI 10.1016/j.molliq.2020.113873
   Farrar GJ, 2013, TRENDS GENET, V29, P488, DOI 10.1016/j.tig.2013.05.005
   Fontaine F., 2015, EMPIR SOFTW ENG, P1, DOI [10.1007/s10658-015-0770-0/, DOI 10.1007/S10664-015-9378-4, 10.1002/9780470015902.a0001380.pub2]
   Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267
   Ganly I, 2019, THYROID, V29, P471, DOI 10.1089/thy.2019.0088
   Ganly I, 2018, CANCER CELL, V34, P256, DOI 10.1016/j.ccell.2018.07.002
   Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gruntman AM, 2018, FASEB J, V32, P1733, DOI 10.1096/fj.201700982R
   Guo Y, 2018, INT J DEV NEUROSCI, V71, P172, DOI 10.1016/j.ijdevneu.2018.09.007
   Guzman-Villanueva D, 2019, METHODS MOL BIOL, V2000, P183, DOI 10.1007/978-1-4939-9516-5_12
   Hahn A, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090392
   Han L, 2013, SMALL, V9, P3647, DOI 10.1002/smll.201300279
   Hebert-Chatelain E, 2016, NATURE, V539, P555, DOI 10.1038/nature20127
   Henry C, 2017, OCHSNER J, V17, P296
   Herrera Arturo S., 2015, Central Nervous System Agents in Medicinal Chemistry, V15, P32
   Herrero M.J., 2017, SAF EFFIC GENE BASED, P113, DOI [10.1007/978-3-319-53457-2_6, DOI 10.1007/978-3-319-53457-2_6]
   Horten P, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10071008
   Huang RQ, 2008, BIOMATERIALS, V29, P238, DOI 10.1016/j.biomaterials.2007.09.024
   Huang SX, 2013, ACS NANO, V7, P2860, DOI 10.1021/nn400548g
   Indoria S, 2020, INT J PHARMACEUT, V582, DOI 10.1016/j.ijpharm.2020.119314
   Ishikawa T, 2018, J CONTROL RELEASE, V274, P109, DOI 10.1016/j.jconrel.2018.02.005
   Jang YH, 2018, MOLECULES, V23, DOI 10.3390/molecules23092316
   Jedynak-Slyvka M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22157999
   Jerome MS, 2022, BIOCHIMIE, V198, P96, DOI 10.1016/j.biochi.2022.03.013
   Johnston IG, 2016, CELL SYST, V2, P101, DOI 10.1016/j.cels.2016.01.013
   Kawamura E, 2020, MOL THER-NUCL ACIDS, V20, P687, DOI 10.1016/j.omtn.2020.04.004
   Kawamura E, 2019, MITOCHONDRION, V49, P178, DOI 10.1016/j.mito.2019.08.004
   Kawamura E, 2013, MITOCHONDRION, V13, P610, DOI 10.1016/j.mito.2013.08.010
   Khair SZNM, 2021, DIS MARKERS, V2021, DOI 10.1155/2021/7675269
   Khalil IA, 2007, GENE THER, V14, P682, DOI 10.1038/sj.gt.3302910
   Kim H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122049
   Kinnear C, 2017, CHEM REV, V117, P11476, DOI 10.1021/acs.chemrev.7b00194
   Komura K, 2003, PEDIATR NEUROL, V28, P53, DOI 10.1016/S0887-8994(02)00469-1
   Kotrys AV, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010017
   Kulkarni CA, 2021, J MED CHEM, V64, P662, DOI 10.1021/acs.jmedchem.0c01671
   Lalrohlui F, 2020, MITOCHONDRION, V51, P7, DOI 10.1016/j.mito.2019.12.001
   Lalrohlui F, 2016, GENES ENVIRON, V38, DOI 10.1186/s41021-016-0034-z
   Lang M, 2015, MODERN PATHOL, V28, P1458, DOI 10.1038/modpathol.2015.101
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Lawless C, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200061
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Li HR, 2020, INT J NANOMED, V15, P7199, DOI 10.2147/IJN.S270229
   Li JM, 2018, BIOMATER SCI-UK, V6, P2998, DOI 10.1039/c8bm00889b
   Li LY, 2021, CLIN TRANSL MED, V11, DOI 10.1002/ctm2.529
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   Ma JC, 2018, CANCER-AM CANCER SOC, V124, P2289, DOI 10.1002/cncr.31248
   Maksum IP, 2017, BIOINFORM BIOL INSIG, V11, DOI 10.1177/1177932217728515
   Mallick S, 2019, INT J BIOL MACROMOL, V132, P451, DOI 10.1016/j.ijbiomac.2019.03.215
   Marrache S, 2013, ACS NANO, V7, P7392, DOI 10.1021/nn403158n
   McManus MJ, 2019, CELL METAB, V29, P78, DOI 10.1016/j.cmet.2018.08.002
   Morrow RM, 2017, P NATL ACAD SCI USA, V114, P2705, DOI 10.1073/pnas.1700997114
   Moslemi AR, 2008, NEUROPEDIATRICS, V39, P24, DOI 10.1055/s-2008-1076739
   Muramatsu H, 2019, FORENS SCI INT-GEN S, V7, P698, DOI 10.1016/j.fsigss.2019.10.143
   Nikzamir M, 2021, J INORG ORGANOMET P, V31, P2246, DOI 10.1007/s10904-021-01925-2
   Nissanka N, 2020, EMBO REP, V21, DOI 10.15252/embr.201949612
   Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956
   Nolfi-Donegan D, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101674
   Nomikou N, 2018, J TISSUE ENG REGEN M, V12, pE250, DOI 10.1002/term.2406
   Obrador E, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126352
   Oddone N, 2016, J NANOBIOTECHNOL, V14, DOI 10.1186/s12951-016-0197-6
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454
   Picard M, 2018, PSYCHOSOM MED, V80, P141, DOI 10.1097/PSY.0000000000000545
   Polyakova T, 2017, IEEE MAGN LETT, V8, DOI 10.1109/LMAG.2017.2732361
   Porcelli AM, 2010, HUM MOL GENET, V19, P1019, DOI 10.1093/hmg/ddp566
   Prasai Kanchanjunga, 2017, Pathophysiology, V24, P107, DOI 10.1016/j.pathophys.2017.03.001
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Roger AJ, 2017, CURR BIOL, V27, pR1177, DOI 10.1016/j.cub.2017.09.015
   Rudolph G, 2013, J NEURO-OPHTHALMOL, V33, P30, DOI 10.1097/WNO.0b013e318272c643
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Saki M, 2017, FREE RADICAL BIO MED, V107, P216, DOI 10.1016/j.freeradbiomed.2016.11.050
   Salvado R, 2015, COLLOID SURFACE A, V480, P287, DOI 10.1016/j.colsurfa.2014.12.013
   Santos J, 2014, COLLOID SURFACE B, V121, P129, DOI 10.1016/j.colsurfb.2014.06.003
   Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schwarz D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02560-7
   Seeman NC, 2018, NAT REV MATER, V3, DOI 10.1038/natrevmats.2017.68
   Sharma A, 2018, THERANOSTICS, V8, P5529, DOI 10.7150/thno.29039
   Sharma S, 2021, MOL NEUROBIOL, V58, P65, DOI 10.1007/s12035-020-02080-4
   Smith ALM, 2022, MOL ONCOL, V16, P3276, DOI 10.1002/1878-0261.13291
   Smolina N, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165745
   Solmonson A, 2018, J BIOL CHEM, V293, P7522, DOI 10.1074/jbc.TM117.000259
   Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1
   Stefano GB, 2016, BIOMED REP, V4, P259, DOI 10.3892/br.2016.590
   Sun YJ, 2021, FRONT BIOENG BIOTECH, V9, DOI 10.3389/fbioe.2021.755727
   Surekha B, 2021, COLLOID SURFACE B, V204, DOI 10.1016/j.colsurfb.2021.111837
   Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461
   Tarnopolsky MA, 2011, AMINO ACIDS, V40, P1397, DOI 10.1007/s00726-011-0876-4
   Thapa S, 2016, BREAST CANCER-TOKYO, V23, P607, DOI 10.1007/s12282-015-0611-1
   Tian HY, 2013, SMALL, V9, P2034, DOI 10.1002/smll.201202485
   Tinker RJ, 2021, MOL DIAGN THER, V25, P181, DOI 10.1007/s40291-020-00510-6
   Trecarichi A, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0262544
   van Horssen J, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.050
   Wang F, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.675465
   Wang XY, 2014, J MATER CHEM B, V2, P2546, DOI 10.1039/c3tb21348j
   Weissig V, 2020, TRENDS MOL MED, V26, P40, DOI 10.1016/j.molmed.2019.09.002
   Weissig V, 2014, INT J NANOMED, V9, P4357, DOI 10.2147/IJN.S46900
   Wolfram RK, 2018, EUR J MED CHEM, V152, P21, DOI 10.1016/j.ejmech.2018.04.031
   Yamada Y, 2008, ADV DRUG DELIVER REV, V60, P1439, DOI 10.1016/j.addr.2008.04.016
   Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002
   Yamada Y, 2020, NUCLEOS NUCLEOT NUCL, V39, P141, DOI 10.1080/15257770.2019.1675167
   Yamada Y, 2015, J CONTROL RELEASE, V213, P86, DOI 10.1016/j.jconrel.2015.06.037
   Yamada Y, 2012, METHOD ENZYMOL, V509, P301, DOI 10.1016/B978-0-12-391858-1.00015-0
   Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99
   Yang P, 2020, BIOMATERIALS, V238, DOI 10.1016/j.biomaterials.2020.119844
   Yasuzaki Y, 2015, MOL PHARMACEUT, V12, P4311, DOI 10.1021/acs.molpharmaceut.5b00511
   Yu H, 2020, THERANOSTICS, V10, P2342, DOI 10.7150/thno.40395
   Yuan Y, 2019, SMALL, V15, DOI 10.1002/smll.201900172
   Zhang LF, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2019.10.113
   Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200
   Zheng FF, 2019, NANOPHOTONICS-BERLIN, V8, P391, DOI 10.1515/nanoph-2018-0219
   Zhou W, 2017, NANOSCALE, V9, P17044, DOI 10.1039/c7nr06130g
   Zielonka J, 2017, CHEM REV, V117, P10043, DOI 10.1021/acs.chemrev.7b00042
NR 162
TC 7
Z9 7
U1 0
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4923
J9 PHARMACEUTICS
JI Pharmaceutics
PD FEB
PY 2023
VL 15
IS 2
AR 572
DI 10.3390/pharmaceutics15020572
PG 25
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 9L6AK
UT WOS:000941630400001
PM 36839894
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Capiau, S
   Smet, J
   De Paepe, B
   Yildiz, Y
   Arslan, M
   Stevens, O
   Verschoore, M
   Stepman, H
   Seneca, S
   Vanlander, A
AF Capiau, Sara
   Smet, Joel
   De Paepe, Boel
   Yildiz, Yilmaz
   Arslan, Mutluay
   Stevens, Olivier
   Verschoore, Maxime
   Stepman, Hedwig
   Seneca, Sara
   Vanlander, Arnaud
TI Clinical Heterogeneity in <i>MT-ATP6</i> Pathogenic Variants: Same
   Genotype-Different Onset
SO CELLS
LA English
DT Article
DE ATP-synthase; complex V deficiency; MT-ATP6;
   NC_012920.1(MT-ATP6):m.9035T > C; p.L170P; genotype-phenotype
   correlation; mitochondrial disorder
ID CYTOCHROME-C-OXIDASE; MITOCHONDRIAL-DNA; RESPIRATORY-CHAIN; ATP
   SYNTHASE; MUTATIONS; ELECTROPHORESIS; IDENTIFICATION; ORGANIZATION;
   DEFICIENCY; PHENOTYPE
AB Human mitochondrial disease exhibits large variation of clinical phenotypes, even in patients with the same causative gene defect. We illustrate this heterogeneity by confronting clinical and biochemical data of two patients with the uncommon pathogenic homoplasmic NC_012920.1(MT-ATP6):m.9035T > C variant in MT-ATP6. Patient 1 presented as a toddler with severe motor and speech delay and spastic ataxia without extra-neurologic involvement. Patient 2 presented in adolescence with ataxia and ophthalmoplegia without cognitive or motor impairment. Respiratory chain complex activities were normal in cultured skin fibroblasts from both patients when calculated as ratios over citrate synthase activity. Native gels found presence of subcomplexes of complex V in fibroblast and/or skeletal muscle. Bioenergetic measurements in fibroblasts from both patients detected reduced spare respiratory capacities and altered extracellular acidification rates, revealing a switch from mitochondrial respiration to glycolysis to uphold ATP production. Thus, in contrast to the differing disease presentation, biochemical evidence of mitochondrial deficiency turned out quite similar. We conclude that biochemical analysis remains a valuable tool to confirm the genetic diagnosis of mitochondrial disease, especially in patients with new gene variants or atypical clinical presentation.
C1 [Capiau, Sara] Ghent Univ Hosp, Dept Lab Med, B-9000 Ghent, Belgium.
   [Smet, Joel; De Paepe, Boel; Verschoore, Maxime; Vanlander, Arnaud] Ghent Univ Hosp, Dept Child Neurol & Metab, B-9000 Ghent, Belgium.
   [Smet, Joel; De Paepe, Boel; Verschoore, Maxime; Vanlander, Arnaud] Univ Ghent, Lab Mitochondrial Invest, B-9000 Ghent, Belgium.
   [Yildiz, Yilmaz] Hacettepe Univ, Dept Pediat Metab, Ihsan Dogramaci Childrens Hosp, TR-06230 Ankara, Turkey.
   [Yildiz, Yilmaz] Univ Hlth Sci, Pediat Metab Dis Unit, Gulhane Training & Res Hosp, TR-06010 Gulhane, Turkey.
   [Arslan, Mutluay] Univ Hlth Sci, Gulhane Training & Res Hosp, Dept Pediat Neurol, TR-06010 Gulhane, Turkey.
   [Stevens, Olivier] Maria Middelares Gen Hosp, Dept Neurol, B-9000 Ghent, Belgium.
   [Seneca, Sara] Free Univ Brussels VUB, Res Grp Reprod & Genet REGE, B-1090 Brussels, Belgium.
   [Seneca, Sara] Free Univ Brussels VUB, Univ Hosp Brussels, Ctr Med Genet, B-1090 Brussels, Belgium.
C3 Ghent University; Ghent University Hospital; Ghent University; Ghent
   University Hospital; Ghent University; Hacettepe University; Gulhane
   Training & Research Hospital; Gulhane Training & Research Hospital;
   Vrije Universiteit Brussel; University Hospital Brussels; Vrije
   Universiteit Brussel
RP Capiau, S (corresponding author), Ghent Univ Hosp, Dept Lab Med, B-9000 Ghent, Belgium.; Vanlander, A (corresponding author), Ghent Univ Hosp, Dept Child Neurol & Metab, B-9000 Ghent, Belgium.; Vanlander, A (corresponding author), Univ Ghent, Lab Mitochondrial Invest, B-9000 Ghent, Belgium.
EM sara.capiau@uzgent.be; joel.smet@ugent.be; boel.depaepe@ugent.be;
   yilmaz.yildiz@hacettepe.edu.tr; mutluayarslan@yahoo.com;
   olivier.stevens@azmmsj.be; maxime.verschoore@ugent.be;
   hedwig.stepman@uzgent.be; sara.seneca@uzbrussel.be;
   arnaud.vanlander@ugent.be
RI Arnaud, Vanlander/ABB-5978-2021; YILDIZ, YILMAZ/AAJ-8666-2020; De Paepe,
   Boel/B-7548-2013
OI Seneca, Sara/0000-0002-0853-9890; YILDIZ, YILMAZ/0000-0001-9076-1388;
   Vanlander, Arnaud/0000-0002-9520-5564; ARSLAN,
   MUTLUAY/0000-0002-6520-1810; De Paepe, Boel/0000-0001-9403-4401; Capiau,
   Sara/0000-0003-3062-8299; Stevens, Olivier/0000-0002-8212-6664
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BIRCHMACHIN MA, 1989, PEDIATR RES, V25, P553, DOI 10.1203/00006450-198905000-00025
   D'Aurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Dautant A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00329
   De A, 2007, BIOCHEM J, V402, P175, DOI 10.1042/BJ20061004
   De Paepe B, 2012, PEDIATR RES, V72, P232, DOI 10.1038/pr.2012.84
   Devreese B, 2002, ELECTROPHORESIS, V23, P2525, DOI 10.1002/1522-2683(200208)23:15<2525::AID-ELPS2525>3.0.CO;2-I
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   Ganetzky RD, 2019, HUM MUTAT, V40, P499, DOI 10.1002/humu.23723
   Garret P, 2019, HUM MUTAT, V40, P2430, DOI 10.1002/humu.23885
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Haraux F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221886
   Hatefi Y, 1978, Methods Enzymol, V53, P21
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   Jesina P, 2004, BIOCHEM J, V383, P561, DOI 10.1042/BJ20040407
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Lombès A, 2014, BIOCHIMIE, V100, P171, DOI 10.1016/j.biochi.2013.08.012
   Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b
   Mezghani N, 2011, BIOCHEM BIOPH RES CO, V411, P247, DOI 10.1016/j.bbrc.2011.06.106
   Ng YS, 2019, ANN NEUROL, V86, P310, DOI 10.1002/ana.25525
   Nolte D, 2021, J NEUROL, V268, P4866, DOI 10.1007/s00415-021-10607-5
   Panneman DM, 2020, CLIN GENET, V97, P556, DOI 10.1111/cge.13706
   Pfeffer G, 2012, J NEUROL NEUROSUR PS, V83, P883, DOI 10.1136/jnnp-2012-302568
   Rucheton B, 2020, MITOCHONDRION, V55, P64, DOI 10.1016/j.mito.2020.08.004
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Sikorska M, 2009, MUSCLE NERVE, V40, P381, DOI 10.1002/mus.21355
   Smet J, 2011, J INHERIT METAB DIS, V34, P741, DOI 10.1007/s10545-011-9315-7
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   Srere PA., 1969, METHOD ENZYMOL, V13, P3, DOI [DOI 10.1016/0076-6879(69)13005-0, 10.1016/0076-6879(69)13005-0]
   Stendel C, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000393
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   van der Westhuizen FH, 2010, J INHERIT METAB DIS, V33, pS55, DOI 10.1007/s10545-009-9020-y
   Vantroys E, 2017, MOL GENET METAB, V122, P172, DOI 10.1016/j.ymgme.2017.10.004
   Villanueva-Paz M, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165726
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027
   Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
NR 43
TC 8
Z9 8
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD FEB
PY 2022
VL 11
IS 3
AR 489
DI 10.3390/cells11030489
PG 18
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA YZ2XX
UT WOS:000755345100001
PM 35159298
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Zhao, XT
   Yu, M
   Zhao, YW
   Zheng, YM
   Meng, LC
   Du, K
   Xie, ZY
   Lv, H
   Zhang, W
   Liu, J
   Wang, QQ
   Yuan, Y
   Wang, ZX
   Deng, JW
AF Zhao, Xutong
   Yu, Meng
   Zhao, Yawen
   Zheng, Yiming
   Meng, Lingchao
   Du, Kang
   Xie, Zhiying
   Lv, He
   Zhang, Wei
   Liu, Jing
   Wang, Qingqing
   Yuan, Yun
   Wang, Zhaoxia
   Deng, Jianwen
TI Circulating cell-free mtDNA release is associated with the activation of
   cGAS-STING pathway and inflammation in mitochondrial diseases
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Mitochondrial diseases; Ccf-mtDNA; cGAS-STING pathway; Inflammation
ID CEREBROSPINAL-FLUID; DNA; INFECTION; BIOMARKER; RESPONSES
AB Background There is increasing evidence for the role of inflammation in the pathogenesis of mitochondrial diseases (MDs). However, the mechanisms underlying mutation-induced inflammation in MD remain elusive. Our previous study suggested that mitophagy is impaired in the skeletal muscle of those with MD, likely causing mitochondrial DNA (mtDNA) release and thereby triggering inflammation. We here aimed to decipher the role of the cGAS-STING pathway in inflammatory process in MDs. Methods We investigated the levels of circulating cell-free mtDNA (ccf-mtDNA) in the serum of 104 patients with MDs. Immunofluorescence was performed in skeletal muscles in MDs and control. Biochemical analysis of muscle biopsies was conducted with western blot to detect cGAS, STING, TBK1, IRF3 and phosphorylated IRF3 (p-IRF3). RT-qPCR was performed to detect the downstream genes of type I interferon in skeletal muscles. Furthermore, a protein microarray was used to examine the cytokine levels in the serum of patients with MDs. Results We found that ccf-mtDNA levels were significantly increased in those with MDs compared to the controls. Consistently, the immunofluorescent results showed that cytosolic dsDNA levels were increased in the muscle samples of MD patients. Biochemical analysis of muscle biopsies showed that cGAS, IRF3, and TBK1 protein levels were significantly increased in those with MDs, indicating that there was activation of the cGAS-STING pathway. RT-qPCR showed that downstream genes of type I interferon were upregulated in muscle samples of MDs. Protein microarray results showed that a total of six cytokines associated with the cGAS-STING pathway were significantly increased in MD patients (fold change > 1.2, p value < 0.05). Conclusions These findings suggest that increases in ccf-mtDNA levels is associated with the activation of the cGAS-STING pathway, thereby triggering inflammation in MDs.
C1 [Zhao, Xutong; Yu, Meng; Zhao, Yawen; Zheng, Yiming; Meng, Lingchao; Du, Kang; Xie, Zhiying; Lv, He; Zhang, Wei; Liu, Jing; Wang, Qingqing; Yuan, Yun; Wang, Zhaoxia; Deng, Jianwen] Peking Univ First Hosp, Dept Neurol, 8 Xishiku St, Beijing 100034, Peoples R China.
   [Wang, Zhaoxia; Deng, Jianwen] Beijing Key Lab Neurovasc Dis Discovery, Beijing 100034, Peoples R China.
C3 Peking University
RP Wang, ZX; Deng, JW (corresponding author), Peking Univ First Hosp, Dept Neurol, 8 Xishiku St, Beijing 100034, Peoples R China.; Wang, ZX; Deng, JW (corresponding author), Beijing Key Lab Neurovasc Dis Discovery, Beijing 100034, Peoples R China.
EM drwangzx@163.com; jianwendeng@pkufh.com
RI li, mengjie/GRS-3931-2022; chen, minghui/KFR-8832-2024; Zheng,
   Yiming/AFQ-9684-2022
OI Xie, Zhiying/0000-0003-2102-6026; Deng, Jianwen/0000-0003-1206-1778
FU National Natural Science Foundation of China [81571219, 82071409,
   82171846, U20A20356]; Capital's Funds for Health Improvement and
   Research [2022-4-40716]
FX The work was funded by the National Natural Science Foundation of China
   (No. 81571219, 82071409, 82171846 and U20A20356). Capital's Funds for
   Health Improvement and Research (2022-4-40716).
CR Arshad O, 2018, JAIDS-J ACQ IMM DEF, V78, P111, DOI 10.1097/QAI.0000000000001650
   Bai JL, 2017, P NATL ACAD SCI USA, V114, P12196, DOI 10.1073/pnas.1708744114
   Balsa E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16423-1
   Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921
   Barichello T, 2010, BRAIN RES BULL, V82, P302, DOI 10.1016/j.brainresbull.2010.05.012
   Blot M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30226-x
   Borsche M, 2020, BRAIN, V143, P3041, DOI 10.1093/brain/awaa246
   Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Deng JW, 2020, BIOCHEM BIOPH RES CO, V523, P91, DOI 10.1016/j.bbrc.2019.12.005
   Denton AE, 2019, J EXP MED, V216, P621, DOI 10.1084/jem.20181216
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fang CJ, 2016, PROTEIN CELL, V7, P11, DOI 10.1007/s13238-015-0222-9
   Gambardella S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01064
   Gopinathan U, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-017-0229-5
   Grabosch S, 2019, ONCOGENE, V38, P2380, DOI 10.1038/s41388-018-0581-9
   Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Koti M, 2019, BLADDER CANCER, V5, P225, DOI 10.3233/BLC-190228
   Lepelley A, 2021, J EXP MED, V218, DOI 10.1084/jem.20201560
   Li Q, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040895
   Liu PY, 2021, NAT CELL BIOL, V23, P355, DOI 10.1038/s41556-021-00656-3
   Mancuso M, 2013, NEUROMUSCULAR DISORD, V23, P907, DOI 10.1016/j.nmd.2013.07.011
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   Mehta SR, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0848-z
   Perry EA, 2021, NAT METAB, V3, P33, DOI 10.1038/s42255-020-00334-y
   Pyle A, 2015, ANN NEUROL, V78, P1000, DOI 10.1002/ana.24515
   Roers A, 2016, IMMUNITY, V44, P739, DOI 10.1016/j.immuni.2016.04.002
   Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9
   Soustek MS, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0696-5
   Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458
   Trifunov S, 2021, CLIN CHEM, V67, P1113, DOI 10.1093/clinchem/hvab091
   Tsai CH, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04136-2
   West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036
   Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020
   Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhao HK, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00658-5
   Zhao J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128629
NR 41
TC 13
Z9 13
U1 2
U2 23
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD SEP
PY 2022
VL 269
IS 9
BP 4985
EP 4996
DI 10.1007/s00415-022-11146-3
EA APR 2022
PG 12
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 3Q4FB
UT WOS:000788980700001
PM 35486214
DA 2024-11-01
ER

PT J
AU Yoo, DH
   Choi, YC
   Nam, DE
   Choi, SS
   Kim, JW
   Choi, BO
   Chung, KW
AF Yoo, Da Hye
   Choi, Young-Chul
   Nam, Da Eun
   Choi, Sun Seong
   Kim, Ji Won
   Choi, Byung-Ok
   Chung, Ki Wha
TI Identification of <i>FASTKD2</i> compound heterozygous mutations as the
   underlying cause of autosomal recessive MELAS-like syndrome
SO MITOCHONDRION
LA English
DT Article
DE MELAS; Mitochondrial encephalomyopathy; FASTKD2; Target sequencing;
   Korean
ID OVERLAP SYNDROME; POINT MUTATION; GENE; MTDNA; NEUROPATHY; FAMILY
AB Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a condition that affects many parts of the body, particularly the brain and muscles. This study examined a Korean MELAS-like syndrome patient with seizure, stroke-like episode, and optic atrophy. Target sequencing of whole mtDNA and 73 nuclear genes identified compound heterozygous mutations p.R205X and p.L255P in the FASTKD2. Each of his unaffected parents has one of the two mutations, and both mutations were not found in 302 controls. FASTKD2 encodes a FAS-activated serine-threonine (FAST) kinase domain 2 which locates in the mitochondrial inner compartment. A FASTKD2 nonsense mutation was once reported as the cause of a recessive infantile mitochondrial encephalomyopathy. The present case showed relatively mild symptoms with a late onset age, compared to a previous patient with FASTKD2 mutation, implicating an inter-allelic clinical heterogeneity. Because this study is the second report of an autosomal recessive mitochondrial encephalomyopathy patient with a FASTKD2 mutation, it will extend the phenotypic spectrum of the FASTKD2 mutation.
C1 [Yoo, Da Hye; Nam, Da Eun; Choi, Sun Seong; Kim, Ji Won; Chung, Ki Wha] Kongju Natl Univ, Dept Biol Sci, 56 Gonjudaehak Ro, Gongju, South Korea.
   [Choi, Young-Chul] Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea.
   [Choi, Byung-Ok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.
   [Choi, Byung-Ok] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Tech, Dept Hlth Sci & Technol, Seoul, South Korea.
C3 Kongju National University; Yonsei University; Yonsei University Health
   System; Sungkyunkwan University (SKKU); Samsung Medical Center;
   Sungkyunkwan University (SKKU)
RP Chung, KW (corresponding author), Kongju Natl Univ, Dept Biol Sci, 56 Gonjudaehak Ro, Gongju, South Korea.; Choi, BO (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.
EM bochoi77@hanmail.net; kwchung@kongju.ac.kr
OI Choi, Young-Chul/0000-0001-5525-6861
FU Kongju National University; Korean Health Technology R & D Project,
   Ministry of Health Welfare [H112C0135, HI14C3484]; National Research
   Foundation - MSIP, Republic of Korea [2017R1A2A2A05001356]
FX This study was supported by Kongju National University (2015) and the
   Korean Health Technology R & D Project, Ministry of Health & Welfare
   (H112C0135 and HI14C3484), and the National Research Foundation funded
   by the MSIP (2017R1A2A2A05001356), Republic of Korea.
CR Antoniadi T, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0224-8
   Carroll CJ, 2014, BRIT J PHARMACOL, V171, P1837, DOI 10.1111/bph.12469
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   Das Sharmistha, 2014, BMC Cancer, V14, P852, DOI 10.1186/1471-2407-14-852
   Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE, pS107
   HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   NAKAMURA M, 1995, BIOCHEM BIOPH RES CO, V214, P86, DOI 10.1006/bbrc.1995.2260
   Nam SH, 2016, MOL CELLS, V39, P382, DOI 10.14348/molcells.2016.2288
   Popow J, 2015, RNA, V21, P1873, DOI 10.1261/rna.052365.115
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   SATO W, 1994, BIOCHEM MOL BIOL INT, V33, P1055
   Simarro M, 2010, BIOCHEM BIOPH RES CO, V401, P440, DOI 10.1016/j.bbrc.2010.09.075
   Vellarikkal SK, 2015, HUM MUTAT, V36, P419, DOI 10.1002/humu.22767
   Vill K, 2015, NEUROPEDIATRICS, V46, P282, DOI 10.1055/s-0035-1554100
   von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034
   Ylikallio E, 2014, EUR J HUM GENET, V22, P522, DOI 10.1038/ejhg.2013.190
   Zeviani Massimo, 1993, European Journal of Human Genetics, V1, P80
NR 20
TC 31
Z9 36
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL
PY 2017
VL 35
BP 54
EP 58
DI 10.1016/j.mito.2017.05.005
PG 5
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA EZ9QK
UT WOS:000405064700007
PM 28499982
DA 2024-11-01
ER

PT J
AU Greaves, LC
   Turnbull, DM
AF Greaves, Laura C.
   Turnbull, Doug M.
TI Mitochondrial DNA mutations and ageing
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Review
DE Mitochondria; Mitochondrial DNA; Ageing; Mutation; Respiratory chain
   dysfunction
ID SOMATIC MTDNA MUTATIONS; POINT MUTATIONS; SKELETAL-MUSCLE; LIFE-SPAN;
   DILATED CARDIOMYOPATHY; DEOXYRIBONUCLEIC-ACID; RADICAL PRODUCTION;
   CHOROID-PLEXUS; CONTROL-REGION; HEARING-LOSS
AB The mechanism by which we age has sparked a huge number of theories, and is an area of intense debate. As the elderly population rises, the importance of elucidating these mechanisms is becoming more apparent as age is the single biggest risk factor for a number of diseases such as cancer, diabetes and neurodegenerative disease. Mitochondrial DNA (MtDNA) mutations have been shown to accumulate in cells and tissues during the ageing process; however the question as to whether these mutations have a causal role in the ageing process remains an area of uncertainty. Here we review the current literature, and discuss the evidence for and against a causal role of mtDNA mutations in ageing and in the pathogenesis of age-related disease. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Greaves, Laura C.; Turnbull, Doug M.] Univ Newcastle, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Turnbull, DM (corresponding author), Univ Newcastle, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM D.M.Turnbull@ncl.ac.uk
OI Greaves, Laura/0000-0002-8071-5916
FU Wellcome Trust; Food Standards Agency (UK) [N12015]; Newcastle
   University Centre for Brain Ageing Vitality; BBSRC; EPSRC; ESRC; MRC;
   crosscouncil Lifelong Health and Wellbeing Initiative; MRC [G0700718]
   Funding Source: UKRI
FX This work has been supported by the Wellcome Trust, The Food Standards
   Agency (UK) [N12015] and the Newcastle University Centre for Brain
   Ageing & Vitality supported by the BBSRC, EPSRC, ESRC and MRC as part of
   the crosscouncil Lifelong Health and Wellbeing Initiative.
CR Agarwal S, 1996, EXP GERONTOL, V31, P365, DOI 10.1016/0531-5565(95)02039-X
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Barreau E, 1996, INVEST OPHTH VIS SCI, V37, P384
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BENDER A, 2008, J NEUROL
   Birket MJ, 2007, AGING CELL, V6, P557, DOI 10.1111/j.1474-9726.2007.00310.x
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Bua EA, 2004, FASEB J, V18, P582, DOI 10.1096/fj.03-0668fje
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Chinnery PF, 1999, LANCET, V354, pSI17
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Cottrell DA, 2001, NEUROPATH APPL NEURO, V27, P206, DOI 10.1046/j.1365-2990.2001.00315.x
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   FELLOUS TG, 2008, HEPATOLOGY
   FUKUI H, 2008, HUM MOL GENET
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Herrero A, 1997, MECH AGEING DEV, V98, P95, DOI 10.1016/S0047-6374(97)00076-6
   Huang TT, 2001, FREE RADICAL BIO MED, V31, P1101, DOI 10.1016/S0891-5849(01)00694-3
   KAO SH, 1995, BIOL REPROD, V52, P729, DOI 10.1095/biolreprod52.4.729
   KITAGAWA T, 1993, BIOL REPROD, V49, P730, DOI 10.1095/biolreprod49.4.730
   Kowald A, 1999, EXP GERONTOL, V34, P605, DOI 10.1016/S0531-5565(99)00011-X
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukat A, 2009, EXP GERONTOL, V44, P101, DOI 10.1016/j.exger.2008.05.006
   LARSSON NG, 1995, MOL GENETIC ASPECTS, P151
   LEE CM, 1993, J GERONTOL, V48, pB201, DOI 10.1093/geronj/48.6.B201
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Mott JL, 1999, ANN NY ACAD SCI, V893, P353, DOI 10.1111/j.1749-6632.1999.tb07853.x
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   NASS MMK, 1966, P NATL ACAD SCI USA, V56, P1215, DOI 10.1073/pnas.56.4.1215
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Niu X, 2007, EXP CELL RES, V313, P3924, DOI 10.1016/j.yexcr.2007.05.029
   PANG CY, 1994, ARCH BIOCHEM BIOPHYS, V312, P534, DOI 10.1006/abbi.1994.1342
   PRYOR WA, 1973, FED PROC, V32, P1862
   RAO KS, 1992, MUTAT RES, V275, P317
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SHADEL GS, 1997, MITOCHONDRIAL DNA MA, P409
   SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   SOHAL RS, 1989, MECH AGEING DEV, V49, P129, DOI 10.1016/0047-6374(89)90096-1
   Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Troen BR, 2003, MT SINAI J MED, V70, P3
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZHANG CF, 1993, BIOCHEM BIOPH RES CO, V195, P1104, DOI 10.1006/bbrc.1993.2158
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
NR 76
TC 40
Z9 45
U1 0
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD OCT
PY 2009
VL 1790
IS 10
BP 1015
EP 1020
DI 10.1016/j.bbagen.2009.04.018
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 503EO
UT WOS:000270516100008
PM 19409965
DA 2024-11-01
ER

PT J
AU Kim, JY
   Yang, HK
   Kim, N
   Kim, MJ
   Cho, SI
   Seong, MW
   Park, SS
   Hwang, JM
AF Kim, Ji Yeon
   Yang, Hee Kyung
   Kim, Namju
   Kim, Man Jin
   Cho, Sung Im
   Seong, Moon-Woo
   Park, Sung Sup
   Hwang, Jeong-Min
TI Strabismus in chronic progressive external ophthalmoplegia
SO ACTA OPHTHALMOLOGICA
LA English
DT Article
DE chronic progressive external ophthalmoplegia; ophthalmoplegia;
   strabismus
ID MITOCHONDRIAL-DNA; DELETIONS; MANAGEMENT; REPEAT; PTOSIS
AB Purpose To elucidate the patterns of strabismus and ophthalmoplegia associated with chronic progressive external ophthalmoplegia (CPEO) confirmed by mitochondrial DNA (mtDNA) deletions in Asians.
   Methods A total of 10 patients confirmed to have mtDNA deletion associated with CPEO were included. Long-range PCR encompassing the entire mtDNA was carried out. In the cases with mtDNA deletion, the exact deletion ranges of mtDNA were identified by sequencing. A full ophthalmologic examination including prism and alternate cover test in the primary position, evaluation of ductions and versions, and binocularity was performed in 10 patients with confirmed mtDNA deletions associated with CPEO.
   Results All of the patients showed ophthalmoplegia as well as ptosis, even after eyelid surgeries. Ophthalmoplegia was symmetric between both eyes in nine patients (90%) while one patient (10%) showed asymmetric ophthalmoplegia with esotropia and left hypotropia. Among the nine patients with symmetric involvement, four patients (44%) showed exotropia, three (33%) had exotropia with vertical deviation, and the remaining two patients (22%) showed orthotropia. Five out of 10 patients (50%) complained of diplopia associated with strabismus, four of whom (80%) had vertical deviation. Three out of five patients (60%) without diplopia showed exotropia of 20 prism diopters (PD) to 50 PD.
   Conclusions Exotropia with/without vertical deviation is the most common form of strabismus in Asian patients with CPEO and only one of them showed a small angle of esotropia. Ophthalmoplegia could be asymmetric in 10% of CPEO patients.
C1 [Kim, Ji Yeon; Seong, Moon-Woo; Park, Sung Sup] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea.
   [Yang, Hee Kyung; Kim, Namju; Hwang, Jeong-Min] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Ophthalmol, 82 Gumi Ro,173 Beon Gil, Seongnam, Gyeonggi Do, South Korea.
   [Kim, Man Jin; Cho, Sung Im; Seong, Moon-Woo; Park, Sung Sup] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Lab Med, 101 Daehak Ro, Seoul 03080, South Korea.
C3 Seoul National University (SNU); Seoul National University Hospital;
   Seoul National University (SNU); Seoul National University (SNU); Seoul
   National University Hospital
RP Hwang, JM (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Ophthalmol, 82 Gumi Ro,173 Beon Gil, Seongnam, Gyeonggi Do, South Korea.; Park, SS (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Lab Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM sparkle@snu.ac.kr; hjm@snu.ac.kr
RI Kim, Nam-Joong/J-2735-2012; Kim, Dokyun/IYJ-2278-2023; Kim,
   Ji-Soo/D-8744-2012
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education, Science and Technology
   [NRF-2010-0014167]
FX This study was supported by the Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education, Science and Technology (NRF-2010-0014167).
CR Ahn J, 2008, BRIT J OPHTHALMOL, V92, P1685, DOI 10.1136/bjo.2008.144816
   Ahn J, 2018, J CLIN NEUROL, V14, P333, DOI 10.3988/jcn.2018.14.3.333
   BRUST JCM, 1974, NEUROLOGY, V24, P755, DOI 10.1212/WNL.24.8.755
   Chatzistefanou KI, 2019, INT OPHTHALMOL, V39, P213, DOI 10.1007/s10792-017-0781-2
   Chia A, 2007, BRIT J OPHTHALMOL, V91, DOI 10.1136/bjo.2007.116905
   Coulter-Mackie MB, 1998, CLIN BIOCHEM, V31, P627, DOI 10.1016/S0009-9120(98)00074-5
   Das JC, 2002, J PEDIAT OPHTH STRAB, V39, P52, DOI 10.3928/0191-3913-20020101-13
   Gonzalez-Moron D, 2013, BMJ CASE REP, V2013, pbcr201301018
   Hansen A C, 1966, J Natl Med Assoc, V58, P436
   Hwang JM, 2009, OPHTHALMOLOGY, V116, P813, DOI 10.1016/j.ophtha.2008.12.006
   JOHNS DR, 1989, P NATL ACAD SCI USA, V86, P8059, DOI 10.1073/pnas.86.20.8059
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Kee C, 2013, J CHILD NEUROL, V28, P108, DOI 10.1177/0883073812438101
   Kersten RC, 2005, OPHTHAL PLAST RECONS, V21, P412, DOI 10.1097/01.iop.0000180068.17344.80
   Kim JH, 2003, OPHTHALMOLOGY, V110, P1458, DOI 10.1016/S0161-6420(03)00460-3
   Kim U, 2009, EYE, V23, P1560, DOI 10.1038/eye.2008.309
   LEFORESTIER N, 1995, MUSCLE NERVE, V18, P1338, DOI 10.1002/mus.880181120
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Moon-Woo S, 2005, J KOREAN OPHTHALMOL, V46, P323
   Murdock J, 2016, NEURO-OPHTHALMOLOGY, V40, P44, DOI 10.3109/01658107.2015.1122815
   Rajput Rehan, 2018, Orbit, V37, P385, DOI 10.1080/01676830.2017.1423350
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Simon DK, 1999, ANNU REV MED, V50, P111
   Solano A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e86
   Sorkin JA, 1997, AM J OPHTHALMOL, V123, P235, DOI 10.1016/S0002-9394(14)71041-4
   Tinley C, 2010, STRABISMUS, V18, P41, DOI 10.3109/09273971003758388
   Wabbels B, 2008, OPHTHALMOLOGE, V105, P550, DOI 10.1007/s00347-007-1643-5
   Wallace DK, 1997, OPHTHALMOLOGY, V104, P695, DOI 10.1016/S0161-6420(97)30250-4
NR 30
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1755-375X
EI 1755-3768
J9 ACTA OPHTHALMOL
JI Acta Ophthalmol.
PD MAR
PY 2021
VL 99
IS 2
BP E274
EP E280
DI 10.1111/aos.14558
EA NOV 2020
PG 7
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA QT2FQ
UT WOS:000589552900001
PM 33191655
OA Bronze
DA 2024-11-01
ER

PT J
AU Popoiu, TA
   Dudek, J
   Maack, C
   Bertero, E
AF Popoiu, Tudor-Alexandru
   Dudek, Jan
   Maack, Christoph
   Bertero, Edoardo
TI Cardiac Involvement in Mitochondrial Disorders
SO CURRENT HEART FAILURE REPORTS
LA English
DT Article
DE Mitochondrial disease; Cardiomyopathy; Mitochondrial DNA; Cardiolipin;
   Electron transport chain
ID KEARNS-SAYRE SYNDROME; CLINICAL-FEATURES; SKELETAL-MUSCLE;
   LEIGH-SYNDROME; CARDIOLIPIN BIOSYNTHESIS; DILATED CARDIOMYOPATHY;
   LACTIC-ACIDOSIS; BARTH-SYNDROME; HEART-FAILURE; ATAXIA
AB Purpose of ReviewWe review pathophysiology and clinical features of mitochondrial disorders manifesting with cardiomyopathy.Recent FindingsMechanistic studies have shed light into the underpinnings of mitochondrial disorders, providing novel insights into mitochondrial physiology and identifying new therapeutic targets.Mitochondrial disorders are a group of rare genetic diseases that are caused by mutations in mitochondrial DNA (mtDNA) or in nuclear genes that are essential to mitochondrial function. The clinical picture is extremely heterogeneous, the onset can occur at any age, and virtually, any organ or tissue can be involved. Since the heart relies primarily on mitochondrial oxidative metabolism to fuel contraction and relaxation, cardiac involvement is common in mitochondrial disorders and often represents a major determinant of their prognosis.
C1 [Popoiu, Tudor-Alexandru; Dudek, Jan; Maack, Christoph; Bertero, Edoardo] Univ Clin Wurzburg, Comprehens Heart Failure Ctr, Dept Translat Res, Wurzburg, Germany.
   [Popoiu, Tudor-Alexandru] Victor Babes Univ Med & Pharm, Timisoara, Romania.
   [Bertero, Edoardo] Univ Genoa, Dept Internal Med & Specialties Di MI, Genoa, Italy.
C3 University of Wurzburg; Victor Babes University of Medicine & Pharmacy,
   Timisoara; University of Genoa
RP Bertero, E (corresponding author), Univ Clin Wurzburg, Comprehens Heart Failure Ctr, Dept Translat Res, Wurzburg, Germany.; Bertero, E (corresponding author), Univ Genoa, Dept Internal Med & Specialties Di MI, Genoa, Italy.
EM edo.bertero@gmail.com
RI Bertero, Edoardo/X-3132-2019
OI Maack, Christoph/0000-0003-3694-4559
CR Abeti R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.111
   Al Tuwaijri A, 2022, MOL GENET GENOM MED, V10, DOI 10.1002/mgg3.1969
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Anheim M, 2012, ARCH NEUROL-CHICAGO, V69, P912, DOI 10.1001/archneurol.2011.834
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Bayeva M, 2014, CIRC-HEART FAIL, V7, P680, DOI 10.1161/CIRCHEARTFAILURE.113.000912
   Benson MD, 2017, OPHTHALMIC GENET, V38, P88, DOI 10.3109/13816810.2015.1137327
   Bertero E, 2021, CIRCULATION, V144, P1694, DOI 10.1161/CIRCULATIONAHA.121.053755
   Bertero E, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165803
   Bertero E, 2018, CIRC RES, V122, P1460, DOI 10.1161/CIRCRESAHA.118.310082
   Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385
   Brambilla A, 2019, INT J CARDIOL, V276, P14, DOI 10.1016/j.ijcard.2018.10.051
   Brandes R, 1997, CIRC RES, V80, P82, DOI 10.1161/01.RES.80.1.82
   Byers SL, 2014, WORLD J CARDIOL, V6, P1149, DOI 10.4330/wjc.v6.i11.1149
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   CHANNER KS, 1988, BRIT HEART J, V59, P486
   Chatfield KC, 2014, J MOL CELL CARDIOL, V74, P251, DOI 10.1016/j.yjmcc.2014.06.002
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Chowdhury S, 2022, PEDIATR CARDIOL, V43, P1251, DOI 10.1007/s00246-022-02846-8
   Chu B., 2021, FRONT CELL DEV BIOL, V9, P1
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Cook A, 2017, BRIT MED BULL, V124, P19, DOI 10.1093/bmb/ldx034
   Cotticelli MG, 2019, J PHARMACOL EXP THER, V369, P47, DOI 10.1124/jpet.118.252759
   Das AM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/340849
   Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657
   Delatycki MB, 2019, NEUROBIOL DIS, V132, DOI 10.1016/j.nbd.2019.104606
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2002, ADV NEUROL, V89, P217
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   EI-Gharbawy A, 2018, PEDIATR CLIN N AM, V65, P317, DOI 10.1016/j.pcl.2017.11.006
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Finsterer J, 2017, BIOMED REP, V6, P487, DOI 10.3892/br.2017.892
   Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Fsadni MG, BRAIN, V90, P249, DOI [10.1111/j.1755-3768.2012.T132.x, DOI 10.1111/J.1755-3768.2012.T132.X]
   Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gasanoff ES, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071721
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Haghighi A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0119-3
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009
   Inak G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22117-z
   Ishikawa K, 2010, J EXP MED, V207, P2297, DOI 10.1084/jem.20092296
   Jackson TD, 2021, MOL BIOL CELL, V32, P475, DOI 10.1091/mbc.E20-06-0390
   Janz A, 2020, STEM CELL RES, V46, DOI 10.1016/j.scr.2020.101856
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jeukendrup AE, 1998, INT J SPORTS MED, V19, P293, DOI 10.1055/s-2007-971921
   Jiang HJ, 2020, BLOOD, V136, P119, DOI 10.1182/blood.2019003851
   Jiang XJ, 2021, NAT REV MOL CELL BIO, V22, P266, DOI 10.1038/s41580-020-00324-8
   Johnson JM, 2018, J MOL CELL CARDIOL, V121, P94, DOI 10.1016/j.yjmcc.2018.07.001
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   Kalkhoran S, 2018, J AM COLL CARDIOL, V72, P2964, DOI 10.1016/j.jacc.2018.10.020
   Kazuhito T, 2020, J BIOCHEM, V168, P435, DOI 10.1093/jb/mvaa098
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Koeppen AH, 2017, J NEUROPATH EXP NEUR, V76, P101, DOI 10.1093/jnen/nlw111
   KOGA Y, 1988, ANN NEUROL, V24, P749, DOI 10.1002/ana.410240609
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lee JS, 2016, J CLIN NEUROL, V12, P181, DOI 10.3988/jcn.2016.12.2.181
   Lemieux H, 2011, MITOCHONDRION, V11, P97, DOI 10.1016/j.mito.2010.07.014
   Liu XJ, 2021, CIRCULATION, V143, P1894, DOI 10.1161/CIRCULATIONAHA.120.048698
   Machiraju P, 2022, J INHERIT METAB DIS, V45, P366, DOI 10.1002/jimd.12441
   Martin-Perez M, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00319-x
   Martinez ARM, 2017, CEREBELLUM, V16, P253, DOI 10.1007/s12311-015-0755-8
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Meyers DE, 2013, TEX HEART I J, V40, P385
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   Morava E, 2004, EUR J PEDIATR, V163, P467, DOI 10.1007/s00431-004-1465-2
   Moreira JD, 2021, GENES-BASEL, V12, DOI 10.3390/genes12111668
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   O'Rourke B, 1999, CIRC RES, V84, P562, DOI 10.1161/01.RES.84.5.562
   Ojala T, 2012, PEDIATR RES, V72, P432, DOI 10.1038/pr.2012.92
   Orssaud C, 2018, J NEURO-OPHTHALMOL, V38, P466, DOI 10.1097/WNO.0000000000000623
   Orsucci D, 2021, J CLIN MED, V10, DOI 10.3390/jcm10061249
   Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Petit PX, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102333
   Pousset F, 2015, JAMA NEUROL, V72, P1334, DOI 10.1001/jamaneurol.2015.1855
   Quadir A, 2019, NEUROL-GENET, V5, DOI 10.1212/NXG.0000000000000339
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Ranea-Robles P., 2022, CARDIOVASC RES, V267, P36
   Reetz K, 2015, LANCET NEUROL, V14, P174, DOI 10.1016/S1474-4422(14)70321-7
   Regner SR, 2012, AM J CARDIOL, V109, P401, DOI 10.1016/j.amjcard.2011.09.025
   Thompson WR, 2021, GENET MED, V23, P471, DOI 10.1038/s41436-020-01006-8
   Richter-Dennerlein R, 2014, CELL METAB, V20, P158, DOI 10.1016/j.cmet.2014.04.016
   Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705
   Rubio-Gozalbo M. E., 2004, Molecular Aspects of Medicine, V25, P521, DOI 10.1016/j.mam.2004.06.007
   Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0
   Sadun Alfredo A, 2002, Trans Am Ophthalmol Soc, V100, P169
   Sadun AA, 2011, CURR TREAT OPTION NE, V13, P109, DOI 10.1007/s11940-010-0100-y
   Saini-Chohan HK, 2009, J LIPID RES, V50, P1600, DOI 10.1194/jlr.M800561-JLR200
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Schlame M, 1999, J LIPID RES, V40, P1585
   Schleiff E, 2011, NAT REV MOL CELL BIO, V12, P48, DOI 10.1038/nrm3027
   Schlieben LD, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.600079
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sehgal Swati, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2015-213813
   Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001
   Shan YX, 2013, ANTIOXID REDOX SIGN, V19, P1481, DOI 10.1089/ars.2012.4537
   Sharma P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020100
   Sinha D, 2016, J BIOL CHEM, V291, P17345, DOI 10.1074/jbc.M116.738146
   Smith EC, 2011, RHEUM DIS CLIN N AM, V37, P201, DOI 10.1016/j.rdc.2011.01.004
   SO N, 1989, BRAIN, V112, P1261, DOI 10.1093/brain/112.5.1261
   Sofou K, 2018, J MED GENET, V55, P21, DOI 10.1136/jmedgenet-2017-104891
   Sorajja P, 2003, HEART, V89, P791, DOI 10.1136/heart.89.7.791
   Sparkes R, 2007, CARDIOL YOUNG, V17, P215, DOI 10.1017/S1047951107000042
   Spencer CT, 2006, PEDIATRICS, V118, pE337, DOI 10.1542/peds.2005-2667
   Spencer CT, 2011, AM J PHYSIOL-HEART C, V301, pH2122, DOI 10.1152/ajpheart.00479.2010
   Spencer CT, 2005, PEDIATR CARDIOL, V26, P632, DOI 10.1007/s00246-005-0873-z
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stenton SL, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102784
   Towbin JA., 2018, Heart Failure in the Child and Young Adult, P269
   Tsou AY, 2011, J NEUROL SCI, V307, P46, DOI 10.1016/j.jns.2011.05.023
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VANEKEREN GJ, 1993, EUR J PEDIATR, V152, P255, DOI 10.1007/BF01956157
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang SY, 2020, CIRC RES, V126, P1024, DOI 10.1161/CIRCRESAHA.119.315956
   Weidemann F, 2013, J NEUROCHEM, V126, P88, DOI 10.1111/jnc.12217
   Weidemann F, 2012, CIRCULATION, V125, P1626, DOI 10.1161/CIRCULATIONAHA.111.059477
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
   Xu Y, 2016, NAT CHEM BIOL, V12, P641, DOI [10.1038/nchembio.2113, 10.1038/NCHEMBIO.2113]
   Yan CJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040379
   Yoon J-Y., 2022, CLIN TRANSL MED, V141, P70
NR 132
TC 4
Z9 4
U1 1
U2 1
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1546-9530
EI 1546-9549
J9 CURR HEART FAIL REP
JI Curr. Heart Fail. Rep.
PD FEB
PY 2023
VL 20
IS 1
BP 76
EP 87
DI 10.1007/s11897-023-00592-3
EA FEB 2023
PG 12
WC Cardiac & Cardiovascular Systems
WE Emerging Sources Citation Index (ESCI)
SC Cardiovascular System & Cardiology
GA 9I0YK
UT WOS:000934848900001
PM 36802007
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Baruffini, E
   Ferrero, I
   Foury, F
AF Baruffini, Enrico
   Ferrero, Iliana
   Foury, Francoise
TI Mitochondrial DNA defects in <i>Saccharomyces cerevisiae</i> caused by
   functional interactions between DNA polymerase gamma mutations
   associated with disease in human
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE POLG; mutation; disease; yeast; mip1 mutant; mtDNA
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; POLG MUTATIONS; ALPERS-SYNDROME;
   GENE; MTDNA; DISORDERS; MUTANTS; FAMILY; ATAXIA; CHAIN
AB The yeast mitochondrial DNA (mtDNA) replicase Mip1 has been used as a model to generate five mutations equivalent to POLG mutations associated with a broad spectrum of diseases in human. All mip1 mutations, alone or in combination in cis or in trans, increase mtDNA instability as measured by petite frequency and Ery(R) mutant accumulation. This phenotype is associated with decreased Mip1 levels in mitochondrial extracts and/or decreased polymerase activity. We have demonstrated that (1) in the mip1(G651S) (hG848S) mutant the high mtDNA instability and increased frequency of point Ery(R) mutations is associated with low Mip1 levels and polymerase activity; (2) in the mip1(A692T-E900G) (hA889T-hE1143G) mutant, A692T is the major contributor to mtDNA instability by decreasing polymerase activity, and E900G acts synergistically by decreasing Mip1 levels; (3) in the mip1(H734Y)/mip1(G807R) (hH932Y/hG1051R) mutant, H734Y is the most deleterious mutation and acts synergistically with G807R as a result of its dominant character; (4) the mip1(E900G) (h1143G) mutation is not neutral but results in a temperature-sensitive phenotype associated with decreased Mip1 levels, a property explaining its synergistic effect with mutations impairing the polymerase activity. Thus, the human E1143G mutation is not a true polymorphism. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Baruffini, Enrico; Foury, Francoise] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium.
   [Baruffini, Enrico; Ferrero, Iliana] Univ Parma, Dept Genet, I-43100 Parma, Italy.
C3 Universite Catholique Louvain; University of Parma
RP Foury, F (corresponding author), Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium.
EM foury@fysa.ucl.ac.be
RI Baruffini, Enrico/C-1057-2015
OI Baruffini, Enrico/0000-0002-8280-7849
CR Baruffini E, 2007, GENETICS, V177, P1227, DOI 10.1534/genetics.107.079293
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   DUJON B, MOL BIOL YEAST SACCH, P505
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x
   Hisama FM, 2005, AM J MED GENET A, V135A, P217, DOI 10.1002/ajmg.a.30672
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kaiser C, 1994, METHODS YEAST GENETI
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   LECRENIER N, 1995, MOL GEN GENET, V249, P1, DOI 10.1007/BF00290229
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   MATHEWS S, 1977, PREFERENTIAL LOSS RE, P133
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   SLONIMSKI PP, 1976, EUR J BIOCHEM, V61, P27, DOI 10.1111/j.1432-1033.1976.tb09994.x
   SOR F, 1984, NUCLEIC ACIDS RES, V12, P8313, DOI 10.1093/nar/12.22.8313
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8236
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
NR 35
TC 43
Z9 51
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD DEC
PY 2007
VL 1772
IS 11-12
BP 1225
EP 1235
DI 10.1016/j.bbadis.2007.10.002
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 249OR
UT WOS:000252238800005
PM 17980715
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Grazina, M
   Silva, F
   Santana, I
   Pratas, J
   Santiago, B
   Oliveira, M
   Carreira, I
   Cunha, LS
   Oliveira, C
AF Grazina, M
   Silva, F
   Santana, I
   Pratas, J
   Santiago, B
   Oliveira, M
   Carreira, I
   Cunha, LS
   Oliveira, C
TI Mitochondrial DNA variants in a Portuguese population of patients with
   Alzheimer's disease
SO EUROPEAN NEUROLOGY
LA English
DT Article
DE Alzheimer's disease; nitochondrial DNA; NADH dehydrogenase subunit 1;
   16S rRNA; nucleotides
ID PARKINSONS-DISEASE; POINT MUTATIONS; SEQUENCE; CARDIOMYOPATHY; DEMENTIA;
   REGION
AB Alzheimer's disease ( AD) is the most common neurodegenerative disorder associated with dementia in late adulthood. Mitochondrial respiratory chain impairment has been detected in the brain, muscle, fibroblasts and platelets of AD patients, indicating a possible involvement of mitochondrial DNA ( mtDNA) in the etiology of the disease. Several reports have identified mtDNA mutations in AD patients, but there is no consensual opinion regarding the cause of the impairment. We have studied mtDNA NADH dehydrogenase subunit 1 nucleotides 3337 - 3340, searching for mutations. Our study group included 129 AD patients and 125 healthy age- matched controls. We have found alterations in two AD patients: one had two already known mtDNA modifications ( 3197 T- C and 3338 T- C) and the other a novel transition ( 3199 T- C) which, to our knowledge, has not been described before. Copyright (C) 2005 S. Karger AG, Basel.
C1 Univ Coimbra, Fac Med, Inst Biochem, PT-30004504 Coimbra, Portugal.
   Univ Hosp Coimbra, Neurol Unit, Coimbra, Portugal.
   Univ Hosp Coimbra, Ctr Neurosci Coimbra, Coimbra, Portugal.
C3 Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e
   Universitario de Coimbra (CHUC); Universidade de Coimbra; Centro
   Hospitalar e Universitario de Coimbra (CHUC)
RP Univ Coimbra, Fac Med, Inst Biochem, Rua Larga, PT-30004504 Coimbra, Portugal.
EM mgrazina@ci.uc.pt
RI Pratas, João/N-5309-2019; Oliveira, Catarina/F-3685-2010; Silva,
   Filipe/P-1339-2016; Grazina, Manuela/W-3759-2017; Carreira, Isabel
   M/C-7711-2018
OI Oliveira, Catarina/0000-0001-6942-4328; Grazina,
   Manuela/0000-0002-1173-6481; Santana, Isabel/0000-0002-8114-9434; Cunha,
   Luis/0000-0002-0828-3485; Carreira, Isabel M/0000-0001-6842-1707
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   BERG L, 1988, PSYCHOPHARMACOL BULL, V24, P637
   BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   CHALMERS RM, 1995, J NEUROL, V242, P332, DOI 10.1007/BF00878877
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Grazina M, 2004, NEUROBIOL DIS, V15, P306, DOI 10.1016/j.nbd.2003.11.004
   Grazina M, 2003, EUR NEUROL, V50, P60, DOI 10.1159/000070863
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   HESS J, 1995, LANCET, V346, P189, DOI 10.1016/S0140-6736(95)91251-7
   HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566
   Kosel S, 1998, NEUROGENETICS, V1, P197, DOI 10.1007/s100480050029
   LIN FH, 1992, BIOCHEM BIOPH RES CO, V182, P238, DOI 10.1016/S0006-291X(05)80136-6
   MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
   Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006
   OBAYASHI T, 1992, AM HEART J, V124, P1263, DOI 10.1016/0002-8703(92)90410-W
   OZAWA T, 1991, BIOCHEM BIOPH RES CO, V177, P518, DOI 10.1016/0006-291X(91)92014-B
   PETRUZZELLA V, 1992, BIOCHEM BIOPH RES CO, V186, P491, DOI 10.1016/S0006-291X(05)80834-4
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Swerdlow RH, 2002, INT REV NEUROBIOL, V53, P341
NR 20
TC 8
Z9 13
U1 0
U2 5
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0014-3022
EI 1421-9913
J9 EUR NEUROL
JI Eur. Neurol.
PY 2005
VL 53
IS 3
BP 121
EP 124
DI 10.1159/000085555
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 937JV
UT WOS:000229921300002
PM 15860916
OA Green Published
DA 2024-11-01
ER

PT J
AU Di Pierro, E
   Perrone, M
   Franco, M
   Granata, F
   Duca, L
   Lattuada, D
   De Luca, G
   Graziadei, G
AF Di Pierro, Elena
   Perrone, Miriana
   Franco, Milena
   Granata, Francesca
   Duca, Lorena
   Lattuada, Debora
   De Luca, Giacomo
   Graziadei, Giovanna
TI Mitochondrial DNA Copy Number Drives the Penetrance of Acute
   Intermittent Porphyria
SO LIFE-BASEL
LA English
DT Article
DE acute intermittent porphyria; heme; mtDNA copy number; mitochondrial
   biogenesis; PERM1; incomplete penetrance
ID MUTATIONS; HEME; PORPHOBILINOGEN; TRANSCRIPTION; BIOGENESIS; MUSCLE;
   MODEL
AB No published study has investigated the mitochondrial count in patients suffering from acute intermittent porphyria (AIP). In order to determine whether mitochondrial content can influence the pathogenesis of porphyria, we measured the mitochondrial DNA (mtDNA) copy number in the peripheral blood cells of 34 patients and 37 healthy individuals. We found that all AIP patients had a low number of mitochondria, likely as a result of a protective mechanism against an inherited heme synthesis deficiency. Furthermore, we identified a close correlation between disease penetrance and decreases in the mitochondrial content and serum levels of PERM1, a marker of mitochondrial biogenesis. In a healthy individual, mitochondrial count is usually modulated to fit its ability to respond to various environmental stressors and bioenergetic demands. In AIP patients, coincidentally, the phenotype only manifests in response to endogenous and exogenous triggers factors. Therefore, these new findings suggest that a deficiency in mitochondrial proliferation could affect the individual responsiveness to stimuli, providing a new explanation for the variability in the clinical manifestations of porphyria. However, the metabolic and/or genetic factors responsible for this impairment remain to be identified. In conclusion, both mtDNA copy number per cell and mitochondrial biogenesis seem to play a role in either inhibiting or promoting disease expression. They could serve as two novel biomarkers for porphyria.
C1 [Di Pierro, Elena; Perrone, Miriana; Granata, Francesca; Duca, Lorena; Lattuada, Debora; Graziadei, Giovanna] Fdn IRCCS CaGranda Osped Maggiore Policlin, I-20122 Milan, Italy.
   [Franco, Milena] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy.
   [De Luca, Giacomo] Univ Milan, Sch Internal Med, I-20122 Milan, Italy.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Pavia;
   University of Milan
RP Di Pierro, E (corresponding author), Fdn IRCCS CaGranda Osped Maggiore Policlin, I-20122 Milan, Italy.
EM elena.dipierro@policlinico.mi.it; labporfirie@policlinico.mi.it;
   milena.franco01@universitadipavia.it;
   francesca.granata@policlinico.mi.it; lorena.duca@policlinico.mi.it;
   debora.lattuada@policlinico.mi.it; giacomodeluca29@gmail.com;
   giovanna.graziadei@policlinico.mi.it
RI Duca, Lorena/K-6909-2012; Giovanna, Graziadei/AAC-1722-2019; De+Luca,
   Giacomo/AAB-2933-2019; Granata, Francesca/K-8635-2016; Lattuada,
   Debora/C-1671-2016; Di Pierro, Elena/A-3157-2009
OI Granata, Francesca/0000-0002-1115-3374; Graziadei,
   Giovanna/0000-0002-6801-5730; Lattuada, Debora/0000-0002-4705-7966; Di
   Pierro, Elena/0000-0002-1413-1349; Duca, Lorena/0000-0002-2008-3187
FU The authors are grateful to all patients and healthy subjects who
   donated samples for this study. We also thank the administrative and
   nursing team for their support in sample collection.
FX The authors are grateful to all patients and healthy subjects who
   donated samples for this study. We also thank the administrative and
   nursing team for their support in sample collection.
CR Atamna H, 2002, ARCH BIOCHEM BIOPHYS, V397, P345, DOI 10.1006/abbi.2001.2671
   Atamna H, 2002, P NATL ACAD SCI USA, V99, P14807, DOI 10.1073/pnas.192585799
   Atamna H, 2001, J BIOL CHEM, V276, P48410, DOI 10.1074/jbc.M108362200
   Bissell DM, 2017, NEW ENGL J MED, V377, P862, DOI 10.1056/NEJMra1608634
   Bissell DM, 2015, J CLIN TRANSL HEPATO, V3, P17, DOI 10.14218/JCTH.2014.00039
   Bonkovsky HL, 2014, AM J MED, V127, P1233, DOI 10.1016/j.amjmed.2014.06.036
   Chen B, 2019, MOL GENET METAB, V128, P382, DOI 10.1016/j.ymgme.2018.12.010
   Chen B, 2016, HUM MUTAT, V37, P1215, DOI 10.1002/humu.23067
   Chien MC, 2012, GENET MOL RES, V11, P3339, DOI 10.4238/2012.September.17.4
   Cho Y, 2013, J BIOL CHEM, V288, P25207, DOI 10.1074/jbc.M113.489674
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Di Pierro E, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11081343
   Di Pierro E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103462
   Dixon N, 2019, MOL GENET METAB, V128, P228, DOI 10.1016/j.ymgme.2019.05.010
   Elder G, 2013, J INHERIT METAB DIS, V36, P849, DOI 10.1007/s10545-012-9544-4
   Falkenberg M, 2018, ESSAYS BIOCHEM, V62, P287, DOI 10.1042/EBC20170100
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Mehta RKG, 2021, MUSCLE NERVE, V64, P140, DOI 10.1002/mus.27232
   Gonzalez-Mosquera L F., 2023, ACUTE INTERMITTENT P
   Gouya L, 2020, HEPATOLOGY, V71, P1546, DOI 10.1002/hep.30936
   Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040
   He YH, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.015
   Homedan C, 2015, HUM MOL GENET, V24, P5015, DOI 10.1093/hmg/ddv222
   Homedan C, 2014, INT J BIOCHEM CELL B, V51, P93, DOI 10.1016/j.biocel.2014.03.032
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]
   Karim Z, 2015, CLIN RES HEPATOL GAS, V39, P412, DOI 10.1016/j.clinre.2015.05.009
   Kazamel M, 2022, FRONT NEUROL, V13, DOI 10.3389/fneur.2022.1004125
   Kazamel M, 2020, CURR NEUROL NEUROSCI, V20, DOI 10.1007/s11910-020-01078-8
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   Kothadia J. P., 2023, Acute hepatic porphyria
   Kozhukhar N, 2023, BIOLOGY-BASEL, V12, DOI 10.3390/biology12060823
   La Morgia C, 2020, J INTERN MED, V287, P592, DOI 10.1111/joim.13064
   Lenglet H, 2018, HUM MOL GENET, V27, P1164, DOI 10.1093/hmg/ddy030
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067146
   Longchamps RJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228166
   Ma LY, 2020, INTRACTABLE RARE DIS, V9, P196, DOI 10.5582/irdr.2020.03082
   Marsden JT, 2014, J CLIN PATHOL, V67, P60, DOI 10.1136/jclinpath-2012-201367
   Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036
   Mohamed SA, 2006, EXP GERONTOL, V41, P508, DOI 10.1016/j.exger.2006.03.014
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nordmann Y, 1997, J INTERN MED, V242, P213, DOI 10.1046/j.1365-2796.1997.00189.x
   Phillips JD, 2019, MOL GENET METAB, V128, P164, DOI 10.1016/j.ymgme.2019.04.008
   Pischik E, 2009, CELL MOL BIOL, V55, P72
   Pischik E, 2015, APPL CLIN GENET, V8, P201, DOI 10.2147/TACG.S48605
   Ploumi C, 2017, FEBS J, V284, P183, DOI 10.1111/febs.13820
   Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955
   Popov LD, 2020, J CELL MOL MED, V24, P4892, DOI 10.1111/jcmm.15194
   Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5
   Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033
   Sardh E, 2022, J INTERN MED, V291, P593, DOI 10.1111/joim.13443
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Stein PE, 2023, J INHERIT METAB DIS, V46, P662, DOI 10.1002/jimd.12612
   Storjord E, 2019, MOL GENET METAB, V128, P254, DOI 10.1016/j.ymgme.2018.12.006
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Vecoli C, 2018, ATHEROSCLEROSIS, V276, P91, DOI 10.1016/j.atherosclerosis.2018.07.015
   Venegas Victor, 2011, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1907s68
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wang B, 2019, HEPATOL COMMUN, V3, P193, DOI 10.1002/hep4.1297
   Yasuda M, 2019, MOL GENET METAB, V128, P320, DOI 10.1016/j.ymgme.2018.11.012
   Yau WW, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21083020
   Zhang GJ, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-173
NR 63
TC 3
Z9 3
U1 3
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-1729
J9 LIFE-BASEL
JI Life-Basel
PD SEP
PY 2023
VL 13
IS 9
AR 1923
DI 10.3390/life13091923
PG 12
WC Biology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Microbiology
GA S5QY2
UT WOS:001071722200001
PM 37763326
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Suomalainen, A
AF Suomalainen, Anu
TI Biomarkers for mitochondrial respiratory chain disorders
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
ID DISEASE; MUTATION; ATAXIA; DNA; INVOLVEMENT; DEFICIENCY; NEUROPATHY;
   DELETIONS; CHILDREN; LACTATE
AB Mitochondrial respiratory chain deficiencies are a group of more than 100 disorders of adults and children, with highly variable phenotypes. Their diagnosis is a great challenge, in spite of the fact that knowledge on their molecular genetic background has increased considerably during the last 20 years. Muscle biopsy is the key diagnostic procedure, including histological and biochemical analysis of mitochondria. Less invasive, specific and sensitive diagnostic tools based on serum biomarkers are still lacking. Recent technological developments, especially in mass spectrometry, enable novel tools for identification of local and global molecular consequences of mitochondrial respiratory chain dysfunction in patient samples. Furthermore, emerging disease models, especially genetically modified mice, offer unique materials to tackle pathophysiology with modern transcriptomic, proteomic, and metabolomic approaches. Identified molecular signals or metabolic fingerprints have the potential to be highly useful biomarkers for future diagnosis of mitochondrial respiratory chain disorders.
C1 [Suomalainen, Anu] Univ Helsinki, Biomedicum Helsinki, Res Program Mol Neurol, FIN-00290 Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.
   [Suomalainen, Anu] Finnish Inst Mol Med, Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; Helsinki University
   Central Hospital
RP Suomalainen, A (corresponding author), Univ Helsinki, Biomedicum Helsinki, Res Program Mol Neurol, RC523B,Haartmaninkatu 8, FIN-00290 Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
OI Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195
FU Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; Centre of
   Excellence Program of the Academy of Finland; University of Helsinki;
   Biocentrum Helsinki; Helsinki University Central Hospital
FX During the writing of this overview, the author was financially
   supported by Sigrid Juselius Foundation, Jane and Aatos Erkko
   Foundation, Centre of Excellence Program of the Academy of Finland,
   University of Helsinki, Biocentrum Helsinki, and Helsinki University
   Central Hospital.
CR Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   [Anonymous], 2000, GENEREVIEWS
   Atkuri KR, 2009, P NATL ACAD SCI USA, V106, P3941, DOI 10.1073/pnas.0813409106
   Boot RG, 2004, BLOOD, V103, P33, DOI 10.1182/blood-2003-05-1612
   Bylesjö M, 2007, PLANT J, V52, P1181, DOI 10.1111/j.1365-313X.2007.03293.x
   Chretien D, 1998, BIOCHEM J, V329, P249, DOI 10.1042/bj3290249
   Davidov E, 2004, OMICS, V8, P267, DOI 10.1089/omi.2004.8.267
   Gloerich J, 2007, J PROTEOME RES, V6, P506, DOI 10.1021/pr060487w
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   Lindroos MM, 2009, BRAIN, V132, P3274, DOI 10.1093/brain/awp259
   Linnankivi T, 2004, NEUROLOGY, V63, P688, DOI 10.1212/01.WNL.0000134658.35601.41
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Schweitzer PJ, 2010, DRUG DISCOV TODAY, V15, P933, DOI 10.1016/j.drudis.2010.08.012
   Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   van der Knaap MS, 2003, ANN NEUROL, V53, P252, DOI 10.1002/ana.10456
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
NR 24
TC 35
Z9 37
U1 1
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-8955
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD APR
PY 2011
VL 34
IS 2
BP 277
EP 282
DI 10.1007/s10545-010-9222-3
PG 6
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 739YI
UT WOS:000288757700005
PM 20941643
DA 2024-11-01
ER

PT J
AU Rothwell, S
   Lilleker, JB
   Lamb, JA
AF Rothwell, Simon
   Lilleker, James B.
   Lamb, Janine A.
TI Genetics in inclusion body myositis
SO CURRENT OPINION IN RHEUMATOLOGY
LA English
DT Review
DE degeneration; genetic association study; genetics; inclusion body
   myositis; mitochondria; sequencing
ID CYTOSOLIC 5'-NUCLEOTIDASE 1A; MITOCHONDRIAL-DNA DELETIONS; ASSOCIATION;
   MYOPATHIES; DISEASES; ALLELES; MHC; POLYMORPHISMS; ARTHRITIS; PROTEINS
AB Purpose of review
   To review the advances in our understanding of the genetics of inclusion body myositis (IBM) in the past year.
   Recent findings
   One large genetic association study focusing on immune-related genes in IBM has refined the association within the human leukocyte antigen (HLA) region to HLA-DRB1 alleles, and identified certain amino acid positions in HLA-DRB1 that may explain this risk. A suggestive association with CCR5 may indicate genetic overlap with other autoimmune diseases. Sequencing studies of candidate genes involved in related neuromuscular or neurodegenerative diseases have identified rare variants in VCP and SQSTM1. Proteomic studies of rimmed vacuoles in IBM and subsequent genetic analyses of candidate genes identified rare missense variants in FYCO1. Complex, large-scale mitochondrial deletions in cytochrome c oxidase-deficient muscle fibres expand our understanding of mitochondrial abnormalities in IBM.
   Summary
   The pathogenesis of IBM is likely multifactorial, including inflammatory and degenerative changes, and mitochondrial abnormalities. There has been considerable progress in our understanding of the genetic architecture of IBM, using complementary genetic approaches to investigate these different pathways.
C1 [Rothwell, Simon; Lilleker, James B.] Univ Manchester, Ctr Musculoskeletal Res, Div Musculoskeletal & Dermatol Sci, Fac Biol Med & Hlth,Manchester Acad Hlth Sci Ctr, Oxford Rd, Manchester M13 9PT, Lancs, England.
   [Lilleker, James B.] Salford Royal NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Greater Manchester Neurosci Ctr, Stott Lane, Salford, Lancs, England.
   [Lamb, Janine A.] Univ Manchester, Ctr Epidemiol, Manchester Acad Hlth Sci Ctr,Div Populat Hlth, Hlth Serv Res & Primary Care,Fac Biol Med & Hlth, Manchester, Lancs, England.
C3 University of Manchester; Salford Royal NHS Foundation Trust; University
   of Manchester
RP Rothwell, S (corresponding author), Univ Manchester, Ctr Musculoskeletal Res, Div Musculoskeletal & Dermatol Sci, Fac Biol Med & Hlth,Manchester Acad Hlth Sci Ctr, Oxford Rd, Manchester M13 9PT, Lancs, England.
EM s.rothwell@manchester.ac.uk
RI Lilleker, James/U-6121-2019
OI Lilleker, James/0000-0002-9230-4137; Lamb, Janine/0000-0002-7248-0539;
   Rothwell, Simon/0000-0003-2123-9902
FU MRC [MR/N003322/1]; MRC [MR/N003322/1] Funding Source: UKRI
FX This work was funded by an MRC Partnership Grant (MR/N003322/1).
CR Ahmed M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad4583
   Benveniste O, 2015, ACTA NEUROPATHOL, V129, P611, DOI 10.1007/s00401-015-1384-5
   Broccolini A, 2015, BBA-MOL BASIS DIS, V1852, P644, DOI 10.1016/j.bbadis.2014.08.007
   Catalán-García M, 2016, CLIN SCI, V130, P1741, DOI 10.1042/CS20160080
   Chinoy H, 2007, RHEUMATOLOGY, V46, P1411, DOI 10.1093/rheumatology/kem145
   Chinoy H, 2012, RHEUMATOLOGY, V51, P794, DOI 10.1093/rheumatology/ker379
   Evilä A, 2016, NEUROMUSCULAR DISORD, V26, P7, DOI 10.1016/j.nmd.2015.10.003
   Gang Q, 2016, NEUROBIOL AGING, V47, DOI 10.1016/j.neurobiolaging.2016.07.024
   Gang Q, 2015, CURR OPIN RHEUMATOL, V27, P586, DOI 10.1097/BOR.0000000000000213
   Gang Q, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.12.039
   Gang Q, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-88
   Garlepp MJ, 1995, ANN NEUROL, V38, P957, DOI 10.1002/ana.410380619
   Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176
   Greenberg SA, 2005, NEUROLOGY, V65, P1782, DOI 10.1212/01.wnl.0000187124.92826.20
   Güttsches AK, 2017, ANN NEUROL, V81, P227, DOI 10.1002/ana.24847
   Hinks A, 2013, NAT GENET, V45, P664, DOI 10.1038/ng.2614
   Johari M, 2017, EUR J NEUROL, V24, P572, DOI 10.1111/ene.13244
   Kirino Y, 2015, NAT REV RHEUMATOL, V11, P401, DOI 10.1038/nrrheum.2015.41
   Koffman BM, 1998, J NEUROIMMUNOL, V84, P139, DOI 10.1016/S0165-5728(97)00245-2
   Larman HB, 2013, ANN NEUROL, V73, P408, DOI 10.1002/ana.23840
   Liley J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004926
   Limaye VS, 2016, MUSCLE NERVE, V53, P654, DOI 10.1002/mus.24989
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Mastaglia FL, 2009, NEUROMUSCULAR DISORD, V19, P763, DOI 10.1016/j.nmd.2009.07.015
   Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Needham M, 2007, MUSCLE NERVE, V35, P549, DOI 10.1002/mus.20766
   Needham M, 2008, NEUROMUSCULAR DISORD, V18, P150, DOI 10.1016/j.nmd.2007.09.005
   Needham M, 2007, LANCET NEUROL, V6, P620, DOI 10.1016/S1474-4422(07)70171-0
   Nogalska A, 2009, ACTA NEUROPATHOL, V118, P407, DOI 10.1007/s00401-009-0564-6
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Pluk H, 2013, ANN NEUROL, V73, P397, DOI 10.1002/ana.23822
   Price AL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1684
   Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076
   Rojana-udomsart A, 2013, J NEUROIMMUNOL, V254, P174, DOI 10.1016/j.jneuroim.2012.09.003
   Rojana-Udomsart A, 2012, J NEUROIMMUNOL, V250, P77, DOI 10.1016/j.jneuroim.2012.05.003
   Rothwell S, 2017, ARTHRITIS RHEUMATOL, V69, P1090, DOI 10.1002/art.40045
   Rothwell S, 2016, ANN RHEUM DIS, V75, P1558, DOI 10.1136/annrheumdis-2015-208119
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Salajegheh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020266
   Schmidt J, 2004, BRAIN, V127, P1182, DOI 10.1093/brain/awh148
   Scott AP, 2012, J NEUROIMMUNOL, V250, P66, DOI 10.1016/j.jneuroim.2012.04.021
   SIVAKUMAR K, 1995, ANN NEUROL, V38, P267, DOI 10.1002/ana.410380222
   Weihl CC, 2015, NEUROMUSCULAR DISORD, V25, P289, DOI 10.1016/j.nmd.2014.12.009
NR 45
TC 10
Z9 10
U1 0
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8711
EI 1531-6963
J9 CURR OPIN RHEUMATOL
JI Curr. Opin. Rheumatol.
PD NOV
PY 2017
VL 29
IS 6
BP 639
EP 644
DI 10.1097/BOR.0000000000000431
PG 6
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA FJ2IK
UT WOS:000412548600013
PM 28777108
OA Green Published
DA 2024-11-01
ER

PT J
AU Kucharczyk, R
   Rak, M
   di Rago, JP
AF Kucharczyk, Roza
   Rak, Malgorzata
   di Rago, Jean-Paul
TI Biochemical consequences in yeast of the human mitochondrial DNA
   8993T&gt;C mutation in the ATPase6 gene found in NARP/MILS patients
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
LA English
DT Article
DE ATP6; F1F0 ATP synthase, NARP/MILS disease; Mitochondrial DNA; Yeast
ID ATP-SYNTHASE; SACCHAROMYCES-CEREVISIAE; LEIGH-SYNDROME; T8993G MUTATION;
   OXIDATIVE-PHOSPHORYLATION; NARP MUTATION; MTDNA; EXPRESSION; CELLS;
   FIBROBLASTS
AB We have created and analyzed the properties of a yeast model of the human mitochondrial DNA T8993C mutation that has been associated with maternally-inherited Leigh syndrome and/or with neurogenic muscle weakness, ataxia and retinitis pigmentosa. This mutation changes a highly conserved leucine to proline in the Atp6p subunit of the ATP synthase, at position 156 in the human protein, position 183 in yeast. In vitro the yeast T8993C mitochondria showed a 40-50% decrease in the rate of ATP synthesis. The ATP-driven translocation of protons across the inner mitochondrial membrane was normal in the mutant and fully sensitive to oligomycin, an inhibitor of the ATP synthase proton channel. However under conditions of maximal ATP hydrolytic activity, using non-osmotically protected mitochondria, the mutant ATPase activity was poorly inhibited by oligomycin (by 40% versus 85% in wild type cells). These anomalies were attributed by BN-PAGE and mitochondrial protein synthesis analyses to a less efficient incorporation of Atp6p within the ATP synthase. Interestingly,the cytochrome c oxidase content was selectively decreased by 40-50% in T8993C yeast, apparently due to a reduced synthesis of its mitochondrially encoded Cox1p subunit. This observation further supports the existence of a control of cytochrome c oxidase expression by the ATP synthase in yeast mitochondria. Despite the ATPase deficiency, growth of the atp6-L183P mutant on respiratory substrates and the efficiency of oxidative phosphorylation were similar to that of wild type, indicating that the mutation did not affect the proton permeability of the mitochondrial inner membrane. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Kucharczyk, Roza; Rak, Malgorzata; di Rago, Jean-Paul] Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, F-33076 Bordeaux, France.
   [Kucharczyk, Roza] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.
C3 Centre National de la Recherche Scientifique (CNRS); Universite de
   Bordeaux; Polish Academy of Sciences; Institute of Biochemistry &
   Biophysics - Polish Academy of Sciences
RP di Rago, JP (corresponding author), Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, F-33076 Bordeaux, France.
EM jp.dirago@ibgc.u-bordeaux2.fr
RI Rak, Malgorzata/HZJ-8533-2023; Kucharczyk, Roza/H-8154-2012
OI Rak, Malgorzata/0000-0003-2057-1890; Kucharczyk,
   Roza/0000-0002-8712-7535
FU French Ministry of Research; Agence Nationale de la Recherche (ANR);
   Association Francaise contre les Myopathies (AFM); GIS-Maladies rares;
   ANR; Conseil de la Region Aquitaine
FX We are grateful to J. Velours for the generous gift of antibodies, M.
   Maciag and B. Burzynska for the help in real-time PCR experiment and M.
   Ding for English revisions. R.K was supported by post-doctoral
   fellowships from the French Ministry of Research and the Agence
   Nationale de la Recherche (ANR). M.R. was a fellow from the Retina
   Foundation and the French Embassy in Warsaw. This work was supported by
   grants from the Association Francaise contre les Myopathies (AFM), the
   GIS-Maladies rares, the ANR and the Conseil de la Region Aquitaine.
CR Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0
   Ackerman SH, 2002, BBA-BIOENERGETICS, V1555, P101, DOI 10.1016/S0005-2728(02)00262-1
   Arselin G, 1996, J BIOL CHEM, V271, P20284, DOI 10.1074/jbc.271.34.20284
   Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4
   Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358
   Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2
   Ciesla M, 2007, MOL CELL BIOL, V27, P7693, DOI 10.1128/MCB.01051-07
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   CLAISSE ML, 1974, EUR J BIOCHEM, V49, P49, DOI 10.1111/j.1432-1033.1974.tb03810.x
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   Cortés-Hernández P, 2007, J BIOL CHEM, V282, P1051, DOI 10.1074/jbc.M606828200
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X
   Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3
   García JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075
   Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221
   Guerin B, 1979, Methods Enzymol, V55, P149
   HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A
   Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006
   KUCHARCZYK R, 2009, BIOCHIM BIOPHYS ACTA, V1739, P186
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lefebvre-Legendre L, 2001, J BIOL CHEM, V276, P6789, DOI 10.1074/jbc.M009557200
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   MUKHOPADHYAY A, 1994, FEBS LETT, V343, P160, DOI 10.1016/0014-5793(94)80310-2
   Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566
   Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200
   Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200
   RIGOULET M, 1979, FEBS LETT, V102, P18, DOI 10.1016/0014-5793(79)80919-9
   SANTORELLI FM, 1994, NEUROLOGY, V44, P972, DOI 10.1212/WNL.44.5.972
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   SOMLO M, 1968, EUR J BIOCHEM, V5, P276, DOI 10.1111/j.1432-1033.1968.tb00368.x
   Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334
   Tzagoloff A, 2004, J BIOL CHEM, V279, P19775, DOI 10.1074/jbc.M401506200
   VazquezMemije ME, 1996, J INHERIT METAB DIS, V19, P43, DOI 10.1007/BF01799347
   Velours J, 2000, J BIOENERG BIOMEMBR, V32, P383, DOI 10.1023/A:1005580020547
   Venard R, 2003, BIOCHEMISTRY-US, V42, P7626, DOI 10.1021/bi034394t
   Wittig I, 2007, METHOD CELL BIOL, V80, P723, DOI 10.1016/S0091-679X(06)80033-6
   Zeng XM, 2007, J BIOL CHEM, V282, P36167, DOI 10.1074/jbc.M705436200
   Zeng XM, 2007, MOL BIOL CELL, V18, P617, DOI 10.1091/mbc.E06-09-0801
NR 50
TC 54
Z9 57
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-4889
EI 0006-3002
J9 BBA-MOL CELL RES
JI Biochim. Biophys. Acta-Mol. Cell Res.
PD MAY
PY 2009
VL 1793
IS 5
BP 817
EP 824
DI 10.1016/j.bbamcr.2009.02.011
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 453YZ
UT WOS:000266650100008
PM 19269308
OA Bronze
DA 2024-11-01
ER

PT J
AU Kato, T
AF Kato, T
TI Mitochondrial dysfunction in bipolar disorder:: From
   <SUP>31</SUP>P-magnetic resonance spectroscopic findings to their
   molecular mechanisms
SO INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 63
SE INTERNATIONAL REVIEW OF NEUROBIOLOGY
LA English
DT Review
ID N-ACETYL-ASPARTATE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; BRAIN
   PHOSPHORUS-METABOLISM; WOLFRAM-SYNDROME GENE; MOOD DISORDERS; SYNAPTIC
   PLASTICITY; INTRACELLULAR PH; DNA DELETION; FRONTAL-LOBE;
   PHOSPHOINOSITIDE METABOLISM
RI Kato, Tadafumi/J-3583-2014
OI Kato, Tadafumi/0000-0001-7856-3952
CR BARBER D, 1993, EDUC TRAIN MENT RET, V28, P13
   Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273
   BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587
   Bertolino A, 2003, BIOL PSYCHIAT, V53, P906, DOI 10.1016/S0006-3223(02)01911-X
   BROOKE NSR, 1994, P NATL ACAD SCI USA, V91, P1903, DOI 10.1073/pnas.91.5.1903
   Cecil KM, 2002, BIPOLAR DISORD, V4, P357, DOI 10.1034/j.1399-5618.2002.02235.x
   Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x
   CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204
   Dager SR, 2004, ARCH GEN PSYCHIAT, V61, P450, DOI 10.1001/archpsyc.61.5.450
   DEICKEN RF, 1995, J AFFECT DISORDERS, V33, P195, DOI 10.1016/0165-0327(94)00089-R
   Deicken RF, 2003, AM J PSYCHIAT, V160, P873, DOI 10.1176/appi.ajp.160.5.873
   DEICKEN RF, 1995, AM J PSYCHIAT, V152, P915
   Evans KL, 2000, AM J MED GENET, V96, P158, DOI 10.1002/(SICI)1096-8628(20000403)96:2<158::AID-AJMG6>3.0.CO;2-8
   Furlong RA, 1999, NEUROSCI LETT, V277, P123, DOI 10.1016/S0304-3940(99)00865-4
   Goodwin F.K., 2007, MANIC DEPRESSIVE ILL
   Hamakawa H, 2004, PSYCHIAT CLIN NEUROS, V58, P82, DOI 10.1111/j.1440-1819.2004.01197.x
   Hamakawa H, 1999, PSYCHOL MED, V29, P639, DOI 10.1017/S0033291799008442
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441
   Iwamoto K, 2004, MOL PSYCHIATR, V9, P406, DOI 10.1038/sj.mp.4001437
   IWAMOTO K, 2004, HUM MOL GENET   1124
   Jonas EA, 2003, J NEUROSCI, V23, P8423
   Karry R, 2004, BIOL PSYCHIAT, V55, P676, DOI 10.1016/j.biopsych.2003.12.012
   KATO T, 1995, PSYCHOL MED, V25, P557, DOI 10.1017/S003329170003347X
   Kato T, 1998, J NEUROL SCI, V155, P182, DOI 10.1016/S0022-510X(97)00308-0
   Kato T, 1996, J AFFECT DISORDERS, V37, P67, DOI 10.1016/0165-0327(95)00050-X
   Kato T, 1997, BIOL PSYCHIAT, V42, P871, DOI 10.1016/S0006-3223(97)00012-7
   Kato T, 1996, AM J MED GENET, V67, P546, DOI 10.1002/(SICI)1096-8628(19961122)67:6<546::AID-AJMG6>3.0.CO;2-F
   Kato T, 1998, J NEUROPSYCH CLIN N, V10, P133, DOI 10.1176/jnp.10.2.133
   KATO T, 1992, J AFFECT DISORDERS, V26, P223, DOI 10.1016/0165-0327(92)90099-R
   Kato T, 2000, INT J NEUROPSYCHOPH, V3, P83, DOI 10.1017/S1461145799001674
   Kato T, 2003, INT J NEUROPSYCHOPH, V6, P379, DOI 10.1017/S1461145703003717
   Kato T, 2003, NEUROSCI LETT, V338, P21, DOI 10.1016/S0304-3940(02)01334-4
   Kato T, 1998, EUR ARCH PSY CLIN N, V248, P301, DOI 10.1007/s004060050054
   Kato T, 2001, J AFFECT DISORDERS, V62, P151, DOI 10.1016/S0165-0327(99)00173-1
   KATO T, 1994, J AFFECT DISORDERS, V31, P125, DOI 10.1016/0165-0327(94)90116-3
   KATO T, 1993, J AFFECT DISORDERS, V27, P53, DOI 10.1016/0165-0327(93)90097-4
   KATO T, 1991, J AFFECT DISORDERS, V22, P185, DOI 10.1016/0165-0327(91)90064-Y
   Kato T, 1997, BIOL PSYCHIAT, V42, P311, DOI 10.1016/S0006-3223(96)00377-0
   Kato T, 2001, MOL PSYCHIATR, V6, P625, DOI 10.1038/sj.mp.4000926
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246
   Kirk R, 1999, AM J HUM GENET, V65, P508, DOI 10.1086/302507
   Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300
   Lambert D, 2002, BIPOLAR DISORD, V4, P31, DOI 10.1034/j.1399-5618.4.s1.7.x
   Levy M, 2003, J BIOL CHEM, V278, P17727, DOI 10.1074/jbc.M212878200
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Manji H K, 2001, Psychopharmacol Bull, V35, P5
   Matsuo K, 2002, PSYCHOL MED, V32, P1029, DOI 10.1017/S0033291702005974
   MATSUO K, 2004, WORLD FED SOC BIOL P
   MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277
   McMahon FJ, 2000, AM J PSYCHIAT, V157, P1058, DOI 10.1176/appi.ajp.157.7.1058
   Middle F, 2000, AM J MED GENET, V96, P154, DOI 10.1002/(SICI)1096-8628(20000403)96:2<154::AID-AJMG5>3.0.CO;2-F
   Miyaoka H, 1997, BIOL PSYCHIAT, V42, P524, DOI 10.1016/S0006-3223(97)00280-1
   Modica-Napolitano JS, 2004, BIOL PSYCHIAT, V55, P273, DOI 10.1016/S0006-3223(03)00784-4
   Moore CM, 2000, BIPOLAR DISORD, V2, P207, DOI 10.1034/j.1399-5618.2000.20302.x
   Moore GJ, 2000, BIOL PSYCHIAT, V48, P1, DOI 10.1016/S0006-3223(00)00252-3
   Munakata K, 2004, GENOMICS, V84, P1041, DOI 10.1016/j.ygeno.2004.08.015
   Murashita J, 2000, PSYCHOL MED, V30, P107, DOI 10.1017/S0033291799001439
   NAKASHIMA K, 1996, ACTA NEUROL SCAND  S, V166, P96
   Nakatani N, 2004, PHARMACOGENOMICS J, V4, P114, DOI 10.1038/sj.tpj.6500234
   Ohtsuki T, 2000, J AFFECT DISORDERS, V58, P11, DOI 10.1016/S0165-0327(99)00099-3
   Öngür D, 1998, P NATL ACAD SCI USA, V95, P13290, DOI 10.1073/pnas.95.22.13290
   Onishi H, 1997, BIOL PSYCHIAT, V41, P1137, DOI 10.1016/S0006-3223(97)00005-X
   Pfeiffer DR, 2001, IUBMB LIFE, V52, P205, DOI 10.1080/15216540152846019
   Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   Rae C, 1996, P ROY SOC B-BIOL SCI, V263, P1061, DOI 10.1098/rspb.1996.0156
   Rae C, 2003, DEV NEUROSCI-BASEL, V25, P324, DOI 10.1159/000073509
   Rajkowska G, 2001, BIOL PSYCHIAT, V49, P741, DOI 10.1016/S0006-3223(01)01080-0
   Rango M, 2001, J CEREBR BLOOD F MET, V21, P85, DOI 10.1097/00004647-200101000-00011
   RENSHAW PF, 1987, MAGN RESON MED, V4, P221, DOI 10.1002/mrm.1910040303
   Riehemann S, 2002, PSYCHIAT RES-NEUROIM, V114, P113, DOI 10.1016/S0925-4927(02)00007-0
   Schroeter ML, 2002, NEUROREPORT, V13, P1675, DOI 10.1097/00001756-200209160-00021
   Serretti A, 2003, PSYCHIAT GENET, V13, P121, DOI 10.1097/01.ypg.0000056172.32550.f9
   Sharpe JC, 2004, BBA-MOL CELL RES, V1644, P107, DOI 10.1016/j.bbamcr.2003.10.016
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Silverstone PH, 2003, INT CLIN PSYCHOPHARM, V18, P73, DOI 10.1097/00004850-200303000-00002
   Silverstone PH, 2002, HUM PSYCHOPHARM CLIN, V17, P425, DOI 10.1002/hup.434
   Soares JC, 1997, PSYCHOPHARMACOL BULL, V33, P685
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   STANTON PK, 1986, BRAIN RES, V382, P185, DOI 10.1016/0006-8993(86)90130-7
   STINE OC, 1993, BIOL PSYCHIAT, V42, P311
   Strakowski SM, 2000, BIPOLAR DISORD, V2, P148, DOI 10.1034/j.1399-5618.2000.020302.x
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   SWIFT RG, 1990, LANCET, V336, P667, DOI 10.1016/0140-6736(90)92157-D
   SWIFT RG, 1991, AM J PSYCHIAT, V148, P775
   Torres R, 2001, MOL PSYCHIATR, V6, P39, DOI 10.1038/sj.mp.4000787
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Volz HP, 1998, EUR ARCH PSY CLIN N, V248, P289, DOI 10.1007/s004060050052
   Washizuka S, 2004, BIOL PSYCHIAT, V56, P483, DOI 10.1016/j.biopsych.2004.07.004
   Washizuka S, 2003, INT J NEUROPSYCHOPH, V6, P421, DOI 10.1017/S1461145703003778
   Washizuka S, 2003, AM J MED GENET B, V120B, P72, DOI 10.1002/ajmg.b.20041
   Weeber EJ, 2002, J BIOL CHEM, V277, P18891, DOI 10.1074/jbc.M201649200
   Winsberg ME, 2000, BIOL PSYCHIAT, V47, P475, DOI 10.1016/S0006-3223(99)00183-3
   Yamawaki S, 1998, LIFE SCI, V62, P1665, DOI 10.1016/S0024-3205(98)00125-8
   Yildiz A, 2001, BIOL PSYCHIAT, V50, P3, DOI 10.1016/S0006-3223(01)01069-1
   Yildiz A, 2001, PSYCHIAT RES-NEUROIM, V106, P181, DOI 10.1016/S0925-4927(01)00082-8
   Zazueta C, 2003, J MEMBRANE BIOL, V191, P113, DOI 10.1007/s00232-002-1047-z
   Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980
NR 100
TC 23
Z9 26
U1 0
U2 6
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0074-7742
J9 INT REV NEUROBIOL
PY 2005
VL 63
BP 21
EP 40
DI 10.1016/S0074-7742(05)63002-4
PG 20
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA BBW53
UT WOS:000228146100002
PM 15797464
DA 2024-11-01
ER

PT J
AU Cree, LM
   Samuels, DC
   Chinnery, PF
AF Cree, L. M.
   Samuels, D. C.
   Chinnery, P. F.
TI The inheritance of pathogenic mitochondrial DNA mutations
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Review
DE mtDNA; Mitochondria; Genetic bottleneck; Inheritance
ID HEREDITARY OPTIC NEUROPATHY; RANDOM GENETIC DRIFT; MTDNA MUTATION;
   PATERNAL INHERITANCE; RAPID SEGREGATION; PEDIGREE ANALYSIS;
   SKELETAL-MUSCLE; NUCLEOTIDE 8993; MOUSE EMBRYOS; SELECTION
AB Mitochondrial DNA mutations cause disease in > 1 in 5000 of the population, and similar to 1 in 200 of the population are asymptomatic carriers of a pathogenic mtDNA mutation. Many patients with these pathogenic mtDNA mutations present with a progressive, disabling neurological syndrome that leads to major disability and premature death. There is currently no effective treatment for mitochondrial disorders, placing great emphasis on preventing the transmission of these diseases. An empiric approach can be used to guide genetic counseling for common mtDNA mutations, but many families transmit rare or unique molecular defects. There is therefore a pressing need to develop techniques to prevent transmission based on a solid understanding of the biological mechanisms. Several recent studies have cast new light on the genetics and cell biology of mtDNA inheritance, but these studies have also raised new controversies. Here we compare and contrast these findings and discuss their relevance for the transmission of human mtDNA diseases. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Chinnery, P. F.] Newcastle Univ, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Samuels, D. C.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN USA.
C3 Newcastle University - UK; Vanderbilt University
RP Chinnery, PF (corresponding author), Newcastle Univ, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM P.F.Chinnery@ncl.ac.uk
RI ; Samuels, David/A-5393-2008
OI Chinnery, Patrick/0000-0002-7065-6617; Samuels,
   David/0000-0003-3529-7791; Cree, Lynsey/0000-0003-2090-1589
FU Ataxia (UK); Parkinson's disease Society (UK); Medical Research Council
   (UK); UK NIHR Biomedical Research Centre
FX PFC is a Wellcome Trust Senior Fellow in Clinical Science. PFC also
   receives funding from Ataxia (UK), the Parkinson's disease Society (UK),
   and the Medical Research Council (UK), and the UK NIHR Biomedical
   Research Centre.
CR Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Chinnery PF, 2006, COCHRANE DB SYST REV, V25
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   DOWNS KM, 1993, DEVELOPMENT, V118, P1255
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   Fischel-Ghodsian N, 1998, AM J HUM GENET, V62, P15, DOI 10.1086/301695
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389
   HARDING AE, 1995, AM J HUM GENET, V57, P77
   HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horvath R, 2008, NEUROTHERAPEUTICS, V5, P558, DOI 10.1016/j.nurt.2008.07.002
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Jacobs LJAM, 2006, HUM REPROD UPDATE, V12, P119, DOI 10.1093/humupd/dmi042
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Macmillan C, 1998, NEUROLOGY, V50, P417, DOI 10.1212/WNL.50.2.417
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187
   Poulton J, 2000, NEUROMUSCULAR DISORD, V10, P484, DOI 10.1016/S0960-8966(00)00130-9
   Poulton J, 2006, LANCET, V368, P841, DOI 10.1016/S0140-6736(06)69326-4
   POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   Stewart J.B., 2008, NAT REV GENET
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466
   Taylor RW, 2003, ANN NEUROL, V54, P521, DOI 10.1002/ana.10673
   Thundathil J, 2005, MOL REPROD DEV, V71, P405, DOI 10.1002/mrd.20260
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Weber K, 1997, AM J HUM GENET, V60, P373
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   Wonnapinij P, 2008, AM J HUM GENET, V83, P582, DOI 10.1016/j.ajhg.2008.10.007
   Wright S, 1969, EVOLUTION GENETICS P
NR 56
TC 67
Z9 75
U1 0
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 0006-3002
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD DEC
PY 2009
VL 1792
IS 12
BP 1097
EP 1102
DI 10.1016/j.bbadis.2009.03.002
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 530HG
UT WOS:000272579400002
PM 19303927
OA Green Submitted, Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Longo, N
   Frigeni, M
   Pasquali, M
AF Longo, Nicola
   Frigeni, Marta
   Pasquali, Marzia
TI Carnitine transport and fatty acid oxidation
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
LA English
DT Article
DE Carnitine; Arrhythmia; SLC22A5; OCTN2; Newborn screening; Autism
ID ACYL-COA SYNTHETASE; ORGANIC CATION/CARNITINE TRANSPORTER; BINDING
   PROTEIN GENE; GENOTYPE-PHENOTYPE CORRELATIONS; LIPID-METABOLISM;
   VECTORIAL ACYLATION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; FAROE-ISLANDS;
   OCTN2 GENE
AB Carnitine is essential for the transfer of long-chain fatty acids across the inner mitochondrial membrane for subsequent Is-oxidation. It can be synthesized by the body or assumed with the diet from meat and dairy products. Defects in carnitine biosynthesis do not routinely result in low plasma carnitine levels. Carnitine is accumulated by the cells and retained by kidneys using OCTN2, a high affinity organic cation transporter specific for carnitine. Defects in the OCTN2 carnitine transporter results in autosomal recessive primary carnitine deficiency characterized by decreased intracellular carnitine accumulation, increased losses of carnitine in the urine, and low serum carnitine levels. Patients can present early in life with hypoketotic hypoglycemia and hepatic encephalopathy, or later in life with skeletal and cardiac myopathy or sudden death from cardiac arrhythmia, usually triggered by fasting or catabolic state. This disease responds to oral carnitine that, in pharmacological doses, enters cells using the amino acid transporter B-0,B-+. Primary carnitine deficiency can be suspected from the clinical presentation or identified by low levels of free carnitine (CO) in the newborn screening. Some adult patients have been diagnosed following the birth of an unaffected child with very low carnitine levels in the newborn screening. The diagnosis is confirmed by measuring low carnitine uptake in the patients' fibroblasts or by DNA sequencing of the SLC22A5 gene encoding the OCTN2 carnitine transporter. Some mutations are specific for certain ethnic backgrounds, but the majority are private and identified only in individual families. Although the genotype usually does not correlate with metabolic or cardiac involvement in primary carnitine deficiency, patients presenting as adults tend to have at least one missense mutation retaining residual activity. This article is part of a Special Issue entitled: Mitochondrial Channels edited by Pierre Sonveaux, Pierre Maechler and Jean-Claude Martinou. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Longo, Nicola; Frigeni, Marta] Univ Utah, Dept Pediat, Div Med Genet, 500 Chipeta Way, Salt Lake City, UT USA.
   [Longo, Nicola; Pasquali, Marzia] Univ Utah, Dept Pathol, 500 Chipeta Way, Salt Lake City, UT USA.
   [Longo, Nicola; Pasquali, Marzia] ARUP Labs, 500 Chipeta Way, Salt Lake City, UT USA.
C3 Utah System of Higher Education; University of Utah; Utah System of
   Higher Education; University of Utah; Utah System of Higher Education;
   University of Utah; ARUP Laboratories
RP Longo, N (corresponding author), Univ UT, Dept Pediat, Div Med Genet, 695 Chipeta Way, Salt Lake City, UT 84108 USA.
EM Nicola.Longo@hsc.utah.edu
RI Frigeni, Marta/AAX-4535-2021
OI Frigeni, Marta/0000-0001-8544-7175
FU National Institutes of Health [R01 DK 53824]
FX National Institutes of Health; contract grant number: R01 DK 53824
CR Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636
   Akpinar B., 2010, CLIN GENET, V78, P89
   Anderson CM, 2013, MOL ASPECTS MED, V34, P516, DOI 10.1016/j.mam.2012.07.010
   Anichini A, 2011, NEUROL RES, V33, P24, DOI 10.1179/016164110X12767786356390
   Arias-Barrau E, 2009, METHODS MOL BIOL, V580, P233, DOI 10.1007/978-1-60761-325-1_13
   Auinger A, 2012, BRIT J NUTR, V107, P1422, DOI 10.1017/S0007114511004727
   Berlanga A, 2014, CLIN EXP GASTROENTER, V7, P221, DOI 10.2147/CEG.S62831
   BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401
   Binnert C, 2000, AM J PHYSIOL-ENDOC M, V279, pE1072, DOI 10.1152/ajpendo.2000.279.5.E1072
   Black Paul N, 2007, Novartis Found Symp, V286, P127
   Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003
   BLACK PN, 2007, NOVART FDN SYMP, V286, P138
   BLACK PN, 2007, NOVART FDN SYMP, V286, P162
   BLACK PN, 2007, NOVART FDN SYMP, V286, P196
   Boord JB, 2002, ARTERIOSCL THROM VAS, V22, P1686, DOI 10.1161/01.ATV.0000033090.81345.E6
   Borum P R, 1995, J Child Neurol, V10 Suppl 2, pS25
   Burckhardt G, 2000, AM J PHYSIOL-RENAL, V278, pF853, DOI 10.1152/ajprenal.2000.278.6.F853
   Burwinkel B, 1999, BIOCHEM BIOPH RES CO, V261, P484, DOI 10.1006/bbrc.1999.1060
   Carter A L, 1995, J Child Neurol, V10 Suppl 2, pS3
   Cederbaum SD, 2002, MOL GENET METAB, V77, P195, DOI 10.1016/S1096-7192(02)00169-5
   Celestino-Soper PBS, 2012, P NATL ACAD SCI USA, V109, P7974, DOI 10.1073/pnas.1120210109
   Celestino-Soper PBS, 2011, HUM MOL GENET, V20, P4360, DOI 10.1093/hmg/ddr363
   Cooper DE, 2015, J BIOL CHEM, V290, P20023, DOI 10.1074/jbc.R115.663260
   Crombez EA, 2008, MOL GENET METAB, V94, P132, DOI 10.1016/j.ymgme.2008.01.005
   De Biase I, 2012, JIMD REP, V2, P87, DOI 10.1007/8904_2011_52
   de Sain-van der Velden MGM, 2013, MOL GENET METAB, V110, P116, DOI 10.1016/j.ymgme.2013.04.008
   di San Filippo CA, 2004, J BIOL CHEM, V279, P7247, DOI 10.1074/jbc.M309171200
   di San Filippo CA, 2003, J BIOL CHEM, V278, P47776, DOI 10.1074/jbc.M307911200
   Dobrowolski SE, 2005, HUM MUTAT, V25, P306, DOI 10.1002/humu.20137
   Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006
   Drosatos Konstantinos, 2013, Curr Heart Fail Rep, V10, P109, DOI 10.1007/s11897-013-0133-0
   El-Hattab A.W., 2015, MOL GENET METAB
   El-Hattab AW, 2010, GENET MED, V12, P19, DOI 10.1097/GIM.0b013e3181c5e6f7
   Filipek PA, 2004, J AUTISM DEV DISORD, V34, P615, DOI 10.1007/s10803-004-5283-1
   Filippo CADS, 2008, MOL GENET METAB, V94, P162, DOI 10.1016/j.ymgme.2008.02.002
   Filippo CAD, 2006, HUM MUTAT, V27, P513, DOI 10.1002/humu.20314
   Filippo CADS, 2011, BBA-MOL BASIS DIS, V1812, P312, DOI 10.1016/j.bbadis.2010.11.007
   Frigeni M., 2015, J INHERIT METAB D S1, V38, pS199
   Fu Li-jun, 2012, Zhonghua Er Ke Za Zhi, V50, P929
   Fu LJ, 2013, KOREAN CIRC J, V43, P785, DOI 10.4070/kcj.2013.43.12.785
   Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589
   Gazzerro E, 2010, EUR J HUM GENET, V18, P137, DOI 10.1038/ejhg.2009.103
   Glatz JFC, 2006, CARDIOVASC DRUG THER, V20, P471, DOI 10.1007/s10557-006-0582-8
   Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541
   Han LS, 2014, EUR J MED GENET, V57, P571, DOI 10.1016/j.ejmg.2014.08.001
   Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004
   Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080
   Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9
   Hirano T, 2006, BBA-BIOMEMBRANES, V1758, P1743, DOI 10.1016/j.bbamem.2006.07.002
   Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200
   Hoffmann L, 2014, LIPIDS, V49, P25, DOI 10.1007/s11745-013-3865-4
   Hotamisligil GS, 2015, NAT REV ENDOCRINOL, V11, P592, DOI 10.1038/nrendo.2015.122
   Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377
   Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2
   Hu CX, 2012, MOL CANCER THER, V11, P921, DOI 10.1158/1535-7163.MCT-11-0980
   Hubbard B, 2006, GASTROENTEROLOGY, V130, P1259, DOI 10.1053/j.gastro.2006.02.012
   Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004
   Kilic M, 2012, JIMD REP, V3, P17, DOI 10.1007/8904_2011_36
   Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328
   Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021
   Koizumi A, 1999, HUM MOL GENET, V8, P2247, DOI 10.1093/hmg/8.12.2247
   Komlósi K, 2009, J INHERIT METAB DIS, V32, pS15, DOI 10.1007/s10545-009-0926-1
   Kör D, 2015, J PEDIATR ENDOCR MET, V28, P669, DOI 10.1515/jpem-2014-0302
   Krammer J, 2011, INT J MED SCI, V8, P599, DOI 10.7150/ijms.8.599
   Lamhonwah AM, 2002, AM J MED GENET, V111, P271, DOI 10.1002/ajmg.10585
   Le Borgne F, 2011, BIOCHEM BIOPH RES CO, V409, P699, DOI 10.1016/j.bbrc.2011.05.068
   Lee J, 2012, J TURBUL, V13, P1, DOI 10.1080/14685248.2012.684387
   Lee NC, 2010, MOL GENET METAB, V100, P46, DOI 10.1016/j.ymgme.2009.12.015
   Leydiker KB, 2011, MOL GENET METAB, V103, P92, DOI 10.1016/j.ymgme.2011.01.011
   Li FY, 2010, HUM MUTAT, V31, pE1632, DOI 10.1002/humu.21311
   LOMBARD KA, 1989, AM J CLIN NUTR, V50, P301, DOI 10.1093/ajcn/50.2.301
   Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087
   Longo N, 2001, AM J PHYSIOL-CELL PH, V280, pC912, DOI 10.1152/ajpcell.2001.280.4.C912
   Lousa CD, 2013, P NATL ACAD SCI USA, V110, P1279, DOI 10.1073/pnas.1218034110
   Lund AM, 2007, J INHERIT METAB DIS, V30, P341, DOI 10.1007/s10545-007-0527-9
   Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300
   Makhseed N, 2004, J INHERIT METAB DIS, V27, P778, DOI 10.1023/B:BOLI.0000045837.23328.f4
   Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076
   Martin GG, 2006, AM J PHYSIOL-GASTR L, V290, pG36, DOI 10.1152/ajpgi.00510.2004
   Martin GG, 2003, J BIOL CHEM, V278, P21429, DOI 10.1074/jbc.M300287200
   Masuda D, 2009, J LIPID RES, V50, P999, DOI 10.1194/jlr.P700032-JLR200
   Mayatepek E, 2000, Hum Mutat, V15, P118, DOI 10.1002/(SICI)1098-1004(200001)15:1<118::AID-HUMU28>3.0.CO;2-8
   Mazzini M, 2011, CARDIOLOGY, V120, P52, DOI 10.1159/000333127
   Melton EM, 2011, J BIOL CHEM, V286, P30670, DOI 10.1074/jbc.M111.226316
   Méndez-Giménez L, 2014, MOL CELL ENDOCRINOL, V397, P78, DOI 10.1016/j.mce.2014.06.017
   Mitsuyoshi H, 2009, HEPATOL RES, V39, P366, DOI 10.1111/j.1872-034X.2008.00464.x
   Mutlu-Albayrak H., 2015, CASE REP GENET, V2015
   Nakanishi T, 2001, J PHYSIOL-LONDON, V532, P297, DOI 10.1111/j.1469-7793.2001.0297f.x
   Nava C, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.102
   Neess D, 2015, PROG LIPID RES, V59, P1, DOI 10.1016/j.plipres.2015.04.001
   Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200
   Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030
   OLSON AL, 1987, J NUTR, V117, P1024, DOI 10.1093/jn/117.6.1024
   OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6
   PAIK WK, 1971, SCIENCE, V174, P114, DOI 10.1126/science.174.4005.114
   Pasquali M, 2006, AM J MED GENET C, V142C, P64, DOI 10.1002/ajmg.c.30086
   Pochini L, 2013, J BIOMOL SCREEN, V18, P851, DOI 10.1177/1087057113493006
   Pochini L, 2009, CHEM-BIOL INTERACT, V179, P394, DOI 10.1016/j.cbi.2008.10.052
   Rahbeeni Z, 2002, J INHERIT METAB DIS, V25, P363, DOI 10.1023/A:1020143632011
   Rashidi-Nezhad A, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-75
   Rasmussen J, 2015, JIMD REP, V20, P103, DOI 10.1007/8904_2014_398
   Rasmussen J, 2014, MOLEC GENET METAB RE, V1, P241, DOI 10.1016/j.ymgmr.2014.04.008
   Rasmussen J, 2014, J INHERIT METAB DIS, V37, P215, DOI 10.1007/s10545-013-9606-2
   Rasmussen J, 2014, J INHERIT METAB DIS, V37, P223, DOI 10.1007/s10545-013-9640-0
   Rasmussen J, 2013, J INHERIT METAB DIS, V36, P35, DOI 10.1007/s10545-012-9488-8
   Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002
   Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200
   REBOUCHE CJ, 1984, J CLIN INVEST, V73, P857, DOI 10.1172/JCI111281
   Rebouche CJ, 2004, ANN NY ACAD SCI, V1033, P30, DOI 10.1196/annals.1320.003
   REBOUCHE CJ, 1980, BIOCHIM BIOPHYS ACTA, V630, P22, DOI 10.1016/0304-4165(80)90133-6
   Rigault C, 2006, BBA-MOL CELL BIOL L, V1761, P1469, DOI 10.1016/j.bbalip.2006.09.014
   Rijlaarsdam RS, 2004, PACE, V27, P675, DOI 10.1111/j.1540-8159.2004.00507.x
   Roe CR., 2001, METABOLIC MOL BASES, P2297
   Rose EC, 2012, HUM MUTAT, V33, P118, DOI 10.1002/humu.21607
   Saheki T, 2000, MOL GENET METAB, V71, P545, DOI 10.1006/mgme.2000.3093
   Saini-Chohan HK, 2012, J LIPID RES, V53, P4, DOI 10.1194/jlr.R012120
   Sanders RJ, 2008, FASEB J, V22, P2064, DOI 10.1096/fj.07-099150
   Sarafoglou K, 2010, CLIN GENET, V78, P191, DOI 10.1111/j.1399-0004.2009.01368.x
   Scaglia F, 1998, GENET MED, V1, P34
   Scaglia F, 1999, ARCH BIOCHEM BIOPHYS, V364, P99, DOI 10.1006/abbi.1999.1118
   Scaglia F, 1999, SEMIN PERINATOL, V23, P152, DOI 10.1016/S0146-0005(99)80047-0
   Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131
   Schimmenti LA, 2007, MOL GENET METAB, V90, P441, DOI 10.1016/j.ymgme.2006.10.003
   SCHMIDTSOMMERFELD E, 1990, BIOL NEONATE, V58, P81, DOI 10.1159/000243302
   Schrader M, 2015, J INHERIT METAB DIS, V38, P681, DOI 10.1007/s10545-015-9819-7
   Shibbani K, 2014, CLIN GENET, V85, P127, DOI 10.1111/cge.12112
   SLONIM AE, 1981, J PEDIATR-US, V99, P551, DOI 10.1016/S0022-3476(81)80252-1
   Sobol PT, 2011, MOL THER, V19, P335, DOI 10.1038/mt.2010.264
   Spiekerkoetter U, 2003, J INHERIT METAB DIS, V26, P613, DOI 10.1023/A:1025968502527
   Stanley C A, 1995, Adv Pediatr, V42, P209
   Stanley CA, 2004, ANN NY ACAD SCI, V1033, P42, DOI 10.1196/annals.1320.004
   Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378
   Tang NLS, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9053
   Tang NLS, 1999, HUM MOL GENET, V8, P655, DOI 10.1093/hmg/8.4.655
   Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255
   Therrell BL, 2014, MOL GENET METAB, V113, P14, DOI 10.1016/j.ymgme.2014.07.009
   Tong FM, 2006, ARCH BIOCHEM BIOPHYS, V447, P46, DOI 10.1016/j.abb.2006.01.005
   Urban TJ, 2006, MOL PHARMACOL, V70, P1602, DOI 10.1124/mol.106.028126
   Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388
   van Roermund CWT, 2014, BBA-MOL CELL BIOL L, V1841, P563, DOI 10.1016/j.bbalip.2013.12.001
   van Roermund CWT, 2011, BBA-MOL CELL BIOL L, V1811, P148, DOI 10.1016/j.bbalip.2010.11.010
   van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866
   Vaz FM, 1999, HUM GENET, V105, P157, DOI 10.1007/s004390051079
   Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417
   Vijay S, 2006, J INHERIT METAB DIS, V29, P627, DOI 10.1007/s10545-006-0376-y
   Violante S, 2013, BBA-MOL CELL BIOL L, V1831, P1467, DOI 10.1016/j.bbalip.2013.06.007
   Wakahara T, 2007, DEV BIOL, V303, P527, DOI 10.1016/j.ydbio.2006.11.041
   Wanders RJA, 2010, BBA-MOL CELL BIOL L, V1801, P272, DOI 10.1016/j.bbalip.2010.01.001
   Wanders RJA, 2014, BIOCHIMIE, V98, P36, DOI 10.1016/j.biochi.2013.08.022
   Wanders Ronald J A, 2013, Subcell Biochem, V69, P23, DOI 10.1007/978-94-007-6889-5_2
   Wanders RJA, 2011, BBA-MOL CELL BIOL L, V1811, P498, DOI 10.1016/j.bbalip.2011.06.006
   Wanders RJA, 2011, FEBS J, V278, P182, DOI 10.1111/j.1742-4658.2010.07947.x
   Wang YH, 2000, HUM MUTAT, V16, P401, DOI 10.1002/1098-1004(200011)16:5<401::AID-HUMU4>3.0.CO;2-J
   Wang YH, 2000, HUM MUTAT, V15, P238, DOI 10.1002/(SICI)1098-1004(200003)15:3<238::AID-HUMU4>3.0.CO;2-3
   Wang YH, 2000, J BIOL CHEM, V275, P20782, DOI 10.1074/jbc.M000194200
   Wang YH, 1999, P NATL ACAD SCI USA, V96, P2356, DOI 10.1073/pnas.96.5.2356
   Wang YH, 2001, GENET MED, V3, P387, DOI 10.1097/00125817-200111000-00002
   Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200
   Wilcken B, 2001, J PEDIATR-US, V138, P581, DOI 10.1067/mpd.2001.111813
   Wong GK, 2011, ANESTHESIOLOGY, V114, P1417, DOI 10.1097/ALN.0b013e31821a8d46
   Wu X, 1998, BIOCHEM BIOPH RES CO, V246, P589, DOI 10.1006/bbrc.1998.8669
   Wu X, 1999, J PHARMACOL EXP THER, V290, P1482
   Wu Zheng-Mu, 2012, Zhonghua Nan Ke Xue, V18, P253
   Yeung DCY, 2008, EUR HEART J, V29, P2156, DOI 10.1093/eurheartj/ehn295
   Ziats MN, 2015, AM J MED GENET A, V167, P2496, DOI 10.1002/ajmg.a.37192
   Ziats MN, 2015, AM J MED GENET A, V167, P2162, DOI 10.1002/ajmg.a.37144
   Zou ZY, 2003, J BIOL CHEM, V278, P16414, DOI 10.1074/jbc.M210557200
NR 167
TC 541
Z9 596
U1 5
U2 84
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-4889
EI 0006-3002
J9 BBA-MOL CELL RES
JI Biochim. Biophys. Acta-Mol. Cell Res.
PD OCT
PY 2016
VL 1863
IS 10
SI SI
BP 2422
EP 2435
DI 10.1016/j.bbamcr.2016.01.023
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA DU6TR
UT WOS:000382348000006
PM 26828774
OA Green Accepted
HC Y
HP N
DA 2024-11-01
ER

PT J
AU Mahad, DJ
   Ziabreva, I
   Campbell, G
   Laulund, F
   Murphy, JL
   Reeve, AK
   Greaves, L
   Smith, KJ
   Turnbull, DM
AF Mahad, D. J.
   Ziabreva, I.
   Campbell, G.
   Laulund, F.
   Murphy, J. L.
   Reeve, A. K.
   Greaves, L.
   Smith, K. J.
   Turnbull, D. M.
TI Detection of cytochrome c oxidase activity and mitochondrial proteins in
   single cells
SO JOURNAL OF NEUROSCIENCE METHODS
LA English
DT Article
DE Mitochondria; Cytochrome c oxidase; Neurodegeneration;
   Immunohistochemistry and histochemistry
ID AMYOTROPHIC-LATERAL-SCLEROSIS; SUBSTANTIA-NIGRA NEURONS; DNA MUTATIONS;
   MUSCLE-FIBERS; NITRIC-OXIDE; STEM-CELLS; RAT-BRAIN; DISEASE; MECHANISMS;
   DELETIONS
AB Cytochrome c oxidase or mitochondrial respiratory chain complex IV is where over 90% of oxygen is consumed. The relationship between complex IV activity and mitochondrial proteins, which provides a guide to understanding the mechanisms in primary mitochondrial disorders, has been determined by histochemistry (activity) and immunohistochemistry in serial sections. In the central nervous system (CNS), mitochondrial activity and immunoreactivity have been determined in populations of cells in serial sections as capturing cells in more than one section is difficult. In this report we describe a method to determine complex IV activity in relation to mitochondrial proteins at a single cell level in the CNS. We performed complex IV histochemistry and immunohistochemistry consecutively in snap frozen sections. Although the product of complex IV histochemistry reduces the sensitivity of standard immunohistochemistry (secondary antibody and ABC method) the biotin-free Menapath polymer detection system (A. Menarini Diagnostics, Wokingham, UK) enables mitochondrial proteins to be detected following complex IV histochemistry. The co-occurring chromogens may then be separately visualised and analysed using multi-spectral imaging (Nuance system CRI, Woburn, MA). Our technique is applicable for exploring mitochondrial defects within single cells in a variety of CNS disorders and animal models of those diseases. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Mahad, D. J.; Ziabreva, I.; Campbell, G.; Murphy, J. L.; Reeve, A. K.; Greaves, L.; Turnbull, D. M.] Univ Newcastle, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Laulund, F.; Smith, K. J.] Inst Neurol, Dept Neuroinflammat, London WC1N 3BG, England.
C3 Newcastle University - UK; University of London; University College
   London
RP Mahad, DJ (corresponding author), Univ Newcastle, Inst Ageing & Hlth, Mitochondrial Res Grp, Framlington Rd, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM mahadd@doctors.org.uk
RI Smith, Kenneth/I-9197-2014; Murphy, Jennifer/AAD-4630-2020
OI Greaves, Laura/0000-0002-8071-5916; Turnbull, Doug/0000-0002-8878-9901;
   Campbell, Graham/0000-0003-4828-421X; Reeve, Amy/0000-0002-4474-2204
FU Wellcome Trust; Medical Research Council; European Union; Multiple
   Sclerosis Society of Great Britain and Northern Ireland; MRC [G0500814,
   G0800954, G0700718] Funding Source: UKRI
FX We would like to thank the Wellcome Trust (DJ.M. and D.M.T.), Medical
   Research Council (K.J.S.), European Union (NeuroproMiSe, KJ.S.) and
   Multiple Sclerosis Society of Great Britain and Northern Ireland (DJ.M.
   and KJ.S.) for funding this study.
CR Aboul-Enein F, 2005, ACTA NEUROPATHOL, V109, P49, DOI 10.1007/s00401-004-0954-8
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d
   Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8
   Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DIMLICH RVW, 1990, BRAIN RES, V516, P181, DOI 10.1016/0006-8993(90)90917-Z
   Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736
   Elfering SL, 2004, AM J PHYSIOL-HEART C, V286, pH22, DOI 10.1152/ajpheart.00766.2003
   Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   HEVNER RF, 1995, NEUROSCIENCE, V65, P313, DOI 10.1016/0306-4522(94)00514-6
   JOHNSON MA, 1993, ANN NEUROL, V33, P28, DOI 10.1002/ana.410330106
   JOHNSON MA, 1988, J NEUROL SCI, V87, P75, DOI 10.1016/0022-510X(88)90056-1
   KEILIN D, 1945, BIOCHEM J, V39, P148, DOI 10.1042/bj0390148
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Mannella CA, 1998, J STRUCT BIOL, V121, P207, DOI 10.1006/jsbi.1997.3954
   Mansfield James R, 2008, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1419s84
   Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160
   Pye D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl516
   Rahman S, 2000, BRAIN, V123, P591, DOI 10.1093/brain/123.3.591
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Taanman JW, 2001, BIOCHEM SOC T, V29, P446, DOI 10.1042/BST0290446
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Tanji K, 2000, BRAIN PATHOL, V10, P422
   Tanji K, 2008, METHODS, V46, P274, DOI 10.1016/j.ymeth.2008.09.027
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
NR 33
TC 26
Z9 28
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0270
J9 J NEUROSCI METH
JI J. Neurosci. Methods
PD NOV 15
PY 2009
VL 184
IS 2
BP 310
EP 319
DI 10.1016/j.jneumeth.2009.08.020
PG 10
WC Biochemical Research Methods; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 521IN
UT WOS:000271914400015
PM 19723540
DA 2024-11-01
ER

PT J
AU Liu, H
   Liu, X
   Zhou, JX
   Li, T
AF Liu, Hui
   Liu, Xin
   Zhou, Jingxin
   Li, Tao
TI Mitochondrial DNA Is a Vital Driving Force in Ischemia-Reperfusion
   Injury in Cardiovascular Diseases
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Review
ID CORONARY-HEART-DISEASE; NLRP3 INFLAMMASOME ACTIVATION; PRESERVED
   EJECTION FRACTION; ACUTE MYOCARDIAL-INFARCTION; LIFE-SPAN; STERILE
   INFLAMMATION; AIM2 INFLAMMASOME; OXIDATIVE STRESS; SKELETAL-MUSCLE; COPY
   NUMBER
AB According to the latest Global Burden of Disease Study, cardiovascular disease (CVD) is the leading cause of death, and ischemic heart disease and stroke are the cause of death in approximately half of CVD patients. In CVD, mitochondrial dysfunction following ischemia-reperfusion (I/R) injury results in heart failure. The proper functioning of oxidative phosphorylation (OXPHOS) and the mitochondrial life cycle in cardiac mitochondria are closely related to mitochondrial DNA (mtDNA). Following myocardial I/R injury, mitochondria activate multiple repair and clearance mechanisms to repair damaged mtDNA. When these repair mechanisms are insufficient to restore the structure and function of mtDNA, irreversible mtDNA damage occurs, leading to mtDNA mutations. Since mtDNA mutations aggravate OXPHOS dysfunction and affect mitophagy, mtDNA mutation accumulation leads to leakage of mtDNA and proteins outside the mitochondria, inducing an innate immune response, aggravating cardiovascular injury, and leading to the need for external interventions to stop or slow the disease course. On the other hand, mtDNA released into the circulation after cardiac injury can serve as a biomarker for CVD diagnosis and prognosis. This article reviews the pathogenic basis and related research findings of mtDNA oxidative damage and mtDNA leak-triggered innate immune response associated with I/R injury in CVD and summarizes therapeutic options that target mtDNA.
C1 [Liu, Hui; Liu, Xin; Li, Tao] Natl Local Joint Engn Res Ctr Translat Med Anesthe, Dept Anesthesiol, Lab Mitochondria & Metab, Chengdu 610041, Peoples R China.
   [Liu, Hui; Zhou, Jingxin] Sichuan Univ, West China Second Univ Hosp, Dept Anesthesiol, Key Lab Birth Defects & Related Dis Women & Childr, Chengdu 610041, Peoples R China.
C3 Sichuan University
RP Li, T (corresponding author), Natl Local Joint Engn Res Ctr Translat Med Anesthe, Dept Anesthesiol, Lab Mitochondria & Metab, Chengdu 610041, Peoples R China.
EM liuhui_scu@163.com; liuxin.1113@163.com; 403030869@qq.com;
   scutaoli1981@scu.edu.cn
RI Liu, Xin/JRE-6411-2023; Li, Tao/ADA-1377-2022
OI Li, Tao/0000-0002-7988-3090; Liu, Hui/0000-0003-0481-2607; Liu,
   Xin/0000-0002-5157-9863
FU National Natural Science Foundation of China [81970715]; Key Research
   and Development Program of Sichuan Province [22ZDYF2138]; Innovation
   Spark Project of Sichuan University [2018SCUH0065]
FX AcknowledgmentsThis study was supported in part by the National Natural
   Science Foundation of China (81970715), the Key Research and Development
   Program of Sichuan Province (22ZDYF2138), and the Innovation Spark
   Project of Sichuan University (2018SCUH0065).
CR Abbafati C, 2020, LANCET, V396, P1204
   Abu-Amero KK, 2010, GENET TEST MOL BIOMA, V14, P43, DOI 10.1089/gtmb.2009.0095
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andres AM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89303
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   [Anonymous], 2008, RTI PRESS RES REPORT
   Antozzi C, 1997, CARDIOVASC RES, V35, P184, DOI 10.1016/S0008-6363(97)00141-7
   Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3
   Atar D, 2012, CARDIOLOGY, V123, P201, DOI 10.1159/000342981
   Bai J, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.623450
   Bai JL, 2019, DIABETES, V68, P1099, DOI 10.2337/dbi18-0052
   Barisic N, 2002, CROAT MED J, V43, P37
   Bliksoen M, 2012, INT J CARDIOL, V158, P132, DOI 10.1016/j.ijcard.2012.04.047
   Blitzer D, 2020, ANN THORAC SURG, V109, P711, DOI 10.1016/j.athoracsur.2019.06.075
   Bray AW, 2017, CURR OPIN CARDIOL, V32, P267, DOI 10.1097/HCO.0000000000000383
   Buford TW, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010009
   Butterick TA, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0555-4
   Calabrese C, 2022, PLOS GENET, V18, DOI 10.1371/journal.pgen.1010068
   Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008
   Chapman J, 2020, LIFE-BASEL, V10, DOI 10.3390/life10090164
   Chen SY, 2014, ATHEROSCLEROSIS, V237, P220, DOI 10.1016/j.atherosclerosis.2014.08.051
   Chen X, 2018, EUR REV MED PHARMACO, V22, P5248, DOI 10.26355/eurrev_201808_15723
   Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585
   Chernyak BV, 2020, BIOCHEMISTRY-MOSCOW+, V85, P636, DOI 10.1134/S0006297920050132
   Cho Y, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100825
   Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   Crewe C, 2021, CELL METAB, V33, P1853, DOI 10.1016/j.cmet.2021.08.002
   Dabravolski SA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22168770
   Decout A, 2021, NAT REV IMMUNOL, V21, P548, DOI 10.1038/s41577-021-00524-z
   Deng Y, 2021, CIRC RES, V128, P232, DOI 10.1161/CIRCRESAHA.120.317933
   Dhondup Y, 2016, J CARD FAIL, V22, P823, DOI 10.1016/j.cardfail.2016.06.013
   Ding Y, 2013, INT J MOL MED, V32, P768, DOI 10.3892/ijmm.2013.1459
   Donnino MW, 2017, RESUSCITATION, V113, P56, DOI 10.1016/j.resuscitation.2016.12.029
   Dorn GW, 2015, EMBO MOL MED, V7, P865, DOI 10.15252/emmm.201404575
   Du Y, 2019, J ATHEROSCLER THROMB, V26, P868, DOI 10.5551/jat.47019
   Dunlay SM, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2017.65
   Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222
   Fernández-Ruiz I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095073
   Fox BM, 2019, KIDNEY INT, V95, P590, DOI 10.1016/j.kint.2018.10.020
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28
   Fu MH, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1623-0
   Gabaldón T, 2005, BIOINFORMATICS, V21, P144, DOI 10.1093/bioinformatics/bti1124
   Galera-Monge T, 2019, J CELL PHYSIOL, V234, P19511, DOI 10.1002/jcp.28549
   Gallucci S, 2017, TRENDS IMMUNOL, V38, P719, DOI 10.1016/j.it.2017.07.012
   Gan WQ, 2018, BBA-MOL BASIS DIS, V1864, P1, DOI 10.1016/j.bbadis.2017.10.001
   Gentili M, 2019, CELL REP, V26, P2377, DOI 10.1016/j.celrep.2019.01.105
   Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940
   Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720
   Guo H, 2022, AM J HYPERTENS, V35, P96, DOI 10.1093/ajh/hpab123
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hassanpour SH, 2018, J CARDIOVASC THORAC, V10, P1, DOI 10.15171/jcvtr.2018.01
   He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002
   Hotz MJ, 2018, AM J RESP CRIT CARE, V197, P470, DOI 10.1164/rccm.201706-1161OC
   Hu D, 2020, AM J PHYSIOL-HEART C, V318, pH1525, DOI 10.1152/ajpheart.00097.2020
   Hu HC, 2020, EXP MOL PATHOL, V114, DOI 10.1016/j.yexmp.2020.104412
   Hu QY, 2019, SHOCK, V51, P52, DOI 10.1097/SHK.0000000000001190
   Huang LS, 2020, IMMUNITY, V52, P475, DOI 10.1016/j.immuni.2020.02.002
   Huang X, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.682409
   Ikeda G, 2021, J AM COLL CARDIOL, V77, P1073, DOI 10.1016/j.jacc.2020.12.060
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346
   Jabir MS, 2015, AUTOPHAGY, V11, P166, DOI 10.4161/15548627.2014.981915
   Ji QW, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/165742
   Jiang K, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI151268
   Jiao HF, 2021, CELL, V184, P2896, DOI 10.1016/j.cell.2021.04.027
   Jo A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/305716
   Kato K, 2017, ANNU REV BIOCHEM, V86, P541, DOI 10.1146/annurev-biochem-061516-044813
   Khwaja B, 2021, MOL CELL BIOCHEM, V476, P1915, DOI 10.1007/s11010-021-04061-0
   Kitazume-Taneike R, 2019, BIOCHEM BIOPH RES CO, V515, P442, DOI 10.1016/j.bbrc.2019.05.150
   Komada T, 2018, J AM SOC NEPHROL, V29, P1165, DOI 10.1681/ASN.2017080863
   Konerman MC, 2018, J CARD FAIL, V24, P90, DOI 10.1016/j.cardfail.2017.10.010
   Kowalska M, 2020, DNA CELL BIOL, V39, P1410, DOI 10.1089/dna.2019.5347
   Krychtiuk KA, 2020, EUR HEART J-ACUTE CA, V9, P419, DOI 10.1177/2048872618823405
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lakshmanan LN, 2018, AGING CELL, V17, DOI 10.1111/acel.12814
   Lam LKM, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abj1008
   Lampert MA, 2019, AUTOPHAGY, V15, P1182, DOI 10.1080/15548627.2019.1580095
   Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028
   Lauritzen KH, 2021, ELIFE, V10, DOI 10.7554/eLife.59828
   Lee CF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39419-4
   LEE WJ, 1995, GENETICS, V139, P873
   Li SC, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6914849
   Li T, 2017, CELL METAB, V25, P374, DOI 10.1016/j.cmet.2016.11.005
   Li X, 2021, ADV MATER, V33, DOI 10.1002/adma.202105348
   Liang WJJ, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00018
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Liu CY, 2018, HUM GENET, V137, P203, DOI 10.1007/s00439-018-1873-4
   Liu JK, 2009, ADV DRUG DELIVER REV, V61, P1343, DOI 10.1016/j.addr.2009.06.007
   Liu J, 2016, J DIABETES INVEST, V7, P109, DOI 10.1111/jdi.12366
   Liu J, 2015, CLIN LAB, V61, P661, DOI 10.7754/Clin.Lab.2014.141132
   Liu L., 2004, CHINESE J CLIN REHAB, V8, P2271
   Liu L, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12579
   Liu XQ, 2017, NAT GENET, V49, P1152, DOI 10.1038/ng.3870
   Liu X, 2022, J MOL CELL CARDIOL, V165, P76, DOI 10.1016/j.yjmcc.2021.12.015
   Liu YJ, 2019, INT J EPIDEMIOL, V48, P455, DOI 10.1093/ije/dyz009
   Liu YQ, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.634137
   Maeda H, 2020, J CELL MOL MED, V24, P5007, DOI 10.1111/jcmm.15120
   Man SM, 2016, EUR J IMMUNOL, V46, P269, DOI 10.1002/eji.201545839
   Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936
   Mann Douglas L, 2010, Trans Am Clin Climatol Assoc, V121, P34
   Marin-Garcia J, 1999, PEDIATRICS, V103, P456, DOI 10.1542/peds.103.2.456
   Marín-García J, 2016, HEART FAIL REV, V21, P475, DOI 10.1007/s10741-016-9543-x
   MarinGarcia J, 1996, CARDIOVASC RES, V31, P306
   Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3
   Matheoud D, 2016, CELL, V166, P314, DOI 10.1016/j.cell.2016.05.039
   McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047
   McElroy GS, 2020, CELL METAB, V32, P301, DOI 10.1016/j.cmet.2020.06.003
   McIlroy DJ, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.07.013
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Mesquita T, 2021, AGING CELL, V20, DOI 10.1111/acel.13453
   Mezzaroma E, 2021, MOLECULES, V26, DOI 10.3390/molecules26040976
   Mezzaroma E, 2011, P NATL ACAD SCI USA, V108, P19725, DOI 10.1073/pnas.1108586108
   Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026
   Mohammed SF, 2015, CIRCULATION, V131, P550, DOI 10.1161/CIRCULATIONAHA.114.009625
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Morton AC, 2015, EUR HEART J, V36, P377, DOI 10.1093/eurheartj/ehu272
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Nakayama H, 2018, BIOCHEM J, V475, P839, DOI 10.1042/BCJ20170714
   Nicolás-Avila JA, 2020, CELL, V183, P94, DOI 10.1016/j.cell.2020.08.031
   Nishida K, 2017, CIRC J, V81, P622, DOI 10.1253/circj.CJ-17-0261
   O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Onódi Z, 2021, CARDIOVASC RES, V117, P2639, DOI 10.1093/cvr/cvab202
   Orekhov AN, 2021, CURR PHARM DESIGN, V27, P276, DOI 10.2174/1381612826666201012164330
   Ou W, 2021, REDOX BIOL, V43, DOI 10.1016/j.redox.2021.101994
   Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10
   Pazmandi K, 2014, FREE RADICAL BIO MED, V77, P281, DOI 10.1016/j.freeradbiomed.2014.09.028
   Picca A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.601740
   Pisano A, 2016, CARDIOVASC PATHOL, V25, P103, DOI 10.1016/j.carpath.2015.09.009
   Protasoni M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020586
   Qiao L, 2021, AM J HUM GENET, V108, P1964, DOI 10.1016/j.ajhg.2021.08.011
   Qin CY, 2017, ANATOL J CARDIOL, V17, P224, DOI 10.14744/AnatolJCardiol.2016.7209
   Qin CY, 2016, J CARDIOTHORAC SURG, V11, DOI 10.1186/s13019-016-0481-4
   Qin CY, 2015, J CARDIOTHORAC SURG, V10, DOI 10.1186/s13019-015-0298-6
   Quan Y, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9423593
   Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864
   Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009
   Riley JS, 2018, EMBO J, V37, DOI 10.15252/embj.201899238
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Roth GA, 2020, J AM COLL CARDIOL, V76, P2982, DOI 10.1016/j.jacc.2020.11.010
   Ryan FP, 2009, J ROY SOC MED, V102, P272, DOI 10.1258/jrsm.2009.080372
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106
   Sandler N, 2018, HEART LUNG CIRC, V27, P122, DOI 10.1016/j.hlc.2017.02.014
   Santulli G, 2015, P NATL ACAD SCI USA, V112, P11389, DOI 10.1073/pnas.1513047112
   Sazonova MA, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/9749457
   Severino P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093167
   Shah SJ, 2016, CIRCULATION, V134, P73, DOI 10.1161/CIRCULATIONAHA.116.021884
   Sharma A, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002639
   Sharma BR, 2019, EUR J IMMUNOL, V49, P1998, DOI 10.1002/eji.201848070
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Shin B, 2019, JACC-BASIC TRANSL SC, V4, P871, DOI 10.1016/j.jacbts.2019.08.007
   Sobenin IA, 2015, CURR PHARM DESIGN, V21, P1158, DOI 10.2174/1381612820666141013133000
   Srivaratharajah K, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002562
   Steenman Marja, 2017, Biophys Rev, V9, P131, DOI 10.1007/s12551-017-0255-9
   Sudakov NP, 2017, EUR J MED RES, V22, DOI 10.1186/s40001-016-0241-x
   Suetomi T, 2018, CIRCULATION, V138, P2530, DOI 10.1161/CIRCULATIONAHA.118.034621
   Takeda N, 1996, ANN NY ACAD SCI, V793, P282, DOI 10.1111/j.1749-6632.1996.tb33521.x
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tansel T, 2014, CARDIOL YOUNG, V24, P531, DOI 10.1017/S1047951113000668
   Tian R, 2019, CIRCULATION, V140, P1205, DOI 10.1161/CIRCULATIONAHA.119.040551
   Tian XC, 2017, J BIOMED SCI, V24, P1, DOI 10.1186/s12929-017-0345-9
   Tian YK, 2019, J THORAC CARDIOV SUR, V157, P2256, DOI 10.1016/j.jtcvs.2018.09.043
   Todkar K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21984-w
   Torralba D, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00107
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Umbria M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59631-x
   van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025
   Vásquez-Trincado C, 2016, J PHYSIOL-LONDON, V594, P509, DOI 10.1113/JP271301
   Vezza T, 2022, WORLD J MENS HEALTH, V40, P399, DOI 10.5534/wjmh.210146
   Volt H, 2016, J PINEAL RES, V60, P193, DOI 10.1111/jpi.12303
   Walensky LD, 2019, NAT CHEM BIOL, V15, P657, DOI 10.1038/s41589-019-0306-6
   Wang L, 2015, CORONARY ARTERY DIS, V26, P296, DOI 10.1097/MCA.0000000000000231
   Wang LL, 2021, DIS MARKERS, V2021, DOI 10.1155/2021/7157109
   Wang SY, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0171-5
   Wang XW, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-00832-w
   West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   Willcox JAL, 2022, AM J HUM GENET, V109, P961, DOI 10.1016/j.ajhg.2022.03.011
   Willeford A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97054
   Wu XQ, 2020, FOOD FUNCT, V11, P5621, DOI [10.1039/d0fo00694g, 10.1039/D0FO00694G]
   Xia N, 2017, BRIT J PHARMACOL, V174, P1633, DOI 10.1111/bph.13492
   Xie L, 2017, REGUL TOXICOL PHARM, V89, P148, DOI 10.1016/j.yrtph.2017.07.028
   Xu F, 2017, INDIAN HEART J, V69, P797, DOI 10.1016/j.ihj.2017.03.009
   Xue L, 2016, MITOCHONDRION, V30, P208, DOI 10.1016/j.mito.2016.08.008
   Xue RQ, 2017, J CELL MOL MED, V21, P58, DOI 10.1111/jcmm.12938
   Yamazoe M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85204-7
   Yang J, 2019, J MOL CELL CARDIOL, V130, P36, DOI 10.1016/j.yjmcc.2019.03.008
   Yang XM, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-014-0459-0
   Yang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks639
   Ye W, 2017, MOL IMMUNOL, V87, P114, DOI 10.1016/j.molimm.2017.03.011
   Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Yue P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206003
   Zeng L, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan5689
   Zhang HL, 2020, ELIFE, V9, DOI 10.7554/eLife.60827
   Zhang ZX, 2019, BMC CARDIOVASC DISOR, V19, DOI 10.1186/s12872-019-01284-4
   Zhao Y, 2018, MITOCHONDRIAL DNA A, V29, P1090, DOI 10.1080/24701394.2017.1407762
   Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z
   Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057
   Zhou H, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-019-0773-7
   Zhou H, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12413
   Zhou ZL, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/1209307
   Zhou ZX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122064
   Zhu Y, 2020, BMC MED GENET, V21, DOI 10.1186/s12881-020-01045-7
   Zhuge Ruiqi, 2017, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V39, P438, DOI 10.3881/j.issn.1000-503X.2017.03.024
NR 212
TC 16
Z9 20
U1 8
U2 26
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD MAY 17
PY 2022
VL 2022
AR 6235747
DI 10.1155/2022/6235747
PG 19
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 1W9YW
UT WOS:000807123100007
PM 35620580
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Naess, K
   Freyer, C
   Bruhn, H
   Wibom, R
   Malm, G
   Nennesmo, I
   Döbeln, U
   Larsson, NG
AF Naess, Karin
   Freyer, Christoph
   Bruhn, Helene
   Wibom, Rolf
   Malm, Gunilla
   Nennesmo, Inger
   von Dobeln, Ulrika
   Larsson, Nils-Goran
TI MtDNA mutations are a common cause of severe disease phenotypes in
   children with Leigh syndrome
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
CT International Symposium on Mitchondrial Physiology and Pathology
CY JUN, 2008
CL Bari, ITALY
DE Leigh syndrome; Encephalopathy; Mitochondrial disorder; Neurologic
   disease/disorder; Paediatric disease
ID MITOCHONDRIAL-DNA MUTATION; COMPLEX-I DEFICIENCY; CYTOCHROME-C-OXIDASE;
   HEREDITARY OPTIC NEUROPATHY; MISSENSE MUTATION;
   OXIDATIVE-PHOSPHORYLATION; CLINICAL-FEATURES; ALPERS-SYNDROME; POLG
   MUTATIONS; ATP PRODUCTION
AB Leigh syndrome is a common clinical manifestation in children with mitochondrial disease and other types of inborn errors of metabolism. We characterised clinical symptoms, prognosis, respiratory chain function and performed extensive genetic analysis of 25 Swedish children suffering from Leigh syndrome with the aim to obtain insights into the molecular pathophysiology and to provide a rationale for genetic counselling. We reviewed the clinical history of all patients and used muscle biopsies in order to perform molecular, biochemical and genetic investigations, including sequencing the entire mitochondrial DNA (mtDNA), the mitochondrial DNA polymerase (POLGA) gene and the surfeit locus protein 1 (SURF1) gene. Respiratory chain enzyme activity measurements identified five patients with isolated complex I deficiency and five with combined enzyme deficiencies. No patient presented with isolated complex IV deficiency. Seven patients had a decreased ATP production rate. Extensive sequence analysis identified eight patients with pathogenic mtDNA mutations and one patient with mutations in POLGA. Mutations of mtDNA are a common cause of LS and mtDNA analysis should always be included in the diagnosis of LS patients, whereas SURF1 mutations are not a common cause of LS in Sweden. Unexpectedly, age of onset, clinical symptoms and prognosis did not reveal any clear differences in LS patients with mtDNA or nuclear DNA mutations. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Freyer, Christoph; Larsson, Nils-Goran] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany.
   [Naess, Karin; Freyer, Christoph; Bruhn, Helene; Wibom, Rolf; Nennesmo, Inger; von Dobeln, Ulrika; Larsson, Nils-Goran] Karolinska Inst, Dept Lab Med, S-14186 Huddinge, Sweden.
   [Naess, Karin; Malm, Gunilla] Karolinska Univ Hosp, Dept Clin Sci, S-14186 Huddinge, Sweden.
C3 Max Planck Society; Karolinska Institutet; Karolinska Institutet;
   Karolinska University Hospital
RP Larsson, NG (corresponding author), Max Planck Inst Biol Ageing, Gleueler Str 50A, D-50931 Cologne, Germany.
EM larsson@age.mpg.de
RI Larsson, Nils-Göran/GVS-5578-2022
OI Freyer, Christoph/0000-0003-0418-1673; Bruhn,
   Helene/0009-0007-4449-5382; Naess, Karin/0000-0003-4310-7927; Larsson,
   Nils-Goran/0000-0001-5100-996X
CR Abu-Amero Khaled K, 2005, Ophthalmic Genet, V26, P31, DOI 10.1080/13816810590918235
   ALM J, 1978, ANN CLIN BIOCHEM, V15, P245, DOI 10.1177/000456327801500159
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   Batandier C, 2000, Hum Mutat, V16, P532, DOI 10.1002/1098-1004(200012)16:6<532::AID-HUMU19>3.0.CO;2-P
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   CAVANAGH JB, 1994, BRAIN, V117, P1357, DOI 10.1093/brain/117.6.1357
   Chae JH, 2007, PEDIATR RES, V61, P622, DOI 10.1203/pdr.0b013e3180459f2d
   CONSTANTINTEODOSIU D, 1991, ANAL BIOCHEM, V198, P347, DOI 10.1016/0003-2697(91)90437-X
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Esteitie N, 2005, ANN NEUROL, V58, P544, DOI 10.1002/ana.20570
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Howell N, 2003, AM J HUM GENET, V72, P1460, DOI 10.1086/375537
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Larsson NG, 2001, ACTA PHYSIOL SCAND, V171, P385, DOI 10.1046/j.1365-201x.2001.00842.x
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Merenda A, 2006, CURR OPIN CRIT CARE, V12, P90, DOI 10.1097/01.ccx.0000216573.26686.27
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   VONDOBELN U, 1993, ACTA PAEDIATR, V82, P1079, DOI 10.1111/j.1651-2227.1993.tb12818.x
   WIBOM R, 1990, AM J PHYSIOL, V259, pE204, DOI 10.1152/ajpendo.1990.259.2.E204
   Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4
   WONG LJC, 2008, HUM MUTAT, V1020, pE150
   Wortmann S, 2006, MOL GENET METAB, V88, P47, DOI 10.1016/j.ymgme.2006.01.013
   Zeviani Massimo, 2004, Suppl Clin Neurophysiol, V57, P304
   Zhang Y, 2007, J INHERIT METAB DIS, V30, P265, DOI 10.1007/s10545-006-0481-y
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
   2007, MITOMAP
NR 48
TC 39
Z9 46
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD MAY
PY 2009
VL 1787
IS 5
SI SI
BP 484
EP 490
DI 10.1016/j.bbabio.2008.11.014
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Biophysics
GA 451MX
UT WOS:000266475400024
PM 19103152
DA 2024-11-01
ER

PT J
AU Ercan, A
   Kulaksiz, G
   Dalmizrak, O
   Muftuoglu, M
   Ogus, H
   Cavdar, L
   Inan, L
   Ozer, N
AF Ercan, Ayse
   Kulaksiz, Gulnihal
   Dalmizrak, Ozlem
   Muftuoglu, Meltem
   Ogus, Hamdi
   Cavdar, Leyla
   Inan, Levent
   Ozer, Nazmi
TI Mitochondrial Respiratory Chain Enzyme Activities, mtDNA Variants and
   Gene Expression Levels in Idiopathic Parkinson's Disease
SO TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
LA English
DT Article
DE Idiopathic PD; Complex I; glutathione; ND2; ND4
ID COMPLEX-I ACTIVITY; SKELETAL-MUSCLE; GLUTATHIONE DEPLETION; DNA;
   DYSFUNCTION; INHIBITION; MUTATIONS; PLATELETS; BRAIN
AB Purpose: Mitochondrial dysfunction has been implicated in the development of idiopathic Parkinson's disease. In this study, it was aimed to investigate the relationship between mitochondrial respiratory chain enzyme deficiency and variants in ND2 and ND4 region of Complex I and expressions of these genes. Complex IV activity and glutathione level were also studied.
   Methods: Activities of Complex I, Complex IV, citrate synthase and glutathione levels were measured from muscle biopsy samples of 19 idiopathic Parkinson's Disease patients. Entire ND2 and ND4 regions of Complex I were screened by sequencing and expression levels of these regions were also examined by using relative quantitative RT-PCR.
   Results: A significant decrease in Complex I and IV activities was found in Parkinson's Disease patients (19.73 +/- 8.24 U/mg protein, 11.51 +/- 6.45 U/mg protein) compared with the control group (31.48 +/- 8.28 U/mg protein, 30.02 +/- 14.76 U/mg protein), respectively. Although several sequence variants were detected in ND2 and ND4 genes, they didn't account for the decrease in Complex I activity. ND2 (19 % and 21 %) and ND4 (14 % and 13 %) mRNA expressions were reduced in two of 19 patients.
   Conclusion: Taken together, Complex I and IV dysfunctions and mitochondrial abnormalities might be the result of oxidative stress contributing to the pathogenesis of idiopathic Parkinson's Disease since we found that reduced glutathione levels were decreased 47 % in these patients.
C1 [Kulaksiz, Gulnihal; Dalmizrak, Ozlem; Muftuoglu, Meltem; Ogus, Hamdi; Ozer, Nazmi] Hacettepe Univ, Fac Med, Dept Biochem, TR-06100 Ankara, Turkey.
   [Ercan, Ayse] Hacettepe Univ, Fac Pharm, Dept Biochem, TR-06100 Ankara, Turkey.
   [Dalmizrak, Ozlem; Ozer, Nazmi] Near East Univ, Fac Med, Dept Basic Med Sci, TR-10 Nicosia, Mersin, Turkey.
   [Cavdar, Leyla; Inan, Levent] Ankara Res & Training Hosp, Dept Neurol, TR-06100 Ankara, Turkey.
C3 Hacettepe University; Hacettepe University; Mersin University; Near East
   University; Ankara Training & Research Hospital
RP Ozer, N (corresponding author), Hacettepe Univ, Fac Med, Dept Biochem, TR-06100 Ankara, Turkey.
EM naozer@hacettepe.edu.tr
RI Albayrak, Levent/V-7188-2018; Ozer, Nazmi/JBJ-2721-2023; Dalmizrak,
   Ozlem/JCD-9924-2023; Ercan, Ayse/I-8424-2013; Muftuoglu,
   Meltem/AAG-5004-2019
OI Ercan, Ayse/0000-0003-1499-2410; Muftuoglu, Meltem/0000-0001-5372-4780
FU Scientific and Technical Research Council of Turkey [SBAG-2596];
   Hacettepe University Scientific Research Unit [02G112]
FX This work was supported by the Scientific and Technical Research Council
   of Turkey (Grant No. SBAG-2596) and by Hacettepe University Scientific
   Research Unit (Grant No. 02G112).
CR Abril J, 2008, PROSTATE, V68, P1086, DOI 10.1002/pros.20771
   ANDERSON JJ, 1993, J NEUROL NEUROSUR PS, V56, P477, DOI 10.1136/jnnp.56.5.477
   [Anonymous], TURK J BIOCH
   BENECKE R, 1993, BRAIN, V116, P1451, DOI 10.1093/brain/116.6.1451
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Bragoszewski P, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-292
   BRAVI D, 1992, MOVEMENT DISORD, V7, P228, DOI 10.1002/mds.870070307
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Chinta SJ, 2006, FREE RADICAL BIO MED, V41, P1442, DOI 10.1016/j.freeradbiomed.2006.08.002
   Davis G. C., 1979, PSYCHIAT RES, V1, P649
   DIDONATO S, 1993, NEUROLOGY, V43, P2262, DOI 10.1212/WNL.43.11.2262
   Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Jha N, 2000, J BIOL CHEM, V275, P26096, DOI 10.1074/jbc.M000120200
   Kosel S, 1998, NEUROGENETICS, V1, P197, DOI 10.1007/s100480050029
   KOSOWER NS, 1979, P NATL ACAD SCI USA, V76, P3382, DOI 10.1073/pnas.76.7.3382
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   Mizuno Y, 1998, ANN NEUROL, V44, pS99, DOI 10.1002/ana.410440715
   Müftüoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695
   NAKAGAWAHATTORI Y, 1992, J NEUROL SCI, V107, P29, DOI 10.1016/0022-510X(92)90205-Y
   Pich MM, 1996, FEBS LETT, V380, P176, DOI 10.1016/0014-5793(96)00037-3
   REICHMANN H, 1994, EUR NEUROL, V34, P263, DOI 10.1159/000117053
   Reichmann H, 2000, J NEUROL, V247, P63
   Riess O, 1998, MOL MED TODAY, V4, P438, DOI 10.1016/S1357-4310(98)01343-4
   Schapira AHV, 2007, CELL DEATH DIFFER, V14, P1261, DOI 10.1038/sj.cdd.4402160
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304
   Shoffner JM, 2000, NEUROL CLIN, V18, P105, DOI 10.1016/S0733-8619(05)70180-8
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   SHULTS CW, 1995, NEUROLOGY, V45, P344, DOI 10.1212/WNL.45.2.344
   SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B
   Sun F, 2007, PHARMACOL THERAPEUT, V114, P327, DOI 10.1016/j.pharmthera.2007.04.001
   Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Valdivieso AG, 2007, BIOCHEM BIOPH RES CO, V356, P805, DOI 10.1016/j.bbrc.2007.03.057
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Winkler-Stuck K, 2005, J NEURAL TRANSM, V112, P499, DOI 10.1007/s00702-004-0195-y
NR 45
TC 2
Z9 2
U1 0
U2 4
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0250-4685
EI 1303-829X
J9 TURK J BIOCHEM
JI Turk. J. Biochem.
PY 2009
VL 34
IS 2
BP 97
EP 104
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 508MJ
UT WOS:000270935200007
DA 2024-11-01
ER

PT J
AU Safdar, A
   Annis, S
   Kraytsberg, Y
   Laverack, C
   Saleem, A
   Popadin, K
   Woods, DC
   Tilly, JL
   Khrapko, K
AF Safdar, Adeel
   Annis, Sofia
   Kraytsberg, Yevgenya
   Laverack, Chloe
   Saleem, Ayesha
   Popadin, Konstantin
   Woods, Dori C.
   Tilly, Jonathan L.
   Khrapko, Konstantin
TI Amelioration of premature aging in mtDNA mutator mouse by exercise: the
   interplay of oxidative stress, PGC-1α, p53, and DNA damage. A hypothesis
SO CURRENT OPINION IN GENETICS & DEVELOPMENT
LA English
DT Article
ID SKELETAL-MUSCLE; MUTATIONS; MICE; MITOCHONDRIA; DISEASE; PROTEIN;
   MUTAGENESIS; BYPASS; CARDIOMYOPATHY; SUPPRESSION
AB The mtDNA mutator mouse lacks the proofreading capacity of the sole mtDNA polymerase, leading to accumulation of somatic mtDNA mutations, and a profound premature aging phenotype including elevated oxidative stress and apoptosis, and reduced mitochondrial function. We have previously reported that endurance exercise alleviates the aging phenotype in the mutator mice, reduces oxidative stress, and enhances mitochondrial biogenesis. Here we summarize our findings, with the emphasis on the central role of p53 in these adaptations. We demonstrate that mtDNA in sedentary and exercised PoIG mice carry similar amounts of mutations in muscle, but in addition to that sedentary mice have more non-mutational damage, which is mitigated by exercise. It follows therefore that the profound alleviation of the mtDNA mutator phenotype in muscle by exercise may not require a reduction in mtDNA mutational load, but rather a decrease of mtDNA damage and/or oxidative stress. We further hypothesize that the observed 'alleviation without a reduction of mutational load' implies that the oxidative stress in PoIG muscle is maintained, at least in part, by the 'malicious cycle', a hypothetical positive feedback potentially driven by the 'transcriptional mutagenesis', that is the conversion of chemically modified nucleotides into mutant RNA bases by the mitochondrial RNA polymerase.
C1 [Safdar, Adeel; Saleem, Ayesha] McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.
   [Annis, Sofia; Laverack, Chloe; Woods, Dori C.; Tilly, Jonathan L.; Khrapko, Konstantin] Northeastern Univ, Dept Biol, Boston, MA 02215 USA.
   [Kraytsberg, Yevgenya] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   [Kraytsberg, Yevgenya] Harvard Med Sch, Boston, MA 02215 USA.
   [Popadin, Konstantin] Univ Lausanne, Lausanne, Switzerland.
C3 McMaster University; Northeastern University; Harvard University; Beth
   Israel Deaconess Medical Center; Harvard University; Harvard Medical
   School; University of Lausanne
RP Khrapko, K (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02215 USA.
EM kkhrapko@gmail.com
RI Saleem, Ayesha/J-6685-2019; Khrapko, Konstantin/A-3244-2009; Popadin,
   Konstantin/L-7459-2017
OI Saleem, Ayesha/0000-0003-2146-5379; khrapko,
   konstantin/0000-0002-9250-8033; Kinton, Sofia/0000-0003-3264-5260;
   Safdar, Adeel/0000-0003-2469-0467
FU Canadian Institutes of Health Research Banting Fellowship; American
   Federation for Aging Research Fellowship; Natural Sciences and
   Engineering Research Council of Canada; NIH [R37-AG012279]; Ellison
   Medical Foundation Senior Scholar Award
FX The authors thank Ms. Jenny Nguyen for artwork. This work is supported
   by the Canadian Institutes of Health Research Banting Fellowship and
   American Federation for Aging Research Fellowship (A Safdar), Natural
   Sciences and Engineering Research Council of Canada Postdoctoral
   Fellowship (A Saleem), NIH grant R37-AG012279 to JT, and the Ellison
   Medical Foundation Senior Scholar Award to KK.
CR Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Bakhanashvili M, 2008, CELL DEATH DIFFER, V15, P1865, DOI 10.1038/cdd.2008.122
   Bakhanashvili M, 2009, AIDS, V23, P779, DOI 10.1097/QAD.0b013e328329c74e
   Bandy B, 1990, FREE RADIC BIOL MED, V5, P3
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   de Souza-Pinto NC, 2004, ONCOGENE, V23, P6559, DOI 10.1038/sj.onc.1207874
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Granata C, 2016, FASEB J, V30, P959, DOI 10.1096/fj.15-276907
   Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Khrapko K, 2014, PROG MOL BIOL TRANSL, V127, P29, DOI 10.1016/B978-0-12-394625-6.00002-7
   Kolesar JE, 2014, FREE RADICAL BIO MED, V75, P241, DOI 10.1016/j.freeradbiomed.2014.07.038
   Kraytsberg Y, 2008, METHODS, V46, P269, DOI 10.1016/j.ymeth.2008.10.005
   Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Maslov A. Y., 2013, AGING CELL
   Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716
   Nakanishi N, 2013, MUTAGENESIS, V28, P117, DOI 10.1093/mutage/ges060
   Park JH, 2016, FEBS LETT, V590, P924, DOI 10.1002/1873-3468.12061
   Safdar A, 2016, SKELETAL MUSCLE, V6, P520
   Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Saleem A, 2013, J PHYSIOL-LONDON, V591, P3625, DOI 10.1113/jphysiol.2013.252791
   Saxowsky TT, 2008, P NATL ACAD SCI USA, V105, P18877, DOI 10.1073/pnas.0806464105
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9065
   Viswanathan A, 1999, SCIENCE, V284, P159, DOI 10.1126/science.284.5411.159
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Zhang D, 2003, CARDIOVASC RES, V57, P147, DOI 10.1016/S0008-6363(02)00695-8
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
NR 39
TC 32
Z9 34
U1 0
U2 11
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-437X
EI 1879-0380
J9 CURR OPIN GENET DEV
JI Curr. Opin. Genet. Dev.
PD JUN
PY 2016
VL 38
BP 127
EP 132
DI 10.1016/j.gde.2016.06.011
PG 6
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA EA6LH
UT WOS:000386740200019
PM 27497229
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Tarnopolsky, MA
   Bourgeois, JM
   Fu, MH
   Kataeva, G
   Shah, J
   Simon, DK
   Mahoney, D
   Johns, D
   MacKay, N
   Robinson, BH
AF Tarnopolsky, MA
   Bourgeois, JM
   Fu, MH
   Kataeva, G
   Shah, J
   Simon, DK
   Mahoney, D
   Johns, D
   MacKay, N
   Robinson, BH
TI Novel SCO2 mutation (G1521A) presenting as a spinal muscular atrophy
   type I phenotype
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE mitochondrial disease; Werdnig-Hoffman; nuclear mutation; cytochrome
   oxidase deficiency
ID C-OXIDASE DEFICIENCY; HYPERTROPHIC CARDIOMYOPATHY; MITOCHONDRIAL-DNA;
   GENE; FEATURES; PROTEIN; MNGIE
AB Rare cases of suspected spinal muscular atrophy (SMA) have been found to have cytochrome c oxidase (COX) deficiency. To date, four cases with SMA features have been reported in children with mutations in the synthesis of cytochrome oxidase 2 (SCO2) gene. We report a male neonate who was born hypotonic, with persistent lactic acidosis, spontaneous activity with EMG testing, development of respiratory distress in the first few hours of life, and died at 30 days of age with progressive cardiomyopathy. Testing for survival motor neurone (smn) and NAIP deletions were negative and a skeletal muscle biopsy showed neurogenic features with severe reductions of COX enzymatic and histochemical staining intensity. Postmortem muscle, heart, and liver biopsies showed severe, moderate, and mild reductions in COX activity, respectively, with parallel findings in the protein content for the mitochondrial DNA (COII) and nuclear DNA (COIV) encoded subunits. DNA sequencing of exon 2 of the SCO2 gene revealed compound heterozygosity with mutations at G1541A (common mutation, E140K) and also at a novel site in the copper binding region (G1521A in the current case (converting a highly conserved cysteine to serine (C133S)); mother heterozygous for G1521A; and father heterozygous for G1541A). This case provides strong support that SCO2 mutations can result in neonatal hypotonia with an SMA 1 phenotype. SCO2 mutations should be screened in suspected SMA cases with normal smn mutation analysis and any one of; cardiomyopathy, lactic acidosis, or COX deficiency in muscle. (C) 2003 Wiley-Liss, Inc.
C1 McMaster Univ, Med Ctr, Dept Neurol, Hamilton, ON L8N 3Z5, Canada.
   Univ Toronto, Dept Biochem, Toronto, ON, Canada.
   Univ Toronto, Dept Pediat, Toronto, ON, Canada.
   Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada.
   Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.
   McMaster Univ, Inst Mol Biol & Biotechnol MOBIX & Pediat, Hamilton, ON, Canada.
   McMaster Univ, Inst Mol Biol & Biotechnol MOBIX, Hamilton, ON, Canada.
   McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.
   McMaster Univ, Dept Phys Med & Rehabil, Hamilton, ON, Canada.
C3 McMaster University; University of Toronto; University of Toronto;
   University of Toronto; Hospital for Sick Children (SickKids); Harvard
   University; Beth Israel Deaconess Medical Center; McMaster University;
   McMaster University; McMaster University; McMaster University
RP Tarnopolsky, MA (corresponding author), McMaster Univ, Med Ctr, Dept Neurol, Rm 4U4,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
RI Robinson, B/LBH-2242-2024
CR Akita Y, 2000, HUM MUTAT, V15, P382, DOI 10.1002/(SICI)1098-1004(200004)15:4<382::AID-HUMU15>3.0.CO;2-B
   Carter SL, 2001, CAN J PHYSIOL PHARM, V79, P386, DOI 10.1139/cjpp-79-5-386
   Chinenov YV, 2000, J MOL MED, V78, P239, DOI 10.1007/s001090000110
   Dickinson EK, 2000, J BIOL CHEM, V275, P26780
   HIRUTA Y, 1995, INTERNAL MED, V34, P670, DOI 10.2169/internalmedicine.34.670
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Jaksch M, 2001, HUM MOL GENET, V10, P3025, DOI 10.1093/hmg/10.26.3025
   Jaksch M, 2001, NEUROLOGY, V57, P1440, DOI 10.1212/WNL.57.8.1440
   LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3
   McKenzie S, 2000, AM J PHYSIOL-ENDOC M, V278, pE580, DOI 10.1152/ajpendo.2000.278.4.E580
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Pons R, 1996, PEDIATR NEUROL, V15, P153, DOI 10.1016/0887-8994(96)00118-X
   Rubio-Gozalbo ME, 1999, NEUROLOGY, V52, P383, DOI 10.1212/WNL.52.2.383
   Salviati L, 2002, ARCH NEUROL-CHICAGO, V59, P862, DOI 10.1001/archneur.59.5.862
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Simon DK, 1999, ANNU REV MED, V50, P111
   Sue CM, 2000, ANN NEUROL, V47, P589, DOI 10.1002/1531-8249(200005)47:5<589::AID-ANA6>3.3.CO;2-4
   Tarnopolsky MA, 2001, MUSCLE NERVE, V24, P682, DOI 10.1002/mus.1055
NR 20
TC 43
Z9 47
U1 0
U2 2
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0148-7299
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD MAR 15
PY 2004
VL 125A
IS 3
BP 310
EP 314
DI 10.1002/ajmg.a.20466
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 779TK
UT WOS:000189316800016
PM 14994243
DA 2024-11-01
ER

PT J
AU Escames, G
   López, LC
   García, JA
   García-Corzo, L
   Ortiz, F
   Acuña-Castroviejo, D
AF Escames, Germaine
   Carlos Lopez, Luis
   Antonio Garcia, Jose
   Garcia-Corzo, Laura
   Ortiz, Francisco
   Acuna-Castroviejo, Dario
TI Mitochondrial DNA and inflammatory diseases
SO HUMAN GENETICS
LA English
DT Review
ID NITRIC-OXIDE SYNTHASE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS;
   THIOREDOXIN-INTERACTING PROTEIN; EMBRYONIC STEM-CELLS; NF-KAPPA-B;
   OXIDATIVE STRESS; AMYLOID-BETA; PARKINSONS-DISEASE; REACTIVE OXYGEN;
   SKELETAL-MUSCLE
AB Increasing experimental evidence supports a connection between inflammation and mitochondrial dysfunction. Both acute and chronic inflammatory diseases course with elevated free radicals production that may affect mitochondrial proteins, lipids, and mtDNA. The subsequent mitochondrial impairment produces more reactive oxygen species that further reduce the ATP generation, increasing the probability of cell death. Mitochondrial impairment in now considered a key factor in inflammation because (1) there are specific pathologies directly derived from mtDNA mutations, causing chronic inflammatory diseases such as neuromuscular and neurodegenerative disorders, (2) there are neurodegenerative, metabolic, and other inflammatory diseases in which their progression is accompanied by mitochondrial dysfunction, which is directly involved in the cell death. Recently, a direct implication of mitochondrial reactive oxygen species and, particularly, mtDNA in the innate immune response has been reported. Thus, the mitochondria should be considered targets for new therapies related to the treatment of acute and chronic inflammatory diseases, including the auto-inflammatory ones.
C1 [Escames, Germaine; Carlos Lopez, Luis; Antonio Garcia, Jose; Garcia-Corzo, Laura; Ortiz, Francisco; Acuna-Castroviejo, Dario] Univ Granada, Inst Biotecnol, Ctr Invest Biomed, Granada 18100, Spain.
   [Escames, Germaine; Carlos Lopez, Luis; Antonio Garcia, Jose; Garcia-Corzo, Laura; Ortiz, Francisco; Acuna-Castroviejo, Dario] Univ Granada, Dept Fisiol, Fac Med, Granada 18100, Spain.
C3 University of Granada; University of Granada
RP Acuña-Castroviejo, D (corresponding author), Univ Granada, Inst Biotecnol, Ctr Invest Biomed, Parque Tecnol Ciencias Salud,Ave Conocimiento S-N, Granada 18100, Spain.
EM dacuna@ugr.es
RI Ortiz, Fernández/I-9365-2018; Lopez, Luis Carlos/L-5129-2014; Escames,
   Germaine/N-7501-2016; garcia corzo, laura/H-7237-2015;
   Acuna-Castroviejo, Dario/N-7456-2016
OI Lopez, Luis Carlos/0000-0003-3355-0298; Escames,
   Germaine/0000-0003-1256-7656; garcia corzo, laura/0000-0001-5571-6776;
   Acuna-Castroviejo, Dario/0000-0002-9680-1560
FU European Community [COQMITMEL-266691]; Ministerio de Ciencia e
   Innovacion, Spain [SAF200908315]; Consejeria de Economia, Innovacion y
   Ciencia, Junta de Andalucia [P10-CTS-6133, P07-CTS-03135, CTS-101];
   Instituto de Salud Carlos III, Spain [RD06/0013/0008, PI08-1664]
FX This study was partially supported by grants from the Marie Curie
   International Reintegration Grant Programme (COQMITMEL-266691) within
   the 7th European Community Framework Programme, from the Instituto de
   Salud Carlos III, Spain (RD06/0013/0008, PI08-1664), from the Ministerio
   de Ciencia e Innovacion, Spain (SAF200908315) and from the Consejeria de
   Economia, Innovacion y Ciencia, Junta de Andalucia (P10-CTS-6133,
   P07-CTS-03135 and CTS-101).
CR Castroviejo DA, 2011, CURR TOP MED CHEM, V11, P221
   Acuña-Castroviejo D, 2001, J PINEAL RES, V30, P65, DOI 10.1034/j.1600-079X.2001.300201.x
   Acuna-Castroviejo D, 2007, FRONT BIOSCI-LANDMRK, V12, P947, DOI 10.2741/2116
   Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509
   Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9
   Aliev G, 2008, VASC HEALTH RISK MAN, V4, P721, DOI 10.2147/VHRM.S2608
   ALVAREZBUYLLA A, 1995, STEM CELLS, V13, P263, DOI 10.1002/stem.5530130307
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Angus DC, 2001, CRIT CARE MED, V29, pS109, DOI 10.1097/00003246-200107001-00035
   Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522
   Baharvand Hossein, 2003, Reprod Biomed Online, V7, P330
   Bartz RR, 2011, AM J RESP CRIT CARE, V183, P226, DOI 10.1164/rccm.200911-1709OC
   Biolo G, 2007, CRIT CARE MED, V35, pS591, DOI 10.1097/01.CCM.0000278913.19123.13
   Bogenhagen DF, 2010, EXP GERONTOL, V45, P473, DOI 10.1016/j.exger.2009.12.002
   Bolaños JP, 2006, ANTIOXID REDOX SIGN, V8, P955, DOI 10.1089/ars.2006.8.955
   Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X
   Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Callahan LA, 2005, AM J RESP CRIT CARE, V172, P861, DOI 10.1164/rccm.200410-1344OC
   Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040
   Cardinali DP, 2010, CURR NEUROPHARMACOL, V8, P218, DOI 10.2174/157015910792246209
   Cardinali DR, 2011, NEUROENDOCRINOLOGY, V93, P133, DOI 10.1159/000324699
   Carretero M, 2009, J PINEAL RES, V47, P192, DOI 10.1111/j.1600-079X.2009.00700.x
   Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje
   Cassel SL, 2009, SEMIN IMMUNOL, V21, P194, DOI 10.1016/j.smim.2009.05.002
   Castroviejo Dario Acuna, 2002, Current Topics in Medicinal Chemistry, V2, P133, DOI 10.2174/1568026023394344
   Chahbouni M, 2010, J PINEAL RES, V48, P282, DOI 10.1111/j.1600-079X.2010.00752.x
   Chen DX, 2000, J NEUROSCI RES, V61, P225, DOI 10.1002/1097-4547(20000715)61:2<225::AID-JNR13>3.0.CO;2-0
   Chen JX, 2010, J ALZHEIMERS DIS, V20, pS569, DOI 10.3233/JAD-2010-100357
   Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020
   Coto-Montes A, 2006, AUTOPHAGY, V2, P126, DOI 10.4161/auto.2.2.2351
   Crespo E, 1999, FASEB J, V13, P1537, DOI 10.1096/fasebj.13.12.1537
   Crimi E, 2006, FREE RADICAL BIO MED, V40, P398, DOI 10.1016/j.freeradbiomed.2005.10.054
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007
   Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006
   DiMauro S, 2004, BBA-BIOENERGETICS, V1659, P107, DOI 10.1016/j.bbabio.2004.08.003
   DiMauro S, 2010, Acta Myol, V29, P333
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Driver JA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d198
   Dunne A, 2011, BIOCHEM SOC T, V39, P669, DOI 10.1042/BST0390669
   Escames G, 2006, J PINEAL RES, V40, P71, DOI 10.1111/j.1600-079X.2005.00281.x
   Escames G, 2003, FASEB J, V17, P932, DOI 10.1096/fj.02-0692fje
   Escames G, 2007, FEBS J, V274, P2135, DOI 10.1111/j.1742-4658.2007.05755.x
   Escames G, 2006, J PHARM PHARMACOL, V58, P1153, DOI 10.1211/jpp.58.9.0001
   Escames G, 2010, CURR NEUROPHARMACOL, V8, P182, DOI 10.2174/157015910792246245
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fike JR, 2009, SEMIN RADIAT ONCOL, V19, P122, DOI 10.1016/j.semradonc.2008.12.003
   Frazier AE, 2006, BIOL CHEM, V387, P1551, DOI 10.1515/BC.2006.193
   Fröjdö S, 2009, BBA-MOL BASIS DIS, V1792, P83, DOI 10.1016/j.bbadis.2008.10.019
   Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008
   Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Galley HF, 2010, CRIT CARE, V14, DOI 10.1186/cc9098
   Garcia JJ, 2010, NEUROBIOL A IN PRESS
   Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311
   Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC
   Halberg F, 2005, BIOMED PHARMACOTHER, V59, pS192, DOI 10.1016/S0753-3322(05)80031-9
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Hardeland R, 2009, J PINEAL RES, V47, P109, DOI 10.1111/j.1600-079X.2009.00701.x
   Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022
   HARRIS ED, 1992, FASEB J, V6, P2675, DOI 10.1096/fasebj.6.9.1612291
   Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5
   Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3
   Jou MJ, 2010, J PINEAL RES, V48, P20, DOI 10.1111/j.1600-079X.2009.00721.x
   Kennaway David J., 2002, Current Topics in Medicinal Chemistry, V2, P199, DOI 10.2174/1568026023394380
   Khaldy H, 2003, NEUROBIOL AGING, V24, P491, DOI 10.1016/S0197-4580(02)00133-1
   Kienhöfer J, 2009, FASEB J, V23, P2034, DOI 10.1096/fj.08-113571
   Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900
   Kirby DM, 2009, CELL PROLIFERAT, V42, P413, DOI 10.1111/j.1365-2184.2009.00612.x
   Koziróg M, 2011, J PINEAL RES, V50, P261, DOI 10.1111/j.1600-079X.2010.00835.x
   Kubota T, 2010, MOD RHEUMATOL, V20, P213, DOI 10.1007/s10165-009-0271-0
   Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Liberatore GT, 1999, NAT MED, V5, P1403
   Lim S, 2010, ANN NY ACAD SCI, V1201, P166, DOI 10.1111/j.1749-6632.2010.05622.x
   Lonergan T, 2007, MITOCHONDRION, V7, P289, DOI 10.1016/j.mito.2007.05.002
   Lonergan T, 2006, J CELL PHYSIOL, V208, P149, DOI 10.1002/jcp.20641
   López A, 2009, J PINEAL RES, V46, P188, DOI 10.1111/j.1600-079X.2008.00647.x
   López LC, 2006, INT J BIOCHEM CELL B, V38, P267, DOI 10.1016/j.biocel.2005.09.008
   López LC, 2006, NEUROENDOCRINOL LETT, V27, P623
   Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066
   Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664
   Mariathasan S, 2007, MICROBES INFECT, V9, P664, DOI 10.1016/j.micinf.2007.01.017
   Martí R, 2003, CLIN CHEM LAB MED, V41, P845, DOI 10.1515/CCLM.2003.128
   Martín M, 2002, INT J BIOCHEM CELL B, V34, P348, DOI 10.1016/S1357-2725(01)00138-8
   Martín M, 2000, FASEB J, V14, P1677
   Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3
   Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627
   McMorrow JP, 2011, BIOCHEM SOC T, V39, P688, DOI 10.1042/BST0390688
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151
   Müller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5
   Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423
   Neven B, 2008, NAT CLIN PRACT RHEUM, V4, P481, DOI 10.1038/ncprheum0874
   Nishikawa T, 2007, ANTIOXID REDOX SIGN, V9, P343, DOI 10.1089/ars.2006.1458
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Olcese JM, 2009, J PINEAL RES, V47, P82, DOI 10.1111/j.1600-079X.2009.00692.x
   Paradies G, 2010, J PINEAL RES, V48, P297, DOI 10.1111/j.1600-079X.2010.00759.x
   Poderoso JJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P85, DOI 10.1006/abbi.1996.0146
   Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002
   Reddy PH, 2008, NEUROMOL MED, V10, P291, DOI 10.1007/s12017-008-8044-z
   REITER RJ, 1980, INT J BIOMETEOROL, V24, P57, DOI 10.1007/BF02245542
   Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569
   Roifman I, 2011, CAN J CARDIOL, V27, P174, DOI 10.1016/j.cjca.2010.12.040
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schapira AHV, 1999, BBA-BIOENERGETICS, V1410, P159, DOI 10.1016/S0005-2728(98)00164-9
   Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003
   Semple RK, 2004, INT J OBESITY, V28, P176, DOI 10.1038/sj.ijo.0802482
   SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X
   Siggins RW, 2008, INT J CLIN EXP MED, V1, P2
   Sonnen JA, 2010, NEUROLOGY, V75, P1203, DOI 10.1212/WNL.0b013e3181f52db1
   St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141
   Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011
   Stuart JA, 2005, FREE RADICAL BIO MED, V38, P737, DOI 10.1016/j.freeradbiomed.2004.12.003
   Suliman HB, 2005, FASEB J, V19, P1531, DOI 10.1096/fj.04-3500fje
   Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005
   Suliman HB, 2003, AM J RESP CRIT CARE, V167, P570, DOI 10.1164/rccm.200206-518OC
   Svistunenko DA, 2006, BBA-BIOENERGETICS, V1757, P262, DOI 10.1016/j.bbabio.2006.03.007
   Sweeney E, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009518, 10.1371/journal.pone.0011606]
   Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, pS265, DOI 10.3233/JAD-2010-100339
   Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9
   Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x
   Tan DX, 2010, BIOL REV, V85, P607, DOI 10.1111/j.1469-185X.2009.00118.x
   Tan DX, 2001, FASEB J, V15, P2294, DOI 10.1096/fj.01-0309fje
   Tan DX, 1998, BIOCHEM BIOPH RES CO, V253, P614, DOI 10.1006/bbrc.1998.9826
   TAN DX, 1993, CANCER LETT, V70, P65, DOI 10.1016/0304-3835(93)90076-L
   Tang L, 1998, MOL CELL BIOCHEM, V178, P299, DOI 10.1023/A:1006815530519
   Tapias V, 2009, J NEUROSCI RES, V87, P3002, DOI 10.1002/jnr.22123
   Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788
   Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436
   Tsutsui H, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/641865
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Van Blerkom J, 2004, REPRODUCTION, V128, P269, DOI 10.1530/rep.1.00240
   Voloboueva LA, 2010, J NEUROSCI, V30, P12242, DOI 10.1523/JNEUROSCI.1752-10.2010
   Wang W, 2010, STEM CELLS, V28, P2195, DOI 10.1002/stem.542
   Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x
   Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Yoo YM, 2010, J PINEAL RES, V48, P204, DOI 10.1111/j.1600-079X.2010.00744.x
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhou LZH, 2001, FREE RADICAL BIO MED, V31, P1405, DOI 10.1016/S0891-5849(01)00719-5
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
   Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831
   Zingarelli B, 2005, CRIT CARE MED, V33, pS414, DOI 10.1097/01.CCM.0000186079.88909.94
   Zingarelli B, 2003, CRIT CARE MED, V31, pS105, DOI 10.1097/00003246-200301001-00015
NR 158
TC 82
Z9 89
U1 0
U2 21
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0340-6717
EI 1432-1203
J9 HUM GENET
JI Hum. Genet.
PD FEB
PY 2012
VL 131
IS 2
BP 161
EP 173
DI 10.1007/s00439-011-1057-y
PG 13
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 876QQ
UT WOS:000299123000001
PM 21735170
DA 2024-11-01
ER

PT S
AU Ng, YS
   Taylor, RW
   Schaefer, AM
AF Ng, Yi Shiau
   Taylor, Robert W.
   Schaefer, Andrew M.
BE Barbetti, F
   Ghizzoni, L
   Guaraldi, F
TI Diabetes Mellitus in Mitochondrial Disease
SO DIABETES ASSOCIATED WITH SINGLE GENE DEFECTS AND CHROMOSOMAL
   ABNORMALITIES
SE Frontiers in Diabetes
LA English
DT Article; Book Chapter
ID TRNA(LEU(UUR)) GENE; M.3243A-GREATER-THAN-G MUTATION; CLINICAL-FEATURES;
   DNA MUTATION; MTDNA MUTATION; POINT MUTATION; BETA-CELLS; DEAFNESS;
   ADULTS; SPECTRUM
AB Mitochondrial diseases arise as a consequence of respiratory chain dysfunction caused by mutations in the mitochondrial genome (mtDNA) or nuclear-encoded mitochondrial genes. Multisystem involvement is a hallmark of many subtypes of mitochondrial disease in which energy-dependent organs including the brain, skeletal muscles, and heart are commonly affected. The most common mitochondrial genotype that causes diabetes mellitus is a single nucleotide substitution (m.3243A>G) in the mitochondrial tRNA(Leu(UUR)) gene which is linked to a distinctive clinical phenotype-maternally inherited diabetes and deafness. Diabetes mellitus often arises insidiously as part of the clinical presentation associated with mitochondrial disease; however, there are unique clinical features and associated complications compared to other diabetes subtypes. Overall, the treatment of patients with mitochondrial diabetes is similar to those with other causes of diabetes but with additional emphasis on the screening and subsequent management of additional multiorgan involvement. (C) 2017 S. Karger AG, Basel
C1 [Ng, Yi Shiau; Taylor, Robert W.; Schaefer, Andrew M.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Neurosci, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Taylor, RW; Schaefer, AM (corresponding author), Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Neurosci, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.taylor@newcastle.ac.uk; andrew.schaefer@nuth.nhs.uk
RI Ng, Yi/AFF-1445-2022
OI Ng, Yi Shiau/0000-0002-7591-2034; Schaefer, Andrew/0000-0001-9891-7332
CR [Anonymous], 2013, QUAL OUTC FRAM ACH P
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Brändle M, 2001, DIABETES CARE, V24, P1253, DOI 10.2337/diacare.24.7.1253
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   El-Hattab AW, 2014, MITOCHONDRION, V18, P63, DOI 10.1016/j.mito.2014.07.008
   Feigl B, 2013, CAN J OPHTHALMOL, V48, pE111, DOI 10.1016/j.jcjo.2013.02.013
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Gebhart SSP, 1996, METABOLISM, V45, P526, DOI 10.1016/S0026-0495(96)90231-0
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Guillausseau PJ, 2004, DIABETES METAB, V30, P181, DOI 10.1016/S1262-3636(07)70105-2
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   Holmes-Walker DJ, 1998, DIABETIC MED, V15, P946, DOI 10.1002/(SICI)1096-9136(1998110)15:11<946::AID-DIA707>3.0.CO;2-L
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Iwasaki N, 2001, J HUM GENET, V46, P330, DOI 10.1007/s100380170068
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Lindroos MM, 2009, DIABETES, V58, P543, DOI 10.2337/db08-0981
   Lynn S, 2003, DIABETOLOGIA, V46, P296, DOI 10.1007/s00125-002-1018-z
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Massin P, 2008, DIABETOLOGIA, V51, P1664, DOI 10.1007/s00125-008-1073-1
   Momiyama Y, 2002, DIABETES CARE, V25, P2308, DOI 10.2337/diacare.25.12.2308
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Otabe S, 1999, BIOCHEM BIOPH RES CO, V259, P149, DOI 10.1006/bbrc.1999.0650
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Salles JE, 2007, PANCREAS, V34, P133, DOI 10.1097/01.mpa.0000246659.38375.4d
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   SUZUKI S, 1994, DIABETES CARE, V17, P1428, DOI 10.2337/diacare.17.12.1428
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Suzuki Y, 2003, DIABETES CARE, V26, P1315, DOI 10.2337/diacare.26.4.1315
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tsukuda K, 1997, DIABETIC MED, V14, P1032, DOI 10.1002/(SICI)1096-9136(199712)14:12<1032::AID-DIA504>3.0.CO;2-Y
   Ueno H, 1999, JPN CIRC J, V63, P877, DOI 10.1253/jcj.63.877
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   WALKER M, 1995, DIABETES CARE, V18, P1507, DOI 10.2337/diacare.18.11.1507
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 49
TC 1
Z9 1
U1 0
U2 1
PU KARGER
PI BASEL
PA POSTFACH, CH-4009 BASEL, SWITZERLAND
SN 0251-5342
BN 978-3-318-06025-6; 978-3-318-06024-9
J9 FRONT DIABETES
JI Front.Diabetes
PY 2017
VL 25
BP 55
EP 68
DI 10.1159/000454701
D2 10.1159/isbn.978-3-318-06025-6
PG 14
WC Endocrinology & Metabolism; Genetics & Heredity
WE Book Citation Index – Science (BKCI-S)
SC Endocrinology & Metabolism; Genetics & Heredity
GA BI4YX
UT WOS:000412098300006
DA 2024-11-01
ER

PT J
AU Joshi, PR
   Vetterke, M
   Hauburger, A
   Tacik, P
   Stoltenburg, G
   Hanisch, F
AF Joshi, Pushpa Raj
   Vetterke, Mirjam
   Hauburger, Anja
   Tacik, Pawel
   Stoltenburg, Gisela
   Hanisch, Frank
TI Functional relevance of mitochondrial abnormalities in sporadic
   inclusion body myositis
SO JOURNAL OF CLINICAL NEUROSCIENCE
LA English
DT Article
DE Cycle ergometry test; Forearm exercise test; Mitochondria; Multiple
   deletions; Oxygen consumption; Sporadic inclusion body myositis
ID AEROBIC FOREARM EXERCISE; DNA DELETIONS; INFLAMMATORY MYOPATHIES;
   MUSCLE; DISEASE; DISORDERS; FEATURES; MTDNA
AB Cytochrome c oxidase (COX)-deficient fibers and multiple mitochondrial DNA (mtDNA) deletions are frequent findings in sporadic inclusion body myositis (s-IBM). However, the functional impact of these defects is not known. We investigated oxygen desaturation during exercise using the forearm exercise test, accumulation of lactate during exercise using a cycle ergometry test and mitochondrial changes (COX-deficient fibers, biochemical activities of respiratory chain complexes, multiple mtDNA deletions by long-range polymerase chain reaction) in 10 patients with s-IBM and compared the findings with age and sex-matched normal and diseased controls (without mitochondrial disorders) as well as patients with mitochondrial disorder due to nuclear gene defects resulting in multiple mtDNA deletions (MITO group). The mean age of the s-IBM patients was 68.2 +/- 5.7 years (range: 56-75). Patients with s-IBM had statistically significantly reduced oxygen desaturation (Delta sO(2)) during the handgrip exercise (p < 0.05) and elevated peak serum lactate levels during cycle ergometry compared to normal controls (p < 0.05). The percentage of COX-deficient fibers in s-IBM and MITO patients was significantly increased compared to normal controls (p < 0.01). Five out of nine s-IBM patients had multiple mtDNA deletions. Thirty-three percent of s-IBM patients showed an increased citrate synthase content and decreased activities of complex IV (COX). The biochemical pattern of respiratory chain complexes in patients with s-IBM and MITO was similar. Histopathological analysis showed similar changes in s-IBM and MITO due to nuclear gene defects. Functional tests reflecting mitochondrial impairment suggest a contribution of mitochondrial defects to disease-related symptoms such as fatigue and exertion-induced symptoms. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Joshi, Pushpa Raj; Vetterke, Mirjam; Hauburger, Anja; Stoltenburg, Gisela; Hanisch, Frank] Univ Halle Wittenberg, Dept Neurol, D-06120 Halle, Saale, Germany.
   [Tacik, Pawel] Hannover Med Sch, Dept Neurol, Hannover, Germany.
   [Stoltenburg, Gisela] Charite, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany.
C3 Martin Luther University Halle Wittenberg; Hannover Medical School;
   Berlin Institute of Health; Berlin Institute of Health; Free University
   of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin
   Berlin
RP Joshi, PR (corresponding author), Univ Halle Wittenberg, Dept Neurol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany.
EM pushpa.joshi@medizin.uni-halle.de
CR Argov Z, 1998, MUSCLE NERVE, V21, P1523, DOI 10.1002/(SICI)1097-4598(199811)21:11<1523::AID-MUS22>3.0.CO;2-#
   Askanas V, 2006, NEUROLOGY, V66, pS39, DOI 10.1212/01.wnl.0000192128.13875.1e
   Askanas V, 2012, J NEUROPATH EXP NEUR, V71, P680, DOI 10.1097/NEN.0b013e31826183c8
   Badrising UA, 2005, J NEUROL, V252, P1448, DOI 10.1007/s00415-005-0884-y
   Brady S, 2013, J NEUROL NEUROSUR PS, V84, P1240, DOI 10.1136/jnnp-2013-305690
   Chariot P, 1996, ACTA NEUROPATHOL, V91, P530, DOI 10.1007/s004010050462
   Alverne ARDM, 2013, ACTA REUMATOL PORT, V38, P179
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504
   Hanisch F, 2006, J NEUROL, V253, P417, DOI 10.1007/s00415-006-0987-0
   Jensen TD, 2002, NEUROLOGY, V58, P1533, DOI 10.1212/WNL.58.10.1533
   Jones K, 2013, J NEUROL NEUROSUR PS, V84, DOI 10.1136/jnnp-2013-306573.204
   Joshi PR, 2009, NEUROMUSCULAR DISORD, V19, P654, DOI 10.1016/j.nmd.2009.06.341
   Koene S, 2013, MITOCHONDRION, V13, P15, DOI 10.1016/j.mito.2012.11.002
   Krasnianski A, 2005, BRAIN, V128, P1870, DOI 10.1093/brain/awh540
   Mancuso M, 2012, NEUROMUSCULAR DISORD, V22, pS226, DOI 10.1016/j.nmd.2012.10.012
   Meulemans A, 2007, ACTA NEUROL BELG, V107, P78
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Oldfors A, 2006, NEUROLOGY, V66, pS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Peng A, 2000, NEUROLOGY, V55, P296, DOI 10.1212/WNL.55.2.296
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   SAYERS ME, 1992, J RHEUMATOL, V19, P1385
   Taivassalo T, 2002, ANN NEUROL, V51, P38, DOI 10.1002/ana.10027
   Varadhachary AS, 2010, CURR OPIN RHEUMATOL, V22, P651, DOI 10.1097/BOR.0b013e32833f108a
NR 28
TC 18
Z9 19
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0967-5868
EI 1532-2653
J9 J CLIN NEUROSCI
JI J. Clin. Neurosci.
PD NOV
PY 2014
VL 21
IS 11
BP 1959
EP 1963
DI 10.1016/j.jocn.2014.05.051
PG 5
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AU4TK
UT WOS:000345604100022
PM 25311418
DA 2024-11-01
ER

PT J
AU Ben Rhouma, F
   Messai, H
   Hsouna, S
   Ben Halim, N
   Cherif, W
   Ben Fadhel, S
   Tiar, A
   Nagara, M
   Azzouz, H
   Sfar, MT
   Ben Dridi, MF
   Tebib, N
   Ayadi, A
   Abdelhak, S
   Kefi, R
AF Ben Rhouma, Faten
   Messai, Habib
   Hsouna, Sana
   Ben Halim, Nizar
   Cherif, Wafa
   Ben Fadhel, Sihem
   Tiar, Afaf
   Nagara, Majdi
   Azzouz, Hatem
   Sfar, Mohamed-Tahar
   Ben Dridi, Marie-Francoise
   Tebib, Neji
   Ayadi, Abdelkarim
   Abdelhak, Sonia
   Kefi, Rym
TI History of settlement of villages from Central Tunisia by studying
   families sharing a common founder Glycogenosis type III mutation
SO MITOCHONDRIAL DNA PART A
LA English
DT Article
DE Consanguinity; gene flow; haplotype; haplogroup; p.W1327X
ID HIGH-RESOLUTION ANALYSIS; HUMAN MITOCHONDRIAL-DNA; DISEASE TYPE-III;
   Y-CHROMOSOME; NORTH-AFRICA; DEBRANCHING ENZYME; MTDNA VARIATION;
   ETHNIC-GROUPS; DIVERSITY; GENE
AB Glycogen storage disease type III (GSD III; Cori disease; Forbes disease) is an autosomal recessive inherited metabolic disorder resulting from deficient glycogen debrancher enzyme activity in liver and muscle. In this study, we focused on a single AGL gene mutation p.W1327X in 16 Tunisian patients from rural area surrounding the region of Mahdia in Central Tunisia. This constitutes the largest pool of patients with this mutation ever described. This study was performed to trace the history of the patients' ancestries in a single region. After extraction of genomic DNA, exon 31 of AGL gene was sequenced. The patients were investigated for the hypervariable segment 1 of mitochondrial DNA and 17 Y-STR markers. We found that the p.W1327X mutation was a founder mutation in Tunisia Analysis of maternal lineages shows an admixture of autochthonous North African, sub-Saharan and a predominance of Eurasian haplogroups. Heterogeneity of maternal haplogroups indicates an ancient settlement. However, paternal gene flow was highly homogeneous and originates from the Near East. We hypothesize that the p.W1327X mutation was introduced into the Tunisian population probably by a recent migration event; then the mutation was fixed in a small region due to the high rate of consanguineous marriages and genetic drift. The screening for this mutation should be performed in priority for GSD III molecular diagnosis, for patients from the region of Mahdia and those from regions sharing the same settlement history.
C1 [Ben Rhouma, Faten; Messai, Habib; Hsouna, Sana; Ben Halim, Nizar; Cherif, Wafa; Ben Fadhel, Sihem; Tiar, Afaf; Nagara, Majdi; Abdelhak, Sonia; Kefi, Rym] Inst Pasteur Tunis, Lab Genom Biomed & Oncogenet LR11IPT05, Tunis 1002, Belvedere, Tunisia.
   [Ben Rhouma, Faten; Messai, Habib; Hsouna, Sana; Ben Halim, Nizar; Cherif, Wafa; Ben Fadhel, Sihem; Tiar, Afaf; Nagara, Majdi; Abdelhak, Sonia; Kefi, Rym] Univ Tunis El Manar, Tunis, Tunisia.
   [Azzouz, Hatem; Ben Dridi, Marie-Francoise; Tebib, Neji] Hoop La Rabta Tunis, Dept Pediat, Unite Malad Metab Hereditaires, Tunis, Tunisia.
   [Azzouz, Hatem; Ben Dridi, Marie-Francoise; Tebib, Neji] Fac Med Tunis, Tunis, Tunisia.
   [Sfar, Mohamed-Tahar] Hop Tahar Sfar, Dept Pediat, Mahdia, Tunisia.
C3 Pasteur Network; Universite de Tunis-El-Manar; Institut Pasteur Tunis;
   Universite de Tunis-El-Manar; Universite de Tunis-El-Manar; Faculte de
   Medecine de Tunis (FMT); Universite de Monastir; Hopital Universitaire
   Tahar Sfar
RP Kefi, R (corresponding author), Pasteur Inst Tunis, Biomed Genom & Oncogenet Lab, BP74,13 Pl Pasteur, Tunis 1002, Belvedere, Tunisia.
EM rym.kefi@pasteur.rns.tn
RI hsouna, sana/AAC-9034-2022; KEFI, Rym/IAP-4090-2023; Abdelhak,
   Sonia/L-2831-2013
OI Abdelhak, Sonia/0000-0001-8466-5525
FU Tunisian Ministry of Public Health; Ministry of Higher Education and
   Scientific Research
FX This work was supported by the Tunisian Ministry of Public Health and
   the Ministry of Higher Education and Scientific Research.
CR Al-Zahery N, 2003, MOL PHYLOGENET EVOL, V28, P458, DOI 10.1016/S1055-7903(03)00039-3
   Alonso S, 2005, EUR J HUM GENET, V13, P1293, DOI 10.1038/sj.ejhg.5201482
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   [Anonymous], 2005, J Genet Geneal
   Arredi B, 2004, AM J HUM GENET, V75, P338, DOI 10.1086/423147
   Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036
   Ben Arab S, 2004, GENET EPIDEMIOL, V27, P74, DOI 10.1002/gepi.10321
   Ben Halim N, 2013, J COMMUN GENET, V4, P273, DOI 10.1007/s12687-012-0128-7
   Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521
   Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934
   Cherni L, 2005, HUM BIOL, V77, P61, DOI 10.1353/hub.2005.0028
   Cherni L, 2005, FORENSIC SCI INT, V152, P95, DOI 10.1016/j.forsciint.2005.02.007
   Cherni L, 2005, FORENSIC SCI INT, V147, P101, DOI 10.1016/j.forsciint.2004.04.009
   Cherni L, 2009, AM J PHYS ANTHROPOL, V139, P253, DOI 10.1002/ajpa.20979
   Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257
   DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597
   El-Sibai M, 2009, ANN HUM GENET, V73, P568, DOI 10.1111/j.1469-1809.2009.00538.x
   Endo Y, 2005, J HUM GENET, V50, P538, DOI 10.1007/s10038-005-0291-3
   Ennafaa H, 2011, J HUM GENET, V56, P734, DOI 10.1038/jhg.2011.92
   Fadhlaoui-Zid K, 2004, ANN HUM GENET, V68, P222, DOI 10.1046/j.1529-8817.2004.00096.x
   Fadhlaoui-Zid K, 2011, AM J PHYS ANTHROPOL, V146, P271, DOI 10.1002/ajpa.21581
   Falchi A, 2006, J HUM GENET, V51, P9, DOI 10.1007/s10038-005-0324-y
   Hsouna S, 2014, MITOCHONDR DNA, V10, P1
   Kefi R, 2014, MITOCHONDRIAL DNA
   Kerkeni E, 2007, CROAT MED J, V48, P701
   Loueslati BY, 2006, AM J HUM BIOL, V18, P149, DOI 10.1002/ajhb.20473
   Mili A, 2012, J HUM GENET, V57, P170, DOI 10.1038/jhg.2011.122
   Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038
   Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295
   Shen JJ, 1996, J CLIN INVEST, V98, P352, DOI 10.1172/JCI118799
   YANG BZ, 1992, J BIOL CHEM, V267, P9294
   Zalloua PA, 2008, AM J HUM GENET, V83, P633, DOI 10.1016/j.ajhg.2008.10.012
   Zalloua PA, 2008, AM J HUM GENET, V82, P873, DOI 10.1016/j.ajhg.2008.01.020
NR 33
TC 2
Z9 2
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2470-1394
EI 2470-1408
J9 MITOCHONDRIAL DNA A
JI Mitochondrial DNA Part A
PY 2016
VL 27
IS 5
BP 3194
EP 3198
DI 10.3109/19401736.2015.1007331
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA DO7IU
UT WOS:000377956700057
PM 26704523
DA 2024-11-01
ER

PT J
AU Holmbeck, MA
   Donner, JR
   Villa-Cuesta, E
   Rand, DM
AF Holmbeck, Marissa A.
   Donner, Julia R.
   Villa-Cuesta, Eugenia
   Rand, David M.
TI A <i>Drosophila</i> model for mito-nuclear diseases generated by an
   incompatible interaction between tRNA and tRNA synthetase
SO DISEASE MODELS & MECHANISMS
LA English
DT Article
DE Disease; Epistasis; Mitochondria
ID MITOCHONDRIAL PROTEIN-SYNTHESIS; HEREDITARY OPTIC NEUROPATHY;
   SIDEROBLASTIC ANEMIA; LACTIC-ACIDOSIS; MUSCLE DEGENERATION;
   ENERGY-METABOLISM; YARS2 MUTATIONS; PARKIN MUTANTS; INNER-MEMBRANE;
   FLIGHT-MUSCLE
AB Communication between the mitochondrial and nuclear genomes is vital for cellular function. The assembly of mitochondrial enzyme complexes, which produce the majority of cellular energy, requires the coordinated expression and translation of both mitochondrially and nuclear-encoded proteins. The joint genetic architecture of this system complicates the basis of mitochondrial diseases, and mutations both in mitochondrial DNA (mtDNA)- and nuclear-encoded genes have been implicated in mitochondrial dysfunction. Previously, in a set of mitochondrial-nuclear introgression strains, we characterized a dual genome epistasis in which a naturally occurring mutation in the Drosophila simulans simw(501) mtDNA-encoded transfer RNA (tRNA) for tyrosine (tRNA(Tyr)) interacts with a mutation in the nuclear-encoded mitochondrially localized tyrosyl-tRNA synthetase from Drosophila melanogaster. Here, we show that the incompatible mitochondrial-nuclear combination results in locomotor defects, reduced mitochondrial respiratory capacity, decreased oxidative phosphorylation (OXPHOS) enzyme activity and severe alterations in mitochondrial morphology. Transgenic rescue strains containing nuclear variants of the tyrosyl-tRNA synthetase are sufficient to rescue many of the deleterious phenotypes identified when paired with the simw(501) mtDNA. However, the severity of this defective mito-nuclear interaction varies across traits and genetic backgrounds, suggesting that the impact of mitochondrial dysfunction might be tissue specific. Because mutations in mitochondrial tRNA(Tyr) are associated with exercise intolerance in humans, this mitochondrial-nuclear introgression model in Drosophila provides a means to dissect the molecular basis of these, and other, mitochondrial diseases that are a consequence of the joint genetic architecture of mitochondrial function.
C1 [Holmbeck, Marissa A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.
   [Donner, Julia R.; Rand, David M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.
   [Villa-Cuesta, Eugenia] Adelphi Univ, Dept Biol, Garden City, NY 11530 USA.
C3 Brown University; Brown University; Adelphi University
RP Rand, DM (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.
EM David_Rand@Brown.edu
OI Villa-Cuesta, Eugenia/0000-0002-8919-6788
FU NIGMS awarded [R15GM113156]; NIGMS [R01GM067862]; NIA [R01AG027849]; 
   [1F31AG040925-02]
FX This work was supported by grants 1F31AG040925-02 awarded to M.A.H.,
   grant R15GM113156 from NIGMS awarded to E.V.-C., and grant R01GM067862
   from NIGMS and grant R01AG027849 from NIA awarded to D.M.R.
CR Arnqvist G, 2010, EVOLUTION, V64, P3354, DOI 10.1111/j.1558-5646.2010.01135.x
   Augustin H, 2009, BBA-GEN SUBJECTS, V1790, P1084, DOI 10.1016/j.bbagen.2009.06.011
   Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288
   BEENAKKERS AMT, 1984, INSECT BIOCHEM, V14, P243, DOI 10.1016/0020-1790(84)90057-X
   BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24
   Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0
   Carta A, 2005, BRIT J OPHTHALMOL, V89, P825, DOI 10.1136/bjo.2004.060590
   Chae S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003266
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Daum B, 2013, P NATL ACAD SCI USA, V110, P15301, DOI 10.1073/pnas.1305462110
   DEAK II, 1977, J MORPHOL, V153, P307, DOI 10.1002/jmor.1051530209
   Demontis F, 2013, DIS MODEL MECH, V6, P1339, DOI 10.1242/dmm.012559
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011
   Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Jacobs HT, 2003, HUM MOL GENET, V12, pR293, DOI 10.1093/hmg/ddg285
   Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320
   Klein P, 2014, EMBO J, V33, P341, DOI 10.1002/embj.201284290
   Klose J, 1999, ELECTROPHORESIS, V20, P643
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   Meiklejohn CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003238
   Montooth KL, 2010, EVOLUTION, V64, P3364, DOI 10.1111/j.1558-5646.2010.01077.x
   Moreno-Loshuertos R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001379
   ODONNELL PT, 1989, GENE DEV, V3, P1233, DOI 10.1101/gad.3.8.1233
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   PECKHAM M, 1990, J MUSCLE RES CELL M, V11, P203, DOI 10.1007/BF01843574
   Perli E, 2014, EMBO MOL MED, V6, P169, DOI 10.1002/emmm.201303198
   Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095
   Pulkes T, 2000, NEUROLOGY, V55, P1210, DOI 10.1212/WNL.55.8.1210
   Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003
   Rand DM, 2006, GENETICS, V172, P329, DOI 10.1534/genetics.105.046698
   Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146
   Rhodenizer D, 2008, EXP GERONTOL, V43, P739, DOI 10.1016/j.exger.2008.04.011
   Riley LG, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-193
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147
   Sacktor B, 1976, Biochem Soc Symp, P111
   Saini N, 2011, MOL CELL BIOL, V31, P2151, DOI 10.1128/MCB.05207-11
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schriner SE, 2009, FREE RADICAL RES, V43, P836, DOI 10.1080/10715760903089724
   SHAFIQ SA, 1963, J CELL BIOL, V17, P351, DOI 10.1083/jcb.17.2.351
   Shahni R, 2013, AM J MED GENET A, V161, P2334, DOI 10.1002/ajmg.a.36065
   Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385
   Suarez RK, 1996, P NATL ACAD SCI USA, V93, P12616, DOI 10.1073/pnas.93.22.12616
   Suarez RK, 2000, PHYSIOL BIOCHEM ZOOL, V73, P765, DOI 10.1086/318112
   Sugiyama S, 2007, GENETICS, V176, P927, DOI 10.1534/genetics.107.072074
   Toivonen JM, 2001, GENETICS, V159, P241
   Tran Hornig-Do H., 2014, EMBO MOL MED, V6, P183
   Vartiainen S, 2014, DIS MODEL MECH, V7, P635, DOI 10.1242/dmm.016527
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   Yen MY, 2002, BRIT J OPHTHALMOL, V86, P1027, DOI 10.1136/bjo.86.9.1027
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhu CT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004354
NR 61
TC 30
Z9 36
U1 1
U2 15
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 1754-8403
EI 1754-8411
J9 DIS MODEL MECH
JI Dis. Model. Mech.
PD AUG
PY 2015
VL 8
IS 8
BP 843
EP U530
DI 10.1242/dmm.019323
PG 23
WC Cell Biology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Pathology
GA CN3DD
UT WOS:000358303200008
PM 26035388
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Vladutiu, GD
AF Vladutiu, Georgirene D.
TI Genetic predisposition to statin myopathy
SO CURRENT OPINION IN RHEUMATOLOGY
LA English
DT Review
DE carnitine palmitoyltransferase II deficiency; coenzyme Q10; cytochrome
   P-450; genetic predisposition; McArdle disease; muscle disease;
   pharmacogenetics; pharmacogenomics; rhabdomyolysis; statin myopathy
ID ADVERSE DRUG-REACTIONS; SLCO1B1 POLYMORPHISM; SKELETAL-MUSCLE;
   RISK-FACTORS; PHARMACOGENOMICS; COENZYME-Q10; MUTATIONS; ATORVASTATIN;
   DEFICIENCY; THERAPY
AB Purpose of review Genetic predisposition to statin myopathy is a rapidly expanding area of investigation. This review summarizes the latest information on genetic risk factors associated with statin-induced myopathy. Genetic determinants involved in both pharmacokinetics of statins and metabolic muscle diseases are discussed. Data are provided on the prevalence of statin use in the United States; incidence of associated myopathy; terminology relating to statin myopathy and genetic susceptibility; and common myths surrounding this disorder.
   Recent findings Technological advances now make it possible to identify genetic variation in the human genome that reveals disease-causing mutations and single nucleotide polymorphisms associated with disease. More than 30 000 individuals in the United States suffer from severe life-threatening symptoms of statin-induced myopathy that may, in some cases, persist long after the cessation of therapy. Genes of interest include those involved in the pharmacokinetics of the statin response, muscle atrophy, exercise intolerance, pain perception, and mitochondrial energy metabolism.
   Summary Genetic analysis for variants and disease-causing mutations relevant to statin myopathy will provide predisposition testing for this and other drug-induced disorders. This testing will become an integral part of personalized medicine that will contribute to the safe and informed use of selected drugs and improved compliance.
C1 [Vladutiu, Georgirene D.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Pediat Neurol & Pathol, Buffalo, NY 14260 USA.
   [Vladutiu, Georgirene D.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Anat Sci, Buffalo, NY 14260 USA.
C3 State University of New York (SUNY) System; University at Buffalo, SUNY;
   State University of New York (SUNY) System; University at Buffalo, SUNY
RP Vladutiu, GD (corresponding author), Buffalo Gen Hosp, 100 High St, Buffalo, NY 14203 USA.
EM gdv@buffalo.edu
CR Ansell BJ, 2006, AM HEART J, V152, P976, DOI 10.1016/j.ahj.2006.05.013
   Baer AN, 2007, CURR OPIN RHEUMATOL, V19, P67
   Baker SK, 2008, CAN J NEUROL SCI, V35, P8, DOI 10.1017/S0317167100007514
   Bays H, 2006, AM J CARDIOL, V97, p6C, DOI 10.1016/j.amjcard.2005.12.006
   Capasso M, 2006, MUSCLE NERVE, V33, P760, DOI 10.1002/mus.20525
   Casarin A, 2008, BIOCHEM BIOPH RES CO, V372, P35, DOI 10.1016/j.bbrc.2008.04.172
   Caso G, 2007, AM J CARDIOL, V99, P1409, DOI 10.1016/j.amjcard.2006.12.063
   Chan J, 2005, ANN PHARMACOTHER, V39, P1611, DOI 10.1345/aph.1G035
   Christopher-Stine L, 2006, CURR OPIN RHEUMATOL, V18, P647
   Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184
   DiMauro S, 2007, J CLIN INVEST, V117, P587, DOI 10.1172/JCI31423
   Draeger A, 2006, J PATHOL, V210, P94, DOI 10.1002/path.2018
   Frudakis TN, 2007, PHARMACOGENET GENOM, V17, P695, DOI 10.1097/FPC.0b013e328012d0a9
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585
   Guis S, 2006, ARTHRIT RHEUM-ARTHR, V55, P551, DOI 10.1002/art.22100
   Haller RG, 2000, ARCH NEUROL-CHICAGO, V57, P923, DOI 10.1001/archneur.57.7.923
   Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741
   Harper CR, 2007, CURR OPIN LIPIDOL, V18, P401, DOI 10.1097/MOL.0b013e32825a6773
   Kawashiri MA, 2008, CLIN PHARMACOL THER, V83, P731, DOI 10.1038/sj.clpt.6100396
   Kollek R, 2006, COMMUNITY GENET, V9, P50, DOI 10.1159/000090693
   König J, 2006, N-S ARCH PHARMACOL, V372, P432, DOI 10.1007/s00210-006-0040-y
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010
   Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   Mangravite LM, 2007, CURR OPIN LIPIDOL, V18, P409
   Marcoff L, 2007, J AM COLL CARDIOL, V49, P2231, DOI 10.1016/j.jacc.2007.02.049
   McKenney JM, 2006, AM J CARDIOL, V97, p89C, DOI 10.1016/j.amjcard.2006.02.030
   *MED EXP PAN SURV, 2005, AG HEALTHC RES QUAL
   Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089
   Needham M, 2007, NEUROMUSCULAR DISORD, V17, P194, DOI 10.1016/j.nmd.2006.10.007
   Niemi M, 2006, CLIN PHARMACOL THER, V80, P356, DOI 10.1016/j.clpt.2006.06.010
   Oh J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-7
   Pasanen MK, 2007, CLIN PHARMACOL THER, V82, P726, DOI 10.1038/sj.clpt.6100220
   Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2
   Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Rodrigues AC, 2007, CURR OPIN MOL THER, V9, P545
   Ross CJD, 2007, ANN NY ACAD SCI, V1110, P177, DOI 10.1196/annals.1423.020
   Ruaño G, 2005, PHARMACOGENOMICS, V6, P865, DOI 10.2217/14622416.6.8.865
   Ruaño G, 2007, MUSCLE NERVE, V36, P329, DOI 10.1002/mus.20871
   Sailler L, 2008, ANN RHEUM DIS, V67, P614, DOI 10.1136/ard.2007.075523
   Schmitz G, 2007, CURR OPIN LIPIDOL, V18, P164, DOI 10.1097/MOL.0b013e3280555083
   Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078
   Shek A, 2001, ANN PHARMACOTHER, V35, P908, DOI 10.1345/aph.10315
   Shurin SB, 2008, NEW ENGL J MED, V358, P1061, DOI 10.1056/NEJMe0800801
   Thompson PD, 2006, AM J CARDIOL, V97, p69C, DOI 10.1016/j.amjcard.2005.12.013
   Vladutiu G, 2007, ARTHRIT RHEUM-ARTHR, V57, P186, DOI 10.1002/art.22487
   Vladutiu GD, 2006, MUSCLE NERVE, V34, P153, DOI 10.1002/mus.20567
   Wilke RA, 2007, NAT REV DRUG DISCOV, V6, P904, DOI 10.1038/nrd2423
NR 51
TC 58
Z9 63
U1 1
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8711
EI 1531-6963
J9 CURR OPIN RHEUMATOL
JI Curr. Opin. Rheumatol.
PD NOV
PY 2008
VL 20
IS 6
BP 648
EP 655
DI 10.1097/BOR.0b013e328314b7b4
PG 8
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA 374LW
UT WOS:000261045900002
PM 18946323
DA 2024-11-01
ER

PT J
AU Ma, L
   Mao, W
   Xu, EH
   Cai, YN
   Wang, CD
   Chhetri, JK
   Chan, P
AF Ma, Lin
   Mao, Wei
   Xu, Erhe
   Cai, Yanning
   Wang, Chaodong
   Chhetri, Jagadish K.
   Chan, Piu
TI Novel <i>POLG</i> mutation in a patient with early-onset parkinsonism,
   progressive external ophthalmoplegia and optic atrophy
SO INTERNATIONAL JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE POLG; parkinsonism; external ophthalmoplegia; optic atrophy
ID POLYMERASE
AB Introduction: Mitochondrial DNA polymerase gamma (pol gamma) encoded by POLG plays an indispensable role in the process of mitochondrial DNA replication and repair. The mutation of POLG can result in mitochondrial dysfunction leading to a broad spectrum of disease. Methods: We report a 29-year-old Chinese female presented with levodopa-responsive parkinsonism, external ophthalmoplegia and optic atrophy. We conducted clinical, molecular iconographic, histological and genetic analyses on this patient. Results: Sequencing of the POLG gene revealed compound heterozygote mutations of a novel c.2693T > C (p.I898T) mutation in exon17 and c.2993C > T (p.S998L) in exon19. The mutation c.2693T > C (p.I898T) has never been reported. Also our patient's cardinal symptoms are rare and different from other cases which have been reported. Conclusion: This finding of ours has broadened the spectrum of phenotype caused by the mutation of POLG.
C1 [Ma, Lin; Mao, Wei; Xu, Erhe; Cai, Yanning; Wang, Chaodong; Chhetri, Jagadish K.; Chan, Piu] Capital Med Univ, Beijing Inst Brain Disorders, Dept Neurol Neurobiol & Geriatr, Xuanwu Hosp, Beijing, Peoples R China.
   [Chan, Piu] Capital Med Univ, Clin Ctr Parkinsons Dis, Beijing, Peoples R China.
   [Chan, Piu] Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China.
   [Chan, Piu] Natl Clin Res Ctr Geriatr, Beijing, Peoples R China.
C3 Capital Medical University; Capital Medical University
RP Chan, P (corresponding author), 45 Changchun St, Beijing 100053, Peoples R China.
EM pbchan90@gmail.com
RI Chhetri, Jagadish k/A-4892-2019
OI Chhetri, Jagadish k/0000-0002-8053-4429
FU Beijing Municipal Administration of Hospitals' Mission Plan
   [SML20150803]; Beijing Municipal Science & Technology Commission
   [Z161100000216140, Z171100000117013]; Beijing Municipal commission of
   Health and Family Planning [PXM2018_026283_000002]
FX This research was supported by Beijing Municipal Administration of
   Hospitals' Mission Plan (Code: SML20150803), Beijing Municipal Science &
   Technology Commission (Nos. Z161100000216140, Z171100000117013) and
   Beijing Municipal commission of Health and Family Planning (No.
   PXM2018_026283_000002).
CR Bandettini di Poggio Monica, 2013, BMC Med Genet, V14, P105, DOI 10.1186/1471-2350-14-105
   Batabyal D, 2010, J BIOL CHEM, V285, P34191, DOI 10.1074/jbc.M110.156182
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   Delgado-Alvarado M, 2015, J NEUROL SCI, V350, P93, DOI 10.1016/j.jns.2015.02.011
   Dolhun R, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-92
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Martikainen MH, 2010, BMJ CASE REP, V2010
   Milone M, 2011, ARCH NEUROL-CHICAGO, V68, P806, DOI 10.1001/archneurol.2011.124
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
NR 10
TC 9
Z9 10
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0020-7454
EI 1563-5279
J9 INT J NEUROSCI
JI Int. J. Neurosci.
PD APR 2
PY 2020
VL 130
IS 4
BP 319
EP 321
DI 10.1080/00207454.2019.1681422
EA OCT 2019
PG 3
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA KW6MO
UT WOS:000494993800001
PM 31613174
DA 2024-11-01
ER

PT J
AU Leshinsky-Silver, E
   Lev, D
   Malinger, G
   Shapira, D
   Cohen, S
   Lerman-Sagie, T
   Saada, A
AF Leshinsky-Silver, Esther
   Lev, Dorit
   Malinger, Gustavo
   Shapira, Daniel
   Cohen, Sarit
   Lerman-Sagie, Tally
   Saada, Ann
TI Leigh disease presenting in utero due to a novel missense mutation in
   the mitochondrial DNA-ND3
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Mitochondria; Respiratory chain; Leigh syndrome; mtDNA; ND3
ID RESPIRATORY-CHAIN DEFICIENCY; DNA G13513A MUTATION; COMPLEX-I; ND3 GENE;
   TRNA(TRP) GENE; ENCEPHALOPATHY; CHILDHOOD; INSERTION; CHILDREN
AB Leigh syndrome can be caused by defects in both nuclear and mitochondrial genes involved in energy metabolism. Recently, an increasing number of mutations in mitochondrial DNA encoding regions, especially in NADH dehydrogenase (respiratory chain complex I) subunits, have been reported as causative of early onset Leigh syndrome.
   We describe a patient whose fetal brain ultrasound demonstrated periventricular pseudocyst suggestive of a possible mitochondrial disorder who presented postnatally with Leigh syndrome. A muscle biopsy demonstrated a partial decrease in complex I and pyruvate dehydrogenase (PDH-E1 alpha) activity.
   Sequencing of the PDH-E1 alpha gene did not reveal any mutation. Sequencing of the mtDNA revealed a novel heteroplasmic G10254A (D66N) mutation in the ND3 gene. This change results in a substitution of aspartic acid to asparagine in a highly conserved domain of the ND3 subunit. The mutation could not be detected in the mother's blood or urine sediment.
   Blue native gel electrophoresis of muscle mitochondria revealed a normal size, albeit a decreased level of complex I.
   The G10254A substitution in the mtDNA-ND3 gene is another cause of maternally inherited Leigh syndrome. This case demonstrates that periventricular pseudocysts may be the initial in utero presentation in patients with mitochondrial disorders. We emphasize the importance of screening the mtDNA in pediatric patients as the first step in molecular diagnosis of Leigh syndrome. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Leshinsky-Silver, Esther; Cohen, Sarit] Wolfson Med Ctr, Mol Genet Lab, Holon, Israel.
   [Leshinsky-Silver, Esther; Cohen, Sarit] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.
   [Leshinsky-Silver, Esther; Lev, Dorit; Lerman-Sagie, Tally] Wolfson Med Ctr, Mitochondrial Dis Ctr, Holon, Israel.
   [Lev, Dorit] Wolfson Med Ctr, Inst Med Genet, Holon, Israel.
   [Lev, Dorit; Malinger, Gustavo; Lerman-Sagie, Tally] Wolfson Med Ctr, Dept Obstet & Gynecol, Prenatal Diag Unit, Fetal Neurol Clin, Holon, Israel.
   [Shapira, Daniel; Lerman-Sagie, Tally] Wolfson Med Ctr, Pediat Neurol Unit, Holon, Israel.
   [Saada, Ann] Hadassah Hebrew Univ, Med Ctr, Dept Genet & Metab Dis, Jerusalem, Israel.
C3 Tel Aviv University; Hebrew University of Jerusalem; Hadassah University
   Medical Center
RP Leshinsky-Silver, E (corresponding author), Wolfson Med Ctr, Mol Genet Lab, Holon, Israel.
EM leshinsky@wolfson.health.gov.il
RI Lerman-Sagie, Tally/AAY-7598-2021; Saada, Ann/J-6864-2017
OI Lerman-Sagie, Tally/0000-0001-6641-6875; Malinger,
   Gustavo/0000-0003-0864-206X; Saada, Ann/0000-0003-2951-0656
CR Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200
   BACH MR, 2009, FETAL DIAGN THER, V25, P177
   Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023
   Chae JH, 2007, PEDIATR RES, V61, P622, DOI 10.1203/pdr.0b013e3180459f2d
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Gire C, 2002, CHILD NERV SYST, V18, P621, DOI 10.1007/s00381-002-0621-0
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Komaki H, 2003, MITOCHONDRION, V2, P293, DOI 10.1016/S1567-7249(03)00003-5
   Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Leshinsky-Silver E, 2005, BIOCHEM BIOPH RES CO, V334, P582, DOI 10.1016/j.bbrc.2005.06.134
   Leshinsky-Silver E, 2009, MOL GENET METAB, V97, P185, DOI 10.1016/j.ymgme.2009.03.002
   Lim BC, 2009, J CHILD NEUROL, V24, P828, DOI 10.1177/0883073808331085
   Malinger G, 2002, ULTRASOUND OBST GYN, V20, P447, DOI 10.1046/j.1469-0705.2002.00840.x
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Naess K, 2009, BBA-BIOENERGETICS, V1787, P484, DOI 10.1016/j.bbabio.2008.11.014
   Papa S, 2008, BBA-BIOENERGETICS, V1777, P719, DOI 10.1016/j.bbabio.2008.04.005
   Prasad AN, 2009, CLIN PERINATOL, V36, P621, DOI 10.1016/j.clp.2009.06.004
   Reisch AS, 2007, METHOD CELL BIOL, V80, P199, DOI 10.1016/S0091-679X(06)80010-5
   Remacle C, 2008, MOL GENET GENOMICS, V280, P93, DOI 10.1007/s00438-008-0350-5
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   Taylor RW, 2002, EUR J HUM GENET, V10, P141, DOI 10.1038/sj.ejhg.5200773
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Tsao CY, 2003, J CHILD NEUROL, V18, P62, DOI 10.1177/08830738030180011401
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
   Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262
   Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071
   Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407
   von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6
NR 40
TC 20
Z9 22
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD MAY
PY 2010
VL 100
IS 1
BP 65
EP 70
DI 10.1016/j.ymgme.2010.02.002
PG 6
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 587IO
UT WOS:000276984700012
PM 20202874
DA 2024-11-01
ER

PT J
AU Schneider, AM
   ÖOzsoy, M
   Zimmermann, FA
   Feichtinger, RG
   Mayr, JA
   Kofler, B
   Sperl, W
   Weghuber, D
   Mörwald, K
AF Schneider, Anna M.
   Ozsoy, Mihriban
   Zimmermann, Franz A.
   Feichtinger, Rene G.
   Mayr, Johannes A.
   Kofler, Barbara
   Sperl, Wolfgang
   Weghuber, Daniel
   Moerwald, Katharina
TI Age-Related Deterioration of Mitochondrial Function in the Intestine
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Review
ID CYTOCHROME-C-OXIDASE; RESPIRATORY-CHAIN FUNCTION; OXIDATIVE STRESS;
   SKELETAL-MUSCLE; DNA MUTATIONS; FRAILTY SYNDROME; POINT MUTATIONS;
   STEM-CELLS; COMPLEX-I; DELETIONS
AB Aging is an important and inevitable biological process in human life, associated with the onset of chronic disease and death. The mechanisms behind aging remain unclear. However, changes in mitochondrial function and structure, including reduced activity of the mitochondrial respiratory chain and increased production of reactive oxygen species-thus oxidative damage-are believed to play a major role. Mitochondria are the main source of cellular energy, producing adenosine triphosphate (ATP) via oxidative phosphorylation. Accumulation of damaged cellular components reduces a body's capacity to preserve tissue homeostasis and affects biological aging and all age-related chronic conditions. This includes the onset and progression of classic degenerative diseases such as cardiovascular disease, kidney failure, neurodegenerative diseases, and cancer. Clinical manifestations of intestinal disorders, such as mucosal barrier dysfunction, intestinal dysmotility, and chronic obstipation, are highly prevalent in the elderly population and have been shown to be associated with an age-dependent decline of mitochondrial function. This review summarizes our current understanding of the role of mitochondrial dysfunction in intestinal aging.
C1 [Schneider, Anna M.; Ozsoy, Mihriban; Zimmermann, Franz A.; Feichtinger, Rene G.; Mayr, Johannes A.; Kofler, Barbara; Sperl, Wolfgang; Weghuber, Daniel; Moerwald, Katharina] Paracelsus Med Univ, Dept Pediat, Salzburg, Austria.
   [Zimmermann, Franz A.; Feichtinger, Rene G.; Kofler, Barbara] Paracelsus Med Univ, Dept Pediat, Res Program Receptor Biochem & Tumor Metab, Salzburg, Austria.
C3 Paracelsus Private Medical University; Paracelsus Private Medical
   University
RP Weghuber, D (corresponding author), Paracelsus Med Univ, Dept Pediat, Salzburg, Austria.
EM d.weghuber@salk.at
RI Weghuber, Daniel/AAN-1422-2020
OI Mayr, Johannes/0000-0001-6970-336X; Kofler, Barbara/0000-0002-1198-4776;
   Weghuber, Daniel/0000-0002-4389-0379
FU "Association for Pediatric Research and Education," University Hospital
   of Pediatrics, Paracelsus Medical University, Salzburg, Austria
FX This work was supported by the "Association for Pediatric Research and
   Education," University Hospital of Pediatrics, Paracelsus Medical
   University, Salzburg, Austria, in terms of language editing and
   publication costs.
CR Acín-Pérez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8
   Acín-Pérez R, 2020, METHOD CELL BIOL, V155, P181, DOI 10.1016/bs.mcb.2019.12.002
   Acin-Pérez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x
   ANTONERXLEBEN F, 1983, MECH AGEING DEV, V23, P265, DOI 10.1016/0047-6374(83)90027-1
   Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8
   Beltrán B, 2010, INFLAMM BOWEL DIS, V16, P76, DOI 10.1002/ibd.21027
   Bertram R, 2006, J THEOR BIOL, V243, P575, DOI 10.1016/j.jtbi.2006.07.019
   Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389
   Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Canugovi C, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101288
   Chalmers S, 2016, J PHYSIOL-LONDON, V594, P4283, DOI 10.1113/JP271942
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen XJ, 2013, MICROBIOL MOL BIOL R, V77, P476, DOI 10.1128/MMBR.00007-13
   Chistiakov DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238463
   Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   da Costa JP, 2016, AGEING RES REV, V29, P90, DOI 10.1016/j.arr.2016.06.005
   Dakubo GD, 2010, MITOCHONDRIAL GENETICS AND CANCER, P321, DOI 10.1007/978-3-642-11416-8_14
   Deepa SS, 2017, GEROSCIENCE, V39, P187, DOI 10.1007/s11357-017-9975-9
   Di Sabatino A, 2018, DIGEST LIVER DIS, V50, P533, DOI 10.1016/j.dld.2018.03.010
   Din S, 2014, CIRC RES, V115, P376, DOI 10.1161/CIRCRESAHA.115.304441
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   England K, 2017, EUR J PUBLIC HEALTH, V27, P9, DOI 10.1093/eurpub/ckx159
   Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, pG914, DOI 10.1152/ajpgi.00402.2011
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gidwaney NG, 2016, J CLIN GASTROENTEROL, V50, P819, DOI 10.1097/MCG.0000000000000650
   Greaves LC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003082
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Gruber J, 2008, FRONT BIOSCI-LANDMRK, V13, P6554, DOI 10.2741/3174
   Guha M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206897
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Horvath R, 2009, J NEUROL, V256, P810, DOI 10.1007/s00415-009-5023-8
   HSIEH RH, 1994, BIOCHEM MOL BIOL INT, V32, P1009
   Inglés M, 2014, J AM GERIATR SOC, V62, P1324, DOI 10.1111/jgs.12876
   Kim MJ, 2019, EXP GERONTOL, V125, DOI 10.1016/j.exger.2019.110675
   Kozlov AV, 2005, BBA-MOL BASIS DIS, V1740, P382, DOI 10.1016/j.bbadis.2004.11.004
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14
   Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106
   Lefai E, 1997, BBA-BIOENERGETICS, V1318, P191, DOI 10.1016/S0005-2728(96)00136-3
   Letts JA, 2019, MOL CELL, V75, P1131, DOI 10.1016/j.molcel.2019.07.022
   Letts JA, 2017, NAT STRUCT MOL BIOL, V24, P800, DOI 10.1038/nsmb.3460
   Lobo-Jarne T, 2020, EMBO J, V39, DOI 10.15252/embj.2019103912
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lowes DA, 2013, BRIT J ANAESTH, V110, P472, DOI 10.1093/bja/aes577
   Man AL, 2015, CLIN SCI, V129, P515, DOI 10.1042/CS20150046
   McQuade RM, 2016, BRIT J PHARMACOL, V173, P3502, DOI 10.1111/bph.13646
   Mellem D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174469
   Michielan A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/628157
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Mitchell EL, 2017, J NUTR HEALTH AGING, V21, P354, DOI 10.1007/s12603-016-0725-y
   Moher D, 2015, SYST REV-LONDON, V4, DOI [10.1371/journal.pmed.1000097, 10.1186/2046-4053-4-1, 10.1016/j.ijsu.2010.07.299, 10.1136/bmj.i4086, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2700, 10.1136/bmj.b2535]
   Mohler MJ, 2014, EXP GERONTOL, V54, P6, DOI 10.1016/j.exger.2014.01.024
   Moore AZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011069
   Moorefield EC, 2017, AGING-US, V9, P1898, DOI 10.18632/aging.101279
   Mora AL, 2017, J CLIN INVEST, V127, P405, DOI 10.1172/JCI87440
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Nagarajan P, 2019, AGING CELL, V18, DOI 10.1111/acel.12992
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nooteboom M, 2010, AGING CELL, V9, P96, DOI 10.1111/j.1474-9726.2009.00531.x
   O'Mahoney D, 2002, DRUG AGING, V19, P515, DOI 10.2165/00002512-200219070-00005
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Olgar Y, 2018, EXP GERONTOL, V110, P172, DOI 10.1016/j.exger.2018.06.012
   Özsoy M, 2020, EXP GERONTOL, V135, DOI 10.1016/j.exger.2020.110924
   Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200
   Regmi SG, 2014, AGING-US, V6, P118, DOI 10.18632/aging.100639
   Reichart G, 2019, ACTA PHYSIOL, V225, DOI 10.1111/apha.13214
   Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008
   Rybka V, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8060171
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Savitha S, 2006, MECH AGEING DEV, V127, P349, DOI 10.1016/j.mad.2005.12.004
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Schiavi A, 2014, EXP GERONTOL, V56, P147, DOI 10.1016/j.exger.2014.02.015
   Sedelnikova OA, 2010, MUTAT RES-REV MUTAT, V704, P152, DOI 10.1016/j.mrrev.2009.12.005
   Serviddio G, 2009, INT J IMMUNOPATH PH, V22, P819, DOI 10.1177/039463200902200328
   Sifroni KG, 2010, MOL CELL BIOCHEM, V342, P111, DOI 10.1007/s11010-010-0474-x
   Stahon KE, 2016, J NEUROSCI, V36, P9990, DOI 10.1523/JNEUROSCI.1316-16.2016
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Szeto HH, 2018, ARCH BIOCHEM BIOPHYS, V660, P137, DOI 10.1016/j.abb.2018.10.013
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Troen BR, 2003, MT SINAI J MED, V70, P3
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Tsurudome Y, 2001, J GERONTOL A-BIOL, V56, pB483, DOI 10.1093/gerona/56.11.B483
   Tuo BG, 2012, AM J PHYSIOL-GASTR L, V303, pG1312, DOI 10.1152/ajpgi.00035.2012
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   Vasileiou PVS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081821
   Vásquez-Trincado C, 2016, J PHYSIOL-LONDON, V594, P509, DOI 10.1113/JP271301
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Viña J, 2018, FREE RADICAL BIO MED, V124, P358, DOI 10.1016/j.freeradbiomed.2018.06.028
   Vissing J, 2002, NEUROLOGY, V59, P926, DOI 10.1212/WNL.59.6.926
   Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Walston J, 2008, J GERONTOL A-BIOL, V63, P391, DOI 10.1093/gerona/63.4.391
   Wu IC, 2009, J AM GERIATR SOC, V57, P1666, DOI 10.1111/j.1532-5415.2009.02392.x
   Xue X, 2017, P NATL ACAD SCI USA, V114, pE9608, DOI 10.1073/pnas.1712946114
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
   Zeki SS, 2011, NAT REV GASTRO HEPAT, V8, P90, DOI 10.1038/nrgastro.2010.211
   Zhang XY, 2010, HEPATOLOGY, V52, P2137, DOI 10.1002/hep.23909
   ZsNagy I, 1997, J MOL MED, V75, P703
NR 117
TC 11
Z9 11
U1 0
U2 13
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD AUG 19
PY 2020
VL 2020
AR 4898217
DI 10.1155/2020/4898217
PG 12
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Cell Biology
GA NL0QN
UT WOS:000567130800001
PM 32922652
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Euro, L
   Farnum, GA
   Palin, E
   Suomalainen, A
   Kaguni, LS
AF Euro, Liliya
   Farnum, Gregory A.
   Palin, Eino
   Suomalainen, Anu
   Kaguni, Laurie S.
TI Clustering of Alpers disease mutations and catalytic defects in
   biochemical variants reveal new features of molecular mechanism of the
   human mitochondrial replicase, Pol γ
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; VIRION
   RNA-POLYMERASE; ACCESSORY SUBUNIT; STRUCTURAL BASIS;
   SACCHAROMYCES-CEREVISIAE; MULTIPLE DELETIONS; CRYSTAL-STRUCTURE;
   ESCHERICHIA-COLI; W748S MUTATION
AB Mutations in Pol gamma represent a major cause of human mitochondrial diseases, especially those affecting the nervous system in adults and in children. Recessive mutations in Pol gamma represent nearly half of those reported to date, and they are nearly uniformly distributed along the length of the POLG1 gene (Human DNA Polymerase gamma Mutation Database); the majority of them are linked to the most severe form of POLG syndrome, Alpers-Huttenlocher syndrome. In this report, we assess the structure-function relationships for recessive disease mutations by reviewing existing biochemical data on site-directed mutagenesis of the human, Drosophila and yeast Pol gamma s, and their homologs from the family A DNA polymerase group. We do so in the context of a molecular model of Pol gamma in complex with primer-template DNA, which we have developed based upon the recently solved crystal structure of the apoenzyme form. We present evidence that recessive mutations cluster within five distinct functional modules in the catalytic core of Pol gamma. Our results suggest that cluster prediction can be used as a diagnosis-supporting tool to evaluate the pathogenic role of new Pol gamma variants.
C1 [Farnum, Gregory A.; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
   [Farnum, Gregory A.; Kaguni, Laurie S.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA.
   [Euro, Liliya; Palin, Eino; Suomalainen, Anu] Univ Helsinki, Biomedicum Helsinki, Res Programs Unit, FIN-00290 Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.
C3 Michigan State University; Michigan State University; University of
   Helsinki; University of Helsinki; Helsinki University Central Hospital
RP Kaguni, LS (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
EM lskaguni@msu.edu
RI ; Liliya, Euro/F-3808-2015
OI Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Farnum,
   Gregory/0000-0002-0192-8252; Liliya, Euro/0000-0001-9705-3886
FU National Institutes of Health [GM45295]; Academy of Finland; University
   of Helsinki; Jane, and Aatos Erkko Foundation; Sigrid Juselius
   Foundation
FX National Institutes of Health (GM45295 to L. S. K.); Academy of Finland,
   University of Helsinki, Jane, and Aatos Erkko Foundation and Sigrid
   Juselius Foundation (to A. S.). Funding for open access charge: National
   Institutes of Health (GM45295 to L. S. K.).
CR Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565
   Baqri RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007874
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2011, MITOCHONDRION, V11, P182, DOI 10.1016/j.mito.2010.09.007
   Baruffini E, 2010, MITOCHONDRION, V10, P183, DOI 10.1016/j.mito.2009.10.002
   Berdis AJ, 2009, CHEM REV, V109, P2862, DOI 10.1021/cr800530b
   Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Doublié S, 1998, NATURE, V391, P251, DOI 10.1038/34593
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Gleghorn ML, 2008, MOL CELL, V32, P707, DOI 10.1016/j.molcel.2008.11.010
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Iyengar B, 1999, GENETICS, V153, P1809
   Jeruzalmi D, 1998, EMBO J, V17, P4101, DOI 10.1093/emboj/17.14.4101
   Jin ZN, 2011, J BIOL CHEM, V286, P1312, DOI 10.1074/jbc.M110.156737
   Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006
   Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Lee HR, 2008, J BIOL CHEM, V283, P14411, DOI 10.1074/jbc.M705006200
   Lee HR, 2008, J BIOL CHEM, V283, P14402, DOI 10.1074/jbc.M705007200
   Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283
   Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Murakami KS, 2008, P NATL ACAD SCI USA, V105, P5046, DOI 10.1073/pnas.0712325105
   Naviaux RK, 2005, ANN NEUROL, V58, P491, DOI 10.1002/ana.20544
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Palin EJH, 2010, BBA-MOL BASIS DIS, V1802, P545, DOI 10.1016/j.bbadis.2010.02.003
   POLESKY AH, 1992, J BIOL CHEM, V267, P8417
   POLESKY AH, 1990, J BIOL CHEM, V265, P14579
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 51
TC 38
Z9 41
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD NOV
PY 2011
VL 39
IS 21
BP 9072
EP 9084
DI 10.1093/nar/gkr618
PG 13
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 852RR
UT WOS:000297375700009
PM 21824913
OA Green Submitted, gold, Green Published
DA 2024-11-01
ER

PT J
AU Lewis, CJ
   Dixit, B
   Batiuk, E
   Hall, CJ
   O'Connor, MS
   Boominathan, A
AF Lewis, Caitlin J.
   Dixit, Bhavna
   Batiuk, Elizabeth
   Hall, Carter J.
   O'Connor, Matthew S.
   Boominathan, Amutha
TI Codon optimization is an essential parameter for the efficient allotopic
   expression of mtDNA genes
SO REDOX BIOLOGY
LA English
DT Article
DE Allotopic expression; Mitochondrial DNA (mtDNA); Mitochondrial disease;
   Gene therapy; Codon optimization; Protein expression; Mitochondrial
   respiratory chain complex; ATP synthase; Gene transfer
ID MITOCHONDRIAL-DNA MUTATIONS; MESSENGER-RNA LOCALIZATION; COMPLEX I
   DEFICIENCY; ATP SYNTHASE; YEAST MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION;
   HARBORING MUTATIONS; DISEASES; IMPORT; PROTEINS
AB Mutations in mitochondrial DNA can be inherited or occur de novo leading to several debilitating myopathies with no curative option and few or no effective treatments. Allotopic expression of recoded mitochondrial genes from the nucleus has potential as a gene therapy strategy for such conditions, however progress in this field has been hampered by technical challenges. Here we employed codon optimization as a tool to re-engineer the protein-coding genes of the human mitochondrial genome for robust, efficient expression from the nucleus. All 13 codon-optimized constructs exhibited substantially higher protein expression than minimally-recoded genes when expressed transiently, and steady-state mRNA levels for optimized gene constructs were 5-180 fold enriched over recoded versions in stably-selected wildtype cells. Eight of thirteen mitochondria-encoded oxidative phosphorylation (OxPhos) proteins maintained protein expression following stable selection, with mitochondrial localization of expression products. We also assessed the utility of this strategy in rescuing mitochondrial disease cell models and found the rescue capacity of allotopic expression constructs to be gene specific. Allotopic expression of codon optimized ATP8 in disease models could restore protein levels and respiratory function, however, rescue of the pathogenic phenotype for another gene, ND1 was only partially successful. These results imply that though codon-optimization alone is not sufficient for functional allotopic expression of most mitochondrial genes, it is an essential consideration in their design.
C1 [Lewis, Caitlin J.; Dixit, Bhavna; Batiuk, Elizabeth; Hall, Carter J.; O'Connor, Matthew S.; Boominathan, Amutha] SENS Res Fdn, Dept Mitochondrial Res, Mountain View, CA 94041 USA.
   [Batiuk, Elizabeth] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97239 USA.
C3 Oregon Health & Science University
RP O'Connor, MS; Boominathan, A (corresponding author), SENS Res Fdn, Dept Mitochondrial Res, Mountain View, CA 94041 USA.
EM matthew.oconnor@sens.org; amutha.boominathan@sens.org
RI Lewis, Caitlin/JFJ-7083-2023; Hall, Carter/HJY-3141-2023
OI Lewis, Caitlin/0000-0001-5521-2607; Dixit, Bhavna/0000-0003-2030-0580;
   O'Connor, Matthew/0000-0003-1997-983X
CR Acín-Pérez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8
   Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Akouchekian M, 2011, J RES MED SCI, V16, P50
   Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200
   Arpa J, 2003, MUSCLE NERVE, V28, P690, DOI 10.1002/mus.10507
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Bietenhader M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002876
   Bokori-Brown M, 2006, REJUV RES, V9, P455, DOI 10.1089/rej.2006.9.455
   Bonnet C, 2008, BBA-MOL CELL RES, V1783, P1707, DOI 10.1016/j.bbamcr.2008.04.018
   Bonnet C, 2007, REJUV RES, V10, P127, DOI 10.1089/rej.2006.0526
   Boominathan A, 2016, NUCLEIC ACIDS RES, V44, P9342, DOI 10.1093/nar/gkw756
   BROWN MD, 1992, AM J HUM GENET, V51, P446
   Calabrese C, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-11
   Campbell A, 1999, P NATL ACAD SCI USA, V96, P9184, DOI 10.1073/pnas.96.16.9184
   Chin RM, 2018, CELL REP, V22, P2818, DOI 10.1016/j.celrep.2018.02.059
   Chinnery PF, 2000, MOL MED TODAY, V6, P425, DOI 10.1016/S1357-4310(00)01805-0
   CLAROS MG, 1995, EUR J BIOCHEM, V228, P762, DOI 10.1111/j.1432-1033.1995.0762m.x
   Cruz-Torres V, 2012, BBA-BIOENERGETICS, V1817, P2128, DOI 10.1016/j.bbabio.2012.09.006
   Cwerman-Thibault H, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.3
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   Eipel C, 2011, LIFE SCI, V88, P343, DOI 10.1016/j.lfs.2010.12.011
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   FARRELL LB, 1988, EUR J BIOCHEM, V173, P131, DOI 10.1111/j.1432-1033.1988.tb13976.x
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   GALANIS M, 1991, FEBS LETT, V282, P425, DOI 10.1016/0014-5793(91)80529-C
   GEARING DP, 1985, BIOCHEM INT, V10, P907
   GEARING DP, 1986, EMBO J, V5, P3651, DOI 10.1002/j.1460-2075.1986.tb04695.x
   Golubitzky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026883
   González-Halphen D, 2004, ANN NY ACAD SCI, V1019, P232, DOI 10.1196/annals.1297.039
   Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   Guy J, 2017, OPHTHALMOLOGY, V124, P1621, DOI 10.1016/j.ophtha.2017.05.016
   Hanson G, 2018, NAT REV MOL CELL BIO, V19, P20, DOI 10.1038/nrm.2017.91
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892
   Inouye S, 2015, PROTEIN EXPRES PURIF, V109, P47, DOI 10.1016/j.pep.2015.02.002
   Iommarini L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030764
   Iommarini L, 2014, HUM MOL GENET, V23, P1453, DOI 10.1093/hmg/ddt533
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   Johnston IG, 2016, CELL SYST, V2, P101, DOI 10.1016/j.cels.2016.01.013
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Kaltimbacher V, 2006, RNA, V12, P1408, DOI 10.1261/rna.18206
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   LAW RHP, 1988, FEBS LETT, V236, P501, DOI 10.1016/0014-5793(88)80086-3
   LAW RHP, 1990, BIOCHIM BIOPHYS ACTA, V1027, P141, DOI 10.1016/0005-2736(90)90077-2
   Lim SC, 2016, FASEB J, V30, P2236, DOI 10.1096/fj.201500137R
   Lu YY, 2017, J NEUROL SCI, V379, P137, DOI 10.1016/j.jns.2017.05.056
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Marella M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025910
   Marella M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011472
   Marella M, 2009, J BIOENERG BIOMEMBR, V41, P493, DOI 10.1007/s10863-009-9249-z
   MARGULIS I, 1970, J THEOR BIOL, V26, P337, DOI 10.1016/S0022-5193(70)80023-6
   Mauro VP, 2018, BIODRUGS, V32, P69, DOI 10.1007/s40259-018-0261-x
   Mauro VP, 2014, TRENDS MOL MED, V20, P604, DOI 10.1016/j.molmed.2014.09.003
   McKenzie M, 2014, HUM MUTAT, V35, P1476, DOI 10.1002/humu.22694
   Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010
   Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015
   NAGLEY P, 1989, TRENDS BIOCHEM SCI, V14, P31, DOI 10.1016/0968-0004(89)90087-X
   NAGLEY P, 1988, P NATL ACAD SCI USA, V85, P2091, DOI 10.1073/pnas.85.7.2091
   Oca-Cossio J, 2003, GENETICS, V165, P707
   Ojaimi J, 2002, MOL BIOL CELL, V13, P3836, DOI 10.1091/mbc.E02-05-0306
   Pasi KJ, 2017, NEW ENGL J MED, V377, P819, DOI [10.1056/NEJMoa1616569, 10.1056/NEJMoa1708483]
   Perales-Clemente E, 2011, NUCLEIC ACIDS RES, V39, P225, DOI 10.1093/nar/gkq769
   Pereira CV, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708084
   Rendón OZ, 2012, HUM MOL GENET, V21, P3815, DOI 10.1093/hmg/dds209
   Roucou X, 1999, EUR J BIOCHEM, V261, P444, DOI 10.1046/j.1432-1327.1999.00289.x
   Rubalcava-Gracia D, 2018, MOL BIOL CELL, V29, P820, DOI 10.1091/mbc.E17-09-0560
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schägger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schröder T, 2016, MOL METAB, V5, P283, DOI 10.1016/j.molmet.2016.01.010
   Seo BB, 2006, J BIOL CHEM, V281, P14250, DOI 10.1074/jbc.M600922200
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Stachyra A, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0599-y
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Supekova L, 2010, P NATL ACAD SCI USA, V107, P5047, DOI 10.1073/pnas.1000735107
   Sylvestre J, 2003, MOL BIOL CELL, V14, P3848, DOI 10.1091/mbc.E03-02-0074
   Tachibana M, 2018, REPROD MED BIOL, V17, P421, DOI 10.1002/rmb2.12230
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Valenci I, 2015, MITOCHONDRION, V20, P64, DOI 10.1016/j.mito.2014.11.001
   Ward NJ, 2011, BLOOD, V117, P798, DOI 10.1182/blood-2010-05-282707
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Webster GR, 2017, BIOTECHNOL BIOENG, V114, P492, DOI 10.1002/bit.26183
   Weiss H, 2012, ENDOCRINOLOGY, V153, P4666, DOI 10.1210/en.2012-1296
   Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200
   Wolf DP, 2017, EMBO J, V36, P2177, DOI 10.15252/embj.201797606
   Yagi T, 2006, REJUV RES, V9, P191, DOI 10.1089/rej.2006.9.191
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
   Yu XH, 2009, HUM MOL GENET, V18, P4689, DOI 10.1093/hmg/ddp432
   Yu X, 2009, GENOME RES, V19, P159, DOI 10.1101/gr.078865.108
   Zhao F, 2017, NUCLEIC ACIDS RES, V45, P8484, DOI 10.1093/nar/gkx501
NR 96
TC 10
Z9 11
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2213-2317
J9 REDOX BIOL
JI Redox Biol.
PD FEB
PY 2020
VL 30
AR 101429
DI 10.1016/j.redox.2020.101429
PG 15
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA KM1PL
UT WOS:000513891900005
PM 31981894
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Xie, HBM
   Perin, JC
   Schurr, TG
   Dulik, MC
   Zhadanov, SI
   Baur, JA
   King, MP
   Place, E
   Clarke, C
   Grauer, M
   Schug, J
   Santani, A
   Albano, A
   Kim, C
   Procaccio, V
   Hakonarson, H
   Gai, XW
   Falk, MJ
AF Xie, Hongbo M.
   Perin, Juan C.
   Schurr, Theodore G.
   Dulik, Matthew C.
   Zhadanov, Sergey I.
   Baur, Joseph A.
   King, Michael P.
   Place, Emily
   Clarke, Colleen
   Grauer, Michael
   Schug, Jonathan
   Santani, Avni
   Albano, Anthony
   Kim, Cecilia
   Procaccio, Vincent
   Hakonarson, Hakon
   Gai, Xiaowu
   Falk, Marni J.
TI Mitochondrial genome sequence analysis: A custom bioinformatics pipeline
   substantially improves Affymetrix MitoChip v2.0 call rate and accuracy
SO BMC BIOINFORMATICS
LA English
DT Article
ID DNA; MICROARRAY; HETEROPLASMY
AB Background: Mitochondrial genome sequence analysis is critical to the diagnostic evaluation of mitochondrial disease. Existing methodologies differ widely in throughput, complexity, cost efficiency, and sensitivity of heteroplasmy detection. Affymetrix MitoChip v2.0, which uses a sequencing-by-genotyping technology, allows potentially accurate and high-throughput sequencing of the entire human mitochondrial genome to be completed in a cost-effective fashion. However, the relatively low call rate achieved using existing software tools has limited the wide adoption of this platform for either clinical or research applications. Here, we report the design and development of a custom bioinformatics software pipeline that achieves a much improved call rate and accuracy for the Affymetrix MitoChip v2.0 platform. We used this custom pipeline to analyze MitoChip v2.0 data from 24 DNA samples representing a broad range of tissue types (18 whole blood, 3 skeletal muscle, 3 cell lines), mutations (a 5.8 kilobase pair deletion and 6 known heteroplasmic mutations), and haplogroup origins. All results were compared to those obtained by at least one other mitochondrial DNA sequence analysis method, including Sanger sequencing, denaturing HPLC-based heteroduplex analysis, and/or the Illumina Genome Analyzer II next generation sequencing platform.
   Results: An average call rate of 99.75% was achieved across all samples with our custom pipeline. Comparison of calls for 15 samples characterized previously by Sanger sequencing revealed a total of 29 discordant calls, which translates to an estimated 0.012% for the base call error rate. We successfully identified 4 known heteroplasmic mutations and 24 other potential heteroplasmic mutations across 20 samples that passed quality control.
   Conclusions: Affymetrix MitoChip v2.0 analysis using our optimized MitoChip Filtering Protocol (MFP) bioinformatics pipeline now offers the high sensitivity and accuracy needed for reliable, high-throughput and cost-efficient whole mitochondrial genome sequencing. This approach provides a viable alternative of potential utility for both clinical diagnostic and research applications to traditional Sanger and other emerging sequencing technologies for whole mitochondrial genome analysis.
C1 [Xie, Hongbo M.; Perin, Juan C.; Grauer, Michael; Gai, Xiaowu] Childrens Hosp Philadelphia, Ctr Informat Biol, Philadelphia, PA 19104 USA.
   [Schurr, Theodore G.; Dulik, Matthew C.; Zhadanov, Sergey I.] Univ Penn, Dept Anthropol, Sch Arts & Sci, Philadelphia, PA 19104 USA.
   [Baur, Joseph A.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [King, Michael P.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.
   [Place, Emily; Clarke, Colleen; Falk, Marni J.] Childrens Hosp Philadelphia, Div Human Genet, Dept Pediat, Philadelphia, PA 19104 USA.
   [Schug, Jonathan] Univ Penn, Computat Biol & Informat Lab, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Santani, Avni] Childrens Hosp Philadelphia, Mol Genet Lab, Dept Pathol, Philadelphia, PA 19104 USA.
   [Albano, Anthony; Kim, Cecilia; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Dept Pediat, Philadelphia, PA 19104 USA.
   [Procaccio, Vincent] Angers Univ Hosp, Dept Biochem & Genet, Sch Med, F-49000 Angers, France.
   [Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Pulm Med, Dept Pediat, Philadelphia, PA 19104 USA.
   [Gai, Xiaowu] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Stritch Sch Med, Maywood, IL 60153 USA.
   [Falk, Marni J.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of
   Philadelphia; University of Pennsylvania; University of Pennsylvania;
   Jefferson University; University of Pennsylvania; Pennsylvania Medicine;
   Childrens Hospital of Philadelphia; University of Pennsylvania;
   University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of
   Philadelphia; University of Pennsylvania; Pennsylvania Medicine;
   Childrens Hospital of Philadelphia; Universite d'Angers; Centre
   Hospitalier Universitaire d'Angers; University of Pennsylvania;
   Pennsylvania Medicine; Childrens Hospital of Philadelphia; Loyola
   University Chicago; University of Pennsylvania
RP Gai, XW (corresponding author), Childrens Hosp Philadelphia, Ctr Informat Biol, Philadelphia, PA 19104 USA.
EM xigai@lumc.edu; falkm@email.chop.edu
RI Baur, Joseph/D-8163-2011; Falk, Marni/K-1997-2014; Hakonarson,
   Hakon/ABZ-4865-2022; Procaccio, Vincent/M-2596-2015; gai,
   Xiaowu/ISA-3238-2023
OI procaccio, Vincent/0000-0002-1537-4684; Xie, Hongbo
   M./0000-0003-2223-0029; gai, Xiaowu/0000-0001-8679-9703; Baur,
   Joseph/0000-0001-8262-6549; Falk, Marni/0000-0002-1723-6728
FU Children's Hospital of Philadelphia Research Institute Mitochondria
   Research Affinity Group; National Institutes of Health [R03-DK082521];
   University of Pennsylvania; Social Sciences and the Humanities Research
   Council of Canada [MCRI 412-2005-1004]
FX We are grateful to Pr. Paquis-Flucklinger, Dr. Valerie Desquiret-Dumas,
   and investigators of the mitochondrial French consortium for
   contributing the sample data for the validation data set. This work was
   funded in part through a Children's Hospital of Philadelphia Research
   Institute Mitochondria Research Affinity Group Pilot and Feasibility
   Award (X.G.), a Grant from the National Institutes of Health
   (R03-DK082521 to M.J.F.), and through support from the University of
   Pennsylvania (T.G.S.), and the Social Sciences and the Humanities
   Research Council of Canada (MCRI 412-2005-1004 to T.G.S.). The content
   is solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health. The
   funding agencies had no role in study design, data analysis or
   interpretation, or manuscript preparation.
CR Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   [Anonymous], 1993, DETECT HANDLE OUTLIE
   Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002
   Behar DM, 2007, PLOS GENET, V3, P1083, DOI 10.1371/journal.pgen.0030104
   Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201
   Hartmann A, 2009, HUM MUTAT, V30, P115, DOI 10.1002/humu.20816
   Leveque M, 2007, EUR J HUM GENET, V15, P1145, DOI 10.1038/sj.ejhg.5201891
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504
   Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666
   Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871
   Pandya GA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm918
   Tang S, 2010, BIOTECHNIQUES, V48, P287, DOI 10.2144/000113389
   Thieme M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-440
   Wang Jing, 2011, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1906s68
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
   Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008
NR 20
TC 19
Z9 22
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD OCT 19
PY 2011
VL 12
AR 402
DI 10.1186/1471-2105-12-402
PG 16
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA 858GT
UT WOS:000297784600001
PM 22011106
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Peter, B
   Waddington, CL
   Oláhová, M
   Sommerville, EW
   Hopton, S
   Pyle, A
   Champion, M
   Ohlson, M
   Siibak, T
   Chrzanowska-Lightowlers, ZMA
   Taylor, RW
   Falkenberg, M
   Lightowlers, RN
AF Peter, Bradley
   Waddington, Christie L.
   Olahova, Monika
   Sommerville, Ewen W.
   Hopton, Sila
   Pyle, Angela
   Champion, Michael
   Ohlson, Monica
   Siibak, Triinu
   Chrzanowska-Lightowlers, Zofia M. A.
   Taylor, Robert W.
   Falkenberg, Maria
   Lightowlers, Robert N.
TI Defective mitochondrial protease LonP1 can cause classical mitochondrial
   disease
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID CODAS SYNDROME; AAA PROTEASE; TRANSCRIPTION FACTOR; COPY NUMBER; DNA;
   MUTATIONS; BINDING; TRANSLOCATION; DEGRADATION; SUBSTRATE
AB LonP1 is a mitochondrial matrix protease whose selective substrate specificity is essential for maintaining mitochondrial homeostasis. Recessively inherited, pathogenic defects in LonP1 have been previously reported to underlie cerebral, ocular, dental, auricular and skeletal anomalies (CODAS) syndrome, a complex multisystemic and developmental disorder. Intriguingly, although classical mitochondrial disease presentations are well-known to exhibit marked clinical heterogeneity, the skeletal and dental features associated with CODAS syndrome are pathognomonic. We have applied whole exome sequencing to a patient with congenital lactic acidosis, muscle weakness, profound deficiencies in mitochondrial oxidative phosphorylation associated with loss of mtDNA copy number and MRI abnormalities consistent with Leigh syndrome, identifying biallelic variants in the LONP1 (NM_004793.3) gene; c.1693T > C predicting p.(Tyr565His) and c.2197G > A predicting p.(Glu733Lys); no evidence of the classical skeletal or dental defects observed in CODAS syndrome patients were noted in our patient. In vitro experiments confirmed the p.(Tyr565His) LonP1 mutant alone could not bind or degrade a substrate, consistent with the predicted function of Tyr565, whilst a second missense [p.(Glu733Lys)] variant had minimal effect. Mixtures of p.(Tyr565His) mutant and wild-type LonP1 retained partial protease activity but this was severely depleted when the p.(Tyr565His) mutant was mixed with the p.(Glu733Lys) mutant, data consistent with the compound heterozygosity detected in our patient. In summary, we conclude that pathogenic LONP1 variants can lead to a classical mitochondrial disease presentations associated with severe biochemical defects in oxidative phosphorylation in clinically relevant tissues.
C1 [Peter, Bradley; Ohlson, Monica; Siibak, Triinu; Falkenberg, Maria] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Gothenburg, Sweden.
   [Waddington, Christie L.; Olahova, Monika; Sommerville, Ewen W.; Hopton, Sila; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Sch Med, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Sommerville, Ewen W.; Chrzanowska-Lightowlers, Zofia M. A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Pyle, Angela] Newcastle Univ, Inst Genet, Sch Med, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Champion, Michael] Guys NHS Fdn Trust, Evelina London Childrens Hosp, Dept Inherited Metab Dis, London, England.
   [Champion, Michael] St Thomas NHS Fdn Trust, Evelina London Childrens Hosp, Dept Inherited Metab Dis, London, England.
   [Lightowlers, Robert N.] Newcastle Univ, Sch Med, Wellcome Ctr Mitochondrial Res, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England.
C3 University of Gothenburg; Newcastle University - UK; Baylor College of
   Medicine; Newcastle University - UK; Guy's & St Thomas' NHS Foundation
   Trust; Newcastle University - UK
RP Lightowlers, RN (corresponding author), Newcastle Univ, Sch Med, Wellcome Ctr Mitochondrial Res, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England.
EM robert.lightowlers@ncl.ac.uk
OI Falkenberg, Maria/0000-0001-8713-173X
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Swedish
   Research Council [2013-3621]; Swedish Cancer Foundation [CAN 2016/816];
   European Research Council; MRC Centre for Neuromuscular Diseases
   [G0601943]; UK NHS Highly Specialized 'Rare Mitochondrial Disorders of
   Adults and Children' Service; Lily Foundation; Medical Research Council
   (MRC); Wellcome; MRC [G0601943] Funding Source: UKRI
FX This study was supported by funding from the Wellcome Centre for
   Mitochondrial Research (203105/Z/16/Z) (R.N.L., Z.M.A.C.L. and R.W.T.)
   and Swedish Research Council grants to M.F. (2013-3621), the Swedish
   Cancer Foundation to M.F. (CAN 2016/816) and the European Research
   Council to M.F. (DELMIT). R.W.T. also receives support from the MRC
   Centre for Neuromuscular Diseases (G0601943), the UK NHS Highly
   Specialized 'Rare Mitochondrial Disorders of Adults and Children'
   Service and the Lily Foundation. R.N.L. and Z.M.A.C.L. would like to
   thank Rawaa Al-Faresi for help with cloning and sequencing. E.W.S. was
   supported by a Medical Research Council (MRC) funded PhD studentship.
   Funding to pay the Open Access publication charges for this article was
   provided by Wellcome.
CR Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7
   Bar-Nun S, 2012, BBA-MOL CELL RES, V1823, P67, DOI 10.1016/j.bbamcr.2011.07.009
   Bota DA, 2016, FREE RADICAL BIO MED, V100, P188, DOI 10.1016/j.freeradbiomed.2016.06.031
   Chen SH, 2008, NUCLEIC ACIDS RES, V36, P1273, DOI 10.1093/nar/gkm1140
   Dikoglu E, 2015, AM J MED GENET A, V167, P1501, DOI 10.1002/ajmg.a.37029
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Farge G, 2014, CELL REP, V8, P66, DOI 10.1016/j.celrep.2014.05.046
   Fu GK, 1998, BIOCHEMISTRY-US, V37, P1905, DOI 10.1021/bi970928c
   Gerdes F, 2012, BBA-MOL CELL RES, V1823, P49, DOI 10.1016/j.bbamcr.2011.09.015
   Graef M, 2006, J STRUCT BIOL, V156, P101, DOI 10.1016/j.jsb.2006.01.009
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012
   Inui T, 2017, J HUM GENET, V62, P653, DOI 10.1038/jhg.2017.11
   Kereïche S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33631
   Khan Arif O, 2015, Trans Am Ophthalmol Soc, V113, pT7
   Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200
   Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503
   Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107
   Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v
   Okuno T, 2006, J STRUCT BIOL, V156, P109, DOI 10.1016/j.jsb.2006.02.003
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   Oppenheim MLS, 2009, J INHERIT METAB DIS, V32, P269, DOI 10.1007/s10545-009-1061-8
   Quirós PM, 2014, CELL REP, V8, P541, DOI 10.1016/j.celrep.2014.06.018
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623
   Strauss KA, 2015, AM J HUM GENET, V96, P121, DOI 10.1016/j.ajhg.2014.12.003
   Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395
   Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200
NR 28
TC 41
Z9 46
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAY 15
PY 2018
VL 27
IS 10
BP 1743
EP 1753
DI 10.1093/hmg/ddy080
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA GF3VX
UT WOS:000431886200006
PM 29518248
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Zhao, Y
   Zhao, XT
   Ji, KQ
   Wang, JL
   Zhao, YY
   Lin, J
   Gang, Q
   Yu, M
   Yuan, Y
   Jiang, HS
   Sun, C
   Fang, F
   Yan, CZ
   Wang, ZX
AF Zhao, Yang
   Zhao, Xutong
   Ji, Kunqian
   Wang, Junling
   Zhao, Yuying
   Lin, Jie
   Gang, Qiang
   Yu, Meng
   Yuan, Yun
   Jiang, Haishan
   Sun, Chong
   Fang, Fang
   Yan, Chuanzhu
   Wang, Zhaoxia
TI The clinical and genetic spectrum of mitochondrial diseases in China: A
   multicenter retrospective cross-sectional study
SO CLINICAL GENETICS
LA English
DT Article; Early Access
DE genotype; heterogeneity; mitochondrial diseases; phenotype
ID HEREDITARY OPTIC NEUROPATHY; DNA; MUTATIONS; COHORT; PREVALENCE;
   CHILDREN; SINGLE; MELAS; LEIGH; PROGRESSION
AB Mitochondrial diseases (MtDs) present diverse clinical phenotypes, yet large-scale studies are hindered by their rarity. This retrospective, multicenter study, conducted across five Chinese hospitals' neurology departments from 2009 to 2019, aimed to address this gap. Nationwide, 1351 patients were enrolled, with a median onset age of 14.0 (18.5) years. The predominant phenotype was mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) (45.0%). Mitochondrial DNA (mtDNA) mutations were prevalent (87.4%), with m.3243A>G being the most common locus (48.7%). Meanwhile, POLG mutations in nuclear DNA (nDNA) accounted for 16.5%. Comparative analysis based on age groups (with a cut-off at 14 years) revealed the highest prevalence of MELAS, with Leigh syndrome (LS) and chronic progressive external ophthalmoplegia (CPEO) being the second most common phenotypes in junior and senior groups, respectively. Notably, the most commonly mutated nuclear genes varied across age groups. In conclusion, MELAS predominated in this Chinese MtD cohort, underscored by m.3243A>G and POLG as principal mtDNA mutations and pathogenic nuclear genes. The phenotypic and genotypic disparities observed among different age cohorts highlight the complex nature of MtDs.
C1 [Zhao, Yang; Zhao, Xutong; Gang, Qiang; Yu, Meng; Yuan, Yun; Wang, Zhaoxia] Peking Univ First Hosp, Dept Neurol, Beijing, Peoples R China.
   [Ji, Kunqian; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Dept Neurol, Qilu Hosp, 107 West Wenhua Rd, Jinan 250012, Peoples R China.
   [Wang, Junling; Fang, Fang] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Neurol, 56 Nanlishi Rd, Beijing 100045, Peoples R China.
   [Wang, Junling] Zhengzhou Univ, Dept Pediat, Affiliated Hosp 3, Zhengzhou, Peoples R China.
   [Lin, Jie; Sun, Chong] Fudan Univ, Dept Neurol, Huashan Hosp, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.
   [Jiang, Haishan] Southern Med Univ, Nanfang Hosp, Dept Neurol, 1838 North Guangzhou Ave, Guangzhou 510515, Peoples R China.
   [Wang, Zhaoxia] Peking Univ First Hosp, Dept Neurol, Beijing Key Lab Neurovasc Dis Discovery, 8 Xishiku St, Beijing 100034, Peoples R China.
C3 Peking University; Shandong University; Capital Medical University;
   Zhengzhou University; Fudan University; Southern Medical University -
   China
RP Yan, CZ (corresponding author), Shandong Univ, Dept Neurol, Qilu Hosp, 107 West Wenhua Rd, Jinan 250012, Peoples R China.; Fang, F (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Neurol, 56 Nanlishi Rd, Beijing 100045, Peoples R China.; Sun, C (corresponding author), Fudan Univ, Dept Neurol, Huashan Hosp, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.; Jiang, HS (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Neurol, 1838 North Guangzhou Ave, Guangzhou 510515, Peoples R China.; Wang, ZX (corresponding author), Peking Univ First Hosp, Dept Neurol, Beijing Key Lab Neurovasc Dis Discovery, 8 Xishiku St, Beijing 100034, Peoples R China.
EM jianghs@smu.edu.cn; 08301010238@fudan.edu.cn; fangfang@bch.com.cn;
   chuanzhuyan@163.com; drwangzx@163.com
OI Zhao, Yang/0009-0003-1006-741X; Lin, Jie/0000-0001-6351-3389
FU National High Level Hospital Clinical Research Funding (High Quality
   Clinical Research Project of Peking University First Hospital)
   [2023HQ03]; R&D Program of Beijing Municipal Education Commission
   [BS20210103]; National Natural Science Foundation of China
   [LHGJ20220525]; R&D Program of Beijing Municipal Education Commission
   [KZ202210025033]
FX National High Level Hospital Clinical Research Funding (High Quality
   Clinical Research Project of Peking University First
   Hospital),Grant/Award Number: 2023HQ03; R&D Program of Beijing Municipal
   Education Commission, Grant/Award Number:KZ202210025033; National
   Natural Science Foundation of China, Grant/Award Number:82271493; the
   Medical Science and Technology Planning Project of Henan Province,
   China, Grant/Award Number:LHGJ20220525; the PhD research startup
   foundation of the Third Affiliated Hospital of Zhengzhou University,
   Grant/Award Number:BS20210103
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Anteneová N, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10110766
   Arpa J, 2003, MUSCLE NERVE, V28, P690, DOI 10.1002/mus.10507
   Barca E, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000402
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fang F, 2017, SCI CHINA LIFE SCI, V60, P746, DOI 10.1007/s11427-017-9080-y
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hou Y, 2022, MOL GENET GENOM MED, V10, DOI 10.1002/mgg3.1921
   Hu CP, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2020.103898
   Hunter MF, 2011, PEDIATR NEUROL, V45, P311, DOI 10.1016/j.pediatrneurol.2011.07.008
   Ji YC, 2019, HUM MOL GENET, V28, P1515, DOI 10.1093/hmg/ddy450
   Jiang PP, 2015, INVEST OPHTH VIS SCI, V56, P4778, DOI 10.1167/iovs.14-16158
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lin Y, 2024, J NEUROL, V271, P864, DOI 10.1007/s00415-023-12005-5
   Lu YY, 2017, J NEUROL SCI, V379, P137, DOI 10.1016/j.jns.2017.05.056
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   Ng YS, 2022, BRAIN, V145, P542, DOI 10.1093/brain/awab353
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Ogasawara Y, 2005, BLOOD, V106, P3271, DOI 10.1182/blood-2005-01-0150
   Ogawa E, 2020, J INHERIT METAB DIS, V43, P819, DOI 10.1002/jimd.12218
   Orsucci D, 2021, J CLIN MED, V10, DOI 10.3390/jcm10061249
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Shi YQ, 2022, MITOCHONDRION, V62, P139, DOI 10.1016/j.mito.2021.11.006
   Stendel C, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000393
   Stenton SL, 2022, ANN NEUROL, V91, P466, DOI 10.1002/ana.26313
   Stenton SL, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102784
   Tetsuka S, 2021, METAB BRAIN DIS, V36, P2181, DOI 10.1007/s11011-021-00772-x
   Wang W, 2023, ANN CLIN TRANSL NEUR, V10, P1035, DOI 10.1002/acn3.51787
   Yang MG, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.728043
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yen MY, 2006, PROG RETIN EYE RES, V25, P381, DOI 10.1016/j.preteyeres.2006.05.002
   Yu M, 2016, CHINESE MED J-PEKING, V129, P1419, DOI 10.4103/0366-6999.183417
   Yu XL, 2018, CHINESE MED J-PEKING, V131, P2705, DOI 10.4103/0366-6999.245265
   Zhang JJ, 2018, MITOCHONDRION, V42, P84, DOI 10.1016/j.mito.2017.12.003
   Zhang Z, 2018, J NEUROL SCI, V385, P151, DOI 10.1016/j.jns.2017.12.033
   Zhao Y, 2024, MOL GENET GENOM MED, V12, DOI 10.1002/mgg3.2328
NR 47
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9163
EI 1399-0004
J9 CLIN GENET
JI Clin. Genet.
PD 2024 AUG 9
PY 2024
DI 10.1111/cge.14605
EA AUG 2024
PG 12
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA C1Y0B
UT WOS:001287371200001
PM 39118480
OA hybrid
DA 2024-11-01
ER

PT J
AU Gershoni, M
   Levin, L
   Ovadia, O
   Toiw, Y
   Shani, N
   Dadon, S
   Barzilai, N
   Bergman, A
   Atzmon, G
   Wainstein, J
   Tsur, A
   Nijtmans, L
   Glaser, B
   Mishmar, D
AF Gershoni, Moran
   Levin, Liron
   Ovadia, Ofer
   Toiw, Yasmin
   Shani, Naama
   Dadon, Sara
   Barzilai, Nir
   Bergman, Aviv
   Atzmon, Gil
   Wainstein, Julio
   Tsur, Anat
   Nijtmans, Leo
   Glaser, Benjamin
   Mishmar, Dan
TI Disrupting Mitochondrial-Nuclear Coevolution Affects OXPHOS Complex I
   Integrity and Impacts Human Health
SO GENOME BIOLOGY AND EVOLUTION
LA English
DT Article
DE coevolution; complex I; mitonuclear interaction; mitochondria; mtDNA;
   NDUFC2
ID ELECTRON-TRANSPORT CHAIN; HUMAN SKELETAL-MUSCLE; MTDNA HAPLOGROUP
   DISTRIBUTION; FALSE DISCOVERY RATES; INSULIN-SECRETION;
   OXIDATIVE-PHOSPHORYLATION; DISEASE; POLYMORPHISMS; EVOLUTION; OBESITY
AB The mutation rate of the mitochondrial DNA (mtDNA), which is higher by an order of magnitude as compared with the nuclear genome, enforces tight mitonuclear coevolution to maintain mitochondrial activities. Interruption of such coevolution plays a role in interpopulation hybrid breakdown, speciation events, and disease susceptibility. Previously, we found an elevated amino acid replacement rate and positive selection in the nuclear DNA-encoded oxidative phosphorylation (OXPHOS) complex I subunit NDUFC2, a phenomenon important for the direct interaction of NDUFC2 with the mtDNA-encoded complex I subunit ND4. This finding underlines the importance of mitonuclear coevolution to physical interactions between mtDNA and nuclear DNA-encoded factors. Nevertheless, it remains unclear whether this interaction is important for the stability and activity of complex I. Here, we show that siRNA silencing of NDUFC2 reduced growth of human D-407 retinal pigment epithelial cells, significantly diminished mitochondrial membrane potential, and interfered with complex I integrity. Moreover, site-directed mutagenesis of a positively selected amino acid in NDUFC2 significantly interfered with the interaction of NDUFC2 with its mtDNA-encoded partner ND4. Finally, we show that a genotype combination involving this amino acid (NDUFC2 residue 46) and the mtDNA haplogroup HV likely altered susceptibility to type 2 diabetes mellitus in Ashkenazi Jews. Therefore, mitonuclear coevolution is important for maintaining mitonuclear factor interactions, OXPHOS, and for human health.
C1 [Gershoni, Moran; Levin, Liron; Ovadia, Ofer; Toiw, Yasmin; Shani, Naama; Dadon, Sara; Mishmar, Dan] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.
   [Barzilai, Nir; Atzmon, Gil] Albert Einstein Coll Med, Inst Aging, Div Endocrinol, Dept Med, New York, NY USA.
   [Barzilai, Nir; Atzmon, Gil] Albert Einstein Coll Med, Dept Genet, New York, NY USA.
   [Bergman, Aviv] Albert Einstein Coll Med, Dept Syst & Computat Biol, New York, NY USA.
   [Wainstein, Julio] E Wolfson Med Ctr, Diabet Unit, Holon, Israel.
   [Tsur, Anat] Clalit Hlth Serv, Endocrine Clin, Jerusalem, Israel.
   [Nijtmans, Leo] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, NL-6525 ED Nijmegen, Netherlands.
   [Glaser, Benjamin] Hadassah Hebrew Univ, Med Ctr, Endocrinol & Metab Serv, Jerusalem, Israel.
C3 Ben Gurion University; Yeshiva University; Yeshiva University; Yeshiva
   University; Clalit Health Services; Radboud University Nijmegen; Hebrew
   University of Jerusalem; Hadassah University Medical Center
RP Mishmar, D (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.
EM dmishmar@bgu.ac.il
RI Nijtmans, L.G.J./L-4549-2015; Ovadia, Ofer/C-8292-2012; Gershoni,
   Moran/AAB-9493-2019; Mishmar, Dan/AAJ-6109-2020; atzmon,
   gil/N-3967-2017; atzmon, gil/E-8983-2017; Glaser, Benjamin/F-8411-2017
OI atzmon, gil/0000-0001-6895-3607; Glaser, Benjamin/0000-0003-4711-5000;
   Mishmar, Dan/0000-0003-3488-8792; Ovadia, Ofer/0000-0002-4941-4947;
   Gershoni, Moran/0000-0002-2179-0799
FU National Institutes of Health [AG028872, AG042188, AG021654-01,
   AG-18728-02A1]; Israeli Science Foundation [ISF 387/08, 610/12]; Ori
   foundation
FX We thank Mariel van den Brandt for her excellent technical support with
   the BN-PAGE experiments and Dr. Raz Zarivach for critical comments. We
   also thank Itamar Raz, Ardon Rubenstein, Ilana Harman-Boehm, Joseph
   Cohen, Oscar Minuchin, Yair Yerushalmi, Andreas Buchs and Clara
   Norymberg, members of the Israel Diabetes Research Group, who played
   active roles in this research. This work was supported by a grant from
   the National Institutes of Health (AG028872 to A.B., AG042188 to G.A.,
   AG021654-01 to N.B., AG-18728-02A1 to N.B.) and Israeli Science
   Foundation (ISF 387/08, 610/12 to D.M). The authors extend their thanks
   for the Ori foundation for granting a scholarship of excellence to M.G.
   The grant foundations had no competing interest in the study and did not
   interfere with the study design.
CR Achilli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021029
   Amar S, 2007, SCHIZOPHR RES, V94, P354, DOI 10.1016/j.schres.2007.04.020
   Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015
   Bar-Yaacov D, 2012, BBA-GENE REGUL MECH, V1819, P1107, DOI 10.1016/j.bbagrm.2011.10.008
   Barreto FS, 2013, MOL BIOL EVOL, V30, P310, DOI 10.1093/molbev/mss228
   Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210
   Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052
   Burton RS, 2006, AM NAT, V168, pS14, DOI 10.1086/509046
   Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   DAVIS AA, 1995, INVEST OPHTH VIS SCI, V36, P955
   Dowling DK, 2014, BBA-GEN SUBJECTS, V1840, P1393, DOI 10.1016/j.bbagen.2013.11.013
   Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330
   EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8
   Feder J, 2007, EUR J HUM GENET, V15, P498, DOI 10.1038/sj.ejhg.5201764
   Feder J, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-60
   Feder J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-198
   Fridman Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000507
   Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202
   Gabaldón T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067
   Gaweda-Walerych K, 2010, NEUROSCI LETT, V469, P24, DOI 10.1016/j.neulet.2009.11.037
   Gershoni M, 2010, J MOL BIOL, V404, P158, DOI 10.1016/j.jmb.2010.09.029
   Gershoni M, 2009, BIOESSAYS, V31, P642, DOI 10.1002/bies.200800139
   Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403
   Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002
   Guo LJ, 2005, MITOCHONDRION, V5, P15, DOI 10.1016/j.mito.2004.09.001
   Guzmán-Fulgencio M, 2013, JAIDS-J ACQ IMM DEF, V63, P178, DOI 10.1097/QAI.0b013e3182893f74
   Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577
   Hoekstra LA, 2013, GENETICS, V195, P1129, DOI 10.1534/genetics.113.154914
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046
   Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831
   Kloss-Brandstätter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382
   Krempler F, 2002, DIABETES, V51, P3331, DOI 10.2337/diabetes.51.11.3331
   Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381
   Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047
   Lefort N, 2010, DIABETES, V59, P2444, DOI 10.2337/db10-0174
   Lemasters JJ, 2007, METHOD CELL BIOL, V80, P283, DOI 10.1016/S0091-679X(06)80014-2
   Lindholm E, 2004, J DIABETES COMPLICAT, V18, P103, DOI 10.1016/S1056-8727(03)00019-9
   Ling C, 2007, J CLIN INVEST, V117, P3427, DOI 10.1172/JCI30938
   Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429
   Meiklejohn CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003238
   Mimaki M., 2011, BIOCHIM BIOPHYS ACTA, V1817, P851
   Mishmar D, 2006, GENE, V378, P11, DOI 10.1016/j.gene.2006.03.015
   Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4
   Muller YL, 2003, DIABETES, V52, P895, DOI 10.2337/diabetes.52.3.895
   Nishigaki Y, 2007, HUM GENET, V120, P827, DOI 10.1007/s00439-006-0269-z
   Olsson AH, 2011, EUR J ENDOCRINOL, V164, P765, DOI 10.1530/EJE-10-0995
   Bayona-Bafaluy MP, 2011, MITOCHONDRION, V11, P467, DOI 10.1016/j.mito.2011.01.007
   Potluri P, 2009, MOL GENET METAB, V96, P189, DOI 10.1016/j.ymgme.2008.12.004
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Rai E, 2007, HUM GENET, V122, P535, DOI 10.1007/s00439-007-0421-4
   REITZER LJ, 1979, J BIOL CHEM, V254, P2669
   Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009
   Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382
   Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x
   Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Ueki M, 2012, PLOS GENET, V8, P141, DOI 10.1371/journal.pgen.1002625
   Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686
   Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008
   Wang H, 2004, AM J PHYSIOL-ENDOC M, V286, pE1, DOI 10.1152/ajpendo.00231.2003
   Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhu CT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004354
   Zimmermann Franz A, 2011, Front Biosci (Elite Ed), V3, P315
NR 69
TC 59
Z9 61
U1 0
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1759-6653
J9 GENOME BIOL EVOL
JI Genome Biol. Evol.
PD OCT
PY 2014
VL 6
IS 10
BP 2665
EP 2680
DI 10.1093/gbe/evu208
PG 16
WC Evolutionary Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Evolutionary Biology; Genetics & Heredity
GA AX2LQ
UT WOS:000346775800008
PM 25245408
OA Green Submitted, gold, Green Published
DA 2024-11-01
ER

PT J
AU Zifa, E
   Giannouli, S
   Theotokis, P
   Stamatis, O
   Mamuris, Z
   Stathopoulos, C
AF Zifa, Emily
   Giannouli, Stamatina
   Theotokis, Paschalis
   Stamatis, Ostas
   Mamuris, Zissis
   Stathopoulos, Constantinos
TI Mitochondrial tRNA mutations - Clinical and functional perturbations
SO RNA BIOLOGY
LA English
DT Review
DE tRNA; mitochondrion; encephalopathies; myopathies; mitochondrial tRNA
   mutations
ID STROKE-LIKE EPISODES; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; RAGGED-RED
   FIBERS; MATERNALLY INHERITED CARDIOMYOPATHY; MERRF/MELAS OVERLAP
   SYNDROME; HEREDITARY OPTIC NEUROPATHY; COMPLEX-I DEFICIENCY; MTDNA POINT
   MUTATION; IDIOPATHIC SIDEROBLASTIC ANEMIA; ANTICODON WOBBLE NUCLEOTIDE
AB During the last decade, there has been a progressive accumulation of reports that connect the identification of specific mitochondrial tRNA gene mutations to severe disorders in human. As a result, mitochondrial tRNA genes and their products have emerged as novel and essential molecular markers for wide biochemical and genetic screenings among different human populations. So far, 139 pathogenic and 243 polymorphic mt tRNA mutations have been described and they have become the foreground of numerous case reports. Given the complexity of mitochondrial genetics and biochemistry, the clinical manifestations of mitochondrial disorders are extremely heterogeneous. They range from lesions of single tissues or structures to more severe impairements including myopathies, encephalomyopothies, cardiomyopothies, or complex multisystem syndromes. Moreover, the exact mechanisms by which biochemical cascades can be dramatically affected by mitochondrial tRNA mutations still remain uncharacterized. However and regardless of the vast amount of information that daily emerges, only few efforts have been carried out to systematically record all the mitochondrial tRNA-associated pathogenic mutations or polymorphisms. in this report, we summarize all the clinical phenotypes associated with mitochondrial tRNA pathogenic mutations that have been reported so for. In a next step we describe in detail all the pathogenic and polymorphic mutations that have been recorded so far and we categorize them per tRNA species and per associated disease. Finally, we discuss the impact of the frequency of mitochondrial tRNA mutations in general population surveys and we preview any relevant implications on the essential functional integrity of mitochondrial biochemical pathways.
C1 [Zifa, Emily; Giannouli, Stamatina; Theotokis, Paschalis; Stamatis, Ostas; Mamuris, Zissis; Stathopoulos, Constantinos] Univ Thessaly, Dept Biochem & Biotechnol, Larisa 41221, Greece.
   [Stathopoulos, Constantinos] CERETETH, Inst Biomed Res & Technol BIOMED, Larisa, Greece.
C3 University of Thessaly
RP Stathopoulos, C (corresponding author), Univ Thessaly, Dept Biochem & Biotechnol, 26 Ploutonos St, Larisa 41221, Greece.
EM cstath@bio.uth.gr
RI Theotokis, Paschalis/AAU-8003-2021; Mamuris, Zissis/AAN-2576-2021
OI Stathopoulos, Constantinos/0000-0002-5699-4118; Theotokis,
   Paschalis/0000-0001-8607-6695
CR AATO, 1998, J NEUROLSCIE, V127, P235
   Abu-Amero EK, 2006, J CHILD NEUROL, V21, P971, DOI 10.2310/7010.2006.00208
   Akita Y, 2000, HUM MUTAT, V15, P382, DOI 10.1002/(SICI)1098-1004(200004)15:4<382::AID-HUMU15>3.0.CO;2-B
   Allen JF, 1996, J MOL EVOL, V42, P482, DOI 10.1007/BF02352278
   AN, 2002, J MED, V39, P262
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Annunen-Rasila J, 2007, MITOCHONDRION, V7, P96, DOI 10.1016/j.mito.2006.11.004
   Arenas J, 1999, NEUROLOGY, V52, P377, DOI 10.1212/WNL.52.2.377
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   BAU, 2005, SCRABISMUS, V13, P133
   Bau V, 2005, STRABISMUS, V13, P133, DOI 10.1080/09273970500216432
   BETA, 2001, NEUROLYG, V56, P405
   Bidooki S, 2004, NEUROMUSCULAR DISORD, V14, P417, DOI 10.1016/j.nmd.2004.03.004
   Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460
   BINDOFF LA, 1993, J BIOL CHEM, V268, P19559
   Blakely EL, 2004, J NEUROL SCI, V225, P99, DOI 10.1016/j.jns.2004.07.007
   BLAKELY EL, 2007, IN PRESS J NEUROL
   Blondon H, 2005, GASTROEN CLIN BIOL, V29, P773, DOI 10.1016/S0399-8320(05)86346-8
   Börner GV, 2000, HUM MOL GENET, V9, P467, DOI 10.1093/hmg/9.4.467
   Borthwick Gillian M, 2006, Ann Neurol, V59, P570, DOI 10.1002/ana.20758
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   BROWN MD, 1992, AM J HUM GENET, V51, P446
   Brulé H, 1998, NUCLEIC ACIDS RES, V26, P537, DOI 10.1093/nar/26.2.537
   Bruno C, 2003, J CHILD NEUROL, V18, P300, DOI 10.1177/08830738030180040401
   Bruno C, 1999, J PEDIATR-US, V135, P197, DOI 10.1016/S0022-3476(99)70022-3
   Campos Y, 2001, NEUROMUSCULAR DISORD, V11, P477, DOI 10.1016/S0960-8966(00)00223-6
   Campos Y, 1996, MUSCLE NERVE, V19, P187, DOI 10.1002/(SICI)1097-4598(199602)19:2<187::AID-MUS10>3.0.CO;2-S
   Campos Y, 2000, NEUROMUSCULAR DISORD, V10, P493, DOI 10.1016/S0960-8966(00)00107-3
   Cardaioli E, 2005, BIOCHEM BIOPH RES CO, V327, P675, DOI 10.1016/j.bbrc.2004.11.170
   Carnpos Y, 2003, NEUROMUSCULAR DISORD, V13, P416, DOI 10.1016/S0960-8966(03)00039-7
   Casali C, 1999, NEUROLOGY, V52, P1103, DOI 10.1212/WNL.52.5.1103
   Casali C, 1999, J AM COLL CARDIOL, V33, P1584, DOI 10.1016/S0735-1097(99)00079-0
   Chalmers RM, 1997, NEUROLOGY, V49, P589, DOI 10.1212/WNL.49.2.589
   CHANG TS, 1993, ARCH OPHTHALMOL-CHIC, V111, P1254, DOI 10.1001/archopht.1993.01090090106028
   Chapiro E, 2002, EUR J HUM GENET, V10, P851, DOI 10.1038/sj.ejhg.5200894
   Chen Y, 2000, DIABETES RES CLIN PR, V48, P29, DOI 10.1016/S0168-8227(99)00138-2
   Cheong HI, 1999, PEDIATR NEPHROL, V13, P477, DOI 10.1007/s004670050641
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1997, ANN NEUROL, V41, P408, DOI 10.1002/ana.410410319
   Chinnery PF, 1997, NEUROLOGY, V49, P1166, DOI 10.1212/WNL.49.4.1166
   Chomyn A, 1998, AM J HUM GENET, V62, P745, DOI 10.1086/301813
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Corona P, 2002, ANN NEUROL, V51, P118, DOI 10.1002/ana.10059
   Coulbault L, 2005, BIOCHEM BIOPH RES CO, V329, P1152, DOI 10.1016/j.bbrc.2005.02.083
   Crimi M, 2004, MITOCHONDRION, V3, P279, DOI 10.1016/j.mito.2004.02.004
   Crimi M, 2003, NEUROLOGY, V60, P1200, DOI 10.1212/01.WNL.0000055865.30580.39
   Damore ME, 1999, J PEDIATR ENDOCR MET, V12, P207
   Darin N, 2006, NEUROMUSCULAR DISORD, V16, P504, DOI 10.1016/j.nmd.2006.05.010
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   de Coo IFM, 1998, NEUROLOGY, V50, P293, DOI 10.1212/WNL.50.1.293
   Deschauer M, 2004, J NEUROL NEUROSUR PS, V75, P1204, DOI 10.1136/jnnp.2003.026278
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   Dey R, 2000, NEUROMUSCULAR DISORD, V10, P488, DOI 10.1016/S0960-8966(00)00125-5
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   DiMauro S, 1998, CURR OPIN CARDIOL, V13, P190
   DIMAURO S, 2007, IN PRESS BIOSCI REP
   DIMAURO S, 2007, BIOSCIENCE REP, P125
   DiMauro S, 2006, CURR OPIN RHEUMATOL, V18, P636, DOI 10.1097/01.bor.0000245729.17759.f2
   Dinour D, 2004, CLIN NEPHROL, V62, P149
   Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221
   Egensperger R, 1997, NEUROPATH APPL NEURO, V23, P315, DOI 10.1046/j.1365-2990.1997.4098040.x
   El Meziane A, 1998, HUM MOL GENET, V7, P2141, DOI 10.1093/hmg/7.13.2141
   Elson JL, 2006, HUM GENET, V119, P241, DOI 10.1007/s00439-005-0123-8
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   Feigenbaum A, 2006, AM J MED GENET A, V140A, P2216, DOI 10.1002/ajmg.a.31436
   Finnilä S, 2001, J MOL MED, V79, P641, DOI 10.1007/s001090100268
   Fischel-Ghodsian N, 1998, AM J HUM GENET, V62, P15, DOI 10.1086/301695
   FISCHELGHODSIAN N, 1995, AM J OTOLARYNG, V16, P403, DOI 10.1016/0196-0709(95)90078-0
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   Florentz C, 2002, BIOSCIENCE REP, V22, P81, DOI 10.1023/A:1016065107165
   Florentz C, 2001, EMBO REP, V2, P481, DOI 10.1093/embo-reports/kve111
   FOLGERO T, 1995, EUR NEUROL, V35, P168, DOI 10.1159/000117115
   Franceschina L, 1998, J NEUROL, V245, P755, DOI 10.1007/s004150050283
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Gámez J, 1998, NEUROLOGY, V51, P258, DOI 10.1212/WNL.51.1.258
   GARC, 2000, HUMAN  MUTAT, V15, P120
   Garcia-Lozano J R, 2000, Hum Mutat, V15, P120, DOI 10.1002/(SICI)1098-1004(200001)15:1<120::AID-HUMU33>3.0.CO;2-8
   GARDNER JL, 2007, BIOSCIENCE REP, P139
   Gattermann N, 2000, LEUKEMIA RES, V24, P141, DOI 10.1016/S0145-2126(99)00160-5
   Gattermann N, 1996, BRIT J HAEMATOL, V93, P845, DOI 10.1046/j.1365-2141.1996.d01-1724.x
   Giegé R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017
   Goldstein JD, 1999, PEDIATR DEVEL PATHOL, V2, P78, DOI 10.1007/s100249900094
   GOTO Y, 1992, ANN NEUROL, V31, P672, DOI 10.1002/ana.410310617
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601
   Grafakou O, 2003, J INHERIT METAB DIS, V26, P593, DOI 10.1023/A:1025960300710
   Grasbon-Frodl EM, 1999, NEUROGENETICS, V2, P121, DOI 10.1007/s100480050063
   Grasso M, 2001, EUR J HUM GENET, V9, P311, DOI 10.1038/sj.ejhg.5200622
   Grünewald T, 1999, DRUG DEVELOP RES, V46, P80
   GRUNEWELD, 1999, DRUG DEVELOP RES, V46, P80
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Hadjigeorgiou GM, 1999, J NEUROL SCI, V164, P153, DOI 10.1016/S0022-510X(99)00062-3
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   Hansrote S, 2002, J NEUROL SCI, V197, P63, DOI 10.1016/S0022-510X(02)00048-5
   Hao HL, 1997, MOL CELL BIOL, V17, P6831, DOI 10.1128/MCB.17.12.6831
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Hao HL, 1996, J BIOL CHEM, V271, P2347, DOI 10.1074/jbc.271.4.2347
   Hao R, 2005, NUCLEIC ACIDS RES, V33, P3606, DOI 10.1093/nar/gki677
   HATTORI Y, 1994, J NEUROL SCI, V125, P50, DOI 10.1016/0022-510X(94)90241-0
   Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   Hino N, 2004, GENES CELLS, V9, P243, DOI 10.1111/j.1356-9597.2004.00718.x
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horváth R, 2003, J MED GENET, V40, P752, DOI 10.1136/jmg.40.10.752
   Houshmand M, 1999, HUM MUTAT, V13, P203, DOI 10.1002/(SICI)1098-1004(1999)13:3<203::AID-HUMU4>3.0.CO;2-3
   Houshmand M, 1996, HUM GENET, V97, P269, DOI 10.1007/BF02185750
   Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   Hunter Senyene Eyo, 2004, RNA Biol, V1, P95, DOI 10.4161/rna.1.2.1034
   HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892
   Hutchin TP, 2000, J MED GENET, V37, P692, DOI 10.1136/jmg.37.9.692
   Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064
   INGMAN M, 2000, NATRE, V408, P7808
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   IONASESCU VV, 1994, NEUROLOGY, V44, P975, DOI 10.1212/WNL.44.5.975
   Jaksch M, 1998, J MED GENET, V35, P895, DOI 10.1136/jmg.35.11.895
   Jaksch M, 2001, NEUROLOGY, V57, P1930, DOI 10.1212/WNL.57.10.1930
   Janssen GMC, 1999, J BIOL CHEM, V274, P29744, DOI 10.1074/jbc.274.42.29744
   JENO, 2004, IRAL HEART, V5, P460
   Jeppesen TD, 2003, J NEUROL SCI, V214, P17, DOI 10.1016/S0022-510X(03)00168-0
   Jones CI, 2006, J MOL BIOL, V362, P771, DOI 10.1016/j.jmb.2006.07.036
   Kalman B, 1999, ACTA NEUROL SCAND, V99, P16
   Kameoka K, 1998, BIOCHEM BIOPH RES CO, V245, P523, DOI 10.1006/bbrc.1998.8437
   Karadimas C, 2001, J CHILD NEUROL, V16, P531, DOI 10.1177/088307380101600715
   Karadimas CL, 2002, NEUROMUSCULAR DISORD, V12, P865, DOI 10.1016/S0960-8966(02)00072-X
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x
   Kawarai T, 1997, NEUROLOGY, V49, P598, DOI 10.1212/WNL.49.2.598
   Kelley SO, 2001, J BIOL CHEM, V276, P10607, DOI 10.1074/jbc.M008320200
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Kirino Yohei, 2005, RNA Biol, V2, P41, DOI 10.4161/rna.2.2.1610
   KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x
   Kleinle S, 1998, BIOCHEM BIOPH RES CO, V247, P112, DOI 10.1006/bbrc.1998.8729
   Klopstock T, 1997, MOL CELL BIOCHEM, V174, P271, DOI 10.1023/A:1006877012241
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   KOGA Y, 1995, MUSCLE NERVE, pS119
   Kolesnikova OA, 2000, SCIENCE, V289, P1931, DOI 10.1126/science.289.5486.1931
   Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267
   LARSSON NG, 1995, MUSCLE NERVE       S, V3, P102
   LAUBER J, 1991, NUCLEIC ACIDS RES, V19, P1393, DOI 10.1093/nar/19.7.1393
   LEROY D, 1994, CLIN GENET, V45, P109
   Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884
   Levinger L, 2003, NUCLEIC ACIDS RES, V31, P1904, DOI 10.1093/nar/gkg282
   LI R, 2006, GENE, V47, P475
   Li RH, 2005, BIOCHEM BIOPH RES CO, V328, P32, DOI 10.1016/j.bbrc.2004.12.140
   Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   Lu JX, 2006, BIOCHEM BIOPH RES CO, V348, P115, DOI 10.1016/j.bbrc.2006.07.010
   Lynn S, 1998, DIABETES, V47, P1800, DOI 10.2337/diabetes.47.11.1800
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Maeso E, 2007, NEUROMUSCULAR DISORD, V17, P415, DOI 10.1016/j.nmd.2007.01.015
   Mahata B, 2006, SCIENCE, V314, P471, DOI 10.1126/science.1129754
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa-Voltti K, 2004, ANN MED, V36, P225, DOI 10.1080/07853890410028456
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Manfredi G, 1996, HUM MUTAT, V7, P158
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   Matsumoto Joyce, 2005, Rev Neurol Dis, V2, P30
   Mayr-Wohlfart U, 1997, Eur J Med Res, V2, P111
   MayrWohlfart U, 1996, ACTA NEUROL SCAND, V94, P167, DOI 10.1111/j.1600-0404.1996.tb07048.x
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Melone MAB, 2004, ARCH NEUROL-CHICAGO, V61, P269, DOI 10.1001/archneur.61.2.269
   Menotti Francesca, 2004, Ital Heart J, V5, P460
   MERANTE F, 1994, AM J HUM GENET, V55, P437
   Merante F, 1996, HUM MUTAT, V8, P216, DOI 10.1002/(SICI)1098-1004(1996)8:3<216::AID-HUMU4>3.0.CO;2-7
   Mimaki M, 2003, J HUM GENET, V48, P47, DOI 10.1007/s100380300005
   Möllers M, 2005, NUCLEIC ACIDS RES, V33, P5647, DOI 10.1093/nar/gki876
   Mongini T, 2002, CLIN NEUROPATHOL, V21, P72
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   Moslemi AR, 2004, NEUROMUSCULAR DISORD, V14, P46, DOI 10.1016/S0960-8966(03)00168-8
   Mukherjee S, 2007, EMBO REP, V8, P589, DOI 10.1038/sj.embor.7400979
   Müller T, 2005, ACTA NEUROPATHOL, V110, P426, DOI 10.1007/s00401-005-1063-z
   Munakata K, 2005, BIOL PSYCHIAT, V57, P525, DOI 10.1016/j.biopsych.2004.11.041
   MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099
   NAKAMURA M, 1995, BIOCHEM BIOPH RES CO, V214, P86, DOI 10.1006/bbrc.1995.2260
   Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nishigaki Y, 2002, NEUROLOGY, V58, P1282, DOI 10.1212/WNL.58.8.1282
   Nishino I, 1996, BIOCHEM BIOPH RES CO, V225, P180, DOI 10.1006/bbrc.1996.1150
   Ohkubo K, 2001, CLIN CHEM, V47, P1641
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Pandya A, 1999, AM J HUM GENET, V65, P1803, DOI 10.1086/302658
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   Perucca-Lostanlen D, 2002, BBA-MOL BASIS DIS, V1588, P210, DOI 10.1016/S0925-4439(02)00167-9
   Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487
   Petruzzella V, 2004, CLIN GENET, V65, P64, DOI 10.1111/j..2004.00185.x
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Pineda M, 2004, PEDIATR RES, V56, P55, DOI 10.1203/01.PDR.0000130475.20571.98
   Pulkes T, 2000, NEUROLOGY, V55, P1210, DOI 10.1212/WNL.55.8.1210
   Pulkes T, 2005, NEUROMUSCULAR DISORD, V15, P364, DOI 10.1016/j.nmd.2005.01.006
   Pulkes T, 2003, NEUROLOGY, V61, P1144, DOI 10.1212/01.WNL.0000090465.27024.3D
   Pulkes T, 2000, LANCET, V356, P2068, DOI 10.1016/S0140-6736(00)03408-5
   Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665
   Rabilloud T, 2002, BIOCHEMISTRY-US, V41, P144, DOI 10.1021/bi0114776
   Raffelsberger T, 2001, NEUROLOGY, V57, P2298, DOI 10.1212/WNL.57.12.2298
   Ramelli GP, 2006, J CHILD NEUROL, V21, P253, DOI 10.2310/7010.2006.00047
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Remes AM, 2003, J NEUROL NEUROSUR PS, V74, P1158, DOI 10.1136/jnnp.74.8.1158
   Rigoli L, 1999, ACTA DIABETOL, V36, P163, DOI 10.1007/s005920050161
   Rigoli L, 2001, DIABETIC MED, V18, P334, DOI 10.1046/j.1464-5491.2001.00429-2.x
   Ronghua L, 2006, GENE, V376, P79, DOI 10.1016/j.gene.2006.02.014
   Rossmanith W, 2003, ANN NEUROL, V54, P820, DOI 10.1002/ana.10753
   Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4
   Rötig A, 2003, J NEPHROL, V16, P286
   Sacconi S, 2002, ARCH NEUROL-CHICAGO, V59, P1013, DOI 10.1001/archneur.59.6.1013
   Sahashi K, 2001, J MED GENET, V38, P703, DOI 10.1136/jmg.38.10.703
   Sakuta R, 2002, PEDIATR NEUROL, V27, P397, DOI 10.1016/S0887-8994(02)00456-3
   SAKUTA R, 1993, J NEUROL SCI, V115, P158, DOI 10.1016/0022-510X(93)90219-O
   Saneto RP, 2006, J CHILD NEUROL, V21, P77, DOI 10.1177/08830738060210010601
   Sanger TD, 1996, PEDIATR NEUROL, V14, P57, DOI 10.1016/0887-8994(95)00226-X
   SANTORELLI FM, 1995, BIOCHEM BIOPH RES CO, V216, P835, DOI 10.1006/bbrc.1995.2697
   Santorelli FM, 1996, PEDIATR NEUROL, V15, P145, DOI 10.1016/0887-8994(96)00163-4
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Santorelli FM, 1997, NEUROMUSCULAR DISORD, V7, P156, DOI 10.1016/S0960-8966(97)00444-6
   Santorelli FM, 1998, ANN NEUROL, V44, P962, DOI 10.1002/ana.410440616
   Santorelli FM, 2001, AM HEART J, V141, P1
   SARO W, 1994, J NEUROL SCI, V127, P236
   SATO W, 1994, BIOCHEM MOL BIOL INT, V33, P1055
   Scaglia F, 2004, AM J MED GENET A, V131A, P109, DOI 10.1002/ajmg.a.30319
   SCHAEFER AM, 2004, BIOCHIM BIOPHYS ACTA, V1695, P115
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   SCHAPR, 2006, LACNET, V368, P70
   Scheffler IE, 2001, ADV DRUG DELIVER REV, V49, P3, DOI 10.1016/S0169-409X(01)00123-5
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Schuelke M, 1998, ANN NEUROL, V44, P700, DOI 10.1002/ana.410440420
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Scuderi C, 2007, NEUROMUSCULAR DISORD, V17, P258, DOI 10.1016/j.nmd.2006.11.006
   SEIBEL P, 1994, BIOCHEM BIOPH RES CO, V204, P482, DOI 10.1006/bbrc.1994.2485
   Seki A, 1997, PEDIATR NEUROL, V17, P161, DOI 10.1016/S0887-8994(97)00080-5
   Seneca S, 2000, J INHERIT METAB DIS, V23, P853, DOI 10.1023/A:1026729223050
   Seneca S, 2005, AM J MED GENET A, V137A, P170, DOI 10.1002/ajmg.a.30854
   Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113
   Seneca S, 1998, J MED GENET, V35, P963, DOI 10.1136/jmg.35.11.963
   Sevior KB, 1998, AM J MED GENET, V75, P179, DOI 10.1002/(SICI)1096-8628(19980113)75:2<179::AID-AJMG11>3.0.CO;2-M
   Shaag A, 1997, BIOCHEM BIOPH RES CO, V233, P637, DOI 10.1006/bbrc.1997.6496
   Shin WS, 2000, AM J HUM GENET, V67, P1617, DOI 10.1086/316896
   SHOFFNER JM, 1993, AM J HUM GENET, V53, P949
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SHOFFNER JM, 1995, NEUROLOGY, V45, P286, DOI 10.1212/WNL.45.2.286
   Shtilbans A, 2000, J CHILD NEUROL, V15, P759, DOI 10.1177/088307380001501109
   Shtilbans A, 1999, J CHILD NEUROL, V14, P610, DOI 10.1177/088307389901400910
   SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Silvestri G, 1996, BIOCHEM BIOPH RES CO, V220, P623, DOI 10.1006/bbrc.1996.0453
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   Sissler M, 2004, RNA, V10, P841, DOI 10.1261/rna.5267604
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X
   Spinazzola A, 2004, NEUROMUSCULAR DISORD, V14, P815, DOI 10.1016/j.nmd.2004.09.002
   Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   SUE, NATUER, V52, P107
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   Suzuki H, 2007, J BIOL CHEM, V282, P4076, DOI 10.1074/jbc.M608187200
   SUZUKI S, 1994, DIABETES CARE, V17, P1428, DOI 10.2337/diacare.17.12.1428
   Suzuki Y, 1997, DIABETES CARE, V20, P1138, DOI 10.2337/diacare.20.7.1138
   Suzuki Y, 2004, DIABETES RES CLIN PR, V63, P225, DOI 10.1016/j.diabres.2003.10.024
   Swalwell H, 2006, NEUROLOGY, V66, P447, DOI 10.1212/01.wnl.0000196490.36349.83
   SWEENEY MG, 1993, Q J MED, V86, P435
   SWEENEY MG, 1993, Q J MED, V86, P709
   SZUR, 2004, J MED GENT, V14, P124
   TANAKA M, 1990, LANCET, V336, P1452, DOI 10.1016/0140-6736(90)93162-I
   TANIIKE M, 1992, BIOCHEM BIOPH RES CO, V186, P47, DOI 10.1016/S0006-291X(05)80773-9
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   Tay SKH, 2005, J CHILD NEUROL, V20, P142, DOI 10.1177/08830738050200022301
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Taylor RW, 2004, NEUROLOGY, V62, P1420, DOI 10.1212/01.WNL.0000120667.77372.46
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 2002, NEUROMUSCULAR DISORD, V12, P659, DOI 10.1016/S0960-8966(02)00026-3
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Terasaki F, 2001, JPN CIRC J, V65, P691, DOI 10.1253/jcj.65.691
   Thambisetty M, 2004, EXPERT REV MOL DIAGN, V4, P631, DOI 10.1586/14737159.4.5.631
   Tiranti V, 1999, NEUROMUSCULAR DISORD, V9, P66, DOI 10.1016/S0960-8966(98)00103-5
   Tiranti V, 1998, ANN NEUROL, V43, P98, DOI 10.1002/ana.410430116
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Tomari Y, 2003, J BIOL CHEM, V278, P16828, DOI 10.1074/jbc.M213216200
   Toompuu M, 1999, HUM MOL GENET, V8, P2275, DOI 10.1093/hmg/8.12.2275
   Toompuu M, 2004, BIOCHEM BIOPH RES CO, V322, P803, DOI 10.1016/j.bbrc.2004.07.181
   Toompuu M, 2002, J BIOL CHEM, V277, P22240, DOI 10.1074/jbc.M200338200
   Toyono M, 2001, NEUROMUSCULAR DISORD, V11, P300, DOI 10.1016/S0960-8966(00)00176-0
   Tryoen-Tóth P, 2003, J BIOL CHEM, V278, P24314, DOI 10.1074/jbc.M301530200
   Tsao CY, 2003, J CHILD NEUROL, V18, P62, DOI 10.1177/08830738030180011401
   Tsukuda K, 1997, DIABETIC MED, V14, P1032, DOI 10.1002/(SICI)1096-9136(199712)14:12<1032::AID-DIA504>3.0.CO;2-Y
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
   Tysoe C, 1996, J MED GENET, V33, P1002, DOI 10.1136/jmg.33.12.1002
   Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x
   Ueda Y, 2004, PEDIATR NEPHROL, V19, P107, DOI 10.1007/s00467-003-1318-7
   Uziel G, 2000, NEUROMUSCULAR DISORD, V10, P415, DOI 10.1016/S0960-8966(99)00115-7
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   Van Camp G, 2000, CLIN GENET, V57, P409, DOI 10.1034/j.1399-0004.2000.570601.x
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   VANDENOUWELAND JMW, 1992, NUCLEIC ACIDS RES, V20, P679, DOI 10.1093/nar/20.4.679
   Verhoeven K, 1999, EUR J HUM GENET, V7, P45, DOI 10.1038/sj.ejhg.5200247
   Verma A, 1996, NEUROLOGY, V46, P1334, DOI 10.1212/WNL.46.5.1334
   Verma A, 1997, PEDIATR RES, V42, P448, DOI 10.1203/00006450-199710000-00005
   Vialettes BH, 1997, DIABETES CARE, V20, P1731, DOI 10.2337/diacare.20.11.1731
   Vilarinho L, 1997, J INHERIT METAB DIS, V20, P704, DOI 10.1023/A:1005330611147
   Vilarinho L, 1997, J MED GENET, V34, P607, DOI 10.1136/jmg.34.7.607
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
   Vives-Bauza C, 2003, J INHERIT METAB DIS, V26, P507, DOI 10.1023/A:1025133629685
   Vives-Bauza C, 2001, ANN MED, V33, P493, DOI 10.3109/07853890109002099
   Wang YL, 1999, AM J HEMATOL, V60, P83, DOI 10.1002/(SICI)1096-8652(199901)60:1<83::AID-AJH19>3.0.CO;2-N
   Weber K, 1997, AM J HUM GENET, V60, P373
   Wedel T, 2003, EUR J PEDIATR SURG, V13, P201
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006
   Wittenhagen LM, 2003, NUCLEIC ACIDS RES, V31, P596, DOI 10.1093/nar/gkg131
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   Wong LJC, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.040626
   WONG LJ, 2007, IN PRESS MUSCLE NERV
   Wong LJC, 2002, AM J MED GENET, V113, P59, DOI 10.1002/ajmg.10767
   Yasukawa T, 2000, NUCLEIC ACIDS RES, V28, P3779, DOI 10.1093/nar/28.19.3779
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   YOON KL, 1991, BIOCHEM BIOPH RES CO, V176, P1112, DOI 10.1016/0006-291X(91)90399-R
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zeviani Massimo, 1993, European Journal of Human Genetics, V1, P80
   Zsurka G, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.022566
   2001, NUCL ACIDS RES, V29, P4334
NR 346
TC 50
Z9 54
U1 0
U2 12
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1547-6286
EI 1555-8584
J9 RNA BIOL
JI RNA Biol.
PD JAN-MAR
PY 2007
VL 4
IS 1
BP 38
EP 66
DI 10.4161/rna.4.1.4548
PG 29
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 256WS
UT WOS:000252761200007
PM 17617745
OA hybrid
DA 2024-11-01
ER

PT J
AU Mensah, EA
   Sarfo, B
   Yawson, AE
   Arthur, J
   Ocloo, A
AF Mensah, Eric A.
   Sarfo, Bismark
   Yawson, Alfred E.
   Arthur, Joshua
   Ocloo, Augustine
TI Knowledge and awareness of mitochondrial diseases among physicians in
   the tertiary hospitals in Ghana
SO PLOS ONE
LA English
DT Article
ID RESPIRATORY-CHAIN DISORDERS; DIAGNOSTIC-CRITERIA; METABOLOMICS;
   MANAGEMENT; COHORT
AB Background Mitochondrial diseases/disorders (MDs), for decades, have been identified as a key underlying condition for many chronic diseases globally. However, data on the knowledge and prevalence of MDs in many countries in sub-Saharan Africa are lacking. This study assessed the knowledge, and awareness, of MDs among senior medical doctors in the five tertiary hospitals in Ghana.
   Method Data were collected from one hundred and twenty-eight (128) medical doctors in the five Tertiary Hospitals in Ghana using both closed and open-ended questionnaires and analysed using descriptive statistics.
   Results Of the 128 respondents, 70.32% were senior medical officers and above, 87% of them indicated that they were aware of MDs and over 90% said physicians do not often diagnose MDs in Ghana. About 81% indicated that MDs are associated with chronic illnesses whilst 72% said the disease is diagnosed in both males and females. About 45% of the respondents alluded to the fact that MDs are difficult to diagnose, are associated with mutations in both the mitochondrial and the nuclear DNA, and are non-infectious diseases. Approximately 85% said nervous system dysfunction and muscle weakness are some of the symptoms associated with MDs whilst 77% said fatigue is also one of the symptoms. About 38% of the respondents specified that they encounter myopathies. A majority (70%) did not know about the availability of any consensus or standard diagnostic procedure and/or drugs for MDs.
   Conclusion There is a high level of knowledge and awareness of MDs among the respondents. However, there is a low disease encounter, which could be due to a lack of diagnostic protocols or a low disease prevalence. It is, therefore recommend that a patient perspective study, which looks at clinical records and laboratory data be conducted to fully ascertain the prevalence of MDs in Ghana and that appropriate educational strategies and interventions aimed at improving the diagnosis of mitochondrial diseases in Ghana be put in place.
C1 [Mensah, Eric A.; Ocloo, Augustine] Univ Ghana, Coll Basic & Appl Sci, Sch Biol Sci, Dept Biochem Cell & Mol Biol, Legon, Accra, Ghana.
   [Mensah, Eric A.] Univ Ghana, West African Ctr Cell Biol Infect Pathogens, Legon, Accra, Ghana.
   [Sarfo, Bismark] Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Dis Control, Legon, Accra, Ghana.
   [Yawson, Alfred E.] Univ Ghana, Dept Community Hlth, Med Sch, Coll Hlth Sci,Univ Ghana Korle Bu, Accra, Ghana.
   [Arthur, Joshua] Komfo Anokye Teaching Hosp, Publ Hlth Unit, Kumasi, Ghana.
C3 University of Ghana; University of Ghana; University of Ghana;
   University of Ghana; Kwame Nkrumah University Science & Technology
RP Ocloo, A (corresponding author), Univ Ghana, Coll Basic & Appl Sci, Sch Biol Sci, Dept Biochem Cell & Mol Biol, Legon, Accra, Ghana.
EM aocloo@ug.edu.gh
RI Arthur, Joshua/HGV-0940-2022; Ocloo, Augustine/AAD-6182-2020; YAWSON,
   ALFRED/R-8013-2019; Sarfo, Bismark/JAX-8677-2023
OI Ocloo, Augustine/0000-0003-1249-5349; Sarfo,
   Bismark/0000-0002-6995-6364; Arthur, Joshua/0000-0003-0315-784X
FU West African Centre for the Cell Biology of Infectious Pathogens
   (WACCBIP), University of Ghana, Legon
FX Data collection was supported by the West African Centre for the Cell
   Biology of Infectious Pathogens (WACCBIP), University of Ghana, Legon.
   The funders had no role in study design, data collection, and analysis,
   decision to publish, or preparation of the manuscript.
CR Afrifa J, 2019, MITOCHONDRION, V47, P238, DOI 10.1016/j.mito.2018.12.003
   Bajgain KT, 2021, AM J INFECT CONTROL, V49, P238, DOI 10.1016/j.ajic.2020.06.213
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Breton CV, 2019, MITOCHONDRION, V46, P22, DOI 10.1016/j.mito.2019.04.001
   Davison J., 2019, PAED CHILD HEALT-CAN, V29, P116
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Esterhuizen K, 2017, MITOCHONDRION, V35, P97, DOI 10.1016/j.mito.2017.05.012
   Forbes-Hernández TY, 2014, FOOD CHEM TOXICOL, V68, P154, DOI 10.1016/j.fct.2014.03.017
   Grier J, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000230
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hettiarachchi D, 2022, MITOCHONDRION, V62, P24, DOI 10.1016/j.mito.2021.10.007
   Houston BA, 2017, J CARD FAIL, V23, P652, DOI 10.1016/j.cardfail.2017.06.001
   Karaa A, 2019, MOL GENET METAB, V127, P122, DOI 10.1016/j.ymgme.2019.05.012
   Karaa A, 2019, MITOCHONDRION, V46, P214, DOI 10.1016/j.mito.2018.06.007
   Koene S, 2016, J INHERIT METAB DIS, V39, P705, DOI 10.1007/s10545-016-9948-7
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   Meldau S, 2018, CLIN GENET, V93, P1093, DOI 10.1111/cge.13208
   Menezes MJ, 2014, BBA-GEN SUBJECTS, V1840, P1368, DOI 10.1016/j.bbagen.2013.12.025
   Miller R.L., 2003, AZ SOCIAL RES DICT K
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Pal A, 2018, INDIAN J ANIM SCI, V88, P637
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Phoenix C, 2006, NEUROMUSCULAR DISORD, V16, P814, DOI 10.1016/j.nmd.2006.08.006
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Pulkes T, 2001, ADV DRUG DELIVER REV, V49, P27, DOI 10.1016/S0169-409X(01)00124-7
   Reinecke CJ, 2012, METABOLOMICS, V8, P264, DOI 10.1007/s11306-011-0309-0
   Saleh J, 2020, MITOCHONDRION, V54, P1, DOI 10.1016/j.mito.2020.06.008
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Singh K.K., 2015, Mitochondrion, V24, pS6
   Smeitink JAM, 2003, J INHERIT METAB DIS, V26, P199, DOI 10.1023/A:1024489218004
   Smuts I, 2010, J INHERIT METAB DIS, V33, pS95, DOI 10.1007/s10545-009-9031-8
   Taivassalo T, 2012, BRAIN, V135, P53, DOI 10.1093/brain/awr293
   van der Walt EM, 2012, EUR J HUM GENET, V20, P650, DOI 10.1038/ejhg.2011.262
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
NR 34
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 20
PY 2022
VL 17
IS 10
AR e0276549
DI 10.1371/journal.pone.0276549
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 8N3QK
UT WOS:000925064400104
PM 36264964
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Somasundaram, I
   Jain, SM
   Blot-Chabaud, M
   Pathak, S
   Banerjee, A
   Rawat, S
   Sharma, NR
   Duttaroy, AK
AF Somasundaram, Indumathi
   Jain, Samatha M.
   Blot-Chabaud, Marcel
   Pathak, Surajit
   Banerjee, Antara
   Rawat, Sonali
   Sharma, Neeta Raj
   Duttaroy, Asim K.
TI Mitochondrial dysfunction and its association with age-related disorders
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Review
DE mitochondrial dysfunction; mitochondrial DNA; ROS production;
   chromosomal aberrations; mitophagy
ID SKELETAL-MUSCLE MITOCHONDRIAL; OXIDATIVE STRESS; LIFE-SPAN; CELLULAR
   SENESCENCE; ANTIOXIDANT ENZYMES; DNA MUTATIONS; APOPTOSIS; AUTOPHAGY;
   DISEASE; HEALTH
AB Aging is a complex process that features a functional decline in many organelles. Various factors influence the aging process, such as chromosomal abnormalities, epigenetic changes, telomere shortening, oxidative stress, and mitochondrial dysfunction. Mitochondrial dysfunction significantly impacts aging because mitochondria regulate cellular energy, oxidative balance, and calcium levels. Mitochondrial integrity is maintained by mitophagy, which helps maintain cellular homeostasis, prevents ROS production, and protects against mtDNA damage. However, increased calcium uptake and oxidative stress can disrupt mitochondrial membrane potential and permeability, leading to the apoptotic cascade. This disruption causes increased production of free radicals, leading to oxidative modification and accumulation of mitochondrial DNA mutations, which contribute to cellular dysfunction and aging. Mitochondrial dysfunction, resulting from structural and functional changes, is linked to age-related degenerative diseases. This review focuses on mitochondrial dysfunction, its implications in aging and age-related disorders, and potential anti-aging strategies through targeting mitochondrial dysfunction.
   The figure shows the effect of mitochondrial dysfunction and mitophagy on stem cells leading to aging.
C1 [Somasundaram, Indumathi] Kolhapur Inst Technol Coll Engn, Biotechnol Engn, Dept Biotechnol Engn, Kolhapur, India.
   [Jain, Samatha M.; Pathak, Surajit; Banerjee, Antara] Chettinad Hosp & Res Inst, Chettinad Acad Res & Educ, Fac Allied Hlth Sci, Dept Biotechnol, Chennai, India.
   [Blot-Chabaud, Marcel] Aix Marseille Univ, C2VN, Marseille, France.
   [Rawat, Sonali] All India Inst Med Sci, DBT Ctr Excellence Stem Cell Res, Stem Cell Facil, New Delhi, India.
   [Sharma, Neeta Raj] Lovely Profess Univ, Sch Bioengn & Biosci, Phagwara, India.
   [Duttaroy, Asim K.] Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Nutr, Oslo, Norway.
C3 Aix-Marseille Universite; All India Institute of Medical Sciences
   (AIIMS) New Delhi; Lovely Professional University; University of Oslo
RP Somasundaram, I (corresponding author), Kolhapur Inst Technol Coll Engn, Biotechnol Engn, Dept Biotechnol Engn, Kolhapur, India.; Pathak, S (corresponding author), Chettinad Hosp & Res Inst, Chettinad Acad Res & Educ, Fac Allied Hlth Sci, Dept Biotechnol, Chennai, India.; Duttaroy, AK (corresponding author), Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Nutr, Oslo, Norway.
EM a.k.duttaroy@medisin.uio.no; drindumathisomasundaram@gmail.com;
   drsurajitpathak@care.edu.in
RI Blot-Chabaud, Marcel/D-4064-2017
FX The author(s) declare that no financial support was received for the
   research, authorship, and/or publication of this article.
CR Agil A, 2015, J PINEAL RES, V59, P70, DOI 10.1111/jpi.12241
   Alberts B., 2002, Molecular biology of the cell, V4th ed
   Andreux PA, 2019, NAT METAB, V1, P595, DOI 10.1038/s42255-019-0073-4
   [Anonymous], 2020, World population ageing 2019. Report ST/ESA/SER.A/444), DOI [10.18356/9789210051934, DOI 10.18356/9789210051934]
   Atayik MC, 2022, BIOGERONTOLOGY, V23, P401, DOI 10.1007/s10522-022-09973-y
   Bakula D, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00239
   Balcázar M, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00919
   Balmik AA, 2018, J ALZHEIMERS DIS, V62, P1481, DOI 10.3233/JAD-170900
   Bar-Ziv R, 2020, EMBO REP, V21, DOI 10.15252/embr.202050094
   Basu A, 2022, PHARMACOL THERAPEUT, V230, DOI 10.1016/j.pharmthera.2021.107943
   Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522
   Bernardini JP, 2017, ONCOGENE, V36, P1315, DOI 10.1038/onc.2016.302
   Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Boos F, 2020, TRENDS CELL BIOL, V30, P241, DOI 10.1016/j.tcb.2019.12.003
   BOWLING AC, 1995, LIFE SCI, V56, P1151, DOI 10.1016/0024-3205(95)00055-B
   Bratic A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9808
   Bratic I, 2010, BBA-BIOENERGETICS, V1797, P961, DOI 10.1016/j.bbabio.2010.01.004
   Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Burtscher J, 2023, AGING CELL, V22, DOI 10.1111/acel.13770
   Byun HO, 2012, EXP CELL RES, V318, P1808, DOI 10.1016/j.yexcr.2012.04.012
   Camell CD, 2021, SCIENCE, V373, DOI 10.1126/science.abe4832
   Camplejohn RS, 2003, BRIT J CANCER, V88, P487, DOI 10.1038/sj.bjc.6600767
   Pelegay EC, 2019, ADV EXP MED BIOL, V1134, P89, DOI 10.1007/978-3-030-12668-1_5
   Cedikova M, 2016, PHYSIOL RES, V65, pS519, DOI 10.33549/physiolres.933538
   Chapman J, 2019, FEBS LETT, V593, P1566, DOI 10.1002/1873-3468.13498
   CHATTERJEE A, 1967, TETRAHEDRON, V23, P1769, DOI 10.1016/S0040-4020(01)82575-8
   Chen G, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00200
   Chen HS, 2015, MOL CELL, V59, P719, DOI 10.1016/j.molcel.2015.07.011
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chistiakov DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238463
   Cho SJ, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24087628
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   Cloonan SM, 2020, EUR RESPIR REV, V29, DOI 10.1183/16000617.0165-2020
   Cohen AA, 2018, BBA-MOL BASIS DIS, V1864, P2680, DOI 10.1016/j.bbadis.2017.05.028
   Conte M, 2019, J GERONTOL A-BIOL, V74, P600, DOI 10.1093/gerona/gly153
   Costello MJ, 2013, EXP EYE RES, V116, P141, DOI 10.1016/j.exer.2013.08.017
   Crane JD, 2010, J GERONTOL A-BIOL, V65, P119, DOI 10.1093/gerona/glp179
   Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354
   Davalli P, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2389523
   Decout A, 2021, NAT REV IMMUNOL, V21, P548, DOI 10.1038/s41577-021-00524-z
   Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031
   Dziechciaz M, 2014, ANN AGR ENV MED, V21, P835, DOI 10.5604/12321966.1129943
   Eberle J, 2008, CURR GENOMICS, V9, P409, DOI 10.2174/138920208785699571
   Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Evangelou K, 2023, PHYSIOL REV, V103, DOI 10.1152/physrev.00007.2022
   Fivenson EM, 2017, NEUROCHEM INT, V109, P202, DOI 10.1016/j.neuint.2017.02.007
   Ganley IG, 2022, J CELL SCI, V135, DOI 10.1242/jcs.259748
   Gioscia-Ryan RA, 2016, AGING-US, V8, P2897, DOI 10.18632/aging.101099
   Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620
   Greenhalgh DG, 1998, INT J BIOCHEM CELL B, V30, P1019, DOI 10.1016/S1357-2725(98)00058-2
   Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308
   Indo HP, 2015, J CLIN BIOCHEM NUTR, V56, P1, DOI 10.3164/jcbn.14-42
   Iwashita M, 2007, EUR J PHARMACOL, V570, P38, DOI 10.1016/j.ejphar.2007.05.073
   Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759
   Jiang YH, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00512
   Jiménez-Loygorri JI, 2024, NAT COMMUN, V15, DOI 10.1038/s41467-024-45044-1
   Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Khan N, 2013, ANTIOXID REDOX SIGN, V19, P151, DOI 10.1089/ars.2012.4901
   Kietzmann T, 2017, BRIT J PHARMACOL, V174, P1533, DOI 10.1111/bph.13792
   Kizhakekuttu TJ, 2010, CARDIOVASC THER, V28, pe20, DOI 10.1111/j.1755-5922.2010.00137.x
   Kopustinskiene DM, 2021, PHARMACEUTICS, V13, DOI 10.3390/pharmaceutics13020129
   Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793
   Kowaltowski AJ, 2000, BRAZ J MED BIOL RES, V33, P241, DOI 10.1590/S0100-879X2000000200014
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Kurosaka K, 2003, J IMMUNOL, V171, P4672, DOI 10.4049/jimmunol.171.9.4672
   Kwak S, 2014, INFLAMM RES, V63, P779, DOI 10.1007/s00011-014-0750-4
   Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486
   Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009
   Lee SM, 2012, BIOGERONTOLOGY, V13, P525, DOI 10.1007/s10522-012-9397-0
   Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200
   Lemasters JJ, 2005, GASTROENTEROLOGY, V129, P351, DOI 10.1053/j.gastro.2005.06.006
   Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048
   Li Z, 2021, BIOGERONTOLOGY, V22, P165, DOI 10.1007/s10522-021-09910-5
   Liao ZH, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9121769
   Liu JP, 2014, CLIN EXP PHARMACOL P, V41, P445, DOI 10.1111/1440-1681.12247
   Liu L, 2002, AGING CELL, V1, P40, DOI 10.1046/j.1474-9728.2002.00004.x
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842
   Madreiter-Sokolowski CT, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030165
   Mahmoud YI, 2016, BIOTECH HISTOCHEM, V91, P86, DOI 10.3109/10520295.2015.1076578
   Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139
   Markovic ZS, 2011, J MOL MODEL, V17, P2575, DOI 10.1007/s00894-010-0942-y
   Martini H, 2023, FEBS J, V290, P1186, DOI 10.1111/febs.16361
   Marycz K, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4710326
   Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011
   Mitchell SJ, 2015, ANNU REV ANIM BIOSCI, V3, P283, DOI 10.1146/annurev-animal-022114-110829
   Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149
   Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08
   Molenaars M, 2020, CELL METAB, V31, P549, DOI 10.1016/j.cmet.2020.01.011
   Mondello C, 2010, SUBCELL BIOCHEM, V50, P307, DOI 10.1007/978-90-481-3471-7_16
   Morita M, 2017, MOL CELL, V67, P922, DOI 10.1016/j.molcel.2017.08.013
   Morita M, 2015, CELL CYCLE, V14, P473, DOI 10.4161/15384101.2014.991572
   Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001
   Mortensen M, 2010, CELL CYCLE, V9, P1901, DOI 10.4161/cc.9.10.11603
   Mottis A, 2019, SCIENCE, V366, P827, DOI 10.1126/science.aax3768
   Nehlin JO, 2023, ADV PROTEIN CHEM STR, V136, P217, DOI 10.1016/bs.apcsb.2023.02.020
   Nicolson GL, 2017, BBA-BIOMEMBRANES, V1859, P1704, DOI 10.1016/j.bbamem.2017.04.013
   Nicolson GL, 2014, ALTERN THER HEALTH M, V20, P18
   Nilsson MI, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020040
   Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956
   Norat P, 2020, NPJ REGEN MED, V5, DOI 10.1038/s41536-020-00107-x
   Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169
   Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2
   Palomera-Avalos V, 2017, MOL NEUROBIOL, V54, P1661, DOI 10.1007/s12035-016-9770-0
   Papácková Z, 2014, PHYSIOL RES, V63, P409, DOI 10.33549/physiolres.932684
   Paraskevaidi M, 2017, MUTAGENESIS, V32, P335, DOI 10.1093/mutage/gew058
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Pérez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x
   Pollack M, 2001, J GERONTOL A-BIOL, V56, pB475, DOI 10.1093/gerona/56.11.B475
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Rai SN, 2020, MOL NEUROBIOL, V57, P3075, DOI 10.1007/s12035-020-01945-y
   Ramos ES, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008085
   Ravindran J, 2011, APOPTOSIS, V16, P145, DOI 10.1007/s10495-010-0554-0
   Rinnerthaler M, 2015, BIOMOLECULES, V5, P545, DOI 10.3390/biom5020545
   Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow
   Ross JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Roy M, 2015, CURR OPIN CELL BIOL, V33, P111, DOI 10.1016/j.ceb.2015.02.001
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Saccon TD, 2021, J GERONTOL A-BIOL, V76, P1895, DOI 10.1093/gerona/glab002
   Salabei JK, 2013, REDOX BIOL, V1, P542, DOI 10.1016/j.redox.2013.10.011
   Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010
   Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006
   Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y
   Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445
   Shao YD, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.937502
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Shum LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155709
   Sonawane SK, 2019, ARCH BIOCHEM BIOPHYS, V675, DOI 10.1016/j.abb.2019.108119
   Srivastava S, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120398
   Stancu Andreea L, 2015, Discoveries (Craiova), V3, pe53, DOI 10.15190/d.2015.45
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tan DX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122124
   Taniguchi H, 2016, J CLIN ENDOCR METAB, V101, P190, DOI 10.1210/jc.2015-3308
   Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598
   Tower J, 2015, AGEING RES REV, V23, P90, DOI 10.1016/j.arr.2015.04.002
   Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TURK PW, 1995, CARCINOGENESIS, V16, P1253, DOI 10.1093/carcin/16.5.1253
   Tzameli I, 2012, TRENDS ENDOCRIN MET, V23, P417, DOI 10.1016/j.tem.2012.07.008
   van der Rijt S, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.594416
   van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Wall CE, 2019, CELL REP, V29, P3280, DOI 10.1016/j.celrep.2019.10.130
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wang J, 2020, ANGIOGENESIS, V23, P299, DOI 10.1007/s10456-020-09720-2
   Wang L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74102-z
   Wang R, 2021, SPECTROCHIM ACTA A, V253, DOI 10.1016/j.saa.2021.119605
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Wu Y, 2022, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.808120
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yan LJ, 2014, REDOX BIOL, V2, P165, DOI 10.1016/j.redox.2014.01.002
   Yang SS, 2020, MOL CELL BIOCHEM, V467, P1, DOI 10.1007/s11010-019-03667-9
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753
   Yoon YS, 2003, J BIOL CHEM, V278, P51577, DOI 10.1074/jbc.M308489200
   Youm YH, 2016, P NATL ACAD SCI USA, V113, P1026, DOI 10.1073/pnas.1514511113
   Yousefzadeh MJ, 2018, EBIOMEDICINE, V36, P18, DOI 10.1016/j.ebiom.2018.09.015
   Zhang HB, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.143420
   Zhang H, 2019, AM J PHYSIOL-ENDOC M, V316, pE829, DOI 10.1152/ajpendo.00439.2018
   Zhou ZX, 2022, AGEING RES REV, V81, DOI 10.1016/j.arr.2022.101702
   Zhu JH, 2013, AUTOPHAGY, V9, P1663, DOI 10.4161/auto.24135
   Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287
   Zimmermann A, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.656201
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
NR 176
TC 0
Z9 0
U1 9
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PD JUL 2
PY 2024
VL 15
AR 1384966
DI 10.3389/fphys.2024.1384966
PG 13
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA YU9K5
UT WOS:001271115000001
PM 39015222
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Brantová, O
   Tesarová, M
   Hansiková, H
   Elleder, M
   Zeman, J
   Sládková, J
AF Brantova, Olga
   Tesarova, Marketa
   Hansikova, Hana
   Elleder, Milan
   Zeman, Jiri
   Sladkova, Jana
TI Ultrastructural changes of mitochondria in the cultivated skin
   fibroblasts of patients with point mutations in mitochondrial DNA
SO ULTRASTRUCTURAL PATHOLOGY
LA English
DT Article
DE cristae; human skin fibroblasts; mitochondria; mitochondrial disease;
   mtDNA mutation; ultrastructure
ID BLUE-NATIVE-ELECTROPHORESIS; OXIDATIVE-PHOSPHORYLATION;
   ELECTRON-MICROSCOPY; LACTIC-ACIDOSIS; CELLS; MEMBRANE; DYNAMICS;
   PERMANGANATE; DYSFUNCTION; MORPHOLOGY
AB Mitochondrial disorders represent a heterogeneous group of multisystem diseases with extreme variability in clinical phenotype. The diagnosis of mitochondrial disorders relies heavily on extensive biochemical and molecular analyses combined with morphological studies including electron microscopy. Although muscle is the tissue of choice for electron microscopic studies, the authors investigated cultivated human skin fibroblasts (HSF) harboring 3 different pathologic mtDNA mutations: 3243A > G, 8344A > G, 8993T > G. They addressed to the possibility of whether mtDNA mutations influence mitochondrial morphology in HSF and if ultrastructural changes of mitochondria may be used for differential diagnostics of mitochondrial disorders caused by mtDNA mutations. Ultrastructural analysis of patients' HSF revealed a heterogeneous mixture of mainly abnormal, partially swelling mitochondria with unusual and sparse cristae. The most characteristic cristal abnormalities were heterogeneity in size and shapes or their absence. Typical filamentous and branched mitochondria with numerous cristae as appeared in control HSF were almost not observed. In all lines of cultured HSF with various mtDNA mutations, similar ultrastructural abnormalities and severely changed mitochondrial interior were found, although no alterations in function and amount of OXPHOS were detected by routinely used biochemical methods in two lines of cultured HSF. This highlights the importance of morphological analysis, even in cultured fibroblasts, in diagnostics of mitochondrial disorders.
C1 Charles Univ, Dept Paediat, Fac Med, Prague 12808 2, Czech Republic.
C3 Charles University Prague
RP Sládková, J (corresponding author), Charles Univ, Dept Paediat, Fac Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.
EM jsladkova@centrum.cz
RI Hansikova, Hana/E-9350-2017; Zeman, Jiri/K-2691-2017; Tesarova,
   Marketa/I-1531-2016
OI Zeman, Jiri/0000-0002-2678-7919; Tesarova, Marketa/0000-0002-5141-2289
CR Bakker A, 2000, PEDIATR RES, V48, P143, DOI 10.1203/00006450-200008000-00005
   BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Gilkerson RW, 2003, FEBS LETT, V546, P355, DOI 10.1016/S0014-5793(03)00633-1
   Handran SD, 1997, NEUROBIOL DIS, V3, P287, DOI 10.1006/nbdi.1996.0125
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HAYASHI JI, 1994, J BIOL CHEM, V269, P19060
   KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523
   LEA PJ, 1994, MICROSC RES TECHNIQ, V27, P269, DOI 10.1002/jemt.1070270402
   LUFT JH, 1956, J BIOPHYS BIOCHEM CY, V2, P799, DOI 10.1083/jcb.2.6.799
   Mannella CA, 2001, IUBMB LIFE, V52, P93, DOI 10.1080/15216540152845885
   Marusich MF, 1997, BBA-MOL BASIS DIS, V1362, P145, DOI 10.1016/S0925-4439(97)00061-6
   Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221
   Procaccio V, 1999, J CLIN INVEST, V104, P83, DOI 10.1172/JCI6184
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   SONG JD, 1991, J STRUCT BIOL, V107, P106, DOI 10.1016/1047-8477(91)90014-N
NR 21
TC 19
Z9 19
U1 0
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0191-3123
J9 ULTRASTRUCT PATHOL
JI Ultrastruct. Pathol.
PD JUL-AUG
PY 2006
VL 30
IS 4
BP 239
EP 245
DI 10.1080/01913120600820112
PG 7
WC Microscopy; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microscopy; Pathology
GA 083XD
UT WOS:000240490600001
PM 16971348
DA 2024-11-01
ER

PT J
AU Grazina, M
   Pratas, J
   Silva, F
   Oliveira, S
   Santana, I
   Oliveira, C
AF Grazina, M
   Pratas, J
   Silva, F
   Oliveira, S
   Santana, I
   Oliveira, C
TI Genetic basis of Alzheimer's dementia: role of mtDNA mutations
SO GENES BRAIN AND BEHAVIOR
LA English
DT Review
DE 16S rRNA; age of onset; Alzheimer's disease; amyloid; gene;
   mitochondria; mtDNA; ND1; oxidative stress; point mutation
ID AMYLOID-BETA-PEPTIDE; CYTOCHROME-C-OXIDASE; MITOCHONDRIAL-DNA MUTATIONS;
   POINT MUTATIONS; PRECURSOR PROTEIN; OXIDATIVE DAMAGE; A-BETA;
   PARKINSONS-DISEASE; NADH DEHYDROGENASE; APOLIPOPROTEIN-E
AB Alzheimer's disease (AD) is the most common neurodegenerative disorder associated to dementia in late adulthood. Amyloid precursor protein, presenilin 1 and presenilin 2 genes have been identified as causative genes for familial AD, whereas apolipoprotein E epsilon 4 allele has been associated to the risk for late onset AD. However, mutations on these genes do not explain the majority of cases. Mitochondrial respiratory chain (MRC) impairment has been detected in brain, muscle, fibroblasts and platelets of Alzheimer's patients, indicating a possible involvement of mitochondrial DNA (mtDNA) in the aetiology of the disease. Several reports have identified mtDNA mutations in Alzheimer's patients, suggesting the existence of related causal factors probably of mtDNA origin, thus pointing to the involvement of mtDNA in the risk contributing to dementia, but there is no consensual opinion in finding the cause for impairment. However, mtDNA mutations might modify age of onset, contributing to the neurodegenerative process, probably due to an impairment of MRC and/or translation mechanisms.
C1 Univ Coimbra, Fac Med, Inst Biochem, P-3004504 Coimbra, Portugal.
   Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.
   Univ Hosp Coimbra, Neurol Unit, Coimbra, Portugal.
C3 Universidade de Coimbra; Universidade de Coimbra; Universidade de
   Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC)
RP Univ Coimbra, Fac Med, Inst Biochem, Rua Larga, P-3004504 Coimbra, Portugal.
EM catarina@cnc.cj.uc.pt
RI Silva, Filipe/P-1339-2016; Pratas, João/N-5309-2019; Oliveira,
   Catarina/F-3685-2010; Grazina, Manuela/W-3759-2017
OI Grazina, Manuela/0000-0002-1173-6481; Oliveira,
   Catarina/0000-0001-6942-4328; Santana, Isabel/0000-0002-8114-9434
CR Abe T, 2002, J NEUROSCI RES, V70, P447, DOI 10.1002/jnr.10349
   Aksenov MY, 1999, NEUROCHEM RES, V24, P767, DOI 10.1023/A:1020783614031
   Aliev G, 2003, NEUROL RES, V25, P665, DOI 10.1179/016164103101201977
   Aliyev A, 2005, J NEUROL SCI, V229, P285, DOI 10.1016/j.jns.2004.11.040
   Alzheimer A., 1907, Allgemeine Zeitschrift fur Psychiatrie und psychisch-gerichtliche Medizin, P146
   Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Apelt J, 2004, INT J DEV NEUROSCI, V22, P475, DOI 10.1016/j.ijdevneu.2004.07.006
   Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0
   Arias C, 2002, EXP NEUROL, V176, P163, DOI 10.1006/exnr.2002.7912
   Beal MF, 2004, J BIOENERG BIOMEMBR, V36, P381, DOI 10.1023/B:JOBB.0000041772.74810.92
   BEHL C, 1992, BIOCHEM BIOPH RES CO, V186, P944, DOI 10.1016/0006-291X(92)90837-B
   BEHL C, 1994, BRAIN RES, V645, P253, DOI 10.1016/0006-8993(94)91659-4
   Behl C, 2005, SUB CELL BIOCHEM, V38, P65
   BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7
   BLANCHARD BJ, 1993, NEUROREPORT, V4, P799, DOI 10.1097/00001756-199306000-00051
   BLASS JP, 1991, REV NEUROL, V147, P513
   Blass JP, 2001, J NEUROSCI RES, V66, P851, DOI 10.1002/jnr.10087
   Bonilla E, 1999, BBA-BIOENERGETICS, V1410, P171, DOI 10.1016/S0005-2728(98)00165-0
   BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   BROWN MD, 1994, J BIOENERG BIOMEMBR, V26, P273, DOI 10.1007/BF00763099
   Burns MP, 2003, MOL BRAIN RES, V110, P119, DOI 10.1016/S0169-328X(02)00647-2
   Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6
   Byrne E, 2002, J CLIN NEUROSCI, V9, P497, DOI 10.1054/jocn.2001.0991
   CANDY JM, 1983, J NEUROL SCI, V59, P277, DOI 10.1016/0022-510X(83)90045-X
   Canevari L, 2004, NEUROCHEM RES, V29, P637, DOI 10.1023/B:NERE.0000014834.06405.af
   Cardoso SM, 2005, BRAIN RES, V1050, P1, DOI 10.1016/j.brainres.2005.04.078
   Cardoso SM, 2004, J NEUROCHEM, V89, P1417, DOI 10.1111/j.1471-4159.2004.02438.x
   Cardoso SM, 2004, NEUROBIOL AGING, V25, P105, DOI 10.1016/S0197-4580(03)00033-2
   Cardoso SM, 2001, FASEB J, V15, P1439, DOI 10.1096/fj.00-0561fje
   Cardoso SM, 2002, BRAIN RES, V931, P117, DOI 10.1016/S0006-8993(02)02256-4
   Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463
   Casadesus G, 2005, CELL MOL LIFE SCI, V62, P293, DOI 10.1007/s00018-004-4384-0
   Casley CS, 2002, J NEUROCHEM, V80, P91, DOI 10.1046/j.0022-3042.2001.00681.x
   Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389
   Castellani RJ, 2004, AGEING RES REV, V3, P319, DOI 10.1016/j.arr.2004.01.002
   CHALMERS RM, 1995, J NEUROL, V242, P332, DOI 10.1007/BF00878877
   Chang SW, 2000, BIOCHEM BIOPH RES CO, V273, P203, DOI 10.1006/bbrc.2000.2885
   Chong ZZ, 2005, BRAIN RES REV, V49, P1, DOI 10.1016/j.brainresrev.2004.11.005
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   Cortopassi G. A., 1994, American Journal of Human Genetics, V55, pA149
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   DAVIS JN, 1995, MOL MED TODAY, V1, P240, DOI 10.1016/S1357-4310(95)91532-X
   Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526
   de la Monte SM, 2000, LAB INVEST, V80, P1323, DOI 10.1038/labinvest.3780140
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   Dickson DW, 2004, J CLIN INVEST, V114, P23, DOI 10.1172/JC1200422317
   Dong HH, 2004, J NEUROSCI, V24, P8950, DOI 10.1523/JNEUROSCI.2106-04.2004
   DUARA R, 1993, NEUROLOGY, V43, P1377, DOI 10.1212/WNL.43.7.1377
   Eckert A, 2003, BIOCHEM PHARMACOL, V66, P1627, DOI 10.1016/S0006-2952(03)00534-3
   Edland SD, 2002, ALZ DIS ASSOC DIS, V16, P1, DOI 10.1097/00002093-200201000-00001
   Edland SD, 1996, NEUROLOGY, V47, P254, DOI 10.1212/WNL.47.1.254
   Egensperger R, 1997, NEUROPATH APPL NEURO, V23, P315, DOI 10.1046/j.1365-2990.1997.4098040.x
   Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004
   Fodero LR, 2004, J NEUROCHEM, V88, P1186, DOI 10.1046/j.1471-4159.2003.02296.x
   Franciosi S, 2005, J NEUROIMMUNOL, V159, P66, DOI 10.1016/j.jneuroim.2004.10.006
   German DC, 2004, REV NEUROSCIENCE, V15, P353, DOI 10.1515/REVNEURO.2004.15.5.353
   Ghosh SS, 1999, ANN NY ACAD SCI, V893, P176, DOI 10.1111/j.1749-6632.1999.tb07825.x
   Gibson GE, 2002, FRONT BIOSCI, V7, pD1007, DOI 10.2741/gibson
   Gibson GE, 1998, AGE, V21, P7, DOI 10.1007/s11357-998-0002-z
   Gleason CE, 2005, CELL MOL LIFE SCI, V62, P299, DOI 10.1007/s00018-004-4385-z
   Golde TE, 2003, J CLIN INVEST, V111, P11, DOI 10.1172/JCI200317527
   Graeber MB, 1998, J NEUROSCI RES, V52, P1
   Grazina M, 2005, EUR NEUROL, V53, P121, DOI 10.1159/000085555
   Grazina M, 2004, NEUROBIOL DIS, V15, P306, DOI 10.1016/j.nbd.2003.11.004
   Guo L, 2004, J MOL NEUROSCI, V23, P205, DOI 10.1385/JMN:23:3:205
   Hamblet NS, 1997, MUTAT RES-FUND MOL M, V379, P253, DOI 10.1016/S0027-5107(97)00158-9
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   HARRIS ME, 1995, NEUROREPORT, V6, P1875, DOI 10.1097/00001756-199510020-00013
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   HESS J, 1995, LANCET, V346, P189, DOI 10.1016/S0140-6736(95)91251-7
   Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001
   Hirano M, 1997, P NATL ACAD SCI USA, V94, P14894, DOI 10.1073/pnas.94.26.14894
   HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532
   Howland DS, 1998, J BIOL CHEM, V273, P16576, DOI 10.1074/jbc.273.26.16576
   Hoyer A, 2005, J NEURAL TRANSM, V112, P239, DOI 10.1007/s00702-004-0176-1
   HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892
   Hutchin TP, 1997, BIOCHEM BIOPH RES CO, V241, P221, DOI 10.1006/bbrc.1997.7793
   Inestrosa NC, 2005, SUB CELL BIOCHEM, V38, P299
   Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008
   Ito S, 1999, P NATL ACAD SCI USA, V96, P2099, DOI 10.1073/pnas.96.5.2099
   Janetzky B, 1996, EUR NEUROL, V36, P149, DOI 10.1159/000117233
   Katayama T, 2004, J CHEM NEUROANAT, V28, P67, DOI 10.1016/j.jchemneu.2003.12.004
   Kawahara M, 2004, CURR ALZHEIMER RES, V1, P87, DOI 10.2174/1567205043332234
   Khan SM, 2000, ANN NEUROL, V48, P148, DOI 10.1002/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Klemm T, 2001, EXP CLIN ENDOCR DIAB, V109, P283, DOI 10.1055/s-2001-16348
   Kok CC, 2000, NEUROMUSCULAR DISORD, V10, P604, DOI 10.1016/S0960-8966(00)00144-9
   Kontush A, 2004, ANN NY ACAD SCI, V1031, P249, DOI 10.1196/annals.1331.025
   Kosel S, 1998, NEUROGENETICS, V1, P197, DOI 10.1007/s100480050029
   KOSEL S, 1994, BIOCHEM BIOPH RES CO, V203, P745, DOI 10.1006/bbrc.1994.2245
   KUMAR U, 1994, LIFE SCI, V54, P1855, DOI 10.1016/0024-3205(94)90142-2
   Kuo YM, 1996, J BIOL CHEM, V271, P4077
   LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960
   Lee HC, 1997, J BIOMED SCI, V4, P319, DOI 10.1007/BF02258357
   Lee HG, 2004, J ALZHEIMERS DIS, V6, P137
   Lendon CL, 1997, JAMA-J AM MED ASSOC, V277, P825, DOI 10.1001/jama.277.10.825
   LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622
   Li R, 2004, J NEUROSCI, V24, P1760, DOI 10.1523/JNEUROSCI.4580-03.2004
   LIN FH, 1992, BIOCHEM BIOPH RES CO, V182, P238, DOI 10.1016/S0006-291X(05)80136-6
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230
   Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204
   Maillet M, 2004, CURR ALZHEIMER RES, V1, P79, DOI 10.2174/1567205043332252
   Manczak M, 2004, NEUROMOL MED, V5, P147, DOI 10.1385/NMM:5:2:147
   Mark RJ, 1996, MOL NEUROBIOL, V12, P211, DOI 10.1007/BF02755589
   Mark RJ, 1997, J NEUROCHEM, V68, P255
   Mattson MP, 2004, ANN NY ACAD SCI, V1012, P37, DOI 10.1196/annals.1306.004
   Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3
   Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510
   Meltzer CC, 1998, NEUROPSYCHOPHARMACOL, V18, P407
   Mighore L, 2005, NEUROBIOL AGING, V26, P567, DOI 10.1016/j.neurobiolaging.2004.07.016
   Moreira P, 2000, ANTIOXID REDOX SIGN, V2, P317, DOI 10.1089/ars.2000.2.2-317
   Moreira PI, 2001, BIOSCIENCE REP, V21, P789, DOI 10.1023/A:1015536808304
   Mori T, 2001, J NEUROPATH EXP NEUR, V60, P778, DOI 10.1093/jnen/60.8.778
   NOLLER HF, 1991, ANNU REV BIOCHEM, V60, P191, DOI 10.1146/annurev.bi.60.070191.001203
   O'Day DH, 2004, BIOCHEM BIOPH RES CO, V320, P1051, DOI 10.1016/j.bbrc.2004.06.070
   OBAYASHI T, 1992, AM HEART J, V124, P1263, DOI 10.1016/0002-8703(92)90410-W
   Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425
   OZAWA T, 1991, BIOCHEM BIOPH RES CO, V177, P518, DOI 10.1016/0006-291X(91)92014-B
   PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302
   Pereira C, 1998, NEUROREPORT, V9, P1749, DOI 10.1097/00001756-199806010-00015
   Pereira C, 2005, CNS NEUROL DISORD-DR, V4, P383, DOI 10.2174/1568007054546117
   Pereira C, 2004, J MOL NEUROSCI, V23, P97, DOI 10.1385/JMN:23:1-2:097
   PEREIRA C, 2001, MITOCHONDRIAL UBIQUI, P283
   PETRUZZELLA V, 1992, BIOCHEM BIOPH RES CO, V186, P491, DOI 10.1016/S0006-291X(05)80834-4
   Praticò D, 2005, NEUROBIOL AGING, V26, P581, DOI 10.1016/j.neurobiolaging.2004.09.020
   Praticò D, 2002, ARCH NEUROL-CHICAGO, V59, P972, DOI 10.1001/archneur.59.6.972
   Praticò D, 2000, ANN NEUROL, V48, P809, DOI 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9
   Qiu XZ, 2001, BRAIN RES, V893, P261, DOI 10.1016/S0006-8993(00)03190-5
   Rademakers Rosa, 2003, ScientificWorldJournal, V3, P497
   Reddy PH, 2004, HUM MOL GENET, V13, P1225, DOI 10.1093/hmg/ddh140
   Rogers JT, 2004, CURR DRUG TARGETS, V5, P535, DOI 10.2174/1389450043345272
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Ruppert V, 2004, BIOCHEM BIOPH RES CO, V318, P535, DOI 10.1016/j.bbrc.2004.04.061
   Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704
   SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467
   SCHAPIRA AHV, 1994, MOVEMENT DISORD, V9, P125, DOI 10.1002/mds.870090202
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047
   Shie FS, 2002, NEUROREPORT, V13, P455, DOI 10.1097/00001756-200203250-00019
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Simpkins JW, 2005, CELL MOL LIFE SCI, V62, P271, DOI 10.1007/s00018-004-4382-2
   Sternberg D, 1998, HUM MOL GENET, V7, P33, DOI 10.1093/hmg/7.1.33
   Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626
   STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330
   STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399
   Sullivan PG, 2005, PROG NEURO-PSYCHOPH, V29, P407, DOI 10.1016/j.pnpbp.2004.12.007
   Sung S, 2004, FASEB J, V18, DOI 10.1096/fj.03-0961fje
   Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045
   Swerdlow RH, 2002, INT REV NEUROBIOL, V53, P341
   Takuma K, 2005, J PHARMACOL SCI, V97, P312, DOI 10.1254/jphs.CPJ04006X
   Tannenberg RK, 2004, CURR ALZHEIMER RES, V1, P11, DOI 10.2174/1567205043480591
   Tanno Y, 1998, NEUROBIOL AGING, V19, pS47, DOI 10.1016/S0197-4580(98)00028-1
   TERRY RD, 1983, ANN NEUROL, V14, P497, DOI 10.1002/ana.410140502
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Trimmer PA, 2000, EXP NEUROL, V162, P37, DOI 10.1006/exnr.2000.7333
   Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009
   Tysoe C, 1996, J MED GENET, V33, P1002, DOI 10.1136/jmg.33.12.1002
   VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Vance JE, 2005, SEMIN CELL DEV BIOL, V16, P193, DOI 10.1016/j.semcdb.2005.01.005
   Verkhratsky A, 2003, J CELL MOL MED, V7, P351, DOI 10.1111/j.1582-4934.2003.tb00238.x
   Vina Jose, 2004, Molecular Aspects of Medicine, V25, P117, DOI 10.1016/j.mam.2004.02.013
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Walker ES, 2005, J NEUROCHEM, V92, P294, DOI 10.1111/j.1471-4159.2004.02858.x
   Wallace D. C., 1992, American Journal of Human Genetics, V51, pA30
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   Wallace DC, 1997, P NATL ACAD SCI USA, V94, P14900, DOI 10.1073/pnas.94.26.14900
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010
   Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174
   Webber KM, 2005, ANN NY ACAD SCI, V1052, P201, DOI 10.1196/annals.1347.020
   Webber KM, 2004, ACTA NEUROBIOL EXP, V64, P113, DOI 10.55782/ane-2004-1497
   White JA, 2005, NEUROBIOL DIS, V18, P459, DOI 10.1016/j.nbd.2004.12.013
   Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x
   Wragg MA, 1995, NEUROSCI LETT, V201, P107, DOI 10.1016/0304-3940(95)12146-3
   Yan SD, 2005, INT J EXP PATHOL, V86, P161, DOI 10.1111/j.0959-9673.2005.00427.x
   Zhu Xiongwei, 2004, Am J Alzheimers Dis Other Demen, V19, P345, DOI 10.1177/153331750401900611
NR 183
TC 39
Z9 51
U1 1
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1601-1848
EI 1601-183X
J9 GENES BRAIN BEHAV
JI Genes Brain Behav.
PY 2006
VL 5
SU 2
BP 92
EP 107
DI 10.1111/j.1601-183X.2006.00225.x
PG 16
WC Behavioral Sciences; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Behavioral Sciences; Neurosciences & Neurology
GA 036TO
UT WOS:000237098600009
PM 16681804
OA Bronze, Green Submitted
DA 2024-11-01
ER

PT J
AU Catteruccia, M
   Sauchelli, D
   Della Marca, G
   Primiano, G
   Cuccagna, C
   Bernardo, D
   Leo, M
   Camporeale, A
   Sanna, T
   Cianfoni, A
   Servidei, S
AF Catteruccia, Michela
   Sauchelli, Donato
   Della Marca, Giacomo
   Primiano, Guido
   Cuccagna, Cristina
   Bernardo, Daniela
   Leo, Milena
   Camporeale, Antonella
   Sanna, Tommaso
   Cianfoni, Alessandro
   Servidei, Serenella
TI "Myo-cardiomyopathy" is commonly associated with the A8344G "MERRF"
   mutation
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Mitochondrial encephalomyopathies; MERRF syndrome; Cardiomyopathy;
   Respiratory insufficiency
ID RAGGED-RED FIBERS; MITOCHONDRIAL-DNA; MYOCLONIC EPILEPSY;
   LACTIC-ACIDOSIS; PULMONARY-HYPERTENSION; CARDIAC INVOLVEMENT; OXIDASE
   DEFICIENCY; CLINICAL-FEATURES; LEIGH-DISEASE; DISORDERS
AB The objective of the study was to better characterize the clinical phenotype associated with the A8344G "MERRF" mutation of mitochondrial DNA. Fifteen mutated patients were extensively investigated. The frequency of main clinical features was: exercise intolerance and/or muscle weakness 67 %, respiratory involvement 67 %, lactic acidosis 67 %, cardiac abnormalities 53 %, peripheral neuropathy 47 %, myoclonus 40 %, epilepsy 40 %, ataxia 13 %. A restrictive respiratory insufficiency requiring ventilatory support was observed in about half of our patients. One patient developed a severe and rapidly progressive cardiomyopathy requiring cardioverter-defibrillator implantation. Five patients died of overwhelming, intractable lactic acidosis. Serial muscle MRIs identified a consistent pattern of muscle involvement and progression. Cardiac MRI showed non-ischemic late gadolinium enhancement in the left ventricle inferolateral part as early sign of myocardial involvement. Brain spectroscopy demonstrated increased peak of choline and reduction of N-acetylaspartate. Lactate was never detected in brain areas, while it could be documented in ventricles. We confirm that muscle involvement is the most frequent clinical feature associated with A8443G mutation. In contrast with previous reports, however, about half of our patients did not develop signs of CNS involvement even in later stages of the disease. The difference may be related to the infrequent investigation of A8344G mutation in 'pure' mitochondrial myo-cardiomyopathy, representing a bias and a possible cause of syndrome's underestimation. Our study highlights the importance of lactic acidosis and respiratory muscle insufficiency as critical prognostic factors. Muscle and cardiac MRI and brain spectroscopy may be useful tools in diagnosis and follow-up of MERRF.
C1 [Catteruccia, Michela; Sauchelli, Donato; Della Marca, Giacomo; Primiano, Guido; Cuccagna, Cristina; Bernardo, Daniela; Servidei, Serenella] Univ Cattolica Sacro Cuore, Dept Geriatr Neurosci & Orthoped, Inst Neurol, I-00168 Rome, Italy.
   [Catteruccia, Michela] Bambino Gesii Childrens Hosp, Mol Med Lab, Unit Neuromuscular & Neurodegenerat Disorders, Dept Neurosci & Neurorehabil, Rome, Italy.
   [Leo, Milena; Camporeale, Antonella; Sanna, Tommaso] Univ Cattolica Sacro Cuore, Inst Cardiol, I-00168 Rome, Italy.
   [Cianfoni, Alessandro] Lugano Hosp, Neuroradiol, Neuroctr Southern Switzerland, Lugano, Switzerland.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli;
   Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli
RP Servidei, S (corresponding author), Univ Cattolica Sacro Cuore, Dept Geriatr Neurosci & Orthoped, Inst Neurol, Largo A Gemelli 8, I-00168 Rome, Italy.
EM s.servidei@rm.unicatt.it
RI Sanna, Tommaso/AAC-9487-2021; Catteruccia, Michela/AAB-5714-2020;
   Camporeale, Antonia/K-9012-2016; Cuccagna, Cristina/AAB-3967-2019;
   Servidei, Serenella/ABC-4262-2021; Primiano, Guido/AAB-7829-2019; Della
   Marca, Giacomo/A-8159-2010
OI Primiano, Guido/0000-0001-7616-7008; SANNA, Tommaso/0000-0002-5760-6885;
   Sauchelli, Donato/0000-0003-0254-0767; Della Marca,
   Giacomo/0000-0001-6914-799X; SERVIDEI, Serenella/0000-0001-8478-2799;
   Cuccagna, Cristina/0000-0001-8180-2942; Camporeale,
   Antonia/0000-0001-7604-0496
FU Telethon [GUP09004]
FX This study was partially supported by Telethon Grant GUP09004.
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   Chuang CS, 2007, NEUROL INDIA, V55, P385
   DiMauro S, 2002, ADV NEUROL, V89, P217
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Finsterer J, 2013, BRAIN DEV-JPN, V35, P466, DOI 10.1016/j.braindev.2012.07.015
   FUKUHARA N, 1991, REV NEUROL, V147, P476
   FUKUHARA N, 1995, MUSCLE NERVE, pS90
   Hirano M, 1994, CHILD NEUROL, V9, P4, DOI DOI 10.1177/088307389400900102
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Ito S, 2008, AM J NEURORADIOL, V29, P392, DOI 10.3174/ajnr.A0865
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   KENDALL BE, 1992, AM J NEURORADIOL, V13, P621
   LOMBES A, 1989, ANN NEUROL, V26, P20, DOI 10.1002/ana.410260104
   Mancuso M, 2007, BIOCHEM BIOPH RES CO, V354, P1058, DOI 10.1016/j.bbrc.2007.01.099
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   MATTHEWS PM, 1993, NEUROLOGY, V43, P2484, DOI 10.1212/WNL.43.12.2484
   Orcesi S, 2006, J CHILD NEUROL, V21, P79, DOI 10.1177/08830738060210010901
   Sanger TD, 1996, PEDIATR NEUROL, V14, P57, DOI 10.1016/0887-8994(95)00226-X
   Scalais E, 2007, Eur J Neurol, V14, pe3, DOI 10.1111/j.1468-1331.2007.01926.x
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   SILVESTRI G, 1996, BIOCHEM BIOPH RES CO, V20, P221
   SPROULE BJ, 1966, CAN MED ASSOC J, V94, P141
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   TEPLINSKY K, 1990, AM J PHYSIOL, V258, pH1193, DOI 10.1152/ajpheart.1990.258.4.H1193
   Tsao CY, 2003, J CHILD NEUROL, V18, P62, DOI 10.1177/08830738030180011401
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wiedemann FR, 2008, CLIN NEUROL NEUROSUR, V110, P859, DOI 10.1016/j.clineuro.2008.06.010
   Yilmaz A, 2012, CLIN RES CARDIOL, V101, P255, DOI 10.1007/s00392-011-0387-z
   Zaganas I, 2009, J NEUROL, V256, P271, DOI 10.1007/s00415-009-0921-3
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
NR 33
TC 40
Z9 44
U1 0
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD MAR
PY 2015
VL 262
IS 3
BP 701
EP 710
DI 10.1007/s00415-014-7632-0
PG 10
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA CE0BX
UT WOS:000351469200025
PM 25559684
DA 2024-11-01
ER

PT J
AU Pätsi, J
   Maliniemi, P
   Pakanen, S
   Hinttala, R
   Uusimaa, J
   Majamaa, K
   Nyström, T
   Kervinen, M
   Hassinen, IE
AF Patsi, Jukka
   Maliniemi, Pilvi
   Pakanen, Salla
   Hinttala, Reetta
   Uusimaa, Johanna
   Majamaa, Kari
   Nystrom, Thomas
   Kervinen, Marko
   Hassinen, Ilmo E.
TI LHON/MELAS overlap mutation in ND1 subunit of mitochondrial complex I
   affects ubiquinone binding as revealed by modeling in <i>Escherichia
   coli</i> NDH-1
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article
DE Escherichia coli; Leber hereditary optic neuropathy; MELAS;
   Mitochondria; NADH-ubiquinone oxidoreductase; Ubiquinone
ID HEREDITARY OPTIC NEUROPATHY; MEMBRANE DOMAIN; REDUCTION KINETICS; ACIDIC
   RESIDUES; 49-KDA SUBUNIT; NADH; OXIDOREDUCTASE; DEFICIENCY; GENES; DNA
AB Defects in complex 1 due to mutations in mitochondrial DNA are associated with clinical features ranging from single organ manifestation like Leber hereditary optic neuropathy (LHON) to multiorgan disorders like mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome. Specific mutations cause overlap syndromes combining several phenotypes, but the mechanisms of their biochemical effects are largely unknown. The m.3376G>A transition leading to p.E24K substitution in ND1 with LHON/MELAS phenotype was modeled here in a homologous position (NuoH-E36K) in the Escherichia coli enzyme and it almost totally abolished complex I activity. The more conservative mutation NuoH-E36Q resulted in higher apparent K-m for ubiquinone and diminished inhibitor sensitivity. A NuoH homolog of the m.3865A > G transition, which has been found concomitantly in the overlap syndrome patient with the m.3376G>A, had only a minor effect. Consequences of a primary LHON-mutation m.3460G > A affecting the same extramembrane loop as the m.3376G > A substitution were also studied in the E. coli model and were found to be mild. The results indicate that the overlap syndrome-associated m.3376G > A transition in MTND1 is the pathogenic mutation and m.3865A>G transition has minor, if any, effect on presentation of the disease. The kinetic effects of the NuoH-E36Q mutation suggest its proximity to the putative ubiquinone binding domain in 49 kD/PSST subunits. In all, m.3376G > A perturbs ubiquinone binding, a phenomenon found in LHON, and decreases the activity of fully assembled complex I as in MELAS. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Pakanen, Salla; Kervinen, Marko] Univ Oulu, Dept Ophthalmol, Inst Clin Med, FIN-90014 Oulu, Finland.
   [Patsi, Jukka; Maliniemi, Pilvi; Kervinen, Marko; Hassinen, Ilmo E.] Univ Oulu, Dept Med Biochem & Mol Biol, Inst Biomed, FIN-90014 Oulu, Finland.
   [Pakanen, Salla; Uusimaa, Johanna] Univ Oulu, Dept Paediat, Inst Clin Med, FIN-90014 Oulu, Finland.
   [Hinttala, Reetta; Majamaa, Kari] Univ Oulu, Dept Neurol, Inst Clin Med, FIN-90014 Oulu, Finland.
   [Pakanen, Salla; Hinttala, Reetta; Uusimaa, Johanna; Majamaa, Kari; Kervinen, Marko] Univ Oulu, Oulu Univ Hosp, Clin Res Ctr, FIN-90014 Oulu, Finland.
   [Nystrom, Thomas] Univ Gothenburg, Dept Cell & Mol Biol, SE-40530 Gothenburg, Sweden.
C3 University of Oulu; University of Oulu; University of Oulu; University
   of Oulu; University of Oulu; University of Gothenburg
RP Kervinen, M (corresponding author), Univ Oulu, Dept Ophthalmol, Inst Clin Med, POB 5000, FIN-90014 Oulu, Finland.
EM marko.kervinen@oulu.fi; ilmo.hassinen@oulu.fi
RI Majamaa, Kari/A-1344-2012; Maliniemi, Pilvi/J-1001-2016
OI Hinttala, Reetta/0000-0002-7642-4008; Majamaa, Kari/0000-0002-9070-3791;
   Maliniemi, Pilvi/0000-0002-7360-154X
FU Academy of Finland Council for Health and Council for Biosciences and
   Environment; Sigrid Juselius foundation; Academy of Finland [216378];
   Eye Foundation; Evald and Hilda Nissi Foundation; Finnish Medical
   Foundation; Oulu University Scholarship foundation; Foundation for
   Paediatric Research; Alfred Kordelin Foundation; Alma and K.A. Snellman
   Foundation; Emil Aaltonen Foundation; Arvo and Lea Ylppo Foundation;
   Academy of Finland (AKA) [216378] Funding Source: Academy of Finland
   (AKA)
FX M.K. wishes to thank Dr Martin Lovmar for valuable discussions on
   inhibitor binding kinetics. We are indebted to Mrs. Aila Holappa and
   Mrs. Raija Pietila for their skillful technical assistance. Financial
   support by grants from the Academy of Finland Council for Health and
   Council for Biosciences and Environment, Sigrid Juselius foundation
   (I.H.), ERA-AGE FLARE program (Academy of Finland project #216378), The
   Eye Foundation (Silmasaatio), Evald and Hilda Nissi Foundation, Finnish
   Medical Foundation (M.K.), Oulu University Scholarship foundation (J.
   P.), the Foundation for Paediatric Research (J.U.), Alfred Kordelin
   Foundation, The Alma and K.A. Snellman Foundation, Emil Aaltonen
   Foundation (R.H.), and the Arvo and Lea Ylppo Foundation (J.U.) is also
   gratefully acknowledged.
CR Ahlers PM, 2000, J BIOL CHEM, V275, P23577, DOI 10.1074/jbc.M002074200
   Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050
   Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026
   Björklöf K, 2000, FEBS LETT, V467, P105, DOI 10.1016/S0014-5793(00)01130-3
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200
   Cortés A, 2001, BIOCHEM J, V357, P263, DOI 10.1042/0264-6021:3570263
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330
   Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066
   Fendel U, 2008, BBA-BIOENERGETICS, V1777, P660, DOI 10.1016/j.bbabio.2008.04.033
   FRIEDRICH T, 1994, EUR J BIOCHEM, V219, P691, DOI 10.1111/j.1432-1033.1994.tb19985.x
   Gerencer Laszlo, 2004, Acta Biologica Szegediensis, V48, P25
   Ghelli A, 1997, MOL ASPECTS MED, V18, pS263
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grönlund MA, 2010, BRIT J OPHTHALMOL, V94, P121, DOI 10.1136/bjo.2008.154187
   Hinttala R, 2010, MITOCHONDRION, V10, P358, DOI 10.1016/j.mito.2010.02.002
   Horváth R, 2008, NEUROMUSCULAR DISORD, V18, P553, DOI 10.1016/j.nmd.2008.05.002
   Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046
   HUOPONEN K, 1991, AM J HUM GENET, V48, P1147
   Kakutani N, 2010, BIOCHEMISTRY-US, V49, P4794, DOI 10.1021/bi100454b
   Kashani-Poor N, 2001, J BIOL CHEM, V276, P24082, DOI 10.1074/jbc.M102296200
   Kervinen M, 2004, BIOCHEMISTRY-US, V43, P773, DOI 10.1021/bi0355903
   Kervinen M, 2006, HUM MOL GENET, V15, P2543, DOI 10.1093/hmg/ddl176
   King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Kurki S, 2000, BIOCHEMISTRY-US, V39, P13496, DOI 10.1021/bi001134s
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Liang M, 2009, BIOCHEM BIOPH RES CO, V383, P286, DOI 10.1016/j.bbrc.2009.03.097
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lunardi J, 1998, BBA-MOL BASIS DIS, V1407, P114, DOI 10.1016/S0925-4439(98)00036-2
   Majander A, 1996, EUR J BIOCHEM, V239, P201, DOI 10.1111/j.1432-1033.1996.0201u.x
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Maliniemi P, 2009, MITOCHONDRION, V9, P394, DOI 10.1016/j.mito.2009.07.001
   Matsuoka R, 1999, BIOCHEM BIOPH RES CO, V257, P228, DOI 10.1006/bbrc.1999.0443
   Montoya J., 2009, BIOCHIM BIOPHYS ACTA, V1787, P470
   Moslemi AR, 2008, NEUROPEDIATRICS, V39, P24, DOI 10.1055/s-2008-1076739
   Okun JG, 1999, J BIOL CHEM, V274, P2625, DOI 10.1074/jbc.274.5.2625
   Pätsi J, 2008, BIOCHEM J, V409, P129, DOI 10.1042/BJ20070866
   Pohl T, 2007, BIOCHEMISTRY-US, V46, P10694, DOI 10.1021/bi701057t
   Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809
   Sazanov LA, 2003, J BIOL CHEM, V278, P19483, DOI 10.1074/jbc.M208959200
   Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6
   Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x
   Sinegina L, 2005, BIOCHEMISTRY-US, V44, P8500, DOI 10.1021/bi050134v
   Sinha PK, 2009, J BIOL CHEM, V284, P9814, DOI 10.1074/jbc.M809468200
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tocilescu MA, 2007, J BIOL CHEM, V282, P29514, DOI 10.1074/jbc.M704519200
   Tocilescu MA, 2010, BBA-BIOENERGETICS, V1797, P625, DOI 10.1016/j.bbabio.2010.01.029
   Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
   Zickermann V, 1998, BIOCHEMISTRY-US, V37, P11792, DOI 10.1021/bi9810555
NR 58
TC 16
Z9 19
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 1879-2650
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD FEB
PY 2012
VL 1817
IS 2
BP 312
EP 318
DI 10.1016/j.bbabio.2011.10.014
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 892CW
UT WOS:000300265300007
PM 22079202
OA Bronze
DA 2024-11-01
ER

PT J
AU Yang, YL
   Sun, F
   Zhang, Y
   Qian, N
   Yuan, Y
   Wang, ZX
   Qi, Y
   Xiao, JX
   Wang, XY
   Qi, ZY
   Zhang, YH
   Jiang, YW
   Bao, XH
   Qin, J
   Wu, XR
AF Yang, YL
   Sun, F
   Zhang, Y
   Qian, N
   Yuan, Y
   Wang, ZX
   Qi, Y
   Xiao, JX
   Wang, XY
   Qi, ZY
   Zhang, YH
   Jiang, YW
   Bao, XH
   Qin, J
   Wu, XR
TI Clinical and laboratory survey of 65 Chinese patients with Leigh
   syndrome
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE Leigh syndrome; mitochondrial genes; cytochrome c oxidase deficiency;
   SURF1 gene
ID CYTOCHROME-C-OXIDASE; SURF1 GENE-MUTATIONS; MITOCHONDRIAL-DNA;
   DEFICIENCY; CHILDREN; DISEASE; GC/MS
AB Background Leigh syndrome is an inherited neurodegenerative disease that emerges in infancy and childhood and presents with a clinically heterogeneous variety of neuromuscular and non-neuromuscular disorders. It can result from the inheritance of mutations in either nuclear or mitochondrial DNA. In the current study, we performed a retrospective study in 65 patients in order to investigate the clinical and genetic characteristics of Leigh syndrome in Chinese patients.
   Methods Sixty-five unrelated cases (35 men and 30 women) who were hospitalized in the past 12 years were reviewed. Diagnosis was based on both the clinical presentation and the characteristic neuropathologic findings of bilateral symmetric necrotizing lesions in the basal ganglia and brain stem as detected using cranial computed tomography (CT) scan or magnetic resonance imaging (MRI). The differential diagnosis of organic acidurias and fatty acid beta-oxidation defects were performed. Specific point mutations and deletions in mitochondrial DNA (T8993G; T8993C, T9176C, A8344G, A3243G) were screened by PCR-restriction analysis and Southern blot. The SURF1 gene was sequenced. Skeletal muscle biopsies were performed in 17 (26.2%) of the patients. The diagnosis was confirmed by autopsy in 6 (9.2%) patients.
   Results The patients had various forms of metabolic encephalomyopathy. Fifty-nine (90.8%) of the patients had the typical neuroradiological features of Leigh syndrome, including symmetrical necrotizing lesions scattered within the basal ganglia, thalamus and brain stem. Twenty (30.8%) patients were confirmed by genetic, biochemical analysis and autopsy. Specific point mutations in mitochondrial DNA were found in 5 cases (7.7%). Of these, the A8344G mutation was detected in 2 patients. The T8993G, T8993C, and A3243G point mutations were identified in 3 other patients, respectively. SURF1 mutations associated with cytochrome c oxidase deficiency were identified in 8 (12.3%) families by DNA sequencing. A G604C mutation was identified in 6 (9.2%) patients. The genotypes of 52 patients remained unknown.
   Conclusions Leigh syndrome presents as a diverse array of clinical features and can result from specific mutations in nuclear or mitochondrial DNA. In this study, SURF1 mutations associated with cytochrome c oxidase deficiency were identified in 8 (12.3%) out of 65 patients with Leigh syndrome. It indicates that SURF1 mutations might be a common cause of Leigh syndrome in China. The etiology of Leigh syndrome in Chinese patients represents a persistent challenge to clinicians.
C1 Peking Univ, Hosp 1, Dept Pediat, Beijing 100034, Peoples R China.
   Peking Univ, Hosp 1, Dept Neurol, Beijing 100034, Peoples R China.
   Peking Univ, Hosp 1, Cent Lab, Beijing 100034, Peoples R China.
   Peking Univ, Hosp 1, Dept Med Radiol, Beijing 100034, Peoples R China.
C3 Peking University; Peking University; Peking University; Peking
   University
RP Peking Univ, Hosp 1, Dept Pediat, Beijing 100034, Peoples R China.
EM organic.acid@126.com
OI Zhang, Yuehua/0000-0003-1432-5423
CR Akagi M, 2002, NEUROMUSCULAR DISORD, V12, P53, DOI 10.1016/S0960-8966(01)00242-5
   Darin N, 2003, NEUROPEDIATRICS, V34, P311
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Fu XW, 2000, EARLY HUM DEV, V58, P41, DOI 10.1016/S0378-3782(00)00053-0
   Fujii T, 1998, PEDIATR NEUROL, V18, P275, DOI 10.1016/S0887-8994(97)00187-2
   Head RA, 2004, J INHERIT METAB DIS, V27, P57, DOI 10.1023/B:BOLI.0000016622.05609.b8
   Hori D, 2005, BRAIN DEV-JPN, V27, P39, DOI 10.1016/j.braindev.2004.04.004
   Jiang YW, 2002, J CHILD NEUROL, V17, P450, DOI 10.1177/088307380201700611
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Moroni I, 2002, NEUROPEDIATRICS, V33, P79, DOI 10.1055/s-2002-32372
   Moslemi AR, 2003, NEUROLOGY, V61, P991, DOI 10.1212/01.WNL.0000082391.98672.0A
   Munnich A., 2001, METABOLIC MOL BASES, P2261
   Ogawa Y, 2002, PEDIATR NEUROL, V26, P196, DOI 10.1016/S0887-8994(01)00382-4
   Poyau A, 1999, FEBS LETT, V462, P416, DOI 10.1016/S0014-5793(99)01571-9
   Rossi A, 2003, AM J NEURORADIOL, V24, P1188
   Sacconi S, 2003, PEDIATR RES, V53, P224, DOI 10.1203/01.PDR.0000048100.91730.6A
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Shigematsu Y, 2002, J CHROMATOGR B, V776, P39, DOI 10.1016/S1570-0232(02)00077-6
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Sue CM, 1999, J PEDIATR-US, V134, P696, DOI 10.1016/S0022-3476(99)70283-0
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   [王朝霞 Wang Zhaoxia], 2003, [中华神经科杂志, Chinese Journal of Neurology], V36, P28
   Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 24
TC 32
Z9 43
U1 0
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0366-6999
EI 2542-5641
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD MAR 5
PY 2006
VL 119
IS 5
BP 373
EP 377
DI 10.1097/00029330-200603010-00004
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 021NT
UT WOS:000235990600004
PM 16542579
OA gold
DA 2024-11-01
ER

PT J
AU Shabalina, IG
   Vyssokikh, MY
   Gibanova, N
   Csikasz, RI
   Edgar, D
   Hallden-Waldemarson, A
   Rozhdestvenskaya, Z
   Bakeeva, LE
   Vays, VB
   Pustovidko, AV
   Skulachev, MV
   Cannon, B
   Skulachev, VP
   Nedergaard, J
AF Shabalina, Irina G.
   Vyssokikh, Mikhail Yu.
   Gibanova, Natalia
   Csikasz, Robert I.
   Edgar, Daniel
   Hallden-Waldemarson, Anne
   Rozhdestvenskaya, Zinaida
   Bakeeva, Lora E.
   Vays, Valeria B.
   Pustovidko, Antonina V.
   Skulachev, Maxim V.
   Cannon, Barbara
   Skulachev, Vladimir P.
   Nedergaard, Jan
TI Improved health-span and lifespan in mtDNA mutator mice treated with the
   mitochondrially targeted antioxidant SkQ1
SO AGING-US
LA English
DT Article
DE reactive oxygen species; oxidative stress; mitochondria; cardiolipin;
   thermogenesis; brown adipose tissue; longevity
ID OXIDATIVE STRESS; ADIPOSE-TISSUE; DNA MUTATIONS; FATTY-ACID; ASSAY; AGE;
   GENERATION; PREVENTION; PHENOTYPES; MUSCLE
AB MtDNA mutator mice exhibit marked features of premature aging. We find that these mice treated from age of approximate to 100 days with the mitochondria-targeted antioxidant SkQ1 showed a delayed appearance of traits of aging such as kyphosis, alopecia, lowering of body temperature, body weight loss, as well as ameliorated heart, kidney and liver pathologies. These effects of SkQ1 are suggested to be related to an alleviation of the effects of an enhanced reactive oxygen species (ROS) level in mtDNA mutator mice: the increased mitochondrial ROS released due to mitochondrial mutations probably interact with polyunsaturated fatty acids in cardiolipin, releasing malondialdehyde and 4-hydroxynonenal that form protein adducts and thus diminishes mitochondrial functions. SkQ1 counteracts this as it scavenges mitochondrial ROS. As the results, the normal mitochondrial ultrastructure is preserved in liver and heart; the phosphorylation capacity of skeletal muscle mitochondria as well as the thermogenic capacity of brown adipose tissue is also improved. The SkQ1-treated mice live significantly longer (335 versus 290 days). These data may be relevant in relation to treatment of mitochondrial diseases particularly and the process of aging in general.
C1 [Shabalina, Irina G.; Gibanova, Natalia; Csikasz, Robert I.; Edgar, Daniel; Hallden-Waldemarson, Anne; Rozhdestvenskaya, Zinaida; Cannon, Barbara; Nedergaard, Jan] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.
   [Vyssokikh, Mikhail Yu.; Bakeeva, Lora E.; Vays, Valeria B.; Pustovidko, Antonina V.; Skulachev, Vladimir P.] Lomonosov Moscow State Univ, Belozersky Inst Physico Chem Biol, Moscow 119992, Russia.
   [Bakeeva, Lora E.; Skulachev, Maxim V.; Skulachev, Vladimir P.] Moscow MV Lomonosov State Univ, Inst Mitoengineering, Moscow 119992, Russia.
   [Edgar, Daniel] Buck Inst Res aging, Novato, CA 94945 USA.
C3 Stockholm University; Lomonosov Moscow State University; Lomonosov
   Moscow State University; Buck Institute for Research on Aging
RP Nedergaard, J (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.; Skulachev, VP (corresponding author), Lomonosov Moscow State Univ, Belozersky Inst Physico Chem Biol, Moscow 119992, Russia.
EM skulach@belozersky.msu.ru; jan@metabol.su.se
RI Nedergaard, Jan/A-1706-2010; Skulachev, Maxim/AAD-1869-2019; Shabalina,
   Irina/AAC-3720-2019; Skulachev, Vladimir/J-4164-2012; Cannon,
   Barbara/B-3089-2016; Vyssokikh, Mikhail/H-4744-2014
OI Cannon, Barbara/0000-0001-6594-2363; Skulachev,
   Maxim/0000-0001-6147-8583; Skulachev, Vladimir/0000-0001-5141-7517;
   Nedergaard, Jan/0000-0003-2070-1587; Vyssokikh,
   Mikhail/0000-0002-4047-6201
FU Mitotech; Russian Scientific Foundation [14-24-00107, 14-50-00029];
   Swedish Research Council; Knut and Alice Wallenberg Foundation; Russian
   Science Foundation [17-24-00014] Funding Source: Russian Science
   Foundation
FX This study was supported by Mitotech (phospholipid studies) and Russian
   Scientific Foundation (mitochondrial in vitro studies, project No
   14-24-00107 and life span studies, project No 14-50-00029). JN, BC are
   supported by the Swedish Research Council and the Knut and Alice
   Wallenberg Foundation.
CR Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Anisimov VN, 2011, AGING-US, V3, P1110, DOI 10.18632/aging.100404
   Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438
   BARTLETT GR, 1959, J BIOL CHEM, V234, P466
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Cottrell D A, 2000, Curr Opin Clin Nutr Metab Care, V3, P473, DOI 10.1097/00075197-200011000-00009
   Currais A, 2015, AGEING RES REV, V21, P30, DOI 10.1016/j.arr.2015.02.001
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Fischer AW, 2016, AM J PHYSIOL-ENDOC M, V311, pE202, DOI 10.1152/ajpendo.00093.2016
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Goonesinghe A, 2005, BIOCHEM J, V387, P109, DOI 10.1042/BJ20041389
   Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Kanyicska B, 2003, ENDOCRINE, V20, P53, DOI 10.1385/ENDO:20:1-2:53
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kolesar JE, 2014, FREE RADICAL BIO MED, V75, P241, DOI 10.1016/j.freeradbiomed.2014.07.038
   Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukat A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004385
   Kukat A, 2011, BIOCHEM BIOPH RES CO, V409, P394, DOI 10.1016/j.bbrc.2011.04.145
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x
   Li XY, 2016, ARTERIOSCL THROM VAS, V36, P1090, DOI 10.1161/ATVBAHA.115.306964
   Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212
   Lokhmatikov AV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1081, DOI 10.1134/S0006297914100101
   Manskikh VN, 2015, HISTOL HISTOPATHOL, V30, P353, DOI 10.14670/HH-30.353
   Mizuno S, 2014, MAMM GENOME, V25, P327, DOI 10.1007/s00335-014-9524-0
   Nacarelli T, 2016, HEALTHY AGEING LONG, V4, P169, DOI 10.1007/978-3-319-26239-0_10
   Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005
   Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Scialò F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009
   Shabalina IG, 2006, J BIOL CHEM, V281, P13882, DOI 10.1074/jbc.M601387200
   Shabalina IG, 2014, BBA-BIOENERGETICS, V1837, P2017, DOI 10.1016/j.bbabio.2014.04.005
   Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044
   Shabalina IG, 2011, BIOCHEM SOC T, V39, P1305, DOI 10.1042/BST0391305
   Shabalina IG, 2010, BBA-BIOENERGETICS, V1797, P968, DOI 10.1016/j.bbabio.2010.02.033
   Skulachev VP, 2010, BBA-BIOENERGETICS, V1797, P878, DOI 10.1016/j.bbabio.2010.03.015
   Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008
   Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x
   Thompson LV, 2006, EXP GERONTOL, V41, P1220, DOI 10.1016/j.exger.2006.10.018
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871
   Vyssokikh Mikhail Y, 2015, Methods Mol Biol, V1265, P149, DOI 10.1007/978-1-4939-2288-8_12
   Wallace D C, 2001, Novartis Found Symp, V235, P247
   Wang Y, 2015, SCIENCE, V350, P1204, DOI 10.1126/science.aac4357
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   Wiswedel I, 2010, FREE RADICAL RES, V44, P135, DOI 10.3109/10715760903352841
   Yagi K, 1998, Methods Mol Biol, V108, P101
NR 55
TC 72
Z9 80
U1 3
U2 14
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD FEB
PY 2017
VL 9
IS 2
BP 315
EP 339
DI 10.18632/aging.101174
PG 25
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EO7TH
UT WOS:000396892500005
PM 28209927
OA gold, Green Submitted, Green Published
DA 2024-11-01
ER

PT S
AU McFarland, R
   Taylor, RW
   Turnbull, DM
AF McFarland, R.
   Taylor, R. W.
   Turnbull, D. M.
BE StJohn, JC
TI Mitochondrial disease - Its impact, etiology, and pathology
SO MITOCHONDRION IN THE GERMLINE AND EARLY DEVELOPMENT
SE Current Topics in Developmental Biology
LA English
DT Review
ID HEREDITARY OPTIC NEUROPATHY; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   CYTOCHROME-C-OXIDASE; STROKE-LIKE EPISODES; COMPLEX-I DEFICIENCY;
   RAGGED-RED FIBERS; RESPIRATORY-CHAIN ACTIVITY; TRANSFER RNALEU(UUR)
   GENE; SUBSTANTIA-NIGRA NEURONS; DNA REPLICATION BUBBLE
AB Mitochondria are ubiquitous organelles that are intimately involved in many cellular processes, but whose principal task is to provide the energy necessary for normal cell functioning and maintenance. Disruption of this energy supply can have devastating consequences for the cell, organ, and individual. Over the last two decades, mutations in both mitochondrial DNA (mtDNA) and nuclear DNA have been identified as causative in a number of well-characterized clinical syndromes, although for mtDNA mutations in particular, this relationship between genotype and phenotype is often not straightforward. Despite this, a number of epidemiological studies have been undertaken to assess the prevalence of mtDNA mutations and these have highlighted the impact that mtDNA disease has on both the community and individual families. Although there has been considerable improvement in the diagnosis of mitochondrial disorders, disappointingly this has not been matched by developments toward effective treatment. Nevertheless, our understanding of mitochondrial biology is gathering pace and progress in this area will be crucial to devising future treatment strategies. In addition to mitochondrial disease, evidence for a central role of mitochondria in other processes, such as aging and neurodegeneration, is slowly accumulating, although their role in cancer remains controversial. In this chapter, we discuss these issues and offer our own views based on our cumulative experience of investigating and managing these diseases over the last 20 years. (c) 2007, Elsevier Inc.
C1 Newcastle Univ, Sch Med, Mitochondrial Res Grp, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP McFarland, R (corresponding author), Newcastle Univ, Sch Med, Mitochondrial Res Grp, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
OI McFarland, Robert/0000-0002-8833-2688
FU MRC [G108/539] Funding Source: UKRI; Medical Research Council [G108/539]
   Funding Source: Medline; Wellcome Trust Funding Source: Medline
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Biggin A, 2005, MOL GENET METAB, V84, P61, DOI 10.1016/j.ymgme.2004.09.011
   Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P404, DOI 10.1016/S0968-0004(03)00165-8
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Bykhovskaya Y, 2004, MOL GENET METAB, V83, P199, DOI 10.1016/j.ymgme.2004.07.009
   Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012
   Campos Y, 2001, NEUROMUSCULAR DISORD, V11, P477, DOI 10.1016/S0960-8966(00)00223-6
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   CHANG DD, 1984, CELL, V36, P635, DOI 10.1016/0092-8674(84)90343-X
   CHANG DD, 1985, EMBO J, V4, P1559, DOI 10.1002/j.1460-2075.1985.tb03817.x
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2005, LANCET, V366, P1650, DOI 10.1016/S0140-6736(05)67492-2
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, ANN NEUROL, V47, P381, DOI 10.1002/1531-8249(200003)47:3<381::AID-ANA17>3.0.CO;2-2
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   CLAYTON DA, 1992, INT REV CYTOL, V141, P217, DOI 10.1016/S0074-7696(08)62067-7
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859
   D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326
   DAMIAN MS, 1995, ACTA NEUROL SCAND, V92, P409
   de Coo IFM, 1998, NEUROLOGY, V50, P293, DOI 10.1212/WNL.50.1.293
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2003, AM J MED GENET A, V121A, P126, DOI 10.1002/ajmg.a.20171
   Deschauer M, 1999, NEUROMUSCULAR DISORD, V9, P305, DOI 10.1016/S0960-8966(99)00019-X
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Elson JL, 2001, AM J HUM GENET, V68, P145, DOI 10.1086/316938
   Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   FANG W, 1993, ARCH NEUROL-CHICAGO, V50, P977, DOI 10.1001/archneur.1993.00540090074013
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   Gabaldón T, 2004, BBA-BIOENERGETICS, V1659, P212, DOI 10.1016/j.bbabio.2004.07.011
   Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465
   GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4
   GOTO Y, 1992, ANN NEUROL, V31, P672, DOI 10.1002/ana.410310617
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Griggs RC, 1999, NEW ENGL J MED, V341, P1077, DOI 10.1056/NEJM199909303411411
   GROHMANN K, 1978, NUCLEIC ACIDS RES, V5, P637, DOI 10.1093/nar/5.3.637
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573
   GUENTHARD J, 1995, ARCH DIS CHILD, V72, P223, DOI 10.1136/adc.72.3.223
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   HANNA MG, 1995, J NEUROL SCI, V130, P154, DOI 10.1016/0022-510X(95)00022-T
   Hao R, 2004, FEBS LETT, V578, P135, DOI 10.1016/j.febslet.2004.11.004
   HARDING AE, 1995, MUSCLE NERVE, pS82
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   He L, 2003, LEUKEMIA, V17, P2487, DOI 10.1038/sj.leu.2403146
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Huoponen K, 2001, NEUROGENETICS, V3, P119, DOI 10.1007/s100480100115
   HUTTENLOCHER PR, 1976, ARCH NEUROL-CHICAGO, V33, P186, DOI 10.1001/archneur.1976.00500030042009
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Jerónimo C, 2001, ONCOGENE, V20, P5195, DOI 10.1038/sj.onc.1204646
   Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177
   Jones JB, 2001, CANCER RES, V61, P1299
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Khogali SS, 2001, LANCET, V357, P1265, DOI 10.1016/S0140-6736(00)04422-6
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kirches E, 2001, INT J CANCER, V93, P534, DOI 10.1002/ijc.1375
   Kleiner L, 1996, Optom Clin, V5, P77
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Lister R, 2005, MOL MEMBR BIOL, V22, P87, DOI 10.1080/09687860500041247
   Lodi R, 1999, P NATL ACAD SCI USA, V96, P11492, DOI 10.1073/pnas.96.20.11492
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Lutsenko S, 1998, P NATL ACAD SCI USA, V95, P6004, DOI 10.1073/pnas.95.11.6004
   MACKEY DA, 1992, AUST NZ J OPHTHALMOL, V20, P177, DOI 10.1111/j.1442-9071.1992.tb00937.x
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Margineantu DH, 2002, MITOCHONDRION, V1, P425, DOI 10.1016/S1567-7249(02)00006-5
   MARGULIS L, 1976, EXP PARASITOL, V39, P277, DOI 10.1016/0014-4894(76)90127-2
   MARTINUZZI A, 1992, J NEUROL SCI, V113, P222, DOI 10.1016/0022-510X(92)90250-O
   MATTHES M, 1982, J VIROL, V42, P301, DOI 10.1128/JVI.42.1.301-305.1982
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067
   Meirelles FV, 1997, GENETICS, V145, P445
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   *MITOMAP, 2005, HUM MIT GEN DAT
   *MITOMAP, 2006, HUM MIT GEN DAT
   MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195
   MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORIKAWA Y, 1993, VIRCHOWS ARCH A, V423, P227, DOI 10.1007/BF01614775
   MORTEN KJ, 1995, HUM MOL GENET, V4, P1689
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OBERMAIERKUSSER B, 1991, FEBS LETT, V286, P67, DOI 10.1016/0014-5793(91)80942-V
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   OLDFORS A, 1995, ACTA NEUROPATHOL, V90, P328
   OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   POULTON J, 1995, MUSCLE NERVE       S, V3, P154
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Rigoli L, 2001, DIABETIC MED, V18, P334, DOI 10.1046/j.1464-5491.2001.00429-2.x
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saker PJ, 1997, DIABETIC MED, V14, P42, DOI 10.1002/(SICI)1096-9136(199701)14:1<42::AID-DIA295>3.0.CO;2-T
   Santorelli F M, 2001, Am Heart J, V141, pE1, DOI 10.1067/mhj.2001.112088
   Sato A, 2005, P NATL ACAD SCI USA, V102, P6057, DOI 10.1073/pnas.0408666102
   SAUNIER P, 1995, NEUROMUSCULAR DISORD, V5, P285, DOI 10.1016/0960-8966(94)00071-G
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   SCHON EA, 1992, BIOCHIM BIOPHYS ACTA, V1101, P206, DOI 10.1016/0005-2728(92)90226-R
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shoubridge EA, 2002, NAT GENET, V31, P227, DOI 10.1038/ng0702-227
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Sissler M, 2004, RNA, V10, P841, DOI 10.1261/rna.5267604
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2004, NEUROMUSCULAR DISORD, V14, P815, DOI 10.1016/j.nmd.2004.09.002
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Steuerwald N, 2000, ZYGOTE, V8, P209, DOI 10.1017/S0967199400001003
   STONE EM, 1992, J CLIN NEURO-OPHTHAL, V12, P10
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Toompuu M, 2002, J BIOL CHEM, V277, P22240, DOI 10.1074/jbc.M200338200
   TRAFF J, 1995, ACTA NEUROL SCAND, V92, P394
   Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Twelves D, 2003, MOVEMENT DISORD, V18, P19, DOI 10.1002/mds.10305
   Uusimaa J, 2000, PEDIATRICS, V105, P598, DOI 10.1542/peds.105.3.598
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van den Bosch BJC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e89
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   Wong VA, 2002, OPHTHALMOLOGY, V109, P1023, DOI 10.1016/S0161-6420(02)01009-6
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1990, AM J HUM GENET, V47, P904
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
   Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606
   ZUPANC ML, 1991, ANN NEUROL, V29, P680, DOI 10.1002/ana.410290619
NR 206
TC 150
Z9 167
U1 0
U2 24
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0070-2153
BN 978-0-12-373662-8
J9 CURR TOP DEV BIOL
JI Curr. Top. Dev. Biol.
PY 2007
VL 77
BP 113
EP +
DI 10.1016/S0070-2153(06)77005-3
PG 46
WC Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Developmental Biology
GA BFR59
UT WOS:000244033600005
PM 17222702
DA 2024-11-01
ER

PT J
AU Viikov, K
   Väljamäe, P
   Sedman, J
AF Viikov, Katrin
   Vaeljamaee, Priit
   Sedman, Juhan
TI Yeast mitochondrial DNA polymerase is a highly processive single-subunit
   enzyme
SO MITOCHONDRION
LA English
DT Article
DE DNA polymerase gamma; Mip1; Yeast mtDNA replication; Processivity;
   Strand displacement DNA synthesis
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SACCHAROMYCES-CEREVISIAE;
   ACCESSORY SUBUNIT; IN-VITRO; CATALYTIC SUBUNIT; GAMMA; REPLICATION;
   IDENTIFICATION; MUTATIONS; HELICASE
AB Polymerase gamma is solely responsible for fast and faithful replication of the mitochondrial genome. High processivity of the polymerase gamma is often achieved by association of the catalytic subunit with accessory factors that enhance its catalytic activity and/or DNA binding. Here we characterize the intrinsic catalytic activity and processivity of the recombinant catalytic subunit of yeast polymerase gamma, the Mip1 protein. We demonstrate that Mip1 can efficiently synthesize DNA stretches of up to several thousand nucleotides without dissociation from the template. Furthermore, we show that Mip1 can perform DNA synthesis on double-stranded templates utilizing a strand displacement mechanism. Our observations confirm that in contrast to its homologues in other organisms, Mip1 can function as a single-subunit replicative polymerase. (C) 2010 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Viikov, Katrin; Vaeljamaee, Priit; Sedman, Juhan] Univ Tartu, Dept Biochem, Inst Mol & Cell Biol, EE-51014 Tartu, Estonia.
C3 University of Tartu
RP Sedman, J (corresponding author), Univ Tartu, Dept Biochem, Inst Mol & Cell Biol, Vanemuise 46, EE-51014 Tartu, Estonia.
EM jsedman@ebc.ee
RI Sedman, Juhan/H-1820-2011; Valjamae, Priit/O-6468-2018
OI Sedman, Juhan/0000-0003-2081-1452; Valjamae, Priit/0000-0002-1035-9493
FU Estonian Science Foundation [7013]
FX This work was supported by grant 7013 from Estonian Science Foundation.
CR Andraos N, 2004, J BIOL CHEM, V279, P50609, DOI 10.1074/jbc.M408428200
   Bambara RA, 1995, METHOD ENZYMOL, V262, P270
   Baruffini E, 2007, GENETICS, V177, P1227, DOI 10.1534/genetics.107.079293
   BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0
   BISWAS TK, 1995, ACTA BIOCHIM POL, V42, P317
   BLANCO L, 1991, NUCLEIC ACIDS RES, V19, P955, DOI 10.1093/nar/19.4.955
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   DAS SK, 1979, J BIOL CHEM, V254, P1227
   DAUM G, 1982, J BIOL CHEM, V257, P3028
   Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903
   ERIKSSON S, 1995, J BIOL CHEM, V270, P18929, DOI 10.1074/jbc.270.32.18929
   Falkenberg M, 2000, P NATL ACAD SCI USA, V97, P3896, DOI 10.1073/pnas.97.8.3896
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   FOURY F, 1987, EMBO J, V6, P1441, DOI 10.1002/j.1460-2075.1987.tb02385.x
   FOURY F, 1983, P NATL ACAD SCI-BIOL, V80, P5345, DOI 10.1073/pnas.80.17.5345
   FUJIMURA RK, 1976, J BIOL CHEM, V251, P2168
   GENGA A, 1986, J BIOL CHEM, V261, P9328
   Graves SW, 1998, BIOCHEMISTRY-US, V37, P6050, DOI 10.1021/bi972685u
   GRAY H, 1992, J BIOL CHEM, V267, P5835
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200
   HUBER HE, 1987, J BIOL CHEM, V262, P16224
   INSDORF NF, 1989, J BIOL CHEM, V264, P21491
   ITO J, 1990, NUCLEIC ACIDS RES, V18, P6716, DOI 10.1093/nar/18.22.6716
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   JONES EW, 1991, METHOD ENZYMOL, V194, P428
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kelman Z, 1998, STRUCTURE, V6, P121, DOI 10.1016/S0969-2126(98)00014-8
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kuusk S, 2005, J BIOL CHEM, V280, P24322, DOI 10.1074/jbc.M500354200
   LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   LESTIENNE P, 1987, BIOCHEM BIOPH RES CO, V146, P1146, DOI 10.1016/0006-291X(87)90767-4
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Lucas P, 2004, MITOCHONDRION, V4, P13, DOI 10.1016/j.mito.2004.04.001
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   MALESZKA R, 1991, EMBO J, V10, P3923, DOI 10.1002/j.1460-2075.1991.tb04962.x
   Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1
   O'Rourke TW, 2002, MOL CELL BIOL, V22, P4086, DOI 10.1128/MCB.22.12.4086-4093.2002
   OLSON MW, 1995, J BIOL CHEM, V270, P28932, DOI 10.1074/jbc.270.48.28932
   Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257
   Sedman T, 2000, MOL CELL BIOL, V20, P1816, DOI 10.1128/MCB.20.5.1816-1824.2000
   Sedman T, 2005, CURR GENET, V47, P213, DOI 10.1007/s00294-005-0566-4
   TABOR S, 1987, J BIOL CHEM, V262, P16212
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   WERNETTE CM, 1986, J BIOL CHEM, V261, P4764
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Young MJ, 2006, YEAST, V23, P101, DOI 10.1002/yea.1344
NR 55
TC 23
Z9 28
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN
PY 2011
VL 11
IS 1
BP 119
EP 126
DI 10.1016/j.mito.2010.08.007
PG 8
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 709OP
UT WOS:000286450300017
PM 20807588
DA 2024-11-01
ER

PT J
AU Zheng, WM
   Khrapko, K
   Coller, HA
   Thilly, WG
   Copeland, WC
AF Zheng, Weiming
   Khrapko, Konstantin
   Coller, Hilary A.
   Thilly, William G.
   Copeland, William C.
TI Origins of human mitochondrial point mutations as DNA polymerase
   γ-mediated errors
SO MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
LA English
DT Article
DE mitochondrial DNA; mutagenesis; DNA polymerase gamma
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HUMAN-CELLS; POLG MUTATIONS;
   STEM-CELLS; HUMAN MTDNA; REPLICATION; SELECTION; FIDELITY; SPECTRUM;
   GENE
AB Mitochondrial mutational spectra in human cells, tissues and derived tumors for bp 10,030-10,130 are essentially identical, suggesting a predominant mutagenic role for endogenous processes. We hypothesized that errors mediated by mitochondrial DNA polymerase gamma were the primary sources of mutations. Point mutations created in this sequence by human DNA pol gamma in vitro were thus compared to the eighteen mutational hotspots, all single base substitutions, previously found in human tissues. The set of concordant hotspots accounted for 83% of these in vivo mutational events. About half of these mutations are insensitive to prolonged heating of DNA during PCR and half increase proportionally with heating time at 98 degrees C. Primary misincorporation errors and miscopying errors past thermal denaturing products such as dearninated cytosines (uracils) thus appear to be of approximately equal importance. For the sequence studied, these data support the conclusion that, endogenous error mediated by DNA pol gamma constitutes the primary source of mitochondrial point mutations in human tissues. Published by Elsevier B.V.
C1 Natl Inst Environm Hlth Sci, Mol Genet Lab, Res Triangle Pk, NC 27709 USA.
   MIT, Biol Engn Div, Cambridge, MA 02139 USA.
   Beth Israel Deaconess Med Ctr, Gerontol Div, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA 02115 USA.
   Fred Hutchinson Canc Res Ctr, Seattle, WA 98119 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS); Massachusetts Institute of
   Technology (MIT); Harvard University; Beth Israel Deaconess Medical
   Center; Harvard University; Harvard Medical School; Fred Hutchinson
   Cancer Center
RP Copeland, WC (corresponding author), Natl Inst Environm Hlth Sci, Mol Genet Lab, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI zheng, weiming/B-1911-2012; Khrapko, Konstantin/A-3244-2009; Copeland,
   William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953; khrapko,
   konstantin/0000-0002-9250-8033
FU Intramural NIH HHS Funding Source: Medline; NIEHS NIH HHS [5P30ES02109,
   P01-ES07168] Funding Source: Medline
CR Andre P, 1997, GENOME RES, V7, P843, DOI 10.1101/gr.7.8.843
   Baluska F, 2004, ANN BOT-LONDON, V94, P9, DOI 10.1093/aob/mch109
   Bohr VA, 2002, J INHERIT METAB DIS, V25, P215, DOI 10.1023/A:1015681929316
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Coller HA, 2005, MUTAT RES-FUND MOL M, V578, P256, DOI 10.1016/j.mrfmmm.2005.05.014
   Coller HA, 1998, CANCER RES, V58, P1268
   Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859
   Copeland WC, 2003, ACTA BIOCHIM POL, V50, P155
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Fuku N, 2002, BIOCHEM BIOPH RES CO, V290, P1199, DOI 10.1006/bbrc.2002.6330
   Gostjeva EV, 2006, CANCER GENET CYTOGEN, V164, P16, DOI 10.1016/j.cancergencyto.2005.05.005
   GOSTJEVA EV, IN PRESS STEM CELL R
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   HIGUCHI Y, 1995, J BIOL CHEM, V270, P7950, DOI 10.1074/jbc.270.14.7950
   Jensen M, 2004, HUM REPROD, V19, P65, DOI 10.1093/humrep/deh038
   KEOHAVONG P, 1989, P NATL ACAD SCI USA, V86, P9253, DOI 10.1073/pnas.86.23.9253
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Khrapko K, 1997, NUCLEIC ACIDS RES, V25, P685, DOI 10.1093/nar/25.4.685
   Loewenstein W R, 1992, Semin Cell Biol, V3, P59
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Marcelino LA, 1998, CANCER RES, V58, P2857
   Marcelino LA, 1999, MUTAT RES-DNA REPAIR, V434, P177, DOI 10.1016/S0921-8777(99)00028-2
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100
   Mott JL, 2004, BIOCHEM BIOPH RES CO, V319, P1210, DOI 10.1016/j.bbrc.2004.05.104
   Muniappan BP, 2002, CANCER RES, V62, P3271
   Naviaux RK, 2004, MITOCHONDRION, V4, P351, DOI 10.1016/j.mito.2004.07.002
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   NEDDERMANN P, 1994, P NATL ACAD SCI USA, V91, P1642, DOI 10.1073/pnas.91.5.1642
   Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Thilly WG, 2003, NAT GENET, V34, P255, DOI 10.1038/ng1205
   Tomita-Mitchell A, 2003, CANCER RES, V63, P5793
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Zhang D, 2003, CARDIOVASC RES, V57, P147, DOI 10.1016/S0008-6363(02)00695-8
   2001, MITOMAP HUMAN MITOCH
NR 50
TC 100
Z9 177
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0027-5107
J9 MUTAT RES-FUND MOL M
JI Mutat. Res.-Fundam. Mol. Mech. Mutagen.
PD JUL 25
PY 2006
VL 599
IS 1-2
BP 11
EP 20
DI 10.1016/j.mrfmmm.2005.12.012
PG 10
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA 071BH
UT WOS:000239571400002
PM 16490220
DA 2024-11-01
ER

PT J
AU Stenton, SL
   Prokisch, H
AF Stenton, Sarah L.
   Prokisch, Holger
TI Genetics of mitochondrial diseases: Identifying mutations to help
   diagnosis
SO EBIOMEDICINE
LA English
DT Review
DE Mitochondrial disease; Mutation; Diagnostic; Genetic; Multi-omic
ID COMPLEX; DNA; DISORDERS; PATHWAY; DELETIONS; MUSCLE
AB Mitochondrial diseases are amongst the most genetically and phenotypically diverse groups of inherited diseases. The vast phenotypic overlap with other disease entities together with the absence of reliable biomarkers act as driving forces for the integration of unbiased methodologies early in the diagnostic algorithm, such as whole exome sequencing (WES) and whole genome sequencing (WGS). Such approaches are used in variant discovery and in combination with high-throughput functional assays such as transcriptomics in simultaneous variant discovery and validation. By capturing all genes, they not only increase the diagnostic rate in heterogenous mitochondrial disease patients, but accelerate novel disease gene discovery, and are valuable in side-stepping the risk of overlooking unexpected or even treatable genetic disease diagnoses. (c) 2020 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)
C1 [Stenton, Sarah L.; Prokisch, Holger] Tech Univ Munich, Klinikum Rechts Isar, Inst Humangenet, Trogerstr 32, D-81675 Munich, Germany.
   [Stenton, Sarah L.; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Neurogen, Ingolstaedter Landstr 1, D-85764 Neuherberg, Germany.
C3 Technical University of Munich; Helmholtz Association; Helmholtz-Center
   Munich - German Research Center for Environmental Health
RP Prokisch, H (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Humangenet, Trogerstr 32, D-81675 Munich, Germany.
EM prokisch@helmholtz-muenchen.de
RI Prokisch, Holger/N-8964-2013
OI Prokisch, Holger/0000-0003-2379-6286; Stenton, Sarah
   Louise/0000-0003-4071-449X
FU German Federal Ministry of Education and Research (BMBF) [01GM1906B];
   German BMBF; Horizon2020 through the E-Rare project GENOMIT [01GM1603]
FX This study was supported by a German Federal Ministry of Education and
   Research (BMBF) grant to the German Network for Mitochondrial Disorders
   (mitoNET, 01GM1906B) and by the German BMBF and Horizon2020 through the
   E-Rare project GENOMIT (01GM1603). The funders had no role in design,
   literature analysis and interpretation, writing of the report.
CR Brechtmann F, 2018, AM J HUM GENET, V103, P907, DOI 10.1016/j.ajhg.2018.10.025
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Clark MM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat6177
   Coene KLM, 2018, J INHERIT METAB DIS, V41, P337, DOI 10.1007/s10545-017-0131-6
   Cummings BB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5209
   DaRe JT, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-118
   de la Barca JMC, 2020, HUM MOL GENET, V29, P1319, DOI 10.1093/hmg/ddaa047
   Del Dotto V, 2020, J CLIN INVEST, V130, P108, DOI 10.1172/JCI128514
   Distelmaier F, 2017, BRAIN, V140, DOI 10.1093/brain/aww303
   Ferreira CR, 2019, GENET MED, V21, P102, DOI 10.1038/s41436-018-0022-8
   French CE, 2019, INTENS CARE MED, V45, P627, DOI 10.1007/s00134-019-05552-x
   Fresard L, 2019, NAT MED, V25, P911, DOI 10.1038/s41591-019-0457-8
   Giordano C, 2016, BRAIN, V139, DOI 10.1093/brain/awv217
   Gonorazky HD, 2019, AM J HUM GENET, V104, P466, DOI 10.1016/j.ajhg.2019.01.012
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Khera AV, 2019, CIRCULATION, V139, P1593, DOI 10.1161/CIRCULATIONAHA.118.035658
   Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z
   Kohda M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005679
   Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824
   Kremer LS, 2017, METHODS MOL BIOL, V1567, P391, DOI 10.1007/978-1-4939-6824-4_24
   Lake NJ, 2017, AM J HUM GENET, V101, P239, DOI 10.1016/j.ajhg.2017.07.005
   Lee HN, 2020, GENET MED, V22, P490, DOI 10.1038/s41436-019-0672-1
   Legati A, 2016, BBA-BIOENERGETICS, V1857, P1326, DOI 10.1016/j.bbabio.2016.02.022
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Ma M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S3
   Malicdan MCV, 2018, HUM MUTAT, V39, P69, DOI 10.1002/humu.23345
   Miyaue Noriyuki, 2019, eNeurologicalSci, V14, P74, DOI 10.1016/j.ensci.2019.01.002
   Nambot S, 2018, GENET MED, V20, P645, DOI 10.1038/gim.2017.162
   Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450
   Oetjens MT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12869-0
   Ohtake A, 2014, BBA-GEN SUBJECTS, V1840, P1355, DOI 10.1016/j.bbagen.2014.01.025
   Pronicka E, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0930-9
   Puusepp S, 2018, MOL GENET METAB REP, V15, P80, DOI 10.1016/j.ymgmr.2018.03.004
   Rahman J, 2017, ANN NEUROL, V81, P9, DOI 10.1002/ana.24835
   Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013
   Schofield D, 2019, GENET MED, V21, P2586, DOI 10.1038/s41436-019-0534-x
   Skrzypek MS, 2018, NUCLEIC ACIDS RES, V46, pD736, DOI 10.1093/nar/gkx1112
   Sommerville Ewen W, 2014, J Neuromuscul Dis, V1, P119
   Stark Z, 2019, GENET MED, V21, P173, DOI 10.1038/s41436-018-0006-8
   Stendel C, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000393
   Stenton SL, 2020, J INHERIT METAB DIS, V43, P25, DOI 10.1002/jimd.12130
   Taliun D., 2019, BIORXIV, P563866, DOI [10.1101/563866, DOI 10.1101/563866]
   Tamiya G, 2014, AM J HUM GENET, V95, P294, DOI 10.1016/j.ajhg.2014.07.013
   Tan J, 2020, EBIOMEDICINE, V54, DOI 10.1016/j.ebiom.2020.102730
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   The NIHR BioResource on behalf of the 100000 Genomes Project, 2019, BIORXIV, DOI [10.1101/507244, DOI 10.1101/507244]
   Theunissen TEJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00400
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Van Hout C. V, 2019, WHOLE EXOME SEQUENCI, DOI DOI 10.1101/572347
   Vasta V, 2012, PEDIATR INT, V54, P585, DOI 10.1111/j.1442-200X.2012.03644.x
   Wagner M, 2019, J INHERIT METAB DIS, V42, P909, DOI 10.1002/jimd.12109
   Wai HA, 2020, GENET MED, V22, P1005, DOI 10.1038/s41436-020-0766-9
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wanders RJA, 2019, J INHERIT METAB DIS, V42, P197, DOI 10.1002/jimd.12008
   Weissig V, 2020, TRENDS MOL MED, V26, P40, DOI 10.1016/j.molmed.2019.09.002
   Wenger AM, 2017, GENET MED, V19, P209, DOI 10.1038/gim.2016.88
   Witters P, 2018, GENET MED, V20, P444, DOI 10.1038/gim.2017.125
   Wortmann SB, 2017, NEUROPEDIATRICS, V48, P309, DOI 10.1055/s-0037-1603776
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Wright CF, 2018, GENET MED, V20, P1216, DOI 10.1038/gim.2017.246
   Yépez VA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199938
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhang AH, 2016, BIOMED CHROMATOGR, V30, P7, DOI 10.1002/bmc.3453
NR 73
TC 120
Z9 128
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD JUN
PY 2020
VL 56
AR 102784
DI 10.1016/j.ebiom.2020.102784
PG 11
WC Medicine, General & Internal; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Research & Experimental Medicine
GA MH3RP
UT WOS:000546651000006
PM 32454403
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Auré, K
   Fayet, G
   Chicherin, I
   Rucheton, B
   Filaut, S
   Heckel, AM
   Eichler, J
   Caillon, F
   Péréon, Y
   Entelis, N
   Tarassov, I
   Lombès, A
AF Aure, Karine
   Fayet, Guillemette
   Chicherin, Ivan
   Rucheton, Benoit
   Filaut, Sandrine
   Heckel, Anne-Marie
   Eichler, Julie
   Caillon, Florence
   Pereon, Yann
   Entelis, Nina
   Tarassov, Ivan
   Lombes, Anne
TI Homoplasmic mitochondrial tRNA<SUP>Pro</SUP> mutation causing
   exercise-induced muscle swelling and fatigue
SO NEUROLOGY-GENETICS
LA English
DT Article
ID HEREDITARY OPTIC NEUROPATHY; OXIDATIVE-PHOSPHORYLATION; HUMAN-CELLS;
   DNA; EXPRESSION; DEFECT; MTDNA
AB Objective To demonstrate the causal role in disease of the MT-TP m.15992A>T mutation observed in patients from 5 independent families.
   Methods Lactate measurement, muscle histology, and mitochondrial activities in patients; PCR-based analyses of the size, amount, and sequence of muscle mitochondrial DNA (mtDNA) and proportion of the mutation; respiration, mitochondrial activities, proteins, translation, transfer RNA (tRNA) levels, and base modification state in skin fibroblasts and cybrids; and reactive oxygen species production, proliferation in the absence of glucose, and plasma membrane potential in cybrids.
   Results All patients presented with severe exercise intolerance and hyperlactatemia. They were associated with prominent exercise-induced muscle swelling, conspicuous in masseter muscles (2 families), and/or with congenital cataract (2 families). MRI confirmed exercise-induced muscle edema. Muscle disclosed severe combined respiratory defect. Muscle mtDNA had normal size and amount. Its sequence was almost identical in all patients, defining the haplotype as J1c10, and sharing 31 variants, only 1 of which, MT-TP m.15992A>T, was likely pathogenic. The mutation was homoplasmic in all tissues and family members. Fibroblasts and cybrids with homoplasmic mutation had defective respiration, low complex III activity, and decreased tRNA(Pro) amount. Their respiratory complexes amount and tRNA(Pro) aminoacylation appeared normal. Low proliferation in the absence of glucose demonstrated the relevance of the defects on cybrid biology while abnormal loss of cell volume when faced to plasma membrane depolarization provided a link to the muscle edema observed in patients.
   Conclusions The homoplasmic MT-TP m.15992A>T mutation in the J1c10 haplotype causes exercise-induced muscle swelling and fatigue.
C1 [Aure, Karine; Rucheton, Benoit; Lombes, Anne] INSERM, Inst Cochin, U1016, Paris, France.
   [Aure, Karine] Foch Hosp, Dept Neurophysiol, Suresnes, France.
   [Fayet, Guillemette; Pereon, Yann] CHU Nantes, Hotel Dieu AOC, Ctr Reference Malad Neuromusculaires, Nantes, France.
   [Chicherin, Ivan; Heckel, Anne-Marie; Eichler, Julie; Entelis, Nina; Tarassov, Ivan] Univ Strasbourg, CNRS, UMR 7156 GMGM, Strasbourg, France.
   [Rucheton, Benoit; Filaut, Sandrine] CHU Pitie Salpetriere, AP HP, Serv Biochim Metab, Paris, France.
   [Caillon, Florence] CHU Nantes, Hotel Dieu, Serv Radiol & Imagerie Med, Nantes, France.
   [Lombes, Anne] Univ Paris Descartes Paris5, CNRS, UMR 8104, Paris, France.
   [Chicherin, Ivan] MV Lomonossov State Univ, Moscow, Russia.
C3 Universite Paris Cite; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Hospital Foch; Nantes Universite; CHU de Nantes;
   Centre National de la Recherche Scientifique (CNRS); CNRS - National
   Institute for Biology (INSB); Universites de Strasbourg Etablissements
   Associes; Universite de Strasbourg; Sorbonne Universite; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere
   - APHP; Nantes Universite; CHU de Nantes; Universite Paris Cite; Centre
   National de la Recherche Scientifique (CNRS); CNRS - National Institute
   for Biology (INSB); Lomonosov Moscow State University
RP Lombès, A (corresponding author), INSERM, Inst Cochin, U1016, Paris, France.; Tarassov, I (corresponding author), Univ Strasbourg, CNRS, UMR 7156 GMGM, Strasbourg, France.
EM i.tarassov@unistra.fr; anne.lombes@inserm.fr
RI Chicherin, Ivan/ABG-5039-2021
OI Pereon, Yann/0000-0002-0090-3571; Tarassov, Ivan/0000-0001-8763-6703;
   rucheton, benoit/0000-0002-5893-6595; Entelis, Nina/0000-0002-7915-5528
CR Agier V, 2012, BBA-MOL BASIS DIS, V1822, P1570, DOI 10.1016/j.bbadis.2012.07.002
   [Anonymous], 2013, MUSCLE BIOPSY PRACTI
   Auré K, 2007, NEUROMUSCULAR DISORD, V17, P368, DOI 10.1016/j.nmd.2007.01.019
   Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Auré K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   de Crécy-Lagard V, 2019, NUCLEIC ACIDS RES, V47, P2143, DOI 10.1093/nar/gkz011
   Fender A, 2004, BIOCHIMIE, V86, P21, DOI 10.1016/j.biochi.2003.11.011
   Grosjean H, 2010, FEBS LETT, V584, P252, DOI 10.1016/j.febslet.2009.11.052
   Haraux F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221886
   Hogrel JY, 2001, NEUROLOGY, V56, P1733, DOI 10.1212/WNL.56.12.1733
   Howell N, 1997, J BIOENERG BIOMEMBR, V29, P165, DOI 10.1023/A:1022690030664
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Jun AS, 1996, MOL CELL BIOL, V16, P771
   Karicheva OZ, 2011, NUCLEIC ACIDS RES, V39, P8173, DOI 10.1093/nar/gkr546
   Kawahara Y, 2012, NAT PROTOC, V7, P1426, DOI 10.1038/nprot.2012.073
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3
   POSSEKEL S, 1995, HISTOCHEM CELL BIOL, V103, P59, DOI 10.1007/BF01464476
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898
   REITZER LJ, 1979, J BIOL CHEM, V254, P2669
   Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75
   Rorbach J, 2016, P NATL ACAD SCI USA, V113, P12198, DOI 10.1073/pnas.1609338113
   Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045
   Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Strobbe D, 2018, NEUROBIOL DIS, V114, P129, DOI 10.1016/j.nbd.2018.02.010
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Toompuu M, 1999, HUM MOL GENET, V8, P2275, DOI 10.1093/hmg/8.12.2275
   VARSHNEY U, 1991, J BIOL CHEM, V266, P24712
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Watanabe K, 2010, P JPN ACAD B-PHYS, V86, P11, DOI 10.2183/pjab.86.11
   Will Y, 2014, EXPERT OPIN DRUG MET, V10, P1061, DOI 10.1517/17425255.2014.939628
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
NR 39
TC 2
Z9 2
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2376-7839
J9 NEUROL-GENET
JI Neurol.-Genet.
PD AUG
PY 2020
VL 6
IS 4
AR e480
DI 10.1212/NXG.0000000000000480
PG 10
WC Genetics & Heredity; Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Neurosciences & Neurology
GA ON2IO
UT WOS:000586531700020
PM 32802947
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Fujiwara, T
   Harigae, H
AF Fujiwara, Tohru
   Harigae, Hideo
TI Pathophysiology and genetic mutations in congenital sideroblastic anemia
SO PEDIATRICS INTERNATIONAL
LA English
DT Review
DE ALAS2; congenital sideroblastic anemia; heme; iron; mitochondria
ID LACTIC-ACIDOSIS; CAUSES MYOPATHY; ALAS2 GENE; HEME; ATAXIA;
   IDENTIFICATION; TRANSPORTER; BIOGENESIS; DEFICIENCY; MECHANISMS
AB Sideroblastic anemias are heterogeneous congenital and acquired disorders characterized by anemia and the presence of ringed sideroblasts in the bone marrow. Congenital sideroblastic anemia (CSA) is a rare disease caused by mutations of genes involved in heme biosynthesis, iron-sulfur [Fe-S] cluster biosynthesis, and mitochondrial protein synthesis. The most common form is X-linked sideroblastic anemia, due to mutations in the erythroid-specific -aminolevulinate synthase (ALAS2), which is the first enzyme of the heme biosynthesis pathway in erythroid cells. Other known etiologies include mutations in the erythroid specific mitochondrial transporter (SLC25A38), adenosine triphosphate (ATP) binding cassette B7 (ABCB7), glutaredoxin 5 (GLRX5), thiamine transporter SLC19A2, the RNA-modifying enzyme pseudouridine synthase (PUS1), and mitochondrial tyrosyl-tRNA synthase (YARS2), as well as mitochondrial DNA deletions. Due to its rarity, however, there have been few systematic pathophysiological and genetic investigations focusing on sideroblastic anemia. Therefore, a nationwide survey of sideroblastic anemia was conducted in Japan to investigate the epidemiology and pathogenesis of this disease. This review will cover the findings of this recent survey and summarize the current understanding of the pathophysiology and genetic mutations involved in CSA.
C1 [Fujiwara, Tohru; Harigae, Hideo] Tohoku Univ, Dept Hematol & Rheumatol, Grad Sch Med, Sendai, Miyagi 9808575, Japan.
   [Fujiwara, Tohru; Harigae, Hideo] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 9808575, Japan.
C3 Tohoku University; Tohoku University
RP Harigae, H (corresponding author), Tohoku Univ, Dept Hematol & Rheumatol, Grad Sch Med, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.
EM harigae@med.tohoku.ac.jp
RI Fujiwara, Tohru/GOG-9775-2022
OI Fujiwara, Tohru/0000-0003-0089-3163
FU Ministry of Health, Labour and Welfare of Japan
FX The work was supported by a Grant-in-Aid from the Ministry of Health,
   Labour and Welfare of Japan.
CR Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743
   Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792
   Bekri S, 2000, BLOOD, V96, P3256
   Bekri S, 2003, BLOOD, V102, P698, DOI 10.1182/blood-2002-06-1623
   Bergmann AK, 2009, J PEDIATR-US, V155, P888, DOI 10.1016/j.jpeds.2009.06.017
   Bergmann AK, 2010, PEDIATR BLOOD CANCER, V54, P273, DOI 10.1002/pbc.22244
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520
   Camaschella C, 2009, SEMIN HEMATOL, V46, P371, DOI 10.1053/j.seminhematol.2009.07.001
   COX TC, 1994, NEW ENGL J MED, V330, P675, DOI 10.1056/NEJM199403103301004
   Ducamp S, 2011, HUM MUTAT, V32, P590, DOI 10.1002/humu.21455
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Fleming MD, 2011, HEMATOL-AM SOC HEMAT, P525, DOI 10.1182/asheducation-2011.1.525
   Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001
   Furuyama K, 2003, BLOOD, V101, P4623, DOI 10.1182/blood-2002-09-2804
   Furuyama K, 2002, CELL MOL BIOL, V48, P5
   Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1
   Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359
   Harigae H, 1998, BLOOD, V91, P798, DOI 10.1182/blood.V91.3.798.798_798_805
   Harigae H, 2010, INT J HEMATOL, V92, P425, DOI 10.1007/s12185-010-0688-4
   Kaneko K, 2013, HAEMATOLOGICA, DOI 10.3324/haematol.2013.085449
   Kannengiesser C, 2011, HAEMATOL-HEMATOL J, V96, P808, DOI 10.3324/haematol.2010.039164
   Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981
   Labay V, 1999, NAT GENET, V22, P300, DOI 10.1038/10372
   Ohba R, 2013, ANN HEMATOL, V92, P1, DOI 10.1007/s00277-012-1564-5
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pondarre C, 2007, BLOOD, V109, P3567, DOI 10.1182/blood-2006-04-015768
   Ponka P., 2010, WILLIAMS HEMATOLOGY, P865
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   WILLIAMS DM, 1983, SEMIN HEMATOL, V20, P118
   Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887
   Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372
   YUNIS AA, 1980, CLIN HAEMATOL, V9, P607
NR 36
TC 38
Z9 46
U1 1
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1328-8067
EI 1442-200X
J9 PEDIATR INT
JI Pediatr. Int.
PD DEC
PY 2013
VL 55
IS 6
BP 675
EP 679
DI 10.1111/ped.12217
PG 5
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 271BL
UT WOS:000328365300009
PM 24003969
DA 2024-11-01
ER

PT J
AU Jakus, IA
   Jakus, D
   Marinovic, J
   Cavar, M
   Banic, I
   Vilovic, K
AF Jakus, Ivana Alujevic
   Jakus, Dora
   Marinovic, Jasna
   Cavar, Marija
   Banic, Ivana
   Vilovic, Katarina
TI Expression of Mitochondrial Respiratory Chain Complexes in the Vaginal
   Wall in Postmenopausal Women with Pelvic Organ Prolapse
SO GYNECOLOGIC AND OBSTETRIC INVESTIGATION
LA English
DT Article
DE Mitochondria; Pelvic organ prolapse; Postmenopause; Vagina
ID DNA DELETION MUTATIONS; MUSCLE-FIBER ATROPHY; UTEROSACRAL LIGAMENTS;
   ABNORMALITIES
AB Background/Aims: Pelvic organ prolapse (POP) is a common disease affecting adult women. It is a result of the vaginal wall disorder as well as damage of the supportive structures contributing to the integrity of the pelvic floor. Mitochondrial disorders may have an important role in the vaginal wall degeneration leading to POP. The goal of this research is to examine if POP is associated with an altered expression of mitochondrial respiratory chain complexes. Methods: Samples of vaginal tissue were collected from 16 postmenopausal women: 10 had POP and 6 had other forms of benign gynecological disease. Using western blot, samples were analyzed to assess the expression of mitochondrial proteins including citrate synthase (CS), individual complexes of the mitochondrial respiratory chain and alpha smooth muscle actin (SMA). Results: A significantly reduced expression of SMA and complex II in vaginal tissue of women with POP was found, compared to the control group (p < 0.05), with a tendency for a reduced expression of CS (p = 0.06) and other complexes in the POP group. Conclusions: Our results indicate that there is a decreased quantity of the smooth muscle and a decreased expression of mitochondria! markers in the vaginal wall of women with prolapse suggesting their possible role in the pathogenesis of POP. (C) 2017 S. Karger AG, Basel
C1 [Jakus, Ivana Alujevic] Split Univ Hosp, Clin Dept Gynecol & Obstet, Spinciceva 1, HR-21000 Split, Croatia.
   [Jakus, Dora; Marinovic, Jasna; Cavar, Marija; Banic, Ivana] Univ Split, Sch Med, Dept Physiol, Split, Croatia.
   [Vilovic, Katarina] Split Univ Hosp, Clin Dept Pathol, Split, Croatia.
C3 University of Split; University of Split; University of Split
RP Jakus, IA (corresponding author), Split Univ Hosp, Clin Dept Gynecol & Obstet, Spinciceva 1, HR-21000 Split, Croatia.
EM alujevicivana@hotmail.com
RI Marinovic, Jasna/D-8080-2017; Vilović, Katarina/E-1090-2017
OI Vilovic, Katarina/0000-0001-7052-8204; Jakus, Dora/0000-0001-8500-3996;
   Marinovic, Jasna/0000-0002-9463-6493
FU Ministry of Science, Education and Sports of the Republic of Croatia
   [021-2160528-0507]
FX This study was supported by the Ministry of Science, Education and
   Sports of the Republic of Croatia (grant No. 021-2160528-0507).
CR Ackrell BAC, 2002, MOL ASPECTS MED, V23, P369, DOI 10.1016/S0098-2997(02)00012-2
   Badiou W, 2008, INT UROGYNECOL J, V19, P723, DOI 10.1007/s00192-007-0516-4
   BITTLES AH, 1992, MUTAT RES, V275, P217, DOI 10.1016/0921-8734(92)90025-K
   Boreham MK, 2002, AM J OBSTET GYNECOL, V187, P1501, DOI 10.1067/mob.2002.130005
   Boreham MK, 2002, AM J OBSTET GYNECOL, V187, P56, DOI 10.1067/mob.2002.124843
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Cortopassi GA, 1999, BBA-BIOENERGETICS, V1410, P183, DOI 10.1016/S0005-2728(98)00166-2
   DELANCEY JOL, 1992, AM J OBSTET GYNECOL, V166, P1717, DOI 10.1016/0002-9378(92)91562-O
   Healy JC., 2008, Gray's Anatomy- The anatomical basis of clinical practice, V40th, P1279
   Kerkhof MH, 2009, INT UROGYNECOL J, V20, P461, DOI 10.1007/s00192-008-0737-1
   Knuuti E, 2011, ARCH GYNECOL OBSTET, V283, P1081, DOI 10.1007/s00404-010-1518-x
   Kokcu A., 2002, Archives of Gynecology and Obstetrics, V266, P75, DOI 10.1007/s004040100194
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lopez ME, 2000, MUTAT RES-FUND MOL M, V452, P123, DOI 10.1016/S0027-5107(00)00059-2
   Maher C, 2008, NEUROUROL URODYNAM, V27, P3, DOI 10.1002/nau.20542
   Meijerink AM, 2013, GYNECOL OBSTET INVES, V75, P21, DOI 10.1159/000341709
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Novara G, 2005, CURR OPIN UROL, V15, P256, DOI 10.1097/01.mou.0000172399.47019.e9
   Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6
   Persu C, 2011, J Med Life, V4, P75
   RICHTER C, 1988, FEBS LETT, V241, P1, DOI 10.1016/0014-5793(88)81018-4
   Sun MJ, 2009, INT UROGYNECOL J, V20, P867, DOI 10.1007/s00192-009-0871-4
   Takacs P, 2010, ARCH GYNECOL OBSTET, V282, P389, DOI 10.1007/s00404-009-1262-2
   Towers, 2004, J PELVIC MED SURG, V10, P109, DOI [10.1097/01.spv.0000130408.99003.7c, DOI 10.1097/01.SPV.0000130408.99003.7C]
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Weber AM, 2005, OBSTET GYNECOL, V106, P615, DOI 10.1097/01.AOG.0000175832.13266.bb
   Yiou R, 2012, J UROLOGY, V188, P1772
NR 30
TC 4
Z9 5
U1 0
U2 3
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0378-7346
EI 1423-002X
J9 GYNECOL OBSTET INVES
JI Gynecol.Obstet.Invest.
PY 2018
VL 83
IS 5
BP 487
EP 492
DI 10.1159/000480236
PG 6
WC Obstetrics & Gynecology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Obstetrics & Gynecology
GA GT7YO
UT WOS:000444748800011
PM 28850957
DA 2024-11-01
ER

PT J
AU Tanaka, K
   Ueno, T
   Yoshida, M
   Shimizu, Y
   Ogawa, T
   Nishisaka, T
   Kurashige, T
   Masaki, T
AF Tanaka, Kenta
   Ueno, Toshinori
   Yoshida, Maria
   Shimizu, Yuka
   Ogawa, Takahiko
   Nishisaka, Takashi
   Kurashige, Takashi
   Masaki, Takao
TI Chronic kidney disease caused by maternally inherited diabetes and
   deafness: a case report
SO CEN CASE REPORTS
LA English
DT Article
DE Maternally inherited diabetes and deafness; Mitochondrial disease;
   Chronic kidney disease
ID MITOCHONDRIAL DYSFUNCTION; MODIFICATION DEFECT; G MUTATION; INVOLVEMENT;
   NUCLEOTIDE; MELLITUS; FEATURES; JAPANESE
AB Maternally inherited diabetes and deafness (MIDD) is a mitochondrial genetic disorder with variable clinical presentations, which can delay its diagnosis. Herein, we report the case of a 57-year-old Japanese man with MIDD who developed chronic kidney disease. He developed proteinuria long before his diabetes and deafness; at the age of 36 years, a renal biopsy showed minor glomerular abnormality and electron microscopy showed mild mitochondrial degeneration in the distal tubular epithelial cells. Twenty years later, a second renal biopsy showed nephrosclerosis with interstitial fibrosis and arteriolar hyaline thickening, despite the absence of hypertension and relatively good glycemic control. Granular swollen epithelial cells were found in the medullary collecting duct epithelium. Electron microscopy showed accumulating mitochondria in podocytes and tubular cells, leading to the diagnosis of MIDD. A muscle biopsy also showed ragged-red fibers, despite the absence of muscle weakness. Mitochondrial DNA analysis revealed an m.3243A > G mutation, and taurine supplementation was initiated. Our findings suggest that mitochondrial dysfunction is mainly associated with progressive renal damage.
C1 [Tanaka, Kenta; Ueno, Toshinori; Shimizu, Yuka; Ogawa, Takahiko] Hiroshima Prefectural Hosp, Dept Nephrol, Minami Ku, 1-5-54,Ujinakanda, Hiroshima 7348530, Japan.
   [Yoshida, Maria; Masaki, Takao] Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan.
   [Nishisaka, Takashi] Hiroshima Prefectural Hosp, Dept Pathol, Hiroshima, Japan.
   [Kurashige, Takashi] Natl Hosp Org Kure Med Ctr, Dept Neurol, Hiroshima, Japan.
   [Kurashige, Takashi] Chugoku Canc Ctr, Hiroshima, Japan.
C3 Hiroshima University
RP Ueno, T (corresponding author), Hiroshima Prefectural Hosp, Dept Nephrol, Minami Ku, 1-5-54,Ujinakanda, Hiroshima 7348530, Japan.
EM tueno-ygc@umin.ac.jp
RI Kurashige, Takashi/N-1767-2014
OI Kurashige, Takashi/0000-0002-5206-5979
CR Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Granata S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-388
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Imasawa T, 2013, INT J BIOCHEM CELL B, V45, P2109, DOI 10.1016/j.biocel.2013.06.013
   Kobayashi A, 2010, AM J SURG PATHOL, V34, P262, DOI 10.1097/PAS.0b013e3181cb4ed3
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Müller-Deile J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00209
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   Seidowsky A, 2013, CLIN NEPHROL, V80, P456, DOI 10.5414/CN107063
   Suzuki S, 1998, DIABETOLOGIA, V41, P584, DOI 10.1007/s001250050950
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Yamagata K, 2000, NEPHROL DIAL TRANSPL, V15, P385, DOI 10.1093/ndt/15.3.385
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
NR 19
TC 6
Z9 7
U1 0
U2 1
PU SPRINGER JAPAN KK
PI TOKYO
PA SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005,
   JAPAN
SN 2192-4449
J9 CEN CASE REP
JI CEN CASE REP.
PD MAY
PY 2021
VL 10
IS 2
BP 220
EP 225
DI 10.1007/s13730-020-00547-w
EA OCT 2020
PG 6
WC Urology & Nephrology
WE Emerging Sources Citation Index (ESCI)
SC Urology & Nephrology
GA RH7ZR
UT WOS:000582993100002
PM 33125665
OA Green Published
DA 2024-11-01
ER

PT J
AU Gupta, R
   Karczewski, KJ
   Howrigan, D
   Neale, BM
   Mootha, VK
AF Gupta, Rahul
   Karczewski, Konrad J.
   Howrigan, Daniel
   Neale, Benjamin M.
   Mootha, Vamsi K.
TI Human genetic analyses of organelles highlight the nucleus in
   age-related trait heritability
SO ELIFE
LA English
DT Article
DE aging; mitochondria; transcription factors; haplosufficiency;
   enrichment; constraint; Human
ID MITOCHONDRIAL-DNA VARIANTS; GENOME-WIDE ASSOCIATION; HUMAN
   SKELETAL-MUSCLE; HUMAN-DISEASES; OXIDATIVE-PHOSPHORYLATION; MISSING
   HERITABILITY; SUSCEPTIBILITY LOCI; TRANSCRIPTION; DYSFUNCTION; COMMON
AB eLife digest Getting older increases our risk of experiencing a wide range of diseases, such as diabetes, heart disease and neurodegenerative disease. The genetic variations that we inherit from our parents play a major role in predicting this risk. However, the biological networks involved in this process are extremely complex and remain challenging to decipher. Prior studies have suggested that specialised structures inside our body's cells, called organelles, may have an important role to play in aging. Organelles represent self-contained biological factories inside each cell, designed to perform specific tasks. Examples include the nucleus, which harbours most of the cell's genetic material, and mitochondria, which help provide cells with energy. Organelles tend to deteriorate and become dysfunctional with age, and mitochondria in particular are badly affected by the ageing process. A decline in organelle activity has been thought to explain ageing and the development of age-related diseases. However, this has never been systematically tested on a large scale at the inherited genetic level. Gupta et al. assessed whether common inherited genetic variation in genes associated with ten different organelles could affect the risk of age-related disease, using a database of DNA samples from more than 300,000 individuals. They considered 24 diseases and traits that become more common with advanced age. Gupta et al. discovered that inherited variants in or near genes associated with the nucleus were consistently linked to age-related disease risks. Most of this signal arose from genes encoding the nuclear transcription factors, proteins that help to control the rate at which genes are expressed. However, variants in genes associated with other organelles, including mitochondria, did not appear to be linked to age-related diseases. This research suggests that inherited variation in transcription factors in the nucleus could act as genetic levers that increase the risk of common, age-related diseases. It also suggests that common genetic variation in other cellular organelles may not be as heavily involved in the development of such diseases. Such insights into the cellular structures and biological pathways involved in ageing and age-related disease also establish new targets for drugs to prevent or treat disease.
   Most age-related human diseases are accompanied by a decline in cellular organelle integrity, including impaired lysosomal proteostasis and defective mitochondrial oxidative phosphorylation. An open question, however, is the degree to which inherited variation in or near genes encoding each organelle contributes to age-related disease pathogenesis. Here, we evaluate if genetic loci encoding organelle proteomes confer greater-than-expected age-related disease risk. As mitochondrial dysfunction is a 'hallmark' of aging, we begin by assessing nuclear and mitochondrial DNA loci near genes encoding the mitochondrial proteome and surprisingly observe a lack of enrichment across 24 age-related traits. Within nine other organelles, we find no enrichment with one exception: the nucleus, where enrichment emanates from nuclear transcription factors. In agreement, we find that genes encoding several organelles tend to be 'haplosufficient,' while we observe strong purifying selection against heterozygous protein-truncating variants impacting the nucleus. Our work identifies common variation near transcription factors as having outsize influence on age-related trait risk, motivating future efforts to determine if and how this inherited variation then contributes to observed age-related organelle deterioration.
C1 [Gupta, Rahul; Mootha, Vamsi K.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.
   [Gupta, Rahul; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.
   [Gupta, Rahul; Karczewski, Konrad J.; Howrigan, Daniel; Neale, Benjamin M.; Mootha, Vamsi K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Gupta, Rahul; Karczewski, Konrad J.; Howrigan, Daniel; Neale, Benjamin M.] Massachusetts Gen Hosp, Ctr Genom Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA.
C3 Harvard University; Massachusetts General Hospital; Howard Hughes
   Medical Institute; Harvard University; Massachusetts General Hospital;
   Harvard University; Massachusetts Institute of Technology (MIT); Broad
   Institute; Harvard University; Massachusetts General Hospital
RP Gupta, R; Mootha, VK (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.; Gupta, R; Mootha, VK (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Gupta, R; Neale, BM; Mootha, VK (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Gupta, R; Neale, BM (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA.
EM rahul_gupta@hms.harvard.edu; bneale@broadinstitute.org;
   vamsi_mootha@hms.harvard.edu
RI Gupta, Rahul/ABF-1099-2021; Neale, Benjamin/LFS-2894-2024
OI Gupta, Rahul/0000-0001-8263-2455; Mootha, Vamsi/0000-0001-9924-642X
FU National Institutes of Health [T32AG000222, R35GM122455, R01MH101244];
   National Institute of General Medical Sciences [R35GM122455] Funding
   Source: NIH RePORTER
FX National Institutes of Health T32AG000222 Rahul GuptaNational Institutes
   of Health R35GM122455 Vamsi K MoothaNational Institutes of Health
   R01MH101244 Benjamin M NealeThe funders had no role in study design,
   data collection and interpretation, or the decision to submit the work
   for publication.
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   [Anonymous], 2017, Details and Considerations of the UK Biobank GWAS
   [Anonymous], 2021, HERITAGE
   [Anonymous], 2021, HERITAGE
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844
   BALABAN RS, 1986, SCIENCE, V232, P1121, DOI 10.1126/science.3704638
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bhattarai KR, 2020, TRENDS CELL BIOL, V30, P672, DOI 10.1016/j.tcb.2020.05.004
   Biffi A, 2010, AM J HUM GENET, V86, P904, DOI 10.1016/j.ajhg.2010.05.005
   Billingsley KJ, 2019, NPJ PARKINSONS DIS, V5, DOI 10.1038/s41531-019-0080-x
   Binder JX, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau012
   Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38
   Bose A, 2016, J NEUROCHEM, V139, P216, DOI 10.1111/jnc.13731
   Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055
   CHANCE B, 1955, J BIOL CHEM, V217, P409
   Christophersen IE, 2017, NAT GENET, V49, P946, DOI 10.1038/ng.3843
   Claussnitzer M, 2020, NATURE, V577, P179, DOI 10.1038/s41586-019-1879-7
   CLEAVER JE, 1994, CELL, V76, P1, DOI 10.1016/0092-8674(94)90165-1
   Colacurcio DJ, 2016, AGEING RES REV, V32, P75, DOI 10.1016/j.arr.2016.05.004
   Curran JE, 2007, HUM MOL GENET, V16, P1504, DOI 10.1093/hmg/ddm101
   D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037
   de Leeuw CA, 2016, NAT REV GENET, V17, P353, DOI 10.1038/nrg.2016.29
   de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219
   Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405
   Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249
   Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508
   Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4
   Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404
   FLAMENG W, 1991, J MOL CELL CARDIOL, V23, P1, DOI 10.1016/0022-2828(91)90034-J
   Fleischman A, 2010, J CLIN ENDOCR METAB, V95, pE69, DOI 10.1210/jc.2010-0527
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642
   Garcia CK, 2007, NUCLEIC ACIDS RES, V35, P7406, DOI 10.1093/nar/gkm644
   Ge P, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00367-7
   Golan D, 2014, P NATL ACAD SCI USA, V111, pE5272, DOI 10.1073/pnas.1419064111
   Grünewald A, 2019, PROG NEUROBIOL, V177, P73, DOI 10.1016/j.pneurobio.2018.09.003
   Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393
   Han S, 2012, TRENDS CELL BIOL, V22, P42, DOI 10.1016/j.tcb.2011.11.001
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005
   Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008
   Howrigan DP, 2021, HERITAGE
   Hudson G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004369
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Hudson G, 2013, ANN RHEUM DIS, V72, P136, DOI 10.1136/annrheumdis-2012-201932
   Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9
   Jimenez-Sanchez G, 2001, NATURE, V409, P853, DOI 10.1038/35057050
   KACSER H, 1981, GENETICS, V97, P639
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x
   Kapopoulou A, 2016, EVOLUTION, V70, P167, DOI 10.1111/evo.12819
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7
   Karczewski KJ, 2013, P NATL ACAD SCI USA, V110, P9607, DOI 10.1073/pnas.1219099110
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   Kraja AT, 2019, AM J HUM GENET, V104, P112, DOI 10.1016/j.ajhg.2018.12.001
   Kuan V, 2019, LANCET DIGIT HEALTH, V1, pE63, DOI 10.1016/S2589-7500(19)30012-3
   Kubben N, 2017, NAT REV MOL CELL BIO, V18, P595, DOI 10.1038/nrm.2017.68
   Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802
   Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029
   Lane RK, 2015, BBA-BIOENERGETICS, V1847, P1387, DOI 10.1016/j.bbabio.2015.05.021
   Litman T, 2019, SEMIN ONCOL, V46, P3, DOI 10.1053/j.seminoncol.2018.11.002
   Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133
   Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274
   Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794
   Melé M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383
   Morris JA, 2010, BIOINFORMATICS, V26, P1786, DOI 10.1093/bioinformatics/btq280
   Müller-Nedebock AC, 2019, NEUROCHEM INT, V129, DOI 10.1016/j.neuint.2019.104495
   Nalls MA, 2019, LANCET NEUROL, V18, P1091, DOI 10.1016/S1474-4422(19)30320-5
   Nguyen M, 2019, TRENDS NEUROSCI, V42, P140, DOI 10.1016/j.tins.2018.11.001
   Özcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Pardiñas AF, 2018, NAT GENET, V50, P381, DOI 10.1038/s41588-018-0059-2
   Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   PETERSEN KF, 2004, NEW ENGL J MED, V350, P664, DOI [DOI 10.1056/NEJMOA031314, 10.1056/NEJMoa031314]
   Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285
   Rand DM, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0188
   Raule N, 2007, MITOCHONDRION, V7, P29, DOI 10.1016/j.mito.2006.11.013
   Sackton TB, 2016, CELL, V166, P279, DOI 10.1016/j.cell.2016.06.047
   Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682
   Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]
   Segrè AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058
   Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043
   Solenski NJ, 2002, STROKE, V33, P816, DOI 10.1161/hs0302.104541
   Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100
   Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270
   Timmers PRHJ, 2019, ELIFE, V8, DOI 10.7554/eLife.39856
   To TL, 2019, CELL, V179, P1222, DOI 10.1016/j.cell.2019.10.032
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   van Der Lee R, 2020, TRENDS GENET, V36, P523, DOI 10.1016/j.tig.2020.04.006
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang K, 2017, NAT GENET, V49, P1319, DOI 10.1038/ng.3931
   Wasmer K, 2017, J GERIATR CARDIOL, V14, P179, DOI 10.11909/j.issn.1671-5411.2017.03.010
   Weinbrenner C, 1998, CARDIOVASC RES, V38, P676, DOI 10.1016/S0008-6363(98)00064-9
   Worman HJ, 2002, TRENDS CELL BIOL, V12, P591, DOI 10.1016/S0962-8924(02)02401-7
   Wright S, 1934, AM NAT, V68, P24, DOI 10.1086/280521
   Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213
   Xue A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04951-w
   Yamamoto K, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0812-9
   Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042
   Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966
   Yu XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001530
   Zenin A, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0290-0
   Zhu ZH, 2015, AM J HUM GENET, V96, P377, DOI 10.1016/j.ajhg.2015.01.001
NR 118
TC 5
Z9 6
U1 0
U2 3
PU eLIFE SCIENCES PUBL LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD SEP 1
PY 2021
VL 10
AR e68610
DI 10.7554/eLife.68610; 10.7554/eLife.68610.sa1; 10.7554/eLife.68610.sa2
PG 33
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA WA8AC
UT WOS:000703105100001
PM 34467851
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Chawla, S
   Coku, J
   Forbes, T
   Kannan, S
AF Chawla, Sanjay
   Coku, Jorida
   Forbes, Thomas
   Kannan, Sujatha
TI Kearns-Sayre syndrome presenting as complete heart block
SO PEDIATRIC CARDIOLOGY
LA English
DT Article
DE Kearns-Sayre syndrome; mitochondrial disorder; heart block
ID MITOCHONDRIAL-DNA DELETIONS; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA
AB Kearns-Sayre syndrome (KSS) is a rare mitochondrial disorder characterized by large-scale deletions of mitochondrial DNA. Neuromuscular and cardiac conduction systems are most commonly involved in these patients. Here, we discuss a 10-year-old patient with diabetes mellitus who presented in complete heart block leading to the diagnosis of KSS. The cardiovascular complications of this syndrome are reviewed and discussed.
C1 [Chawla, Sanjay; Forbes, Thomas; Kannan, Sujatha] Childrens Hosp Michigan, Detroit, MI 48201 USA.
   [Coku, Jorida] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
C3 Children's Hospital of Michigan; Columbia University
RP Kannan, S (corresponding author), Childrens Hosp Michigan, 3901 Beaubien Blvd, Detroit, MI 48201 USA.
EM skannan@med.wayne.edu
OI Kannan, Sujatha/0000-0002-9497-5786
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104
   Gregoratos Gabriel, 2002, Circulation, V106, P2145, DOI 10.1161/01.CIR.0000035996.46455.09
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   Karanikis P, 2005, INT J CARDIOL, V101, P147, DOI 10.1016/j.ijcard.2004.01.027
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   PAVLAKIS SG, 1988, ADV CONT NEUROLOGY, P95
   ROBERTS NK, 1979, AM J CARDIOL, V44, P1396, DOI 10.1016/0002-9149(79)90459-4
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Young TJ, 2005, PACE, V28, P454, DOI 10.1111/j.1540-8159.2005.40049.x
NR 12
TC 16
Z9 19
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0172-0643
J9 PEDIATR CARDIOL
JI Pediatr. Cardiol.
PD MAY
PY 2008
VL 29
IS 3
BP 659
EP 662
DI 10.1007/s00246-007-9040-z
PG 4
WC Cardiac & Cardiovascular Systems; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Pediatrics
GA 299KI
UT WOS:000255754100032
PM 17763890
DA 2024-11-01
ER

PT J
AU Seo, GH
   Oh, A
   Kim, EN
   Lee, Y
   Park, J
   Kim, T
   Lim, YM
   Kim, GH
   Kim, CJ
   Yoo, HW
   Kang, E
   Lee, BH
AF Seo, Go Hun
   Oh, Arum
   Kim, Eun Na
   Lee, Yeonmi
   Park, Jumi
   Kim, Taeho
   Lim, Young-Min
   Kim, Gu-Hwan
   Kim, Chong Jai
   Yoo, Han-Wook
   Kang, Eunju
   Lee, Beom Hee
TI Identification of extremely rare mitochondrial disorders by whole exome
   sequencing
SO JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID TRANSLATION; SPECTRUM; MUTATION; DISEASE
AB Whole exome sequencing (WES) is an effective tool for the genetic diagnosis of mitochondrial disorders due to various nuclear genetic defects. In this study, three patients affected by extremely rare mitochondrial disorders caused by nuclear genetic defects are described. The medical records of each patient were reviewed to obtain clinical symptoms, results of biochemical and imaging studies, and muscle biopsies. WES and massive parallel sequencing of whole mtDNA were performed for each patient. The oxygen consumption rate (OCR) and complex activity I and IV was measured. Patients 1 and 2 had exhibited global developmental delay and seizure since early infancy. Blood lactate, the lactate-to-pyruvate ratio, and urinary excretion of Krebs cycle intermediates were markedly elevated. Patient 1 also was noted for ophthalmoplegia. Patient 2 had left ventricular hypertrophy and ataxia. Patient 3 developed dysarthria, gait disturbance, and right-side weakness at age 29. Brain magnetic resonance imaging demonstrated abnormal signal intensity involving the bilateral thalami, midbrain, or pons. Based on WES, patient 1 had p.Glu415Gly and p.Arg484Trp variants in MTO1 . In patient 2, p.Gln111ThrfsTer5 and RNA mis-splicing were identified in TSFM. Patient 3 carried p.Met151Thr and p.Met246Lys variants in AARS2. Skin fibroblasts of three patients exhibited decreased OCRs and complex 1 activity, and mitochondrial DNA was normal. These results demonstrate the utility of WES for identifying the genetic cause of extremely rare mitochondrial disorders, which has implications for genetic counseling.
C1 [Seo, Go Hun; Oh, Arum; Yoo, Han-Wook; Lee, Beom Hee] Univ Ulsan, Coll Med, Dept Pediat, ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.
   [Kim, Eun Na; Kim, Chong Jai] Univ Ulsan, Coll Med, Dept Pathol, ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.
   [Lee, Yeonmi; Park, Jumi; Kang, Eunju] Univ Ulsan, Coll Med, Asan Med Ctr Childrens Hosp, Stem Cell Ctr,ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.
   [Kim, Taeho] Univ Ulsan, Coll Med, Biomed Res Ctr, ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.
   [Lim, Young-Min] Univ Ulsan, Coll Med, Dept Neurol, ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.
   [Kim, Gu-Hwan; Yoo, Han-Wook; Lee, Beom Hee] Univ Ulsan, Coll Med, Ctr Med Genet, ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.
C3 University of Ulsan; University of Ulsan; University of Ulsan;
   University of Ulsan; University of Ulsan; University of Ulsan
RP Lee, BH (corresponding author), Univ Ulsan, Coll Med, Dept Pediat, ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.; Kang, E (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr Childrens Hosp, Stem Cell Ctr,ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.; Lee, BH (corresponding author), Univ Ulsan, Coll Med, Ctr Med Genet, ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.
EM kangeun@amc.seoul.kr; bhlee@amc.seoul.kr
RI Kim, Eun Na/GVU-5478-2022; Kim, Hyeon/F-8796-2019
OI Kim, Eun Na/0000-0003-2992-7881; Kim, Gu-Hwan/0000-0002-7056-7446
FU National Research Foundation of Korea - Ministry of Education, Science,
   and Technology [NRF-2018M3A9H1078335]; Asan Institute for Life Sciences,
   Asan Medical Center, Seoul, Korea [2017-756, 2018-756]
FX This study was supported by a grant from the National Research
   Foundation of Korea, funded by the Ministry of Education, Science, and
   Technology (NRF-2018M3A9H1078335), and the Asan Institute for Life
   Sciences, Asan Medical Center, Seoul, Korea (Nos. 2017-756 and
   2018-756).
CR Ahola S, 2014, NEUROLOGY, V83, P743, DOI 10.1212/WNL.0000000000000716
   Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497
   Emperador S, 2017, EUR J HUM GENET, V25, P153, DOI 10.1038/ejhg.2016.124
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   Lee JM, 2017, EUR J NEUROL, V24, pE21, DOI 10.1111/ene.13245
   Lynch DS, 2016, JAMA NEUROL, V73, P1433, DOI 10.1001/jamaneurol.2016.2229
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Merz TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178946
   Meyer S, 2008, J MOL BIOL, V380, P532, DOI 10.1016/j.jmb.2008.04.072
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Murayama K, 2019, J HUM GENET, V64, P113, DOI 10.1038/s10038-018-0528-6
   Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450
   O'Byrne JJ, 2018, MOL GENET METAB, V123, P28, DOI 10.1016/j.ymgme.2017.11.003
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Powell CA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00079
   Pronicka E, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0930-9
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Traschütz A, 2019, PARKINSONISM RELAT D, V60, P176, DOI 10.1016/j.parkreldis.2018.09.031
   Vedrenne V, 2012, J HEPATOL, V56, P294, DOI 10.1016/j.jhep.2011.06.014
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
NR 26
TC 12
Z9 12
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1434-5161
EI 1435-232X
J9 J HUM GENET
JI J. Hum. Genet.
PD NOV
PY 2019
VL 64
IS 11
BP 1117
EP 1125
DI 10.1038/s10038-019-0660-y
PG 9
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA JI2KB
UT WOS:000493291400008
PM 31451716
DA 2024-11-01
ER

PT J
AU Orekhov, AN
   Ivanova, EA
   Markin, AM
   Nikiforov, NG
   Sobenin, IA
AF Orekhov, Alexander N.
   Ivanova, Ekaterina A.
   Markin, Alexander M.
   Nikiforov, Nikita G.
   Sobenin, Igor A.
TI Genetics of Arterial-Wall-Specific Mechanisms in Atherosclerosis: Focus
   on Mitochondrial Mutations
SO CURRENT ATHEROSCLEROSIS REPORTS
LA English
DT Review
DE Atherosclerosis; Nuclear genome; Mitochondria; Mutations; Inflammation;
   Mitochondrial DNA
ID SMOOTH-MUSCLE-CELLS; DNA-DAMAGE; MICROSATELLITE INSTABILITY; SOMATIC
   MUTATIONS; RISK-FACTORS; DISEASE; SUSCEPTIBILITY; HETEROZYGOSITY;
   ASSOCIATION; RECEPTOR
AB Purpose of ReviewMutations in both nuclear and mitochondrial genes are associated with the development of atherosclerotic lesions in arteries and may provide a partial explanation to the focal nature of lesion distribution in the arterial wall. This review is aimed to discuss the genetic aspects of atherogenesis with a special focus on possible pro-atherogenic variants (mutations) of the nuclear and mitochondrial genomes that may be implicated in atherosclerosis development and progression.Recent FindingsMutations in the nuclear genes generally do not cause a phenotype restricted to a specific vascular wall cell and manifest themselves mostly at the organism level. Such mutations can act as important contributors to changes in lipid metabolism and modulate other risk factors of atherosclerosis. By contrast, mitochondrial DNA (mtDNA) mutations occurring locally in the arterial wall cells or in circulating immune cells may play a site-specific role in atherogenesis. The mosaic distribution of heteroplasmic mtDNA mutations in the arterial wall tissue may explain, at least to some extent, the locality and focality of atherosclerotic lesions distribution.SummaryThe genetic mechanisms of atherogenesis include alterations of both nuclear and mitochondrial genomes. Altered lipid metabolism and inflammatory response of resident arterial wall and circulating immune cells may be related to mtDNA damage and defective mitophagy, which hinders clearance of dysfunctional mitochondria. Mutations of mtDNA can have mosaic distribution and locally affect functionality of endothelial and subendothelial intimal cells in the arterial wall contributing to atherosclerotic lesion development.
C1 [Orekhov, Alexander N.; Sobenin, Igor A.] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, 8 Baltiiskaya St, Moscow 125315, Russia.
   [Orekhov, Alexander N.; Markin, Alexander M.] Inst Human Morphol, Lab Infect Pathol & Mol Microecol, 3 Tsyurupa St, Moscow 117418, Russia.
   [Ivanova, Ekaterina A.] Inst Atherosclerosis Res, 2-1-207 Osennyaya St, Moscow 121609, Russia.
   [Nikiforov, Nikita G.] Russian Acad Sci, Ctr Collect Usage, Inst Gene Biol, 34-5 Vavilova St, Moscow 119334, Russia.
   [Nikiforov, Nikita G.; Sobenin, Igor A.] Natl Med Res Ctr Cardiol, Inst Expt Cardiol, Lab Med Genet, 15A 3 Rd Cherepkovskaya St, Moscow 121552, Russia.
C3 Russian Academy of Medical Sciences; Institute of General Pathology &
   Pathophysiology, RAMS; Russian Academy of Medical Sciences; Research
   Institute of Human Morphology; Russian Academy of Sciences; Institute of
   Gene Biology (IGB) of Russian Academy of Sciences; National Medical
   Research Center of Cardiology
RP Orekhov, AN (corresponding author), Inst Gen Pathol & Pathophysiol, Lab Angiopathol, 8 Baltiiskaya St, Moscow 125315, Russia.; Orekhov, AN (corresponding author), Inst Human Morphol, Lab Infect Pathol & Mol Microecol, 3 Tsyurupa St, Moscow 117418, Russia.; Ivanova, EA (corresponding author), Inst Atherosclerosis Res, 2-1-207 Osennyaya St, Moscow 121609, Russia.
EM a.h.opexob@gmail.com; kate.ivanov@gmail.com
RI Sobenin, Igor/J-4282-2013; Markin, Alexander/AAO-8626-2020
OI Markin, Alexander/0000-0002-6649-7924
FU Russian Science Foundation [19-15-00297]; Russian Science Foundation
   [19-15-00297] Funding Source: Russian Science Foundation
FX This work was supported by the Russian Science Foundation (grant no.
   19-15-00297).
CR Andreassi MG, 2000, ENVIRON MOL MUTAGEN, V35, P265, DOI 10.1002/1098-2280(2000)35:4<265::AID-EM1>3.0.CO;2-M
   Andreassi MG, 2003, TRENDS CARDIOVAS MED, V13, P270, DOI 10.1016/S1050-1738(03)00109-9
   Belsky DW, 2013, BIODEMOGR SOC BIOL, V59, P85, DOI 10.1080/19485565.2013.774628
   BENDITT EP, 1973, P NATL ACAD SCI USA, V70, P1753, DOI 10.1073/pnas.70.6.1753
   Binková B, 2002, MUTAT RES-FUND MOL M, V501, P115, DOI 10.1016/S0027-5107(02)00019-2
   Borghini A, 2013, ATHEROSCLEROSIS, V230, P202, DOI 10.1016/j.atherosclerosis.2013.07.038
   Botto N, 2001, MUTAT RES-GEN TOX EN, V493, P23, DOI 10.1016/S1383-5718(01)00162-0
   Brozovich FV, 2016, PHARMACOL REV, V68, P476, DOI 10.1124/pr.115.010652
   Cariou B, 2020, ATHEROSCLEROSIS, V292, P204, DOI 10.1016/j.atherosclerosis.2019.11.010
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Cho DH, 2020, MOL CELLS, V43, P10, DOI 10.14348/molcells.2020.2329
   Chung IM, 1998, AM J PATHOL, V152, P913
   Clark KJ, 2001, ARTERIOSCL THROM VAS, V21, P555, DOI 10.1161/01.ATV.21.4.555
   Craven L, 2017, HUM REPROD UPDATE, V23, P501, DOI 10.1093/humupd/dmx018
   Dandona Sonny, 2009, Curr Cardiol Rep, V11, P282
   De Flora S, 2007, MUTAT RES-FUND MOL M, V621, P5, DOI 10.1016/j.mrfmmm.2006.12.008
   DeFlora S, 1997, FASEB J, V11, P1021, DOI 10.1096/fasebj.11.12.9337155
   DeFlora S, 1996, MUTAT RES-REV GENET, V366, P197, DOI 10.1016/S0165-1110(96)00043-7
   Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480
   den Hoed M, 2015, ATHEROSCLEROSIS, V239, P304, DOI 10.1016/j.atherosclerosis.2015.01.032
   Fiotti N, 2006, ARTERIOSCL THROM VAS, V26, P1330, DOI 10.1161/01.ATV.0000219233.31702.c9
   Fouchier SW, 2014, CIRC RES, V115, P552, DOI 10.1161/CIRCRESAHA.115.304660
   Frades I, 2019, CIRC-GENOM PRECIS ME, V12, DOI 10.1161/CIRCGEN.118.002390
   Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620
   Ghosh P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093363
   Goldstein I, 2012, TRENDS ENDOCRIN MET, V23, P567, DOI 10.1016/j.tem.2012.06.007
   Grati FR, 2001, ATHEROSCLEROSIS, V159, P261, DOI 10.1016/S0021-9150(01)00466-X
   Gu HM, 2013, J LIPID RES, V54, P3345, DOI 10.1194/jlr.M041129
   Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585
   Hatzistamou J, 1996, BIOCHEM BIOPH RES CO, V225, P186, DOI 10.1006/bbrc.1996.1151
   Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835
   Holdt LM, 2015, ESC TXB PREVENTIVE C
   Howson JMM, 2017, NAT GENET, V49, P1113, DOI 10.1038/ng.3874
   Huan TX, 2013, ARTERIOSCL THROM VAS, V33, P1427, DOI 10.1161/ATVBAHA.112.300112
   Ioannidis JPA, 2009, CIRC-CARDIOVASC GENE, V2, P7, DOI 10.1161/CIRCGENETICS.108.833392
   Itsara LS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003974
   Ivanova EA, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/7321404
   Ivanova EA, 2015, WORLD J CARDIOL, V7, P583, DOI 10.4330/wjc.v7.i10.583
   Izzotti A, 2001, FASEB J, V15, P752, DOI 10.1096/fj.00-0312com
   Kiaris H, 1996, ATHEROSCLEROSIS, V125, P47, DOI 10.1016/0021-9150(96)05841-8
   Kong YH, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00405
   Lee SH, 2001, TRENDS CARDIOVAS MED, V11, P148, DOI 10.1016/S1050-1738(01)00094-9
   Lee SR, 2017, ADV EXP MED BIOL, V982, P81, DOI 10.1007/978-3-319-55330-6_5
   Li HZ, 2017, BBA-MOL BASIS DIS, V1863, P2266, DOI 10.1016/j.bbadis.2017.05.022
   Li RL, 2001, ATHEROSCLEROSIS, V154, P729, DOI 10.1016/S0021-9150(00)00582-7
   Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146
   Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Malik Q, 2012, FREE RADICAL RES, V46, P554, DOI 10.3109/10715762.2012.663913
   Markowitz SD, 1997, J CLIN INVEST, V100, P2143, DOI 10.1172/JCI119749
   McCaffrey TA, 1997, J CLIN INVEST, V100, P2182, DOI 10.1172/JCI119754
   Millonig G, 2001, LAB INVEST, V81, P639, DOI 10.1038/labinvest.3780273
   Miniati P, 2001, INT J BIOL MARKER, V16, P167, DOI 10.1177/172460080101600302
   Murry CE, 1997, AM J PATHOL, V151, P697
   Orekhov AN, 2015, EXP MOL PATHOL, V99, P672, DOI 10.1016/j.yexmp.2015.11.006
   Orekhov AN, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040978
   Orekhov AN, 2020, CURR NEUROPHARMACOL, V18, P1064, DOI 10.2174/1570159X17666191118125018
   Orekhov AN, 2018, CURR PHARM DESIGN, V24, P2883, DOI 10.2174/1381612824666180911120726
   Orekhov AN, 2014, CARDIOVASC RES, V103, P438, DOI 10.1093/cvr/cvu168
   Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360
   PARKES JL, 1991, AM J PATHOL, V138, P765
   Peng WX, 2019, DNA CELL BIOL, V38, P597, DOI 10.1089/dna.2018.4552
   Piantadosi CA, 2020, FREE RADICAL BIO MED, V152, P455, DOI 10.1016/j.freeradbiomed.2020.01.013
   Poznyak AV, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030584
   ROMANOV YA, 1995, ANN NY ACAD SCI, V748, P12
   Ross JS, 2001, ANN NY ACAD SCI, V947, P271
   Samuels DC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003929
   Skilton MR, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081201
   Sobenin IA, 2017, GENETIC POLYMORPHISM
   Sobenin IA, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9090455
   Sobenin IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068070
   Sobenin IA, 2013, ATHEROSCLEROSIS, V227, P283, DOI 10.1016/j.atherosclerosis.2013.01.006
   Sobenin IA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/832464
   Spandidos DA, 1996, BIOCHEM BIOPH RES CO, V220, P137, DOI 10.1006/bbrc.1996.0370
   Strassheim Derek, 2018, Vessel Plus, V2, DOI 10.20517/2574-1209.2018.44
   Tabas I, 2001, CIRC RES, V88, P747, DOI 10.1161/hh0801.090536
   Talukdar HA, 2016, CELL SYST, V2, P196, DOI 10.1016/j.cels.2016.02.002
   Tang XQ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00175
   TERTOV VV, 1992, CIRC RES, V71, P218, DOI 10.1161/01.RES.71.1.218
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Van Schooten FJ, 1998, FASEB J, V12, P1409, DOI 10.1096/fasebj.12.13.1409
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Weakley SM, 2010, EXPERT REV MOL DIAGN, V10, P173, DOI 10.1586/ERM.10.1
   Weinberg RA, 1996, MOL ONCOLOGY, P179
   Wu GZ, 2014, CIRCULATION, V130, P1452, DOI 10.1161/CIRCULATIONAHA.114.011675
   Yu EPK, 2014, TRENDS ENDOCRIN MET, V25, P481, DOI 10.1016/j.tem.2014.06.008
   Zhelankin A, 2015, J HYPERTENS, V33, pE2, DOI 10.1097/01.hjh.0000467356.04711.50
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
NR 88
TC 10
Z9 11
U1 0
U2 4
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1523-3804
EI 1534-6242
J9 CURR ATHEROSCLER REP
JI Curr. Atheroscleros. Rep.
PD AUG 9
PY 2020
VL 22
IS 10
AR 54
DI 10.1007/s11883-020-00873-5
PG 11
WC Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA ND3KT
UT WOS:000561803400004
PM 32772280
DA 2024-11-01
ER

PT J
AU Wiedemann, FR
   Bartels, C
   Kirches, E
   Mawrin, C
   Wallesch, CW
AF Wiedemann, Falk R.
   Bartels, Claudius
   Kirches, Elmar
   Mawrin, Christian
   Wallesch, Claus-W.
TI Unusual presentations of patients with the mitochondrial MERRF mutation
   A8344G
SO CLINICAL NEUROLOGY AND NEUROSURGERY
LA English
DT Article
DE MERRF; phenotype; respiratory failure; mutation analysis
ID RAGGED-RED FIBERS; STROKE-LIKE EPISODES; MYOCLONIC EPILEPSY;
   CLINICAL-FEATURES; RESPIRATORY-CHAIN; OVERLAP SYNDROME; SKELETAL-MUSCLE;
   DNA MUTATION; MTDNA; DYSFUNCTION
AB MERRF is typically characterized by myoclonus, generalized seizures and ragged-red fibers in Muscular biopsy. We report a family (harbouring the A8344G mutation) with a late onset of the disease and an uncommon clinical manifestation, including episodes of reversible respiratory failure, the presence of ophthalmoplegia, and the absence of seizures and myoclonus in most subjects. We conducted histochemical, biochemical and molecular genetic studies. Mutation analysis revealed that the level of Mutated mitochondrial DNA (mtDNA) was above 80% in the skeletal muscle of all siblings. Nevertheless, one severely affected individual did neither present cytochrome c oxidase-negative fibers nor ragged-red fibers in the skeletal muscle biopsy. These data extend the phenotypic range associated with the MERRF syndrome. We suggest that the analysis of mtDNA could be of importance in many cases of unclear multisystem disorders in later life. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Wiedemann, Falk R.; Bartels, Claudius; Wallesch, Claus-W.] Otto von Guericke Univ, Univ Klinikum Magdeburg, Neurol Klin, D-39120 Magdeburg, Germany.
   [Kirches, Elmar] Otto von Guericke Univ, Inst Neuropathol, D-39120 Magdeburg, Germany.
   [Mawrin, Christian] Univ Jena, Abt Neuropathol, D-07747 Jena, Germany.
C3 Otto von Guericke University; University Hospital Magdeburg; Otto von
   Guericke University; Friedrich Schiller University of Jena
RP Wiedemann, FR (corresponding author), Otto von Guericke Univ, Univ Klinikum Magdeburg, Neurol Klin, Leipziger Str 44, D-39120 Magdeburg, Germany.
EM falk.wiedemann@medizin.uni-magdeburg.de
FU BMBF NBL3 [01220107]
FX The excellent technical assistance of S. Hartmann, K. Kaiser, I.
   Schellhase, and J. Witzke are gratefully acknowledged. The work was
   supported by grant BMBF NBL3 (01220107).
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Arpa J, 1997, ACTA NEUROL SCAND, V96, P65
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   Blumenthal DT, 1998, NEUROLOGY, V50, P524, DOI 10.1212/WNL.50.2.524
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   Dubowitz V., 1973, MUSCLE BIOPSY MODERN
   Gignoux L, 2001, REV NEUROL-FRANCE, V157, P427
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   Melone MAB, 2004, ARCH NEUROL-CHICAGO, V61, P269, DOI 10.1001/archneur.61.2.269
   Mongini T, 2002, CLIN NEUROPATHOL, V21, P72
   Moslemi AR, 1998, NEUROMUSCULAR DISORD, V8, P345, DOI 10.1016/S0960-8966(98)00029-7
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   ROSING HS, 1985, ANN NEUROL, V17, P228, DOI 10.1002/ana.410170303
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Sitburana Oraporn, 2001, Journal of the Medical Association of Thailand, V84, P1051
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   Verma A, 1996, NEUROLOGY, V46, P1334, DOI 10.1212/WNL.46.5.1334
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Wiedemann FR, 2000, ANAL BIOCHEM, V279, P55, DOI 10.1006/abio.1999.4434
   Winkler-Stuck K, 2005, J NEURAL TRANSM, V112, P499, DOI 10.1007/s00702-004-0195-y
   ZEVIANI M, 1991, AM J HUM GENET, V48, P203
NR 25
TC 18
Z9 22
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0303-8467
J9 CLIN NEUROL NEUROSUR
JI Clin. Neurol. Neurosurg.
PD SEP
PY 2008
VL 110
IS 8
BP 859
EP 863
DI 10.1016/j.clineuro.2008.06.010
PG 5
WC Clinical Neurology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Surgery
GA 356GG
UT WOS:000259766100021
PM 18657354
DA 2024-11-01
ER

PT J
AU Dolhun, R
   Presant, EM
   Hedera, P
AF Dolhun, Rachel
   Presant, Erin M.
   Hedera, Peter
TI Novel polymerase gamma (<i>POLG1</i>) gene mutation in the linker domain
   associated with parkinsonism
SO BMC NEUROLOGY
LA English
DT Article
DE Mitochondrial DNA polymerase gamma (POLG1); Parkinsonism; Progressive
   external ophthalmoplegia; Ataxia; Sensory neuropathy
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; FAMILIAL PARKINSONISM; NEUROPATHY;
   ATAXIA
AB Background: Mutations in the POLG1 gene have variable phenotypic presentations and a high degree of clinical suspicion is necessary for their recognition. Parkinsonism and ataxia are the most common movement disorders associated with POLG1 mutations but no phenotype-genotype correlation has been established.
   Case presentation: We identified a male patient with progressive external ophthalmoplegia who also developed a progressive bradykinesia, rigidity and camptocormia in the third decade. Parkinsonism was partially responsive to dopaminegic replacement. His father and brother had reportedly similar clinical problems. Genetic analysis identified a novel mutation p.K512M in the POLG1 gene.
   Conclusion: This report further expands the spectrum of POLG1-associated neurologic problems with the report of a novel mutation in the linker region of the gene, which are rarely associated with parkinsonism.
C1 [Dolhun, Rachel; Presant, Erin M.; Hedera, Peter] Vanderbilt Univ, Dept Neurol, Nashville, TN 37203 USA.
C3 Vanderbilt University
RP Hedera, P (corresponding author), Vanderbilt Univ, Dept Neurol, 465 21st Ave South,6140 MRB 3, Nashville, TN 37203 USA.
EM peter.hedera@vanderbilt.edu
RI HEDERA, PETER/LKK-4666-2024
OI Hedera, Peter/0000-0003-2699-4085
CR Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488
   Synofzik M, 2010, MOVEMENT DISORD, V25, P243, DOI 10.1002/mds.22865
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 17
TC 13
Z9 14
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2377
J9 BMC NEUROL
JI BMC Neurol.
PD JUL 18
PY 2013
VL 13
AR 92
DI 10.1186/1471-2377-13-92
PG 4
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 191ZW
UT WOS:000322454700001
PM 23865558
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Crouch, ML
   Knowels, G
   Stuppard, R
   Ericson, NG
   Bielas, JH
   Marcinek, DJ
   Syrjala, KL
AF Crouch, Marie-Laure
   Knowels, Gary
   Stuppard, Rudolph
   Ericson, Nolan G.
   Bielas, Jason H.
   Marcinek, David J.
   Syrjala, Karen L.
TI Cyclophosphamide leads to persistent deficits in physical performance
   and in vivo mitochondria function in a mouse model of chemotherapy late
   effects
SO PLOS ONE
LA English
DT Article
ID STEM-CELL TRANSPLANTATION; BREAST-CANCER SURVIVORS; CHILDHOOD-CANCER;
   ADULT SURVIVORS; INDUCED HEPATOTOXICITY; GLUTATHIONE DEPLETION;
   DOXORUBICIN ACTS; BODY-COMPOSITION; DNA DELETIONS; VITAMIN-E
AB Fatigue is the symptom most commonly reported by long-term cancer survivors and is increasingly recognized as related to skeletal muscle dysfunction. Traditional chemotherapeutic agents can cause acute toxicities including cardiac and skeletal myopathies. To investigate the mechanism by which chemotherapy may lead to persistent skeletal muscle dysfunction, mature adult mice were injected with a single cyclophosphamide dose and evaluated for 6 weeks. We found that exposed mice developed a persistent decrease in treadmill running time compared to baseline (25.7 +/- 10.6 vs. 49.0 +/- 16.8 min, P = 0.0012). Further, 6 weeks after drug exposure, in vivo parameters of mitochondrial function remained below baseline including maximum ATP production (482.1 +/- 48.6 vs. 696.2 +/- 76.6, P = 0.029) and phosphocreatine to ATP ratio (3.243 +/- 0.1 vs. 3.878 +/- 0.1, P = 0.004). Immunoblotting of homogenized muscles from treated animals demonstrated a transient increase in HNE adducts 1 week after exposure that resolved by 6 weeks. However, there was no evidence of an oxidative stress response as measured by quantitation of SOD1, SOD2, and catalase protein levels. Examination of mtDNA demonstrated that the mutation frequency remained comparable between control and treated groups. Interestingly, there was evidence of a transient increase in NF-B p65 protein 1 day after drug exposure as compared to saline controls (0.091 +/- 0.017 vs. 0.053 +/- 0.022, P = 0.033). These data suggest that continued impairment in muscle and mitochondria function in cyclophosphamide-treated animals is not linked to persistent oxidative stress and that alternative mechanisms need to be considered.
C1 [Crouch, Marie-Laure; Syrjala, Karen L.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.
   [Knowels, Gary; Stuppard, Rudolph; Marcinek, David J.] Univ Washington, Sch Med, Dept Radiol, Seattle, WA 98195 USA.
   [Ericson, Nolan G.; Bielas, Jason H.] Fred Hutchinson Canc Res Ctr, Translat Res Program, Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.
   [Ericson, Nolan G.; Bielas, Jason H.] Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Bielas, Jason H.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
   [Syrjala, Karen L.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.
C3 Fred Hutchinson Cancer Center; University of Washington; University of
   Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson
   Cancer Center; University of Washington; University of Washington
   Seattle; University of Washington; University of Washington Seattle
RP Syrjala, KL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.; Syrjala, KL (corresponding author), Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.
EM ksyrjala@fredhutch.org
FU National Institutes of Health/National Cancer Institute [P30 CA015704,
   R01 CA112631, R01 CA160684, R01 CA215134]; National Cancer Institute and
   National Institute on Aging [P20 CA103728]
FX KLS: Private donation from Robert E. Frey. P30 CA015704, R01 CA112631,
   R01 CA160684, R01 CA215134, National Institutes of Health/National
   Cancer Institute; P20 CA103728, National Cancer Institute and National
   Institute on Aging.
CR Abraham P, 2011, HUM EXP TOXICOL, V30, P1924, DOI 10.1177/0960327111402240
   Ahlberg K, 2003, LANCET, V362, P640, DOI 10.1016/S0140-6736(03)14186-4
   al-Majid S, 2001, Biol Res Nurs, V2, P186, DOI 10.1177/109980040100200304
   Anton E, 2002, INT J EXP PATHOL, V83, P47, DOI 10.1046/j.1365-2613.2002.00208.x
   Arakaki LSL, 2007, APPL SPECTROSC, V61, P978, DOI 10.1366/000370207781745928
   Asiri YA, 2010, OXID MED CELL LONGEV, V3, P308, DOI 10.4161/oxim.3.5.13107
   Banthia R, 2006, J BEHAV MED, V29, P269, DOI 10.1007/s10865-006-9053-8
   Bennett Jill A, 2013, Oncol Nurs Forum, V40, pE126, DOI 10.1188/13.ONF.E126-E134
   Berger AM, 2010, J NATL COMPR CANC NE, V8, P904, DOI 10.6004/jnccn.2010.0067
   Bertram LAC, 2011, CANCER CAUSE CONTROL, V22, P427, DOI 10.1007/s10552-010-9714-3
   Bjelogrlic SK, 2005, BASIC CLIN PHARMACOL, V97, P311, DOI 10.1111/j.1742-7843.2005.pto_166.x
   Bjelogrlic SK, 2013, BASIC CLIN PHARMACOL, V113, P228, DOI 10.1111/bcpt.12086
   BLEI ML, 1993, P NATL ACAD SCI USA, V90, P7396, DOI 10.1073/pnas.90.15.7396
   BLEI ML, 1993, J PHYSIOL-LONDON, V465, P203, DOI 10.1113/jphysiol.1993.sp019673
   Bower JE, 2000, J CLIN ONCOL, V18, P743, DOI 10.1200/JCO.2000.18.4.743
   Braithwaite D, 2010, JNCI-J NATL CANCER I, V102, P1468, DOI 10.1093/jnci/djq344
   Braun TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106489
   Bylow K, 2011, UROLOGY, V77, P934, DOI 10.1016/j.urology.2010.11.024
   Calvani R, 2013, BIOL CHEM, V394, P393, DOI 10.1515/hsz-2012-0247
   Chen JA, 2015, J CACHEXIA SARCOPENI, V6, P132, DOI 10.1002/jcsm.12023
   Conklin DJ, 2009, J PHARMACOL EXP THER, V331, P456, DOI 10.1124/jpet.109.156513
   CROOK TR, 1986, CANCER RES, V46, P5035
   CROOK TR, 1986, CANCER RES, V46, P5029
   Cuce G, 2015, CHEM-BIOL INTERACT, V232, P7, DOI 10.1016/j.cbi.2015.02.016
   DORR RT, 1994, CHEM-BIOL INTERACT, V93, P117, DOI 10.1016/0009-2797(94)90091-4
   Ferrucci L, 2002, J AM GERIATR SOC, V50, P1947, DOI 10.1046/j.1532-5415.2002.50605.x
   Ganz PA, 2003, J CLIN ONCOL, V21, P4184, DOI 10.1200/JCO.2003.04.196
   Gilliam LAA, 2013, FREE RADICAL BIO MED, V65, P988, DOI 10.1016/j.freeradbiomed.2013.08.191
   Gilliam LAA, 2012, AM J PHYSIOL-CELL PH, V302, pC195, DOI 10.1152/ajpcell.00217.2011
   Gilliam LAA, 2011, ANTIOXID REDOX SIGN, V15, P2543, DOI 10.1089/ars.2011.3965
   Gilliam LAA, 2011, AM J PHYSIOL-LUNG C, V300, pL225, DOI 10.1152/ajplung.00264.2010
   Gilliam LAA, 2011, MUSCLE NERVE, V43, P94, DOI 10.1002/mus.21809
   Gilliam LAA, 2009, J APPL PHYSIOL, V107, P1935, DOI 10.1152/japplphysiol.00776.2009
   Giraud B, 2010, EXPERT OPIN DRUG MET, V6, P919, DOI 10.1517/17425255.2010.487861
   GOLDING EM, 1995, J EXP BIOL, V198, P1775
   Gouspillou G, 2015, SCI REP-UK, V5, DOI 10.1038/srep08717
   Gurney JG, 2006, CANCER-AM CANCER SOC, V106, P1402, DOI 10.1002/cncr.21752
   HEINEMAN FW, 1990, MAGN RESON MED, V13, P490, DOI 10.1002/mrm.1910130316
   Hewitt M, 2003, J GERONTOL A-BIOL, V58, P82
   Hochman DJ, 2014, ENVIRON TOXICOL, V29, P908, DOI 10.1002/tox.21818
   Hoffman MC, 2013, J CLIN ONCOL, V31, P2799, DOI 10.1200/JCO.2012.47.8081
   Hoffmeister PA, 2013, BIOL BLOOD MARROW TR, V19, P1081, DOI 10.1016/j.bbmt.2013.04.017
   Jones LW, 2012, J CLIN ONCOL, V30, P2530, DOI 10.1200/JCO.2011.39.9014
   Kim Sung-Hwan, 2013, Lab Anim Res, V29, P204, DOI 10.5625/lar.2013.29.4.204
   Kumari KK, 2012, J BIOENERG BIOMEMBR, V44, P179, DOI 10.1007/s10863-012-9423-6
   Kushmerick MJ, 1997, AM J PHYSIOL-CELL PH, V272, pC1739, DOI 10.1152/ajpcell.1997.272.5.C1739
   Kwolek-Mirek M, 2015, CELL BIOCHEM BIOPHYS, V71, P1525, DOI 10.1007/s12013-014-0376-8
   Lebrecht D, 2005, J PATHOL, V207, P436, DOI 10.1002/path.1863
   Lebrecht D, 2003, CIRCULATION, V108, P2423, DOI 10.1161/01.CIR.0000093196.59829.DF
   Gomes PRL, 2014, REV BRAS GINECOL OBS, V36, P244
   Luo J, 2005, NEUROCHEM INT, V46, P243, DOI 10.1016/j.neuint.2004.09.001
   Luo J, 2005, NEUROCHEM INT, V47, P449, DOI 10.1016/j.neuint.2005.07.002
   Maccormick RE, 2006, MED HYPOTHESES, V67, P212, DOI 10.1016/j.mehy.2006.01.045
   Marcinek DJ, 2004, AM J PHYSIOL-CELL PH, V286, pC457, DOI 10.1152/ajpcell.00237.2003
   McDonald C, 2011, CANCER FORUM, V35, P102
   Moghe A, 2015, TOXICOL SCI, V143, P242, DOI 10.1093/toxsci/kfu233
   Mukherjee N, 2011, NEUROSCIENCE, V192, P732, DOI 10.1016/j.neuroscience.2011.07.006
   Ness KK, 2015, CANCER-AM CANCER SOC, V121, P1540, DOI 10.1002/cncr.29211
   Ness KK, 2013, J CLIN ONCOL, V31, P4496, DOI 10.1200/JCO.2013.52.2268
   Ness KK, 2012, CANCER-AM CANCER SOC, V118, P828, DOI 10.1002/cncr.26337
   Nishikawa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131394
   Patterson RE, 2011, BREAST CANCER RES TR, V127, P541, DOI 10.1007/s10549-010-1236-x
   Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3
   Petrick JL, 2014, J GERIATR ONCOL, V5, P359, DOI 10.1016/j.jgo.2014.06.002
   Petrick JL, 2014, CANCER CAUSE CONTROL, V25, P1179, DOI 10.1007/s10552-014-0421-3
   Rom O, 2013, FREE RADICAL BIO MED, V65, P190, DOI 10.1016/j.freeradbiomed.2013.06.024
   Saquib N, 2011, PSYCHO-ONCOLOGY, V20, P252, DOI 10.1002/pon.1742
   Sayed-Ahmed MM, 2014, INHI BITION OF GENE
   Sehl M, 2013, J CANCER SURVIV, V7, P20, DOI 10.1007/s11764-012-0239-5
   Sekeroglu V, 2011, ASIAN PAC J CANCER P, V12, P2925
   Sheean PM, 2012, BREAST CANCER RES TR, V135, P663, DOI 10.1007/s10549-012-2200-8
   Siegel MP, 2013, AGING CELL, V12, P763, DOI 10.1111/acel.12102
   Siegel MP, 2012, MECH AGEING DEV, V133, P620, DOI 10.1016/j.mad.2012.08.002
   Siegel MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026963
   Slater ME, 2015, BIOL BLOOD MARROW TR, V21, P1278, DOI 10.1016/j.bbmt.2015.04.007
   Smith LB, 2014, THE ROLE OF IL 1BETA
   Sun Y, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/170309
   Syrjala KL, 2010, J CANCER SURVIV, V4, P225, DOI 10.1007/s11764-010-0126-x
   Taylor D J, 1983, Mol Biol Med, V1, P77
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Thompson LV, 2006, J APPL PHYSIOL, V101, P1581, DOI 10.1152/japplphysiol.00426.2006
   Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058
   Wanagat J, 2015, EXP GERONTOL, V61, P15, DOI 10.1016/j.exger.2014.11.012
   Wardell TM, 2003, MUTAT RES-FUND MOL M, V525, P19, DOI 10.1016/S0027-5107(02)00313-5
   Wei C, 2015, PEDIATR BLOOD CANCER, V62, P1992, DOI 10.1002/pbc.25601
   Winters-Stone KM, 2011, BREAST CANCER RES TR, V127, P447, DOI 10.1007/s10549-011-1444-z
   Zhu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep17536
NR 87
TC 28
Z9 31
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 10
PY 2017
VL 12
IS 7
AR e0181086
DI 10.1371/journal.pone.0181086
PG 18
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FA6HV
UT WOS:000405544800119
PM 28700655
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Li, D
   Yang, SJ
   Xing, YW
   Pan, LM
   Zhao, R
   Zhao, YX
   Liu, LT
   Wu, M
AF Li, Dan
   Yang, Shengjie
   Xing, Yanwei
   Pan, Limin
   Zhao, Ran
   Zhao, Yixi
   Liu, Longtao
   Wu, Min
TI Novel Insights and Current Evidence for Mechanisms of Atherosclerosis:
   Mitochondrial Dynamics as a Potential Therapeutic Target
SO FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE mitochondria; morphology; fission; fusion; cytoskeleton; transport
ID SMOOTH-MUSCLE-CELLS; NLRP3 INFLAMMASOME ACTIVATION;
   LOW-DENSITY-LIPOPROTEIN; HIGHER-RISK PLAQUES; NF-KAPPA-B; OXIDATIVE
   STRESS; CARDIOVASCULAR-DISEASE; ALLEVIATES ATHEROSCLEROSIS; ENDOTHELIAL
   DYSFUNCTION; PULMONARY-HYPERTENSION
AB Cardiovascular disease (CVD) is the main cause of death worldwide. Atherosclerosis is the underlying pathological basis of CVD. Mitochondrial homeostasis is maintained through the dynamic processes of fusion and fission. Mitochondria are involved in many cellular processes, such as steroid biosynthesis, calcium homeostasis, immune cell activation, redox signaling, apoptosis, and inflammation, among others. Under stress conditions, mitochondrial dynamics, mitochondrial cristae remodeling, and mitochondrial ROS (mitoROS) production increase, mitochondrial membrane potential (MMP) decreases, calcium homeostasis is imbalanced, and mitochondrial permeability transition pore open (mPTP) and release of mitochondrial DNA (mtDNA) are activated. mtDNA recognized by TLR9 can lead to NF-kappa B pathway activation and pro-inflammatory factor expression. At the same time, TLR9 can also activate NLRP3 inflammasomes and release interleukin, an event that eventually leads to tissue damage and inflammatory responses. In addition, mitochondrial dysfunction may amplify the activation of NLRP3 through the production of mitochondrial ROS, which together aggravate accumulating mitochondrial damage. In addition, mtDNA defects or gene mutation can lead to mitochondrial oxidative stress. Finally, obesity, diabetes, hypertension and aging are risk factors for the progression of CVD, which are closely related to mitochondrial dynamics. Mitochondrial dynamics may represent a new target in the treatment of atherosclerosis. Antioxidants, mitochondrial inhibitors, and various new therapies to correct mitochondrial dysfunction represent a few directions for future research on therapeutic intervention and amelioration of atherosclerosis.
C1 [Li, Dan; Yang, Shengjie; Xing, Yanwei; Pan, Limin; Zhao, Ran; Zhao, Yixi; Wu, Min] China Acad Chinese Med Sci, Guangan Men Hosp, Beijing, Peoples R China.
   [Liu, Longtao] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing, Peoples R China.
C3 China Academy of Chinese Medical Sciences; China Academy of Chinese
   Medical Sciences; Xiyuan Hospital, CACMS
RP Wu, M (corresponding author), China Acad Chinese Med Sci, Guangan Men Hosp, Beijing, Peoples R China.; Liu, LT (corresponding author), China Acad Chinese Med Sci, Xiyuan Hosp, Beijing, Peoples R China.
EM liulongtao1976@126.com; wumin19762000@126.com
RI Li, Chun/KBC-9591-2024; Yang, Shengjie/IYS-5374-2023; li,
   dan/GYU-7569-2022
OI Li, Dan/0000-0002-4852-5485; Wu, Min/0009-0004-8965-4701; Liu,
   Longtao/0000-0002-4842-6241
FU National Natural Science Foundation of China [81202805, 81973689,
   81573821, 82074254]; Beijing Natural Science Foundation [7172185,
   7202176]
FX This work was supported by the National Natural Science Foundation of
   China (Grant Nos. 81202805, 81973689, 81573821, and 82074254) and the
   Beijing Natural Science Foundation (Nos. 7172185 and 7202176).
CR Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116
   Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Ames BN, 2004, ANN NY ACAD SCI, V1019, P406, DOI 10.1196/annals.1297.073
   Apostolova N, 2020, REDOX BIOL, V34, DOI 10.1016/j.redox.2020.101517
   Bernal-Mizrachi C, 2005, NATURE, V435, P502, DOI 10.1038/nature03527
   Blüher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8
   Boekholdt SM, 2014, J AM COLL CARDIOL, V64, P485, DOI 10.1016/j.jacc.2014.02.615
   Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904
   Boudina S, 2009, CIRCULATION, V119, P1272, DOI 10.1161/CIRCULATIONAHA.108.792101
   Breitzig MT, 2018, AM J PHYSIOL-CELL PH, V315, pC80, DOI 10.1152/ajpcell.00042.2018
   Bugger H, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165768
   Cader MZ, 2016, NAT IMMUNOL, V17, P1046, DOI 10.1038/ni.3532
   Cai Y, 2018, J CARDIOVASC TRANSL, V11, P450, DOI 10.1007/s12265-018-9828-7
   Corona JC, 2014, EXP NEUROL, V253, P16, DOI 10.1016/j.expneurol.2013.12.012
   Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019
   Chen AO, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03389-1
   Chen CC, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040275
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen Y, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6699516
   Chen YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065455
   Cheng GJ, 2015, BIOCHEM BIOPH RES CO, V465, P41, DOI 10.1016/j.bbrc.2015.07.118
   Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116
   Chiong M, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00072
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Cid-Castro C, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/8832863
   Commodore-Mensah Y, 2021, DIABETES CARE, V44, P1657, DOI 10.2337/dc20-2227
   Cui L, 2017, VASC PHARMACOL, V88, P21, DOI 10.1016/j.vph.2016.11.006
   D'Amico D, 2019, MOL CELL, V73, P775, DOI 10.1016/j.molcel.2018.11.034
   Dehnavi S, 2021, DRUGS, V81, P923, DOI 10.1007/s40265-021-01510-4
   Dikalova AE, 2020, CIRC RES, V126, P439, DOI 10.1161/CIRCRESAHA.119.315767
   Ding ZF, 2014, CARDIOVASC RES, V103, P619, DOI 10.1093/cvr/cvu114
   Du JK, 2022, PSYCHOPHARMACOLOGY, V239, P2083, DOI 10.1007/s00213-021-05811-0
   Ducommun S, 2015, CELL SIGNAL, V27, P978, DOI 10.1016/j.cellsig.2015.02.008
   Duicu OM, 2013, CAN J PHYSIOL PHARM, V91, P593, DOI 10.1139/cjpp-2012-0422
   Elorza AA, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.625020
   Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833
   Faelber K, 2019, NATURE, V571, P429, DOI 10.1038/s41586-019-1372-3
   Fang X, 2016, J CARDIOVASC PHARM, V67, P164, DOI 10.1097/FJC.0000000000000333
   Farré AL, 2001, HYPERTENSION, V38, P1400, DOI 10.1161/hy1201.099612
   Fetterman JL, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0372-y
   Fletcher EA, 2018, PUBLIC HEALTH NUTR, V21, P1115, DOI [10.1017/s136898001700372x, 10.1017/S136898001700372X]
   Förstermann U, 2017, CIRC RES, V120, P713, DOI 10.1161/CIRCRESAHA.116.309326
   Foote K, 2018, AGING CELL, V17, DOI 10.1111/acel.12773
   Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401
   Forte M, 2019, J MOL MED, V97, P579, DOI 10.1007/s00109-019-01771-3
   Freigang S, 2013, NAT IMMUNOL, V14, P1045, DOI 10.1038/ni.2704
   Fukai T, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081849
   Gao P, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.604240
   Gent S, 2017, AM J PHYSIOL-HEART C, V312, pH478, DOI 10.1152/ajpheart.00749.2016
   Gherardi G, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.554904
   Gisterå A, 2018, CURR OPIN LIPIDOL, V29, P375, DOI 10.1097/MOL.0000000000000540
   Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008
   Gross CJ, 2016, IMMUNITY, V45, P761, DOI 10.1016/j.immuni.2016.08.010
   Gu Q, 2014, EXP GERONTOL, V56, P37, DOI 10.1016/j.exger.2014.02.014
   Guo DQ, 2017, ONCOTARGET, V8, P77020, DOI 10.18632/oncotarget.20331
   Guo XM, 2007, CIRC RES, V101, P1113, DOI 10.1161/CIRCRESAHA.107.157644
   Guo YH, 2007, BIOCHEM BIOPH RES CO, V363, P411, DOI 10.1016/j.bbrc.2007.08.191
   Haghikia A, 2014, CARDIOVASC RES, V102, P281, DOI 10.1093/cvr/cvu034
   Hasan P, 2018, J MOL CELL CARDIOL, V121, P103, DOI 10.1016/j.yjmcc.2018.07.004
   Heusch G, 2011, CIRC RES, V109, P1302, DOI 10.1161/CIRCRESAHA.111.255604
   Hong ST, 2017, BIOCHEM BIOPH RES CO, V487, P728, DOI 10.1016/j.bbrc.2017.04.126
   Hu C, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03152-y
   Hu L, 2019, THERANOSTICS, V9, P3687, DOI 10.7150/thno.33684
   Huang D, 2020, AGING-US, V12, P18181, DOI 10.18632/aging.103666
   Hughes WE, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0802-6
   Humeres C, 2019, JACC-BASIC TRANSL SC, V4, P449, DOI 10.1016/j.jacbts.2019.02.006
   Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356
   Jong CJ, 2019, MOL CELL BIOCHEM, V454, P33, DOI 10.1007/s11010-018-3450-5
   Jonsson AL, 2017, NAT REV CARDIOL, V14, P79, DOI 10.1038/nrcardio.2016.183
   Kaludercic N, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00012
   Karnewar S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24108
   Kepp O, 2011, NAT IMMUNOL, V12, P199, DOI 10.1038/ni0311-199
   Kim J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25437
   Kim YM, 2018, CELL REP, V23, P3565, DOI 10.1016/j.celrep.2018.05.054
   Kiyuna LA, 2018, FREE RADICAL BIO MED, V129, P155, DOI 10.1016/j.freeradbiomed.2018.09.019
   Kleinbongard P, 2018, BASIC RES CARDIOL, V113, P1, DOI 10.1007/s00395-017-0660-z
   Knight-Lozano CA, 2002, CIRCULATION, V105, P849, DOI 10.1161/hc0702.103977
   Koltover Vitaly K, 2017, Curr Aging Sci, V10, P12
   Kuznetsova DA, 2019, J MATER CHEM B, V7, P7351, DOI 10.1039/c9tb01853k
   Kyriakoudi S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094617
   Lackner LL, 2019, TRENDS CELL BIOL, V29, P580, DOI 10.1016/j.tcb.2019.02.009
   Laslett LJ, 2012, J AM COLL CARDIOL, V60, pS1, DOI 10.1016/j.jacc.2012.11.002
   Li AX, 2022, HEART FAIL REV, V27, P1387, DOI 10.1007/s10741-021-10109-6
   Li J, 2015, J MOL CELL CARDIOL, V86, P62, DOI 10.1016/j.yjmcc.2015.07.010
   Li J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12724
   Li SS, 2017, EUR J PHARMACOL, V815, P118, DOI 10.1016/j.ejphar.2017.07.041
   Li Y, 2016, ANTIOXID REDOX SIGN, V24, P893, DOI 10.1089/ars.2015.6479
   Linton MF, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112703
   Liu M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.598078
   Liu MY, 2016, HYPERTENSION, V68, P1245, DOI 10.1161/HYPERTENSIONAHA.116.07974
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Luptak I, 2019, ANTIOXID REDOX SIGN, V31, P539, DOI 10.1089/ars.2018.7707
   Makino A, 2010, DIABETOLOGIA, V53, P1783, DOI 10.1007/s00125-010-1770-4
   Mao Y, 2017, ARTERIOSCL THROM VAS, V37, P920, DOI [10.1161/ATVBAHA.117.309017, 10.1161/atvbaha.117.309017]
   Markin AM, 2021, LIFE-BASEL, V11, DOI 10.3390/life11020165
   Marshall JD, 2018, AM J PHYSIOL-LUNG C, V314, pL782, DOI 10.1152/ajplung.00331.2017
   Mathew A, 2012, J ALZHEIMERS DIS, V30, P617, DOI 10.3233/JAD-2012-120145
   Matsunaga H, 2001, DIABETES CARE, V24, P500, DOI 10.2337/diacare.24.3.500
   Micha R, 2009, NAT REV ENDOCRINOL, V5, P335, DOI 10.1038/nrendo.2009.79
   Mohanty A, 2019, J CELL COMMUN SIGNAL, V13, P303, DOI 10.1007/s12079-019-00507-9
   Morales PE, 2020, MOL ASPECTS MED, V71, DOI 10.1016/j.mam.2019.09.006
   Mottis A, 2019, SCIENCE, V366, P827, DOI 10.1126/science.aax3768
   Müller J, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0440-y
   Muñoz-Carvajal F, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.581849
   Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367
   Navaratnarajah T, 2021, INT J BIOCHEM CELL B, V134, DOI 10.1016/j.biocel.2021.105951
   Nazzal D, 2006, J INFECT DIS, V193, P136, DOI 10.1086/498617
   Ni R, 2016, FREE RADICAL BIO MED, V90, P12, DOI 10.1016/j.freeradbiomed.2015.11.013
   Nielsen SH, 2019, MATRIX BIOL, V75-76, P43, DOI 10.1016/j.matbio.2017.12.001
   Norton M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004374
   Oesterle A, 2017, CIRC RES, V120, P229, DOI 10.1161/CIRCRESAHA.116.308537
   Ordog K, 2021, LIFE SCI, V268, DOI 10.1016/j.lfs.2020.118936
   Ostojic SM, 2016, CLIN SCI, V130, P1407, DOI 10.1042/CS20160200
   Ota A, 2020, J BIOCHEM, V167, P287, DOI 10.1093/jb/mvz112
   Paltauf-Doburzynska J, 2004, J CARDIOVASC PHARM, V44, P423, DOI 10.1097/01.fjc.0000139449.64337.1b
   Pataky MW, 2021, CELL METAB, V33, P847, DOI 10.1016/j.cmet.2021.04.008
   Pennanen C, 2014, J CELL SCI, V127, P2659, DOI 10.1242/jcs.139394
   Peyravi A, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13125
   Pham L, 2021, BIOMATERIALS, V269, DOI 10.1016/j.biomaterials.2021.120677
   Phillips NR, 2014, ALZHEIMERS DEMENT, V10, P393, DOI 10.1016/j.jalz.2013.04.508
   Picca A, 2018, NAT REV CARDIOL, V15, P543, DOI 10.1038/s41569-018-0059-z
   Picca A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050933
   Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439
   Qin X, 2019, THERANOSTICS, V9, P1698, DOI 10.7150/thno.30640
   Qiu Y, 2020, MOL THER-NUCL ACIDS, V19, P1343, DOI 10.1016/j.omtn.2020.01.017
   Rababa'h AM, 2018, CURR CARDIOL REV, V14, P53, DOI 10.2174/1573403X14666180111145207
   Rodriguez-Iturbe B, 2007, J APPL PHYSIOL, V102, P255, DOI 10.1152/japplphysiol.00513.2006
   Saigusa R, 2020, NAT REV CARDIOL, V17, P387, DOI 10.1038/s41569-020-0352-5
   Sazonova M, 2009, ATHEROSCLEROSIS, V204, P184, DOI 10.1016/j.atherosclerosis.2008.09.001
   Sazonova MA, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6934394
   Schiano C, 2015, TRENDS PHARMACOL SCI, V36, P226, DOI 10.1016/j.tips.2015.02.005
   Sebastián D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084
   Shao ZQ, 2021, NEURAL REGEN RES, V16, P1044, DOI 10.4103/1673-5374.300725
   Sharp WW, 2015, J MOL MED, V93, P225, DOI 10.1007/s00109-015-1258-2
   Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87
   Sobenin IA, 2013, CURR PHARM DESIGN, V19, P5942
   Sobenin IA, 2013, ATHEROSCLEROSIS, V227, P283, DOI 10.1016/j.atherosclerosis.2013.01.006
   Song R, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121475
   Stanzione R, 2022, CURR NEUROPHARMACOL, V20, P662, DOI 10.2174/1570159X19666210421094204
   Strutynska N A, 2016, Fiziol Zh, V62, P3
   Suárez-Rivero JM, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9030258
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Tang JX, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113820
   Teixeira LD, 2021, FOOD FUNCT, V12, P3680, DOI [10.1039/d0fo03245j, 10.1039/D0FO03245J]
   Thijssen DHJ, 2010, EUR J APPL PHYSIOL, V108, P845, DOI 10.1007/s00421-009-1260-x
   Tibaut M, 2019, HEART LUNG CIRC, V28, P667, DOI 10.1016/j.hlc.2018.06.1057
   Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760
   Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138
   Triantafilou K, 2013, J CELL SCI, V126, P2903, DOI 10.1242/jcs.124388
   Tuder RM, 2012, AM J RESP CRIT CARE, V185, P260, DOI 10.1164/rccm.201108-1536PP
   Tumurkhuu G, 2016, CIRC RES, V119, pE76, DOI 10.1161/CIRCRESAHA.116.308362
   Ueda S, 2015, FREE RADICAL BIO MED, V87, P181, DOI 10.1016/j.freeradbiomed.2015.06.028
   Vaka VR, 2018, HYPERTENSION, V72, P703, DOI 10.1161/HYPERTENSIONAHA.118.11290
   Valenzuela CA, 2019, PROG LIPID RES, V76, DOI 10.1016/j.plipres.2019.101009
   van Empel VPM, 2004, CARDIOVASC RES, V63, P487, DOI 10.1016/j.cardiores.2004.02.013
   Vendrov AE, 2015, ANTIOXID REDOX SIGN, V23, P1389, DOI 10.1089/ars.2014.6221
   Victor VM, 2015, ATHEROSCLEROSIS, V242, P167, DOI 10.1016/j.atherosclerosis.2015.07.017
   Vindis C, 2005, ARTERIOSCL THROM VAS, V25, P639, DOI 10.1161/01.ATV.0000154359.60886.33
   Volobueva A, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9080377
   Wang L, 2015, CARDIOVASC RES, V106, P272, DOI 10.1093/cvr/cvv005
   Wang QL, 2017, AUTOPHAGY, V13, P404, DOI 10.1080/15548627.2016.1263776
   Wang QL, 2017, DIABETES, V66, P193, DOI 10.2337/db16-0915
   Wang RH, 2021, MOL BIOL CELL, V32, P157, DOI 10.1091/mbc.E20-09-0605
   Wang SS, 2021, EXP GERONTOL, V143, DOI 10.1016/j.exger.2020.111152
   Wang YX, 2011, AM J PHYSIOL-CELL PH, V301, pC695, DOI 10.1152/ajpcell.00322.2010
   Watanabe T, 2014, EXP CELL RES, V323, P314, DOI 10.1016/j.yexcr.2014.02.027
   Weaver D, 2014, MOL CELL, V54, P870, DOI 10.1016/j.molcel.2014.03.048
   West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   Wolf C, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040815
   Wu YL, 2018, BIOMED PHARMACOTHER, V97, P1673, DOI 10.1016/j.biopha.2017.12.024
   Xie TQ, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01034
   Xin YG, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.647631
   Xing SS, 2015, VASC PHARMACOL, V72, P141, DOI 10.1016/j.vph.2015.07.004
   Xue W, 2020, BIOMED PHARMACOTHER, V124, DOI 10.1016/j.biopha.2020.109849
   Yan Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113534
   Yang JN, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0338-7
   Yapa NMB, 2021, FEBS LETT, V595, P1184, DOI 10.1002/1873-3468.14077
   Yeh HL, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5086869
   Yu E, 2014, CIRCULATION, V129, pE408, DOI 10.1161/CIRCULATIONAHA.113.008032
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu EPK, 2017, ARTERIOSCL THROM VAS, V37, P2322, DOI 10.1161/ATVBAHA.117.310042
   Yu SJ, 2019, EXP CELL RES, V379, P191, DOI 10.1016/j.yexcr.2019.04.002
   Zhang BB, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600710
   Zhang JZ, 2014, INT J MOL MED, V33, P817, DOI 10.3892/ijmm.2014.1650
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhao J, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-019-0721-6
   Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057
   Zhou J, 2016, ONCOTARGET, V7, P31284, DOI 10.18632/oncotarget.8893
   Zhou Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154720
   Zhu YC, 2019, DRUG DEVELOP RES, V80, P481, DOI 10.1002/ddr.21521
   Zhuan B, 2020, AGING-US, V12, P23684, DOI 10.18632/aging.103892
   Zhuang XY, 2017, EXP THER MED, V14, P515, DOI 10.3892/etm.2017.4541
   Zielonka J, 2017, CHEM REV, V117, P10043, DOI 10.1021/acs.chemrev.7b00042
NR 197
TC 33
Z9 33
U1 1
U2 29
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-634X
J9 FRONT CELL DEV BIOL
JI Front. Cell. Dev. Biol.
PD JUL 7
PY 2021
VL 9
AR 673839
DI 10.3389/fcell.2021.673839
PG 16
WC Cell Biology; Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology
GA TL6EO
UT WOS:000674952500001
PM 34307357
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Strazielle, C
   Dumont, M
   Fukuchi, K
   Lalonde, R
AF Strazielle, C
   Dumont, M
   Fukuchi, K
   Lalonde, R
TI Transgenic mice expressing the human C99 terminal fragment of βAPP::
   effects on cytochrome oxidase activity in skeletal muscle and brain
SO JOURNAL OF CHEMICAL NEUROANATOMY
LA English
DT Article
DE amyloid-beta; beta-amyloid precursor protein; inclusion body myopathy;
   regional brain; metabolism
ID AMYLOID PRECURSOR PROTEIN; INCLUSION-BODY MYOSITIS; MITOCHONDRIAL-DNA
   DELETIONS; ALZHEIMERS-DISEASE; INTRACELLULAR ACCUMULATION;
   ABNORMALITIES; HEREDITARY; SYSTEM; HIPPOCAMPUS; METABOLISM
AB In order to furnish a combined model of relevance to human inclusion-body myopathy and Alzheimer's disease, transgenic mice expressing human betaAPP-C99 in skeletal muscle and brain under the control of the cytomegalovirus/beta-actin promoter were produced (Tg13592). These transgenic mice develop Abeta deposits in muscles but not in brain. Cell metabolic activity was analyzed in brain regions and muscle by cytochrome oxidase (CO) histochemistry, the terminal enzyme of the electron transport chain. By comparison to age-matched controls of the C57BL/6 strain, CO activity was selectively increased in dark skeletal muscle fibers of Tg13592 mice. In addition, only increases in CO activity were obtained in those brain regions where a significant difference appeared. The CO activity of Tg13592 mice was elevated in several thalamic nuclei, including laterodorsal, ventromedial, and midline as well as submedial, intralaminar, and reticular. In contrast, the groups did,not differ in most cortical regions, except for prefrontal, secondary motor, and auditory cortices, and in most brainstem regions, except for cerebellar (fastigial and interpositus) nuclei and related areas (red and lateral vestibular nuclei). No variation in cell density and surface area appeared in conjunction with these enzymatic alterations. The overproduction of betaAPP-C99 fragments in brain without (amyloidosis did not appear to affect the metabolic activity of structures particularly vulnerable in Alzheimer's disease. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Henri Poincare, Lab Pathol Mol & Cellulair Nutr, EMI 0014, INSERM, Nancy 1, France.
   Univ Henri Poincare, Serv Microscopie Electron, Fac Med, Nancy 1, France.
   Univ Rouen, Fac Med & Pharm, INSERM, EMI 9906,IFRMP23, F-76183 Rouen, France.
   Univ Alabama Birmingham, Sch Med & Dent, Dept Genet, Birmingham, AL 35294 USA.
   CHUM St Luc, Ctr Rech Neurosci, Montreal, PQ H2X 3J4, Canada.
C3 Universite de Lorraine; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite de Lorraine; Universite de Rouen
   Normandie; Institut National de la Sante et de la Recherche Medicale
   (Inserm); University of Alabama System; University of Alabama
   Birmingham; Universite de Montreal
RP Univ Henri Poincare, Lab Pathol Mol & Cellulair Nutr, EMI 0014, INSERM, Nancy 1, France.
EM straziel@persmail.uhp-nancy.fr
RI Strazielle, Catherine/HTR-7269-2023
OI DUMONT, MAGALI/0000-0001-9990-6512
FU NINDS NIH HHS [R01 NS43947] Funding Source: Medline
CR Amaral David G., 1995, P443
   ASKANAS V, 1994, CURR OPIN NEUROL, V7, P448, DOI 10.1097/00019052-199410000-00013
   Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314
   Askanas V, 1998, ANN NY ACAD SCI, V841, P28, DOI 10.1111/j.1749-6632.1998.tb10908.x
   Askanas Valerie, 1998, Current Opinion in Rheumatology, V10, P530, DOI 10.1097/00002281-199811000-00005
   Baloyannis SJ, 2000, ACTA OTO-LARYNGOL, V120, P247
   Braak H, 1999, CELL DEATH AND DISEASES OF THE NERVOUS SYSTEM, P497
   Butcher Larry L., 1995, P1003
   COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589
   de la Torre JC, 2000, NEUROBIOL AGING, V21, P331, DOI 10.1016/S0197-4580(00)00111-1
   FERRANDIZ ML, 1994, BRAIN RES, V644, P335, DOI 10.1016/0006-8993(94)91699-3
   Franklin KBJ., 2013, Paxinos and franklin's the mouse brain in stereotaxic coordinates
   FUKUCHI K, 1993, NEUROSCI LETT, V154, P145, DOI 10.1016/0304-3940(93)90192-N
   Fukuchi K, 1996, AM J PATHOL, V149, P219
   FUKUCHI K, 1992, MOL BRAIN RES, V16, P37, DOI 10.1016/0169-328X(92)90191-D
   Fukuchi K, 1998, AM J PATHOL, V153, P1687, DOI 10.1016/S0002-9440(10)65682-9
   FUKUCHI KI, 1994, EXP NEUROL, V127, P253, DOI 10.1006/exnr.1994.1101
   GONZALEZLIMA F, 1994, BRAIN RES, V660, P34, DOI 10.1016/0006-8993(94)90836-2
   Hermanns B, 2000, J NEUROL SCI, V179, P92, DOI 10.1016/S0022-510X(00)00395-6
   HESS HH, 1953, J BIOL CHEM, V204, P295
   Ibáñez V, 1998, NEUROLOGY, V50, P1585, DOI 10.1212/WNL.50.6.1585
   Jansson M, 2000, ACTA NEUROPATHOL, V100, P23, DOI 10.1007/s004010051188
   Johnson KA, 2000, NEUROBIOL AGING, V21, P289, DOI 10.1016/S0197-4580(00)00137-8
   KAMMESHEIDT A, 1992, P NATL ACAD SCI USA, V89, P10857, DOI 10.1073/pnas.89.22.10857
   Kish SJ, 1999, J NEUROCHEM, V72, P700, DOI 10.1046/j.1471-4159.1999.0720700.x
   KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x
   Lalonde R, 2002, EXP GERONTOL, V37, P1401, DOI 10.1016/S0531-5565(02)00123-7
   Lalonde R., 1999, TEC BEHAV N, P627
   Li QX, 1999, J NEUROCHEM, V72, P2479, DOI 10.1046/j.1471-4159.1999.0722479.x
   Liu QL, 2003, J APPL PHYSIOL, V95, P2285, DOI 10.1152/japplphysiol.00638.2003
   Lodi R, 1998, BRAIN, V121, P2119, DOI 10.1093/brain/121.11.2119
   McPhie DL, 1997, J BIOL CHEM, V272, P24743, DOI 10.1074/jbc.272.40.24743
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   Nagy Z, 1999, ACTA NEUROPATHOL, V97, P346, DOI 10.1007/s004010050997
   Nair HP, 1999, DEV BRAIN RES, V118, P197, DOI 10.1016/S0165-3806(99)00149-2
   NEVE RL, 1992, P NATL ACAD SCI USA, V89, P3448, DOI 10.1073/pnas.89.8.3448
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   PETTEGREW JW, 1994, NEUROBIOL AGING, V15, P117, DOI 10.1016/0197-4580(94)90152-X
   Price Joseph L., 1995, P629
   Rapoport SI, 1999, ANN NY ACAD SCI, V893, P138, DOI 10.1111/j.1749-6632.1999.tb07823.x
   READER TA, 1999, NEUROMETH, V33, P1
   Reiman EM, 2000, NEUROREPORT, V11, P987, DOI 10.1097/00001756-200004070-00018
   Rubertone Joseph A., 1995, P773
   Ruigrok Tom J. H., 1995, P277
   SANDHU FA, 1991, J BIOL CHEM, V266, P21331
   Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0
   Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023
   Sjöbeck M, 2001, DEMENT GERIATR COGN, V12, P211, DOI 10.1159/000051260
   Strazielle C, 2003, NEUROSCIENCE, V118, P1151, DOI 10.1016/S0306-4522(03)00037-X
   Strazielle C, 1998, EXP BRAIN RES, V121, P35, DOI 10.1007/s002210050434
   Valla J, 2001, J NEUROSCI, V21, P4923, DOI 10.1523/JNEUROSCI.21-13-04923.2001
   WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5
   WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3
   Zhang CY, 1999, J NEUROCYTOL, V28, P525, DOI 10.1023/A:1007053204929
NR 54
TC 6
Z9 7
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0891-0618
EI 1873-6300
J9 J CHEM NEUROANAT
JI J. Chem. Neuroanat.
PD JUL
PY 2004
VL 27
IS 4
BP 237
EP 246
DI 10.1016/j.jchemneu.2004.03.009
PG 10
WC Biochemistry & Molecular Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 842TE
UT WOS:000223026300002
PM 15261330
DA 2024-11-01
ER

PT J
AU Lin, Y
   Xu, XB
   Zhao, DD
   Liu, FC
   Luo, YB
   Du, JX
   Wang, DD
   Ji, KQ
   Zhao, YY
   Yan, CZ
AF Lin, Yan
   Xu, Xuebi
   Zhao, Dandan
   Liu, Fuchen
   Luo, Yuebei
   Du, Jixiang
   Wang, Dongdong
   Ji, Kunqian
   Zhao, Yuying
   Yan, Chuanzhu
TI A novel m.11406 T &gt; A mutation in mitochondrial <i>ND4</i> gene
   causes MELAS syndrome
SO MITOCHONDRION
LA English
DT Article
DE MELAS syndrome; ND4 gene; Complex I; Mitochondrial DNA; Mutation
ID HEREDITARY OPTIC NEUROPATHY; COMPLEX I DEFICIENCY; EXERCISE INTOLERANCE;
   DNA MUTATIONS; PATHOGENICITY; DEHYDROGENASE; SUBUNIT
AB Pathogenic point mutations of mitochondrial DNA (mtDNA) are associated with a large number of heterogeneous diseases involving multiple systems with which patients may present with a wide range of clinical phenotypes. In this study, we describe a novel heteroplasmic missense mutation, m.11406 T > A, of the ND4 gene encoding the subunit 4 of mitochondrial complex I in a 32-year-old woman with recurrent epileptic seizure, headache and bilateral hearing loss. Skeletal muscle histochemistry demonstrated that approximately 20% of fibers were cytochrome C oxidase (COX) deficient with increased activity of succinate dehydrogenase (SDH). Further investigations in muscle specimens showed significantly reduced level of ND4 protein. It is interesting that the subunits of complex I (ND1 and NDFUB8) and complex IV(CO1) were also remarkably decreased. These findings indicate that ND1, NDFUB8 and COl are more susceptible than other subunits to mutations in the mitochondrial ND4 gene.
C1 [Lin, Yan; Zhao, Dandan; Du, Jixiang; Wang, Dongdong; Ji, Kunqian; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Res Inst Neuromuscular & Neurodegenerat Dis, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
   [Lin, Yan; Zhao, Dandan; Du, Jixiang; Wang, Dongdong; Ji, Kunqian; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
   [Xu, Xuebi] Wenzhou Med Univ, Dept Neurol, Affiliated Hosp 1, Nanbaixiang St, Wenzhou 325000, Peoples R China.
   [Liu, Fuchen] Yale Univ, Dept Neurobiol, Sch Med, New Haven, CT 06511 USA.
   [Luo, Yuebei] Cent South Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, Jinan 266035, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Jinan 250012, Shandong, Peoples R China.
C3 Shandong University; Shandong University; Wenzhou Medical University;
   Yale University; Central South University; Shandong University; Shandong
   University
RP Ji, KQ; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Res Inst Neuromuscular & Neurodegenerat Dis, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.; Ji, KQ; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
EM jikunqian@qiluhospital.com; czyan@sdu.edu.cn
RI L, YB/AAF-9728-2021; zhao, dandan/AAP-3407-2021
OI Du, Jixiang/0000-0002-5365-0336; Lin, Yan/0000-0003-0282-6749
FU Shandong Provincial Natural Science Foundation of China [ZR2017BH033];
   National Natural Science Foundation of China [81701237, 81671235];
   People's benefit project of science and technology in Qingdao
   [16-6-2-1-nsh]; Taishan Scholars Program of Shandong Province
FX This study was supported by the Grants from the Shandong Provincial
   Natural Science Foundation of China (No. ZR2017BH033) and National
   Natural Science Foundation of China (Nos. 81701237 and 81671235),
   People's benefit project of science and technology in Qingdao
   (16-6-2-1-nsh) and the Taishan Scholars Program of Shandong Province.
CR Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295
   Abu-Amero KK, 2005, ONCOGENE, V24, P1455, DOI 10.1038/sj.onc.1208292
   Bacalhau M, 2017, EUR J MED GENET, V60, P172, DOI 10.1016/j.ejmg.2016.12.009
   Barshad G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46446-8
   Chakrabarty S, 2018, MITOCHONDRION, V43, P25, DOI 10.1016/j.mito.2018.06.006
   Chalmers RM, 1996, BRAIN, V119, P1481, DOI 10.1093/brain/119.5.1481
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   Damm F, 2012, LEUKEMIA, V26, P289, DOI 10.1038/leu.2011.200
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Dubowitz V., 2013, MUSCLE BIOPSY PRACTI, V4th, P1, DOI DOI 10.1177/000271623618500112
   Endres D, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00412
   Fang HZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10480
   Fedor JG, 2017, P NATL ACAD SCI USA, V114, P12737, DOI 10.1073/pnas.1714074114
   Fiedorczuk K, 2018, TRENDS CELL BIOL, V28, P835, DOI 10.1016/j.tcb.2018.06.006
   Gershoni M, 2010, J MOL BIOL, V404, P158, DOI 10.1016/j.jmb.2010.09.029
   Gorman GS, 2015, CLIN SCI, V128, P895, DOI 10.1042/CS20140705
   Haapanen O, 2018, BBA-BIOENERGETICS, V1859, P510, DOI 10.1016/j.bbabio.2018.04.001
   Hernansanz-Agustín P, 2017, REDOX BIOL, V12, P1040, DOI 10.1016/j.redox.2017.04.025
   Jiang PP, 2015, INVEST OPHTH VIS SCI, V56, P4778, DOI 10.1167/iovs.14-16158
   Kabekkodu SP, 2015, MITOCHONDRION, V24, P93, DOI 10.1016/j.mito.2015.07.008
   Komaki H, 2003, MITOCHONDRION, V2, P293, DOI 10.1016/S1567-7249(03)00003-5
   Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300
   Leo-Kottler B, 2002, GRAEF ARCH CLIN EXP, V240, P758, DOI 10.1007/s00417-002-0494-7
   LERTRIT P, 1992, AM J HUM GENET, V51, P457
   Liu CY, 2018, HUM GENET, V137, P203, DOI 10.1007/s00439-018-1873-4
   Lyu LH, 2019, MITOCHONDRION, V45, P1, DOI 10.1016/j.mito.2018.01.008
   Minocherhomji S, 2012, EPIGENETICS-US, V7, P326, DOI 10.4161/epi.19547
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   O'Keefe H, 2018, J MOL EVOL, V86, P395, DOI 10.1007/s00239-018-9855-7
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pereira L, 2011, AM J HUM GENET, V88, P433, DOI 10.1016/j.ajhg.2011.03.006
   Porras CA, 2015, FRONT BIOSCI-LANDMRK, V20, P621, DOI 10.2741/4327
   Rani DS, 2006, FERTIL STERIL, V86, P1783, DOI 10.1016/j.fertnstert.2006.04.044
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Taivassalo T, 2002, ANN NEUROL, V51, P38, DOI 10.1002/ana.10027
   Tawata M, 1998, DIABETES, V47, P276, DOI 10.2337/diab.47.2.276
   Vanniarajan A, 2006, ACTA NEUROL SCAND, V114, P350, DOI 10.1111/j.1600-0404.2006.00673.x
   Vartak R, 2013, PROTEIN CELL, V4, P582, DOI 10.1007/s13238-013-3032-y
   Vartak RS, 2014, J BIOENERG BIOMEMBR, V46, P323, DOI 10.1007/s10863-014-9564-x
   Xu B, 2017, J HUM GENET, V62, P291, DOI 10.1038/jhg.2016.127
   Yan WS, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1202459
   Zhang J, 2015, EUR J HUM GENET, V23, P86, DOI 10.1038/ejhg.2014.52
   Zhou XT, 2006, BIOCHEM BIOPH RES CO, V340, P69, DOI 10.1016/j.bbrc.2005.11.150
NR 48
TC 5
Z9 6
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP
PY 2020
VL 54
BP 57
EP 64
DI 10.1016/j.mito.2020.06.011
PG 8
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA NX5WU
UT WOS:000575782000008
PM 32659360
DA 2024-11-01
ER

PT J
AU Finsterer, J
AF Finsterer, Josef
TI Lifestyle Changes Normalize Serum Lactate Levels in an m.3243A&gt;G
   Carrier
SO AMERICAN JOURNAL OF CASE REPORTS
LA English
DT Article
DE MELAS Syndrome; Mitochondria; Mitochondrial Proton-Translocating ATPases
ID MITOCHONDRIAL DISEASE; MELAS
AB Objective: Challenging differential diagnosis
   Background: The normalization of serum lactate levels in a patient with non-syndromic mitochondrial disorder due to the m.3243A>G mitochondrial DNA (mtDNA) variant has not been previously reported.
   Case Report: A 57-year-old woman was diagnosed with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) due to the m.3243A>G variant, with low heteroplasmy rates (31%), at age 50. The initial manifestations were short stature, migraine, and diabetes. With progression of the disease, multisystem involvement developed, affecting the brain (stroke-like episode, mild cognitive impairment), eyes (pigmentary retinopathy), ears and the vestibular system (impaired hearing, tinnitus, imbalance, drop attacks, vertigo), intestines (constipation, distended abdomen, gastro-esophageal reflux, gastroparesis), and the muscles (muscle weakness). The gastrointestinal involvement was most prominent and most significantly lowered the patient's quality of life. The diabetes was well controlled with an insulin pump. Recurrent, acute deteriorations responded favorably to L-arginine. Owing to lifestyle and diet changes 2 years after diagnosis (start of art classes, increase in spin biking to 22.5 km 3 times per week, travel to Hawaii, adherence to low-carbohydrate high-protein diet), the patient managed to lower elevated serum lactate levels to largely normal values.
   Conclusions: Gastrointestinal compromise may be the prominent manifestation of the m.3243A>G variant, lifestyle and diet changes may lower serum lactate in m.3243A>G carriers, and low heteroplasmy rates of the m.3243A>G variant in scarcely affected tissues do not exclude pathogenicity.
C1 [Finsterer, Josef] Messerli Inst, Landstrasse Clin, Dept Neurol, Vienna, Austria.
RP Finsterer, J (corresponding author), Messerli Inst, Landstrasse Clin, Dept Neurol, Vienna, Austria.
EM fifigs1@yahoo.de
CR de Laat P, 2015, NETH J MED, V73, P30
   El-Hattab A.W., 1993, GENEREVIEWS
   Finsterer J, 2020, HERZ, V45, P356, DOI 10.1007/s00059-018-4739-6
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Finsterer J, 2018, INTERNAL MED, V57, P769, DOI 10.2169/internalmedicine.9439-17
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Ng YS, 2016, ANN NEUROL, V80, P686, DOI 10.1002/ana.24736
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yee ML., 2018, Endocrinol Diabetes Metab Case Rep, V2018, P18
NR 10
TC 2
Z9 2
U1 1
U2 1
PU INT SCIENTIFIC INFORMATION, INC
PI MELVILLE
PA 150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA
EI 1941-5923
J9 AM J CASE REP
JI Am. J. Case Rep.
PD APR 19
PY 2021
VL 22
AR e930175
DI 10.12659/AJCR.930175
PG 5
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA RQ5PG
UT WOS:000642470200002
PM 33867519
OA Green Published
DA 2024-11-01
ER

PT J
AU Gomes, TMB
   Vincent, AE
   Menger, KE
   Stewart, JB
   Nicholls, TJ
AF Gomes, Tiago M. Bernardino
   Vincent, Amy E.
   Menger, Katja E.
   Stewart, James B.
   Nicholls, Thomas J.
TI Mechanisms and pathologies of human mitochondrial DNA replication and
   deletion formation
SO BIOCHEMICAL JOURNAL
LA English
DT Review
ID MOUSE L-CELLS; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; TOPOISOMERASE
   III-ALPHA; LARGE-SCALE DELETIONS; MARIE-TOOTH DISEASE; POLYMERASE-GAMMA;
   BINDING-PROTEIN; RNA-POLYMERASE; TRANSCRIPTION FACTOR; SKELETAL-MUSCLE
AB Human mitochondria possess a multi-copy circular genome, mitochondrial DNA (mtDNA), that is essential for cellular energy metabolism. The number of copies of mtDNA per cell, and their integrity, are maintained by nuclear-encoded mtDNA replication and repair machineries. Aberrant mtDNA replication and mtDNA breakage are believed to cause deletions within mtDNA. The genomic location and breakpoint sequences of these deletions show similar patterns across various inherited and acquired diseases, and are also observed during normal ageing, suggesting a common mechanism of deletion formation. However, an ongoing debate over the mechanism by which mtDNA replicates has made it difficult to develop clear and testable models for how mtDNA rearrangements arise and propagate at a molecular and cellular level. These deletions may impair energy metabolism if present in a high proportion of the mtDNA copies within the cell, and can be seen in primary mitochondrial diseases, either in sporadic cases or caused by autosomal variants in nuclear-encoded mtDNA maintenance genes. These mitochondrial diseases have diverse genetic causes and multiple modes of inheritance, and show notoriously broad clinical heterogeneity with complex tissue specificities, which further makes establishing genotype-phenotype relationships challenging. In this review, we aim to cover our current understanding of how the human mitochondrial genome is replicated, the mechanisms by which mtDNA replication and repair can lead to mtDNA instability in the form of large-scale rearrangements, how rearranged mtDNAs subsequently accumulate within cells, and the pathological consequences when this occurs.
C1 [Gomes, Tiago M. Bernardino; Vincent, Amy E.] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, England.
   [Gomes, Tiago M. Bernardino; Vincent, Amy E.; Menger, Katja E.; Stewart, James B.; Nicholls, Thomas J.] Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, England.
   [Gomes, Tiago M. Bernardino] Newcastle Tyne Hosp NHS Fdn Trust, NHS England Highly Specialised Serv Rare Mitochond, Newcastle Upon Tyne NE2 4HH, England.
   [Menger, Katja E.; Stewart, James B.; Nicholls, Thomas J.] Newcastle Univ, Biosci Inst, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle Upon
   Tyne Hospitals NHS Foundation Trust; Newcastle University - UK
RP Nicholls, TJ (corresponding author), Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, England.; Nicholls, TJ (corresponding author), Newcastle Univ, Biosci Inst, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, England.
EM thomas.nicholls@newcastle.ac.uk
RI Stewart, Jim/C-9633-2011
OI Stewart, Jim/0000-0002-2902-4968; Nicholls, Thomas/0000-0002-3034-4109
CR Agaronyan K, 2015, SCIENCE, V347, P548, DOI 10.1126/science.aaa0986
   Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Al-Behadili A, 2018, NUCLEIC ACIDS RES, V46, P9471, DOI 10.1093/nar/gky708
   Al-Gadi IS, 2018, J ENDOCR SOC, V2, P361, DOI 10.1210/js.2017-00434
   Al-Hussaini A, 2014, J PEDIATR-US, V164, P553, DOI 10.1016/j.jpeds.2013.10.082
   ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9
   Alonzo JR, 2018, J BIOL CHEM, V293, P20285, DOI 10.1074/jbc.RA118.004788
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Antes A, 2010, NUCLEIC ACIDS RES, V38, P6466, DOI 10.1093/nar/gkq493
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   Bailey LJ, 2017, BIOCHEM SOC T, V45, P513, DOI 10.1042/BST20160162
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Basu S, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009242
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bedford E, 1997, P NATL ACAD SCI USA, V94, P479, DOI 10.1073/pnas.94.2.479
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berardo A, 2022, J NEUROMUSCULAR DIS, V9, P225, DOI 10.3233/JND-210786
   BERK AJ, 1974, J MOL BIOL, V86, P801, DOI 10.1016/0022-2836(74)90355-6
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073
   Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035
   Bizard AH, 2020, J BIOL CHEM, V295, P7138, DOI 10.1074/jbc.REV120.008286
   BOGENHAGEN D, 1978, J MOL BIOL, V119, P49, DOI 10.1016/0022-2836(78)90269-3
   Bombelli F, 2014, JAMA NEUROL, V71, P1036, DOI 10.1001/jamaneurol.2014.629
   Bonnen PE, 2013, AM J HUM GENET, V93, P773, DOI 10.1016/j.ajhg.2013.09.003
   Borsche M, 2024, CEREBELLUM, V23, P479, DOI 10.1007/s12311-023-01557-x
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004
   Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Buchaklian AH, 2012, MOL GENET METAB, V107, P92, DOI 10.1016/j.ymgme.2012.04.019
   Bugiardini E, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000149
   Burr SP, 2018, DEV GROWTH DIFFER, V60, P21, DOI 10.1111/dgd.12420
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Carreño-Gago L, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00576
   Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200
   Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Carrozzo R, 2016, J INHERIT METAB DIS, V39, P243, DOI 10.1007/s10545-015-9894-9
   Cejka P, 2021, ANNU REV GENET, V55, P285, DOI 10.1146/annurev-genet-071719-020312
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   CHANG DD, 1987, EMBO J, V6, P409, DOI 10.1002/j.1460-2075.1987.tb04770.x
   Chapman J, 2020, LIFE-BASEL, V10, DOI 10.3390/life10090164
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chung KW, 2006, BRAIN, V129, P2103, DOI 10.1093/brain/awl174
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Cluett TJ, 2018, NUCLEIC ACIDS RES, V46, P10771, DOI 10.1093/nar/gky852
   Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0
   Conti F, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms242316746
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Dalla Rosa I, 2017, J BIOL CHEM, V292, P20162, DOI 10.1074/jbc.M117.815241
   Dalla Rosa I, 2014, J BIOL CHEM, V289, P18595, DOI 10.1074/jbc.M114.555367
   Damas J, 2014, NUCLEIC ACIDS RES, V42, pD1261, DOI 10.1093/nar/gkt982
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Doimo M, 2023, NUCLEIC ACIDS RES, V51, P7392, DOI 10.1093/nar/gkad535
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677
   Dosekova P, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2019.103821
   DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619
   Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88
   Durham SE, 2006, NEUROLOGY, V67, P502, DOI 10.1212/01.wnl.0000227961.55640.2f
   El-Hattab AW, 2018, HUM MUTAT, V39, P461, DOI 10.1002/humu.23387
   El-Hattab AW, 2017, HUM MUTAT, V38, P1649, DOI 10.1002/humu.23341
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Erdinc D, 2023, EMBO MOL MED, V15, DOI 10.15252/emmm.202216775
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779
   Farruggia P, 2016, JIMD REP, V26, P37, DOI 10.1007/8904_2015_470
   Fellman V, 2011, SEMIN FETAL NEONAT M, V16, P222, DOI 10.1016/j.siny.2011.05.002
   Ferreira CR, 2021, J INHERIT METAB DIS, V44, P164, DOI 10.1002/jimd.12348
   Finsterer J, 2018, BIOMED REP, V9, P119, DOI 10.3892/br.2018.1115
   Finsterer J, 2018, NEUROPEDIATRICS, V49, P231, DOI 10.1055/s-0037-1609039
   Finsterer J, 2017, THER ADV GASTROENTER, V10, P142, DOI 10.1177/1756283X16666806
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Frascarelli C, 2023, FRONT GENET, V14, DOI 10.3389/fgene.2023.1089956
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   FRIDLENDER B, 1972, P NATL ACAD SCI USA, V69, P452, DOI 10.1073/pnas.69.2.452
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Fusté JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004832
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773
   García-Gómez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465
   GILLUM AM, 1979, J MOL BIOL, V135, P353, DOI 10.1016/0022-2836(79)90441-8
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Glastad RC, 2023, PLOS COMPUT BIOL, V19, DOI 10.1371/journal.pcbi.1010953
   González-del Angel A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01049
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Govers LP, 2021, PEDIATR NEPHROL, V36, P9, DOI 10.1007/s00467-019-04404-6
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   GRAY H, 1992, J BIOL CHEM, V267, P5835
   Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476
   Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620
   GREENLEAF AL, 1986, P NATL ACAD SCI USA, V83, P3391, DOI 10.1073/pnas.83.10.3391
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hagström E, 2014, NUCLEIC ACIDS RES, V42, P1111, DOI 10.1093/nar/gkt969
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Hangas A, 2022, NUCLEIC ACIDS RES, V50, P8733, DOI 10.1093/nar/gkac660
   Hangas A, 2018, NUCLEIC ACIDS RES, V46, P9625, DOI 10.1093/nar/gky793
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Hillen HS, 2017, CELL, V171, P1072, DOI 10.1016/j.cell.2017.10.036
   Holmes JB, 2015, P NATL ACAD SCI USA, V112, P9334, DOI 10.1073/pnas.1503653112
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012971
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013
   HOWELL N, 1983, SOMAT CELL GENET, V9, P1, DOI 10.1007/BF01544045
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Imasawa T, 2022, KIDNEY INT REP, V7, P580, DOI 10.1016/j.ekir.2021.12.028
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Insalata F, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2122073119
   Itoh Y, 2021, SCIENCE, V371, P846, DOI 10.1126/science.abe0763
   JAEKEN J, 1984, NEUROPEDIATRICS, V15, P165, DOI 10.1055/s-2008-1052362
   Jeedigunta SP, 2021, ANNU REV GENOM HUM G, V22, P55, DOI 10.1146/annurev-genom-121420-081805
   Jiang M, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf8631
   Jiang S, 2019, EMBO REP, V20, DOI 10.15252/embr.201948101
   Jiang WJ, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2021.166106
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kaur P, 2018, NUCLEIC ACIDS RES, V46, P11287, DOI 10.1093/nar/gky875
   Kazama T, 2008, PLANT J, V55, P619, DOI 10.1111/j.1365-313X.2008.03529.x
   Keshavan N, 2018, ESSAYS BIOCHEM, V62, P423, DOI 10.1042/EBC20170108
   KISS T, 1992, EMBO J, V11, P3737, DOI 10.1002/j.1460-2075.1992.tb05459.x
   KISS T, 1992, CELL, V70, P11, DOI 10.1016/0092-8674(92)90528-K
   Koenig MK, 2017, NEUROLOGY, V88, P1919, DOI 10.1212/WNL.0000000000003936
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507
   Kowald A, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030126
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Krasich R, 2017, FRONT BIOSCI-LANDMRK, V22, P692, DOI 10.2741/4510
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Lawless C, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200061
   Lax NZ, 2017, NEUROPATH APPL NEURO, V43, P102, DOI 10.1111/nan.12333
   Lee DY, 1998, J BIOL CHEM, V273, P30614, DOI 10.1074/jbc.273.46.30614
   Lee DY, 1997, GENE DEV, V11, P582, DOI 10.1101/gad.11.5.582
   Lehmann D, 2019, NUCLEIC ACIDS RES, V47, P7430, DOI 10.1093/nar/gkz472
   Li W, 1998, P NATL ACAD SCI USA, V95, P1010, DOI 10.1073/pnas.95.3.1010
   Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918
   LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024
   Llauradó A, 2023, CLIN GENET, V103, P492, DOI 10.1111/cge.14287
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Low RL, 2003, EUR J BIOCHEM, V270, P4173, DOI 10.1046/j.1432-1033.2003.03814.x
   Lujan SA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02138-5
   Ma Y, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.757518
   Macao B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8303
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef
   Manini A, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.906667
   MARTENS PA, 1979, J MOL BIOL, V135, P327, DOI 10.1016/0022-2836(79)90440-6
   Martin CA, 2018, AM J HUM GENET, V103, P221, DOI 10.1016/j.ajhg.2018.07.001
   MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4
   Mathews CK, 2007, FASEB J, V21, P2294, DOI 10.1096/fj.06-7977rev
   Matic S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03552-x
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Menger KE, 2022, NUCLEIC ACIDS RES, V50, P11154, DOI 10.1093/nar/gkac857
   Menger KE, 2021, OPEN BIOL, V11, DOI 10.1098/rsob.210168
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Minczuk M, 2011, NUCLEIC ACIDS RES, V39, P4284, DOI 10.1093/nar/gkq1224
   Misic J, 2022, NUCLEIC ACIDS RES, V50, P8749, DOI 10.1093/nar/gkac661
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1995, MUSCLE NERVE, pS150
   Moretton A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176795
   Morozov YI, 2014, NUCLEIC ACIDS RES, V42, P3884, DOI 10.1093/nar/gkt1356
   Muraki K, 1997, J INHERIT METAB DIS, V20, P697, DOI 10.1023/A:1005378527077
   Nasca A, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0641-1
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   Ng YS, 2022, BRAIN, V145, P542, DOI 10.1093/brain/awab353
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   Nissanka N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04895-1
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   OJALA D, 1981, J MOL BIOL, V150, P303, DOI 10.1016/0022-2836(81)90454-X
   Orsucci D, 2017, J NEUROL, V264, P1777, DOI 10.1007/s00415-017-8567-z
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Peeva V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04131-w
   Persson Ö, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08673-5
   Peter BJ, 1998, CELL, V94, P819, DOI 10.1016/S0092-8674(00)81740-7
   Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Phowthongkum P, 2017, NEUROMUSCULAR DISORD, V27, P616, DOI 10.1016/j.nmd.2017.03.013
   Pipis M, 2020, BRAIN, V143, P3589, DOI 10.1093/brain/awaa323
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Pohjoismäki JLO, 2011, MITOCHONDRION, V11, P630, DOI 10.1016/j.mito.2011.04.002
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Pommier Y, 2022, NAT REV MOL CELL BIO, V23, P407, DOI 10.1038/s41580-022-00452-3
   Posse V, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007781
   Posse V, 2017, J BIOL CHEM, V292, P2637, DOI 10.1074/jbc.M116.751008
   Posse V, 2015, NUCLEIC ACIDS RES, V43, P2615, DOI 10.1093/nar/gkv105
   POULTON J, 1989, LANCET, V1, P236
   Prasad R, 2017, DNA REPAIR, V60, P77, DOI 10.1016/j.dnarep.2017.10.011
   Primiano G, 2022, NEUROL-GENET, V8, DOI 10.1212/NXG.0000000000200007
   Qian YF, 2017, J BIOL CHEM, V292, P13068, DOI 10.1074/jbc.M117.791392
   RADLOFF R, 1967, P NATL ACAD SCI USA, V57, P1514, DOI 10.1073/pnas.57.5.1514
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Ramos ES, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008085
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Remtulla S, 2019, PEDIATR NEUROL, V90, P61, DOI 10.1016/j.pediatrneurol.2018.08.007
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   Richter-Dennerlein R, 2016, CELL, V167, P471, DOI 10.1016/j.cell.2016.09.003
   ROBBERSON DL, 1974, P NATL ACAD SCI USA, V71, P4447, DOI 10.1073/pnas.71.11.4447
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Rocha EBD, 2023, NEUROMUSCULAR DISORD, V33, P692, DOI 10.1016/j.nmd.2023.06.004
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saha LK, 2024, CELL CYCLE, V23, P115, DOI 10.1080/15384101.2024.2314440
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060
   Sarfallah A, 2021, EMBO J, V40, DOI 10.15252/embj.2021107988
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schreier HK, 2022, GENES-BASEL, V13, DOI 10.3390/genes13050879
   Sebastián D, 2017, TRENDS MOL MED, V23, P201, DOI 10.1016/j.molmed.2017.01.003
   Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064
   SENGERS RCA, 1975, J PEDIATR-US, V86, P873, DOI 10.1016/S0022-3476(75)80217-4
   Shi YH, 2012, P NATL ACAD SCI USA, V109, P16510, DOI 10.1073/pnas.1119738109
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794
   Singh B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140409
   Sobek S, 2013, NUCLEIC ACIDS RES, V41, P9848, DOI 10.1093/nar/gkt768
   Solano A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e86
   SOONG NW, 1992, NAT GENET, V2, P318
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2024, TRENDS PHARMACOL SCI, V45, P225, DOI 10.1016/j.tips.2024.01.011
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10
   Sykora P, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00237-17
   Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029
   Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260
   Takamatsu C, 2002, EMBO REP, V3, P451, DOI 10.1093/embo-reports/kvf099
   Tan BG, 2024, NAT REV MOL CELL BIO, V25, P119, DOI 10.1038/s41580-023-00661-4
   Tan BG, 2022, MOL CELL, V82, P3646, DOI 10.1016/j.molcel.2022.08.011
   Tang YY, 2000, MOL BIOL CELL, V11, P1471, DOI 10.1091/mbc.11.4.1471
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Ticci C, 2021, J CLIN MED, V10, DOI 10.3390/jcm10102063
   TIRANTI V, 1993, GENE, V126, P219, DOI 10.1016/0378-1119(93)90370-I
   Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615
   Tranchant C, 2016, REV NEUROL-FRANCE, V172, P524, DOI 10.1016/j.neurol.2016.07.003
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tuppen HAL, 2023, METHODS MOL BIOL, V2615, P443, DOI 10.1007/978-1-0716-2922-2_29
   Uhler JP, 2016, NUCLEIC ACIDS RES, V44, P5861, DOI 10.1093/nar/gkw468
   Uhler JP, 2015, DNA REPAIR, V34, P28, DOI 10.1016/j.dnarep.2015.07.003
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vandiver AR, 2023, AGING CELL, V22, DOI 10.1111/acel.13842
   Vandiver AR, 2022, MITOCHONDRION, V65, P176, DOI 10.1016/j.mito.2022.06.003
   VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x
   Vara R, 2023, J INHERIT METAB DIS, V46, P634, DOI 10.1002/jimd.12633
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wang HY, 2022, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.808115
   Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499
   Wanrooij PH, 2012, NUCLEIC ACIDS RES, V40, P10334, DOI 10.1093/nar/gks802
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   Whittaker RG, 2015, ANN NEUROL, V78, P949, DOI 10.1002/ana.24525
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Wisnovsky S, 2018, ACS CHEM BIOL, V13, P900, DOI 10.1021/acschembio.8b00072
   Wisnovsky S, 2016, NAT CHEM BIOL, V12, P567, DOI [10.1038/nchembio.2102, 10.1038/NCHEMBIO.2102]
   Woodbridge P, 2013, INTERN MED J, V43, P150, DOI 10.1111/j.1445-5994.2012.02847.x
   Wu CHW, 2023, MOL GENET METAB, V139, DOI 10.1016/j.ymgme.2023.107626
   XU BJ, 1995, MOL CELL BIOL, V15, P580, DOI 10.1128/MCB.15.1.580
   Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yan B, 2022, GENOME RES, V32, P162, DOI 10.1101/gr.275784.121
   Yanagihara I, 2001, J PEDIATR-US, V139, P452, DOI 10.1067/mpd.2001.116296
   Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153
   Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   Yoshimi A, 2022, ORPHANET J RARE DIS, V17, DOI 10.1186/s13023-022-02538-9
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zeviani M, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23010210
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
   Zhang HL, 2008, BIOCHEMISTRY-US, V47, P11196, DOI 10.1021/bi800774b
   Zhang HL, 2014, NUCLEIC ACIDS RES, V42, P7259, DOI 10.1093/nar/gku384
   Zhu XF, 2022, CELL, V185, P2309, DOI 10.1016/j.cell.2022.05.006
   Zollo O, 2012, P NATL ACAD SCI USA, V109, P6508, DOI 10.1073/pnas.1118594109
   Zorkau M, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2008778118
NR 348
TC 0
Z9 0
U1 2
U2 2
PU PORTLAND PRESS LTD
PI LONDON
PA 1ST FLR, 10 QUEEN STREET PLACE, LONDON, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD JUN
PY 2024
VL 481
IS 11
BP 683
EP 715
DI 10.1042/BCJ20230262
PG 33
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA SQ1P4
UT WOS:001235827100001
PM 38804971
OA hybrid
DA 2024-11-01
ER

PT J
AU Rucheton, B
   Jardel, C
   Filaut, S
   Amador, MD
   Maisonobe, T
   Serre, I
   Romero, NB
   Leonard-Louis, S
   Haraux, F
   Lombès, A
AF Rucheton, Benoit
   Jardel, Claude
   Filaut, Sandrine
   Amador, Maria del Mar
   Maisonobe, Thierry
   Serre, Isabelle
   Romero, Norma Beatriz
   Leonard-Louis, Sarah
   Haraux, Francis
   Lombes, Anne
TI Homoplasmic deleterious <i>MT</i>-<i>ATP6/8</i> mutations in adult
   patients
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial DNA; ATP synthase; Cybrids; Oxidative phosphorylation;
   Mitochondrial disease; Homoplasmy
ID HUMAN MITOCHONDRIAL-DNA; ATP SYNTHASE DEFICIENCY; CYTOCHROME-C-OXIDASE;
   LEIGH-SYNDROME; T9176C MUTATION; GENE; ATAXIA; YEAST; MTDNA;
   MICRODELETION
AB To address the frequency of complex V defects, we systematically sequenced MT-ATP6/8 genes in 512 consecutive patients.
   We performed functional analysis in muscle or fibroblasts for 12 out of 27 putative homoplasmic mutations and in cybrids for four. Fibroblasts, muscle and cybrids with known deleterious mutations underwent parallel analysis. It included oxidative phosphorylation spectrophotometric assays, western blots, structural analysis, ATP production, glycolysis and cell proliferation evaluation.
   We demonstrated the deleterious nature of three original mutations. Striking gradation in severity of the mutations consequences and differences between muscle, fibroblasts and cybrids implied a likely under -diagnosis of human complex V defects.
C1 [Rucheton, Benoit; Jardel, Claude; Filaut, Sandrine] CHU Pitie Salpetriere, AP HP, Ctr Genet Mol & Chromosom, Serv Biochim Metab, Paris, France.
   [Amador, Maria del Mar] CHU Pitie Salpetriere, AP HP, Dept Neurol, Paris, France.
   [Maisonobe, Thierry; Leonard-Louis, Sarah] UPMC Univ Paris 06, Sorbonne Univ, CHU Pitie Salpetriere, AP HP,Dept Neurophysiol Clin & Neuropathol, Paris, France.
   [Serre, Isabelle] CHU Reims, Dept Neurol, Reims, France.
   [Romero, Norma Beatriz] UPMC Univ Paris 06, Sorbonne Univ, CHU Pitie Salpetriere, INSERM UMRS974,Ctr Res Myol, Paris, France.
   [Haraux, Francis] Univ Paris Saclay, Univ Paris Sud, Inst Integrat Biol Cell I2BC, CEA,CNRS, Gif Sur Yvette, France.
   [Lombes, Anne] Univ Paris Decartes Paris5, CNRS UMR 8104, Inst Cochin, INSERM U1016, Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Pitie-Salpetriere - APHP; Sorbonne Universite; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP;
   Sorbonne Universite; Sorbonne Universite; Assistance Publique Hopitaux
   Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Universite
   de Reims Champagne-Ardenne; CHU de Reims; Institut National de la Sante
   et de la Recherche Medicale (Inserm); Sorbonne Universite; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere
   - APHP; Universite Paris Saclay; Centre National de la Recherche
   Scientifique (CNRS); Universite Paris Cite; CEA; Centre National de la
   Recherche Scientifique (CNRS); CNRS - National Institute for Biology
   (INSB); Institut National de la Sante et de la Recherche Medicale
   (Inserm); Universite Paris Cite
RP Rucheton, B; Lombès, A (corresponding author), INSERM U1016, Fac Med Cochin, 24 Rue Faubourg St Jacques, F-75014 Paris, France.; Rucheton, B; Lombès, A (corresponding author), CHU Pitie Salpetriere, Ctr Genet Mol & Chromosom, Serv Biochim Metab, 81 Bd Hop, F-75013 Paris, France.
EM benoit.rucheton@aphp.fr; anne.lombes@inserm.fr
RI Amador, MariadelMar/KIG-6768-2024
FU Fondation pour la Recherche Medicale (FRM) [DPM20121125550]; AFM
   Telethon; AMMi
FX This work was supported by the Fondation pour la Recherche Medicale
   (FRM-grant DPM20121125550 to AL), the AFM Telethon and the AMMi. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Auré K, 2007, NEUROMUSCULAR DISORD, V17, P368, DOI 10.1016/j.nmd.2007.01.019
   Auré K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Barca E, 2018, HUM MOL GENET, V27, P3305, DOI 10.1093/hmg/ddy231
   Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs
   Bayani J, 2003, GENE CHROMOSOME CANC, V36, P7, DOI 10.1002/gcc.10132
   Campos Y, 1997, NEUROLOGY, V49, P595, DOI 10.1212/WNL.49.2.595
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   CHRETIEN D, 1990, BIOCHEM BIOPH RES CO, V173, P26, DOI 10.1016/S0006-291X(05)81016-2
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Cortés-Hernández P, 2007, J BIOL CHEM, V282, P1051, DOI 10.1074/jbc.M606828200
   Craig K, 2007, J MED GENET, V44, P797, DOI 10.1136/jmg.2007.052902
   Dautant A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00329
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   Vazquez-Memije ME, 2009, J CELL BIOCHEM, V106, P878, DOI 10.1002/jcb.22055
   Frey S, 2017, BBA-MOL BASIS DIS, V1863, P284, DOI 10.1016/j.bbadis.2016.10.028
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Habersetzer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075429
   Haraux F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221886
   Havlícková V, 2010, BBA-BIOENERGETICS, V1797, P1124, DOI 10.1016/j.bbabio.2009.12.009
   Hejzlarová K, 2014, PHYSIOL RES, V63, pS57, DOI 10.33549/physiolres.932643
   Hejzlarová K, 2015, BIOCHEM J, V466, P601, DOI 10.1042/BJ20141462
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A
   Jesina P, 2004, BIOCHEM J, V383, P561, DOI 10.1042/BJ20040407
   Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086
   Kabala AM, 2014, BIOCHIMIE, V100, P200, DOI 10.1016/j.biochi.2013.11.024
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kogelnik AM, 1997, NUCLEIC ACIDS RES, V25, P196, DOI 10.1093/nar/25.1.196
   Kucharczyk R, 2010, BBA-BIOENERGETICS, V1797, P1105, DOI 10.1016/j.bbabio.2009.12.022
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P817, DOI 10.1016/j.bbamcr.2009.02.011
   Macnamara EF, 2019, HUM MUTAT, V40, P532, DOI 10.1002/humu.23722
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Meulemans A, 2010, J BIOL CHEM, V285, P4099, DOI 10.1074/jbc.M109.046920
   Mitome N, 2010, BIOCHEM J, V430, P171, DOI 10.1042/BJ20100621
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   Mrácek T, 2006, EXP GERONTOL, V41, P683, DOI 10.1016/j.exger.2006.02.009
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Pfeffer G, 2012, J NEUROL NEUROSUR PS, V83, P883, DOI 10.1136/jnnp-2012-302568
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75
   Sammut IA, 1998, CRYOBIOLOGY, V36, P49, DOI 10.1006/cryo.1997.2063
   Seneca S, 1996, J INHERIT METAB DIS, V19, P115, DOI 10.1007/BF01799407
   Squire JA, 2003, GENE CHROMOSOME CANC, V38, P215, DOI 10.1002/gcc.10273
   Synofzik M, 2012, EUR J NEUROL, V19, pe114, DOI 10.1111/j.1468-1331.2012.03812.x
   Temperley RJ, 2003, HUM MOL GENET, V12, P2341, DOI 10.1093/hmg/ddg238
   Thompson K, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809060
   TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334
   Verny C, 2011, MITOCHONDRION, V11, P70, DOI 10.1016/j.mito.2010.07.006
   Vojtísková A, 2004, TOXICOL MECH METHOD, V14, P7, DOI 10.1080/15376520490257347
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 62
TC 7
Z9 7
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV
PY 2020
VL 55
BP 64
EP 77
DI 10.1016/j.mito.2020.08.004
PG 14
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA PQ1TF
UT WOS:000606333400006
PM 32858252
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Zhang, J
   Guo, JH
   Fang, WH
   Jun, QL
   Shi, KL
AF Zhang, Jin
   Guo, Junhong
   Fang, Wanghui
   Jun, Qili
   Shi, Kaili
TI Clinical features of MELAS and its relation with A3243G gene point
   mutation
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
LA English
DT Article
DE MELAS; point mutation; mitochondrial DNA; maternal inheritance
ID PARKINSONS-DISEASE; MITOCHONDRIAL; PREVALENCE; FAMILIES; ADULTS
AB Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) mostly occur in children. The point mutation A3243G of mitochondrial DNA (mtDNA) may work as a specific bio-marker for mitochondrial disorders. The related clinical features, however, may vary among individuals. This study therefore investigated the relation between MELAS clinical features and point mutation A3243G of mtDNA, in an attempt to provide further evidences for genetic diagnosis of MELAS. Children with MELAS-like syndromes were tested for both blood lactate level and point mutation A3243G of mtDNA. Further family study was performed by mtDNA mutation screening at the same loci for those who had positive gene mutation at A3243G loci. Those who were negative for A3243G point mutation were examined by muscle biopsy and genetic screening. Both clinical and genetic features were analyzed. In all 40 cases with positive A3243G mutation, 36 children fitted clinical diagnosis of MELAS. In other 484 cases with negative mutation, only 8 children were clinically diagnosed with MELAS. Blood lactate levels in both groups were all elevated (P>O. 05). In a further genetic screening of 28 families, 10 biological mothers and 8 silbings of MELAS children had positive A3243G point mutations but without any clinical symptoms. Certain difference existed in the clinical manifestations between children who were positive and negative for A3243G mutation of mtDNA but without statistical significance. MELAS showed maternal inheritance under most circumstances.
C1 [Zhang, Jin; Guo, Junhong; Fang, Wanghui; Jun, Qili] Shanxi Med Univ, Hosp 1, Dept Internal Med Neurol, Taiyuan 030001, Shanxi, Peoples R China.
   [Shi, Kaili] Shanxi Prov Childrens Hosp, Dept Neurol, Taiyuan 030001, Shanxi, Peoples R China.
C3 Shanxi Medical University
RP Zhang, J (corresponding author), Shanxi Med Univ, Hosp 1, Dept Internal Med Neurol, 85 Jiefang South Rd, Taiyuan 030001, Shanxi, Peoples R China.
EM zhangjindoctor88@126.com
RI Guo, Junhong/O-6316-2017
FU Department of science research project in Shanxi Province [20130313022];
   Yuan funds The first hospital of ShanXi medical university [YJ1402]
FX Department of science research project in Shanxi Province (NO.
   20130313022), Yuan funds The first hospital of ShanXi medical university
   (YJ1402).
CR Abeliovich A, 2010, NATURE, V463, P744, DOI 10.1038/463744a
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Clark J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-69
   Cwerman-Thibault H, 2011, J INHERIT METAB DIS, V34, P327, DOI 10.1007/s10545-010-9131-5
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Halter J, 2011, BONE MARROW TRANSPL, V46, P330, DOI 10.1038/bmt.2010.100
   Ito H, 2011, BRAIN DEV-JPN, V33, P283, DOI 10.1016/j.braindev.2010.06.010
   Kim HK, 2010, ANN NY ACAD SCI, V1201, P177, DOI 10.1111/j.1749-6632.2010.05623.x
   Lembke A, 2013, PSYCHONEUROENDOCRINO, V38, P115, DOI 10.1016/j.psyneuen.2012.05.006
   Lim ST, 2011, NEUROPHARMACOLOGY, V60, P1160, DOI 10.1016/j.neuropharm.2010.10.012
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Prasad M, 2014, CAN J NEUROL SCI, V41, P210, DOI 10.1017/S0317167100016607
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Suomalainen A, 2011, J INHERIT METAB DIS, V34, P277, DOI 10.1007/s10545-010-9222-3
   Tschampa HJ, 2013, J NEUROL, V260, P1071, DOI 10.1007/s00415-012-6763-4
   Wang K, 2009, NEUROGENETICS, V10, P337, DOI 10.1007/s10048-009-0194-0
   Zhang Yong-Mei, 2010, Yichuan, V32, P353, DOI 10.3724/SP.J.1005.2010.00353
NR 20
TC 15
Z9 19
U1 0
U2 4
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1936-2625
J9 INT J CLIN EXP PATHO
JI Int. J. Clin. Exp. Pathol.
PY 2015
VL 8
IS 10
BP 13411
EP 13415
PG 5
WC Oncology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pathology
GA DA5AJ
UT WOS:000367814200169
PM 26722549
DA 2024-11-01
ER

PT J
AU Schoeler, S
   Hertel, S
   Haroon, MF
   Winkler-Stuck, K
   Mawrin, C
   Kirches, E
AF Schoeler, S.
   Hertel, S.
   Haroon, M. F.
   Winkler-Stuck, K.
   Mawrin, C.
   Kirches, E.
TI Absence of major accumulation of mitochondrial ND5 mutations in
   Parkinson patient muscle
SO CLINICAL NEUROPATHOLOGY
LA English
DT Article
DE Parkinson; mitochondria; mtDNA; oxidative stress; complex I; ND5
ID COMPLEX-I; RESPIRATORY-CHAIN; SKELETAL-MUSCLE; DISEASE; ABNORMALITIES;
   DEFECTS
AB The pathogenesis of the selective loss of dopaminergic neurons in idiopathic Parkinson's disease (PD) has not been understood up to now. Respiratory chain dysfunction and accumulation of mitochondrial DNA deletions to biochemically relevant levels have been observed in the dopaminergic neurons. However, respiratory chain defects have also been reported in other tissues, pointing to a generalized component of oxidative stress in PD. Recently, somatic point mutations in a narrow region of the complex I polypeptide ND5 (codons 120 - 150) were suggested to separate PD patients from age-matched controls, using frontal cortex homogenates. Objective: The present study intended to analyze whether those recently described ND5 mutations may also generally occur in skeletal muscle tissue of PD patients, in which complex I dysfunction had been measured earlier with biochemical approaches. Material: Skeletal muscle biopsy samples of 5 PD individuals with a previously characterized biochemical complex I defect and of 5 age-matched controls were used. Method: DNA was extracted from the muscle samples. The relevant ND5 region was PCR-cloned using a high fidelity Pfu polymerase and a low number of PCR cycles (15). A mean number of 96 clones were randomly selected from the ampicillin plates and sequenced by the dye terminator method to allow the detection of low abundance mutations with a sensitivity around 1%. Results: Mutations between codons 120 and 150 were only slightly more frequent in PD versus controls (60 versus 40% of samples affected), while this ratio had been 100 versus 12.5% in frontal cortex. Conclusions: In contrast to results reported for PD frontal cortex, low-level ND5 mutations between codons 120 and 150 do not accumulate severely in biochemically affected skeletal muscle samples of PD patients.
C1 Otto Von Guericke Univ, Inst Neuropathol, D-39120 Magdeburg, Germany.
   Otto Von Guericke Univ, Neurol Hosp, D-39120 Magdeburg, Germany.
   Otto Von Guericke Univ, Inst Med Neurobiol, D-39120 Magdeburg, Germany.
   Univ Jena, Inst Neuropathol, Jena, Germany.
C3 Otto von Guericke University; Otto von Guericke University; Otto von
   Guericke University; Friedrich Schiller University of Jena
RP Kirches, E (corresponding author), Otto Von Guericke Univ, Inst Neuropathol, Leipziger Str 44, D-39120 Magdeburg, Germany.
EM Elmar.kirches@medizin.uni-magdeburg.de
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   CARDELLACH F, 1993, NEUROLOGY, V43, P1273
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409
   Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8
   NAKAGAWAHATTORI Y, 1992, J NEUROL SCI, V107, P29, DOI 10.1016/0022-510X(92)90205-Y
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wiedemann FR, 1999, ANN NY ACAD SCI, V893, P426, DOI 10.1111/j.1749-6632.1999.tb07870.x
   Winkler-Stuck K, 2005, J NEURAL TRANSM, V112, P499, DOI 10.1007/s00702-004-0195-y
NR 19
TC 2
Z9 2
U1 0
U2 4
PU DUSTRI-VERLAG DR KARL FEISTLE
PI DEISENHOFEN-MUENCHEN
PA BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY
SN 0722-5091
J9 CLIN NEUROPATHOL
JI Clin. Neuropathol.
PD JUL-AUG
PY 2007
VL 26
IS 4
BP 164
EP 168
PG 5
WC Clinical Neurology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA 188HG
UT WOS:000247910400003
PM 17702497
DA 2024-11-01
ER

PT J
AU Lee, YC
   Lu, YC
   Chang, MH
   Soong, BW
AF Lee, Yi-Chung
   Lu, Yi-Chun
   Chang, Ming-Hon
   Soong, Bing-Wen
TI Common mitochondrial DNA and <i>POLG1</i> mutations are rare in the
   Chinese patients with adult-onset ataxia on Taiwan
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE SCA; ataxia; POLG1; POLG; mitochondria; MIRAS
ID RED FIBERS MERRF; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SPINOCEREBELLAR
   ATAXIA; MYOCLONIC EPILEPSY; EPIDEMIOLOGY; FAMILY
AB Background and purpose: Spinocerebellar ataxia (SCA) is a heterogeneous group of neurodegenerative disorders with common features of adult-onset cerebellar ataxia. Many patients with clinically suspected SCA are subsequently diagnosed with common SCA gene mutations. Previous reports suggest some common mitochondrial DNA (mtDNA) point mutations and mitochondrial DNA polymerase gene (POLG1) mutations might be additional underlying genetic causes of cerebellar ataxia. We tested whether mtDNA point mutations A3243G, A8344G, T8993G, and T8993C, or POLG1 mutations W748S and A467T are found in patients with adult-onset ataxia who did not have common SCA mutations.
   Methods: Four hundred seventy-six unrelated patients with suspected SCA underwent genetic testing for SCA 1, 2, 3, 6, 7, 8, 10, 12, 17, and DRPLA gene mutations. After excluding these SCA mutations and patients with paternal transmission history, 265 patients were tested for mtDNA mutations A3243G, A8344G, T8993G, T8993C, and POLG1 W748S and A467T mutations.
   Results: No mtDNA A3243G, A8344G, T8993G, T8993C, or POLG1 W748S and A467T mutation was detected in any of the 265 ataxia patients, suggesting that the upper limit of the 95% confidence interval for the prevalence of these mitochondrial mutations in Chinese patients with adult-onset non-SCA ataxia is no higher than 1.1%.
   Conclusions: The mtDNA mutations A3243G, A8344G, T8993G, T8993C, or POLG1 W748S and A467T are very rare causes of adult-onset ataxia in Taiwan. Routine screening for these mutations in ataxia patients with Chinese origin is of limited clinical value. (c) 2007 Elsevier B.V. All rights reserved.
C1 Vet Gen Hosp, Neurol Inst, Taipei 11217, Taiwan.
   Taichung Vet Gen Hosp, Neurol Sect, Taichung, Taiwan.
   Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan.
   Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan.
C3 Taichung Veterans General Hospital; National Yang Ming Chiao Tung
   University; National Yang Ming Chiao Tung University
RP Soong, BW (corresponding author), Vet Gen Hosp, Neurol Inst, 201,Sec 2,Shih Pai Rd, Taipei 11217, Taiwan.
EM bwsoong@vghtpe.gov.tw
RI Lee, Yi-Chung/H-8813-2019
OI Lee, Yi-Chung/0000-0003-0102-164X
CR Abele M, 2002, BRAIN, V125, P961, DOI 10.1093/brain/awf107
   Brusco A, 2004, ARCH NEUROL-CHICAGO, V61, P727, DOI 10.1001/archneur.61.5.727
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   FANG W, 1994, MUSCLE NERVE, V17, P52, DOI 10.1002/mus.880170107
   Goodship JA, 2002, J MED GENET, V39, P221, DOI 10.1136/jmg.39.3.221
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1
   HUANG CC, 1994, J NEUROL NEUROSUR PS, V57, P586, DOI 10.1136/jnnp.57.5.586
   Kaplan J, 2002, NEUROCHEM INT, V40, P553, DOI 10.1016/S0197-0186(01)00127-9
   Labuda M, 2000, NEUROLOGY, V54, P2322, DOI 10.1212/WNL.54.12.2322
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Modi G, 2000, J NEUROL NEUROSUR PS, V68, P393, DOI 10.1136/jnnp.68.3.393
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORGANHUGHES JA, 1995, BBA-MOL BASIS DIS, V1271, P135, DOI 10.1016/0925-4439(95)00020-5
   Moseley ML, 1998, NEUROLOGY, V51, P1666, DOI 10.1212/WNL.51.6.1666
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   NEWMAN TB, 1995, JAMA-J AM MED ASSOC, V274, P1013, DOI 10.1001/jama.1995.03530130019013
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Remes AM, 2003, J NEUROL NEUROSUR PS, V74, P1158, DOI 10.1136/jnnp.74.8.1158
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Schöls L, 2000, HUM GENET, V107, P132, DOI 10.1007/s004390000346
   van de Warrenburg BPC, 2005, J NEUROPATH EXP NEUR, V64, P171, DOI 10.1093/jnen/64.3.171
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Vilarinho L, 2001, J INHERIT METAB DIS, V24, P883, DOI 10.1023/A:1013908728445
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 27
TC 11
Z9 12
U1 1
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD MAR 15
PY 2007
VL 254
IS 1-2
BP 65
EP 68
DI 10.1016/j.jns.2007.01.005
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 152VX
UT WOS:000245391200013
PM 17300808
DA 2024-11-01
ER

PT J
AU Santoro, A
   Salvioli, S
   Raule, N
   Capri, M
   Sevini, F
   Valensin, S
   Monti, D
   Bellizzi, D
   Passarino, G
   Rose, G
   De Benedictis, G
   Franceschi, C
AF Santoro, Aurelia
   Salvioli, Stefano
   Raule, Nicola
   Capri, Miriam
   Sevini, Federica
   Valensin, Silvana
   Monti, Daniela
   Bellizzi, Dina
   Passarino, Giuseppe
   Rose, Giuseppina
   De Benedictis, Glovanna
   Franceschi, Claudio
TI Mitochondrial DNA involvement in human longevity
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article; Proceedings Paper
CT Bari Conference on Mitochondria and Bioenergetics
CY DEC, 2005
CL Bari, ITALY
DE mitochondrial DNA; longevity; mtDNA mutation; mtDNA haplogroup;
   centenarian; nuclear-mitochondrial interaction; Alzheimer's disease
ID HEALTHY OLD-PEOPLE; HUMAN LIFE-SPAN; SKELETAL-MUSCLE; MTDNA MUTATIONS;
   COPY NUMBER; TRANSCRIPTION FACTOR; PARKINSONS-DISEASE;
   ALZHEIMER-DISEASE; HUMAN-EVOLUTION; PHENOTYPIC ALTERATIONS
AB The main message of this review can be summarized as follows: aging and longevity, as complex traits having a significant genetic component, likely depend on a number of nuclear gene variants interacting with mtDNA variability both inherited and somatic. We reviewed the data available in the literature with particular attention to human longevity, and argued that what we hypothesize for aging and longevity could have a more general relevance and be extended to other age-related complex traits such as Alzheimer's and Parkinson's diseases. The genetics which emerges for complex traits, including aging and longevity, is thus even more complicated than previously thought, as epistatic interactions between nuclear gene polymorphisms and mtDNA variability (both somatic and inherited) as well as between mtDNA somatic mutations (tissue specific) and mtDNA inherited variants (haplogroups and sub-haplogroups) must be considered as additional players capable of explaining a part of the aging and longevity phenotype. To test this hypothesis is one of the main challenge in the genetics of aging and longevity in the next future. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Bologna, Dept Expt Pathol, Ctr Interdipartimentale L Galvani, I-40126 Bologna, Italy.
   ER Gentech Lab, I-44100 Ferrara, Italy.
   Dept Expt Pathol & Oncol, I-50134 Florence, Italy.
   Univ Calabria, Dept Cell Biol, I-87030 Arcavacata Di Rende, Italy.
   INRCA Ancona, Dept Gerontol Sci, I-60121 Ancona, Italy.
C3 University of Bologna; University of Calabria; IRCCS INRCA
RP Franceschi, C (corresponding author), Univ Bologna, Dept Expt Pathol, Ctr Interdipartimentale L Galvani, Via S Giacomo 12, I-40126 Bologna, Italy.
EM audio.franceschi@unibo.it
RI Salvioli, Stefano/K-6663-2016; Passarino, Giuseppe/ISB-6758-2023;
   Franceschi, Claudio/L-4484-2017; Monti, Daniela/G-9556-2012; Capri,
   Miriam/K-4700-2016
OI Rose, Giuseppina/0000-0002-4264-4184; Bellizzi,
   Dina/0000-0001-9986-456X; Monti, Daniela/0000-0001-8651-8123; Santoro,
   Aurelia/0000-0002-7187-1116; Capri, Miriam/0000-0001-9077-0401
CR Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590
   Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9
   Bagnara GP, 2000, J GERONTOL A-BIOL, V55, pB61
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs
   Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7
   Biggin A, 2005, MOL GENET METAB, V84, P61, DOI 10.1016/j.ymgme.2004.09.011
   Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596
   Bonafé M, 2004, CELL DEATH DIFFER, V11, P962, DOI 10.1038/sj.cdd.4401415
   Bonafè M, 2002, GENE, V286, P121, DOI 10.1016/S0378-1119(01)00812-5
   Bonafè M, 1999, AM J HUM GENET, V64, P292, DOI 10.1086/302196
   Booker LM, 2006, J UROLOGY, V175, P468, DOI 10.1016/S0022-5347(05)00163-1
   Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8
   Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Carelli V., 2002, MITOCHONDRIAL DISORD, P115
   Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463
   Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   Chinnery PF, 2000, NEUROLOGY, V55, P302, DOI 10.1212/WNL.55.2.302
   Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9
   CLAYTON DA, 1987, PHILOS T ROY SOC B, V317, P473, DOI 10.1098/rstb.1987.0074
   Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100
   D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326
   Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278
   De Benedictis G, 1998, EUR J HUM GENET, V6, P534, DOI 10.1038/sj.ejhg.5200222
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   De Benedictis G, 2000, EXP GERONTOL, V35, P795, DOI 10.1016/S0531-5565(00)00169-8
   de Souza-Pinto NC, 2004, ONCOGENE, V23, P6559, DOI 10.1038/sj.onc.1207874
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   ELSON JL, 2006, HUM GENET, V12, P1
   Fagnoni FF, 2000, BLOOD, V95, P2860, DOI 10.1182/blood.V95.9.2860.009k35_2860_2868
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Franceschi C, 2000, VACCINE, V18, P1717, DOI 10.1016/S0264-410X(99)00513-7
   Franceschi C, 2000, AGING-CLIN EXP RES, V12, P77, DOI 10.1007/BF03339894
   Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Giacchetti M, 2004, J MED GENET, V41, P293, DOI 10.1136/jmg.2003.015289
   Gibson BW, 2005, INT J BIOCHEM CELL B, V37, P927, DOI 10.1016/j.biocel.2004.11.013
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   Guo LJ, 2005, MITOCHONDRION, V5, P15, DOI 10.1016/j.mito.2004.09.001
   Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812
   HARRISON DE, 1975, J GERONTOL, V30, P286, DOI 10.1093/geronj/30.3.286
   Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492
   Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012
   Imam SZ, 2006, NEUROBIOL AGING, V27, P1129, DOI 10.1016/j.neurobiolaging.2005.06.002
   Jazwinski SM, 2005, GENE, V354, P22, DOI 10.1016/j.gene.2005.03.040
   King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4
   King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kirchman PA, 1999, GENETICS, V152, P179
   Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901
   Korpelainen H, 1999, HUM HERED, V49, P183, DOI 10.1159/000022871
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lezza AMS, 2001, FEBS LETT, V501, P74, DOI 10.1016/S0014-5793(01)02628-X
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Moresi R, 2005, BIOGERONTOLOGY, V6, P185, DOI 10.1007/s10522-005-7954-5
   NAGLEY P, 1970, BIOCHEM BIOPH RES CO, V39, P989, DOI 10.1016/0006-291X(70)90422-5
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308
   Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y
   Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200
   Osiewacz HD, 1999, EXP GERONTOL, V34, P901, DOI 10.1016/S0531-5565(99)00063-7
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Pesce V, 2005, J GERONTOL A-BIOL, V60, P715, DOI 10.1093/gerona/60.6.715
   Prolla TA, 2005, SCIENCE, V310, P441
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Rand DM, 2006, GENETICS, V172, P329, DOI 10.1534/genetics.105.046698
   RAND DM, 2005, SCI AGING KNOWLEDGE, V45, pRE5
   Reynier P, 1999, EUR J HUM GENET, V7, P404, DOI 10.1038/sj.ejhg.5200293
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8
   Roubertoux PL, 2003, NAT GENET, V35, P65, DOI 10.1038/ng1230
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040
   Salvioli S, 2001, FEBS LETT, V492, P9, DOI 10.1016/S0014-5793(01)02199-8
   Samuels DC, 2004, TRENDS GENET, V20, P226, DOI 10.1016/j.tig.2004.03.003
   SANSONI P, 1993, BLOOD, V82, P2767
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Singh KK, 2005, GENE, V354, P140, DOI 10.1016/j.gene.2005.03.027
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Tan QH, 2001, BIOGERONTOLOGY, V2, P141, DOI 10.1023/A:1011557022985
   Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Torroni A, 1996, GENETICS, V144, P1835
   TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   TORRONI A, 1994, AM J HUM GENET, V55, P760
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Turnbull DM, 1998, NAT GENET, V18, P199, DOI 10.1038/ng0398-199
   van der Walt JM, 2005, HUM GENET, V118, P115, DOI 10.1007/s00439-005-0032-x
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   van Heemst D, 2005, EXP GERONTOL, V40, P11, DOI 10.1016/j.exger.2004.10.001
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4
   WALLACE DC, 1995, AM J HUM GENET, V57, P201
   WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Welle S, 2003, J APPL PHYSIOL, V94, P1479, DOI 10.1152/japplphysiol.01061.2002
   Woodman R, 2005, CURR OPIN HEMATOL, V12, P123
   Yashin AI, 1999, AM J HUM GENET, V65, P1178, DOI 10.1086/302572
   Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399
   Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606
NR 115
TC 58
Z9 66
U1 0
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 1879-2650
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD SEP-OCT
PY 2006
VL 1757
IS 9-10
BP 1388
EP 1399
DI 10.1016/j.bbabio.2006.05.040
PG 12
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Biophysics
GA 100AN
UT WOS:000241639600036
PM 16857160
OA Bronze
DA 2024-11-01
ER

PT J
AU Greenfield, A
   Braude, P
   Flinter, F
   Lovell-Badge, R
   Ogilvie, C
   Perry, ACF
AF Greenfield, Andy
   Braude, Peter
   Flinter, Frances
   Lovell-Badge, Robin
   Ogilvie, Caroline
   Perry, Anthony C. F.
TI Assisted reproductive technologies to prevent human mitochondrial
   disease transmission
SO NATURE BIOTECHNOLOGY
LA English
DT Review
ID PREIMPLANTATION GENETIC DIAGNOSIS; REPLACEMENT TECHNIQUES; POLAR BODY;
   PRONUCLEAR TRANSFER; SPINDLE TRANSFER; EMBRYONIC-DEVELOPMENT;
   PLURIPOTENT CELLS; DNA SEGREGATION; GENOME TRANSFER; IN-VITRO
AB Mitochondria are essential cytoplasmic organelles that generate energy (ATP) by oxidative phosphorylation and mediate key cellular processes such as apoptosis. They are maternally inherited and in humans contain a 16,569-base-pair circular genome (mtDNA) encoding 37 genes required for oxidative phosphorylation. Mutations in mtDNA cause a range of pathologies, commonly affecting energy-demanding tissues such as muscle and brain. Because mitochondrial diseases are incurable, attention has focused on limiting the inheritance of pathogenic mtDNA by mitochondrial replacement therapy (MRT). MRT aims to avoid pathogenic mtDNA transmission between generations by maternal spindle transfer, pronuclear transfer or polar body transfer: all involve the transfer of nuclear DNA from an egg or zygote containing defective mitochondria to a corresponding egg or zygote with normal mitochondria. Here we review recent developments in animal and human models of MRT and the underlying biology. These have led to potential clinical applications; we identify challenges to their technical refinement.
C1 [Greenfield, Andy] MRC Harwell Inst, Mammalian Genet Unit, Harwell Campus, Harwell, Oxon, England.
   [Braude, Peter] Kings Coll London, Div Womens Hlth, London, England.
   [Flinter, Frances] Guys Hosp, Clin Genet Dept, London, England.
   [Lovell-Badge, Robin] Francis Crick Inst, London, England.
   [Ogilvie, Caroline] Guys & St Thomas NHS Fdn Trust, Genet Dept, London, England.
   [Ogilvie, Caroline] Kings Coll London, Div Womens Hlth, London, England.
   [Perry, Anthony C. F.] Univ Bath, Dept Biol & Biochem, Lab Mammalian Mol Embryol, Bath, Avon, England.
C3 MRC Harwell; University of London; King's College London; Guy's & St
   Thomas' NHS Foundation Trust; Francis Crick Institute; Guy's & St
   Thomas' NHS Foundation Trust; University of London; King's College
   London; University of Bath
RP Greenfield, A (corresponding author), MRC Harwell Inst, Mammalian Genet Unit, Harwell Campus, Harwell, Oxon, England.
EM a.greenfield@har.mrc.ac.uk
RI Ogilve, Caroline/AAW-3793-2021; Greenfield, Andy/F-5099-2017
OI Lovell-Badge, Robin/0000-0001-9364-4179; Perry, Anthony
   C.F./0000-0003-3136-5355; Greenfield, Andy/0000-0002-1477-1776
FU Medical Research Council, UK [MR/N000080/1, MR/N020294/1]; MRC
   [MR/N020294/1, MC_U117562207, MR/N000080/1, MC_U142684167] Funding
   Source: UKRI
FX A.C.F.P. is grateful for support from the Medical Research Council, UK
   (grants MR/N000080/1 and MR/N020294/1).
CR Akman G, 2016, P NATL ACAD SCI USA, V113, pE4276, DOI 10.1073/pnas.1600537113
   Alikani M, 2017, REPROD BIOMED ONLINE, V34, P333, DOI 10.1016/j.rbmo.2017.02.004
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Appleby JB, 2017, BIOETHICS, V31, P2, DOI 10.1111/bioe.12313
   Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044
   Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041
   Boudoures AL, 2017, DEV BIOL, V426, P126, DOI 10.1016/j.ydbio.2017.04.005
   Bredenoord AL, 2017, CELL STEM CELL, V21, P301, DOI 10.1016/j.stem.2017.08.009
   Bredenoord AL, 2017, EMBO MOL MED, V9, P396, DOI 10.15252/emmm.201607291
   Cao LQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000756
   Caporali L, 2017, MITOCHONDRION, V36, P130, DOI 10.1016/j.mito.2017.07.004
   CHA KY, 1991, FERTIL STERIL, V55, P109
   Chaigne A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10253
   Chinnery PF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004315
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Chinnery PF, 2001, AM J MED GENET, V98, P235, DOI 10.1002/1096-8628(20010122)98:3<235::AID-AJMG1086>3.0.CO;2-O
   Cohen IG, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2959
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Cross P C, 1970, Biol Reprod, V3, P298
   Dalton CM, 2013, J CELL SCI, V126, P2955, DOI 10.1242/jcs.128744
   Deglincerti A, 2016, CURR TOP DEV BIOL, V116, P99, DOI 10.1016/bs.ctdb.2015.11.010
   Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898
   Eyre-Walker A, 2017, GENETICS, V205, P1365, DOI 10.1534/genetics.116.196436
   Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676
   Gleicher N., 2017, REPROD BIOMED ONLINE
   Hayashi JI, 2016, CURR OPIN GENET DEV, V38, P63, DOI 10.1016/j.gde.2016.03.004
   Heindryckx B, 2014, MITOCHONDRION, V18, P12, DOI 10.1016/j.mito.2014.08.005
   Hikabe O, 2016, NATURE, V539, P299, DOI 10.1038/nature20104
   Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature183030, 10.1038/nature18303]
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Ishii T, 2014, REPROD BIOMED ONLINE, V29, P150, DOI 10.1016/j.rbmo.2014.04.001
   Jo A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/305716
   KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   Katayama M, 2006, DEV BIOL, V299, P206, DOI 10.1016/j.ydbio.2006.07.022
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   KIMURA Y, 1995, BIOL REPROD, V53, P855, DOI 10.1095/biolreprod53.4.855
   Kondoh H, 2007, HISTOL HISTOPATHOL, V22, P85, DOI 10.14670/HH-22.85
   Koutsopoulos OS, 2010, BBA-MOL CELL RES, V1803, P564, DOI 10.1016/j.bbamcr.2010.03.006
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Ledford H, 2016, NATURE, V532, P427, DOI 10.1038/nature.2016.19797
   Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Liao SM, 2017, BIOETHICS, V31, P20, DOI 10.1111/bioe.12308
   Lonergan T, 2007, MITOCHONDRION, V7, P289, DOI 10.1016/j.mito.2007.05.002
   Luo SM, 2013, P NATL ACAD SCI USA, V110, P13038, DOI 10.1073/pnas.1303231110
   Ma H, 2017, CELL STEM CELL, V20, P112, DOI 10.1016/j.stem.2016.10.001
   Ma H, 2016, CELL METAB, V24, P283, DOI 10.1016/j.cmet.2016.06.012
   Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546
   MANN JR, 1984, NATURE, V310, P66, DOI 10.1038/310066a0
   Matilainen O, 2017, TRENDS CELL BIOL, V27, P453, DOI 10.1016/j.tcb.2017.02.004
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Mitalipov S, 2014, CELL REP, V7, P935, DOI 10.1016/j.celrep.2014.05.004
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Nakada K, 2001, SEMIN CELL DEV BIOL, V12, P459, DOI 10.1006/scdb.2001.0283
   Newson AJ, 2017, BIOETHICS, V31, P55, DOI 10.1111/bioe.12312
   Nuffield Council on Bioethics, 2012, NOV TECHN PREV MIT D
   Otten ABC, 2015, HUM REPROD UPDATE, V21, P671, DOI 10.1093/humupd/dmv024
   Palacios-González C, 2017, J LAW BIOSCI, V4, P50, DOI 10.1093/jlb/lsw065
   Palacios-González C, 2016, MONASH BIOETH REV, V34, P37, DOI 10.1007/s40592-016-0059-x
   Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800
   Poulton J, 2017, MOL DIAGN THER, V21, P419, DOI 10.1007/s40291-017-0279-7
   Prigione A, 2010, INT J DEV BIOL, V54, P1729, DOI 10.1387/ijdb.103198ap
   Quirós PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146
   Rishishwar L, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3539-3
   Saben JL, 2016, CELL REP, V16, P1, DOI 10.1016/j.celrep.2016.05.065
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Sallevelt SCEH, 2013, J MED GENET, V50, P125, DOI 10.1136/jmedgenet-2012-101172
   Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347
   Shitara H, 2000, GENETICS, V156, P1277
   Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953
   Song WH, 2016, P NATL ACAD SCI USA, V113, pE5261, DOI 10.1073/pnas.1605844113
   Song WH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/981867
   Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326
   Steffann J, 2014, CELL REP, V7, P933, DOI 10.1016/j.celrep.2014.05.005
   Steuerwald N, 2000, ZYGOTE, V8, P209, DOI 10.1017/S0967199400001003
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Thorburn DR, 2009, MOL GENET METAB, V98, P5
   Treff NR, 2012, FERTIL STERIL, V98, P1236, DOI 10.1016/j.fertnstert.2012.07.1119
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tucker KL, 1996, P NATL ACAD SCI USA, V93, P12920, DOI 10.1073/pnas.93.23.12920
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615
   Wakayama T, 1997, J REPROD FERTIL, V110, P263, DOI 10.1530/jrf.0.1100263
   Wakayama T, 1998, BIOL REPROD, V59, P100, DOI 10.1095/biolreprod59.1.100
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Wang MK, 2001, ZYGOTE, V9, P9, DOI 10.1017/S0967199401001022
   Wang T, 2014, CELL, V157, P1591, DOI 10.1016/j.cell.2014.04.042
   Wolf DP, 2017, EMBO J, V36, P2659, DOI 10.15252/embj.201797843
   Yamada M, 2016, CELL STEM CELL, V18, P749, DOI 10.1016/j.stem.2016.04.001
   Yamada M, 2014, NATURE, V510, P533, DOI 10.1038/nature13287
   Yang VS, 2011, CURR BIOL, V21, P692, DOI 10.1016/j.cub.2011.03.026
   Zhang J, 2017, REPROD BIOMED ONLINE, V34, P361, DOI 10.1016/j.rbmo.2017.01.013
   Zhang J, 2016, REPROD BIOMED ONLINE, V33, P529, DOI 10.1016/j.rbmo.2016.07.008
NR 98
TC 79
Z9 83
U1 0
U2 52
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1087-0156
EI 1546-1696
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD NOV
PY 2017
VL 35
IS 11
BP 1059
EP 1068
DI 10.1038/nbt.3997
PG 10
WC Biotechnology & Applied Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology
GA FM2UM
UT WOS:000414856200022
PM 29121011
DA 2024-11-01
ER

PT J
AU Izumi, R
   Ikeda, K
   Niihori, T
   Suzuki, N
   Shirota, M
   Funayama, R
   Nakayama, K
   Warita, H
   Tateyama, M
   Aoki, Y
   Aoki, M
AF Izumi, Rumiko
   Ikeda, Kensuke
   Niihori, Tetsuya
   Suzuki, Naoki
   Shirota, Matsuyuki
   Funayama, Ryo
   Nakayama, Keiko
   Warita, Hitoshi
   Tateyama, Maki
   Aoki, Yoko
   Aoki, Masashi
TI Nuclear pore pathology underlying multisystem proteinopathy type
   3-related inclusion body myopathy
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
ID DISTAL MYOPATHY; NUCLEOCYTOPLASMIC TRANSPORT; MISSENSE MUTATION; N-CAM;
   EXPRESSION; HNRNPA1
AB Objective Multisystem proteinopathy type 3 (MSP3) is an inherited, pleiotropic degenerative disorder caused by a mutation in heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1), which can affect the muscle, bone, and/or nervous system. This study aimed to determine detailed histopathological features and transcriptomic profile of HNRNPA1-mutated skeletal muscles to reveal the core pathomechanism of hereditary inclusion body myopathy (hIBM), a predominant phenotype of MSP3.Methods Histopathological analyses and RNA sequencing of HNRNPA1-mutated skeletal muscles harboring a c.940G > A (p.D314N) mutation (NM_031157) were performed, and the results were compared with those of HNRNPA1-unlinked hIBM and control muscle tissues.Results RNA sequencing revealed aberrant alternative splicing events that predominantly occurred in myofibril components and mitochondrial respiratory complex. Enrichment analyses identified the nuclear pore complex (NPC) and nucleocytoplasmic transport as suppressed pathways. These two pathways were linked by the hub genes NUP50, NUP98, NUP153, NUP205, and RanBP2. In immunohistochemistry, these nucleoporin proteins (NUPs) were mislocalized to the cytoplasm and aggregated mostly with TAR DNA-binding protein 43 kDa and, to a lesser extent, with hnRNPA1. Based on ultrastructural observation, irregularly shaped myonuclei with deep invaginations were frequently observed in atrophic fibers, consistent with the disorganization of NPCs. Additionally, regarding the expression profiles of overall NUPs, reduced expression of NUP98, NUP153, and RanBP2 was shared with HNRNPA1-unlinked hIBMs.Interpretation The shared subset of altered NUPs in amyotrophic lateral sclerosis (ALS), as demonstrated in prior research, HNRNPA1-mutated, and HNRNPA1-unlinked hIBM muscle tissues may provide evidence regarding the underlying common nuclear pore pathology of hIBM, ALS, and MSP.
C1 [Izumi, Rumiko; Ikeda, Kensuke; Suzuki, Naoki; Warita, Hitoshi; Aoki, Masashi] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Japan.
   [Izumi, Rumiko; Niihori, Tetsuya; Aoki, Yoko] Tohoku Univ, Grad Sch Med, Dept Med Genet, Sendai, Japan.
   [Shirota, Matsuyuki] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Sendai, Japan.
   [Funayama, Ryo; Nakayama, Keiko] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Div Cell Proliferat, Sendai, Japan.
   [Tateyama, Maki] Natl Hosp Org, Iwate Hosp, Ichinoseki, Japan.
   [Aoki, Masashi] Tohoku Univ, Grad Sch Med, Dept Neurol, 1-1 Seiryo machi,Aoba ku, Sendai 9808574, Japan.
C3 Tohoku University; Tohoku University; Tohoku University; Tohoku
   University; Tohoku University
RP Aoki, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Neurol, 1-1 Seiryo machi,Aoba ku, Sendai 9808574, Japan.
EM aokim@med.tohoku.ac.jp
RI Niihori, Tetsuya/ABE-2350-2021; Warita, Hitoshi/T-1970-2019
OI Izumi, Rumiko/0000-0002-6701-7814
FU Grant-in-Aid for Early-Career Scientists from Japan Society for the
   Promotion of Science (JSPS); Biomedical Research Core of Tohoku
   University Graduate School of Medicine
FX The authors sincerely appreciate the cooperation of the patients and
   their families. We are also grateful to Drs. Kodai Kume and Hideshi
   Kawakami for their assistance with genetic analyses of patients with
   OPDM; Drs. Taiki Abe and Koki Nagai for their useful advice; and Yoko
   Tateda, Kumi Kato, Naoko Shimakura, Mai Kakinuma, Kazumi Ogawa, Teruki
   Koizumi, Yudu Adachi, Miyuki Tsuda, Makiko Nakagawa, Mami Kikuchi, and
   Kiyotaka Kuroda for their excellent technical assistance. Moreover, we
   acknowledge the generous support of the Biomedical Research Core of
   Tohoku University Graduate School of Medicine.
CR Beijer D, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.148363
   Chompoopong P, 2022, NEUROMUSCULAR DISORD, V32, P521, DOI 10.1016/j.nmd.2022.03.009
   Chou CC, 2018, NAT NEUROSCI, V21, P228, DOI 10.1038/s41593-017-0047-3
   COVAULT J, 1985, P NATL ACAD SCI USA, V82, P4544, DOI 10.1073/pnas.82.13.4544
   Coyne AN, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abe1923
   Coyne AN, 2020, NEURON, V107, P1124, DOI 10.1016/j.neuron.2020.06.027
   Eftekharzadeh B, 2018, NEURON, V99, P925, DOI 10.1016/j.neuron.2018.07.039
   Pereira PE, 2023, ACTA NEUROPATHOL, V145, P793, DOI 10.1007/s00401-023-02565-1
   Gasset-Rosa F, 2017, NEURON, V94, P48, DOI 10.1016/j.neuron.2017.03.027
   Gosztonyi G, 2001, MICROSC RES TECHNIQ, V55, P187, DOI 10.1002/jemt.1170
   Grassano M, 2022, J NEUROL NEUROSUR PS, V93, P1190, DOI 10.1136/jnnp-2022-328931
   Hachiya N, 2021, MOL NEUROBIOL, V58, P983, DOI 10.1007/s12035-020-02168-x
   Hackman P, 2021, NEUROL-GENET, V7, DOI 10.1212/NXG.0000000000000632
   Han M, 2019, HUM MUTAT, V40, P310, DOI 10.1002/humu.23691
   Han XC, 2022, ANN CLIN TRANSL NEUR, V9, P1910, DOI 10.1002/acn3.51682
   Höhn A, 2013, REDOX BIOL, V1, P140, DOI 10.1016/j.redox.2013.01.006
   Izumi R, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000023
   Janin A, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0698-x
   Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922
   Koike Y, 2023, PLOS BIOL, V21, DOI 10.1371/journal.pbio.3002028
   Kottlors M, 2010, J NEUROL SCI, V291, P79, DOI 10.1016/j.jns.2009.12.008
   Li C, 2016, NUCLEUS-PHILA, V7, P430, DOI 10.1080/19491034.2016.1238997
   Li YI, 2018, NAT GENET, V50, P151, DOI 10.1038/s41588-017-0004-9
   Lin YC, 2021, NAT NEUROSCI, V24, P1077, DOI 10.1038/s41593-021-00859-9
   Liu Q, 2016, NEUROLOGY, V87, P1763, DOI 10.1212/WNL.0000000000003256
   Liu XY, 2015, J NEUROCHEM, V133, P187, DOI 10.1111/jnc.13069
   LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8
   Lussi YC, 2011, MOL BIOL CELL, V22, P1080, DOI 10.1091/mbc.E10-05-0463
   Ma XR, 2022, NATURE, V603, P124, DOI 10.1038/s41586-022-04424-7
   Müller TJ, 2014, ANN NEUROL, V76, P669, DOI 10.1002/ana.24255
   Naruse H, 2018, NEUROBIOL AGING, V61, DOI 10.1016/j.neurobiolaging.2017.08.030
   Raices M, 2012, NAT REV MOL CELL BIO, V13, P687, DOI 10.1038/nrm3461
   Senderek J, 2009, AM J HUM GENET, V84, P511, DOI 10.1016/j.ajhg.2009.03.006
   Shijo T, 2018, J NEUROSCI RES, V96, P222, DOI 10.1002/jnr.24127
   Smythe C, 2000, EMBO J, V19, P3918, DOI 10.1093/emboj/19.15.3918
   Suzuki N, 2005, MUSCLE NERVE, V32, P812, DOI 10.1002/mus.20417
   Töpf A, 2020, GENET MED, V22, P1478, DOI 10.1038/s41436-020-0840-3
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Xie ZR, 2021, CURR PROTOC, V1, DOI 10.1002/cpz1.90
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973
NR 41
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD MAR
PY 2024
VL 11
IS 3
BP 577
EP 592
DI 10.1002/acn3.51977
EA DEC 2023
PG 16
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA NC7L8
UT WOS:001134328700001
PM 38158701
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Chan, SSL
   Longley, MJ
   Copeland, WC
AF Chan, Sherine S. L.
   Longley, Matthew J.
   Copeland, William C.
TI Modulation of the W748S mutation in DNA polymerase γ by the E1143G
   polymorphismin mitochondrial disorders
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; POLG MUTATIONS; SUBUNIT;
   IDENTIFICATION; DELETIONS; TOXICITY; SPECTRUM; BINDING; ATAXIA; A467T
AB DNA polymerase gamma (pol gamma) is required for replication and repair of mitochondrial DNA. Over 80 mutations in POLG, the gene encoding the catalytic subunit of pol gamma, have been linked with disease. The W748S mutation in POLG is the most common mutation in ataxia-neuropathy spectrum disorders and is generally found in cis with the common E1143G polymorphism. It has been unclear whether E1143G participates in the disease process. We investigated the biochemical consequences of pol gamma proteins containing W748S or E1143G, or both. W748S pol gamma exhibited low DNA polymerase activity, low processivity and a severe DNA-binding defect. However, interactions between the catalytic and accessory subunits were normal. Despite the benefits derived from binding with the accessory subunit, catalytic activities did not reach wild-type (WT) levels. Also, nucleotide selectivity decreased 2.1-fold compared with WT. Surprisingly, pol gamma containing only E1143G was 1.4-fold more active than WT, and this increased polymerase activity could be due to higher thermal stability for E1143G pol gamma. The E1143G substitution partially rescued the deleterious effects of the W748S mutation, as DNA binding, catalytic activity and fidelity values were intermediate for W748S-E1143G. However, W748S-E1143G had a notably lower change in enthalpy for protein folding than W748S alone. We suggest that when E1143G is in cis with other pathogenic mutations, it can modulate the effects of these mutations. For W748S-E1143G pol gamma, the benefits bestowed by E1143G include increased DNA binding and polymerase activity; however, E1143G was somewhat detrimental to protein stability.
C1 NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, POB 12233,111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
RI Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953
CR Bienstock RJ, 2004, MITOCHONDRION, V4, P203, DOI 10.1016/j.mito.2004.05.018
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   DeLano WL., 2002, The PyMOL molecular graphics system
   DeRose EF, 2004, STRUCTURE, V12, P2221, DOI 10.1016/j.str.2004.09.019
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   *GENESNPS, 2004, SNP CARD POLG
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hisama FM, 2005, AM J MED GENET A, V135A, P217, DOI 10.1002/ajmg.a.30672
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, NEUROLOGY, V66, P1439, DOI 10.1212/01.wnl.0000210486.32196.24
   Kim SJ, 2003, J BIOL CHEM, V278, P5072, DOI 10.1074/jbc.M208472200
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley Matthew J, 2002, Methods Mol Biol, V197, P245, DOI 10.1385/1-59259-284-8:245
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Punga AR, 2006, CLIN NEUROPHYSIOL, V117, P1434, DOI 10.1016/j.clinph.2006.03.028
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
NR 38
TC 80
Z9 88
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD DEC
PY 2006
VL 15
IS 23
BP 3473
EP 3483
DI 10.1093/hmg/ddl424
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 108XA
UT WOS:000242271300010
PM 17088268
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Vita, G
   Vita, GL
   Musumeci, O
   Rodolico, C
   Messina, S
AF Vita, Giuseppe
   Vita, Gian Luca
   Musumeci, Olimpia
   Rodolico, Carmelo
   Messina, Sonia
TI Genetic neuromuscular disorders: living the era of a therapeutic
   revolution. Part 2: diseases of motor neuron and skeletal muscle
SO NEUROLOGICAL SCIENCES
LA English
DT Review
DE Spinal muscular atrophy; Nusinersen; SMN1 gene replacement; Duchenne
   muscular dystrophy; Ataluren; Exon skipping
ID DUCHENNE MUSCULAR-DYSTROPHY; DOUBLE-BLIND; NONDYSTROPHIC MYOTONIAS;
   ISOFLAVONE GENISTEIN; SHAM CONTROL; SMA TYPE; DIAGNOSIS; ATROPHY; CARE;
   MANAGEMENT
AB This is the second part of a two-part document intended to discuss recent therapeutic progresses in genetic neuromuscular disorders. The present review is for diseases of motor neuron and skeletal muscle, some of which reached recently the most innovative therapeutic approaches. Nusinersen, an SMN2 mRNA splicing modifier, was approved as first-ever therapy of spinal muscular atrophy (SMA) by FDA in 2016 and by EMA in 2017. The orally administered small-molecule risdiplam, which increases SMN protein levels similarly but also in peripheral organs, is tested in ongoing phase 2 and 3 trials. After positive results with phase 1 treatment with AAV9-SMN, the first gene therapy for SMA, a phase 3 clinical trial is ongoing. Ataluren is the first approved drug for Duchenne muscular dystrophy (DMD) patients with premature stop codon mutations and its indication has been recently extended since the age of 2years. Exon skipping technology was and is currently tested in many phase 3 trials, and eteplirsen received a conditional approval by FDA for patients amenable to exon 51 skipping, but not by EMA. Many other compounds with different mechanisms of action are now tested in DMD by phase 2 and 3 trials, including phase 1 gene therapy. Other innovative approaches are under investigation, i.e., gene therapy in X-linked myotubular myopathy and Pompe disease, and antisense oligonucleotides in myotonic dystrophy type 1. Positive evidences are discussed about lamotrigine and ranolazine in non-dystrophic myotonias, chaperons in Pompe disease, and nucleosides in mitochondrial DNA depletion induced by thymidine kinase 2 deficiency.
C1 [Vita, Giuseppe; Musumeci, Olimpia; Rodolico, Carmelo; Messina, Sonia] Univ Messina, Dept Clin & Expt Med, Unit Neurol & Neuromuscular Dis, Messina, Italy.
   [Vita, Giuseppe; Vita, Gian Luca; Messina, Sonia] Nemo Sud Clin Ctr Neuromuscular Disorders, Messina, Italy.
C3 University of Messina
RP Vita, G (corresponding author), Univ Messina, Dept Clin & Expt Med, Unit Neurol & Neuromuscular Dis, Messina, Italy.; Vita, G (corresponding author), Nemo Sud Clin Ctr Neuromuscular Disorders, Messina, Italy.
EM vitag@unime.it
RI Vita, Gianluca/AAR-4587-2020; Musumeci, Olimpia/AHE-3041-2022
OI Vita, Gianluca/0000-0003-4190-8042; RODOLICO,
   Carmelo/0000-0003-2543-6356; Vita, Giuseppe/0000-0002-5204-7826
CR Aartsma-Rus A, 2019, NUCLEIC ACID THER, V29, P13, DOI 10.1089/nat.2018.0756
   Al-Zaidy S, 2019, PEDIATR PULM, V54, P179, DOI 10.1002/ppul.24203
   Amoasii L, 2018, SCIENCE, V362, P86, DOI 10.1126/science.aau1549
   Andersen G, 2017, BRAIN, V140, P2295, DOI 10.1093/brain/awx192
   Angelini C, 2012, J NEUROL, V259, P952, DOI 10.1007/s00415-011-6293-5
   Arnold WD, 2017, NEUROLOGY, V89, P710, DOI 10.1212/WNL.0000000000004229
   Bach JR, 2011, RESP CARE, V56, P744, DOI 10.4187/respcare.00831
   Barthélémy F, 2018, NEUROMUSCULAR DISORD, V28, P803, DOI 10.1016/j.nmd.2018.06.009
   Bassez G, 2018, BRAIN, V141, P2855, DOI 10.1093/brain/awy231
   Bertini E, 2017, LANCET NEUROL, V16, P513, DOI 10.1016/S1474-4422(17)30085-6
   Bettica P, 2016, NEUROMUSCULAR DISORD, V26, P643, DOI 10.1016/j.nmd.2016.07.002
   Biogen, 2018, REACTIONS WEEKLY, V1714, P3, DOI [DOI 10.1007/S40278-018-50183-2, 10.1007/s40278-018-50183-2]
   Birnkrant DJ, 2018, LANCET NEUROL, V17, P347, DOI 10.1016/S1474-4422(18)30025-5
   Birnkrant DJ, 2018, LANCET NEUROL, V17, P445, DOI 10.1016/S1474-4422(18)30026-7
   Birnkrant DJ, 2018, LANCET NEUROL, V17, P251, DOI 10.1016/S1474-4422(18)30024-3
   Calucho M, 2018, NEUROMUSCULAR DISORD, V28, P208, DOI 10.1016/j.nmd.2018.01.003
   Cassandrini D, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0419-z
   Corti M, 2017, HUM GENE THER CL DEV, V28, P208, DOI 10.1089/humc.2017.146
   D'Amico A, 2017, NEUROMUSCULAR DISORD, V27, P447, DOI 10.1016/j.nmd.2017.02.006
   De Antonio M, 2016, REV NEUROL-FRANCE, V172, P572, DOI 10.1016/j.neurol.2016.08.003
   Elverman M, 2017, MUSCLE NERVE, V56, P943, DOI 10.1002/mus.25658
   Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752
   Finkel RS, 2018, NEUROMUSCULAR DISORD, V28, P197, DOI 10.1016/j.nmd.2017.11.004
   Finkel RS, 2017, NEUROMUSCULAR DISORD, V27, P596, DOI 10.1016/j.nmd.2017.02.014
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Guglieri M, 2017, CONTEMP CLIN TRIALS, V58, P34, DOI 10.1016/j.cct.2017.04.008
   Han SO, 2017, MOL THER-METH CLIN D, V4, P126, DOI 10.1016/j.omtm.2016.12.010
   Hoffman EP, 2018, STEROIDS, V134, P43, DOI 10.1016/j.steroids.2018.02.010
   Iwamoto N, 2017, NAT BIOTECHNOL, V35, P845, DOI 10.1038/nbt.3948
   Jauvin D, 2017, MOL THER-NUCL ACIDS, V7, P465, DOI 10.1016/j.omtn.2017.05.007
   Kinane T Bernard, 2018, J Neuromuscul Dis, V5, P47, DOI 10.3233/JND-170272
   Klug C, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0424-0
   Koeberl DD, 2011, MOL GENET METAB, V103, P107, DOI 10.1016/j.ymgme.2011.02.006
   Kuntz N, 2018, NEUROMUSCULAR DISORD, V28, pS91, DOI 10.1016/j.nmd.2018.06.240
   La Foresta S, 2018, NEUROL SCI, V39, P1961, DOI 10.1007/s10072-018-3506-z
   Laustriat D, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.35
   Li DH, 2018, TRENDS PHARMACOL SCI, V39, P982, DOI 10.1016/j.tips.2018.09.001
   López-Bastida J, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0695-0
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   LoRusso S, 2019, MUSCLE NERVE, V59, P240, DOI 10.1002/mus.26372
   Maga JA, 2013, J BIOL CHEM, V288, P1428, DOI 10.1074/jbc.M112.438663
   Mah JK, 2018, METHODS MOL BIOL, V1687, P3, DOI 10.1007/978-1-4939-7374-3_1
   Matthews E, 2010, BRAIN, V133, P9, DOI 10.1093/brain/awp294
   Matthews E, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub4
   McDonald CM, 2017, LANCET, V390, P1489, DOI 10.1016/S0140-6736(17)31611-2
   Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198
   Mendell JR, 2016, ANN NEUROL, V79, P257, DOI 10.1002/ana.24555
   Mercuri E, 2018, NEW ENGL J MED, V378, P625, DOI 10.1056/NEJMoa1710504
   Mercuri E, 2018, NEUROMUSCULAR DISORD, V28, P103, DOI 10.1016/j.nmd.2017.11.005
   Messina S, 2018, NEUROL SCI, V39, P1837, DOI 10.1007/s10072-018-3555-3
   Messina S, 2018, J CLIN MED, V7, DOI 10.3390/jcm7090251
   Messina S, 2017, NEUROMUSCULAR DISORD, V27, P1084, DOI 10.1016/j.nmd.2017.09.006
   Messina S, 2015, BIOFACTORS, V41, P324, DOI 10.1002/biof.1226
   Messina S, 2011, NEUROMUSCULAR DISORD, V21, P579, DOI 10.1016/j.nmd.2011.04.014
   Messina S, 2009, EXP NEUROL, V220, P349, DOI 10.1016/j.expneurol.2009.09.015
   Meyer K, 2015, MOL THER, V23, P477, DOI 10.1038/mt.2014.210
   Pacione M, 2019, J NEUROMUSCULAR DIS, V6, P119, DOI 10.3233/JND-180330
   Pane M, 2018, NEUROMUSCULAR DISORD, V28, P582, DOI 10.1016/j.nmd.2018.05.010
   Parenti G, 2014, MOL THER, V22, P2004, DOI 10.1038/mt.2014.138
   Parenti G, 2014, FUTURE MED CHEM, V6, P1031, DOI [10.4155/fmc.14.40, 10.4155/FMC.14.40]
   Pena LDM, 2019, NEUROMUSCULAR DISORD, V29, P167, DOI 10.1016/j.nmd.2018.12.004
   Portaro S, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3289
   Puzzo F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam6375
   Quinlivan R, 2014, CURR OPIN NEUROL, V27, P607, DOI 10.1097/WCO.0000000000000132
   Rahbek J, 2015, NEUROMUSCULAR DISORD, V25, P727, DOI 10.1016/j.nmd.2015.05.005
   Ratni H, 2018, J MED CHEM, V61, P6501, DOI 10.1021/acs.jmedchem.8b00741
   Schoser B, 2017, J NEUROL, V264, P621, DOI 10.1007/s00415-016-8219-8
   Smith BK, 2017, EXP NEUROL, V287, P216, DOI 10.1016/j.expneurol.2016.07.013
   Statland JM, 2012, JAMA-J AM MED ASSOC, V308, P1357, DOI 10.1001/jama.2012.12607
   Stein CA, 2017, MOL THER, V25, P1069, DOI 10.1016/j.ymthe.2017.03.023
   Sturm S, 2019, BRIT J CLIN PHARMACO, V85, P181, DOI 10.1111/bcp.13786
   Terracciano C, 2018, J NEUROL NEUROSUR PS, V89, P1232, DOI 10.1136/jnnp-2017-317615
   Tizzano EF, 2018, EUR J PAEDIATR NEURO, V22, P944, DOI 10.1016/j.ejpn.2018.08.009
   Trivedi JR, 2013, BRAIN, V136, P2189, DOI 10.1093/brain/awt133
   van Agtmaal EL, 2017, MOL THER, V25, P24, DOI 10.1016/j.ymthe.2016.10.014
   van der Ploeg AT, 2008, LANCET, V372, P1342, DOI 10.1016/S0140-6736(08)61555-X
   Vita GL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205514
   Zuluaga-Sanchez S, 2019, PHARMACOECONOMICS, V37, P845, DOI 10.1007/s40273-019-00769-6
NR 79
TC 21
Z9 23
U1 1
U2 31
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD APR
PY 2019
VL 40
IS 4
BP 671
EP 681
DI 10.1007/s10072-019-03764-z
PG 11
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA HT7TG
UT WOS:000464766700002
PM 30805745
OA Bronze
DA 2024-11-01
ER

PT J
AU Yin, YY
   Shen, HT
AF Yin, Yiyuan
   Shen, Haitao
TI Common methods in mitochondrial research (Review)
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Review
DE mitochondria; mitochondrial morphology; mitochondrial dysfunction;
   mitochondrial DNA; mitochondrial diseases
ID RESPIRATORY-CHAIN SUPERCOMPLEXES; SAYRE SYNDROME STILL;
   OXYGEN-CONSUMPTION; ATOMIC-FORCE; ALZHEIMERS-DISEASE; HIGH-RESOLUTION;
   PEPTIDE SS31; BIALLELIC VARIANTS; ARRHYTHMIC RISK; REDOX IMBALANCE
AB Mitochondrial abnormalities are primarily seen in morphology, structure and function. They can cause damage to organs, including the heart, brain and muscle, by various mechanisms, such as oxidative stress, abnormal energy metabolism, or genetic mutations. Identifying and detecting pathophysiological alterations in mitochondria is the principal means of studying mitochondrial abnormalities. The present study reviewed methods in mitochondrial research and focused on three aspects: Mitochondrial extraction and purification, morphology and structure and function. In addition to classical methods, such as electron microscopy and mitochondrial membrane potential monitoring, newly developed methods, such as mitochondrial ultrastructural determination, mtDNA mutation assays, metabolomics and analyses of regulatory mechanisms, have also been utilized in recent years. These approaches enable the accurate detection of mitochondrial abnormalities and provide guidance for the diagnosis and treatment of related diseases.
C1 [Yin, Yiyuan; Shen, Haitao] Shengjing Hosp China Med Univ, Dept Emergency Med, Shenyang 110004, Liaoning, Peoples R China.
   [Shen, Haitao] China Med Univ, Shengjing Hosp, Dept Emergency Med, 36 Sanhao St, Shenyang 110004, Liaoning, Peoples R China.
C3 China Medical University
RP Shen, HT (corresponding author), China Med Univ, Shengjing Hosp, Dept Emergency Med, 36 Sanhao St, Shenyang 110004, Liaoning, Peoples R China.
EM shenht@sj-hospital.org
RI Yin, Yiyuan/AAP-3069-2020
FU Foundation of Liaoning Education Department
FX The present study was supported by the Foundation of Liaoning Education
   Department (grant no. JCZR2020014), the Liaoning Province Key R&D
   Program (grant no. 2020JH2/10300141) and the 345 Talent Project of
   Shengjing Hospital.
CR Acetoze G, 2018, J ANIM PHYSIOL AN N, V102, pE787, DOI 10.1111/jpn.12836
   Adam N, 2021, AGEING RES REV, V68, DOI 10.1016/j.arr.2021.101320
   Akbari M, 2019, AGEING RES REV, V54, DOI 10.1016/j.arr.2019.100940
   Alexander JF, 2021, THERANOSTICS, V11, P3109, DOI 10.7150/thno.53474
   Algieri C, 2021, ARCH BIOCHEM BIOPHYS, V712, DOI 10.1016/j.abb.2021.109027
   Allouche J, 2021, CELL, V184, P4268, DOI 10.1016/j.cell.2021.06.022
   Alpert NM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190968
   Alyasin A, 2020, ANDROLOGIA, V52, DOI 10.1111/and.13588
   Amore G, 2021, DRUGS, V81, P57, DOI 10.1007/s40265-020-01428-3
   Andersen JV, 2019, J NEUROSCI RES, V97, P961, DOI 10.1002/jnr.24371
   Andrieux P, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222111338
   Angelova PR, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10071021
   Angelova PR, 2021, MED RES REV, V41, P770, DOI 10.1002/med.21712
   Ansó E, 2017, NAT CELL BIOL, V19, P614, DOI 10.1038/ncb3529
   Aqawi M, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.656471
   Arai S, 2018, ANGEW CHEM INT EDIT, V57, P10873, DOI 10.1002/anie.201804304
   Asfaram S, 2022, ACTA PARASITOL, V67, P842, DOI 10.1007/s11686-022-00528-2
   Ashton TM, 2018, CLIN CANCER RES, V24, P2482, DOI 10.1158/1078-0432.CCR-17-3070
   Asperti M, 2021, FREE RADICAL BIO MED, V169, P294, DOI 10.1016/j.freeradbiomed.2021.04.024
   Bagge EK, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00890-5
   Baines CP, 2018, CELL CALCIUM, V73, P121, DOI 10.1016/j.ceca.2018.05.003
   Ballarò R, 2021, CANCERS, V13, DOI 10.3390/cancers13040850
   Balsa E, 2019, MOL CELL, V74, P877, DOI 10.1016/j.molcel.2019.03.031
   Banh RS, 2016, NAT CELL BIOL, V18, P803, DOI 10.1038/ncb3376
   Bartolák-Suki E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57301-1
   Bastian C, 2019, NEUROMOL MED, V21, P484, DOI 10.1007/s12017-019-08550-w
   Baumann K, 2019, NAT REV MOL CELL BIO, V20, P663, DOI 10.1038/s41580-019-0182-7
   Beamer E, 2019, BRAIN RES BULL, V151, P65, DOI 10.1016/j.brainresbull.2018.12.021
   Bhargava P, 2017, NAT REV NEPHROL, V13, P629, DOI 10.1038/nrneph.2017.107
   Bhatti JS, 2021, MITOCHONDRION, V58, P49, DOI 10.1016/j.mito.2021.02.007
   Bhatti JS, 2021, MOL NEUROBIOL, V58, P795, DOI 10.1007/s12035-020-02142-7
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Bikas A, 2019, INT J ONCOL, V55, P7, DOI 10.3892/ijo.2019.4802
   Billingham LK, 2022, NAT IMMUNOL, V23, P692, DOI 10.1038/s41590-022-01185-3
   Bjorklund G, 2020, FREE RADICAL BIO MED, V160, P149, DOI 10.1016/j.freeradbiomed.2020.07.017
   Blanco FJ, 2018, NAT REV RHEUMATOL, V14, P327, DOI 10.1038/s41584-018-0001-0
   Blotto BL, 2021, CLADISTICS, V37, P36, DOI 10.1111/cla.12409
   Bock FJ, 2020, NAT REV MOL CELL BIO, V21, P85, DOI 10.1038/s41580-019-0173-8
   Bonora E, 2021, BRAIN, V144, P1451, DOI 10.1093/brain/awab056
   Bonora M, 2019, NAT REV CARDIOL, V16, P33, DOI 10.1038/s41569-018-0074-0
   Borsche M, 2020, BRAIN, V143, P3041, DOI 10.1093/brain/awaa246
   Boussardon Clement, 2022, Methods Mol Biol, V2363, P13, DOI 10.1007/978-1-0716-1653-6_2
   Boyman L, 2020, TRENDS MOL MED, V26, P21, DOI 10.1016/j.molmed.2019.10.007
   Bozi LHM, 2020, MOL ASPECTS MED, V71, DOI 10.1016/j.mam.2019.100836
   Bravo-Sagua R, 2017, COMPR PHYSIOL, V7, P623, DOI 10.1002/cphy.c160013
   Briston T, 2019, TRENDS PHARMACOL SCI, V40, P50, DOI 10.1016/j.tips.2018.11.004
   Buckel W, 2004, CURR OPIN CHEM BIOL, V8, P462, DOI 10.1016/j.cbpa.2004.07.001
   Burke PJ, 2017, TRENDS CANCER, V3, P857, DOI 10.1016/j.trecan.2017.10.006
   Calvo-Rodriguez M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16074-2
   Campos JC, 2017, AUTOPHAGY, V13, P1304, DOI 10.1080/15548627.2017.1325062
   Cano M, 2021, AGING CELL, V20, DOI 10.1111/acel.13444
   Cartuche L, 2019, MAR DRUGS, V17, DOI 10.3390/md17100588
   Castellana S, 2021, NUCLEIC ACIDS RES, V49, pD1282, DOI 10.1093/nar/gkaa1032
   Chakrabarty RP, 2021, CELL STEM CELL, V28, P394, DOI 10.1016/j.stem.2021.02.011
   Chandhok G, 2018, BIOL REV, V93, P933, DOI 10.1111/brv.12378
   Chandra K, 2017, ACS OMEGA, V2, P4878, DOI 10.1021/acsomega.7b00871
   Chen BY, 2019, CLIN CHIM ACTA, V493, P14, DOI 10.1016/j.cca.2019.02.021
   Chen HG, 2021, CRIT REV BIOTECHNOL, V41, P16, DOI 10.1080/07388551.2020.1826403
   Chen JJ, 2021, OPHTHALMOLOGY, V128, P661, DOI 10.1016/j.ophtha.2021.01.023
   Chen JZ, 2022, J COLLOID INTERF SCI, V605, P263, DOI 10.1016/j.jcis.2021.07.080
   Chen M, 2020, ACS CHEM NEUROSCI, V11, P1283, DOI 10.1021/acschemneuro.0c00041
   Chen WW, 2017, NAT PROTOC, V12, P2215, DOI 10.1038/nprot.2017.104
   Chiang JL, 2020, AGEING RES REV, V63, DOI 10.1016/j.arr.2020.101168
   Chinopoulos C, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113218
   Chinopoulos C, 2018, NEUROCHEM INT, V117, P49, DOI 10.1016/j.neuint.2017.06.010
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Cho H, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165808
   Chow J, 2017, NAT REV ENDOCRINOL, V13, P92, DOI 10.1038/nrendo.2016.151
   Cieluch A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082852
   Cogliati S, 2018, J MOL BIOL, V430, P4849, DOI 10.1016/j.jmb.2018.09.016
   Colaço HG, 2021, IMMUNITY, V54, P53, DOI 10.1016/j.immuni.2020.09.011
   Cornman RS, 2021, PEERJ, V9, DOI 10.7717/peerj.10539
   Correia-Alvarez E, 2020, NICOTINE TOB RES, V22, pS4, DOI 10.1093/ntr/ntaa177
   Costa R, 2019, CELL REP, V28, P1949, DOI 10.1016/j.celrep.2019.07.050
   Country MW, 2021, J EXP BIOL, V224, DOI 10.1242/jeb.242634
   Csordás G, 2018, TRENDS CELL BIOL, V28, P523, DOI 10.1016/j.tcb.2018.02.009
   Cui YX, 2021, ACTA BIOMATER, V131, P544, DOI 10.1016/j.actbio.2021.07.018
   Cui YT, 2021, MOL CELL BIOCHEM, V476, P493, DOI 10.1007/s11010-020-03926-0
   D'Angelo R, 2020, J NEUROL, V267, P3702, DOI 10.1007/s00415-020-10051-x
   Dabravolski SA, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23031323
   Dalecká M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22157805
   Daniyal M, 2021, PHYTOTHER RES, V35, P3977, DOI 10.1002/ptr.7114
   Darr CR, 2016, THERIOGENOLOGY, V86, P1382, DOI 10.1016/j.theriogenology.2016.04.082
   Datki Z, 2021, ECOTOX ENVIRON SAFE, V208, DOI 10.1016/j.ecoenv.2020.111666
   Davidson SM, 2021, CARDIOVASC RES, V117, P2161, DOI 10.1093/cvr/cvab200
   Del Monte F, 2021, EUROPACE, V23, P980, DOI 10.1093/europace/euab104
   Deng HF, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.624529
   Deng XH, 2020, INT J BIOL SCI, V16, P1403, DOI 10.7150/ijbs.41768
   Deng YY, 2020, SMALL, V16, DOI 10.1002/smll.202001747
   Dennerlein S, 2017, TRENDS CELL BIOL, V27, P712, DOI 10.1016/j.tcb.2017.05.004
   Depaoli MR, 2018, CELL REP, V25, P501, DOI 10.1016/j.celrep.2018.09.027
   Di Mambro C, 2021, EUROPACE, V23, P981, DOI 10.1093/europace/euab105
   Di Nora C, 2019, TRANSPLANTATION, V103, pE393, DOI 10.1097/TP.0000000000002860
   Diebold LP, 2019, NAT METAB, V1, P158, DOI 10.1038/s42255-018-0011-x
   Ding XW, 2021, PHARMACOL RES, V171, DOI 10.1016/j.phrs.2021.105783
   Dominkus PP, 2018, BBA-BIOMEMBRANES, V1860, P1350, DOI 10.1016/j.bbamem.2018.03.013
   Dorr BM, 2018, CURR OPIN CHEM BIOL, V43, P127, DOI 10.1016/j.cbpa.2018.01.008
   Dreier DA, 2019, J CHEM INF MODEL, V59, P702, DOI 10.1021/acs.jcim.8b00433
   Du RL, 2020, J PHARMACOL TOX MET, V101, DOI 10.1016/j.vascn.2019.106664
   Dumitru AC, 2021, NANO LETT, V21, P4950, DOI 10.1021/acs.nanolett.1c00599
   Durand MJ, 2019, CARDIOVASC RES, V115, P1546, DOI 10.1093/cvr/cvy294
   Eagleson KL, 2020, NEUROBIOL STRESS, V13, DOI 10.1016/j.ynstr.2020.100251
   Écija-Arenas A, 2021, TALANTA, V222, DOI 10.1016/j.talanta.2020.121532
   El Manaa W, 2021, AUTOPHAGY, V17, P4363, DOI 10.1080/15548627.2021.1917129
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   Elekofehinti OO, 2019, J ETHNOPHARMACOL, V242, DOI 10.1016/j.jep.2019.112026
   Elgamal S, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.137937
   Emoto MC, 2021, FREE RADICAL BIO MED, V172, P9, DOI 10.1016/j.freeradbiomed.2021.05.035
   Erard M, 2018, AM J PHYSIOL-REG I, V314, pR667, DOI 10.1152/ajpregu.00140.2017
   Espinosa JA, 2021, CURR PROTOC, V1, DOI 10.1002/cpz1.75
   Fan YX, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091071
   Fang HB, 2019, ACS NANO, V13, P14426, DOI 10.1021/acsnano.9b08011
   Feng BD, 2019, ANAL CHEM, V91, P13962, DOI 10.1021/acs.analchem.9b03494
   Feng RQ, 2019, ANAL CHEM, V91, P3704, DOI 10.1021/acs.analchem.8b05822
   Fernandez-Vizarra E, 2021, FEBS LETT, V595, P1062, DOI 10.1002/1873-3468.13995
   Fernström J, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-021-01723-x
   Fernström J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0259591
   Finley D, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a033985
   Fisher JJ, 2021, J PHYSIOL-LONDON, V599, P1291, DOI 10.1113/JP280593
   Flones IH, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00915-8
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Formosa LE, 2018, SEMIN CELL DEV BIOL, V76, P154, DOI 10.1016/j.semcdb.2017.08.011
   Franco-Iborra S, 2021, AUTOPHAGY, V17, P672, DOI 10.1080/15548627.2020.1728096
   Fu Y, 2020, NEURO-ONCOLOGY, V22, P240, DOI 10.1093/neuonc/noz183
   Fuhrmann DC, 2017, REDOX BIOL, V12, P208, DOI 10.1016/j.redox.2017.02.012
   Gabandé-Rodríguez E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010082
   Gäbelein CG, 2022, PLOS BIOL, V20, DOI 10.1371/journal.pbio.3001576
   Galla L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22189945
   Galvan DL, 2017, KIDNEY INT, V92, P1051, DOI 10.1016/j.kint.2017.05.034
   Ganta KK, 2017, CELL BIOL TOXICOL, V33, P69, DOI 10.1007/s10565-016-9362-9
   Gao CH, 2020, ACTA BIOMATER, V108, P285, DOI 10.1016/j.actbio.2020.03.029
   Gao FL, 2019, ANAL CHEM, V91, P3336, DOI 10.1021/acs.analchem.8b04418
   Gao G, 2017, BIOMED PHARMACOTHER, V96, P1380, DOI 10.1016/j.biopha.2017.11.057
   Gao J, 2020, ADV MATER, V32, DOI 10.1002/adma.201805798
   Gao MH, 2019, MOL CELL, V73, P354, DOI 10.1016/j.molcel.2018.10.042
   Ge YQ, 2021, LANGMUIR, V37, P11657, DOI 10.1021/acs.langmuir.1c01376
   Georgakopoulos ND, 2017, NAT CHEM BIOL, V13, P136, DOI [10.1038/nchembio.2287, 10.1038/NCHEMBIO.2287]
   Ghosh P, 2018, J CELL PHYSIOL, V233, P1041, DOI 10.1002/jcp.25958
   Gloria A, 2018, ANIM REPROD SCI, V189, P51, DOI 10.1016/j.anireprosci.2017.12.007
   Gonçalves VF, 2021, J PSYCHIATR RES, V139, P25, DOI 10.1016/j.jpsychires.2021.05.015
   Gong Xiaodi, 2021, Int J Nanomedicine, V16, P6661, DOI 10.2147/IJN.S329341
   Gonzalez LF, 2021, PHARMACEUTICS, V13, DOI 10.3390/pharmaceutics13122055
   Gotham JP, 2020, FREE RADICAL BIO MED, V154, P84, DOI 10.1016/j.freeradbiomed.2020.04.020
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Granata C, 2018, SPORTS MED, V48, P1809, DOI 10.1007/s40279-018-0936-y
   Grist TM, 2022, RADIOLOGY, V304, P289, DOI 10.1148/radiol.221183
   Grosser JA, 2021, BMC RES NOTES, V14, DOI 10.1186/s13104-021-05613-9
   Grünewald A, 2019, PROG NEUROBIOL, V177, P73, DOI 10.1016/j.pneurobio.2018.09.003
   Gu X, 2021, STAR PROTOC, V2, DOI 10.1016/j.xpro.2020.100245
   Gu XG, 2017, BIOMATERIALS, V146, P115, DOI 10.1016/j.biomaterials.2017.09.004
   Guntur AR, 2018, J BONE MINER RES, V33, P1052, DOI 10.1002/jbmr.3390
   Guo QL, 2021, EMERG MICROBES INFEC, V10, P19, DOI 10.1080/22221751.2020.1861913
   Guo RL, 2021, BIOMED OPT EXPRESS, V12, P1869, DOI 10.1364/BOE.419598
   Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050
   Haider SZ, 2021, EXP EYE RES, V202, DOI 10.1016/j.exer.2020.108318
   Hamel Y, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100370
   Hamilton K, 2021, J CYST FIBROS, V20, P664, DOI 10.1016/j.jcf.2020.10.006
   Hammler D, 2018, CHEM-EUR J, V24, P15329, DOI 10.1002/chem.201803234
   Hammond K, 2021, BBA-BIOMEMBRANES, V1863, DOI 10.1016/j.bbamem.2020.183447
   Hampl V, 2019, TRENDS MICROBIOL, V27, P96, DOI 10.1016/j.tim.2018.10.005
   Han Y, 2020, DRUG DELIV, V27, P502, DOI 10.1080/10717544.2020.1745328
   Hassani M, 2020, J LEUKOCYTE BIOL, V107, P809, DOI 10.1002/JLB.5HR0120-459R
   He AQ, 2020, PLAST RECONSTR SURG, V145, P712, DOI 10.1097/PRS.0000000000006607
   He CY, 2019, NANOMED-NANOTECHNOL, V15, P59, DOI 10.1016/j.nano.2018.09.003
   He GP, 2020, ACS APPL MATER INTER, V12, P48296, DOI 10.1021/acsami.0c12139
   He L, 2021, J HAZARD MATER, V417, DOI 10.1016/j.jhazmat.2021.126113
   He Y, 2022, BIOMED RES INT, V2022, DOI 10.1155/2022/6180349
   He Y, 2021, J BIOMED NANOTECHNOL, V17, P1679, DOI 10.1166/jbn.2021.3141
   He Y, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/9915699
   Heath GR, 2021, NATURE, V594, P385, DOI 10.1038/s41586-021-03551-x
   Heighton JN, 2019, MITOCHONDRION, V49, P227, DOI 10.1016/j.mito.2019.09.002
   Hernansanz-Agustín P, 2020, NATURE, V586, P287, DOI 10.1038/s41586-020-2551-y
   Heyman E, 2020, DIABETES CARE, V43, P209, DOI 10.2337/dc19-1125
   Hinoshita M, 2021, J APPL TOXICOL, V41, P247, DOI 10.1002/jat.4040
   Hirano M, 2021, J INHERIT METAB DIS, V44, P376, DOI 10.1002/jimd.12300
   Hong HTK, 2019, PROTEIN EXPRES PURIF, V155, P86, DOI 10.1016/j.pep.2018.11.010
   Hood DA, 2019, ANNU REV PHYSIOL, V81, P19, DOI 10.1146/annurev-physiol-020518-114310
   Hu P, 2017, MOL CELL, V68, P1006, DOI 10.1016/j.molcel.2017.11.017
   Huang LZ, 2021, LIGHT-SCI APPL, V10, DOI 10.1038/s41377-021-00506-9
   Hubbard WB, 2019, J NEUROTRAUM, V36, P1252, DOI 10.1089/neu.2018.5990
   Ignatenko O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-01859-9
   Inoue T, 2021, J HEPATOL, V75, P302, DOI 10.1016/j.jhep.2021.02.017
   Ishida A, 2008, ANAL BIOANAL CHEM, V392, P987, DOI 10.1007/s00216-008-2334-z
   Isshiki M, 2013, CELL CALCIUM, V54, P395, DOI 10.1016/j.ceca.2013.09.002
   Jackson CB, 2020, TRENDS MOL MED, V26, P698, DOI 10.1016/j.molmed.2020.02.006
   Jelenik T, 2013, ANTIOXID REDOX SIGN, V19, P258, DOI 10.1089/ars.2012.4910
   Jerri HA, 2010, LANGMUIR, V26, P4725, DOI 10.1021/la903616p
   Jian CS, 2017, J CELL SCI, V130, P2620, DOI 10.1242/jcs.198523
   Jiang H, 2019, SMALL, V15, DOI 10.1002/smll.201901787
   Jiang Q, 2021, THERANOSTICS, V11, P1814, DOI 10.7150/thno.51550
   Jiang SQ, 2021, MAR DRUGS, V19, DOI 10.3390/md19110599
   Jiang SG, 2011, PLANTA MED, V77, P1005, DOI 10.1055/s-0030-1270732
   Jiang XQ, 2018, ANTIOXID REDOX SIGN, V29, P518, DOI 10.1089/ars.2017.7491
   Jiang YY, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01167
   Jiang ZX, 2022, REPROD SCI, V29, P711, DOI 10.1007/s43032-021-00523-4
   Jing XM, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1089-9
   Johnson ME, 2016, ANAL BIOANAL CHEM, V408, P7629, DOI 10.1007/s00216-016-9844-x
   Pérez MJ, 2018, REDOX BIOL, V19, P290, DOI 10.1016/j.redox.2018.09.001
   Jung HS, 2017, J AM CHEM SOC, V139, P9972, DOI 10.1021/jacs.7b04263
   Kalani K, 2018, DRUG DISCOV TODAY, V23, P1983, DOI 10.1016/j.drudis.2018.08.001
   Kalyanaraman B, 2018, REDOX BIOL, V14, P316, DOI 10.1016/j.redox.2017.09.020
   Kambe Y, 2021, ACTA BIOMATER, V130, P199, DOI 10.1016/j.actbio.2021.05.030
   Kaplan P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207698
   Karshovska E, 2020, ARTERIOSCL THROM VAS, V40, P583, DOI 10.1161/ATVBAHA.119.313290
   Kasahara T, 2018, BIOL PSYCHIAT, V83, P731, DOI 10.1016/j.biopsych.2017.09.010
   Kazak L, 2017, P NATL ACAD SCI USA, V114, P7981, DOI 10.1073/pnas.1705406114
   Ke HJ, 2018, J BIOL CHEM, V293, P8128, DOI [10.1074/jbc.RA118.002552, 10.1074/jbc.ra118.002552]
   Kelly B, 2020, CELL METAB, V32, P154, DOI 10.1016/j.cmet.2020.06.010
   Kim HK, 2017, SEMIN CANCER BIOL, V47, P154, DOI 10.1016/j.semcancer.2017.06.006
   Kim HJ, 2017, SEMIN CANCER BIOL, V47, P67, DOI 10.1016/j.semcancer.2017.04.004
   Kirk NM, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.621732
   Kleih M, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2081-4
   Klier PEZ, 2021, J AM CHEM SOC, V143, P4095, DOI 10.1021/jacs.0c13110
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Kobayashi A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186683
   Koch RE, 2017, BIOL REV, V92, P1459, DOI 10.1111/brv.12291
   Kolossov VL, 2018, MICROSC RES TECHNIQ, V81, P115, DOI 10.1002/jemt.22968
   Kowaltowski AJ, 2019, FASEB J, V33, P13176, DOI 10.1096/fj.201901136R
   Kozlov AV, 2017, REDOX BIOL, V13, P170, DOI 10.1016/j.redox.2017.05.017
   Kripps KA, 2020, MOL GENET METAB, V130, P58, DOI 10.1016/j.ymgme.2020.03.001
   Kurhaluk N, 2019, CAN J PHYSIOL PHARM, V97, P392, DOI 10.1139/cjpp-2018-0642
   Kuwahara Y, 2016, INT J RADIAT ONCOL, V96, P556, DOI 10.1016/j.ijrobp.2016.07.002
   Labarta E, 2019, FERTIL STERIL, V111, P219, DOI 10.1016/j.fertnstert.2018.10.036
   Lamers MM, 2021, EMBO J, V40, DOI 10.15252/embj.2020105912
   Lan HY, 2021, J ETHNOPHARMACOL, V274, DOI 10.1016/j.jep.2021.114073
   Langton AK, 2021, J EUR ACAD DERMATOL, V35, P762, DOI 10.1111/jdv.17063
   Larsson NG, 2020, J INTERN MED, V287, P589, DOI 10.1111/joim.13088
   Laskaratou D, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22816-7
   Lazo S, 2021, AGING CELL, V20, DOI 10.1111/acel.13283
   Le Gal K, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10020163
   Leduc-Gaudet JP, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22158179
   Lee D, 2020, MOLECULES, V25, DOI 10.3390/molecules25071708
   Lee H, 2020, ACS SENSORS, V5, P655, DOI 10.1021/acssensors.9b01456
   Lee JH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194924
   Lee JH, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101511
   Lee JY, 2019, PESTIC BIOCHEM PHYS, V159, P144, DOI 10.1016/j.pestbp.2019.06.009
   Lee P, 2020, NAT REV MOL CELL BIO, V21, P268, DOI 10.1038/s41580-020-0227-y
   Léger JL, 2021, METHODS MOL BIOL, V2276, P57, DOI 10.1007/978-1-0716-1266-8_4
   Léger JL, 2020, PLATELETS, V31, P258, DOI 10.1080/09537104.2019.1609666
   Letts JA, 2017, NAT STRUCT MOL BIOL, V24, P800, DOI 10.1038/nsmb.3460
   Li CN, 2020, ACS APPL MATER INTER, V12, P30077, DOI 10.1021/acsami.0c06144
   Li C, 2021, PHARMACOL RES, V174, DOI 10.1016/j.phrs.2021.105933
   Li DY, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0638-6
   Li HZ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060608
   Li KL, 2019, J ORG CHEM, V84, P12626, DOI 10.1021/acs.joc.9b01270
   Li L, 2021, NAT METAB, V3, P1242, DOI 10.1038/s42255-021-00443-2
   Li S, 2021, BASIC RES CARDIOL, V116, DOI 10.1007/s00395-021-00905-4
   Li WQ, 2017, ACS APPL MATER INTER, V9, P16794, DOI 10.1021/acsami.7b01540
   Liang SZ, 2022, IEEE T ULTRASON FERR, V69, P98, DOI 10.1109/TUFFC.2021.3108163
   Liao PC, 2020, METHOD CELL BIOL, V155, P3, DOI 10.1016/bs.mcb.2019.10.002
   Lin KH, 2019, CELL METAB, V29, P1217, DOI 10.1016/j.cmet.2019.01.011
   Lin YX, 2020, ACS NANO, V14, P11846, DOI 10.1021/acsnano.0c04727
   Lin YT, 2019, LAB CHIP, V19, P3862, DOI 10.1039/c9lc00633h
   Liu C, 2020, ANGEW CHEM INT EDIT, V59, P2634, DOI 10.1002/anie.201911508
   Liu KM, 2021, CNS NEUROSCI THER, V27, P733, DOI 10.1111/cns.13618
   Liu L, 2022, BIOSENS BIOELECTRON, V212, DOI 10.1016/j.bios.2022.114389
   Liu LY, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01042
   Liu XT, 2021, SPECTROCHIM ACTA A, V250, DOI 10.1016/j.saa.2020.119363
   Liu Y, 2021, MOL THER-NUCL ACIDS, V23, P657, DOI 10.1016/j.omtn.2020.12.017
   Lleonart ME, 2017, MED RES REV, V37, P1275, DOI 10.1002/med.21459
   Lobo-Jarne T, 2020, EMBO J, V39, DOI 10.15252/embj.2019103912
   Lobo-Jarne T, 2018, SEMIN CELL DEV BIOL, V76, P179, DOI 10.1016/j.semcdb.2017.07.021
   Long QQ, 2019, METHODS MOL BIOL, V1966, P237, DOI 10.1007/978-1-4939-9195-2_19
   Lu MR, 2020, ANGEW CHEM INT EDIT, V59, P8698, DOI 10.1002/anie.202002576
   Luo XJ, 2021, ANGEW CHEM INT EDIT, V60, P1403, DOI 10.1002/anie.202012237
   Luo ZL, 2021, FOOD FUNCT, V12, P5658, DOI [10.1039/d1fo01154e, 10.1039/D1FO01154E]
   Ma ZJ, 2018, EUR J PHARMACOL, V821, P1, DOI 10.1016/j.ejphar.2017.12.027
   Macdonald R, 2018, BIOCHEM SOC T, V46, P891, DOI 10.1042/BST20170501
   Maclean AE, 2018, CURR BIOL, V28, P1614, DOI 10.1016/j.cub.2018.03.036
   Madreiter-Sokolowski CT, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101678
   Maksimovic JD, 2021, PHYSIOL PLANTARUM, V173, P818, DOI 10.1111/ppl.13476
   Manczak M, 2019, HUM MOL GENET, V28, P177, DOI 10.1093/hmg/ddy335
   Marchi S, 2018, CELL CALCIUM, V69, P62, DOI 10.1016/j.ceca.2017.05.003
   Marcondes NA, 2019, CYTOM PART A, V95A, P214, DOI 10.1002/cyto.a.23567
   Maremanda KP, 2021, REDOX BIOL, V45, DOI 10.1016/j.redox.2021.102055
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   Sabogal-Guáqueta AM, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109295
   Markevich NI, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101630
   Martínez-Reyes I, 2020, NATURE, V585, P288, DOI 10.1038/s41586-020-2475-6
   Martínez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3
   Martins WK, 2019, AUTOPHAGY, V15, P259, DOI 10.1080/15548627.2018.1515609
   Mata-Martínez E, 2021, ANDROLOGY-US, V9, P1227, DOI 10.1111/andr.12989
   Matsui H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23452-x
   Matsumoto K, 2021, FREE RADICAL RES, V55, P450, DOI 10.1080/10715762.2021.1899171
   Mazat JP, 2020, CELL MOL LIFE SCI, V77, P455, DOI 10.1007/s00018-019-03381-1
   McAlpin BR, 2022, THERANOSTICS, V12, P603, DOI 10.7150/thno.67410
   Medeiros TC, 2019, AUTOPHAGY, V15, P178, DOI 10.1080/15548627.2018.1532263
   Mejia-Vergara AJ, 2020, CURR NEUROL NEUROSCI, V20, DOI 10.1007/s11910-020-01032-8
   Mendoza C, 2021, ENVIRON SCI POLLUT R, V28, P25124, DOI 10.1007/s11356-019-04763-5
   Messal HA, 2021, NAT PROTOC, V16, P239, DOI 10.1038/s41596-020-00414-z
   MIDELFORT CF, 1976, J BIOL CHEM, V251, P5881
   Mirali S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz8264
   Mita M, 2022, CELL CHEM BIOL, V29, P98, DOI 10.1016/j.chembiol.2021.06.002
   Miyashita L, 2021, ENVIRON SCI POLLUT R, V28, P30384, DOI 10.1007/s11356-021-14025-y
   Mohammadinejad R, 2019, AUTOPHAGY, V15, P4, DOI 10.1080/15548627.2018.1509171
   Mohanraj K, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809561
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Mollazadeh H, 2021, J CACHEXIA SARCOPENI, V12, P237, DOI 10.1002/jcsm.12654
   Morimoto N, 2020, J ASSIST REPROD GEN, V37, P1815, DOI 10.1007/s10815-020-01869-5
   Moriyama M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12632-5
   Müller DJ, 2021, CHEM REV, V121, P11701, DOI 10.1021/acs.chemrev.0c00617
   Müller ME, 2019, ENVIRON TOXICOL CHEM, V38, P1000, DOI 10.1002/etc.4396
   Mukherjee R, 2016, GUT, V65, P1333, DOI 10.1136/gutjnl-2014-308553
   Mulhern JG, 2022, SEMIN NUCL MED, V52, P453, DOI 10.1053/j.semnuclmed.2021.12.005
   Murata O, 2020, ANAL CHEM, V92, P966, DOI 10.1021/acs.analchem.9b03872
   Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87
   Nagao T, 2020, FASEB J, V34, P1859, DOI 10.1096/fj.201800389R
   Nakamura T, 2021, EMBO REP, V22, DOI 10.15252/embr.202051532
   Nam HY, 2018, BIOCONJUGATE CHEM, V29, P1669, DOI 10.1021/acs.bioconjchem.8b00148
   Naryzhnaya NV, 2019, DRUG DEVELOP RES, V80, P1013, DOI 10.1002/ddr.21593
   Nash GT, 2021, J AM CHEM SOC, V143, P2194, DOI 10.1021/jacs.0c12330
   Ndi M, 2018, J MOL BIOL, V430, P3892, DOI 10.1016/j.jmb.2018.04.036
   Nesci S, 2020, CRIT REV BIOCHEM MOL, V55, P309, DOI 10.1080/10409238.2020.1784084
   Nesci S, 2018, BIOCHIMIE, V152, P85, DOI 10.1016/j.biochi.2018.06.022
   Newman NJ, 2021, OPHTHALMOLOGY, V128, P649, DOI 10.1016/j.ophtha.2020.12.012
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Nguyen MTB, 2019, NEUROLOGY, V92, pE519, DOI 10.1212/WNL.0000000000006861
   Ni KY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06655-7
   Nie S, 2020, IUBMB LIFE, V72, P1879, DOI 10.1002/iub.2339
   Nishida M, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2021-002954
   Nishida Y, 2020, J CACHEXIA SARCOPENI, V11, P241, DOI 10.1002/jcsm.12530
   Nissanka N, 2020, EMBO REP, V21, DOI 10.15252/embr.201949612
   Okazaki Y, 2021, ARCH BIOCHEM BIOPHYS, V700, DOI 10.1016/j.abb.2021.108762
   Olgar Y, 2020, EXP GERONTOL, V136, DOI 10.1016/j.exger.2020.110961
   Ooi K, 2021, MOL NEUROBIOL, V58, P6625, DOI 10.1007/s12035-021-02488-6
   Ortega-Villasante C, 2018, FREE RADICAL BIO MED, V122, P202, DOI 10.1016/j.freeradbiomed.2018.04.005
   Ortega-Villasante C, 2016, METHODS, V109, P92, DOI 10.1016/j.ymeth.2016.07.009
   Panel M, 2019, GASTROENTEROLOGY, V157, P1368, DOI 10.1053/j.gastro.2019.07.026
   Parés M, 2021, HUM GENE THER, V32, P1210, DOI 10.1089/hum.2021.152
   Porporato PE, 2018, CELL RES, V28, P265, DOI 10.1038/cr.2017.155
   Potter M, 2016, BIOCHEM SOC T, V44, P1499, DOI 10.1042/BST20160094
   Poznanski RR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183677
   Prasad A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22189963
   Priesnitz C, 2018, GENE DEV, V32, P1285, DOI 10.1101/gad.316547.118
   Qattan AT, 2010, J PROTEOME RES, V9, P495, DOI 10.1021/pr9008332
   Qi T, 2019, BIOMATERIALS, V213, DOI 10.1016/j.biomaterials.2019.05.030
   Rabinovich-Nikitin I, 2021, AUTOPHAGY, V17, P3794, DOI 10.1080/15548627.2021.1938913
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Rahman MH., 2021, MOL BIOL+, V343, P355, DOI [10.1007/978-1-0716-1266-8_26, DOI 10.1007/978-1-0716-1266-8_26]
   Ramachandra CJA, 2020, EBIOMEDICINE, V57, DOI 10.1016/j.ebiom.2020.102884
   Rambold AS, 2018, TRENDS IMMUNOL, V39, P6, DOI 10.1016/j.it.2017.08.006
   Ramezani Maral, 2021, Asian Pac J Cancer Prev, V22, P2295, DOI 10.31557/APJCP.2021.22.7.2295
   Rao M, 2018, CURR OPIN NEPHROL HY, V27, P113, DOI 10.1097/MNH.0000000000000393
   Raut S, 2021, FLUIDS BARRIERS CNS, V18, DOI 10.1186/s12987-020-00235-y
   Rawat PS, 2021, BIOMED PHARMACOTHER, V139, DOI 10.1016/j.biopha.2021.111708
   Rebelo AP, 2021, BRAIN, V144, P1467, DOI 10.1093/brain/awab071
   Restall BS, 2021, J BIOMED OPT, V26, DOI 10.1117/1.JBO.26.9.096501
   Rhie A, 2021, NATURE, V592, P737, DOI 10.1038/s41586-021-03451-0
   Rocha EM, 2018, NEUROBIOL DIS, V109, P249, DOI 10.1016/j.nbd.2017.04.004
   Rodriguez-Gallardo S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0258111
   Roger AJ, 2017, CURR BIOL, V27, pR1177, DOI 10.1016/j.cub.2017.09.015
   Rossmann MP, 2021, SCIENCE, V372, P716, DOI 10.1126/science.aaz2740
   Rossow HA, 2018, JOVE-J VIS EXP, DOI 10.3791/58387
   Roth KG, 2020, TRENDS MOL MED, V26, P119, DOI 10.1016/j.molmed.2019.06.009
   Rottenberg H, 2017, AGING CELL, V16, P943, DOI 10.1111/acel.12650
   Rovini A, 2021, FASEB J, V35, DOI 10.1096/fj.202001693R
   Rovira-Llopis S, 2017, REDOX BIOL, V11, P637, DOI 10.1016/j.redox.2017.01.013
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Ruzzenente B, 2021, METHODS MOL BIOL, V2224, P47, DOI 10.1007/978-1-0716-1008-4_3
   Saeb-Parsy K, 2021, TRENDS MOL MED, V27, P185, DOI 10.1016/j.molmed.2020.08.001
   Sakthivel R, 2018, BIOMED PHARMACOTHER, V105, P742, DOI 10.1016/j.biopha.2018.06.035
   Samuvel DJ, 2022, AUTOPHAGY, V18, P2671, DOI 10.1080/15548627.2022.2046457
   Saraf KK, 2017, ANIM REPROD SCI, V180, P30, DOI 10.1016/j.anireprosci.2017.02.010
   Schönfeld P, 2016, J LIPID RES, V57, P943, DOI 10.1194/jlr.R067629
   Semerikov VL, 2022, PLANTS-BASEL, V11, DOI 10.3390/plants11060762
   Senkler J, 2018, CURR BIOL, V28, P1606, DOI 10.1016/j.cub.2018.03.050
   Shah SS, 2019, J AM SOC NEPHROL, V30, P2355, DOI 10.1681/ASN.2019020114
   Shetty T, 2021, STAR PROTOC, V2, DOI 10.1016/j.xpro.2021.100533
   Shi W, 2020, INT IMMUNOPHARMACOL, V85, DOI 10.1016/j.intimp.2020.106632
   Shoshan-Barmatz V, 2018, PHARMACOL RES, V131, P87, DOI 10.1016/j.phrs.2018.03.010
   Sidlauskaite E, 2018, REDOX BIOL, V16, P344, DOI 10.1016/j.redox.2018.03.012
   Signes A, 2018, ESSAYS BIOCHEM, V62, P255, DOI 10.1042/EBC20170098
   Smith GM, 2018, DEV NEUROBIOL, V78, P221, DOI 10.1002/dneu.22546
   Soukas AA, 2019, TRENDS ENDOCRIN MET, V30, P745, DOI 10.1016/j.tem.2019.07.015
   Spinelli JB, 2021, SCIENCE, V374, P1227, DOI 10.1126/science.abi7495
   Stenton SL, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI138267
   Strobbe D, 2018, TRENDS PHARMACOL SCI, V39, P437, DOI 10.1016/j.tips.2018.02.008
   Sugiura A, 2013, MOL CELL, V51, P20, DOI 10.1016/j.molcel.2013.04.023
   Sun C, 2019, THERANOSTICS, V9, P3595, DOI 10.7150/thno.33100
   Sun J, 2019, J AM SOC NEPHROL, V30, P1151, DOI 10.1681/ASN.2018111126
   Sun JY, 2021, TRANSL STROKE RES, V12, P1067, DOI 10.1007/s12975-021-00906-4
   Sun Min, 2021, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V33, P1418, DOI 10.3760/cma.j.cn121430-20210719-01063
   Suo L, 2022, THERANOSTICS, V12, P277, DOI 10.7150/thno.63441
   Szymanski J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071576
   Tabish TA, 2021, ACTA BIOMATER, V129, P43, DOI 10.1016/j.actbio.2021.04.054
   Tan DX, 2013, J PINEAL RES, V54, P127, DOI 10.1111/jpi.12026
   Tan KY, 2017, ANAL CHEM, V89, P1749, DOI 10.1021/acs.analchem.6b04020
   Tao L, 2020, NEUROL RES, V42, P597, DOI 10.1080/01616412.2020.1773610
   Tay E, 2022, J FUNGI, V8, DOI 10.3390/jof8050462
   Thiele JC, 2020, ACS NANO, V14, P14190, DOI 10.1021/acsnano.0c07322
   Thomas LW, 2019, CELL MOL LIFE SCI, V76, P1759, DOI 10.1007/s00018-019-03039-y
   Tian J, 2021, ACTA BIOMATER, V130, P447, DOI 10.1016/j.actbio.2021.05.048
   Tian T, 2019, J CELL BIOCHEM, V120, P3621, DOI 10.1002/jcb.27639
   Timón-Gómez A, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107607
   Tóth EA, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12140
   Tricaud N, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10061447
   Tsai YL, 2020, GENE DEV, V34, P785, DOI 10.1101/gad.335836.119
   Tuncer S, 2021, N-S ARCH PHARMACOL, V394, P545, DOI 10.1007/s00210-020-02039-1
   Ucar H, 2021, NATURE, V600, P686, DOI 10.1038/s41586-021-04125-7
   Urbani A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12331-1
   Usaj M, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01574-0
   Valenti D, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22158312
   van der Reest J, 2021, AGEING RES REV, V70, DOI 10.1016/j.arr.2021.101378
   Vankayala R, 2018, ADV MATER, V30, DOI 10.1002/adma.201706320
   Vasta JD, 2018, CELL CHEM BIOL, V25, P206, DOI 10.1016/j.chembiol.2017.10.010
   Veerman RE, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12128
   Vercellino I, 2022, NAT REV MOL CELL BIO, V23, P141, DOI 10.1038/s41580-021-00415-0
   Vincent AE, 2017, TRENDS CELL BIOL, V27, P797, DOI 10.1016/j.tcb.2017.08.009
   Vogt N, 2021, NAT METHODS, V18, P859, DOI 10.1038/s41592-021-01246-9
   Vrijsen S, 2020, P NATL ACAD SCI USA, V117, P31198, DOI 10.1073/pnas.1922342117
   Wacquier B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60177-1
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wang CX, 2017, ANAL CHEM, V89, P11514, DOI 10.1021/acs.analchem.7b02781
   Wang H, 2021, J NANOBIOTECHNOL, V19, DOI 10.1186/s12951-021-00895-4
   Wang HW, 2020, CHEMOSPHERE, V238, DOI 10.1016/j.chemosphere.2019.124607
   Wang J, 2016, J HEPATOL, V65, P700, DOI 10.1016/j.jhep.2016.05.029
   Wang J, 2022, MOL GENET METAB, V135, P93, DOI 10.1016/j.ymgme.2021.12.006
   Wang L, 2021, EUR J NEUROL, V28, P2871, DOI 10.1111/ene.14995
   Wang M, 2020, MOL PLANT PATHOL, V21, P1529, DOI 10.1111/mpp.12993
   Wang QC, 2021, J OVARIAN RES, V14, DOI 10.1186/s13048-021-00817-w
   Wang SH, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03821-6
   Wang S, 2021, ACTA BIOMATER, V130, P138, DOI 10.1016/j.actbio.2021.05.027
   Wang XQ, 2018, NANO LETT, V18, P6804, DOI 10.1021/acs.nanolett.8b02670
   Wang Y, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.652782
   Wanrooij PH, 2020, P NATL ACAD SCI USA, V117, P14306, DOI 10.1073/pnas.1916851117
   Wei W, 2020, J INTERN MED, V287, P634, DOI 10.1111/joim.13047
   Weiland D, 2018, J INVEST DERMATOL, V138, P132, DOI 10.1016/j.jid.2017.08.019
   Weinberg SE, 2019, NATURE, V565, P495, DOI 10.1038/s41586-018-0846-z
   West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21
   Wiemerslage L, 2016, J NEUROSCI METH, V262, P56, DOI 10.1016/j.jneumeth.2016.01.008
   Wiessner M, 2021, BRAIN, V144, P1422, DOI 10.1093/brain/awab041
   Winquist RJ, 2020, BIOCHEM PHARMACOL, V177, DOI 10.1016/j.bcp.2020.113995
   Wong HH, 2021, AM J HUM GENET, V108, P1301, DOI 10.1016/j.ajhg.2021.05.003
   Wu HC, 2021, CANCER DISCOV, V11, P3198, DOI 10.1158/2159-8290.CD-21-0177
   Wu M, 2020, PROTEIN CELL, V11, P318, DOI 10.1007/s13238-019-00681-x
   Wu SN, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21144987
   Wu TS, 2020, PART FIBRE TOXICOL, V17, DOI 10.1186/s12989-020-00363-1
   Wu YC, 2021, NATURE, V600, P279, DOI 10.1038/s41586-021-04110-0
   Wu Y, 2019, CHINESE MED J-PEKING, V132, P1202, DOI 10.1097/CM9.0000000000000262
   Xie LL, 2018, CANCER SCI, V109, P3686, DOI 10.1111/cas.13830
   Xiong B, 2011, J CHROMATOGR A, V1218, P3823, DOI 10.1016/j.chroma.2011.04.038
   Yamada S, 2020, PLANT CELL PHYSIOL, V61, P283, DOI 10.1093/pcp/pcz193
   Yamaguchi M, 2021, LANGMUIR, V37, P9883, DOI 10.1021/acs.langmuir.1c01578
   Yamashita K, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00374-19
   Yang GL, 2019, ACS APPL MATER INTER, V11, P44961, DOI 10.1021/acsami.9b15996
   Yang JQ, 2021, DRUG DES DEV THER, V15, P233, DOI 10.2147/DDDT.S278975
   Yang J, 2018, REDOX BIOL, V19, P158, DOI 10.1016/j.redox.2018.08.016
   Yang ZY, 2022, CURR PROTOC, V2, DOI 10.1002/cpz1.412
   Yazdankhah M, 2021, AUTOPHAGY, V17, P3140, DOI 10.1080/15548627.2020.1871204
   Ying ZF, 2018, CELL METAB, V28, P935, DOI 10.1016/j.cmet.2018.08.001
   Yoon S, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20174998
   Yordanov S, 2021, BIOMED OPT EXPRESS, V12, P3372, DOI 10.1364/BOE.420788
   Young VC, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2019317118
   Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020
   Yu-Wai-Man P, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz7423
   Yuan P, 2021, ADV HEALTHC MATER, V10, DOI 10.1002/adhm.202100198
   Zeng WN, 2021, J NANOBIOTECHNOL, V19, DOI 10.1186/s12951-021-00831-6
   Zhan Y, 2021, ANGEW CHEM INT EDIT, V60, P2637, DOI 10.1002/anie.202011903
   Zhang CX, 2019, J NANOBIOTECHNOL, V17, DOI 10.1186/s12951-019-0451-9
   Zhang DG, 2021, FOOD CHEM, V360, DOI 10.1016/j.foodchem.2021.129814
   Zhang GW, 2019, HUM REPROD, V34, P3, DOI 10.1093/humrep/dey335
   Zhang KX, 2018, J AM CHEM SOC, V140, P11293, DOI 10.1021/jacs.8b05309
   Zhang LX, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101284
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhang S, 2019, CELL METAB, V29, P443, DOI 10.1016/j.cmet.2018.12.004
   Zhang Y, 2021, J AM CHEM SOC, V143, P11490, DOI 10.1021/jacs.1c03642
   Zhao HX, 2019, NAT CELL BIOL, V21, P476, DOI 10.1038/s41556-019-0296-3
   Zhao M, 2021, ACS NANO, V15, P1519, DOI 10.1021/acsnano.0c08947
   Zhao YY, 2021, IEEE T PATTERN ANAL, V43, P2206, DOI 10.1109/TPAMI.2021.3075366
   Zheng X, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2020.1750202
   Zhong XY, 2022, J CLIN LAB ANAL, V36, DOI 10.1002/jcla.24558
   Zhou B, 2019, CELL, V177, P299, DOI 10.1016/j.cell.2019.02.013
   Zhou GL, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.719451
   Zhou YS, 2020, AUTOPHAGY, V16, P562, DOI 10.1080/15548627.2019.1634944
   Zhu JM, 2019, THERANOSTICS, V9, P6901, DOI 10.7150/thno.37357
   Zhu SC, 2020, PFLUG ARCH EUR J PHY, V472, P367, DOI 10.1007/s00424-020-02355-8
   Zhu XJ, 2020, ANAL CHEM, V92, P10815, DOI 10.1021/acs.analchem.0c02298
   Zhu YX, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/1295509
NR 478
TC 16
Z9 16
U1 5
U2 54
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD OCT
PY 2022
VL 50
IS 4
AR 126
DI 10.3892/ijmm.2022.5182
PG 29
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 6E0FZ
UT WOS:000883061400001
PM 36004457
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Torraco, A
   Diaz, F
   Vempati, UD
   Moraes, CT
AF Torraco, Alessandra
   Diaz, Francisca
   Vempati, Uma D.
   Moraes, Carlos T.
TI Mouse models of oxidative phosphorylation defects: Powerful tools to
   study the pathobiology of mitochondrial diseases
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
LA English
DT Review
DE Mitochondria; Mitochondrial disease; Knockout mouse; Knock-in mouse;
   Conditional knockout mouse
ID CYTOCHROME-C-OXIDASE; TRANSCRIPTION-FACTOR-A; DNA-POLYMERASE-GAMMA;
   ADENINE-NUCLEOTIDE TRANSLOCATOR; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   EMBRYONIC STEM-CELLS; MTDNA COPY NUMBER; DIABETES-MELLITUS;
   ALZHEIMERS-DISEASE; TERMINATION FACTOR
AB Defects in the oxidative phosphorylation system (OXPHOS) are responsible for a group of extremely heterogeneous and pleiotropic pathologies commonly known as mitochondrial diseases. Although many mutations have been found to be responsible for OXPHOS defects, their pathogenetic mechanisms are still poorly understood. An important contribution to investigate the in vivo function of several mitochondrial proteins and their role in mitochondrial dysfunction, has been provided by mouse models. Thanks to their genetic and physiologic similarity to humans, mouse models represent a powerful tool to investigate the impact of pathological mutations on metabolic pathways. In this review we discuss the main mouse models of mitochondrial disease developed, focusing on the ones that directly affect the OXPHOS system. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Torraco, Alessandra; Diaz, Francisca; Vempati, Uma D.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA.
C3 University of Miami; University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, 1095 NW 14th Terrace, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
RI Moraes, Carlos/AAT-3818-2021; Torraco, Alessandra/AAA-6212-2020
OI Torraco, Alessandra/0000-0002-8148-9295
FU Public Health Service [NS041777, CA85700, EY10804]; Muscular Dystrophy
   Association
FX Our work is supported by Public Health Service grants NS041777, CA85700,
   and EY10804 and by the Muscular Dystrophy Association.
CR AGNATI LF, 1995, PROG NEUROBIOL, V46, P561, DOI 10.1016/0301-0082(95)00017-P
   Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049
   Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bensch KG, 2007, DIABETES OBES METAB, V9, P74, DOI 10.1111/j.1463-1326.2007.00776.x
   Blesa JR, 2007, NEUROMOL MED, V9, P285, DOI 10.1007/s12017-007-8000-3
   Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F
   Cardaioli E, 1999, J SUBMICR CYTOL PATH, V31, P301
   Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200
   CARRY MR, 1986, ANAT RECORD, V214, P8, DOI 10.1002/ar.1092140103
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   Coenen MJH, 2004, ANN NEUROL, V56, P560, DOI 10.1002/ana.20229
   Coulbault L, 2007, BIOCHEM BIOPH RES CO, V362, P601, DOI 10.1016/j.bbrc.2007.08.040
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   DAGA A, 1993, J BIOL CHEM, V268, P8123
   Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Diaz F, 2008, GUT, V57, P232, DOI 10.1136/gut.2006.119180
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   DiMauro S, 2007, BIOSCIENCE REP, V27, P5, DOI 10.1007/s10540-007-9032-5
   Dobie KW, 1996, P NATL ACAD SCI USA, V93, P6659, DOI 10.1073/pnas.93.13.6659
   DONOVAN DM, 1995, MOL BRAIN RES, V30, P327, DOI 10.1016/0169-328X(95)00018-N
   DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006
   Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008
   Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104
   Fukushima H, 2006, ARCH OTOLARYNGOL, V132, P934, DOI 10.1001/archotol.132.9.934
   Garstka HL, 2003, NUCLEIC ACIDS RES, V31, P5039, DOI 10.1093/nar/gkg717
   Golden TR, 2007, WORMBOOK, P1, DOI DOI 10.I895/W0RMB00K.I.127.2
   Goto A, 2001, BIOCHEM J, V354, P243, DOI 10.1042/0264-6021:3540243
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016
   Hardy J, 2006, J ALZHEIMERS DIS, V9, P151
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   Hsieh RH, 2001, J BIOMED SCI, V8, P328, DOI 10.1159/000054051
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Hunsberger JG, 2005, MOL BRAIN RES, V141, P95, DOI 10.1016/j.molbrainres.2005.08.005
   Hyvärinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676
   Inoue K, 2001, Tanpakushitsu Kakusan Koso, V46, P829
   Irwin R.W., 2008, Endocrinology
   Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3
   Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017
   Kariya S, 2007, OTOL NEUROTOL, V28, P1063, DOI 10.1097/MAO.0b013e31815a8433
   Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005
   Kasashima K, 2008, EXP CELL RES, V314, P988, DOI 10.1016/j.yexcr.2008.01.005
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KLINGENBERG M, 1992, BIOCHEM SOC T, V20, P547, DOI 10.1042/bst0200547
   Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LARSSON NG, 1992, AM J HUM GENET, V50, P360
   Laurent G, 2008, CELL METAB, V7, P113, DOI 10.1016/j.cmet.2007.12.010
   LeDoux SP, 2007, NEUROSCIENCE, V145, P1249, DOI 10.1016/j.neuroscience.2006.10.002
   Levy SE, 1999, TRANSGENIC RES, V8, P137, DOI 10.1023/A:1008967412955
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   Li JY, 2007, J FORMOS MED ASSOC, V106, P528, DOI 10.1016/S0929-6646(07)60003-5
   Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1
   Li M, 2007, PROG NEUROBIOL, V83, P131, DOI 10.1016/j.pneurobio.2007.08.002
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001
   Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921
   Marchington DR, 1999, NAT MED, V5, P957, DOI 10.1038/11403
   Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040
   Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027
   Matsushima Y, 2003, J BIOL CHEM, V278, P31149, DOI 10.1074/jbc.M303842200
   Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Miyakawa I, 1994, Tanpakushitsu Kakusan Koso, V39, P601
   Moslemi AR, 2007, MITOCHONDRION, V7, P241, DOI 10.1016/j.mito.2007.02.002
   Munnich A, 1996, EUR J PEDIATR, V155, P262
   Murakami T, 1997, GENOMICS, V42, P161, DOI 10.1006/geno.1997.4711
   Narisawa S, 2002, MOL CELL BIOL, V22, P5554, DOI 10.1128/MCB.22.15.5554-5562.2002
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   Nijtmans LGJ, 2001, FEBS LETT, V498, P46, DOI 10.1016/S0014-5793(01)02447-4
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0
   Pancrudo J, 2007, NEUROMUSCULAR DISORD, V17, P651, DOI 10.1016/j.nmd.2007.04.005
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   PARK KS, 2008, DIABETOLOGIA
   Parsons WJ, 1996, AM J PHYSIOL-HEART C, V270, pH567, DOI 10.1152/ajpheart.1996.270.2.H567
   PIATTO VB, 2007, NEUROBIOL AGING
   Pohjoismäki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703
   Pu JZ, 2008, P NATL ACAD SCI USA, V105, P1192, DOI 10.1073/pnas.0708746105
   Radford NB, 2002, AM J PHYSIOL-HEART C, V282, pH726, DOI 10.1152/ajpheart.00308.2001
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0
   Rorbach J, 2007, BIOCHEM SOC T, V35, P1290, DOI 10.1042/BST0351290
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schon EA, 2004, J CLIN INVEST, V114, P760, DOI 10.1172/JCI200422942
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Schultz RA, 1998, J BIOL CHEM, V273, P3447, DOI 10.1074/jbc.273.6.3447
   Schulz TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001013
   SHANG J, 1994, J BIOL CHEM, V269, P29112
   Shibata Noriyuki, 2008, Brain and Nerve (Tokyo), V60, P157
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   SOMEYA S, 2007, NEUROBIOL AGING
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   STEPIEN G, 1992, J BIOL CHEM, V267, P14592
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   STUBBS L, 1990, GENOMICS, V6, P645, DOI 10.1016/0888-7543(90)90499-K
   Sun JT, 2002, GENETICS, V161, P661
   TAANMAN JW, 1993, BIOCHIM BIOPHYS ACTA, V1225, P95, DOI 10.1016/0925-4439(93)90128-N
   Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9
   Tiranti V, 1999, ANN NEUROL, V46, P161, DOI 10.1002/1531-8249(199908)46:2<161::AID-ANA4>3.0.CO;2-O
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   Vempati UD, 2007, MOL CELL BIOL, V27, P1771, DOI 10.1128/MCB.00287-06
   Viña J, 2007, J ALZHEIMERS DIS, V11, P175
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   WATANABE T, 1978, P NATL ACAD SCI USA, V75, P5113, DOI 10.1073/pnas.75.10.5113
   Williams SL, 2001, LAB INVEST, V81, P1069, DOI 10.1038/labinvest.3780319
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469
   Yamasoba T, 2007, HEARING RES, V226, P185, DOI 10.1016/j.heares.2006.06.004
   Yin H, 2005, INVEST OPHTH VIS SCI, V46, P4555, DOI 10.1167/iovs.05-0695
   YOUNG P, 1994, BIOCHEM BIOPH RES CO, V203, P46, DOI 10.1006/bbrc.1994.2146
   Zeviani M, 2003, CURR OPIN GENET DEV, V13, P262, DOI 10.1016/S0959-437X(03)00052-2
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
   ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A
   Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2
NR 165
TC 28
Z9 31
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-4889
EI 0006-3002
J9 BBA-MOL CELL RES
JI Biochim. Biophys. Acta-Mol. Cell Res.
PD JAN
PY 2009
VL 1793
IS 1
BP 171
EP 180
DI 10.1016/j.bbamcr.2008.06.003
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 398NH
UT WOS:000262738300020
PM 18601959
OA Bronze, Green Accepted
DA 2024-11-01
ER

PT J
AU Lee, S
   Han, MJ
   Lee, KS
   Back, SC
   Hwang, D
   Kim, HY
   Shin, JH
   Suh, SP
   Ryang, DW
   Kim, HR
   Shin, MG
AF Lee, Soong
   Han, Moon-Jong
   Lee, Ki-Sang
   Back, Seung-Chul
   Hwang, David
   Kim, Hwan-Young
   Shin, Jong-Hee
   Suh, Soon-Pal
   Ryang, Dong-Wook
   Kim, Hye-Ran
   Shin, Myung-Geun
TI Frequent Occurrence of Mitochondrial DNA Mutations in Barrett's
   Metaplasia without the Presence of Dysplasia
SO PLOS ONE
LA English
DT Article
ID ESOPHAGEAL ADENOCARCINOMA; ATRIAL-FIBRILLATION; CANCER; PROGRESSION;
   TISSUE; MUSCLE
AB Background: Barrett's esophagus (BE) is one of the most common premalignant lesions and can progress to esophageal adenocarcinoma (EA). The numerous molecular events may play a role in the neoplastic transformation of Barrett's mucosa such as the change of DNA ploidy, p53 mutation and alteration of adhesion molecules. However, the molecular mechanism of the progression of BE to EA remains unclear and most studies of mitochondrial DNA (mtDNA) mutations in BE have performed on BE with the presence of dysplasia.
   Methods/Findings: Thus, the current study is to investigate new molecular events (Barrett's esophageal tissue-specific-mtDNA alterations/instabilities) in mitochondrial genome and causative factors for their alterations using the corresponding adjacent normal mucosal tissue (NT) and tissue (BT) from 34 patients having Barrett's metaplasia without the presence of dysplasia. Eighteen patients (53%) exhibited mtDNA mutations which were not found in adjacent NT. mtDNA copy number was about 3 times higher in BT than in adjacent NT. The activity of the mitochondrial respiratory chain enzyme complexes in tissues from Barrett's metaplasia without the presence of dysplasia was impaired. Reactive oxygen species (ROS) level in BT was significantly higher than those in corresponding samples.
   Conclusion/Significance: High ROS level in BT may contribute to the development of mtDNA mutations, which may play a crucial role in disease progression and tumorigenesis in BE.
C1 [Lee, Soong; Han, Moon-Jong; Lee, Ki-Sang; Back, Seung-Chul; Hwang, David] Seonam Univ, Coll Med, Dept Internal Med, Namwon, South Korea.
   [Kim, Hwan-Young; Shin, Jong-Hee; Suh, Soon-Pal; Ryang, Dong-Wook; Shin, Myung-Geun] Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea.
   [Kim, Hwan-Young; Shin, Jong-Hee; Suh, Soon-Pal; Ryang, Dong-Wook; Shin, Myung-Geun] Chonnam Natl Univ, Dept Lab Med, Hwasun, South Korea.
   [Kim, Hye-Ran] Chonnam Natl Univ, Ctr Biomed Human Resources, Brain Korea Project 21, Kwangju, South Korea.
   [Kim, Hye-Ran; Shin, Myung-Geun] Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea.
   [Kim, Hye-Ran; Shin, Myung-Geun] Chonnam Natl Univ, Sch Med, Environm Hlth Ctr Childhood Leukemia & Canc, Hwasun, South Korea.
C3 Seonam University; Chonnam National University; Chonnam National
   University; Chonnam National University; Chonnam National University;
   Chonnam National University
RP Lee, S (corresponding author), Seonam Univ, Coll Med, Dept Internal Med, Namwon, South Korea.
EM KimHR@chonnam.ac.kr; mgshin@chonnam.ac.kr
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF); Ministry of Education, Science and Technology
   [2010-0024326]
FX This work was supported by the Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education, Science and Technology (No. 2010-0024326). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Baumann S, 2006, INT J CANCER, V119, P264, DOI 10.1002/ijc.21848
   BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004
   Fléjou JF, 2005, GUT, V54, pI6, DOI 10.1136/gut.2004.041525
   HAGGITT RC, 1994, HUM PATHOL, V25, P982, DOI 10.1016/0046-8177(94)90057-4
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Jankowski JA, 2002, GASTROENTEROLOGY, V122, P588, DOI 10.1053/gast.2002.31599
   Lee JS, 2001, MUTAT RES-FUND MOL M, V480, P189, DOI 10.1016/S0027-5107(01)00199-3
   Lee S, 2007, CLIN CHEM, V53, P1390, DOI 10.1373/clinchem.2007.088047
   Lin PH, 2003, FREE RADICAL BIO MED, V35, P1310, DOI 10.1016/j.freeradbiomed.2003.07.002
   Nishikawa M, 2005, BRIT J CANCER, V93, P331, DOI 10.1038/sj.bjc.6602664
   Park HW, 2007, J CLIN PATHOL, V60, P948, DOI 10.1136/jcp.2007.047134
   Park SY, 2009, MITOCHONDRION, V9, P318, DOI 10.1016/j.mito.2009.04.006
   PERA M, 1993, ANN THORAC SURG, V56, P1191, DOI 10.1016/0003-4975(95)90050-0
   Sharma P, 2006, ENDOSCOPY, V38, P1206, DOI 10.1055/s-2006-944974
   Shin MG, 2007, LEUKEMIA, V21, P369, DOI 10.1038/sj.leu.2404502
   Shin MG, 2006, ELECTROPHORESIS, V27, P1331, DOI 10.1002/elps.200500551
   Shin MG, 2004, BLOOD, V103, P553, DOI 10.1182/blood-2003-05-1724
   Sommerer F, 2004, ONCOGENE, V23, P554, DOI 10.1038/sj.onc.1207189
   Sui GP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-73
   Tan BHL, 2009, EUR J CANCER, V45, P736, DOI 10.1016/j.ejca.2009.01.013
   Tischoff Iris, 2008, Expert Rev Gastroenterol Hepatol, V2, P653, DOI 10.1586/17474124.2.5.653
   Zagorowicz E, 2007, POSTGRAD MED J, V83, P529, DOI 10.1136/pgmj.2006.052910
NR 23
TC 12
Z9 12
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 22
PY 2012
VL 7
IS 5
AR e37571
DI 10.1371/journal.pone.0037571
PG 7
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 959VQ
UT WOS:000305345300053
PM 22629421
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Sparaco, M
   Feleppa, M
   Lipton, RB
   Rapoport, AM
   Bigal, ME
AF Sparaco, M
   Feleppa, M
   Lipton, RB
   Rapoport, AM
   Bigal, ME
TI Mitochondrial dysfunction and migraine: evidence and hypotheses
SO CEPHALALGIA
LA English
DT Review
DE brain oxidative metabolism; magnetic resonance spectroscopy; migraine;
   mitochondrial dysfunction; mutation
ID MAGNETIC-RESONANCE-SPECTROSCOPY; FAMILIAL HEMIPLEGIC MIGRAINE; BRAIN
   ENERGY-METABOLISM; RAGGED-RED FIBERS; TRANSFER RNALEU(UUR) GENE;
   CYTOCHROME-C-OXIDASE; LACTIC-ACIDOSIS; NITRIC-OXIDE; CLINICAL-FEATURES;
   RESPIRATORY-CHAIN
AB The molecular basis of migraine is still not completely understood. An impairment of mitochondrial oxidative metabolism might play a role in the pathophysiology of this disease, by influencing neuronal information processing. Biochemical assays of platelets and muscle biopsies performed in migraine sufferers have shown a decreased activity of the respiratory chain enzymes. Studies with phosphorus magnetic resonance spectroscopy (P-31-MRS) have demonstrated an impairment of the brain oxidative energy metabolism both during and between migraine attacks. However, molecular genetic studies have not detected specific mitochondrial DNA (mtDNA) mutations in patients with migraine, although other studies suggest that particular genetic markers (i.e. neutral polymorphisms or secondary mtDNA mutations) might be present in some migraine sufferers. Further studies are still needed to clarify if migraine is associated with unidentified mutations on the mtDNA or on nuclear genes that code mitochondrial proteins. In this paper, we review morphological, biochemical, imaging and genetic studies which bear on the hypothesis that migraine may be related to mitochondrial dysfunction at least in some individuals.
C1 Hosp G Rummo, Dept Neurol, Benevento, Italy.
   Hosp G Rummo, Headache Ctr, Benevento, Italy.
   Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA.
   Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.
   Montefiore Headache Unit, Bronx, NY USA.
   New England Ctr Headache, Stamford, CT USA.
   Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.
C3 Montefiore Medical Center; Albert Einstein College of Medicine; Yeshiva
   University; Montefiore Medical Center; Albert Einstein College of
   Medicine; Yeshiva University; Columbia University
RP Hosp G Rummo, Dept Neurol, Benevento, Italy.
EM marcosparaco@aliceposta.it
RI Lipton, Richard/AAY-2818-2021
CR Akerman S, 2002, BRIT J PHARMACOL, V137, P62, DOI 10.1038/sj.bjp.0704842
   Almeida A, 2005, J NEUROSCI RES, V79, P166, DOI 10.1002/jnr.20281
   ANTOZZI C, 1994, NEUROLOGY, V44, P2153, DOI 10.1212/WNL.44.11.2153
   ARGOV Z, 1987, NEUROLOGY, V37, P257, DOI 10.1212/WNL.37.2.257
   ARNOLD DL, 1985, ANN NEUROL, V18, P189, DOI 10.1002/ana.410180205
   Aurora SK, 1998, CURR OPIN NEUROL, V11, P205, DOI 10.1097/00019052-199806000-00003
   BARBIROLI B, 1993, J CEREBR BLOOD F MET, V13, P469, DOI 10.1038/jcbfm.1993.61
   BARBIROLI B, 1992, NEUROLOGY, V42, P1209, DOI 10.1212/WNL.42.6.1209
   BARBIROLI B, 1990, CEPHALALGIA, V10, P263, DOI 10.1046/j.1468-2982.1990.1005263.x
   Bigal Marcelo E, 2004, Curr Pain Headache Rep, V8, P178, DOI 10.1007/s11916-004-0049-1
   BOLANOS JP, 1994, J NEUROCHEM, V63, P910
   BOLANOS JP, 2004, FREE RADIC BIOL MED, V21, P995
   Boles RG, 1997, LANCET, V350, P1299, DOI 10.1016/S0140-6736(05)62477-4
   BONILLA E, 1992, BRAIN PATHOL, V2, P113, DOI 10.1111/j.1750-3639.1992.tb00679.x
   Boska MD, 2002, NEUROLOGY, V58, P1227, DOI 10.1212/WNL.58.8.1227
   BRESOLIN N, 1991, J NEUROL SCI, V104, P182, DOI 10.1016/0022-510X(91)90308-T
   Buzzi MG, 2000, NEUROLOGY, V54, P1005, DOI 10.1212/WNL.54.4.1005
   Cao Y, 2002, NEUROLOGY, V59, P72, DOI 10.1212/WNL.59.1.72
   Capuano A, 2004, Clin Ter, V155, P79
   Casas F, 2000, FEBS LETT, V482, P71, DOI 10.1016/S0014-5793(00)02023-8
   Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700
   CHANCE B, 1985, CIRCULATION, V72, P103
   Chinnery PF, 2003, J NEUROL SCI, V211, P63, DOI 10.1016/S0022-510X(03)00039-X
   Christiansen I, 1999, CEPHALALGIA, V19, P660, DOI 10.1046/j.1468-2982.1999.019007660.x
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Cidad P, 2004, BIOCHEM J, V384, P629, DOI 10.1042/BJ20040886
   CORTELLI P, 1995, LANCET, V345, P1120, DOI 10.1016/S0140-6736(95)90853-6
   CURTRER FM, 2000, NEUROLOGY S2, V55, pS36
   De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081
   DEVOTO M, 1986, CEPHALALGIA, V6, P101, DOI 10.1046/j.1468-2982.1986.0602101.x
   Di Gennaro G, 2000, HEADACHE, V40, P568, DOI 10.1046/j.1526-4610.2000.00088.x
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DIMAURO S, 1990, NEUROL CLIN, V8, P483, DOI 10.1016/S0733-8619(18)30332-3
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   ELEFF SM, 1990, ANN NEUROL, V27, P626, DOI 10.1002/ana.410270607
   Estevez M, 2004, HUM GENET, V114, P225, DOI 10.1007/s00439-003-1055-9
   Finnilä S, 2001, J MED GENET, V38, P400, DOI 10.1136/jmg.38.6.400
   FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686
   Goadsby PJ, 1997, NEUROL CLIN, V15, P27, DOI 10.1016/S0733-8619(05)70293-0
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Haan J, 1999, CEPHALALGIA, V19, P20, DOI 10.1046/j.1468-2982.1999.1901020.x
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   Hao HL, 1999, HUM MOL GENET, V8, P1117, DOI 10.1093/hmg/8.6.1117
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Huoponen K, 2001, NEUROGENETICS, V3, P119, DOI 10.1007/s100480100115
   Isobe K, 1998, J BIOL CHEM, V273, P4601, DOI 10.1074/jbc.273.8.4601
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Kabbouche MA, 2003, HEADACHE, V43, P490, DOI 10.1046/j.1526-4610.2003.03095.x
   Kalfakis N, 1996, HEADACHE, V36, P320, DOI 10.1046/j.1526-4610.1996.3605320.x
   Klopstock T, 1996, NEUROLOGY, V46, P1735, DOI 10.1212/WNL.46.6.1735
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   KOO B, 1993, ANN NEUROL, V34, P25, DOI 10.1002/ana.410340107
   LAURITZEN M, 1983, ANN NEUROL, V14, P569, DOI 10.1002/ana.410140512
   Lefai E, 1997, BBA-BIOENERGETICS, V1318, P191, DOI 10.1016/S0005-2728(96)00136-3
   LERTRIT P, 1992, AM J HUM GENET, V51, P457
   LITTLEWOOD J, 1984, J NEUROL NEUROSUR PS, V47, P338, DOI 10.1136/jnnp.47.4.338
   Lodi R, 2001, BRAIN RES BULL, V54, P437, DOI 10.1016/S0361-9230(01)00440-3
   Majamaa K, 1998, LANCET, V352, P455, DOI 10.1016/S0140-6736(05)79190-X
   Marriage B, 2003, J AM DIET ASSOC, V103, P1029, DOI 10.1016/S0002-8223(03)00476-0
   MOCHI M, 1993, CEPHALALGIA, V13, P389, DOI 10.1046/j.1468-2982.1993.1306389.x
   MONTAGNA P, 1988, HEADACHE, V28, P477, DOI 10.1111/j.1526-4610.1988.hed2807477.x
   MONTAGNA P, 1994, CEPHALALGIA, V14, P184, DOI 10.1046/j.1468-2982.1994.014003184.x
   MONTAGNA P, 1994, NEUROLOGY, V44, P666, DOI 10.1212/WNL.44.4.666
   Montagna P, 1998, MUSCLE NERVE, V21, P127
   Montagna P, 2000, CEPHALALGIA, V20, P3, DOI 10.1046/j.1468-2982.2000.00003.x
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   Moskowitz MA, 2004, ANN NEUROL, V55, P276, DOI 10.1002/ana.20035
   Odawara M, 1997, MUSCLE NERVE, V20, P394
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Ojaimi J, 1998, CEREBROVASC DIS, V8, P102, DOI 10.1159/000015826
   Okada H, 1998, HEADACHE, V38, P39, DOI 10.1046/j.1526-4610.1998.3801039.x
   Oldfors A, 2003, J NEUROPATH EXP NEUR, V62, P217, DOI 10.1093/jnen/62.3.217
   OLESEN J, 1981, ANN NEUROL, V9, P344, DOI 10.1002/ana.410090406
   Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2
   PALADE GE, 1953, J HISTOCHEM CYTOCHEM, V1, P188, DOI 10.1177/1.4.188
   PENN AMW, 1992, NEUROLOGY, V42, P2147, DOI 10.1212/WNL.42.11.2147
   Peroutka SJ, 1998, CLIN NEUROSCI, V5, P34
   PHELPS ME, 1981, SCIENCE, V211, P1445, DOI 10.1126/science.6970412
   Powers HJ, 2003, AM J CLIN NUTR, V77, P1352
   PRICHARD J, 1991, P NATL ACAD SCI USA, V88, P5829, DOI 10.1073/pnas.88.13.5829
   Rozen TD, 2002, CEPHALALGIA, V22, P137, DOI 10.1046/j.1468-2982.2002.00335.x
   RUSSELL MB, 1993, CEPHALALGIA, V13, P245, DOI 10.1046/j.1468-2982.1993.1304245.x
   RUSSELL MB, 1995, HUM GENET, V96, P726, DOI 10.1007/BF00210307
   RUSSELL MB, 1993, NEUROLOGY, V43, P1369, DOI 10.1212/WNL.43.7.1369
   Russell MB, 1997, ACTA NEUROL SCAND, V96, P171
   Sacconi S, 2002, ARCH NEUROL-CHICAGO, V59, P1013, DOI 10.1001/archneur.59.6.1013
   SACQUEGNA T, 1992, ACTA NEUROL SCAND, V86, P376, DOI 10.1111/j.1600-0404.1992.tb05104.x
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   Sándor PS, 2005, NEUROLOGY, V64, P713, DOI 10.1212/01.WNL.0000151975.03598.ED
   SANGIORGI S, 1994, CEPHALALGIA, V14, P21, DOI 10.1046/j.1468-2982.1994.1401021.x
   Schapira AHV, 2002, J INHERIT METAB DIS, V25, P207, DOI 10.1023/A:1015629912477
   Schoenen J, 1996, BIOMED PHARMACOTHER, V50, P71, DOI 10.1016/0753-3322(96)84716-0
   Schoenen J, 1998, CLIN NEUROSCI, V5, P10
   Schoenen J, 1998, NEUROLOGY, V50, P466, DOI 10.1212/WNL.50.2.466
   SCHOLTE HR, 1995, BBA-MOL BASIS DIS, V1271, P75, DOI 10.1016/0925-4439(95)00013-T
   Seibel P, 1996, J NEUROL, V243, P305, DOI 10.1007/BF00868402
   SHERRATT HSA, 1991, REV NEUROL, V147, P417
   SHIMOMURA T, 1994, LANCET, V344, P625, DOI 10.1016/S0140-6736(94)92015-X
   Shimomura TKA, 1995, CEPHALALGIA, V15, P10
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Silvestri G, 2000, AM J MED GENET, V94, P201, DOI 10.1002/1096-8628(20000918)94:3<201::AID-AJMG5>3.0.CO;2-2
   SKINHOJ E, 1973, ARCH NEUROL-CHICAGO, V29, P95, DOI 10.1001/archneur.1973.00490260039007
   Smith M, 2002, NEUROLOGY, V58, P1308, DOI 10.1212/WNL.58.8.1308-a
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   STADHOUDERS AM, 1987, J INHERIT METAB DIS, V10, P62, DOI 10.1007/BF01812848
   Takeshima T, 2001, CEPHALALGIA, V21, P987, DOI 10.1046/j.1468-2982.2001.00305.x
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   TOKUNAGA M, 1993, ANN NEUROL, V33, P275, DOI 10.1002/ana.410330308
   Tyni T, 2004, PEDIATR RES, V56, P744, DOI 10.1203/01.PDR.0000141967.52759.83
   UNCINI A, 1995, J NEUROL SCI, V129, P214, DOI 10.1016/0022-510X(94)00283-T
   Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674
   Wallace DC, 2001, MENT RETARD DEV D R, V7, P158, DOI 10.1002/mrdd.1023
   Wanic-Kossowska M, 1997, Pol Arch Med Wewn, V97, P534
   Watanabe H., 1996, Neurology, V47, P1093
   Welch KMA, 1998, CURR OPIN NEUROL, V11, P193, DOI 10.1097/00019052-199806000-00001
   Welch KMA, 2003, NEUROLOGY, V61, pS2, DOI 10.1212/WNL.61.8_suppl_4.S2
   WELCH KMA, 1990, NEUROL CLIN, V8, P817, DOI 10.1016/S0733-8619(18)30319-0
   WELCH KMA, 1989, NEUROLOGY, V39, P538, DOI 10.1212/WNL.39.4.538
   Young William B, 2004, Curr Pain Headache Rep, V8, P244, DOI 10.1007/s11916-004-0059-z
   Zhou L, 1997, J NEUROSCI, V17, P7746
NR 125
TC 135
Z9 142
U1 0
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0333-1024
EI 1468-2982
J9 CEPHALALGIA
JI Cephalalgia
PD APR
PY 2006
VL 26
IS 4
BP 361
EP 372
DI 10.1111/j.1468-2982.2005.01059.x
PG 12
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 024VJ
UT WOS:000236224100001
PM 16556237
DA 2024-11-01
ER

PT J
AU Garcia-Gaona, E
   García-Gregorio, A
   García-Jiménez, C
   López-Olaiz, M
   Mendoza-Ramírez, P
   Fernandez-Guzman, D
   Pillado-Sánchez, R
   Soto-Pacheco, A
   Yareni-Zuñiga, L
   Sánchez--Parada, M
   González-Santiago, A
   Román-Pintos, L
   Castañeda-Arellano, R
   Hernández-Ortega, L
   Mercado-Sesma, A
   Orozco-Luna, F
   Villa-Angulo, C
   Villa-Angulo, R
   Baptista-Rosas, RC
AF Garcia-Gaona, Enrique
   Garcia-Gregorio, Alheli
   Garcia-Jimenez, Camila
   Alejandra Lopez-Olaiz, Mildred
   Mendoza-Ramirez, Paola
   Fernandez-Guzman, Daniel
   Alberto Pillado-Sanchez, Rolando
   David Soto-Pacheco, Axel
   Yareni-Zuniga, Laura
   Guadalupe Sanchez-Parada, Maria
   Elizabeth Gonzalez-Santiago, Ana
   Miguel Roman-Pintos, Luis
   Castaneda-Arellano, Rolando
   Daniel Hernandez-Ortega, Luis
   Roldan Mercado-Sesma, Arieh
   de Jesus Orozco-Luna, Felipe
   Villa-Angulo, Carlos
   Villa-Angulo, Rafael
   Baptista-Rosas, Raul C.
TI mtDNA Single-Nucleotide Variants Associated with Type 2 Diabetes
SO CURRENT ISSUES IN MOLECULAR BIOLOGY
LA English
DT Article
DE mtDNA; mitogenome; type 2 diabetes; variant; polymorphism
ID HUMAN SKELETAL-MUSCLE; BETA-CELL MITOCHONDRIA; INSULIN-RESISTANCE;
   PROTEOME ANALYSIS; LIPID-CONTENT; DYSFUNCTION; GENE; HETEROPLASMY;
   MELLITUS; SEQUENCE
AB Type 2 diabetes (T2D) is a chronic systemic disease with a complex etiology, characterized by insulin resistance and mitochondrial dysfunction in various cell tissues. To explore this relationship, we conducted a secondary analysis of complete mtDNA sequences from 1261 T2D patients and 1105 control individuals. Our findings revealed significant associations between certain single-nucleotide polymorphisms (SNPs) and T2D. Notably, the variants m.1438A>G (rs2001030) (controls: 32 [27.6%], T2D: 84 [72.4%]; OR: 2.46; 95%CI: 1.64-3.78; p < 0.001), m.14766C>T (rs193302980) (controls: 498 [36.9%], T2D: 853 [63.1%]; OR: 2.57, 95%CI: 2.18-3.04, p < 0.001), and m.16519T>C (rs3937033) (controls: 363 [43.4%], T2D: 474 [56.6%]; OR: 1.24, 95%CI: 1.05-1.47, p = 0.012) were significantly associated with the likelihood of developing diabetes. The variant m.16189T>C (rs28693675), which has been previously documented in several studies across diverse populations, showed no association with T2D in our analysis (controls: 148 [13.39] T2D: 171 [13.56%]; OR: 1.03; 95%CI: 0.815-1.31; p = 0.83). These results provide evidence suggesting a link between specific mtDNA polymorphisms and T2D, possibly related to association rules, topological patterns, and three-dimensional conformations associated with regions where changes occur, rather than specific point mutations in the sequence.
C1 [Garcia-Gaona, Enrique] Benemerita Univ Autonoma Puebla, Fac Med, Puebla 72420, Mexico.
   [Garcia-Gregorio, Alheli] Univ Veracruzana, Fac Enfermeria Reg Poza R Tuxpan, Tuxpan 91700, Veracruz, Mexico.
   [Garcia-Jimenez, Camila] Univ Michoacana, Fac Ciencias Med & Biol Dr Ignacio Chavez, Morelia 58000, Mexico.
   [Alejandra Lopez-Olaiz, Mildred] Univ Valle Atemajac, Escuela Nutr, Leon 37330, Mexico.
   [Mendoza-Ramirez, Paola] Benemerita Univ Autonoma Puebla, Fac Ciencias Biol, Puebla 72420, Mexico.
   [Fernandez-Guzman, Daniel] Univ Cient Sur, Carrera Med Humana, Lima 15067, Peru.
   [Alberto Pillado-Sanchez, Rolando; David Soto-Pacheco, Axel] Univ Autonoma Sinaloa, Fac Med Extens Los Mochis, Sinaloa 81223, Mexico.
   [Yareni-Zuniga, Laura; Miguel Roman-Pintos, Luis; Roldan Mercado-Sesma, Arieh; Baptista-Rosas, Raul C.] Univ Guadalajara, Ctr Univ Tonala, Dept Ciencias Salud Enfermedad como Proc Individua, Tonala 45425, Mexico.
   [Guadalupe Sanchez-Parada, Maria; Elizabeth Gonzalez-Santiago, Ana; Castaneda-Arellano, Rolando; Daniel Hernandez-Ortega, Luis] Univ Guadalajara, Ctr Univ Tonala, Dept Ciencias Biomed, Tonala 45425, Mexico.
   [Guadalupe Sanchez-Parada, Maria; Elizabeth Gonzalez-Santiago, Ana; Miguel Roman-Pintos, Luis; Castaneda-Arellano, Rolando; Daniel Hernandez-Ortega, Luis; Roldan Mercado-Sesma, Arieh; Baptista-Rosas, Raul C.] Univ Guadalajara, Ctr Invest Multidisciplinaria Salud, Tonala 45425, Mexico.
   [de Jesus Orozco-Luna, Felipe] Univ Guadalajara, Ctr Anal Datos & Supercomputo, Tonala 45425, Mexico.
   [Villa-Angulo, Carlos; Villa-Angulo, Rafael] Univ Autonoma Baja California, Inst Ingn, Lab Bioinformat & Biofoton, Mexicali 21100, Mexico.
   [Baptista-Rosas, Raul C.] Secretaria Salud Jalisco, Hosp Gen Occidente, Zapopan 45170, Mexico.
C3 Benemerita Universidad Autonoma de Puebla; Universidad Veracruzana;
   Universidad Michoacana de San Nicolas de Hidalgo; Benemerita Universidad
   Autonoma de Puebla; Universidad Cientifica del Sur (CIENTIFICA);
   Universidad Autonoma de Sinaloa; Universidad de Guadalajara; Universidad
   de Guadalajara; Universidad de Guadalajara; Universidad de Guadalajara;
   Universidad Autonoma de Baja California
RP Baptista-Rosas, RC (corresponding author), Univ Guadalajara, Ctr Univ Tonala, Dept Ciencias Salud Enfermedad como Proc Individua, Tonala 45425, Mexico.; Baptista-Rosas, RC (corresponding author), Univ Guadalajara, Ctr Invest Multidisciplinaria Salud, Tonala 45425, Mexico.; Baptista-Rosas, RC (corresponding author), Secretaria Salud Jalisco, Hosp Gen Occidente, Zapopan 45170, Mexico.
EM enrique.garciaga@alumno.buap.mx; zs18005332@estudiantes.uv.mx;
   1593027a@umich.mx; milyolaiz@gmail.com; paola.mendozaramirez1@gmail.com;
   dfernandezg@cientifica.edu.pe; rolandops20@ms.uas.edu.mx;
   axelsoto.fm@uas.edu.mx; lauray.zuniga@academicos.udg.mx;
   maria.sparada@academicos.udg.mx; ana.gonzalez@academicos.udg.mx;
   luis.roman@acaemicos.udg.mx; rolando.castaneda@academicos.udg.mx;
   luis.hortega@academicos.udg.mx; arieh.mercado@academicos.udg.mx;
   felipe.orozco@academicos.udg.mx; villac@uabc.edu.mx;
   rafael.villa@uabc.edu.mx; raul.baptista@academicos.udg.mx
RI Mercado Sesma, Arieh R/AAB-8355-2020; Gonzalez-Santiago,
   Ana/JAC-7829-2023; Fernandez-Guzman, Daniel/GLR-4227-2022; Rosas,
   Raúl/C-3358-2018; Roman Pintos, Luis Miguel/B-8464-2014
OI Mercado Sesma, Arieh Roldan/0000-0002-9025-9328; Roman Pintos, Luis
   Miguel/0000-0002-5180-3810; Orozco, Felipe/0000-0002-3712-9997;
   Castaneda Arellano, Rolando/0000-0001-6940-5899; Baptista Rosas, Raul
   C./0000-0002-0273-4740; Villa-Angulo, Carlos/0000-0001-6940-3711;
   Garcia-Gregorio, Alheli/0000-0002-3517-3062; GONZALEZ-SANTIAGO,
   ANA/0000-0001-6923-9771; Lopez Olaiz, Mildred
   Alejandra/0000-0002-1929-346X
FU University of Guadalajara
FX We appreciate the support for publication through the PRO-SNI 2023
   program to researchers from the University of Guadalajara. This project
   did not receive any specific grant from funding agencies in the public,
   commercial, or not-for-profit sectors.
CR Ahmad E, 2022, LANCET, V400, P1803, DOI 10.1016/S0140-6736(22)01655-5
   Alwehaidah MS, 2021, BIOMED REP, V14, DOI 10.3892/br.2021.1417
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230
   Avital G, 2012, HUM MOL GENET, V21, P4214, DOI 10.1093/hmg/dds245
   Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783
   Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3
   Chen ZZ, 2020, CIRC RES, V126, P1613, DOI 10.1161/CIRCRESAHA.120.315898
   Cooper AJ, 2021, CURR OBES REP, V10, P458, DOI 10.1007/s13679-021-00453-x
   Cousin E, 2022, LANCET DIABETES ENDO, V10, P655, DOI 10.1016/S2213-8587(22)00186-3
   Czibula G, 2012, EVOL BIOINFORM, V8, P181, DOI 10.4137/EBO.S9376
   Dela F, 2013, INT J BIOCHEM CELL B, V45, P11, DOI 10.1016/j.biocel.2012.09.019
   Diaz-Morales N, 2018, J CLIN MED, V7, DOI 10.3390/jcm7080220
   Fex M, 2018, J ENDOCRINOL, V236, pR145, DOI 10.1530/JOE-17-0367
   Floris M, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-06749-w
   Galicia-Garcia U, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176275
   Gaona E.G., 2022, Preprints, P2022100025, DOI [10.20944/preprints202210.0025.v1, DOI 10.20944/PREPRINTS202210.0025.V1]
   Guo LJ, 2005, MITOCHONDRION, V5, P15, DOI 10.1016/j.mito.2004.09.001
   Hallgrimsson B, 2019, SEMIN CELL DEV BIOL, V88, P67, DOI 10.1016/j.semcdb.2018.05.019
   He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817
   Hesselink MKC, 2016, NAT REV ENDOCRINOL, V12, P633, DOI 10.1038/nrendo.2016.104
   Hittel DS, 2005, DIABETES, V54, P1283, DOI 10.2337/diabetes.54.5.1283
   Hojlund K, 2003, J BIOL CHEM, V278, P10436, DOI 10.1074/jbc.M212881200
   Hojlund K, 2008, ENDOCRIN METAB CLIN, V37, P713, DOI 10.1016/j.ecl.2008.06.006
   Hojlund K, 2006, CURR DIABETES REV, V2, P375, DOI 10.2174/1573399810602040375
   Justino JR, 2021, GENET MOL BIOL, V44, DOI [10.1590/1678-4685-GMB-2021-0109, 10.1590/1678-4685-gmb-2021-0109]
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130
   Kronenberg F, 2022, CLIN J AM SOC NEPHRO, V17, P942, DOI 10.2215/CJN.05820522
   Kruszynska YT, 1998, DIABETES, V47, P1107, DOI 10.2337/diabetes.47.7.1107
   Kwak SH, 2016, FRONT BIOSCI-LANDMRK, V21, P1151, DOI 10.2741/4447
   Kwak SH, 2010, J DIABETES INVEST, V1, P161, DOI 10.1111/j.2040-1124.2010.00047.x
   Lamolle G, 2018, AN FAC MED-UNIV REPU, V5, P12, DOI 10.25184/anfamed2018v5n2a10
   Langenberg C, 2018, LANCET, V391, P2463, DOI 10.1016/S0140-6736(18)31132-2
   Leung KS, 2010, NUCLEIC ACIDS RES, V38, P6324, DOI 10.1093/nar/gkq500
   Li CH, 2022, INT J DIABETES DEV C, V42, P713, DOI 10.1007/s13410-021-01031-6
   Li JR, 2019, FEBS LETT, V593, P2525, DOI 10.1002/1873-3468.13546
   Liao WQ, 2008, TOHOKU J EXP MED, V215, P377, DOI 10.1620/tjem.215.377
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Lin XL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71908-9
   Liou CW, 2010, J MED GENET, V47, P723, DOI 10.1136/jmg.2010.077552
   Liu JL, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09502-x
   Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44
   Mallik S, 2015, IEEE T NANOBIOSCI, V14, P59, DOI 10.1109/TNB.2014.2359494
   Martín-Jiménez R, 2020, DNA CELL BIOL, V39, P1421, DOI 10.1089/dna.2020.5398
   Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100
   Mkaouar-Rebai E, 2008, BIOCHEM BIOPH RES CO, V369, P849, DOI 10.1016/j.bbrc.2008.02.107
   Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981
   Moody L, 2022, PLOS COMPUT BIOL, V18, DOI 10.1371/journal.pcbi.1010109
   Moody Laura, 2019, J Biomed Inform, V100S, P100001, DOI 10.1016/j.yjbinx.2018.100001
   Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151
   Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002
   Mulder H, 2017, MOL METAB, V6, P1040, DOI 10.1016/j.molmet.2017.05.014
   Nahili H, 2010, INT J PEDIATR OTORHI, V74, P1071, DOI 10.1016/j.ijporl.2010.06.008
   Naue J, 2015, MITOCHONDRION, V20, P82, DOI 10.1016/j.mito.2014.12.002
   Nissanka N, 2020, EMBO REP, V21, DOI 10.15252/embr.201949612
   Oellrich A, 2014, BIOINFORMATICS, V30, P52, DOI 10.1093/bioinformatics/btu260
   Parsons MJ, 2004, BIOL PSYCHIAT, V56, P406, DOI 10.1016/j.biopsych.2004.06.020
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Prasad RB, 2015, GENES-BASEL, V6, P87, DOI 10.3390/genes6010087
   Ptitsyn A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-318
   Rambani Vibhuti, 2022, Endocr Regul, V56, P232, DOI 10.2478/enr-2022-0025
   Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Sangwung P, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa017
   Santander-Lucio H, 2023, ARCH MED RES, V54, P113, DOI 10.1016/j.arcmed.2022.12.014
   Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412
   Schrauwen-Hinderling VB, 2007, DIABETOLOGIA, V50, P113, DOI 10.1007/s00125-006-0475-1
   Sikhayeva N, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0443-2
   Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070
   Soini Heidi K, 2012, BMC Res Notes, V5, P350, DOI 10.1186/1756-0500-5-350
   Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100
   Sudoyo H, 2003, ADV EXP MED BIOL, V531, P19
   Swan EJ, 2015, DIABETIC MED, V32, P1104, DOI 10.1111/dme.12763
   Szendroedi J, 2007, PLOS MED, V4, P858, DOI 10.1371/journal.pmed.0040154
   Tabebi M, 2017, J DIABETES COMPLICAT, V31, P253, DOI 10.1016/j.jdiacomp.2016.06.028
   Tang DL, 2006, DIABETES RES CLIN PR, V73, P77, DOI 10.1016/j.diabres.2005.12.001
   Tawata M, 1998, DIABETES, V47, P276, DOI 10.2337/diab.47.2.276
   Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001
   Umetsu Kazuo, 2005, Legal Medicine, V7, P259, DOI 10.1016/j.legalmed.2005.01.005
   van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
   Vringer E, 2023, CELL DEATH DIFFER, V30, P304, DOI 10.1038/s41418-022-01094-w
   Wang D, 2001, EXP CLIN ENDOCR DIAB, V109, P361, DOI 10.1055/s-2001-17407
   Weksler-Zangen S, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11101617
   Wong MH, 2015, IEEE ACM T COMPUT BI, V12, P142, DOI 10.1109/TCBB.2014.2343952
   Wu HM, 2018, NEUROBIOL DIS, V114, P17, DOI 10.1016/j.nbd.2018.02.015
   Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004
   Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8
NR 93
TC 0
Z9 0
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1467-3037
EI 1467-3045
J9 CURR ISSUES MOL BIOL
JI Curr. Issues Mol. Biol.
PD NOV
PY 2023
VL 45
IS 11
BP 8716
EP 8732
DI 10.3390/cimb45110548
PG 17
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA Z1DT3
UT WOS:001109562800001
PM 37998725
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Vattemi, G
   Marini, M
   Ferreri, NR
   Hao, SJ
   Malatesta, M
   Meneguzzi, A
   Guglielmi, V
   Fava, C
   Minuz, P
   Tomelleri, G
AF Vattemi, Gaetano
   Marini, Matteo
   Ferreri, Nicholas R.
   Hao, Shoujin
   Malatesta, Manuela
   Meneguzzi, Alessandra
   Guglielmi, Valeria
   Fava, Cristiano
   Minuz, Pietro
   Tomelleri, Giuliano
TI Overexpression of TNF-α in mitochondrial diseases caused by mutations in
   mtDNA: evidence for signaling through its receptors on mitochondria
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Mitochondrial diseases; Tumor necrosis factor-alpha; TNF receptor type
   1; TNF receptor type 2; Mitochondria; Free radicals
ID TUMOR-NECROSIS-FACTOR; FACTOR-INDUCED APOPTOSIS; INFLAMMATORY
   MYOPATHIES; SKELETAL-MUSCLE; INSULIN-RESISTANCE; EXPRESSION;
   DIFFERENTIATION; INHIBITION; ACTIVATION; MECHANISMS
AB Mitochondrial diseases (MDs) are heterogeneous disorders due to impaired respiratory chain function causing defective ATP production. Although the disruption of oxidative phosphorylation is central to the MD pathophysiology, other factors may contribute to these disorders. We investigated the expression and the cellular localization of TNF-alpha and its receptors, TNFR1 and TNFR2, in muscle biopsies from 15 patients with mitochondrial respiratory chain dysfunction. Our data unambiguously demonstrate that TNF-alpha is expressed in muscle fibers with abnormal focal accumulations of mitochondria, so-called ragged red fibers, and is delivered to mitochondria where both receptors are localized. Moreover TNF receptors are differentially regulated in patients' muscle in which the expression levels of TNFR1 mRNA are decreased and those of TNFR2 mRNA are increased compared with controls. These findings suggest for the first time that TNF-alpha could exert a direct effect on mitochondria via its receptors. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Vattemi, Gaetano; Marini, Matteo; Guglielmi, Valeria; Tomelleri, Giuliano] Univ Verona, Sect Clin Neurol, Dept Neurol Neuropsychol Morphol & Movement Sci, I-37134 Verona, Italy.
   [Ferreri, Nicholas R.; Hao, Shoujin] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA.
   [Malatesta, Manuela] Univ Verona, Sect Anat & Histol, Dept Neurol Neuropsychol Morphol & Movement Sci, I-37134 Verona, Italy.
   [Meneguzzi, Alessandra; Fava, Cristiano; Minuz, Pietro] Univ Verona, Sect Internal Med, Dept Biomed & Surg Sci, I-37134 Verona, Italy.
C3 University of Verona; New York Medical College; University of Verona;
   University of Verona
RP Vattemi, G (corresponding author), Univ Verona, Sect Clin Neurol, Dept Neurol Neuropsychol Morphol & Movement Sci, I-37134 Verona, Italy.
EM gaetano.vattemi@univr.it
RI Minuz, Pietro/K-7067-2016; Marini, Matteo/C-7544-2016; Vattemi,
   Gaetano/AAC-4668-2022; GUGLIELMI, Valeria/JYQ-9589-2024; FAVA,
   Cristiano/K-9590-2015
OI FAVA, Cristiano/0000-0002-8910-7378; MALATESTA,
   Manuela/0000-0001-8196-9232; MENEGUZZI, Alessandra/0000-0003-4269-9924;
   GUGLIELMI, Valeria/0000-0003-0968-0498; Vattemi,
   Gaetano/0000-0003-3412-8339
CR Al-Lamki RS, 2009, AM J TRANSPLANT, V9, P2679, DOI 10.1111/j.1600-6143.2009.02831.x
   Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x
   Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287
   Busquets S, 2003, CYTOKINE, V22, P1, DOI 10.1016/S1043-4666(03)00098-X
   De Bleecker JL, 1999, NEUROMUSCULAR DISORD, V9, P239, DOI 10.1016/S0960-8966(98)00126-6
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dirks AJ, 2006, J NUTR BIOCHEM, V17, P501, DOI 10.1016/j.jnutbio.2005.11.002
   Harry GJ, 2008, J NEUROCHEM, V106, P281, DOI 10.1111/j.1471-4159.2008.05382.x
   Jaaskelainen M., 2010, MOL CELL ENDOCRINOL, V330, P17
   James AM, 2002, J BIOMED SCI, V9, P475, DOI 10.1159/000064721
   Keller C, 2006, CYTOKINE, V36, P141, DOI 10.1016/j.cyto.2006.10.014
   Kuru S, 2003, ACTA NEUROPATHOL, V105, P217, DOI 10.1007/s00401-002-0632-4
   Lacerda L, 2010, BASIC RES CARDIOL, V105, P751, DOI 10.1007/s00395-010-0113-4
   LANCASTER JR, 1989, FEBS LETT, V248, P169, DOI 10.1016/0014-5793(89)80454-5
   Ledgerwood EC, 1998, LAB INVEST, V78, P1583
   Li YP, 2001, FASEB J, V15, P1413, DOI 10.1096/fj.00-0632fje
   LINDBERG C, 1995, SCAND J IMMUNOL, V41, P421, DOI 10.1111/j.1365-3083.1995.tb03587.x
   Luce A, 2009, CARCINOGENESIS, V30, P432, DOI 10.1093/carcin/bgp008
   Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245
   Manna SK, 1999, ONCOGENE, V18, P4371, DOI 10.1038/sj.onc.1202811
   McKenzie M, 2004, NEUROCHEM RES, V29, P589, DOI 10.1023/B:NERE.0000014829.42364.dd
   Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939
   Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504
   TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292
   Tews DS, 1996, J NEUROPATH EXP NEUR, V55, P342, DOI 10.1097/00005072-199603000-00009
   TORREAMIONE G, 1995, CIRCULATION, V92, P1487, DOI 10.1161/01.CIR.92.6.1487
   VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211
   Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 29
TC 9
Z9 9
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD OCT
PY 2013
VL 63
SI SI
BP 108
EP 114
DI 10.1016/j.freeradbiomed.2013.04.025
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 200TV
UT WOS:000323094700009
PM 23619127
DA 2024-11-01
ER

PT J
AU Boyer, O
   Butler-Browne, G
   Chinoy, H
   Cossu, G
   Galli, F
   Lilleker, JB
   Magli, A
   Mouly, V
   Perlingeiro, RCR
   Previtali, SC
   Sampaolesi, M
   Smeets, H
   Schoewel-Wolf, V
   Spuler, S
   Torrente, Y
   Van Tienen, F
AF Boyer, Olivier
   Butler-Browne, Gillian
   Chinoy, Hector
   Cossu, Giulio
   Galli, Francesco
   Lilleker, James B.
   Magli, Alessandro
   Mouly, Vincent
   Perlingeiro, Rita C. R.
   Previtali, Stefano C.
   Sampaolesi, Maurilio
   Smeets, Hubert
   Schoewel-Wolf, Verena
   Spuler, Simone
   Torrente, Yvan
   Van Tienen, Florence
CA Study Grp
TI Myogenic Cell Transplantation in Genetic and Acquired Diseases of
   Skeletal Muscle
SO FRONTIERS IN GENETICS
LA English
DT Review
DE cell transplantation; muscle stem cells; muscular dystrophies;
   mitochondrial myopathies; inflammatory myopathies; sphincter
   incontinence; volumetric muscle loss
ID DUCHENNE MUSCULAR-DYSTROPHY; MESENCHYMAL STEM-CELLS; AUTOLOGOUS MYOBLAST
   TRANSPLANTATION; MITOCHONDRIAL-DNA DELETIONS; LONG-TERM PERSISTENCE;
   SATELLITE CELLS; URINARY-INCONTINENCE; SELF-RENEWAL; RESTORE DYSTROPHIN;
   BLADDER EXSTROPHY
AB This article will review myogenic cell transplantation for congenital and acquired diseases of skeletal muscle. There are already a number of excellent reviews on this topic, but they are mostly focused on a specific disease, muscular dystrophies and in particular Duchenne Muscular Dystrophy. There are also recent reviews on cell transplantation for inflammatory myopathies, volumetric muscle loss (VML) (this usually with biomaterials), sarcopenia and sphincter incontinence, mainly urinary but also fecal. We believe it would be useful at this stage, to compare the same strategy as adopted in all these different diseases, in order to outline similarities and differences in cell source, pre-clinical models, administration route, and outcome measures. This in turn may help to understand which common or disease-specific problems have so far limited clinical success of cell transplantation in this area, especially when compared to other fields, such as epithelial cell transplantation. We also hope that this may be useful to people outside the field to get a comprehensive view in a single review. As for any cell transplantation procedure, the choice between autologous and heterologous cells is dictated by a number of criteria, such as cell availability, possibility of in vitro expansion to reach the number required, need for genetic correction for many but not necessarily all muscular dystrophies, and immune reaction, mainly to a heterologous, even if HLA-matched cells and, to a minor extent, to the therapeutic gene product, a possible antigen for the patient. Finally, induced pluripotent stem cell derivatives, that have entered clinical experimentation for other diseases, may in the future offer a bank of immune-privileged cells, available for all patients and after a genetic correction for muscular dystrophies and other myopathies.
C1 [Boyer, Olivier] Normandy Univ, Rouen Univ Hosp, Inserm U1234, Dept Immunol & Biotherapy, Rouen, France.
   [Butler-Browne, Gillian; Mouly, Vincent] Sorbonne Univ, INSERM, Inst Myol, Ctr Rech Myol, Paris, France.
   [Chinoy, Hector; Lilleker, James B.] Salford Royal NHS Fdn, Manchester Acad Hlth Sci Ctr, Manchester Ctr Clin Neurosci, Salford, Lancs, England.
   [Chinoy, Hector; Galli, Francesco; Lilleker, James B.] Univ Manchester, Manchester Univ NHS Fdn Trust, Natl Inst Hlth Res, Manchester Biomed Res Ctr, Manchester, Lancs, England.
   [Cossu, Giulio] Univ Manchester, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England.
   [Cossu, Giulio; Schoewel-Wolf, Verena; Spuler, Simone] Univ Med Berlin, Expeninental & Clin Res Ctr, Muscle Res Unit, Berlin, Germany.
   [Cossu, Giulio; Previtali, Stefano C.] Ist Ric & Cure Carattere Sci IRCCS Osped San Raff, InSpe, Milan, Italy.
   [Cossu, Giulio; Previtali, Stefano C.] Ist Ric & Cura Carattere Sci IRCCS Osped San Raff, Div Neurosci, Milan, Italy.
   [Magli, Alessandro; Perlingeiro, Rita C. R.] Univ Minnesota, Stem Cell Inst, Lillehei Heart Inst, Dept Med, Minneapolis, MN USA.
   [Sampaolesi, Maurilio] Katholieke Univ Leuven, Dept Dev & Regenerat, Translat Cardiomyol Lab, Leuven, Belgium.
   [Sampaolesi, Maurilio] Univ Pavia, Dept Publ Hlth Expt & Forens Med, Human Anat Unit, Pavia, Italy.
   [Smeets, Hubert; Van Tienen, Florence] Maastricht Univ, Med Ctr, Dept Toxicogen, Maastricht, Netherlands.
   [Smeets, Hubert] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Maastricht, Netherlands.
   [Smeets, Hubert] Maastricht Univ, Sch Dev Biol & Oncol GROW, Maastricht, Netherlands.
   [Torrente, Yvan] Univ Milan, Fdn Ist Ric & Cura Carattere Sci IRCCS Ca Granda, Ctr Dino Ferrari,Unit Neurol, Dept Pathophysiol & Transplantat,Stem Cell Lab, Milan, Italy.
C3 Universite de Rouen Normandie; CHU de Rouen; Sorbonne Universite;
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   Salford Royal NHS Foundation Trust; University of Manchester; University
   of Manchester; Berlin Institute of Health; Berlin Institute of Health;
   Free University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; University of Minnesota System; University
   of Minnesota Twin Cities; KU Leuven; University of Pavia; Maastricht
   University; Maastricht University; Maastricht University; University of
   Milan
RP Cossu, G (corresponding author), Univ Manchester, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England.; Cossu, G (corresponding author), Univ Med Berlin, Expeninental & Clin Res Ctr, Muscle Res Unit, Berlin, Germany.
EM giulio.cossu@manchester.ac.uk
RI Lilleker, James/U-6121-2019; Kuehn, Simone/P-6145-2014; Previtali,
   Stefano/Z-1962-2019; Boyer, Olivier/N-6552-2013; Chinoy,
   Hector/C-7832-2013; Sampaolesi, Maurilio/H-6509-2013; Mouly,
   Vincent/JMR-3570-2023
OI Villa, Chiara/0000-0002-3002-3372; Farini, Andrea/0000-0002-8514-4921;
   Mouly, Vincent/0000-0003-3809-4033; Schoewel,
   Verena/0000-0002-5924-3088; Yedigaryan, Laura/0000-0002-1701-9109;
   Negroni, Elisa/0000-0001-8302-2544; Duelen, Robin/0000-0003-0904-1215;
   butler-browne, gillian/0000-0002-3431-242X
FU PHRC National Research Program [P020908/AOM02100]; Association Francaise
   contre les Myopathies; Fondation de l'Avenir; NIHR Manchester Biomedical
   Research Centre Funding Scheme; ERC [AIG 844952]; EC
   [H2020-MSCA-ITN-2019 860034, 20150256]; MRC [MR/S015116]; Duchenne
   Parent Project (Italy) [GOSH V4618]; NIHR Clinical Lecturship
   [MWN/006/025/A, R01AR071439]; Department of Defense [MD160035]; Duchenne
   UK; Fondazione Regionale per la Ricerca Biomedica FRRB [EJPRD19-118];
   Telethon [GGP17009, RF-201602361246, 2020-EMR116]; FWO [G0D4517N,
   G066821N]; Deutsche Forschungsgemeinschaft (DFG) [KFO192]; DFG
   [IGK1631]; Foundations Gisela Krebs; French Telethon AFM [21104,
   2014055]; Prinses Beatrix Spierfonds [PBS W.0R15-09]; British Academy
   [MD160035] Funding Source: British Academy
FX Work in the authors laboratories was supported by grants from PHRC
   National Research Program (P020908/AOM02100), Association Francaise
   contre les Myopathies (GB-B, VM, and OB); Fondation de l'Avenir (OB);
   NIHR Manchester Biomedical Research Centre Funding Scheme (HC); ERC AIG
   844952, EC H2020-MSCA-ITN-2019 860034, UMIP No. 20150256, MRC
   MR/S015116, Duchenne Parent Project (Italy), GOSH V4618, Wellcome Trust
   HICF 107572 (GC); NIHR Clinical Lecturship MWN/006/025/A (JL); Greg
   Marzolf Junior Foundation Award (AM); NIH R01AR071439, Department of
   Defense MD160035, Duchenne UK 2019-08 (RCRP); Fondazione Regionale per
   la Ricerca Biomedica FRRB CP2_10/2018, EJPRD19-118, Telethon GGP17009,
   Ministry of Health RF-201602361246 (SCP); INTERREG-Euregio Meuse-Rhine,
   GYMGenerate your muscle 2020-EMR116, FWO (G0D4517N and G066821N), C1-KU
   Leuven grant 3DMUSYC, C14/17/111 (MS); Deutsche Forschungsgemeinschaft
   (DFG) KFO192, DFG IGK1631: MyoGrad, the Helmholtz Validation
   Fund/Helmholtz Association, SPARK-Berlin Institute of Health Validation
   Fund, the Foundations Gisela Krebs and Else Kroner-Fresenius (VS-W);
   French Telethon AFM 21104, Ricerca Finalizzata 2016 (YT); Interreg EMR
   116, Metakids "ING goede doelen fonds" (2014055), and the Prinses
   Beatrix Spierfonds (PBS W.0R15-09) (HS and FV).
CR Aghajanian H, 2019, NATURE, V573, P430, DOI 10.1038/s41586-019-1546-z
   Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Albini S, 2013, CELL REP, V3, P661, DOI 10.1016/j.celrep.2013.02.012
   Alexander MS, 2016, CELL STEM CELL, V19, P800, DOI 10.1016/j.stem.2016.08.006
   Allen DG, 2016, PHYSIOL REV, V96, P253, DOI 10.1152/physrev.00007.2015
   Alonso-Martin S, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00058
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Andrews PW, 2017, STEM CELL REP, V9, P1, DOI 10.1016/j.stemcr.2017.05.029
   Azzag K, 2020, SKELET MUSCLE, V10, DOI 10.1186/s13395-020-00228-3
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bae Y, 2017, MITOCHONDRION, V37, P27, DOI 10.1016/j.mito.2017.06.005
   Banerjee A, 2013, FEBS J, V280, P4230, DOI 10.1111/febs.12294
   Bar-Nur O, 2018, STEM CELL REP, V10, P1505, DOI 10.1016/j.stemcr.2018.04.009
   Benchaouir R, 2008, M S-MED SCI, V24, P99, DOI 10.1051/medsci/200824199
   Benchaouir R, 2007, CELL STEM CELL, V1, P646, DOI 10.1016/j.stem.2007.09.016
   Berardi E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00119
   Betteridge Z, 2019, J AUTOIMMUN, V101, P48, DOI 10.1016/j.jaut.2019.04.001
   Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028
   Biressi S, 2020, J CLIN INVEST, V130, P5652, DOI 10.1172/JCI142031
   Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237
   BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623
   Borchin B, 2013, STEM CELL REP, V1, P620, DOI 10.1016/j.stemcr.2013.10.007
   Bougl A, 2019, MUSCLE NERVE, V60, P328, DOI 10.1002/mus.26614
   Boyer O, 2018, ANN SURG, V267, P443, DOI 10.1097/SLA.0000000000002268
   Brzeszczynska J, 2016, AGING-US, V8, P1690, DOI 10.18632/aging.101006
   Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020
   Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027
   Canon S, 2008, J UROLOGY, V180, P2636, DOI 10.1016/j.juro.2008.08.048
   CARPENTER S, 1979, BRAIN, V102, P147, DOI 10.1093/brain/102.1.147
   Cassano M, 2009, J MUSCLE RES CELL M, V30, P243, DOI 10.1007/s10974-010-9204-y
   Centre for Canadian Language Benchmarks, 2019, CLB
   Chal J, 2015, NAT BIOTECHNOL, V33, P962, DOI 10.1038/nbt.3297
   Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547
   Chan DY, 2001, UROLOGY, V57, P774, DOI 10.1016/S0090-4295(00)01102-X
   Chan J, 2007, STEM CELLS, V25, P875, DOI 10.1634/stemcells.2006-0694
   Chan SSK, 2018, CELL STEM CELL, V23, P74, DOI 10.1016/j.stem.2018.06.010
   Charville GW, 2015, STEM CELL REP, V5, P621, DOI 10.1016/j.stemcr.2015.08.004
   Chermansky CJ, 2004, UROLOGY, V63, P780, DOI 10.1016/j.urology.2003.10.035
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Choi A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176269
   Choi IY, 2016, CELL REP, V15, P2301, DOI 10.1016/j.celrep.2016.05.016
   Chow SC, 2020, J BIOPHARM STAT, V30, P537, DOI 10.1080/10543406.2020.1726371
   Cordova G, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00114
   Cossu G, 2003, CURR OPIN GENET DEV, V13, P537, DOI 10.1016/j.gde.2003.08.001
   Cossu G, 2018, LANCET, V391, P883, DOI 10.1016/S0140-6736(17)31366-1
   Cossu G, 2015, EMBO MOL MED, V7, P1513, DOI 10.15252/emmm.201505636
   Costamagna D, 2020, J CACHEXIA SARCOPENI, V11, P783, DOI 10.1002/jcsm.12539
   Costamagna D, 2016, J MOL CELL BIOL, V8, P73, DOI 10.1093/jmcb/mjv059
   Dai A, 2018, DEGENER NEUROL NEURO, V8, P63, DOI 10.2147/DNND.S170087
   Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705
   Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015
   de Barcelos IP, 2019, CURR OPIN NEUROL, V32, P715, DOI 10.1097/WCO.0000000000000743
   De Bari C, 2003, J CELL BIOL, V160, P909, DOI 10.1083/jcb.200212064
   Deasy BM, 2001, BLOOD CELL MOL DIS, V27, P924, DOI 10.1006/bcmd.2001.0463
   Dell'Agnola C, 2004, BLOOD, V104, P4311, DOI 10.1182/blood-2004-06-2247
   Dellavalle A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1508
   Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542
   DENIS P, 1992, GASTROEN CLIN BIOL, V16, P344
   Díaz-Manera J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.35
   Domi T, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0055-5
   Ebert AK, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00174
   Ebert AK, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-23
   Elmi A, 2011, J UROLOGY, V186, P2021, DOI 10.1016/j.juro.2011.07.029
   Elsallab M, 2020, MOL THER-METH CLIN D, V18, P269, DOI 10.1016/j.omtm.2020.05.035
   English K, 2013, STEM CELLS DEV, V22, P512, DOI 10.1089/scd.2012.0386
   Escobar H, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.145994
   Fabry V, 2017, NEUROMUSCULAR DISORD, V27, pS155, DOI 10.1016/j.nmd.2017.06.225
   Feige P, 2018, CELL STEM CELL, V23, P653, DOI 10.1016/j.stem.2018.10.006
   Feng SW, 2008, CYTOTHERAPY, V10, P254, DOI 10.1080/14653240802020381
   Ferrari G, 2001, NATURE, V411, P1014, DOI 10.1038/35082631
   Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528
   Ferrua F, 2017, HUM GENE THER, V28, P972, DOI 10.1089/hum.2017.175
   Filareto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2550
   Filograna R, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav9824
   Forcina L, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051297
   Frattini P, 2017, HUM MOL GENET, V26, P3682, DOI 10.1093/hmg/ddx252
   Frudinger A, 2010, GUT, V59, P55, DOI 10.1136/gut.2009.181347
   Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Furrer R, 2019, ANNU REV PHARMACOL, V59, P315, DOI 10.1146/annurev-pharmtox-010818-021041
   Galvez BG, 2006, J CELL BIOL, V174, P231, DOI 10.1083/jcb.200512085
   Gang EJ, 2009, EXP CELL RES, V315, P2624, DOI 10.1016/j.yexcr.2009.05.009
   Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gomes JP, 2018, DNA CELL BIOL, V37, P798, DOI 10.1089/dna.2018.4158
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Greenberg SA, 2019, NAT REV RHEUMATOL, V15, P257, DOI 10.1038/s41584-019-0186-x
   Greenberg SA, 2016, BRAIN, V139, P1348, DOI 10.1093/brain/aww024
   Gussoni E, 2002, J CLIN INVEST, V110, P807, DOI 10.1172/JCI200216098
   Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970
   Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Hashimoto N, 2004, DEVELOPMENT, V131, P5481, DOI 10.1242/dev.01395
   He RJ, 2020, BIOL RES, V53, DOI 10.1186/s40659-020-00288-1
   He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523
   Hicks MR, 2018, NAT CELL BIOL, V20, P46, DOI 10.1038/s41556-017-0010-2
   HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4
   HUARD J, 1992, MUSCLE NERVE, V15, P550, DOI 10.1002/mus.880150504
   Ichim TE, 2010, CELL IMMUNOL, V260, P75, DOI 10.1016/j.cellimm.2009.10.006
   Incitti T, 2019, P NATL ACAD SCI USA, V116, P4346, DOI 10.1073/pnas.1808303116
   Ito N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08232-2
   Jankowski RJ, 2018, INT UROL NEPHROL, V50, P2153, DOI 10.1007/s11255-018-2005-8
   Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Jo A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/305716
   Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015
   Kajbafzadeh AM, 2008, J UROLOGY, V180, P1098, DOI 10.1016/j.juro.2008.05.057
   Kang PB, 2010, MUSCLE NERVE, V41, P746, DOI 10.1002/mus.21702
   KARPATI G, 1993, ANN NEUROL, V34, P8, DOI 10.1002/ana.410340105
   Keefe AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8087
   Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35
   Klimczak A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051119
   Kuehn BM, 2006, JAMA-J AM MED ASSOC, V295, P1362, DOI 10.1001/jama.295.12.1362
   LaCross A, 2015, J MIDWIFERY WOM HEAL, V60, P37, DOI 10.1111/jmwh.12283
   Lam, 1999, Colorectal Dis, V1, P197, DOI 10.1046/j.1463-1318.1999.00044.x
   Lanza R, 2019, NAT REV IMMUNOL, V19, P723, DOI 10.1038/s41577-019-0200-1
   Leriche-Guérin K, 2002, NEUROMUSCULAR DISORD, V12, P167, DOI 10.1016/S0960-8966(01)00254-1
   Li P, 2015, INT J MOL MED, V35, P1051, DOI 10.3892/ijmm.2015.2084
   Liang Q, 2018, NATURE, V563, P701, DOI 10.1038/s41586-018-0733-7
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Liu N, 2017, NAT CELL BIOL, V19, P202, DOI 10.1038/ncb3477
   Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665
   Liu YN, 2007, STEM CELLS DEV, V16, P695, DOI 10.1089/scd.2006.0118
   Loboda A, 2020, PHARMACOL REP, V72, P1227, DOI 10.1007/s43440-020-00134-x
   Lu AP, 2014, HUM MOL GENET, V23, P4786, DOI 10.1093/hmg/ddu194
   Maesner CC, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0106-6
   Maffioletti SM, 2015, NAT PROTOC, V10, P941, DOI 10.1038/nprot.2015.057
   Magli A, 2017, SEMIN CELL DEV BIOL, V72, P87, DOI 10.1016/j.semcdb.2017.10.031
   Magli A, 2017, CELL REP, V19, P2867, DOI 10.1016/j.celrep.2017.06.005
   Marg A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13650-z
   Marg A, 2014, J CLIN INVEST, V124, P4257, DOI 10.1172/JCI63992
   Aragón IM, 2018, INT J MED SCI, V15, P195, DOI 10.7150/ijms.22130
   Mariampillai K, 2018, JAMA NEUROL, V75, P1528, DOI 10.1001/jamaneurol.2018.2598
   Martin I, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat2189
   Maruf M, 2020, J UROLOGY, V203, P200, DOI 10.1097/JU.0000000000000505
   Matthias N, 2018, STEM CELL RES, V27, P65, DOI 10.1016/j.scr.2018.01.008
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303
   Meng JH, 2018, STEM CELL RES, V30, P43, DOI 10.1016/j.scr.2018.05.004
   Meregalli M, 2013, FEBS J, V280, P6045, DOI 10.1111/febs.12523
   Meyer A, 2015, RHEUMATOLOGY, V54, P50, DOI 10.1093/rheumatology/keu289
   Miller RG, 1997, MUSCLE NERVE, V20, P469, DOI 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.3.CO;2-1
   Minasi MG, 2002, DEVELOPMENT, V129, P2773
   Minetto MA, 2021, CURR OPIN PHARMACOL, V57, P148, DOI 10.1016/j.coph.2021.02.002
   Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025
   Mizuno Y, 2010, FASEB J, V24, P2245, DOI 10.1096/fj.09-137174
   Mollard P., 2001, ATLAS UROLOGIC CLIN, V9, P9, DOI [10.1016/s1063-5777(05)70073-6, DOI 10.1016/S1063-5777(05)70073-6]
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORGAN JE, 1993, J NEUROL SCI, V115, P191, DOI 10.1016/0022-510X(93)90224-M
   Morgan J, 2010, MUSCLE NERVE, V42, P584, DOI 10.1002/mus.21737
   Mouriquand PDE, 2003, BJU INT, V92, P997, DOI 10.1111/j.1464-410X.2003.04518.x
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Muskiewicz KR, 2005, J HISTOCHEM CYTOCHEM, V53, P861, DOI 10.1369/jhc.4A6573.2005
   Nederveen JP, 2018, J PHYSIOL-LONDON, V596, P1063, DOI 10.1113/JP275155
   Negroni E, 2016, HUM GENE THER, V27, P117, DOI 10.1089/hum.2015.139
   Negroni E, 2009, MOL THER, V17, P1771, DOI 10.1038/mt.2009.167
   Neumeyer AM, 1998, NEUROLOGY, V51, P589, DOI 10.1212/WNL.51.2.589
   Norton P, 2006, LANCET, V367, P57, DOI 10.1016/S0140-6736(06)67925-7
   Oldroyd A, 2017, CLIN MED, V17, P322, DOI 10.7861/clinmedicine.17-4-322
   Ono Y, 2011, CELL DEATH DIFFER, V18, P222, DOI 10.1038/cdd.2010.95
   Ortiz-Vitali JL, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010020
   Pandya JM, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0974-5
   Parés D, 2015, DIS COLON RECTUM, V58, P1098, DOI 10.1097/DCR.0000000000000471
   PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0
   Pelatti MV, 2016, STEM CELL REV REP, V12, P448, DOI 10.1007/s12015-016-9659-3
   Périé S, 2006, NEUROMUSCULAR DISORD, V16, P770, DOI 10.1016/j.nmd.2006.07.022
   Périé S, 2014, MOL THER, V22, P219, DOI 10.1038/mt.2013.155
   Perry S, 2002, GUT, V50, P480, DOI 10.1136/gut.50.4.480
   Petrany MJ, 2019, TRENDS CELL BIOL, V29, P964, DOI 10.1016/j.tcb.2019.09.002
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   Porrett PM, 2014, CLIN LIVER DIS, V18, P687, DOI 10.1016/j.cld.2014.05.012
   Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049
   Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224
   Rose MR, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001555.pub5
   Rotini A, 2018, PHARMACOL RES, V127, P58, DOI 10.1016/j.phrs.2017.05.029
   Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025
   Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384
   Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254
   Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282
   Sato T, 2019, STEM CELL REP, V13, P352, DOI 10.1016/j.stemcr.2019.06.006
   Scharner J, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-28
   Schrey A, 2017, J NEUROL SCI, V380, P142, DOI 10.1016/j.jns.2017.07.031
   Scimeca M, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1143-6
   Seale Patrick, 2000, Cell, V102, P777, DOI 10.1016/S0092-8674(00)00066-0
   Shabbir A, 2009, TRANSPLANTATION, V87, P1275, DOI 10.1097/TP.0b013e3181a1719b
   Sharma G, 2021, MOL THER, V29, P571, DOI 10.1016/j.ymthe.2020.09.028
   Shieh PB, 2013, NEUROL CLIN, V31, P1009, DOI 10.1016/j.ncl.2013.04.004
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Shoukry AI, 2009, J PEDIATR UROL, V5, P496, DOI 10.1016/j.jpurol.2009.03.015
   Siproudhis L, 2006, DIS COLON RECTUM, V49, P219, DOI 10.1007/s10350-005-0249-8
   Sitzia C, 2016, MOL THER, V24, P1949, DOI 10.1038/mt.2016.163
   Skuk D, 2004, MOL THER, V9, P475, DOI 10.1016/j.ymthe.2003.11.023
   Skuk D, 2020, J NEUROPATH EXP NEUR, V79, P1265, DOI 10.1093/jnen/nlaa110
   Skuk D, 2017, TRANSPLANT DIRECT, V3, DOI 10.1097/TXD.0000000000000740
   Skuk D, 2006, J NEUROPATH EXP NEUR, V65, P371, DOI 10.1097/01.jnen.0000218443.45782.81
   Skuk D, 2014, CELL TRANSPLANT, V23, pS141, DOI 10.3727/096368914X685032
   Skuk D, 2014, MOL THER, V22, P897, DOI 10.1038/mt.2014.57
   Skuk D, 2014, CELL TRANSPLANT, V23, P13, DOI 10.3727/096368912X661337
   Skuk D, 2012, NEUROMUSCULAR DISORD, V22, P997, DOI 10.1016/j.nmd.2012.05.005
   Skuk D, 2011, J NEUROPATH EXP NEUR, V70, P770, DOI 10.1097/NEN.0b013e31822a6baa
   Snijders T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00283
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   Staal FJT, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00443
   Sun CS, 2020, EXP NEUROL, V323, DOI 10.1016/j.expneurol.2019.113086
   Surer I, 2003, J UROLOGY, V169, P1102, DOI 10.1097/01.ju.0000044921.19074.d0
   Suzuki N, 2013, MOL THER, V21, P1424, DOI 10.1038/mt.2013.71
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Tedesco FS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003541
   Tedesco FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002342
   Thin NN, 2013, BRIT J SURG, V100, P1430, DOI 10.1002/bjs.9226
   Torrente Y, 2007, CELL TRANSPLANT, V16, P563, DOI 10.3727/000000007783465064
   Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325
   TREMBLAY JP, 1993, CELL TRANSPLANT, V2, P99, DOI 10.1177/096368979300200203
   Uezumi A, 2016, STEM CELL REP, V7, P263, DOI 10.1016/j.stemcr.2016.07.004
   Valero MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029760
   van Tienen F, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1510-8
   Vieira NM, 2012, CELL TRANSPLANT, V21, P1407, DOI 10.3727/096368911X
   Vieira NM, 2010, STEM CELL REV REP, V6, P560, DOI 10.1007/s12015-010-9187-5
   Vilquin JT, 1999, GENE THER, V6, P792, DOI 10.1038/sj.gt.3300889
   Wilson JM, 2020, HUM GENE THER, V31, P695, DOI 10.1089/hum.2020.182
   Wu JB, 2021, MOL THER, V29, P121, DOI 10.1016/j.ymthe.2020.09.012
   Wu JB, 2018, CELL REP, V25, P1966, DOI 10.1016/j.celrep.2018.10.067
   Xi HB, 2017, CELL REP, V18, P1573, DOI 10.1016/j.celrep.2017.01.040
   Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002
   Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021
   Zhao MM, 2020, STEM CELL REP, V15, P80, DOI 10.1016/j.stemcr.2020.06.004
   Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x
NR 230
TC 18
Z9 18
U1 3
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD AUG 2
PY 2021
VL 12
AR 702547
DI 10.3389/fgene.2021.702547
PG 20
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA UJ5FO
UT WOS:000691311000001
PM 34408774
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Chumarina, M
   Russ, K
   Azevedo, C
   Heuer, A
   Pihl, M
   Collin, A
   Frostner, EÅ
   Elmer, E
   Hyttel, P
   Cappelletti, G
   Zini, M
   Goldwurm, S
   Roybon, L
AF Chumarina, Margarita
   Russ, Kaspar
   Azevedo, Carla
   Heuer, Andreas
   Pihl, Maria
   Collin, Anna
   Frostner, Eleonor Asander
   Elmer, Eskil
   Hyttel, Poul
   Cappelletti, Graziella
   Zini, Michela
   Goldwurm, Stefano
   Roybon, Laurent
TI Cellular alterations identified in pluripotent stem cell-derived
   midbrain spheroids generated from a female patient with progressive
   external ophthalmoplegia and parkinsonism who carries a novel variation
   (p.Q811R) in the POLG1 gene
SO ACTA NEUROPATHOLOGICA COMMUNICATIONS
LA English
DT Article
DE Parkinson's disease; POLG1; iPSCs; Midbrain spheroids; Proteomics;
   MAO-B; Glycolysis; Alpha-synuclein
ID MITOCHONDRIAL TRANSCRIPTION FACTOR; DNA-POLYMERASE-GAMMA;
   MONOAMINE-OXIDASE B; ALPHA-SYNUCLEIN; SUBSTANTIA-NIGRA; LYSOSOMAL
   DYSFUNCTION; LACTATE-DEHYDROGENASE; MOUSE MODEL; DOPAMINE; DISEASE
AB Variations in the POLG1 gene encoding the catalytic subunit of the mitochondrial DNA polymerase gamma, have recently been associated with Parkinson's disease (PD), especially in patients diagnosed with progressive external ophthalmoplegia (PEO). However, the majority of the studies reporting this association mainly focused on the genetic identification of the variation in POLG1 in PD patient primary cells, and determination of mitochondrial DNA copy number, providing little information about the cellular alterations existing in patient brain cells, in particular dopaminergic neurons. Therefore, through the use of induced pluripotent stem cells (iPSCs), we assessed cellular alterations in novel p.Q811R POLG1 (POLG1(Q811R)) variant midbrain dopaminergic neuron-containing spheroids (MDNS) from a female patient who developed early-onset PD, and compared them to cultures derived from a healthy control of the same gender. Both POLG1 variant and control MDNS contained functional midbrain regionalized TH/FOXA2-positive dopaminergic neurons, capable of releasing dopamine. Western blot analysis identified the presence of high molecular weight oligomeric alpha-synuclein in POLG1(Q811R) MDNS compared to control cultures. In order to assess POLG1(Q811R)-related cellular alterations within the MDNS, we applied mass-spectrometry based quantitative proteomic analysis. In total, 6749 proteins were identified, with 61 significantly differentially expressed between POLG1(Q811R) and control samples. Pro- and anti-inflammatory signaling and pathways involved in energy metabolism were altered. Notably, increased glycolysis in POLG1(Q811R) MDNS was suggested by the increase in PFKM and LDHA levels and confirmed using functional analysis of glycolytic rate and oxygen consumption levels. Our results validate the use of iPSCs to assess cellular alterations in relation to PD pathogenesis, in a unique PD patient carrying a novel p.Q811R variation in POLG1, and identify several altered pathways that may be relevant to PD pathogenesis.
C1 [Chumarina, Margarita; Russ, Kaspar; Azevedo, Carla; Roybon, Laurent] Lund Univ, Dept Expt Med Sci, Cell Stem Cell Lab CNS Dis Modeling, S-22184 Lund, Sweden.
   [Chumarina, Margarita; Russ, Kaspar; Azevedo, Carla; Roybon, Laurent] Lund Univ, MultiPk, S-22184 Lund, Sweden.
   [Chumarina, Margarita; Russ, Kaspar; Azevedo, Carla; Roybon, Laurent] Lund Univ, Lund Stem Cell Ctr, S-22184 Lund, Sweden.
   [Heuer, Andreas] Lund Univ, Dept Expt Med Sci, Behav Neurosci Lab, S-22184 Lund, Sweden.
   [Pihl, Maria; Hyttel, Poul] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, DK-1870 Copenhagen, Denmark.
   [Collin, Anna] Dept Clin Genet & Pathol, Div Lab Med, Off Med Serv, Lund, Sweden.
   [Frostner, Eleonor Asander; Elmer, Eskil] Lund Univ, Dept Clin Sci Lund, Mitochondrial Med, S-22184 Lund, Sweden.
   [Cappelletti, Graziella] Univ Milan, Dept Biosci, Via Celoria 26, I-20133 Milan, Italy.
   [Cappelletti, Graziella] Univ Milan, Ctr Excellence Neurodegenerat Dis, Via Balzaretti, I-20133 Milan, Italy.
   [Zini, Michela; Goldwurm, Stefano] ASST Pini CTO, Parkinson Inst, Via Bignami 1, I-20126 Milan, Italy.
C3 Lund University; Lund University; Lund University; Lund University;
   University of Copenhagen; Lund University; University of Milan;
   University of Milan
RP Roybon, L (corresponding author), Lund Univ, Dept Expt Med Sci, Cell Stem Cell Lab CNS Dis Modeling, S-22184 Lund, Sweden.; Roybon, L (corresponding author), Lund Univ, MultiPk, S-22184 Lund, Sweden.; Roybon, L (corresponding author), Lund Univ, Lund Stem Cell Ctr, S-22184 Lund, Sweden.
EM laurent.roybon@med.lu.se
RI Hyttel, Poul/AAP-9918-2020; Cappelletti, Graziella/AAS-7780-2021; Elmér,
   Eskil/F-9341-2014; Heuer, Andreas/F-8975-2013
OI Russ, Kaspar/0000-0002-4049-3319; Heuer, Andreas/0000-0003-0300-7606;
   Pihl, Maria/0000-0001-9846-6164; Azevedo, Carla/0000-0003-3909-8984;
   Asander Frostner, Eleonor/0000-0001-8426-4836
FU Holger Crafoord Foundation; Thelma Zoegas Foundation; Shaking Generation
   Foundation; Ake Wibergs Foundation; Magnus Bergvalls Foundation; Greta
   och Johan Kocks Foundation; Swedish Research Council [VR-2015-03684, VR
   2016-01789]; Brainstem - Stem Cell Center for Excellence in Neurology -
   Innovation Fund Denmark; Lund University; Olav Thon Foundation;
   donations for science, medicine and technology at Fysiografen in Lund;
   Vinnova [2016-01789] Funding Source: Vinnova; Swedish Research Council
   [2016-01789, 2015-03684] Funding Source: Swedish Research Council
FX This work was specifically supported by the Holger Crafoord Foundation,
   the Thelma Zoegas Foundation, the Shaking Generation Foundation, the Ake
   Wibergs Foundation, the Magnus Bergvalls Foundation, the Greta och Johan
   Kocks Foundation, donations for science, medicine and technology at
   Fysiografen in Lund, the Swedish Research Council (grant # VR-2015-03684
   to LR), The Olav Thon Foundation, and Brainstem - Stem Cell Center for
   Excellence in Neurology funded by the Innovation Fund Denmark. A.H. is
   funded by a starting grant from the Swedish Research Council (VR
   2016-01789). Open access funding provided by Lund University.
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   Agnihotri S, 2016, CANCER RES, V76, P4708, DOI 10.1158/0008-5472.CAN-15-3079
   Ahmad AS, 2016, J NEUROL NEUROSCI, V7, P88, DOI [10.21767/2171-6625.100088, DOI 10.21767/2171-6625.100088]
   Aldrin-Kirk P, 2018, NEUROBIOL DIS, V109, P148, DOI 10.1016/j.nbd.2017.10.010
   Allocati N, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-017-0025-3
   Bachstetter AD, 2010, AGING DIS, V1, P199
   Bélanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016
   Bellinger FP, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-8
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   Bogetofte H, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00297
   Booth HDE, 2017, TRENDS NEUROSCI, V40, P358, DOI 10.1016/j.tins.2017.04.001
   Burbulla LF, 2017, SCIENCE, V357, P1255, DOI 10.1126/science.aam9080
   Cai R, 2019, J CLIN INVEST, V129, P4539, DOI 10.1172/JCI129987
   Chung SY, 2016, STEM CELL REP, V7, P664, DOI 10.1016/j.stemcr.2016.08.012
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170
   Feng YB, 2018, CANCER MED-US, V7, P6124, DOI 10.1002/cam4.1820
   Finberg JPM, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00340
   Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478
   Giannoccaro MP, 2017, MOVEMENT DISORD, V32, P346, DOI 10.1002/mds.26966
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hansmannel F, 2010, J ALZHEIMERS DIS, V21, P1013, DOI 10.3233/JAD-2010-100630
   Harris RA, 2016, J NEUROSCI, V36, P1871, DOI 10.1523/JNEUROSCI.3131-15.2016
   Hoffman AF, 1998, J NEUROCHEM, V70, P179
   Holmqvist S, 2016, NPJ PARKINSONS DIS, V2, DOI 10.1038/npjparkd.2016.9
   Holmqvist S, 2015, STEM CELL RES, V15, P203, DOI 10.1016/j.scr.2015.05.014
   Hong CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep25344
   Hu QS, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0060-6
   Jha SK, 2015, INT J MOL CELL MED, V4, P67
   Jiang HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1669
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3
   Kaludercic N, 2014, ANTIOXID REDOX SIGN, V20, P267, DOI 10.1089/ars.2012.4616
   Kang SS, 2018, EMBO J, V37, DOI 10.15252/embj.201798878
   Kim JM, 2006, DNA RES, V13, P275, DOI 10.1093/dnares/dsl016
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Liu P, 2014, NEUROBIOL AGING, V35, P1992, DOI 10.1016/j.neurobiolaging.2014.03.013
   Del Rey NLG, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00113
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mazzulli JR, 2016, P NATL ACAD SCI USA, V113, P1931, DOI 10.1073/pnas.1520335113
   Mehta SH, 2016, PARKINSONISM RELAT D, V30, P83, DOI 10.1016/j.parkreldis.2016.06.013
   Müller-Nedebock AC, 2019, NEUROCHEM INT, V129, DOI 10.1016/j.neuint.2019.104495
   Muñoz P, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/920953
   Newington JT, 2012, J BIOL CHEM, V287, P37245, DOI 10.1074/jbc.M112.366195
   NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8
   Park JS, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0829-3
   Peng KG, 2017, MOL NEUROBIOL, V54, P3783, DOI 10.1007/s12035-016-9944-9
   Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   RENIS M, 1977, PHARMACOLOGY, V15, P392, DOI 10.1159/000136715
   Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107
   Roussa E, 2004, CELL TISSUE RES, V318, P23, DOI 10.1007/s00441-004-0916-4
   Ryu EJ, 2005, NEUROBIOL DIS, V18, P54, DOI 10.1016/j.nbd.2004.08.016
   Santacatterina F, 2018, FREE RADICAL BIO MED, V126, P235, DOI 10.1016/j.freeradbiomed.2018.08.020
   Santos D, 2015, MOL NEUROBIOL, V52, P573, DOI 10.1007/s12035-014-8893-4
   Sato K, 2011, J NEUROL, V258, P1327, DOI 10.1007/s00415-011-5936-x
   Segura-Aguilar J, 2014, J NEUROCHEM, V129, P898, DOI 10.1111/jnc.12686
   SeguraAguilar J, 1997, J BIOL CHEM, V272, P5727, DOI 10.1074/jbc.272.9.5727
   SEGURAAGUILAR J, 1989, CHEM-BIOL INTERACT, V72, P309, DOI 10.1016/0009-2797(89)90006-9
   Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035
   Smith AM, 2018, MOVEMENT DISORD, V33, P1580, DOI 10.1002/mds.104
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Sturza A, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8954201
   Sulzer D, 2000, P NATL ACAD SCI USA, V97, P11869, DOI 10.1073/pnas.97.22.11869
   Tong JC, 2017, BRAIN, V140, P2460, DOI 10.1093/brain/awx172
   Tong JC, 2015, NEUROBIOL DIS, V82, P243, DOI 10.1016/j.nbd.2015.06.010
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Wilms H, 2003, FASEB J, V17, P500, DOI 10.1096/fj.02-0314fje
   Woodard CM, 2014, CELL REP, V9, P1173, DOI 10.1016/j.celrep.2014.10.023
   Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883
   Youdim MBH, 2006, BRIT J PHARMACOL, V147, pS287, DOI 10.1038/sj.bjp.0706464
   Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108
   Zhang M, 2018, J NEUROPATH EXP NEUR, V77, P1163, DOI 10.1093/jnen/nly102
   Zhang XD, 2016, ELIFE, V5, DOI 10.7754/eLife.13374
   Zucca FA, 2017, PROG NEUROBIOL, V155, P96, DOI 10.1016/j.pneurobio.2015.09.012
NR 82
TC 21
Z9 21
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2051-5960
J9 ACTA NEUROPATHOL COM
JI Acta Neuropathol. Commun.
PD DEC 16
PY 2019
VL 7
IS 1
AR 208
DI 10.1186/s40478-019-0863-7
PG 19
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA KF9UI
UT WOS:000509587600001
PM 31843010
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Young, MJ
   Longley, MJ
   Li, FY
   Kasiviswanathan, R
   Wong, LJ
   Copeland, WC
AF Young, Matthew J.
   Longley, Matthew J.
   Li, Fang-Yuan
   Kasiviswanathan, Rajesh
   Wong, Lee-Jun
   Copeland, William C.
TI Biochemical analysis of human <i>POLG2</i> variants associated with
   mitochondrial disease
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID DNA-POLYMERASE-GAMMA; TRANSFER-RNA SYNTHETASES; PROGRESSIVE EXTERNAL
   OPHTHALMOPLEGIA; COMPARATIVE GENOMIC HYBRIDIZATION; ACCESSORY SUBUNIT;
   PROCESSIVITY FACTOR; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CATALYTIC
   SUBUNIT; MUTATIONS
AB Defects in mitochondrial DNA (mtDNA) maintenance comprise an expanding repertoire of polymorphic diseases caused, in part, by mutations in the genes encoding the p140 mtDNA polymerase (POLG), its p55 accessory subunit (POLG2) or the mtDNA helicase (C10orf2). In an exploration of nuclear genes for mtDNA maintenance linked to mitochondrial disease, eight heterozygous mutations (six novel) in POLG2 were identified in one control and eight patients with POLG-related mitochondrial disease that lacked POLG mutations. Of these eight mutations, we biochemically characterized seven variants [c.307G>A (G103S); c.457C>G (L153V); c.614C>G (P205R); c.1105A>G (R369G); c.1158T>G (D386E); c.1268C>A (S423Y); c.1423_1424delTT (L475DfsX2)] that were previously uncharacterized along with the wild-type protein and the G451E pathogenic variant. These seven mutations encode amino acid substitutions that map throughout the protein, including the p55 dimer interface and the C-terminal domain that interacts with the catalytic subunit. Recombinant proteins harboring these alterations were assessed for stimulation of processive DNA synthesis, binding to the p140 catalytic subunit, binding to dsDNA and self-dimerization. Whereas the G103S, L153V, D386E and S423Y proteins displayed wild-type behavior, the P205R and R369G p55 variants had reduced stimulation of processivity and decreased affinity for the catalytic subunit. Additionally, the L475DfsX2 variant, which possesses a C-terminal truncation, was unable to bind the p140 catalytic subunit, unable to bind dsDNA and formed aberrant oligomeric complexes. Our biochemical analysis helps explain the pathogenesis of POLG2 mutations in mitochondrial disease and emphasizes the need to quantitatively characterize the biochemical consequences of newly discovered mutations before classifying them as pathogenic.
C1 [Li, Fang-Yuan; Wong, Lee-Jun] Baylor Coll Med, Dept Mol & Human Genet, Mitochondrial Diagnost Lab, Houston, TX 77030 USA.
   [Young, Matthew J.; Longley, Matthew J.; Kasiviswanathan, Rajesh; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, DHHS, Res Triangle Pk, NC 27709 USA.
C3 Baylor College of Medicine; National Institutes of Health (NIH) - USA;
   NIH National Institute of Environmental Health Sciences (NIEHS)
RP Wong, LJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Mitochondrial Diagnost Lab, 1 Baylor Plaza,NAB 2015, Houston, TX 77030 USA.
EM ljwong@bcm.edu; copelan1@niehs.nih.gov
RI Kasiviswanathan, Rajesh/D-2744-2012; Copeland, William/C-4242-2019
OI Young, Matthew/0000-0002-5109-4719; Copeland,
   William/0000-0002-0359-0953
FU NIH, National Institute of Environmental Health Sciences [ES 065078]
FX This research was supported by the Intramural Research Program of the
   NIH, National Institute of Environmental Health Sciences (ES 065078).
CR Appleton BA, 2004, MOL CELL, V15, P233, DOI 10.1016/j.molcel.2004.06.018
   Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029
   Carrodeguas JA, 2000, NUCLEIC ACIDS RES, V28, P1237, DOI 10.1093/nar/28.5.1237
   Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200
   Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Chinault AC, 2009, GENET MED, V11, P518, DOI 10.1097/GIM.0b013e3181abd83c
   Cohen BH, 2010, POLG RELATED DISORDE
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614
   Doublié S, 1998, NATURE, V391, P251, DOI 10.1038/34593
   Fan L, 1999, P NATL ACAD SCI USA, V96, P9527, DOI 10.1073/pnas.96.17.9527
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102
   HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744
   Iyengar B, 2002, P NATL ACAD SCI USA, V99, P4483, DOI 10.1073/pnas.072664899
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I
   KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283
   Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wong LJC, 2008, CLIN CHEM, V54, P1141, DOI 10.1373/clinchem.2008.103721
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yakubovskaya E, 2007, EMBO J, V26, P4283, DOI 10.1038/sj.emboj.7601843
   Zuccola HJ, 2000, MOL CELL, V5, P267, DOI 10.1016/S1097-2765(00)80422-0
NR 46
TC 51
Z9 53
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD AUG 1
PY 2011
VL 20
IS 15
BP 3052
EP 3066
DI 10.1093/hmg/ddr209
PG 15
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 790AD
UT WOS:000292560000014
PM 21555342
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Dong, HB
   Guo, W
   Yue, RC
   Sun, XG
   Zhou, ZX
AF Dong, Haibo
   Guo, Wei
   Yue, Ruichao
   Sun, Xinguo
   Zhou, Zhanxiang
TI Nuclear Nicotinamide Adenine Dinucleotide Deficiency by Nmnat1 Deletion
   Impaired Hepatic Insulin Signaling, Mitochondrial Function, and
   Hepatokine Expression in Mice Fed a High-Fat Diet
SO LABORATORY INVESTIGATION
LA English
DT Article
DE glucose metabolism; hepatokines; insulin resistance; mitochondrial
   dysfunction; metabolic syndrome; NAD plus
ID METABOLIC SYNDROME; NAD(+) METABOLISM; LIVER; DISEASE; PATHOPHYSIOLOGY;
   BIOSYNTHESIS; SIRTUINS; MUSCLE; SIRT1
AB Metabolic syndrome (MetS) is a worldwide challenge that is closely associated with obesity, nonalcoholic liver disease, insulin resistance, and type 2 diabetes. Boosting nicotinamide adenine dinucleotide (NAD+) presents great potential in preventing MetS. However, the function of nuclear NAD+ in the development of MetS remains poorly understood. In this study, hepatocyte-specific Nmnat1 knockout mice were used to determine a possible link between nuclear NAD+ and high-fat diet (HFD)-induced MetS. We found that Nmnat1 knockout significantly reduced hepatic nuclear NAD+ levels but did not exacerbate HFD-induced obesity and hepatic triglycerides accumulation. Interestingly, loss of Nmnat1 caused insulin resistance. Further analysis revealed that Nmnat1 deletion promoted gluconeogenesis but inhibited glycogen synthesis in the liver. Moreover, Nmnat1 deficiency induced mitochondrial dysfunction by decreasing mitochondrial DNA (mtDNA)-encoded complexes I and IV, suppressing mtDNA replication and mtRNA transcription and reducing mtDNA copy number. In addition, Nmnat1 depletion affected the expression of hepatokines in the liver, particularly downregulating the expression of follistatin. These findings highlight the importance of nuclear NAD+ in maintaining insulin sensitivity and provide insights into the mechanisms underlying HFD-induced insulin resistance. (c) 2024 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights reserved.
C1 [Dong, Haibo; Guo, Wei; Yue, Ruichao; Sun, Xinguo; Zhou, Zhanxiang] Univ N Carolina, Ctr Translat Biomed Res, North Carolina Res Campus, Kannapolis, NC 27412 USA.
   [Zhou, Zhanxiang] Univ N Carolina, Dept Nutr, Greensboro, NC 27412 USA.
C3 University of North Carolina; University of North Carolina; University
   of North Carolina Greensboro
RP Zhou, ZX (corresponding author), Univ N Carolina, Ctr Translat Biomed Res, North Carolina Res Campus, Kannapolis, NC 27412 USA.; Zhou, ZX (corresponding author), Univ N Carolina, Dept Nutr, Greensboro, NC 27412 USA.
EM z_zhou@uncg.edu
RI Dong, Haibo/AFK-5099-2022; Yue, Ruichao/JOK-7199-2023
FU National Institutes of Health [R01AA018844, R01AA020212]
FX This research was supported by the National Institutes of Health grants,
   R01AA018844 (Zhanxiang Zhou) and R01AA020212 (Zhanxiang Zhou) .
CR Amjad S, 2021, MOL METAB, V49, DOI 10.1016/j.molmet.2021.101195
   Arenillas JF, 2007, STROKE, V38, P2196, DOI 10.1161/STROKEAHA.106.480004
   Cambronne XA, 2020, TRENDS BIOCHEM SCI, V45, P858, DOI 10.1016/j.tibs.2020.05.010
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Carafa V, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0224-3
   Charni-Natan M, 2020, STAR PROTOC, V1, DOI 10.1016/j.xpro.2020.100086
   Covarrubias AJ, 2021, NAT REV MOL CELL BIO, V22, P119, DOI 10.1038/s41580-020-00313-x
   Dall M, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101388
   Ding RB, 2017, INT J BIOL SCI, V13, P852, DOI 10.7150/ijbs.19370
   Dong HB, 2021, CELL MOL GASTROENTER, V12, P793, DOI 10.1016/j.jcmgh.2021.05.013
   Eblimit A, 2018, EXP EYE RES, V173, P32, DOI 10.1016/j.exer.2018.04.010
   Elhassan YS, 2017, J ENDOCR SOC, V1, P816, DOI 10.1210/js.2017-00092
   Ennequin G, 2019, AM J PHYSIOL-ENDOC M, V317, pE11, DOI 10.1152/ajpendo.00433.2018
   Fan L, 2020, J DIABETES INVEST, V11, P1403, DOI 10.1111/jdi.13303
   Frederick DW, 2015, J BIOL CHEM, V290, P1546, DOI 10.1074/jbc.M114.579565
   Gao P, 2014, J MOL MED, V92, P347, DOI 10.1007/s00109-013-1111-4
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Han XQ, 2019, J CACHEXIA SARCOPENI, V10, P1241, DOI 10.1002/jcsm.12474
   Holper L, 2019, NEUROPSYCHOPHARMACOL, V44, P837, DOI 10.1038/s41386-018-0090-0
   Iqbal T, 2022, BIOCHEM BIOPH RES CO, V636, P89, DOI 10.1016/j.bbrc.2022.10.072
   Jensen-Cody SO, 2021, MOL METAB, V44, DOI 10.1016/j.molmet.2020.101138
   Kane AE, 2018, CIRC RES, V123, P868, DOI 10.1161/CIRCRESAHA.118.312498
   Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791
   Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472
   Meex RCR, 2017, NAT REV ENDOCRINOL, V13, P508, DOI 10.1038/nrendo.2017.56
   Mukherjee S, 2017, HEPATOLOGY, V65, P616, DOI 10.1002/hep.28912
   Nassir F, 2016, WORLD J GASTROENTERO, V22, P10084, DOI 10.3748/wjg.v22.i46.10084
   North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224
   Rochlani Y, 2017, THER ADV CARDIO DIS, V11, P215, DOI 10.1177/1753944717711379
   Roden M, 2008, WIEN MED WOCHENSCHR, V158, P558, DOI 10.1007/s10354-008-0595-y
   Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z
   Sangwung P, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa017
   Sergi D, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00532
   Stott NL, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123650
   Stromsdorfer KL, 2016, CELL REP, V16, P1851, DOI 10.1016/j.celrep.2016.07.027
   Takamura T, 2008, OBESITY, V16, P2601, DOI 10.1038/oby.2008.419
   Tao RY, 2018, NAT MED, V24, P1058, DOI 10.1038/s41591-018-0048-0
   Tong JL, 2022, DIABET METAB SYND OB, V15, P3285, DOI 10.2147/DMSO.S380053
   Trammell SAJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26933
   Wang LF, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0464-z
   Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528
   Xiao WS, 2018, ANTIOXID REDOX SIGN, V28, P251, DOI 10.1089/ars.2017.7216
   Yang Y, 2016, BBA-PROTEINS PROTEOM, V1864, P1787, DOI 10.1016/j.bbapap.2016.06.014
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Zhou CC, 2016, BRIT J PHARMACOL, V173, P2352, DOI 10.1111/bph.13513
NR 45
TC 3
Z9 3
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0023-6837
EI 1530-0307
J9 LAB INVEST
JI Lab. Invest.
PD MAR
PY 2024
VL 104
IS 3
AR 100329
DI 10.1016/j.labinv.2024.100329
EA FEB 2024
PG 10
WC Medicine, Research & Experimental; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pathology
GA LH4W8
UT WOS:001185895600001
PM 38237740
DA 2024-11-01
ER

PT S
AU Tanji, K
   Bonilla, E
AF Tanji, Kurenai
   Bonilla, Eduardo
BE Pon, LA
   Schon, EA
TI Optical Imaging techniques (histochemical, immunohistochemical, and
   <i>in situ</i> hybridization staining methods) to visualize mitochondria
SO MITOCHONDRIA, 2ND EDITION
SE Methods in Cell Biology
LA English
DT Review; Book Chapter
ID CYTOCHROME-C-OXIDASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   KEARNS-SAYRE-SYNDROME; STROKE-LIKE EPISODES; RED FIBERS MERRF; MYOCLONIC
   EPILEPSY; SKELETAL-MUSCLE; DNA DELETIONS; RESPIRATORY-CHAIN; MTDNA
   MUTATION
C1 Columbia Univ, Dept Pathol, New York, NY 10032 USA.
   Columbia Univ, Dept Neurol, New York, NY 10032 USA.
C3 Columbia University; Columbia University
RP Tanji, K (corresponding author), Columbia Univ, Dept Pathol, New York, NY 10032 USA.
FU NICHD NIH HHS [P01 HD 32062] Funding Source: Medline; NINDS NIH HHS [NS
   11766] Funding Source: Medline
CR Ackrell BAC, 2002, MOL ASPECTS MED, V23, P369, DOI 10.1016/S0098-2997(02)00012-2
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ANDREETTA F, 1991, J NEUROL SCI, V105, P88, DOI 10.1016/0022-510X(91)90123-O
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   BEDETTI CD, 1985, J HISTOCHEM CYTOCHEM, V33, P446, DOI 10.1177/33.5.2580882
   BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991
   Bonilla E, 1999, BBA-BIOENERGETICS, V1410, P171, DOI 10.1016/S0005-2728(98)00165-0
   BONILLA E, 1992, BRAIN PATHOL, V2, P113, DOI 10.1111/j.1750-3639.1992.tb00679.x
   BONILLA E, 1975, J ULTRA MOL STRUCT R, V51, P404, DOI 10.1016/S0022-5320(75)80103-1
   CAPALDI RA, 1990, ARCH BIOCHEM BIOPHYS, V280, P252, DOI 10.1016/0003-9861(90)90327-U
   COOPER CE, 1991, BIOCH CELL BIOL, V69, P596
   Di Mauro S., 2004, MYOLOGY PHILADELPHIA, P1623
   DIMAURO S, 1994, MITOCHONDRIAL DISORD, P91
   ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015
   HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661
   JOHNSON MA, 1983, J NEUROL SCI, V60, P31, DOI 10.1016/0022-510X(83)90125-9
   JOHNSON MA, 1988, J NEUROL SCI, V87, P75, DOI 10.1016/0022-510X(88)90056-1
   KADENBACH B, 1987, CURR TOP BIOENERG, V15, P113
   KLOECKENERGRUISSEM B, 1987, CURR GENET, V12, P311, DOI 10.1007/BF00405753
   Manfredi G, 1997, ANN NEUROL, V42, P180, DOI 10.1002/ana.410420208
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   NAKASE H, 1990, AM J HUM GENET, V46, P418
   Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   PEL HJ, 1992, CURR GENET, V21, P139, DOI 10.1007/BF00318473
   PETTE D, 1981, HISTOCHEM J, V13, P319, DOI 10.1007/BF01006885
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   SELIGMAN AM, 1951, SCIENCE, V113, P317, DOI 10.1126/science.113.2934.317-a
   SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Shoubridge Eric A., 1993, P109
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   SPARACO M, 1995, BRAIN PATHOL, V5, P125, DOI 10.1111/j.1750-3639.1995.tb00586.x
   SZABOLCS MJ, 1994, KIDNEY INT, V45, P1388, DOI 10.1038/ki.1994.181
   Taanman JW, 1997, J BIOENERG BIOMEMBR, V29, P151, DOI 10.1023/A:1022638013825
   Taanman JW, 1996, BBA-MOL BASIS DIS, V1315, P199, DOI 10.1016/0925-4439(95)00127-1
   Tanji K, 1999, ANN NEUROL, V45, P377, DOI 10.1002/1531-8249(199903)45:3<377::AID-ANA14>3.0.CO;2-M
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   Taylor RW, 1996, ANN NEUROL, V39, P224, DOI 10.1002/ana.410390212
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209
   Vu TH, 1998, NEUROLOGY, V51, P1190, DOI 10.1212/WNL.51.4.1190
   Vu TH, 2000, MUSCLE NERVE, V23, P80, DOI 10.1002/(SICI)1097-4598(200001)23:1<80::AID-MUS10>3.0.CO;2-V
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 57
TC 11
Z9 11
U1 0
U2 5
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0091-679X
BN 978-0-12-544173-5
J9 METHOD CELL BIOL
JI Methods Cell Biol.
PY 2007
VL 80
BP 135
EP +
DI 10.1016/S0091-679X(06)80006-3
PG 22
WC Biochemistry & Molecular Biology; Cell Biology
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA BGB65
UT WOS:000245920700006
PM 17445692
DA 2024-11-01
ER

PT J
AU Namani, S
   Kavetsky, K
   Lin, CY
   Maharjan, S
   Gamper, HB
   Li, NS
   Piccirilli, JA
   Hou, YM
   Drndic, M
AF Namani, Srilahari
   Kavetsky, Kyril
   Lin, Chih-Yuan
   Maharjan, Sunita
   Gamper, Howard B.
   Li, Nan-Sheng
   Piccirilli, Joseph A.
   Hou, Ya-Ming
   Drndic, Marija
TI Unraveling RNA Conformation Dynamics in Mitochondrial Encephalomyopathy,
   Lactic Acidosis, and Stroke-like Episode Syndrome with Solid-State
   Nanopores
SO ACS NANO
LA English
DT Article
DE nanopore; MELAS; tRNA conformation; silicon nitride; m(1)G9 methylation;
   mitochondrialtRNA
ID MOLECULE MASS-SPECTROMETRY; TRANSFER RNALEU(UUR) GENE;
   SINGLE-STRANDED-DNA; SALT; ENCEPHALOPATHY; TRANSLOCATION; MYOPATHY;
   MUTATION; STABILITY; NUCLEOTIDE
AB This study investigates transfer ribonucleic acid (tRNA) conformational dynamics in the context of MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) using solid-state silicon nitride (SiN) nanopore technology. SiN nanopores in thin membranes with specific dimensions exhibit high signal resolution, enabling real-time and single-molecule electronic detection of tRNA conformational changes. We focus on human mitochondrial tRNALeu(UAA) (mt-Leu(UAA)) that decodes Leu codons UUA/UUG (UUR) during protein synthesis on the mt-ribosome. The single A14G substitution in mt-Leu(UAA) is the major cause of MELAS disease. Measurements of current blockades and dwell times reveal distinct conformational dynamics of the wild-type (WT) and the A14G variant of mt-Leu(UAA) in response to the conserved post-transcriptional m(1)G9 methylation. While the m(1)G9-modified WT transcript adopts a more stable structure relative to the unmodified transcript, the m(1)G9-modified MELAS transcript adopts a less stable structure relative to the unmodified transcript. Notably, these differential features were observed at 0.4 M KCl, but not at 3 M KCl, highlighting the importance of experimental settings that are closer to physiological conditions. This work demonstrates the feasibility of the nanopore platform to discern tRNA molecules that differ by a single-nucleotide substitution or by a single methylation event, providing an important step forward to explore changes in the conformational dynamics of other RNA molecules in human diseases.
C1 [Namani, Srilahari; Lin, Chih-Yuan; Drndic, Marija] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.
   [Kavetsky, Kyril] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
   [Maharjan, Sunita; Gamper, Howard B.; Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.
   [Li, Nan-Sheng; Piccirilli, Joseph A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA.
   [Piccirilli, Joseph A.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA.
C3 University of Pennsylvania; University of Pennsylvania; Jefferson
   University; University of Chicago; University of Chicago
RP Drndic, M (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.; Hou, YM (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.
EM ya-ming.hou@jefferson.edu; drndic@physics.upenn.edu
RI ; Piccirilli, Joseph/HSG-2238-2023
OI Namani, Srilahari/0000-0003-3146-8880; Piccirilli,
   Joseph/0000-0002-0541-6270; Hou, Ya-Ming/0000-0001-6546-2597; Li,
   Nan-Sheng/0000-0002-1185-3688; Kavetsky, Kyril/0000-0001-7213-1219
FU NIH Opportunity Fund grant "Probing RNA conformational dynamics through
   a solid-state nanopore with sub-100 nanosecond time resolution" from the
   Technology Development Coordinating Center (TDCC) [U24 HG011735]; NIH
   [R21 HG011120, R21 HG-12395, R35 GM149336]; NSF [NNCI-1542153]; NSF
   through the University of Pennsylvania Materials Research Science and
   Engineering Center (MRSEC) [DMR-1720530]
FX This work was supported by the NIH Opportunity Fund grant "Probing RNA
   conformational dynamics through a solid-state nanopore with sub-100
   nanosecond time resolution" from the Technology Development Coordinating
   Center (TDCC) under the NHGRI federal award no. U24 HG011735. Y.M.H.
   also acknowledges partial support from the parent NIH R21 HG011120
   grant, M.D. acknowledges partial support from the parent NIH R21
   HG-12395 grant, and J.A.P. acknowledges support from NIH R35 GM149336
   grant. The Si-based chips were fabricated in the Singh Center for
   Nanotechnology at the University of Pennsylvania, supported by the NSF
   grant no. NNCI-1542153. M.D. acknowledges the use of TEM instrumentation
   supported by the NSF through the University of Pennsylvania Materials
   Research Science and Engineering Center (MRSEC) DMR-1720530.
CR Al-Hashimi HM, 2008, CURR OPIN STRUC BIOL, V18, P321, DOI 10.1016/j.sbi.2008.04.004
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Baaken G, 2011, ACS NANO, V5, P8080, DOI 10.1021/nn202670z
   Bakshloo MA, 2023, ACS CHEM NEUROSCI, V14, P2517, DOI 10.1021/acschemneuro.3c00164
   Bakshloo MA, 2022, J AM CHEM SOC, V144, P2716, DOI 10.1021/jacs.1c11758
   Bandarkar P, 2020, BIOPHYS J, V118, P1612, DOI 10.1016/j.bpj.2020.01.030
   Bezrukov SM, 2000, J MEMBRANE BIOL, V174, P1, DOI 10.1007/s002320001026
   Bhatta A, 2021, NAT STRUCT MOL BIOL, V28, P713, DOI 10.1038/s41594-021-00637-y
   Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101
   Boskovic F, 2022, NAT CHEM, V14, P1258, DOI 10.1038/s41557-022-01037-5
   Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106
   Chau C, 2022, ACS NANO, V16, P20075, DOI 10.1021/acsnano.2c08312
   Chien CC, 2019, ACS NANO, V13, P10545, DOI 10.1021/acsnano.9b04626
   Chou YC, 2021, J CHEM PHYS, V154, DOI 10.1063/5.0044227
   Chou YC, 2020, ACS NANO, V14, P6715, DOI 10.1021/acsnano.9b09964
   Erxleben DA, 2024, ANAL CHEM, V96, P1606, DOI 10.1021/acs.analchem.3c04387
   Ettedgui J, 2016, J AM CHEM SOC, V138, P7228, DOI 10.1021/jacs.6b02917
   Fan HC, 2021, LIFE-BASEL, V11, DOI 10.3390/life11111111
   Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5
   Firnkes M, 2010, NANO LETT, V10, P2162, DOI 10.1021/nl100861c
   Fischer NM, 2018, NUCLEIC ACIDS RES, V46, P4872, DOI 10.1093/nar/gky221
   Fologea D, 2005, NANO LETT, V5, P1734, DOI 10.1021/nl051063o
   Fuller CW, 2016, P NATL ACAD SCI USA, V113, P5233, DOI 10.1073/pnas.1601782113
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Halverson KM, 2005, J BIOL CHEM, V280, P34056, DOI 10.1074/jbc.M507928200
   Helm M, 1999, BIOCHEMISTRY-US, V38, P13338, DOI 10.1021/bi991061g
   Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636
   Henley RY, 2016, PROG MOL BIOL TRANSL, V139, P73, DOI 10.1016/bs.pmbts.2015.10.020
   Henley RY, 2016, NANO LETT, V16, P138, DOI 10.1021/acs.nanolett.5b03331
   Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013
   Hopkins JF, 2009, NUCLEIC ACIDS RES, V37, P6205, DOI 10.1093/nar/gkp646
   Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749
   Ivankin A, 2014, ACS NANO, V8, P10774, DOI 10.1021/nn504551d
   Kasianowicz J. J., 2008, HDB BIOSENSORSAND BI
   Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770
   Kasianowicz JJ, 2001, ANAL CHEM, V73, P2268, DOI 10.1021/ac000958c
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kim HD, 2002, P NATL ACAD SCI USA, V99, P4284, DOI 10.1073/pnas.032077799
   Klein DJ, 2004, RNA, V10, P1366, DOI 10.1261/rna.7390804
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Koculi E, 2007, J AM CHEM SOC, V129, P2676, DOI 10.1021/ja068027r
   Kumar S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00684
   Larkin J, 2014, BIOPHYS J, V106, P696, DOI 10.1016/j.bpj.2013.12.025
   Lin CY, 2022, NANO LETT, V22, P8719, DOI 10.1021/acs.nanolett.2c03546
   Liu K, 2014, ACS NANO, V8, P2504, DOI 10.1021/nn406102h
   Lott MT., 2013, Curr Protoc Bioinf, V44, P1231, DOI DOI 10.1002/0471250953.BI0123S44
   Maharjan Sunita, 2023, bioRxiv, DOI 10.1101/2023.12.09.569632
   Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171
   McDermott JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209713
   McLaughlin S., 1977, CURR TOP MEMBR TRANS, V9, P71
   Owczarzy R, 2008, BIOCHEMISTRY-US, V47, P5336, DOI 10.1021/bi702363u
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pia S., 2022, MELAS SYNDROME
   Reiner JE, 2010, P NATL ACAD SCI USA, V107, P12080, DOI 10.1073/pnas.1002194107
   Reinhard L, 2017, NUCLEIC ACIDS RES, V45, P12469, DOI 10.1093/nar/gkx902
   Reinhard L, 2015, NUCLEIC ACIDS RES, V43, P5664, DOI 10.1093/nar/gkv481
   Robertson JWF, 2007, P NATL ACAD SCI USA, V104, P8207, DOI 10.1073/pnas.0611085104
   Rosenstein JK, 2012, NAT METHODS, V9, P487, DOI [10.1038/nmeth.1932, 10.1038/NMETH.1932]
   Rozevsky Y, 2020, ACS NANO, V14, P13964, DOI 10.1021/acsnano.0c06375
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Schibel AEP, 2010, J AM CHEM SOC, V132, P17992, DOI 10.1021/ja109501x
   Schneider GF, 2010, NANO LETT, V10, P3163, DOI [10.1021/nl102069z, 10.1021/nl101046t]
   Sethi K, 2021, ACS NANO, V15, P8474, DOI 10.1021/acsnano.0c10887
   Smeets RMM, 2006, NANO LETT, V6, P89, DOI 10.1021/nl052107w
   Soni N, 2022, ACS NANO, V16, P11405, DOI 10.1021/acsnano.2c05391
   Suzuki T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18068-6
   Tan ZJ, 2011, BIOPHYS J, V101, P176, DOI 10.1016/j.bpj.2011.05.050
   Tan ZJ, 2006, BIOPHYS J, V90, P1175, DOI 10.1529/biophysj.105.070904
   Tian FJ, 2023, P NATL ACAD SCI USA, V120, DOI 10.1073/pnas.2218425120
   Vaidyanathan S, 2023, ANAL CHEM, V95, P9892, DOI 10.1021/acs.analchem.3c00855
   Venta K, 2013, ACS NANO, V7, P4629, DOI 10.1021/nn4014388
   Vilardo E, 2012, NUCLEIC ACIDS RES, V40, P11583, DOI 10.1093/nar/gks910
   Voigts-Hoffmann F, 2007, J AM CHEM SOC, V129, P13382, DOI 10.1021/ja075520+
   Waduge P, 2017, ACS NANO, V11, P5706, DOI 10.1021/acsnano.7b01212
   Wang YJ, 2020, RNA, V26, P470, DOI 10.1261/rna.073882.119
   Wanunu M, 2011, ACS NANO, V5, P9345, DOI 10.1021/nn203764j
   Wanunu M, 2011, J AM CHEM SOC, V133, P486, DOI 10.1021/ja107836t
   Wanunu M, 2010, NAT NANOTECHNOL, V5, P807, DOI [10.1038/NNANO.2010.202, 10.1038/nnano.2010.202]
   WILLIAMS AP, 1989, BIOCHEMISTRY-US, V28, P4283, DOI 10.1021/bi00436a025
   Woodson SA, 2009, METHOD ENZYMOL, V469, P189, DOI 10.1016/S0076-6879(09)69009-1
   Xia ZH, 2022, PROTEOMICS, V22, DOI 10.1002/pmic.202100071
   Yao HT, 2023, ALGORITHM MOL BIOL, V18, DOI 10.1186/s13015-023-00236-0
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Ying YL, 2022, NAT NANOTECHNOL, V17, P1136, DOI 10.1038/s41565-022-01193-2
   Yusko EC, 2017, NAT NANOTECHNOL, V12, P360, DOI [10.1038/NNANO.2016.267, 10.1038/nnano.2016.267]
   Zahid OK, 2016, SCI REP-UK, V6, DOI 10.1038/srep29565
NR 88
TC 1
Z9 1
U1 8
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD JUN 21
PY 2024
VL 18
IS 26
BP 17240
EP 17250
DI 10.1021/acsnano.4c04625
EA JUN 2024
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA XG9T7
UT WOS:001253168700001
PM 38906834
DA 2024-11-01
ER

PT J
AU Villanueva-Paz, M
   Povea-Cabello, S
   Villalón-García, I
   Alvarez-Córdoba, M
   Suárez-Rivero, JM
   Talaverón-Rey, M
   Jackson, S
   Falcón-Moya, R
   Rodríguez-Moreno, A
   Sánchez-Alcázar, JA
AF Villanueva-Paz, Marina
   Povea-Cabello, Suleva
   Villalon-Garcia, Irene
   Alvarez-Cordoba, Monica
   Suarez-Rivero, Juan M.
   Talaveron-Rey, Marta
   Jackson, Sandra
   Falcon-Moya, Rafael
   Rodriguez-Moreno, Antonio
   Sanchez-Alcazar, Jose A.
TI Parkin-mediated mitophagy and autophagy flux disruption in cellular
   models of MERRF syndrome
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Mitochondria; Mitochondrial diseases; Autophagy; Mitophagy; Coenzyme
   Q(10)
ID ACTIVATED PROTEIN-KINASE; RAGGED-RED FIBERS; MITOCHONDRIAL-DNA
   MUTATIONS; OXIDATIVE STRESS; COENZYME Q(10); MYOCLONIC EPILEPSY; HUMAN
   FIBROBLASTS; SKELETAL-MUSCLE; MTDNA MUTATION; DOUBLE-BLIND
AB Mitochondrial diseases are considered rare genetic disorders characterized by defects in oxidative phosphorylation (OXPHOS). They can be provoked by mutations in nuclear DNA (nDNA) or mitochondrial DNA (mtDNA). MERRF (Myoclonic Epilepsy with Ragged-Red Fibers) syndrome is one of the most frequent mitochondrial diseases, principally caused by the m.8344A> G mutation in mtDNA, which affects the translation of all mtDNA-encoded proteins and therefore impairs mitochondrial function.
   In the present work, we evaluated autophagy and mitophagy flux in transmitochondrial cybrids and fibroblasts derived from a MERRF patient, reporting that Parkin-mediated mitophagy is increased in MERRF cell cultures. Our results suggest that supplementation with coenzyme Q(10) (CoQ), a component of the electron transport chain (ETC) and lipid antioxidant, prevents Parkin translocation to the mitochondria. In addition, CoQ acts as an enhancer of autophagy and mitophagy flux, which partially improves cell pathophysiology. The significance of Parkin-mediated mitophagy in cell survival was evaluated by silencing the expression of Parkin in MERRF cybrids. Our results show that mitophagy acts as a cell survival mechanism in mutant cells.
   To confirm these results in one of the main affected cell types in MERRF syndrome, mutant induced neurons (iNs) were generated by direct reprogramming of patients-derived skin fibroblasts. The treatment of MERRF iNs with Guttaquinon CoQ(10) (GuttaQ), a water-soluble derivative of CoQ, revealed a significant improvement in cell bioenergetics. These results indicate that iNs, along with fibroblasts and cybrids, can be utilized as reliable cellular models to shed light on disease pathomechanisms as well as for drug screening.
C1 [Villanueva-Paz, Marina; Povea-Cabello, Suleva; Villalon-Garcia, Irene; Alvarez-Cordoba, Monica; Suarez-Rivero, Juan M.; Talaveron-Rey, Marta; Sanchez-Alcazar, Jose A.] Univ Pablo de Olavide, CSIC, CABD, Carretera Utrera Km 1, Seville 41013, Spain.
   [Villanueva-Paz, Marina; Povea-Cabello, Suleva; Villalon-Garcia, Irene; Alvarez-Cordoba, Monica; Suarez-Rivero, Juan M.; Talaveron-Rey, Marta; Sanchez-Alcazar, Jose A.] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain.
   [Jackson, Sandra] Uniklinikum CG Carus, Dept Neurol, Dresden, Germany.
   [Falcon-Moya, Rafael; Rodriguez-Moreno, Antonio] Univ Pablo de Olavide, Dept Fisiol Anat & Biol Celular, Lab Neurociencia Celular & Plasticidad, Seville 41013, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); Universidad
   Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology
   (CABD); CIBER - Centro de Investigacion Biomedica en Red; CIBERER;
   Instituto de Salud Carlos III; Technische Universitat Dresden;
   Universidad Pablo de Olavide
RP Sánchez-Alcázar, JA (corresponding author), Univ Pablo de Olavide, CSIC, CABD, Carretera Utrera Km 1, Seville 41013, Spain.
EM jasanalc@upo.es
RI Povea, Suleva/LCE-7098-2024; Sanchéz-Alcázar, José/L-4925-2014;
   Villanueva, Marina/AAN-9818-2020; Rodriguez-Moreno, Antonio/I-5225-2015
OI Villanueva Paz, Marina/0000-0003-4728-201X; Alvarez-Cordoba,
   Monica/0000-0002-7596-8708; Suarez-Rivero, Juan
   Miguel/0000-0002-6260-7284; Rodriguez-Moreno,
   Antonio/0000-0002-8078-6175; Talaveron, Marta/0000-0002-5006-3814
FU FIS [PI16/00786]; Ministerio de Sanidad, Spain; Fondo Europeo de
   Desarrollo Regional (FEDERUnion Europea); Spanish Ministry of Education,
   Culture and Sports; "Ayudas para la Formacion de Profesorado
   Universitario" (FPU); AEPMI (Asociacion de Enfermos de Patologia
   Mitocondrial); ENACH (Asociacion de enfermos de Neurodegeneracion con
   Acumulacion Cerebral de Hierro); EMBO
FX This work was supported by FIS PI16/00786 grant, Ministerio de Sanidad,
   Spain and Fondo Europeo de Desarrollo Regional (FEDERUnion Europea),
   Spanish Ministry of Education, Culture and Sports, "Ayudas para la
   Formacion de Profesorado Universitario" (FPU) and AEPMI (Asociacion de
   Enfermos de Patologia Mitocondrial) and ENACH (Asociacion de enfermos de
   Neurodegeneracion con Acumulacion Cerebral de Hierro). We thank Dr.
   Malin Parmar group (Developmental and Regenerative Neurobiology, Lund
   University, Sweden), specially Janelle Drouin-Ouellet for her helpful
   experience and advise on direct reprogramming technical issues. The
   support of an EMBO short term fellowship to MVP is gratefully
   acknowledged.
CR ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   BOWMAN PD, 1975, EXP CELL RES, V93, P184, DOI 10.1016/0014-4827(75)90438-3
   Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082
   BRESOLIN N, 1990, J NEUROL SCI, V100, P70, DOI 10.1016/0022-510X(90)90015-F
   Chen RS, 1997, EUR NEUROL, V37, P212, DOI 10.1159/000117445
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   Chuang YC, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5691215
   Cloonan SM, 2016, J CLIN INVEST, V126, P809, DOI 10.1172/JCI81113
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   Cronin-Furman EN, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-6
   De la Mata M, 2012, NEUROTHERAPEUTICS, V9, P446, DOI 10.1007/s13311-012-0103-3
   Decleer M, 2018, TOXINS, V10, DOI 10.3390/toxins10070266
   DiMauro S., 2003, GENEREVIEWS R
   DiMauro S, 2007, BIOSCIENCE REP, V27, P5, DOI 10.1007/s10540-007-9032-5
   Ding J, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005306, 10.1371/journal.pgen.1005549]
   Drouin-Ouellet J, 2017, EMBO MOL MED, V9, P1117, DOI 10.15252/emmm.201607471
   Duberley KEC, 2013, J INHERIT METAB DIS, V36, P63, DOI 10.1007/s10545-012-9511-0
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Erol I, 2009, NEUROMUSCULAR DISORD, V19, P275, DOI 10.1016/j.nmd.2009.01.012
   ESTORNELL E, 1992, FEBS LETT, V311, P107, DOI 10.1016/0014-5793(92)81378-Y
   Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108
   Fukuda T, 2006, MOL THER, V14, P831, DOI 10.1016/j.ymthe.2006.08.009
   Garrido-Maraver J, 2015, BBA-MOL BASIS DIS, V1852, P2535, DOI 10.1016/j.bbadis.2015.08.027
   Garrido-Maraver J, 2012, BRIT J PHARMACOL, V167, P1311, DOI 10.1111/j.1476-5381.2012.02086.x
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Glover EI, 2010, MUSCLE NERVE, V42, P739, DOI 10.1002/mus.21758
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074
   Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879
   Iommarini L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030764
   Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Jing L, 2015, INT J BIOL SCI, V11, P59, DOI 10.7150/ijbs.10174
   Khandelwal PJ, 2011, HUM MOL GENET, V20, P2091, DOI 10.1093/hmg/ddr091
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Le Boedec K, 2016, VET CLIN PATH, V45, P648, DOI 10.1111/vcp.12390
   Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451
   Lee SK, 2012, CELL SIGNAL, V24, P2329, DOI 10.1016/j.cellsig.2012.07.022
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Lin DS, 2017, ONCOTARGET, V8, P73627, DOI 10.18632/oncotarget.20617
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   Lorenzoni PJ, 2014, ARQ NEURO-PSIQUIAT, V72, P803, DOI 10.1590/0004-282X20140124
   Malicdan MCV, 2012, BRAIN PATHOL, V22, P82, DOI 10.1111/j.1750-3639.2011.00543.x
   Marco-Brualla J, 2019, CANCERS, V11, DOI 10.3390/cancers11071027
   Martín-Maestro P, 2016, HUM MOL GENET, V25, P792, DOI 10.1093/hmg/ddv616
   Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528
   Mastroeni D, 2018, ALZHEIMERS DEMENT, V14, P775, DOI 10.1016/j.jalz.2017.12.005
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Mauro-Lizcano M, 2015, AUTOPHAGY, V11, P833, DOI 10.1080/15548627.2015.1034403
   Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985
   Morán M, 2014, BBA-MOL BASIS DIS, V1842, P1059, DOI 10.1016/j.bbadis.2014.03.013
   Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511
   Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604
   Oropesa-Avila M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.58
   OZAWA M, 1995, NEUROMUSCULAR DISORD, V5, P483, DOI 10.1016/0960-8966(95)00009-C
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639
   Parikh SM, 2015, SEMIN NEPHROL, V35, P108, DOI 10.1016/j.semnephrol.2015.01.011
   Paz MV, 2016, EXPERT OPIN THER TAR, V20, P487, DOI 10.1517/14728222.2016.1101068
   Pereira CV, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708084
   Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680
   Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108
   Rodríguez-Hernández A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174
   Sánchez-Alcázar JA, 2007, APOPTOSIS, V12, P1195, DOI 10.1007/s10495-006-0044-6
   Shepherd RK, 2006, J INHERIT METAB DIS, V29, P86, DOI 10.1007/s10545-006-0148-8
   Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shrigley S, 2018, JOVE-J VIS EXP, DOI 10.3791/56904
   Sinha RA, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0113-7
   Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Szczepanowska J, 2012, BBA-BIOENERGETICS, V1817, P1740, DOI 10.1016/j.bbabio.2012.02.028
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Tsai HY, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/6384759
   Tsai KL, 2011, MOL NUTR FOOD RES, V55, pS227, DOI 10.1002/mnfr.201100147
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X
   Villanueva-Paz M, 2019, BBA-MOL CELL RES, V1866, P861, DOI 10.1016/j.bbamcr.2019.02.010
   Villanueva-Paz M, 2016, EXPERIENTIA SUPPL, V107, P45, DOI 10.1007/978-3-319-43589-3_3
   Virgilio R, 2009, J NEUROL SCI, V281, P85, DOI 10.1016/j.jns.2009.01.025
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739
   Wang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150441
   Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018
   Webb JL, 2004, INT J BIOCHEM CELL B, V36, P2541, DOI 10.1016/j.biocel.2004.02.003
   Wong YC, 2014, J NEUROSCI, V34, P1293, DOI 10.1523/JNEUROSCI.1870-13.2014
   Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
   Xu Z., 2017, SCI REP, V7
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Ye X, 2015, HUM MOL GENET, V24, P2938, DOI 10.1093/hmg/ddv056
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Yuan JH, 2013, J CLIN PATHOL, V66, P659, DOI 10.1136/jclinpath-2012-201431
   Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200
   Zhang XJ, 2013, ACTA PHARMACOL SIN, V34, P595, DOI 10.1038/aps.2012.184
   Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797
   Zhao BZ, 2016, GENES DIS, V3, P82, DOI 10.1016/j.gendis.2015.12.002
   Zhao CY, 2017, ONCOTARGET, V8, P20988, DOI 10.18632/oncotarget.15470
   Zhu YS, 2014, METHOD ENZYMOL, V547, P39, DOI 10.1016/B978-0-12-801415-8.00003-5
   Zsurka G, 2007, AM J HUM GENET, V80, P298, DOI 10.1086/511282
   Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871
NR 118
TC 26
Z9 26
U1 0
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD JUN 1
PY 2020
VL 1866
IS 6
AR 165726
DI 10.1016/j.bbadis.2020.165726
PG 25
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA LG2PT
UT WOS:000527950000023
PM 32061767
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Al-Shahoumi, R
   Brady, LI
   Tarnopolsky, MA
AF Al-Shahoumi, Rashid
   Brady, Lauren I.
   Tarnopolsky, Mark A.
TI A mitochondrial disorder with ptosis and exercise intolerance without
   ophthalmoparesis secondary to m.5865 T &gt; C variant
SO MITOCHONDRION
LA English
DT Article
ID DNA MUTATIONS; GENETICS; GENOME
AB We describe a novel mitochondrial variant (m.5865 T > C) in a patient with decreased exercise endurance and juvenile onset slowly progressive bilateral ptosis without ophthamloparesis. The m.5865 T > C variant was seen in 82.9% of mtDNA molecules in skeletal muscle tissue and similar to 8% of mtDNA molecules in urine epithelium, but was not detected in blood leukocytes. The proband does not demonstrate any additional features often seen in individuals with a mitochondrial disorder (i.e., sensorineural hearing loss, type 2 diabetes, stroke-like episodes, muscle weakness, ophthalmoparesis, cardiomyopathy or cardiac arrhythmias). This case suggests that ptosis and exercise intolerance, without ophthalmoparesis, are the primary clinical features of the m.5865 T > C. mtDNA variant.
C1 [Al-Shahoumi, Rashid; Brady, Lauren I.; Tarnopolsky, Mark A.] McMaster Univ, Dept Paediat, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.
C3 McMaster University
RP Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Paediat, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
FU CIHR Foundation [143325]; Warren Lammert and Family; Dan Wright and
   family
FX Dr. Tarnopolsky was funded by a CIHR Foundation grant (#143325) and
   research into mitochondrial diseases has also been supported by Warren
   Lammert and Family and Dan Wright and family. We would like to thank Dr.
   Jian-Qiang Lu for the muscle biopsy pathology images.
CR El-Hattab AW, 2016, CELL CALCIUM, V60, P199, DOI 10.1016/j.ceca.2016.03.003
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Heighton JN, 2019, MITOCHONDRION, V49, P227, DOI 10.1016/j.mito.2019.09.002
   Heighton JN, 2019, MITOCHONDRION, V44, P15, DOI 10.1016/j.mito.2017.12.006
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Kerkhof J, 2017, J MOL DIAGN, V19, P905, DOI 10.1016/j.jmoldx.2017.07.004
   Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153
   Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44
   Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Sonney S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005867
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Wong LJC, 2020, GENET MED, DOI 10.1038/s41436-019-0746-0
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   Zsurka G., 2009, MITOWHEEL VISUALIZIN
NR 17
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL
PY 2020
VL 53
BP 150
EP 153
DI 10.1016/j.mito.2020.05.006
PG 4
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA MO6RS
UT WOS:000551651100016
PM 32485333
DA 2024-11-01
ER

PT J
AU Valentino, ML
   Barboni, P
   Rengo, C
   Achilli, A
   Torroni, A
   Lodi, R
   Tonon, C
   Barbiroli, B
   Fortuna, F
   Montagna, P
   Baruzzi, A
   Carelli, V
AF Valentino, M. L.
   Barboni, P.
   Rengo, C.
   Achilli, A.
   Torroni, A.
   Lodi, R.
   Tonon, C.
   Barbiroli, B.
   Fortuna, F.
   Montagna, P.
   Baruzzi, A.
   Carelli, V.
TI The 13042G→A/ND5 mutation in mtDNA is pathogenic and can be associated
   also with a prevalent ocular phenotype
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID HEREDITARY OPTIC NEUROPATHY; LHON/MELAS OVERLAP SYNDROME;
   MITOCHONDRIAL-DNA MUTATION; MELAS-SYNDROME; COMPLEX-I;
   CLINICAL-FEATURES; G13513A MUTATION; FREQUENT CAUSE; ND5 MUTATION;
   HOT-SPOT
AB Background: Overlapping phenotypes including LHON, MELAS, and Leigh syndrome have recently been associated with numerous mtDNA point mutations in the ND5 gene of complex I, now considered a mutational hot spot.
   Objective: To identify the mtDNA defect in a family with a prevalent ocular phenotype, including LHON-like optic neuropathy, retinopathy, and cataract, but characterised also by strokes, early deaths, and miscarriages on the maternal line.
   Results: Sequencing of the entire mitochondrial genome from the proband's muscle DNA identified the heteroplasmic 13042G -> A transition, which was previously described only once in a patient with a different mitochondrial disease. This mutation fulfils the major pathogenic criteria, inducing an amino acid change (A236T) at an invariant position in a highly conserved domain of the ND5 gene. Phosphorus magnetic resonance spectroscopy in the proband disclosed an in vivo brain and skeletal muscle energy metabolism deficit.
   Conclusions: These findings conclusively establish the pathogenic role of the 13042G -> A mutation and underscore its variable clinical expression.
C1 Univ Bologna, Dipartimento Sci Neurol, I-40123 Bologna, Italy.
   Ctr Oftalmol Salus, Bologna, Italy.
   Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy.
   Univ Bologna, Dipartimento Med Clin & Biotecnol Applicata D Cam, Bologna, Italy.
C3 University of Bologna; University of Pavia; University of Bologna
RP Carelli, V (corresponding author), Univ Bologna, Dipartimento Sci Neurol, Via Ugo Foscolo 7, I-40123 Bologna, Italy.
EM carelli@neuro.unibo.it
RI Lodi, Raffaele/K-4984-2016; Torroni, Antonio/E-1557-2011; Tonon,
   Caterina/K-6680-2016; Achilli, Alessandro/I-9236-2012; Barboni,
   Piero/AAA-9936-2020
OI Achilli, Alessandro/0000-0001-6871-3451; Lodi,
   Raffaele/0000-0003-3878-304X; Barboni, Piero/0000-0002-0118-4177;
   Torroni, Antonio/0000-0002-4163-4478; CARELLI,
   VALERIO/0000-0003-4923-6404; TONON, CATERINA/0000-0002-0506-499X;
   VALENTINO, MARIA LUCIA/0000-0001-5323-0115
FU Telethon [GGP02323] Funding Source: Medline
CR Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   BOTTOMLY PA, 1989, CLIN CHEM, V59, P392
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   Crimi M, 2003, NEUROLOGY, V60, P1857, DOI 10.1212/01.WNL.0000066048.72780.69
   *EEC CONC RES PROJ, 1995, MAGN RESON IMAGING, V13, P115
   Isashiki Y, 1998, ACTA OPHTHALMOL SCAN, V76, P6, DOI 10.1034/j.1600-0420.1998.760103.x
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Lodi R, 2000, BRAIN, V123, P1896, DOI 10.1093/brain/123.9.1896
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Penisson-Besnier I, 2000, NEUROLOGY, V55, P317, DOI 10.1212/WNL.55.2.317
   Petruzzella V, 2003, NEUROLOGY, V61, P1017, DOI 10.1212/01.WNL.0000080363.10902.E9
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   RUMMELT V, 1993, OPHTHALMOLOGY, V100, P1757
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   Taylor RW, 2002, EUR J HUM GENET, V10, P141, DOI 10.1038/sj.ejhg.5200773
   Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511
   Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236
   Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193
NR 26
TC 23
Z9 24
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD JUL
PY 2006
VL 43
IS 7
AR e38
DI 10.1136/jmg.2005.037507
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 059DP
UT WOS:000238713800020
PM 16816025
OA Green Published
DA 2024-11-01
ER

PT J
AU Sobenin, IA
   Zhelankin, AV
   Sinyov, VV
   Bobryshev, YV
   Orekhov, AN
AF Sobenin, Igor A.
   Zhelankin, Andrey V.
   Sinyov, Vasily V.
   Bobryshev, Yuri V.
   Orekhov, Alexander N.
TI Mitochondrial Aging: Focus on Mitochondrial DNA Damage in
   Atherosclerosis - A Mini-Review
SO GERONTOLOGY
LA English
DT Review
DE Atherosclerosis; Aging; Mitochondria; Mitochondrial DNA; Cell
   senescence; Mutations
ID OXIDATIVE STRESS; CHOLESTEROL ACCUMULATION; TELOMERE LENGTH; MUTATIONS;
   CELLS; DISEASE; MTDNA; RISK; INFLAMMATION; LIPOPROTEIN
AB Atherosclerosis is a complex disease which can be described as an excessive fibrofatty, proliferative, inflammatory response to damage to the artery wall involving several cell types such as smooth muscle cells, monocyte- derived macrophages, lymphocytes, dendritic cells and platelets. On the other hand, atherosclerosis is a typical age-related degenerative pathology, which is characterized by signs of cell senescence in the arterial wall including reduced cell proliferation, irreversible growth arrest and apoptosis, increased DNA damage, the presence of epigenetic modifications, shortening of telomere length and mitochondrial dysfunction. The most prominent characteristics of mitochondrial aging are their structural alterations and mitochondrial DNA damage. The mechanisms of mitochondrial genome damage in the development of chronic age-related diseases such as atherosclerosis are not yet well understood. This review focuses on the latest findings from studies of those mutations of the mitochondrial genome which may play an important role in the development of atherosclerosis and which are, at the same time, also markers of mitochondrial aging and cell senescence. (C) 2014 S. Karger AG, Basel
C1 [Sobenin, Igor A.; Zhelankin, Andrey V.; Sinyov, Vasily V.] Russian Acad Med Sci, Inst Clin Cardiol, Russian Cardiol Res & Prod Complex, Med Genet Lab, Moscow, Russia.
   [Sobenin, Igor A.; Zhelankin, Andrey V.; Bobryshev, Yuri V.; Orekhov, Alexander N.] Russian Acad Med Sci, Inst Gen Pathol & Pathophysiol, Lab Angiopathol, Moscow, Russia.
   [Orekhov, Alexander N.] Skolkovo Innovat Ctr, Atherosclerosis Res Inst, Moscow, Russia.
   [Bobryshev, Yuri V.] Univ New S Wales, Fac Med, Sch Med Sci, Sydney, NSW 2052, Australia.
   [Bobryshev, Yuri V.] Univ Western Sydney, Sch Med, Campbelltown, NSW, Australia.
C3 National Medical Research Center of Cardiology; Russian Academy of
   Medical Sciences; Russian Academy of Medical Sciences; Institute of
   General Pathology & Pathophysiology, RAMS; University of New South Wales
   Sydney; Western Sydney University
RP Bobryshev, YV (corresponding author), Univ New S Wales, Fac Med, Sch Med Sci, Sydney, NSW 2052, Australia.
EM y.bobryshev@unsw.edu.au
RI Bobryshev, Yuri/J-2838-2013; Sinyov, Vasiliy/K-9084-2014; Sobenin,
   Igor/J-4282-2013; Zhelankin, Andrey/F-8247-2014
OI Sinyov, Vasiliy/0000-0001-5105-5763; Sobenin, Igor/0000-0003-0978-6444;
   Zhelankin, Andrey/0000-0002-3014-2005
FU Russian Scientific Foundation [14-14-01038]; Russian Science Foundation
   [14-14-01038] Funding Source: Russian Science Foundation
FX The authors wish to acknowledge the support from the Russian Scientific
   Foundation (grant No. 14-14-01038).
CR Andreassi MG, 2003, MUTAT RES-REV MUTAT, V543, P67, DOI 10.1016/S1383-5742(02)00089-3
   Avital G, 2012, HUM MOL GENET, V21, P4214, DOI 10.1093/hmg/dds245
   Bhopal RS, 2009, INT J EPIDEMIOL, V38, P1072, DOI 10.1093/ije/dyp202
   Bobryshev YV, 2011, ATHEROSCLEROSIS, V219, P171, DOI 10.1016/j.atherosclerosis.2011.07.016
   Bogliolo M, 1999, MUTAGENESIS, V14, P77, DOI 10.1093/mutage/14.1.77
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Chistiakov DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238463
   Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572
   Chung IM, 1998, AM J PATHOL, V152, P913
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d
   Ding Y, 2013, INT J MOL MED, V32, P768, DOI 10.3892/ijmm.2013.1459
   Ding ZF, 2014, CARDIOVASC RES, V103, P619, DOI 10.1093/cvr/cvu114
   Ding ZF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01077
   Gerhard M, 1996, HYPERTENSION, V27, P849, DOI 10.1161/01.HYP.27.4.849
   HARIRI RJ, 1988, AM J PATHOL, V131, P132
   Harrison CM, 2011, ENVIRON HEALTH PERSP, V119, P676, DOI 10.1289/ehp.1002857
   Horan MP, 2014, HUM GENET, V133, P435, DOI 10.1007/s00439-013-1402-4
   Ioannidis JPA, 2009, CIRC-CARDIOVASC GENE, V2, P7, DOI 10.1161/CIRCGENETICS.108.833392
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Kroenke CH, 2012, ATHEROSCLEROSIS, V220, P506, DOI 10.1016/j.atherosclerosis.2011.10.041
   Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14
   Lee HY, 2006, ANN HUM GENET, V70, P59, DOI 10.1111/j.1529-8817.2005.00217.x
   Lenaz G, 2006, ANTIOXID REDOX SIGN, V8, P417, DOI 10.1089/ars.2006.8.417
   Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146
   Liu CS, 2005, ANN NY ACAD SCI, V1042, P70, DOI 10.1196/annals.1338.008
   Marian AJ, 2011, CIRC RES, V108, P784, DOI 10.1161/CIRCRESAHA.111.242768
   Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966
   Miller YI, 2010, SUBCELL BIOCHEM, V51, P229, DOI 10.1007/978-90-481-8622-8_8
   Moslehi J, 2012, CIRC RES, V110, P1226, DOI 10.1161/CIRCRESAHA.111.246868
   Mueller EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016455
   Nomiyama T, 2004, ANN NY ACAD SCI, V1011, P193, DOI 10.1196/annals.1293.020
   OREKHOV AN, 1990, CIRC RES, V66, P311, DOI 10.1161/01.RES.66.2.311
   OREKHOV AN, 1985, EXP MOL PATHOL, V42, P117, DOI 10.1016/0014-4800(85)90022-X
   Raschenberger J, 2013, ATHEROSCLEROSIS, V229, P469, DOI 10.1016/j.atherosclerosis.2013.05.027
   Rizza S, 2014, ATHEROSCLEROSIS, V232, P260, DOI 10.1016/j.atherosclerosis.2013.10.029
   Sazonova M, 2009, ATHEROSCLEROSIS, V204, P184, DOI 10.1016/j.atherosclerosis.2008.09.001
   SCHWARTZ CJ, 1993, AM J CARDIOL, V71, pB9, DOI 10.1016/0002-9149(93)90139-4
   Schwartz SM, 1998, ANNU REV MED, V49, P437
   Sobenin IA, 2013, CURR PHARM DESIGN, V19, P5942
   Sobenin IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068070
   Sobenin IA, 2013, ATHEROSCLEROSIS, V227, P283, DOI 10.1016/j.atherosclerosis.2013.01.006
   Sobenin IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046573
   Sobenin IA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/832464
   STEMERMAN MB, 1982, P NATL ACAD SCI-BIOL, V79, P3863, DOI 10.1073/pnas.79.12.3863
   TERTOV VV, 1988, TISSUE CELL, V20, P849, DOI 10.1016/0040-8166(88)90026-2
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wallace DC, 2010, P NATL ACAD SCI USA, V107, P8947, DOI 10.1073/pnas.0914635107
   Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388
   Wang YC, 2011, J NEPHROL, V24, P351, DOI 10.5301/JN.2010.5816
   Wang Y, 2014, CIRC RES, V114, P421, DOI 10.1161/CIRCRESAHA.114.302153
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X
   Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010
   Yao YG, 2013, STEM CELL RES, V10, P361, DOI 10.1016/j.scr.2013.01.006
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
NR 56
TC 26
Z9 27
U1 1
U2 8
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
EI 1423-0003
J9 GERONTOLOGY
JI Gerontology
PY 2015
VL 61
IS 4
BP 343
EP 349
DI 10.1159/000368923
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA CL4TV
UT WOS:000356948800007
PM 25531813
OA Bronze
DA 2024-11-01
ER

PT J
AU Hsiao, CW
   Peng, TI
   Peng, AC
   Reiter, RJ
   Tanaka, M
   Lai, YK
   Jou, MJ
AF Hsiao, Chia-Wei
   Peng, Tsung-I.
   Peng, Alexander C.
   Reiter, Russel J.
   Tanaka, Masashi
   Lai, Yiu-Kay
   Jou, Mei-Jie
TI Long-term Aβ exposure augments mCa<SUP>2+</SUP>-independent
   mROS-mediated depletion of cardiolipin for the shift of a lethal
   transient mitochondrial permeability transition to its permanent mode in
   NARP cybrids: a protective targeting of melatonin
SO JOURNAL OF PINEAL RESEARCH
LA English
DT Article
DE amyloid beta-peptide; cardiolipin; mCa(2+); melatonin; mitochondrial
   reactive oxygen species; neurological muscle weakness; ataxia; and
   retinitis pigmentosa cybrids; transient-MPT
ID OXYGEN SPECIES GENERATION; ALZHEIMERS-DISEASE; AMYLOID-BETA; OXIDATIVE
   STRESS; CALCIUM HOMEOSTASIS; COGNITIVE DECLINE; INDUCED APOPTOSIS;
   T8993G MUTATION; COMMON DELETION; ROS RELEASE
AB Mitochondrial dysfunction is a hallmark of amyloid beta-peptide (A beta)-induced neurodegeneration of Alzheimer's disease (AD). This study investigated whether mtDNA T8993G mutation-induced complex V inhibition, clinically associated with neurological muscle weakness, ataxia, and retinitis pigmentosa (NARP), is a potential risk factor for AD and the pathological link for long-term exposure of A beta-induced mitochondrial toxicity and apoptosis in NARP cybrids. Using noninvasive fluorescence probe-coupled laser scanning imaging microscopy and NARP cybrids harboring 98% mutant genes along with its parental 143B osteosarcoma cells, we demonstrated that A beta-augmented mitochondrial Ca2+ (mCa(2+))-independent mitochondrial reactive oxygen species (mROS) formation for a cardiolipin (CL, a major mitochondrial protective phospholipid)-dependent lethal modulation of the mitochondrial permeability transition (MPT). A beta augmented not only the amount but also the propagation rate of mROS-induced mROS formation to significantly depolarize mitochondrial membrane potential (Delta Psi(m)) and reduce mCa(2+) stress. A beta-augmented mROS oxidized and depleted CL, thereby enhances mitochondrial fission and movement retardation, which promoted the NARP-augmented lethal transient-MPT (t-MPT) to switch to its irreversible mode of permanent-MPT (p-MPT). Interestingly, melatonin, a multiple mitochondrial protector, markedly reduced A beta-augmented mROS formation and therefore significantly reduced mROS-mediated depolarization of Delta Psi(m), fission of mitochondria and retardation of mitochondrial movement to stabilize CL and hence the MPT. In the presence of melatonin, A beta-promoted p-MPT was reversed to a protective t-MPT, which preserved Delta Psi(m) and lowered elevated mCa(2+) to sublethal levels for an enhanced mCa(2+)-dependent O-2 consumption. Thus, melatonin may potentially rescue AD patients associated with NARP symptoms.
C1 [Hsiao, Chia-Wei; Lai, Yiu-Kay] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan.
   [Hsiao, Chia-Wei; Lai, Yiu-Kay] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan.
   [Peng, Tsung-I.] Chang Gung Mem Hosp, Dept Neurol, Kee Lung Med Ctr, Kee Lung, Taiwan.
   [Peng, Tsung-I.] Chang Gung Univ, Dept Med, Tao Yuan 333, Taiwan.
   [Peng, Alexander C.] Williston Northampton Sch, Easthampton, MA USA.
   [Reiter, Russel J.] Univ Texas San Antonio, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA.
   [Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Tokyo, Japan.
   [Jou, Mei-Jie] Chang Gung Univ, Dept Physiol & Pharmacol, Coll Med, Tao Yuan 333, Taiwan.
C3 National Tsing Hua University; National Tsing Hua University; Chang Gung
   Memorial Hospital; Chang Gung University; University of Texas System;
   University of Texas Health Science Center at San Antonio; Tokyo
   Metropolitan Institute of Gerontology; Chang Gung University
RP Jou, MJ (corresponding author), Chang Gung Univ, Dept Physiol & Pharmacol, Sch Med, 259 Wen Hwa 1st Rd, Tao Yuan 333, Taiwan.
EM mjjou@mail.cgu.edu.tw
RI Reiter, Russel/D-3221-2009
FU Chang Gung Medical Research Foundation, Taiwan [CMRPD 180491-3, CMRPD
   170411-3, CMRPG 270341-2]
FX This work was supported by the grants CMRPD 180491-3 and CMRPD 170411-3
   (to Jou) and CMRPG 270341-2 (to Peng) from the Chang Gung Medical
   Research Foundation, Taiwan.
CR Acin-Pérez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021
   Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010
   Alikhani N, 2009, J BIOENERG BIOMEMBR, V41, P447, DOI 10.1007/s10863-009-9244-4
   Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177
   Beal MF, 2000, TRENDS NEUROSCI, V23, P298, DOI 10.1016/S0166-2236(00)01584-8
   Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001
   Bojarski L, 2008, NEUROCHEM INT, V52, P621, DOI 10.1016/j.neuint.2007.10.002
   Camandola S, 2011, BBA-MOL CELL RES, V1813, P965, DOI 10.1016/j.bbamcr.2010.10.005
   Canevari L, 1999, FEBS LETT, V457, P131, DOI 10.1016/S0014-5793(99)01028-5
   Cardoso SM, 2004, J NEUROCHEM, V89, P1417, DOI 10.1111/j.1471-4159.2004.02438.x
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Clementi ME, 2005, FEBS LETT, V579, P2913, DOI 10.1016/j.febslet.2005.04.041
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Dragicevic N, 2011, J PINEAL RES, V51, P75, DOI 10.1111/j.1600-079X.2011.00864.x
   Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868
   Du H, 2010, BBA-MOL BASIS DIS, V1802, P198, DOI 10.1016/j.bbadis.2009.07.005
   Eckert A, 2008, J MOL MED, V86, P1255, DOI 10.1007/s00109-008-0391-6
   Ferreira IL, 2012, CELL CALCIUM, V51, P95, DOI 10.1016/j.ceca.2011.11.008
   Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x
   Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42
   Gleichmann M, 2011, ANTIOXID REDOX SIGN, V14, P1261, DOI 10.1089/ars.2010.3386
   Griffiths EJ, 2012, ADV EXP MED BIOL, V942, P249, DOI 10.1007/978-94-007-2869-1_11
   Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005
   He Y, 2011, ASN NEURO, V3, P13, DOI 10.1042/AN20100025
   Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001
   Hung CHL, 2010, AGEING RES REV, V9, P447, DOI 10.1016/j.arr.2010.05.003
   Jou MJ, 2008, ADV DRUG DELIVER REV, V60, P1512, DOI 10.1016/j.addr.2008.06.004
   Jou MJ, 2007, J PINEAL RES, V43, P389, DOI 10.1111/j.1600-079X.2007.00490.x
   Jou MJ, 2011, J PINEAL RES, V50, P427, DOI 10.1111/j.1600-079X.2011.00861.x
   Jou MJ, 2010, J PINEAL RES, V48, P20, DOI 10.1111/j.1600-079X.2009.00721.x
   Jou MJ, 2004, J PINEAL RES, V37, P55, DOI 10.1111/j.1600-079X.2004.00140.x
   Jou MJ, 2002, J BIOMED SCI, V9, P507
   Jou MJ, 2004, ANN NY ACAD SCI, V1011, P45, DOI 10.1196/annals.1293.005
   Khan SM, 2000, ANN NEUROL, V48, P148, DOI 10.1002/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7
   Kim HS, 2002, NEUROREPORT, V13, P1989, DOI 10.1097/00001756-200210280-00032
   LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960
   Leuner K, 2007, ANTIOXID REDOX SIGN, V9, P1659, DOI 10.1089/ars.2007.1763
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230
   Mancuso M, 2007, ANTIOXID REDOX SIGN, V9, P1631, DOI 10.1089/ars.2007.1761
   Mao PZ, 2011, BBA-MOL BASIS DIS, V1812, P1359, DOI 10.1016/j.bbadis.2011.08.005
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010
   MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992
   Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3
   Meratan AA, 2011, J MOL BIOL, V409, P826, DOI 10.1016/j.jmb.2011.04.045
   Moreira PI, 2007, ANTIOXID REDOX SIGN, V9, P1621, DOI 10.1089/ars.2007.1703
   Moreira PI, 2001, BIOSCIENCE REP, V21, P789, DOI 10.1023/A:1015536808304
   Moreira PI, 2002, J NEUROSCI RES, V69, P257, DOI 10.1002/jnr.10282
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Onyango IG, 2005, NEUROBIOL DIS, V19, P312, DOI 10.1016/j.nbd.2005.01.026
   Onyango I, 2006, J ALZHEIMERS DIS, V9, P183
   Pagani Lucia, 2011, Int J Alzheimers Dis, V2011, P925050, DOI 10.4061/2011/925050
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Park J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023211
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Peng TI, 2006, BBA-MOL BASIS DIS, V1762, P241, DOI 10.1016/j.bbadis.2005.10.008
   Peng TI, 2012, J PINEAL RES, V52, P93, DOI 10.1111/j.1600-079X.2011.00923.x
   Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105
   Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002
   Reddy PH, 2007, ANTIOXID REDOX SIGN, V9, P1647, DOI 10.1089/ars.2007.1754
   Reddy PH, 2006, NEUROBIOL AGING, V27, P1060, DOI 10.1016/j.neurobiolaging.2005.04.014
   Reddy PH, 2009, EXP NEUROL, V218, P286, DOI 10.1016/j.expneurol.2009.03.042
   Reddy PH, 2005, BRAIN RES REV, V49, P618, DOI 10.1016/j.brainresrev.2005.03.004
   Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106
   Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943
   Rosales-Corral SA, 2012, J PINEAL RES, V52, P167, DOI 10.1111/j.1600-079X.2011.00937.x
   SanMartin CD, 2012, NEURODEGENER DIS, V10, P34, DOI 10.1159/000334901
   Sanz-Blasco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002718
   SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467
   Schönfeld P, 2007, ANTIOXID REDOX SIGN, V9, P191, DOI 10.1089/ars.2007.9.191
   Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003
   Sheehan JP, 1997, J NEUROSCI, V17, P4612
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918
   Swerdlow RH, 2007, J NEUROSCI RES, V85, P3416, DOI 10.1002/jnr.21167
   Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje
   Tillement L, 2006, STEROIDS, V71, P725, DOI 10.1016/j.steroids.2006.05.003
   Tillement L, 2011, MITOCHONDRION, V11, P13, DOI 10.1016/j.mito.2010.08.009
   Toescu EC, 2007, AGING CELL, V6, P267, DOI 10.1111/j.1474-9726.2007.00296.x
   Venegas C, 2012, J PINEAL RES, V52, P217, DOI 10.1111/j.1600-079X.2011.00931.x
   Villani G, 2001, METHOD CELL BIOL, V65, P119, DOI 10.1016/S0091-679X(01)65007-6
   Yu JT, 2009, PROG NEUROBIOL, V89, P240, DOI 10.1016/j.pneurobio.2009.07.009
   ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367
   Zhu YJ, 2000, FASEB J, V14, P1244, DOI 10.1096/fasebj.14.9.1244
   Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001
   Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029
NR 95
TC 22
Z9 22
U1 1
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3098
EI 1600-079X
J9 J PINEAL RES
JI J. Pineal Res.
PD JAN
PY 2013
VL 54
IS 1
BP 107
EP 125
DI 10.1111/jpi.12004
PG 19
WC Endocrinology & Metabolism; Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Neurosciences & Neurology; Physiology
GA 088PV
UT WOS:000314848500011
PM 24446866
DA 2024-11-01
ER

PT S
AU Molnar, MJ
   Kovacs, GG
AF Molnar, Maria J.
   Kovacs, Gabor G.
BE Kovacs, GG
   Alafuzoff, I
TI Mitochondrial diseases
SO NEUROPATHOLOGY
SE Handbook of Clinical Neurology
LA English
DT Article; Book Chapter
ID MUTATIONS; DISORDERS; ENCEPHALOMYOPATHY; NUCLEAR; GENES
AB Mitochondrial disorders represent a major challenge in medicine. Most of the mitochondrial proteins are encoded by the nuclearDNA(nDNA), whereas a very small fraction is encoded by the mitochondrial DNA (mtDNA). Mutations in mtDNA or mitochondria-related nDNA genes can result in mitochondrial dysfunction. The disease usually affects multiple organs in varying locations and severity; however, there are some forms which affect a single organ. The diagnosis of mitochondrial disorders is based on clinical examination, biochemical and histopathologic examinations, functional studies, and molecular genetic testing. Neuropathologic alterations of the muscle are variable and can range from striking abnormalities, such as cytochrome oxidase-negative and ragged red fibers, to nonspecific or minimal changes. Neuropathologic alterations in the brain show common features in disorders with different genetic background. These are characterized by various degrees of vacuolation in the white and gray matter, regional neurodegeneration with reactive astrogliosis, loss of oligodendrocytes, presence of macrophages and microgliosis, capillary proliferation, and mineralization of vessel walls. The advent of molecular genetics, the discovery of biomarkers and new sequencing platforms to perform targeted exome and whole-genome sequencing have changed traditional approaches to diagnose mitochondrial diseases.
C1 [Molnar, Maria J.] Semmelweis Univ, Rare Disorders, Inst Genom Med, Budapest, Hungary.
   [Kovacs, Gabor G.] Med Univ Vienna, Inst Neurol, Vienna, Austria.
C3 Semmelweis University; Medical University of Vienna
RP Molnar, MJ (corresponding author), Semmelweis Univ, Inst Genom Med & Rare Disorders, Tomostr 25-29, H-1083 Budapest, Hungary.
EM molnarmj@gmail.com
RI Kovacs, Gabor/A-7468-2013
CR Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Cohen BH, 2013, NEUROTHERAPEUTICS, V10, P227, DOI 10.1007/s13311-013-0188-3
   CRIMMINS D, 1993, J NEUROL NEUROSUR PS, V56, P900, DOI 10.1136/jnnp.56.8.900
   Delarue A, 2000, Pediatr Transplant, V4, P67, DOI 10.1034/j.1399-3046.2000.00090.x
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Kovács GG, 2005, BRAIN, V128, P35, DOI 10.1093/brain/awh310
   Legati A, 2016, BBA-BIOENERGETICS, V1857, P1326, DOI 10.1016/j.bbabio.2016.02.022
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Molnar MJ, 2009, ENCY MOL MECH DIS
   Remenyi V, 2015, MITOCHONDR DNA, V26, P572, DOI 10.3109/19401736.2013.878901
   Saneto RP, 2013, NEUROTHERAPEUTICS, V10, P199, DOI 10.1007/s13311-012-0167-0
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Shoubridge EA, 2003, STRUCTURAL MOL BASIS, P202
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Szalardy L, 2016, FOLIA NEUROPATHOL, V54, P9, DOI 10.5114/fn.2016.58911
   Taft RJ, 2013, AM J HUM GENET, V92, P774, DOI 10.1016/j.ajhg.2013.04.006
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2010, DEV DISABIL RES REV, V16, P154, DOI 10.1002/ddrr.104
NR 25
TC 30
Z9 30
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0072-9752
BN 978-0-12-802615-1; 978-0-12-802395-2
J9 HAND CLINIC
PY 2018
VL 145
BP 147
EP 155
DI 10.1016/B978-0-12-802395-2.00010-9
PG 9
WC Clinical Neurology
WE Book Citation Index – Science (BKCI-S)
SC Neurosciences & Neurology
GA BM3UR
UT WOS:000462710900012
DA 2024-11-01
ER

PT J
AU Gómez-Durán, A
   Pacheu-Grau, D
   Martínez-Romero, I
   López-Gallardo, E
   López-Pérez, MJ
   Montoya, J
   Ruiz-Pesini, E
AF Gomez-Duran, Aurora
   Pacheu-Grau, David
   Martinez-Romero, Inigo
   Lopez-Gallardo, Ester
   Lopez-Perez, Manuel J.
   Montoya, Julio
   Ruiz-Pesini, Eduardo
TI Oxidative phosphorylation differences between mitochondrial DNA
   haplogroups modify the risk of Leber's hereditary optic neuropathy
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Leber's hereditary optic neuropathy; Oxidative phosphorylation;
   Mitochondrial DNA; Haplogroup; Cybrid
ID GENE-EXPRESSION; MESSENGER-RNA; COPY NUMBER; CELL-LINES; MTDNA;
   TRANSCRIPTION; MUTATIONS; MUSCLE; ENCEPHALOMYOPATHY; REPLICATION
AB Leber's hereditary optic neuropathy is a maternally inherited optic atrophy caused by mitochondrial DNA point mutations. Previous epidemiological studies have shown that individuals from mitochondrial genetic backgrounds (haplogroups) J/Uk and H have a higher and a lower risk, respectively, of suffering this disorder. To analyze the bases of these associations at cellular and molecular levels, functional studies with cybrids provide high quality evidence. Cybrids from haplogroup J contain less mitochondrial deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) and synthesize a smaller amount of mitochondrial DNA-encoded polypeptides than those from haplogroup H. Haplogroup J cybrids also display lower oxygen consumption, mitochondrial inner membrane potential and total adenosine-5'-triphosphate (ATP) levels. Moreover, mitochondrial DNA levels correlate with many parameters of the oxidative phosphorylation system. These results suggest that the mitochondria! DNA amount determines oxidative phosphorylation capacity and, along with other recently published observations, support the possibility that mitochondrial DNA levels may be responsible for the bias of the disorder toward males, for the incomplete penetrance of mutations causing Leber's hereditary optic neuropathy and for the association of the disease with particular mitochondria! DNA haplogroups. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Gomez-Duran, Aurora; Pacheu-Grau, David; Martinez-Romero, Inigo; Lopez-Gallardo, Ester; Lopez-Perez, Manuel J.; Montoya, Julio; Ruiz-Pesini, Eduardo] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, CIBERER, E-50013 Zaragoza, Spain.
   [Ruiz-Pesini, Eduardo] Univ Zaragoza, Fdn ARAID, E-50013 Zaragoza, Spain.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of
   Zaragoza; University of Zaragoza
RP Ruiz-Pesini, E (corresponding author), Univ Zaragoza, Dept Bioquim Biol Mol & Celular, CIBERER, C Miguel Servet 177, E-50013 Zaragoza, Spain.
EM eduruiz@unizar.es
RI Gomez-Duran, Aurora/ABE-1973-2021; Pacheu-Grau, David/A-9074-2017;
   Gomez-Duran, Aurora/T-6392-2017
OI Lopez Gallardo, Ester/0000-0002-3217-1424; Pacheu-Grau,
   David/0000-0003-2645-3983; Gomez-Duran, Aurora/0000-0002-5895-6860
FU Instituto de Salud Carlos III [FIS-PI10/00662, PI08/0264, PI11/01301];
   Departamento de Ciencia, Tecnologia y Universidad del Gobierno de Aragon
   y Fondo Social Europeo [B33]; Instituto Aragones de Ciencias de la Salud
   [PIPAMER10-010]; Fundacion ARAID; Asociacion de Enfermos de Patologia
   Mitocondrial (AEPMI)
FX This work was supported by grants from Instituto de Salud Carlos III
   (FIS-PI10/00662 to JM; PI08/0264 and PI11/01301 to ER-P); Departamento
   de Ciencia, Tecnologia y Universidad del Gobierno de Aragon y Fondo
   Social Europeo (Grupos Consolidados B33 to JM); Instituto Aragones de
   Ciencias de la Salud (PIPAMER10-010 to ER-P); Fundacion ARAID (Programa
   de Apoyo a la I + D + I para jovenes investigadores 2010 to EL-G); and
   Asociacion de Enfermos de Patologia Mitocondrial (AEPMI) to AG-D. The
   CIBERER is an initiative of the ISCIII.
CR Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Arning L, 2010, J MOL MED, V88, P431, DOI 10.1007/s00109-010-0589-2
   Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188
   Beckstead WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005836
   Bellizzi D, 2009, CELL STRESS CHAPERON, V14, P265, DOI 10.1007/s12192-008-0081-x
   Bellizzi D, 2006, GENES CELLS, V11, P883, DOI 10.1111/j.1365-2443.2006.00986.x
   Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   Bouhours-Nouet N, 2005, AM J PHYSIOL-ENDOC M, V288, pE171, DOI 10.1152/ajpendo.00260.2003
   Brown MD, 1997, AM J HUM GENET, V60, P381
   Bruni F, 2010, J BIOL CHEM, V285, P3939, DOI 10.1074/jbc.M109.044305
   Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424
   Desquiret V, 2006, BBA-BIOENERGETICS, V1757, P21, DOI 10.1016/j.bbabio.2005.11.005
   Fernández-Vizarra E, 2011, MITOCHONDRION, V11, P207, DOI 10.1016/j.mito.2010.09.011
   Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Hinttala R, 2010, MITOCHONDRION, V10, P358, DOI 10.1016/j.mito.2010.02.002
   Hofmann S, 1997, GENOMICS, V39, P8, DOI 10.1006/geno.1996.4474
   Houshmand M, 2004, ANN NY ACAD SCI, V1011, P345, DOI 10.1196/annals.1293.035
   Howell N, 2003, AM J MED GENET A, V119A, P147, DOI 10.1002/ajmg.a.20135
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Hwang S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022116
   Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6
   Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753
   Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Kulawiec M, 2009, J HUM GENET, V54, P647, DOI 10.1038/jhg.2009.89
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   Lamminen T, 1997, EUR J HUM GENET, V5, P271, DOI 10.1159/000484777
   Li YF, 2010, NUCLEIC ACIDS RES, V38, P1913, DOI 10.1093/nar/gkp1162
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Marcuello A, 2009, MITOCHONDRION, V9, P27, DOI 10.1016/j.mito.2008.10.002
   Martínez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005
   McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Nishioka T, 2004, J HUM GENET, V49, P701, DOI 10.1007/s10038-004-0209-5
   Parasassi T, 2010, THESCIENTIFICWORLDJO, V10, P1192, DOI 10.1100/tsw.2010.104
   Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303
   Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236
   Rocher C, 2008, J BIOENERG BIOMEMBR, V40, P59, DOI 10.1007/s10863-008-9130-5
   SHIBANUMA M, 1994, FEBS LETT, V353, P62, DOI 10.1016/0014-5793(94)01014-5
   Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   Welle S, 2003, J APPL PHYSIOL, V94, P1479, DOI 10.1152/japplphysiol.01061.2002
   WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
NR 50
TC 81
Z9 86
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD AUG
PY 2012
VL 1822
IS 8
BP 1216
EP 1222
DI 10.1016/j.bbadis.2012.04.014
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 969CH
UT WOS:000306032800005
PM 22561905
OA Bronze
DA 2024-11-01
ER

PT J
AU Li, L
   Wu, CS
   Hou, GM
   Dong, MZ
   Wang, ZB
   Hou, Y
   Schatten, H
   Zhang, GR
   Sun, QY
AF Li, Li
   Wu, Chang-Sheng
   Hou, Guan-Mei
   Dong, Ming-Zhe
   Wang, Zhen-Bo
   Hou, Yi
   Schatten, Heide
   Zhang, Gui-Rong
   Sun, Qing-Yuan
TI Type 2 diabetes increases oocyte mtDNA mutations which are eliminated in
   the offspring by bottleneck effect
SO REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY
LA English
DT Article
DE Diabetes; Oocyte; mtDNA mutation; Bottleneck
ID MITOCHONDRIAL-DNA MUTATIONS; DYSFUNCTION; PREVALENCE; FERTILITY;
   DISEASE; MUSCLE; GROWTH
AB BackgroundDiabetes induces many complications including reduced fertility and low oocyte quality, but whether it causes increased mtDNA mutations is unknown.MethodsWe generated a T2D mouse model by using high-fat-diet (HFD) and Streptozotocin (STZ) injection. We examined mtDNA mutations in oocytes of diabetic mice by high-throughput sequencing techniques.ResultsT2D mice showed glucose intolerance, insulin resistance, low fecundity compared to the control group. T2D oocytes showed increased mtDNA mutation sites and mutation numbers compared to the control counterparts. mtDNA mutation examination in F1 mice showed that the mitochondrial bottleneck could eliminate mtDNA mutations.ConclusionsT2D mice have increased mtDNA mutation sites and mtDNA mutation numbers in oocytes compared to the counterparts, while these adverse effects can be eliminated by the bottleneck effect in their offspring. This is the first study using a small number of oocytes to examine mtDNA mutations in diabetic mothers and offspring.
C1 [Li, Li; Hou, Guan-Mei; Dong, Ming-Zhe; Wang, Zhen-Bo; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.
   [Li, Li; Dong, Ming-Zhe; Wang, Zhen-Bo; Sun, Qing-Yuan] Univ Chinese Acad Sci, Beijing 100101, Peoples R China.
   [Wu, Chang-Sheng; Zhang, Gui-Rong] Peking Medriv Acad Genet & Reprod, Beijing 102629, Peoples R China.
   [Hou, Guan-Mei] Qingdao Agr Univ, Coll Life Sci, Qingdao 266109, Peoples R China.
   [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.
C3 Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy
   of Sciences; University of Chinese Academy of Sciences, CAS; Qingdao
   Agricultural University; University of Missouri System; University of
   Missouri Columbia
RP Sun, QY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Sun, QY (corresponding author), Univ Chinese Acad Sci, Beijing 100101, Peoples R China.; Zhang, GR (corresponding author), Peking Medriv Acad Genet & Reprod, Beijing 102629, Peoples R China.
EM guirong_zhang@126.com; sunqy1@yahoo.com
RI Zhang, He/GXN-0028-2022
FU National Key R&D Program of China [2016YFA0100400]; National Natural
   Science Foundation of China [31272260, 31371451]
FX This study was supported by the National Key R&D Program of China
   (2016YFA0100400) and the National Natural Science Foundation of China
   (No. 31272260, 31371451).
CR Abuaisha B, 1998, DIABETES RES CLIN PR, V39, P93, DOI 10.1016/S0168-8227(97)00111-3
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinnery PF, 2000, ANN NEUROL, V48, P1097, DOI [10. 1002/1531-8249(200008)48:2&LT;188::AID-ANA8&GT;3. 0. CO;2-P, DOI 10.1002/1531-8249(200008)48:2]
   Diot A, 2016, BIOCHEM SOC T, V44, P1091, DOI 10.1042/BST20160095
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Gokina NI, 2013, AM J PHYSIOL-HEART C, V304, pH935, DOI 10.1152/ajpheart.00513.2012
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   HOLT IJ, 1989, NUCLEIC ACIDS RES, V17, P4465, DOI 10.1093/nar/17.12.4465
   Jiang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154665
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Isidro ML, 2012, POSTGRAD MED J, V88, P152, DOI 10.1136/postgradmedj-2011-130069
   Luo J, 1998, METABOLISM, V47, P663, DOI 10.1016/S0026-0495(98)90027-0
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4
   Morimoto S, 2012, J DEV ORIG HLTH DIS, V3, P483, DOI 10.1017/S2040174412000463
   Navarro-Casado L, 2010, J ANDROL, V31, P584, DOI 10.2164/jandrol.108.007260
   Otten ABC, 2015, HUM REPROD UPDATE, V21, P671, DOI 10.1093/humupd/dmv024
   Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b
   Pamir N, 2003, AM J PHYSIOL-ENDOC M, V284, pE931, DOI 10.1152/ajpendo.00270.2002
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Sutton-McDowall ML, 2010, REPRODUCTION, V139, P685, DOI 10.1530/REP-09-0345
   Tam ZY, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004183
   Tian Y, 2016, TRENDS CELL BIOL, V26, P563, DOI 10.1016/j.tcb.2016.06.006
   Vrachnis N, 2012, EXP DIABETES RES, DOI 10.1155/2012/538474
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang QA, 2010, MITOCHONDRION, V10, P403, DOI 10.1016/j.mito.2010.03.002
   Wei YC, 2014, P NATL ACAD SCI USA, V111, P1873, DOI 10.1073/pnas.1321195111
   Wyman A, 2008, ENDOCRINOLOGY, V149, P466, DOI 10.1210/en.2007-1273
   Zhang CH, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-31
NR 38
TC 16
Z9 16
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1477-7827
J9 REPROD BIOL ENDOCRIN
JI Reprod. Biol. Endocrinol.
PD NOV 3
PY 2018
VL 16
AR 110
DI 10.1186/s12958-018-0423-1
PG 8
WC Endocrinology & Metabolism; Reproductive Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Reproductive Biology
GA HC3ZB
UT WOS:000451741000001
PM 30390692
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Iyer, S
   Thomas, RR
   Portell, FR
   Dunham, LD
   Quigley, CK
   Bennett, JP
AF Iyer, Shilpa
   Thomas, Ravindar R.
   Portell, Francisco R.
   Dunham, Lisa D.
   Quigley, Caitlin K.
   Bennett, James P., Jr.
TI Recombinant mitochondrial transcription factor A with N-terminal
   mitochondrial transduction domain increases respiration and
   mitochondrial gene expression
SO MITOCHONDRION
LA English
DT Article
DE TFAM; Respiration; Mitochondrial gene expression; Respiratory proteins
ID FACTOR-A TFAM; HEREDITARY OPTIC NEUROPATHY; MTDNA COPY NUMBER; DNA
   NUCLEOIDS; REPLICATION; DISEASE; OVEREXPRESSION; MAINTENANCE;
   BIOGENESIS; CHAPERONES
AB We developed a scalable procedure to produce human mitochondrial transcription factor A (TFAM) modified with an N-terminal protein transduction domain (PTD) and mitochondrial localization signal (MLS) that allow it to cross membranes and enter mitochondria through its "mitochondrial transduction domain" (MTD = PTD + MLS). Alexa488-labeled MTD-TFAM rapidly entered the mitochondrial compartment of cybrid cells carrying the G11778A LHON mutation. MTD-TFAM reversibly increased respiration and levels of respiratory proteins. In vivo treatment of mice with MTD-TFAM increased motor endurance and complex I-driven respiration in mitochondria from brain and skeletal muscle. MTD-TFAM increases mitochondrial bioenergetics and holds promise for treatment of mitochondrial diseases involving deficiencies of energy production. (C) 2009 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Iyer, Shilpa; Thomas, Ravindar R.; Dunham, Lisa D.; Quigley, Caitlin K.; Bennett, James P., Jr.] Univ Virginia, Ctr Study Neurodegenerat Dis, Charlottesville, VA 22908 USA.
   [Iyer, Shilpa; Thomas, Ravindar R.; Dunham, Lisa D.; Quigley, Caitlin K.; Bennett, James P., Jr.] Univ Virginia, Morris K Udall Parkinsons Dis Res Ctr Excellence, Charlottesville, VA 22908 USA.
   [Portell, Francisco R.] Gencia Corp, Charlottesville, VA USA.
C3 University of Virginia; University of Virginia
RP Bennett, JP (corresponding author), Univ Virginia, Ctr Study Neurodegenerat Dis, POB 800394, Charlottesville, VA 22908 USA.
EM bennett@virginia.edu
OI Iyer, Shilpa/0000-0001-6287-2232
FU National Institute of Health [NS39788, AG023443]; American Parkinson's
   Disease Association (Iyer); Parkinson's Disease Foundation (Iyer)
FX We would like to thank Russell Swerdlow for access to the LHON cybrid
   cells and Kate Borland for all the work on confocal ETC immunostaining.
   We also thank members of the Clayton Laboratory for useful discussions
   and Shaharyar Khan and Raj Rao for critical reading of the manuscript.
   This work was supported in part by funds from the National Institute of
   Health (NS39788, AG023443, Bennett), from the American Parkinson's
   Disease Association (Iyer) and the Parkinson's Disease Foundation (Iyer)
   and the D. Loy Stewart Research Fund.
CR Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424
   DIMAURO S, 2008, ANN REV NEUROSCI
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Garstka HL, 2003, NUCLEIC ACIDS RES, V31, P5039, DOI 10.1093/nar/gkg717
   Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004
   Hütter E, 2006, EXP GERONTOL, V41, P103, DOI 10.1016/j.exger.2005.09.011
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017
   Khan SM, 2004, J BIOENERG BIOMEMBR, V36, P387, DOI 10.1023/B:JOBB.0000041773.20072.9e
   Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007
   Kutik S, 2007, J CELL BIOL, V179, P585, DOI 10.1083/jcb.200708199
   Leidhold C, 2007, ANN NY ACAD SCI, V1113, P72, DOI 10.1196/annals.1391.011
   Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921
   Pohjoismäki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Shadel GS, 2008, AM J PATHOL, V172, P1445, DOI 10.2353/ajpath.2008.071163
   Szabadkai G, 2007, ADV EXP MED BIOL, V594, P64
   Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace Douglas C, 2002, Methods Mol Biol, V197, P3, DOI 10.1385/1-59259-284-8:003
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Yen MY, 2006, PROG RETIN EYE RES, V25, P381, DOI 10.1016/j.preteyeres.2006.05.002
NR 26
TC 46
Z9 54
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUN
PY 2009
VL 9
IS 3
BP 196
EP 203
DI 10.1016/j.mito.2009.01.012
PG 8
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 443YI
UT WOS:000265946300004
PM 19460293
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Chatfield, KC
   Coughlin, CR
   Friederich, MW
   Gallagher, RC
   Hesselberth, JR
   Lovell, MA
   Ofman, R
   Swanson, MA
   Thomas, JA
   Wanders, RJA
   Wartchow, EP
   Van Hove, JLK
AF Chatfield, Kathryn C.
   Coughlin, Curtis R., II
   Friederich, Marisa W.
   Gallagher, Renata C.
   Hesselberth, Jay R.
   Lovell, Mark A.
   Ofman, Rob
   Swanson, Michael A.
   Thomas, Janet A.
   Wanders, Ronald J. A.
   Wartchow, Eric P.
   Van Hove, Johan L. K.
TI Mitochondrial energy failure in HSD10 disease is due to defective mtDNA
   transcript processing
SO MITOCHONDRION
LA English
DT Article
DE MHBD disease; HSD10 disease; RNase P; MRPP2; RNA processing
ID 2-METHYL-3-HYDROXYBUTYRYL-COA DEHYDROGENASE-DEFICIENCY;
   17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 10; AMYLOID-BETA; RNASE P;
   MUTATIONS; CARDIOMYOPATHY; BIOGENESIS; DIAGNOSIS; GENE; DNA
AB Muscle, heart and liver were analyzed in a male subject who succumbed to HSD10 disease. Respiratory chain enzyme analysis and BN-PAGE showed reduced activities and assembly of complexes I, III, IV, and V. The mRNAs of all RNase P subunits were preserved in heart and overexpressed in muscle, but MRPP2 protein was severely decreased. RNase P upregulation correlated with increased expression of mitochondrial biogenesis factors and preserved mitochondrial enzymes in muscle, but not in heart where this compensatory mechanism was incomplete. We demonstrate elevated amounts of unprocessed pre-tRNAs and mRNA transcripts encoding mitochondrial subunits indicating deficient RNase P activity. This study provides evidence of abnormal mitochondrial RNA processing causing mitochondrial energy failure in HSD10 disease. (C) 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Chatfield, Kathryn C.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Pediat Cardiol, Aurora, CO 80045 USA.
   [Coughlin, Curtis R., II; Friederich, Marisa W.; Gallagher, Renata C.; Swanson, Michael A.; Thomas, Janet A.; Van Hove, Johan L. K.] Univ Colorado, Sect Clin Genet & Metab, Dept Pediat, Aurora, CO 80045 USA.
   [Hesselberth, Jay R.] Univ Colorado, Sch Med, Program Mol Biol, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.
   [Lovell, Mark A.] Univ Colorado, Dept Pathol, Aurora, CO 80045 USA.
   [Lovell, Mark A.; Wartchow, Eric P.] Childrens Hosp Colorado, Dept Pathol, Aurora, CO USA.
   [Ofman, Rob; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands.
C3 University of Colorado System; University of Colorado Anschutz Medical
   Campus; Children's Hospital Colorado; University of Colorado System;
   University of Colorado Anschutz Medical Campus; University of Colorado
   System; University of Colorado Anschutz Medical Campus; University of
   Colorado System; University of Colorado Anschutz Medical Campus;
   Children's Hospital Colorado; University of Amsterdam; Academic Medical
   Center Amsterdam
RP Van Hove, JLK (corresponding author), Univ Colorado, Genet Sect, Dept Pediat, Aurora, CO 80045 USA.
EM Johan.Vanhove@ucdenver.edu
RI Wartchow, Eric/AAZ-8554-2021
OI Coughlin II, Curtis/0000-0002-3545-7903; Hesselberth,
   Jay/0000-0002-6299-179X
FU NIH/NCATS Colorado CTSI [UL1 TR000154]; Miracles for Mito
FX This work was supported in part by funds from a grant to K.C.C. from the
   NIH/NCATS Colorado CTSI (UL1 TR000154) and support in part for M.W.F.
   and J.V.H was provided from Miracles for Mito. Contents are the authors'
   sole responsibility and do not necessarily represent official NIH views.
   The authors have no conflicts to declare.
CR Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015
   Ahuja P, 2013, CIRCULATION, V127, P1957, DOI 10.1161/CIRCULATIONAHA.112.001219
   Chen JX, 2007, J ALZHEIMERS DIS, V12, P177
   Chen JX, 2010, J ALZHEIMERS DIS, V20, pS569, DOI 10.3233/JAD-2010-100357
   Crosby AH, 2010, AM J HUM GENET, V87, P655, DOI 10.1016/j.ajhg.2010.09.013
   Deutschmann AJ, 2014, HUM MOL GENET, V23, P3618, DOI 10.1093/hmg/ddu072
   Ensenauer R, 2002, ANN NEUROL, V51, P656, DOI 10.1002/ana.10169
   Fersht A., 1985, Enzyme structure and mechanism, V2nd ed.
   García-Villoria J, 2005, PEDIATR RES, V58, P488, DOI 10.1203/01.pdr.0000176916.94328.cd
   García-Villoria J, 2009, CLIN BIOCHEM, V42, P27, DOI 10.1016/j.clinbiochem.2008.10.006
   Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006
   Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013
   Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005
   Korman SH, 2006, MOL GENET METAB, V89, P289, DOI 10.1016/j.ymgme.2006.07.010
   Ofman R, 2003, AM J HUM GENET, V72, P1300, DOI 10.1086/375116
   Olpin SE, 2002, J INHERIT METAB DIS, V25, P477, DOI 10.1023/A:1021251202287
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rauschenberger K, 2010, EMBO MOL MED, V2, P51, DOI 10.1002/emmm.200900055
   Rorbach J, 2012, BIOCHEM J, V444, P357, DOI 10.1042/BJ20112208
   ROSSMANITH W, 1995, J BIOL CHEM, V270, P12885, DOI 10.1074/jbc.270.21.12885
   Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060
   Sass JO, 2004, BRAIN DEV-JPN, V26, P12, DOI 10.1016/S0387-7604(03)00071-8
   Smet J., 2005, CELL BIOL LAB HDB, V4, P259
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   SMITH L, 1955, Methods Biochem Anal, V2, P427, DOI 10.1002/9780470110188.ch13
   Sriram G, 2005, AM J HUM GENET, V76, P911, DOI 10.1086/430799
   Temperley RJ, 2010, BBA-BIOENERGETICS, V1797, P1081, DOI 10.1016/j.bbabio.2010.02.036
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   Vilardo E, 2012, NUCLEIC ACIDS RES, V40, P11583, DOI 10.1093/nar/gks910
   Yang SY, 2005, TRENDS ENDOCRIN MET, V16, P167, DOI 10.1016/j.tem.2005.03.006
   Zschocke J, 2000, PEDIATR RES, V48, P852, DOI 10.1203/00006450-200012000-00025
   Zschocke J, 2012, J INHERIT METAB DIS, V35, P81, DOI 10.1007/s10545-011-9415-4
NR 32
TC 48
Z9 55
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR
PY 2015
VL 21
BP 1
EP 10
DI 10.1016/j.mito.2014.12.005
PG 10
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA CD8ET
UT WOS:000351328700001
PM 25575635
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Leshinsky-Silver, E
   Shuvalov, R
   Inbar, S
   Cohen, S
   Lev, D
   Lerman-Sagie, T
AF Leshinsky-Silver, Esther
   Shuvalov, Ruslan
   Inbar, Shani
   Cohen, Sarit
   Lev, Dorit
   Lerman-Sagie, Tally
TI Juvenile Leigh Syndrome, Optic Atrophy, Ataxia, Dystonia, and Epilepsy
   due to T14487C Mutation in the mtDNA-ND6 Gene: A Mitochondrial Syndrome
   Presenting From Birth to Adolescence
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE Leigh syndrome; ND6; dystonia; optic atrophy; ataxia
ID COMPLEX-I DEFICIENCY; DNA G13513A MUTATION; ND3 GENE; MISSENSE MUTATION;
   TRNA(TRP) GENE; DISEASE; ENCEPHALOPATHY; SECONDARY; INSERTION; CHILDREN
AB An increasing number of reports describe mutations in mitochondrial DNA coding regions, especially in mitochondrial DNA-encoded nicotinamide adenine dinucleotide dehydrogenase subunit genes of the respiratory chain complex I, as causing early-onset Leigh syndrome. The authors report the molecular findings in a 24-year-old patient with juvenile-onset Leigh syndrome presenting with optic atrophy, ataxia dystonia, and epilepsy. A brain magnetic resonance imaging revealed bilateral basal ganglia and thalamic hypointensities, and a magnetic resonance spectroscopy revealed an increased lactate peak. The authors identified a T14487C change causing M63V substitution in the mitochondrial ND6 gene. The mutation was heteroplasmic in muscle and blood samples, with different mutation loads, and was absent in the patient's mother's urine and blood samples. They suggest that the T14487C mtDNA mutation should be analyzed in Leigh syndrome, presenting with optic atrophy, ataxia, dystonia, and epilepsy, regardless of age.
C1 [Leshinsky-Silver, Esther; Inbar, Shani; Cohen, Sarit] Wolfson Med Ctr, Mol Genet Lab, IL-58100 Holon, Israel.
   [Leshinsky-Silver, Esther; Shuvalov, Ruslan; Lev, Dorit] Wolfson Med Ctr, Mitochondrial Dis Ctr, IL-58100 Holon, Israel.
   [Leshinsky-Silver, Esther; Lev, Dorit; Lerman-Sagie, Tally] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.
   [Shuvalov, Ruslan; Lerman-Sagie, Tally] Wolfson Med Ctr, Pediat Neurol Unit, IL-58100 Holon, Israel.
   [Lev, Dorit] Wolfson Med Ctr, Inst Med Genet, IL-58100 Holon, Israel.
C3 Tel Aviv University
RP Leshinsky-Silver, E (corresponding author), Wolfson Med Ctr, Mol Genet Lab, IL-58100 Holon, Israel.
EM leshinsky@wolfson.health.gov.il
RI Lerman-Sagie, Tally/AAY-7598-2021
OI Lerman-Sagie, Tally/0000-0001-6641-6875
CR Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Dermaut B, 2010, J NEUROL NEUROSUR PS, V81, P90, DOI 10.1136/jnnp.2008.157354
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Esteitie N, 2005, ANN NEUROL, V58, P544, DOI 10.1002/ana.20570
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Komaki H, 2003, MITOCHONDRION, V2, P293, DOI 10.1016/S1567-7249(03)00003-5
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Naess K, 2009, BBA-BIOENERGETICS, V1787, P484, DOI 10.1016/j.bbabio.2008.11.014
   Raspall-Chaure M, 2004, REV NEUROLOGIA, V39, P1129, DOI 10.33588/rn.3912.2004296
   Reisch AS, 2007, METHOD CELL BIOL, V80, P199, DOI 10.1016/S0091-679X(06)80010-5
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Schapira AHV, 2010, EXP NEUROL, V224, P331, DOI 10.1016/j.expneurol.2010.03.028
   Solano A, 2003, ANN NEUROL, V54, P527, DOI 10.1002/ana.10682
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   Taylor RW, 2002, EUR J HUM GENET, V10, P141, DOI 10.1038/sj.ejhg.5200773
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Tsao CY, 2003, J CHILD NEUROL, V18, P62, DOI 10.1177/08830738030180011401
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
   Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734
   Wang J, 2009, MOL GENET METAB, V96, P59, DOI 10.1016/j.ymgme.2008.10.006
NR 30
TC 14
Z9 15
U1 0
U2 7
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
J9 J CHILD NEUROL
JI J. Child Neurol.
PD APR
PY 2011
VL 26
IS 4
BP 476
EP 481
DI 10.1177/0883073810384615
PG 6
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 751OO
UT WOS:000289627600010
PM 21196529
DA 2024-11-01
ER

PT J
AU Heidari, MM
   Khatami, M
   Talebi, AR
AF Heidari, Mohammad Mehdi
   Khatami, Mehri
   Talebi, Ali Reza
TI The <i>POLG</i> Gene Polymorphism in Iranian Varicocele-Associated
   Infertility Patients
SO IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES
LA English
DT Article
DE CAG repeats length; Infertility; Mitochondria; POLG gene; Varicocele
ID MITOCHONDRIAL-DNA POLYMERASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CAG
   REPEAT; GAMMA POLG; MEN; MUTATIONS; SPERMATOZOA; INTEGRITY; DELETIONS
AB Objective(s)
   Varicocele is associated with impaired testicular function and male infertility, but the molecular mechanisms by which fertility is affected have not been satisfactorily explained. The aim of our study was to investigate whether or not the polymerase gamma (POLG) polymorphism is associated with Iranian varicocele patients.
   Materials and Methods
   We determined the POLG CAG repeat length in DNA samples extracted from 40 varicocele patients and 30 control subjects by PCR-denature polyacrylamide gel electrophoresis and sequencing.
   Results
   The distribution of the CAG repeat length in varicocele patients showed no notable difference from that in control subjects, but we found a significant statistical inverse correlation between 10/10 and 10/#10 genotypes and varicocele grade.
   Conclusion
   These findings indicate that POLG CAG repeats may affects the varicocele grade, but the mechanisms remain to be elucidated.
C1 [Heidari, Mohammad Mehdi; Khatami, Mehri] Yazd Univ, Sch Sci, Dept Biol, Yazd, Iran.
   [Talebi, Ali Reza] Shahid Sadughi Univ Med Sci, Res Clin Ctr Infertil, Dept Anat, Yazd, Iran.
C3 University of Yazd
RP Heidari, MM (corresponding author), Yazd Univ, Sch Sci, Dept Biol, Yazd, Iran.
EM Heidarimm@yazduni.ac.ir
RI Heidari‬‏, ‪Mohammad/AAC-3894-2022; Talebi, Alireza/AAQ-3144-2021
OI Heidari, Mohammad mehdi/0000-0002-3328-4746
FU Yazd University
FX This work was supported by Yazd University. We thank all the patients
   for providing blood samples for the scientific research as well as the
   Research and Clinical Center for Infertility, Shahid Sadughi University
   of Medical Sciences, Yazd, Iran. The authors declare that they have no
   conflict of interests.
CR Aknin-Seifer IE, 2005, HUM REPROD, V20, P736, DOI 10.1093/humrep/deh666
   Allamaneni SSR, 2004, FERTIL STERIL, V82, P1684, DOI 10.1016/j.fertnstert.2004.04.071
   [Anonymous], 2008, FERTIL STERIL, V90, pS241
   [Anonymous], 1999, WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction
   BERTAZZONI U, 1977, EUR J BIOCHEM, V81, P237, DOI 10.1111/j.1432-1033.1977.tb11945.x
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Heidari M, 2008, NEUROL SCI, V29, P489, DOI 10.1007/s10072-008-1026-y
   Jarow JP, 1996, UROLOGY, V47, P73, DOI 10.1016/S0090-4295(99)80385-9
   Krausz C, 2004, J CLIN ENDOCR METAB, V89, P4292, DOI 10.1210/jc.2004-0008
   Kumar R, 2009, INDIAN J BIOCHEM BIO, V46, P172
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   MIEUSSET R, 1995, INT J ANDROL, V18, P169, DOI 10.1111/j.1365-2605.1995.tb00408.x
   Moro E, 2000, MOL CELL ENDOCRINOL, V161, P67, DOI 10.1016/S0303-7207(99)00226-9
   Rani DS, 2006, FERTIL STERIL, V86, P1783, DOI 10.1016/j.fertnstert.2006.04.044
   Richens J, 2004, BRIT MED J, V328, P1251, DOI 10.1136/bmj.328.7450.1251
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rovio A, 1999, EUR J HUM GENET, V7, P140, DOI 10.1038/sj.ejhg.5200244
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   St John JC, 2001, MOL HUM REPROD, V7, P103, DOI 10.1093/molehr/7.1.103
   Talebi AR, 2008, ANDROLOGIA, V40, P245, DOI 10.1111/j.1439-0272.2008.00852.x
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Zini A, 2005, HUM REPROD, V20, P1018, DOI 10.1093/humrep/deh701
   Zullo SJ, 1997, CYTOGENET CELL GENET, V78, P281, DOI 10.1159/000134672
NR 25
TC 11
Z9 11
U1 0
U2 2
PU MASHHAD UNIV MED SCIENCES
PI MASHHAD
PA VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 -
   445, MASHHAD, 00000, IRAN
SN 2008-3866
J9 IRAN J BASIC MED SCI
JI Iran. J. Basic Med. Sci.
PD MAR-APR
PY 2012
VL 15
IS 2
BP 739
EP 744
PG 6
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 918OG
UT WOS:000302259000007
PM 23493802
DA 2024-11-01
ER

PT S
AU Wu, SB
   Wu, YT
   Wang, CH
   Lee, WY
   Wei, YH
AF Wu, Shi-Bei
   Wu, Yu-Ting
   Wang, Chih-Hao
   Lee, Wan-Yu
   Wei, Yau-Huei
BE Bondy, S
   Maiese, K
TI Mitochondrial Respiratory Function Decline in Aging and Life-Span
   Extension by Caloric Restriction
SO AGING AND AGE-RELATED DISORDERS
SE Oxidative Stress in Applied Basic Research and Clinical Practice
LA English
DT Article; Book Chapter
DE Aging; Mitochondrial dysfunction; Oxidative stress; mtDNA mutation;
   Vicious cycle; Caloric restriction; Sirt1
ID GENE-EXPRESSION PROFILE; HUMAN SKELETAL-MUSCLE; CYTOCHROME-C-OXIDASE;
   FOXO TRANSCRIPTION FACTORS; OXYGEN SPECIES PRODUCTION; FREE-RADICAL
   PRODUCTION; HUMAN SKIN FIBROBLASTS; OXIDATIVE DAMAGE; DNA MUTATIONS;
   ELECTRON-TRANSPORT
AB Extensive studies have established that progressive accumulation of somatic mutations in mitochondrial DNA (mtDNA) leads to a decline in mitochondrial bioenergetic function and contributes to human aging. Mitochondrial respiratory chain dysfunction not only causes inefficient ATP production but also increases mitochondrial generation of reactive oxygen species (ROS), which can induce further oxidative damage and mutation to mtDNA during the aging process. Indeed, a wide spectrum of mtDNA mutations has been found to occur in somatic tissues of elderly subjects. Besides, mitochondrial abnormalities have been associated with age-related diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). On the other hand, age-associated reduction in the efficiency of oxidative phosphorylation (OXPHOS) may cause alterations of gene expression in affected tissues for the sake of compensation or adaptation. Recent studies have revealed that the expression levels of several clusters of genes and posttranslational modifications of proteins are changed in various tissues of old animals and cultured cells from elderly subjects. In addition, the changes in age-associated gene expression profiles were tissue-specific, which suggests that different tissues are subject to different degree of oxidative stress during the aging process. Surprisingly, the majority of the age-related alterations in gene expression can be reversed by caloric restriction (CR) through the elevation of sirtuin 1 (Sirt1) expression, which promotes survival in organisms ranging from yeast to rodents and primates. The anti-aging effects of Sirt1 mediated by CR could be conferred by the activation of mitochondrial biogenesis and respiratory function. On the other hand, the mitochondrial sirtuins (Sirt3, Sirt4, and Sirt5) also play a critical role not only in the upregulation of mitochondrial function but also in the protection against oxidative stress and culminate in the extension of the life span of animals. Taking these findings together, we suggest that mitochondria' dysfunction, accumulation of mtDNA mutation, enhanced oxidative stress, and alteration of gene expression are important contributors to human aging. On the other hand, Sirt1 and mitochondrial sirtuins could be the therapeutic targets for the treatment of various age-related diseases such as mitochondrial disorders, neurodegenerative diseases, and metabolic syndrome.
C1 [Wu, Shi-Bei; Wu, Yu-Ting; Wang, Chih-Hao; Lee, Wan-Yu; Wei, Yau-Huei] Natl Yang Ming Univ, Dept Biochem & Mol Biol, Sch Life Sci, Taipei 112, Taiwan.
C3 National Yang Ming Chiao Tung University
RP Wei, YH (corresponding author), Natl Yang Ming Univ, Dept Biochem & Mol Biol, Sch Life Sci, Taipei 112, Taiwan.
EM joeman@ym.edu.tw
RI TMU, barry0110/AAV-4030-2021; Wei, Yau-Huei/ABA-6841-2021
OI Wei, Yau-Huei/0000-0002-6429-2546
CR Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Ashmore LJ, 2009, HUM GENET, V126, P431, DOI 10.1007/s00439-009-0673-2
   Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213
   Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berneburg M, 2004, J INVEST DERMATOL, V122, P1277, DOI 10.1111/j.0022-202X.2004.22502.x
   Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345
   Bodyak N, 2002, NUCLEIC ACIDS RES, V30, P3788, DOI 10.1093/nar/gkf497
   Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031
   Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x
   Bosetti F, 2002, NEUROBIOL AGING, V23, P371, DOI 10.1016/S0197-4580(01)00314-1
   Bregere C, 2008, METHOD ENZYMOL, V441, P339, DOI 10.1016/S0076-6879(08)01219-6
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Byun HO, 2008, J CELL BIOCHEM, V104, P1747, DOI 10.1002/jcb.21741
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Chabi B, 2005, BIOCHEM BIOPH RES CO, V332, P542, DOI 10.1016/j.bbrc.2005.04.153
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357
   Chen JH, 2004, J BIOL CHEM, V279, P49439, DOI 10.1074/jbc.M409153200
   Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509
   Chretien D, 1998, BIOCHEM J, V329, P249, DOI 10.1042/bj3290249
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2
   Colom B, 2007, CARDIOVASC RES, V74, P456, DOI 10.1016/j.cardiores.2007.02.001
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194
   Debacq-Chainlaux F, 2005, J CELL SCI, V118, P743, DOI 10.1242/jcs.01651
   Dencher NA, 2007, ANN NY ACAD SCI, V1100, P291, DOI 10.1196/annals.1395.030
   Desai VG, 1996, ARCH BIOCHEM BIOPHYS, V333, P145, DOI 10.1006/abbi.1996.0375
   DIDONATO S, 1993, NEUROLOGY, V43, P2262, DOI 10.1212/WNL.43.11.2262
   Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002
   Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X
   Dupuis L, 2004, NEURODEGENER DIS, V1, P245, DOI 10.1159/000085063
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Feng J, 2008, J GERONTOL A-BIOL, V63, P1137, DOI 10.1093/gerona/63.11.1137
   Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130
   Figueiredo PA, 2009, J GERONTOL A-BIOL, V64, P21, DOI 10.1093/gerona/gln048
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515
   Gannon J, 2008, INT J MOL MED, V22, P33
   Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104
   Gelfi C, 2006, J PROTEOME RES, V5, P1344, DOI 10.1021/pr050414x
   Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086
   Gruber J, 2008, FRONT BIOSCI-LANDMRK, V13, P6554, DOI 10.2741/3174
   Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029
   Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486
   Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057
   Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103
   Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYAKAWA M, 1992, BIOCHEM BIOPH RES CO, V189, P979, DOI 10.1016/0006-291X(92)92300-M
   HORTON AA, 1981, MECH AGEING DEV, V17, P253, DOI 10.1016/0047-6374(81)90062-2
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095
   Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382
   Jeng JY, 2008, J CELL BIOCHEM, V103, P347, DOI 10.1002/jcb.21625
   Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930
   Johnston APW, 2008, APPL PHYSIOL NUTR ME, V33, P191, DOI 10.1139/H07-141
   Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Kopsidas G, 1998, MUTAT RES-FUND MOL M, V421, P27, DOI 10.1016/S0027-5107(98)00150-X
   Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kumaran S, 2005, MOL CELL BIOCHEM, V280, P83, DOI 10.1007/s11010-005-8234-z
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978
   Lee HC, 1999, ARCH BIOCHEM BIOPHYS, V362, P309, DOI 10.1006/abbi.1998.1036
   LEE HC, 1994, FEBS LETT, V354, P79, DOI 10.1016/0014-5793(94)01063-3
   Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957
   Li M, 2007, J BIOCHEM MOL BIOL, V40, P72
   Lin G, 2009, CELL MOL LIFE SCI, V66, P919, DOI 10.1007/s00018-009-8696-3
   Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829
   Linford NJ, 2007, AGING CELL, V6, P673, DOI 10.1111/j.1474-9726.2007.00319.x
   Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   Lu CY, 1999, MUTAT RES-FUND MOL M, V423, P11, DOI 10.1016/S0027-5107(98)00220-6
   Ma YS, 2009, BBA-GEN SUBJECTS, V1790, P1021, DOI 10.1016/j.bbagen.2009.04.012
   Mambo E, 2003, P NATL ACAD SCI USA, V100, P1838, DOI 10.1073/pnas.0437910100
   Manfredi G, 2000, BRAIN PATHOL, V10, P462
   Markaryan A, 2008, MUTAT RES-FUND MOL M, V640, P38, DOI 10.1016/j.mrfmmm.2007.12.007
   McInerny SC, 2009, MECH AGEING DEV, V130, P343, DOI 10.1016/j.mad.2009.01.008
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Meissner C, 2006, EXP GERONTOL, V41, P518, DOI 10.1016/j.exger.2006.03.010
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Miyazawa M, 2009, J RADIAT RES, V50, P73, DOI 10.1269/jrr.08097
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026
   Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728
   OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G
   Otaegui D, 2004, NEUROSCI LETT, V370, P171, DOI 10.1016/j.neulet.2004.08.012
   OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z
   Pak JW, 2003, AGING CELL, V2, P1, DOI 10.1046/j.1474-9728.2003.00034.x
   Pang CY, 2008, FRONT BIOSCI-LANDMRK, V13, P3661, DOI 10.2741/2957
   Pang CY, 2001, DIABETES RES CLIN PR, V54, pS45, DOI 10.1016/S0168-8227(01)00335-7
   Park SK, 2005, AGEING RES REV, V4, P55, DOI 10.1016/j.arr.2004.09.003
   Park SK, 2005, CARDIOVASC RES, V66, P205, DOI 10.1016/j.cardiores.2005.01.005
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131
   Petrosillo G, 2009, FREE RADICAL BIO MED, V46, P88, DOI 10.1016/j.freeradbiomed.2008.09.031
   Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583
   Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010
   Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078
   Rebrin I, 2007, BIOCHEMISTRY-US, V46, P10130, DOI 10.1021/bi7001482
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S
   Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Schroeder P, 2008, J INVEST DERMATOL, V128, P2297, DOI 10.1038/jid.2008.57
   Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200
   Shimokawa I, 2008, MOL CELLS, V26, P427
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SOHAL RS, 1995, FREE RADICAL BIO MED, V19, P499, DOI 10.1016/0891-5849(95)00037-X
   Solvioli Stefano, 2008, Biotechnology Journal, V3, P740, DOI 10.1002/biot.200800046
   Sorarù G, 2007, NEUROPATH APPL NEURO, V33, P204, DOI 10.1111/j.1365-2990.2006.00791.x
   Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001
   Stöckl P, 2007, FREE RADICAL BIO MED, V43, P947, DOI 10.1016/j.freeradbiomed.2007.06.005
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739
   Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
   Wei YH, 2003, ADV CLIN CHEM, V37, P83, DOI 10.1016/S0065-2423(03)37007-6
   Wei YH, 1998, ANN NY ACAD SCI, V854, P155, DOI 10.1111/j.1749-6632.1998.tb09899.x
   WEI YH, 1981, BIOCHEM BIOPH RES CO, V99, P1411, DOI 10.1016/0006-291X(81)90776-2
   Weindruch R, 2001, J NUTR, V131, p918S, DOI 10.1093/jn/131.3.918S
   Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
   Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399
NR 153
TC 0
Z9 0
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 2197-7224
BN 978-1-60761-601-6
J9 OXID STRESS APPL BAS
JI Oxid. Stress Appl. Basic Res. Clin. Pract.
PY 2010
BP 129
EP 148
DI 10.1007/978-1-60761-602-3_7
D2 10.1007/978-1-60761-602-3
PG 20
WC Medicine, General & Internal
WE Book Citation Index – Science (BKCI-S)
SC General & Internal Medicine
GA BQX53
UT WOS:000282063600007
DA 2024-11-01
ER

PT J
AU van Eijsden, RGE
   Eijssen, LMT
   Lindsey, PJ
   van den Burg, CMM
   de Wit, LEA
   Rubio-Gozalbo, ME
   de Die, CEM
   Ayoubi, T
   Sluiter, W
   de Coo, IFM
   Smeets, HJM
AF van Eijsden, R. G. E.
   Eijssen, L. M. T.
   Lindsey, P. J.
   van den Burg, C. M. M.
   de Wit, L. E. A.
   Rubio-Gozalbo, M. E.
   de Die, C. E. M.
   Ayoubi, T.
   Sluiter, W.
   de Coo, I. F. M.
   Smeets, H. J. M.
TI Termination of damaged protein repair defines the occurrence of symptoms
   in carriers of the m.3243A&gt;G tRNA<SUP>Leu</SUP> mutation
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID MITOCHONDRIAL-DNA; GENE-EXPRESSION; CELL-DEATH; A3243G MUTATION;
   APOPTOSIS; KINASE; FAMILY; ENCEPHALOMYOPATHY; PROLIFERATION;
   TRANSCRIPTION
AB Background: The m.3243A>G mutation in the mitochondrial tRNA(Leu(UUR)) gene is an example of a mutation causing a very heterogeneous phenotype. It is the most frequent cause (80%) of the MELAS syndrome ( mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes), but it can also lead in addition or separately to type 2 diabetes, deafness, renal tubulopathy and/or cardiomyopathy.
   Methods: To identify pathogenic processes induced by this mutation, we compared global gene expression levels of muscle biopsies from affected and unaffected mutation carriers with controls.
   Results and conclusions: Gene expression changes were relatively subtle. In the asymptomatic group 200 transcripts were upregulated and 12 were downregulated, whereas in the symptomatic group 15 transcripts were upregulated and 52 were downregulated. In the asymptomatic group, oxidative phosphorylation (OXPHOS) complex I and IV genes were induced. Protein turnover and apoptosis were elevated, most likely due to the formation of dysfunctional and reactive oxygen species (ROS) damaged proteins. These processes returned to normal in symptomatic patients. Components of the complement system were upregulated in both groups, but the strongest in the symptomatic group, which might indicate muscle regeneration-most likely, protein damage and OXPHOS dysfunction stimulate repair ( protein regeneration) and metabolic adaptation ( OXPHOS). In asymptomatic individuals these processes suffice to prevent the occurrence of symptoms. However, in affected individuals the repair process terminates, presumably because of excessive damage, and switches to muscle regeneration, as indicated by a stronger complement activation. This switch leaves increasingly damaged tissue in place and muscle pathology becomes manifest. Therefore, the expression of complement components might be a marker for the severity and progression of MELAS clinical course.
C1 [van Eijsden, R. G. E.; Eijssen, L. M. T.; Lindsey, P. J.; van den Burg, C. M. M.; Ayoubi, T.; Smeets, H. J. M.] Maastricht Univ, Dept Genet & Cell Biol, NL-6200 MD Maastricht, Netherlands.
   [van Eijsden, R. G. E.; Smeets, H. J. M.] Maastricht Univ, Res Inst Growth & Dev, NL-6200 MD Maastricht, Netherlands.
   [van Eijsden, R. G. E.] VIB, MicroArray Facil, Louvain, Belgium.
   [Eijssen, L. M. T.] Maastricht Univ, BiGCaT Bioinformat, NL-6200 MD Maastricht, Netherlands.
   [de Wit, L. E. A.; Sluiter, W.] Erasmus MC, Dept Biochem, Mitochondrial Res Unit, Rotterdam, Netherlands.
   [Rubio-Gozalbo, M. E.] Maastricht Univ Hosp, Dept Paediat, Maastricht, Netherlands.
   [Rubio-Gozalbo, M. E.] Maastricht Univ Hosp, Lab Genet Metab Dis, Maastricht, Netherlands.
   [de Die, C. E. M.] Maastricht Univ Hosp, Dept Clin Genet, Maastricht, Netherlands.
   [Ayoubi, T.] Maastricht Univ, Inst Cardiovasc Res Maastricht CARIM, NL-6200 MD Maastricht, Netherlands.
   [de Coo, I. F. M.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
C3 Maastricht University; Maastricht University; Flanders Institute for
   Biotechnology (VIB); Maastricht University; Erasmus University
   Rotterdam; Erasmus MC; Maastricht University; Maastricht University
   Medical Centre (MUMC); Maastricht University; Maastricht University
   Medical Centre (MUMC); Maastricht University; Maastricht University
   Medical Centre (MUMC); Maastricht University; Erasmus University
   Rotterdam; Erasmus MC
RP Smeets, HJM (corresponding author), Maastricht Univ, Dept Genet & Cell Biol, POB 616,Post Box 16, NL-6200 MD Maastricht, Netherlands.
EM Bert.Smeets@Molcelb.Unimaas.nl
RI Lindsey, Patrick/AAD-8100-2021; rubio, estela/H-1833-2011
CR Akaike H., 1973, 2 INT S INFORM THEOR, P267
   Alamdari DH, 2005, FREE RADICAL BIO MED, V39, P1362, DOI 10.1016/j.freeradbiomed.2005.06.023
   Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001
   [Anonymous], 1999, Models for Repeated Measurements
   ATKINSON AC, 1980, BIOMETRIKA, V67, P413, DOI 10.1093/biomet/67.2.413
   Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Bilodeau PS, 2004, J BIOL CHEM, V279, P54808, DOI 10.1074/jbc.M406654200
   BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933
   CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6
   Chen RH, 2006, J BIOMED SCI, V13, P193, DOI 10.1007/s11373-005-9063-5
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714
   Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189
   Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405
   Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005
   Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968
   Howard TL, 2001, J CELL SCI, V114, P2395
   Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001
   Ishida M, 2007, MOL CELL BIOL, V27, P1348, DOI 10.1128/MCB.00658-06
   Liou ML, 1999, J BIOL CHEM, V274, P10145, DOI 10.1074/jbc.274.15.10145
   Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863
   Mork CN, 2005, CURR PHARM DESIGN, V11, P1091, DOI 10.2174/1381612053507567
   MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729
   Nazarian J, 2005, PHYSIOL GENOMICS, V21, P70, DOI 10.1152/physiolgenomics.00227.2004
   Ozawa M, 1998, J NEUROL SCI, V159, P170, DOI 10.1016/S0022-510X(98)00152-X
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   R Core Development Team, 1999, R LANG ENV STAT COMP
   Sanjo H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/jbc.273.44.29066
   Shannan B, 2006, J MOL HISTOL, V37, P183, DOI 10.1007/s10735-006-9052-7
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Silvestri G, 2000, AM J MED GENET, V94, P201, DOI 10.1002/1096-8628(20000918)94:3<201::AID-AJMG5>3.0.CO;2-2
   Stefanovic B, 2004, MOL CELL BIOL, V24, P1758, DOI 10.1128/MCB.24.4.1758-1768.2004
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Torroni A, 2003, AM J HUM GENET, V72, P1005, DOI 10.1086/373936
   Tsang HTH, 2006, GENOMICS, V88, P333, DOI 10.1016/j.ygeno.2006.04.003
   van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28
   van Essen EHR, 2000, DIABETIC MED, V17, P841, DOI 10.1046/j.1464-5491.2000.00379.x
   WANKER EE, 1995, J CELL BIOL, V130, P29, DOI 10.1083/jcb.130.1.29
   XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0
   Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4
   Zhao P, 2004, DEV DYNAM, V229, P380, DOI 10.1002/dvdy.10457
NR 48
TC 9
Z9 9
U1 0
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD AUG
PY 2008
VL 45
IS 8
BP 525
EP 534
DI 10.1136/jmg.2008.057497
PG 10
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 333HK
UT WOS:000258143400007
PM 18456717
DA 2024-11-01
ER

PT J
AU Zecic, A
   Smet, JE
   De Praeter, CM
   Vanhaesebrouck, P
   Viscomi, C
   Van Den Broecke, C
   De Paepe, B
   Lohse, P
   Martin, JJ
   Jackson, JG
   Campbell, CR
   De Meirleir, LJ
   Zeviani, M
   Seneca, SH
   Lissens, W
   Van Coster, RN
AF Zecic, Alexandra
   Smet, Joel E.
   De Praeter, Claudine M.
   Vanhaesebrouck, Piet
   Viscomi, Carlo
   Van Den Broecke, Caroline
   De Paepe, Boel
   Lohse, Peter
   Martin, Jean-Jacques
   Jackson, Joshua G.
   Campbell, Colin R.
   De Meirleir, Linda J.
   Zeviani, Massimo
   Seneca, Sara H.
   Lissens, Willy
   Van Coster, Rudy N.
TI Lactic Acidosis in a Newborn With Adrenal Calcifications
SO PEDIATRIC RESEARCH
LA English
DT Article
ID RESPIRATORY-CHAIN; MUTATION; TRANSLATION; DEFICIENCY; SIBLINGS; DEFECTS;
   DISEASE; INFANCY
AB A patient is reported who presented in the newborn period with an unusual combination of congenital lactic acidosis and bilateral calcifications in the adrenal medulla, visible on standard abdominal x-ray and ultrasound examination. At birth, the proband was hypotonic and dystrophic. She developed respiratory insufficiency, cardiomegaly, and hepatomegaly and died at the age of 38 d. Examination of postmortem heart muscle revealed multiple areas of myocardial infarction with dystrophic calcifications. In the medulla of the adrenal glands, foci of necrosis and calcifications, and in the liver, multiple zones of necrosis and iron deposition were detected. Biochemical-analysis in heart muscle revealed a decreased activity of complex IV of the oxidative phosphorylation (OXPHOS) and in liver a combined deficiency involving the complexes I, III, IV, and V. The findings were suggestive of a defect in biosynthesis of the mitochondrially encoded subunits of the OXPHOS complexes. Extensive analysis of the proband's mitochondrial DNA revealed neither pathogenic deletions and point mutations nor copy number alterations. Relative amounts of mitochondrial transcripts for the ribosomal mitochondrial 12S rRNA (12S) and mitochondrial 16S rRNA (16S) were significantly increased suggesting a compensatory mechanism involving the transcription machinery to low levels of translation. The underlying molecular defect has not been identified yet. (Pediatr Res 66: 317-322, 2009)
C1 [Zecic, Alexandra; De Praeter, Claudine M.; Vanhaesebrouck, Piet] Ghent Univ Hosp, Dept Neonatol, B-9000 Ghent, Belgium.
   [Smet, Joel E.; De Paepe, Boel; Van Coster, Rudy N.] Ghent Univ Hosp, Dept Pediat Neurol & Metab, B-9000 Ghent, Belgium.
   [Van Den Broecke, Caroline] Ghent Univ Hosp, Dept Pathol, B-9000 Ghent, Belgium.
   [Viscomi, Carlo; Zeviani, Massimo] Ist Nazl Neurol Carlo Besta, Dept Mol Neurogenet, I-20126 Milan, Italy.
   [Lohse, Peter] Univ Munich, Dept Clin Chem, D-81377 Munich, Germany.
   [Martin, Jean-Jacques] Univ Antwerp, Dept Neuropathol, B-2610 Antwerp, Belgium.
   [Jackson, Joshua G.; Campbell, Colin R.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA.
   [De Meirleir, Linda J.; Seneca, Sara H.; Lissens, Willy] Univ Hosp Brussels, Dept Med Genet, B-1090 Brussels, Belgium.
C3 Ghent University; Ghent University Hospital; Ghent University; Ghent
   University Hospital; Ghent University; Ghent University Hospital;
   Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Munich;
   University of Antwerp; University of Minnesota System; University of
   Minnesota Twin Cities; University Hospital Brussels
RP Van Coster, RN (corresponding author), Ghent Univ Hosp, Dept Pediat, Div Pediat Neurol & Metab, Pintelaan 185, B-9000 Ghent, Belgium.
EM rudy.vancoster@ugent.be
RI De Meirleir, Linda/D-6591-2016; Zeviani, Massimo/K-2891-2014; viscomi,
   Carlo/R-1940-2016; Lissens, Willy/B-2892-2013; Smet, Joel/B-7428-2013;
   De Paepe, Boel/B-7548-2013
OI Zeviani, Massimo/0000-0002-9067-5508; Jackson,
   Joshua/0000-0003-4166-9213; Lissens, Willy/0000-0003-3875-9955; Seneca,
   Sara/0000-0002-0853-9890; Viscomi, Carlo/0000-0001-6050-0566; Smet,
   Joel/0000-0002-9551-6282; De Paepe, Boel/0000-0001-9403-4401
FU Fund for Scientific Research (FWO) Belgium [G.0666.06]; Kid-AuQuai
   foundation
FX Supported by grants from the Fund for Scientific Research (FWO) Belgium,
   contract grant number G.0666.06 (Universiteit Gent, Vrije Universiteit
   Brussel), and the Kid-AuQuai foundation.
CR BIRCHMACHIN MA, 1989, PEDIATR RES, V25, P553, DOI 10.1203/00006450-198905000-00025
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   De A, 2007, BIOCHEM J, V402, P175, DOI 10.1042/BJ20061004
   De Paepe B, 2006, PEDIATR RES, V59, P2, DOI 10.1203/01.pdr.0000191294.34122.ab
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   Indumathi C. K., 2005, Indian Journal of Pediatrics, V72, P1049, DOI 10.1007/BF02724410
   Lohse P, 2000, J LIPID RES, V41, P23
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAGNIN D, 1973, HELV PAEDIATR ACTA, V28, P135
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   MORRISON SC, 1988, PEDIATR RADIOL, V18, P240, DOI 10.1007/BF02390405
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   ROBINSON BH, 1992, EUR J PEDIATR, V151, P347, DOI 10.1007/BF02113256
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   Srere P.A., 1969, Methods in Enzymology, V13, P3
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   van Straaten HLM, 2005, NEUROPEDIATRICS, V36, P193, DOI 10.1055/s-2005-865713
   WOLMAN M, 1961, PEDIATRICS, V28, P742
NR 24
TC 4
Z9 4
U1 0
U2 4
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0031-3998
EI 1530-0447
J9 PEDIATR RES
JI Pediatr. Res.
PD SEP
PY 2009
VL 66
IS 3
BP 317
EP 322
DI 10.1203/PDR.0b013e3181b40a80
PG 6
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 488HK
UT WOS:000269339800014
PM 19581830
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Thomas, A
   Rey, M
   Aubry, L
   Pelosi, L
AF Thomas, Amandine
   Rey, Martial
   Aubry, Laurence
   Pelosi, Ludovic
TI A hybrid model to study pathological mutations of the human ADP/ATP
   carriers
SO BIOCHIMIE
LA English
DT Article
DE ADP/ATP carrier; Mitochondrial diseases; Saccharomyces cerevisiae;
   Dictyostelium discoideum
ID ADENINE-NUCLEOTIDE TRANSLOCATOR; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   YEAST SACCHAROMYCES-CEREVISIAE; ANT1 GENE; FUNCTIONAL-CHARACTERIZATION;
   DICTYOSTELIUM-DISCOIDEUM; MOLECULAR-MECHANISMS; MITOCHONDRIAL-DNA;
   PROTEIN; PURIFICATION
AB The adenine nucleotide carrier (Ancp) plays an essential role in the metabolism of cellular energy by catalyzing the transport of ADP and ATP across the inner mitochondria! membrane. Previous reports have indicated that mutations in the HANC1 gene, encoding the muscle isoform of human Ancp (HAnc1p), are directly involved in several diseases, including autosomal dominant progressive external ophthalmoplegia and cardiomyopathies. In this work, we studied three pathogenic HANC1 mutations at the biochemical level. To do so, we expressed the DdANCA gene, encoding the unique Ancp carrier of Dictyostelium discoideum (DdAncAp), in a yeast strain lacking all endogenous ANC genes. Our results indicate that DdAncAp is a good model for the human protein. It allows the carrier to be studied in yeast, and provides information on how the HANC1 mutations impair ADP/ATP transport in humans. A94D, A126D and V291M mutations, corresponding to A90D, A123D and V289M in HAnc1p, respectively, did not affect levels of DdAncAp in yeast mitochondria. However, while the wild-type DdAncAp fully restored growth of the ANC-null yeast strain on a non-fermentable carbon source, the carriers encompassing either the A94D or the A126D mutation failed to complement the null strain. The effect of the V291M mutation was not as pronounced, but led to impairment mainly of the nucleotide translocation process per se. These findings provide new insights into the mechanisms responsible for the diseases induced by HAnc1p mutations. (C) 2011 Elsevier Masson SAS. All rights reserved.
C1 [Pelosi, Ludovic] Univ Grenoble 1, CNRS, CEA,UMR 5092, BBSI,iRTSV,DSV,Lab Biochim & Biophys Syst Integre, F-38054 Grenoble, France.
   [Thomas, Amandine; Rey, Martial; Aubry, Laurence; Pelosi, Ludovic] CNRS, UMR5092, LBBSI, F-38054 Grenoble, France.
C3 CEA; Centre National de la Recherche Scientifique (CNRS); Communaute
   Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre
   National de la Recherche Scientifique (CNRS)
RP Pelosi, L (corresponding author), Univ Grenoble 1, CNRS, CEA,UMR 5092, BBSI,iRTSV,DSV,Lab Biochim & Biophys Syst Integre, F-38054 Grenoble, France.
EM ludovic.pelosi@cea.fr
RI Rey, Martial/JEZ-9086-2023; Pelosi, Ludovic/AAB-9832-2020
OI Aubry, Laurence/0000-0001-7640-1706; Rey, Martial/0000-0002-7378-1106
FU Universite Joseph Fourier (UJF); French Centre National de la Recherche
   Scientifique (CNRS); Commissariat a l'Energie Atomique (CEA)
FX Martial Rey was supported by fellowships from the Universite Joseph
   Fourier (UJF). This work was supported by grants from the UJF, the
   French Centre National de la Recherche Scientifique (CNRS) and the
   Commissariat a l'Energie Atomique (CEA). We thank Dr Veronique Trezeguet
   for assistance with molecular biology experiments, Dr Gerard Klein and
   Dr Gerard Brandolin for constructive discussions and Dr Jean Gagnon for
   critical comments on the manuscript.
CR Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855
   Bof M, 1999, EUR J BIOCHEM, V259, P795, DOI 10.1046/j.1432-1327.1999.00088.x
   BRANDOLIN G, 1974, FEBS LETT, V46, P149, DOI 10.1016/0014-5793(74)80356-X
   BRANDOLIN G, 1989, BIOCHEMISTRY-US, V28, P1093, DOI 10.1021/bi00429a025
   BRANDOLIN G, 1993, BIOCHEM BIOPH RES CO, V192, P143, DOI 10.1006/bbrc.1993.1393
   BRANDOLIN G, 1993, J BIOENERG BIOMEMBR, V25, P459, DOI 10.1007/BF01108403
   Chen XJ, 2002, HUM MOL GENET, V11, P1835, DOI 10.1093/hmg/11.16.1835
   Clémencon B, 2008, J BIOL CHEM, V283, P11218, DOI 10.1074/jbc.M709565200
   Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006
   Dahout-Gonzalez C, 2005, BIOCHEMISTRY-US, V44, P16310, DOI 10.1021/bi0514820
   Dassa EP, 2005, PROTEIN EXPRES PURIF, V40, P358, DOI 10.1016/j.pep.2004.12.019
   DAUM G, 1982, J BIOL CHEM, V257, P3028
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   DRGON T, 1991, FEBS LETT, V289, P159, DOI 10.1016/0014-5793(91)81059-H
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   LeSaux A, 1996, BIOCHEMISTRY-US, V35, P16116, DOI 10.1021/bi961714i
   LI K, 1989, J BIOL CHEM, V264, P13998
   Lodi T, 2006, BIOCHEM BIOPH RES CO, V341, P810, DOI 10.1016/j.bbrc.2006.01.034
   Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056
   Rey M, 2010, J BIOL CHEM, V285, P34981, DOI 10.1074/jbc.M110.146209
   Satre M, 2007, BIOCHIMIE, V89, P1058, DOI 10.1016/j.biochi.2007.03.004
   Schwimmer Christine, 2006, Biotechnology Journal, V1, P270, DOI 10.1002/biot.200500053
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Trézéguet V, 2008, J BIOENERG BIOMEMBR, V40, P435, DOI 10.1007/s10863-008-9178-2
   WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171
NR 34
TC 2
Z9 2
U1 0
U2 8
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0300-9084
J9 BIOCHIMIE
JI Biochimie
PD SEP
PY 2011
VL 93
IS 9
BP 1415
EP 1423
DI 10.1016/j.biochi.2011.04.015
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 811TA
UT WOS:000294237800006
PM 21549803
DA 2024-11-01
ER

PT J
AU Rouzier, C
   Chaussenot, A
   Serre, V
   Fragaki, K
   Bannwarth, S
   Ait-El-Mkadem, S
   Attarian, S
   Kaphan, E
   Cano, A
   Delmont, E
   Sacconi, S
   de Camaret, BM
   Rio, M
   Lebre, AS
   Jardel, C
   Deschamps, R
   Richelme, C
   Pouget, J
   Chabrol, B
   Paquis-Flucklinger, V
AF Rouzier, Cecile
   Chaussenot, Annabelle
   Serre, Valerie
   Fragaki, Konstantina
   Bannwarth, Sylvie
   Ait-El-Mkadem, Samira
   Attarian, Shahram
   Kaphan, Elsa
   Cano, Aline
   Delmont, Emilien
   Sacconi, Sabrina
   de Camaret, Benedicte Mousson
   Rio, Marlene
   Lebre, Anne-Sophie
   Jardel, Claude
   Deschamps, Romain
   Richelme, Christian
   Pouget, Jean
   Chabrol, Brigitte
   Paquis-Flucklinger, Veronique
TI Quantitative multiplex PCR of short fluorescent fragments for the
   detection of large intragenic <i>POLG</i> rearrangements in a large
   French cohort
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE POLG; QMPSF; intragenic deletion; EPC; polyendocrinopathy
ID DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   MITOCHONDRIAL-DNA; HEPATOCEREBRAL SYNDROMES; AUTOSOMAL-DOMINANT;
   ALPERS-SYNDROME; COPY NUMBER; MUTATIONS; DELETIONS; DISEASE
AB Polymerase gamma (POLG) is the gene most commonly involved in mitochondrial disorders with mitochondrial DNA instability and causes a wide range of diseases with recessive or dominant transmission. More than 170 mutations have been reported. Most of them are missense mutations, although nonsense mutations, splice-site mutations, small deletions and insertions have also been identified. However, to date, only one large-scale rearrangement has been described in a child with Alpers syndrome. Below, we report a large cohort of 160 patients with clinical, molecular and/or biochemical presentation suggestive of POLG deficiency. Using sequencing, we identified POLG variants in 22 patients (18 kindreds) including five novel pathogenic mutations. Two patients with novel mutations had unusual clinical presentation: the first exhibited an isolated ataxic neuropathy and the second was a child who presented with endocrine signs. We completed the sequencing step by quantitative multiplex PCR of short fluorescent fragments (QMPSF) analysis in 37 patients with either only one POLG heterozygous variant or a family history suggesting a dominant transmission. We identified a large intragenic deletion encompassing part of intron 21 and exon 22 of POLG in a child with refractory epilepsia partialis continua. In conclusion, we describe the first large French cohort of patients with POLG mutations, expanding the wide clinical and molecular spectrum observed in POLG disease. We confirm that large deletions in the POLG gene are rare events and we highlight the importance of QMPSF in patients with a single heterozygous POLG mutation, particularly in severe infantile phenotypes.
C1 [Rouzier, Cecile; Chaussenot, Annabelle; Fragaki, Konstantina; Bannwarth, Sylvie; Ait-El-Mkadem, Samira; Paquis-Flucklinger, Veronique] Nice Teaching Hosp, Dept Med Genet, Natl Ctr Mitochondrial Dis, Nice, France.
   [Rouzier, Cecile; Fragaki, Konstantina; Bannwarth, Sylvie; Ait-El-Mkadem, Samira; Paquis-Flucklinger, Veronique] Univ Nice Sophia Antipolis, CNRS UMR 7284, Sch Med, IRCAN,INSERM U1081,UNS, F-06189 Nice, France.
   [Serre, Valerie] Univ Paris Diderot, Inst Jacques Monod, CNRS, Paris, France.
   [Attarian, Shahram; Kaphan, Elsa; Pouget, Jean] Marseille Teaching Hosp, Timone Hosp, Dept Neurol, Marseille, France.
   [Cano, Aline; Chabrol, Brigitte] Marseille Teaching Hosp, Timone Hosp, Dept Neuropediat, Marseille, France.
   [Delmont, Emilien; Sacconi, Sabrina] Nice Teaching Hosp, Dept Neurol, Nice, France.
   [de Camaret, Benedicte Mousson] Lyon Teaching Hosp, Dept Metab Dis, Biol & Pathol Ctr Est, Lyon, France.
   [Rio, Marlene; Lebre, Anne-Sophie] Paris Teaching Hosp, Necker Hosp, Dept Med Genet, Paris, France.
   [Jardel, Claude] Paris Teaching Hosp, Pitie Salpetriere Hosp, Dept Mol & Chromosomal Genet, Paris, France.
   [Deschamps, Romain] Ft France Teaching Hosp, Dept Neuromuscular Disorders, Fort De France, Martinique, France.
   [Richelme, Christian] Nice Teaching Hosp, Lenval Hosp, Dept Pediat, Nice, France.
C3 CHU Nice; Universite Cote d'Azur; Centre National de la Recherche
   Scientifique (CNRS); CNRS - National Institute for Biology (INSB);
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite Paris Cite; Centre National de la Recherche Scientifique
   (CNRS); Aix-Marseille Universite; Assistance Publique-Hopitaux de
   Marseille; Aix-Marseille Universite; Assistance Publique-Hopitaux de
   Marseille; CHU Nice; CHU Lyon; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants
   Malades - APHP; Hopital Universitaire Pitie-Salpetriere - APHP;
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Pitie-Salpetriere - APHP; Sorbonne Universite; CHU Martinique; CHU Nice
RP Paquis-Flucklinger, V (corresponding author), IRCAN, CNRS UMR 7284, Sch Med, INSERM U1081,UNS, 28 Valombrose, F-06107 Nice, France.
EM paquis@hermes.unice.fr
RI Attarian, Shahram/AAE-6214-2021; Rouzier, Cecile/KCY-3619-2024; Kaphan,
   Elsa/AAC-7574-2020; SACCONI, Sabrina/AFT-1096-2022; Lebre,
   Anne-Sophie/AAO-1413-2020
OI Serre, Valerie/0000-0001-5277-1120; kaphan, elsa/0000-0002-0155-8597;
   SACCONI, Sabrina/0000-0002-0246-1455
FU Association Francaise contre les Myopathies (AFM); CHU of Nice
FX We thank Christelle Camuso and Bernadette Chafino for technical help.
   This work was made possible by grants to VP-F from the Association
   Francaise contre les Myopathies (AFM) and to CR from the CHU of Nice.
CR Amara A, 2012, EUR J PAEDIATR NEURO, V16, P167, DOI 10.1016/j.ejpn.2011.07.007
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Ceulemans S, 2012, METHODS MOL BIOL, V838, P311, DOI 10.1007/978-1-61779-507-7_15
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Charbonnier F, 2000, CANCER RES, V60, P2760
   Compton AG, 2011, MITOCHONDRION, V11, P104, DOI 10.1016/j.mito.2010.07.012
   Férec C, 2006, EUR J HUM GENET, V14, P567, DOI 10.1038/sj.ejhg.5201590
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Gouas L, 2008, PATHOL BIOL, V56, P345, DOI 10.1016/j.patbio.2008.03.010
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   Hopkins SE, 2010, J CHILD NEUROL, V25, P752, DOI 10.1177/0883073809343313
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Isohanni P, 2011, NEUROLOGY, V76, P811, DOI 10.1212/WNL.0b013e31820e7b25
   Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Kurt B, 2010, ARCH NEUROL-CHICAGO, V67, P239, DOI 10.1001/archneurol.2009.332
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Paul R, 1996, TRENDS GENET, V12, P131
   Reichenbach J, 2006, PEDIATR RES, V60, P321, DOI 10.1203/01.pdr.0000233252.60457.cf
   Rouzier C, 2010, J MED GENET, V47, P670, DOI 10.1136/jmg.2009.073445
   Saugier-Veber P, 2006, EUR J HUM GENET, V14, P1009, DOI 10.1038/sj.ejhg.5201661
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 34
TC 28
Z9 28
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD APR
PY 2014
VL 22
IS 4
BP 542
EP 550
DI 10.1038/ejhg.2013.171
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AD0QE
UT WOS:000332938400026
PM 23921535
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Liu, YH
   Xue, JF
   Zhao, DH
   Chen, L
   Yuan, Y
   Wang, ZX
AF Liu Yuhe
   Xue Junfang
   Zhao Danhua
   Chen Li
   Yuan Yun
   Wang Zhaoxia
TI Audiological evaluation in Chinese patients with mitochondrial
   encephalomyopathies
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE mitochondrial disorder; hearing impairment; auditory neuropathy spectrum
   disorder
ID HEARING-LOSS; A3243G MUTATION; POINT MUTATION; DNA; CHILDREN; DISEASE;
   MELAS
AB Background Hearing impairment has been reported to be common in patients with mitochondrial disorders, a group of diseases characterized by pleiomorphic clinical manifestations due to defects in oxidative phosphorylation of mitochondria. This study aimed to investigate the audiological characteristics in a large cohort of patients with mitochondria! disease.
   Methods Comprehensive audiological evaluations, including pure tone audiometry, tympanometry, speech audiometry, otoacoustic emissions, electrocochleography and auditory brainstem evoked potentials, were performed in 73 Chinese patients with mitochondrial encephalomyopathy and with confirmed mitochondria! DNA (mtDNA) defects.
   Results Among the patients, 71% had hearing impairment. However, the incidence rate and severity of hearing impairment were much less in the chronic progressive external ophthalmoplegia (CPEO) subtype than in the mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), myoclonic epilepsy with ragged red fibers (MERRF) and Kearns-Sayre syndrome (KSS) subtypes. While most of our patients had a predominantly cochlea origin for the hearing deficit, five patients had an auditory neuropathy spectrum disorder and three patients had impairment of both cochlea and auditory cortex.
   Conclusions Various portions of the auditory system could be involved in patients with mitochondrial diseases, including cochlea, auditory nerve, auditory pathway and cortex. Hearing loss was more associated with multisystem involvement. Genotype, mutant load of mtDNA and other unknown factors could contribute to heterogeneity of hearing impairment in mitochondria! disease.
C1 [Liu Yuhe; Xue Junfang; Chen Li] Peking Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Beijing 100034, Peoples R China.
   [Zhao Danhua; Yuan Yun; Wang Zhaoxia] Peking Univ, Hosp 1, Dept Neurol, Beijing 100034, Peoples R China.
C3 Peking University; Peking University
RP Wang, ZX (corresponding author), Peking Univ, Hosp 1, Dept Neurol, Beijing 100034, Peoples R China.
EM drwangzx@163.com
RI Liu, Yuhe/B-1558-2015
CR Braverman I, 1996, ARCH OTOLARYNGOL, V122, P1001
   Ceranic B, 2004, J NEUROL NEUROSUR PS, V75, P626, DOI 10.1136/jnnp.2003.017673
   Chennupati SK, 2011, INT J PEDIATR OTORHI, V75, P1519, DOI 10.1016/j.ijporl.2011.08.019
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   Deschauer M, 2001, ARCH NEUROL-CHICAGO, V58, P1885, DOI 10.1001/archneur.58.11.1885
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Edmonds JL, 2002, ARCH OTOLARYNGOL, V128, P355, DOI 10.1001/archotol.128.4.355
   ELVERLAND HH, 1991, AM J OTOL, V12, P459
   Forli F, 2007, BIOSCIENCE REP, V27, P113, DOI 10.1007/s10540-007-9040-5
   Gamez J, 2006, CLIN NEUROPHYSIOL, V117, P2385, DOI 10.1016/j.clinph.2006.07.138
   Iwasaki S, 2011, LARYNGOSCOPE, V121, P1821, DOI 10.1002/lary.21879
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Moilanen JS, 2001, EUR J HUM GENET, V9, P59, DOI 10.1038/sj.ejhg.5200550
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Oshima T, 1999, LARYNGOSCOPE, V109, P334, DOI 10.1097/00005537-199902000-00029
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Scarpelli M, 2012, GENET RES INT, V2012, DOI 10.1155/2012/287432
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   Takahashi K, 2003, LARYNGOSCOPE, V113, P1362, DOI 10.1097/00005537-200308000-00018
   Xue Jun-fang, 2012, Zhonghua Yi Xue Za Zhi, V92, P2830
   Yamasoba T, 1996, LARYNGOSCOPE, V106, P49, DOI 10.1097/00005537-199601000-00010
   Zwirner P, 2001, LARYNGOSCOPE, V111, P515, DOI 10.1097/00005537-200103000-00024
NR 25
TC 5
Z9 7
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0366-6999
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD JUN 20
PY 2014
VL 127
IS 12
BP 2304
EP 2309
DI 10.3760/cma.j.issn.0366-6999.20132799
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA AL6CU
UT WOS:000339220700020
PM 24931247
OA gold
DA 2024-11-01
ER

PT J
AU Janssen, GMC
   Hensbergen, PJ
   van Bussel, FJ
   Balog, CIA
   Maassen, JA
   Deelder, AM
   Raap, AK
AF Janssen, George M. C.
   Hensbergen, Paul J.
   van Bussel, Frans J.
   Balog, Crina I. A.
   Maassen, J. Antonie
   Deelder, Andre M.
   Raap, Anton K.
TI The A3243G tRNA<SUP>Leu(UUR)</SUP> mutation induces mitochondrial
   dysfunction and variable disease expression without dominant negative
   acting translational defects in complex IV subunits at UUR codons
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID CYTOCHROME-C-OXIDASE; WOBBLE MODIFICATION DEFICIENCY;
   AMINOACYL-TRANSFER-RNA; MUSCLE-FIBER ANALYSIS; MUTANT TRANSFER-RNAS;
   PROTEIN-SYNTHESIS; LACTIC-ACIDOSIS; MYOCLONUS EPILEPSY;
   DIABETES-MELLITUS; MELAS MUTATION
AB Mutations in the mitochondrial tRNA (Leu( UUR)) gene are associated with a large variety of human diseases through a largely undisclosed mechanism. The A3243G tRNA (Leu(UUR)) mutation leads to reduction of mitochondrial DNA (mtDNA)-encoded proteins and oxidative phosphorylation activity even when the cells are competent in mitochondrial translation. These two aspects led to the suggestion that a dominant negative factor may underlie the diversity of disease expression. Here we test the hypothesis that A3243G tRNA Leu( UUR) generates such a dominant negative gain-of-function defect through misincorporation of amino acids at UUR codons of mtDNA-encoded proteins. Using an anti-complex IV immunocapture technique and mass spectrometry, we show that the mtDNA- encoded cytochrome c oxidase I (COX I) and COX II exist exclusively with the correct amino acid sequences in A3243G cells in a misassembled complex IV. A dominant negative component therefore cannot account for disease phenotype, leaving tissue-specific accumulation by mtDNA segregation as the most likely cause of variable mitochondrial disease expression.
C1 Leiden Univ, Ctr Med, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands.
   Leiden Univ, Ctr Med, Biomol Mass Spectrometry Unit, Dept Parasitol, NL-2300 RC Leiden, Netherlands.
C3 Leiden University; Leiden University - Excl LUMC; Leiden University;
   Leiden University - Excl LUMC
RP Janssen, GMC (corresponding author), Leiden Univ, Ctr Med, Dept Mol Cell Biol, Post Zone S1-P,Einthovenweg 20,POB 9600, NL-2300 RC Leiden, Netherlands.
EM G.M.C.Janssen@lumc.nl
OI Raap, Anton Klaas/0000-0003-1483-7816; Hensbergen,
   Paul/0000-0002-3193-5445
CR Börner GV, 2000, HUM MOL GENET, V9, P467, DOI 10.1093/hmg/9.4.467
   Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   El Meziane A, 1998, NAT GENET, V18, P350
   El Meziane A, 1998, HUM MOL GENET, V7, P2141, DOI 10.1093/hmg/7.13.2141
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584
   Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617
   Jacobs HT, 2003, HUM MOL GENET, V12, pR293, DOI 10.1093/hmg/ddg285
   Jacobs HT, 2000, HUM MOL GENET, V9, P463, DOI 10.1093/hmg/9.4.463
   JAHANGIR TRS, 2005, MUTAT RES, V578, P43
   Janssen GMC, 1999, J BIOL CHEM, V274, P29744, DOI 10.1074/jbc.274.42.29744
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirino Y, 2006, HUM MOL GENET, V15, P897, DOI 10.1093/hmg/ddl007
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Kobayashi T, 1997, DIABETES, V46, P1567, DOI 10.2337/diabetes.46.10.1567
   KOGA Y, 1995, MUSCLE NERVE, pS119
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096
   Lynn S, 2003, DIABETOLOGIA, V46, P296, DOI 10.1007/s00125-002-1018-z
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Maassen JA, 2001, EXP CLIN ENDOCR DIAB, V109, P127, DOI 10.1055/s-2001-14834
   Mita S, 1998, MUSCLE NERVE, V21, P490, DOI 10.1002/(SICI)1097-4598(199804)21:4<490::AID-MUS7>3.0.CO;2-4
   Murray J, 2004, BBA-BIOENERGETICS, V1659, P206, DOI 10.1016/j.bbabio.2004.07.005
   NEGRUTSKII BS, 1991, P NATL ACAD SCI USA, V88, P4991, DOI 10.1073/pnas.88.11.4991
   Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x
   NIJTMANS LGJ, 1995, BBA-MOL CELL RES, V1265, P117, DOI 10.1016/0167-4889(94)00203-Q
   Ozawa M, 1998, J NEUROL SCI, V159, P170, DOI 10.1016/S0022-510X(98)00152-X
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   Qiu H, 2001, EMBO J, V20, P1425, DOI 10.1093/emboj/20.6.1425
   Rabilloud T, 2002, BIOCHEMISTRY-US, V41, P144, DOI 10.1021/bi0114776
   REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3
   Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4
   Schägger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Silvestri G, 2000, AM J MED GENET, V94, P201, DOI 10.1002/1096-8628(20000918)94:3<201::AID-AJMG5>3.0.CO;2-2
   STEEN H, 2002, SCI STKE, V154, pPL16
   Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656
   Szuhai K, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e13
   Taanman JW, 1996, BBA-MOL BASIS DIS, V1315, P199, DOI 10.1016/0925-4439(95)00127-1
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tryoen-Tóth P, 2003, J BIOL CHEM, V278, P24314, DOI 10.1074/jbc.M301530200
   Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136
   van den Ouweland JMW, 1999, DIABETOLOGIA, V42, P485, DOI 10.1007/s001250051183
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Yasukawa T, 2005, FEBS LETT, V579, P2948, DOI 10.1016/j.febslet.2005.04.038
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
NR 55
TC 25
Z9 28
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD OCT 15
PY 2007
VL 16
IS 20
BP 2472
EP 2481
DI 10.1093/hmg/ddm203
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 227SP
UT WOS:000250678400008
PM 17656376
OA Bronze
DA 2024-11-01
ER

PT S
AU DiMauro, S
   Hirano, M
AF DiMauro, Salvatore
   Hirano, Michio
BE Espinos, C
   Felipo, V
   Palau, F
TI Pathogenesis and Treatment of Mitochondrial Disorders
SO INHERITED NEUROMUSCULAR DISEASES: TRANSLATION FROM PATHMECHANISMS TO
   THERAPIES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT International Symposium on Rare Diseases - Inherited Neuromuscular
   Diseases, Translation from Pathomechanisms to Therapies
CY NOV 16-18, 2008
CL Valencia, SPAIN
DE Mitochondrial diseases; Respiratory chain defects; Energy failure;
   Oxidative stress; Symptomatic therapy; Pharmacological therapy; Gene
   therapy
ID HEREDITARY OPTIC NEUROPATHY; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   COMPLEX-I ACTIVITY; OPTIMIZED ALLOTOPIC EXPRESSION; CONGENITAL
   LACTIC-ACIDOSIS; COENZYME-Q DEFICIENCY; KEARNS-SAYRE-SYNDROME;
   STROKE-LIKE EPISODES; OXIDATIVE-PHOSPHORYLATION; CEREBELLAR-ATAXIA
AB In the past 50 years, our understanding of the biochemical and molecular causes of mitochondrial diseases, defined restrictively as disorders due to defects of the mitochondrial respiratory chain (RC), has made great strides. Mitochondrial diseases can be due to mutations in mitochondrial DNA (mtDNA) or in nuclear DNA (nDNA) and each group can be subdivided into more specific classes. Thus, mtDNA-related disorders can result from mutations in genes affecting protein synthesis in toto or mutations in protein-coding genes. Mendelian mitochondrial disorders can be attributed to mutations in genes that (i) encode subunits of the RC ("direct hits"); (ii) encode assembly proteins or RC complexes ("indirect hits"); (iii) encode factors needed for mtDNA maintenance, replication, or translation (intergenomic signaling); (iv) encode components of the mitochondrial protein import machinery; (v) control the synthesis and composition of mitochondrial membrane phospholipids; and (vi) encode proteins involved in mitochondrial dynamics.
   In contrast to this wealth of knowledge about etiology, our understanding of pathogenic mechanism is very limited. We discuss pathogenic factors that can influence clinical expression, especially ATP shortage and reactive oxygen radicals (ROS) excess.
   Therapeutic options are limited and fall into three modalities: (;) symptomatic interventions, which are palliative but crucial for day-to-day management; (ii) radical approaches aimed at correcting the biochemical or molecular error, which are interesting but still largely experimental; and (iii) pharmacological means of interfering with the pathogenic cascade of events (e.g. boosting ATP production or scavenging ROS), which are inconsistently and incompletely effective, but can be safe and helpful.
C1 [DiMauro, Salvatore; Hirano, Michio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
C3 Columbia University
RP DiMauro, S (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, 3-313 Russ Berrie Med Sci Pavil, New York, NY 10032 USA.
EM sd12@columbia.edu
FU NICHD NIH HHS [R01 HD056103, P01 HD032062, P01 HD080642, HD32062]
   Funding Source: Medline; NINDS NIH HHS [P01 NS011766, RC1 NS070232]
   Funding Source: Medline
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   ALLEN RJ, 1983, ANN NEUROL, V13, P679, DOI 10.1002/ana.410130620
   Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Bai YD, 2001, J BIOL CHEM, V276, P38808, DOI 10.1074/jbc.M106363200
   BAKER SK, 2003, EXPERT OPIN INV DRUG, V12, P1
   Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177
   Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Barbiroli B, 1999, BIOFACTORS, V9, P253, DOI 10.1002/biof.5520090221
   Barth PG, 1999, J INHERIT METAB DIS, V22, P555, DOI 10.1023/A:1005568609936
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Bianchi K, 2004, BBA-MOL CELL RES, V1742, P119, DOI 10.1016/j.bbamcr.2004.09.015
   Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Bonnet C, 2008, BBA-MOL CELL RES, V1783, P1707, DOI 10.1016/j.bbamcr.2008.04.018
   Bonnet D, 2001, HEART, V86, P570, DOI 10.1136/heart.86.5.570
   Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Carelli V., 2006, Mitochondrial Medicine, P105
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Carrozzo R, 2000, FEBS LETT, V486, P297, DOI 10.1016/S0014-5793(00)02244-4
   Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Chinnery PF, 2000, ANN NEUROL, V47, P381, DOI 10.1002/1531-8249(200003)47:3<381::AID-ANA17>3.0.CO;2-2
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Cortelli P, 1997, J NEUROL SCI, V148, P25, DOI 10.1016/S0022-510X(96)00311-5
   Cortés-Hernández P, 2007, J BIOL CHEM, V282, P1051, DOI 10.1074/jbc.M606828200
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Di Giovanni S, 2001, NEUROLOGY, V57, P515, DOI 10.1212/WNL.57.3.515
   Di Prospero NA, 2007, LANCET NEUROL, V6, P878, DOI 10.1016/S1474-4422(07)70220-X
   DiMauro S, 2003, BASIC APPL MYOL, V13, P145
   DIMAURO S, 2006, MITOCHONDRIAL MED
   DiMauro S., 2006, Mitochondrial Medicine, P261
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598
   Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833
   DOUGADOS M, 1983, ANN NEUROL, V13, P687, DOI 10.1002/ana.410130624
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Edmonds JL, 2004, MITOCHONDRION, V4, P543, DOI 10.1016/j.mito.2004.07.012
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919
   Felitsyn N, 2007, J NEUROCHEM, V100, P429, DOI 10.1111/j.1471-4159.2006.04248.x
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Fichera M, 2004, NEUROLOGY, V63, P1108, DOI 10.1212/01.WNL.0000138731.60693.D2
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   García JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Gironi M, 2004, NEUROLOGY, V62, P818, DOI 10.1212/01.WNL.0000113719.67643.B7
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   GVOZDJAKOVA A, 2008, MITOCHONDRIAL MED
   Hakkaart GAJ, 2006, EMBO REP, V7, P341, DOI 10.1038/sj.embor.7400601
   HALLER RG, 2004, MYOLOGY, V1, P665
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirano M, 2005, ARCH NEUROL-CHICAGO, V62, P711, DOI 10.1001/archneur.62.5.711
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Klopstock T, 1999, NEUROLOGY, V52, pA543
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267
   Kubota M, 2004, BRAIN DEV-JPN, V26, P481, DOI 10.1016/j.braindev.2004.01.006
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317
   Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC
   Lawson VH, 2005, NEUROLOGY, V65, P197, DOI 10.1212/01.wnl.0000168898.76071.70
   Lee WS, 2007, HEPATOLOGY, V45, P1555, DOI 10.1002/hep.21710
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Lodi R, 2002, J NEUROL NEUROSUR PS, V72, P805, DOI 10.1136/jnnp.72.6.805
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Marriage BJ, 2004, MOL GENET METAB, V81, P263, DOI 10.1016/j.ymgme.2003.12.008
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Millhouse-Flourie TJ, 2004, MITOCHONDRION, V4, P549, DOI 10.1016/j.mito.2004.07.013
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   MIT, 2003, MITOMAP HUM MIT GEN
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089
   MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257
   Pedrola L, 2005, HUM MOL GENET, V14, P1087, DOI 10.1093/hmg/ddi121
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   QUINZII C, 2008, FASEB J IN PRESS
   Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58
   Rimessi A, 2008, BBA-BIOENERGETICS, V1777, P808, DOI 10.1016/j.bbabio.2008.05.449
   Roesch K, 2002, HUM MOL GENET, V11, P477, DOI 10.1093/hmg/11.5.477
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   Rotig A., 2006, Mitochondrial Medicine, P197
   Sabatini S, 2009, J AM SOC NEPHROL, V20, P692, DOI 10.1681/ASN.2007121329
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Salviati L, 2005, NEUROLOGY, V65, P606, DOI 10.1212/01.wnl.0000172859.55579.a7
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281
   Seo BB, 2002, MOL THER, V6, P336, DOI 10.1006/mthe.2002.0674
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   SHAPIRA Y, 1977, ISRAEL J MED SCI, V13, P161
   SHY GM, 1966, BRAIN, V89, P133, DOI 10.1093/brain/89.1.133
   SHY GM, 1964, SCIENCE, V145, P493, DOI 10.1126/science.145.3631.493
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238
   Solaini G, 2008, BBA-BIOENERGETICS, V1777, P941, DOI 10.1016/j.bbabio.2008.04.034
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stacpoole PW, 2008, PEDIATRICS, V121, pE1223, DOI 10.1542/peds.2007-2062
   Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226
   STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6
   SZADBADKAI G, 2006, BIOCHIM BIOPHYS ACTA, V1763, P442
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tanji K, 2000, J NEUROL SCI, V178, P29, DOI 10.1016/S0022-510X(00)00354-3
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Tarnopolsky MA, 1999, MUSCLE NERVE, V22, P1228, DOI 10.1002/(SICI)1097-4598(199909)22:9<1228::AID-MUS9>3.3.CO;2-Y
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   TATUCH Y, 1994, EUR J HUM GENET
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Valentino ML, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037507
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Maldergem L, 2002, ANN NEUROL, V52, P750, DOI 10.1002/ana.10371
   Vázquez-Memije ME, 1998, J INHERIT METAB DIS, V21, P829, DOI 10.1023/A:1005418718299
   VazquezMemije ME, 1996, J INHERIT METAB DIS, V19, P43, DOI 10.1007/BF01799347
   Verkaart S, 2007, BBA-MOL BASIS DIS, V1772, P373, DOI 10.1016/j.bbadis.2006.12.009
   Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 181
TC 28
Z9 30
U1 0
U2 6
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
EI 2214-8019
BN 978-90-481-2812-9
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2009
VL 652
BP 139
EP 170
DI 10.1007/978-90-481-2813-6_10
PG 32
WC Medicine, Research & Experimental
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA BOT76
UT WOS:000277561400010
PM 20225024
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Finsterer, J
AF Finsterer, Josef
TI Obstetric involvement in mitochondrial disorders: A review
SO MEDICINE
LA English
DT Review
DE eclampsia; mitochondrial disorder; motherhood; mtDNA; oxidative
   phosphorylation; polyhydramnion; premature delivery; stillbirth
ID STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; MTDNA MUTATION; PREGNANCY;
   ENCEPHALOPATHY; MYOPATHY
AB This is the first review about obstetric involvement in mitochondrial disorders (MIDs). The purpose of the review was to discuss recent advances and knowledge about the type and frequency of obstetric complications in MIDs. A narrative review for preferred reporting items was performed in MEDLINE, Current Contents, EMBASE, Web of Science, Web of Knowledge, LILACS, SCOPUS, and Google Scholar. The author searched for studies examining obstetric complications in patients with a definite MID. Obstetric complications described in MIDs include eclampsia, preeclampsia, intra uterine growth retardation, polyhydramnion, oligoamnion, decreased fetal movements, premature delivery, stillbirth, blow weakness, dystocia, breech presentation, retained placenta, postnatal hemorrhage, low birth weight, and early postnatal death. The most common of these complications are polyhydramnion, stillbirth, premature delivery, and low birth weight. The data show that some obstetric complications are more common in MIDs than in healthy females. MIDs can be associated with various obstetric complications. Some of these complications are more common in pregnant females with MID compared with healthy pregnant females. Obstetricians should be aware of MIDs and should know that pregnant females with a MID have an increased risk of developing complications during pregnancy or delivery.
C1 [Finsterer, Josef] Neurol & Neurophysiol Ctr, Postfach 20, A-1180 Vienna, Austria.
RP Finsterer, J (corresponding author), Neurol & Neurophysiol Ctr, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
RI Finsterer, J/AAE-5733-2020
OI finsterer, josef/0000-0003-2839-7305
CR Aggarwal P, 2000, HUM HERED, V51, P114
   Arnon S, 2002, PRENATAL DIAG, V22, P34, DOI 10.1002/pd.232
   Bell JD, 2017, A A CASE REP, V9, P38, DOI 10.1213/XAA.0000000000000520
   BERKOWITZ K, 1990, AM J OBSTET GYNECOL, V162, P146, DOI 10.1016/0002-9378(90)90837-W
   Chandra SR, 2015, J POSTGRAD MED, V61, P200, DOI 10.4103/0022-3859.150905
   Chou YJ, 2004, PRENATAL DIAG, V24, P367, DOI 10.1002/pd.876
   Chow J, 2017, NAT REV ENDOCRINOL, V13, P92, DOI 10.1038/nrendo.2016.151
   Chuang LM, 1996, PANCREAS, V12, P243, DOI 10.1097/00006676-199604000-00006
   Cunningham F G., 1993, Williams Obstetrics, V19th, P763
   de Laat P, 2015, MITOCHONDRION, V25, P98, DOI 10.1016/j.mito.2015.10.005
   Ewart RM, 1997, AM J PERINAT, V14, P293, DOI 10.1055/s-2007-994147
   Faris AS, 2014, KOREAN J ANESTHESIOL, V67, P283, DOI 10.4097/kjae.2014.67.4.283
   Finsterer J, 2019, Z RHEUMATOL, V78, P875, DOI 10.1007/s00393-018-0551-1
   Gabbe S G., 1991, Obstetrics: Normal and Problem Pregnancies, V2nd
   Göpel W, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-210
   Guitart-Mampel M, 2019, J CELL MOL MED, V23, P3962, DOI 10.1111/jcmm.14282
   Inbar-Feigenberg M, 2018, METAB BRAIN DIS, V33, P1369, DOI 10.1007/s11011-018-0218-2
   Khan IA, 2015, SAUDI J BIOL SCI, V22, P243, DOI 10.1016/j.sjbs.2014.11.001
   Kuleva M, 2019, BJOG-INT J OBSTET GY, V126, P1372, DOI 10.1111/1471-0528.15515
   Lin L, 2019, EXP THER MED, V17, P1855, DOI 10.3892/etm.2018.7143
   Okhuijsen-Kroes EJ, 2001, NEUROPEDIATRICS, V32, P183, DOI 10.1055/s-2001-17372
   Sikdar S, 2007, NEUROL INDIA, V55, P82
   TORBERGSEN T, 1989, ACTA OBSTET GYN SCAN, V68, P145, DOI 10.3109/00016348909009902
   van Rij MC, 2016, CLIN CASE REP, V4, P425, DOI 10.1002/ccr3.511
   Velez DR, 2008, MITOCHONDRION, V8, P130, DOI 10.1016/j.mito.2007.10.007
   von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6
   Yanagawa T, 1998, INTERNAL MED, V37, P780, DOI 10.2169/internalmedicine.37.780
NR 27
TC 2
Z9 2
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD MAR 17
PY 2023
VL 102
IS 11
DI 10.1097/MD.0000000000033336
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA J6WE8
UT WOS:001010994900016
PM 36930069
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Moslemi, AR
   Darin, N
   Tulinius, M
   Oldfors, A
   Holme, E
AF Moslemi, AR
   Darin, N
   Tulinius, M
   Oldfors, A
   Holme, E
TI Two new mutations in the <i>MTATP6</i> gene associated with Leigh
   syndrome
SO NEUROPEDIATRICS
LA English
DT Article
DE Leigh syndrome; mtDNA; MTATP6; complex V; ATP synthase
ID ATPASE 6 GENE; MITOCHONDRIAL-DNA DELETIONS; C-OXIDASE DEFICIENCY;
   ESCHERICHIA-COLI; T9176C MUTATION; MUSCLE-FIBERS; SYNTHASE; DISEASE;
   ENCEPHALOMYOPATHIES; CHILDHOOD
AB In this study we have analyzed the mtDNA encoded ATPase 6 and 8 genes (MTATP6 and MTATP8) in two children with Leigh syndrome (LS) and reduced Mg2+ ATPase activity in muscle mitochondria. In patient 1, with a mild and reversible phenotype, mutational analysis revealed a heteroplasmic T -> C mutation at nt position 9185 (T9185C) in the MTATP6. The mutation resulted in substitution of a highly conserved leucine to proline at codon 220. The proportion of the mutation was > 97% in the patient's blood and muscle and 85% in blood of his asymptomatic mother. Patient 2, with severe clinical phenotype and death at 2 years of age, exhibited a novel heteroplasmic T9191C missense mutation in the MTATP6, which converted a highly conserved leucine to a proline at position 222 of the polypeptide. The proportion of the mutation was 90% in fibroblasts and 94% muscle tissue. This mutation was absent in the patient's parents and sister suggesting that the mutation was de novo. Our findings expand the spectrum of mutations causing LS and emphasize the role of MTATP6 gene mutations in pathogenesis of LS.
C1 Sahlgrens Univ Hosp, Dept Pathol, S-41345 Gothenburg, Sweden.
   Sahlgrens Univ Hosp, Dept Paediat, S-41345 Gothenburg, Sweden.
   Sahlgrens Univ Hosp, Dept Clin Chem, S-41345 Gothenburg, Sweden.
C3 Sahlgrenska University Hospital; Sahlgrenska University Hospital;
   Sahlgrenska University Hospital
RP Moslemi, AR (corresponding author), Sahlgrens Univ Hosp, Dept Pathol, S-41345 Gothenburg, Sweden.
EM ali-reza.moslemi@pathology.gu.se
RI Darin, Niklas/AAL-6345-2020
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Campos Y, 1997, NEUROLOGY, V49, P595, DOI 10.1212/WNL.49.2.595
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   DAVIS PC, 1987, AM J NEURORADIOL, V8, P71
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Dionisi-Vici C, 1998, J INHERIT METAB DIS, V21, P2, DOI 10.1023/A:1005397227996
   García JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075
   HARTZOG PE, 1993, J BIOL CHEM, V268, P12250
   Hartzog PE, 1999, INT J BIOCHEM CELL B, V31, P769, DOI 10.1016/S1357-2725(99)00029-1
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   LAMMINEN T, 1995, AM J HUM GENET, V56, P1238
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Moslemi AR, 1998, NEUROMUSCULAR DISORD, V8, P345, DOI 10.1016/S0960-8966(98)00029-7
   Moslemi AR, 2003, NEUROLOGY, V61, P991, DOI 10.1212/01.WNL.0000082391.98672.0A
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Ogilvie I, 1999, FEBS LETT, V453, P179, DOI 10.1016/S0014-5793(99)00605-5
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Santorelli FM, 1996, PEDIATR RES, V39, P914, DOI 10.1203/00006450-199605000-00028
   SANTORELLI FM, 1994, NEUROLOGY, V44, P972, DOI 10.1212/WNL.44.5.972
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
   TULINIUS MH, 1995, HUM GENET, V96, P290
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
NR 25
TC 52
Z9 60
U1 0
U2 5
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0174-304X
J9 NEUROPEDIATRICS
JI Neuropediatrics
PD OCT
PY 2005
VL 36
IS 5
BP 314
EP 318
DI 10.1055/s-2005-872845
PG 5
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 976RG
UT WOS:000232750300005
PM 16217706
DA 2024-11-01
ER

PT J
AU Librado, P
   Fages, A
   Gaunitz, C
   Leonardi, M
   Wagner, S
   Khan, N
   Hanghoj, K
   Alquraishi, SA
   Alfarhan, AH
   Al-Rasheid, KA
   Sarkissian, CD
   Schubert, M
   Orlando, L
AF Librado, Pablo
   Fages, Antoine
   Gaunitz, Charleen
   Leonardi, Michela
   Wagner, Stefanie
   Khan, Naveed
   Hanghoj, Kristian
   Alquraishi, Saleh A.
   Alfarhan, Ahmed H.
   Al-Rasheid, Khaled A.
   Sarkissian, Clio Der
   Schubert, Mikkel
   Orlando, Ludovic
TI The Evolutionary Origin and Genetic Makeup of Domestic Horses
SO GENETICS
LA English
DT Review
ID STATIONARY NIGHT BLINDNESS; POLYSACCHARIDE STORAGE MYOPATHY; OPTIMUM
   RACING DISTANCE; SYNTHASE GYS1 MUTATION; GAIT KEEPER MUTATION; ANCIENT
   DNA; GENOME SEQUENCE; MITOCHONDRIAL GENOMES; DELETERIOUS MUTATIONS;
   POSITIVE SELECTION
AB The horse was domesticated only 5.5 KYA, thousands of years after dogs, cattle, pigs, sheep, and goats. The horse nonetheless represents the domestic animal that most impacted human history; providing us with rapid transportation, which has considerably changed the speed and magnitude of the circulation of goods and people, as well as their cultures and diseases. By revolutionizing warfare and agriculture, horses also deeply influenced the politico-economic trajectory of human societies. Reciprocally, human activities have circled back on the recent evolution of the horse, by creating hundreds of domestic breeds through selective programs, while leading all wild populations to near extinction. Despite being tightly associated with humans, several aspects in the evolution of the domestic horse remain controversial. Here, we review recent advances in comparative genomics and paleogenomics that helped advance our understanding of the genetic foundation of domestic horses.
C1 [Librado, Pablo; Fages, Antoine; Gaunitz, Charleen; Leonardi, Michela; Wagner, Stefanie; Khan, Naveed; Hanghoj, Kristian; Sarkissian, Clio Der; Schubert, Mikkel; Orlando, Ludovic] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark.
   [Fages, Antoine; Hanghoj, Kristian; Orlando, Ludovic] Univ Toulouse 3, CNRS, UMR 5288, Lab Anthropobiol Mol & Imagerie Synth, F-31000 Toulouse, France.
   [Wagner, Stefanie] Univ Bordeaux, INRA, Biodiversite Genes & Communautes UMR1202, F-33610 Cestas, France.
   [Wagner, Stefanie] Univ Bordeaux, Biodiversite Genes & Communautes UMR1202, F-33170 Talence, France.
   [Khan, Naveed] Abdul Wali Khan Univ, Dept Biotechnol, Mardan 23200, Pakistan.
   [Alquraishi, Saleh A.; Alfarhan, Ahmed H.; Al-Rasheid, Khaled A.] King Saud Univ, Dept Zool, Coll Sci, Riyadh 11451, Saudi Arabia.
C3 University of Copenhagen; Centre National de la Recherche Scientifique
   (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universites de
   Strasbourg Etablissements Associes; Universite de Strasbourg; Universite
   de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Universite
   de Bordeaux; Universite de Bordeaux; Abdul Wali Khan University; King
   Saud University
RP Orlando, L (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark.
EM Lorlando@snm.ku.dk
RI AL-Rasheid, Khaled/C-2486-2008; DERSARKISSIAN, CLIO/J-4476-2014;
   Alfarhan, Ahmed/GQH-6118-2022; Leonardi, Michela/C-5431-2019; Khan,
   Naveed/AAM-2892-2021; Schubert, Mikkel/I-6911-2013; Orlando,
   Ludovic/A-8932-2013; Khan, Naveed/GVT-1251-2022
OI Leonardi, Michela/0000-0001-8933-9374; Khan, Naveed/0000-0001-7667-8553;
   Librado, Pablo/0000-0001-5974-2189; Wagner,
   Stefanie/0000-0003-1737-9021; Schubert, Mikkel/0000-0003-2401-9921;
   Orlando, Ludovic/0000-0003-3936-1850; Hanghoj,
   Kristian/0000-0003-1941-5495; Khan, Naveed/0000-0002-6502-9774; Fages,
   Antoine/0000-0001-6985-4360
FU Danish Council for Independent Research, Natural Sciences [4002-00152B];
   Danish National Research Foundation [DNRF94]; Initiative d'Excellence
   Chaires d'attractivite, Universite de Toulouse (OURASI); International
   Research Group Program [IRG14-08]; Deanship of Scientific Research, King
   Saud University; Marie-Curie Individual Fellowship [MSCA-IF-657852];
   Villum Fonden Blokstipendier grant; Villum Fonden research project grant
   (miGENEPI)
FX This work is dedicated to the memory of Dr. Teri Lear, a fantastic
   scientist, friend and horse lover, who recently passed away. This work
   was supported by the Danish Council for Independent Research, Natural
   Sciences (Grant 4002-00152B); the Danish National Research Foundation
   (Grant DNRF94); Initiative d'Excellence Chaires d'attractivite,
   Universite de Toulouse (OURASI); the International Research Group
   Program (Grant IRG14-08), Deanship of Scientific Research, King Saud
   University; a Marie-Curie Individual Fellowship (MSCA-IF-657852); a
   Villum Fonden Blokstipendier grant, and; a Villum Fonden research
   project grant (miGENEPI).
CR Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109
   Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536
   Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342
   Andersson L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0622-4
   Andersson LS, 2012, NATURE, V488, P642, DOI 10.1038/nature11399
   [Anonymous], 2015, 2 REP STAT WORLD AN
   [Anonymous], 2010, HORSE WHEEL LANGUAGE
   [Anonymous], 2009, HORSE HUMAN HIST
   Baird JD, 2010, VET REC, V167, P781, DOI 10.1136/vr.c3447
   Beaumont MA, 2002, GENETICS, V162, P2025
   Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807
   Bellone RR, 2010, BRIEF FUNCT GENOMICS, V9, P193, DOI 10.1093/bfgp/elq002
   Bendrey R, 2012, WORLD ARCHAEOL, V44, P135, DOI 10.1080/00438243.2012.647571
   Binns MM, 2010, ANIM GENET, V41, P154, DOI 10.1111/j.1365-2052.2010.02126.x
   Bollongino R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003418
   Boyle K.V., 2006, P10
   Brandariz-Fontes C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064985
   Brooks SA, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2010.02127.x
   Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203
   Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022
   Cardona A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098076
   Carpenter ML, 2013, AM J HUM GENET, V93, P852, DOI 10.1016/j.ajhg.2013.10.002
   Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526
   Cieslak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015311
   Crubézy E, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-25
   Cruz F, 2008, MOL BIOL EVOL, V25, P2331, DOI 10.1093/molbev/msn177
   Csilléry K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001
   Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]
   Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020
   Faith JT, 2009, P NATL ACAD SCI USA, V106, P20641, DOI 10.1073/pnas.0908153106
   Fegraeus KJ, 2015, J HERED, V106, P734, DOI 10.1093/jhered/esv062
   Firestone RB, 2007, P NATL ACAD SCI USA, V104, P16016, DOI 10.1073/pnas.0706977104
   Flink LG, 2014, P NATL ACAD SCI USA, V111, P6184, DOI 10.1073/pnas.1308939110
   Frantz LAF, 2015, NAT GENET, V47, P1141, DOI 10.1038/ng.3394
   Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993
   Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110
   Gallimore R, 2005, CLIM DYNAM, V25, P755, DOI 10.1007/s00382-005-0054-z
   Gamba C, 2016, MOL ECOL RESOUR, V16, P459, DOI 10.1111/1755-0998.12470
   Gansauge MT, 2014, GENOME RES, V24, P1543, DOI 10.1101/gr.174201.114
   Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038
   Gokhman D, 2016, TRENDS ECOL EVOL, V31, P290, DOI 10.1016/j.tree.2016.01.010
   Gokhman D, 2014, SCIENCE, V344, P523, DOI 10.1126/science.1250368
   Götherström A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243
   Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x
   Guthrie RD, 2006, NATURE, V441, P207, DOI 10.1038/nature04604
   Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106
   Han HY, 2015, ASIAN AUSTRAL J ANIM, V28, P1066, DOI 10.5713/ajas.14.0784
   Heller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062992
   HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0
   Hill EW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-552
   Hill EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008645
   Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x
   Huntley B., 1988, Vegetation History
   Imsland F, 2016, NAT GENET, V48, P152, DOI 10.1038/ng.3475
   Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099
   Jónsson H, 2014, P NATL ACAD SCI USA, V111, P18655, DOI 10.1073/pnas.1412627111
   Kimura B, 2011, P ROY SOC B-BIOL SCI, V278, P50, DOI 10.1098/rspb.2010.0708
   King S.R.B., 2015, IUCN RED LIST THREAT, V2015
   Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415
   Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110
   Kreutzmann N, 2014, ANIM GENET, V45, P460, DOI 10.1111/age.12149
   Kristjansson T, 2014, J ANIM BREED GENET, V131, P415, DOI 10.1111/jbg.12112
   Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231
   Librado P, 2015, P NATL ACAD SCI USA, V112, pE6889, DOI 10.1073/pnas.1513696112
   Lindgren G, 2004, NAT GENET, V36, P335, DOI 10.1038/ng1326
   Lippold S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-328
   Lira J, 2010, MOL ECOL, V19, P64, DOI 10.1111/j.1365-294X.2009.04430.x
   Lister A.M., 1998, Ancient Biomolecules, V2, P267
   Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574
   Lu J, 2006, TRENDS GENET, V22, P126, DOI 10.1016/j.tig.2006.01.004
   Ludwig A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0386
   Ludwig A, 2009, SCIENCE, V324, P485, DOI 10.1126/science.1172750
   Lynch VJ, 2015, CELL REP, V12, P217, DOI 10.1016/j.celrep.2015.06.027
   MacFadden BJ, 2005, SCIENCE, V307, P1728, DOI 10.1126/science.1105458
   Makvandi-Nejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039929
   Malaspinas AS, 2012, GENETICS, V192, P599, DOI 10.1534/genetics.112.140939
   Marsden CD, 2016, P NATL ACAD SCI USA, V113, P152, DOI 10.1073/pnas.1512501113
   McCoy AM, 2014, J HERED, V105, P163, DOI 10.1093/jhered/est075
   McCue ME, 2010, ANIM GENET, V41, P145, DOI 10.1111/j.1365-2052.2010.02124.x
   Mccue ME, 2008, GENOMICS, V91, P458, DOI 10.1016/j.ygeno.2008.01.011
   McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451
   McGivney BA, 2012, ANIM GENET, V43, P810, DOI 10.1111/j.1365-2052.2012.02329.x
   Meadows JRS, 2004, ANIM GENET, V35, P379, DOI 10.1111/j.1365-2052.2004.01180.x
   Meiri M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03035
   Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344
   Natanaelsson C, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-45
   Ollivier M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075110
   Orlando L, 2006, MOL ECOL, V15, P2083, DOI 10.1111/j.1365-294X.2006.02922.x
   Orlando L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0793-z
   Orlando L, 2015, NAT REV GENET, V16, P395, DOI 10.1038/nrg3935
   Orlando L, 2014, SCIENCE, V345, P511, DOI 10.1126/science.1256515
   Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323
   Orlando L, 2009, P NATL ACAD SCI USA, V106, P21754, DOI 10.1073/pnas.0903672106
   Ottoni C, 2013, MOL BIOL EVOL, V30, P824, DOI 10.1093/molbev/mss261
   Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594
   OWENSMITH N, 1987, PALEOBIOLOGY, V13, P351
   Pakendorf B, 2006, HUM GENET, V120, P334, DOI 10.1007/s00439-006-0213-2
   Park SDE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0790-2
   Pedersen JS, 2014, GENOME RES, V24, P454, DOI 10.1101/gr.163592.113
   Petersen JL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054997, 10.1371/journal.pone.0069819, 10.1371/journal.pone.0068620]
   Petersen JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003211
   Promerová M, 2014, ANIM GENET, V45, P274, DOI 10.1111/age.12120
   Pruvost M, 2011, P NATL ACAD SCI USA, V108, P18626, DOI 10.1073/pnas.1108982108
   Ramírez O, 2015, HEREDITY, V114, P175, DOI 10.1038/hdy.2014.81
   Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025
   Römpler H, 2006, NAT PROTOC, V1, P720, DOI 10.1038/nprot.2006.84
   Sandmeyer LS, 2012, VET OPHTHALMOL, V15, P18, DOI 10.1111/j.1463-5224.2011.00903.x
   Sarkissian CD, 2015, CURR BIOL, V25, P2577, DOI 10.1016/j.cub.2015.08.032
   Sarkissian CD, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.1058
   Scheu A, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0203-2
   Schraiber JG, 2016, GENETICS, V203, P493, DOI 10.1534/genetics.116.187278
   Schubert M, 2014, P NATL ACAD SCI USA, V111, pE5661, DOI 10.1073/pnas.1416991111
   Sommer RS, 2011, J QUATERNARY SCI, V26, P805, DOI 10.1002/jqs.1509
   Sundqvist AK, 2006, GENETICS, V172, P1121, DOI 10.1534/genetics.105.042358
   Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650
   Tozaki T, 2010, ANIM GENET, V41, P28, DOI 10.1111/j.1365-2052.2010.02095.x
   Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285
   van den Hoven R, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0428-3
   Vilà C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474
   Vilstrup JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055950
   Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158
   Wallner B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060015
   Warinner C, 2014, SCI REP-UK, V4, DOI 10.1038/srep07104
   Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109
   Warmuth V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018194
   Warmuth VM, 2013, MOL ECOL, V22, P5340, DOI 10.1111/mec.12491
   Weinstock J, 2005, PLOS BIOL, V3, P1373, DOI 10.1371/journal.pbio.0030241
   Zeder MA, 2006, TRENDS GENET, V22, P139, DOI 10.1016/j.tig.2006.01.007
   Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432
NR 130
TC 51
Z9 59
U1 5
U2 126
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0016-6731
EI 1943-2631
J9 GENETICS
JI Genetics
PD OCT
PY 2016
VL 204
IS 2
BP 423
EP 434
DI 10.1534/genetics.116.194860
PG 12
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA DZ4ZP
UT WOS:000385871400006
PM 27729493
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Chatzovoulou, K
   Mayeur, A
   Cagnard, N
   Zarhrate, M
   Bole, C
   Nitschke, P
   Jabot-Hanin, F
   Rötig, A
   Monnot, S
   Munnich, A
   Frydman, N
   Steffann, J
AF Chatzovoulou, Kalliopi
   Mayeur, Anne
   Cagnard, Nicolas
   Zarhrate, Mohammed
   Bole, Christine
   Nitschke, Patrick
   Jabot-Hanin, Fabienne
   Rotig, Agnes
   Monnot, Sophie
   Munnich, Arnold
   Frydman, Nelly
   Steffann, Julie
TI A shared pattern of altered gene expression in human embryos affected by
   mitochondrial diseases
SO HUMAN REPRODUCTION
LA English
DT Article
DE mitochondrial mutation; human embryo development; mitochondrial
   metabolism; transcriptome; RNA sequencing; differential gene expression
ID DNA COPY NUMBER; MUTATION
AB STUDY QUESTION Does mitochondrial deficiency affect human embryonic preimplantation development? SUMMARY ANSWER The presence of a pathogenic mitochondrial variant triggers changes in the gene expression of preimplantation human embryos, compromising their development, cell differentiation, and survival. WHAT IS KNOWN ALREADY Quantitative and qualitative anomalies of mitochondrial DNA (mtDNA) are reportedly associated with impaired human embryonic development, but the underlying mechanisms remain unexplained. STUDY DESIGN, SIZE, DURATION Taking advantage of the preimplantation genetic testing for mitochondrial disorders in at-risk couples, we have compared gene expression of 9 human embryos carrying pathogenic variants in either mtDNA genes or nuclear genes encoding mitochondrial protein to 33 age-matched control embryos. PARTICIPANTS/MATERIALS, SETTING, METHODS Single-embryo transcriptomic analysis was performed on whole human blastocyst embryos donated to research. MAIN RESULTS AND THE ROLE OF CHANCE Specific pathogenic mitochondrial variants downregulate gene expression in preimplantation human embryos [566 genes in oxidative phosphorylation (OXPHOS)-deficient embryos], impacting transcriptional regulators, differentiation factors, and nuclear genes encoding mitochondrial proteins. These changes in gene expression primarily alter OXPHOS and cell survival pathways. LIMITATIONS, REASONS FOR CAUTION The number of OXPHOS-deficient embryos available for the study was limited owing to the rarity of this material. However, the molecular signature shared by all these embryos supports the relevance of the findings. WIDER IMPLICATIONS OF THE FINDINGS While identification of reliable markers of normal embryonic development is urgently needed in ART, our study prompts us to consider under-expression of the targeted genes reported here, as predictive biomarkers of mitochondrial dysfunction during preimplantation development. STUDY FUNDING/COMPETING INTEREST(S) This work was supported by the 'Association Francaise contre les Myopathies (AFM-Telethon)' and the 'La Fondation Maladies Rares'. No competing interests to declare.
C1 [Chatzovoulou, Kalliopi; Rotig, Agnes; Munnich, Arnold; Steffann, Julie] Paris Cite Univ, Imagine Inst, INSERM UMR 1163, Genet Mitochondrial Disorders, Paris, France.
   [Mayeur, Anne] Paris Saclay Univ, Antoine Beclere Hosp, AP HP, Reprod Biol Dept,CECOS, Clamart, France.
   [Cagnard, Nicolas; Nitschke, Patrick; Jabot-Hanin, Fabienne] Paris Cite Univ, Bioinformat Core Facil, INSERM US24, CNRS UMS3633,Struct Federat Rech Necker, Paris, France.
   [Zarhrate, Mohammed; Bole, Christine] Paris Cite Univ, Inst Imagine Struct Federat Rech Necker, Genom Core Facil, INSERM U1163, Paris, France.
   [Zarhrate, Mohammed; Bole, Christine] Paris Descartes Sorbonne Paris Cite Univ, INSERM US24, CNRS UAR3633, Paris, France.
   [Monnot, Sophie; Munnich, Arnold; Steffann, Julie] Necker Enfants Malad Hosp, AP HP, Genom Med Dept, F-75015 Paris, France.
C3 Universite Paris Cite; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite Paris Saclay; Assistance Publique Hopitaux
   Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Centre
   National de la Recherche Scientifique (CNRS); CNRS - National Institute
   for Biology (INSB); Universite Paris Cite; Institut National de la Sante
   et de la Recherche Medicale (Inserm); Institut National de la Sante et
   de la Recherche Medicale (Inserm); Universite Paris Cite; Universite
   Paris Cite; Institut National de la Sante et de la Recherche Medicale
   (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris
   Cite; Hopital Universitaire Necker-Enfants Malades - APHP
RP Steffann, J (corresponding author), Necker Enfants Malad Hosp, AP HP, Genom Med Dept, F-75015 Paris, France.
EM julie.steffann@aphp.fr
RI Steffann, julie/H-1305-2017; ROTIG, AGNES/G-9592-2017; Cagnard,
   Nicolas/K-2754-2014
OI JABOT-HANIN, Fabienne/0000-0001-9294-7135; ROTIG,
   AGNES/0000-0003-0589-0703; Mayeur, Anne/0000-0002-5764-5382; Cagnard,
   Nicolas/0000-0002-9051-1896; Chatzovoulou, Kalliopi/0000-0002-1441-3450
FU 'Association Francaise contre les Myopathies (AFM-Telethon)' [20304];
   Fondation Maladies Rares [GenOmics_202003003]; AFM-Telethon [22112]
FX 'Association Francaise contre les Myopathies (AFM-Telethon)' (grant
   number: 20304); 'Fondation Maladies Rares' (grant number:
   GenOmics_202003003). K.C. was funded by AFM-Telethon (PhD Fellowship, no
   22112).
CR Allshire RC, 2018, NAT REV MOL CELL BIO, V19, P229, DOI 10.1038/nrm.2017.119
   Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037
   Azadi A, 2018, MITOCHONDRIAL DNA A, V29, P674, DOI 10.1080/24701394.2017.1350854
   Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI [10.1242/dev.123547, 10.1242/dev.131235]
   BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0
   Chen SH, 2016, REPROD BIOMED ONLINE, V33, P737, DOI 10.1016/j.rbmo.2016.10.003
   Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7
   Cohen J, 1998, MOL HUM REPROD, V4, P269, DOI 10.1093/molehr/4.3.269
   Feeney CL, 2019, BJOG-INT J OBSTET GY, V126, P1380, DOI 10.1111/1471-0528.15667
   Floros VI, 2018, NAT CELL BIOL, V20, P144, DOI 10.1038/s41556-017-0017-8
   Gigarel N, 2005, MOL GENET METAB, V84, P289, DOI 10.1016/j.ymgme.2004.10.008
   Groff AF, 2019, GENOME RES, V29, P1705, DOI 10.1101/gr.252981.119
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Kuleva M, 2019, BJOG-INT J OBSTET GY, V126, P1372, DOI 10.1111/1471-0528.15515
   Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham
   Monnot S, 2013, HUM MOL GENET, V22, P1867, DOI 10.1093/hmg/ddt040
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Nagaraj R, 2017, CELL, V168, P210, DOI 10.1016/j.cell.2016.12.026
   Petropoulos S, 2016, CELL, V165, P1012, DOI [10.1016/j.cell.2016.08.009, 10.1016/j.cell.2016.03.023]
   Qi SY, 2022, PLOS BIOL, V20, DOI 10.1371/journal.pbio.3001741
   Schulz KN, 2019, NAT REV GENET, V20, P221, DOI 10.1038/s41576-018-0087-x
   Shaw L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064192
   Sirard MA, 2022, REPROD FERT DEVELOP, V34, P203, DOI 10.1071/RD21266
   Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
NR 26
TC 2
Z9 2
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD MAY 2
PY 2023
VL 38
IS 5
BP 992
EP 1002
DI 10.1093/humrep/dead052
EA MAR 2023
PG 11
WC Obstetrics & Gynecology; Reproductive Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Obstetrics & Gynecology; Reproductive Biology
GA AJ6V0
UT WOS:000955082300001
PM 36952633
OA Bronze
DA 2024-11-01
ER

PT J
AU Liu, CH
   Chang, CH
   Kuo, HC
   Ro, LS
   Liou, CW
   Wei, YH
   Huang, CC
AF Liu, Chi-Hung
   Chang, Chien-Hung
   Kuo, Hung-Chou
   Ro, Long-Sun
   Liou, Chia-Wei
   Wei, Yau-Huei
   Huang, Chin-Chang
TI Prognosis of symptomatic patients with the A3243G mutation of
   mitochondrial DNA
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Article
DE A3243G mutation; MELAS; mitochondrial disease; mitochondrial DNA;
   prognosis; seizures; Taiwanese
ID STROKE-LIKE-EPISODES; MELAS-SYNDROME; PEDIATRIC-PATIENTS; CLINICAL
   SPECTRUM; LACTIC-ACIDOSIS; GENE MUTATION; FOLLOW-UP; DISORDERS;
   3243A-GREATER-THAN-G; MANIFESTATIONS
AB Background/Purpose: The clinical analyses and prognoses of mitochondrial diseases with A3243G mutation are rarely documented in Taiwan. Our study investigated the clinical phenotypes and the outcomes of patients with mitochondrial disease and the A3243G mutation of mtDNA in a Taiwanese population, and compared these with previous reports.
   Methods: We retrospectively studied 22 consecutive patients with mitochondrial disease and the A3243G mutation of mtDNA in Chang Gung Memorial Hospital between 1988 and 2009. All patients underwent a detailed demographic registration, neurological examinations, a muscle biopsy, and mitochondrial DNA analysis. Modified Rankin scale, the presence of recurrent strokes or seizures, critical medical complications, and death were monitored during the follow-up period.
   Results: Of the 22 patients, seizures and stroke-like episodes were found in 12 (55%). Visceral involvement, including cardiomyopathy, nephropathy, and pulmonary hypertension, were noted in five patients (23%). Patients with seizures had a high frequency of status epilepticus (92%) and a younger age of onset (21.3 +/- 7.2 years). Both the Kaplan-Meier survival analysis and the Cox-regression model showed a marked deterioration in patients with seizures after 7 years of follow-up.
   Conclusion: Our study found that seizures and status epilepticus are the most important predictive values for a poor outcome in patients with the mtA3243G mutation of mtDNA. Age of onset and visceral organ involvement had no prominent influence on the prognosis. Some medical complications could be well controlled or even reversed after management. Copyright (C) 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.
C1 [Liu, Chi-Hung; Chang, Chien-Hung; Kuo, Hung-Chou; Ro, Long-Sun; Huang, Chin-Chang] Chang Gung Mem Hosp, Dept Neurol, Linkou branch, Tao Yuan, Taiwan.
   [Liou, Chia-Wei] Chang Gung Mem Hosp, Dept Neurol, Kaohsiung branch, Kaohsiung, Taiwan.
   [Wei, Yau-Huei] Mackay Med Coll, Dept Med, Taipei, Taiwan.
   [Wei, Yau-Huei] Natl Yang Ming Univ, Sch Life Sci, Dept Biochem, Taipei 112, Taiwan.
   [Huang, Chin-Chang] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan.
C3 Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Mackay
   Medical College; National Yang Ming Chiao Tung University; Chang Gung
   University
RP Huang, CC (corresponding author), Chang Gung Mem Hosp, Dept Neurol, Chang Gung Mem Hosp, 199 Tung Hua N Rd, Taipei, Taiwan.
EM cch0537@adm.cgmh.org.tw
RI Wei, Yau-Huei/ABA-6841-2021
OI Wei, Yau-Huei/0000-0002-6429-2546
FU National Science Council [NSC 95-2314-B-184A-067]
FX We have no conflicts of interest. The authors are grateful to Ms Y-C
   Hsieh for typing the manuscript. The authors wish to thank Dr Yu-Yi
   Chien (Department of Neurology, Keelung branch, Chang Gung Memorial
   Hospital), Dr Chun-Che Chu, Hong-Shiu Chang, and Jou-Hsien Chen
   (Department of Neurology, Linkou branch, Chang Gung Memorial Hospital)
   for providing some patient information. This study was supported in part
   by a grant from the National Science Council (NSC 95-2314-B-184A-067).
CR Barclay AR, 2005, J INHERIT METAB DIS, V28, P1081, DOI 10.1007/s10545-005-4484-x
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   El Sabbagh S, 2010, EPILEPSIA, V51, P1225, DOI 10.1111/j.1528-1167.2009.02504.x
   FANG W, 1993, ARCH NEUROL-CHICAGO, V50, P977, DOI 10.1001/archneur.1993.00540090074013
   Finsterer J, 2011, EUR J NEUROL, V18, P28, DOI 10.1111/j.1468-1331.2010.03086.x
   Finsterer J, 2009, EUR J NEUROL, V16, P1178, DOI 10.1111/j.1468-1331.2009.02789.x
   Finsterer J, 2010, EPILEPTIC DISORD, V12, P330, DOI 10.1684/epd.2010.0338
   García-Cazorla A, 2005, PEDIATRICS, V116, P1170, DOI 10.1542/peds.2004-2407
   Huang CC, 1996, ACTA NEUROL SCAND, V93, P198
   HUANG CC, 1994, J NEUROL NEUROSUR PS, V57, P586, DOI 10.1136/jnnp.57.5.586
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   Krähenbühl S, 2000, LIVER, V20, P346, DOI 10.1034/j.1600-0676.2000.020004346.x
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   Lin CM, 2007, METAB BRAIN DIS, V22, P105, DOI 10.1007/s11011-006-9039-9
   Majamaa-Voltti K, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.122648
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Sunada Y, 2001, INTERNAL MED, V40, P561, DOI 10.2169/internalmedicine.40.561
   Tay SHK, 2006, ARCH NEUROL-CHICAGO, V63, P281, DOI 10.1001/archneur.63.2.281
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769
   Wang W, 2008, AM J EMERG MED, V26, DOI 10.1016/j.ajem.2007.05.027
   Yu Q, 2007, MITOCHONDRION, V7, P147, DOI 10.1016/j.mito.2006.11.019
NR 25
TC 14
Z9 15
U1 1
U2 4
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD SEP
PY 2012
VL 111
IS 9
BP 489
EP 494
DI 10.1016/j.jfma.2011.06.014
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 032LD
UT WOS:000310719200005
PM 23021505
OA Bronze
DA 2024-11-01
ER

PT J
AU Hattori, Y
   Takeoka, M
   Nakajima, K
   Ehara, T
   Koyama, M
AF Hattori, Y
   Takeoka, M
   Nakajima, K
   Ehara, T
   Koyama, M
TI A heteroplasmic mitochondrial DNA 3310 mutation in the ND1 gene in a
   patient with type 2 diabetes, hypertrophic cardiornyopathy, and mental
   retardation
SO EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
LA English
DT Article
DE type 2 diabetes; hypertrophic cardiomyopathy; left ventricular
   hypertrophy; ND1 gene; heteroplasmic mutation
ID HEREDITARY OPTIC NEUROPATHY; NADH DEHYDROGENASE; COMPLEX-I; MUTATION;
   MELLITUS; LHON
AB A mentally retarded 57-year-old Japanese man with maternally-inherited type 2 diabetes was found to have hypertrophic cardiomyopathy (HCM) that was associated with pathological changes in the myocardial mitochondria. The mitochondrial DNA (mtDNA) of this patient was examined and a C3310T mutation was found in the ND1 gene, which resulted in the substitution of serine for proline. The normal 3310 mtDNA band could not be detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in mtDNA from his myocardium, pancreas, cerebral tissue, skeletal muscle, and lymphocytes. However two clones sequenced from his pancreatic tissue did not show this C3310T mutation while forty-eight did. Mitochondria isolated from the lymphocytes of his two sisters also had this mutation. mtDNA point mutations in the ND1 gene region reported thus far have been mostly homoplasmic. However, the C3310T point mutation that was found in this patient was heteroplasmic, which is a high level of mutation and may represent the pathogenic gene that was responsible for causing mitochondrial disease.
C1 Shinshu Univ, Grad Sch Med, Inst Aging & Adaptat, Dept Mol Oncol,Div Mol & Cellular Biol, Matsumoto, Nagano 390, Japan.
   Asama Gen Hosp, Dept Internal Med, Saku, Japan.
   Shinshu Univ, Sch Med, Dept Histopathol, Matsumoto, Nagano 390, Japan.
   Komoro Kosei Gen Hosp, Dept Pathol, Komoro, Japan.
C3 Shinshu University; Shinshu University
RP Shinshu Univ, Grad Sch Med, Inst Aging & Adaptat, Dept Mol Oncol,Div Mol & Cellular Biol, Asahi 3-1-1, Matsumoto, Nagano 390, Japan.
EM u-chan@avis.ne.jp
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   EARLEY FGP, 1984, BIOCHEM J, V224, P525, DOI 10.1042/bj2240525
   FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I
   Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HANZLIKOVA V, 1977, J ULTRA MOL STRUCT R, V60, P121, DOI 10.1016/S0022-5320(77)80048-8
   Hattori Y, 2003, DIABETES CARE, V26, P952, DOI 10.2337/diacare.26.3.952
   Hirai M, 1996, BIOCHEM BIOPH RES CO, V219, P951, DOI 10.1006/bbrc.1996.0324
   Howell N, 1997, VISION RES, V37, P3495, DOI 10.1016/S0042-6989(96)00167-8
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   KARPATI G, 1974, J NEUROL SCI, V23, P129, DOI 10.1016/0022-510X(74)90148-8
   Kobayashi T, 1997, DIABETES, V46, P1567, DOI 10.2337/diabetes.46.10.1567
   Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226
   Mackey DA, 1996, AM J HUM GENET, V59, P481
   Momiyama Y, 2001, DIABETES CARE, V24, P604, DOI 10.2337/diacare.24.3.604
   NAKAGAWA Y, 1995, BIOCHEM BIOPH RES CO, V209, P664, DOI 10.1006/bbrc.1995.1550
   NIKOSKELAINEN EK, 1994, CLIN NEUROSCI, V2, P115
   RAGAN CI, 1987, CURR TOP BIOENERG, V15, P1
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   SHOFFNER JM, 1998, METABOLIC MOL BASES, P1535
   STADHOUDERS AM, 1994, P NATL ACAD SCI USA, V91, P5089, DOI 10.1073/pnas.91.11.5089
   Torroni A, 1997, AM J HUM GENET, V60, P1107
NR 23
TC 14
Z9 15
U1 0
U2 1
PU JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH
PI STUTTGART
PA RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0947-7349
EI 1439-3646
J9 EXP CLIN ENDOCR DIAB
JI Exp. Clin. Endocrinol. Diabet.
PD JUN
PY 2005
VL 113
IS 6
BP 318
EP 323
DI 10.1055/s-2005-865646
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 939KX
UT WOS:000230072700002
PM 15977098
DA 2024-11-01
ER

PT J
AU Finsterer, J
AF Finsterer, Josef
TI Inherited mitochondrial neuropathies
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Review
DE Neuromuscular; Encephalomyopathy; Metabolic disease; Multisystem
   disease; Mitochondrial DNA; Neuropathy; Nerve conduction
ID KEARNS-SAYRE-SYNDROME; MARIE-TOOTH-DISEASE; ONSET SPINOCEREBELLAR
   ATAXIA; HEREDITARY OPTIC NEUROPATHY; PROGRESSIVE EXTERNAL
   OPHTHALMOPLEGIA; NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY MNGIE;
   SENSORY-MOTOR NEUROPATHY; C-OXIDASE DEFICIENCY; LEIGH-SYNDROME;
   PERIPHERAL NEUROPATHY
AB Mitochondrial disorders (MIDs) occasionally manifest as polyneuropathy either as the dominant feature or as one of many other manifestations (inherited mitochondrial neuropathy). MIDs in which polyneuropathy is the dominant feature, include NARP syndrome due to the transition m.8993T>, CMT2A due to MFN2 mutations, CMT2K and CMT4A due to GDAP1 mutations, and axonal/demyelinating neuropathy with external ophthalmoplegia due to POLG1 mutations. MIDs in which polyneuropathy is an inconstant feature among others is the MELAS syndrome, MERRF syndrome, LHON, Mendelian PEO, KSS, Leigh syndrome, MNGIE, SANDO; MIRAS, MEMSA, AHS, MDS (hepato-cerebral form), IOSCA, and ADOA syndrome. In the majority of the cases polyneuropathy presents in a multiplex neuropathy distribution. Nerve conduction studies may reveal either axonal or demyelinated or mixed types of neuropathies. If a hereditary neuropathy is due to mitochondrial dysfunction, the management of these patients is at variance from non-mitochondrial hereditary neuropathies. Patients with mitochondrial hereditary neuropathy need to be carefully investigated for clinical or subclinical involvement of other organs or systems. Supportive treatment with co-factors, antioxidants, alternative energy sources, or lactate lowering agents can be tried. Involvement of other organs may require specific treatment. Mitochondrial neuropathies should be included in the differential diagnosis of hereditary neuropathies. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
C3 Rudolfstiftung Hospital
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Al-Dosary M, 2009, NEUROMUSCULAR DISORD, V19, P841, DOI 10.1016/j.nmd.2009.10.001
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   [Anonymous], 2003, GENEREVIEWS
   [Anonymous], 2000, GENEREVIEWS
   APPENZELLER O, 1976, ARCH NEUROL-CHICAGO, V33, P733, DOI 10.1001/archneur.1976.00500110001001
   Bedlack RS, 2004, MUSCLE NERVE, V29, P364, DOI 10.1002/mus.10546
   Bhatti MT, 1999, J NEURO-OPHTHALMOL, V19, P28
   Cassereau J, 2011, EXP NEUROL, V227, P31, DOI 10.1016/j.expneurol.2010.09.006
   Cassereau J, 2009, NEUROGENETICS, V10, P145, DOI 10.1007/s10048-008-0166-9
   CHABROL B, 1994, J CHILD NEUROL, V9, P52, DOI 10.1177/088307389400900113
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   Chu CC, 1997, EUR NEUROL, V37, P110, DOI 10.1159/000117420
   COKER SB, 1993, PEDIATR NEUROL, V9, P61, DOI 10.1016/0887-8994(93)90013-3
   Colomer J, 2000, REV NEUROLOGIA, V30, P1117, DOI 10.33588/rn.3012.2000079
   Consalvo D, 1997, MEDICINA-BUENOS AIRE, V57, P67
   Corrado G, 2006, CARDIOLOGY, V105, P142, DOI 10.1159/000091152
   Crimella C, 2010, J MED GENET, V47, P712, DOI 10.1136/jmg.2010.077909
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Debouverie M, 1997, REV NEUROL, V153, P547
   Debray FG, 2007, AM J MED GENET A, V143A, P2046, DOI 10.1002/ajmg.a.31880
   Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   DiTrapani G, 1997, CLIN NEUROPATHOL, V16, P195
   Erol I, 2009, NEUROMUSCULAR DISORD, V19, P275, DOI 10.1016/j.nmd.2009.01.012
   EYMARD B, 1991, REV NEUROL, V147, P508
   Finsterer J, 2005, CLIN NEUROL NEUROSUR, V107, P181, DOI 10.1016/j.clineuro.2004.07.001
   Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x
   Funalot B, 2009, REV NEUROL-FRANCE, V165, P1118, DOI 10.1016/j.neurol.2009.10.001
   Funalot B, 2009, B ACAD NAT MED PARIS, V193, P151, DOI 10.1016/S0001-4079(19)32613-5
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Gelfand JM, 2011, J NEUROL, V258, P440, DOI 10.1007/s00415-010-5775-1
   Gilhuis HJ, 2006, NEUROMUSCULAR DISORD, V16, P394, DOI 10.1016/j.nmd.2006.03.006
   GOEBEL HH, 1986, MUSCLE NERVE, V9, P165, DOI 10.1002/mus.880090210
   Gómez-Zaera M, 2001, MOL GENET METAB, V72, P72, DOI 10.1006/mgme.2000.3107
   Gordon N, 2006, DEV MED CHILD NEUROL, V48, P1001, DOI 10.1017/S0012162206002209
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hakonen Anna H, 2010, Duodecim, V126, P1552
   Hamano H, 1997, Rinsho Shinkeigaku, V37, P917
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   HIRANO M, 1996, HDB MUSCLE DIS, V1, P479
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hourani RG, 2006, NEUROPEDIATRICS, V37, P110, DOI 10.1055/s-2006-924226
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   JACOBS JM, 1990, BRAIN, V113, P447, DOI 10.1093/brain/113.2.447
   JOHNSEN SD, 1993, NEUROLOGY, V43, P1120, DOI 10.1212/WNL.43.6.1120
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Klimek Andrzej, 1997, Polish Journal of Pathology, V48, P197
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507
   Lamperti C, 2009, Acta Myol, V28, P2
   Lawlor M W, 2000, Electromyogr Clin Neurophysiol, V40, P211
   Liguori M, 2008, J NEUROL, V255, P127, DOI 10.1007/s00415-008-0571-x
   Lissens W, 2000, HUM MUTAT, V15, P209, DOI 10.1002/(SICI)1098-1004(200003)15:3<209::AID-HUMU1>3.3.CO;2-B
   Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Makino M, 1998, NEUROMUSCULAR DISORD, V8, P149, DOI 10.1016/S0960-8966(98)00017-0
   Malandrini A, 1998, J NEUROL SCI, V155, P218, DOI 10.1016/S0022-510X(98)00014-8
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mano Atsushi, 2003, Rinsho Shinkeigaku, V43, P564
   McDonald DGM, 2002, AM J MED GENET, V111, P191, DOI 10.1002/ajmg.10522
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Melberg A, 1996, MUSCLE NERVE, V19, P751
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010
   MIZUSAWA H, 1991, REV NEUROL, V147, P501
   MOLNAR M, 1995, NEUROPATH APPL NEURO, V21, P432, DOI 10.1111/j.1365-2990.1995.tb01080.x
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   Nagashima T, 2001, NEUROMUSCULAR DISORD, V11, P470, DOI 10.1016/S0960-8966(01)00190-0
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Naumann M, 1997, MUSCLE NERVE, V20, P833, DOI 10.1002/(SICI)1097-4598(199707)20:7<833::AID-MUS7>3.0.CO;2-8
   Naviaux RK, 2005, ANN NEUROL, V58, P491, DOI 10.1002/ana.20544
   Niemann A, 2009, NEUROBIOL DIS, V36, P509, DOI 10.1016/j.nbd.2009.09.011
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   Okun MS, 2004, AM J OPHTHALMOL, V137, P951, DOI 10.1016/j.ajo.2003.10.046
   Pedrola L, 2005, HUM MOL GENET, V14, P1087, DOI 10.1093/hmg/ddi121
   Peng Y, 2003, MOVEMENT DISORD, V18, P716, DOI 10.1002/mds.10428
   Riera ARP, 2008, J ELECTROCARDIOL, V41, P675, DOI 10.1016/j.jelectrocard.2008.04.001
   Posada IJ, 2010, MED CLIN-BARCELONA, V135, P452, DOI 10.1016/j.medcli.2010.03.031
   Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Reilly MM, 2009, J NEUROL NEUROSUR PS, V80, P1304, DOI 10.1136/jnnp.2008.158295
   Rossi A, 2003, AM J NEURORADIOL, V24, P1188
   RUSANEN H, 1995, NEUROLOGY, V45, P1188, DOI 10.1212/WNL.45.6.1188
   Sahin-Calapoglu N, 2009, NEUROMOL MED, V11, P106, DOI 10.1007/s12017-009-8062-5
   Said G, 2005, J NEUROL, V252, P655, DOI 10.1007/s00415-005-0712-4
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   Santoro L, 2006, J NEUROL, V253, P869, DOI 10.1007/s00415-006-0082-6
   Schoffer K, 2006, MUSCLE NERVE, V33, P142, DOI 10.1002/mus.20406
   SCHRODER JM, 1993, BRAIN PATHOL, V3, P177, DOI 10.1111/j.1750-3639.1993.tb00742.x
   Simonati A, 2003, J NEUROL, V250, P702, DOI 10.1007/s00415-003-1065-5
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spiegel R, 2009, ANN NEUROL, V66, P419, DOI 10.1002/ana.21752
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Stickler DE, 2003, J CHILD NEUROL, V18, P574, DOI 10.1177/08830738030180081101
   Tsao CY, 2001, J CHILD NEUROL, V16, P533, DOI 10.1177/088307380101600716
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Uusimaa J, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e262
   van de Glind G, 2007, EUR J PAEDIATR NEURO, V11, P243, DOI 10.1016/j.ejpn.2007.01.004
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Voo I, 2003, AM J OPHTHALMOL, V136, P670, DOI 10.1016/S0002-9394(03)00390-8
   Wagner KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005160
   Watanabe Yuka, 2009, Brain and Nerve (Tokyo), V61, P309
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Wiedemann FR, 2008, CLIN NEUROL NEUROSUR, V110, P859, DOI 10.1016/j.clineuro.2008.06.010
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Zanssen S, 1998, CLIN NEUROPATHOL, V17, P291
   Zoccolella S, 2006, FUNCT NEUROL, V21, P39
NR 121
TC 46
Z9 49
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD MAY 15
PY 2011
VL 304
IS 1-2
BP 9
EP 16
DI 10.1016/j.jns.2011.02.012
PG 8
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 757GD
UT WOS:000290072600002
PM 21402391
DA 2024-11-01
ER

PT J
AU Pichaud, N
   Bérubé, R
   Côté, G
   Belzile, C
   Dufresne, F
   Morrows, G
   Tanguays, RM
   Rands, DM
   Blier, PU
AF Pichaud, Nicolas
   Berube, Roxanne
   Cote, Genevieve
   Belzile, Claude
   Dufresne, France
   Morrows, Genevieve
   Tanguays, Robert M.
   Rands, David M.
   Blier, Pierre U.
TI Age Dependent Dysfunction of Mitochondrial and ROS Metabolism Induced by
   Mitonuclear Mismatch
SO FRONTIERS IN GENETICS
LA English
DT Article
DE aging; Drosophila; mitochondrial respiration; mitonuclear
   incompatibility; reactive oxygen species; replication; tRNA
ID PERMEABILIZED MUSCLE-FIBERS; XENOMITOCHONDRIAL CYBRIDS;
   DROSOPHILA-SIMULANS; THERMAL SENSITIVITY; DNA REPLICATION; BIOGENESIS;
   MITOPHAGY; DISEASE; FITNESS; POPULATIONS
AB Mitochondrial and nuclear genomes have to coevolve to ensure the proper functioning of the different mitochondrial complexes that are assembled from peptides encoded by both genomes. Mismatch between these genomes is believed to be strongly selected against due to the consequent impairments of mitochondrial functions and induction of oxidative stress. Here, we used a Drosophila model harboring an incompatibility between a mitochondrial tRNA(t)(yr) and its nuclear-encoded mitochondrial tyrosine synthetase to assess the cellular mechanisms affected by this incompatibility and to test the relative contribution of mitonuclear interactions and aging on the expression of impaired phenotypes. Our results show that the mitochondrial tRNA mutation caused a decrease in mitochondrial oxygen consumption in the incompatible nuclear background but no effect with the compatible nuclear background. Mitochondrial DNA copy number increased in the incompatible genotype but that increase failed to rescue mitochondrial functions. The flies harboring mismatch between nuclear and mitochondrial genomes had almost three times the relative mtDNA copy number and fifty percent higher rate of hydrogen peroxide production compared to other genome combinations at 25 days of age. We also found that aging exacerbated the mitochondrial dysfunctions. Our results reveal the tight interactions linking mitonuclear mismatch to mitochondrial dysfunction, mitochondrial DNA regulation, ROS production and aging.
C1 [Pichaud, Nicolas] Univ Moncton, Lab Comparat Biochem & Physiol, Dept Chem & Biochem, Moncton, NB, Canada.
   [Berube, Roxanne; Cote, Genevieve; Blier, Pierre U.] Univ Quebec Rimouski, Lab Physiol Anim Integrat, Dept Biol, Rimouski, PQ, Canada.
   [Belzile, Claude] Univ Quebec Rimouski, Inst Sci Mer Rimouski, Rimouski, PQ, Canada.
   [Dufresne, France] Univ Quebec Rimouski, Lab Ecol Mol, Dept Biol, Rimouski, PQ, Canada.
   [Morrows, Genevieve; Tanguays, Robert M.] Univ Laval, Lab Genet Cellulaire & Dev, Dept Biol Mol Biochim Med & Pathol, Quebec City, PQ, Canada.
   [Rands, David M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.
C3 University of Moncton; University of Quebec; Universite du Quebec a
   Rimouski; University of Quebec; Universite du Quebec a Rimouski;
   University of Quebec; Universite du Quebec a Rimouski; Laval University;
   Brown University
RP Pichaud, N (corresponding author), Univ Moncton, Lab Comparat Biochem & Physiol, Dept Chem & Biochem, Moncton, NB, Canada.; Blier, PU (corresponding author), Univ Quebec Rimouski, Lab Physiol Anim Integrat, Dept Biol, Rimouski, PQ, Canada.
EM Nicolas.pichaud@umoncton.ca; Pierre_blier@uqar.ca
RI Berube, Roxanne/CAJ-2552-2022
OI Belzile, Claude/0000-0003-3908-7433; Pichaud,
   Nicolas/0000-0002-2820-8124; Berube, Roxanne/0000-0002-3715-9600
FU Natural Sciences and Engineering Research Council of Canada [RGPIN
   2017-05-100, RGPIN 155926-2011]; Fonds de Recherche du Quebec - Nature
   et Technologies Quebec team Grant [166783]; CIHR grant
FX All sequences mentioned in this article are available in GenBank
   (KR231637 to KR231660). This work was funded by the Natural Sciences and
   Engineering Research Council of Canada Discovery grant to NP (RGPIN
   2017-05-100) and to PB (RGPIN 155926-2011), and by a Fonds de Recherche
   du Quebec - Nature et Technologies Quebec team Grant (166783) to RT and
   PB. The aging work was partly supported by a CIHR grant to RT.
CR Andreyev AY, 2015, BIOCHEMISTRY-MOSCOW+, V80, P517, DOI 10.1134/S0006297915050028
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Ballard JWO, 2014, FUNCT ECOL, V28, P218, DOI 10.1111/1365-2435.12177
   Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210
   Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Buchanan JL, 2018, INTEGR COMP BIOL, V58, P591, DOI 10.1093/icb/icy078
   Burton RS, 2007, GENE, V403, P53, DOI 10.1016/j.gene.2007.07.026
   Camus MF, 2012, CURR BIOL, V22, P1717, DOI 10.1016/j.cub.2012.07.018
   Chandra A, 2016, HUM MOL GENET, V25, P2269, DOI 10.1093/hmg/ddw095
   Correa CC, 2012, MITOCHONDRION, V12, P459, DOI 10.1016/j.mito.2012.06.005
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Dobler R, 2014, J EVOLUTION BIOL, V27, P2021, DOI 10.1111/jeb.12468
   Ellison CK, 2008, EVOLUTION, V62, P631, DOI 10.1111/j.1558-5646.2007.00305.x
   Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002
   Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Holmbeck MA, 2015, DIS MODEL MECH, V8, P843, DOI 10.1242/dmm.019323
   Horan MP, 2013, EUR J HUM GENET, V21, P1335, DOI 10.1038/ejhg.2013.75
   Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263
   Innocenti P, 2011, SCIENCE, V332, P845, DOI 10.1126/science.1201157
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Lane N, 2011, BIOESSAYS, V33, P860, DOI 10.1002/bies.201100051
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010
   Lemieux H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02789-8
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   McDonald AE, 2018, COMP BIOCHEM PHYS B, V224, P185, DOI 10.1016/j.cbpb.2017.11.006
   McKenzie M, 2003, MOL BIOL EVOL, V20, P1117, DOI 10.1093/molbev/msg132
   Meiklejohn CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003238
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Montooth KL, 2010, EVOLUTION, V64, P3364, DOI 10.1111/j.1558-5646.2010.01077.x
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Moreno-Loshuertos R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001379
   Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322
   Mrácek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014
   Orr AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089938
   Osada N, 2012, MOL BIOL EVOL, V29, P337, DOI 10.1093/molbev/msr211
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Palikaras K, 2014, EXP GERONTOL, V56, P182, DOI 10.1016/j.exger.2014.01.021
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Pichaud N, 2013, MITOCHONDRION, V13, P817, DOI 10.1016/j.mito.2013.05.008
   Pichaud N, 2012, EVOLUTION, V66, P3189, DOI 10.1111/j.1558-5646.2012.01683.x
   Pichaud N, 2011, AM J PHYSIOL-REG I, V301, pR48, DOI 10.1152/ajpregu.00542.2010
   Pichaud N, 2010, J EXP BIOL, V213, P1665, DOI 10.1242/jeb.040261
   Potluri P, 2009, MOL GENET METAB, V96, P189, DOI 10.1016/j.ymgme.2008.12.004
   Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003
   Rand DM, 2001, ANNU REV ECOL SYST, V32, P415, DOI 10.1146/annurev.ecolsys.32.081501.114109
   Sackton TB, 2003, EVOLUTION, V57, P2315
   Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001
   Simard CJ, 2018, JOVE-J VIS EXP, DOI 10.3791/57376
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wolff JN, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0443
   Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011
   Zhang CY, 2017, DEVELOPMENT, V144, P2490, DOI 10.1242/dev.151951
   Zhu CT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004354
NR 61
TC 37
Z9 39
U1 0
U2 16
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD FEB 20
PY 2019
VL 10
AR 130
DI 10.3389/fgene.2019.00130
PG 12
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA HM0XR
UT WOS:000459171500001
PM 30842791
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Castro, MG
   Terrados, N
   Reguero, JR
   Alvarez, V
   Coto, E
AF Castro, Monica G.
   Terrados, Nicolas
   Reguero, Julian R.
   Alvarez, Victoria
   Coto, Eliecer
TI Mitochondrial haplogroup T is negatively associated with the status of
   elite endurance athlete
SO MITOCHONDRION
LA English
DT Article
DE mitochondrial DNA; endurance capacity; mitochondrial haplogroups;
   genetic association
ID FAMILIAL RESEMBLANCE; RISK; POLYMORPHISMS; PERFORMANCE; CAPACITY;
   DISEASE; VO2MAX; MUSCLE
AB Mitochondrial function is absolutely necessary to supply the energy required for muscles, and germ line mutations in mitochondrial genes have been related with impaired cardiac function and exercise intolerance. In addition, alleles at several polymorphic sites in mtDNA define nine common haplogroups, and some of these haplogroups have been implicated in the risk of developing several diseases. In this study, we analysed the association between mtHaplogroups and the capacity to reach the status of elite endurance athlete. DNA was obtained from blood leukocytes of 95 Spanish elite endurance athletes and 250 healthy male population controls. We analysed eight mitochondrial polymorphisms and the frequencies were statistically compared between elite athletes and controls. Haplogroup T, specifically defined by 13368A, was significantly less frequent among elite endurance athletes (p = 0.012, Fisher's exact test). Our study suggests that allele 13368A and mitochondrial haplogroup T might be a marker negatively associated with the status of elite endurance athlete. This mitochondrial variant could be related with a lower capacity to respond to endurance training, through unknown mechanisms involving a less efficient mitochondrial workload. (c) 2007 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 Univ Oviedo, Hosp Cent Asturias, Inst Mol Genet Estudios Nefrol, E-33080 Oviedo, Spain.
   Funt Univ, Dept Biol, Oviedo, Spain.
   Fdn Dep Municipal Aviles, Aviles, Spain.
   Univ Oviedo, Hosp Cent Asturias, E-33080 Oviedo, Spain.
C3 University of Oviedo; Central University Hospital Asturias; University
   of Oviedo; Central University Hospital Asturias
RP Coto, E (corresponding author), Univ Oviedo, Hosp Cent Asturias, Inst Mol Genet Estudios Nefrol, E-33080 Oviedo, Spain.
EM eliecer.coto@sespa.princast.es
RI alvarez, victoria/GXV-1088-2022; Terrados, Nicolas/R-6778-2018; alvarez,
   victoria/ABC-7891-2021
OI Terrados, Nicolas/0000-0002-2730-3410; Castro, Maria
   Graciela/0000-0003-2237-2756; alvarez, victoria/0000-0002-1916-2523
CR Alvarez R, 2000, EUR J APPL PHYSIOL, V82, P117, DOI 10.1007/s004210050660
   Bouchard C, 1998, MED SCI SPORT EXER, V30, P252, DOI 10.1097/00005768-199802000-00013
   BOUCHARD C, 1986, MED SCI SPORT EXER, V18, P639
   Castro MG, 2006, INT J CARDIOL, V112, P202, DOI 10.1016/j.ijcard.2005.09.008
   di Prampero PE, 2003, EUR J APPL PHYSIOL, V90, P420, DOI 10.1007/s00421-003-0926-z
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DIONNE FT, 1991, MED SCI SPORT EXER, V23, P177
   HAMEL P, 1986, MED SCI SPORT EXER, V18, P690
   HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831
   Hoppeler H, 1998, J EXP BIOL, V201, P1051
   HOPPELER H, 1985, J APPL PHYSIOL, V59, P320, DOI 10.1152/jappl.1985.59.2.320
   LESAGE R, 1985, HUM HERED, V35, P182, DOI 10.1159/000153540
   LORTIE G, 1984, INT J SPORTS MED, V5, P232, DOI 10.1055/s-2008-1025911
   Montgomery HE, 1998, NATURE, V393, P221, DOI 10.1038/30374
   Murakami H, 2001, JPN J PHYSIOL, V51, P563, DOI 10.2170/jjphysiol.51.563
   Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308
   Nishigaki Y, 2007, MITOCHONDRION, V7, P72, DOI 10.1016/j.mito.2006.11.002
   Rankinen T, 2004, MED SCI SPORT EXER, V36, P1451, DOI 10.1249/01.MSS.0000139902.42385.5F
   Rivera MA, 1998, MED SCI SPORT EXER, V30, P687, DOI 10.1097/00005768-199805000-00007
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040
   Scott RA, 2005, COMP BIOCHEM PHYS B, V140, P497, DOI 10.1016/j.cbpc.2004.11.014
   Torroni A, 1996, GENETICS, V144, P1835
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Zoll J, 2002, J PHYSIOL-LONDON, V543, P191, DOI 10.1113/jphysiol.2002.019661
NR 26
TC 43
Z9 47
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP
PY 2007
VL 7
IS 5
BP 354
EP 357
DI 10.1016/j.mito.2007.06.002
PG 4
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 217RG
UT WOS:000249964400008
PM 17660050
OA Bronze
DA 2024-11-01
ER

PT J
AU Yao, YG
   Ellison, FM
   McCoy, JP
   Chen, JC
   Young, NS
AF Yao, Yong-Gang
   Ellison, Felicia M.
   McCoy, J. Philip
   Chen, Jichun
   Young, Neal S.
TI Age-dependent accumulation of mtDNA mutations in murine hematopoietic
   stem cells is modulated by the nuclear genetic background
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID MITOCHONDRIAL-DNA MUTATIONS; POINT MUTATIONS; DEGENERATIVE DISEASES;
   OXIDATIVE STRESS; SKELETAL-MUSCLE; CONTROL REGION; MICE; REPLICATION;
   SEQUENCE; SENESCENCE
AB Alterations in mitochondrial DNA (mtDNA) and consequent loss of mitochondrial function underlie the mitochondrial theory of aging. In this study, we systematically analyzed the mtDNA control region somatic mutation pattern in 2864 single hematopoietic stem cells (HSCs) and progenitors, isolated by flow cytometry sorting on Lin(-)Kit(+)CD34(-) parameters from young and old C57BL/6 (B6) and BALB/cBy (BALB) mice, to test the hypothesis that the accumulated mtDNA mutations in HSCs were strain-correlated and associated with HSC functional senescence during aging. An increased level of mtDNA mutations in single HSCs was observed in old B6 when compared with young B6 mice (P=0.003); in contrast, no significant age-dependent accumulation of mutations was observed in BALB mice (old versus young, P=0.202) and the level of mutations in both young and old BALB mice was close to that of old B6 mice (P > 0.280). Cellular reactive oxygen species (ROS) in mouse HSCs could not be correlated with the level of mtDNA mutations in these cells, although B6 mice had a higher proportion of ROS- cells when compared with the BALB mice. Propagation assays of single HSCs showed B6 cells form larger colonies compared with cells from BALB mice, irrespective of age and mtDNA mutation load. We infer from our data that age-related mtDNA somatic mutation accumulation in mouse HSCs is influenced by the nuclear genetic background and that these mutations may not obviously correlate to either cellular ROS content or HSC senescence.
C1 NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA.
   NHLBI, Flow Cytometry Core Facil, NIH, Bethesda, MD 20892 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Heart Lung &
   Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH
   National Heart Lung & Blood Institute (NHLBI)
RP Yao, YG (corresponding author), NHLBI, Hematol Branch, NIH, Bldg 10 CRC,Rm 3E-5140,10 Ctr Dr, Bethesda, MD 20892 USA.
EM yaoy3@nhlbi.nih.gov
RI mccoy, john/ABD-9348-2021; Yao, Yong-Gang/AAH-2303-2021
OI Yao, Yong-Gang/0000-0002-2955-0693
CR Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, P5349, DOI 10.1093/nar/gkg739
   Berkahn Leanne, 2004, Hematology, V9, P159, DOI 10.1080/10245330410001701468
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655
   Chen JC, 1999, EXP HEMATOL, V27, P928, DOI 10.1016/S0301-472X(99)00018-1
   Chen JC, 2000, EXP HEMATOL, V28, P442, DOI 10.1016/S0301-472X(99)00157-5
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   de Grey ADNJ, 2004, REJUV RES, V7, P171, DOI 10.1089/rej.2004.7.171
   Dick JE, 2005, INT J HEMATOL, V82, P389, DOI 10.1532/IJH97.05144
   Driver C, 2004, BIOESSAYS, V26, P1160, DOI 10.1002/bies.20149
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   HARRISON DE, 1989, J IMMUNOL, V142, P3833
   Howes RM, 2006, ANN NY ACAD SCI, V1067, P22, DOI 10.1196/annals.1354.004
   Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282
   Lin PH, 2003, FREE RADICAL BIO MED, V35, P1310, DOI 10.1016/j.freeradbiomed.2003.07.002
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011
   Mott JL, 2001, MUTAT RES-FUND MOL M, V474, P35, DOI 10.1016/S0027-5107(00)00159-7
   Nagley P, 1998, TRENDS GENET, V14, P513, DOI 10.1016/S0168-9525(98)01580-7
   Ogasawara Y, 2005, BLOOD, V106, P3271, DOI 10.1182/blood-2005-01-0150
   Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242
   Pak JW, 2003, AGING CELL, V2, P1, DOI 10.1046/j.1474-9728.2003.00034.x
   Pallotti F, 1996, AM J HUM GENET, V59, P591
   Shin MG, 2004, BLOOD, V103, P553, DOI 10.1182/blood-2003-05-1724
   Song XF, 2005, GENE, V350, P193, DOI 10.1016/j.gene.2005.02.008
   Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trifunovic A, 2006, BBA-BIOENERGETICS, V1757, P611, DOI 10.1016/j.bbabio.2006.03.003
   Van Zant G, 2003, INT J HEMATOL, V77, P29, DOI 10.1007/BF02982600
   Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Yao YG, 2007, BLOOD, V109, P756, DOI 10.1182/blood-2006-01-011007
   Zhang D, 2003, CARDIOVASC RES, V57, P147, DOI 10.1016/S0008-6363(02)00695-8
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
   Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399
NR 47
TC 26
Z9 33
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD FEB 1
PY 2007
VL 16
IS 3
BP 286
EP 294
DI 10.1093/hmg/ddl457
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 135AK
UT WOS:000244126000005
PM 17185390
OA Bronze
DA 2024-11-01
ER

PT J
AU Vianello, C
   Cocetta, V
   Caicci, F
   Boldrin, F
   Montopoli, M
   Martinuzzi, A
   Carelli, V
   Giacomello, M
AF Vianello, Caterina
   Cocetta, Veronica
   Caicci, Federico
   Boldrin, Francesco
   Montopoli, Monica
   Martinuzzi, Andrea
   Carelli, Valerio
   Giacomello, Marta
TI Interaction between Mitochondrial DNA Variants and
   Mitochondria/Endoplasmic Reticulum Contact Sites: A Perspective Review
SO DNA AND CELL BIOLOGY
LA English
DT Review
DE mtDNA; mitochondria; ER contacts; LHON disease; haplogroup
ID HEREDITARY OPTIC NEUROPATHY; MTDNA MUTATIONS; ANTIOXIDANT DEFENSES;
   MITOFUSIN 2; COMPLEX-I; GLUTAMATE TRANSPORT; LIPID-PEROXIDATION;
   SKELETAL-MUSCLE; ER MEMBRANES; RISK
AB Mitochondria contain their own genome, mitochondrial DNA (mtDNA), essential to support their fundamental intracellular role in ATP production and other key metabolic and homeostatic pathways. Mitochondria are highly dynamic organelles that communicate with all the other cellular compartments, through sites of high physical proximity. Among all, their crosstalk with the endoplasmic reticulum (ER) appears particularly important as its derangement is tightly implicated with several human disorders. Population-specific mtDNA variants clustered in defining the haplogroups have been shown to exacerbate or mitigate these pathological conditions. The exact mechanisms of the mtDNA background-modifying effect are not completely clear and a possible explanation is the outcome of mitochondrial efficiency on retrograde signaling to the nucleus. However, the possibility that different haplogroups shape the proximity and crosstalk between mitochondria and the ER has never been proposed neither investigated. In this study, we pose and discuss this question and provide preliminary data to answer it. Besides, we also address the possibility that single, disease-causing mtDNA point mutations may act also by reshaping organelle communication. Overall, this perspective review provides a theoretical platform for future studies on the interaction between mtDNA variants and organelle contact sites.
C1 [Vianello, Caterina; Caicci, Federico; Boldrin, Francesco; Giacomello, Marta] Univ Padua, Dept Biol, Via Ugo Bassi 58b, I-35121 Padua, Italy.
   [Cocetta, Veronica; Montopoli, Monica] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy.
   [Montopoli, Monica] VIMM Veneto Inst Mol Med, Padua, Italy.
   [Martinuzzi, Andrea] IRCCS E Medea Sci Inst, Dept Neurorehabil, Conegliano Res Ctr, Treviso, Italy.
   [Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Bologna, Italy.
   [Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, UOC Clin Neurol, Bologna, Italy.
   [Giacomello, Marta] Univ Padua, Dept Biomed Sci, Via Ugo Bassi 58b, I-35121 Padua, Italy.
C3 University of Padua; University of Padua; IRCCS Eugenio Medea;
   University of Bologna; IRCCS Istituto delle Scienze Neurologiche di
   Bologna (ISNB); University of Padua
RP Giacomello, M (corresponding author), Univ Padua, Dept Biol, Via Ugo Bassi 58b, I-35121 Padua, Italy.; Giacomello, M (corresponding author), Univ Padua, Dept Biomed Sci, Via Ugo Bassi 58b, I-35121 Padua, Italy.
EM marta.giacomello@unipd.it
RI GIACOMELLO, MARTA/HGB-1486-2022; Montopoli, Monica/W-9666-2019;
   Martinuzzi, Andrea/K-3887-2016
OI Giacomello, Marta/0000-0002-0290-6602; Martinuzzi,
   Andrea/0000-0002-0319-3579; COCETTA, VERONICA/0000-0002-0350-8403;
   MONTOPOLI, MONICA/0000-0001-6182-4132
FU Ministry of Health; CARIPARO Starting Grant 2016 AIFbiol; Unipd STARS
   Consolidator FIRMESs; PRIN 2017 FS5SHL "RADIUS''; PRID 2018
   [MONT_SID18_01]
FX This work was supported by the Ministry of Health (Ricerca corrente) to
   V.C.: to M.G., CARIPARO Starting Grant 2016 AIFbiol; Unipd STARS
   Consolidator FIRMESs and PRIN 2017 FS5SHL "RADIUS''; to M.M., PRID 2018,
   MONT_SID18_01.
CR Ademowo OS, 2017, BIOGERONTOLOGY, V18, P859, DOI 10.1007/s10522-017-9710-z
   Anderson EJ, 2012, CLIN EXP PHARMACOL P, V39, P179, DOI 10.1111/j.1440-1681.2011.05641.x
   Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202
   Arruda AP, 2015, CELL METAB, V22, P381, DOI 10.1016/j.cmet.2015.06.010
   Asterholm IW, 2012, CELL METAB, V15, P171, DOI 10.1016/j.cmet.2012.01.004
   Bantug GR, 2018, IMMUNITY, V48, P542, DOI 10.1016/j.immuni.2018.02.012
   Barodia SK, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01171
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258
   Beretta S, 2006, NEUROBIOL DIS, V24, P308, DOI 10.1016/j.nbd.2006.07.016
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020
   Caboni P, 2004, CHEM RES TOXICOL, V17, P1540, DOI 10.1021/tx049867r
   Cárdenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007
   Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Carelli V, 1997, NEUROLOGY, V48, P1623, DOI 10.1212/WNL.48.6.1623
   Carelli V, 2018, ESSAYS BIOCHEM, V62, P235, DOI 10.1042/EBC20170097
   Carrì MT, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00041
   Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463
   Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K
   Chakraborty J, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809014
   Chinnery PF, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00682
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Coxhead J, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.036
   Crispim D, 2006, ANN HUM GENET, V70, P488, DOI 10.1111/j.1469-1809.2005.00249.x
   Csordás G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   ESPOSTI MD, 1994, FEBS LETT, V352, P375, DOI 10.1016/0014-5793(94)00971-6
   Fernández-Caggiano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044128
   Floreani M, 2005, FEBS J, V272, P1124, DOI 10.1111/j.1742-4658.2004.04542.x
   Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385
   Fu ZJ, 2021, J LIPID RES, V62, DOI 10.1194/jlr.TR120000618
   Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Giacomello M, 2016, CELL DEATH DIFFER, V23, P1417, DOI 10.1038/cdd.2016.52
   Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7
   Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Gómez-Suaga P, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0079-3
   Granatiero V, 2016, CELL DEATH DIFFER, V23, P231, DOI 10.1038/cdd.2015.84
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110
   Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910
   Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002
   Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb
   HRUSZKEWYCZ AM, 1988, BIOCHEM BIOPH RES CO, V153, P191, DOI 10.1016/S0006-291X(88)81207-5
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128
   Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35
   Larrea D, 2019, HUM MOL GENET, V28, P1782, DOI 10.1093/hmg/ddz008
   Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549
   Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051
   Man PYW, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011247
   Mancuso M, 2004, NEUROSCI LETT, V371, P158, DOI 10.1016/j.neulet.2004.08.060
   Mancuso R, 2015, PROG NEUROBIOL, V133, P1, DOI 10.1016/j.pneurobio.2015.07.004
   Martin WF, 2017, J THEOR BIOL, V434, P2, DOI 10.1016/j.jtbi.2017.01.004
   McMahon FJ, 2000, AM J PSYCHIAT, V157, P1058, DOI 10.1176/appi.ajp.157.7.1058
   Moltedo O, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00172
   Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030874
   Müller-Nedebock AC, 2019, NEUROCHEM INT, V129, DOI 10.1016/j.neuint.2019.104495
   Naon D, 2016, P NATL ACAD SCI USA, V113, P11249, DOI 10.1073/pnas.1606786113
   Nardelli C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/631082
   Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512
   Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Potluri P, 2009, MOL GENET METAB, V96, P189, DOI 10.1016/j.ymgme.2008.12.004
   Prudent J, 2017, CURR OPIN CELL BIOL, V47, P52, DOI 10.1016/j.ceb.2017.03.007
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007
   Ravera S, 2019, J NEUROCHEM, V151, P336, DOI 10.1111/jnc.14819
   ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5
   Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   RUSINOL AE, 1994, J BIOL CHEM, V269, P27494
   Sala-Vila A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27351
   Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003
   Schon EA, 2013, MOL CELL NEUROSCI, V55, P26, DOI 10.1016/j.mcn.2012.07.011
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sebastián D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109
   SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101
   Sood A, 2014, P NATL ACAD SCI USA, V111, P16017, DOI 10.1073/pnas.1408061111
   Strobbe D, 2018, NEUROBIOL DIS, V114, P129, DOI 10.1016/j.nbd.2018.02.010
   Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630
   Szczepanowska J, 2012, BBA-BIOENERGETICS, V1817, P1740, DOI 10.1016/j.bbabio.2012.02.028
   Tambini MD, 2016, EMBO REP, V17, P27, DOI 10.15252/embr.201540614
   Torroni A, 1996, GENETICS, V144, P1835
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   Tubbs E, 2017, J MOL ENDOCRINOL, V58, pR87, DOI 10.1530/JME-16-0189
   Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014
   Vergani L, 2004, EUR J BIOCHEM, V271, P3646, DOI 10.1111/j.1432-1033.2004.04298.x
   Vielhaber S, 1999, J NEUROL SCI, V169, P133, DOI 10.1016/S0022-510X(99)00236-1
   Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   Wallace R, 2013, MATHEMATICAL APPROACH TO MULTILEVEL, MULTISCALE HEALTH INTERVENTIONS: PHARMACEUTICAL INDUSTRY DECLINE AND POLICY RESPONSE, P1
   Wang YW, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00232
   Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x
   Winanto, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2383-6
   Wong-Ekkabut J, 2007, BIOPHYS J, V93, P4225, DOI 10.1529/biophysj.107.112565
   Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Zhou L, 1997, J NEUROSCI, V17, P7746
NR 112
TC 3
Z9 3
U1 0
U2 8
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1044-5498
EI 1557-7430
J9 DNA CELL BIOL
JI DNA Cell Biol.
PD AUG 1
PY 2020
VL 39
IS 8
BP 1431
EP 1443
DI 10.1089/dna.2020.5614
EA JUN 2020
PG 13
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA MU1AS
UT WOS:000546064200001
PM 32598172
DA 2024-11-01
ER

PT J
AU Sciacco, M
   Prelle, A
   Fagiolari, G
   Bordoni, A
   Crimi, M
   Di Fonzo, A
   Ciscato, P
   Lamperti, C
   D'Adda, E
   Jann, S
   Bresolin, N
   Comi, GP
   Moggio, M
AF Sciacco, M
   Prelle, A
   Fagiolari, G
   Bordoni, A
   Crimi, M
   Di Fonzo, A
   Ciscato, P
   Lamperti, C
   D'Adda, E
   Jann, S
   Bresolin, N
   Comi, GP
   Moggio, M
TI A case of CPT deficiency, homoplasmic mtDNA mutation and ragged red
   fibers at muscle biopsy
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE myoglobinuria; CPT deficiency; mitochondrial disorder; RRFs
ID II DEFICIENCY; IDENTIFICATION; RHABDOMYOLYSIS; GENE
AB A 45-year-old male patient had all episode of acute renal failure with myoglobinuria, myalgias, weakness, and markedly increased serum CK levels. Similar episodes had occurred in the past.
   Carnitine palmitoyl-transferase II (CPT II) deficiency was documented both biochemically and genetically. Interestingly, muscle biopsy also showed some ragged red fibers (RRF) and complete mitochondrial DNA (mtDNA) sequence disclosed a homoplasmic T3394C point mutation. This mutation is described in Leber's hereditary optic neuropathy (LHON) or in patients with diabetes mellitus. (c) 2005 Elsevier B.V. All rights reserved.
C1 Fdn IRCCS, Osped Maggiore, Policlin Mangiagalli & Regina Elena, Dipartimento Neurosci,Ctr Dino Ferrari, I-20122 Milan, Italy.
   IRCCS, Ist E Medea, Bosisio Parini, LC, Italy.
   Osped Maggiore Niguarda, Div Neurol, Milan, Italy.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Eugenio Medea
RP Fdn IRCCS, Osped Maggiore, Policlin Mangiagalli & Regina Elena, Dipartimento Neurosci,Ctr Dino Ferrari, Via Francesco Sforza 35, I-20122 Milan, Italy.
EM maurizio.moggio@unimi.it
RI Padovani, Alessandro/ABI-7312-2020; Crimi, Marco/A-4032-2008; Di Fonzo,
   Alessio/A-5702-2013; Sciacco, Monica/AAC-6500-2022; Comi,
   Giacomo/K-5702-2016; lamperti, costanza/J-8801-2016
OI prelle, alessandro/0000-0002-7019-5291; Comi,
   Giacomo/0000-0002-1383-5248; Di Fonzo, Alessio/0000-0001-6478-026X;
   Sciacco, Monica/0000-0003-4593-4977; Bresolin,
   Nereo/0000-0001-6694-3595; Crimi, Marco/0000-0001-6903-9163
FU Telethon [GTF02008] Funding Source: Medline
CR CAREY MP, 1987, J NEUROL NEUROSUR PS, V50, P1060, DOI 10.1136/jnnp.50.8.1060
   CRIMI M, 2002, HUM MUTAT, V50, P409
   Engel A.G. F-AC., 1994, Myology, V2nd
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   Ohkubo K, 2001, CLIN CHEM, V47, P1641
   Servidei Serenella, 2004, Neuromuscul Disord, V14, P107
   Smeets RJP, 2003, J HUM GENET, V48, P8, DOI 10.1007/s100380300001
   TARONI F, 1993, NAT GENET, V4, P314, DOI 10.1038/ng0793-314
   Warren JD, 2002, MUSCLE NERVE, V25, P332, DOI 10.1002/mus.10053
   Yang BZ, 1998, MOL GENET METAB, V64, P229, DOI 10.1006/mgme.1998.2711
NR 10
TC 11
Z9 13
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD DEC 15
PY 2005
VL 239
IS 1
BP 21
EP 24
DI 10.1016/j.jns.2005.07.008
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 989DC
UT WOS:000233652100004
PM 16168441
DA 2024-11-01
ER

PT J
AU Sohl, CD
   Kasiviswanathan, R
   Copeland, WC
   Anderson, KS
AF Sohl, Christal D.
   Kasiviswanathan, Rajesh
   Copeland, William C.
   Anderson, Karen S.
TI Mutations in human DNA polymerase γ confer unique mechanisms of
   catalytic deficiency that mirror the disease severity in mitochondrial
   disorder patients
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; REVERSE-TRANSCRIPTASE;
   AUTOSOMAL-DOMINANT; POLG1 MUTATIONS; TOXICITY; REPLICATION; DEFECTS;
   SUBUNIT; DISCRIMINATION; PARKINSONISM
AB Human mitochondrial DNA polymerase gamma (pol gamma) is solely responsible for the replication and repair of the mitochondrial genome. Unsurprisingly, alterations in pol gamma activity have been associated with mitochondrial diseases such as Alpers syndrome and progressive external ophthalmoplegia. Thus far, predicting the severity of mitochondrial disease based the magnitude of deficiency in pol gamma activity has been difficult. In order to understand the relationship between disease severity in patients and enzymatic defects in vitro, we characterized the molecular mechanisms of four pol gamma mutations, A957P, A957S, R1096C and R1096H, which have been found in patients suffering from aggressive Alpers syndrome to mild progressive external ophthalmoplegia. The A957P mutant showed the most striking deficiencies in the incorporation efficiency of a correct deoxyribonucleotide triphosphate (dNTP) relative to wild-type pol gamma, with less, but still significant incorporation efficiency defects seen in R1096H and R1096C, and only a small decrease in incorporation efficiency observed for A957S. Importantly, this trend matches the disease severity observed in patients very well (approximated as A957P >> R1096C >= R1096H >> A957S, from most severe disease to least severe). Further, the A957P mutation conferred a two orders of magnitude loss of fidelity relative to wild-type pol gamma, indicating that a buildup of mitochondrial genomic mutations may contribute to the death in infancy seen with these patients. We conclude that characterizing the unique molecular mechanisms of pol gamma deficiency for physiologically important mutant enzymes is important for understanding mitochondrial disease and for predicting disease severity.
C1 [Sohl, Christal D.; Anderson, Karen S.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA.
   [Kasiviswanathan, Rajesh; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, DHHS, Res Triangle Pk, NC 27709 USA.
C3 Yale University; National Institutes of Health (NIH) - USA; NIH National
   Institute of Environmental Health Sciences (NIEHS)
RP Anderson, KS (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.
EM karen.anderson@yale.edu
RI Copeland, William/C-4242-2019
OI Copeland, William/0000-0002-0359-0953
FU National Institutes of Health [GM049551, GM099289, ES 065080]
FX This work was supported by the National Institutes of Health (GM049551
   to K.S.A., GM099289 to C.D.S., ES 065080 to W.C.C.).
CR Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565
   Bailey CM, 2010, BBA-PROTEINS PROTEOM, V1804, P1213, DOI 10.1016/j.bbapap.2010.01.007
   Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   Batabyal D, 2010, J BIOL CHEM, V285, P34191, DOI 10.1074/jbc.M110.156182
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Estep PA, 2011, BIOCHEMISTRY-US, V50, P6376, DOI 10.1021/bi200280r
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Graves SW, 1998, BIOCHEMISTRY-US, V37, P6050, DOI 10.1021/bi972685u
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003
   Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Li Y, 2004, NAT STRUCT MOL BIOL, V11, P784, DOI 10.1038/nsmb792
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Rajender S, 2010, MITOCHONDRION, V10, P419, DOI 10.1016/j.mito.2010.05.015
   Ray AS, 2002, J BIOL CHEM, V277, P40479, DOI 10.1074/jbc.M205303200
   Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488
   Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71
   Smits BW, 2011, NEUROMUSCULAR DISORD, V21, P272, DOI 10.1016/j.nmd.2010.12.008
   Sohl CD, 2012, MOL PHARMACOL, V82, P125, DOI 10.1124/mol.112.078758
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
NR 46
TC 13
Z9 15
U1 0
U2 12
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAR 15
PY 2013
VL 22
IS 6
BP 1074
EP 1085
DI 10.1093/hmg/dds509
PG 12
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 108MD
UT WOS:000316296600002
PM 23208208
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Ameur, A
   Stewart, JB
   Freyer, C
   Hagström, E
   Ingman, M
   Larsson, NG
   Gyllensten, U
AF Ameur, Adam
   Stewart, James B.
   Freyer, Christoph
   Hagstrom, Erik
   Ingman, Max
   Larsson, Nils-Goran
   Gyllensten, Ulf
TI Ultra-Deep Sequencing of Mouse Mitochondrial DNA: Mutational Patterns
   and Their Origins
SO PLOS GENETICS
LA English
DT Article
ID SOMATIC MTDNA MUTATIONS; SKELETAL-MUSCLE; POINT MUTATIONS; DELETIONS;
   MICE; TRANSCRIPTION; REPLICATION; POLYMERASE; INCREASE; DISEASE
AB Somatic mutations of mtDNA are implicated in the aging process, but there is no universally accepted method for their accurate quantification. We have used ultra-deep sequencing to study genome-wide mtDNA mutation load in the liver of normally-and prematurely-aging mice. Mice that are homozygous for an allele expressing a proof-reading-deficient mtDNA polymerase (mtDNA mutator mice) have 10-times-higher point mutation loads than their wildtype siblings. In addition, the mtDNA mutator mice have increased levels of a truncated linear mtDNA molecule, resulting in decreased sequence coverage in the deleted region. In contrast, circular mtDNA molecules with large deletions occur at extremely low frequencies in mtDNA mutator mice and can therefore not drive the premature aging phenotype. Sequence analysis shows that the main proportion of the mutation load in heterozygous mtDNA mutator mice and their wildtype siblings is inherited from their heterozygous mothers consistent with germline transmission. We found no increase in levels of point mutations or deletions in wildtype C57Bl/6N mice with increasing age, thus questioning the causative role of these changes in aging. In addition, there was no increased frequency of transversion mutations with time in any of the studied genotypes, arguing against oxidative damage as a major cause of mtDNA mutations. Our results from studies of mice thus indicate that most somatic mtDNA mutations occur as replication errors during development and do not result from damage accumulation in adult life.
C1 [Ameur, Adam; Ingman, Max; Gyllensten, Ulf] Uppsala Univ, Rudbeck Lab, SciLifeLab Uppsala, Dept Immunol Genet & Pathol, Uppsala, Sweden.
   [Stewart, James B.; Freyer, Christoph; Larsson, Nils-Goran] Max Planck Inst Biol Ageing, Cologne, Germany.
   [Hagstrom, Erik; Larsson, Nils-Goran] Karolinska Inst, Dept Lab Med, Div Metab Dis, Stockholm, Sweden.
C3 SciLifeLab; Uppsala University; Max Planck Society; Karolinska
   Institutet
RP Ameur, A (corresponding author), Uppsala Univ, Rudbeck Lab, SciLifeLab Uppsala, Dept Immunol Genet & Pathol, Uppsala, Sweden.
EM ulf.gyllensten@igp.uu.se
RI Larsson, Nils-Göran/GVS-5578-2022; Ameur, Adam/E-6207-2011; Stewart,
   Jim/C-9633-2011
OI Ameur, Adam/0000-0001-6085-6749; Larsson,
   Nils-Goran/0000-0001-5100-996X; Freyer, Christoph/0000-0003-0418-1673;
   Stewart, Jim/0000-0002-2902-4968
FU Swedish Research Council (VR); Knut and Alice Wallenberg Foundation,
   through the Center for Metagenomic Sequence Analysis (CMS); ERC
FX This study was supported by Swedish Research Council (VR) grants (to UG
   and N-GL) and the Knut and Alice Wallenberg Foundation, through the
   Center for Metagenomic Sequence Analysis (CMS), as well as an ERC
   Advanced Investigator grant to N-GL. The funders had no role in study
   design, data collection, decision to publish, or preparation of the
   manuscript.
CR Ameur A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r34
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, P5349, DOI 10.1093/nar/gkg739
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Edgar D, 2010, CELL METAB, V11, P1, DOI 10.1016/j.cmet.2009.12.001
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jensen-Seaman MI, 2009, J MOL EVOL, V68, P688, DOI 10.1007/s00239-009-9243-4
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x
   Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukat A, 2009, EXP GERONTOL, V44, P101, DOI 10.1016/j.exger.2008.05.006
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   NAKASE H, 1990, AM J HUM GENET, V46, P418
   PIKO L, 1992, ANN NY ACAD SCI, V663, P450, DOI 10.1111/j.1749-6632.1992.tb38698.x
   ROVIO AT, 2006, DNA POLYMERASE GAMMA
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vermulst M, 2009, CELL METAB, V10, P437, DOI 10.1016/j.cmet.2009.11.001
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 39
TC 136
Z9 163
U1 0
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD MAR
PY 2011
VL 7
IS 3
AR e1002028
DI 10.1371/journal.pgen.1002028
PG 9
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 743DD
UT WOS:000288996600057
PM 21455489
OA gold, Green Submitted, Green Published
DA 2024-11-01
ER

EF